PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Quinones, MM; Winston, JT; Stromhaug, PE				Quinones, Mariana Morales; Winston, Jared T.; Stromhaug, Per E.			Propeptide of Aminopeptidase 1 Protein Mediates Aggregation and Vesicle Formation in Cytoplasm-to-Vacuole Targeting Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; IN-VIVO; SELECTIVE AUTOPHAGY; CELL-DEATH; ANTIBACTERIAL AUTOPHAGY; ENDOPLASMIC-RETICULUM; QUATERNARY STRUCTURE; MAGNETIC-RESONANCE; ALPHA-MANNOSIDASE; TRANSPORT	Misfolded protein aggregation causes disease and aging; autophagy counteracts this by eliminating damaged components, enabling cells to survive starvation. The cytoplasm-to-vacuole targeting pathway in yeast encompasses the aggregation of the premature form of aminopeptidase 1 (prApe1) in cytosol and its sequestration by autophagic proteins into a vesicle for vacuolar transport. We show that the propeptide of Ape1 is important for aggregation and vesicle formation and that it is sufficient for binding to prApe1 and Atg19. Defective aggregation disrupts vacuolar transport, suggesting that aggregate shape is important in vesicle formation, whereas Atg19 binding is not sufficient for vacuolar transport. Aggregation involves hydrophobicity, whereas Atg19 binding requires additional electrostatic interactions. Ape1 dodecamerization may cluster propeptides into trimeric structures, with sufficient affinity to form propeptide hexamers by binding to other dodecamers, causing aggregation. We show that Ape1 aggregates bind Atg19 and Atg8 in vitro; this could be used as a scaffold for an in vitro assay of autophagosome formation to elucidate the mechanisms of autophagy.	[Quinones, Mariana Morales; Winston, Jared T.; Stromhaug, Per E.] Univ Missouri, Dept Biol Sci, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia	Stromhaug, PE (corresponding author), SUNY Binghamton, POB 6000, Binghamton, NY 13902 USA.	per@binghamton.edu						Adachi W, 2007, ACTA CRYSTALLOGR F, V63, P200, DOI 10.1107/S1744309107005441; Amar N, 2006, EMBO REP, V7, P635, DOI 10.1038/sj.embor.7400698; Andrei-Selmer C, 2001, J BIOL CHEM, V276, P11606, DOI 10.1074/jbc.M003846200; BABA M, 1994, J CELL BIOL, V124, P903, DOI 10.1083/jcb.124.6.903; Baumeister W, 2000, TRENDS BIOCHEM SCI, V25, P624, DOI 10.1016/S0968-0004(00)01720-5; Beeler T, 1997, BBA-BIOMEMBRANES, V1323, P310, DOI 10.1016/S0005-2736(96)00199-X; Bhatia D, 2009, ANGEW CHEM INT EDIT, V48, P4134, DOI 10.1002/anie.200806000; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Broering JM, 2005, J PHYS CHEM B, V109, P20612, DOI 10.1021/jp053618+; Chang CY, 2007, MOL BIOL CELL, V18, P919, DOI 10.1091/mbc.E06-08-0683; CHANG YH, 1989, J BIOL CHEM, V264, P6979; Collins KD, 2004, METHODS, V34, P300, DOI 10.1016/j.ymeth.2004.03.021; Coury LA, 1999, FEMS MICROBIOL LETT, V179, P327, DOI 10.1111/j.1574-6968.1999.tb08745.x; CROWTHER RA, 1981, J CELL BIOL, V91, P790, DOI 10.1083/jcb.91.3.790; CUEVA R, 1989, FEBS LETT, V259, P125, DOI 10.1016/0014-5793(89)81510-8; Dalby KN, 2010, AUTOPHAGY, V6, P322, DOI 10.4161/auto.6.3.11625; DAVISSALINAS J, 1995, J NEUROCHEM, V65, P931; Deretic V, 2008, SCI AM, V298, P74, DOI 10.1038/scientificamerican0508-74; Dikic I, 2010, CANCER RES, V70, P3431, DOI 10.1158/0008-5472.CAN-09-4027; EILAM Y, 1982, MICROBIOS, V35, P99; ELSKENS MT, 1991, J GEN MICROBIOL, V137, P637, DOI 10.1099/00221287-137-3-637; Farre JC, 2007, AUTOPHAGY, V3, P230, DOI 10.4161/auto.3905; Fornasari MS, 2004, MOL BIOL EVOL, V21, P97, DOI 10.1093/molbev/msg244; Gonzalez B, 2000, YEAST, V16, P483, DOI 10.1002/(SICI)1097-0061(200004)16:6<483::AID-YEA542>3.0.CO;2-E; GREENFIELD NJ, 1987, BIOCHIM BIOPHYS ACTA, V926, P205, DOI 10.1016/0304-4165(87)90205-4; Haji-Akbari A, 2009, NATURE, V462, P773, DOI 10.1038/nature08641; Harding TM, 1996, J BIOL CHEM, V271, P17621, DOI 10.1074/jbc.271.30.17621; Hayward AP, 2009, SEMIN CELL DEV BIOL, V20, P1041, DOI 10.1016/j.semcdb.2009.04.012; Hino T, 2004, ACTA CRYSTALLOGR D, V60, P803, DOI 10.1107/S0907444904003233; Hofmeister F, 1888, ARCH EXP PATHOL PHAR, V25, P1, DOI [10.1007/BF01918191, DOI 10.1007/BF01918191]; Huang J, 2011, AUTOPHAGY, V7, P17, DOI 10.4161/auto.7.1.13840; Huang THJ, 2000, J BIOL CHEM, V275, P36436, DOI 10.1074/jbc.M005698200; Hutchins MU, 2001, J BIOL CHEM, V276, P20491, DOI 10.1074/jbc.M101150200; Kageyama T, 2009, BIOCHEM BIOPH RES CO, V378, P551, DOI 10.1016/j.bbrc.2008.11.084; Kentsis A, 2004, CURR PROTEIN PEPT SC, V5, P125, DOI 10.2174/1389203043486856; Kim J, 1997, J CELL BIOL, V137, P609, DOI 10.1083/jcb.137.3.609; Kim J, 2002, J BIOL CHEM, V277, P763, DOI 10.1074/jbc.M109134200; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Kuhn RJ, 2005, ADV VIRUS RES, V64, P263, DOI 10.1016/S0065-3527(05)64008-0; Lang F, 2007, J AM COLL NUTR, V26, p613S, DOI 10.1080/07315724.2007.10719667; Liu B, 2010, ACTA PHARMACOL SIN, V31, P1154, DOI 10.1038/aps.2010.118; Lunemann JD, 2007, ANN NEUROL, V61, P476, DOI 10.1002/ana.21115; Lynch-Day MA, 2010, FEBS LETT, V584, P1359, DOI 10.1016/j.febslet.2010.02.013; Martinez E, 1997, J MOL BIOL, V267, P1124, DOI 10.1006/jmbi.1997.0925; Mazon MJ, 2007, MOL MICROBIOL, V63, P1069, DOI 10.1111/j.1365-2958.2006.05580.x; Meijer WH, 2007, AUTOPHAGY, V3, P106, DOI 10.4161/auto.3595; Menzies FM, 2010, BRAIN, V133, P93, DOI 10.1093/brain/awp292; METZ G, 1977, Z NATURFORSCH C, V32, P929; Milne JLS, 2002, EMBO J, V21, P5587, DOI 10.1093/emboj/cdf574; Moelbert S, 2004, BIOPHYS CHEM, V112, P45, DOI 10.1016/j.bpc.2004.06.012; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Newcomb WW, 1996, J MOL BIOL, V263, P432, DOI 10.1006/jmbi.1996.0587; Noda NN, 2008, GENES CELLS, V13, P1211, DOI 10.1111/j.1365-2443.2008.01238.x; Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256; Oda MN, 1996, J CELL BIOL, V132, P999, DOI 10.1083/jcb.132.6.999; Okorokov LA, 1997, FEMS MICROBIOL LETT, V146, P39, DOI 10.1016/S0378-1097(96)00437-5; OLZ R, 1993, J BACTERIOL, V175, P2205, DOI 10.1128/JB.175.8.2205-2213.1993; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Perez-Jimenez R, 2004, BIOPHYS J, V86, P2414, DOI 10.1016/S0006-3495(04)74298-8; Pyo JO, 2005, J BIOL CHEM, V280, P20722, DOI 10.1074/jbc.M413934200; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Raman S, 2006, NANOMED-NANOTECHNOL, V2, P95, DOI 10.1016/j.nano.2006.04.007; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; ROOMANS GM, 1976, J CELL SCI, V21, P119; Schu P, 2008, METHOD ENZYMOL, V451, P67, DOI 10.1016/S0076-6879(08)03206-0; Schweers RL, 2007, P NATL ACAD SCI USA, V104, P19500, DOI 10.1073/pnas.0708818104; Scott SV, 2001, MOL CELL, V7, P1131, DOI 10.1016/S1097-2765(01)00263-5; Shahnazari S, 2011, AUTOPHAGY, V7, P331, DOI 10.4161/auto.7.3.14045; Shahnazari S, 2010, CELL HOST MICROBE, V8, P137, DOI 10.1016/j.chom.2010.07.002; Shintani T, 2004, J BIOL CHEM, V279, P29889, DOI 10.1074/jbc.M404399200; Shintani T, 2002, DEV CELL, V3, P825, DOI 10.1016/S1534-5807(02)00373-8; Sunder S, 1996, MOL CELL BIOCHEM, V158, P121; Talloczy Z, 2006, AUTOPHAGY, V2, P24, DOI 10.4161/auto.2176; Theobald U, 1996, BIOTECHNOL TECH, V10, P297; Thurston TLM, 2009, NAT IMMUNOL, V10, P1215, DOI 10.1038/ni.1800; Tunnicliffe HE, 1925, BIOCHEM J, V19, P194, DOI 10.1042/bj0190194; van Eunen K, 2010, FEBS J, V277, P749, DOI 10.1111/j.1742-4658.2009.07524.x; Vrbka L, 2006, J PHYS CHEM B, V110, P7036, DOI 10.1021/jp0567624; Walz J, 1997, MOL CELL, V1, P59, DOI 10.1016/S1097-2765(00)80007-6; Wang T, 2009, J CELL BIOL, V186, P703, DOI 10.1083/jcb.200904090; Watanabe Y, 2010, J BIOL CHEM, V285, P30026, DOI 10.1074/jbc.M110.143545; Wild P, 2011, SCIENCE, V333, P228, DOI 10.1126/science.1205405; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Yorimitsu T, 2005, MOL BIOL CELL, V16, P1593, DOI 10.1091/mbc.E04-11-1035; Yuga M, 2011, J BIOL CHEM, V286, P13704, DOI 10.1074/jbc.M110.173906; Zheng YT, 2009, J IMMUNOL, V183, P5909, DOI 10.4049/jimmunol.0900441; Zhou HX, 2005, PROTEINS, V61, P69, DOI 10.1002/prot.20500	88	16	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10121	10133		10.1074/jbc.M111.311696	http://dx.doi.org/10.1074/jbc.M111.311696			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22123825	Green Published, hybrid			2022-12-27	WOS:000302167200044
J	Chen, HK; Liu, ZP; Meyer-Franke, A; Brodbeck, J; Miranda, RD; McGuire, JG; Pleiss, MA; Ji, ZS; Balestra, ME; Walker, DW; Xu, Q; Jeong, DE; Budamagunta, MS; Voss, JC; Freedman, SB; Weisgraber, KH; Huang, YD; Mahley, RW				Chen, Hung-Kai; Liu, Zhaoping; Meyer-Franke, Anke; Brodbeck, Jens; Miranda, Rene D.; McGuire, James G.; Pleiss, Michael A.; Ji, Zhong-Sheng; Balestra, Maureen E.; Walker, David W.; Xu, Qin; Jeong, Dah-eun; Budamagunta, Madhu S.; Voss, John C.; Freedman, Stephen B.; Weisgraber, Karl H.; Huang, Yadong; Mahley, Robert W.			Small Molecule Structure Correctors Abolish Detrimental Effects of Apolipoprotein E4 in Cultured Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL ALZHEIMER-DISEASE; SITE SPECIFIC CHAPERONE; ALPHA-GALACTOSIDASE-A; E TYPE-4 ALLELE; MUTANT P53; DOMAIN INTERACTION; FABRY-DISEASE; NEURITE OUTGROWTH; TRANSGENIC MICE; PHARMACOLOGICAL CHAPERONE	Apolipoprotein E4 (apoE4), the major genetic risk factor for late onset Alzheimer disease, assumes a pathological conformation, intramolecular domain interaction. ApoE4 domain interaction mediates the detrimental effects of apoE4, including decreased mitochondrial cytochrome c oxidase subunit 1 levels, reduced mitochondrial motility, and reduced neurite outgrowth in vitro. Mutant apoE4 (apoE4-R61T) lacks domain interaction, behaves like apoE3, and does not cause detrimental effects. To identify small molecules that inhibit domain interaction (i.e. structure correctors) and reverse the apoE4 detrimental effects, we established a high throughput cell-based FRET primary assay that determines apoE4 domain interaction and secondary cell- and function-based assays. Screening a ChemBridge library with the FRET assay identified CB9032258 (a phthalazinone derivative), which inhibits domain interaction in neuronal cells. In secondary functional assays, CB9032258 restored mitochondrial cytochrome c oxidase subunit 1 levels and rescued impairments of mitochondrial motility and neurite outgrowth in apoE4-expressing neuronal cells. These benefits were apoE4-specific and dose-dependent. Modifying CB9032258 yielded well defined structure-activity relationships and more active compounds with enhanced potencies in the FRET assay (IC50 of 23 and 116 nM, respectively). These compounds efficiently restored functional activities of apoE4-expressing cells in secondary assays. An EPR binding assay showed that the apoE4 structure correction resulted from direct interaction of a phthalazinone. With these data, a six-feature pharmacophore model was constructed for future drug design. Our results serve as a proof of concept that pharmacological intervention with apoE4 structure correctors negates apoE4 detrimental effects in neuronal cells and could be further developed as an Alzheimer disease therapeutic.	[Xu, Qin; Weisgraber, Karl H.; Huang, Yadong; Mahley, Robert W.] Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Chen, Hung-Kai; Liu, Zhaoping; Meyer-Franke, Anke; Brodbeck, Jens; Miranda, Rene D.; McGuire, James G.; Pleiss, Michael A.; Ji, Zhong-Sheng; Balestra, Maureen E.; Walker, David W.; Xu, Qin; Jeong, Dah-eun; Freedman, Stephen B.; Weisgraber, Karl H.; Huang, Yadong; Mahley, Robert W.] Gladstone Ctr Translat Res, San Francisco, CA 94158 USA; [Weisgraber, Karl H.; Huang, Yadong; Mahley, Robert W.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Mahley, Robert W.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Huang, Yadong] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Weisgraber, Karl H.; Mahley, Robert W.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Budamagunta, Madhu S.; Voss, John C.] Univ Calif Davis, Dept Biol Chem, Sch Med, Davis, CA 95616 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Davis	Mahley, RW (corresponding author), Gladstone Inst Neurol Dis, 1650 Owens St, San Francisco, CA 94158 USA.	rmahley@gladstone.ucsf.edu	Brodbeck, Jens/AAB-9275-2020; Budamagunta, Madhu S/C-4628-2011; liu, zhao/GXV-6141-2022	Voss, John/0000-0001-9279-209X; Chen, Hung-Kai/0000-0002-2169-4924	National Institutes of Health [P01 AG022074]; Merck Research Laboratories; NATIONAL INSTITUTE ON AGING [R01AG029246, P01AG022074] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merck Research Laboratories(Merck & Company); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Program Project Grant P01 AG022074. This work was also supported by Merck Research Laboratories.	[Anonymous], 2009, MOL THER, V17, P1309; Askari H, 2007, VIRCHOWS ARCH, V451, P823, DOI 10.1007/s00428-007-0468-6; Bales KR, 1999, P NATL ACAD SCI USA, V96, P15233, DOI 10.1073/pnas.96.26.15233; BELLOSTA S, 1995, J BIOL CHEM, V270, P27063, DOI 10.1074/jbc.270.45.27063; Benjamin ER, 2009, J INHERIT METAB DIS, V32, P424, DOI 10.1007/s10545-009-1077-0; Bien-Ly N, 2011, P NATL ACAD SCI USA, V108, P4236, DOI 10.1073/pnas.1018381108; Boeckler FM, 2008, P NATL ACAD SCI USA, V105, P10360, DOI 10.1073/pnas.0805326105; BRADY RO, 1967, NEW ENGL J MED, V276, P1163, DOI 10.1056/NEJM196705252762101; Brecht WJ, 2004, J NEUROSCI, V24, P2527, DOI 10.1523/JNEUROSCI.4315-03.2004; Brodbeck J, 2008, P NATL ACAD SCI USA, V105, P1343, DOI 10.1073/pnas.0709906104; Brodbeck J, 2011, J BIOL CHEM, V286, P17217, DOI 10.1074/jbc.M110.217380; Brown CJ, 2009, NAT REV CANCER, V9, P862, DOI 10.1038/nrc2763; Buttini M, 1999, J NEUROSCI, V19, P4867; Bykov VJN, 2005, J BIOL CHEM, V280, P30384, DOI 10.1074/jbc.M501664200; Bykov VJN, 2002, NAT MED, V8, P282, DOI 10.1038/nm0302-282; Chang SJ, 2005, P NATL ACAD SCI USA, V102, P18694, DOI 10.1073/pnas.0508254102; Chen HK, 2011, J BIOL CHEM, V286, P5215, DOI 10.1074/jbc.M110.151084; Clayton T, 2007, CURR MED CHEM, V14, P2755, DOI 10.2174/092986707782360097; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; DONG LM, 1994, J BIOL CHEM, V269, P22358; Dong LM, 1996, J BIOL CHEM, V271, P19053, DOI 10.1074/jbc.271.32.19053; Fan JQ, 2003, METHOD ENZYMOL, V363, P412; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Fossa P, 2001, QUANT STRUCT-ACT REL, V20, P17, DOI 10.1002/1521-3838(200105)20:1<17::AID-QSAR17>3.3.CO;2-O; Foster BA, 1999, SCIENCE, V286, P2507, DOI 10.1126/science.286.5449.2507; Guner O, 2004, CURR MED CHEM, V11, P2991, DOI 10.2174/0929867043364036; Harris FM, 2004, J BIOL CHEM, V279, P3862, DOI 10.1074/jbc.M309475200; Harris FM, 2003, P NATL ACAD SCI USA, V100, P10966, DOI 10.1073/pnas.1434398100; Hatters DM, 2005, J BIOL CHEM, V280, P26477, DOI 10.1074/jbc.M503910200; Hatters DM, 2005, J BIOL CHEM, V280, P34288, DOI 10.1074/jbc.M506044200; HOLTZMAN DM, 1995, P NATL ACAD SCI USA, V92, P9480, DOI 10.1073/pnas.92.21.9480; Holtzman DM, 2000, P NATL ACAD SCI USA, V97, P2892, DOI 10.1073/pnas.050004797; Huang YD, 2010, TRENDS MOL MED, V16, P287, DOI 10.1016/j.molmed.2010.04.004; Huang YD, 2001, P NATL ACAD SCI USA, V98, P8838, DOI 10.1073/pnas.151254698; Hughes D, 2010, J INHERIT METAB DIS, V33, pS148; Irizarry MC, 2000, ACTA NEUROPATHOL, V100, P451, DOI 10.1007/s004010000263; Ishii S, 2004, BBA-MOL BASIS DIS, V1690, P250, DOI 10.1016/j.bbadis.2004.07.001; Ji ZS, 2002, J BIOL CHEM, V277, P21821, DOI 10.1074/jbc.M112109200; Kalid O, 2010, J COMPUT AID MOL DES, V24, P971, DOI 10.1007/s10822-010-9390-0; Khanna R, 2010, MOL THER, V18, P23, DOI 10.1038/mt.2009.220; Lambert JMR, 2010, ONCOGENE, V29, P1329, DOI 10.1038/onc.2009.425; Lambert JMR, 2009, CANCER CELL, V15, P376, DOI 10.1016/j.ccr.2009.03.003; Lee JY, 2007, B KOR CHEM SOC, V28, P379; LEMANSKY P, 1987, J BIOL CHEM, V262, P2062; Li G, 2009, CELL STEM CELL, V5, P634, DOI 10.1016/j.stem.2009.10.015; Li Y, 2002, CURR PHARM DESIGN, V8, P99, DOI 10.2174/1381612023396546; Mahley RW, 2009, ANN NEUROL, V65, P623, DOI 10.1002/ana.21736; Mahley RW, 2009, J LIPID RES, V50, pS183, DOI 10.1194/jlr.R800069-JLR200; Mahley RW, 2006, P NATL ACAD SCI USA, V103, P5644, DOI 10.1073/pnas.0600549103; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Martin Y., 2007, COMPR MED CHEM 2, V4, P119; Morrow JA, 1999, PROTEIN EXPRES PURIF, V16, P224, DOI 10.1006/prep.1999.1069; Mosconi L, 2008, ANN NY ACAD SCI, V1147, P180, DOI 10.1196/annals.1427.007; NATHAN BP, 1995, J BIOL CHEM, V270, P19791, DOI 10.1074/jbc.270.34.19791; NATHAN BP, 1994, SCIENCE, V264, P850, DOI 10.1126/science.8171342; Nicolotti O, 2004, CURR TOP MED CHEM, V4, P335, DOI 10.2174/1568026043451384; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; Pedemonte N, 2010, AM J PHYSIOL-CELL PH, V298, pC866, DOI 10.1152/ajpcell.00404.2009; Raber J, 1998, P NATL ACAD SCI USA, V95, P10914, DOI 10.1073/pnas.95.18.10914; Raber J, 2000, NATURE, V404, P352, DOI 10.1038/35006165; Raffai RL, 2001, P NATL ACAD SCI USA, V98, P11587, DOI 10.1073/pnas.201279298; Reiman EM, 2005, P NATL ACAD SCI USA, V102, P8299, DOI 10.1073/pnas.0500579102; Reiman EM, 2004, P NATL ACAD SCI USA, V101, P284, DOI 10.1073/pnas.2635903100; Riordan JR, 2008, ANNU REV BIOCHEM, V77, P701, DOI 10.1146/annurev.biochem.75.103004.142532; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Singh N, 2008, J MOL GRAPH MODEL, V27, P131, DOI 10.1016/j.jmgm.2008.03.007; SMALL GW, 1995, JAMA-J AM MED ASSOC, V273, P942, DOI 10.1001/jama.273.12.942; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Van Goor F, 2006, AM J PHYSIOL-LUNG C, V290, pL1117, DOI 10.1152/ajplung.00169.2005; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vossel KA, 2010, SCIENCE, V330, P198, DOI 10.1126/science.1194653; Wang W, 2008, CURR OPIN ONCOL, V20, P90, DOI 10.1097/CCO.0b013e3282f31d6f; WEISGRABER KH, 1994, ADV PROTEIN CHEM, V45, P249; Wiman KG, 2010, ONCOGENE, V29, P4245, DOI 10.1038/onc.2010.188; Wolber G, 2008, DRUG DISCOV TODAY, V13, P23, DOI 10.1016/j.drudis.2007.09.007; Xu Q, 2004, J BIOL CHEM, V279, P25511, DOI 10.1074/jbc.M311256200; Yam GHF, 2005, FASEB J, V19, P12, DOI 10.1096/fj.04-2375com; Ye SM, 2005, P NATL ACAD SCI USA, V102, P18700, DOI 10.1073/pnas.0508693102; Zarate YA, 2008, LANCET, V372, P1427, DOI 10.1016/S0140-6736(08)61589-5; Zhang J, 2002, NAT REV MOL CELL BIO, V3, P906, DOI 10.1038/nrm976; Zhong N, 2008, ALZHEIMERS DEMENT, V4, P179, DOI 10.1016/j.jalz.2008.01.006; Zhong N, 2009, J BIOL CHEM, V284, P6027, DOI 10.1074/jbc.R800009200	83	94	97	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5253	5266		10.1074/jbc.M111.276162	http://dx.doi.org/10.1074/jbc.M111.276162			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22158868	Green Published, hybrid			2022-12-27	WOS:000300638000008
J	Foveau, B; Boulay, G; Pinte, S; Van Rechem, C; Rood, BR; Leprince, D				Foveau, Benedicte; Boulay, Gaylor; Pinte, Sebastien; Van Rechem, Capucine; Rood, Brian R.; Leprince, Dominique			The Receptor Tyrosine Kinase EphA2 Is a Direct Target Gene of Hypermethylated in Cancer 1 (HIC1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR GENE; HUMAN BREAST-CANCER; CLINICAL-SIGNIFICANCE; CARCINOMA-CELLS; LIGAND-BINDING; EXPRESSION; GROWTH; METHYLATION; INVASION; MICE	The tumor suppressor gene hypermethylated in cancer 1 (HIC1), which encodes a transcriptional repressor, is epigenetically silenced in many human tumors. Here, we show that ectopic expression of HIC1 in the highly malignant MDA-MB-231 breast cancer cell line severely impairs cell proliferation, migration, and invasion in vitro. In parallel, infection of breast cancer cell lines with a retrovirus expressing HIC1 also induces decreased mRNA and protein expression of the tyrosine kinase receptor EphA2. Moreover, chromatin immunoprecipitation (ChIP) and sequential ChIP experiments demonstrate that endogenous HIC1 proteins are bound, together with the MTA1 corepressor, to the EphA2 promoter in WI38 cells. Taken together, our results identify EphA2 as a new direct target gene of HIC1. Finally, we observe that inactivation of endogenous HIC1 through RNA interference in normal breast epithelial cells results in the up-regulation of EphA2 and is correlated with increased cellular migration. To conclude, our results involve the tumor suppressor HIC1 in the transcriptional regulation of the tyrosine kinase receptor EphA2, whose ligand ephrin-A1 is also a HIC1 target gene. Thus, loss of the regulation of this Eph pathway through HIC1 epigenetic silencing could be an important mechanism in the pathogenesis of epithelial cancers.	[Foveau, Benedicte; Boulay, Gaylor; Pinte, Sebastien; Van Rechem, Capucine; Leprince, Dominique] Univ Lille 2, Univ Lille 1, CNRS, UMR 8161,Inst Pasteur Lille,Inst Biol Lille, F-59021 Lille, France; [Rood, Brian R.] George Washington Univ, Childrens Natl Med Ctr, Sch Med, Washington, DC 20010 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Children's National Health System; George Washington University	Leprince, D (corresponding author), Univ Lille 2, Univ Lille 1, CNRS, UMR 8161,Inst Pasteur Lille,Inst Biol Lille, BP 447, F-59021 Lille, France.	dominique.leprince@ibl.fr		Van Rechem, Capucine/0000-0002-5408-6124; Leprince, Dominique/0000-0002-1999-0775	National Institutes of Health from NINDS [1K08NS051477]; CNRS; Association for International Cancer Research; Association pour la Recherche Contre le Cancer [ARC 3983, ARC 1081]; CNRS/Region Nord-Pas de Calais; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS051477] Funding Source: NIH RePORTER	National Institutes of Health from NINDS; CNRS(Centre National de la Recherche Scientifique (CNRS)); Association for International Cancer Research; Association pour la Recherche Contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); CNRS/Region Nord-Pas de Calais(Centre National de la Recherche Scientifique (CNRS)Region Hauts-de-France); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1K08NS051477 from NINDS (for work performed in the laboratory of B. R. R.). This work was also supported by CNRS, the Association for International Cancer Research), and the Association pour la Recherche Contre le Cancer Grants ARC 3983 and ARC 1081 (to D. L.).; Supported by fellowships from the CNRS/Region Nord-Pas de Calais and from the Association pour la Recherche Contre le Cancer. Present address: Harvard Medical School and Massachusetts General Hospital Cancer Center, Charlestown, MA 02129.	ANDRES AC, 1994, ONCOGENE, V9, P1461; Annamalai B, 2009, MOL CANCER RES, V7, P1021, DOI 10.1158/1541-7786.MCR-08-0582; BAE SN, 1993, BREAST CANCER RES TR, V24, P241, DOI 10.1007/BF01833264; Beauchamp A., 2011, SEMIN CELL IN PRESS; Bin Fang W, 2008, J BIOL CHEM, V283, P16017, DOI 10.1074/jbc.M709934200; Boulay G, 2012, J BIOL CHEM, V287, P5379, DOI 10.1074/jbc.M111.304287; Brantley-Sieders D, 2004, CURR PHARM DESIGN, V10, P3431, DOI 10.2174/1381612043383160; Brantley-Sieders DM, 2008, J CLIN INVEST, V118, P64, DOI 10.1172/JCI33154; Brantley-Sieders Dana M., 2004, Angiogenesis, V7, P17, DOI 10.1023/B:AGEN.0000037340.33788.87; Brieger J, 2010, ORAL ONCOL, V46, P678, DOI 10.1016/j.oraloncology.2010.06.016; Briggs KJ, 2008, CANCER RES, V68, P8654, DOI 10.1158/0008-5472.CAN-08-1904; Briones VR, 2006, BIOCHEM BIOPH RES CO, V345, P595, DOI 10.1016/j.bbrc.2006.04.052; Carles-Kinch K, 2002, CANCER RES, V62, P2840; Chen Jin, 2008, Cancer Res, V68, P10031, DOI 10.1158/0008-5472.CAN-08-3010; Chen WY, 2005, CELL, V123, P437, DOI 10.1016/j.cell.2005.08.011; Chen WY, 2003, NAT GENET, V33, P197, DOI 10.1038/ng1077; Dahl JA, 2007, STEM CELLS, V25, P1037, DOI 10.1634/stemcells.2006-0430; Deltour S, 1999, P NATL ACAD SCI USA, V96, P14831, DOI 10.1073/pnas.96.26.14831; Deltour S, 2002, MOL CELL BIOL, V22, P4890, DOI 10.1128/MCB.22.13.4890-4901.2002; Dohn M, 2001, ONCOGENE, V20, P6503, DOI 10.1038/sj.onc.1204816; Eguchi K, 1997, CANCER RES, V57, P4913; Fang BW, 2008, J CELL SCI, V121, P358, DOI 10.1242/jcs.017145; Fleuriel C, 2009, INT J BIOCHEM CELL B, V41, P26, DOI 10.1016/j.biocel.2008.05.028; Fox BP, 2004, BIOCHEM BIOPH RES CO, V318, P882, DOI 10.1016/j.bbrc.2004.04.102; Fujii H, 1998, ONCOGENE, V16, P2159, DOI 10.1038/sj.onc.1201976; Giunciuglio D, 1995, INT J CANCER, V63, P815, DOI 10.1002/ijc.2910630612; Han LQ, 2005, GYNECOL ONCOL, V99, P278, DOI 10.1016/j.ygyno.2005.06.036; Hayashi M, 2001, ANTICANCER RES, V21, P535; Ireton RC, 2005, CURR CANCER DRUG TAR, V5, P149, DOI 10.2174/1568009053765780; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kawabe M, 2009, CANCER RES, V69, P6995, DOI 10.1158/0008-5472.CAN-08-4511; Kinch MS, 2003, CLIN EXP METASTAS, V20, P59, DOI 10.1023/A:1022546620495; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Larsen AB, 2007, MOL CANCER RES, V5, P283, DOI 10.1158/1541-7786.MCR-06-0321; Larsen AB, 2010, CELL SIGNAL, V22, P636, DOI 10.1016/j.cellsig.2009.11.018; Lu YL, 1999, ONCOGENE, V18, P7034, DOI 10.1038/sj.onc.1203183; Macrae M, 2005, CANCER CELL, V8, P111, DOI 10.1016/j.ccr.2005.07.005; Miao H., 2011, SEMIN CELL IN PRESS; Miao H, 2009, CANCER CELL, V16, P9, DOI 10.1016/j.ccr.2009.04.009; Mohammad HP, 2011, ONCOGENE, V30, P2659, DOI 10.1038/onc.2010.633; Morton RA, 1996, J UROLOGY, V156, P512, DOI 10.1016/S0022-5347(01)65916-0; Nicoll G, 2001, BRIT J CANCER, V85, P1878, DOI 10.1054/bjoc.2001.2163; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Pinte S, 2004, J BIOL CHEM, V279, P38313, DOI 10.1074/jbc.M401610200; Pratt RL, 2003, MOL CANCER RES, V1, P1070; Ramnarain DB, 2006, CANCER RES, V66, P867, DOI 10.1158/0008-5472.CAN-05-2753; Rood BR, 2002, CANCER RES, V62, P3794; Stankovic-Valentin N, 2006, FEBS J, V273, P2879, DOI 10.1111/j.1742-4658.2006.05301.x; Taddei ML, 2009, AM J PATHOL, V174, P1492, DOI 10.2353/ajpath.2009.080473; Tandon M, 2011, EXPERT OPIN THER TAR, V15, P31, DOI 10.1517/14728222.2011.538682; Van Rechem C, 2010, MOL CELL BIOL, V30, P4045, DOI 10.1128/MCB.00582-09; Van Rechem C, 2009, J BIOL CHEM, V284, P20927, DOI 10.1074/jbc.M109.022350; Vaught D, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2207; Vilgelm A, 2008, ONCOGENE, V27, P2170, DOI 10.1038/sj.onc.1210862; Waha A, 2004, INT J CANCER, V110, P542, DOI 10.1002/ijc.20165; WALES MM, 1995, NAT MED, V1, P570, DOI 10.1038/nm0695-570; Walker-Daniels J, 2002, MOL CANCER RES, V1, P79; Wykosky J, 2008, MOL CANCER RES, V6, P1795, DOI 10.1158/1541-7786.MCR-08-0244; Zantek ND, 1999, CELL GROWTH DIFFER, V10, P629; Zantek ND, 2001, CLIN CANCER RES, V7, P3640; Zelinski DP, 2002, J CELL BIOCHEM, V85, P714, DOI 10.1002/jcb.10186; Zelinski DP, 2001, CANCER RES, V61, P2301; Zhang GQ, 2008, CANCER RES, V68, P1691, DOI 10.1158/0008-5472.CAN-07-2372; Zhang W, 2010, ONCOGENE, V29, P2467, DOI 10.1038/onc.2010.12; Zhou N, 2011, MICROVASC RES, V82, P113, DOI 10.1016/j.mvr.2011.06.005	66	29	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5366	5378		10.1074/jbc.M111.329466	http://dx.doi.org/10.1074/jbc.M111.329466			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22184117	Green Published, hybrid			2022-12-27	WOS:000300638000018
J	Oh, RS; Pan, WC; Yalcin, A; Zhang, H; Guilarte, TR; Hotamisligil, GS; Christiani, DC; Lu, Q				Oh, Raymond S.; Pan, Wen-Chi; Yalcin, Abdullah; Zhang, Hong; Guilarte, Tomas R.; Hotamisligil, Goekhan S.; Christiani, David C.; Lu, Quan			Functional RNA Interference (RNAi) Screen Identifies System A Neutral Amino Acid Transporter 2 (SNAT2) as a Mediator of Arsenic-induced Endoplasmic Reticulum Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; P70 S6 KINASE; MESSENGER-RNA; ER STRESS; MAMMALIAN TARGET; OXIDATIVE STRESS; COMPOSITE SITE; CHOP PROMOTER; MUSCLE-CELLS; TUMOR-GROWTH	Exposure to the toxic metalloid arsenic is associated with diabetes and cancer and causes proteotoxicity and endoplasmic reticulum (ER) stress at the cellular level. Adaptive responses to ER stress are implicated in cancer and diabetes; thus, understanding mechanisms of arsenic-induced ER stress may offer insights into pathogenesis. Here, we identify genes required for arsenite-induced ER stress response in a genome-wide RNAi screen. Using an shRNA library targeting similar to 20,000 human genes, together with an ER stress cell model, we performed flow cytometry-based cell sorting to isolate cells with defective response to arsenite. Our screen discovered several genes modulating arsenite-induced ER stress, including sodium-dependent neutral amino acid transporter, SNAT2. SNAT2 expression and activity are up-regulated by arsenite, in a manner dependent on activating transcription factor 4 (ATF4), an important mediator of the integrated stress response. Inhibition of SNAT2 expression or activity or deprivation of its primary substrate, glutamine, specifically suppressed ER stress induced by arsenite but not tunicamycin. Induction of SNAT2 is coincident with the activation of the nutrient-sensing mammalian target of rapamycin (mTOR) pathway, which is at least partially required for arsenite-induced ER stress. Importantly, inhibition of the SNAT2 or the System L transporter, LAT1, suppressed mTOR activation by arsenite, supporting a role for these transporters in modulating amino acid signaling. These findings reveal SNAT2 as an important and specific mediator of arsenic-induced ER stress, and suggest a role for aberrant mTOR activation in arsenic-related human diseases. Further-more, this study demonstrates the utility of RNAi screens in elucidating cellular mechanisms of environmental toxins.	[Oh, Raymond S.; Pan, Wen-Chi; Lu, Quan] Harvard Univ, Sch Publ Hlth, Program Mol & Integrat Physiol Sci, Boston, MA 02115 USA; [Oh, Raymond S.; Pan, Wen-Chi; Christiani, David C.; Lu, Quan] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Oh, Raymond S.; Yalcin, Abdullah; Hotamisligil, Goekhan S.] Harvard Univ, Dept Genet & Complex Dis, Dept Environm Hlth, Boston, MA 02115 USA; [Zhang, Hong] Univ Massachusetts, Dept Cell Biol, Sch Med, Worcester, MA 01655 USA; [Guilarte, Tomas R.] Columbia Univ, Dept Environm Hlth Sci, Mailman Sch Publ Hlth, New York, NY 10032 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; University of Massachusetts System; University of Massachusetts Worcester; Columbia University	Lu, Q (corresponding author), Harvard Univ, Sch Publ Hlth, Program Mol & Integrat Physiol Sci, Bldg I-305,665 Huntington Ave, Boston, MA 02115 USA.	qlu@hsph.harvard.edu	Yalcin, Abdullah/AAG-4175-2019	Yalcin, Abdullah/0000-0001-8604-4749; Pan, Wen-Chi/0000-0002-0588-8083	National Institutes of Health; Harvard-NIEHS Center [P30ES000002]; NIEHS [P42ES016454]; National Institutes of Health [DK052539, DK090942]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052539, RC4DK090942] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000002, P42ES016454] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard-NIEHS Center; NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health, Harvard-NIEHS Center, Grant P30ES000002 and NIEHS Superfund Research Program Grant P42ES016454 (to Q. L.) and National Institutes of Health Grants DK052539 and DK090942 (to G. S. H.).	Alfieri RR, 2001, BIOCHEM BIOPH RES CO, V283, P174, DOI 10.1006/bbrc.2001.4729; Avruch J, 2009, AM J PHYSIOL-ENDOC M, V296, pE592, DOI 10.1152/ajpendo.90645.2008; Baird FE, 2009, AM J PHYSIOL-ENDOC M, V297, pE822, DOI 10.1152/ajpendo.00330.2009; BARBER EF, 1982, J BIOL CHEM, V257, P4960; Bernstam L, 2000, J TOXICOL ENV HEAL B, V3, P293, DOI 10.1080/109374000436355; Bi MX, 2005, EMBO J, V24, P3470, DOI 10.1038/sj.emboj.7600777; Bruhat A, 2000, MOL CELL BIOL, V20, P7192, DOI 10.1128/MCB.20.19.7192-7204.2000; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Cullinan SB, 2004, J BIOL CHEM, V279, P20108, DOI 10.1074/jbc.M314219200; DeBerardinis RJ, 2010, ONCOGENE, V29, P313, DOI 10.1038/onc.2009.358; Del Razo LM, 2001, TOXICOL APPL PHARM, V177, P132, DOI 10.1006/taap.2001.9291; Donze O, 1999, MOL CELL BIOL, V19, P8422, DOI 10.1128/mcb.19.12.8422; Evans K, 2007, J AM SOC NEPHROL, V18, P1426, DOI 10.1681/ASN.2006091014; Fawcett TW, 1999, BIOCHEM J, V339, P135, DOI 10.1042/0264-6021:3390135; Fung H, 2007, MOL CELL BIOL, V27, P8834, DOI 10.1128/MCB.00974-07; Gaccioli F, 2006, J BIOL CHEM, V281, P17929, DOI 10.1074/jbc.M600341200; Gazzola RF, 2001, FEBS LETT, V490, P11; Gjymishka A, 2008, J BIOL CHEM, V283, P27736, DOI 10.1074/jbc.M803781200; Guyton KZ, 1996, BIOCHEM J, V314, P547, DOI 10.1042/bj3140547; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Hotamisligil GS, 2008, NAT REV IMMUNOL, V8, P923, DOI 10.1038/nri2449; Jiang HY, 2007, J BIOL CHEM, V282, P3755, DOI 10.1074/jbc.M606461200; Jousse C, 2001, NUCLEIC ACIDS RES, V29, P4341, DOI 10.1093/nar/29.21.4341; Jung DK, 2003, EXP CELL RES, V290, P144, DOI 10.1016/S0014-4827(03)00320-3; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Lin AMY, 2007, TOXICOL APPL PHARM, V224, P138, DOI 10.1016/j.taap.2007.06.016; Lu LR, 2001, MOL CELL BIOL, V21, P7971, DOI 10.1128/MCB.21.23.7971-7980.2001; Lu TH, 2011, TOXICOL LETT, V201, P15, DOI 10.1016/j.toxlet.2010.11.019; Ma YJ, 2002, J MOL BIOL, V318, P1351, DOI 10.1016/S0022-2836(02)00234-6; Mackenzie B, 2004, PFLUG ARCH EUR J PHY, V447, P784, DOI 10.1007/s00424-003-1117-9; McDowell HE, 1998, FEBS LETT, V441, P15, DOI 10.1016/S0014-5793(98)01508-7; McGivan JD, 2007, FRONT BIOSCI, V12, P874, DOI 10.2741/2109; Nabhan JF, 2010, EMBO REP, V11, P605, DOI 10.1038/embor.2010.80; Navas-Acien A, 2008, JAMA-J AM MED ASSOC, V300, P814, DOI 10.1001/jama.300.7.814; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Ozean U, 2008, MOL CELL, V29, P541, DOI [10.1016/j.moicel.2007.12.023, 10.1016/j.molcel.2007.12.023]; Palii SS, 2006, BIOCHEM J, V395, P517, DOI 10.1042/BJ20051867; Patel CV, 2000, J BIOL CHEM, V275, P37993, DOI 10.1074/jbc.M004762200; Patterson J, 2008, CANCER CHEMOTH PHARM, V61, P923, DOI 10.1007/s00280-007-0546-0; Peterfi Z, 2009, AM J PATHOL, V175, P725, DOI 10.2353/ajpath.2009.080693; Romero-Ramirez L, 2004, CANCER RES, V64, P5943, DOI 10.1158/0008-5472.CAN-04-1606; Rossman TG, 2003, MUTAT RES-FUND MOL M, V533, P37, DOI 10.1016/j.mrfmmm.2003.07.009; Roybal CN, 2005, J BIOL CHEM, V280, P20331, DOI 10.1074/jbc.M411275200; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Sambrook J., 2001, MOL CLONING LAB MANU; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Shao J, 2001, J BIOL CHEM, V276, P206, DOI 10.1074/jbc.M007583200; Stanhill A, 2006, MOL CELL, V23, P875, DOI 10.1016/j.molcel.2006.07.023; States JC, 2009, TOXICOL SCI, V107, P312, DOI 10.1093/toxsci/kfn236; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Varoqui H, 2002, BIOCHEM BIOPH RES CO, V290, P903, DOI 10.1006/bbrc.2001.6281; Walton FS, 2004, TOXICOL APPL PHARM, V198, P424, DOI 10.1016/j.taap.2003.10.026; Wang XM, 1997, BIOCHEM BIOPH RES CO, V238, P207, DOI 10.1006/bbrc.1997.7273; Wang XZ, 1998, EMBO J, V17, P5708, DOI 10.1093/emboj/17.19.5708; Wu XN, 2011, J BIOL CHEM, V286, P31501, DOI 10.1074/jbc.M111.233122; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xu HY, 1999, J BIOL CHEM, V274, P26287, DOI 10.1074/jbc.274.37.26287; Yanagida O, 2001, BBA-BIOMEMBRANES, V1514, P291, DOI 10.1016/S0005-2736(01)00384-4; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000	66	26	29	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					6025	6034		10.1074/jbc.M111.311217	http://dx.doi.org/10.1074/jbc.M111.311217			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22215663	Green Published, hybrid			2022-12-27	WOS:000300638000075
J	Burkart, C; Fan, JB; Zhang, DE				Burkart, Christoph; Fan, Jun-Bao; Zhang, Dong-Er			Two Independent Mechanisms Promote Expression of an N-terminal Truncated USP18 Isoform with Higher DeISGylation Activity in the Nucleus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERNAL RIBOSOME ENTRY; INTERFERON-STIMULATED GENES; TRANS-ACTING FACTORS; UBIQUITIN-SPECIFIC PROTEASE; MESSENGER-RNA TRANSLATION; HEPATITIS-C VIRUS; UBP43 USP18; MEDIATED TRANSLATION; MAMMALIAN-CELLS; SECONDARY STRUCTURE	Expression of the ISG15 specific protease USP18 is highly induced by type I interferons. The two main functions of USP18, i.e. its enzymatic activity and down-regulation of type I interferon signaling, are well characterized. However, to date all functional studies focused on full-length USP18. Here, we report that translation of human USP18 is initiated by a rare start codon (CUG). Usage of this non-canonical initiation site with its weak translation initiation efficiency promotes expression of an N-terminal truncated isoform (USP18-sf). In addition, an internal ribosome entry site (IRES) located in the 5'-coding region of USP18 also contributes to translation of USP18-sf. Functionally, both isoforms exhibit enzymatic activity and interfere with type I interferon signaling. However, USP18-sf shows different subcellular distribution compared with the full-length protein and enhanced deISGylation activity in the nucleus. Taken together, we report the existence of an N-terminal truncated isoform of USP18, whose expression is controlled on translational level by two independent mechanisms providing translational flexibility as well as cell type-specific resistance to inhibition of cap-dependent translation.	[Zhang, Dong-Er] Univ Calif San Diego, Moores Canc Ctr, Dept Pathol, La Jolla, CA 92093 USA; [Zhang, Dong-Er] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Zhang, DE (corresponding author), Univ Calif San Diego, Moores Canc Ctr, Dept Pathol, 3855 Hlth Sci Dr, La Jolla, CA 92093 USA.	d7zhang@ucsd.edu	Fan, Jun-bao/E-7155-2012	Fan, Junbao/0000-0002-1709-3659	National Institutes of Health [HL091549]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091549] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL091549 (to D.-E. Z.).	Baird SD, 2006, RNA, V12, P1755, DOI 10.1261/rna.157806; Biron CA, 2001, IMMUNITY, V14, P661, DOI 10.1016/S1074-7613(01)00154-6; Bonnet ME, 2008, PHARM RES-DORDR, V25, P2972, DOI 10.1007/s11095-008-9693-1; Borden EC, 2011, J INTERF CYTOK RES, V31, P1, DOI 10.1089/jir.2010.0129; Calkhoven CF, 2000, GENE DEV, V14, P1920; Chawla-Sarkar M, 2003, APOPTOSIS, V8, P237, DOI 10.1023/A:1023668705040; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; Dhar D, 2007, NUCLEIC ACIDS RES, V35, P5409, DOI 10.1093/nar/gkm524; Duex JE, 2009, MOL BIOL CELL, V20, P1833, DOI 10.1091/mbc.E08-08-0880; Fernandez J, 2002, J BIOL CHEM, V277, P19198, DOI 10.1074/jbc.M201052200; Fitzgerald KD, 2009, BBA-GENE REGUL MECH, V1789, P518, DOI 10.1016/j.bbagrm.2009.07.004; Gerashchenko MV, 2010, J BIOL CHEM, V285, P4595, DOI 10.1074/jbc.M109.070532; Gradi A, 1998, P NATL ACAD SCI USA, V95, P11089, DOI 10.1073/pnas.95.19.11089; HANN SR, 1994, GENE DEV, V8, P2441, DOI 10.1101/gad.8.20.2441; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Holcik M, 2005, RNA, V11, P1605, DOI 10.1261/rna.2158605; JANG SK, 1988, J VIROL, V62, P2636, DOI 10.1128/JVI.62.8.2636-2643.1988; Kim JH, 2011, EMBO J, V30, P2454, DOI 10.1038/emboj.2011.146; Kim JH, 2008, J IMMUNOL, V181, P6467, DOI 10.4049/jimmunol.181.9.6467; Kim KI, 2004, MOL CELL BIOL, V24, P9592, DOI 10.1128/MCB.24.21.9592-9600.2004; Kim KI, 2005, METHOD ENZYMOL, V398, P491, DOI 10.1016/S0076-6879(05)98040-3; Komar AA, 2011, CELL CYCLE, V10, P229, DOI 10.4161/cc.10.2.14472; Kozak M, 2002, GENE, V299, P1, DOI 10.1016/S0378-1119(02)01056-9; KOZAK M, 1986, P NATL ACAD SCI USA, V83, P2850, DOI 10.1073/pnas.83.9.2850; Kozak M, 1999, GENE, V234, P187, DOI 10.1016/S0378-1119(99)00210-3; Leaman DW, 2003, J INTERF CYTOK RES, V23, P745, DOI 10.1089/107999003772084860; Lewis SM, 2008, ONCOGENE, V27, P1033, DOI 10.1038/sj.onc.1210777; Liu LQ, 1999, MOL CELL BIOL, V19, P3029; Lu G, 2006, CELL MOL BIOL, V52, P29, DOI 10.1170/T695; Malakhov MP, 2002, J BIOL CHEM, V277, P9976, DOI 10.1074/jbc.M109078200; Malakhova OA, 2006, EMBO J, V25, P2358, DOI 10.1038/sj.emboj.7601149; Marissen WE, 1998, MOL CELL BIOL, V18, P7565, DOI 10.1128/MCB.18.12.7565; Mokrejs M, 2006, NUCLEIC ACIDS RES, V34, pD125, DOI 10.1093/nar/gkj081; Morris DR, 2000, MOL CELL BIOL, V20, P8635, DOI 10.1128/MCB.20.23.8635-8642.2000; Oumard A, 2000, MOL CELL BIOL, V20, P2755, DOI 10.1128/MCB.20.8.2755-2759.2000; Palam LR, 2011, J BIOL CHEM, V286, P10939, DOI 10.1074/jbc.M110.216093; PAPA FR, 1993, NATURE, V366, P313, DOI 10.1038/366313a0; PEABODY DS, 1989, J BIOL CHEM, V264, P5031; PELLETIER J, 1985, CELL, V40, P515, DOI 10.1016/0092-8674(85)90200-4; Pestka S, 2004, IMMUNOL REV, V202, P8, DOI 10.1111/j.0105-2896.2004.00204.x; Platanias LC, 1999, EXP HEMATOL, V27, P1583, DOI 10.1016/S0301-472X(99)00109-5; Potu H, 2010, CANCER RES, V70, P655, DOI 10.1158/0008-5472.CAN-09-1942; Randall G, 2006, GASTROENTEROLOGY, V131, P1584, DOI 10.1053/j.gastro.2006.08.043; Ritchie KJ, 2004, NAT MED, V10, P1374, DOI 10.1038/nm1133; Robert F, 2006, MOL BIOL CELL, V17, P4632, DOI 10.1091/mbc.E06-06-0478; Roth W, 1998, J NEUROIMMUNOL, V87, P121, DOI 10.1016/S0165-5728(98)00079-4; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Sarasin-Filipowicz M, 2009, MOL CELL BIOL, V29, P4841, DOI 10.1128/MCB.00224-09; Sasaki A, 2003, J BIOL CHEM, V278, P2432, DOI 10.1074/jbc.C200608200; Schwab SR, 2004, PLOS BIOL, V2, P1774, DOI 10.1371/journal.pbio.0020366; Schwer H, 2000, GENOMICS, V65, P44, DOI 10.1006/geno.2000.6148; Semler BL, 2008, TRENDS MICROBIOL, V16, P1, DOI 10.1016/j.tim.2007.11.001; Shi HX, 2010, MOL CELL BIOL, V30, P2424, DOI 10.1128/MCB.01466-09; Spotts GD, 1997, MOL CELL BIOL, V17, P1459, DOI 10.1128/MCB.17.3.1459; Spriggs KA, 2005, CELL DEATH DIFFER, V12, P585, DOI 10.1038/sj.cdd.4401642; Stoneley M, 2000, NUCLEIC ACIDS RES, V28, P687, DOI 10.1093/nar/28.3.687; Sudhakar A, 2000, BIOCHEMISTRY-US, V39, P12929, DOI 10.1021/bi0008682; Van Eden ME, 2004, RNA, V10, P720, DOI 10.1261/rna.5225204; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Warnakulasuriyarachchi D, 2004, J BIOL CHEM, V279, P17148, DOI 10.1074/jbc.M308737200; Wegrzyn JL, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-232; Zhu YA, 1997, J BIOL CHEM, V272, P51	62	25	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4883	4893		10.1074/jbc.M111.255570	http://dx.doi.org/10.1074/jbc.M111.255570			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22170061	hybrid, Green Published			2022-12-27	WOS:000300608500049
J	Gomez, IG; Tang, JJ; Wilson, CL; Yan, W; Heinecke, JW; Harlan, JM; Raines, EW				Gomez, Ivan G.; Tang, Jingjing; Wilson, Carole L.; Yan, Wei; Heinecke, Jay W.; Harlan, John M.; Raines, Elaine W.			Metalloproteinase-mediated Shedding of Integrin beta 2 Promotes Macrophage Efflux from Inflammatory Sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VIVO; BLOOD-VESSELS; ROLES; MAC-1; MIGRATION; LFA-1; MICE; CD18; ALPHA(M)BETA(2); FIBRIN(OGEN)	Macrophage exiting from inflammatory sites is critical to limit the local innate immune response. With tissue insult, resident tissue macrophages rapidly efflux to lymph nodes where they modulate the adaptive immune response, and inflammatory macrophages attracted to the site of injury then exit during the resolution phase. However, the mechanisms that regulate macrophage efflux are poorly understood. This study has investigated soluble forms of integrin beta 2 whose levels are elevated in experimental peritonitis at times when macrophages are exiting the peritoneum, suggesting that its proteolytic shedding may be involved in macrophage efflux. Both constitutive and inducible metalloproteinase-dependent shedding of integrin beta 2 from mouse macrophages are demonstrated. Soluble integrin beta 2 is primarily released as a heterodimeric complex with alpha M that retains its ability to bind its ligands intracellular adhesion molecule-1, fibrin, and collagen and thus may serve as a soluble antagonist. In a model of accelerated exiting, administration of a metalloproteinase inhibitor prevents macrophage efflux by 50% and impedes loss of macrophage integrin beta 2 from the cell surface. Exiting of peritoneal macrophages in mice lacking integrin beta 2 is accelerated, and antibody disruption of integrin beta 2-substrate interactions can reverse 50% of the metalloprotease inhibitor blockade of macrophage exiting. Thus, our study demonstrates the ability of metalloproteinase-mediated shedding of integrin beta 2 to promote macrophage efflux from inflammatory sites, and the release of soluble integrin heterodimers may also limit local inflammation.	[Raines, Elaine W.] Univ Washington, Harborview Med Ctr, Dept Pathol, Seattle, WA 98104 USA; [Heinecke, Jay W.; Harlan, John M.] Univ Washington, Dept Med, Seattle, WA 98104 USA; [Yan, Wei] Inst Syst Biol, Seattle, WA 98109 USA	Harborview Medical Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Institute for Systems Biology (ISB)	Raines, EW (corresponding author), Univ Washington, Harborview Med Ctr, Dept Pathol, 325 9Th Ave, Seattle, WA 98104 USA.	ewraines@u.washington.edu	Yan, Wei/AAI-9905-2020	Yan, Wei/0000-0003-0619-5876	National Institutes of Health [5P01 HL018645, R01 HL067267, HL081795, 5P01 HL030086]; Mass Spectrometry Core, Diabetes Education and Research Center, University of Washington [P30 DK017047]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL018645, R01HL081795, P01HL030086, R01HL067267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK017047] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mass Spectrometry Core, Diabetes Education and Research Center, University of Washington; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Identification of increased Grants 5P01 HL018645 (to E. W. R., J. M. H., and J. W. H.), R01 HL067267 and HL081795 (to E. W. R.), and 5P01 HL030086 (to J. W. H.). This work was also supported by Grant P30 DK017047 from the Mass Spectrometry Core, Diabetes Education and Research Center, University of Washington.	Alon R, 2002, SEMIN IMMUNOL, V14, P93, DOI 10.1006/smim.2001.0346; Alon R, 2007, IMMUNITY, V26, P17, DOI 10.1016/j.immuni.2007.01.002; Bannenberg GL, 2005, J IMMUNOL, V174, P4345, DOI 10.4049/jimmunol.174.7.4345; Bellingan GJ, 1996, J IMMUNOL, V157, P2577; Cao CZ, 2006, EMBO J, V25, P1860, DOI 10.1038/sj.emboj.7601082; Cao CZ, 2005, BLOOD, V106, P3234, DOI 10.1182/blood-2005-03-1288; Carman CV, 2003, CURR OPIN CELL BIOL, V15, P547, DOI 10.1016/j.ceb.2003.08.003; COLVIN RB, 1975, J EXP MED, V142, P1377, DOI 10.1084/jem.142.6.1377; Cook AD, 2006, THROMB HAEMOSTASIS, V95, P659, DOI 10.1160/TH05-06-0405; Evans BJ, 2006, BLOOD, V107, P3593, DOI 10.1182/blood-2005-09-3695; Filep JG, 1999, BLOOD, V94, P4132, DOI 10.1182/blood.V94.12.4132.424k25_4132_4142; Flick MJ, 2004, J CLIN INVEST, V113, P1596, DOI 10.1172/JCI200420741; Garton KJ, 2006, J LEUKOCYTE BIOL, V79, P1105, DOI 10.1189/jlb.0106038; Gibb DR, 2010, J EXP MED, V207, P623, DOI 10.1084/jem.20091990; Gjelstrup LC, 2010, J IMMUNOL, V185, P4154, DOI 10.4049/jimmunol.1000952; Gong YQ, 2008, J CLIN INVEST, V118, P3012, DOI 10.1172/JCI32750; ISSEKUTZ TB, 1995, J IMMUNOL, V154, P6533; Iwata A, 2002, BLOOD, V100, P2077, DOI 10.1182/blood-2002-03-0752; Lefort CT, 2009, J IMMUNOL, V183, P6460, DOI 10.4049/jimmunol.0900983; Matsukawa A, 2005, J IMMUNOL, V175, P3354, DOI 10.4049/jimmunol.175.5.3354; MELNICOFF MJ, 1989, CELL IMMUNOL, V118, P178, DOI 10.1016/0008-8749(89)90367-5; MILLER LJ, 1987, J CLIN INVEST, V80, P535, DOI 10.1172/JCI113102; Murphy G, 2008, TRENDS IMMUNOL, V29, P75, DOI 10.1016/j.it.2007.10.009; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Ranganathan S, 2011, J BIOL CHEM, V286, P30535, DOI 10.1074/jbc.M111.265413; Reiss K, 2009, SEMIN CELL DEV BIOL, V20, P126, DOI 10.1016/j.semcdb.2008.11.002; Scharffetter-Kochanek K, 1998, J EXP MED, V188, P119, DOI 10.1084/jem.188.1.119; Schif-Zuck S, 2011, EUR J IMMUNOL, V41, P366, DOI 10.1002/eji.201040801; Semmrich M, 2005, J EXP MED, V201, P1987, DOI 10.1084/jem.20041850; Solovjov DA, 2005, J BIOL CHEM, V280, P1336, DOI 10.1074/jbc.M406968200; Szaba FM, 2002, BLOOD, V99, P1053, DOI 10.1182/blood.V99.3.1053; Tang JJ, 2011, BLOOD, V118, P786, DOI 10.1182/blood-2010-11-321406; Ulyanova T, 2007, EXP HEMATOL, V35, P1256, DOI 10.1016/j.exphem.2007.04.015; Vaisar T, 2009, MOL CELL PROTEOMICS, V8, P1044, DOI 10.1074/mcp.M800449-MCP200; Yakubenko VP, 2006, BLOOD, V107, P1643, DOI 10.1182/blood-2005-06-2509; Youker KA, 2000, J IMMUNOL, V164, P2752, DOI 10.4049/jimmunol.164.5.2752; Zen K, 2011, BLOOD, V117, P4885, DOI 10.1182/blood-2010-05-287722	37	35	36	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4581	4589		10.1074/jbc.M111.321182	http://dx.doi.org/10.1074/jbc.M111.321182			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22170060	Green Published, hybrid			2022-12-27	WOS:000300608500021
J	Hedrich, CM; Rauen, T; Kis-Toth, K; Kyttaris, VC; Tsokos, GC				Hedrich, Christian M.; Rauen, Thomas; Kis-Toth, Katalin; Kyttaris, Vasileios C.; Tsokos, George C.			cAMP-responsive Element Modulator alpha (CREM alpha) Suppresses IL-17F Protein Expression in T Lymphocytes from Patients with Systemic Lupus Erythematosus (SLE)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IL-2 PRODUCTION; HETERODIMERIC CYTOKINE; AUTOIMMUNE-DISEASES; HOST-DEFENSE; CELLS; GENE; BINDING; TRANSCRIPTION; PROMOTER; IDENTIFICATION	The proinflammatory cytokines IL-17A and IL-17F are primarily produced by Th17 lymphocytes. Both are involved in host defense mechanisms against bacterial and fungal pathogens and contribute to the development of various autoimmune diseases. T lymphocytes from patients with systemic lupus erythematosus (SLE) display increased expression of transcription factor cAMP-responsive element modulator alpha (CREM alpha), which has been documented to account for aberrant T cell function and contributes to the pathogenesis of SLE. Here, we provide evidence that IL-17F expression is reduced in SLE T cells. We demonstrate that CREM alpha binds to a yet unidentified CRE site within the proximal promoter. This results in reduced IL-17F expression in SLE T lymphocytes and is independent of activating epigenetic patterns (increased histone H3 Lys-18 acetylation, reduced histone H3 Lys-27 trimethylation, and CpG-DNA demethylation). Forced CREM alpha expression in human T lymphocytes results in reduced IL-17F expression. Our findings demonstrate extended involvement of CREM alpha in cytokine dysregulation in SLE by contributing to a disrupted balance between IL-17A and IL-17F. An increased IL-17A/IL-17F ratio may aggravate the proinflammatory phenotype of SLE.	[Hedrich, Christian M.; Rauen, Thomas; Kis-Toth, Katalin; Kyttaris, Vasileios C.; Tsokos, George C.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Rheumatol,Dept Med, Boston, MA 02115 USA; [Rauen, Thomas] Rhein Westfal TH Aachen, Dept Nephrol & Clin Immunol, D-50062 Aachen, Germany	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; RWTH Aachen University	Tsokos, GC (corresponding author), Beth Israel Deaconess Med Ctr CLS 937, Div Rheumatol, Dept Med, 330 Brookline Ave, Boston, MA 02115 USA.	chedrich@bidmc.harvard.edu; gtsokos@bidmc.harvard.edu	Hedrich, Christian/AAD-6855-2019; Hedrich, Christian/AAW-3958-2020; tsokos, george C/O-3360-2013	tsokos, george C/0000-0001-9589-2360; Hedrich, Christian/0000-0002-1295-6179	National Institutes of Health [K23 AR055672, R01 AI42269, R01 AI49954, R01 AI85567]; Deutsche Forschungsgemeinschaft [RA1927-1/1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI049954, R01AI085567, R01AI049954, R01AI042269] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K23AR055672, R01AR060849] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants K23 AR055672 (to V. C. K.) and R01 AI42269, R01 AI49954, and R01 AI85567 (to G. C. T.). This work was also supported by Deutsche Forschungsgemeinschaft Grant RA1927-1/1 (to T. R.).	Ahlmann M, 2009, J IMMUNOL, V182, P4167, DOI 10.4049/jimmunol.0802976; Bailey J, 2005, J MOL ENDOCRINOL, V34, P1, DOI 10.1677/jme.1.01594; Brenner C, 2006, CURR TOP MICROBIOL, V301, P45; Brenner C, 2007, DEV CELL, V12, P843, DOI 10.1016/j.devcel.2007.05.011; Chang SH, 2007, CELL RES, V17, P435, DOI 10.1038/cr.2007.35; Crispin JC, 2008, TRENDS IMMUNOL, V29, P110, DOI 10.1016/j.it.2007.12.003; Crispin JC, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/943254; Crispin JC, 2009, J IMMUNOL, V183, P4675, DOI 10.4049/jimmunol.0901533; Crispin JC, 2008, J IMMUNOL, V181, P8761, DOI 10.4049/jimmunol.181.12.8761; Fletcher JM, 2010, CLIN EXP IMMUNOL, V162, P1, DOI 10.1111/j.1365-2249.2010.04143.x; FOULKES NS, 1991, CELL, V64, P739, DOI 10.1016/0092-8674(91)90503-Q; Hedrich CM, 2011, J BIOL CHEM, V286, P43429, DOI 10.1074/jbc.M111.299339; Hedrich CM, 2011, TRENDS MOL MED, V17, P714, DOI 10.1016/j.molmed.2011.07.005; Hot A, 2011, ANN RHEUM DIS, V70, P727, DOI 10.1136/ard.2010.143768; Hu Y, 2011, ANN NY ACAD SCI, V1217, P60, DOI 10.1111/j.1749-6632.2010.05825.x; Iwakura Y, 2008, IMMUNOL REV, V226, P57, DOI 10.1111/j.1600-065X.2008.00699.x; Juang YT, 2005, J CLIN INVEST, V115, P996, DOI 10.1172/JCI22854; Juang YT, 2011, J BIOL CHEM, V286, P1795, DOI 10.1074/jbc.M110.166785; Kyttaris VC, 2006, LUPUS, V15, P840, DOI 10.1177/0961203306069985; Kyttaris VC, 2004, J IMMUNOL, V173, P3557, DOI 10.4049/jimmunol.173.5.3557; Liang SC, 2007, J IMMUNOL, V179, P7791, DOI 10.4049/jimmunol.179.11.7791; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Pappu R, 2011, IMMUNOLOGY, V134, P8, DOI 10.1111/j.1365-2567.2011.03465.x; Rauen T, 2011, J BIOL CHEM, V286, P43437, DOI 10.1074/jbc.M111.299313; Rauen T, 2011, J BIOL CHEM, V286, P32366, DOI 10.1074/jbc.M111.245811; ROUVIER E, 1993, J IMMUNOL, V150, P5445; Solomou EE, 2001, J IMMUNOL, V166, P4216, DOI 10.4049/jimmunol.166.6.4216; Tenbrock K, 2005, J IMMUNOL, V175, P5975, DOI 10.4049/jimmunol.175.9.5975; Tenbrock K, 2003, J IMMUNOL, V170, P2971, DOI 10.4049/jimmunol.170.6.2971; Tenbrock K, 2002, J IMMUNOL, V169, P4147, DOI 10.4049/jimmunol.169.8.4147; Tenbrock K, 2006, J IMMUNOL, V177, P6159, DOI 10.4049/jimmunol.177.9.6159; Tokura Yoshiki, 2010, Journal of UOEH, V32, P317; Wright JF, 2008, J IMMUNOL, V181, P2799, DOI 10.4049/jimmunol.181.4.2799; Wright JF, 2007, J BIOL CHEM, V282, P13447, DOI 10.1074/jbc.M700499200; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007; Zepp J, 2011, TRENDS IMMUNOL, V32, P232, DOI 10.1016/j.it.2011.02.007; Zhang XP, 2011, PROTEIN CELL, V2, P26, DOI 10.1007/s13238-011-1006-5	37	49	51	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4715	4725		10.1074/jbc.M111.323261	http://dx.doi.org/10.1074/jbc.M111.323261			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22184122	hybrid, Green Published			2022-12-27	WOS:000300608500033
J	Vainio, L; Perjes, A; Ryti, N; Magga, J; Alakoski, T; Serpi, R; Kaikkonen, L; Piuhola, J; Szokodi, I; Ruskoaho, H; Kerkela, R				Vainio, Laura; Perjes, Abel; Ryti, Niilo; Magga, Johanna; Alakoski, Tarja; Serpi, Raisa; Kaikkonen, Leena; Piuhola, Jarkko; Szokodi, Istvan; Ruskoaho, Heikki; Kerkela, Risto			Neuronostatin, a Novel Peptide Encoded by Somatostatin Gene, Regulates Cardiac Contractile Function and Cardiomyocyte Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; GATA-4 TRANSCRIPTION FACTOR; IN-VIVO; VENTRICULAR CARDIOMYOCYTES; SIGNAL-TRANSDUCTION; MYOCYTE APOPTOSIS; CELL-GROWTH; EEF2 KINASE; P38; HEART	Neuronostatin, a recently discovered peptide encoded by somatostatin gene, is involved in regulation of neuronal function, blood pressure, food intake, and drinking behavior. However, the biological effects of neuronostatin on cardiac myocytes are not known, and the intracellular signaling mechanisms induced by neuronostatin remain unidentified. We analyzed the effect of neuronostatin in isolated perfused rat hearts and in cultured primary cardiomyocytes. Neuronostatin infusion alone had no effect on left ventricular (LV) contractile function or on isoprenaline-or preload-induced increase in cardiac contractility. However, infusion of neuronostatin significantly decreased the positive inotropic response to endothelin-1 (ET-1). This was associated with an increase in phosphorylation of p38 mitogen-activated protein kinase and c-Jun N-terminal kinase (JNK). Treatment of both neonatal and adult cardiomyocytes with neuronostatin resulted in reduced cardiomyocyte viability. Inhibition of JNK further increased the neuronostatin-induced cell death. We conclude that neuronostatin regulates cardiac contractile function and cardiomyocyte survival. Receptors for neuronostatin need to be identified to further characterize the biological functions of the peptide.	[Vainio, Laura; Perjes, Abel; Ryti, Niilo; Magga, Johanna; Alakoski, Tarja; Serpi, Raisa; Kaikkonen, Leena; Ruskoaho, Heikki; Kerkela, Risto] Univ Oulu, Inst Biomed, Dept Pharmacol & Toxicol, FIN-90014 Oulu, Finland; [Piuhola, Jarkko] Univ Oulu, Dept Internal Med, FIN-90014 Oulu, Finland; [Perjes, Abel; Szokodi, Istvan] Univ Pecs, Sch Med, Inst Heart, H-7624 Pecs, Hungary	University of Oulu; University of Oulu; University of Pecs	Kerkela, R (corresponding author), Univ Oulu, Inst Biomed, Dept Pharmacol & Toxicol, POB 5000, FIN-90014 Oulu, Finland.	Risto.Kerkela@oulu.fi	Szokodi, Istvan/X-3704-2019	Szokodi, Istvan/0000-0002-2162-6155; Serpi, Raisa/0000-0002-8207-4673; Magga, Johanna/0000-0003-4688-9098; Ryti, Niilo/0000-0001-5357-1251	Finnish Foundation for Cardiovascular Research; Sigrid Juselius Foundation; Academy of Finland (Center of Excellence); Emil Aaltonen Foundation; Hungarian Scientific Research Fund [K69118]	Finnish Foundation for Cardiovascular Research; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland (Center of Excellence)(Academy of Finland); Emil Aaltonen Foundation; Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This work was supported, in whole or in part, by the Finnish Foundation for Cardiovascular Research, Sigrid Juselius Foundation, Academy of Finland (Center of Excellence) and Emil Aaltonen Foundation (to R. K.) and by Hungarian Scientific Research Fund (K69118) (to I. S.).	Andreka P, 2001, CIRC RES, V88, P305, DOI 10.1161/01.RES.88.3.305; Baines CP, 2005, J MOL CELL CARDIOL, V38, P47, DOI 10.1016/j.yjmcc.2004.11.004; Bell D, 2008, CELL PHYSIOL BIOCHEM, V22, P653, DOI 10.1159/000185549; Bellahcene M, 2006, J AM COLL CARDIOL, V48, P545, DOI 10.1016/j.jacc.2006.02.072; Bogazzi F, 2005, CLIN ENDOCRINOL, V62, P590, DOI 10.1111/j.1365-2265.2005.02265.x; Braz JC, 2003, J CLIN INVEST, V111, P1475, DOI 10.1172/JCI200317295; BRAZEAU P, 1973, SCIENCE, V179, P77, DOI 10.1126/science.179.4068.77; BRUNO JF, 1993, ENDOCRINOLOGY, V133, P2561, DOI 10.1210/en.133.6.2561; Chadee DN, 2004, NAT CELL BIOL, V6, P770, DOI 10.1038/ncb1152; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; ENDOU M, 1989, J PHARMACOL EXP THER, V250, P726; Ferrandi C, 2004, BRIT J PHARMACOL, V142, P953, DOI 10.1038/sj.bjp.0705873; Hua YA, 2009, AM J PHYSIOL-REG I, V297, pR682, DOI 10.1152/ajpregu.00196.2009; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Kerkela R, 2002, J BIOL CHEM, V277, P13752, DOI 10.1074/jbc.M105736200; Kerkela R, 2006, NAT MED, V12, P908, DOI 10.1038/nm1446; Kerkela R, 2006, J AM COLL CARDIOL, V48, P556, DOI 10.1016/j.jacc.2006.05.005; Kerkela R, 2009, CTS-CLIN TRANSL SCI, V2, P15, DOI 10.1111/j.1752-8062.2008.00090.x; Knebel A, 2002, BIOCHEM J, V367, P525, DOI 10.1042/BJ20020916; Knebel A, 2001, EMBO J, V20, P4360, DOI 10.1093/emboj/20.16.4360; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Liao P, 2002, CIRC RES, V90, P190, DOI 10.1161/hh0202.104220; Liao P, 2001, P NATL ACAD SCI USA, V98, P12283, DOI 10.1073/pnas.211086598; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Martini JS, 2008, P NATL ACAD SCI USA, V105, P12457, DOI 10.1073/pnas.0803153105; Matsui T, 2001, CIRCULATION, V104, P330; Matsui T, 2003, CELL CYCLE, V2, P220, DOI 10.4161/cc.2.3.381; Minamino T, 2002, P NATL ACAD SCI USA, V99, P3866, DOI 10.1073/pnas.062453699; Moller LN, 2003, BBA-BIOMEMBRANES, V1616, P1, DOI 10.1016/S0005-2736(03)00235-9; Murray F, 2001, J CARDIOVASC PHARM, V37, P324, DOI 10.1097/00005344-200103000-00011; Nishida K, 2004, MOL CELL BIOL, V24, P10611, DOI 10.1128/MCB.24.24.10611-10620.2004; Pikkarainen S, 2002, J MOL MED, V80, P51, DOI 10.1007/s001090100278; Piuhola J, 2003, HYPERTENSION, V41, P93, DOI 10.1161/01.HYP.0000050929.96979.EC; Pollari E, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-74; Rose BA, 2010, PHYSIOL REV, V90, P1507, DOI 10.1152/physrev.00054.2009; Russell FD, 2001, BRIT J PHARMACOL, V132, P5, DOI 10.1038/sj.bjp.0703811; Samson WK, 2008, J BIOL CHEM, V283, P31949, DOI 10.1074/jbc.M804784200; Schwabe W, 1996, GENE, V168, P233, DOI 10.1016/0378-1119(95)00748-2; Shao ZL, 2006, CIRC RES, V98, P111, DOI 10.1161/01.RES.0000197781.20524.b9; Smith EM, 2008, EMBO J, V27, P1005, DOI 10.1038/emboj.2008.39; Szokodi I, 2002, CIRC RES, V91, P434, DOI 10.1161/01.RES.0000033522.37861.69; Szokodi I, 1996, ACTA PHYSIOL SCAND, V156, P151, DOI 10.1046/j.1365-201X.1996.454169000.x; Szokodi I, 2008, CIRCULATION, V118, P1651, DOI 10.1161/CIRCULATIONAHA.107.758623; Tenhunen O, 2004, J BIOL CHEM, V279, P24852, DOI 10.1074/jbc.M314317200; Ventura JJ, 2006, MOL CELL, V21, P701, DOI 10.1016/j.molcel.2006.01.018; Wang XM, 2006, PHYSIOLOGY, V21, P362, DOI 10.1152/physiol.00024.2006; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257; Zechner D, 1997, J CELL BIOL, V139, P115, DOI 10.1083/jcb.139.1.115	48	19	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4572	4580		10.1074/jbc.M111.289215	http://dx.doi.org/10.1074/jbc.M111.289215			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22170057	Green Published, hybrid			2022-12-27	WOS:000300608500020
J	Krastanova, I; Sannino, V; Amenitsch, H; Gileadi, O; Pisani, FM; Onesti, S				Krastanova, Ivet; Sannino, Vincenzo; Amenitsch, Heinz; Gileadi, Opher; Pisani, Francesca M.; Onesti, Silvia			Structural and Functional Insights into the DNA Replication Factor Cdc45 Reveal an Evolutionary Relationship to the DHH Family of Phosphoesterases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-ANGLE SCATTERING; S-PHASE; GINS COMPLEX; STRUCTURE PREDICTION; RECJ EXONUCLEASE; MCM2-7 HELICASE; HIGH-THROUGHPUT; PROTEIN; ASSOCIATION; INITIATION	Cdc45 is an essential protein conserved in all eukaryotes and is involved both in the initiation of DNA replication and the progression of the replication fork. With GINS, Cdc45 is an essential cofactor of the Mcm2-7 replicative helicase complex. Despite its importance, no detailed information is available on either the structure or the biochemistry of the protein. Intriguingly, whereas homologues of both GINS and Mcm proteins have been described in Archaea, no counterpart for Cdc45 is known. Herein we report a bioinformatic analysis that shows a weak but significant relationship among eukaryotic Cdc45 proteins and a large family of phosphoesterases that has been described as the DHH family, including inorganic pyrophosphatases and RecJ ssDNA exonucleases. These enzymes catalyze the hydrolysis of phosphodiester bonds via a mechanism involving two Mn2+ ions. Only a subset of the amino acids that coordinates Mn2+ is conserved in Cdc45. We report biochemical and structural data on the recombinant human Cdc45 protein, consistent with the proposed DHH family affiliation. Like the RecJ exonucleases, the human Cdc45 protein is able to bind single-stranded, but not double-stranded DNA. Small angle x-ray scattering data are consistent with a model compatible with the crystallographic structure of the RecJ/DHH family members.	[Sannino, Vincenzo; Pisani, Francesca M.] CNR, Ist Biochim Prot, I-80131 Naples, Italy; [Krastanova, Ivet; Onesti, Silvia] Sincrotrone Trieste, Struct Biol Lab, I-34149 Trieste, Italy; [Amenitsch, Heinz] Austrian Acad Sci, Inst Biophys & Nanosyst Res, A-8042 Graz, Austria; [Gileadi, Opher] Struct Genom Consortium, Oxford OX3 7DQ, England	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR); Elettra Sincrotrone Trieste; Austrian Academy of Sciences; University of Oxford	Pisani, FM (corresponding author), CNR, Ist Biochim Prot, I-80131 Naples, Italy.	fm.pisani@ibp.cnr.it; silvia.onesti@elettra.trieste.it	Gileadi, Opher/F-1105-2013; Pisani, Francesca M./AAX-4025-2020	Gileadi, Opher/0000-0001-6886-898X; Onesti, Silvia/0000-0002-0612-7948; Amenitsch, Heinz/0000-0002-0788-1336; Sannino, Vincenzo/0000-0002-3570-7810	Friuli Venezia Giulia; Associazione Italiana per la Ricerca sul Cancro [IG10646, IG9087]	Friuli Venezia Giulia(Regione Friuli Venezia Giulia); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	The work was supported by a Friuli Venezia Giulia grant (DAGEAST to I. K.) and by the Associazione Italiana per la Ricerca sul Cancro (Grant IG10646 to S. O. and Grant IG9087 to F. M. P.).	Amenitsch H, 1997, J APPL CRYSTALLOGR, V30, P872, DOI 10.1107/S0021889897001593; Aparicio OM, 1997, CELL, V91, P59, DOI 10.1016/S0092-8674(01)80009-X; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P17, DOI 10.1016/S0968-0004(97)01162-6; Aravind L, 1998, NUCLEIC ACIDS RES, V26, P3746, DOI 10.1093/nar/26.16.3746; Bauerschmidt C, 2007, GENES CELLS, V12, P745, DOI 10.1111/j.1365-2443.2007.01090.x; Costa A, 2011, NAT STRUCT MOL BIOL, V18, P471, DOI 10.1038/nsmb.2004; Costa A, 2009, CRIT REV BIOCHEM MOL, V44, P326, DOI 10.1080/10409230903186012; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fabrichniy IP, 2004, BIOCHEMISTRY-US, V43, P14403, DOI 10.1021/bi0484973; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Ilves I, 2010, MOL CELL, V37, P247, DOI 10.1016/j.molcel.2009.12.030; Jaroszewski L, 2005, NUCLEIC ACIDS RES, V33, pW284, DOI 10.1093/nar/gki418; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Li Z, 2011, NUCLEIC ACIDS RES, V39, P6114, DOI 10.1093/nar/gkr181; Makarova KS, 2005, NUCLEIC ACIDS RES, V33, P4626, DOI 10.1093/nar/gki775; Marinsek N, 2006, EMBO REP, V7, P539, DOI 10.1038/sj.embor.7400649; Mimura S, 1998, EMBO J, V17, P5699, DOI 10.1093/emboj/17.19.5699; Motz M, 2002, J BIOL CHEM, V277, P16179, DOI 10.1074/jbc.M107793200; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; Owens JC, 1997, P NATL ACAD SCI USA, V94, P12521, DOI 10.1073/pnas.94.23.12521; Pacek M, 2006, MOL CELL, V21, P581, DOI 10.1016/j.molcel.2006.01.030; Pacek M, 2004, EMBO J, V23, P3667, DOI 10.1038/sj.emboj.7600369; Pollok S, 2007, FEBS J, V274, P3669, DOI 10.1111/j.1742-4658.2007.05900.x; Pospiech H, 2010, SUBCELL BIOCHEM, V50, P79, DOI 10.1007/978-90-481-3471-7_5; Rajman LA, 2000, J BACTERIOL, V182, P607, DOI 10.1128/JB.182.3.607-612.2000; Sakakibara N, 2009, MOL MICROBIOL, V72, P286, DOI 10.1111/j.1365-2958.2009.06663.x; Sanchez-Pulido L, 2011, BIOINFORMATICS, V27, P1885, DOI 10.1093/bioinformatics/btr332; Savitsky P, 2010, J STRUCT BIOL, V172, P3, DOI 10.1016/j.jsb.2010.06.008; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tercero JA, 2000, EMBO J, V19, P2082, DOI 10.1093/emboj/19.9.2082; Uchiyama M, 2001, MOL GENET GENOMICS, V265, P1039, DOI 10.1007/s004380100499; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wakamatsu T, 2010, J BIOL CHEM, V285, P9762, DOI 10.1074/jbc.M109.096487; Yamagata A, 2002, P NATL ACAD SCI USA, V99, P5908, DOI 10.1073/pnas.092547099; Yoshimochi T, 2008, J BIOL CHEM, V283, P1601, DOI 10.1074/jbc.M707654200; Zou L, 2000, MOL CELL BIOL, V20, P3086, DOI 10.1128/MCB.20.9.3086-3096.2000	41	41	41	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					4121	4128		10.1074/jbc.M111.285395	http://dx.doi.org/10.1074/jbc.M111.285395			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22147708	Green Published, hybrid			2022-12-27	WOS:000300410900045
J	Lee, J; Kim, HR; Quinley, C; Kim, J; Gonzalez-Navajas, J; Xavier, R; Raz, E				Lee, Jongdae; Kim, Hye Ri; Quinley, Christine; Kim, Joanna; Gonzalez-Navajas, Jose; Xavier, Ramnik; Raz, Eyal			Autophagy Suppresses Interleukin-1 beta (IL-1 beta) Signaling by Activation of p62 Degradation via Lysosomal and Proteasomal Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR NRF2; NF-KAPPA-B; CROHNS-DISEASE; IMPAIRED AUTOPHAGY; GENE ATG16L1; ASSOCIATION; P62/SQSTM1; CULLIN3; CELLS; KEAP1	ATG16L1 is an essential component of the autophagasome. The T300A allele of ATG16L1 is associated with the increased susceptibility to Crohn disease. In this study, we identified a novel function of ATG16L1, which suppresses signaling of the pro-inflammatory cytokine IL-1 beta. Deletion of ATG16L1 in mouse embryonic fibroblasts significantly amplifies IL-1 beta signal transduction cascades. This amplification is due to elevated p62 levels in ATG16L1-deficient cells. We found that ATG16L1 regulates p62 levels via both autolysosomal and proteasomal pathways. For proteasomal degradation, we found that Cullin-3 (Cul-3) is a E3 ubiquitin ligase of p62 and that ATG16L1 is essential for neddylation of Cul-3, a step required for Cul-3 activation. Taken together our data indicate that loss-of-function of ATG16L1 results in a hyper-responsiveness to the IL-1 beta signaling because of the increased p62 level.	[Lee, Jongdae; Kim, Hye Ri; Quinley, Christine; Kim, Joanna; Gonzalez-Navajas, Jose; Raz, Eyal] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Xavier, Ramnik] Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA 02114 USA; [Xavier, Ramnik] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA	University of California System; University of California San Diego; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Lee, J (corresponding author), 9500 Gilman Dr, La Jolla, CA 92093 USA.	j142lee@ucsd.edu; eraz@ucsd.edu	González-Navajas, Jose Manuel/AAB-1575-2019	González-Navajas, Jose Manuel/0000-0002-1591-939X; Lee, Jongdae/0000-0002-6270-4658	National Institutes of Health [A1068685, A1095623, DK35108, DK080506]; CCFA; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI095623, R01AI068685] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK080506, P30DK043351, P01DK035108] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CCFA; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants A1068685, A1095623, DK35108, and DK080506, and a grant from CCFA.	Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; Gao L, 2007, J BIOL CHEM, V282, P2529, DOI 10.1074/jbc.M607622200; Hotton SK, 2008, ANNU REV PLANT BIOL, V59, P467, DOI 10.1146/annurev.arplant.58.032806.104011; Into T, 2010, J BIOL CHEM, V285, P35759, DOI 10.1074/jbc.M110.126904; Jain A, 2010, J BIOL CHEM, V285, P22576, DOI 10.1074/jbc.M110.118976; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Knaevelsrud H, 2010, FEBS LETT, V584, P2635, DOI 10.1016/j.febslet.2010.04.041; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Kuballa P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003391; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lapaquette P, 2010, CELL MICROBIOL, V12, P99, DOI 10.1111/j.1462-5822.2009.01381.x; Lee J, 2006, NAT CELL BIOL, V8, P1327, DOI 10.1038/ncb1500; Liu J, 2010, BIOPHYS J, V99, P736, DOI 10.1016/j.bpj.2010.05.021; Mistry H, 2004, MECH DEVELOP, V121, P1495, DOI 10.1016/j.mod.2004.07.007; Mizushima N, 1999, EMBO J, V18, P3888, DOI 10.1093/emboj/18.14.3888; Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023; Myeku N, 2011, J BIOL CHEM, V286, P22426, DOI 10.1074/jbc.M110.149252; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Sanz L, 2000, EMBO J, V19, P1576, DOI 10.1093/emboj/19.7.1576; Seibenhener ML, 2004, MOL CELL BIOL, V24, P8055, DOI 10.1128/MCB.24.18.8055-8068.2004; Verstrepen L, 2008, CELL MOL LIFE SCI, V65, P2964, DOI 10.1007/s00018-008-8064-8; Wimuttisuk W, 2007, MOL BIOL CELL, V18, P899, DOI 10.1091/mbc.E06-06-0542	25	77	79	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					4033	4040		10.1074/jbc.M111.280065	http://dx.doi.org/10.1074/jbc.M111.280065			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22167182	Green Published, hybrid			2022-12-27	WOS:000300410900037
J	Ohashi, Y; Iijima, H; Yamaotsu, N; Yamazaki, K; Sato, S; Okamura, M; Sugimoto, K; Dan, S; Hirono, S; Yamori, T				Ohashi, Yoshimi; Iijima, Hiroshi; Yamaotsu, Noriyuki; Yamazaki, Kanami; Sato, Shigeo; Okamura, Mutsumi; Sugimoto, Kenji; Dan, Shingo; Hirono, Shuichi; Yamori, Takao			AMF-26, a Novel Inhibitor of the Golgi System, Targeting ADP-ribosylation Factor 1 (Arf1) with Potential for Cancer Therapy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ITERATIVE PARTIAL EQUALIZATION; NUCLEOTIDE EXCHANGE FACTORS; SMALL-MOLECULE INHIBITORS; ANTICANCER DRUG SCREEN; TUMOR-CELL-LINES; BREFELDIN-A; ORBITAL ELECTRONEGATIVITY; CONFORMATIONAL ENERGIES; ENDOPLASMIC-RETICULUM; 3-KINASE INHIBITOR	ADP-ribosylation factor1(Arf1) plays a major role in mediating vesicular transport. Brefeldin A (BFA), a known inhibitor of the Arf1-guanine nucleotide exchange factor (GEF) interaction, is highly cytotoxic. Therefore, interaction of Arf1 with ArfGEF is an attractive target for cancer treatment. However, BFA and its derivatives have not progressed beyond the pre-clinical stage of drug development because of their poor bioavailability. Here, we aimed to identify novel inhibitors of the Arf1-ArfGEF interaction that display potent antitumor activity in vivo but with a chemical structure distinct from that of BFA. We exploited a panel of 39 cell lines (termed JFCR39) coupled with a drug sensitivity data base and COMPARE algorithm, resulting in the identification of a possible novel Arf1-ArfGEF inhibitor AMF-26, which differed structurally from BFA. By using a pulldown assay with GGA3-conjugated beads, we demonstrated that AMF-26 inhibited Arf1 activation. Subsequently, AMF-26 induced Golgi disruption, apoptosis, and cell growth inhibition. Computer modeling/molecular dynamics (MD) simulation suggested that AMF-26 bound to the contact surface of the Arf1-Sec7 domain where BFA bound. AMF-26 affected membrane traffic, including the cis-Golgi and trans-Golgi networks, and the endosomal systems. Furthermore, using AMF-26 and its derivatives, we demonstrated that there was a significant correlation between cell growth inhibition and Golgi disruption. In addition, orally administrated AMF-26(83 mg/kg of body weight; 5 days) induced complete regression of human breast cancer BSY-1 xenografts in vivo, suggesting that AMF-26 is a novel anticancer drug candidate that inhibits the Golgi system, targeting Arf1 activation.	[Ohashi, Yoshimi; Yamazaki, Kanami; Okamura, Mutsumi; Dan, Shingo; Yamori, Takao] Japanese Fdn Canc Res, Div Mol Pharmacol, Ctr Canc Chemotherapy, Tokyo 1358550, Japan; [Sato, Shigeo] Japanese Fdn Canc Res, Div Expt Chemotherapy, Ctr Canc Chemotherapy, Tokyo 1358550, Japan; [Iijima, Hiroshi; Yamaotsu, Noriyuki; Hirono, Shuichi] Kitasato Univ, Sch Pharm, Tokyo 1088641, Japan; [Sugimoto, Kenji] Osaka Prefecture Univ, Div Appl Biochem, Lab Appl Mol Biol, Grad Sch Agr & Biol Sci, Osaka 5998531, Japan	Japanese Foundation for Cancer Research; Japanese Foundation for Cancer Research; Kitasato University; Osaka Metropolitan University	Yamori, T (corresponding author), Japanese Fdn Canc Res, Div Mol Pharmacol, Ctr Canc Chemotherapy, Tokyo 1358550, Japan.	yamori@jfcr.or.jp	Yamaotsu, Noriyuki/AAW-2545-2020	Yamaotsu, Noriyuki/0000-0002-4302-1085	Japan Society for the Promotion of Science [22240092]; Ministry of Education, Culture, Sports, Science and Technology [11177101]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-aid for Scientific Research (A) 22240092 from the Japan Society for the Promotion of Science (to T. Y.) and Grant-in-aid for Scientific Research on Priority Areas 11177101 from the Ministry of Education, Culture, Sports, Science and Technology (to T. Y.).	Anadu NO, 2006, J MED CHEM, V49, P3897, DOI 10.1021/jm0602817; Appenzeller-Herzog C, 2006, J CELL SCI, V119, P2173, DOI 10.1242/jcs.03019; Azmi AS, 2009, J CELL PHYSIOL, V218, P13, DOI 10.1002/jcp.21567; Berg T, 2008, CURR OPIN DRUG DISC, V11, P666; BRUNING A, 1992, J BIOL CHEM, V267, P7726; Casanova JE, 2007, TRAFFIC, V8, P1476, DOI 10.1111/j.1600-0854.2007.00634.x; Case D, 2006, AMBER 9; CIEPLAK P, 1995, J COMPUT CHEM, V16, P1357, DOI 10.1002/jcc.540161106; Citterio C, 2008, P NATL ACAD SCI USA, V105, P2877, DOI 10.1073/pnas.0712224105; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Dan S, 2002, CANCER RES, V62, P1139; Dan S, 2010, CANCER RES, V70, P4982, DOI 10.1158/0008-5472.CAN-09-4172; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Doray B, 2002, SCIENCE, V297, P1700, DOI 10.1126/science.1075327; Feng Y, 2003, P NATL ACAD SCI USA, V100, P6469, DOI 10.1073/pnas.0631766100; Feng Y, 2004, EMBO REP, V5, P596, DOI 10.1038/sj.embor.7400152; Frisch M.J., 2016, GAUSSIAN16 REV B01; GASTEIGER J, 1981, ORG MAGN RESONANCE, V15, P353, DOI 10.1002/mrc.1270150408; GASTEIGER J, 1980, TETRAHEDRON, V36, P3219, DOI 10.1016/0040-4020(80)80168-2; Hacki J, 2000, ONCOGENE, V19, P2286, DOI 10.1038/sj.onc.1203592; Halgren TA, 1999, J COMPUT CHEM, V20, P730, DOI 10.1002/(SICI)1096-987X(199905)20:7<730::AID-JCC8>3.0.CO;2-T; Halgren TA, 1999, J COMPUT CHEM, V20, P720, DOI 10.1002/(SICI)1096-987X(199905)20:7<720::AID-JCC7>3.0.CO;2-X; Ishizaki R, 2008, MOL BIOL CELL, V19, P2650, DOI 10.1091/mbc.E07-10-1067; Iwase K, 1999, J COMPUT AID MOL DES, V13, P499, DOI 10.1023/A:1008011422113; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kong DX, 2010, EUR J CANCER, V46, P1111, DOI 10.1016/j.ejca.2010.01.005; Lauria A, 2010, CURR MED CHEM, V17, P3142, DOI 10.2174/092986710792232021; LIPPINCOTTSCHWARTZ J, 1991, CELL, V67, P601, DOI 10.1016/0092-8674(91)90534-6; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; MARSILI M, 1980, CROAT CHEM ACTA, V53, P601; MONKS A, 1991, J NATL CANCER I, V83, P757, DOI 10.1093/jnci/83.11.757; MORRE DJ, 1985, EUR J CELL BIOL, V37, P107; Mossessova E, 1998, CELL, V92, P415, DOI 10.1016/S0092-8674(00)80933-2; Naasani I, 1999, CANCER RES, V59, P4004; Nakayama K, 2003, CELL STRUCT FUNCT, V28, P431, DOI 10.1247/csf.28.431; Niu TK, 2005, MOL BIOL CELL, V16, P1213, DOI 10.1091/mbc.E04-07-0599; Pan HL, 2008, J BIOL CHEM, V283, P31087, DOI 10.1074/jbc.M806592200; PAULL KD, 1989, J NATL CANCER I, V81, P1088, DOI 10.1093/jnci/81.14.1088; Presley JF, 2002, NATURE, V417, P187, DOI 10.1038/417187a; Puertollano R, 2001, CELL, V105, P93, DOI 10.1016/S0092-8674(01)00299-9; PURCELL WP, 1967, J CHEM ENG DATA, V12, P235, DOI 10.1021/je60033a020; Renault L, 2003, NATURE, V426, P525, DOI 10.1038/nature02197; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Saenz JB, 2009, NAT CHEM BIOL, V5, P157, DOI 10.1038/nchembio.144; Sakaushi S, 2007, BIOSCI BIOTECH BIOCH, V71, P571, DOI 10.1271/bbb.60434; Sausville E A, 1996, Cancer J Sci Am, V2, P52; Sharma SV, 2010, NAT REV CANCER, V10, P241, DOI 10.1038/nrc2820; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Takatsu H, 2002, BIOCHEM J, V365, P369, DOI 10.1042/BJ20020428; Thyberg J, 1999, EXP CELL RES, V246, P263, DOI 10.1006/excr.1998.4326; THYBERG J, 1989, J SUBMICR CYTOL PATH, V21, P259; Tsujishita H, 1997, J COMPUT AID MOL DES, V11, P305, DOI 10.1023/A:1007964913898; Viaud J, 2007, P NATL ACAD SCI USA, V104, P10370, DOI 10.1073/pnas.0700773104; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Watari K, 2012, INT J CANCER, V131, P310, DOI 10.1002/ijc.26356; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; WOOD SA, 1991, CELL, V67, P591, DOI 10.1016/0092-8674(91)90533-5; Yaguchi SI, 2006, JNCI-J NATL CANCER I, V98, P545, DOI 10.1093/jnci/djj133; Yamori T, 2003, CANCER CHEMOTH PHARM, V52, pS74, DOI 10.1007/s00280-003-0649-1; Yamori T, 1999, CANCER RES, V59, P4042; Zeeh JC, 2006, J BIOL CHEM, V281, P11805, DOI 10.1074/jbc.M600149200	64	48	51	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					3885	3897		10.1074/jbc.M111.316125	http://dx.doi.org/10.1074/jbc.M111.316125			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22158626	Green Published, hybrid			2022-12-27	WOS:000300410900025
J	Rohde, LAH; Ahring, PK; Jensen, ML; Nielsen, EO; Peters, D; Helgstrand, C; Krintel, C; Harpsoe, K; Gajhede, M; Kastrup, JS; Balle, T				Rohde, Line Aagot Hede; Ahring, Philip Kiaer; Jensen, Marianne Lerbech; Nielsen, Elsebet Ostergaard; Peters, Dan; Helgstrand, Charlotte; Krintel, Christian; Harpsoe, Kasper; Gajhede, Michael; Kastrup, Jette Sandholm; Balle, Thomas			Intersubunit Bridge Formation Governs Agonist Efficacy at Nicotinic Acetylcholine alpha 4 beta 2 Receptors UNIQUE ROLE OF HALOGEN BONDING REVEALED	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-PROTEIN; STRUCTURAL DETERMINANTS; CRYSTAL-STRUCTURE; LIGAND-BINDING; SMOKING-CESSATION; POTENT AGONISTS; ACHBP; SUBTYPE; ALPHA-7; AFFINITY	The alpha 4 beta 2 subtype of the nicotinic acetylcholine receptor has been pursued as a drug target for treatment of psychiatric and neurodegenerative disorders and smoking cessation aids for decades. Still, a thorough understanding of structure-function relationships of alpha 4 beta 2 agonists is lacking. Using binding experiments, electrophysiology and x-ray crystallography we have investigated a consecutive series of five prototypical pyridine-containing agonists derived from 1-(pyridin-3-yl)-1,4-diazepane. A correlation between binding affinities at alpha 4 beta 2 and the acetylcholine-binding protein from Lymnaea stagnalis (Ls-AChBP) confirms Ls-AChBP as structural surrogate for alpha 4 beta 2 receptors. Crystal structures of five agonists with efficacies at alpha 4 beta 2 from 21-76% were determined in complex with Ls-AChBP. No variation in closure of loop C is observed despite large efficacy variations. Instead, the efficacy of a compound appears tightly coupled to its ability to form a strong intersubunit bridge linking the primary and complementary binding interfaces. For the tested agonists, a specific halogen bond was observed to play a large role in establishing such strong intersubunit anchoring.	[Helgstrand, Charlotte; Krintel, Christian; Harpsoe, Kasper; Gajhede, Michael; Kastrup, Jette Sandholm; Balle, Thomas] Univ Copenhagen, Dept Med Chem, Fac Pharmaceut Sci, DK-2100 Copenhagen, Denmark; [Rohde, Line Aagot Hede; Ahring, Philip Kiaer; Jensen, Marianne Lerbech; Nielsen, Elsebet Ostergaard; Peters, Dan] NeuroSearch AS, DK-2750 Ballerup, Denmark	University of Copenhagen	Balle, T (corresponding author), Univ Copenhagen, Dept Med Chem, Fac Pharmaceut Sci, DK-2100 Copenhagen, Denmark.	tb@farma.ku.dk	Harpsøe, Kasper/V-6870-2018	Harpsøe, Kasper/0000-0002-9326-9644; Gajhede, Michael/0000-0001-9864-2287; Ahring, Joergen Philip Kiaer/0000-0003-1807-3331; Balle, Thomas/0000-0002-0233-8350; krintel, christian/0000-0001-5925-5639; Kastrup, Jette Sandholm/0000-0003-2654-1510				Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andreasen JT, 2011, J PSYCHOPHARMACOL, V25, P1347, DOI 10.1177/0269881110364271; Atack JR, 2008, CNS NEUROSCI THER, V14, P25, DOI 10.1111/j.1527-3458.2007.00034.x; Audouze K, 2006, J MED CHEM, V49, P3159, DOI 10.1021/jm058058h; Bissantz C, 2010, J MED CHEM, V53, P5061, DOI 10.1021/jm100112j; Bisson WH, 2008, J MOL MODEL, V14, P891, DOI 10.1007/s00894-008-0340-x; Blum AP, 2010, P NATL ACAD SCI USA, V107, P13206, DOI 10.1073/pnas.1007140107; Bourne Y, 2005, EMBO J, V24, P1512, DOI 10.1038/sj.emboj.7600620; Bourne Y, 2010, P NATL ACAD SCI USA, V107, P6076, DOI 10.1073/pnas.0912372107; Bouzat C, 2004, NATURE, V430, P896, DOI 10.1038/nature02753; Brams M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001034; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Bunnelle WH, 2007, J MED CHEM, V50, P3627, DOI 10.1021/jm070018l; Bunnelle WH, 2009, J MED CHEM, V52, P4126, DOI 10.1021/jm900249k; Burmeister WP, 2000, ACTA CRYSTALLOGR D, V56, P328, DOI 10.1107/S0907444999016261; Carroll FI, 2004, BIOORG MED CHEM LETT, V14, P1889, DOI 10.1016/j.bmcl.2004.02.007; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Celie PHN, 2005, NAT STRUCT MOL BIOL, V12, P582, DOI 10.1038/nsmb951; Cunningham CS, 2011, EUR J PHARMACOL, V654, P47, DOI 10.1016/j.ejphar.2010.12.003; Dutertre S, 2007, EMBO J, V26, P3858, DOI 10.1038/sj.emboj.7601785; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Etter JF, 2006, TOB CONTROL, V15, DOI 10.1136/tc.2005.015487; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Frost JM, 2006, J MED CHEM, V49, P7843, DOI 10.1021/jm060846z; Gay EA, 2008, J PHYSIOL-LONDON, V586, P1105, DOI 10.1113/jphysiol.2007.149492; Gay EA, 2007, MOL PHARMACOL, V72, P838, DOI 10.1124/mol.107.035527; Geitmann M, 2010, BIOCHEMISTRY-US, V49, P8143, DOI 10.1021/bi1006354; Glennon RA, 2004, BIOORG MED CHEM LETT, V14, P1841, DOI 10.1016/j.bmcl.2003.07.035; Gotti C, 2006, TRENDS PHARMACOL SCI, V27, P482, DOI 10.1016/j.tips.2006.07.004; Grottick AJ, 2000, BEHAV BRAIN RES, V117, P197, DOI 10.1016/S0166-4328(00)00305-3; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Hansen SB, 2002, J BIOL CHEM, V277, P41299, DOI 10.1074/jbc.C200462200; Harpsoe K, 2011, J NEUROSCI, V31, P10759, DOI 10.1523/JNEUROSCI.1509-11.2011; Henderson BJ, 2010, J PHARMACOL EXP THER, V334, P761, DOI 10.1124/jpet.110.168211; Hibbs RE, 2009, EMBO J, V28, P3040, DOI 10.1038/emboj.2009.227; Houlihan LM, 2001, J NEUROCHEM, V78, P1029, DOI 10.1046/j.1471-4159.2001.00481.x; Ihara Makoto, 2008, Invertebrate Neuroscience, V8, P71, DOI 10.1007/s10158-008-0069-3; Jensen AA, 2003, MOL PHARMACOL, V64, P865, DOI 10.1124/mol.64.4.865; Jensen AA, 2005, J MED CHEM, V48, P4705, DOI 10.1021/jm040219e; Ji J, 2007, J MED CHEM, V50, P5493, DOI 10.1021/jm070755h; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Lamb PW, 2005, J MOL NEUROSCI, V27, P13, DOI 10.1385/JMN:27:1:013; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Levin ED, 1999, COGNITIVE BRAIN RES, V7, P405, DOI 10.1016/S0926-6410(98)00044-5; Lu Yan-Hui, 2009, Acta Entomologica Sinica, V52, P52; Ludwig J, 2010, J RECEPT SIG TRANSD, V30, P469, DOI 10.3109/10799893.2010.505239; Luttmann E, 2009, CHEMMEDCHEM, V4, P1874, DOI 10.1002/cmdc.200900320; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moroni M, 2006, MOL PHARMACOL, V70, P755, DOI 10.1124/mol.106.023044; Nelson ME, 2003, MOL PHARMACOL, V63, P332, DOI 10.1124/mol.63.2.332; Nielsen SF, 2000, J MED CHEM, V43, P2217, DOI 10.1021/jm990973d; Peters D., 1999, Patent No. [WO9921834, 9921834]; Ravelli RBG, 2000, STRUCTURE, V8, P315, DOI 10.1016/S0969-2126(00)00109-X; Rollema H, 2007, NEUROPHARMACOLOGY, V52, P985, DOI 10.1016/j.neuropharm.2006.10.016; Rucktooa P, 2009, BIOCHEM PHARMACOL, V78, P777, DOI 10.1016/j.bcp.2009.06.098; Sander T, 2011, PROTEINS, V79, P1458, DOI 10.1002/prot.22975; Sander T, 2010, J MOL GRAPH MODEL, V29, P415, DOI 10.1016/j.jmgm.2010.08.004; Schneider JS, 1998, ANN NEUROL, V43, P311, DOI 10.1002/ana.410430308; Smit AB, 2001, NATURE, V411, P261, DOI 10.1038/35077000; STEINLEIN OK, 1995, NAT GENET, V11, P201, DOI 10.1038/ng1095-201; Talley TT, 2008, P NATL ACAD SCI USA, V105, P7606, DOI 10.1073/pnas.0802197105; Tonstad Serena, 2010, Expert Rev Respir Med, V4, P291, DOI 10.1586/ers.10.27; Tosco P, 2009, J MED CHEM, V52, P2311, DOI 10.1021/jm801060h; Ulens C, 2006, P NATL ACAD SCI USA, V103, P3615, DOI 10.1073/pnas.0507889103; Ulens C, 2009, J MED CHEM, V52, P2372, DOI 10.1021/jm801400g; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Unwin N, 2002, J MOL BIOL, V319, P1165, DOI 10.1016/S0022-2836(02)00381-9; Weik M, 2000, P NATL ACAD SCI USA, V97, P623, DOI 10.1073/pnas.97.2.623; Williams DK, 2009, J PHARMACOL EXP THER, V330, P40, DOI 10.1124/jpet.109.151225; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yakel JL, 2010, J PHYSIOL-LONDON, V588, P597, DOI 10.1113/jphysiol.2009.182691; Zhou Y, 2003, J NEUROSCI, V23, P9004	72	40	40	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					4248	4259		10.1074/jbc.M111.292243	http://dx.doi.org/10.1074/jbc.M111.292243			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22170047	Green Published, hybrid			2022-12-27	WOS:000300410900057
J	Sanchez, EJ; Lewis, KM; Munske, GR; Nissen, MS; Kang, C				Sanchez, Emiliano J.; Lewis, Kevin M.; Munske, Gerhard R.; Nissen, Mark S.; Kang, ChulHee			Glycosylation of Skeletal Calsequestrin IMPLICATIONS FOR ITS FUNCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOPLASMIC-RETICULUM; CARDIAC CALSEQUESTRIN; CA2+ RELEASE; MUSCLE CALSEQUESTRIN; LUMINAL CA2+; PROTEIN; BINDING; PHOSPHORYLATION; MECHANISM; IDENTIFICATION	Calsequestrin (CASQ) serves as a major Ca2+ storage/buffer protein in the sarcoplasmic reticulum (SR). When purified from skeletal muscle, CASQ1 is obtained in its glycosylated form. Here, we have confirmed the specific site and degree of glycosylation of native rabbit CASQ1 and have investigated its effect on critical properties of CASQ by comparison with the non-glycosylated recombinant form. Based on our comparative approach utilizing crystal structures, Ca2+ binding capacities, analytical ultracentrifugation, and light-scattering profiles of the native and recombinant rabbit CASQ1, we propose a novel and dynamic role for glycosylation in CASQ. CASQ undergoes a unique degree of mannose trimming as it is trafficked from the proximal endoplasmic reticulum to the SR. The major glycoform of CASQ (GlcNAc(2)Man(9)) found in the proximal endoplasmic reticulum can severely hinder formation of the back-to-back interface, potentially preventing premature Ca2+-dependent polymerization of CASQ and ensuring its continuous mobility to the SR. Only trimmed glycans can stabilize both front-to-front and the back-to-back interfaces of CASQ through extensive hydrogen bonding and electrostatic interactions. Therefore, the mature glycoform of CASQ (GlcNAc(2)Man(1-4)) within the SR can be retained upon establishing a functional high capacity Ca2+ binding polymer. In addition, based on the high resolution structures, we propose a molecular mechanism for the catecholaminergic polymorphic ventricular tachycardia (CPVT2) mutation, K206N.	[Sanchez, Emiliano J.; Munske, Gerhard R.; Kang, ChulHee] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA; [Lewis, Kevin M.; Nissen, Mark S.; Kang, ChulHee] Washington State Univ, Dept Chem, Pullman, WA 99164 USA	Washington State University; Washington State University	Kang, C (corresponding author), Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA.	chkang@wsu.edu		Lewis, Kevin/0000-0003-3403-9520; Kang, ChulHee/0000-0002-0693-7860	American Heart Association [0850084Z]; National Science Foundation [MCB 1021148, DBI 0959778]; M. J. Murdock Charitable Trust; National Institutes of Health [T32GM083864]; National Institutes of Health/Center for Research Resources [P20RR016454]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM083864] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Science Foundation(National Science Foundation (NSF)); M. J. Murdock Charitable Trust; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health/Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by American Heart Association Grant 0850084Z, National Science Foundation Grants MCB 1021148 and DBI 0959778, and by the M. J. Murdock Charitable Trust. This work was also supported in part by National Institutes of Health Grant T32GM083864 (NIGMS; to E. J. S.).; We thank L. M. Gloss and T. Topping (Washington State University) and J. T. Oxford (Boise State University, M. J. Murdock Charitable Trust, and National Institutes of Health/Center for Research Resources Grant P20RR016454).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Beard NA, 2008, CELL CALCIUM, V44, P363, DOI 10.1016/j.ceca.2008.01.005; CALA SE, 1991, J BIOL CHEM, V266, P391; CAMPBELL KP, 1983, J BIOL CHEM, V258, P1197; Cho JH, 2007, J CELL SCI, V120, P1551, DOI 10.1242/jcs.001016; Chopra N, 2007, CIRC RES, V101, P617, DOI 10.1161/CIRCRESAHA.107.157552; Domingues MRM, 2003, J AM SOC MASS SPECTR, V14, P406, DOI 10.1016/S1044-0305(03)00127-2; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FRANZINIARMSTRONG C, 1987, J CELL BIOL, V105, P49, DOI 10.1083/jcb.105.1.49; Gatti G, 2001, J CELL BIOL, V154, P525, DOI 10.1083/jcb.200103002; HE ZP, 1993, J BIOL CHEM, V268, P24635; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Herzog A, 2000, FEBS LETT, V472, P73, DOI 10.1016/S0014-5793(00)01431-9; Hidalgo C, 1996, BIOPHYS J, V71, P2130, DOI 10.1016/S0006-3495(96)79413-4; Houle TD, 2004, CARDIOVASC RES, V64, P227, DOI 10.1016/j.cardiores.2004.09.009; Houle TD, 2006, EXP CELL RES, V312, P4150, DOI 10.1016/j.yexcr.2006.09.010; HUBBARD MJ, 1993, TRENDS BIOCHEM SCI, V18, P172, DOI 10.1016/0968-0004(93)90109-Z; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; IKEMOTO N, 1974, J BIOL CHEM, V249, P2357; JAENICKE R, 1991, BIOCHEMISTRY-US, V30, P3147, DOI 10.1021/bi00227a001; Johnson LN, 2009, BIOCHEM SOC T, V37, P627, DOI 10.1042/BST0370627; Kalyanasundaram A, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.053892; Kiarash A, 2004, CARDIOVASC RES, V63, P264, DOI 10.1016/j.cardiores.2004.04.001; Kim E, 2007, J MOL BIOL, V373, P1047, DOI 10.1016/j.jmb.2007.08.055; Kirchhefer U, 2010, J MOL CELL CARDIOL, V49, P95, DOI 10.1016/j.yjmcc.2010.03.006; Larkin A, 2011, BIOCHEMISTRY-US, V50, P4411, DOI 10.1021/bi200346n; Launikonis BS, 2006, P NATL ACAD SCI USA, V103, P2982, DOI 10.1073/pnas.0511252103; MacLennan DH, 2009, J PHYSIOL-LONDON, V587, P3113, DOI 10.1113/jphysiol.2009.172155; MacLennan DH, 1998, NAT STRUCT BIOL, V5, P409, DOI 10.1038/nsb0698-409; MacLennan DH, 2002, J MOL CELL CARDIOL, V34, P897, DOI 10.1006/jmcc.2002.2031; MACLENNAN DH, 1971, P NATL ACAD SCI USA, V68, P1231, DOI 10.1073/pnas.68.6.1231; McFarland TP, 2010, J MOL CELL CARDIOL, V49, P556, DOI 10.1016/j.yjmcc.2010.05.012; MEISSNER G, 1973, BIOCHIM BIOPHYS ACTA, V298, P246, DOI 10.1016/0005-2736(73)90355-6; Milstein ML, 2009, EXP CELL RES, V315, P523, DOI 10.1016/j.yexcr.2008.11.006; MITCHELL RD, 1988, J BIOL CHEM, V263, P1376; Mitra N, 2006, TRENDS BIOCHEM SCI, V31, P156, DOI 10.1016/j.tibs.2006.01.003; Moremen KW, 2002, BBA-GEN SUBJECTS, V1573, P225, DOI 10.1016/S0304-4165(02)00388-4; Noh SM, 2008, INFECT IMMUN, V76, P2219, DOI 10.1128/IAI.00008-08; O'Brian JJ, 2002, J BIOL CHEM, V277, P37154, DOI 10.1074/jbc.M204370200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park HJ, 2003, J BIOL CHEM, V278, P16176, DOI 10.1074/jbc.M300120200; Park HJ, 2004, J BIOL CHEM, V279, P18026, DOI 10.1074/jbc.M311553200; Priori SG, 2011, CIRC RES, V108, P871, DOI 10.1161/CIRCRESAHA.110.226845; Ram ML, 2004, MOL CELL BIOCHEM, V266, P209, DOI 10.1023/B:MCBI.0000049164.28580.56; Rodriguez MM, 1999, FEBS LETT, V454, P240, DOI 10.1016/S0014-5793(99)00697-3; Royer L, 2009, J PHYSIOL-LONDON, V587, P3101, DOI 10.1113/jphysiol.2009.171934; SALVATORI S, 1994, BIOCHEM BIOPH RES CO, V198, P144, DOI 10.1006/bbrc.1994.1021; Sanchez EJ, 2011, MOL CELL BIOCHEM, V353, P195, DOI 10.1007/s11010-011-0787-4; Shental-Bechor D, 2008, P NATL ACAD SCI USA, V105, P8256, DOI 10.1073/pnas.0801340105; Shoshan-Barmatz V, 1998, INT REV CYTOL, V183, P185, DOI 10.1016/S0074-7696(08)60145-X; ShoshanBarmatz V, 1996, BBA-BIOMEMBRANES, V1283, P89, DOI 10.1016/0005-2736(96)00079-X; SLUPSKY JR, 1987, BIOCHEMISTRY-US, V26, P6539, DOI 10.1021/bi00394a038; Szegedi C, 1999, BIOCHEM J, V337, P19, DOI 10.1042/0264-6021:3370019; VARSANYI M, 1980, FEBS LETT, V122, P227, DOI 10.1016/0014-5793(80)80444-3; Wang SR, 1998, NAT STRUCT BIOL, V5, P476, DOI 10.1038/nsb0698-476	55	14	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3042	3050		10.1074/jbc.M111.326363	http://dx.doi.org/10.1074/jbc.M111.326363			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22170046	Green Published, hybrid			2022-12-27	WOS:000300295100011
J	Gebendorfer, KM; Drazic, A; Le, Y; Gundlach, J; Bepperling, A; Kastenmuller, A; Ganzinger, KA; Braun, N; Franzmann, TM; Winter, J				Gebendorfer, Katharina M.; Drazic, Adrian; Le, Yan; Gundlach, Jasmin; Bepperling, Alexander; Kastenmueller, Andreas; Ganzinger, Kristina A.; Braun, Nathalie; Franzmann, Titus M.; Winter, Jeannette			Identification of a Hypochlorite-specific Transcription Factor from Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REDOX-REGULATED CHAPERONE; ACID; STRESS; MYELOPEROXIDASE; SUPEROXIDE; METABOLISM; RESISTANCE; REVEAL; SWITCH; OXYR	Hypochlorite is a powerful oxidant produced by neutrophils to kill invading microorganisms. Despite this important physiological role of HOCl in fighting bacterial infections, no hypochlorite- specific stress response has been identified yet. Here, we identified a hypochlorite-responsive transcription factor, YjiE, which is conserved in proteobacteria and eukaryotes. YjiE forms unusual dodecameric ring-like structures in vitro that undergo large DNA-induced conformational changes to form dimers and tetramers as shown by transmission electron microscopy and analytical ultracentrifugation. Such smaller oligomers are predominant in hypochlorite-stressed cells and are the active species as shown by fluorescence anisotropy and analytical ultracentrifugation. YjiE regulates a large number of genes upon hypochlorite stress. Among them are genes involved in cysteine, methionine biosynthesis, and sulfur metabolism (up-regulated) and genes involved in iron acquisition and homeostasis (down-regulated), thus supposedly replenishing oxidized metabolites and decreasing the hypochlorite-mediated amplification of intracellular reactive oxygen species. As a result, YjiE specifically confers hypochlorite resistance to E. coli cells. Thus, to our knowledge, YjiE is the first described hypochlorite-specific transcription factor.	[Gebendorfer, Katharina M.; Drazic, Adrian; Le, Yan; Gundlach, Jasmin; Bepperling, Alexander; Franzmann, Titus M.; Winter, Jeannette] Tech Univ Munich, CiPSM, Dept Chem, Sect Biotechnol, D-85747 Garching, Germany; [Kastenmueller, Andreas; Ganzinger, Kristina A.; Braun, Nathalie] Tech Univ Munich, CiPSM, Dept Chem, Sect Electron Microscopy, D-85747 Garching, Germany	Technical University of Munich; Technical University of Munich	Winter, J (corresponding author), Tech Univ Munich, CiPSM, Dept Chem, Sect Biotechnol, Lichtenbergstr 4, D-85747 Garching, Germany.	jeannette.winter@tum.de	Franzmann, Titus M/D-1962-2011; Ganzinger, Kristina/AAD-5584-2020; Drazic, Adrian/AAC-6120-2019	Ganzinger, Kristina/0000-0001-9106-9406; Drazic, Adrian/0000-0001-9263-5502; Franzmann, Titus/0000-0002-4281-7209	Elitenetzwerk Bayern; Boeh-ringer Ingelheim Fonds; Deutsche Forschungsgemeinschaft;  [pr28ci]	Elitenetzwerk Bayern; Boeh-ringer Ingelheim Fonds(Boehringer Ingelheim); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); 	This work was supported by project pr28ci (to Johannes Buchner and T. M. F.), the Elitenetzwerk Bayern (to K. M. G., T. M. F., and J. G.), the Boeh-ringer Ingelheim Fonds (to Y. L.), and the Emmy-Noether program of the Deutsche Forschungsgemeinschaft (to J. W.).	BARRETTE WC, 1987, INFECT IMMUN, V55, P2518, DOI 10.1128/IAI.55.10.2518-2525.1987; Barth E, 2009, MICROBIOL-SGM, V155, P1680, DOI 10.1099/mic.0.026021-0; Bender RA, 2010, J BACTERIOL, V192, P4801, DOI 10.1128/JB.00266-10; Blanchard JL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001186; Brookes E, 2010, EUR BIOPHYS J BIOPHY, V39, P405, DOI 10.1007/s00249-009-0413-5; CANDEIAS LP, 1994, FREE RADICAL RES, V20, P241, DOI 10.3109/10715769409147520; Chen J, 2010, J MOL BIOL, V398, P122, DOI 10.1016/j.jmb.2010.02.022; Chi BK, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009506; Choi HJ, 2001, CELL, V105, P103, DOI 10.1016/S0092-8674(01)00300-2; Davies MJ, 2005, BBA-PROTEINS PROTEOM, V1703, P93, DOI 10.1016/j.bbapap.2004.08.007; Dukan S, 1996, J BACTERIOL, V178, P6145, DOI 10.1128/jb.178.21.6145-6150.1996; Dukan S, 1996, APPL ENVIRON MICROB, V62, P4003, DOI 10.1128/AEM.62.11.4003-4008.1996; Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269; Gu MZ, 2011, MOL MICROBIOL, V79, P1136, DOI 10.1111/j.1365-2958.2010.07520.x; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; Habdas BJ, 2010, J BACTERIOL, V192, P3699, DOI 10.1128/JB.00382-10; Ignatova Z, 2008, METHOD CELL BIOL, V89, P59, DOI 10.1016/S0091-679X(08)00603-1; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; Jakob U, 1999, CELL, V96, P341, DOI 10.1016/S0092-8674(00)80547-4; Jang SJ, 2007, J BIOL CHEM, V282, P929, DOI 10.1074/jbc.M607646200; Lee JW, 2007, P NATL ACAD SCI USA, V104, P8743, DOI 10.1073/pnas.0702081104; Liu YY, 2011, J BACTERIOL, V193, P2186, DOI 10.1128/JB.00001-11; Lochowska A, 2001, J BIOL CHEM, V276, P2098, DOI 10.1074/jbc.M007192200; MacGregor IK, 2004, BIOPHYS CHEM, V108, P165, DOI 10.1016/j.bpc.2003.10.018; Maddocks SE, 2008, MICROBIOL-SGM, V154, P3609, DOI 10.1099/mic.0.2008/022772-0; McHugh JP, 2003, J BIOL CHEM, V278, P29478, DOI 10.1074/jbc.M303381200; Monferrer D, 2010, MOL MICROBIOL, V75, P1199, DOI 10.1111/j.1365-2958.2010.07043.x; Mongkolsuk S, 2002, MOL MICROBIOL, V45, P9, DOI 10.1046/j.1365-2958.2002.03015.x; Pattison DI, 2001, CHEM RES TOXICOL, V14, P1453, DOI 10.1021/tx0155451; Peschek J, 2009, P NATL ACAD SCI USA, V106, P13272, DOI 10.1073/pnas.0902651106; Rosen H, 2009, P NATL ACAD SCI USA, V106, P18686, DOI 10.1073/pnas.0909464106; Sainsbury S, 2009, NUCLEIC ACIDS RES, V37, P4545, DOI 10.1093/nar/gkp445; Souza CEA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027641; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Wang SY, 2009, APPL ENVIRON MICROB, V75, P6110, DOI 10.1128/AEM.00914-09; Winter J, 2008, CELL, V135, P691, DOI 10.1016/j.cell.2008.09.024; Winter J, 2005, MOL CELL, V17, P381, DOI 10.1016/j.molcel.2004.12.027; Winterbourn CC, 2006, J BIOL CHEM, V281, P39860, DOI 10.1074/jbc.M605898200; Zheng M, 1999, J BACTERIOL, V181, P4639, DOI 10.1128/JB.181.15.4639-4643.1999; Zheng M, 2001, J BACTERIOL, V183, P4562, DOI 10.1128/JB.183.15.4562-4570.2001	40	47	50	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6892	6903		10.1074/jbc.M111.287219	http://dx.doi.org/10.1074/jbc.M111.287219			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22223481	Green Published, hybrid			2022-12-27	WOS:000300791800074
J	Campbell, M; Chang, PC; Huerta, S; Izumiya, C; Davis, R; Tepper, CG; Kim, KY; Shevchenko, B; Wang, DH; Jung, JU; Luciw, PA; Kung, HJ; Izumiya, Y				Campbell, Mel; Chang, Pei-Ching; Huerta, Steve; Izumiya, Chie; Davis, Ryan; Tepper, Clifford G.; Kim, Kevin Y.; Shevchenko, Bogdan; Wang, Don-Hong; Jung, Jae U.; Luciw, Paul A.; Kung, Hsing-Jien; Izumiya, Yoshihiro			Protein Arginine Methyltransferase 1-directed Methylation of Kaposi Sarcoma-associated Herpesvirus Latency-associated Nuclear Antigen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; K-BZIP; CHROMOSOME BINDING; SIGNALING PATHWAY; DNA-REPLICATION; VIRAL GENE; J-KAPPA; LANA; TRANSCRIPTION; KINASE	The Kaposi sarcoma-associated herpesvirus (KSHV) latency-associated nuclear antigen (LANA) is a multifunctional protein with roles in gene regulation and maintenance of viral latency. Post-translational modification of LANA is important for functional diversification. Here, we report that LANA is subject to arginine methylation by protein arginine methyltransferase 1 in vitro and in vivo. The major arginine methylation site in LANA was mapped to arginine 20. This site was mutated to either phenylalanine (bulky hydrophobic, constitutive methylated mimetic) or lysine (positively charged, non-arginine methylatable) residues. The significance of the methylation in LANA function was examined in both the isolated form and in the context of the viral genome through the generation of recombinant KSHV. In addition, authentic LANA binding sites on the KSHV episome in naturally infected cells were identified using a whole genome KSHV tiling array. Although mutation of the methylation site resulted in no significant difference in KSHV LANA subcellular localization, we found that the methylation mimetic mutation resulted in augmented histone binding in vitro and increased LANA occupancy at identified LANA target promoters in vivo. Moreover, a cell line carrying the methylation mimetic mutant KSHV showed reduced viral gene expression relative to controls both in latency and in the course of reactivation. These results suggest that residue 20 is important for modulation of a subset of LANA functions and properties of this residue, including the hydrophobic character induced by arginine methylation, may contribute to the observed effects.	[Izumiya, Yoshihiro] Univ Calif Davis, Dept Dermatol, Ctr Canc, Sacramento, CA 95817 USA; [Chang, Pei-Ching; Davis, Ryan; Tepper, Clifford G.; Kung, Hsing-Jien] Univ Calif Davis, Dept Biochem & Mol Med, Davis, CA 95616 USA; [Luciw, Paul A.] Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA; [Jung, Jae U.] Univ So Calif, Dept Mol Med, Keck Sch Med, Los Angeles, CA 90033 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of Southern California	Izumiya, Y (corresponding author), Univ Calif Davis, Dept Dermatol, Ctr Canc, Res 3 Rm 2400,4645 2nd Ave, Sacramento, CA 95817 USA.	yizumiya@ucdavis.edu	Tepper, Clifford G/H-6527-2011; Kung, Hsing-Jien/C-7651-2013	Davis, Ryan/0000-0001-7439-6683; Izumiya, Yoshihiro/0000-0002-9184-2603	National Institutes of Health [R01-CA147791, P01-DE19085]; University of California Davis Cancer Center [P30 CA93373]; NATIONAL CANCER INSTITUTE [R01CA147791, P30CA093373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [P01DE019085] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California Davis Cancer Center(University of California System); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-CA147791 (to Y. I.) and P01-DE19085 (to H.-J. K., J. U. J., and Y. I.). Additional funding was provided by University of California Davis Cancer Center Support Grant P30 CA93373.	An FQ, 2005, J BIOL CHEM, V280, P3862, DOI 10.1074/jbc.M407435200; Arad U, 1998, BIOTECHNIQUES, V24, P760, DOI 10.2144/98245bm14; Barbera AJ, 2006, SCIENCE, V311, P856, DOI 10.1126/science.1120541; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Boisvert FM, 2003, MOL CELL PROTEOMICS, V2, P1319, DOI 10.1074/mcp.M300088-MCP200; Buchholz F, 1998, NAT BIOTECHNOL, V16, P657, DOI 10.1038/nbt0798-657; Cesarman E, 1999, SEMIN CANCER BIOL, V9, P165, DOI 10.1006/scbi.1998.0118; Chang PC, 2011, J VIROL, V85, P3283, DOI 10.1128/JVI.02485-10; Chang PC, 2009, CANCER RES, V69, P5681, DOI 10.1158/0008-5472.CAN-08-4570; Cheng F, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000324; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; Fischle W, 2003, NATURE, V425, P475, DOI 10.1038/nature02017; Friborg J, 1999, NATURE, V402, P889, DOI 10.1038/47266; Ganem D, 2010, J CLIN INVEST, V120, P939, DOI 10.1172/JCI40567; Gary JD, 1998, PROG NUCLEIC ACID RE, V61, P65, DOI 10.1016/S0079-6603(08)60825-9; Gross H, 2010, VIROLOGY, V397, P299, DOI 10.1016/j.virol.2009.11.023; Grundhoff A, 2003, J VIROL, V77, P2779, DOI 10.1128/JVI.77.4.2779-2783.2003; Gunther T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000935; Hamza MS, 2004, J BIOL CHEM, V279, P38325, DOI 10.1074/jbc.M400964200; Han SJ, 2010, J GEN VIROL, V91, P2203, DOI 10.1099/vir.0.020958-0; HERNDIER BG, 1994, AIDS, V8, P575, DOI 10.1097/00002030-199405000-00002; HIBBARD MK, 1995, J VIROL, V69, P4656, DOI 10.1128/JVI.69.8.4656-4667.1995; Hu JH, 2002, J VIROL, V76, P11677, DOI 10.1128/JVI.76.22.11677-11687.2002; Huq MDM, 2006, EMBO J, V25, P5094, DOI 10.1038/sj.emboj.7601389; Izumiya Y, 2005, J VIROL, V79, P9912, DOI 10.1128/JVI.79.15.9912-9925.2005; Izumiya Y, 2003, J VIROL, V77, P9652, DOI 10.1128/JVI.77.17.9652-9661.2003; Izumiya Y, 2003, J VIROL, V77, P1441, DOI 10.1128/JVI.77.2.1441-1451.2003; Izumiya Y, 2009, J VIROL, V83, P4435, DOI 10.1128/JVI.01999-08; Kedes DH, 1997, J CLIN INVEST, V100, P2606, DOI 10.1172/JCI119804; Kelley-Clarke B, 2009, J VIROL, V83, P4326, DOI 10.1128/JVI.02395-08; Koyuncu OO, 2009, J VIROL, V83, P4778, DOI 10.1128/JVI.02493-08; Lacovides DC, 2007, J VIROL, V81, P13209, DOI 10.1128/JVI.01415-06; Lan K, 2005, J VIROL, V79, P3468, DOI 10.1128/JVI.79.6.3468-3478.2005; Lee J, 2005, J BIOL CHEM, V280, P32890, DOI 10.1074/jbc.M506944200; Lei NZ, 2009, NUCLEIC ACIDS RES, V37, P832, DOI 10.1093/nar/gkn941; Li QH, 2008, VIROLOGY, V379, P234, DOI 10.1016/j.virol.2008.06.043; Li YJ, 2004, J VIROL, V78, P13325, DOI 10.1128/JVI.78.23.13325-13334.2004; Lim C, 2002, J VIROL, V76, P10320, DOI 10.1128/JVI.76.20.10320-10331.2002; Lim C, 2001, J BIOL CHEM, V276, P31016, DOI 10.1074/jbc.M102431200; Lu F, 2006, J VIROL, V80, P5273, DOI 10.1128/JVI.02541-05; Mears WE, 1996, J VIROL, V70, P7445, DOI 10.1128/JVI.70.11.7445-7453.1996; Mesri EA, 2010, NAT REV CANCER, V10, P707, DOI 10.1038/nrc2888; Murakami Y, 2006, J BIOL CHEM, V281, P28113, DOI 10.1074/jbc.M602026200; Nakamura H, 2003, J VIROL, V77, P4205, DOI 10.1128/JVI.77.7.4205-4220.2003; Ohsaki E, 2004, J VIROL, V78, P9936, DOI 10.1128/JVI.78.18.9936-9946.2004; Ohsaki E, 2009, VIRUS RES, V139, P74, DOI 10.1016/j.virusres.2008.10.011; Piolot T, 2001, J VIROL, V75, P3948, DOI 10.1128/JVI.75.8.3948-3959.2001; Platt GM, 1999, J VIROL, V73, P9789, DOI 10.1128/JVI.73.12.9789-9795.1999; Radkov SA, 2000, NAT MED, V6, P1121, DOI 10.1038/80459; Renne R, 2001, J VIROL, V75, P458, DOI 10.1128/JVI.75.1.458-468.2001; Rho J, 2001, J VIROL, V75, P8031, DOI 10.1128/JVI.75.17.8031-8044.2001; Robin-Lespinasse Y, 2007, J CELL SCI, V120, P638, DOI 10.1242/jcs.03357; Rust HL, 2011, ACS CHEM BIOL, V6, P881, DOI 10.1021/cb200171d; Schulz TF, 2006, J PATHOL, V208, P187, DOI 10.1002/path.1904; Shinohara H, 2002, J VIROL, V76, P12917, DOI 10.1128/JVI.76.24.12917-12924.2002; Shire K, 2006, J VIROL, V80, P5261, DOI 10.1128/JVI.02682-05; SIEGAL B, 1990, CANCER, V65, P492, DOI 10.1002/1097-0142(19900201)65:3<492::AID-CNCR2820650320>3.0.CO;2-C; Sun R, 1998, P NATL ACAD SCI USA, V95, P10866, DOI 10.1073/pnas.95.18.10866; Swaminathan S, 2001, GENESIS, V29, P14, DOI 10.1002/1526-968X(200101)29:1<14::AID-GENE1001>3.0.CO;2-X; Toth Z, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001013; Varjosalo M, 2008, CELL, V133, P537, DOI 10.1016/j.cell.2008.02.047; Verma SC, 2007, CURR TOP MICROBIOL, V312, P101; Verma SC, 2004, J VIROL, V78, P10348, DOI 10.1128/JVI.78.19.10348-10359.2004; Vieira J, 2004, VIROLOGY, V325, P225, DOI 10.1016/j.virol.2004.03.049; Wong Emily L, 2005, Curr Oncol Rep, V7, P349, DOI 10.1007/s11912-005-0061-6; Xie B, 2007, J VIROL, V81, P4226, DOI 10.1128/JVI.01888-06; Yang YP, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng080; Yu J, 2010, BIOCHEM BIOPH RES CO, V391, P322, DOI 10.1016/j.bbrc.2009.11.057; Yun MY, 2011, CELL RES, V21, P564, DOI 10.1038/cr.2011.42	70	40	40	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5806	5818		10.1074/jbc.M111.289496	http://dx.doi.org/10.1074/jbc.M111.289496			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22179613	Green Published, hybrid			2022-12-27	WOS:000300638000056
J	Eapen, A; Ramachandran, A; George, A				Eapen, Asha; Ramachandran, Amsaveni; George, Anne			Dentin Phosphoprotein (DPP) Activates Integrin-mediated Anchorage-dependent Signals in Undifferentiated Mesenchymal Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; SIALOPHOSPHOPROTEIN DSPP; RAT DENTIN; EXPRESSION PATTERNS; MATRIX PROTEINS; TYROSINE KINASE; GENE-EXPRESSION; MAP KINASES; IN-VIVO; PHOSPHOPHORYN	Dentin phosphoprotein (DPP), a major noncollagenous protein of the dentin matrix, is a highly acidic protein that binds Ca2+ avidly and is thus linked to matrix mineralization. Here, we demonstrate that the RGD domain in DPP can bind to integrins on the cell surface of undifferentiated mesenchymal stem cells and pulp cells. This coupling generates intracellular signals that are channeled along cytoskeletal filaments and activate the non-receptor tyrosine kinase focal adhesion kinase, which plays a key role in signaling at sites of cellular adhesion. The putative focal adhesion kinase autophosphorylation site Tyr397 is phosphorylated during focal adhesion assembly induced by DPP on the substrate. We further demonstrate that these intracellular signals propagate through the cytoplasm and activate anchorage-dependent ERK signaling. Activated ERK translocates to the nucleus and phosphorylates the transcription factor ELK-1, which in turn coordinates the expression of downstream target genes such as DMP1 and dentin sialoprotein (DSP). These studies suggest a novel paradigm demonstrating that extracellular DPP can induce intracellular signaling that can be propagated to the nucleus and thus alter gene activities.	[Eapen, Asha; Ramachandran, Amsaveni; George, Anne] Univ Illinois, Brodie Tooth Dev Genet & Regenerat Med Res Lab, Dept Oral Biol, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	George, A (corresponding author), Univ Illinois, Brodie Tooth Dev Genet & Regenerat Med Res Lab, Dept Oral Biol, Chicago, IL 60612 USA.	anneg@uic.edu		GEORGE, ANNE/0000-0002-9008-7642	National Institutes of Health [DE 19633]; Brodie Endowment Fund; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019633] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brodie Endowment Fund; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant DE 19633. This work was also supported by the Brodie Endowment Fund.	Alvares K, 2006, DEV DYNAM, V235, P2980, DOI 10.1002/dvdy.20935; Aplin AE, 2003, FEBS LETT, V534, P11, DOI 10.1016/S0014-5793(02)03840-1; Aplin AE, 2002, J CELL SCI, V115, P2781; Aplin AE, 2001, J CELL BIOL, V153, P273, DOI 10.1083/jcb.153.2.273; Brown MC, 2002, MOL BIOL CELL, V13, P1550, DOI 10.1091/mbc.02-02-0015; Cance WG, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.120pe22; DSouza RN, 1997, J BONE MINER RES, V12, P2040, DOI 10.1359/jbmr.1997.12.12.2040; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Feng JQ, 1998, J BIOL CHEM, V273, P9457, DOI 10.1074/jbc.273.16.9457; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; George A, 1999, CONNECT TISSUE RES, V40, P49, DOI 10.3109/03008209909005277; George A, 1996, J BIOL CHEM, V271, P32869, DOI 10.1074/jbc.271.51.32869; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035; Golubovskaya V, 2004, BBA-GENE STRUCT EXPR, V1678, P111, DOI 10.1016/j.bbaexp.2004.03.002; Hao JJ, 2004, BONE, V34, P921, DOI 10.1016/j.bone.2004.01.020; Hart PS, 2007, CELLS TISSUES ORGANS, V186, P70, DOI 10.1159/000102682; He G, 2005, J BIOL CHEM, V280, P33109, DOI 10.1074/jbc.M500159200; Howe AK, 2002, CURR OPIN GENET DEV, V12, P30, DOI 10.1016/S0959-437X(01)00260-X; Hynes RO, 2004, MATRIX BIOL, V23, P333, DOI 10.1016/j.matbio.2004.08.001; Jaalouk DE, 2009, NAT REV MOL CELL BIO, V10, P63, DOI 10.1038/nrm2597; Jadlowiec J, 2004, J BIOL CHEM, V279, P53323, DOI 10.1074/jbc.M404934200; Juliano RL, 2001, METHOD ENZYMOL, V333, P151; KORNBERG L, 1992, J BIOL CHEM, V267, P23439; Lim ST, 2008, MOL CELL, V29, P9, DOI 10.1016/j.molcel.2007.11.031; LINDE A, 1981, BIOCHIM BIOPHYS ACTA, V667, P341, DOI 10.1016/0005-2795(81)90200-2; MacDougall M, 1997, CYTOGENET CELL GENET, V79, P121, DOI 10.1159/000134697; MacDougall M, 2006, AM J MED GENET A, V140A, P2536, DOI 10.1002/ajmg.a.31359; Malik RK, 1996, J BIOL CHEM, V271, P29785, DOI 10.1074/jbc.271.47.29785; Mamali I, 2008, J CELL PHYSIOL, V216, P198, DOI 10.1002/jcp.21390; Mamali I, 2008, J CELL BIOCHEM, V103, P1895, DOI 10.1002/jcb.21580; Ruoslahti E, 1996, TUMOR BIOL, V17, P117, DOI 10.1159/000217975; RUOSLAHTI E, 1988, ANNU REV BIOCHEM, V57, P375, DOI 10.1146/annurev.bi.57.070188.002111; SABSAY B, 1991, BIOCHEM J, V276, P699, DOI 10.1042/bj2760699; SFEIR C, 1995, J BONE MINER RES, V10, P607; Shemesh T, 2005, J PHYS-CONDENS MAT, V17, pS3913, DOI 10.1088/0953-8984/17/47/019; Sreenath T, 2003, J BIOL CHEM, V278, P24874, DOI 10.1074/jbc.M303908200; Staquet MJ, 2006, CELL TISSUE RES, V323, P457, DOI 10.1007/s00441-005-0104-1; STETLERSTEVENSON WG, 1983, BIOCHEMISTRY-US, V22, P4326, DOI 10.1021/bi00287a025; Suzuki S, 2009, MATRIX BIOL, V28, P221, DOI 10.1016/j.matbio.2009.03.006; Thotakura SR, 2000, J DENT RES, V79, P835, DOI 10.1177/00220345000790030901; Tilghman RW, 2005, J CELL SCI, V118, P2613, DOI 10.1242/jcs.02380; Turner CE, 2000, NAT CELL BIOL, V2, pE231, DOI 10.1038/35046659; TURNER CE, 1991, J CELL BIOL, V115, P201, DOI 10.1083/jcb.115.1.201; VEIS A, 1988, CIBA F SYMP, V136, P161; Veis A, 1998, EUR J ORAL SCI, V106, P234, DOI 10.1111/j.1600-0722.1998.tb02181.x; Yamakoshi Y, 2005, J BIOL CHEM, V280, P17472, DOI 10.1074/jbc.M413220200; Yamakoshi Y, 2008, J BIOL CHEM, V283, P14835, DOI 10.1074/jbc.M800633200; Yamakoshi Y, 2006, J BIOL CHEM, V281, P38235, DOI 10.1074/jbc.M607767200	49	24	25	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5211	5224		10.1074/jbc.M111.290080	http://dx.doi.org/10.1074/jbc.M111.290080			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22134916	Green Published, hybrid			2022-12-27	WOS:000300638000004
J	Fisher, IB; Ostrowski, M; Muthusamy, N				Fisher, Ian B.; Ostrowski, Mike; Muthusamy, Natarajan			Role for Ets-2(Thr-72) Transcription Factor in Stage-specific Thymocyte Development and Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSITIVE SELECTION; NEGATIVE SELECTION; GENE-EXPRESSION; SIGNAL-TRANSDUCTION; ERK ACTIVATION; KAPPA-B; ETS-2; MICE; PROTEIN; PATHWAY	Interference of Ras signaling deregulates thymocyte development in mouse models. However, the role of Ets-2, a transcription factor that is phosphorylated on a critical threonine residue (Thr-72) by the Ras/MAPK pathway in thymocyte development, has not been defined. Transgenic mice overexpressing a phosphomutant Ets-2 (T72A) in the thymus displayed reduced thymus size associated with a 60-80% reduction in thymocyte populations. The transgenic mice exhibited a 20-fold increase in a c-Kit(+) CD4(+) CD8(+) CD3(-) population and a 5-fold increase in a unique CD5(low) population associated with a partial developmental block at the DN2-DN3 stage of thymocytes. Transgenic thymocytes exhibited increased apoptosis, and overexpression of Bcl-2 rescued the hypocellularity and associated thymocyte developmental block in double transgenic mice. The observed defects in these mice are not dependent on Ets-1 expression. These studies implicate for the first time a stage-specific Ets-1-independent regulatory role for Ets-2 in early thymocyte development and survival.	[Fisher, Ian B.; Ostrowski, Mike; Muthusamy, Natarajan] Ohio State Univ, Ctr Comprehens Canc, Mol Cellular Dev Biol Program, Div Hematol, Columbus, OH 43210 USA; [Muthusamy, Natarajan] Ohio State Univ, Ctr Comprehens Canc, Dept Internal Med, Columbus, OH 43210 USA; [Ostrowski, Mike; Muthusamy, Natarajan] Ohio State Univ, Ctr Comprehens Canc, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Muthusamy, Natarajan] Ohio State Univ, Ctr Comprehens Canc, Dept Vet Biosci, Columbus, OH 43210 USA	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Muthusamy, N (corresponding author), 455E Ohio State Univ Comprehens Canc Ctr, Div Hematol, Dept Internal Med, 410W12th Ave, Columbus, OH 43210 USA.	raj.muthusamy@osumc.edu	Ostrowski, Michael/H-3108-2011	Ostrowski, Michael/0000-0003-2948-6297				Akashi K, 1996, IMMUNITY, V5, P147, DOI 10.1016/S1074-7613(00)80491-4; Akashi K, 1998, P NATL ACAD SCI USA, V95, P2486, DOI 10.1073/pnas.95.5.2486; AlberolaIla J, 1996, J EXP MED, V184, P9, DOI 10.1084/jem.184.1.9; Anderson MK, 1999, DEVELOPMENT, V126, P3131; Azzam HS, 1998, J EXP MED, V188, P2301, DOI 10.1084/jem.188.12.2301; Azzam HS, 2001, J IMMUNOL, V166, P5464, DOI 10.4049/jimmunol.166.9.5464; Baker KM, 2003, J BIOL CHEM, V278, P17876, DOI 10.1074/jbc.M209480200; Barton K, 1998, IMMUNITY, V9, P555, DOI 10.1016/S1074-7613(00)80638-X; Barton K, 1996, NATURE, V379, P81, DOI 10.1038/379081a0; Bommhardt U, 2000, J IMMUNOL, V164, P2326, DOI 10.4049/jimmunol.164.5.2326; Cantrell DA, 2002, NAT REV IMMUNOL, V2, P20, DOI 10.1038/nri703; Costello PS, 2004, NAT IMMUNOL, V5, P289, DOI 10.1038/ni1038; Delgado P, 2000, NATURE, V406, P426, DOI 10.1038/35019102; DUDLEY EC, 1994, IMMUNITY, V1, P83, DOI 10.1016/1074-7613(94)90102-3; Eyquem S, 2004, P NATL ACAD SCI USA, V101, P15712, DOI 10.1073/pnas.0405546101; Ezashi T, 1998, P NATL ACAD SCI USA, V95, P7882, DOI 10.1073/pnas.95.14.7882; Foos G, 2000, ONCOGENE, V19, P5507, DOI 10.1038/sj.onc.1203946; Foulds CE, 2004, MOL CELL BIOL, V24, P10954, DOI 10.1128/MCB.24.24.10954-10964.2004; FUJIWARA S, 1990, MOL CELL BIOL, V10, P1249, DOI 10.1128/MCB.10.3.1249; FUJIWARA S, 1988, MOL CELL BIOL, V8, P4700, DOI 10.1128/MCB.8.11.4700; Hettmann T, 2000, J IMMUNOL, V165, P5004, DOI 10.4049/jimmunol.165.9.5004; Hettmann T, 1999, J EXP MED, V189, P145, DOI 10.1084/jem.189.1.145; Mariathasan S, 2000, EUR J IMMUNOL, V30, P1060, DOI 10.1002/(SICI)1521-4141(200004)30:4<1060::AID-IMMU1060>3.0.CO;2-2; McCarthy SA, 1997, MOL CELL BIOL, V17, P2401, DOI 10.1128/MCB.17.5.2401; Moisan J, 2007, J EXP MED, V204, P2825, DOI 10.1084/jem.20070994; MUTHUSAMY N, 1995, NATURE, V377, P639, DOI 10.1038/377639a0; Na SY, 2003, J IMMUNOL, V171, P1285, DOI 10.4049/jimmunol.171.3.1285; NEGISHI I, 1995, NATURE, V376, P435, DOI 10.1038/376435a0; OShea CC, 1996, EUR J IMMUNOL, V26, P2350, DOI 10.1002/eji.1830261012; Pages G, 1999, SCIENCE, V286, P1374, DOI 10.1126/science.286.5443.1374; Pivniouk VI, 2000, CURR OPIN IMMUNOL, V12, P173, DOI 10.1016/S0952-7915(99)00068-0; Seidel JJ, 2002, GENE DEV, V16, P127, DOI 10.1101/gad.950902; Smith JL, 2000, MOL CELL BIOL, V20, P8026, DOI 10.1128/MCB.20.21.8026-8034.2000; STRASSER A, 1991, CELL, V67, P889, DOI 10.1016/0092-8674(91)90362-3; STRASSER A, 1994, NATURE, V368, P457, DOI 10.1038/368457a0; SWAN KA, 1995, EMBO J, V14, P276, DOI 10.1002/j.1460-2075.1995.tb07001.x; Swat W, 1996, P NATL ACAD SCI USA, V93, P4683, DOI 10.1073/pnas.93.10.4683; TARAKHOVSKY A, 1995, SCIENCE, V269, P535, DOI 10.1126/science.7542801; Villalba M, 2000, EUR J IMMUNOL, V30, P1587, DOI 10.1002/1521-4141(200006)30:6<1587::AID-IMMU1587>3.0.CO;2-T; Wei G, 2003, ANTICANCER RES, V23, P2173; Wolvetang EJ, 2003, NEUROBIOL DIS, V14, P349, DOI 10.1016/S0969-9961(03)00107-4; Wolvetang EJ, 2003, HUM MOL GENET, V12, P247, DOI 10.1093/hmg/ddg015; Yamamoto H, 1998, GENE DEV, V12, P1315, DOI 10.1101/gad.12.9.1315; Yang BS, 1996, MOL CELL BIOL, V16, P538; Zabuawala T, 2010, CANCER RES, V70, P1323, DOI 10.1158/0008-5472.CAN-09-1474; Zaldumbide A, 2002, J IMMUNOL, V169, P4873, DOI 10.4049/jimmunol.169.9.4873; Zamisch M, 2009, J EXP MED, V206, P2685, DOI 10.1084/jem.20092024	47	4	4	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5199	5210		10.1074/jbc.M111.242602	http://dx.doi.org/10.1074/jbc.M111.242602			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22128184	hybrid, Green Published			2022-12-27	WOS:000300638000003
J	Raycroft, MT; Harvey, BP; Bruck, MJ; Mamula, MJ				Raycroft, Maurice T.; Harvey, Bohdan P.; Bruck, Matthew J.; Mamula, Mark J.			Inhibition of Antigen Trafficking through Scavenger Receptor A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B-CELLS; T-CELLS; LYMPHOCYTES; AUTOIMMUNITY; MACROPHAGES; CONSUMPTION; IMMUNITY; LIGANDS; MOUSE; JOINT	B cell acquisition and presentation of specific autoantigens (auto-Ags) are thought to play an important and complex role in autoimmunity development. We previously identified scavenger receptor A (SR-A) as an early target in altering B cell-mediated autoimmunity. SR-A is highly expressed on professional antigen-presenting cells such as macrophages (M Phi s) and dendritic cells (DCs). In this study, we demonstrate that SR-A is responsible for controlling B cell interactions with DCs/M Phi s to promote Ag transfer from B cells to qDCs/M Phi s. We established a high-throughput ELISA-based screen to identify novel SR-A inhibitors, the specificity of which was determined by dose dependence and Biacore surface plasmon resonance testing. We identified small molecule inhibitors (SMIs) able to reduce SR-A-mediated Ag transfer in human cells. In particular, the SMIs prevented SR-A-positive cells from accumulating/loading Ag over time. Furthermore, we determined that one SMI, sennoside B, can reduce SR-A-mediated capture of B cells. Finally, SMI-mediated decreases in Ag transfer or accumulation reduced T cell proliferation in vitro and in vivo. These observations demonstrate that B cell-DC/M Phi interactions are conducive to promoting Ag trafficking between these cell types via SR-A. Inhibitors of SR-A may provide a novel therapeutic strategy in ameliorating autoimmune disease development.	[Raycroft, Maurice T.; Harvey, Bohdan P.; Bruck, Matthew J.; Mamula, Mark J.] Yale Univ, Sch Med, Rheumatol Sect, Dept Internal Med, New Haven, CT 06520 USA	Yale University	Mamula, MJ (corresponding author), Yale Univ, Sch Med, Rheumatol Sect, Dept Internal Med, 300 Cedar St,TAC S-525,POB 208031, New Haven, CT 06520 USA.	mark.mamula@yale.edu			National Institutes of Health [AR41032]; Alliance for Lupus Research Target Identification in Lupus award; Heimbold Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026992] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041032, R29AR041032] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alliance for Lupus Research Target Identification in Lupus award; Heimbold Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AR41032. This work was also supported by an Alliance for Lupus Research Target Identification in Lupus award (to M. J. M.) and by Leif and Adrienne Heimbold with a generous contribution from the Heimbold Foundation.	Chan OTM, 1999, J EXP MED, V189, P1639, DOI 10.1084/jem.189.10.1639; Chen YC, 2009, LIFE SCI, V84, P915, DOI 10.1016/j.lfs.2009.04.003; GOLDSTEIN JL, 1976, CELL, V7, P85, DOI 10.1016/0092-8674(76)90258-0; Guarize L., 2011, NAT PROD RES, V1, P1; Guo CQ, 2012, IMMUNOL CELL BIOL, V90, P101, DOI 10.1038/icb.2011.10; Harshyne LA, 2003, J IMMUNOL, V170, P2302, DOI 10.4049/jimmunol.170.5.2302; Harvey BP, 2008, J IMMUNOL, V181, P4043, DOI 10.4049/jimmunol.181.6.4043; Harvey BP, 2007, EUR J IMMUNOL, V37, P1739, DOI 10.1002/eji.200636452; Howell AB, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-94; Hueza IM, 2007, J VET MED A, V54, P179, DOI 10.1111/j.1439-0442.2007.00917.x; Juthani-Mehta M, 2010, J AM GERIATR SOC, V58, P2028, DOI 10.1111/j.1532-5415.2010.03080.x; Krajka-Kuzniak V, 2003, TOXICOL LETT, V143, P209, DOI 10.1016/S0378-4274(03)00177-2; LANZAVECCHIA A, 1990, ANNU REV IMMUNOL, V8, P773, DOI 10.1146/annurev.immunol.8.1.773; Maranon C, 2004, P NATL ACAD SCI USA, V101, P6092, DOI 10.1073/pnas.0304860101; Musso G, 2011, ANNU REV MED, V62, P361, DOI 10.1146/annurev-med-012510-175505; PIERCE SK, 1988, IMMUNOL REV, V106, P149, DOI 10.1111/j.1600-065X.1988.tb00778.x; Platt N, 2001, J CLIN INVEST, V108, P649, DOI 10.1172/JCI200113903; Pluddemann Annette, 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406000159; Santiago-Garcia J, 2001, J BIOL CHEM, V276, P30655, DOI 10.1074/jbc.M102879200; Scheinecker C, 2011, NAT REV RHEUMATOL, V7, P73, DOI 10.1038/nrrheum.2010.226; Shukla M, 2008, NUTRITION, V24, P733, DOI 10.1016/j.nut.2008.03.013; Suzuki H, 1997, NATURE, V386, P292, DOI 10.1038/386292a0; TZEHOVAL E, 1983, EUR J IMMUNOL, V13, P89, DOI 10.1002/eji.1830130202; Wang XY, 2007, CANCER RES, V67, P4996, DOI 10.1158/0008-5472.CAN-06-3138; Yan J, 2005, INT IMMUNOL, V17, P869, DOI 10.1093/intimm/dxh266; Yan J, 2002, INT IMMUNOL, V14, P963, DOI 10.1093/intimm/dxf064; Yan J, 2006, J IMMUNOL, V177, P4481, DOI 10.4049/jimmunol.177.7.4481; Yokota T, 1998, EXP CELL RES, V239, P16, DOI 10.1006/excr.1997.3876	28	21	23	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5310	5316		10.1074/jbc.M111.316356	http://dx.doi.org/10.1074/jbc.M111.316356			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22215667	Green Published, hybrid			2022-12-27	WOS:000300638000013
J	Anderson, DD; Eom, JY; Stover, PJ				Anderson, Donald D.; Eom, Jae Y.; Stover, Patrick J.			Competition between Sumoylation and Ubiquitination of Serine Hydroxymethyltransferase 1 Determines Its Nuclear Localization and Its Accumulation in the Nucleus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN THYMIDYLATE SYNTHASE; DIHYDROFOLATE-REDUCTASE; BIOSYNTHESIS; PROTEASOME; DEOXYRIBONUCLEOTIDE; CHAIN; CYCLE; POOL	Serine hydroxymethyltransferase 1 (SHMT1) expression limits rates of de novo dTMP synthesis in the nucleus. Here we report that SHMT1 is ubiquitinated at the small ubiquitin-like modifier (SUMO) consensus motif and that ubiquitination at that site is required for SHMT1 degradation. SHMT1 protein levels are cell cycle-regulated, and Ub-SHMT1 levels are lowest at S phase when SHMT1 undergoes SUMO modification and nuclear transport. Mutation of the SUMO consensus motif increases SHMT1 stability. SHMT1 interacts with components of the proteasome in both the nucleus and cytoplasm, indicating that degradation occurs in both compartments. Ubc13-mediated ubiquitination is required for SHMT1 nuclear export and increases stability of SHMT1 within the nucleus, whereas Ubc9-mediated modification with Sumo2/3 is involved in nuclear degradation. These data demonstrate that SUMO and ubiquitin modification of SHMT1 occurs on the same lysine residue and determine the localization and accumulation of SHMT1 in the nucleus.	[Anderson, Donald D.; Stover, Patrick J.] Cornell Univ, Grad Field Biochem & Mol & Cell Biol, Ithaca, NY 14853 USA; [Eom, Jae Y.; Stover, Patrick J.] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA	Cornell University; Cornell University	Stover, PJ (corresponding author), Cornell Univ, Grad Field Biochem & Mol & Cell Biol, Ithaca, NY 14853 USA.	pjs13@cornell.edu			National Institutes of Health [DK58144]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058144, R37DK058144] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant DK58144 (to P. J. S.).	Anderson DD, 2007, CLIN CHEM LAB MED, V45, P1760, DOI 10.1515/CCLM.2007.355; Anderson DD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005839; Brooks P, 2000, BIOCHEM J, V346, P155, DOI 10.1042/0264-6021:3460155; Fox JT, 2009, J BIOL CHEM, V284, P31097, DOI 10.1074/jbc.M109.015800; Herbig K, 2002, J BIOL CHEM, V277, P38381, DOI 10.1074/jbc.M205000200; Ke PY, 2005, GENE DEV, V19, P1920, DOI 10.1101/gad.1322905; Lafarga M, 2002, MOL BIOL CELL, V13, P2771, DOI 10.1091/mbc.E02-03-0122; Laine A, 2006, MOL CELL BIOL, V26, P8901, DOI 10.1128/MCB.01156-06; MacFarlane AJ, 2008, J BIOL CHEM, V283, P25846, DOI 10.1074/jbc.M802671200; Maguire M, 2008, CANCER RES, V68, P3232, DOI 10.1158/0008-5472.CAN-07-5271; Melo SP, 2010, BIOCHEM J, V432, P217, DOI 10.1042/BJ20101027; Oppenheim EW, 2001, J BIOL CHEM, V276, P19855, DOI 10.1074/jbc.M100039200; Pena MMO, 2009, J BIOL CHEM, V284, P31597, DOI 10.1074/jbc.M109.038455; Pena MMO, 2006, BIOCHEM J, V394, P355, DOI 10.1042/BJ20051479; REICHARD P, 1988, ANNU REV BIOCHEM, V57, P349, DOI 10.1146/annurev.bi.57.070188.002025; Saeki Y, 2009, EMBO J, V28, P359, DOI 10.1038/emboj.2008.305; Samsonoff WA, 1997, J BIOL CHEM, V272, P13281, DOI 10.1074/jbc.272.20.13281; Schimmel J, 2008, MOL CELL PROTEOMICS, V7, P2107, DOI 10.1074/mcp.M800025-MCP200; SPYROU G, 1988, MUTAT RES, V200, P37, DOI 10.1016/0027-5107(88)90069-3; Ulrich HD, 2009, DNA REPAIR, V8, P461, DOI 10.1016/j.dnarep.2009.01.006; Woeller CF, 2007, J BIOL CHEM, V282, P17623, DOI 10.1074/jbc.M702526200	21	48	48	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4790	4799		10.1074/jbc.M111.302174	http://dx.doi.org/10.1074/jbc.M111.302174			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22194612	Green Published, hybrid			2022-12-27	WOS:000300608500040
J	Bovijn, C; Ulrichts, P; De Smet, AS; Catteeuw, D; Beyaert, R; Tavernier, J; Peelman, F				Bovijn, Celia; Ulrichts, Peter; De Smet, Anne-Sophie; Catteeuw, Dominiek; Beyaert, Rudi; Tavernier, Jan; Peelman, Frank			Identification of Interaction Sites for Dimerization and Adapter Recruitment in Toll/Interleukin-1 Receptor (TIR) Domain of Toll-like Receptor 4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; MULTIPLE SEQUENCE ALIGNMENT; SIGNAL-TRANSDUCTION; CRYSTAL-STRUCTURE; INTERACTION TRAP; STRUCTURAL BASIS; PROTEINS; TLR4; ACTIVATION; DIMER	Toll-like receptor signaling requires interactions of the Toll/IL-1 receptor (TIR) domains of the receptor and adapter proteins. Using the mammalian protein-protein interaction trap strategy, homology modeling, and site-directed mutagenesis, we identify the interaction surfaces in the TLR4 TIR domain for the TLR4-TLR4, TLR4-MyD88 adapter-like (MAL), and TLR4-TRIF-related adapter molecule (TRAM) interaction. Two binding sites are equally important for TLR4 dimerization and adapter recruitment. In a model based on the crystal structure of the dimeric TLR10 TIR domain, the first binding site mediates TLR4-TLR4 TIR-TIR interaction. Upon dimerization, two identical second binding sites of the TLR4 TIR domain are juxtaposed and form an extended binding platform for both MAL and TRAM. In our mammalian protein-protein interaction trap assay, MAL and TRAM compete for binding to this platform. Our data suggest that adapter binding can stabilize the TLR4 TIR dimerization.	[Bovijn, Celia; Ulrichts, Peter; De Smet, Anne-Sophie; Catteeuw, Dominiek; Tavernier, Jan; Peelman, Frank] Univ Ghent VIB, Dept Med Prot Res, B-9000 Ghent, Belgium; [Beyaert, Rudi] Univ Ghent VIB, Dept Mol Biomed Res, Unit Mol Signal Transduct Inflammat, B-9000 Ghent, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University	Peelman, F (corresponding author), Univ Ghent VIB, Dept Med Prot Res, B-9000 Ghent, Belgium.	frank.peelman@vib-ugent.be	Beyaert, Rudi/B-2589-2009; Tavernier, Jan/AAG-3636-2019	Beyaert, Rudi/0000-0002-5704-582X	Ugent BOF [01Z03306]; FWO "Krediet aan Navorsers" [1.5.256.08N]	Ugent BOF; FWO "Krediet aan Navorsers"(FWO)	This work was supported by Ugent BOF Grant 01Z03306 and FWO "Krediet aan Navorsers" Grant 1.5.256.08N.	Bartfai T, 2003, P NATL ACAD SCI USA, V100, P7971, DOI 10.1073/pnas.0932746100; Brown V, 2006, EUR J IMMUNOL, V36, P742, DOI 10.1002/eji.200535158; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Eyckerman S, 2001, NAT CELL BIOL, V3, P1114, DOI 10.1038/ncb1201-1114; Eyckerman S, 1999, EUR CYTOKINE NETW, V10, P549; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Gautam JK, 2006, J BIOL CHEM, V281, P30132, DOI 10.1074/jbc.M602057200; Gay NJ, 2007, ANNU REV BIOCHEM, V76, P141, DOI 10.1146/annurev.biochem.76.060305.151318; Gay NJ, 2011, TRENDS IMMUNOL, V32, P104, DOI 10.1016/j.it.2010.12.005; Hennessy EJ, 2010, NAT REV DRUG DISCOV, V9, P293, DOI 10.1038/nrd3203; Hubbard SJ, 1993, NACCESS COMPUTER PRO; Jenkins KA, 2010, CYTOKINE, V49, P237, DOI 10.1016/j.cyto.2009.01.009; Jiang ZF, 2006, P NATL ACAD SCI USA, V103, P10961, DOI 10.1073/pnas.0603804103; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Khan JA, 2004, J BIOL CHEM, V279, P31664, DOI 10.1074/jbc.M403434200; Kobayashi M, 2006, J IMMUNOL, V176, P6211, DOI 10.4049/jimmunol.176.10.6211; Loiarro M, 2005, J BIOL CHEM, V280, P15809, DOI 10.1074/jbc.C400613200; Loiarro M, 2007, J LEUKOCYTE BIOL, V82, P801, DOI 10.1189/jlb.1206746; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Miggin SM, 2007, P NATL ACAD SCI USA, V104, P3372, DOI 10.1073/pnas.0608100104; Miguel RN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000788; Monie TP, 2009, IMMUNOL REV, V227, P161, DOI 10.1111/j.1600-065X.2008.00735.x; Nyman T, 2008, J BIOL CHEM, V283, P11861, DOI 10.1074/jbc.C800001200; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Ohnishi H, 2009, P NATL ACAD SCI USA, V106, P10260, DOI 10.1073/pnas.0812956106; Pattyn E, 2008, J VIROL METHODS, V153, P7, DOI 10.1016/j.jviromet.2008.06.021; Peelman F, 2004, J BIOL CHEM, V279, P41038, DOI 10.1074/jbc.M404962200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Piessevaux J, 2006, J BIOL CHEM, V281, P32953, DOI 10.1074/jbc.M600776200; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Ronni T, 2003, MOL CELL BIOL, V23, P2543, DOI 10.1128/MCB.23.7.2543-2555.2003; Slack JL, 2000, J BIOL CHEM, V275, P4670, DOI 10.1074/jbc.275.7.4670; Takashima K, 2009, BRIT J PHARMACOL, V157, P1250, DOI 10.1111/j.1476-5381.2009.00297.x; Tao X, 2002, BIOCHEM BIOPH RES CO, V299, P216, DOI 10.1016/S0006-291X(02)02581-0; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Toshchakov VY, 2007, J IMMUNOL, V178, P2655, DOI 10.4049/jimmunol.178.5.2655; Toshchakov VU, 2005, J IMMUNOL, V175, P494, DOI 10.4049/jimmunol.175.1.494; Ulrichts P, 2007, FEBS LETT, V581, P629, DOI 10.1016/j.febslet.2007.01.026; Ulrichts P, 2010, J CELL SCI, V123, P256, DOI 10.1242/jcs.056002; Valkov E, 2011, P NATL ACAD SCI USA, V108, P14879, DOI 10.1073/pnas.1104780108; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600; Yan JP, 2010, J VIROL, V84, P76, DOI 10.1128/JVI.01647-09; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087	47	51	52	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					4088	4098		10.1074/jbc.M111.282350	http://dx.doi.org/10.1074/jbc.M111.282350			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22139835	Green Published, hybrid			2022-12-27	WOS:000300410900042
J	Feng, XL; Liu, QT; Cao, RB; Zhou, B; Ma, ZY; Deng, WL; Wei, JC; Qiu, YF; Wang, FQ; Gu, JY; Wang, FJ; Zheng, QS; Ishag, H; Chen, PY				Feng, Xiu-Li; Liu, Qing-Tao; Cao, Rui-Bing; Zhou, Bin; Ma, Zhi-Yong; Deng, Wen-Lei; Wei, Jian-Chao; Qiu, Ya-Feng; Wang, Fang-Quan; Gu, Jin-Yan; Wang, Feng-Juan; Zheng, Qi-Sheng; Ishag, Hassan; Chen, Pu-Yan			Identification and Characterization of Novel Immunomodulatory Bursal-derived Pentapeptide-II (BPP-II)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P53 TUMOR-SUPPRESSOR; B-CELL DEVELOPMENT; IN-VIVO; DIFFERENTIATING HORMONE; APOPTOTIC RESPONSE; FAMILY-MEMBERS; FABRICIUS; PROTEIN; CANCER; DEATH	The bursa of Fabricius, the acknowledged central humoral immune organ, plays a vital role in B lymphocyte differentiation. However, there are few reports of the molecular basis of the mechanism on immune induction and potential antitumor activity of bursal-derived peptides. In this paper, a novel bursal-derived pentapeptide-II (BPP-II, MTLTG) was isolated and exerted immunomodulatory functions on antibody responses in vitro. Gene microarray analyses demonstrated that BPP-II regulated expression of 2478 genes in a mouse-derived hybridoma cell line. Immune-related gene ontology functional procedures were employed for further functional analysis. Furthermore, the majority of BPP-II-regulated pathways were associated with immune responses and tumor processes. Moreover, BPP-II exhibited immunomodulatory effects on antigen-specific immune responses in vivo, including enhancement of avian influenza virus (H9N2 subtype)-specific antibody and cytokine production and modification of T cell immunophenotypes and lymphocyte proliferation. Finally, BPP-II triggered p53 expression and stabilization and selectively inhibited tumor cell proliferation. These data identified the multifunctional factor, BPP-II, as a novel biomaterial representing an important linking between the humoral central immune system and immune induction, including antitumor. Information generated in this study elucidates further the mechanisms involved in humoral immune system and represents the potential basis of effective immunotherapeutic strategies for treating human tumors and immune improvement.	[Feng, Xiu-Li; Cao, Rui-Bing; Zhou, Bin; Deng, Wen-Lei; Wang, Fang-Quan; Gu, Jin-Yan; Wang, Feng-Juan; Ishag, Hassan; Chen, Pu-Yan] Nanjing Agr Univ, Dept Agr China, Div Key Lab Anim Dis Diag & Immunol, Nanjing 210095, Jiangsu, Peoples R China; [Liu, Qing-Tao] Yangzhou Univ, Yangzhou 225009, Peoples R China; [Ma, Zhi-Yong; Wei, Jian-Chao; Qiu, Ya-Feng] Chinese Acad Agr Sci, Shanghai Vet Res Inst, Shanghai 200241, Peoples R China; [Zheng, Qi-Sheng] Engn Res Ctr, Div Natl Vet Biol Med, Nanjing 210014, Peoples R China	Nanjing Agricultural University; Yangzhou University; Chinese Academy of Agricultural Sciences; Shanghai Veterinary Research Institute, CAAS	Chen, PY (corresponding author), Nanjing Agr Univ, Dept Agr China, Div Key Lab Anim Dis Diag & Immunol, Nanjing 210095, Jiangsu, Peoples R China.	puyanchen@yahoo.com.cn		Ali, Hassan/0000-0003-4723-1909	Ministry of Agriculture, China [200803020]; Jiangsu Higher Education Institutions (PAPD)	Ministry of Agriculture, China(Ministry of Agriculture & Rural Affairs); Jiangsu Higher Education Institutions (PAPD)	This work was supported by Grant 200803020 from the National Agriculture Special Research Project for Nonprofit Trades, Ministry of Agriculture, China, and by a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	Adam JK, 2003, PHARMACOL THERAPEUT, V99, P113, DOI 10.1016/S0163-7258(03)00056-1; Arakawa H, 2004, DEV DYNAM, V229, P458, DOI 10.1002/dvdy.10495; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; AUDHYA T, 1986, SCIENCE, V231, P997, DOI 10.1126/science.3484838; BABA T, 1977, IMMUNOLOGY, V32, P271; Beurel E, 2008, J BIOL CHEM, V283, P21934, DOI 10.1074/jbc.M802481200; BRAND A, 1976, SCIENCE, V193, P319, DOI 10.1126/science.180600; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; CHAPPEY O, 1994, J IMMUNOL METHODS, V172, P219, DOI 10.1016/0022-1759(94)90109-0; Chernov AV, 2010, J BIOL CHEM, V285, P19647, DOI 10.1074/jbc.M109.088153; Del-Val M, 2002, MOL IMMUNOL, V39, P235, DOI 10.1016/S0161-5890(02)00104-9; Deng L, 2005, J BIOL CHEM, V280, P27561, DOI 10.1074/jbc.M502660200; Dombrowicz D, 1998, IMMUNITY, V8, P517, DOI 10.1016/S1074-7613(00)80556-7; Du JA, 2006, J BIOL CHEM, V281, P37416, DOI 10.1074/jbc.M605063200; Du LH, 2004, J BIOL CHEM, V279, P11957, DOI 10.1074/jbc.M304935200; Feng XL, 2012, AMINO ACIDS, V42, P2215, DOI 10.1007/s00726-011-0961-8; Feng XL, 2011, PEPTIDES, V32, P1103, DOI 10.1016/j.peptides.2011.04.020; Feng XL, 2010, PEPTIDES, V31, P1562, DOI 10.1016/j.peptides.2010.05.007; Fred D., 2008, AVIAN IMMUNOLOGY, P1; Gorr SU, 2008, PEPTIDES, V29, P2118, DOI 10.1016/j.peptides.2008.09.019; Gromme M, 2002, MOL IMMUNOL, V39, P181, DOI 10.1016/S0161-5890(02)00101-3; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hegde AN, 2004, PROG NEUROBIOL, V73, P311, DOI 10.1016/j.pneurobio.2004.05.005; Hokibara Sho, 2000, Archivum Immunologiae et Therapiae Experimentalis, V48, P267; Igney FH, 2002, NAT REV CANCER, V2, P277, DOI 10.1038/nrc776; Lamprecht B, 2010, NAT MED, V16, P571, DOI 10.1038/nm.2129; LANZAVECCHIA A, 1990, ANNU REV IMMUNOL, V8, P773, DOI 10.1146/annurev.immunol.8.1.773; LASSILA O, 1989, CELL IMMUNOL, V122, P319, DOI 10.1016/0008-8749(89)90080-4; Lawrence MC, 2011, J BIOL CHEM, V286, P1025, DOI 10.1074/jbc.M110.158675; Lecompte O, 2008, TRENDS BIOCHEM SCI, V33, P453, DOI 10.1016/j.tibs.2008.07.002; Lee JT, 2010, CELL DEATH DIFFER, V17, P86, DOI 10.1038/cdd.2009.77; Li DY, 2011, AMINO ACIDS, V40, P505, DOI 10.1007/s00726-010-0663-7; Mandapathil M, 2010, J BIOL CHEM, V285, P7176, DOI 10.1074/jbc.M109.047423; Mikoshiba K, 2007, J NEUROCHEM, V102, P1426, DOI 10.1111/j.1471-4159.2007.04825.x; Moody TW, 2004, J BIOL CHEM, V279, P23580, DOI 10.1074/jbc.M401938200; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; Niiro H, 2002, NAT REV IMMUNOL, V2, P945, DOI 10.1038/nri955; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Pal S, 2007, J BIOL CHEM, V282, P8969, DOI 10.1074/jbc.M605927200; Qiu YF, 2008, BIOCHEM BIOPH RES CO, V377, P151, DOI 10.1016/j.bbrc.2008.09.117; Ranger AM, 2001, NAT GENET, V28, P113, DOI 10.1038/88815; Ratcliffe MJH, 2006, DEV COMP IMMUNOL, V30, P101, DOI 10.1016/j.dci.2005.06.018; Riese MJ, 2011, J BIOL CHEM, V286, P5254, DOI 10.1074/jbc.M110.171884; Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100; Rosse T, 1998, NATURE, V391, P496, DOI 10.1038/35160; Saville MK, 2004, J BIOL CHEM, V279, P42169, DOI 10.1074/jbc.M403362200; SCHMID I, 1992, CYTOMETRY, V13, P204, DOI 10.1002/cyto.990130216; Thanos CD, 1999, PROTEIN SCI, V8, P1708, DOI 10.1110/ps.8.8.1708; Vikstrom I, 2010, SCIENCE, V330, P1095, DOI 10.1126/science.1191793; Walton MI, 2005, MOL CANCER THER, V4, P1369, DOI 10.1158/1535-7163.MCT-04-0341; Xu WW, 2010, IMMUNITY, V33, P340, DOI 10.1016/j.immuni.2010.08.015; Xu WF, 2005, J INTERF CYTOK RES, V25, P113, DOI 10.1089/jir.2005.25.113; Yamaguchi H, 2004, J BIOL CHEM, V279, P39431, DOI 10.1074/jbc.M401530200; Yoshida K, 2006, J BIOL CHEM, V281, P5734, DOI 10.1074/jbc.M512074200	55	15	20	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					3798	3807		10.1074/jbc.M111.273854	http://dx.doi.org/10.1074/jbc.M111.273854			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22184121	hybrid, Green Published			2022-12-27	WOS:000300410900017
J	Patel, N; Masaratana, P; Diaz-Castro, J; Latunde-Dada, GO; Qureshi, A; Lockyer, P; Jacob, M; Arno, M; Matak, P; Mitry, RR; Hughes, RD; Dhawan, A; Patterson, C; Simpson, RJ; Mckie, AT				Patel, Neeta; Masaratana, Patarabutr; Diaz-Castro, Javier; Latunde-Dada, Gladys O.; Qureshi, Aakafa; Lockyer, Pamela; Jacob, Molly; Arno, Matthew; Matak, Pavle; Mitry, Ragai R.; Hughes, Robin D.; Dhawan, Anil; Patterson, Cam; Simpson, Robert J.; McKie, Andrew T.			BMPER Protein Is a Negative Regulator of Hepcidin and Is Up-regulated in Hypotransferrinemic Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDE HEPCIDIN; GENE-EXPRESSION; IRON; ANEMIA; CROSSVEINLESS-2; TRANSFERRIN; FERROPORTIN; INHIBITOR	The BMP/SMAD4 pathway has major effects on liver hepcidin levels. Bone morphogenetic protein-binding endothelial cell precursor-derived regulator (Bmper), a known regulator of BMP signaling, was found to be overexpressed at the mRNA and protein levels in liver of genetically hypotransferrinemic mice (Trfhpx/hpx). Soluble BMPER peptide inhibited BMP2- and BMP6-dependent hepcidin promoter activity in both HepG2 and HuH7 cells. These effects correlated with reduced cellular levels of pSMAD1/5/8. Addition of BMPER peptide to primary human hepatocytes abolished the BMP2-dependent increase in hepcidin mRNA, whereas injection of Bmper peptide into mice resulted in reduced liver hepcidin and increased serum iron levels. Thus Bmper may play an important role in suppressing hepcidin production in hypotransferrinemic mice.	[Patel, Neeta; Masaratana, Patarabutr; Latunde-Dada, Gladys O.; Qureshi, Aakafa; Simpson, Robert J.; McKie, Andrew T.] Kings Coll London, Diabet & Nutr Sci Div, Sch Med, London WC2R 2LS, England; [Masaratana, Patarabutr] Siriraj Hosp, Dept Biochem, Fac Med, Bangkok 10700, Thailand; [Diaz-Castro, Javier] Univ Granada, Dept Physiol, Granada 10871, Spain; [Lockyer, Pamela; Patterson, Cam] Univ N Carolina, Div Cardiol, Chapel Hill, NC 27599 USA; [Jacob, Molly] Christian Med Coll & Hosp, Dept Biochem, Vellore 632002, Tamil Nadu, India; [Arno, Matthew] Kings Coll London, Genom Ctr, London WC2R 2LS, England; [Matak, Pavle] Univ Paris 05, Inst Cochin, F-75014 Paris, France; [Mitry, Ragai R.; Hughes, Robin D.; Dhawan, Anil] Kings Coll Hosp London, Hepatocyte Biol & Transplantat Grp, London SE5 9RS, England	University of London; King's College London; Mahidol University; University of Granada; University of North Carolina; University of North Carolina Chapel Hill; Christian Medical College & Hospital (CMCH) Vellore; University of London; King's College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; King's College Hospital NHS Foundation Trust; King's College Hospital	Mckie, AT (corresponding author), Kings Coll London, Div Diabet & Nutr, London SE1 9NH, England.	andrew.t.mckie@kcl.ac.uk	Dhawan, Anil/B-6730-2009; Díaz-Castro, Javier/AAX-6697-2021; Diaz-Castro, Javier/H-2985-2015; Simpson, Robert J/A-8776-2013	Díaz-Castro, Javier/0000-0003-3659-1757; Diaz-Castro, Javier/0000-0003-3659-1757; Simpson, Robert J/0000-0002-2196-5368; Dhawan, Anil/0000-0002-4942-0845; , Patarabutr/0000-0001-7228-7176	Kings College Graduate School Bursary; Anandamahidol Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER	Kings College Graduate School Bursary; Anandamahidol Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the Kings College Graduate School Bursary (to N. P.) and by the Anandamahidol Foundation (to P. M.).	Ambrosio AL, 2008, DEV CELL, V15, P248, DOI 10.1016/j.devcel.2008.06.013; Andriopoulos B, 2009, NAT GENET, V41, P482, DOI 10.1038/ng.335; Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Babitt JL, 2007, J CLIN INVEST, V117, P1933, DOI 10.1172/JCI31342; Bartnikas TB, 2011, BLOOD, V117, P630, DOI 10.1182/blood-2010-05-287359; Bier E, 2008, DEV CELL, V15, P176, DOI 10.1016/j.devcel.2008.07.012; Binnerts ME, 2004, BIOCHEM BIOPH RES CO, V315, P272, DOI 10.1016/j.bbrc.2004.01.048; Casanovas G, 2009, J MOL MED, V87, P471, DOI 10.1007/s00109-009-0447-2; Conley CA, 2000, DEVELOPMENT, V127, P3947; De Domenico I, 2007, MOL BIOL CELL, V18, P2569, DOI 10.1091/mbc.E07-01-0060; Latunde-Dada GO, 2006, BBA-MOL BASIS DIS, V1762, P414, DOI 10.1016/j.bbadis.2005.12.007; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McKie AT, 2000, MOL CELL, V5, P299, DOI 10.1016/S1097-2765(00)80425-6; Meynard D, 2009, NAT GENET, V41, P478, DOI 10.1038/ng.320; Mitry RR, 2003, CELL TRANSPLANT, V12, P69, DOI 10.3727/000000003783985197; Moser M, 2003, MOL CELL BIOL, V23, P5664, DOI 10.1128/MCB.23.16.5664-5679.2003; Moser M, 2007, J MOL CELL CARDIOL, V43, P243, DOI 10.1016/j.yjmcc.2007.05.008; Nemeth E, 2003, BLOOD, V101, P2461, DOI 10.1182/blood-2002-10-3235; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nemeth E, 2006, ANNU REV NUTR, V26, P323, DOI 10.1146/annurev.nutr.26.061505.111303; Nemeth E, 2006, HAEMATOLOGICA, V91, P727; Nicolas G, 2002, J CLIN INVEST, V110, P1037, DOI 10.1172/JCI200215686; Nicolas G, 2001, P NATL ACAD SCI USA, V98, P8780, DOI 10.1073/pnas.151179498; Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; Raja KB, 1999, BLOOD, V94, P3185, DOI 10.1182/blood.V94.9.3185.421a20_3185_3192; Rentzsch F, 2006, DEVELOPMENT, V133, P801, DOI 10.1242/dev.02250; Robb A, 2004, BLOOD, V104, P4294, DOI 10.1182/blood-2004-06-2481; Tanno T, 2009, BLOOD, V114, P181, DOI 10.1182/blood-2008-12-195503; Weinstein DA, 2002, BLOOD, V100, P3776, DOI 10.1182/blood-2002-04-1260; Zhang JL, 2008, DEV CELL, V14, P739, DOI 10.1016/j.devcel.2008.02.017; Zhang JL, 2007, J BIOL CHEM, V282, P20002, DOI 10.1074/jbc.M700456200	32	24	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					4099	4106		10.1074/jbc.M111.310789	http://dx.doi.org/10.1074/jbc.M111.310789			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22144676	hybrid, Green Published			2022-12-27	WOS:000300410900043
J	Rooj, AK; McNicholas, CM; Bartoszewski, R; Bebok, Z; Benos, DJ; Fuller, CM				Rooj, Arun K.; McNicholas, Carmel M.; Bartoszewski, Rafal; Bebok, Zsuzsanna; Benos, Dale J.; Fuller, Catherine M.			Glioma-specific Cation Conductance Regulates Migration and Cell Cycle Progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-CHANNEL ENAC; ION CHANNELS; MEMBRANE DEPOLARIZATION; NA+ CHANNELS; HYBRID-CELLS; K+ CHANNELS; PROLIFERATION; AMILORIDE; EXPRESSION; CANCER	In this study, we have investigated the role of a glioma-specific cation channel assembled from subunits of the Deg/epithelial sodium channel (ENaC) superfamily, in the regulation of migration and cell cycle progression in glioma cells. Channel inhibition by psalmotoxin-1 (PcTX-1) significantly inhibited migration and proliferation of D54-MG glioma cells. Both PcTX-1 and benzamil, an amiloride analog, caused cell cycle arrest of D54-MG cells inG(0)/G(1) phases (by 30 and 40%, respectively) and reduced cell accumulation in S and G(2)/M phases after 24 h of incubation. Both PcTX-1 and benzamil up-regulated expression of cyclin-dependent kinase inhibitor proteins p21(Cip1) and p27(Kip1). Similar results were obtained in U87MG and primary glioblastoma multiforme cells maintained in primary culture and following knockdown of one of the component subunits, ASIC1. In contrast, knocking down delta ENaC, which is not a component of the glioma cation channel complex, had no effect on cyclin-dependent kinase inhibitor expression. Phosphorylation of ERK1/2 was also inhibited by PcTX-1, benzamil, and knockdown of ASIC1 but not delta ENaC in D54MG cells. Our data suggest that a specific cation conductance composed of acid-sensing ion channels and ENaC subunits regulates migration and cell cycle progression in gliomas.	[Rooj, Arun K.; McNicholas, Carmel M.; Benos, Dale J.; Fuller, Catherine M.] Univ Alabama Birmingham, Dept Physiol & Biophys, Birmingham, AL 35294 USA; [Bartoszewski, Rafal; Bebok, Zsuzsanna; Benos, Dale J.; Fuller, Catherine M.] Univ Alabama Birmingham, Dept Cell Biol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Fuller, CM (corresponding author), Univ Alabama Birmingham, Dept Physiol & Biophys, MCLM 830,1530 3rd Ave S, Birmingham, AL 35294 USA.	cfuller@uab.edu	Bartoszewski, Rafal A/D-6311-2011	Bartoszewski, Rafal A/0000-0002-2864-6757; McNicholas-Bevensee, Carmel/0000-0002-7013-8764	National Institutes of Health [DK37206]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK037206, R01DK037206] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK37206.	AKAIKE N, 1994, JPN J PHYSIOL, V44, P433, DOI 10.2170/jjphysiol.44.433; Berdiev BK, 2003, J BIOL CHEM, V278, P15023, DOI 10.1074/jbc.M300991200; Bondarava M, 2009, PFLUG ARCH EUR J PHY, V458, P675, DOI 10.1007/s00424-009-0649-z; Bubien JK, 2004, AM J PHYSIOL-CELL PH, V287, pC1282, DOI 10.1152/ajpcell.00077.2004; Bubien JK, 1999, AM J PHYSIOL-CELL PH, V276, pC1405, DOI 10.1152/ajpcell.1999.276.6.C1405; Chifflet S, 2005, AM J PHYSIOL-CELL PH, V288, pC1420, DOI 10.1152/ajpcell.00259.2004; Chioni AM, 2009, INT J BIOCHEM CELL B, V41, P1216, DOI 10.1016/j.biocel.2008.11.001; Cuddapah VA, 2011, AM J PHYSIOL-CELL PH, V301, pC541, DOI 10.1152/ajpcell.00102.2011; del Monaco SM, 2009, J MEMBRANE BIOL, V232, P1, DOI 10.1007/s00232-009-9206-0; Escoubas P, 2000, J BIOL CHEM, V275, P25116, DOI 10.1074/jbc.M003643200; Falin RA, 2007, J GEN PHYSIOL, V130, P313, DOI 10.1085/jgp.200709775; Fanton CP, 2001, J BIOL CHEM, V276, P18871, DOI 10.1074/jbc.M011514200; George J, 2010, INT J BIOCHEM CELL B, V42, P1164, DOI 10.1016/j.biocel.2010.04.002; Ghiani CA, 1999, J NEUROSCI, V19, P5380; Glassmann A, 2011, INT J ONCOL, V39, P1567, DOI 10.3892/ijo.2011.1165; GomezManzano C, 1996, CANCER RES, V56, P694; Grifoni SC, 2008, MICROVASC RES, V75, P202, DOI 10.1016/j.mvr.2007.08.003; Grifoni SC, 2006, AM J PHYSIOL-HEART C, V291, pH3076, DOI 10.1152/ajpheart.00333.2006; Gysin S, 2005, CANCER RES, V65, P4870, DOI 10.1158/0008-5472.CAN-04-2848; Haerteis S, 2009, J BIOL CHEM, V284, P29024, DOI 10.1074/jbc.M109.018945; Herrero-Gonzalez S, 2010, ONCOGENE, V29, P5712, DOI 10.1038/onc.2010.299; Hwang CY, 2009, MOL CELL BIOL, V29, P3379, DOI 10.1128/MCB.01758-08; Jia LJ, 2009, CANCER RES, V69, P4974, DOI 10.1158/0008-5472.CAN-08-4671; Joshi AD, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-17; Jung YS, 2010, CELL SIGNAL, V22, P1003, DOI 10.1016/j.cellsig.2010.01.013; Kapoor N, 2009, J BIOL CHEM, V284, P24526, DOI 10.1074/jbc.M109.037390; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Komata T, 2003, BRIT J CANCER, V88, P1277, DOI 10.1038/sj.bjc.6600862; Kortylewski M, 2001, BIOCHEM J, V357, P297, DOI 10.1042/0264-6021:3570297; Kunzelmann K, 2005, J MEMBRANE BIOL, V205, P159, DOI 10.1007/s00232-005-0781-4; Lopez-Gines C, 2008, NEUROPATHOLOGY, V28, P507, DOI 10.1111/j.1440-1789.2008.00911.x; McLean LA, 2000, AM J PHYSIOL-CELL PH, V278, pC676, DOI 10.1152/ajpcell.2000.278.4.C676; McLendon RE, 2007, ARCH PATHOL LAB MED, V131, P1585; Nakabayashi H, 2011, CANCER SCI, V102, P393, DOI 10.1111/j.1349-7006.2010.01794.x; Nakamura K, 2008, AM J PHYSIOL-HEART C, V294, pH1700, DOI 10.1152/ajpheart.01203.2007; ODONNELL ME, 1982, J CELL PHYSIOL, V113, P405, DOI 10.1002/jcp.1041130308; ODONNELL ME, 1983, J PHARMACOL EXP THER, V226, P368; Prevarskaya N, 2007, BBA-MOL BASIS DIS, V1772, P937, DOI 10.1016/j.bbadis.2007.05.006; Ransom CB, 2001, J NEUROSCI, V21, P7674, DOI 10.1523/JNEUROSCI.21-19-07674.2001; Roderick HL, 2008, NAT REV CANCER, V8, P361, DOI 10.1038/nrc2374; Ross SB, 2007, AM J PHYSIOL-CELL PH, V293, pC1181, DOI 10.1152/ajpcell.00066.2007; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Slepkov ER, 2007, BIOCHEM J, V401, P623, DOI 10.1042/BJ20061062; Slingerland J, 2000, J CELL PHYSIOL, V183, P10, DOI 10.1002/(SICI)1097-4652(200004)183:1<10::AID-JCP2>3.0.CO;2-I; Soroceanu L, 1999, J NEUROSCI, V19, P5942, DOI 10.1523/JNEUROSCI.19-14-05942.1999; Soundararajan R, 2009, P NATL ACAD SCI USA, V106, P7804, DOI 10.1073/pnas.0809892106; Ullrich N, 1996, NEUROREPORT, V7, P1020, DOI 10.1097/00001756-199604100-00013; Vervoorts J, 2008, CELL MOL LIFE SCI, V65, P3255, DOI 10.1007/s00018-008-8296-7; Vila-Carriles WH, 2006, J BIOL CHEM, V281, P19220, DOI 10.1074/jbc.M603100200; Wang K, 2010, J NEURO-ONCOL, V98, P319, DOI 10.1007/s11060-009-0082-3; Wang ZG, 2004, PFLUG ARCH EUR J PHY, V448, P274, DOI 10.1007/s00424-004-1258-5; Xu JH, 2011, J NEURO-ONCOL, V105, P241, DOI 10.1007/s11060-011-0604-7; Yang LM, 2006, J BIOL CHEM, V281, P9859, DOI 10.1074/jbc.M512046200; Zohrabian VM, 2009, ANTICANCER RES, V29, P119	54	64	65	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					4053	4065		10.1074/jbc.M111.311688	http://dx.doi.org/10.1074/jbc.M111.311688			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22130665	hybrid, Green Published			2022-12-27	WOS:000300410900039
J	Birkenstock, T; Liebeke, M; Winstel, V; Krismer, B; Gekeler, C; Niemiec, MJ; Bisswanger, H; Lalk, M; Peschel, A				Birkenstock, Timo; Liebeke, Manuel; Winstel, Volker; Krismer, Bernhard; Gekeler, Cordula; Niemiec, Maria J.; Bisswanger, Hans; Lalk, Michael; Peschel, Andreas			Exometabolome Analysis Identifies Pyruvate Dehydrogenase as a Target for the Antibiotic Triphenylbismuthdichloride in Multiresistant Bacterial Pathogens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STAPHYLOCOCCUS-AUREUS; ESCHERICHIA-COLI; MYCOBACTERIUM-TUBERCULOSIS; MULTIENZYME COMPLEX; NMR METABOLOMICS; INACTIVATION; GROWTH; GENES; RESISTANCE; FLUOROPYRUVATE	The desperate need for new therapeutics against notoriously antibiotic-resistant bacteria has led to a quest for novel antibacterial target structures and compounds. Moreover, defining targets and modes of action of new antimicrobial compounds remains a major challenge with standard technologies. Here we characterize the antibacterial properties of triphenylbismuthdichloride (TPBC), which has recently been successfully used against device-associated infections. We demonstrate that TPBC has potent antimicrobial activity against many bacterial pathogens. Using an exometabolome profiling approach, a unique TPBC-mediated change in the metabolites of Staphylococcus aureus was identified, indicating that TPBC blocks bacterial pyruvate catabolism. Enzymatic studies showed that TPBC is a highly efficient, uncompetitive inhibitor of the bacterial pyruvate dehydrogenase complex. Our study demonstrates that metabolomics approaches can offer new avenues for studying the modes of action of antimicrobial compounds, and it indicates that inhibition of the bacterial pyruvate dehydrogenase complex may represent a promising strategy for combating multidrug-resistant bacteria.	[Birkenstock, Timo; Winstel, Volker; Krismer, Bernhard; Gekeler, Cordula; Niemiec, Maria J.; Peschel, Andreas] Univ Tubingen, Cellular & Mol Microbiol Div, Interfac Inst Microbiol & Infect Med, D-72076 Tubingen, Germany; [Bisswanger, Hans] Univ Tubingen, Interfac Inst Biochem, D-72076 Tubingen, Germany; [Liebeke, Manuel; Lalk, Michael] Ernst Moritz Arndt Univ Greifswald, Inst Pharm, D-17487 Greifswald, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Ernst Moritz Arndt Universitat Greifswald	Lalk, M (corresponding author), Friedrich Ludwig Jahn Str 17, D-17487 Greifswald, Germany.	lalk@uni-greifswald.de; andreas.peschel@med.uni-tuebingen.de	Krismer, Bernhard/O-3741-2019; Liebeke, Manuel/F-3559-2012; Lalk, Michael/C-1618-2010; Krismer, Bernhard/V-1380-2017	Krismer, Bernhard/0000-0002-9505-8285; Liebeke, Manuel/0000-0002-2339-1409; Lalk, Michael/0000-0002-9230-0267; Winstel, Volker/0000-0002-3248-2572; Niemiec, Maria Joanna/0000-0001-5667-6032; Gekeler, Cordula/0000-0001-9041-6672	German Ministry of Education and Research; Gambro Inc. (ABBA-Tech); German Science Foundation [TRR34, SFB766]; IZKF of the Medical Faculty, University of Tubingen; Alfried Krupp von Bohlen Halbach-Stiftung	German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Gambro Inc. (ABBA-Tech); German Science Foundation(German Research Foundation (DFG)); IZKF of the Medical Faculty, University of Tubingen; Alfried Krupp von Bohlen Halbach-Stiftung	This work was supported by grants from the German Ministry of Education and Research with Gambro Inc. (ABBA-Tech), the German Science Foundation (TRR34, SFB766), and the IZKF Program of the Medical Faculty, University of Tubingen (to A. P.).; Recipient of a fellowship from the Alfried Krupp von Bohlen Halbach-Stiftung: "A Functional Genomics Approach in Infection Biology." Present address: Biomolecular Medicine, Dept. of Surgery and Cancer, Faculty of Medicine, Imperial College London, London SW7 2AZ, United Kingdom.	ADLER LA, 1988, J BACTERIOL, V170, P5337, DOI 10.1128/jb.170.11.5337-5343.1988; Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; Arias CA, 2009, NEW ENGL J MED, V360, P439, DOI 10.1056/NEJMp0804651; Bandow JE, 2003, ANTIMICROB AGENTS CH, V47, P948, DOI 10.1128/AAC.47.3.948-955.2003; BARTON DHR, 1985, J CHEM SOC PERK T 1, P2667, DOI 10.1039/p19850002667; Bathe OF, 2011, CANCER EPIDEM BIOMAR, V20, P140, DOI 10.1158/1055-9965.EPI-10-0712; BISSWANGER H, 1981, J BIOL CHEM, V256, P815; Brotz-Oesterhelt H, 2005, NAT MED, V11, P1082, DOI 10.1038/nm1306; BROWN JP, 1976, BIOCHEM J, V155, P419, DOI 10.1042/bj1550419; Bundy JG, 2005, FEMS MICROBIOL LETT, V242, P127, DOI 10.1016/j.femsle.2004.10.048; Chaudhuri RR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-291; Cook P. F., 2007, ENZYME KINETICS MECH; DANSON MJ, 1976, BIOCHEM J, V159, P677, DOI 10.1042/bj1590677; de Kok A, 1998, BBA-PROTEIN STRUCT M, V1385, P353, DOI 10.1016/S0167-4838(98)00079-X; Ferreras JA, 2005, NAT CHEM BIOL, V1, P29, DOI 10.1038/nchembio706; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; FLOURNOY DS, 1989, BIOCHEMISTRY-US, V28, P9594, DOI 10.1021/bi00451a007; Forsyth RA, 2002, MOL MICROBIOL, V43, P1387, DOI 10.1046/j.1365-2958.2002.02832.x; Halouska S, 2007, J PROTEOME RES, V6, P4608, DOI 10.1021/pr0704332; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Haydon DJ, 2008, SCIENCE, V321, P1673, DOI 10.1126/science.1159961; Herbert M, 2003, INT J MED MICROBIOL, V293, P145, DOI 10.1078/1438-4221-00261; HINMAN LM, 1981, J BIOL CHEM, V256, P6583; Hutter B, 2004, ANTIMICROB AGENTS CH, V48, P2838, DOI 10.1128/AAC.48.8.2838-2844.2004; Jang HJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-411; Leebrick J. R., 1966, United States Patent, Patent No. [3,239,411, 323941118]; Lentino JR, 2008, EUR J CLIN MICROBIOL, V27, P3, DOI 10.1007/s10096-007-0389-y; Liebeke M, 2010, CHEM BIOL, V17, P820, DOI 10.1016/j.chembiol.2010.06.012; Liebeke M, 2010, ANAL BIOCHEM, V401, P312, DOI 10.1016/j.ab.2009.04.030; Liebeke M, 2009, APPL MICROBIOL BIOT, V83, P161, DOI 10.1007/s00253-009-1965-0; Lowy FD, 2003, J CLIN INVEST, V111, P1265, DOI 10.1172/JC1200318535; MAGER J, 1954, NATURE, V173, P126, DOI 10.1038/173126a0; Mashego MR, 2007, BIOTECHNOL LETT, V29, P1, DOI 10.1007/s10529-006-9218-0; Nakano MM, 1997, J BACTERIOL, V179, P6749, DOI 10.1128/jb.179.21.6749-6755.1997; Pathania R, 2009, NAT CHEM BIOL, V5, P849, DOI 10.1038/nchembio.221; Peschel A, 2000, ANTIMICROB AGENTS CH, V44, P2845, DOI 10.1128/AAC.44.10.2845-2847.2000; Proctor RA, 2006, NAT REV MICROBIOL, V4, P295, DOI 10.1038/nrmicro1384; Projan SJ, 2007, CURR OPIN MICROBIOL, V10, P441, DOI 10.1016/j.mib.2007.08.007; Rice KC, 2008, MICROBIOL MOL BIOL R, V72, P85, DOI 10.1128/MMBR.00030-07; Sadykov MR, 2010, J BIOL CHEM, V285, P36616, DOI 10.1074/jbc.M110.152843; Sass V, 2008, INT J MED MICROBIOL, V298, P619, DOI 10.1016/j.ijmm.2008.01.011; Schindler R, 2010, NEPHROL DIAL TRANSPL, V25, P2651, DOI 10.1093/ndt/gfq052; Schneider T, 2010, SCIENCE, V328, P1168, DOI 10.1126/science.1185723; Schnell A, 2007, INT J ARTIF ORGANS, V30, P746; SCHWARTZ ER, 1968, BIOCHEM BIOPH RES CO, V31, P495, DOI 10.1016/0006-291X(68)90504-4; Smith PA, 2007, NAT CHEM BIOL, V3, P549, DOI 10.1038/nchembio.2007.27; Somerville GA, 2003, INFECT IMMUN, V71, P4724, DOI 10.1128/IAI.71.8.4724-4732.2003; Somerville GA, 2002, INFECT IMMUN, V70, P6373, DOI 10.1128/IAI.70.11.6373-6382.2002; Sun HZ, 2004, MET IONS BIOL SYST, V41, P333; URBAN P, 1988, EUR J BIOCHEM, V173, P155, DOI 10.1111/j.1432-1033.1988.tb13979.x; Vinayavekhin N, 2010, ACS CHEM BIOL, V5, P91, DOI 10.1021/cb900271r; Weidenmaier C, 2003, CURR DRUG TARGETS, V4, P643, DOI 10.2174/1389450033490731; White AP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011814	53	47	49	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2887	2895		10.1074/jbc.M111.288894	http://dx.doi.org/10.1074/jbc.M111.288894			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22144679	hybrid, Green Published			2022-12-27	WOS:000300292300060
J	Bultynck, G; Kiviluoto, S; Henke, N; Ivanova, H; Schneider, L; Rybalchenko, V; Luyten, T; Nuyts, K; De Borggraeve, W; Bezprozvanny, I; Parys, JB; De Smedt, H; Missiaen, L; Methner, A				Bultynck, Geert; Kiviluoto, Santeri; Henke, Nadine; Ivanova, Hristina; Schneider, Lars; Rybalchenko, Volodymyr; Luyten, Tomas; Nuyts, Koen; De Borggraeve, Wim; Bezprozvanny, Ilya; Parys, Jan B.; De Smedt, Humbert; Missiaen, Ludwig; Methner, Axel			The C Terminus of Bax Inhibitor-1 Forms a Ca2+-permeable Channel Pore	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; ENDOPLASMIC-RETICULUM STRESS; OXYGEN-GLUCOSE DEPRIVATION; IP3 RECEPTOR; CELL-DEATH; ER-STRESS; ALZHEIMERS-DISEASE; CA2+ HOMEOSTASIS; CALCIUM-RELEASE; FAMILY-MEMBERS	Bax inhibitor-1 (BI-1) is a multitransmembrane domain-spanning endoplasmic reticulum (ER)-located protein that is evolutionarily conserved and protects against apoptosis and ER stress. Furthermore, BI-1 is proposed to modulate ER Ca2+ homeostasis by acting as a Ca2+-leak channel. Based on experimental determination of the BI-1 topology, we propose that its C terminus forms a Ca2+ pore responsible for its Ca2+-leak properties. We utilized a set of C-terminal peptides to screen for Ca2+ leak activity in unidirectional Ca-45(2+)-flux experiments and identified an alpha-helical 20-amino acid peptide causing Ca2+ leak from the ER. The Ca2+ leak was independent of endogenous ER Ca2+-release channels or other Ca2+-leak mechanisms, namely translocons and presenilins. The Ca2+-permeating property of the peptide was confirmed in lipid-bilayer experiments. Using mutant peptides, we identified critical residues responsible for the Ca2+-leak properties of this BI-1 peptide, including a series of critical negatively charged aspartate residues. Using peptides corresponding to the equivalent BI-1 domain from various organisms, we found that the Ca2+-leak properties were conserved among animal, but not plant and yeast orthologs. By mutating one of the critical aspartate residues in the proposed Ca2+-channel pore in full-length BI-1, we found that Asp-213 was essential for BI-1-dependent ER Ca2+ leak. Thus, we elucidated residues critically important for BI-1-mediated Ca2+ leak and its potential channel pore. Remarkably, one of these residues was not conserved among plant and yeast BI-1 orthologs, indicating that the ER Ca2+-leak properties of BI-1 are an added function during evolution.	[Bultynck, Geert; Kiviluoto, Santeri; Ivanova, Hristina; Luyten, Tomas; Parys, Jan B.; De Smedt, Humbert; Missiaen, Ludwig] Katholieke Univ Leuven, Dept Mol Cell Biol, Lab Mol & Cellular Signaling, B-3000 Louvain, Belgium; [Nuyts, Koen; De Borggraeve, Wim] Katholieke Univ Leuven, Dept Mol Design & Synth, B-3000 Louvain, Belgium; [Henke, Nadine; Schneider, Lars; Methner, Axel] Univ Dusseldorf, Dept Neurol, D-40225 Dusseldorf, Germany; [Rybalchenko, Volodymyr; Bezprozvanny, Ilya] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA	KU Leuven; KU Leuven; Heinrich Heine University Dusseldorf; University of Texas System; University of Texas Southwestern Medical Center Dallas	Bultynck, G (corresponding author), Katholieke Univ Leuven, Campus Gasthuisberg O-N-1 Bus 802,Herestr 49, BE-3000 Louvain, Belgium.	geert.bultynck@med.kuleuven.be	Nuyts, Koen/L-9930-2017; De Borggraeve, Wim/AGE-5612-2022; Kiviluoto, Santeri/M-2743-2014	Nuyts, Koen/0000-0003-0387-9965; De Borggraeve, Wim/0000-0001-7813-6192; Kiviluoto, Santeri/0000-0001-5010-5327; Methner, Axel/0000-0002-8774-0057; Rybalchenko, Volodymyr/0000-0003-4092-0779; Nickel, Nadine/0000-0002-0609-0735; Parys, Jan/0000-0002-3591-4967; Bultynck, Geert/0000-0002-5968-4828	Deutsche Forschungsgemeinschaft [ME1922/9-1]; Forschungskommission of the Heinrich Heine-University Dusseldorf; Research Foundation-Flanders (F. W. O.) [G.0604.07N, G.0788.11N, G.0724.09]; Research Council of the K.U. Leuven [GOA/09/012]; OT START [SRT/10/044]; Interuniversity Attraction Poles Program Belgian Science Policy [P6/28]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Forschungskommission of the Heinrich Heine-University Dusseldorf; Research Foundation-Flanders (F. W. O.)(FWO); Research Council of the K.U. Leuven(KU Leuven); OT START; Interuniversity Attraction Poles Program Belgian Science Policy(Belgian Federal Science Policy Office)	This work was supported by Deutsche Forschungsgemeinschaft Grant ME1922/9-1 and the Forschungskommission of the Heinrich Heine-University Dusseldorf (to A. M.), by Research Foundation-Flanders (F. W. O.) Grants G.0604.07N (to H. D. S.), G.0788.11N (to G. B. and W. D. B.), and G.0724.09 (to L. M.), by the Research Council of the K.U. Leuven via the Concerted Actions program (GOA/09/012) and an OT START (SRT/10/044), and by Interuniversity Attraction Poles Program Belgian Science Policy P6/28 (to H. D. S., J. B. P., and L. M.).	Ahn T, 2010, CELL CALCIUM, V47, P387, DOI 10.1016/j.ceca.2010.02.003; Ahn T, 2009, FEBS J, V276, P2285, DOI 10.1111/j.1742-4658.2009.06956.x; Austin RC, 2009, ANTIOXID REDOX SIGN, V11, P2279, DOI [10.1089/ars.2009.2686, 10.1089/ARS.2009.2686]; Bailly-Maitre B, 2006, P NATL ACAD SCI USA, V103, P2809, DOI 10.1073/pnas.0506854103; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bultynck G, 2004, BIOCHEM J, V381, P87, DOI 10.1042/BJ20040072; Castillo K, 2011, EMBO J, V30, P4465, DOI 10.1038/emboj.2011.318; Chae HJ, 2004, MOL CELL, V15, P355, DOI 10.1016/j.molcel.2004.06.038; Chae HJ, 2003, GENE, V323, P101, DOI 10.1016/j.gene.2003.09.011; Cheung KH, 2008, NEURON, V58, P871, DOI 10.1016/j.neuron.2008.04.015; Cheung KH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000818; D'hondt C, 2011, CELL SIGNAL, V23, P305, DOI 10.1016/j.cellsig.2010.07.018; Decuypere JP, 2010, CELL CALCIUM, V48, P161, DOI 10.1016/j.ceca.2010.08.003; Dohm CP, 2006, J MOL NEUROSCI, V29, P1, DOI 10.1385/JMN:29:1:1; Giorgi C, 2008, CURR MOL MED, V8, P119; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Grzmil M, 2006, J PATHOL, V208, P340, DOI 10.1002/path.1902; Grzmil M, 2003, AM J PATHOL, V163, P543, DOI 10.1016/S0002-9440(10)63682-6; Hemrajani C, 2010, P NATL ACAD SCI USA, V107, P3129, DOI 10.1073/pnas.0911609106; Henke N, 2011, CELL CALCIUM, V50, P251, DOI 10.1016/j.ceca.2011.05.005; Kasri NN, 2006, CELL CALCIUM, V40, P41, DOI 10.1016/j.ceca.2006.03.005; Kasri NN, 2005, MOL PHARMACOL, V68, P241, DOI 10.1124/mol.105.013045; Keddie NS, 2011, CHEM COMMUN, V47, P242, DOI 10.1039/c0cc03003a; Kim HR, 2008, J BIOL CHEM, V283, P15946, DOI 10.1074/jbc.M800075200; Kim HR, 2009, J CELL SCI, V122, P1126, DOI 10.1242/jcs.038430; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lee GH, 2010, ONCOGENE, V29, P2130, DOI 10.1038/onc.2009.491; Lee GH, 2010, MOL CELL BIOL, V30, P1800, DOI 10.1128/MCB.01357-09; Li XY, 2010, CELL BIOL INT, V34, P1099, DOI 10.1042/CBI20090400; Lisbona F, 2009, MOL CELL, V33, P679, DOI 10.1016/j.molcel.2009.02.017; Mackrill JJ, 1996, BIOCHEM J, V318, P871, DOI 10.1042/bj3180871; Madeo F, 2009, MOL CELL, V33, P669, DOI 10.1016/j.molcel.2009.03.002; MISSIAEN L, 1992, NATURE, V357, P599, DOI 10.1038/357599a0; Miyakawa T, 1999, EMBO J, V18, P1303, DOI 10.1093/emboj/18.5.1303; MIYAWAKI A, 1990, NEURON, V5, P11, DOI 10.1016/0896-6273(90)90029-F; Nelson O, 2007, J CLIN INVEST, V117, P1230, DOI 10.1172/JCI30447; Oakes SA, 2003, BIOCHEM PHARMACOL, V66, P1335, DOI 10.1016/S0006-2952(03)00482-9; Pinton P, 2008, ONCOGENE, V27, P6407, DOI 10.1038/onc.2008.308; Pinton P, 2006, CELL DEATH DIFFER, V13, P1409, DOI 10.1038/sj.cdd.4401960; Romagnoli A., 2007, NOVART FDN SYMP, V287, P131; Romagnoli Anna, 2007, Novartis Found Symp, V287, P122; Rong YP, 2009, P NATL ACAD SCI USA, V106, P14397, DOI 10.1073/pnas.0907555106; Rong Y, 2008, ANNU REV PHYSIOL, V70, P73, DOI 10.1146/annurev.physiol.70.021507.105852; Sammels E, 2010, CELL CALCIUM, V47, P297, DOI 10.1016/j.ceca.2010.02.001; Tanaka R, 2006, CANCER-AM CANCER SOC, V106, P648, DOI 10.1002/cncr.21639; Thomenius MJ, 2003, J CELL SCI, V116, P4493, DOI 10.1242/jcs.00829; Tovey SC, 2006, NAT PROTOC, V1, P259, DOI 10.1038/nprot.2006.40; Westphalen BC, 2005, CELL DEATH DIFFER, V12, P304, DOI 10.1038/sj.cdd.4401547; Xu CY, 2008, J BIOL CHEM, V283, P11477, DOI 10.1074/jbc.M708385200; Xu QL, 1998, MOL CELL, V1, P337, DOI 10.1016/S1097-2765(00)80034-9; Zhang MH, 2010, MOL CELL BIOCHEM, V333, P1, DOI 10.1007/s11010-009-0198-y	51	70	72	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2544	2557		10.1074/jbc.M111.275354	http://dx.doi.org/10.1074/jbc.M111.275354			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22128171	hybrid, Green Published			2022-12-27	WOS:000300292300028
J	Park, JH; Johansson, HE; Aoki, H; Huang, BX; Kim, HY; Ganoza, MC; Park, MH				Park, Jong-Hwan; Johansson, Hans E.; Aoki, Hiroyuki; Huang, Bill X.; Kim, Hee-Yong; Ganoza, M. Clelia; Park, Myung Hee			Post-translational Modification by beta-Lysylation Is Required for Activity of Escherichia coli Elongation Factor P (EF-P)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDE-BOND SYNTHESIS; SYNTHESIS INITIATION-FACTORS; PROTEIN-SYNTHESIS; CRYSTAL-STRUCTURE; SACCHAROMYCES-CEREVISIAE; TRANSLATION ELONGATION; HYPUSINE MODIFICATION; BACILLUS-SUBTILIS; GENE-PRODUCT; EXPRESSION	Bacterial elongation factor P (EF-P) is the ortholog of archaeal and eukaryotic initiation factor 5A (eIF5A). EF-P shares sequence homology and crystal structure with eIF5A, but unlike eIF5A, EF-P does not undergo hypusine modification. Recently, two bacterial genes, yjeA and yjeK, encoding truncated homologs of class II lysyl-tRNA synthetase and of lysine-2,3-aminomutase, respectively, have been implicated in the modification of EF-P to convert a specific lysine to a hypothetical beta-lysyl-lysine. Here we present biochemical evidence for beta-lysyl-lysine modification in Escherichia coli EF-P and for its role in EF-P activity by characterizing native and recombinant EF-P proteins for their modification status and activity in vitro. Mass spectrometric analyses confirmed the lysyl modification at lysine 34 in native and recombinant EF-P proteins. The beta-lysyl-lysine isopeptide was identified in the exhaustive Pronase digests of native EF-P and recombinant EF-P isolated from E. coli coexpressing EF-P, YjeA, and YjeK but not in the digests of proteins derived from the vectors encoding EF-P alone or EF-P together with YjeA, indicating that both enzymes, YjeA and YjeK, are required for beta-lysylation of EF-P. Endogenous EF-P as well as the recombinant EF-P preparation containing beta-lysyl-EF-P stimulated N-formyl-methionyl-puromycin synthesis similar to 4-fold over the preparations containing unmodified EF-P and/or alpha-lysyl-EF-P. The mutant lacking the modification site lysine (K34A) was inactive. This is the first report of biochemical evidence for the beta-lysylation of EF-P in vivo and the requirement for this modification for the activity of EF-P.	[Johansson, Hans E.] Biosearch Technol Inc, Novato, CA 94949 USA; [Park, Jong-Hwan; Park, Myung Hee] NIDCR, Oral & Pharyngeal Canc Branch, Bethesda, MD 20892 USA; [Huang, Bill X.; Kim, Hee-Yong] NIAAA, Lab Mol Signaling, NIH, Bethesda, MD 20892 USA; [Aoki, Hiroyuki; Ganoza, M. Clelia] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5G 1L6, Canada	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); University of Toronto	Johansson, HE (corresponding author), Biosearch Technol Inc, 81 Digital Dr, Novato, CA 94949 USA.	hjohansson@biosearchtech.com; mhpark@nih.gov	Johansson, Hans E./C-5113-2017	Johansson, Hans E./0000-0001-9495-6107; GANOZA MELGAREJO, MICHAEL RICHARD/0000-0003-0196-8104	NIDCR; NIAAA, National Institutes of Health; Carl Trygger Foundation; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000608] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000284] Funding Source: NIH RePORTER	NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIAAA, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Carl Trygger Foundation; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by the Intramural Research Program of NIDCR and NIAAA, National Institutes of Health. This work was also supported in part by a grant from the Carl Trygger Foundation (to H. E. J.).	Ambrogelly A, 2010, FEBS LETT, V584, P3055, DOI 10.1016/j.febslet.2010.05.036; Aoki H, 1997, BIOCHIMIE, V79, P7, DOI 10.1016/S0300-9084(97)87619-5; Aoki H, 1997, J BIOL CHEM, V272, P32254, DOI 10.1074/jbc.272.51.32254; AOKI H, 1991, NUCLEIC ACIDS RES, V19, P6215, DOI 10.1093/nar/19.22.6215; Aoki H, 2008, FEBS J, V275, P671, DOI 10.1111/j.1742-4658.2007.06228.x; Bailly M, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-3; Behshad E, 2006, BIOCHEMISTRY-US, V45, P12639, DOI 10.1021/bi061328t; BENNE R, 1978, J BIOL CHEM, V253, P3078; Blaha G, 2009, SCIENCE, V325, P966, DOI 10.1126/science.1175800; BYERS TL, 1992, BIOCHEM J, V287, P717, DOI 10.1042/bj2870717; Chattopadhyay MK, 2008, P NATL ACAD SCI USA, V105, P6554, DOI 10.1073/pnas.0710970105; Chattopadhyay MK, 2009, J BACTERIOL, V191, P5549, DOI 10.1128/JB.00381-09; Cornish PV, 2009, P NATL ACAD SCI USA, V106, P2571, DOI 10.1073/pnas.0813180106; FOLK JE, 1980, J BIOL CHEM, V255, P3695; Ganoza MC, 2002, MICROBIOL MOL BIOL R, V66, P460, DOI 10.1128/MMBR.66.3.460-485.2002; Ganoza MC, 2000, BIOL CHEM, V381, P553, DOI 10.1515/BC.2000.071; GLICK BR, 1979, EUR J BIOCHEM, V97, P23, DOI 10.1111/j.1432-1033.1979.tb13081.x; GLICK BR, 1975, P NATL ACAD SCI USA, V72, P4257, DOI 10.1073/pnas.72.11.4257; GREEN RH, 1985, BIOCHEM BIOPH RES CO, V126, P792, DOI 10.1016/0006-291X(85)90254-2; Gregio APB, 2009, BIOCHEM BIOPH RES CO, V380, P785, DOI 10.1016/j.bbrc.2009.01.148; Hanawa-Suetsugu K, 2004, P NATL ACAD SCI USA, V101, P9595, DOI 10.1073/pnas.0308667101; Henderson A, 2011, P NATL ACAD SCI USA, V108, P6415, DOI 10.1073/pnas.1008150108; Jansson BPM, 2000, J BACTERIOL, V182, P1158, DOI 10.1128/JB.182.4.1158-1161.2000; JOE YA, 1995, J BIOL CHEM, V270, P22386, DOI 10.1074/jbc.270.38.22386; Kearns DB, 2004, MOL MICROBIOL, V52, P357, DOI 10.1111/j.1365-2958.2004.03996.x; KEMPER WM, 1976, J BIOL CHEM, V251, P5551; Kim KK, 1998, P NATL ACAD SCI USA, V95, P10419, DOI 10.1073/pnas.95.18.10419; Kyrpides NC, 1998, P NATL ACAD SCI USA, V95, P224, DOI 10.1073/pnas.95.1.224; Ma FS, 2010, PLANT CELL ENVIRON, V33, P1682, DOI 10.1111/j.1365-3040.2010.02173.x; Navarre WW, 2010, MOL CELL, V39, P209, DOI 10.1016/j.molcel.2010.06.021; Ohashi Y, 2003, BIOSCI BIOTECH BIOCH, V67, P2245, DOI 10.1271/bbb.67.2245; Park JH, 2006, P NATL ACAD SCI USA, V103, P51, DOI 10.1073/pnas.0509348102; Park JH, 2011, PROTEIN ENG DES SEL, V24, P301, DOI 10.1093/protein/gzq110; Park MH, 2010, AMINO ACIDS, V38, P491, DOI 10.1007/s00726-009-0408-7; Ramakrishnan V, 2002, CELL, V108, P557, DOI 10.1016/S0092-8674(02)00619-0; Roy H, 2011, NAT CHEM BIOL, V7, P667, DOI [10.1038/NCHEMBIO.632, 10.1038/nchembio.632]; Saini P, 2009, NATURE, V459, P118, DOI 10.1038/nature08034; Tan S, 2001, PROTEIN EXPRES PURIF, V21, P224, DOI 10.1006/prep.2000.1363; Tong YF, 2009, PROTEINS, V75, P1040, DOI 10.1002/prot.22378; Umland TC, 2004, J BIOL CHEM, V279, P28697, DOI 10.1074/jbc.M404095200; Xu JY, 2011, PLANT MOL BIOL, V75, P167, DOI 10.1007/s11103-010-9716-2; Yanagisawa T, 2010, NAT STRUCT MOL BIOL, V17, P1136, DOI 10.1038/nsmb.1889; Zanelli CF, 2007, AMINO ACIDS, V33, P351, DOI 10.1007/s00726-007-0533-0; Zou SB, 2011, VIRULENCE, V2, P147, DOI 10.4161/viru.2.2.15039	44	46	50	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2579	2590		10.1074/jbc.M111.309633	http://dx.doi.org/10.1074/jbc.M111.309633			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22128152	hybrid, Green Published			2022-12-27	WOS:000300292300031
J	Altun, M; Zhao, B; Velasco, K; Liu, HY; Hassink, G; Paschke, J; Pereira, T; Lindsten, K				Altun, Mikael; Zhao, Bin; Velasco, Kelly; Liu, Haiyin; Hassink, Gerco; Paschke, Julia; Pereira, Teresa; Lindsten, Kristina			Ubiquitin-specific Protease 19 (USP19) Regulates Hypoxia-inducible Factor 1 alpha (HIF-1 alpha) during Hypoxia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEUBIQUITINATING ENZYME; PROLYL HYDROXYLATION; DEGRADATION; SUPPRESSION; STABILITY; MECHANISM; PROTEINS; BINDING; DOMAIN; ALPHA	A proper cellular adaptation to low oxygen levels is essential for processes such as development, growth, metabolism, and angiogenesis. The response to decrease in oxygen supply, referred to as hypoxia, is also involved in numerous human diseases including cancer, inflammatory conditions, and vascular disease. The hypoxia-inducible factor 1-alpha (HIF-1 alpha), a key player in the hypoxic response, is kept under stringent regulation. At normoxia, the levels are kept low as a consequence of the efficient degradation by the ubiquitin-proteasome system, and in response to hypoxia, the degradation is blocked and the accumulating HIF-1 alpha promotes a transcriptional response essential for proper adaptation and survival. Here we show that the ubiquitin-specific protease-19 (USP19) interacts with components of the hypoxia pathway including HIF-1 alpha and rescues it from degradation independent of its catalytic activity. In the absence of USP19, cells fail to mount an appropriate response to hypoxia, indicating an important role for this enzyme in normal or pathological conditions.	[Altun, Mikael; Zhao, Bin; Velasco, Kelly; Liu, Haiyin; Hassink, Gerco; Paschke, Julia; Pereira, Teresa; Lindsten, Kristina] Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden; [Altun, Mikael] Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Lindsten, K (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, Box 285, S-17177 Stockholm, Sweden.	kristina.lindsten@ki.se	Altun, Mikael/AAF-5496-2020; Pereira, Teresa/AAP-8197-2020; Zhao, Bin/F-1055-2018; Altun, Mikael/AAI-9527-2020; Zhao, Bin/ABB-6186-2021	Pereira, Teresa/0000-0001-8654-2385; Zhao, Bin/0000-0001-7065-2416; Altun, Mikael/0000-0002-6937-6124; Zhao, Bin/0000-0001-7065-2416; Velasco, Kelly/0000-0002-9376-6034; Liu, Haiyin/0000-0003-3103-6949	Swedish Research council; Karolinska Institutet; Magn Bergvalls stiftelse; Ake Wibergs Stiftelse; Swedish Cancer Society; ERACOL	Swedish Research council(Swedish Research CouncilEuropean Commission); Karolinska Institutet(Karolinska Institutet); Magn Bergvalls stiftelse; Ake Wibergs Stiftelse; Swedish Cancer Society(Swedish Cancer Society); ERACOL	This work was supported by grants from the Swedish Research council (to K. L., T. P., and M. A.), Karolinska Institutet (to K. L., B. Z., and M. A.), Magn Bergvalls stiftelse (to K. L.), Ake Wibergs Stiftelse (to K. L.), The Swedish Cancer Society (to T. P.), and ERACOL (to K. V.).	Andre H, 2008, J BIOL CHEM, V283, P29375, DOI 10.1074/jbc.M805919200; Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Barth S, 2007, MOL CELL BIOL, V27, P3758, DOI 10.1128/MCB.01324-06; Barth S, 2009, J BIOL CHEM, V284, P23046, DOI 10.1074/jbc.M109.032631; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Borodovsky A, 2002, CHEM BIOL, V9, P1149, DOI 10.1016/S1074-5521(02)00248-X; Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8; Carrero P, 2000, MOL CELL BIOL, V20, P402, DOI 10.1128/MCB.20.1.402-415.2000; CARTHEW RW, 1990, CELL, V63, P561, DOI 10.1016/0092-8674(90)90452-K; Combaret L, 2005, AM J PHYSIOL-ENDOC M, V288, pE693, DOI 10.1152/ajpendo.00281.2004; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; De Bels D, 2011, NEW ENGL J MED, V365, P1845, DOI 10.1056/NEJMc1110602; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Garcia-Ranea JA, 2002, FEBS LETT, V529, P162, DOI 10.1016/S0014-5793(02)03321-5; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Gu YZ, 1998, GENE EXPRESSION, V7, P205; Hanna J, 2006, CELL, V127, P99, DOI 10.1016/j.cell.2006.07.038; Hassink GC, 2009, EMBO REP, V10, P755, DOI 10.1038/embor.2009.69; Heikkila M, 2011, CELL MOL LIFE SCI, V68, P3885, DOI 10.1007/s00018-011-0679-5; Hock A, 2010, INT J BIOCHEM CELL B, V42, P1618, DOI 10.1016/j.biocel.2010.06.011; Holmquist-Mengelbier L, 2006, CANCER CELL, V10, P413, DOI 10.1016/j.ccr.2006.08.026; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Hubbi ME, 2011, MOL CELL, V42, P700, DOI 10.1016/j.molcel.2011.03.029; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Laughner E, 2001, MOL CELL BIOL, V21, P3995, DOI 10.1128/MCB.21.12.3995-4004.2001; Lee YT, 2004, J BIOL CHEM, V279, P16511, DOI 10.1074/jbc.M400215200; Li ZB, 2005, EMBO REP, V6, P373, DOI 10.1038/sj.embor.7400377; Liu YV, 2007, MOL CELL, V25, P207, DOI 10.1016/j.molcel.2007.01.001; Loboda A, 2010, MOL CELLS, V29, P435, DOI 10.1007/s10059-010-0067-2; Lu Y, 2009, MOL CELL BIOL, V29, P547, DOI 10.1128/MCB.00329-08; Matsuzawa S, 1998, EMBO J, V17, P2736, DOI 10.1093/emboj/17.10.2736; Mei YD, 2011, J BIOL CHEM, V286, P35380, DOI 10.1074/jbc.M111.282020; Nakayama K, 2004, CELL, V117, P941, DOI 10.1016/j.cell.2004.06.001; Nakayama K, 2009, MOL CANCER RES, V7, P443, DOI 10.1158/1541-7786.MCR-08-0458; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Patel SA, 2008, CELL DEATH DIFFER, V15, P628, DOI 10.1038/cdd.2008.17; Peth A, 2009, MOL CELL, V36, P794, DOI 10.1016/j.molcel.2009.11.015; Ratcliffe PJ, 1998, J EXP BIOL, V201, P1153; Roperch JP, 1999, P NATL ACAD SCI USA, V96, P8070, DOI 10.1073/pnas.96.14.8070; Tanimoto K, 2000, EMBO J, V19, P4298, DOI 10.1093/emboj/19.16.4298; Tu BP, 2004, J CELL BIOL, V164, P341, DOI 10.1083/jcb.200311055; Wiesener MS, 2002, FASEB J, V16, P271, DOI 10.1096/fj.02-0445fje; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064	46	59	66	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					1962	1969		10.1074/jbc.M111.305615	http://dx.doi.org/10.1074/jbc.M111.305615			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22128162	Green Published, hybrid			2022-12-27	WOS:000299321000037
J	Kasiviswanathan, R; Gustafson, MA; Copeland, WC; Meyer, JN				Kasiviswanathan, Rajesh; Gustafson, Margaret A.; Copeland, William C.; Meyer, Joel N.			Human Mitochondrial DNA Polymerase gamma Exhibits Potential for Bypass and Mutagenesis at UV-induced Cyclobutane Thymine Dimers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ULTRAVIOLET-RADIATION EXPOSURE; MISMATCH-REPAIR ACTIVITY; NONMELANOMA SKIN-CANCER; ESCHERICHIA-COLI; NUCLEOTIDE INCORPORATION; MAMMALIAN MITOCHONDRIA; MALIGNANT-MELANOMA; OXIDATIVE STRESS; COMMON DELETION; LESION BYPASS	Cyclobutane thymine dimers (T-T) comprise the majority of DNA damage caused by short wavelength ultraviolet radiation. These lesions generally block replicative DNA polymerases and are repaired by nucleotide excision repair or bypassed by translesion polymerases in the nucleus. Mitochondria lack nucleotide excision repair, and therefore, it is important to understand how the sole mitochondrial DNA polymerase, pol gamma, interacts with irreparable lesions such as T-T. We performed in vitro DNA polymerization assays to measure the kinetics of incorporation opposite the lesion and bypass of the lesion by pol gamma with a dimer-containing template. Exonuclease-deficient pol gamma bypassed thymine dimers with low relative efficiency; bypass was attenuated but still detectable when using exonuclease-proficient pol gamma. When bypass did occur, pol gamma misincorporated a guanine residue opposite the 3'-thymine of the dimer only 4-fold less efficiently than it incorporated an adenine. Surprisingly, the pol gamma exonuclease-proficient enzyme excised the incorrectly incorporated guanine at similar rates irrespective of the nature of the thymines in the template. In the presence of all four dNTPs, pol gamma extended the primer after incorporation of two adenines opposite the lesion with relatively higher efficiency compared with extension past either an adenine or a guanine incorporated opposite the 3'-thymine of the T-T. Our results suggest that T-T usually stalls mitochondrial DNA replication but also suggest a mechanism for the introduction of point mutations and deletions in the mitochondrial genomes of chronically UV-exposed cells.	[Gustafson, Margaret A.; Meyer, Joel N.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Kasiviswanathan, Rajesh; Copeland, William C.] NIEHS, Mol Genet Lab, NIH, Res Triangle Pk, NC 27709 USA	Duke University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Meyer, JN (corresponding author), Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA.	joel.meyer@duke.edu	Copeland, William/C-4242-2019; Kasiviswanathan, Rajesh/D-2744-2012; Meyer, Joel/G-9836-2017	Copeland, William/0000-0002-0359-0953; Meyer, Joel/0000-0003-1219-0983	National Institutes of Health [R21 NS065468, ES 065078]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES017540, Z01ES065078, ZIAES065078] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS065468] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R21 NS065468 (to J. N. M.) and ES 065078 (to W. C. C.).	Alberts B., 2008, MOL BIOL CELL, P856; Berneburg M, 2004, J INVEST DERMATOL, V122, P1277, DOI 10.1111/j.0022-202X.2004.22502.x; Berneburg M, 1997, PHOTOCHEM PHOTOBIOL, V66, P271, DOI 10.1111/j.1751-1097.1997.tb08654.x; Birch-Machin MA, 2010, MUTAGENESIS, V25, P101, DOI 10.1093/mutage/gep061; Birket MJ, 2007, AGING CELL, V6, P557, DOI 10.1111/j.1474-9726.2007.00310.x; Bohr VA, 1999, J BIOENERG BIOMEMBR, V31, P391, DOI 10.1023/A:1005484004167; BOLLUM FJ, 1963, BIOCHIM BIOPHYS ACTA, V68, P599; BOOTSMA D, 1968, MUTAT RES, V5, P289, DOI 10.1016/0027-5107(68)90027-4; Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040; CLAYTON DA, 1974, P NATL ACAD SCI USA, V71, P2777, DOI 10.1073/pnas.71.7.2777; CLEAVER JE, 1967, RADIAT RES, V30, P795, DOI 10.2307/3572145; de Souza-Pinto NC, 2009, DNA REPAIR, V8, P704, DOI 10.1016/j.dnarep.2009.01.021; Diaz F, 2002, NUCLEIC ACIDS RES, V30, P4626, DOI 10.1093/nar/gkf602; Durham SE, 2003, BRIT J CANCER, V88, P90, DOI 10.1038/sj.bjc.6600773; EDENBERG HJ, 1976, BIOPHYS J, V16, P849, DOI 10.1016/S0006-3495(76)85735-9; Friedberg EC, 2006, DNA REPAIR MUTAGENES, pxxix; Gandhi VV, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002078; Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d; Graziewicz MA, 2004, NUCLEIC ACIDS RES, V32, P397, DOI 10.1093/nar/gkh213; Gueranger Q, 2008, DNA REPAIR, V7, P1551, DOI 10.1016/j.dnarep.2008.05.012; Harbottle A, 2006, BRIT J CANCER, V94, P1887, DOI 10.1038/sj.bjc.6603178; HAYES FN, 1971, J AM CHEM SOC, V93, P4940, DOI 10.1021/ja00748a065; HEYDUK T, 1990, P NATL ACAD SCI USA, V87, P1744, DOI 10.1073/pnas.87.5.1744; HIXON S, 1978, BIOCHEM BIOPH RES CO, V81, P288, DOI 10.1016/0006-291X(78)91531-0; KAGUNI LS, 1989, P NATL ACAD SCI USA, V86, P6469, DOI 10.1073/pnas.86.17.6469; KALINOWSKI DP, 1992, NUCLEIC ACIDS RES, V20, P3485, DOI 10.1093/nar/20.13.3485; Kasiviswanathan R, 2010, METHODS, V51, P379, DOI 10.1016/j.ymeth.2010.02.015; Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94; Lim SE, 2003, J MOL BIOL, V329, P45, DOI 10.1016/S0022-2836(03)00405-4; Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197; LIVNEH Z, 1986, P NATL ACAD SCI USA, V83, P4599, DOI 10.1073/pnas.83.13.4599; Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303; Longley MJ, 2010, J BIOL CHEM, V285, P29690, DOI 10.1074/jbc.M110.151795; Longley MJ, 1998, BIOCHEMISTRY-US, V37, P10529, DOI 10.1021/bi980772w; Mason PA, 2003, NUCLEIC ACIDS RES, V31, P1052, DOI 10.1093/nar/gkg167; McCulloch SD, 2006, DNA REPAIR, V5, P1373, DOI 10.1016/j.dnarep.2006.06.003; McCulloch SD, 2004, NATURE, V428, P97, DOI 10.1038/nature02352; Meyer JN, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r70; Nelson JR, 1996, SCIENCE, V272, P1646, DOI 10.1126/science.272.5268.1646; OLSON MW, 1992, J BIOL CHEM, V267, P23136; Pascucci B, 1997, J MOL BIOL, V273, P417, DOI 10.1006/jmbi.1997.1268; Pfeifer GP, 2005, MUTAT RES-FUND MOL M, V571, P19, DOI 10.1016/j.mrfmmm.2004.06.057; PINZ KG, 1995, J BIOL CHEM, V270, P9202, DOI 10.1074/jbc.270.16.9202; Poetsch M, 2004, MELANOMA RES, V14, P501, DOI 10.1097/00008390-200412000-00010; Poetsch M, 2004, DIAGN MOL PATHOL, V13, P26, DOI 10.1097/00019606-200403000-00005; RABKIN SD, 1983, P NATL ACAD SCI-BIOL, V80, P1541, DOI 10.1073/pnas.80.6.1541; Ray AJ, 2000, J INVEST DERMATOL, V115, P674, DOI 10.1046/j.1523-1747.2000.00092.x; Reimann V, 2008, J INVEST DERMATOL, V128, P1294, DOI 10.1038/sj.jid.5701151; Schroeder P, 2008, J INVEST DERMATOL, V128, P2297, DOI 10.1038/jid.2008.57; SETLOW RB, 1963, SCIENCE, V142, P1464, DOI 10.1126/science.142.3598.1464; Shidara Y, 2005, CANCER RES, V65, P1655, DOI 10.1158/0008-5472.CAN-04-2012; Song SW, 2005, P NATL ACAD SCI USA, V102, P4990, DOI 10.1073/pnas.0500253102; Takeuchi H, 2004, ANN NY ACAD SCI, V1022, P50, DOI 10.1196/annals.1318.009; Tanaka H, 2000, NATURE, V404, P42, DOI 10.1038/35003506; Tissier A, 2000, EMBO J, V19, P5259, DOI 10.1093/emboj/19.19.5259; Vaisman A, 1999, BIOCHEMISTRY-US, V38, P11026, DOI 10.1021/bi9909187; Van Houten B, 2006, DNA REPAIR, V5, P145, DOI 10.1016/j.dnarep.2005.03.002; YOSHIDA S, 1981, BIOCHIM BIOPHYS ACTA, V652, P324, DOI 10.1016/0005-2787(81)90122-2; Zhang YB, 2002, J BIOL CHEM, V277, P44582, DOI 10.1074/jbc.M207297200	59	28	31	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9222	9229		10.1074/jbc.M111.306852	http://dx.doi.org/10.1074/jbc.M111.306852			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22194617	hybrid, Green Published			2022-12-27	WOS:000301797800050
J	Baglieri, J; Beck, D; Vasisht, N; Smith, CJ; Robinson, C				Baglieri, Jacopo; Beck, Daniel; Vasisht, Nishi; Smith, Corinne J.; Robinson, Colin			Structure of TatA Paralog, TatE, Suggests a Structurally Homogeneous Form of Tat Protein Translocase That Transports Folded Proteins of Differing Diameter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEC-INDEPENDENT PROTEIN; TWIN-ARGININE TRANSLOCASE; BLUE NATIVE ELECTROPHORESIS; ESCHERICHIA-COLI; MEMBRANE-PROTEIN; ELECTRON-MICROSCOPY; SIGNAL PEPTIDE; BACILLUS-SUBTILIS; SINGLE PARTICLES; OXIDE REDUCTASE	The twin-arginine translocation (Tat) system transports folded proteins across bacterial and plant thylakoid membranes. Most current models for the translocation mechanism propose the coalescence of a substrate-binding TatABC complex with a separate TatA complex. In Escherichia coli, TatA complexes are widely believed to form the translocation pore, and the size variation of TatA has been linked to the transport of differently sized substrates. Here, we show that the TatA paralog TatE can substitute for TatA and support translocation of Tat substrates including AmiA, AmiC, and TorA. However, TatE is found as much smaller, discrete complexes. Gel filtration and blue native electrophoresis suggest sizes between similar to 50 and 110 kDa, and single-particle processing of electron micrographs gives size estimates of 70-90 kDa. Three-dimensional models of the two principal TatE complexes show estimated diameters of 6-8 nm and potential clefts or channels of up to 2.5 nm diameter. The ability of TatE to support translocation of the 90-kDa TorA protein suggests alternative translocation models in which single TatA/E complexes do not contribute the bulk of the translocation channel. The homogeneity of both the TatABC and the TatE complexes further suggests that a discrete Tat translocase can translocate a variety of substrates, presumably through the use of a flexible channel. The presence and possible significance of double- or triple-ring TatE forms is discussed.	[Baglieri, Jacopo; Beck, Daniel; Vasisht, Nishi; Smith, Corinne J.; Robinson, Colin] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England	University of Warwick	Robinson, C (corresponding author), Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England.	colin.robinson@warwick.ac.uk	Baglieri, Jacopo/AAR-9696-2020; Smith, Corinne J/A-3170-2009	Smith, Corinne J/0000-0003-3364-7946; Baglieri, Jacopo/0000-0002-5760-4812	Transys ITN (Marie Curie Initial Training Network) [215524]; Wellcome Trust [055663/Z/98/Z]; Biotechnology and Biological Sciences Research Council [BB/E010245/1] Funding Source: researchfish; BBSRC [BB/E010245/1] Funding Source: UKRI	Transys ITN (Marie Curie Initial Training Network); Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funded by Transys ITN (Marie Curie Initial Training Network, Project 215524).; We are grateful to Ian Portman for technical help with electron microscopy and to the Wellcome Trust for generous support (Grant 055663/Z/98/Z) to the Imaging Suite at the University of Warwick. We thank Dr. James P Barnett for advice and useful discussions and Professor Gunner Von Heijne for providing the leader peptidase expression plasmid and anti-leader peptidase antiserum.	Alami M, 2003, MOL CELL, V12, P937, DOI 10.1016/S1097-2765(03)00398-8; Beloin C, 2004, MOL MICROBIOL, V51, P659, DOI 10.1046/j.1365-2958.2003.03865.x; Bernhardt TG, 2003, MOL MICROBIOL, V48, P1171, DOI 10.1046/j.1365-2958.2003.03511.x; Bogsch EG, 1998, J BIOL CHEM, V273, P18003, DOI 10.1074/jbc.273.29.18003; Bolhuis A, 2001, J BIOL CHEM, V276, P20213, DOI 10.1074/jbc.M100682200; CASADABAN MJ, 1979, P NATL ACAD SCI USA, V76, P4530, DOI 10.1073/pnas.76.9.4530; CHADDOCK AM, 1995, EMBO J, V14, P2715, DOI 10.1002/j.1460-2075.1995.tb07272.x; DALBEY RE, 1985, J BIOL CHEM, V260, P5925; deGier JWL, 1996, FEBS LETT, V399, P307, DOI 10.1016/S0014-5793(96)01354-3; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gerard F, 2006, J BIOL CHEM, V281, P6130, DOI 10.1074/jbc.M512733200; Gohlke U, 2005, P NATL ACAD SCI USA, V102, P10482, DOI 10.1073/pnas.0503558102; Heikkila MP, 2001, J BACTERIOL, V183, P1663, DOI 10.1128/JB.183.5.1663-1671.2001; Hu YF, 2010, J AM CHEM SOC, V132, P15942, DOI 10.1021/ja1053785; Ikeda M, 2003, APPL MICROBIOL BIOT, V62, P99, DOI 10.1007/s00253-003-1328-1; Ize B, 2003, MOL MICROBIOL, V48, P1183, DOI 10.1046/j.1365-2958.2003.03504.x; Jack RL, 2001, J BACTERIOL, V183, P1801, DOI 10.1128/JB.183.5.1801-1804.2001; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Mori H, 2002, J CELL BIOL, V157, P205, DOI 10.1083/jcb.200202048; Muller M, 2005, MOL MEMBR BIOL, V22, P113, DOI 10.1080/09687860500041809; Oates J, 2005, J MOL BIOL, V346, P295, DOI 10.1016/j.jmb.2004.11.047; PENCZEK P, 1992, ULTRAMICROSCOPY, V40, P33, DOI 10.1016/0304-3991(92)90233-A; Porcelli I, 2002, BIOCHEMISTRY-US, V41, P13690, DOI 10.1021/bi026142i; Robinson C, 2011, BBA-BIOMEMBRANES, V1808, P876, DOI 10.1016/j.bbamem.2010.11.023; Rubinstein JL, 2007, METHODS, V41, P409, DOI 10.1016/j.ymeth.2006.07.019; Sargent F, 1998, EMBO J, V17, P3640, DOI 10.1093/emboj/17.13.3640; Sargent F, 1999, J BIOL CHEM, V274, P36073, DOI 10.1074/jbc.274.51.36073; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Shaikh TR, 2008, NAT PROTOC, V3, P1941, DOI 10.1038/nprot.2008.156; SILVESTRO A, 1989, BIOCHIM BIOPHYS ACTA, V999, P208, DOI 10.1016/0167-4838(89)90220-3; Stanley NR, 2000, J BIOL CHEM, V275, P11591, DOI 10.1074/jbc.275.16.11591; Tarry MJ, 2009, P NATL ACAD SCI USA, V106, P13284, DOI 10.1073/pnas.0901566106; Walther TH, 2010, J AM CHEM SOC, V132, P15945, DOI 10.1021/ja106963s; Warren G, 2009, J MOL BIOL, V388, P122, DOI 10.1016/j.jmb.2009.02.060; Weiner JH, 1998, CELL, V93, P93, DOI 10.1016/S0092-8674(00)81149-6; Wexler M, 2000, J BIOL CHEM, V275, P16717, DOI 10.1074/jbc.M000800200; White HE, 2004, J MOL BIOL, V336, P453, DOI 10.1016/j.jmb.2003.12.015; Yen MR, 2002, ARCH MICROBIOL, V177, P441, DOI 10.1007/s00203-002-0408-4	40	28	28	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7335	7344		10.1074/jbc.M111.326355	http://dx.doi.org/10.1074/jbc.M111.326355			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22190680	Green Published, hybrid			2022-12-27	WOS:000301060200035
J	Orme, CM; Bogan, JS				Orme, Charisse M.; Bogan, Jonathan S.			The Ubiquitin Regulatory X (UBX) Domain-containing Protein TUG Regulates the p97 ATPase and Resides at the Endoplasmic Reticulum-Golgi Intermediate Compartment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VALOSIN-CONTAINING PROTEIN; AAA-ATPASE; CONFORMATIONAL-CHANGES; CELL-SURFACE; SECRETORY PATHWAY; MEMBRANE-FUSION; MATRIX PROTEIN; BREFELDIN-A; GLUT4; BINDING	p97/VCP is a hexameric ATPase that is coupled to diverse cellular processes, such as membrane fusion and proteolysis. How p97 activity is regulated is not fully understood. Here we studied the potential role of TUG, a widely expressed protein containing a UBX domain, to control mammalian p97. In HEK293 cells, the vast majority of TUG was bound to p97. Surprisingly, the TUG UBX domain was neither necessary nor sufficient for this interaction. Rather, an extended sequence, comprising three regions of TUG, bound to the p97 N-terminal domain. The TUG C terminus resembled the Arabidopsis protein PUX1. Similar to the previously described action of PUX1 on AtCDC48, TUG caused the conversion of p97 hexamers into monomers. Hexamer disassembly was stoichiometric rather than catalytic and was not greatly affected by the p97 ATP-binding state or by TUG N-terminal regions in vitro. In HeLa cells, TUG localized to the endoplasmic reticulum-to-Golgi intermediate compartment and endoplasmic reticulum exit sites. Although siRNA-mediated TUG depletion had no marked effect on total ubiquitylated proteins or p97 localization, TUG overexpression caused an accumulation of ubiquitylated substrates and targeted both TUG and p97 to the nucleus. A physiologic role of TUG was revealed by siRNA-mediated depletion, which showed that TUG is required for efficient reassembly of the Golgi complex after brefeldin A removal. Together, these data support a model in which TUG controls p97 oligomeric status at a particular location in the early secretory pathway and in which this process regulates membrane trafficking in various cell types.	[Bogan, Jonathan S.] Yale Univ, Sect Endocrinol & Metab, Dept Internal Med, Sch Med, New Haven, CT 06520 USA; Yale Univ, Dept Cell Biol, Sch Med, New Haven, CT 06520 USA	Yale University; Yale University	Bogan, JS (corresponding author), Yale Univ, Sect Endocrinol & Metab, Dept Internal Med, Sch Med, POB 208020, New Haven, CT 06520 USA.	jonathan.bogan@yale.edu	Bogan, Jonathan S/A-1575-2010	Bogan, Jonathan S/0000-0001-6463-8466	National Institutes of Health [R21 DK70812, R01 DK075772, T32 GM07205, F30 DK086109]; O'Brien Kidney Center at Yale [P30 DK079310]; W.M. Keck Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075772, R21DK070812, P30DK079310, F30DK086109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); O'Brien Kidney Center at Yale; W.M. Keck Foundation(W.M. Keck Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R21 DK70812 and R01 DK075772. This work was also supported by a pilot grant from the O'Brien Kidney Center at Yale (P30 DK079310) and by a W.M. Keck Foundation Distinguished Young Scholar in Medical Research Award (to J.S.B.).; Supported by National Institutes of Health Grants T32 GM07205 and F30 DK086109.	Aker J, 2007, PLANT PHYSIOL, V145, P339, DOI 10.1104/pp.107.103986; Alberts SM, 2009, J BIOL CHEM, V284, P16082, DOI 10.1074/jbc.M809282200; Alexandru G, 2008, CELL, V134, P804, DOI 10.1016/j.cell.2008.06.048; Alvarez C, 2001, J BIOL CHEM, V276, P2693, DOI 10.1074/jbc.M007957200; Beuron F, 2006, EMBO J, V25, P1967, DOI 10.1038/sj.emboj.7601055; Bogan JS, 2010, CURR OPIN CELL BIOL, V22, P506, DOI 10.1016/j.ceb.2010.03.012; Bogan JS, 2003, NATURE, V425, P727, DOI 10.1038/nature01989; Brandon E, 2003, EUR J CELL BIOL, V82, P411, DOI 10.1078/0171-9335-00327; Briggs LC, 2008, J BIOL CHEM, V283, P13745, DOI 10.1074/jbc.M709632200; Brunger AT, 2003, FEBS LETT, V555, P126, DOI 10.1016/S0014-5793(03)01107-4; Buchberger A, 2001, J MOL BIOL, V307, P17, DOI 10.1006/jmbi.2000.4462; Castorena CM, 2011, J APPL PHYSIOL, V111, P1106, DOI 10.1152/japplphysiol.00631.2011; Dalal S, 2004, MOL BIOL CELL, V15, P637, DOI 10.1091/mbc.E03-02-0097; Davies JM, 2005, STRUCTURE, V13, P183, DOI 10.1016/j.str.2004.11.014; Decottignies A, 2004, YEAST, V21, P127, DOI 10.1002/yea.1071; DeLaBarre B, 2005, J MOL BIOL, V347, P437, DOI 10.1016/j.jmb.2005.01.060; Dreveny I, 2004, EMBO J, V23, P1030, DOI 10.1038/sj.emboj.7600139; Grieve AG, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005298; Hanzelmann P, 2011, J BIOL CHEM, V286, P38679, DOI 10.1074/jbc.M111.274506; Hanzelmann P, 2011, STRUCTURE, V19, P833, DOI 10.1016/j.str.2011.03.018; Hauri HP, 2000, J CELL SCI, V113, P587; Hicks SW, 2006, TRAFFIC, V7, P1666, DOI 10.1111/j.1600-0854.2006.00504.x; Hosaka T, 2005, MOL BIOL CELL, V16, P2882, DOI 10.1091/mbc.E05-01-0072; Jordens I, 2010, MOL BIOL CELL, V21, P2034, DOI 10.1091/mbc.E10-02-0158; Kandror KV, 2011, TRAFFIC, V12, P665, DOI 10.1111/j.1600-0854.2011.01175.x; Kaneko Y, 2010, FEBS LETT, V584, P3873, DOI 10.1016/j.febslet.2010.07.061; Kern M, 2009, BIOCHEM BIOPH RES CO, V380, P303, DOI 10.1016/j.bbrc.2009.01.076; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Kondo H, 1997, NATURE, V388, P75, DOI 10.1038/40411; KREIS TE, 1986, CELL, V46, P929, DOI 10.1016/0092-8674(86)90075-9; Kreykenbohm V, 2002, EUR J CELL BIOL, V81, P273, DOI 10.1078/0171-9335-00247; Krick R, 2010, J CELL BIOL, V190, P965, DOI 10.1083/jcb.201002075; Ladanyi M, 2001, ONCOGENE, V20, P48, DOI 10.1038/sj.onc.1204074; Liang J, 2006, J CELL SCI, V119, P4011, DOI 10.1242/jcs.03163; Madsen L, 2008, INT J BIOCHEM CELL B, V40, P2927, DOI 10.1016/j.biocel.2008.06.008; Mallard F, 2002, J CELL BIOL, V156, P653, DOI 10.1083/jcb.200110081; Marra P, 2001, NAT CELL BIOL, V3, P1101, DOI 10.1038/ncb1201-1101; Marra P, 2007, MOL BIOL CELL, V18, P1595, DOI 10.1091/mbc.E06-10-0886; Meyer HH, 2000, EMBO J, V19, P2181, DOI 10.1093/emboj/19.10.2181; Meyer HH, 1998, FEBS LETT, V437, P255, DOI 10.1016/S0014-5793(98)01232-0; Mori-Konya C, 2009, GENES CELLS, V14, P483, DOI 10.1111/j.1365-2443.2009.01286.x; Nagahama M, 2009, BIOCHEM BIOPH RES CO, V382, P303, DOI 10.1016/j.bbrc.2009.03.012; Nakamura N, 1997, CELL, V89, P445, DOI 10.1016/S0092-8674(00)80225-1; Nakamura N, 2010, J PHARMACOL SCI, V112, P255, DOI 10.1254/jphs.09R03CR; ORCI L, 1991, CELL, V64, P1183; Paro S, 2007, J BIOL CHEM, V282, P5217, DOI 10.1074/jbc.M609042200; PLEASURE IT, 1993, NATURE, V365, P459, DOI 10.1038/365459a0; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Pye VE, 2006, J STRUCT BIOL, V156, P12, DOI 10.1016/j.jsb.2006.03.003; Ramanathan HN, 2012, CELL RES, V22, P346, DOI 10.1038/cr.2011.80; Rancour DM, 2004, J BIOL CHEM, V279, P54264, DOI 10.1074/jbc.M405498200; Ren JH, 2008, J BIOL CHEM, V283, P21599, DOI 10.1074/jbc.M802982200; Rezvani K, 2009, J NEUROSCI, V29, P6883, DOI 10.1523/JNEUROSCI.4723-08.2009; Rubin BR, 2009, VITAM HORM, V80, P155, DOI 10.1016/S0083-6729(08)00607-9; Sato BK, 2006, YEAST, V23, P1053, DOI 10.1002/yea.1407; Schuberth C, 2008, CELL MOL LIFE SCI, V65, P2360, DOI 10.1007/s00018-008-8072-8; Shin HY, 2010, ACTA CRYSTALLOGR F, V66, P41, DOI 10.1107/S1744309109047691; Shugrue CA, 1999, J CELL SCI, V112, P4547; Simossis VA, 2005, NUCLEIC ACIDS RES, V33, P816, DOI 10.1093/nar/gki233; Stapf C, 2011, J BIOL CHEM, V286, P38670, DOI 10.1074/jbc.M111.274472; Stolz A, 2011, TRENDS BIOCHEM SCI, V36, P515, DOI 10.1016/j.tibs.2011.06.001; Tang DM, 2008, J BIOL CHEM, V283, P6085, DOI 10.1074/jbc.M707715200; Tettamanzi MC, 2006, PROTEIN SCI, V15, P498, DOI 10.1110/ps.051901806; Tresse E, 2010, AUTOPHAGY, V6, P217, DOI 10.4161/auto.6.2.11014; Uchiyama K, 2005, J BIOCHEM, V137, P115, DOI 10.1093/jb/mvi028; Uchiyama K, 2003, J CELL BIOL, V161, P1067, DOI 10.1083/jcb.200303048; Uchiyama K, 2006, DEV CELL, V11, P803, DOI 10.1016/j.devcel.2006.10.016; Verma R, 2011, MOL CELL, V41, P82, DOI 10.1016/j.molcel.2010.12.017; Vij N, 2008, J CELL MOL MED, V12, P2511, DOI 10.1111/j.1582-4934.2008.00462.x; Wang Q, 2003, J BIOL CHEM, V278, P32784, DOI 10.1074/jbc.M303869200; White SR, 2007, TRAFFIC, V8, P1657, DOI 10.1111/j.1600-0854.2007.00642.x; Williams D, 2006, MOL BIOL CELL, V17, P5346, DOI 10.1091/mbc.E06-05-0386; Wojcik C, 2004, J CELL SCI, V117, P281, DOI 10.1242/jcs.00841; Xu YK, 2011, J CELL BIOL, V193, P643, DOI 10.1083/jcb.201008135; Yeh TYJ, 2007, BIOCHEM J, V402, P279, DOI 10.1042/BJ20060793; Yeung HO, 2008, BIOCHEM SOC T, V36, P62, DOI 10.1042/BST0360062; Yu CF, 2007, J BIOL CHEM, V282, P7710, DOI 10.1074/jbc.M610824200	77	37	39	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6679	6692		10.1074/jbc.M111.284232	http://dx.doi.org/10.1074/jbc.M111.284232			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22207755	Green Published, hybrid			2022-12-27	WOS:000300791800054
J	Guillot-Sestier, MV; Sunyach, C; Ferreira, ST; Marzolo, MP; Bauer, C; Thevenet, A; Checler, F				Guillot-Sestier, Marie-Victoire; Sunyach, Claire; Ferreira, Sergio T.; Marzolo, Maria-Paz; Bauer, Charlotte; Thevenet, Aurelie; Checler, Frederic			alpha-Secretase-derived Fragment of Cellular Prion, N1, Protects against Monomeric and Oligomeric Amyloid beta (A beta)-associated Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-RELATED PROTEIN; HEK293 HUMAN-CELLS; PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; WILD-TYPE; MUSCARINIC RECEPTORS; SYNAPTIC PLASTICITY; P53; PRESENILIN-1; CLEAVAGE	In physiological conditions, both beta-amyloid precursor protein (beta APP) and cellular prion (PrPc) undergo similar disintegrin-mediated alpha-secretase cleavage yielding N-terminal secreted products referred to as soluble amyloid precursor protein-alpha (sAPP alpha) and N1, respectively. We recently demonstrated that N1 displays neuroprotective properties by reducing p53-dependent cell death both in vitro and in vivo. In this study, we examined the potential of N1 as a neuroprotector against amyloid beta (A beta)-mediated toxicity. We first show that both recombinant sAPP alpha and N1, but not its inactive parent fragment N2, reduce staurosporine-stimulated caspase-3 activation and TUNEL-positive cell death by lowering p53 promoter transactivation and activity in human cells. We demonstrate that N1 also lowers toxicity, cell death, and p53 pathway exacerbation triggered by Swedish mutated beta APP overexpression in human cells. We designed a CHO cell line overexpressing the London mutated beta APP (APP(LDN)) that yields A beta oligomers. N1 protected primary cultured neurons against toxicity and cell death triggered by oligomer-enriched APP(LDN)-derived conditioned medium. Finally, we establish that N1 also protects neurons against oligomers extracted from Alzheimer disease-affected brain tissues. Overall, our data indicate that a cellular prion catabolite could interfere with A beta-associated toxicity and that its production could be seen as a cellular protective mechanism aimed at compensating for an sAPP alpha deficit taking place at the early asymptomatic phase of Alzheimer disease.	[Guillot-Sestier, Marie-Victoire; Sunyach, Claire; Bauer, Charlotte; Thevenet, Aurelie; Checler, Frederic] Univ Nice Sophia Antipolis UNSA, Inst Pharmacol Mol & Cellulaire, CNRS, UMR6097, F-06560 Valbonne, France; [Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Med Biochem, BR-21941590 Rio De Janeiro, RJ, Brazil; [Marzolo, Maria-Paz] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Lab Traf Intracelular & Senalizac, Dept Biol Celular & Mol, Santiago 6513492, Chile	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Universidade Federal do Rio de Janeiro; Pontificia Universidad Catolica de Chile	Checler, F (corresponding author), Univ Nice Sophia Antipolis UNSA, Inst Pharmacol Mol & Cellulaire, CNRS, UMR6097, 660 Route Lucioles, F-06560 Valbonne, France.	checler@ipmc.cnrs.fr	Ferreira, Sergio/AAZ-1576-2020; Neurociencia, Inct/I-1011-2013; Checler, Frederic/C-1241-2009	Ferreira, Sergio/0000-0001-7160-9866; Checler, Frederic/0000-0003-2098-1750; Guillot-Sestier, Marie-Victoire/0000-0001-9674-7114	Fondation pour la Recherche Medicale; Conseil general des Alpes Maritimes; Fondecyt [1110382]; Millennium Nucleus [P-07-011-F]	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Conseil general des Alpes Maritimes(Region Provence-Alpes-Cote d'Azur); Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Millennium Nucleus	This work was supported in part by the Fondation pour la Recherche Medicale and by the Conseil general des Alpes Maritimes.; Supported by Fondecyt Grant 1110382 and Millennium Nucleus Grant P-07-011-F.	Altmeppen HC, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-36; Andrau D, 2003, J BIOL CHEM, V278, P25859, DOI 10.1074/jbc.M302622200; Armogida M, 2001, NAT CELL BIOL, V3, P1030, DOI 10.1038/ncb1101-1030; Barelli HL, 1997, MOL MED, V3, P695, DOI 10.1007/BF03401708; Benilova I, 2010, EMBO MOL MED, V2, P289, DOI 10.1002/emmm.201000088; Brandan E, 2006, J BIOL CHEM, V281, P31562, DOI 10.1074/jbc.M602919200; Caccamo A, 2006, NEURON, V49, P671, DOI 10.1016/j.neuron.2006.01.020; Caetano FA, 2011, J NEUROCHEM, V117, P538, DOI 10.1111/j.1471-4159.2011.07225.x; Calella AM, 2010, EMBO MOL MED, V2, P306, DOI 10.1002/emmm.201000082; CHECLER F, 1995, J NEUROCHEM, V65, P1431; Chen SG, 2010, J BIOL CHEM, V285, P26377, DOI 10.1074/jbc.M110.145516; Cheng GJ, 2002, EXP NEUROL, V175, P407, DOI 10.1006/exnr.2002.7920; Chevallier N, 1997, BRIT J PHARMACOL, V121, P556, DOI 10.1038/sj.bjp.0701151; Cisse M, 2011, J BIOL CHEM, V286, P29192, DOI 10.1074/jbc.M110.208249; Cisse M, 2011, J NEUROSCI, V31, P10427, DOI 10.1523/JNEUROSCI.1459-11.2011; Cisse M, 2011, MOL CELL NEUROSCI, V47, P223, DOI 10.1016/j.mcn.2011.04.008; Cisse MA, 2007, J NEUROSCI, V27, P4083, DOI 10.1523/JNEUROSCI.5293-06.2007; da Costa CA, 2000, J BIOL CHEM, V275, P24065, DOI 10.1074/jbc.M002413200; da Costa CA, 2006, J NEUROSCI, V26, P6377, DOI 10.1523/JNEUROSCI.0651-06.2006; da Costa CA, 2002, P NATL ACAD SCI USA, V99, P4043, DOI 10.1073/pnas.062059899; Etcheberrigaray R, 2004, P NATL ACAD SCI USA, V101, P11141, DOI 10.1073/pnas.0403921101; Ferreira ST, 2011, NEUROBIOL LEARN MEM, V96, P529, DOI 10.1016/j.nlm.2011.08.003; Fuentealba RA, 2009, J BIOL CHEM, V284, P34045, DOI 10.1074/jbc.M109.021030; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; GOODMAN Y, 1994, EXP NEUROL, V128, P1, DOI 10.1006/exnr.1994.1107; Gralle M, 2002, BIOPHYS J, V83, P3513, DOI 10.1016/S0006-3495(02)75351-4; Guillot-Sestier MV, 2009, J BIOL CHEM, V284, P35973, DOI 10.1074/jbc.M109.051086; HAASS C, 1993, CELL, V75, P1039, DOI 10.1016/0092-8674(93)90312-E; Heber S, 2000, J NEUROSCI, V20, P7951; Henry A, 1997, PROTEIN EXPRES PURIF, V10, P283, DOI 10.1006/prep.1997.0748; Herreman A, 2000, NAT CELL BIOL, V2, P461, DOI 10.1038/35017105; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Huber G, 1997, NEUROSCIENCE, V80, P313, DOI 10.1016/S0306-4522(97)00120-6; Iwatsubo T, 2004, CURR OPIN NEUROBIOL, V14, P379, DOI 10.1016/j.conb.2004.05.010; Jimenez S, 2011, J BIOL CHEM, V286, P18414, DOI 10.1074/jbc.M110.209718; Kessels HW, 2010, NATURE, V466, pE3, DOI 10.1038/nature09217; KOUNNAS MZ, 1995, CELL, V82, P331, DOI 10.1016/0092-8674(95)90320-8; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lefranc-Jullien S, 2005, BRIT J PHARMACOL, V145, P228, DOI 10.1038/sj.bjp.0706183; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; Ma L, 2009, J ALZHEIMERS DIS, V16, P565, DOI 10.3233/JAD-2009-0990; MATTSON MP, 1993, NEURON, V10, P243, DOI 10.1016/0896-6273(93)90315-I; MENSAWILMOT K, 1994, J CELL BIOL, V124, P935, DOI 10.1083/jcb.124.6.935; Morel M, 2009, NEUROBIOL DIS, V36, P151, DOI 10.1016/j.nbd.2009.07.004; Nygaard HB, 2009, ARCH NEUROL-CHICAGO, V66, P1325, DOI 10.1001/archneurol.2009.223; Ohyagi Y, 2005, FASEB J, V19, P255, DOI 10.1096/fj.04-2637fje; Paitel E, 2004, J BIOL CHEM, V279, P612, DOI 10.1074/jbc.M310453200; Parkyn CJ, 2008, J CELL SCI, V121, P773, DOI 10.1242/jcs.021816; Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864; Prusiner SB, 1998, CELL, V93, P337, DOI 10.1016/S0092-8674(00)81163-0; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Sevalle J, 2009, J NEUROCHEM, V110, P275, DOI 10.1111/j.1471-4159.2009.06131.x; Sevalle J, 2009, J NEUROCHEM, V109, P248, DOI 10.1111/j.1471-4159.2009.05950.x; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shankar GM, 2011, METHODS MOL BIOL, V670, P33, DOI 10.1007/978-1-60761-744-0_3; STAHL N, 1987, CELL, V51, P229, DOI 10.1016/0092-8674(87)90150-4; Sunyach C, 2007, J BIOL CHEM, V282, P1956, DOI 10.1074/jbc.M609663200; Taylor DR, 2007, BIOCHEM J, V402, P17, DOI 10.1042/BJ20061736; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vincent B, 2000, J BIOL CHEM, V275, P35612, DOI 10.1074/jbc.M004628200; Vincent B, 2001, J BIOL CHEM, V276, P37743; Vincent B, 1996, J NEUROSCI, V16, P5049; Vincent B, 2008, CURR ALZHEIMER RES, V5, P202, DOI 10.2174/156720508783954749; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Xu X, 1999, P NATL ACAD SCI USA, V96, P7547, DOI 10.1073/pnas.96.13.7547; Zhang Y, 2002, J CELL BIOL, V156, P519, DOI 10.1083/jcb.200110119	69	74	75	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					5021	5032		10.1074/jbc.M111.323626	http://dx.doi.org/10.1074/jbc.M111.323626			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22184125	hybrid, Green Published			2022-12-27	WOS:000300608500061
J	Hauk, P; Barbosa, AS; Ho, PL; Farah, CS				Hauk, Pricila; Barbosa, Angela Silva; Ho, Paulo Lee; Farah, Chuck Shaker			Calcium Binding to Leptospira Outer Membrane Antigen LipL32 Is Not Necessary for Its Interaction with Plasma Fibronectin, Collagen Type IV, and Plasminogen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR-MATRIX PROTEINS; PATHOGENIC LEPTOSPIRA; SURFACE PROTEIN; INTERROGANS; IDENTIFICATION; LIPOPROTEIN; DYE; EXPRESSION; ADHERENCE; LAMININ	LipL32 is the most abundant outer membrane protein from pathogenic Leptospira and has been shown to bind extracellular matrix (ECM) proteins as well as Ca2+. Recent crystal structures have been obtained for the protein in the apo-and Ca2+-bound forms. In this work, we produced three LipL32 mutants (D163-168A, Q67A, and S247A) and evaluated their ability to interact with Ca2+ and with ECM glycoproteins and human plasminogen. The D163-168A mutant modifies aspartate residues involved in Ca2+ binding, whereas the other two modify residues in a cavity on the other side of the protein structure. Loss of calcium binding in the D163-D168A mutant was confirmed using intrinsic tryptophan fluorescence, circular dichroism, and thermal denaturation whereas the Q67A and S247A mutants presented the same Ca2+ affinity as the wild-type protein. We then evaluated if Ca2+ binding to LipL32 would be crucial for its interaction with collagen type IV and plasma proteins fibronectin and plasminogen. Surprisingly, the wild-type protein and all three mutants, including the D163-168A variant, bound to these ECM proteins with very similar affinities, both in the presence and absence of Ca2+ ions. In conclusion, calcium binding to LipL32 may be important to stabilize the protein, but is not necessary to mediate interaction with host extracellular matrix proteins.	[Barbosa, Angela Silva] Inst Butantan, Bacteriol Lab, BR-05503900 Sao Paulo, Brazil; [Hauk, Pricila; Farah, Chuck Shaker] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-05513970 Sao Paulo, Brazil; [Ho, Paulo Lee] Inst Butantan, Ctr Biotecnol, BR-05503900 Sao Paulo, Brazil	Instituto Butantan; Universidade de Sao Paulo; Instituto Butantan	Barbosa, AS (corresponding author), Inst Butantan, Bacteriol Lab, BR-05503900 Sao Paulo, Brazil.	angelabarbosa@butantan.gov.br; chsfarah@iq.usp.br	Farah, Chuck Shaker/G-5565-2012; 4, INCT/H-4499-2013; Inbeqmedi, Inct/I-1929-2013; Barbosa, Angela S/I-3518-2013; Hauk, Pricila/AAS-9424-2021; Hauk, Pricila/C-8559-2013; Ho, Paulo/P-8267-2015	Farah, Chuck Shaker/0000-0003-3110-6302; Barbosa, Angela S/0000-0002-6458-9489; Hauk, Pricila/0000-0002-4761-1920; Ho, Paulo/0000-0003-3652-241X	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Fundacao Butantan; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundacao Butantan; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), the Fundacao Butantan, and the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq).	Adler B, 2010, VET MICROBIOL, V140, P287, DOI 10.1016/j.vetmic.2009.03.012; Barbosa AS, 2006, INFECT IMMUN, V74, P6356, DOI 10.1128/IAI.00460-06; Bers D., 1994, METHODS CELL BIOL; Bhandari P, 1997, J BACTERIOL, V179, P4403, DOI 10.1128/jb.179.13.4403-4406.1997; Branger C, 2001, INFECT IMMUN, V69, P6831, DOI 10.1128/IAI.69.11.6831-6838.2001; Branger C, 2005, INFECT IMMUN, V73, P4062, DOI 10.1128/IAI.73.7.4062-4069.2005; Breiner DD, 2009, INFECT IMMUN, V77, P5528, DOI 10.1128/IAI.00546-09; CADAY CG, 1986, BIOPOLYMERS, V25, P1579, DOI 10.1002/bip.360250814; CADAY CG, 1985, J BIOL CHEM, V260, P5985; Cameron CE, 2003, INFECT IMMUN, V71, P2525, DOI 10.1128/IAI.71.5.2525-2533.2003; Candela M, 2007, J BACTERIOL, V189, P5929, DOI 10.1128/JB.00159-07; Choy HA, 2007, INFECT IMMUN, V75, P2441, DOI 10.1128/IAI.01635-06; Cork AJ, 2009, J BIOL CHEM, V284, P17129, DOI 10.1074/jbc.M109.004317; Cullen PA, 2005, INFECT IMMUN, V73, P4853, DOI 10.1128/IAI.73.8.4853-4863.2005; Dabo SM, 2006, MICROB PATHOGENESIS, V41, P10, DOI 10.1016/j.micpath.2006.04.003; DUNCANSON GO, 1990, CLIN CHEM, V36, P756; Faine S, 1999, LEPTOSPIRA LEPTOSPIR, V2nd; Haake DA, 2000, INFECT IMMUN, V68, P2276, DOI 10.1128/IAI.68.4.2276-2285.2000; Hauk P, 2011, BRAZ J MED BIOL RES, V44, P297, DOI 10.1590/S0100-879X2011007500025; Hauk P, 2008, INFECT IMMUN, V76, P2642, DOI 10.1128/IAI.01639-07; Hauk P, 2009, J MOL BIOL, V390, P722, DOI 10.1016/j.jmb.2009.05.034; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Hoke DE, 2008, INFECT IMMUN, V76, P2063, DOI 10.1128/IAI.01643-07; KLOTZ SA, 1993, MICROB PATHOGENESIS, V14, P133, DOI 10.1006/mpat.1993.1014; Lin YP, 2009, J BIOL CHEM, V284, P23547, DOI 10.1074/jbc.M109.031369; LOWRANCE JH, 1988, INFECT IMMUN, V56, P2279, DOI 10.1128/IAI.56.9.2279-2285.1988; Murray GL, 2009, INFECT IMMUN, V77, P952, DOI 10.1128/IAI.01370-08; Pace C. N., 1997, PROTEIN STRUCTURE PR, V2, P299; Picardeau M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001607; Ramos CRR, 2004, BRAZ J MED BIOL RES, V37, P1103, DOI 10.1590/S0100-879X2004000800001; Seixas FK, 2007, VACCINE, V26, P88, DOI 10.1016/j.vaccine.2007.10.052; SHARMA Y, 1989, J BIOL CHEM, V264, P20923; Stevenson B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001188; Tung JY, 2010, J BIOL CHEM, V285, P3245, DOI 10.1074/jbc.M109.006320; Verma A, 2010, INFECT IMMUN, V78, P2053, DOI 10.1128/IAI.01282-09; Vieira ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011259; Vivian JP, 2009, J MOL BIOL, V387, P1229, DOI 10.1016/j.jmb.2009.02.038; WANG LP, 1994, INVEST OPHTH VIS SCI, V35, P2421; Yang CW, 2006, KIDNEY INT, V69, P815, DOI 10.1038/sj.ki.5000119; Yang CW, 2002, J AM SOC NEPHROL, V13, P2037, DOI 10.1097/01.ASN.0000022007.91733.62	40	11	11	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4826	4834		10.1074/jbc.M111.277210	http://dx.doi.org/10.1074/jbc.M111.277210			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22147698	hybrid, Green Published			2022-12-27	WOS:000300608500044
J	Huang, Z; Hoffmann, FW; Fay, JD; Hashimoto, AC; Chapagain, ML; Kaufusi, PH; Hoffmann, PR				Huang, Zhi; Hoffmann, FuKun W.; Fay, Jeffrey D.; Hashimoto, Ann C.; Chapagain, Moti L.; Kaufusi, Pakieli H.; Hoffmann, Peter R.			Stimulation of Unprimed Macrophages with Immune Complexes Triggers a Low Output of Nitric Oxide by Calcium-dependent Neuronal Nitric-oxide Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MURINE MACROPHAGES; MAMMALIAN-CELLS; L-ARGININE; GAMMA; PHAGOCYTOSIS; EXPRESSION; LOCATION; DYSFUNCTION; ACTIVATION; INHIBITION	Immune complexes composed of IgG-opsonized pathogens, particles, or proteins are phagocytosed by macrophages through Fc gamma receptors (Fc gamma Rs). Macrophages primed with IFN gamma or other pro-inflammatory mediators respond to Fc gamma R engagement by secreting high levels of cytokines and nitric oxide (NO). We found that unprimed macrophages produced lower levels of NO, which required efficient calcium (Ca2+) flux as demonstrated by using macrophages lacking selenoprotein K, which is required for Fc gamma R-induced Ca2+ flux. Thus, we further investigated the signaling pathways involved in low output NO and its functional significance. Evaluation of inducible, endothelial, and neuronal nitric-oxide synthases (iNOS, eNOS, and nNOS) revealed that Fc gamma R stimulation in unprimed macrophages caused a marked Ca2+-dependent increase in both total and phosphorylated nNOS and slightly elevated levels of phosphorylated eNOS. Also activated were three MAP kinases, ERK, JNK, and p38, of which ERK activation was highly dependent on Ca2+ flux. Inhibition of ERK reduced both nNOS activation and NO secretion. Finally, Transwell experiments showed that Fc gamma R-induced NO functioned to increase the phagocytic capacity of other macrophages and required both NOS and ERK activity. The production of NO by macrophages is conventionally attributed to iNOS, but we have revealed an iNOS-independent receptor/enzyme system in unprimed macrophages that produces low output NO. Under these conditions, Fc gamma R engagement relies on Ca2+-dependent ERK phosphorylation, which in turn increases nNOS and, to a lesser extent, eNOS, both of which produce low levels of NO that function to promote phagocytosis.	[Huang, Zhi; Hoffmann, FuKun W.; Fay, Jeffrey D.; Hashimoto, Ann C.; Hoffmann, Peter R.] Univ Hawaii, John A Burns Sch Med, Dept Cell & Mol Biol, Honolulu, HI 96813 USA; [Chapagain, Moti L.; Kaufusi, Pakieli H.] Univ Hawaii, John A Burns Sch Med, Dept Trop Med Med Microbiol & Pharmacol, Honolulu, HI 96813 USA; [Huang, Zhi] Jinan Univ, Coll Life Sci & Technol, Dept Biotechnol, Guangzhou 510632, Guangdong, Peoples R China	University of Hawaii System; University of Hawaii System; Jinan University	Hoffmann, PR (corresponding author), Univ Hawaii, John A Burns Sch Med, Dept Cell & Mol Biol, 651 Ilalo St, Honolulu, HI 96813 USA.	peterh@pbrc.hawaii.edu			National Institutes of Health [R21AT004844, R01AI089999]; Fundamental Research Funds for the Central Universities; National Natural Science Foundation of China [20975045]; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R21AT004844] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089999] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R21AT004844 and R01AI089999. This work was also supported by the Fundamental Research Funds for the Central Universities and the National Natural Science Foundation (Grant 20975045) of China.	BIRMELIN M, 1983, EUR J BIOCHEM, V131, P539, DOI 10.1111/j.1432-1033.1983.tb07295.x; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Braun A, 2009, BLOOD, V113, P1097, DOI 10.1182/blood-2008-05-158477; BREDT DS, 1990, NATURE, V347, P768, DOI 10.1038/347768a0; Chauhan SD, 2003, FASEB J, V17, P773, DOI 10.1096/fj.02-0668fje; CHESROWN SE, 1994, BIOCHEM BIOPH RES CO, V200, P126, DOI 10.1006/bbrc.1994.1424; Connelly L, 2003, J BIOL CHEM, V278, P26480, DOI 10.1074/jbc.M302238200; Daeron M, 1997, ANNU REV IMMUNOL, V15, P203, DOI 10.1146/annurev.immunol.15.1.203; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Fernandez-Boyanapalli R, 2010, J IMMUNOL, V185, P4030, DOI 10.4049/jimmunol.1001778; Fox SW, 1998, BONE, V23, P1, DOI 10.1016/S8756-3282(98)00070-2; GRANGER DL, 1988, J CLIN INVEST, V81, P1129, DOI 10.1172/JCI113427; HECKER M, 1992, J CARDIOVASC PHARM, V20, pS139, DOI 10.1097/00005344-199204002-00039; Huang Z, 2011, J BIOL CHEM, V286, P34830, DOI 10.1074/jbc.M111.265520; Jagnandan D, 2005, AM J PHYSIOL-CELL PH, V289, pC1024, DOI 10.1152/ajpcell.00162.2005; KASTEN TP, 1994, P NATL ACAD SCI USA, V91, P3569, DOI 10.1073/pnas.91.9.3569; Kim J, 2008, ARCH BIOCHEM BIOPHYS, V472, P58, DOI 10.1016/j.abb.2008.01.020; Lancaster JR, 1997, NITRIC OXIDE-BIOL CH, V1, P18, DOI 10.1006/niox.1996.0112; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Mayer B, 1997, TRENDS BIOCHEM SCI, V22, P477, DOI 10.1016/S0968-0004(97)01147-X; Miller L, 1996, J LEUKOCYTE BIOL, V59, P442, DOI 10.1002/jlb.59.3.442; MOZAFFARIAN N, 1995, J LEUKOCYTE BIOL, V57, P657, DOI 10.1002/jlb.57.4.657; Mungrue IN, 2004, J CELL SCI, V117, P2627, DOI 10.1242/jcs.01187; NATHAN C, 1992, FASEB J, V6, P3051, DOI 10.1096/fasebj.6.12.1381691; Nicolin V, 2005, ANAT REC PART A, V286A, P945, DOI 10.1002/ar.a.20239; Nimmerjahn F, 2006, IMMUNITY, V24, P19, DOI 10.1016/j.immuni.2005.11.010; Nimmerjahn F, 2005, IMMUNITY, V23, P41, DOI 10.1016/j.immuni.2005.05.010; Nimmerjahn F, 2007, ADV IMMUNOL, V96, P179, DOI 10.1016/S0065-2776(07)96005-8; Nunes P, 2010, J LEUKOCYTE BIOL, V88, P57, DOI 10.1189/jlb.0110028; Paludan SR, 2000, J LEUKOCYTE BIOL, V67, P18, DOI 10.1002/jlb.67.1.18; Roman V, 1997, IMMUNOLOGY, V91, P643, DOI 10.1046/j.1365-2567.1997.d01-2263.x; Rose DM, 1997, J IMMUNOL, V158, P3433; SCHMIDT HHHW, 1992, MOL PHARMACOL, V41, P615; Schodel J, 2009, ATHEROSCLEROSIS, V206, P383, DOI 10.1016/j.atherosclerosis.2009.02.033; Schwartz D, 1997, J CLIN INVEST, V100, P439, DOI 10.1172/JCI119551; Shaul PW, 2002, ANNU REV PHYSIOL, V64, P749, DOI 10.1146/annurev.physiol.64.081501.155952; Tejle K, 2002, BIOSCIENCE REP, V22, P529, DOI 10.1023/A:1022025903688; Tripathi P, 2007, FEMS IMMUNOL MED MIC, V51, P443, DOI 10.1111/j.1574-695X.2007.00329.x; Tumer C, 2007, CELL BIOL INT, V31, P565, DOI 10.1016/j.cellbi.2006.11.029; Vaughn MW, 1998, AM J PHYSIOL-HEART C, V274, pH2163, DOI 10.1152/ajpheart.1998.274.6.H2163; Verma S, 2011, J IMMUNOL, V186, P2127, DOI 10.4049/jimmunol.1002878; Waterman PM, 2010, FEBS LETT, V584, P4878, DOI 10.1016/j.febslet.2010.09.029; YOUNG JDE, 1984, P NATL ACAD SCI-BIOL, V81, P5430, DOI 10.1073/pnas.81.17.5430	43	44	47	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4492	4502		10.1074/jbc.M111.315598	http://dx.doi.org/10.1074/jbc.M111.315598			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22205701	hybrid, Green Published			2022-12-27	WOS:000300608500013
J	Qian, P; Marklew, CJ; Viney, J; Davison, PA; Brindley, AA; Soderberg, C; Al-Karadaghi, S; Bullough, PA; Grossmann, JG; Hunter, CN				Qian, Pu; Marklew, Christopher J.; Viney, Joanne; Davison, Paul A.; Brindley, Amanda A.; Soderberg, Christopher; Al-Karadaghi, Salam; Bullough, Per A.; Grossmann, J. Guenter; Hunter, C. Neil			Structure of the Cyanobacterial Magnesium Chelatase H Subunit Determined by Single Particle Reconstruction and Small-angle X-ray Scattering	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTOPORPHYRIN-IX METHYLTRANSFERASE; MG-CHELATASE; ATPASE ACTIVITY; ABSCISIC-ACID; CHLOROPHYLL BIOSYNTHESIS; RHODOBACTER-SPHAEROIDES; SYNECHOCYSTIS PCC6803; ESCHERICHIA-COLI; BCHH; GUN4	The biosynthesis of chlorophyll, an essential cofactor for photosynthesis, requires the ATP-dependent insertion of Mg2+ into protoporphyrin IX catalyzed by the multisubunit enzyme magnesium chelatase. This enzyme complex consists of the I subunit, an ATPase that forms a complex with the D subunit, and an H subunit that binds both the protoporphyrin substrate and the magnesium protoporphyrin product. In this study we used electron microscopy and small-angle x-ray scattering to investigate the structure of the magnesium chelatase H subunit, ChlH, from the thermophilic cyanobacterium Thermosynechococcus elongatus. Single particle reconstruction of negatively stained apo-ChlH and Chl-porphyrin proteins was used to reconstitute three-dimensional structures to a resolution of similar to 30 angstrom. ChlH is a large, 148-kDa protein of 1326 residues, forming a cage-like assembly comprising the majority of the structure, attached to a globular N-terminal domain of similar to 16 kDa by a narrow linker region. This N-terminal domain is adjacent to a 5 nm-diameter opening in the structure that allows access to a cavity. Small-angle x-ray scattering analysis of ChlH, performed on soluble, catalytically active ChlH, verifies the presence of two domains and their relative sizes. Our results provide a basis for the multiple regulatory and catalytic functions of ChlH of oxygenic photosynthetic organisms and for a chaperoning function that sequesters the enzyme-bound magnesium protoporphyrin product prior to its delivery to the next enzyme in the chlorophyll biosynthetic pathway, magnesium protoporphyrin methyltransferase.	[Qian, Pu; Marklew, Christopher J.; Viney, Joanne; Davison, Paul A.; Brindley, Amanda A.; Bullough, Per A.; Hunter, C. Neil] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England; [Soderberg, Christopher; Al-Karadaghi, Salam] Lund Univ, Dept Mol Biophys, Ctr Mol Prot Sci, S-22100 Lund, Sweden; [Grossmann, J. Guenter] Univ Liverpool, Fac Hlth & Life Sci, Inst Integrat Biol, Mol Biophys Grp, Liverpool L69 7ZB, Merseyside, England	University of Sheffield; Lund University; University of Liverpool	Hunter, CN (corresponding author), Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England.	c.n.hunter@sheffield.ac	Al-karadaghi, Salam/F-1492-2011; Qian, Pu/GZM-2400-2022	Al-karadaghi, Salam/0000-0001-8608-0635; Bullough, Per/0000-0001-8147-1127	Biotechnology and Biological Sciences Research Council (UK); Biotechnology and Biological Sciences Research Council [BB/G021546/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a grant from the Biotechnology and Biological Sciences Research Council (UK) (to C. N. H. and P. A. B.). This work was also supported by doctoral studentships from the Biotechnology and Biological Sciences Research Council (UK) (to J. V. and C. J. M.).	Adhikari ND, 2011, PLANT CELL, V23, P1449, DOI 10.1105/tpc.110.082503; Alawady A, 2005, PLANT MOL BIOL, V57, P679, DOI 10.1007/s11103-005-1427-8; Bjorn L, 2009, PHOTOSYNTH RES, V99, P85, DOI 10.1007/s11120-008-9395-x; Chew AGM, 2009, PHOTOSYNTH RES, V101, P21, DOI 10.1007/s11120-009-9460-0; Davison PA, 2005, BIOCHEMISTRY-US, V44, P7603, DOI 10.1021/bi050240x; Davison PA, 2011, FEBS LETT, V585, P183, DOI 10.1016/j.febslet.2010.11.037; Elmlund H, 2008, J MOL BIOL, V375, P934, DOI 10.1016/j.jmb.2007.11.028; Fodje MN, 2001, J MOL BIOL, V311, P111, DOI 10.1006/jmbi.2001.4834; Gibson LCD, 1999, BIOCHEM J, V337, P243, DOI 10.1042/0264-6021:3370243; GIBSON LCD, 1995, P NATL ACAD SCI USA, V92, P1941, DOI 10.1073/pnas.92.6.1941; Gibson LCD, 1996, PLANT PHYSIOL, V111, P61, DOI 10.1104/pp.111.1.61; Grossmann J. G., 2002, SCATTERING, P1123; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Hinchigeri SB, 1997, FEBS LETT, V407, P337, DOI 10.1016/S0014-5793(97)00371-2; HUDSON A, 1993, EMBO J, V12, P3711, DOI 10.1002/j.1460-2075.1993.tb06048.x; Jensen PE, 1999, BIOCHEM J, V339, P127, DOI 10.1042/0264-6021:3390127; Jensen PE, 1998, BIOCHEM J, V334, P335, DOI 10.1042/bj3340335; Jensen PE, 1996, J BIOL CHEM, V271, P16662, DOI 10.1074/jbc.271.28.16662; Johnson ET, 2008, J BIOL CHEM, V283, P27776, DOI 10.1074/jbc.M804486200; Karger GA, 2001, BIOCHEMISTRY-US, V40, P9291, DOI 10.1021/bi010562a; KNIGHT S, 1990, J MOL BIOL, V215, P113, DOI 10.1016/S0022-2836(05)80100-7; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Larkin RM, 2003, SCIENCE, V299, P902, DOI 10.1126/science.1079978; Lundqvist J, 2010, STRUCTURE, V18, P354, DOI 10.1016/j.str.2010.01.001; Maqueo Chew AG, 2007, ANNU REV MICROBIOL, V61, P113, DOI 10.1146/annurev.micro.61.080706.093242; MEISENBERGER O, 1984, J BIOL CHEM, V259, P4463; Mochizuki N, 2001, P NATL ACAD SCI USA, V98, P2053, DOI 10.1073/pnas.98.4.2053; Muller AH, 2009, PLANT PHYSIOL, V150, P157, DOI 10.1104/pp.109.135277; Osanai T, 2009, P NATL ACAD SCI USA, V106, P6860, DOI 10.1073/pnas.0810040106; Papenbrock J, 1997, PLANT J, V12, P981, DOI 10.1046/j.1365-313X.1997.12050981.x; Peter E, 2009, MOL PLANT, V2, P1198, DOI 10.1093/mp/ssp072; Petersen BL, 1998, J BACTERIOL, V180, P699, DOI 10.1128/JB.180.3.699-704.1998; Petoukhov MV, 2003, J APPL CRYSTALLOGR, V36, P540, DOI 10.1107/S0021889803000591; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Reid JD, 2003, BIOCHEMISTRY-US, V42, P6912, DOI 10.1021/bi034082q; Reid JD, 2004, J BIOL CHEM, V279, P26893, DOI 10.1074/jbc.M400958200; Ruzheinikov SN, 2001, STRUCTURE, V9, P789, DOI 10.1016/S0969-2126(01)00645-1; Sawicki A, 2007, BIOCHEM J, V406, P469, DOI 10.1042/BJ20070284; Sawicki A, 2010, FEBS J, V277, P4709, DOI 10.1111/j.1742-4658.2010.07877.x; SCHATZ M, 1990, ULTRAMICROSCOPY, V32, P255, DOI 10.1016/0304-3991(90)90003-5; Shang Y, 2010, PLANT CELL, V22, P1909, DOI 10.1105/tpc.110.073874; Shen Y, 2005, CHEM-EUR J, V11, P1549, DOI 10.1002/chem.200400298; Shen YY, 2006, NATURE, V443, P823, DOI 10.1038/nature05176; Shepherd M, 2005, FEBS J, V272, P4532, DOI 10.1111/j.1742-4658.2005.04873.x; Shepherd M, 2004, BIOCHEM J, V382, P1009, DOI 10.1042/BJ20040661; Shepherd M, 2003, BIOCHEM J, V371, P351, DOI 10.1042/BJ20021394; Sirijovski N, 2008, J BIOL CHEM, V283, P11652, DOI 10.1074/jbc.M709172200; Sobotka R, 2008, J BIOL CHEM, V283, P25794, DOI 10.1074/jbc.M803787200; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2002, CURR OPIN STRUC BIOL, V12, P654, DOI 10.1016/S0959-440X(02)00363-9; Tanaka R, 2007, ANNU REV PLANT BIOL, V58, P321, DOI 10.1146/annurev.arplant.57.032905.105448; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tsuzuki T, 2011, J PLANT RES, V124, P527, DOI 10.1007/s10265-011-0426-x; van Heel M, 2005, J STRUCT BIOL, V151, P250, DOI 10.1016/j.jsb.2005.05.009; VANHEEL M, 1985, EMBO J, V4, P2389, DOI 10.1002/j.1460-2075.1985.tb03944.x; VANHEEL M, 1981, ULTRAMICROSCOPY, V6, P187, DOI 10.1016/0304-3991(81)90059-0; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Verdecia MA, 2005, PLOS BIOL, V3, P777, DOI 10.1371/journal.pbio.0030151; Viney J, 2007, BIOCHEMISTRY-US, V46, P12788, DOI 10.1021/bi701515y; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wilde A, 2004, FEBS LETT, V571, P119, DOI 10.1016/j.febslet.2004.06.063; Willows RD, 2004, J STRUCT BIOL, V146, P227, DOI 10.1016/j.jsb.2003.11.019; Willows RD, 2003, J BACTERIOL, V185, P3249, DOI 10.1128/JB.185.11.3249-3258.2003; Wu FQ, 2009, PLANT PHYSIOL, V150, P1940, DOI 10.1104/pp.109.140731	64	16	16	0	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4946	4956		10.1074/jbc.M111.308239	http://dx.doi.org/10.1074/jbc.M111.308239			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22179610	Green Published, hybrid			2022-12-27	WOS:000300608500055
J	Wu, JY; Kuo, CC				Wu, Jing-Yiing; Kuo, Cheng-Chin			Pivotal Role of ADP-ribosylation Factor 6 in Toll-like Receptor 9-mediated Immune Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEOXYRIBONUCLEIC-ACID FRACTION; CPG-B OLIGODEOXYNUCLEOTIDE; MYCOBACTERIUM-BOVIS BCG; BACTERIAL-DNA; INTERFERON-GAMMA; DENDRITIC CELLS; ARF GAPS; RECOGNITION; ACTIVATION; TLR9	CpG oligodeoxynucleotide (CpG ODN) cellular uptake into endosomes, the rate-limiting step of Toll-like receptor 9 (TLR9) signaling, is critical in eliciting innate immune responses. ADP-ribosylation factor 6 (ARF6) is a member of the Ras superfamily, which is critical to a wide variety of cellular events including endocytosis. Here, we found that inhibition of ARF6 by dominant mutants and siRNA impaired CpG ODN-mediated responses, whereas cells expressing the constitutively active ARF6 mutant enhanced CpG ODN-induced cytokine production. Inhibition of ARF6 impaired TLR9 trafficking into endolysosomes, thereby inhibiting proceed functional cleavage of TLR9. Additional studies showed that CpG ODN uptake was increased in ARF6-activated cells but impaired in ARF6-defective cells. Furthermore, cells pretreated with CpG ODN but not GpC ODN had increased CpG ODN uptake due to CpG ODN-induced ARF6 activity. Further studies with ARF6-defective and ARF6-activated cells demonstrated that class III phosphatidylinositol 3-kinases (PI3K) was required for downstream ARF6 regulation of CpG ODN uptake. Together, our findings demonstrate that a novel class III PI3K-ARF6 axis pathway mediates TLR9 signaling by regulating the cellular uptake of CpG ODN.	[Wu, Jing-Yiing; Kuo, Cheng-Chin] Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan 35053, Miaoli, Taiwan; [Wu, Jing-Yiing] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu 30013, Taiwan; [Kuo, Cheng-Chin] China Med Univ, Grad Inst Basic Med Sci, Taichung 40402, Taiwan	National Health Research Institutes - Taiwan; National Tsing Hua University; China Medical University Taiwan	Kuo, CC (corresponding author), Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan 35053, Miaoli, Taiwan.	kuocc@nhri.org.tw	Kuo, Cheng-Chin/B-1064-2010		National Health Research Institutes [99A1-CSPP09-014]; National Science Council of Taiwan [98-2320-B-400-007-MY3]; National Tsing Hua University	National Health Research Institutes(National Health Research Institutes, Japan); National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); National Tsing Hua University	This work was supported by grants from National Health Research Institutes (99A1-CSPP09-014) and the National Science Council (98-2320-B-400-007-MY3) of Taiwan.; This research was conducted under the Graduate Program of Biotechnology in Medicine sponsored by National Tsing Hua University and the National Health Research Institutes.	Akira S, 2003, IMMUNOL LETT, V85, P85, DOI 10.1016/S0165-2478(02)00228-6; Anderson RB, 2008, J LEUKOCYTE BIOL, V83, P381, DOI 10.1189/jlb.0407236; Bauer S, 2001, P NATL ACAD SCI USA, V98, P9237, DOI 10.1073/pnas.161293498; Burns K, 1998, J BIOL CHEM, V273, P12203, DOI 10.1074/jbc.273.20.12203; Butler M, 2000, J PHARMACOL EXP THER, V292, P489; Chockalingam A, 2009, IMMUNOL CELL BIOL, V87, P209, DOI 10.1038/icb.2008.101; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Ewald SE, 2008, NATURE, V456, P658, DOI 10.1038/nature07405; Gursel M, 2006, J IMMUNOL, V177, P1575, DOI 10.4049/jimmunol.177.3.1575; Hacker H, 2000, J EXP MED, V192, P595, DOI 10.1084/jem.192.4.595; Hacker H, 1998, EMBO J, V17, P6230, DOI 10.1093/emboj/17.21.6230; Halpern MD, 1996, CELL IMMUNOL, V167, P72, DOI 10.1006/cimm.1996.0009; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Inoue H, 2007, TRAFFIC, V8, P1465, DOI 10.1111/j.1600-0854.2007.00624.x; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Kline JN, 1998, J IMMUNOL, V160, P2555; Kobayashi T, 2004, MICROBES INFECT, V6, P1333, DOI 10.1016/j.micinf.2004.09.001; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Krieg AM, 2007, J CLIN INVEST, V117, P1184, DOI 10.1172/JCI31414; Krug A, 2004, IMMUNITY, V21, P107, DOI 10.1016/j.immuni.2004.06.007; Kumagai Y, 2008, ADV DRUG DELIVER REV, V60, P795, DOI 10.1016/j.addr.2007.12.004; Kuo CC, 2005, PROTEOMICS, V5, P894, DOI 10.1002/pmic.200401144; Kuo CC, 2007, J IMMUNOL, V178, P6100, DOI 10.4049/jimmunol.178.10.6100; Kuo CC, 2006, J BIOL CHEM, V281, P38200, DOI 10.1074/jbc.M605439200; Kuo CC, 2006, J IMMUNOL, V176, P5943, DOI 10.4049/jimmunol.176.10.5943; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Lund J, 2003, J EXP MED, V198, P513, DOI 10.1084/jem.20030162; MESSINA JP, 1991, J IMMUNOL, V147, P1759; O'Neill LAJ, 2006, CURR OPIN IMMUNOL, V18, P3, DOI 10.1016/j.coi.2005.11.012; Park B, 2008, NAT IMMUNOL, V9, P1407, DOI 10.1038/ni.1669; Randazzo PA, 2007, BIOL CELL, V99, P583, DOI 10.1042/BC20070034; Shirota H, 2001, J IMMUNOL, V167, P66, DOI 10.4049/jimmunol.167.1.66; Sivori S, 2010, BLOOD, V116, P1637, DOI 10.1182/blood-2009-12-256586; Stacey KJ, 1996, J IMMUNOL, V157, P2116; Stein MP, 2003, TRAFFIC, V4, P754, DOI 10.1034/j.1600-0854.2003.00133.x; Takeda K, 2001, GENES CELLS, V6, P733, DOI 10.1046/j.1365-2443.2001.00458.x; Takeshita F, 2004, SEMIN IMMUNOL, V16, P17, DOI 10.1016/j.smim.2003.10.009; TOKUNAGA T, 1984, J NATL CANCER I, V72, P955; Vilaysane A, 2009, SEMIN IMMUNOL, V21, P208, DOI 10.1016/j.smim.2009.05.006; YAMAMOTO S, 1988, JPN J CANCER RES, V79, P866, DOI 10.1111/j.1349-7006.1988.tb00049.x; Yi AK, 1998, J IMMUNOL, V160, P1240; Yi AK, 1998, J IMMUNOL, V160, P4755	44	24	25	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					4323	4334		10.1074/jbc.M111.295113	http://dx.doi.org/10.1074/jbc.M111.295113			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22170068	Green Published, hybrid			2022-12-27	WOS:000300410900063
J	Kumar, S; Das, M; Hadad, CM; Musier-Forsyth, K				Kumar, Sandeep; Das, Mom; Hadad, Christopher M.; Musier-Forsyth, Karin			Substrate Specificity of Bacterial Prolyl-tRNA Synthetase Editing Domain Is Controlled by a Tunable Hydrophobic Pocket	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAEMOPHILUS-INFLUENZAE YBAK; MISCHARGED TRANSFER-RNA; AMINO-ACID; STRUCTURAL BASIS; FORCE-FIELD; PROTEIN; DISCRIMINATION; CYS-TRNA(PRO); RECOGNITION; VALINE	Aminoacyl-tRNA synthetases catalyze the covalent attachment of amino acids onto their cognate tRNAs. High fidelity in this reaction is crucial to the accurate decoding of genetic information and is ensured, in part, by proofreading of the newly synthesized aminoacyl-tRNAs. Prolyl-tRNA synthetases (ProRS) mischarge tRNA(Pro) with alanine or cysteine due to their smaller or similar sizes relative to cognate proline. Mischarged Ala-tRNA(Pro) is hydrolyzed by an editing domain (INS) present in most bacterial ProRSs. In contrast, the INS domain is unable to deacylate Cys-tRNA(Pro), which is hydrolyzed exclusively by a freestanding trans-editing domain known as YbaK. Here, we have used computational and experimental approaches to probe the molecular basis of INS domain alanine specificity. We show that the methyl side chain of alanine binds in a well defined hydrophobic pocket characterized by conserved residues Ile-263, Leu-266, and Lys-279 and partially conserved residue Thr-277 in Escherichia coli ProRS. Site-specific mutation of these residues leads to a significant loss in Ala-tRNA(Pro) hydrolysis, and altering the size of the pocket modulates the substrate specificity. Remarkably, one ProRS INS domain variant displays a complete switch in substrate specificity from alanine to cysteine. The mutually exclusive aminoacyl-tRNA substrate specificities of the WT and engineered INS domains is consistent with the evolution of two distinct editing domains that function to clear Ala-tRNA(Pro) and Cys-tRNA(Pro) in vivo.	[Kumar, Sandeep; Das, Mom; Hadad, Christopher M.; Musier-Forsyth, Karin] Ohio State Univ, Dept Chem & Biochem, Columbus, OH 43210 USA; [Das, Mom; Musier-Forsyth, Karin] Ohio State Univ, Ohio State Biochem Program, Columbus, OH 43210 USA; [Kumar, Sandeep; Das, Mom; Musier-Forsyth, Karin] Ohio State Univ, Ctr RNA Biol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Musier-Forsyth, K (corresponding author), Ohio State Univ, Dept Chem & Biochem, 100 W 18th Ave, Columbus, OH 43210 USA.	musier@chemistry.ohio-state.edu		Hadad, Christopher/0000-0003-1211-4315; Das, Mom/0000-0002-9436-6809	National Institutes of Health [GM049928]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM049928, R01GM049928, R55GM049928] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM049928 (to K. M.-F.).	Ahel I, 2003, P NATL ACAD SCI USA, V100, P15422, DOI 10.1073/pnas.2136934100; An S, 2005, J BIOL CHEM, V280, P34465, DOI 10.1074/jbc.M507550200; An SG, 2004, J BIOL CHEM, V279, P42359, DOI 10.1074/jbc.C400304200; [Anonymous], 2008, AMBER 10; Bates PA, 2001, PROTEINS, P39; Beebe K, 2003, EMBO J, V22, P668, DOI 10.1093/emboj/cdg065; Beuning PJ, 2000, P NATL ACAD SCI USA, V97, P8916, DOI 10.1073/pnas.97.16.8916; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Crepin T, 2006, STRUCTURE, V14, P1511, DOI 10.1016/j.str.2006.08.007; Dock-Bregeon AC, 2000, CELL, V103, P877, DOI 10.1016/S0092-8674(00)00191-4; Doring V, 2001, SCIENCE, V292, P501, DOI 10.1126/science.1057718; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Fersht AR, 1998, SCIENCE, V280, P541, DOI 10.1126/science.280.5363.541; FERSHT AR, 1975, BIOCHEMISTRY-US, V14, P1, DOI 10.1021/bi00672a001; Fukai S, 2000, CELL, V103, P793, DOI 10.1016/S0092-8674(00)00182-3; Hendrickson TL, 2004, ANNU REV BIOCHEM, V73, P147, DOI 10.1146/annurev.biochem.73.012803.092429; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; JAKUBOWSKI H, 1992, MICROBIOL REV, V56, P412, DOI 10.1128/MMBR.56.3.412-429.1992; Jensen JH, 2005, J PHYS CHEM A, V109, P6634, DOI 10.1021/jp051922x; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; Ling JQ, 2009, ANNU REV MICROBIOL, V63, P61, DOI 10.1146/annurev.micro.091208.073210; Ling JQ, 2009, MOL CELL, V33, P654, DOI 10.1016/j.molcel.2009.01.031; Mascarenhas A. P., 2009, V22, P155; Nangle LA, 2006, CHEM BIOL, V13, P1091, DOI 10.1016/j.chembiol.2006.08.011; Nordin BE, 2002, J BIOL CHEM, V277, P20510, DOI 10.1074/jbc.M202023200; Nureki O, 2001, COLD SPRING HARB SYM, V66, P167, DOI 10.1101/sqb.2001.66.167; Reynolds NM, 2010, NAT REV MICROBIOL, V8, P849, DOI 10.1038/nrmicro2472; Roy H, 2004, EMBO J, V23, P4639, DOI 10.1038/sj.emboj.7600474; Ruan BF, 2005, J BIOL CHEM, V280, P25887, DOI 10.1074/jbc.M502174200; So BR, 2011, J BIOL CHEM, V286, P31810, DOI 10.1074/jbc.M111.232611; Sokabe M, 2005, P NATL ACAD SCI USA, V102, P11669, DOI 10.1073/pnas.0502119102; Sokabe M, 2009, P NATL ACAD SCI USA, V106, P11028, DOI 10.1073/pnas.0904645106; Wolfson AD, 2002, P NATL ACAD SCI USA, V99, P5965, DOI 10.1073/pnas.092152799; Wong FC, 2002, BIOCHEMISTRY-US, V41, P7108, DOI 10.1021/bi012178j; Zaher HS, 2009, NATURE, V457, P161, DOI 10.1038/nature07582; Zhang H, 2000, PROTEINS, V40, P86, DOI 10.1002/(SICI)1097-0134(20000701)40:1<86::AID-PROT100>3.0.CO;2-Y	37	19	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3175	3184		10.1074/jbc.M111.313619	http://dx.doi.org/10.1074/jbc.M111.313619			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22128149	Green Published, hybrid			2022-12-27	WOS:000300295100023
J	Li, HB; Panina, S; Kaur, A; Ruano, MJ; Sanchez-Gonzalez, P; la Cour, JM; Stephan, A; Olesen, UH; Berchtold, MW; Villalobo, A				Li, Hongbing; Panina, Svetlana; Kaur, Amandeep; Ruano, Maria J.; Sanchez-Gonzalez, Pablo; la Cour, Jonas M.; Stephan, Alexander; Olesen, Uffe H.; Berchtold, Martin W.; Villalobo, Antonio			Regulation of the Ligand-dependent Activation of the Epidermal Growth Factor Receptor by Calmodulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE; EGF-RECEPTOR; JUXTAMEMBRANE REGION; PLASMA-MEMBRANE; BINDING SITE; CALCIUM; CELLS; PHOSPHORYLATION; MECHANISM; PROTEIN	Calmodulin (CaM) is the major component of calcium signaling pathways mediating the action of various effectors. Transient increases in the intracellular calcium level triggered by a variety of stimuli lead to the formation of Ca2+/CaM complexes, which interact with and activate target proteins. In the present study the role of Ca2+/CaM in the regulation of the ligand-dependent activation of the epidermal growth factor receptor (EGFR) has been examined in living cells. We show that addition of different cell permeable CaM antagonists to cultured cells or loading cells with a Ca2+ chelator inhibited ligand-dependent EGFR auto(trans) phosphorylation. This occurred also in the presence of inhibitors of protein kinase C, CaM-dependent protein kinase II and calcineurin, which are known Ca2+-and/or Ca2+/CaM-dependent EGFR regulators, pointing to a direct effect of Ca2+/CaM on the receptor. Furthermore, we demonstrate that down-regulation of CaM in conditional CaM knock out cells stably transfected with the human EGFR decreased its ligand-dependent phosphorylation. Substitution of six basic amino acid residues within the CaM-binding domain (CaM-BD) of the EGFR by alanine resulted in a decreased phosphorylation of the receptor and of its downstream substrate phospholipase C gamma 1. These results support the hypothesis that CaCa2+/CaM reg-ulates the EGFR activity by directly interacting with the CaM-BD of the receptor located at its cytosolic juxtamembrane region.	[Li, Hongbing; Kaur, Amandeep; Ruano, Maria J.; Sanchez-Gonzalez, Pablo; Villalobo, Antonio] CSIC, Inst Invest Biomed, E-28029 Madrid, Spain; [Li, Hongbing; Kaur, Amandeep; Ruano, Maria J.; Sanchez-Gonzalez, Pablo; Villalobo, Antonio] Univ Autonoma Madrid, E-28049 Madrid, Spain; [Panina, Svetlana] Novo Nordisk AS, Dept Monocyte Biol, DK-2760 Malov, Denmark; [la Cour, Jonas M.; Stephan, Alexander; Olesen, Uffe H.; Berchtold, Martin W.] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen, Denmark	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Autonomous University of Madrid; Novo Nordisk; University of Copenhagen	Villalobo, A (corresponding author), CSIC, Inst Invest Biomed, Arturo Duperier 4, E-28029 Madrid, Spain.	hongbing.li@sickkids.ca; mruanor@mapa.es; antonio.villalobo@iib.uam.es	Villalobo, Antonio/O-9621-2019; Berchtold, Martin/L-1695-2014; Villalobo, Antonio/K-2902-2017; la Cour, Jonas/M-5088-2016	Villalobo, Antonio/0000-0002-4200-374X; Berchtold, Martin/0000-0001-8995-9047; Sanhez, Pablo/0000-0002-2844-6843; Olesen, Uffe Hogh/0000-0002-4578-684X; la Cour, Jonas/0000-0002-1588-0608	Ministerio de Ciencia e Innovacion [SAF2008-00986, SAF2011-23494]; European Commission [ITN 289033]; Danish Research Council; Lundbeck Foundation; AP Moller Fonden; Dagmar Marshall Fonden; Willumsen Fonden; Danielsen Fonden; Wedell Wedellsborg Fonden; Junta de Ampliacion de Estudios, CSIC, Spain	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); European Commission(European CommissionEuropean Commission Joint Research Centre); Danish Research Council(Det Frie Forskningsrad (DFF)); Lundbeck Foundation(Lundbeckfonden); AP Moller Fonden; Dagmar Marshall Fonden; Willumsen Fonden; Danielsen Fonden; Wedell Wedellsborg Fonden; Junta de Ampliacion de Estudios, CSIC, Spain	This work was financed by grants (to A. V.) from the Ministerio de Ciencia e Innovacion (SAF2008-00986 and SAF2011-23494) and the European Commission (contract ITN 289033); Grant from the Danish Research Council (to M. W. B.), the Lundbeck Foundation, AP Moller Fonden, Dagmar Marshall Fonden, Willumsen Fonden, Danielsen Fonden, and Wedell Wedellsborg Fonden.; Supported by a predoctoral fellowship from the Junta de Ampliacion de Estudios, CSIC, Spain.	Aifa S, 2006, PROTEINS, V62, P1036, DOI 10.1002/prot.20780; Aifa S, 2005, EXP CELL RES, V302, P108, DOI 10.1016/j.yexcr.2004.08.032; Aifa S, 2002, CELL SIGNAL, V14, P1005, DOI 10.1016/S0898-6568(02)00034-7; Ainscow EK, 2002, J PHYSIOL-LONDON, V544, P429, DOI 10.1113/jphysiol.2002.022434; ALTMAN SA, 1993, BIOTECHNOL PROGR, V9, P671, DOI 10.1021/bp00024a017; Benaim G, 2002, EUR J BIOCHEM, V269, P3619, DOI 10.1046/j.1432-1033.2002.03038.x; BENGURIA A, 1994, EUR J BIOCHEM, V224, P909, DOI 10.1111/j.1432-1033.1994.00909.x; Benguria A, 1995, ANN NY ACAD SCI, V766, P472, DOI 10.1111/j.1749-6632.1995.tb26698.x; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Berridge MJ, 2005, ANNU REV PHYSIOL, V67, P1, DOI 10.1146/annurev.physiol.67.040103.152647; BURGESS WH, 1980, BIOCHIM BIOPHYS ACTA, V623, P257, DOI 10.1016/0005-2795(80)90254-8; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; COUNTAWAY JL, 1992, J BIOL CHEM, V267, P1129; Dagher R, 2011, BBA-MOL CELL RES, V1813, P1059, DOI 10.1016/j.bbamcr.2010.11.004; EMERY AEH, 1967, BIOCHEM J, V105, P599, DOI 10.1042/bj1050599; Hackl H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013013; Hsu SC, 2007, J BIOL CHEM, V282, P10432, DOI 10.1074/jbc.M610014200; HUNTER T, 1984, NATURE, V311, P480, DOI 10.1038/311480a0; Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025; Jurado LA, 1999, PHYSIOL REV, V79, P661, DOI 10.1152/physrev.1999.79.3.661; KIMMICH GA, 1975, ANAL BIOCHEM, V69, P187, DOI 10.1016/0003-2697(75)90580-1; KLEE CB, 1982, ADV PROTEIN CHEM, V35, P213, DOI 10.1016/S0065-3233(08)60470-2; Kroll T, 2002, J CANCER RES CLIN, V128, P125, DOI 10.1007/s00432-001-0308-z; LAX I, 1989, EMBO J, V8, P421, DOI 10.1002/j.1460-2075.1989.tb03393.x; Lee YJ, 2008, AM J PHYSIOL-RENAL, V294, pF534, DOI 10.1152/ajprenal.00408.2007; Li HB, 2004, BIOCHEM J, V381, P257, DOI 10.1042/BJ20040515; Li HB, 2004, FEBS LETT, V559, P175, DOI 10.1016/S0014-5793(04)00067-5; Li HB, 2002, BIOCHEM J, V362, P499, DOI 10.1042/bj3620499; MARTIN BL, 1993, BIOCHEM BIOPH RES CO, V194, P150, DOI 10.1006/bbrc.1993.1797; Martin-Nieto J, 1998, BIOCHEMISTRY-US, V37, P227, DOI 10.1021/bi971765v; MARTINNIETO J, 2002, RRD BIOCHEM 1, V3, P41; McLaughlin S, 2005, J GEN PHYSIOL, V126, P41, DOI 10.1085/jgp.200509274; Nelson AR, 2007, BIOCHEMISTRY-US, V46, P14771, DOI 10.1021/bi701295k; PALLEN CJ, 1985, BIOCHEMISTRY-US, V24, P4727, DOI 10.1021/bi00339a003; Persechini A, 1999, J BIOL CHEM, V274, P6827, DOI 10.1074/jbc.274.11.6827; Poppleton HM, 2000, ARCH BIOCHEM BIOPHYS, V383, P309, DOI 10.1006/abbi.2000.2095; Red Brewer M, 2009, MOL CELL, V34, P641, DOI 10.1016/j.molcel.2009.04.034; Sanchez-Gonzalez P, 2010, FEBS J, V277, P327, DOI 10.1111/j.1742-4658.2009.07469.x; SANJOSE E, 1992, J BIOL CHEM, V267, P15237; Sato T, 2006, BIOCHEMISTRY-US, V45, P12704, DOI 10.1021/bi061264m; Schmalzigaug R, 2001, IMMUNOLOGY, V103, P332, DOI 10.1046/j.1365-2567.2001.01259.x; Sengupta P, 2007, J BIOL CHEM, V282, P8474, DOI 10.1074/jbc.M607211200; STOSCHECK CM, 1990, METHOD ENZYMOL, V182, P50; Thiel KW, 2007, P NATL ACAD SCI USA, V104, P19238, DOI 10.1073/pnas.0703854104; TOJYO Y, 1990, BIOCHEM PHARMACOL, V39, P1775; TOROK K, 1994, BIOCHEMISTRY-US, V33, P12807, DOI 10.1021/bi00209a012; Villalobo A., 2000, CALCIUM MOL BASIS CA, P45; WANG H, 1991, BIOCHEMISTRY-US, V30, P3019, DOI 10.1021/bi00226a006; White CD, 2011, BBA-MOL CELL RES, V1813, P1074, DOI 10.1016/j.bbamcr.2010.12.016; Winding P, 2001, J IMMUNOL METHODS, V249, P1, DOI 10.1016/S0022-1759(00)00333-1; YAMANE K, 1992, BIOCHEM BIOPH RES CO, V184, P1301, DOI 10.1016/S0006-291X(05)80024-5; Yun CH, 2008, P NATL ACAD SCI USA, V105, P2070, DOI 10.1073/pnas.0709662105; Zhang L, 2007, MOL CELL BIOCHEM, V305, P19, DOI 10.1007/s11010-007-9523-5; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	55	27	29	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3273	3281		10.1074/jbc.M111.317529	http://dx.doi.org/10.1074/jbc.M111.317529			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22157759	Green Published, hybrid			2022-12-27	WOS:000300295100033
J	Ohto, U; Usui, K; Ochi, T; Yuki, K; Satow, Y; Shimizu, T				Ohto, Umeharu; Usui, Kimihito; Ochi, Toshinari; Yuki, Kenjiro; Satow, Yoshinori; Shimizu, Toshiyuki			Crystal Structure of Human beta-Galactosidase STRUCTURAL BASIS OF G(M1) GANGLIOSIDOSIS AND MORQUIO B DISEASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GM1 GANGLIOSIDOSIS; GENE-MUTATIONS; GM1-GANGLIOSIDOSIS; PRECURSOR; COMPLEX; FORMS; CLASSIFICATION; PURIFICATION; SPECIFICITY; PROGRAM	G(M1) gangliosidosis and Morquio B are autosomal recessive lysosomal storage diseases associated with a neurodegenerative disorder or dwarfism and skeletal abnormalities, respectively. These diseases are caused by deficiencies in the lysosomal enzyme beta-D-galactosidase (beta-Gal), which lead to accumulations of the beta-Gal substrates, G(M1) ganglioside, and keratan sulfate. beta-Gal is an exoglycosidase that catalyzes the hydrolysis of terminal beta-linked galactose residues. This study shows the crystal structures of human beta-Gal in complex with its catalytic product galactose or with its inhibitor 1-deoxygalactonojirimycin. Human beta-Gal is composed of a catalytic TIM barrel domain followed by beta-domain 1 and beta-domain 2. To gain structural insight into the molecular defects of beta-Gal in the above diseases, the disease-causing mutations were mapped onto the three-dimensional structure. Finally, the possible causes of the diseases are discussed.	[Ohto, Umeharu; Usui, Kimihito; Ochi, Toshinari; Yuki, Kenjiro; Satow, Yoshinori; Shimizu, Toshiyuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo	Shimizu, T (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	shimizu@mol.f.u-tokyo.ac.jp			Targeted Proteins Research Program; Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan	Targeted Proteins Research Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by the Targeted Proteins Research Program and by grants-in-aid for Scientific Research from Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan (to U. O., Y. S., and T. S.).	Aguilar CF, 1997, J MOL BIOL, V271, P789, DOI 10.1006/jmbi.1997.1215; ALPERS DH, 1969, J BIOL CHEM, V244, P1238; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; ASP NG, 1972, ANAL BIOCHEM, V47, P527, DOI 10.1016/0003-2697(72)90147-9; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunetti-Pierri N, 2008, MOL GENET METAB, V94, P391, DOI 10.1016/j.ymgme.2008.04.012; Caciotti A, 2011, BBA-MOL BASIS DIS, V1812, P782, DOI 10.1016/j.bbadis.2011.03.018; Callahan JW, 1999, BBA-MOL BASIS DIS, V1455, P85, DOI 10.1016/S0925-4439(99)00075-7; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; DISTLER JJ, 1973, J BIOL CHEM, V248, P6772; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; HENRISSAT B, 1995, P NATL ACAD SCI USA, V92, P7090, DOI 10.1073/pnas.92.15.7090; Hidaka M, 2002, J MOL BIOL, V322, P79, DOI 10.1016/S0022-2836(02)00746-5; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; HOOGEVEEN AT, 1986, J BIOL CHEM, V261, P5702; HOOGEVEEN AT, 1983, J BIOL CHEM, V258, P2143; HOOGEVEEN AT, 1984, J BIOL CHEM, V259, P1974; HUBBES M, 1992, BIOCHEM J, V285, P827, DOI 10.1042/bj2850827; JACOBSON RH, 1994, NATURE, V369, P761, DOI 10.1038/369761a0; JONES CS, 1984, CAN J BIOCHEM CELL B, V62, P529, DOI 10.1139/o84-070; Juers DH, 1999, PROTEIN SCI, V8, P122; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Maksimainen M, 2011, J STRUCT BIOL, V174, P156, DOI 10.1016/j.jsb.2010.11.024; MCCARTER JD, 1994, CURR OPIN STRUC BIOL, V4, P885, DOI 10.1016/0959-440X(94)90271-2; McCarter JD, 1997, J BIOL CHEM, V272, P396; Montanier C, 2009, P NATL ACAD SCI USA, V106, P3065, DOI 10.1073/pnas.0808972106; MORREAU H, 1989, J BIOL CHEM, V264, P20655; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NORDEN AGW, 1974, J BIOL CHEM, V249, P7969; Okumiya T, 2003, MOL GENET METAB, V78, P51, DOI 10.1016/S1096-7192(02)00199-3; OSHIMA A, 1991, AM J HUM GENET, V49, P1091; OSHIMA A, 1988, BIOCHEM BIOPH RES CO, V157, P238, DOI 10.1016/S0006-291X(88)80038-X; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Privitera S, 1998, J BIOL CHEM, V273, P6319, DOI 10.1074/jbc.273.11.6319; REARDON D, 1995, FASEB J, V9, P497, DOI 10.1096/fasebj.9.7.7737457; Rojas AL, 2004, J MOL BIOL, V343, P1281, DOI 10.1016/j.jmb.2004.09.012; Skalova T, 2005, J MOL BIOL, V353, P282, DOI 10.1016/j.jmb.2005.08.028; Suzuki Y., 2001, METABOLIC MOL BASES, P3775; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Usui K., 2011, ACTA CRYS F IN PRESS; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; van der Spoel A, 2000, J BIOL CHEM, V275, P10035, DOI 10.1074/jbc.275.14.10035; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; YAMAMOTO Y, 1990, DNA CELL BIOL, V9, P119, DOI 10.1089/dna.1990.9.119; YAMAMOTO Y, 1982, J BIOCHEM, V92, P13, DOI 10.1093/oxfordjournals.jbchem.a133910; YOSHIDA K, 1991, AM J HUM GENET, V49, P435; ZHANG SQ, 1994, BIOCHEM J, V304, P281, DOI 10.1042/bj3040281	49	77	85	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					1801	1812		10.1074/jbc.M111.293795	http://dx.doi.org/10.1074/jbc.M111.293795			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22128166	Green Published, hybrid			2022-12-27	WOS:000299321000022
J	Peng, HM; Morishima, Y; Pratt, WB; Osawa, Y				Peng, Hwei-Ming; Morishima, Yoshihiro; Pratt, William B.; Osawa, Yoichi			Modulation of Heme/Substrate Binding Cleft of Neuronal Nitric-oxide Synthase (nNOS) Regulates Binding of Hsp90 and Hsp70 Proteins and nNOS Ubiquitination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HSP90/HSP70-BASED CHAPERONE MACHINERY; HEAT-SHOCK-PROTEIN; IN-VITRO; PROTEOLYTIC DEGRADATION; ACTIVATION; HEAT-SHOCK-PROTEIN-90; CALMODULIN; DOMAIN; HEME; VIVO	Like other nitric-oxide synthase (NOS) enzymes, neuronal NOS (nNOS) turnover and activity are regulated by the Hsp90/Hsp70-based chaperone machinery, which regulates signaling proteins by modulating ligand binding clefts (Pratt, W. B., Morishima, Y., and Osawa, Y. (2008) J. Biol. Chem. 283, 22885-22889). We have previously shown that nNOS turnover is due to Hsp70/CHIP-dependent ubiquitination and proteasomal degradation. In this work, we use an intracellular cross-linking approach to study both chaperone binding and nNOS ubiquitination in intact HEK293 cells. Treatment of cells with N-G-nitro-L-arginine, a slowly reversible competitive inhibitor that stabilizes nNOS, decreases both nNOS ubiquitination and binding of Hsp90, Hsp70, and CHIP. Treatment with the calcium ionophore A23187, which increases Ca2+-calmodulin binding to nNOS, increases nNOS ubiquitination and binding of Hsp90, Hsp70, and CHIP in a manner that is specific for changes in the heme/substrate binding cleft. Both Hsp90 and Hsp70 are bound to the expressed nNOS oxygenase domain, which contains the heme/substrate binding cleft, but not to the reductase domain, and binding is increased to an expressed fragment containing both the oxygenase domain and the calmodulin binding site. Overexpression of Hsp70 promotes nNOS ubiquitination and decreases nNOS protein, and overexpression of Hsp90 inhibits nNOS ubiquitination and increases nNOS protein, showing the opposing effects of the two chaperones as they participate in nNOS quality control in the cell. These observations support the notion that changes in the state of the heme/substrate binding cleft affect chaperone binding and thus nNOS ubiquitination.	[Peng, Hwei-Ming; Morishima, Yoshihiro; Pratt, William B.; Osawa, Yoichi] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Osawa, Y (corresponding author), Univ Michigan, Sch Med, Dept Pharmacol, Med Sci Res Bldg 3, Ann Arbor, MI 48109 USA.	osawa@umich.edu			National Institutes of Health [GM077430]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077430] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM077430 (to Y.O.).	ABUSOUD HM, 1993, P NATL ACAD SCI USA, V90, P10769, DOI 10.1073/pnas.90.22.10769; Bender AT, 2000, J BIOL CHEM, V275, P17407, DOI 10.1074/jbc.M000155200; Bender AT, 1999, J BIOL CHEM, V274, P1472, DOI 10.1074/jbc.274.3.1472; Billecke SS, 2002, J BIOL CHEM, V277, P20504, DOI 10.1074/jbc.M201940200; Brouet A, 2001, J BIOL CHEM, V276, P32663, DOI 10.1074/jbc.M101371200; Citri A, 2002, EMBO J, V21, P2407, DOI 10.1093/emboj/21.10.2407; Clapp KM, 2010, J BIOL CHEM, V285, P33642, DOI 10.1074/jbc.M110.159178; Cyr DM, 2002, TRENDS BIOCHEM SCI, V27, P368, DOI 10.1016/S0968-0004(02)02125-4; Dunbar AY, 2006, DRUG METAB DISPOS, V34, P1448, DOI 10.1124/dmd.106.009951; Dunbar AY, 2004, MOL PHARMACOL, V66, P964, DOI 10.1124/mol.104.000125; Fontana J, 2002, CIRC RES, V90, P866, DOI 10.1161/01.RES.0000016837.26733.BE; Garcia-Cardena G, 1998, NATURE, V392, P821, DOI 10.1038/33934; Ghosh A, 2011, FASEB J, V25, P2049, DOI 10.1096/fj.10-180554; Gratton JP, 2000, J BIOL CHEM, V275, P22268, DOI 10.1074/jbc.M001644200; Han GC, 2009, J PHARMACOL EXP THER, V329, P850, DOI 10.1124/jpet.108.149112; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; Isaacs JS, 2003, CANCER CELL, V3, P213, DOI 10.1016/S1535-6108(03)00029-1; Kamada Y, 2005, MOL BRAIN RES, V142, P19, DOI 10.1016/j.molbrainres.2005.09.003; Leu JIJ, 2009, MOL CELL, V36, P15, DOI 10.1016/j.molcel.2009.09.023; MARLETTA MA, 1993, J BIOL CHEM, V268, P12231; MCMILLAN K, 1992, P NATL ACAD SCI USA, V89, P11141, DOI 10.1073/pnas.89.23.11141; Morishima Y, 2008, HUM MOL GENET, V17, P3942, DOI 10.1093/hmg/ddn296; Noguchi S, 2000, J BIOL CHEM, V275, P2376, DOI 10.1074/jbc.275.4.2376; Osawa Y, 2003, J PHARMACOL EXP THER, V304, P493, DOI 10.1124/jpet.102.035055; OSAWA Y, 1989, CHEM RES TOXICOL, V2, P131, DOI 10.1021/tx00009a001; OSAWA Y, 1993, J BIOL CHEM, V268, P2953; Peng HM, 2004, J BIOL CHEM, V279, P52970, DOI 10.1074/jbc.M406926200; Peng HM, 2009, BIOCHEMISTRY-US, V48, P8483, DOI 10.1021/bi901058g; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Pratt WB, 2008, J BIOL CHEM, V283, P22885, DOI 10.1074/jbc.R800023200; Pratt WB, 2010, EXP BIOL MED, V235, P278, DOI 10.1258/ebm.2009.009250; Schulte TW, 1998, CELL STRESS CHAPERON, V3, P100, DOI 10.1379/1466-1268(1998)003<0100:ARBTTN>2.3.CO;2; Song Y, 2001, BIOCHEM J, V355, P357, DOI 10.1042/0264-6021:3550357; Song Y, 2001, AM J PHYSIOL-CELL PH, V281, pC1819, DOI 10.1152/ajpcell.2001.281.6.C1819; STANCATO LF, 1993, J BIOL CHEM, V268, P21711; Takahashi S, 2003, J BIOL CHEM, V278, P30821, DOI 10.1074/jbc.M304471200; Takahashi S, 2003, J BIOL CHEM, V278, P9339, DOI 10.1074/jbc.M212651200; Vuletich JL, 2002, MOL PHARMACOL, V62, P110, DOI 10.1124/mol.62.1.110; Wang AM, 2010, J BIOL CHEM, V285, P15714, DOI 10.1074/jbc.M109.098806; Xu H, 2007, J BIOL CHEM, V282, P37567, DOI 10.1074/jbc.M706464200; Xu WP, 2001, J BIOL CHEM, V276, P3702, DOI 10.1074/jbc.M006864200; Yoshida M, 2003, J BIOL CHEM, V278, P36953, DOI 10.1074/jbc.M305214200; Zhout PC, 2003, J BIOL CHEM, V278, P13829, DOI 10.1074/jbc.M209640200	44	31	31	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1556	1565		10.1074/jbc.M111.323295	http://dx.doi.org/10.1074/jbc.M111.323295			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22128174	Green Published, hybrid			2022-12-27	WOS:000299170300069
J	Harkewicz, R; Du, HJ; Tong, ZZ; Alkuraya, H; Bedell, M; Sun, WO; Wang, XL; Hsu, YH; Esteve-Rudd, J; Hughes, G; Su, ZG; Zhang, M; Lopes, VS; Molday, RS; Williams, DS; Dennis, EA; Zhang, K				Harkewicz, Richard; Du, Hongjun; Tong, Zongzhong; Alkuraya, Hisham; Bedell, Matthew; Sun, Woong; Wang, Xiaolei; Hsu, Yuan-Hao; Esteve-Rudd, Julian; Hughes, Guy; Su, Zhiguang; Zhang, Ming; Lopes, Vanda S.; Molday, Robert S.; Williams, David S.; Dennis, Edward A.; Zhang, Kang			Essential Role of ELOVL4 Protein in Very Long Chain Fatty Acid Synthesis and Retinal Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MACULAR DYSTROPHY; ENDOPLASMIC-RETICULUM; TRANSMEMBRANE PROTEINS; CRE RECOMBINASE; TRANSGENIC MICE; COA DESATURASE; GENE; BIOSYNTHESIS; MOUSE; EXPRESSION	Very long chain polyunsaturated fatty acid (VLC-PUFA)-containing glycerophospholipids are highly enriched in the retina; however, details regarding the specific synthesis and function of these highly unusual retinal glycerophospholipids are lacking. Elongation of very long chain fatty acids-4 (ELOVL4) has been identified as a fatty acid elongase protein involved in the synthesis of VLC-PUFAs. Mutations in ELOVL4 have also been implicated in an autosomal dominant form of Stargardt disease (STGD3), a type of juvenile macular degeneration. We have generated photoreceptor-specific conditional knock-out mice and used high performance liquid chromatography-massspectrometry (HPLC-MS) to examine and analyze the fatty acid composition of retinal membrane glycerophosphatidylcholine and glycerophosphatidylethanolamine species. We also used immunofluorescent staining and histology coupled with electrophysiological data to assess retinal morphology and visual response. The conditional knock-out mice showed a significant decrease in retinal glycerophospholipids containing VLC-PUFAs, specifically contained in the sn-1 position of glycerophosphatidylcholine, implicating the role of Elovl4 in their synthesis. Conditional knock-out mice were also found to have abnormal accumulation of lipid droplets and lipofuscin-like granules while demonstrating photoreceptor-specific abnormalities in visual response, indicating the critical role of Elovl4 for proper rod or cone photoreceptor function. Altogether, this study demonstrates the essential role of ELOVL4 in VLCPUFA synthesis and retinal function.	[Harkewicz, Richard; Hsu, Yuan-Hao; Dennis, Edward A.] Univ Calif San Diego, Dept Chem & Biochem, Dept Pharmacol, La Jolla, CA 92093 USA; [Harkewicz, Richard; Hsu, Yuan-Hao; Dennis, Edward A.] Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA; [Du, Hongjun; Tong, Zongzhong; Alkuraya, Hisham; Bedell, Matthew; Sun, Woong; Wang, Xiaolei; Hughes, Guy; Zhang, Kang] Univ Calif San Diego, Dept Ophthalmol, Shiley Eye Ctr, La Jolla, CA 92093 USA; [Du, Hongjun; Tong, Zongzhong; Alkuraya, Hisham; Bedell, Matthew; Sun, Woong; Wang, Xiaolei; Hughes, Guy; Zhang, Kang] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA; [Du, Hongjun; Su, Zhiguang; Zhang, Ming; Zhang, Kang] Sichuan Univ, W China Hosp, Mol Med Res Ctr, Chengdu 610041, Peoples R China; [Du, Hongjun; Su, Zhiguang; Zhang, Ming; Zhang, Kang] Sichuan Univ, W China Hosp, Dept Ophthalmol, Chengdu 610041, Peoples R China; [Du, Hongjun] Fourth Mil Med Univ, Xijing Hosp, Dept Ophthalmol, Xian 710032, Peoples R China; [Wang, Xiaolei] Tong Ren Eye Hosp, Beijing 100730, Peoples R China; [Esteve-Rudd, Julian; Lopes, Vanda S.; Williams, David S.] Univ Calif Los Angeles, Sch Med, Jules Stein Eye Inst, Los Angeles, CA 90095 USA; [Esteve-Rudd, Julian; Lopes, Vanda S.; Williams, David S.] Univ Calif Los Angeles, Sch Med, Dept Ophthalmol, Los Angeles, CA 90095 USA; [Esteve-Rudd, Julian; Lopes, Vanda S.; Williams, David S.] Univ Calif Los Angeles, Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA; [Molday, Robert S.] Univ British Columbia, Ctr Macular Res, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Molday, Robert S.] Univ British Columbia, Ctr Macular Res, Dept Ophthalmol & Visual Sci, Vancouver, BC V6T 1Z3, Canada	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Sichuan University; Sichuan University; Air Force Military Medical University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of British Columbia; University of British Columbia	Dennis, EA (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, Dept Pharmacol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	edennis@ucsd.edu; kang.zhang@gmail.com	Zhang, Kang/Y-2740-2019; Su, Zhiguang/AFS-0022-2022; Dennis, Edward A./M-5554-2019; hsu, yuan-hao/B-5744-2009	Zhang, Kang/0000-0002-4549-1697; Dennis, Edward A./0000-0003-3738-3140; sun, woong/0000-0003-1792-4894; Su, Zhiguang/0000-0001-8635-9310	National Institutes of Health from NEI [EY014428, EY018660, EY019270, EY07042, U54 GM069338]; NIGMS; Research to Prevent Blindness; National Basic Research Program of China (973 Program [2011CB510200]; Veterans Affairs; Wellcome Fund; King Abdulaziz City for Science and Technology (KACST); NATIONAL EYE INSTITUTE [R01EY002422, R01EY007042, R01EY021374, R01EY019270, R01EY014428, R01EY018660] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM069338] Funding Source: NIH RePORTER	National Institutes of Health from NEI; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); National Basic Research Program of China (973 Program(National Basic Research Program of China); Veterans Affairs(US Department of Veterans Affairs); Wellcome Fund(Burroughs Wellcome Fund); King Abdulaziz City for Science and Technology (KACST); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants EY014428, EY018660, and EY019270 (to K. Z.) and EY07042 (to D. S. W.) from the NEI and Grant U54 GM069338, a LIPID MAPS large scale collaborative "glue" grant from the NIGMS(to E. A. D.).; Supported by Research to Prevent Blindness Jules and Doris Stein Professorship.; Supported by the National Basic Research Program of China (973 Program, Grant 2011CB510200), a Veterans Affairs merit award, Research to Prevent Blindness, a Burroughs Wellcome Fund clinical scientist award in translational research, and the King Abdulaziz City for Science and Technology (KACST).	Adams DJ, 2005, GENOMICS, V86, P753, DOI 10.1016/j.ygeno.2005.08.003; Agbaga MP, 2008, P NATL ACAD SCI USA, V105, P12843, DOI 10.1073/pnas.0802607105; Agbaga MP, 2010, J LIPID RES, V51, P1624, DOI 10.1194/jlr.R005025; AVELDANO MI, 1988, BIOCHEMISTRY-US, V27, P1229, DOI 10.1021/bi00404a024; Bazan NG, 2010, J LIPID RES, V51, P2018, DOI 10.1194/jlr.R001131; Bernstein PS, 2001, INVEST OPHTH VIS SCI, V42, P3331; Boon CJF, 2009, OPHTHALMOLOGY, V116, P771, DOI 10.1016/j.ophtha.2008.12.019; Cameron DJ, 2007, INT J BIOL SCI, V3, P111; CINTI DL, 1992, PROG LIPID RES, V31, P1, DOI 10.1016/0163-7827(92)90014-A; Dennis EA, 2011, CHEM REV, V111, P6130, DOI 10.1021/cr200085w; Edwards AO, 2001, INVEST OPHTH VIS SCI, V42, P2652; FOX BG, 1994, BIOCHEMISTRY-US, V33, P12776, DOI 10.1021/bi00209a008; Galle-Le Bastard AM, 2000, PHYSIOL PLANTARUM, V108, P118, DOI 10.1034/j.1399-3054.2000.108002118.x; Grayson C, 2005, J BIOL CHEM, V280, P32521, DOI 10.1074/jbc.M503411200; GRIFFITHS G, 1988, BIOCHEM J, V252, P641, DOI 10.1042/bj2520641; Harkewicz R, 2011, ANNU REV BIOCHEM, V80, P301, DOI 10.1146/annurev-biochem-060409-092612; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; HAZLETT TL, 1985, TOXICON, V23, P457, DOI 10.1016/0041-0101(85)90029-7; Jackson FM, 1998, EUR J BIOCHEM, V252, P513, DOI 10.1046/j.1432-1327.1998.2520513.x; JACKSON MR, 1993, J CELL BIOL, V121, P317, DOI 10.1083/jcb.121.2.317; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; Jakobsson A, 2006, PROG LIPID RES, V45, P237, DOI 10.1016/j.plipres.2006.01.004; Kahn-Kirby AH, 2004, CELL, V119, P889, DOI 10.1016/j.cell.2004.11.005; KAPLAN J, 1990, HUM GENET, V85, P635; Karan G, 2005, MOL VIS, V11, P657; Kokotos G, 2010, J MED CHEM, V53, P3602, DOI 10.1021/jm901872v; Lands WEM, 2000, BBA-MOL CELL BIOL L, V1483, P1, DOI 10.1016/S1388-1981(99)00177-8; Le YZ, 2006, MOL VIS, V12, P389; Le YZ, 2004, MOL VIS, V10, P1011; Libby RT, 2003, EXP EYE RES, V77, P731, DOI 10.1016/j.exer.2003.07.007; Liu AH, 2010, J LIPID RES, V51, P3217, DOI 10.1194/jlr.M007518; Lucas KK, 2005, PROSTAG OTH LIPID M, V77, P235, DOI 10.1016/j.prostaglandins.2005.02.004; Mandal MNA, 2004, GENOMICS, V83, P626, DOI 10.1016/j.ygeno.2003.09.020; Maugeri A, 2004, INVEST OPHTH VIS SCI, V45, P4263, DOI 10.1167/iovs.04-0078; McMahon A, 2007, FEBS LETT, V581, P5459, DOI 10.1016/j.febslet.2007.10.050; McMahon A, 2011, J LIPID RES, V52, P1128, DOI 10.1194/jlr.M014415; Murphy RC, 2009, J LIPID RES, V50, pS317, DOI 10.1194/jlr.R800051-JLR200; Newsome D. A., 1988, RETINAL DYSTROPHIES, P135; Oh CS, 1997, J BIOL CHEM, V272, P17376, DOI 10.1074/jbc.272.28.17376; OKAYASU T, 1981, ARCH BIOCHEM BIOPHYS, V206, P21, DOI 10.1016/0003-9861(81)90061-8; REZANKA T, 1989, PROG LIPID RES, V28, P147, DOI 10.1016/0163-7827(89)90011-8; SCHRODER S, 1995, J CELL BIOL, V131, P895, DOI 10.1083/jcb.131.4.895; SHANKLIN J, 1994, BIOCHEMISTRY-US, V33, P12787, DOI 10.1021/bi00209a009; Sprecher H, 1999, Curr Opin Clin Nutr Metab Care, V2, P135, DOI 10.1097/00075197-199903000-00007; Sprecher H, 1995, J LIPID RES, V36, P2471; STONE EM, 1994, ARCH OPHTHALMOL-CHIC, V112, P765, DOI 10.1001/archopht.1994.01090180063036; Suh M, 2005, CURR EYE RES, V30, P959, DOI 10.1080/02713680500246957; Tvrdik P, 2000, J CELL BIOL, V149, P707, DOI 10.1083/jcb.149.3.707; Vasireddy V, 2005, MOL VIS, V11, P665; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9; Yamashita A, 1997, J BIOCHEM-TOKYO, V122, P1; Zhang K, 2001, NAT GENET, V27, P89, DOI 10.1038/83817; Zhang XM, 2003, MOL VIS, V9, P301	53	63	68	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11469	11480		10.1074/jbc.M111.256073	http://dx.doi.org/10.1074/jbc.M111.256073			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22199362	Green Published, hybrid			2022-12-27	WOS:000302780100075
J	Chan, CY; Prudom, C; Raines, SM; Charkhzarrin, S; Melman, SD; De Haro, LP; Allen, C; Lee, SA; Sklar, LA; Parra, KJ				Chan, Chun-Yuan; Prudom, Catherine; Raines, Summer M.; Charkhzarrin, Sahba; Melman, Sandra D.; De Haro, Leyma P.; Allen, Chris; Lee, Samuel A.; Sklar, Larry A.; Parra, Karlett J.			Inhibitors of V-ATPase Proton Transport Reveal Uncoupling Functions of Tether Linking Cytosolic and Membrane Domains of V-0 Subunit a (Vph1p)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							H+-ATPASE; VACUOLAR ATPASE; NONHOMOLOGOUS REGION; MUTATIONAL ANALYSIS; NEUROSPORA-CRASSA; CELLULAR PH; YEAST; CHLORHEXIDINE; HOMEOSTASIS; ALEXIDINE	Vacuolar ATPases (V-ATPases) are important for many cellular processes, as they regulate pH by pumping cytosolic protons into intracellular organelles. The cytoplasm is acidified when V-ATPase is inhibited; thus we conducted a high-throughput screen of a chemical library to search for compounds that acidify the yeast cytosol in vivo using pHluorin-based flow cytometry. Two inhibitors, alexidine dihydrochloride (EC50 = 39 mu M) and thonzonium bromide (EC50 = 69 mu M), prevented ATP-dependent proton transport in purified vacuolar membranes. They acidified the yeast cytosol and caused pH-sensitive growth defects typical of V-ATPase mutants (vma phenotype). At concentrations greater than 10 mu M the inhibitors were cytotoxic, even at the permissive pH (pH 5.0). Membrane fractions treated with alexidine dihydrochloride and thonzonium bromide fully retained concanamycin A-sensitive ATPase activity despite the fact that proton translocation was inhibited by 80-90%, indicating that V-ATPases were uncoupled. Mutant V-ATPase membranes lacking residues 362-407 of the tether of Vph1p subunit a of V-0 were resistant to thonzonium bromide but not to alexidine dihydrochloride, suggesting that this conserved sequence confers uncoupling potential to V1V0 complexes and that alexidine dihydrochloride uncouples the enzyme by a different mechanism. The inhibitors also uncoupled the Candida albicans enzyme and prevented cell growth, showing further specificity for V-ATPases. Thus, a new class of V-ATPase inhibitors (uncouplers), which are not simply ionophores, provided new insights into the enzyme mechanism and original evidence supporting the hypothesis that V-ATPases may not be optimally coupled in vivo. The consequences of uncoupling V-ATPases in vivo as potential drug targets are discussed.	[Chan, Chun-Yuan; Raines, Summer M.; Charkhzarrin, Sahba; Melman, Sandra D.; De Haro, Leyma P.; Parra, Karlett J.] Univ New Mexico, Dept Biochem & Mol Biol, Hlth Sci Ctr, Sch Med, Albuquerque, NM 87131 USA; [Lee, Samuel A.] Univ New Mexico, Dept Internal Med, Hlth Sci Ctr, Sch Med, Albuquerque, NM 87131 USA; [Sklar, Larry A.] Univ New Mexico, Dept Pathol, Hlth Sci Ctr, Sch Med, Albuquerque, NM 87131 USA; [Sklar, Larry A.] Univ New Mexico, Ctr Canc, Hlth Sci Ctr, Sch Med, Albuquerque, NM 87131 USA; [Prudom, Catherine; Allen, Chris; Sklar, Larry A.] Univ New Mexico, Ctr Mol Discovery, Hlth Sci Ctr, Sch Med, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center	Parra, KJ (corresponding author), Univ New Mexico, Dept Biochem & Mol Biol, Hlth Sci Ctr, Sch Med, MSC08 4670, Albuquerque, NM 87131 USA.	kjparra@salud.unm.edu	Chan, Chun Yuan/F-5811-2010	Allen, Christopher/0000-0003-3808-5209	National Institutes of Health [5R01GM086495, 1U54MH084690, CA118100, K12GM088021]; NATIONAL CANCER INSTITUTE [P30CA118100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM088021, R01GM086495] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH084690] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants 5R01GM086495 (to K. J. P.), 1U54MH084690 (to L. A. S., C. P., and C. A.), and CA118100 (to the University of New Mexico Cancer Center).; Supported by National Institutes of Health Grant K12GM088021.	ARAI H, 1989, BIOCHEMISTRY-US, V28, P3075, DOI 10.1021/bi00433a051; Bishop AL, 2007, MOL MICROBIOL, V63, P507, DOI 10.1111/j.1365-2958.2006.05504.x; Bockelmann S, 2010, J BIOL CHEM, V285, P38304, DOI 10.1074/jbc.M110.137539; Bowman BJ, 2006, J BIOL CHEM, V281, P31885, DOI 10.1074/jbc.M605532200; Bowman EJ, 2005, J BIOENERG BIOMEMBR, V37, P431, DOI 10.1007/s10863-005-9485-9; Bowman EJ, 1997, J BIOL CHEM, V272, P14776, DOI 10.1074/jbc.272.23.14776; Bowman EJ, 2000, J EXP BIOL, V203, P97; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brett CL, 2005, MOL BIOL CELL, V16, P1396, DOI 10.1091/mbc.E04-11-0999; Brown D, 2009, TRAFFIC, V10, P275, DOI 10.1111/j.1600-0854.2008.00867.x; CHAWNER JA, 1989, J APPL BACTERIOL, V66, P253, DOI 10.1111/j.1365-2672.1989.tb02476.x; Ediger B, 2009, J BIOL CHEM, V284, P19522, DOI 10.1074/jbc.M109.013375; Edwards BS, 2004, CURR OPIN CHEM BIOL, V8, P392, DOI 10.1016/j.cbpa.2004.06.007; El Far O, 2011, J NEUROCHEM, V117, P603, DOI 10.1111/j.1471-4159.2011.07234.x; ELBLE R, 1992, BIOTECHNIQUES, V13, P18; Erickson T, 2001, MOL MICROBIOL, V42, P1121, DOI 10.1046/j.1365-2958.2001.02712.x; FORGAC M, 1983, P NATL ACAD SCI-BIOL, V80, P1300, DOI 10.1073/pnas.80.5.1300; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Forster C, 2000, J BIOL CHEM, V275, P38245, DOI 10.1074/jbc.M006650200; Ganendren R, 2004, ANTIMICROB AGENTS CH, V48, P1561, DOI 10.1128/AAC.48.5.1561-1569.2004; Hilty J, 2008, MOL MICROBIOL, V70, P127, DOI 10.1111/j.1365-2958.2008.06395.x; Huss M, 2011, EUR J CELL BIOL, V90, P688, DOI 10.1016/j.ejcb.2011.04.009; Huss M, 2009, J EXP BIOL, V212, P341, DOI 10.1242/jeb.024067; Inoue T, 2005, J BIOL CHEM, V280, P27896, DOI 10.1074/jbc.M504890200; Johnson RM, 2010, ANAL BIOCHEM, V398, P203, DOI 10.1016/j.ab.2009.12.020; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; Kane PM, 2007, J BIOENERG BIOMEMBR, V39, P415, DOI 10.1007/s10863-007-9112-z; Kawasaki-Nishi S, 2003, J BIOL CHEM, V278, P41908, DOI 10.1074/jbc.M308026200; Klionsky DJ, 2008, AUTOPHAGY, V4, P849, DOI 10.4161/auto.6845; Landolt-Marticorena C, 2000, J BIOL CHEM, V275, P15449, DOI 10.1074/jbc.M000207200; Liu ML, 2005, J BIOL CHEM, V280, P36978, DOI 10.1074/jbc.M505296200; LOTSCHER HR, 1984, BIOCHEMISTRY-US, V23, P4140, DOI 10.1021/bi00313a020; Mahon Matthew J, 2011, Adv Biosci Biotechnol, V2, P132; MANOLSON MF, 1994, J BIOL CHEM, V269, P14064; Martinez-Munoz GA, 2008, J BIOL CHEM, V283, P20309, DOI 10.1074/jbc.M710470200; Mijaljica D, 2011, AUTOPHAGY, V7, P666, DOI 10.4161/auto.7.6.15812; Moriyama Y, 1988, Prog Clin Biol Res, V273, P387; Nakanishi-Matsui M, 2010, BBA-BIOENERGETICS, V1797, P1343, DOI 10.1016/j.bbabio.2010.02.014; NELSON H, 1990, P NATL ACAD SCI USA, V87, P3503, DOI 10.1073/pnas.87.9.3503; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Ochotny N, 2011, J BONE MINER RES, V26, P1484, DOI 10.1002/jbmr.355; OHYA Y, 1991, J BIOL CHEM, V266, P13971; Ostrosky-Zeichner L, 2010, NAT REV DRUG DISCOV, V9, P719, DOI 10.1038/nrd3074; Owegi MA, 2005, J BIOL CHEM, V280, P18393, DOI 10.1074/jbc.M412567200; Owegi MA, 2006, J BIOL CHEM, V281, P30001, DOI 10.1074/jbc.M605006200; Poltermann S, 2005, MICROBIOL-SGM, V151, P1645, DOI 10.1099/mic.0.27505-0; Qi J, 2008, J BIOL CHEM, V283, P19274, DOI 10.1074/jbc.M802442200; ROBERTS WR, 1981, J CLIN PERIODONTOL, V8, P213, DOI 10.1111/j.1600-051X.1981.tb02032.x; Shao E, 2004, J BIOL CHEM, V279, P48663, DOI 10.1074/jbc.M408278200; Shao E, 2003, J BIOL CHEM, V278, P12985, DOI 10.1074/jbc.M212096200; Shum WWC, 2011, J ANDROL, V32, P576, DOI 10.2164/jandrol.111.012971; Soares DA, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-241; Tarsio M, 2011, J BIOL CHEM, V286, P28089, DOI 10.1074/jbc.M111.251363; Vasilyeva E, 1998, J BIOL CHEM, V273, P23823, DOI 10.1074/jbc.273.37.23823; Xu T, 2000, J BIOL CHEM, V275, P22075, DOI 10.1074/jbc.M002983200; Zhang JW, 1998, J BIOL CHEM, V273, P18470, DOI 10.1074/jbc.273.29.18470; Zhang YQ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000939; Zhang ZY, 2008, J BIOL CHEM, V283, P35983, DOI 10.1074/jbc.M805345200; Zorko M, 2008, J ANTIMICROB CHEMOTH, V62, P730, DOI 10.1093/jac/dkn270	59	40	41	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10236	10250		10.1074/jbc.M111.321133	http://dx.doi.org/10.1074/jbc.M111.321133			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22215674	hybrid, Green Published			2022-12-27	WOS:000302167200054
J	Gruninger, RJ; Dobing, S; Smith, AD; Bruder, LM; Selinger, LB; Wieden, HJ; Mosimann, SC				Gruninger, Robert J.; Dobing, Selina; Smith, Adam D.; Bruder, Lisza M.; Selinger, L. Brent; Wieden, Hans-Joachim; Mosimann, Steven C.			Substrate Binding in Protein-tyrosine Phosphatase-like Inositol Polyphosphatases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY CRYSTALLOGRAPHY; MYOINOSITOL HEXAKISPHOSPHATE; STRUCTURAL-ANALYSIS; PHYTASE; HYDROLYSIS; STEREOSPECIFICITY; SPECIFICITY; MECHANISM; PATHWAY; COMPLEX	Protein-tyrosine phosphatase-like inositol polyphosphatases are microbial enzymes that catalyze the stepwise removal of one or more phosphates from highly phosphorylated myo-inositols via a relatively ordered pathway. To understand the substrate specificity and kinetic mechanism of these enzymes we have determined high resolution, single crystal, x-ray crystallographic structures of inactive Selenomonas ruminantium PhyA in complex with myo-inositol hexa-and pentakisphosphate. These structures provide the first glimpse of a myo-inositol polyphosphatase-ligand complex consistent with its known specificity and reveal novel features of the kinetic mechanism. To complement the structural studies, fluorescent binding assays have been developed and demonstrate that the K-d for this enzyme is several orders of magnitude lower than the K-m. Together with rapid kinetics data, these results suggest that the protein tyrosine phosphatase-like inositol polyphosphatases have a two-step, substrate-binding mechanism that facilitates catalysis.	[Gruninger, Robert J.; Dobing, Selina; Smith, Adam D.; Bruder, Lisza M.; Wieden, Hans-Joachim; Mosimann, Steven C.] Univ Lethbridge, Dept Chem & Biochem, Lethbridge, AB T1K 3M4, Canada; [Selinger, L. Brent] Univ Lethbridge, Dept Biol Sci, Lethbridge, AB T1K 3M4, Canada	University of Lethbridge; University of Lethbridge	Mosimann, SC (corresponding author), 4401 Univ Dr, Lethbridge, AB T1K 3M4, Canada.	steven.mosimann@uleth.ca		Selinger, Leonard/0000-0001-8205-8334	National Science and Engineering Research Council of Canada (NSERC); NSERC	National Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by National Science and Engineering Research Council of Canada (NSERC) discovery grants (to H.-J.W., L. B. S., and S. C. M.) and NSERC studentships (to R.J.G., S. D., and L.M.B.).	Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Caffrey JJ, 1999, FEBS LETT, V442, P99, DOI 10.1016/S0014-5793(98)01636-6; Chatterjee S, 2003, MOL PLANT MICROBE IN, V16, P973, DOI 10.1094/MPMI.2003.16.11.973; Chu HM, 2004, STRUCTURE, V12, P2015, DOI 10.1016/j.str.2004.08.010; Davies GJ, 2003, BIOCHEM SOC T, V31, P523, DOI 10.1042/BST0310523; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Goodrich J. A., 2007, BINDING KINETICS MOL, P135; Greiner R, 2002, J AGR FOOD CHEM, V50, P6865, DOI 10.1021/jf025620t; Gruninger RJ, 2008, FEBS J, V275, P3783, DOI 10.1111/j.1742-4658.2008.06524.x; Gruninger RJ, 2009, J MOL BIOL, V392, P75, DOI 10.1016/j.jmb.2009.05.079; Hanakahi LA, 2000, CELL, V102, P721, DOI 10.1016/S0092-8674(00)00061-1; Irvine RF, 2001, NAT REV MOL CELL BIO, V2, P327, DOI 10.1038/35073015; Jackson SG, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-80; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laskowski RA, 1997, TRENDS BIOCHEM SCI, V22, P488, DOI 10.1016/S0968-0004(97)01140-7; Lim D, 2000, NAT STRUCT BIOL, V7, P108; Macbeth MR, 2005, SCIENCE, V309, P1534, DOI 10.1126/science.1113150; Majerus PW, 2008, ADV ENZYME REGUL, V48, P10, DOI 10.1016/j.advenzreg.2008.04.001; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Mullaney EJ, 2000, ADV APPL MICROBIOL, V47, P157, DOI 10.1016/S0065-2164(00)47004-8; Mullaney EJ, 2003, BIOCHEM BIOPH RES CO, V312, P179, DOI 10.1016/j.bbrc.2003.09.176; Nakashima BA, 2007, MICROB ECOL, V53, P82, DOI 10.1007/s00248-006-9147-4; Pannifer ADB, 1998, J BIOL CHEM, V273, P10454, DOI 10.1074/jbc.273.17.10454; Puhl AA, 2008, BIOCHEM CELL BIOL, V86, P322, DOI 10.1139/o08-095; Puhl AA, 2008, INT J BIOCHEM CELL B, V40, P2053, DOI 10.1016/j.biocel.2008.02.003; Puhl AA, 2007, PROTEIN SCI, V16, P1368, DOI 10.1110/ps.062738307; Puhl AA, 2009, APPL MICROBIOL BIOT, V82, P95, DOI 10.1007/s00253-008-1734-5; Rao DECS, 2009, CRIT REV BIOTECHNOL, V29, P182, DOI 10.1080/07388550902919571; Shah N, 2003, BIOCHEMISTRY-US, V42, P13812, DOI 10.1021/bi034742r; STREET IP, 1991, TETRAHEDRON, V47, P5919, DOI 10.1016/S0040-4020(01)86484-X; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Ullah AHJ, 1998, BIOCHEM BIOPH RES CO, V251, P260, DOI 10.1006/bbrc.1998.9456; Ullah AHJ, 2000, BIOCHEM BIOPH RES CO, V275, P279, DOI 10.1006/bbrc.2000.3271; Wilden B, 2006, P NATL ACAD SCI USA, V103, P13670, DOI 10.1073/pnas.0606099103; York JD, 1999, SCIENCE, V285, P96, DOI 10.1126/science.285.5424.96; Zou JY, 1999, STRUCTURE, V7, P1035, DOI 10.1016/S0969-2126(99)80171-3	37	10	11	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					9722	9730		10.1074/jbc.M111.309872	http://dx.doi.org/10.1074/jbc.M111.309872			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22139834	hybrid, Green Published			2022-12-27	WOS:000302167200006
J	Liao, HC; Chen, MY				Liao, Hsien-Ching; Chen, Mei-Yu			Target of Rapamycin Complex 2 Signals to Downstream Effector Yeast Protein Kinase 2 (Ypk2) through Adheres-Voraciously-to-Target-of-Rapamycin-2 Protein 1 (Avo1) in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-WALL INTEGRITY; ACTIN CYTOSKELETON; MOTIF PHOSPHORYLATION; GROWTH CONTROL; TOR COMPLEX-2; MTOR COMPLEX; AGC KINASES; RAPTOR; BIOSYNTHESIS; ORGANIZATION	The conserved Ser/Thr kinase target of rapamycin (TOR) serves as a central regulator in controlling cell growth-related functions. There exist two distinct TOR complexes, TORC1 and TORC2, each coupling to specific downstream effectors and signaling pathways. In Saccharomyces cerevisiae, TORC2 is involved in regulating actin organization and maintaining cell wall integrity. Ypk2 (yeast protein kinase 2), a member of the cAMP-dependent, cGMP-dependent, and PKC (AGC) kinase family, is a TORC2 substrate known to participate in actin and cell wall regulation. Employing avo3(ts) mutants with defects in TORC2 functions that are suppressible by active Ypk2, we investigated the molecular interactions involved in mediating TORC2 signaling to Ypk2. GST pulldown assays in yeast lysates demonstrated physical interactions between Ypk2 and components of TORC2. In vitro binding assays revealed that Avo1 directly binds to Ypk2. In avo3ts mutants, the TORC2-Ypk2 interaction was reduced and could be restored by AVO1 overexpression, highlighting the important role of Avo1 in coupling TORC2 to Ypk2. The interaction was mapped to an internal region (amino acids 600-840) of Avo1 and a C-terminal region of Ypk2. Ypk2(334-677), a truncated form of Ypk2 containing the Avo1-interacting region, was able to interfere with Avo1-Ypk2 interaction in vitro. Overexpressing Ypk2(334-677) in yeast cells resulted in a perturbation of TORC2 functions, causing defective cell wall integrity, aberrant actin organization, and diminished TORC2-dependent Ypk2 phosphorylation evidenced by the loss of an electrophoretic mobility shift. Together, our data support the conclusion that the direct Avo1-Ypk2 interaction is crucial for TORC2 signaling to the downstream Ypk2 pathway.	[Liao, Hsien-Ching; Chen, Mei-Yu] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 11221, Taiwan	National Yang Ming Chiao Tung University	Chen, MY (corresponding author), Natl Yang Ming Univ, Inst Biochem & Mol Biol, 155,Sec 2,Li Nong St, Taipei 11221, Taiwan.	meychen@ym.edu.tw		CHEN, MEI-YU/0000-0002-5765-9178	National Science Council, Taiwan [NSC94-2311-B-010-010, NSC95-2311-B-010-013]; Ministry of Education, Taiwan [100AC-T506]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Education, Taiwan(Ministry of Education, Taiwan)	This work was supported by Grants NSC94-2311-B-010-010 and NSC95-2311-B-010-013 from the National Science Council, Taiwan, and "Aim for the Top University Plan" grant 100AC-T506 from the Ministry of Education, Taiwan.	Aronova S, 2008, CELL METAB, V7, P148, DOI 10.1016/j.cmet.2007.11.015; Audhya A, 2004, EMBO J, V23, P3747, DOI 10.1038/sj.emboj.7600384; Barbet NC, 1996, MOL BIOL CELL, V7, P25, DOI 10.1091/mbc.7.1.25; Cameron AJM, 2011, BIOCHEM J, V439, P287, DOI 10.1042/BJ20110678; Cardenas ME, 1999, GENE DEV, V13, P3271, DOI 10.1101/gad.13.24.3271; Casamayor A, 1999, CURR BIOL, V9, P186, DOI 10.1016/S0960-9822(99)80088-8; CHEN P, 1993, MOL GEN GENET, V236, P443, DOI 10.1007/BF00277146; Fadri M, 2005, MOL BIOL CELL, V16, P1883, DOI 10.1091/mbc.e04-07-0564; Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; Goodson HV, 1996, J CELL BIOL, V133, P1277, DOI 10.1083/jcb.133.6.1277; Grosshans BL, 2006, J BIOL CHEM, V281, P11104, DOI 10.1074/jbc.M508933200; HELLIWELL SB, 1994, MOL BIOL CELL, V5, P105, DOI 10.1091/mbc.5.1.105; Ho HL, 2005, CURR GENET, V47, P273, DOI 10.1007/s00294-005-0570-8; Ho HL, 2008, EUKARYOT CELL, V7, P1328, DOI 10.1128/EC.00065-08; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Inoki K, 2005, MICROBIOL MOL BIOL R, V69, P79, DOI 10.1128/MMBR.69.1.79-100.2005; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jacinto E, 2008, BIOCHEM J, V410, P19, DOI 10.1042/BJ20071518; Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507; Kamada Y, 2005, MOL CELL BIOL, V25, P7239, DOI 10.1128/MCB.25.16.7239-7248.2005; Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Laplante M, 2009, CURR BIOL, V19, pR1046, DOI 10.1016/j.cub.2009.09.058; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lu M, 2011, J BIOL CHEM, V286, P30647, DOI 10.1074/jbc.M111.257592; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Nojima H, 2003, J BIOL CHEM, V278, P15461, DOI 10.1074/jbc.C200665200; Reinke A, 2004, J BIOL CHEM, V279, P14752, DOI 10.1074/jbc.M313062200; Roelants FM, 2002, MOL BIOL CELL, V13, P3005, DOI 10.1091/mbc.E02-04-0201; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Schaim SS, 2003, CURR BIOL, V13, P797, DOI 10.1016/S0960-9822(03)00329-4; Shinozaki-Yabana S, 2000, MOL CELL BIOL, V20, P1234, DOI 10.1128/MCB.20.4.1234-1242.2000; SIKORSKI RS, 1989, GENETICS, V122, P19; Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020; Wedaman KP, 2003, MOL BIOL CELL, V14, P1204, DOI 10.1091/mbc.E02-09-0609; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Wullschleger S, 2005, J BIOL CHEM, V280, P30697, DOI 10.1074/jbc.M505553200; Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	43	18	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6089	6099		10.1074/jbc.M111.303701	http://dx.doi.org/10.1074/jbc.M111.303701			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22207764	Green Published, hybrid			2022-12-27	WOS:000300791800003
J	Dirkx, E; Schwenk, RW; Coumans, WA; Hoebers, N; Angin, Y; Viollet, B; Bonen, A; van Eys, GJJM; Glatz, JFC; Luiken, JJFP				Dirkx, Ellen; Schwenk, Robert W.; Coumans, Will A.; Hoebers, Nicole; Angin, Yeliz; Viollet, Benoit; Bonen, Arend; van Eys, Guillaume J. J. M.; Glatz, Jan F. C.; Luiken, Joost J. F. P.			Protein Kinase D1 Is Essential for Contraction-induced Glucose Uptake but Is Not Involved in Fatty Acid Uptake into Cardiomyocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR SUPPRESSIVE FUNCTIONS; SKELETAL-MUSCLE; GLUT4 TRANSLOCATION; CARDIAC MYOCYTES; OXIDATIVE STRESS; INSULIN; AMPK; ACTIVATION; TRANSPORT; ROS	Increased contraction enhances substrate uptake into cardiomyocytes via translocation of the glucose transporter GLUT4 and the long chain fatty acid (LCFA) transporter CD36 from intracellular stores to the sarcolemma. Additionally, contraction activates the signaling enzymes AMP-activated protein kinase (AMPK) and protein kinase D1 (PKD1). Although AMPK has been implicated in contraction-induced GLUT4 and CD36 translocation in cardiomyocytes, the precise role of PKD1 in these processes is not known. To study this, we triggered contractions in cardiomyocytes by electric field stimulation (EFS). First, the role of PKD1 in GLUT4 and CD36 translocation was defined. In PKD1 siRNA-treated cardiomyocytes as well as cardiomyocytes from PKD1 knock-out mice, EFS-induced translocation of GLUT4, but not CD36, was abolished. In AMPK siRNA-treated cardiomyocytes and cardiomyocytes from AMPK alpha 2 knock-out mice, both GLUT4 and CD36 translocation were abrogated. Hence, unlike AMPK, PKD1 is selectively involved in glucose uptake. Second, we analyzed upstream factors in PKD1 activation. Cardiomyocyte contractions enhanced reactive oxygen species (ROS) production. Using ROS scavengers, we found that PKD1 signaling and glucose uptake are more sensitive to changes in intracellular ROS than AMPK signaling or LCFA uptake. Furthermore, silencing of death-activated protein kinase (DAPK) abrogated EFS-induced GLUT4 but not CD36 translocation. Finally, possible links between PKD1 and AMPK signaling were investigated. PKD1 silencing did not affect AMPK activation. Reciprocally, AMPK silencing did not alter PKD1 activation. In conclusion, we present a novel contraction-induced ROS-DAPK-PKD1 pathway in cardiomyocytes. This pathway is activated separately from AMPK and mediates GLUT4 translocation/glucose uptake, but not CD36 translocation/LCFA uptake.	[Dirkx, Ellen; Schwenk, Robert W.; Coumans, Will A.; Hoebers, Nicole; Angin, Yeliz; van Eys, Guillaume J. J. M.; Glatz, Jan F. C.; Luiken, Joost J. F. P.] Maastricht Univ, Dept Mol Genet, NL-6200 MD Maastricht, Netherlands; [Dirkx, Ellen; Schwenk, Robert W.; Coumans, Will A.; Hoebers, Nicole; Angin, Yeliz; van Eys, Guillaume J. J. M.; Glatz, Jan F. C.; Luiken, Joost J. F. P.] Maastricht Univ, Cardiovasc Res Inst Maastricht, NL-6200 MD Maastricht, Netherlands; [Viollet, Benoit] Univ Paris 05, Inst Cochin, INSERM, CNRS,U1016,UMR 8104, F-75014 Paris, France; [Bonen, Arend] Univ Guelph, Dept Human Hlth & Nutr Sci, Coll Biol Sci, Guelph, ON N1G 2W1, Canada	Maastricht University; Maastricht University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Guelph	Luiken, JJFP (corresponding author), POB 616, NL-6200 MD Maastricht, Netherlands.	j.luiken@maastrichtuniversity.nl	Viollet, Benoit/O-6927-2017; Viollet, Benoit/N-2397-2019	Viollet, Benoit/0000-0002-0121-0224; Viollet, Benoit/0000-0002-0121-0224	Transnational University Limburg; European Community [LSHM-CT-2004-005272]	Transnational University Limburg; European Community(European Commission)	This work was supported by the Transnational University Limburg and European Community Integrated Project LSHM-CT-2004-005272 (Exgenesis).	De Giusti VC, 2009, J MOL CELL CARDIOL, V47, P716, DOI 10.1016/j.yjmcc.2009.07.023; Eisenberg-Lerner A, 2007, CELL DEATH DIFFER, V14, P1908, DOI 10.1038/sj.cdd.4402212; Fujii N, 2005, J BIOL CHEM, V280, P39033, DOI 10.1074/jbc.M504208200; Ghanekar Y, 2005, NAT CELL BIOL, V7, P851, DOI 10.1038/ncb0905-851; Glatz JFC, 2010, PHYSIOL REV, V90, P367, DOI 10.1152/physrev.00003.2009; Habets DDJ, 2009, BBA-MOL CELL BIOL L, V1791, P212, DOI 10.1016/j.bbalip.2008.12.009; Hardie DG, 2006, J PHYSIOL-LONDON, V574, P7, DOI 10.1113/jphysiol.2006.108944; Hausser A, 2005, NAT CELL BIOL, V7, P880, DOI 10.1038/ncb1289; Heinzel FR, 2006, CARDIOVASC RES, V71, P374, DOI 10.1016/j.cardiores.2006.05.014; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Horie T, 2008, J CELL PHYSIOL, V215, P733, DOI 10.1002/jcp.21353; Kurth-Kraczek EJ, 1999, DIABETES, V48, P1667, DOI 10.2337/diabetes.48.8.1667; Lefort N, 2008, AM J PHYSIOL-ENDOC M, V295, pE1447, DOI 10.1152/ajpendo.90362.2008; Levy-Strumpf N, 1998, ONCOGENE, V17, P3331, DOI 10.1038/sj.onc.1202588; Luiken JJFP, 2003, DIABETES, V52, P1627, DOI 10.2337/diabetes.52.7.1627; Luiken JJFP, 1997, J LIPID RES, V38, P745; Luiken JJFP, 2008, CELL SIGNAL, V20, P543, DOI 10.1016/j.cellsig.2007.11.007; Merrill GF, 1997, AM J PHYSIOL-ENDOC M, V273, pE1107, DOI 10.1152/ajpendo.1997.273.6.E1107; Merry TL, 2010, AM J PHYSIOL-ENDOC M, V298, pE577, DOI 10.1152/ajpendo.00239.2009; Musi N, 2001, AM J PHYSIOL-ENDOC M, V280, pE677, DOI 10.1152/ajpendo.2001.280.5.E677; Ng MHL, 2002, APOPTOSIS, V7, P261, DOI 10.1023/A:1015364104672; Schwenk RW, 2010, DIABETOLOGIA, V53, P2209, DOI 10.1007/s00125-010-1832-7; Smith MA, 2006, RESP PHYSIOL NEUROBI, V151, P229, DOI 10.1016/j.resp.2005.12.011; Storz P, 2007, TRENDS CELL BIOL, V17, P13, DOI 10.1016/j.tcb.2006.11.003; Taylor EB, 2008, J BIOL CHEM, V283, P9787, DOI 10.1074/jbc.M708839200; Viollet B, 2003, J CLIN INVEST, V111, P91, DOI 10.1172/JCI200316567; Wang QH, 1998, FEBS LETT, V427, P193, DOI 10.1016/S0014-5793(98)00423-2; Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599; Zugaza JL, 1996, EMBO J, V15, P6220, DOI 10.1002/j.1460-2075.1996.tb01012.x	29	30	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5871	5881		10.1074/jbc.M111.281881	http://dx.doi.org/10.1074/jbc.M111.281881			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22158620	Green Published, hybrid			2022-12-27	WOS:000300638000061
J	Jeziorska, DM; Koentges, G; Vance, KW				Jeziorska, Danuta M.; Koentges, Georgy; Vance, Keith W.			Novel cis-Regulatory Modules Control Expression of the Hairy and Enhancer of Split-1 (HES1) Transcription Factor in Myoblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-ACTIN PROMOTER; NOTCH PATHWAY; GENE HES1; FACTOR-I; CHROMOSOME CONFORMATION; NEURAL PROGENITORS; ORGAN SIZE; WRPW MOTIF; M-CAT; ACTIVATION	The expression profile of a gene is controlled by DNA sequences called cis-regulatory modules (CRMs). CRMs can function over large genomic distances and can be located many kilobases away from their target promoters. hes1 is a key developmental gene that is overexpressed in certain cancers and is a primary target of NOTCH signaling. Despite this, analysis of hes1 transcriptional control has been limited solely to its promoter. Here, we identify seven conserved DNA sequence blocks, representing the hes1 promoter and six novel CRMs, within 57 kb upstream of the mouse hes1 gene. We identify 12 binding sites for the RBP-J kappa NOTCH effector and a single M-CAT motif within these regions. We validate RBP-J kappa and TEAD family occupancy in cells in culture and test the response of each of these CRMs to active NOTCH. We show that two regions, CRM5 and CRM7, function as enhancers, and four can repress transcription. A pair of RBP-J kappa motifs arranged in a tail-tail configuration in CRM5 and the M-CAT motif in CRM7 are necessary for enhancer function. Furthermore, these enhancers are occupied by transcriptional co-activators and loop onto the hes1 promoter within the endogenous hes1 locus. This work demonstrates the power of combining computational genomics and experimental methodologies to identify novel CRMs and characterize their function.	[Vance, Keith W.] Univ Oxford, Dept Physiol Anat & Genet, MRC Funct Genom Unit, Oxford OX1 3QX, England; [Jeziorska, Danuta M.; Koentges, Georgy; Vance, Keith W.] Univ Warwick, Sch Life Sci, Lab Genom Syst Anal, Coventry CV4 7AL, W Midlands, England	University of Oxford; University of Warwick	Vance, KW (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, MRC Funct Genom Unit, S Parks Rd, Oxford OX1 3QX, England.	keith.vance@dpag.ox.ac.uk	Vance, Keith/AAK-5410-2021	Vance, Keith/0000-0002-3411-8213	Wellcome Trust [WT 066790/E/02/Z, 066745/Z/01/Z]; Human Frontier Science Program [RGP0029/2007-C]; Warwick University; MRC [MC_U137761446] Funding Source: UKRI; Medical Research Council [MC_U137761446] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Human Frontier Science Program(Human Frontier Science Program); Warwick University; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Wellcome Trust Grants WT 066790/E/02/Z and 066745/Z/01/Z, Human Frontier Science Program Grant RGP0029/2007-C (to G. K.), and a Warwick University Senior Research Fellowship (to K. W. V.).	Aguilera C, 2004, P NATL ACAD SCI USA, V101, P16537, DOI 10.1073/pnas.0404429101; Arnett KL, 2010, NAT STRUCT MOL BIOL, V17, P1312, DOI 10.1038/nsmb.1938; Azakie A, 2005, AM J PHYSIOL-CELL PH, V289, pC1522, DOI 10.1152/ajpcell.00126.2005; Baek JH, 2006, DEVELOPMENT, V133, P2467, DOI 10.1242/dev.02403; BAILEY AM, 1995, GENE DEV, V9, P2609, DOI 10.1101/gad.9.21.2609; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Cave JW, 2005, CURR BIOL, V15, P94, DOI 10.1016/j.cub.2004.12.070; Cuevas IC, 2005, CANCER RES, V65, P5070, DOI 10.1158/0008-5472.CAN-05-0240; Curry CL, 2006, LAB INVEST, V86, P842, DOI 10.1038/labinvest.3700442; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Fan X, 2006, CANCER RES, V66, P7445, DOI 10.1158/0008-5472.CAN-06-0858; Farnie G, 2007, JNCI-J NATL CANCER I, V99, P616, DOI 10.1093/jnci/djk133; Fisher AL, 1996, MOL CELL BIOL, V16, P2670; Granier C, 2011, DEV BIOL, V349, P350, DOI 10.1016/j.ydbio.2010.10.036; Grbavec D, 1996, BIOCHEM BIOPH RES CO, V223, P701, DOI 10.1006/bbrc.1996.0959; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Hallahan AR, 2004, CANCER RES, V64, P7794, DOI 10.1158/0008-5472.CAN-04-1813; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hirata H, 2002, SCIENCE, V298, P840, DOI 10.1126/science.1074560; Hopfer O, 2005, BRIT J CANCER, V93, P709, DOI 10.1038/sj.bjc.6602719; Hucl T, 2007, CANCER RES, V67, P9055, DOI 10.1158/0008-5472.CAN-07-0474; HWANG JJ, 1993, EMBO J, V12, P2337, DOI 10.1002/j.1460-2075.1993.tb05888.x; Ingram WJ, 2008, ONCOGENE, V27, P1489, DOI 10.1038/sj.onc.1210767; Issack PS, 1998, CELL GROWTH DIFFER, V9, P827; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Jarriault S, 1998, MOL CELL BIOL, V18, P7423, DOI 10.1128/MCB.18.12.7423; Jouve C, 2000, DEVELOPMENT, V127, P1421; Kageyama R, 2000, MOL CELLS, V10, P1, DOI 10.1007/s10059-000-0001-0; KARNS LR, 1995, J BIOL CHEM, V270, P410, DOI 10.1074/jbc.270.1.410; Kobayashi T, 2009, GENE DEV, V23, P1870, DOI 10.1101/gad.1823109; Konishi J, 2007, CANCER RES, V67, P8051, DOI 10.1158/0008-5472.CAN-07-1022; Krebs LT, 2003, GENE DEV, V17, P1207, DOI 10.1101/gad.1084703; Kuroda K, 1999, J BIOL CHEM, V274, P7238, DOI 10.1074/jbc.274.11.7238; Lai EC, 2004, DEVELOPMENT, V131, P965, DOI 10.1242/dev.01074; Morel V, 2000, GENE DEV, V14, P377; Nakayama K, 2008, CURR BIOL, V18, pR332, DOI 10.1016/j.cub.2008.03.013; Nam YS, 2007, P NATL ACAD SCI USA, V104, P2103, DOI 10.1073/pnas.0611092104; Ong CT, 2006, J BIOL CHEM, V281, P5106, DOI 10.1074/jbc.M506108200; Oswald F, 2001, MOL CELL BIOL, V21, P7761, DOI 10.1128/MCB.21.22.7761-7774.2001; PAROUSH Z, 1994, CELL, V79, P805, DOI 10.1016/0092-8674(94)90070-1; Rebeiz M, 2002, P NATL ACAD SCI USA, V99, P9888, DOI 10.1073/pnas.152320899; Sanalkumar R, 2010, J NEUROCHEM, V113, P807, DOI 10.1111/j.1471-4159.2010.06574.x; Sang LY, 2008, SCIENCE, V321, P1095, DOI 10.1126/science.1155998; Sang LY, 2010, TRENDS MOL MED, V16, P17, DOI 10.1016/j.molmed.2009.11.001; SASAI Y, 1992, GENE DEV, V6, P2620, DOI 10.1101/gad.6.12b.2620; SHIMIZU N, 1993, NUCLEIC ACIDS RES, V21, P4103, DOI 10.1093/nar/21.17.4103; Shimojo H, 2008, NEURON, V58, P52, DOI 10.1016/j.neuron.2008.02.014; Strano S, 2005, MOL CELL, V18, P447, DOI 10.1016/j.molcel.2005.04.008; Swartz EA, 1998, AM J PHYSIOL-CELL PH, V275, pC608, DOI 10.1152/ajpcell.1998.275.2.C608; Takata T, 2003, BIOCHEM BIOPH RES CO, V301, P250, DOI 10.1016/S0006-291X(02)03020-6; TAKEBAYASHI K, 1994, J BIOL CHEM, V269, P5150; Tiwari VK, 2008, PLOS BIOL, V6, P2911, DOI 10.1371/journal.pbio.0060306; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Tomczak KK, 2003, FASEB J, V17, P403, DOI 10.1096/f.03-0568fje; Vance KW, 2005, CANCER RES, V65, P2260, DOI 10.1158/0008-5472.CAN-04-3045; Vassilev A, 2001, GENE DEV, V15, P1229, DOI 10.1101/gad.888601; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Wall DS, 2009, J CELL BIOL, V184, P101, DOI 10.1083/jcb.200805155; Yagi R, 1999, EMBO J, V18, P2551, DOI 10.1093/emboj/18.9.2551; Zhao B, 2008, CURR OPIN CELL BIOL, V20, P638, DOI 10.1016/j.ceb.2008.10.001	61	6	6	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5687	5697		10.1074/jbc.M111.286484	http://dx.doi.org/10.1074/jbc.M111.286484			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22167192	Green Published, hybrid			2022-12-27	WOS:000300638000045
J	Shimozaki, K; Zhang, CL; Suh, H; Denli, AM; Evans, RM; Gage, FH				Shimozaki, Koji; Zhang, Chun-Li; Suh, Hoonkyo; Denli, Ahmet M.; Evans, Ronald M.; Gage, Fred H.			SRY-box-containing Gene 2 Regulation of Nuclear Receptor Tailless (Tlx) Transcription in Adult Neural Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELF-RENEWAL; SOX2 FUNCTIONS; MOUSE BRAIN; EXPRESSION; PROLIFERATION; NEUROGENESIS; TUMORIGENICITY; COACTIVATOR; MULTIPOTENT; RECRUITS	Adult neurogenesis is maintained by self-renewable neural stem cells (NSCs). Their activity is regulated by multiple signaling pathways and key transcription factors. However, it has been unclear whether these factors interplay with each other at the molecular level. Here we show that SRY-box-containing gene 2 (Sox2) and nuclear receptor tailless (TLX) form a molecular network in adult NSCs. We observed that both Sox2 and TLX proteins bind to the upstream region of Tlx gene. Sox2 positively regulates Tlx expression, whereas the binding of TLX to its own promoter suppresses its transcriptional activity in luciferase reporter assays. Such TLX-mediated suppression can be antagonized by overexpressing wild-type Sox2 but not a mutant lacking the transcriptional activation domain. Furthermore, through regions involved in DNA-binding activity, Sox2 and TLX physically interact to form a complex on DNAs that contain a consensus binding site for TLX. Finally, depletion of Sox2 revealed the potential negative feedback loop of TLX expression that is antagonized by Sox2 in adult NSCs. These data suggest that Sox2 plays an important role in Tlx transcription in cultured adult NSCs.	[Shimozaki, Koji] Nagasaki Univ, Div Funct Genom, Ctr Frontier Life Sci, Nagasaki 8528102, Japan; [Shimozaki, Koji; Suh, Hoonkyo; Denli, Ahmet M.; Gage, Fred H.] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; [Zhang, Chun-Li; Evans, Ronald M.] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Zhang, Chun-Li] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	Nagasaki University; Salk Institute; Salk Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Shimozaki, K (corresponding author), Nagasaki Univ, Div Funct Genom, Ctr Frontier Life Sci, Nagasaki 8528102, Japan.	shimozak@nagasaki-u.ac.jp; gage@salk.edu	Evans, Ronald/AAF-4001-2019	Evans, Ronald/0000-0002-9986-5965; Suh, Hoonkyo/0000-0002-4227-2982	National Institutes of Health [NIMH-MH090258]; McDonnell Foundation; Mothers Foundation; Lookout Foundation; Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Uehara Memorial Foundation of Japan; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK057978] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH090258] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070981] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006484] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23700383] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McDonnell Foundation; Mothers Foundation; Lookout Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation of Japan(Uehara Memorial Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in whole or in part, by National Institutes of Health Grant NIMH-MH090258. This work was also supported by the McDonnell Foundation, the Mothers Foundation, and the Lookout Foundation, a Grant-in-Aid from the Japan Society for the Promotion of Science, a Grant-in-Aid for Research Activity Start-up from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and the Uehara Memorial Foundation of Japan.	Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bergsland M, 2011, GENE DEV, V25, P2453, DOI 10.1101/gad.176008.111; Bylund M, 2003, NAT NEUROSCI, V6, P1162, DOI 10.1038/nn1131; Catena R, 2004, J BIOL CHEM, V279, P41846, DOI 10.1074/jbc.M405514200; Cavallaro M, 2008, DEVELOPMENT, V135, P541, DOI 10.1242/dev.010801; Clement V, 2007, CURR BIOL, V17, P165, DOI 10.1016/j.cub.2006.11.033; Elmi M, 2010, MOL CELL NEUROSCI, V45, P121, DOI 10.1016/j.mcn.2010.06.003; Episkopou V, 2005, TRENDS NEUROSCI, V28, P219, DOI 10.1016/j.tins.2005.03.003; Favaro R, 2009, NAT NEUROSCI, V12, P1248, DOI 10.1038/nn.2397; Ferri ALM, 2004, DEVELOPMENT, V131, P3805, DOI 10.1242/dev.01204; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gangemi RMR, 2009, STEM CELLS, V27, P40, DOI 10.1634/stemcells.2008-0493; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Han YG, 2008, NAT NEUROSCI, V11, P277, DOI 10.1038/nn2059; Hu QK, 2010, STEM CELLS, V28, P279, DOI 10.1002/stem.246; Josephson R, 1998, DEVELOPMENT, V125, P3087; Kondoh H, 2010, INT J BIOCHEM CELL B, V42, P391, DOI 10.1016/j.biocel.2009.09.003; Liu HK, 2008, GENE DEV, V22, P2473, DOI 10.1101/gad.479308; Liu HK, 2010, GENE DEV, V24, P683, DOI 10.1101/gad.560310; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Miyagi S, 2008, FEBS LETT, V582, P2811, DOI 10.1016/j.febslet.2008.07.011; Monaghan AP, 1997, NATURE, V390, P515, DOI 10.1038/37364; Nowling T, 2003, J BIOL CHEM, V278, P13696, DOI 10.1074/jbc.M207567200; Nowling TK, 2000, J BIOL CHEM, V275, P3810, DOI 10.1074/jbc.275.6.3810; PALMER TD, 1995, MOL CELL NEUROSCI, V6, P474, DOI 10.1006/mcne.1995.1035; Pevny LH, 2010, INT J BIOCHEM CELL B, V42, P421, DOI 10.1016/j.biocel.2009.08.018; Ray J, 2006, MOL CELL NEUROSCI, V31, P560, DOI 10.1016/j.mcn.2005.11.010; RAY J, 1993, P NATL ACAD SCI USA, V90, P3602, DOI 10.1073/pnas.90.8.3602; Shi YH, 2008, CRIT REV ONCOL HEMAT, V65, P43, DOI 10.1016/j.critrevonc.2007.06.004; Shi YH, 2004, NATURE, V427, P78, DOI 10.1038/nature02211; Shimozaki K, 2005, J NEUROCHEM, V93, P432, DOI 10.1111/j.1471-4159.2005.03031.x; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Sun GQ, 2007, P NATL ACAD SCI USA, V104, P15282, DOI 10.1073/pnas.0704089104; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takanaga H, 2009, STEM CELLS, V27, P165, DOI 10.1634/stemcells.2008-0580; Tanaka S, 2004, MOL CELL BIOL, V24, P8834, DOI 10.1128/MCB.24.20.8834-8846.2004; Taranova OV, 2006, GENE DEV, V20, P1187, DOI 10.1101/gad.1407906; Yokoyama A, 2008, MOL CELL BIOL, V28, P3995, DOI 10.1128/MCB.02030-07; YU RT, 1994, NATURE, V370, P375, DOI 10.1038/370375a0; Zhang CL, 2008, NATURE, V451, P1004, DOI 10.1038/nature06562; Zhang CL, 2006, GENE DEV, V20, P1308, DOI 10.1101/gad.1413606	42	41	45	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5969	5978		10.1074/jbc.M111.290403	http://dx.doi.org/10.1074/jbc.M111.290403			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22194602	hybrid, Green Submitted, Green Published			2022-12-27	WOS:000300638000070
J	Catterall, JB; Hsueh, MF; Stabler, TV; McCudden, CR; Bolognesi, M; Zura, R; Jordan, JM; Renner, JB; Feng, S; Kraus, VB				Catterall, Jonathan B.; Hsueh, Ming F.; Stabler, Thomas V.; McCudden, Christopher R.; Bolognesi, Michael; Zura, Robert; Jordan, Joanne M.; Renner, Jordan B.; Feng, Sheng; Kraus, Virginia B.			Protein Modification by Deamidation Indicates Variations in Joint Extracellular Matrix Turnover	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RADIOGRAPHIC HIP OSTEOARTHRITIS; HUMAN ARTICULAR-CARTILAGE; 5-STRANDED COILED-COIL; KNEE OSTEOARTHRITIS; MONOCLONAL-ANTIBODIES; ACID RACEMIZATION; CRYSTAL-STRUCTURE; ASPARTIC-ACID; ASSOCIATION; SYMPTOMS	As extracellular proteins age, they undergo and accumulate nonenzymatic post-translational modifications that cannot be repaired. We hypothesized that these could be used to systemically monitor loss of extracellular matrix due to chronic arthritic diseases such as osteoarthritis (OA). To test this, we predicted sites of deamidation in cartilage oligomeric matrix protein (COMP) and confirmed, by mass spectroscopy, the presence of deamidated (Asp(64)) and native (Asn(64)) COMP epitopes (mean 0.95% deamidated COMP (D-COMP) relative to native COMP) in cartilage. An Asp64, D-COMP-specific ELISA was developed using a newly created monoclonal antibody 6-1A12. In a joint replacement study, serum D-COMP (p = 0.017), but not total COMP (p = 0.5), declined significantly after replacement demonstrating a joint tissue source for D-COMP. In analyses of 450 participants from the Johnston County Osteoarthritis Project controlled for age, gender, and race, D-COMP was associated with radiographic hip (p < 0.0001) but not knee (p = 0.95) OA severity. In contrast, total COMP was associated with radiographic knee (p < 0.0001) but not hip (p = 0.47) OA severity. D-COMP was higher in soluble proteins extracted from hip cartilage proximal to OA lesions compared with remote from lesions (p = 0.007) or lesional and remote OA knee (p < 0.01) cartilage. Total COMP in cartilage did not vary by joint site or proximity to the lesion. This study demonstrates the presence of D-COMP in articular cartilage and the systemic circulation, and to our knowledge, it is the first biomarker to show specificity for a particular joint site. We believe that enrichment of deamidated epitope in hip OA cartilage indicates a lesser repair response of hip OA compared with knee OA cartilage.	[Catterall, Jonathan B.; Stabler, Thomas V.; McCudden, Christopher R.; Kraus, Virginia B.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Hsueh, Ming F.; Kraus, Virginia B.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Bolognesi, Michael; Zura, Robert; Kraus, Virginia B.] Duke Univ, Med Ctr, Dept Orthopaed Surg, Durham, NC 27710 USA; [Jordan, Joanne M.; Renner, Jordan B.] Univ N Carolina, Thurston Arthrit Res Ctr, Chapel Hill, NC 27514 USA; [Jordan, Joanne M.] Univ N Carolina, Dept Med, Chapel Hill, NC 27514 USA; [Jordan, Joanne M.] Univ N Carolina, Dept Orthopaed, Chapel Hill, NC 27514 USA; [Renner, Jordan B.] Univ N Carolina, Dept Radiol, Chapel Hill, NC 27514 USA; [Feng, Sheng] Duke Univ, Med Ctr, Dept Biostat & Bioinformat, Durham, NC 27710 USA	Duke University; Duke University; Duke University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Duke University	Kraus, VB (corresponding author), Duke Univ, Med Ctr, Dept Med, Box 3416, Durham, NC 27710 USA.	vbk@duke.edu	Hsueh, Ming-Feng/AAB-5300-2022	Hsueh, Ming-Feng/0000-0002-2334-1604; McCudden, Christopher/0000-0002-4172-4641	National Institutes of Health from NIA (Claude D. Pepper Older Americans Independence Centers) [5P30 AG028716]; NIAMS [P01 AR050245]; NIAMS (Multidisciplinary Clinical Research Center) [5-P60-AR49465]; NIAMS (Multipurpose Arthritis and Musculoskeletal Diseases Center 1) [5-P60-AR-3070]; Centers for Disease Control and Prevention/Association of Schools of Public Health [S043, S3486]; National Institutes of Health [5 U42 RR006042]; NATIONAL CENTER FOR RESEARCH RESOURCES [U42RR006042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P60AR049465, P01AR050245] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG028716] Funding Source: NIH RePORTER	National Institutes of Health from NIA (Claude D. Pepper Older Americans Independence Centers); NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS (Multidisciplinary Clinical Research Center)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS (Multipurpose Arthritis and Musculoskeletal Diseases Center 1); Centers for Disease Control and Prevention/Association of Schools of Public Health(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant 5P30 AG028716 from NIA (Claude D. Pepper Older Americans Independence Centers), Grant P01 AR050245 from NIAMS, Grant 5-P60-AR49465 from NIAMS (Multidisciplinary Clinical Research Center), and Grant 5-P60-AR-3070 from NIAMS (Multipurpose Arthritis and Musculoskeletal Diseases Center 1). This work was also supported by Centers for Disease Control and Prevention/Association of Schools of Public Health Grants S043 and S3486. We acknowledge use of tissues procured by the National Disease Research Interchange (NDRI) with support from National Institutes of Health Grant 5 U42 RR006042.	Burnett S., 1994, RADIOGRAPHIC ATLAS O, P1; Chaganti RK, 2008, OSTEOARTHR CARTILAGE, V16, P566, DOI 10.1016/j.joca.2007.09.008; CHANDRASEKHAR S, 1987, ANAL BIOCHEM, V161, P103, DOI 10.1016/0003-2697(87)90658-0; Clark AG, 1999, ARTHRITIS RHEUM, V42, P2356, DOI 10.1002/1529-0131(199911)42:11<2356::AID-ANR14>3.0.CO;2-R; Cloos PAC, 2002, MATRIX BIOL, V21, P39, DOI 10.1016/S0945-053X(01)00188-3; Conrozier T, 1998, ANN RHEUM DIS, V57, P527, DOI 10.1136/ard.57.9.527; DAUMY GO, 1991, FEBS LETT, V278, P98, DOI 10.1016/0014-5793(91)80093-I; Deverman BE, 2002, CELL, V111, P51, DOI 10.1016/S0092-8674(02)00972-8; Dragomir AD, 2002, OSTEOARTHR CARTILAGE, V10, P687, DOI 10.1053/joca.2002.0816; Golightly YM, 2011, ARTHRITIS RHEUM-US, V63, P2276, DOI 10.1002/art.30412; Guo Y, 1998, EMBO J, V17, P5265, DOI 10.1093/emboj/17.18.5265; HALLAHAN TW, 1992, BIOCHEMISTRY-US, V31, P8022, DOI 10.1021/bi00149a036; HEDBOM E, 1992, J BIOL CHEM, V267, P6132; Hunter DJ, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2314; Jordan JM, 1995, ARTHRIT CARE RES, V8, P242, DOI 10.1002/art.1790080407; Jordan JM, 2007, J RHEUMATOL, V34, P172; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Kelman A, 2006, ARTHRITIS RHEUM-US, V54, P236, DOI 10.1002/art.21527; Kraus VB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009739; Leslie M., 1999, T ORTHOP RES, V24, P581; Malashkevich VN, 1996, SCIENCE, V274, P761, DOI 10.1126/science.274.5288.761; Maroudas A, 1998, ARCH BIOCHEM BIOPHYS, V350, P61, DOI 10.1006/abbi.1997.0492; MAROUDAS A, 1992, CONNECT TISSUE RES, V28, P161, DOI 10.3109/03008209209015033; MAROUDAS A, 1975, PHILOS T ROY SOC B, V271, P293, DOI 10.1098/rstb.1975.0054; McCudden CR, 2006, CLIN BIOCHEM, V39, P1112, DOI 10.1016/j.clinbiochem.2006.07.009; MORGELIN M, 1992, J BIOL CHEM, V267, P6137; Moss CX, 2005, J BIOL CHEM, V280, P18498, DOI 10.1074/jbc.M501241200; Ozbek S, 2002, EMBO J, V21, P5960, DOI 10.1093/emboj/cdf628; Robinson N. E, 2004, MOL CLOCKS DEAMIDATI, P1; Rosenberg K, 1998, J BIOL CHEM, V273, P20397, DOI 10.1074/jbc.273.32.20397; Sharif M, 2004, ARTHRITIS RHEUM, V50, P2479, DOI 10.1002/art.20365; Soderblom EJ, 2011, ANAL CHEM, V83, P3758, DOI 10.1021/ac200213b; Sofat N, 2009, INT J EXP PATHOL, V90, P463, DOI 10.1111/j.1365-2613.2009.00676.x; Sowers MF, 2009, OSTEOARTHR CARTILAGE, V17, P1609, DOI 10.1016/j.joca.2009.06.001; TESHIMA G, 1991, BIOCHEMISTRY-US, V30, P3916, DOI 10.1021/bi00230a016; Tseng S, 2009, BIOMARK INSIGHTS, V4, P33; Verzijl N, 2000, J BIOL CHEM, V275, P39027, DOI 10.1074/jbc.M006700200; Vilim V, 2003, CLIN CHIM ACTA, V328, P59, DOI 10.1016/S0009-8981(02)00375-3; Vilim V, 2002, OSTEOARTHR CARTILAGE, V10, P707, DOI 10.1053/joca.2002.0819; Vilim V, 2001, OSTEOARTHR CARTILAGE, V9, P612, DOI 10.1053/joca.2001.0434; Vilim V, 1997, ARCH BIOCHEM BIOPHYS, V341, P8, DOI 10.1006/abbi.1997.9941	41	37	38	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4640	4651		10.1074/jbc.M111.249649	http://dx.doi.org/10.1074/jbc.M111.249649			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22179616	Green Published, hybrid			2022-12-27	WOS:000300608500026
J	Ray, RM; Viar, MJ; Johnson, LR				Ray, Ramesh M.; Viar, Mary Jane; Johnson, Leonard R.			Amino Acids Regulate Expression of Antizyme-1 to Modulate Ornithine Decarboxylase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						f	INTESTINAL EPITHELIAL-CELLS; MESSENGER-RNA; PROTEIN-SYNTHESIS; GENE-EXPRESSION; TRANSLATION INITIATION; POLYAMINE DEPLETION; NEOPLASTIC GROWTH; RAG GTPASES; IEC-6 CELLS; INDUCTION	In a glucose-salt solution (Earle's balanced salt solution), asparagine (Asn) stimulates ornithine decarboxylase (ODC) activity in a dose-dependent manner, and the addition of epidermal growth factor (EGF) potentiates the effect of Asn. However, EGF alone fails to activate ODC. Thus, the mechanism by which Asn activates ODC is important for understanding the regulation of ODC activity. Asn reduced antizyme-1 (AZ1) mRNA and protein. Among the amino acids tested, Asn and glutamine (Gln) effectively inhibited AZ1 expression, suggesting a differential role for amino acids in the regulation of ODC activity. Asn decreased the putrescine-induced AZ1 translation. The absence of amino acids increased the binding of eukaryotic initiation factor 4E-binding protein (4EBP1) to 5'-mRNA cap and thereby inhibited global protein synthesis. Asn failed to prevent the binding of 4EBP1 to mRNA, and the bound 4EBP1 was unphosphorylated, suggesting the involvement of the mammalian target of rapamycin (mTOR) in the regulation of AZ1 synthesis. Rapamycin treatment (4 h) failed to alter the expression of AZ1. However, extending the treatment (24 h) allowed expression in the presence of amino acids, indicating that AZ1 is expressed when TORC1 signaling is decreased. This suggests the involvement of cap-independent translation. However, transient inhibition of mTORC2 by PP242 completely abolished the phosphorylation of 4EBP1 and decreased basal as well as putrescine-induced AZ1 expression. Asn decreased the phosphorylation of mTOR-Ser(2448) and AKT-Ser(473), suggesting the inhibition of mTORC2. In the absence of amino acids, mTORC1 is inhibited, whereas mTORC2 is activated, leading to the inhibition of global protein synthesis and increased AZ1 synthesis via a cap-independent mechanism.	[Ray, Ramesh M.; Viar, Mary Jane; Johnson, Leonard R.] Univ Tennessee, Hlth Sci Ctr, Dept Physiol, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center	Ray, RM (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Physiol, 894 Union Ave,Nash Bldg, Memphis, TN 38163 USA.	rray3@uthsc.edu			National Institutes of Health; NIDDK [DK-16505, DK-052784, ARRA-USPHS-GR-DK052784-13S1]; Thomas A. Gerwin endowment; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK016505, R37DK016505, R01DK052784] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Thomas A. Gerwin endowment; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health, NIDDK, Grants DK-16505 and DK-052784 and Grant ARRA-USPHS-GR-DK052784-13S1. This work was also supported by the Thomas A. Gerwin endowment.	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Canellakis E S, 1979, Curr Top Cell Regul, V15, P155; CHEN KY, 1977, P NATL ACAD SCI USA, V74, P3791, DOI 10.1073/pnas.74.9.3791; CHEN ZP, 1992, J BIOL CHEM, V267, P6946; Childs AC, 2003, CELL MOL LIFE SCI, V60, P1394, DOI 10.1007/s00018-003-2332-4; Choo AY, 2009, CELL CYCLE, V8, P567, DOI 10.4161/cc.8.4.7659; Christian BE, 2010, BIOCHEM BIOPH RES CO, V391, P942, DOI 10.1016/j.bbrc.2009.11.169; Coffino P, 2001, NAT REV MOL CELL BIO, V2, P188, DOI 10.1038/35056508; DEBENEDETTI A, 1990, P NATL ACAD SCI USA, V87, P8212, DOI 10.1073/pnas.87.21.8212; ELIAS S, 1995, EUR J BIOCHEM, V229, P276, DOI 10.1111/j.1432-1033.1995.0276l.x; FAUSTO N, 1971, BIOCHIM BIOPHYS ACTA, V238, P116, DOI 10.1016/0005-2787(71)90015-3; Feith DJ, 2001, CANCER RES, V61, P6073; Fong LYY, 2003, CANCER RES, V63, P3945; Fox CJ, 2003, GENE DEV, V17, P1841, DOI 10.1101/gad.1105003; GAZZOLA GC, 1972, BIOCHIM BIOPHYS ACTA, V266, P407, DOI 10.1016/0005-2736(72)90097-1; Gerner EW, 2004, NAT REV CANCER, V4, P781, DOI 10.1038/nrc1454; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Hayashi S, 1996, TRENDS BIOCHEM SCI, V21, P27, DOI 10.1016/0968-0004(96)80882-6; Hayashi S., 1989, ORNITHINE DECARBOXYL, P35; HAYASHI SI, 1995, BIOCHEM J, V306, P1; HELLER JS, 1976, P NATL ACAD SCI USA, V73, P1858, DOI 10.1073/pnas.73.6.1858; HOLTTA E, 1993, J CELL BIOL, V122, P903, DOI 10.1083/jcb.122.4.903; HOLTTA E, 1988, J BIOL CHEM, V263, P4500; HOVIS JG, 1986, J BIOL CHEM, V261, P380; Ivanov IP, 2000, NUCLEIC ACIDS RES, V28, P3185, DOI 10.1093/nar/28.17.3185; Ivanov IP, 1998, RNA, V4, P1230, DOI 10.1017/S1355838298980864; Jiang Y, 1999, EMBO J, V18, P2782, DOI 10.1093/emboj/18.10.2782; Kilberg MS, 2005, ANNU REV NUTR, V25, P59, DOI 10.1146/annurev.nutr.24.012003.132145; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; KITANI T, 1984, J BIOL CHEM, V259, P36; KONTULA KK, 1984, P NATL ACAD SCI-BIOL, V81, P731, DOI 10.1073/pnas.81.3.731; Kumar V, 2000, J BIOL CHEM, V275, P10779, DOI 10.1074/jbc.275.15.10779; Leung-Pineda V, 2004, BIOCHEM J, V379, P79, DOI 10.1042/BJ20031383; LI XQ, 1992, MOL CELL BIOL, V12, P3556, DOI 10.1128/MCB.12.8.3556; Lim SK, 2007, ONCOGENE, V26, P6593, DOI 10.1038/sj.onc.1210482; Lin Y, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-15; LOPATIN AN, 1994, NATURE, V372, P366, DOI 10.1038/372366a0; Mangold U, 2005, IUBMB LIFE, V57, P671, DOI 10.1080/15216540500307031; MATSUFUJI S, 1995, CELL, V80, P51, DOI 10.1016/0092-8674(95)90450-6; MATSUFUJI S, 1990, J BIOCHEM-TOKYO, V108, P365, DOI 10.1093/oxfordjournals.jbchem.a123207; MAUDSLEY DV, 1976, AM J PHYSIOL, V231, P1557, DOI 10.1152/ajplegacy.1976.231.5.1557; MCCORMACK SA, 1993, AM J PHYSIOL, V264, pG367, DOI 10.1152/ajpgi.1993.264.2.G367; MCGIVAN JD, 1994, BIOCHEM J, V299, P321, DOI 10.1042/bj2990321; MINAMI H, 1985, J BIOCHEM-TOKYO, V98, P133, DOI 10.1093/oxfordjournals.jbchem.a135251; MITCHELL JLA, 1990, BIOCHIM BIOPHYS ACTA, V1037, P115, DOI 10.1016/0167-4838(90)90109-S; MOSHIER JA, 1993, CANCER RES, V53, P2618; MURAKAMI Y, 1992, NATURE, V360, P597, DOI 10.1038/360597a0; Nakajo T, 2005, BIOCHEM BIOPH RES CO, V326, P174, DOI 10.1016/j.bbrc.2004.11.015; Newman RM, 2004, J BIOL CHEM, V279, P41504, DOI 10.1074/jbc.M407349200; Nilsson J, 1997, EUR J BIOCHEM, V250, P223, DOI 10.1111/j.1432-1033.1997.0223a.x; PEGG AE, 1988, CANCER RES, V48, P759; Pegg AE, 2003, BIOCHEM SOC T, V31, P356, DOI 10.1042/BST0310356; Pegg AE, 2006, J BIOL CHEM, V281, P14529, DOI 10.1074/jbc.R500031200; Peterson RT, 1999, P NATL ACAD SCI USA, V96, P4438, DOI 10.1073/pnas.96.8.4438; Pham FH, 2000, CIRC RES, V86, P1252, DOI 10.1161/01.RES.86.12.1252; Proud CG, 2006, BIOCHEM SOC T, V34, P213, DOI 10.1042/BST0340213; Ray RM, 1999, AM J PHYSIOL-GASTR L, V276, pG773, DOI 10.1152/ajpgi.1999.276.3.G773; Ray RM, 2000, AM J PHYSIOL-CELL PH, V278, pC480, DOI 10.1152/ajpcell.2000.278.3.C480; Rhoads RE, 2009, J BIOL CHEM, V284, P16711, DOI 10.1074/jbc.R900002200; RICHMAN RA, 1971, P SOC EXP BIOL MED, V138, P880; RINEHART CA, 1985, J CELL PHYSIOL, V123, P435, DOI 10.1002/jcp.1041230321; RINEHART CA, 1985, P NATL ACAD SCI USA, V82, P4365, DOI 10.1073/pnas.82.13.4365; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Shantz LM, 1998, CANCER RES, V58, P2748; Shantz LM, 1996, CANCER RES, V56, P3265; Shantz LM, 1996, CANCER RES, V56, P5136; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; VICEPSMADORE D, 1982, BIOCHIM BIOPHYS ACTA, V717, P305, DOI 10.1016/0304-4165(82)90184-2; WANG JY, 1993, AM J PHYSIOL, V265, pG331, DOI 10.1152/ajpgi.1993.265.2.G331; Wang XM, 2005, MOL CELL BIOL, V25, P2558, DOI 10.1128/MCB.25.7.2558-2572.2005; Wang XM, 2003, MOL CELL BIOL, V23, P1546, DOI 10.1128/MCB.23.5.1546-1557.2003; Wang XM, 2006, PHYSIOLOGY, V21, P362, DOI 10.1152/physiol.00024.2006	73	18	19	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					3674	3690		10.1074/jbc.M111.232561	http://dx.doi.org/10.1074/jbc.M111.232561			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22157018	hybrid, Green Published			2022-12-27	WOS:000300410900006
J	Sabotic, J; Bleuler-Martinez, S; Renko, M; Caglic, PA; Kallert, S; Strukelj, B; Turk, D; Aebi, M; Kos, J; Kunzler, M				Sabotic, Jerica; Bleuler-Martinez, Silvia; Renko, Miha; Caglic, Petra Avanzo; Kallert, Sandra; Strukelj, Borut; Turk, Dusan; Aebi, Markus; Kos, Janko; Kuenzler, Markus			Structural Basis of Trypsin Inhibition and Entomotoxicity of Cospin, Serine Protease Inhibitor Involved in Defense of Coprinopsis cinerea Fruiting Bodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSHROOM CLITOCYBE-NEBULARIS; PROTEINASE-INHIBITOR; COPRINUS-CINEREUS; INTRAMOLECULAR CHAPERONE; CAENORHABDITIS-ELEGANS; PARTIAL-PURIFICATION; CRYSTAL-STRUCTURE; HIGHER FUNGI; ENZYMES; BASIDIOMYCETE	Cospin (PIC1) from Coprinopsis cinerea is a serine protease inhibitor with biochemical properties similar to those of the previously characterized fungal serine protease inhibitors, cnispin from Clitocybe nebularis and LeSPI from Lentinus edodes, classified in the family I66 of the MEROPS protease inhibitor classification. In particular, it exhibits a highly specific inhibitory profile as a very strong inhibitor of trypsin with K-i in the picomolar range. Determination of the crystal structure revealed that the protein has a beta-trefoil fold. Site-directed mutagenesis and mass spectrometry results have confirmed Arg-27 as the reactive binding site for trypsin inhibition. The loop containing Arg-27 is positioned between the beta 2 and beta 3 strands, distinguishing cospin from other beta-trefoil-fold serine protease inhibitors in which beta 4-beta 5 or beta 5-beta 6 loops are involved in protease inhibition. Biotoxicity assays of cospin on various model organisms revealed a strong and specific entomotoxic activity against Drosophila melanogaster. The inhibitory inactive R27N mutant was not entomotoxic, associating toxicity with inhibitory activity. Along with the abundance of cospin in fruiting bodies of C. cinerea and the lack of trypsin-like proteases in the C. cinerea genome, these results suggest that cospin and its homologs are effectors of a fungal defense mechanism against fungivorous insects that function by specific inhibition of serine proteases in the insect gut.	[Sabotic, Jerica; Caglic, Petra Avanzo; Strukelj, Borut; Kos, Janko] Jozef Stefan Inst, Dept Biotechnol, Ljubljana, Slovenia; [Renko, Miha; Turk, Dusan] Jozef Stefan Inst, Dept Biochem Mol & Struct Biol, Ljubljana, Slovenia; [Turk, Dusan] Ctr Excellence Integrated Approaches Chem & Biol, Ljubljana, Slovenia; [Bleuler-Martinez, Silvia; Kallert, Sandra; Aebi, Markus; Kuenzler, Markus] Swiss Fed Inst Technol, Inst Microbiol, Dept Biol, CH-8093 Zurich, Switzerland	Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; Swiss Federal Institutes of Technology Domain; ETH Zurich	Sabotic, J (corresponding author), Jozef Stefan Inst, Dept Biotechnol, Jamova 39, Ljubljana, Slovenia.	Jerica.Sabotic@ijs.si	Sabotič, Jerica/AAJ-5050-2021	Sabotič, Jerica/0000-0002-2404-0192; Kunzler, Markus/0000-0003-1275-0629; Turk, Dusan/0000-0003-0205-6609	Swiss National Science Foundation [31003A-130671]; ETH Zurich; Slovenian Research Agency [P4-0127, P1-0048, PR-02266]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ETH Zurich(ETH Zurich); Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This work was supported by the Swiss National Science Foundation Grant 31003A-130671 (to M. K., M. O. Hengartner and M. A.), by ETH Zurich, and by Slovenian Research Agency Grants P4-0127 (to J. K.) and P1-0048 and PR-02266 (to D. T.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; AGO H, 1991, J BIOCHEM-TOKYO, V110, P360, DOI 10.1093/oxfordjournals.jbchem.a123586; Avanzo P, 2009, MICROBIOL-SGM, V155, P3971, DOI 10.1099/mic.0.032805-0; Bertossa RC, 2004, FUNGAL GENET BIOL, V41, P1120, DOI 10.1016/j.fgb.2004.09.001; Bleuler-Martinez S, 2011, MOL ECOL, V20, P3056, DOI 10.1111/j.1365-294X.2011.05093.x; BLUMBERG S, 1970, EUR J BIOCHEM, V15, P97, DOI 10.1111/j.1432-1033.1970.tb00981.x; Borovsky D, 2003, IUBMB LIFE, V55, P435, DOI 10.1080/15216540310001597721; Brzin J, 2000, J BIOL CHEM, V275, P20104, DOI 10.1074/jbc.M001392200; Carlini CR, 2002, TOXICON, V40, P1515, DOI 10.1016/S0041-0101(02)00240-4; CHASE T, 1969, BIOCHEMISTRY-US, V8, P2212, DOI 10.1021/bi00833a063; DOHMAE N, 1995, BIOSCI BIOTECH BIOCH, V59, P2074, DOI 10.1271/bbb.59.2074; Dubovenko AG, 2010, FUNGAL BIOL-UK, V114, P151, DOI 10.1016/j.funbio.2009.11.004; Goldstein IJ, 2007, COMPREHENSIVE GLYCOS, V3, P601; GRAVES BJ, 1990, BIOCHEMISTRY-US, V29, P2679, DOI 10.1021/bi00463a009; Gzogyan LA, 2005, APPL BIOCHEM MICRO+, V41, P538, DOI 10.1007/s10438-005-0097-2; HABIB, 2007, BIOTECH MOL BIOL REV, V2, P68; Hansen D, 2007, BIOCHEM BIOPH RES CO, V360, P735, DOI 10.1016/j.bbrc.2007.06.144; Haq SK, 2004, ARCH BIOCHEM BIOPHYS, V431, P145, DOI 10.1016/j.abb.2004.07.022; HENDERSON PJ, 1972, BIOCHEM J, V127, P321, DOI 10.1042/bj1270321; Hu G, 2004, J EVOLUTION BIOL, V17, P1204, DOI 10.1111/j.1420-9101.2004.00786.x; Kojima S, 2005, FEBS LETT, V579, P4430, DOI 10.1016/j.febslet.2005.06.083; Krivosheina N. P., 2008, ENTOMOLOGICAL REV, V88, P778, DOI DOI 10.1134/S0013873808070038; Kudryavtseva OA, 2008, MICROBIOLOGY+, V77, P643, DOI 10.1134/S0026261708060015; Kunzler M, 2010, METHOD ENZYMOL, V480, P141, DOI 10.1016/S0076-6879(10)80007-2; Laskowski M, 2000, BBA-PROTEIN STRUCT M, V1477, P324, DOI 10.1016/S0167-4838(99)00284-8; Lawrence PK, 2002, ELECTRON J BIOTECHN, V5, DOI 10.2225/vol5-issue1-fulltext-3; Miyatake H, 2006, ACTA CRYSTALLOGR D, V62, P280, DOI 10.1107/S0907444905041909; MORRISON JF, 1982, TRENDS BIOCHEM SCI, V7, P102, DOI 10.1016/0968-0004(82)90157-8; Murdock LL, 2002, J AGR FOOD CHEM, V50, P6605, DOI 10.1021/jf020192c; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakamura M, 2011, MYCOSCIENCE, V52, P234, DOI 10.1007/s10267-010-0089-9; Navaza J, 1997, METHOD ENZYMOL, V276, P581, DOI 10.1016/S0076-6879(97)76079-8; Odani S, 1999, EUR J BIOCHEM, V262, P915, DOI 10.1046/j.1432-1327.1999.00463.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pohleven J, 2009, BBA-GEN SUBJECTS, V1790, P173, DOI 10.1016/j.bbagen.2008.11.006; Ravichandran S, 1999, ACTA CRYSTALLOGR D, V55, P1814, DOI 10.1107/S0907444999009877; Rawlings ND, 2010, BIOCHIMIE, V92, P1463, DOI 10.1016/j.biochi.2010.04.013; RAY C, 1992, MOL BIOCHEM PARASIT, V51, P239, DOI 10.1016/0166-6851(92)90074-T; Renko M, 2010, J BIOL CHEM, V285, P308, DOI 10.1074/jbc.M109.043331; Rouge P., 2007, COMPREHENSIVE GLYCOS, V3, P563; RYAN CA, 1990, ANNU REV PHYTOPATHOL, V28, P425, DOI 10.1146/annurev.py.28.090190.002233; Sabotic J, 2007, J BIOTECHNOL, V128, P297, DOI 10.1016/j.jbiotec.2006.10.006; Sabotic J, 2006, BIOL CHEM, V387, P1559, DOI 10.1515/BC.2006.194; Sabotic J, 2009, FEBS J, V276, P4334, DOI 10.1111/j.1742-4658.2009.07138.x; Sasakawa H, 2002, J MOL BIOL, V317, P159, DOI 10.1006/jmbi.2002.5412; Serrano-Luna JD, 2006, CAN J MICROBIOL, V52, P16, DOI 10.1139/W05-114; Song HK, 1998, J MOL BIOL, V275, P347, DOI 10.1006/jmbi.1997.1469; Stajich JE, 2010, P NATL ACAD SCI USA, V107, P11889, DOI 10.1073/pnas.1003391107; SWAMY S, 1984, J GEN MICROBIOL, V130, P3219; Tcherepanova I, 2000, J BIOL CHEM, V275, P26359, DOI 10.1074/jbc.M000956200; Terra, 2005, COMPREHENSIVE MOL IN, P171, DOI [10.1016/B0-44-451924-6/00053-3, DOI 10.1016/B0-44-451924-6/00053-3]; TERRA WR, 1994, COMP BIOCHEM PHYS B, V109, P1, DOI 10.1016/0305-0491(94)90141-4; TURK D, 1992, WEITERENTWICKLUNG PR; Vetter J, 2000, EUR FOOD RES TECHNOL, V211, P346, DOI 10.1007/s002170000180; WEINER MP, 1994, PCR METH APPL, V4, pS131; Zuchowski J, 2009, BIOCHEMISTRY-MOSCOW+, V74, P226, DOI 10.1134/S0006297909020151; Zuchowski J, 2006, CURR MICROBIOL, V53, P259, DOI 10.1007/s00284-005-0386-2	58	37	38	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					3898	3907		10.1074/jbc.M111.285304	http://dx.doi.org/10.1074/jbc.M111.285304			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22167196	Green Published, hybrid			2022-12-27	WOS:000300410900026
J	Warfel, NA; Newton, AC				Warfel, Noel A.; Newton, Alexandra C.			Pleckstrin Homology Domain Leucine-rich Repeat Protein Phosphatase (PHLPP): A New Player in Cell Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							KINASE; AKT; ACTIVATION; FEEDBACK; PTEN; IDENTIFICATION; DEFICIENT; MECHANISM; ISOFORM; SCOP	Precise balance between phosphorylation, catalyzed by protein kinases, and dephosphorylation, catalyzed by protein phosphatases, is essential for cellular homeostasis. Deregulation of this balance leads to pathophysiological states that drive diseases such as cancer, heart disease, and diabetes. The recent discovery of the PHLPP (pleckstrin homology domain leucinerich repeat protein phosphatase) family of Ser/Thr phosphatases adds a new player to the cast of phosphate-controlling enzymes in cell signaling. PHLPP isozymes catalyze the dephosphorylation of a conserved regulatory motif, the hydrophobic motif, on the AGC kinases Akt, PKC, and S6 kinase, as well as an inhibitory site on the kinase Mst1, to inhibit cellular proliferation and induce apoptosis. The frequent deletion of PHLPP in cancer, coupled with the development of prostate tumors in mice lacking PHLPP1, identifies PHLPP as a novel tumor suppressor. This minireview discusses the structure, function, and regulation of PHLPP, with particular focus on its role in disease.	[Warfel, Noel A.; Newton, Alexandra C.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Warfel, Noel A.] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Newton, AC (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.	anewton@ucsd.edu		Warfel, Noel/0000-0001-6410-9011	National Institutes of Health [GM067946]; Department of Defense from the United States Army Medical Research Acquisition Activity [BC093021]; University of California through National Institutes of Health from NIGMS [T32 GM007752]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007752, R01GM067946] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense from the United States Army Medical Research Acquisition Activity; University of California through National Institutes of Health from NIGMS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM067946 (to A.C.N.). This work was also supported by Department of Defense Breast Cancer Research Program Award BC093021 from the United States Army Medical Research Acquisition Activity (to N.A.W.).; Supported in part by the University of California San Diego Graduate Training Program in Cellular and Molecular Pharmacology through National Institutes of Health Institutional Training Grant T32 GM007752 from NIGMS.	Alessi DR, 1998, CURR OPIN GENET DEV, V8, P55, DOI 10.1016/S0959-437X(98)80062-2; Andreozzi F, 2011, DIABETOLOGIA, V54, P1879, DOI 10.1007/s00125-011-2116-6; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Bredel M, 2005, CANCER RES, V65, P4088, DOI 10.1158/0008-5472.CAN-04-4229; Brognard J, 2008, TRENDS ENDOCRIN MET, V19, P223, DOI 10.1016/j.tem.2008.04.001; Brognard J, 2007, MOL CELL, V25, P917, DOI 10.1016/j.molcel.2007.02.017; Brognard J, 2009, J BIOL CHEM, V284, P15215, DOI 10.1074/jbc.M901468200; Carver BS, 2011, CANCER CELL, V19, P575, DOI 10.1016/j.ccr.2011.04.008; Chan SL, 1999, J NEUROSCI RES, V58, P167, DOI 10.1002/(SICI)1097-4547(19991001)58:1<167::AID-JNR16>3.0.CO;2-K; Chen MH, 2011, CANCER CELL, V20, P173, DOI 10.1016/j.ccr.2011.07.013; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; CHUNG J, 1992, CELL, V69, P1227, DOI 10.1016/0092-8674(92)90643-Q; Cozzone D, 2008, DIABETOLOGIA, V51, P512, DOI 10.1007/s00125-007-0913-8; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; de Souza PM, 2004, BIOCHEM SOC T, V32, P485, DOI 10.1042/BST0320485; Gao T, 2008, J BIOL CHEM, V283, P6300, DOI 10.1074/jbc.M707319200; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372; Li X, 2011, EMBO REP, V12, P818, DOI 10.1038/embor.2011.106; Li X, 2009, MOL CELL BIOL, V29, P6192, DOI 10.1128/MCB.00681-09; Liu J, 2009, ONCOGENE, V28, P994, DOI 10.1038/onc.2008.450; Liu JY, 2011, MOL CELL BIOL, V31, P4917, DOI 10.1128/MCB.05799-11; Liu JY, 2011, J BIOL CHEM, V286, P6510, DOI 10.1074/jbc.M110.183087; Masubuchi S, 2010, P NATL ACAD SCI USA, V107, P1642, DOI 10.1073/pnas.0910292107; MATSUMOTO K, 1982, P NATL ACAD SCI-BIOL, V79, P2355, DOI 10.1073/pnas.79.7.2355; Miyamoto S, 2010, CIRC RES, V107, P476, DOI 10.1161/CIRCRESAHA.109.215020; Molina JR, 2012, ONCOGENE, V31, P1264, DOI 10.1038/onc.2011.324; Mulholland DJ, 2011, CANCER CELL, V19, P792, DOI 10.1016/j.ccr.2011.05.006; Park WS, 2008, MOL CELL, V30, P381, DOI 10.1016/j.molcel.2008.04.008; Patterson SJ, 2011, J IMMUNOL, V186, P5533, DOI 10.4049/jimmunol.1002126; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Pei HD, 2009, CANCER CELL, V16, P259, DOI 10.1016/j.ccr.2009.07.016; Qiao M, 2010, MOL CELL, V38, P512, DOI 10.1016/j.molcel.2010.03.017; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Shimizu K, 2003, J BIOL CHEM, V278, P14920, DOI 10.1074/jbc.M213214200; Shimizu K, 1999, FEBS LETT, V458, P363, DOI 10.1016/S0014-5793(99)01190-4; Shimizu K, 2007, CELL, V128, P1219, DOI 10.1016/j.cell.2006.12.047; Sierecki E, 2010, J MED CHEM, V53, P6899, DOI 10.1021/jm100331d; Talantov D, 2005, CLIN CANCER RES, V11, P7234, DOI 10.1158/1078-0432.CCR-05-0683; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Warfel NA, 2011, J BIOL CHEM, V286, P19777, DOI 10.1074/jbc.M111.237081	44	56	57	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					3610	3616		10.1074/jbc.R111.318675	http://dx.doi.org/10.1074/jbc.R111.318675			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22144674	Green Published, hybrid			2022-12-27	WOS:000300410900001
J	Izawa, R; Onoue, T; Furukawa, N; Mima, J				Izawa, Ryota; Onoue, Toshitaka; Furukawa, Noriko; Mima, Joji			Distinct Contributions of Vacuolar Qabc- and R-SNARE Proteins to Membrane Fusion Specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; T-SNARES; SUBCELLULAR MEMBRANES; REGULATORY LIPIDS; HOMOTYPIC FUSION; V-SNARES; YEAST; COMPLEX; CHAPERONES; PHOSPHOINOSITIDES	In eukaryotic endomembrane systems, Qabc-SNAREs (soluble N-ethylmaleimide-sensitive factor attachment protein receptors) on one membrane and R-SNARE on the opposing membrane assemble into a trans-QabcR-SNARE complex to drive membrane fusion. However, it remains ambiguous whether pairing of Qabc- and R-SNAREs mediates membrane fusion specificity. Here, we explored the fusion specificity of reconstituted proteoliposomes bearing purified SNAREs in yeast vacuoles and other organelles. We found that not only vacuolar R-SNARE Nyv1p but also the non-cognate R-SNAREs, endosomal Snc2p, and endoplasmic reticulum-Golgi Sec22p caused efficient fusion with vacuolar Qabc-SNAREs. In contrast, their fusion is blocked completely by replacing vacuolar Qc-SNARE Vam7p with the non-cognate endosomal Tlg1p and Syn8p, although these endosomal Qc-SNAREs fully retained the ability to form cis-SNARE complexes with vacuolar SNAREs in solution and on membranes. Thus, our current study establishes that an appropriate assembly of Qabc-SNAREs is crucial for regulating fusion specificity, whereas R-SNARE itself has little contribution to specificity.	[Izawa, Ryota; Onoue, Toshitaka; Furukawa, Noriko; Mima, Joji] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan	Osaka University	Mima, J (corresponding author), Osaka Univ, Inst Prot Res, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan.	Joji.Mima@protein.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology; MEXT; Naito Foundation	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Naito Foundation(Naito Memorial Foundation)	This work was supported by the Program to Disseminate Tenure Tracking System (Ministry of Education, Culture, Sports, Science and Technology, Ministry of Education, Culture, Sports, Science and Technology), grants-in-aid for scientific research (MEXT), and the Naito Foundation (to J. M.).	Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Bowers K, 2005, BBA-MOL CELL RES, V1744, P438, DOI 10.1016/j.bbamcr.2005.04.004; Brandhorst D, 2006, P NATL ACAD SCI USA, V103, P2701, DOI 10.1073/pnas.0511138103; Burri L, 2004, TRAFFIC, V5, P45, DOI 10.1046/j.1600-0854.2003.00151.x; Carr CM, 2010, CURR OPIN CELL BIOL, V22, P488, DOI 10.1016/j.ceb.2010.04.006; Dennison SM, 2006, BIOPHYS J, V90, P1661, DOI 10.1529/biophysj.105.069617; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Fasshauer D, 1999, J BIOL CHEM, V274, P15440, DOI 10.1074/jbc.274.22.15440; Fratti RA, 2004, J CELL BIOL, V167, P1087, DOI 10.1083/jcb.200409068; Fukuda R, 2000, NATURE, V407, P198, DOI 10.1038/35025084; Gerrard SR, 2000, TRAFFIC, V1, P45, DOI 10.1034/j.1600-0854.2000.010108.x; Hickey CM, 2010, MOL BIOL CELL, V21, P2297, DOI 10.1091/mbc.E10-01-0044; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; James DJ, 2008, J CELL BIOL, V182, P355, DOI 10.1083/jcb.200801056; Lang T, 2001, EMBO J, V20, P2202, DOI 10.1093/emboj/20.9.2202; Liu S, 2007, TRAFFIC, V8, P1630, DOI 10.1111/j.1600-0854.2007.00628.x; McNew JA, 2000, NATURE, V407, P153, DOI 10.1038/35025000; Miaczynska M, 2002, EXP CELL RES, V272, P8, DOI 10.1006/excr.2001.5401; Mima J, 2008, EMBO J, V27, P2031, DOI 10.1038/emboj.2008.139; Mima J, 2009, J BIOL CHEM, V284, P27114, DOI 10.1074/jbc.M109.010223; Mima J, 2009, P NATL ACAD SCI USA, V106, P16191, DOI 10.1073/pnas.0908694106; Nickel W, 1999, P NATL ACAD SCI USA, V96, P12571, DOI 10.1073/pnas.96.22.12571; Ostrowicz CW, 2008, AUTOPHAGY, V4, P5, DOI 10.4161/auto.5054; Parlati F, 2002, P NATL ACAD SCI USA, V99, P5424, DOI 10.1073/pnas.082100899; Paumet F, 2005, J BIOL CHEM, V280, P21137, DOI 10.1074/jbc.M500841200; Poirier MA, 1998, NAT STRUCT BIOL, V5, P765, DOI 10.1038/1799; Rizo J, 2002, NAT REV NEUROSCI, V3, P641, DOI 10.1038/nrn898; Schneiter R, 1999, J CELL BIOL, V146, P741, DOI 10.1083/jcb.146.4.741; Schuette CG, 2004, P NATL ACAD SCI USA, V101, P2858, DOI 10.1073/pnas.0400044101; Seeley ES, 2002, MOL BIOL CELL, V13, P782, DOI 10.1091/mbc.01-10-0512; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; STRUCK DK, 1981, BIOCHEMISTRY-US, V20, P4093, DOI 10.1021/bi00517a023; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Ungermann C, 1999, J CELL BIOL, V145, P1435, DOI 10.1083/jcb.145.7.1435; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Wickner W, 2008, NAT STRUCT MOL BIOL, V15, P658, DOI 10.1038/nsmb.1451; Wickner W, 2010, ANNU REV CELL DEV BI, V26, P115, DOI 10.1146/annurev-cellbio-100109-104131; Xu H, 2010, J BIOL CHEM, V285, P39359, DOI 10.1074/jbc.M110.183111; Yang B, 1999, J BIOL CHEM, V274, P5649, DOI 10.1074/jbc.274.9.5649; ZINSER E, 1991, J BACTERIOL, V173, P2026, DOI 10.1128/jb.173.6.2026-2034.1991; ZINSER E, 1995, YEAST, V11, P493, DOI 10.1002/yea.320110602; Zwilling D, 2007, EMBO J, V26, P9, DOI 10.1038/sj.emboj.7601467	44	19	19	3	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3445	3453		10.1074/jbc.M111.307439	http://dx.doi.org/10.1074/jbc.M111.307439			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22174414	Green Published, hybrid			2022-12-27	WOS:000300295100049
J	Milanese, C; Sager, JJ; Bai, Q; Farrell, TC; Cannon, JR; Greenamyre, JT; Burton, EA				Milanese, Chiara; Sager, Jonathan J.; Bai, Qing; Farrell, Thomas C.; Cannon, Jason R.; Greenamyre, J. Timothy; Burton, Edward A.			Hypokinesia and Reduced Dopamine Levels in Zebrafish Lacking beta- and gamma 1-Synucleins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENOME-WIDE ASSOCIATION; ALPHA-SYNUCLEIN; TRANSGENIC ZEBRAFISH; GAMMA-SYNUCLEIN; MICE LACKING; KNOCKOUT MICE; RISK-FACTORS; NEURON LOSS; IN-VIVO; GENE	alpha-Synuclein is strongly implicated in the pathogenesis of Parkinson disease. However, the normal functions of synucleins and how these relate to disease pathogenesis are uncertain. We characterized endogenous zebrafish synucleins in order to develop tractable models to elucidate the physiological roles of synucleins in neurons in vivo. Three zebrafish genes, sncb, sncg1, and sncg2 (encoding beta-, gamma 1-, and gamma 2-synucleins respectively), show extensive phylogenetic conservation with respect to their human paralogues. A zebrafish alpha-synuclein orthologue was not found. Abundant 1.45-kb sncb and 2.7-kb sncg1 mRNAs were detected in the CNS from early development through adulthood and showed overlapping but distinct expression patterns. Both transcripts were detected in catecholaminergic neurons throughout the CNS. Zebrafish lacking beta-, gamma 1-, or both synucleins during early development showed normal CNS and body morphology but exhibited decreased spontaneous motor activity that resolved as gene expression recovered. Zebrafish lacking both beta- and gamma 1-synucleins were more severely hypokinetic than animals lacking one or the other synuclein and showed delayed differentiation of dopaminergic neurons and reduced dopamine levels. Phenotypic abnormalities resulting from loss of endogenous zebrafish synucleins were rescued by expression of human alpha-synuclein. These data demonstrate that synucleins have essential phylogenetically conserved neuronal functions that regulate dopamine homeostasis and spontaneous motor behavior. Zebrafish models will allow further elucidation of the molecular physiology and pathophysiology of synucleins in vivo.	[Milanese, Chiara; Sager, Jonathan J.; Bai, Qing; Farrell, Thomas C.; Cannon, Jason R.; Greenamyre, J. Timothy; Burton, Edward A.] Univ Pittsburgh, Dept Neurol, Pittsburgh, PA 15213 USA; [Milanese, Chiara; Sager, Jonathan J.; Bai, Qing; Farrell, Thomas C.; Cannon, Jason R.; Greenamyre, J. Timothy; Burton, Edward A.] Univ Pittsburgh, Pittsburgh Inst Neurodegenerat Dis, Pittsburgh, PA 15213 USA; [Sager, Jonathan J.] Univ Pittsburgh, Dept Neurobiol, Pittsburgh, PA 15213 USA; [Burton, Edward A.] Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA 15213 USA; [Milanese, Chiara] Ri MED Fdn, I-90133 Palermo, Italy; [Greenamyre, J. Timothy; Burton, Edward A.] Pittsburgh Vet Affairs Healthcare Syst, Geriatr Res Educ & Clin Ctr, Pittsburgh, PA 15240 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Geriatric Research Education & Clinical Center	Burton, EA (corresponding author), Univ Pittsburgh, Dept Neurol, 7015 BST-3,3501 5th Ave, Pittsburgh, PA 15213 USA.	eab25@pitt.edu	Cannon, Jason/F-2435-2012; Burton, Edward/AAO-9677-2021; Burton, Edward/ABB-1324-2021; Milanese, Chiara/AAA-9267-2019	Cannon, Jason/0000-0003-1907-4555; Burton, Edward/0000-0002-8072-4636; Milanese, Chiara/0000-0001-8696-2603; Greenamyre, J. Timothy/0000-0003-3468-7878	National Institutes of Health [NS0583691, ES019879]; Pittsburgh Foundation [M2005-0071]; Ri.MED Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K99ES019879, R00ES019879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG024827] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pittsburgh Foundation; Ri.MED Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants NS0583691 and ES019879. This work was also supported by Pittsburgh Foundation Grant M2005-0071 and the Ri.MED Foundation.	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Amsterdam A, 1999, GENE DEV, V13, P2713, DOI 10.1101/gad.13.20.2713; Anichtchik OV, 2004, J NEUROCHEM, V88, P443, DOI 10.1046/j.1471-4159.2003.02190.x; Anwar S, 2011, J NEUROSCI, V31, P7264, DOI 10.1523/JNEUROSCI.6194-10.2011; Bai Q, 2009, NEUROSCIENCE, V164, P1138, DOI 10.1016/j.neuroscience.2009.09.014; Bai Q, 2007, NUCLEIC ACIDS RES, V35, P6501, DOI 10.1093/nar/gkm608; Bai Q, 2006, BRAIN RES, V1113, P33, DOI 10.1016/j.brainres.2006.07.057; Bai Q, 2011, J COMP NEUROL, V519, P1580, DOI 10.1002/cne.22587; Bai Q, 2009, NEUROSCI LETT, V449, P252, DOI 10.1016/j.neulet.2008.10.101; Bandmann O, 2010, NEUROBIOL DIS, V40, P58, DOI 10.1016/j.nbd.2010.05.017; Bretaud S, 2004, NEUROTOXICOL TERATOL, V26, P857, DOI 10.1016/j.ntt.2004.06.014; Bretaud S, 2007, J NEUROCHEM, V100, P1626, DOI 10.1111/j.1471-4159.2006.04291.x; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Cabin DE, 2002, J NEUROSCI, V22, P8797; Chandra S, 2004, P NATL ACAD SCI USA, V101, P14966, DOI 10.1073/pnas.0406283101; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chen YC, 2009, DEV DYNAM, V238, P746, DOI 10.1002/dvdy.21877; Clayton DF, 1998, TRENDS NEUROSCI, V21, P249, DOI 10.1016/S0166-2236(97)01213-7; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Dauer W, 2002, P NATL ACAD SCI USA, V99, P14524, DOI 10.1073/pnas.172514599; Edwards TL, 2010, ANN HUM GENET, V74, P97, DOI 10.1111/j.1469-1809.2009.00560.x; Flinn L, 2009, BRAIN, V132, P1613, DOI 10.1093/brain/awp108; Fuchs J, 2008, FASEB J, V22, P1327, DOI 10.1096/fj.07-9348com; Greten-Harrison B, 2010, P NATL ACAD SCI USA, V107, P19573, DOI 10.1073/pnas.1005005107; Hayashi S, 2000, MOVEMENT DISORD, V15, P884, DOI 10.1002/1531-8257(200009)15:5<884::AID-MDS1019>3.0.CO;2-8; Holzschuh J, 2001, MECH DEVELOP, V101, P237, DOI 10.1016/S0925-4773(01)00287-8; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lam CS, 2005, EUR J NEUROSCI, V21, P1758, DOI 10.1111/j.1460-9568.2005.03988.x; Lepiller S, 2009, GENE, V445, P58, DOI 10.1016/j.gene.2009.05.016; Liang J, 2008, HUM MOL GENET, V17, P3784, DOI 10.1093/hmg/ddn276; Lo K, 1996, GENE, V182, P13, DOI 10.1016/S0378-1119(96)00438-6; Ma PM, 2003, J COMP NEUROL, V460, P13, DOI 10.1002/cne.10544; McKinley ET, 2005, MOL BRAIN RES, V141, P128, DOI 10.1016/j.molbrainres.2005.08.014; McLean DL, 2009, J NEUROSCI, V29, P13566, DOI 10.1523/JNEUROSCI.3277-09.2009; MULLINS MC, 1994, CURR BIOL, V4, P189, DOI 10.1016/S0960-9822(00)00048-8; Muto A, 2011, P NATL ACAD SCI USA, V108, P5425, DOI 10.1073/pnas.1000887108; Naumann EA, 2010, NAT NEUROSCI, V13, P513, DOI 10.1038/nn.2518; Ninkina N, 2003, MOL CELL BIOL, V23, P8233, DOI 10.1128/MCB.23.22.8233-8245.2003; Panula P, 2010, NEUROBIOL DIS, V40, P46, DOI 10.1016/j.nbd.2010.05.010; Park HC, 2000, DEV BIOL, V227, P279, DOI 10.1006/dbio.2000.9898; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rihel J, 2010, SCIENCE, V327, P348, DOI 10.1126/science.1183090; Robertson DC, 2004, J NEUROCHEM, V89, P1126, DOI 10.1111/j.1471-4159.2004.02378.x; Sager JJ, 2010, BRAIN STRUCT FUNCT, V214, P285, DOI 10.1007/s00429-009-0237-1; Sallinen V, 2009, J NEUROCHEM, V108, P719, DOI 10.1111/j.1471-4159.2008.05793.x; Sallinen V, 2010, NEUROBIOL DIS, V40, P93, DOI 10.1016/j.nbd.2010.06.001; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; Schluter OM, 2003, NEUROSCIENCE, V118, P985, DOI 10.1016/S0306-4522(03)00036-8; Sheng DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000914; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Sinha AU, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-82; Specht CG, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-11; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Sun ZH, 2008, DEV DYNAM, V237, P2490, DOI 10.1002/dvdy.21569; Thisse C., 2004, ZFIN; Trinh K, 2008, J NEUROSCI, V28, P465, DOI 10.1523/JNEUROSCI.4778-07.2008; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; Wider C, 2010, NEURODEGENER DIS, V7, P175, DOI 10.1159/000289232; Willingham S, 2003, SCIENCE, V302, P1769, DOI 10.1126/science.1090389; Yoshida H, 2006, BIOCHEMISTRY-US, V45, P2599, DOI 10.1021/bi051993m; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zon LI, 2005, NAT REV DRUG DISCOV, V4, P35, DOI 10.1038/nrd1606	64	59	61	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					2971	2983		10.1074/jbc.M111.308312	http://dx.doi.org/10.1074/jbc.M111.308312			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22128150	hybrid, Green Published			2022-12-27	WOS:000300295100005
J	Santhekadur, PK; Gredler, R; Chen, D; Siddiq, A; Shen, XN; Das, SK; Emdad, L; Fisher, PB; Sarkar, D				Santhekadur, Prasanna K.; Gredler, Rachel; Chen, Dong; Siddiq, Ayesha; Shen, Xue-Ning; Das, Swadesh K.; Emdad, Luni; Fisher, Paul B.; Sarkar, Devanand			Late SV40 Factor (LSF) Enhances Angiogenesis by Transcriptionally Up-regulating Matrix Metalloproteinase-9 (MMP-9)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCELLULAR-CARCINOMA; IV COLLAGENASE; MATRIX METALLOPROTEINASES; TUMOR ANGIOGENESIS; CELLS; METASTASIS; EXPRESSION; INVASION; CARCINOGENESIS; ADENOCARCINOMA	The transcription factor late SV40 factor (LSF) is overexpressed in human hepatocellular carcinoma (HCC) fostering a highly aggressive and metastatic phenotype. Angiogenesis is an essential component of cancer aggression and metastasis and HCC is a highly aggressive and angiogenic cancer. In the present studies, we analyzed the molecular mechanism of LSF-induced angiogenesis in HCC. Employing human umbilical vein endothelial cells (HUVEC) differentiation assay and chicken chorioallantoic membrane (CAM) assay we document that stable LSF overexpression augments and stable dominant negative inhibition of LSF (LSFdn) abrogates angiogenesis by human HCC cells. A quest for LSF-regulated factors contributing to angiogenesis, by chromatin immunoprecipitation-on-chip (ChIP-on-chip) assay, identified matrix metalloproteinase-9 (MMP-9) as a direct target of LSF. MMP-9 expression and enzymatic activity were higher in LSF-overexpressing cells and lower in LSFdn-expressing cells. Deletion mutation analysis identified the LSF-responsive regions in the MMP-9 promoter and ChIP assay confirmed LSF binding to the MMP-9 promoter. Inhibition of MMP-9 significantly abrogated LSF-induced angiogenesis as well as in vivo tumorigenesis, thus reinforcing the role of MMP-9 in facilitating LSF function. The present findings identify a novel target of LSF contributing to its oncogenic properties.	[Santhekadur, Prasanna K.; Gredler, Rachel; Siddiq, Ayesha; Shen, Xue-Ning; Das, Swadesh K.; Emdad, Luni; Fisher, Paul B.; Sarkar, Devanand] Virginia Commonwealth Univ, Dept Human & Mol Genet, Sch Med, Richmond, VA 23298 USA; [Chen, Dong; Sarkar, Devanand] Virginia Commonwealth Univ, Dept Pathol, Sch Med, Richmond, VA 23298 USA; [Fisher, Paul B.; Sarkar, Devanand] Virginia Commonwealth Univ, VCU Inst Mol Med, Sch Med, Richmond, VA 23298 USA; [Fisher, Paul B.; Sarkar, Devanand] Virginia Commonwealth Univ, VCU Massey Canc Ctr, Sch Med, Richmond, VA 23298 USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Sarkar, D (corresponding author), Virginia Commonwealth Univ, Dept Human & Mol Genet, Sch Med, 1220 E Broad St,POB 980035, Richmond, VA 23298 USA.	dsarkar@vcu.edu	Santhekadur, Prasanna/O-7006-2019; chen, dong/A-6889-2012	Santhekadur, Prasanna/0000-0003-3338-375X; chen, dong/0000-0001-6661-9410	NCI, National Institutes of Health [R01 CA138540, R01 CA134721]; Dana Foundation; James S. McDonnell Foundation; Samuel Waxman Cancer Research Foundation (SWCRF); NATIONAL CANCER INSTITUTE [R01CA138540, R01CA134721] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Dana Foundation; James S. McDonnell Foundation; Samuel Waxman Cancer Research Foundation (SWCRF); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by NCI, National Institutes of Health Grants R01 CA138540 (to D. S.) and R01 CA134721 (to P. B. F.). This work study was also supported in part by grants from the Dana Foundation, the James S. McDonnell Foundation, and the Samuel Waxman Cancer Research Foundation (SWCRF).	Aalinkeel R, 2004, CANCER RES, V64, P5311, DOI 10.1158/0008-5472.CAN-2506-2; Ahn GO, 2008, CANCER CELL, V13, P193, DOI 10.1016/j.ccr.2007.11.032; Arii S, 1996, HEPATOLOGY, V24, P316; Bausch D, 2011, ANGIOGENESIS, V14, P235, DOI 10.1007/s10456-011-9207-3; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Bruni-Cardoso A, 2010, MOL CANCER RES, V8, P459, DOI 10.1158/1541-7786.MCR-09-0445; Chantrain CF, 2006, EUR J CANCER, V42, P310, DOI 10.1016/j.ejca.2005.11.010; Chen YJ, 2009, J CELL PHYSIOL, V221, P98, DOI 10.1002/jcp.21835; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Emdad L, 2010, MOL CANCER THER, V9, P79, DOI 10.1158/1535-7163.MCT-09-0752; Harper J, 2006, EXP SUPPL, V96, P223; Hayasaka A, 1996, HEPATOLOGY, V24, P1058; Hiratsuka S, 2002, CANCER CELL, V2, P289, DOI 10.1016/S1535-6108(02)00153-8; Kuang DM, 2011, J HEPATOL, V54, P948, DOI 10.1016/j.jhep.2010.08.041; LENGYEL E, 1995, CANCER RES, V55, P963; LEVY AT, 1991, CANCER RES, V51, P439; LIBRACH CL, 1991, J CELL BIOL, V113, P437, DOI 10.1083/jcb.113.2.437; NAKAJIMA M, 1993, CANCER RES, V53, P5802; Nikkola J, 2005, CLIN CANCER RES, V11, P5158, DOI 10.1158/1078-0432.CCR-04-2478; Parekh V, 2004, MOL CELL BIOL, V24, P7113, DOI 10.1128/MCB.24.16.7113-7129.2004; Pfeifer A, 2000, P NATL ACAD SCI USA, V97, P12227, DOI 10.1073/pnas.220399597; Redondo-Munoz J, 2010, CANCER CELL, V17, P160, DOI 10.1016/j.ccr.2009.12.044; Rocnik EF, 2006, J BIOL CHEM, V281, P22855, DOI 10.1074/jbc.M513463200; Rundhaug JE, 2005, J CELL MOL MED, V9, P267, DOI 10.1111/j.1582-4934.2005.tb00355.x; Stetler-Stevenson WG, 1999, J CLIN INVEST, V103, P1237, DOI 10.1172/JCI6870; Takafuji V, 2007, ONCOGENE, V26, P6361, DOI 10.1038/sj.onc.1210463; WATANABE H, 1993, J CELL SCI, V104, P991; Yoo BK, 2011, J HEPATOL, V55, P1317, DOI 10.1016/j.jhep.2011.02.036; Yoo BK, 2010, P NATL ACAD SCI USA, V107, P8357, DOI 10.1073/pnas.1000374107; Yoo BK, 2009, P NATL ACAD SCI USA, V106, P12938, DOI 10.1073/pnas.0901451106	32	29	29	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3425	3432		10.1074/jbc.M111.298976	http://dx.doi.org/10.1074/jbc.M111.298976			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22167195	Green Published, hybrid			2022-12-27	WOS:000300295100047
J	Top, D; Read, JA; Dawe, SJ; Syvitski, RT; Duncan, R				Top, Deniz; Read, Jolene A.; Dawe, Sandra J.; Syvitski, Raymond T.; Duncan, Roy			Cell-Cell Membrane Fusion Induced by p15 Fusion-associated Small Transmembrane (FAST) Protein Requires a Novel Fusion Peptide Motif Containing a Myristoylated Polyproline Type II Helix	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STOMATITIS-VIRUS GLYCOPROTEIN; BABOON REOVIRUS; VIRAL FUSION; CONFORMATIONS; AQUAREOVIRUS; ARRANGEMENT; PLASTICITY; VESICLES; RESIDUES; HAIRPIN	The p15 fusion-associated small transmembrane (FAST) protein is a nonstructural viral protein that induces cell-cell fusion and syncytium formation. The exceptionally small, myristoylated N-terminal ectodomain of p15 lacks any of the defining features of a typical viral fusion protein. NMR and CD spectroscopy indicate this small fusion module comprises a left-handed polyproline type II (PPII) helix flanked by small, unstructured N and C termini. Individual prolines in the 6-residue proline-rich motif are highly tolerant of alanine substitutions, but multiple substitutions that disrupt the PPII helix eliminate cell-cell fusion activity. A synthetic p15 ectodomain peptide induces lipid mixing between liposomes, but with unusual kinetics that involve a long lag phase before the onset of rapid lipid mixing, and the length of the lag phase correlates with the kinetics of peptide-induced liposome aggregation. Lipid mixing, liposome aggregation, and stable peptide-membrane interactions are all dependent on both the N-terminal myristate and the presence of the PPII helix. We present a model for the mechanism of action of this novel viral fusion peptide, whereby the N-terminal myristate mediates initial, reversible peptide-membrane binding that is stabilized by subsequent amino acid-membrane interactions. These interactions induce a biphasic membrane fusion reaction, with peptide-induced liposome aggregation representing a distinct, rate-limiting event that precedes membrane merger. Although the prolines in the proline-rich motif do not directly interact with membranes, the PPII helix may function to force solvent exposure of hydrophobic amino acid side chains in the regions flanking the helix to promote membrane binding, apposition, and fusion.	[Top, Deniz; Read, Jolene A.; Dawe, Sandra J.; Duncan, Roy] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS B3H 4R2, Canada; [Duncan, Roy] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS B3H 4R2, Canada; [Syvitski, Raymond T.] CNR, Inst Marine Biosci, Halifax, NS B3H3Z1, Canada; [Duncan, Roy] Dalhousie Univ, Dept Pediat, Halifax, NS B3H 4R2, Canada	Dalhousie University; Dalhousie University; National Research Council Canada; Dalhousie University	Duncan, R (corresponding author), Dalhousie Univ, Dept Microbiol & Immunol, 5850 Coll St,POB 15000, Halifax, NS B3H 4R2, Canada.	roy.duncan@dal.ca		Top, Deniz/0000-0002-1042-8460; Duncan, Roy/0000-0002-5162-5081	Canadian Institutes of Health Research (CIHR); Nova Scotia Health Research Foundation (NSHRF); Cancer Research Training Program with the Dalhousie Cancer Research Program; Eliza Ritchie scholarship; Natural Sciences and Engineering Research Council (NSERC) of Canada; Killam Foundation	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Nova Scotia Health Research Foundation (NSHRF); Cancer Research Training Program with the Dalhousie Cancer Research Program; Eliza Ritchie scholarship; Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Killam Foundation	This work was supported in part by grants from the Canadian Institutes of Health Research (CIHR).; Supported by scholarships from the Nova Scotia Health Research Foundation (NSHRF) and the Cancer Research Training Program with funding from the Dalhousie Cancer Research Program.; Supported by scholarships from the CIHR and NSHRF and an Eliza Ritchie scholarship.; Supported by scholarships from the Natural Sciences and Engineering Research Council (NSERC) of Canada, the Killam Foundation, and the NSHRF.	Attoui H, 2002, J GEN VIROL, V83, P1941, DOI 10.1099/0022-1317-83-8-1941; Barry C, 2010, J BIOL CHEM, V285, P16424, DOI 10.1074/jbc.M110.118232; Barry C, 2009, J VIROL, V83, P12185, DOI 10.1128/JVI.01667-09; Bochicchio B, 2002, CHIRALITY, V14, P782, DOI 10.1002/chir.10153; Boutilier J, 2011, CURR TOP MEMBR, V68, P107, DOI 10.1016/B978-0-12-385891-7.00005-2; Chappell J. D., 2005, ORTHOREOVIRUS REOVIR, P455; Chernomordik LV, 2008, NAT STRUCT MOL BIOL, V15, P675, DOI 10.1038/nsmb.1455; Clancy EK, 2011, J VIROL, V85, P4707, DOI 10.1128/JVI.02223-10; Clancy EK, 2009, J VIROL, V83, P2941, DOI 10.1128/JVI.01869-08; Corcoran JA, 2004, J BIOL CHEM, V279, P51386, DOI 10.1074/jbc.M406990200; Corcoran JA, 2004, J VIROL, V78, P4342, DOI 10.1128/JVI.78.8.4342-4351.2004; Dawe S, 2005, J VIROL, V79, P6216, DOI 10.1128/JVI.79.10.6216-6226.2005; Dawe S, 2002, J VIROL, V76, P2131, DOI 10.1128/JVI.76.5.2131-2140.2002; Epand RM, 2003, BBA-BIOMEMBRANES, V1614, P116, DOI 10.1016/S0005-2736(03)00169-X; Findlay B, 2010, ANTIMICROB AGENTS CH, V54, P4049, DOI 10.1128/AAC.00530-10; Foroutan A, 2011, J PHYS CHEM B, V115, P3622, DOI 10.1021/jp1101253; Gibbons DL, 2004, NATURE, V427, P320, DOI 10.1038/nature02239; Gregory SM, 2011, P NATL ACAD SCI USA, V108, P11211, DOI 10.1073/pnas.1104760108; Groffen AJ, 2010, SCIENCE, V327, P1614, DOI 10.1126/science.1183765; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Hui EF, 2009, CELL, V138, P709, DOI 10.1016/j.cell.2009.05.049; JOSEPH M, 1995, J BIOL CHEM, V270, P16749, DOI 10.1074/jbc.270.28.16749; Kadlec J, 2008, NAT STRUCT MOL BIOL, V15, P1024, DOI 10.1038/nsmb.1484; Kelly MA, 2001, BIOCHEMISTRY-US, V40, P14376, DOI 10.1021/bi011043a; Kielian M, 2006, NAT REV MICROBIOL, V4, P67, DOI 10.1038/nrmicro1326; Korte T, 2001, VIROLOGY, V289, P353, DOI 10.1006/viro.2001.1108; Kozlov MM, 2010, TRENDS BIOCHEM SCI, V35, P699, DOI 10.1016/j.tibs.2010.06.003; Lai AL, 2006, J BIOL CHEM, V281, P5760, DOI 10.1074/jbc.M512280200; Lev N, 2007, J MOL BIOL, V374, P220, DOI 10.1016/j.jmb.2007.09.008; Li YL, 2007, BIOPHYS J, V93, P876, DOI 10.1529/biophysj.106.102335; Lorieau JL, 2010, P NATL ACAD SCI USA, V107, P11341, DOI 10.1073/pnas.1006142107; Melikyan GB, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-111; Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165; NILGES M, 1991, COMPUTATIONAL ASPECT; Park SH, 1997, PROTEIN SCI, V6, P1694, DOI 10.1002/pro.5560060809; Pecheur EI, 1997, BIOCHEMISTRY-US, V36, P3773, DOI 10.1021/bi9622128; Peisajovich SG, 2000, BIOCHEMISTRY-US, V39, P1826, DOI 10.1021/bi991887i; Peisajovich SG, 2002, EUR J BIOCHEM, V269, P4342, DOI 10.1046/j.1432-1033.2002.03132.x; Pereira FB, 1997, BIOPHYS J, V73, P1977, DOI 10.1016/S0006-3495(97)78228-6; Pereira FB, 1999, CHEM PHYS LIPIDS, V103, P11, DOI 10.1016/S0009-3084(99)00087-0; Racine T, 2009, J VIROL, V83, P5951, DOI 10.1128/JVI.00171-09; Rath A, 2005, BIOPOLYMERS, V80, P179, DOI 10.1002/bip.20227; Reichert J, 2007, EUR BIOPHYS J BIOPHY, V36, P405, DOI 10.1007/s00249-006-0106-2; Resh MD, 2004, P NATL ACAD SCI USA, V101, P417, DOI 10.1073/pnas.0308043101; Rey FA, 2006, EMBO REP, V7, P1000, DOI 10.1038/sj.embor.7400807; Roche S, 2008, CELL MOL LIFE SCI, V65, P1716, DOI 10.1007/s00018-008-7534-3; Roche S, 2006, SCIENCE, V313, P187, DOI 10.1126/science.1127683; RONISH EW, 1974, BIOPOLYMERS, V13, P1635, DOI 10.1002/bip.1974.360130810; Shmulevitz M, 2004, J VIROL, V78, P2808, DOI 10.1128/JVI.78.6.2808-2818.2004; Shmulevitz M, 2003, J VIROL, V77, P9769, DOI 10.1128/JVI.77.18.9769-9779.2003; Shmulevitz M, 2000, EMBO J, V19, P902, DOI 10.1093/emboj/19.5.902; Stapley BJ, 1999, PROTEIN SCI, V8, P587; STEWART JCM, 1980, ANAL BIOCHEM, V104, P10, DOI 10.1016/0003-2697(80)90269-9; Syvitski RT, 2005, BIOCHEMISTRY-US, V44, P7282, DOI 10.1021/bi0504005; Tamm LK, 2002, BIOPOLYMERS, V66, P249, DOI 10.1002/bip.10261; Tamm LK, 2003, CURR OPIN STRUC BIOL, V13, P453, DOI 10.1016/S0959-440X(03)00107-6; Thalmann CM, 2010, VIROLOGY, V402, P26, DOI 10.1016/j.virol.2009.11.048; White JM, 2008, CRIT REV BIOCHEM MOL, V43, P189, DOI [10.1080/10409230802058320, 10.1080/10409230802058320 ]; Whittington SJ, 2005, BIOCHEMISTRY-US, V44, P6269, DOI 10.1021/bi050124u; Whittington SJ, 2003, BIOCHEMISTRY-US, V42, P14690, DOI 10.1021/bi035565x; Zagrovic B, 2005, P NATL ACAD SCI USA, V102, P11698, DOI 10.1073/pnas.0409693102	61	31	31	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3403	3414		10.1074/jbc.M111.305268	http://dx.doi.org/10.1074/jbc.M111.305268			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22170056	Green Published, hybrid			2022-12-27	WOS:000300295100045
J	Yamagata, K; Li, X; Ikegaki, S; Oneyama, C; Okada, M; Nishita, M; Minami, Y				Yamagata, Kaoru; Li, Xin; Ikegaki, Shunkichi; Oneyama, Chitose; Okada, Masato; Nishita, Michiru; Minami, Yasuhiro			Dissection of Wnt5a-Ror2 Signaling Leading to Matrix Metalloproteinase (MMP-13) Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE ROR2; SQUAMOUS-CELL CARCINOMAS; COLLAGENASE-3 MMP-13; GROWTH-FACTOR; TRANSCRIPTION FACTOR; BREAST CARCINOMAS; GENE-EXPRESSION; BETA-CATENIN; RECEPTOR; CANCER	It has been shown that constitutively active Wnt5a-Ror2 signaling in osteosarcoma cell lines plays crucial roles in induced expression of matrix metalloproteinase-13 (MMP-13), required for their invasiveness; however, it remains largely unclear about the molecular basis of MMP-13 gene induction by Wnt5a-Ror2 signaling. Here we show by reporter assay that the activator protein 1 (AP1) (binding site in the promoter region of MMP-13 gene is primarily responsible for its transcriptional activation by Wnt5a-Ror2 signaling in osteosarcoma cell lines SaOS-2 and U2OS. Chromatin immunoprecipitation assays revealed that c-Jun and ATF2 are crucial transcription factors recruited to the AP1-binding site in the MMP-13 gene promoter during Wnt5a-Ror2 signaling in SaOS-2 cells. Using siRNA-mediated suppression or specific inhibitors, we also show that Dishevelled2 (Dvl2) and c-Jun N-terminal kinase are required for MMP-13 gene induction presumably via phosphorylation of c-Jun and ATF2 during Wnt5a-Ror2 signaling in SaOS-2 cells. Interestingly, Dvl2 and Rac1, but not Dvl3, are required for MMP-13 expression in SaOS-2 cells, whereas Dvl3, but not Dvl2 and Rac1, is required for its expression in U2OS cells, indicating the presence of distinct intracellular signaling machineries leading to expression of the same gene, in this case MMP-13 gene in different osteosarcoma cell lines. Moreover, we provide evidence suggesting that Wnt5a-Ror2 signaling might also be required for expression of MMP-13 gene during the development of the cartilaginous tissue.	[Yamagata, Kaoru; Li, Xin; Ikegaki, Shunkichi; Nishita, Michiru; Minami, Yasuhiro] Kobe Univ, Dept Physiol & Cell Biol, Grad Sch Med, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Oneyama, Chitose; Okada, Masato] Osaka Univ, Dept Oncogene Res, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan	Kobe University; Osaka University	Minami, Y (corresponding author), Kobe Univ, Dept Physiol & Cell Biol, Grad Sch Med, Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	minami@kobe-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan; Tokyo Biochemical Research Foundation; Hyogo Science and Technology Association; Uehara Memorial Foundation; Foundation for Promotion of Cancer Research; Grants-in-Aid for Scientific Research [22689009, 22790291] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Tokyo Biochemical Research Foundation; Hyogo Science and Technology Association; Uehara Memorial Foundation(Uehara Memorial Foundation); Foundation for Promotion of Cancer Research; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid for Scientific Research (B), for Young Scientists (B), Scientific Research on Innovative Areas, and for Global Center of Excellence Program from the Ministry of Education, Culture, Sports, Science, and Technology, Japan, and grants from the Tokyo Biochemical Research Foundation, Hyogo Science and Technology Association, Uehara Memorial Foundation, and Foundation for Promotion of Cancer Research.	Airola K, 1999, BRIT J CANCER, V80, P733, DOI 10.1038/sj.bjc.6690417; Airola K, 1997, J INVEST DERMATOL, V109, P225, DOI 10.1111/1523-1747.ep12319441; Ala-Aho R, 2005, BIOCHIMIE, V87, P273, DOI 10.1016/j.biochi.2004.12.009; Borden P, 1996, J BIOL CHEM, V271, P23577, DOI 10.1074/jbc.271.38.23577; Boumah CE, 2009, MOL ENDOCRINOL, V23, P1255, DOI 10.1210/me.2008-0217; Enomoto M, 2009, ONCOGENE, V28, P3197, DOI 10.1038/onc.2009.175; Etoh T, 2000, GUT, V47, P50, DOI 10.1136/gut.47.1.50; FREIJE JMP, 1994, J BIOL CHEM, V269, P16766; Gonzalez-Sancho JM, 2004, MOL CELL BIOL, V24, P4757, DOI 10.1128/MCB.24.11.4757-4768.2004; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; Inada M, 2004, P NATL ACAD SCI USA, V101, P17192, DOI 10.1073/pnas.0407788101; IOZZO RV, 1995, CANCER RES, V55, P3495; Johansson N, 1999, AM J PATHOL, V154, P469, DOI 10.1016/S0002-9440(10)65293-5; Johansson N, 1997, AM J PATHOL, V151, P499; Kanazawa S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012228; Kani S, 2004, J BIOL CHEM, V279, P50102, DOI 10.1074/jbc.M409039200; Kobayashi M, 2005, ARTHRITIS RHEUM-US, V52, P128, DOI 10.1002/art.20776; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kurayoshi M, 2006, CANCER RES, V66, P10439, DOI 10.1158/0008-5472.CAN-06-2359; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Masckauchan TNH, 2006, MOL BIOL CELL, V17, P5163, DOI 10.1091/mbc.E06-04-0320; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Morioka K, 2009, CANCER SCI, V100, P1227, DOI 10.1111/j.1349-7006.2009.01165.x; Nishita M, 2006, J CELL BIOL, V175, P555, DOI 10.1083/jcb.200607127; Nishita M, 2010, TRENDS CELL BIOL, V20, P346, DOI 10.1016/j.tcb.2010.03.001; Nishita M, 2010, MOL CELL BIOL, V30, P3610, DOI 10.1128/MCB.00177-10; Nomachi A, 2008, J BIOL CHEM, V283, P27973, DOI 10.1074/jbc.M802325200; Nomi M, 2001, MOL CELL BIOL, V21, P8329, DOI 10.1128/MCB.21.24.8329-8335.2001; Oishi I, 2003, GENES CELLS, V8, P645, DOI 10.1046/j.1365-2443.2003.00662.x; Pukrop T, 2006, P NATL ACAD SCI USA, V103, P5454, DOI 10.1073/pnas.0509703103; Ren DY, 2011, GENES CELLS, V16, P304, DOI 10.1111/j.1365-2443.2011.01487.x; Solis-Herruzo JA, 1999, J BIOL CHEM, V274, P30919, DOI 10.1074/jbc.274.43.30919; StahleBackdahl M, 1997, LAB INVEST, V76, P717; Uria JA, 1998, J BIOL CHEM, V273, P9769, DOI 10.1074/jbc.273.16.9769; Uria JA, 1998, AM J PATHOL, V153, P91, DOI 10.1016/S0002-9440(10)65549-6; Uria JA, 1997, CANCER RES, V57, P4882; Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4; Witte F, 2010, FASEB J, V24, P2417, DOI 10.1096/fj.09-150615; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Wright TM, 2009, ONCOGENE, V28, P2513, DOI 10.1038/onc.2009.116; Yamada T, 2010, ANTICANCER RES, V30, P2693; Yamagata K, 2009, MOL CELL, V36, P340, DOI 10.1016/j.molcel.2009.08.017; Yamamoto H, 2010, ONCOGENE, V29, P2036, DOI 10.1038/onc.2009.496; Yamamoto S, 2008, DEV CELL, V15, P23, DOI 10.1016/j.devcel.2008.05.007	44	56	61	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1588	1599		10.1074/jbc.M111.315127	http://dx.doi.org/10.1074/jbc.M111.315127			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22128168	Green Published, hybrid			2022-12-27	WOS:000299170300072
J	Behal, RH; Miller, MS; Qin, HM; Lucker, BF; Jones, A; Cole, DG				Behal, Robert H.; Miller, Mark S.; Qin, Hongmin; Lucker, Ben F.; Jones, Alexis; Cole, Douglas G.			Subunit Interactions and Organization of the Chlamydomonas reinhardtii Intraflagellar Transport Complex A Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINESIN-LIKE PROTEIN; DISEASE GENE TG737; CAENORHABDITIS-ELEGANS; SENSORY CILIA; C-ELEGANS; FUNCTIONAL-ANALYSIS; CYTOPLASMIC DYNEIN; IFT PARTICLE; HEAVY-CHAIN; CELL BODY	Chlamydomonas reinhardtii intraflagellar transport (IFT) particles can be biochemically resolved into two smaller assemblies, complexes A and B, that contain up to six and 15 protein subunits, respectively. We provide here the proteomic and immunological analyses that verify the identity of all six Chlamydomonas A proteins. Using sucrose density gradient centrifugation and antibody pulldowns, we show that all six A subunits are associated in a 16 S complex in both the cell bodies and flagella. A significant fraction of the cell body IFT43, however, exhibits a much slower sedimentation of similar to 2 S and is not associated with the IFT A complex. To identify interactions between the six A proteins, we combined exhaustive yeast-based two-hybrid analysis, heterologous recombinant protein expression in Escherichia coli, and analysis of the newly identified complex A mutants, ift121 and ift122. We show that IFT121 and IFT43 interact directly and provide evidence for additional interactions between IFT121 and IFT139, IFT121 and IFT122, IFT140 and IFT122, and IFT140 and IFT144. The mutant analysis further allows us to propose that a subset of complex A proteins, IFT144/140/122, can form a stable 12 S subcomplex that we refer to as the IFT A core. Based on these results, we propose a model for the spatial arrangement of the six IFT A components.	[Behal, Robert H.; Miller, Mark S.; Lucker, Ben F.; Jones, Alexis; Cole, Douglas G.] Univ Idaho, Dept Biol Sci, Moscow, ID 83844 USA; [Behal, Robert H.; Miller, Mark S.; Lucker, Ben F.; Jones, Alexis; Cole, Douglas G.] Univ Idaho, Ctr Reprod Biol, Moscow, ID 83844 USA; [Qin, Hongmin] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA	Idaho; University of Idaho; Idaho; University of Idaho; Texas A&M University System; Texas A&M University College Station	Cole, DG (corresponding author), Univ Idaho, Dept Biol Sci, BIOL LSS 252, Moscow, ID 83844 USA.	dcole@uidaho.edu			National Institutes of Health [R01-GM61920]; INBRE of the National Center for Research Resources [P20-RR016454]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061920] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); INBRE of the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-GM61920 (to D. G. C.) and INBRE Program of the National Center for Research Resources Grant P20-RR016454.	Absalon S, 2008, MOL BIOL CELL, V19, P929, DOI 10.1091/mbc.E07-08-0749; AFZELIUS BA, 1995, CELL MOTIL CYTOSKEL, V32, P95, DOI 10.1002/cm.970320204; Arts HH, 2011, J MED GENET, V48, P390, DOI 10.1136/jmg.2011.088864; Asamiziu E, 2000, DNA RES, V7, P305, DOI 10.1093/dnares/7.5.305; Asamizu E, 1999, DNA Res, V6, P369, DOI 10.1093/dnares/6.6.369; Avidor-Reiss T, 2004, CELL, V117, P527, DOI 10.1016/S0092-8674(04)00412-X; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Baker K, 2009, AM J MED GENET C, V151C, P281, DOI 10.1002/ajmg.c.30231; Baker SA, 2003, J BIOL CHEM, V278, P34211, DOI 10.1074/jbc.M300156200; Bell LR, 2006, GENETICS, V173, P1275, DOI 10.1534/genetics.106.056721; Berbari NF, 2009, CURR BIOL, V19, pR526, DOI 10.1016/j.cub.2009.05.025; Berthold P, 2002, PROTIST, V153, P401, DOI 10.1078/14344610260450136; Betleja E, 2010, CURR BIOL, V20, pR928, DOI 10.1016/j.cub.2010.09.058; Blacque OE, 2008, FRONT BIOSCI-LANDMRK, V13, P2633, DOI 10.2741/2871; Blacque OE, 2006, MOL BIOL CELL, V17, P5053, DOI 10.1091/mbc.E06-06-0571; Boesger J, 2009, EUKARYOT CELL, V8, P922, DOI 10.1128/EC.00067-09; Brazelton WJ, 2001, CURR BIOL, V11, P1591, DOI 10.1016/S0960-9822(01)00485-7; Bredrup C, 2011, AM J HUM GENET, V89, P634, DOI 10.1016/j.ajhg.2011.10.001; Brugmann SA, 2010, AM J MED GENET A, V152A, P2995, DOI 10.1002/ajmg.a.33727; Cardenas-Rodriguez M, 2009, AM J MED GENET C, V151C, P263, DOI 10.1002/ajmg.c.30227; COLE D, 2009, CHLAMYDOMONAS SOURCE, V3, P71; Cole DG, 1998, J CELL BIOL, V141, P993, DOI 10.1083/jcb.141.4.993; Cole DG, 2009, CELL, V137, P784, DOI 10.1016/j.cell.2009.04.053; Collet J, 1998, GENETICS, V148, P187; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Cortellino S, 2009, DEV BIOL, V325, P225, DOI 10.1016/j.ydbio.2008.10.020; Craige B, 2010, J CELL BIOL, V190, P927, DOI 10.1083/jcb.201006105; Das AK, 1998, EMBO J, V17, P1192, DOI 10.1093/emboj/17.5.1192; Davis EE, 2011, NAT GENET, V43, P189, DOI 10.1038/ng.756; Efimenko E, 2006, MOL BIOL CELL, V17, P4801, DOI 10.1091/mbc.E06-04-0260; Eggenschwiler JT, 2007, ANNU REV CELL DEV BI, V23, P345, DOI 10.1146/annurev.cellbio.23.090506.123249; Fan ZC, 2010, MOL BIOL CELL, V21, P2696, DOI 10.1091/mbc.E10-03-0191; Gilissen C, 2010, AM J HUM GENET, V87, P418, DOI 10.1016/j.ajhg.2010.08.004; GORMAN DS, 1965, P NATL ACAD SCI USA, V54, P1665, DOI 10.1073/pnas.54.6.1665; Haycraft CJ, 2003, EXP CELL RES, V284, P251, DOI 10.1016/S0014-4827(02)00089-7; Haycraft CJ, 2001, DEVELOPMENT, V128, P1493; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; Hou YQ, 2007, J CELL BIOL, V176, P653, DOI 10.1083/jcb.200608041; Inglis PN, 2009, METHOD CELL BIOL, V93, P267, DOI 10.1016/S0091-679X(08)93014-4; Iomini C, 2001, J CELL BIOL, V153, P13, DOI 10.1083/jcb.153.1.13; Iomini C, 2009, GENETICS, V183, P885, DOI 10.1534/genetics.109.101915; Kathir P, 2003, EUKARYOT CELL, V2, P362, DOI 10.1128/EC.2.2.362-379.2003; KOZMINSKI KG, 1995, J CELL BIOL, V131, P1517, DOI 10.1083/jcb.131.6.1517; KOZMINSKI KG, 1993, P NATL ACAD SCI USA, V90, P5519, DOI 10.1073/pnas.90.12.5519; Lechtreck KF, 2009, CELL MOTIL CYTOSKEL, V66, P469, DOI 10.1002/cm.20369; Lee E, 2008, CURR BIOL, V18, P1899, DOI 10.1016/j.cub.2008.11.020; Lee L, 2011, GENE, V473, P57, DOI 10.1016/j.gene.2010.11.006; Lucker BF, 2010, J BIOL CHEM, V285, P21508, DOI 10.1074/jbc.M110.106997; Lucker BF, 2005, J BIOL CHEM, V280, P27688, DOI 10.1074/jbc.M505062200; Marshall WF, 2008, J CELL BIOL, V180, P17, DOI 10.1083/jcb.200710085; Mill P, 2011, AM J HUM GENET, V88, P508, DOI 10.1016/j.ajhg.2011.03.015; Mukhopadhyay S, 2010, GENE DEV, V24, P2180, DOI 10.1101/gad.1966210; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Pazour GJ, 1999, J CELL BIOL, V144, P473, DOI 10.1083/jcb.144.3.473; Pazour GJ, 2005, J CELL BIOL, V170, P103, DOI 10.1083/jcb.200504008; Pazour GJ, 2002, J CELL BIOL, V157, P103, DOI 10.1083/jcb.200107108; Pazour GJ, 2000, METHODS, V22, P285, DOI 10.1006/meth.2000.1081; Pedersen LB, 2005, CURR BIOL, V15, P262, DOI 10.1016/j.cub.2005.01.037; Pedersen LB, 2008, CURR TOP DEV BIOL, V85, P23, DOI 10.1016/S0070-2153(08)00802-8; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; Pigino G, 2009, J CELL BIOL, V187, P135, DOI 10.1083/jcb.200905103; Piperno G, 1998, J CELL BIOL, V143, P1591, DOI 10.1083/jcb.143.6.1591; Piperno G, 1997, P NATL ACAD SCI USA, V94, P4457, DOI 10.1073/pnas.94.9.4457; Porter ME, 1999, MOL BIOL CELL, V10, P693, DOI 10.1091/mbc.10.3.693; Qin HM, 2004, J CELL BIOL, V164, P255, DOI 10.1083/jcb.200308132; Qin HM, 2001, CURR BIOL, V11, P457, DOI 10.1016/S0960-9822(01)00122-1; Qin HM, 2007, CURR BIOL, V17, P193, DOI 10.1016/j.cub.2006.12.040; Qin JA, 2011, P NATL ACAD SCI USA, V108, P1456, DOI 10.1073/pnas.1011410108; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Sambrook J., 2002, MOL CLONING LAB MANU; Scholey JM, 2003, ANNU REV CELL DEV BI, V19, P423, DOI 10.1146/annurev.cellbio.19.111401.091318; SCHULER GD, 1991, PROTEINS, V9, P180, DOI 10.1002/prot.340090304; SHAKIR MA, 1993, NEUROREPORT, V4, P891, DOI 10.1097/00001756-199307000-00013; Signor D, 1999, MOL BIOL CELL, V10, P345, DOI 10.1091/mbc.10.2.345; Silverman MA, 2009, TRENDS CELL BIOL, V19, P306, DOI 10.1016/j.tcb.2009.04.002; Sizova I, 2001, GENE, V277, P221, DOI 10.1016/S0378-1119(01)00616-3; Taschner M, 2011, J BIOL CHEM, V286, P26344, DOI 10.1074/jbc.M111.254920; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tran PV, 2008, NAT GENET, V40, P403, DOI 10.1038/ng.105; Tsao CC, 2008, J CELL SCI, V121, P428, DOI 10.1242/jcs.015826; Vincensini L, 2011, BIOL CELL, V103, P109, DOI 10.1042/BC20100104; Walczak-Sztulpa J, 2010, AM J HUM GENET, V86, P949, DOI 10.1016/j.ajhg.2010.04.012; WALTHER Z, 1994, J CELL BIOL, V126, P175, DOI 10.1083/jcb.126.1.175; Wang ZH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005384; WILKERSON CG, 1994, J CELL SCI, V107, P497; WITMAN GB, 1972, J CELL BIOL, V54, P507, DOI 10.1083/jcb.54.3.507; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Zhao CT, 2011, EMBO J, V30, P2532, DOI 10.1038/emboj.2011.165	88	67	69	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					11689	11703		10.1074/jbc.M111.287102	http://dx.doi.org/10.1074/jbc.M111.287102			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22170070	Green Published, hybrid			2022-12-27	WOS:000302782200009
J	Yamasaki, K; Kigawa, T; Watanabe, S; Inoue, M; Yamasaki, T; Seki, M; Shinozaki, K; Yokoyama, S				Yamasaki, Kazuhiko; Kigawa, Takanori; Watanabe, Satoru; Inoue, Makoto; Yamasaki, Tomoko; Seki, Motoaki; Shinozaki, Kazuo; Yokoyama, Shigeyuki			Structural Basis for Sequence-specific DNA Recognition by an Arabidopsis WRKY Transcription Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; BINDING PROTEINS; DOMAIN; GENES; TOBACCO; COMPLEX; DROUGHT; FAMILY; EXPRESSION; PROMOTERS	The WRKY family transcription factors regulate plant-specific reactions that are mostly related to biotic and abiotic stresses. They share the WRKY domain, which recognizes a DNA element (TTGAC(C/T)) termed the W-box, in target genes. Here, we determined the solution structure of the C-terminal WRKY domain of Arabidopsis WRKY4 in complex with the W-box DNA by NMR. A four-stranded beta-sheet enters the major groove of DNA in an atypical mode termed the beta-wedge, where the sheet is nearly perpendicular to the DNA helical axis. Residues in the conserved WRKYGQK motif contact DNA bases mainly through extensive apolar contacts with thymine methyl groups. The importance of these contacts was verified by substituting the relevant T bases with U and by surface plasmon resonance analyses of DNA binding.	[Yamasaki, Kazuhiko; Yamasaki, Tomoko] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Tsukuba, Ibaraki 3058566, Japan; [Yamasaki, Kazuhiko; Kigawa, Takanori; Watanabe, Satoru; Inoue, Makoto; Yokoyama, Shigeyuki] RIKEN, Syst & Struct Biol Ctr, Tsuzuki Ku, Yokohama, Kanagawa 2300045, Japan; [Seki, Motoaki; Shinozaki, Kazuo] RIKEN, Plant Sci Ctr, Tsuzuki Ku, Yokohama, Kanagawa 2300045, Japan; [Kigawa, Takanori] Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Dept Computat Intelligence & Syst Sci, Midori Ku, Yokohama, Kanagawa 2268503, Japan; [Yokoyama, Shigeyuki] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 1130033, Japan	National Institute of Advanced Industrial Science & Technology (AIST); RIKEN; RIKEN; Tokyo Institute of Technology; University of Tokyo	Yamasaki, K (corresponding author), AIST, 1-1-1 Higashi, Tsukuba, Ibaraki 3058566, Japan.	k-yamasaki@aist.go.jp	Shinozaki, Kazuo/AAB-4945-2019; Yokoyama, Shigeyuki/N-6911-2015; Kigawa, Takanori/A-7679-2010; Seki, Motoaki/I-2854-2012; Yamasaki, Kazuhiko/L-7108-2018; watanabe, satoru s/E-9501-2012; Shinozaki, Kazuo/G-4202-2013	Shinozaki, Kazuo/0000-0002-6317-9867; Yokoyama, Shigeyuki/0000-0003-3133-7338; Kigawa, Takanori/0000-0003-0146-9719; Seki, Motoaki/0000-0001-8288-0467; Yamasaki, Kazuhiko/0000-0003-0320-9697; watanabe, satoru s/0000-0001-5329-9278; Shinozaki, Kazuo/0000-0002-6317-9867	RIKEN Structural Genomics/Proteomics Initiative (RSGI); Ministry of Education, Culture, Sports, Science, and Technology	RIKEN Structural Genomics/Proteomics Initiative (RSGI); Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by the RIKEN Structural Genomics/Proteomics Initiative (RSGI) and the National Project on Protein Structural and Functional Analyses, Ministry of Education, Culture, Sports, Science, and Technology.	Allen MD, 1998, EMBO J, V17, P5484, DOI 10.1093/emboj/17.18.5484; Aoki M, 2009, PROTEIN EXPRES PURIF, V68, P128, DOI 10.1016/j.pep.2009.07.017; Babu MM, 2006, NUCLEIC ACIDS RES, V34, P6505, DOI 10.1093/nar/gkl888; BAX A, 1994, CURR OPIN STRUC BIOL, V4, P738, DOI 10.1016/S0959-440X(94)90173-2; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Campagne S, 2010, NUCLEIC ACIDS RES, V38, P3466, DOI 10.1093/nar/gkq053; Chen CH, 2000, PLANT MOL BIOL, V42, P387, DOI 10.1023/A:1006399311615; Ciolkowski I, 2008, PLANT MOL BIOL, V68, P81, DOI 10.1007/s11103-008-9353-1; Cohen SX, 2003, EMBO J, V22, P1835, DOI 10.1093/emboj/cdg182; dePater S, 1996, NUCLEIC ACIDS RES, V24, P4624, DOI 10.1093/nar/24.23.4624; Duan MR, 2007, NUCLEIC ACIDS RES, V35, P1145, DOI 10.1093/nar/gkm001; Ernst HA, 2004, EMBO REP, V5, P297, DOI 10.1038/sj.embor.7400093; Eulgem T, 1999, EMBO J, V18, P4689, DOI 10.1093/emboj/18.17.4689; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Hansen MR, 1998, NAT STRUCT BIOL, V5, P1065, DOI 10.1038/4176; Hara K, 2000, MOL GEN GENET, V263, P30, DOI 10.1007/PL00008673; ISHIGURO S, 1994, MOL GEN GENET, V244, P563, DOI 10.1007/BF00282746; Kigawa T, 1999, FEBS LETT, V442, P15, DOI 10.1016/S0014-5793(98)01620-2; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Maeo K, 2001, BIOSCI BIOTECH BIOCH, V65, P2428, DOI 10.1271/bbb.65.2428; Matsuda Takayoshi, 2006, Journal of Structural and Functional Genomics, V7, P93, DOI 10.1007/s10969-006-9012-1; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; PABO CO, 1992, ANNU REV BIOCHEM, V61, P1053, DOI 10.1146/annurev.bi.61.070192.005201; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pnueli L, 2002, PLANT J, V31, P319, DOI 10.1046/j.1365-313X.2002.01364.x; RAUMANN BE, 1994, NATURE, V367, P754, DOI 10.1038/367754a0; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Rizhsky L, 2002, PLANT PHYSIOL, V130, P1143, DOI 10.1104/pp.006858; Rushton PJ, 1995, PLANT MOL BIOL, V29, P691, DOI 10.1007/BF00041160; Rushton PJ, 1996, EMBO J, V15, P5690, DOI 10.1002/j.1460-2075.1996.tb00953.x; Sabogal A, 2010, NAT STRUCT MOL BIOL, V17, P117, DOI 10.1038/nsmb.1742; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; SOMERS WS, 1992, NATURE, V359, P387, DOI 10.1038/359387a0; Tjandra N, 1996, J AM CHEM SOC, V118, P6264, DOI 10.1021/ja960106n; TOLMAN JR, 1995, P NATL ACAD SCI USA, V92, P9279, DOI 10.1073/pnas.92.20.9279; Wojciak JM, 1999, NAT STRUCT BIOL, V6, P366; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Yamasaki K, 2005, PLANT CELL, V17, P944, DOI 10.1105/tpc.104.026435; Yamasaki K, 2008, PLANT PHYSIOL BIOCH, V46, P394, DOI 10.1016/j.plaphy.2007.12.015	41	65	74	3	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7683	7691		10.1074/jbc.M111.279844	http://dx.doi.org/10.1074/jbc.M111.279844			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22219184	Green Published, hybrid			2022-12-27	WOS:000301060200067
J	Alliegro, MC; Hartson, S; Alliegro, MA				Alliegro, Mark C.; Hartson, Steven; Alliegro, Mary Anne			Composition and Dynamics of the Nucleolinus, a Link between the Nucleolus and Cell Division Apparatus in Surf Clam (Spisula) Oocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOPROTEINS; INACTIVATION; PROTEINS	The nucleolinus is a little-known cellular structure, discovered over 150 years ago (Agassiz, L. (1857) Contributions to the Natural History of the United States of America, First Monograph, Part IIL, Little, Brown and Co., Boston) and thought by some investigators in the late 19th to mid-20th century to function in the formation of the centrosomes or spindle. A role for the nucleolinus in formation of the cell division apparatus has recently been confirmed in oocytes of the surf clam, Spisula solidissima (Alliegro, M. A., Henry, J. J., and Alliegro, M. C. (2010) Proc. Natl. Acad. Sci. U.S.A. 107, 13718-13723). However, we know so little about the composition and dynamics of this compartment, it is difficult to construct mechanistic hypotheses or even to be sure that prior reports were describing analogous structures in the cells of mammals, amphibians, plants, and other organisms where it was observed. Surf clam oocytes are an attractive model to approach this problem because the nucleolinus is easily visible by light microscopy, making it accessible by laser microsurgery as well as isolation by common cell fractionation techniques. In this report, we analyze the macromolecular composition of isolated Spisula nucleolini and examine the relationship of this structure to the nucleolus and cell division apparatus. Analysis of nucleolinar RNA and protein revealed a set of molecules that overlaps with but is nevertheless distinct from the nucleolus. The proteins identified were primarily ones involved in nucleic acid metabolism and cell cycle regulation. Monoclonal antibodies generated against isolated nucleolini revealed centrosomal forerunners in the oocyte cytoplasm. Finally, induction of damage to the nucleolinus by laser microsurgery altered the trafficking of alpha- and gamma-tubulin after fertilization. These observations strongly support a role for the nucleolinus in cell division and represent our first clues regarding mechanism.	[Alliegro, Mark C.; Alliegro, Mary Anne] Josephine Bay Paul Ctr Comparat Mol Biol & Evolut, Marine Biol Lab, Woods Hole, MA 02543 USA; [Hartson, Steven] Oklahoma State Univ, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA	Marine Biological Laboratory - Woods Hole; Oklahoma State University System; Oklahoma State University - Stillwater	Alliegro, MC (corresponding author), Josephine Bay Paul Ctr, Marine Biol Lab, 7 MBL St, Woods Hole, MA 02543 USA.	malliegro@mbl.edu			National Institutes of Health [GM088503]; National Science Foundation [0722494]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088503] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM088503 (to M. C. A.).; We are indebted to Lily Reed, Alex Ziolkowski, and Hamilton Thorne Biosciences for the loan of a XYClone laser system, without which functional studies would not have been possible. Mass spectrometry analyses were performed in the DNA/Protein Resource Facility at Oklahoma State University, using resources supported by the National Science Foundation Major Research Instrumentation and Experimental Program to Stimulate Competitive Research (EPSCoR) programs (Award 0722494 to Steven D. Hartsan).	Agassiz L., 1857, CONTRIBUTIONS NATURA; Alberts B, 2008, MOL BIOL CELL; ALLEN RD, 1951, BIOL BULL, V101, P214; ALLEN RD, 1953, BIOL BULL, V105, P213, DOI 10.2307/1538639; Alliegro M C, 1997, Exp Cell Res, V231, P386; Alliegro MC, 2008, P NATL ACAD SCI USA, V105, P6993, DOI 10.1073/pnas.0802293105; Alliegro Mark C, 2011, Commun Integr Biol, V4, P147, DOI 10.4161/cib.4.2.14545; Alliegro MA, 2010, P NATL ACAD SCI USA, V107, P13718, DOI 10.1073/pnas.1008469107; Caileton HM, 1920, Q J MICROSC SCI, V64, P329; Fenn S, 2011, EMBO J, V30, P2153, DOI 10.1038/emboj.2011.118; Gates RR, 1942, BIOL BULL-US, V82, P47, DOI 10.2307/1537935; GAULDEN ME, 1958, P NATL ACAD SCI USA, V44, P553, DOI 10.1073/pnas.44.6.553; Goyal P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016249; Hofmann WA, 2009, INT REV CEL MOL BIO, V273, P219, DOI 10.1016/S1937-6448(08)01806-6; Huen J, 2010, BIOCHEM CELL BIOL, V88, P29, DOI [10.1139/o09-122, 10.1139/O09-122]; Hutten S, 2011, CHROMOSOMA, V120, P481, DOI 10.1007/s00412-011-0327-8; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; LAANE M M, 1974, Norwegian Journal of Botany, V21, P309; Lavdowsky M, 1894, ZELLEN MERKEL BONNEF, V4, P13; LOVE R, 1963, J CELL BIOL, V17, P237, DOI 10.1083/jcb.17.2.237; LOVE R, 1970, CANCER RES, V30, P990; LOVE R, 1959, J HISTOCHEM CYTOCHEM, V7, P164, DOI 10.1177/7.3.164; LOVE R, 1959, NATURE, V183, P1453, DOI 10.1038/1831453a0; MAUL GG, 1980, EXP CELL RES, V130, P229, DOI 10.1016/0014-4827(80)90059-2; MIRONESCU S, 1968, JNCI-J NATL CANCER I, V40, P917; Montgomery T. S. H., 1898, J MORPHOL, V15, P265, DOI DOI 10.1002/JMOR.1050150204; Ove R, 1966, Natl Cancer Inst Monogr, V23, P167; PALAZZO RE, 1992, SCIENCE, V256, P219, DOI 10.1126/science.1566068; Pederson T, 2011, COLD SPRING HARB PER, V3, P1; Politz JCR, 2009, RNA, V15, P1705, DOI 10.1261/rna.1470409; Pollock C, 2009, J CELL BIOCHEM, V107, P189, DOI 10.1002/jcb.22107; TANAKA K, 1973, J CELL BIOL, V57, P220, DOI 10.1083/jcb.57.1.220; Ugrinova I, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-66; Weber JD, 1999, NAT CELL BIOL, V1, P20, DOI 10.1038/8991	34	7	7	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6702	6713		10.1074/jbc.M111.288506	http://dx.doi.org/10.1074/jbc.M111.288506			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22219192	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000300791800056
J	Obianyo, O; Thompson, PR				Obianyo, Obiamaka; Thompson, Paul R.			Kinetic Mechanism of Protein Arginine Methyltransferase 6 (PRMT6)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-SPECIFICITY; METHYLATION; INHIBITOR; PATHWAY; CARM1	The protein arginine methyltransferases (PRMTs) are a family of enzymes that catalyze the mono- and dimethylation of arginine residues in a variety of proteins. Although these enzymes play important roles in a variety of cellular processes, aberrant PRMT activity is associated with several disease states, including heart disease and cancer. In an effort to guide the development of inhibitors targeting individual PRMTs, we initiated studies to characterize the molecular mechanisms of PRMT catalysis. Herein, we report studies on the kinetic mechanism of PRMT6. Initial velocity, product inhibition, and dead-end analog inhibition studies with the AcH4-21 and R1 peptides, as well as their monomethylated versions, indicate, in contrast to a previous report, that PRMT6 utilizes a rapid equilibrium random mechanism with dead-end EAP and EBQ complexes.	[Obianyo, Obiamaka; Thompson, Paul R.] Scripps Res Inst, Dept Chem, Jupiter, FL 33458 USA	Scripps Research Institute	Thompson, PR (corresponding author), Scripps Res Inst, Dept Chem, 130 Scripps Way, Jupiter, FL 33458 USA.	pthompso@scripps.edu			The Scripps Research Institute, Scripps Florida	The Scripps Research Institute, Scripps Florida	This work was supported by The Scripps Research Institute, Scripps Florida.	Bedford MT, 2007, J CELL SCI, V120, P4243, DOI 10.1242/jcs.019885; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Chumanevich AA, 2011, AM J PHYSIOL-GASTR L, V300, pG929, DOI 10.1152/ajpgi.00435.2010; El-Andaloussi N, 2006, MOL CELL, V22, P51, DOI 10.1016/j.molcel.2006.02.013; Hassa PO, 2008, J MOL BIOL, V377, P668, DOI 10.1016/j.jmb.2008.01.044; Hyllus D, 2007, GENE DEV, V21, P3369, DOI 10.1101/gad.447007; Jones JE, 2009, CURR OPIN DRUG DISC, V12, P616; Krause CD, 2007, PHARMACOL THERAPEUT, V113, P50, DOI 10.1016/j.pharmthera.2006.06.007; Lakowski TM, 2008, J BIOL CHEM, V283, P10015, DOI 10.1074/jbc.M710176200; Lakowski TM, 2010, ACS CHEM BIOL, V5, P1053, DOI 10.1021/cb100161u; Le Romancer M, 2008, MOL CELL, V31, P212, DOI 10.1016/j.molcel.2008.05.025; Leatherbarrow R. J., 2004, GRAFIT VERSION 5 0; Leiper J, 2007, NAT MED, V13, P198, DOI 10.1038/nm1543; Marks PA, 2007, NAT BIOTECHNOL, V25, P84, DOI 10.1038/nbt1272; McBride AE, 2001, CELL, V106, P5, DOI 10.1016/S0092-8674(01)00423-8; Michaud-Levesque J, 2009, J BIOL CHEM, V284, P21338, DOI 10.1074/jbc.M109.005322; Miranda TB, 2004, J BIOL CHEM, V279, P22902, DOI 10.1074/jbc.M312904200; Obianyo O, 2008, BIOCHEMISTRY-US, V47, P10420, DOI 10.1021/bi800904m; Obianyo O, 2010, CHEMBIOCHEM, V11, P1219, DOI 10.1002/cbic.201000209; Osborne TC, 2007, BIOCHEMISTRY-US, V46, P13370, DOI 10.1021/bi701558t; Rust HL, 2011, BIOCHEMISTRY-US, V50, P3332, DOI 10.1021/bi102022e; Sack JS, 2011, BIOCHEM J, V436, P331, DOI 10.1042/BJ20102161; Tang J, 1998, J BIOL CHEM, V273, P16935, DOI 10.1074/jbc.273.27.16935; Tang J, 2000, J BIOL CHEM, V275, P7723, DOI 10.1074/jbc.275.11.7723; Torres-Padilla ME, 2007, NATURE, V445, P214, DOI 10.1038/nature05458; Tran CTL, 2003, ATHEROSCLEROSIS SUPP, V4, P33, DOI 10.1016/S1567-5688(03)00032-1; Vallance P, 2004, ARTERIOSCL THROM VAS, V24, P1023, DOI 10.1161/01.ATV.0000128897.54893.26; VALLANCE P, 1992, LANCET, V339, P572; Willis V, 2011, J IMMUNOL, V186, P4396, DOI 10.4049/jimmunol.1001620; Yoshimatsu M, 2011, INT J CANCER, V128, P562, DOI 10.1002/ijc.25366	30	33	33	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					6062	6071		10.1074/jbc.M111.333609	http://dx.doi.org/10.1074/jbc.M111.333609			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22219200	hybrid, Green Published			2022-12-27	WOS:000300638000079
J	Qiao, DH; Meyer, K; Friedl, A				Qiao, Dianhua; Meyer, Kristy; Friedl, Andreas			Glypican-1 Stimulates Skp2 Autoinduction Loop and G(1)/S Transition in Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANAPHASE PROMOTING COMPLEX/CYCLOSOME; TGF-BETA; CYCLIN D1; C-MYC; CDK INHIBITORS; GROWTH; CANCER; ANGIOGENESIS; DEGRADATION; MECHANISMS	The heparan sulfate proteoglycan glypican-1 (GPC1) is involved in tumorigenesis and angiogenesis and is overexpressed frequently in tumor and endothelial cells (ECs) in human gliomas. We demonstrated previously that in brain EC, GPC1 regulates mitotic cyclins and securin as well as mitosis and that GPC1 is required for progression through the cell cycle. To characterize the molecular mechanism underlying cell cycle regulation by GPC1, we systematically investigated its effects on key G(1)/S checkpoint regulators and on major signaling pathways reportedly activated by Dally (Division abnormally delayed) the Drosophila GPC1 homologue. We found that elevated GPC1 affected a wide range of G(1)/S checkpoint regulators, leading to inactivation of the G(1)/S checkpoint and increased S phase entry, apparently by activating the mitogen-independent Skp2 autoinduction loop. Specifically, GPC1 suppressed CDK inhibitors (CKIs), including p21, p27, p16, and p19, and the D cyclins, and induced CDK2 and Skp2. GPC1 may trigger the Skp2 autoinduction loop at least partially by suppressing p21 transcription as knockdown of p21 by RNAi can mimic the effect of GPC1 on the cell cycle regulators related to the loop. Moreover, multiple mitogenic signaling pathways, including ERK MAPK, Wnt and BMP signaling, were significantly stimulated by GPC1 as has been reported for Dally in Drosophila. Notably, the c-Myc oncoprotein, which is frequently up-regulated by both ERK and Wnt signaling and functions as a potent transcription repressor for CKIs as well as D cyclins, was also significantly induced by GPC1. These findings provide mechanistic insights into how GPC1 regulates the cell cycle and proliferation.	[Qiao, Dianhua; Meyer, Kristy; Friedl, Andreas] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53705 USA; [Friedl, Andreas] William S Middleton Mem Vet Adm Med Ctr, Pathol & Lab Med Serv, Dept Vet Affairs Med Ctr, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital	Friedl, A (corresponding author), WIMR Room 6051,1111 Highland Ave, Madison, WI 53705 USA.	afriedl@wisc.edu						Aikawa T, 2008, J CLIN INVEST, V118, P89, DOI 10.1172/JCI32412; Alao JP, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-24; Assoian RK, 2008, CELL CYCLE, V7, P24, DOI 10.4161/cc.7.1.5232; Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; Bornstein G, 2003, J BIOL CHEM, V278, P25752, DOI 10.1074/jbc.M301774200; Candia AF, 1997, DEVELOPMENT, V124, P4467; Canepa ET, 2007, IUBMB LIFE, V59, P419, DOI 10.1080/15216540701488358; Castro A, 2005, ONCOGENE, V24, P314, DOI 10.1038/sj.onc.1207973; Dimova DK, 2005, ONCOGENE, V24, P2810, DOI 10.1038/sj.onc.1208612; Eto I, 2000, CELL PROLIFERAT, V33, P167, DOI 10.1046/j.1365-2184.2000.00176.x; Fico A, 2011, CELL MOL LIFE SCI, V68, P923, DOI 10.1007/s00018-007-7471-6; Filmus J, 2001, J CLIN INVEST, V108, P497, DOI 10.1172/JCI13712; Filmus J, 2001, GLYCOBIOLOGY, V11, p19R, DOI 10.1093/glycob/11.3.19R; Filmus J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-224; Gartel AL, 2003, EXP CELL RES, V283, P17, DOI 10.1016/S0014-4827(02)00020-4; Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995; Giacinti C, 2006, ONCOGENE, V25, P5220, DOI 10.1038/sj.onc.1209615; Gil J, 2006, NAT REV MOL CELL BIO, V7, P667, DOI 10.1038/nrm1987; Ivanchuk SM, 2004, NEUROSURGERY, V54, P692, DOI 10.1227/01.NEU.0000109534.28063.5D; Jackson SM, 1997, DEVELOPMENT, V124, P4113; Jain RK, 2007, NAT REV NEUROSCI, V8, P610, DOI 10.1038/nrn2175; Jen YHLD, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-33; Kargiotis O, 2006, J NEURO-ONCOL, V78, P281, DOI 10.1007/s11060-005-9097-6; Kleeff J, 1999, PANCREAS, V19, P281, DOI 10.1097/00006676-199910000-00009; Langley RR, 2003, CANCER RES, V63, P2971; Litwack ED, 1998, DEV DYNAM, V211, P72, DOI 10.1002/(SICI)1097-0177(199801)211:1<72::AID-AJA7>3.3.CO;2-8; Massague J, 2004, NATURE, V432, P298, DOI 10.1038/nature03094; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Matsuda K, 2001, CANCER RES, V61, P5562; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; PHILIPP A, 1994, MOL CELL BIOL, V14, P4032, DOI 10.1128/MCB.14.6.4032; Qiao DH, 2003, J BIOL CHEM, V278, P16045, DOI 10.1074/jbc.M211259200; Qiao DH, 2008, MOL BIOL CELL, V19, P2789, DOI 10.1091/mbc.E07-10-1025; Sears RC, 2004, CELL CYCLE, V3, P1133, DOI 10.4161/cc.3.9.1145; Seoane J, 2001, NAT CELL BIOL, V3, P400, DOI 10.1038/35070086; Shirako E, 2008, J CELL BIOCHEM, V104, P176, DOI 10.1002/jcb.21614; Sikder HA, 2003, CANCER CELL, V3, P525, DOI 10.1016/S1535-6108(03)00141-7; Su G, 2006, AM J PATHOL, V168, P2014, DOI 10.2353/ajpath.2006.050800; Sutterluty H, 1999, NAT CELL BIOL, V1, P207, DOI 10.1038/12027; Tabu K, 2006, J CELL SCI, V119, P1433, DOI 10.1242/jcs.02854; Tsou MFB, 2006, CURR OPIN CELL BIOL, V18, P74, DOI 10.1016/j.ceb.2005.12.008; Tsuda M, 1999, NATURE, V400, P276, DOI 10.1038/22336; Vidal A, 2000, GENE, V247, P1, DOI 10.1016/S0378-1119(00)00092-5; Vodermaier HC, 2004, CURR BIOL, V14, pR787, DOI 10.1016/j.cub.2004.09.020; Wang ZY, 1999, BLOOD, V93, P4208, DOI 10.1182/blood.V93.12.4208.412k17_4208_4221; Warner BJ, 1999, MOL CELL BIOL, V19, P5913; Wasch R, 2005, ONCOGENE, V24, P1, DOI 10.1038/sj.onc.1208017; Wierstra I, 2008, ADV CANCER RES, V99, P113, DOI 10.1016/S0065-230X(07)99004-1; Yan D, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002493; Yung Y, 2007, J CELL BIOL, V178, P741, DOI 10.1083/jcb.200703034	50	18	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5898	5909		10.1074/jbc.M111.325282	http://dx.doi.org/10.1074/jbc.M111.325282			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22203671	Green Published, hybrid			2022-12-27	WOS:000300638000064
J	Li, Y; Wu, J; Song, F; Tang, J; Wang, SJ; Yu, XL; Chen, ZN; Jiang, JL				Li, Yong; Wu, Jiao; Song, Fei; Tang, Juan; Wang, Shi-Jie; Yu, Xiao-Ling; Chen, Zhi-Nan; Jiang, Jian-Li			Extracellular Membrane-proximal Domain of HAb18G/CD147 Binds to Metal Ion-dependent Adhesion Site (MIDAS) Motif of Integrin beta 1 to Modulate Malignant Properties of Hepatoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCELLULAR-CARCINOMA; CRYSTAL-STRUCTURE; ADENOVIRAL VECTORS; GENE-TRANSFER; GROWTH; CANCER; ALPHA-V-BETA-3; METASTASIS; RECEPTOR; INVOLVEMENT	Several lines of evidence suggest that HAb18G/CD147 interacts with the integrin variants alpha 3 beta 1 and alpha 6 beta 1. However, the mechanism of the interaction remains largely unknown. In this study, mammalian protein-protein interaction trap (MAPPIT), a mammalian two-hybrid method, was used to study the CD147-integrin beta 1 subunit interaction. CD147 in human hepatocellular carcinoma (HCC) cells was interfered with by small hairpin RNA. Nude mouse xenograft model and metastatic model of HCC were used to detect the role of CD147 in carcinogenesis and metastasis. We found that the extracellular membrane-proximal domain of HAb18G/CD147 (I-type domain) binds at the metal ion-dependent adhesion site in the beta A domain of the integrin beta 1 subunit, and Asp(179) in the I-type domain of HAb18G/CD147 plays an important role in the interaction. The levels of the proteins that act downstream of integrin, including focal adhesion kinase (FAK) and phospho-FAK, were decreased, and the cytoskeletal structures of HCC cells were rearranged bearing the HAb18G/CD147 deletion. Simultaneously, the migration and invasion capacities, secretion of matrix metalloproteinases, colony formation rate in vitro, and tumor growth and metastatic potential in vivo were decreased. These results indicate that the interaction of HAb18G/CD147 extracellular I-type domain with the integrin beta 1 metal ion-dependent adhesion site motif activates the downstream FAK signaling pathway, subsequently enhancing the malignant properties of HCC cells.	[Li, Yong; Wu, Jiao; Song, Fei; Tang, Juan; Wang, Shi-Jie; Yu, Xiao-Ling; Chen, Zhi-Nan; Jiang, Jian-Li] Fourth Mil Med Univ, Cell Engn Res Ctr, State Key Lab Canc Biol, Dept Cell Biol, Xian 710032, Peoples R China	Air Force Military Medical University	Chen, ZN (corresponding author), Fourth Mil Med Univ, Cell Engn Res Ctr, State Key Lab Canc Biol, Dept Cell Biol, Xian 710032, Peoples R China.	znchen@fmmu.edu.cn; jiangjl@fmmu.edu.cn	YU, Xiaoling/M-8815-2018	YU, Xiaoling/0000-0001-6035-3906; Chen, Zhi-Nan/0000-0001-5512-4623	National Basic Research Program of China [2009CB521704]; National Science and Technology Major Project [2011ZX09102-001-21, 2012ZX10002017-002]; National Natural Science Foundation of China [81071691, 30970564, 81030058]	National Basic Research Program of China(National Basic Research Program of China); National Science and Technology Major Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China Grant 2009CB521704, National Science and Technology Major Project Grants 2011ZX09102-001-21 and 2012ZX10002017-002, and National Natural Science Foundation of China Grants 81071691, 30970564, and 81030058.	Arnaout MA, 2002, IMMUNOL REV, V186, P125, DOI 10.1034/j.1600-065X.2002.18612.x; Arnaout MA, 2002, CURR OPIN CELL BIOL, V14, P641, DOI 10.1016/S0955-0674(02)00371-X; Berditchevski F, 1997, J BIOL CHEM, V272, P29174, DOI 10.1074/jbc.272.46.29174; Carragher NO, 2004, TRENDS CELL BIOL, V14, P241, DOI 10.1016/j.tcb.2004.03.011; Chen LL, 1998, BIOCHEMISTRY-US, V37, P8743, DOI 10.1021/bi980311a; Chen ZN, 2006, INT J RADIAT ONCOL, V65, P435, DOI 10.1016/j.ijrobp.2005.12.034; Cho JY, 2001, BLOOD, V98, P374, DOI 10.1182/blood.V98.2.374; Curtin KD, 2005, J CELL SCI, V118, P2649, DOI 10.1242/jcs.02408; Dai JY, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-337; Eyckerman S, 2001, NAT CELL BIOL, V3, P1114, DOI 10.1038/ncb1201-1114; Fadool JM, 1996, BIOCHEM BIOPH RES CO, V229, P280, DOI 10.1006/bbrc.1996.1793; Grill J, 2001, CLIN CANCER RES, V7, P641; Iacono KT, 2007, EXP MOL PATHOL, V83, P283, DOI 10.1016/j.yexmp.2007.08.014; Jiang JL, 2001, J BIOL CHEM, V276, P46870, DOI 10.1074/jbc.M108291200; Li PC, 2010, MOL THER, V18, P921, DOI 10.1038/mt.2010.5; Liu S, 2009, BIOCONJUGATE CHEM, V20, P2199, DOI 10.1021/bc900167c; Moreno-Manzano V, 2000, BIOCHEM BIOPH RES CO, V277, P293, DOI 10.1006/bbrc.2000.3654; Mould AP, 2002, J BIOL CHEM, V277, P19800, DOI 10.1074/jbc.M201571200; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; Tang J, 2008, CELL MOL LIFE SCI, V65, P2933, DOI 10.1007/s00018-008-8315-8; Ulrichts P, 2010, J CELL SCI, V123, P256, DOI 10.1242/jcs.056002; Wesseling JG, 2001, GENE THER, V8, P969, DOI 10.1038/sj.gt.3301473; Witlox AM, 2004, CLIN CANCER RES, V10, P61, DOI 10.1158/1078-0432.CCR-0609-03; Wu H, 2004, GENE THER, V11, P874, DOI 10.1038/sj.gt.3302249; Xiao WW, 2010, MOL CANCER THER, V9, P2714, DOI 10.1158/1535-7163.MCT-10-0308; Xiong JP, 2009, J CELL BIOL, V186, P589, DOI 10.1083/jcb.200905085; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Xu HY, 2007, CANCER LETT, V247, P336, DOI 10.1016/j.canlet.2006.05.017; Xu J, 2007, MOL CANCER RES, V5, P605, DOI 10.1158/1541-7786.MCR-06-0286; Xu J, 2007, HEPATOLOGY, V45, P269, DOI 10.1002/hep.21465; Yong KT, 2010, PANCREATOLOGY, V10, P553, DOI 10.1159/000283577; Yu XL, 2008, J BIOL CHEM, V283, P18056, DOI 10.1074/jbc.M802694200; Zhao P, 2011, HEPATOLOGY, V54, P2012, DOI 10.1002/hep.24592	34	56	60	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4759	4772		10.1074/jbc.M111.277699	http://dx.doi.org/10.1074/jbc.M111.277699			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22130661	hybrid, Green Published			2022-12-27	WOS:000300608500037
J	Rai, V; Maldonado, AY; Burz, DS; Reverdatto, S; Schmidt, AM; Shekhtman, A				Rai, Vivek; Maldonado, Andres Y.; Burz, David S.; Reverdatto, Sergey; Schmidt, Ann Marie; Shekhtman, Alexander			Signal Transduction in Receptor for Advanced Glycation End Products (RAGE) SOLUTION STRUCTURE OF C-TERMINAL RAGE (ctRAGE) AND ITS BINDING TO mDia1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURFACE RECEPTOR; PROTEIN; ACTIVATION; DOMAIN; RECOGNITION; LIGAND; RHO; CLASSIFICATION; IDENTIFICATION; INHIBITION	The receptor for advanced glycation end products (RAGE) is a multiligand cell surface macromolecule that plays a central role in the etiology of diabetes complications, inflammation, and neurodegeneration. The cytoplasmic domain of RAGE (C-terminal RAGE; ctRAGE) is critical for RAGE-dependent signal transduction. As the most membrane-proximal event, mDia1 binds to ctRAGE, and it is essential for RAGE ligand-stimulated phosphorylation of AKT and cell proliferation/migration. We show that ctRAGE contains an unusual alpha-turn that mediates the mDia1-ctRAGE interaction and is required for RAGE-dependent signaling. The results establish a novel mechanism through which an extracellular signal initiated by RAGE ligands regulates RAGE signaling in a manner requiring mDia1.	[Maldonado, Andres Y.; Burz, David S.; Reverdatto, Sergey; Shekhtman, Alexander] SUNY Albany, Dept Chem, Albany, NY 12222 USA; [Rai, Vivek; Schmidt, Ann Marie] NYU, Med Ctr, New York, NY 10016 USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany; New York University	Shekhtman, A (corresponding author), SUNY Albany, Dept Chem, Albany, NY 12222 USA.	ashekhta@albany.edu		Shekhtman, Alexander/0000-0003-2649-2675	National Institutes of Health [R01 GM085006-01A2]; American Diabetes Association [1-06-CD-23]; Juvenile Diabetes Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085006] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM085006-01A2. This work was also supported by American Diabetes Association Grant 1-06-CD-23 and the Juvenile Diabetes Research Foundation.	Alberts AS, 2001, J BIOL CHEM, V276, P2824, DOI 10.1074/jbc.M006205200; Alexandrov A, 2001, BIOTECHNIQUES, V30, P1194, DOI 10.2144/01306bm01; Alvarez Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007867; Anderson JS, 2008, BIOCHEMISTRY-US, V47, P6178, DOI 10.1021/bi800284y; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; Barbar E, 2001, BIOCHEMISTRY-US, V40, P9734, DOI 10.1021/bi010483z; Cavanagh J., 1996, PROTEIN NMR SPECTROS, P457; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Dattilo BM, 2007, BIOCHEMISTRY-US, V46, P6957, DOI 10.1021/bi7003735; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Fogh Rasmus, 2002, Nature Structural Biology, V9, P416, DOI 10.1038/nsb0602-416; Fushman D, 1997, J MOL BIOL, V266, P173, DOI 10.1006/jmbi.1996.0771; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Harja E, 2008, J CLIN INVEST, V118, P183, DOI 10.1172/JCI32703; He M, 2011, EMBO REP, V12, P358, DOI 10.1038/embor.2011.28; Higashida C, 2004, SCIENCE, V303, P2007, DOI 10.1126/science.1093923; Higgs HN, 2005, TRENDS BIOCHEM SCI, V30, P342, DOI 10.1016/j.tibs.2005.04.014; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; Hori O, 1996, NEPHROL DIAL TRANSPL, V11, P13; Hudson BI, 2008, FASEB J, V22, P1572, DOI 10.1096/fj.07-9909com; Hudson BI, 2008, J BIOL CHEM, V283, P34457, DOI 10.1074/jbc.M801465200; Koch M, 2010, STRUCTURE, V18, P1342, DOI 10.1016/j.str.2010.05.017; Lammers M, 2005, EMBO J, V24, P4176, DOI 10.1038/sj.emboj.7600879; Lander HM, 1997, J BIOL CHEM, V272, P17810, DOI 10.1074/jbc.272.28.17810; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Masse JE, 2005, J MAGN RESON, V174, P133, DOI 10.1016/j.jmr.2005.01.017; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Nezami AG, 2006, STRUCTURE, V14, P257, DOI 10.1016/j.str.2005.12.003; Ostendorp T, 2007, EMBO J, V26, P3868, DOI 10.1038/sj.emboj.7601805; Otomo T, 2005, NATURE, V433, P488, DOI 10.1038/nature03251; Otomo T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012896; Pavone V, 1996, BIOPOLYMERS, V38, P705, DOI 10.1002/(SICI)1097-0282(199606)38:6<705::AID-BIP3>3.3.CO;2-O; RODER H, 1985, BIOCHEMISTRY-US, V24, P7396, DOI 10.1021/bi00346a055; Rong LL, 2004, FASEB J, V18, P1818, DOI 10.1096/fj.04-1900com; Rose R, 2005, NATURE, V435, P513, DOI 10.1038/nature03604; ROSS R, 1977, AM J PATHOL, V86, P675; Sakaguchi T, 2003, J CLIN INVEST, V111, P959, DOI 10.1172/JCI200317115; SANDERS CR, 1990, BIOPHYS J, V58, P447, DOI 10.1016/S0006-3495(90)82390-0; Schmidt AM, 1999, CIRC RES, V84, P489, DOI 10.1161/01.RES.84.5.489; Shimada A, 2004, MOL CELL, V13, P511, DOI 10.1016/S1097-2765(04)00059-0; SKELTON NJ, 1993, J MAGN RESON SER B, V102, P253, DOI 10.1006/jmrb.1993.1095; STALEY JP, 1994, PROTEIN SCI, V3, P1822, DOI 10.1002/pro.5560031021; Taguchi A, 2000, NATURE, V405, P354, DOI 10.1038/35012626; TONIOLO C, 1980, CRC CR REV BIOCH MOL, V9, P1, DOI 10.3109/10409238009105471; Wallar BJ, 2003, TRENDS CELL BIOL, V13, P435, DOI 10.1016/S0962-8924(03)00153-3; Watanabe N, 1997, EMBO J, V16, P3044, DOI 10.1093/emboj/16.11.3044; Wuthrich K., 1986, NMR PROTEINS NUCL AC, P6; Xie JJ, 2008, J BIOL CHEM, V283, P27255, DOI 10.1074/jbc.M801622200; Xie J, 2007, J BIOL CHEM, V282, P4218, DOI 10.1074/jbc.M608888200; Xue J, 2011, STRUCTURE, V19, P722, DOI 10.1016/j.str.2011.02.013; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; ZANOTTI G, 1992, INT J PEPT PROT RES, V40, P551; Zanotti G, 1998, J PEPT RES, V51, P460; Zong HL, 2010, J BIOL CHEM, V285, P23135, DOI 10.1074/jbc.M110.133827; Zuiderweg ERP, 2002, BIOCHEMISTRY-US, V41, P1, DOI 10.1021/bi011870b	55	81	84	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					5133	5144		10.1074/jbc.M111.277731	http://dx.doi.org/10.1074/jbc.M111.277731			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22194616	Green Published, hybrid			2022-12-27	WOS:000300608500071
J	Gortat, A; San-Roman, MJ; Vannier, C; Schmidt, AA				Gortat, Anna; San-Roman, Mabel Jouve; Vannier, Christian; Schmidt, Anne A.			Single Point Mutation in Bin/Amphiphysin/Rvs (BAR) Sequence of Endophilin Impairs Dimerization, Membrane Shaping, and Src Homology 3 Domain-mediated Partnership	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNAPTIC VESICLE ENDOCYTOSIS; CENTRAL-NERVOUS-SYSTEM; SH3 DOMAIN; AMPHIPATHIC HELICES; CONTAINING PROTEINS; STRUCTURAL BASIS; CURVATURE; SYNAPTOJANIN; AMPHIPHYSIN; MECHANISM	Bin/Amphiphysin/Rvs ( BAR) domain-containing proteins are essential players in the dynamics of intracellular compartments. The BAR domain is an evolutionarily conserved dimeric module characterized by a crescent-shaped structure whose intrinsic curvature, flexibility, and ability to assemble into highly ordered oligomers contribute to inducing the curvature of target membranes. Endophilins, diverging into A and B subgroups, are BAR and SH3 domain-containing proteins. They exert activities in membrane dynamic processes such as endocytosis, autophagy, mitochondrial dynamics, and permeabilization during apoptosis. Here, we report on the involvement of the third alpha-helix of the endophilin A BAR sequence in dimerization and identify leucine 215 as a key residue within a network of hydrophobic interactions stabilizing the entire BAR dimer interface. With the combination of N-terminal truncation retaining the high dimerization capacity of the third alpha-helices of endophilin A and leucine 215 substitution by aspartate (L215D), we demonstrate the essential role of BAR sequence-mediated dimerization on SH3 domain partnership. In comparison with wild type, full-length endophilin A2 heterodimers with one protomer bearing the L215D substitution exhibit very significant changes in membrane binding and shaping activities as well as a dramatic decrease of SH3 domain partnership. This suggests that subtle changes in the conformation and/or rigidity of the BAR domain impact both the control of membrane curvature and downstream binding to effectors. Finally, we show that expression, in mammalian cells, of endophilin A2 bearing the L215D substitution impairs the endocytic recycling of transferrin receptors.	[Gortat, Anna; San-Roman, Mabel Jouve; Vannier, Christian; Schmidt, Anne A.] Univ Paris Diderot, CNRS, UMR7592, Inst Jacques Monod, F-75205 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Schmidt, AA (corresponding author), Univ Paris Diderot, CNRS, UMR7592, Inst Jacques Monod, Batiment Buffon,15 Rue Helene Brion, F-75205 Paris, France.	schmidt.anne@ijm.univ-paris-diderot.fr		Schmidt, Anne/0000-0002-8326-0937; Jouve San Roman, Mabel Juana/0000-0002-3115-4681	CNRS; French Ministry of Research [ACI BCMS 2004 2 421]; Charities Association pour la Recherche sur le Cancer; La Ligue Nationale Contre le Cancer, Comite de Paris	CNRS(Centre National de la Recherche Scientifique (CNRS)); French Ministry of Research(Ministry of Research, FranceEuropean Commission); Charities Association pour la Recherche sur le Cancer; La Ligue Nationale Contre le Cancer, Comite de Paris	This work was supported in part by CNRS, by Grant ACI BCMS 2004 2 421 from the French Ministry of Research, and by grants from the Charities Association pour la Recherche sur le Cancer and La Ligue Nationale Contre le Cancer, Comite de Paris.	Bhatia VK, 2009, EMBO J, V28, P3303, DOI 10.1038/emboj.2009.261; Cestra G, 1999, J BIOL CHEM, V274, P32001, DOI 10.1074/jbc.274.45.32001; Childress C, 2006, BIOCHEM J, V394, P693, DOI 10.1042/BJ20050576; Cuddeback SM, 2001, J BIOL CHEM, V276, P20559, DOI 10.1074/jbc.M101527200; deHeuvel E, 1997, J BIOL CHEM, V272, P8710, DOI 10.1074/jbc.272.13.8710; Etxebarria A, 2009, J BIOL CHEM, V284, P4200, DOI 10.1074/jbc.M808050200; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Frost A, 2008, CELL, V132, P807, DOI 10.1016/j.cell.2007.12.041; Frost A, 2009, CELL, V137, P191, DOI 10.1016/j.cell.2009.04.010; Gad H, 2000, NEURON, V27, P301, DOI 10.1016/S0896-6273(00)00038-6; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; Giachino C, 1997, GENOMICS, V41, P427, DOI 10.1006/geno.1997.4645; Guichet A, 2002, EMBO J, V21, P1661, DOI 10.1093/emboj/21.7.1661; Howard L, 1999, J BIOL CHEM, V274, P31693, DOI 10.1074/jbc.274.44.31693; Huttner WB, 2000, CURR OPIN NEUROBIOL, V10, P543, DOI 10.1016/S0959-4388(00)00126-4; Jao CC, 2010, J BIOL CHEM, V285, P20164, DOI 10.1074/jbc.M110.127811; Karbowski M, 2004, J CELL BIOL, V166, P1027, DOI 10.1083/jcb.200407046; Kjaerulff O, 2011, CELL BIOCHEM BIOPHYS, V60, P137, DOI 10.1007/s12013-010-9137-5; LIM K, 1994, PROTEIN SCI, V3, P2233, DOI 10.1002/pro.5560031209; Loll PJ, 2008, ACTA CRYSTALLOGR F, V64, P243, DOI 10.1107/S1744309108007574; Madsen KL, 2010, FEBS LETT, V584, P1848, DOI 10.1016/j.febslet.2010.01.053; Masuda M, 2006, EMBO J, V25, P2889, DOI 10.1038/sj.emboj.7601176; Mattila PK, 2007, J CELL BIOL, V176, P953, DOI 10.1083/jcb.200609176; Micheva KD, 1997, FEBS LETT, V414, P308, DOI 10.1016/S0014-5793(97)01016-8; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Pierrat B, 2001, GENOMICS, V71, P222, DOI 10.1006/geno.2000.6378; Rao YJ, 2010, P NATL ACAD SCI USA, V107, P8213, DOI 10.1073/pnas.1003478107; Rikhy R, 2002, J NEUROSCI, V22, P7478; Ringstad N, 1997, P NATL ACAD SCI USA, V94, P8569, DOI 10.1073/pnas.94.16.8569; Ringstad N, 2001, J BIOL CHEM, V276, P40424, DOI 10.1074/jbc.M106338200; Ringstad N, 1999, NEURON, V24, P143, DOI 10.1016/S0896-6273(00)80828-4; Ross JA, 2011, BIOPHYS J, V100, P729, DOI 10.1016/j.bpj.2010.12.3717; Rostovtseva TK, 2009, J BIOL CHEM, V284, P34390, DOI 10.1074/jbc.M109.021873; Saarikangas J, 2009, CURR BIOL, V19, P95, DOI 10.1016/j.cub.2008.12.029; Schmidt A, 1998, METHODS, V16, P160, DOI 10.1006/meth.1998.0663; Schmidt A, 1997, J CELL BIOL, V137, P445, DOI 10.1083/jcb.137.2.445; Schmidt A, 1999, NATURE, V401, P133, DOI 10.1038/43613; Schuske KR, 2003, NEURON, V40, P749, DOI 10.1016/S0896-6273(03)00667-6; Sparks AB, 1996, NAT BIOTECHNOL, V14, P741, DOI 10.1038/nbt0696-741; Takahashi Y, 2005, MOL CELL BIOL, V25, P9369, DOI 10.1128/MCB.25.21.9369-9382.2005; Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634; Tarricone C, 2001, NATURE, V411, P215, DOI 10.1038/35075620; Verstreken P, 2002, CELL, V109, P101, DOI 10.1016/S0092-8674(02)00688-8; Wan J, 2008, J NEUROSCI, V28, P9002, DOI 10.1523/JNEUROSCI.0767-08.2008; Wang Q, 2008, STRUCTURE, V16, P1574, DOI 10.1016/j.str.2008.07.016; Weissenhorn W, 2005, J MOL BIOL, V351, P653, DOI 10.1016/j.jmb.2005.06.013; Wong ASL, 2011, NAT CELL BIOL, V13, P568, DOI 10.1038/ncb2217; Yang JS, 2006, NAT CELL BIOL, V8, P1376, DOI 10.1038/ncb1503	48	18	21	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					4232	4247		10.1074/jbc.M111.325837	http://dx.doi.org/10.1074/jbc.M111.325837			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22167186	hybrid, Green Published			2022-12-27	WOS:000300410900056
J	Hartel, T; Eylert, E; Schulz, C; Petruschka, L; Gierok, P; Grubmuller, S; Lalk, M; Eisenreich, W; Hammerschmidt, S				Haertel, Tobias; Eylert, Eva; Schulz, Christian; Petruschka, Lothar; Gierok, Philipp; Grubmueller, Stephanie; Lalk, Michael; Eisenreich, Wolfgang; Hammerschmidt, Sven			Characterization of Central Carbon Metabolism of Streptococcus pneumoniae by Isotopologue Profiling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE HYDROXYMETHYL TRANSFERASE; DEPENDENT SALMONELLA-TYPHIMURIUM; NASOPHARYNGEAL COLONIZATION; DIOXIDE FIXATION; ABC TRANSPORTER; FAECALIS VAR; IRON UPTAKE; VIRULENCE; PROTEIN; ADHERENCE	The metabolism of Streptococcus pneumoniae was studied by isotopologue profiling after bacterial cultivation in chemically defined medium supplemented with [U-C-13(6)]- or [1,2-C-13(2)] glucose. GC/MS analysis of protein-derived amino acids showed lack of C-13 label in amino acids that were also essential for pneumococcal growth. Ala, Ser, Asp, and Thr displayed high C-13 enrichments, whereas Phe, Tyr, and Gly were only slightly labeled. The analysis of the labeling patterns showed formation of triose phosphate and pyruvate via the Embden-Meyerhof-Parnas pathway. The labeling patterns of Asp and Thr suggested formation of oxaloacetate exclusively via the phosphoenolpyruvate carboxylase reaction. Apparently, alpha-ketoglutarate was generated from unlabeled glutamate via the aspartate transaminase reaction. A fraction of Phe and Tyr obtained label via the chorismate route from erythrose 4-phosphate, generated via the pentose phosphate pathway, and phosphoenolpyruvate. Strikingly, the data revealed no significant flux from phosphoglycerate to Ser and Gly but showed formation of Ser via the reverse reaction, namely by hydroxymethylation of Gly. The essential Gly was acquired from the medium, and the biosynthesis pathway was confirmed in experiments using [U-C-13(2)] glycine as a tracer. The hydroxymethyl group in Ser originated from formate, which was generated by the pyruvate formate-lyase. Highly similar isotopologue profiles were observed in corresponding experiments with pneumococcal mutants deficient in PavA, CodY, and glucose-6-phosphate dehydrogenase pointing to the robustness of the core metabolic network used by these facultative pathogenic bacteria. In conclusion, this study demonstrates the dual utilization of carbohydrates and amino acids under in vitro conditions and identifies the unconventional de novo biosynthesis of serine by pneumococci.	[Haertel, Tobias; Schulz, Christian; Petruschka, Lothar; Hammerschmidt, Sven] Ernst Moritz Arndt Univ Greifswald, Dept Genet Microorganisms, Interfac Inst Genet & Funct Genom, D-17487 Greifswald, Germany; [Eylert, Eva; Grubmueller, Stephanie; Eisenreich, Wolfgang] Tech Univ Munich, Lehrstuhl Biochem, D-85747 Garching, Germany; [Gierok, Philipp; Lalk, Michael] Ernst Moritz Arndt Univ Greifswald, Inst Pharm, D-17487 Greifswald, Germany	Ernst Moritz Arndt Universitat Greifswald; Technical University of Munich; Ernst Moritz Arndt Universitat Greifswald	Hammerschmidt, S (corresponding author), Ernst Moritz Arndt Univ Greifswald, Dept Genet Microorganisms, Interfac Inst Genet & Funct Genom, Friedrich Ludwig Jahn Str 15A, D-17487 Greifswald, Germany.	sven.hammerschmidt@uni-greifswald.de	Westhoff, Philipp/AAV-1542-2020; Eisenreich, Wolfgang/A-1258-2013; Hammerschmidt, Sven/G-2598-2010; Lalk, Michael/C-1618-2010	Westhoff, Philipp/0000-0002-3494-9420; Eisenreich, Wolfgang/0000-0002-9832-8279; Hammerschmidt, Sven/0000-0002-6382-6681; Lalk, Michael/0000-0002-9230-0267	Deutsche Forschungsgemeinschaft [DFG HA 3125/3-1, EI-384/5-1, SPP1316]; European Union [EU-CP223111]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union(European Commission)	This work was supported by Deutsche Forschungsgemeinschaft Grants DFG HA 3125/3-1 and EI-384/5-1 within the SPP1316 and EU FP7 CARE-PNEUMO Grant EU-CP223111 from the European Union.	Basavanna S, 2009, INFECT IMMUN, V77, P3412, DOI 10.1128/IAI.01543-08; Bergmann S, 2006, MICROBIOL-SGM, V152, P295, DOI 10.1099/mic.0.28610-0; Beste DJV, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002091; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Brinsmade SR, 2010, J BACTERIOL, V192, P6357, DOI 10.1128/JB.00937-10; Brown JS, 2002, INFECT IMMUN, V70, P4389, DOI 10.1128/IAI.70.8.4389-4398.2002; Brown JS, 2001, MOL MICROBIOL, V40, P572, DOI 10.1046/j.1365-2958.2001.02414.x; Cartwright K, 2002, EUR J PEDIATR, V161, P188, DOI 10.1007/s00431-001-0907-3; Caymaris S, 2010, MOL MICROBIOL, V78, P344, DOI 10.1111/j.1365-2958.2010.07339.x; CHEN JD, 1988, GENE, V64, P155, DOI 10.1016/0378-1119(88)90489-1; Chien MC, 2004, SCIENCE, V305, P1966, DOI 10.1126/science.1099776; Claverys JP, 2000, RES MICROBIOL, V151, P457, DOI 10.1016/S0923-2508(00)00169-8; Eisenreich W, 2006, P NATL ACAD SCI USA, V103, P2040, DOI 10.1073/pnas.0507580103; Eisenreich W, 2010, NAT REV MICROBIOL, V8, P401, DOI 10.1038/nrmicro2351; Eylert E, 2008, MOL MICROBIOL, V69, P1008, DOI 10.1111/j.1365-2958.2008.06337.x; Eylert E, 2010, J BIOL CHEM, V285, P22232, DOI 10.1074/jbc.M110.128678; FIELDS PI, 1986, P NATL ACAD SCI USA, V83, P5189, DOI 10.1073/pnas.83.14.5189; GOFF RC, 1970, J BACTERIOL, V104, P27, DOI 10.1128/JB.104.1.27-33.1970; Gutierrez ML, 2008, CHEM-EUR J, V14, P4647, DOI 10.1002/chem.200800031; Hartel T, 2011, INFECT IMMUN, V79, P44, DOI 10.1128/IAI.00855-10; Hammerschmidt S, 2006, CURR OPIN MICROBIOL, V9, P12, DOI 10.1016/j.mib.2005.11.001; Hammerschmidt S, 2007, J IMMUNOL, V178, P5848, DOI 10.4049/jimmunol.178.9.5848; HARTMAN RE, 1970, J BACTERIOL, V102, P341, DOI 10.1128/JB.102.2.341-346.1970; Hava D, 2002, MOL MICROBIOL, V45, P1389, DOI 10.1046/j.1365-2958.2002.03106.x; Hendriksen WT, 2008, INFECT IMMUN, V76, P1230, DOI 10.1128/IAI.01004-07; Hendriksen WT, 2008, J BACTERIOL, V190, P590, DOI 10.1128/JB.00917-07; Herrmann KM, 1999, ANNU REV PLANT PHYS, V50, P473, DOI 10.1146/annurev.arplant.50.1.473; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Holmes AR, 2001, MOL MICROBIOL, V41, P1395, DOI 10.1046/j.1365-2958.2001.02610.x; Hoskins J, 2001, J BACTERIOL, V183, P5709, DOI 10.1128/JB.183.19.5709-5717.2001; Iyer R, 2005, J BACTERIOL, V187, P8340, DOI 10.1128/JB.187.24.8340-8349.2005; Jensch I, 2010, MOL MICROBIOL, V77, P22, DOI 10.1111/j.1365-2958.2010.07189.x; Kadioglu A, 2010, MOL ORAL MICROBIOL, V25, P50, DOI 10.1111/j.2041-1014.2009.00561.x; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Kerr AR, 2004, INFECT IMMUN, V72, P3902, DOI 10.1128/IAI.72.7.3902-3906.2004; Kloosterman TG, 2006, J BIOL CHEM, V281, P25097, DOI 10.1074/jbc.M601661200; LACHICA VF, 1969, CAN J MICROBIOL, V15, P57, DOI 10.1139/m69-009; Lau GW, 2001, MOL MICROBIOL, V40, P555, DOI 10.1046/j.1365-2958.2001.02335.x; LEE WNP, 1991, BIOCHEM MED METAB B, V45, P298, DOI 10.1016/0885-4505(91)90034-I; Leibig M, 2011, J BACTERIOL, V193, P952, DOI 10.1128/JB.01161-10; LEONARD CG, 1970, J BACTERIOL, V104, P674, DOI 10.1128/JB.104.2.674-683.1970; Liebeke M, 2011, MOL BIOSYST, V7, P1241, DOI 10.1039/c0mb00315h; Marra A, 2002, INFECT IMMUN, V70, P1422, DOI 10.1128/IAI.70.3.1422-1433.2002; Marra A, 2002, MICROBIOL-SGM, V148, P1483, DOI 10.1099/00221287-148-5-1483; MCFARLAND WC, 1987, MICROB PATHOGENESIS, V3, P129, DOI 10.1016/0882-4010(87)90071-4; MICKELSO MN, 1964, J BACTERIOL, V88, P158, DOI 10.1128/JB.88.1.158-164.1964; Munoz-Elias EJ, 2006, CELL MICROBIOL, V8, P10, DOI 10.1111/j.1462-5822.2005.00648.x; MUSHER DM, 1992, CLIN INFECT DIS, V14, P801, DOI 10.1093/clinids/14.4.801; Nobbs AH, 2009, MICROBIOL MOL BIOL R, V73, P407, DOI 10.1128/MMBR.00014-09; Noske N, 2009, J IMMUNOL, V183, P1952, DOI 10.4049/jimmunol.0804383; Obert C, 2006, INFECT IMMUN, V74, P4766, DOI 10.1128/IAI.00316-06; OCALLAGHAN D, 1988, INFECT IMMUN, V56, P419, DOI 10.1128/IAI.56.2.419-423.1988; Panina EM, 2003, FEMS MICROBIOL LETT, V222, P211, DOI 10.1016/S0378-1097(03)00303-3; Paulsen IT, 2000, J MOL BIOL, V301, P75, DOI 10.1006/jmbi.2000.3961; Philips BJ, 2003, INTENS CARE MED, V29, P2204, DOI 10.1007/s00134-003-1961-2; PINE L, 1979, J CLIN MICROBIOL, V9, P615; PIZER LI, 1965, J BACTERIOL, V89, P1145, DOI 10.1128/JB.89.4.1145-1150.1965; Polissi A, 1998, INFECT IMMUN, V66, P5620, DOI 10.1128/IAI.66.12.5620-5629.1998; POOLMAN B, 1993, FEMS MICROBIOL REV, V12, P125, DOI 10.1111/j.1574-6976.1993.tb00015.x; Pracht D, 2005, INFECT IMMUN, V73, P2680, DOI 10.1128/IAI.73.5.2680-2689.2005; Rennemeier C, 2007, FASEB J, V21, P3118, DOI 10.1096/fj.06-7992com; SAMPSON JS, 1994, INFECT IMMUN, V62, P319, DOI 10.1128/IAI.62.1.319-324.1994; Shafeeq S, 2011, MOL MICROBIOL, V81, P1255, DOI 10.1111/j.1365-2958.2011.07758.x; Smith AW, 2002, MOL MICROBIOL, V44, P431, DOI 10.1046/j.1365-2958.2002.02883.x; Somerville GA, 2009, MICROBIOL MOL BIOL R, V73, P233, DOI 10.1128/MMBR.00005-09; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Tseng HJ, 2002, INFECT IMMUN, V70, P1635, DOI 10.1128/IAI.70.3.1635-1639.2002; Vidal L, 2005, APPL MICROBIOL BIOT, V68, P489, DOI 10.1007/s00253-005-1934-1; Yesilkaya H, 2009, INFECT IMMUN, V77, P5418, DOI 10.1128/IAI.00178-09	69	48	48	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					4260	4274		10.1074/jbc.M111.304311	http://dx.doi.org/10.1074/jbc.M111.304311			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22167202	Green Published, hybrid			2022-12-27	WOS:000300410900058
J	Patel, AG; Flatten, KS; Schneider, PA; Dai, NT; McDonald, JS; Poirier, GG; Kaufmann, SH				Patel, Anand G.; Flatten, Karen S.; Schneider, Paula A.; Dai, Nga T.; McDonald, Jennifer S.; Poirier, Guy G.; Kaufmann, Scott H.			Enhanced Killing of Cancer Cells by Poly(ADP-ribose) Polymerase Inhibitors and Topoisomerase I Inhibitors Reflects Poisoning of Both Enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSE POLYMERASE; SINGLE-STRAND BREAK; DNA-DAMAGE; HOMOLOGOUS RECOMBINATION; MAMMALIAN-CELLS; REPLICATION FORKS; LEUKEMIA-CELLS; PARP INHIBITOR; POSTTRANSLATIONAL MODIFICATION; TRANSDOMINANT INHIBITION	Poly(ADP-ribose) polymerase-1 (PARP1) plays critical roles in the regulation of DNA repair. Accordingly, small molecule inhibitors of PARP are being developed as agents that could modulate the activity of genotoxic chemotherapy, such as topoisomerase I poisons. In this study we evaluated the ability of the PARP inhibitor veliparib to enhance the cytotoxicity of the topoisomerase I poisons topotecan and camptothecin (CPT). Veliparib increased the cell cycle and cytotoxic effects of topotecan in multiple cell line models. Importantly, this sensitization occurred at veliparib concentrations far below those required to substantially inhibit poly(ADP-ribose) polymer synthesis and at least an order of magnitude lower than those involved in selective killing of homologous recombination-deficient cells. Further studies demonstrated that veliparib enhanced the effects of CPT in wild-type mouse embryonic fibroblasts (MEFs) but not Parp1(-/-) MEFs, confirming that PARP1 is the critical target for this sensitization. Importantly, parental and Parp1(-/-) MEFs had indistinguishable CPT sensitivities, ruling out models in which PARP1 catalytic activity plays a role in protecting cells from topoisomerase I poisons. To the contrary, cells were sensitized to CPT in a veliparib-independent manner upon transfection with PARP1 E988K, which lacks catalytic activity, or the isolated PARP1 DNA binding domain. These results are consistent with a model in which small molecule inhibitors convert PARP1 into a protein that potentiates the effects of topoisomerase I poisons by binding to damaged DNA and preventing its normal repair.	[Patel, Anand G.; Flatten, Karen S.; Schneider, Paula A.; Dai, Nga T.; McDonald, Jennifer S.; Kaufmann, Scott H.] Mayo Clin, Div Oncol Res, Rochester, MN 55905 USA; [Patel, Anand G.; Kaufmann, Scott H.] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55905 USA; [Poirier, Guy G.] Univ Laval, Med Ctr, Quebec City, PQ G1V 4G2, Canada	Mayo Clinic; Mayo Clinic; Laval University	Kaufmann, SH (corresponding author), Mayo Clin, Div Oncol Res, Gonda 19-212,200 1st St SW, Rochester, MN 55905 USA.	Kaufmann.Scott@mayo.edu	Patel, Anand/G-9877-2018	Patel, Anand/0000-0002-1438-8275; Poirier, Guy/0000-0002-4869-1424; Kaufmann, Scott/0000-0002-4900-7145	National Institutes of Health [T32 GM072474, P50 CA136393, R01 CA73709]; Mayo Foundation for Research and Education; NATIONAL CANCER INSTITUTE [R01CA073709, P50CA136393] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM072474] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation for Research and Education; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by National Institutes of Health Grant T32 GM072474 and a pre-doctoral fellowship from the Mayo Foundation for Research and Education.; This work was supported, in whole or in part, by National Institutes of Health Grants P50 CA136393 and R01 CA73709.	Adjei AA, 1998, CLIN CANCER RES, V4, P683; Affar EB, 1999, BBA-GEN SUBJECTS, V1428, P137, DOI 10.1016/S0304-4165(99)00054-9; Aggarwal M, 2011, P NATL ACAD SCI USA, V108, P1525, DOI 10.1073/pnas.1006423108; Alexander B. M., 2011, J NEUROONCO IN PRESS; AVEMANN K, 1988, MOL CELL BIOL, V8, P3026, DOI 10.1128/MCB.8.8.3026; Barrows LR, 1998, MUTAT RES-DNA REPAIR, V408, P103, DOI 10.1016/S0921-8777(98)00022-6; Bauer PI, 2000, INT J MOL MED, V5, P533; Bauer PI, 2001, FEBS LETT, V506, P239, DOI 10.1016/S0014-5793(01)02919-2; Bowman KJ, 2001, BRIT J CANCER, V84, P106, DOI 10.1054/bjoc.2000.1555; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Bryant HE, 2009, EMBO J, V28, P2601, DOI 10.1038/emboj.2009.206; Calabrese CR, 2004, J NATL CANCER I, V96, P56, DOI 10.1093/jnci/djh005; Calabrese CR, 2003, CLIN CANCER RES, V9, P2711; CHAMBON P, 1963, BIOCHEM BIOPH RES CO, V11, P39, DOI 10.1016/0006-291X(63)90024-X; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; CHAMPOUX JJ, 1976, P NATL ACAD SCI USA, V73, P3488, DOI 10.1073/pnas.73.10.3488; Cliby WA, 2002, J BIOL CHEM, V277, P1599, DOI 10.1074/jbc.M106287200; COVEY JM, 1989, CANCER RES, V49, P5016; Delaney CA, 2000, CLIN CANCER RES, V6, P2860; DEMURCIA G, 1994, TRENDS BIOCHEM SCI, V19, P172, DOI 10.1016/0968-0004(94)90280-1; deMurcia JM, 1997, P NATL ACAD SCI USA, V94, P7303, DOI 10.1073/pnas.94.14.7303; Desnoyers S, 1996, EXP CELL RES, V227, P146, DOI 10.1006/excr.1996.0259; Donawho CK, 2007, CLIN CANCER RES, V13, P2728, DOI 10.1158/1078-0432.CCR-06-3039; Duro E, 2010, MOL CELL, V40, P632, DOI 10.1016/j.molcel.2010.10.023; El-Khamisy SF, 2005, NATURE, V434, P108, DOI 10.1038/nature03314; Erlichman C, 2001, CANCER RES, V61, P739; FAKAN S, 1988, EXP CELL RES, V179, P517, DOI 10.1016/0014-4827(88)90289-3; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Ferraris DV, 2010, J MED CHEM, V53, P4561, DOI 10.1021/jm100012m; Flatten K, 2005, J BIOL CHEM, V280, P14349, DOI 10.1074/jbc.M411890200; Gagne JP, 2008, NUCLEIC ACIDS RES, V36, P6959, DOI 10.1093/nar/gkn771; Galvez-Peralta M, 2008, MOL PHARMACOL, V74, P724, DOI 10.1124/mol.108.047787; Goldwasser F, 1996, CANCER RES, V56, P4430; Haince J. F., 2001, CURRENT PROTOCOLS CE; Haince JF, 2008, J BIOL CHEM, V283, P1197, DOI 10.1074/jbc.M706734200; Haince JF, 2005, TRENDS MOL MED, V11, P456, DOI 10.1016/j.molmed.2005.08.003; Hans MA, 1999, ONCOGENE, V18, P7010, DOI 10.1038/sj.onc.1203178; HECK MMS, 1988, P NATL ACAD SCI USA, V85, P1086, DOI 10.1073/pnas.85.4.1086; HSIANG YH, 1989, CANCER RES, V49, P5077; HSIANG YH, 1985, J BIOL CHEM, V260, P4873; Interthal H, 2005, EMBO J, V24, P2224, DOI 10.1038/sj.emboj.7600694; Kameoka M, 2004, J VIROL, V78, P8931, DOI 10.1128/JVI.78.16.8931-8934.2004; KASID UN, 1989, J BIOL CHEM, V264, P18687; KAUFMANN SH, 1989, CANCER RES, V49, P5870; Kaufmann SH, 1997, BLOOD, V89, P2098, DOI 10.1182/blood.V89.6.2098; Kaufmann SH, 2001, ANAL BIOCHEM, V296, P283, DOI 10.1006/abio.2001.5313; KAUFMANN SH, 1989, J BIOL CHEM, V264, P13946; Koch SSC, 2002, J MED CHEM, V45, P4961, DOI 10.1021/jm02059n; KOHN KW, 1976, BIOCHEMISTRY-US, V15, P4629, DOI 10.1021/bi00666a013; Krishnakumar R, 2010, MOL CELL, V39, P8, DOI 10.1016/j.molcel.2010.06.017; Kummar S, 2009, J CLIN ONCOL, V27, P2705, DOI 10.1200/JCO.2008.19.7681; Kupper JH, 1996, CANCER RES, V56, P2715; KUPPER JH, 1995, MOL CELL BIOL, V15, P3154; LAMARRE D, 1988, BIOCHIM BIOPHYS ACTA, V950, P147, DOI 10.1016/0167-4781(88)90007-3; Leppard JB, 2003, MOL CELL BIOL, V23, P5919, DOI 10.1128/MCB.23.16.5919-5927.2003; Li XF, 2011, DRUG METAB DISPOS, V39, P1161, DOI 10.1124/dmd.110.037820; LIU LF, 1989, ANNU REV BIOCHEM, V58, P351, DOI 10.1146/annurev.bi.58.070189.002031; Liu XS, 2009, MOL CANCER RES, V7, P1686, DOI 10.1158/1541-7786.MCR-09-0299; Marple T, 2006, MUTAT RES-FUND MOL M, V602, P110, DOI 10.1016/j.mrfmmm.2006.08.005; Martins LM, 1997, BLOOD, V90, P4283, DOI 10.1182/blood.V90.11.4283.4283_4283_4296; Meder VS, 2005, J CELL SCI, V118, P211, DOI 10.1242/jcs.01606; Meng XW, 2011, J BIOL CHEM, V286, P35823, DOI 10.1074/jbc.M111.240432; Meng XW, 2003, J BIOL CHEM, V278, P47326, DOI 10.1074/jbc.M304793200; MULLER MT, 1985, BIOCHIM BIOPHYS ACTA, V824, P263, DOI 10.1016/0167-4781(85)90057-0; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; O'Donnell L, 2010, MOL CELL, V40, P619, DOI 10.1016/j.molcel.2010.10.024; Okano S, 2003, MOL CELL BIOL, V23, P3974, DOI 10.1128/MCB.23.11.3974-3981.2003; Park SY, 2005, CANCER RES, V65, P3894, DOI 10.1158/0008-5472.CAN-04-4014; Park SY, 2002, CANCER RES, V62, P459; Patel AG, 2011, P NATL ACAD SCI USA, V108, P3406, DOI 10.1073/pnas.1013715108; Penning TD, 2009, J MED CHEM, V52, P514, DOI 10.1021/jm801171j; PIKE BL, 1970, J CELL PHYSIOL, V76, P77, DOI 10.1002/jcp.1040760111; Plo I, 2003, DNA REPAIR, V2, P1087, DOI 10.1016/S1568-7864(03)00116-2; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; POTMESIL M, 1988, CANCER RES, V48, P3537; Pouliot JJ, 1999, SCIENCE, V286, P552, DOI 10.1126/science.286.5439.552; Rolli V, 1997, BIOCHEMISTRY-US, V36, P12147, DOI 10.1021/bi971055p; Rouleau M, 2010, NAT REV CANCER, V10, P293, DOI 10.1038/nrc2812; RYAN AJ, 1991, NUCLEIC ACIDS RES, V19, P3295, DOI 10.1093/nar/19.12.3295; SATOH MS, 1992, NATURE, V356, P356, DOI 10.1038/356356a0; SCHREIBER V, 1995, P NATL ACAD SCI USA, V92, P4753, DOI 10.1073/pnas.92.11.4753; Segovis CM, 2009, J IMMUNOL, V182, P6933, DOI 10.4049/jimmunol.0803840; Smith LM, 2005, CLIN CANCER RES, V11, P8449, DOI 10.1158/1078-0432.CCR-05-1224; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SNAPKA RM, 1986, MOL CELL BIOL, V6, P4221, DOI 10.1128/MCB.6.12.4221; Staker BL, 2002, P NATL ACAD SCI USA, V99, P15387, DOI 10.1073/pnas.242259599; Stewart L, 1998, SCIENCE, V279, P1534, DOI 10.1126/science.279.5356.1534; Taniguchi T, 2003, NAT MED, V9, P568, DOI 10.1038/nm852; Thomas HD, 2007, MOL CANCER THER, V6, P945, DOI 10.1158/1535-7163.MCT-06-0552; Tikhe JG, 2004, J MED CHEM, V47, P5467, DOI 10.1021/jm030513r; von Kobbe C, 2004, NUCLEIC ACIDS RES, V32, P4003, DOI 10.1093/nar/gkh721; WANG ZQ, 1995, GENE DEV, V9, P509, DOI 10.1101/gad.9.5.509; White AW, 2000, J MED CHEM, V43, P4084, DOI 10.1021/jm000950v; Yang SX, 2009, CANCER BIOL THER, V8, P2004, DOI 10.4161/cbt.8.21.9917; Yang YG, 2004, ONCOGENE, V23, P3872, DOI 10.1038/sj.onc.1207491; Yung TMC, 2004, J BIOL CHEM, V279, P39686, DOI 10.1074/jbc.M402729200; ZECHIEDRICH EL, 1990, EMBO J, V9, P4555, DOI 10.1002/j.1460-2075.1990.tb07908.x; Zhang YW, 2011, NUCLEIC ACIDS RES, V39, P3607, DOI 10.1093/nar/gkq1304	99	78	79	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					4198	4210		10.1074/jbc.M111.296475	http://dx.doi.org/10.1074/jbc.M111.296475			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22158865	Green Published, hybrid			2022-12-27	WOS:000300410900053
J	Perugino, G; Vettone, A; Illiano, G; Valenti, A; Ferrara, MC; Rossi, M; Ciaramella, M				Perugino, Giuseppe; Vettone, Antonella; Illiano, Giuseppina; Valenti, Anna; Ferrara, Maria C.; Rossi, Mose; Ciaramella, Maria			Activity and Regulation of Archaeal DNA Alkyltransferase CONSERVED PROTEIN INVOLVED IN REPAIR OF DNA ALKYLATION DAMAGE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							O-6-METHYLGUANINE-DNA METHYLTRANSFERASE; O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE; FUSION PROTEINS; REVERSE GYRASE; BINDING; DEGRADATION	Agents that form methylation adducts in DNA are highly mutagenic and carcinogenic, and organisms have evolved specialized cellular pathways devoted to their repair, including DNA alkyltransferases. These are proteins conserved in eucarya, bacteria and archaea, acting by a unique reaction mechanism, which leads to direct repair of DNA alkylation damage and irreversible protein alkylation. The alkylated form of DNA alkyltransferases is inactive, and in eukaryotes, it is rapidly directed to degradation. We report here in vitro and in vivo studies on the DNA alkyltransferase from the thermophilic archaeon Sulfolobus solfataricus (SsOGT). The development of a novel, simple, and sensitive fluorescence-based assay allowed a careful characterization of the SsOGT biochemical and DNA binding activities. In addition, transcriptional and post-translational regulation of SsOGT by DNA damage was studied. We show that although the gene transcription is induced by alkylating agent treatment, the protein is degraded in vivo by an alkylation-dependent mechanism. These experiments suggest a striking conservation, from archaea to humans, of this important pathway safeguarding genome stability.	[Perugino, Giuseppe; Vettone, Antonella; Illiano, Giuseppina; Valenti, Anna; Ferrara, Maria C.; Rossi, Mose; Ciaramella, Maria] CNR, Inst Prot Biochem, I-80131 Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR)	Ciaramella, M (corresponding author), CNR, Inst Prot Biochem, Via P Castellino 111, I-80131 Naples, Italy.	m.ciaramella@ibp.cnr.it	Perugino, Giuseppe/P-8147-2016; Ciaramella, Maria/O-1152-2015	Ciaramella, Maria/0000-0003-1583-1694; Perugino, Giuseppe/0000-0003-3266-4744; Valenti, Anna/0000-0002-5278-3524	Merit Grant [RBNE08YFN3]; Ministero degli Affari Esteri [L. 401/1990]	Merit Grant; Ministero degli Affari Esteri(Ministry of Foreign Affairs and International Cooperation (Italy))	This work was partially supported by Merit Grant RBNE08YFN3 and Ministero degli Affari Esteri (Grant L. 401/1990).	Daniels DS, 2000, EMBO J, V19, P1719, DOI 10.1093/emboj/19.7.1719; Daniels DS, 2004, NAT STRUCT MOL BIOL, V11, P714, DOI 10.1038/nsmb791; Fang QM, 2005, BIOCHEMISTRY-US, V44, P15396, DOI 10.1021/bi051460d; Gautier A, 2008, CHEM BIOL, V15, P128, DOI 10.1016/j.chembiol.2008.01.007; Humbard MA, 2010, NATURE, V463, P54, DOI 10.1038/nature08659; Hwang CS, 2009, P NATL ACAD SCI USA, V106, P2142, DOI 10.1073/pnas.0812316106; Ishiguro K, 2008, ANAL BIOCHEM, V383, P44, DOI 10.1016/j.ab.2008.08.009; Ishiguro K, 2010, BIOCHEM PHARMACOL, V80, P1317, DOI 10.1016/j.bcp.2010.07.022; Kanugula S, 2003, BIOCHEM J, V375, P449, DOI 10.1042/BJ20030809; Kelman Z, 2005, CURR OPIN MICROBIOL, V8, P669, DOI 10.1016/j.mib.2005.10.001; Keppler A, 2004, METHODS, V32, P437, DOI 10.1016/j.ymeth.2003.10.007; Keppler A, 2003, NAT BIOTECHNOL, V21, P86, DOI 10.1038/nbt765; Leatherbarrow R. J., 2004, GRAFIT VERSION 5 0; Leclere MM, 1998, MOL GEN GENET, V258, P69, DOI 10.1007/s004380050708; Lim A, 1996, EMBO J, V15, P4050, DOI 10.1002/j.1460-2075.1996.tb00778.x; Makarova KS, 2010, ARCHAEA, V2010, DOI 10.1155/2010/710303; Margison GP, 2003, CARCINOGENESIS, V24, P625, DOI 10.1093/carcin/bgg005; Maupin-Furlow JA, 2006, CURR TOP DEV BIOL, V75, P125, DOI 10.1016/S0070-2153(06)75005-0; Morita R, 2008, J BIOCHEM, V144, P267, DOI 10.1093/jb/mvn065; Napoli A, 2004, J BIOL CHEM, V279, P33192, DOI 10.1074/jbc.M402619200; Nishikori S, 2004, J BIOCHEM, V136, P503, DOI 10.1093/jb/mvh149; Pegg AE, 2011, CHEM RES TOXICOL, V24, P618, DOI 10.1021/tx200031q; Rabik CA, 2006, CANCER TREAT REV, V32, P261, DOI 10.1016/j.ctrv.2006.03.004; Rasimas JJ, 2003, J BIOL CHEM, V278, P7973, DOI 10.1074/jbc.M211854200; Roberts A, 2006, MAGN RESON CHEM, V44, pS71, DOI 10.1002/mrc.1823; She Q, 2001, P NATL ACAD SCI USA, V98, P7835, DOI 10.1073/pnas.141222098; Tintore M, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/632041; Valenti A, 2006, NUCLEIC ACIDS RES, V34, P2098, DOI 10.1093/nar/gkl115; Valenti A, 2009, NUCLEIC ACIDS RES, V37, P4287, DOI 10.1093/nar/gkp386; Wadsworth RIM, 2001, NUCLEIC ACIDS RES, V29, P914, DOI 10.1093/nar/29.4.914; Xu-Welliver M, 2002, CARCINOGENESIS, V23, P823, DOI 10.1093/carcin/23.5.823; Yang CG, 2009, CHEMBIOCHEM, V10, P417, DOI 10.1002/cbic.200800580	32	30	30	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					4222	4231		10.1074/jbc.M111.308320	http://dx.doi.org/10.1074/jbc.M111.308320			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22167184	hybrid, Green Published			2022-12-27	WOS:000300410900055
J	Kurihara, Y; Kanki, T; Aoki, Y; Hirota, Y; Saigusa, T; Uchiumi, T; Kang, DC				Kurihara, Yusuke; Kanki, Tomotake; Aoki, Yoshimasa; Hirota, Yuko; Saigusa, Tetsu; Uchiumi, Takeshi; Kang, Dongchon			Mitophagy Plays an Essential Role in Reducing Mitochondrial Production of Reactive Oxygen Species and Mutation of Mitochondrial DNA by Maintaining Mitochondrial Quantity and Quality in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARKIN-DEFICIENT MICE; SACCHAROMYCES-CEREVISIAE; AUTOPHAGY; MECHANISM; ATG32; INDUCTION; MUTANTS; PROTEIN; NEURONS	In mammalian cells, the autophagy-dependent degradation of mitochondria (mitophagy) is thought to maintain mitochondrial quality by eliminating damaged mitochondria. However, the physiological importance of mitophagy has not been clarified in yeast. Here, we investigated the physiological role of mitophagy in yeast using mitophagy-deficient atg32- or atg11-knock-out cells. When wild-type yeast cells in respiratory growth encounter nitrogen starvation, mitophagy is initiated, excess mitochondria are degraded, and reactive oxygen species (ROS) production from mitochondria is suppressed; as a result, the mitochondria escape oxidative damage. On the other hand, in nitrogen-starved mitophagy-deficient yeast, excess mitochondria are not degraded and the undegraded mitochondria spontaneously age and produce surplus ROS. The surplus ROS damage the mitochondria themselves and the damaged mitochondria produce more ROS in a vicious circle, ultimately leading to mitochondrial DNA deletion and the so-called "petitemutant" phenotype. Cells strictly regulate mitochondrial quantity and quality because mitochondria produce both necessary energy and harmful ROS. Mitophagy contributes to this process by eliminating the mitochondria to a basal level to fulfill cellular energy requirements and preventing excess ROS production.	[Kurihara, Yusuke; Kanki, Tomotake; Aoki, Yoshimasa; Hirota, Yuko; Saigusa, Tetsu; Uchiumi, Takeshi; Kang, Dongchon] Kyushu Univ, Grad Sch Med Sci, Dept Clin Chem & Lab Med, Fukuoka 8128582, Japan	Kyushu University	Kanki, T (corresponding author), 3-1-1 Maidashi,Higashi Ku, Fukuoka 8128582, Japan.	kanki@cclm.med.kyushu-u.ac.jp	Kanki, Tomotake/H-7250-2012	Kanki, Tomotake/0000-0001-9646-5379	Ministry of Education, Culture, Sports, Science and Technology of Japan [23689032, 22020028, 22249018]; Takeda Science Foundation; Naito Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Kowa Life Science Foundation; Kyushu University; Grants-in-Aid for Scientific Research [23689032] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Naito Foundation(Naito Memorial Foundation); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Kowa Life Science Foundation; Kyushu University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid for Scientific Research 23689032 (to T. K.), 22020028 (to T. K.), and 22249018 (to D. K.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, a grant from the Takeda Science Foundation (to T. K.), the Naito Foundation (to T. K.), the Mochida Memorial Foundation for Medical and Pharmaceutical Research (to T. K.), the Kowa Life Science Foundation (to T. K.), and the Kyushu University Interdisciplinary Programs in Education and Projects in Research Development (to T. K.).	Aoki Y, 2011, MOL BIOL CELL, V22, P3206, DOI 10.1091/mbc.E11-02-0145; CLARK SL, 1957, J BIOPHYS BIOCHEM CY, V3, P349, DOI 10.1083/jcb.3.3.349; Deas E, 2011, BBA-MOL CELL RES, V1813, P623, DOI 10.1016/j.bbamcr.2010.08.007; FERGUSON LR, 1992, MUTAT RES, V265, P103, DOI 10.1016/0027-5107(92)90042-Z; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Goldberg MS, 2003, J BIOL CHEM, V278, P43628, DOI 10.1074/jbc.M308947200; Itier JM, 2003, HUM MOL GENET, V12, P2277, DOI 10.1093/hmg/ddg239; Kanki T, 2008, J BIOL CHEM, V283, P32386, DOI 10.1074/jbc.M802403200; Kanki T, 2011, ANTIOXID REDOX SIGN, V14, P1989, DOI 10.1089/ars.2010.3762; Kanki T, 2010, MOL MICROBIOL, V75, P795, DOI 10.1111/j.1365-2958.2009.07035.x; Kanki T, 2009, MOL BIOL CELL, V20, P4730, DOI 10.1091/mbc.E09-03-0225; Kanki T, 2009, DEV CELL, V17, P98, DOI 10.1016/j.devcel.2009.06.014; Lemasters JJ, 2005, REJUV RES, V8, P3, DOI 10.1089/rej.2005.8.3; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Noda T, 2008, METHOD ENZYMOL, V451, P27, DOI 10.1016/S0076-6879(08)03202-3; Okamoto K, 2009, DEV CELL, V17, P87, DOI 10.1016/j.devcel.2009.06.013; Perez FA, 2005, P NATL ACAD SCI USA, V102, P2174, DOI 10.1073/pnas.0409598102; Priault M, 2005, CELL DEATH DIFFER, V12, P1613, DOI 10.1038/sj.cdd.4401697; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; Shintani T, 2002, DEV CELL, V3, P825, DOI 10.1016/S1534-5807(02)00373-8; Suzuki SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017412; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; Vives-Bauza C, 2011, TRENDS MOL MED, V17, P158, DOI 10.1016/j.molmed.2010.11.002; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; von Coelln R, 2004, P NATL ACAD SCI USA, V101, P10744, DOI 10.1073/pnas.0401297101; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Ziviani E, 2010, P NATL ACAD SCI USA, V107, P5018, DOI 10.1073/pnas.0913485107	30	187	195	5	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3265	3272		10.1074/jbc.M111.280156	http://dx.doi.org/10.1074/jbc.M111.280156			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22157017	Green Accepted, hybrid, Green Published			2022-12-27	WOS:000300295100032
J	Nadtochiy, SM; Zhu, QY; Urciuoli, W; Rafikov, R; Black, SM; Brookes, PS				Nadtochiy, Sergiy M.; Zhu, Qiuyu; Urciuoli, William; Rafikov, Ruslan; Black, Stephen M.; Brookes, Paul S.			Nitroalkenes Confer Acute Cardioprotection via Adenine Nucleotide Translocase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; ISCHEMIA-REPERFUSION INJURY; NITRATED FATTY-ACIDS; NITRIC-OXIDE; ADP/ATP CARRIER; REACTIVE OXYGEN; CYCLOPHILIN-D; CARDIAC MITOCHONDRIA; N-ETHYLMALEIMIDE; OXIDATIVE STRESS	Electrophilic nitrated lipids (nitroalkenes) are emerging as an important class of protective cardiovascular signaling molecules. Although species such as nitro-linoleate (LNO2) and nitro-oleate can confer acute protection against cardiac ischemic injury, their mechanism of action is unclear. Mild uncoupling of mitochondria is known to be cardioprotective, and adenine nucleotide translocase 1 (ANT1) is a key mediator of mitochondrial uncoupling. ANT1 also contains redox-sensitive cysteines that may be targets for modification by nitroalkenes. Therefore, in this study we tested the hypothesis that nitroalkenes directly modify ANT1 and that nitroalkene-mediated cardioprotection requires ANT1. Using biotin-tagged LNO2 infused into intact perfused hearts, we obtained mass spectrometric (MALDI-TOF-TOF) evidence for direct modification (nitroalkylation) of ANT1 on cysteine 57. Furthermore, in a cell model of ischemia-reperfusion injury, siRNA knockdown of ANT1 inhibited the cardioprotective effect of LNO2. Although the molecular mechanism linking ANT1-Cys(57) nitroalkylation and uncoupling is not yet known, these data suggest that ANT1-mediated uncoupling may be a mechanism for nitroalkene-induced cardioprotection.	[Nadtochiy, Sergiy M.; Urciuoli, William; Brookes, Paul S.] Univ Rochester, Med Ctr, Dept Anesthesiol, Rochester, NY 14642 USA; [Zhu, Qiuyu] Univ Rochester, Med Ctr, Aab Cardiovas Res Inst, Rochester, NY 14642 USA; [Rafikov, Ruslan; Black, Stephen M.] Georgia Hlth Sci Univ, Vasc Biol Ctr, Augusta, GA 30912 USA	University of Rochester; University of Rochester; University System of Georgia; Augusta University	Brookes, PS (corresponding author), Univ Rochester, Med Ctr, Dept Anesthesiol, Box 604,601 Elmwood Ave, Rochester, NY 14642 USA.	paul_brookes@urmc.rochester.edu	Rafikov, Ruslan/AAG-9352-2019; Zhu, Qiuyu/M-7578-2017	Zhu, Qiuyu/0000-0003-2751-7985; Brookes, Paul/0000-0002-8639-8413; Rafikov, Ruslan/0000-0001-5950-4076	National Institutes of Health [HL071158, HL101902, HL067841, 5T32HL06699]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL101902, R01HL067841, R01HL071158] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL071158 (to P. S. B.) and HL101902 and HL067841 (to S. M. B.).; Supported in part by National Institutes of Health Training Grant 5T32HL06699.	Al-Khalifa A, 2007, AM J PHYSIOL-REG I, V292, pR1198, DOI 10.1152/ajpregu.00661.2006; Baines CP, 2009, J MOL CELL CARDIOL, V46, P969, DOI 10.1016/j.yjmcc.2009.01.016; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Baker PRS, 2009, FREE RADICAL BIO MED, V46, P989, DOI 10.1016/j.freeradbiomed.2008.11.021; Baker PRS, 2005, J BIOL CHEM, V280, P42464, DOI 10.1074/jbc.M504212200; Baker PRS, 2004, P NATL ACAD SCI USA, V101, P11577, DOI 10.1073/pnas.0402587101; Batthyany C, 2006, J BIOL CHEM, V281, P20450, DOI 10.1074/jbc.M602814200; Bosetti F, 2004, FEBS LETT, V563, P161, DOI 10.1016/S0014-5793(04)00294-7; BOULAY F, 1984, BIOCHEMISTRY-US, V23, P4807, DOI 10.1021/bi00315a042; Brand MD, 2005, BIOCHEM J, V392, P353, DOI 10.1042/BJ20050890; Brennan JP, 2006, CARDIOVASC RES, V72, P313, DOI 10.1016/j.cardiores.2006.07.019; Brennan JP, 2006, CARDIOVASC RES, V72, P322, DOI 10.1016/j.cardiores.2006.08.006; Brookes PS, 2005, FREE RADICAL BIO MED, V38, P12, DOI 10.1016/j.freeradbiomed.2004.10.016; Brookes PS, 2002, FREE RADICAL BIO MED, V33, P755, DOI 10.1016/S0891-5849(02)00901-2; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Brustovetsky N, 1996, BIOCHEMISTRY-US, V35, P8483, DOI 10.1021/bi960833v; Cadenas S, 2000, BIOCHEM J, V351, P307, DOI 10.1042/0264-6021:3510307; Carpi A, 2009, BBA-BIOENERGETICS, V1787, P774, DOI 10.1016/j.bbabio.2009.04.001; Chavez JD, 2011, J PROTEOMICS, V74, P2417, DOI 10.1016/j.jprot.2011.03.031; Chen Q, 2008, AM J PHYSIOL-CELL PH, V294, pC460, DOI 10.1152/ajpcell.00211.2007; Costantini P, 2000, ONCOGENE, V19, P307, DOI 10.1038/sj.onc.1203299; Cui T, 2006, J BIOL CHEM, V281, P35686, DOI 10.1074/jbc.M603357200; DAUM G, 1985, BIOCHIM BIOPHYS ACTA, V822, P1, DOI 10.1016/0304-4157(85)90002-4; Di Lisa F, 2009, J MOL CELL CARDIOL, V46, P775, DOI 10.1016/j.yjmcc.2009.03.006; Dong Y, 2010, J CARDIOVASC PHARM T, V15, P220, DOI 10.1177/1074248410370327; Gerencser AA, 2009, ANAL CHEM, V81, P6868, DOI 10.1021/ac900881z; Gertz M, 2008, P NATL ACAD SCI USA, V105, P5705, DOI 10.1073/pnas.0800691105; GIRONCALLE J, 1994, ARCH BIOCHEM BIOPHYS, V315, P1, DOI 10.1006/abbi.1994.1463; Groeger AL, 2010, MOL INTERV, V10, P39, DOI 10.1124/mi.10.1.7; Halestrap AP, 2010, BIOCHEM SOC T, V38, P841, DOI 10.1042/BST0380841; Halestrap AP, 2009, J BIOENERG BIOMEMBR, V41, P113, DOI 10.1007/s10863-009-9206-x; Halestrap AP, 1997, J BIOL CHEM, V272, P3346, DOI 10.1074/jbc.272.6.3346; Halestrap AP, 2002, BIOCHIMIE, V84, P153, DOI 10.1016/S0300-9084(02)01375-5; Huang CQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020975; Huang CQ, 2010, J CARDIOVASC TRANSL, V3, P365, DOI 10.1007/s12265-010-9189-3; Klingenberg M, 2008, BBA-BIOMEMBRANES, V1778, P1978, DOI 10.1016/j.bbamem.2008.04.011; Koenitzer JR, 2010, ANN NY ACAD SCI, V1203, P45, DOI 10.1111/j.1749-6632.2010.05559.x; Kohr MJ, 2011, CIRC RES, V108, P418, DOI 10.1161/CIRCRESAHA.110.232173; Kokoszka JE, 2004, NATURE, V427, P461, DOI 10.1038/nature02229; Kristal BS, 1996, J BIOL CHEM, V271, P6033, DOI 10.1074/jbc.271.11.6033; Landar A, 2006, BIOCHEM J, V394, P185, DOI 10.1042/BJ20051259; Legros F, 2002, MOL BIOL CELL, V13, P4343, DOI 10.1091/mbc.E02-06-0330; LEPRAN I, 1992, J CARDIOVASC PHARM, V19, P40, DOI 10.1097/00005344-199201000-00006; Levy SE, 2000, GENE, V254, P57, DOI 10.1016/S0378-1119(00)00252-3; Lim DG, 2002, P NATL ACAD SCI USA, V99, P15941, DOI 10.1073/pnas.232409599; Lin TK, 2002, J BIOL CHEM, V277, P17048, DOI 10.1074/jbc.M110797200; MAJIMA E, 1993, J BIOL CHEM, V268, P22181; McStay GP, 2002, BIOCHEM J, V367, P541, DOI 10.1042/BJ20011672; Muscari C, 2006, CELL BIOCHEM FUNCT, V24, P511, DOI 10.1002/cbf.1294; Nadtochiy SM, 2011, CARDIOVASC RES, V89, P643, DOI 10.1093/cvr/cvq287; Nadtochiy SM, 2009, CARDIOVASC RES, V82, P333, DOI 10.1093/cvr/cvn323; Nadtochiy SM, 2006, BIOCHEM J, V395, P611, DOI 10.1042/BJ20051927; Nemoto S, 2006, J BIOL CHEM, V281, P10555, DOI 10.1074/jbc.M511626200; O'Donnell VB, 1999, CHEM RES TOXICOL, V12, P83, DOI 10.1021/tx980207u; Petrovski G, 2011, ANTIOXID REDOX SIGN, V14, P2191, DOI 10.1089/ars.2010.3486; Quarrie R, 2011, J SURG RES, V165, P5, DOI 10.1016/j.jss.2010.09.018; Rodriguez J, 2003, P NATL ACAD SCI USA, V100, P336, DOI 10.1073/pnas.0234600100; Rudolph V, 2010, CARDIOVASC RES, V85, P155, DOI 10.1093/cvr/cvp275; Schopfer FJ, 2005, P NATL ACAD SCI USA, V102, P2340, DOI 10.1073/pnas.0408384102; Teshima Y, 2003, CIRC RES, V93, P192, DOI 10.1161/01.RES.0000085581.60197.4D; Vyssokikh MY, 2001, BIOCHEM J, V358, P349, DOI 10.1042/0264-6021:3580349; Wang SB, 2011, CIRC RES, V109, P750, DOI 10.1161/CIRCRESAHA.111.246124; Wong HL, 2008, CHEM RES TOXICOL, V21, P796, DOI 10.1021/tx700433m; Woodfield K, 1998, BIOCHEM J, V336, P287, DOI 10.1042/bj3360287	64	37	45	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3573	3580		10.1074/jbc.M111.298406	http://dx.doi.org/10.1074/jbc.M111.298406			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22158628	Green Published, hybrid			2022-12-27	WOS:000300295100061
J	Otero, M; Plumb, DA; Tsuchimochi, K; Dragomir, CL; Hashimoto, K; Peng, HB; Olivotto, E; Bevilacqua, M; Tan, LJ; Yang, ZY; Zhan, YM; Oettgen, P; Li, YF; Marcu, KB; Goldring, MB				Otero, Miguel; Plumb, Darren A.; Tsuchimochi, Kaneyuki; Dragomir, Cecilia L.; Hashimoto, Ko; Peng, Haibing; Olivotto, Eleonora; Bevilacqua, Michael; Tan, Lujian; Yang, Zhiyong; Zhan, Yumei; Oettgen, Peter; Li, Yefu; Marcu, Kenneth B.; Goldring, Mary B.			E74-like Factor 3 (ELF3) Impacts on Matrix Metalloproteinase 13 (MMP13) Transcriptional Control in Articular Chondrocytes under Proinflammatory Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN OSTEOARTHRITIC CHONDROCYTES; FACTOR-KAPPA-B; MESSENGER-RNA EXPRESSION; MAMMARY EPITHELIAL-CELLS; NITRIC-OXIDE SYNTHASE; BINDING-PROTEIN-BETA; GENE-EXPRESSION; HUMAN COLLAGENASE-3; FACTOR ESE-1; II COLLAGEN	Matrix metalloproteinase (MMP)-13 has a pivotal, rate-limiting function in cartilage remodeling and degradation due to its specificity for cleaving type II collagen. The proximal MMP13 promoter contains evolutionarily conserved E26 transformation-specific sequence binding sites that are closely flanked by AP-1 and Runx2 binding motifs, and interplay among these and other factors has been implicated in regulation by stress and inflammatory signals. Here we report that ELF3 directly controls MMP13 promoter activity by targeting an E26 transformation-specific sequence binding site at position -78 bp and by cooperating with AP-1. In addition, ELF3 binding to the proximal MMP13 promoter is enhanced by IL-1 beta stimulation in chondrocytes, and the IL-1 beta-induced MMP13 expression is inhibited in primary human chondrocytes by siRNA-ELF3 knockdown and in chondrocytes from Elf3(-/-) mice. Further, we found that MEK/ERK signaling enhances ELF3-driven MMP13 transactivation and is required for IL-1 beta-induced ELF3 binding to the MMP13 promoter, as assessed by chromatin immunoprecipitation. Finally, we show that enhanced levels of ELF3 co-localize with MMP13 protein and activity in human osteoarthritic cartilage. These studies define a novel role for ELF3 as a procatabolic factor that may contribute to cartilage remodeling and degradation by regulating MMP13 gene transcription.	[Otero, Miguel; Plumb, Darren A.; Tsuchimochi, Kaneyuki; Dragomir, Cecilia L.; Hashimoto, Ko; Bevilacqua, Michael; Goldring, Mary B.] Hosp Special Surg, Lab Cartilage Biol, Div Res, Weill Cornell Med Coll, New York, NY 10021 USA; [Peng, Haibing; Tan, Lujian; Zhan, Yumei; Oettgen, Peter] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02115 USA; [Peng, Haibing; Tan, Lujian; Zhan, Yumei; Oettgen, Peter] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Olivotto, Eleonora; Marcu, Kenneth B.] Ist Ortoped Rizzoli, Ctr Ric Codivilla Putti, SC Lab Immunoreumatol & Rigeneraz Tissutale, I-40136 Bologna, Italy; [Yang, Zhiyong] Pfizer Biotherapeut Res, Inflammat & Remodeling Res Unit, Cambridge, MA 02140 USA; [Li, Yefu] Harvard Univ, Sch Dent Med, Boston, MA 02115 USA; [Marcu, Kenneth B.] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA	Cornell University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; IRCCS Istituto Ortopedico Rizzoli; Pfizer; Harvard University; Harvard School of Dental Medicine; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Goldring, MB (corresponding author), Hosp Special Surg, Lab Cartilage Biol, Div Res, Weill Cornell Med Coll, Caspary Res Bldg,5th Floor,535 E 70th St, New York, NY 10021 USA.	goldringm@hss.edu	Oettgen, Peter/AAF-5026-2021; Olivotto, Eleonora/AAE-5763-2020; Olivotto, Eleonora/C-6938-2019	Olivotto, Eleonora/0000-0002-6726-3177; Hashimoto, Ko/0000-0002-9644-054X	National Institutes of Health [R01-AG022021, R21-AR054887, RC4 AR060546]; Arthritis Foundation; Osteoarthritis Research Society; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR054887, RC4AR060546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG022021] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arthritis Foundation; Osteoarthritis Research Society; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-AG022021, R21-AR054887, and RC4 AR060546 (to M. B. G.). This work was also supported by an Arthritis Foundation postdoctoral fellowship (to M. O.) and an Osteoarthritis Research Society international scholarship (to E. O.).	Bau B, 2002, ARTHRITIS RHEUM, V46, P2648, DOI 10.1002/art.10531; Benderdour M, 2002, J RHEUMATOL, V29, P1262; Benderdour M, 2002, BIOCHEM BIOPH RES CO, V291, P1151, DOI 10.1006/bbrc.2002.6580; Billinghurst RC, 1997, J CLIN INVEST, V99, P1534, DOI 10.1172/JCI119316; Borden P, 1996, J BIOL CHEM, V271, P23577, DOI 10.1074/jbc.271.38.23577; Brown C, 2004, J BIOL CHEM, V279, P12794, DOI 10.1074/jbc.M308593200; Cabral A, 2003, J BIOL CHEM, V278, P17792, DOI 10.1074/jbc.M300508200; Diaz-Sanjuan T, 2009, J HEPATOL, V50, P128, DOI 10.1016/j.jhep.2008.07.034; Eckel KL, 2003, DNA CELL BIOL, V22, P79, DOI 10.1089/104454903321515896; Fan ZY, 2006, ARTHRITIS RHEUM-US, V54, P2471, DOI 10.1002/art.21961; Freemont AJ, 1997, ANN RHEUM DIS, V56, P542, DOI 10.1136/ard.56.9.542; Geng Y, 1996, J CLIN INVEST, V98, P2425, DOI 10.1172/JCI119056; Goldring MB, 2011, EUR CELLS MATER, V21, P202, DOI 10.22203/eCM.v021a16; GOLDRING MB, 1994, J CLIN INVEST, V94, P2307, DOI 10.1172/JCI117595; Gosset M, 2008, NAT PROTOC, V3, P1253, DOI 10.1038/nprot.2008.95; Grall F, 2003, ARTHRITIS RHEUM, V48, P1249, DOI 10.1002/art.10942; Grall FT, 2005, FEBS J, V272, P1676, DOI 10.1111/j.1742-4658.2005.04592.x; Hayashida M, 2009, ARTHRITIS RHEUM-US, V60, P708, DOI 10.1002/art.24332; Ijiri K, 2008, ARTHRITIS RHEUM-US, V58, P2075, DOI 10.1002/art.23504; Inada M, 2004, P NATL ACAD SCI USA, V101, P17192, DOI 10.1073/pnas.0407788101; Iwai S, 2008, ORAL DIS, V14, P144, DOI 10.1111/j.1601-0825.2007.01360.x; Joosten LAB, 1999, J IMMUNOL, V163, P5049; Kas K, 2000, J BIOL CHEM, V275, P2986, DOI 10.1074/jbc.275.4.2986; Knauper V, 1996, J BIOL CHEM, V271, P1544, DOI 10.1074/jbc.271.3.1544; Kopp JL, 2007, J BIOL CHEM, V282, P3027, DOI 10.1074/jbc.M609907200; Koshy PJT, 2002, ARTHRITIS RHEUM, V46, P961, DOI 10.1002/art.10212; Lee SH, 2008, MOL CANCER THER, V7, P3739, DOI 10.1158/1535-7163.MCT-08-0548; Liacini A, 2002, MATRIX BIOL, V21, P251, DOI 10.1016/S0945-053X(02)00007-0; Litherland GJ, 2010, J BIOL CHEM, V285, P22414, DOI 10.1074/jbc.M110.120121; Little CB, 2009, ARTHRITIS RHEUM-US, V60, P3723, DOI 10.1002/art.25002; Lo YYC, 1998, J CELL BIOCHEM, V69, P19, DOI 10.1002/(SICI)1097-4644(19980401)69:1<19::AID-JCB3>3.0.CO;2-Y; Manavathi B, 2007, J BIOL CHEM, V282, P19820, DOI 10.1074/jbc.M702309200; Melchiorri C, 1998, ARTHRITIS RHEUM-US, V41, P2165, DOI 10.1002/1529-0131(199812)41:12<2165::AID-ART11>3.3.CO;2-F; Mengshol JA, 2000, ARTHRITIS RHEUM, V43, P801, DOI 10.1002/1529-0131(200004)43:4<801::AID-ANR10>3.0.CO;2-4; Mengshol JA, 2001, NUCLEIC ACIDS RES, V29, P4361, DOI 10.1093/nar/29.21.4361; Mitchell PG, 1996, J CLIN INVEST, V97, P761, DOI 10.1172/JCI118475; Muddasani P, 2007, J BIOL CHEM, V282, P31409, DOI 10.1074/jbc.M706508200; Murphy G, 2008, NAT CLIN PRACT RHEUM, V4, P128, DOI 10.1038/ncprheum0727; Nagarajan P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004179; Neuhold LA, 2001, J CLIN INVEST, V107, P35, DOI 10.1172/JCI10564; Neve R, 1998, FASEB J, V12, P1541, DOI 10.1096/fasebj.12.14.1541; Ng AYN, 2002, GASTROENTEROLOGY, V122, P1455, DOI 10.1053/gast.2002.32990; Nieminen R, 2005, MEDIAT INFLAMM, P249, DOI 10.1155/MI.2005.249; Oettgen P, 1997, MOL CELL BIOL, V17, P4419, DOI 10.1128/MCB.17.8.4419; Oettgen P, 1999, J BIOL CHEM, V274, P29439, DOI 10.1074/jbc.274.41.29439; Okazaki K, 2002, J BIOL CHEM, V277, P31526, DOI 10.1074/jbc.M202815200; Pei Y, 2006, OSTEOARTHR CARTILAGE, V14, P749, DOI 10.1016/j.joca.2006.01.017; Pendas AM, 1997, GENOMICS, V40, P222, DOI 10.1006/geno.1996.4554; Peng H, 2008, J CELL PHYSIOL, V215, P562, DOI 10.1002/jcp.21338; Prescott JD, 2004, MOL CELL BIOL, V24, P5548, DOI 10.1128/MCB.24.12.5548-5564.2004; Pritzker KPH, 2006, OSTEOARTHR CARTILAGE, V14, P13, DOI 10.1016/j.joca.2005.07.014; Reboul P, 1996, J CLIN INVEST, V97, P2011, DOI 10.1172/JCI118636; Reddy SPM, 2003, J BIOL CHEM, V278, P21378, DOI 10.1074/jbc.M212258200; Rogerson FM, 2010, ARTHRITIS RHEUM-US, V62, P3365, DOI 10.1002/art.27661; Rudders S, 2001, J BIOL CHEM, V276, P3302, DOI 10.1074/jbc.M006507200; Schedin PJ, 2004, ONCOGENE, V23, P1766, DOI 10.1038/sj.onc.1207391; Seidel JJ, 2002, GENE DEV, V16, P127, DOI 10.1101/gad.950902; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Tan LJ, 2003, J BIOL CHEM, V278, P17688, DOI 10.1074/jbc.M301676200; Tardif G, 2001, J RHEUMATOL, V28, P1631; Tetlow LC, 2001, ARTHRITIS RHEUM-US, V44, P585, DOI 10.1002/1529-0131(200103)44:3<585::AID-ANR107>3.0.CO;2-C; Tootle TL, 2005, BIOESSAYS, V27, P285, DOI 10.1002/bies.20198; Trojanowska M, 2000, ONCOGENE, V19, P6464, DOI 10.1038/sj.onc.1204043; Tsuchimochi K, 2010, J BIOL CHEM, V285, P8395, DOI 10.1074/jbc.M109.038638; Wu J, 2008, CELL RES, V18, P649, DOI 10.1038/cr.2008.57; Xu L, 2005, J BIOL CHEM, V280, P548, DOI 10.1074/jbc.M411036200; Yan CH, 2007, J CELL PHYSIOL, V211, P19, DOI 10.1002/jcp.20948; Yang S, 2010, NAT MED, V16, P687, DOI 10.1038/nm.2153; Zwerina J, 2007, P NATL ACAD SCI USA, V104, P11742, DOI 10.1073/pnas.0610812104	69	58	60	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3559	3572		10.1074/jbc.M111.265744	http://dx.doi.org/10.1074/jbc.M111.265744			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22158614	Green Published, hybrid			2022-12-27	WOS:000300295100060
J	Pelaez, R; Fernandez-Garcia, P; Herrero, P; Moreno, F				Pelaez, Rafael; Fernandez-Garcia, Paula; Herrero, Pilar; Moreno, Fernando			Nuclear Import of the Yeast Hexokinase 2 Protein Requires alpha/beta-Importin-dependent Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; LOCALIZATION SIGNALS; NUCLEOCYTOPLASMIC TRANSPORT; REPRESSOR; KINASE; EXPORT; MIG1; PHOSPHORYLATION; GENES; HXT1	Hexokinase 2 (Hxk2) from Saccharomyces cerevisiae was one of the first metabolic enzymes described as a multifunctional protein. Hxk2 has a double subcellular localization and role, it functions as a glycolytic enzyme in the cytoplasm and as a regulator of gene transcription of several Mig1-regulated genes in the nucleus. However, the mechanism by which Hxk2 enters in the nucleus was unknown until now. Here, we report that the Hxk2 protein is an import substrate of the carriers alpha-importin (Kap60 in yeast) and beta-importin (Kap95 in yeast). We also show that the Hxk2 nuclear import and the binding of Hxk2 with Kap60 are glucose-dependent and involve one lysine-rich nuclear localization sequence (NLS), located between lysine 6 and lysine 12. Moreover, Kap95 facilitates the recognition of the Hxk2 NLS1 motif by Kap60 and both importins are essential for Hxk2 nuclear import. It is also demonstrated that Hxk2 nuclear import and its binding to Kap95 and Kap60 depend on the Gsp1-GTP/GDP protein levels. Thus, our study uncovers Hxk2 as a new cargo for the alpha/beta-importin pathway of S. cerevisiae.	[Pelaez, Rafael; Fernandez-Garcia, Paula; Herrero, Pilar; Moreno, Fernando] Univ Oviedo, Dept Biochem & Mol Biol, Oviedo 33006, Spain	University of Oviedo	Moreno, F (corresponding author), Campus El Cristo, Oviedo 33006, Spain.	fmoreno@uniovi.es	Fernández-García, Paula/M-5227-2019; Peláez, Rafael/R-9458-2019; Fernández García, Paula/L-8101-2014	Fernández-García, Paula/0000-0002-8128-7028; Peláez, Rafael/0000-0002-4047-6017; 	Ministerio de Ciencia e Innovacion (Spain) [BFU2007-66063-C02-02, BFU2010-19628-C02-01]; FICYT Foundation (Principado de Asturias); MICINN (Spain) [BFU2007-66063-C02-02]	Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); FICYT Foundation (Principado de Asturias); MICINN (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by Grants BFU2007-66063-C02-02 and BFU2010-19628-C02-01 from the Ministerio de Ciencia e Innovacion (Spain).; Supported by a Severo Ochoa fellowship from the FICYT Foundation (Principado de Asturias). Present address: Centro de Investigacion Medica Aplicada (CIMA), Universidad de Navarra, 31008 Pamplona, Spain.; Supported by Formacion de Personal Investigador fellowship Grant BFU2007-66063-C02-02 from the MICINN (Spain).	Ahuatzi D, 2004, J BIOL CHEM, V279, P14440, DOI 10.1074/jbc.M313431200; Ahuatzi D, 2007, J BIOL CHEM, V282, P4485, DOI 10.1074/jbc.M606854200; Belinchon MM, 2007, FEMS YEAST RES, V7, P40, DOI 10.1111/j.1567-1364.2006.00136.x; Cook A, 2007, ANNU REV BIOCHEM, V76, P647, DOI 10.1146/annurev.biochem.76.052705.161529; DeVit MJ, 1999, CURR BIOL, V9, P1231, DOI 10.1016/S0960-9822(99)80503-X; Ferrigno P, 1998, EMBO J, V17, P5606, DOI 10.1093/emboj/17.19.5606; GASCON S, 1968, J BIOL CHEM, V243, P1567; GORLICH D, 1994, CELL, V79, P767, DOI 10.1016/0092-8674(94)90067-1; GORLICH D, 1995, CURR BIOL, V5, P383, DOI 10.1016/S0960-9822(95)00079-0; HERRERO P, 1995, YEAST, V11, P137, DOI 10.1002/yea.320110205; KADOWAKI H, 1989, GENE, V76, P161, DOI 10.1016/0378-1119(89)90018-8; Kalab P, 2002, SCIENCE, V295, P2452, DOI 10.1126/science.1068798; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Kosugi S, 2009, J BIOL CHEM, V284, P478, DOI 10.1074/jbc.M807017200; Kunzler M, 2000, MOL CELL BIOL, V20, P4295, DOI 10.1128/MCB.20.12.4295-4308.2000; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Leslie DM, 2006, METHODS, V39, P291, DOI 10.1016/j.ymeth.2006.07.013; MA H, 1986, MOL CELL BIOL, V6, P4046, DOI 10.1128/MCB.6.11.4046; Moreno F, 2005, BIOCHEM SOC T, V33, P265, DOI 10.1042/BST0330265; Pelaez R, 2009, J BIOL CHEM, V284, P20548, DOI 10.1074/jbc.M109.013730; Polizotto RS, 2001, J CELL BIOL, V154, P951, DOI 10.1083/jcb.200104078; Quan XX, 2007, BBA-MOL CELL RES, V1773, P1052, DOI 10.1016/j.bbamcr.2007.04.014; RADU A, 1995, P NATL ACAD SCI USA, V92, P1769, DOI 10.1073/pnas.92.5.1769; Randez-Gil F, 1998, FEBS LETT, V425, P475, DOI 10.1016/S0014-5793(98)00289-0; Smith AE, 2002, SCIENCE, V295, P488, DOI 10.1126/science.1064732; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; Taberner FJ, 2009, CELL CYCLE, V8, P3010; Tomas-Cobos L, 2002, BIOCHEM J, V368, P657, DOI 10.1042/BJ20020984; Treitel MA, 1998, MOL CELL BIOL, V18, P6273, DOI 10.1128/MCB.18.11.6273; WALLIS JW, 1989, CELL, V58, P409, DOI 10.1016/0092-8674(89)90855-6; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5	31	15	15	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3518	3529		10.1074/jbc.M111.317230	http://dx.doi.org/10.1074/jbc.M111.317230			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22157003	Green Published, hybrid			2022-12-27	WOS:000300295100056
J	Tidhar, R; Ben-Dor, S; Wang, E; Kelly, S; Merrill, AH; Futerman, AH				Tidhar, Rotem; Ben-Dor, Shifra; Wang, Elaine; Kelly, Samuel; Merrill, Alfred H., Jr.; Futerman, Anthony H.			Acyl Chain Specificity of Ceramide Synthases Is Determined within a Region of 150 Residues in the Tram-Lag-CLN8 (TLC) Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE PROTEIN TOPOLOGY; LONGEVITY ASSURANCE GENES; HIGH-THROUGHPUT; FAMILY-MEMBERS; PREDICTION; LAG1; SPHINGOLIPIDS; ACCURACY; YEAST; CLASSIFICATION	In mammals, ceramides are synthesized by a family of six ceramide synthases (CerS), transmembrane proteins located in the endoplasmic reticulum, where each use fatty acyl-CoAs of defined chain length for ceramide synthesis. Little is known about the molecular features of the CerS that determine acyl-CoA selectivity. We now explore CerS structure-function relationships by constructing chimeric proteins combining sequences from CerS2, which uses C22-CoA for ceramide synthesis, and CerS5, which uses C16-CoA. CerS2 and -5 are 41% identical and 63% similar. Chimeras containing approximately half of CerS5 (from the N terminus) and half of CerS2 (from the C terminus) were catalytically inactive. However, the first 158 residues of CerS5 could be replaced with the equivalent region of CerS2 without affecting specificity of CerS5 toward C16-CoA; likewise, the putative sixth transmembrane domain (at the C terminus) of CerS5 could be replaced with the corresponding sequence of CerS2 without affecting CerS5 specificity. Remarkably, a chimeric CerS5/2 protein containing the first 158 residues and the last 83 residues of CerS2 displayed specificity toward C16-CoA, and a chimeric CerS2/5 protein containing the first 150 residues and the last 79 residues of CerS5 displayed specificity toward C22-CoA, demonstrating that a minimal region of 150 residues is sufficient for retaining CerS specificity.	[Tidhar, Rotem; Futerman, Anthony H.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Ben-Dor, Shifra] Weizmann Inst Sci, Dept Biol Serv, IL-76100 Rehovot, Israel; [Wang, Elaine; Kelly, Samuel; Merrill, Alfred H., Jr.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Wang, Elaine; Kelly, Samuel; Merrill, Alfred H., Jr.] Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA	Weizmann Institute of Science; Weizmann Institute of Science; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Futerman, AH (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	tony.futerman@weizmann.ac.il	BEN-DOR, SHIFRA/M-6718-2019	BEN-DOR, SHIFRA/0000-0001-9604-1939; Futerman, Anthony/0000-0003-0013-0115; Merrill, Alfred/0000-0002-6673-968X	National Institutes of Health [GM076217]; Israel Science Foundation [1404/07]; Minerva Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076217] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Israel Science Foundation(Israel Science Foundation); Minerva Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM076217, and by the Israel Science Foundation (1404/07) and the Minerva Foundation.	Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; Cserzo M, 2002, PROTEIN ENG, V15, P745, DOI 10.1093/protein/15.9.745; Drummond AJ, 2010, GENEIOUS V5 3; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Futerman AH, 2005, TRENDS CELL BIOL, V15, P312, DOI 10.1016/j.tcb.2005.04.006; Goldfinger M, 2009, J IMMUNOL, V182, P7038, DOI 10.4049/jimmunol.0802990; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; Hannun YA, 2011, J BIOL CHEM, V286, P27855, DOI 10.1074/jbc.R111.254359; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; HIRSCHBERG K, 1993, BIOCHEM J, V290, P751, DOI 10.1042/bj2900751; Hofmann K., 1993, BIOL CHEM H-S, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Jiang JC, 1998, GENOME RES, V8, P1259, DOI 10.1101/gr.8.12.1259; Jones DT, 2007, BIOINFORMATICS, V23, P538, DOI 10.1093/bioinformatics/btl677; Juretic D, 2002, J CHEM INF COMP SCI, V42, P620, DOI 10.1021/ci010263s; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Kageyama-Yahara N, 2006, BIOCHEM J, V398, P585, DOI 10.1042/BJ20060697; Kolesnick R, 2002, J CLIN INVEST, V110, P3, DOI 10.1172/JCI200216127; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lahiri S, 2007, CELL MOL LIFE SCI, V64, P2270, DOI 10.1007/s00018-007-7076-0; Lahiri S, 2005, J BIOL CHEM, V280, P33735, DOI 10.1074/jbc.M506485200; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laviad EL, 2008, J BIOL CHEM, V283, P5677, DOI 10.1074/jbc.M707386200; Levy M, 2010, IUBMB LIFE, V62, P347, DOI 10.1002/iub.319; Merrill AH, 2005, METHODS, V36, P207, DOI 10.1016/j.ymeth.2005.01.009; Mesika A, 2007, J BIOL CHEM, V282, P27366, DOI 10.1074/jbc.M703487200; Mizutani Y, 2005, BIOCHEM J, V390, P263, DOI 10.1042/BJ20050291; Pasquier C, 1999, PROTEIN ENG, V12, P631, DOI 10.1093/protein/12.8.631; Pewzner-Jung Y, 2006, J BIOL CHEM, V281, P25001, DOI 10.1074/jbc.R600010200; Reynolds SM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000213; Riebeling C, 2003, J BIOL CHEM, V278, P43452, DOI 10.1074/jbc.M307104200; Rost B, 1996, METHOD ENZYMOL, V266, P525; Shabi Uri, 2010, Syst Synth Biol, V4, P227, DOI 10.1007/s11693-010-9059-y; Shen HB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002399; Spassieva S, 2006, J BIOL CHEM, V281, P33931, DOI 10.1074/jbc.M608092200; Sridevi P, 2009, BBA-MOL CELL RES, V1793, P1218, DOI 10.1016/j.bbamcr.2009.04.006; Stiban J, 2010, ADV EXP MED BIOL, V688, P60; Sullards M C, 2001, Sci STKE, V2001, ppl1; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; Venkataraman K, 2002, FEBS LETT, V528, P3, DOI 10.1016/S0014-5793(02)03248-9; Venkataraman K, 2002, J BIOL CHEM, V277, P35642, DOI 10.1074/jbc.M205211200; Winter E, 2002, TRENDS BIOCHEM SCI, V27, P381, DOI 10.1016/S0968-0004(02)02154-0; Yuan Z, 2004, J COMPUT CHEM, V25, P632, DOI 10.1002/jcc.10411; Zhao LH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002063	45	44	44	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3197	3206		10.1074/jbc.M111.280271	http://dx.doi.org/10.1074/jbc.M111.280271			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22144673	Green Published, hybrid			2022-12-27	WOS:000300295100025
J	Zhang, PX; Takeuchi, K; Csaki, LS; Reue, K				Zhang, Peixiang; Takeuchi, Kazuharu; Csaki, Lauren S.; Reue, Karen			Lipin-1 Phosphatidic Phosphatase Activity Modulates Phosphatidate Levels to Promote Peroxisome Proliferator-activated Receptor gamma (PPAR gamma) Gene Expression during Adipogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBCELLULAR-LOCALIZATION; C/EBP-DELTA; ACID; LIPODYSTROPHY; OBESITY; ALPHA; PROTEIN; ROLES; PHOSPHORYLATION; TRANSCRIPTION	Adipose tissue plays a key role in metabolic homeostasis. Disruption of the Lpin1 gene encoding lipin-1 causes impaired adipose tissue development and function in rodents. Lipin-1 functions as a phosphatidate phosphatase (PAP) enzyme in the glycerol 3-phosphate pathway for triglyceride storage and as a transcriptional coactivator/corepressor for metabolic nuclear receptors. Previous studies established that lipin-1 is required at an early step in adipocyte differentiation for induction of the adipogenic gene transcription program, including the key regulator peroxisome proliferator-activated receptor gamma (PPAR gamma). Here, we investigate the requirement of lipin-1 PAP versus coactivator function in the establishment of Pparg expression during adipocyte differentiation. We demonstrate that PAP activity supplied by lipin-1, lipin-2, or lipin-3, but not lipin-1 coactivator activity, can rescue Pparg gene expression and lipogenesis during adipogenesis in lipin-1-deficient preadipocytes. In adipose tissue from lipin-1-deficient mice, there is an accumulation of phosphatidate species containing a range of medium chain fatty acids and an activation of the MAPK/extracellular signal-related kinase (ERK) signaling pathway. Phosphatidate inhibits differentiation of cultured adipocytes, and this can be rescued by the expression of lipin-1 PAP activity or by inhibition of ERK signaling. These results emphasize the importance of lipid intermediates as choreographers of gene regulation during adipogenesis, and the results highlight a specific role for lipins as determinants of levels of a phosphatidic acid pool that influences Pparg expression.	[Zhang, Peixiang; Takeuchi, Kazuharu; Csaki, Lauren S.; Reue, Karen] Univ Calif Los Angeles, Dept Human Genet, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Reue, Karen] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Reue, K (corresponding author), Univ Calif Los Angeles, Dept Human Genet, David Geffen Sch Med, Gonda 6506A,695 Charles E Young Dr S, Los Angeles, CA 90095 USA.	reuek@ucla.edu			National Institutes of Health [P01 HL90553, P01 HL28481, T32 HG002536, P20RR16475]; National Science Foundation [EPS 0236913, MCB 0455318, 0920663, DBI 0521587]; Kansas Technology Enterprise Corp.; K-IDeA Networks of Biomedical Research Excellence; Kansas State University; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016475] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL090553, P01HL028481] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG002536] Funding Source: NIH RePORTER; Direct For Biological Sciences [0920663] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Kansas Technology Enterprise Corp.; K-IDeA Networks of Biomedical Research Excellence; Kansas State University; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 HL90553 and P01 HL28481 (to K.R.) and T32 HG002536 (to L.C.).; The lipidomic analyses by mass spectrometry were performed at the Kansas Lipidomics Research Center Analytical Laboratory. Instrument acquisition and methods development at the Kansas Lipidomics Research Center were supported by National Science Foundation Grants EPS 0236913, MCB 0455318 and 0920663, and DBI 0521587, the Kansas Technology Enterprise Corp., National Institutes of Health Grant P20RR16475, K-IDeA Networks of Biomedical Research Excellence, and Kansas State University.	Andresen BT, 2002, FEBS LETT, V531, P65, DOI 10.1016/S0014-5793(02)03483-X; Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; BELL RM, 1980, ANNU REV BIOCHEM, V49, P459, DOI 10.1146/annurev.bi.49.070180.002331; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brindley DN, 2009, BBA-MOL CELL BIOL L, V1791, P956, DOI 10.1016/j.bbalip.2009.02.007; Cortes VA, 2009, CELL METAB, V9, P165, DOI 10.1016/j.cmet.2009.01.002; Csaki LS, 2010, ANNU REV NUTR, V30, P257, DOI 10.1146/annurev.nutr.012809.104729; Devaiah SP, 2006, PHYTOCHEMISTRY, V67, P1907, DOI 10.1016/j.phytochem.2006.06.005; Donkor J, 2007, J BIOL CHEM, V282, P3450, DOI 10.1074/jbc.M610745200; Donkor J, 2009, J BIOL CHEM, V284, P29968, DOI 10.1074/jbc.M109.023663; Fakas S, 2011, J BIOL CHEM, V286, P29074, DOI 10.1074/jbc.M111.258798; Finck BN, 2005, CELL METAB, V1, P133, DOI 10.1016/j.cmet.2005.01.006; Foster DA, 2007, CANCER RES, V67, P1, DOI 10.1158/0008-5472.CAN-06-3016; FRANCKHAUSER S, 1995, BIOCHEM J, V305, P65, DOI 10.1042/bj3050065; Gale SE, 2006, J BIOL CHEM, V281, P11082, DOI 10.1074/jbc.M509612200; Gangoiti P, 2008, CELL SIGNAL, V20, P726, DOI 10.1016/j.cellsig.2007.12.008; Golden A, 2009, J CELL SCI, V122, P1970, DOI 10.1242/jcs.044743; Grkovich A, 2009, ADV ENZYME REGUL, V49, P114, DOI 10.1016/j.advenzreg.2009.01.005; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Harris TE, 2007, J BIOL CHEM, V282, P277, DOI 10.1074/jbc.M609537200; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Huang HY, 2011, DEV CELL, V20, P376, DOI 10.1016/j.devcel.2011.01.004; Huang-Doran I, 2010, J ENDOCRINOL, V207, P245, DOI 10.1677/JOE-10-0272; Hummasti S, 2006, MOL ENDOCRINOL, V20, P1261, DOI 10.1210/me.2006-0025; Itoh T, 2008, NAT STRUCT MOL BIOL, V15, P924, DOI 10.1038/nsmb.1474; Kim HB, 2010, MOL CELL BIOL, V30, P3126, DOI 10.1128/MCB.01671-09; Kim KA, 2007, MOL CELL BIOL, V27, P2294, DOI 10.1128/MCB.02207-06; Koh YK, 2008, J BIOL CHEM, V283, P34896, DOI 10.1074/jbc.M804007200; Kraft CA, 2008, J BIOL CHEM, V283, P36636, DOI 10.1074/jbc.M804633200; Lowe CE, 2011, J CELL SCI, V124, P2681, DOI 10.1242/jcs.079699; Lusis AJ, 2008, NAT REV GENET, V9, P819, DOI 10.1038/nrg2468; Mitra MS, 2011, J MOL CELL CARDIOL, V51, P120, DOI 10.1016/j.yjmcc.2011.04.009; Morita S, 2009, J LIPID RES, V50, P1945, DOI 10.1194/jlr.D900014-JLR200; Mul JD, 2011, J BIOL CHEM, V286, P26781, DOI 10.1074/jbc.M110.197947; Nadra K, 2008, GENE DEV, V22, P1647, DOI 10.1101/gad.1638008; Patwardhan GA, 2011, PROG LIPID RES, V50, P104, DOI 10.1016/j.plipres.2010.10.003; Payne VA, 2010, BIOCHEM J, V425, P215, DOI 10.1042/BJ20091112; Peterfy M, 2005, J BIOL CHEM, V280, P32883, DOI 10.1074/jbc.M503885200; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Phan J, 2005, DRUG NEWS PERSPECT, V18, P5, DOI 10.1358/dnp.2005.18.1.877165; Phan J, 2005, CELL METAB, V1, P73, DOI 10.1016/j.cmet.2004.12.002; Phan J, 2004, J BIOL CHEM, V279, P29558, DOI 10.1074/jbc.M403506200; Ren HM, 2010, MOL BIOL CELL, V21, P3171, DOI 10.1091/mbc.E10-01-0073; Reue K, 2006, CURR OPIN CLIN NUTR, V9, P436, DOI 10.1097/01.mco.0000232904.82038.db; Ross SE, 2002, MOL CELL BIOL, V22, P5989, DOI 10.1128/MCB.22.16.5989-5999.2002; Shan DD, 2010, J LIPID RES, V51, P1971, DOI 10.1194/jlr.M006304; Simha V, 2009, CURR OPIN LIPIDOL, V20, P300, DOI 10.1097/MOL.0b013e32832d4a33; Stace CL, 2006, BBA-MOL CELL BIOL L, V1761, P913, DOI 10.1016/j.bbalip.2006.03.006; Stapleton CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018932; STUDENT AK, 1980, J BIOL CHEM, V255, P4745; Subbaramaiah K, 1998, J BIOL CHEM, V273, P32943, DOI 10.1074/jbc.273.49.32943; Takeuchi K, 2009, AM J PHYSIOL-ENDOC M, V296, pE1195, DOI 10.1152/ajpendo.90958.2008; Tanaka T, 1997, EMBO J, V16, P7432, DOI 10.1093/emboj/16.24.7432; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Tsukahara T, 2010, MOL CELL, V39, P421, DOI 10.1016/j.molcel.2010.07.022; Ugrankar R, 2011, MOL CELL BIOL, V31, P1646, DOI 10.1128/MCB.01335-10; Vernochet C, 2009, FEBS J, V276, P5729, DOI 10.1111/j.1742-4658.2009.07302.x; Villanueva CJ, 2011, CELL METAB, V13, P413, DOI 10.1016/j.cmet.2011.02.014; Welti R, 2002, J BIOL CHEM, V277, P31994, DOI 10.1074/jbc.M205375200; White UA, 2010, MOL CELL ENDOCRINOL, V318, P10, DOI 10.1016/j.mce.2009.08.023; Wu ZD, 1996, MOL CELL BIOL, V16, P4128; Zalesin KC, 2011, MED CLIN N AM, V95, P919, DOI 10.1016/j.mcna.2011.06.005; Zhang P, 2008, J LIPID RES, V49, P1519, DOI 10.1194/jlr.M800061-JLR200	64	58	60	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3485	3494		10.1074/jbc.M111.296681	http://dx.doi.org/10.1074/jbc.M111.296681			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22157014	Green Published, hybrid			2022-12-27	WOS:000300295100053
J	Wang, JC; Chen, L; Ko, CI; Zhang, L; Puga, A; Xia, Y				Wang, Jingcai; Chen, Liang; Ko, Chia-I; Zhang, Lin; Puga, Alvaro; Xia, Ying			Distinct Signaling Properties of Mitogen-activated Protein Kinase Kinases 4 (MKK4) and 7 (MKK7) in Embryonic Stem Cell (ESC) Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JUN NH2-TERMINAL KINASE; SYNERGISTIC ACTIVATION; CARDIAC-FUNCTION; APOPTOSIS; P38; EXPRESSION; REVEALS; PATHWAY; GROWTH; MICE	Signal transduction pathways are integral components of the developmental regulatory network that guides progressive cell fate determination. MKK4 and MKK7 are upstream kinases of the mitogen-activated protein kinases (MAPKs), responsible for channeling physiological and environmental signals to their cellular responses. Both kinases are essential for survival of mouse embryos, but because of embryonic lethality, their precise developmental roles remain largely unknown. Using gene knock-out mouse ESCs, we studied the roles of MKK4 and MKK7 in differentiation in vitro. While MKK4 and MKK7 were dispensable for ESC self-renewal and pluripotency maintenance, they exhibited unique signaling and functional properties in differentiation. MKK4 and MKK7 complemented each other in activation of the JNK-c-Jun cascades and loss of both led to senescence upon cell differentiation. On the other hand, MKK4 and MKK7 had opposite effects on activation of the p38 cascades during differentiation. Specifically, MKK7 reduced p38 activation, while Mkk7(-/-) ESCs had elevated phosphorylation of MKK4, p38, and ATF2, and increased MEF2C expression. Consequently, Mkk7(-/-) ESCs had higher expression of MHC and MLC and enhanced formation of contractile cardiomyocytes. In contrast, MKK4 was required for p38 activation and Mkk4(-/-) ESCs exhibited diminished p-ATF2 and MEF2C expression, resulting in impaired MHC induction and defective cardiomyocyte differentiation. Exogenous MKK4 expression partially restored the ability of Mkk4(-/-) ESCs to differentiate into cardiomyocytes. Our results uncover complementary and interdependent roles of MKK4 and MKK7 in development, and identify the essential requirement for MKK4 in p38 activation and cardiomyocyte differentiation.	[Wang, Jingcai; Zhang, Lin] So Med Univ, Dept Histol & Embryol, Guangzhou 510515, Guangdong, Peoples R China; [Wang, Jingcai; Chen, Liang; Ko, Chia-I; Puga, Alvaro; Xia, Ying] Univ Cincinnati, Coll Med, Dept Environm Hlth, Cincinnati, OH 45367 USA	Southern Medical University - China; University System of Ohio; University of Cincinnati	Zhang, L (corresponding author), So Med Univ, Dept Histol & Embryol, Guangzhou 510515, Guangdong, Peoples R China.	zlilyzh@126.com; ying.xia@uc.edu	Chen, Liang/G-2990-2013	Chen, Liang/0000-0002-6748-9416	National Institutes of Health [EY15227]; NIEHS [ES006273, P30 ES006096]; Ryan Foundation; National Natural Science Foundation of China [30973129]; program for New Century Excellent Talents in University [NCET-08-0647, NCET-09-0088]; Foundation for Science & Tech Research Project of Guangdong [2009A030200015]; Natural Science Foundation of Guangdong Province [92510515000008]; Program for Changjiang Scholars and Innovative Research Team in University [IRT0731]; NATIONAL EYE INSTITUTE [R01EY015227] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES006273, P30ES006096, R56ES006273] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Ryan Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Foundation for Science & Tech Research Project of Guangdong; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by funding from the National Institutes of Health, Grant EY15227 (to J. W., L. C., and Y. X.), NIEHS ES006273 (to C. K., and A. P.), and NIEHS P30 ES006096 (to J. W., L. C., C. K., A. P., and Y. X.), and Ryan Foundation (to L. C.).; Supported in part by grants from The National Natural Science Foundation of China (No. 30973129) and the program for New Century Excellent Talents in University (No. NCET-08-0647 and NCET-09-0088), Foundation for Science & Tech Research Project of Guangdong (2009A030200015), Key Program of Natural Science Foundation of Guangdong Province (92510515000008), and Program for Changjiang Scholars and Innovative Research Team in University (IRT0731).	Aikawa R, 2002, HYPERTENSION, V39, P233, DOI 10.1161/hy0202.102699; Amura CR, 2005, MOL CELL BIOL, V25, P10791, DOI 10.1128/MCB.25.24.10791-10802.2005; Aouadi M, 2006, STEM CELLS, V24, P1399, DOI 10.1634/stemcells.2005-0398; Asaoka Y, 2010, J BIOCHEM, V148, P393, DOI 10.1093/jb/mvq098; Barruet E, 2011, STEM CELLS DEV, V20, P1233, DOI 10.1089/scd.2010.0213; Belanger LF, 2003, MOL CELL BIOL, V23, P4778, DOI 10.1128/MCB.23.14.4778-4787.2003; Bi WZ, 1999, DEV BIOL, V211, P255, DOI 10.1006/dbio.1999.9307; Bissonauth V, 2006, DEVELOPMENT, V133, P3429, DOI 10.1242/dev.02526; Brancho D, 2003, GENE DEV, V17, P1969, DOI 10.1101/gad.1107303; Chen AE, 2005, NATURE, V433, P317, DOI 10.1038/nature03126; Davidson SM, 2000, DEV BIOL, V218, P146, DOI 10.1006/dbio.1999.9596; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; Di Felice V, 2009, ANAT REC, V292, P449, DOI 10.1002/ar.20858; Doss MX, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r56; DOWNS KM, 1993, DEVELOPMENT, V118, P1255; Dworkin S, 2009, STEM CELLS, V27, P1347, DOI 10.1002/stem.56; Eriksson M, 2002, J BIOL CHEM, V277, P15992, DOI 10.1074/jbc.M107340200; Ganiatsas S, 1998, P NATL ACAD SCI USA, V95, P6881, DOI 10.1073/pnas.95.12.6881; Giroux S, 1999, CURR BIOL, V9, P369, DOI 10.1016/S0960-9822(99)80164-X; Glise B, 1997, GENE DEV, V11, P1738, DOI 10.1101/gad.11.13.1738; Gribaldo Laura, 2002, Experimental Hematology (Charlottesville), V30, P628, DOI 10.1016/S0301-472X(02)00827-5; GRIGORIADIS AE, 1993, J CELL BIOL, V122, P685, DOI 10.1083/jcb.122.3.685; Han J, 1997, NATURE, V386, P296, DOI 10.1038/386296a0; Harvey RP, 1999, SEMIN CELL DEV BIOL, V10, P99, DOI 10.1006/scdb.1998.0277; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; Hopfl G, 2004, METH MOL B, V254, P79; Itskovitz-Eldor J, 2000, MOL MED, V6, P88, DOI 10.1007/BF03401776; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Kim NY, 2009, ARCH PHARM RES, V32, P737, DOI 10.1007/s12272-009-1513-6; Kuan CY, 1999, NEURON, V22, P667, DOI 10.1016/S0896-6273(00)80727-8; Lawler S, 1998, CURR BIOL, V8, P1387, DOI 10.1016/S0960-9822(98)00019-0; Li ZH, 2006, AM J PHYSIOL-HEART C, V291, pH1972, DOI 10.1152/ajpheart.00043.2006; Lim JY, 2005, J MOL CELL CARDIOL, V39, P627, DOI 10.1016/j.yjmcc.2005.06.016; LIN AN, 1995, SCIENCE, V268, P286, DOI 10.1126/science.7716521; Lin Q, 1997, SCIENCE, V276, P1404, DOI 10.1126/science.276.5317.1404; Liu W, 2009, CIRC RES, V104, P905, DOI 10.1161/CIRCRESAHA.108.188292; Maekawa T, 1999, J BIOL CHEM, V274, P17813, DOI 10.1074/jbc.274.25.17813; Nishina H, 1997, NATURE, V385, P350, DOI 10.1038/385350a0; Nishina H, 1999, DEVELOPMENT, V126, P505; Nishitai G, 2004, J BIOL CHEM, V279, P1621, DOI 10.1074/jbc.M310335200; Peng ZM, 2007, J BIOL CHEM, V282, P21487, DOI 10.1074/jbc.M702510200; Rui YN, 2007, DEV CELL, V13, P268, DOI 10.1016/j.devcel.2007.07.006; Saba-El-Leil MK, 2003, EMBO REP, V4, P964, DOI 10.1038/sj.embor.embor939; Sabapathy K, 1999, CURR BIOL, V9, P116, DOI 10.1016/S0960-9822(99)80065-7; Sasaki T, 2001, J EXP MED, V194, P757, DOI 10.1084/jem.194.6.757; Schnekenburger M, 2007, BBA-GENE STRUCT EXPR, V1769, P569, DOI 10.1016/j.bbaexp.2007.07.002; Seo J, 2010, J CELL BIOCHEM, V110, P1022, DOI 10.1002/jcb.22616; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; Sugden PH, 1998, J MOL MED, V76, P725, DOI 10.1007/s001090050275; Tamura K, 2000, CELL, V102, P221, DOI 10.1016/S0092-8674(00)00027-1; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wada T, 2004, ONCOGENE, V23, P2838, DOI 10.1038/sj.onc.1207556; Wada T, 2001, J BIOL CHEM, V276, P30892, DOI 10.1074/jbc.M011780200; Wang JY, 2010, FASEB J, V24, P2066, DOI 10.1096/fj.09-142315; Xia Y, 1998, GENE DEV, V12, P3369, DOI 10.1101/gad.12.21.3369; Xu P, 2010, MOL CELL BIOL, V30, P1329, DOI 10.1128/MCB.00795-09; Yang D, 1997, P NATL ACAD SCI USA, V94, P3004, DOI 10.1073/pnas.94.7.3004; Yao Y, 2003, P NATL ACAD SCI USA, V100, P12759, DOI 10.1073/pnas.2134254100; Yu AL, 2010, INVEST OPHTH VIS SCI, V51, P5718, DOI 10.1167/iovs.10-5679; Zechner D, 1997, J CELL BIOL, V139, P115, DOI 10.1083/jcb.139.1.115	61	17	18	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2787	2797		10.1074/jbc.M111.281915	http://dx.doi.org/10.1074/jbc.M111.281915			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22130668	Green Published, hybrid			2022-12-27	WOS:000300292300050
J	Fischer, A; Sambashivan, S; Brunger, AT; Montal, M				Fischer, Audrey; Sambashivan, Shilpa; Brunger, Axel T.; Montal, Mauricio			Beltless Translocation Domain of Botulinum Neurotoxin A Embodies a Minimum Ion-conductive Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL-ANALYSIS; RECEPTOR-BINDING; ANTHRAX TOXIN; HEAVY-CHAIN; SUBSTRATE RECOGNITION; CRYSTAL-STRUCTURE; PROTEIN-RECEPTOR; MEMBRANE-FUSION; PORE FORMATION; LIGHT-CHAIN	Botulinum neurotoxin, the causative agent of the paralytic disease botulism, is an endopeptidase composed of a catalytic domain (or light chain (LC)) and a heavy chain (HC) encompassing the translocation domain (TD) and receptor-binding domain. Upon receptor-mediated endocytosis, the LC and TD are proposed to undergo conformational changes in the acidic endocytic environment resulting in the formation of an LC protein-conducting TD channel. The mechanism of channel formation and the conformational changes in the toxin upon acidification are important but less well understood aspects of botulinum neurotoxin intoxication. Here, we have identified a minimum channel-forming truncation of the TD, the "beltless" TD, that forms transmembrane channels with ion conduction properties similar to those of the full-length TD. At variance with the holotoxin and the HC, channel formation for both the TD and the beltless TD occurs independent of a transmembrane pH gradient. Furthermore, acidification in solution induces moderate secondary structure changes. The subtle nature of the conformational changes evoked by acidification on the TD suggests that, in the context of the holotoxin, larger structural rearrangements and LC unfolding occur preceding or concurrent to channel formation. This notion is consistent with the hypothesis that although each domain of the holotoxin functions individually, each domain serves as a chaperone for the others.	[Fischer, Audrey; Montal, Mauricio] Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA; [Sambashivan, Shilpa; Brunger, Axel T.] Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Brunger, Axel T.] Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Brunger, Axel T.] Stanford Univ, Dept Biol Struct, Stanford, CA 94305 USA; [Brunger, Axel T.] Stanford Univ, Dept Photon Sci, Stanford, CA 94305 USA; [Brunger, Axel T.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	University of California System; University of California San Diego; Stanford University; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Montal, M (corresponding author), Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA.	mmontal@ucsd.edu	Pacific-Southwest, RCE/B-6155-2009	Brunger, Axel/0000-0001-5121-2036	Howard Hughes Medical Institute; National Institutes of Health [MH63105, GM49711, AI065359]; Genentech Foundation; Stanford University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI065359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049711] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH063105, R01MH063105] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genentech Foundation(Roche HoldingGenentech); Stanford University(Stanford University); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Howard Hughes Medical Institute. This work was also supported, in whole or in part, by National Institutes of Health Grants MH63105 (to A. T. B.), GM49711, and AI065359 (to M. M).; Supported by the Genentech Foundation postdoctoral fellowship, Stanford University. Present address: Dept. of Neurosciences, Amgen Inc., South San Francisco, CA 94080.	Agarwal R, 2009, NAT STRUCT MOL BIOL, V16, P789, DOI 10.1038/nsmb.1626; Bade S, 2004, J NEUROCHEM, V91, P1461, DOI 10.1111/j.1471-4159.2004.02844.x; Basilio D, 2009, J GEN PHYSIOL, V133, P307, DOI 10.1085/jgp.200810170; Blocker D, 2003, J BIOL CHEM, V278, P37360, DOI 10.1074/jbc.M305849200; Breidenbach MA, 2004, NATURE, V432, P925, DOI 10.1038/nature03123; Brunger AT, 2007, PLOS PATHOG, V3, P1191, DOI 10.1371/journal.ppat.0030113; Carpaneto A, 1999, EXP BRAIN RES, V124, P193, DOI 10.1007/s002210050614; Dong M, 2006, SCIENCE, V312, P592, DOI 10.1126/science.1123654; Dong M, 2003, J CELL BIOL, V162, P1293, DOI 10.1083/jcb.200305098; Fanucchi S, 2008, BIOCHEMISTRY-US, V47, P11674, DOI 10.1021/bi801147r; Fischer A, 2007, J BIOL CHEM, V282, P29604, DOI 10.1074/jbc.M703619200; Fischer A, 2007, P NATL ACAD SCI USA, V104, P10447, DOI 10.1073/pnas.0700046104; Fischer A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000245; Fu ZJ, 2009, BIOCHEMISTRY-US, V48, P5631, DOI 10.1021/bi9002138; Galloux M, 2008, J BIOL CHEM, V283, P27668, DOI 10.1074/jbc.M802557200; Haug G, 2003, BIOCHEMISTRY-US, V42, P15284, DOI 10.1021/bi0354278; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Koriazova LK, 2003, NAT STRUCT BIOL, V10, P13, DOI 10.1038/nsb879; Krantz BA, 2006, J MOL BIOL, V355, P968, DOI 10.1016/j.jmb.2005.11.030; Krieger E., 2011, YASARA; Kumaran D, 2009, J MOL BIOL, V386, P233, DOI 10.1016/j.jmb.2008.12.027; Lacy DB, 1999, J MOL BIOL, V291, P1091, DOI 10.1006/jmbi.1999.2945; Lacy DB, 1998, NAT STRUCT BIOL, V5, P898, DOI 10.1038/2338; Lai B, 2010, J MEMBRANE BIOL, V236, P191, DOI 10.1007/s00232-010-9292-z; Lascola CD, 1998, J NEUROSCI, V18, P1679; LEBEDA FJ, 1995, TOXICON, V33, P559, DOI 10.1016/0041-0101(94)00192-B; Mahrhold S, 2006, FEBS LETT, V580, P2011, DOI 10.1016/j.febslet.2006.02.074; Montal M, 2010, ANNU REV BIOCHEM, V79, P591, DOI 10.1146/annurev.biochem.051908.125345; MONTAL MS, 1992, FEBS LETT, V313, P12, DOI 10.1016/0014-5793(92)81173-J; Montecucco C, 1995, Q REV BIOPHYS, V28, P423, DOI 10.1017/S0033583500003292; MONTECUCCO C, 1994, MOL MICROBIOL, V13, P1, DOI 10.1111/j.1365-2958.1994.tb00396.x; Mushrush DJ, 2011, J BIOL CHEM, V286, P27011, DOI 10.1074/jbc.M111.256982; OBLATTMONTAL M, 1995, PROTEIN SCI, V4, P1490, DOI 10.1002/pro.5560040806; Pirazzini M, 2011, CELL MICROBIOL, V13, P1731, DOI 10.1111/j.1462-5822.2011.01654.x; Ren JH, 1999, SCIENCE, V284, P955, DOI 10.1126/science.284.5416.955; Rummel A, 2007, P NATL ACAD SCI USA, V104, P359, DOI 10.1073/pnas.0609713104; Rummel A, 2009, J NEUROCHEM, V110, P1942, DOI 10.1111/j.1471-4159.2009.06298.x; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; Schmitt J, 2010, BIOCHEMISTRY-US, V49, P5200, DOI 10.1021/bi100412v; Simpson LL, 2004, ANNU REV PHARMACOL, V44, P167, DOI 10.1146/annurev.pharmtox.44.101802.121554; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Swaminathan S, 2000, NAT STRUCT BIOL, V7, P693, DOI 10.1038/78005; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Young JAT, 2007, ANNU REV BIOCHEM, V76, P243, DOI 10.1146/annurev.biochem.75.103004.142728	45	23	24	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					1657	1661		10.1074/jbc.C111.319400	http://dx.doi.org/10.1074/jbc.C111.319400			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22158863	Green Published, hybrid			2022-12-27	WOS:000299321000008
J	Arumugam, K; MacNicol, MC; Wang, YY; Cragle, CE; Tackett, AJ; Hardy, LL; MacNicol, AM				Arumugam, Karthik; MacNicol, Melanie C.; Wang, Yiying; Cragle, Chad E.; Tackett, Alan J.; Hardy, Linda L.; MacNicol, Angus M.			Ringo/Cyclin-dependent Kinase and Mitogen-activated Protein Kinase Signaling Pathways Regulate the Activity of the Cell Fate Determinant Musashi to Promote Cell Cycle Re-entry in Xenopus Oocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA TRANSLATION; CYTOPLASMIC POLYADENYLATION; MAP KINASE; CPEB ACTIVATION; IN-VITRO; C-MOS; MATURATION; INDUCTION; PHOSPHORYLATION; IDENTIFICATION	Cell cycle re-entry during vertebrate oocyte maturation is mediated through translational activation of select target mRNAs, culminating in the activation of mitogen-activated protein kinase and cyclin B/cyclin-dependent kinase (CDK) signaling. The temporal order of targeted mRNA translation is crucial for cell cycle progression and is determined by the timing of activation of distinct mRNA-binding proteins. We have previously shown in oocytes from Xenopus laevis that the mRNA-binding protein Musashi targets translational activation of early class mRNAs including the mRNA encoding the Mos proto-oncogene. However, the molecular mechanism by which Musashi function is activated is unknown. We report here that activation of Musashi1 is mediated by Ringo/CDK signaling, revealing a novel role for early Ringo/CDK function. Interestingly, Musashi1 activation is subsequently sustained through mitogen-activated protein kinase signaling, the downstream effector of Mos mRNA translation, thus establishing a positive feedback loop to amplify Musashi function. The identified regulatory sites are present in mammalian Musashi proteins, and our data suggest that phosphorylation may represent an evolutionarily conserved mechanism to control Musashi-dependent target mRNA translation.	[MacNicol, Melanie C.; Hardy, Linda L.; MacNicol, Angus M.] Univ Arkansas Med Sci, Dept Neurobiol & Dev Sci, Little Rock, AR 72205 USA; [Arumugam, Karthik; Wang, Yiying; MacNicol, Angus M.] Univ Arkansas Med Sci, Dept Physiol & Biophys, Little Rock, AR 72205 USA; [MacNicol, Melanie C.] Univ Arkansas Med Sci, Ctr Translat Neurosci, Little Rock, AR 72205 USA; [Cragle, Chad E.] Univ Arkansas Med Sci, Interdisciplinary BioSci Grad Program, Little Rock, AR 72205 USA; [Tackett, Alan J.] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA; [MacNicol, Angus M.] Univ Arkansas Med Sci, Winthrop P Rockefeller Canc Inst, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	MacNicol, AM (corresponding author), Univ Arkansas Med Sci, Dept Neurobiol & Dev Sci, 4301 W Markham,Slot 814, Little Rock, AR 72205 USA.	Angus@UAMS.edu	Arumugam, Karthik/L-2233-2014	Arumugam, Karthik/0000-0001-5204-2331	National Institutes of Health [RO1 HD35688, RR020146, P20RR015569, P20RR16460]; University of Arkansas for Medical Sciences Proteomics Facility; National Institutes of Health National Center for Research Resources [UL1 RR029884]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD035688] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020146, UL1RR029884, P20RR015569, P20RR016460] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103450] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Arkansas for Medical Sciences Proteomics Facility; National Institutes of Health National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 HD35688 (to A. M. M.) and RR020146 (to M. C. M.).; Mass spectrometry support was provided by the University of Arkansas for Medical Sciences Proteomics Facility and National Institutes of Health Grants P20RR015569 and P20RR16460. DNA sequencing was provided by the University of Arkansas for Medical Sciences Translational Research Institute supported by National Institutes of Health National Center for Research Resources Grant UL1 RR029884.	Arumugam K, 2010, EMBO J, V29, P387, DOI 10.1038/emboj.2009.337; Ballantyne S, 1997, MOL BIOL CELL, V8, P1633, DOI 10.1091/mbc.8.8.1633; Bettegowda A, 2007, FRONT BIOSCI-LANDMRK, V12, P3713, DOI 10.2741/2346; Cao QP, 2010, RNA, V16, P221, DOI 10.1261/rna.1884610; Chang EJ, 2004, ANAL CHEM, V76, P4472, DOI 10.1021/ac049637h; Charlesworth A, 2004, J BIOL CHEM, V279, P17650, DOI 10.1074/jbc.M313837200; Charlesworth A, 2002, EMBO J, V21, P2798, DOI 10.1093/emboj/21.11.2798; Charlesworth A, 2006, EMBO J, V25, P2792, DOI 10.1038/sj.emboj.7601159; Cheng A, 2005, CELL CYCLE, V4, P155, DOI 10.4161/cc.4.1.1347; de Andres-Aguayo L, 2011, BLOOD, V118, P554, DOI 10.1182/blood-2010-12-322081; deMoor CH, 1997, MOL CELL BIOL, V17, P6419, DOI 10.1128/MCB.17.11.6419; Deng J, 2009, STEROIDS, V74, P595, DOI 10.1016/j.steroids.2008.11.010; Downs SM, 2010, MOL REPROD DEV, V77, P566, DOI 10.1002/mrd.21175; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Ferby I, 1999, GENE DEV, V13, P2177, DOI 10.1101/gad.13.16.2177; Ferrell JE, 2009, FEBS LETT, V583, P3999, DOI 10.1016/j.febslet.2009.10.068; GOTOH Y, 1995, J BIOL CHEM, V270, P25898, DOI 10.1074/jbc.270.43.25898; Gradolatto A, 2009, MOL CELL BIOL, V29, P4604, DOI 10.1128/MCB.00160-09; Gross SD, 2000, CURR BIOL, V10, P430, DOI 10.1016/S0960-9822(00)00425-5; Haccard O, 2006, CELL CYCLE, V5, P1152, DOI 10.4161/cc.5.11.2800; HAKE LE, 1994, CELL, V79, P617, DOI 10.1016/0092-8674(94)90547-9; Howard EL, 1999, MOL CELL BIOL, V19, P1990; Imai T, 2001, MOL CELL BIOL, V21, P3888, DOI 10.1128/MCB.21.12.3888-3900.2001; Karaiskou A, 2001, J BIOL CHEM, V276, P36028, DOI 10.1074/jbc.M104722200; Keady BT, 2007, J CELL SCI, V120, P1093, DOI 10.1242/jcs.03416; Lenormand JL, 1999, EMBO J, V18, P1869, DOI 10.1093/emboj/18.7.1869; Machaca K, 2002, J CELL BIOL, V156, P75, DOI 10.1083/jcb.200110059; MACNICOL AM, 1993, CELL, V73, P571, DOI 10.1016/0092-8674(93)90143-E; MacNicol MC, 2011, CELL CYCLE, V10, P39, DOI 10.4161/cc.10.1.14388; Macnicol MC, 2010, MOL REPROD DEV, V77, P662, DOI 10.1002/mrd.21191; Matten WT, 1996, DEV BIOL, V179, P485, DOI 10.1006/dbio.1996.0277; Moore MAS, 2010, NAT MED, V16, P963, DOI 10.1038/nm0910-963; MUSLIN AJ, 1993, MOL CELL BIOL, V13, P4197, DOI 10.1128/MCB.13.7.4197; Nakahata S, 2003, MECH DEVELOP, V120, P865, DOI 10.1016/S0925-4773(03)00160-6; NAKAMURA M, 1994, NEURON, V13, P67, DOI 10.1016/0896-6273(94)90460-X; NEBREDA AR, 1993, EMBO J, V12, P1979, DOI 10.1002/j.1460-2075.1993.tb05847.x; Nishimoto Y, 2010, CELL RES, V20, P1083, DOI 10.1038/cr.2010.122; Okano H, 2005, EXP CELL RES, V306, P349, DOI 10.1016/j.yexcr.2005.02.021; Ota R, 2011, J BIOL CHEM, V286, P2853, DOI 10.1074/jbc.M110.155523; Padmanabhan K, 2006, GENE DEV, V20, P199, DOI 10.1101/gad.1383106; POSADA J, 1993, MOL CELL BIOL, V13, P2546, DOI 10.1128/MCB.13.4.2546; Radford HE, 2008, BBA-GENE REGUL MECH, V1779, P217, DOI 10.1016/j.bbagrm.2008.02.002; Roy LM, 1996, ONCOGENE, V12, P2203; Ruiz EJ, 2008, MOL CELL, V32, P210, DOI 10.1016/j.molcel.2008.08.029; Sakakibara S, 1997, J NEUROSCI, V17, P8300; SHIBUYA EK, 1993, MOL BIOL CELL, V4, P781, DOI 10.1091/mbc.4.8.781; Tackett AJ, 2005, J PROTEOME RES, V4, P1752, DOI 10.1021/pr050225e; Villalba A, 2011, CURR OPIN GENET DEV, V21, P452, DOI 10.1016/j.gde.2011.04.006; Wang XY, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-221	49	24	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10639	10649		10.1074/jbc.M111.300681	http://dx.doi.org/10.1074/jbc.M111.300681			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22215682	Green Published, hybrid			2022-12-27	WOS:000302167200089
J	Cabello-Verrugio, C; Santander, C; Cofre, C; Acuna, MJ; Melo, F; Brandan, E				Cabello-Verrugio, Claudio; Santander, Cristian; Cofre, Catalina; Jose Acuna, Maria; Melo, Francisco; Brandan, Enrique			The Internal Region Leucine-rich Repeat 6 of Decorin Interacts with Low Density Lipoprotein Receptor-related Protein-1, Modulates Transforming Growth Factor (TGF)-beta-dependent Signaling, and Inhibits TGF-beta-dependent Fibrotic Response in Skeletal Muscles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; EXTRACELLULAR-MATRIX; CELL-GROWTH; EXPRESSION; BIGLYCAN; FIBROSIS; COLLAGEN; DISEASE; CORE; REGENERATION	Decorin is a small proteoglycan, composed of 12 leucine-rich repeats (LRRs) that modulates the activity of transforming growth factor type beta (TGF-beta) and other growth factors, and thereby influences proliferation and differentiation in a wide array of physiological and pathological processes, such as fibrosis, in several tissues and organs. Previously we described two novel modulators of the TGF-beta-dependent signaling pathway: LDL receptor-related protein (LRP-1) and decorin. Here we have determined the regions in decorin that are responsible for interaction with LRP-1 and are involved in TGF-beta-dependent binding and signaling. Specifically, we used decorin deletion mutants, as well as peptides derived from internal LRR regions, to determine the LRRs responsible for these decorin functions. Our results indicate that LRR6 and LRR5 participate in the interaction with LRP-1 and TGF-beta as well as in its dependent signaling. Furthermore, the internal region (LRR6i), composed of 11 amino acids, is responsible for decorin binding to LRP-1 and subsequent TGF-beta-dependent signaling. Furthermore, using an in vivo approach, we also demonstrate that the LRR6 region of decorin can inhibit TGF-beta mediated action in response to skeletal muscle injury.	[Brandan, Enrique] Pontificia Univ Catolica Chile, CRCP, Ctr Regenerac & Envejecimiento CARE, Dept Biol Celular & Mol,Fac Ciencias Biol, Santiago, Chile; [Melo, Francisco] Pontificia Univ Catolica Chile, Millennium Inst Immunol & Immunotherapy, Fac Ciencias Biol, Santiago, Chile; [Melo, Francisco] Pontificia Univ Catolica Chile, Dept Mol Genet & Microbiol, Fac Ciencias Biol, Santiago, Chile; [Cabello-Verrugio, Claudio] Univ Desarrollo, CGH, Fac Med, Clin Alemana, Santiago, Chile	Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Clinica Alemana; Universidad del Desarrollo	Brandan, E (corresponding author), Pontificia Univ Catolica Chile, CRCP, Ctr Regenerac & Envejecimiento CARE, Dept Biol Celular & Mol,Fac Ciencias Biol, Casilla 114-D, Santiago, Chile.	ebrandan@bio.puc.cl	Melo, Francisco/M-3923-2014; Acuna, Maria Jose/V-5926-2019; Melo, Francisco/I-5139-2012; Cabello-Verrugio, Claudio/AAD-1454-2020; Brandan, Enrique/A-7063-2017	Acuna, Maria Jose/0000-0002-7117-3844; Cabello-Verrugio, Claudio/0000-0001-7273-2102; Brandan, Enrique/0000-0002-6820-5059; Melo, Francisco/0000-0002-0424-5991	FONDAP-Biomedicin [13980001, CARE PFB12/2007, FONDECYT 11080212, FONDECYT 1110400, ICM P09-016-F, MDA 89419]; Fundacion Chilena para Biologia Celular Proyecto [MF-100]	FONDAP-Biomedicin(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDAP); Fundacion Chilena para Biologia Celular Proyecto	This work was supported by FONDAP-Biomedicine Grants 13980001, CARE PFB12/2007, FONDECYT 11080212, FONDECYT 1110400, ICM P09-016-F, and MDA 89419 and Fundacion Chilena para Biologia Celular Proyecto MF-100.	Abreu JG, 2002, NAT CELL BIOL, V4, P599, DOI 10.1038/ncb826; Alvarez K, 2002, J CELL BIOCHEM, V85, P703, DOI 10.1002/jcb.10184; Bernasconi P, 1999, NEUROMUSCULAR DISORD, V9, P28, DOI 10.1016/S0960-8966(98)00093-5; BOLSTER MB, 1993, BAILLIERE CLIN RHEUM, V7, P79, DOI 10.1016/S0950-3579(05)80269-9; Brandan E, 1996, EUR J CELL BIOL, V71, P170; Brandan E, 2006, J BIOL CHEM, V281, P31562, DOI 10.1074/jbc.M602919200; Brandan E, 2008, MATRIX BIOL, V27, P700, DOI 10.1016/j.matbio.2008.07.004; Cabello-Verrugio C, 2007, J BIOL CHEM, V282, P18842, DOI 10.1074/jbc.M700243200; Cabello-Verrugio C, 2011, CELL SIGNAL, V23, P449, DOI 10.1016/j.cellsig.2010.10.019; Caceres S, 2000, EUR J CELL BIOL, V79, P173, DOI 10.1078/S0171-9335(04)70020-5; CALDWELL CJ, 1990, NEUROPATH APPL NEURO, V16, P225, DOI 10.1111/j.1365-2990.1990.tb01159.x; Casar JC, 2004, DEV BIOL, V268, P358, DOI 10.1016/j.ydbio.2003.12.025; Casar JC, 2004, J CELL SCI, V117, P73, DOI 10.1242/jcs.00828; Denton CP, 2001, CURR OPIN RHEUMATOL, V13, P505, DOI 10.1097/00002281-200111000-00010; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103; Droguett R, 2006, MATRIX BIOL, V25, P332, DOI 10.1016/j.matbio.2006.04.004; Duncan MR, 1999, FASEB J, V13, P1774, DOI 10.1096/fasebj.13.13.1774; Fadic R, 2006, J CELL MOL MED, V10, P758, DOI 10.1111/j.1582-4934.2006.tb00435.x; Folger PA, 2001, INVEST OPHTH VIS SCI, V42, P2534; Frazier K, 1996, J INVEST DERMATOL, V107, P404, DOI 10.1111/1523-1747.ep12363389; Gargioli C, 2008, NAT MED, V14, P973, DOI 10.1038/nm.1852; Giri SN, 2003, ANNU REV PHARMACOL, V43, P73, DOI 10.1146/annurev.pharmtox.43.100901.135740; Goldoni S, 2009, J CELL BIOL, V185, P743, DOI 10.1083/jcb.200901129; Gonias SL, 2004, THROMB HAEMOSTASIS, V91, P1056, DOI 10.1160/TH04-01-0023; Gray PC, 2002, MOL CELL ENDOCRINOL, V188, P253, DOI 10.1016/S0303-7207(02)00037-0; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; HILDEBRAND A, 1994, BIOCHEM J, V302, P527, DOI 10.1042/bj3020527; Hu K, 2007, J CLIN INVEST, V117, P3821, DOI 10.1172/JCI32301; Huang SS, 2003, FASEB J, V17, P2068, DOI 10.1096/fj.03-0256com; Iozzo RV, 2010, FEBS J, V277, P3864, DOI 10.1111/j.1742-4658.2010.07797.x; Iozzo RV, 2010, FEBS J, V277, P3863, DOI 10.1111/j.1742-4658.2010.07796.x; Iozzo RV, 1999, J BIOL CHEM, V274, P18843, DOI 10.1074/jbc.274.27.18843; Kalamajski S, 2007, J BIOL CHEM, V282, P16062, DOI 10.1074/jbc.M700073200; Kang JS, 2009, TRENDS CELL BIOL, V19, P385, DOI 10.1016/j.tcb.2009.05.008; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Kresse H, 2001, J CELL PHYSIOL, V189, P266, DOI 10.1002/jcp.10030; KRUSIUS T, 1986, P NATL ACAD SCI USA, V83, P7683, DOI 10.1073/pnas.83.20.7683; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massague J, 2006, FEBS LETT, V580, P2811, DOI 10.1016/j.febslet.2006.04.033; McEwan PA, 2006, J STRUCT BIOL, V155, P294, DOI 10.1016/j.jsb.2006.01.016; McLennan IS, 1997, DEV DYNAM, V208, P278, DOI 10.1002/(SICI)1097-0177(199702)208:2<278::AID-AJA14>3.0.CO;2-#; Moscatello DK, 1998, J CLIN INVEST, V101, P406, DOI 10.1172/JCI846; Olguin HC, 2003, DEV BIOL, V259, P209, DOI 10.1016/S0012-1606(03)00180-5; Orgel JPRO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007028; Pohlers D, 2009, BBA-MOL BASIS DIS, V1792, P746, DOI 10.1016/j.bbadis.2009.06.004; Prud'homme GJ, 2007, LAB INVEST, V87, P1077, DOI 10.1038/labinvest.3700669; Riquelme C, 2001, J BIOL CHEM, V276, P3589, DOI 10.1074/jbc.M004602200; Santra M, 2002, J BIOL CHEM, V277, P35671, DOI 10.1074/jbc.M205317200; Schaefer L, 2008, J BIOL CHEM, V283, P21305, DOI 10.1074/jbc.R800020200; Schaefer L, 2007, AM J PATHOL, V170, P301, DOI 10.2353/ajpath.2007.060497; Schonherr E, 2005, J BIOL CHEM, V280, P15767, DOI 10.1074/jbc.M500451200; Schonherr E, 1998, ARCH BIOCHEM BIOPHYS, V355, P241, DOI 10.1006/abbi.1998.0720; Scott PG, 2004, P NATL ACAD SCI USA, V101, P15633, DOI 10.1073/pnas.0402976101; Segarini PR, 2001, J BIOL CHEM, V276, P40659, DOI 10.1074/jbc.M105180200; Shinozaki M, 1997, BIOCHEM BIOPH RES CO, V237, P292, DOI 10.1006/bbrc.1997.7134; Slater Clarke R., 2008, V3, P303; TAKEUCHI Y, 1994, J BIOL CHEM, V269, P32634; VARGA J, 1987, BIOCHEM J, V247, P597, DOI 10.1042/bj2470597; Vial C, 2008, J CELL PHYSIOL, V215, P410, DOI 10.1002/jcp.21324; Vial C, 2011, J BIOL CHEM, V286, P24242, DOI 10.1074/jbc.M110.189365; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; YAMAGUCHI Y, 1990, NATURE, V346, P281, DOI 10.1038/346281a0; ZIYADEH FN, 1993, AM J KIDNEY DIS, V22, P736, DOI 10.1016/S0272-6386(12)80440-9	64	54	58	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6773	6787		10.1074/jbc.M111.312488	http://dx.doi.org/10.1074/jbc.M111.312488			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22203668	Green Published, hybrid			2022-12-27	WOS:000300791800063
J	Dochow, M; Krumm, SA; Crowe, JE; Moore, ML; Plemper, RK				Dochow, Melanie; Krumm, Stefanie A.; Crowe, James E., Jr.; Moore, Martin L.; Plemper, Richard K.			Independent Structural Domains in Paramyxovirus Polymerase Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT RNA-POLYMERASE; RESPIRATORY SYNCYTIAL VIRUS; VESICULAR STOMATITIS-VIRUS; CANINE-DISTEMPER VIRUS; AMINO-ACID-SEQUENCES; SENDAI-VIRUS; RINDERPEST VIRUS; MESSENGER-RNA; MOLECULAR CHARACTERIZATION; PARAINFLUENZA VIRUS	All enzymatic activities required for genomic replication and transcription of nonsegmented negative strand RNA viruses (or Mononegavirales) are believed to be concentrated in the viral polymerase (L) protein. However, our insight into the organization of these different enzymatic activities into a bioactive tertiary structure remains rudimentary. Fragments of Mononegavirales polymerases analyzed to date cannot restore bioactivity through trans-complementation, unlike the related L proteins of segmented NSVs. We investigated the domain organization of phylogenetically diverse Paramyxovirus L proteins derived from measles virus (MeV), Nipah virus (NiV), and respiratory syncytial virus (RSV). Through a comprehensive in silico and experimental analysis of domain intersections, we defined MeV L position 615 as an interdomain candidate in addition to the previously reported residue 1708. Only position 1708 of MeV and the homologous positions in NiV and RSV L also tolerated the insertion of epitope tags. Splitting of MeV L at residue 1708 created fragments that were unable to physically interact and trans-complement, but strikingly, these activities were reconstituted by the addition of dimerization tags to the fragments. Equivalently split fragments of NiV, RSV, and MeV L oligomerized with comparable efficiency in all homo- and heterotypic combinations, but only the homotypic pairs were able to trans-complement. These results demonstrate that synthesis as a single polypeptide is not required for the Mononegavirales polymerases to adopt a proper tertiary conformation. Paramyxovirus polymerases are composed of at least two truly independent folding domains that lack a traditional interface but require molecular compatibility for bioactivity. The functional probing of the L domain architecture through trans-complementation is anticipated to be applicable to all Mononegavirales polymerases.	[Moore, Martin L.; Plemper, Richard K.] Childrens Healthcare Atlanta, Atlanta, GA 30322 USA; [Crowe, James E., Jr.] Vanderbilt Univ, Dept Pediat & Pathol, Med Ctr, Nashville, TN 37232 USA; [Dochow, Melanie; Krumm, Stefanie A.; Moore, Martin L.; Plemper, Richard K.] Emory Univ, Dept Pediat, Sch Med, Atlanta, GA 30322 USA	Children's Healthcare of Atlanta (CHOA); Vanderbilt University; Emory University	Plemper, RK (corresponding author), Emory Univ, Dept Pediat & Childrens Healthcare Atlanta, Sch Med, 2015 Uppergate Dr, Atlanta, GA 30322 USA.	rplempe@emory.edu	Crowe, James/B-5549-2009	Crowe, James/0000-0002-0049-1079	National Institutes of Health (NIAID) [AI071002, AI085328]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083402, R01AI087798, R21AI085328, R01AI071002] Funding Source: NIH RePORTER	National Institutes of Health (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI071002 and AI085328 (NIAID to R. K. P.).	Bailey D, 2005, VIRUS RES, V110, P119, DOI 10.1016/j.virusres.2005.01.013; Bankamp B, 1999, J GEN VIROL, V80, P1617, DOI 10.1099/0022-1317-80-7-1617; BARON MD, 1995, J GEN VIROL, V76, P593, DOI 10.1099/0022-1317-76-3-593; Baron MD, 1996, J GEN VIROL, V77, P3041, DOI 10.1099/0022-1317-77-12-3041; Brautigam CA, 1998, CURR OPIN STRUC BIOL, V8, P54, DOI 10.1016/S0959-440X(98)80010-9; Brown DD, 2005, J VIROL, V79, P14330, DOI 10.1128/JVI.79.22.14330-14338.2005; Brunotte L, 2011, J VIROL, V85, P324, DOI 10.1128/JVI.00721-10; Buchholz UJ, 1999, J VIROL, V73, P251, DOI 10.1128/JVI.73.1.251-259.1999; Cevik B, 2004, VIROLOGY, V327, P297, DOI 10.1016/j.virol.2004.07.002; Cevik B, 2003, VIROLOGY, V313, P525, DOI 10.1016/S0042-6822(03)00342-8; Chandonia JM, 1999, PROTEINS, V35, P293; Chandonia JM, 2007, BIOINFORMATICS, V23, P2018, DOI 10.1093/bioinformatics/btm269; CHANDRIKA R, 1995, VIROLOGY, V213, P352, DOI 10.1006/viro.1995.0008; Chattopadhyay A, 2004, VIRUS GENES, V28, P169, DOI 10.1023/B:VIRU.0000016855.25662.95; Cheetham GMT, 2000, CURR OPIN STRUC BIOL, V10, P117, DOI 10.1016/S0959-440X(99)00058-5; Chua KB, 2000, SCIENCE, V288, P1432, DOI 10.1126/science.288.5470.1432; De Clercq E, 2004, NAT REV MICROBIOL, V2, P704, DOI 10.1038/nrmicro975; Deore RR, 2010, CURR MED CHEM, V17, P3806; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Druelle J, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-22; Duprex WP, 2002, J VIROL, V76, P7322, DOI 10.1128/JVI.76.14.7322-7328.2002; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ferrer-Orta C, 2006, CURR OPIN STRUC BIOL, V16, P27, DOI 10.1016/j.sbi.2005.12.002; Ferrer-Orta C, 2009, CURR OPIN STRUC BIOL, V19, P752, DOI 10.1016/j.sbi.2009.10.016; Ferron F, 2005, J GEN VIROL, V86, P743, DOI 10.1099/vir.0.80590-0; Ferron F, 2002, TRENDS BIOCHEM SCI, V27, P222, DOI 10.1016/S0968-0004(02)02091-1; Ferron F, 2006, PROTEINS, V65, P1, DOI 10.1002/prot.21075; FIELD J, 1988, MOL CELL BIOL, V8, P2159, DOI 10.1128/MCB.8.5.2159; Gassen U, 2000, J VIROL, V74, P10737, DOI 10.1128/JVI.74.22.10737-10744.2000; Gopinath M, 2009, J GEN VIROL, V90, P1748, DOI 10.1099/vir.0.010975-0; Grdzelishvili VZ, 2005, J VIROL, V79, P7327, DOI 10.1128/JVI.79.12.7327-7337.2005; GROSFELD H, 1995, J VIROL, V69, P5677, DOI 10.1128/JVI.69.9.5677-5686.1995; Halpin K, 2004, J GEN VIROL, V85, P701, DOI 10.1099/vir.0.19685-0; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; Harcourt BH, 2001, VIROLOGY, V287, P192, DOI 10.1006/viro.2001.1026; Holmes DE, 2002, J VIROL, V76, P3078, DOI 10.1128/JVI.76.6.3078-3083.2002; HOPP TP, 1988, BIO-TECHNOL, V6, P1204, DOI 10.1038/nbt1088-1204; HORIKAMI SM, 1994, VIROLOGY, V205, P540, DOI 10.1006/viro.1994.1676; HORIKAMI SM, 1992, J VIROL, V66, P4901, DOI 10.1128/JVI.66.8.4901-4908.1992; Koch U, 2007, CURR TOP MED CHEM, V7, P1302; Kranzusch PJ, 2010, P NATL ACAD SCI USA, V107, P20069, DOI 10.1073/pnas.1007152107; Kusumaningtyas E, 2004, ARCH VIROL, V149, P1859, DOI 10.1007/s00705-004-0336-5; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lieutaud P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S25; Lij J, 2008, J VIROL, V82, P775, DOI 10.1128/JVI.02107-07; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Lyles D. S., 2007, FIELDS VIROLOGY, V1, P1364; Malur AG, 2002, GENE EXPRESSION, V10, P93; McIlhatton MA, 1997, J GEN VIROL, V78, P571, DOI 10.1099/0022-1317-78-3-571; Moulin E, 2011, J MED VIROL, V83, P1614, DOI 10.1002/jmv.22152; Ng KKS, 2008, CURR TOP MICROBIOL, V320, P137; Nishio M, 2005, J VIROL, V79, P8591, DOI 10.1128/JVI.79.13.8591-8601.2005; Nishio M, 2011, J VIROL, V85, P725, DOI 10.1128/JVI.01226-10; Ogino T, 2005, J BIOL CHEM, V280, P4429, DOI 10.1074/jbc.M411167200; Ogino T, 2007, MOL CELL, V25, P85, DOI 10.1016/j.molcel.2006.11.013; OHGIMOTO S, 1990, VIROLOGY, V177, P116, DOI 10.1016/0042-6822(90)90465-4; OKAZAKI K, 1992, VIROLOGY, V188, P926, DOI 10.1016/0042-6822(92)90555-4; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P1989, DOI 10.1021/bi047993o; Palacios G, 2011, EMERG INFECT DIS, V17, P711, DOI 10.3201/eid1704.100883; Parks CL, 2001, J VIROL, V75, P910, DOI 10.1128/JVI.75.2.910-920.2001; Plemper RK, 2005, ANTIMICROB AGENTS CH, V49, P3755, DOI 10.1128/AAC.49.9.3755-3761.2005; POCH O, 1990, J GEN VIROL, V71, P1153, DOI 10.1099/0022-1317-71-5-1153; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Qanungo KR, 2004, P NATL ACAD SCI USA, V101, P5952, DOI 10.1073/pnas.0401449101; Rahmeh AA, 2010, P NATL ACAD SCI USA, V107, P20075, DOI 10.1073/pnas.1013559107; Rima BK, 2005, VIRUS GENES, V30, P113, DOI 10.1007/s11262-004-4588-7; Roth JP, 2009, ANTIVIR RES, V82, P12, DOI 10.1016/j.antiviral.2009.01.001; Ruedas JB, 2009, J VIROL, V83, P12241, DOI 10.1128/JVI.01273-09; Schaeffer RD, 2011, PROTEIN ENG DES SEL, V24, P11, DOI 10.1093/protein/gzq096; Shuman S, 2004, CURR OPIN STRUC BIOL, V14, P757, DOI 10.1016/j.sbi.2004.10.006; SIDHU MS, 1993, VIROLOGY, V193, P50, DOI 10.1006/viro.1993.1102; SIDHU MS, 1995, VIROLOGY, V208, P800, DOI 10.1006/viro.1995.1215; SLEAT DE, 1993, J VIROL, V67, P1334, DOI 10.1128/JVI.67.3.1334-1339.1993; Smallwood S, 2004, VIROLOGY, V318, P439, DOI 10.1016/j.virol.2003.09.045; Suyama M, 2003, BIOINFORMATICS, V19, P673, DOI 10.1093/bioinformatics/btg031; Takimoto T, 2000, VIRUS RES, V70, P45, DOI 10.1016/S0168-1702(00)00207-0; Tao YJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000943; Tawar RG, 2009, SCIENCE, V326, P1279, DOI 10.1126/science.1177634; Tidona CA, 1999, VIROLOGY, V258, P425, DOI 10.1006/viro.1999.9693; Uversky Vladimir N., 2007, V408, P69; Vermehren J, 2011, CLIN MICROBIOL INFEC, V17, P122, DOI 10.1111/j.1469-0691.2010.03430.x; von Messling V, 2003, J VIROL, V77, P12579, DOI 10.1128/JVI.77.23.12579-12591.2003; White LK, 2007, ANTIMICROB AGENTS CH, V51, P2293, DOI 10.1128/AAC.00289-07; Whitehead SS, 1998, J VIROL, V72, P4467, DOI 10.1128/JVI.72.5.4467-4471.1998; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Yang HT, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-58; Yang ZR, 2005, BIOINFORMATICS, V21, P3369, DOI 10.1093/bioinformatics/bti534; Yea C, 2009, VIRUSES-BASEL, V1, P26, DOI 10.3390/v1010026; Yoon JJ, 2009, ANTIMICROB AGENTS CH, V53, P3860, DOI 10.1128/AAC.00503-09	90	40	41	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6878	6891		10.1074/jbc.M111.325258	http://dx.doi.org/10.1074/jbc.M111.325258			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22215662	Green Published, hybrid			2022-12-27	WOS:000300791800073
J	Lee, S; Thebault, P; Freschi, L; Beaufils, S; Blundell, TL; Landry, CR; Bolanos-Garcia, VM; Elowe, S				Lee, Semin; Thebault, Philippe; Freschi, Luca; Beaufils, Sylvie; Blundell, Tom L.; Landry, Christian R.; Bolanos-Garcia, Victor M.; Elowe, Sabine			Characterization of Spindle Checkpoint Kinase Mps1 Reveals Domain with Functional and Structural Similarities to Tetratricopeptide Repeat Motifs of Bub1 and BubR1 Checkpoint Kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE MEIOSIS I; MITOTIC CHECKPOINT; KINETOCHORE LOCALIZATION; CHROMOSOMAL INSTABILITY; ASSEMBLY CHECKPOINT; PROTEIN MODELS; CENP-E; MITOSIS; ACTIVATION; CELLS	Kinetochore targeting of the mitotic kinases Bub1, BubR1, and Mps1 has been implicated in efficient execution of their functions in the spindle checkpoint, the self-monitoring system of the eukaryotic cell cycle that ensures chromosome segregation occurs with high fidelity. In all three kinases, kinetochore docking is mediated by the N-terminal region of the protein. Deletions within this region result in checkpoint failure and chromosome segregation defects. Here, we use an interdisciplinary approach that includes biophysical, biochemical, cell biological, and bioinformatics methods to study the N-terminal region of human Mps1. We report the identification of a tandem repeat of the tetratricopeptide repeat (TPR) motif in the N-terminal kinetochore binding region of Mps1, with close homology to the tandem TPR motif of Bub1 and BubR1. Phylogenetic analysis indicates that TPR Mps1 was acquired after the split between deutorostomes and protostomes, as it is distinguishable in chordates and echinoderms. Overexpression of TPR Mps1 resulted in decreased efficiency of both chromosome alignment and mitotic arrest, likely through displacement of endogenous Mps1 from the kinetochore and decreased Mps1 catalytic activity. Taken together, our multidisciplinary strategy provides new insights into the evolution, structural organization, and function of Mps1 N-terminal region.	[Lee, Semin; Blundell, Tom L.; Bolanos-Garcia, Victor M.] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England; [Thebault, Philippe; Elowe, Sabine] Ctr Hosp Univ Quebec, Ctr Rech, Quebec City, PQ G1V 4G2, Canada; [Freschi, Luca; Landry, Christian R.] Univ Laval, Inst Biol Integrat & Syst, PROTEO, Dept Biol, Quebec City, PQ G1V 0A6, Canada; [Beaufils, Sylvie] Univ Rennes 1, Inst Phys Rennes, CNRS, UMR 6251, F-35042 Rennes, France; [Elowe, Sabine] Univ Laval, Fac Med, Dept Pediat, Quebec City, PQ G1V 4G2, Canada	University of Cambridge; Laval University; Laval University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Rennes; Laval University	Bolanos-Garcia, VM (corresponding author), Univ Cambridge, Dept Biochem, 80 Tennis Court Rd, Cambridge CB2 1GA, England.	victor@cryst.bioc.cam.ac.uk; sabine.elowe@crchuq.ulaval.ca	Pillay, Nischalan/F-9536-2012; Landry, Christian R/F-3890-2011; Freschi, Luca/AAS-9589-2020; Bolanos-Garcia, Victor M./AAN-8575-2020; sylvie, beaufils F/N-1563-2014; Lee, Semin/S-2629-2016	Bolanos-Garcia, Victor M./0000-0003-2700-1479; sylvie, beaufils F/0000-0001-5968-8119; Lee, Semin/0000-0002-9015-6046; Landry, Christian/0000-0003-3028-6866	Fondation des Etoiles; Wellcome Trust Programme [RG44650]; Canadian Institutes [GMX-191597]	Fondation des Etoiles; Wellcome Trust Programme(Wellcome Trust); Canadian Institutes(Canadian Institutes of Health Research (CIHR))	This work was supported by a "Fondation des Etoiles" starting grant (to S. E.), Wellcome Trust Programme Grant RG44650 (Structural Biology of Cell Signalling and Regulation: Multiprotein Systems and the Achievement of High Signal-to-Noise Ratios) (to T. L. B.), and Canadian Institutes of Health Research Grant GMX-191597 (to C. R. L.).	Abrieu A, 2001, CELL, V106, P83, DOI 10.1016/S0092-8674(01)00410-X; Araki Y, 2010, J CELL BIOL, V189, P41, DOI 10.1083/jcb.200910027; Azzam RMA., 1977, ELLIPSOMETRY POLARIZ; Baumann C, 2007, CELL, V128, P101, DOI 10.1016/j.cell.2006.11.041; Beaufils S, 2008, J PHYS CHEM B, V112, P7984, DOI 10.1021/jp711222s; Beddoe T, 2004, J BIOL CHEM, V279, P46448, DOI 10.1074/jbc.M405639200; BERGE B, 1993, EUROPHYS LETT, V21, P773, DOI 10.1209/0295-5075/21/7/010; Bolanos-Garcia VM, 2011, TRENDS BIOCHEM SCI, V36, P141, DOI 10.1016/j.tibs.2010.08.004; Bolanos-Garcia VM, 2005, BIOPHYS J, V89, P2640, DOI 10.1529/biophysj.105.063511; Chan YW, 2009, J CELL BIOL, V185, P859, DOI 10.1083/jcb.200812167; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; D'Arcy S, 2010, J BIOL CHEM, V285, P14764, DOI 10.1074/jbc.M109.082016; Das AK, 1998, EMBO J, V17, P1192, DOI 10.1093/emboj/17.5.1192; de Bakker PIW, 2001, BIOINFORMATICS, V17, P748, DOI 10.1093/bioinformatics/17.8.748; DEFEIJTER JA, 1978, BIOPOLYMERS, V17, P1759, DOI 10.1002/bip.1978.360170711; Dou Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018793; Dubreil L, 2003, BIOPHYS J, V85, P2650, DOI 10.1016/S0006-3495(03)74688-8; Elowe S, 2007, GENE DEV, V21, P2205, DOI 10.1101/gad.436007; Fava LL, 2011, EMBO J, V30, P3322, DOI 10.1038/emboj.2011.239; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Gromiha MM, 2004, PROG BIOPHYS MOL BIO, V86, P235, DOI 10.1016/j.pbiomolbio.2003.09.003; Hached K, 2011, DEVELOPMENT, V138, P2261, DOI 10.1242/dev.061317; He XW, 1998, J CELL SCI, V111, P1635; Hewitt L, 2010, J CELL BIOL, V190, P25, DOI 10.1083/jcb.201002133; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Hubner NC, 2010, CHROMOSOMA, V119, P149, DOI 10.1007/s00412-009-0244-2; Jelluma N, 2008, CELL, V132, P233, DOI 10.1016/j.cell.2007.11.046; Jelluma N, 2010, J CELL BIOL, V191, P281, DOI 10.1083/jcb.201003038; Jelluma N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002415; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Jones MH, 2005, CURR BIOL, V15, P160, DOI 10.1016/j.cub.2005.01.010; Kang JS, 2007, P NATL ACAD SCI USA, V104, P20232, DOI 10.1073/pnas.0710519105; Kiyomitsu T, 2007, DEV CELL, V13, P663, DOI 10.1016/j.devcel.2007.09.005; Kiyomitsu T, 2011, MOL CELL BIOL, V31, P998, DOI 10.1128/MCB.00815-10; Klebig C, 2009, J CELL BIOL, V185, P841, DOI 10.1083/jcb.200902128; Laskowski RA, 1998, CURR OPIN STRUC BIOL, V8, P631, DOI 10.1016/S0959-440X(98)80156-5; Liu ST, 2003, MOL BIOL CELL, V14, P1638, DOI 10.1091/mbc.02-05-0074; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Maciejowski J, 2010, J CELL BIOL, V190, P89, DOI 10.1083/jcb.201001050; Martin-Lluesma S, 2002, SCIENCE, V297, P2267, DOI 10.1126/science.1075596; Mattison CP, 2007, J BIOL CHEM, V282, P30553, DOI 10.1074/jbc.M707063200; Mizuguchi K, 1998, BIOINFORMATICS, V14, P617, DOI 10.1093/bioinformatics/14.7.617; Niault T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001165; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Renault A, 1999, BIOPHYS J, V76, P1580, DOI 10.1016/S0006-3495(99)77317-0; Rieder CL, 2004, DEV CELL, V7, P637, DOI 10.1016/j.devcel.2004.09.002; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Santaguida S, 2010, J CELL BIOL, V190, P73, DOI 10.1083/jcb.201001036; Santaguida S, 2009, EMBO J, V28, P2511, DOI 10.1038/emboj.2009.173; Saurin AT, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1319; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Stucke VM, 2004, CHROMOSOMA, V113, P1, DOI 10.1007/s00412-004-0288-2; Tanudji M, 2004, MOL BIOL CELL, V15, P3771, DOI 10.1091/mbc.E03-07-0482; Thompson SL, 2008, J CELL BIOL, V180, P665, DOI 10.1083/jcb.200712029; Tighe A, 2008, J CELL BIOL, V181, P893, DOI 10.1083/jcb.200712028; Tyler RK, 2009, BIOCHEM J, V417, P173, DOI 10.1042/BJ20081310; Venien-Bryan C, 1998, BIOPHYS J, V74, P2649, DOI 10.1016/S0006-3495(98)77970-6; Vie V, 2010, BBA-BIOMEMBRANES, V1798, P1503, DOI 10.1016/j.bbamem.2010.04.005; Vigneron S, 2004, MOL BIOL CELL, V15, P4584, DOI 10.1091/mbc.E04-01-0051; Weiss E, 1996, J CELL BIOL, V132, P111, DOI 10.1083/jcb.132.1.111; Welburn JPI, 2008, DEV CELL, V15, P645, DOI 10.1016/j.devcel.2008.10.011; Xu QB, 2009, MOL BIOL CELL, V20, P10, DOI 10.1091/mbc.E08-03-0324; Yang ZY, 2009, J CELL BIOL, V186, P675, DOI 10.1083/jcb.200906150; Zhao Y, 2006, CURR BIOL, V16, P1764, DOI 10.1016/j.cub.2006.07.058	66	25	26	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5988	6001		10.1074/jbc.M111.307355	http://dx.doi.org/10.1074/jbc.M111.307355			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22187426	Green Published, hybrid			2022-12-27	WOS:000300638000072
J	Neill, T; Painter, H; Buraschi, S; Owens, RT; Lisanti, MP; Schaefer, L; Iozzo, RV				Neill, Thomas; Painter, Hannah; Buraschi, Simone; Owens, Rick T.; Lisanti, Michael P.; Schaefer, Liliana; Iozzo, Renato V.			Decorin Antagonizes the Angiogenic Network CONCURRENT INHIBITION OF MET, HYPOXIA INDUCIBLE FACTOR 1 alpha, VASCULAR ENDOTHELIAL GROWTH FACTOR A, AND INDUCTION OF THROMBOSPONDIN-1 AND TIMP3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUCINE-RICH PROTEOGLYCANS; HYPOXIA-INDUCIBLE FACTOR-1; CYCLIN-DEPENDENT KINASES; FACTOR RECEPTOR; IN-VIVO; SIGNAL-TRANSDUCTION; DOWN-REGULATION; DEFICIENT MICE; BREAST-CANCER; MATRIX METALLOPROTEINASES	Decorin, a small leucine-rich proteoglycan, inhibits tumor growth by antagonizing multiple receptor tyrosine kinases including EGFR and Met. Here, we investigated decorin during normoxic angiogenic signaling. An angiogenic PCR array revealed a profound decorin-evoked transcriptional inhibition of pro-angiogenic genes, such as HIF1A. Decorin evoked a reduction of hypoxia inducible factor (HIF)-1 alpha and vascular endothelial growth factor A (VEGFA) in MDA-231 breast carcinoma cells expressing constitutively-active HIF-1 alpha. Suppression of Met with decorin or siRNA evoked a similar reduction of VEGFA by attenuating downstream beta-catenin signaling. These data establish a noncanonical role for beta-catenin in regulating VEGFA expression. We found that exogenous decorin induced expression of thrombospondin-1 and TIMP3, two powerful angiostatic agents. In contrast, decorin suppressed both the expression and enzymatic activity of matrix metalloprotease (MMP)-9 and MMP-2, two pro-angiogenic proteases. Our data establish a novel duality for decorin as a suppressor of tumor angiogenesis under normoxia by simultaneously down-regulating potent pro-angiogenic factors and inducing endogenous anti-angiogenic agents.	[Neill, Thomas; Painter, Hannah; Buraschi, Simone; Iozzo, Renato V.] Thomas Jefferson Univ, Canc Cell Biol & Signaling Program, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA; [Lisanti, Michael P.] Thomas Jefferson Univ, Kimmel Canc Ctr, Stem Cell Biol & Regenerat Med Ctr, Philadelphia, PA 19107 USA; [Schaefer, Liliana] Goethe Univ Frankfurt, D-60590 Frankfurt, Germany; [Owens, Rick T.] LifeCell Corp, Branchburg, NJ 08876 USA	Jefferson University; Jefferson University; Goethe University Frankfurt	Iozzo, RV (corresponding author), Thomas Jefferson Univ, Canc Cell Biol & Signaling Program, Dept Pathol Anat & Cell Biol, 1020 Locust St,Rm 249 JAH, Philadelphia, PA 19107 USA.	iozzo@kimmelcancercenter.org	Iozzo, Renato/AAS-1980-2020; Lisanti, Michael/B-6131-2018; Lisanti, Michael P/C-6866-2013	Lisanti, Michael/0000-0003-2034-1382; Schaefer, Liliana/0000-0002-3318-3005; Painter, Hannah/0000-0003-0445-7473	National Institutes of Health [RO1 CA39481, RO1 CA47282, RO1 CA120975, T32 AA07463]; NATIONAL CANCER INSTITUTE [R01CA047282, R01CA120975, R01CA039481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [T32AA007463] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 CA39481, RO1 CA47282, and RO1 CA120975 (to R. V. I.).; Supported by National Institutes of Health Training Grant T32 AA07463. This work is in partial fulfillment of a doctoral thesis in Cell and Developmental Biology, Thomas Jefferson University.	ADANY R, 1990, J BIOL CHEM, V265, P11389; Armstrong LC, 2003, MATRIX BIOL, V22, P63, DOI 10.1016/S0945-053X(03)00005-2; Avraamides CJ, 2008, NAT REV CANCER, V8, P604, DOI 10.1038/nrc2353; Bachman KE, 1999, CANCER RES, V59, P798; Baghy K, 2011, LAB INVEST, V91, P439, DOI 10.1038/labinvest.2010.172; Barski D, 2010, BRAIN PATHOL, V20, P623, DOI 10.1111/j.1750-3639.2009.00340.x; Bernabeu C, 2009, BBA-MOL BASIS DIS, V1792, P954, DOI 10.1016/j.bbadis.2009.07.003; Bi XL, 2008, CARCINOGENESIS, V29, P1435, DOI 10.1093/carcin/bgn141; Bi YM, 2005, J BIOL CHEM, V280, P30481, DOI 10.1074/jbc.M500573200; Bissell MJ, 2011, NAT MED, V17, P320, DOI 10.1038/nm.2328; Bourboulia D, 2010, SEMIN CANCER BIOL, V20, P161, DOI 10.1016/j.semcancer.2010.05.002; Brandan E, 2008, MATRIX BIOL, V27, P700, DOI 10.1016/j.matbio.2008.07.004; Brown EL, 2001, J CLIN INVEST, V107, P845, DOI 10.1172/JCI11692; Buraschi Simone, 2010, J Biol Chem, V285, P42075, DOI 10.1074/jbc.M110.172841; Chen SJ, 2011, AM J PATHOL, V179, P2409, DOI 10.1016/j.ajpath.2011.07.026; Chiavarina B, 2010, CELL CYCLE, V9, P3534, DOI 10.4161/cc.9.17.12908; COHEN IR, 1994, CANCER RES, V54, P5771; Corsi A, 2002, J BONE MINER RES, V17, P1180, DOI 10.1359/jbmr.2002.17.7.1180; Csordas G, 2000, J BIOL CHEM, V275, P32879, DOI 10.1074/jbc.M005609200; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; Daum G, 2009, ARTERIOSCL THROM VAS, V29, P1439, DOI 10.1161/ATVBAHA.108.175240; Davies CD, 2001, MICROVASC RES, V62, P26, DOI 10.1006/mvre.2001.2311; DeLuca A, 1996, J BIOL CHEM, V271, P18961, DOI 10.1074/jbc.271.31.18961; Easwaran V, 2003, CANCER RES, V63, P3145; Elliott DM, 2003, ANN BIOMED ENG, V31, P599, DOI 10.1114/1.1567282; Fata JE, 2001, J CLIN INVEST, V108, P831, DOI 10.1172/JCI13171; Ferdous Z, 2007, J BIOL CHEM, V282, P35887, DOI 10.1074/jbc.M705180200; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Fust A, 2005, AM J PHYSIOL-LUNG C, V288, pL159, DOI 10.1152/ajplung.00089.2004; Gialeli C, 2011, FEBS J, V278, P16, DOI 10.1111/j.1742-4658.2010.07919.x; Goldberg M, 2005, CALCIFIED TISSUE INT, V77, P297, DOI 10.1007/s00223-005-0026-7; Goldoni S, 2008, INT J CANCER, V123, P2473, DOI 10.1002/ijc.23930; Goldoni S, 2008, AM J PATHOL, V173, P844, DOI 10.2353/ajpath.2008.080275; Goldoni S, 2009, J CELL BIOL, V185, P743, DOI 10.1083/jcb.200901129; Goyal A, 2011, J BIOL CHEM, V286, P25947, DOI 10.1074/jbc.M111.243626; Grant DS, 2002, ONCOGENE, V21, P4765, DOI 10.1038/sj.onc.1205595; GRANT DS, 1993, P NATL ACAD SCI USA, V90, P1937, DOI 10.1073/pnas.90.5.1937; Hahn WC, 2002, NEW ENGL J MED, V347, P1593, DOI 10.1056/NEJMra021902; Haruyama N, 2009, MATRIX BIOL, V28, P129, DOI 10.1016/j.matbio.2009.01.005; Hembry Rosalind M., 2007, V135, P227; Hu YP, 2009, NEOPLASIA, V11, P1042, DOI 10.1593/neo.09760; Hynes RO, 2007, J THROMB HAEMOST, V5, P32, DOI 10.1111/j.1538-7836.2007.02569.x; Iozzo RV, 2011, J BIOL CHEM, V286, P34712, DOI 10.1074/jbc.M111.262766; Iozzo RV, 2011, J CELL MOL MED, V15, P1013, DOI 10.1111/j.1582-4934.2010.01236.x; Iozzo RV, 2010, FEBS J, V277, P3864, DOI 10.1111/j.1742-4658.2010.07797.x; Iozzo RV, 1999, P NATL ACAD SCI USA, V96, P3092, DOI 10.1073/pnas.96.6.3092; Iozzo RV, 1999, J BIOL CHEM, V274, P18843, DOI 10.1074/jbc.274.27.18843; Iozzo RV, 2005, NAT REV MOL CELL BIO, V6, P646, DOI 10.1038/nrm1702; Iozzo RV, 1999, J BIOL CHEM, V274, P4489, DOI 10.1074/jbc.274.8.4489; Iozzo RV, 1996, FASEB J, V10, P598, DOI 10.1096/fasebj.10.5.8621059; Iozzo RV, 1998, ANNU REV BIOCHEM, V67, P609, DOI 10.1146/annurev.biochem.67.1.609; IOZZO RV, 1994, MATRIX BIOL, V14, P203, DOI 10.1016/0945-053X(94)90183-X; Jarvelainen H, 2006, WOUND REPAIR REGEN, V14, P443, DOI 10.1111/j.1743-6109.2006.00150.x; Kalamajski S, 2010, MATRIX BIOL, V29, P248, DOI 10.1016/j.matbio.2010.01.001; Keene DR, 2000, J BIOL CHEM, V275, P21801, DOI 10.1074/jbc.C000278200; Kermorgant S, 2005, CELL CYCLE, V4, P352, DOI 10.4161/cc.4.3.1519; Khan GA, 2011, MOL ENDOCRINOL, V25, P1431, DOI 10.1210/me.2010-0426; Kinsella MG, 2000, J BIOL CHEM, V275, P13924, DOI 10.1074/jbc.275.18.13924; Lai AZ, 2009, TRENDS CELL BIOL, V19, P542, DOI 10.1016/j.tcb.2009.07.002; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Lee S, 2005, J CELL BIOL, V169, P681, DOI 10.1083/jcb.200409115; Li X, 2008, BLOOD, V112, P159, DOI 10.1182/blood-2007-11-124164; Liang FT, 2004, AM J PATHOL, V165, P977, DOI 10.1016/S0002-9440(10)63359-7; Liau SS, 2006, CANCER RES, V66, P11613, DOI 10.1158/0008-5472.CAN-06-1460; Liu ZX, 2002, J BIOL CHEM, V277, P10452, DOI 10.1074/jbc.M107551200; Merline R, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001868; Milanini-Mongiat J, 2002, J BIOL CHEM, V277, P20631, DOI 10.1074/jbc.M201753200; Mohan R, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0026846, 10.1371/journal.pone.0026432]; Moscatello DK, 1998, J CLIN INVEST, V101, P406, DOI 10.1172/JCI846; Nath D, 2001, J CELL SCI, V114, P1213; Nelimarkka L, 1997, J BIOL CHEM, V272, P12730, DOI 10.1074/jbc.272.19.12730; Nelimarkka L, 2001, AM J PATHOL, V158, P345, DOI 10.1016/S0002-9440(10)63975-2; Ngo CV, 2000, CELL GROWTH DIFFER, V11, P201; Okawa T, 2007, GENE DEV, V21, P2788, DOI 10.1101/gad.1544507; Pages G, 2005, CARDIOVASC RES, V65, P564, DOI 10.1016/j.cardiores.2004.09.032; Patel S, 1998, J BIOL CHEM, V273, P3121, DOI 10.1074/jbc.273.6.3121; Rangel R, 2007, P NATL ACAD SCI USA, V104, P4588, DOI 10.1073/pnas.0611653104; Rasola A, 2007, ONCOGENE, V26, P1078, DOI 10.1038/sj.onc.1209859; Reed CC, 2005, ONCOGENE, V24, P1104, DOI 10.1038/sj.onc.1208329; Reed CC, 2002, GLYCOCONJUGATE J, V19, P249, DOI 10.1023/A:1025383913444; Reed CC, 2002, ONCOGENE, V21, P3688, DOI 10.1038/sj.onc.1205470; Riggins KS, 2010, EXP CELL RES, V316, P2993, DOI 10.1016/j.yexcr.2010.08.003; Robinson PS, 2005, J BIOMECH ENG-T ASME, V127, P181, DOI 10.1115/1.1835363; Robinson PS, 2004, ANN BIOMED ENG, V32, P924, DOI 10.1023/B:ABME.0000032455.78459.56; Ruehland C, 2007, FEBS J, V274, P4246, DOI 10.1111/j.1742-4658.2007.05951.x; Salomaki HH, 2008, J HISTOCHEM CYTOCHEM, V56, P639, DOI 10.1369/jhc.2008.950287; Sanches JCT, 2010, J ANAT, V216, P144, DOI 10.1111/j.1469-7580.2009.01170.x; Santra M, 1997, J CLIN INVEST, V100, P149, DOI 10.1172/JCI119507; Santra M, 2002, J BIOL CHEM, V277, P35671, DOI 10.1074/jbc.M205317200; SANTRA M, 1995, P NATL ACAD SCI USA, V92, P7016, DOI 10.1073/pnas.92.15.7016; Santra M, 2000, J BIOL CHEM, V275, P35153, DOI 10.1074/jbc.M006821200; Santra M, 2008, J NEUROCHEM, V105, P324, DOI 10.1111/j.1471-4159.2007.05134.x; Schaefer L, 2002, AM J PATHOL, V160, P1181, DOI 10.1016/S0002-9440(10)64937-1; Schaefer L, 2004, AM J PATHOL, V165, P383, DOI 10.1016/S0002-9440(10)63305-6; Schaefer L, 2008, J BIOL CHEM, V283, P21305, DOI 10.1074/jbc.R800020200; Schaefer L, 2007, AM J PATHOL, V170, P301, DOI 10.2353/ajpath.2007.060497; Schaefer L, 2011, J AM SOC NEPHROL, V22, P1200, DOI 10.1681/ASN.2010050570; Schonherr E, 2004, J VASC RES, V41, P499, DOI 10.1159/000081806; Schonherr E, 2001, J BIOL CHEM, V276, P40687, DOI 10.1074/jbc.M105426200; Seidler DG, 2006, J BIOL CHEM, V281, P26408, DOI 10.1074/jbc.M602853200; Semenza GL, 2002, BIOCHEM PHARMACOL, V64, P993, DOI 10.1016/S0006-2952(02)01168-1; Semenza GL, 2009, SEMIN CANCER BIOL, V19, P12, DOI 10.1016/j.semcancer.2008.11.009; Tikhonenko AT, 1996, J BIOL CHEM, V271, P30741, DOI 10.1074/jbc.271.48.30741; Tralhao JG, 2003, FASEB J, V17, P464, DOI 10.1096/fj.02-0534fje; VONIOZZO R, 1982, LAB INVEST, V47, P124; Watnick RS, 2003, CANCER CELL, V3, P219, DOI 10.1016/S1535-6108(03)00030-8; Weis SM, 2005, MATRIX BIOL, V24, P313, DOI 10.1016/j.matbio.2005.05.003; Whitelock JM, 1996, J BIOL CHEM, V271, P10079, DOI 10.1074/jbc.271.17.10079; Williams KJ, 2007, AM J PATHOL, V171, P1441, DOI 10.2353/ajpath.2007.070079; Woodfin A, 2007, ARTERIOSCL THROM VAS, V27, P2514, DOI 10.1161/ATVBAHA.107.151456; Wu BB, 2007, IMMUNITY, V26, P227, DOI 10.1016/j.immuni.2006.12.007; Zafiropoulos A, 2008, MOL CANCER RES, V6, P785, DOI 10.1158/1541-7786.MCR-07-0165; Zarrabi K, 2011, J BIOL CHEM, V286, P33167, DOI 10.1074/jbc.M111.256644; Zhang GY, 2006, J CELL BIOCHEM, V98, P1436, DOI 10.1002/jcb.20776; Zhang G, 2009, J BIOL CHEM, V284, P8888, DOI 10.1074/jbc.M806590200; Zhang XF, 2007, MICROVASC RES, V74, P90, DOI 10.1016/j.mvr.2007.04.007; Zhang YW, 2003, P NATL ACAD SCI USA, V100, P12718, DOI 10.1073/pnas.2135113100; Zhu JX, 2005, J BIOL CHEM, V280, P32468, DOI 10.1074/jbc.M503833200; Zochbauer-Muller S, 2001, CANCER RES, V61, P249; Zoeller JJ, 2008, J CELL BIOL, V181, P381, DOI 10.1083/jcb.200708022; Zoeller JJ, 2009, J BIOL CHEM, V284, P11728, DOI 10.1074/jbc.M808991200	121	125	130	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5492	5506		10.1074/jbc.M111.283499	http://dx.doi.org/10.1074/jbc.M111.283499			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22194599	hybrid, Green Published			2022-12-27	WOS:000300638000029
J	Zhang, SY; Condac, E; Qiu, H; Jiang, JL; Gutierrez-Sanchez, G; Bergmann, C; Handel, T; Wang, LC				Zhang, Siyuan; Condac, Eduard; Qiu, Hong; Jiang, Junlin; Gutierrez-Sanchez, Gerardo; Bergmann, Carl; Handel, Tracy; Wang, Lianchun			Heparin-induced Leukocytosis Requires 6-O-Sulfation and Is Caused by Blockade of Selectin- and CXCL12 Protein-mediated Leukocyte Trafficking in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMATOPOIETIC PROGENITOR CELLS; COLONY-STIMULATING FACTOR; P-SELECTIN; BONE-MARROW; LYMPHOCYTE RECIRCULATION; SULFATED POLYSACCHARIDES; NEUTROPHIL HOMEOSTASIS; STROMAL CELLS; STEM-CELLS; G-CSF	Leukocytosis refers to an increase in leukocyte count above the normal range in the blood and is a common laboratory finding in patients. In many cases, the mechanisms underlying leukocytosis are not known. In this study, we examined the effects, the structural determinants, and the underlying mechanisms of heparin-induced leukocytosis, a side effect occurring in 0.44% of patients receiving heparin. We observed that heparin induced both lymphocytosis and neutrophilia, and the effects required heparin to be 6-O-sulfated but did not require its anticoagulant activity. Cell mobilization studies revealed that the lymphocytosis was attributable to a combination of blockage of lymphocyte homing and the release of thymocytes from the thymus, whereas the neutrophilia was caused primarily by neutrophil release from the bone marrow and demargination in the vasculature. Mechanistic studies revealed that heparin inhibits L-and P-selectin, as well as the chemokine CXCL12, leading to leukocytosis. Heparin is known to require 6-O-sulfate to inhibit L-and P-selectin function, and in this study we observed that 6-O-sulfate is required for its interaction with CXCL12. We conclude that heparin-induced leukocytosis requires glucosamine 6-O-sulfation and is caused by blockade of L-selectin-, P-selectin-, and CXCL12-mediated leukocyte trafficking.	[Zhang, Siyuan; Condac, Eduard; Qiu, Hong; Jiang, Junlin; Gutierrez-Sanchez, Gerardo; Bergmann, Carl; Wang, Lianchun] Univ Georgia, Complex Carbohydrate Res Ctr, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Handel, Tracy] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA	University System of Georgia; University of Georgia; University of California System; University of California San Diego	Wang, LC (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, Dept Biochem & Mol Biol, 315 Riverbend Rd, Athens, GA 30602 USA.	Lwang@ccrc.uga.edu	Qiu, Hong/C-5888-2011	Qiu, Hong/0000-0002-4088-7828	National Institutes of Health from NHLBI [R01HL093339]; National Institutes of Health from NIAID [RR005351]; National Institutes of Health [R01AI37113]; American Heart Association; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR005351] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI037113] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103390] Funding Source: NIH RePORTER	National Institutes of Health from NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health from NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL093339 from NHLBI (to L. W.), RR005351 from NIAID (to L. W./James Prestegard), and R01AI37113 (to T. M. H.). This work was also supported by American Heart Association postdoctoral fellowship (to S. Y. Z.) and a scientist development grant (to L. W.).	Abramson N, 2000, AM FAM PHYSICIAN, V62, P2053; Albanese P, 2009, EXP HEMATOL, V37, P1072, DOI 10.1016/j.exphem.2009.06.005; Amara A, 1999, J BIOL CHEM, V274, P23916, DOI 10.1074/jbc.274.34.23916; Basu S, 2002, BLOOD, V100, P854, DOI 10.1182/blood.V100.3.854; Borsig L, 2001, P NATL ACAD SCI USA, V98, P3352, DOI 10.1073/pnas.061615598; BRADFIEL.JW, 1969, NATURE, V222, P1183, DOI 10.1038/2221183a0; BRADFIELD JW, 1974, CELL IMMUNOL, V14, P22, DOI 10.1016/0008-8749(74)90165-8; Christopher MJ, 2007, CURR OPIN HEMATOL, V14, P3, DOI 10.1097/00062752-200701000-00003; Dar A, 2011, LEUKEMIA, V25, P1286, DOI 10.1038/leu.2011.62; de Haan G, 2000, BRIT J HAEMATOL, V110, P638, DOI 10.1046/j.1365-2141.2000.02252.x; Eash KJ, 2010, J CLIN INVEST, V120, P2423, DOI 10.1172/JCI41649; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Fahey V A, 1995, J Vasc Nurs, V13, P112, DOI 10.1016/S1062-0303(05)80003-2; FORD WL, 1969, SEMIN HEMATOL, V6, P67; Frenette PS, 2000, BLOOD, V96, P2460, DOI 10.1182/blood.V96.7.2460.h8002460_2460_2468; Furze RC, 2008, IMMUNOLOGY, V125, P281, DOI 10.1111/j.1365-2567.2008.02950.x; GODLOWSKI ZZ, 1951, BRIT MED J, V1, P854, DOI 10.1136/bmj.1.4711.854; Handel TM, 2005, ANNU REV BIOCHEM, V74, P385, DOI 10.1146/annurev.biochem.72.121801.161747; Hattori K, 2001, BLOOD, V97, P3354, DOI 10.1182/blood.V97.11.3354; Horwitz BH, 2001, BLOOD, V97, P1578, DOI 10.1182/blood.V97.6.1578; JOHNSON RC, 1995, BLOOD, V86, P1106; Kim CH, 1999, J LEUKOCYTE BIOL, V65, P6, DOI 10.1002/jlb.65.1.6; Lapidot T, 2002, EXP HEMATOL, V30, P973, DOI 10.1016/S0301-472X(02)00883-4; Leppanen A, 2000, J BIOL CHEM, V275, P39569, DOI 10.1074/jbc.M005005200; Maly P, 1996, CELL, V86, P643, DOI 10.1016/S0092-8674(00)80137-3; Martin C, 2003, IMMUNITY, V19, P583, DOI 10.1016/S1074-7613(03)00263-2; Nakagawa M, 1998, CIRCULATION, V98, P2307, DOI 10.1161/01.CIR.98.21.2307; NELSON RM, 1993, BLOOD, V82, P3253; Netelenbos T, 2003, J LEUKOCYTE BIOL, V74, P1035, DOI 10.1189/jlb.1202593; Netelenbos T, 2003, LEUKEMIA, V17, P175, DOI 10.1038/sj.leu.2402738; Netelenbos T, 2002, J LEUKOCYTE BIOL, V72, P353; Opdenakker G, 1998, IMMUNOL TODAY, V19, P182, DOI 10.1016/S0167-5699(97)01243-7; Osmond RIW, 2002, ANAL BIOCHEM, V310, P199, DOI 10.1016/S0003-2697(02)00396-2; Papayannopoulou T, 2004, BLOOD, V103, P1580, DOI 10.1182/blood-2003-05-1595; Petit I, 2002, NAT IMMUNOL, V3, P687, DOI 10.1038/ni813; Sadir R, 2001, J BIOL CHEM, V276, P8288, DOI 10.1074/jbc.M008110200; SASAKI S, 1967, NATURE, V214, P1041, DOI 10.1038/2141041a0; SCOLLAY RG, 1980, EUR J IMMUNOL, V10, P210, DOI 10.1002/eji.1830100310; Shen HM, 2001, J IMMUNOL, V166, P5027, DOI 10.4049/jimmunol.166.8.5027; Sierra MD, 2004, BLOOD, V103, P2452; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Stekel DJ, 1997, IMMUNOL TODAY, V18, P216; Stevenson JL, 2007, THROMB RES, V120, pS107, DOI 10.1016/S0049-3848(07)70138-X; Stevenson JL, 2005, CLIN CANCER RES, V11, P7003, DOI 10.1158/1078-0432.CCR-05-1131; Suratt BT, 2004, BLOOD, V104, P565, DOI 10.1182/blood-2003-10-3638; Sweeney EA, 2002, BLOOD, V99, P44, DOI 10.1182/blood.V99.1.44; Thelen M, 2008, NAT IMMUNOL, V9, P953, DOI 10.1038/ni.f.207; Tyrrell DJ, 1999, ADV PHARMACOL, V46, P151, DOI 10.1016/S1054-3589(08)60471-8; Wang JB, 1997, J LEUKOCYTE BIOL, V62, P503, DOI 10.1002/jlb.62.4.503; Wang LC, 2005, NAT IMMUNOL, V6, P902, DOI 10.1038/ni1233; Wang LC, 2002, J CLIN INVEST, V110, P127, DOI 10.1172/JCI200214996; Weninger W, 2000, IMMUNITY, V12, P665, DOI 10.1016/S1074-7613(00)80217-4; Wijelath E, 2010, J CELL BIOCHEM, V111, P461, DOI 10.1002/jcb.22727; Zhang FM, 2011, ANAL BIOANAL CHEM, V401, P2793, DOI 10.1007/s00216-011-5367-7; Zhang P, 2005, SHOCK, V23, P344, DOI 10.1097/01.shk.0000158960.93832.de; Zhou B, 2011, J CLIN INVEST, V121, P1894, DOI 10.1172/JCI45529	56	22	22	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5542	5553		10.1074/jbc.M111.314716	http://dx.doi.org/10.1074/jbc.M111.314716			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22194593	hybrid, Green Published			2022-12-27	WOS:000300638000033
J	Grimaldi, S; Arias-Cartin, R; Lanciano, P; Lyubenova, S; Szenes, R; Endeward, B; Prisner, TF; Guigliarelli, B; Magalon, A				Grimaldi, Stephane; Arias-Cartin, Rodrigo; Lanciano, Pascal; Lyubenova, Sevdalina; Szenes, Rodolphe; Endeward, Burkhard; Prisner, Thomas F.; Guigliarelli, Bruno; Magalon, Axel			Determination of the Proton Environment of High Stability Menasemiquinone Intermediate in Escherichia coli Nitrate Reductase A by Pulsed EPR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR DOUBLE-RESONANCE; ELECTRON-PARAMAGNETIC-RESONANCE; BACTERIAL REACTION CENTERS; PROTEIN-COFACTOR INTERACTIONS; DENSITY-FUNCTIONAL THEORY; PHOTOSYSTEM-I; ANION-RADICALS; QUINOL OXIDASE; BINDING-SITE; RHODOPSEUDOMONAS-SPHAEROIDES	Escherichia coli nitrate reductase A (NarGHI) is a membrane-bound enzyme that couples quinol oxidation at a periplasmically oriented Q-site (Q(D)) to proton release into the periplasm during anaerobic respiration. To elucidate the molecular mechanism underlying such a coupling, endogenous menasemiquinone- 8 intermediates stabilized at the Q(D) site (MSQ(D)) of NarGHI have been studied by high-resolution pulsed EPR methods in combination with (H2O)-H-1/(H2O)-H-2 exchange experiments. One of the two non-exchangeable proton hyperfine couplings resolved in hyperfine sublevel correlation (HYSCORE) spectra of the radical displays characteristics typical from quinone methyl protons. However, its unusually small isotropic value reflects a singularly low spin density on the quinone carbon alpha carrying the methyl group, which is ascribed to a strong asymmetry of the MSQ(D) binding mode and consistent with singlesided hydrogen bonding to the quinone oxygen O1. Furthermore, a single exchangeable proton hyperfine coupling is resolved, both by comparing the HYSCORE spectra of the radical in (H2O)-H-1 and (H2O)-H-2 samples and by selective detection of the exchanged deuterons using Q-band H-2 Mims electron nuclear double resonance (ENDOR) spectroscopy. Spectral analysis reveals its peculiar characteristics, i. e. a large anisotropic hyper-fine coupling together with an almost zero isotropic contribution. It is assigned to a proton involved in a short similar to 1.6 angstrom inplane hydrogen bond between the quinone O1 oxygen and the N delta of the His-66 residue, an axial ligand of the distal heme b(D). Structural and mechanistic implications of these results for the electron-coupled proton translocation mechanism at the Q(D) site are discussed, in light of the unusually high thermodynamic stability of MSQ(D).	[Grimaldi, Stephane; Lanciano, Pascal; Szenes, Rodolphe; Guigliarelli, Bruno] CNRS, Unite Bioenerget & Ingn Prot, UPR9036, Inst Microbiol Mediterranee, F-13009 Marseille, France; [Arias-Cartin, Rodrigo; Magalon, Axel] CNRS, Inst Microbiol Mediterranee, Chim Bacterienne Lab, UPR9043, F-13009 Marseille, France; [Arias-Cartin, Rodrigo; Magalon, Axel] Aix Marseille Univ, F-13009 Marseille, France; [Lyubenova, Sevdalina; Endeward, Burkhard; Prisner, Thomas F.] Goethe Univ Frankfurt, Inst Phys & Theoret Chem, D-60438 Frankfurt, Germany	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Goethe University Frankfurt	Grimaldi, S (corresponding author), CNRS, Unite Bioenerget & Ingn Prot BIP, Inst Microbiol Mediterranee, UPR9036, 31 Chemin Joseph Aiguier, F-13402 Marseille 20, France.	grimaldi@ifr88.cnrs-mrs.fr	Grimaldi, Stephane/G-9884-2013; Grimaldi, Stephane/AAF-7138-2020	Grimaldi, Stephane/0000-0002-9559-6112; Magalon, Axel/0000-0002-3375-738X; Prisner, Thomas F./0000-0003-2850-9573; Arias-Cartin, Rodrigo/0000-0001-5008-6437	CNRS; Agence Nationale de la Recherche,; Aix-Marseille Universite; European Community (EU-NMR) [RII3-026145]; European Cooperation in Science and Technology Action [COST P15]	CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche,(French National Research Agency (ANR)); Aix-Marseille Universite; European Community (EU-NMR)(European Commission); European Cooperation in Science and Technology Action	This work was supported by the CNRS, the Agence Nationale de la Recherche, and Aix-Marseille Universite. This work was also supported by Research Infrastructures Activity in the 6th Framework Program of the European Community (Contract RII3-026145, EU-NMR) for financial support (to S. G.), as well as the European Cooperation in Science and Technology Action (COST P15) "Advanced Paramagnetic Resonance Methods in Molecular Biophysics" for Short-Term Scientific Mission funding (to S. G.).	Arias-Cartin R, 2011, P NATL ACAD SCI USA, V108, P7781, DOI 10.1073/pnas.1010427108; Arias-Cartin R, 2010, J AM CHEM SOC, V132, P5942, DOI 10.1021/ja1009234; Bertero MG, 2005, J BIOL CHEM, V280, P14836, DOI 10.1074/jbc.M410457200; Bertero MG, 2003, NAT STRUCT BIOL, V10, P681, DOI 10.1038/nsb969; Blasco F, 2001, CELL MOL LIFE SCI, V58, P179, DOI 10.1007/PL00000846; Chatterjee R, 2011, BIOCHEMISTRY-US, V50, P491, DOI 10.1021/bi101883y; DAS MR, 1970, J AM CHEM SOC, V92, P2258, DOI 10.1021/ja00711a011; DIKANOV SA, 1995, J MAGN RESON SER A, V116, P125, DOI 10.1006/jmra.1995.1199; Dikanov SA, 2004, J BIOL CHEM, V279, P15814, DOI 10.1074/jbc.M313417200; Epel B, 2006, J PHYS CHEM B, V110, P11549, DOI 10.1021/jp060548d; Feher G., 1985, ANTENNAS REACTION CT, V42, P174; Flores M, 2007, BIOPHYS J, V92, P671, DOI 10.1529/biophysj.106.092460; Flores M, 2003, CHEM PHYS, V294, P401, DOI 10.1016/S0301-0104(03)00321-5; Fritscher J, 2004, PHYS CHEM CHEM PHYS, V6, P4950, DOI 10.1039/b408764j; Gardiner AT, 1999, BIOCHEMISTRY-US, V38, P11773, DOI 10.1021/bi990661c; Grimaldi S, 2005, BIOCHEMISTRY-US, V44, P1300, DOI 10.1021/bi048009r; Grimaldi S, 2003, BIOCHEMISTRY-US, V42, P5632, DOI 10.1021/bi034010z; Grimaldi S, 2010, J BIOL CHEM, V285, P179, DOI 10.1074/jbc.M109.060251; Guigliarelli B, 1996, BIOCHEMISTRY-US, V35, P4828, DOI 10.1021/bi952459p; Hastings SF, 2000, EUR J BIOCHEM, V267, P5638, DOI 10.1046/j.1432-1327.2000.01643.x; HUNT MJ, 1974, J MAGN RESON, V15, P402, DOI 10.1016/0022-2364(74)90143-7; Kacprzak S, 2006, J AM CHEM SOC, V128, P5659, DOI 10.1021/ja053988b; Kevan L., 1976, ELECT SPIN DOUBLE RE; Lanciano P, 2007, J PHYS CHEM B, V111, P13632, DOI 10.1021/jp075243t; Lanciano P, 2007, BIOCHEMISTRY-US, V46, P5323, DOI 10.1021/bi700074y; LUBITZ W, 1985, BIOCHIM BIOPHYS ACTA, V808, P464, DOI 10.1016/0005-2728(85)90155-0; Lubitz W, 1999, APPL MAGN RESON, V17, P1, DOI 10.1007/BF03162067; MacMillan F, 1995, MAGN RESON CHEM, V33, pS81, DOI 10.1002/mrc.1260331314; MacMillan F, 2011, FARADAY DISCUSS, V148, P315, DOI 10.1039/c005149g; Martin E, 2011, J AM CHEM SOC, V133, P5525, DOI 10.1021/ja2001538; MCCONNELL HM, 1956, J CHEM PHYS, V24, P764, DOI 10.1063/1.1742605; MIMS WB, 1965, PROC R SOC LON SER-A, V283, P452, DOI 10.1098/rspa.1965.0034; Nicholls D., 2002, BIOENERGETICS; Niklas J, 2009, J PHYS CHEM B, V113, P10367, DOI 10.1021/jp901890z; O'Malley PJ, 1999, BBA-BIOENERGETICS, V1411, P101, DOI 10.1016/S0005-2728(99)00036-5; O'Malley PJ, 1998, CHEM PHYS LETT, V291, P367, DOI 10.1016/S0009-2614(98)00571-5; OMALLEY PJ, 1986, J AM CHEM SOC, V108, P3995, DOI 10.1021/ja00274a024; Potter LC, 1999, BIOCHEM J, V344, P77, DOI 10.1042/0264-6021:3440077; REIJERSE EJ, 1991, J CHEM PHYS, V95, P836, DOI 10.1063/1.461091; Rigby SEJ, 1996, BIOCHEMISTRY-US, V35, P6651, DOI 10.1021/bi952619x; Rigby SEJ, 2001, BBA-BIOENERGETICS, V1507, P247, DOI 10.1016/S0005-2728(01)00211-0; ROBERTSON DE, 1984, J BIOL CHEM, V259, P1758; Rothery RA, 2001, J MOL MICROB BIOTECH, V3, P273; RUTHERFORD AW, 1980, FEBS LETT, V110, P257, DOI 10.1016/0014-5793(80)80086-X; Schweiger A., 2001, PRINCIPLES PULSE ELE; Sinnecker S, 2004, J AM CHEM SOC, V126, P3280, DOI 10.1021/ja0392014; Sinnecker S, 2006, PHYS CHEM CHEM PHYS, V8, P5659, DOI 10.1039/b612568a; SODA G, 1969, J CHEM PHYS, V50, P439, DOI 10.1063/1.1670818; Srinivasan N, 2011, BIOCHEMISTRY-US, V50, P3495, DOI 10.1021/bi102056q; Srinivasan N, 2009, BBA-BIOENERGETICS, V1787, P1057, DOI 10.1016/j.bbabio.2009.04.010; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; Stowell MHB, 1997, SCIENCE, V276, P812, DOI 10.1126/science.276.5313.812; Teutloff C, 2004, APPL MAGN RESON, V26, P5, DOI 10.1007/BF03166559; Yap LL, 2006, J BIOL CHEM, V281, P16879, DOI 10.1074/jbc.M602544200; Yi SM, 2010, J BIOL CHEM, V285, P18241, DOI 10.1074/jbc.M110.116186; Zheng M, 1996, BIOCHEMISTRY-US, V35, P8955, DOI 10.1021/bi9522209	56	17	17	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4662	4670		10.1074/jbc.M111.325100	http://dx.doi.org/10.1074/jbc.M111.325100			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22190684	Green Published, hybrid			2022-12-27	WOS:000300608500028
J	Gupta, A; Dong, A; Lowe, AW				Gupta, Aparna; Dong, Aiwen; Lowe, Anson W.			AGR2 Gene Function Requires a Unique Endoplasmic Reticulum Localization Motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LUMINAL ER PROTEINS; CANCER CELL-LINES; ESTROGEN-RECEPTOR; LIMB REGENERATION; XENOPUS-LAEVIS; HUMAN HOMOLOG; LUNG-CANCER; YEAST-CELLS; DIFFERENTIATION; EXPRESSION	Soluble proteins are enriched in the endoplasmic reticulum (ER) by retrograde transport from the Golgi that is mediated by the KDEL receptors. In addition to the classic carboxyl-terminal KDEL motif, a variety of sequence variants are also capable of receptor binding that result in ER localization. Although different ER localization signals that exhibit varying affinities for the KDEL receptors exist, whether there are functional implications was unknown. The present study determines whether AGR2 requires a specific ER localization signal to be functionally active. AGR2 is expressed in most human adenocarcinomas and serves a role in promoting growth and the transformed phenotype. Using two different cell lines in which AGR2 induces expression of either the EGFR ligand amphiregulin or the transcription factor CDX2, only the highly conserved wild-type carboxyl-terminal KTEL motif results in the appropriate outcome. Deletion of the KTEL motif results in AGR2 secretion and loss of AGR2 function. AGR2 function is also lost when ER residence is achieved with a carboxyl-terminal KDEL or KSEL instead of a KTEL motif. Thus variations in ER localization sequences may serve a specific functional role, and in the case of AGR2, this role is served specifically by KTEL.	[Gupta, Aparna; Dong, Aiwen; Lowe, Anson W.] Stanford Univ, Dept Med, Stanford, CA 94305 USA; [Gupta, Aparna; Dong, Aiwen; Lowe, Anson W.] Stanford Univ, Stanford Digest Dis Ctr, Stanford, CA 94305 USA	Stanford University; Stanford University	Lowe, AW (corresponding author), Stanford Univ, Dept Med, Alway Bldg,Rm M211,300 Pasteur Dr, Stanford, CA 94305 USA.	lowe@stanford.edu	Dong, Aiwen/B-1258-2013	Dong, Aiwen/0000-0003-4931-3633	National Institutes of Health [DK063624, DK56339]; Stanford Cancer Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063624, P30DK056339] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford Cancer Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK063624 (to A. W. L.) and DK56339 (to the Stanford University Digestive Disease Center). This work was also supported by the Stanford Cancer Center.	Aberger F, 1998, MECH DEVELOP, V72, P115, DOI 10.1016/S0925-4773(98)00021-5; Alanen HI, 2011, J MOL BIOL, V409, P291, DOI 10.1016/j.jmb.2011.03.070; Capitani M, 2009, FEBS LETT, V583, P3863, DOI 10.1016/j.febslet.2009.10.053; DEAN N, 1990, J CELL BIOL, V111, P369, DOI 10.1083/jcb.111.2.369; Dong AW, 2011, J BIOL CHEM, V286, P18301, DOI 10.1074/jbc.M110.215707; Edgell TA, 2010, CLIN SCI, V118, P717, DOI 10.1042/CS20090537; Escaffit F, 2006, BIOCHEM BIOPH RES CO, V342, P66, DOI 10.1016/j.bbrc.2006.01.128; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Fletcher GC, 2003, BRIT J CANCER, V88, P579, DOI 10.1038/sj.bjc.6600740; Fritzsche FR, 2007, HISTOL HISTOPATHOL, V22, P703, DOI 10.14670/HH-22.703; Hao Y, 2006, GASTROENTEROLOGY, V131, P925, DOI 10.1053/j.gastro.2006.04.026; HARDWICK KG, 1992, EMBO J, V11, P4187, DOI 10.1002/j.1460-2075.1992.tb05512.x; Kumar A, 2007, SCIENCE, V318, P772, DOI 10.1126/science.1147710; Kumar A, 2011, P NATL ACAD SCI USA, V108, P13588, DOI 10.1073/pnas.1108472108; LEWIS MJ, 1990, CELL, V61, P1359, DOI 10.1016/0092-8674(90)90699-F; Li CH, 1998, PATTERN RECOGN LETT, V19, P771, DOI 10.1016/S0167-8655(98)00057-9; Liu D, 2005, CANCER RES, V65, P3796, DOI 10.1158/0008-5472.CAN-04-3823; Lowe AW, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000323; Miller JP, 2005, P NATL ACAD SCI USA, V102, P12123, DOI 10.1073/pnas.0505482102; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; Park SW, 2009, P NATL ACAD SCI USA, V106, P6950, DOI 10.1073/pnas.0808722106; PELHAM HRB, 1990, TRENDS BIOCHEM SCI, V15, P483, DOI 10.1016/0968-0004(90)90303-S; QUARONI A, 1979, J CELL BIOL, V80, P248, DOI 10.1083/jcb.80.2.248; Ramachandran V, 2008, CANCER RES, V68, P7811, DOI 10.1158/0008-5472.CAN-08-1320; Raykhel I, 2007, J CELL BIOL, V179, P1193, DOI 10.1083/jcb.200705180; Ruan J, 2008, NUCLEIC ACIDS RES, V36, pD735, DOI 10.1093/nar/gkm1005; SEMENZA JC, 1990, CELL, V61, P1349, DOI 10.1016/0092-8674(90)90698-E; SIVE HL, 1989, CELL, V58, P171, DOI 10.1016/0092-8674(89)90413-3; Snapp EL, 2006, P NATL ACAD SCI USA, V103, P6536, DOI 10.1073/pnas.0510657103; Soubeyran P, 1999, GASTROENTEROLOGY, V117, P1326, DOI 10.1016/S0016-5085(99)70283-0; Suh E, 1996, MOL CELL BIOL, V16, P619; Thompson DA, 1998, BIOCHEM BIOPH RES CO, V251, P111, DOI 10.1006/bbrc.1998.9440; TOWNSLEY FM, 1994, J CELL BIOL, V127, P21, DOI 10.1083/jcb.127.1.21; Wang Z, 2008, CANCER RES, V68, P492, DOI 10.1158/0008-5472.CAN-07-2930; WILSON DW, 1993, J BIOL CHEM, V268, P7465; Yamamoto K, 2003, J BIOL CHEM, V278, P34525, DOI 10.1074/jbc.M304188200; Yoshida S, 2002, DIABETES, V51, P2505, DOI 10.2337/diabetes.51.8.2505; Zhang JS, 2005, GENE CHROMOSOME CANC, V43, P249, DOI 10.1002/gcc.20188; Zhao F, 2010, DEV BIOL, V338, P268, DOI 10.1016/j.ydbio.2009.12.008; Zhu H, 2007, CANCER LETT, V245, P303, DOI 10.1016/j.canlet.2006.01.020	40	35	38	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4773	4782		10.1074/jbc.M111.301531	http://dx.doi.org/10.1074/jbc.M111.301531			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22184114	Green Published, hybrid			2022-12-27	WOS:000300608500038
J	Kim, PY; Tieu, LD; Stafford, AR; Fredenburgh, JC; Weitz, JI				Kim, Paul Y.; Tieu, Long D.; Stafford, Alan R.; Fredenburgh, James C.; Weitz, Jeffrey I.			A High Affinity Interaction of Plasminogen with Fibrin Is Not Essential for Efficient Activation by Tissue-type Plasminogen Activator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYS-PLASMINOGEN; LIGAND-BINDING; INTACT FIBRIN; IN-VITRO; DOMAIN; DERIVATIVES; INHIBITION; THROMBIN; KINETICS; H-1-NMR	Fibrin (Fn) enhances plasminogen (Pg) activation by tissue-type plasminogen activator(tPA) by serving as a template onto which Pg and tPA assemble. To explore the contribution of the Pg/Fn interaction to Fn cofactor activity, Pg variants were generated and their affinities for Fn were determined using surface plasmon resonance (SPR). Glu-Pg, Lys-Pg (des(1-77)), and Mini-Pg (lacking kringles 1-4) bound Fn with K-d values of 3.1, 0.21, and 24.5 mu M, respectively, whereas Micro-Pg (lacking all kringles) did not bind. The kinetics of activation of the Pg variants by tPA were then examined in the absence or presence of Fn. Whereas Fn had no effect on Micro-Pg activation, the catalytic efficiencies of Glu-Pg, Lys-Pg, and Mini-Pg activation in the presence of Fn were 300- to 600-fold higher than in its absence. The retention of Fn cofactor activity with Mini-Pg, which has low affinity for Fn, suggests that Mini-Pg binds the tPA-Fn complex more tightly than tPA alone. To explore this possibility, SPR was used to examine the interaction of Mini-Pg with Fn in the absence or presence of tPA. There was 50% more Mini-Pg binding to Fn in the presence of tPA than in its absence, suggesting that formation of the tPA-Fn complex exposes a cryptic site that binds Mini-Pg. Thus, our data (a) indicate that high affinity binding of Pg to Fn is not essential for Fn cofactor activity, and (b) suggest that kringle 5 localizes and stabilizes Pg within the tPA-Fn complex and contributes to its efficient activation.	[Kim, Paul Y.; Tieu, Long D.; Stafford, Alan R.; Fredenburgh, James C.; Weitz, Jeffrey I.] McMaster Univ, Dept Med, Hamilton, ON L8L 2X2, Canada; [Kim, Paul Y.; Tieu, Long D.; Stafford, Alan R.; Fredenburgh, James C.; Weitz, Jeffrey I.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8L 2X2, Canada; [Kim, Paul Y.; Tieu, Long D.; Stafford, Alan R.; Fredenburgh, James C.; Weitz, Jeffrey I.] Thrombosis & Atherosclerosis Res Inst, Hamilton, ON L8L 2X2, Canada	McMaster University; McMaster University; McMaster University	Weitz, JI (corresponding author), 237 Barton St E, Hamilton, ON L8L 2X2, Canada.	weitzj@taari.ca	Weitz, Jeffrey/AAD-1929-2019; Kim, Paul/GYV-3258-2022	Weitz, Jeffrey/0000-0002-1092-7550; Kim, Paul/0000-0003-0943-4924	Canadian Institutes of Health Research [MOP3992, MOP102735, CTP 79846]; Heart and Stroke Foundation of Ontario; Ontario Research and Development Challenge Fund; Heart and Stroke Foundation of Canada; AstraZeneca Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Ontario Research and Development Challenge Fund(General Electric); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); AstraZeneca Canada(AstraZeneca)	The work was supported in part by Canadian Institutes of Health Research Grants MOP3992, MOP102735, and CTP 79846, the Heart and Stroke Foundation of Ontario, and the Ontario Research and Development Challenge Fund.; Recipient of a Research Fellowship Award from the Heart and Stroke Foundation of Canada and AstraZeneca Canada.	Bachmann F., 2001, HEMOSTASIS THROMBOSI; Bachmann F., 1994, HEMOSTASIS THROMBOSI; CASTELLINO FJ, 1981, METHOD ENZYMOL, V80, P365; CASTELLINO FJ, 1981, J BIOL CHEM, V256, P4778; COLLEN D, 1991, BLOOD, V78, P3114; Dobrovolsky AB, 2002, BIOCHEMISTRY-MOSCOW+, V67, P99, DOI 10.1023/A:1013960416302; Fredenburgh JC, 2008, J BIOL CHEM, V283, P2470, DOI 10.1074/jbc.M707710200; FREDENBURGH JC, 1992, J BIOL CHEM, V267, P26150; Horrevoets AJG, 1997, J BIOL CHEM, V272, P2183; HORREVOETS AJG, 1995, J BIOL CHEM, V270, P15770, DOI 10.1074/jbc.270.26.15770; HOYLAERTS M, 1982, J BIOL CHEM, V257, P2912; Komorowicz E, 1998, BIOCHEMISTRY-US, V37, P9112, DOI 10.1021/bi980180d; Lamba D, 1996, J MOL BIOL, V258, P117, DOI 10.1006/jmbi.1996.0238; Lijnen H. R., 1995, HEMATOLOGY BASIC PRI; LIJNEN HR, 1994, J INTERN MED, V236, P415, DOI 10.1111/j.1365-2796.1994.tb00819.x; Lijnen HR, 2001, ANN NY ACAD SCI, V936, P226; Lin X, 2006, INT J MOL MED, V17, P833; LUCAS MA, 1983, J BIOL CHEM, V258, P4249; MOTTA A, 1987, BIOCHEMISTRY-US, V26, P3827, DOI 10.1021/bi00387a014; NESHEIM M, 1990, J BIOL CHEM, V265, P21541; PETROS AM, 1989, BIOCHEMISTRY-US, V28, P1368, DOI 10.1021/bi00429a064; Renatus M, 1997, J BIOL CHEM, V272, P21713, DOI 10.1074/jbc.272.35.21713; Schneider M, 2004, J BIOL CHEM, V279, P13333, DOI 10.1074/jbc.M313164200; Senis YA, 2006, BBA-PROTEINS PROTEOM, V1764, P863, DOI 10.1016/j.bbapap.2006.03.004; SHI GY, 1988, J BIOL CHEM, V263, P17071; Sottrup-Jensen L., 1978, PROGR CHEM FIBRINOLY; Stewart RJ, 1998, J BIOL CHEM, V273, P18292, DOI 10.1074/jbc.273.29.18292; STRAUGHN W, 1966, THROMB DIATH HAEMOST, V16, P198, DOI 10.1055/s-0038-1655637; SUENSON E, 1988, BIOCHEMISTRY-US, V27, P2435, DOI 10.1021/bi00407a029; THEWES T, 1990, J BIOL CHEM, V265, P3906; Vu TT, 2011, J BIOL CHEM, V286, P30314, DOI 10.1074/jbc.M111.253831; Walker JB, 1999, J BIOL CHEM, V274, P5201, DOI 10.1074/jbc.274.8.5201; WU HL, 1990, J BIOL CHEM, V265, P19658	33	26	27	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4652	4661		10.1074/jbc.M111.317719	http://dx.doi.org/10.1074/jbc.M111.317719			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22187433	Green Published, hybrid			2022-12-27	WOS:000300608500027
J	Negoro, S; Shibata, N; Tanaka, Y; Yasuhira, K; Shibata, H; Hashimoto, H; Lee, YH; Oshima, S; Santa, R; Oshima, S; Mochiji, K; Goto, Y; Ikegami, T; Nagai, K; Kato, D; Takeo, M; Higuchi, Y				Negoro, Seiji; Shibata, Naoki; Tanaka, Yusuke; Yasuhira, Kengo; Shibata, Hiroshi; Hashimoto, Haruka; Lee, Young-Ho; Oshima, Shohei; Santa, Ryuji; Oshima, Shohei; Mochiji, Kozo; Goto, Yuji; Ikegami, Takahisa; Nagai, Keisuke; Kato, Dai-ichiro; Takeo, Masahiro; Higuchi, Yoshiki			Three-dimensional Structure of Nylon Hydrolase and Mechanism of Nylon-6 Hydrolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-GLUTAMYL-TRANSPEPTIDASE; RAY CRYSTALLOGRAPHIC ANALYSIS; OLIGOMER DEGRADATION GENE; CRYSTAL-STRUCTURE; ORNITHINE ACETYLTRANSFERASE; 6-AMINOHEXANOATE-DIMER HYDROLASE; CATALYTIC MECHANISM; PRECURSOR PROTEIN; ESCHERICHIA-COLI; PLASMID POAD2	We performed x-ray crystallographic analyses of the 6-aminohexanoate oligomer hydrolase (NylC) from Agromyces sp. at 2.0 angstrom-resolution. This enzyme is a member of the N-terminal nucleophile hydrolase superfamily that is responsible for the degradation of the nylon-6 industry byproduct. We observed four identical heterodimers (27 kDa + 9 kDa), which resulted from the autoprocessing of the precursor protein (36 kDa) and which constitute the doughnut-shaped quaternary structure. The catalytic residue of NylC was identified as the N-terminal Thr-267 of the 9-kDa subunit. Furthermore, each heterodimer is folded into a single domain, generating a stacked alpha beta beta alpha core structure. Amino acid mutations at subunit interfaces of the tetramer were observed to drastically alter the thermostability of the protein. In particular, four mutations (D122G/H130Y/D36A/E263Q) of wild-type NylC from Arthrobacter sp. (plasmid pOAD2-encoding enzyme), with a heat denaturation temperature of T-m = 52 degrees C, enhanced the protein thermostability by 36 degrees C (T-m = 88 degrees C), whereas a single mutation (G111S or L137A) decreased the stability by similar to 10 degrees C. We examined the enzymatic hydrolysis of nylon-6 by the thermostable NylC mutant. Argon cluster secondary ion mass spectrometry analyses of the reaction products revealed that the major peak of nylon-6 (m/z 10,000-25,000) shifted to a smaller range, producing a new peak corresponding to m/z 1500-3000 after the enzyme treatment at 60 degrees C. In addition, smaller fragments in the soluble fraction were successively hydrolyzed to dimers and monomers. Based on these data, we propose that NylC should be designated as nylon hydrolase (or nylonase). Three potential uses of NylC for industrial and environmental applications are also discussed.	[Negoro, Seiji; Tanaka, Yusuke; Yasuhira, Kengo; Shibata, Hiroshi; Hashimoto, Haruka; Santa, Ryuji; Oshima, Shohei; Nagai, Keisuke; Kato, Dai-ichiro; Takeo, Masahiro] Univ Hyogo, Dept Mat Sci & Chem, Grad Sch Engn, Himeji, Hyogo 6712280, Japan; [Shibata, Naoki; Higuchi, Yoshiki] Univ Hyogo, Dept Life Sci, Grad Sch Life Sci, Kamigori, Hyogo 6781297, Japan; [Shibata, Naoki; Higuchi, Yoshiki] RIKEN Harima Inst, SPring Ctr 8, Mikazuki, Hyogo 6795148, Japan; [Lee, Young-Ho; Goto, Yuji; Ikegami, Takahisa] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; [Oshima, Shohei; Mochiji, Kozo] Univ Hyogo, Dept Intelligence Mech Technol, Grad Sch Engn, Himeji, Hyogo 6712280, Japan	University of Hyogo; University of Hyogo; RIKEN; Osaka University; University of Hyogo	Negoro, S (corresponding author), Univ Hyogo, Dept Mat Sci & Chem, Grad Sch Engn, 2167 Shosha, Himeji, Hyogo 6712280, Japan.	negoro@eng.u-hyogo.ac.jp; hig@sci.u-hyogo.ac.jp	Ikegami, Takahisa/I-9626-2017; Shibata, Naoki/AFK-9971-2022; Takeo, Masahiro/GYA-3639-2022	Ikegami, Takahisa/0000-0002-1429-1844; Shibata, Naoki/0000-0002-5096-1104; Higuchi, Yoshiki/0000-0001-8284-5709	Japan Society for Promotion of Science; Global Center of Excellence Program; Japan Aerospace Exploration Agency	Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Global Center of Excellence Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Aerospace Exploration Agency	This work was supported in part by a grant-in-aid for scientific research (Japan Society for Promotion of Science) and grants from the Global Center of Excellence Program and the Japan Aerospace Exploration Agency project.	Bompard-Gilles C, 2000, STRUCTURE, V8, P153, DOI 10.1016/S0969-2126(00)00091-5; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cheng H, 2005, PROTEIN SCI, V14, P1902, DOI 10.1110/ps.051364905; Dasgupta S, 1996, J AM CHEM SOC, V118, P12291, DOI 10.1021/ja944125d; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Elkins JM, 2005, BIOCHEM J, V385, P565, DOI 10.1042/BJ20040814; Fanuel L, 1999, BIOCHEM J, V341, P147, DOI 10.1042/0264-6021:3410147; Geueke B, 2006, FEBS J, V273, P5261, DOI 10.1111/j.1742-4658.2006.05519.x; Guan C, 1998, J BIOL CHEM, V273, P9695, DOI 10.1074/jbc.273.16.9695; Guo HC, 1998, J BIOL CHEM, V273, P20205, DOI 10.1074/jbc.273.32.20205; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; KAKUDO S, 1995, J FERMENT BIOENG, V80, P12, DOI 10.1016/0922-338X(95)98169-L; KAKUDO S, 1993, APPL ENVIRON MICROB, V59, P3978, DOI 10.1128/AEM.59.11.3978-3980.1993; KATO K, 1995, MICROBIOL-UK, V141, P2585, DOI 10.1099/13500872-141-10-2585; Kawashima Y, 2009, FEBS J, V276, P2547, DOI 10.1111/j.1742-4658.2009.06978.x; Kim Y, 2000, STRUCTURE, V8, P1059, DOI 10.1016/S0969-2126(00)00505-0; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Marc F, 2001, J BIOL CHEM, V276, P25404, DOI 10.1074/jbc.M100392200; McRee D.E., 1999, PRACTICAL PROTEIN CR, V2nd ed., P91; Michalska K, 2005, J BIOL CHEM, V280, P28484, DOI 10.1074/jbc.M504501200; Michalska K, 2008, J BIOL CHEM, V283, P13388, DOI 10.1074/jbc.M800746200; Mochiji K, 2009, RAPID COMMUN MASS SP, V23, P648, DOI 10.1002/rcm.3922; Moritani K, 2009, APPL PHYS EXPRESS, V2, DOI 10.1143/APEX.2.046001; NEGORO S, 1992, J BACTERIOL, V174, P7948, DOI 10.1128/JB.174.24.7948-7953.1992; Negoro S, 2000, APPL MICROBIOL BIOT, V54, P461, DOI 10.1007/s002530000434; Negoro S, 2005, J BIOL CHEM, V280, P39644, DOI 10.1074/jbc.M505946200; Negoro S, 2007, J MOL BIOL, V370, P142, DOI 10.1016/j.jmb.2007.04.043; Ohki T, 2006, FEBS LETT, V580, P5054, DOI 10.1016/j.febslet.2006.08.031; Ohki T, 2009, PROTEIN SCI, V18, P1662, DOI 10.1002/pro.185; Oinonen C, 2000, PROTEIN SCI, V9, P2329, DOI 10.1110/ps.9.12.2329; OKADA H, 1983, NATURE, V306, P203, DOI 10.1038/306203a0; Okada T, 2006, P NATL ACAD SCI USA, V103, P6471, DOI 10.1073/pnas.0511020103; Okada T, 2007, J BIOL CHEM, V282, P2433, DOI 10.1074/jbc.M607490200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Saarela J, 2004, BIOCHEM J, V378, P363, DOI 10.1042/BJ20031496; Sambrook J., 2001, MOL CLONING LAB MANU; Sankaranarayanan R, 2010, J MOL BIOL, V397, P979, DOI 10.1016/j.jmb.2010.02.018; Schmidtke G, 1996, EMBO J, V15, P6887, DOI 10.1002/j.1460-2075.1996.tb01081.x; Tikkanen R, 1996, EMBO J, V15, P2954, DOI 10.1002/j.1460-2075.1996.tb00658.x; Weeks CM, 2002, Z KRISTALLOGR, V217, P686, DOI 10.1524/zkri.217.12.686.20659; Yasuhira K, 2007, J BIOSCI BIOENG, V104, P521, DOI 10.1263/jbb.104.521; Yasuhira K, 2007, APPL ENVIRON MICROB, V73, P7099, DOI 10.1128/AEM.00777-07; Yasuhira K, 2011, ACTA CRYSTALLOGR F, V67, P892, DOI 10.1107/S1744309111022858; Yasuhira K, 2010, J BIOL CHEM, V285, P1239, DOI 10.1074/jbc.M109.041285	44	23	25	2	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					5079	5090		10.1074/jbc.M111.321992	http://dx.doi.org/10.1074/jbc.M111.321992			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22187439	Green Published, hybrid			2022-12-27	WOS:000300608500066
J	Dwivedi, VP; Tousif, S; Bhattacharya, D; Prasad, DVR; Van Kaer, L; Das, J; Das, G				Dwivedi, Ved Prakash; Tousif, Sultan; Bhattacharya, Debapriya; Prasad, Durbaka Vijay Raghva; Luc Van Kaer; Das, Jyoti; Das, Gobardhan			Transforming Growth Factor-beta Protein Inversely Regulates in Vivo Differentiation of Interleukin-17 (IL-17)-producing CD4(+) and CD8(+) T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLAMMATORY-BOWEL-DISEASE; SUPPRESSION; MECHANISMS; T(H)17; PLAYS	TGF-beta is a pleiotropic cytokine that predominantly exerts inhibitory functions in the immune system. Unexpectedly, the in vitro differentiation of both Th17 and Tc17 cells requires TGF-beta. However, animals that are impaired in TGF-beta signaling (TGF-beta RIIDN mice) display multiorgan autoimmune disorders. Here we show that CD4(+) T cells from TGF-beta RIIDN mice are resistant to Th17 cell differentiation and, paradoxically, that CD8(+) T cells from these animals spontaneously acquire an IL-17-producing phenotype. Neutralization of IL-17 or depletion of CD8(+) T cells dramatically inhibited inflammation in TGF-beta RIIDN mice. Therefore, the absence of TGF-beta triggers spontaneous differentiation of IL-17-producing CD8(+) T cells, suggesting that the in vivo and in vitro conditions that promote the differentiation of IL-17-producing CD8(+) T cells are distinct.	[Dwivedi, Ved Prakash; Tousif, Sultan; Bhattacharya, Debapriya; Das, Jyoti; Das, Gobardhan] Int Ctr Genet Engn & Biotechnol, Immunol Grp, New Delhi 110067, India; [Luc Van Kaer] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA; [Das, Jyoti] Natl Inst Malaria Res, Immunol Sect, New Delhi 110077, India; [Prasad, Durbaka Vijay Raghva] Yogi Vamana Univ, Dept Microbiol, Kadapa 516003, Andhra Pradesh, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Vanderbilt University; Indian Council of Medical Research (ICMR); ICMR - National Institute of Malaria Research (NIMR); Yogi Vemana University	Das, G (corresponding author), Int Ctr Genet Engn & Biotechnol, Immunol Grp, Aruna Asaf Ali Marg, New Delhi 110067, India.	dasgo@icgeb.res.in	Van Kaer, Luc/H-1033-2015	Van Kaer, Luc/0000-0001-5275-2309; Tousif, Sultan/0000-0001-6174-6541; Dwivedi, Ved Prakash/0000-0003-4321-2567	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Das J, 2009, J EXP MED, V206, P2407, DOI 10.1084/jem.20082286; Gorelik L, 2000, IMMUNITY, V12, P171, DOI 10.1016/S1074-7613(00)80170-3; Hatton RD, 2003, SCIENCE, V302, P993, DOI 10.1126/science.1092040; Hemdan NY, 2010, AUTOIMMUN REV, V9, P785, DOI 10.1016/j.autrev.2010.07.003; Horwitz DA, 2008, TRENDS IMMUNOL, V29, P429, DOI 10.1016/j.it.2008.06.005; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Kim IY, 2005, J BIOCHEM MOL BIOL, V38, P1; Kulkarni A, 1997, DIGEST DIS SCI, V42, P1142, DOI 10.1023/A:1018825301263; Kullberg MC, 2006, J EXP MED, V203, P2485, DOI 10.1084/jem.20061082; Liu SJ, 2007, J LEUKOCYTE BIOL, V82, P354, DOI 10.1189/jlb.0207111; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Mantel PY, 2011, METHODS MOL BIOL, V677, P303, DOI 10.1007/978-1-60761-869-0_21; Mi S, 2011, J IMMUNOL, V187, P3003, DOI 10.4049/jimmunol.1004081; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Veldhoen M, 2006, NAT IMMUNOL, V7, P1151, DOI 10.1038/ni1391; Wahl SM, 2007, CURR OPIN IMMUNOL, V19, P55, DOI 10.1016/j.coi.2006.11.008; Wilke CM, 2011, TRENDS IMMUNOL, V32, P603, DOI 10.1016/j.it.2011.08.003; Yoshimura A, 2011, CURR TOP MICROBIOL, V350, P127, DOI 10.1007/82_2010_87; Zamiri P, 2005, INVEST OPHTH VIS SCI, V46, P908, DOI 10.1167/iovs.04-0362	21	11	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					2943	2947		10.1074/jbc.C111.327627	http://dx.doi.org/10.1074/jbc.C111.327627			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22170065	Green Published, hybrid			2022-12-27	WOS:000300295100002
J	Jamison, DK; Driver, JW; Diehl, MR				Jamison, D. Kenneth; Driver, Jonathan W.; Diehl, Michael R.			Cooperative Responses of Multiple Kinesins to Variable and Constant Loads	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUG-OF-WAR; CARGO TRANSPORT; BIDIRECTIONAL TRANSPORT; MICROTUBULE MOTORS; PROCESSIVITY; MECHANISM; PROTEINS	Microtubule-dependent transport is most often driven by collections of kinesins and dyneins that function in either a concerted fashion or antagonistically. Several lines of evidence suggest that cargo transport may not be influenced appreciably by the combined action of multiple kinesins. Yet, as in previous optical trapping experiments, the forces imposed on cargos will vary spatially and temporally in cells depending on a number of local environmental factors, and the influence of these conditions has been largely overlooked. Here, we characterize the dynamics of structurally defined complexes containing multiple kinesins under the controlled loads of an optical force clamp. While demonstrating that there are generic kinetic barriers that restrict the ability of multiple kinesins to cooperate productively, the spatial and temporal properties of applied loads is found to play an important role in the collective dynamics of multiple motor systems. We propose this dependence has implications for intracellular transport processes, especially for bidirectional transport.	[Jamison, D. Kenneth; Driver, Jonathan W.; Diehl, Michael R.] Rice Univ, Dept Chem, Houston, TX 77005 USA; [Diehl, Michael R.] Rice Univ, Dept Bioengn, Houston, TX 77005 USA	Rice University; Rice University	Diehl, MR (corresponding author), Rice Univ, Dept Chem, 6100 Main St,MS 142, Houston, TX 77005 USA.	diehl@rice.edu			National Institutes of Health [1R01GM094489-01, F31GM089062]; National Science Foundation [MCB-0643832]; Welch Foundation [C-1559]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM089062, R01GM094489] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R01GM094489-01 and F31GM089062 and by the National Science Foundation (MCB-0643832) and the Welch Foundation (C-1559).	Ali MY, 2008, P NATL ACAD SCI USA, V105, P4691, DOI 10.1073/pnas.0711531105; Ally S, 2009, J CELL BIOL, V187, P1071, DOI 10.1083/jcb.200908075; Beeg J, 2008, BIOPHYS J, V94, P532, DOI 10.1529/biophysj.106.097881; Caviston JP, 2006, TRENDS CELL BIOL, V16, P530, DOI 10.1016/j.tcb.2006.08.002; Driver JW, 2011, BIOPHYS J, V101, P386, DOI 10.1016/j.bpj.2011.05.067; Driver JW, 2010, PHYS CHEM CHEM PHYS, V12, P10398, DOI 10.1039/c0cp00117a; Fisher ME, 2005, P NATL ACAD SCI USA, V102, P16209, DOI 10.1073/pnas.0507802102; Gennerich A, 2006, PHYS BIOL, V3, P45, DOI 10.1088/1478-3975/3/1/005; Gross SP, 2004, PHYS BIOL, V1, pR1, DOI 10.1088/1478-3967/1/2/R01; Hendricks AG, 2010, CURR BIOL, V20, P697, DOI 10.1016/j.cub.2010.02.058; Holzbaur ELF, 2010, CURR OPIN CELL BIOL, V22, P4, DOI 10.1016/j.ceb.2009.12.014; Jamison DK, 2010, BIOPHYS J, V99, P2967, DOI 10.1016/j.bpj.2010.08.025; Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928; Klumpp S, 2005, P NATL ACAD SCI USA, V102, P17284, DOI 10.1073/pnas.0507363102; Kural C, 2005, SCIENCE, V308, P1469, DOI 10.1126/science.1108408; Leduc C, 2007, P NATL ACAD SCI USA, V104, P10847, DOI 10.1073/pnas.0701B64104; Muller MJI, 2008, P NATL ACAD SCI USA, V105, P4609, DOI 10.1073/pnas.0706825105; Muller MJI, 2010, BIOPHYS J, V98, P2610, DOI 10.1016/j.bpj.2010.02.037; Rogers AR, 2009, PHYS CHEM CHEM PHYS, V11, P4882, DOI 10.1039/b900964g; Schweller RM, 2008, BIOCONJUGATE CHEM, V19, P2304, DOI 10.1021/bc8003606; Shtridelman Y, 2008, CELL BIOCHEM BIOPHYS, V52, P19, DOI 10.1007/s12013-008-9021-8; Soppina V, 2009, P NATL ACAD SCI USA, V106, P19381, DOI 10.1073/pnas.0906524106; Telley IA, 2009, BIOPHYS J, V96, P3341, DOI 10.1016/j.bpj.2009.01.015; Visscher K, 1999, NATURE, V400, P184, DOI 10.1038/22146; Welte MA, 2004, CURR BIOL, V14, pR525, DOI 10.1016/j.cub.2004.06.045	25	50	50	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3357	3365		10.1074/jbc.M111.296582	http://dx.doi.org/10.1074/jbc.M111.296582			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22158622	Green Published, hybrid			2022-12-27	WOS:000300295100041
J	Mburu, YK; Egloff, AM; Walker, WH; Wang, L; Seethala, RR; van Waes, C; Ferris, RL				Mburu, Yvonne K.; Egloff, Ann Marie; Walker, William H.; Wang, Lin; Seethala, Raja R.; van Waes, Carter; Ferris, Robert L.			Chemokine Receptor 7 (CCR7) Gene Expression Is Regulated by NF-kappa B and Activator Protein 1 (AP1) in Metastatic Squamous Cell Carcinoma of Head and Neck (SCCHN)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER; PROLIFERATION; TRANSCRIPTION; PATHWAYS; APOPTOSIS; CYTOKINES; BIOLOGY; LINES; IL-8; AP-1	The chemokine receptor CCR7 is a seven-transmembrane domain G-protein-coupled receptor that facilitates leukocyte migration to regional lymph nodes. Aberrant CCR7 expression in a number of human malignancies has been linked to prosurvival, -invasive, and -metastatic pathways. We demonstrate here that up-regulation of CCR7 in squamous cell carcinoma of the head and neck (SCCHN) patient tumors correlates with lower survival because of metastatic disease. Because of this important oncogenic phenotype, we investigated the mechanisms that regulate CCR7 expression in these tumors. Interestingly, the inflammatory transcription factor NF-kappa B has been associated with a more aggressive SCCHN phenotype. Immunohistochemical staining of a SCCHN tumor cohort (n = 47) strongly linked NF-kappa B staining and CCR7 expression in SCCHN. Thus, we investigated whether NF-kappa B contributes to metastatic disease by promoting CCR7 expression in SCCHN tumor cells. Wecharacterized four novel, potential NF-kappa B binding sites in the 1000-bp promoter region upstream of the CCR7 gene, using luciferase, ChIP, and EMSA. However, NF-kappa B inhibition only resulted in partial reduction in CCR7 expression, prompting consideration of other co-regulators of CCR7. Indeed, cooperation between NF-kappa B and AP1 transcription factors, which are often co-activated, is crucial to the regulation of CCR7 mRNA expression in metastatic SCCHN cells. Thus, our findings support an important biological role for inflammatory NF-kappa B and AP1 in the regulation of CCR7 expression in metastatic SCCHN. As such, CCR7, NF-kappa B, and AP1 could be potentially useful therapeutic targets in controlling the progression and metastasis of SCCHN tumors.	[Ferris, Robert L.] Univ Pittsburgh, Inst Canc, Hillman Canc Ctr, Pittsburgh, PA 15213 USA; [Mburu, Yvonne K.; Ferris, Robert L.] Univ Pittsburgh, Dept Immunol, Pittsburgh, PA 15261 USA; [Egloff, Ann Marie; Ferris, Robert L.] Univ Pittsburgh, Med Ctr, Dept Otolaryngol, Pittsburgh, PA 15213 USA; [Walker, William H.] Univ Pittsburgh, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA 15213 USA; [Wang, Lin; Seethala, Raja R.] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15261 USA; [van Waes, Carter] Natl Inst Deafness & Other Commun Disorders, Head & Neck Surg Branch, Bethesda, MD 20892 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Ferris, RL (corresponding author), Univ Pittsburgh, Inst Canc, Hillman Canc Ctr, Res Wing,Rm 2-26B,5117 Ctr Ave, Pittsburgh, PA 15213 USA.	ferrisrl@upmc.edu		Ferris, Robert/0000-0001-6605-2071	National Institutes of Health [1R01 CA115902]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIADC000016] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01 CA115902 (to R. L. F.).	Bancroft CC, 2001, CLIN CANCER RES, V7, P435; Bonizzi G, 2004, EMBO J, V23, P4202, DOI 10.1038/sj.emboj.7600391; Chen Z, 1999, CLIN CANCER RES, V5, P1369; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Egloff AM, 2009, CLIN CANCER RES, V15, P6529, DOI 10.1158/1078-0432.CCR-09-0862; Godfrey TE, 2000, J MOL DIAGN, V2, P84, DOI 10.1016/S1525-1578(10)60621-6; Helbig G, 2003, J BIOL CHEM, V278, P21631, DOI 10.1074/jbc.M300609200; HEO DS, 1989, CANCER RES, V49, P5167; Hinz M, 2002, J EXP MED, V196, P605, DOI 10.1084/jem.20020062; Hopken UE, 2002, BLOOD, V99, P1109, DOI 10.1182/blood.V99.4.1109; Jackson-Bernitsas DG, 2007, ONCOGENE, V26, P1385, DOI 10.1038/sj.onc.1209945; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kim JW, 2005, CLIN CANCER RES, V11, P7901, DOI 10.1158/1078-0432.CCR-05-1346; Knowles LM, 2009, CLIN CANCER RES, V15, P3740, DOI 10.1158/1078-0432.CCR-08-3252; Mathas S, 2002, EMBO J, V21, P4104, DOI 10.1093/emboj/cdf389; Mburu YK, 2011, CARCINOGENESIS, V32, P168, DOI 10.1093/carcin/bgq236; Mishra A, 2010, INT J CANCER, V126, P819, DOI 10.1002/ijc.24807; Nakayama T, 2008, ONCOGENE, V27, P3221, DOI 10.1038/sj.onc.1210984; Ondrey FG, 1999, MOL CARCINOGEN, V26, P119, DOI 10.1002/(SICI)1098-2744(199910)26:2<119::AID-MC6>3.0.CO;2-N; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; Richmond A, 2002, NAT REV IMMUNOL, V2, P664, DOI 10.1038/nri887; Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217; Sanchez-Sanchez N, 2004, BLOOD, V104, P619, DOI 10.1182/blood-2003-11-3943; Wang J, 2005, ONCOGENE, V24, P5897, DOI 10.1038/sj.onc.1208740; Wang J, 2004, CANCER RES, V64, P1861, DOI 10.1158/0008-5472.CAN-03-2968; Wang J, 2008, JNCI-J NATL CANCER I, V100, P502, DOI 10.1093/jnci/djn059; Wiley HE, 2001, J NATL CANCER I, V93, P1638, DOI 10.1093/jnci/93.21.1638; Wolf JS, 2001, CLIN CANCER RES, V7, P1812	28	44	46	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3581	3590		10.1074/jbc.M111.294876	http://dx.doi.org/10.1074/jbc.M111.294876			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22158872	hybrid, Green Published			2022-12-27	WOS:000300295100062
J	Materia, S; Cater, MA; Klomp, LWJ; Mercer, JFB; La Fontaine, S				Materia, Stephanie; Cater, Michael A.; Klomp, Leo W. J.; Mercer, Julian F. B.; La Fontaine, Sharon			Clusterin and COMMD1 Independently Regulate Degradation of the Mammalian Copper ATPases ATP7A and ATP7B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOXIC MILK MOUSE; P-TYPE ATPASE; WILSON-DISEASE; MENKES DISEASE; TRANSPORTING ATPASE; IN-VIVO; PROTEIN; TRAFFICKING; BINDING; EXPRESSION	ATP7A and ATP7B are copper-transporting P-1B-type ATPases (Cu-ATPases) that are critical for regulating intracellular copper homeostasis. Mutations in the genes encoding ATP7A and ATP7B lead to copper deficiency and copper toxicity disorders, Menkes and Wilson diseases, respectively. Clusterin and COMMD1 were previously identified as interacting partners of these Cu-ATPases. In this study, we confirmed that clusterin and COMMD1 interact to down-regulate both ATP7A and ATP7B. Overexpression and knockdown of clusterin/COMMD1 decreased and increased, respectively, endogenous levels of ATP7A and ATP7B, consistent with a role in facilitating Cu-ATPase degradation. We demonstrate that whereas the clusterin/ATP7B interaction was enhanced by oxidative stress or mutation of ATP7B, the COMMD1/ATP7B interaction did not change under oxidative stress conditions, and only increased with ATP7B mutations that led to its misfolding. Clusterin and COMMD1 facilitated the degradation of ATP7B containing the same Wilson disease-causing C-terminal mutations via different degradation pathways, clusterin via the lysosomal pathway and COMMD1 via the proteasomal pathway. Furthermore, endogenous ATP7B existed in a complex with clusterin and COMMD1, but these interactions were neither competitive nor cooperative and occurred independently of each other. Together these data indicate that clusterin and COMMD1 represent alternative and independent systems regulating Cu-ATPase quality control, and consequently contributing to the maintenance of copper homeostasis.	[Materia, Stephanie; Mercer, Julian F. B.; La Fontaine, Sharon] Deakin Univ, Strateg Res Ctr Mol & Med Res, Burwood, Vic 3125, Australia; [Materia, Stephanie; Mercer, Julian F. B.; La Fontaine, Sharon] Deakin Univ, Sch Life & Environm Sci, Ctr Cellular & Mol Biol, Burwood, Vic 3125, Australia; [Cater, Michael A.] Peter MacCallum Canc Ctr, Div Res, Melbourne, Vic 3002, Australia; [Klomp, Leo W. J.] Univ Med Ctr, Lab Metab & Endocrine Dis, NL-3584 EA Utrecht, Netherlands	Deakin University; Deakin University; Peter Maccallum Cancer Center; Utrecht University; Utrecht University Medical Center	La Fontaine, S (corresponding author), 221 Burwood Hwy, Burwood, Vic 3125, Australia.	sharon.lafontaine@deakin.edu.au	La Fontaine, Sharon/G-7113-2018; Mercer, Julian/R-8583-2019	La Fontaine, Sharon/0000-0002-9948-074X; 	National Health and Medical Research Council of Australia (NHMRC); NHMRC [520345]; Dutch Digestive Disease Foundation [WS02-34]; NOW Program [912.04.106]; Netherlands Organisation for Scientific Research-Earth and Life Sciences [817.02.022]	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Dutch Digestive Disease Foundation; NOW Program; Netherlands Organisation for Scientific Research-Earth and Life Sciences(Netherlands Organization for Scientific Research (NWO))	This work was supported by grants from the National Health and Medical Research Council of Australia (NHMRC) (to S. L. and J. F. B. M.), NHMRC Biomedical Research Fellowship 520345 (to M. A. C.), Dutch Digestive Disease Foundation Grant WS02-34, NOW Program Grant 912.04.106, and The Netherlands Organisation for Scientific Research-Earth and Life Sciences Grant 817.02.022 (to L. W. J. K.).	[Anonymous], 1995, METABOLIC BASIS INHE; ARONOW BJ, 1993, P NATL ACAD SCI USA, V90, P725, DOI 10.1073/pnas.90.2.725; Bailey RW, 2001, BIOCHEMISTRY-US, V40, P11828, DOI 10.1021/bi010135x; Balantinou E, 2009, FREE RADICAL BIO MED, V46, P1267, DOI 10.1016/j.freeradbiomed.2009.01.025; Barnes N, 2009, TRAFFIC, V10, P767, DOI 10.1111/j.1600-0854.2009.00901.x; Biasio W, 2004, J BIOL CHEM, V279, P5429, DOI 10.1074/jbc.M311155200; Borm B, 2004, J PEDIATR-US, V145, P119, DOI 10.1016/j.jpeds.2004.04.033; Burkhead JL, 2009, J BIOL CHEM, V284, P696, DOI 10.1074/jbc.M804766200; Burstein E, 2004, EMBO J, V23, P244, DOI 10.1038/sj.emboj.7600031; Cater MA, 2006, GASTROENTEROLOGY, V130, P493, DOI 10.1053/j.gastro.2005.10.054; Cater MA, 2004, BIOCHEM J, V380, P805, DOI 10.1042/BJ20031804; Das SK, 2006, NAT CLIN PRACT NEURO, V2, P482, DOI 10.1038/ncpneuro0291; de Bie P, 2007, J MED GENET, V44, P673, DOI 10.1136/jmg.2007.052746; De Bie P, 2005, J HERED, V96, P803, DOI 10.1093/jhered/esi110; de Bie P, 2007, GASTROENTEROLOGY, V133, P1316, DOI 10.1053/j.gastro.2007.07.020; Drevillon L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018334; Gouider-Khouja N, 2009, PARKINSONISM RELAT D, V15, pS126, DOI 10.1016/S1353-8020(09)70798-9; Guo Y, 2005, AM J PHYSIOL-GASTR L, V289, pG904, DOI 10.1152/ajpgi.00262.2005; Gupta A, 2011, P NATL ACAD SCI USA, V108, P5390, DOI 10.1073/pnas.1014959108; Horslen S, 2010, J CLIN GASTROENTEROL, V44, P387, DOI 10.1097/MCG.0b013e3181d96ac4; Huang Y, 2008, J BIOL CHEM, V283, P11453, DOI 10.1074/jbc.M708544200; Humphreys DT, 1999, J BIOL CHEM, V274, P6875, DOI 10.1074/jbc.274.11.6875; Kaler SG, 2011, NAT REV NEUROL, V7, P15, DOI 10.1038/nrneurol.2010.180; Ke BX, 2006, AM J PHYSIOL-REG I, V290, pR1460, DOI 10.1152/ajpregu.00806.2005; Ke Y, 2010, AM J PHYSIOL-RENAL, V298, pF1445, DOI 10.1152/ajprenal.00257.2009; Kim BE, 2007, J MED GENET, V44, P641, DOI 10.1136/jmg.2007.049627; Klomp AEM, 2003, J HEPATOL, V39, P703, DOI 10.1016/S0168-8278(03)00380-5; La Fontaine S, 2001, HUM MOL GENET, V10, P361, DOI 10.1093/hmg/10.4.361; La Fontaine S, 2007, ARCH BIOCHEM BIOPHYS, V463, P149, DOI 10.1016/j.abb.2007.04.021; Leskov KS, 2003, J BIOL CHEM, V278, P11590, DOI 10.1074/jbc.M209233200; Lutsenko S, 1997, J BIOL CHEM, V272, P18939, DOI 10.1074/jbc.272.30.18939; Lutsenko S, 2007, PHYSIOL REV, V87, P1011, DOI 10.1152/physrev.00004.2006; Maine GN, 2007, CELL MOL LIFE SCI, V64, P1997, DOI 10.1007/s00018-007-7078-y; Maine GN, 2007, EMBO J, V26, P436, DOI 10.1038/sj.emboj.7601489; Majumdar R, 2000, J NEUROL SCI, V179, P140, DOI 10.1016/S0022-510X(00)00399-3; Materia S, 2011, J BIOL CHEM, V286, P10073, DOI 10.1074/jbc.M110.190546; Miyayama T, 2010, BIOCHEM J, V429, P53, DOI 10.1042/BJ20100223; Moller LB, 2009, BIOCHIMIE, V91, P1273, DOI 10.1016/j.biochi.2009.05.011; Monty JF, 2005, J NUTR, V135, P2762, DOI 10.1093/jn/135.12.2762; Nuutinen T, 2009, BRAIN RES REV, V61, P89, DOI 10.1016/j.brainresrev.2009.05.007; Nyasae L, 2007, AM J PHYSIOL-GASTR L, V292, pG1181, DOI 10.1152/ajpgi.00472.2006; Payne AS, 1998, P NATL ACAD SCI USA, V95, P10854, DOI 10.1073/pnas.95.18.10854; Pucci S, 2009, ADV CANCER RES, V105, P93, DOI 10.1016/S0065-230X(09)05006-4; Rizzi F, 2009, J CELL PHYSIOL, V219, P314, DOI 10.1002/jcp.21671; Roelofsen H, 2000, GASTROENTEROLOGY, V119, P782, DOI 10.1053/gast.2000.17834; Sarkar B, 2011, METALLOMICS, V3, P20, DOI 10.1039/c0mt00031k; Senzolo M, 2007, CLIN NEUROL NEUROSUR, V109, P71, DOI 10.1016/j.clineuro.2006.01.008; Sommerhalter M, 2007, J MOL BIOL, V365, P715, DOI 10.1016/j.jmb.2006.10.030; Spee B, 2007, ANIM GENET, V38, P168, DOI 10.1111/j.1365-2052.2007.01580.x; Strausak D, 1999, J BIOL CHEM, V274, P11170, DOI 10.1074/jbc.274.16.11170; Takeshita Y, 2002, J HUM GENET, V47, P543, DOI 10.1007/s100380200082; Tao TY, 2003, J BIOL CHEM, V278, P41593, DOI 10.1074/jbc.C300391200; Terada K, 1999, FEBS LETT, V448, P53, DOI 10.1016/S0014-5793(99)00319-1; Theophilos MB, 1996, HUM MOL GENET, V5, P1619, DOI 10.1093/hmg/5.10.1619; Thoms HC, 2010, CANCER RES, V70, P139, DOI 10.1158/0008-5472.CAN-09-1397; Trougakos IP, 2006, FREE RADICAL RES, V40, P1324, DOI 10.1080/10715760600902310; van de Sluis B, 2002, HUM MOL GENET, V11, P165, DOI 10.1093/hmg/11.2.165; van de Sluis B, 2007, CELL CYCLE, V6, P2091, DOI 10.4161/cc.6.17.4646; van de Sluis B, 2007, MOL CELL BIOL, V27, P4142, DOI 10.1128/MCB.01932-06; van de Sluis B, 2010, J CLIN INVEST, V120, P2119, DOI 10.1172/JCI40583; van de Sluis B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007332; Van den Berghe PVE, 2007, BIOCHEM J, V407, P49, DOI 10.1042/BJ20070705; van den Berghe PVE, 2009, HEPATOLOGY, V50, P1783, DOI 10.1002/hep.23209; Vonk WIM, 2012, CELL MOL LIFE SCI, V69, P149, DOI 10.1007/s00018-011-0743-1; Vonk WIM, 2010, J BIOL CHEM, V285, P28991, DOI 10.1074/jbc.M110.101477; Voskoboinik I, 2001, BIOCHEM BIOPH RES CO, V281, P966, DOI 10.1006/bbrc.2001.4445; Wilson MR, 2008, MOL BIOSYST, V4, P42, DOI 10.1039/b712728f; Wyatt AR, 2011, CELL MOL LIFE SCI, V68, P3919, DOI [10.1007/s00018-011-0684-8, 10.1007/s00018-011-0684-8)]; Zoubeidi A, 2010, MOL CANCER RES, V8, P119, DOI 10.1158/1541-7786.MCR-09-0277	69	57	59	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2485	2499		10.1074/jbc.M111.302216	http://dx.doi.org/10.1074/jbc.M111.302216			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22130675	hybrid, Green Published			2022-12-27	WOS:000300292300023
J	Matthews, LA; Jones, DR; Prasad, AA; Duncker, BP; Guarne, A				Matthews, Lindsay A.; Jones, Darryl R.; Prasad, Ajai A.; Duncker, Bernard P.; Guarne, Alba			Saccharomyces cerevisiae Dbf4 Has Unique Fold Necessary for Interaction with Rad53 Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE PROGRESSION; DNA-REPLICATION; S-PHASE; FHA DOMAIN; CHECKPOINT RESPONSE; PROTEIN-KINASE; BRCT DOMAINS; CDC7 KINASE; COMPLEX; BINDING	Dbf4 is a conserved eukaryotic protein that functions as the regulatory subunit of the Dbf4-dependent kinase (DDK) complex. DDK plays essential roles in DNA replication initiation and checkpoint activation. During the replication checkpoint, Saccharomyces cerevisiae Dbf4 is phosphorylated in a Rad53-dependent manner, and this, in turn, inhibits initiation of replication at late origins. We have determined the minimal region of Dbf4 required for the interaction with the checkpoint kinase Rad53 and solved its crystal structure. The core of this fragment of Dbf4 folds as a BRCT domain, but it includes an additional N-terminal helix unique to Dbf4. Mutation of the residues that anchor this helix to the domain core abolish the interaction between Dbf4 and Rad53, indicating that this helix is an integral element of the domain. The structure also reveals that previously characterized Dbf4 mutants with checkpoint phenotypes destabilize the domain, indicating that its structural integrity is essential for the interaction with Rad53. Collectively, these results allow us to propose a model for the association between Dbf4 and Rad53.	[Guarne, Alba] McMaster Univ, Hlth Sci Ctr 4N57A, Dept Biochem & Biomed Sci, Hamilton, ON L8S 4K1, Canada; [Jones, Darryl R.; Prasad, Ajai A.; Duncker, Bernard P.] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada	McMaster University; University of Waterloo	Guarne, A (corresponding author), McMaster Univ, Hlth Sci Ctr 4N57A, Dept Biochem & Biomed Sci, 1280 Main St W, Hamilton, ON L8S 4K1, Canada.	guarnea@mcmaster.ca		Duncker, Bernard/0000-0002-6055-9522	Canadian Institutes of Health Research [MOP 67189]; Natural Sciences and Engineering Research Council [RGPIN 238392]; Canadian Institutes of Health Research; Ontario Graduate Scholarship; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Graduate Scholarship(Ontario Graduate Scholarship); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by Canadian Institutes of Health Research Grant MOP 67189 (to A. G.) and Natural Sciences and Engineering Research Council Grant RGPIN 238392 (to B. P. D.).; Supported by a doctoral scholarship from the Canadian Institutes of Health Research.; Recipient of an Ontario Graduate Scholarship doctoral award.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Ausubel FM, 1995, SHORT PROTOCOLS MOL, V3rd; Bruck I, 2009, J BIOL CHEM, V284, P28823, DOI 10.1074/jbc.M109.039123; Campbell SJ, 2010, STRUCTURE, V18, P167, DOI 10.1016/j.str.2009.12.008; Chen YC, 2010, J BIOL CHEM, V285, P41244, DOI 10.1074/jbc.M110.155242; Cheng LA, 1999, MOL CELL BIOL, V19, P4270; Cormack B, 2002, METHOD ENZYMOL, V350, P199, DOI 10.1016/S0076-6879(02)50964-2; DeLano W.L, PYMOL MOL GRAPHICS S; Dohrmann PR, 1999, GENETICS, V151, P965; Duch A, 2011, J BIOL CHEM, V286, P2486, DOI 10.1074/jbc.M110.190843; Duncker BP, 2002, P NATL ACAD SCI USA, V99, P16087, DOI 10.1073/pnas.252093999; Durocher D, 1999, MOL CELL, V4, P387, DOI 10.1016/S1097-2765(00)80340-8; Durocher D, 2000, MOL CELL, V6, P1169, DOI 10.1016/S1097-2765(00)00114-3; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferreira MG, 2000, MOL CELL BIOL, V20, P242; Gabrielse C, 2006, GENETICS, V173, P541, DOI 10.1534/genetics.106.057521; Glover JNM, 2004, TRENDS BIOCHEM SCI, V29, P579, DOI 10.1016/j.tibs.2004.09.010; Harkins V, 2009, GENETICS, V183, P1269, DOI 10.1534/genetics.109.110155; Heffernan TP, 2007, J BIOL CHEM, V282, P9458, DOI 10.1074/jbc.M611292200; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; JACKSON AL, 1993, MOL CELL BIOL, V13, P2899, DOI 10.1128/MCB.13.5.2899; Jones DR, 2010, CELL CYCLE, V9, P2018, DOI 10.4161/cc.9.10.11752; Kihara M, 2000, J BIOL CHEM, V275, P35051, DOI 10.1074/jbc.M003491200; Kim JM, 2003, MUTAT RES-FUND MOL M, V532, P29, DOI 10.1016/j.mrfmmm.2003.08.008; Kobayashi M, 2010, J BIOL CHEM, V285, P10087, DOI 10.1074/jbc.M109.054106; Leung CCY, 2011, CELL CYCLE, V10, P2461, DOI 10.4161/cc.10.15.16312; Lloyd J, 2009, CELL, V139, P100, DOI 10.1016/j.cell.2009.07.043; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; Lopez-Mosqueda J, 2010, NATURE, V467, P479, DOI 10.1038/nature09377; Lucca C, 2004, ONCOGENE, V23, P1206, DOI 10.1038/sj.onc.1207199; Marston AL, 2009, CURR BIOL, V19, pR74, DOI 10.1016/j.cub.2008.12.003; Martin-Garcia R, 2011, CELL MOL LIFE SCI, V68, P2907, DOI 10.1007/s00018-010-0596-z; Masai H, 2000, BIOCHEM BIOPH RES CO, V275, P228, DOI 10.1006/bbrc.2000.3281; Matos J, 2008, CELL, V135, P662, DOI 10.1016/j.cell.2008.10.026; Matthews LA, 2009, ACTA CRYSTALLOGR F, V65, P890, DOI 10.1107/S1744309109029376; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miller CT, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000498; Mohammad DH, 2009, DNA REPAIR, V8, P1009, DOI 10.1016/j.dnarep.2009.04.004; Nott TJ, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000212; Ogino K, 2001, J BIOL CHEM, V276, P31376, DOI 10.1074/jbc.M102197200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PATTERSON M, 1986, MOL CELL BIOL, V6, P1590, DOI 10.1128/MCB.6.5.1590; Pellicioli A, 1999, EMBO J, V18, P6561, DOI 10.1093/emboj/18.22.6561; Pellicioli A, 2005, CURR BIOL, V15, pR769, DOI 10.1016/j.cub.2005.08.057; Pessoa-Brandao L, 2004, GENETICS, V167, P1597, DOI 10.1534/genetics.103.021675; Pike BL, 2004, MOL CELL BIOL, V24, P2779, DOI 10.1128/MCB.24.7.2779-2788.2004; Santocanale C, 1998, NATURE, V395, P615, DOI 10.1038/27001; Shirahige K, 1998, NATURE, V395, P618, DOI 10.1038/27007; Varrin AE, 2005, MOL CELL BIOL, V25, P7494, DOI 10.1128/MCB.25.17.7494-7504.2005; Weinreich M, 1999, EMBO J, V18, P5334, DOI 10.1093/emboj/18.19.5334; Williams RS, 2009, CELL, V139, P87, DOI 10.1016/j.cell.2009.07.033; Williams RS, 2001, NAT STRUCT BIOL, V8, P838, DOI 10.1038/nsb1001-838; Zegerman P, 2010, NATURE, V467, P474, DOI 10.1038/nature09373	53	17	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2378	2387		10.1074/jbc.M111.233973	http://dx.doi.org/10.1074/jbc.M111.233973			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22130670	hybrid, Green Published			2022-12-27	WOS:000300292300013
J	Demont, Y; Corbet, C; Page, A; Ataman-Onal, Y; Choquet-Kastylevsky, G; Fliniaux, I; Le Bourhis, X; Toillon, RA; Bradshaw, RA; Hondermarck, H				Demont, Yohann; Corbet, Cyril; Page, Adeline; Ataman-Oenal, Yasemin; Choquet-Kastylevsky, Genevieve; Fliniaux, Ingrid; Le Bourhis, Xuefen; Toillon, Robert-Alain; Bradshaw, Ralph A.; Hondermarck, Hubert			Pro-nerve Growth Factor Induces Autocrine Stimulation of Breast Cancer Cell Invasion through Tropomyosin-related Kinase A (TrkA) and Sortilin Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR RECEPTORS; FACTOR PRECURSOR; PROLIFERATION; EXPRESSION; OVEREXPRESSION; DEGRADATION; METASTASIS; APOPTOSIS; SURVIVAL	The precursor of nerve growth factor (proNGF) has been described as a biologically active polypeptide able to induce apoptosis in neuronal cells, via the neurotrophin receptor p75(NTR) and the sortilin receptor. Herein, it is shown that proNGF is produced and secreted by breast cancer cells, stimulating their invasion. Using Western blotting and mass spectrometry, proNGF was detected in a panel of breast cancer cells as well as in their conditioned media. Immunohistochemical analysis indicated an overproduction of proNGF in breast tumors, when compared with benign and normal breast biopsies, and a relationship to lymph node invasion in ductal carcinomas. Interestingly, siRNA against proNGF induced a decrease of breast cancer cell invasion that was restored by the addition of non-cleavable proNGF. The activation of TrkA, Akt, and Src, but not the MAP kinases, was observed. In addition, the proNGF invasive effect was inhibited by the Trk pharmacological inhibitor K252a, a kinase-dead TrkA, and siRNA against TrkA sortilin, neurotensin, whereas siRNA against p75(NTR) and the MAP kinase inhibitor PD98059 had no impact. These data reveal the existence of an autocrine loop stimulated by proNGF and mediated by TrkA and sortilin, with the activation of Akt and Src, for the stimulation of breast cancer cell invasion.	[Demont, Yohann; Corbet, Cyril; Fliniaux, Ingrid; Le Bourhis, Xuefen; Toillon, Robert-Alain; Hondermarck, Hubert] Univ Lille, INSERM Growth Factor Signaling Breast Canc U908, F-59655 Villeneuve Dascq, France; [Page, Adeline] Univ Lille, Mass Spectrometry Facil, IFR 147, F-59655 Villeneuve Dascq, France; [Ataman-Oenal, Yasemin; Choquet-Kastylevsky, Genevieve] BioMerieux, Dept Biomarker Res & Validat, F-69280 Marcy Letoile, France; [Bradshaw, Ralph A.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; bioMerieux; University of California System; University of California San Francisco	Hondermarck, H (corresponding author), Univ Newcastle, Sch Biomed Sci & Pharm, Callaghan, NSW 2308, Australia.	hubert.hondermarck@newcastle.edu.au	Toillon, Robert-Alain/Q-2286-2018; Bradshaw, Ralph A/K-1515-2013; Fliniaux, Ingrid/D-9129-2015; Le+Bourhis, Xuefen/AAL-5141-2021	Toillon, Robert-Alain/0000-0001-5483-2118; Fliniaux, Ingrid/0000-0001-6377-5098	Ligue Nationale Contre le Cancer; INSERM; French Ministry for Research and Education; Groupement des Entreprises Francaises pour la Lutte Contre le Cancer (GEFLUC); Region Nord-Pas-de-Calais; Association pour la Recherche sur le Cancer	Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); French Ministry for Research and Education; Groupement des Entreprises Francaises pour la Lutte Contre le Cancer (GEFLUC); Region Nord-Pas-de-Calais(Region Hauts-de-FranceEuropean Commission); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council)	This work was supported by grants from the "Ligue Nationale Contre le Cancer" (Equipe labellisee 2009 and the Comite du Nord), the INSERM, the French Ministry for Research and Education, the Groupement des Entreprises Francaises pour la Lutte Contre le Cancer (GEFLUC), and the "Region Nord-Pas-de-Calais."; Recipient of a fellowship from the "Association pour la Recherche sur le Cancer."	Adriaenssens E, 2008, CANCER RES, V68, P346, DOI 10.1158/0008-5472.CAN-07-1183; Aragona M, 2001, CANCER INVEST, V19, P692, DOI 10.1081/CNV-100106144; Bloom AP, 2011, J PAIN, V12, P698, DOI 10.1016/j.jpain.2010.12.016; Boutilier J, 2008, J BIOL CHEM, V283, P12709, DOI 10.1074/jbc.M710018200; BRESNAHAN PA, 1990, J CELL BIOL, V111, P2851, DOI 10.1083/jcb.111.6.2851; Bruno MA, 2006, P NATL ACAD SCI USA, V103, P6735, DOI 10.1073/pnas.0510645103; Chiarenza A, 2001, CANCER RES, V61, P3002; Clewes O, 2008, J NEUROCHEM, V107, P1124, DOI 10.1111/j.1471-4159.2008.05698.x; Davidson B, 2004, BREAST CANCER RES TR, V83, P119, DOI 10.1023/B:BREA.0000010704.17479.8a; Descamps S, 2001, CANCER RES, V61, P4337; Descamps S, 2001, J BIOL CHEM, V276, P17864, DOI 10.1074/jbc.M010499200; Dillon RL, 2010, CANCER RES, V70, P4260, DOI 10.1158/0008-5472.CAN-10-0266; Dolle L, 2003, ONCOGENE, V22, P5592, DOI 10.1038/sj.onc.1206805; El Yazidi-Belkoura I, 2003, J BIOL CHEM, V278, P16952, DOI 10.1074/jbc.M300631200; Feng D, 2010, J MOL BIOL, V396, P967, DOI 10.1016/j.jmb.2009.12.030; Harrington AW, 2004, P NATL ACAD SCI USA, V101, P6226, DOI 10.1073/pnas.0305755101; Hempstead Barbara L., 2006, Current Alzheimer Research, V3, P19, DOI 10.2174/156720506775697061; Kim LC, 2009, NAT REV CLIN ONCOL, V6, P587, DOI 10.1038/nrclinonc.2009.129; Lagadec C, 2009, ONCOGENE, V28, P1960, DOI 10.1038/onc.2009.61; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Masoudi R, 2009, J BIOL CHEM, V284, P18424, DOI 10.1074/jbc.M109.007104; Matrone C, 2009, P NATL ACAD SCI USA, V106, P11358, DOI 10.1073/pnas.0904998106; Montano X, 2009, ONCOGENE, V28, P3787, DOI 10.1038/onc.2009.143; Naderi A, 2007, CANCER RES, V67, P6725, DOI 10.1158/0008-5472.CAN-06-4394; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; Pagadala PC, 2006, P NATL ACAD SCI USA, V103, P17939, DOI 10.1073/pnas.0604139103; Pedraza CE, 2005, AM J PATHOL, V166, P533, DOI 10.1016/S0002-9440(10)62275-4; Quistgaard EM, 2009, NAT STRUCT MOL BIOL, V16, P96, DOI 10.1038/nsmb.1543; Romon R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-157; Seidah NG, 1996, BIOCHEM J, V314, P951, DOI 10.1042/bj3140951; Shooter EM, 2001, ANNU REV NEUROSCI, V24, P601, DOI 10.1146/annurev.neuro.24.1.601; Tagliabue E, 2000, J BIOL CHEM, V275, P5388, DOI 10.1074/jbc.275.8.5388; Truzzi F, 2008, J INVEST DERMATOL, V128, P2031, DOI 10.1038/jid.2008.21; Vaegter CB, 2011, NAT NEUROSCI, V14, P54, DOI 10.1038/nn.2689; Vanhecke E, 2011, CLIN CANCER RES, V17, P1741, DOI 10.1158/1078-0432.CCR-10-1890; Verbeke S, 2010, CELL SIGNAL, V22, P1864, DOI 10.1016/j.cellsig.2010.07.014; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670	37	56	62	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					1923	1931		10.1074/jbc.M110.211714	http://dx.doi.org/10.1074/jbc.M110.211714			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22128158	Green Published, hybrid			2022-12-27	WOS:000299321000033
J	Mankad, P; James, A; Siriwardena, AK; Elliott, AC; Bruce, JIE				Mankad, Parini; James, Andrew; Siriwardena, Ajith K.; Elliott, Austin C.; Bruce, Jason I. E.			Insulin Protects Pancreatic Acinar Cells from Cytosolic Calcium Overload and Inhibition of Plasma Membrane Calcium Pump	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REDUCED ANESTHETIC REQUIREMENTS; CERULEIN-INDUCED PANCREATITIS; HORMONE-SPECIFIC DEFECT; DIABETIC-RATS; CANCER-CELLS; GLUCOSE-TRANSPORT; EXOCRINE PANCREAS; OXIDATIVE STRESS; HEXOKINASE-II; CA2+ UPTAKE	Acute pancreatitis is a serious and sometimes fatal inflammatory disease of the pancreas without any reliable treatment or imminent cure. In recent years, impaired metabolism and cytosolic Ca2+ ([Ca2+](i)) overload in pancreatic acinar cells have been implicated as the cardinal pathological events common to most forms of pancreatitis, regardless of the precise causative factor. Therefore, restoration of metabolism and protection against cytosolic Ca2+ overload likely represent key therapeutic untapped strategies for the treatment of this disease. The plasma membrane Ca2+-ATPase (PMCA) provides a final common path for cells to "defend" [Ca2+](i) during cellular injury. In this paper, we use fluorescence imaging to show for the first time that insulin treatment, which is protective in animal models and clinical studies of human pancreatitis, directly protects pancreatic acinar cells from oxidant-induced cytosolic Ca2+ overload and inhibition of the PMCA. This protection was independent of oxidative stress or mitochondrial membrane potential but appeared to involve the activation of Akt and an acute metabolic switch from mitochondrial to predominantly glycolytic metabolism. This switch to glycolysis appeared to be sufficient to maintain cellular ATP and thus PMCA activity, thereby preventing Ca2+ overload, even in the face of impaired mitochondrial function.	[Mankad, Parini; James, Andrew; Elliott, Austin C.; Bruce, Jason I. E.] Univ Manchester, Fac Life Sci, Manchester M13 9NT, Lancs, England; [Siriwardena, Ajith K.] Manchester Royal Infirm, Hepatobiliary Surg Unit, Manchester M13 9NT, Lancs, England	University of Manchester; University of Manchester	Bruce, JIE (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9NT, Lancs, England.	jason.bruce@manchester.ac.uk		James, Andrew/0000-0002-2432-5948; Elliott, Austin/0000-0003-3569-9002	Biotechnology and Biological Sciences Research Council New Investigator; Central Manchester Foundation Trust/National Institutes of Health Research Manchester Biological Research Centre; Biotechnology and Biological Sciences Research Council; Biotechnology and Biological Sciences Research Council [BB/C514607/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council New Investigator(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Central Manchester Foundation Trust/National Institutes of Health Research Manchester Biological Research Centre; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Biotechnology and Biological Sciences Research Council New Investigator Grant (to J. I. E. B.) and a Central Manchester Foundation Trust/National Institutes of Health Research Manchester Biological Research Centre pump priming fund (to A. K. S. and J. I. E. B.). Preliminary accounts of these data have been presented at meetings of the Physiological Society and American Pancreatic Association.; Supported by a Biotechnology and Biological Sciences Research Council Ph.D. studentship.	Baggaley EM, 2008, AM J PHYSIOL-CELL PH, V295, pC1247, DOI 10.1152/ajpcell.00083.2008; Berna MJ, 2009, CELL SIGNAL, V21, P622, DOI 10.1016/j.cellsig.2009.01.003; Berwick DC, 2002, J BIOL CHEM, V277, P33895, DOI 10.1074/jbc.M204681200; BORTHWICK AC, 1990, BIOCHEM J, V270, P795, DOI 10.1042/bj2700795; Bruce JIE, 2007, AM J PHYSIOL-CELL PH, V293, pC938, DOI 10.1152/ajpcell.00582.2006; Bruce Jason Ie, 2010, World J Biol Chem, V1, P221, DOI 10.4331/wjbc.v1.i7.221; CORVERA S, 1991, J BIOL CHEM, V266, P9271; Dembinski A, 2006, GROWTH HORM IGF RES, V16, P348, DOI 10.1016/j.ghir.2006.09.003; Denton RM, 1996, ADV ENZYME REGUL, V36, P183, DOI 10.1016/0065-2571(95)00020-8; Deprez J, 1997, J BIOL CHEM, V272, P17269, DOI 10.1074/jbc.272.28.17269; Dolado I, 2008, CANCER CELL, V14, P427, DOI 10.1016/j.ccr.2008.11.006; Duchen MR, 2000, J PHYSIOL-LONDON, V529, P57, DOI 10.1111/j.1469-7793.2000.00057.x; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Fischer L, 2007, AM J PHYSIOL-GASTR L, V292, pG875, DOI 10.1152/ajpgi.00558.2005; Fischer L, 2004, AM J PHYSIOL-GASTR L, V287, pG1200, DOI 10.1152/ajpgi.00212.2004; Foster FM, 2003, J CELL SCI, V116, P3037, DOI 10.1242/jcs.00609; Gukovskaya AS, 2006, J GASTROEN HEPATOL, V21, pS10, DOI 10.1111/j.1440-1746.2006.04571.x; Gukovsky I, 2004, GASTROENTEROLOGY, V126, P554, DOI 10.1053/j.gastro.2003.11.017; HALLBERG D, 1977, ACTA CHIR SCAND, V143, P451; HARDIN CD, 1993, AM J PHYSIOL, V265, pH1326, DOI 10.1152/ajpheart.1993.265.4.H1326; HARDIN CD, 1992, J GEN PHYSIOL, V99, P21, DOI 10.1085/jgp.99.1.21; Hegyi P, 2000, J PHYSIOLOGY-PARIS, V94, P51, DOI 10.1016/S0928-4257(99)00103-5; Hegyi P, 2004, WORLD J GASTROENTERO, V10, P2003, DOI 10.3748/wjg.v10.i14.2003; JAMES DE, 1988, NATURE, V333, P183, DOI 10.1038/333183a0; JANICKI PK, 1994, LIFE SCI, V55, pPL359, DOI 10.1016/0024-3205(94)00761-6; JANICKI PK, 1995, LIFE SCI, V56, pPL357, DOI 10.1016/0024-3205(95)00117-O; LEVY J, 1994, METABOLISM, V43, P1055, DOI 10.1016/0026-0495(94)90189-9; LEVY J, 1995, INT J OBESITY, V19, P97; LEVY J, 1994, METABOLISM, V43, P604, DOI 10.1016/0026-0495(94)90203-8; Lupia E, 2004, AM J PATHOL, V165, P2003, DOI 10.1016/S0002-9440(10)63251-8; Majewski N, 2004, MOL CELL, V16, P819, DOI 10.1016/j.molcel.2004.11.014; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Miyamoto S, 2008, CELL DEATH DIFFER, V15, P521, DOI 10.1038/sj.cdd.4402285; MUALLEM S, 1988, J MEMBRANE BIOL, V102, P153, DOI 10.1007/BF01870453; Odinokova IV, 2008, J GASTROEN HEPATOL, V23, pS25, DOI 10.1111/j.1440-1746.2007.05271.x; Pandol SJ, 2007, GASTROENTEROLOGY, V132, P1127, DOI 10.1053/j.gastro.2007.01.055; Pastorino JG, 2005, CANCER RES, V65, P10545, DOI 10.1158/0008-5472.CAN-05-1925; PAUL RJ, 1989, FASEB J, V3, P2298, DOI 10.1096/fasebj.3.11.2528493; Pedersen PL, 2007, J BIOENERG BIOMEMBR, V39, P1, DOI 10.1007/s10863-007-9070-5; Peter H, 2004, WORLD J GASTROENTERO, V10, P2275; Petersen OH, 2009, CELL CALCIUM, V45, P634, DOI 10.1016/j.ceca.2009.02.005; Rathmell JC, 2003, MOL CELL BIOL, V23, P7315, DOI 10.1128/MCB.23.20.7315-7328.2003; Savkovic V, 2004, DIGEST DIS, V22, P239, DOI 10.1159/000082795; Schmidt Maike M, 2009, Front Neuroenergetics, V1, P1, DOI 10.3389/neuro.14.001.2009; Singh VP, 2001, J CLIN INVEST, V108, P1387, DOI 10.1172/JCI200112874; SUZUKI H, 1993, PANCREAS, V8, P465, DOI 10.1097/00006676-199307000-00010; SVENSSON JO, 1975, SCAND J GASTROENTERO, V10, P487; Takacs T, 2001, PHARMACOL RES, V44, P363, DOI 10.1006/phrs.2001.0843; TANNER LI, 1987, J BIOL CHEM, V262, P8975; Tsuang W, 2009, AM J GASTROENTEROL, V104, P984, DOI 10.1038/ajg.2009.27; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Warzecha Z, 2003, J PHYSIOL PHARMACOL, V54, P575; Warzecha Z, 2001, EUR J PHARMACOL, V430, P113, DOI 10.1016/S0014-2999(01)01352-8; Weber CK, 2001, PANCREATOLOGY, V1, P356, DOI 10.1159/000055834; Wu P, 2010, CURR MED CHEM, V17, P4326, DOI 10.2174/092986710793361234; Wymann MP, 2003, TRENDS PHARMACOL SCI, V24, P366, DOI 10.1016/S0165-6147(03)00163-9; Wymann MP, 2003, BIOCHEM SOC T, V31, P275, DOI 10.1042/bst0310275; Zhou YJ, 2009, LIFE SCI, V85, P670, DOI 10.1016/j.lfs.2009.09.006	58	26	28	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					1823	1836		10.1074/jbc.M111.326272	http://dx.doi.org/10.1074/jbc.M111.326272			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22128146	Green Published, hybrid			2022-12-27	WOS:000299321000024
J	Sauve, S; Buijs, D; Gingras, G; Aubin, Y				Sauve, Simon; Buijs, Daniel; Gingras, Genevieve; Aubin, Yves			Interactions between the Conserved Hydrophobic Region of the Prion Protein and Dodecylphosphocholine Micelles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLID-STATE NMR; MEMBRANE-PROTEINS; PEPTIDE; VISUALIZATION; SPECTROSCOPY; SIMULATIONS; ORIENTATION; RESIDUES; DYNAMICS; SYSTEM	The three-dimensional structure of PrP110-136, a peptide encompassing the conserved hydrophobic region of the human prion protein, has been determined at high resolution in dodecylphosphocholine micelles by NMR. The results support the conclusion that the (PrP)-Pr-Ctm, a transmembrane form of the prion protein, adopts a different conformation than the reported structures of the normal prion protein determined in solution. Paramagnetic relaxation enhancement studies with gadolinium-diethylenetriaminepentaacetic acid indicated that the conserved hydrophobic region peptide is not inserted symmetrically in the micelle, thus suggesting the presence of a guanidium-phosphate ion pair involving the side chain of the terminal arginine and the detergent headgroup. Titration of dodecylphosphocholine into a solution of PrP110-136 revealed the presence of a surface-bound species. In addition, paramagnetic probes located the surface-bound peptide somewhere below the micelle-water interface when using the inserted helix as a positional reference. This localization of the unknown population would allow a similar ion pair interaction.	[Sauve, Simon; Buijs, Daniel; Gingras, Genevieve; Aubin, Yves] Hlth Canada, Ctr Vaccine Evaluat, Biol & Genet Therapies Directorate, Ottawa, ON K1A 0K9, Canada; [Buijs, Daniel; Aubin, Yves] Carleton Univ, Dept Chem, Ottawa, ON K1S 5B6, Canada	Health Canada; Carleton University	Aubin, Y (corresponding author), 251 Sir Frederick Banting Driveway, Ottawa, ON K1A 0K9, Canada.	yves.aubin@hc-sc.gc.ca			Bovine Sponqiform Encephalopathy initiative of the Government of Canada; National Science and Engineering Research Council	Bovine Sponqiform Encephalopathy initiative of the Government of Canada; National Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the Bovine Sponqiform Encephalopathy initiative of the Government of Canada.; Supported by a National Science and Engineering Research Council discovery grant. To whom correspondence should be addressed: 251 Sir Frederick Banting Driveway, Ottawa, ON K1A 0K9, Canada. Fax: 613-941-8933; E-mail: yves.aubin@hc-sc.gc.ca.	Baker M, 2010, NAT METHODS, V7, P429, DOI 10.1038/nmeth0610-429; Baron GS, 2003, J BIOL CHEM, V278, P14883, DOI 10.1074/jbc.M210840200; Bremer J, 2010, NAT NEUROSCI, V13, P310, DOI 10.1038/nn.2483; Chakrabarti O, 2009, TRENDS BIOCHEM SCI, V34, P287, DOI 10.1016/j.tibs.2009.03.001; Cobb NJ, 2009, BIOCHEMISTRY-US, V48, P2574, DOI 10.1021/bi900108v; DEFEA KA, 1994, J BIOL CHEM, V269, P16810; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Di Natale G, 2005, ORG BIOMOL CHEM, V3, P490, DOI 10.1039/b407928k; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Glover KJ, 1999, ANAL BIOCHEM, V272, P270, DOI 10.1006/abio.1999.4182; Glover KJ, 2001, BIOCHEMISTRY-US, V40, P13137, DOI 10.1021/bi011485m; Gobl C, 2010, J PHYS CHEM B, V114, P4717, DOI 10.1021/jp9114089; Guntert P, 2003, PROG NUCL MAG RES SP, V43, P105, DOI 10.1016/S0079-6565(03)00021-9; Hegde RS, 1998, SCIENCE, V279, P827, DOI 10.1126/science.279.5352.827; Hodak M, 2009, P NATL ACAD SCI USA, V106, P11576, DOI 10.1073/pnas.0903807106; Hornemann S, 2009, J BIOL CHEM, V284, P22713, DOI 10.1074/jbc.M109.000430; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kuwata K, 2003, P NATL ACAD SCI USA, V100, P14790, DOI 10.1073/pnas.2433563100; Lawson VA, 2001, J BIOL CHEM, V276, P35265, DOI 10.1074/jbc.M103799200; Lazaridis T, 2005, J PHYS CHEM B, V109, P15098, DOI 10.1021/jp0516801; Liang BY, 2006, J AM CHEM SOC, V128, P4389, DOI 10.1021/ja0574825; Luhrs TT, 2006, J MOL BIOL, V357, P833, DOI 10.1016/j.jmb.2006.01.016; Moore RA, 2009, CURR OPIN STRUC BIOL, V19, P14, DOI 10.1016/j.sbi.2008.12.007; Morillas M, 1999, J BIOL CHEM, V274, P36859, DOI 10.1074/jbc.274.52.36859; Opella SJ, 2004, CHEM REV, V104, P3587, DOI 10.1021/cr0304121; Palladino P, 2010, J FLUORESC, V20, P191, DOI 10.1007/s10895-009-0537-0; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Respondek M, 2007, J AM CHEM SOC, V129, P5228, DOI 10.1021/ja069004f; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; STAFFORD RE, 1989, BIOCHEMISTRY-US, V28, P5113, DOI 10.1021/bi00438a031; Stewart RS, 2001, J BIOL CHEM, V276, P2212, DOI 10.1074/jbc.M006763200; Su YC, 2010, BIOCHEMISTRY-US, V49, P6009, DOI 10.1021/bi100642n; Tanford C., 1980, HYDROPHOBIC EFFECT F, V2; Tang M, 2007, J AM CHEM SOC, V129, P11438, DOI 10.1021/ja072511s; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Will R. G., 2004, PRION BIOL DIS, P631; Wuthrich K, 2001, ADV PROTEIN CHEM, V57, P55; Wymore T, 1999, J MOL STRUCT, V485, P195, DOI 10.1016/S0022-2860(99)00090-3; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145	39	14	14	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					1915	1922		10.1074/jbc.M111.279364	http://dx.doi.org/10.1074/jbc.M111.279364			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22128151	hybrid, Green Published			2022-12-27	WOS:000299321000032
J	Srivastava, RM; Srivastava, S; Singh, M; Bajpai, VK; Ghosh, JK				Srivastava, Raghvendra M.; Srivastava, Saurabh; Singh, Manish; Bajpai, Virendra Kumar; Ghosh, Jimut Kanti			Consequences of Alteration in Leucine Zipper Sequence of Melittin in Its Neutralization of Lipopolysaccharide-induced Proinflammatory Response in Macrophage Cells and Interaction with Lipopolysaccharide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE PRODUCTION; NF-KAPPA-B; TARGET GENE-EXPRESSION; GRAM-NEGATIVE BACTERIA; HOST-DEFENSE PEPTIDES; ANTIMICROBIAL PEPTIDES; ENDOTOXIN NEUTRALIZATION; CATHELICIDIN FAMILY; MEDIATOR GENERATION; CATIONIC PEPTIDES	The bee venom antimicrobial peptide, melittin, besides showing versatile activity against microorganisms also neutralizes lipopolysaccharide (LPS)-induced proinflammatory responses in macrophage cells. However, how the amino acid sequence of melittin contributes in its anti-inflammatory properties is mostly unknown. To determine the importance of the leucine zipper sequence of melittin in its neutralization of LPS-induced inflammatory responses in macrophages and interaction with LPS, anti-inflammatory properties of melittin and its three analogues and their interactions with LPS were studied in detail. Two of these analogues, namely melittin Mut-1 (MM-1) and melittin Mut-2 (MM-2), possess leucine to alanine substitutions in the single and double heptadic leucine residue(s) of melittin, respectively, whereas the third analogue is a scrambled peptide (Mel-SCR) that contains the amino acid composition of melittin with minor rearrangement in its leucine zipper sequence. Although MM-1 partly inhibited the production of proinflammatory cytokines in RAW 264.7 and rat primary macrophage cells in the presence of LPS, MM-2 and Mel-SCR were negligibly active. A progressive decrease in interaction of melittin with LPS, aggregation in LPS, and dissociation of LPS aggregates with alteration in the leucine zipper sequence of melittin was observed. Furthermore, with alteration in the leucine zipper sequence of melittin, these analogues failed to exhibit cellular responses associated with neutralization of LPS-induced inflammatory responses in macrophage cells by melittin. The data indicated a probable important role of the leucine zipper sequence of melittin in neutralizing LPS-induced proinflammatory responses in macrophage cells as well as in its interaction with LPS.	[Srivastava, Raghvendra M.; Srivastava, Saurabh; Ghosh, Jimut Kanti] Cent Drug Res Inst, Mol & Struct Biol Div, Sophisticated Analyt Instrument Facil, Council Sci & Ind Res, Lucknow 226001, Uttar Pradesh, India; [Singh, Manish; Bajpai, Virendra Kumar] Cent Drug Res Inst, Electron Microscopy Unit, Sophisticated Analyt Instrument Facil, Council Sci & Ind Res, Lucknow 226001, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Ghosh, JK (corresponding author), Cent Drug Res Inst, Mol & Struct Biol Div, Sophisticated Analyt Instrument Facil, Council Sci & Ind Res, Chattar Manzil Palace,POB 173, Lucknow 226001, Uttar Pradesh, India.	jighosh@yahoo.com	Srivastava, Raghvendra/F-7211-2017; Srivastava, Saurabh/L-1188-2017	Srivastava, Saurabh/0000-0003-3159-7826; Singh, Manish/0000-0002-9124-1859	Council of Scientific and Industrial Research network [NWP 0005]; Council of Scientific and Industrial Research (CSIR) [NWP 0005]; Council of Scientific and Industrial Research (CSIR), India	Council of Scientific and Industrial Research network; Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India)	The work was supported in part by Council of Scientific and Industrial Research network project NWP 0005. This is Council of Scientific and Industrial Research-Central Drug Research Institute communication number 8164.; Supported as a project assistant (level 4) position under Council of Scientific and Industrial Research (CSIR), NWP 0005.; Supported by senior research fellowships from Council of Scientific and Industrial Research (CSIR), India.	Afaq F, 2003, ONCOGENE, V22, P1035, DOI 10.1038/sj.onc.1206206; Ahmad A, 2009, BIOCHEMISTRY-US, V48, P10905, DOI 10.1021/bi9009874; Ahmad A, 2009, BBA-BIOMEMBRANES, V1788, P2411, DOI 10.1016/j.bbamem.2009.08.021; Andra J, 2007, BIOCHEM J, V406, P297, DOI 10.1042/BJ20070279; Asthana N, 2004, J BIOL CHEM, V279, P55042, DOI 10.1074/jbc.M408881200; Bhunia A, 2007, BBA-BIOMEMBRANES, V1768, P3282, DOI 10.1016/j.bbamem.2007.07.017; Bhunia A, 2009, J BIOL CHEM, V284, P21991, DOI 10.1074/jbc.M109.013573; Bhunia A, 2009, BIOPOLYMERS, V92, P9, DOI 10.1002/bip.21104; BOLTZNITULESCU G, 1987, J LEUKOCYTE BIOL, V41, P83, DOI 10.1002/jlb.41.1.83; Comalada N, 2003, AM J PHYSIOL-CELL PH, V285, pC1235, DOI 10.1152/ajpcell.00228.2003; DAVID SA, 1992, BIOCHIM BIOPHYS ACTA, V1123, P269, DOI 10.1016/0005-2760(92)90006-H; de Haas CJC, 2000, J IMMUNOL METHODS, V242, P79, DOI 10.1016/S0022-1759(00)00207-6; Devadas S, 2002, J EXP MED, V195, P59, DOI 10.1084/jem.20010659; Ding L, 2003, BIOCHEMISTRY-US, V42, P12251, DOI 10.1021/bi035130+; Downey J. S., 1998, FRONT BIOSCI, V3, pd468; Ferguson AD, 1998, SCIENCE, V282, P2215, DOI 10.1126/science.282.5397.2215; FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x; Giacometti A, 2002, ANTIMICROB AGENTS CH, V46, P2132, DOI 10.1128/AAC.46.7.2132-2136.2002; Giacometti A, 2006, ANTIMICROB AGENTS CH, V50, P2478, DOI 10.1128/AAC.01553-05; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Gough M, 1996, INFECT IMMUN, V64, P4922, DOI 10.1128/IAI.64.12.4922-4927.1996; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Havenga MJE, 2001, ANAL BIOCHEM, V290, P283, DOI 10.1006/abio.2000.4966; HAYTER JB, 1987, J BIOL CHEM, V262, P5100; HIRATA M, 1994, INFECT IMMUN, V62, P1421, DOI 10.1128/IAI.62.4.1421-1426.1994; Japelj B, 2005, J BIOL CHEM, V280, P16955, DOI 10.1074/jbc.M500266200; Kadowaki S, 2004, MOL CELL BIOCHEM, V262, P51, DOI 10.1023/B:MCBI.0000038215.89821.7f; Kennedy MN, 2004, J BIOL CHEM, V279, P34698, DOI 10.1074/jbc.M405444200; Kitchens RL, 2005, J ENDOTOXIN RES, V11, P225, DOI 10.1179/096805105X46565; Li P, 2004, J BIOL CHEM, V279, P50150, DOI 10.1074/jbc.M405606200; Mamani-Matsuda M, 2004, ANTIMICROB AGENTS CH, V48, P924, DOI 10.1128/AAC.48.3.924-929.2004; Mangoni ML, 2008, J BIOL CHEM, V283, P22907, DOI 10.1074/jbc.M800495200; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Moynagh Paul N, 2005, J Cell Sci, V118, P4589, DOI 10.1242/jcs.02579; Nagaoka I, 2001, J IMMUNOL, V167, P3329, DOI 10.4049/jimmunol.167.6.3329; Pandey BK, 2010, BIOCHEMISTRY-US, V49, P7920, DOI 10.1021/bi100729m; Papo N, 2005, J BIOL CHEM, V280, P10378, DOI 10.1074/jbc.M412865200; Park HJ, 2004, ARTHRITIS RHEUM-US, V50, P3504, DOI 10.1002/art.20626; Park HJ, 2007, BIOCHEM PHARMACOL, V73, P237, DOI 10.1016/j.bcp.2006.09.023; Park HJ, 2008, J INFLAMM-LOND, V5, DOI 10.1186/1476-9255-5-7; Pattanaik U, 1996, ANN NY ACAD SCI, V793, P506, DOI 10.1111/j.1749-6632.1996.tb33551.x; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Petruson K, 2005, RHINOLOGY, V43, P18; PIERS KL, 1994, MOL MICROBIOL, V12, P951, DOI 10.1111/j.1365-2958.1994.tb01083.x; Privat C, 1997, LIFE SCI, V61, P1193, DOI 10.1016/S0024-3205(97)00661-9; Reid AB, 2005, J PHARMACOL EXP THER, V312, P509, DOI 10.1124/jpet.104.075945; RIFKIND D, 1966, J BACTERIOL, V92, P815, DOI 10.1128/JB.92.4.815-819.1966; Rosenfeld Y, 2006, J BIOL CHEM, V281, P1636, DOI 10.1074/jbc.M504327200; Schulke S, 2010, MOL IMMUNOL, V48, P341, DOI 10.1016/j.molimm.2010.07.006; Scott MG, 1999, INFECT IMMUN, V67, P6445; Scott MG, 2000, J IMMUNOL, V164, P549, DOI 10.4049/jimmunol.164.2.549; Shaw PJ, 2007, TOXICOL SCI, V100, P259, DOI 10.1093/toxsci/kfm218; Tack BF, 2002, EUR J BIOCHEM, V269, P1181, DOI 10.1046/j.0014-2956.2002.02751.x; Tepel M, 2000, KIDNEY INT, V58, P867, DOI 10.1046/j.1523-1755.2000.00236.x; Tsuzuki H, 2001, J SURG RES, V100, P127, DOI 10.1006/jsre.2001.6227; Turnbull IR, 2005, J EXP MED, V202, P363, DOI 10.1084/jem.20050986; Turpin P, 1999, J BIOL CHEM, V274, P6804, DOI 10.1074/jbc.274.10.6804; Vasselon T, 1999, J EXP MED, V190, P509, DOI 10.1084/jem.190.4.509; WU CSC, 1981, BIOCHEMISTRY-US, V20, P566, DOI 10.1021/bi00506a019; Xiao YJ, 2006, FEBS J, V273, P2581, DOI 10.1111/j.1742-4658.2006.05261.x; Yadav SP, 2003, J BIOL CHEM, V278, P51023, DOI 10.1074/jbc.M310052200; Yu Z, 2007, GYNECOL ONCOL, V106, P541, DOI 10.1016/j.ygyno.2007.05.024; Zhu WL, 2007, BBA-BIOMEMBRANES, V1768, P1506, DOI 10.1016/j.bbamem.2007.03.010	65	33	34	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					1980	1995		10.1074/jbc.M111.302893	http://dx.doi.org/10.1074/jbc.M111.302893			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22128186	Green Published, hybrid			2022-12-27	WOS:000299321000039
J	Samways, DSK; Khakh, BS; Egan, TM				Samways, Damien S. K.; Khakh, Baljit S.; Egan, Terrance M.			Allosteric Modulation of Ca2+ flux in Ligand-gated Cation Channel (P2X4) by Actions on Lateral Portals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIRST TRANSMEMBRANE DOMAIN; P2X(4) RECEPTOR CHANNELS; AMINO-ACID-RESIDUES; CALCIUM PERMEABILITY; ION CHANNELS; PORE; IDENTIFICATION; SELECTIVITY; IVERMECTIN; CONDUCTANCE	Human P2X receptors are a family of seven ATP-gated ion channels that transport Na+, K+, and Ca2+ across cell surface membranes. The P2X4 receptor is unique among family members in its sensitivity to the macrocyclic lactone, ivermectin, which allosterically modulates both ion conduction and channel gating. In this paper we show that removing the fixed negative charge of a single acidic amino acid (Glu(51)) in the lateral entrance to the transmembrane pore markedly attenuates the effect of ivermectin on Ca2+ current and channel gating. Ca2+ entry through P2X4 receptors is known to trigger downstream signaling pathways in microglia. Our experiments show that the lateral portals could present a novel target for drugs in the treatment of microglia-associated disease including neuropathic pain.	[Samways, Damien S. K.; Egan, Terrance M.] St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA; [Samways, Damien S. K.; Egan, Terrance M.] St Louis Univ, Sch Med, Ctr Excellence Neurosci, St Louis, MO 63104 USA; [Khakh, Baljit S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; [Khakh, Baljit S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA	Saint Louis University; Saint Louis University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Egan, TM (corresponding author), St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, 1402 S Grand Blvd, St Louis, MO 63104 USA.	egantm@slu.edu		Egan, Terrance/0000-0002-7249-3161	National Institutes of Health [HL56236, NS073980]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS073980] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL56236 (to T. M. E.) and NS073980 (to B. S. K.).	Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Browne LE, 2011, NAT NEUROSCI, V14, P17, DOI 10.1038/nn.2705; Burnashev N, 1998, CELL CALCIUM, V24, P325, DOI 10.1016/S0143-4160(98)90056-2; Cao LS, 2007, J NEUROSCI, V27, P12916, DOI 10.1523/JNEUROSCI.4036-07.2007; Chung MK, 2008, NAT NEUROSCI, V11, P555, DOI 10.1038/nn.2102; Coddou C, 2011, PHARMACOL REV, V63, P641, DOI 10.1124/pr.110.003129; Egan TM, 1998, J NEUROSCI, V18, P2350; Egan TM, 2004, J NEUROSCI, V24, P3413, DOI 10.1523/JNEUROSCI.5429-03.2004; Fesce R, 2011, J GEN PHYSIOL, V138, P367, DOI 10.1085/jgp.201110690; Haines WR, 2001, J NEUROSCI, V21, P5885, DOI 10.1523/JNEUROSCI.21-16-05885.2001; Haines WR, 2001, J BIOL CHEM, V276, P32793, DOI 10.1074/jbc.M104216200; Jarvis MF, 2009, NEUROPHARMACOLOGY, V56, P208, DOI 10.1016/j.neuropharm.2008.06.067; Jelinkova I, 2008, PFLUG ARCH EUR J PHY, V456, P939, DOI 10.1007/s00424-008-0450-4; Jelinkova I, 2006, BIOCHEM BIOPH RES CO, V349, P619, DOI 10.1016/j.bbrc.2006.08.084; Jindrichova M, 2011, J NEUROCHEM, V119, P676, DOI 10.1111/j.1471-4159.2011.07463.x; Jindrichova M, 2009, J NEUROCHEM, V109, P923, DOI 10.1111/j.1471-4159.2009.06021.x; Karashima Y, 2010, BIOPHYS J, V98, P773, DOI 10.1016/j.bpj.2009.11.007; Kawate T, 2011, J GEN PHYSIOL, V137, P579, DOI 10.1085/jgp.201010593; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Keceli B, 2009, J PHYSIOL-LONDON, V587, P5801, DOI 10.1113/jphysiol.2009.182824; Khakh BS, 1999, J NEUROSCI, V19, P7289, DOI 10.1523/JNEUROSCI.19-17-07289.1999; Khakh BS, 1999, NAT NEUROSCI, V2, P322, DOI 10.1038/7233; Kisilevsky Alexandra E., 2008, V184, P45; Kracun S, 2010, J BIOL CHEM, V285, P10110, DOI 10.1074/jbc.M109.089185; LEWIS CA, 1979, J PHYSIOL-LONDON, V286, P417, DOI 10.1113/jphysiol.1979.sp012629; Li MF, 2008, NAT NEUROSCI, V11, P883, DOI 10.1038/nn.2151; Li MF, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1048; Migita K, 2001, J BIOL CHEM, V276, P30934, DOI 10.1074/jbc.M103366200; Nakazawa K, 1998, EUR J PHARMACOL, V347, P141, DOI 10.1016/S0014-2999(98)00207-6; NEHER E, 1995, NEUROPHARMACOLOGY, V34, P1423, DOI 10.1016/0028-3908(95)00144-U; Priel A, 2004, J GEN PHYSIOL, V123, P281, DOI 10.1085/jgp.200308986; Rassendren F, 1997, EMBO J, V16, P3446, DOI 10.1093/emboj/16.12.3446; Samways DSK, 2008, J BIOL CHEM, V283, P31274, DOI 10.1074/jbc.C800131200; Samways DSK, 2008, J BIOL CHEM, V283, P5110, DOI 10.1074/jbc.M708713200; Samways DSK, 2007, J GEN PHYSIOL, V129, P245, DOI 10.1085/jgp.200609677; Samways DSK, 2011, P NATL ACAD SCI USA, V108, P13800, DOI 10.1073/pnas.1017550108; SCHNEGGENBURGER R, 1993, NEURON, V11, P133, DOI 10.1016/0896-6273(93)90277-X; Silberberg SD, 2007, NEURON, V54, P263, DOI 10.1016/j.neuron.2007.03.020; Skeberdis VA, 2006, NAT NEUROSCI, V9, P501, DOI 10.1038/nn1664; Toulme E, 2010, J GEN PHYSIOL, V135, P333, DOI 10.1085/jgp.200910336; Tsuda M, 2003, NATURE, V424, P778, DOI 10.1038/nature01786; VERNINO S, 1994, J NEUROSCI, V14, P5514; Yamamoto K, 2006, NAT MED, V12, P133, DOI 10.1038/nm1338	43	30	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7594	7602		10.1074/jbc.M111.322461	http://dx.doi.org/10.1074/jbc.M111.322461			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22219189	Green Published, hybrid			2022-12-27	WOS:000301060200059
J	Zhou, ZQ; Li, KL; Rieck, D; Ouyang, YX; Chandra, M; Dong, WJ				Zhou, Zhiqun; Li, King-Lun; Rieck, Daniel; Ouyang, Yexin; Chandra, Murali; Dong, Wen-Ji			Structural Dynamics of C-domain of Cardiac Troponin I Protein in Reconstituted Thin Filament	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INHIBITORY REGION; CONFORMATIONAL TRANSITIONS; MUSCLE-CONTRACTION; ACTIN-TROPOMYOSIN; 3-STATE MODEL; RESONANCE; COMPLEX; KINETICS; CA2+; CALCIUM	The regulatory function of cardiac troponin I (cTnI) involves three important contiguous regions within its C-domain: the inhibitory region (IR), the regulatory region (RR), and the mobile domain (MD). Within these regions, the dynamics of regional structure and kinetics of transitions in dynamic state are believed to facilitate regulatory signaling. This study was designed to use fluorescence anisotropy techniques to acquire steady-state and kinetic information on the dynamic state of the C-domain of cTnI in the reconstituted thin filament. A series of single cysteine cTnI mutants was generated, labeled with the fluorophore tetramethylrhodamine, and subjected to various anisotropy experiments at the thin filament level. The structure of the IR was found to be less dynamic than that of the RR and the MD, and Ca2+ binding induced minimal changes in IR dynamics: the flexibility of the RR decreased, whereas the MD became more flexible. Anisotropy stopped-flow experiments showed that the kinetics describing the transition of the MD and RR from the Ca2+-bound to the Ca2+-free dynamic states were significantly faster (53.2-116.8 s(-1)) than that of the IR (14.1 s(-1)). Our results support the fly casting mechanism, implying that an unstructured MD with rapid dynamics and kinetics plays a critical role to initiate relaxation upon Ca2+ dissociation by rapidly interacting with actin to promote the dissociation of the RR from the N-domain of cTnC. In contrast, the IR responds to Ca2+ signals with slow structural dynamics and transition kinetics. The collective findings suggested a fourth state of activation.	[Zhou, Zhiqun; Ouyang, Yexin; Dong, Wen-Ji] Washington State Univ, Dept Vet & Comparat Anat Pharmacol & Physiol, Pullman, WA 99164 USA; [Li, King-Lun; Rieck, Daniel; Chandra, Murali] Washington State Univ, Voiland Sch Chem Engn & Bioengn, Pullman, WA 99164 USA	Washington State University; Washington State University	Dong, WJ (corresponding author), Washington State Univ, Dept Vet & Comparat Anat Pharmacol & Physiol, 205 Wegner Hall, Pullman, WA 99164 USA.	wdong@vetmed.wsu.edu	Dong, Wenji/A-8579-2011	zhou, zhiqun/0000-0001-5248-8931	National Institutes of Health [HL80186, HL80186-5S1, HL075643]; M. J. Murdock Charitable Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080186, R01HL075643] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008336] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); M. J. Murdock Charitable Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL80186 (to W.-J. D.), HL80186-5S1 (to W.-J. D.), and HL075643 (to M. C.). This work was also supported by the M. J. Murdock Charitable Trust (to W.-J. D.).	Blumenschein TMA, 2006, BIOPHYS J, V90, P2436, DOI 10.1529/biophysj.105.076216; Brown MP, 1997, CURR OPIN BIOTECH, V8, P45, DOI 10.1016/S0958-1669(97)80156-5; CACHIA PJ, 1983, BIOCHEMISTRY-US, V22, P4145, DOI 10.1021/bi00286a024; Chandra M, 1999, BIOCHEM BIOPH RES CO, V263, P219, DOI 10.1006/bbrc.1999.1341; Dong WJ, 2008, J BIOL CHEM, V283, P3424, DOI 10.1074/jbc.M703822200; Dong WJ, 2007, BIOCHEMISTRY-US, V46, P9752, DOI 10.1021/bi700574n; Dong WJ, 1997, BIOCHEMISTRY-US, V36, P6745, DOI 10.1021/bi962226d; Dong WJ, 2003, J BIOL CHEM, V278, P42394, DOI 10.1074/jbc.M304858200; Dong WJ, 1999, J BIOL CHEM, V274, P31382, DOI 10.1074/jbc.274.44.31382; Dong WJ, 2003, J BIOL CHEM, V278, P8686, DOI 10.1074/jbc.M212886200; Dong WJ, 2001, J MOL BIOL, V314, P51, DOI 10.1006/jmbi.2001.5118; EBASHI S, 1969, Quarterly Reviews of Biophysics, V2, P351; FARAH CS, 1995, FASEB J, V9, P755, DOI 10.1096/fasebj.9.9.7601340; Galinska A, 2010, CIRC RES, V106, P705, DOI 10.1161/CIRCRESAHA.109.210047; Galinska-Rakoczy A, 2008, J MOL BIOL, V379, P929, DOI 10.1016/j.jmb.2008.04.062; Gomez-Hens A, 2003, COMB CHEM HIGH T SCR, V6, P177, DOI 10.2174/138620703106298356; Goodey NM, 2008, NAT CHEM BIOL, V4, P474, DOI 10.1038/nchembio.98; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; HASELGROVE JC, 1973, COLD SPRING HARB SYM, V37, P341, DOI 10.1101/SQB.1973.037.01.044; Hoffman RMB, 2006, J MOL BIOL, V361, P625, DOI 10.1016/j.jmb.2006.06.031; HUXLEY HE, 1973, COLD SPRING HARB SYM, V37, P361, DOI 10.1101/SQB.1973.037.01.046; Julien O, 2011, PROTEINS, V79, P1240, DOI 10.1002/prot.22959; Kobayashi T, 2005, ANNU REV PHYSIOL, V67, P39, DOI 10.1146/annurev.physiol.67.040403.114025; Kobayashi T, 2000, BIOCHEMISTRY-US, V39, P86, DOI 10.1021/bi991903b; Lakowicz J. R., 1999, PRINCIPLES FLUORESCE, P285; LEHMAN W, 1994, NATURE, V368, P65, DOI 10.1038/368065a0; Lehman W, 2009, J MOL BIOL, V388, P673, DOI 10.1016/j.jmb.2009.03.060; Lehrer SS, 2011, J MUSCLE RES CELL M, V32, P203, DOI 10.1007/s10974-011-9263-8; Li MX, 2004, J MUSCLE RES CELL M, V25, P559, DOI 10.1007/s10974-004-5879-2; Li MX, 1999, BIOCHEMISTRY-US, V38, P8289, DOI 10.1021/bi9901679; LIAO RL, 1992, BIOPHYS J, V63, P986, DOI 10.1016/S0006-3495(92)81685-5; Maytum R, 1999, BIOCHEMISTRY-US, V38, P1102, DOI 10.1021/bi981603e; Mudalige WAKA, 2009, J MOL BIOL, V389, P575, DOI 10.1016/j.jmb.2009.04.027; Murakami K, 2005, J MOL BIOL, V352, P178, DOI 10.1016/j.jmb.2005.06.067; Narolska NA, 2006, CIRC RES, V99, P1012, DOI 10.1161/01.RES.0000248753.30340.af; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; PARRY DAD, 1973, J MOL BIOL, V75, P33, DOI 10.1016/0022-2836(73)90527-5; Robinson JM, 2004, J MOL BIOL, V340, P295, DOI 10.1016/j.jmb.2004.04.046; Serdyuk IN, 2007, METHODS IN MOLECULAR BIOPHYSICS: STRUCTURE, DYNAMICS, FUNCTION, P1; Shitaka Y, 2004, BIOCHEMISTRY-US, V43, P10739, DOI 10.1021/bi0492713; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; SMILLIE LB, 1982, METHOD ENZYMOL, V85, P234; Sykes BD, 2003, NAT STRUCT BIOL, V10, P588, DOI 10.1038/nsb0803-588; Tachampa K, 2008, J BIOL CHEM, V283, P15114, DOI 10.1074/jbc.M801636200; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; Tripet B, 1997, J MOL BIOL, V271, P728, DOI 10.1006/jmbi.1997.1200; XING J, 1994, ARCH BIOCHEM BIOPHYS, V313, P229, DOI 10.1006/abbi.1994.1381; Xing J, 2009, J BIOL CHEM, V284, P16432, DOI 10.1074/jbc.M808075200; Xing J, 2008, BIOCHEMISTRY-US, V47, P13383, DOI 10.1021/bi801492x; Zhou X, 2000, BIOCHEMISTRY-US, V39, P1128, DOI 10.1021/bi992327m	50	25	25	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7661	7674		10.1074/jbc.M111.281600	http://dx.doi.org/10.1074/jbc.M111.281600			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22207765	Green Published, hybrid			2022-12-27	WOS:000301060200065
J	Cohen-Kaplan, V; Jrbashyan, J; Yanir, Y; Naroditsky, I; Ben-Izhak, O; Ilan, N; Doweck, I; Vlodavsky, I				Cohen-Kaplan, Victoria; Jrbashyan, Jenny; Yanir, Yoav; Naroditsky, Inna; Ben-Izhak, Ofer; Ilan, Neta; Doweck, Ilana; Vlodavsky, Israel			Heparanase Induces Signal Transducer and Activator of Transcription (STAT) Protein Phosphorylation PRECLINICAL AND CLINICAL SIGNIFICANCE IN HEAD AND NECK CANCER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONSTITUTIVE ACTIVATION; TUMOR PROGRESSION; GROWTH; EXPRESSION; LOCALIZATION; SULFATE; PROTEOGLYCANS; CONTRIBUTES; METASTASIS; REGULATOR	Activity of heparanase is implicated strongly in dissemination of metastatic tumor cells and cells of the immune system. In addition, heparanase enhances the phosphorylation of selected signaling molecules, including SRC and EGFR, in a manner that requires secretion but not enzymatic activity of heparanase and is mediated by its C-terminal domain. Clinically, heparanase staining is associated with larger tumors and increased EGFR phosphorylation in head and neck carcinoma. We hypothesized that signal transducer and activator of transcription (STAT) proteins mediate the protumorigenic function of heparanase downstream of the EGFR. We provide evidence that heparanase enhances the phosphorylation of STAT3 and STAT5b but not STAT5a. Moreover, enhanced proliferation of heparanase transfected cells was attenuated by STAT3 and STAT5b siRNA, but not STAT5a or STAT1 siRNA. Clinically, STAT3 phosphorylation was associated with head and neck cancer progression, EGFR phosphorylation, and heparanase expression and cellular localization. Notably, cytoplasmic rather than nuclear phospho-STAT3 correlated with increased tumor size (T-stage; p = 0.007), number of metastatic neck lymph nodes (p = 0.05), and reduced survival of patients (p = 0.04).	[Jrbashyan, Jenny; Yanir, Yoav; Doweck, Ilana] Carmel Hosp, Dept Otolaryngol Head & Neck Surg, IL-34362 Haifa, Israel; [Vlodavsky, Israel] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Canc & Vasc Biol Res Ctr, IL-31096 Haifa, Israel; [Naroditsky, Inna; Ben-Izhak, Ofer] Rambam Hlth Care Campus, Dept Pathol, IL-31096 Haifa, Israel	Clalit Health Services; Carmel Medical Center; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Rambam Health Care Campus	Doweck, I (corresponding author), Carmel Hosp, Dept Otolaryngol Head & Neck Surg, 7 Michal St, IL-34362 Haifa, Israel.	idoweck@netvision.net.il; vlodavsk@cc.huji.ac.il		Doweck, Ilana/0000-0002-1065-0299	NCI; National Institutes of Health [CA106456]; Israel Science Foundation [593/10]; Israel Cancer Research Fund; US-Israel Binational Science Foundation; Rappaport Family Institute Fund; NATIONAL CANCER INSTITUTE [R01CA106456] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Israel Science Foundation(Israel Science Foundation); Israel Cancer Research Fund; US-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Rappaport Family Institute Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by NCI, National Institutes of Health Grant CA106456. This work was also supported by Israel Science Foundation Grant 593/10; the Israel Cancer Research Fund; the US-Israel Binational Science Foundation, and the Rappaport Family Institute Fund (to I.V.).	Atkinson GP, 2010, EXPERT REV NEUROTHER, V10, P575, DOI [10.1586/ern.10.21, 10.1586/ERN.10.21]; Barash U, 2010, FEBS J, V277, P3890, DOI 10.1111/j.1742-4658.2010.07799.x; Barash U, 2010, FASEB J, V24, P1239, DOI 10.1096/fj.09-147074; Ben-Zaken O, 2007, BIOCHEM BIOPH RES CO, V361, P829, DOI 10.1016/j.bbrc.2007.06.188; Casu B, 2007, PATHOPHYSIOL HAEMO T, V36, P195, DOI 10.1159/000175157; Chen Z, 2008, MED RES REV, V28, P185, DOI 10.1002/med.20101; Cohen-Kaplan V, 2008, INT J CANCER, V123, P2566, DOI 10.1002/ijc.23898; Cohen-Kaplan V, 2008, CANCER RES, V68, P10077, DOI 10.1158/0008-5472.CAN-08-2910; Dempsey LA, 2000, TRENDS BIOCHEM SCI, V25, P349, DOI 10.1016/S0968-0004(00)01619-4; Doweck I, 2006, NEOPLASIA, V8, P1055, DOI 10.1593/neo.06577; Dredge K, 2010, INVEST NEW DRUG, V28, P276, DOI 10.1007/s10637-009-9245-5; Frank DA, 2007, CANCER LETT, V251, P199, DOI 10.1016/j.canlet.2006.10.017; Fung C, 2010, EXPERT OPIN EMERG DR, V15, P355, DOI 10.1517/14728214.2010.497754; Fux L, 2009, TRENDS BIOCHEM SCI, V34, P511, DOI 10.1016/j.tibs.2009.06.005; Fux L, 2009, CANCER RES, V69, P1758, DOI 10.1158/0008-5472.CAN-08-1837; Germain D, 2007, CLIN CANCER RES, V13, P5665, DOI 10.1158/1078-0432.CCR-06-2491; Gingis-Velitski S, 2004, J BIOL CHEM, V279, P23536, DOI 10.1074/jbc.M400554200; Ilan N, 2006, INT J BIOCHEM CELL B, V38, P2018, DOI 10.1016/j.biocel.2006.06.004; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Koppikar P, 2008, CLIN CANCER RES, V14, P7682, DOI 10.1158/1078-0432.CCR-08-1328; Lai SY, 2010, DRUG RESIST UPDATE, V13, P67, DOI 10.1016/j.drup.2010.04.001; Leeman RJ, 2006, EXPERT OPIN BIOL TH, V6, P231, DOI 10.1517/14712598.6.3.231; Lerner I, 2008, CLIN CANCER RES, V14, P668, DOI 10.1158/1078-0432.CCR-07-1866; Lerner I, 2011, J CLIN INVEST, V121, P1709, DOI 10.1172/JCI43792; Levy-Adam F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002319; Levy-Adam F, 2010, SEMIN CANCER BIOL, V20, P153, DOI 10.1016/j.semcancer.2010.06.005; Levy-Adam F, 2010, J BIOL CHEM, V285, P28010, DOI 10.1074/jbc.M110.116384; Li HZ, 2005, CLIN CANCER RES, V11, P5863, DOI 10.1158/1078-0432.CCR-05-0562; McKenzie EA, 2007, BRIT J PHARMACOL, V151, P1, DOI 10.1038/sj.bjp.0707182; Miao HQ, 2006, CURR MED CHEM, V13, P2101, DOI 10.2174/092986706777935230; Nadav L, 2006, CANCER RES, V66, P8608, DOI 10.1158/0008-5472.CAN-06-1301; Okawa T, 2005, CLIN CANCER RES, V11, P7995, DOI 10.1158/1078-0432.CCR-05-1103; Parish CR, 2001, BBA-REV CANCER, V1471, pM99, DOI 10.1016/S0304-419X(01)00017-8; Paukku K, 2004, CYTOKINE GROWTH F R, V15, P435, DOI 10.1016/j.cytogfr.2004.09.001; Pectasides E, 2010, CLIN CANCER RES, V16, P2427, DOI 10.1158/1078-0432.CCR-09-2658; Ramani VC, 2011, J BIOL CHEM, V286, P6490, DOI 10.1074/jbc.M110.183277; Reich NC, 2006, NAT REV IMMUNOL, V6, P602, DOI 10.1038/nri1885; Rosenthal EL, 2006, LARYNGOSCOPE, V116, P1636, DOI 10.1097/01.mlg.0000232513.19873.da; Sanderson RD, 2005, J CELL BIOCHEM, V96, P897, DOI 10.1002/jcb.20602; Schlessinger K, 2005, CANCER RES, V65, P5828, DOI 10.1158/0008-5472.CAN-05-0317; Seethala RR, 2008, CLIN CANCER RES, V14, P1303, DOI 10.1158/1078-0432.CCR-07-1543; Sehgal PB, 2008, SEMIN CELL DEV BIOL, V19, P329, DOI 10.1016/j.semcdb.2008.07.003; Shafat I, 2011, J CELL MOL MED, V15, P1857, DOI 10.1111/j.1582-4934.2010.01190.x; Silver DL, 2004, CANCER RES, V64, P3550, DOI 10.1158/0008-5472.CAN-03-3959; Song JI, 2000, ONCOGENE, V19, P2489, DOI 10.1038/sj.onc.1203483; Valgeirsdottir S, 1999, FEBS LETT, V450, P1, DOI 10.1016/S0014-5793(99)00459-7; Vlodavsky I, 2001, J CLIN INVEST, V108, P341, DOI 10.1172/JCI200113662; Vlodavsky I, 2007, CURR PHARM DESIGN, V13, P2057; Vreys V, 2007, J CELL MOL MED, V11, P427, DOI 10.1111/j.1582-4934.2007.00039.x; WEICHSELBAUM RR, 1989, HEAD NECK-J SCI SPEC, V11, P437, DOI 10.1002/hed.2880110510; Xi SC, 2003, CANCER RES, V63, P6763; Yang Y, 2010, CANCER RES, V70, P8329, DOI 10.1158/0008-5472.CAN-10-2179; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zetser A, 2006, CANCER RES, V66, P1455, DOI 10.1158/0008-5472.CAN-05-1811; Zetser A, 2004, J CELL SCI, V117, P2249, DOI 10.1242/jcs.01068	56	42	47	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6668	6678		10.1074/jbc.M111.271346	http://dx.doi.org/10.1074/jbc.M111.271346			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22194600	Green Published, hybrid			2022-12-27	WOS:000300791800053
J	Khan, SR; Kuzminov, A				Khan, Sharik R.; Kuzminov, Andrei			Replication Forks Stalled at Ultraviolet Lesions Are Rescued via RecA and RuvABC Protein-catalyzed Disintegration in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; DNA-REPLICATION; CHROMOSOMAL FRAGMENTATION; RECBCD ENZYME; RECOMBINATIONAL REPAIR; POSTREPLICATION REPAIR; MAMMALIAN-CELLS; EXCISION-REPAIR; NALIDIXIC-ACID; SKIN-CANCER	Ultraviolet (UV) irradiation is not known to induce chromosomal fragmentation in sublethal doses, and yet UV irradiation causes genetic instability and cancer, suggesting that chromosomes are fragmented. Here we show that UV irradiation induces fragmentation in sublethal doses, but the broken chromosomes are repaired or degraded by RecBCD; therefore, to observe full fragmentation, RecBCD enzyme needs to be inactivated. Using quantitative pulsed field gel electrophoresis and sensitive DNA synthesis measurements, we investigated the mechanisms of UV radiation-induced chromosomal fragmentation in recBC mutants, comparing five existing models of DNA damage-induced fragmentation. We found that fragmentation depends on active DNA synthesis before, but not after, UV irradiation. At low UV irradiation doses, fragmentation does not need excision repair or daughter strand gap repair. Fragmentation absolutely depends on both RecA-catalyzed homologous strand exchange and RuvABC-catalyzed Holliday junction resolution. Thus, chromosomes fragment when replication forks stall at UV lesions and regress, generating Holliday junctions. Remarkably, cells specifically utilize fork breakage to rescue stalled replication and avoid lethality.	[Khan, Sharik R.; Kuzminov, Andrei] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Kuzminov, A (corresponding author), Univ Illinois, Dept Microbiol, B103 C&LSL,601 S Goodwin Ave, Urbana, IL 61801 USA.	kuzminov@life.illinois.edu			National Institutes of Health [GM073115]; American Cancer Society [RSG-05-135-01-GMC]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073115] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM073115. This work was also supported by American Cancer Society Grant RSG-05-135-01-GMC.	BENDER MA, 1973, MUTAT RES, V20, P387, DOI 10.1016/0027-5107(73)90060-2; BILLEN D, 1969, J BACTERIOL, V97, P1169, DOI 10.1128/JB.97.3.1169-1175.1969; BONURA T, 1975, RADIAT RES, V63, P567, DOI 10.2307/3574108; BONURA T, 1975, J BACTERIOL, V121, P511, DOI 10.1128/JB.121.2.511-517.1975; BRADLEY MO, 1983, CARCINOGENESIS, V4, P1513, DOI 10.1093/carcin/4.12.1513; BRADLEY MO, 1981, P NATL ACAD SCI-BIOL, V78, P3619, DOI 10.1073/pnas.78.6.3619; BRCICKOSTIC K, 1991, MOL GEN GENET, V228, P136, DOI 10.1007/BF00282458; Briggs GS, 2004, PHILOS T R SOC B, V359, P49, DOI 10.1098/rstb.2003.1364; Budke B, 2010, MOL MICROBIOL, V75, P230, DOI 10.1111/j.1365-2958.2009.06994.x; CHURCHILL GA, 1990, NUCLEIC ACIDS RES, V18, P589, DOI 10.1093/nar/18.3.589; Courcelle J, 2001, GENETICS, V158, P41; Courcelle J, 2003, ANNU REV GENET, V37, P611, DOI 10.1146/annurev.genet.37.110801.142616; Courcelle J, 1997, P NATL ACAD SCI USA, V94, P3714, DOI 10.1073/pnas.94.8.3714; Courcelle J, 1999, J BACTERIOL, V181, P916, DOI 10.1128/JB.181.3.916-922.1999; D'souza DI, 2003, NUCLEIC ACIDS RES, V31, P4573, DOI 10.1093/nar/gkg493; DIANOV GL, 1991, MOL GEN GENET, V225, P448, DOI 10.1007/BF00261686; Difilippantonio MJ, 2002, J EXP MED, V196, P469, DOI 10.1084/jem.20020851; Dillingham MS, 2008, MICROBIOL MOL BIOL R, V72, P642, DOI 10.1128/MMBR.00020-08; DOUDNEY CO, 1973, MUTAT RES, V17, P1, DOI 10.1016/0027-5107(73)90247-9; DUGLE DL, 1976, P NATL ACAD SCI USA, V73, P809, DOI 10.1073/pnas.73.3.809; Dworaczek Hanna, 2007, Critical Reviews in Oncogenesis, V13, P159; EPSTEIN JH, 1983, J AM ACAD DERMATOL, V9, P487, DOI 10.1016/S0190-9622(83)70160-X; Fasullo M, 2008, MUTAT RES-FUND MOL M, V648, P73, DOI 10.1016/j.mrfmmm.2008.09.009; Fedorova LV, 2001, RUSS J GENET+, V37, P358, DOI 10.1023/A:1016642107465; Flores MJ, 2005, MOL MICROBIOL, V57, P1664, DOI 10.1111/j.1365-2958.2005.04753.x; Flores MJ, 2001, EMBO J, V20, P619, DOI 10.1093/emboj/20.3.619; FRIEDBERG EC, 2006, DNA REPAIR MUTAGENES, P227; GOSS WA, 1965, J BACTERIOL, V89, P1068, DOI 10.1128/JB.89.4.1068-1074.1965; Hanawalt P C, 1966, Photochem Photobiol, V5, P1, DOI 10.1111/j.1751-1097.1966.tb05756.x; HIGGINS NP, 1976, J MOL BIOL, V101, P417, DOI 10.1016/0022-2836(76)90156-X; JONCZYK P, 1979, MOL GEN GENET, V171, P53, DOI 10.1007/BF00274014; KELNER A, 1953, J BACTERIOL, V65, P252, DOI 10.1128/JB.65.3.252-262.1953; KHIDHIR MA, 1985, MOL GEN GENET, V199, P133, DOI 10.1007/BF00327522; Kouzminova EA, 2006, J MOL BIOL, V355, P20, DOI 10.1016/j.jmb.2005.10.044; Kouzminova EA, 2004, P NATL ACAD SCI USA, V101, P16262, DOI 10.1073/pnas.0405943101; Kouzminova EA, 2004, MOL MICROBIOL, V51, P1279, DOI 10.1111/j.1365-2958.2003.03924.x; Kouzminova EA, 2008, MOL MICROBIOL, V68, P202, DOI 10.1111/j.1365-2958.2008.06149.x; Kuong KJ, 2009, J MOL BIOL, V390, P845, DOI 10.1016/j.jmb.2009.05.038; Kuzminov A, 1999, MICROBIOL MOL BIOL R, V63, P751, DOI 10.1128/MMBR.63.4.751-813.1999; KUZMINOV A, 1995, BIOESSAYS, V17, P733, DOI 10.1002/bies.950170810; KUZMINOV A, 1995, MOL MICROBIOL, V16, P373, DOI 10.1111/j.1365-2958.1995.tb02403.x; Kuzminov A., 2011, ECOSAL ESCHERICHIA C, DOI [10.1128/ecosal.7.2.6, DOI 10.1128/ECOSAL.7.2.6]; Limoli CL, 1997, CANCER RES, V57, P4048; Long DT, 2008, P NATL ACAD SCI USA, V105, P6852, DOI 10.1073/pnas.0711999105; Long DT, 2009, EMBO REP, V10, P394, DOI 10.1038/embor.2009.13; MAGEE TR, 1990, J BACTERIOL, V172, P1834, DOI 10.1128/jb.172.4.1834-1839.1990; MARSDEN HS, 1974, J BACTERIOL, V118, P465, DOI 10.1128/JB.118.2.465-470.1974; Michel B, 1997, EMBO J, V16, P430, DOI 10.1093/emboj/16.2.430; Michel B, 2007, DNA REPAIR, V6, P967, DOI 10.1016/j.dnarep.2007.02.016; Miller J.H., 1972, EXPT MOL GENETICS; Miranda A, 2003, GENETICS, V163, P1255; MORGAN AR, 1990, J THEOR BIOL, V144, P195, DOI 10.1016/S0022-5193(05)80318-2; OTSUJI N, 1974, J BACTERIOL, V117, P337, DOI 10.1128/JB.117.2.337-344.1974; Pierce AJ, 2001, TRENDS CELL BIOL, V11, pS52, DOI 10.1016/S0962-8924(01)02149-3; Pohlhaus JR, 2008, J BACTERIOL, V190, P5239, DOI 10.1128/JB.00173-08; PRELL A, 1980, EUR J BIOCHEM, V105, P109, DOI 10.1111/j.1432-1033.1980.tb04480.x; Rass K, 2008, ADV EXP MED BIOL, V624, P162, DOI 10.1007/978-0-387-77574-6_13; RESNICK MA, 1976, J THEOR BIOL, V59, P97, DOI 10.1016/S0022-5193(76)80025-2; RINKEN R, 1992, J BACTERIOL, V174, P1172, DOI 10.1128/jb.174.4.1172-1178.1992; RINKEN R, 1992, J BACTERIOL, V174, P5424, DOI 10.1128/JB.174.16.5424-5429.1992; Rossi MJ, 2011, P NATL ACAD SCI USA, V108, P6432, DOI 10.1073/pnas.1016072108; Rothkamm K, 2002, INT J ONCOL, V21, P433; Rudolph CJ, 2007, GENE DEV, V21, P668, DOI 10.1101/gad.417607; RUPP WD, 1968, J MOL BIOL, V31, P291, DOI 10.1016/0022-2836(68)90445-2; SCHIESTL R, 1983, MOL GEN GENET, V191, P59, DOI 10.1007/BF00330890; SCHNIPPER LE, 1989, CANCER RES, V49, P6640; SEDGWICK SG, 1975, J BACTERIOL, V123, P154, DOI 10.1128/JB.123.1.154-161.1975; Seigneur M, 2000, MOL MICROBIOL, V38, P565, DOI 10.1046/j.1365-2958.2000.02152.x; Seigneur M, 1998, CELL, V95, P419, DOI 10.1016/S0092-8674(00)81772-9; Seigneur M, 1997, MOL MICROBIOL, V26, P569, DOI 10.1046/j.1365-2958.1997.6021977.x; TAYLOR AF, 1985, J MOL BIOL, V185, P431, DOI 10.1016/0022-2836(85)90414-0; Thoms B, 1998, J BACTERIOL, V180, P5639, DOI 10.1128/JB.180.21.5639-5645.1998; Vilenchik MM, 2003, P NATL ACAD SCI USA, V100, P12871, DOI 10.1073/pnas.2135498100; WANG TCV, 1983, J BACTERIOL, V156, P1093, DOI 10.1128/JB.156.3.1093-1098.1983; WANG TV, 1986, MUTAT RES, V165, P39, DOI 10.1016/0167-8817(86)90007-6; West SC, 1997, ANNU REV GENET, V31, P213, DOI 10.1146/annurev.genet.31.1.213; WILLETTS NS, 1969, J BACTERIOL, V100, P231, DOI 10.1128/JB.100.1.231-239.1969; YI TM, 1988, J BACTERIOL, V170, P2898, DOI 10.1128/jb.170.7.2898-2903.1988	78	43	46	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6250	6265		10.1074/jbc.M111.322990	http://dx.doi.org/10.1074/jbc.M111.322990			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22194615	hybrid, Green Published			2022-12-27	WOS:000300791800018
J	Feng, Y; Mckee, K; Tran, K; O'Dell, S; Schmidt, SD; Phogat, A; Forsell, MN; Hedestam, GBK; Mascola, JR; Wyatt, RT				Feng, Yu; Mckee, Krisha; Tran, Karen; O'Dell, Sijy; Schmidt, Stephen D.; Phogat, Adhuna; Forsell, Mattias N.; Hedestam, Gunilla B. Karlsson; Mascola, John R.; Wyatt, Richard T.			Biochemically Defined HIV-1 Envelope Glycoprotein Variant Immunogens Display Differential Binding and Neutralizing Specificities to the CD4-binding Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; B-CELL RESPONSES; SUBTYPE-C; ANTIBODY-SPECIFICITIES; MONOCLONAL-ANTIBODIES; OLIGOMERIC STRUCTURE; GP120 GLYCOPROTEINS; IMMUNE-RESPONSES; ENV CLONES; RECEPTOR	HIV-1 gp120 binds the primary receptor CD4. Recently, a plethora of broadly neutralizing antibodies to the gp120 CD4-binding site (CD4bs) validated this region as a target for immunogen design. Here, we asked if modified HIV-1 envelope glycoproteins (Env) designed to increase CD4 recognition might improve recognition by CD4bs neutralizing antibodies and more efficiently elicit such reactivities. We also asked if CD4bs stabilization, coupled with altering the Env format (monomer to trimer or cross-clade), might better elicit neutralizing antibodies by focusing the immune response on the functionally conserved CD4bs. We produced monomeric and trimeric Envs stabilized by mutations within the gp120 CD4bs cavity (pocket-filling; PF2) or by appending heterologous trimerization motifs to soluble Env ectodomains (gp120/gp140). Recombinant glycoproteins were purified to relative homogeneity, and ligand binding properties were analyzed by ELISA, surface plasmon resonance, and isothermal titration microcalorimetry. In some formats, the PF2 substitutions increased CD4 affinity, and importantly, PF2-containing proteins were better recognized by the broadly neutralizing CD4bs mAbs, VRC01 and VRC-PG04. Based on this analysis, we immunized selected Env variants into rabbits using heterologous or homologous regimens. Analysis of the sera revealed that homologous inoculation of the PF2-containing, variable region-deleted YU2 gp120 trimers (Delta V123/PF2-GCN4) more rapidly elicited CD4bs-directed neutralizing antibodies compared with other regimens, whereas homologous trimers elicited increased neutralization potency, mapping predominantly to the gp120 third major variable region (V3). These results suggest that some engineered Env proteins may more efficiently direct responses toward the conserved CD4bs and be valuable to elicit antibodies of greater neutralizing capacity.	[Feng, Yu; Tran, Karen; Wyatt, Richard T.] Scripps Res Inst, Dept Immunol & Microbial Sci, IAVI Neutralizing Antibody Ctr, La Jolla, CA 92037 USA; [Mckee, Krisha; O'Dell, Sijy; Schmidt, Stephen D.; Phogat, Adhuna; Mascola, John R.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Hedestam, Gunilla B. Karlsson] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, SE-17177 Stockholm, Sweden; [Forsell, Mattias N.] Karolinska Inst, Dept Med, Translat Immunol Unit, SE-17177 Stockholm, Sweden	International AIDS Vaccine Initiative; Scripps Research Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Karolinska Institutet; Karolinska Institutet	Wyatt, RT (corresponding author), 10550 N Torrey Pines Rd, La Jolla, CA USA.	wyatt@scripps.edu	Feng, Yu/A-3396-2012; Hedestam, Gunilla Karlsson/AAN-9616-2021; Forsell, Mattias/L-9618-2016; Schmidt, Stephen/B-5398-2012; Mascola, John/AAI-7193-2021; Schmidt, Stephen/AAC-6967-2019	Forsell, Mattias/0000-0001-6904-742X; 	National Institutes of Health NIAID; International AIDS Vaccine Initiative; Bill and Melinda Gates Foundation; Swedish Research Council	National Institutes of Health NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); International AIDS Vaccine Initiative; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported, in whole or in part, by National Institutes of Health NIAID intramural research program. This work was also supported by the International AIDS Vaccine Initiative, the Bill and Melinda Gates Foundation, and the Swedish Research Council.	Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; Barnett SW, 1997, VACCINE, V15, P869, DOI 10.1016/S0264-410X(96)00264-2; Belshe RB, 1998, AIDS, V12, P2407, DOI 10.1097/00002030-199818000-00009; BERMAN PW, 1990, NATURE, V345, P622, DOI 10.1038/345622a0; Binley JM, 2008, J VIROL, V82, P11651, DOI 10.1128/JVI.01762-08; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chen L, 2009, SCIENCE, V326, P1123, DOI 10.1126/science.1175868; Ching L, 2010, J VIROL, V84, P9932, DOI 10.1128/JVI.00868-10; Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6; Connor RI, 1998, J VIROL, V72, P1552, DOI 10.1128/JVI.72.2.1552-1576.1998; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Dey AK, 2009, VIROLOGY, V385, P275, DOI 10.1016/j.virol.2008.12.009; Dey B, 2007, J VIROL, V81, P5579, DOI 10.1128/JVI.02500-06; Dey B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000445; Dhillon AK, 2007, J VIROL, V81, P6548, DOI 10.1128/JVI.02749-06; Doranz BJ, 1996, CELL, V85, P1149, DOI 10.1016/S0092-8674(00)81314-8; Douagi I, 2010, J VIROL, V84, P1683, DOI 10.1128/JVI.01896-09; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; EARL PL, 1994, J VIROL, V68, P3015, DOI 10.1128/JVI.68.5.3015-3026.1994; Earl PL, 2001, J VIROL, V75, P645, DOI 10.1128/JVI.75.2.645-653.2001; EARL PL, 1990, P NATL ACAD SCI USA, V87, P648, DOI 10.1073/pnas.87.2.648; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Forsell MNE, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000171; Furuta RA, 1998, NAT STRUCT BIOL, V5, P276, DOI 10.1038/nsb0498-276; Gao F, 2005, J VIROL, V79, P1154, DOI 10.1128/JVI.79.2.1154-1163.2005; Gray ES, 2009, J VIROL, V83, P8925, DOI 10.1128/JVI.00758-09; Grundner C, 2005, VIROLOGY, V331, P33, DOI 10.1016/j.virol.2004.09.022; He Y, 2003, J VIROL, V77, P1666, DOI 10.1128/JVI.77.3.1666-1671.2003; KLATZMANN D, 1984, NATURE, V312, P767, DOI 10.1038/312767a0; Koshiba T, 2003, J BIOL CHEM, V278, P7573, DOI 10.1074/jbc.M211154200; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Li M, 2006, J VIROL, V80, P11776, DOI 10.1128/JVI.01730-06; Li Y, 2006, J VIROL, V80, P1414, DOI 10.1128/JVI.80.3.1414-1426.2006; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; Li YX, 2009, J VIROL, V83, P1045, DOI 10.1128/JVI.01992-08; Liao HX, 2006, VIROLOGY, V353, P268, DOI 10.1016/j.virol.2006.04.043; LU M, 1995, NAT STRUCT BIOL, V2, P1075, DOI 10.1038/nsb1295-1075; Mascola JR, 2010, ANNU REV IMMUNOL, V28, P413, DOI 10.1146/annurev-immunol-030409-101256; Mascola JR, 2002, J VIROL, V76, P4810, DOI 10.1128/JVI.76.10.4810-4821.2002; Mascola JR, 1996, J INFECT DIS, V173, P340, DOI 10.1093/infdis/173.2.340; MCDOUGAL JS, 1986, SCIENCE, V231, P382, DOI 10.1126/science.3001934; Morner A, 2009, J VIROL, V83, P540, DOI 10.1128/JVI.01102-08; Nkolola JP, 2010, J VIROL, V84, P3270, DOI 10.1128/JVI.02252-09; Pancera M, 2005, J VIROL, V79, P9954, DOI 10.1128/JVI.79.15.9954-9969.2005; Pantophlet R, 2006, ANNU REV IMMUNOL, V24, P739, DOI 10.1146/annurev.immunol.24.021605.090557; PINTER A, 1989, J VIROL, V63, P2674, DOI 10.1128/JVI.63.6.2674-2679.1989; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Si ZH, 2004, P NATL ACAD SCI USA, V101, P5036, DOI 10.1073/pnas.0307953101; Srivastava IK, 2003, J VIROL, V77, P11244, DOI 10.1128/JVI.77.20.11244-11259.2003; Srivastava IK, 2008, VIROLOGY, V372, P273, DOI 10.1016/j.virol.2007.10.022; Sundling C, 2010, J EXP MED, V207, P2003, DOI 10.1084/jem.20100025; Trkola A, 1996, NATURE, V384, P184, DOI 10.1038/384184a0; Vaine M, 2008, J VIROL, V82, P7369, DOI 10.1128/JVI.00562-08; Vaine M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013916; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; WEISS CD, 1990, J VIROL, V64, P5674, DOI 10.1128/JVI.64.11.5674-5677.1990; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; WYATT R, 1995, J VIROL, V69, P5723, DOI 10.1128/JVI.69.9.5723-5733.1995; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Xiang SH, 2003, VIROLOGY, V315, P124, DOI 10.1016/S0042-6822(03)00521-X; Yang XZ, 2002, J VIROL, V76, P4634, DOI 10.1128/JVI.76.9.4634-4642.2002; Zhang CWH, 2001, J BIOL CHEM, V276, P39577, DOI 10.1074/jbc.M107147200; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580	70	49	49	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5673	5686		10.1074/jbc.M111.317776	http://dx.doi.org/10.1074/jbc.M111.317776			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22167180	Green Published, hybrid			2022-12-27	WOS:000300638000044
J	Lan, HC; Wu, CF; Shih, HM; Chung, BC				Lan, Hsin-Chieh; Wu, Chih-Feng; Shih, Hsiu-Ming; Chung, Bon-chu			Death-associated Protein 6 (Daxx) Mediates cAMP-dependent Stimulation of Cyp11a1 (P450scc) Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JUN NH2-TERMINAL KINASE; C-JUN; INTERACTING PROTEIN; STEROIDOGENIC FACTOR-1; SUMO MODIFICATION; INDUCED APOPTOSIS; BINDING PROTEIN; JNK ACTIVATION; CYCLIC-AMP; CELL-DEATH	SF-1 is a key transcription factor for all steroidogenic genes. It up-regulates the expression of the steroidogenic Cyp11a1 gene in the adrenal in a pathway stimulated by cAMP through HIPK3-mediated JNK/c-Jun phosphorylation. In the present study, we have investigated the factors mediating cAMP-dependent HIPK3 action to potentiate the activity of SF-1 for Cyp11a1 transcription in mouse adrenocortical Y1 cells. We found Daxx, a HIPK kinase substrate in the apoptosis pathway, was phosphorylated by HIPK3 at Ser-669 in response to cAMP stimulation. Daxx participated in SF-1-dependent Cyp11a1 expression as shown by experiments involving both overexpression and down-regulation via a dominant negative Daxx mutant. The S669A mutant of Daxx, which could not be phosphorylated by HIPK3, lost the ability to potentiate SF-1 activity for Cyp11a1 expression. The enhancement of SF-1 activity by Daxx required JNK and c-Jun phosphorylation. Thus, Daxx functioned as a signal transducer linking cAMP-stimulated HIPK3 activity with JNK/c-Jun phosphorylation and SF-1-dependent Cyp11a1 transcription for steroid synthesis.	[Lan, Hsin-Chieh; Wu, Chih-Feng; Chung, Bon-chu] Acad Sinica, Inst Mol Biol, Taipei 115, Taiwan; [Shih, Hsiu-Ming] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan; [Lan, Hsin-Chieh] Natl Def Med Ctr, Inst Biol & Anat, Taipei 114, Taiwan; [Wu, Chih-Feng; Chung, Bon-chu] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Defense Medical Center; National Yang Ming Chiao Tung University	Chung, BC (corresponding author), Acad Sinica, Inst Mol Biol, Taipei 115, Taiwan.	mbchung@sinica.edu.tw	Shih, Hsiu-Ming/S-7023-2018	Chung, Bon-chu/0000-0002-8612-0219	Academia Sinica, NHRI [NHRI-EX100-9710SI]; National Science Council [NSC100-2321-B-001-006]	Academia Sinica, NHRI; National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by grants from Academia Sinica, NHRI (NHRI-EX100-9710SI), and the National Science Council (NSC100-2321-B-001-006).	Auwerx J, 1999, CELL, V97, P161; Chang CC, 2011, MOL CELL, V42, P62, DOI 10.1016/j.molcel.2011.02.022; Chang HY, 1998, SCIENCE, V281, P1860, DOI 10.1126/science.281.5384.1860; Chen LY, 2003, MOL CELL BIOL, V23, P7108, DOI 10.1128/MCB.23.20.7108-7121.2003; Chen WY, 2005, MOL CELL BIOL, V25, P10442, DOI 10.1128/MCB.25.23.10442-10453.2005; Chen WY, 2004, J BIOL CHEM, V279, P38730, DOI 10.1074/jbc.M405006200; Ecsedy JA, 2003, MOL CELL BIOL, V23, P950, DOI 10.1128/MCB.23.3.950-960.2003; Guo IC, 2007, J BIOMED SCI, V14, P509, DOI 10.1007/s11373-007-9177-z; Hammer GD, 1999, MOL CELL, V3, P521, DOI 10.1016/S1097-2765(00)80480-3; Hofmann TG, 2003, CANCER RES, V63, P8271; Hu MC, 1999, ENDOCRINOLOGY, V140, P5609, DOI 10.1210/en.140.12.5609; HU MC, 1991, BIOCHEM J, V274, P813, DOI 10.1042/bj2740813; Khelifi AF, 2005, CELL DEATH DIFFER, V12, P724, DOI 10.1038/sj.cdd.4401559; Kim YH, 1998, J BIOL CHEM, V273, P25875, DOI 10.1074/jbc.273.40.25875; Kuo HY, 2005, P NATL ACAD SCI USA, V102, P16973, DOI 10.1073/pnas.0504460102; Lalioti VS, 2009, J CELL PHYSIOL, V218, P416, DOI 10.1002/jcp.21614; Lan HC, 2007, MOL CELL BIOL, V27, P2027, DOI 10.1128/MCB.02253-06; Li LA, 1999, MOL ENDOCRINOL, V13, P1588, DOI 10.1210/me.13.9.1588; Li QX, 2007, CANCER RES, V67, P66, DOI 10.1158/0008-5472.CAN-06-1671; Lin DY, 2006, MOL CELL, V24, P341, DOI 10.1016/j.molcel.2006.10.019; Lin DY, 2004, MOL CELL BIOL, V24, P10529, DOI 10.1128/MCB.24.24.10529-10541.2004; Luo XR, 1999, J STEROID BIOCHEM, V69, P13, DOI 10.1016/S0960-0760(98)00146-0; McDonough H, 2009, J BIOL CHEM, V284, P20649, DOI 10.1074/jbc.M109.011767; Meloni A, 2010, J BIOL CHEM, V285, P13012, DOI 10.1074/jbc.M109.037747; Michaelson JS, 2003, J CELL SCI, V116, P345, DOI 10.1242/jcs.00234; Michaelson JS, 1999, GENE DEV, V13, P1918, DOI 10.1101/gad.13.15.1918; Moilanen AM, 1998, MOL BIOL CELL, V9, P2527, DOI 10.1091/mbc.9.9.2527; Monte D, 1998, J BIOL CHEM, V273, P4585, DOI 10.1074/jbc.273.8.4585; Morozov VM, 2008, ONCOGENE, V27, P2177, DOI 10.1038/sj.onc.1210865; Perlman R, 2001, NAT CELL BIOL, V3, P708, DOI 10.1038/35087019; Rochat-Steiner V, 2000, J EXP MED, V192, P1165, DOI 10.1084/jem.192.8.1165; Shih MCM, 2011, MOL CELL ENDOCRINOL, V336, P80, DOI 10.1016/j.mce.2010.12.017; Song JJ, 2003, J BIOL CHEM, V278, P47245, DOI 10.1074/jbc.M213201200; Song JJ, 2004, J BIOL CHEM, V279, P30573, DOI 10.1074/jbc.M404512200; Tang J, 2006, NAT CELL BIOL, V8, P855, DOI 10.1038/ncb1442; Torii S, 1999, EMBO J, V18, P6037, DOI 10.1093/emboj/18.21.6037; Tournier C, 1997, P NATL ACAD SCI USA, V94, P7337, DOI 10.1073/pnas.94.14.7337; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; Tzeng SL, 2006, J BIOL CHEM, V281, P15405, DOI 10.1074/jbc.M601807200; Val Pierre, 2003, Nucl Recept, V1, P8, DOI 10.1186/1478-1336-1-8; Wethkamp N, 2009, J BIOL CHEM, V284, P28783, DOI 10.1074/jbc.M109.041186; Yang XL, 1997, CELL, V89, P1067, DOI 10.1016/S0092-8674(00)80294-9	42	9	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5910	5916		10.1074/jbc.M111.307603	http://dx.doi.org/10.1074/jbc.M111.307603			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22199361	Green Published, hybrid			2022-12-27	WOS:000300638000065
J	Luhovy, AY; Jaberi, A; Papillon, J; Guillemette, J; Cybulsky, AV				Luhovy, Artem Y.; Jaberi, Aala; Papillon, Joan; Guillemette, Julie; Cybulsky, Andrey V.			Regulation of the Ste20-like Kinase, SLK INVOLVEMENT OF ACTIVATION SEGMENT PHOSPHORYLATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GERMINAL CENTER KINASE; STE20-RELATED KINASE; PROTEIN-KINASES; MAP KINASES; APOPTOSIS; EXPRESSION; AUTOPHOSPHORYLATION; MECHANISM; DOMAIN; CELLS	Expression and activation of the Ste20-like kinase, SLK, is increased during kidney development and recovery from ischemic acute kidney injury. SLK promotes apoptosis, and it may regulate cell survival during injury or repair. This study addresses the role of phosphorylation in the regulation of kinase activity. We mutated serine and threonine residues in the putative activation segment of the SLK catalytic domain and expressed wild type (WT) and mutant proteins in COS-1 or glomerular epithelial cells. Compared with SLK WT, the T183A, S189A, and T183A/S189A mutants showed reduced in vitro kinase activity. SLK WT, but not mutants, increased activation-specific phosphorylation of c-Jun N-terminal kinase (JNK) and p38 kinase. Similarly, SLK WT stimulated activator protein-1 reporter activity, but activation of activator protein-1 by the three SLK mutants was ineffective. To test if homodimerization of SLK affects phosphorylation, the cDNA encoding SLK amino acids 1-373 (which include the catalytic domain) was fused with a cDNA for a modified FK506-binding protein, Fv (Fv-SLK 1-373). After transfection, the addition of AP20187 (an FK506 analog) induced regulated dimerization of Fv-SLK 1-373. AP20187-stimulated dimerization enhanced the kinase activity of Fv-SLK 1-373 WT. In contrast, kinase activity of Fv-SLK 1-373 T183A/S189A was weak and was not enhanced after dimerization. Finally, apoptosis was increased after expression of Fv-SLK 1-373 WT but not T183A/S189A. Thus, phosphorylation of Thr-183 and Ser-189 plays a key role in the activation and signaling of SLK and could represent a target for novel therapeutic approaches to renal injury.	[Luhovy, Artem Y.; Jaberi, Aala; Papillon, Joan; Guillemette, Julie; Cybulsky, Andrey V.] McGill Univ, Dept Med, McGill Univ Hlth Ctr, Montreal, PQ H3A 1A1, Canada	McGill University	Cybulsky, AV (corresponding author), Royal Victoria Hosp, Div Nephrol, 687 Pine Ave W, Montreal, PQ H3A 1A1, Canada.	andrey.cybulsky@mcgill.ca	Cybulsky, Andrey V./AAG-8238-2020; Jaberi, Aala/J-9239-2019	Cybulsky, Andrey V./0000-0003-4348-2348; Jaberi, Aala/0000-0003-0318-2826	Canadian Institutes of Health Research [MOP-53264, MOP-84213]; Kidney Foundation of Canada; Catherine McLaughlin Hakim Chair	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Kidney Foundation of Canada; Catherine McLaughlin Hakim Chair	This work was supported by Canadian Institutes of Health Research Grants MOP-53264 and MOP-84213 and the Kidney Foundation of Canada.; Supported by the Catherine McLaughlin Hakim Chair. To whom correspondence should be addressed: Division of Nephrology, Royal Victoria Hospital, 687 Pine Ave. W., Montreal, Quebec, Canada H3A 1A1. Tel.: 514-398-8148; Fax: 514-843-2815; E-mail: andrey.cybulsky@mcgill.ca.	Ali AS, 2009, CANCER TREAT REV, V35, P1, DOI 10.1016/j.ctrv.2008.07.006; Amara JF, 1997, P NATL ACAD SCI USA, V94, P10618, DOI 10.1073/pnas.94.20.10618; Burakov AV, 2008, MOL BIOL CELL, V19, P1952, DOI 10.1091/mbc.E06-12-1156; Chaar Z, 2006, J BIOL CHEM, V281, P28193, DOI 10.1074/jbc.M605665200; Chang David W, 2003, Sci STKE, V2003, pPL1, DOI 10.1126/stke.2003.167.pl1; Coers W, 1996, EXP NEPHROL, V4, P184; Corbit KC, 2003, J BIOL CHEM, V278, P13061, DOI 10.1074/jbc.M210015200; Cowley BD, 2008, KIDNEY INT, V73, P251, DOI 10.1038/sj.ki.5002695; Crabtree GR, 1996, TRENDS BIOCHEM SCI, V21, P418, DOI 10.1016/S0968-0004(96)20027-1; Cybulsky AV, 2007, AM J PHYSIOL-RENAL, V292, pF845, DOI 10.1152/ajprenal.00234.2006; Cybulsky AV, 2010, AM J PATHOL, V177, P2290, DOI 10.2353/ajpath.2010.100263; Cybulsky AV, 2009, AM J PHYSIOL-RENAL, V297, pF971, DOI 10.1152/ajprenal.00294.2009; Cybulsky AV, 2004, AM J PHYSIOL-RENAL, V286, pF16, DOI 10.1152/ajprenal.00144.2003; Dan I, 2001, TRENDS CELL BIOL, V11, P220, DOI 10.1016/S0962-8924(01)01980-8; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; De Chiara G, 2006, J BIOL CHEM, V281, P21353, DOI 10.1074/jbc.M511052200; Delarosa S, 2011, AM J PHYSIOL-RENAL, V301, pF554, DOI 10.1152/ajprenal.00062.2011; Delpire E, 2009, PFLUG ARCH EUR J PHY, V458, P953, DOI 10.1007/s00424-009-0674-y; Ellinger-Ziegelbauer H, 2000, GENES CELLS, V5, P491, DOI 10.1046/j.1365-2443.2000.00337.x; Guilluy C, 2008, CIRC RES, V102, P1265, DOI 10.1161/CIRCRESAHA.107.164764; Hao W, 2006, J BIOL CHEM, V281, P3075, DOI 10.1074/jbc.M511744200; Hassoun HT, 2009, AM J PHYSIOL-RENAL, V297, pF125, DOI 10.1152/ajprenal.90666.2008; Huber TB, 2001, J BIOL CHEM, V276, P41543, DOI 10.1074/jbc.C100452200; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; Lee SJ, 2009, PROTEIN SCI, V18, P304, DOI 10.1002/pro.27; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Li Y, 2009, PROTEIN SCI, V18, P678, DOI 10.1002/pro.98; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Muthuswamy SK, 1999, MOL CELL BIOL, V19, P6845; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; O'Reilly PG, 2005, J BIOL CHEM, V280, P42383, DOI 10.1074/jbc.M510763200; Oliver AW, 2007, TRENDS BIOCHEM SCI, V32, P351, DOI 10.1016/j.tibs.2007.06.004; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Paleologou KE, 2008, J BIOL CHEM, V283, P16895, DOI 10.1074/jbc.M800747200; Pike ACW, 2008, EMBO J, V27, P704, DOI 10.1038/emboj.2008.8; Pirruccello M, 2006, J MOL BIOL, V361, P312, DOI 10.1016/j.jmb.2006.06.017; Rinschen MM, 2010, P NATL ACAD SCI USA, V107, P3882, DOI 10.1073/pnas.0910646107; Roovers K, 2009, ONCOGENE, V28, P2839, DOI 10.1038/onc.2009.146; Sabourin LA, 2000, MOL CELL BIOL, V20, P684, DOI 10.1128/MCB.20.2.684-696.2000; Sabourin LA, 1999, ONCOGENE, V18, P7566, DOI 10.1038/sj.onc.1203119; Scheeff ED, 2005, PLOS COMPUT BIOL, V1, P359, DOI 10.1371/journal.pcbi.0010049; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Wagner S, 2002, J BIOL CHEM, V277, P37685, DOI 10.1074/jbc.M205899200; Weintz G, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.29; Yamada E, 2000, BBA-MOL CELL RES, V1495, P250, DOI 10.1016/S0167-4889(99)00164-0; Zhang YH, 2002, DEV BRAIN RES, V139, P205, DOI 10.1016/S0165-3806(02)00551-5; ZHAO ZS, 1995, MOL CELL BIOL, V15, P5246; Zinovkina LA, 1997, FEBS LETT, V414, P135, DOI 10.1016/S0014-5793(97)00952-6	49	16	16	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5446	5458		10.1074/jbc.M111.302018	http://dx.doi.org/10.1074/jbc.M111.302018			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22203681	Green Published, hybrid			2022-12-27	WOS:000300638000025
J	Naydenov, NG; Harris, G; Brown, B; Schaefer, KL; Das, SK; Fisher, PB; Ivanov, AI				Naydenov, Nayden G.; Harris, Gianni; Brown, Bryan; Schaefer, Katherine L.; Das, Swadesh K.; Fisher, Paul B.; Ivanov, Andrei I.			Loss of Soluble N-Ethylmaleimide-sensitive Factor Attachment Protein alpha (alpha SNAP) Induces Epithelial Cell Apoptosis via Down-regulation of Bcl-2 Expression and Disruption of the Golgi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; MEMBRANE-FUSION; SECRETORY PATHWAY; CANCER-CELLS; APICAL JUNCTIONS; COPI VESICLES; SYNTAXIN 5; DEATH; NSF; ER	Intracellular trafficking represents a key mechanism that regulates cell fate by participating in either prodeath or prosurvival signaling. Soluble N-ethylmaleimide-sensitive factor (NSF) attachment protein alpha (alpha SNAP) is a well known component of vesicle trafficking machinery that mediates intermembrane fusion. alpha SNAP increases cell resistance to cytotoxic stimuli, although mechanisms of its prosurvival function are poorly understood. In this study, we found that either siRNA-mediated knockdown of alpha SNAP or expression of its dominant negative mutant induced epithelial cell apoptosis. Apoptosis was not caused by activation of the major prodeath regulators Bax and p53 and was independent of a key alpha SNAP binding partner, NSF. Instead, death of alpha SNAP-depleted cells was accompanied by down-regulation of the antiapoptotic Bcl-2 protein; it was mimicked by inhibition and attenuated by overexpression of Bcl-2. Knockdown of alpha SNAP resulted in impairment of Golgi to endoplasmic reticulum (ER) trafficking and fragmentation of the Golgi. Moreover, pharmacological disruption of ER-Golgi transport by brefeldin A and eeyarestatin 1 or siRNA-mediated depletion of an ER/Golgi-associated p97 ATPase recapitulated the effects of alpha SNAP inhibition by decreasing Bcl-2 level and triggering apoptosis. These results reveal a novel role for alpha SNAP in promoting epithelial cell survival by unique mechanisms involving regulation of Bcl-2 expression and Golgi biogenesis.	[Ivanov, Andrei I.] Univ Rochester, Dept Med, Med Ctr, Rochester, NY 14642 USA; [Das, Swadesh K.; Fisher, Paul B.] Virginia Commonwealth Univ, Dept Human & Mol Genet, VCU Inst Mol Med, Sch Med, Richmond, VA 23298 USA; [Das, Swadesh K.; Fisher, Paul B.] Virginia Commonwealth Univ, VCU Massey Canc Ctr, Sch Med, Richmond, VA 23298 USA	University of Rochester; Virginia Commonwealth University; Virginia Commonwealth University	Ivanov, AI (corresponding author), Univ Rochester, Dept Med, Med Ctr, 601 Elmwood Ave,Box 646, Rochester, NY 14642 USA.	Andrei_Ivanov@urmc.rochester.edu	Ivanov, Andrei/V-1672-2019		National Institutes of Health [RO1 DK083968, R01 DK084953, R01 CA97318, P01 CA104177]; NATIONAL CANCER INSTITUTE [P01CA104177, R01CA097318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083968, R01DK084953] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 DK083968 and R01 DK084953 (to A. I. I.) and R01 CA97318 and P01 CA104177 (to P. B. F.).	Akdis CA, 2004, CURR OPIN IMMUNOL, V16, P717, DOI 10.1016/j.coi.2004.09.004; Aletrari MO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022713; Andreeva AV, 2006, EXPERT OPIN THER TAR, V10, P723, DOI 10.1517/14728222.10.5.723; Aoki T, 2008, BIOCHEM J, V410, P93, DOI 10.1042/BJ20071304; Aslan JE, 2009, TRAFFIC, V10, P1390, DOI 10.1111/j.1600-0854.2009.00951.x; Babcock M, 2004, J NEUROSCI, V24, P3964, DOI 10.1523/JNEUROSCI.5259-03.2004; Barnard RJO, 1997, J CELL BIOL, V139, P875, DOI 10.1083/jcb.139.4.875; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; BOYD JM, 1994, CELL, V79, P341, DOI 10.1016/0092-8674(94)90202-X; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Burgoyne RD, 1998, BIOESSAYS, V20, P328, DOI 10.1002/(SICI)1521-1878(199804)20:4<328::AID-BIES9>3.0.CO;2-L; Capitani M, 2009, FEBS LETT, V583, P3863, DOI 10.1016/j.febslet.2009.10.053; Chae TH, 2004, NAT GENET, V36, P264, DOI 10.1038/ng1302; Chen CL, 2011, TRAFFIC, V12, P1327, DOI 10.1111/j.1600-0854.2011.01245.x; Chen LZ, 2002, NEUROCHEM RES, V27, P891, DOI 10.1023/A:1020387414086; Citterio C, 2008, P NATL ACAD SCI USA, V105, P2877, DOI 10.1073/pnas.0712224105; Cotter TG, 2009, NAT REV CANCER, V9, P501, DOI 10.1038/nrc2663; Dalal S, 2004, MOL BIOL CELL, V15, P637, DOI 10.1091/mbc.E03-02-0097; Degterev A, 2008, NAT REV MOL CELL BIO, V9, P378, DOI 10.1038/nrm2393; Ferland RJ, 2009, HUM MOL GENET, V18, P497, DOI 10.1093/hmg/ddn377; Fernandez-Ulibarri I, 2007, MOL BIOL CELL, V18, P3250, DOI 10.1091/mbc.E07-04-0334; Ferri KF, 2001, NAT CELL BIOL, V3, pE255, DOI 10.1038/ncb1101-e255; Foger N, 2009, FEBS J, V276, P4256, DOI 10.1111/j.1742-4658.2009.07134.x; Fu Y, 2007, CANCER RES, V67, P3734, DOI 10.1158/0008-5472.CAN-06-4594; Galluzzi L, 2009, CELL DEATH DIFFER, V16, P1093, DOI 10.1038/cdd.2009.44; Guicciardi ME, 2009, FASEB J, V23, P1625, DOI 10.1096/fj.08-111005; Ho YHS, 2009, BIOCHEM BIOPH RES CO, V387, P371, DOI 10.1016/j.bbrc.2009.07.028; Hong WJ, 2005, BBA-MOL CELL RES, V1744, P120, DOI 10.1016/j.bbamcr.2005.03.014; Hotchkiss RS, 2006, NAT REV IMMUNOL, V6, P813, DOI 10.1038/nri1943; Ivanov AI, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000658; Ivanov AI, 2010, AM J PATHOL, V176, P134, DOI 10.2353/ajpath.2010.090220; Jackson C L, 2000, Subcell Biochem, V34, P233; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Joshi A, 2011, J BIOL CHEM, V286, P29861, DOI 10.1074/jbc.M111.241521; Kano F, 2005, GENES CELLS, V10, P989, DOI 10.1111/j.1365-2443.2005.00894.x; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Landry MC, 2009, MOL BIOL CELL, V20, P4091, DOI 10.1091/mbc.E09-01-0057; Lebedeva IV, 2003, ONCOGENE, V22, P8758, DOI 10.1038/sj.onc.1206891; LEBIVIC A, 1989, P NATL ACAD SCI USA, V86, P9313; Lipschutz JH, 2003, J BIOL CHEM, V278, P20954, DOI 10.1074/jbc.M213210200; Maag RS, 2003, CURR OPIN CELL BIOL, V15, P456, DOI 10.1016/S0955-0674(03)00075-9; Malsam J, 2008, CELL MOL LIFE SCI, V65, P2814, DOI 10.1007/s00018-008-8352-3; Marash L, 2008, MOL CELL, V30, P447, DOI 10.1016/j.molcel.2008.03.018; Martin HGS, 2006, J CELL BIOCHEM, V99, P1203, DOI 10.1002/jcb.20998; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Nakajima K, 2004, EMBO J, V23, P3216, DOI 10.1038/sj.emboj.7600333; Naydenov NG, 2010, MOL BIOL CELL, V21, P3506, DOI 10.1091/mbc.E10-03-0259; Perrotta C, 2010, J BIOL CHEM, V285, P40240, DOI 10.1074/jbc.M110.139287; Peter F, 1998, J CELL SCI, V111, P2625; Pulvirenti T, 2008, NAT CELL BIOL, V10, P912, DOI 10.1038/ncb1751; Rabouille C, 1998, CELL, V92, P603, DOI 10.1016/S0092-8674(00)81128-9; Reddy RK, 2003, J BIOL CHEM, V278, P20915, DOI 10.1074/jbc.M212328200; Reed JC, 1998, ONCOGENE, V17, P3225, DOI 10.1038/sj.onc.1202591; RIPLEY CR, 1993, J BIOL CHEM, V268, P3677; Rosales KR, 2009, MOL BIOL CELL, V20, P2831, DOI 10.1091/mbc.E08-09-0911; Roy L, 2000, MOL BIOL CELL, V11, P2529, DOI 10.1091/mbc.11.8.2529; Schutze S, 2008, NAT REV MOL CELL BIO, V9, P655, DOI 10.1038/nrm2430; Sherrill KW, 2004, J BIOL CHEM, V279, P29066, DOI 10.1074/jbc.M402727200; Stauber T, 2006, CURR BIOL, V16, P2245, DOI 10.1016/j.cub.2006.09.060; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Uemura T, 2009, MOL CELL BIOL, V29, P1869, DOI 10.1128/MCB.01089-08; Ungar D, 2003, ANNU REV CELL DEV BI, V19, P493, DOI 10.1146/annurev.cellbio.19.110701.155609; Verrier SE, 2008, EUR J CELL BIOL, V87, P863, DOI 10.1016/j.ejcb.2008.07.003; Viana RJS, 2010, CNS NEUROL DISORD-DR, V9, P679; Wang JL, 2000, P NATL ACAD SCI USA, V97, P7124, DOI 10.1073/pnas.97.13.7124; Wang QY, 2008, J BIOL CHEM, V283, P7445, DOI 10.1074/jbc.M708347200; Whiteheart SW, 2001, INT REV CYTOL, V207, P71; WHITEHEART SW, 1994, J CELL BIOL, V126, P945, DOI 10.1083/jcb.126.4.945; Winter U, 2009, J BIOL CHEM, V284, P31817, DOI 10.1074/jbc.M109.045286; Wu ZZ, 2010, BIOCHEM PHARMACOL, V80, P827, DOI 10.1016/j.bcp.2010.05.026; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhang L, 2000, SCIENCE, V290, P989, DOI 10.1126/science.290.5493.989; Zhang YH, 2008, J BIOL CHEM, V283, P30689, DOI 10.1074/jbc.M801711200	74	27	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5928	5941		10.1074/jbc.M111.278358	http://dx.doi.org/10.1074/jbc.M111.278358			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22194596	Green Published, hybrid			2022-12-27	WOS:000300638000067
J	Song, HW; Wohltmann, M; Tan, M; Bao, SZ; Ladenson, JH; Turk, J				Song, Haowei; Wohltmann, Mary; Tan, Min; Bao, Shunzhong; Ladenson, Jack H.; Turk, John			Group VIA PLA(2) (iPLA(2)beta) Is Activated Upstream of p38 Mitogen-activated Protein Kinase (MAPK) in Pancreatic Islet beta-Cell Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDEPENDENT PHOSPHOLIPASE A(2); ENDOPLASMIC-RETICULUM STRESS; ARACHIDONIC-ACID RELEASE; TYPE-2 DIABETES-MELLITUS; MECHANISM-BASED DISCRIMINATION; INSULIN SECRETORY RESPONSES; GLUCOSE-INDUCED ACTIVATION; TANDEM MASS-SPECTROMETRY; SMOOTH-MUSCLE-CELLS; K+ CHANNELS	Group VIA phospholipase A(2) (iPLA(2)beta) in pancreatic islet beta-cells participates in glucose-stimulated insulin secretion and sarco(endo) plasmic reticulum ATPase (SERCA) inhibitor-induced apoptosis, and both are attenuated by pharmacologic or genetic reductions in iPLA(2)beta activity and amplified by iPLA(2)beta overexpression. While exploring signaling events that occur downstream of iPLA(2)beta activation, we found that p38 MAPK is activated by phosphorylation in INS-1 insulinoma cells and mouse pancreatic islets, that this increases with iPLA(2)beta expression level, and that it is stimulated by the iPLA(2)beta reaction product arachidonic acid. The insulin secretagogue D-glucose also stimulates beta-cell p38 MAPK phosphorylation, and this is prevented by the iPLA(2)beta inhibitor bromoenol lactone. Insulin secretion induced by D-glucose and forskolin is amplified by overexpressing iPLA(2)beta in INS-1 cells and in mouse islets, and the p38 MAPK inhibitor PD169316 prevents both responses. The SERCA inhibitor thapsigargin also stimulates phosphorylation of both beta-cell MAPK kinase isoforms and p38 MAPK, and bromoenol lactone prevents both events. Others have reported that iPLA(2)beta products activate Rho family G-proteins that promote MAPK kinase activation via a mechanism inhibited by Clostridium difficile toxin B, which we find to inhibit thapsigargin-induced beta-cell p38 MAPK phosphorylation. Thapsigargin-induced beta-cell apoptosis and ceramide generation are also prevented by the p38 MAPK inhibitor PD169316. These observations indicate that p38 MAPK is activated downstream of iPLA(2)beta in beta-cells incubated with insulin secretagogues or thapsigargin, that this requires prior iPLA(2)beta activation, and that p38 MAPK is involved in the beta-cell functional responses of insulin secretion and apoptosis in which iPLA(2)beta participates.	[Song, Haowei; Wohltmann, Mary; Tan, Min; Bao, Shunzhong; Turk, John] Washington Univ, Sch Med, Dept Med, Div Endocrinol Metab & Lipid Res, St Louis, MO 63110 USA; [Ladenson, Jack H.] Washington Univ, Sch Med, Dept Pathol & Immunol, Div Lab & Genom Med, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Turk, J (corresponding author), Washington Univ, Sch Med, Dept Med, Div Endocrinol Metab & Lipid Res, Campus Box 8127,660 S Euclid Ave, St Louis, MO 63110 USA.	jturk@DOM.wustl.edu			National Institutes of Health United States Public Health Service [R37-DK34388, P41-RR00954, P60-DK20579, P30-DK56341]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341, R37DK034388, P60DK020579, P30DK020579] Funding Source: NIH RePORTER	National Institutes of Health United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health United States Public Health Service Grants R37-DK34388, P41-RR00954, P60-DK20579, and P30-DK56341.	Araki E, 2003, EXP BIOL MED, V228, P1213, DOI 10.1177/153537020322801018; ARKHAMMAR P, 1987, J BIOL CHEM, V262, P5448; ASHCROFT SJH, 1980, DIABETOLOGIA, V18, P5, DOI 10.1007/BF01228295; BAGRODIA S, 1995, J BIOL CHEM, V270, P27995; Bao S, 2008, AM J PHYSIOL-ENDOC M, V294, pE217, DOI 10.1152/ajpendo.00474.2007; Bao S, 2007, J BIOL CHEM, V282, P27100, DOI 10.1074/jbc.M701316200; Bao SZ, 2006, J BIOL CHEM, V281, P20958, DOI 10.1074/jbc.M600075200; Bao SZ, 2006, J BIOL CHEM, V281, P187, DOI 10.1074/jbc.M509105200; Bordin S, 2003, J IMMUNOL, V170, P667, DOI 10.4049/jimmunol.170.2.667; BROWN LJ, 1994, J BIOL CHEM, V269, P14363; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Cheng H, 2002, J CELL PHYSIOL, V192, P234, DOI 10.1002/jcp.10134; COOK DL, 1984, NATURE, V311, P271, DOI 10.1038/311271a0; Dukes I. D., 1997, CURR OPIN ENDOCRINOL, V4, P262; DUNLOP ME, 1984, BIOCHEM BIOPH RES CO, V120, P820, DOI 10.1016/S0006-291X(84)80180-1; Easom RA, 1999, DIABETES, V48, P675, DOI 10.2337/diabetes.48.4.675; Eto K, 1999, SCIENCE, V283, P981, DOI 10.1126/science.283.5404.981; GARVEY WT, 1992, DIABETES CARE, V15, P396, DOI 10.2337/diacare.15.3.396; Gerich JE, 1998, ENDOCR REV, V19, P491, DOI 10.1210/er.19.4.491; GHOSH A, 1991, J BIOL CHEM, V266, P22887; Gilon P, 1999, J BIOL CHEM, V274, P20197, DOI 10.1074/jbc.274.29.20197; GROSS RW, 1993, BIOCHEMISTRY-US, V32, P327, DOI 10.1021/bi00052a041; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; HAZEN SL, 1991, J BIOL CHEM, V266, P7227; Hii CST, 1998, J BIOL CHEM, V273, P19277, DOI 10.1074/jbc.273.30.19277; Hossain P, 2007, NEW ENGL J MED, V356, P213, DOI 10.1056/NEJMp068177; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Hsu FF, 2002, J AM SOC MASS SPECTR, V13, P558, DOI 10.1016/S1044-0305(02)00358-6; Hsu FF, 2002, J AM SOC MASS SPECTR, V13, P680, DOI 10.1016/S1044-0305(02)00362-8; Jacobson DA, 2007, CELL METAB, V6, P229, DOI 10.1016/j.cmet.2007.07.010; Jacobson DA, 2007, J BIOL CHEM, V282, P7442, DOI 10.1074/jbc.M607858200; Jenkins CM, 2002, J BIOL CHEM, V277, P32807, DOI 10.1074/jbc.M202568200; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; Kahn BB, 1998, CELL, V92, P593, DOI 10.1016/S0092-8674(00)81125-3; KAKEI M, 1986, FEBS LETT, V208, P63, DOI 10.1016/0014-5793(86)81533-2; Khaled AR, 2001, MOL CELL BIOL, V21, P7545, DOI 10.1128/MCB.21.22.7545-7557.2001; Kienesberger PC, 2009, J LIPID RES, V50, pS63, DOI 10.1194/jlr.R800082-JLR200; KLOPPEL G, 1985, SURV SYN PATHOL RES, V4, P110; Laing SP, 2003, DIABETOLOGIA, V46, P760, DOI 10.1007/s00125-003-1116-6; LAYCHOCK SG, 1982, CELL CALCIUM, V3, P43, DOI 10.1016/0143-4160(82)90036-7; Lei XY, 2007, BIOCHEMISTRY-US, V46, P10170, DOI 10.1021/bi700017z; Lei XY, 2010, J BIOL CHEM, V285, P6693, DOI 10.1074/jbc.M109.084293; Lei XY, 2008, J BIOL CHEM, V283, P34819, DOI 10.1074/jbc.M807409200; Ma YJ, 2002, J MOL BIOL, V318, P1351, DOI 10.1016/S0022-2836(02)00234-6; Ma ZM, 2001, J BIOL CHEM, V276, P13198, DOI 10.1074/jbc.M010423200; Ma ZM, 1999, J BIOL CHEM, V274, P9607, DOI 10.1074/jbc.274.14.9607; Ma ZM, 1997, J BIOL CHEM, V272, P11118; MACDONALD MJ, 1995, J BIOL CHEM, V270, P20051; Mahler RJ, 1999, J CLIN ENDOCR METAB, V84, P1165, DOI 10.1210/jc.84.4.1165; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; MARTIN GA, 1995, EMBO J, V14, P1970, DOI 10.1002/j.1460-2075.1995.tb07189.x; MATSCHINSKY FM, 1990, DIABETES, V39, P647, DOI 10.2337/diabetes.39.6.647; McDonald P, 2007, AM J PHYSIOL-CELL PH, V292, pC1216, DOI 10.1152/ajpcell.00467.2006; MEGLASSON M D, 1986, Diabetes Metabolism Reviews, V2, P163; METZ SA, 1991, DIABETES, V40, P1565, DOI 10.2337/diabetes.40.12.1565; MISLER S, 1992, DIABETES, V41, P662, DOI 10.2337/diabetes.41.6.662; Moon SH, 2008, J BIOL CHEM, V283, P33975, DOI 10.1074/jbc.M805817200; Moran JM, 2005, J BIOL CHEM, V280, P28162, DOI 10.1074/jbc.M500013200; Nikolic DM, 2007, J BIOL CHEM, V282, P33405, DOI 10.1074/jbc.M704133200; Nowatzke W, 1998, ENDOCRINOLOGY, V139, P4073, DOI 10.1210/en.139.10.4073; Ogden CL, 2010, JAMA-J AM MED ASSOC, V303, P242, DOI 10.1001/jama.2009.2012; Owada S, 1999, J BIOL CHEM, V274, P2000, DOI 10.1074/jbc.274.4.2000; Oyadomari S, 2002, APOPTOSIS, V7, P335, DOI 10.1023/A:1016175429877; Park KS, 2006, SCIENCE, V313, P976, DOI 10.1126/science.1124254; Poitout V, 2008, AM J PHYSIOL-ENDOC M, V294, pE214, DOI 10.1152/ajpendo.00638.2007; PRENTKI M, 1987, PHYSIOL REV, V67, P1185, DOI 10.1152/physrev.1987.67.4.1185; RAMANADHAM S, 1993, BIOCHEMISTRY-US, V32, P337, DOI 10.1021/bi00052a042; Ramanadham S, 2004, BIOCHEMISTRY-US, V43, P918, DOI 10.1021/bi035536m; Ramanadham S, 2003, BIOCHEMISTRY-US, V42, P13929, DOI 10.1021/bi034843p; Ramanadham S, 1999, J BIOL CHEM, V274, P13915, DOI 10.1074/jbc.274.20.13915; RAMANADHAM S, 1992, BIOCHEM BIOPH RES CO, V184, P647, DOI 10.1016/0006-291X(92)90638-2; Ramanadham S, 1997, BBA-LIPID LIPID MET, V1344, P153, DOI 10.1016/S0005-2760(96)00139-7; RAMANADHAM S, 1994, BIOCHEMISTRY-US, V33, P7442, DOI 10.1021/bi00189a052; Rao RV, 2004, CELL DEATH DIFFER, V11, P372, DOI 10.1038/sj.cdd.4401378; Ravier MA, 2000, J BIOL CHEM, V275, P1587, DOI 10.1074/jbc.275.3.1587; Redman PT, 2007, P NATL ACAD SCI USA, V104, P3568, DOI 10.1073/pnas.0610159104; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sato Y, 1999, ENDOCRINOLOGY, V140, P2252, DOI 10.1210/en.140.5.2252; Seino S, 2005, PHYSIOL REV, V85, P1303, DOI 10.1152/physrev.00001.2005; Seleznev K, 2006, J BIOL CHEM, V281, P22275, DOI 10.1074/jbc.M604330200; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Simonsson E, 2000, INT J PANCREATOL, V27, P1, DOI 10.1385/IJGC:27:1:01; Song HW, 2010, J BIOL CHEM, V285, P33843, DOI 10.1074/jbc.M110.153197; Song HW, 2010, AM J PHYSIOL-ENDOC M, V298, pE1097, DOI 10.1152/ajpendo.00780.2009; Song HW, 2006, BIOCHEMISTRY-US, V45, P1061, DOI 10.1021/bi052065q; Song K, 2005, MOL ENDOCRINOL, V19, P504, DOI 10.1210/me.2004-0169; STEFAN Y, 1982, DIABETES, V31, P694, DOI 10.2337/diabetes.31.8.694; Sun B, 2010, BIOCHEM PHARMACOL, V79, P1727, DOI 10.1016/j.bcp.2010.02.005; Talukdar I, 2005, J BIOL CHEM, V280, P40660, DOI 10.1074/jbc.M505531200; Thams P, 1997, BIOCHEM PHARMACOL, V53, P1077, DOI 10.1016/S0006-2952(96)00813-1; Tibbles LA, 1996, EMBO J, V15, P7026, DOI 10.1002/j.1460-2075.1996.tb01094.x; Tiran Z, 2003, J BIOL CHEM, V278, P17509, DOI 10.1074/jbc.M212766200; Turk J, 2004, CAN J PHYSIOL PHARM, V82, P824, DOI 10.1139/Y04-064; TURK J, 1992, BIOCHIM BIOPHYS ACTA, V1125, P280, DOI 10.1016/0005-2760(92)90057-3; Weyer C, 1999, J CLIN INVEST, V104, P787, DOI 10.1172/JCI7231; WOLF BA, 1991, BIOCHEMISTRY-US, V30, P6372, DOI 10.1021/bi00240a004; WOLF BA, 1986, J BIOL CHEM, V261, P3501; Wolf MJ, 1997, J BIOL CHEM, V272, P1522, DOI 10.1074/jbc.272.3.1522; Wollheim CB, 2000, DIABETOLOGIA, V43, P265, DOI 10.1007/s001250050044; Xie Z, 2007, J BIOL CHEM, V282, P25278, DOI 10.1074/jbc.M611206200; Xie ZW, 2010, J BIOL CHEM, V285, P8628, DOI 10.1074/jbc.M109.057711; Yajima H, 1999, DIABETES, V48, P1006, DOI 10.2337/diabetes.48.5.1006; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257; ZHANG SJ, 1995, J BIOL CHEM, V270, P23934, DOI 10.1074/jbc.270.41.23934; Zhao ZS, 2010, ENDOCRINOLOGY, V151, P3038, DOI 10.1210/en.2010-0016; ZUPAN LA, 1993, J MED CHEM, V36, P95, DOI 10.1021/jm00053a012	107	21	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5528	5541		10.1074/jbc.M111.285114	http://dx.doi.org/10.1074/jbc.M111.285114			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22194610	hybrid, Green Published			2022-12-27	WOS:000300638000032
J	Cho, CC; Su, LH; Huang, YC; Pan, YJ; Sun, CH				Cho, Chao-Cheng; Su, Li-Hsin; Huang, Yu-Chang; Pan, Yu-Jiao; Sun, Chin-Hung			Regulation of a Myb Transcription Factor by Cyclin-dependent Kinase 2 in Giardia lamblia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRRITABLE-BOWEL-SYNDROME; WALL PROTEIN GENES; CELL-CYCLE; CYST WALL; C-MYB; B-MYB; ACTIVATION; EXPRESSION; ENCYSTATION; DNA	The protozoan Giardia lamblia parasitizes the human small intestine to cause diseases. It undergoes differentiation into infectious cysts by responding to intestinal stimulation. How the activated signal transduction pathways relate to encystation stimulation remain largely unknown. During encystation, genes encoding cyst wall proteins (CWPs) are coordinately up-regulated by a Myb2 transcription factor. Because cell differentiation is linked to cell cycle regulation, we tried to understand the role of cell cycle regulators, cyclin-dependent kinases (Cdks), in encystation. We found that the recombinant Myb2 was phosphorylated by Cdk-associated complexes and the levels of phosphorylation increased significantly during encystation. We have identified a putative cdk gene (cdk2) by searching the Giardia genome database. Cdk2 was found to localize in the cytoplasm with higher expression during encystation. Interestingly, overexpression of Cdk2 resulted in a significant increase of the levels of cwp gene expression and cyst formation. In addition, the Cdk2-associated complexes can phosphorylate Myb2 and the levels of phosphorylation increased significantly during encystation. Mutations of important catalytic residues of Cdk2 resulted in a significant decrease of kinase activity and ability of inducing cyst formation. Addition of a Cdk inhibitor, purvalanol A, significantly decreased the Cdk2 kinase activity and the levels of cwp gene expression and cyst formation. Our results suggest that the Cdk2 pathway may be involved in phosphorylation of Myb2, leading to activation of the Myb2 function and up-regulation of cwp genes during encystation. The results provide insights into the use of Cdk inhibitory drugs in disruption of Giardia differentiation into cysts.	[Cho, Chao-Cheng; Su, Li-Hsin; Huang, Yu-Chang; Pan, Yu-Jiao; Sun, Chin-Hung] Natl Taiwan Univ, Dept Parasitol, Coll Med, Taipei 100, Taiwan	National Taiwan University	Sun, CH (corresponding author), Natl Taiwan Univ, Dept Parasitol, Coll Med, Taipei 100, Taiwan.	chinhsun@ntu.edu.tw	Shin, Jerry/AAO-2515-2021	SUN, CHIN-HUNG/0000-0002-8604-8085	National Science Council [NSC 98-2320-B-002-018-MY2, NSC 99-2320-B-002-017-MY3, NSC 100-2325-B-002039]; National Health Research Institutes in Taiwan [NHRI-EX98-9510NC, NHRI-EX99-9510NC]; Department of Medical Research in the National Taiwan University Hospital; National Taiwan University	National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institutes in Taiwan(National Health Research Institutes - Taiwan); Department of Medical Research in the National Taiwan University Hospital; National Taiwan University(National Taiwan University)	This work was supported by National Science Council Grants NSC 98-2320-B-002-018-MY2, NSC 99-2320-B-002-017-MY3, and NSC 100-2325-B-002039, National Health Research Institutes Grants NHRI-EX98-9510NC and NHRI-EX99-9510NC in Taiwan, the Department of Medical Research in the National Taiwan University Hospital, and the Aim for the Top University Program of the National Taiwan University.	Adam RD, 2001, CLIN MICROBIOL REV, V14, P447, DOI 10.1128/CMR.14.3.447-475.2001; Allen RD, 1999, GENE DEV, V13, P1073, DOI 10.1101/gad.13.9.1073; Ankarklev J, 2010, NAT REV MICROBIOL, V8, P413, DOI 10.1038/nrmicro2317; Ansieau S, 1997, J MOL MED-JMM, V75, P815, DOI 10.1007/s001090050170; Araki S, 2004, J BIOL CHEM, V279, P32979, DOI 10.1074/jbc.M403171200; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Banerjee S, 2006, FEMS MICROBIOL LETT, V256, P75, DOI 10.1111/j.1574-6968.2006.00105.x; Bennett JD, 1996, ONCOGENE, V13, P1073; Bernander R, 2001, CELL MICROBIOL, V3, P55, DOI 10.1046/j.1462-5822.2001.00094.x; Bessa M, 2001, ONCOGENE, V20, P3376, DOI 10.1038/sj.onc.1204439; Best AA, 2004, GENOME RES, V14, P1537, DOI 10.1101/gr.2256604; Carranza PG, 2010, MICROBES INFECT, V12, P71, DOI 10.1016/j.micinf.2009.09.008; Celiksoz A, 2005, PEDIATR INT, V47, P567, DOI 10.1111/j.1442-200x.2005.02110.x; Chen YH, 2008, INT J PARASITOL, V38, P1305, DOI 10.1016/j.ijpara.2008.02.006; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Chiappetta A, 2011, ANN BOT-LONDON, V107, P1223, DOI 10.1093/aob/mcq127; Chiu PW, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000677; Chuang S. F., 2012, PLOS ONE IN PRESS; Cotton JA, 2011, INT J PARASITOL, V41, P925, DOI 10.1016/j.ijpara.2011.05.002; Davis-Hayman SR, 2003, INT J PARASITOL, V33, P1005, DOI 10.1016/S0020-7519(03)00177-2; Doonan JH, 2009, MOL BIOTECHNOL, V42, P14, DOI 10.1007/s12033-008-9126-8; Dynlacht BD, 1997, MOL CELL BIOL, V17, P3867, DOI 10.1128/MCB.17.7.3867; Ellis J, 2004, MOL MICROBIOL, V53, P1487, DOI 10.1111/j.1365-2958.2004.04218.x; Elmendorf HG, 2001, MOL BIOCHEM PARASIT, V113, P157, DOI 10.1016/S0166-6851(01)00211-0; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Ghosh E, 2009, DRUG DES DEV THER, V3, P103; Gomes FC, 2010, MOL BIOCHEM PARASIT, V171, P89, DOI 10.1016/j.molbiopara.2010.03.002; Gourguechon S, 2011, EUKARYOT CELL, V10, P142, DOI 10.1128/EC.00190-10; Gray NS, 1998, SCIENCE, V281, P533, DOI 10.1126/science.281.5376.533; Guo ZH, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-69; Hanevik K., 2009, BMC GASTROENTEROL, V21, P9; HAYLES J, 1986, EMBO J, V5, P3373, DOI 10.1002/j.1460-2075.1986.tb04653.x; HOLBERTON DV, 1995, NUCLEIC ACIDS RES, V23, P2945, DOI 10.1093/nar/23.15.2945; Huang YC, 2008, J BIOL CHEM, V283, P31021, DOI 10.1074/jbc.M805023200; Ito M, 2001, PLANT CELL, V13, P1891, DOI 10.1105/tpc.13.8.1891; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; Jin HL, 1999, PLANT MOL BIOL, V41, P577, DOI 10.1023/A:1006319732410; Jirage D, 2010, MOL BIOCHEM PARASIT, V172, P9, DOI 10.1016/j.molbiopara.2010.03.009; KEISTER DB, 1983, T ROY SOC TROP MED H, V77, P487, DOI 10.1016/0035-9203(83)90120-7; KLEMPNAUER KH, 1987, EMBO J, V6, P2719, DOI 10.1002/j.1460-2075.1987.tb02565.x; Knodler LA, 1999, MOL MICROBIOL, V34, P327, DOI 10.1046/j.1365-2958.1999.01602.x; KU DH, 1993, J BIOL CHEM, V268, P2255; Lalioti V, 2010, CELL CYCLE, V9, P284, DOI 10.4161/cc.9.2.10466; Lauwaet T, 2007, CURR OPIN MICROBIOL, V10, P554, DOI 10.1016/j.mib.2007.09.011; Lauwaet T, 2011, INT J PARASITOL, V41, P1079, DOI 10.1016/j.ijpara.2011.06.001; LUJAN HD, 1995, J BIOL CHEM, V270, P29307, DOI 10.1074/jbc.270.49.29307; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; Martin-Castellanos C, 1997, TRENDS CELL BIOL, V7, P95, DOI 10.1016/S0962-8924(96)10055-6; McArthur AG, 2000, FEMS MICROBIOL LETT, V189, P271, DOI 10.1111/j.1574-6968.2000.tb09242.x; Morch K, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-206; Morf L, 2010, EUKARYOT CELL, V9, P1566, DOI 10.1128/EC.00100-10; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Morken MH, 2009, SCAND J GASTROENTERO, V44, P308, DOI 10.1080/00365520802588091; Morrison HG, 2007, SCIENCE, V317, P1921, DOI 10.1126/science.1143837; MOWATT MR, 1995, MOL MICROBIOL, V15, P955, DOI 10.1111/j.1365-2958.1995.tb02364.x; Muller-Tidow C, 2001, BLOOD, V97, P2091, DOI 10.1182/blood.V97.7.2091; Nakata Y, 2007, MOL CELL BIOL, V27, P2048, DOI 10.1128/MCB.01100-06; Noble MEM, 1997, TRENDS BIOCHEM SCI, V22, P482, DOI 10.1016/S0968-0004(97)01144-4; Oh IH, 1999, ONCOGENE, V18, P3017, DOI 10.1038/sj.onc.1202839; Ondarza R. N., 2007, Infectious Disorders - Drug Targets, V7, P266, DOI 10.2174/187152607782110059; Pan YJ, 2009, J BIOL CHEM, V284, P17975, DOI 10.1074/jbc.M109.012047; Pavletich NP, 1999, J MOL BIOL, V287, P821, DOI 10.1006/jmbi.1999.2640; Poxleitner MK, 2008, EUKARYOT CELL, V7, P569, DOI 10.1128/EC.00415-07; Reiner DS, 2008, INT J PARASITOL, V38, P935, DOI 10.1016/j.ijpara.2007.12.005; Robertson LJ, 2010, TRENDS PARASITOL, V26, P75, DOI 10.1016/j.pt.2009.11.010; SAKURA H, 1989, P NATL ACAD SCI USA, V86, P5758, DOI 10.1073/pnas.86.15.5758; Sala A, 1997, P NATL ACAD SCI USA, V94, P532, DOI 10.1073/pnas.94.2.532; Santori MI, 2002, MOL BIOCHEM PARASIT, V121, P225, DOI 10.1016/S0166-6851(02)00039-7; Saraiya AA, 2011, RNA, V17, P2152, DOI 10.1261/rna.028118.111; Seshadri V, 2003, J BIOL CHEM, V278, P27804, DOI 10.1074/jbc.M303316200; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; Singer SM, 1998, MOL BIOCHEM PARASIT, V92, P59, DOI 10.1016/S0166-6851(97)00225-9; Stark D, 2007, INT J PARASITOL, V37, P11, DOI 10.1016/j.ijpara.2006.09.009; Stracke R, 2001, CURR OPIN PLANT BIOL, V4, P447, DOI 10.1016/S1369-5266(00)00199-0; Su LH, 2007, MOL BIOCHEM PARASIT, V156, P124, DOI 10.1016/j.molbiopara.2007.07.015; Su LH, 2011, J BIOL CHEM, V286, P34101, DOI 10.1074/jbc.M111.280206; Sun CH, 2003, J BIOL CHEM, V278, P21701, DOI 10.1074/jbc.M302023200; Sun CH, 2006, MOL BIOCHEM PARASIT, V146, P45, DOI 10.1016/j.molbiopara.2005.10.017; Sun CH, 2005, MOL BIOCHEM PARASIT, V142, P1, DOI 10.1016/j.molbiopara.2005.03.003; Sun CH, 1999, J BIOL CHEM, V274, P19699, DOI 10.1074/jbc.274.28.19699; Sun CH, 2002, MOL MICROBIOL, V46, P971, DOI 10.1046/j.1365-2958.2002.03233.x; Svard SG, 2003, FEMS MICROBIOL LETT, V218, P3, DOI 10.1016/S0378-1097(02)01107-2; TRAVALI S, 1991, ONCOGENE, V6, P887; VANDENHEUVEL S, 1993, SCIENCE, V262, P2050, DOI 10.1126/science.8266103; Villerbu N, 2002, INT J CANCER, V97, P761, DOI 10.1002/ijc.10125; Wang CH, 2007, J BIOL CHEM, V282, P8905, DOI 10.1074/jbc.M611170200; Weston K, 1998, CURR OPIN GENET DEV, V8, P76, DOI 10.1016/S0959-437X(98)80065-8; WIESER J, 1995, GENE DEV, V9, P491, DOI 10.1101/gad.9.4.491; Yee J, 2000, J BIOL CHEM, V275, P11432, DOI 10.1074/jbc.275.15.11432; Zhang H, 2002, BBA-MOL CELL RES, V1591, P119, DOI 10.1016/S0167-4889(02)00258-6; Ziebold U, 1997, CURR BIOL, V7, P253, DOI 10.1016/S0960-9822(06)00121-7	91	9	9	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					3733	3750		10.1074/jbc.M111.298893	http://dx.doi.org/10.1074/jbc.M111.298893			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22167200	Green Published, hybrid			2022-12-27	WOS:000300410900011
J	Storch, U; Forst, AL; Philipp, M; Gudermann, T; Schnitzler, MMY				Storch, Ursula; Forst, Anna-Lena; Philipp, Maximilian; Gudermann, Thomas; Mederos y Schnitzler, Michael			Transient Receptor Potential Channel 1 (TRPC1) Reduces Calcium Permeability in Heteromeric Channel Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; CATION CHANNEL; SIRNA DESIGN; RAT-BRAIN; LOCALIZATION; PROTEIN; PROLIFERATION; ACTIVATION; EXPRESSION; ISOFORM	Specific biological roles of the classical transient receptor potential channel 1 (TRPC1) are still largely elusive. To investigate the function of TRPC1 proteins in cell physiology, we studied heterologously expressed TRPC1 channels and found that recombinant TRPC1 subunits do not form functional homomeric channels. Instead, by electrophysiological analysis TRPC1 was shown to form functional heteromeric, receptor-operated channel complexes with TRPC3, -4, -5, -6, and -7 indicating that TRPC1 proteins can co-assemble with all members of the TRPC subfamily. In all TRPC1-containing heteromers, TRPC1 subunits significantly decreased calcium permeation. The exchange of select amino acids in the putative pore-forming region of TRPC1 further reduced calcium permeability, suggesting that TRPC1 subunits contribute to the channel pore. In immortalized immature gonadotropin-releasing hormone neurons endogenously expressing TRPC1, -2, -5, and -6, down-regulation of TRPC1 resulted in increased calcium permeability and elevated basal cytosolic calcium concentrations. We did not observe any involvement of TRPC1 in storeoperated cation influx. Notably, TRPC1 suppressed the migration of gonadotropin-releasing hormone neurons without affecting cell proliferation. Conversely, in TRPC1 knockdown neurons, specific migratory properties like distance covered, locomotion speed, and directionality were increased. These findings suggest a novel regulatory mechanism relying on the expression of TRPC1 and the subsequent formation of heteromeric TRPC channel complexes with reduced calcium permeability, thereby fine-tuning neuronal migration.	[Storch, Ursula; Forst, Anna-Lena; Gudermann, Thomas; Mederos y Schnitzler, Michael] Univ Munich, Walther Straub Inst Pharmacol & Toxicol, D-80336 Munich, Germany; [Philipp, Maximilian] Univ Marburg, Inst Pharmacol & Toxicol, D-35032 Marburg, Germany	University of Munich; Philipps University Marburg	Gudermann, T (corresponding author), Univ Munich, Walther Straub Inst Pharmacol & Toxicol, Goethestr 33, D-80336 Munich, Germany.	thomas.gudermann@lrz.uni-muenchen.de	Forst, Anna-Lena/K-1909-2015					Ambudkar IS, 2007, CELL CALCIUM, V42, P213, DOI 10.1016/j.ceca.2007.01.013; Ariano P, 2011, CELL CALCIUM, V49, P387, DOI 10.1016/j.ceca.2011.03.007; Beech DJ, 2005, PFLUG ARCH EUR J PHY, V451, P53, DOI 10.1007/s00424-005-1441-3; Berbey C, 2009, J BIOL CHEM, V284, P36387, DOI 10.1074/jbc.M109.073221; Bollimuntha S, 2011, ADV EXP MED BIOL, V704, P573, DOI 10.1007/978-94-007-0265-3_31; Brownlow SL, 2005, THROMB HAEMOSTASIS, V94, P839, DOI 10.1160/TH05-06-0391; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Cui Kai, 2007, P55; Dalmazzo S, 2008, BRAIN RES, V1230, P27, DOI 10.1016/j.brainres.2008.07.019; Dietrich A, 2003, J BIOL CHEM, V278, P47842, DOI 10.1074/jbc.M302983200; Dietrich A, 2007, PFLUG ARCH EUR J PHY, V455, P465, DOI 10.1007/s00424-007-0314-3; Fabian A, 2008, PFLUG ARCH EUR J PHY, V457, P475, DOI 10.1007/s00424-008-0515-4; Fabian A, 2011, PFLUG ARCH EUR J PHY, V461, P295, DOI 10.1007/s00424-010-0901-6; Goel M, 2002, J BIOL CHEM, V277, P48303, DOI 10.1074/jbc.M207882200; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; LEWIS CA, 1979, J PHYSIOL-LONDON, V286, P417, DOI 10.1113/jphysiol.1979.sp012629; Lintschinger B, 2000, J BIOL CHEM, V275, P27799; Liu XB, 2005, J BIOL CHEM, V280, P21600, DOI 10.1074/jbc.c400492200; Machesky LM, 1999, J CELL BIOL, V146, P267, DOI 10.1083/jcb.146.2.267; Maroto R, 2005, NAT CELL BIOL, V7, P179, DOI 10.1038/ncb1218; Otsuguro KI, 2008, J BIOL CHEM, V283, P10026, DOI 10.1074/jbc.M707306200; Potier M, 2009, FASEB J, V23, P2425, DOI 10.1096/fj.09-131128; RADOVICK S, 1991, P NATL ACAD SCI USA, V88, P3402, DOI 10.1073/pnas.88.8.3402; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Rychkov G., 2007, V179, P23; Saleh SN, 2009, J PHYSIOL-LONDON, V587, P5361, DOI 10.1113/jphysiol.2009.180331; Salido GM, 2009, BBA-MOL CELL RES, V1793, P223, DOI 10.1016/j.bbamcr.2008.11.001; Selvaraj S, 2010, CNS NEUROL DISORD-DR, V9, P94, DOI 10.2174/187152710790966650; Strubing C, 2003, J BIOL CHEM, V278, P39014, DOI 10.1074/jbc.M306705200; Strubing C, 2001, NEURON, V29, P645, DOI 10.1016/S0896-6273(01)00240-9; Tang DD, 2005, J BIOL CHEM, V280, P23380, DOI 10.1074/jbc.M413390200; Trebak M, 2009, PFLUG ARCH EUR J PHY, V457, P757, DOI 10.1007/s00424-008-0550-1; Uehara K, 2005, HISTOCHEM CELL BIOL, V123, P347, DOI 10.1007/s00418-004-0741-6; Varga-Szabo D, 2008, PFLUG ARCH EUR J PHY, V457, P377, DOI 10.1007/s00424-008-0531-4; Wang WC, 1999, AM J PHYSIOL-CELL PH, V276, pC969, DOI 10.1152/ajpcell.1999.276.4.C969; Wu LJ, 2010, PHARMACOL REV, V62, P381, DOI 10.1124/pr.110.002725; Wu XY, 2004, J BIOL CHEM, V279, P43392, DOI 10.1074/jbc.M408959200; Yiu SM, 2005, BIOINFORMATICS, V21, P144, DOI 10.1093/bioinformatics/bth498; Yuan JP, 2009, CHANNELS, V3, P221, DOI 10.4161/chan.3.4.9198; Zagranichnaya TK, 2005, J BIOL CHEM, V280, P29559, DOI 10.1074/jbc.M505842200; Zaninetti R, 2008, MOL ENDOCRINOL, V22, P729, DOI 10.1210/me.2007-0277	43	111	112	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3530	3540		10.1074/jbc.M111.283218	http://dx.doi.org/10.1074/jbc.M111.283218			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22157757	Green Published, hybrid			2022-12-27	WOS:000300295100057
J	Kuo, CJ; Bell, H; Hsieh, CL; Ptak, CP; Chang, YF				Kuo, Chih-Jung; Bell, Hannah; Hsieh, Ching-Lin; Ptak, Christopher P.; Chang, Yung-Fu			Novel Mycobacteria Antigen 85 Complex Binding Motif on Fibronectin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNOGLOBULIN-LIKE PROTEIN; STAPHYLOCOCCUS-AUREUS; ATTACHMENT PROTEIN; BACTERIAL ADHERENCE; PROTECTIVE EFFICACY; CRYSTAL-STRUCTURE; SECRETED PROTEIN; CALCIUM BINDS; TUBERCULOSIS; ADHESIN	The members of the antigen 85 protein family (Ag85), consisting of members Ag85A, Ag85B, and Ag85C, are the predominantly secreted proteins of mycobacteria and possess the ability to specifically interact with fibronectin (Fn). Because Fn-binding proteins are likely to be important virulence factors of Mycobacterium spp., Ag85 may contribute to the adherence, invasion, and dissemination of organisms in host tissue. In this study, we reported the Fn binding affinity of Ag85A, Ag85B, and Ag85C from Mycobacterium avium subsp. paratuberculosis (MAP) (K-D values were determined from 33.6 to 68.4 nM) and mapped the Ag85-binding motifs of Fn. Fn14, a type III module located on the heparin-binding domain II (Hep-2) of Fn, was discovered to interact with Ag85 from MAP. The peptide inhibition assay subsequently demonstrated that a peptide consisting of residues 17-26 from Fn14 ((17)SLLVSWQPPR(26), termed P17-26) could interfere with Ag85B binding to Fn (73.3% reduction). In addition, single alanine substitutions along the sequence of P17-26 revealed that the key residues involved in Ag85-Fn binding likely contribute through hydrophobic and charge interactions. Moreover, binding of Ag85 on Fn siRNA-transfected Caco2 cells was dramatically reduced (44.6%), implying the physiological significance of the Ag85-Fn interaction between mycobacteria and host cells during infection. Our results indicate that Ag85 binds to Fn at a novel motif and plays a critical role in mycobacteria adherence to host cells by initiating infection. Ag85 might serve as an important colonization factor potentially contributing to mycobacterial virulence.	[Kuo, Chih-Jung; Bell, Hannah; Hsieh, Ching-Lin; Chang, Yung-Fu] Cornell Univ, Dept Populat Med & Diagnost Sci, Coll Vet Med, Ithaca, NY 14853 USA; [Ptak, Christopher P.] Cornell Univ, Dept Mol Med, Coll Vet Med, Ithaca, NY 14853 USA	Cornell University; Cornell University	Chang, YF (corresponding author), Cornell Univ, Dept Populat Med & Diagnost Sci, Coll Vet Med, Ithaca, NY 14853 USA.	yc42@cornell.edu	Ptak, Christopher/AAP-7763-2021; Hsieh, Ching-Lin/ABA-6461-2021; Ptak, Christopher/I-3126-2012; Hsieh, Ching-Lin/K-4139-2018	Ptak, Christopher/0000-0003-2752-0367; Ptak, Christopher/0000-0003-2752-0367; Kuo, Chih-Jung/0000-0002-4988-5124; Hsieh, Ching-Lin/0000-0002-3665-5717	Agriculture and Food Research Initiative, United States Department of Agriculture Cooperative State Research, Education, and Extension Service [2008-55620-18710, 2009-65119-05993]; National Research Initiative, United States Department of Agriculture Cooperative State Research, Education, and Extension Service [2008-35204-04626]; Biotechnology Research and Development Corporation (BRDC); Animal Formula Fund [NY-478455, NY-478437]	Agriculture and Food Research Initiative, United States Department of Agriculture Cooperative State Research, Education, and Extension Service; National Research Initiative, United States Department of Agriculture Cooperative State Research, Education, and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Biotechnology Research and Development Corporation (BRDC); Animal Formula Fund	This work was supported by Agriculture and Food Research Initiative, United States Department of Agriculture Cooperative State Research, Education, and Extension Service Grant 2008-55620-18710 (Johne's Disease Integrated Program), the National Research Initiative, United States Department of Agriculture Cooperative State Research, Education, and Extension Service Grant 2008-35204-04626, the Agriculture and Food Research Initiative, United States Department of Agriculture Cooperative State Research, Education, and Extension Service Grant 2009-65119-05993, the Biotechnology Research and Development Corporation (BRDC), and the Animal Formula Fund Grant NY-478455 and NY-478437.	AMBLER RP, 1968, BIOCHEM J, V108, P893, DOI 10.1042/bj1080893; Anderson DH, 2001, J MOL BIOL, V307, P671, DOI 10.1006/jmbi.2001.4461; Armitige LY, 2000, INFECT IMMUN, V68, P767, DOI 10.1128/IAI.68.2.767-778.2000; Baldwin S. L., 1999, Tubercle and Lung Disease, V79, P251, DOI 10.1054/tuld.1998.0196; Belisle JT, 1997, SCIENCE, V276, P1420, DOI 10.1126/science.276.5317.1420; Chessa D, 2008, MOL MICROBIOL, V68, P573, DOI 10.1111/j.1365-2958.2008.06185.x; COCITO C, 1994, CLIN MICROBIOL REV, V7, P328, DOI 10.1128/CMR.7.3.328-345.1994; Dabo SM, 2006, INFECT IMMUN, V74, P2513, DOI 10.1128/IAI.74.5.2513-2521.2006; Denis O, 1997, INFECT IMMUN, V65, P676, DOI 10.1128/IAI.65.2.676-684.1997; Hermon-Taylor J, 2009, GUT PATHOG, V1, DOI 10.1186/1757-4749-1-15; Holmes AR, 2001, MOL MICROBIOL, V41, P1395, DOI 10.1046/j.1365-2958.2001.02610.x; Huygen K, 1996, NAT MED, V2, P893, DOI 10.1038/nm0896-893; JANICKI BW, 1971, AM REV RESPIR DIS, V104, P602; Janvilisri T, 2010, J INFECT DIS, V202, P282, DOI 10.1086/653484; Joh D, 1998, EUR J BIOCHEM, V258, P897, DOI 10.1046/j.1432-1327.1998.2580897.x; Joh D, 1999, MATRIX BIOL, V18, P211, DOI 10.1016/S0945-053X(99)00025-6; JOHNE HA, 1895, DTSCH Z TIERMED PATH, V21, P438; Kamath AT, 1999, INFECT IMMUN, V67, P1702; Kingsley RA, 2004, MOL MICROBIOL, V52, P345, DOI 10.1111/j.1365-2958.2004.03995.x; Langermans JAM, 2005, VACCINE, V23, P2740, DOI 10.1016/j.vaccine.2004.11.051; Lin XP, 2008, J VET SCI, V9, P133; Lin YP, 2008, J BIOL CHEM, V283, P25140, DOI 10.1074/jbc.M801350200; Lin YP, 2011, J BIOL CHEM, V286, P3957, DOI 10.1074/jbc.M110.184523; Lin YP, 2009, J BIOL CHEM, V284, P23547, DOI 10.1074/jbc.M109.031369; Lin YP, 2009, J BIOL CHEM, V284, P19380, DOI 10.1074/jbc.M109.004531; Mempel M, 2002, BRIT J DERMATOL, V146, P943, DOI 10.1046/j.1365-2133.2002.04752.x; NAGAI S, 1991, INFECT IMMUN, V59, P372, DOI 10.1128/IAI.59.1.372-382.1991; Naito M, 2000, BIOCHEM J, V347, P725, DOI 10.1042/0264-6021:3470725; Naito M, 1998, J BIOL CHEM, V273, P2905, DOI 10.1074/jbc.273.5.2905; National Animal Health Monitoring System, 1997, JOHN DIS US DAIR OP; OHARA N, 1995, SCAND J IMMUNOL, V41, P433, DOI 10.1111/j.1365-3083.1995.tb03589.x; PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101; Peacock SJ, 1999, MICROBIOL-SGM, V145, P3477, DOI 10.1099/00221287-145-12-3477; PEAKE P, 1993, INFECT IMMUN, V61, P4828, DOI 10.1128/IAI.61.11.4828-4834.1993; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; POTTS JR, 1994, CURR OPIN CELL BIOL, V6, P648, DOI 10.1016/0955-0674(94)90090-6; Probert WS, 2001, INFECT IMMUN, V69, P4129, DOI 10.1128/IAI.69.6.4129-4133.2001; RATLIFF TL, 1993, INFECT IMMUN, V61, P1889, DOI 10.1128/IAI.61.5.1889-1894.1993; Ronning DR, 2004, J BIOL CHEM, V279, P36771, DOI 10.1074/jbc.M400811200; Ronning DR, 2000, NAT STRUCT BIOL, V7, P141; Sanki AK, 2009, MOL BIOSYST, V5, P945, DOI 10.1039/b902284h; Santos R, 2001, MOL PLANT MICROBE IN, V14, P758, DOI 10.1094/MPMI.2001.14.6.758; SCHOREY JS, 1995, INFECT IMMUN, V63, P2652, DOI 10.1128/IAI.63.7.2652-2657.1995; Schorey JS, 1996, MOL MICROBIOL, V21, P321, DOI 10.1046/j.1365-2958.1996.6381353.x; Schwarz-Linek U, 2004, J BIOL CHEM, V279, P39017, DOI 10.1074/jbc.M405083200; Schwarz-Linek U, 2004, MOL MICROBIOL, V52, P631, DOI 10.1111/j.1365-2958.2004.04027.x; Secott TE, 2001, INFECT IMMUN, V69, P2075, DOI 10.1128/IAI.69.4.2075-2082.2001; Sharma A, 1999, EMBO J, V18, P1468, DOI 10.1093/emboj/18.6.1468; Soto GE, 1999, J BACTERIOL, V181, P1059, DOI 10.1128/JB.181.4.1059-1071.1999; Tung JY, 2010, J BIOL CHEM, V285, P3245, DOI 10.1074/jbc.M109.006320; Vakonakis L, 2007, CURR OPIN CELL BIOL, V19, P578, DOI 10.1016/j.ceb.2007.09.005; Vazquez V, 2011, J BIOL CHEM, V286, P29797, DOI 10.1074/jbc.M110.214981; WIKER HG, 1992, MICROBIOL REV, V56, P648, DOI 10.1128/MMBR.56.4.648-661.1992; Xu QJ, 2004, J BIOL CHEM, V279, P4269, DOI 10.1074/jbc.M311586200; Zhao WC, 1999, J BIOL CHEM, V274, P4521, DOI 10.1074/jbc.274.8.4521	55	32	35	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					1892	1902		10.1074/jbc.M111.298687	http://dx.doi.org/10.1074/jbc.M111.298687			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22128161	Green Published, hybrid			2022-12-27	WOS:000299321000030
J	Pfister, AS; Tanneberger, K; Schambony, A; Behrens, J				Pfister, Astrid S.; Tanneberger, Kristina; Schambony, Alexandra; Behrens, Juergen			Amer2 Protein Is a Novel Negative Regulator of Wnt/beta-Catenin Signaling Involved in Neuroectodermal Patterning	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CATENIN; FUNCTIONAL INTERACTION; GENE FAMILY; WILMS-TUMOR; XENOPUS; EXPRESSION; APC; WTX; TRANSCRIPTION; MEMBRANE	Wnt/beta-catenin signaling is negatively controlled by the adenomatous polyposis coli (APC) tumor suppressor, which induces proteasomal degradation of beta-catenin as part of the beta-catenin destruction complex. Amer2 (APC membrane recruitment 2; FAM123A) is a direct interaction partner of APC, related to the tumor suppressor Amer1/WTX, but its function in Wnt signaling is not known. Here, we show that Amer2 recruits APC to the plasma membrane by binding to phosphatidylinositol 4,5-bispho-sphate lipids via lysine-rich motifs and that APC links beta-catenin and the destruction complex components axin and conductin to Amer2. Knockdown of Amer2 increased Wnt target gene expression and reporter activity in cell lines, and overexpression reduced reporter activity, which required membrane association of Amer2. In Xenopus embryos, Amer2 is expressed mainly in the dorsal neuroectoderm and neural tissues. Down-regulation of Amer2 by specific morpholino oligonucleotides altered neuroectodermal patterning, which could be rescued by expression of a dominant-negative mutant of Lef1 that interferes with beta-catenin-dependent transcription. Our data characterize Amer2 for the first time as a negative regulator of Wnt signaling both in cell lines and in vivo and define Amer proteins as a novel family of Wnt pathway regulators.	[Pfister, Astrid S.; Tanneberger, Kristina; Behrens, Juergen] Univ Erlangen Nurnberg, Nikolaus Fiebiger Ctr Mol Med, D-91054 Erlangen, Germany; [Schambony, Alexandra] Univ Erlangen Nurnberg, Dept Biol, D-91058 Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg	Behrens, J (corresponding author), Univ Erlangen Nurnberg, Nikolaus Fiebiger Ctr, Gluckstr 6, D-91054 Erlangen, Germany.	jbehrens@molmed.uni-erlangen.de		Schambony, Alexandra/0000-0001-8771-5487	Deutsche Forschungsgemeinschaft [Be1550/6-1, SCHA965/6-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants Be1550/6-1 (to J. B.) and SCHA965/6-1 (to A. S.).	Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Boutet A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-280; BRADLEY LC, 1993, MECH DEVELOP, V40, P73, DOI 10.1016/0925-4773(93)90089-G; Casarosa S, 1997, MECH DEVELOP, V61, P187, DOI 10.1016/S0925-4773(96)00640-5; Comai G, 2010, DEV DYNAM, V239, P1867, DOI 10.1002/dvdy.22313; Conacci-Sorrell ME, 2002, GENE DEV, V16, P2058, DOI 10.1101/gad.227502; De Robertis EM, 1997, COLD SPRING HARB SYM, V62, P169; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Domingos PM, 2001, DEV BIOL, V239, P148, DOI 10.1006/dbio.2001.0431; Grohmann A, 2007, J CELL SCI, V120, P3738, DOI 10.1242/jcs.011320; Hamada F, 2002, NAT CELL BIOL, V4, P208, DOI 10.1038/ncb755; HEMMATIBRIVANLOU A, 1991, DEVELOPMENT, V111, P715; Jenkins ZA, 2009, NAT GENET, V41, P95, DOI 10.1038/ng.270; Kiecker C, 2001, DEVELOPMENT, V128, P4189; Kohler EM, 2008, HUM MOL GENET, V17, P1978, DOI 10.1093/hmg/ddn095; Krieghoff E, 2006, J CELL SCI, V119, P1453, DOI 10.1242/jcs.02864; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Maher MT, 2009, J CELL BIOL, V186, P219, DOI 10.1083/jcb.200811108; Major MB, 2007, SCIENCE, V316, P1043, DOI 10.1126/science/1141515; McKendry R, 1997, DEV BIOL, V192, P420, DOI 10.1006/dbio.1997.8797; Michiue T, 2004, DEV DYNAM, V230, P79, DOI 10.1002/dvdy.20037; Moisan A, 2011, DEV CELL, V20, P583, DOI 10.1016/j.devcel.2011.03.013; Polakis P, 2000, GENE DEV, V14, P1837; Rivera MN, 2007, SCIENCE, V315, P642, DOI 10.1126/science.1137509; Tanneberger K, 2011, J BIOL CHEM, V286, P19204, DOI 10.1074/jbc.M111.224881; Tanneberger K, 2011, EMBO J, V30, P1433, DOI 10.1038/emboj.2011.28; Unterseher F, 2004, EMBO J, V23, P3259, DOI 10.1038/sj.emboj.7600332; Yamamoto Y, 2003, HEPATOLOGY, V37, P528, DOI 10.1053/jhep.2003.50029; Zhou ZF, 2011, P NATL ACAD SCI USA, V108, P6626, DOI 10.1073/pnas.1018514108	31	18	22	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					1734	1741		10.1074/jbc.M111.308650	http://dx.doi.org/10.1074/jbc.M111.308650			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22128170	Green Published, hybrid			2022-12-27	WOS:000299321000016
J	Takahashi, K; Makita, N; Manaka, K; Hisano, M; Akioka, Y; Miura, K; Takubo, N; Iida, A; Ueda, N; Hashimoto, M; Fujita, T; Igarashi, T; Sekine, T; Iiri, T				Takahashi, Kazuhiro; Makita, Noriko; Manaka, Katsunori; Hisano, Masataka; Akioka, Yuko; Miura, Kenichiro; Takubo, Noriyuki; Iida, Atsuko; Ueda, Norishi; Hashimoto, Makiko; Fujita, Toshiro; Igarashi, Takashi; Sekine, Takashi; Iiri, Taroh			V2 Vasopressin Receptor (V2R) Mutations in Partial Nephrogenic Diabetes Insipidus Highlight Protean Agonism of V2R Antagonists	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COUPLED-RECEPTORS; INAPPROPRIATE ANTIDIURESIS; FUNCTIONAL-CHARACTERIZATION; MOLECULAR-MECHANISMS; AVPR2 MUTATIONS; TYPE-2 RECEPTOR; MUTANT; ACTIVATION; G(S-ALPHA); FAMILIES	Inactivating mutations of the V2 vasopressin receptor (V2R) cause cross-linked congenital nephrogenic diabetes insipidus (NDI), resulting in renal resistance to the antidiuretic hormone AVP. In two families showing partial NDI, characterized by an apparently normal response to diagnostic tests and an increase in the basal ADH levels suggesting AVP resistance, we have identified two V2R mutations, Ser-333del and Y128S. Both mutant V2Rs, when expressed in COS-7 cells, show partial defects in vasopressin-stimulated cAMP accumulation and intracellular localization. The inhibition of internalization does not rescue their localization. In contrast, the non-peptide V2R antagonists OPC41061 and OPC31260 partially rescue the membrane localization and basal function of these V2R mutants, whereas they inhibit the basal activity of the wild-type V2R. These results indicate that a partial loss of function of Ser-333del and Y128S mutant V2Rs results from defective membrane trafficking. These findings further indicate that V2R antagonists can act as protean agonists, serving as pharmacological chaperones for inactivating V2R mutants and also as inverse agonists of wild-type receptors. We speculate that this protean agonism could underlie the possible dual beneficial effects of the V2R antagonist: improvement of hyponatremia with heart failure or polycystic kidney disease and potential rescue of NDI.	[Takahashi, Kazuhiro; Miura, Kenichiro; Igarashi, Takashi; Sekine, Takashi] Univ Tokyo, Dept Pediat, Tokyo 1138655, Japan; [Makita, Noriko; Manaka, Katsunori; Hashimoto, Makiko; Fujita, Toshiro; Iiri, Taroh] Univ Tokyo, Dept Endocrinol & Nephrol, Tokyo 1138655, Japan; [Hisano, Masataka] Chiba Childrens Hosp, Dept Pediat Nephrol, Chiba 2660007, Japan; [Akioka, Yuko] Tokyo Womans Med Univ, Dept Pediat Nephrol, Tokyo 1628666, Japan; [Takubo, Noriyuki] Kitasato Univ, Dept Pediat, Sch Med, Kanagawa 2520375, Japan; [Iida, Atsuko] Tokyo Womans Med Univ, Dept Pediat, Med Ctr E, Tokyo 1168567, Japan; [Ueda, Norishi] Nagoya Univ, Dept Pediat, Grad Sch Med, Nagoya, Aichi 4660065, Japan; [Sekine, Takashi] Toho Univ, Dept Pediat, Ohashi Hosp, Med Ctr, Tokyo 1538515, Japan	University of Tokyo; University of Tokyo; Chiba Children's Hospital; Tokyo Women's Medical University; Kitasato University; Tokyo Women's Medical University; Nagoya University; Toho University	Makita, N (corresponding author), 7-3-1 Hongo,Bunkyo Ku, Tokyo 1138655, Japan.	norimaki-tky@umin.ac.jp; tsekine@med.toho-u.ac.jp; tiiri-tky@umin.ac.jp	Makita, Noriko/GQY-8175-2022		Ministry of Education, Science, Sports, and Culture, Japan; Grants-in-Aid for Scientific Research [22591008, 23591586] Funding Source: KAKEN	Ministry of Education, Science, Sports, and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid for scientific research from the Ministry of Education, Science, Sports, and Culture, Japan.	Ala Y, 1998, J AM SOC NEPHROL, V9, P1861; Arthus MF, 2000, J AM SOC NEPHROL, V11, P1044, DOI 10.1681/ASN.V1161044; Azzi M, 2003, P NATL ACAD SCI USA, V100, P11406, DOI 10.1073/pnas.1936664100; Baldassarre M, 2003, MOL BIOL CELL, V14, P1074, DOI 10.1091/mbc.E02-05-0308; Barak LS, 2001, P NATL ACAD SCI USA, V98, P93, DOI 10.1073/pnas.011303698; Bernier V, 2004, MOL ENDOCRINOL, V18, P2074, DOI 10.1210/me.2004-0080; Bernier V, 2006, J AM SOC NEPHROL, V17, P232, DOI 10.1681/ASN.2005080854; Bichet DG, 2006, ADV CHRONIC KIDNEY D, V13, P96, DOI 10.1053/j.ackd.2006.01.006; BICHET DG, 1993, J CLIN INVEST, V92, P1262, DOI 10.1172/JCI116698; BICHET DG, 1994, AM J HUM GENET, V55, P278; Boson L, 2006, GENET TEST, V10, P157, DOI 10.1089/gte.2006.10.157; Carroll P, 2006, GENET MED, V8, P443, DOI 10.1097/01.gim.0000223554.46981.7a; Chen CH, 2002, J HUM GENET, V47, P66, DOI 10.1007/s100380200002; Faerch M, 2008, CLIN ENDOCRINOL, V68, P395, DOI 10.1111/j.1365-2265.2007.03054.x; Faerch M, 2009, AM J PHYSIOL-RENAL, V297, pF1518, DOI 10.1152/ajprenal.00331.2009; Farmakis D, 2009, HEART FAIL REV, V14, P59, DOI 10.1007/s10741-008-9109-7; Feldman BJ, 2005, NEW ENGL J MED, V352, P1884, DOI 10.1056/NEJMoa042743; Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90; Hill SJ, 2006, BRIT J PHARMACOL, V147, pS27, DOI 10.1038/sj.bjp.0706455; Iiri T, 1997, P NATL ACAD SCI USA, V94, P5656, DOI 10.1073/pnas.94.11.5656; Iiri T, 1999, P NATL ACAD SCI USA, V96, P499, DOI 10.1073/pnas.96.2.499; IIRI T, 1994, NATURE, V371, P164, DOI 10.1038/371164a0; Inaba S, 2001, J CLIN ENDOCR METAB, V86, P381, DOI 10.1210/jc.86.1.381; Irazabal MV, 2011, KIDNEY INT, V80, P295, DOI 10.1038/ki.2011.119; Jean-Alphonse F, 2009, J AM SOC NEPHROL, V20, P2190, DOI 10.1681/ASN.2008121289; Kalenga K, 2002, AM J KIDNEY DIS, V39, P737, DOI 10.1053/ajkd.2002.31993; Kenakin T, 2001, FASEB J, V15, P598, DOI 10.1096/fj.00-0438rev; Kenakin T, 2007, MOL PHARMACOL, V72, P1393, DOI 10.1124/mol.107.040352; Kocan M, 2009, MOL ENDOCRINOL, V23, P559, DOI 10.1210/me.2008-0321; Leach K, 2007, TRENDS PHARMACOL SCI, V28, P382, DOI 10.1016/j.tips.2007.06.004; Macion-Dazard R, 2006, J PHARMACOL EXP THER, V316, P564, DOI 10.1124/jpet.105.095554; Makita N, 2008, CALCIUM SENSING RECE, DOI [10.1038/mp.a004000.01, DOI 10.1038/MP.A004000.01]; Makita N, 2007, P NATL ACAD SCI USA, V104, P17424, DOI 10.1073/pnas.0708561104; Makita N, 2007, P NATL ACAD SCI USA, V104, P5443, DOI 10.1073/pnas.0701290104; Morello JP, 2001, ANNU REV PHYSIOL, V63, P607, DOI 10.1146/annurev.physiol.63.1.607; Neubig RR, 2007, MOL PHARMACOL, V71, P1200, DOI 10.1124/mol.107.034926; Pasel K, 2000, J CLIN ENDOCR METAB, V85, P1703, DOI 10.1210/jc.85.4.1703; Robben JH, 2007, AM J PHYSIOL-RENAL, V292, pF253, DOI 10.1152/ajprenal.00247.2006; Robben JH, 2006, AM J PHYSIOL-RENAL, V291, pF257, DOI 10.1152/ajprenal.00491.2005; Rochdi MD, 2010, MOL PHARMACOL, V77, P836, DOI 10.1124/mol.109.061804; Sadeghi H, 1997, MOL ENDOCRINOL, V11, P1806, DOI 10.1210/me.11.12.1806; Schoneberg T, 1998, HUM MUTAT, V12, P196, DOI 10.1002/(SICI)1098-1004(1998)12:3<196::AID-HUMU7>3.0.CO;2-F; Shoji Y, 1998, HUM MUTAT, pS278; Spiegel AM, 2004, ANNU REV MED, V55, P27, DOI 10.1146/annurev.med.55.091902.103843; Suzuki J, 2001, J CLIN INVEST, V107, P363, DOI 10.1172/JCI10254; Tao YX, 2006, PHARMACOL THERAPEUT, V111, P949, DOI 10.1016/j.pharmthera.2006.02.008; Tenenbaum J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008383; Torres VE, 2011, AM J KIDNEY DIS, V57, P692, DOI 10.1053/j.ajkd.2010.11.029; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; Zmily HD, 2011, INT J NEPHROL RENOV, V4, P57, DOI 10.2147/IJNRD.S7032	50	27	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					2099	2106		10.1074/jbc.M111.268797	http://dx.doi.org/10.1074/jbc.M111.268797			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22144672	Green Published, hybrid			2022-12-27	WOS:000299321000050
J	Usukura, E; Suzuki, T; Furuike, S; Soga, N; Saita, E; Hisabori, T; Kinosita, K; Yoshida, M				Usukura, Eiji; Suzuki, Toshiharu; Furuike, Shou; Soga, Naoki; Saita, Ei-ichiro; Hisabori, Toru; Kinosita, Kazuhiko, Jr.; Yoshida, Masasuke			Torque Generation and Utilization in Motor Enzyme F0F1-ATP Synthase HALF-TORQUE F-1 WITH SHORT-SIZED PUSHROD HELIX AND REDUCED ATP SYNTHESIS BY HALF-TORQUE F0F1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE HEART-MITOCHONDRIA; PROTON MOTIVE FORCE; BETA-SUBUNIT; CATALYTIC SUBUNITS; FOF1-ATP SYNTHASE; ROTARY MECHANISM; EPSILON-SUBUNIT; F-1-ATPASE; ROTATION; RESOLUTION	ATP synthase (F0F1) is made of two motors, a proton-driven motor (F-0) and an ATP-driven motor (F-1), connected by a common rotary shaft, and catalyzes proton flow-driven ATP synthesis and ATP-driven proton pumping. In F-1, the central gamma subunit rotates inside the alpha(3)beta(3) ring. Here we report structural features of F-1 responsible for torque generation and the catalytic ability of the low-torque F0F1. (i) Deletion of one or two turns in the alpha-helix in the C-terminal domain of catalytic beta subunit at the rotor/stator contact region generates mutant F(1)s, termed F-1(1/2)s, that rotate with about half of the normal torque. This helix would support the helix-loop-helix structure acting as a solid "pushrod" to push the rotor gamma subunit, but the short helix in F-1(1/2) s would fail to accomplish this task. (ii) Three different half-torque F0F1(1/2)s were purified and reconstituted into proteoliposomes. They carry out ATP-driven proton pumping and build up the same small transmembrane Delta pH, indicating that the final Delta pH is directly related to the amount of torque. (iii) The half-torque F0F1(1/2)s can catalyze ATP synthesis, although slowly. The rate of synthesis varies widely among the three F0F1(1/2)s, which suggests that the rate reflects subtle conformational variations of individual mutants.	[Yoshida, Masasuke] Kyoto Sangyo Univ, Dept Mol Biosci, Kyoto 6038555, Japan; [Usukura, Eiji; Hisabori, Toru] Tokyo Inst Technol, Chem Resources Lab, Yokohama, Kanagawa 2268503, Japan; [Suzuki, Toshiharu; Saita, Ei-ichiro; Hisabori, Toru; Yoshida, Masasuke] Japan Sci & Technol Agcy JST, Int Cooperat Res Project ICORP, ATP Synth Regulat Project, Tokyo 1350064, Japan; [Furuike, Shou] Osaka Med Coll, Dept Phys, Takatsuki, Osaka 5698686, Japan; [Soga, Naoki; Kinosita, Kazuhiko, Jr.] Waseda Univ, Dept Phys, Shinjuku Ku, Tokyo 1710033, Japan	Kyoto Sangyo University; Tokyo Institute of Technology; Japan Science & Technology Agency (JST); Osaka Medical College; Waseda University	Yoshida, M (corresponding author), Kyoto Sangyo Univ, Dept Mol Biosci, Kyoto 6038555, Japan.	masasuke.yoshida@cc.kyoto-su.ac.jp	Hisabori, Toru/E-5205-2014	Hisabori, Toru/0000-0003-2046-0277	Japan Science and Technology Agency; Grants-in-Aid for Scientific Research [21000011] Funding Source: KAKEN	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the ATP synthesis Regulation Project (ICORP) through Japan Science and Technology Agency (to M.Y.).	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Adachi K, 2007, CELL, V130, P309, DOI 10.1016/j.cell.2007.05.020; Ariga T, 2007, NAT STRUCT MOL BIOL, V14, P841, DOI 10.1038/nsmb1296; Bowler MW, 2007, J BIOL CHEM, V282, P14238, DOI 10.1074/jbc.M700203200; Bowler MW, 2006, P NATL ACAD SCI USA, V103, P8646, DOI 10.1073/pnas.0602915103; Boyer PD, 2002, J BIOL CHEM, V277, P39045, DOI 10.1074/jbc.X200001200; Duser MG, 2009, EMBO J, V28, P2689, DOI 10.1038/emboj.2009.213; Feniouk BA, 2007, J BIOL CHEM, V282, P764, DOI 10.1074/jbc.M606321200; Furuike S, 2008, BIOPHYS J, V95, P761, DOI 10.1529/biophysj.107.123307; Furuike S, 2008, SCIENCE, V319, P955, DOI 10.1126/science.1151343; Hara KY, 2000, J BIOL CHEM, V275, P14260, DOI 10.1074/jbc.275.19.14260; Hayashi K, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.218103; Hossain MD, 2008, BIOPHYS J, V95, P4837, DOI 10.1529/biophysj.108.140061; Itoh H, 2004, NATURE, V427, P465, DOI 10.1038/nature02212; Junge W, 2009, NATURE, V459, P364, DOI 10.1038/nature08145; Kinosita K, 2004, ANNU REV BIOPH BIOM, V33, P245, DOI 10.1146/annurev.biophys.33.110502.132716; Kohori A, 2011, BIOPHYS J, V101, P188, DOI 10.1016/j.bpj.2011.05.008; Konno H, 2004, BIOCHEM BIOPH RES CO, V318, P17, DOI 10.1016/j.bbrc.2004.03.179; Masaike T, 2006, BIOCHEM BIOPH RES CO, V342, P800, DOI 10.1016/j.bbrc.2006.02.017; Masaike T, 2008, NAT STRUCT MOL BIOL, V15, P1326, DOI 10.1038/nsmb.1510; Mnatsakanyan N, 2011, J BIOL CHEM, V286, P29788, DOI 10.1074/jbc.M111.254730; Mnatsakanyan N, 2009, J BIOL CHEM, V284, P11336, DOI 10.1074/jbc.M900374200; Nakamoto RK, 2008, ARCH BIOCHEM BIOPHYS, V476, P43, DOI 10.1016/j.abb.2008.05.004; Nakanishi-Matsui M, 2010, BBA-BIOENERGETICS, V1797, P1343, DOI 10.1016/j.bbabio.2010.02.014; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Oster G, 2003, TRENDS CELL BIOL, V13, P114, DOI 10.1016/S0962-8924(03)00004-7; Panke O, 2001, BIOPHYS J, V81, P1220, DOI 10.1016/S0006-3495(01)75780-3; Sakaki N, 2005, BIOPHYS J, V88, P2047, DOI 10.1529/biophysj.104.054668; Senior AE, 2002, BBA-BIOENERGETICS, V1553, P188, DOI 10.1016/S0005-2728(02)00185-8; Shimabukuro K, 2003, P NATL ACAD SCI USA, V100, P14731, DOI 10.1073/pnas.2434983100; Soga N, 2011, FEBS J, V278, P2647, DOI 10.1111/j.1742-4658.2011.08191.x; Suzuki T, 2003, J BIOL CHEM, V278, P46840, DOI 10.1074/jbc.M307165200; Suzuki T, 2002, J BIOL CHEM, V277, P13281, DOI 10.1074/jbc.M111210200; Uchihashi T, 2011, SCIENCE, V333, P755, DOI 10.1126/science.1205510; von Ballmoos C, 2009, ANNU REV BIOCHEM, V78, P649, DOI 10.1146/annurev.biochem.78.081307.104803; Weber J, 2006, BBA-BIOENERGETICS, V1757, P1162, DOI 10.1016/j.bbabio.2006.04.007; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513; Yasuda R, 1998, CELL, V93, P1117, DOI 10.1016/S0092-8674(00)81456-7; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509	40	35	35	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					1884	1891		10.1074/jbc.M111.305938	http://dx.doi.org/10.1074/jbc.M111.305938			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22128167	hybrid, Green Published			2022-12-27	WOS:000299321000029
J	Veshnyakova, A; Piontek, J; Protze, J; Waziri, N; Heise, I; Krause, G				Veshnyakova, Anna; Piontek, Joerg; Protze, Jonas; Waziri, Negar; Heise, Ivonne; Krause, Gerd			Mechanism of Clostridium perfringens Enterotoxin Interaction with Claudin-3/-4 Protein Suggests Structural Modifications of the Toxin to Target Specific Claudins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL FRAGMENT; PORE-FORMING TOXINS; TIGHT JUNCTION; BARRIER; CANCER; IDENTIFICATION; DETERMINANTS; METASTASIS; MODULATOR; DOMAIN	Claudins (Cld) are essential constituents of tight junctions. Domain I of Clostridium perfringens enterotoxin (cCPE) binds to the second extracellular loop (ECL2) of a subset of claudins, e. g. Cld3/4 and influences tight junction formation. We aimed to identify interacting interfaces and to alter claudin specificity of cCPE. Mutagenesis, binding assays, and molecular modeling were performed. Mutation-guided ECL2 docking of Cld3/4 onto the crystal structure of cCPE revealed a common orientation of the proposed ECL2 helix-turn-helix motif in the binding cavity of cCPE: residues Leu(150)/Leu(151) of Cld3/4 bind similarly to a hydrophobic pit formed by Tyr(306), Tyr(310), and Tyr(312) of cCPE, and Pro(152)/Ala(153) of Cld3/4 is proposed to bind to a second pit close to Leu(223), Leu(254), and Leu(315). However, sequence variation in ECL2 of these claudins is likely responsible for slightly different conformation in the turn region, which is in line with different cCPE interaction modes of Cld3 and Cld4. Substitutions of other so far not characterized cCPE residues lining the pocket revealed two spatially separated groups of residues (Leu(223), Asp(225), and Arg(227) and Leu(254), lle(258), and Asp(284)), which are involved in binding to Cld3 and Cld4, albeit differently. Involvement of Asn(148) of Cld3 in cCPE binding was confirmed, whereas no evidence for involvement of Lys(156) or Arg(157) was found. We show structure-based alteration of cCPE generating claudin binders, which interact subtype-specific preferentially either with Cld3 or with Cld4. The obtained mutants and mechanistic insights will advance the design of cCPE-based modulators to target specific claudin subtypes related either to paracellular barriers that impede drug delivery or to tumors.	[Veshnyakova, Anna; Piontek, Joerg; Protze, Jonas; Waziri, Negar; Heise, Ivonne; Krause, Gerd] Leibniz Inst Mol Pharmacol, D-13125 Berlin, Germany	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP)	Piontek, J (corresponding author), Leibniz Inst Mol Pharmacol, Robert Rossle Str 10, D-13125 Berlin, Germany.	piontek@fmp-berlin.de	Piontek, Joerg/K-6305-2013; Protze, Jonas/ABB-9737-2020	Piontek, Joerg/0000-0002-0880-8915; Protze, Jonas/0000-0002-1506-9831	Deutsche Forschungsgemeinschaft [KR 1273/3-2, PI 837/2-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants KR 1273/3-2 and PI 837/2-1.	Angelow S, 2008, AM J PHYSIOL-RENAL, V295, pF867, DOI 10.1152/ajprenal.90264.2008; Blasig IE, 2006, CELL MOL LIFE SCI, V63, P505, DOI 10.1007/s00018-005-5472-x; Briggs DC, 2011, J MOL BIOL, V413, P138, DOI 10.1016/j.jmb.2011.07.066; Casagrande F, 2011, CANCER-AM CANCER SOC, V117, P5519, DOI 10.1002/cncr.26215; Ebihara C, 2006, J PHARMACOL EXP THER, V316, P255, DOI 10.1124/jpet.105.093351; Escudero-Esparza A, 2011, FRONT BIOSCI-LANDMRK, V16, P1069, DOI 10.2741/3736; Fofana I, 2010, GASTROENTEROLOGY, V139, P953, DOI 10.1053/j.gastro.2010.05.073; Fujita K, 2000, FEBS LETT, V476, P258, DOI 10.1016/S0014-5793(00)01744-0; Harada M, 2007, BIOCHEM PHARMACOL, V73, P206, DOI 10.1016/j.bcp.2006.10.002; Kakutani H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016611; Katahira J, 1997, J BIOL CHEM, V272, P26652, DOI 10.1074/jbc.272.42.26652; Kimura J, 2010, J BIOL CHEM, V285, P401, DOI 10.1074/jbc.M109.051417; Kitadokoro K, 2011, J BIOL CHEM, V286, P19549, DOI 10.1074/jbc.M111.228478; KokaiKun JF, 1997, INFECT IMMUN, V65, P1014, DOI 10.1128/IAI.65.3.1014-1022.1997; Kominsky SL, 2007, CANCER RES, V67, P7977, DOI 10.1158/0008-5472.CAN-07-1314; Kondoh M, 2006, BIOL PHARM BULL, V29, P1783, DOI 10.1248/bpb.29.1783; Krause G, 2008, BBA-BIOMEMBRANES, V1778, P631, DOI 10.1016/j.bbamem.2007.10.018; Krause G, 2009, ANN NY ACAD SCI, V1165, P34, DOI 10.1111/j.1749-6632.2009.04057.x; McClane BA, 2001, TOXICON, V39, P1781, DOI 10.1016/S0041-0101(01)00164-7; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Ouban A, 2010, HISTOL HISTOPATHOL, V25, P83, DOI 10.14670/HH-25.83; Piehl C, 2010, CELL MOL LIFE SCI, V67, P2131, DOI 10.1007/s00018-010-0332-8; Piontek J, 2008, FASEB J, V22, P146, DOI 10.1096/fj.07-8319com; Piontek J, 2011, CELL MOL LIFE SCI, V68, P3903, DOI 10.1007/s00018-011-0680-z; Robertson SL, 2010, INFECT IMMUN, V78, P505, DOI 10.1128/IAI.00778-09; Saeki R, 2009, MOL PHARMACOL, V76, P918, DOI 10.1124/mol.109.058412; Smedley JG, 2007, INFECT IMMUN, V75, P2381, DOI 10.1128/IAI.01737-06; Sonoda N, 1999, J CELL BIOL, V147, P195, DOI 10.1083/jcb.147.1.195; Takahashi A, 2011, CURR MED CHEM, V18, P1861, DOI 10.2174/092986711795496809; Takahashi A, 2008, BIOCHEM PHARMACOL, V75, P1639, DOI 10.1016/j.bcp.2007.12.016; Turksen K, 2011, BBA-REV CANCER, V1816, P73, DOI 10.1016/j.bbcan.2011.04.001; Van Itallie CM, 2008, J BIOL CHEM, V283, P268, DOI 10.1074/jbc.M708066200; Veshnyakova A, 2010, TOXINS, V2, P1336, DOI 10.3390/toxins2061336; Walther W, 2012, GENE THER, V19, P494, DOI 10.1038/gt.2011.136; Winkler L, 2009, J BIOL CHEM, V284, P18863, DOI 10.1074/jbc.M109.008623; Yu ASL, 2009, J GEN PHYSIOL, V133, P111, DOI 10.1085/jgp.200810154; Zhang JJ, 2010, P NATL ACAD SCI USA, V107, P1425, DOI 10.1073/pnas.0911996107	37	67	68	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					1698	1708		10.1074/jbc.M111.312165	http://dx.doi.org/10.1074/jbc.M111.312165			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22128179	Green Published, hybrid			2022-12-27	WOS:000299321000013
J	Soto-Cardalda, A; Fakas, S; Pascual, F; Choi, HS; Carman, GM				Soto-Cardalda, Anibal; Fakas, Stylianos; Pascual, Florencia; Choi, Hyeon-Son; Carman, George M.			Phosphatidate Phosphatase Plays Role in Zinc-mediated Regulation of Phospholipid Synthesis in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIACYLGLYCEROL PYROPHOSPHATE PHOSPHATASE; SACCHAROMYCES-CEREVISIAE; PHOSPHATIDYLSERINE SYNTHASE; TRANSCRIPTIONAL ACTIVATOR; TRANSPORTER PROTEIN; GENETIC-REGULATION; ESCHERICHIA-COLI; CHOLINE KINASE; LIPIN HOMOLOG; BIOSYNTHESIS	In the yeast Saccharomyces cerevisiae, the synthesis of phospholipids is coordinately regulated by mechanisms that control the homeostasis of the essential mineral zinc (Carman, G. M., and Han, G. S. (2007) Regulation of phospholipid synthesis in Saccharomyces cerevisiae by zinc depletion. Biochim. Biophys. Acta 1771, 322-330; Eide, D. J. (2009) Homeostatic and adaptive responses to zinc deficiency in Saccharomyces cerevisiae. J. Biol. Chem. 284, 18565-18569). The synthesis of phosphatidylcholine is balanced by the repression of CDP-diacylglycerol pathway enzymes and the induction of Kennedy pathway enzymes. PAH1-encoded phosphatidate phosphatase catalyzes the penultimate step in triacylglycerol synthesis, and the diacylglycerol generated in the reaction may also be used for phosphatidylcholine synthesis via the Kennedy pathway. In this work, we showed that the expression of PAH1-encoded phosphatidate phosphatase was induced by zinc deficiency through a mechanism that involved interaction of the Zap1p zinc-responsive transcription factor with putative upstream activating sequence zinc-responsive elements in the PAH1 promoter. The pah1 Delta mutation resulted in the derepression of the CHO1-encoded phosphatidylserine synthase (CDP-diacylglycerol pathway enzyme) and loss of the zinc-mediated regulation of the enzyme. Loss of phosphatidate phosphatase also resulted in the derepression of the CKI1-encoded choline kinase (Kennedy pathway enzyme) but decreased the synthesis of phosphatidylcholine when cells were deficient of zinc. This result confirmed the role phosphatidate phosphatase plays in phosphatidylcholine synthesis via the Kennedy pathway.	[Carman, George M.] Rutgers State Univ, Dept Food Sci, New Brunswick, NJ 08901 USA; Rutgers State Univ, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Carman, GM (corresponding author), Rutgers State Univ, Dept Food Sci, 65 Dudley Rd, New Brunswick, NJ 08901 USA.	carman@aesop.rutgers.edu	Fakas, Stylianos/R-9908-2019; Fakas, Stylianos/AAQ-7594-2020	Fakas, Stylianos/0000-0001-8692-1326; Fakas, Stylianos/0000-0001-8692-1326	National Institutes of Health from the USPHS [GM-28140, GM-75378]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028140, F31GM075378, R37GM028140] Funding Source: NIH RePORTER	National Institutes of Health from the USPHS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM-28140 (to G. M. C.) and GM-75378 (to A. S.-C.) from the USPHS.	BAILIS AM, 1992, NUCLEIC ACIDS RES, V20, P1411, DOI 10.1093/nar/20.6.1411; BAILIS AM, 1987, MOL CELL BIOL, V7, P167, DOI 10.1128/MCB.7.1.167; Bird A, 2000, J BIOL CHEM, V275, P16160, DOI 10.1074/jbc.M000664200; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carman GM, 2007, J BIOL CHEM, V282, P37293, DOI 10.1074/jbc.R700038200; Carman GM, 2007, BBA-MOL CELL BIOL L, V1771, P322, DOI 10.1016/j.bbalip.2006.05.006; Carman GM, 2006, TRENDS BIOCHEM SCI, V31, P694, DOI 10.1016/j.tibs.2006.10.003; Carman GM, 2011, ANNU REV BIOCHEM, V80, P859, DOI 10.1146/annurev-biochem-060409-092229; Carman GM, 2009, J LIPID RES, V50, pS69, DOI 10.1194/jlr.R800043-JLR200; Carman GM, 2009, J BIOL CHEM, V284, P2593, DOI 10.1074/jbc.R800059200; CARMAN GM, 1992, METHOD ENZYMOL, V209, P298; Carman GM, 1999, PROG LIPID RES, V38, P361, DOI 10.1016/S0163-7827(99)00010-7; CARMAN GM, 1991, METHOD ENZYMOL, V197, P548; Carman GM, 1997, BBA-LIPID LIPID MET, V1348, P45, DOI 10.1016/S0005-2760(97)00095-7; Choi HS, 2011, J BIOL CHEM, V286, P1486, DOI 10.1074/jbc.M110.155598; CRAVEN GR, 1965, J BIOL CHEM, V240, P2468; Devirgiliis C, 2004, BIOCHEM BIOPH RES CO, V323, P58, DOI 10.1016/j.bbrc.2004.08.051; Eide DJ, 2009, J BIOL CHEM, V284, P18565, DOI 10.1074/jbc.R900014200; Eide DJ, 2003, J NUTR, V133, p1532S, DOI 10.1093/jn/133.5.1532S; Ellis CD, 2005, J BIOL CHEM, V280, P28811, DOI 10.1074/jbc.M505500200; Ellis CD, 2004, J CELL BIOL, V166, P325, DOI 10.1083/jcb.200401157; Fakas S, 2011, J BIOL CHEM, V286, P29074, DOI 10.1074/jbc.M111.258798; Fakas S, 2011, J BIOL CHEM, V286, P1464, DOI 10.1074/jbc.M110.194308; Furneisen JM, 2000, BBA-MOL CELL BIOL L, V1484, P71, DOI 10.1016/S1388-1981(99)00202-4; Gaspar ML, 2007, BBA-MOL CELL BIOL L, V1771, P241, DOI 10.1016/j.bbalip.2006.06.011; Greenberg ML, 1996, MICROBIOL REV, V60, P1; GURUPRASAD K, 1990, PROTEIN ENG, V4, P155, DOI 10.1093/protein/4.2.155; Habeler G, 2002, NUCLEIC ACIDS RES, V30, P80, DOI 10.1093/nar/30.1.80; Han GS, 2007, J BIOL CHEM, V282, P37026, DOI 10.1074/jbc.M705777200; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Han GS, 2004, J BIOL CHEM, V279, P5338, DOI 10.1074/jbc.M311779200; Han GS, 2001, J BIOL CHEM, V276, P10126, DOI 10.1074/jbc.M011421200; Han SH, 2005, J BIOL CHEM, V280, P29017, DOI 10.1074/jbc.M505881200; Henry SA, 1998, PROG NUCLEIC ACID RE, V61, P133, DOI 10.1016/S0079-6603(08)60826-0; Innis MA, 1990, PCR PROTOCOLS GUIDE, P3; IRIE K, 1993, MOL GEN GENET, V236, P283, DOI 10.1007/BF00277124; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Iwanyshyn WM, 2004, J BIOL CHEM, V279, P21976, DOI 10.1074/jbc.M402047200; Karanasios E, 2010, P NATL ACAD SCI USA, V107, P17539, DOI 10.1073/pnas.1007974107; Kersting MC, 2006, J BIOL CHEM, V281, P13110, DOI 10.1074/jbc.M601612200; Kim KH, 1998, J BIOL CHEM, V273, P6844, DOI 10.1074/jbc.273.12.6844; Kumar A, 2002, GENE DEV, V16, P707, DOI 10.1101/gad.970902; LAMPING E, 1994, GENETICS, V137, P55; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; Lyons TJ, 2000, P NATL ACAD SCI USA, V97, P7957, DOI 10.1073/pnas.97.14.7957; MacDiarmid CW, 2003, J BIOL CHEM, V278, P15065, DOI 10.1074/jbc.M300568200; MacDiarmid CW, 2000, EMBO J, V19, P2845, DOI 10.1093/emboj/19.12.2845; Miyabe S, 2001, BIOCHEM BIOPH RES CO, V282, P79, DOI 10.1006/bbrc.2001.4522; Muhlenhoff U, 2003, J BIOL CHEM, V278, P40612, DOI 10.1074/jbc.M307847200; NIKAWA J, 1993, MOL MICROBIOL, V10, P955, DOI 10.1111/j.1365-2958.1993.tb00967.x; O'Hara L, 2006, J BIOL CHEM, V281, P34537, DOI 10.1074/jbc.M606654200; Oshiro J, 2003, BBA-MOL CELL BIOL L, V1635, P1, DOI 10.1016/j.bbalip.2003.10.002; Oshiro J, 2000, J BIOL CHEM, V275, P40887, DOI 10.1074/jbc.M008144200; POOLE MA, 1986, J BACTERIOL, V168, P668, DOI 10.1128/jb.168.2.668-672.1986; PORTER TJ, 1992, METHOD ENZYMOL, V209, P134; RATTRAY JBM, 1975, BACTERIOL REV, V39, P197, DOI 10.1128/MMBR.39.3.197-231.1975; Rose MD., 1990, METHODS YEAST GENETI; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; SCHWABE JWR, 1994, NAT STRUCT BIOL, V1, P345, DOI 10.1038/nsb0694-345; Soto A, 2008, J BIOL CHEM, V283, P10079, DOI 10.1074/jbc.M800502200; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Toke DA, 1998, J BIOL CHEM, V273, P3278, DOI 10.1074/jbc.273.6.3278; Toke DA, 1998, J BIOL CHEM, V273, P14331, DOI 10.1074/jbc.273.23.14331; VALLEE BL, 1993, PHYSIOL REV, V73, P79, DOI 10.2466/pr0.1993.73.1.79; Wagner C, 2001, MOL MICROBIOL, V41, P155, DOI 10.1046/j.1365-2958.2001.02495.x; Waters BM, 2002, J BIOL CHEM, V277, P33749, DOI 10.1074/jbc.M206214200; Wu WI, 1996, J BIOL CHEM, V271, P1868, DOI 10.1074/jbc.271.4.1868; Zhao H, 1998, J BIOL CHEM, V273, P28713, DOI 10.1074/jbc.273.44.28713; Zhao H, 1997, MOL CELL BIOL, V17, P5044, DOI 10.1128/MCB.17.9.5044; Zhao H, 1996, J BIOL CHEM, V271, P23203, DOI 10.1074/jbc.271.38.23203; Zhao H, 1996, P NATL ACAD SCI USA, V93, P2454, DOI 10.1073/pnas.93.6.2454	74	36	40	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					968	977		10.1074/jbc.M111.313130	http://dx.doi.org/10.1074/jbc.M111.313130			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22128164	hybrid, Green Published			2022-12-27	WOS:000299170300015
J	Wang, LW; Cvetkov, TL; Chance, MR; Moiseenkova-Bell, VY				Wang, Liwen; Cvetkov, Teresa L.; Chance, Mark R.; Moiseenkova-Bell, Vera Y.			Identification of in Vivo Disulfide Conformation of TRPA1 Ion Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; REDOX REGULATION; COVALENT MODIFICATION; TRPV1 CHANNEL; RECEPTOR; ACTIVATION; GLUTATHIONYLATION; PHOSPHATASE; MASSMATRIX; PEPTIDES	TRPA1(transient receptor potential ankyrin 1) is an ion channel expressed in the termini of sensory neurons and is activated in response to a broad array of noxious exogenous and endogenous thiol-reactive compounds, making it a crucial player in chemical nociception. A number of conserved cysteine residues on the N-terminal domain of the channel have been identified as critical for sensing these electrophilic pungent chemicals, and our recent EM structure with modeled domains predicts that these cysteines form a ligand-binding pocket, allowing for the possibility of disulfide bonding between the cysteine residues. Here, we present a comprehensive mass spectrometry investigation of the in vivo disulfide bonding conformation and in vitro reactivity of 30 of the 31 cysteine residues in the TRPA1 ion channel. Four disulfide bonds were detected in the in vivo TRPA1 structure: Cys-666-Cys-622, Cys-666-Cys-463, Cys-622-Cys-609, and Cys-666-Cys-193. All of the cysteines detected were reactive to N-methylmaleimide (NMM) in vitro, with varying degrees of labeling efficiency. Comparison of the ratio of the labeling efficiency at 300 mu M versus 2 mM NMM identified a number of cysteine residues that were outliers from the mean labeling ratio, suggesting that protein conformation changes rendered these cysteines either more or less protected from labeling at the higher NMM concentrations. These results indicate that the activation mechanism of TRPA1 may involve N-terminal conformation changes and disulfide bonding between critical cysteine residues.	[Cvetkov, Teresa L.; Moiseenkova-Bell, Vera Y.] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Wang, Liwen; Chance, Mark R.] Case Western Reserve Univ, Sch Med, Ctr Prote, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Moiseenkova-Bell, VY (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, Wood Bldg,W151D,10900 Euclid Ave, Cleveland, OH 44106 USA.	vxm102@case.edu			National Institutes of Health, NIBIB [R01 EB09688]; American Lung Association [RG-166985-N]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009688] Funding Source: NIH RePORTER	National Institutes of Health, NIBIB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); American Lung Association; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 EB09688 from NIBIB (to M. R. C.). This work was also supported by American Lung Association Biomedical Research Grant RG-166985-N (to V.Y.M.-B.).	Auchere F, 2008, HUM MOL GENET, V17, P2790, DOI 10.1093/hmg/ddn178; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Barrett WC, 1999, BIOCHEMISTRY-US, V38, P6699, DOI 10.1021/bi990240v; Bautista DM, 2005, P NATL ACAD SCI USA, V102, P12248, DOI 10.1073/pnas.0505356102; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Caterina MJ, 2007, NATURE, V445, P491, DOI 10.1038/nature05565; Chen CY, 2009, BIOCHEMISTRY-US, V48, P1399, DOI 10.1021/bi801973z; Cordero-Morales JF, 2011, P NATL ACAD SCI USA, V108, pE1184, DOI 10.1073/pnas.1114124108; Cvetkov TL, 2011, J BIOL CHEM, V286, P38168, DOI 10.1074/jbc.M111.288993; Fernandez-Ballester G, 2008, J MEMBRANE BIOL, V223, P161, DOI 10.1007/s00232-008-9123-7; Filomeni G, 2005, CELL DEATH DIFFER, V12, P1555, DOI 10.1038/sj.cdd.4401754; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; Hu JJ, 2008, J BIOL CHEM, V283, P29126, DOI 10.1074/jbc.M803028200; Kang K, 2010, NATURE, V464, P597, DOI 10.1038/nature08848; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; Mieyal JJ, 2008, ANTIOXID REDOX SIGN, V10, P1941, DOI 10.1089/ars.2008.2089; Moiseenkova VY, 2003, BIOCHEM BIOPH RES CO, V310, P196, DOI 10.1016/j.bbrc.2003.09.011; Moiseenkova-Bell V, 2011, ADV EXP MED BIOL, V704, P25, DOI 10.1007/978-94-007-0265-3_2; Moiseenkova-Bell VY, 2008, P NATL ACAD SCI USA, V105, P7451, DOI 10.1073/pnas.0711835105; Moiseenkova-Bell VY, 2009, J GEN PHYSIOL, V133, P239, DOI 10.1085/jgp.200810123; Murray DB, 2011, BBA-GEN SUBJECTS, V1810, P945, DOI 10.1016/j.bbagen.2011.04.005; Myers BR, 2008, NEURON, V58, P362, DOI 10.1016/j.neuron.2008.04.012; Myers BR, 2008, J GEN PHYSIOL, V132, P481, DOI 10.1085/jgp.200810104; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Rodriguez CE, 2004, TOXICOLOGY, V201, P185, DOI 10.1016/j.tox.2004.04.016; Seth D, 2006, BIOCHEMISTRY-US, V45, P8476, DOI 10.1021/bi060157p; Sohn J, 2003, BIOCHEMISTRY-US, V42, P10060, DOI 10.1021/bi0345081; Takahashi N, 2008, CHANNELS, V2, P287, DOI 10.4161/chan.2.4.6745; Takahashi N, 2011, NAT CHEM BIOL, V7, P701, DOI [10.1038/NCHEMBIO.640, 10.1038/nchembio.640]; Trevisani M, 2007, P NATL ACAD SCI USA, V104, P13519, DOI 10.1073/pnas.0705923104; Tsai SJ, 2009, BIOCHEMISTRY-US, V48, P4838, DOI 10.1021/bi900166y; Xu H, 2008, J PROTEOME RES, V7, P138, DOI 10.1021/pr070363z; Xu H, 2009, PROTEOMICS, V9, P1763, DOI 10.1002/pmic.200800282; Xu H, 2009, PROTEOMICS, V9, P1548, DOI 10.1002/pmic.200700322	34	53	55	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6169	6176		10.1074/jbc.M111.329748	http://dx.doi.org/10.1074/jbc.M111.329748			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22207754	Green Published, hybrid			2022-12-27	WOS:000300791800010
J	Bedrood, S; Li, YY; Isas, JM; Hegde, BG; Baxa, U; Haworth, IS; Langen, R				Bedrood, Sahar; Li, Yiyu; Isas, J. Mario; Hegde, Balachandra G.; Baxa, Ulrich; Haworth, Ian S.; Langen, Ralf			Fibril Structure of Human Islet Amyloid Polypeptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLID-STATE NMR; EXPERIMENTAL CONSTRAINTS; INSULIN-SECRETION; HUMAN AMYLIN; PEPTIDE; PROTEIN; MODEL; MICE; CONFORMATION; AGGREGATION	Misfolding and amyloid fibril formation by human islet amyloid polypeptide (hIAPP) are thought to be important in the pathogenesis of type 2 diabetes, but the structures of the misfolded forms remain poorly understood. Here we developed an approach that combines site-directed spin labeling with continuous wave and pulsed EPR to investigate local secondary structure and to determine the relative orientation of the secondary structure elements with respect to each other. These data indicated that individual hIAPP molecules take up a hairpin fold within the fibril. This fold contains two beta-strands that are much farther apart than expected from previous models. Atomistic structural models were obtained using computational refinement with EPR data as constraints. The resulting family of structures exhibited a left-handed helical twist, in agreement with the twisted morphology observed by electron microscopy. The fibril protofilaments contain stacked hIAPP monomers that form opposing beta-sheets that twist around each other. The two beta-strands of the monomer adopt out-of-plane positions and are staggered by about three peptide layers (similar to 15 angstrom). These results provide a mechanism for hIAPP fibril formation and could explain the remarkable stability of the fibrils. Thus, the structural model serves as a starting point for understanding and preventing hIAPP misfolding.	[Langen, Ralf] Univ So Calif, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA; [Li, Yiyu; Haworth, Ian S.] Univ So Calif, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA 90089 USA; [Baxa, Ulrich] NIAMS, Struct Biol Lab, NIH, Bethesda, MD 20892 USA	University of Southern California; University of Southern California; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Langen, R (corresponding author), Univ So Calif, Zilkha Neurogenet Inst, 1501 San Pablo St, Los Angeles, CA 90033 USA.	langen@usc.edu	Hegde, Balachandra/GPS-6028-2022	Baxa, Ulrich/0000-0002-7263-5078	National Institutes of Health [AG027936]; University of Southern California Center for High-performance Computing and Communications; NATIONAL INSTITUTE ON AGING [R01AG027936] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Southern California Center for High-performance Computing and Communications; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG027936 (to R. L.).; Computation for the work described in this study was supported by the University of Southern California Center for High-performance Computing and Communications.	Ahren B, 1998, DIABETOLOGIA, V41, P1374, DOI 10.1007/s001250051079; Antzutkin ON, 2002, BIOCHEMISTRY-US, V41, P15436, DOI 10.1021/bi0204185; Butler AE, 2004, DIABETES, V53, P1509, DOI 10.2337/diabetes.53.6.1509; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chiang YW, 2005, J MAGN RESON, V172, P279, DOI 10.1016/j.jmr.2004.10.012; CLARK A, 1995, DIABETES RES CLIN PR, V28, pS39, DOI 10.1016/0168-8227(95)01075-O; CLARK A, 1987, LANCET, V2, P231; COOPER GJS, 1987, P NATL ACAD SCI USA, V84, P8628, DOI 10.1073/pnas.84.23.8628; Gebre-Medhin S, 1998, BIOCHEM BIOPH RES CO, V250, P271, DOI 10.1006/bbrc.1998.9308; Goldsbury CS, 1997, J STRUCT BIOL, V119, P17, DOI 10.1006/jsbi.1997.3858; Hatmal MM, 2012, BIOPOLYMERS, V97, P35, DOI 10.1002/bip.21699; Higham CE, 2000, FEBS LETT, V470, P55, DOI 10.1016/S0014-5793(00)01287-4; Janson J, 1996, P NATL ACAD SCI USA, V93, P7283, DOI 10.1073/pnas.93.14.7283; Jao CC, 2010, J BIOL CHEM, V285, P20164, DOI 10.1074/jbc.M110.127811; Jao CC, 2008, P NATL ACAD SCI USA, V105, P19666, DOI 10.1073/pnas.0807826105; Jayasinghe SA, 2004, J BIOL CHEM, V279, P48420, DOI 10.1074/jbc.M406853200; Jeschke G, 2006, APPL MAGN RESON, V30, P473, DOI 10.1007/BF03166213; KAHN SE, 1990, DIABETES, V39, P634, DOI 10.2337/diabetes.39.5.634; Kahn SE, 1999, DIABETES, V48, P241, DOI 10.2337/diabetes.48.2.241; Kajava AV, 2005, J MOL BIOL, V348, P247, DOI 10.1016/j.jmb.2005.02.029; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Luca S, 2007, BIOCHEMISTRY-US, V46, P13505, DOI 10.1021/bi701427q; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Makin OS, 2004, J MOL BIOL, V335, P1279, DOI 10.1016/j.jmb.2003.11.048; Mchaourab HS, 1996, BIOCHEMISTRY-US, V35, P7692, DOI 10.1021/bi960482k; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Petkova AT, 2006, BIOCHEMISTRY-US, V45, P498, DOI 10.1021/bi051952q; Radovan D, 2008, BIOCHEMISTRY-US, V47, P6352, DOI 10.1021/bi800503j; Stefani M, 2004, BBA-MOL BASIS DIS, V1739, P5, DOI 10.1016/j.bbadis.2004.08.004; Torok M, 2002, J BIOL CHEM, V277, P40810, DOI 10.1074/jbc.M205659200; WESTERMARK P, 1987, LANCET, V2, P623; WESTERMARK P, 1987, P NATL ACAD SCI USA, V84, P3881, DOI 10.1073/pnas.84.11.3881; Wiltzius JJW, 2008, PROTEIN SCI, V17, P1467, DOI 10.1110/ps.036509.108; Young Andrew, 2005, Adv Pharmacol, V52, P79, DOI 10.1016/S1054-3589(05)52005-2	34	119	119	1	53	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5235	5241		10.1074/jbc.M111.327817	http://dx.doi.org/10.1074/jbc.M111.327817			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22187437	hybrid, Green Published			2022-12-27	WOS:000300638000006
J	Reid, DW; Nicchitta, CV				Reid, David W.; Nicchitta, Christopher V.			Primary Role for Endoplasmic Reticulum-bound Ribosomes in Cellular Translation Identified by Ribosome Profiling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA TRANSLATION; PANCREATIC EXOCRINE CELL; GENOME-WIDE ANALYSIS; PROTEIN-SYNTHESIS; MAMMALIAN-CELLS; STAPHYLOCOCCUS-AUREUS; GENE-EXPRESSION; RAT-LIVER; MEMBRANE; LOCALIZATION	In eukaryotic cells, the spatial regulation of protein expression is frequently conferred through the coupling of mRNA localization and the local control of translation. mRNA localization to the endoplasmic reticulum (ER) is a prominent example of such regulation and serves a ubiquitous role in segregating the synthesis of secretory and integral membrane proteins to the ER. Recent genomic and biochemical studies have now expanded this view to suggest a more substantial role for the ER cellular protein synthesis. We have utilized cell fractionation and ribosome profiling to obtain a genomic survey of the subcellular organization of mRNA translation and report that ribosomal loading of mRNAs, a proxy for mRNA translation, is biased to the ER. Notably, ER-associated mRNAs encoding both cytosolic and topogenic signal-encoding proteins display similar ribosome loading densities, suggesting that ER-associated ribosomes serve a global role in mRNA translation. We propose that the partitioning of mRNAs and their translation between the cytosol and ER compartments may represent a novel mechanism for the post-transcriptional regulation of gene expression.	[Reid, David W.; Nicchitta, Christopher V.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Nicchitta, Christopher V.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA	Duke University; Duke University	Nicchitta, CV (corresponding author), Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA.	christopher.nicchitta@duke.edu			National Institutes of Health [GM077382, GM077382-OS31]; Duke University School of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077382, R01GM101533] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Duke University School of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM077382 and GM077382-OS31 (to C. V. N.). This work was also supported by a Core Facilities voucher from the Duke University School of Medicine.	Aragon T, 2009, NATURE, V457, P736, DOI 10.1038/nature07641; Arava Y, 2003, P NATL ACAD SCI USA, V100, P3889, DOI 10.1073/pnas.0635171100; ARNONE A, 1971, J BIOL CHEM, V246, P2302; Besse F, 2008, NAT REV MOL CELL BIO, V9, P971, DOI 10.1038/nrm2548; Blobel G, 1979, Symp Soc Exp Biol, V33, P9; BLOBEL G, 1971, P NATL ACAD SCI USA, V68, P390, DOI 10.1073/pnas.68.2.390; CARO LG, 1964, J CELL BIOL, V20, P473, DOI 10.1083/jcb.20.3.473; Chen Q, 2011, MOL BIOL CELL, V22, P2646, DOI 10.1091/mbc.E11-03-0239; Diehn M, 2000, NAT GENET, V25, P58, DOI 10.1038/75603; Diehn M, 2006, PLOS GENET, V2, P39, DOI 10.1371/journal.pgen.0020011; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; HEINS JN, 1967, J BIOL CHEM, V242, P1016; HICKS SJ, 1969, SCIENCE, V164, P584, DOI 10.1126/science.164.3879.584; Hyde M, 2002, J CELL BIOL, V156, P993, DOI 10.1083/jcb.200112008; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Jagannathan S, 2011, METHODS MOL BIOL, V714, P301, DOI 10.1007/978-1-61779-005-8_19; JAMIESON JD, 1967, J CELL BIOL, V34, P577, DOI 10.1083/jcb.34.2.577; Kondrashov N, 2011, CELL, V145, P383, DOI 10.1016/j.cell.2011.03.028; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lerner RS, 2006, RNA, V12, P775, DOI 10.1261/rna.2318906; Lerner RS, 2003, RNA, V9, P1123, DOI 10.1261/rna.5610403; Liao GN, 2011, J CELL SCI, V124, P589, DOI 10.1242/jcs.072421; Mansfield KD, 2009, BIOL CELL, V101, P169, DOI 10.1042/BC20080055; Martin KC, 2009, CELL, V136, P719, DOI 10.1016/j.cell.2009.01.044; MATLASHEWSKI G, 1984, EMBO J, V3, P3257, DOI 10.1002/j.1460-2075.1984.tb02287.x; MECHLER B, 1981, J CELL BIOL, V88, P29, DOI 10.1083/jcb.88.1.29; MUECKLER MM, 1981, J CELL BIOL, V90, P495, DOI 10.1083/jcb.90.2.495; Nicchitta CV, 2005, BIOCHEM CELL BIOL, V83, P687, DOI 10.1139/O05-147; Potter MD, 2000, J BIOL CHEM, V275, P33828, DOI 10.1074/jbc.M005294200; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; RABINOVITZ M, 1962, J BIOL CHEM, V237, P477; REDMAN CM, 1969, J BIOL CHEM, V244, P4308; Seiser RM, 2000, J BIOL CHEM, V275, P33820, DOI 10.1074/jbc.M004462200; SIEKEVITZ P, 1958, J BIOPHYS BIOCHEM CY, V4, P203, DOI 10.1083/jcb.4.2.203; Stephens SB, 2008, MOL BIOL CELL, V19, P623, DOI 10.1091/mbc.E07-07-0677; Stephens Samuel B., 2008, V419, P197, DOI 10.1007/978-1-59745-033-1_14; Stephens SB, 2007, METHOD ENZYMOL, V431, P47, DOI 10.1016/S0076-6879(07)31004-5; Stephens SB, 2005, MOL BIOL CELL, V16, P5819, DOI 10.1091/mbc.E05-07-0685; Togawa K, 2000, J CELL PHYSIOL, V183, P129, DOI 10.1002/(SICI)1097-4652(200004)183:1<129::AID-JCP15>3.0.CO;2-S; Unsworth H, 2010, FASEB J, V24, P3370, DOI 10.1096/fj.09-151142; WALTER P, 1980, P NATL ACAD SCI-BIOL, V77, P7112, DOI 10.1073/pnas.77.12.7112; WALTER P, 1981, J CELL BIOL, V91, P551, DOI 10.1083/jcb.91.2.551; WOLIN SL, 1988, EMBO J, V7, P3559, DOI 10.1002/j.1460-2075.1988.tb03233.x	45	130	133	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5518	5527		10.1074/jbc.M111.312280	http://dx.doi.org/10.1074/jbc.M111.312280			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22199352	hybrid, Green Published			2022-12-27	WOS:000300638000031
J	Lee, HJ; Mariappan, MM; Feliers, D; Cavaglieri, RC; Sataranatarajan, K; Abboud, HE; Choudhury, GG; Kasinath, BS				Lee, Hak Joo; Mariappan, Meenalakshmi M.; Feliers, Denis; Cavaglieri, Rita C.; Sataranatarajan, Kavithalakshmi; Abboud, Hanna E.; Choudhury, Goutam Ghosh; Kasinath, Balakuntalam S.			Hydrogen Sulfide Inhibits High Glucose-induced Matrix Protein Synthesis by Activating AMP-activated Protein Kinase in Renal Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA TRANSLATION; CYSTATHIONINE-GAMMA-LYASE; DIABETIC-NEPHROPATHY; MYOCARDIAL-ISCHEMIA; REPERFUSION INJURY; SULFANE SULFUR; KNOCKOUT MICE; HYPERTROPHY; GROWTH; RAT	Hydrogen sulfide, a signaling gas, affects several cell functions. We hypothesized that hydrogen sulfide modulates high glucose (30 mM) stimulation of matrix protein synthesis in glomerular epithelial cells. High glucose stimulation of global protein synthesis, cellular hypertrophy, and matrix laminin and type IV collagen content was inhibited by sodium hydrosulfide (NaHS), an H2S donor. High glucose activation of mammalian target of rapamycin (mTOR) complex 1 (mTORC1), shown by phosphorylation of p70S6 kinase and 4E-BP1, was inhibited by NaHS. High glucose stimulated mTORC1 to promote key events in the initiation and elongation phases of mRNA translation: binding of eIF4A to eIF4G, reduction in PDCD4 expression and inhibition of its binding to eIF4A, eEF2 kinase phosphorylation, and dephosphorylation of eEF2; these events were inhibited by NaHS. The role of AMP-activated protein kinase (AMPK), an inhibitor of protein synthesis, was examined. NaHS dose-dependently stimulated AMPK phosphorylation and restored AMPK phosphorylation reduced by high glucose. Compound C, an AMPK inhibitor, abolished NaHS modulation of high glucose effect on events in mRNA translation as well as global and matrix protein synthesis. NaHS induction of AMPK phosphorylation was inhibited by siRNA for calmodulin kinase kinase beta, but not LKB1, upstream kinases for AMPK; STO-609, a calmodulin kinase kinase beta inhibitor, had the same effect. Renal cortical content of cystathionine beta-synthase and cystathionine gamma-lyase, hydrogen sulfide-generating enzymes, was significantly reduced in mice with type 1 diabetes or type 2 diabetes, coinciding with renal hypertrophy and matrix accumulation. Hydrogen sulfide is a newly identified modulator of protein synthesis in the kidney, and reduction in its generation may contribute to kidney injury in diabetes.	[Lee, Hak Joo; Mariappan, Meenalakshmi M.; Feliers, Denis; Cavaglieri, Rita C.; Sataranatarajan, Kavithalakshmi; Abboud, Hanna E.; Choudhury, Goutam Ghosh; Kasinath, Balakuntalam S.] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Lee, Hak Joo; Mariappan, Meenalakshmi M.; Sataranatarajan, Kavithalakshmi; Abboud, Hanna E.; Choudhury, Goutam Ghosh; Kasinath, Balakuntalam S.] S Texas Vet Hlth Care Syst, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Kasinath, BS (corresponding author), 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	kasinath@uthscsa.edu		Feliers, Denis/0000-0003-1952-1386	National Institutes of Health [DK077295, RC2AG036613, DK050190]; Veterans Affairs Medical Research Service; Juvenile Diabetes Research Foundation [1-2010-141, 1-2008-185]; Veterans Affairs Research Career Scientist Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077295, R01DK050190, R29DK050190, R01DK078971] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RC2AG036613] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Medical Research Service(US Department of Veterans Affairs); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Veterans Affairs Research Career Scientist Award(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants DK077295 and RC2AG036613 (to B. S. K.) and DK050190 (to G. G. C.). This work was also supported by a grant from the Veterans Affairs Medical Research Service (to B. S. K. and G. G. C.) and Juvenile Diabetes Research Foundation Grants 1-2010-141 (to D. F.) and 1-2008-185 (to G. G. C.).; Recipient of a Veterans Affairs Research Career Scientist Award.	Abe K, 1996, J NEUROSCI, V16, P1066; Bian JS, 2006, J PHARMACOL EXP THER, V316, P670, DOI 10.1124/jpet.105.092023; Blattler SM, 2007, P NATL ACAD SCI USA, V104, P1045, DOI 10.1073/pnas.0610216104; Calvert JW, 2009, CIRC RES, V105, P365, DOI 10.1161/CIRCRESAHA.109.199919; Carling D, 2008, INT J OBESITY, V32, pS55, DOI 10.1038/ijo.2008.124; Carrera AC, 2004, J CELL SCI, V117, P4615, DOI 10.1242/jcs.01311; Castro AF, 2003, J BIOL CHEM, V278, P32493, DOI 10.1074/jbc.C300226200; Das F, 2008, CELL SIGNAL, V20, P409, DOI 10.1016/j.cellsig.2007.10.027; Das F, 2011, CELL SIGNAL, V23, P1311, DOI 10.1016/j.cellsig.2011.03.012; Dey N, 2010, J CELL PHYSIOL, V225, P27, DOI 10.1002/jcp.22186; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Eid AA, 2010, J BIOL CHEM, V285, P37503, DOI 10.1074/jbc.M110.136796; Elrod JW, 2007, P NATL ACAD SCI USA, V104, P15560, DOI 10.1073/pnas.0705891104; EPSTEIN PN, 1989, CELL, V58, P1067, DOI 10.1016/0092-8674(89)90505-9; Givvimani S, 2011, J APPL PHYSIOL, V110, P1093, DOI 10.1152/japplphysiol.01064.2010; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Ha TS, 1999, J AM SOC NEPHROL, V10, P1931; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hawley SA, 2010, CELL METAB, V11, P554, DOI 10.1016/j.cmet.2010.04.001; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Ishigami M, 2009, ANTIOXID REDOX SIGN, V11, P205, DOI [10.1089/ars.2008.2132, 10.1089/ARS.2008.2132]; Jain SK, 2010, ANTIOXID REDOX SIGN, V12, P1333, DOI 10.1089/ars.2009.2956; Kasinath B. S., 2003, CONT DIABETES DIABET, P97; Kasinath BS, 2009, AM J PHYSIOL-RENAL, V297, pF1153, DOI 10.1152/ajprenal.90748.2008; Kim EK, 2004, J BIOL CHEM, V279, P19970, DOI 10.1074/jbc.M402165200; Lee MJ, 2007, AM J PHYSIOL-RENAL, V292, pF617, DOI 10.1152/ajprenal.00278.2006; Lee MJ, 2010, CELL SIGNAL, V22, P65, DOI 10.1016/j.cellsig.2009.09.011; Li L, 2011, ANNU REV PHARMACOL, V51, P169, DOI 10.1146/annurev-pharmtox-010510-100505; Lu M, 2010, J AM SOC NEPHROL, V21, P993, DOI 10.1681/ASN.2009090949; Mariappan MM, 2008, J BIOL CHEM, V283, P30566, DOI 10.1074/jbc.M801756200; Mariappan MM, 2011, AM J PHYSIOL-RENAL, V300, pF219, DOI 10.1152/ajprenal.00207.2010; Mariappan MM, 2005, J BIOL CHEM, V280, P28402, DOI 10.1074/jbc.M504861200; Minamishima S, 2009, CIRCULATION, V120, P888, DOI 10.1161/CIRCULATIONAHA.108.833491; Miner JH, 2011, PEDIATR NEPHROL, V26, P1413, DOI 10.1007/s00467-011-1785-1; NAIRN AC, 1987, J BIOL CHEM, V262, P17299; Parsyan A, 2011, NAT REV MOL CELL BIO, V12, P235, DOI 10.1038/nrm3083; Perna AF, 2009, NEPHROL DIAL TRANSPL, V24, P3756, DOI 10.1093/ndt/gfp378; Predmore Benjamin L, 2011, Expert Rev Clin Pharmacol, V4, P83, DOI 10.1586/ecp.10.56; Redpath NT, 1996, EMBO J, V15, P2291, DOI 10.1002/j.1460-2075.1996.tb00582.x; Rogers GW, 2001, J BIOL CHEM, V276, P30914, DOI 10.1074/jbc.M100157200; Sataranatarajan K, 2007, AM J PATHOL, V171, P1733, DOI 10.2353/ajpath.2007.070412; Scotland RS, 2005, CIRCULATION, V111, P796, DOI 10.1161/01.CIR.0000155238.70797.4E; Sen U, 2010, AM J NEPHROL, V31, P442, DOI 10.1159/000296717; Sen U, 2009, AM J PHYSIOL-RENAL, V297, pF410, DOI 10.1152/ajprenal.00145.2009; Senthil D, 2003, KIDNEY INT, V64, P468, DOI 10.1046/j.1523-1755.2003.00135.x; Shi YX, 2007, AM J PHYSIOL-HEART C, V293, pH2093, DOI 10.1152/ajpheart.00088.2007; Shibuya N, 2009, ANTIOXID REDOX SIGN, V11, P703, DOI [10.1089/ars.2008.2253, 10.1089/ARS.2008.2253]; Sivarajah A, 2006, SHOCK, V26, P154, DOI 10.1097/01.shk.0000225722.56681.64; Sonenberg N, 2007, MOL CELL, V28, P721, DOI 10.1016/j.molcel.2007.11.018; STIPANUK MH, 1982, BIOCHEM J, V206, P267, DOI 10.1042/bj2060267; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P917, DOI 10.1038/nrd2425; TOOHEY JI, 1989, BIOCHEM J, V264, P625, DOI 10.1042/bj2640625; Tripatara P, 2008, LAB INVEST, V88, P1038, DOI 10.1038/labinvest.2008.73; Wang R, 2002, FASEB J, V16, P1792, DOI 10.1096/fj.02-0211hyp; Wang XM, 2001, EMBO J, V20, P4370, DOI 10.1093/emboj/20.16.4370; Whiteman M, 2010, DIABETOLOGIA, V53, P1722, DOI 10.1007/s00125-010-1761-5; Wolf G, 2005, KIDNEY INT, V68, P1583, DOI 10.1111/j.1523-1755.2005.00570.x; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Yang HS, 2004, MOL CELL BIOL, V24, P3894, DOI 10.1128/MCB.24.9.3894-3906.2004; Yuan P, 2011, NEPHROL DIAL TRANSPL, V26, P2119, DOI 10.1093/ndt/gfq749; Zhao WM, 2002, AM J PHYSIOL-HEART C, V283, pH474, DOI 10.1152/ajpheart.00013.2002; Zheng SR, 2004, DIABETES, V53, P3248, DOI 10.2337/diabetes.53.12.3248; Zhu YZ, 2007, J APPL PHYSIOL, V102, P261, DOI 10.1152/japplphysiol.00096.2006; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	65	92	100	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4451	4461		10.1074/jbc.M111.278325	http://dx.doi.org/10.1074/jbc.M111.278325			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22158625	hybrid, Green Published			2022-12-27	WOS:000300608500009
J	Ohana, E; Shcheynikov, N; Park, M; Muallem, S				Ohana, Ehud; Shcheynikov, Nikolay; Park, Meeyoung; Muallem, Shmuel			Solute Carrier Family 26 Member a2 (Slc26a2) Protein Functions as an Electroneutral SO42-/OH-/Cl- Exchanger Regulated by Extracellular Cl-	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DYSPLASIA SULFATE TRANSPORTER; MULTIPLE EPIPHYSEAL DYSPLASIA; CYSTIC-FIBROSIS; DTDST GENE; CHONDRODYSPLASIA PHENOTYPE; CHLORIDE CHANNEL; PANCREATIC-DUCT; HCO3-SECRETION; MALE-FERTILITY; FINE-STRUCTURE	Slc26a2 is a ubiquitously expressed SO42- transporter with high expression levels in cartilage and several epithelia. Mutations in SLC26A2 are associated with diastrophic dysplasia. The mechanism by which Slc26a2 transports SO42- and the ion gradients that mediate SO42- uptake are poorly understood. We report here that Slc26a2 functions as an SO42-/2OH(-), SO42-/2Cl(-), andSO(4)(2-)/OH-/Cl- exchanger, depending on the Cl- and OH- gradients. At inward Cl- and outward pH gradients (high Cl-o(-) and low pH(o)) Slc26a2 functions primarily as an SO4o2-/2OH(i)(-) exchanger. At low Cl-o(-) and high pH(o) Slc26a2 functions increasingly as an SO4o2-/2Cl(i)(-) exchanger. The reverse is observed for SO4i2-/2OH(o)(-) and SO4i2-/2Cl(o)(-) exchange. Slc26a2 also exchanges Cl- for I-, Br-, and NO3- and Cl-o(-) competes with SO42- on the transport site. Interestingly, Slc26a2 is regulated by an extracellular anion site, required to activate SO4i2-/2OH(o)(-) exchange. Slc26a2 can transport oxalate in exchange for OH- and/or Cl- with properties similar to SO42- transport. Modeling of the Slc26a2 transmembrane domain (TMD) structure identified a conserved extracellular sequence (367)GFXXP(371) between TMD7 and TMD8 close to the conserved Glu(417) in the permeation pathway. Mutation of Glu(417) eliminated transport by Slc26a2, whereas mutation of Phe(368) increased the affinity for SO4o2- 8-fold while reducing the affinity for Cl-o(-) 2 fold, but without affecting regulation by Cl-o(-). These findings clarify the mechanism of net SO42- transport and describe a novel regulation of Slc26a2 by an extracellular anion binding site and should help in further understanding aberrant SLC26A2 function in diastrophic dysplasia.	[Ohana, Ehud; Shcheynikov, Nikolay; Park, Meeyoung; Muallem, Shmuel] NIDCR, Epithelial Signaling & Transport Sect, Mol Physiol & Therapeut Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Muallem, S (corresponding author), NIDCR, Epithelial Signaling & Transport Sect, Mol Physiol & Therapeut Branch, NIH, Bldg 10,Room 1N-113, Bethesda, MD 20892 USA.	shmuel.muallem@nih.gov	Ohana, Ehud/ABB-3060-2020	Ohana, Ehud/0000-0001-8598-4042	National Institutes of Health from NIDCR [Z1A-DE000735]; Machiah Foundation [2008-0702]; foundation of the Jewish Community Federation of San Francisco; Peninsula, Marin, and Sonoma Counties; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000735] Funding Source: NIH RePORTER	National Institutes of Health from NIDCR; Machiah Foundation; foundation of the Jewish Community Federation of San Francisco; Peninsula, Marin, and Sonoma Counties; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant Z1A-DE000735 from NIDCR.; Supported by a Machiah Fellowship (Grant 2008-0702) awarded through the Machiah Foundation, a supporting foundation of the Jewish Community Federation of San Francisco, the Peninsula, Marin, and Sonoma Counties.	Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; Alnouti Y, 2009, TOXICOL SCI, V108, P225, DOI 10.1093/toxsci/kfn268; ANDERSON RJ, 1984, MINER ELECTROL METAB, V10, P92; Ballhausen D, 2003, J MED GENET, V40, P65, DOI 10.1136/jmg.40.1.65; Becker HM, 2004, BIOPHYS J, V86, P235, DOI 10.1016/S0006-3495(04)74099-0; Bergsdorf EY, 2009, J BIOL CHEM, V284, P11184, DOI 10.1074/jbc.M901170200; Catalan MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016549; Chapman JM, 2010, HISTOCHEM CELL BIOL, V133, P541, DOI 10.1007/s00418-010-0694-x; Compton ELR, 2011, J BIOL CHEM, V286, P27058, DOI 10.1074/jbc.M111.244533; Coulter-Mackie M. B., 1993, GENEREVIEWS; Dorwart MR, 2008, PHYSIOLOGY, V23, P104, DOI 10.1152/physiol.00037.2007; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; ELGAVISH A, 1991, AM J PHYSIOL, V260, pL450, DOI 10.1152/ajplung.1991.260.6.L450; Everett LA, 1997, NAT GENET, V17, P411, DOI 10.1038/ng1297-411; Faraldo-Gomez JD, 2004, J MOL BIOL, V339, P981, DOI 10.1016/j.jmb.2004.04.023; Feng LA, 2010, SCIENCE, V330, P635, DOI 10.1126/science.1195230; FLORIN T, 1991, GUT, V32, P766, DOI 10.1136/gut.32.7.766; Forlino A, 2005, HUM MOL GENET, V14, P859, DOI 10.1093/hmg/ddi079; Gorsi B, 2007, TRENDS CELL BIOL, V17, P173, DOI 10.1016/j.tcb.2007.02.006; Guyton A.C., 2006, TXB MED PHYSL; Habuchi O, 2000, BBA-GEN SUBJECTS, V1474, P115, DOI 10.1016/S0304-4165(00)00016-7; Haila S, 2001, J HISTOCHEM CYTOCHEM, V49, P973, DOI 10.1177/002215540104900805; HASTBACKA J, 1994, CELL, V78, P1073, DOI 10.1016/0092-8674(94)90281-X; Heneghan JF, 2010, AM J PHYSIOL-CELL PH, V298, pC1363, DOI 10.1152/ajpcell.00004.2010; Hoglund P, 1996, NAT GENET, V14, P316, DOI 10.1038/ng1196-316; Jiang ZR, 2006, NAT GENET, V38, P474, DOI 10.1038/ng1762; Karniski LP, 2004, HUM MOL GENET, V13, P2165, DOI 10.1093/hmg/ddh242; Karniski LP, 2001, HUM MOL GENET, V10, P1485, DOI 10.1093/hmg/10.14.1485; Kato A, 2011, ANNU REV PHYSIOL, V73, P261, DOI 10.1146/annurev-physiol-012110-142244; Kerr BJ, 2011, J ANIM SCI, V89, P426, DOI 10.2527/jas.2010-3228; Ko SBH, 2002, EMBO J, V21, P5662, DOI 10.1093/emboj/cdf580; Kujala M, 2007, REPRODUCTION, V133, P775, DOI 10.1530/rep.1.00964; Liu XZ, 2003, HUM MOL GENET, V12, P1155, DOI 10.1093/hmg/ddg127; Markovich D, 2007, ANNU REV PHYSIOL, V69, P361, DOI 10.1146/annurev.physiol.69.040705.141319; Melvin JE, 2005, ANNU REV PHYSIOL, V67, P445, DOI 10.1146/annurev.physiol.67.041703.084745; Nakato H, 2002, BBA-GEN SUBJECTS, V1573, P312, DOI 10.1016/S0304-4165(02)00398-7; Neel NF, 2005, CYTOKINE GROWTH F R, V16, P637, DOI 10.1016/j.cytogfr.2005.05.008; Ohana E, 2011, J GEN PHYSIOL, V137, P239, DOI 10.1085/jgp.201010531; Ohana E, 2009, J PHYSIOL-LONDON, V587, P2179, DOI 10.1113/jphysiol.2008.164863; Picollo A, 2005, NATURE, V436, P420, DOI 10.1038/nature03720; Rossi A, 2001, HUM MUTAT, V17, P159, DOI 10.1002/humu.1; RUPPIN H, 1980, GASTROENTEROLOGY, V78, P1500; Sachs G, 2003, PHARMACOTHERAPY, V23, p68S, DOI 10.1592/phco.23.13.68S.31931; Satoh H, 1998, J BIOL CHEM, V273, P12307, DOI 10.1074/jbc.273.20.12307; Shcheynikov N, 2006, J GEN PHYSIOL, V127, P511, DOI 10.1085/jgp.200509392; Shcheynikov N, 2008, J PHYSIOL-LONDON, V586, P3813, DOI 10.1113/jphysiol.2008.154468; Steward MC, 2005, ANNU REV PHYSIOL, V67, P377, DOI 10.1146/annurev.physiol.67.031103.153247; Stone MJ, 2009, NEW BIOTECHNOL, V25, P299, DOI 10.1016/j.nbt.2009.03.011; Superti-Furga A, 1999, J MED GENET, V36, P621; SupertiFurga A, 1996, AM J MED GENET, V63, P144, DOI 10.1002/(SICI)1096-8628(19960503)63:1<144::AID-AJMG25>3.0.CO;2-N; SupertiFurga A, 1996, NAT GENET, V12, P100, DOI 10.1038/ng0196-100; Toure A, 2007, HUM MOL GENET, V16, P1783, DOI 10.1093/hmg/ddm117; TREUHAFT PS, 1971, ARTHRITIS RHEUM, V14, P475, DOI 10.1002/art.1780140407; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Wang YX, 2006, EMBO J, V25, P5049, DOI 10.1038/sj.emboj.7601387; Xu WM, 2007, P NATL ACAD SCI USA, V104, P9816, DOI 10.1073/pnas.0609253104; Zdebik AA, 2008, J BIOL CHEM, V283, P4219, DOI 10.1074/jbc.M708368200	57	33	34	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					5122	5132		10.1074/jbc.M111.297192	http://dx.doi.org/10.1074/jbc.M111.297192			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22190686	hybrid, Green Published			2022-12-27	WOS:000300608500070
J	Tang, MC; Fu, CY; Tang, GL				Tang, Man-Cheng; Fu, Cheng-Yu; Tang, Gong-Li			Characterization of SfmD as a Heme Peroxidase That Catalyzes the Regioselective Hydroxylation of 3-Methyltyrosine to 3-Hydroxy-5-methyltyrosine in Saframycin A Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							L-TYROSINE; CONVERSION; CHEMISTRY; HISTIDINE	Saframycin A (SFM-A) is a potent antitumor antibiotic that belongs to the tetrahydroisoquinoline family. Biosynthetic studies have revealed that its unique pentacyclic core structure is derived from alanine, glycine, and non-proteinogenic amino acid 3-hydroxy-5-methyl-O-methyltyrosine (3-OH-5-Me-OMe-Tyr). SfmD, a hypothetical protein in the biosynthetic pathway of SFM-A, was hypothesized to be responsible for the generation of the 3-hydroxy group of 3-OH-5-Me-OMe-Tyr based on previously heterologous expression results. We now report the in vitro characterization of SfmD as a novel hemecontaining peroxidase that catalyzes the hydroxylation of 3-methyltyrosine to 3-hydroxy-5-methyltyrosine using hydrogen peroxide as the oxidant. In addition, we elucidated the biosynthetic pathway of 3-OH-5-Me-OMe-Tyr by kinetic studies of SfmD in combination with biochemical assays of SfmM2, a methyltransferase within the same pathway. Furthermore, SacD, a counterpart of SfmD involved in safracin B biosynthesis, was also characterized as a heme-containing peroxidase, suggesting that SfmD-like heme-containing peroxidases may be commonly involved in the biosynthesis of SFM-A and its analogs. Finally, we found that the conserved motif HXXXC is crucial for heme binding using comparative UV-Vis and Magnetic Circular Dichroism (MCD) spectra studies of SfmD wild-type and mutants. Together, these findings expand the category of heme-containing peroxidases and set the stage for further mechanistic studies. In addition, this study has critical implications for delineating the biosynthetic pathway of other related tetrahydroisoquinoline family members.	[Tang, Man-Cheng; Fu, Cheng-Yu; Tang, Gong-Li] Chinese Acad Sci, Shanghai Inst Organ Chem, State Key Lab Bioorgan & Nat Prod Chem, Shanghai 200032, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Organic Chemistry, CAS	Tang, GL (corresponding author), Chinese Acad Sci, Shanghai Inst Organ Chem, State Key Lab Bioorgan & Nat Prod Chem, 345 Lingling Rd, Shanghai 200032, Peoples R China.	gltang@sioc.ac.cn			National Basic Research Program of China (973 Program) [2010CB833200, 2012CB721100]; National Natural Science Foundation of China [20832009, 20921091]; Chinese Academy of Science [KJCX2-YW-H08]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Science(Chinese Academy of Sciences)	This work was supported in part by grants from the National Basic Research Program of China (973 Program) (2010CB833200 and 2012CB721100), the National Natural Science Foundation of China (20832009 and 20921091), and the Chinese Academy of Science (KJCX2-YW-H08).	ALBERTA JA, 1987, J BIOL CHEM, V262, P11857; Allen JWA, 2005, BIOCHEM J, V389, P587, DOI 10.1042/BJ20041894; ARAI T, 1977, J ANTIBIOT, V30, P1015; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chowdhury G, 2010, CHEM RES TOXICOL, V23, P1018, DOI 10.1021/tx900367p; Connor KL, 2011, BIOCHEMISTRY-US, V50, P8926, DOI 10.1021/bi201148a; Cuevas C, 2009, NAT PROD REP, V26, P322, DOI 10.1039/b808331m; Deboves HJC, 2001, J CHEM SOC PERK T 1, P1876, DOI 10.1039/b103832j; Fitzpatrick PF, 1999, ANNU REV BIOCHEM, V68, P355, DOI 10.1146/annurev.biochem.68.1.355; Fu CY, 2009, J MICROBIOL BIOTECHN, V19, P439, DOI 10.4014/jmb.0808.484; Guillou H, 2004, J LIPID RES, V45, P32, DOI 10.1194/jlr.M300339-JLR200; Hannemann F, 2007, BBA-GEN SUBJECTS, V1770, P330, DOI 10.1016/j.bbagen.2006.07.017; Hofrichter M, 2006, APPL MICROBIOL BIOT, V71, P276, DOI 10.1007/s00253-006-0417-3; Hofrichter M, 2010, APPL MICROBIOL BIOT, V87, P871, DOI 10.1007/s00253-010-2633-0; HUFF AM, 1993, INORG CHEM, V32, P1460, DOI 10.1021/ic00060a023; HURLEY LH, 1983, J ANTIBIOT, V36, P383, DOI 10.7164/antibiotics.36.383; Khatri Y, 2010, CHEM BIOL, V17, P1295, DOI 10.1016/j.chembiol.2010.10.010; Khindaria A, 1996, BIOCHEMISTRY-US, V35, P13107, DOI 10.1021/bi961297+; Koketsu K, 2010, NAT CHEM BIOL, V6, P408, DOI 10.1038/nchembio.365; Li L, 2008, J BACTERIOL, V190, P251, DOI 10.1128/JB.00826-07; Lin SJ, 2008, J AM CHEM SOC, V130, P6616, DOI 10.1021/ja710601d; Mense SM, 2006, CELL RES, V16, P681, DOI 10.1038/sj.cr.7310086; MIKAMI Y, 1985, J BIOL CHEM, V260, P344; Neusser D, 1998, ARCH MICROBIOL, V169, P322, DOI 10.1007/s002030050578; PALANISWAMY VA, 1986, J AM CHEM SOC, V108, P5651, DOI 10.1021/ja00278a062; Palmer G., 1983, IRON PORPHYRINS 2; Poulos TL, 2010, ARCH BIOCHEM BIOPHYS, V500, P3, DOI 10.1016/j.abb.2010.02.008; Sambrook J., 2001, MOL CLONING LAB MANU; SANCHEZFERRER A, 1995, BBA-PROTEIN STRUCT M, V1247, P1; Scott JD, 2002, CHEM REV, V102, P1669, DOI 10.1021/cr010212u; Sheoran A, 2008, MOL BIOSYST, V4, P622, DOI 10.1039/b801391h; SMITH PI, 1976, BIOCHEM J, V153, P403, DOI 10.1042/bj1530403; SMITH WL, 1991, BIOCHIM BIOPHYS ACTA, V1083, P1, DOI 10.1016/0005-2760(91)90119-3; Sono M, 1996, CHEM REV, V96, P2841, DOI 10.1021/cr9500500; Sugano Y, 2009, CELL MOL LIFE SCI, V66, P1387, DOI 10.1007/s00018-008-8651-8; TENHUNEN R, 1968, P NATL ACAD SCI USA, V61, P748, DOI 10.1073/pnas.61.2.748; Trost BM, 2003, ORG LETT, V5, P4599, DOI 10.1021/ol035752n; Velasco A, 2005, MOL MICROBIOL, V56, P144, DOI 10.1111/j.1365-2958.2004.04433.x; Zamocky M, 2010, BIOCATALYSIS BASED ON HEME PEROXIDASES, P7, DOI 10.1007/978-3-642-12627-7_2	40	28	32	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					5112	5121		10.1074/jbc.M111.306316	http://dx.doi.org/10.1074/jbc.M111.306316			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22187429	hybrid, Green Published			2022-12-27	WOS:000300608500069
J	Hass, CS; Lam, K; Wold, MS				Hass, Cathy S.; Lam, Koonyee; Wold, Marc S.			Repair-specific Functions of Replication Protein A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; EXCISION-REPAIR; KDA SUBUNIT; BINDING; RPA; DOMAINS; CHECKPOINT; SSDNA; BRCA2; RECONSTITUTION	Replication protein A (RPA), the major eukaryotic single-strand DNA (ssDNA)-binding protein, is essential for replication, repair, recombination, and checkpoint activation. Defects in RPA-associated cellular activities lead to genomic instability, a major factor in the pathogenesis of cancer and other diseases. ssDNA binding activity is primarily mediated by two domains in the 70-kDa subunit of the RPA complex. These ssDNA interactions are mediated by a combination of polar residues and four conserved aromatic residues. Mutation of the aromatic residues causes a modest decrease in binding to long (30-nucleotide) ssDNA fragments but results in checkpoint activation and cell cycle arrest in cells. We have used a combination of biochemical analysis and knockdown replacement studies in cells to determine the contribution of these aromatic residues to RPA function. Cells containing the aromatic residue mutants were able to progress normally through S-phase but were defective in DNA repair. Biochemical characterization revealed that mutation of the aromatic residues severely decreased binding to short ssDNA fragments less than 20 nucleotides long. These data indicate that altered binding of RPA to short ssDNA intermediates causes a defect in DNA repair but not in DNA replication. These studies show that cells require different RPA functions in DNA replication and DNA repair.	[Hass, Cathy S.; Lam, Koonyee; Wold, Marc S.] Univ Iowa, Dept Biochem, Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa	Wold, MS (corresponding author), Univ Iowa, Dept Biochem, Carver Coll Med, 3107 MERF,375 Newton Rd, Iowa City, IA 52242 USA.	marc-wold@uiowa.edu		Wold, Marc/0000-0002-4580-1624	National Institutes of Health [GM44721]; American Heart Association [09PRE2160147]; NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044721] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant (GM44721) (to M. S. W.). This work was also supported by the American Heart Association Fellowship 09PRE2160147 (to C. S. H.).	Arunkumar AI, 2003, J BIOL CHEM, V278, P41077, DOI 10.1074/jbc.M305871200; Bastin-Shanower SA, 2001, J BIOL CHEM, V276, P36446, DOI 10.1074/jbc.M104386200; Binz SK, 2008, J BIOL CHEM, V283, P21559, DOI 10.1074/jbc.M802450200; Binz SK, 2006, METHOD ENZYMOL, V409, P11, DOI 10.1016/S0076-6879(05)09002-6; BLACKWELL LJ, 1994, MOL CELL BIOL, V14, P3993, DOI 10.1128/MCB.14.6.3993; Bochkarev A, 2004, CURR OPIN STRUC BIOL, V14, P36, DOI 10.1016/j.sbi.2004.01.001; Bochkareva E, 2001, EMBO J, V20, P612, DOI 10.1093/emboj/20.3.612; Bochkareva E, 2000, J BIOL CHEM, V275, P27332; Bochkareva E, 2005, P NATL ACAD SCI USA, V102, P15412, DOI 10.1073/pnas.0504614102; Braun KA, 1997, BIOCHEMISTRY-US, V36, P8443, DOI 10.1021/bi970473r; Brill SJ, 1998, MOL CELL BIOL, V18, P7225, DOI 10.1128/MCB.18.12.7225; Broderick S, 2010, SUBCELL BIOCHEM, V50, P143, DOI 10.1007/978-90-481-3471-7_8; Cai LF, 2007, BIOCHEMISTRY-US, V46, P8226, DOI 10.1021/bi7004976; CHEN LC, 1991, P NATL ACAD SCI USA, V88, P3847, DOI 10.1073/pnas.88.9.3847; Choi JH, 2010, P NATL ACAD SCI USA, V107, P13660, DOI 10.1073/pnas.1007856107; COLES C, 1990, LANCET, V336, P761, DOI 10.1016/0140-6736(90)93236-I; Daughdrill GW, 2001, NUCLEIC ACIDS RES, V29, P3270, DOI 10.1093/nar/29.15.3270; de Laat WL, 1998, GENE DEV, V12, P2598, DOI 10.1101/gad.12.16.2598; DeMott MS, 1998, J BIOL CHEM, V273, P27492, DOI 10.1074/jbc.273.42.27492; Dickey JS, 2009, CHROMOSOMA, V118, P683, DOI 10.1007/s00412-009-0234-4; Dickson AM, 2009, NUCLEIC ACIDS RES, V37, P2313, DOI 10.1093/nar/gkp090; Eggler AL, 2002, J BIOL CHEM, V277, P39280, DOI 10.1074/jbc.M204328200; ERDILE LF, 1990, J BIOL CHEM, V265, P3177; Fanning E, 2006, NUCLEIC ACIDS RES, V34, P4126, DOI 10.1093/nar/gkl550; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Gao H, 2007, NAT STRUCT MOL BIOL, V14, P208, DOI 10.1038/nsmb1205; Givalos N, 2007, MODERN PATHOL, V20, P159, DOI 10.1038/modpathol.3800719; Gomes XV, 1996, BIOCHEMISTRY-US, V35, P10558, DOI 10.1021/bi9607517; Haring SJ, 2008, J BIOL CHEM, V283, P19095, DOI 10.1074/jbc.M800881200; Hass CS, 2010, MOL CANCER RES, V8, P1017, DOI 10.1158/1541-7786.MCR-10-0161; Iftode C, 1999, CRIT REV BIOCHEM MOL, V34, P141, DOI 10.1080/10409239991209255; Jensen RB, 2010, NATURE, V467, P678, DOI 10.1038/nature09399; KIM C, 1995, BIOCHEMISTRY-US, V34, P2058, DOI 10.1021/bi00006a028; KIM CS, 1994, BIOCHEMISTRY-US, V33, P14197, DOI 10.1021/bi00251a031; KIM CS, 1992, MOL CELL BIOL, V12, P3050, DOI 10.1128/MCB.12.7.3050; Krokan HE, 2000, FEBS LETT, V476, P73, DOI 10.1016/S0014-5793(00)01674-4; Kumaran S, 2006, BIOCHEMISTRY-US, V45, P11958, DOI 10.1021/bi060994r; Lao Y, 2000, BIOCHEMISTRY-US, V39, P850, DOI 10.1021/bi991704s; Liu J, 2010, NAT STRUCT MOL BIOL, V17, P1260, DOI 10.1038/nsmb.1904; O'Driscoll M, 2007, AM J HUM GENET, V81, P77, DOI 10.1086/518696; Oakley GG, 2010, FRONT BIOSCI-LANDMRK, V15, P883, DOI 10.2741/3652; Olson E, 2007, MOL CELL BIOL, V27, P6053, DOI 10.1128/MCB.00532-07; Philipova D, 1996, GENE DEV, V10, P2222, DOI 10.1101/gad.10.17.2222; Pommier Y, 2009, CHEM REV, V109, P2894, DOI 10.1021/cr900097c; Ramilo C, 2002, MOL CELL BIOL, V22, P2037, DOI 10.1128/MCB.22.7.2037-2046.2002; Reardon JT, 2005, PROG NUCLEIC ACID RE, V79, P183, DOI 10.1016/S0079-6603(04)79004-2; Riedl T, 2003, EMBO J, V22, P5293, DOI 10.1093/emboj/cdg489; Salas TR, 2006, NUCLEIC ACIDS RES, V34, P4857, DOI 10.1093/nar/gkl564; Smith J, 2010, ADV CANCER RES, V108, P73, DOI [10.1016/B978-0-12-380888-2.00003-0, 10.1016/S0065.230X(10)08002.4]; Tomkiel JE, 2002, CLIN CANCER RES, V8, P752; Vassin VM, 2004, MOL CELL BIOL, V24, P1930, DOI 10.1128/MCB.24.5.1930-1943.2004; Walther AP, 1999, BIOCHEMISTRY-US, V38, P3963, DOI 10.1021/bi982370u; Wang YX, 2005, NAT GENET, V37, P750, DOI 10.1038/ng1587; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Wu XM, 2005, ONCOGENE, V24, P4728, DOI 10.1038/sj.onc.1208674; Wyka IM, 2003, BIOCHEMISTRY-US, V42, P12909, DOI 10.1021/bi034930h; Xu X, 2008, MOL CELL BIOL, V28, P7345, DOI 10.1128/MCB.01079-08; Zou L, 2003, P NATL ACAD SCI USA, V100, P13827, DOI 10.1073/pnas.2336100100; Zou Y, 2006, J CELL PHYSIOL, V208, P267, DOI 10.1002/jcp.20622	59	29	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					3908	3918		10.1074/jbc.M111.287441	http://dx.doi.org/10.1074/jbc.M111.287441			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22179778	Green Published, hybrid			2022-12-27	WOS:000300410900027
J	Sun, Y; Liou, B; Xu, YH; Quinn, B; Zhang, WJ; Hamler, R; Setchell, KDR; Grabowski, GA				Sun, Ying; Liou, Benjamin; Xu, You-Hai; Quinn, Brian; Zhang, Wujuan; Hamler, Rick; Setchell, Kenneth D. R.; Grabowski, Gregory A.			Ex Vivo and in Vivo Effects of Isofagomine on Acid beta-Glucosidase Variants and Substrate Levels in Gaucher Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAPERONES INCREASE; POINT MUTATIONS; MOUSE MODELS; FIBROBLASTS; EXPRESSION; PHENOTYPE; TRANSPORT; STRATEGY	Isofagomine (IFG) is an acid beta-glucosidase (GCase) active site inhibitor that acts as a pharmacological chaperone. The effect of IFG on GCase function was investigated in GCase mutant fibroblasts and mouse models. IFG inhibits GCase with K-i similar to 30 nM for wild-type and mutant enzymes (N370S and V394L). Fibroblasts treated with IFG at mu M concentrations showed enhancement of WT and mutant GCase activities and protein levels. Administration of IFG (30 mg/kg/day) to the mice homozygous for GCase mutations (V394L, D409H, or D409V) led to increased GCase activity in visceral tissues and brain extracts. IFG effects on GCase stability and substrate levels were evaluated in a mouse model (hG/4L/PS-NA) that has doxycycline-controlled human WT GCase (hGCase) expression driven by a liver-specific promoter and is also homozygous for the IFG-responsive V394L GCase. Both human and mouse GCase activity and protein levels were increased in IFG-treated mice. The liver-secreted hGCase in serum was stabilized, and its effect on the lung and spleen involvement was enhanced by IFG treatment. In 8-week IFG-treated mice, the accumulated glucosylceramide and glucosylsphingosine were reduced by 75 and 33%, respectively. Decreases of storage cells were correlated with >50% reductions in substrate levels. These results indicate that IFG stabilizes GCase in tissues and serum and can reduce visceral substrates in vivo.	[Sun, Ying; Liou, Benjamin; Xu, You-Hai; Quinn, Brian; Grabowski, Gregory A.] Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Cincinnati, OH 45229 USA; [Zhang, Wujuan; Setchell, Kenneth D. R.] Cincinnati Childrens Hosp Med Ctr, Div Pathol & Lab Med, Cincinnati, OH 45229 USA; [Sun, Ying; Xu, You-Hai; Setchell, Kenneth D. R.; Grabowski, Gregory A.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45229 USA; [Hamler, Rick] Amicus Therapeut Inc, Cranbury, NJ 08512 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Grabowski, GA (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Human Genet, 3333 Burnet Ave,MLC 4006, Cincinnati, OH 45229 USA.	greg.grabowski@cchmc.org			National Institutes of Health [HD 059823, DK 36729, NS 36681]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD059823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK036729] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036681] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants HD 059823, DK 36729, and NS 36681 (to G. A. G.).	Bulow A, 2000, J AM CHEM SOC, V122, P8567, DOI 10.1021/ja001762x; Chang HH, 2006, FEBS J, V273, P4082, DOI 10.1111/j.1742-4658.2006.05410.x; Charrow J, 2000, ARCH INTERN MED, V160, P2835, DOI 10.1001/archinte.160.18.2835; Cullen V, 2011, ANN NEUROL, V69, P940, DOI 10.1002/ana.22400; Dreyfus H, 1997, ANAL BIOCHEM, V249, P67, DOI 10.1006/abio.1997.2143; EYAL N, 1990, GENE, V96, P277, DOI 10.1016/0378-1119(90)90264-R; Fan JQ, 1999, NAT MED, V5, P112, DOI 10.1038/4801; GRABOWSKI GA, 2010, ONLINE METABOLIC MOL, pCH146; HOROWITZ M, 1989, GENOMICS, V4, P87, DOI 10.1016/0888-7543(89)90319-4; Ishii S, 2009, J PHARMACOL EXP THER, V328, P723, DOI 10.1124/jpet.108.149054; Khanna R, 2010, FEBS J, V277, P1618, DOI 10.1111/j.1742-4658.2010.07588.x; Kolodny E H, 1982, Prog Clin Biol Res, V95, P33; Koprivica V, 2000, AM J HUM GENET, V66, P1777, DOI 10.1086/302925; Leonova T, 2000, MOL GENET METAB, V70, P281, DOI 10.1006/mgme.2000.3035; Lieberman RL, 2007, NAT CHEM BIOL, V3, P101, DOI 10.1038/nchembio850; Lieberman RL, 2009, BIOCHEMISTRY-US, V48, P4816, DOI 10.1021/bi9002265; Liou B, 2006, J BIOL CHEM, V281, P4242, DOI 10.1074/jbc.M511110200; Liu YJ, 1998, P NATL ACAD SCI USA, V95, P2503, DOI 10.1073/pnas.95.5.2503; PasmanikChor M, 1996, BIOCHEM MOL MED, V59, P125, DOI 10.1006/bmme.1996.0077; Sawkar AR, 2002, P NATL ACAD SCI USA, V99, P15428, DOI 10.1073/pnas.192582899; Steet RA, 2006, P NATL ACAD SCI USA, V103, P13813, DOI 10.1073/pnas.0605928103; Sun Y, 2005, J LIPID RES, V46, P2102, DOI 10.1194/jlr.M500202-JLR200; Sun Y, 2006, J LIPID RES, V47, P2161, DOI 10.1194/jlr.M600239-JLR200; Sun Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019037; THEOPHILUS B, 1989, AM J HUM GENET, V45, P212; TSUJI A, 1988, J BIOCHEM-TOKYO, V104, P276, DOI 10.1093/oxfordjournals.jbchem.a122457; VACCARO AM, 1985, EUR J BIOCHEM, V146, P315, DOI 10.1111/j.1432-1033.1985.tb08655.x; VOLK BW, 1967, J NEUROPATH EXP NEUR, V26, P176; Wei RR, 2011, J BIOL CHEM, V286, P299, DOI 10.1074/jbc.M110.150433; Xu YH, 2003, AM J PATHOL, V163, P2093, DOI 10.1016/S0002-9440(10)63566-3; Xu YH, 1996, PEDIATR RES, V39, P313, DOI 10.1203/00006450-199602000-00021; Xu YH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010750; Yu ZQ, 2007, FEBS J, V274, P4944, DOI 10.1111/j.1742-4658.2007.06042.x	33	74	78	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					4275	4287		10.1074/jbc.M111.280016	http://dx.doi.org/10.1074/jbc.M111.280016			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22167193	Green Published, hybrid			2022-12-27	WOS:000300410900059
J	Bayro, MJ; Daviso, E; Belenky, M; Griffin, RG; Herzfeld, J				Bayro, Marvin J.; Daviso, Eugenio; Belenky, Marina; Griffin, Robert G.; Herzfeld, Judith			An Amyloid Organelle, Solid-state NMR Evidence for Cross-beta Assembly of Gas Vesicles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-DIFFRACTION; PROTEIN; FIBRILS; HYDROPHOBIN; DISEASE; GVPA	Functional amyloids have been identified in a wide range of organisms, taking on a variety of biological roles and being controlled by remarkable mechanisms of directed assembly. Here, we report that amyloid fibrils constitute the ribs of the buoyancy organelles of Anabaena flos-aquae. The walls of these gas-filled vesicles are known to comprise a single protein, GvpA, arranged in a low pitch helix. However, the tertiary and quaternary structures have been elusive. Using solid-state NMR correlation spectroscopy we find detailed evidence for an extended cross-beta structure. This amyloid assembly helps to account for the strength and amphiphilic properties of the vesicle wall. Buoyancy organelles thus dramatically extend the scope of known functional amyloids.	[Daviso, Eugenio; Belenky, Marina; Herzfeld, Judith] Brandeis Univ, Dept Chem, Waltham, MA 02454 USA; [Bayro, Marvin J.; Griffin, Robert G.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Bayro, Marvin J.; Daviso, Eugenio; Griffin, Robert G.] MIT, Francis Bitter Magnet Lab, Cambridge, MA 02139 USA	Brandeis University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Herzfeld, J (corresponding author), Brandeis Univ, Dept Chem, Waltham, MA 02454 USA.	herzfeld@brandeis.edu	Bayro, Marvin/Q-4643-2016	Bayro, Marvin/0000-0003-1482-9381	National Institutes of Health [EB001035, EB003151, EB002026]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB001035, P41EB002026, R01EB003151] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported, in whole or in part, by National Institutes of Health Grants EB001035, EB003151, and EB002026.	Bayro MJ, 2010, BIOCHEMISTRY-US, V49, P7474, DOI 10.1021/bi100864t; Bayro MJ, 2009, ANGEW CHEM INT EDIT, V48, P5708, DOI 10.1002/anie.200901520; Belenky M, 2004, BIOPHYS J, V86, P499, DOI 10.1016/S0006-3495(04)74128-4; BENNETT AE, 1995, J CHEM PHYS, V103, P6951, DOI 10.1063/1.470372; BLAUROCK AE, 1976, J MOL BIOL, V105, P183, DOI 10.1016/0022-2836(76)90106-6; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; De Paepe G, 2008, J CHEM PHYS, V129, DOI 10.1063/1.3036928; de Vocht ML, 2000, J BIOL CHEM, V275, P28428, DOI 10.1074/jbc.M000691200; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; EANES ED, 1968, J HISTOCHEM CYTOCHEM, V16, P673, DOI 10.1177/16.11.673; Fandrich M, 2007, CELL MOL LIFE SCI, V64, P2066, DOI 10.1007/s00018-007-7110-2; Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; Hakanpaa J, 2004, J BIOL CHEM, V279, P534, DOI 10.1074/jbc.M309650200; Hammer ND, 2007, P NATL ACAD SCI USA, V104, P12494, DOI 10.1073/pnas.0703310104; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jean L, 2010, FASEB J, V24, P309, DOI 10.1096/fj.09-137653; JOST M, 1970, CAN J MICROBIOL, V16, P159, DOI 10.1139/m70-028; Kwan AHY, 2006, P NATL ACAD SCI USA, V103, P3621, DOI 10.1073/pnas.0505704103; McMaster TJ, 1996, BIOPHYS J, V70, P2432, DOI 10.1016/S0006-3495(96)79813-2; Morcombe CR, 2004, J AM CHEM SOC, V126, P7196, DOI 10.1021/ja047919t; Offner S, 1998, MICROBIOL-UK, V144, P1331, DOI 10.1099/00221287-144-5-1331; Otzen D, 2008, CELL MOL LIFE SCI, V65, P910, DOI 10.1007/s00018-007-7404-4; Pronchik J, 2010, J AM CHEM SOC, V132, P9797, DOI 10.1021/ja102896h; Schladitz C, 1999, BIOPHYS J, V77, P3305, DOI 10.1016/S0006-3495(99)77161-4; Shewmaker F, 2011, J BIOL CHEM, V286, P16533, DOI 10.1074/jbc.R111.227108; Sivertsen AC, 2010, BIOPHYS J, V99, P1932, DOI 10.1016/j.bpj.2010.06.041; Sivertsen AC, 2009, J MOL BIOL, V387, P1032, DOI 10.1016/j.jmb.2009.02.015; Smith AM, 2010, MACROMOL CHEM PHYS, V211, P127, DOI 10.1002/macp.200900420; Strunk T, 2011, MOL MICROBIOL, V81, P56, DOI 10.1111/j.1365-2958.2011.07669.x; Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348; SZEVERENYI NM, 1982, J MAGN RESON, V47, P462, DOI 10.1016/0022-2364(82)90213-X; Takegoshi K, 2001, CHEM PHYS LETT, V344, P631, DOI 10.1016/S0009-2614(01)00791-6; Tartaglia GG, 2008, J MOL BIOL, V380, P425, DOI 10.1016/j.jmb.2008.05.013; WALSBY AE, 1994, MICROBIOL REV, V58, P94, DOI 10.1128/MMBR.58.1.94-144.1994	36	30	31	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3479	3484		10.1074/jbc.M111.313049	http://dx.doi.org/10.1074/jbc.M111.313049			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22147705	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000300295100052
J	Han, S; Bahmanyar, S; Zhang, PX; Grishin, N; Oegema, K; Crooke, R; Graham, M; Reue, K; Dixon, JE; Goodman, JM				Han, Sungwon; Bahmanyar, Shirin; Zhang, Peixiang; Grishin, Nick; Oegema, Karen; Crooke, Roseann; Graham, Mark; Reue, Karen; Dixon, Jack E.; Goodman, Joel M.			Nuclear Envelope Phosphatase 1-Regulatory Subunit 1 (Formerly TMEM188) Is the Metazoan Spo7p Ortholog and Functions in the Lipin Activation Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; DIACYLGLYCEROL KINASES; CAENORHABDITIS-ELEGANS; ENDOPLASMIC-RETICULUM; YEAST; PROTEIN; GENE; MEMBRANE; PHOSPHORYLATION; MUTATIONS	Lipin-1 catalyzes the formation of diacylglycerol from phosphatidicacid. Lipin-1 mutations cause lipodystrophy in mice and acute myopathy in humans. It is heavily phosphorylated, and the yeast ortholog Pah1p becomes membrane-associated and active upon dephosphorylation by the Nem1p-Spo7p membrane complex. A mammalian ortholog of Nem1p is the C-terminal domain nuclear envelope phosphatase 1 (CTDNEP1, formerly "dullard"), but its Spo7p-like partner is unknown, and the need for its existence is debated. Here, we identify the metazoan ortholog of Spo7p, TMEM188, renamed nuclear envelope phosphatase 1-regulatory subunit 1 (NEP1-R1). CTDNEP1 and NEP1-R1 together complement a nem1 Delta spo7 Delta strain to block endoplasmic reticulum proliferation and restore triacylglycerol levels and lipid droplet number. The two human orthologs are in a complex in cells, and the amount of CTDNEP1 is increased in the presence of NEP1-R1. In the Caenorhabditis elegans embryo, expression of nematode CTDNEP1 and NEP1-R1, as well as lipin-1, is required for normal nuclear membrane breakdown after zygote formation. Theexpression pattern of NEP1-R1 and CTDNEP1 in human and mouse tissues closely mirrors that of lipin-1. CTDNEP1 can dephosphorylate lipins-1a, -1b, and -2 in human cells only in the presence of NEP1-R1. The nuclear fraction of lipin-1b is increased when CTD-NEP1 and NEP1-R1 are co-expressed. Therefore, NEP1-R1 is functionally conserved from yeast to humans and functions in the lipin activation pathway.	[Han, Sungwon; Goodman, Joel M.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Grishin, Nick] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Bahmanyar, Shirin; Oegema, Karen] Univ Calif San Diego, Ludwig Inst Canc Res, Dept Cell & Mol Med, La Jolla, CA 92093 USA; [Dixon, Jack E.] Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA; [Zhang, Peixiang; Reue, Karen] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Crooke, Roseann; Graham, Mark] ISIS Pharmaceut Inc, Carlsbad, CA 92008 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Isis Pharmaceuticals Inc	Goodman, JM (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA.	joel.goodman@utsouthwestern.edu	Han, Sungwon/B-8115-2012	Han, Sungwon/0000-0002-4097-856X	National Institutes of Health [GM094575, HL90553, DK18849, DK18024, GM084210]; Jan and Bob Bullock Endowment; Welch Foundation [I-1506]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL090553, P01HL028481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK018024, R37DK018024, R01DK018849] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084210, R01GM094575] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jan and Bob Bullock Endowment; Welch Foundation(The Welch Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM094575, HL90553 (to K. R.), DK18849 and DK18024 (to J. E. D.), and GM084210 (to J. M. G.). This work was also supported by The Jan and Bob Bullock Endowment (to S. H.) and The Welch Foundation I-1506 (to N. G.),	Adeyo O, 2011, J CELL BIOL, V192, P1043, DOI 10.1083/jcb.201010111; Binns D, 2006, J CELL BIOL, V173, P719, DOI 10.1083/jcb.200511125; Cai JJ, 2009, BBA-MOL CELL BIOL L, V1791, P942, DOI 10.1016/j.bbalip.2009.02.010; Carman GM, 2007, J BIOL CHEM, V282, P37293, DOI 10.1074/jbc.R700038200; Carman GM, 2009, J LIPID RES, V50, pS69, DOI 10.1194/jlr.R800043-JLR200; Carman GM, 1997, BBA-LIPID LIPID MET, V1348, P45, DOI 10.1016/S0005-2760(97)00095-7; Chianale F, 2010, P NATL ACAD SCI USA, V107, P4182, DOI 10.1073/pnas.0908326107; Choi HS, 2011, J BIOL CHEM, V286, P1486, DOI 10.1074/jbc.M110.155598; Coleman RA, 2004, PROG LIPID RES, V43, P134, DOI 10.1016/S0163-7827(03)00051-1; Csaki LS, 2010, ANNU REV NUTR, V30, P257, DOI 10.1146/annurev.nutr.012809.104729; Donkor J, 2007, J BIOL CHEM, V282, P3450, DOI 10.1074/jbc.M610745200; ESPOSITO MS, 1969, GENETICS, V61, P79; Fei WH, 2008, J CELL BIOL, V180, P473, DOI 10.1083/jcb.200711136; Ferguson PJ, 2005, J MED GENET, V42, P551, DOI 10.1136/jmg.2005.030759; Gelperin DM, 2005, GENE DEV, V19, P2816, DOI 10.1101/gad.1362105; GOCZE PM, 1994, CYTOMETRY, V17, P151, DOI 10.1002/cyto.990170207; Golden A, 2009, J CELL SCI, V122, P1970, DOI 10.1242/jcs.044743; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Gorjanacz M, 2009, J CELL SCI, V122, P1963, DOI 10.1242/jcs.044750; Goto K, 2008, TOHOKU J EXP MED, V214, P199, DOI 10.1620/tjem.214.199; Han GS, 2007, J BIOL CHEM, V282, P37026, DOI 10.1074/jbc.M705777200; Han GS, 2010, J BIOL CHEM, V285, P14628, DOI 10.1074/jbc.M110.117747; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Harris TE, 2007, J BIOL CHEM, V282, P277, DOI 10.1074/jbc.M609537200; Huffman TA, 2002, P NATL ACAD SCI USA, V99, P1047, DOI 10.1073/pnas.022634399; IRIE K, 1993, MOL GEN GENET, V236, P283, DOI 10.1007/BF00277124; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Kim YJ, 2007, P NATL ACAD SCI USA, V104, P6596, DOI 10.1073/pnas.0702099104; Knapek K, 2010, MOL CELL BIOL, V30, P4492, DOI 10.1128/MCB.00229-10; Kornmann B, 2010, J CELL SCI, V123, P1389, DOI 10.1242/jcs.058636; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Merz S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r95; Michot C, 2010, HUM MUTAT, V31, pE1564, DOI 10.1002/humu.21282; O'Hara L, 2006, J BIOL CHEM, V281, P34537, DOI 10.1074/jbc.M606654200; Oegema K, 2001, J CELL BIOL, V153, P1209, DOI 10.1083/jcb.153.6.1209; Oegema K., 2005, WORMBOOK C ELEGANS, DOI 10.1895/wormbook.1.72.1; Osman C, 2011, J CELL BIOL, V192, P7, DOI 10.1083/jcb.201006159; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; Prinz WA, 2000, J CELL BIOL, V150, P461, DOI 10.1083/jcb.150.3.461; Reue K, 2000, J LIPID RES, V41, P1067; Reue K, 2009, CURR OPIN LIPIDOL, V20, P165, DOI 10.1097/MOL.0b013e32832adee5; Roth MG, 2008, TRAFFIC, V9, P1233, DOI 10.1111/j.1600-0854.2008.00742.x; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; Satow R, 2002, BIOCHEM BIOPH RES CO, V295, P85, DOI 10.1016/S0006-291X(02)00641-1; SCHLAME M, 1993, J BIOL CHEM, V268, P74; SCHLAME M, 1993, EUR J BIOCHEM, V212, P727, DOI 10.1111/j.1432-1033.1993.tb17711.x; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Siniossoglou S, 1998, EMBO J, V17, P6449, DOI 10.1093/emboj/17.22.6449; Skinner JR, 2009, J BIOL CHEM, V284, P30941, DOI 10.1074/jbc.M109.013995; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Sun YT, 2008, CELL CYCLE, V7, P3118, DOI 10.4161/cc.7.20.6881; Szymanski KM, 2007, P NATL ACAD SCI USA, V104, P20890, DOI 10.1073/pnas.0704154104; Topham MK, 2006, J CELL BIOCHEM, V97, P474, DOI 10.1002/jcb.20704; Wang XM, 2006, PROG LIPID RES, V45, P250, DOI 10.1016/j.plipres.2006.01.005; Wang Y, 2009, NUCLEIC ACIDS RES, V37, P3522, DOI 10.1093/nar/gkp212; WEINER MP, 1994, PCR METH APPL, V4, pS131; Wu R, 2011, BIOCHEMISTRY-US, V50, P3045, DOI 10.1021/bi200336b; Zeharia A, 2008, AM J HUM GENET, V83, P489, DOI 10.1016/j.ajhg.2008.09.002; Zhong XP, 2008, IMMUNOL REV, V224, P249, DOI 10.1111/j.1600-065X.2008.00647.x	63	59	73	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3123	3137		10.1074/jbc.M111.324350	http://dx.doi.org/10.1074/jbc.M111.324350			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22134922	Green Published, hybrid			2022-12-27	WOS:000300295100018
J	Kogai, T; Liu, YY; Mody, K; Shamsian, DV; Brent, GA				Kogai, Takahiko; Liu, Yan-Yun; Mody, Kaizeen; Shamsian, Deborah V.; Brent, Gregory A.			Regulation of Sodium Iodide Symporter Gene Expression by Rac1/p38 beta Mitogen-activated Protein Kinase Signaling Pathway in MCF-7 Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYROID-STIMULATING HORMONE; SODIUM/IODIDE SYMPORTER; RETINOIC ACID; SELECTIVE ACTIVATION; RADIOIODIDE UPTAKE; NIS; RADIOVIROTHERAPY; TRANSPORTER; INHIBITION; PROSTATE	Activation of p38 MAPK is a key pathway for cell proliferation and differentiation in breast cancer and thyroid cells. The sodium/iodide symporter (NIS) concentrates iodide in the thyroid and lactating breast. All-trans-retinoic acid (tRA) markedly induces NIS activity in some breast cancer cell lines and promotes uptake of beta-emitting radioiodide I-131 sufficient for targeted cytotoxicity. To identify a signal transduction pathway that selectively stimulates NIS expression, we investigated regulation by the Rac1-p38 signaling pathway in MCF-7 breast cancer cells and compared it with regulation in FRTL-5 rat thyroid cells. Loss of function experiments with pharmacologic inhibitors and small interfering RNA, as well as RT-PCR analysis of p38 isoforms, demonstrated the requirement of Rac1, MAPK kinase 3B, and p38 beta for the full expression of NIS in MCF-7 cells. In contrast, p38 alpha was critical for NIS expression in FRTL-5 cells. Treatment with tRA or overexpression of Rac1 induced the phosphorylation of p38 isoforms, including p38 beta. A dominant negative mutant of Rac1 abolished tRA-induced phosphorylation in MCF-7 cells. Overexpression of p38 beta or Rac1 significantly enhanced (1.9- and 3.9-fold, respectively), the tRA-stimulated NIS expression in MCF-7 cells. This study demonstrates differential regulation of NIS by distinct p38 isoforms in breast cancer cells and thyroid cells. Targeting isoform-selective activation of p38 may enhance NIS induction, resulting in higher efficacy of I-131 concentration and treatment of breast cancer.	[Kogai, Takahiko; Brent, Gregory A.] Vet Affairs Greater Los Angeles Healthcare Syst, Mol Endocrinol Lab, Los Angeles, CA 90073 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90073 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90073 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Kogai, T (corresponding author), Vet Affairs Greater Los Angeles Healthcare Syst, Mol Endocrinol Lab, Bldg 114,Rm 229,11301 Wilshire Blvd, Los Angeles, CA 90073 USA.	tkogai@ucla.edu; gbrent@ucla.edu			National Institutes of Health [RO1 CA089364]; Veterans Affairs Merit Review Funds; NATIONAL CANCER INSTITUTE [R01CA089364] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Review Funds(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 CA089364 (to G. A. B.). This work was also supported by Veterans Affairs Merit Review Funds.	Alsayed Y, 2001, J BIOL CHEM, V276, P4012, DOI 10.1074/jbc.M007431200; Barros LF, 1997, J PHYSIOL-LONDON, V504, P517, DOI 10.1111/j.1469-7793.1997.517bd.x; Beardmore VA, 2005, MOL CELL BIOL, V25, P10454, DOI 10.1128/MCB.25.23.10454-10464.2005; Boelaert K, 2003, LANCET, V361, P796, DOI 10.1016/S0140-6736(03)12720-1; Conrad PW, 1999, J BIOL CHEM, V274, P23570, DOI 10.1074/jbc.274.33.23570; Dohan O, 2003, ENDOCR REV, V24, P48, DOI 10.1210/er.2001-0029; Enslen H, 2000, EMBO J, V19, P1301, DOI 10.1093/emboj/19.6.1301; Eyers PA, 1998, CHEM BIOL, V5, P321, DOI 10.1016/S1074-5521(98)90170-3; Jiang Y, 1996, J BIOL CHEM, V271, P17920, DOI 10.1074/jbc.271.30.17920; Ju HS, 2002, J PHARMACOL EXP THER, V301, P15, DOI 10.1124/jpet.301.1.15; Klutz K, 2011, HUM GENE THER, V22, P1403, DOI 10.1089/hum.2010.158; Kogai T, 2000, P NATL ACAD SCI USA, V97, P8519, DOI 10.1073/pnas.140217197; Kogai T, 1997, ENDOCRINOLOGY, V138, P2227, DOI 10.1210/en.138.6.2227; Kogai T, 2006, ENDOCR-RELAT CANCER, V13, P797, DOI 10.1677/erc.1.01143; Kogai T, 2005, ENDOCRINOLOGY, V146, P3059, DOI 10.1210/en.2004-1334; Kogai T, 2004, CANCER RES, V64, P415, DOI 10.1158/0008-5472.CAN-03-2285; Kogai T, 2003, BREAST CANCER RES TR, V78, P119, DOI 10.1023/A:1022179717847; Kogai T, 2008, J ENDOCRINOL, V199, P243, DOI [10.1677/JOE-08-0333, 10.1677/JOE-08-0333e]; Kogai T, 2008, J CLIN ENDOCR METAB, V93, P1884, DOI 10.1210/jc.2007-1627; Munoz L, 2010, EUR J PHARMACOL, V635, P212, DOI 10.1016/j.ejphar.2010.02.037; Ohashi E, 2009, CANCER RES, V69, P3443, DOI 10.1158/0008-5472.CAN-08-3234; Penheiter AR, 2010, AM J ROENTGENOL, V195, P341, DOI 10.2214/AJR.09.3672; Pomerance M, 2003, MOL ENDOCRINOL, V17, P2283, DOI 10.1210/me.2002-0400; Pomerance M, 2000, J BIOL CHEM, V275, P40539, DOI 10.1074/jbc.M002097200; Pramanik R, 2003, J BIOL CHEM, V278, P4831, DOI 10.1074/jbc.M207732200; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; Riesco-Eizaguirre G, 2011, J CLIN ENDOCR METAB, V96, pE1435, DOI 10.1210/jc.2010-2373; Schmutzler C, 1997, BIOCHEM BIOPH RES CO, V240, P832, DOI 10.1006/bbrc.1997.7715; Tanosaki S, 2003, BREAST CANCER RES TR, V79, P335, DOI 10.1023/A:1024064424855; Tazebay UH, 2000, NAT MED, V6, P871, DOI 10.1038/78630; Trujillo MA, 2010, GENE THER, V17, P1325, DOI 10.1038/gt.2010.63; Unterholzner S, 2006, J CLIN ENDOCR METAB, V91, P69, DOI 10.1210/jc.2005-0779; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wang XS, 1997, J BIOL CHEM, V272, P23668, DOI 10.1074/jbc.272.38.23668; Wapnir IL, 2003, J CLIN ENDOCR METAB, V88, P1880, DOI 10.1210/jc.2002-021544; WEISS SJ, 1984, ENDOCRINOLOGY, V114, P1090, DOI 10.1210/endo-114-4-1090; Welcsh PL, 2000, NATURE, V406, P688, DOI 10.1038/35021173	37	11	11	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3292	3300		10.1074/jbc.M111.315523	http://dx.doi.org/10.1074/jbc.M111.315523			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22157753	Green Published, hybrid			2022-12-27	WOS:000300295100035
J	Strozecka, J; Chrusciel, E; Gorna, E; Szymanska, A; Zietkiewicz, S; Liberek, K				Strozecka, Joanna; Chrusciel, Elzbieta; Gorna, Emilia; Szymanska, Aneta; Zietkiewicz, Szymon; Liberek, Krzysztof			Importance of N- and C-terminal Regions of IbpA, Escherichia coli Small Heat Shock Protein, for Chaperone Function and Oligomerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTICHAPERONE NETWORK; CRYSTAL-STRUCTURE; COMPETENT STATE; DISAGGREGATION; SUBSTRATE; BINDING; AGGREGATION; EFFICIENT; HSP26; CLPB	Small heat shock proteins are ubiquitous molecular chaperones that, during cellular stress, bind to misfolded proteins and maintain them in a refolding competent state. Two members of the small heat shock protein family, IbpA and IbpB, are present in Escherichia coli. Despite 48% sequence identity, the proteins have distinct activities in promoting protein disaggregation. Cooperation between IbpA and IbpB is crucial for prevention of the irreversible aggregation of proteins. In this study, we investigated the importance of the N- and C-terminal regions of IbpA for self-oligomerization and chaperone functions. Deletion of either the N- or C-terminal region of IbpA resulted in a defect in the IbpA fibril formation process. The deletions also impaired IbpA chaperone function, defined as the ability to stabilize, in cooperation with IbpB, protein aggregates in a disaggregation-competent state. Our results show that the defect in chaperone function, observed in truncated versions of IbpA, is due to the inability of these proteins to interact with substrate proteins and consequently to change the properties of aggregates. At the same time, these versions of IbpA interact with IbpB similarly to the wild type protein. Competition experiments performed with the pC peptide, which corresponds to the IbpA C terminus, suggested the importance of IbpA intermolecular interactions in the stabilization of aggregates in a state competent for disaggregation. Our results suggest that these interactions are not only dependent on the universally conserved IEI motif but also on arginine 133 neighboring the IEI motif. IbpA mutated at arginine 133 to alanine lacked chaperone activity.	[Strozecka, Joanna; Chrusciel, Elzbieta; Zietkiewicz, Szymon; Liberek, Krzysztof] Univ Gdansk, Dept Mol & Cellular Biol, Intercollegiate Fac Biotechnol, PL-80822 Gdansk, Poland; [Gorna, Emilia; Szymanska, Aneta] Univ Gdansk, Fac Chem, PL-80852 Gdansk, Poland	Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; University of Gdansk	Liberek, K (corresponding author), Univ Gdansk, Dept Mol & Cellular Biol, Intercollegiate Fac Biotechnol, Kladki 24, PL-80822 Gdansk, Poland.	liberek@biotech.ug.gda.pl	Ziętkiewicz, Szymon/L-5259-2014; Liberek, Krzysztof/F-5812-2011; Szymanska, Aneta/AAZ-2783-2021	Szymanska, Aneta/0000-0002-8664-2041; Zietkiewicz, Szymon/0000-0002-3435-4603; Ilowska, Emilia/0000-0002-5774-3644; Chrusciel, Elzbieta/0000-0001-9621-2013; Liberek, Krzysztof/0000-0002-7532-9279	Polish Ministry of Science and Higher Education [N N301 197239]; TEAM/2009/-13/5 program	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); TEAM/2009/-13/5 program	This work was supported by Polish Ministry of Science and Higher Education Grant N N301 197239.; Supported by the TEAM/2009/-13/5 program.	ALLEN SP, 1992, J BACTERIOL, V174, P6938, DOI 10.1128/JB.174.21.6938-6947.1992; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Basha E, 2006, J BIOL CHEM, V281, P39943, DOI 10.1074/jbc.M607677200; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; CHUANG SE, 1993, GENE, V134, P1, DOI 10.1016/0378-1119(93)90167-2; Ehrnsperger M, 1997, EMBO J, V16, P221, DOI 10.1093/emboj/16.2.221; Fu XM, 2005, J BIOL CHEM, V280, P6337, DOI 10.1074/jbc.M406319200; Giese KC, 2004, J BIOL CHEM, V279, P32674, DOI 10.1074/jbc.M404455200; Haslbeck M, 2002, CELL MOL LIFE SCI, V59, P1649, DOI 10.1007/PL00012492; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993; Haslbeck M, 2005, J BIOL CHEM, V280, P23861, DOI 10.1074/jbc.M502697200; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jaya N, 2009, P NATL ACAD SCI USA, V106, P15604, DOI 10.1073/pnas.0902177106; Jiao WW, 2005, J MOL BIOL, V347, P871, DOI 10.1016/j.jmb.2005.01.029; Kim KK, 1998, NATURE, V394, P595, DOI 10.1038/29106; Kitagawa M, 2002, EUR J BIOCHEM, V269, P2907, DOI 10.1046/j.1432-1033.2002.02958.x; Kuczynska-Wisnik D, 2002, MICROBIOL-SGM, V148, P1757, DOI 10.1099/00221287-148-6-1757; Laskowska E, 1996, BIOCHIMIE, V78, P117, DOI 10.1016/0300-9084(96)82643-5; Lee GJ, 2000, PLANT PHYSIOL, V122, P189, DOI 10.1104/pp.122.1.189; Lee GJ, 1997, EMBO J, V16, P659, DOI 10.1093/emboj/16.3.659; Leroux MR, 1997, J BIOL CHEM, V272, P24646, DOI 10.1074/jbc.272.39.24646; Matuszewska M, 2005, J BIOL CHEM, V280, P12292, DOI 10.1074/jbc.M412706200; Mogk A, 2003, MOL MICROBIOL, V50, P585, DOI 10.1046/j.1365-2958.2003.03710.x; Mogk A, 2003, J BIOL CHEM, V278, P31033, DOI 10.1074/jbc.M303587200; Narberhaus F, 2002, MICROBIOL MOL BIOL R, V66, P64, DOI 10.1128/MMBR.66.1.64-93.2002; Ratajczak E, 2010, FEBS LETT, V584, P2253, DOI 10.1016/j.febslet.2010.04.060; Ratajczak E, 2009, J MOL BIOL, V386, P178, DOI 10.1016/j.jmb.2008.12.009; Shearstone JR, 1999, J BIOL CHEM, V274, P9937, DOI 10.1074/jbc.274.15.9937; Stromer T, 2004, J BIOL CHEM, V279, P11222, DOI 10.1074/jbc.M310149200; Van Montfort R, 2002, ADV PROTEIN CHEM, V59, P105; van Montfort RLM, 2001, NAT STRUCT BIOL, V8, P1025, DOI 10.1038/nsb722; Veinger L, 1998, J BIOL CHEM, V273, P11032, DOI 10.1074/jbc.273.18.11032; WOO KM, 1992, J BIOL CHEM, V267, P20429; Zietkiewicz S, 2006, J BIOL CHEM, V281, P7022, DOI 10.1074/jbc.M507893200; ZYLICZ M, 1989, EMBO J, V8, P1601, DOI 10.1002/j.1460-2075.1989.tb03544.x	36	28	29	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2843	2853		10.1074/jbc.M111.273847	http://dx.doi.org/10.1074/jbc.M111.273847			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22139842	hybrid, Green Published			2022-12-27	WOS:000300292300056
J	Zuo, XP; Sheng, JP; Lau, HT; McDonald, CM; Andrade, M; Cullen, DE; Bell, FT; Iacovino, M; Kyba, M; Xu, GL; Li, XJ				Zuo, Xiaopan; Sheng, Jipo; Lau, Ho-Tak; McDonald, Carol M.; Andrade, Monica; Cullen, Dana E.; Bell, Fong T.; Iacovino, Michelina; Kyba, Michael; Xu, Guoliang; Li, Xiajun			Zinc Finger Protein ZFP57 Requires Its Co-factor to Recruit DNA Methyltransferases and Maintains DNA Methylation Imprint in Embryonic Stem Cells via Its Transcriptional Repression Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DE-NOVO METHYLATION; RNAI SCREEN; EFFECT GENE; INSIGHTS; HETEROCHROMATIN; COREPRESSOR; PATTERNS; DNMT3L; PHD; RECONSTITUTION	Previously, we discovered that ZFP57 is a maternal-zygotic effect gene, and it maintains DNA methylation genomic imprint at multiple imprinted regions in mouse embryos. Despite these findings, it remains elusive how DNA methyltransferases are targeted to the imprinting control regions to initiate and maintain DNA methylation imprint. To gain insights into these essential processes in genomic imprinting, we examined how ZFP57 maintains genomic DNA methylation imprint in mouse embryonic stem (ES) cells. Here we demonstrate that the loss of ZFP57 in mouse ES cells led to a complete loss of genomic DNA methylation imprint at multiple imprinted regions, similar to its role in mouse embryos. However, reintroduction of ZFP57 into Zfp57-null ES cells did not result in reacquisition of DNA methylation imprint, suggesting that the memory for genomic imprinting had been lost or altered in Zfp57-null ES cells in culture. Interestingly, ZFP57 and DNA methyltransferases could form complexes in the presence of KAP1/TRIM28/TIF1 beta when co-expressed in COS cells. We also found that the wildtype exogenous ZFP57 but not the mutant ZFP57 lacking the KRAB box that interacts with its co-factor KAP1/TRIM28/TIF1 beta could substitute for the endogenous ZFP57 in maintaining the DNA methylation imprint in ES cells. These results suggest that ZFP57 may recruit DNA methyltransferases to its target regions to maintain DNA methylation imprint, and this interaction is likely facilitated by KAP1/TRIM28/TIF1 beta.	[Zuo, Xiaopan; Sheng, Jipo; Lau, Ho-Tak; McDonald, Carol M.; Andrade, Monica; Cullen, Dana E.; Bell, Fong T.; Li, Xiajun] Mt Sinai Sch Med, Black Family Stem Cell Inst, Dept Dev & Regenerat Biol, New York, NY 10029 USA; [Iacovino, Michelina; Kyba, Michael] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA; [Iacovino, Michelina; Kyba, Michael] Univ Minnesota, Lillehei Heart Inst, Minneapolis, MN 55455 USA; [Xu, Guoliang] Chinese Acad Sci, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China	Icahn School of Medicine at Mount Sinai; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Li, XJ (corresponding author), Mt Sinai Sch Med, Black Family Stem Cell Inst, Dept Dev & Regenerat Biol, New York, NY 10029 USA.	Xiajun.li@mssm.edu	zuo, xiaopan/B-7991-2013	iacovino, michelina/0000-0002-1076-3146; Kyba, Michael/0000-0002-5579-7534	National Institutes of Health [GM093335]; March of Dimes Basil O'Connor Starter Research Award; New York State NYSTEM [C026434]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093335] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes Basil O'Connor Starter Research Award; New York State NYSTEM; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM093335 (to X. L.). This work was also supported in part by the March of Dimes Basil O'Connor Starter Research Award (to X. L.) and New York State NYSTEM Contract C026434 (to X. L.).	Bartolomei MS, 2009, GENE DEV, V23, P2124, DOI 10.1101/gad.1841409; Ben-Porath I, 2000, CURR OPIN GENET DEV, V10, P550, DOI 10.1016/S0959-437X(00)00126-X; Borden KLB, 2000, J MOL BIOL, V295, P1103, DOI 10.1006/jmbi.1999.3429; Borowczyk E, 2009, P NATL ACAD SCI USA, V106, P20806, DOI 10.1073/pnas.0905668106; Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; Cammas F, 2004, GENE DEV, V18, P2147, DOI 10.1101/gad.302904; CATTANACH BM, 1986, J EMBRYOL EXP MORPH, V97, P137; Chedin F, 2002, P NATL ACAD SCI USA, V99, P16916, DOI 10.1073/pnas.262443999; Edwards CA, 2007, CURR OPIN CELL BIOL, V19, P281, DOI 10.1016/j.ceb.2007.04.013; Fazzio TG, 2008, CELL, V134, P162, DOI 10.1016/j.cell.2008.05.031; Feil R, 2007, TRENDS GENET, V23, P192, DOI 10.1016/j.tig.2007.02.004; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; Ge YZ, 2004, J BIOL CHEM, V279, P25447, DOI 10.1074/jbc.M312296200; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Hata K, 2002, DEVELOPMENT, V129, P1983; Hu G, 2009, GENE DEV, V23, P837, DOI 10.1101/gad.1769609; Humpherys D, 2001, SCIENCE, V293, P95, DOI 10.1126/science.1061402; Iacovino M, 2009, STEM CELLS DEV, V18, P783, DOI 10.1089/scd.2008.0227; Ivanov AV, 2007, MOL CELL, V28, P823, DOI 10.1016/j.molcel.2007.11.012; Jones MJ, 2011, MOL CELL BIOL, V31, P2827, DOI 10.1128/MCB.01435-10; Jullien PE, 2009, CURR OPIN PLANT BIOL, V12, P637, DOI 10.1016/j.pbi.2009.07.004; Kareta MS, 2006, J BIOL CHEM, V281, P25893, DOI 10.1074/jbc.M603140200; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Koerner MV, 2009, DEVELOPMENT, V136, P1771, DOI 10.1242/dev.030403; Latos PA, 2009, DEVELOPMENT, V136, P437, DOI 10.1242/dev.032060; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lewis A, 2006, DEVELOPMENT, V133, P4203, DOI 10.1242/dev.02612; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Li JY, 2007, MOL CELL BIOL, V27, P8748, DOI 10.1128/MCB.01380-07; Li XJ, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-37; Li XJ, 2008, DEV CELL, V15, P547, DOI 10.1016/j.devcel.2008.08.014; Li XJ, 2010, MOL HUM REPROD, V16, P695, DOI 10.1093/molehr/gaq028; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Looman C, 2002, MOL BIOL EVOL, V19, P2118, DOI 10.1093/oxfordjournals.molbev.a004037; Mackay DJG, 2008, NAT GENET, V40, P949, DOI 10.1038/ng.187; MacLean JA, 2011, MOL CELL BIOL, V31, P1275, DOI 10.1128/MCB.00734-10; Matsuda E, 2001, J BIOL CHEM, V276, P14222, DOI 10.1074/jbc.M010663200; Murakami K, 2011, DEVELOPMENT, V138, P197, DOI 10.1242/dev.056606; Nakamura T, 2007, NAT CELL BIOL, V9, P64, DOI 10.1038/ncb1519; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Ooi SKT, 2009, J CELL SCI, V122, P2787, DOI 10.1242/jcs.015123; Payer B, 2003, CURR BIOL, V13, P2110, DOI 10.1016/j.cub.2003.11.026; Peng HZ, 2000, J BIOL CHEM, V275, P18000, DOI 10.1074/jbc.M001499200; Peng HZ, 2000, J MOL BIOL, V295, P1139, DOI 10.1006/jmbi.1999.3402; Peng J, 2008, TRENDS BIOCHEM SCI, V33, P191, DOI 10.1016/j.tibs.2008.02.003; Reik W, 2004, COLD SPRING HARB SYM, V69, P29, DOI 10.1101/sqb.2004.69.29; Renfree MB, 2009, ANNU REV GENOM HUM G, V10, P241, DOI 10.1146/annurev-genom-082908-150026; Ryan RF, 1999, MOL CELL BIOL, V19, P4366; Schumacher A, 2004, NUCLEIC ACIDS RES, V32, P1566, DOI 10.1093/nar/gkh322; Seki Y, 2010, P NATL ACAD SCI USA, V107, P10926, DOI 10.1073/pnas.0907601107; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Tilghman SM, 1999, CELL, V96, P185, DOI 10.1016/S0092-8674(00)80559-0; Tucker KL, 1996, GENE DEV, V10, P1008, DOI 10.1101/gad.10.8.1008; Tucker KL, 1996, P NATL ACAD SCI USA, V93, P12920, DOI 10.1073/pnas.93.23.12920; Verona RI, 2003, ANNU REV CELL DEV BI, V19, P237, DOI 10.1146/annurev.cellbio.19.111401.092717; Wiznerowicz M, 2007, J BIOL CHEM, V282, P34535, DOI 10.1074/jbc.M705898200; Wolf D, 2007, CELL, V131, P46, DOI 10.1016/j.cell.2007.07.026; Wolf D, 2009, NATURE, V458, P1201, DOI 10.1038/nature07844; Zeng L, 2008, NAT STRUCT MOL BIOL, V15, P626, DOI 10.1038/nsmb.1416	60	123	128	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					2107	2118		10.1074/jbc.M111.322644	http://dx.doi.org/10.1074/jbc.M111.322644			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22144682	Green Published, hybrid			2022-12-27	WOS:000299321000051
J	Rienmuller, F; Dreyer, I; Schonknecht, G; Schulz, A; Schumacher, K; Nagy, R; Martinoia, E; Marten, I; Hedrich, R				Rienmueller, Florian; Dreyer, Ingo; Schoenknecht, Gerald; Schulz, Alexander; Schumacher, Karin; Nagy, Reka; Martinoia, Enrico; Marten, Irene; Hedrich, Rainer			Luminal and Cytosolic pH Feedback on Proton Pump Activity and ATP Affinity of V-type ATPase from Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE H+-ATPASE; GUARD-CELLS; COUPLING RATIO; STORAGE TISSUE; BETA-VULGARIS; SUBUNIT-C; VACUOLAR; CHANNELS; TONOPLAST; K+	Proton pumping of the vacuolar-type H+-ATPase into the lumen of the central plant organelle generates a proton gradient of often 1-2 pH units or more. Although structural aspects of the V-type ATPase have been studied in great detail, the question of whether and how the proton pump action is controlled by the proton concentration on both sides of the membrane is not understood. Applying the patch clamp technique to isolated vacuoles from Arabidopsis mesophyll cells in the whole-vacuole mode, we studied the response of the V-ATPase to protons, voltage, and ATP. Current-voltage relationships at different luminal pH values indicated decreasing coupling ratios with acidification. A detailed study of ATP-dependent H+-pump currents at a variety of different pH conditions showed a complex regulation of V-ATPase activity by both cytosolic and vacuolar pH. At cytosolic pH 7.5, vacuolar pH changes had relative little effects. Yet, at cytosolic pH 5.5, a 100-fold increase in vacuolar proton concentration resulted in a 70-fold increase of the affinity for ATP binding on the cytosolic side. Changes in pH on either side of the membrane seem to be transferred by the V-ATPase to the other side. A mathematical model was developed that indicates a feedback of proton concentration on peak H+ current amplitude (v(max)) and ATP consumption (K-m) of the V-ATPase. It proposes that for efficient V-ATPase function dissociation of transported protons from the pump protein might become higher with increasing pH. This feature results in an optimization of H+ pumping by the V-ATPase according to existing H+ concentrations.	[Dreyer, Ingo] Univ Politecn Madrid, Ctr Biotecnol & Genom Plantas, Pozuelo De Alarcon 28223, Madrid, Spain; [Rienmueller, Florian; Schulz, Alexander; Marten, Irene; Hedrich, Rainer] Univ Wurzburg, Inst Mol Plant Physiol & Biophys, D-97082 Wurzburg, Germany; [Schoenknecht, Gerald] Oklahoma State Univ, Dept Bot, Stillwater, OK 74078 USA; [Schumacher, Karin] Heidelberg Univ, Heidelberg Inst Plant Sci, D-69120 Heidelberg, Germany; [Nagy, Reka; Martinoia, Enrico] Univ Zurich, Inst Plant Biol, CH-8008 Zurich, Switzerland; [Hedrich, Rainer] King Saud Univ, Riyadh 11451, Saudi Arabia	Universidad Politecnica de Madrid; University of Wurzburg; Oklahoma State University System; Oklahoma State University - Stillwater; Ruprecht Karls University Heidelberg; University of Zurich; King Saud University	Dreyer, I (corresponding author), Univ Politecn Madrid, Ctr Biotecnol & Genom Plantas, Campus Montegancedo,Carretera M-40,Km 37-7, Pozuelo De Alarcon 28223, Madrid, Spain.	ingo.dreyer@upm.es; hedrich@botanik.uni-wuerzburg.de	Hedrich, Rainer/G-8771-2011; Schoenknecht, Gerald/L-8848-2013; Dreyer, Ingo/N-4747-2014; Schumacher, Karin/E-8500-2014; Martinoia, Enrico/AAH-8712-2021; Marten, Irene/AAS-8555-2021	Hedrich, Rainer/0000-0003-3224-1362; Schoenknecht, Gerald/0000-0003-3762-4880; Dreyer, Ingo/0000-0002-2781-0359; Schumacher, Karin/0000-0001-6484-8105; Marten, Irene/0000-0001-8402-869X	Deutsche Forschungsgemeinschaft [FOR1061, GK1342]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants FOR1061 and GK1342 (to R. H.) and GK1342 (to I. M.).	BENNETT AB, 1984, PLANT PHYSIOL, V74, P545, DOI 10.1104/pp.74.3.545; BERTL A, 1992, SCIENCE, V258, P873, DOI 10.1126/science.1439795; BETHMANN B, 1995, PLANT PHYSIOL, V109, P1317, DOI 10.1104/pp.109.4.1317; Beyhl D, 2009, PLANT J, V58, P715, DOI 10.1111/j.1365-313X.2009.03820.x; BLATT MR, 1992, J GEN PHYSIOL, V99, P615, DOI 10.1085/jgp.99.4.615; BRISKIN DP, 1992, J EXP BOT, V43, P269, DOI 10.1093/jxb/43.3.269; Cipriano DJ, 2008, BBA-BIOENERGETICS, V1777, P599, DOI 10.1016/j.bbabio.2008.03.013; Cross RL, 2004, FEBS LETT, V576, P1, DOI 10.1016/j.febslet.2004.08.065; CROSS RL, 1990, FEBS LETT, V259, P227, DOI 10.1016/0014-5793(90)80014-A; Dadacz-Narloch B, 2011, PLANT CELL, V23, P2696, DOI 10.1105/tpc.111.086751; DAVIES JM, 1994, P NATL ACAD SCI USA, V91, P8547, DOI 10.1073/pnas.91.18.8547; GAMBALE F, 1994, EUR BIOPHYS J BIOPHY, V22, P399, DOI 10.1007/BF00180161; Grabe M, 2000, BIOPHYS J, V78, P2798, DOI 10.1016/S0006-3495(00)76823-8; GUERN J, 1989, PLANT PHYSIOL, V89, P27, DOI 10.1104/pp.89.1.27; Hedrich R, 2011, MOL PLANT, V4, P428, DOI 10.1093/mp/ssr017; Hirata T, 2000, J BIOL CHEM, V275, P386, DOI 10.1074/jbc.275.1.386; Ivashikina N, 2005, PLANT J, V41, P606, DOI 10.1111/j.1365-313X.2004.02324.x; Junge W, 2009, NATURE, V459, P364, DOI 10.1038/nature08145; Kettner C, 2003, BIOPHYS J, V85, P3730, DOI 10.1016/S0006-3495(03)74789-4; Klenk HP, 1997, NATURE, V390, P364, DOI 10.1038/37052; Krebs M, 2010, P NATL ACAD SCI USA, V107, P3251, DOI 10.1073/pnas.0913035107; LOHSE G, 1992, PLANTA, V188, P206, DOI 10.1007/BF00216815; Marcel D, 2010, FEBS LETT, V584, P2433, DOI 10.1016/j.febslet.2010.04.038; Meyer S, 2011, PLANT J, V67, P247, DOI 10.1111/j.1365-313X.2011.04587.x; Muller ML, 2002, J MEMBRANE BIOL, V185, P209, DOI 10.1007/s00232-001-0124-z; Muller ML, 1999, J BIOL CHEM, V274, P10706, DOI 10.1074/jbc.274.16.10706; NEHER E, 1992, METHOD ENZYMOL, V207, P123; Okuno D, 2011, J BIOCHEM, V149, P655, DOI 10.1093/jb/mvr049; Peiter E, 2005, NATURE, V434, P404, DOI 10.1038/nature03381; Rastogi VK, 1999, NATURE, V402, P263, DOI 10.1038/46224; Ruppert C, 2001, FEMS MICROBIOL LETT, V195, P47, DOI 10.1016/S0378-1097(00)00544-9; SCHMIDT AL, 1993, ARCH BIOCHEM BIOPHYS, V301, P165, DOI 10.1006/abbi.1993.1129; Schulz A, 2011, PLANT J, V68, P129, DOI 10.1111/j.1365-313X.2011.04672.x; SCHULZLESSDORF B, 1995, PLANTA, V197, P655; Schumacher K, 1999, GENE DEV, V13, P3259, DOI 10.1101/gad.13.24.3259; Voelker C, 2010, PLANT BIOLOGY, V12, P56, DOI 10.1111/j.1438-8677.2010.00353.x; Walker DJ, 1996, P NATL ACAD SCI USA, V93, P10510, DOI 10.1073/pnas.93.19.10510; Yabe I, 1999, J BIOL CHEM, V274, P34903, DOI 10.1074/jbc.274.49.34903; Yokoyama K, 1998, J BIOL CHEM, V273, P20504, DOI 10.1074/jbc.273.32.20504; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	40	30	30	1	28	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					8986	8993		10.1074/jbc.M111.310367	http://dx.doi.org/10.1074/jbc.M111.310367			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22215665	Green Published, hybrid, Green Accepted			2022-12-27	WOS:000301797800029
J	Chervin-Petinot, A; Courcon, M; Almagro, S; Nicolas, A; Grichine, A; Grunwald, D; Prandini, MH; Huber, P; Gulino-Debrac, D				Chervin-Petinot, Adeline; Courcon, Marie; Almagro, Sebastien; Nicolas, Alice; Grichine, Alexei; Grunwald, Didier; Prandini, Marie-Helene; Huber, Philippe; Gulino-Debrac, Danielle			Epithelial Protein Lost In Neoplasm (EPLIN) Interacts with alpha-Catenin and Actin Filaments in Endothelial Cells and Stabilizes Vascular Capillary Network in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADHERENS JUNCTIONS; BLOOD-VESSELS; CROSS-LINKING; VE-CADHERIN; COMPLEX; VINCULIN; ADHESION; TENSION; CANCER; LOCALIZATION	Adherens junctions are required for vascular endothelium integrity. These structures are formed by the clustering of the homophilic adhesive protein VE-cadherin, which recruits intracellular partners, such as beta- and alpha-catenins, vinculin, and actin filaments. The dogma according to which alpha-catenin bridges cadherin beta-catenin complexes to the actin cytoskeleton has been challenged during the past few years, and the link between the E-cadherin.catenin complex and the actin cytoskeleton remains unclear. Recently, epithelial protein lost in neoplasm (EPLIN) has been proposed as a possible bond between the VE-cadherin.catenin complex and actin in epithelial cells. Herein, we show that EPLIN is expressed at similar levels in endothelial and epithelial cells and is located at interendothelial junctions in confluent cells. Co-immunoprecipitation and GST pulldown experiments provided evidence that EPLIN interacts directly with alpha-catenin and tethers the VE-cadherin.catenin complex to the actin cytoskeleton. In the absence of EPLIN, vinculin was delocalized from the junctions. Furthermore, suppression of actomyosin tension using blebbistatin triggered a similar vinculin delocalization from the junctions. In a Matrigel assay, EPLIN-depleted endothelial cells exhibited a reduced capacity to form pseudocapillary networks because of numerous breakage events. In conclusion, we propose a model in which EPLIN establishes a link between the cadherin.catenin complex and actin that is independent of actomyosin tension. This link acts as a mechanotransmitter, allowing vinculin binding to beta-catenin and formation of a secondary molecular bond between the adherens complex and the cytoskeleton through vinculin. In addition, we provide evidence that the EPLIN clutch is necessary for stabilization of capillary structures in an angiogenesis model.	[Chervin-Petinot, Adeline; Courcon, Marie; Almagro, Sebastien; Prandini, Marie-Helene; Huber, Philippe; Gulino-Debrac, Danielle] INSERM, U882, F-38054 Grenoble, France; [Chervin-Petinot, Adeline; Courcon, Marie; Almagro, Sebastien; Grunwald, Didier; Prandini, Marie-Helene; Huber, Philippe; Gulino-Debrac, Danielle] Commissariat Energie Atom & Energies Alternat CEA, DSV, iRTSV, F-38054 Grenoble, France; [Chervin-Petinot, Adeline; Courcon, Marie; Almagro, Sebastien; Grichine, Alexei; Prandini, Marie-Helene; Huber, Philippe; Gulino-Debrac, Danielle] Univ Grenoble 1, F-38041 Grenoble, France; [Nicolas, Alice] CNRS, Lab Technol Microelect LETI, UMR5129, F-38054 Grenoble, France; [Nicolas, Alice] CEA LETI Dept Nanotec D2NT, F-38054 Grenoble, France; [Grichine, Alexei] INSERM, U823, F-38706 La Tronche, France	Institut National de la Sante et de la Recherche Medicale (Inserm); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm)	Gulino-Debrac, D (corresponding author), CEA, iRTSV, U1036, INSERM, 17 Rue Martyrs, F-38054 Grenoble 9, France.	danielle.gulino@cea.fr	Grichine, Alexei/M-3923-2013; Huber, Philippe/C-7971-2019; Grichine, Alexei/P-8377-2019	Grichine, Alexei/0000-0002-7335-9706; Huber, Philippe/0000-0002-4153-7694; Grichine, Alexei/0000-0002-7335-9706; COURCON, Marie/0000-0001-7152-1768; Nicolas, Alice/0000-0003-1758-1174				Abe K, 2008, P NATL ACAD SCI USA, V105, P13, DOI 10.1073/pnas.0710504105; Aird WC, 2007, CIRC RES, V100, P174, DOI 10.1161/01.RES.0000255690.03436.ae; Almagro S, 2010, MOL CELL BIOL, V30, P1703, DOI 10.1128/MCB.01226-09; Arnaoutova I, 2009, ANGIOGENESIS, V12, P267, DOI 10.1007/s10456-009-9146-4; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Baluk P, 2005, CURR OPIN GENET DEV, V15, P102, DOI 10.1016/j.gde.2004.12.005; BREVIARIO F, 1995, ARTERIOSCL THROM VAS, V15, P1229, DOI 10.1161/01.ATV.15.8.1229; Carisey A, 2011, EUR J CELL BIOL, V90, P157, DOI 10.1016/j.ejcb.2010.06.007; Cavey M, 2008, NATURE, V453, P751, DOI 10.1038/nature06953; Chang DD, 1998, ONCOGENE, V16, P1921, DOI 10.1038/sj.onc.1201715; Chen SX, 2000, GENE, V248, P69, DOI 10.1016/S0378-1119(00)00144-X; Chircop M, 2009, CELL CYCLE, V8, P757, DOI 10.4161/cc.8.5.7878; Comunale F, 2007, BIOL CELL, V99, P503, DOI 10.1042/BC20070011; Delanoe-Ayari H, 2004, P NATL ACAD SCI USA, V101, P2229, DOI 10.1073/pnas.0304297101; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Gavard J, 2009, FEBS LETT, V583, P1, DOI 10.1016/j.febslet.2008.11.032; Han MY, 2007, MOL CELL BIOL, V27, P8190, DOI 10.1128/MCB.00661-07; Harris ES, 2010, CURR OPIN CELL BIOL, V22, P651, DOI 10.1016/j.ceb.2010.07.006; Heyraud S, 2008, MOL CELL BIOL, V28, P1657, DOI 10.1128/MCB.00695-07; Imamura Y, 1999, J CELL BIOL, V144, P1311, DOI 10.1083/jcb.144.6.1311; Jiang WG, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-71; Kiener HP, 2006, MOL BIOL CELL, V17, P2366, DOI 10.1091/mbc.E05-08-0745; Kobielak A, 2004, NAT CELL BIOL, V6, P21, DOI 10.1038/ncb1075; Liao F, 2002, CANCER RES, V62, P2567; Liebner S, 2006, ARTERIOSCL THROM VAS, V26, P1431, DOI 10.1161/01.ATV.0000218510.04541.5e; Liu ZJ, 2010, P NATL ACAD SCI USA, V107, P9944, DOI 10.1073/pnas.0914547107; Marie H, 2003, J BIOL CHEM, V278, P1220, DOI 10.1074/jbc.M205391200; Maruthamuthu V, 2011, P NATL ACAD SCI USA, V108, P4708, DOI 10.1073/pnas.1011123108; Maul RS, 2003, J CELL BIOL, V160, P399, DOI 10.1083/jcb.200212057; Maul RS, 1999, ONCOGENE, V18, P7838, DOI 10.1038/sj.onc.1203206; McDonald DM, 2005, CHEST, V128, p602S, DOI 10.1378/chest.128.6_suppl.602S-a; Mierke CT, 2009, CELL BIOCHEM BIOPHYS, V53, P115, DOI 10.1007/s12013-009-9047-6; Nieset JE, 1997, J CELL SCI, V110, P1013; Sanders AJ, 2010, ANGIOGENESIS, V13, P317, DOI 10.1007/s10456-010-9188-7; Shapiro L, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003053; Smutny M, 2010, J CELL BIOL, V189, P1075, DOI 10.1083/jcb.201005151; Song YH, 2002, MOL BIOL CELL, V13, P1408, DOI 10.1091/mbc.01-08-0414; Stephanou A, 2007, MICROVASC RES, V73, P182, DOI 10.1016/j.mvr.2006.12.002; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Vestweber D, 2008, ARTERIOSCL THROM VAS, V28, P223, DOI 10.1161/ATVBAHA.107.158014; Vestweber D, 2009, TRENDS CELL BIOL, V19, P8, DOI 10.1016/j.tcb.2008.10.001; Watabe-Uchida M, 1998, J CELL BIOL, V142, P847, DOI 10.1083/jcb.142.3.847; Weiss EE, 1998, J CELL BIOL, V141, P755, DOI 10.1083/jcb.141.3.755; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055; Zheng Q, 2007, BIOL CELL, V99, P489, DOI 10.1042/BC20060126	47	53	54	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7556	7572		10.1074/jbc.M111.328682	http://dx.doi.org/10.1074/jbc.M111.328682			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22194609	Green Published, hybrid			2022-12-27	WOS:000301060200056
J	Chen, P; Song, ZL; Qi, YH; Feng, XF; Xu, NQ; Sun, YY; Wu, X; Yao, X; Mao, QY; Li, XL; Dong, WJ; Wan, XB; Huang, N; Shen, XL; Liang, ZL; Li, WH				Chen, Pan; Song, Zilin; Qi, Yonghe; Feng, Xiaofeng; Xu, Naiqing; Sun, Yinyan; Wu, Xing; Yao, Xin; Mao, Qunyin; Li, Xiuling; Dong, Wenjuan; Wan, Xiaobo; Huang, Niu; Shen, Xinliang; Liang, Zhenglun; Li, Wenhui			Molecular Determinants of Enterovirus 71 Viral Entry CLEFT AROUND GLN-172 ON VP1 PROTEIN INTERACTS WITH VARIABLE REGION ON SCAVENGE RECEPTOR B 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELLULAR RECEPTOR; UCSF CHIMERA; PROTEIN; POLIOVIRUS; INFECTION; VP1; EPIDEMIC; DISEASE; VISUALIZATION; ADAPTATION	Enterovirus 71 (EV71) is one of the major pathogens that cause hand, foot, and mouth disease outbreaks in young children in the Asia-Pacific region in recent years. Human scavenger receptor class B 2 (SCARB2) is the main cellular receptor for EV71 on target cells. The requirements of the EV71-SCARB2 interaction have not been fully characterized, and it has not been determined whether SCARB2 serves as an uncoating receptor for EV71. Here we compared the efficiency of the receptor from different species including human, horseshoe bat, mouse, and hamster and demonstrated that the residues between 144 and 151 are critical for SCARB2 binding to viral capsid protein VP1 of EV71 and seven residues from the human receptor could convert murine SCARB2, an otherwise inefficient receptor, to an efficient receptor for EV71 viral infection. We also identified that EV71 binds to SCARB2 via a canyon of VP1 around residue Gln-172. Soluble SCARB2 could convert the EV71 virions from 160 S to 135 S particles, indicating that SCARB2 is an uncoating receptor of the virus. The uncoating efficiency of SCARB2 significantly increased in an acidic environment (pH 5.6). These studies elucidated the viral capsid and receptor determinants of enterovirus 71 infection and revealed a possible target for antiviral interventions.	[Chen, Pan; Song, Zilin; Qi, Yonghe; Feng, Xiaofeng; Xu, Naiqing; Sun, Yinyan; Dong, Wenjuan; Wan, Xiaobo; Huang, Niu; Li, Wenhui] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Chen, Pan] Chinese Acad Med Sci, Grad Program, Beijing 100730, Peoples R China; [Chen, Pan] Peking Union Med Coll, Beijing 100730, Peoples R China; [Wu, Xing; Yao, Xin; Mao, Qunyin; Liang, Zhenglun] Natl Inst Food & Drug Control, Beijing 100050, Peoples R China; [Li, Xiuling; Shen, Xinliang] Natl Vaccine & Serum Inst, Beijing 100024, Peoples R China	National Institute of Biological Sciences, Beijing; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; National Institute of Food & Drug Control - China	Li, WH (corresponding author), Natl Inst Biol Sci, 7 Sci Pk Rd,ZGC Life Sci Pk, Beijing 102206, Peoples R China.	liwenhui@nibs.ac.cn	Huang, Niu/J-9656-2012; li, xiu/GXV-1745-2022	Li, Wenhui/0000-0003-1305-7404; Huang, Niu/0000-0002-6912-033X	Major State Basic Research Development Program of China (973 Program) [2010CB530101]; Beijing Municipal Government	Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); Beijing Municipal Government	This work was supported by the Major State Basic Research Development Program of China (973 Program Grant 2010CB530101) and a research and development grant from the Beijing Municipal Government.	Arita M, 2008, J VIROL, V82, P1787, DOI 10.1128/JVI.01798-07; Arita M, 2007, J VIROL, V81, P9386, DOI 10.1128/JVI.02856-06; Blanz J, 2010, HUM MOL GENET, V19, P563, DOI 10.1093/hmg/ddp523; Broo K, 2001, P NATL ACAD SCI USA, V98, P2274, DOI 10.1073/pnas.051598298; Bubeck D, 2005, J VIROL, V79, P7745, DOI 10.1128/JVI.79.12.7745-7755.2005; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Chan LG, 2000, CLIN INFECT DIS, V31, P678, DOI 10.1086/314032; Chua BH, 2008, J GEN VIROL, V89, P1622, DOI 10.1099/vir.0.83676-0; CHUMAKOV M, 1979, ARCH VIROL, V60, P329, DOI 10.1007/BF01317504; Eckhardt ERM, 2004, J BIOL CHEM, V279, P14372, DOI 10.1074/jbc.M313793200; Eskelinen EL, 2003, TRENDS CELL BIOL, V13, P137, DOI 10.1016/S0962-8924(03)00005-9; FILMAN DJ, 1989, EMBO J, V8, P1567, DOI 10.1002/j.1460-2075.1989.tb03541.x; FUJITA H, 1991, BIOCHEM BIOPH RES CO, V178, P444, DOI 10.1016/0006-291X(91)90127-S; Goddard TD, 2005, STRUCTURE, V13, P473, DOI 10.1016/j.str.2005.01.006; GREVE JM, 1989, CELL, V56, P839, DOI 10.1016/0092-8674(89)90688-0; Guang D, 2007, VIRUS RES, V125, P61, DOI 10.1016/j.virusres.2006.12.005; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Hogle JM, 2002, ANNU REV MICROBIOL, V56, P677, DOI 10.1146/annurev.micro.56.012302.160757; Howley PM, 2007, FIELDS VIROLOGY, V1, P839; Huang CC, 1999, NEW ENGL J MED, V341, P936, DOI 10.1056/NEJM199909233411302; Hussain KM, 2011, J BIOL CHEM, V286, P309, DOI 10.1074/jbc.M110.168468; Lal SK, 2006, J MED VIROL, V78, P582, DOI 10.1002/jmv.20579; Lau SKP, 2011, J VIROL, V85, P8819, DOI 10.1128/JVI.02364-10; Levy HC, 2010, J VIROL, V84, P4426, DOI 10.1128/JVI.02393-09; Lewis JK, 1998, P NATL ACAD SCI USA, V95, P6774, DOI 10.1073/pnas.95.12.6774; Li WH, 2005, EMBO J, V24, P1634, DOI 10.1038/sj.emboj.7600640; Lin YW, 2009, EXP BIOL MED, V234, P1166, DOI 10.3181/0903-RM-116; Lu Min, 2009, Chinese Journal of Pathology, V38, P81, DOI 10.3760/cma.j.issn.0529-5807.2009.02.004; Lum LCS, 1998, LANCET, V352, P1391, DOI 10.1016/S0140-6736(05)60789-1; MENDELSOHN CL, 1989, CELL, V56, P855, DOI 10.1016/0092-8674(89)90690-9; NAGY G, 1982, ARCH VIROL, V71, P217, DOI 10.1007/BF01314873; Nishimura Y, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001174; Nishimura Y, 2009, NAT MED, V15, P794, DOI 10.1038/nm.1961; Oberste MS, 1999, J VIROL, V73, P1941, DOI 10.1128/JVI.73.3.1941-1948.1999; OLSON NH, 1993, P NATL ACAD SCI USA, V90, P507, DOI 10.1073/pnas.90.2.507; Ooi MH, 2010, LANCET NEUROL, V9, P1097, DOI 10.1016/S1474-4422(10)70209-X; PEREZ L, 1993, J VIROL, V67, P4543; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Racaniello VR, 2007, FIELDS VIROLOGY, P795; Ranganathan Shoba, 2002, Appl Bioinformatics, V1, P43; Reczek D, 2007, CELL, V131, P770, DOI 10.1016/j.cell.2007.10.018; ROSSMANN MG, 1985, NATURE, V317, P145, DOI 10.1038/317145a0; ROSSMANN MG, 1989, ANNU REV BIOCHEM, V58, P533, DOI 10.1146/annurev.bi.58.070189.002533; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SANDOVAL IV, 1994, J BIOL CHEM, V269, P6622; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Simmons NB, 2008, NATURE, V451, P818, DOI 10.1038/nature06549; SMITH TJ, 1986, SCIENCE, V233, P1286, DOI 10.1126/science.3018924; Tee KK, 2010, J VIROL, V84, P3339, DOI 10.1128/JVI.01019-09; Tuthill TJ, 2010, CURR TOP MICROBIOL, V343, P43, DOI 10.1007/82_2010_37; Vallet S, 2009, EMERG INFECT DIS, V15, P1837, DOI 10.3201/eid1511.090493; Xu J, 2010, VACCINE, V28, P3516, DOI 10.1016/j.vaccine.2010.03.003; Yamayoshi S, 2011, J VIROL, V85, P4937, DOI 10.1128/JVI.02358-10; Yamayoshi S, 2009, NAT MED, V15, P798, DOI 10.1038/nm.1992; Yang B, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-141; Yang SL, 2011, J VIROL, V85, P11809, DOI 10.1128/JVI.00297-11; Zhang P, 2008, P NATL ACAD SCI USA, V105, P18284, DOI 10.1073/pnas.0807848105	57	94	107	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6406	6420		10.1074/jbc.M111.301622	http://dx.doi.org/10.1074/jbc.M111.301622			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22219187	Green Published, hybrid			2022-12-27	WOS:000300791800031
J	Hubbi, ME; Gilkes, DM; Baek, JH; Semenza, GL				Hubbi, Maimon E.; Gilkes, Daniele M.; Baek, Jin H.; Semenza, Gregg L.			Four-and-a-Half LIM Domain Proteins Inhibit Transactivation by Hypoxia-inducible Factor 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CATENIN; TRANSCRIPTIONAL ACTIVITY; PROLINE HYDROXYLATION; CANCER-THERAPY; FACTOR 2-ALPHA; FACTOR 1-ALPHA; HIF-ALPHA; HIF-1-ALPHA; FHL2; DEGRADATION	Hypoxia-inducible factor 1 (HIF-1) is a transcription factor that promotes angiogenesis, metabolic reprogramming, and other critical aspects of cancer biology. The four-and-a-half LIM domain (FHL) proteins are a family of LIM domain-only proteins implicated in transcriptional regulation and suppression of tumor growth. Here we describe functional interactions between the FHL proteins and HIF-1. FHL1-3 inhibit HIF-1 transcriptional activity and HIF-1 alpha transactivation domain function by oxygen-independent mechanisms. FHL2 directly interacts with HIF-1 alpha to repress transcriptional activity. FHL1 binds to the p300/CBP co-activators and disrupts binding with HIF-1 alpha. FHL3 does not bind to HIF-1 alpha or p300, indicating that it regulates transactivation by a novel molecular mechanism. Expression of the FHL proteins increased upon HIF-1 alpha induction, suggesting the existence of a feedback loop. These results identify FHL proteins as negative regulators of HIF-1 activity, which may provide a mechanism by which they suppress tumor growth.	[Hubbi, Maimon E.] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Grad Training Program Cellular & Mol Med, Baltimore, MD 21205 USA; [Hubbi, Maimon E.; Gilkes, Daniele M.; Baek, Jin H.; Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Radiat Oncol, Baltimore, MD 21205 USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Hubbi, Maimon E.; Gilkes, Daniele M.; Baek, Jin H.; Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Vasc Program, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Semenza, GL (corresponding author), 733 N Broadway, Baltimore, MD 21205 USA.	gsemenza@jhmi.edu	Gilkes, Daniele M/AAI-8133-2020	Gilkes, Daniele M/0000-0003-3984-9338; Hubbi, Maimon/0000-0001-9763-287X	National Institutes of Health Public Health Service [N01-HV28180, HHS-N268201000032C]; Johns Hopkins Institute for Cell Engineering; National Institutes of Health [T32-HL007525-27]; Cellular and Molecular Medicine Predoctoral Training Grant [T32-GM008752-11]; Komen Postdoctoral Fellowship; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028180] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008752] Funding Source: NIH RePORTER	National Institutes of Health Public Health Service(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); Johns Hopkins Institute for Cell Engineering; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cellular and Molecular Medicine Predoctoral Training Grant; Komen Postdoctoral Fellowship(Susan G. Komen Breast Cancer Foundation); DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Public Health Service Contracts N01-HV28180 and HHS-N268201000032C. This work was also supported by funds from the Johns Hopkins Institute for Cell Engineering.; Supported by National Institutes of Health Hematology Postdoctoral Training Grant T32-HL007525-27 and Cellular and Molecular Medicine Predoctoral Training Grant T32-GM008752-11.; Supported by a Komen Postdoctoral Fellowship.	Amir S, 2009, J BIOL CHEM, V284, P11142, DOI 10.1074/jbc.M808348200; Baek JH, 2005, MOL CELL, V17, P503, DOI 10.1016/j.molcel.2005.01.011; Baek JH, 2007, J BIOL CHEM, V282, P33358, DOI 10.1074/jbc.M705627200; Baek JH, 2007, J BIOL CHEM, V282, P23572, DOI 10.1074/jbc.M703504200; Bamforth SD, 2001, NAT GENET, V29, P469, DOI 10.1038/ng768; Bhattacharya S, 1999, GENE DEV, V13, P64, DOI 10.1101/gad.13.1.64; Bracken CP, 2005, J BIOL CHEM, V280, P14240, DOI 10.1074/jbc.M409987200; Cowling BS, 2008, J CELL BIOL, V183, P1033, DOI 10.1083/jcb.200804077; Ding LH, 2009, J CLIN INVEST, V119, P349, DOI 10.1172/JCI35930; Dioum EM, 2009, SCIENCE, V324, P1289, DOI 10.1126/science.1169956; EBERT BL, 1995, J BIOL CHEM, V270, P29083, DOI 10.1074/jbc.270.49.29083; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Freedman SJ, 2002, P NATL ACAD SCI USA, V99, P5367, DOI 10.1073/pnas.082117899; Hubbi ME, 2011, MOL CELL, V42, P700, DOI 10.1016/j.molcel.2011.03.029; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Johannessen M, 2006, CELL MOL LIFE SCI, V63, P268, DOI 10.1007/s00018-005-5438-z; Kadrmas JL, 2004, NAT REV MOL CELL BIO, V5, P920, DOI 10.1038/nrm1499; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kleiber K, 2007, ANTICANCER RES, V27, P55; Koh MY, 2008, MOL CELL BIOL, V28, P7081, DOI 10.1128/MCB.00773-08; Koh MY, 2011, CANCER RES, V71, P4015, DOI 10.1158/0008-5472.CAN-10-4142; Kong YF, 2001, CIRCULATION, V103, P2731; Kwapiszewska G, 2008, CIRCULATION, V118, P1183, DOI 10.1161/CIRCULATIONAHA.107.761916; Labalette C, 2004, MOL CELL BIOL, V24, P10689, DOI 10.1128/MCB.24.24.10689-10702.2004; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Lee JS, 2010, MOL CELL, V39, P71, DOI 10.1016/j.molcel.2010.06.008; Liu YV, 2007, J BIOL CHEM, V282, P37064, DOI 10.1074/jbc.M705015200; Liu YV, 2007, MOL CELL, V25, P207, DOI 10.1016/j.molcel.2007.01.001; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Luo WB, 2010, J BIOL CHEM, V285, P3651, DOI 10.1074/jbc.M109.068577; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Martin B, 2002, J CELL BIOL, V159, P113, DOI 10.1083/jcb.200202075; Melillo G, 2007, CANCER METAST REV, V26, P341, DOI 10.1007/s10555-007-9059-x; Patel SA, 2008, CELL DEATH DIFFER, V15, P628, DOI 10.1038/cdd.2008.17; Schessl J, 2008, J CLIN INVEST, V118, P904, DOI 10.1172/JCI34450; Scortegagna M, 2003, NAT GENET, V35, P331, DOI 10.1038/ng1266; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Semenza GL, 2009, PHYSIOLOGY, V24, P97, DOI 10.1152/physiol.00045.2008; Sheikh F, 2008, J CLIN INVEST, V118, P3870, DOI 10.1172/JCI34472; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wei Y, 2003, J BIOL CHEM, V278, P5188, DOI 10.1074/jbc.M207216200; Wong CCL, 2011, P NATL ACAD SCI USA, V108, P16369, DOI 10.1073/pnas.1113483108; Xu B, 2007, DEV BIOL, V301, P130, DOI 10.1016/j.ydbio.2006.08.072; Yang YH, 2005, EMBO J, V24, P1021, DOI 10.1038/sj.emboj.7600570; Yin Z, 2002, P NATL ACAD SCI USA, V99, P10488, DOI 10.1073/pnas.162371799; Yu F, 2001, P NATL ACAD SCI USA, V98, P9630, DOI 10.1073/pnas.181341498; Zhang HF, 2008, P NATL ACAD SCI USA, V105, P19579, DOI 10.1073/pnas.0809763105; Zhong H, 1999, CANCER RES, V59, P5830	53	40	44	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6139	6149		10.1074/jbc.M111.278630	http://dx.doi.org/10.1074/jbc.M111.278630			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22219185	hybrid, Green Published			2022-12-27	WOS:000300791800007
J	Boulay, G; Malaquin, N; Loison, I; Foveau, B; Van Rechem, C; Rood, BR; Pourtier, A; Leprince, D				Boulay, Gaylor; Malaquin, Nicolas; Loison, Ingrid; Foveau, Benedicte; Van Rechem, Capucine; Rood, Brian R.; Pourtier, Albin; Leprince, Dominique			Loss of Hypermethylated in Cancer 1 (HIC1) in Breast Cancer Cells Contributes to Stress-induced Migration and Invasion through beta-2 Adrenergic Receptor (ADRB2) Misregulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR GENE; BETA(2)-ADRENERGIC RECEPTOR; TRANSCRIPTIONAL REPRESSION; CARCINOMA-CELLS; BETA-BLOCKERS; CYCLIC-AMP; EXPRESSION; MOTIF; METHYLATION; METASTASIS	The transcriptional repressor HIC1 (Hypermethylated in Cancer 1) is a tumor suppressor gene inactivated in many human cancers including breast carcinomas. In this study, we show that HIC1 is a direct transcriptional repressor of beta-2 adrenergic receptor (ADRB2). Through promoter luciferase activity, chromatin immunoprecipitation (ChIP) and sequential ChIP experiments, we demonstrate that ADRB2 is a direct target gene of HIC1, endogenously in WI-38 cells and following HIC1 re-expression in breast cancer cells. Agonist-mediated stimulation of ADRB2 increases the migration and invasion of highly malignant MDA-MB-231 breast cancer cells but these effects are abolished following HIC1 re-expression or specific down-regulation of ADRB2 by siRNA treatment. Our results suggest that early inactivation of HIC1 in breast carcinomas could predispose to stress-induced metastasis through up-regulation of the beta-2 adrenergic receptor.	[Boulay, Gaylor; Malaquin, Nicolas; Loison, Ingrid; Foveau, Benedicte; Van Rechem, Capucine; Pourtier, Albin; Leprince, Dominique] Univ Lille 2, Univ Lille 1, CNRS, UMR 8161,Inst Biol Lille,Inst Pasteur Lille, F-590213 Lille, France; [Rood, Brian R.] George Washington Univ, Childrens Natl Med Ctr, Sch Med, Washington, DC 20010 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Children's National Health System; George Washington University	Leprince, D (corresponding author), Univ Lille 2, Univ Lille 1, CNRS, UMR 8161,Inst Biol Lille,Inst Pasteur Lille, BP 447, F-590213 Lille, France.	dominique.leprince@ibl.fr	POURTIER, ALBIN/G-7401-2012	POURTIER, ALBIN/0000-0002-1576-3946; Leprince, Dominique/0000-0002-1999-0775; Malaquin, Nicolas/0000-0002-1227-6341; Van Rechem, Capucine/0000-0002-5408-6124	National Institutes of Health/NINDS [1K08NS051477]; Centre National de la Recherche Scientifique (CNRS); Pasteur Institute of Lille; Ligue Nationale contre le Cancer (Comite Interregional du Septentrion); Association for International Cancer Research (AICR); Association pour la Recherche contre le Cancer (ARC) [ARC 3983, ARC 1081]; CNRS/Region Nord-Pas de Calais; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS051477] Funding Source: NIH RePORTER	National Institutes of Health/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Pasteur Institute of Lille; Ligue Nationale contre le Cancer (Comite Interregional du Septentrion); Association for International Cancer Research (AICR); Association pour la Recherche contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le CancerFrench National Research Agency (ANR)); CNRS/Region Nord-Pas de Calais(Region Hauts-de-FranceCentre National de la Recherche Scientifique (CNRS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health/NINDS Grant 1K08NS051477. This work was also supported by the Centre National de la Recherche Scientifique (CNRS), the Pasteur Institute of Lille, the Ligue Nationale contre le Cancer (Comite Interregional du Septentrion), the Association for International Cancer Research (AICR), and the Association pour la Recherche contre le Cancer (ARC) (Grant Numbers ARC 3983 and ARC 1081, to D. L.).; Supported by fellowships from the CNRS/Region Nord-Pas de Calais.	Briggs KJ, 2008, GENE DEV, V22, P770, DOI 10.1101/gad.1640908; Chen WY, 2005, CELL, V123, P437, DOI 10.1016/j.cell.2005.08.011; Dahl JA, 2007, STEM CELLS, V25, P1037, DOI 10.1634/stemcells.2006-0430; Deltour S, 2002, MOL CELL BIOL, V22, P4890, DOI 10.1128/MCB.22.13.4890-4901.2002; Du T, 2010, J NEUROCHEM, V115, P1007, DOI 10.1111/j.1471-4159.2010.06995.x; EDWARDS JG, 1993, J CELL SCI, V104, P399; EMORINE LJ, 1987, P NATL ACAD SCI USA, V84, P6995, DOI 10.1073/pnas.84.20.6995; Fleuriel C, 2009, INT J BIOCHEM CELL B, V41, P26, DOI 10.1016/j.biocel.2008.05.028; Foveau B, 2012, J BIOL CHEM, V287, P5366, DOI 10.1074/jbc.M111.329466; Fujii H, 1998, ONCOGENE, V16, P2159, DOI 10.1038/sj.onc.1201976; Guo K, 2009, ONCOL REP, V22, P825, DOI 10.3892/or_00000505; Lang K, 2004, INT J CANCER, V112, P231, DOI 10.1002/ijc.20410; Martin P, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-4; Masur K, 2001, CANCER RES, V61, P2866; Mohammad HP, 2011, ONCOGENE, V30, P2659, DOI 10.1038/onc.2010.633; Nicoll G, 2001, BRIT J CANCER, V85, P1878, DOI 10.1054/bjoc.2001.2163; Palm D, 2006, INT J CANCER, V118, P2744, DOI 10.1002/ijc.21723; Parrella P, 2005, CANCER LETT, V222, P75, DOI 10.1016/j.canlet.2004.08.026; Pinte S, 2004, J BIOL CHEM, V279, P38313, DOI 10.1074/jbc.M401610200; Powe DG, 2010, ONCOTARGET, V1, P628, DOI 10.18632/oncotarget.197; Rangarajan S, 2003, J CELL BIOL, V160, P487, DOI 10.1083/jcb.200209105; Shahzad MMK, 2010, J BIOL CHEM, V285, P35462, DOI 10.1074/jbc.M110.109579; Slotkin TA, 2000, BREAST CANCER RES TR, V60, P153, DOI 10.1023/A:1006338232150; Sood AK, 2006, CLIN CANCER RES, V12, P369, DOI 10.1158/1078-0432.CCR-05-1698; Stankovic-Valentin N, 2007, MOL CELL BIOL, V27, P2661, DOI 10.1128/MCB.01098-06; Thaker PH, 2007, CELL CYCLE, V6, P430, DOI 10.4161/cc.6.4.3829; Thaker PH, 2006, NAT MED, V12, P939, DOI 10.1038/nm1447; Van Rechem C, 2010, MOL CELL BIOL, V30, P4045, DOI 10.1128/MCB.00582-09; Van Rechem C, 2009, J BIOL CHEM, V284, P20927, DOI 10.1074/jbc.M109.022350; Van Rechem C, 2009, BIOCHEM BIOPH RES CO, V385, P586, DOI 10.1016/j.bbrc.2009.05.115; Vilgelm AE, 2010, ONCOGENE, V29, P5861, DOI 10.1038/onc.2010.319; Violin JD, 2008, J BIOL CHEM, V283, P2949, DOI 10.1074/jbc.M707009200; WALES MM, 1995, NAT MED, V1, P570, DOI 10.1038/nm0695-570; Zhang W, 2010, ONCOGENE, V29, P2467, DOI 10.1038/onc.2010.12	34	27	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5379	5389		10.1074/jbc.M111.304287	http://dx.doi.org/10.1074/jbc.M111.304287			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22194601	hybrid, Green Published			2022-12-27	WOS:000300638000019
J	Lee, HH; Nemecek, D; Schindler, C; Smith, WJ; Ghirlando, R; Steven, AC; Bonifacino, JS; Hurley, JH				Lee, Hyung Ho; Nemecek, Daniel; Schindler, Christina; Smith, William J.; Ghirlando, Rodolfo; Steven, Alasdair C.; Bonifacino, Juan S.; Hurley, James H.			Assembly and Architecture of Biogenesis of Lysosome-related Organelles Complex-1 (BLOC-1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HERMANSKY-PUDLAK-SYNDROME; ANALYTICAL ULTRACENTRIFUGATION; PROTEIN COMPLEX; MOUSE MODEL; DYSBINDIN; GENE; PALLIDIN; SUBUNIT; ENCODES; PIGMENTATION	BLOC-1 (biogenesis of lysosome-related organelles complex-1) is critical for melanosome biogenesis and has also been implicated in neurological function and disease. We show that BLOC-1 is an elongated complex that contains one copy each of the eight subunits pallidin, Cappuccino, dysbindin, Snapin, Muted, BLOS1, BLOS2, and BLOS3. The complex appears as a linear chain of eight globular domains, similar to 300 angstrom long and similar to 30 angstrom in diameter. The individual domains are flexibly connected such that the linear chain undergoes bending by as much as 45 degrees. Two stable subcomplexes were defined, pallidin-Cappuccino-BLOS1 and dysbindin-Snapin-BLOS2. Both subcomplexes are 1:1:1 heterotrimers that form extended structures as indicated by their hydrodynamic properties. The two subcomplexes appear to constitute flexible units within the larger BLOC-1 chain, an arrangement conducive to simultaneous interactions with multiple BLOC-1 partners in the course of tubular endosome biogenesis and sorting.	[Steven, Alasdair C.] NIAMS, NIH, Bethesda, MD 20892 USA; [Lee, Hyung Ho] Kookmin Univ, Dept Bio & Nano Chem, Seoul 136702, South Korea; [Lee, Hyung Ho] Kookmin Univ, Dept Integrat Biomed Sci & Engn, Seoul 136702, South Korea; [Lee, Hyung Ho; Ghirlando, Rodolfo; Hurley, James H.] NIDDK, Mol Biol Lab, Bethesda, MD 20892 USA; [Schindler, Christina; Smith, William J.; Bonifacino, Juan S.] Eunice Kennedy Shriver NICHD, Cell Biol & Metab Program, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Kookmin University; Kookmin University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Steven, AC (corresponding author), NIAMS, NIH, Bldg 50,Rm 1517, Bethesda, MD 20892 USA.	stevena@mail.nih.gov; juan@helix.nih.gov; hurley@helix.nih.gov		Bonifacino, Juan S./0000-0002-5673-6370	National Institutes of Health of NIDDK; NICHD; NIAMS; Deutsche Forschungsgemeinschaft; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001607] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR027015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK036130, ZIADK033007] Funding Source: NIH RePORTER	National Institutes of Health of NIDDK; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Programs of NIDDK (to J. H. H.), NICHD (to J. S. B.), and NIAMS (to A. C. S.). This work was also supported by a fellowship from the Deutsche Forschungsgemeinschaft (to C. S.).	Benson MA, 2001, J BIOL CHEM, V276, P24232, DOI 10.1074/jbc.M010418200; Chaudhuri R, 2007, J VIROL, V81, P3877, DOI 10.1128/JVI.02725-06; Ciciotte SL, 2003, BLOOD, V101, P4402, DOI 10.1182/blood-2003-01-0020; Cole JL, 2008, METHOD CELL BIOL, V84, P143, DOI 10.1016/S0091-679X(07)84006-4; Cullinane AR, 2011, AM J HUM GENET, V88, P778, DOI 10.1016/j.ajhg.2011.05.009; Dell'Angelica EC, 2004, CURR OPIN CELL BIOL, V16, P458, DOI 10.1016/j.ceb.2004.05.001; Dell'Angelica EC, 2000, J BIOL CHEM, V275, P1300, DOI 10.1074/jbc.275.2.1300; DellAngelica EC, 1997, J BIOL CHEM, V272, P15078, DOI 10.1074/jbc.272.24.15078; DellAngelica EC, 1997, EMBO J, V16, P917, DOI 10.1093/emboj/16.5.917; Di Pietro SM, 2006, MOL BIOL CELL, V17, P4027, DOI 10.1091/mbc.E06-05-0379; Falcon-Perez JM, 2002, J BIOL CHEM, V277, P28191, DOI 10.1074/jbc.M204011200; Ghiani CA, 2010, MOL PSYCHIATR, V15, P204, DOI 10.1038/mp.2009.58; Gwynn B, 2004, BLOOD, V104, P3181, DOI 10.1182/blood-2004-04-1538; Gwynn B, 2000, BLOOD, V96, P4227; Hayes MJ, 2011, TRAFFIC, V12, P260, DOI 10.1111/j.1600-0854.2010.01151.x; Heymann JB, 2007, J STRUCT BIOL, V157, P3, DOI 10.1016/j.jsb.2006.06.006; Hierro A, 2005, METHOD ENZYMOL, V403, P322, DOI 10.1016/S0076-6879(05)03027-2; Hoover DM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e43; Huang LP, 1999, NAT GENET, V23, P329, DOI 10.1038/15507; Ilardi JM, 1999, NAT NEUROSCI, V2, P119, DOI 10.1038/5673; Larimore J, 2011, MOL BIOL CELL, V22, P4854, DOI 10.1091/mbc.E11-07-0592; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Li W, 2003, NAT GENET, V35, P84, DOI 10.1038/ng1229; Monfregola J, 2010, J BIOL CHEM, V285, P16951, DOI 10.1074/jbc.M109.078501; Morgan NV, 2006, AM J HUM GENET, V78, P160, DOI 10.1086/499338; Moriyama K, 2002, TRAFFIC, V3, P666, DOI 10.1034/j.1600-0854.2002.30908.x; Mullin AP, 2011, MOL NEUROBIOL, V44, P53, DOI 10.1007/s12035-011-8183-3; Nazarian R, 2006, BIOCHEM J, V395, P587, DOI 10.1042/BJ20051965; PENCZEK P, 1992, ULTRAMICROSCOPY, V40, P33, DOI 10.1016/0304-3991(92)90233-A; Raposo G, 2007, NAT REV MOL CELL BIO, V8, P786, DOI 10.1038/nrm2258; Ren Y, 2009, CELL, V139, P1119, DOI 10.1016/j.cell.2009.11.002; Rodriguez-Fernandez IA, 2009, J INHERIT METAB DIS, V32, P190, DOI 10.1007/s10545-008-1014-7; Salazar G, 2006, MOL BIOL CELL, V17, P4014, DOI 10.1091/mbc.E06-02-0103; Setty SRG, 2007, MOL BIOL CELL, V18, P768, DOI 10.1091/mbc.E06-12-1066; Shaikh TR, 2008, NAT PROTOC, V3, P1941, DOI 10.1038/nprot.2008.156; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Starcevic M, 2004, J BIOL CHEM, V279, P28393, DOI 10.1074/jbc.M402513200; Straub RE, 2002, AM J HUM GENET, V71, P337, DOI 10.1086/341750; Sviderskaya EV, 2002, JNCI-J NATL CANCER I, V94, P446; Talbot K, 2006, HUM MOL GENET, V15, P3041, DOI 10.1093/hmg/ddl246; VALENTINE RC, 1967, J MOL BIOL, V27, P615, DOI 10.1016/0022-2836(67)90063-0; Wolf E, 1997, PROTEIN SCI, V6, P1179, DOI 10.1002/pro.5560060606	42	44	53	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5882	5890		10.1074/jbc.M111.325746	http://dx.doi.org/10.1074/jbc.M111.325746			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22203680	Green Published, hybrid			2022-12-27	WOS:000300638000062
J	Shprung, T; Peleg, A; Rosenfeld, Y; Trieu-Cuot, P; Shai, Y				Shprung, Tal; Peleg, Adi; Rosenfeld, Yosef; Trieu-Cuot, Patrick; Shai, Yechiel			Effect of PhoP-PhoQ Activation by Broad Repertoire of Antimicrobial Peptides on Bacterial Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2-COMPONENT REGULATORY SYSTEM; ENTERICA SEROVAR TYPHIMURIUM; OUTER-MEMBRANE; SEQUENCE ALTERATION; VIRULENCE GENE; POLYMYXIN-B; SALMONELLA; SENSOR; REGULON; PROTEIN	Pathogenic bacteria can resist their microenvironment by changing the expression of virulence genes. In Salmonella typhimurium, some of these genes are controlled by the two-component system PhoP-PhoQ. Studies have shown that activation of the system by cationic antimicrobial peptides (AMPs) results, among other changes, in outer membrane remodeling. However, it is not fully clear what characteristics of AMPs are required to activate the PhoP-PhoQ system and whether activation can induce resistance to the various AMPs. For that purpose, we investigated the ability of a broad repertoire of AMPs to traverse the inner membrane, to activate the PhoP-PhoQ system, and to induce bacterial resistance. The AMPs differ in length, composition, and net positive charge, and the tested bacteria include two wild-type (WT) Salmonella strains and their corresponding PhoP-PhoQ knock-out mutants. A lacZ-reporting system was adapted to follow PhoP-PhoQ activation. The data revealed that: (i) a good correlation exists among the extent of the positive charge, hydrophobicity, and amphipathicity of an AMP and its potency to activate PhoP-PhoQ; (ii) a + 1 charged peptide containing histidines was highly potent, suggesting the existence of an additional mechanism independent of the peptide charge; (iii) the WT bacteria are more resistant to AMPs that are potent activators of PhoP-PhoQ; (iv) only a subset of AMPs, independent of their potency to activate the system, is more toxic to the mutated bacteria compared with the WT strains; and (v) short term exposure of WT bacteria to these AMPs does not enhance resistance. Overall, this study advances our understanding of the molecular mechanism by which AMPs activate PhoP-PhoQ and induce bacterial resistance. It also reveals that some AMPs can overcome such a resistance mechanism.	[Shprung, Tal; Peleg, Adi; Rosenfeld, Yosef; Shai, Yechiel] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Trieu-Cuot, Patrick] CNRS, Inst Pasteur, Unite Biol Bacteries Pathogenes Gram positif, URA 2172, F-75724 Paris, France	Weizmann Institute of Science; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Shai, Y (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	Yechiel.Shai@weizmann.ac.il		TRIEU-CUOT, Patrick/0000-0002-2768-9587	German-Israel Foundation for Scientific Research and Development (GIF); Weizmann-Pasteur Joint Research Program	German-Israel Foundation for Scientific Research and Development (GIF)(German-Israeli Foundation for Scientific Research and Development); Weizmann-Pasteur Joint Research Program	This work was supported in part by the German-Israel Foundation for Scientific Research and Development (GIF) and by the Weizmann-Pasteur Joint Research Program.	Bader MW, 2005, CELL, V122, P461, DOI 10.1016/j.cell.2005.05.030; Bader MW, 2003, MOL MICROBIOL, V50, P219, DOI 10.1046/j.1365-2958.2003.03675.x; Baker SJ, 1997, MICROB PATHOGENESIS, V22, P165, DOI 10.1006/mpat.1996.0099; Bijlsma JJE, 2005, MOL MICROBIOL, V57, P85, DOI 10.1111/j.1365-2958.2005.04668.x; Bishop JL, 2006, TRENDS MOL MED, V12, P3, DOI 10.1016/j.molmed.2005.11.001; Bishop RE, 2000, EMBO J, V19, P5071, DOI 10.1093/emboj/19.19.5071; Choi E, 2009, J BACTERIOL, V191, P7174, DOI 10.1128/JB.00958-09; Detweiler CS, 2003, MOL MICROBIOL, V48, P385, DOI 10.1046/j.1365-2958.2003.03455.x; Ernst RK, 2001, MICROBES INFECT, V3, P1327, DOI 10.1016/S1286-4579(01)01494-0; Groisman EA, 2001, J BACTERIOL, V183, P1835, DOI 10.1128/JB.183.6.1835-1842.2001; GROISMAN EA, 1989, P NATL ACAD SCI USA, V86, P7077, DOI 10.1073/pnas.86.18.7077; Groisman EA, 1997, J BACTERIOL, V179, P7040, DOI 10.1128/jb.179.22.7040-7045.1997; Guina T, 2000, J BACTERIOL, V182, P4077, DOI 10.1128/JB.182.14.4077-4086.2000; Gunn JS, 2008, TRENDS MICROBIOL, V16, P284, DOI 10.1016/j.tim.2008.03.007; Gunn JS, 1996, J BACTERIOL, V178, P6857, DOI 10.1128/jb.178.23.6857-6864.1996; Guo L, 1998, CELL, V95, P189, DOI 10.1016/S0092-8674(00)81750-X; Kato A, 2007, P NATL ACAD SCI USA, V104, P12063, DOI 10.1073/pnas.0704462104; Kindrachuk J, 2007, ANTIMICROB AGENTS CH, V51, P4374, DOI 10.1128/AAC.00854-07; Kox LFF, 2000, EMBO J, V19, P1861, DOI 10.1093/emboj/19.8.1861; Macfarlane ELA, 2000, MICROBIOL-SGM, V146, P2543, DOI 10.1099/00221287-146-10-2543; Makovitzki A, 2009, CANCER RES, V69, P3458, DOI 10.1158/0008-5472.CAN-08-3021; Matson JS, 2010, J BACTERIOL, V192, P2044, DOI 10.1128/JB.00023-10; McPhee JB, 2003, MOL MICROBIOL, V50, P205, DOI 10.1046/j.1365-2958.2003.03673.x; Miller J. H, 1972, EXPT MOL GENETICS; MILLER SI, 1990, J BACTERIOL, V172, P2485, DOI 10.1128/jb.172.5.2485-2490.1990; MILLER SI, 1989, P NATL ACAD SCI USA, V86, P5054, DOI 10.1073/pnas.86.13.5054; Mouslim C, 2003, MOL MICROBIOL, V47, P335, DOI 10.1046/j.1365-2958.2003.03318.x; Murata T, 2007, J BACTERIOL, V189, P7213, DOI 10.1128/JB.00973-07; Papo N, 2004, BIOCHEMISTRY-US, V43, P6393, DOI 10.1021/bi049944h; Papo N, 2002, J BIOL CHEM, V277, P33913, DOI 10.1074/jbc.M204928200; Prost LR, 2008, CELL MICROBIOL, V10, P576, DOI 10.1111/j.1462-5822.2007.01111.x; Prost LR, 2007, MOL CELL, V26, P165, DOI 10.1016/j.molcel.2007.03.008; ROLAND KL, 1993, J BACTERIOL, V175, P4154, DOI 10.1128/JB.175.13.4154-4164.1993; Schurek KN, 2009, ANTIMICROB AGENTS CH, V53, P4345, DOI 10.1128/AAC.01267-08; Shi YX, 2004, MOL MICROBIOL, V53, P229, DOI 10.1111/j.1365-2958.2004.04107.x; SIMONS RW, 1987, GENE, V53, P85, DOI 10.1016/0378-1119(87)90095-3; Soncini FC, 1996, J BACTERIOL, V178, P5092, DOI 10.1128/jb.178.17.5092-5099.1996; Trent MS, 2001, J BIOL CHEM, V276, P9083, DOI 10.1074/jbc.M010730200; VESCOVI EG, 1994, RES MICROBIOL, V145, P473, DOI 10.1016/0923-2508(94)90096-5; Vescovi EG, 1996, CELL, V84, P165, DOI 10.1016/S0092-8674(00)81003-X; Vescovi EG, 1997, J BIOL CHEM, V272, P1440, DOI 10.1074/jbc.272.3.1440; Yu JL, 2011, J PROTEOME RES, V10, P2992, DOI 10.1021/pr101177g	42	29	35	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4544	4551		10.1074/jbc.M111.278523	http://dx.doi.org/10.1074/jbc.M111.278523			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22158870	Green Published, hybrid			2022-12-27	WOS:000300608500017
J	Chang, YC; Wu, CH; Yen, TC; Ouyang, P				Chang, Yu-Chen; Wu, Chu-Hen; Yen, Tzu-Chen; Ouyang, Pin			Centrosomal Protein 55 (Cep55) Stability Is Negatively Regulated by p53 Protein through Polo-like Kinase 1 (Plk1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SQUAMOUS-CELL CARCINOMA; PLK1-DEPENDENT PHOSPHORYLATION; TUMOR SUPPRESSION; DNA-DAMAGE; CYTOKINESIS; MIDBODY; CANCER; EXPRESSION; FOXM1; ESCRT	Centrosomal protein 55 (Cep55), which is localized to the centrosome in interphase cells and recruited to the midbody during cytokinesis, is a regulator required for the completion of cell abscission. Up-regulation of Cep55 and inactivation of p53 occur in the majority of human cancers, raising the possibility of a link between these two genes. In this study we evaluated the role of p53 in Cep55 regulation. We demonstrated that Cep55 expression levels are well correlated with cancer cell growth rate and that p53 is able to negatively regulate Cep55 protein and promoter activity. Down-regulation of expression of Cep55 was accompanied by repression of polo-like kinase 1 (Plk1) levels due to p53 induction. Overexpression of Plk1 and knockdown of p53 expression both enhanced the post-translational protein stability of Cep55. BI 2356, a selective Plk1 inhibitor, however, prevented Cep55 accumulation in p53 knockdown cells while persistently keeping Plk1 levels elevated. Our results, therefore, indicate the existence of a p53-Plk1-Cep55 axis in which p53 negatively regulates expression of Cep55, through Plk1 which, in turn, is a positive regulator of Cep55 protein stability.	[Wu, Chu-Hen; Ouyang, Pin] Chang Gung Univ, Dept Anat, Tao Yuan 333, Taiwan; [Chang, Yu-Chen] Chang Gung Mem Hosp, Grad Inst Clin Med Sci, Coll Med, Tao Yuan 333, Taiwan; [Chang, Yu-Chen; Yen, Tzu-Chen] Chang Gung Mem Hosp, Dept Nucl Med, Tao Yuan 333, Taiwan; [Chang, Yu-Chen; Yen, Tzu-Chen] Chang Gung Mem Hosp, Mol Imaging Ctr, Tao Yuan 333, Taiwan; [Wu, Chu-Hen; Ouyang, Pin] Chang Gung Univ, Mol Med Res Ctr, Tao Yuan 333, Taiwan; [Ouyang, Pin] Chang Gung Univ, Transgen Mouse Core Lab, Tao Yuan 333, Taiwan	Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University	Ouyang, P (corresponding author), Chang Gung Univ, Dept Anat, 259 Wen Hwa 1st Rd, Tao Yuan 333, Taiwan.	ouyang@mail.cgu.edu.tw			Chang Gung Memorial Hospital [CMRPD170073]; Ministry of Education (Tope Center) [EMRPD190481]; National Science Council, Taiwan [NSC-98-2320-B-182-019-MY3]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); Ministry of Education (Tope Center); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by Chang Gung Memorial Hospital Grant CMRPD170073, the Ministry of Education (Tope Center Grant EMRPD190481), and National Science Council, Taiwan Grant NSC-98-2320-B-182-019-MY3.	Bartek J, 2001, NAT REV MOL CELL BIO, V2, P877, DOI 10.1038/35103059; Bartek J, 2001, CURR OPIN CELL BIOL, V13, P738, DOI 10.1016/S0955-0674(00)00280-5; Bastos RN, 2010, J CELL BIOL, V191, P751, DOI 10.1083/jcb.201008108; Bohlig L, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/464916; Carlton JG, 2008, P NATL ACAD SCI USA, V105, P10541, DOI 10.1073/pnas.0802008105; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Chang YC, 2010, J CELL BIOCHEM, V109, P1274, DOI 10.1002/jcb.22517; Chen CH, 2007, ONCOGENE, V26, P4272, DOI 10.1038/sj.onc.1210207; Chen CH, 2009, ONCOGENE, V28, P2723, DOI 10.1038/onc.2009.128; Chen CH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005052; Chopra P, 2010, EXPERT OPIN INV DRUG, V19, P27, DOI 10.1517/13543780903483191; Dai C, 2010, TRENDS MOL MED, V16, P528, DOI 10.1016/j.molmed.2010.09.002; Doxsey S, 2005, ANNU REV CELL DEV BI, V21, P411, DOI 10.1146/annurev.cellbio.21.122303.120418; Doxsey SJ, 2005, MOL CELL, V20, P170, DOI 10.1016/j.molcel.2005.10.010; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fabbro M, 2005, DEV CELL, V9, P477, DOI 10.1016/j.devcel.2005.09.003; Fu Z, 2008, NAT CELL BIOL, V10, P1076, DOI 10.1038/ncb1767; Gemenetzidis E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004849; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Inoda S, 2011, AM J PATHOL, V178, P1805, DOI 10.1016/j.ajpath.2011.01.004; Inoda S, 2011, EXP MOL PATHOL, V90, P55, DOI 10.1016/j.yexmp.2010.10.001; Inoda S, 2009, J IMMUNOTHER, V32, P474, DOI 10.1097/CJI.0b013e3181a1d109; Kho PS, 2004, J BIOL CHEM, V279, P21183, DOI 10.1074/jbc.M311912200; Kneisel L, 2002, J CUTAN PATHOL, V29, P354, DOI 10.1034/j.1600-0560.2002.290605.x; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Martinez-Garay I, 2006, GENOMICS, V87, P243, DOI 10.1016/j.ygeno.2005.11.006; McKenzie L, 2010, CELL CYCLE, V9, P4200, DOI 10.4161/cc.9.20.13532; Montoya M, 2007, NAT STRUCT MOL BIOL, V14, P579, DOI 10.1038/nsmb0707-579; Morita E, 2007, EMBO J, V26, P4215, DOI 10.1038/sj.emboj.7601850; Muller PAJ, 2011, J CELL BIOL, V192, P209, DOI 10.1083/jcb.201009059; Mundt KE, 1997, BIOCHEM BIOPH RES CO, V239, P377, DOI 10.1006/bbrc.1997.7378; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Pandit B, 2009, CELL CYCLE, V8, P3425, DOI 10.4161/cc.8.20.9628; Petronczki M, 2008, DEV CELL, V14, P646, DOI 10.1016/j.devcel.2008.04.014; Plyte S, 2007, CURR BIOL, V17, pR280, DOI 10.1016/j.cub.2007.02.018; Prives C, 1999, J PATHOL, V187, P112; Rozan LM, 2007, CELL DEATH DIFFER, V14, P3, DOI 10.1038/sj.cdd.4402058; Sachdeva M, 2009, P NATL ACAD SCI USA, V106, P3207, DOI 10.1073/pnas.0808042106; Sakai M, 2006, ONCOGENE, V25, P480, DOI 10.1038/sj.onc.1209051; Schoffski P, 2009, ONCOLOGIST, V14, P559, DOI 10.1634/theoncologist.2009-0010; Sionov RV, 1999, ONCOGENE, V18, P6145, DOI 10.1038/sj.onc.1203130; Soussi T, 2001, NAT REV CANCER, V1, P233, DOI 10.1038/35106009; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; Sur S, 2009, P NATL ACAD SCI USA, V106, P3964, DOI 10.1073/pnas.0813333106; Takaki T, 2008, CURR OPIN CELL BIOL, V20, P650, DOI 10.1016/j.ceb.2008.10.005; van de Weerdt BCM, 2006, CELL CYCLE, V5, P853, DOI 10.4161/cc.5.8.2692; van der Horst A, 2009, CELL CYCLE, V8, P3742, DOI 10.4161/cc.8.22.10047; van Vugt MATM, 2005, ONCOGENE, V24, P2844, DOI 10.1038/sj.onc.1208617; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wasch R, 2010, RECENT RESULTS CANC, V184, P215, DOI 10.1007/978-3-642-01222-8_15; Weichert W, 2004, BRIT J CANCER, V90, P815, DOI 10.1038/sj.bjc.6601610; Weichert W, 2004, PROSTATE, V60, P240, DOI 10.1002/pros.20050; Yu J, 2003, CANCER CELL, V4, P248, DOI 10.1016/S1535-6108(03)00249-6; Zhao WM, 2006, MOL BIOL CELL, V17, P3881, DOI 10.1091/mbc.E06-01-0015	56	23	24	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					4376	4385		10.1074/jbc.M111.289108	http://dx.doi.org/10.1074/jbc.M111.289108			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22184120	Green Published, hybrid			2022-12-27	WOS:000300410900068
J	Guangqi, E; Cao, Y; Bhattacharya, S; Dutta, S; Wang, EF; Mukhopadhyay, D				Guangqi, E.; Cao, Ying; Bhattacharya, Santanu; Dutta, Shamit; Wang, Enfeng; Mukhopadhyay, Debabrata			Endogenous Vascular Endothelial Growth Factor-A (VEGF-A) Maintains Endothelial Cell Homeostasis by Regulating VEGF Receptor-2 Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; PERMEABILITY FACTOR; SIGNAL-TRANSDUCTION; AUTOCRINE VEGF; TYROSINE PHOSPHORYLATION; TUMOR ANGIOGENESIS; GENE-EXPRESSION; CADHERIN; KDR/FLK-1; CANCER	Vascular endothelial growth factor A (VEGF-A) is one of the most important factors controlling angiogenesis. Although the functions of exogenous VEGF-A have been widely studied, the roles of endogenous VEGF-A remain unclear. Here we focused on the mechanistic functions of endogenous VEGF-A in endothelial cells. We found that it is complexed with VEGF receptor 2 (VEGFR-2) and maintains a basal expression level for VEGFR-2 and its downstream signaling activation. Endogenous VEGF-A also controls expression of key endothelial specific genes including VEGFR-2, Tie-2, and vascular endothelial cadherin. Of importance, endogenous VEGF-A differs from exogenous VEGF-A by regulating VEGFR-2 transcription through mediation of FoxC2 binding to the FOX: ETS motif, and the complex formed by endogenous VEGF-A with VEGFR-2 is localized within the EEA1 (early endosome antigen 1) endosomal compartment. Taken together, our results emphasize the importance of endogenous VEGF-A in endothelial cells by regulating key vascular proteins and maintaining the endothelial homeostasis.	[Guangqi, E.; Cao, Ying; Bhattacharya, Santanu; Dutta, Shamit; Wang, Enfeng; Mukhopadhyay, Debabrata] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA	Mayo Clinic	Mukhopadhyay, D (corresponding author), Guggenheim 1321C,200 1st St SW, Rochester, MN 55905 USA.	mukhopadhyay.debabrata@mayo.edu	Bhattacharya, Santanu/GRS-4780-2022; Bhattacharya, Santanu/N-6531-2019	Bhattacharya, Santanu/0000-0001-9040-8971	National Institutes of Health [HL070567, CA78383, CA150190]; NATIONAL CANCER INSTITUTE [R01CA078383, R01CA150190, R29CA078383] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK084567] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL070567, CA78383, and CA150190. This work was also supported by a generous gift from Bruce and Martha Atwater.	Abedi H, 1997, J BIOL CHEM, V272, P15442, DOI 10.1074/jbc.272.24.15442; Al-Nedawi K, 2009, P NATL ACAD SCI USA, V106, P3794, DOI 10.1073/pnas.0804543106; Benjamin LE, 1997, P NATL ACAD SCI USA, V94, P8761, DOI 10.1073/pnas.94.16.8761; Bhattacharya R, 2005, FASEB J, V19, P1692, DOI 10.1096/fj.05-3889fje; Bruns AF, 2010, TRAFFIC, V11, P161, DOI 10.1111/j.1600-0854.2009.01001.x; Cao Y, 2008, CANCER RES, V68, P8667, DOI 10.1158/0008-5472.CAN-08-2614; Cao Y, 2010, J BIOL CHEM, V285, P31840, DOI 10.1074/jbc.M110.151696; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; De Val S, 2008, CELL, V135, P1053, DOI 10.1016/j.cell.2008.10.049; Dejana E, 2007, BBA-REV CANCER, V1775, P298, DOI 10.1016/j.bbcan.2007.05.003; Dvorak HF, 2006, EXP CELL RES, V312, P522, DOI 10.1016/j.yexcr.2005.11.026; Dvorak HF, 1999, CURR TOP MICROBIOL, V237, P97; Dvorak HF, 2005, J THROMB HAEMOST, V3, P1835, DOI 10.1111/j.1538-7836.2005.01361.x; Ewan LC, 2006, TRAFFIC, V7, P1270, DOI 10.1111/j.1600-0854.2006.00462.x; Ferrara N, 2005, BIOCHEM BIOPH RES CO, V333, P328, DOI 10.1016/j.bbrc.2005.05.132; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Gampel A, 2006, BLOOD, V108, P2624, DOI 10.1182/blood-2005-12-007484; Gonzalez-Pacheco FR, 2006, AM J PHYSIOL-HEART C, V291, pH1395, DOI 10.1152/ajpheart.01277.2005; Gory-Faure S, 1999, DEVELOPMENT, V126, P2093; Grunewald FS, 2010, BBA-PROTEINS PROTEOM, V1804, P567, DOI 10.1016/j.bbapap.2009.09.002; Guan FX, 2006, AM J PHYSIOL-RENAL, V291, pF422, DOI 10.1152/ajprenal.00448.2005; GUO DQ, 1995, J BIOL CHEM, V270, P6729, DOI 10.1074/jbc.270.12.6729; Harris ES, 2010, CURR OPIN CELL BIOL, V22, P651, DOI 10.1016/j.ceb.2010.07.006; Hayashi H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002401; Herve MAJ, 2006, J ENDOCRINOL, V188, P91, DOI 10.1677/joe.1.06184; Holmqvist K, 2004, J BIOL CHEM, V279, P22267, DOI 10.1074/jbc.M312729200; Jubb AM, 2010, LANCET ONCOL, V11, P1172, DOI 10.1016/S1470-2045(10)70232-1; Kang JH, 2005, CELL, V123, P833, DOI 10.1016/j.cell.2005.09.011; Lampugnani MG, 2006, J CELL BIOL, V174, P593, DOI 10.1083/jcb.200602080; Lanahan AA, 2010, DEV CELL, V18, P713, DOI 10.1016/j.devcel.2010.02.016; Le Boeuf F, 2004, J BIOL CHEM, V279, P39175, DOI 10.1074/jbc.M405493200; Lee S, 2007, CELL, V130, P691, DOI 10.1016/j.cell.2007.06.054; Manickam V, 2011, BLOOD, V117, P1425, DOI 10.1182/blood-2010-06-291690; Matsumoto T, 2005, EMBO J, V24, P2342, DOI 10.1038/sj.emboj.7600709; Meissner M, 2009, CANCER RES, V69, P1976, DOI 10.1158/0008-5472.CAN-08-3150; Miaczynska M, 2004, CELL, V116, P445, DOI 10.1016/S0092-8674(04)00117-5; Miquerol L, 2000, DEVELOPMENT, V127, P3941; Mukhopadhyay D, 2004, MOL CELL BIOCHEM, V264, P51, DOI 10.1023/B:MCBI.0000044374.85095.df; Nagy JA, 2002, COLD SPRING HARB SYM, V67, P227, DOI 10.1101/sqb.2002.67.227; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; PATTERSON C, 1995, J BIOL CHEM, V270, P23111, DOI 10.1074/jbc.270.39.23111; Pettersson A, 2000, LAB INVEST, V80, P99, DOI 10.1038/labinvest.3780013; Pilecka I, 2007, EUR J CELL BIOL, V86, P533, DOI 10.1016/j.ejcb.2007.04.004; Ptaszynska MM, 2010, MOL CANCER RES, V8, P309, DOI 10.1158/1541-7786.MCR-09-0288; Rabascio C, 2004, CANCER RES, V64, P4373, DOI 10.1158/0008-5472.CAN-04-0265; Sakurai Y, 2005, P NATL ACAD SCI USA, V102, P1076, DOI 10.1073/pnas.0404984102; SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126/science.6823562; Shen BQ, 1998, J BIOL CHEM, V273, P29979, DOI 10.1074/jbc.273.45.29979; Shibuya M, 2006, EXP CELL RES, V312, P549, DOI 10.1016/j.yexcr.2005.11.012; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Takahashi T, 2001, EMBO J, V20, P2768, DOI 10.1093/emboj/20.11.2768; Varsano T, 2006, MOL CELL BIOL, V26, P8942, DOI 10.1128/MCB.00305-06; Wang DF, 2000, J BIOL CHEM, V275, P15905, DOI 10.1074/jbc.M001847200; Ward NL, 2002, SEMIN CELL DEV BIOL, V13, P19, DOI 10.1006/scdb.2001.0288; Watanabe Y, 1997, ONCOGENE, V14, P2025, DOI 10.1038/sj.onc.1201033; Yamaoka-Tojo M, 2006, ARTERIOSCL THROM VAS, V26, P1991, DOI 10.1161/01.ATV.0000231524.14873.e7; Yang SY, 2001, ARTERIOSCL THROM VAS, V21, P1934, DOI 10.1161/hq1201.099432; Zeng HY, 2001, J BIOL CHEM, V276, P32714, DOI 10.1074/jbc.M103130200	59	31	33	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3029	3041		10.1074/jbc.M111.293985	http://dx.doi.org/10.1074/jbc.M111.293985			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22167188	Green Published, hybrid			2022-12-27	WOS:000300295100010
J	Jurado, S; Conlan, LA; Baker, EK; Ng, JL; Tenis, N; Hoch, NC; Gleeson, K; Smeets, M; Izon, D; Heierhorst, J				Jurado, Sabine; Conlan, Lindus A.; Baker, Emma K.; Ng, Jane-Lee; Tenis, Nora; Hoch, Nicolas C.; Gleeson, Kimberly; Smeets, Monique; Izon, David; Heierhorst, Joerg			ATM Substrate Chk2-interacting Zn2+ Finger (ASCIZ) Is a Bi-functional Transcriptional Activator and Feedback Sensor in the Regulation of Dynein Light Chain (DYNLL1) Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPONSE PROTEIN ASCIZ; DNA-DAMAGE; INTERACTING PROTEIN; INTERMEDIATE CHAIN; CELL-DEATH; BINDS; AUTOREGULATION; ACCUMULATION; DROSOPHILA; NETWORKS	The highly conserved DYNLL1 (LC8) protein was originally discovered as a light chain of the dynein motor complex, but is increasingly emerging as a sequence-specific regulator of protein dimerization with hundreds of targets and wide-ranging cellular functions. Despite its important roles, DYNLL1's own regulation remains poorly understood. Here we identify ASCIZ (ATMIN/ZNF822), an essential Zn2+ finger protein with dual roles in the DNA base damage response and as a developmental transcription factor, as a conserved regulator of Dynll1 gene expression. DYNLL1 levels are reduced by similar to 10-fold in the absence of ASCIZ in human, mouse and chicken cells. ASCIZ binds directly to the Dynll1 promoter and regulates its activity in a Zn2+ finger-dependent manner. DYNLL1 protein in turn interacts with ten binding sites in the ASCIZ transcription activation domain, and high DYNLL1 levels inhibit the transcriptional activity of ASCIZ. In addition, DYNLL1 was also required for DNA damage-induced ASCIZ focus formation. The dual ability of ASCIZ to activate Dynll1 gene expression and to sense free DYNLL1 protein levels enables a simple dynamic feedback loop to adjust DYNLL1 levels to cellular needs. The ASCIZ-DYNLL1 feedback loop represents a novel mechanism for auto-regulation of gene expression, where the gene product directly inhibits the transcriptional activator while bound at its own promoter.	[Jurado, Sabine; Conlan, Lindus A.; Baker, Emma K.; Ng, Jane-Lee; Tenis, Nora; Hoch, Nicolas C.; Gleeson, Kimberly; Smeets, Monique; Izon, David; Heierhorst, Joerg] Univ Melbourne, St Vincents Inst Med Res, St Vincents Hosp, Fitzroy, Vic 3065, Australia; [Jurado, Sabine; Ng, Jane-Lee; Hoch, Nicolas C.; Heierhorst, Joerg] Univ Melbourne, Dept Med, St Vincents Hosp, Fitzroy, Vic 3065, Australia	St Vincent's Hospital Melbourne; St. Vincent's Institute of Medical Research; University of Melbourne; St Vincent's Hospital Melbourne; University of Melbourne	Heierhorst, J (corresponding author), Univ Melbourne, St Vincents Inst Med Res, St Vincents Hosp, 9 Princes St, Fitzroy, Vic 3065, Australia.	jheierhorst@svi.edu.au	Hoch, Nicolas/J-5288-2012	Hoch, Nicolas/0000-0002-7610-1305; Heierhorst, Jorg/0000-0003-2789-9514	National Health and Medical Research Council (NHMRC) of Australia; Cooperative Research Centre Cancer Therapeutics; Victorian Government	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cooperative Research Centre Cancer Therapeutics(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Victorian Government	This work was supported by grants and a Senior Research Fellowship from the National Health and Medical Research Council (NHMRC) of Australia (to J. H.), a PhD scholarship from the Cooperative Research Centre Cancer Therapeutics (to S. J.), and in part by the Victorian Government's Operational Infrastructure Support Program.	Barbar E, 2008, BIOCHEMISTRY-US, V47, P503, DOI 10.1021/bi701995m; Batlevi Y, 2010, P NATL ACAD SCI USA, V107, P742, DOI 10.1073/pnas.0907967107; Crews ST, 2009, CURR BIOL, V19, pR241, DOI 10.1016/j.cub.2009.01.015; Dick T, 1996, MOL CELL BIOL, V16, P1966; Dorsett M, 2009, MOL CELL BIOL, V29, P6128, DOI 10.1128/MCB.00815-09; Fejtova A, 2009, J CELL BIOL, V185, P341, DOI 10.1083/jcb.200807155; Heierhorst J, 2011, CELL CYCLE, V10, P1222, DOI 10.4161/cc.10.8.15336; Jaffrey SR, 1996, SCIENCE, V274, P774, DOI 10.1126/science.274.5288.774; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Jurado S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001170; Kanu N, 2010, J BIOL CHEM, V285, P38534, DOI 10.1074/jbc.M110.145896; KING SM, 1995, J BIOL CHEM, V270, P11445, DOI 10.1074/jbc.270.19.11445; King SM, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.147pe51; Liu XY, 2011, CANCER CELL, V19, P569, DOI 10.1016/j.ccr.2011.05.002; Lo KWH, 2005, J BIOL CHEM, V280, P8172, DOI 10.1074/jbc.M411408200; Loizou JI, 2011, CANCER CELL, V19, P587, DOI 10.1016/j.ccr.2011.03.022; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; McNees CJ, 2005, EMBO J, V24, P2447, DOI 10.1038/sj.emboj.7600704; Navarro C, 2004, NAT CELL BIOL, V6, P427, DOI 10.1038/ncb1122; Nyarko A, 2011, J BIOL CHEM, V286, P1556, DOI 10.1074/jbc.M110.171686; Oka H, 2008, BIOCHEM BIOPH RES CO, V371, P225, DOI 10.1016/j.bbrc.2008.04.052; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; PENN LJZ, 1990, EMBO J, V9, P1113, DOI 10.1002/j.1460-2075.1990.tb08217.x; Perdomo J, 2002, EUR J BIOCHEM, V269, P5885, DOI 10.1046/j.1432-1033.2002.03313.x; Pike BL, 2004, MOL CELL BIOL, V24, P2779, DOI 10.1128/MCB.24.7.2779-2788.2004; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; Rapali P, 2011, BIOCHEM BIOPH RES CO, V414, P493, DOI 10.1016/j.bbrc.2011.09.093; Rapali P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018818; Rayala SK, 2005, EMBO REP, V6, P538, DOI 10.1038/sj.embor.7400417; Traven A, 2005, BIOESSAYS, V27, P397, DOI 10.1002/bies.20204; Varma D, 2010, P NATL ACAD SCI USA, V107, P3493, DOI 10.1073/pnas.0908959107; Williams JC, 2007, P NATL ACAD SCI USA, V104, P10028, DOI 10.1073/pnas.0703614104	32	48	51	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3156	3164		10.1074/jbc.M111.306019	http://dx.doi.org/10.1074/jbc.M111.306019			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22167198	Green Published, hybrid			2022-12-27	WOS:000300295100021
J	Gabunia, K; Ellison, SP; Singh, H; Datta, P; Kelemen, SE; Rizzo, V; Autieri, MV				Gabunia, Khatuna; Ellison, Stephen P.; Singh, Harrinder; Datta, Prasun; Kelemen, Sheri E.; Rizzo, Victor; Autieri, Michael V.			Interleukin-19 (IL-19) Induces Heme Oxygenase-1 (HO-1) Expression and Decreases Reactive Oxygen Species in Human Vascular Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATHEROSCLEROTIC LESION FORMATION; ENDOTHELIAL-CELLS; TNF-ALPHA; INDUCED APOPTOSIS; OXIDATIVE STRESS; GENE; CYTOKINES; GROWTH; PROGRESSION; ACTIVATION	Heme oxygenase-1 (HO-1) has potent anti-inflammatory activity and recognized vascular protective effects. We have recently described the expression and vascular protective effects of an anti-inflammatory interleukin (IL-19), in vascular smooth muscle cells (VSMC) and injured arteries. The objective of this study was to link the anti-inflammatory effects of IL-19 with HO-1 expression in resident vascular cells. IL-19 induced HO-1 mRNA and protein in cultured human VSMC, as assayed by quantitative RT-PCR, immunoblot, and ELISA. IL-19 does not induce HO-1 mRNA or protein in human endothelial cells. IL-19 activates STAT3 in VSMC, and IL-19-induced HO-1 expression is significantly reduced by transfection of VSMC with STAT3 siRNA or mutation of the consensus STAT binding site in the HO-1 promoter. IL-19 treatment can significantly reduce ROS-induced apoptosis, as assayed by Annexin V flow cytometry. IL-19 significantly reduced ROS concentrations in cultured VSMC. The IL-19-induced reduction in ROS concentration is attenuated when HO-1 is reduced by siRNA, indicating that the IL-19-driven decrease in ROS is mediated by HO-1 expression. IL-19 reduces vascular ROS in vivo in mice treated with TNF alpha. This points to IL-19 as a potential therapeutic for vascular inflammatory diseases and a link for two previously unassociated protective processes: Th2 cytokine-induced anti-inflammation and ROS reduction.	[Autieri, Michael V.] Temple Univ, Sch Med, Dept Physiol, IBC Cardiovasc Res Ctr, Philadelphia, PA 19140 USA; [Gabunia, Khatuna; Ellison, Stephen P.; Singh, Harrinder; Kelemen, Sheri E.; Rizzo, Victor; Autieri, Michael V.] Temple Univ, Sch Med, Independence Blue Cross Cardiovasc Res Ctr, Philadelphia, PA 19140 USA; [Singh, Harrinder; Rizzo, Victor] Temple Univ, Sch Med, Dept Anat & Cell Biol, Philadelphia, PA 19140 USA; [Datta, Prasun] Temple Univ, Sch Med, Dept Neurosci, Philadelphia, PA 19140 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Autieri, MV (corresponding author), Temple Univ, Sch Med, Dept Physiol, IBC Cardiovasc Res Ctr, Room 1050,MERB,3500 N Broad St, Philadelphia, PA 19140 USA.	mautieri@temple.edu		Datta, Prasun/0000-0001-5133-253X; Singh, Harinder/0000-0002-0160-1575	NHLBI, National Institutes of Health [HL090885]; American Heart Association [11POST7530001]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090885] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by Grant HL090885 from the NHLBI, National Institutes of Health (to M. V. A.) and postdoctoral grant 11POST7530001 from the American Heart Association (to K. G.).	Abraham NG, 2005, FREE RADICAL BIO MED, V39, P1, DOI 10.1016/j.freeradbiomed.2005.03.010; Abraham NG, 2003, CIRC RES, V93, P507, DOI 10.1161/01.RES.0000091828.36599.34; ALAM J, 1994, J BIOL CHEM, V269, P25049; Cheng C, 2009, CIRCULATION, V119, P3017, DOI 10.1161/CIRCULATIONAHA.108.808618; Cuneo AA, 2010, J MOL CELL CARDIOL, V49, P647, DOI 10.1016/j.yjmcc.2010.04.016; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Durante W, 2003, J CELL PHYSIOL, V195, P373, DOI 10.1002/jcp.10274; Ferris CD, 1999, NAT CELL BIOL, V1, P152, DOI 10.1038/11072; Frey RS, 2002, CIRC RES, V90, P1012, DOI 10.1161/01.RES.0000017631.28815.8E; Gabunia K, 2011, AM J PHYSIOL-CELL PH, V300, pC896, DOI 10.1152/ajpcell.00439.2010; Gallagher G, 2004, INT IMMUNOPHARMACOL, V4, P615, DOI 10.1016/j.intimp.2004.01.005; Hafer K, 2008, RADIAT RES, V169, P460, DOI 10.1667/RR1212.1; Ishikawa K, 2001, CIRC RES, V88, P506, DOI 10.1161/01.RES.88.5.506; Jain S, 2011, ARTERIOSCL THROM VAS, V31, P167, DOI 10.1161/ATVBAHA.110.214916; LAVROVSKY Y, 1994, P NATL ACAD SCI USA, V91, P5987, DOI 10.1073/pnas.91.13.5987; Lee TS, 2002, NAT MED, V8, P240, DOI 10.1038/nm0302-240; Li PF, 1997, FEBS LETT, V404, P249, DOI 10.1016/S0014-5793(97)00093-8; Li PF, 1999, CIRCULATION, V100, P967, DOI 10.1161/01.CIR.100.9.967; Liao YC, 2002, J IMMUNOL, V169, P4288, DOI 10.4049/jimmunol.169.8.4288; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Maranto J, 2008, J NEUROIMMUNE PHARM, V3, P43, DOI 10.1007/s11481-007-9096-9; Miller FJ, 1998, CIRC RES, V82, P1298, DOI 10.1161/01.RES.82.12.1298; Morita T, 2005, ARTERIOSCL THROM VAS, V25, P1786, DOI 10.1161/01.ATV.0000178169.95781.49; Oral HB, 2006, EUR J IMMUNOL, V36, P380, DOI 10.1002/eji.200425523; Papaharalambus CA, 2007, TRENDS CARDIOVAS MED, V17, P48, DOI 10.1016/j.tcm.2006.11.005; Pestka S, 2004, ANNU REV IMMUNOL, V22, P929, DOI 10.1146/annurev.immunol.22.012703.104622; Petrache I, 2000, AM J PHYSIOL-LUNG C, V278, pL312, DOI 10.1152/ajplung.2000.278.2.L312; Peyton KJ, 2002, BLOOD, V99, P4443, DOI 10.1182/blood.V99.12.4443; Raines EW, 2005, J LIPID RES, V46, P1081, DOI 10.1194/jlr.R500004-JLR200; ROSS, 1999, J MED, V340, P115; Seshiah PN, 2002, CIRC RES, V91, P406, DOI 10.1161/01.RES.0000033523.08033.16; Singer CA, 2004, BIOESSAYS, V26, P646, DOI 10.1002/bies.20041; Soares MP, 1998, NAT MED, V4, P1073, DOI 10.1038/2063; Takahashi S, 1999, BBA-GENE STRUCT EXPR, V1447, P231, DOI 10.1016/S0167-4781(99)00156-6; Tian Y, 2008, AM J PATHOL, V173, P901, DOI 10.2353/ajpath.2008.080163; Tulis DA, 2001, CIRCULATION, V104, P2710, DOI 10.1161/hc4701.099585; Volti GL, 2002, BIOCHEM BIOPH RES CO, V296, P1077, DOI 10.1016/S0006-291X(02)02054-5; Wang LJ, 1998, AM J PATHOL, V152, P711; Yet SF, 2003, FASEB J, V17, P1759, DOI 10.1096/fj.03-0187fje	39	41	45	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2477	2484		10.1074/jbc.M111.312470	http://dx.doi.org/10.1074/jbc.M111.312470			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22158875	Green Published, hybrid			2022-12-27	WOS:000300292300022
J	Guo, QX; Li, HM; Gaddam, SSK; Justice, NJ; Robertson, CS; Zheng, H				Guo, Qinxi; Li, Hongmei; Gaddam, Samson S. K.; Justice, Nicholas J.; Robertson, Claudia S.; Zheng, Hui			Amyloid Precursor Protein Revisited NEURON-SPECIFIC EXPRESSION AND HIGHLY STABLE NATURE OF SOLUBLE DERIVATIVES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; MESSENGER-RNAS; DYSTROPHIC NEURITES; HIPPOCAMPAL-NEURONS; REACTIVE ASTROCYTES; ASTROGLIAL CELLS; SENILE PLAQUES; GLIAL-CELLS; IN-VIVO	APP processing and amyloid-beta production play a central role in Alzheimer disease pathogenesis. APP has been considered a ubiquitously expressed protein. In addition to amyloid-beta, alpha- or beta-secretase-dependent cleavage of APP also generates soluble secreted APP (APPs alpha or APPs beta, respectively). Interestingly, APPs beta has been shown to be subject to further cleavage to create an N-APP fragment that binds to the DR6 death receptor and mediates axon pruning and degeneration under trophic factor withdrawal conditions. By performing APP immunocytochemical staining, we found that, unexpectedly, many antibodies yielded nonspecific staining in APP-null samples. Screening of a series of antibodies allowed us to identify a rabbit monoclonal antibody Y188 that is highly specific for APP and prompted us to re-examine the expression, localization, and stability of endogenous APP and APPs beta in wild-type and in APPs beta knock-in mice, respectively. In contrast to earlier studies, we found that APP is specifically expressed in neurons and that its expression cannot be detected in major types of glial cells under basal or neuroinflammatory conditions. Both APPs alpha and APPs beta are highly stable in the central nervous system (CNS) and do not undergo further cleavage with or without trophic factor support. Our results clarify several key questions with regard to the fundamental properties of APP and offer critical cellular insights into the pathophysiology of APP.	[Guo, Qinxi; Li, Hongmei; Justice, Nicholas J.; Zheng, Hui] Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA; [Guo, Qinxi] Baylor Coll Med, Interdept Program Translat Biol & Mol Med, Houston, TX 77030 USA; [Gaddam, Samson S. K.; Robertson, Claudia S.] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Zheng, H (corresponding author), Baylor Coll Med, Huffington Ctr Aging, BCM230,1 Baylor Plaza, Houston, TX 77030 USA.	huiz@bcm.edu	Li, Hongmei/L-2595-2013; Guo, Qinxi/J-1473-2014	Li, Hongmei/0000-0002-4952-1734; Guo, Qinxi/0000-0003-4320-6757	National Institutes of Health [P01 NS38660, R01 AG032051, AG033467, NS076117]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076117, P01NS038660] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG032051, R01AG033467, R01AG020670] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 NS38660 (to C. S. R.) and R01 AG032051, AG033467, and NS076117 (to H. Z.).	Bai Y, 2008, MOL CELL PROTEOMICS, V7, P15, DOI 10.1074/mcp.M700077-MCP200; BENOWITZ LI, 1989, EXP NEUROL, V106, P237, DOI 10.1016/0014-4886(89)90156-8; BERKENBOSCH F, 1990, J NEUROSCI RES, V25, P431, DOI 10.1002/jnr.490250321; Bitner BR, 2010, J CEREBR BLOOD F MET, V30, P1105, DOI 10.1038/jcbfm.2010.47; CAPORASO GL, 1994, J NEUROSCI, V14, P3122; Chauvet N, 1997, J COMP NEUROL, V377, P550; Clarner T, 2011, J MOL NEUROSCI, V43, P268, DOI 10.1007/s12031-010-9419-9; CRAS P, 1991, P NATL ACAD SCI USA, V88, P7552, DOI 10.1073/pnas.88.17.7552; CUMMINGS BJ, 1992, NEUROSCIENCE, V48, P763, DOI 10.1016/0306-4522(92)90265-4; deSilva HAR, 1997, MOL BRAIN RES, V47, P147; FORLONI G, 1992, MOL BRAIN RES, V16, P128, DOI 10.1016/0169-328X(92)90202-M; Guo Q, 1999, NAT MED, V5, P101, DOI 10.1038/4789; Hoshino T, 2007, BIOCHEM J, V402, P581, DOI 10.1042/BJ20061318; Hsu WC, 2008, J NEURAL TRANSM, V115, P1537, DOI 10.1007/s00702-008-0117-5; HYMAN BT, 1992, J NEUROPATH EXP NEUR, V51, P76, DOI 10.1097/00005072-199201000-00009; Kaden D, 2009, J CELL SCI, V122, P368, DOI 10.1242/jcs.034058; Kohler C, 2005, NEUROBIOL DIS, V20, P528, DOI 10.1016/j.nbd.2005.04.009; LeBlanc AC, 1997, J NEUROCHEM, V68, P1183; Li HM, 2010, P NATL ACAD SCI USA, V107, P17362, DOI 10.1073/pnas.1012568107; Li HM, 2010, J BIOL CHEM, V285, P30598, DOI 10.1074/jbc.M110.137729; Lu DC, 2000, NAT MED, V6, P397, DOI 10.1038/74656; Martins RN, 2001, NEUROSCIENCE, V106, P557, DOI 10.1016/S0306-4522(01)00289-5; Matsui T, 2007, BRAIN RES, V1161, P116, DOI 10.1016/j.brainres.2007.05.050; Moreno-Flores MT, 1998, J NEUROSCI RES, V52, P661, DOI 10.1002/(SICI)1097-4547(19980615)52:6<661::AID-JNR5>3.0.CO;2-6; Ni M, 2011, BIOCHEM J, V434, P181, DOI 10.1042/BJ20101569; Nihashi T, 2001, ACTA NEUROCHIR, V143, P287, DOI 10.1007/s007010170109; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Norstrom EM, 2010, J NEUROSCI, V30, P15677, DOI 10.1523/JNEUROSCI.4464-10.2010; OTSUKA N, 1991, BRAIN RES, V568, P335, DOI 10.1016/0006-8993(91)91422-W; PALACIOS G, 1995, EUR J NEUROSCI, V7, P501, DOI 10.1111/j.1460-9568.1995.tb00346.x; PALACIOS G, 1992, MOL BRAIN RES, V15, P195, DOI 10.1016/0169-328X(92)90109-O; Palmert M R, 1989, Prog Clin Biol Res, V317, P971; PALMERT MR, 1988, BIOCHEM BIOPH RES CO, V156, P432, DOI 10.1016/S0006-291X(88)80859-3; Pierce JES, 1996, J NEUROSCI, V16, P1083; Shim DJ, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-42; SHIVERS BD, 1988, EMBO J, V7, P1365, DOI 10.1002/j.1460-2075.1988.tb02952.x; SHOJI M, 1990, BRAIN RES, V512, P164, DOI 10.1016/0006-8993(90)91187-L; SIMAN R, 1989, NEURON, V3, P275, DOI 10.1016/0896-6273(89)90252-3; SOLA C, 1993, MOL BRAIN RES, V17, P41, DOI 10.1016/0169-328X(93)90071-V; Szczygielski J, 2005, J NEURAL TRANSM, V112, P1547, DOI 10.1007/s00702-005-0326-0; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Tran MD, 2011, NEUROSCI LETT, V492, P155, DOI 10.1016/j.neulet.2011.01.078; Xia XF, 2001, P NATL ACAD SCI USA, V98, P10863, DOI 10.1073/pnas.191284198; Yang YN, 1998, J BIOL CHEM, V273, P25552, DOI 10.1074/jbc.273.40.25552; Yasuoka K, 2004, J ANAT, V205, P135, DOI 10.1111/j.0021-8782.2004.00320.x; Young MJ, 1999, BRAIN RES BULL, V50, P27, DOI 10.1016/S0361-9230(99)00084-2; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X; Zheng H, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-27; Zink BJ, 2010, PSYCHIAT CLIN N AM, V33, P741, DOI 10.1016/j.psc.2010.08.005	49	62	62	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2437	2445		10.1074/jbc.M111.315051	http://dx.doi.org/10.1074/jbc.M111.315051			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22144675	hybrid, Green Published			2022-12-27	WOS:000300292300018
J	Nanda, V; Miano, JM				Nanda, Vivek; Miano, Joseph M.			Leiomodin 1, a New Serum Response Factor-dependent Target Gene Expressed Preferentially in Differentiated Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SLOW-GROWING END; SM22-ALPHA TRANSCRIPTION; CONTRACTILE APPARATUS; MASTER REGULATOR; ACTIN-FILAMENT; CALPONIN GENE; MYOCARDIN; TROPOMODULIN; HEART; CARDIOMYOCYTES	Smooth muscle cell (SMC) differentiation is defined largely by a number of cell-restricted genes governed directly by the serum response factor (SRF)/myocardin (MYOCD) transcriptional switch. Here, we describe a new SRF/MYOCD-dependent, SMC-restricted gene known as Leiomodin 1 (Lmod1). Conventional and quantitative RT-PCRs indicate that Lmod1 mRNA expression is enriched in SMC-containing tissues of the mouse, whereas its two paralogs, Lmod2 and Lmod3, exhibit abundant expression in skeletal and cardiac muscle with very low levels in SMC-containing tissues. Western blotting and immunostaining of various adult and embryonic mouse tissues further confirm SMC-specific expression of the LMOD1 protein. Comparative genomic analysis of the human LMOD1 and LMOD2 genes with their respective mouse and rat orthologs shows high conservation between the three exons and several noncoding sequences, including the immediate 5' promoter region. Two conserved CArG boxes are present in both the LMOD1 and LMOD2 promoter regions, although LMOD1 displays much higher promoter activity and is more responsive to SRF/MYOCD stimulation. Gel shift assays demonstrate clear binding between SRF and the two CArG boxes in human LMOD1. Although the CArG boxes in LMOD1 and LMOD2 are similar, only LMOD1 displays SRF or MYOCD-dependent activation. Transgenic mouse studies reveal wild type LMOD1 promoter activity in cardiac and vascular SMC. Such activity is abolished upon mutation of both CArG boxes. Collectively, these data demonstrate that Lmod1 is a new SMC-restricted SRF/MYOCD target gene.	[Nanda, Vivek; Miano, Joseph M.] Univ Rochester, Sch Med & Dent, Aab Cardiovasc Res Inst, Rochester, NY 14642 USA; [Nanda, Vivek] Univ Rochester, Sch Med & Dent, Dept Pharmacol & Physiol, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Miano, JM (corresponding author), Univ Rochester, Sch Med & Dent, Aab Cardiovasc Res Inst, 601 Elmwood Ave, Rochester, NY 14642 USA.	j.m.miano@rochester.edu	Nanda, Vivek/L-8189-2019; Miano, Joseph/L-5634-2018	Miano, Joseph/0000-0001-7522-3207; Nanda, Vivek/0000-0003-1724-7168	National Institutes of Health [HL091168, HL62572]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091168, R01HL062572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL091168 and HL62572.	Balza RO, 2006, J BIOL CHEM, V281, P6498, DOI 10.1074/jbc.M509487200; Beamish JA, 2010, TISSUE ENG PART B-RE, V16, P467, DOI [10.1089/ten.teb.2009.0630, 10.1089/ten.TEB.2009.0630]; Benson CC, 2011, PHYSIOL GENOMICS, V43, P1038, DOI 10.1152/physiolgenomics.00098.2011; Chen JY, 2002, J MOL CELL CARDIOL, V34, P1345, DOI 10.1006/jmcc.2002.2086; Chereau D, 2008, SCIENCE, V320, P239, DOI 10.1126/science.1155313; Chow N, 2007, P NATL ACAD SCI USA, V104, P823, DOI 10.1073/pnas.0608251104; Chu X, 2003, AM J PHYSIOL-HEART C, V284, pH1827, DOI 10.1152/ajpheart.00947.2002; Conley CA, 2001, GENOMICS, V73, P127, DOI 10.1006/geno.2000.6501; Conley CA, 2001, AM J PHYSIOL-CELL PH, V280, pC1645, DOI 10.1152/ajpcell.2001.280.6.C1645; Cooper SJ, 2007, GENOME RES, V17, P136, DOI 10.1101/gr.5875007; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DONG Q, 1991, J CLIN ENDOCR METAB, V72, P1375, DOI 10.1210/jcem-72-6-1375; Du KL, 2003, MOL CELL BIOL, V23, P2425, DOI 10.1128/MCB.23.7.2425-2437.2003; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Hirota JA, 2009, PULM PHARMACOL THER, V22, P370, DOI 10.1016/j.pupt.2008.12.004; Huang JH, 2008, J CLIN INVEST, V118, P515, DOI [10.1172/JC133304, 10.1172/JCI33304]; Huang JH, 2009, P NATL ACAD SCI USA, V106, P18734, DOI 10.1073/pnas.0910749106; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Imamura M, 2010, GENE, V464, P1, DOI 10.1016/j.gene.2010.03.012; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kostyukova AS, 2008, BIOCHEMISTRY-MOSCOW+, V73, P1467, DOI 10.1134/S0006297908130075; Kostyukova AS, 2007, ARCH BIOCHEM BIOPHYS, V465, P227, DOI 10.1016/j.abb.2007.05.012; Li L, 1996, CIRC RES, V78, P188, DOI 10.1161/01.RES.78.2.188; Li L, 1997, DEV BIOL, V187, P311, DOI 10.1006/dbio.1997.8621; Li SJ, 2003, P NATL ACAD SCI USA, V100, P9366, DOI 10.1073/pnas.1233635100; Long XC, 2008, ARTERIOSCL THROM VAS, V28, P1505, DOI 10.1161/ATVBAHA.108.166066; Long X, 2009, J BIOL CHEM, V284, P33671, DOI 10.1074/jbc.M109.050419; Mayor C, 2000, BIOINFORMATICS, V16, P1046, DOI 10.1093/bioinformatics/16.11.1046; McKeown CR, 2008, CIRC RES, V103, P1241, DOI 10.1161/CIRCRESAHA.108.178749; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Miano JM, 2004, P NATL ACAD SCI USA, V101, P17132, DOI 10.1073/pnas.0406041101; Miano JM, 2003, J MOL CELL CARDIOL, V35, P577, DOI 10.1016/S0022-2828(03)00110-X; Miano JM, 1996, J BIOL CHEM, V271, P7095, DOI 10.1074/jbc.271.12.7095; Miano JM, 2000, J BIOL CHEM, V275, P9814, DOI 10.1074/jbc.275.13.9814; Miano JM, 2007, AM J PHYSIOL-CELL PH, V292, pC70, DOI 10.1152/ajpcell.00386.2006; MINTY A, 1986, MOL CELL BIOL, V6, P2125, DOI 10.1128/MCB.6.6.2125; Niu Z, 2008, P NATL ACAD SCI USA, V105, P17824, DOI 10.1073/pnas.0805491105; NORMAN C, 1988, CELL, V55, P989, DOI 10.1016/0092-8674(88)90244-9; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Philippar U, 2004, MOL CELL, V16, P867, DOI 10.1016/j.molcel.2004.11.039; Qiu P, 2005, CIRC RES, V97, P983, DOI 10.1161/01.RES.0000190604.90049.71; Qualmann B, 2009, TRENDS CELL BIOL, V19, P276, DOI 10.1016/j.tcb.2009.03.004; ROTHMAN A, 1992, CIRCULATION, V86, P1977, DOI 10.1161/01.CIR.86.6.1977; Schratt G., J CELL BIOL, V156, P737; Selvaraj A, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-13; Streb JW, 2005, J BIOL CHEM, V280, P4125, DOI 10.1074/jbc.M412466200; Sun Q, 2006, GENOME RES, V16, P197, DOI 10.1101/gr.4108706; Sussman MA, 1998, J CLIN INVEST, V101, P51, DOI 10.1172/JCI1167; Valouev A, 2008, NAT METHODS, V5, P829, DOI 10.1038/NMETH.1246; Wang CB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024242; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang ZG, 2003, P NATL ACAD SCI USA, V100, P7129, DOI 10.1073/pnas.1232341100; Wirth A, 2008, NAT MED, V14, P64, DOI 10.1038/nm1666; Yoshida T, 2003, CIRC RES, V92, P856, DOI 10.1161/01.RES.0000068405.49081.09; Zhang SX, 2005, J BIOL CHEM, V280, P19115, DOI 10.1074/jbc.M413793200	56	64	67	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2459	2467		10.1074/jbc.M111.302224	http://dx.doi.org/10.1074/jbc.M111.302224			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22157009	Green Published, hybrid			2022-12-27	WOS:000300292300020
J	Contois, LW; Nugent, DP; Caron, JM; Cretu, A; Tweedie, E; Akalu, A; Liebes, L; Friesel, R; Rosen, C; Vary, C; Brooks, PC				Contois, Liangru W.; Nugent, Desiree P.; Caron, Jennifer M.; Cretu, Alexandra; Tweedie, Eric; Akalu, Abebe; Liebes, Leonard; Friesel, Robert; Rosen, Clifford; Vary, Calvin; Brooks, Peter C.			Insulin-like Growth Factor Binding Protein-4 Differentially Inhibits Growth Factor-induced Angiogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLLAGEN TYPE-IV; ENDOTHELIAL-CELL SURVIVAL; HUMANIZED ANTIBODY D93; SMOOTH-MUSCLE-CELLS; P38 MAP KINASE; TUMOR-GROWTH; EXTRACELLULAR-MATRIX; TRANSGENIC MICE; BLOOD-VESSELS; IN-VIVO	An in-depth understanding of the molecular and cellular complexity of angiogenesis continues to advance as new stimulators and inhibitors of blood vessel formation are uncovered. Gaining a more complete understanding of the response of blood vessels to both stimulatory and inhibitory molecules will likely contribute to more effective strategies to control pathological angiogenesis. Here, we provide evidence that endothelial cell interactions with structurally altered collagen type IV may suppress the expression of insulin-like growth factor binding protein-4 (IGFBP-4), a well documented inhibitor of the IGF-1/IGF-1R signaling axis. We report for the first time that IGFBP-4 differentially inhibits angiogenesis induced by distinct growth factor signaling pathways as IGFBP-4 inhibited FGF-2- and IGF-1-stimulated angiogenesis but failed to inhibit VEGF-induced angiogenesis. The resistance of VEGF-stimulated angiogenesis to IGFBP-4 inhibition appears to depend on sustained activation of p38 MAPK as blocking its activity restored the anti-angiogenic effects of IGFBP-4 on VEGF-induced blood vessel growth in vivo. These novel findings provide new insight into how blood vessels respond to endogenous inhibitors during angiogenesis stimulated by distinct growth factor signaling pathways.	[Contois, Liangru W.; Nugent, Desiree P.; Caron, Jennifer M.; Tweedie, Eric; Friesel, Robert; Rosen, Clifford; Vary, Calvin; Brooks, Peter C.] Maine Med Ctr Res Inst, Ctr Mol Med, Scarborough, ME 04074 USA; [Cretu, Alexandra] Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA; [Akalu, Abebe; Liebes, Leonard] NYU, Sch Med, Dept Med, New York, NY 10016 USA	Maine Medical Center; University of Pennsylvania; New York University	Brooks, PC (corresponding author), Maine Med Ctr Res Inst, Ctr Mol Med, 81 Res Dr, Scarborough, ME 04074 USA.	brookp1@mmc.org			National Institutes of Health [CA91645, HL65301]; Protein, Nucleic Acid Analysis, and Cell Imaging Core [HL083151, P20RR15555]; Bioinformatic Core [P20 RR181789]; National Centre for Research Resources [P20RR15555]; Maine Medical Center; NATIONAL CANCER INSTITUTE [R01CA091645] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015555] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065301, R01HL083151] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Protein, Nucleic Acid Analysis, and Cell Imaging Core; Bioinformatic Core; National Centre for Research Resources; Maine Medical Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA91645 (to P. C. B.), Grant HL65301 (to R. F.), Grants HL083151 and P20RR15555 (Protein, Nucleic Acid Analysis, and Cell Imaging Core) (to C. P. H. V.), and Grant P20 RR181789 (Bioinformatic Core) (to D. M. Wojchowski). This work was also supported by National Centre for Research Resources Grant P20RR15555 and sub-project to PCB (to R. F.) and by institutional support from the Maine Medical Center.	Akaht A, 2007, CANCER RES, V67, P4353, DOI 10.1158/0008-5472.CAN-06-0482; Allen M, 2011, J PATHOL, V223, P162, DOI 10.1002/path.2803; Brooks PC, 1999, METH MOL B, V129, P257; BROOKS PC, 1994, CELL, V79, P1157, DOI 10.1016/0092-8674(94)90007-8; Cheresh DA, 2008, ONCOGENE, V27, P6285, DOI 10.1038/onc.2008.304; Chitnis MM, 2008, CLIN CANCER RES, V14, P6364, DOI 10.1158/1078-0432.CCR-07-4879; Clemmons DR, 2005, MOL ENDOCRINOL, V19, P1, DOI 10.1210/me.2004-0376; Cretu A, 2007, CLIN CANCER RES, V13, P3068, DOI 10.1158/1078-0432.CCR-06-2342; Damon SE, 1998, ENDOCRINOLOGY, V139, P3456, DOI 10.1210/en.139.8.3456; Delafontaine P, 2004, ARTERIOSCL THROM VAS, V24, P435, DOI 10.1161/01.ATV.0000105902.89459.09; Duan C, 2002, J ENDOCRINOL, V175, P41, DOI 10.1677/joe.0.1750041; Duan CM, 1998, J BIOL CHEM, V273, P16836, DOI 10.1074/jbc.273.27.16836; Durai R, 2007, INT J ONCOL, V30, P883; Durai R, 2006, INT J ONCOL, V28, P1317; Eliceiri BP, 1998, J CELL BIOL, V140, P1255, DOI 10.1083/jcb.140.5.1255; Freimark B, 2007, MOL IMMUNOL, V44, P3741, DOI 10.1016/j.molimm.2007.03.027; FRIEDLANDER M, 1995, SCIENCE, V270, P1500, DOI 10.1126/science.270.5241.1500; Gee E, 2010, J CELL PHYSIOL, V222, P120, DOI 10.1002/jcp.21924; Hangai M, 2002, AM J PATHOL, V161, P1429, DOI 10.1016/S0002-9440(10)64418-5; Hood JD, 2003, J CELL BIOL, V162, P933, DOI 10.1083/jcb.200304105; Hwa V, 1999, ENDOCR REV, V20, P761, DOI 10.1210/er.20.6.761; Jo N, 2006, MOL VIS, V12, P1243; Laursen LS, 2007, MOL ENDOCRINOL, V21, P1246, DOI 10.1210/me.2006-0522; Leong KG, 2002, MOL CELL BIOL, V22, P2830, DOI 10.1128/MCB.22.8.2830-2841.2002; Lobov IB, 2002, P NATL ACAD SCI USA, V99, P11205, DOI 10.1073/pnas.172161899; Mast J, 1998, VET IMMUNOL IMMUNOP, V61, P343, DOI 10.1016/S0165-2427(97)00152-9; Matsumoto T, 2002, J CELL BIOL, V156, P149, DOI 10.1083/jcb.200103096; Moreno MJ, 2006, GLIA, V53, P845, DOI 10.1002/glia.20345; Mudgett JS, 2000, P NATL ACAD SCI USA, V97, P10454, DOI 10.1073/pnas.180316397; Nagarajan R, 2007, BIOCHEMISTRY-US, V46, P192, DOI 10.1021/bi061706u; Noonan DM, 2008, CANCER METAST REV, V27, P31, DOI 10.1007/s10555-007-9108-5; Odaka C, 2005, J IMMUNOL, V174, P846, DOI 10.4049/jimmunol.174.2.846; Pernasetti F, 2006, INT J ONCOL, V29, P1371; Petitclerc E, 2000, J BIOL CHEM, V275, P8051, DOI 10.1074/jbc.275.11.8051; Pozzi A, 2009, WIRES SYST BIOL MED, V1, P254, DOI 10.1002/wsbm.7; Rajashekhar G, 2011, J CELL PHYSIOL, V226, P800, DOI 10.1002/jcp.22404; Rini BI, 2005, J CLIN ONCOL, V23, P1028, DOI 10.1200/JCO.2005.01.186; Robert F., 2010, ASCO ANN M; Ryan AJ, 2009, BRIT J CANCER, V101, P278, DOI 10.1038/sj.bjc.6605141; Sanz L, 2003, TRENDS MOL MED, V9, P256, DOI 10.1016/S1471-4914(03)00070-4; Ueno K, 2011, INT J CANCER, V129, P2360, DOI 10.1002/ijc.25899; Wang JW, 1998, ENDOCRINOLOGY, V139, P2605, DOI 10.1210/en.139.5.2605; Xie HL, 2010, J DIGEST DIS, V11, P167, DOI 10.1111/j.1751-2980.2010.00432.x; Xu JS, 2001, J CELL BIOL, V154, P1069, DOI 10.1083/jcb.200103111; Yu JZ, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-70; Zheng B, 1998, J BIOL CHEM, V273, P8994, DOI 10.1074/jbc.273.15.8994; Zhou R, 2004, J MOL ENDOCRINOL, V32, P349, DOI 10.1677/jme.0.0320349	47	31	34	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					1779	1789		10.1074/jbc.M111.267732	http://dx.doi.org/10.1074/jbc.M111.267732			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22134921	hybrid, Green Published			2022-12-27	WOS:000299321000020
J	Chruszcz, M; Pomes, A; Glesner, J; Vailes, LD; Osinski, T; Porebski, PJ; Majorek, KA; Heymann, PW; Platts-Mills, TAE; Minor, W; Chapman, MD				Chruszcz, Maksymilian; Pomes, Anna; Glesner, Jill; Vailes, Lisa D.; Osinski, Tomasz; Porebski, Przemyslaw J.; Majorek, Karolina A.; Heymann, Peter W.; Platts-Mills, Thomas A. E.; Minor, Wladek; Chapman, Martin D.			Molecular Determinants for Antibody Binding on Group 1 House Dust Mite Allergens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DER-P-I; X-RAY-DIFFRACTION; DERMATOPHAGOIDES-PTERONYSSINUS; EPITOPE SPECIFICITY; CROSS-REACTIVITY; MAJOR ALLERGEN; HOT-SPOTS; F-I; IGE; EXPOSURE	House dust mites produce potent allergens, Der p 1 and Der f 1, that cause allergic sensitization and asthma. Der p 1 and Der f 1 are cysteine proteases that elicit IgE responses in 80% of mite-allergic subjects and have proinflammatory properties. Their antigenic structure is unknown. Here, we present crystal structures of natural Der p 1 and Der f 1 in complex with a monoclonal antibody, 4C1, which binds to a unique cross-reactive epitope on both allergens associated with IgE recognition. The 4C1 epitope is formed by almost identical amino acid sequences and contact residues. Mutations of the contact residues abrogate mAb 4C1 binding and reduce IgE antibody binding. These surface-exposed residues are molecular targets that can be exploited for development of recombinant allergen vaccines.	[Chruszcz, Maksymilian; Osinski, Tomasz; Porebski, Przemyslaw J.; Majorek, Karolina A.; Minor, Wladek] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA; [Pomes, Anna; Glesner, Jill; Vailes, Lisa D.; Chapman, Martin D.] INDOOR Biotechnol Inc, Charlottesville, VA 22903 USA; [Heymann, Peter W.; Platts-Mills, Thomas A. E.] Univ Virginia Hlth Syst, Div Allergy, Charlottesville, VA 22908 USA	University of Virginia; INDOOR Biotechnologies; University of Virginia	Chruszcz, M (corresponding author), Univ Virginia, Dept Mol Physiol & Biol Phys, 1340 Jefferson Pk Ave, Charlottesville, VA 22908 USA.	maks@iwonka.med.virginia.edu; wladek@iwonka.med.virginia.edu	Minor, Wladek/F-3096-2014; Chruszcz, Maksymilian/E-6407-2011; Pomés, Anna/H-7010-2019; Porebski, Przemyslaw/D-9661-2018	Minor, Wladek/0000-0001-7075-7090; Chruszcz, Maksymilian/0000-0001-7521-5485; Pomés, Anna/0000-0002-8729-1829; Porebski, Przemyslaw/0000-0001-8012-5791; Osinski, Tomasz/0000-0001-9933-346X; Chapman, Martin/0000-0002-0845-3632; Platts-Mills, Thomas/0000-0002-1263-329X	National Institutes of Health [AI077653, GM53163, AI120565]; United States Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077653] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053163] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI077653, GM53163, and AI120565.; We thank David Cooper and Rob Solberg for valuable discussions and Igor Shumilin for help with isothermal titration calorimetry experiments. The structural results shown in this report are derived from work performed at Argonne National Laboratory at the Structural Biology Center of the Advanced Photon Source. Argonne is operated by University of Chicago Argonne, LLC for the United States Department of Energy, Office of Biological and Environmental Research under Contract DE-AC02-06CH11357.	AlLazikani B, 1997, J MOL BIOL, V273, P927, DOI 10.1006/jmbi.1997.1354; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BERZOFSKY JA, 1981, MOL IMMUNOL, V18, P751, DOI 10.1016/0161-5890(81)90067-5; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; CHAPMAN MD, 1987, J IMMUNOL, V139, P1479; CHAPMAN MD, 1980, J IMMUNOL, V125, P587; Cheong N, 2003, ALLERGY, V58, P912, DOI 10.1034/j.1398-9995.2003.00215.x; CHOTHIA C, 1989, NATURE, V342, P877, DOI 10.1038/342877a0; Chruszcz M, 2009, J MOL BIOL, V386, P520, DOI 10.1016/j.jmb.2008.12.049; Cruz LM, 2008, P R HEALTH SCI J, V27, P163; Cymborowski M., 2010, Journal of Structural and Functional Genomics, V11, P211, DOI 10.1007/s10969-010-9092-9; de Halleux S, 2006, J ALLERGY CLIN IMMUN, V117, P571, DOI 10.1016/j.jaci.2005.11.032; DeLano W.L, PYMOL MOL GRAPHICS S; Earle CD, 2007, J ALLERGY CLIN IMMUN, V119, P428, DOI 10.1016/j.jaci.2006.11.004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fellouse FA, 2006, J MOL BIOL, V357, P100, DOI 10.1016/j.jmb.2005.11.092; Fellouse FA, 2004, P NATL ACAD SCI USA, V101, P12467, DOI 10.1073/pnas.0401786101; Gough L, 1999, J EXP MED, V190, P1897, DOI 10.1084/jem.190.12.1897; Gront D, 2006, BIOINFORMATICS, V22, P621, DOI 10.1093/bioinformatics/btk037; Hales BJ, 2006, J ALLERGY CLIN IMMUN, V118, P361, DOI 10.1016/j.jaci.2006.04.001; HEYMANN PW, 1986, J IMMUNOL, V137, P2841; Hu ZJ, 2000, PROTEINS, V39, P331, DOI 10.1002/(SICI)1097-0134(20000601)39:4<331::AID-PROT60>3.0.CO;2-A; Illi S, 2006, LANCET, V368, P763, DOI 10.1016/S0140-6736(06)69286-6; KABSCH W, 1978, ACTA CRYSTALLOGR A, V34, P827, DOI 10.1107/S0567739478001680; King EM, 2007, J ALLERGY CLIN IMMUN, V120, P1126, DOI 10.1016/j.jaci.2007.06.043; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LIND P, 1988, J IMMUNOL, V140, P4256; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; McElveen JE, 1998, CLIN EXP ALLERGY, V28, P1427, DOI 10.1046/j.1365-2222.1998.00378.x; Meno K, 2005, J IMMUNOL, V175, P3835, DOI 10.4049/jimmunol.175.6.3835; MIAN IS, 1991, J MOL BIOL, V217, P133, DOI 10.1016/0022-2836(91)90617-F; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakamura T, 2006, J INVEST DERMATOL, V126, P2719, DOI 10.1038/sj.jid.5700584; Niemi M, 2007, STRUCTURE, V15, P1413, DOI 10.1016/j.str.2007.09.012; North B, 2011, J MOL BIOL, V406, P228, DOI 10.1016/j.jmb.2010.10.030; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Padavattan S, 2009, J IMMUNOL, V182, P2141, DOI 10.4049/jimmunol.0803018; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Piboonpocanun S, 2006, CLIN EXP ALLERGY, V36, P510, DOI 10.1111/j.1365-2222.2006.02464.x; Platts-Mills TAE, 2009, AM J RESP CRIT CARE, V180, P109, DOI 10.1164/rccm.200811-1756PR; Rashin AA, 2010, BIOCHEMISTRY-US, V49, P5683, DOI 10.1021/bi100110x; Rashin AA, 2009, ACTA CRYSTALLOGR D, V65, P1140, DOI 10.1107/S090744490903145X; Rosenbaum G, 2006, J SYNCHROTRON RADIAT, V13, P30, DOI 10.1107/S0909049505036721; Salo PM, 2008, J ALLERGY CLIN IMMUN, V121, P678, DOI 10.1016/j.jaci.2007.12.1164; Sears MR, 2003, NEW ENGL J MED, V349, P1414, DOI 10.1056/NEJMoa022363; Shakib F, 2008, TRENDS IMMUNOL, V29, P633, DOI 10.1016/j.it.2008.08.007; SPORIK R, 1990, NEW ENGL J MED, V323, P502, DOI 10.1056/NEJM199008233230802; Stanfield RL, 2006, J MOL BIOL, V357, P1566, DOI 10.1016/j.jmb.2006.01.023; Takai T, 2005, J ALLERGY CLIN IMMUN, V115, P555, DOI 10.1016/j.jaci.2004.11.024; Thomas WR, 2010, TRENDS MOL MED, V16, P321, DOI 10.1016/j.molmed.2010.04.008; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Victor BC, 2007, BIOL CHEM, V388, P1131, DOI 10.1515/BC.2007.150; Wu Di, 2010, Immunome Res, V6 Suppl 1, pS1, DOI 10.1186/1745-7580-6-S1-S1; Yang HW, 2004, ACTA CRYSTALLOGR D, V60, P1833, DOI 10.1107/S0907444904019419; Zheng H, 2008, J INORG BIOCHEM, V102, P1765, DOI 10.1016/j.jinorgbio.2008.05.006; Zimmerman M, 2005, ACTA CRYSTALLOGR A, V61, pC178, DOI 10.1107/S0108767305092391	58	67	71	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7388	7398		10.1074/jbc.M111.311159	http://dx.doi.org/10.1074/jbc.M111.311159			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22210776	Green Published, hybrid			2022-12-27	WOS:000301060200040
J	Kedar, VP; Zucconi, BE; Wilson, GM; Blackshear, PJ				Kedar, Vishram P.; Zucconi, Beth E.; Wilson, Gerald M.; Blackshear, Perry J.			Direct Binding of Specific AUF1 Isoforms to Tandem Zinc Finger Domains of Tristetraprolin (TTP) Family Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA DEADENYLATION; RICH ELEMENT; POLY(A) TAIL; POLY(A)-BINDING PROTEIN; DEFICIENCY SYNDROME; TNF-ALPHA; TURNOVER; STABILITY; YEAST; DECAY	Tristetraprolin (TTP) is the prototype of a family of CCCH tandem zinc finger proteins that can bind to AU-rich elements in mRNAs and promote their decay. TTP binds to mRNA through its central tandem zinc finger domain; it then promotes mRNA deadenylation, considered to be the rate-limiting step in eukaryotic mRNA decay. We found that TTP and its related family members could bind to certain isoforms of another AU-rich element-binding protein, HNRNPD/AUF1, as well as a related protein, laAUF1. The interaction domain within AUF1p45 appeared to be a C-terminal "GY" region, and the interaction domain within TTP was the tandem zinc finger domain. Surprisingly, binding of AUF1p45 to TTP occurred even with TTP mutants that lacked RNA binding activity. In cell extracts, binding of AUF1p45 to TTP potentiated TTP binding to ARE-containing RNA probes, as determined by RNA gel shift assays; AUF1p45 did not bind to the RNA probes under these conditions. Using purified, recombinant proteins and a synthetic RNA target in FRET assays, we demonstrated that AUF1p45, but not AUF1p37, increased TTP binding affinity for RNA similar to 5-fold. These data suggest that certain isoforms of AUF1 can serve as "co-activators" of TTP family protein binding to RNA. The results raise interesting questions about the ability of AUF1 isoforms to regulate the mRNA binding and decay-promoting activities of TTP and its family members as well as the ability of AUF1 proteins to serve as possible physical links between TTP and other mRNA decay proteins and structures.	[Kedar, Vishram P.; Blackshear, Perry J.] NIEHS, Lab Signal Transduct, NIH, Res Triangle Pk, NC 27709 USA; [Zucconi, Beth E.; Wilson, Gerald M.] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Blackshear, Perry J.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Blackshear, Perry J.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University System of Maryland; University of Maryland Baltimore; Duke University; Duke University	Blackshear, PJ (corresponding author), F1-13 NIEHS,111 Alexander Dr, Res Triangle Pk, NC 27709 USA.	black009@niehs.nih.gov	Blackshear, Perry J./C-6206-2019; Wilson, Gerald/AAF-3874-2019	Blackshear, Perry J./0000-0002-9561-8529; Wilson, Gerald/0000-0002-1273-7507	National Institutes of Health (NIEHS); American Heart Association [11PRE6900008]; National Institutes of Health [T32 GM066706];  [R01 CA102428]; NATIONAL CANCER INSTITUTE [R01CA102428] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES090080] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM066706] Funding Source: NIH RePORTER	National Institutes of Health (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program (NIEHS) and by Grant R01 CA102428 (to G. M. W.).; Supported by American Heart Association Grant 11PRE6900008 and National Institutes of Health Grant T32 GM066706.	Brewer BY, 2004, J BIOL CHEM, V279, P27870, DOI 10.1074/jbc.M402551200; BREWER G, 1991, MOL CELL BIOL, V11, P2460, DOI 10.1128/MCB.11.5.2460; Cao H, 2007, EXPERT REV PROTEOMIC, V4, P711, DOI 10.1586/14789450.4.6.711; CAPONIGRO G, 1995, GENE DEV, V9, P2421, DOI 10.1101/gad.9.19.2421; Carballo E, 1997, J CLIN INVEST, V100, P986, DOI 10.1172/JCI119649; Carballo E, 2000, BLOOD, V95, P1891, DOI 10.1182/blood.V95.6.1891; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Carballo E, 2001, BLOOD, V98, P2389, DOI 10.1182/blood.V98.8.2389; Carman JA, 2004, BIOCHEM BIOPH RES CO, V315, P445, DOI 10.1016/j.bbrc.2004.01.080; Carrick DM, 2004, ARTHRITIS RES THER, V6, P248, DOI 10.1186/ar1441; Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; DECKER CJ, 1993, GENE DEV, V7, P1632, DOI 10.1101/gad.7.8.1632; DeGrado-Warren J, 2008, BIOTECHNIQUES, V44, P265, DOI 10.2144/000112674; Doi A, 1998, BBA-GENE STRUCT EXPR, V1396, P51, DOI 10.1016/S0167-4781(97)00223-6; Frederick ED, 2008, J BIOL CHEM, V283, P14792, DOI 10.1074/jbc.M801234200; Funakoshi Y, 2007, GENE DEV, V21, P3135, DOI 10.1101/gad.1597707; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; Goldstrohm AC, 2008, NAT REV MOL CELL BIO, V9, P337, DOI 10.1038/nrm2370; Guhaniyogi J, 2001, GENE, V265, P11, DOI 10.1016/S0378-1119(01)00350-X; Hudson BP, 2004, NAT STRUCT MOL BIOL, V11, P257, DOI 10.1038/nsmb738; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; Johnson BA, 2002, J BIOL CHEM, V277, P18029, DOI 10.1074/jbc.M110465200; Kahvejian A, 2005, GENE DEV, V19, P104, DOI 10.1101/gad.1262905; Kedar V, 2004, P NATL ACAD SCI USA, V101, P18135, DOI 10.1073/pnas.0404341102; Kedar VP, 2010, PLOS ONE, V5, pA213, DOI 10.1371/journal.pone.0009588; Korner CG, 1997, J BIOL CHEM, V272, P10448; Korner CG, 1998, EMBO J, V17, P5427, DOI 10.1093/emboj/17.18.5427; Lai WS, 2001, J BIOL CHEM, V276, P23144, DOI 10.1074/jbc.M100680200; Lai WS, 2003, MOL CELL BIOL, V23, P3798, DOI 10.1128/MCB.23.11.3798-3812.2003; Lai WS, 2000, J BIOL CHEM, V275, P17827, DOI 10.1074/jbc.M001696200; Lai WS, 2005, J BIOL CHEM, V280, P34365, DOI 10.1074/jbc.M506757200; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Lai WS, 2002, J BIOL CHEM, V277, P9606, DOI 10.1074/jbc.M110395200; Lakowicz J.R, 1999, PRINCIPLES FLUORESCE, P368; Lu JY, 2006, GENE DEV, V20, P3174, DOI 10.1101/gad.1467606; Lu JY, 2006, RNA, V12, P883, DOI 10.1261/rna.2308106; Lykke-Andersen J, 2005, GENE DEV, V19, P351, DOI 10.1101/gad.1282305; Mahtani KR, 2001, MOL CELL BIOL, V21, P6461, DOI 10.1128/MCB.21.9.6461-6469.2001; Mazan-Mamczarz K, 2009, NUCLEIC ACIDS RES, V37, P204, DOI 10.1093/nar/gkn929; Phillips RS, 2002, J BIOL CHEM, V277, P11606, DOI 10.1074/jbc.M111457200; Sadri N, 2009, J INVEST DERMATOL, V129, P657, DOI 10.1038/jid.2008.298; Sandler H, 2008, BIOCHEM SOC T, V36, P491, DOI 10.1042/BST0360491; Stumpo DJ, 2009, BLOOD, V114, P2401, DOI 10.1182/blood-2009-04-214619; Stumpo DJ, 2004, MOL CELL BIOL, V24, P6445, DOI 10.1128/MCB.24.14.6445-6455.2004; Sun L, 2007, J BIOL CHEM, V282, P3766, DOI 10.1074/jbc.M607347200; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; Wagner BJ, 1998, GENOMICS, V48, P195, DOI 10.1006/geno.1997.5142; Wilson GM, 2005, REV FLUORESCENCE, V2, P223; Wilson GM, 2001, J BIOL CHEM, V276, P8695, DOI 10.1074/jbc.M009848200; ZHANG W, 1993, MOL CELL BIOL, V13, P7652, DOI 10.1128/MCB.13.12.7652; Zucconi B. E., 2012, FRONT BIOSCI, V17, P2307; Zucconi BE, 2010, J BIOL CHEM, V285, P39127, DOI 10.1074/jbc.M110.180182	52	30	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5459	5471		10.1074/jbc.M111.312652	http://dx.doi.org/10.1074/jbc.M111.312652			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22203679	hybrid, Green Published			2022-12-27	WOS:000300638000026
J	Manavathi, B; Lo, D; Bugide, S; Dey, O; Imren, S; Weiss, MJ; Humphries, RK				Manavathi, Bramanandam; Lo, Dennis; Bugide, Suresh; Dey, Oindrilla; Imren, Suzan; Weiss, Mitchell J.; Humphries, R. Keith			Functional Regulation of Pre-B-cell Leukemia Homeobox Interacting Protein 1 (PBXIP1/HPIP) in Erythroid Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR GATA-1; ACUTE MYELOID-LEUKEMIA; HEMATOPOIETIC-CELLS; STEM-CELLS; PHOSPHATIDYLINOSITOL 3-KINASE; PROGENITOR CELLS; GENE-EXPRESSION; KINASE-B; IN-VITRO; ERYTHROPOIETIN	Pre-B-cell leukemia homeobox interacting protein 1 or human PBX1 interacting protein (PBXIP1/HPIP) is a co-repressor of pre-B-cell leukemia homeobox 1 (PBX1) and is also known to regulate estrogen receptor functions by associating with the microtubule network. Despite its initial discovery in the context of hematopoietic cells, little is yet known about the role of HPIP in hematopoiesis. Here, we show that lentivirus-mediated overexpression of HPIP in human CD34(+) cells enhances hematopoietic colony formation in vitro, whereas HPIP knockdown leads to a reduction in the number of such colonies. Interestingly, erythroid colony number was significantly higher in HPIP-overexpressing cells. In addition, forced expression of HPIP in K562 cells, a multipotent erythro-megakaryoblastic leukemia cell line, led to an induction of erythroid differentiation. HPIP overexpression in both CD34(+) and K562 cells was associated with increased activation of the PI3K/AKT pathway, and corresponding treatment with a PI3K-specific inhibitor, LY-294002, caused a reduction in clonogenic progenitor number in HPIP-expressing CD34(+) cells and decreased K562 cell differentiation. Combined, these findings point to an important role of the PI3K/AKT pathway in mediating HPIP-induced effects on the growth and differentiation of hematopoietic cells. Interestingly, HPIP gene expression was found to be induced in K562 cells in response to erythroid differentiation signals such as DMSO and erythropoietin. The erythroid lineage-specific transcription factor GATA1 binds to the HPIP promoter and activates HPIP gene transcription in a CCCTC-binding factor (CTCF)-dependent manner. Co-immunoprecipitation and co-localization experiments revealed the association of CTCF with GATA1 indicating the recruitment of CTCF/GATA1 transcription factor complex onto the HPIP promoter. Together, this study provides evidence that HPIP is a target of GATA1 and CTCF in erythroid cells and plays an important role in erythroid differentiation by modulating the PI3K/AKT pathway.	[Manavathi, Bramanandam; Bugide, Suresh; Dey, Oindrilla] Univ Hyderabad, Sch Life Sci, Dept Biochem, Mol & Cellular Oncol Lab, Hyderabad 500046, Andhra Pradesh, India; [Lo, Dennis; Imren, Suzan; Humphries, R. Keith] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada; [Lo, Dennis; Imren, Suzan; Humphries, R. Keith] Univ British Columbia, Dept Med, Vancouver, BC V5Z 1L3, Canada; [Weiss, Mitchell J.] Childrens Hosp, Div Hematol, Philadelphia, PA 19104 USA	University of Hyderabad; British Columbia Cancer Agency; University of British Columbia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Manavathi, B (corresponding author), Univ Hyderabad, Sch Life Sci, Dept Biochem, Mol & Cellular Oncol Lab, Hyderabad 500046, Andhra Pradesh, India.	manavathibsl@uohyd.ernet.in; khumphri@bccrc.ca	Weiss, Mitchell J/W-9814-2018; Weiss, Mitchell J/A-1245-2013; Bugide, Suresh/AAD-6053-2022	Weiss, Mitchell J/0000-0003-2460-3036; Manavathi, Bramanandam/0000-0002-1797-398X; Humphries, Richard/0000-0003-0540-7005	Department of Science and Technology; Terry Fox Foundation; British Columbia Cancer Foundation	Department of Science and Technology(Department of Science & Technology (India)); Terry Fox Foundation; British Columbia Cancer Foundation	This work was supported by Department of Science and Technology under Better Opportunities for Young Scientist in Chosen Areas of Science and Technology (to B. M.), a Terry Fox Foundation program project grant (to R. K. H.), the British Columbia Cancer Foundation, and in part by the Department of Science and Technology under the Fast-Track Program young investigator award (to B. M.).	Abramovich C, 2000, J BIOL CHEM, V275, P26172, DOI 10.1074/jbc.M001323200; Abramovich C, 2002, ONCOGENE, V21, P6766, DOI 10.1038/sj.onc.1205784; AI ZW, 1995, EXP CELL RES, V219, P454, DOI 10.1006/excr.1995.1252; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Bone HK, 2007, J CELL SCI, V120, P1752, DOI 10.1242/jcs.003772; Buitenhuis M, 2009, CELL CYCLE, V8, P560, DOI 10.4161/cc.8.4.7654; BUSFIELD SJ, 1995, EUR J BIOCHEM, V230, P475; Cantor AB, 2002, ONCOGENE, V21, P3368, DOI 10.1038/sj.onc.1205326; Cheng Y, 2009, GENOME RES, V19, P2172, DOI 10.1101/gr.098921.109; Crispino JD, 2005, SEMIN CELL DEV BIOL, V16, P137, DOI 10.1016/j.semcdb.2004.11.002; Crooks GM, 1999, BLOOD, V94, P519, DOI 10.1182/blood.V94.2.519.414k20_519_528; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; DiMartino JF, 2001, BLOOD, V98, P618, DOI 10.1182/blood.V98.3.618; Fischbach NA, 2005, BLOOD, V105, P1456, DOI 10.1182/blood-2004-04-1583; Gambone JE, 2011, BLOOD, V117, P5733, DOI 10.1182/blood-2009-09-242131; Hope KJ, 2003, ARCH MED RES, V34, P507, DOI 10.1016/j.arcmed.2003.08.007; Imren S, 2004, J CLIN INVEST, V114, P953, DOI 10.1172/JCI200421838; Kadri Z, 2005, MOL CELL BIOL, V25, P7412, DOI 10.1128/MCB.25.17.7412-7422.2005; KAMPS MP, 1990, CELL, V60, P547, DOI 10.1016/0092-8674(90)90658-2; Kappen C, 2000, AM J HEMATOL, V65, P111, DOI 10.1002/1096-8652(200010)65:2<111::AID-AJH4>3.0.CO;2-Z; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kubota Y, 2001, EMBO J, V20, P5666, DOI 10.1093/emboj/20.20.5666; Liu LH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002850; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; Manavathi B, 2006, P NATL ACAD SCI USA, V103, P15981, DOI 10.1073/pnas.0607445103; Marques-Garcia F, 2009, J BIOL CHEM, V284, P21139, DOI 10.1074/jbc.M109.026849; Moens CB, 2006, DEV BIOL, V291, P193, DOI 10.1016/j.ydbio.2005.10.032; Myklebust JH, 2002, EXP HEMATOL, V30, P990, DOI 10.1016/S0301-472X(02)00868-8; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; PEVNY L, 1995, DEVELOPMENT, V121, P163; Saitoh N, 2000, EMBO J, V19, P2315, DOI 10.1093/emboj/19.10.2315; Sauvageau G, 2004, ONCOGENE, V23, P7223, DOI 10.1038/sj.onc.1207942; Selleri L, 2001, DEVELOPMENT, V128, P3543; Shimamoto T, 1998, INT J HEMATOL, V67, P339; SUTHERLAND HJ, 1989, BLOOD, V74, P1563; Tanimoto K, 2003, MOL CELL BIOL, V23, P8946, DOI 10.1128/MCB.23.24.8946-8952.2003; Thorsteinsdottir U, 1997, MOL CELL BIOL, V17, P495, DOI 10.1128/MCB.17.1.495; Torrano V, 2005, J BIOL CHEM, V280, P28152, DOI 10.1074/jbc.M501481200; Tsai FY, 1997, BLOOD, V89, P3636, DOI 10.1182/blood.V89.10.3636.3636_3636_3643; Uhlen M, 2005, MOL CELL PROTEOMICS, V4, P1920, DOI 10.1074/mcp.M500279-MCP200; Wang XH, 2008, BBA-MOL CELL RES, V1783, P1220, DOI 10.1016/j.bbamcr.2008.01.026; Weiss MJ, 1997, MOL CELL BIOL, V17, P1642, DOI 10.1128/MCB.17.3.1642; Weissman IL, 2001, ANNU REV CELL DEV BI, V17, P387, DOI 10.1146/annurev.cellbio.17.1.387; Welch JJ, 2004, BLOOD, V104, P3136, DOI 10.1182/blood-2004-04-1603; Zon LI, 2008, NATURE, V453, P306, DOI 10.1038/nature07038	46	28	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5600	5614		10.1074/jbc.M111.289843	http://dx.doi.org/10.1074/jbc.M111.289843			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22187427	Green Published, hybrid			2022-12-27	WOS:000300638000038
J	Schlick, T; Hayes, J; Grigoryev, S				Schlick, Tamar; Hayes, Jeff; Grigoryev, Sergei			Toward Convergence of Experimental Studies and Theoretical Modeling of the Chromatin Fiber	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							HIGHER-ORDER STRUCTURE; MOLECULE FORCE SPECTROSCOPY; RESONANCE ENERGY-TRANSFER; NUCLEOSOME CORE PARTICLE; DNA LINKER LENGTH; X-RAY-DIFFRACTION; TERMINAL DOMAIN; METAPHASE CHROMOSOMES; ANGSTROM RESOLUTION; H4-K16 ACETYLATION	Understanding the structural organization of eukaryotic chromatin and its control of gene expression represents one of the most fundamental and open challenges in modern biology. Recent experimental advances have revealed important characteristics of chromatin in response to changes in external conditions and histone composition, such as the conformational complexity of linker DNA and histone tail domains upon compact folding of the fiber. In addition, modeling studies based on high-resolution nucleosome models have helped explain the conformational features of chromatin structural elements and their interactions in terms of chromatin fiber models. This minireview discusses recent progress and evidence supporting structural heterogeneity in chromatin fibers, reconciling apparently contradictory fiber models.	[Schlick, Tamar] NYU, Dept Chem, New York, NY 10003 USA; [Schlick, Tamar] NYU, Courant Inst Math Sci, New York, NY 10012 USA; [Hayes, Jeff] Univ Rochester, Dept Biochem & Biophys, Med Ctr, Rochester, NY 14642 USA; [Grigoryev, Sergei] Penn State Univ, Dept Biochem & Mol Biol, Coll Med, Hershey, PA 17033 USA	New York University; New York University; University of Rochester; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Schlick, T (corresponding author), NYU, Dept Chem, New York, NY 10003 USA.	schlick@nyu.edu		Schlick, Tamar/0000-0002-2392-2062	National Institutes of Health [R01 GM055164, R01 GM52426]; National Science Foundation [MCB-0316771, MCB-1021681]; Philip-Morris International; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052426, R01GM055164] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Philip-Morris International; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM055164 (to T. S.) and R01 GM52426 (to J. H.). This work was also supported by National Science Foundation Grants MCB-0316771 (to T. S.) and MCB-1021681 (to S. G.) and Philip-Morris International (to T. S.).	Allahverdi A, 2011, NUCLEIC ACIDS RES, V39, P1680, DOI 10.1093/nar/gkq900; Arya G, 2009, J PHYS CHEM A, V113, P4045, DOI 10.1021/jp810375d; ATHEY BD, 1990, J CELL BIOL, V111, P795, DOI 10.1083/jcb.111.3.795; Bancaud A, 2009, EMBO J, V28, P3785, DOI 10.1038/emboj.2009.340; Bao YH, 2006, J MOL BIOL, V361, P617, DOI 10.1016/j.jmb.2006.06.051; Bednar J, 1998, P NATL ACAD SCI USA, V95, P14173, DOI 10.1073/pnas.95.24.14173; Bharath MMS, 2003, NUCLEIC ACIDS RES, V31, P4264, DOI 10.1093/nar/gkg481; Brown DT, 2003, BIOCHEM CELL BIOL, V81, P221, DOI 10.1139/o03-049; Carrero G, 2004, B MATH BIOL, V66, P1515, DOI 10.1016/j.bulm.2004.02.005; Carruthers LM, 1998, BIOCHEMISTRY-US, V37, P14776, DOI 10.1021/bi981684e; Caterino TL, 2011, MOL CELL BIOL, V31, P2341, DOI 10.1128/MCB.05145-11; Chen DY, 2005, J CELL BIOL, V168, P41, DOI 10.1083/jcb.200407182; Cheutin T, 2003, SCIENCE, V299, P721, DOI 10.1126/science.1078572; Chien FT, 2009, CURR PHARM BIOTECHNO, V10, P474, DOI 10.2174/138920109788922128; Chodaparambil JV, 2007, NAT STRUCT MOL BIOL, V14, P1105, DOI 10.1038/nsmb1334; Collepardo-Guevara R, 2011, BIOPHYS J, V101, P1670, DOI 10.1016/j.bpj.2011.07.044; Cui Y, 2000, P NATL ACAD SCI USA, V97, P127, DOI 10.1073/pnas.97.1.127; Daban JR, 1998, BIOCHEMISTRY-US, V37, P4299, DOI 10.1021/bi973117h; Davey CA, 2002, J MOL BIOL, V319, P1097, DOI 10.1016/S0022-2836(02)00386-8; Dion MF, 2005, P NATL ACAD SCI USA, V102, P5501, DOI 10.1073/pnas.0500136102; Dorigo B, 2004, SCIENCE, V306, P1571, DOI 10.1126/science.1103124; Dorigo B, 2003, J MOL BIOL, V327, P85, DOI 10.1016/S0022-2836(03)00025-1; Eltsov M, 2008, P NATL ACAD SCI USA, V105, P19732, DOI 10.1073/pnas.0810057105; Fan L, 2006, P NATL ACAD SCI USA, V103, P8384, DOI 10.1073/pnas.0508951103; Faye G, 2005, J BIOL CHEM, V280, P33701, DOI 10.1074/jbc.M507048200; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; Fierz B, 2011, NAT CHEM BIOL, V7, P113, DOI 10.1038/NCHEMBIO.501; Fussner E, 2011, EMBO J, V30, P1778, DOI 10.1038/emboj.2011.96; Fussner E, 2011, TRENDS BIOCHEM SCI, V36, P1, DOI 10.1016/j.tibs.2010.09.002; Grigoryev SA, 2006, CHROMOSOME RES, V14, P53, DOI 10.1007/s10577-005-1021-6; Grigoryev SA, 1999, J BIOL CHEM, V274, P5626, DOI 10.1074/jbc.274.9.5626; Grigoryev SA, 2009, P NATL ACAD SCI USA, V106, P13317, DOI 10.1073/pnas.0903280106; Horn PJ, 2002, SCIENCE, V297, P1824, DOI 10.1126/science.1074200; HOROWITZ RA, 1994, J CELL BIOL, V125, P1, DOI 10.1083/jcb.125.1.1; Iwasaki W, 2011, BIOCHEMISTRY-US, V50, P7822, DOI 10.1021/bi201021h; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kan PY, 2007, MOL CELL BIOL, V27, P2084, DOI 10.1128/MCB.02181-06; Kan PY, 2009, MOL CELL BIOL, V29, P538, DOI 10.1128/MCB.01343-08; Kireev I, 2008, NAT METHODS, V5, P311, DOI [10.1038/NMETH.1196, 10.1038/nmeth.1196]; Kireeva N, 2004, J CELL BIOL, V166, P775, DOI 10.1083/jcb.200406049; Kizilyaprak C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011039; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kruithof M, 2009, NAT STRUCT MOL BIOL, V16, P534, DOI 10.1038/nsmb.1590; LANGMORE JP, 1983, J CELL BIOL, V96, P1120, DOI 10.1083/jcb.96.4.1120; Lantermann AB, 2010, NAT STRUCT MOL BIOL, V17, P251, DOI 10.1038/nsmb.1741; Lavelle C, 2010, INT J MOL SCI, V11, P1557, DOI 10.3390/ijms11041557; LEUBA SH, 1994, P NATL ACAD SCI USA, V91, P11621, DOI 10.1073/pnas.91.24.11621; Lever MA, 2000, NATURE, V408, P873, DOI 10.1038/35048603; Li G, 2005, NAT STRUCT MOL BIOL, V12, P46, DOI 10.1038/nsmb869; Li GH, 2011, CURR OPIN GENET DEV, V21, P175, DOI 10.1016/j.gde.2011.01.022; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Lu X, 2008, NAT STRUCT MOL BIOL, V15, P1122, DOI 10.1038/nsmb.1489; Lu X, 2009, BIOCHEMISTRY-US, V48, P164, DOI 10.1021/bi801636y; Luger K, 2005, CURR OPIN STRUC BIOL, V15, P188, DOI 10.1016/j.sbi.2005.03.006; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luger K, 1998, CURR OPIN GENET DEV, V8, P140, DOI 10.1016/S0959-437X(98)80134-2; McBryant SJ, 2006, CHROMOSOME RES, V14, P39, DOI 10.1007/s10577-006-1025-x; McBryant SJ, 2009, J BIOL CHEM, V284, P16716, DOI 10.1074/jbc.M109.011288; Meyer S, 2011, NUCLEIC ACIDS RES, V39, P9139, DOI 10.1093/nar/gkr573; Misteli T, 2000, NATURE, V408, P877, DOI 10.1038/35048610; Panchenko T, 2011, P NATL ACAD SCI USA, V108, P16588, DOI 10.1073/pnas.1113621108; PAULSON JR, 1983, J CELL BIOL, V96, P1132, DOI 10.1083/jcb.96.4.1132; Perez A, 2007, BIOPHYS J, V92, P3817, DOI 10.1529/biophysj.106.097782; Perisic O, 2010, J MOL BIOL, V403, P777, DOI 10.1016/j.jmb.2010.07.057; Poirier MG, 2008, J MOL BIOL, V379, P772, DOI 10.1016/j.jmb.2008.04.025; Robinson PJJ, 2008, J MOL BIOL, V381, P816, DOI 10.1016/j.jmb.2008.04.050; Robinson PJJ, 2006, CURR OPIN STRUC BIOL, V16, P336, DOI 10.1016/j.sbi.2006.05.007; Robinson PJJ, 2006, P NATL ACAD SCI USA, V103, P6506, DOI 10.1073/pnas.0601212103; Routh A, 2008, P NATL ACAD SCI USA, V105, P8872, DOI 10.1073/pnas.0802336105; Schalch T, 2005, NATURE, V436, P138, DOI 10.1038/nature03686; Schlick T, 2009, PHYS CHEM CHEM PHYS, V11, P10729, DOI 10.1039/b918629h; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; SIMPSON RT, 1985, CELL, V42, P799, DOI 10.1016/0092-8674(85)90276-4; Sinha D, 2010, J BIOL CHEM, V285, P16572, DOI 10.1074/jbc.M109.091298; Stasevich TJ, 2010, EMBO J, V29, P1225, DOI 10.1038/emboj.2010.24; Stehr R, 2008, BIOPHYS J, V95, P3677, DOI 10.1529/biophysj.107.120543; Stehr R, 2010, BIOPHYS J, V98, P1028, DOI 10.1016/j.bpj.2009.11.040; Syed SH, 2010, P NATL ACAD SCI USA, V107, P9620, DOI 10.1073/pnas.1000309107; Tachiwana H, 2011, NATURE, V476, P232, DOI 10.1038/nature10258; THOMA F, 1979, J CELL BIOL, V83, P403, DOI 10.1083/jcb.83.2.403; Tomschik M, 2005, P NATL ACAD SCI USA, V102, P3278, DOI 10.1073/pnas.0500189102; Toth K, 2001, BIOCHEMISTRY-US, V40, P6921, DOI 10.1021/bi002695m; Tremethick DJ, 2007, CELL, V128, P651, DOI 10.1016/j.cell.2007.02.008; Tse C, 1998, MOL CELL BIOL, V18, P4629, DOI 10.1128/MCB.18.8.4629; Tumbar T, 1999, J CELL BIOL, V145, P1341, DOI 10.1083/jcb.145.7.1341; van Holde K.E., 1988, CHROMATIN; van Holde K, 2007, SEMIN CELL DEV BIOL, V18, P651, DOI 10.1016/j.semcdb.2007.08.005; Wang GG, 2007, TRENDS MOL MED, V13, P363, DOI 10.1016/j.molmed.2007.07.003; Wang XD, 2007, J BIOL CHEM, V282, P32867, DOI 10.1074/jbc.M706035200; Wang YM, 2009, J CELL BIOL, V184, P205, DOI 10.1083/jcb.200806072; WIDOM J, 1986, J MOL BIOL, V190, P411, DOI 10.1016/0022-2836(86)90012-4; WIDOM J, 1992, P NATL ACAD SCI USA, V89, P1095, DOI 10.1073/pnas.89.3.1095; Wong H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000877; WOODCOCK CL, 1993, P NATL ACAD SCI USA, V90, P9021, DOI 10.1073/pnas.90.19.9021; Woodcock CL, 2001, CURR OPIN GENET DEV, V11, P130, DOI 10.1016/S0959-437X(00)00169-6; Wu B, 2008, NAT CHEM BIOL, V4, P110, DOI 10.1038/nchembio.2007.58; Wu CY, 2007, EMBO REP, V8, P1129, DOI 10.1038/sj.embor.7401115; Yang DR, 2011, PHYS CHEM CHEM PHYS, V13, P2911, DOI 10.1039/c0cp01487g; Zheng CY, 2003, BIOPOLYMERS, V68, P539, DOI 10.1002/bip.10303; Zhou JS, 2007, NAT STRUCT MOL BIOL, V14, P1070, DOI 10.1038/nsmb1323	100	75	75	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5183	5191		10.1074/jbc.R111.305763	http://dx.doi.org/10.1074/jbc.R111.305763			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22157002	Green Published, hybrid			2022-12-27	WOS:000300638000001
J	Yang, HJ; Sugiura, Y; Ikegami, K; Konishi, Y; Setou, M				Yang, Hyun-Jeong; Sugiura, Yuki; Ikegami, Koji; Konishi, Yoshiyuki; Setou, Mitsutoshi			Axonal Gradient of Arachidonic Acid-containing Phosphatidylcholine and Its Dependence on Actin Dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ION MASS-SPECTROMETRY; PHOSPHOLIPASE A(2); DOCOSAHEXAENOIC ACID; MITOCHONDRIAL-FUNCTION; ALZHEIMERS-DISEASE; MEMBRANE-LIPIDS; MYOSIN-II; CELLS; NEURONS; BRAIN	Phosphatidylcholine (PC) is the most abundant component of lipid bilayers and exists in various molecular forms, through combinations of two acylated fatty acids. Arachidonic acid (AA)-containing PC (AA-PC) can be a source of AA, which is a crucial mediator of synaptic transmission and intracellular signaling. However, the distribution of AA-PC within neurons has not been indicated. In the present study, we used imaging mass spectrometry to characterize the distribution of PC species in cultured neurons of superior cervical ganglia. Intriguingly, PC species exhibited a unique distribution that was dependent on the acyl chains at the sn-2 position. In particular, we found that AA-PC is enriched within the axon and is distributed across a proximal-to-distal gradient. Inhibitors of actin dynamics (cytochalasin D and phallacidin) disrupted this gradient. This is the first report of the gradual distribution of AA-PC along the axon and its association with actin dynamics.	[Yang, Hyun-Jeong; Sugiura, Yuki; Ikegami, Koji; Konishi, Yoshiyuki; Setou, Mitsutoshi] Hamamatsu Univ Sch Med, Dept Cell Biol & Anat, Hamamatsu, Shizuoka 4313192, Japan	Hamamatsu University School of Medicine	Setou, M (corresponding author), Hamamatsu Univ Sch Med, Dept Cell Biol & Anat, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	setou@hama-med.ac.jp		Sugiura, Yuki/0000-0002-6983-8958	Japanese Science and Technology Agency; Monbu Kagakusho; Grants-in-Aid for Scientific Research [23500443] Funding Source: KAKEN	Japanese Science and Technology Agency(Japan Science & Technology Agency (JST)); Monbu Kagakusho(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid for SENTAN (Development of Systems and Technology for Advanced Measurement and Analysis) from the Japanese Science and Technology Agency, Wakate S, and Tokutei (to M. S.). The "Lipid Machineries" research was supported by Monbu Kagakusho.	BARAK LS, 1981, J CELL BIOL, V89, P368, DOI 10.1083/jcb.89.2.368; Boland LM, 2008, CELL BIOCHEM BIOPHYS, V52, P59, DOI 10.1007/s12013-008-9027-2; Brown J, 2003, J HISTOCHEM CYTOCHEM, V51, P421, DOI 10.1177/002215540305100403; Brugger B, 1997, P NATL ACAD SCI USA, V94, P2339, DOI 10.1073/pnas.94.6.2339; Bruno MJ, 2007, P NATL ACAD SCI USA, V104, P9638, DOI 10.1073/pnas.0701015104; CLARK JD, 1991, CELL, V65, P1043, DOI 10.1016/0092-8674(91)90556-E; DAI JW, 1995, CELL, V83, P693; DIEZ E, 1990, J BIOL CHEM, V265, P14654; Farber SA, 2000, FASEB J, V14, P2198, DOI 10.1096/fj.99-0853; Ferreri C, 2004, J AM CHEM SOC, V126, P1063, DOI 10.1021/ja038072o; Hanson RM, 2010, J APPL CRYSTALLOGR, V43, P1250, DOI 10.1107/S0021889810030256; Hirokawa N, 2010, NEURON, V68, P610, DOI 10.1016/j.neuron.2010.09.039; Hishikawa D, 2008, P NATL ACAD SCI USA, V105, P2830, DOI 10.1073/pnas.0712245105; HOLTE LL, 1995, BIOPHYS J, V68, P2396, DOI 10.1016/S0006-3495(95)80422-4; Ikegami K, 2003, NEUROSCIENCE, V122, P617, DOI 10.1016/j.neuroscience.2003.08.057; Jenkins CM, 2002, J BIOL CHEM, V277, P32807, DOI 10.1074/jbc.M202568200; KOBAYASHI H, 1977, J BIOCHEM-TOKYO, V81, P1071, DOI 10.1093/oxfordjournals.jbchem.a131530; Lang T, 2000, BIOPHYS J, V78, P2863, DOI 10.1016/S0006-3495(00)76828-7; LIN TN, 1988, LIPIDS, V23, P942, DOI 10.1007/BF02536341; Merrifield CJ, 1999, NAT CELL BIOL, V1, P72, DOI 10.1038/9048; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; MOORE SA, 1991, J NEUROCHEM, V56, P518, DOI 10.1111/j.1471-4159.1991.tb08180.x; Morioka N, 2002, J NEUROCHEM, V80, P989, DOI 10.1046/j.0022-3042.2002.00722.x; MUALLEM S, 1995, J CELL BIOL, V128, P589, DOI 10.1083/jcb.128.4.589; Murakami M, 2002, J BIOCHEM, V131, P285, DOI 10.1093/oxfordjournals.jbchem.a003101; Nakanishi H, 2009, METHODS MOL BIOL, V579, P287, DOI 10.1007/978-1-60761-322-0_15; Nomura T, 2001, LIFE SCI, V68, P2885, DOI 10.1016/S0024-3205(01)01072-4; Ostrowski SG, 2004, SCIENCE, V305, P71, DOI 10.1126/science.1099791; QUIK M, 1987, J NEUROCHEM, V48, P217, DOI 10.1111/j.1471-4159.1987.tb13150.x; Rubakhin SS, 2007, NAT PROTOC, V2, P1987, DOI 10.1038/nprot.2007.277; Rubakhin SS, 2006, ANAL CHEM, V78, P7267, DOI 10.1021/ac0607010; SAMPATH P, 1991, BIOCHEMISTRY-US, V30, P1973, DOI 10.1021/bi00221a034; Sanchez-Mejia RO, 2008, NAT NEUROSCI, V11, P1311, DOI 10.1038/nn.2213; Sanchez-Mejia RO, 2010, BBA-MOL CELL BIOL L, V1801, P784, DOI 10.1016/j.bbalip.2010.05.013; SCHLIWA M, 1982, J CELL BIOL, V92, P79, DOI 10.1083/jcb.92.1.79; Shetty HU, 1996, J NEUROCHEM, V67, P1702; Shindou H, 2009, J BIOL CHEM, V284, P1, DOI 10.1074/jbc.R800046200; Sjovall P, 2003, ANAL CHEM, V75, P3429, DOI 10.1021/ac0207675; Small JV, 2005, CURR OPIN CELL BIOL, V17, P517, DOI 10.1016/j.ceb.2005.08.004; SONTAG JM, 1988, EUR J CELL BIOL, V46, P316; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Strokin M, 2003, BRIT J PHARMACOL, V139, P1014, DOI 10.1038/sj.bjp.0705326; Sugiura Y, 2009, J LIPID RES, V50, P1776, DOI 10.1194/jlr.M900047-JLR200; Sun GY, 2004, J LIPID RES, V45, P205, DOI 10.1194/jlr.R300016-JLR200; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; THERIOT JA, 1992, NATURE, V357, P257, DOI 10.1038/357257a0; VIJAYARAGHAVAN S, 1995, J NEUROSCI, V15, P3679; WILLIAMS JH, 1989, NATURE, V341, P739, DOI 10.1038/341739a0; Yang HJ, 2010, SURF INTERFACE ANAL, V42, P1606, DOI 10.1002/sia.3581	49	30	30	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5290	5300		10.1074/jbc.M111.316877	http://dx.doi.org/10.1074/jbc.M111.316877			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22207757	hybrid, Green Published			2022-12-27	WOS:000300638000011
J	Lambert, E; Coissieux, MM; Laudet, V; Mehlen, P				Lambert, Elise; Coissieux, Marie-May; Laudet, Vincent; Mehlen, Patrick			Netrin-4 Acts as a Pro-angiogenic Factor during Zebrafish Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; OKADAIC ACID; VASCULAR DEVELOPMENT; NETWORK FORMATION; GUIDANCE; UNC5B; RECRUITMENT; INHIBITION; MECHANISMS; EXPRESSION	Netrins form a heterogeneous family of laminin-related molecules with multifunctional activities. Netrin-4, the most distant member of this family, is related to the laminin beta chain and has recently been proposed to play an important role in embryonic and pathological angiogenesis. However, the data reported so far lead to the apparently contradictory conclusions supporting Netrin-4 as either a pro- or an anti-angiogenic factor. To elucidate this controversy, Netrin-4 was analyzed for a vascular activity in both cell-based models (human umbilical vein endothelial cells and human umbilical artery endothelial cells) and two zebrafish models: the wild-type AB/Tu strain and the transgenic Tg(fli1a:EGFP)(y1) strain. We show that Netrin-4 is expressed in endothelial cells and in the zebrafish vascular system. We also show evidence that Netrin-4 activates various kinases and induces various biological effects directly linked to angiogenesis in vitro. Using a morpholinos strategy, we demonstrate that Netrin-4 expression is crucial for zebrafish vessel formation and that a blood vessel formation defect induced by netrin-4 morpholinos can be partially rescued through drug delivery leading to protein kinase activation. Together these data underscore the crucial role of Netrin-4 in blood vessel formation and the involvement of protein kinases activation in Netrin-4-induced biological effects related to vascular development.	[Lambert, Elise; Coissieux, Marie-May; Mehlen, Patrick] Univ Lyon, Ctr Leon Berard, Apoptosis Canc & Dev Lab,Equipe Labellisee La Lig, LabEx DEVweCAN,Ctr Cancerol Lyon,INSERM U1052,CNR, F-69008 Lyon, France; [Lambert, Elise; Laudet, Vincent] Univ Lyon, Ecole Normale Super Lyon, Inst Genom Fonct Lyon, CNRS UMR5242,BioSci Gerland Lyon Sud UMS3444, F-69364 Lyon 07, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON)	Mehlen, P (corresponding author), Univ Lyon, Ctr Leon Berard, Apoptosis Canc & Dev Lab,Equipe Labellisee La Lig, LabEx DEVweCAN,Ctr Cancerol Lyon,INSERM U1052,CNR, 28 Rue Laennec, F-69008 Lyon, France.	patrick.mehlen@lyon.unicancer.fr		Coissieux, Marie-May/0000-0001-5017-5253; LAMBERT, Elise/0000-0003-1192-0112	Ligue Contre le Cancer; Agence Nationale de la Recherche; Institut National du Cancer	Ligue Contre le Cancer(Ligue nationale contre le cancer); Agence Nationale de la Recherche(French National Research Agency (ANR)); Institut National du Cancer(Institut National du Cancer (INCA) France)	This work was supported by the Ligue Contre le Cancer, the Agence Nationale de la Recherche, and the Institut National du Cancer (to P. M.).	Atkinson T, 2009, BIOCHEM BIOPH RES CO, V378, P394, DOI 10.1016/j.bbrc.2008.11.036; Barallobre MJ, 2005, BRAIN RES REV, V49, P22, DOI 10.1016/j.brainresrev.2004.11.003; Carmeliet P, 2005, NATURE, V436, P193, DOI 10.1038/nature03875; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Castets M, 2010, CELL CYCLE, V9, P1466, DOI 10.4161/cc.9.8.11197; Castets M, 2009, DEV CELL, V16, P614, DOI 10.1016/j.devcel.2009.02.006; Cirulli V, 2007, NAT REV MOL CELL BIO, V8, P296, DOI 10.1038/nrm2142; Covassin LD, 2006, P NATL ACAD SCI USA, V103, P6554, DOI 10.1073/pnas.0506886103; Draper BW, 2001, GENESIS, V30, P154, DOI 10.1002/gene.1053; Ekker SC, 2000, YEAST, V17, P302, DOI 10.1002/1097-0061(200012)17:4<302::AID-YEA53>3.0.CO;2-#; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; FUJIKI H, 1993, ADV CANCER RES, V61, P143, DOI 10.1016/S0065-230X(08)60958-6; Hoang S, 2009, J CEREBR BLOOD F MET, V29, P385, DOI 10.1038/jcbfm.2008.128; Isogai S, 2003, DEVELOPMENT, V130, P5281, DOI 10.1242/dev.00733; Ivy SP, 2009, NAT REV CLIN ONCOL, V6, P569, DOI 10.1038/nrclinonc.2009.130; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Koch M, 2000, J CELL BIOL, V151, P221, DOI 10.1083/jcb.151.2.221; Larrieu-Lahargue F, 2011, CIRC RES, V109, P770, DOI 10.1161/CIRCRESAHA.111.247239; Larrieu-Lahargue F, 2010, BLOOD, V115, P5418, DOI 10.1182/blood-2009-11-252338; Larrivee B, 2009, CIRC RES, V104, P428, DOI 10.1161/CIRCRESAHA.108.188144; Lawson ND, 2002, NAT REV GENET, V3, P674, DOI 10.1038/nrg888; Lejmi E, 2008, P NATL ACAD SCI USA, V105, P12491, DOI 10.1073/pnas.0804008105; Lu XW, 2004, NATURE, V432, P179, DOI 10.1038/nature03080; Martyn U, 2004, DEV DYNAM, V231, P33, DOI 10.1002/dvdy.20048; Milman G, 2006, P NATL ACAD SCI USA, V103, P2428, DOI 10.1073/pnas.0510676103; Nacht M, 2009, EXP CELL RES, V315, P784, DOI 10.1016/j.yexcr.2008.11.018; Navankasattusas S, 2008, DEVELOPMENT, V135, P659, DOI 10.1242/dev.013623; Nguyen A, 2006, P NATL ACAD SCI USA, V103, P6530, DOI 10.1073/pnas.0511011103; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Provis JM, 1997, EXP EYE RES, V65, P555, DOI 10.1006/exer.1997.0365; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Salameh A, 2005, BLOOD, V106, P3423, DOI 10.1182/blood-2005-04-1388; Suchting S, 2006, EXP CELL RES, V312, P668, DOI 10.1016/j.yexcr.2005.11.009; Sugiyama N, 2007, BIOCHEMISTRY-US, V46, P11410, DOI 10.1021/bi700490n; Tammela T, 2008, NATURE, V454, P656, DOI 10.1038/nature07083; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Wilson BD, 2006, SCIENCE, V313, P640, DOI 10.1126/science.1124704; Yang Y, 2007, CANCER BIOL THER, V6, P743, DOI 10.4161/cbt.6.5.3976; Yebra M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022750; Zachary I, 2005, NEUROSIGNALS, V14, P207, DOI 10.1159/000088637; Zhang X, 2010, BRIT J PHARMACOL, V160, P1583, DOI 10.1111/j.1476-5381.2010.00841.x	41	29	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					3987	3999		10.1074/jbc.M111.289371	http://dx.doi.org/10.1074/jbc.M111.289371			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22179604	hybrid, Green Published			2022-12-27	WOS:000300410900033
J	Singh, P; Doshi, S; Spaethling, JM; Hockenberry, AJ; Patel, TP; Geddes-Klein, DM; Lynch, DR; Meaney, DF				Singh, Pallab; Doshi, Shachee; Spaethling, Jennifer M.; Hockenberry, Adam J.; Patel, Tapan P.; Geddes-Klein, Donna M.; Lynch, David R.; Meaney, David F.			N-Methyl-D-aspartate Receptor Mechanosensitivity Is Governed by C Terminus of NR2B Subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRAUMATIC BRAIN-INJURY; NR2B-CONTAINING NMDA RECEPTORS; EXCITATORY AMINO-ACIDS; IN-VITRO; DIFFERENTIAL ROLES; SIGNALING PATHWAYS; DISTINCT ROLES; NEURONAL DEATH; NR1 SUBUNIT; CELL-DEATH	N-Methyl-D-aspartate receptors (NMDARs), critical mediators of both physiologic and pathologic neurological signaling, have previously been shown to be sensitive to mechanical stretch through the loss of its native Mg2+ block. However, the regulation of this mechanosensitivity has yet to be further explored. Furthermore, as it has become apparent that NMDAR-mediated signaling is dependent on specific NMDAR subtypes, as governed by the identity of the NR2 subunit, a crucial unanswered question is the role of subunit composition in observed NMDAR mechanosensitivity. Here, we used a recombinant system to assess the mechanosensitivity of specific subtypes and demonstrate that the mechanosensitive property is uniquely governed by the NR2B subunit. NR1/NR2B NMDARs displayed significant stretch sensitivity, whereas NR1/NR2A NMDARs did not respond to stretch. Furthermore, NR2B mechanosensitivity was regulated by PKC activity, because PKC inhibition reduced stretch responses in transfected HEK 293 cells and primary cortical neurons. Finally, using NR2B point mutations, we identified a PKC phosphorylation site, Ser-1323 on NR2B, as a unique critical regulator of stretch sensitivity. These data suggest that the selective mechanosensitivity of NR2B can significantly impact neuronal response to traumatic brain injury and illustrate that the mechanical tone of the neuron can be dynamically regulated by PKC activity.	[Doshi, Shachee; Lynch, David R.] Childrens Hosp Philadelphia, Div Neurol, Philadelphia, PA 19194 USA; [Lynch, David R.] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA; [Singh, Pallab; Spaethling, Jennifer M.; Hockenberry, Adam J.; Patel, Tapan P.; Geddes-Klein, Donna M.; Meaney, David F.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania	Meaney, DF (corresponding author), 240 Skirkanich Hall,210 S 33rd St, Philadelphia, PA 19104 USA.	dmeaney@seas.upenn.edu		Meaney, David/0000-0002-0954-4122; Hockenberry, Adam/0000-0001-9476-0104; Patel, Tapan/0000-0001-8959-6645	National Institutes of Health [HD41699, NS35712, NS015212]; U.S. Department of Defense [W911NF-10-1-0526]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD041699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS015212, R01NS035712] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Defense(United States Department of Defense); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants HD41699, NS35712, and NS015212. This work was also supported by a U.S. Department of Defense Grant W911NF-10-1-0526.	Al-Hallaq RA, 2007, J NEUROSCI, V27, P8334, DOI 10.1523/JNEUROSCI.2155-07.2007; Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; BOECKMAN FA, 1994, NEUROSCI LETT, V173, P189, DOI 10.1016/0304-3940(94)90180-5; Boeckman FA, 1996, J PHARMACOL EXP THER, V279, P515; Bullock R, 1995, ANN NY ACAD SCI, V765, P290, DOI 10.1111/j.1749-6632.1995.tb16586.x; Casado M, 1998, J PHYSIOL-LONDON, V513, P317, DOI 10.1111/j.1469-7793.1998.317bb.x; Chen BS, 2007, NEUROPHARMACOLOGY, V53, P362, DOI 10.1016/j.neuropharm.2007.05.018; CHEN L, 1992, NATURE, V356, P521, DOI 10.1038/356521a0; Chen M, 2008, STROKE, V39, P3042, DOI 10.1161/STROKEAHA.108.521898; Cull-Candy Stuart G, 2004, Sci STKE, V2004, pre16, DOI 10.1126/stke.2552004re16; Dempsey RJ, 2000, NEUROSURGERY, V47, P399, DOI 10.1097/00006123-200008000-00024; DeRidder MN, 2006, NEUROBIOL DIS, V22, P165, DOI 10.1016/j.nbd.2005.10.011; Dingledine R, 1999, PHARMACOL REV, V51, P7; Ehlers MD, 1998, J NEUROSCI, V18, P720; Erreger K, 2005, J PHYSIOL-LONDON, V563, P345, DOI 10.1113/jphysiol.2004.080028; Ewald RC, 2008, J NEUROSCI, V28, P850, DOI 10.1523/JNEUROSCI.5078-07.2008; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Foster KA, 2010, J NEUROSCI, V30, P2676, DOI 10.1523/JNEUROSCI.4022-09.2010; Gallagher MJ, 1996, J BIOL CHEM, V271, P9603, DOI 10.1074/jbc.271.16.9603; Geddes-Klein DM, 2006, J NEUROCHEM, V97, P462, DOI 10.1111/j.1471-4159.2006.03761.x; Gogas KR, 2006, CURR OPIN PHARMACOL, V6, P68, DOI 10.1016/j.coph.2005.11.001; Grant ER, 1998, J NEUROCHEM, V71, P1471; Guttmann RP, 2001, J NEUROCHEM, V78, P1083, DOI 10.1046/j.1471-4159.2001.00493.x; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Hatton CJ, 2005, NEURON, V46, P261, DOI 10.1016/j.neuron.2005.03.005; Hetman M, 2006, CURR TOP MED CHEM, V6, P787, DOI 10.2174/156802606777057553; Ikonomidou C, 1999, SCIENCE, V283, P70, DOI 10.1126/science.283.5398.70; Ikonomidou C, 2000, P NATL ACAD SCI USA, V97, P12885, DOI 10.1073/pnas.220412197; Jin SX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011732; Jones ML, 2005, J NEUROCHEM, V92, P1431, DOI 10.1111/j.1471-4159.2004.02985.x; Kashiwagi K, 2002, MOL PHARMACOL, V61, P533, DOI 10.1124/mol.61.3.533; Kendrick SJ, 1996, J NEUROCHEM, V67, P608; Kim MJ, 2005, NEURON, V46, P745, DOI 10.1016/j.neuron.2005.04.031; Kinney JW, 2006, J NEUROSCI, V26, P1604, DOI 10.1523/JNEUROSCI.4722-05.2006; Kohr G, 2003, J NEUROSCI, V23, P10791; Krapivinsky G, 2003, NEURON, V40, P775, DOI 10.1016/S0896-6273(03)00645-7; Li SM, 2006, J NEUROSCI, V26, P1721, DOI 10.1523/JNEUROSCI.3990-05.2006; Liao GY, 2001, MOL PHARMACOL, V59, P960, DOI 10.1124/mol.59.5.960; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; Liu XB, 2004, J NEUROSCI, V24, P8885, DOI 10.1523/JNEUROSCI.2476-04.2004; Liu YT, 2007, J NEUROSCI, V27, P2846, DOI 10.1523/JNEUROSCI.0116-07.2007; Lusardi TA, 2004, ANN BIOMED ENG, V32, P1546, DOI 10.1114/B:ABME.0000049038.75368.75; Lynch DR, 2001, CURR DRUG TARGETS, V2, P215, DOI 10.2174/1389450013348434; Lynch DR, 2002, J PHARMACOL EXP THER, V300, P717, DOI 10.1124/jpet.300.3.717; Massey PV, 2004, J NEUROSCI, V24, P7821, DOI 10.1523/JNEUROSCI.1697-04.2004; Matsuda S, 1999, NEUROSCI RES, V34, P157, DOI 10.1016/S0168-0102(99)00046-2; MCINTOSH TK, 1990, J NEUROCHEM, V55, P1170, DOI 10.1111/j.1471-4159.1990.tb03122.x; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; Nelson TJ, 2008, EUR J PHARMACOL, V585, P76, DOI 10.1016/j.ejphar.2008.01.051; Neyton J, 2006, J NEUROSCI, V26, P1331, DOI 10.1523/JNEUROSCI.5242-05.2006; NILSSON P, 1994, BRAIN RES, V637, P227, DOI 10.1016/0006-8993(94)91237-8; Okiyama K, 1997, J NEUROTRAUM, V14, P211, DOI 10.1089/neu.1997.14.211; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; PAOLETTI P, 1994, NEURON, V13, P645, DOI 10.1016/0896-6273(94)90032-9; Rao VLR, 2001, BRAIN RES, V911, P96; Rauner C, 2011, J BIOL CHEM, V286, P7558, DOI 10.1074/jbc.M110.182600; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; Santucci DM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000208; Sattler R, 1999, SCIENCE, V284, P1845, DOI 10.1126/science.284.5421.1845; SHAPIRA Y, 1990, Journal of Neurotrauma, V7, P131, DOI 10.1089/neu.1990.7.131; Singh P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002106; SMITH DH, 1993, NEUROSCI LETT, V157, P211, DOI 10.1016/0304-3940(93)90739-8; Spaethling JM, 2007, PROG BRAIN RES, V161, P27, DOI 10.1016/S0079-6123(06)61003-0; Tovar KR, 1999, J NEUROSCI, V19, P4180; von Engelhardt J, 2007, NEUROPHARMACOLOGY, V53, P10, DOI 10.1016/j.neuropharm.2007.04.015; Waxman EA, 2005, NEUROSCIENTIST, V11, P37, DOI 10.1177/1073858404269012; Wechsler A, 1998, EMBO J, V17, P3931, DOI 10.1093/emboj/17.14.3931; WILLIAMS K, 1993, NEURON, V10, P267, DOI 10.1016/0896-6273(93)90317-K; Wu HY, 2007, J BIOL CHEM, V282, P20075, DOI 10.1074/jbc.M700624200; Wyszynski M, 1997, NATURE, V385, P439, DOI 10.1038/385439a0; Zhang L, 1996, SCIENCE, V274, P1921, DOI 10.1126/science.274.5294.1921; Zhou M, 2006, J NEUROSCI, V26, P2956, DOI 10.1523/JNEUROSCI.4299-05.2006; Zohar O, 2011, NEUROBIOL DIS, V41, P329, DOI 10.1016/j.nbd.2010.10.001	75	46	46	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					4348	4359		10.1074/jbc.M111.253740	http://dx.doi.org/10.1074/jbc.M111.253740			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22179603	Green Published, hybrid			2022-12-27	WOS:000300410900065
J	Goda, K; Ito, H; Kondo, T; Oyama, T				Goda, Kazuhito; Ito, Hiroshi; Kondo, Takao; Oyama, Tokitaka			Fluorescence Correlation Spectroscopy to Monitor Kai Protein-based Circadian Oscillations in Real Time	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONNATURAL AMINO-ACIDS; IN-VITRO; PHOSPHORYLATION RHYTHM; CYANOBACTERIA; CLOCK; ENTRAINMENT; PROTEOMICS; COMPLEXES; DYNAMICS; POSITION	Dynamic protein-protein interactions play an essential role in cellular regulatory systems. The cyanobacterial circadian clock is an oscillatory system that can be reconstituted in vitro by mixing ATP and three clock proteins: KaiA, KaiB, and KaiC. Association and dissociation of KaiB from KaiC-containing complexes are critical to circadian phosphorylation and dephosphorylation of KaiC. We developed an automated and noninvasive method to monitor dynamic complex formation in real time using confocal fluorescence correlation spectroscopy (FCS) and uniformly labeled KaiB as a probe. A nanomolar concentration of the labeled KaiB for FCS measurement did not interfere with the oscillatory system but behaved similarly to the wild-type one during the measurement period (>5 days). The fluorescent probe was stable against repeated laser exposure. As an application, we show that this detection system allowed analysis of the dynamics of both long term circadian oscillations and short term responses to temperature changes (similar to 10 min) in the same sample. This suggested that a phase shift of the clock with a high temperature pulse occurred just after the stimulus through dissociation of KaiB from the KaiC complex. This monitoring method should improve our understanding of the mechanisms underlying this cellular circadian oscillator and provide a means to assess dynamic protein interactions in biological systems characterized by rates similar to those observed with the Kai proteins.	[Goda, Kazuhito] Olympus Corp, Med Technol Res & Dev Div, Adv Anal Technol Res & Dev Dept, Tokyo 1920904, Japan; [Ito, Hiroshi; Kondo, Takao; Oyama, Tokitaka] Nagarjuna Univ, Div Biol Sci, Grad Sch Sci, Nagoya, Aichi 4648602, Japan; [Kondo, Takao; Oyama, Tokitaka] Japan Sci & Technol Corp, Nagoya, Aichi 4648602, Japan	Olympus Corporation; Japan Science & Technology Agency (JST)	Oyama, T (corresponding author), Kyoto Univ, Dept Bot, Grad Sch Sci, Sakyo Ku, Kitashirakawa Oiwake Cho, Kyoto 6068502, Japan.	oyama@cosmos.bot.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [15GS0308]; Japan Society for the Promotion of Science [17370088, 21010517]; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by Grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Grant 15GS0308 to T. K. and T. O.), the Japan Society for the Promotion of Science (Grant 17370088 to T. O. and Grant 21010517 to H. I.), and Takeda Science Foundation (to T. O.).	Abe R, 2010, J BIOSCI BIOENG, V110, P32, DOI 10.1016/j.jbiosc.2010.01.003; Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Akiyama S, 2008, MOL CELL, V29, P703, DOI 10.1016/j.molcel.2008.01.015; Burckstummer T, 2006, NAT METHODS, V3, P1013, DOI 10.1038/nmeth968; Hohsaka T, 2002, CURR OPIN CHEM BIOL, V6, P809, DOI 10.1016/S1367-5931(02)00376-9; Hori K., 2003, Current Pharmaceutical Biotechnology, V4, P477, DOI 10.2174/1389201033377391; Ishiura M, 1998, SCIENCE, V281, P1519, DOI 10.1126/science.281.5382.1519; Ito H, 2007, NAT STRUCT MOL BIOL, V14, P1084, DOI 10.1038/nsmb1312; Iwasaki H, 2002, P NATL ACAD SCI USA, V99, P15788, DOI 10.1073/pnas.222467299; Johnson C. H., 2004, BIOL TIMEKEEPING, P67; Kageyama H, 2003, J BIOL CHEM, V278, P2388, DOI 10.1074/jbc.M208899200; Kageyama H, 2006, MOL CELL, V23, P161, DOI 10.1016/j.molcel.2006.05.039; Kitayama Y, 2003, EMBO J, V22, P2127, DOI 10.1093/emboj/cdg212; KONDO T, 1994, SCIENCE, V266, P1233, DOI 10.1126/science.7973706; Krichevsky O, 2002, REP PROG PHYS, V65, P251, DOI 10.1088/0034-4885/65/2/203; Meseth U, 1999, BIOPHYS J, V76, P1619, DOI 10.1016/S0006-3495(99)77321-2; Mori T, 2007, PLOS BIOL, V5, P841, DOI 10.1371/journal.pbio.0050093; Murayama Y, 2011, EMBO J, V30, P68, DOI 10.1038/emboj.2010.298; Nakajima M, 2005, SCIENCE, V308, P414, DOI 10.1126/science.1108451; Nakata H, 2009, ANAL BIOCHEM, V390, P121, DOI 10.1016/j.ab.2009.03.049; Nishiwaki T, 2007, EMBO J, V26, P4029, DOI 10.1038/sj.emboj.7601832; Parrish JR, 2006, CURR OPIN BIOTECH, V17, P387, DOI 10.1016/j.copbio.2006.06.006; Piehler J, 2005, CURR OPIN STRUC BIOL, V15, P4, DOI 10.1016/j.sbi.2005.01.008; Rensing L, 2002, CHRONOBIOL INT, V19, P807, DOI 10.1081/CBI-120014569; Schmid JA, 2005, CHEMBIOCHEM, V6, P1149, DOI 10.1002/cbic.200500029; Stoevesandt O, 2005, NAT METHODS, V2, P833, DOI 10.1038/NMETH802; Terauchi K, 2007, P NATL ACAD SCI USA, V104, P16377, DOI 10.1073/pnas.0706292104; Yan YL, 2003, CURR OPIN CHEM BIOL, V7, P635, DOI 10.1016/j.cbpa.2003.08.017; Yoshida T, 2009, P NATL ACAD SCI USA, V106, P1648, DOI 10.1073/pnas.0806741106	29	9	9	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3241	3248		10.1074/jbc.M111.265777	http://dx.doi.org/10.1074/jbc.M111.265777			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22157012	Green Published, hybrid			2022-12-27	WOS:000300295100029
J	Zielonka, J; Zielonka, M; Sikora, A; Adamus, J; Joseph, J; Hardy, M; Ouari, O; Dranka, BP; Kalyanaraman, B				Zielonka, Jacek; Zielonka, Monika; Sikora, Adam; Adamus, Jan; Joseph, Joy; Hardy, Micael; Ouari, Olivier; Dranka, Brian P.; Kalyanaraman, Balaraman			Global Profiling of Reactive Oxygen and Nitrogen Species in Biological Systems HIGH-THROUGHPUT REAL-TIME ANALYSES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-PEROXIDE; NITRIC-OXIDE; INTRACELLULAR SUPEROXIDE; MEDIATED OXIDATION; CYTOCHROME-C; HYDROETHIDINE; PEROXYNITRITE; FLUORESCENCE; PRODUCT; HPLC	Herein we describe a high-throughput fluorescence and HPLC-based methodology for global profiling of reactive oxygen and nitrogen species (ROS/RNS) in biological systems. The combined use of HPLC and fluorescence detection is key to successful implementation and validation of this methodology. Included here are methods to specifically detect and quantitate the products formed from interaction between the ROS/RNS species and the fluorogenic probes, as follows: superoxide using hydroethidine, peroxynitrite using boronate-based probes, nitric oxide-derived nitrosating species with 4,5-diaminofluorescein, and hydrogen peroxide and other oxidants using 10-acetyl-3,7-dihydroxyphenoxazine (Amplex (R) Red) with and without horseradish peroxidase, respectively. In this study, we demonstrate real-time monitoring of ROS/RNS in activated macrophages using high-throughput fluorescence and HPLC methods. This global profiling approach, simultaneous detection of multiple ROS/RNS products of fluorescent probes, developed in this study will be useful in unraveling the complex role of ROS/RNS in redox regulation, cell signaling, and cellular oxidative processes and in high-throughput screening of anti-inflammatory antioxidants.	[Dranka, Brian P.; Kalyanaraman, Balaraman] Med Coll Wisconsin, Dept Biophys, Milwaukee, WI 53226 USA; [Dranka, Brian P.; Kalyanaraman, Balaraman] Med Coll Wisconsin, Free Rad Res Ctr, Milwaukee, WI 53226 USA; [Sikora, Adam; Adamus, Jan] Tech Univ Lodz, Inst Appl Radiat Chem, PL-90924 Lodz, Poland; [Hardy, Micael; Ouari, Olivier] Univ Aix Marseille, Lab Chim Prov, UMR 6264, F-13397 Marseille 20, France; [Hardy, Micael; Ouari, Olivier] CNRS, F-13397 Marseille 20, France	Medical College of Wisconsin; Medical College of Wisconsin; Lodz University of Technology; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS)	Kalyanaraman, B (corresponding author), Med Coll Wisconsin, Dept Biophys, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	balarama@mcw.edu	Hardy, micael/ABF-3357-2020; Zielonka, Jacek/N-9546-2014; Sikora, Adam B/I-2756-2014; Dranka, Brian/B-8701-2016	Hardy, micael/0000-0003-2976-7785; Zielonka, Jacek/0000-0002-2524-0145; Sikora, Adam B/0000-0002-4962-8945; Dranka, Brian/0000-0002-1377-377X; Ouari, Olivier/0000-0003-4320-4313	National Institutes of Health [R01 HL063119]; Foundation for Polish Science (FNP) within European Union; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063119] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation for Polish Science (FNP) within European Union; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL063119 (to B. K.).; Supported by a grant from the Foundation for Polish Science (FNP) within the "Homing Plus" program supported by the European Union within the European Regional Development Fund, through the Innovative Economy Program.	Bonini MG, 2006, FREE RADICAL BIO MED, V40, P968, DOI 10.1016/j.freeradbiomed.2005.10.042; Buettner GR, 1996, RADIAT RES, V145, P532, DOI 10.2307/3579271; Burkitt MJ, 2001, BIOCHEM BIOPH RES CO, V282, P329, DOI 10.1006/bbrc.2001.4578; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Dikalov S, 2007, HYPERTENSION, V49, P717, DOI 10.1161/01.HYP.0000258594.87211.6b; Folkes LK, 2009, ARCH BIOCHEM BIOPHYS, V484, P122, DOI 10.1016/j.abb.2008.10.014; Fruehauf JP, 2007, CLIN CANCER RES, V13, P789, DOI 10.1158/1078-0432.CCR-06-2082; Groeger AL, 2010, MOL INTERV, V10, P39, DOI 10.1124/mi.10.1.7; Gutscher M, 2008, NAT METHODS, V5, P553, DOI 10.1038/NMETH.1212; HOGG N, 1994, ARCH BIOCHEM BIOPHYS, V314, P153, DOI 10.1006/abbi.1994.1423; Maghzal GJ, 2007, FREE RADICAL BIO MED, V43, P1095, DOI 10.1016/j.freeradbiomed.2007.06.023; Miller EW, 2005, J AM CHEM SOC, V127, P16652, DOI 10.1021/ja054474f; Mishin V, 2010, FREE RADICAL BIO MED, V48, P1485, DOI 10.1016/j.freeradbiomed.2010.02.030; Murphy MP, 2011, CELL METAB, V13, P361, DOI 10.1016/j.cmet.2011.03.010; Quijano C, 1997, BIOCHEM J, V322, P167, DOI 10.1042/bj3220167; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Ridnour LA, 2004, BIOL CHEM, V385, P1, DOI 10.1515/BC.2004.001; Robinson KM, 2008, NAT PROTOC, V3, P941, DOI 10.1038/nprot.2008.56; Sikora A, 2011, CHEM RES TOXICOL, V24, P687, DOI 10.1021/tx100439a; Sikora A, 2009, FREE RADICAL BIO MED, V47, P1401, DOI 10.1016/j.freeradbiomed.2009.08.006; Thomas S, 2007, FREE RADICAL BIO MED, V42, P1049, DOI 10.1016/j.freeradbiomed.2007.01.005; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85; Zhang HW, 1997, ARCH BIOCHEM BIOPHYS, V339, P183, DOI 10.1006/abbi.1996.9863; Zhao HT, 2003, FREE RADICAL BIO MED, V34, P1359, DOI 10.1016/S0891-5849(03)00142-4; Zhao HT, 2005, P NATL ACAD SCI USA, V102, P5727, DOI 10.1073/pnas.0501719102; Zielonka J, 2008, FREE RADICAL BIO MED, V44, P835, DOI 10.1016/j.freeradbiomed.2007.11.013; Zielonka J, 2008, NAT PROTOC, V3, P8, DOI 10.1038/nprot.2007.473; Zielonka J, 2006, ARCH BIOCHEM BIOPHYS, V456, P39, DOI 10.1016/j.abb.2006.09.031; Zielonka J, 2006, FREE RADICAL BIO MED, V41, P1050, DOI 10.1016/j.freeradbiomed.2006.04.017; Zielonka J, 2010, J BIOL CHEM, V285, P14210, DOI 10.1074/jbc.M110.110080; Zielonka J, 2010, FREE RADICAL BIO MED, V48, P983, DOI 10.1016/j.freeradbiomed.2010.01.028; Zielonka J, 2009, FREE RADICAL BIO MED, V46, P329, DOI 10.1016/j.freeradbiomed.2008.10.031	33	127	135	3	48	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					2984	2995		10.1074/jbc.M111.309062	http://dx.doi.org/10.1074/jbc.M111.309062			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22139901	hybrid, Green Published			2022-12-27	WOS:000300295100006
J	Uyama, T; Ichi, I; Kono, N; Inoue, A; Tsuboi, K; Jin, XH; Araki, N; Aoki, J; Arai, H; Ueda, N				Uyama, Toru; Ichi, Ikuyo; Kono, Nozomu; Inoue, Asuka; Tsuboi, Kazuhito; Jin, Xing-Hua; Araki, Nobukazu; Aoki, Junken; Arai, Hiroyuki; Ueda, Natsuo			Regulation of Peroxisomal Lipid Metabolism by Catalytic Activity of Tumor Suppressor H-rev107	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL-CHARACTERIZATION; PLASMALOGEN BIOSYNTHESIS; BIOGENESIS DISORDERS; MASS-SPECTROMETRY; GENE; CLONING; IDENTIFICATION; BIOCHEMISTRY; SYNTHASE; MUTANT	H-rev107 is a mammalian protein belonging to the HRAS-like suppressor family. Although the protein was originally found as a tumor suppressor, currently it is receiving considerable attention as a regulator of adipocyte lipolysis. We recently revealed that purified recombinant H-rev107 has phospholipase A(1/2) activity, releasing free fatty acids from glycerophospholipids with a preference for esterolysis at the sn-1 position. In the present study, we constitutively expressed H-rev107 in cloned HEK293 cells to examine its biological function in living cells. Initially, the cells accumulated free fatty acids. We also found a remarkable decrease in the levels of ether-type lipids, including plasmalogen and ether-type triglyceride, with a concomitant increase in fatty alcohols, substrates for the biosynthesis of ether-type lipids. Considering that peroxisomes are involved in the ether-type lipid biosynthesis, we next focused on peroxisomes and found that the peroxisomal markers 70-kDa peroxisomal membrane protein and catalase were abnormally distributed in the transfected cells. These biochemical and morphological abnormalities were not seen in HEK293 cells stably expressing a catalytically inactive mutant of H-rev107. When H-rev107 or its fusion protein with enhanced green fluorescence protein was transiently expressed in mammalian cells, both proteins were associated with peroxisomes in some of the observed cells. These results suggest that H-rev107 interferes with the biosynthesis of ether-type lipids and is responsible for the dysfunction of peroxisomes in H-rev107-expressing cells.	[Uyama, Toru; Tsuboi, Kazuhito; Jin, Xing-Hua; Ueda, Natsuo] Kagawa Univ, Sch Med, Dept Biochem, Miki, Kagawa 7610793, Japan; [Araki, Nobukazu] Kagawa Univ, Sch Med, Dept Histol & Cell Biol, Miki, Kagawa 7610793, Japan; [Ichi, Ikuyo; Kono, Nozomu; Arai, Hiroyuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo 1130033, Japan; [Kono, Nozomu; Arai, Hiroyuki] Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan; [Inoue, Asuka; Aoki, Junken] Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi 9808578, Japan	Kagawa University; Kagawa University; University of Tokyo; Japan Science & Technology Agency (JST); Tohoku University	Ueda, N (corresponding author), Kagawa Univ, Sch Med, Dept Biochem, 1750-1 Ikenobe, Miki, Kagawa 7610793, Japan.	nueda@med.kagawa-u.ac.jp	KONO, nozomu/AAM-3178-2020; Jin, Xinghua/K-1142-2015	Jin, Xinghua/0000-0002-8883-5234; Aoki, Junken/0000-0001-9435-1896; Araki, Nobukazu/0000-0001-6160-210X	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science; Kagawa University Faculty of Medicine; Kagawa University; Ichiro Kanehara Foundation; Sumitomo Foundation; Uehara Memorial Foundation; Core Research for Evolutional Science and Technology (CREST); Grants-in-Aid for Scientific Research [23227004, 23617004] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Kagawa University Faculty of Medicine; Kagawa University; Ichiro Kanehara Foundation; Sumitomo Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Core Research for Evolutional Science and Technology (CREST)(Core Research for Evolutional Science and Technology (CREST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to T. U.) and the Japan Society for the Promotion of Science (to N. U.). This work was also supported by grants from the Kagawa University Faculty of Medicine Specially Promoted Research Fund 2010 (to T. U.), the Fund for Kagawa University Young Scientists 2011 (to T. U.), the Ichiro Kanehara Foundation (to T. U.), the Sumitomo Foundation (to T. U.), the Uehara Memorial Foundation (to T. U.), and Core Research for Evolutional Science and Technology (CREST) (to N. K. and H. A.).	Araki N, 2003, J CELL SCI, V116, P247, DOI 10.1242/jcs.00235; Bartz R, 2007, J LIPID RES, V48, P837, DOI 10.1194/jlr.M600413-JLR200; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Duncan RE, 2008, J BIOL CHEM, V283, P25428, DOI 10.1074/jbc.M804146200; Fujiki Y, 2006, BBA-MOL CELL RES, V1763, P1374, DOI 10.1016/j.bbamcr.2006.09.012; Girzalsky W, 2010, BBA-MOL CELL RES, V1803, P724, DOI 10.1016/j.bbamcr.2010.01.002; HAJNAL A, 1994, ONCOGENE, V9, P479; Honsho M, 2008, BBA-MOL CELL RES, V1783, P1857, DOI 10.1016/j.bbamcr.2008.05.018; Honsho M, 2010, J BIOL CHEM, V285, P8537, DOI 10.1074/jbc.M109.083311; Hsu FF, 2003, J MASS SPECTROM, V38, P752, DOI 10.1002/jms.491; Hummasti S, 2008, J LIPID RES, V49, P2535, DOI 10.1194/jlr.M800269-JLR200; Islinger M, 2010, BBA-MOL CELL RES, V1803, P881, DOI 10.1016/j.bbamcr.2010.03.013; Jaworski K, 2009, NAT MED, V15, P159, DOI 10.1038/nm.1904; Jin XH, 2007, J BIOL CHEM, V282, P3614, DOI 10.1074/jbc.M606369200; Jin XH, 2009, BBA-MOL CELL BIOL L, V1791, P32, DOI 10.1016/j.bbalip.2008.09.006; Kanzawa N, 2009, P NATL ACAD SCI USA, V106, P17711, DOI 10.1073/pnas.0904762106; KERWIN JL, 1994, J LIPID RES, V35, P1102; Lee HC, 2008, MOL BIOL CELL, V19, P1174, DOI 10.1091/mbc.E07-09-0893; Lotz K, 2005, INT J CANCER, V116, P894, DOI 10.1002/ijc.21127; Medina-Gomez G, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030064; Nagan N, 1997, P NATL ACAD SCI USA, V94, P4475, DOI 10.1073/pnas.94.9.4475; Nagan N, 1998, BIOCHEM J, V332, P273, DOI 10.1042/bj3320273; Nagan N, 2001, PROG LIPID RES, V40, P199, DOI 10.1016/S0163-7827(01)00003-0; OSUMI T, 1978, J BIOCHEM, V83, P1361, DOI 10.1093/oxfordjournals.jbchem.a132044; Ren XB, 2010, FEBS LETT, V584, P4222, DOI 10.1016/j.febslet.2010.09.015; Sers C, 1997, J CELL BIOL, V136, P935, DOI 10.1083/jcb.136.4.935; Shyu RY, 2008, AMINO ACIDS, V35, P129, DOI 10.1007/s00726-007-0612-2; South ST, 1999, J CELL BIOL, V144, P255, DOI 10.1083/jcb.144.2.255; Steinberg SJ, 2006, BBA-MOL CELL RES, V1763, P1733, DOI 10.1016/j.bbamcr.2006.09.010; Ueda N, 2010, BBA-MOL CELL BIOL L, V1801, P1274, DOI 10.1016/j.bbalip.2010.08.010; Uyama T, 2009, BBA-MOL CELL BIOL L, V1791, P1114, DOI 10.1016/j.bbalip.2009.07.001; Uyama T, 2009, J LIPID RES, V50, P685, DOI 10.1194/jlr.M800453-JLR200; Van Veldhoven PP, 2010, J LIPID RES, V51, P2863, DOI 10.1194/jlr.R005959; Wanders RJA, 2006, ANNU REV BIOCHEM, V75, P295, DOI 10.1146/annurev.biochem.74.082803.133329; Weller S, 2003, ANNU REV GENOM HUM G, V4, P165, DOI 10.1146/annurev.genom.4.070802.110424; Yamasaki M, 1999, J BIOL CHEM, V274, P35293, DOI 10.1074/jbc.274.50.35293; Yan MD, 2005, CURR OPIN CELL BIOL, V17, P376, DOI 10.1016/j.ceb.2005.06.003	37	31	32	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2706	2718		10.1074/jbc.M111.267575	http://dx.doi.org/10.1074/jbc.M111.267575			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22134920	Green Published, hybrid			2022-12-27	WOS:000300292300042
J	Lewis, WG; Robinson, LS; Perry, J; Bick, JL; Peipert, JF; Allsworth, JE; Lewis, AL				Lewis, Warren G.; Robinson, Lloyd S.; Perry, Justin; Bick, Jennifer L.; Peipert, Jeffrey F.; Allsworth, Jenifer E.; Lewis, Amanda L.			Hydrolysis of Secreted Sialoglycoprotein Immunoglobulin A (IgA) in ex Vivo and Biochemical Models of Bacterial Vaginosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-BIRTH-WEIGHT; PRETERM DELIVERY; IMMUNE EXCLUSION; PREGNANT-WOMEN; INFECTION; SIALIDASE; COMPONENT; RISK; METRONIDAZOLE; ENDOMETRITIS	Bacterial vaginosis (BV) is a common polymicrobial imbalance of the vaginal flora associated with a wide variety of obstetric and gynecologic complications including serious infections and preterm birth. As evidenced by high recurrence rates following treatment, interventions for BV are still lacking. Several hydrolytic activities, including glycosidases and proteases, have been previously correlated with BV and have been hypothesized to degrade host sialoglycoproteins that participate in mucosal immune functions. Sialidase activity is most predictive of BV status and correlates strongly with adverse health outcomes. Here we combine clinical specimens with biochemical approaches to investigate secretory immunoglobulin A (SIgA) as a substrate of BV-associated glycosidases and proteases. We show that BV clinical specimens hydrolyze sialic acid from SIgA, but not in the presence of the sialidase inhibitor dehydro-deoxysialic acid. The collective action of BV-associated glycosidases exposes underlying mannose residues of SIgA, most apparent on the heavily N-glycosylated secretory component of the antibody. Terminal sialic acid residues on SIgA protect underlying carbohydrate residues from exposure and hydrolysis by exoglycosidases (galactosidase and hexosaminidase). It is known that both IgG and SIgA are present in the human reproductive tract. We show that the IgG heavy chain is more susceptible to proteolysis than its IgA counterpart. Gentle partial deglycosylation of the SIgA secretory component enhanced susceptibility to proteolysis. Together, these data support a model of BV in which SIgA is subject to stepwise exodeglycosylation and enhanced proteolysis, likely compromising the ability of the	[Lewis, Warren G.] Washington Univ, Dept Med, Ctr Womens Infect Dis Res, Sch Med, St Louis, MO 63110 USA; [Robinson, Lloyd S.; Perry, Justin; Lewis, Amanda L.] Washington Univ, Dept Mol Microbiol, Ctr Womens Infect Dis Res, Sch Med, St Louis, MO 63110 USA; [Bick, Jennifer L.; Peipert, Jeffrey F.; Allsworth, Jenifer E.; Lewis, Amanda L.] Washington Univ, Dept Obstet & Gynecol, Ctr Womens Infect Dis Res, Sch Med, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Lewis, AL (corresponding author), 660 S Euclid Ave,Campus Box 8230, St Louis, MO 63110 USA.	allewis@wustl.edu	Lewis, Warren G/W-4369-2019; Allsworth, Jenifer/J-2475-2019	Lewis, Warren G/0000-0003-1210-6403; Allsworth, Jenifer/0000-0001-6559-8638; Lewis, Amanda/0000-0001-6195-3030	March of Dimes; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000450] Funding Source: NIH RePORTER	March of Dimes(March of Dimes); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported in part by an anonymous donation to the Choice project (to J. F. P.), and laboratory analysis was funded (in part) by a Basil O'Connor Award from the March of Dimes (to A. L. L.).	Allsworth JE, 2007, OBSTET GYNECOL, V109, P114, DOI 10.1097/01.AOG.0000247627.84791.91; AMSEL R, 1983, AM J MED, V74, P14, DOI 10.1016/0002-9343(83)91112-9; Angata T, 2002, CHEM REV, V102, P439, DOI 10.1021/cr000407m; BAENZIGER J, 1974, J BIOL CHEM, V249, P7260; Bonner A, 2009, J BIOL CHEM, V284, P5077, DOI 10.1074/jbc.M807529200; Boullier S, 2009, J IMMUNOL, V183, P5879, DOI 10.4049/jimmunol.0901838; Bradshaw CS, 2006, J INFECT DIS, V193, P1478, DOI 10.1086/503780; Bradshaw CS, 2005, J CLIN MICROBIOL, V43, P1304, DOI 10.1128/JCM.43.3.1304-1308.2005; BRISELDEN AM, 1992, J CLIN MICROBIOL, V30, P663, DOI 10.1128/JCM.30.3.663-666.1992; Carey JC, 2000, NEW ENGL J MED, V342, P534, DOI 10.1056/NEJM200002243420802; Cauci S, 2005, AM J OBSTET GYNECOL, V192, P489, DOI 10.1016/j.ajog.2004.07.023; Cauci S, 2002, J INFECT DIS, V185, P1614, DOI 10.1086/340417; Cauci S, 1998, J INFECT DIS, V178, P1698, DOI 10.1086/314505; Cerutti A, 2011, ANNU REV IMMUNOL, V29, P273, DOI 10.1146/annurev-immunol-031210-101317; Daele J, 2000, Acta Otorhinolaryngol Belg, V54, P373; Deshpande N, 2010, J PROTEOME RES, V9, P1063, DOI 10.1021/pr900956x; DiGiulio DB, 2010, AM J REPROD IMMUNOL, V64, P38, DOI 10.1111/j.1600-0897.2010.00830.x; Donders GG, 2009, BJOG-INT J OBSTET GY, V116, P1315, DOI 10.1111/j.1471-0528.2009.02237.x; Hillier SL, 1995, NEW ENGL J MED, V333, P1737, DOI 10.1056/NEJM199512283332604; Hitti J, 2001, OBSTET GYNECOL, V97, P211, DOI 10.1016/S0029-7844(00)01146-7; KERR MA, 1990, BIOCHEM J, V271, P285, DOI 10.1042/bj2710285; Kilian M, 1996, APMIS, V104, P321, DOI 10.1111/j.1699-0463.1996.tb00724.x; LARSSON PG, 1992, INT J STD AIDS, V3, P239, DOI 10.1177/095646249200300402; Lewis AL, 2009, P NATL ACAD SCI USA, V106, P13552, DOI 10.1073/pnas.0902431106; Linden SK, 2008, MUCOSAL IMMUNOL, V1, P183, DOI 10.1038/mi.2008.5; LINDH E, 1975, J IMMUNOL, V114, P284; Mattu TS, 1998, J BIOL CHEM, V273, P2260, DOI 10.1074/jbc.273.4.2260; McDonald HM, 2007, COCHRANE DB SYST REV; McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538; MONCLA BJ, 1990, J CLIN MICROBIOL, V28, P422, DOI 10.1128/JCM.28.3.422-425.1990; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Oakley BB, 2008, APPL ENVIRON MICROB, V74, P4898, DOI 10.1128/AEM.02884-07; Olmsted SS, 2003, SEX TRANSM DIS, V30, P257, DOI 10.1097/00007435-200303000-00016; Perrier C, 2006, J BIOL CHEM, V281, P14280, DOI 10.1074/jbc.M512958200; Phalipon A, 2002, IMMUNITY, V17, P107, DOI 10.1016/S1074-7613(02)00341-2; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Rezeberga D, 2008, ACTA OBSTET GYN SCAN, V87, P360, DOI 10.1080/00016340801936487; Royle L, 2002, ANAL BIOCHEM, V304, P70, DOI 10.1006/abio.2002.5619; Royle L, 2003, J BIOL CHEM, V278, P20140, DOI 10.1074/jbc.M301436200; Secura GM, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.04.017; Simcox R, 2007, AUST NZ J OBSTET GYN, V47, P368, DOI 10.1111/j.1479-828X.2007.00759.x; Srinivasan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010197; STOKES CR, 1975, NATURE, V255, P745, DOI 10.1038/255745a0; Svare JA, 2006, BJOG-INT J OBSTET GY, V113, P1419, DOI 10.1111/j.1471-0528.2006.01087.x; Tanaka M, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/470803; van Egmond M, 2001, TRENDS IMMUNOL, V22, P205, DOI 10.1016/S1471-4906(01)01873-7; Varki A., 2009, SIALIC ACIDS ESSENTI; WATTS DH, 1990, OBSTET GYNECOL, V75, P52; Wiesenfeld HC, 2003, CLIN INFECT DIS, V36, P663, DOI 10.1086/367658; Wiesenfeld HC, 2002, OBSTET GYNECOL, V100, P456, DOI 10.1016/S0029-7844(02)02118-X; Wiggins R, 2002, INT J STD AIDS, V13, P755, DOI 10.1258/095646202320753709; Yel L, 2010, J CLIN IMMUNOL, V30, P10, DOI 10.1007/s10875-009-9357-x; Zhang Xin, 2002, Zhonghua Fu Chan Ke Za Zhi, V37, P588	53	48	49	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					2079	2089		10.1074/jbc.M111.278135	http://dx.doi.org/10.1074/jbc.M111.278135			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22134918	hybrid, Green Published			2022-12-27	WOS:000299321000048
J	Qiu, C; Kershner, A; Wang, YM; Holley, CP; Wilinski, D; Keles, S; Kimble, J; Wickens, M; Hall, TMT				Qiu, Chen; Kershner, Aaron; Wang, Yeming; Holley, Cynthia P.; Wilinski, Daniel; Keles, Sunduz; Kimble, Judith; Wickens, Marvin; Hall, Traci M. Tanaka			Divergence of Pumilio/fem-3 mRNA Binding Factor (PUF) Protein Specificity through Variations in an RNA-binding Pocket	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; RECOGNITION; TARGETS; FEM-3; GENE; CODE	mRNA control networks depend on recognition of specific RNA sequences. Pumilio-fem-3 mRNA binding factor (PUF) RNA-binding proteins achieve that specificity through variations on a conserved scaffold. Saccharomyces cerevisiae Puf3p achieves specificity through an additional binding pocket for a cytosine base upstream of the core RNA recognition site. Here we demonstrate that this chemically simple adaptation is prevalent and contributes to the diversity of RNA specificities among PUF proteins. Bioinformatics analysis shows that mRNAs associated with Caenorhabditis elegans fem-3 mRNA binding factor (FBF)-2 in vivo contain an upstream cytosine required for biological regulation. Crystal structures of FBF-2 and C. elegans PUF-6 reveal binding pockets structurally similar to that of Puf3p, whereas sequence alignments predict a pocket in PUF-11. For Puf3p, FBF-2, PUF-6, and PUF-11, the upstream pockets and a cytosine are required for maximal binding to RNA, but the quantitative impact on binding affinity varies. Furthermore, the position of the upstream cytosine relative to the core PUF recognition site can differ, which in the case of FBF-2 originally masked the identification of this consensus sequence feature. Importantly, other PUF proteins lack the pocket and so do not discriminate upstream bases. A structure-based alignment reveals that these proteins lack key residues that would contact the cytosine, and in some instances, they also present amino acid side chains that interfere with binding. Loss of the pocket requires only substitution of one serine, as appears to have occurred during the evolution of certain fungal species.	[Wilinski, Daniel; Kimble, Judith; Wickens, Marvin] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Kershner, Aaron; Kimble, Judith; Wickens, Marvin] Univ Wisconsin, Program Cellular & Mol Biol, Madison, WI 53706 USA; [Keles, Sunduz] Univ Wisconsin, Dept Stat, Madison, WI 53706 USA; [Keles, Sunduz] Univ Wisconsin, Dept Biostat & Med Informat, Madison, WI 53706 USA; [Kimble, Judith] Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA; [Qiu, Chen; Wang, Yeming; Holley, Cynthia P.; Hall, Traci M. Tanaka] NIEHS, Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Wickens, M (corresponding author), Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA.	wickens@biochem.wisc.edu; hall4@niehs.nih.gov	Hall, Traci/F-5849-2019; Wang, Yeming/C-9082-2013	Hall, Traci/0000-0001-6166-3009; Wilinski, Daniel/0000-0002-6178-8925	National Institutes of Health [GM50942, HG003747]; Howard Hughes Medical Institute; National Institute of Environmental Health Sciences; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003747] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES050165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050942] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM50942 (to M.W.) and HG003747 (to S.K.). This work was also supported by a Howard Hughes Medical Institute grant (to J.K.) and by the Intramural Research Program of the National Institute of Environmental Health Sciences (to T.M.T.H.).; We thank Cary Valley for discussions and creating and testing mutant constructs; Maria Wooten for assistance with site-directed mutagenesis; Kathryne Hawthorne for assistance with PUF-6 protein purification, crystallization, and RNA-binding analyses; and Dr. Lars Pedersen and the staff at the Southeast Regional Collaborative Access Team beamline for help with x-ray data collection. Data were collected at Southeast Regional Collaborative Access Team 22-ID beamline at the Advanced Photon Source, Argonne National Laboratory. Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract no. W-31-109-Eng-38.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AHRINGER J, 1991, NATURE, V349, P346, DOI 10.1038/349346a0; BARTON MK, 1987, GENETICS, V115, P107; Bembom O, 2007, STAT APPL GENET MOL, V6; Bernstein D, 2005, RNA, V11, P447, DOI 10.1261/rna.7255805; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carlson CD, 2010, P NATL ACAD SCI USA, V107, P4544, DOI 10.1073/pnas.0914023107; Cheong CG, 2006, P NATL ACAD SCI USA, V103, P13635, DOI 10.1073/pnas.0606294103; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dong SY, 2011, J BIOL CHEM, V286, P26732, DOI 10.1074/jbc.M111.244889; Edwards TA, 2001, CELL, V105, P281, DOI 10.1016/S0092-8674(01)00318-X; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Filipovska A, 2011, NAT CHEM BIOL, V7, P425, DOI [10.1038/NCHEMBIO.577, 10.1038/nchembio.577]; Gerber AP, 2004, PLOS BIOL, V2, P342, DOI 10.1371/journal.pbio.0020079; Jones DT, 1999, J MOL BIOL, V287, P797, DOI 10.1006/jmbi.1999.2583; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Kershner AM, 2010, P NATL ACAD SCI USA, V107, P3936, DOI 10.1073/pnas.1000495107; Koh YY, 2011, RNA, V17, P718, DOI 10.1261/rna.2540311; Koh YY, 2009, RNA, V15, P1090, DOI 10.1261/rna.1545309; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Merritt C, 2010, DEVELOPMENT, V137, P1787, DOI 10.1242/dev.050799; Miller MT, 2008, NAT STRUCT MOL BIOL, V15, P397, DOI 10.1038/nsmb.1390; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Opperman L, 2005, NAT STRUCT MOL BIOL, V12, P945, DOI 10.1038/nsmb1010; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Stumpf CR, 2008, RNA, V14, P1550, DOI 10.1261/rna.1095908; Thompson B, 2007, TRANSLATIONAL CONTRO, V48, P507; Ule J, 2006, CURR OPIN NEUROBIOL, V16, P102, DOI 10.1016/j.conb.2006.01.003; Wang XQ, 2002, CELL, V110, P501, DOI 10.1016/S0092-8674(02)00873-5; Wang XQ, 2001, MOL CELL, V7, P855, DOI 10.1016/S1097-2765(01)00229-5; Wang Y, 2009, NAT METHODS, V6, P825, DOI [10.1038/nmeth.1379, 10.1038/NMETH.1379]; Wang YM, 2009, P NATL ACAD SCI USA, V106, P20186, DOI 10.1073/pnas.0812076106; Wapinski I, 2007, NATURE, V449, P54, DOI 10.1038/nature06107; Zhu DY, 2009, P NATL ACAD SCI USA, V106, P20192, DOI 10.1073/pnas.0812079106	35	33	41	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6949	6957		10.1074/jbc.M111.326264	http://dx.doi.org/10.1074/jbc.M111.326264			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22205700	Green Published, hybrid			2022-12-27	WOS:000300791800079
J	Shao, BH; Pennathur, S; Heinecke, JW				Shao, Baohai; Pennathur, Subramaniam; Heinecke, Jay W.			Myeloperoxidase Targets Apolipoprotein A-I, the Major High Density Lipoprotein Protein, for Site-Specific Oxidation in Human Atherosclerotic Lesions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ABCA1-DEPENDENT CHOLESTEROL TRANSPORT; SMOOTH-MUSCLE CELLS; HYPOCHLOROUS ACID; HUMAN NEUTROPHILS; NITRIC-OXIDE; CARDIOVASCULAR-DISEASE; METHIONINE OXIDATION; TYROSINE NITRATION; HYDROGEN-PEROXIDE; MASS-SPECTROMETRY	Oxidative damage by myeloperoxidase (MPO) has been proposed to deprive HDL of its cardioprotective effects. In vitro studies reveal that MPO chlorinates and nitrates specific tyrosine residues of apoA-I, the major HDL protein. After Tyr-192 is chlorinated, apoA-I is less able to promote cholesterol efflux by the ABCA1 pathway. To investigate the potential role of this pathway in vivo, we used tandem mass spectrometry with selected reaction monitoring to quantify the regiospecific oxidation of apoA-I. This approach demonstrated that Tyr-192 is the major chlorination site in apoA-I in both plasma and lesion HDL of humans. We also found that Tyr-192 is the major nitration site in apoA-I of circulating HDL but that Tyr-18 is the major site in lesion HDL. Levels of 3-nitrotyrosine strongly correlated with levels of 3-chlorotyrosine in lesion HDL, and Tyr-18 of apoA-I was the major nitration site in HDL exposed to MPO in vitro, suggesting that MPO is the major pathway for chlorination and nitration of HDL in human atherosclerotic tissue. These observations may have implications for treating cardiovascular disease, because recombinant apoA-I is under investigation as a therapeutic agent and mutant forms of apoA-I that resist oxidation might be more cardioprotective than the native form.	[Shao, Baohai; Heinecke, Jay W.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Shao, Baohai; Heinecke, Jay W.] Univ Washington, Diabet & Obes Ctr Excellence, Seattle, WA 98195 USA; [Pennathur, Subramaniam] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Michigan System; University of Michigan	Shao, BH (corresponding author), Univ Washington, S Lake Union, Dept Med, Div Metab Endocrinol & Nutr, Box 358055,815 Mercer St, Seattle, WA 98109 USA.	bhshao@u.washington.edu		Shao, Baohai/0000-0001-8832-2845	National Institutes of Health [R00HL091055, R01HL086798, R01HL085437, R01HL077268]; University of Washington [UWPR95794]; NHLBI, National Institutes of Health [R00HL091055]; University of Washington Diabetes Research Center [P30DK017047]; Doris Duke Foundation; American College of Rheumatology; Michigan Nutrition and Obesity Research Center [DK089503]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085437, R01HL086798, R00HL091055, R01HL077268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK017047, P30DK089503, P30DK020572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Washington(University of Washington); NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); University of Washington Diabetes Research Center; Doris Duke Foundation(Doris Duke Charitable Foundation (DDCF)); American College of Rheumatology(General Electric); Michigan Nutrition and Obesity Research Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R00HL091055, R01HL086798, R01HL085437, and R01HL077268. This work was also supported in part by the Proteomics Resource, University of Washington Grant UWPR95794.; Supported by NHLBI, National Institutes of Health K99/R00 Award R00HL091055 and also by a Pilot and Feasibility Award from the University of Washington Diabetes Research Center (P30DK017047). To whom correspondence should be addressed: Box 358055, Division of Metabolism, Endocrinology, and Nutrition, Dept. of Medicine, University of Washington-South Lake Union, 815 Mercer St., Seattle, WA 98109. E-mail: bhshao@u.washington.edu.; Supported by Doris Duke Foundation Clinical Scientist Development Award, the American College of Rheumatology within Our Reach Award, and by the Molecular Phenotyping Core of the Michigan Nutrition and Obesity Research Center (Grant DK089503).	Aiello RJ, 2002, ARTERIOSCL THROM VAS, V22, P630, DOI 10.1161/01.ATV.0000014804.35824.DA; Anderson L, 2006, MOL CELL PROTEOMICS, V5, P573, DOI 10.1074/mcp.M500331-MCP200; Barter PJ, 2004, CIRC RES, V95, P764, DOI 10.1161/01.RES.0000146094.59640.13; BECKMAN JS, 1994, METHOD ENZYMOL, V233, P229; Bergt C, 2004, P NATL ACAD SCI USA, V101, P13032, DOI 10.1073/pnas.0405292101; Bergt C, 2004, J BIOL CHEM, V279, P7856, DOI 10.1074/jbc.M309046200; Berliner JA, 1996, FREE RADICAL BIO MED, V20, P707, DOI 10.1016/0891-5849(95)02173-6; Brunham LR, 2009, ARTERIOSCL THROM VAS, V29, P548, DOI 10.1161/ATVBAHA.108.182303; Calabresi Laura, 2006, Curr Atheroscler Rep, V8, P163, DOI 10.1007/s11883-006-0054-4; Carr AC, 2000, ARTERIOSCL THROM VAS, V20, P1716, DOI 10.1161/01.ATV.20.7.1716; Chiesa G, 2003, ANN MED, V35, P267, DOI 10.1080/07853890310005281; Cooper CE, 2002, TRENDS BIOCHEM SCI, V27, P489, DOI 10.1016/S0968-0004(02)02191-6; Crouch EC, 2010, J BIOL CHEM, V285, P16757, DOI 10.1074/jbc.M109.097048; DAUGHERTY A, 1994, J CLIN INVEST, V94, P437, DOI 10.1172/JCI117342; DOMIGAN NM, 1995, J BIOL CHEM, V270, P16542, DOI 10.1074/jbc.270.28.16542; Eiserich JP, 1998, NATURE, V391, P393, DOI 10.1038/34923; Francis GA, 2010, BBA-MOL CELL BIOL L, V1801, P1286, DOI 10.1016/j.bbalip.2010.08.009; Gaut JP, 2002, J CLIN INVEST, V109, P1311, DOI 10.1172/JCI200215021; Gaut JP, 2001, P NATL ACAD SCI USA, V98, P11961, DOI 10.1073/pnas.211190298; Gerber SA, 2003, P NATL ACAD SCI USA, V100, P6940, DOI 10.1073/pnas.0832254100; GLOMSET JA, 1968, J LIPID RES, V9, P155; GORDON DJ, 1989, NEW ENGL J MED, V321, P1311; Gordon SM, 2011, TRENDS ENDOCRIN MET, V22, P9, DOI 10.1016/j.tem.2010.10.001; Hazen SL, 1996, J CLIN INVEST, V98, P1283, DOI 10.1172/JCI118914; HEINECKE JW, 1984, J CLIN INVEST, V74, P1890, DOI 10.1172/JCI111609; HEINECKE JW, 1986, J CLIN INVEST, V77, P757, DOI 10.1172/JCI112371; Heinecke JW, 1999, METHOD ENZYMOL, V300, P124; HEINECKE JW, 1993, J BIOL CHEM, V268, P4069; Heinecke JW, 1998, ATHEROSCLEROSIS, V141, P1, DOI 10.1016/S0021-9150(98)00173-7; HUNT S, 1984, METHOD ENZYMOL, V107, P413; Ischiropoulos H, 2003, BIOCHEM BIOPH RES CO, V305, P776, DOI 10.1016/S0006-291X(03)00814-3; Jiang Q, 1997, CHEM RES TOXICOL, V10, P1080, DOI 10.1021/tx9700984; JONAS A, 1991, BIOCHIM BIOPHYS ACTA, V1084, P205, DOI 10.1016/0005-2760(91)90062-M; Kettle AJ, 1997, REDOX REP, V3, P257, DOI 10.1080/13510002.1997.11747120; Klebanoff SJ, 1999, P ASSOC AM PHYSICIAN, V111, P383, DOI 10.1111/paa.1999.111.5.383; KLEBANOFF SJ, 1993, FREE RADICAL BIO MED, V14, P351, DOI 10.1016/0891-5849(93)90084-8; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; MALAN PG, 1970, BIOCHEMISTRY-US, V9, P3205, DOI 10.1021/bi00818a013; Mallick P, 2007, NAT BIOTECHNOL, V25, P125, DOI 10.1038/nbt1275; MENDEZ AJ, 1991, J BIOL CHEM, V266, P10104; MONCADA S, 1991, PHARMACOL REV, V43, P109; MORITA Y, 1986, J BIOCHEM-TOKYO, V99, P761, DOI 10.1093/oxfordjournals.jbchem.a135535; Movva R, 2009, ANN BIOL CLIN-PARIS, V67, P7, DOI [10.1373/clinchem.2007.101923, 10.1684/abc.2008.0284]; NELSON DP, 1972, ANAL BIOCHEM, V49, P474, DOI 10.1016/0003-2697(72)90451-4; Nissen SE, 2003, JAMA-J AM MED ASSOC, V290, P2292, DOI 10.1001/jama.290.17.2292; Oda MN, 2003, NAT STRUCT BIOL, V10, P455, DOI 10.1038/nsb931; Oram JF, 2005, PHYSIOL REV, V85, P1343, DOI 10.1152/physrev.00005.2005; Ory DS, 2010, DIABETES, V59, P2358, DOI 10.2337/db10-1040; Out R, 2008, ARTERIOSCL THROM VAS, V28, P258, DOI 10.1161/ATVBAHA.107.156935; Pennathur S, 2004, J BIOL CHEM, V279, P42977, DOI 10.1074/jbc.M406762200; Radi R, 2001, FREE RADICAL BIO MED, V30, P463, DOI 10.1016/S0891-5849(00)00373-7; Rothblat GH, 2010, CURR OPIN LIPIDOL, V21, P229, DOI 10.1097/MOL.0b013e328338472d; Ryan RO, 2003, PROTEIN EXPRES PURIF, V27, P98, DOI 10.1016/S1046-5928(02)00568-5; Shao B., CHEM RES TOXICOL, V23, P447; Shao BH, 2008, P NATL ACAD SCI USA, V105, P12224, DOI 10.1073/pnas.0802025105; Shao BH, 2008, METHOD ENZYMOL, V440, P33, DOI 10.1016/S0076-6879(07)00803-8; Shao BH, 2010, J BIOL CHEM, V285, P18473, DOI 10.1074/jbc.M110.118182; Shao BH, 2006, J BIOL CHEM, V281, P9001, DOI 10.1074/jbc.C600011200; Shao BH, 2005, J BIOL CHEM, V280, P36386, DOI 10.1074/jbc.M508169200; Shao BH, 2005, J BIOL CHEM, V280, P5983, DOI 10.1074/jbc.M411484200; Souza JM, 1999, ARCH BIOCHEM BIOPHYS, V371, P169, DOI 10.1006/abbi.1999.1480; Van Eck M, 2006, ARTERIOSCL THROM VAS, V26, P929, DOI 10.1161/01.ATV.0000208364.22732.16; Vaughan AM, 2006, J LIPID RES, V47, P2433, DOI 10.1194/jlr.M600218-JLR200; Wink DA, 1998, FREE RADICAL BIO MED, V25, P434, DOI 10.1016/S0891-5849(98)00092-6; Winterbourn CC, 2000, FREE RADICAL BIO MED, V29, P403, DOI 10.1016/S0891-5849(00)00204-5; Wu Z, 2007, NAT STRUCT MOL BIOL, V14, P861, DOI 10.1038/nsmb1284; Yvan-Charvet L, 2007, J CLIN INVEST, V117, P3900, DOI 10.1172/JCI33372; Yvan-Charvet L, 2010, ARTERIOSCL THROM VAS, V30, P139, DOI 10.1161/ATVBAHA.108.179283; Zheng L, 2005, J BIOL CHEM, V280, P38, DOI 10.1074/jbc.M407019200; Zheng LM, 2004, J CLIN INVEST, V114, P529, DOI 10.1172/JCI200421109	70	138	145	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6375	6386		10.1074/jbc.M111.337345	http://dx.doi.org/10.1074/jbc.M111.337345			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22219194	Green Published, hybrid			2022-12-27	WOS:000300791800029
J	Leskela, TT; Lackman, JJ; Vierimaa, MM; Kobayashi, H; Bouvier, M; Petaja-Repo, UE				Leskela, Tarja T.; Lackman, Jarkko J.; Vierimaa, Miia M.; Kobayashi, Hiroyuki; Bouvier, Michel; Petaja-Repo, Ulla E.			Cys-27 Variant of Human delta-Opioid Receptor Modulates Maturation and Cell Surface Delivery of Phe-27 Variant via Heteromerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LUTEINIZING-HORMONE RECEPTOR; RESONANCE ENERGY-TRANSFER; PHARMACOLOGICAL CHAPERONES; ENDOPLASMIC-RETICULUM; SPLICE VARIANT; SUBCELLULAR-LOCALIZATION; QUALITY-CONTROL; LIVING CELLS; PROTEIN; HETERODIMERIZATION	The important role of G protein-coupled receptor homo/heteromerization in receptor folding, maturation, trafficking, and cell surface expression has become increasingly evident. Here we investigated whether the human delta-opioid receptor (h delta OR) Cys-27 variant that shows inherent compromised maturation has an effect on the behavior of the more common Phe-27 variant in the early secretory pathway. We demonstrate that h delta OR-Cys-27 acts in a dominant negative manner and impairs cell surface delivery of the co-expressed h delta OR-Phe-27 and impairs conversion of precursors to the mature form. This was demonstrated by metabolic labeling, Western blotting, flow cytometry, and confocal microscopy in HEK293 and human SH-SY5Y neuroblastoma cells using differentially epitope-tagged variants. The h delta OR-Phe-27 precursors that were redirected to the endoplasmic reticulum-associated degradation were, however, rescued by a pharmacological chaperone, the opioid antagonist naltrexone. Co-immunoprecipitation of metabolically labeled variants revealed that both endoplasmic reticulum-localized precursors and mature receptors exist as homo/heteromers. The existence of homo/heteromers was confirmed in living cells by bioluminescence resonance energy transfer measurements, showing that the variants have a similar propensity to form homo/heteromers. By forming both homomers and heteromers, the h delta OR-Cys-27 variant may thus regulate the levels of receptors at the cell surface, possibly leading to altered responsiveness to opioid ligands in individuals carrying the Cys-27 variant.	[Leskela, Tarja T.; Lackman, Jarkko J.; Vierimaa, Miia M.; Petaja-Repo, Ulla E.] Univ Oulu, Dept Anat & Cell Biol, Inst Biomed, FI-90014 Oulu, Finland; [Kobayashi, Hiroyuki; Bouvier, Michel] Univ Montreal, Dept Biochem, Inst Res Immunol & Canc, Montreal, PQ H3C 3J7, Canada; [Kobayashi, Hiroyuki; Bouvier, Michel] Univ Montreal, Grp Rech Univ Medicament, Montreal, PQ H3C 3J7, Canada	University of Oulu; Universite de Montreal; Universite de Montreal	Petaja-Repo, UE (corresponding author), Univ Oulu, Dept Anat & Cell Biol, Inst Biomed, POB 5000, FI-90014 Oulu, Finland.	Ulla.Petaja-Repo@oulu.fi	Bouvier, Michel/H-2758-2014; Kobayashi, Hiroyuki/F-6386-2013; Petäjä-Repo, Ulla/AAV-6115-2021	Bouvier, Michel/0000-0003-1128-0100; Kobayashi, Hiroyuki/0000-0003-4965-0883; Lackman, Jarkko/0000-0002-0422-5157	Sigrid Juselius Foundation; Academy of Finland [127199]; Canadian Institutes for Health Research [MOP-11215]; Finnish Cultural Foundation; Finnish Glycoscience Graduate School	Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Finnish Glycoscience Graduate School	This work was supported by the Sigrid Juselius Foundation and Academy of Finland Grant 127199 (to U. E. P.-R.) and Canadian Institutes for Health Research Grant MOP-11215 (to M. B.).; A Ph.D. student of the Biocenter Oulu Doctoral Program and supported by the Finnish Cultural Foundation.; Supported by the Finnish Glycoscience Graduate School.	Apaja PM, 2006, MOL BIOL CELL, V17, P2243, DOI 10.1091/mbc.E05-09-0875; Beaumont KA, 2007, HUM MOL GENET, V16, P2249, DOI 10.1093/hmg/ddm177; Benkirane M, 1997, J BIOL CHEM, V272, P30603, DOI 10.1074/jbc.272.49.30603; Breit A, 2006, MOL PHARMACOL, V70, P686, DOI 10.1124/mol.106.022897; Brothers SP, 2004, MOL ENDOCRINOL, V18, P1787, DOI 10.1210/me.2004-0091; Bulenger S, 2005, TRENDS PHARMACOL SCI, V26, P131, DOI 10.1016/j.tips.2005.01.004; Calebiro D, 2005, HUM MOL GENET, V14, P2991, DOI 10.1093/hmg/ddi329; Canals M, 2009, BIOCHEM J, V417, P161, DOI 10.1042/BJ20081227; Cvejic S, 1997, J BIOL CHEM, V272, P26959, DOI 10.1074/jbc.272.43.26959; DO SI, 1992, GLYCOBIOLOGY, V2, P345, DOI 10.1093/glycob/2.4.345; Gelernter J, 2000, HUM GENET, V107, P86; George SR, 2000, J BIOL CHEM, V275, P26128, DOI 10.1074/jbc.M000345200; Grosse R, 1997, MOL ENDOCRINOL, V11, P1305, DOI 10.1210/me.11.9.1305; Gupta A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000807; Hague C, 2004, J BIOL CHEM, V279, P15541, DOI 10.1074/jbc.M314014200; Hasbi A, 2007, BIOCHEMISTRY-US, V46, P12997, DOI 10.1021/bi701436w; Jordan BA, 1999, NATURE, V399, P697, DOI 10.1038/21441; Karpa KD, 2000, MOL PHARMACOL, V58, P677, DOI 10.1124/mol.58.4.677; Kniazeff J, 2011, PHARMACOL THERAPEUT, V130, P9, DOI 10.1016/j.pharmthera.2011.01.006; Kobayashi H, 2009, TRAFFIC, V10, P1019, DOI 10.1111/j.1600-0854.2009.00932.x; Law PY, 2005, J BIOL CHEM, V280, P11152, DOI 10.1074/jbc.M500171200; Lee SP, 2000, MOL PHARMACOL, V58, P120, DOI 10.1124/mol.58.1.120; Leskela TT, 2007, J BIOL CHEM, V282, P23171, DOI 10.1074/jbc.M610896200; Leskela TT, 2009, TRAFFIC, V10, P116, DOI 10.1111/j.1600-0854.2008.00846.x; Levitt ES, 2011, MOL PHARMACOL, V79, P461, DOI 10.1124/mol.110.064816; Markkanen PMH, 2008, J BIOL CHEM, V283, P29086, DOI 10.1074/jbc.M801880200; McVey M, 2001, J BIOL CHEM, V276, P14092, DOI 10.1074/jbc.M008902200; Mercier JF, 2002, J BIOL CHEM, V277, P44925, DOI 10.1074/jbc.M205767200; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Okiyoneda T, 2011, CURR OPIN CELL BIOL, V23, P483, DOI 10.1016/j.ceb.2011.04.012; Parenty G, 2008, BIOCHEM J, V412, P245, DOI 10.1042/BJ20071689; Petaja-Repo UE, 2002, EMBO J, V21, P1628, DOI 10.1093/emboj/21.7.1628; Petaja-Repo UE, 2001, J BIOL CHEM, V276, P4416, DOI 10.1074/jbc.M007151200; Petaja-Repo UE, 2006, J BIOL CHEM, V281, P15780, DOI 10.1074/jbc.M602267200; Pietila EM, 2005, J BIOL CHEM, V280, P26622, DOI 10.1074/jbc.M413815200; Rajan RS, 2005, J BIOL CHEM, V280, P1284, DOI 10.1074/jbc.M406448200; Ramsay D, 2002, BIOCHEM J, V365, P429, DOI 10.1042/BJ20020251; Rozenfeld R, 2011, BIOCHEM J, V433, P11, DOI 10.1042/BJ20100458; Salahpour A, 2004, J BIOL CHEM, V279, P33390, DOI 10.1074/jbc.M403363200; Sanchez-Laorden BL, 2006, J INVEST DERMATOL, V126, P172, DOI 10.1038/sj.jid.5700036; Sarajarvi T, 2011, MOL CELL BIOL, V31, P2326, DOI 10.1128/MCB.05015-11; Shioda T, 2001, J VIROL, V75, P3462, DOI 10.1128/JVI.75.7.3462-3468.2001; Terrillon S, 2003, MOL ENDOCRINOL, V17, P677, DOI 10.1210/me.2002-0222; Tuusa JT, 2010, FEBS J, V277, P2815, DOI 10.1111/j.1742-4658.2010.07699.x; van Rijn RM, 2010, CURR OPIN PHARMACOL, V10, P73, DOI 10.1016/j.coph.2009.09.007; Villemure JF, 2005, BIOCHEM J, V388, P47, DOI 10.1042/BJ20041435; Waldhoer M, 2005, P NATL ACAD SCI USA, V102, P9050, DOI 10.1073/pnas.0501112102; Waldhoer M, 2004, ANNU REV BIOCHEM, V73, P953, DOI 10.1146/annurev.biochem.73.011303.073940; Wang DX, 2005, MOL PHARMACOL, V67, P2173, DOI 10.1124/mol.104.010272; Xie ZH, 2005, MOL PHARMACOL, V68, P1079, DOI 10.1124/mol.105.012070; YANG B, 1993, J BIOL CHEM, V268, P7435; Zhu XY, 1998, BIOCHEMISTRY-US, V37, P15773, DOI 10.1021/bi981162z	52	17	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					5008	5020		10.1074/jbc.M111.305656	http://dx.doi.org/10.1074/jbc.M111.305656			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22184124	Green Published, hybrid			2022-12-27	WOS:000300608500060
J	Xu, FH; Flowers, S; Moran, E				Xu, Fuhua; Flowers, Stephen; Moran, Elizabeth			Essential Role of ARID2 Protein-containing SWI/SNF Complex in Tissue-specific Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN-REMODELING COMPLEX; CELL-CYCLE ARREST; OSTEOBLAST DIFFERENTIATION; TRANSCRIPTIONAL ACTIVATION; FAMILY PROTEINS; STEM-CELLS; CARCINOMA; MUTATION; BAF180; BRD7	Unfolding of the gene expression program that converts precursor cells to their terminally differentiated counterparts is critically dependent on the nucleosome-remodeling activity of the mammalian SWI/SNF complex. The complex can be powered by either of two alternative ATPases, BRM or BRG1. BRG1 is critical for development and the activation of tissue specific genes and is found in two major stable configurations. The complex of BRG1-associated factors termed BAF is the originally characterized form of mammalian SWI/SNF. A more recently recognized configuration shares many of the same subunits but is termed PBAF in recognition of a unique subunit, the polybromo protein (PBRM1). Two other unique subunits, BRD7 and ARID2, are also diagnostic of PBAF. PBAF plays an essential role in development, apparent from the embryonic lethality of Pbmr1-null mice, but very little is known about the role of PBAF, or its signature subunits, in tissue-specific gene expression in individual differentiation programs. Osteoblast differentiation is an attractive model for tissue-specific gene expression because the process is highly regulated and remains tightly synchronized over a period of several weeks. This model was used here, with a stable shRNA-mediated depletion approach, to examine the role of the signature PBAF subunit, ARID2, during differentiation. This analysis identifies a critical role for ARID2-containing complexes in promoting osteoblast differentiation and supports a view that the PBAF subset of SWI/SNF contributes importantly to maintaining cellular identity and activating tissue-specific gene expression.	[Xu, Fuhua; Flowers, Stephen; Moran, Elizabeth] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Orthopaed, Univ Hosp,Canc Ctr, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Moran, E (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Orthopaed, Univ Hosp,Canc Ctr, 205 S Orange Ave, Newark, NJ 07103 USA.	moranel@umdnj.edu	Xu, Fuhua/B-8937-2014		National Institutes of Health through the United States Public Health Service [GM073257, T32-CA134268]; NATIONAL CANCER INSTITUTE [T32CA134268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073257] Funding Source: NIH RePORTER	National Institutes of Health through the United States Public Health Service; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM073257 (to E. M.) and T32-CA134268 (to S. F.) through the United States Public Health Service.	Allis CD, 2007, CELL, V131, P633, DOI 10.1016/j.cell.2007.10.039; Bajpai R, 2010, NATURE, V463, P958, DOI 10.1038/nature08733; Beck GR, 2001, CELL GROWTH DIFFER, V12, P61; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Burrows AE, 2010, P NATL ACAD SCI USA, V107, P14280, DOI 10.1073/pnas.1009559107; Chi TH, 2002, NATURE, V418, P195, DOI 10.1038/nature00876; Cordonnier T, 2011, TISSUE ENG PART C-ME, V17, P249, DOI [10.1089/ten.tec.2010.0387, 10.1089/ten.TEC.2010.0387]; de la Serna IL, 2006, NAT REV GENET, V7, P461, DOI 10.1038/nrg1882; Drost J, 2010, NAT CELL BIOL, V12, P380, DOI 10.1038/ncb2038; Easley R, 2010, VIROLOGY, V405, P322, DOI 10.1016/j.virol.2010.06.009; Feng JQ, 2002, J BONE MINER RES, V17, P1822, DOI 10.1359/jbmr.2002.17.10.1822; Flores-Alcantar A, 2011, CELL TISSUE RES, V345, P137, DOI 10.1007/s00441-011-1182-x; Flowers S, 2011, J BIOL CHEM, V286, P27867, DOI 10.1074/jbc.C111.255091; Flowers S, 2010, CANCER RES, V70, P8282, DOI 10.1158/0008-5472.CAN-10-2205; Flowers S, 2009, J BIOL CHEM, V284, P10067, DOI 10.1074/jbc.M808782200; Gao XL, 2008, P NATL ACAD SCI USA, V105, P6656, DOI 10.1073/pnas.0801802105; GEORGE A, 1993, J BIOL CHEM, V268, P12624; Gluhak-Heinrich J, 2010, BONE, V46, P1533, DOI 10.1016/j.bone.2010.02.024; Goldman DC, 2009, BLOOD, V114, P4393, DOI 10.1182/blood-2009-02-206433; Guan B, 2011, AM J SURG PATHOL, V35, P625, DOI 10.1097/PAS.0b013e318212782a; Ho L, 2009, P NATL ACAD SCI USA, V106, P5181, DOI 10.1073/pnas.0812889106; Huang HY, 2009, P NATL ACAD SCI USA, V106, P12670, DOI 10.1073/pnas.0906266106; Huang XL, 2008, DEV BIOL, V319, P258, DOI 10.1016/j.ydbio.2008.04.020; Inoue H, 2002, J BIOL CHEM, V277, P41674, DOI 10.1074/jbc.M205961200; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Kaeser MD, 2008, J BIOL CHEM, V283, P32254, DOI 10.1074/jbc.M806061200; Li M, 2011, NAT GENET, V43, P828, DOI 10.1038/ng.903; Nagl NG, 2006, CANCER RES, V66, P1289, DOI 10.1158/0008-5472.CAN-05-3427; Nagl NG, 2005, CANCER RES, V65, P9236, DOI 10.1158/0008-5472.CAN-05-1225; Nagl NG, 2007, EMBO J, V26, P752, DOI 10.1038/sj.emboj.7601541; Patsialou A, 2005, NUCLEIC ACIDS RES, V33, P66, DOI 10.1093/nar/gki145; Ruchon AF, 2000, J BONE MINER RES, V15, P1440, DOI 10.1359/jbmr.2000.15.8.1440; Ryme J, 2009, J CELL BIOCHEM, V108, P565, DOI 10.1002/jcb.22288; Schroeder TM, 2004, J BIOL CHEM, V279, P41998, DOI 10.1074/jbc.M403702200; Sinha KM, 2010, EMBO J, V29, P68, DOI 10.1038/emboj.2009.332; Smith CL, 2005, CURR TOP DEV BIOL, V65, P115; Stein GS, 1996, PHYSIOL REV, V76, P593, DOI 10.1152/physrev.1996.76.2.593; Toyosawa S, 2001, J BONE MINER RES, V16, P2017, DOI 10.1359/jbmr.2001.16.11.2017; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Vicent GP, 2010, MOL ENDOCRINOL, V24, P2088, DOI 10.1210/me.2010-0027; Wang WD, 1996, EMBO J, V15, P5370, DOI 10.1002/j.1460-2075.1996.tb00921.x; Wang XM, 2004, INT J CANCER, V112, P636, DOI 10.1002/ijc.20450; Wang XM, 2004, BIOCHEM J, V383, P319, DOI 10.1042/BJ20040524; Wang Z, 2004, GENE DEV, V18, P3106, DOI 10.1101/gad.1238104; Westendorf JJ, 2007, J CELL BIOCHEM, V102, P332, DOI 10.1002/jcb.21486; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Wilsker D, 2005, GENOMICS, V86, P242, DOI 10.1016/j.ygeno.2005.03.013; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Xia W, 2008, CANCER RES, V68, P1667, DOI 10.1158/0008-5472.CAN-07-5276; Yan ZJ, 2005, GENE DEV, V19, P1662, DOI 10.1101/gad.1323805; Young DW, 2005, J CELL BIOCHEM, V94, P720, DOI 10.1002/jcb.20332; Zhang XM, 2006, BIOCHEM BIOPH RES CO, V346, P794, DOI 10.1016/j.bbrc.2006.05.211; Zhou M, 2006, J CELL BIOCHEM, V98, P920, DOI 10.1002/jcb.20788	53	45	48	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					5033	5041		10.1074/jbc.M111.279968	http://dx.doi.org/10.1074/jbc.M111.279968			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22184115	Green Published, hybrid			2022-12-27	WOS:000300608500062
J	Chandrayan, SK; McTernan, PM; Hopkins, RC; Sun, JS; Jenney, FE; Adams, MWW				Chandrayan, Sanjeev K.; McTernan, Patrick M.; Hopkins, R. Christopher; Sun, Junsong; Jenney, Francis E., Jr.; Adams, Michael W. W.			Engineering Hyperthermophilic Archaeon Pyrococcus furiosus to Overproduce Its Cytoplasmic [NiFe]-Hydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NIFE HYDROGENASE; DESULFOVIBRIO-GIGAS; ESCHERICHIA-COLI; ACTIVE-SITE; MATURATION; METABOLISM; ENZYMES; METALLOENZYME; PURIFICATION; QUANTITATION	The cytoplasmic hydrogenase (SHI) of the hyperthermophilic archaeon Pyrococcus furiosus is an NADP(H)-dependent heterotetrameric enzyme that contains a nickel-iron catalytic site, flavin, and six iron-sulfur clusters. It has potential utility in a range of bioenergy systems in vitro, but a major obstacle in its use is generating sufficient amounts. We have engineered P. furiosus to overproduce SHI utilizing a recently developed genetic system. In the overexpression (OE-SHI) strain, transcription of the four-gene SHI operon was under the control of a strong constitutive promoter, and a Strep-tag II was added to the N terminus of one subunit. OE-SHI and wild-type P. furiosus strains had similar rates of growth and H-2 production on maltose. Strain OE-SHI had a 20-fold higher transcription of the polycistronic hydrogenase mRNA encoding SHI, and the specific activity of the cytoplasmic hydrogenase was similar to 10-fold higher when compared with the wild-type strain, although the expression levels of genes encoding processing and maturation of SHI were the same in both strains. Overexpressed SHI was purified by a single affinity chromatography step using the Strep-tag II, and it and the native form had comparable activities and physical properties. Based on protein yield per gram of cells (wet weight), the OE-SHI strain yields a 100-fold higher amount of hydrogenase when compared with the highest homologous [NiFe]-hydrogenase system previously reported (from Synechocystis). This new P. furiosus system will allow further engineering of SHI and provide hydrogenase for efficient in vitro biohydrogen production.	[Chandrayan, Sanjeev K.; McTernan, Patrick M.; Hopkins, R. Christopher; Sun, Junsong; Adams, Michael W. W.] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Jenney, Francis E., Jr.] Philadelphia Coll Osteopath Med, Suwanee, GA 30024 USA	University System of Georgia; University of Georgia	Adams, MWW (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA.	adams@bmb.uga.edu	McTernan, Patrick/HGV-0762-2022; CHANDRAYAN, SANJEEV/M-1662-2016	CHANDRAYAN, SANJEEV/0000-0003-2219-4654; Adams, Michael/0000-0002-9796-5014; Jenney, Francis/0000-0002-1667-6924	Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, Office of Science, United States Department of Energy [DE-FG05-95ER20175, DE-FG02-05ER15710]	Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, Office of Science, United States Department of Energy(United States Department of Energy (DOE))	This work was supported by Grants DE-FG05-95ER20175 and DE-FG02-05ER15710 from the Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, Office of Science, United States Department of Energy (to M. W. W. A.).	Blokesch M, 2002, J MOL BIOL, V324, P287, DOI 10.1016/S0022-2836(02)01070-7; Blokesch M, 2004, J MOL BIOL, V344, P155, DOI 10.1016/j.jmb.2004.09.040; Bock A, 2006, ADV MICROB PHYSIOL, V51, P1, DOI 10.1016/S0065-2911(06)51001-X; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRYANT FO, 1989, J BIOL CHEM, V264, P5070; Cammack R., 2001, HYDROGEN FUEL LEARNI, P201; Cvetkovic A, 2010, NATURE, V466, P779, DOI 10.1038/nature09265; English CM, 2009, DALTON T, P9970, DOI 10.1039/b913426n; Fontecilla-Camps JC, 2007, CHEM REV, V107, P4273, DOI 10.1021/cr050195z; Forzi L, 2007, BIOMETALS, V20, P565, DOI 10.1007/s10534-006-9048-5; Germer F, 2009, J BIOL CHEM, V284, P36462, DOI 10.1074/jbc.M109.028795; Gupta R. B., 2009, HYDROGEN FUEL PRODUC, P1; Hopkins RC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026569; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Jenney FE, 2008, ANN NY ACAD SCI, V1125, P252, DOI 10.1196/annals.1419.013; Kallnik V, 2011, APPL MICROBIOL BIOT, V90, P1285, DOI 10.1007/s00253-011-3187-5; Krassen H, 2009, ACS NANO, V3, P4055, DOI 10.1021/nn900748j; Lee HS, 2006, J BACTERIOL, V188, P2115, DOI 10.1128/JB.188.6.2115-2125.2006; Lee HS, 2010, TRENDS BIOTECHNOL, V28, P262, DOI 10.1016/j.tibtech.2010.01.007; Lenz O, 2005, J BACTERIOL, V187, P6590, DOI 10.1128/JB.187.18.6590-6595.2005; Lipscomb GL, 2011, APPL ENVIRON MICROB, V77, P2232, DOI 10.1128/AEM.02624-10; Lubitz W, 2007, CHEM REV, V107, P4331, DOI 10.1021/cr050186q; Ma KS, 2000, J BACTERIOL, V182, P1864, DOI 10.1128/JB.182.7.1864-1871.2000; MA KS, 1994, FEMS MICROBIOL LETT, V122, P245, DOI 10.1016/0378-1097(94)00330-0; Maier T, 1998, ANAL BIOCHEM, V259, P68, DOI 10.1006/abio.1998.2649; Marques MC, 2010, J MOL BIOL, V396, P893, DOI 10.1016/j.jmb.2009.12.013; Mukherjee S, 2005, ANAL BIOCHEM, V347, P49, DOI 10.1016/j.ab.2005.08.028; Ogata H, 2005, STRUCTURE, V13, P1635, DOI 10.1016/j.str.2005.07.018; Ogata H, 2010, J MOL BIOL, V402, P428, DOI 10.1016/j.jmb.2010.07.041; Pandelia ME, 2010, CHEMPHYSCHEM, V11, P1127, DOI 10.1002/cphc.200900950; Porthun A, 2002, ARCH MICROBIOL, V177, P159, DOI 10.1007/s00203-001-0371-5; Rousset M, 1998, J BACTERIOL, V180, P4982, DOI 10.1128/JB.180.18.4982-4986.1998; Sambrook J, 2001, MOL CLONING LAB MANU, p[38, 51]; Schut GJ, 2007, J BACTERIOL, V189, P4431, DOI 10.1128/JB.00031-07; Silva PJ, 2000, EUR J BIOCHEM, V267, P6541, DOI 10.1046/j.1432-1327.2000.01745.x; Sun JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010526; Verhagen MFJM, 2001, METHOD ENZYMOL, V330, P25; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; Vignais PM, 2004, CURR ISSUES MOL BIOL, V6, P159; Volbeda A, 2005, J BIOL INORG CHEM, V10, P239, DOI 10.1007/s00775-005-0632-x; VOLBEDA A, 1995, NATURE, V373, P580, DOI 10.1038/373580a0; Zhang YHP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000456; Zhang YHP, 2010, CURR OPIN BIOTECH, V21, P663, DOI 10.1016/j.copbio.2010.05.005	43	43	45	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3257	3264		10.1074/jbc.M111.290916	http://dx.doi.org/10.1074/jbc.M111.290916			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22157005	Green Published, hybrid			2022-12-27	WOS:000300295100031
J	Cullen, TW; Madsen, JA; Ivanov, PL; Brodbelt, JS; Trent, MS				Cullen, Thomas W.; Madsen, James A.; Ivanov, Petko L.; Brodbelt, Jennifer S.; Trent, M. Stephen			Characterization of Unique Modification of Flagellar Rod Protein FlgG by Campylobacter jejuni Lipid A Phosphoethanolamine Transferase, Linking Bacterial Locomotion and Antimicrobial Peptide Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEISSERIA-GONORRHOEAE; IV PILI; SALMONELLA-ENTERICA; HELICOBACTER-PYLORI; MASS-SPECTROMETRY; SEQUENCE ANALYSIS; ESCHERICHIA-COLI; INNER-CORE; LIPOPOLYSACCHARIDE; IDENTIFICATION	Gram-negative bacteria assemble complex surface structures that interface with the surrounding environment and are involved in pathogenesis. Recent work in Campylobacter jejuni identified a gene encoding a novel phosphoethanolamine (pEtN) transferase Cj0256, renamed EptC, that serves a dual role in modifying the flagellar rod protein, FlgG, and the lipid A domain of C. jejuni lipooligosaccharide with a pEtN residue. In this work, we characterize the unique post-translational pEtN modification of FlgG using collision-induced and electron transfer dissociation mass spectrometry, as well as a genetic approach using site-directed mutagenesis to determine the site of modification. Specifically, we show that FlgG is modified with pEtN at a single site (Thr(75)) by EptC and demonstrate enzyme specificity by showing that EptC is unable to modify other amino acids (e. g. serine and tyrosine). Using Campylobacter strains expressing site-directed FlgG mutants, we also show that defects in motility arise directly from the loss of pEtN modification of FlgG. Interestingly, alignments of FlgG from most epsilon proteobacteria reveal a conserved site of modification. Characterization of EptC and its enzymatic targets expands on the increasingly important field of prokaryotic post-translational modification of bacterial surface structures and the unidentified role they may play in pathogenesis.	[Cullen, Thomas W.; Ivanov, Petko L.; Trent, M. Stephen] Univ Texas Austin, Sect Mol Genet & Microbiol, Austin, TX 78712 USA; [Madsen, James A.; Brodbelt, Jennifer S.] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA; [Trent, M. Stephen] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Trent, MS (corresponding author), 1 Univ Stn,A5000, Austin, TX 78712 USA.	strent@mail.utexas.edu			National Institutes of Health [AI064184, AI76322]; National Science Foundation [CHE-1012622]; Welch Foundation [F-1155]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI076322, R01AI076322, R01AI064184] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI064184 and AI76322 (to M. S. T.).; Supported by National Science Foundation Grant CHE-1012622 and Welch Foundation Grant F-1155.	Aas FE, 2006, J BIOL CHEM, V281, P27712, DOI 10.1074/jbc.M604324200; Ang CW, 2002, INFECT IMMUN, V70, P1202, DOI 10.1128/IAI.70.3.1202-1208.2002; ASPINALL GO, 1995, EUR J BIOCHEM, V231, P570, DOI 10.1111/j.1432-1033.1995.0570d.x; Balaban M, 2009, J BACTERIOL, V191, P6602, DOI 10.1128/JB.00884-09; BLACK RE, 1988, J INFECT DIS, V157, P472, DOI 10.1093/infdis/157.3.472; Chalker AF, 2001, J BACTERIOL, V183, P1259, DOI 10.1128/JB.183.4.1259-1268.2001; Chamot-Rooke J, 2011, SCIENCE, V331, P778, DOI 10.1126/science.1200729; Chen SY, 2011, EMBO J, V30, P2972, DOI 10.1038/emboj.2011.186; Chevance FFV, 2007, GENE DEV, V21, P2326, DOI 10.1101/gad.1571607; Coon JJ, 2009, ANAL CHEM, V81, P3208, DOI 10.1021/ac802330b; Cox AD, 2003, J BACTERIOL, V185, P3270, DOI 10.1128/JB.185.11.3270-3277.2003; Cullen TW, 2010, P NATL ACAD SCI USA, V107, P5160, DOI 10.1073/pnas.0913451107; Ewing CP, 2009, J BACTERIOL, V191, P7086, DOI 10.1128/JB.00378-09; Guerry P, 2006, MOL MICROBIOL, V60, P299, DOI 10.1111/j.1365-2958.2006.05100.x; Hegge FT, 2004, P NATL ACAD SCI USA, V101, P10798, DOI 10.1073/pnas.0402397101; Hendrixson DR, 2004, MOL MICROBIOL, V52, P471, DOI 10.1111/j.1365-2958.2004.03988.x; Kowarik M, 2006, SCIENCE, V314, P1148, DOI 10.1126/science.1134351; Lee H, 2004, J BACTERIOL, V186, P4124, DOI 10.1128/JB.186.13.4124-4133.2004; Mackinnon FG, 2002, MOL MICROBIOL, V43, P931, DOI 10.1046/j.1365-2958.2002.02754.x; McLuckey SA, 2011, J AM SOC MASS SPECTR, V22, P3, DOI 10.1007/s13361-010-0004-9; Naessan CL, 2008, J BACTERIOL, V190, P387, DOI 10.1128/JB.00765-07; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Reynolds CM, 2005, J BIOL CHEM, V280, P21202, DOI 10.1074/jbc.M500964200; Samuel MC, 2004, CLIN INFECT DIS, V38, pS165, DOI 10.1086/381583; Scott NE, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M000031-MCP201; SHI WY, 1993, J BACTERIOL, V175, P7711, DOI 10.1128/JB.175.23.7711-7714.1993; Syka JEP, 2004, P NATL ACAD SCI USA, V101, P9528, DOI 10.1073/pnas.0402700101; Szymanski CM, 2003, J BIOL CHEM, V278, P24509, DOI 10.1074/jbc.M301273200; Szymanski CM, 2003, TRENDS MICROBIOL, V11, P233, DOI 10.1016/S0966-842X(03)00079-9; Tamayo R, 2005, J BACTERIOL, V187, P3391, DOI 10.1128/JB.187.10.3391-3399.2005; Tran AX, 2004, J BIOL CHEM, V279, P55780, DOI 10.1074/jbc.M406480200; Trent MS, 2006, J ENDOTOXIN RES, V12, P205, DOI 10.1179/096805106X118825; Walsh CT, 2005, ANGEW CHEM INT EDIT, V44, P7342, DOI 10.1002/anie.200501023; WASSENAAR TM, 1993, J GEN MICROBIOL, V139, P1171, DOI 10.1099/00221287-139-6-1171; Wright JC, 2004, J BACTERIOL, V186, P6970, DOI 10.1128/JB.186.20.6970-6982.2004; YAO RJ, 1993, GENE, V130, P127, DOI 10.1016/0378-1119(93)90355-7; Yao RJ, 1996, J BACTERIOL, V178, P3335, DOI 10.1128/jb.178.11.3335-3338.1996	37	36	38	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3326	3336		10.1074/jbc.M111.321737	http://dx.doi.org/10.1074/jbc.M111.321737			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22158617	Green Published, hybrid			2022-12-27	WOS:000300295100038
J	Liu, ZJ; Feng, BS; Yang, SB; Chen, X; Su, JL; Yang, PC				Liu, Zhanju; Feng, Bai-Sui; Yang, Shao-Bo; Chen, Xiao; Su, Jingling; Yang, Ping-Chang			Interleukin (IL)-23 Suppresses IL-10 in Inflammatory Bowel Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY T-CELLS; IMMUNOGLOBULIN-A PRODUCTION; CROHNS-DISEASE; INTESTINAL HOMEOSTASIS; ULCERATIVE-COLITIS; COMMENSAL BACTERIA; SECRETORY IGA; B-LYMPHOCYTES; IFN-GAMMA; MUCOSAL	Interleukin (IL)-10 plays an important role in immune regulation in the intestine. Immune deregulation is suggested in the pathogenesis of inflammatory bowel disease (IBD). This study aims to elucidate the role of IL-23 in the suppression of IL-10 in the IBD intestinal mucosa. Surgically removed colon specimens were obtained from 16 IBD patients. The expressions of IL-10, IL-23, and IgA in the specimens were examined at the protein and gene transcriptional levels. The gene transcription of IL-10 was assessed by chromatin immunoprecipitation assay and promoter accessibility assay. The levels of IgA and IL-10 were significantly lower, whereas the levels of IL-23 were higher, in IBD specimens than in normal controls. The levels of IgA and IL-10 were negatively correlated with the infiltration of inflammatory cells in the IBD mucosa. The production of IL-10 by lamina propria mononuclear cells was lower in the IBD group than in the control group, and these levels could be enhanced by blocking IL-23. The gene transcription of IL-10 was significantly suppressed in CD4(+) T cells of IBD mucosa; this phenomenon could be replicated in vitro by adding IL-23 in the culture of polarized Th2 cells. Overexpression of IL-23 in the intestinal mucosa suppresses the production of IL-10, which weakens the defensive barrier by reducing the production of IgA in the gut.	[Liu, Zhanju; Su, Jingling] Tongji Univ, Dept Gastroenterol, Shanghai Peoples Hosp 10, Shanghai 200072, Peoples R China; [Feng, Bai-Sui; Chen, Xiao; Yang, Ping-Chang] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON L8S 4A6, Canada; [Yang, Shao-Bo] China Peoples Liberat Army PLA, Dept Gastroenterol, Gen Hosp, Beijing 100853, Peoples R China	Tongji University; McMaster University	Liu, ZJ (corresponding author), Tongji Univ, Dept Gastroenterol, Shanghai Peoples Hosp 10, Shanghai 200072, Peoples R China.	liuzhanju88@126.com; yangp@mcmaster.ca	Yang, Ping-Chang/K-4669-2019		Canadian Institute of Health Research (CIHR) [191063, 220058, 177843]; Natural Sciences, Engineering Research Council of Canada (NSERC) [371268]; Natural Science Foundation of China [30971358]	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences, Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Canadian Institute of Health Research (CIHR) (Grants 191063, 220058, and 177843), the Natural Sciences, Engineering Research Council of Canada (NSERC) (Grant 371268), and the Natural Science Foundation of China (Grant 30971358).	Barnes MJ, 2009, IMMUNITY, V31, P401, DOI 10.1016/j.immuni.2009.08.011; Bazzoni F, 2010, EUR J IMMUNOL, V40, P2360, DOI 10.1002/eji.200940294; Boschetti G, 2011, INFLAMM BOWEL DIS, V17, P160, DOI 10.1002/ibd.21308; Coffman RL, 2009, J IMMUNOL, V182, P8; Correa F, 2011, BRAIN BEHAV IMMUN, V25, P736, DOI 10.1016/j.bbi.2011.01.020; D'Haens G, 2010, AM J GASTROENTEROL, V105, P1140, DOI 10.1038/ajg.2010.15; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Fava F, 2011, WORLD J GASTROENTERO, V17, P557, DOI 10.3748/wjg.v17.i5.557; Frossard CP, 2007, J ALLERGY CLIN IMMUN, V119, P952, DOI 10.1016/j.jaci.2006.12.615; Frossard CP, 2004, J ALLERGY CLIN IMMUN, V114, P377, DOI 10.1016/j.jaci.2004.03.040; Fuss IJ, 1996, J IMMUNOL, V157, P1261; Geremia A, 2011, J EXP MED, V208, P1127, DOI 10.1084/jem.20101712; Jarry A, 2008, J CLIN INVEST, V118, P1132, DOI 10.1172/JCI32140; Kaneko M, 2005, IMMUNOLOGY, V116, P64, DOI 10.1111/j.1365-2567.2005.02198.x; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Lafarge S, 2011, CLIN EXP IMMUNOL, V166, P171, DOI 10.1111/j.1365-2249.2011.04465.x; Liu ZJ, 2011, J LEUKOCYTE BIOL, V89, P597, DOI 10.1189/jlb.0810456; Macpherson AJ, 2008, MUCOSAL IMMUNOL, V1, P11, DOI 10.1038/mi.2007.6; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Macpherson AJ, 2007, CURR OPIN GASTROEN, V23, P673, DOI 10.1097/MOG.0b013e3282f0d012; Monteleone G, 1997, GASTROENTEROLOGY, V112, P1169, DOI 10.1016/S0016-5085(97)70128-8; Napimoga MH, 2011, SCAND J IMMUNOL, V74, P596, DOI 10.1111/j.1365-3083.2011.02605.x; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013; PODOLSKY DK, 1991, NEW ENGL J MED, V325, P1008, DOI 10.1056/NEJM199110033251406; PODOLSKY DK, 1991, NEW ENGL J MED, V325, P928, DOI 10.1056/NEJM199109263251306; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rao SH, 2001, J IMMUNOL, V167, P4494, DOI 10.4049/jimmunol.167.8.4494; Roncucci L, 2008, CANCER EPIDEM BIOMAR, V17, P2291, DOI 10.1158/1055-9965.EPI-08-0224; ROUSSET F, 1995, INT IMMUNOL, V7, P1243, DOI 10.1093/intimm/7.8.1243; Sakaguchi S, 2009, INT IMMUNOL, V21, P1105, DOI 10.1093/intimm/dxp095; Sarra M, 2010, INFLAMM BOWEL DIS, V16, P1808, DOI 10.1002/ibd.21248; Schicho R, 2010, J PROTEOME RES, V9, P6265, DOI 10.1021/pr100547y; SHROFF KE, 1995, INFECT IMMUN, V63, P3904, DOI 10.1128/IAI.63.10.3904-3913.1995; Strober W, 2011, GASTROENTEROLOGY, V140, P1756, DOI 10.1053/j.gastro.2011.02.016; Uhlig HH, 2006, IMMUNITY, V25, P309, DOI 10.1016/j.immuni.2006.05.017; Wang Y, 2011, J DIGEST DIS, V12, P286, DOI 10.1111/j.1751-2980.2011.00505.x	37	34	35	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3591	3597		10.1074/jbc.M111.304949	http://dx.doi.org/10.1074/jbc.M111.304949			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22158873	hybrid, Green Published			2022-12-27	WOS:000300295100063
J	Bounedjah, O; Hamon, L; Savarin, P; Desforges, B; Curmi, PA; Pastre, D				Bounedjah, Ouissame; Hamon, Loic; Savarin, Philippe; Desforges, Benedicte; Curmi, Patrick A.; Pastre, David			Macromolecular Crowding Regulates Assembly of mRNA Stress Granules after Osmotic Stress NEW ROLE FOR COMPATIBLE OSMOLYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAP-JUNCTION COMMUNICATION; ENHANCER-BINDING PROTEIN; RENAL MEDULLARY CELLS; RAT-KIDNEY; STIMULATES TRANSCRIPTION; BUNDLE FORMATION; GENE-EXPRESSION; HEPATOMA-CELLS; LIPID OLEAMIDE; MDCK CELLS	The massive uptake of compatible osmolytes such as betaine, taurine, and myo-inositol is a protective response shared by all eukaryotes exposed to hypertonic stress. Their accumulation results mostly from the expression of specific transporters triggered by the transcriptional factor NFAT5/TonEBP. This allows the recovery of the cell volume without increasing intracellular ionic strength. In this study we consider the assembly and dissociation of mRNA stress granules (SGs) in hypertonic-stressed cells and the role of compatible osmolytes. In agreement with in vitro results obtained on isolated mRNAs, both macromolecular crowding and a high ionic strength favor the assembly of SGs in normal rat kidney epithelial cells. However, after hours of constant hypertonicity, the slow accumulation in the cytoplasm of compatible osmolytes via specific transporters both reduces macromolecular crowding and ionic strength, thus leading to the progressive dissociation of SGs. In line with this, when cells are exposed to hypertonicity to accumulate a large amount of compatible osmolytes, the formation of SGs is severely impaired, and cells increase their chances of survival to another hypertonic episode. Altogether, these results indicate that the impact of compatible osmolytes on the mRNA-associated machineries and especially that associated with SGs may play an important role in cell resistance and adaption to hyperosmolarity in many tissues like kidney and liver.	[Pastre, David] INSERM, Lab Struct Act Biomol Normales & Pathol, U829, F-91025 Evry, France; Univ Evry Val Essonne, F-91025 Evry, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Pastre, D (corresponding author), INSERM, Lab Struct Act Biomol Normales & Pathol, U829, F-91025 Evry, France.	david.pastre@univ-evry.fr	Pastre, David/B-2958-2014; CURMI, Patrick/G-4036-2013	Pastre, David/0000-0002-3348-9514; hamon, loic/0000-0003-2032-7994; CURMI, Patrick A./0000-0001-5045-8501	INSERM	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This work was supported by funds from the INSERM.	Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BARAJAS L, 1994, KIDNEY INT, V46, P621, DOI 10.1038/ki.1994.314; Bevilacqua E, 2010, J BIOL CHEM, V285, P17098, DOI 10.1074/jbc.M110.109439; Boger DL, 1998, P NATL ACAD SCI USA, V95, P4810, DOI 10.1073/pnas.95.9.4810; Brigotti M, 2003, BIOCHEM J, V369, P369, DOI 10.1042/BJ20021056; Burg MB, 2008, J BIOL CHEM, V283, P7309, DOI 10.1074/jbc.R700042200; Burg MB, 1997, ANNU REV PHYSIOL, V59, P437, DOI 10.1146/annurev.physiol.59.1.437; Chernov KG, 2009, J BIOL CHEM, V284, P36569, DOI 10.1074/jbc.M109.042879; Davydova EK, 1997, NUCLEIC ACIDS RES, V25, P2911, DOI 10.1093/nar/25.14.2911; de Vries R, 2001, BIOPHYS J, V80, P1186, DOI 10.1016/S0006-3495(01)76095-X; DEBRABANDER M, 1981, P NATL ACAD SCI-BIOL, V78, P5608; Desforges B, 2011, AM J PHYSIOL-CELL PH, V301, pC705, DOI 10.1152/ajpcell.00128.2011; Dewey CM, 2011, MOL CELL BIOL, V31, P1098, DOI 10.1128/MCB.01279-10; Di Ciano C, 2002, AM J PHYSIOL-CELL PH, V283, pC850, DOI 10.1152/ajpcell.00018.2002; Dmitrieva NI, 2004, P NATL ACAD SCI USA, V101, P2317, DOI 10.1073/pnas.0308463100; Ellis RJ, 2001, TRENDS BIOCHEM SCI, V26, P597, DOI 10.1016/S0968-0004(01)01938-7; Evdokimova V, 2001, EMBO J, V20, P5491, DOI 10.1093/emboj/20.19.5491; Ferraris JD, 1999, AM J PHYSIOL-CELL PH, V276, pC667, DOI 10.1152/ajpcell.1999.276.3.C667; Foulks GN, 2007, SURV OPHTHALMOL, V52, P369, DOI 10.1016/j.survophthal.2007.04.009; Gallazzini M, 2006, P NATL ACAD SCI USA, V103, P15260, DOI 10.1073/pnas.0607133103; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; Go WY, 2004, P NATL ACAD SCI USA, V101, P10673, DOI 10.1073/pnas.0403139101; GRINSTEIN S, 1992, J BIOL CHEM, V267, P23823; Guan XJ, 1997, J CELL BIOL, V139, P1785, DOI 10.1083/jcb.139.7.1785; Guil S, 2006, MOL CELL BIOL, V26, P5744, DOI 10.1128/MCB.00224-06; Hamon L, 2011, BIOPHYS J, V101, P205, DOI 10.1016/j.bpj.2011.05.022; Haussinger D, 1996, BIOCHEM J, V313, P697; Horio M, 2001, NEPHROL DIAL TRANSPL, V16, P483, DOI 10.1093/ndt/16.3.483; Ignatova Z, 2006, P NATL ACAD SCI USA, V103, P13357, DOI 10.1073/pnas.0603772103; Ito T, 2004, BIOCHEM J, V382, P177, DOI 10.1042/BJ20031838; Kedersha N, 2000, J CELL BIOL, V151, P1257, DOI 10.1083/jcb.151.6.1257; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Kimball SR, 2003, AM J PHYSIOL-CELL PH, V284, pC273, DOI 10.1152/ajpcell.00314.2002; Ko K, 2000, AM J PHYSIOL-CELL PH, V279, pC147, DOI 10.1152/ajpcell.2000.279.1.C147; KWON ED, 1995, AM J PHYSIOL-CELL PH, V268, pC402, DOI 10.1152/ajpcell.1995.268.2.C402; Lang F, 1998, PHYSIOL REV, V78, P247, DOI 10.1152/physrev.1998.78.1.247; Liu YF, 2006, P NATL ACAD SCI USA, V103, P10654, DOI 10.1073/pnas.0510381103; Liu ZJ, 2002, P NATL ACAD SCI USA, V99, P6053, DOI 10.1073/pnas.092131899; Lopez-Rodriguez C, 2004, P NATL ACAD SCI USA, V101, P2392, DOI 10.1073/pnas.0308703100; Loyher ML, 2004, NEUROSCIENCE, V124, P89, DOI 10.1016/j.neuroscience.2003.10.025; Luby-Phelps K, 2000, INT REV CYTOL, V192, P189; Marenduzzo D, 2006, J CELL BIOL, V175, P681, DOI 10.1083/jcb.200609066; Mazroui R, 2006, MOL BIOL CELL, V17, P4212, DOI 10.1091/mbc.E06-04-0318; McEwen E, 2005, J BIOL CHEM, V280, P16925, DOI 10.1074/jbc.M412882200; Minton AP, 1997, CURR OPIN BIOTECH, V8, P65, DOI 10.1016/S0958-1669(97)80159-0; Minton AP, 2000, CURR OPIN STRUC BIOL, V10, P34, DOI 10.1016/S0959-440X(99)00045-7; Minton AP, 2001, J BIOL CHEM, V276, P10577, DOI 10.1074/jbc.R100005200; Miyakawa H, 1999, P NATL ACAD SCI USA, V96, P2538, DOI 10.1073/pnas.96.5.2538; MORIYAMA T, 1989, J BIOL CHEM, V264, P16810; Morley SJ, 2002, J BIOL CHEM, V277, P32855, DOI 10.1074/jbc.C200376200; Munishkina LA, 2004, J MOL RECOGNIT, V17, P456, DOI 10.1002/jmr.699; NAKANISHI T, 1989, P NATL ACAD SCI USA, V86, P6002, DOI 10.1073/pnas.86.15.6002; NAKANISHI T, 1989, AM J PHYSIOL, V257, pC964, DOI 10.1152/ajpcell.1989.257.5.C964; NAKANISHI T, 1990, AM J PHYSIOL, V258, pF1061, DOI 10.1152/ajprenal.1990.258.4.F1061; Natalello A, 2009, PROTEINS, V75, P509, DOI 10.1002/prot.22266; Navarro P, 2008, BIOCHEM BIOPH RES CO, V372, P326, DOI 10.1016/j.bbrc.2008.05.067; Neuhofer W, 2010, CURR GENOMICS, V11, P584, DOI 10.2174/138920210793360961; Pastre D, 2007, BIOMACROMOLECULES, V8, P3712, DOI 10.1021/bm700856u; Patel J, 2002, EUR J BIOCHEM, V269, P3076, DOI 10.1046/j.1432-1033.2002.02992.x; PETRONINI PG, 1992, BIOCHEM J, V282, P69, DOI 10.1042/bj2820069; Rodgaard T, 2008, AM J PHYSIOL-CELL PH, V295, pC1528, DOI 10.1152/ajpcell.00081.2008; Roger F, 1999, J BIOL CHEM, V274, P34103, DOI 10.1074/jbc.274.48.34103; SAIKIA TC, 1965, Q J EXP PHYSIOL CMS, V50, P146, DOI 10.1113/expphysiol.1965.sp001777; Schafer C, 2007, AM J PHYSIOL-GASTR L, V292, pG1089, DOI 10.1152/ajpgi.00088.2006; Slow S, 2009, PHYSIOL RES, V58, P403, DOI 10.33549/physiolres.931569; Strange K, 2004, ADV PHYSIOL EDUC, V28, P155, DOI 10.1152/advan.00034.2004; Strange K, 1996, AM J PHYSIOL-CELL PH, V270, pC711, DOI 10.1152/ajpcell.1996.270.3.C711; STRANGE K, 1991, AM J PHYSIOL, V260, pC784, DOI 10.1152/ajpcell.1991.260.4.C784; Tang JX, 1997, BIOCHEMISTRY-US, V36, P12600, DOI 10.1021/bi9711386; Tourriere H, 2003, J CELL BIOL, V160, P823, DOI 10.1083/jcb.200212128; WADE JV, 1988, J NEUROCHEM, V51, P740, DOI 10.1111/j.1471-4159.1988.tb01807.x; Wehner F, 2004, REV PHYSIOL BIOCH P, V148, P1, DOI 10.1007/s10254-003-0009-x; WIEGANT FAC, 1993, CELL BIOL TOXICOL, V9, P49, DOI 10.1007/BF00755139; YAMAUCHI A, 1992, J BIOL CHEM, V267, P649; YAMAUCHI A, 1993, AM J PHYSIOL, V264, pF20, DOI 10.1152/ajprenal.1993.264.1.F20; YANCEY PH, 1982, SCIENCE, V217, P1214, DOI 10.1126/science.7112124; ZIMMERMAN SB, 1993, ANNU REV BIOPH BIOM, V22, P27, DOI 10.1146/annurev.bb.22.060193.000331	78	63	64	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2446	2458		10.1074/jbc.M111.292748	http://dx.doi.org/10.1074/jbc.M111.292748			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22147700	Green Published, hybrid			2022-12-27	WOS:000300292300019
J	Issoglio, FM; Carrizo, ME; Romero, JM; Curtino, JA				Issoglio, Federico M.; Carrizo, Maria E.; Romero, Jorge M.; Curtino, Juan A.			Mechanisms of Monomeric and Dimeric Glycogenin Autoglucosylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOSYNTHESIS; INITIATOR; PROTEOGLYCOGEN; SUBUNIT; RETINA	Initiation of glucose polymerization by glycogenin autoglucosylation at Tyr-194 is required to prime de novo biosynthesis of glycogen. It has been proposed that the synthesis of the primer proceeds by intersubunit glucosylation of dimeric glycogenin, even though it has not been demonstrated that this mechanism is responsible for the described polymerization extent of 12 glucoses produced by the dimer. We reported previously the intramonomer glucosylation capability of glycogenin without determining the extent of autoglucopolymerization. Here, we show that the maximum specific autoglucosylation extent (MSAE) produced by the non-glucosylated glycogenin monomer is 13.3 +/- 1.9 glucose units, similar to the 12.5 +/- 1.4 glucose units measured for the dimer. The mechanism and capacity of the dimeric enzyme to carry out full glucopolymerization were also evaluated by construction of heterodimers able to glucosylate exclusively by intrasubunit or intersubunit reaction mechanisms. The MSAE of non-glucosylated glycogenin produced by dimer intrasubunit glucosylation was 16% of that produced by the monomer. However, partially glucosylated glycogenin was able to almost complete its autoglucosylation by the dimer intrasubunit mechanism. The MSAE produced by heterodimer intersubunit glucosylation was 60% of that produced by the wild-type dimer. We conclude that both intrasubunit and intersubunit reaction mechanisms are necessary for the dimeric enzyme to acquire maximum autoglucosylation. The full glucopolymerization capacity of monomeric glycogenin indicates that the enzyme is able to synthesize the glycogen primer without the need for prior dimerization.	[Issoglio, Federico M.; Carrizo, Maria E.; Romero, Jorge M.; Curtino, Juan A.] Univ Nacl Cordoba, Ctr Invest Quim Biol Cordoba, CIQUIBIC, CONICET,Dept Quim Biol,Fac Ciencias Quim, RA-5000 Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba	Curtino, JA (corresponding author), Univ Nacl Cordoba, Ctr Invest Quim Biol Cordoba, CIQUIBIC, CONICET,Dept Quim Biol,Fac Ciencias Quim, Haya de la Torre S-N,X5000HUA, RA-5000 Cordoba, Argentina.	jcurtino@dqb.fcq.unc.edu.ar		Carrizo, Maria Elena/0000-0003-0501-8894; Issoglio, Federico/0000-0001-9225-7855	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Fondo para la Investigacion Cientifica y Tecnologica (FONCyT); Secretaria de Ciencia y Tecnica-Universidad Nacional de Cordoba (SECyT-UNC)	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Fondo para la Investigacion Cientifica y Tecnologica (FONCyT)(FONCyT); Secretaria de Ciencia y Tecnica-Universidad Nacional de Cordoba (SECyT-UNC)(Secretaria de Ciencia y Tecnologia (SECYT))	This work was supported by grants from the Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), the Fondo para la Investigacion Cientifica y Tecnologica (FONCyT), and the Secretaria de Ciencia y Tecnica-Universidad Nacional de Cordoba (SECyT-UNC).	AON MA, 1984, EUR J BIOCHEM, V140, P557, DOI 10.1111/j.1432-1033.1984.tb08138.x; AON MA, 1985, BIOCHEM J, V229, P269, DOI 10.1042/bj2290269; Bazan S, 2005, GLYCOBIOLOGY, V15, pC14, DOI 10.1093/glycob/cwi093; Bazan S, 2008, BIOCHEM BIOPH RES CO, V371, P328, DOI 10.1016/j.bbrc.2008.04.076; Carrizo ME, 1997, GLYCOBIOLOGY, V7, P571, DOI 10.1093/glycob/7.4.571; CHENG C, 1995, MOL CELL BIOL, V15, P6632; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gibbons BJ, 2002, J MOL BIOL, V319, P463, DOI 10.1016/S0022-2836(02)00305-4; Hurley TD, 2005, J BIOL CHEM, V280, P23892, DOI 10.1074/jbc.M502344200; Hurley TD, 2006, BIOCHEM BIOPH RES CO, V348, P374, DOI 10.1016/j.bbrc.2006.07.106; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kennedy L., 1985, MEMBRANES MUSCLE, P65; KRISMAN CR, 1975, EUR J BIOCHEM, V52, P117, DOI 10.1111/j.1432-1033.1975.tb03979.x; Leslie AGW, 1992, PROTEIN CRYSTALLOGR, V26, P27; Lin A, 1999, ARCH BIOCHEM BIOPHYS, V363, P163, DOI 10.1006/abbi.1998.1073; MIOZZO MC, 1989, BIOCHEM J, V260, P287, DOI 10.1042/bj2600287; Moslemi AR, 2010, NEW ENGL J MED, V362, P1203, DOI 10.1056/NEJMoa0900661; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; PITCHER J, 1987, EUR J BIOCHEM, V169, P497, DOI 10.1111/j.1432-1033.1987.tb13637.x; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; SKURAT AV, 1993, J BIOL CHEM, V268, P14701; SMYTHE C, 1988, EMBO J, V7, P2681, DOI 10.1002/j.1460-2075.1988.tb03121.x; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	24	11	11	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					1955	1961		10.1074/jbc.M111.287813	http://dx.doi.org/10.1074/jbc.M111.287813			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22128147	Green Published, hybrid			2022-12-27	WOS:000299321000036
J	White, R; Gonsior, C; Bauer, NM; Kramer-Albers, EM; Luhmann, HJ; Trotter, J				White, Robin; Gonsior, Constantin; Bauer, Nina M.; Kraemer-Albers, Eva-Maria; Luhmann, Heiko J.; Trotter, Jacqueline			Heterogeneous Nuclear Ribonucleoprotein (hnRNP) F Is a Novel Component of Oligodendroglial RNA Transport Granules Contributing to Regulation of Myelin Basic Protein (MBP) Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FYN TYROSINE KINASE; A2 RESPONSE ELEMENT; MESSENGER-RNAS; CNS MYELINATION; INITIAL EVENTS; DEFICIENT MICE; IN-VITRO; DIFFERENTIATION; EXPRESSION; TRANSLATION	Myelin basic protein (MBP) is a major component of central nervous system (CNS) myelin. The absence of MBP results in the loss of almost all compact myelin in the CNS. MBP mRNA is sorted into RNA granules that are transported to the periphery of oligodendrocytes in a translationally inactive state. A central mediator of this transport process is the trans-acting factor heterogeneous nuclear ribonucleoprotein (hnRNP) A2 that binds to the cis-acting A2-response element in the 3' UTR of MBP mRNA. Recently, we found that activation of the Src family nonreceptor tyrosine kinase Fyn in oligodendrocytes leads to phosphorylation of hnRNP A2 and to increased translation of MBP mRNA. Here, we identify the RNA-binding protein hnRNP F as a novel component of MBP mRNA transport granules. It is associated with hnRNP A2 andMBPmRNAin cytoplasmic granular structures and is involved in post-transcriptional regulation of MBP expression. Fyn kinase activity results in phosphorylation of hnRNP F in the cytoplasm and its release from MBP mRNA and RNA granules. Our results define hnRNP F as a regulatory element of MBP expression in oligodendrocytes and imply an important function of hnRNP F in the control of myelin synthesis.	[White, Robin; Bauer, Nina M.; Luhmann, Heiko J.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Physiol & Pathophysiol, D-55128 Mainz, Germany; [Gonsior, Constantin; Kraemer-Albers, Eva-Maria; Trotter, Jacqueline] Johannes Gutenberg Univ Mainz, Dept Biol, D-55128 Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	White, R (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Physiol & Pathophysiol, Duesbergweg 6, D-55128 Mainz, Germany.	white@uni-mainz.de; trotter@uni-mainz.de	Eva-Maria, Kraemer-Albers/AAP-8805-2020; Luhmann, Heiko J./N-8797-2019	Eva-Maria, Kraemer-Albers/0000-0001-7994-1185; Luhmann, Heiko J./0000-0002-7934-8661	Deutsche Forschungsgemeinschaft SPP Glia-Synapse; European Union; Deutsche Forschungsgemeinschaft [GRK 1044]	Deutsche Forschungsgemeinschaft SPP Glia-Synapse(German Research Foundation (DFG)); European Union(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft SPP Glia-Synapse, European Union FP6 Signalling and Traffic, and Deutsche Forschungsgemeinschaft Grant GRK 1044.	Aggarwal S, 2011, TRENDS CELL BIOL, V21, P585, DOI 10.1016/j.tcb.2011.06.004; Aggarwal S, 2011, DEV CELL, V21, P445, DOI 10.1016/j.devcel.2011.08.001; Arthur PK, 2009, J BIOL CHEM, V284, P19982, DOI 10.1074/jbc.M109.009928; Boccaccio GL, 2000, J NEUROSCI RES, V62, P473, DOI 10.1002/1097-4547(20001115)62:4<473::AID-JNR1>3.0.CO;2-F; Bugiani M, 2010, J NEUROPATH EXP NEUR, V69, P987, DOI 10.1097/NEN.0b013e3181f2eafa; Carson JH, 2005, BIOL CELL, V97, P51; COLMAN DR, 1982, J CELL BIOL, V95, P598, DOI 10.1083/jcb.95.2.598; Colognato H, 2004, J CELL BIOL, V167, P365, DOI 10.1083/jcb.200404076; Emery B, 2010, SCIENCE, V330, P779, DOI 10.1126/science.1190927; Fitzner D, 2006, EMBO J, V25, P5037, DOI 10.1038/sj.emboj.7601376; Francone VP, 2007, J NEUROSCI, V27, P7654, DOI 10.1523/JNEUROSCI.0203-07.2007; Gao YZ, 2008, MOL BIOL CELL, V19, P2311, DOI 10.1091/mbc.E07-09-0914; Goto J, 2004, CELL MOL NEUROBIOL, V24, P149, DOI 10.1023/B:CEMN.0000012720.71630.14; Goto J, 2008, MOL CELL NEUROSCI, V38, P203, DOI 10.1016/j.mcn.2008.02.009; Griffiths I, 1998, SCIENCE, V280, P1610, DOI 10.1126/science.280.5369.1610; Han SP, 2010, TRAFFIC, V11, P886, DOI 10.1111/j.1600-0854.2010.01072.x; Hatfield JT, 2002, GENE, V295, P33, DOI 10.1016/S0378-1119(02)00800-4; Homchaudhuri L, 2009, BIOCHEMISTRY-US, V48, P2385, DOI 10.1021/bi8022587; Honore B, 2004, EXP CELL RES, V294, P199, DOI 10.1016/j.yexcr.2003.11.011; Huttelmaier S, 2005, NATURE, V438, P512, DOI 10.1038/nature04115; JUNG M, 1995, EUR J NEUROSCI, V7, P1245, DOI 10.1111/j.1460-9568.1995.tb01115.x; Kalifa Y, 2006, DEV CELL, V10, P291, DOI 10.1016/j.devcel.2006.01.001; Klein C, 2002, J NEUROSCI, V22, P698, DOI 10.1523/JNEUROSCI.22-03-00698.2002; Kosturko LD, 2006, MOL BIOL CELL, V17, P3521, DOI 10.1091/mbc.E05-10-0946; Kramer-Albers EM, 2006, J NEUROSCI, V26, P11743, DOI 10.1523/JNEUROSCI.3581-06.2006; Kramer-Albers EM, 2011, CELL MOL LIFE SCI, V68, P2003, DOI 10.1007/s00018-010-0616-z; Labauge P, 2007, REV NEUROL-FRANCE, V163, P793, DOI 10.1016/S0035-3787(07)91461-7; Laursen LS, 2011, J CELL BIOL, V192, P797, DOI 10.1083/jcb.201007014; Laursen LS, 2009, J NEUROSCI, V29, P9174, DOI 10.1523/JNEUROSCI.5942-08.2009; Liang XQ, 2004, J NEUROSCI, V24, P7140, DOI 10.1523/JNEUROSCI.5319-03.2004; Maggipinto M, 2004, J NEUROSCI RES, V75, P614, DOI 10.1002/jnr.20014; MATUNIS MJ, 1994, NUCLEIC ACIDS RES, V22, P1059, DOI 10.1093/nar/22.6.1059; Munro TP, 1999, J BIOL CHEM, V274, P34389, DOI 10.1074/jbc.274.48.34389; Nakahara J, 2003, DEV CELL, V4, P841, DOI 10.1016/S1534-5807(03)00155-2; Nave KA, 2010, NAT REV NEUROSCI, V11, P275, DOI 10.1038/nrn2797; Ostareck-Lederer A, 2002, MOL CELL BIOL, V22, P4535, DOI 10.1128/MCB.22.13.4535-4543.2002; Osterhout DJ, 1999, J CELL BIOL, V145, P1209, DOI 10.1083/jcb.145.6.1209; POPKO B, 1987, CELL, V48, P713, DOI 10.1016/0092-8674(87)90249-2; READHEAD C, 1990, BEHAV GENET, V20, P213, DOI 10.1007/BF01067791; Simons M, 2007, CURR OPIN NEUROBIOL, V17, P533, DOI 10.1016/j.conb.2007.08.003; Song K. Y., 2011, CELL MOL LI IN PRESS; Sperber BR, 2001, J NEUROSCI, V21, P2039, DOI 10.1523/JNEUROSCI.21-06-02039.2001; TROTTER J, 1989, J NEUROSCI RES, V22, P369, DOI 10.1002/jnr.490220402; TWAMLEYSTEIN GM, 1993, P NATL ACAD SCI USA, V90, P7696, DOI 10.1073/pnas.90.16.7696; UMEMORI H, 1994, NATURE, V367, P572, DOI 10.1038/367572a0; Umemori H, 1999, J NEUROSCI, V19, P1393; Wake H, 2011, SCIENCE, V333, P1647, DOI 10.1126/science.1206998; Wang EM, 2007, NUCLEIC ACIDS RES, V35, P4164, DOI 10.1093/nar/gkm387; Wang EM, 2009, J BIOL CHEM, V284, P11194, DOI 10.1074/jbc.M809373200; White R, 2008, J CELL BIOL, V181, P579, DOI 10.1083/jcb.200706164	50	42	44	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					1742	1754		10.1074/jbc.M111.235010	http://dx.doi.org/10.1074/jbc.M111.235010			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22128153	hybrid, Green Published			2022-12-27	WOS:000299321000017
J	Zheng, BS; Yang, W; Zhao, XY; Wang, YG; Lou, ZY; Rao, ZH; Feng, Y				Zheng, Baisong; Yang, Wen; Zhao, Xinyu; Wang, Yuguo; Lou, Zhiyong; Rao, Zihe; Feng, Yan			Crystal Structure of Hyperthermophilic Endo-beta-1,4-glucanase IMPLICATIONS FOR CATALYTIC MECHANISM AND THERMOSTABILITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-DIFFRACTION; 3-DIMENSIONAL STRUCTURE; ERWINIA-CHRYSANTHEMI; BETA-GALACTOSIDASE; ACTIVE-SITE; CELLULASE; FAMILY; SEQUENCE; CLASSIFICATION; IDENTIFICATION	Endo-beta-1,4-glucanase from thermophilic Fervidobacterium nodosum Rt17-B1 (FnCel5A), a new member of glycosyl hydrolase family 5, is highly thermostable and exhibits the highest activity on carboxymethylcellulose among the reported homologues. To understand the structural basis for the thermostability and catalytic mechanism, we report here the crystal structures of FnCel5A and the complex with glucose at atomic resolution. FnCel5A exhibited a (beta/alpha)(8)-barrel structure typical of clan GH-A of the glycoside hydrolase families with a large and deep catalytic pocket located in the C-terminal end of the beta-strands that may permit substrate access. A comparison of the structure of FnCel5A with related structures from thermopile Clostridium thermocellum, mesophile Clostridium cellulolyticum, and psychrophile Pseudoalteromonas haloplanktis showed significant differences in intramolecular interactions (salt bridges and hydrogen bonds) that may account for the difference in their thermostabilities. The substrate complex structure in combination with a mutagenesis analysis of the catalytic residues implicates a distinctive catalytic module Glu(167)-His(226)-Glu(283), which suggests that the histidine may function as an intermediate for the electron transfer network between the typical Glu-Glu catalytic module. Further investigation suggested that the aromatic residues Trp(61), Trp(204), Phe(231), and Trp(240) as well as polar residues Asn(51), His(127), Tyr(228), and His(235) in the active site not only participated in substrate binding but also provided a unique microenvironment suitable for catalysis. These results provide substantial insight into the unique characteristics of FnCel5A for catalysis and adaptation to extreme temperature.	[Yang, Wen; Lou, Zhiyong; Rao, Zihe] Tsinghua Univ, Sch Med, Struct Biol Lab, Beijing 100084, Peoples R China; [Feng, Yan] Shanghai Jiao Tong Univ, Coll Life Sci & Biotechnol, State Key Lab Microbial Metab, Shanghai 200240, Peoples R China; [Zheng, Baisong; Zhao, Xinyu; Wang, Yuguo; Feng, Yan] Jilin Univ, Minist Educ, Key Lab Mol Enzymol & Engn, Changchun 130023, Peoples R China	Tsinghua University; Shanghai Jiao Tong University; Jilin University	Rao, ZH (corresponding author), Tsinghua Univ, Sch Med, Struct Biol Lab, Beijing 100084, Peoples R China.	raozh@xtal.tsinghua.edu.cn; yfeng2009@mail.sjtu.edu.cn	YANG, WEN/A-1993-2014; Rao, Zihe/HCH-6944-2022		National Basic Research Program of China (973 Program); Natural Science Foundation of China; Science and Technology Commission of the Shanghai Municipality	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of the Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by the National Basic Research Program of China (973 Program), Natural Science Foundation of China, and Science and Technology Commission of the Shanghai Municipality.	BAIRD SD, 1990, BIOCHEM BIOPH RES CO, V169, P1035, DOI 10.1016/0006-291X(90)91998-8; BARRAS F, 1992, FEBS LETT, V300, P145, DOI 10.1016/0014-5793(92)80183-H; BARRETT T, 1995, STRUCTURE, V3, P951, DOI 10.1016/S0969-2126(01)00229-5; BORTOLIGERMAN I, 1995, J MOL BIOL, V246, P82, DOI 10.1006/jmbi.1994.0068; CHAN MK, 1995, SCIENCE, V267, P1463, DOI 10.1126/science.7878465; Chang MCY, 2007, CURR OPIN CHEM BIOL, V11, P677, DOI 10.1016/j.cbpa.2007.08.039; CLARKE AJ, 1985, EUR J BIOCHEM, V149, P233, DOI 10.1111/j.1432-1033.1985.tb08917.x; DAGGETT V, 1993, J MOL BIOL, V232, P600, DOI 10.1006/jmbi.1993.1414; DEREWENDA U, 1994, J BIOL CHEM, V269, P20811; DOMINGUEZ R, 1995, NAT STRUCT BIOL, V2, P569, DOI 10.1038/nsb0795-569; Dominguez R, 1996, J MOL BIOL, V257, P1042, DOI 10.1006/jmbi.1996.0222; DOMINGUEZ R, 1994, PROTEINS, V19, P158, DOI 10.1002/prot.340190209; DUCROS V, 1995, STRUCTURE, V3, P939, DOI 10.1016/S0969-2126(01)00228-3; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; HARRIS GW, 1994, STRUCTURE, V2, P1107, DOI 10.1016/S0969-2126(94)00112-X; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; HENRISSAT B, 1995, P NATL ACAD SCI USA, V92, P7090, DOI 10.1073/pnas.92.15.7090; HENRISSAT B, 1993, BIOCHEM J, V293, P781, DOI 10.1042/bj2930781; JACOBSON RH, 1994, NATURE, V369, P761, DOI 10.1038/369761a0; JENKINS J, 1995, FEBS LETT, V362, P281, DOI 10.1016/0014-5793(95)00252-5; KIM JM, 1987, APPL ENVIRON MICROB, V53, P2656, DOI 10.1128/AEM.53.11.2656-2659.1987; LESZCZYNSKI JF, 1986, SCIENCE, V234, P849, DOI 10.1126/science.3775366; MCCARTER JD, 1994, CURR OPIN STRUC BIOL, V4, P885, DOI 10.1016/0959-440X(94)90271-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; PY B, 1991, PROTEIN ENG, V4, P325, DOI 10.1093/protein/4.3.325; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Rubin EM, 2008, NATURE, V454, P841, DOI 10.1038/nature07190; RUSSELL RJM, 1994, STRUCTURE, V2, P1157, DOI 10.1016/S0969-2126(94)00118-9; Sadeghi M, 2006, BIOPHYS CHEM, V119, P256, DOI 10.1016/j.bpc.2005.09.018; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; SINNOTT ML, 1990, CHEM REV, V90, P1171, DOI 10.1021/cr00105a006; SOGAARD M, 1993, J BIOL CHEM, V268, P22480; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; TOMME P, 1989, FEBS LETT, V243, P239, DOI 10.1016/0014-5793(89)80136-X; VARGHESE JN, 1994, P NATL ACAD SCI USA, V91, P2785, DOI 10.1073/pnas.91.7.2785; Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001; Violot S, 2005, J MOL BIOL, V348, P1211, DOI 10.1016/j.jmb.2005.03.026; Wang YG, 2010, J MOL CATAL B-ENZYM, V66, P294, DOI 10.1016/j.molcatb.2010.06.006; WHITE A, 1994, BIOCHEMISTRY-US, V33, P12546, DOI 10.1021/bi00208a003; WIESMANN C, 1995, STRUCTURE, V3, P961, DOI 10.1016/S0969-2126(01)00230-1; WITHERS SG, 1990, J AM CHEM SOC, V112, P5887, DOI 10.1021/ja00171a043; Zhang YHP, 2006, BIOTECHNOL ADV, V24, P452, DOI 10.1016/j.biotechadv.2006.03.003; Zhaxybayeva O, 2009, P NATL ACAD SCI USA, V106, P5865, DOI 10.1073/pnas.0901260106; Zheng BS, 2009, ACTA CRYSTALLOGR F, V65, P219, DOI 10.1107/S1744309109001316	48	27	29	0	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8336	8346		10.1074/jbc.M111.266346	http://dx.doi.org/10.1074/jbc.M111.266346			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22128157	Green Published, hybrid			2022-12-27	WOS:000301349400048
J	Madan, R; Rastogi, R; Parashuraman, S; Mukhopadhyay, A				Madan, Richa; Rastogi, Ruchir; Parashuraman, Seetharaman; Mukhopadhyay, Amitabha			Salmonella Acquires Lysosome-associated Membrane Protein 1 (LAMP1) on Phagosomes from Golgi via SipC Protein-mediated Recruitment of Host Syntaxin6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOINOSITIDE PHOSPHATASE; MYCOBACTERIUM-TUBERCULOSIS; CONTAINING VACUOLE; SNARE COMPLEX; RAB PROTEINS; TRAFFICKING; EFFECTOR; TRANSPORT; MATURATION; FUSION	Several intracellular pathogens have developed diverse strategies to avoid targeting to lysosomes. However, they universally recruit lysosome-associated membrane protein 1 (LAMP1); the mechanism of LAMP1 recruitment remains unclear. Here, we report that a Salmonella effector protein, SipC, specifically binds with host Syntaxin6 through its C terminus and thereby recruits Syntaxin6 and other accessory molecules like VAMP2, Rab6, and Rab8 on Salmonella-containing phagosomes (SCP) and acquires LAMP1 by fusing with LAMP1-containing Golgi-derived vesicles. In contrast, sipC knock-out: SCP (sipC(-) : SCP) or sipC(M398K): SCP fails to obtain significant amounts of Syntaxin6 and is unable to acquire LAMP1. Moreover, phagosomes containing respective knock-out Salmonella like sipA(-), sipB(-), sipD(-), sopB(-), or sopE(-) recruit LAMP1, demonstrating the specificity of SipC in this process. In addition, depletion of Syntaxin6 by shRNA in macrophages significantly inhibits LAMP1 recruitment on SCP. Additionally, survival of sipC(-) : Salmonella in mice is found to be significantly inhibited in comparison with WT: Salmonella. Our results reveal a novel mechanism showing how Salmonella acquires LAMP1 through a SipC-Syntaxin6-mediated interaction probably to stabilize their niche in macrophages and also suggest that similar modalities might be used by other intracellular pathogens to recruit LAMP1.	[Mukhopadhyay, Amitabha] Natl Inst Immunol, Cell Biol Lab, New Delhi 110067, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Mukhopadhyay, A (corresponding author), Natl Inst Immunol, Cell Biol Lab, New Delhi 110067, India.	amitabha@nii.res.in	Lomash, Richa Madan/I-1307-2019; parashuraman, seetharaman/ABE-2639-2020; Parashuraman, Seetharaman/P-3389-2014	parashuraman, seetharaman/0000-0001-5113-4592; Parashuraman, Seetharaman/0000-0001-5113-4592	National Institute of Immunology, Government of India, New Delhi, India; Council of Scientific and Industrial Research, Government of India	National Institute of Immunology, Government of India, New Delhi, India; Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported in part by a grant from National Institute of Immunology, Government of India, New Delhi, India.; Supported by a fellowship from the Council of Scientific and Industrial Research, Government of India.	Akasaki K, 1996, J BIOCHEM-TOKYO, V120, P1088; Bakowski MA, 2010, CELL HOST MICROBE, V7, P453, DOI 10.1016/j.chom.2010.05.011; Bethani I, 2007, EMBO J, V26, P3981, DOI 10.1038/sj.emboj.7601820; Braun V, 2010, CELL MICROBIOL, V12, P1352, DOI 10.1111/j.1462-5822.2010.01476.x; Brawn LC, 2007, CELL HOST MICROBE, V1, P63, DOI 10.1016/j.chom.2007.02.001; Brurnell JH, 2007, MICROBIOL MOL BIOL R, V71, P636, DOI 10.1128/MMBR.00023-07; Carlton J, 2005, TRAFFIC, V6, P75, DOI 10.1111/j.1600-0854.2005.00260.x; Celli J, 2003, J EXP MED, V198, P545, DOI 10.1084/jem.20030088; Chang JH, 2005, MOL MICROBIOL, V55, P1379, DOI 10.1111/j.1365-2958.2004.04480.x; Cook NR, 2004, TRAFFIC, V5, P685, DOI 10.1111/j.1600-0854.2004.00212.x; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Davanger S, 1997, MOL BIOL CELL, V8, P1261, DOI 10.1091/mbc.8.7.1261; del Toro D, 2009, MOL BIOL CELL, V20, P1478, DOI 10.1091/mbc.E08-07-0726; Delahay RM, 2002, MOL MICROBIOL, V45, P905, DOI 10.1046/j.1365-2958.2002.03083.x; Delevoye C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000022; Dowse T, 2004, CURR OPIN MICROBIOL, V7, P388, DOI 10.1016/j.mib.2004.06.013; Drecktrah D, 2007, TRAFFIC, V8, P212, DOI 10.1111/j.1600-0854.2006.00529.x; Dukes JD, 2006, BIOCHEM J, V395, P239, DOI 10.1042/BJ20051451; Eskelinen EL, 2003, TRENDS CELL BIOL, V13, P137, DOI 10.1016/S0962-8924(03)00005-9; Giacomodonato MN, 2007, MICROBIOL-SGM, V153, P1221, DOI 10.1099/mic.0.2006/002758-0; HACKSTADT T, 1995, P NATL ACAD SCI USA, V92, P4877, DOI 10.1073/pnas.92.11.4877; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; Hashim S, 2000, J BIOL CHEM, V275, P16281, DOI 10.1074/jbc.275.21.16281; Hayward RD, 1999, EMBO J, V18, P4926, DOI 10.1093/emboj/18.18.4926; Hubber A, 2010, ANNU REV CELL DEV BI, V26, P261, DOI 10.1146/annurev-cellbio-100109-104034; HUBER LA, 1993, J CELL BIOL, V123, P35, DOI 10.1083/jcb.123.1.35; Humphreys D, 2009, CELL HOST MICROBE, V5, P225, DOI 10.1016/j.chom.2009.01.010; Huynh KK, 2007, EMBO J, V26, P313, DOI 10.1038/sj.emboj.7601511; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Kagan JC, 2002, NAT CELL BIOL, V4, P945, DOI 10.1038/ncb883; Kreykenbohm V, 2002, EUR J CELL BIOL, V81, P273, DOI 10.1078/0171-9335-00247; Kuhle V, 2006, TRAFFIC, V7, P716, DOI 10.1111/j.1600-0854.2006.00422.x; Liewen H, 2005, EXP CELL RES, V306, P24, DOI 10.1016/j.yexcr.2005.01.022; Lin RC, 2000, ANNU REV CELL DEV BI, V16, P19, DOI 10.1146/annurev.cellbio.16.1.19; Ly KT, 2007, CELL MICROBIOL, V9, P2103, DOI 10.1111/j.1462-5822.2007.00992.x; Mallard F, 2002, J CELL BIOL, V156, P653, DOI 10.1083/jcb.200110081; McGhie EJ, 2009, CURR OPIN MICROBIOL, V12, P117, DOI 10.1016/j.mib.2008.12.001; Moore ER, 2011, MICROBIOL-SGM, V157, P830, DOI 10.1099/mic.0.045856-0; Mukherjee K, 2000, J CELL BIOL, V148, P741, DOI 10.1083/jcb.148.4.741; Murray RZ, 2005, J BIOL CHEM, V280, P10478, DOI 10.1074/jbc.M414420200; Nichols CD, 2010, CURR BIOL, V20, P1316, DOI 10.1016/j.cub.2010.05.065; Parashuraman S, 2010, FEBS LETT, V584, P1251, DOI 10.1016/j.febslet.2010.02.040; Ramsden AE, 2007, TRENDS MICROBIOL, V15, P516, DOI 10.1016/j.tim.2007.10.002; Rohde K, 2007, IMMUNOL REV, V219, P37, DOI 10.1111/j.1600-065X.2007.00547.x; Russell DG, 2001, NAT REV MOL CELL BIO, V2, P569, DOI 10.1038/35085034; Salcedo SP, 2005, CURR OPIN MICROBIOL, V8, P92, DOI 10.1016/j.mib.2004.12.007; Salcedo SP, 2003, EMBO J, V22, P5003, DOI 10.1093/emboj/cdg517; Scherer CA, 2000, MOL MICROBIOL, V37, P1133, DOI 10.1046/j.1365-2958.2000.02066.x; Simonsen A, 1999, J BIOL CHEM, V274, P28857, DOI 10.1074/jbc.274.41.28857; Smith AC, 2005, J BIOL CHEM, V280, P24634, DOI 10.1074/jbc.M500358200; Steele-Mortimer O, 2008, CURR OPIN MICROBIOL, V11, P38, DOI 10.1016/j.mib.2008.01.002; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Voos W, 1998, J CELL BIOL, V140, P577, DOI 10.1083/jcb.140.3.577; Weber SS, 2009, MOL MICROBIOL, V71, P1341, DOI 10.1111/j.1365-2958.2009.06608.x; Wendler F, 2001, MOL BIOL CELL, V12, P1699, DOI 10.1091/mbc.12.6.1699; Wendler F, 2001, TRAFFIC, V2, P606, DOI 10.1034/j.1600-0854.2001.20903.x; Wickner W, 2008, NAT STRUCT MOL BIOL, V15, P658, DOI 10.1038/nsmb.1451; Xu Y, 2001, NAT CELL BIOL, V3, P658, DOI 10.1038/35083051; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhou D, 1999, SCIENCE, V283, P2092, DOI 10.1126/science.283.5410.2092	60	23	23	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5574	5587		10.1074/jbc.M111.286120	http://dx.doi.org/10.1074/jbc.M111.286120			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22190682	hybrid, Green Published			2022-12-27	WOS:000300638000036
J	Ramakrishnan, S; Docampo, MD; MacRae, JI; Pujol, FM; Brooks, CF; van Dooren, GG; Hiltunen, JK; Kastaniotis, AJ; McConville, MJ; Striepen, B				Ramakrishnan, Srinivasan; Docampo, Melissa D.; MacRae, James I.; Pujol, Francois M.; Brooks, Carrie F.; van Dooren, Giel G.; Hiltunen, J. Kalervo; Kastaniotis, Alexander J.; McConville, Malcolm J.; Striepen, Boris			Apicoplast and Endoplasmic Reticulum Cooperate in Fatty Acid Biosynthesis in Apicomplexan Parasite Toxoplasma gondii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEAROYL-COA DESATURASE; PLASMODIUM-FALCIPARUM; CRYPTOSPORIDIUM-PARVUM; FUNCTIONAL-CHARACTERIZATION; SYNTHASE; MALARIA; GROWTH; GENE; ELONGATION; METABOLISM	Apicomplexan parasites are responsible for high impact human diseases such as malaria, toxoplasmosis, and cryptosporidiosis. These obligate intracellular pathogens are dependent on both de novo lipid biosynthesis as well as the uptake of host lipids for biogenesis of parasite membranes. Genome annotations and biochemical studies indicate that apicomplexan parasites can synthesize fatty acids via a number of different biosynthetic pathways that are differentially compartmentalized. However, the relative contribution of each of these biosynthetic pathways to total fatty acid composition of intracellular parasite stages remains poorly defined. Here, we use a combination of genetic, biochemical, and metabolomic approaches to delineate the contribution of fatty acid biosynthetic pathways in Toxoplasma gondii. Metabolic labeling studies with [C-13] glucose showed that intracellular tachyzoites synthesized a range of long and very long chain fatty acids (C14:0-26: 1). Genetic disruption of the apicoplast-localized type II fatty-acid synthase resulted in greatly reduced synthesis of saturated fatty acids up to 18 carbons long. Ablation of type II fatty-acid synthase activity resulted in reduced intracellular growth that was partially restored by addition of long chain fatty acids. In contrast, synthesis of very long chain fatty acids was primarily dependent on a fatty acid elongation system comprising three elongases, two reductases, and a dehydratase that were localized to the endoplasmic reticulum. The function of these enzymes was confirmed by heterologous expression in yeast. This elongase pathway appears to have a unique role in generating very long unsaturated fatty acids (C26:1) that cannot be salvaged from the host.	[Brooks, Carrie F.; van Dooren, Giel G.; Striepen, Boris] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA; [Ramakrishnan, Srinivasan; Docampo, Melissa D.; Striepen, Boris] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA; [MacRae, James I.; McConville, Malcolm J.] Univ Melbourne, Dept Biochem & Mol Biol, Inst Mol Sci & Biotechnol Bio21, Parkville, Vic 3010, Australia; [Pujol, Francois M.; Hiltunen, J. Kalervo; Kastaniotis, Alexander J.] Univ Oulu, Dept Biochem, FIN-90014 Oulu, Finland; [Pujol, Francois M.; Hiltunen, J. Kalervo; Kastaniotis, Alexander J.] Univ Oulu, Bioctr Oulu, FIN-90014 Oulu, Finland	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University of Melbourne; Finland National Institute for Health & Welfare; University of Oulu; University of Oulu	Striepen, B (corresponding author), Univ Georgia, Ctr Trop & Emerging Global Dis, 500 DW Brooks Dr, Athens, GA 30602 USA.	striepen@uga.edu	van Dooren, Giel G/A-8896-2012	van Dooren, Giel G/0000-0003-2455-9821; RAMAKRISHNAN, SRINIVASAN/0000-0001-8370-0528; Kastaniotis, Alexander/0000-0003-3624-9214; Hiltunen, Kalervo/0000-0002-3073-9602; MacRae, James/0000-0002-1464-8583; Striepen, Boris/0000-0002-7426-432X	National Institutes of Health [AI084414, AI064671]; National Health and Medical Research Council [1006024]; American Heart Association; Academy of Finland; Sigrid Juselius Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064671, R01AI084415, R56AI084414] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); American Heart Association(American Heart Association); Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI084414 and AI064671 (to B. S.). This work was also supported by National Health and Medical Research Council Grant 1006024 (to M. J. M.).; Supported by a predoctoral fellowship from the American Heart Association.; Recipient of funding from the Academy of Finland and the Sigrid Juselius Foundation.	Agrawal S, 2009, J BIOL CHEM, V284, P33683, DOI 10.1074/jbc.M109.044024; Amberg D. C., 2005, METHODS YEAST GENETI, P207; Bach L, 2008, P NATL ACAD SCI USA, V105, P14727, DOI 10.1073/pnas.0805089105; Bhatt A, 2007, MOL MICROBIOL, V64, P1442, DOI 10.1111/j.1365-2958.2007.05761.x; Brooks CF, 2010, CELL HOST MICROBE, V7, P62, DOI 10.1016/j.chom.2009.12.002; Carey KL, 2000, MOL BIOCHEM PARASIT, V105, P25, DOI 10.1016/S0166-6851(99)00160-7; Charron AJ, 2002, J CELL SCI, V115, P3049; CINTI DL, 1992, PROG LIPID RES, V31, P1, DOI 10.1016/0163-7827(92)90014-A; Coppens I, 2006, CELL, V125, P261, DOI 10.1016/j.cell.2006.01.056; Coppens I, 2005, INT J PARASITOL, V35, P597, DOI 10.1016/j.ijpara.2005.01.009; Coppens I, 2006, CELL MICROBIOL, V8, P1, DOI 10.1111/j.1462-5822.2005.00647.x; Denic V, 2007, CELL, V130, P663, DOI 10.1016/j.cell.2007.06.031; GEROLD P, 1994, J BIOL CHEM, V269, P2597; Goodman CD, 2007, CURR DRUG TARGETS, V8, P15, DOI 10.2174/138945007779315579; Gratraud P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006889; Gubbels MJ, 2003, ANTIMICROB AGENTS CH, V47, P309, DOI 10.1128/AAC.47.1.309-316.2003; Gupta N, 2005, J BIOL CHEM, V280, P16345, DOI 10.1074/jbc.M501523200; Hager KM, 1999, J CELL SCI, V112, P2631; Hiltunen JK, 2010, PROG LIPID RES, V49, P27, DOI 10.1016/j.plipres.2009.08.001; Jelenska J, 2001, P NATL ACAD SCI USA, V98, P2723, DOI 10.1073/pnas.051629998; Kastaniotis AJ, 2004, MOL MICROBIOL, V53, P1407, DOI 10.1111/j.1365-2958.2004.04191.x; Koo AJK, 2004, J BIOL CHEM, V279, P16101, DOI 10.1074/jbc.M311305200; Lige B, 2009, MOL BIOL CELL, V20, P658, DOI 10.1091/mbc.E08-05-0482; Lim L, 2010, FEBS LETT, V584, P549, DOI 10.1016/j.febslet.2009.11.097; Mazumdar J, 2007, EUKARYOT CELL, V6, P1727, DOI 10.1128/EC.00255-07; Mazumdar J, 2006, P NATL ACAD SCI USA, V103, P13192, DOI 10.1073/pnas.0603391103; McLeod R, 2001, INT J PARASITOL, V31, P109, DOI 10.1016/S0020-7519(01)00111-4; Meissner M, 2002, SCIENCE, V298, P837, DOI 10.1126/science.1074553; Mikolajczak SA, 2007, INT J PARASITOL, V37, P483, DOI 10.1016/j.ijpara.2007.01.002; Misra A, 2009, MOL BIOSYST, V5, P651, DOI 10.1039/b820420a; Nair SC, 2011, J EXP MED, V208, P1547, DOI 10.1084/jem.20110039; Oh CS, 1997, J BIOL CHEM, V272, P17376, DOI 10.1074/jbc.272.28.17376; Prigge ST, 2003, BIOCHEMISTRY-US, V42, P1160, DOI 10.1021/bi026847k; Qin YM, 2005, CELL RES, V15, P465, DOI 10.1038/sj.cr.7290315; Qin YM, 2007, J EXP BOT, V58, P473, DOI 10.1093/jxb/erl218; Saunders EC, 2011, J BIOL CHEM, V286, P27706, DOI 10.1074/jbc.M110.213553; Sharma A, 2008, J BIOL CHEM, V283, P24077, DOI 10.1074/jbc.M801946200; Song WQ, 2009, J EXP BOT, V60, P1839, DOI 10.1093/jxb/erp057; Striepen B., 2007, P391, DOI 10.1016/B978-012369542-0/50017-9; STUKEY JE, 1990, J BIOL CHEM, V265, P20144; Surolia N, 2001, NAT MED, V7, P167, DOI 10.1038/84612; Valdivia RH, 2008, CURR OPIN MICROBIOL, V11, P53, DOI 10.1016/j.mib.2008.01.003; Vaughan AM, 2009, CELL MICROBIOL, V11, P506, DOI 10.1111/j.1462-5822.2008.01270.x; Waller RF, 1998, P NATL ACAD SCI USA, V95, P12352, DOI 10.1073/pnas.95.21.12352; Welti R, 2007, BIOCHEMISTRY-US, V46, P13882, DOI 10.1021/bi7011993; Wu GZ, 2010, PLANT CELL, V22, P3726, DOI 10.1105/tpc.110.075564; Yeh E, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001138; Yu Min, 2008, Cell Host Microbe, V4, P567, DOI 10.1016/j.chom.2008.11.001; Zhu G, 2004, J EUKARYOT MICROBIOL, V51, P381, DOI 10.1111/j.1550-7408.2004.tb00384.x; Zhu G, 2004, MOL BIOCHEM PARASIT, V134, P127, DOI 10.1016/j.molbiopara.2003.11.011; Zhu G, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-46	51	97	100	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4957	4971		10.1074/jbc.M111.310144	http://dx.doi.org/10.1074/jbc.M111.310144			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22179608	Green Published, hybrid			2022-12-27	WOS:000300608500056
J	Sun, J; Lee, KJ; Davis, AJ; Chen, DJ				Sun, Jingxin; Lee, Kyung-Jong; Davis, Anthony J.; Chen, David J.			Human Ku70/80 Protein Blocks Exonuclease 1-mediated DNA Resection in the Presence of Human Mre11 or Mre11/Rad50 Protein Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; HOMOLOGOUS RECOMBINATION; SACCHAROMYCES-CEREVISIAE; MAMMALIAN-CELLS; GENOMIC INTEGRITY; DAMAGE SITES; REPAIR; KU; END; RAD50	DNA double strand breaks (DSB) are repaired by nonhomologous end-joining (NHEJ) or homologous recombination (HR). Recent genetic data in yeast shows that the choice between these two pathways for the repair of DSBs is via competition between the NHEJ protein, Ku, and the HR protein, Mre11/Rad50/Xrs2 (MRX) complex. To study the interrelationship between human Ku and Mre11 or Mre11/Rad50 (MR), we established an in vitro DNA end resection system using a forked model dsDNA substrate and purified human Ku70/80, Mre11, Mre11/Rad50, and exonuclease 1 (Exo1). Our study shows that the addition of Ku70/80 blocks Exo1-mediated DNA end resection of the forked dsDNA substrate. Although human Mre11 and MR bind to the forked double strand DNA, they could not compete with Ku for DNA ends or actively mediate the displacement of Ku from the DNA end either physically or via its exonuclease or endonuclease activity. Our in vitro studies show that Ku can block DNA resection and suggest that Ku must be actively displaced for DNA end processing to occur and is more complicated than the competition model established in yeast.	[Sun, Jingxin; Lee, Kyung-Jong; Davis, Anthony J.; Chen, David J.] Univ Texas SW Med Ctr Dallas, Div Mol Radiat Biol, Dept Radiat Oncol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Chen, DJ (corresponding author), 2201 Inwood Rd, Dallas, TX 75390 USA.	david.chen@utsouthwestern.edu	Classen, Scott/AAY-8176-2020	Davis, Anthony/0000-0003-0184-3651	National Institutes of Health [CA50519, CA134991, CA92584]; Cancer Research Institute of Texas [RP110465]; NATIONAL CANCER INSTITUTE [R01CA162804, R01CA050519, R01CA134991, R37CA050519, P01CA092584] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute of Texas; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA50519, CA134991, and CA92584 and Cancer Research Institute of Texas Grant RP110465.	Allen C, 2002, P NATL ACAD SCI USA, V99, P3758, DOI 10.1073/pnas.052545899; Aravind L, 2000, TRENDS BIOCHEM SCI, V25, P112, DOI 10.1016/S0968-0004(99)01537-6; Bennardo N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000110; Buis J, 2008, CELL, V135, P85, DOI 10.1016/j.cell.2008.08.015; Burma S, 2006, DNA REPAIR, V5, P1042, DOI 10.1016/j.dnarep.2006.05.026; Couedel C, 2004, GENE DEV, V18, P1293, DOI 10.1101/gad.1209204; FALZON M, 1993, J BIOL CHEM, V268, P10546; Feldmann H, 1996, J BIOL CHEM, V271, P27765, DOI 10.1074/jbc.271.44.27765; Fiorentini P, 1997, MOL CELL BIOL, V17, P2764, DOI 10.1128/MCB.17.5.2764; Huertas P, 2008, NATURE, V455, P689, DOI 10.1038/nature07215; Kass EM, 2010, FEBS LETT, V584, P3703, DOI 10.1016/j.febslet.2010.07.057; Kim JS, 2005, J CELL BIOL, V170, P341, DOI 10.1083/jcb.200411083; Langerak P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002271; Lim HS, 2011, GENE DEV, V25, P1091, DOI 10.1101/gad.2037811; LINDAHL T, 1993, COLD SPRING HARB SYM, V58, P619, DOI 10.1101/SQB.1993.058.01.068; Llorente B, 2004, MOL CELL BIOL, V24, P9682, DOI 10.1128/MCB.24.21.9682-9694.2004; Mimitou EP, 2010, EMBO J, V29, P3358, DOI 10.1038/emboj.2010.193; Pastink A, 2001, MUTAT RES-FUND MOL M, V480, P37, DOI 10.1016/S0027-5107(01)00167-1; Paull TT, 1999, GENE DEV, V13, P1276, DOI 10.1101/gad.13.10.1276; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Pierce AJ, 2001, GENE DEV, V15, P3237, DOI 10.1101/gad.946401; Shao ZP, 2012, DNA REPAIR, V11, P310, DOI 10.1016/j.dnarep.2011.12.007; Shim EY, 2010, EMBO J, V29, P3370, DOI 10.1038/emboj.2010.219; Siede W, 1996, GENETICS, V142, P91; So SR, 2009, J CELL BIOL, V187, P977, DOI 10.1083/jcb.200906064; Sonoda E, 2006, DNA REPAIR, V5, P1021, DOI 10.1016/j.dnarep.2006.05.022; SUN H, 1991, CELL, V64, P1155, DOI 10.1016/0092-8674(91)90270-9; Tomita K, 2003, MOL CELL BIOL, V23, P5186, DOI 10.1128/MCB.23.15.5186-5197.2003; Uematsu N, 2007, J CELL BIOL, V177, P219, DOI 10.1083/jcb.200608077; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000; WHITE MB, 1990, MOL CELL BIOL, V10, P3690, DOI 10.1128/MCB.10.7.3690; Williams GJ, 2011, NAT STRUCT MOL BIOL, V18, P423, DOI 10.1038/nsmb.2038; Wu DL, 2008, GENETICS, V178, P1237, DOI 10.1534/genetics.107.083535; Yoo S, 1999, J BIOL CHEM, V274, P20034, DOI 10.1074/jbc.274.28.20034	34	54	58	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4936	4945		10.1074/jbc.M111.306167	http://dx.doi.org/10.1074/jbc.M111.306167			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22179609	Green Published, hybrid			2022-12-27	WOS:000300608500054
J	Namanja, AT; Li, YJ; Su, Y; Wong, S; Lu, JJ; Colson, LT; Wu, CG; Li, SSC; Chen, Y				Namanja, Andrew T.; Li, Yi-Jia; Su, Yang; Wong, Steven; Lu, Jingjun; Colson, Loren T.; Wu, Chenggang; Li, Shawn S. C.; Chen, Yuan			Insights into High Affinity Small Ubiquitin-like Modifier (SUMO) Recognition by SUMO-interacting Motifs (SIMs) Revealed by a Combination of NMR and Peptide Array Analysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING MOTIF; E3 LIGASE; IN-VIVO; SUMOYLATION; MECHANISM; PROTEINS; ROLES; DYNAMICS; FACTOR-1; DOMAINS	The small ubiquitin-like modifiers (SUMOs) regulate many essential cellular functions. Only one type of SUMO-interacting motif (SIM) has been identified that can extend the beta-sheet of SUMO as either a parallel or an antiparallel strand. The molecular determinants of the bound orientation and paralogue specificity of a SIM are unclear. To address this question, we have conducted structural studies of SUMO1 in complex with a SUMO1-specific SIM that binds to SUMO1 with high affinity without post-translational modifications using nuclear magnetic resonance methods. In addition, the SIM sequence requirements have been investigated by peptide arrays in comparison with another high affinity SIM that binds in the opposing orientation. We found that antiparallel binding SIMs tolerate more diverse sequences, whereas the parallel binding SIMs prefer the more strict sequences consisting of (I/V) DLT that have a preference in high affinity SUMO2 and -3 binding. Comparison of two high affinity SUMO1-binding SIMs that bind in opposing orientations has revealed common SUMO1-specific interactions needed for high affinity binding. This study has significantly advanced our understanding of the molecular determinants underlining SUMO-SIM recognition.	[Namanja, Andrew T.; Li, Yi-Jia; Su, Yang; Wong, Steven; Lu, Jingjun; Colson, Loren T.; Chen, Yuan] City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Med, Duarte, CA 91010 USA; [Wu, Chenggang; Li, Shawn S. C.] Univ Western Ontario, Dept Biochem, Schulich Sch Med & Dent, London, ON N6A 5C1, Canada	City of Hope; Beckman Research Institute of City of Hope; Western University (University of Western Ontario)	Chen, Y (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Med, 1500 E Duarte Rd, Duarte, CA 91010 USA.	ychen@coh.org		Li, Yi-Jia/0000-0002-8791-8097; Namanja, Andrew/0000-0001-8950-8860	National Institutes of Health [R01GM074748, R01GM086171, F32CA134180]; AMMI; NATIONAL CANCER INSTITUTE [F32CA134180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086171, R01GM074748] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AMMI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM074748 and R01GM086171 (to Y. C.) and F32CA134180 (to Y. L.).; Supported by an AMMI grant.	Ayaydin F, 2004, MOL BIOL CELL, V15, P5208, DOI 10.1091/mbc.E04-07-0589; Chang CC, 2011, MOL CELL, V42, P62, DOI 10.1016/j.molcel.2011.02.022; Chang PC, 2010, J BIOL CHEM, V285, P5266, DOI 10.1074/jbc.M109.088088; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; Dasso M, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-5; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; DUNITZ JD, 1994, SCIENCE, V264, P670, DOI 10.1126/science.264.5159.670; Escobar-Cabrera E, 2011, J BIOL CHEM, V286, P19816, DOI 10.1074/jbc.M111.231647; Frank R, 2002, J IMMUNOL METHODS, V267, P13, DOI 10.1016/S0022-1759(02)00137-0; Hay RT, 2001, TRENDS BIOCHEM SCI, V26, P332, DOI 10.1016/S0968-0004(01)01849-7; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Joseph J, 2004, CURR BIOL, V14, P611, DOI 10.1016/j.cub.2004.03.031; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kovrigin EL, 2006, BIOCHEMISTRY-US, V45, P2636, DOI 10.1021/bi0525066; Li SSC, 2009, METHODS MOL BIOL, V570, P67, DOI 10.1007/978-1-60327-394-7_3; Li YJ, 2010, ONCOGENE, V29, P3509, DOI 10.1038/onc.2010.108; Martin S, 2007, NAT REV NEUROSCI, V8, P948, DOI 10.1038/nrn2276; Meulmeester E, 2008, MOL CELL, V30, P610, DOI 10.1016/j.molcel.2008.03.021; Meulmeester E, 2008, NATURE, V452, P709, DOI 10.1038/452709a; Mo YY, 2005, ONCOGENE, V24, P2677, DOI 10.1038/sj.onc.1208210; Muller S, 2001, NAT REV MOL CELL BIO, V2, P202, DOI 10.1038/35056591; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Sekiyama N, 2008, J BIOL CHEM, V283, P35966, DOI 10.1074/jbc.M802528200; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Song J, 2005, J BIOL CHEM, V280, P40122, DOI 10.1074/jbc.M507059200; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; Song J, 2009, PROTEIN SCI, V18, P2265, DOI 10.1002/pro.237; Tatham MH, 2005, NAT STRUCT MOL BIOL, V12, P67, DOI 10.1038/nsmb878; Truong K, 2011, BIOCHEMISTRY-US, V50, P5757, DOI 10.1021/bi2001856; Ulrich HD, 2009, DNA REPAIR, V8, P429, DOI 10.1016/j.dnarep.2009.01.012; Varshavsky A, 1997, TRENDS BIOCHEM SCI, V22, P383, DOI 10.1016/S0968-0004(97)01122-5; Zhu SS, 2009, MOL CELL, V33, P570, DOI 10.1016/j.molcel.2009.02.008	33	51	53	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3231	3240		10.1074/jbc.M111.293118	http://dx.doi.org/10.1074/jbc.M111.293118			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22147707	Green Published, hybrid			2022-12-27	WOS:000300295100028
J	Osborn-Heaford, HL; Ryan, AJ; Murthy, S; Racila, AM; He, C; Sieren, JC; Spitz, DR; Carter, AB				Osborn-Heaford, Heather L.; Ryan, Alan J.; Murthy, Shubha; Racila, Ana-Monica; He, Chao; Sieren, Jessica C.; Spitz, Douglas R.; Carter, A. Brent			Mitochondrial Rac1 GTPase Import and Electron Transfer from Cytochrome c Are Required for Pulmonary Fibrosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASBESTOS INDUCES APOPTOSIS; RHO GTPASES; IN-VIVO; REDOX REGULATION; GENE-EXPRESSION; CELL APOPTOSIS; NADPH OXIDASE; TNF-ALPHA; MACROPHAGES; GENERATION	The generation of reactive oxygen species, particularly H2O2, from alveolar macrophages is causally related to the development of pulmonary fibrosis. Rac1, a small GTPase, is known to increase mitochondrial H2O2 generation in macrophages; however, the mechanism by which this occurs is not known. This study shows that Rac1 is localized in the mitochondria of alveolar macrophages from asbestosis patients, and mitochondrial import requires the C-terminal cysteine of Rac1 (Cys-189), which is post-translationally modified by geranylgeranylation. Furthermore, H2O2 generation mediated by mitochondrial Rac1 requires electron transfer from cytochrome c to a cysteine residue on Rac1 (Cys-178). Asbestos-exposed mice harboring a conditional deletion of Rac1 in macrophages demonstrated decreased oxidative stress and were significantly protected from developing pulmonary fibrosis. These observations demonstrate that mitochondrial import and direct electron transfer from cytochrome c to Rac1 modulates mitochondrial H2O2 production in alveolar macrophages pulmonary fibrosis.	[Osborn-Heaford, Heather L.; Ryan, Alan J.; Murthy, Shubha; Racila, Ana-Monica; Carter, A. Brent] Univ Iowa, Carver Coll Med, Dept Internal Med, Free Rad & Radiat Biol Program, Iowa City, IA 52242 USA; [He, Chao; Spitz, Douglas R.; Carter, A. Brent] Univ Iowa, Carver Coll Med, Dept Radiat Oncol, Free Rad & Radiat Biol Program, Iowa City, IA 52242 USA; [Sieren, Jessica C.] Univ Iowa, Carver Coll Med, Dept Radiol, Iowa City, IA 52242 USA; [Carter, A. Brent] Univ Iowa, Coll Publ Hlth, Human Toxicol Program, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa	Carter, AB (corresponding author), Univ Iowa, Carver Coll Med, Dept Internal Med, Free Rad & Radiat Biol Program, C33 GH,200 Hawkins Dr, Iowa City, IA 52242 USA.	brent-carter@uiowa.edu		Sieren, Jessica/0000-0002-1109-7886; Racila, Ana-Monica/0000-0002-5751-5422; Spitz, Douglas/0000-0002-1254-8765	National Institutes of Health [ES015981, ES014871, CA133114, P30 CA086862, UL1RR024979]; Department of Veterans Affairs; NATIONAL CANCER INSTITUTE [R01CA133114, P30CA086862] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024979] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015981, R01ES014871] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants ES015981 and ES014871(to A. B. C.), CA133114 (to D. R. S.), P30 CA086862 (to University of Iowa Cancer Center), and UL1RR024979 (to University of Iowa Institute of Clinical and Translational Science). This work was also supported by a Merit Review from the Department of Veterans Affairs (to A. B. C.).	Attfield M. D., 2004, Morbidity and Mortality Weekly Report, V53, P627; BOIVIN D, 1995, AM J PHYSIOL-RENAL, V269, pF180, DOI 10.1152/ajprenal.1995.269.2.F180; Broaddus VC, 1996, J CLIN INVEST, V98, P2050, DOI 10.1172/JCI119010; Chade AR, 2008, J HYPERTENS, V26, P1651, DOI 10.1097/HJH.0b013e328302833a; Chen CC, 2007, EMBO J, V26, P1257, DOI 10.1038/sj.emboj.7601596; Deshpande SS, 2000, FASEB J, V14, P1705, DOI 10.1096/fj.99-0910com; Deshpande SS, 2003, ARTERIOSCL THROM VAS, V23, pE1, DOI 10.1161/01.ATV.0000047869.13737.53; Giorgio M, 2005, CELL, V122, P221, DOI 10.1016/j.cell.2005.05.011; Glogauer M, 2003, J IMMUNOL, V170, P5652, DOI 10.4049/jimmunol.170.11.5652; Guidotti TL, 2004, AM J RESP CRIT CARE, V170, P691, DOI 10.1164/rccm.200310-1436ST; Hall AB, 2006, IMMUNITY, V24, P305, DOI 10.1016/j.immuni.2006.02.005; Hamilton RF, 1996, AM J PHYSIOL-LUNG C, V271, pL813, DOI 10.1152/ajplung.1996.271.5.L813; Harraz MM, 2008, J CLIN INVEST, V118, P659, DOI 10.1172/JCI34060; He C, 2011, J BIOL CHEM, V286, P15597, DOI 10.1074/jbc.M110.187377; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Heo JY, 2006, BIOCHEMISTRY-US, V45, P14481, DOI 10.1021/bi0610101; Jacobson JR, 2005, AM J PHYSIOL-LUNG C, V288, pL1026, DOI 10.1152/ajplung.00354.2004; Kamp DW, 2002, MOL CELL BIOCHEM, V234, P153, DOI 10.1023/A:1015949118495; Kheradmand F, 1998, SCIENCE, V280, P898, DOI 10.1126/science.280.5365.898; Kowluru A, 2003, ENDOCR RES, V29, P363, DOI 10.1081/ERC-120025043; Li M, 2008, PROTEIN PEPTIDE LETT, V15, P200; Malinouski M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014564; Mesecke N, 2005, CELL, V121, P1059, DOI 10.1016/j.cell.2005.04.011; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Michaelson D, 2008, J CELL BIOL, V181, P485, DOI 10.1083/jcb.200801047; MOSSMAN BT, 1989, ENVIRON HEALTH PERSP, V81, P91, DOI 10.2307/3430811; Murthy S, 2010, J BIOL CHEM, V285, P25062, DOI 10.1074/jbc.M109.099655; Murthy S, 2009, AM J PHYSIOL-LUNG C, V297, pL846, DOI 10.1152/ajplung.90590.2008; Namati E, 2006, PHYS MED BIOL, V51, P6061, DOI 10.1088/0031-9155/51/23/008; Ostrau C, 2009, RADIOTHER ONCOL, V92, P492, DOI 10.1016/j.radonc.2009.06.020; Ozaki M, 2000, J BIOL CHEM, V275, P35377, DOI 10.1074/jbc.M005287200; QIU RG, 1995, NATURE, V374, P457, DOI 10.1038/374457a0; Raghu G, 2006, AM J RESP CRIT CARE, V174, P810, DOI 10.1164/rccm.200602-163OC; Roberts AW, 1999, IMMUNITY, V10, P183, DOI 10.1016/S1074-7613(00)80019-9; Sanlioglu S, 2001, J BIOL CHEM, V276, P30188, DOI 10.1074/jbc.M102061200; Senger DL, 2002, CANCER RES, V62, P2131; Shyamsundar M, 2009, AM J RESP CRIT CARE, V179, P1107, DOI 10.1164/rccm.200810-1584OC; Tephly LA, 2007, AM J PHYSIOL-LUNG C, V293, pL1143, DOI 10.1152/ajplung.00114.2007; Thiesse J, 2010, J APPL PHYSIOL, V109, P1960, DOI 10.1152/japplphysiol.01322.2009; TURRENS JF, 1980, BIOCHEM J, V191, P421, DOI 10.1042/bj1910421; Ueda S, 1998, J IMMUNOL, V161, P6689; Velaithan R, 2011, BLOOD, V117, P6214, DOI 10.1182/blood-2010-08-301283; Watts KL, 2005, AM J RESP CELL MOL, V32, P290, DOI 10.1165/rcmb.2004-0127OC; Wells CM, 2004, J CELL SCI, V117, P1259, DOI 10.1242/jcs.00997; Werner E, 2002, J CELL BIOL, V158, P357, DOI 10.1083/jcb.200111028; Zeng PY, 2003, ONCOGENE, V22, P1124, DOI 10.1038/sj.onc.1206181; Zhang BL, 2004, MOL CELL BIOL, V24, P6205, DOI 10.1128/MCB.24.14.6205-6214.2004; Zhao YG, 2003, J BIOL CHEM, V278, P2356, DOI 10.1074/jbc.M209681200	48	64	67	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3301	3312		10.1074/jbc.M111.308387	http://dx.doi.org/10.1074/jbc.M111.308387			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22157762	hybrid, Green Published			2022-12-27	WOS:000300295100036
J	Hu, SQ; Ye, JS; Zong, YY; Sun, CC; Liu, DH; Wu, YP; Song, T; Zhang, GY				Hu, Shu-Qun; Ye, Jun-Song; Zong, Yan-Yan; Sun, Chang-Cheng; Liu, Dong-Hai; Wu, Yong-Ping; Song, Tao; Zhang, Guang-Yi			S-Nitrosylation of Mixed Lineage Kinase 3 Contributes to Its Activation after Cerebral Ischemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL NITRIC-OXIDE; RAT HIPPOCAMPUS; PROTEIN-KINASE; TUMOR-SUPPRESSOR; APOPTOSIS; MECHANISM; SYNTHASE; RECEPTOR; PATHWAY; INJURY	Previous studies in our laboratory have shown that mixed lineage kinase 3 (MLK3) can be activated following global ischemia. In addition, other laboratories have reported that the activation of MLK3 may be linked to the accumulation of free radicals. However, the mechanism of MLK3 activation remains incompletely understood. We report here that MLK3, overexpressed in HEK293 cells, is S-nitrosylated (forming SNO-MLK3) via a reaction with S-nitrosoglutathione, an exogenous nitric oxide (NO) donor, at one critical cysteine residue (Cys-688). We further show that the S-nitrosylation of MLK3 contributes to its dimerization and activation. We also investigated whether the activation of MLK3 is associated with S-nitrosylation following rat brain is chemia/reperfusion. Our results show that the administration of 7-nitroindazole, an inhibitor of neuronal NO synthase (nNOS), or nNOS antisense oligodeoxy-nucleotides diminished the S-nitrosylation of MLK3 and inhibited its activation induced by cerebral ischemia/reperfusion. In contrast, 2-amino-5,6-dihydro-6-methyl-4H-1,3-thiazine (an inhibitor of inducible NO synthase) or nNOS missense oligode-oxynucleotides did not affect the S-nitrosylation of MLK3. In addition, treatment with sodium nitroprusside (an exogenous NO donor) and S-nitrosoglutathione or MK801, an antagonist of the N-methyl-D-aspartate receptor, also diminished the S-nitrosylation and activation of MLK3 induced by cerebral ischemia/reperfusion. The activation of MLK3 facilitated its downstream protein kinase kinase 4/7 (MKK4/7)-JNK signaling module and both nuclear and non-nuclear apoptosis pathways. These data suggest that the activation of MLK3 during the early stages of ischemia/reperfusion is modulated by S-nitrosylation and provides a potential new approach for stroke therapy whereby the post-translational modification machinery is targeted.	[Hu, Shu-Qun; Ye, Jun-Song; Zong, Yan-Yan; Sun, Chang-Cheng; Liu, Dong-Hai; Zhang, Guang-Yi] Xuzhou Med Coll, Jiangsu Key Lab Brain Dis Bioinformat, Xuzhou 221002, Jiangsu, Peoples R China; [Hu, Shu-Qun; Ye, Jun-Song; Zong, Yan-Yan; Sun, Chang-Cheng; Liu, Dong-Hai; Zhang, Guang-Yi] Xuzhou Med Coll, Res Ctr Biochem & Mol Biol, Xuzhou 221002, Jiangsu, Peoples R China; [Wu, Yong-Ping] Xuzhou Med Coll, Jiangsu Key Lab Anesthesiol, Xuzhou 221002, Jiangsu, Peoples R China; [Song, Tao] China Med Univ, Affiliated Hosp 1, Dept Anesthesiol, Shenyang 110001, Peoples R China	Xuzhou Medical University; Xuzhou Medical University; Xuzhou Medical University; China Medical University	Zhang, GY (corresponding author), Xuzhou Med Coll, Jiangsu Key Lab Brain Dis Bioinformat, Xuzhou 221002, Jiangsu, Peoples R China.	gyzhang@xzmc.edu.cn		Song, Tao/0000-0002-6438-1100	National Natural Science Foundation of China [30870543, 90608015]; Natural Science Foundation of Jiangsu [BK2010171]; Jiangsu Educational Science Foundation [10KJA310053]; Xuzhou Medical College Science Foundation [2010KJZ12]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu(Natural Science Foundation of Jiangsu Province); Jiangsu Educational Science Foundation; Xuzhou Medical College Science Foundation	This work was supported by Project of National Natural Science Foundation of China Grants 30870543 and 90608015, Natural Science Foundation of Jiangsu Grant BK2010171, Jiangsu Educational Science Foundation Grant 10KJA310053, and Xuzhou Medical College Science Foundation Grant 2010KJZ12.	Almeida A, 1999, BRAIN RES, V816, P580, DOI 10.1016/S0006-8993(98)01240-2; Azad N, 2006, J BIOL CHEM, V281, P34124, DOI 10.1074/jbc.M602551200; BOJE KM, 1992, BRAIN RES, V587, P250, DOI 10.1016/0006-8993(92)91004-X; Choi Dennis W., 1995, Trends in Neurosciences, V18, P58, DOI 10.1016/0166-2236(95)93870-4; Christopherson KS, 1999, J BIOL CHEM, V274, P27467, DOI 10.1074/jbc.274.39.27467; Derakhshan B, 2007, CARDIOVASC RES, V75, P210, DOI 10.1016/j.cardiores.2007.04.023; GALLO KA, 1994, J BIOL CHEM, V269, P15092; Gallo KA, 2002, NAT REV MOL CELL BIO, V3, P663, DOI 10.1038/nrm906; Gu ZL, 2001, NEUROREPORT, V12, P897, DOI 10.1097/00001756-200104170-00006; HEWETT SJ, 1994, NEURON, V13, P487, DOI 10.1016/0896-6273(94)90362-X; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Leung IWL, 1998, J BIOL CHEM, V273, P32408, DOI 10.1074/jbc.273.49.32408; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; Lipton SA, 1998, CELL CALCIUM, V23, P165, DOI 10.1016/S0143-4160(98)90115-4; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Park HS, 2000, P NATL ACAD SCI USA, V97, P14382, DOI 10.1073/pnas.97.26.14382; Park HS, 2004, J BIOL CHEM, V279, P7584, DOI 10.1074/jbc.M304183200; Parratt JR, 1998, J ANTIMICROB CHEMOTH, V41, P31, DOI 10.1093/jac/41.suppl_1.31; Pei DS, 2008, J NEUROCHEM, V106, P1952, DOI 10.1111/j.1471-4159.2008.05531.x; Pei DS, 2009, NEUROCHEM RES, V34, P1507, DOI 10.1007/s11064-009-9938-3; Pei DS, 2004, NEUROSCI LETT, V367, P71, DOI 10.1016/j.neulet.2004.05.082; Pi XC, 2009, P NATL ACAD SCI USA, V106, P5675, DOI 10.1073/pnas.0809568106; PULSINELLI WA, 1979, STROKE, V10, P267, DOI 10.1161/01.STR.10.3.267; Rahman MA, 2010, J BIOL CHEM, V285, P3806, DOI 10.1074/jbc.M109.059782; Samdani AF, 1997, STROKE, V28, P1283, DOI 10.1161/01.STR.28.6.1283; Simpson L, 2001, EXP CELL RES, V264, P29, DOI 10.1006/excr.2000.5130; Song Y. J., 2005, ACTA ACAD MED XUZHOU, V25, P385; Stamler JS, 2001, CELL, V106, P675, DOI 10.1016/S0092-8674(01)00495-0; Tenneti L, 1997, NEUROSCI LETT, V236, P139, DOI 10.1016/S0304-3940(97)00780-5; Teramoto H, 1996, J BIOL CHEM, V271, P27225, DOI 10.1074/jbc.271.44.27225; Tian H, 2003, NEUROSCI RES, V47, P47, DOI 10.1016/S0168-0102(03)00186-X; Tsang AHK, 2009, P NATL ACAD SCI USA, V106, P4900, DOI 10.1073/pnas.0810595106; Vazquez F, 2000, BBA-REV CANCER, V1470, pM21, DOI 10.1016/S0304-419X(99)00032-3; Yasukawa T, 2005, J BIOL CHEM, V280, P7511, DOI 10.1074/jbc.M411871200; Yu HM, 2008, NEUROSCIENCE, V155, P1120, DOI 10.1016/j.neuroscience.2008.03.061; Yuan ZQ, 2003, J BIOL CHEM, V278, P23432, DOI 10.1074/jbc.M302674200; Zhang QX, 2007, BIOCHEMISTRY-US, V46, P4006, DOI 10.1021/bi0615386; ZORUMSKI CF, 1993, PHARMACOL THERAPEUT, V59, P145, DOI 10.1016/0163-7258(93)90043-D	38	41	45	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2364	2377		10.1074/jbc.M111.227124	http://dx.doi.org/10.1074/jbc.M111.227124			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22123824	Green Published, hybrid			2022-12-27	WOS:000300292300012
J	Lee, CC; Chen, WS; Chen, CC; Chen, LL; Lin, YS; Fan, CS; Huang, TS				Lee, Chun-Chung; Chen, Wei-Shone; Chen, Chia-Chi; Chen, Li-Li; Lin, Yi-Shing; Fan, Chi-Shuan; Huang, Tze-Sing			TCF12 Protein Functions as Transcriptional Repressor of E-cadherin, and Its Overexpression Is Correlated with Metastasis of Colorectal Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITIONS; LOOP-HELIX PROTEINS; GENE-EXPRESSION; HEPATOCELLULAR-CARCINOMA; TUMOR PROGRESSION; PROSTATE-CANCER; CELL-JUNCTIONS; TWIST; HEB; DIFFERENTIATION	A correlation of TCF12 mRNA overexpression with colorectal cancer (CRC) metastasis was suggested by microarray data and validated by the survey of 120 patients. Thirty-three (27.5%) of the 120 patients showed tumor TCF12 mRNA overexpression and had a higher rate of metastatic occurrence (p = 0.020) and a poorer survival outcome (p = 0.014). Abundant TCF12 levels were also observed in human CRC cell lines such as SW620 and LoVo, but a relatively low level was detected in SW480 cells. Knockdown of TCF12 expression in SW620 and LoVo cells drastically reduced their activities of migration, invasion, and metastasis. Tight cell-cell contact and an increase in E-cadherin but a concomitant decrease in fibronectin were observed in TCF12-knockdown cells. Connexin 26, connexin 43, and gap-junction activity were also increased upon TCF12-knockdown. In contrast, ectopic TCF12 overexpression in SW480 cells facilitated fibronectin expression and cell migration and invasion activities but diminished cellular levels of E-cadherin, connexin 26, connexin 43, and gap junction. A physical association of TCF12 with the E-cadherin promoter was evidenced by chromatin immunoprecipitation assay. TCF12 was tightly correlated with cellular expression of Bmi1 and EZH2 and was co-immunoprecipitable with Bmi1 and EZH2, suggesting that TCF12 transcriptionally suppressed E-cadherin expression via polycomb group-repressive complexes. Clinically, TCF12 mRNA overexpression was also correlated with E-cadherin mRNA down-regulation in the tumor tissues of our 120 patients (p = 0.013). These studies suggested that TCF12 functioned as a transcriptional repressor of E-cadherin and its overexpression was significantly correlated with the occurrence of CRC metastasis.	[Lee, Chun-Chung; Chen, Chia-Chi; Chen, Li-Li; Fan, Chi-Shuan; Huang, Tze-Sing] Natl Hlth Res Inst, Natl Inst Canc Res, Zhunan Town 350, Miaoli, Taiwan; [Chen, Wei-Shone] Natl Yang Ming Univ, Taipei Vet Gen Hosp, Div Expt Surg, Dept Surg, Taipei 112, Taiwan; [Chen, Wei-Shone] Natl Yang Ming Univ, Taipei Vet Gen Hosp, Div Colon & Rectal Surg, Dept Surg, Taipei 112, Taiwan; [Chen, Wei-Shone] Natl Yang Ming Univ, Sch Med, Dept Surg, Taipei 112, Taiwan; [Lin, Yi-Shing] Welgene Biotech Co Ltd, Taipei 115, Taiwan	National Health Research Institutes - Taiwan; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Huang, TS (corresponding author), Natl Hlth Res Inst, Natl Inst Canc Res, 35 Keyan Rd, Zhunan Town 350, Miaoli, Taiwan.	tshuang@nhri.org.tw	Huang, Tze-Sing/E-3667-2010; Huang, Tze-Sing/C-9361-2013	Huang, Tze-Sing/0000-0001-8736-4330	National Health Research Institutes [CA-099-PP-10, CA-100-PP-10]; Department of Health, Taiwan, Republic of China [DOH100-TD-C-111-004]; National Research Program for Genomic Medicine, Taiwan, Republic of China [NSC 97-3112-B-001-016]	National Health Research Institutes(National Health Research Institutes, Japan); Department of Health, Taiwan, Republic of China; National Research Program for Genomic Medicine, Taiwan, Republic of China(Ministry of Science and Technology, Taiwan)	This study was supported by National Health Research Institutes Grants CA-099-PP-10 and CA-100-PP-10 and Department of Health Grant DOH100-TD-C-111-004, Taiwan, Republic of China.; TCF12 shRNA was obtained from the National RNAi Core Facility sponsored by the National Research Program for Genomic Medicine Grants (NSC 97-3112-B-001-016), Taiwan, Republic of China.	Berx G, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003129; BIRCHMEIER W, 1994, BBA-REV CANCER, V1198, P11, DOI 10.1016/0304-419X(94)90003-5; Chakraborty S, 2010, J BIOL CHEM, V285, P10761, DOI 10.1074/jbc.M109.053348; Chen JJW, 2001, CANCER RES, V61, P5223; Chen WX, 2005, COMMUN PUR APPL ANAL, V4, P1; Christiansen JJ, 2006, CANCER RES, V66, P8319, DOI 10.1158/0008-5472.CAN-06-0410; Conway K, 2004, DIFFERENTIATION, V72, P327, DOI 10.1111/j.1432-0436.2004.07207004.x; Czyz J, 2000, EXP CELL RES, V255, P40, DOI 10.1006/excr.1999.4760; de Boer TP, 2007, DIFFERENTIATION, V75, P208, DOI 10.1111/j.1432-0436.2006.00133.x; Ding SJ, 2004, MOL CELL PROTEOMICS, V3, P73, DOI 10.1074/mcp.M300094-MCP200; DOYLE K, 1994, J BIOL CHEM, V269, P12099; Egli D, 2008, NAT REV MOL CELL BIO, V9, P505, DOI 10.1038/nrm2439; Engel I, 2001, NAT REV IMMUNOL, V1, P193, DOI 10.1038/35105060; Fokas E, 2007, CANCER METAST REV, V26, P705, DOI 10.1007/s10555-007-9088-5; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hoek K, 2004, CANCER RES, V64, P5270, DOI 10.1158/0008-5472.CAN-04-0731; Howe LR, 2003, CANCER RES, V63, P1906; HU JS, 1992, MOL CELL BIOL, V12, P1031, DOI 10.1128/MCB.12.3.1031; Khanna C, 2001, CANCER RES, V61, P3750; Kwok WK, 2005, CANCER RES, V65, P5153, DOI 10.1158/0008-5472.CAN-04-3785; Kyo S, 2006, HUM PATHOL, V37, P431, DOI 10.1016/j.humpath.2005.12.021; Li QW, 2008, NEOPLASIA, V10, P1444, DOI 10.1593/neo.08968; Li YJ, 2007, J AM SOC NEPHROL, V18, P449, DOI 10.1681/ASN.2006030236; Magee AI, 1991, CURR OPIN CELL BIOL, V3, P854, DOI 10.1016/0955-0674(91)90060-C; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; McLachlan E, 2006, CANCER RES, V66, P9886, DOI 10.1158/0008-5472.CAN-05-4302; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; SAWADA S, 1993, MOL CELL BIOL, V13, P5620, DOI 10.1128/MCB.13.9.5620; Taylor BS, 2006, BRIT J CANCER, V95, P425, DOI 10.1038/sj.bjc.6603274; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Uittenbogaard M., 2002, Gene Expression Patterns, V1, P115, DOI 10.1016/S1567-133X(01)00022-9; Vesuna F, 2008, BIOCHEM BIOPH RES CO, V367, P235, DOI 10.1016/j.bbrc.2007.11.151; Wang DC, 2006, J IMMUNOL, V177, P109, DOI 10.4049/jimmunol.177.1.109; Wincewicz A, 2010, INT J GYNECOL PATHOL, V29, P358, DOI 10.1097/PGP.0b013e3181c3c57f; Xie FW, 2009, CLIN EXP METASTAS, V26, P1025, DOI 10.1007/s10585-009-9292-5; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang MH, 2010, NAT CELL BIOL, V12, P982, DOI 10.1038/ncb2099; Yang MH, 2009, HEPATOLOGY, V50, P1464, DOI 10.1002/hep.23221; ZHANG Y, 1991, NUCLEIC ACIDS RES, V19, P4555, DOI 10.1093/nar/19.16.4555	41	71	74	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2798	2809		10.1074/jbc.M111.258947	http://dx.doi.org/10.1074/jbc.M111.258947			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22130667	Green Published, hybrid			2022-12-27	WOS:000300292300051
J	Freville, A; Landrieu, I; Garcia-Gimeno, MA; Vicogne, J; Montbarbon, M; Bertin, B; Verger, A; Kalamou, H; Sanz, P; Werkmeister, E; Pierrot, C; Khalife, J				Freville, Aline; Landrieu, Isabelle; Adelaida Garcia-Gimeno, M.; Vicogne, Jerome; Montbarbon, Muriel; Bertin, Benjamin; Verger, Alexis; Kalamou, Hadidjatou; Sanz, Pascual; Werkmeister, Elisabeth; Pierrot, Christine; Khalife, Jamal			Plasmodium falciparum Inhibitor-3 Homolog Increases Protein Phosphatase Type 1 Activity and Is Essential for Parasitic Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RICH REPEAT PROTEIN; SACCHAROMYCES-CEREVISIAE; MALARIA PARASITE; STRUCTURAL BASIS; SERINE/THREONINE PHOSPHATASE; DISORDERED PROTEIN; POTENT INHIBITOR; PP1 PHOSPHATASE; CHEMICAL-SHIFTS; EMERGING ROLES	Growing evidence indicates that the protein regulators governing protein phosphatase 1 (PP1) activity have crucial functions because their deletion drastically affects cell growth and division. PP1 has been found to be essential in Plasmodium falciparum, but little is known about its regulators. In this study, we have identified a homolog of Inhibitor-3 of PP1, named PfI3. NMR analysis shows that PfI3 belongs to the disordered protein family. High affinity interaction of PfI3 and PfPP1 is demonstrated in vitro using several methods, with an apparent dissociation constant K-D of 100 nM. We further show that the conserved (KVVRW45)-K-41 motif is crucial for this interaction as the replacement of the Trp(45) by an Ala(45) severely decreases the binding to PfPP1. Surprisingly, PfI3 was unable to rescue a yeast strain deficient in I3 (Ypi1). This lack of functional orthology was supported as functional assays in vitro have revealed that PfI3, unlike yeast I3 and human I3, increases PfPP1 activity. Reverse genetic approaches suggest an essential role of PfI3 in the growth and/or survival of blood stage parasites because attempts to obtain knockout parasites were unsuccessful, although the locus of PfI3 is accessible. The main localization of a GFP-tagged PfI3 in the nucleus of all blood stage parasites is compatible with a regulatory role of PfI3 on the activity of nuclear PfPP1.	[Freville, Aline; Montbarbon, Muriel; Bertin, Benjamin; Kalamou, Hadidjatou; Pierrot, Christine; Khalife, Jamal] Univ Lille Nord France, Inst Pasteur Lille, Ctr Infect & Immun Lille, Inserm U1019,CNRS UMR 8204, F-59019 Lille, France; [Landrieu, Isabelle] Univ Sci & Technol Lille, Struct & Funct Glycobiol Unit, CNRS UMR8576, F-59655 Villeneuve Dascq, France; [Adelaida Garcia-Gimeno, M.; Sanz, Pascual] CSIC, Inst Biomed Valencia, Valencia 46010, Spain; [Adelaida Garcia-Gimeno, M.; Sanz, Pascual] Ctr Invest Biomed Red Enfermedades Raras, Valencia 46010, Spain; [Verger, Alexis] Univ Lille 2, Univ Lille 1, IRI Inst Rech Interdisciplinaire CNRS USR3078, F-59658 Villeneuve Dascq, France; [Vicogne, Jerome; Werkmeister, Elisabeth] Inst Pasteur, Inst Biol Lille, BICeL IFR142, UMR8161, F-59019 Lille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille	Khalife, J (corresponding author), Univ Lille Nord France, Inst Pasteur Lille, Ctr Infect & Immun Lille, Inserm U1019,CNRS UMR 8204, 1 Rue Prof Calmette, F-59019 Lille, France.	jamal.khalife@pasteur-lille.fr	Sanz, Pascual/K-2751-2014; Khalife, Jamal/AAZ-2833-2020; WERKMEISTER, Elisabeth/GLQ-7361-2022; Landrieu, Isabelle/AAF-8495-2019; García-Gimeno, María Adelaida/K-9855-2014; Bertin, Benjamin/M-8300-2016	Sanz, Pascual/0000-0002-2399-4103; Landrieu, Isabelle/0000-0002-4883-2637; García-Gimeno, María Adelaida/0000-0002-6483-3912; FREVILLE, Aline/0000-0002-0982-5688; Bertin, Benjamin/0000-0002-9160-3717; verger, alexis/0000-0002-0299-2344; Pierrot, Christine/0000-0002-6835-6789; Khalife, Jamal/0000-0002-4359-8976; Vicogne, Jerome/0000-0001-8360-7497	Inserm; Institut Pasteur de Lille; Universite Lille Nord de France; TGE RMN THC, France [FR-3050]; Region Nord; CNRS; Pasteur Institute of Lille; European Community (FEDER); French Research Ministry; University of Sciences and Technologies of Lille I	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Institut Pasteur de Lille; Universite Lille Nord de France; TGE RMN THC, France; Region Nord(Region Hauts-de-France); CNRS(Centre National de la Recherche Scientifique (CNRS)); Pasteur Institute of Lille; European Community (FEDER)(European Commission); French Research Ministry(Ministry of Research, France); University of Sciences and Technologies of Lille I	This work was supported in part by Inserm, Institut Pasteur de Lille, Universite Lille Nord de France, and TGE RMN THC Grant FR-3050, France.; We thank Drs. Edith Browaeys, Katia Cailliau, Guy Lippens, and Jean-Michel Wieruszeski for helpful discussions; Dr. Raymond Pierce for the critical reading of the manuscript, and Claude Godin and Herve Drobecq for technical assistance. The NMR facilities were funded by the Region Nord, CNRS, Pasteur Institute of Lille, European Community (FEDER), French Research Ministry, and the University of Sciences and Technologies of Lille I.	AXTON JM, 1990, CELL, V63, P33, DOI 10.1016/0092-8674(90)90286-N; Baker SH, 1997, GENETICS, V145, P615; Ben Mamoun C, 1998, J BIOL CHEM, V273, P11241, DOI 10.1074/jbc.273.18.11241; Bennett D, 2005, BIOCHEM SOC T, V33, P1444, DOI 10.1042/BST0331444; Berndt N., 1999, FRONT BIOSCI, V4, pD22, DOI DOI 10.2741/BERNDT;PMID:9872729; Bharucha JP, 2008, MOL BIOL CELL, V19, P1032, DOI 10.1091/mbc.E07-05-0499; Bhattacharyya MK, 2002, INT J PARASITOL, V32, P739, DOI 10.1016/S0020-7519(02)00007-3; Blisnick T, 2006, CELL MICROBIOL, V8, P591, DOI 10.1111/j.1462-5822.2005.00650.x; Bollen M, 2010, TRENDS BIOCHEM SCI, V35, P450, DOI 10.1016/j.tibs.2010.03.002; Brady MJ, 2001, RECENT PROG HORM RES, V56, P157, DOI 10.1210/rp.56.1.157; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Chen F, 2007, CURR BIOL, V17, P293, DOI 10.1016/j.cub.2007.01.068; Cheng AY, 2000, J BIOL CHEM, V275, P34744, DOI 10.1074/jbc.M006210200; Daher W, 2006, MOL MICROBIOL, V60, P578, DOI 10.1111/j.1365-2958.2006.05119.x; Daher W, 2006, BIOCHEM J, V395, P433, DOI 10.1042/BJ20051597; Daher W, 2007, EUKARYOT CELL, V6, P1606, DOI 10.1128/EC.00260-07; Dancheck B, 2008, BIOCHEMISTRY-US, V47, P12346, DOI 10.1021/bi801308y; de Koning-Ward TF, 2009, TRENDS PARASITOL, V25, P4, DOI 10.1016/j.pt.2008.09.009; De Wulf P, 2009, CURR OPIN CELL BIOL, V21, P806, DOI 10.1016/j.ceb.2009.08.003; Dobson S, 2001, MOL BIOCHEM PARASIT, V115, P29, DOI 10.1016/S0166-6851(01)00260-2; Dobson S, 1999, MOL BIOCHEM PARASIT, V99, P167, DOI 10.1016/S0166-6851(99)00010-9; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Egloff MP, 1997, EMBO J, V16, P1876, DOI 10.1093/emboj/16.8.1876; Fardilha M, 2010, CURR MED CHEM, V17, P3996, DOI 10.2174/092986710793205363; Garcia-Gimeno MA, 2003, J BIOL CHEM, V278, P47744, DOI 10.1074/jbc.M306157200; GINSBURG H, 1987, ANN PARASIT HUM COMP, V62, P418, DOI 10.1051/parasite/1987625418; Hendrickx A, 2009, CHEM BIOL, V16, P365, DOI 10.1016/j.chembiol.2009.02.012; Hirano K, 1996, FEBS LETT, V389, P191, DOI 10.1016/0014-5793(96)00577-7; HONKANEN RE, 1990, J BIOL CHEM, V265, P19401; Huang H, 2000, J BIOMOL NMR, V17, P359, DOI 10.1023/A:1008355428294; Huang HB, 2007, PROTEINS, V68, P779, DOI 10.1002/prot.21438; Hurley TD, 2007, J BIOL CHEM, V282, P28874, DOI 10.1074/jbc.M703472200; Ishii K, 1996, EMBO J, V15, P6629, DOI 10.1002/j.1460-2075.1996.tb01053.x; Kuhn Y, 2010, TRAFFIC, V11, P236, DOI 10.1111/j.1600-0854.2009.01018.x; Landsverk HB, 2005, BIOCHEM J, V390, P709, DOI 10.1042/BJ20050678; Lee JH, 2010, J BIOL CHEM, V285, P24466, DOI 10.1074/jbc.M110.109801; Lesage B, 2007, BIOCHEMISTRY-US, V46, P8909, DOI 10.1021/bi7003119; Li JL, 1998, MOL BIOCHEM PARASIT, V95, P287, DOI 10.1016/S0166-6851(98)00106-6; Li JL, 1997, EUR J BIOCHEM, V249, P98, DOI 10.1111/j.1432-1033.1997.t01-2-00098.x; Lin TH, 2004, J BIOMOL NMR, V28, P413, DOI 10.1023/B:JNMR.0000015358.20495.b8; Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306; Marsh JA, 2010, STRUCTURE, V18, P1094, DOI 10.1016/j.str.2010.05.015; Moorhead GBG, 2007, NAT REV MOL CELL BIO, V8, P234, DOI 10.1038/nrm2126; Newgard CB, 2000, DIABETES, V49, P1967, DOI 10.2337/diabetes.49.12.1967; Novoyatleva T, 2008, HUM MOL GENET, V17, P52, DOI 10.1093/hmg/ddm284; OHKURA H, 1991, CELL, V64, P149, DOI 10.1016/0092-8674(91)90216-L; OHTA T, 1994, CANCER RES, V54, P6402; Oliver C.J., 1998, FRONT BIOSCI, V3, P961; Pedelini L, 2007, J BIOL CHEM, V282, P3282, DOI 10.1074/jbc.M607171200; Pinheiro AS, 2011, J AM CHEM SOC, V133, P73, DOI 10.1021/ja107810r; Ragusa MJ, 2010, NAT STRUCT MOL BIOL, V17, P459, DOI 10.1038/nsmb.1786; Rocha-Perugini V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001866; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Rose MD., 1990, METHODS YEAST GENETI; Sassoon I, 1999, GENE DEV, V13, P545, DOI 10.1101/gad.13.5.545; Sidhu ABS, 2005, MOL MICROBIOL, V57, P913, DOI 10.1111/j.1365-2958.2005.04729.x; Song WJ, 1998, EMBO J, V17, P5757, DOI 10.1093/emboj/17.19.5757; Sugiyama H, 1997, ONCOGENE, V15, P443, DOI 10.1038/sj.onc.1201207; Takemiya A, 2009, PLANT PHYSIOL, V150, P144, DOI 10.1104/pp.109.135335; Terrak M, 2004, NATURE, V429, P780, DOI 10.1038/nature02582; Thompson LJ, 1997, J BIOL CHEM, V272, P29693, DOI 10.1074/jbc.272.47.29693; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; TU JL, 1995, EMBO J, V14, P5939, DOI 10.1002/j.1460-2075.1995.tb00282.x; UMLAS J, 1971, AM J TROP MED HYG, V20, P527, DOI 10.4269/ajtmh.1971.20.527; VERNES A, 1984, AM J TROP MED HYG, V33, P197, DOI 10.4269/ajtmh.1984.33.197; Vojtek A., 1997, YEAST 2 HYBRID SYSTE, P26; Wakula P, 2003, J BIOL CHEM, V278, P18817, DOI 10.1074/jbc.M300175200; WARD GE, 1994, EXP PARASITOL, V79, P480, DOI 10.1006/expr.1994.1109; WATANABE T, 1992, P NATL ACAD SCI USA, V89, P10159, DOI 10.1073/pnas.89.21.10159; Wheatley SP, 1997, J CELL BIOL, V138, P385, DOI 10.1083/jcb.138.2.385; WISHART DS, 1994, J BIOMOL NMR, V4, P171; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Wu JQ, 2009, NAT CELL BIOL, V11, P644, DOI 10.1038/ncb1871; Yokoyama D, 1998, BIOCHEM BIOPH RES CO, V247, P18, DOI 10.1006/bbrc.1998.8730; Zhang HY, 2003, J BIOMOL NMR, V25, P173, DOI 10.1023/A:1022836027055; Zhang J, 1998, BIOCHEMISTRY-US, V37, P16728, DOI 10.1021/bi981169g; Zhang LF, 2008, BIOCHEM BIOPH RES CO, V377, P710, DOI 10.1016/j.bbrc.2008.10.062	77	17	17	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1306	1321		10.1074/jbc.M111.276865	http://dx.doi.org/10.1074/jbc.M111.276865			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22128182	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000299170300046
J	Ye, ZJ; Go, GW; Singh, R; Liu, WZ; Keramati, AR; Mani, A				Ye, Zhi-jia; Go, Gwang-Woong; Singh, Rajvir; Liu, Wenzhong; Keramati, Ali Reza; Mani, Arya			LRP6 Protein Regulates Low Density Lipoprotein (LDL) Receptor-mediated LDL Uptake	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL HYPERCHOLESTEROLEMIA; MEMBRANE-PROTEIN; ADAPTER PROTEIN; COATED PITS; INTERNALIZATION; CHOLESTEROL; CAVEOLIN-1; GENE; ATHEROSCLEROSIS; IDENTIFICATION	Genetic variations in LRP6 gene are associated with high serum LDL cholesterol levels. We have previously shown that LDL clearance in peripheral B-lymphocytes of the LRP6(R611C) mutation carriers is significantly impaired. In this study we have examined the role of wild type LRP6 (LRP6(WT)) and LRP6(R611C) in LDL receptor (LDLR)-mediated LDL uptake. LDL binding and uptake were increased when LRP6(WT) was overexpressed and modestly reduced when it was knocked down in LDLR-deficient CHO (ldlA7) cells. These findings implicated LRP6 in LDLR-independent cellular LDL binding and uptake. However, LRP6 knockdown in wild type CHO cells resulted in a much greater decline in LDL binding and uptake compared with CHO-ldlA7 cells, suggesting impaired function of the LDLR. LDLR internalization was severely diminished when LRP6 was knocked down and was restored after LRP6 was reintroduced. Further analysis revealed that LRP6(WT) forms a complex with LDLR, clathrin, and ARH and undergoes a clathrin-mediated internalization after stimulation with LDL. LDLR and LRP6 internalizations as well as LDL uptake were all impaired in CHO-k1 cells expressing LRP6(R611C). These studies identify LRP6 as a critical modulator of receptor-mediated LDL endocytosis and introduce a mechanism by which variation in LRP6 may contribute to high serum LDL levels.	[Ye, Zhi-jia; Go, Gwang-Woong; Singh, Rajvir; Liu, Wenzhong; Keramati, Ali Reza; Mani, Arya] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Ye, Zhi-jia; Go, Gwang-Woong; Singh, Rajvir; Liu, Wenzhong; Keramati, Ali Reza; Mani, Arya] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Ye, Zhi-jia] Third Mil Med Univ, Coll Prevent Med, Chongqing 400038, Peoples R China	Yale University; Yale University; Army Medical University	Mani, A (corresponding author), 333 Cedar St, New Haven, CT 06510 USA.	arya.mani@yale.edu	Go, Gwang-woong/H-2733-2013; SINGH, RAJVIR/C-8191-2012	Keramati, Ali/0000-0002-8728-1508	National Institutes of Health [R01HL094784-01, R01HL094574-03]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094784, R01HL094574] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL094784-01 and R01HL094574-03.	BASU SK, 1981, CELL, V24, P493, DOI 10.1016/0092-8674(81)90340-8; Boucrot E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010597; Carozzi AJ, 2000, TRAFFIC, V1, P326, DOI 10.1034/j.1600-0854.2000.010406.x; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Fernandez-Hernando C, 2010, AM J PATHOL, V177, P998, DOI 10.2353/ajpath.2010.091287; Fernandez-Hernando C, 2009, CELL METAB, V10, P48, DOI 10.1016/j.cmet.2009.06.003; Fire E, 1997, J BIOL CHEM, V272, P29538, DOI 10.1074/jbc.272.47.29538; Garuti R, 2005, J BIOL CHEM, V280, P40996, DOI 10.1074/jbc.M509394200; GOLDSTEIN JL, 1973, P NATL ACAD SCI USA, V70, P2804, DOI 10.1073/pnas.70.10.2804; Hobbs Helen H., 1992, Human Mutation, V1, P445, DOI 10.1002/humu.1380010602; HOBBS HH, 1989, J CLIN INVEST, V84, P656, DOI 10.1172/JCI114212; HOBBS HH, 1990, ANNU REV GENET, V24, P133, DOI 10.1146/annurev.ge.24.120190.001025; Kokubu C, 2004, DEVELOPMENT, V131, P5469, DOI 10.1242/dev.01405; Lindvall C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005813; Liu WZ, 2008, CIRC RES, V103, P1280, DOI 10.1161/CIRCRESAHA.108.183863; Loeffler B, 2007, J LIPID RES, V48, P288, DOI 10.1194/jlr.M600292-JLR200; Mani A, 2007, SCIENCE, V315, P1278, DOI 10.1126/science.1136370; NESTEROV A, 1995, J BIOL CHEM, V270, P6320, DOI 10.1074/jbc.270.11.6320; Rahilly-Tierney Catherine R, 2009, Prev Cardiol, V12, P80, DOI 10.1111/j.1751-7141.2008.00018.x; RUSSELL DW, 1986, COLD SPRING HARB SYM, V51, P811, DOI 10.1101/SQB.1986.051.01.094; Sorkin A, 1996, J BIOL CHEM, V271, P13377, DOI 10.1074/jbc.271.23.13377; Tiscornia G, 2006, NAT PROTOC, V1, P234, DOI 10.1038/nprot.2006.36; Tomaszewski M, 2009, ARTERIOSCL THROM VAS, V29, P1316, DOI 10.1161/ATVBAHA.109.185355; Varma R, 2005, AM J CARDIOL, V95, P269, DOI 10.1016/j.amjcard.2004.08.095; Vincent V, 1997, J BIOL CHEM, V272, P7062, DOI 10.1074/jbc.272.11.7062; Yamamoto H, 2006, DEV CELL, V11, P213, DOI 10.1016/j.devcel.2006.07.003; Yokomori H, 2009, LIVER INT, V29, P266, DOI 10.1111/j.1478-3231.2008.01891.x; Zhang Y, 1997, P NATL ACAD SCI USA, V94, P9273, DOI 10.1073/pnas.94.17.9273	28	48	51	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1335	1344		10.1074/jbc.M111.295287	http://dx.doi.org/10.1074/jbc.M111.295287			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22128165	Green Published, hybrid			2022-12-27	WOS:000299170300048
J	Kanade, SR; Eckert, RL				Kanade, Santosh R.; Eckert, Richard L.			Protein Arginine Methyltransferase 5 (PRMT5) Signaling Suppresses Protein Kinase C delta- and p38 delta-dependent Signaling and Keratinocyte Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN INVOLUCRIN PROMOTER; HUMAN EPIDERMAL-KERATINOCYTES; DISTAL REGULATORY REGION; GREEN TEA POLYPHENOL; P38 MAP KINASE; GENE-EXPRESSION; CROSS-LINKING; PKC-DELTA; CORNIFIED ENVELOPE; P38-DELTA MAPK	PKC delta is a key regulator of keratinocyte differentiation that activates p38 delta phosphorylation leading to increased differentiation as measured by an increased expression of the structural protein involucrin. Our previous studies suggest that p38 delta exists in association with protein partners. A major goal is to identify these partners and understand their role in regulating keratinocyte differentiation. In this study we use affinity purification and mass spectrometry to identify protein arginine methyltransferase 5 (PRMT5) as part of the p38 delta signaling complex. PRMT5 is an arginine methyltransferase that symmetrically dimethylates arginine residues on target proteins to alter target protein function. We show that PRMT5 knockdown is associated with increased p38 delta phosphorylation, suggesting that PRMT5 impacts the p38 delta signaling complex. At a functional level we show that PRMT5 inhibits the PKC delta- or 12-O-tetradecanoylphorbol- 13-acetate-dependent increase in human involucrin expression, and PRMT5 dimethylates proteins in the p38 delta complex. Moreover, PKC delta expression reduces the PRMT5 level, suggesting that PKC delta activates differentiation in part by reducing PRMT5 level. These studies indicate antagonism between the PKC delta and PRMT5 signaling in control of keratinocyte differentiation.	[Kanade, Santosh R.; Eckert, Richard L.] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Eckert, Richard L.] Univ Maryland, Sch Med, Dept Dermatol, Baltimore, MD 21201 USA; [Eckert, Richard L.] Univ Maryland, Sch Med, Dept Obstet & Gynecol, Baltimore, MD 21201 USA; [Eckert, Richard L.] Univ Maryland, Sch Med, Dept Reprod Sci, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Eckert, RL (corresponding author), Univ Maryland, Sch Med, Dept Biochem & Mol Biol, 108 N Greene St, Baltimore, MD 21201 USA.	reckert@umaryland.edu	Kanade, Santosh/V-7054-2019	Kanade, Santosh/0000-0002-2184-9973	National Institutes of Health [R01 AR046494]; NATIONAL CANCER INSTITUTE [P30CA134274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046494] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AR046494 (to R. L. E.).	Ancelin K, 2006, NAT CELL BIOL, V8, P623, DOI 10.1038/ncb1413; Bachand F, 2007, EUKARYOT CELL, V6, P889, DOI 10.1128/EC.00099-07; Balasubramanian S, 2002, J BIOL CHEM, V277, P1828, DOI 10.1074/jbc.M110376200; Balasubramanian S, 2007, TOXICOL APPL PHARM, V224, P214, DOI 10.1016/j.taap.2007.03.020; Banks EB, 1998, BIOCHEM J, V331, P61, DOI 10.1042/bj3310061; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Boisvert FM, 2003, MOL CELL PROTEOMICS, V2, P1319, DOI 10.1074/mcp.M300088-MCP200; Cai QS, 2009, J BIOL CHEM, V284, P2150, DOI 10.1074/jbc.M803235200; Cesaro E, 2009, J BIOL CHEM, V284, P32321, DOI 10.1074/jbc.M109.043349; Chang YI, 2010, J BIOL CHEM, V285, P20595, DOI 10.1074/jbc.M109.092411; Crish JF, 2008, J INVEST DERMATOL, V128, P530, DOI 10.1038/sj.jid.5701049; Crish JF, 2006, J INVEST DERMATOL, V126, P305, DOI 10.1038/sj.jid.5700019; Crish JF, 1998, J BIOL CHEM, V273, P30460, DOI 10.1074/jbc.273.46.30460; Dacwag CS, 2007, MOL CELL BIOL, V27, P384, DOI 10.1128/MCB.01528-06; Dashti SR, 2001, J BIOL CHEM, V276, P27214, DOI 10.1074/jbc.M100465200; Dashti SR, 2001, J BIOL CHEM, V276, P8059, DOI 10.1074/jbc.C000862200; Deucher A, 2002, J BIOL CHEM, V277, P17032, DOI 10.1074/jbc.M109076200; Eckert RL, 2006, MOL NUTR FOOD RES, V50, P123, DOI 10.1002/mnfr.200500125; Eckert RL, 2004, BIOCHEM PHARMACOL, V68, P1125, DOI 10.1016/j.bcp.2004.04.029; Eckert RL, 2004, J INVEST DERMATOL, V123, P13, DOI 10.1111/j.0022-202X.2004.22723.x; Eckert RL, 2002, J INVEST DERM SYMP P, V7, P36, DOI 10.1046/j.1523-1747.2002.19634.x; Eckert RL, 2003, J INVEST DERMATOL, V120, P823, DOI 10.1046/j.1523-1747.2003.12120.x; Eckert RL, 1997, PHYSIOL REV, V77, P397, DOI 10.1152/physrev.1997.77.2.397; Efimova T, 2004, MOL CELL BIOL, V24, P8167, DOI 10.1128/MCB.24.18.8167-8183.2004; Efimova T, 2003, J BIOL CHEM, V278, P34277, DOI 10.1074/jbc.M302759200; Efimova T, 1998, J BIOL CHEM, V273, P24387, DOI 10.1074/jbc.273.38.24387; Efimova T, 2000, J BIOL CHEM, V275, P1601, DOI 10.1074/jbc.275.3.1601; Eftmova T, 2002, J BIOL CHEM, V277, P31753, DOI 10.1074/jbc.M205098200; Enslen H, 2000, EMBO J, V19, P1301, DOI 10.1093/emboj/19.6.1301; Fabbrizio E, 2002, EMBO REP, V3, P641, DOI 10.1093/embo-reports/kvf136; Friesen WJ, 2001, MOL CELL BIOL, V21, P8289, DOI 10.1128/MCB.21.24.8289-8300.2001; Guderian G, 2011, J BIOL CHEM, V286, P1976, DOI 10.1074/jbc.M110.148486; Hong S, 2010, P NATL ACAD SCI USA, V107, P21211, DOI 10.1073/pnas.1011987107; Hosohata K, 2003, MOL CELL BIOL, V23, P7019, DOI 10.1128/MCB.23.19.7019-7029.2003; Hsu JM, 2011, NAT CELL BIOL, V13, P174, DOI 10.1038/ncb2158; Igarashi H, 2009, MOL IMMUNOL, V46, P1031, DOI 10.1016/j.molimm.2008.08.272; Kanamaluru D, 2011, MOL CELL BIOL, V31, P1540, DOI 10.1128/MCB.01212-10; Kraft CA, 2007, ARCH DERMATOL RES, V299, P71, DOI 10.1007/s00403-006-0727-4; LaCelle PT, 1998, SKIN PHARMACOL APPL, V11, P214, DOI 10.1159/000029830; Lim Y, 2005, BBA-GEN SUBJECTS, V1723, P240, DOI 10.1016/j.bbagen.2005.02.015; Liu F, 2011, CANCER CELL, V19, P283, DOI 10.1016/j.ccr.2010.12.020; Nemes Z, 1999, J BIOL CHEM, V274, P11013, DOI 10.1074/jbc.274.16.11013; Pahlich S, 2006, BBA-PROTEINS PROTEOM, V1764, P1890, DOI 10.1016/j.bbapap.2006.08.008; Paik WK, 2007, TRENDS BIOCHEM SCI, V32, P146, DOI 10.1016/j.tibs.2007.01.006; Pal S, 2004, MOL CELL BIOL, V24, P9630, DOI 10.1128/MCB.24.21.9630-9645.2004; Pal S, 2003, MOL CELL BIOL, V23, P7475, DOI 10.1128/MCB.23.21.7475-7487.2003; Pal S, 2007, EMBO J, V26, P3558, DOI 10.1038/sj.emboj.7601794; Pollack BP, 1999, J BIOL CHEM, V274, P31531, DOI 10.1074/jbc.274.44.31531; Rank G, 2010, BLOOD, V116, P1585, DOI 10.1182/blood-2009-10-251116; Reno EM, 2008, HUM PATHOL, V39, P21, DOI 10.1016/j.humpath.2007.05.023; RICE RH, 1977, CELL, V11, P417, DOI 10.1016/0092-8674(77)90059-9; RICE RH, 1979, CELL, V18, P681, DOI 10.1016/0092-8674(79)90123-5; Robinson NA, 1996, J INVEST DERMATOL, V107, P101, DOI 10.1111/1523-1747.ep12298323; Robinson NA, 1997, J BIOL CHEM, V272, P12035, DOI 10.1074/jbc.272.18.12035; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Schaeffer HJ, 1999, MOL CELL BIOL, V19, P2435; Scoumanne A, 2009, NUCLEIC ACIDS RES, V37, P4965, DOI 10.1093/nar/gkp516; Steinert PM, 1999, MOL BIOL CELL, V10, P4247, DOI 10.1091/mbc.10.12.4247; Tanaka H, 2009, MOL CANCER RES, V7, P557, DOI 10.1158/1541-7786.MCR-08-0197; Tee WW, 2010, GENE DEV, V24, P2772, DOI 10.1101/gad.606110; WELTER JF, 1995, J BIOL CHEM, V270, P12614, DOI 10.1074/jbc.270.21.12614; Yadav V, 2010, AM J PATHOL, V176, P1091, DOI 10.2353/ajpath.2010.090816	62	20	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7313	7323		10.1074/jbc.M111.331660	http://dx.doi.org/10.1074/jbc.M111.331660			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22199349	Green Published, hybrid			2022-12-27	WOS:000301060200033
J	Guerin, F; Barbe, S; Pizzut-Serin, S; Potocki-Veronese, G; Guieysse, D; Guillet, V; Monsan, P; Mourey, L; Remaud-Simeon, M; Andre, I; Tranier, S				Guerin, Frederic; Barbe, Sophie; Pizzut-Serin, Sandra; Potocki-Veronese, Gabrielle; Guieysse, David; Guillet, Valerie; Monsan, Pierre; Mourey, Lionel; Remaud-Simeon, Magali; Andre, Isabelle; Tranier, Samuel			Structural Investigation of the Thermostability and Product Specificity of Amylosucrase from the Bacterium Deinococcus geothermalis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS; NEISSERIA-POLYSACCHAREA; 3-DIMENSIONAL STRUCTURE; CRYSTAL-STRUCTURE; ALPHA-AMYLASE; FORCE-FIELD; SUCROSE; SEQUENCE; CLASSIFICATION; SIMULATIONS	Amylosucrases are sucrose-utilizing alpha-transglucosidases that naturally catalyze the synthesis of alpha-glucans, linked exclusively through alpha 1,4-linkages. Side products and in particular sucrose isomers such as turanose and trehalulose are also produced by these enzymes. Here, we report the first structural and biophysical characterization of the most thermostable amylosucrase identified so far, the amylosucrase from Deinoccocus geothermalis (DgAS). The three-dimensional structure revealed a homodimeric quaternary organization, never reported before for other amylosucrases. A sequence signature of dimerization was identified from the analysis of the dimer interface and sequence alignments. By rigidifying the DgAS structure, the quaternary organization is likely to participate in the enhanced thermal stability of the protein. Amylosucrase specificity with respect to sucrose isomer formation (turanose or trehalulose) was also investigated. We report the first structures of the amylosucrases from Deinococcus geothermalis and Neisseria polysaccharea in complex with turanose. In the amylosucrase from N. polysaccharea (NpAS), key residues were found to force the fructosyl moiety to bind in an open state with the O3' ideally positioned to explain the preferential formation of turanose by NpAS. Such residues are either not present or not similarly placed in DgAS. As a consequence, DgAS binds the furanoid tautomers of fructose through a weak network of interactions to enable turanose formation. Such topology at subsite +1 is likely favoring other possible fructose binding modes in agreement with the higher amount of trehalulose formed by DgAS. Our findings help to understand the inter-relationships between amylosucrase structure, flexibility, function, and stability and provide new insight for amylosucrase design.	[Andre, Isabelle] Univ Toulouse, INSA, UPS, INP,LISBP,CNRS UMR5504,UMR INRA 792, F-31077 Toulouse 4, France; [Guerin, Frederic; Barbe, Sophie; Pizzut-Serin, Sandra; Potocki-Veronese, Gabrielle; Guieysse, David; Monsan, Pierre; Remaud-Simeon, Magali; Andre, Isabelle] CNRS, UMR5504, F-31400 Toulouse, France; [Guerin, Frederic; Barbe, Sophie; Pizzut-Serin, Sandra; Potocki-Veronese, Gabrielle; Guieysse, David; Monsan, Pierre; Remaud-Simeon, Magali; Andre, Isabelle] INRA, Ingn Syst Biol & Proc UMR792, F-31400 Toulouse, France; [Guerin, Frederic; Guillet, Valerie; Mourey, Lionel; Tranier, Samuel] CNRS, IPBS, Dept Biol Struct & Biophys, F-31077 Toulouse, France; [Guerin, Frederic; Guillet, Valerie; Mourey, Lionel; Tranier, Samuel] Univ Toulouse, UPS, IPBS, F-31077 Toulouse, France; [Monsan, Pierre] Inst Univ France, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Institut Universitaire de France	Andre, I (corresponding author), Univ Toulouse, INSA, UPS, INP,LISBP,CNRS UMR5504,UMR INRA 792, 135 Ave Rangueil, F-31077 Toulouse 4, France.	isabelle.andre@insa-toulouse.fr; samuel.tranier@ipbs.fr	Veronese, Gabrielle/GTF-3473-2022; Barbe, Sophie/ABD-9530-2020; Mourey, Lionel/B-5662-2009; Tranier, Samuel/C-6059-2011	Mourey, Lionel/0000-0002-8259-1259; Tranier, Samuel/0000-0001-9751-163X; Barbe, Sophie/0000-0003-2581-5022; GUIEYSSE, David/0000-0002-8802-4968	Center of Region Midi-Pyrenees (CALMIP, Toulouse, France); Center for Computing Resources (CRI) of INSA-Toulouse; Poles de Recherche et d'Enseignement Superieur de I'Universite de Toulouse; Region Midi-Pyrenees, France	Center of Region Midi-Pyrenees (CALMIP, Toulouse, France)(Region Occitanie); Center for Computing Resources (CRI) of INSA-Toulouse; Poles de Recherche et d'Enseignement Superieur de I'Universite de Toulouse; Region Midi-Pyrenees, France(Region Occitanie)	We thank the Computing Center of Region Midi-Pyrenees (CALMIP, Toulouse, France) and the Center for Computing Resources (CRI) of INSA-Toulouse for providing computing resources and support. We are grateful to the staff of Synchrotron beamlines ID14-1 and ID29 at the European Synchrotron Radiation Facility (Grenoble, France) for providing assistance in using the beamlines. We are grateful to Javier Perez (Synchrotron SOLEIL) for the fruitful discussions. We also thank Stephanie Terme (Wyatt technology France) for helpful assistance in the SEC-MALLS experiments.; Supported by a Ph.D. grant from the Poles de Recherche et d'Enseignement Superieur de I'Universite de Toulouse and the Region Midi-Pyrenees, France.	Andre I, 2010, TOP CURR CHEM, V294, P25, DOI 10.1007/128_2010_52; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Case D, 2006, AMBER 9; Champion E, 2009, J AM CHEM SOC, V131, P7379, DOI 10.1021/ja900183h; Chang A, 2011, CURR OPIN BIOTECH, V22, P800, DOI 10.1016/j.copbio.2011.04.013; de Montalk GP, 2000, FEBS LETT, V471, P219, DOI 10.1016/S0014-5793(00)01406-X; De Montalk GP, 1999, J BACTERIOL, V181, P375; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Emond S, 2008, FEMS MICROBIOL LETT, V285, P25, DOI 10.1111/j.1574-6968.2008.01204.x; Emond S, 2008, PROTEIN SCI, V17, P967, DOI 10.1110/ps.083492608; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fritzsche HB, 2003, EUR J BIOCHEM, V270, P2332, DOI 10.1046/j.1432-1033.2003.03603.x; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Goulter KC, 2012, ENZYME MICROB TECH, V50, P57, DOI 10.1016/j.enzmictec.2011.09.011; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Ha SJ, 2009, BIOSCI BIOTECH BIOCH, V73, P1505, DOI 10.1271/bbb.80891; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; Hondoh H, 2003, J MOL BIOL, V326, P177, DOI 10.1016/S0022-2836(02)01402-X; Jaenicke R, 1998, CURR OPIN STRUC BIOL, V8, P738, DOI 10.1016/S0959-440X(98)80094-8; Jensen MH, 2004, BIOCHEMISTRY-US, V43, P3104, DOI 10.1021/bi0357762; Jung JH, 2009, CARBOHYD RES, V344, P1612, DOI 10.1016/j.carres.2009.04.019; Kim JS, 1999, J BIOL CHEM, V274, P26279, DOI 10.1074/jbc.274.37.26279; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee MC, 2004, PROTEINS, V55, P620, DOI 10.1002/prot.10470; LICHTENTHALER FW, 1990, J CHEM SOC PERK T 2, P1489, DOI 10.1039/p29900001489; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; OKADA G, 1974, J BIOL CHEM, V249, P126; PASTOR RW, 1988, MOL PHYS, V65, P1409, DOI 10.1080/00268978800101881; Pizzut-Serin S, 2005, FEBS LETT, V579, P1405, DOI 10.1016/j.febslet.2004.12.097; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Prakash O, 2010, APPL BIOCHEM BIOTECH, V160, P2401, DOI 10.1007/s12010-009-8735-4; Ravaud S, 2007, J BIOL CHEM, V282, P28126, DOI 10.1074/jbc.M704515200; Ravaud S, 2009, FEBS LETT, V583, P1964, DOI 10.1016/j.febslet.2009.05.002; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sarcabal P, 2000, FEBS LETT, V474, P33, DOI 10.1016/S0014-5793(00)01567-2; Seo DH, 2009, J MOL CATAL B-ENZYM, V60, P113, DOI 10.1016/j.molcatb.2009.04.006; Skov LK, 2002, J BIOL CHEM, V277, P47741, DOI 10.1074/jbc.M207860200; Skov LK, 2001, J BIOL CHEM, V276, P25273, DOI 10.1074/jbc.M010998200; Skov LK, 2000, ACTA CRYSTALLOGR D, V56, P203, DOI 10.1107/S0907444999015887; Thompson J, 2012, MOL ORAL MICROBIOL, V27, P34, DOI 10.1111/j.2041-1014.2011.00627.x; Zhang DH, 2003, FEBS LETT, V534, P151, DOI 10.1016/S0014-5793(02)03835-8	50	50	52	2	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6642	6654		10.1074/jbc.M111.322917	http://dx.doi.org/10.1074/jbc.M111.322917			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22210773	Green Published, hybrid			2022-12-27	WOS:000300791800051
J	Pan, MR; Hsieh, HJ; Dai, H; Hung, WC; Li, KY; Peng, G; Lin, SY				Pan, Mei-Ren; Hsieh, Hui-Ju; Dai, Hui; Hung, Wen-Chun; Li, Kaiyi; Peng, Guang; Lin, Shiaw-Yih			Chromodomain Helicase DNA-binding Protein 4 (CHD4) Regulates Homologous Recombination DNA Repair, and Its Deficiency Sensitizes Cells to Poly(ADP-ribose) Polymerase (PARP) Inhibitor Treatment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DAMAGE RESPONSE; ACTIVATION; CHECKPOINT; PATHWAY; COMPLEX; MICROCEPHALIN/MCPH1; BRIT1/MCPH1; METHYLATION	To ensure genome stability, cells have evolved a robust defense mechanism to detect, signal, and repair damaged DNA that is generated by exogenous stressors such as ionizing radiation, endogenous stressors such as free radicals, or normal physiological processes such as DNA replication. Homologous recombination (HR) repair is a critical pathway of repairing DNA double strand breaks, and it plays an essential role in maintaining genomic integrity. Previous studies have shown that BRIT1, also known as MCPH1, is a key regulator of HR repair. Here, we report that chromodomain helicase DNA-binding protein 4 (CHD4) is a novel BRIT1 binding partner that regulates the HR repair process. The BRCA1 C-terminal domains of BRIT1 are required for its interaction with CHD4. Depletion of CHD4 and overexpression of the ATPase-dead form of CHD4 impairs the recruitment of BRIT1 to the DNA damage lesions. As a functional consequence, CHD4 deficiency sensitizes cells to double strand break-inducing agents, reduces the recruitment of HR repair factor BRCA1, and impairs HR repair efficiency. We further demonstrate that CHD4-depleted cells are more sensitive to poly(ADP-ribose) polymerase inhibitor treatment. In response to DNA damage induced by poly(ADP-ribose) polymerase inhibitors, CHD4 deficiency impairs the recruitment of DNA repair proteins BRIT1, BRCA1, and replication protein A at early steps of HR repair. Taken together, our findings identify an important role of CHD4 in controlling HR repair to maintain genome stability and establish the potential therapeutic implications of targeting CHD4 deficiency in tumors.	[Peng, Guang; Lin, Shiaw-Yih] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Unit 950, Houston, TX 77054 USA; [Hsieh, Hui-Ju; Peng, Guang] Univ Texas MD Anderson Canc Ctr, Dept Clin Canc Prevent, Houston, TX 77054 USA; [Pan, Mei-Ren; Hung, Wen-Chun] Natl Hlth Res Inst, Natl Inst Canc Res, Tainan 704, Taiwan; [Li, Kaiyi] Baylor Coll Med, Dept Surg, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; National Health Research Institutes - Taiwan; Baylor College of Medicine	Peng, G (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Unit 950, 1515 Holcombe Blvd, Houston, TX 77054 USA.	gpeng@mdanderson.org; sylin@mdanderson.org	Hung, Wen-Chun/F-4846-2011; Hsieh, Hui-Ju/Q-1237-2015; Pan, Mei-Ren/I-2021-2013; Hsieh, Hui-Ju/S-3082-2018	Hsieh, Hui-Ju/0000-0002-2583-7670	NCI [R01 CA112291]; NATIONAL CANCER INSTITUTE [R01CA112291] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA112291 from NCI (to S.-Y. L.).	Araujo FD, 2002, ONCOGENE, V21, P4176, DOI 10.1038/sj.onc.1205539; Audeh MW, 2010, LANCET, V376, P245, DOI 10.1016/S0140-6736(10)60893-8; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bilbao C, 2010, EUR J CANCER, V46, P2821, DOI 10.1016/j.ejca.2010.06.116; Downs JA, 2007, NATURE, V447, P951, DOI 10.1038/nature05980; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Heyer WD, 2010, ANNU REV GENET, V44, P113, DOI 10.1146/annurev-genet-051710-150955; Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964; Jasin M, 2002, ONCOGENE, V21, P8981, DOI 10.1038/sj.onc.1206176; Jeffers LJ, 2008, ONCOGENE, V27, P139, DOI 10.1038/sj.onc.1210595; Kim MS, 2011, HISTOPATHOLOGY, V58, P660, DOI 10.1111/j.1365-2559.2011.03819.x; Lai AY, 2011, NAT REV CANCER, V11, P588, DOI 10.1038/nrc3091; Larsen DH, 2010, J CELL BIOL, V190, P731, DOI 10.1083/jcb.200912135; Leung JW, 2011, J BIOL CHEM, V286, P21393, DOI 10.1074/jbc.M110.208793; Liang YL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000826; Lin SY, 2005, P NATL ACAD SCI USA, V102, P15105, DOI 10.1073/pnas.0507722102; Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877; Mansfield RE, 2011, J BIOL CHEM, V286, P11779, DOI 10.1074/jbc.M110.208207; McGuire M, 2003, J APPL PHYSIOL, V95, P1499, DOI 10.1152/japplphysiol.00044.2003; Peng G, 2009, NAT CELL BIOL, V11, P865, DOI 10.1038/ncb1895; Pierce AJ, 2001, TRENDS CELL BIOL, V11, pS52, DOI 10.1016/S0962-8924(01)02149-3; Polo SE, 2010, EMBO J, V29, P3130, DOI 10.1038/emboj.2010.188; Rai R, 2006, CANCER CELL, V10, P145, DOI 10.1016/j.ccr.2006.07.002; Sakasai R, 2006, GENES CELLS, V11, P237, DOI 10.1111/j.1365-2443.2006.00942.x; SATOH MS, 1992, NATURE, V356, P356, DOI 10.1038/356356a0; Shao RG, 1999, EMBO J, V18, P1397, DOI 10.1093/emboj/18.5.1397; Smeenk G, 2010, J CELL BIOL, V190, P741, DOI 10.1083/jcb.201001048; Sun YL, 2009, NAT CELL BIOL, V11, P1376, DOI 10.1038/ncb1982; Tutt A, 2010, LANCET, V376, P235, DOI 10.1016/S0140-6736(10)60892-6; Urquhart Aaron J, 2011, Genome Integr, V2, P1, DOI 10.1186/2041-9414-2-1; Wade PA, 1999, NAT GENET, V23, P62, DOI 10.1038/12664; Wang HB, 2001, NUCLEIC ACIDS RES, V29, P2517, DOI 10.1093/nar/29.12.2517; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Wood JL, 2008, J BIOL CHEM, V283, P29586, DOI 10.1074/jbc.M804080200; Wood JL, 2007, J BIOL CHEM, V282, P35416, DOI 10.1074/jbc.M705245200; Woodhouse BC, 2008, DNA REPAIR, V7, P1077, DOI 10.1016/j.dnarep.2008.03.009; Wu XL, 2009, CANCER RES, V69, P5531, DOI 10.1158/0008-5472.CAN-08-4834; Xu XZ, 2004, J BIOL CHEM, V279, P34091, DOI 10.1074/jbc.C400139200; Yang SZ, 2008, EMBO REP, V9, P907, DOI 10.1038/embor.2008.128; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753; Yun MH, 2009, NATURE, V459, P460, DOI 10.1038/nature07955	42	65	65	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6764	6772		10.1074/jbc.M111.287037	http://dx.doi.org/10.1074/jbc.M111.287037			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22219182	hybrid, Green Published			2022-12-27	WOS:000300791800062
J	Bloem, E; Meems, H; van den Biggelaar, M; Van der Zwaan, C; Mertens, K; Meijer, AB				Bloem, Esther; Meems, Henriet; van den Biggelaar, Maartje; Van der Zwaan, Carmen; Mertens, Koen; Meijer, Alexander B.			Mass Spectrometry-assisted Study Reveals That Lysine Residues 1967 and 1968 Have Opposite Contribution to Stability of Activated Factor VIII	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-IXA; FACTOR-V; CATALYZED INACTIVATION; SUBUNIT DISSOCIATION; CHARGED RESIDUES; LIGHT-CHAIN; A2 SUBUNIT; PROTEIN-C; IDENTIFICATION; QUANTIFICATION	The A2 domain rapidly dissociates from activated factor VIII (FVIIIa) resulting in a dampening of the activity of the activated factor X-generating complex. The amino acid residues that affect A2 domain dissociation are therefore critical for FVIII cofactor function. We have now employed chemical footprinting in conjunction with mass spectrometry to identify lysine residues that contribute to the stability of activated FVIII. We hypothesized that lysine residues, which are buried in FVIII and surface-exposed in dissociated activated FVIII (dis-FVIIIa), may contribute to interdomain interactions. Mass spectrometry analysis revealed that residues Lys(1967) and Lys(1968) of region Thr(1964)-Tyr(1971) are buried in FVIII and exposed to the surface in dis-FVIIIa. This result, combined with the observation that the FVIII variant K1967I is associated with hemophilia A, suggests that these residues contribute to the stability of activated FVIII. Kinetic analysis revealed that the FVIII variants K1967A and K1967I exhibit an almost normal cofactor activity. However, these variants also showed an increased loss in cofactor activity over time compared with that of FVIII WT. Remarkably, the cofactor activity of a K1968A variant was enhanced and sustained for a prolonged time relative to that of FVIII WT. Surface plasmon resonance analysis demonstrated that A2 domain dissociation from activated FVIII was reduced for K1968A and enhanced for K1967A. In conclusion, mass spectrometry analysis combined with site-directed mutagenesis studies revealed that the lysine couple Lys(1967)-Lys(1968) within region Thr(1964)-Tyr(1971) has an opposite contribution to the stability of FVIIIa.	[Bloem, Esther; Meems, Henriet; van den Biggelaar, Maartje; Van der Zwaan, Carmen; Mertens, Koen; Meijer, Alexander B.] Sanquin Res, Dept Plasma Prot, NL-1066 CX Amsterdam, Netherlands; [Mertens, Koen; Meijer, Alexander B.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, NL-3584 CG Utrecht, Netherlands	Utrecht University	Meijer, AB (corresponding author), Sanquin Res, Dept Plasma Prot, Plesmanlaan 125, NL-1066 CX Amsterdam, Netherlands.	s.meijer@sanquin.nl						Camire RM, 2009, J THROMB HAEMOST, V7, P1951, DOI 10.1111/j.1538-7836.2009.03622.x; CHURCH WR, 1984, P NATL ACAD SCI-BIOL, V81, P6934, DOI 10.1073/pnas.81.22.6934; Dayon L, 2010, J PROTEOMICS, V73, P769, DOI 10.1016/j.jprot.2009.10.015; DUFFY EJ, 1992, J BIOL CHEM, V267, P17006; EATON D, 1986, BIOCHEMISTRY-US, V25, P505, DOI 10.1021/bi00350a035; FAY PJ, 1993, J BIOL CHEM, V268, P17861; Fay PJ, 2006, INT J HEMATOL, V83, P103, DOI 10.1532/IJH97.05113; Fay PJ, 1996, J BIOL CHEM, V271, P6027, DOI 10.1074/jbc.271.11.6027; FAY PJ, 1991, J BIOL CHEM, V266, P20139; FAY PJ, 1991, J BIOL CHEM, V266, P8957; Gale AJ, 2006, J THROMB HAEMOST, V4, P1315, DOI 10.1111/j.1538-7836.2006.01951.x; Kemball-Cook G, 1998, NUCLEIC ACIDS RES, V26, P216, DOI 10.1093/nar/26.1.216; LAMPHEAR BJ, 1992, BLOOD, V80, P3120; LAMPHEAR BJ, 1992, J BIOL CHEM, V267, P3725; LENTING PJ, 1994, J BIOL CHEM, V269, P7150; Lillicrap D, 2008, THROMB RES, V122, pS2, DOI 10.1016/S0049-3848(08)70027-6; LIND P, 1995, EUR J BIOCHEM, V232, P19, DOI 10.1111/j.1432-1033.1995.tb20776.x; LOLLAR P, 1990, J BIOL CHEM, V265, P1688; LOLLAR P, 1988, J BIOL CHEM, V263, P10451; LOLLAR P, 1991, J BIOL CHEM, V266, P12481; Lu JH, 2011, BLOOD, V117, P3181, DOI 10.1182/blood-2010-08-301663; Meems H, 2011, INT J BIOCHEM CELL B, V43, P1114, DOI 10.1016/j.biocel.2011.03.014; Meems H, 2009, BLOOD, V114, P3938, DOI 10.1182/blood-2009-01-197707; MERTENS K, 1980, BIOCHEM J, V185, P647, DOI 10.1042/bj1850647; Ngo JCK, 2008, STRUCTURE, V16, P597, DOI 10.1016/j.str.2008.03.001; Nogami K, 2007, J BIOL CHEM, V282, P5287, DOI 10.1074/jbc.M607816200; OBRIEN DP, 1992, BIOCHEMISTRY-US, V31, P2805, DOI 10.1021/bi00125a022; Pipe SW, 1999, BLOOD, V93, P176, DOI 10.1182/blood.V93.1.176.401k07_176_183; Shen BW, 2008, BLOOD, V111, P1240, DOI 10.1182/blood-2007-08-109918; Shkriabai N, 2006, BIOCHEMISTRY-US, V45, P4077, DOI 10.1021/bi052308e; Stel H. V., 1984, THESIS U AMSTERDAM; Thingholm TE, 2010, J PROTEOME RES, V9, P4045, DOI 10.1021/pr100230q; Toso R, 2004, J BIOL CHEM, V279, P21643, DOI 10.1074/jbc.M402107200; van den Biggelaar M, 2009, BLOOD, V113, P3102, DOI 10.1182/blood-2008-05-159699; van Haren SD, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002246; van Helden PMW, 2008, BRIT J HAEMATOL, V142, P644, DOI 10.1111/j.1365-2141.2008.07232.x; VEHAR GA, 1984, NATURE, V312, P337, DOI 10.1038/312337a0; Venkateswarlu D, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-7; Wakabayashi H, 2009, J THROMB HAEMOST, V7, P438, DOI 10.1111/j.1538-7836.2008.03256.x; Wakabayashi H, 2008, BLOOD, V112, P2761, DOI 10.1182/blood-2008-02-142158; Wakabayashi H, 2008, J BIOL CHEM, V283, P11645, DOI 10.1074/jbc.M710252200; Wakabayashi H, 2011, J BIOL CHEM, V286, P25748, DOI 10.1074/jbc.M111.241109	43	15	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5775	5783		10.1074/jbc.M111.308627	http://dx.doi.org/10.1074/jbc.M111.308627			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22215677	Green Published, hybrid			2022-12-27	WOS:000300638000053
J	Maity, B; Stewart, A; Yang, JQ; Loo, L; Sheff, D; Shepherd, AJ; Mohapatra, DP; Fisher, RA				Maity, Biswanath; Stewart, Adele; Yang, Jianqi; Loo, Lipin; Sheff, David; Shepherd, Andrew J.; Mohapatra, Durga P.; Fisher, Rory A.			Regulator of G Protein Signaling 6 (RGS6) Protein Ensures Coordination of Motor Movement by Modulating GABA(B) Receptor Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CEREBELLAR GRANULE CELLS; GTPASE-ACTIVATING PROTEINS; GIRK CHANNELS; MICE LACKING; BEHAVIORAL CHARACTERIZATION; GATING KINETICS; MOUSE MODEL; GGL DOMAIN; INHIBITION; EXPRESSION	gamma-Aminobutyric acid (GABA) release from inhibitory interneurons located within the cerebellar cortex limits the extent of neuronal excitation in part through activation of metabotropic GABA(B) receptors. Stimulation of these receptors triggers a number of downstream signaling events, including activation of GIRK channels by the G beta gamma dimer resulting in membrane hyperpolarization and inhibition of neurotransmitter release from presynaptic sites. Here, we identify RGS6, a member of the R7 subfamily of RGS proteins, as a key regulator of GABA(B)R signaling in cerebellum. RGS6 is enriched in the granule cell layer of the cerebellum along with neuronal GIRK channel subunits 1 and 2 where RGS6 forms a complex with known binding partners G beta(5) and R7BP. Mice lacking RGS6 exhibit abnormal gait and ataxia characterized by impaired rotarod performance improved by treatment with a GABA(B)R antagonist. RGS6(-/-) mice administered baclofen also showed exaggerated motor coordination deficits compared with their wild-type counterparts. Isolated cerebellar neurons natively expressed RGS6, GABA(B)R, and GIRK channel subunits, and cerebellar granule neurons from RGS6(-/-) mice showed a significant delay in the deactivation kinetics of baclofen-induced GIRK channel currents. These results establish RGS6 as a key component of GABABR signaling and represent the first demonstration of an essential role for modulatory actions of RGS proteins in adult cerebellum. Dysregulation of RGS6 expression in human patients could potentially contribute to loss of motor coordination and, thus, pharmacological manipulation of RGS6 levels might represent a viable means to treat patients with ataxias of cerebellar origin.	[Maity, Biswanath; Stewart, Adele; Yang, Jianqi; Loo, Lipin; Sheff, David; Shepherd, Andrew J.; Mohapatra, Durga P.; Fisher, Rory A.] Univ Iowa, Dept Pharmacol, Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa	Fisher, RA (corresponding author), Univ Iowa, Dept Pharmacol, Carver Coll Med, Iowa City, IA 52242 USA.	rory-fisher@uiowa.edu	Mohapatra, Durga/M-2133-2017	Mohapatra, Durga/0000-0001-5016-1281; Fisher, Rory/0000-0003-3108-4836; Stewart, Adele/0000-0003-4968-2471; Maity, Biswanath/0000-0002-3239-3764; Loo, Lipin/0000-0002-4112-1816; Shepherd, Andrew/0000-0002-8440-6192	National Institutes of Health [GM075033-02]; American Recovery & Reinvestment Act (ARRA) [GM075033-03S1, NS069898]; University of Iowa; University of Iowa Graduate College; Pharmaceutical Research and Manufacturers of America (PhRMA) Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069898] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Recovery & Reinvestment Act (ARRA); University of Iowa; University of Iowa Graduate College; Pharmaceutical Research and Manufacturers of America (PhRMA) Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM075033-02 and American Recovery & Reinvestment Act (ARRA) grant GM075033-03S1 (to R. A. F.) and NS069898 (to D. P. M.). This work was also supported by a University of Iowa Carver Collaborative Pilot Grant (to R. A. F. and D. P. M.).; A recipient of the Presidential Fellowship from the University of Iowa Graduate College and a Pre-Doctoral Fellowship in Pharmacology/Toxicology from the Pharmaceutical Research and Manufacturers of America (PhRMA) Foundation.	Anderson GR, 2010, NEUROPSYCHOPHARMACOL, V35, P1040, DOI 10.1038/npp.2009.212; Anderson GR, 2009, CELL BIOCHEM BIOPHYS, V54, P33, DOI 10.1007/s12013-009-9052-9; Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; Blundell J, 2008, BRAIN RES, V1190, P78, DOI 10.1016/j.brainres.2007.11.017; Boy J, 2009, HUM MOL GENET, V18, P4282, DOI 10.1093/hmg/ddp381; Cendelin J, 2010, BEHAV BRAIN RES, V210, P8, DOI 10.1016/j.bbr.2010.01.035; Chatterjee TK, 2003, J BIOL CHEM, V278, P30261, DOI 10.1074/jbc.M212687200; Chen CK, 2003, P NATL ACAD SCI USA, V100, P6604, DOI 10.1073/pnas.0631825100; Chiu CS, 2005, J NEUROSCI, V25, P3234, DOI 10.1523/JNEUROSCI.3364-04.2005; Ciruela F, 2010, EUR J NEUROSCI, V32, P1265, DOI 10.1111/j.1460-9568.2010.07356.x; De Zeeuw CI, 2011, NAT REV NEUROSCI, V12, P327, DOI 10.1038/nrn3011; Doupnik CA, 1996, NEUROPHARMACOLOGY, V35, P923, DOI 10.1016/0028-3908(96)00125-6; Doupnik CA, 1997, P NATL ACAD SCI USA, V94, P10461, DOI 10.1073/pnas.94.19.10461; Drenan RM, 2005, J CELL BIOL, V169, P623, DOI 10.1083/jcb.200502007; Gold SJ, 2007, J NEUROSCI, V27, P14338, DOI 10.1523/JNEUROSCI.4223-07.2007; HOSFORD DA, 1995, J PHARMACOL EXP THER, V274, P1399; Jacobson LH, 2005, PSYCHOPHARMACOLOGY, V179, P688, DOI 10.1007/s00213-004-2086-1; Kovoor A, 2000, J BIOL CHEM, V275, P3397, DOI 10.1074/jbc.275.5.3397; Kovoor A, 2005, J NEUROSCI, V25, P2157, DOI 10.1523/JNEUROSCI.2840-04.2005; Labouebe G, 2007, NAT NEUROSCI, V10, P1559, DOI 10.1038/nn2006; Lalonde R, 2007, BRAIN RES, V1140, P51, DOI 10.1016/j.brainres.2006.01.031; Lambert NA, 2010, P NATL ACAD SCI USA, V107, P7066, DOI 10.1073/pnas.0912934107; Liao YJ, 1996, J NEUROSCI, V16, P7137; Maity B, 2011, J BIOL CHEM, V286, P1409, DOI 10.1074/jbc.M110.186700; Manto M, 2009, CURR OPIN NEUROL, V22, P419, DOI 10.1097/WCO.0b013e32832b9897; Mapelli L, 2009, J NEUROPHYSIOL, V101, P3089, DOI 10.1152/jn.91190.2008; Martemyanov KA, 2005, J BIOL CHEM, V280, P5133, DOI 10.1074/jbc.C400596200; Oliver PL, 2007, BEHAV BRAIN RES, V181, P239, DOI 10.1016/j.bbr.2007.04.012; Perkins EM, 2010, J NEUROSCI, V30, P4857, DOI 10.1523/JNEUROSCI.6065-09.2010; Pinard A, 2010, ADV PHARMACOL, V58, P231, DOI 10.1016/S1054-3589(10)58010-4; Posokhova E, 2010, CIRC RES, V107, P1350, DOI 10.1161/CIRCRESAHA.110.224212; Pravetoni M, 2008, GENES BRAIN BEHAV, V7, P523, DOI 10.1111/j.1601-183X.2008.00388.x; Rahman Z, 2003, NEURON, V38, P941, DOI 10.1016/S0896-6273(03)00321-0; Rossi DJ, 2003, J PHYSIOL-LONDON, V548, P97, DOI 10.1113/jphysiol.2002.036459; Rossi P, 2006, EUR J NEUROSCI, V24, P419, DOI 10.1111/j.1460-9568.2006.04914.x; Saitoh O, 2003, CEREBELLUM, V2, P154, DOI 10.1080/14734220309409; Saitoh O, 2003, BIOCHEM BIOPH RES CO, V309, P836, DOI 10.1016/j.bbrc.2003.08.083; Slesinger PA, 1997, P NATL ACAD SCI USA, V94, P12210, DOI 10.1073/pnas.94.22.12210; Snow BE, 1999, P NATL ACAD SCI USA, V96, P6489, DOI 10.1073/pnas.96.11.6489; Sodickson DL, 1996, J NEUROSCI, V16, P6374; Vigot R, 1997, NEUROSCI RES, V29, P151, DOI 10.1016/S0168-0102(97)00087-4; Watanabe D, 1998, CELL, V95, P17, DOI 10.1016/S0092-8674(00)81779-1; Watson N, 1996, NATURE, V383, P172, DOI 10.1038/383172a0; Xie G, 2010, J BIOL CHEM, V285, P32160, DOI 10.1074/jbc.M110.153676; Xie KQ, 2012, PSYCHOPHARMACOLOGY, V219, P823, DOI 10.1007/s00213-011-2409-y; Xie KQ, 2010, NAT NEUROSCI, V13, P661, DOI 10.1038/nn.2549; Yamamoto M, 2003, J NEUROSCI, V23, P6759; Yang JQ, 2010, CIRC RES, V107, P1345, DOI 10.1161/CIRCRESAHA.110.224220; Zhang JH, 2011, J NEUROCHEM, V119, P544, DOI 10.1111/j.1471-4159.2011.07457.x	49	34	35	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4972	4981		10.1074/jbc.M111.297218	http://dx.doi.org/10.1074/jbc.M111.297218			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22179605	hybrid, Green Published			2022-12-27	WOS:000300608500057
J	Hwang, ES; Brodsky, B				Hwang, Eileen S.; Brodsky, Barbara			Folding Delay and Structural Perturbations Caused by Type IV Collagen Natural Interruptions and Nearby Gly Missense Mutations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DYSTROPHIC EPIDERMOLYSIS-BULLOSA; REPEATING TRIPEPTIDE PATTERN; BASEMENT-MEMBRANE COLLAGEN; TRIPLE-HELIX; HEREDITARY NEPHRITIS; MOLECULAR-STRUCTURE; ANCHORING FIBRILS; PROCOLLAGEN-IV; CHAIN; PEPTIDE	The standard collagen triple helix requires Gly as every third residue in the amino acid sequence, yet all nonfibrillar collagens contain sites where this repeating pattern is interrupted. To explore the effects of such natural interruptions on the triple helix, a 4- or 15-residue sequence from human basement membrane type IV collagen was introduced between (Gly-Xaa-Yaa)(n) domains within a recombinant bacterial collagen. The interruptions had little effect on melting temperature, consistent with the high thermal stability reported for nonfibrillar collagens. Although the 4-residue interruption cannot be accommodated within a standard triple helix, trypsin and thermolysin resistance indicated a tightly packed structure. Central residues of the 15-residue interruption were protease-susceptible, whereas residues near the (Gly-Xaa-Yaa)(n) boundary were resistant, supporting a transition from an alternate conformation to a well packed triple helix. Both interruptions led to a delay in triple-helix folding, with the 15-residue interruption causing slower folding than the 4-residue interruption. These results suggest that propagation through interruptions represents a slow folding step. To clarify the relation between natural interruptions and pathological mutations, a Gly to Ser missense mutation was placed three triplets away from the 4-residue interruption. As a result of this mutation, the 4-residue interruption and nearby triple helix became susceptible to protease digestion, and an additional folding delay was observed. Because Gly missense mutations that cause disease are often located near natural interruptions, structural and folding perturbations arising from such proximity could be a factor in collagen genetic diseases.	[Brodsky, Barbara] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA; [Hwang, Eileen S.; Brodsky, Barbara] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA	Tufts University; Rutgers State University New Brunswick; Rutgers State University Medical Center	Brodsky, B (corresponding author), Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.	barbara.brodsky@tufts.edu		Hwang, Eileen/0000-0003-0161-6977	National Institutes of Health [GM60048, DK089630]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK089630] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060048] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM60048 (to B. B.). This work was also supported by National Institutes of Health F30 Fellowship DK089630 (to E. S. H.).	BABEL W, 1984, EUR J BIOCHEM, V143, P545, DOI 10.1111/j.1432-1033.1984.tb08404.x; BACHINGER HP, 1982, J BIOL CHEM, V257, P4590; BACHINGER HP, 1990, J BIOL CHEM, V265, P10095; BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699; Bella J, 2006, J MOL BIOL, V362, P298, DOI 10.1016/j.jmb.2006.07.014; Bruckner-Tuderman L, 1999, MATRIX BIOL, V18, P43, DOI 10.1016/S0945-053X(98)00007-9; Bruckner-Tuderman L, 2010, DERMATOL CLIN, V28, P107, DOI 10.1016/j.det.2009.10.020; Byers P, 2002, CONNECTIVE TISSUE IT, P385, DOI DOI 10.1002/0471221929.CH8; Cheng HM, 2011, J BIOL CHEM, V286, P2041, DOI 10.1074/jbc.M110.153965; Crockett DK, 2010, HUM MUTAT, V31, pE1652, DOI 10.1002/humu.21312; DAVIS JM, 1989, J BIOL CHEM, V264, P8956; DEHM P, 1978, J BIOL CHEM, V253, P6680; DOLZ R, 1988, EUR J BIOCHEM, V178, P357, DOI 10.1111/j.1432-1033.1988.tb14458.x; Fahnestock S R, 2000, J Biotechnol, V74, P105, DOI 10.1016/S1389-0352(00)00008-8; Feng YB, 1996, BIOPOLYMERS, V39, P859, DOI 10.1002/(SICI)1097-0282(199612)39:6<859::AID-BIP10>3.3.CO;2-Z; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, DOI DOI 10.1385/1592598900; GRANT ME, 1972, J BIOL CHEM, V247, P3539; Grant ME, 2002, COLLAGEN FAMILY STRU, P159, DOI DOI 10.1002/0471221929.CH2; HARRINGT.WF, 1970, BIOCHEMISTRY-US, V9, P3714, DOI 10.1021/bi00821a010; HOFMANN H, 1984, J MOL BIOL, V172, P325, DOI 10.1016/S0022-2836(84)80029-7; HUDSON BG, 1993, J BIOL CHEM, V268, P26033; Hudson BG, 2003, NEW ENGL J MED, V348, P2543, DOI 10.1056/NEJMra022296; Hwang ES, 2010, PROTEIN SCI, V19, P1053, DOI 10.1002/pro.383; Kobayashi T, 2010, BIOMED RES-TOKYO, V31, P371, DOI 10.2220/biomedres.31.371; Li YJ, 2007, J BIOL CHEM, V282, P22699, DOI 10.1074/jbc.M702910200; LONG CG, 1995, BIOPOLYMERS, V35, P621, DOI 10.1002/bip.360350608; LUNSTRUM GP, 1988, J BIOL CHEM, V263, P18318; MACWRIGHT RS, 1983, BIOCHEMISTRY-US, V22, P4940, DOI 10.1021/bi00290a010; Marini JC, 2007, HUM MUTAT, V28, P209, DOI 10.1002/humu.20429; Marutani T, 2004, J CELL SCI, V117, P5913, DOI 10.1242/jcs.01514; MCCOY RC, 1982, KIDNEY INT, V21, P642, DOI 10.1038/ki.1982.72; Mohs A, 2007, J BIOL CHEM, V282, P29757, DOI 10.1074/jbc.M703991200; Mohs A, 2006, J BIOL CHEM, V281, P17197, DOI 10.1074/jbc.M601763200; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; NAKANISHI K, 1994, KIDNEY INT, V46, P1413, DOI 10.1038/ki.1994.413; Persikov AV, 2004, PROTEIN SCI, V13, P893, DOI 10.1110/ps.03501704; Ricard-Blum S, 2005, PATHOL BIOL, V53, P430, DOI 10.1016/j.patbio.2004.12.024; RICH A, 1961, J MOL BIOL, V3, P483, DOI 10.1016/S0022-2836(61)80016-8; SCHMID TM, 1984, BIOCHEMISTRY-US, V23, P553, DOI 10.1021/bi00298a024; Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833; SPIRO RG, 1969, J BIOL CHEM, V244, P2049; Thiagranjan G, 2008, J MOL BIOL, V376, P736, DOI 10.1016/j.jmb.2007.11.075; WELGUS HG, 1990, J BIOL CHEM, V265, P13521; Xu Y, 2002, J BIOL CHEM, V277, P27312, DOI 10.1074/jbc.M201163200; Yoshizumi A, 2009, PROTEIN SCI, V18, P1241, DOI 10.1002/pro.134; Yu ZX, 2010, PROTEIN SCI, V19, P775, DOI 10.1002/pro.356; YURCHENCO PD, 1988, AM J PATHOL, V132, P278	47	16	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					4368	4375		10.1074/jbc.M111.269084	http://dx.doi.org/10.1074/jbc.M111.269084			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22179614	hybrid, Green Published			2022-12-27	WOS:000300410900067
J	Valvezan, AJ; Zhang, F; Diehl, JA; Klein, PS				Valvezan, Alexander J.; Zhang, Fang; Diehl, J. Alan; Klein, Peter S.			Adenomatous Polyposis Coli (APC) Regulates Multiple Signaling Pathways by Enhancing Glycogen Synthase Kinase-3 (GSK-3) Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR PROTEIN; BETA-CATENIN; WNT/BETA-CATENIN; NEURONAL POLARITY; NEGATIVE REGULATOR; AXIN; WNT; PHOSPHORYLATION; CANCER; ACTIVATION	Glycogen synthase kinase-3 (GSK-3) is essential for many signaling pathways and cellular processes. As Adenomatous Polyposis Coli (APC) functions in many of the same processes, we investigated a role for APC in the regulation of GSK-3-dependent signaling. We find that APC directly enhances GSK-3 activity. Furthermore, knockdown of APC mimics inhibition of GSK-3 by reducing phosphorylation of glycogen synthase and by activating mTOR, revealing novel roles for APC in the regulation of these enzymes. Wnt signaling inhibits GSK-3 through an unknown mechanism, and this results in both stabilization of beta-catenin and activation of mTOR. We therefore hypothesized that Wnts may regulate GSK-3 by disrupting the interaction between APC and the Axin-GSK-3 complex. We find that Wnts rapidly induce APC dissociation from Axin, correlating with beta-catenin stabilization. Furthermore, Axin interaction with the Wnt co-receptor LRP6 causes APC dissociation from Axin. We propose that APC regulates multiple signaling pathways by enhancing GSK-3 activity, and that Wnts induce APC dissociation from Axin to reduce GSK-3 activity and activate downstream signaling. APC regulation of GSK-3 also provides a novel mechanism for Wnt regulation of multiple downstream effectors, including beta-catenin and mTOR.	[Valvezan, Alexander J.; Klein, Peter S.] Univ Penn, Sch Med, Cell & Mol Biol Grad Grp, Philadelphia, PA 19104 USA; [Zhang, Fang; Klein, Peter S.] Univ Penn, Sch Med, Pharmacol Grad Grp, Philadelphia, PA 19104 USA; [Zhang, Fang; Diehl, J. Alan] Univ Penn, Sch Med, Dept Canc Biol, Leonard & Madlyn Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Zhang, Fang; Diehl, J. Alan] Univ Penn, Sch Med, Ctr Canc, Philadelphia, PA 19104 USA; [Klein, Peter S.] Univ Penn, Sch Med, Dept Med, Div Hematol Oncol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania	Klein, PS (corresponding author), 364 Clin Res Bldg,415 Curie Blvd, Philadelphia, PA 19104 USA.	pklein@mail.med.upenn.edu			NIMH [1R01MH58324]; NHLBI, National Institutes of Health [1R01HL110806-01]; Training Program in Neuropsychopharmacology [T32 MH14654-33]; NATIONAL CANCER INSTITUTE [R01CA093237] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL110806] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH058324, T32MH014654] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Training Program in Neuropsychopharmacology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by Grant 1R01MH58324 from the NIMH and 1R01HL110806-01 from the NHLBI, National Institutes of Health.; Supported by the Training Program in Neuropsychopharmacology (T32 MH14654-33).	Ahmad I, 2011, ONCOGENE, V30, P178, DOI 10.1038/onc.2010.399; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Brady MJ, 2001, RECENT PROG HORM RES, V56, P157, DOI 10.1210/rp.56.1.157; Caldwell CM, 2009, ADV EXP MED BIOL, V656, P51, DOI 10.1007/978-1-4419-1145-2_5; Chen HJ, 2006, GENE DEV, V20, P1933, DOI 10.1101/gad.1411206; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cook D, 1996, EMBO J, V15, P4526, DOI 10.1002/j.1460-2075.1996.tb00830.x; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Cselenyi CS, 2008, P NATL ACAD SCI USA, V105, P8032, DOI 10.1073/pnas.0803025105; Dajani R, 2001, CELL, V105, P721, DOI 10.1016/S0092-8674(01)00374-9; Ding VW, 2000, J BIOL CHEM, V275, P32475, DOI 10.1074/jbc.M005342200; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Forde JE, 2007, CELL MOL LIFE SCI, V64, P1930, DOI 10.1007/s00018-007-7045-7; Fuentealba LC, 2007, CELL, V131, P980, DOI 10.1016/j.cell.2007.09.027; Fujishita T, 2008, P NATL ACAD SCI USA, V105, P13544, DOI 10.1073/pnas.0800041105; Fukuda T, 2010, DIFFERENTIATION, V80, P46, DOI 10.1016/j.diff.2010.05.002; Gartner A, 2006, J CELL SCI, V119, P3927, DOI 10.1242/jcs.03159; GREENBERG SG, 1992, J BIOL CHEM, V267, P564; Guo X, 2008, GENE DEV, V22, P106, DOI 10.1101/gad.1590908; Hanson CA, 2005, GENE, V361, P1, DOI 10.1016/j.gene.2005.07.024; Hedgepeth CM, 1999, MOL CELL BIOL, V19, P7147; Hernandez F, 2009, BRAIN RES BULL, V80, P248, DOI 10.1016/j.brainresbull.2009.05.017; Hinoi T, 2000, J BIOL CHEM, V275, P34399, DOI 10.1074/jbc.M003997200; Huang J, 2009, J CLIN INVEST, V119, P3519, DOI 10.1172/JCI40572; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Jiang H, 2005, CELL, V120, P123, DOI 10.1016/j.cell.2004.12.033; Jope RS, 2006, CURR DRUG TARGETS, V7, P1421, DOI 10.2174/1389450110607011421; Kawahara K, 2000, J BIOL CHEM, V275, P8369, DOI 10.1074/jbc.275.12.8369; Kishida S, 1998, J BIOL CHEM, V273, P10823, DOI 10.1074/jbc.273.18.10823; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Kockeritz L, 2006, CURR DRUG TARGETS, V7, P1377, DOI 10.2174/1389450110607011377; Koehl GE, 2010, ONCOGENE, V29, P1553, DOI 10.1038/onc.2009.435; Kofron M, 2001, DEV BIOL, V237, P183, DOI 10.1006/dbio.2001.0371; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Luo J, 2009, CANCER LETT, V273, P194, DOI 10.1016/j.canlet.2008.05.045; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; McManus EJ, 2005, EMBO J, V24, P1571, DOI 10.1038/sj.emboj.7600633; Miclea RL, 2011, EXP CELL RES, V317, P1411, DOI 10.1016/j.yexcr.2011.03.007; Morin PJ, 1999, BIOESSAYS, V21, P1021, DOI 10.1002/(SICI)1521-1878(199912)22:1<1021::AID-BIES6>3.0.CO;2-P; MUNEMITSU S, 1995, P NATL ACAD SCI USA, V92, P3046, DOI 10.1073/pnas.92.7.3046; Park KS, 2006, J CELL SCI, V119, P819, DOI 10.1242/jcs.02779; Paul S, 2008, NEOPLASMA, V55, P165; Peterson-Nedry W, 2008, DEV BIOL, V320, P226, DOI 10.1016/j.ydbio.2008.05.521; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; Piao S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004046; Salahshor S, 2005, J CLIN PATHOL, V58, P225, DOI 10.1136/jcp.2003.009506; Schneikert J, 2006, INT J CANCER, V119, P74, DOI 10.1002/ijc.21826; Shi SH, 2004, CURR BIOL, V14, P2025, DOI 10.1016/j.cub.2004.11.009; SMITH KJ, 1994, CANCER RES, V54, P3672; Su YY, 2008, MOL CELL, V32, P652, DOI 10.1016/j.molcel.2008.10.023; Taelman VF, 2010, CELL, V143, P1136, DOI 10.1016/j.cell.2010.11.034; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Tolwinski NS, 2003, DEV CELL, V4, P407, DOI 10.1016/S1534-5807(03)00063-7; von Kries JP, 2000, NAT STRUCT BIOL, V7, P800; Wakefield JG, 2003, J CELL SCI, V116, P637, DOI 10.1242/jcs.00273; Wang Q, 2006, ONCOGENE, V25, P43, DOI 10.1038/sj.onc.1209004; Wang Y, 2008, MOL BIOL CELL, V19, P4076, DOI 10.1091/mbc.E07-12-1296; Wu G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004926; Xu LF, 2000, GENE DEV, V14, P585; Yamazaki H, 2003, BIOCHEM BIOPH RES CO, V304, P229, DOI 10.1016/S0006-291X(03)00582-5; Yang J, 2006, J BIOL CHEM, V281, P17751, DOI 10.1074/jbc.M600831200; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	66	62	64	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					3823	3832		10.1074/jbc.M111.323337	http://dx.doi.org/10.1074/jbc.M111.323337			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22184111	Green Published, hybrid			2022-12-27	WOS:000300410900019
J	Zou, ZY; Wu, LP; Ding, HY; Wang, Y; Zhang, YQ; Chen, XJ; Chen, X; Zhang, CY; Zhang, QP; Zen, K				Zou, Zhenyou; Wu, Linping; Ding, Hanying; Wang, Yang; Zhang, Yaqin; Chen, Xuejiao; Chen, Xi; Zhang, Chen-Yu; Zhang, Qipeng; Zen, Ke			MicroRNA-30a Sensitizes Tumor Cells to cis-Platinum via Suppressing Beclin 1-mediated Autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER-CELLS; HEPATOCELLULAR-CARCINOMA; OVARIAN-CANCER; APOPTOSIS; P53; INHIBITION; EXPRESSION; RESISTANCE; PROTEIN; CHOLANGIOCARCINOMA	Autophagy is activated in cancer cells during chemotherapy and often contributes to tumor chemotherapy resistance. In this study, we characterized the role of microRNA-30a (miR-30a) in the coordination of cancer cell apoptosis and autophagy, which determines the sensitivity of cancer cells to chemotherapy. First, the autophagy activity in cancer cells increased after cis-dichloro-diamine platinum (cis-DDP) or Taxol treatment, as indicated by the enhanced expression of beclin 1, a key regulator of autophagy, and increased number of LC3-positive autophagosomes. Second, miRNA screening using a TaqMan probe-based quantitative RT-PCR assay identified that miR-30a, a miRNA that targets beclin 1, was significantly reduced in tumor cells by cis-DDP treatment. Forced expression of miR-30a significantly reduced beclin 1 and the autophagy activity of tumor cells induced by cis-DDP. Third, the blockade of tumor cell autophagy activity by miR-30a expression or 3-methyladenine significantly increased tumor cell apoptosis induced by cis-DDP treatment. Finally, an in vivo tumor implantation mouse model clearly showed that elevation of miR-30a in implanted tumor cells by administration of the recombinant lentivirus expressing miR-30a strongly enhanced cis-DDP-induced apoptosis of tumor cells. In conclusion, our results demonstrate for the first time that miR-30a can sensitize tumor cells to cis-DDP via reducing beclin 1-mediated autophagy and that increasing miR-30a level in tumor cells represents a novel approach to enhance the efficacy of chemotherapy during cancer treatment.	[Zou, Zhenyou; Wu, Linping; Ding, Hanying; Wang, Yang; Zhang, Yaqin; Chen, Xuejiao; Chen, Xi; Zhang, Chen-Yu; Zhang, Qipeng; Zen, Ke] Nanjing Univ, Sch Life Sci, JERC MBB, State Key Lab Pharmaceut Biotechnol, Nanjing 210093, Jiangsu, Peoples R China	Nanjing University	Zhang, CY (corresponding author), Nanjing Univ, Sch Life Sci, JERC MBB, State Key Lab Pharmaceut Biotechnol, Hankou Rd 22, Nanjing 210093, Jiangsu, Peoples R China.	cyzhang@nju.edu.cn; promoterzhang@gmail.com; kzen@nju.edu.cn		Ding, Hanying/0000-0002-0155-6057	National Natural Science Foundation of China [30988003, 30871019, 30890044, 30890032, 31071232, 31000323, 31100777, 90608010]; National Basic Research Program of China 973 Program [2011CB504803]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China 973 Program(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China Grants 30988003, 30871019, 30890044, 30890032, 31071232, 31000323, 31100777, and 90608010 and National Basic Research Program of China 973 Program No. 2011CB504803.	Ahn CH, 2007, APMIS, V115, P1344, DOI 10.1111/j.1600-0463.2007.00858.x; Amaravadi RK, 2011, CLIN CANCER RES, V17, P654, DOI 10.1158/1078-0432.CCR-10-2634; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brest P, 2011, NAT GENET, V43, P242, DOI 10.1038/ng.762; Chaney SG, 2004, J INORG BIOCHEM, V98, P1551, DOI 10.1016/j.jinorgbio.2004.04.024; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen YS, 2009, PATHOL ONCOL RES, V15, P487, DOI 10.1007/s12253-008-9143-8; Dong J, 2011, ARCH MED RES, V42, P8, DOI 10.1016/j.arcmed.2011.01.006; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fabbri M, 2008, CANCER J, V14, P1, DOI 10.1097/PPO.0b013e318164145e; FAN SJ, 1995, CANCER RES, V55, P1649; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Gottesman MM, 2002, ANNU REV MED, V53, P615, DOI 10.1146/annurev.med.53.082901.103929; HOPPESEYLER F, 1993, J VIROL, V67, P3111, DOI 10.1128/JVI.67.6.3111-3117.1993; Hornstein E, 2005, NATURE, V438, P671, DOI 10.1038/nature04138; Hou XM, 2009, NUCLEIC ACIDS RES, V37, P1400, DOI 10.1093/nar/gkn933; Hou YJ, 2011, LAB INVEST, V91, P1146, DOI 10.1038/labinvest.2011.97; Karantza-Wadsworth V, 2007, GENE DEV, V21, P1621, DOI 10.1101/gad.1565707; Kastl L, 2012, BREAST CANCER RES TR, V131, P445, DOI 10.1007/s10549-011-1424-3; Khan SA, 2005, LANCET, V366, P1303, DOI 10.1016/S0140-6736(05)67530-7; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Koivusalo R, 2002, CANCER RES, V62, P7364; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Lee AJX, 2012, J PATHOL, V226, P482, DOI 10.1002/path.2998; Li J, 2009, ANN SURG ONCOL, V16, P761, DOI 10.1245/s10434-008-0260-0; Li LM, 2011, J IMMUNOL, V186, P2552, DOI 10.4049/jimmunol.1001633; Livesey KM, 2009, CURR OPIN INVEST DR, V10, P1269; Longo L, 2008, MOL CANCER THER, V7, P2476, DOI 10.1158/1535-7163.MCT-08-0361; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Medina PP, 2010, NATURE, V467, P86, DOI 10.1038/nature09284; Miracco C, 2007, INT J ONCOL, V30, P429; Mukhopadhyay P, 2011, ANN NY ACAD SCI, V1215, P109, DOI 10.1111/j.1749-6632.2010.05866.x; Nakatani F, 2012, J PATHOL, V226, P796, DOI 10.1002/path.3007; O'Donovan TR, 2011, AUTOPHAGY, V7, P509, DOI 10.4161/auto.7.5.15066; Rabik CA, 2007, CANCER TREAT REV, V33, P9, DOI 10.1016/j.ctrv.2006.09.006; Sato K, 2007, CANCER RES, V67, P9677, DOI 10.1158/0008-5472.CAN-07-1462; Shen Y, 2008, AUTOPHAGY, V4, P1067, DOI 10.4161/auto.6827; Song B, 2009, ONCOGENE, V28, P4065, DOI 10.1038/onc.2009.274; Stronach EA, 2011, CANCER RES, V71, P4412, DOI 10.1158/0008-5472.CAN-10-4111; Sun QM, 2009, AUTOPHAGY, V5, P713, DOI 10.4161/auto.5.5.8524; Tang R, 2012, CELL RES, V22, P504, DOI 10.1038/cr.2011.137; Tao J, 2011, ONCOL REP, V25, P1721, DOI 10.3892/or.2011.1245; Vollmer CM, 1999, CANCER RES, V59, P4369; White E, 2010, CURR OPIN CELL BIOL, V22, P212, DOI 10.1016/j.ceb.2009.12.008; White NMA, 2011, NAT REV CLIN ONCOL, V8, P75, DOI 10.1038/nrclinonc.2010.173; Xiao J, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-35; Zhang Y, 2012, ONCOGENE, V31, P1055, DOI 10.1038/onc.2011.290; Zhu H, 2009, AUTOPHAGY, V5, P816, DOI 10.4161/auto.9064	49	153	165	1	55	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					4148	4156		10.1074/jbc.M111.307405	http://dx.doi.org/10.1074/jbc.M111.307405			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22157765	Green Published, hybrid			2022-12-27	WOS:000300410900048
J	Jurczak, MJ; Lee, AH; Jornayvaz, FR; Lee, HY; Birkenfeld, AL; Guigni, BA; Kahn, M; Samuel, VT; Glimcher, LH; Shulman, GI				Jurczak, Michael J.; Lee, Ann-Hwee; Jornayvaz, Francois R.; Lee, Hui-Young; Birkenfeld, Andreas L.; Guigni, Blas A.; Kahn, Mario; Samuel, Varman T.; Glimcher, Laurie H.; Shulman, Gerald I.			Dissociation of Inositol-requiring Enzyme (IRE1 alpha)-mediated c-Jun N-terminal Kinase Activation from Hepatic Insulin Resistance in Conditional X-box-binding Protein-1 (XBP1) Knock-out Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; FATTY LIVER-DISEASE; DIET-INDUCED OBESITY; GLUCOSE-HOMEOSTASIS; ER STRESS; RECEPTOR SUBSTRATE-1; TRANSCRIPTION FACTOR; ENERGY-EXPENDITURE; MESSENGER-RNA; STEATOSIS	Hepatic insulin resistance has been attributed to both increased endoplasmic reticulum (ER) stress and accumulation of intracellular lipids, specifically diacylglycerol (DAG). The ER stress response protein, X-box-binding protein-1 (XBP1), was recently shown to regulate hepatic lipogenesis, suggesting that hepatic insulin resistance in models of ER stress may result from defective lipid storage, as opposed to ER-specific stress signals. Studies were designed to dissociate liver lipid accumulation and activation of ER stress signaling pathways, which would allow us to delineate the individual contributions of ER stress and hepatic lipid content to the pathogenesis of hepatic insulin resistance. Conditional XBP1 knock-out (XBP1 Delta) and control mice were fed fructose chow for 1 week. Determinants of whole-body energy balance, weight, and composition were determined. Hepatic lipids including triglyceride, DAGs, and ceramide were measured, alongside markers of ER stress. Whole-body and tissue-specific insulin sensitivity were determined by hyperinsulinemic-euglycemic clamp studies. Hepatic ER stress signaling was increased in fructose chow-fed XBP1 Delta mice as reflected by increased phosphorylated eIF2 alpha, HSPA5 mRNA, and a 2-fold increase in hepatic JNK activity. Despite JNK activation, XBP1 Delta displayed increased hepatic insulin sensitivity during hyperinsulinemic-euglycemic clamp studies, which was associated with increased insulin-stimulated IRS2 tyrosine phosphorylation, reduced hepatic DAG content, and reduced PKC epsilon activity. These studies demonstrate that ER stress and IRE1 alpha-mediated JNK activation can be disassociated from hepatic insulin resistance and support the hypothesis that hepatic insulin resistance in models of ER stress may be secondary to ER stress modulation of hepatic lipogenesis.	[Jurczak, Michael J.; Lee, Hui-Young; Shulman, Gerald I.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06536 USA; [Jornayvaz, Francois R.; Birkenfeld, Andreas L.; Guigni, Blas A.; Kahn, Mario; Samuel, Varman T.; Shulman, Gerald I.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06536 USA; [Shulman, Gerald I.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06536 USA; [Lee, Ann-Hwee; Glimcher, Laurie H.] Harvard Univ, Sch Med, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Glimcher, Laurie H.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Howard Hughes Medical Institute; Yale University; Yale University; Yale University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Shulman, GI (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, TAC S269,POB 9812, New Haven, CT 06536 USA.	gerald.shulman@yale.edu	Jornayvaz, François/AAL-2134-2020; Shulman, Gerald I./P-7176-2019; Birkenfeld, Andreas L./U-3954-2019	Shulman, Gerald I./0000-0003-1529-5668; Birkenfeld, Andreas L./0000-0003-1407-9023; Jurczak, Michael/0000-0002-6335-6915; Lee, Hui-Young/0000-0002-3464-6382; Jornayvaz, Francois/0000-0001-9425-3137; Guigni, Blas/0000-0002-9667-8195	United States Public Health Service [R01 DK-40936, P30 DK-45735, U24 DK-059635, DK-082448]; American Heart Foundation; Swiss National Science Foundation [PASMP3-132563]; German Research Science Foundation [Bi1292/4-1]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK045735, R01DK082448, R01DK040936, U24DK059635] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); American Heart Foundation(American Heart Association); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); German Research Science Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by United States Public Health Service Grants R01 DK-40936, P30 DK-45735, U24 DK-059635, and DK-082448 (to L. H. G.), the American Heart Foundation (to A.-H. L.), Swiss National Science Foundation Grant PASMP3-132563 (to F. R. J.), and German Research Science Foundation Grant Bi1292/4-1 (to A. L. B.).	Acosta-Alvear D, 2007, MOL CELL, V27, P53, DOI 10.1016/j.molcel.2007.06.011; Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; Ayala JE, 2010, DIS MODEL MECH, V3, P525, DOI 10.1242/dmm.006239; Bikman BT, 2011, J CLIN INVEST, V121, P4222, DOI 10.1172/JCI57144; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Choi CS, 2007, P NATL ACAD SCI USA, V104, P16480, DOI 10.1073/pnas.0706794104; Choi CS, 2007, J BIOL CHEM, V282, P22678, DOI 10.1074/jbc.M704213200; Copps KD, 2010, CELL METAB, V11, P84, DOI 10.1016/j.cmet.2009.11.003; Deevska GM, 2009, J BIOL CHEM, V284, P8359, DOI 10.1074/jbc.M807800200; Erion DM, 2010, NAT MED, V16, P400, DOI 10.1038/nm0410-400; Han MS, 2009, DIABETES, V58, P329, DOI 10.2337/db08-0080; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Holland WL, 2011, NAT MED, V17, P55, DOI 10.1038/nm.2277; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Jornayvaz FR, 2010, AM J PHYSIOL-ENDOC M, V299, pE808, DOI 10.1152/ajpendo.00361.2010; Jurczak MJ, 2011, DIABETES, V60, P890, DOI 10.2337/db10-1328; Kim JK, 2001, J CLIN INVEST, V108, P153, DOI 10.1172/JCI10294; Kotani K, 2004, J CLIN INVEST, V114, P1666, DOI 10.1172/JCI200421341; Kumashiro N, 2011, P NATL ACAD SCI USA, V108, P16381, DOI 10.1073/pnas.1113359108; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Lee HY, 2010, CELL METAB, V12, P668, DOI 10.1016/j.cmet.2010.11.004; Matsuzaka T, 2007, NAT MED, V13, P1193, DOI 10.1038/nm1662; Matsuzaki H, 2003, P NATL ACAD SCI USA, V100, P11285, DOI 10.1073/pnas.1934283100; Nakatani Y, 2005, J BIOL CHEM, V280, P847, DOI 10.1074/jbc.M411860200; Neschen S, 2005, CELL METAB, V2, P55, DOI 10.1016/j.cmet.2005.06.006; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Ozawa K, 2005, DIABETES, V54, P657, DOI 10.2337/diabetes.54.3.657; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Petersen KF, 2007, P NATL ACAD SCI USA, V104, P12587, DOI 10.1073/pnas.0705408104; Rizza RA, 2010, DIABETES, V59, P2697, DOI 10.2337/db10-1032; Rutkowski DT, 2008, DEV CELL, V15, P829, DOI 10.1016/j.devcel.2008.10.015; Sabio G, 2008, SCIENCE, V322, P1539, DOI 10.1126/science.1160794; Sabio G, 2010, MOL CELL BIOL, V30, P106, DOI 10.1128/MCB.01162-09; Sabio G, 2009, CELL METAB, V10, P491, DOI 10.1016/j.cmet.2009.09.007; Samuel VT, 2007, J CLIN INVEST, V117, P739, DOI 10.1172/JCI30400; Samuel VT, 2010, LANCET, V375, P2267, DOI 10.1016/S0140-6736(10)60408-4; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Savage DB, 2006, J CLIN INVEST, V116, P817, DOI 10.1172/JCI27300; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Solinas G, 2010, FASEB J, V24, P2596, DOI 10.1096/fj.09-151340; Sreejayan N, 2008, OBESITY, V16, P1331, DOI 10.1038/oby.2008.217; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Whitmarsh AJ, 2001, METHOD ENZYMOL, V332, P319; Wu JJ, 2006, CELL METAB, V4, P61, DOI 10.1016/j.cmet.2006.05.010; Yamamoto K, 2010, MOL BIOL CELL, V21, P2975, DOI 10.1091/mbc.E09-02-0133; Ye RS, 2010, DIABETES, V59, P6, DOI 10.2337/db09-0755; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; YOUN JH, 1993, DIABETES, V42, P757, DOI 10.2337/diabetes.42.5.757; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200; Zhang DY, 2007, P NATL ACAD SCI USA, V104, P17075, DOI 10.1073/pnas.0707060104; Zhou YJ, 2011, NAT MED, V17, P356, DOI 10.1038/nm.2293	54	121	124	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2558	2567		10.1074/jbc.M111.316760	http://dx.doi.org/10.1074/jbc.M111.316760			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22128176	hybrid, Green Published			2022-12-27	WOS:000300292300029
J	Malicdan, MCV; Noguchi, S; Tokutomi, T; Goto, Y; Nonaka, I; Hayashi, YK; Nishino, I				Malicdan, May Christine V.; Noguchi, Satoru; Tokutomi, Tomoharu; Goto, Yu-ichi; Nonaka, Ikuya; Hayashi, Yukiko K.; Nishino, Ichizo			Peracetylated N-Acetylmannosamine, a Synthetic Sugar Molecule, Efficiently Rescues Muscle Phenotype and Biochemical Defects in Mouse Model of Sialic Acid-deficient Myopathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INCLUSION-BODY MYOPATHY; RIMMED VACUOLES; DISTAL MYOPATHY; 2-EPIMERASE/N-ACETYLMANNOSAMINE KINASE; GLYCOLYLNEURAMINIC ACID; ACETYLNEURAMINIC ACID; EXPRESSION; SIALYLATION; MUTATION; ENZYME	Distal myopathy with rimmed vacuoles/hereditary inclusion body myopathy (DMRV/hIBM), characterized by progressive muscle atrophy, weakness, and degeneration, is due to mutations in GNE, a gene encoding a bifunctional enzyme critical in sialic acid biosynthesis. In the DMRV/hIBM mouse model, which exhibits hyposialylation in various tissues in addition to muscle atrophy, weakness, and degeneration, we recently have demonstrated that the myopathic phenotype was prevented by oral administration of N-acetylneuraminic acid, N-acetylmannosamine, and sialyllactose, underscoring the crucial role of hyposialylation in the disease pathomechanism. The choice for the preferred molecule, however, was limited probably by the complex pharmacokinetics of sialic acids and the lack of biomarkers that could clearly show dose response. To address these issues, we screened several synthetic sugar compounds that could increase sialylation more remarkably and allow demonstration of measurable effects in the DMRV/hIBM mice. In this study, we found that tetra-O-acetylated N-acetylmannosamine increased cell sialylation most efficiently, and in vivo evaluation in DMRV/hIBM mice revealed a more dramatic, measurable effect and improvement in muscle phenotype, enabling us to establish analysis of protein biomarkers that can be used for assessing response to treatment. Our results provide a proof of concept in sialic acid-related molecular therapy with synthetic monosaccharides.	[Malicdan, May Christine V.; Noguchi, Satoru; Tokutomi, Tomoharu; Nonaka, Ikuya; Hayashi, Yukiko K.; Nishino, Ichizo] Natl Ctr Neurol & Psychiat, Dept Neuromuscular Res, Natl Inst Neurosci, Kodaira, Tokyo 1878502, Japan; [Goto, Yu-ichi] Natl Ctr Neurol & Psychiat, Dept Mental Retardat & Birth Defect Res, Natl Inst Neurosci, Kodaira, Tokyo 1878502, Japan; [Tokutomi, Tomoharu] Natl Def Med Coll, Dept Pathol & Lab Med, Saitama 3598513, Japan	National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan; National Defense Medical College - Japan	Noguchi, S (corresponding author), Natl Ctr Neurol & Psychiat, Dept Neuromuscular Res, Natl Inst Neurosci, 4-1-1 Ogawahigashi Cho, Kodaira, Tokyo 1878502, Japan.	noguchi@ncnp.go.jp	Nishino, Ichizo/G-2676-2010; Malicdan, May Christine/AAK-7422-2021; Malicdan, May Christine/F-2806-2013	Nishino, Ichizo/0000-0001-9452-112X; 	Japanese Health Sciences Foundation; National Institute of Biomedical Innovation; National Center of Neurology and Psychiatry [22-5, 20B-12, 20B-13]; Kato Memorial Trust; Neuromuscular Disease Foundation; Association Francaise contre les Myopathies; United States National Institute of Child Health and Human Development, National Institutes of Health	Japanese Health Sciences Foundation; National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); National Center of Neurology and Psychiatry(National Center for Neurology & Psychiatry - Japan); Kato Memorial Trust; Neuromuscular Disease Foundation; Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); United States National Institute of Child Health and Human Development, National Institutes of Health	This work was supported in part by Research on Psychiatric and Neurological Diseases and Mental Health from the Japanese Health Sciences Foundation; the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation; Intramural Research Grants 22-5, 20B-12, and 20B-13 for Neurological and Psychiatric Disorders of the National Center of Neurology and Psychiatry; and the Kato Memorial Trust for Nambyo Research.; Supported in part by the Neuromuscular Disease Foundation and Association Francaise contre les Myopathies. Present address: Medical Genetics Branch, National Human Genome Research Institute, NIH, Bethesda, MD 20892.; We thank Fumiko Funato for technical assistance. The monoclonal antibody (H4A3) that recognizes Lamp2, generated by J. T. August and James E. K. Hildreth, was obtained from the Development Studies Hybridoma Bank, developed under the auspices of the United States National Institute of Child Health and Human Development, National Institutes of Health and maintained by the University of Iowa, Department of Biological Sciences, Iowa City, IA.	ARGOV Z, 1984, J NEUROL SCI, V64, P33, DOI 10.1016/0022-510X(84)90053-4; ASKANAS V, 2003, MOL GENETIC BASIS NE, P501; Bardor M, 2005, J BIOL CHEM, V280, P4228, DOI 10.1074/jbc.M412040200; Broccolini A, 2008, J NEUROCHEM, V105, P971, DOI 10.1111/j.1471-4159.2007.05208.x; Collins BE, 2000, GLYCOBIOLOGY, V10, P11, DOI 10.1093/glycob/10.1.11; Eisenberg I, 2001, NAT GENET, V29, P83, DOI 10.1038/ng718; Gagiannis D, 2007, BBA-GEN SUBJECTS, V1770, P297, DOI 10.1016/j.bbagen.2006.09.023; Galeano B, 2007, J CLIN INVEST, V117, P1585, DOI 10.1172/JCI30954; Hackler R, 2000, CLIN CHEM, V46, P483; HARA S, 1989, ANAL BIOCHEM, V179, P162, DOI 10.1016/0003-2697(89)90218-2; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; HIGA HH, 1985, J BIOL CHEM, V260, P8838; Hinderlich S, 2004, FEBS LETT, V566, P105, DOI 10.1016/j.febslet.2004.04.013; Huizing M, 2004, MOL GENET METAB, V81, P196, DOI 10.1016/j.ymgme.2003.11.012; Iijima R, 2004, FEBS LETT, V561, P163, DOI 10.1016/S0014-5793(04)00164-4; Jacobs CL, 2001, BIOCHEMISTRY-US, V40, P12864, DOI 10.1021/bi010862s; Jones MB, 2004, BIOTECHNOL BIOENG, V85, P394, DOI 10.1002/bit.10901; Kayashima T, 2002, J HUM GENET, V47, P77, DOI 10.1007/s100380200004; Keppler OT, 1999, SCIENCE, V284, P1372, DOI 10.1126/science.284.5418.1372; Keppler OT, 2001, GLYCOBIOLOGY, V11, p11R, DOI 10.1093/glycob/11.2.11R; Kim EJ, 2004, J BIOL CHEM, V279, P18342, DOI 10.1074/jbc.M400205200; Kim S, 2000, J CLIN INVEST, V105, P191, DOI 10.1172/JCI7302; Liu YX, 2009, MOL THER, V17, P1381, DOI 10.1038/mt.2009.115; Malicdan MCV, 2007, HUM MOL GENET, V16, P2669, DOI 10.1093/hmg/ddm220; Malicdan MCV, 2009, NAT MED, V15, P690, DOI 10.1038/nm.1956; Malicdan MCV, 2008, PHYSIOL GENOMICS, V35, P106, DOI 10.1152/physiolgenomics.90219.2008; Malicdan MCV, 2009, METHOD ENZYMOL, V453, P379, DOI 10.1016/S0076-6879(08)04019-6; Nishino I, 2005, Acta Myol, V24, P80; Nishino I, 2002, NEUROLOGY, V59, P1689, DOI 10.1212/01.WNL.0000041631.28557.C6; Noguchi S, 2004, J BIOL CHEM, V279, P11402, DOI 10.1074/jbc.M313171200; NONAKA I, 1981, J NEUROL SCI, V51, P141, DOI 10.1016/0022-510X(81)90067-8; Nonaka Ikuya, 2005, Curr Neurol Neurosci Rep, V5, P61, DOI 10.1007/s11910-005-0025-0; Querfurth HW, 2001, MOL CELL NEUROSCI, V17, P793, DOI 10.1006/mcne.2001.0972; Sarkar AK, 1997, J BIOL CHEM, V272, P25608, DOI 10.1074/jbc.272.41.25608; Schauer R, 2004, ZOOLOGY, V107, P49, DOI 10.1016/j.zool.2003.10.002; Stasche R, 1997, J BIOL CHEM, V272, P24319, DOI 10.1074/jbc.272.39.24319; Tajima Y, 2005, AM J PATHOL, V166, P1121, DOI 10.1016/S0002-9440(10)62332-2; Thompson MW, 2003, ARCH BIOCHEM BIOPHYS, V413, P236, DOI 10.1016/S0003-9861(03)00123-1; Varki NM, 2007, LAB INVEST, V87, P851, DOI 10.1038/labinvest.3700656; Vattemi G, 2003, EXP NEUROL, V179, P150, DOI 10.1016/S0014-4886(02)00025-0; Viswanathan K, 2003, BIOCHEMISTRY-US, V42, P15215, DOI 10.1021/bi034994s; Wang ZY, 2006, J BIOL CHEM, V281, P27016, DOI 10.1074/jbc.M604903200; YAMAMOTO H, 1993, J BIOCHEM-TOKYO, V114, P132, DOI 10.1093/oxfordjournals.jbchem.a124128; Yarema KJ, 2001, BIOTECHNIQUES, V31, P384, DOI 10.2144/01312rv02	44	32	34	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2689	2705		10.1074/jbc.M111.297051	http://dx.doi.org/10.1074/jbc.M111.297051			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22157763	Green Published, hybrid			2022-12-27	WOS:000300292300041
J	Mir, SA; Chatterjee, A; Mitra, A; Pathak, K; Mahata, SK; Sarkar, S				Mir, Saiful Anam; Chatterjee, Arunachal; Mitra, Arkadeep; Pathak, Kanchan; Mahata, Sushil K.; Sarkar, Sagartirtha			Inhibition of Signal Transducer and Activator of Transcription 3 (STAT3) Attenuates Interleukin-6 (IL-6)-induced Collagen Synthesis and Resultant Hypertrophy in Rat Heart	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIAC-HYPERTROPHY; ANGIOTENSIN-II; JAK-STAT; GROWTH-FACTOR; UP-REGULATION; CELL-DEATH; ISCHEMIA/REPERFUSION INJURY; DILATED CARDIOMYOPATHY; MYOCARDIAL FIBROSIS; PRESSURE-OVERLOAD	IL-6 has been shown to play a major role in collagen up-regulation process during cardiac hypertrophy, although the precise mechanism is still not known. In this study we have analyzed the mechanism by which IL-6 modulates cardiac hypertrophy. For the in vitro model, IL-6-treated cultured cardiac fibroblasts were used, whereas the in vivo cardiac hypertrophy model was generated by renal artery ligation in adult male Wistar rats (Rattus norvegicus). During induction of hypertrophy, increased phosphorylation of STAT1, STAT3, MAPK, and ERK proteins was observed both in vitro and in vivo. Treatment of fibroblasts with specific inhibitors for STAT1 (fludarabine, 50 mu M), STAT3 (S31-201, 10 mu M), p38 MAPK (SB203580, 10 mu M), and ERK1/2 (U0126, 10 mu M) resulted in down-regulation of IL-6-induced phosphorylation of specific proteins; however, only S31-201 and SB203580 inhibited collagen biosynthesis. In ligated rats in vivo, only STAT3 inhibitors resulted in significant decrease in collagen synthesis and hypertrophy markers such as atrial natriuretic factor and beta-myosin heavy chain. In addition, decreased heart weight to body weight ratio and improved cardiac function as measured by echocardiography was evident in animals treated with STAT3 inhibitor or siRNA. Compared with IL-6 neutralization, more pronounced down-regulation of collagen synthesis and regression of hypertrophy was observed with STAT3 inhibition, suggesting that STAT3 is the major downstream signaling molecule and a potential therapeutic target for cardiac hypertrophy.	[Mir, Saiful Anam; Chatterjee, Arunachal; Mitra, Arkadeep; Pathak, Kanchan; Sarkar, Sagartirtha] Univ Calcutta, Dept Zool, Kolkata 700019, India; [Mahata, Sushil K.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of Calcutta; University of California System; University of California San Diego	Sarkar, S (corresponding author), Univ Calcutta, Dept Zool, 35 Ballygunge Circular Rd, Kolkata 700019, India.	sagartirtha.sarkar@gmail.com	Mitra, Arkadeep/J-4163-2019; Chatterjee, Arunachal/AAW-9807-2021; Mahata, Sushil/AAF-8781-2021	Mitra, Arkadeep/0000-0002-9257-0427; 				Agrawal R, 2010, PHARMACOL RES, V61, P269, DOI 10.1016/j.phrs.2009.11.012; Barry SP, 2007, TRENDS MOL MED, V13, P82, DOI 10.1016/j.molmed.2006.12.002; Battle TE, 2006, CANCER RES, V66, P3649, DOI 10.1158/0008-5472.CAN-05-3612; Behr TM, 2001, CIRCULATION, V104, P1292, DOI 10.1161/hc3601.094275; BISHOP JE, 1994, CARDIOVASC RES, V28, P1581, DOI 10.1093/cvr/28.10.1581; Bolli R, 2001, J MOL CELL CARDIOL, V33, P1893, DOI 10.1006/jmcc.2001.1469; Bueno OF, 2002, CIRC RES, V91, P776, DOI 10.1161/01.RES.0000038488.38975.1A; Bueno OF, 2001, CIRC RES, V88, P88, DOI 10.1161/01.RES.88.1.88; Chatterjee A, 2011, J CELL PHYSIOL, V226, P2543, DOI 10.1002/jcp.22599; Chen LM, 2007, EXP PHYSIOL, V92, P409, DOI 10.1113/expphysiol.2006.036590; Cook SA, 1999, J MOL CELL CARDIOL, V31, P1429, DOI 10.1006/jmcc.1999.0979; CRABOS M, 1994, J CLIN INVEST, V93, P2372, DOI 10.1172/JCI117243; Daniels A, 2009, ACTA PHYSIOL, V195, P321, DOI 10.1111/j.1748-1716.2008.01936.x; Fischer P, 2007, BASIC RES CARDIOL, V102, P279, DOI 10.1007/s00395-007-0658-z; Frias MA, 2007, CARDIOVASC RES, V73, P57, DOI 10.1016/j.cardiores.2006.09.016; Hedayat M, 2010, HEART FAIL REV, V15, P543, DOI 10.1007/s10741-010-9168-4; Hilfiker-Kleiner D, 2004, CIRC RES, V95, P187, DOI 10.1161/01.RES.0000134921.50377.61; Hocher B, 2002, J HYPERTENS, V20, P745, DOI 10.1097/00004872-200204000-00034; Jia N., 2010, CARDIOVASC IN PRESS; Kapoun AM, 2004, CIRC RES, V94, P453, DOI 10.1161/01.RES.0000117070.86556.9F; Kleinbongard P, 2010, PHARMACOL THERAPEUT, V127, P295, DOI 10.1016/j.pharmthera.2010.05.002; Kunisada K, 1998, CIRCULATION, V98, P346, DOI 10.1161/01.CIR.98.4.346; Kurdi M, 2007, J CARDIOVASC PHARM, V50, P126, DOI 10.1097/FJC.0b013e318068dd49; Lin L, 2009, ONCOGENE, V28, P961, DOI 10.1038/onc.2008.448; Maki JM, 2002, CIRCULATION, V106, P2503, DOI 10.1161/01.CIR.0000038109.84500.1E; Mascareno E, 2001, CIRCULATION, V104, P325, DOI 10.1161/01.CIR.104.3.325; Melendez GC, 2010, HYPERTENSION, V56, P225, DOI 10.1161/HYPERTENSIONAHA.109.148635; Negoro S, 2001, CIRCULATION, V104, P979, DOI 10.1161/hc3401.095947; Ng DCH, 2001, J BIOL CHEM, V276, P29490, DOI 10.1074/jbc.M100699200; Oshima Y, 2005, CARDIOVASC RES, V65, P428, DOI 10.1016/j.cardiores.2004.10.021; Pan J, 1999, CIRC RES, V84, P1127, DOI 10.1161/01.RES.84.10.1127; Pathak M, 2001, HYPERTENSION, V37, P833, DOI 10.1161/01.HYP.37.3.833; Podewski EK, 2003, CIRCULATION, V107, P798, DOI 10.1161/01.CIR.0000057545.82749.FF; Ramires FJA, 1998, J MOL CELL CARDIOL, V30, P475, DOI 10.1006/jmcc.1997.0612; Samarel AM, 2001, J MOL CELL CARDIOL, V33, P1637, DOI 10.1006/jmcc.2001.1427; Sano M, 2000, J BIOL CHEM, V275, P29717, DOI 10.1074/jbc.M003128200; Sarkar S, 2004, J BIOL CHEM, V279, P52630, DOI 10.1074/jbc.M402037200; Sarkar S, 2004, AM J PHYSIOL-HEART C, V287, pH107, DOI 10.1152/ajpheart.00763.2003; SEN S, 1974, CIRC RES, V35, P775, DOI 10.1161/01.RES.35.5.775; Shen YH, 2001, P NATL ACAD SCI USA, V98, P1543, DOI 10.1073/pnas.041588198; Siddiquee K, 2007, P NATL ACAD SCI USA, V104, P7391, DOI 10.1073/pnas.0609757104; Sil P, 1997, HYPERTENSION, V30, P209; Sivakumar P, 2008, MOL CELL BIOCHEM, V307, P159, DOI 10.1007/s11010-007-9595-2; Siwik DA, 2000, CIRC RES, V86, P1259, DOI 10.1161/01.RES.86.12.1259; Skoumal R, 2011, J MOL CELL CARDIOL, V50, P634, DOI 10.1016/j.yjmcc.2011.01.001; STEGEMAN.H, 1967, CLIN CHIM ACTA, V18, P267, DOI 10.1016/0009-8981(67)90167-2; Stephanou A, 2000, J BIOL CHEM, V275, P10002, DOI 10.1074/jbc.275.14.10002; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Terui K, 2004, BIOCHEM J, V380, P203, DOI 10.1042/BJ20031891; Tornig J, 1996, J AM SOC NEPHROL, V7, P667; Tyralla K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015287; Vatner DE, 2000, CIRC RES, V86, P802, DOI 10.1161/01.RES.86.7.802; Wang GY, 2008, SCAND J IMMUNOL, V68, P589, DOI 10.1111/j.1365-3083.2008.02174.x; WEBER KT, 1991, CIRCULATION, V83, P1849, DOI 10.1161/01.CIR.83.6.1849; Xiao L, 2001, J MOL CELL CARDIOL, V33, P779, DOI 10.1006/jmcc.2001.1348; Xu B, 2003, MOL CELL BIOL, V23, P3918, DOI 10.1128/MCB.23.11.3918-3928.2003; Yahata Y, 2003, J BIOL CHEM, V278, P40026, DOI 10.1074/jbc.M301866200; Zauberman A, 1999, ONCOGENE, V18, P3886, DOI 10.1038/sj.onc.1202738	58	101	105	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2666	2677		10.1074/jbc.M111.246173	http://dx.doi.org/10.1074/jbc.M111.246173			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22157761	hybrid, Green Published			2022-12-27	WOS:000300292300039
J	Skizim, NJ; Ananyev, GM; Krishnan, A; Dismukes, GC				Skizim, Nicholas J.; Ananyev, Gennady M.; Krishnan, Anagha; Dismukes, G. Charles			Metabolic Pathways for Photobiological Hydrogen Production by Nitrogenase- and Hydrogenase-containing Unicellular Cyanobacteria Cyanothece	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAIN ATCC 51142; DIAZOTROPHIC CYANOBACTERIUM; FIXING CYANOBACTERIA; H-2 PHOTOPRODUCTION; FIXATION; FLUX; CAPACITY; CHAIN; RATES; N-2	Current biotechnological interest in nitrogen-fixing cyanobacteria stems from their robust respiration and capacity to produce hydrogen. Here we quantify both dark-and light-induced H-2 effluxes by Cyanothece sp. Miami BG 043511 and establish their respective origins. Dark, anoxic H-2 production occurs via hydrogenase utilizing reductant from glycolytic catabolism of carbohydrates (autofermentation). Photo-H-2 is shown to occur via nitrogenase and requires illumination of PSI, whereas production of O-2 by co-illumination of PSII is inhibitory to nitrogenase above a threshold pO(2). Carbohydrate also serves as the major source of reductant for the PSI pathway mediated via nonphotochemical reduction of the plastoquinone pool by NADH dehydrogenases type-1 and type-2 (NDH-1 and NDH-2). Redirection of this reductant flux exclusively through the proton-coupled NDH-1 by inhibition of NDH-2 with flavone increases the photo-H-2 production rate by 2-fold (at the expense of the dark-H-2 rate), due to production of additional ATP (via the proton gradient). Comparison of photobiological hydrogen rates, yields, and energy conversion efficiencies reveals opportunities for improvement.	[Skizim, Nicholas J.; Ananyev, Gennady M.; Krishnan, Anagha; Dismukes, G. Charles] Rutgers State Univ, Dept Chem & Chem Biol, Waksman Inst Microbiol, Piscataway, NJ 08854 USA; [Skizim, Nicholas J.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA	Rutgers State University New Brunswick; Princeton University	Dismukes, GC (corresponding author), 190 Frelinghuysen Rd, Piscataway, NJ 08854 USA.	dismukes@rci.rutgers.edu	Dismukes, Gerard C/I-4905-2012	Dismukes, Gerard C/0000-0003-0155-0541	United States Department of Energy [DE-PS02-07ER07-13]; Air Force Office of Scientific Research [AFOSR-MURI-FA9550-05-1-0365]	United States Department of Energy(United States Department of Energy (DOE)); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	This work was supported by United States Department of Energy Genomes to Life program Grant DE-PS02-07ER07-13 and Air Force Office of Scientific Research Grant AFOSR-MURI-FA9550-05-1-0365.	Ananyev G, 2008, APPL ENVIRON MICROB, V74, P6102, DOI 10.1128/AEM.01078-08; Bandyopadhyay A, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1139; Barney BM, 2004, J BIOL CHEM, V279, P53621, DOI 10.1074/jbc.M410247200; Battchikova N, 2011, BBA-BIOENERGETICS, V1807, P935, DOI 10.1016/j.bbabio.2010.10.017; Bennette NB, 2011, ANAL CHEM, V83, P3808, DOI 10.1021/ac200108a; Borodin VB, 2002, MAR BIOL, V140, P455, DOI 10.1007/s00227-001-0721-5; Bothe H, 2010, MICROBIOL MOL BIOL R, V74, P529, DOI 10.1128/MMBR.00033-10; Burgdorf T, 2005, J BACTERIOL, V187, P3122, DOI 10.1128/JB.187.9.3122-3132.2005; Carrieri D, 2008, INT J HYDROGEN ENERG, V33, P2014, DOI 10.1016/j.ijhydene.2008.02.022; Carrieri D, 2010, APPL ENVIRON MICROB, V76, P6455, DOI 10.1128/AEM.00975-10; Cooley JW, 2001, J BACTERIOL, V183, P4251, DOI 10.1128/JB.183.14.4251-4258.2001; DANON A, 1974, P NATL ACAD SCI USA, V71, P1234, DOI 10.1073/pnas.71.4.1234; Dutta D, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-36; Falkowski P. G., 1997, AQUATIC PHOTOSYNTHES, pviii; GALLON JR, 1992, NEW PHYTOL, V122, P571; Ghirardi ML, 2007, ANNU REV PLANT BIOL, V58, P71, DOI 10.1146/annurev.arplant.58.032806.103848; Howitt CA, 1999, J BACTERIOL, V181, P3994, DOI 10.1128/JB.181.13.3994-4003.1999; James B., 2009, SR56046674 US DEP EN, P207; Klamt S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100191; Koebmann BJ, 2002, J BACTERIOL, V184, P3909, DOI 10.1128/JB.184.14.3909-3916.2002; Laurinavichene TV, 2008, J BIOTECHNOL, V134, P275, DOI 10.1016/j.jbiotec.2008.01.006; Ludwig M, 2006, J MOL EVOL, V63, P758, DOI 10.1007/s00239-006-0001-6; Maroti J, 2010, APPL ENVIRON MICROB, V76, P5113, DOI 10.1128/AEM.00351-10; Masukawa H, 2007, APPL ENVIRON MICROB, V73, P7562, DOI 10.1128/AEM.01160-07; McKinlay JB, 2010, CURR OPIN BIOTECH, V21, P244, DOI 10.1016/j.copbio.2010.02.012; McNeely K, 2010, APPL ENVIRON MICROB, V76, P5032, DOI 10.1128/AEM.00862-10; Min HT, 2010, APPL ENVIRON MICROB, V76, P7641, DOI 10.1128/AEM.01456-10; Min HT, 2010, APPL ENVIRON MICROB, V76, P4293, DOI 10.1128/AEM.00146-10; MITSUI A, 1986, NATURE, V323, P720, DOI 10.1038/323720a0; MITSUI A, 1987, PHYSIOL PLANTARUM, V69, P1, DOI 10.1111/j.1399-3054.1987.tb01938.x; MITSUI A, 1995, CURR MICROBIOL, V30, P1, DOI 10.1007/BF00294515; Nixon P. J., 2006, CHLORORESPIRATORY PA, P237; Peschek GA, 2004, PHYSIOL PLANTARUM, V120, P358, DOI 10.1111/j.1399-3054.2004.00274.x; REDDY KJ, 1993, J BACTERIOL, V175, P1284, DOI 10.1128/JB.175.5.1284-1292.1993; Schneegurt MA, 2000, J PHYCOL, V36, P107, DOI 10.1046/j.1529-8817.2000.99152.x; SCHNEEGURT MA, 1994, J BACTERIOL, V176, P1586, DOI 10.1128/jb.176.6.1586-1597.1994; Stoeckel J, 2008, P NATL ACAD SCI USA, V105, P6156, DOI 10.1073/pnas.0711068105; SUDA S, 1992, ARCH MICROBIOL, V158, P1, DOI 10.1007/BF00249056; Toepel J, 2008, J BACTERIOL, V190, P3904, DOI 10.1128/JB.00206-08; Tsygankov AA, 2007, APPL BIOCHEM MICRO+, V43, P250, DOI 10.1134/S0003683807030040; VANDEROOST J, 1989, NUCLEIC ACIDS RES, V17, P10098; Vignais PM, 2001, FEMS MICROBIOL REV, V25, P455, DOI 10.1111/j.1574-6976.2001.tb00587.x; Vincent KA, 2007, CHEM REV, V107, P4366, DOI 10.1021/cr050191u; Zehr JP, 2001, NATURE, V412, P635, DOI 10.1038/35088063	44	26	26	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2777	2786		10.1074/jbc.M111.302125	http://dx.doi.org/10.1074/jbc.M111.302125			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22128188	Green Published, hybrid			2022-12-27	WOS:000300292300049
J	Fallas, JA; Dong, JH; Tao, YZJ; Hartgerink, JD				Fallas, Jorge A.; Dong, Jinhui; Tao, Yizhi J.; Hartgerink, Jeffrey D.			Structural Insights into Charge Pair Interactions in Triple Helical Collagen-like Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTROSTATIC INTERACTIONS; CRYSTAL-STRUCTURE; HIGH-STABILITY; IX COLLAGEN; PEPTIDE; HETEROTRIMERS; RECOGNITION; REFINEMENT; ENSEMBLES	The collagen triple helix is the most abundant protein fold in humans. Despite its deceptively simple structure, very little is understood about its folding and fibrillization energy landscape. In this work, using a combination of x-ray crystallography and nuclear magnetic resonance spectroscopy, we carry out a detailed study of stabilizing pair-wise interactions between the positively charged lysine and the negatively charged amino acids aspartate and glutamate. We find important differences in the side chain conformation of amino acids in the crystalline and solution state. Structures from x-ray crystallography may have similarities to the densely packed triple helices of collagen fibers whereas solution NMR structures reveal the simpler interactions of isolated triple helices. In solution, two distinct types of contacts are observed: axial and lateral. Such register-specific interactions are crucial for the understanding of the registration process of collagens and the overall stability of proteins in this family. However, in the crystalline state, there is a significant rearrangement of the side chain conformation allowing for packing interactions between adjacent helices, which suggests that charged amino acids may play a dual role in collagen stabilization and folding, first at the level of triple helical assembly and second during fibril formation.	[Fallas, Jorge A.; Hartgerink, Jeffrey D.] Rice Univ, Dept Chem, Houston, TX 77005 USA; [Dong, Jinhui; Tao, Yizhi J.] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77005 USA; [Hartgerink, Jeffrey D.] Rice Univ, Dept Bioengn, Houston, TX 77005 USA	Rice University; Rice University; Rice University	Hartgerink, JD (corresponding author), 6100 Main St,MS 602, Houston, TX 77005 USA.	jdh@rice.edu	Hartgerink, Jeffrey D/G-4275-2016	Hartgerink, Jeffrey D/0000-0002-3186-5395; Dong, Jinhui/0000-0003-4542-7756	National Science Foundation [DMR-0645474, EIA-0216467]; Robert A. Welch Foundation [C1557, C1565]; Norman Hackerman Advanced Research Program of Texas; Shared University Grid at Rice	National Science Foundation(National Science Foundation (NSF)); Robert A. Welch Foundation(The Welch Foundation); Norman Hackerman Advanced Research Program of Texas; Shared University Grid at Rice	This work was supported in part by National Science Foundation Career Award DMR-0645474, Robert A. Welch Foundation Grants C1557 and C1565, the Norman Hackerman Advanced Research Program of Texas, the Shared University Grid at Rice funded by National Science Foundation Grant EIA-0216467, and a partnership among Rice University, Sun Microsystems, and Sigma Solutions, Inc.	Abseher R, 1998, PROTEINS, V31, P370; Antipova O, 2010, J BIOL CHEM, V285, P7087, DOI 10.1074/jbc.M109.060400; Boudko SP, 2008, J BIOL CHEM, V283, P32580, DOI 10.1074/jbc.M805394200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buevich AV, 2000, BIOCHEMISTRY-US, V39, P4299, DOI 10.1021/bi992584r; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Emsley J, 2004, J MOL BIOL, V335, P1019, DOI 10.1016/j.jmb.2003.11.030; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fallas JA, 2009, J BIOL CHEM, V284, P26851, DOI 10.1074/jbc.M109.014753; Gauba V, 2008, J AM CHEM SOC, V130, P7509, DOI 10.1021/ja801670v; Gauba V, 2007, J AM CHEM SOC, V129, P15034, DOI 10.1021/ja075854z; Gauba V, 2007, J AM CHEM SOC, V129, P2683, DOI 10.1021/ja0683640; Gurry T, 2010, BIOPHYS J, V98, P2634, DOI 10.1016/j.bpj.2010.01.065; JELINSKI LW, 1980, J MOL BIOL, V138, P255, DOI 10.1016/0022-2836(80)90286-7; Khoshnoodi J, 2006, J BIOL CHEM, V281, P38117, DOI 10.1074/jbc.R600025200; Kissinger CR, 1999, ACTA CRYSTALLOGR D, V55, P484, DOI 10.1107/S0907444998012517; Kramer RZ, 2000, J MOL BIOL, V301, P1191, DOI 10.1006/jmbi.2000.4017; Kumar S, 2002, BIOPHYS J, V83, P1595, DOI 10.1016/S0006-3495(02)73929-5; Morozov AV, 2003, J PHYS CHEM B, V107, P2075, DOI 10.1021/jp0267555; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; O'Leary LER, 2011, J AM CHEM SOC, V133, P5432, DOI 10.1021/ja111239r; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Persikov AV, 2005, J BIOL CHEM, V280, P19343, DOI 10.1074/jbc.M501657200; Persikov AV, 2005, BIOCHEMISTRY-US, V44, P1414, DOI 10.1021/bi048216r; Persikov AV, 2002, J MOL BIOL, V316, P385, DOI 10.1006/jmbi.2001.5342; Pihlajamaa T, 1999, J BIOL CHEM, V274, P22464, DOI 10.1074/jbc.274.32.22464; RAMACHANDRAN GN, 1955, NATURE, V176, P593, DOI 10.1038/176593a0; Russell LE, 2010, J AM CHEM SOC, V132, P3242, DOI 10.1021/ja909720g; Schumacher MA, 2006, J BIOL CHEM, V281, P27566, DOI 10.1074/jbc.M602797200; Schwieters CD, 2002, J BIOMOL NMR, V23, P221, DOI 10.1023/A:1019875223132; Schwieters CD, 2001, J MAGN RESON, V149, P239, DOI 10.1006/jmre.2001.2300; WU JJ, 1992, J BIOL CHEM, V267, P23007	34	64	67	1	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8039	8047		10.1074/jbc.M111.296574	http://dx.doi.org/10.1074/jbc.M111.296574			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22179819	Green Published, hybrid			2022-12-27	WOS:000301349400020
J	Daftary, GS; Lomberk, GA; Buttar, NS; Allen, TW; Grzenda, A; Zhang, JS; Zheng, Y; Mathison, AJ; Gada, RP; Calvo, E; Iovanna, JL; Billadeau, DD; Prendergast, FG; Urrutia, R				Daftary, Gaurang S.; Lomberk, Gwen A.; Buttar, Navtej S.; Allen, Thomas W.; Grzenda, Adrienne; Zhang, Jinsan; Zheng, Ye; Mathison, Angela J.; Gada, Ravi P.; Calvo, Ezequiel; Iovanna, Juan L.; Billadeau, Daniel D.; Prendergast, Franklyn G.; Urrutia, Raul			Detailed Structural-Functional Analysis of the Kruppel-like Factor 16 (KLF16) Transcription Factor Reveals Novel Mechanisms for Silencing Sp/KLF Sites Involved in Metabolism and Endocrinology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOMETRIAL STROMAL CELLS; IN-VITRO DECIDUALIZATION; ESTROGEN-RECEPTOR; REPRESSOR DOMAINS; PAH2 DOMAIN; SRC KINASE; 3 FINGERS; BINDING; PROTEIN; GROWTH	Kruppel-like factor (KLF) proteins have elicited significant attention due to their emerging key role in metabolic and endocrine diseases. Here, we extend this knowledge through the biochemical characterization of KLF16, unveiling novel mechanisms regulating expression of genes involved in reproductive endocrinology. We found that KLF16 selectively binds three distinct KLF-binding sites (GC, CA, and BTE boxes). KLF16 also regulated the expression of several genes essential for metabolic and endocrine processes in sex steroid-sensitive uterine cells. Mechanistically, we determined that KLF16 possesses an activation domain that couples to histone acetyltransferase-mediated pathways, as well as a repression domain that interacts with the histone deacetylase chromatin-remodeling system via all three Sin3 isoforms, suggesting a higher level of plasticity in chromatin cofactor selection. Molecular modeling combined with molecular dynamic simulations of the Sin3a-KLF16 complex revealed important insights into how this interaction occurs at an atomic resolution level, predicting that phosphorylation of Tyr-10 may modulate KLF16 function. Phosphorylation of KLF16 was confirmed by in vivo P-32 incorporation and controlled by a Y10F site-directed mutant. Inhibition of Src-type tyrosine kinase signaling as well as the nonphosphorylatable Y10F mutation disrupted KLF16-mediated gene silencing, demonstrating that its function is regulatable rather than constitutive. Subcellular localization studies revealed that signal-induced nuclear translocation and euchromatic compartmentalization constitute an additional mechanism for regulating KLF16 function. Thus, this study lends insights on key biochemical mechanisms for regulating KLF sites involved in reproductive biology. These data also contribute to the new functional information that is applicable to understanding KLF16 and other highly related KLF proteins.	[Daftary, Gaurang S.; Zheng, Ye; Gada, Ravi P.] Mayo Clin, Dept Obstet & Gynecol, Rochester, MN 55905 USA; [Lomberk, Gwen A.; Buttar, Navtej S.; Grzenda, Adrienne; Mathison, Angela J.; Urrutia, Raul] Mayo Clin, Lab Epigenet & Chromatin Dynam, Rochester, MN 55905 USA; [Lomberk, Gwen A.; Allen, Thomas W.; Prendergast, Franklyn G.; Urrutia, Raul] Mayo Clin, Dept Biol & Mol Biol, Rochester, MN 55905 USA; [Zhang, Jinsan; Billadeau, Daniel D.] Mayo Clin, Dept Oncol Res, Rochester, MN 55905 USA; [Calvo, Ezequiel] CHUL Res Ctr, Mol Endocrinol & Oncol Res Ctr, Quebec City, PQ G1V 4G2, Canada; [Iovanna, Juan L.] INSERM, U624, F-13276 Marseille, France	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Laval University; Institut National de la Sante et de la Recherche Medicale (Inserm)	Daftary, GS (corresponding author), Mayo Clin, Dept Obstet & Gynecol, Guggenheim 10,200 1st St SW, Rochester, MN 55905 USA.	daftary.gaurang@mayo.edu; urrutia.raul@mayo.edu	Grzenda, Adrienne L/K-4421-2019; Lomberk, Gwen/AAL-8490-2020; Iovanna, Juan/M-9805-2017	Grzenda, Adrienne L/0000-0001-5952-6953; Lomberk, Gwen/0000-0001-5463-789X; Iovanna, Juan/0000-0003-1822-2237; Mathison, Angela/0000-0002-6763-2710; Allen, Thomas/0000-0002-1107-1416	National Institutes of Health [DK52913]; Mayo Foundation; NATIONAL CANCER INSTITUTE [T32CA148073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK084567, R56DK052913, R01DK052913] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK52913 (to R. U.). This work was also supported by the Mayo Foundation	Bieker JJ, 2001, J BIOL CHEM, V276, P34355, DOI 10.1074/jbc.R100043200; Brubaker K, 2000, CELL, V103, P655, DOI 10.1016/S0092-8674(00)00168-9; Buttar NS, 2010, J BIOL CHEM, V285, P11433, DOI 10.1074/jbc.M109.077065; Cao S, 2005, J BIOL CHEM, V280, P1901, DOI 10.1074/jbc.M407941200; Cavalieri E, 2000, J Natl Cancer Inst Monogr, P75; Cook T, 1999, J BIOL CHEM, V274, P29500, DOI 10.1074/jbc.274.41.29500; Cook T, 1998, J BIOL CHEM, V273, P25929, DOI 10.1074/jbc.273.40.25929; CUMMINGS AM, 1995, FUND APPL TOXICOL, V27, P287, DOI 10.1006/faat.1995.1135; CUMMINGS AM, 1995, REPROD TOXICOL, V9, P233, DOI 10.1016/0890-6238(95)00004-T; Fernandez-Zapico ME, 2009, J BIOL CHEM, V284, P36482, DOI 10.1074/jbc.M109.028852; Fernandez-Zapico ME, 2003, EMBO J, V22, P4748, DOI 10.1093/emboj/cdg470; FOTSIS T, 1994, NATURE, V368, P237, DOI 10.1038/368237a0; FUJIIKURIYAMA Y, 1992, FASEB J, V6, P706, DOI 10.1096/fasebj.6.2.1537460; Gebelein B, 1998, J CLIN INVEST, V102, P1911, DOI 10.1172/JCI1919; Gebelein B, 2001, MOL CELL BIOL, V21, P928, DOI 10.1128/MCB.21.3.928-939.2001; Gutierrez-Aguilar R, 2008, J CLIN ENDOCR METAB, V93, P3128, DOI 10.1210/jc.2007-2504; Hadfield RM, 2001, MOL HUM REPROD, V7, P1073, DOI 10.1093/molehr/7.11.1073; Hewitt SC, 2005, ANNU REV PHYSIOL, V67, P285, DOI 10.1146/annurev.physiol.67.040403.115914; Honkakoski P, 2000, BIOCHEM J, V347, P321, DOI 10.1042/0264-6021:3470321; Johnson KL, 1997, ENVIRON HEALTH PERSP, V105, P750, DOI 10.1289/ehp.97105750; Kaczynski J, 2001, J BIOL CHEM, V276, P36749, DOI 10.1074/jbc.M105831200; KORACH KS, 1994, SCIENCE, V266, P1524, DOI 10.1126/science.7985022; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee AJ, 2003, ENDOCRINOLOGY, V144, P3382, DOI 10.1210/en.2003-0192; Lomberk G, 2005, BIOCHEM J, V392, P1, DOI 10.1042/BJ20051234; Lomberk G, 2006, NAT CELL BIOL, V8, P407, DOI 10.1038/ncb1383; Maruyama T, 1999, ENDOCRINOLOGY, V140, P2632, DOI 10.1210/en.140.6.2632; Maruyama T, 1999, ENDOCRINOLOGY, V140, P5982, DOI 10.1210/endo.140.12.7184; Mayani A, 1997, HUM REPROD, V12, P373, DOI 10.1093/humrep/12.2.373; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Narayan VA, 1997, J BIOL CHEM, V272, P7801, DOI 10.1074/jbc.272.12.7801; Pang YP, 2003, FEBS LETT, V548, P108, DOI 10.1016/S0014-5793(03)00749-X; Philipsen S, 1999, NUCLEIC ACIDS RES, V27, P2991, DOI 10.1093/nar/27.15.2991; Shah YM, 2005, MOL ENDOCRINOL, V19, P732, DOI 10.1210/me.2004-0298; Shimizu A, 2005, BIOL REPROD, V73, P1219, DOI 10.1095/biolreprod.105.041616; Shiozawa T, 2003, J CLIN ENDOCR METAB, V88, P871, DOI 10.1210/jc.2002-020946; Simmen RCM, 2004, J BIOL CHEM, V279, P29286, DOI 10.1074/jbc.M403139200; Small KS, 2011, NAT GENET, V43, P561, DOI 10.1038/ng.833; Song CZ, 2002, J BIOL CHEM, V277, P7029, DOI 10.1074/jbc.M108826200; Swanson KA, 2004, NAT STRUCT MOL BIOL, V11, P738, DOI 10.1038/nsmb798; Tsuchiya Y, 2005, CANCER LETT, V227, P115, DOI 10.1016/j.canlet.2004.10.007; Vermeulen M, 2006, MOL CELL BIOL, V26, P5226, DOI 10.1128/MCB.00440-06; Whitlock JP, 1999, ANNU REV PHARMACOL, V39, P103, DOI 10.1146/annurev.pharmtox.39.1.103; Yager JD, 1996, ANNU REV PHARMACOL, V36, P203, DOI 10.1146/annurev.pa.36.040196.001223; Zhang DY, 2002, ENDOCRINOLOGY, V143, P62, DOI 10.1210/en.143.1.62; Zhang JS, 2001, MOL CELL BIOL, V21, P5041, DOI 10.1128/MCB.21.15.5041-5049.2001	46	32	32	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7010	7025		10.1074/jbc.M111.266007	http://dx.doi.org/10.1074/jbc.M111.266007			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22203677	Green Published, hybrid			2022-12-27	WOS:000301060200007
J	Venkatachalan, SP; Czajkowski, C				Venkatachalan, Srinivasan P.; Czajkowski, Cynthia			Structural Link between gamma-Aminobutyric Acid Type A (GABA(A)) Receptor Agonist Binding Site and Inner beta-Sheet Governs Channel Activation and Allosteric Drug Modulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; GATED ION-CHANNEL; SINGLE AMINO-ACID; X-RAY-STRUCTURE; BENZODIAZEPINE BINDING; EXTRACELLULAR DOMAIN; CRYSTAL-STRUCTURE; SUBUNIT; INHIBITION; MECHANISM	Rapid opening and closing of pentameric ligand-gated ion channels (pLGICs) regulate information flow throughout the brain. For pLGICs, it is postulated that neurotransmitter-induced movements in the extracellular inner beta-sheet trigger channel activation. Homology modeling reveals that the beta 4-beta 5 linker physically connects the neurotransmitter binding site to the inner beta-sheet. Inserting 1, 2, 4, and 8 glycines in this region of the GABA(A) receptor beta-subunit progressively decreases GABA activation and converts the competitive antagonist SR-95531 into a partial agonist, demonstrating that this linker is a key element whose length and flexibility are optimized for efficient signal propagation. Insertions in the alpha- and gamma-subunits have little effect on GABA or SR-95531 actions, suggesting that asymmetric motions in the extracellular domain power pLGIC gating. The effects of insertions on allosteric modulator actions, pentobarbital, and benzodiazepines, have different subunit dependences, indicating that modulator-induced signaling is distinct from agonist gating.	[Venkatachalan, Srinivasan P.; Czajkowski, Cynthia] Univ Wisconsin, Dept Neurosci, Madison, WI 53711 USA	University of Wisconsin System; University of Wisconsin Madison	Czajkowski, C (corresponding author), Univ Wisconsin, Dept Neurosci, 601 Sci Dr,Rm 135, Madison, WI 53711 USA.	cmczajko@wisc.edu			NINDS [34727]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034727] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant 34727 (to C. C.) from the NINDS.	Akabas MH, 2004, INT REV NEUROBIOL, V62, P1, DOI 10.1016/S0074-7742(04)62001-0; Akk G, 2000, BRIT J PHARMACOL, V130, P249, DOI 10.1038/sj.bjp.0703335; Amin J, 1999, MOL PHARMACOL, V55, P411; AMIN J, 1993, NATURE, V366, P565, DOI 10.1038/366565a0; Bocquet N, 2007, NATURE, V445, P116, DOI 10.1038/nature05371; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Boileau AJ, 1998, MOL PHARMACOL, V53, P295, DOI 10.1124/mol.53.2.295; Boileau AJ, 2002, J BIOL CHEM, V277, P2931, DOI 10.1074/jbc.M109334200; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Buhr A, 1997, P NATL ACAD SCI USA, V94, P8824, DOI 10.1073/pnas.94.16.8824; Cadugan DJ, 2010, BIOPHYS J, V99, P798, DOI 10.1016/j.bpj.2010.05.008; Campo-Soria C, 2006, BRIT J PHARMACOL, V148, P984, DOI 10.1038/sj.bjp.0706796; Chakrapani S, 2003, J GEN PHYSIOL, V122, P521, DOI 10.1085/jgp.200308885; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; CHOU TC, 1974, MOL PHARMACOL, V10, P235; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; Downing SS, 2005, BRIT J PHARMACOL, V145, P894, DOI 10.1038/sj.bjp.0706251; Duncalfe LL, 1996, J BIOL CHEM, V271, P9209, DOI 10.1074/jbc.271.16.9209; Gao F, 2005, J BIOL CHEM, V280, P8443, DOI 10.1074/jbc.M412389200; Goldschen-Ohm MP, 2010, MOL PHARMACOL, V77, P35, DOI 10.1124/mol.109.058289; Hanek AP, 2010, MOL PHARMACOL, V78, P29, DOI 10.1124/mol.109.059832; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Henchman RH, 2003, BIOPHYS J, V85, P3007, DOI 10.1016/S0006-3495(03)74720-1; Henchman RH, 2005, BIOPHYS J, V88, P2564, DOI 10.1529/biophysj.104.053934; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Holden JH, 2002, J BIOL CHEM, V277, P18785, DOI 10.1074/jbc.M111778200; JACKSON MB, 1982, J NEUROSCI, V2, P889; Jones MV, 1998, J NEUROSCI, V18, P8590; Kloda JH, 2007, MOL PHARMACOL, V71, P483, DOI 10.1124/mol.106.028662; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Mercado J, 2006, J NEUROSCI, V26, P2031, DOI 10.1523/JNEUROSCI.4555-05.2006; Mercado J, 2008, J BIOL CHEM, V283, P15250, DOI 10.1074/jbc.M708638200; MIHIC SJ, 1994, J BIOL CHEM, V269, P32768; Miller PS, 2008, NAT STRUCT MOL BIOL, V15, P1084, DOI 10.1038/nsmb.1492; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Mourot A, 2008, J NEUROCHEM, V105, P413, DOI 10.1111/j.1471-4159.2007.05151.x; Newell JG, 2003, J BIOL CHEM, V278, P13166, DOI 10.1074/jbc.M211905200; Pistis M, 1999, J PHYSIOL-LONDON, V515, P3, DOI 10.1111/j.1469-7793.1999.003ad.x; Price KL, 2008, BIOCHEMISTRY-US, V47, P6370, DOI 10.1021/bi800222n; Purohit P, 2007, NATURE, V446, P930, DOI 10.1038/nature05721; Robinson CR, 1998, P NATL ACAD SCI USA, V95, P5929, DOI 10.1073/pnas.95.11.5929; Rosen A, 2007, BIOPHYS J, V92, P3130, DOI 10.1529/biophysj.106.094490; Rusch D, 2005, ANESTHESIOLOGY, V102, P783; Sancar F, 2011, NEUROPHARMACOLOGY, V60, P520, DOI 10.1016/j.neuropharm.2010.11.009; Serafini R, 2000, J PHYSIOL-LONDON, V524, P649, DOI 10.1111/j.1469-7793.2000.00649.x; Sharkey LM, 2008, MOL PHARMACOL, V74, P203, DOI 10.1124/mol.108.044891; Szarecka A, 2007, PROTEINS, V68, P948, DOI 10.1002/prot.21462; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Venkatachalan SP, 2008, FASEB J, V22; Walters RJ, 2000, NAT NEUROSCI, V3, P1274, DOI 10.1038/81800	52	14	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6714	6724		10.1074/jbc.M111.316836	http://dx.doi.org/10.1074/jbc.M111.316836			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22219195	Green Published, hybrid			2022-12-27	WOS:000300791800057
J	Antigny, F; Girardin, N; Frieden, M				Antigny, Fabrice; Girardin, Nathalie; Frieden, Maud			Transient Receptor Potential Canonical Channels Are Required for in Vitro Endothelial Tube Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATES CRAC CHANNELS; PERMANENT CELL-LINE; CA2+ ENTRY; ENDOPLASMIC-RETICULUM; ION CHANNELS; STORE; ANGIOGENESIS; STIM1; ORAI1; PROLIFERATION	In endothelial cells Ca2+ entry is an essential component of the Ca2+ signal that takes place during processes such as cell proliferation or angiogenesis. Ca2+ influx occurs via the store-operated Ca2+ entry pathway, involving stromal interaction molecule-1 (STIM1) and Orai1, but also through channels gated by second messengers like the transient receptor potential canonical (TRPC) channels. The human umbilical vein-derived endothelial cell line EA.hy926 expressed STIM1 and Orai1 as well as several TRPC channels. By invalidating each of these molecules, we showed that TRPC3, TRPC4, and TRPC5 are essential for the formation of tubular structures observed after EA.hy926 cells were plated on Matrigel. On the contrary, the silencing of STIM1 or Orai1 did not prevent tubulogenesis. Soon after being plated on Matrigel, the cells displayed spontaneous Ca2+ oscillations that were strongly reduced by treatment with siRNA against TRPC3, TRPC4, or TRPC5, but not siRNA against STIM1 or Orai1. Furthermore, we showed that cell proliferation was reduced upon siRNA treatment against TRPC3, TRPC5, and Orai1 channels, whereas the knockdown of STIM1 had no effect. On primary human umbilical vein endothelial cells, TRPC1, TRPC4, and STIM1 are involved in tube formation, whereas Orai1 has no effect. These data showed that TRPC channels are essential for in vitro tubulogenesis, both on endothelial cell line and on primary endothelial cells.	[Antigny, Fabrice; Girardin, Nathalie; Frieden, Maud] Ctr Med Univ Geneva, Dept Cell Physiol & Metab, CH-1211 Geneva 4, Switzerland	University of Geneva	Frieden, M (corresponding author), Ctr Med Univ Geneva, Dept Cell Physiol & Metab, 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland.	maud.frieden@unige.ch	Antigny, Fabrice/Q-3999-2018	Antigny, Fabrice/0000-0002-9515-6571; Frieden, Maud/0000-0001-7135-0874	Swiss National Science Foundation [31000-120186/1]; Carlos and Elsie de Reuter Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Carlos and Elsie de Reuter Foundation	This work was supported by the Swiss National Science Foundation Grant 31000-120186/1 and by the Carlos and Elsie de Reuter Foundation.	Abdullaev IF, 2008, CIRC RES, V103, P1289, DOI 10.1161/01.RES.0000338496.95579.56; Alessandro R, 1998, BIOCHEM BIOPH RES CO, V248, P635, DOI 10.1006/bbrc.1998.8705; Antigny F, 2011, CELL CALCIUM, V49, P115, DOI 10.1016/j.ceca.2010.12.001; Arnaoutova I, 2010, NAT PROTOC, V5, P628, DOI 10.1038/nprot.2010.6; Arnaoutova I, 2009, ANGIOGENESIS, V12, P267, DOI 10.1007/s10456-009-9146-4; Arnaudeau S, 2001, J BIOL CHEM, V276, P29430, DOI 10.1074/jbc.M103274200; BAUER J, 1992, J CELL PHYSIOL, V153, P437, DOI 10.1002/jcp.1041530302; Birnbaumer L, 2009, ANNU REV PHARMACOL, V49, P395, DOI 10.1146/annurev.pharmtox.48.113006.094928; Capiod T, 2011, BIOCHIMIE, V93, P2075, DOI 10.1016/j.biochi.2011.07.015; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; El Boustany C, 2010, CELL CALCIUM, V47, P350, DOI 10.1016/j.ceca.2010.01.006; Feng MY, 2010, CELL, V143, P84, DOI 10.1016/j.cell.2010.08.040; Feske S, 2005, J EXP MED, V202, P651, DOI 10.1084/jem.20050687; Ge RL, 2009, CANCER LETT, V283, P43, DOI 10.1016/j.canlet.2009.03.023; Girardin NC, 2010, PFLUG ARCH EUR J PHY, V460, P109, DOI 10.1007/s00424-010-0825-1; Hamdollah Zadeh MA, 2008, MICROCIRCULATION, V15, P605, DOI 10.1080/10739680802220323; Jousset H, 2008, CELL CALCIUM, V43, P83, DOI 10.1016/j.ceca.2007.04.006; Kiyonaka S, 2009, P NATL ACAD SCI USA, V106, P5400, DOI 10.1073/pnas.0808793106; Kleinman HK, 2005, SEMIN CANCER BIOL, V15, P378, DOI 10.1016/j.semcancer.2005.05.004; Li J, 2011, CIRC RES, V108, P1190, DOI 10.1161/CIRCRESAHA.111.243352; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Malli R, 2003, J BIOL CHEM, V278, P44769, DOI 10.1074/jbc.M302511200; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Munaron L, 2009, CURR MED CHEM, V16, P4691, DOI 10.2174/092986709789878210; Nilius B, 2001, PHYSIOL REV, V81, P1415, DOI 10.1152/physrev.2001.81.4.1415; Orci L, 2009, P NATL ACAD SCI USA, V106, P19358, DOI 10.1073/pnas.0911280106; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Park MK, 2000, EMBO J, V19, P5729, DOI 10.1093/emboj/19.21.5729; Piqueras L, 2007, ARTERIOSCL THROM VAS, V27, P63, DOI 10.1161/01.ATV.0000250972.83623.61; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Shuttleworth Trevor J, 2004, Sci STKE, V2004, ppe40, DOI 10.1126/stke.2432004pe40; Tapia V, 2011, GYNECOL ONCOL, V121, P13, DOI 10.1016/j.ygyno.2010.12.341; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Wang YJ, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3148pe42; Wong CO, 2011, ADV EXP MED BIOL, V704, P759, DOI 10.1007/978-94-007-0265-3_40; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Yu PC, 2010, CIRC RES, V106, P1221, DOI 10.1161/CIRCRESAHA.109.207670; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147	41	76	77	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5917	5927		10.1074/jbc.M111.295733	http://dx.doi.org/10.1074/jbc.M111.295733			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22203682	Green Published, hybrid			2022-12-27	WOS:000300638000066
J	Naeeni, AR; Conte, MR; Bayfield, MA				Naeeni, Amir R.; Conte, Maria R.; Bayfield, Mark A.			RNA Chaperone Activity of Human La Protein Is Mediated by Variant RNA Recognition Motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRECURSOR TRANSFER-RNAS; DROSOPHILA-MELANOGASTER; STRUCTURAL-ANALYSIS; MESSENGER-RNA; IN-VITRO; BINDING; TRANSLATION; MATURATION; AUTOANTIGEN; ANTIGEN	La proteins are conserved factors in eukaryotes that bind and protect the 3' trailers of pre-tRNAs from exonuclease digestion via sequence-specific recognition of UUU-3'OH. La has also been hypothesized to assist pre-tRNAs in attaining their native fold through RNA chaperone activity. In addition to binding polymerase III transcripts, human La has also been shown to enhance the translation of several internal ribosome entry sites and upstream ORF-containing mRNA targets, also potentially through RNA chaperone activity. Using in vitro FRET-based assays, we show that human and Schizosaccharomyces pombe La proteins harbor RNA chaperone activity by enhancing RNA strand annealing and strand dissociation. We use various RNA substrates and La mutants to show that UUU-3'OH-dependent La-RNA binding is not required for this function, and we map RNA chaperone activity to its RRM1 motif including a noncanonical alpha 3-helix. We validate the importance of this alpha 3-helix by appending it to the RRM of the unrelated U1A protein and show that this fusion protein acquires significant strand annealing activity. Finally, we show that residues required for La-mediated RNA chaperone activity in vitro are required for La-dependent rescue of tRNA-mediated suppression via a mutated suppressor tRNA in vivo. This work delineates the structural elements required for La-mediated RNA chaperone activity and provides a basis for understanding how La can enhance the folding of its various RNA targets.	[Naeeni, Amir R.; Bayfield, Mark A.] York Univ, Dept Biol, Toronto, ON M3J 1P3, Canada; [Conte, Maria R.] Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England	York University - Canada; University of London; King's College London	Bayfield, MA (corresponding author), York Univ, Dept Biol, 4700 Keele St,Life Sci Bldg 327E, Toronto, ON M3J 1P3, Canada.	bayfield@yorku.ca	Conte, Maria R/C-4102-2008; Conte, Maria/W-3088-2019	Conte, Maria R/0000-0001-8558-2051; Conte, Maria/0000-0001-8558-2051; Bayfield, Mark/0000-0002-8971-7598	Banting Research Foundation; Natural Sciences and Engineering Research Council of Canada; Wellcome Trust; Canadian Institutes of Health Research	Banting Research Foundation; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Wellcome Trust(Wellcome TrustEuropean Commission); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Banting Research Foundation and the Natural Sciences and Engineering Research Council of Canada (to M. A. B.), as well as The Wellcome Trust (to M. R. C.).; Supported by a Canadian Institutes of Health Research Frederick Banting and Charles Best Canada Graduate Scholarship Master's Award.	Alfano C, 2004, NAT STRUCT MOL BIOL, V11, P323, DOI 10.1038/nsmb747; Ali N, 2000, J BIOL CHEM, V275, P27531; Anderson J, 1998, GENE DEV, V12, P3650, DOI 10.1101/gad.12.23.3650; Bai CY, 2000, NUCLEIC ACIDS RES, V28, P1078, DOI 10.1093/nar/28.5.1078; Bayfield MA, 2007, MOL CELL BIOL, V27, P3303, DOI 10.1128/MCB.00026-07; Bayfield MA, 2010, BBA-GENE REGUL MECH, V1799, P365, DOI 10.1016/j.bbagrm.2010.01.011; Bayfield MA, 2009, NAT STRUCT MOL BIOL, V16, P430, DOI 10.1038/nsmb.1573; Belisova A, 2005, RNA, V11, P1084, DOI 10.1261/rna.7263905; Belsham GJ, 2000, TRENDS MICROBIOL, V8, P330, DOI 10.1016/S0966-842X(00)01788-1; Bousquet-Antonelli C, 2009, RNA, V15, P750, DOI 10.1261/rna.1478709; Chakshusmathi G, 2003, EMBO J, V22, P6562, DOI 10.1093/emboj/cdg625; Copela LA, 2006, RNA, V12, P644, DOI 10.1261/rna.2307206; Costa-Mattioli M, 2004, MOL CELL BIOL, V24, P6861, DOI 10.1128/mcb.24.15.6861-6870.2004; Dong G, 2004, EMBO J, V23, P1000, DOI 10.1038/sj.emboj.7600115; Fan H, 1998, MOL CELL BIOL, V18, P3201, DOI 10.1128/MCB.18.6.3201; Goodier JL, 1997, MOL CELL BIOL, V17, P5823, DOI 10.1128/MCB.17.10.5823; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Horke S, 2002, J BIOL CHEM, V277, P34949, DOI 10.1074/jbc.M201911200; Huang Y, 2006, NAT STRUCT MOL BIOL, V13, P611, DOI 10.1038/nsmb1110; Intine RV, 2003, MOL CELL, V12, P1301, DOI 10.1016/S1097-2765(03)00429-5; Intine RV, 2002, MOL CELL, V9, P1113, DOI 10.1016/S1097-2765(02)00533-6; Intine RVA, 2000, MOL CELL, V6, P339, DOI 10.1016/S1097-2765(00)00034-4; Jacks A, 2003, STRUCTURE, V11, P833, DOI 10.1016/S0969-2126(03)00121-7; Johansson MJO, 2002, RNA, V8, P324, DOI 10.1017/S1355838202027851; Katzman S, 2008, BIOINFORMATICS, V24, P2453, DOI 10.1093/bioinformatics/btn438; Kotik-Kogan O, 2008, STRUCTURE, V16, P852, DOI 10.1016/j.str.2008.02.021; Kucera NJ, 2011, P NATL ACAD SCI USA, V108, P1308, DOI 10.1073/pnas.1017085108; Kufel J, 2000, MOL CELL BIOL, V20, P5415, DOI 10.1128/MCB.20.15.5415-5424.2000; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; Martino L., 2011, NUCL ACIDS IN PRESS; MEEROVITCH K, 1993, J VIROL, V67, P3798, DOI 10.1128/JVI.67.7.3798-3807.1993; Park JM, 2006, MOL CELL BIOL, V26, P1445, DOI 10.1128/MCB.26.4.1445-1451.2006; Pudi R, 2004, J BIOL CHEM, V279, P29879, DOI 10.1074/jbc.M403417200; Rajkowitsch L, 2005, BIOCHEM SOC T, V33, P450, DOI 10.1042/BST0330450; Rajkowitsch L, 2007, RNA BIOL, V4, P118, DOI 10.4161/rna.4.3.5445; Rajkowitsch L, 2007, RNA, V13, P2053, DOI 10.1261/rna.671807; Rupert PB, 2003, ACTA CRYSTALLOGR D, V59, P1521, DOI 10.1107/S0907444903011338; Schwartz EI, 2004, MOL CELL BIOL, V24, P9580, DOI 10.1128/MCB.24.21.9580-9591.2004; Sommer G, 2011, ONCOGENE, V30, P434, DOI 10.1038/onc.2010.425; Stone MD, 2007, NATURE, V446, P458, DOI 10.1038/nature05600; SVITKIN YV, 1994, J VIROL, V68, P7001, DOI 10.1128/JVI.68.11.7001-7007.1994; Teplova M, 2006, MOL CELL, V21, P75, DOI 10.1016/j.molcel.2005.10.027; Trotta R, 2003, CANCER CELL, V3, P145, DOI 10.1016/S1535-6108(03)00020-5; Van Horn DJ, 1997, RNA, V3, P1434; Woodson SA, 2010, RNA BIOL, V7, P677, DOI 10.4161/rna.7.6.13615; Xue DH, 2000, EMBO J, V19, P1650, DOI 10.1093/emboj/19.7.1650; YOO CJ, 1994, MOL CELL BIOL, V14, P5412, DOI 10.1128/MCB.14.8.5412; Yoo CJ, 1997, CELL, V89, P393, DOI 10.1016/S0092-8674(00)80220-2	48	32	33	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5472	5482		10.1074/jbc.M111.276071	http://dx.doi.org/10.1074/jbc.M111.276071			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22203678	hybrid, Green Published			2022-12-27	WOS:000300638000027
J	Zhou, ZC; Du, XL; Cai, Z; Song, XM; Zhang, HT; Mizuno, T; Suzuki, E; Yee, MR; Berezov, A; Murali, R; Wu, SL; Karger, BL; Greene, MI; Wang, Q				Zhou, Zhaocai; Du, Xiulian; Cai, Zheng; Song, Xiaomin; Zhang, Hongtao; Mizuno, Takako; Suzuki, Emi; Yee, Marla Rosanne; Berezov, Alan; Murali, Ramachandran; Wu, Shiaw-Lin; Karger, Barry L.; Greene, Mark I.; Wang, Qiang			Structure of Sad1-UNC84 Homology (SUN) Domain Defines Features of Molecular Bridge in Nuclear Envelope.	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINDLE POLE BODY; MEMBRANE-PROTEINS; LOCALIZATION; MIGRATION; RECEPTOR; INTERACTS; NESPRINS; BOUQUET; LAMIN; MATEFIN/SUN-1	The SUN (Sad1-UNC-84 homology) domain is conserved in a number of nuclear envelope proteins involved in nuclear migration, meiotic telomere tethering, and antiviral responses. The LINC (linker of nucleoskeleton and cytoskeleton) complex, formed by the SUN and the nesprin proteins at the nuclear envelope, serves as a mechanical linkage across the nuclear envelope. Here we report the crystal structure of the SUN2 protein SUN domain, which reveals a homotrimer. The SUN domain is sufficient to mediate binding to the KASH (Klarsicht, ANC-1, and Syne homology) domain of nesprin 2, and the regions involved in the interaction have been identified. Binding of the SUN domain to the KASH domain is abolished by deletion of a region important for trimerization or by point mutations associated with nuclear migration failure. We propose a model of the LINC complex, where the SUN and the KASH domains form a higher ordered oligomeric network in the nuclear envelope. These findings provide the structural basis for understanding the function and the regulation of the LINC complex.	[Zhou, Zhaocai; Du, Xiulian; Cai, Zheng; Song, Xiaomin; Zhang, Hongtao; Yee, Marla Rosanne; Berezov, Alan; Murali, Ramachandran; Greene, Mark I.; Wang, Qiang] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Zhou, Zhaocai] Chinese Acad Sci, State Key Lab Cell Biol, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; [Wang, Qiang] Cedars Sinai Med Ctr, Womens Canc Program, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA; [Mizuno, Takako; Suzuki, Emi; Berezov, Alan; Murali, Ramachandran; Greene, Mark I.; Wang, Qiang] Cedars Sinai Med Ctr, Dept Biomed Sci, Los Angeles, CA 90048 USA; [Wu, Shiaw-Lin; Karger, Barry L.] Northeastern Univ, Barnett Inst, Boston, MA 02115 USA	University of Pennsylvania; Pennsylvania Medicine; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Northeastern University	Greene, MI (corresponding author), Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, 252 John Morgan Bldg,36th St & Hamilton Walk, Philadelphia, PA 19104 USA.	greene@reo.med.upenn.edu; qiang.wang@cshs.org	Murali, Ramachandran/D-1132-2009; Wang, Qiang/N-7310-2015	Wang, Qiang/0000-0001-9409-0251; Murali, Ramachandran/0000-0002-8384-2793; Zhang, Hongtao/0000-0001-9173-0049	National Cancer Institute; Abramson Family Cancer Research Institute at the University of Pennsylvania; Samuel Oschin Comprehensive Cancer Institute; Women's Guild Lung Institute of the Cedars-Sinai Medical Center; National Natural Science Foundation of China [30970566, 10979005]; National Institutes of Health [GM15847]; Barnett Institute [992]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM015847, R37GM015847] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Abramson Family Cancer Research Institute at the University of Pennsylvania; Samuel Oschin Comprehensive Cancer Institute; Women's Guild Lung Institute of the Cedars-Sinai Medical Center; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Barnett Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Cancer Institute, the Abramson Family Cancer Research Institute at the University of Pennsylvania, the Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, the Women's Guild Lung Institute of the Cedars-Sinai Medical Center, and Grants 30970566 and 10979005 from the National Natural Science Foundation of China.; Supported by National Institutes of Health Grant GM15847 and contribution number 992 from the Barnett Institute.	Burke B, 2002, NAT REV MOL CELL BIO, V3, P575, DOI 10.1038/nrm879; Burke B, 2002, NAT REV MOL CELL BIO, V3, P487, DOI 10.1038/nrm860; Burke B, 2006, ANNU REV GENOM HUM G, V7, P369, DOI 10.1146/annurev.genom.7.080505.115732; Cerhan JR, 2007, BLOOD, V110, P4455, DOI 10.1182/blood-2007-05-088682; Chikashige Y, 2006, CELL, V125, P59, DOI 10.1016/j.cell.2006.01.048; Conrad MN, 2007, P NATL ACAD SCI USA, V104, P8863, DOI 10.1073/pnas.0606165104; Crisp M, 2006, J CELL BIOL, V172, P41, DOI 10.1083/jcb.200509124; Ding X, 2007, DEV CELL, V12, P863, DOI 10.1016/j.devcel.2007.03.018; Dreger M, 2001, P NATL ACAD SCI USA, V98, P11943, DOI 10.1073/pnas.211201898; Fridkin A, 2004, P NATL ACAD SCI USA, V101, P6987, DOI 10.1073/pnas.0307880101; Fridkin A, 2009, CELL MOL LIFE SCI, V66, P1518, DOI 10.1007/s00018-008-8713-y; HAGAN I, 1995, J CELL BIOL, V129, P1033, DOI 10.1083/jcb.129.4.1033; Haque F, 2006, MOL CELL BIOL, V26, P3738, DOI 10.1128/MCB.26.10.3738-3751.2006; Hodzic DM, 2004, J BIOL CHEM, V279, P25805, DOI 10.1074/jbc.M313157200; Hoffenberg S, 2000, J BIOL CHEM, V275, P24661, DOI 10.1074/jbc.M909600199; HORVITZ HR, 1980, GENETICS, V96, P435; Hung LY, 2008, NUCLEIC ACIDS RES, V36, P4337, DOI 10.1093/nar/gkn417; Jaspersen SL, 2006, J CELL BIOL, V174, P665, DOI 10.1083/jcb.200601062; Kennedy C, 2004, CELL TISSUE RES, V315, P279, DOI 10.1007/s00441-003-0821-2; Ketema M, 2007, J CELL SCI, V120, P3384, DOI 10.1242/jcs.014191; King MC, 2008, CELL, V134, P427, DOI 10.1016/j.cell.2008.06.022; Lee KK, 2002, MOL BIOL CELL, V13, P892, DOI 10.1091/mbc.01-06-0294; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Liu Q, 2007, J CELL BIOL, V178, P785, DOI 10.1083/jcb.200704108; Lombardi ML, 2011, J BIOL CHEM, V286, P26743, DOI 10.1074/jbc.M111.233700; Lu WS, 2008, BBA-MOL CELL RES, V1783, P2415, DOI 10.1016/j.bbamcr.2008.09.001; Luxton GWG, 2010, SCIENCE, V329, P956, DOI 10.1126/science.1189072; Malone CJ, 1999, DEVELOPMENT, V126, P3171; McGee MD, 2006, MOL BIOL CELL, V17, P1790, DOI 10.1091/mbc.E05-09-0894; Oksvold M, 2002, NAT CELL BIOL, V4, pE22, DOI 10.1038/ncb0202-e22a; Padmakumar VC, 2005, J CELL SCI, V118, P3419, DOI 10.1242/jcs.02471; Padmakumar VC, 2004, EXP CELL RES, V295, P330, DOI 10.1016/j.yexcr.2004.01.014; Penkner A, 2007, DEV CELL, V12, P873, DOI 10.1016/j.devcel.2007.05.004; Puckelwartz MJ, 2009, HUM MOL GENET, V18, P607, DOI 10.1093/hmg/ddn386; Roux KJ, 2007, BBA-MOL BASIS DIS, V1772, P118, DOI 10.1016/j.bbadis.2006.06.001; Schmitt J, 2007, P NATL ACAD SCI USA, V104, P7426, DOI 10.1073/pnas.0609198104; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Starr DA, 2005, BIOESSAYS, V27, P1136, DOI 10.1002/bies.20312; Starr DA, 2003, J CELL SCI, V116, P211, DOI 10.1242/jcs.00248; Starr DA, 2002, SCIENCE, V298, P406, DOI 10.1126/science.1075119; Starr DA, 2001, DEVELOPMENT, V128, P5039; Stewart CL, 2007, SCIENCE, V318, P1408, DOI 10.1126/science.1142034; Stewart-Hutchinson PJ, 2008, EXP CELL RES, V314, P1892, DOI 10.1016/j.yexcr.2008.02.022; SULSTON JE, 1981, DEV BIOL, V82, P41, DOI 10.1016/0012-1606(81)90427-9; Tomita K, 2006, CELL, V125, P19, DOI 10.1016/j.cell.2006.03.020; Turgay Y, 2010, EMBO J, V29, P2262, DOI 10.1038/emboj.2010.119; Tzur YB, 2006, NAT REV MOL CELL BIO, V7, P782, DOI 10.1038/nrm2003; Tzur YB, 2006, P NATL ACAD SCI USA, V103, P13397, DOI 10.1073/pnas.0604224103; Wajant H, 2001, INT J BIOCHEM CELL B, V33, P19, DOI 10.1016/S1357-2725(00)00064-9; Wang Q, 2006, DNA CELL BIOL, V25, P554, DOI 10.1089/dna.2006.25.554; Wilhelmsen K, 2006, J CELL SCI, V119, P5021, DOI 10.1242/jcs.03295; Wolf E, 1997, PROTEIN SCI, V6, P1179, DOI 10.1002/pro.5560060606; XIE YM, 1994, BIOCHEM BIOPH RES CO, V203, P1589, DOI 10.1006/bbrc.1994.2368; Xiong HJ, 2008, TRAFFIC, V9, P708, DOI 10.1111/j.1600-0854.2008.00721.x; Ye H, 1999, MOL CELL, V4, P321, DOI 10.1016/S1097-2765(00)80334-2; Yu JH, 2011, HUM MOL GENET, V20, P1061, DOI 10.1093/hmg/ddq549; Zhang QP, 2005, J CELL SCI, V118, P673, DOI 10.1242/jcs.01642; Zhang QP, 2001, J CELL SCI, V114, P4485	58	94	95	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5317	5326		10.1074/jbc.M111.304543	http://dx.doi.org/10.1074/jbc.M111.304543			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22170055	hybrid, Green Published			2022-12-27	WOS:000300638000014
J	Baudouin-Cornu, P; Lagniel, G; Kumar, C; Huang, ME; Labarre, J				Baudouin-Cornu, Peggy; Lagniel, Gilles; Kumar, Chitranshu; Huang, Meng-Er; Labarre, Jean			Glutathione Degradation Is a Key Determinant of Glutathione Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; GAMMA-GLUTAMYL-TRANSPEPTIDASE; SCHIZOSACCHAROMYCES-POMBE; CYSTEINE LIGASE; SULFUR SOURCE; INHIBITION; SYNTHETASE; PROTEOME; CADMIUM; PATHWAY	Glutathione (GSH) has several important functions in eukaryotic cells, and its intracellular concentration is tightly controlled. Combining mathematical models and S-35 labeling, we analyzed Saccharomyces cerevisiae sulfur metabolism. This led us to the observation that GSH recycling is markedly faster than previously estimated. We set up additional in vivo assays and concluded that under standard conditions, GSH half-life is around 90 min. Sulfur starvation and growth with GSH as the sole sulfur source strongly increase GSH degradation, whereas cadmium (Cd2+) treatment inhibits GSH degradation. Whatever the condition tested, GSH is degraded by the cytosolic Dug complex (composed of the three subunits Dug1, Dug2, and Dug3) but not by the gamma-glutamyl-transpeptidase, raising the question of the role of this enzyme. In vivo, both DUG2/3 mRNA levels and Dug activity are quickly induced by sulfur deprivation in a Met4-dependent manner. This suggests that Dug activity is mainly regulated at the transcriptional level. Finally, analysis of dug2 Delta and dug3 Delta mutant cells shows that GSH degradation activity strongly impacts on GSH intracellular concentration and that GSH intracellular concentration does not affect GSH synthesis rate. Altogether, our data led us to reconsider important aspects of GSH metabolism, challenging notions on GSH synthesis and GSH degradation that were considered as established.	[Baudouin-Cornu, Peggy; Lagniel, Gilles; Labarre, Jean] CEA, iBiTecS, SBIGeM, F-91191 Gif Sur Yvette, France; [Kumar, Chitranshu; Huang, Meng-Er] Univ Paris Sud 11, Inst Curie, CNRS, UMR3348 Genotox Stress & Canc, F-91405 Orsay, France	CEA; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Saclay	Labarre, J (corresponding author), CEA, iBiTecS, SBIGeM, F-91191 Gif Sur Yvette, France.	Jean.Labarre@cea.fr		Baudouin-Cornu, Peggy/0000-0001-7296-099X	Agence Nationale de la Recherche	Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by the Agence Nationale de la Recherche.	Ausubel F. M., 2002, SHORT PROTOCOLS MOL, P13; Ballatori N, 2009, BIOL CHEM, V390, P191, DOI 10.1515/BC.2009.033; Barbey R, 2005, EMBO J, V24, P521, DOI 10.1038/sj.emboj.7600556; Baudouin-Cornu P, 2006, BIOCHIMIE, V88, P1673, DOI 10.1016/j.biochi.2006.03.001; Baudouin-Cornu P, 2009, PROTEOMICS, V9, P4606, DOI 10.1002/pmic.200800975; Biterova EI, 2010, J BIOL CHEM, V285, P14459, DOI 10.1074/jbc.M110.104802; Bourbouloux A, 2000, J BIOL CHEM, V275, P13259, DOI 10.1074/jbc.275.18.13259; Brachmann CB, 1998, YEAST, V14, P115; Cuozzo JW, 1999, NAT CELL BIOL, V1, P130, DOI 10.1038/11047; DENNDA G, 1986, Biotechnology and Applied Biochemistry, V8, P459; ELSKENS MT, 1991, J GEN MICROBIOL, V137, P637, DOI 10.1099/00221287-137-3-637; Fauchon M, 2002, MOL CELL, V9, P713, DOI 10.1016/S1097-2765(02)00500-2; Fell DA, 2005, J EXP BOT, V56, P267, DOI 10.1093/jxb/eri011; Fendt SM, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.11; Ganguli D, 2007, GENETICS, V175, P1137, DOI 10.1534/genetics.106.066944; Godat E, 2010, METHOD ENZYMOL, V473, P41, DOI 10.1016/S0076-6879(10)73002-0; Grant CM, 1997, MOL BIOL CELL, V8, P1699, DOI 10.1091/mbc.8.9.1699; HUANG CS, 1988, P NATL ACAD SCI USA, V85, P2464, DOI 10.1073/pnas.85.8.2464; JASPERS CJ, 1985, PHYTOCHEMISTRY, V24, P703; Jez JM, 2004, J BIOL CHEM, V279, P33463, DOI 10.1074/jbc.M405127200; KACSER H, 1995, BIOCHEM SOC T, V23, P341, DOI 10.1042/bst0230341; Kaur H, 2009, J BIOL CHEM, V284, P14493, DOI 10.1074/jbc.M808952200; Kumar C, 2003, FEMS MICROBIOL LETT, V219, P187, DOI 10.1016/S0378-1097(03)00059-4; Lafaye A, 2005, J BIOL CHEM, V280, P24723, DOI 10.1074/JBC.M502285200; Lee TA, 2010, MOL BIOL CELL, V21, P456, DOI 10.1091/mbc.E09-05-0420; Lu SC, 1999, FASEB J, V13, P1169, DOI 10.1096/fasebj.13.10.1169; Lu SC, 2009, MOL ASPECTS MED, V30, P42, DOI 10.1016/j.mam.2008.05.005; Mehdi K, 1997, MICROBIOL-UK, V143, P1885, DOI 10.1099/00221287-143-6-1885; MESSENGUY F, 1980, EUR J BIOCHEM, V108, P439, DOI 10.1111/j.1432-1033.1980.tb04740.x; MORTIMER RK, 1986, GENETICS, V113, P35; Paolicchi A, 1997, FREE RADICAL BIO MED, V22, P853, DOI 10.1016/S0891-5849(96)00422-4; Paolicchi A, 2002, BIOCHEM PHARMACOL, V64, P1027, DOI 10.1016/S0006-2952(02)01173-5; PENNINCKX MJ, 1985, PHYTOCHEMISTRY, V24, P1913, DOI 10.1016/S0031-9422(00)83091-5; Pereira Y, 2008, TOXICOL SCI, V106, P400, DOI 10.1093/toxsci/kfn193; Perrone GG, 2005, MOL BIOL CELL, V16, P218, DOI 10.1091/mbc.E04-07-0560; Rahman I, 2006, NAT PROTOC, V1, P3159, DOI 10.1038/nprot.2006.378; Rebbeor JF, 1998, J BIOL CHEM, V273, P33449, DOI 10.1074/jbc.273.50.33449; RICHMAN PG, 1975, J BIOL CHEM, V250, P1422; Russell JB, 2007, J MOL MICROB BIOTECH, V13, P1, DOI 10.1159/000103591; Song SH, 2008, J MICROBIOL, V46, P70, DOI 10.1007/s12275-007-0244-y; Spector D, 2001, J BIOL CHEM, V276, P7011, DOI 10.1074/jbc.M009814200; Thomas D, 1997, MICROBIOL MOL BIOL R, V61, P503, DOI 10.1128/.61.4.503-532.1997; Thomas D, 2000, J BIOL CHEM, V275, P40718, DOI 10.1074/jbc.M005967200; Ubiyvovk VM, 2006, CELL BIOL INT, V30, P665, DOI 10.1016/j.cellbi.2006.04.006; Vido K, 2001, J BIOL CHEM, V276, P8469, DOI 10.1074/jbc.M008708200; WALLIS JW, 1989, CELL, V58, P409, DOI 10.1016/0092-8674(89)90855-6; Wunschmann J, 2010, PHYTOCHEMISTRY, V71, P54, DOI 10.1016/j.phytochem.2009.09.034	47	38	39	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4552	4561		10.1074/jbc.M111.315705	http://dx.doi.org/10.1074/jbc.M111.315705			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22170048	Green Published, hybrid			2022-12-27	WOS:000300608500018
J	Gareau, JR; Reverter, D; Lima, CD				Gareau, Jaclyn R.; Reverter, David; Lima, Christopher D.			Determinants of Small Ubiquitin-like Modifier 1 (SUMO1) Protein Specificity, E3 Ligase, and SUMO-RanGAP1 Binding Activities of Nucleoporin RanBP2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEIN; STRUCTURAL BASIS; MECHANISTIC INSIGHTS; CONJUGATION; RANGAP1; SUMOYLATION; COMPLEX; SYSTEM; UBC9P; E2	The RanBP2 nucleoporin contains an internal repeat domain (IR1-M-IR2) that catalyzes E3 ligase activity and forms a stable complex with SUMO-modified RanGAP1 and UBC9 at the nuclear pore complex. RanBP2 exhibits specificity for SUMO1 as RanGAP1-SUMO1/UBC9 forms a more stable complex with RanBP2 compared with RanGAP1-SUMO2 that results in greater protection of RanGAP-SUMO1 from proteases. The IR1-M-IR2 SUMO E3 ligase activity also shows a similar preference for SUMO1. We utilized deletions and domain swap constructs in protease protection assays and automodification assays to define RanBP2 domains responsible for RanGAP1-SUMO1 protection and SUMO1-specific E3 ligase activity. Our data suggest that elements in both IR1 and IR2 exhibit specificity for SUMO1. IR1 protects RanGAP1-SUMO1/UBC9 and functions as the primary E3 ligase of RanBP2, whereas IR2 retains the ability to interact with SUMO1 to promote SUMO1-specific E3 ligase activity. To determine the structural basis for SUMO1 specificity, a hybrid IR1 construct and IR1 were used to determine three new structures for complexes containing UBC9 with RanGAP1-SUMO1/2. These structures show more extensive contacts among SUMO, UBC9, and RanBP2 in complexes containing SUMO1 compared with SUMO2 and suggest that differences in SUMO specificity may be achieved through these subtle conformational differences.	[Gareau, Jaclyn R.; Reverter, David; Lima, Christopher D.] Sloan Kettering Inst, Struct Biol Program, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Lima, CD (corresponding author), Sloan Kettering Inst, Struct Biol Program, 1275 York Ave, New York, NY 10065 USA.	limac@mskcc.org	Reverter, David/H-5360-2015	Reverter, David/0000-0002-5347-0992; Lima, Christopher/0000-0002-9163-6092	National Institutes of Health [GM065872]; US Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; National Center for Research Resources at the National Institute of Health [RR-15301]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065872] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); National Center for Research Resources at the National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM065872 (to C. D. L.). Use of the Advanced Photon Source was supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract W-31-109-Eng-38. Use of the NE-CAT beamline at Sector 24 is based upon research conducted at the Northeastern Collaborative Access Team beamlines of the Advanced Photon Source, which is supported by Award RR-15301 from the National Center for Research Resources at the National Institute of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Capili AD, 2007, CURR OPIN STRUC BIOL, V17, P726, DOI 10.1016/j.sbi.2007.08.018; Chang CC, 2011, MOL CELL, V42, P62, DOI 10.1016/j.molcel.2011.02.022; Chang PC, 2010, J BIOL CHEM, V285, P5266, DOI 10.1074/jbc.M109.088088; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Jian OY, 2009, MOL CELL, V34, P145, DOI 10.1016/j.molcel.2009.03.013; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Lois LM, 2005, EMBO J, V24, P439, DOI 10.1038/sj.emboj.7600552; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; Matunis MJ, 1998, J CELL BIOL, V140, P499, DOI 10.1083/jcb.140.3.499; Meulmeester E, 2008, MOL CELL, V30, P610, DOI 10.1016/j.molcel.2008.03.021; Olsen SK, 2010, NATURE, V463, P906, DOI 10.1038/nature08765; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pichler A, 2004, NAT STRUCT MOL BIOL, V11, P984, DOI 10.1038/nsmb834; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Reindle A, 2006, J CELL SCI, V119, P4749, DOI 10.1242/jcs.03243; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Reverter D, 2006, NAT STRUCT MOL BIOL, V13, P1060, DOI 10.1038/nsmb1168; Rodrigo-Brenni MC, 2010, MOL CELL, V39, P548, DOI 10.1016/j.molcel.2010.07.027; Rytinki MM, 2009, CELL MOL LIFE SCI, V66, P3029, DOI 10.1007/s00018-009-0061-z; Saha A, 2011, MOL CELL, V42, P75, DOI 10.1016/j.molcel.2011.03.016; Saitoh H, 1998, CURR BIOL, V8, P121, DOI 10.1016/S0960-9822(98)70044-2; Saitoh H, 1997, P NATL ACAD SCI USA, V94, P3736, DOI 10.1073/pnas.94.8.3736; Sekiyama N, 2008, J BIOL CHEM, V283, P35966, DOI 10.1074/jbc.M802528200; Shen LN, 2006, BIOCHEM J, V397, P279, DOI 10.1042/BJ20052030; Tatham MH, 2005, NAT STRUCT MOL BIOL, V12, P67, DOI 10.1038/nsmb878; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; Wickliffe KE, 2011, CELL, V144, P769, DOI 10.1016/j.cell.2011.01.035; Yunus AA, 2006, NAT STRUCT MOL BIOL, V13, P491, DOI 10.1038/nsmb1104; Yunus AA, 2009, MOL CELL, V35, P669, DOI 10.1016/j.molcel.2009.07.013; Zhang H, 2002, MOL CELL BIOL, V22, P6498, DOI 10.1128/MCB.22.18.6498-6508.2002; Zhu SS, 2009, MOL CELL, V33, P570, DOI 10.1016/j.molcel.2009.02.008	40	51	54	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4740	4751		10.1074/jbc.M111.321141	http://dx.doi.org/10.1074/jbc.M111.321141			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22194619	hybrid, Green Published			2022-12-27	WOS:000300608500035
J	Tribouillard-Tanvier, D; Carroll, JA; Moore, RA; Striebel, JF; Chesebro, B				Tribouillard-Tanvier, Deborah; Carroll, James A.; Moore, Roger A.; Striebel, James F.; Chesebro, Bruce			Role of Cyclophilin A from Brains of Prion-infected Mice in Stimulation of Cytokine Release by Microglia and Astroglia in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; SIGNALING PATHWAY; CREUTZFELDT-JAKOB; PROTEIN; SCRAPIE; ACTIVATION; DISEASE; CELLS; IDENTIFICATION; INFLAMMATION	Prion diseases or transmissible spongiform encephalopathy diseases are typically characterized by deposition of abnormally folded partially protease-resistant host-derived prion protein (PrPres), which is associated with activated glia and increased release of cytokines. This neuroinflammatory response may play a role in transmissible spongiform encephalopathy pathogenesis. We previously reported that brain homogenates from prion-infected mice induced cytokine protein release in primary astroglial and microglial cell cultures. Here we measured cytokine release by cultured glial cells to determine what factors in infected brain contributed to activation of microglia and astroglia. In assays analyzing IL-12p40 and CCL2 (MCP-1), glial cells were not stimulated in vitro by either PrPres purified from infected mouse brains or prion protein amyloid fibrils produced in vitro. However, significant glial stimulation was induced by clarified scrapie brain homogenates lacking PrPres. This stimulation was greatly reduced both by antibody to cyclophilin A (CyPA), a known mediator of inflammation in peripheral tissues, and by cyclosporine A, a CyPA inhibitor. In biochemical studies, purified truncated CyPA fragments stimulated a pattern of cytokine release by microglia and astroglia similar to that induced by scrapie-infected brain homogenates, whereas purified full-length CyPA was a poor stimulator. This requirement for CyPA truncation was not reported in previous studies of stimulation of peripheral macrophages, endothelial cell cardiomyocytes, and vascular smooth muscle cells. Therefore, truncated CyPA detected in brain following prion infection may have an important role in the activation of brain-derived primary astroglia and microglia in prion disease and perhaps other neurodegenerative or neuroinflammatory diseases.	[Tribouillard-Tanvier, Deborah; Carroll, James A.; Moore, Roger A.; Striebel, James F.; Chesebro, Bruce] NIAID, Persistent Viral Dis Lab, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Chesebro, B (corresponding author), NIAID, Persistent Viral Dis Lab, Rocky Mt Labs, NIH, 903 S 4th St, Hamilton, MT 59840 USA.	bchesebro@nih.gov		Tribouillard-Tanvier, Deborah/0000-0002-2290-5375; Carroll, James/0000-0003-4329-1488	National Institutes of Health through the Division of Intramural Research, NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000937] Funding Source: NIH RePORTER	National Institutes of Health through the Division of Intramural Research, NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by the National Institutes of Health through the Division of Intramural Research, NIAID.	Arora K, 2005, J IMMUNOL, V175, P517, DOI 10.4049/jimmunol.175.1.517; BOLTON DC, 1987, ARCH BIOCHEM BIOPHYS, V258, P579, DOI 10.1016/0003-9861(87)90380-8; Boulos S, 2007, NEUROBIOL DIS, V25, P54, DOI 10.1016/j.nbd.2006.08.012; Brown AR, 2003, J GEN VIROL, V84, P2605, DOI 10.1099/vir.0.19137-0; Brown DR, 1996, NATURE, V380, P345, DOI 10.1038/380345a0; Brown GC, 2010, MOL NEUROBIOL, V41, P242, DOI 10.1007/s12035-010-8105-9; BUDKA H, 1995, BRAIN PATHOL, V5, P459, DOI 10.1111/j.1750-3639.1995.tb00625.x; Burwinkel M, 2004, INT J DEV NEUROSCI, V22, P497, DOI 10.1016/j.ijdevneu.2004.07.017; Cohen E, 2003, EMBO J, V22, P404, DOI 10.1093/emboj/cdg045; Dheen ST, 2007, CURR MED CHEM, V14, P1189, DOI 10.2174/092986707780597961; Fischer G, 2004, REV PHYSIOL BIOCH P, V148, P105, DOI 10.1007/s10254-003-0011-3; Fitting S, 2010, J PROTEOME RES, V9, P1795, DOI 10.1021/pr900926n; Giese A, 1998, BRAIN PATHOL, V8, P449; Griffin DE, 2010, IMMUNOL RES, V47, P123, DOI 10.1007/s12026-009-8143-4; Jin ZG, 2000, CIRC RES, V87, P789, DOI 10.1161/01.RES.87.9.789; Jin ZG, 2004, ARTERIOSCL THROM VAS, V24, P1186, DOI 10.1161/01.ATV.0000130664.51010.28; Kielian T, 2004, FRONT BIOSCI-LANDMRK, V9, P732, DOI 10.2741/1266; Kim JY, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/821940; Kim SH, 2004, AM J PATHOL, V164, P1567, DOI 10.1016/S0002-9440(10)63715-7; Kovacs GG, 2005, AM J PATHOL, V166, P287, DOI 10.1016/S0002-9440(10)62252-3; KRUSE M, 1995, J BIOL CHEM, V270, P2588, DOI 10.1074/jbc.270.6.2588; Lim JK, 2011, EXP CELL RES, V317, P569, DOI 10.1016/j.yexcr.2011.01.009; MALLAT M, 1994, J LEUKOCYTE BIOL, V56, P416, DOI 10.1002/jlb.56.3.416; Matsunaga Y, 2001, PROTEINS, V44, P110, DOI 10.1002/prot.1077; Meade-White K, 2007, J VIROL, V81, P4533, DOI 10.1128/JVI.02762-06; Minton Kirsty, 2001, Trends in Immunology, V22, P655, DOI 10.1016/S1471-4906(01)02116-0; Moore RA, 2010, PROTEOMICS, V10, P2858, DOI 10.1002/pmic.201000104; Na YJ, 2007, J NEUROCHEM, V103, P637, DOI 10.1111/j.1471-4159.2007.04769.x; Nakamura Y, 2002, BIOL PHARM BULL, V25, P945, DOI 10.1248/bpb.25.945; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Payeli SK, 2008, ATHEROSCLEROSIS, V197, P564, DOI 10.1016/j.atherosclerosis.2007.08.025; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Perry VH, 2002, CURR OPIN NEUROL, V15, P349, DOI 10.1097/00019052-200206000-00020; Peyrin JM, 1999, NEUROREPORT, V10, P723, DOI 10.1097/00001756-199903170-00012; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; Race B, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000232; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Rezaie P, 2001, BRAIN RES REV, V35, P55, DOI 10.1016/S0165-0173(01)00042-X; Rock RB, 2004, CLIN MICROBIOL REV, V17, P942, DOI 10.1128/CMR.17.4.942-964.2004; Schmidt R, 2008, CIRC RES, V102, P302, DOI 10.1161/CIRCRESAHA.107.157990; Seko Y, 2004, BIOCHEM BIOPH RES CO, V317, P162, DOI 10.1016/j.bbrc.2004.03.021; SHERRY B, 1992, P NATL ACAD SCI USA, V89, P3511, DOI 10.1073/pnas.89.8.3511; Streit WJ, 2002, GLIA, V40, P133, DOI 10.1002/glia.10154; Takamiya M, 2007, J NEUROTRAUM, V24, P1833, DOI 10.1089/neu.2007.0336; Thellung S, 2007, ANN NY ACAD SCI, V1096, P258, DOI 10.1196/annals.1397.092; Tribouillard-Tanvier D, 2009, J VIROL, V83, P11244, DOI 10.1128/JVI.01413-09; Trifilo MJ, 2008, J VIROL, V82, P9890, DOI 10.1128/JVI.00486-08; Van Everbroeck B, 2004, ACTA NEUROPATHOL, V108, P194, DOI 10.1007/s00401-004-0879-2; Veerhuis R, 2002, BRAIN RES, V925, P195, DOI 10.1016/S0006-8993(01)03273-5; Wei YA, 2010, ATHEROSCLEROSIS, V213, P415, DOI 10.1016/j.atherosclerosis.2010.09.033; WELLS GAH, 1993, DEV BIOL STAND, V80, P61; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Williams A, 1997, EXP NEUROL, V144, P433, DOI 10.1006/exnr.1997.6424; Yang Y, 2008, RHEUMATOLOGY, V47, P1299, DOI 10.1093/rheumatology/ken225; Yurchenko V, 2002, J BIOL CHEM, V277, P22959, DOI 10.1074/jbc.M201593200	55	24	25	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4628	4639		10.1074/jbc.M111.269480	http://dx.doi.org/10.1074/jbc.M111.269480			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22179611	Green Published, hybrid			2022-12-27	WOS:000300608500025
J	Chen, XP; Guo, ZM; Okoro, EU; Zhang, HF; Zhou, LC; Lin, XH; Rollins, AT; Yang, H				Chen, Xinping; Guo, Zhongmao; Okoro, Emmanuel U.; Zhang, Hongfeng; Zhou, LiChun; Lin, Xinhua; Rollins, Allman T.; Yang, Hong			Up-regulation of ATP Binding Cassette Transporter A1 Expression by Very Low Density Lipoprotein Receptor and Apolipoprotein E Receptor 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOAM CELL-FORMATION; KINASE-C-ZETA; CHOLESTEROL EFFLUX; TANGIER-DISEASE; VLDL RECEPTOR; LDL RECEPTOR; PROTEIN; ABCA1; INDUCTION; LIVER	Activation of very low density lipoprotein receptor (VLDLR) and apolipoprotein E receptor 2 (apoER2) results in either pro- or anti-atherogenic effects depending on the ligand. Using reelin and apoE as ligands, we studied the impact of VLDLR- and apoER2-mediated signaling on the expression of ATP binding cassette transporter A1 (ABCA1) and cholesterol efflux using RAW264.7 cells. Treatment of these mouse macrophages with reelin or human apoE3 significantly increased ABCA1 mRNA and protein levels, and apoAI-mediated cholesterol efflux. In addition, both reelin and apoE3 significantly increased phosphorylated disabled-1 (Dab1), phosphatidylinositol 3-kinase (PI3K), protein kinase C zeta (PKC zeta), and specificity protein 1 (Sp1). This reelin-or apoER2-mediated up-regulation of ABCA1 expression was suppressed by 1) knockdown of Dab1, VLDLR, and apoER2 with small interfering RNAs (siRNAs), 2) inhibition of PI3K and PKC with kinase inhibitors, 3) overexpression of kinase-dead PKC zeta, and 4) inhibition of Sp1 DNA binding with mithramycin A. Activation of the Dab1-PI3K signaling pathway has been implicated in VLDLR- and apoER2-mediated cellular functions, whereas the PI3K-PKC zeta-Sp1 signaling cascade has been implicated in the regulation of ABCA1 expression induced by apoE/apoB-carrying lipoproteins. Taken together, these data support a model in which activation of VLDLR and apoER2 by reelin and apoE induces ABCA1 expression and cholesterol efflux via a Dab1-PI3K-PKC zeta-Sp1 signaling cascade.	[Chen, Xinping; Guo, Zhongmao; Okoro, Emmanuel U.; Zhang, Hongfeng; Zhou, LiChun; Lin, Xinhua; Rollins, Allman T.; Yang, Hong] Meharry Med Coll, Dept Physiol, Nashville, TN 37208 USA	Meharry Medical College	Yang, H (corresponding author), Meharry Med Coll, Dept Physiol, Nashville, TN 37208 USA.	hyang@mmc.edu			National Institutes of Health [SC1HL101431, U54RR026140, R01ES014471, R01HL089382]; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR026140] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [SC1HL101431, R01HL089382] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES014472] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants SC1HL101431 and U54RR026140 (to H. Y.) and R01ES014471 and R01HL089382 (to Z. G.).	Baitsch D, 2011, ARTERIOSCL THROM VAS, V31, P1160, DOI 10.1161/ATVBAHA.111.222745; Blacklow SC, 2007, CURR OPIN STRUC BIOL, V17, P419, DOI 10.1016/j.sbi.2007.08.017; BLUME SW, 1991, J CLIN INVEST, V88, P1613, DOI 10.1172/JCI115474; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Chen W, 2001, J BIOL CHEM, V276, P43564, DOI 10.1074/jbc.M107938200; Chen XP, 2011, J BIOL CHEM, V286, P8917, DOI 10.1074/jbc.M110.214429; Choi HY, 2009, CIRCULATION, V119, P3223, DOI 10.1161/CIRCULATIONAHA.108.841130; Chou MM, 1998, CURR BIOL, V8, P1069, DOI 10.1016/S0960-9822(98)70444-0; Costet P, 2000, J BIOL CHEM, V275, P28240; Dove DE, 2005, ARTERIOSCL THROM VAS, V25, P128, DOI 10.1161/01.ATV.0000148323.94021.e5; Guo M, 2000, BIOCHEM PHARMACOL, V60, P635, DOI 10.1016/S0006-2952(00)00379-8; Hara M, 2003, ARTERIOSCL THROM VAS, V23, P269, DOI 10.1161/01.ATV.0000054199.78458.4B; Herz J, 2009, J LIPID RES, V50, pS287, DOI 10.1194/jlr.R800077-JLR200; Hiltunen TP, 1998, CIRCULATION, V97, P1079, DOI 10.1161/01.CIR.97.11.1079; Janowski BA, 1999, P NATL ACAD SCI USA, V96, P266, DOI 10.1073/pnas.96.1.266; Krimbou L, 2004, J LIPID RES, V45, P839, DOI 10.1194/jlr.M300418-JLR200; Lin XH, 2011, FREE RADICAL BIO MED, V51, P97, DOI 10.1016/j.freeradbiomed.2011.04.020; Myant NB, 2010, P R SOC B, V277, P345, DOI 10.1098/rspb.2009.1412; Onumah OE, 2009, FREE RADICAL BIO MED, V46, P1658, DOI 10.1016/j.freeradbiomed.2009.03.018; Orso E, 2000, NAT GENET, V24, P192, DOI 10.1038/72869; Samama B, 2005, ANAT REC PART A, V285A, P595, DOI 10.1002/ar.a.20202; Shen GQ, 2007, AM J HUM GENET, V81, P780, DOI 10.1086/521581; Shenoy NG, 2003, J IMMUNOL, V171, P3734, DOI 10.4049/jimmunol.171.7.3734; Singaraja RR, 2002, J CLIN INVEST, V110, P35, DOI 10.1172/JCI200215748; SUZUKI J, 1995, BIOCHEM BIOPH RES CO, V206, P835, DOI 10.1006/bbrc.1995.1119; Tacken PJ, 2002, ATHEROSCLEROSIS, V162, P103, DOI 10.1016/S0021-9150(01)00697-9; Thymiakou E, 2007, BIOCHEMISTRY-US, V46, P11473, DOI 10.1021/bi700994m; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; Vaisman BL, 2012, J LIPID RES, V53, P158, DOI 10.1194/jlr.M018713; Van Eck M, 2005, ATHEROSCLEROSIS, V183, P230, DOI 10.1016/j.atherosclerosis.2005.03.045; Van Eck M, 2006, ARTERIOSCL THROM VAS, V26, P929, DOI 10.1161/01.ATV.0000208364.22732.16; Van Eck M, 2002, P NATL ACAD SCI USA, V99, P6298, DOI 10.1073/pnas.092327399; Von Eckardstein A, 2001, FASEB J, V15, P1555, DOI 10.1096/fj.00-0798com; Wang N, 2003, ARTERIOSCL THROM VAS, V23, P1178, DOI 10.1161/01.ATV.0000075912.83860.26; Wang ZF, 2009, FREE RADICAL BIO MED, V47, P1221, DOI 10.1016/j.freeradbiomed.2009.08.001; Wu DF, 2007, J LIPID RES, V48, P2571, DOI 10.1194/jlr.M700217-JLR200; Yang XV, 2009, P NATL ACAD SCI USA, V106, P274, DOI 10.1073/pnas.0807594106; Yu JH, 1999, J BIOL CHEM, V274, P34327, DOI 10.1074/jbc.274.48.34327; Zhao YF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021453	39	27	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					3751	3759		10.1074/jbc.M111.310888	http://dx.doi.org/10.1074/jbc.M111.310888			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22170052	hybrid, Green Published			2022-12-27	WOS:000300410900012
J	Ianculescu, I; Wu, DY; Siegmund, KD; Stallcup, MR				Ianculescu, Irina; Wu, Dai-Ying; Siegmund, Kimberly D.; Stallcup, Michael R.			Selective Roles for cAMP Response Element-binding Protein Binding Protein and p300 Protein as Coregulators for Androgen-regulated Gene Expression in Advanced Prostate Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR COACTIVATOR; DIFFERENTIAL ROLES; DISTINCT ROLES; CBP; TRANSCRIPTION; DNA; ACTIVATION; PROLIFERATION; RECRUITMENT; ENHANCERS	The protein acetyltransferases p300 and cAMP response element-binding protein binding protein (CBP) are homologous, ubiquitously expressed proteins that interact with hundreds of proteins involved in transcriptional regulation and are involved globally as transcriptional coregulators. Although these two proteins acetylate and interact with overlapping sets of proteins, we found that p300 and CBP contribute to androgen-induced regulation of distinct sets of genes in C4-2B prostate cancer cells, a model of advanced prostate cancer. CBP cannot compensate for the loss of p300 to support androgen-induced expression of many genes, such as TMPRSS2 and PSA. Global gene expression analysis indicated that 47% of androgen-regulated genes are p300-dependent in these cells, whereas, surprisingly, only 0.3% of them are CBP-dependent. Chromatin immunoprecipitation analysis after depletion of cellular p300 indicated that p300 is required for androgen-induced acetylation of histones H3 and H4, methylation of histone H3 at Lys-4, and recruitment of TATA box binding protein (TBP) and RNA polymerase II, but not recruitment of the androgen receptor, on the TMPRSS2 gene in response to androgen. Thus, p300 is the dominant coregulator of the CBP/p300 pair for androgen-regulated gene expression in C4-2B cells. p300 is required at an early stage of chromatin remodeling and transcription complex assembly after binding of androgen receptor to the gene but before many critical histone modifications occur.	[Ianculescu, Irina; Wu, Dai-Ying; Stallcup, Michael R.] Univ So Calif, Norris Comprehens Canc Ctr, Dept Biochem & Mol Biol, Los Angeles, CA 90089 USA; [Siegmund, Kimberly D.] Univ So Calif, Norris Comprehens Canc Ctr, Dept Prevent Med, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California	Stallcup, MR (corresponding author), Univ So Calif, Norris Comprehens Canc Ctr, Dept Biochem & Mol Biol, NOR 6316,1441 Eastlake Ave, Los Angeles, CA 90089 USA.	stallcup@usc.edu		Wu, Dai-Ying/0000-0002-6485-1635	National Institutes of Health [R01DK043093, R01DK055274, T32GM067587]; National Cancer Institute [P30CA014089]; NATIONAL CANCER INSTITUTE [P30CA014089] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055274, R01DK043093] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM067587] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK043093 and R01DK055274 (to M. R. S.) and Training Grant T32GM067587 (for D. Y. W.). This work was also supported by Cancer Center award number P30CA014089 from the National Cancer Institute (for K. S.).	ABRAHAM SE, 1993, ONCOGENE, V8, P1639; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Chakravarti D, 1996, NATURE, V383, P99, DOI 10.1038/383099a0; Claessens Frank, 2008, Nucl Recept Signal, V6, pe008, DOI 10.1621/nrs.06008; Culig Z, 2006, J CELL BIOCHEM, V99, P373, DOI 10.1002/jcb.20898; Dallas PB, 1997, J VIROL, V71, P1726, DOI 10.1128/JVI.71.2.1726-1731.1997; Debes JD, 2003, CANCER RES, V63, P7638; Dutt SS, 2009, FUTURE ONCOL, V5, P1403, DOI 10.2217/FON.09.117; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Glass CK, 2000, GENE DEV, V14, P121; Hall JM, 2002, MOL ENDOCRINOL, V16, P469, DOI 10.1210/me.16.3.469; Heemers HV, 2005, CURR CANCER THER REV, V1, P175, DOI 10.2174/1573394054021745; Heemers HV, 2007, CANCER RES, V67, P3422, DOI 10.1158/0008-5472.CAN-06-2836; Heinlein CA, 2002, ENDOCR REV, V23, P175, DOI 10.1210/er.23.2.175; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Iyer NG, 2004, ONCOGENE, V23, P4225, DOI 10.1038/sj.onc.1207118; Jeong KW, 2011, NAT STRUCT MOL BIOL, V18, P1358, DOI 10.1038/nsmb.2153; Jin QH, 2011, EMBO J, V30, P249, DOI 10.1038/emboj.2010.318; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kalkhoven E, 2004, BIOCHEM PHARMACOL, V68, P1145, DOI 10.1016/j.bcp.2004.03.045; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; Kawasaki H, 1998, NATURE, V393, P284, DOI 10.1038/30538; Kim JH, 2003, MOL CELL, V12, P1537, DOI 10.1016/S1097-2765(03)00450-7; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lamont KR, 2010, ADV CANCER RES, V107, P137, DOI 10.1016/S0065-230X(10)07005-3; Lefstin JA, 1998, NATURE, V392, P885, DOI 10.1038/31860; Lin BY, 1999, CANCER RES, V59, P4180; Lucas J, 2008, J PATHOL, V215, P118, DOI 10.1002/path.2330; Ma H, 2005, ONCOGENE, V24, P3619, DOI 10.1038/sj.onc.1208433; Makkonen H, 2009, NUCLEIC ACIDS RES, V37, P4135, DOI 10.1093/nar/gkp352; McManus KJ, 2001, BIOCHEM CELL BIOL, V79, P253, DOI 10.1139/bcb-79-3-253; Meijsing SH, 2009, SCIENCE, V324, P407, DOI 10.1126/science.1164265; Miyabayashi T, 2007, P NATL ACAD SCI USA, V104, P5668, DOI 10.1073/pnas.0701331104; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Ramos YFM, 2010, NUCLEIC ACIDS RES, V38, P5396, DOI 10.1093/nar/gkq184; Rebel VI, 2002, P NATL ACAD SCI USA, V99, P14789, DOI 10.1073/pnas.232568499; Schultz JR, 2002, J BIOL CHEM, V277, P8702, DOI 10.1074/jbc.M108491200; Shi W, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq871; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Tanaka Y, 1997, P NATL ACAD SCI USA, V94, P10215, DOI 10.1073/pnas.94.19.10215; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Wang QB, 2005, MOL CELL, V19, P631, DOI 10.1016/j.molcel.2005.07.018; Wang QB, 2007, MOL CELL, V27, P380, DOI 10.1016/j.molcel.2007.05.041; Xu JM, 2009, NAT REV CANCER, V9, P615, DOI 10.1038/nrc2695; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4; Yuan ZM, 1999, ONCOGENE, V18, P5714, DOI 10.1038/sj.onc.1202930	48	83	83	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					4000	4013		10.1074/jbc.M111.300194	http://dx.doi.org/10.1074/jbc.M111.300194			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22174411	Green Published, hybrid			2022-12-27	WOS:000300410900034
J	Kang, H; Davis-Dusenbery, BN; Nguyen, PH; Lal, A; Lieberman, J; Van Aelst, L; Lagna, G; Hata, A				Kang, Hara; Davis-Dusenbery, Brandi N.; Nguyen, Peter H.; Lal, Ashish; Lieberman, Judy; Van Aelst, Linda; Lagna, Giorgio; Hata, Akiko			Bone Morphogenetic Protein 4 Promotes Vascular Smooth Muscle Contractility by Activating MicroRNA-21 (miR-21), which Down-regulates Expression of Family of Dedicator of Cytokinesis (DOCK) Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR GENE; CANCER CELLS; TARGETS; PROLIFERATION; INVASION; IDENTIFICATION; RECOGNITION; MODULATION; SIGNATURE; MIGRATION	The bone morphogenetic protein 4 (BMP4) signaling pathway plays a critical role in the promotion and maintenance of the contractile phenotype in vascular smooth muscle cell (vSMC). Misexpression or inactivating mutations of the BMP receptor gene can lead to dedifferentiation of vSMC characterized by increased migration and proliferation that is linked to vascular proliferative disorders. Previously we demonstrated that vSMCs increase microRNA-21 (miR-21) biogenesis upon BMP4 treatment, which induces contractile gene expression by targeting programmed cell death 4 (PDCD4). To identify novel targets of miR-21 that are critical for induction of the contractile phenotype by BMP4, biotinylated miR-21 was expressed in vSMCs followed by an affinity purification of mRNAs associated with miR-21. Nearly all members of the dedicator of cytokinesis (DOCK) 180-related protein superfamily were identified as targets of miR-21. Down-regulation of DOCK4, -5, and -7 by miR-21 inhibited cell migration and promoted cytoskeletal organization by modulating an activity of small GTPase. Thus, this study uncovers a regulatory mechanism of the vSMC phenotype by the BMP4-miR-21 axis through DOCK family proteins.	[Kang, Hara; Lagna, Giorgio; Hata, Akiko] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA; [Kang, Hara; Davis-Dusenbery, Brandi N.; Nguyen, Peter H.; Lagna, Giorgio; Hata, Akiko] Tufts Med Ctr, Mol Cardiol Res Inst, Boston, MA 02111 USA; [Lal, Ashish; Lieberman, Judy] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA; [Lal, Ashish; Lieberman, Judy] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Lal, Ashish] NCI, Genet Branch, NIH, Bethesda, MD 20889 USA; [Van Aelst, Linda] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Hata, Akiko] Tufts Univ, Sch Med, Dept Biochem, Boston, MA 02111 USA	University of California System; University of California San Francisco; Tufts Medical Center; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Cold Spring Harbor Laboratory; Tufts University	Hata, A (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, 555 Mission Bay Blvd, San Francisco, CA 94158 USA.	akiko.hata@ucsf.edu	Davis-Dusenbery, Brandi/N-2798-2013; Lieberman, Judy/A-2717-2015	Davis-Dusenbery, Brandi/0000-0001-7811-8613; 	National Institutes of Health [HD042149, HL093154, HL082854]; American Heart Association [0940095N]; LeDucq Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD042149] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108317, R01HL093154, R01HL082854] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH082808] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); LeDucq Foundation(Leducq Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants HD042149, HL093154, and HL082854 (to A. H.). This work was also supported by American Heart Association Grant 0940095N and a LeDucq Foundation transatlantic network grant (to A. H.).	Adam L, 2009, CLIN CANCER RES, V15, P5060, DOI 10.1158/1078-0432.CCR-08-2245; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Busacca S, 2010, AM J RESP CELL MOL, V42, P312, DOI 10.1165/rcmb.2009-0060OC; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chan MC, 2010, EMBO J, V29, P559, DOI 10.1038/emboj.2009.370; Chang SS, 2008, INT J CANCER, V123, P2791, DOI 10.1002/ijc.23831; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Cheng YH, 2007, AM J PATHOL, V170, P1831, DOI 10.2353/ajpath.2007.061170; Cho WCS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-60; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Davis BN, 2010, MOL CELL, V39, P373, DOI 10.1016/j.molcel.2010.07.011; Davis BN, 2009, J BIOL CHEM, V284, P3728, DOI 10.1074/jbc.M808788200; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Easow G, 2007, RNA, V13, P1198, DOI 10.1261/rna.563707; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Hatley ME, 2010, CANCER CELL, V18, P282, DOI 10.1016/j.ccr.2010.08.013; Ji RR, 2007, CIRC RES, V100, P1579, DOI 10.1161/CIRCRESAHA.106.141986; Kawada K, 2009, MOL CELL BIOL, V29, P4508, DOI 10.1128/MCB.00015-09; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Ladeiro Y, 2008, HEPATOLOGY, V47, P1955, DOI 10.1002/hep.22256; Lagna G, 2007, J BIOL CHEM, V282, P37244, DOI 10.1074/jbc.M708137200; Lal A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002363; Lal A, 2009, MOL CELL, V35, P610, DOI 10.1016/j.molcel.2009.08.020; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Miyamoto Y, 2010, CELL SIGNAL, V22, P175, DOI 10.1016/j.cellsig.2009.09.036; Moriyama T, 2009, MOL CANCER THER, V8, P1067, DOI 10.1158/1535-7163.MCT-08-0592; Orom UA, 2008, MOL CELL, V30, P460, DOI 10.1016/j.molcel.2008.05.001; Orom UA, 2007, METHODS, V43, P162, DOI 10.1016/j.ymeth.2007.04.007; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Qi YX, 2010, J CELL BIOCHEM, V109, P906, DOI 10.1002/jcb.22465; Raman S, 2008, PLANT J, V55, P65, DOI 10.1111/j.1365-313X.2008.03483.x; Roy S, 2009, CARDIOVASC RES, V82, P21, DOI 10.1093/cvr/cvp015; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Silvestri Pasquale, 2009, Recent Pat Cardiovasc Drug Discov, V4, P109; Siomi H, 2009, NATURE, V457, P396, DOI 10.1038/nature07754; Slack Frank J, 2006, Future Oncol, V2, P73, DOI 10.2217/14796694.2.1.73; Small EM, 2010, CIRCULATION, V121, P1022, DOI 10.1161/CIRCULATIONAHA.109.889048; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Watabe-Uchida M, 2006, NEURON, V51, P727, DOI 10.1016/j.neuron.2006.07.020; Yajnik V, 2003, CELL, V112, P673, DOI 10.1016/S0092-8674(03)00155-7; Zhang L, 2007, MOL CELL, V28, P598, DOI 10.1016/j.molcel.2007.09.014; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24; Zhu SM, 2007, J BIOL CHEM, V282, P14328, DOI 10.1074/jbc.M611393200	50	79	87	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					3976	3986		10.1074/jbc.M111.303156	http://dx.doi.org/10.1074/jbc.M111.303156			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22158624	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000300410900032
J	Zhang, L; Conway, JF; Thibodeau, PH				Zhang, Liang; Conway, James F.; Thibodeau, Patrick H.			Calcium-induced Folding and Stabilization of the Pseudomonas aeruginosa Alkaline Protease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI ALPHA-HEMOLYSIN; GRAM-NEGATIVE BACTERIA; I SECRETION SYSTEM; ESCHERICHIA-COLI; ERWINIA-CHRYSANTHEMI; CRYSTAL-STRUCTURE; SERRATIA-MARCESCENS; ABC-TRANSPORTER; CYSTIC-FIBROSIS; PROTEINS	Pseudomonas aeruginosa is an opportunistic pathogen that contributes to the mortality of immunocompromised individuals and patients with cystic fibrosis. Pseudomonas infection presents clinical challenges due to its ability to form biofilms and modulate host-pathogen interactions through the secretion of virulence factors. The calcium-regulated alkaline protease (AP), a member of the repeats in toxin (RTX) family of proteins, is implicated in multiple modes of infection. A series of full-length and truncation mutants were purified for structural and functional studies to evaluate the role of Ca2+ in AP folding and activation. We find that Ca2+ binding induces RTX folding, which serves to chaperone the folding of the protease domain. Subsequent association of the RTX domain with an N-terminal alpha-helix stabilizes AP. These results provide a basis for the Ca2+-mediated regulation of AP and suggest mechanisms by which Ca2+ regulates the RTX family of virulence factors.	[Zhang, Liang; Thibodeau, Patrick H.] Univ Pittsburgh, Dept Cell Biol & Physiol, Sch Med, Pittsburgh, PA 15261 USA; [Conway, James F.] Univ Pittsburgh, Dept Biol Struct, Sch Med, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Thibodeau, PH (corresponding author), Univ Pittsburgh, Dept Cell Biol & Physiol, Sch Med, 3500 Terrace St,S327 BST, Pittsburgh, PA 15261 USA.	thibodea@pitt.edu	Conway, James F/A-2296-2010; Zhang, Liang/D-9446-2015	Conway, James F/0000-0002-6581-4748; Zhang, Liang/0000-0003-4268-6939; Thibodeau, Patrick/0000-0002-6790-144X	National Institutes of Health, NIDDK [DK083284, DK072506]; University of Pittsburgh School of Medicine, Department of Cell Biology and Physiology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072506, R01DK083284, R56DK083284] Funding Source: NIH RePORTER	National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); University of Pittsburgh School of Medicine, Department of Cell Biology and Physiology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health, NIDDK, Grants DK083284 and DK072506 (to P. H. T.). This work was also supported by faculty development funding from the University of Pittsburgh School of Medicine, Department of Cell Biology and Physiology.	Bakas L, 1998, BBA-BIOMEMBRANES, V1368, P225, DOI 10.1016/S0005-2736(97)00181-8; BAUMANN U, 1993, EMBO J, V12, P3357, DOI 10.1002/j.1460-2075.1993.tb06009.x; BAUMANN U, 1994, J MOL BIOL, V242, P244, DOI 10.1006/jmbi.1994.1576; BAUMANN U, 1995, J MOL BIOL, V248, P653, DOI 10.1006/jmbi.1995.0249; Benabdelhak H, 2003, J MOL BIOL, V327, P1169, DOI 10.1016/S0022-2836(03)00204-3; Bertini I, 2008, J AM CHEM SOC, V130, P7011, DOI 10.1021/ja710491y; Binet R, 1997, GENE, V192, P7, DOI 10.1016/S0378-1119(96)00829-3; BLIGHT MA, 1994, MOL GEN GENET, V245, P431, DOI 10.1007/BF00302255; Chenal A, 2009, J BIOL CHEM, V284, P1781, DOI 10.1074/jbc.M807312200; DELEPELAIRE P, 1990, J BIOL CHEM, V265, P17118; Delepelaire P, 2004, BBA-MOL CELL RES, V1694, P149, DOI 10.1016/j.bbamcr.2004.05.001; DELEPELAIRE P, 1991, MOL MICROBIOL, V5, P2427, DOI 10.1111/j.1365-2958.1991.tb02088.x; DUONG F, 1992, GENE, V121, P47, DOI 10.1016/0378-1119(92)90160-Q; Duong F, 2001, GENE, V262, P147, DOI 10.1016/S0378-1119(00)00541-2; GANGOLA P, 1987, J BIOL CHEM, V262, P12570; Guyot N, 2010, BIOL CHEM, V391, P705, DOI 10.1515/BC.2010.066; GUZZO J, 1990, J BACTERIOL, V172, P942, DOI 10.1128/jb.172.2.942-948.1990; Hege T, 2001, J BIOL CHEM, V276, P35087, DOI 10.1074/jbc.M104020200; Hobden JA, 2002, DNA CELL BIOL, V21, P391, DOI 10.1089/10445490260099674; Huang SH, 1999, NAT STRUCT BIOL, V6, P1132; JAFFARBANDJEE MC, 1995, J CLIN MICROBIOL, V33, P924, DOI 10.1128/JCM.33.4.924-929.1995; Junker M, 2009, MOL MICROBIOL, V71, P1323, DOI 10.1111/j.1365-2958.2009.06607.x; KHARAZMI A, 1984, INFECT IMMUN, V44, P587, DOI 10.1128/IAI.44.3.587-591.1984; KHARAZMI A, 1984, INFECT IMMUN, V43, P161, DOI 10.1128/IAI.43.1.161-165.1984; Lang R, 2001, J MOL BIOL, V312, P731, DOI 10.1006/jmbi.2001.4954; Leidal KG, 2003, J INTERF CYTOK RES, V23, P307, DOI 10.1089/107999003766628151; LETOFFE S, 1992, J BACTERIOL, V174, P4920; LETOFFE S, 1994, J BACTERIOL, V176, P5372; Lilie H, 2000, FEBS LETT, V470, P173, DOI 10.1016/S0014-5793(00)01308-9; Linhartova I, 2010, FEMS MICROBIOL REV, V34, P1076, DOI 10.1111/j.1574-6976.2010.00231.x; Louis D, 1999, INT J BIOCHEM CELL B, V31, P1435, DOI 10.1016/S1357-2725(99)00100-4; Louis D, 1998, BBA-PROTEIN STRUCT M, V1387, P378, DOI 10.1016/S0167-4838(98)00144-7; Lyczak JB, 2000, MICROBES INFECT, V2, P1051, DOI 10.1016/S1286-4579(00)01259-4; Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002; Ma QH, 2003, BBA-BIOMEMBRANES, V1611, P223, DOI 10.1016/S0005-2736(03)00059-2; Omori K, 2003, J BIOSCI BIOENG, V95, P1; Pace CN, 2000, PROTEINS, P1; Palacios JL, 2001, J BACTERIOL, V183, P1346, DOI 10.1128/JB.183.4.1346-1358.2001; Ravaud S, 2003, J BACTERIOL, V185, P4195, DOI 10.1128/JB.185.14.4195-4203.2003; Sarkisova S, 2005, J BACTERIOL, V187, P4327, DOI 10.1128/JB.187.13.4327-4337.2005; Soloaga A, 1999, MOL MICROBIOL, V31, P1013, DOI 10.1046/j.1365-2958.1999.01225.x; Sotomayor Perez AC, 2010, J MOL BIOL, V397, P534, DOI 10.1016/j.jmb.2010.01.031	42	39	39	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					4311	4322		10.1074/jbc.M111.310300	http://dx.doi.org/10.1074/jbc.M111.310300			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22170064	Green Published, hybrid			2022-12-27	WOS:000300410900062
J	Zoghbi, ME; Fuson, KL; Sutton, RB; Altenberg, GA				Zoghbi, Maria E.; Fuson, Kerry L.; Sutton, Roger B.; Altenberg, Guillermo A.			Kinetics of the Association/Dissociation Cycle of an ATP-binding Cassette Nucleotide-binding Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ABC TRANSPORTER MSBA; CATALYTIC CYCLE; P-GLYCOPROTEIN; CRYSTAL-STRUCTURES; HYDROLYSIS CYCLE; ACTIVE-SITE; DIMER; MECHANISMS; CLASSIFICATION; FLUORESCENCE	Most ATP binding cassette (ABC) proteins are pumps that transport substrates across biological membranes using the energy of ATP hydrolysis. Functional ABC proteins have two nucleotide-binding domains (NBDs) that bind and hydrolyze ATP, but the molecular mechanism of nucleotide hydrolysis is unresolved. This is due in part to the limited kinetic information on NBD association and dissociation. Here, we show dimerization of a catalytically active NBD and follow in real time the association and dissociation of NBDs from the changes in fluorescence emission of a tryptophan strategically located at the center of the dimer interface. Spectroscopic and structural studies demonstrated that the tryptophan can be used as dimerization probe, and we showed that under hydrolysis conditions (millimolar MgATP), not only the dimer dissociation rate increases, but also the dimerization rate. Neither dimer formation or dissociation are clearly favored, and the end result is a dynamic equilibrium where the concentrations of monomer and dimer are very similar. We proposed that based on their variable rates of hydrolysis, the rate-limiting step of the hydrolysis cycle may differ among full-length ABC proteins.	[Altenberg, Guillermo A.] Texas Tech Hlth Sci Ctr, Dept Cell Physiol & Mol Biophys, Lubbock, TX 79430 USA; Texas Tech Hlth Sci Ctr, Ctr Membrane Prot Res, Lubbock, TX 79430 USA	Texas Tech University System; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University Health Science Center	Altenberg, GA (corresponding author), Texas Tech Hlth Sci Ctr, Dept Cell Physiol & Mol Biophys, Lubbock, TX 79430 USA.	g.altenberg@ttuhsc.edu		Altenberg, Guillermo/0000-0002-8932-740X; Zoghbi, Maria/0000-0002-4206-4673	National Institutes of Health [R01GM79629, 3R01GM079629-03S1]; National Institutes of Health National Center for Research Resources Biomedical Technology [P41RR001209]; Cancer Prevention and Research Institute of Texas [RP101073]; United States Department of Energy Office of Biological and Environmental Research; National Institute of General Medical Sciences; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079629, T32GM008280] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health National Center for Research Resources Biomedical Technology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Cancer Prevention and Research Institute of Texas; United States Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health grants R01GM79629 and 3R01GM079629-03S1 and by National Institutes of Health National Center for Research Resources Biomedical Technology Program grant P41RR001209 (to the Stanford Synchrotron Radiation Laboratory Structural Molecular Biology Program). This work was also supported by Cancer Prevention and Research Institute of Texas grant RP101073 (to G. A. A.). The Stanford Synchrotron Radiation Laboratory Structural Molecular Biology Program is supported by the United States Department of Energy Office of Biological and Environmental Research and the National Institute of General Medical Sciences.	Borbat PP, 2007, PLOS BIOL, V5, P2211, DOI 10.1371/journal.pbio.0050271; Bouige P, 2002, CURR PROTEIN PEPT SC, V3, P541, DOI 10.2174/1389203023380486; Chen J, 2003, MOL CELL, V12, P651, DOI 10.1016/j.molcel.2003.08.004; CHEN RF, 1991, BIOCHEMISTRY-US, V30, P5184, DOI 10.1021/bi00235a011; Csanady L, 2010, J GEN PHYSIOL, V135, P395, DOI 10.1085/jgp.201010443; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Higgins CF, 2007, NATURE, V446, P749, DOI 10.1038/nature05630; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hwang TC, 2009, J PHYSIOL-LONDON, V587, P2151, DOI 10.1113/jphysiol.2009.171595; Janas E, 2003, J BIOL CHEM, V278, P26862, DOI 10.1074/jbc.M301227200; Jones PM, 2007, J BIOL CHEM, V282, P22793, DOI 10.1074/jbc.M700809200; Jones PM, 2011, BIOPHYS J, V100, P3025, DOI 10.1016/j.bpj.2011.05.028; Jones PM, 2009, PROTEINS, V75, P387, DOI 10.1002/prot.22250; Karpowich N, 2001, STRUCTURE, V9, P571, DOI 10.1016/S0969-2126(01)00617-7; Kayser V, 2011, J FLUORESC, V21, P275, DOI 10.1007/s10895-010-0715-0; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; McGaughey GB, 1998, J BIOL CHEM, V273, P15458, DOI 10.1074/jbc.273.25.15458; Moody J. E., 2006, THESIS U TEXAS SW ME; Moody JE, 2002, J BIOL CHEM, V277, P21111, DOI 10.1074/jbc.C200228200; Narita S, 2006, FEBS LETT, V580, P1164, DOI 10.1016/j.febslet.2005.10.038; Oswald C, 2006, N-S ARCH PHARMACOL, V372, P385, DOI 10.1007/s00210-005-0031-4; Ramjeesingh M, 2008, BIOCHEM J, V412, P315, DOI 10.1042/BJ20071719; Sauna ZE, 2007, BIOCHEMISTRY-US, V46, P13787, DOI 10.1021/bi701385t; Sauna ZE, 2007, MOL CANCER THER, V6, P13, DOI 10.1158/1535-7163.MCT-06-0155; Schmitt L, 2003, J MOL BIOL, V330, P333, DOI 10.1016/S0022-2836(03)00592-8; Senior AE, 1995, FEBS LETT, V377, P285, DOI 10.1016/0014-5793(95)01345-8; Sharom FJ, 2008, PHARMACOGENOMICS, V9, P105, DOI 10.2217/14622416.9.1.105; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; URBATSCH IL, 1994, BIOCHEMISTRY-US, V33, P7069, DOI 10.1021/bi00189a008; van der Does C, 2006, J BIOL CHEM, V281, P5694, DOI 10.1074/jbc.M511730200; Verdon G, 2003, J MOL BIOL, V330, P343, DOI 10.1016/S0022-2836(03)00575-8; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Vivian JT, 2001, BIOPHYS J, V80, P2093, DOI 10.1016/S0006-3495(01)76183-8; Wang CY, 2004, J MOL BIOL, V342, P525, DOI 10.1016/j.jmb.2004.07.001; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Westfahl KM, 2008, BIOCHEMISTRY-US, V47, P13878, DOI 10.1021/bi801745u; Zaitseva J, 2005, EMBO J, V24, P1901, DOI 10.1038/sj.emboj.7600657	39	25	25	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					4157	4164		10.1074/jbc.M111.318378	http://dx.doi.org/10.1074/jbc.M111.318378			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22158619	hybrid, Green Published			2022-12-27	WOS:000300410900049
J	Kim, SY; Shim, JH; Chun, E; Lee, KY				Kim, So Yong; Shim, Jea-Hyuck; Chun, Eunyoung; Lee, Ki-Young			Reciprocal Inhibition between the Transforming Growth Factor-beta-activated Kinase 1 (TAK1) and Apoptosis Signal-regulating Kinase 1 (ASK1) Mitogen-activated Protein Kinase Kinase Kinases and Its Suppression by TAK1-binding Protein 2 (TAB2), an Adapter Protein for TAK1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B; PEROXIREDOXIN 6; MAP KINASES; CELL-DEATH; STRESS; PATHWAYS; TRANSDUCTION; RESPONSES; COMPLEX; INNATE	Mitogen-activated protein kinase kinase kinases (MAP3Ks) are activated by a wide spectrum of extracellular stimuli and are involved in various cellular events including proinflammatory and oxidative damage response through activations of two specific transcription factors, nuclear factor kappa B (NF-kappa B) and activator protein-1 (AP-1). Although members of the MAP3K family have both overlapping and distinct functions, the inter-regulatory mechanism of MAP3Ks remains largely unknown. In this study we demonstrated that transforming growth factor-beta-activated kinase 1 (TAK1)-TAK1-binding protein 1 (TAB1) complex negatively regulates ASK1-mediated signaling, and TAB2 reciprocally regulates TAK1-induced NF-kappa B and apoptosis signal-regulating kinase 1 (ASK1)-mediated AP-1 activations through the TAK1-TAB2 interaction and the interferences of TAK1-ASK1 interaction. TAK1 interacted with the N or C terminus of ASK1 through the C-terminal TAB2 binding domain of TAK1, with resultant inhibition of ASK1-induced AP-1 activation. Interestingly, the interaction between TAK1 and TAB2 significantly attenuated the ASK1-TAK1 interaction through the competitive interaction with ASK1 to TAK1 and resulted in the activations of TAK1-induced activations of NF-kappa B and AP-1. More interestingly, H2O2- and TNF-alpha-induced apoptosis in TAK1-deficient mouse embryo fibroblast cells were dramatically enhanced by overexpression of ASK1, whereas the apoptosis was markedly inhibited by the overexpression of TAK1. Overall, these results demonstrate that TAK1 and its adapter protein, TAB2, reciprocally regulate both TAK1- and ASK1-mediated signaling pathways to direct the activations of NF-kappa B and AP-1.	[Kim, So Yong; Lee, Ki-Young] Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Suwon 440746, South Korea; [Kim, So Yong; Lee, Ki-Young] Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Suwon 440746, South Korea; [Shim, Jea-Hyuck; Chun, Eunyoung] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Shim, Jea-Hyuck; Chun, Eunyoung] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School	Chun, E (corresponding author), 665 Huntington Ave,Bldg 1,Rm 904, Boston, MA 02115 USA.	echun@hsph.harvard.edu; thylee@skku.edu			Ministry of Health and Welfare, Republic of Korea [A100289]	Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by a grant from the Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (A100289).	Besse A, 2007, J BIOL CHEM, V282, P3918, DOI 10.1074/jbc.M608867200; Craig EA, 2008, DEV DYNAM, V237, P3102, DOI 10.1002/dvdy.21750; Fan YH, 2010, J BIOL CHEM, V285, P5347, DOI 10.1074/jbc.M109.076976; Hayakawa T, 2006, MICROBES INFECT, V8, P1098, DOI 10.1016/j.micinf.2005.12.001; Honma K, 2009, BLOOD, V114, P2467, DOI 10.1182/blood-2008-12-194852; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Ichijo H, 1999, ONCOGENE, V18, P6087, DOI 10.1038/sj.onc.1203129; Kim SY, 2011, CELL DEATH DIFFER, V18, P1573, DOI 10.1038/cdd.2011.21; Kim S. Y., 2011, IMMUNOL CEL IN PRESS; Kim SW, 2008, BLOOD, V111, P1644, DOI 10.1182/blood-2007-05-088591; Kim SY, 2008, FEBS LETT, V582, P1913, DOI 10.1016/j.febslet.2008.05.015; Kim SY, 2008, J BIOL CHEM, V283, P33563, DOI 10.1074/jbc.M806578200; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Matsuzawa A, 2005, NAT IMMUNOL, V6, P587, DOI 10.1038/ni1200; Matsuzawa A, 2005, ANTIOXID REDOX SIGN, V7, P472, DOI 10.1089/ars.2005.7.472; Matsuzawa A, 2002, ANTIOXID REDOX SIGN, V4, P415, DOI 10.1089/15230860260196218; Mochida Y, 2000, J BIOL CHEM, V275, P32747, DOI 10.1074/jbc.M003042200; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Nishitoh H, 1998, MOL CELL, V2, P389, DOI 10.1016/S1097-2765(00)80283-X; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Qian YC, 2001, J BIOL CHEM, V276, P41661, DOI 10.1074/jbc.M102262200; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Sayama K, 2001, J BIOL CHEM, V276, P999, DOI 10.1074/jbc.M003425200; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Singhirunnusorn P, 2005, J BIOL CHEM, V280, P7359, DOI 10.1074/jbc.M407537200; Sumbayev VV, 2005, ARCH BIOCHEM BIOPHYS, V436, P406, DOI 10.1016/j.abb.2005.02.021; Takeda K, 2004, EMBO REP, V5, P161, DOI 10.1038/sj.embor.7400072; Takeda K, 2007, J BIOL CHEM, V282, P7522, DOI 10.1074/jbc.M607177200; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Zhang LX, 1999, P NATL ACAD SCI USA, V96, P8511, DOI 10.1073/pnas.96.15.8511	33	22	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3381	3391		10.1074/jbc.M111.317875	http://dx.doi.org/10.1074/jbc.M111.317875			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22167179	Green Published, hybrid			2022-12-27	WOS:000300295100043
J	Stoyanova, T; Roy, N; Bhattacharjee, S; Kopanja, D; Valli, T; Bagchi, S; Raychaudhuri, P				Stoyanova, Tanya; Roy, Nilotpal; Bhattacharjee, Shaumick; Kopanja, Dragana; Valli, Ted; Bagchi, Srilata; Raychaudhuri, Pradip			p21 Cooperates with DDB2 Protein in Suppression of Ultraviolet Ray-induced Skin Malignancies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DAMAGED-DNA-BINDING; COMPLEMENTATION GROUP-E; BASAL-CELL CARCINOMAS; G(1) ARREST; P53; REPAIR; FOXM1; GENE; SITES; P21(WAF1/CIP1)	Exposure to ultraviolet rays (UV) in sunlight is the main cause of skin cancer. Here, we show that the p53-induced genes DDB2 and p21 are down-regulated in skin cancer, and in the mouse model they functionally cooperate to prevent UV-induced skin cancer. Our previous studies demonstrated an antagonistic role of DDB2 and p21 in nucleotide excision repair and apoptosis. Surprisingly, we find that the loss of p21 restores nucleotide excision repair and apoptosis in Ddb2(-/-) mice, but it does not protect from UV-mediated skin carcinogenesis. In contrast, Ddb2(-/-)p21(-/-) mice are significantly more susceptible to UV-induced skin cancer than the Ddb2(-/-) or the p21(-/-) mice. We provide evidence that p21 deletion in the Ddb2(-/-) background causes a strong increase in cell proliferation. The increased proliferation in the Ddb2(-/-)p21(-/-) background is related to a severe deficiency in UV-induced premature senescence. Also, the oncogenic pro-proliferation transcription factor FOXM1 is overexpressed in the p21(-/-) background. Our results show that the anti-proliferative and the pro-senescence pathways of DDB2 and p21 are critical protection mechanisms against skin malignancies.	[Bagchi, Srilata] Univ Illinois, Coll Dent, Ctr Canc, Ctr Mol Biol Oral Dis, Chicago, IL 60612 USA; [Stoyanova, Tanya; Roy, Nilotpal; Bhattacharjee, Shaumick; Kopanja, Dragana; Raychaudhuri, Pradip] Univ Illinois, Ctr Canc, Dept Biochem & Mol Genet, Chicago, IL 60607 USA; [Valli, Ted] VDx Pathol, Davis, CA 95616 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Bagchi, S (corresponding author), Univ Illinois, Coll Dent, Ctr Canc, Ctr Mol Biol Oral Dis, 801 S Paulina Ave, Chicago, IL 60612 USA.	sbagchi@uic.edu; pradip@uic.edu			National Institutes of Health from NCI [CA77637, CA 156164]; University of Illinois, College of Medicine; NATIONAL CANCER INSTITUTE [R01CA077637, R01CA156164] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Illinois, College of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA77637 and CA 156164 from NCI.; Supported by a Dean's Scholar Fellowship from the University of Illinois, College of Medicine.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Alekseev S, 2005, CANCER RES, V65, P10298, DOI 10.1158/0008-5472.CAN-05-2295; Alvarez-Fernandez M, 2010, EMBO REP, V11, P452, DOI 10.1038/embor.2010.46; Bagchi S, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-3; Barsotti AM, 2009, ONCOGENE, V28, P4295, DOI 10.1038/onc.2009.282; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; CHEN Q, 1995, P NATL ACAD SCI USA, V92, P4337, DOI 10.1073/pnas.92.10.4337; Chen YJ, 2009, J BIOL CHEM, V284, P30695, DOI 10.1074/jbc.M109.007997; DI LEONARDO A, 1994, GENE DEV, V8, P2540, DOI 10.1101/gad.8.21.2540; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; El-Mahdy MA, 2006, J BIOL CHEM, V281, P13404, DOI 10.1074/jbc.M511834200; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Halasi M, 2009, CELL CYCLE, V8, P1966, DOI 10.4161/cc.8.12.8708; Itoh T, 2004, P NATL ACAD SCI USA, V101, P2052, DOI 10.1073/pnas.0306551101; Kim MY, 2002, J DERMATOL SCI, V29, P1, DOI 10.1016/S0923-1811(01)00170-0; Kulaksiz G, 2005, MOL CELL BIOL, V25, P9784, DOI 10.1128/MCB.25.22.9784-9792.2005; Macip S, 2002, EMBO J, V21, P2180, DOI 10.1093/emboj/21.9.2180; Maeda T, 2005, CARCINOGENESIS, V26, P1804, DOI 10.1093/carcin/bgi140; Nichols AF, 2000, J BIOL CHEM, V275, P21422, DOI 10.1074/jbc.M000960200; Oh KS, 2011, J INVEST DERMATOL, V131, P785, DOI 10.1038/jid.2010.352; Park HJ, 2009, EMBO J, V28, P2908, DOI 10.1038/emboj.2009.239; Reardon JT, 2003, GENE DEV, V17, P2539, DOI 10.1101/gad.1131003; Roy N, 2010, MOL CELL BIOL, V30, P2681, DOI 10.1128/MCB.01480-09; SHEA CR, 1992, AM J PATHOL, V141, P25; Smith ML, 2000, MOL CELL BIOL, V20, P3705, DOI 10.1128/MCB.20.10.3705-3714.2000; Stoyanova T, 2008, MOL CELL BIOL, V28, P177, DOI 10.1128/MCB.00880-07; Stoyanova T, 2009, P NATL ACAD SCI USA, V106, P10690, DOI 10.1073/pnas.0812254106; Sugasawa K, 2005, CELL, V121, P387, DOI 10.1016/j.cell.2005.02.035; Tan T, 2002, MOL CELL BIOL, V22, P3247, DOI 10.1128/MCB.22.10.3247-3254.2002; Tang J, 2002, DNA REPAIR, V1, P601, DOI 10.1016/S1568-7864(02)00052-6; Topley GI, 1999, P NATL ACAD SCI USA, V96, P9089, DOI 10.1073/pnas.96.16.9089; Wakasugi M, 2002, J BIOL CHEM, V277, P1637, DOI 10.1074/jbc.C100610200; WALDMAN T, 1995, CANCER RES, V55, P5187; Wang IC, 2005, MOL CELL BIOL, V25, P10875, DOI 10.1128/MCB.25.24.10875-10894.2005; Wierstra I, 2007, BIOL CHEM, V388, P1257, DOI 10.1515/BC.2007.159; Willenbring H, 2008, CANCER CELL, V14, P59, DOI 10.1016/j.ccr.2008.05.004; Wittschieben BO, 2005, J BIOL CHEM, V280, P39982, DOI 10.1074/jbc.M507854200; Yoon T, 2005, ONCOGENE, V24, P469, DOI 10.1038/sj.onc.1208211	39	27	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3019	3028		10.1074/jbc.M111.295816	http://dx.doi.org/10.1074/jbc.M111.295816			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22167187	Green Published, hybrid			2022-12-27	WOS:000300295100009
J	Cardinale, A; Racaniello, M; Saladini, S; De Chiara, G; Mollinari, C; de Stefano, MC; Pocchiari, M; Garaci, E; Merlo, D				Cardinale, Alessio; Racaniello, Mauro; Saladini, Serena; De Chiara, Giovanna; Mollinari, Cristiana; de Stefano, Maria Chiara; Pocchiari, Maurizio; Garaci, Enrico; Merlo, Daniela			Sublethal Doses of beta-Amyloid Peptide Abrogate DNA-dependent Protein Kinase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; INCREASED OXIDATIVE DAMAGE; SUBSTANTIA-NIGRA NEURONS; DOUBLE-STRAND BREAKS; ALZHEIMERS-DISEASE; CATALYTIC SUBUNIT; HYDROGEN-PEROXIDE; IN-VITRO; TOPOISOMERASE-II; POLY(ADP-RIBOSE) POLYMERASE-1	Accumulation of DNA damage and deficiency in DNA repair potentially contribute to the progressive neuronal loss in neurodegenerative disorders, including Alzheimer disease (AD). In multicellular eukaryotes, double strand breaks (DSBs), the most lethal form of DNA damage, are mainly repaired by the nonhomologous end joining pathway, which relies on DNA-PK complex activity. Both the presence of DSBs and a decreased end joining activity have been reported in AD brains, but the molecular player causing DNA repair dysfunction is still undetermined. beta-Amyloid (A beta), a potential proximate effector of neurotoxicity in AD, might exert cytotoxic effects by reactive oxygen species generation and oxidative stress induction, which may then cause DNA damage. Here, we show that in PC12 cells sublethal concentrations of aggregated A beta (25-35) inhibit DNA-PK kinase activity, compromising DSB repair and sensitizing cells to nonlethal oxidative injury. The inhibition of DNA-PK activity is associated with down-regulation of the catalytic subunit DNA-PK (DNA-PKcs) protein levels, caused by oxidative stress and reversed by antioxidant treatment. Moreover, we show that sublethal doses of A beta(1-42) oligomers enter the nucleus of PC12 cells, accumulate as insoluble oligomeric species, and reduce DNA-PK kinase activity, although in the absence of oxidative stress. Overall, these findings suggest that A beta mediates inhibition of the DNA-PK-dependent nonhomologous end joining pathway contributing to the accumulation of DSBs that, if not efficiently repaired, may lead to the neuronal loss observed in AD.	[Racaniello, Mauro; De Chiara, Giovanna; Mollinari, Cristiana; de Stefano, Maria Chiara; Pocchiari, Maurizio; Merlo, Daniela] Ist Super Sanita, Dept Cell Biol & Neurosci, I-00161 Rome, Italy; [Cardinale, Alessio; Racaniello, Mauro; Saladini, Serena; Merlo, Daniela] Ist Ricovero & Cura Carattere Sci San Raffaele Pi, I-00166 Rome, Italy; [Mollinari, Cristiana] CNR, Ist Farmacol Traslaz, I-00133 Rome, Italy; [Garaci, Enrico] Univ Roma Tor Vergata, Dept Expt Med & Biochem Sci, I-00133 Rome, Italy	Istituto Superiore di Sanita (ISS); Consiglio Nazionale delle Ricerche (CNR); Istituto di Farmacologia Traslazionale (IFT-CNR); University of Rome Tor Vergata	Merlo, D (corresponding author), Ist Super Sanita, Dept Cell Biol & Neurosci, Viale Regina Elena 299, I-00161 Rome, Italy.	daniela.merlo@iss.it	GARACI, ENRICO/AAB-3349-2021; De Chiara, Giovanna/AAJ-7843-2021; de Stefano, Maria Chiara/N-6492-2017; Merlo, Daniela/K-7986-2016; Pocchiari, Maurizio/J-8443-2018; Mollinari, Cristiana/K-4131-2016	De Chiara, Giovanna/0000-0002-2219-6097; de Stefano, Maria Chiara/0000-0002-0770-1411; Merlo, Daniela/0000-0003-4240-5762; Pocchiari, Maurizio/0000-0002-7269-2486; Mollinari, Cristiana/0000-0001-8112-5427	Italian Ministry of Health	Italian Ministry of Health(Ministry of Health, Italy)	This work was supported by the Italian Ministry of Health.	Adamec E, 1999, BRAIN RES, V849, P67, DOI 10.1016/S0006-8993(99)02004-1; Amador FC, 2004, NEUROTOXICOL TERATOL, V26, P387, DOI 10.1016/j.ntt.2003.12.007; Banath JP, 2003, CANCER RES, V63, P4347; Barzilai A, 2007, ANTIOXID REDOX SIGN, V9, P211, DOI 10.1089/ars.2007.9.211; BEHL C, 1994, CELL, V77, P817, DOI 10.1016/0092-8674(94)90131-7; Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769; BOERRIGTER METI, 1992, J GERONTOL, V47, pB177, DOI 10.1093/geronj/47.6.B177; Bogdanov M, 2000, FREE RADICAL BIO MED, V29, P652, DOI 10.1016/S0891-5849(00)00349-X; Boldogh I, 2003, TOXICOLOGY, V193, P137, DOI 10.1016/j.tox.2003.08.013; Buckig A, 2002, HISTOCHEM CELL BIOL, V118, P353, DOI 10.1007/s00418-002-0459-2; Burden DA, 1998, BBA-GENE STRUCT EXPR, V1400, P139, DOI 10.1016/S0167-4781(98)00132-8; Butterfield DA, 2001, TRENDS MOL MED, V7, P548, DOI 10.1016/S1471-4914(01)02173-6; Butterfield DA, 2002, PEPTIDES, V23, P1299, DOI 10.1016/S0196-9781(02)00066-9; CASCIOLAROSEN LA, 1995, J EXP MED, V182, P1625, DOI 10.1084/jem.182.6.1625; Cecarini V, 2008, BRAIN RES, V1209, P8, DOI 10.1016/j.brainres.2008.03.003; Chakravarthy BR, 1999, J NEUROCHEM, V72, P933, DOI 10.1046/j.1471-4159.1999.0720933.x; CHAUHAN A, 1993, BRAIN RES, V629, P47, DOI 10.1016/0006-8993(93)90479-7; Chen L, 2009, INT J BIOCHEM CELL B, V41, P1284, DOI 10.1016/j.biocel.2008.10.029; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cisse M, 2011, NATURE, V469, P47, DOI 10.1038/nature09635; Collis SJ, 2005, ONCOGENE, V24, P949, DOI 10.1038/sj.onc.1208332; Critchlow SE, 1998, TRENDS BIOCHEM SCI, V23, P394, DOI 10.1016/S0968-0004(98)01284-5; Culmsee C, 2001, MOL BRAIN RES, V87, P257, DOI 10.1016/S0169-328X(01)00008-0; Daido S, 2005, CANCER RES, V65, P4368, DOI 10.1158/0008-5472.CAN-04-4202; Diaz JC, 2009, P NATL ACAD SCI USA, V106, P3348, DOI 10.1073/pnas.0813355106; Douglas P, 2001, J BIOL CHEM, V276, P18992, DOI 10.1074/jbc.M011703200; Enokido Y, 2010, J CELL BIOL, V189, P425, DOI 10.1083/jcb.200905138; Ferrante RJ, 1997, J NEUROCHEM, V69, P2064; Giuliano P, 2003, HUM MOL GENET, V12, P2301, DOI 10.1093/hmg/ddg242; GOTTLIEB TM, 1993, CELL, V72, P131, DOI 10.1016/0092-8674(93)90057-W; Grune T, 1997, FASEB J, V11, P526, DOI 10.1096/fasebj.11.7.9212076; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hegde ML, 2004, J MOL NEUROSCI, V22, P19, DOI 10.1385/JMN:22:1-2:19; Huang XD, 1999, BIOCHEMISTRY-US, V38, P7609, DOI 10.1021/bi990438f; Huang XD, 1999, J BIOL CHEM, V274, P37111, DOI 10.1074/jbc.274.52.37111; IIMOTO DS, 1990, BRAIN RES, V507, P273, DOI 10.1016/0006-8993(90)90282-G; IVERSEN LL, 1995, BIOCHEM J, V311, P1; Johnstone EM, 1996, BIOCHEM BIOPH RES CO, V220, P710, DOI 10.1006/bbrc.1996.0469; Kikuchi H, 2002, ACTA NEUROPATHOL, V103, P408, DOI 10.1007/s00401-001-0480-x; Kisby GE, 1997, NEUROREPORT, V8, P1337, DOI 10.1097/00001756-199704140-00004; Kovtun IV, 2007, NATURE, V447, P447, DOI 10.1038/nature05778; Kraemer KH, 2007, NEUROSCIENCE, V145, P1388, DOI 10.1016/j.neuroscience.2006.12.020; Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778; Kruman II, 2004, NEURON, V41, P549, DOI 10.1016/S0896-6273(04)00017-0; Lieber MR, 2003, NAT REV MOL CELL BIO, V4, P712, DOI 10.1038/nrm1202; Lu HR, 2005, MOL PHARMACOL, V68, P983, DOI 10.1124/mol.105.011544; Lucassen PJ, 1997, J NEUROPATH EXP NEUR, V56, P887, DOI 10.1097/00005072-199708000-00007; Martinez-Senac MD, 1999, EUR J BIOCHEM, V265, P744, DOI 10.1046/j.1432-1327.1999.00775.x; McConnell KR, 1997, J IMMUNOL, V158, P2083; McKinnon PJ, 2009, NAT REV NEUROSCI, V10, P100, DOI 10.1038/nrn2559; Merlo D, 2005, CELL DEATH DIFFER, V12, P307, DOI 10.1038/sj.cdd.4401572; Mills KD, 2003, IMMUNOL REV, V194, P77, DOI 10.1034/j.1600-065X.2003.00060.x; MULLAART E, 1990, NEUROBIOL AGING, V11, P169, DOI 10.1016/0197-4580(90)90542-8; Neema M, 2005, HIPPOCAMPUS, V15, P1057, DOI 10.1002/hipo.20123; Nouspikel T, 2003, BIOESSAYS, V25, P168, DOI 10.1002/bies.10227; Nystrom T, 2005, EMBO J, V24, P1311, DOI 10.1038/sj.emboj.7600599; Ohyagi Y, 2005, FASEB J, V19, P255, DOI 10.1096/fj.04-2637fje; Olsen BB, 2010, ONCOGENE, V29, P6016, DOI 10.1038/onc.2010.337; Orii KE, 2006, P NATL ACAD SCI USA, V103, P10017, DOI 10.1073/pnas.0602436103; PIKE CJ, 1995, J NEUROCHEM, V64, P253, DOI 10.1046/j.1471-4159.1995.64010253.x; PIKE CJ, 1993, J NEUROSCI, V13, P1676; Qi ML, 2007, NAT CELL BIOL, V9, P402, DOI 10.1038/ncb1553; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Rashidian J, 2005, P NATL ACAD SCI USA, V102, P14080, DOI 10.1073/pnas.0500099102; ROBBINS JH, 1985, J NEUROL NEUROSUR PS, V48, P916, DOI 10.1136/jnnp.48.9.916; ROBISON SH, 1987, ANN NEUROL, V21, P250, DOI 10.1002/ana.410210306; Roselli F, 2005, J NEUROSCI, V25, P11061, DOI 10.1523/JNEUROSCI.3034-05.2005; Shackelford DA, 2006, NEUROBIOL AGING, V27, P596, DOI 10.1016/j.neurobiolaging.2005.03.009; Shackelford DA, 1999, J NEUROSCI, V19, P4727; Shao L, 2010, EMBO MOL MED, V2, P415, DOI 10.1002/emmm.201000096; SHEARMAN MS, 1994, P NATL ACAD SCI USA, V91, P1470, DOI 10.1073/pnas.91.4.1470; Shimura-Miura H, 1999, ANN NEUROL, V46, P920, DOI 10.1002/1531-8249(199912)46:6<920::AID-ANA17>3.0.CO;2-R; Shrivastav M, 2008, CELL RES, V18, P134, DOI 10.1038/cr.2007.111; Simpson JE, 2010, NEUROPATH APPL NEURO, V36, P25, DOI 10.1111/j.1365-2990.2009.01030.x; Smith GCM, 1999, GENE DEV, V13, P916, DOI 10.1101/gad.13.8.916; Soldani C, 2002, APOPTOSIS, V7, P321, DOI 10.1023/A:1016119328968; Song QZ, 1996, EMBO J, V15, P3238, DOI 10.1002/j.1460-2075.1996.tb00688.x; Stadelmann C, 1998, J NEUROPATH EXP NEUR, V57, P456, DOI 10.1097/00005072-199805000-00009; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Thompson LH, 2001, MUTAT RES-FUND MOL M, V477, P131, DOI 10.1016/S0027-5107(01)00115-4; Trushina E, 2007, NEUROSCIENCE, V145, P1233, DOI 10.1016/j.neuroscience.2006.10.056; Tseng BP, 2008, NEUROBIOL AGING, V29, P1607, DOI 10.1016/j.neurobiolaging.2007.04.014; Varadarajan S, 2001, J AM CHEM SOC, V123, P5625, DOI 10.1021/ja010452r; Veuger SJ, 2003, CANCER RES, V63, P6008; Vintem APB, 2009, NEUROTOXICOL TERATOL, V31, P85, DOI 10.1016/j.ntt.2008.11.001; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Weissman L, 2007, NEUROSCIENCE, V145, P1318, DOI 10.1016/j.neuroscience.2006.08.061; Weissman L, 2007, NUCLEIC ACIDS RES, V35, P5545, DOI 10.1093/nar/gkm605; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Weterings E, 2008, CELL RES, V18, P114, DOI 10.1038/cr.2008.3; Willmore E, 2004, BLOOD, V103, P4659, DOI 10.1182/blood-2003-07-2527; Wong RHF, 2009, CELL, V136, P1056, DOI 10.1016/j.cell.2008.12.040; YANKNER BA, 1989, SCIENCE, V245, P417, DOI 10.1126/science.2474201; Zhao Y, 2006, CANCER RES, V66, P5354, DOI 10.1158/0008-5472.CAN-05-4275	94	37	38	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2618	2631		10.1074/jbc.M111.276550	http://dx.doi.org/10.1074/jbc.M111.276550			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22139836	Green Published, hybrid			2022-12-27	WOS:000300292300035
J	Delley, CL; Striebel, F; Heydenreich, FM; Ozcelik, D; Weber-Ban, E				Delley, Cyrille L.; Striebel, Frank; Heydenreich, Franziska M.; Oezcelik, Dennis; Weber-Ban, Eilika			Activity of the Mycobacterial Proteasomal ATPase Mpa Is Reversibly Regulated by Pupylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-LIKE PROTEIN; AAA PLUS PROTEIN; TUBERCULOSIS; PUP; IDENTIFICATION; TERMINI; PATHWAY; GATE; DOP	Pupylation is a bacterial post-translational modification of target proteins on lysine residues with prokaryotic ubiquitin-like protein Pup. Pup-tagged substrates are recognized by a proteasome-interacting ATPase termed Mpa in Mycobacterium tuberculosis. Mpa unfolds pupylated substrates and threads them into the proteasome core particle for degradation. Interestingly, Mpa itself is also a pupylation target. Here, we show that the Pup ligase PafA predominantly produces monopupylated Mpa modified homogeneously on a single lysine residue within its C-terminal region. We demonstrate that this modification renders Mpa functionally inactive. Pupylated Mpa can no longer support Pup-mediated proteasomal degradation due to its inability to associate with the proteasome core. Mpa is further inactivated by rapid Pup-and ATPase-driven deoligomerization of the hexameric Mpa ring. We show that pupylation of Mpa is chemically and functionally reversible. Mpa regains its enzymatic activity upon depupylation by the depupylase Dop, affording a rapid and reversible activity control over Mpa function.	[Delley, Cyrille L.; Striebel, Frank; Heydenreich, Franziska M.; Oezcelik, Dennis; Weber-Ban, Eilika] ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Weber-Ban, E (corresponding author), ETH, Inst Mol Biol & Biophys, Schafmattstr 20, CH-8093 Zurich, Switzerland.	eilika@mol.biol.ethz.ch	Heydenreich, Franziska M/N-6314-2015; Özcelik, Dennis/M-9961-2019	Heydenreich, Franziska M/0000-0002-8049-4383; Özcelik, Dennis/0000-0002-7185-4690; Weber-Ban, Eilika/0000-0002-5773-9274	Swiss National Science Foundation; National Center for Excellence in Research Structural Biology of the Swiss National Science Foundation; ETH; Kekule fellowship by the "Fonds der Chemischen Industrie"	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Center for Excellence in Research Structural Biology of the Swiss National Science Foundation; ETH(ETH Zurich); Kekule fellowship by the "Fonds der Chemischen Industrie"	This work was supported by the Swiss National Science Foundation, the National Center for Excellence in Research Structural Biology program of the Swiss National Science Foundation, an ETH research grant, and a Kekule fellowship by the "Fonds der Chemischen Industrie" (to F. S.).	BAIS R, 1975, ANAL BIOCHEM, V63, P271, DOI 10.1016/0003-2697(75)90215-8; Burns KE, 2010, MOL CELL, V39, P821, DOI 10.1016/j.molcel.2010.07.019; Burns KE, 2010, J BACTERIOL, V192, P2933, DOI 10.1128/JB.01639-09; Burns KE, 2009, J BIOL CHEM, V284, P3069, DOI 10.1074/jbc.M808032200; Darwin KH, 2005, MOL MICROBIOL, V55, P561, DOI 10.1111/j.1365-2958.2004.04403.x; Darwin KH, 2003, SCIENCE, V302, P1963, DOI 10.1126/science.1091176; FENTON WA, 1994, NATURE, V371, P614, DOI 10.1038/371614a0; Festa RA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008589; Gillette TG, 2008, J BIOL CHEM, V283, P31813, DOI 10.1074/jbc.M805935200; Guth E, 2011, J BIOL CHEM, V286, P4412, DOI 10.1074/jbc.M110.189282; Imkamp F, 2010, EMBO REP, V11, P791, DOI 10.1038/embor.2010.119; Imkamp F, 2010, MOL MICROBIOL, V75, P744, DOI 10.1111/j.1365-2958.2009.07013.x; Kirstein J, 2006, EMBO J, V25, P1481, DOI 10.1038/sj.emboj.7601042; Pearce MJ, 2008, SCIENCE, V322, P1104, DOI 10.1126/science.1163885; Pearce MJ, 2006, EMBO J, V25, P5423, DOI 10.1038/sj.emboj.7601405; Poulsen C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.39; Rabl J, 2008, MOL CELL, V30, P360, DOI 10.1016/j.molcel.2008.03.004; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Striebel F, 2010, EMBO J, V29, P1262, DOI 10.1038/emboj.2010.23; Striebel F, 2009, NAT STRUCT MOL BIOL, V16, P647, DOI 10.1038/nsmb.1597; Summer H, 2006, J STRUCT BIOL, V156, P120, DOI 10.1016/j.jsb.2006.01.010; Sutter M, 2010, J AM CHEM SOC, V132, P5610, DOI 10.1021/ja910546x; Sutter M, 2009, FEBS LETT, V583, P3151, DOI 10.1016/j.febslet.2009.09.020; Wang T, 2010, NAT STRUCT MOL BIOL, V17, P1352, DOI 10.1038/nsmb.1918; Wang T, 2009, STRUCTURE, V17, P1377, DOI 10.1016/j.str.2009.08.010; Watrous J, 2010, MOL BIOSYST, V6, P376, DOI 10.1039/b916104j; Wolf S, 1998, J MOL BIOL, V277, P13, DOI 10.1006/jmbi.1997.1589	27	30	31	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					7907	7914		10.1074/jbc.M111.331124	http://dx.doi.org/10.1074/jbc.M111.331124			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22210775	hybrid, Green Published			2022-12-27	WOS:000301349400007
J	Hall, J; Aulabaugh, A; Rajamohan, F; Liu, SP; Kaila, N; Wan, ZK; Ryan, M; Magyar, R; Qiu, XY				Hall, Justin; Aulabaugh, Ann; Rajamohan, Francis; Liu, Shenping; Kaila, Neelu; Wan, Zhao-Kui; Ryan, Mark; Magyar, Rachelle; Qiu, Xiayang			Biophysical and Mechanistic Insights into Novel Allosteric Inhibitor of Spleen Tyrosine Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY SOLUTION; ANGLE SCATTERING DATA; PROTEIN-KINASE; AKT INHIBITOR; SYK FAMILY; CRYSTAL-STRUCTURE; DOMAIN INTERFACE; STRUCTURAL BASIS; CELL-ACTIVATION; ITAM PEPTIDE	Extracellular stimulation of the B cell receptor or mast cell Fc epsilon RI receptor activates a cascade of protein kinases, ultimately leading to antigenic or inflammation immune responses, respectively. Syk is a soluble kinase responsible for transmission of the receptor activation signal from the membrane to cytosolic targets. Control of Syk function is, therefore, critical to the human antigenic and inflammation immune response, and an inhibitor of Syk could provide therapy for autoimmune or inflammation diseases. We report here a novel allosteric Syk inhibitor, X1, that is noncompetitive against ATP (K-i 4 +/- 1 mu M) and substrate peptide (K-i 5 +/- 1 mu M), and competitive against activation of Syk by its upstream regulatory kinase LynB (K-i 4 +/- 1 mu M). The inhibition mechanism was interrogated using a combination of structural, biophysical, and kinetic methods, which suggest the compound inhibits Syk by reinforcing the natural regulatory interactions between the SH2 and kinase domains. This novel mode of inhibition provides a new opportunity to improve the selectivity profile of Syk inhibitors for the development of safer drug candidates.	[Hall, Justin; Aulabaugh, Ann; Rajamohan, Francis; Liu, Shenping; Magyar, Rachelle; Qiu, Xiayang] Pfizer Inc, Struct Biol & Biophys Grp, Groton, CT 06340 USA; [Kaila, Neelu; Wan, Zhao-Kui; Ryan, Mark] Pfizer, Med Chem Grp, Cambridge, MA 02140 USA	Pfizer; Pfizer	Hall, J (corresponding author), Pfizer Inc, Struct Biol & Biophys Grp, Groton, CT 06340 USA.	Justin.Hall@pfizer.com; Ann.Aulabaugh@pfizer.com						Arias-Palomo E, 2007, BBA-PROTEINS PROTEOM, V1774, P1493, DOI 10.1016/j.bbapap.2007.10.008; Arias-Palomo E, 2009, BBA-PROTEINS PROTEOM, V1794, P1211, DOI 10.1016/j.bbapap.2009.04.010; Atwell S, 2004, J BIOL CHEM, V279, P55827, DOI 10.1074/jbc.M409792200; Aulabaugh A, 2007, BIOCHEMISTRY-US, V46, P9462, DOI 10.1021/bi7000505; Baba Y, 2001, P NATL ACAD SCI USA, V98, P2582, DOI 10.1073/pnas.051626198; Barnett SF, 2005, BIOCHEM J, V385, P399, DOI 10.1042/BJ20041140; Brdicka T, 2005, MOL CELL BIOL, V25, P4924, DOI 10.1128/MCB.25.12.4924-4933.2005; Calleja V, 2009, PLOS BIOL, V7, P189, DOI 10.1371/journal.pbio.1000017; Catalina MI, 2005, J AM SOC MASS SPECTR, V16, P1039, DOI 10.1016/j.jasms.2005.02.011; Cherrin C, 2010, CANCER BIOL THER, V9, P493, DOI 10.4161/cbt.9.7.11100; Chu DH, 1998, IMMUNOL REV, V165, P167, DOI 10.1111/j.1600-065X.1998.tb01238.x; Deindl S, 2007, CELL, V129, P735, DOI 10.1016/j.cell.2007.03.039; DeLano W.L, PYMOL MOL GRAPHICS S; Fischer PM, 2004, CURR MED CHEM, V11, P1563, DOI 10.2174/0929867043365062; Futterer K, 1998, J MOL BIOL, V281, P523, DOI 10.1006/jmbi.1998.1964; GORDON JA, 1991, METHOD ENZYMOL, V201, P477; Green CJ, 2008, J BIOL CHEM, V283, P27653, DOI 10.1074/jbc.M802623200; Hall J, 2009, J BIOL CHEM, V284, P33115, DOI 10.1074/jbc.M109.048587; Hindie V, 2009, NAT CHEM BIOL, V5, P758, DOI 10.1038/nchembio.208; Hirabayashi A, 2008, BIOORGAN MED CHEM, V16, P9247, DOI 10.1016/j.bmc.2008.09.015; Hirabayashi A, 2008, BIOORGAN MED CHEM, V16, P7347, DOI 10.1016/j.bmc.2008.06.017; Hirai H, 2010, MOL CANCER THER, V9, P1956, DOI 10.1158/1535-7163.MCT-09-1012; Hisamichi H, 2005, BIOORGAN MED CHEM, V13, P4936, DOI 10.1016/j.bmc.2005.05.033; JENCKS WP, 1981, P NATL ACAD SCI-BIOL, V78, P4046, DOI 10.1073/pnas.78.7.4046; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Kawakami Y, 2003, P NATL ACAD SCI USA, V100, P9470, DOI 10.1073/pnas.1633695100; Keshvara LM, 1998, J IMMUNOL, V161, P5276; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kuriyan J, 2007, NATURE, V450, P983, DOI 10.1038/nature06524; Laue T.M., 1992, COMPUTER AIDED INTER; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; NARULA SS, 1995, STRUCTURE, V3, P1061, DOI 10.1016/S0969-2126(01)00242-8; PAGE MI, 1971, P NATL ACAD SCI USA, V68, P1678, DOI 10.1073/pnas.68.8.1678; Papp E, 2007, BIOCHEMISTRY-US, V46, P15103, DOI 10.1021/bi701596u; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Reth M, 1997, ANNU REV IMMUNOL, V15, P453, DOI 10.1146/annurev.immunol.15.1.453; Russo AA, 1996, NATURE, V382, P325, DOI 10.1038/382325a0; Ruzza P, 2009, EXPERT OPIN THER PAT, V19, P1361, DOI 10.1517/13543770903207039; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sharma A., 1999, INTRO FLUORESCENCE S; Siraganian RP, 2002, MOL IMMUNOL, V38, P1229, DOI 10.1016/S0161-5890(02)00068-8; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; TAMAOKI T, 1986, BIOCHEM BIOPH RES CO, V135, P397, DOI 10.1016/0006-291X(86)90008-2; Tsang E, 2008, J BIOL CHEM, V283, P32650, DOI 10.1074/jbc.M806340200; Villasenor AG, 2009, CHEM BIOL DRUG DES, V73, P466, DOI 10.1111/j.1747-0285.2009.00785.x; Wei LY, 2010, BIOORG MED CHEM LETT, V20, P3897, DOI 10.1016/j.bmcl.2010.05.019; Wilkins MR, 1999, METH MOL B, V112, P531; Wu H, 2003, J BIOL CHEM, V278, P41768, DOI 10.1074/jbc.M308196200; Zhang JM, 2010, NATURE, V463, P501, DOI 10.1038/nature08675; Zhang XW, 2007, NATURE, V450, P741, DOI 10.1038/nature05998	54	9	9	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7717	7727		10.1074/jbc.M111.311993	http://dx.doi.org/10.1074/jbc.M111.311993			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22219190	hybrid, Green Published			2022-12-27	WOS:000301060200070
J	Klimacek, M; Brunsteiner, M; Nidetzky, B				Klimacek, Mario; Brunsteiner, Michael; Nidetzky, Bernd			Dynamic Mechanism of Proton Transfer in Mannitol 2-Dehydrogenase from Pseudomonas fluorescens MOBILE GLU(292) CONTROLS PROTON RELAY THROUGH A WATER CHANNEL THAT CONNECTS THE ACTIVE SITE WITH BULK SOLVENT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COUPLED ELECTRON-TRANSFER; CYTOCHROME-C-OXIDASE; P-HYDROXYBENZOATE HYDROXYLASE; LIVER ALCOHOL-DEHYDROGENASE; CARBONIC-ANHYDRASE II; CATALYTIC MECHANISM; MEMBRANE-PROTEIN; CHAIN DEHYDROGENASES/REDUCTASES; CONFORMATIONAL-CHANGES; MOLECULAR SIMULATION	The active site of mannitol 2-dehydrogenase from Pseudomonas fluorescens (PfM2DH) is connected with bulk solvent through a narrow protein channel that shows structural resemblance to proton channels utilized by redox-driven proton pumps. A key element of the PfM2DH channel is the "mobile" Glu(292), which was seen crystallographically to adopt distinct positions up and down the channel. It was suggested that the "down -> up" conformational change of Glu(292) could play a proton relay function in enzymatic catalysis, through direct proton shuttling by the Glu or because the channel is opened for water molecules forming a chain along which the protons flow. We report evidence from site-directed mutagenesis (Glu(292) -> Ala) substantiated by data from molecular dynamics simulations that support a role for Glu(292) as a gate in a water chain (von Grotthuss-type) mechanism of proton translocation. Occupancy of the up and down position of Glu(292) is influenced by the bonding and charge state of the catalytic acid base Lys(295), suggesting that channel opening/closing motions of the Glu are synchronized to the reaction progress. Removal of gatekeeper control in the E292A mutant resulted in a selective, up to 120-fold slowing down of microscopic steps immediately preceding catalytic oxidation of mannitol, consistent with the notion that formation of the productive enzyme-NAD(+) -mannitol complex is promoted by a corresponding position change of Glu(292), which at physiological pH is associated with obligatory deprotonation of Lys(295) to solvent. These results underscore the important role of conformational dynamics in the proton transfer steps of alcohol dehydrogenase catalysis.	[Klimacek, Mario; Brunsteiner, Michael; Nidetzky, Bernd] Graz Univ Technol, Inst Biotechnol & Biochem Engn, A-8010 Graz, Austria; [Brunsteiner, Michael; Nidetzky, Bernd] Res Ctr Pharmaceut Engn, A-8010 Graz, Austria	Graz University of Technology; Research Center for Pharmaceutical Engineering (RCPE)	Nidetzky, B (corresponding author), Graz Univ Technol, Inst Biotechnol & Biochem Engn, Petersgasse 12-1, A-8010 Graz, Austria.	bernd.nidetzky@tugraz.at		Nidetzky, Bernd/0000-0002-5030-2643; Brunsteiner, Michael/0000-0002-1149-7847	Austrian Science Fund FWF [P18275-B09]	Austrian Science Fund FWF(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund FWF, Grant P18275-B09 (to B.N.).	AGMON N, 1995, CHEM PHYS LETT, V244, P456, DOI 10.1016/0009-2614(95)00905-J; Basran J., 2007, HYDROGEN TRANSFER RE, P1341; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Belevich I, 2010, P NATL ACAD SCI USA, V107, P18469, DOI 10.1073/pnas.1010974107; Braun-Sand S, 2004, BIOPHYS J, V87, P2221, DOI 10.1529/biophysj.104.043257; de Smidt O, 2008, FEMS YEAST RES, V8, P967, DOI 10.1111/j.1567-1364.2008.00387.x; Dementin S, 2004, J BIOL CHEM, V279, P10508, DOI 10.1074/jbc.M312716200; DePaul AJ, 2010, NUCLEIC ACIDS RES, V38, P4856, DOI 10.1093/nar/gkq134; ELLIS KJ, 1982, METHOD ENZYMOL, V87, P405; Faber K., 2018, BIOTRANSFORMATIONS O; Ferrer S, 2005, CHEM COMMUN, P5873, DOI 10.1039/b510735k; Filling C, 2002, J BIOL CHEM, V277, P25677, DOI 10.1074/jbc.M202160200; Fisher SZ, 2010, BIOCHEMISTRY-US, V49, P415, DOI 10.1021/bi901995n; Fitch CA, 2002, BIOPHYS J, V82, P3289, DOI 10.1016/S0006-3495(02)75670-1; Frederick KK, 2005, BIOCHEMISTRY-US, V44, P13304, DOI 10.1021/bi051119t; Frederick KK, 2001, BIOCHEMISTRY-US, V40, P3891, DOI 10.1021/bi001851m; Freier E, 2011, P NATL ACAD SCI USA, V108, P11435, DOI 10.1073/pnas.1104735108; Furuichi M, 2008, J MOL BIOL, V378, P436, DOI 10.1016/j.jmb.2008.02.062; Garczarek F, 2005, P NATL ACAD SCI USA, V102, P3633, DOI 10.1073/pnas.0500421102; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Hall M, 2011, CHEM REV, V111, P4088, DOI 10.1021/cr200013n; Hammes-Schiffer S, 2002, CHEMPHYSCHEM, V3, P33, DOI 10.1002/1439-7641(20020118)3:1<33::AID-CPHC33>3.0.CO;2-6; Hammes-Schiffer S, 2006, ANNU REV BIOCHEM, V75, P519, DOI 10.1146/annurev.biochem.75.103004.142800; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Heyes DJ, 2011, J BIOL CHEM, V286, P11849, DOI 10.1074/jbc.M111.219626; Hoog JO, 2011, CHEM-BIOL INTERACT, V191, P2, DOI 10.1016/j.cbi.2011.01.028; Hummel W, 1997, Adv Biochem Eng Biotechnol, V58, P145; Hyndman D, 2003, CHEM-BIOL INTERACT, V143, P621, DOI 10.1016/S0009-2797(02)00193-X; Inoue J, 1998, BIOCHEMISTRY-US, V37, P3305, DOI 10.1021/bi970726g; Kavanagh KL, 2002, J BIOL CHEM, V277, P43433, DOI 10.1074/jbc.M206914200; Klimacek M, 2003, CHEM-BIOL INTERACT, V143, P559, DOI 10.1016/S0009-2797(02)00219-3; Klimacek M, 2003, BIOCHEM J, V375, P141, DOI 10.1042/BJ20030733; Klimacek M, 2002, BIOCHEM J, V367, P13, DOI 10.1042/BJ20020932; Klimacek M, 2002, BIOCHEMISTRY-US, V41, P10158, DOI 10.1021/bi025517x; Klimacek M, 2007, BIOCHEM J, V404, P421, DOI 10.1042/BJ20061384; Klimacek M, 2010, BIOCHEM J, V425, P455, DOI 10.1042/BJ20091441; Klimacek M, 2010, J BIOL CHEM, V285, P30644, DOI 10.1074/jbc.M110.108993; Koumanov A, 2003, PROTEINS, V51, P289, DOI 10.1002/prot.10354; Kovaleva EG, 2005, BIOCHEMISTRY-US, V44, P12797, DOI 10.1021/bi050865v; Ladenstein R, 2008, CELL MOL LIFE SCI, V65, P3918, DOI 10.1007/s00018-008-8590-4; Lanyi JK, 2003, J MOL BIOL, V328, P439, DOI 10.1016/S0022-2836(03)00263-8; Leferink NGH, 2011, BIOCHEMISTRY-US, V50, P4121, DOI 10.1021/bi200246f; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Luo J, 2001, J AM CHEM SOC, V123, P11952, DOI 10.1021/ja0109747; Marx D, 2006, CHEMPHYSCHEM, V7, P1848, DOI 10.1002/cphc.200600128; Maupin CM, 2010, BBA-PROTEINS PROTEOM, V1804, P332, DOI 10.1016/j.bbapap.2009.09.006; MEIBOOM S, 1961, J CHEM PHYS, V34, P375, DOI 10.1063/1.1700960; Meijers R., 2004, HDB METALLOPROTEINS, P5; Metzler D. E, 2001, BIOCHEMISTRY-US, P765; Milburn CC, 2006, J BIOL CHEM, V281, P14796, DOI 10.1074/jbc.M601334200; Nagel ZD, 2006, CHEM REV, V106, P3095, DOI 10.1021/cr050301x; Namslauer A, 2004, FEBS LETT, V567, P103, DOI 10.1016/j.febslet.2004.04.027; Neutze R, 2002, BBA-BIOMEMBRANES, V1565, P144, DOI 10.1016/S0005-2736(02)00566-7; Northrop D. B., 1977, ISOTOPE EFFECTS ENZY, P122; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PETTERSSON G, 1987, CRIT REV BIOCHEM MOL, V21, P349, DOI 10.3109/10409238609113616; Plapp B. V., 2006, ISOTOPE EFFECTS CHEM, P811; Plapp BV, 2010, ARCH BIOCHEM BIOPHYS, V493, P3, DOI 10.1016/j.abb.2009.07.001; QUINN DM, 1991, ENZYME MECH ISOTOPE, P73; Reece SY, 2009, ANNU REV BIOCHEM, V78, P673, DOI 10.1146/annurev.biochem.78.080207.092132; ROBERTS SM, 1989, PHILOS T ROY SOC B, V324, P577, DOI 10.1098/rstb.1989.0069; Rostkowski M, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-6; Schwartz S. D., 2007, HYDROGEN TRANSFER RE, P1209; Siegbahn PEM, 2010, CHEM REV, V110, P7040, DOI 10.1021/cr100070p; Silverman D. N., 2006, ISOTOPE EFFECTS CHEM, P847; Slatner M, 1999, BIOCHEMISTRY-US, V38, P10489, DOI 10.1021/bi990327g; Sorin EJ, 2005, BIOPHYS J, V88, P2472, DOI 10.1529/biophysj.104.051938; Toba S, 1999, J AM CHEM SOC, V121, P2290, DOI 10.1021/ja983579y; Tripp BC, 2000, BIOCHEMISTRY-US, V39, P9232, DOI 10.1021/bi0001877; Wikstrom M, 2003, BBA-BIOENERGETICS, V1604, P61, DOI 10.1016/S0005-2728(03)00041-0; Wolf S, 2010, ANGEW CHEM INT EDIT, V49, P6889, DOI 10.1002/anie.201001243; Wolf S, 2008, CHEMPHYSCHEM, V9, P2772, DOI 10.1002/cphc.200800703; Wraight CA, 2006, BBA-BIOENERGETICS, V1757, P886, DOI 10.1016/j.bbabio.2006.06.017	73	6	6	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6655	6667		10.1074/jbc.M111.289223	http://dx.doi.org/10.1074/jbc.M111.289223			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22194597	Green Published, hybrid			2022-12-27	WOS:000300791800052
J	Mori, T; Rezai-Zadeh, K; Koyama, N; Arendash, GW; Yamaguchi, H; Kakuda, N; Horikoshi-Sakuraba, Y; Tan, J; Town, T				Mori, Takashi; Rezai-Zadeh, Kavon; Koyama, Naoki; Arendash, Gary W.; Yamaguchi, Haruyasu; Kakuda, Nobuto; Horikoshi-Sakuraba, Yuko; Tan, Jun; Town, Terrence			Tannic Acid Is a Natural beta-Secretase Inhibitor That Prevents Cognitive Impairment and Mitigates Alzheimer-like Pathology in Transgenic Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; MOUSE MODEL; CEREBRAL AMYLOIDOSIS; TUMOR PROMOTION; GALLIC ACID; IN-VITRO; DISEASE; BRAIN; PRESENILIN-1; DEPOSITION	Amyloid precursor protein (APP) proteolysis is essential for production of amyloid-beta (A beta) peptides that form beta-amyloid plaques in brains of Alzheimer disease (AD) patients. Recent focus has been directed toward a group of naturally occurring anti-amyloidogenic polyphenols known as flavonoids. Weorally administered the flavonoid tannic acid (TA) to the transgenic PSAPP mouse model of cerebral amyloidosis (bearing mutant human APP and presenilin-1 transgenes) and evaluated cognitive function and AD-like pathology. Consumption of TA for 6 months prevented transgene-associated behavioral impairment including hyperactivity, decreased object recognition, and defective spatial reference memory, but did not alter nontransgenic mouse behavior. Accordingly, brain parenchymal and cerebral vascular beta-amyloid deposits and abundance of various A beta species including oligomers were mitigated in TA-treated PSAPP mice. These effects occurred with decreased cleavage of the beta-carboxyl-terminal APP fragment, lowered soluble APP-beta production, reduced beta-site APP cleaving enzyme 1 protein stability and activity, and attenuated neuroinflammation. As in vitro validation, we treated well characterized mutant human APP-overexpressing murine neuron-like cells with TA and found significantly reduced A beta production associated with less amyloidogenic APP proteolysis. Taken together, these results raise the possibility that dietary supplementation with TA may be prophylactic for AD by inhibiting beta-secretase activity and neuroinflammation and thereby mitigating AD pathology.	[Mori, Takashi; Koyama, Naoki] Saitama Med Ctr, Dept Biomed Sci, Kawagoe, Saitama 3508550, Japan; [Mori, Takashi] Saitama Med Ctr, Dept Pathol, Kawagoe, Saitama 3508550, Japan; Univ Kawagoe, Kawagoe, Saitama 3508550, Japan; [Rezai-Zadeh, Kavon; Town, Terrence] Cedars Sinai Med Ctr, Dept Biomed Sci, Los Angeles, CA 90048 USA; [Rezai-Zadeh, Kavon; Town, Terrence] Cedars Sinai Med Ctr, Regenerat Med Inst Neural Program, Los Angeles, CA 90048 USA; [Town, Terrence] Cedars Sinai Med Ctr, Dept Neurosurg, Maxine Dunitz Neurosurg Inst, Los Angeles, CA 90048 USA; [Arendash, Gary W.] Univ S Florida, Florida Alzheimers Dis Res Ctr, Tampa, FL 33620 USA; [Arendash, Gary W.] Univ S Florida, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL 33620 USA; [Yamaguchi, Haruyasu] Gunma Univ Sch Hlth Sci, Maebashi, Gunma 3718514, Japan; [Kakuda, Nobuto; Horikoshi-Sakuraba, Yuko] Immunobiol Labs Co Ltd, Gunma 3750005, Japan; [Tan, Jun] Univ S Florida, Coll Med, Rashid Lab Dev Neurobiol, Silver Child Dev Ctr, Tampa, FL 33613 USA; [Tan, Jun] Univ S Florida, Coll Med, Neuroimmunol Lab, Dept Psychiat & Neurosci, Tampa, FL 33613 USA; [Town, Terrence] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90048 USA	Saitama Medical University; Saitama Medical University; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; Gunma University; Immuno-Biological Laboratories Co. Ltd.; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Mori, T (corresponding author), Saitama Med Ctr, Dept Biomed Sci, Kawagoe, Saitama 3508550, Japan.	t_mori@saitama-med.ac.jp; terrence.town@cshs.org	Kakuda, Nobuto/ABB-5608-2021; Tan, Jun/I-5339-2012	Kakuda, Nobuto/0000-0001-7011-6891	National Institutes of Health, NIA [5R00AG029726-04, 3R00AG029726-04S1, 1R01NS076794-01]; NINDS; Japan Society for the Promotion of Science [22500320]; Ministry of Education, Culture, Sports, Science and Technology [19300122]; Alzheimer's Association [ZEN-10-174633]; American Federation of Aging Research/Ellison Medical Foundation [M11472]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R00AG029726] Funding Source: NIH RePORTER	National Institutes of Health, NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Alzheimer's Association(Alzheimer's Association); American Federation of Aging Research/Ellison Medical Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants 5R00AG029726-04, 3R00AG029726-04S1, and 1R01NS076794-01 from the NIA and the NINDS (to T.T.), Grant-in-aid for Scientific Research (C) 22500320 (to T.M.) from the Japan Society for the Promotion of Science and Grant-in-aid for Scientific Research (B) 19300122 (to H.Y.) from the Ministry of Education, Culture, Sports, Science and Technology, Alzheimer's Association Zenith Fellows Award ZEN-10-174633 (to T.T.), and American Federation of Aging Research/Ellison Medical Foundation Julie Martin Mid-Career Award in Aging Research M11472 (to T.T.).	Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Andrade RG, 2005, ARCH BIOCHEM BIOPHYS, V437, P1, DOI 10.1016/j.abb.2005.02.016; Arendash GW, 2009, J ALZHEIMERS DIS, V17, P661, DOI 10.3233/JAD-2009-1087; Arendash GW, 2001, BRAIN RES, V891, P42, DOI 10.1016/S0006-8993(00)03186-3; Benzing WC, 1999, NEUROBIOL AGING, V20, P581, DOI 10.1016/S0197-4580(99)00065-2; Bian Y, 2009, HUM MOL GENET, V18, P1229, DOI 10.1093/hmg/ddp023; Bieschke J, 2010, P NATL ACAD SCI USA, V107, P7710, DOI 10.1073/pnas.0910723107; Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; BOYD EM, 1965, CAN MED ASSOC J, V92, P1292; Breitner J, 2007, AM J MED, V120, pE3, DOI 10.1016/j.amjmed.2006.09.022; Brookmeyer R, 2000, STAT MED, V19, P1481, DOI 10.1002/(SICI)1097-0258(20000615/30)19:11/12<1481::AID-SIM440>3.0.CO;2-U; Chen SC, 2000, FOOD CHEM TOXICOL, V38, P1, DOI 10.1016/S0278-6915(99)00114-3; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; De Rosa R, 2005, P NATL ACAD SCI USA, V102, P3811, DOI 10.1073/pnas.0500195102; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; DeMattos RB, 2002, SCIENCE, V295, P2264, DOI 10.1126/science.1067568; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Ellis RJ, 1996, NEUROLOGY, V46, P1592, DOI 10.1212/WNL.46.6.1592; Ferruzzi MG, 2009, J ALZHEIMERS DIS, V18, P113, DOI 10.3233/JAD-2009-1135; Franklin K. B. J., 2001, MOUSE BRAIN STEREOTA; GALI HU, 1992, INT J CANCER, V51, P425, DOI 10.1002/ijc.2910510315; Gandhi S, 2004, J MOL NEUROSCI, V24, P137, DOI 10.1385/JMN:24:1:137; Garcia-Alloza M, 2006, NEUROBIOL DIS, V24, P516, DOI 10.1016/j.nbd.2006.08.017; Georgiou NA, 2011, EUR J PHARMACOL, V651, P1, DOI 10.1016/j.ejphar.2010.11.007; Good M, 1997, BEHAV NEUROSCI, V111, P487, DOI 10.1037/0735-7044.111.3.487; Griffin WST, 1998, BRAIN PATHOL, V8, P65; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; Horikoshi Y, 2004, BIOCHEM BIOPH RES CO, V319, P733, DOI 10.1016/j.bbrc.2004.05.051; Ito D, 2001, STROKE, V32, P1208, DOI 10.1161/01.STR.32.5.1208; Jankowsky JL, 2005, PLOS MED, V2, P1318, DOI 10.1371/journal.pmed.0020355; Jankowsky JL, 2004, NEUROBIOL AGING, V25, P885, DOI 10.1016/j.neurobiolaging.2003.09.008; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Kim KS, 2006, J NEUROSCI RES, V83, P497, DOI 10.1002/jnr.20754; King DL, 1999, BEHAV BRAIN RES, V103, P145, DOI 10.1016/S0166-4328(99)00037-6; Konishi Y, 2004, J AGR FOOD CHEM, V52, P2527, DOI 10.1021/jf035366k; Kukar TL, 2008, NATURE, V453, P925, DOI 10.1038/nature07055; Laghmouch A, 1997, BEHAV GENET, V27, P67, DOI 10.1023/A:1025667426222; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lim GP, 2000, J NEUROSCI, V20, P5709, DOI 10.1523/JNEUROSCI.20-15-05709.2000; Mandel S, 2006, MOL NUTR FOOD RES, V50, P229, DOI 10.1002/mnfr.200500156; Marambaud P, 2005, J BIOL CHEM, V280, P37377, DOI 10.1074/jbc.M508246200; MCGEER PL, 1987, NEUROSCI LETT, V79, P195, DOI 10.1016/0304-3940(87)90696-3; Medic-Saric M, 2009, NUTR J, V8, DOI 10.1186/1475-2891-8-33; Meng FL, 2010, BIOCHEMISTRY-US, V49, P8127, DOI 10.1021/bi100939a; Monney L, 2002, NATURE, V415, P536, DOI 10.1038/415536a; Montine TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009340; Mori T, 2006, J PHARMACOL EXP THER, V318, P571, DOI 10.1124/jpet.106.105171; Mori T, 2010, GLIA, V58, P300, DOI 10.1002/glia.20924; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Nepka C, 1999, CANCER LETT, V141, P57, DOI 10.1016/S0304-3835(99)00145-7; Obregon DF, 2006, J BIOL CHEM, V281, P16419, DOI 10.1074/jbc.M600617200; Ono K, 2004, BBA-MOL BASIS DIS, V1690, P193, DOI 10.1016/j.bbadis.2004.06.008; Ono K, 2003, J NEUROCHEM, V87, P172, DOI 10.1046/j.1471-4159.2003.01976.x; Rezai-Zadeh K, 2005, J NEUROSCI, V25, P8807, DOI 10.1523/JNEUROSCI.1521-05.2005; Rezai-Zadeh K, 2009, J CELL MOL MED, V13, P574, DOI 10.1111/j.1582-4934.2008.00344.x; ROZEMULLER JM, 1989, J NEUROPATH EXP NEUR, V48, P674, DOI 10.1097/00005072-198911000-00009; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Sehrawat A, 2006, REDOX REP, V11, P85, DOI 10.1179/135100006X101066; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Serrano J, 2009, MOL NUTR FOOD RES, V53, pS310, DOI 10.1002/mnfr.200900039; Shahrzad S, 2001, J NUTR, V131, P1207, DOI 10.1093/jn/131.4.1207; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Sinha S, 1999, P NATL ACAD SCI USA, V96, P11049, DOI 10.1073/pnas.96.20.11049; Stalder AK, 2005, J NEUROSCI, V25, P11125, DOI 10.1523/JNEUROSCI.2545-05.2005; Stalder M, 1999, AM J PATHOL, V154, P1673, DOI 10.1016/S0002-9440(10)65423-5; Streit W. J., 2005, NEUROGLIA, P60; Tan J, 2002, NAT NEUROSCI, V5, P1288, DOI 10.1038/nn968; Tan J, 2000, J NEUROSCI, V20, P7587; Town T, 2008, NAT MED, V14, P681, DOI 10.1038/nm1781; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vassar R, 2009, J NEUROSCI, V29, P12787, DOI 10.1523/JNEUROSCI.3657-09.2009; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Xia WM, 2009, ARCH NEUROL-CHICAGO, V66, P190, DOI 10.1001/archneurol.2008.565; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; YOKOZAWA T, 1991, NEPHRON, V58, P155, DOI 10.1159/000186406; Zhang H, 2009, J THORAC CARDIOV SUR, V137, P216, DOI 10.1016/j.jtcvs.2008.07.030; Zhu YY, 2011, J NEUROSCI, V31, P1355, DOI 10.1523/JNEUROSCI.3268-10.2011	78	117	122	1	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6912	6927		10.1074/jbc.M111.294025	http://dx.doi.org/10.1074/jbc.M111.294025			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22219198	hybrid, Green Published			2022-12-27	WOS:000300791800076
J	Nelson, C; Glitsch, MD				Nelson, Charmaine; Glitsch, Maike D.			Lack of Kinase Regulation of Canonical Transient Receptor Potential 3 (TRPC3) Channel-dependent Currents in Cerebellar Purkinje Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM DEPRESSION; METABOTROPIC GLUTAMATE-RECEPTOR; PHOSPHOLIPASE-C; PHOSPHORYLATION; DIACYLGLYCEROL; TRAFFICKING; ACTIVATION; INHIBITION; EXPRESSION; INDUCTION	Canonical transient receptor potential (TRPC) channels are widely expressed in the brain and play several roles in development and normal neuronal function. In the cerebellum, Purkinje cell TRPC3 channels underlie the slow excitatory postsynaptic potential observed after parallel fiber stimulation. In these cells TRPC3 channel opening requires stimulation of metabotropic glutamate receptor 1, activation of which can also lead to the induction of long term depression (LTD), which underlies cerebellar motor learning. LTD induction requires protein kinase C (PKC) and protein kinase G (PKG) activation, and although PKC phosphorylation targets are well established, virtually nothing is known about PKG targets in LTD. Because TRPC3 channels are inhibited after phosphorylation by PKC and PKG in expression systems, we examined whether native TRPC3 channels in Purkinje cells are a target for PKG or PKC, thereby contributing to cerebellar LTD. We find that in Purkinje cells, activation of TRPC3-dependent currents is not inhibited by conventional PKC or PKG to any significant extent and that inhibition of these kinases does not significantly impact on TRPC3-mediated currents either. Based on these and previous findings, we propose that TRPC3-dependent currents may differ significantly in their regulation from those overexpressed in expression systems.	[Nelson, Charmaine; Glitsch, Maike D.] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3PT, England	University of Oxford	Glitsch, MD (corresponding author), Univ Oxford, DPAG, Sherrington Bldg,Parks Rd, Oxford OX1 3OT, England.	maike.glitsch@dpag.ox.ac.uk		Glitsch, Maike/0000-0003-0723-3117				Albert AP, 2006, J PHYSIOL-LONDON, V571, P361, DOI 10.1113/jphysiol.2005.102780; Albert AP, 2005, J PHYSIOL-LONDON, V566, P769, DOI 10.1113/jphysiol.2005.090852; Amaral MD, 2007, PHARMACOL THERAPEUT, V113, P394, DOI 10.1016/j.pharmthera.2006.09.005; Ambudkar I.S., 2004, NOVART FDN SYMP, V258; Ambudkar I.S., 2004, NOVART FDN SYMP, V258, P98; Ambudkar I.S., 2004, NOVART FDN SYMP, V258; Ambudkar Indu S, 2004, Novartis Found Symp, V258, P63; Becker EBE, 2009, P NATL ACAD SCI USA, V106, P6706, DOI 10.1073/pnas.0810599106; Belmeguenai A, 2005, J NEUROSCI, V25, P10768, DOI 10.1523/JNEUROSCI.2876-05.2005; Boehm J, 2005, BIOCHEM SOC T, V33, P1354, DOI 10.1042/BST0331354; Bollimuntha S, 2011, ADV EXP MED BIOL, V704, P573, DOI 10.1007/978-94-007-0265-3_31; Canepari M, 2006, J PHYSIOL-LONDON, V573, P65, DOI 10.1113/jphysiol.2005.103770; Chung HJ, 2003, SCIENCE, V300, P1751, DOI 10.1126/science.1082915; Conner MT, 2010, BIOCHEMISTRY-US, V49, P821, DOI 10.1021/bi902068b; Eto M, 2002, NEURON, V36, P1145, DOI 10.1016/S0896-6273(02)01107-8; Glitsch MD, 2010, FASEB J, V24, P318, DOI 10.1096/fj.09-134973; Hartmann J, 2009, ACTA PHYSIOL, V195, P79, DOI 10.1111/j.1748-1716.2008.01923.x; Hartmann J, 2008, NEURON, V59, P392, DOI 10.1016/j.neuron.2008.06.009; Harvey VL, 2004, EUR J NEUROSCI, V20, P684, DOI 10.1111/j.1460-9568.2004.03505.x; Hirono M, 2001, J BIOL CHEM, V276, P45236, DOI 10.1074/jbc.M105413200; Hirono M, 1998, BIOCHEM BIOPH RES CO, V251, P753, DOI 10.1006/bbrc.1998.9465; Huang WC, 2007, CELL CALCIUM, V42, P1, DOI 10.1016/j.ceca.2006.11.002; Hurst RS, 1998, FEBS LETT, V422, P333, DOI 10.1016/S0014-5793(98)00035-0; Jorntell H, 2006, NEURON, V52, P227, DOI 10.1016/j.neuron.2006.09.032; Kamouchi M, 1999, J PHYSIOL-LONDON, V518, P345, DOI 10.1111/j.1469-7793.1999.0345p.x; Kano M, 2008, PHILOS T R SOC B, V363, P2173, DOI 10.1098/rstb.2008.2270; Kiselyov K, 2010, VITAM HORM, V83, P197, DOI 10.1016/S0083-6729(10)83008-0; Kiyonaka S, 2009, P NATL ACAD SCI USA, V106, P5400, DOI 10.1073/pnas.0808793106; Kondo T, 2005, EUR J NEUROSCI, V22, P1817, DOI 10.1111/j.1460-9568.2005.04319.x; Kwan HY, 2009, EUR J PHARMACOL, V602, P181, DOI 10.1016/j.ejphar.2008.10.054; Kwan HY, 2006, J CELL PHYSIOL, V207, P315, DOI 10.1002/jcp.20567; Kwan HY, 2004, P NATL ACAD SCI USA, V101, P2625, DOI 10.1073/pnas.0304471101; Li Y, 2005, NATURE, V434, P894, DOI 10.1038/nature03477; Lu W., 2011, CURR OPIN NEUROBIOL, V22, P1; Pani B, 2009, CELL CALCIUM, V45, P625, DOI 10.1016/j.ceca.2009.02.009; Remillard CV, 2006, MOL PHARMACOL, V70, P1151, DOI 10.1124/mol.106.029280; Sanz-Clemente A, 2010, NEURON, V67, P984, DOI 10.1016/j.neuron.2010.08.011; Schonewille M, 2010, NEURON, V67, P618, DOI 10.1016/j.neuron.2010.07.009; Selvaraj S, 2010, CNS NEUROL DISORD-DR, V9, P94, DOI 10.2174/187152710790966650; Song MY, 2010, ADV EXP MED BIOL, V661, P99, DOI 10.1007/978-1-60761-500-2_6; Tai YL, 2009, PFLUG ARCH EUR J PHY, V458, P283, DOI 10.1007/s00424-008-0618-y; Trebak M., 2007, V179, P593; Trebak M, 2005, MOL PHARMACOL, V67, P558, DOI 10.1124/mol.104.007252; Vazquez G, 2010, CHANNELS, V4, P232, DOI 10.4161/chan.4.3.12058; Venkatachalam K, 2003, J BIOL CHEM, V278, P29031, DOI 10.1074/jbc.M302751200; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Winklhofer A, 2003, NEUROPHARMACOLOGY, V44, P829, DOI 10.1016/S0028-3908(03)00070-4; Xia J, 2000, NEURON, V28, P499, DOI 10.1016/S0896-6273(00)00128-8; Yang JW, 2007, P NATL ACAD SCI USA, V104, P20055, DOI 10.1073/pnas.0708574104; Yoo D, 2005, J BIOL CHEM, V280, P35281, DOI 10.1074/jbc.M504836200; Zitt C, 1997, J CELL BIOL, V138, P1333, DOI 10.1083/jcb.138.6.1333	51	18	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6326	6335		10.1074/jbc.M111.246553	http://dx.doi.org/10.1074/jbc.M111.246553			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22207762	Green Published, hybrid			2022-12-27	WOS:000300791800025
J	Gao, XC; Zhou, CJ; Zhou, ZR; Wu, M; Cao, CY; Hu, HY				Gao, Xue-Chao; Zhou, Chen-Jie; Zhou, Zi-Ren; Wu, Meng; Cao, Chun-Yang; Hu, Hong-Yu			The C-terminal Helices of Heat Shock Protein 70 Are Essential for J-domain Binding and ATPase Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR CHAPERONE DNAK; SUBSTRATE-BINDING; HSP70 CHAPERONES; ALPHA-SYNUCLEIN; NMR STRUCTURE; RICH REGION; PROTEIN; HSP40; COCHAPERONE; DYNAMICS	The J-domain co-chaperones work together with the heat shock protein 70 (HSP70) chaperone to regulate many cellular events, but the mechanism underlying the J-domain-mediated HSP70 function remains elusive. We studied the interaction between human-inducible HSP70 and Homo sapiens J-domain protein (HSJ1a), a J domain and UIM motif-containing co-chaperone. The J domain of HSJ1a shares a conserved structure with other J domains from both eukaryotic and prokaryotic species, and it mediates the interaction with and the ATPase cycle of HSP70. Our in vitro study corroborates that the N terminus of HSP70 including the ATPase domain and the substrate-binding beta-subdomain is not sufficient to bind with the J domain of HSJ1a. The C-terminal helical alpha-subdomain of HSP70, which was considered to function as a lid of the substrate-binding domain, is crucial for binding with the J domain of HSJ1a and stimulating the ATPase activity of HSP70. These fluctuating helices are likely to contribute to a proper conformation of HSP70 for J-domain binding other than directly bind with the J domain. Our findings provide an alternative mechanism of allosteric activation for functional regulation of HSP70 by its J-domain co-chaperones.	[Gao, Xue-Chao; Zhou, Chen-Jie; Zhou, Zi-Ren; Wu, Meng; Hu, Hong-Yu] Chinese Acad Sci, State Key Lab Mol Biol, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; [Cao, Chun-Yang] Chinese Acad Sci, State Key Lab Bioorgan & Nat Prod Chem, Shanghai Inst Organ Chem, Shanghai 200032, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institute of Organic Chemistry, CAS	Hu, HY (corresponding author), Chinese Acad Sci, State Key Lab Mol Biol, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China.	hyhu@sibs.ac.cn	Chou, Steven Ziren/M-1995-2014		National Basic Research Program of China [2011CB911104]; Sino Swiss Science, and Technology Cooperation Program [GJHZ0909]; National Natural Science Foundation of China [10979070]	National Basic Research Program of China(National Basic Research Program of China); Sino Swiss Science, and Technology Cooperation Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Basic Research Program of China (2011CB911104), the Sino Swiss Science, and Technology Cooperation Program (GJHZ0909), and the National Natural Science Foundation of China (10979070).	Bertelsen EB, 1999, PROTEIN SCI, V8, P343; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Cajo GC, 2006, J BIOL CHEM, V281, P12436, DOI 10.1074/jbc.M511192200; Chang YG, 2008, J BIOL CHEM, V283, P13370, DOI 10.1074/jbc.M800162200; CHEETHAM ME, 1992, BIOCHEM J, V284, P469, DOI 10.1042/bj2840469; CHEETHAM ME, 1994, EUR J BIOCHEM, V226, P99, DOI 10.1111/j.1432-1033.1994.tb20030.x; Cowburn David, 2004, Methods Mol Biol, V278, P47; David R, 2004, EUR J BIOCHEM, V271, P663, DOI 10.1111/j.1432-1033.2004.03978.x; Fan CY, 2003, CELL STRESS CHAPERON, V8, P309, DOI 10.1379/1466-1268(2003)008<0309:MFROHF>2.0.CO;2; Fu QS, 2009, PROTEIN PEPTIDE LETT, V16, P1442, DOI 10.2174/092986609789839386; Gao XC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019763; Gao YG, 2006, STRUCTURE, V14, P1755, DOI 10.1016/j.str.2006.09.014; Gassler CS, 1998, P NATL ACAD SCI USA, V95, P15229, DOI 10.1073/pnas.95.26.15229; Greene MK, 1998, P NATL ACAD SCI USA, V95, P6108, DOI 10.1073/pnas.95.11.6108; Huang CJ, 2006, J MOL BIOL, V364, P323, DOI 10.1016/j.jmb.2006.08.062; Jiang JW, 2007, MOL CELL, V28, P422, DOI 10.1016/j.molcel.2007.08.022; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Li HT, 2002, BIOPOLYMERS, V64, P221, DOI 10.1002/bip.10179; Liebscher M, 2009, J BACTERIOL, V191, P1456, DOI 10.1128/JB.01131-08; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Murata S, 2003, INT J BIOCHEM CELL B, V35, P572, DOI 10.1016/S1357-2725(02)00394-1; Nicolai A, 2010, J CHEM THEORY COMPUT, V6, P2501, DOI 10.1021/ct1002169; Pellecchia M, 1996, J MOL BIOL, V260, P236, DOI 10.1006/jmbi.1996.0395; Perales-Calvo J, 2010, J BIOL CHEM, V285, P34231, DOI 10.1074/jbc.M110.144642; Qian YQ, 1996, J MOL BIOL, V260, P224, DOI 10.1006/jmbi.1996.0394; Qiu XB, 2006, CELL MOL LIFE SCI, V63, P2560, DOI 10.1007/s00018-006-6192-6; Quan A, 2005, METHOD ENZYMOL, V404, P556, DOI 10.1016/S0076-6879(05)04049-8; Rust E, 2001, ARCH BIOCHEM BIOPHYS, V392, P333, DOI 10.1006/abbi.2001.2466; SCHMID D, 1994, SCIENCE, V263, P971, DOI 10.1126/science.8310296; Slepenkov SV, 2003, BIOCHEMISTRY-US, V42, P5867, DOI 10.1021/bi034126v; Slepenkov SV, 2002, BIOCHEMISTRY-US, V41, P12224, DOI 10.1021/bi0263208; Smock RG, 2011, J BIOL CHEM, V286, P31821, DOI 10.1074/jbc.M111.265835; Suh WC, 1998, P NATL ACAD SCI USA, V95, P15223, DOI 10.1073/pnas.95.26.15223; SZYPERSKI T, 1994, P NATL ACAD SCI USA, V91, P11343, DOI 10.1073/pnas.91.24.11343; Tsai J, 1996, J BIOL CHEM, V271, P9347, DOI 10.1074/jbc.271.16.9347; Ungewickell E, 1997, J BIOL CHEM, V272, P19594, DOI 10.1074/jbc.272.31.19594; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606	38	21	22	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					6044	6052		10.1074/jbc.M111.294728	http://dx.doi.org/10.1074/jbc.M111.294728			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22219199	Green Published, hybrid			2022-12-27	WOS:000300638000077
J	Kashif, M; Hellwig, A; Hashemolhosseini, S; Kumar, V; Bock, F; Wang, HJ; Shahzad, K; Ranjan, S; Wolter, J; Madhusudhan, T; Bierhaus, A; Nawroth, P; Isermann, B				Kashif, Muhammed; Hellwig, Andrea; Hashemolhosseini, Said; Kumar, Varun; Bock, Fabian; Wang, Hongjie; Shahzad, Khurrum; Ranjan, Satish; Wolter, Juliane; Madhusudhan, Thati; Bierhaus, Angelika; Nawroth, Peter; Isermann, Berend			Nuclear Factor Erythroid-derived 2 (Nfe2) Regulates JunD DNA-binding Activity via Acetylation A NOVEL MECHANISM REGULATING TROPHOBLAST DIFFERENTIATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEACETYLASE ACTIVITY; PLACENTAL VASCULARIZATION; ERYTHROLEUKEMIA-CELLS; TRANSCRIPTION FACTORS; CROSS-TALK; KAPPA-B; C-JUN; PROTEIN; CREB; EXPRESSION	We recently demonstrated that the bZip transcription factor nuclear factor erythroid-derived 2 (Nfe2) represses protein acetylation and expression of the transcription factor glial cell missing 1 (Gcm1) in trophoblast cells, preventing excess syncytiotrophoblast formation and permitting normal placental vascularization and embryonic growth. However, the Gcm1 promoter lacks a Nfe2-binding site and hence the mechanisms linking Nfe2 and Gcm1 expression remained unknown. Here we show that Nfe2 represses JunD DNA-binding activity to the Gcm1 promoter during syncytiotrophoblast differentiation. Interventional studies using knockdown and knockin approaches show that enhanced JunD DNA-binding activity is required for increased expression of Gcm1 and syncytiotrophoblast formation as well as impaired placental vascularization and reduced growth of Nfe2(-/-) embryos. Induction of Gcm1 expression requires binding of JunD to the -1441 site within the Gcm1 promoter, which is distinct from the -1314 site previously shown to induce Gcm1 expression by other bZip transcription factors. Nfe2 modulates JunD binding to the Gcm1 promoter via acetylation, as reducing JunD acetylation using the histone acetyltransferase inhibitor curcumin reverses the increased JunD DNA-binding activity observed in the absence of Nfe2. This identifies a novel mechanism through which bZip transcription factors interact. Within the placenta this interaction regulates Gcm1 expression, syncytiotrophoblast formation, placental vascularization, and embryonic growth.	[Wang, Hongjie; Shahzad, Khurrum; Ranjan, Satish; Wolter, Juliane; Madhusudhan, Thati; Isermann, Berend] Otto von Guericke Univ, D-39120 Magdeburg, Germany; [Bierhaus, Angelika; Nawroth, Peter] Univ Heidelberg, Dept Internal Med & Clin Chem, D-69120 Heidelberg, Germany; [Hellwig, Andrea] Univ Heidelberg, Dept Neurobiol, Interdisciplinary Ctr Neurosci IZN, D-69120 Heidelberg, Germany; [Hashemolhosseini, Said] Univ Erlangen Nurnberg, Inst Biochem, Emil Fischer Ctr, D-91054 Erlangen, Germany; [Wang, Hongjie] Huazhong Univ Sci Technol, Dept Cardiol, Tongji Hosp, Tongji Med Coll, Wuhan 430030, Peoples R China	Otto von Guericke University; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Erlangen Nuremberg; Huazhong University of Science & Technology	Isermann, B (corresponding author), Otto von Guericke Univ, Leipziger Str 44, D-39120 Magdeburg, Germany.	ikcp@med.ovgu.de; berend.isermann@med.ovgu.de	Bock, Fabian/K-3366-2019; Hashemolhosseini, Said/N-2464-2013	Hashemolhosseini, Said/0000-0002-6564-5649; Ranjan, Dr. Satish/0000-0003-0200-5385	Deutsche Forschungsgemeinschaft [IS 67/4-1, IS 67/4-2]; German Israeli Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Israeli Foundation(German-Israeli Foundation for Scientific Research and Development)	This work was supported by Deutsche Forschungsgemeinschaft Grants IS 67/4-1 and IS 67/4-2 (to B. I.) and a grant of the German Israeli Foundation (to B. I. and P. P. N.).	Aguilera C, 2011, NATURE, V469, P231, DOI 10.1038/nature09607; Anson-Cartwright L, 2000, NAT GENET, V25, P311, DOI 10.1038/77076; Balasubramanyam K, 2004, J BIOL CHEM, V279, P51163, DOI 10.1074/jbc.M409024200; Bamberger AM, 2004, MOL HUM REPROD, V10, P223, DOI 10.1093/molehr/gah011; Bierhaus A, 2001, DIABETES, V50, P2792, DOI 10.2337/diabetes.50.12.2792; Chen Z, 2007, BLOOD, V109, P1451, DOI 10.1182/blood-2006-08-038901; Cheng XB, 1997, MOL CELL BIOL, V17, P1407, DOI 10.1128/MCB.17.3.1407; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Dhanasekaran N, 1998, ONCOGENE, V17, P1447, DOI 10.1038/sj.onc.1202251; Follenzi A, 2000, ONCOGENE, V19, P3041, DOI 10.1038/sj.onc.1203620; Francastel C, 1997, ONCOGENE, V14, P873, DOI 10.1038/sj.onc.1200902; Giunta B, 2006, BRAIN RES, V1123, P216, DOI 10.1016/j.brainres.2006.09.057; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Hashemolhosseini S, 2004, J MOL BIOL, V336, P441, DOI 10.1016/j.jmb.2003.12.029; Himeno Emi, 2008, Curr Protoc Stem Cell Biol, VChapter 1, DOI 10.1002/9780470151808.sc01e04s7; Hung HL, 2001, J BIOL CHEM, V276, P10715, DOI 10.1074/jbc.M007846200; Isermann B, 2003, NAT MED, V9, P331, DOI 10.1038/nm825; Johnson KD, 2002, NUCLEIC ACIDS RES, V30, P1522, DOI 10.1093/nar/30.7.1522; Johnson KD, 2002, P NATL ACAD SCI USA, V99, P11760, DOI 10.1073/pnas.192285999; Kallunki T, 1996, CELL, V87, P929, DOI 10.1016/S0092-8674(00)81999-6; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; Kashif M, 2011, DEVELOPMENT, V138, P2235, DOI 10.1242/dev.059105; Lee TL, 2010, P NATL ACAD SCI USA, V107, P52, DOI 10.1073/pnas.0909153107; Maltepe E, 2005, DEVELOPMENT, V132, P3393, DOI 10.1242/dev.01923; McIntire DD, 1999, NEW ENGL J MED, V340, P1234, DOI 10.1056/NEJM199904223401603; Nandiwada SL, 2006, J IMMUNOL, V177, P401, DOI 10.4049/jimmunol.177.1.401; Nervi C, 2001, CANCER RES, V61, P1247; Okada Y, 2007, NAT BIOTECHNOL, V25, P233, DOI 10.1038/nbt1280; Pan Y, 2008, MOL CELLS, V25, P531; Reddy SPM, 2002, AM J PHYSIOL-LUNG C, V283, pL1161, DOI 10.1152/ajplung.00140.2002; Rudofsky G, 2007, HORM METAB RES, V39, P665, DOI 10.1055/s-2007-985395; Schorpp-Kistner M, 1999, EMBO J, V18, P934, DOI 10.1093/emboj/18.4.934; Schreiber M, 2000, DEVELOPMENT, V127, P4937; Schubert SW, 2008, NUCLEIC ACIDS RES, V36, P3834, DOI 10.1093/nar/gkn306; Tachibana H, 2004, BIOFACTORS, V21, P383, DOI 10.1002/biof.552210174; Tachibana H, 2004, NAT STRUCT MOL BIOL, V11, P380, DOI 10.1038/nsmb743; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Thepot D, 2000, DEVELOPMENT, V127, P143	39	13	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5400	5411		10.1074/jbc.M111.289801	http://dx.doi.org/10.1074/jbc.M111.289801			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22174410	Green Published, hybrid			2022-12-27	WOS:000300638000021
J	Pauwels, K; Williams, TL; Morris, KL; Jonckheere, W; Vandersteen, A; Kelly, G; Schymkowitz, J; Rousseau, F; Pastore, A; Serpell, LC; Broersen, K				Pauwels, Kris; Williams, Thomas L.; Morris, Kyle L.; Jonckheere, Wim; Vandersteen, Annelies; Kelly, Geoff; Schymkowitz, Joost; Rousseau, Frederic; Pastore, Annalisa; Serpell, Louise C.; Broersen, Kerensa			Structural Basis for Increased Toxicity of Pathological A beta(42):A beta(40) Ratios in Alzheimer Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID-BETA-PROTEIN; X-RAY-DIFFRACTION; SYNAPTIC PLASTICITY; SOLVENT PROTECTION; IN-VIVO; FIBRILS; AGGREGATION; A-BETA-40; PEPTIDES; NMR	The beta-amyloid peptide (A beta) is directly related to neurotoxicity in Alzheimer disease (AD). The two most abundant alloforms of the peptide co-exist under normal physiological conditions in the brain in an A beta(42):A beta(40) ratio of similar to 1:9. This ratio is often shifted to a higher percentage of A beta(42) in brains of patients with familial AD and this has recently been shown to lead to increased synaptotoxicity. The molecular basis for this phenomenon is unclear. Although the aggregation characteristics of A beta(40) and A beta(42) individually are well established, little is known about the properties of mixtures. We have explored the biophysical and structural properties of physiologically relevant A beta(42): A beta(40) ratios by several techniques. We show that A beta(40) and A beta(42) directly interact as well as modify the behavior of the other. The structures of monomeric and fibrillar assemblies formed from A beta(40) and A beta(42) mixtures do not differ from those formed from either of these peptides alone. Instead, the co-assembly of A beta(40) and A beta(42) influences the aggregation kinetics by altering the pattern of oligomer formation as evidenced by a unique combination of solution nuclear magnetic resonance spectroscopy, high molecular weight mass spectrometry, and cross-seeding experiments. We relate these observations to the observed enhanced toxicity of relevant ratios of A beta(42):A beta(40) in synaptotoxicity assays and in AD patients.	[Pauwels, Kris; Kelly, Geoff; Pastore, Annalisa] Natl Inst Med Res, Med Res Council, Div Mol Struct, London NW7 1AA, England; [Williams, Thomas L.; Morris, Kyle L.; Serpell, Louise C.] Univ Sussex, Sch Life Sci, Falmer BN1 9QJ, E Sussex, England; [Jonckheere, Wim; Vandersteen, Annelies; Schymkowitz, Joost; Rousseau, Frederic; Broersen, Kerensa] VIB, SWITCH Lab, B-1050 Brussels, Belgium; [Jonckheere, Wim; Vandersteen, Annelies; Schymkowitz, Joost; Rousseau, Frederic; Broersen, Kerensa] Vrije Univ Brussel, B-1050 Brussels, Belgium	MRC National Institute for Medical Research; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Sussex; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel	Broersen, K (corresponding author), Univ Twente, MIRA Inst Biomed Technol & Tech Med, Fac Sci & Technol, POB 217, NL-7500 AE Enschede, Netherlands.	k.broersen@utwente.nl	Schymkowitz, Joost/AAV-3680-2021; Rousseau, Frederic/J-9044-2016; Williams, Thomas L./M-1260-2013; Schymkowitz, Joost/K-7764-2016	Rousseau, Frederic/0000-0002-9189-7399; Williams, Thomas L./0000-0003-1710-3914; Pauwels, Kris/0000-0002-7341-0890; Serpell, Louise/0000-0001-9335-7751; Morris, Kyle L/0000-0002-1717-8134; Schymkowitz, Joost/0000-0003-2020-0168	Fund for Scientific Research Flanders; Federal Office for Scientific Affairs, Belgium IUAP [P6/43]; Alzheimer's Research UK; Research Foundation-Flanders (FWO); Stichting Alzheimer Onderzoek (SAO); European Molecular Biology Organization [ALTF 512-2008]; agency for Innovation by Science and Technology; Medical Research Council [MC_U117584256, MC_U117533887] Funding Source: researchfish; BBSRC [BB/E009042/1] Funding Source: UKRI; MRC [MC_U117533887, MC_U117584256] Funding Source: UKRI	Fund for Scientific Research Flanders(FWO); Federal Office for Scientific Affairs, Belgium IUAP; Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); Research Foundation-Flanders (FWO)(FWO); Stichting Alzheimer Onderzoek (SAO); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); agency for Innovation by Science and Technology; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by the Fund for Scientific Research Flanders, the Federal Office for Scientific Affairs, Belgium IUAP P6/43, Alzheimer's Research UK, the Research Foundation-Flanders (FWO), Stichting Alzheimer Onderzoek (SAO), and the FWO Odysseus Program.; Recipient of a European Molecular Biology Organization long term postdoctoral fellowship (ALTF 512-2008).; Supported by an agency for Innovation by Science and Technology doctoral fellowship.	Bitan G, 2003, J BIOL CHEM, V278, P34882, DOI 10.1074/jbc.M300825200; Broersen K, 2011, PROTEIN ENG DES SEL, V24, P743, DOI 10.1093/protein/gzr020; Chen YR, 2006, J BIOL CHEM, V281, P24414, DOI 10.1074/jbc.M602363200; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; EANES ED, 1968, J HISTOCHEM CYTOCHEM, V16, P673, DOI 10.1177/16.11.673; Frost D, 2003, EUR J BIOCHEM, V270, P654, DOI 10.1046/j.1432-1033.2003.03415.x; Hellstrom-Lindahl E, 2009, NEUROCHEM INT, V55, P243, DOI 10.1016/j.neuint.2009.03.007; Hou LM, 2004, J AM CHEM SOC, V126, P1992, DOI 10.1021/ja036813f; IKURA M, 1992, J AM CHEM SOC, V114, P2433, DOI 10.1021/ja00033a019; Jan A, 2008, J BIOL CHEM, V283, P28176, DOI 10.1074/jbc.M803159200; Jan A, 2011, J BIOL CHEM, V286, P8585, DOI 10.1074/jbc.M110.172411; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Kim J, 2007, J NEUROSCI, V27, P627, DOI 10.1523/JNEUROSCI.4849-06.2007; KIRSCHNER DA, 1986, P NATL ACAD SCI USA, V83, P503, DOI 10.1073/pnas.83.2.503; Klyubin I, 2008, J NEUROSCI, V28, P4231, DOI 10.1523/JNEUROSCI.5161-07.2008; Kuperstein I, 2010, EMBO J, V29, P3408, DOI 10.1038/emboj.2010.211; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Makin OS, 2007, J APPL CRYSTALLOGR, V40, P966, DOI 10.1107/S0021889807034681; Makin OS, 2005, FEBS J, V272, P5950, DOI 10.1111/j.1742-4658.2005.05025.x; Malinchik SB, 1998, BIOPHYS J, V74, P537, DOI 10.1016/S0006-3495(98)77812-9; Mann DMA, 1996, ANN NEUROL, V40, P149, DOI 10.1002/ana.410400205; Marshall KE, 2011, BIOCHEMISTRY-US, V50, P2061, DOI 10.1021/bi101936c; Myszka DG, 1999, METHOD ENZYMOL, V309, P386; Olofsson A, 2006, J BIOL CHEM, V281, P477, DOI 10.1074/jbc.M508962200; Olofsson A, 2007, BIOCHEM J, V404, P63, DOI 10.1042/BJ20061561; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Ryu J, 2008, ANAL CHEM, V80, P2400, DOI 10.1021/ac7019514; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Schmidt M, 2009, P NATL ACAD SCI USA, V106, P19813, DOI 10.1073/pnas.0905007106; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Sikorski P, 2003, STRUCTURE, V11, P915, DOI 10.1016/S0969-2126(03)00149-7; SNYDER SW, 1994, BIOPHYS J, V67, P1216, DOI 10.1016/S0006-3495(94)80591-0; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; Wang RS, 2006, J BIOL CHEM, V281, P15330, DOI 10.1074/jbc.M512574200; Wetzel R, 2007, BIOCHEMISTRY-US, V46, P1, DOI 10.1021/bi0620959; Whittemore NA, 2005, BIOCHEMISTRY-US, V44, P4434, DOI 10.1021/bi048292u; Wogulis M, 2005, J NEUROSCI, V25, P1071, DOI 10.1523/JNEUROSCI.2381-04.2005; Yan YL, 2007, J MOL BIOL, V369, P909, DOI 10.1016/j.jmb.2007.04.014; Yoshiike Y, 2003, J BIOL CHEM, V278, P23648, DOI 10.1074/jbc.M212785200	43	174	177	0	63	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5650	5660		10.1074/jbc.M111.264473	http://dx.doi.org/10.1074/jbc.M111.264473			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22157754	hybrid, Green Published			2022-12-27	WOS:000300638000042
J	Xu, XP; Sarbeng, EB; Vorvis, C; Kumar, DP; Zhou, L; Liu, QL				Xu, Xinping; Sarbeng, Evans Boateng; Vorvis, Christina; Kumar, Divya Prasanna; Zhou, Lei; Liu, Qinglian			Unique Peptide Substrate Binding Properties of 110-kDa Heat-shock Protein (Hsp110) Determine Its Distinct Chaperone Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTORS; MOLECULAR CHAPERONE; YEAST HSP110; HSP70 CHAPERONES; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; STRUCTURAL BASIS; DNAK CHAPERONE; ATPASE DOMAIN; SPECIFICITY	The molecular chaperone 70-kDa heat-shock proteins (Hsp70s) play essential roles in maintaining protein homeostasis. Hsp110, an Hsp70 homolog, is highly efficient in preventing protein aggregation but lacks the hallmark folding activity seen in Hsp70s. To understand the mechanistic differences between these two chaperones, we first characterized the distinct peptide substrate binding properties of Hsp110s. In contrast to Hsp70s, Hsp110s prefer aromatic residues in their substrates, and the substrate binding and release exhibit remarkably fast kinetics. Sequence and structure comparison revealed significant differences in the two peptide-binding loops: the length and properties are switched. When we swapped these two loops in an Hsp70, the peptide binding properties of this mutant Hsp70 were converted to Hsp110-like, and more impressively, it functionally behaved like an Hsp110. Thus, the peptide substrate binding properties implemented in the peptide-binding loops may determine the chaperone activity differences between Hsp70s and Hsp110s.	[Xu, Xinping; Sarbeng, Evans Boateng; Vorvis, Christina; Kumar, Divya Prasanna; Zhou, Lei; Liu, Qinglian] Virginia Commonwealth Univ, Dept Physiol & Biophys, Sch Med, Richmond, VA 23298 USA	Virginia Commonwealth University	Liu, QL (corresponding author), Virginia Commonwealth Univ, Dept Physiol & Biophys, Sch Med, Med Coll Virginia Campus, Richmond, VA 23298 USA.	qliu3@vcu.edu	Xu, Xinping/AAA-1304-2020; Prasanna Kumar, Divya/P-2759-2019	Prasanna Kumar, Divya/0000-0001-5935-379X; XU, XINPING/0000-0002-9568-4171	Virginia Commonwealth University School of Medicine; Ellison Medical Foundation; American Heart Association	Virginia Commonwealth University School of Medicine; Ellison Medical Foundation(Lawrence Ellison Foundation); American Heart Association(American Heart Association)	This work was supported by startup funds from the Virginia Commonwealth University School of Medicine (to Q. L.), a New Scholar Award in Aging from the Ellison Medical Foundation (to Q. L.) and a grant-in-aid award from the American Heart Association (to Q. L.).	Albanese V, 2006, CELL, V124, P75, DOI 10.1016/j.cell.2005.11.039; Andreasson C, 2008, P NATL ACAD SCI USA, V105, P16519, DOI 10.1073/pnas.0804187105; Andreasson C, 2008, J BIOL CHEM, V283, P8877, DOI 10.1074/jbc.M710063200; BLONDELGUINDI S, 1993, CELL, V75, P717, DOI 10.1016/0092-8674(93)90492-9; Bogatyreva Natalya S., 2006, Journal of Bioinformatics and Computational Biology, V4, P597, DOI 10.1142/S0219720006002016; Buczynski G, 2001, J BIOL CHEM, V276, P27231, DOI 10.1074/jbc.M100237200; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Burkholder WF, 1996, P NATL ACAD SCI USA, V93, P10632, DOI 10.1073/pnas.93.20.10632; Dragovic Z, 2006, EMBO J, V25, P2519, DOI 10.1038/sj.emboj.7601138; Easton DP, 2000, CELL STRESS CHAPERON, V5, P276, DOI 10.1379/1466-1268(2000)005<0276:THAGSP>2.0.CO;2; Evans CG, 2010, J MED CHEM, V53, P4585, DOI 10.1021/jm100054f; Fan Q, 2007, GENETICS, V177, P1583, DOI 10.1534/genetics.107.077982; Fernandez-Saiz V, 2006, J BIOL CHEM, V281, P7479, DOI 10.1074/jbc.M512744200; FLAHERTY KM, 1990, NATURE, V346, P623, DOI 10.1038/346623a0; FLYNN GC, 1989, SCIENCE, V245, P385, DOI 10.1126/science.2756425; Goeckeler JL, 2008, FEBS LETT, V582, P2393, DOI 10.1016/j.febslet.2008.05.047; Goeckeler JL, 2002, MOL BIOL CELL, V13, P2760, DOI 10.1091/mbc.02-04-0051; GRAGEROV A, 1994, J MOL BIOL, V235, P848, DOI 10.1006/jmbi.1994.1043; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hatayama T, 1998, BIOCHEM BIOPH RES CO, V248, P395, DOI 10.1006/bbrc.1998.8979; Hrizo SL, 2007, J BIOL CHEM, V282, P32665, DOI 10.1074/jbc.M705216200; Jiang JW, 2007, MOL CELL, V28, P422, DOI 10.1016/j.molcel.2007.08.022; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kaul SC, 2005, J BIOL CHEM, V280, P39373, DOI 10.1074/jbc.M500022200; Kryndushkin D, 2007, MOL BIOL CELL, V18, P2149, DOI 10.1091/mbc.E07-02-0128; Liu QL, 2007, CELL, V131, P106, DOI 10.1016/j.cell.2007.08.039; Liu QL, 2001, J BIOL CHEM, V276, P6112, DOI 10.1074/jbc.M009519200; Liu XD, 1999, J BIOL CHEM, V274, P26654, DOI 10.1074/jbc.274.38.26654; Mandal AK, 2010, MOL BIOL CELL, V21, P1439, DOI 10.1091/mbc.E09-09-0779; Manjili MH, 2002, CANCER RES, V62, P1737; Marcinowski M, 2011, NAT STRUCT MOL BIOL, V18, P150, DOI 10.1038/nsmb.1970; Mayer MP, 2010, MOL CELL, V39, P321, DOI 10.1016/j.molcel.2010.07.012; Mayer MP, 2000, NAT STRUCT BIOL, V7, P586; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Montgomery DL, 1999, J MOL BIOL, V286, P915, DOI 10.1006/jmbi.1998.2514; Moro F, 2004, J BIOL CHEM, V279, P19600, DOI 10.1074/jbc.M400921200; MUKAI H, 1993, GENE, V132, P57; Oh HJ, 1999, J BIOL CHEM, V274, P15712, DOI 10.1074/jbc.274.22.15712; Oh HJ, 1997, J BIOL CHEM, V272, P31636, DOI 10.1074/jbc.272.50.31636; Parkhurst MR, 1998, CANCER RES, V58, P4895; Pfund C, 2001, MOL BIOL CELL, V12, P3773, DOI 10.1091/mbc.12.12.3773; Polier S, 2008, CELL, V133, P1068, DOI 10.1016/j.cell.2008.05.022; Polier S, 2010, J MOL BIOL, V401, P696, DOI 10.1016/j.jmb.2010.07.004; Raviol H, 2006, FEBS LETT, V580, P168, DOI 10.1016/j.febslet.2005.11.069; Raviol H, 2006, EMBO J, V25, P2510, DOI 10.1038/sj.emboj.7601139; Rudiger S, 2000, J MOL BIOL, V304, P245, DOI 10.1006/jmbi.2000.4193; Rudiger S, 1997, EMBO J, V16, P1501, DOI 10.1093/emboj/16.7.1501; Sadlish H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001763; Schlecht R, 2011, NAT STRUCT MOL BIOL, V18, P345, DOI 10.1038/nsmb.2006; SCHMID D, 1992, EUR J BIOCHEM, V208, P699, DOI 10.1111/j.1432-1033.1992.tb17237.x; SCHMID D, 1994, SCIENCE, V263, P971, DOI 10.1126/science.8310296; Schuermann JP, 2008, MOL CELL, V31, P232, DOI 10.1016/j.molcel.2008.05.006; Shaner L, 2004, J BIOL CHEM, V279, P21992, DOI 10.1074/jbc.M313739200; Shaner L, 2005, J BIOL CHEM, V280, P41262, DOI 10.1074/jbc.M503614200; Shaner L, 2007, CELL STRESS CHAPERON, V12, P1, DOI 10.1379/CSC-245R.1; Shi L, 1996, BIOCHEMISTRY-US, V35, P3297, DOI 10.1021/bi951984l; Sriram M, 1997, STRUCTURE, V5, P403, DOI 10.1016/S0969-2126(97)00197-4; WANG TF, 1993, J BIOL CHEM, V268, P26049; Wang XY, 2010, J IMMUNOL, V184, P6309, DOI 10.4049/jimmunol.0903891; Wang XY, 2000, FEBS LETT, V465, P98, DOI 10.1016/S0014-5793(99)01733-0; Wang XY, 2005, INT J HYPERTHER, V21, P717, DOI 10.1080/02656730500226407; Wang XY, 2001, J IMMUNOL, V166, P490, DOI 10.4049/jimmunol.166.1.490; Wegele H, 2003, J CHROMATOGR B, V786, P109, DOI 10.1016/S1570-0232(02)00724-9; Wisniewska M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008625; Yam AYW, 2005, J BIOL CHEM, V280, P41252, DOI 10.1074/jbc.M503615200; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606	68	64	64	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5661	5672		10.1074/jbc.M111.275057	http://dx.doi.org/10.1074/jbc.M111.275057			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22157767	Green Published, hybrid			2022-12-27	WOS:000300638000043
J	Banerjee, R; Smith, W				Banerjee, Ruma; Smith, William			Thematic Minireview Series on Redox Sensing and Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review									[Banerjee, Ruma; Smith, William] Univ Michigan, Med Ctr, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Banerjee, R (corresponding author), Univ Michigan, Med Ctr, Dept Biol Chem, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	rbanerje@umich.edu			National Institutes of Health [HL58984]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058984] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL58984.	Banerjee R, 2012, J BIOL CHEM, V287, P4397, DOI 10.1074/jbc.R111.287995; Finkel T, 2012, J BIOL CHEM, V287, P4434, DOI 10.1074/jbc.R111.271999; Herrmann JM, 2012, J BIOL CHEM, V287, P4426, DOI 10.1074/jbc.R111.270678; Hess DT, 2012, J BIOL CHEM, V287, P4411, DOI 10.1074/jbc.R111.285742; Marino SM, 2012, J BIOL CHEM, V287, P4419, DOI 10.1074/jbc.R111.275578; Moriarty-Craige SE, 2004, ANNU REV NUTR, V24, P481, DOI 10.1146/annurev.nutr.24.012003.132208; Rhee SG, 2012, J BIOL CHEM, V287, P4403, DOI 10.1074/jbc.R111.283432	7	3	3	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4395	4396		10.1074/jbc.R111.330761	http://dx.doi.org/10.1074/jbc.R111.330761			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22147699	Green Published, hybrid			2022-12-27	WOS:000300608500001
J	George, A; Panda, S; Kudmulwar, D; Chhatbar, SP; Nayak, SC; Krishnan, HH				George, Anju; Panda, Swarupa; Kudmulwar, Devika; Chhatbar, Salma Pathan; Nayak, Sanjeev Chavan; Krishnan, Harinivas Harshan			Hepatitis C Virus NS5A Binds to the mRNA Cap-binding Eukaryotic Translation Initiation 4F (eIF4F) Complex and Up-regulates Host Translation Initiation Machinery through eIF4E-binding Protein 1 Inactivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR 4E EIF4E; NONSTRUCTURAL PROTEIN; 4E-BINDING PROTEIN-1; DEPENDENT TRANSLATION; MOLECULAR-MECHANISMS; INCREASED EXPRESSION; VIRAL REPLICATION; CELL-SURVIVAL; PHOSPHORYLATION; ACTIVATION	Initiation, a major rate-limiting step of host protein translation, is a critical target in many viral infections. Chronic hepatitis C virus (HCV) infection results in hepatocellular carcinoma. Translation initiation, up-regulated in many cancers, plays a critical role in tumorigenesis. mTOR is a major regulator of host protein translation. Even though activation of PI3K-AKT-mTOR by HCV non-structural protein 5A (NS5A) is known, not much is understood about the regulation of host translation initiation by this virus. Here for the first time we show that HCV up-regulates host cap-dependent translation machinery in Huh7.5 cells through simultaneous activation of mTORC1 and eukaryotic translation initiation factor 4E (eIF4E) by NS5A. NS5A, interestingly, overexpressed and subsequently hyperphosphorylated 4EBP1. NS5A phosphorylated eIF4E through the p38 MAPK-MNK pathway. Both HCV infection and NS5A expression augmented eIF4F complex assembly, an indicator of cap-dependent translation efficiency. Global translation, however, was not altered by HCV NS5A. 4EBP1 phosphorylation, but not that of S6K1, was uniquely resistant to rapamycin in NS5A-Huh7.5 cells, indicative of an alternate phosphorylation mechanism of 4EBP1. Resistance of Ser-473, but not Thr-308, phosphorylation of AKT to PI3K inhibitors suggested an activation of mTORC2 by NS5A. NS5A associated with eIF4F complex and polysomes, suggesting its active involvement in host translation. This is the first report that implicates an HCV protein in the up-regulation of host translation initiation apparatus through concomitant regulation of multiple pathways. Because both mTORC1 activation and eIF4E phosphorylation are involved in tumorigenesis, we propose that their simultaneous activation by NS5A might contribute significantly to the development of hepatocellular carcinoma.	[George, Anju; Panda, Swarupa; Kudmulwar, Devika; Chhatbar, Salma Pathan; Nayak, Sanjeev Chavan; Krishnan, Harinivas Harshan] Ctr Cellular & Mol Biol, Council Sci & Ind Res, Hyderabad 500007, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Krishnan, HH (corresponding author), Ctr Cellular & Mol Biol, Council Sci & Ind Res, Hyderabad 500007, Andhra Pradesh, India.	hkrishnan@ccmb.res.in			Department of Biotechnology, Government of India [BT/PR11339/MED/29/103/2008]; Council of Scientific and Industrial Research, Government of India; Department of Biotechnology, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported by the Department of Biotechnology, Government of India (BT/PR11339/MED/29/103/2008 (to H. H. K.)) and the Council of Scientific and Industrial Research, Government of India.; Supported by a Department of Biotechnology Fellowship, Department of Biotechnology, Government of India.	Aoyagi M, 2010, P NATL ACAD SCI USA, V107, P2640, DOI 10.1073/pnas.0914856107; Arima N, 2001, J BIOL CHEM, V276, P12675, DOI 10.1074/jbc.M008329200; Armengol G, 2007, CANCER RES, V67, P7551, DOI 10.1158/0008-5472.CAN-07-0881; Avdulov S, 2004, CANCER CELL, V5, P553, DOI 10.1016/j.ccr.2004.05.024; Balakumaran BS, 2009, CANCER RES, V69, P7803, DOI 10.1158/0008-5472.CAN-09-0910; Bianchini A, 2008, CARCINOGENESIS, V29, P2279, DOI 10.1093/carcin/bgn221; Bradrick SS, 2006, NUCLEIC ACIDS RES, V34, P1293, DOI 10.1093/nar/gkl019; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Chuluunbaatar U, 2010, GENE DEV, V24, P2627, DOI 10.1101/gad.1978310; Clemens MJ, 1999, INT J BIOCHEM CELL B, V31, P1, DOI 10.1016/S1357-2725(98)00127-7; Cohen AM, 2004, LEUKEMIA LYMPHOMA, V45, P951, DOI 10.1080/10428190310001641251; Cuesta R, 2000, EMBO J, V19, P3465, DOI 10.1093/emboj/19.13.3465; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; Edgil D, 2006, J VIROL, V80, P2976, DOI 10.1128/JVI.80.6.2976-2986.2006; ETCHISON D, 1982, J BIOL CHEM, V257, P4806; Everly DN, 2002, J VIROL, V76, P8560, DOI 10.1128/JVI.76.17.8560-8571.2002; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Gimenez-Barcons M, 2005, J INTERF CYTOK RES, V25, P152, DOI 10.1089/jir.2005.25.152; Gingras AC, 1996, P NATL ACAD SCI USA, V93, P5578, DOI 10.1073/pnas.93.11.5578; Gong JP, 2009, J SURG RES, V153, P17, DOI 10.1016/j.jss.2008.03.033; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; HAGHIGHAT A, 1995, EMBO J, V14, P5701, DOI 10.1002/j.1460-2075.1995.tb00257.x; He YP, 2001, J VIROL, V75, P5090, DOI 10.1128/JVI.75.11.5090-5098.2001; Hershey J. W. B., 2000, TRANSLATIONAL REGULA, P87; Hirota M, 1999, VIROLOGY, V257, P130, DOI 10.1006/viro.1999.9658; Huang LY, 2005, J BIOL CHEM, V280, P36417, DOI 10.1074/jbc.M508175200; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; KANEKO T, 1994, BIOCHEM BIOPH RES CO, V205, P320, DOI 10.1006/bbrc.1994.2667; KEREKATTE V, 1995, INT J CANCER, V64, P27, DOI 10.1002/ijc.2910640107; Kevil CG, 1996, INT J CANCER, V65, P785, DOI 10.1002/(SICI)1097-0215(19960315)65:6<785::AID-IJC14>3.0.CO;2-3; Khaleghpour K, 1999, MOL CELL BIOL, V19, P4302; Li BDL, 1997, CANCER-AM CANCER SOC, V79, P2385; Lin CJ, 2009, CANCER RES, V69, P7491, DOI 10.1158/0008-5472.CAN-09-0813; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; LODISH HF, 1976, ANNU REV BIOCHEM, V45, P39, DOI 10.1146/annurev.bi.45.070176.000351; Macdonald A, 2004, J GEN VIROL, V85, P2485, DOI 10.1099/vir.0.80204-0; MADER S, 1995, MOL CELL BIOL, V15, P4990; Majumder M, 2002, VIROLOGY, V294, P94, DOI 10.1006/viro.2001.1309; Majumder M, 2001, J VIROL, V75, P1401, DOI 10.1128/JVI.75.3.1401-1407.2001; Mamane Y, 2006, ONCOGENE, V25, P6416, DOI 10.1038/sj.onc.1209888; MANILOFF J, 1995, ARCH VIROL, V140, P1515, DOI 10.1007/BF01322679; Mannova P, 2005, J VIROL, V79, P8742, DOI 10.1128/JVI.79.14.8742-8749.2005; Marzec M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024849; Moorman NJ, 2010, J VIROL, V84, P5260, DOI 10.1128/JVI.02733-09; MORLEY SJ, 1995, J CELL SCI, V108, P1751; MORLEY SJ, 1995, BIOCHEM J, V312, P627, DOI 10.1042/bj3120627; Nathan CAO, 1999, LARYNGOSCOPE, V109, P1253, DOI 10.1097/00005537-199908000-00013; Ohlmann T, 1996, EMBO J, V15, P1371, DOI 10.1002/j.1460-2075.1996.tb00479.x; Otto GA, 2004, CELL, V119, P369, DOI 10.1016/j.cell.2004.09.038; Pardo OE, 2002, J BIOL CHEM, V277, P12040, DOI 10.1074/jbc.M109006200; Peng L, 2010, J BIOL CHEM, V285, P20870, DOI 10.1074/jbc.M110.112045; Pestova TV, 2001, P NATL ACAD SCI USA, V98, P7029, DOI 10.1073/pnas.111145798; Preiss T, 2003, BIOESSAYS, V25, P1201, DOI 10.1002/bies.10362; Pyronnet S, 1999, EMBO J, V18, P270, DOI 10.1093/emboj/18.1.270; Raught B, 2000, EMBO J, V19, P434, DOI 10.1093/emboj/19.3.434; Roberts LO, 2009, PROG MOL BIOL TRANSL, V90, P313, DOI 10.1016/S1877-1173(09)90009-6; ROSENWALD IB, 1993, MOL CELL BIOL, V13, P7358, DOI 10.1128/MCB.13.12.7358; Rosenwald IB, 2001, CANCER-AM CANCER SOC, V92, P2164, DOI 10.1002/1097-0142(20011015)92:8<2164::AID-CNCR1559>3.0.CO;2-A; SAITO H, 1983, P NATL ACAD SCI-BIOL, V80, P7476, DOI 10.1073/pnas.80.24.7476; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Scheper GC, 2002, EUR J BIOCHEM, V269, P5350, DOI 10.1046/j.1432-1033.2002.03291.x; Scheper GC, 2002, J BIOL CHEM, V277, P3303, DOI 10.1074/jbc.M103607200; Schlaepfer DD, 1998, MOL CELL BIOL, V18, P2571, DOI 10.1128/MCB.18.5.2571; Seki N, 2002, CLIN CANCER RES, V8, P3046; Shveygert M, 2010, MOL CELL BIOL, V30, P5160, DOI 10.1128/MCB.00448-10; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Street A, 2004, J BIOL CHEM, V279, P12232, DOI 10.1074/jbc.M312245200; Tan SL, 2001, VIROLOGY, V284, P1, DOI 10.1006/viro.2001.0885; TANJI Y, 1995, J VIROL, V69, P3980, DOI 10.1128/JVI.69.7.3980-3986.1995; Vary TC, 2007, AM J PHYSIOL-ENDOC M, V293, pE188, DOI 10.1152/ajpendo.00037.2007; Walsh D, 2005, J VIROL, V79, P8057, DOI 10.1128/JVI.79.13.8057-8064.2005; Walsh D, 2004, GENE DEV, V18, P660, DOI 10.1101/gad.1185304; Wendel HG, 2007, GENE DEV, V21, P3232, DOI 10.1101/gad.1604407; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zindy P, 2011, CANCER RES, V71, P4068, DOI 10.1158/0008-5472.CAN-11-0420	76	37	36	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					5042	5058		10.1074/jbc.M111.308916	http://dx.doi.org/10.1074/jbc.M111.308916			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22184107	Green Published, hybrid			2022-12-27	WOS:000300608500063
J	Robertson, IM; Holmes, PC; Li, MX; Pineda-Sanabria, SE; Baryshnikova, OK; Sykes, BD				Robertson, Ian M.; Holmes, Peter C.; Li, Monica X.; Pineda-Sanabria, Sandra E.; Baryshnikova, Olga K.; Sykes, Brian D.			Elucidation of Isoform-dependent pH Sensitivity of Troponin I by NMR Spectroscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CARDIAC TROPONIN; NUCLEAR MAGNETIC-RESONANCE; CARBON-13 CHEMICAL SHIFTS; CALCIUM-BINDING; ACIDIC PH; CONTRACTILE FUNCTION; REGULATORY DOMAIN; ESCHERICHIA-COLI; STRIATED-MUSCLE; SKELETAL	Myocardial ischemia is characterized by reduced blood flow to cardiomyocytes, which can lead to acidosis. Acidosis decreases the calcium sensitivity and contractile efficiency of cardiac muscle. By contrast, skeletal and neonatal muscles are much less sensitive to changes in pH. The pH sensitivity of cardiac muscle can be reduced by replacing cardiac troponin I with its skeletal or neonatal counterparts. The isoform-specific response of troponin I is dictated by a single histidine, which is replaced by an alanine in cardiac troponin I. The decreased pH sensitivity may stem from the protonation of this histidine at low pH, which would promote the formation of electrostatic interactions with negatively charged residues on troponin C. In this study, we measured acid dissociation constants of glutamate residues on troponin C and of histidine on skeletal troponin I (His-130). The results indicate that Glu-19 comes in close contact with an ionizable group that has a pK(a) of similar to 6.7 when it is in complex with skeletal troponin I but not when it is bound to cardiac troponin I. The pK(a) of Glu-19 is decreased when troponin C is bound to skeletal troponin I and the pK(a) of His-130 is shifted upward. These results strongly suggest that these residues form an electrostatic interaction. Furthermore, we found that skeletal troponin I bound to troponin C tighter at pH 6.1 than at pH 7.5. The data presented here provide insights into the molecular mechanism for the pH sensitivity of different muscle types.	[Robertson, Ian M.; Holmes, Peter C.; Li, Monica X.; Pineda-Sanabria, Sandra E.; Baryshnikova, Olga K.; Sykes, Brian D.] Univ Alberta, Dept Biochem, Fac Med & Dent, Edmonton, AB T6G 2H7, Canada	University of Alberta	Sykes, BD (corresponding author), Univ Alberta, Dept Biochem, Fac Med & Dent, 4-19 Med Sci Bldg, Edmonton, AB T6G 2H7, Canada.	brian.sykes@ualberta.ca	Robertson, Ian/D-8266-2013	Robertson, Ian/0000-0001-9561-1418	Canadian Institute of Health Research; Heart and Stroke Foundation of Canada; Alberta Innovates Health Solutions	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Alberta Innovates Health Solutions	This work was supported by the Canadian Institute of Health Research and the Heart and Stroke Foundation of Canada.; Supported by Alberta Innovates Health Solutions studentships.	ALLEN DG, 1987, CIRC RES, V60, P153, DOI 10.1161/01.RES.60.2.153; Baryshnikova OK, 2008, J BIOMOL NMR, V41, P5, DOI 10.1007/s10858-008-9234-6; BJORNSON ME, 1985, J INORG BIOCHEM, V25, P141, DOI 10.1016/0162-0134(85)80022-2; BLANCHARD EM, 1984, CIRC RES, V55, P382, DOI 10.1161/01.RES.55.3.382; BUNDI A, 1979, BIOPOLYMERS, V18, P285, DOI 10.1002/bip.1979.360180206; CEDERHOLM MT, 1991, P NATL ACAD SCI USA, V88, P8116, DOI 10.1073/pnas.88.18.8116; COHEN P, 1972, FEBS LETT, V25, P282, DOI 10.1016/0014-5793(72)80504-0; Dargis R, 2002, J BIOL CHEM, V277, P34662, DOI 10.1074/jbc.C200419200; Day SM, 2006, NAT MED, V12, P181, DOI 10.1038/nm1346; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DONALDSON SKB, 1978, PFLUG ARCH EUR J PHY, V376, P55; ELSALEH SC, 1988, J BIOL CHEM, V263, P3274; FABIATO A, 1978, J PHYSIOL-LONDON, V276, P233, DOI 10.1113/jphysiol.1978.sp012231; Farrell D, 2010, PROTEINS, V78, P843, DOI 10.1002/prot.22611; Forsyth WR, 2002, PROTEINS, V48, P388, DOI 10.1002/prot.10174; GEMMECKER G, 1992, J MAGN RESON, V96, P199, DOI 10.1016/0022-2364(92)90304-P; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; HAGEN R, 1969, J AM CHEM SOC, V91, P4504, DOI 10.1021/ja01044a032; Hoffman RMB, 2005, BIOCHEMISTRY-US, V44, P15750, DOI 10.1021/bi051583y; HORSLEY WJ, 1968, J AM CHEM SOC, V90, P3738, DOI 10.1021/ja01016a025; IKURA M, 1992, J AM CHEM SOC, V114, P2433, DOI 10.1021/ja00033a019; JACKSON SE, 1993, BIOCHEMISTRY-US, V32, P13909, DOI 10.1021/bi00213a021; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Julien O, 2011, PROTEINS, V79, P1240, DOI 10.1002/prot.22959; Kobayashi T, 2008, PFLUG ARCH EUR J PHY, V457, P37, DOI 10.1007/s00424-008-0511-8; LEE JA, 1991, J CLIN INVEST, V88, P361, DOI 10.1172/JCI115311; Li G, 2001, J MOL CELL CARDIOL, V33, P1309, DOI 10.1006/jmcc.2000.1392; Li MX, 2004, J MUSCLE RES CELL M, V25, P559, DOI 10.1007/s10974-004-5879-2; Li MX, 1999, BIOCHEMISTRY-US, V38, P8289, DOI 10.1021/bi9901679; Li MX, 2002, EUR BIOPHYS J BIOPHY, V31, P245, DOI 10.1007/s00249-002-0227-1; Liou YM, 2004, J BIOCHEM, V136, P683, DOI 10.1093/jb/mvh175; MACIEL GE, 1965, J CHEM PHYS, V42, P2752, DOI 10.1063/1.1703232; MACIEL GE, 1966, J AM CHEM SOC, V88, P220, DOI 10.1021/ja00954a006; MARKLEY JL, 1970, P NATL ACAD SCI USA, V65, P645, DOI 10.1073/pnas.65.3.645; MARKLEY JL, 1975, ACCOUNTS CHEM RES, V8, P70, DOI 10.1021/ar50086a004; Martin SR, 2004, FEBS LETT, V577, P284, DOI 10.1016/j.febslet.2004.10.023; McKay RT, 1999, BIOCHEMISTRY-US, V38, P5478; NELSON DJ, 1979, INT J QUANTUM CHEM, V16, P159, DOI 10.1002/qua.560160118; ODA Y, 1994, BIOCHEMISTRY-US, V33, P5275, DOI 10.1021/bi00183a034; Ogura K, 1996, J BIOMOL NMR, V8, P492, DOI 10.1007/BF00228150; Palpant NJ, 2010, PHYSIOL GENOMICS, V42, P287, DOI 10.1152/physiolgenomics.00033.2010; Parsons B, 1997, J MUSCLE RES CELL M, V18, P599, DOI 10.1023/A:1018623604365; REES DC, 1980, J MOL BIOL, V141, P323, DOI 10.1016/0022-2836(80)90184-9; Robertson IM, 2009, NATO SCI PEACE SEC B, P101, DOI 10.1007/978-90-481-2368-1_7; RUSSELL AJ, 1987, J MOL BIOL, V193, P803, DOI 10.1016/0022-2836(87)90360-3; RUSSELL ST, 1985, J MOL BIOL, V185, P389, DOI 10.1016/0022-2836(85)90411-5; Sheehan KA, 2011, J MOL CELL CARDIOL, V50, P442, DOI 10.1016/j.yjmcc.2010.10.032; Sia SK, 1997, J BIOL CHEM, V272, P18216, DOI 10.1074/jbc.272.29.18216; Slupsky CM, 2003, J BIOMOL NMR, V27, P313, DOI 10.1023/A:1025870122182; SOLARO RJ, 1988, CIRC RES, V63, P779, DOI 10.1161/01.RES.63.4.779; Spyracopoulos L, 1997, BIOCHEMISTRY-US, V36, P12138, DOI 10.1021/bi971223d; STERNBERG MJE, 1987, NATURE, V330, P86, DOI 10.1038/330086a0; Szakacs Z, 2004, ANAL BIOANAL CHEM, V378, P1428, DOI 10.1007/s00216-003-2390-3; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; Tran K, 2010, BIOPHYS J, V98, P267, DOI 10.1016/j.bpj.2009.10.011; Vinogradova MV, 2005, P NATL ACAD SCI USA, V102, P5038, DOI 10.1073/pnas.0408882102; Westfall MV, 1997, P NATL ACAD SCI USA, V94, P5444, DOI 10.1073/pnas.94.10.5444; Westfall MV, 2000, CIRC RES, V86, P470, DOI 10.1161/01.RES.86.4.470; Wuthrich K., 1986, NMR PROTEINS NUCL AC, P1; YAMAZAKI T, 1993, BIOCHEMISTRY-US, V32, P5656, DOI 10.1021/bi00072a023	60	12	12	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4996	5007		10.1074/jbc.M111.301499	http://dx.doi.org/10.1074/jbc.M111.301499			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22179777	Green Published, hybrid			2022-12-27	WOS:000300608500059
J	Timme-Laragy, AR; Karchner, SI; Franks, DG; Jenny, MJ; Harbeitner, RC; Goldstone, JV; McArthur, AG; Hahn, ME				Timme-Laragy, Alicia R.; Karchner, Sibel I.; Franks, Diana G.; Jenny, Matthew J.; Harbeitner, Rachel C.; Goldstone, Jared V.; McArthur, Andrew G.; Hahn, Mark E.			Nrf2b, Novel Zebrafish Paralog of Oxidant-responsive Transcription Factor NF-E2-related Factor 2 (NRF2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARYL-HYDROCARBON RECEPTOR; MULTIPLE SEQUENCE ALIGNMENT; ELEMENT SIGNALING PATHWAY; OXIDATIVE STRESS-RESPONSE; AH GENE BATTERY; DNA-BINDING; CHEMOPREVENTIVE AGENTS; DEVELOPMENTAL TOXICITY; KEAP1-NRF2 SYSTEM; EXPRESSION	NF-E2-related factor 2 (NRF2; also called NFE2L2) and related NRF family members regulate antioxidant defenses by activating gene expression via antioxidant response elements (AREs), but their roles in embryonic development are not well understood. We report here that zebrafish (Danio rerio), an important developmental model species, possesses six nrf genes, including duplicated nrf1 and nrf2 genes. We cloned a novel zebrafish nrf2 paralog, nrf2b. The predicted Nrf2b protein sequence shares several domains with the original Nrf2 (now Nrf2a) but lacks the Neh4 transactivation domain. Zebrafish-human comparisons demonstrate conserved synteny involving nrf2 and hox genes, indicating that nrf2a and nrf2b are co-orthologs of human NRF2. nrf2a and nrf2b displayed distinct patterns of expression during embryonic development; nrf2b was more highly expressed at all stages. Embryos in which Nrf2a expression had been knocked down with morpholino oligo-nucleotides were more sensitive to tert-butylhydroperoxide but not tert-butylhydroquinone, whereas knockdown of Nrf2b did not affect sensitivity of embryos to either chemical. Gene expression profiling by microarray identified a specific role for Nrf2b as a negative regulator of several genes, including p53, cyclin G1, and heme oxygenase 1, in embryos. Nrf2a and Nrf2b exhibited different mechanisms of cross-talk with the Ahr2 signaling pathway. Together, these results demonstrate distinct roles for nrf2a and nrf2b, consistent with sub-function partitioning, and identify a novel negative regulatory role for Nrf2b during development. The identification of zebrafish nrf2 co-orthologs will facilitate new understanding of the multiple roles of NRF2 in protecting vertebrate embryos from oxidative damage.	[Timme-Laragy, Alicia R.; Karchner, Sibel I.; Franks, Diana G.; Jenny, Matthew J.; Harbeitner, Rachel C.; Goldstone, Jared V.; Hahn, Mark E.] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; [Jenny, Matthew J.] Univ Alabama, Dept Biol Sci, Tuscaloosa, AL 35487 USA; [McArthur, Andrew G.] Andrew McArthur Consulting, Hamilton, ON L8S 3P6, Canada	Woods Hole Oceanographic Institution; University of Alabama System; University of Alabama Tuscaloosa	Timme-Laragy, AR (corresponding author), Woods Hole Oceanog Inst, Dept Biol, 266 Woods Hole Rd,MS 32, Woods Hole, MA 02543 USA.	atimmelaragy@whoi.edu	Hahn, Mark/AAV-7516-2020	Hahn, Mark/0000-0003-4358-2082; McArthur, Andrew/0000-0002-1142-3063; Timme-Laragy, Alicia/0000-0002-8835-5038; Goldstone, Jared/0000-0002-9618-4961; Jenny, Matthew/0000-0002-1834-2629	National Institutes of Health [F32ES017585, R00ES017044, R01ES015912, R01ES016366, R01ES006272]; Woods Hole Oceanographic Institution; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R00ES017044, F32ES017585, R01ES006272, R01ES016366, R01ES015912] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Woods Hole Oceanographic Institution; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants F32ES017585 (to A. R. T.-L.), R00ES017044 (to M. J. J.), R01ES015912 (to J. V. G.), and R01ES016366 and R01ES006272 (to M. E. H.). This work was also supported by a Woods Hole Oceanographic Institution postdoctoral scholar award and by Walter A. and Hope Noyes Smith.	Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Anwar-Mohamed A, 2011, TOXICOL IN VITRO, V25, P785, DOI 10.1016/j.tiv.2011.01.014; Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; Bloom D, 2002, ONCOGENE, V21, P2191, DOI 10.1038/sj.onc.1205288; Boutten A, 2010, EXPERT OPIN THER TAR, V14, P329, DOI 10.1517/14728221003629750; Breitling R, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-34; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Calabrese V, 2010, ANTIOXID REDOX SIGN, V13, P1763, DOI 10.1089/ars.2009.3074; Carvan MJ, 2000, ARCH BIOCHEM BIOPHYS, V376, P320, DOI 10.1006/abbi.2000.1727; Carvan MJ, 2001, SCI TOTAL ENVIRON, V274, P183, DOI 10.1016/S0048-9697(01)00742-2; Chan KM, 1996, P NATL ACAD SCI USA, V93, P13943, DOI 10.1073/pnas.93.24.13943; Cho HY, 2005, FREE RADICAL BIO MED, V38, P325, DOI 10.1016/j.freeradbiomed.2004.10.013; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; de Jong Mark, 2010, BMC Res Notes, V3, P73, DOI 10.1186/1756-0500-3-73; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Evans BR, 2008, MOL PHARMACOL, V73, P387, DOI 10.1124/mol.107.040204; Goldstone JV, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-643; Hahn ME, 2007, TOXICOL SCI TOXICO S, V96, P326; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Jain AK, 2007, J BIOL CHEM, V282, P16502, DOI 10.1074/jbc.M611336200; Jain AK, 2005, J BIOL CHEM, V280, P29158, DOI 10.1074/jbc.M502083200; Jenny MJ, 2009, TOXICOL SCI, V110, P426, DOI 10.1093/toxsci/kfp116; Jonsson ME, 2007, TOXICOL APPL PHARM, V221, P29, DOI 10.1016/j.taap.2007.02.017; Kalthoff S, 2010, GASTROENTEROLOGY, V139, P1699, DOI 10.1053/j.gastro.2010.06.048; Kalthoff S, 2010, J BIOL CHEM, V285, P5993, DOI 10.1074/jbc.M109.075770; Katoh Y, 2005, ARCH BIOCHEM BIOPHYS, V433, P342, DOI 10.1016/j.abb.2004.10.012; Katoh Y, 2001, GENES CELLS, V6, P857, DOI 10.1046/j.1365-2443.2001.00469.x; Kawai Y, 2011, J BIOL CHEM, V286, P7629, DOI 10.1074/jbc.M110.208173; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kobayashi M, 2002, GENES CELLS, V7, P807, DOI 10.1046/j.1365-2443.2002.00561.x; Kobayashi M, 2009, MOL CELL BIOL, V29, P493, DOI 10.1128/MCB.01080-08; Kusik BW, 2008, MAR BIOTECHNOL, V10, P750, DOI 10.1007/s10126-008-9113-x; Kwak MK, 2002, MOL CELL BIOL, V22, P2883, DOI 10.1128/MCB.22.9.2883-2892.2002; Lee JM, 2003, J BIOL CHEM, V278, P12029, DOI 10.1074/jbc.M211558200; Lee JM, 2003, J BIOL CHEM, V278, P37948, DOI 10.1074/jbc.M305204200; Lewis KN, 2010, INTEGR COMP BIOL, V50, P829, DOI 10.1093/icb/icq034; Li JQ, 2009, EXPERT OPIN THER TAR, V13, P785, DOI 10.1517/14728220903025762; Li L, 2008, J BIOL CHEM, V283, P3248, DOI 10.1074/jbc.M708702200; Li ZB, 2007, PLOS BIOL, V5, P212, DOI 10.1371/journal.pbio.0050035; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McCurley AT, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-102; McMahon M, 2004, J BIOL CHEM, V279, P31556, DOI 10.1074/jbc.M403061200; McMahon M, 2006, J BIOL CHEM, V281, P24756, DOI 10.1074/jbc.M601119200; Meyer A, 2005, BIOESSAYS, V27, P937, DOI 10.1002/bies.20293; Miao WM, 2005, J BIOL CHEM, V280, P20340, DOI 10.1074/jbc.M412081200; Nebert DW, 2000, BIOCHEM PHARMACOL, V59, P65, DOI 10.1016/S0006-2952(99)00310-X; NEBERT DW, 1993, ANN NY ACAD SCI, V685, P624, DOI 10.1111/j.1749-6632.1993.tb35928.x; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Nioi P, 2005, MOL CELL BIOL, V25, P10895, DOI 10.1128/MCB.25.24.10895-10906.2005; Numazawa S, 2003, AM J PHYSIOL-CELL PH, V285, pC334, DOI 10.1152/ajpcell.00043.2003; Osburn WO, 2006, ARCH BIOCHEM BIOPHYS, V454, P7, DOI 10.1016/j.abb.2006.08.005; Postlethwait J, 2004, TRENDS GENET, V20, P481, DOI 10.1016/j.tig.2004.08.001; Postlethwait JH, 2006, GENOME DYN, V2, P183, DOI 10.1159/000095104; Postlethwait JH, 2007, J EXP ZOOL PART B, V308B, P563, DOI 10.1002/jez.b.21137; Prasch AL, 2003, TOXICOL SCI, V76, P138, DOI 10.1093/toxsci/kfg202; Pratt SJ, 2002, PHYSIOL GENOMICS, V11, P91, DOI 10.1152/physiolgenomics.00112.2001; Rada P, 2011, MOL CELL BIOL, V31, P1121, DOI 10.1128/MCB.01204-10; Reichard JF, 2008, J BIOL CHEM, V283, P22363, DOI 10.1074/jbc.M801784200; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Shenvi SV, 2009, PHARMACOL RES, V60, P229, DOI 10.1016/j.phrs.2009.06.003; Shimamoto K, 2011, TOXICOLOGY, V283, P109, DOI 10.1016/j.tox.2011.03.003; Song HD, 2004, P NATL ACAD SCI USA, V101, P16240, DOI 10.1073/pnas.0407241101; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stegeman JJ, 2010, FISH PHYSIOL, V29, P367, DOI 10.1016/S1546-5098(10)02910-9; Storer NY, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001123; Sun Z, 2009, MOL CELL BIOL, V29, P2658, DOI 10.1128/MCB.01639-08; Sundstrom G, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-254; Suzuki T, 2005, BIOCHEM J, V388, P65, DOI 10.1042/BJ20041860; Swofford D. L., 1998, PAUP PHYLOGENETIC AN; Taguchi K, 2011, GENES CELLS, V16, P123, DOI 10.1111/j.1365-2443.2010.01473.x; Takai D, 2002, P NATL ACAD SCI USA, V99, P3740, DOI 10.1073/pnas.052410099; Tanaka Y, 2008, J PHARMACOL EXP THER, V325, P655, DOI 10.1124/jpet.107.135822; Thangasamy A, 2011, J BIOL CHEM, V286, P32115, DOI 10.1074/jbc.M111.245746; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Timme-Laragy AR, 2009, TOXICOL SCI, V109, P217, DOI 10.1093/toxsci/kfp038; Tong KI, 2006, MOL CELL BIOL, V26, P2887, DOI 10.1128/MCB.26.8.2887-2900.2006; Tong KI, 2006, BIOL CHEM, V387, P1311, DOI 10.1515/BC.2006.164; Tsujita T, 2011, GENES CELLS, V16, P46, DOI 10.1111/j.1365-2443.2010.01466.x; Warnatz HJ, 2011, J BIOL CHEM, V286, P23521, DOI 10.1074/jbc.M111.220178; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; Woltering JM, 2006, NAT GENET, V38, P601, DOI 10.1038/ng0606-601; Yeager RL, 2009, TOXICOL SCI, V111, P238, DOI 10.1093/toxsci/kfp115; You A, 2011, ARCH BIOCHEM BIOPHYS, V507, P356, DOI 10.1016/j.abb.2010.12.034; Zhang DD, 2003, MOL CELL BIOL, V23, P8137, DOI 10.1128/MCB.23.22.8137-8151.2003; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004; Zhang J, 2007, BIOCHEM J, V404, P459, DOI 10.1042/BJ20061611; Zhao L, 2003, MOL CANCER RES, V1, P195	89	70	75	2	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4609	4627		10.1074/jbc.M111.260125	http://dx.doi.org/10.1074/jbc.M111.260125			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22174413	Green Published, hybrid			2022-12-27	WOS:000300608500024
J	Lin, D; Lavender, H; Soilleux, EJ; O'Callaghan, CA				Lin, Da; Lavender, Hayley; Soilleux, Elizabeth J.; O'Callaghan, Christopher A.			NF-kappa B Regulates MICA Gene Transcription in Endothelial Cell through a Genetically Inhibitable Control Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; CORONARY-HEART-DISEASE; NATURAL-KILLER-CELLS; FACTOR-ALPHA; TNF-ALPHA; T-CELLS; ATHEROMATOUS PLAQUES; ATHEROSCLEROSIS RISK; MESSENGER-RNA; ACTIVATION	Endothelial cells form a barrier between blood and the underlying vessel wall, which characteristically demonstrates inflammatory damage in atherosclerotic disease. MICA is a highly polymorphic ligand for the activating immune receptor NKG2D and can be expressed on endothelial cells. We hypothesized that damaged vessel walls, such as those involved in atherosclerosis, might express MICA, which could contribute to the vascular immunopathology. Immune activation resulting from MICA expression could play a significant role in the development of vascular damage. We have demonstrated that TNF alpha up-regulates MICA on human endothelial cells. The up-regulation is mediated by NF-kappa B, and we have defined the regulatory control site responsible for this at -130 bp upstream of the MICA transcription start site. This site overlaps with a heat shock response element and integrates input from the two pathways. We have shown that in atherosclerotic lesions there is expression of MICA on endothelial cells. Using lentivirus-mediated gene delivery in primary human endothelial cells, we were able to inhibit the MICA response to TNF alpha with a truncated HSF1 that lacked a transactivation domain. This highlights the potential for transcription-based therapeutic approaches in atherosclerotic vascular disease to reduce immune-mediated endothelial and vessel wall damage.	[Lin, Da; O'Callaghan, Christopher A.] Univ Oxford, Oxford OX3 7BN, England; [Lavender, Hayley] Univ Oxford, Nuffield Dept Clin Lab Sci, John Radcliffe Hosp, Oxford OX3 9DU, England; [Soilleux, Elizabeth J.] Univ Oxford, Nuffield Dept Clin Lab Sci, Oxford OX3 9DU, England; [Soilleux, Elizabeth J.] John Radcliffe Hosp, Dept Cellular Pathol, Oxford OX3 9DU, England	University of Oxford; University of Oxford; University of Oxford; University of Oxford	O'Callaghan, CA (corresponding author), Univ Oxford, Henry Wellcome Bldg Mol Physiol,Roosevelt Dr, Oxford OX3 7BN, England.	chris.ocallaghan@ndm.ox.ac.uk		Lavender, Hayley/0000-0001-9996-8107; Soilleux, Elizabeth Jane/0000-0002-4032-7249	Medical Research Council; National Institute for Health Research Oxford Comprehensive Biomedical Research Centre; MRC [G116/165] Funding Source: UKRI; British Heart Foundation [PG/11/4/28645] Funding Source: researchfish; Medical Research Council [G116/165] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research Oxford Comprehensive Biomedical Research Centre; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Medical Research Council and the National Institute for Health Research Oxford Comprehensive Biomedical Research Centre Programme.	ABRAVAYA K, 1991, MOL CELL BIOL, V11, P586, DOI 10.1128/MCB.11.1.586; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Beauparlant P, 1996, J VIROL, V70, P5777, DOI 10.1128/JVI.70.9.5777-5785.1996; Bobryshev YV, 2005, ATHEROSCLEROSIS, V180, P423, DOI 10.1016/j.atherosclerosis.2005.01.046; Bruunsgaard H, 2003, AM J MED, V115, P278, DOI 10.1016/S0002-9343(03)00329-2; Champsaur M, 2010, IMMUNOL REV, V235, P267, DOI 10.1111/j.0105-2896.2010.00893.x; Chen DLN, 2008, J IMMUNOL METHODS, V330, P57, DOI 10.1016/j.jim.2007.10.018; Chiu JJ, 2004, ARTERIOSCL THROM VAS, V24, P73, DOI 10.1161/01.ATV.0000106321.63667.24; Cicha I, 2009, ATHEROSCLEROSIS, V207, P93, DOI 10.1016/j.atherosclerosis.2009.04.034; Cines DB, 1998, BLOOD, V91, P3527; Csiszar A, 2008, J APPL PHYSIOL, V105, P1333, DOI 10.1152/japplphysiol.90470.2008; Ehrlich LIR, 2005, J IMMUNOL, V174, P1922, DOI 10.4049/jimmunol.174.4.1922; Espinola-Klein C, 2002, CIRCULATION, V105, P15, DOI 10.1161/hc0102.101362; Feletou M, 2006, AM J PHYSIOL-HEART C, V291, pH985, DOI 10.1152/ajpheart.00292.2006; FRANGOS JA, 1985, SCIENCE, V227, P1477, DOI 10.1126/science.3883488; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; GERRITSEN ME, 1993, FASEB J, V7, P523, DOI 10.1096/fasebj.7.6.8472891; Gourin CG, 1997, J TRAUMA, V42, P1101, DOI 10.1097/00005373-199706000-00020; Groh V, 1996, P NATL ACAD SCI USA, V93, P12445, DOI 10.1073/pnas.93.22.12445; Groh V, 2001, NAT IMMUNOL, V2, P255, DOI 10.1038/85321; Haddy N, 2003, ATHEROSCLEROSIS, V170, P277, DOI 10.1016/S0021-9150(03)00287-9; Hao SL, 2009, NAT IMMUNOL, V10, P281, DOI 10.1038/ni.1699; Hilgendorff A, 2003, INT J CLIN PHARM TH, V41, P397; Holmen C, 2005, J AM SOC NEPHROL, V16, P3110, DOI 10.1681/ASN.2005040347; Holschermann H, 2006, ATHEROSCLEROSIS, V185, P240, DOI 10.1016/j.atherosclerosis.2005.06.019; Jamieson AM, 2002, IMMUNITY, V17, P19, DOI 10.1016/S1074-7613(02)00333-3; Jamison DT, 2006, PRIORITIES HLTH; Jovinge S, 1996, ARTERIOSCL THROM VAS, V16, P1573, DOI 10.1161/01.ATV.16.12.1573; Jovinge S, 1998, METABOLISM, V47, P113, DOI 10.1016/S0026-0495(98)90203-7; Madge LA, 2001, EXP MOL PATHOL, V70, P317, DOI 10.1006/exmp.2001.2368; Mantovani A, 1997, ANN NY ACAD SCI, V832, P93, DOI 10.1111/j.1749-6632.1997.tb46240.x; Maurus CF, 2006, TRANSPLANTATION, V81, P1204, DOI 10.1097/01.tp.0000205175.53938.bd; McGuire TR, 2005, INFLAMM RES, V54, P375, DOI 10.1007/s00011-005-1370-9; Mistry AR, 2007, IMMUNOLOGY, V121, P439, DOI 10.1111/j.1365-2567.2007.02652.x; Molinero LL, 2004, J IMMUNOL, V173, P5583, DOI 10.4049/jimmunol.173.9.5583; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Rayment NB, 1996, CARDIOVASC RES, V32, P1123, DOI 10.1016/S0008-6363(96)00145-9; Ridker PM, 2000, CIRCULATION, V101, P2149, DOI 10.1161/01.CIR.101.18.2149; Robinson J, 2011, NUCLEIC ACIDS RES, V39, pD1171, DOI 10.1093/nar/gkq998; RYAN US, 1987, ANN NY ACAD SCI, V516, P22, DOI 10.1111/j.1749-6632.1987.tb33027.x; Sorlie PD, 2000, ARCH INTERN MED, V160, P2027, DOI 10.1001/archinte.160.13.2027; Sumitran-Holgersson S, 2002, TRANSPLANTATION, V74, P268, DOI 10.1097/00007890-200207270-00019; TIPPING PG, 1993, AM J PATHOL, V142, P1721; Tonetti MS, 2007, NEW ENGL J MED, V356, P911, DOI 10.1056/NEJMoa063186; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; WHITESIDE TL, 1994, CLIN DIAGN LAB IMMUN, V1, P125, DOI 10.1128/CDLI.1.2.125-133.1994; Woollard KJ, 2010, NAT REV CARDIOL, V7, P77, DOI 10.1038/nrcardio.2009.228; YAMASHIROYA HM, 1988, AM J PATHOL, V130, P71; Zhang LS, 2010, HUM MOL GENET, V19, P2754, DOI 10.1093/hmg/ddq172; Zou YZ, 2007, NEW ENGL J MED, V357, P1293, DOI 10.1056/NEJMoa067160	50	46	48	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					4299	4310		10.1074/jbc.M111.282152	http://dx.doi.org/10.1074/jbc.M111.282152			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22170063	Green Published, hybrid			2022-12-27	WOS:000300410900061
J	Soifer, HS; Souleimanian, N; Wu, SJ; Voskresenskiy, AM; Collak, FK; Cinar, B; Stein, CA				Soifer, Harris S.; Souleimanian, Naira; Wu, Sijian; Voskresenskiy, Anatoliy M.; Collak, Filiz Kisaayak; Cinar, Bekir; Stein, Cy A.			Direct Regulation of Androgen Receptor Activity by Potent CYP17 Inhibitors in Prostate Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I CLINICAL-TRIAL; ABIRATERONE ACETATE; ANTITUMOR-ACTIVITY; DOWN-REGULATION; EXPRESSION; GROWTH; GENE; PROGRESSION; INDUCTION; DOCETAXEL	TOK-001 and abiraterone are potent 17-heteroarylsteroid (17-HAS) inhibitors of Cyp17, one of the rate-limiting enzymes in the biosynthesis of testosterone from cholesterol in prostate cancer cells. Nevertheless, the molecular mechanism underlying the prevention of prostate cell growth by 17-HASs still remains elusive. Here, we assess the effects of 17-HASs on androgen receptor (AR) activity in LNCaP and LAPC-4 cells. We demonstrate that both TOK-001 and abiraterone reduced AR protein and mRNA expression, and antagonized AR-dependent promoter activation induced by androgen. TOK-001, but not abiraterone, is an effective apparent competitor of the radioligand [H-3]R1881 for binding to the wild type and various mutant AR (W741C, W741L) proteins. In agreement with these data, TOK-001 is a consistently superior inhibitor than abiraterone of R1881-induced transcriptional activity of both wild type and mutant AR. However, neither agent was able to trans-activate the AR in the absence of R1881. Our data demonstrate that phospho-4EBP1 levels are significantly reduced by TOK-001 and to a lesser extent by abiraterone alcohol, and suggest a mechanism by which cap-dependent translation is suppressed by blocking assembly of the eIF4F and eIF4G complex to the mRNA 5' cap. Thus, the effects of these 17-HASs on AR signaling are complex, ranging from a decrease in testosterone production through the inhibition of Cyp17 as previously described, to directly reducing both AR protein expression and R1881-induced AR trans-activation.	[Soifer, Harris S.; Souleimanian, Naira; Wu, Sijian; Voskresenskiy, Anatoliy M.; Stein, Cy A.] Montefiore Med Ctr, Albert Einstein Montefiore Canc Ctr, Bronx, NY 10467 USA; [Collak, Filiz Kisaayak; Cinar, Bekir] Univ Calif Los Angeles, Cedars Sinai Med Ctr,David Geffen Sch Med, Samuel Oschin Comprehens Canc Inst, Dept Med Hematol Oncol & Biomed Sci,Dept Med, Los Angeles, CA 90048 USA	Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Stein, CA (corresponding author), 111 E 210th St, Bronx, NY 10463 USA.	cstein@montefiore.org	CİNAR, BEKIR MURAT/AAL-4474-2021	CİNAR, BEKIR MURAT/0000-0002-7906-5039; Cinar, Bekir/0000-0003-4028-7600	Tokai Pharmaceuticals, Cambridge, MA; David and Rose Himelberg Foundation; New York Academy of Medicine [R24D00]; Garber Foundation from Cedars-Sinai Medical Center	Tokai Pharmaceuticals, Cambridge, MA; David and Rose Himelberg Foundation; New York Academy of Medicine; Garber Foundation from Cedars-Sinai Medical Center	This work was generously funded by Tokai Pharmaceuticals, Cambridge, MA, the David and Rose Himelberg Foundation (to C. A. S.), the Edwin Beer Fellowship Grant R24D00 from the New York Academy of Medicine, and the Garber Foundation from Cedars-Sinai Medical Center (to B. C.).	Attard G, 2008, J CLIN ONCOL, V26, P4563, DOI 10.1200/JCO.2007.15.9749; Attard G, 2009, J CLIN ONCOL, V27, P3742, DOI 10.1200/JCO.2008.20.0642; Balk SP, 2002, UROLOGY, V60, P132, DOI 10.1016/S0090-4295(02)01593-5; Balk SP, 2008, NUCL RECEPT SIGNAL, V6, pe001, DOI DOI 10.1621/NRS.06001; Bruno RD, 2008, MOL CANCER THER, V7, P2828, DOI 10.1158/1535-7163.MCT-08-0336; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Chiu FL, 2008, PROSTATE, V68, P61, DOI 10.1002/pros.20690; Cinar B, 2005, CANCER RES, V65, P2547, DOI 10.1158/0008-5472.CAN-04-3411; Danila DC, 2010, J CLIN ONCOL, V28, P1496, DOI 10.1200/JCO.2009.25.9259; Eder IE, 2000, CANCER GENE THER, V7, P997, DOI 10.1038/sj.cgt.7700202; Farla P, 2005, J CELL SCI, V118, P4187, DOI 10.1242/jcs.02546; Ferrari N, 2006, ANN NY ACAD SCI, V1082, P91, DOI 10.1196/annals.1348.032; GELLER J, 1979, J STEROID BIOCHEM, V11, P631, DOI 10.1016/0022-4731(79)90092-X; GELLER J, 1978, J CLIN ENDOCR METAB, V46, P440; HALL PF, 1991, J STEROID BIOCHEM, V40, P527, DOI 10.1016/0960-0760(91)90272-7; Handratta VD, 2005, J MED CHEM, V48, P2972, DOI 10.1021/jm040202w; Hara T, 2003, CANCER RES, V63, P149; Holcik M, 1999, NAT CELL BIOL, V1, P190, DOI 10.1038/11109; HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809; Huang ZQ, 2002, MOL ENDOCRINOL, V16, P924, DOI 10.1210/me.16.5.924; Ikezoe T, 2004, CANCER SCI, V95, P271, DOI 10.1111/j.1349-7006.2004.tb02215.x; Kampa M, 2002, FASEB J, V16, P1429, DOI 10.1096/fj.02-0131fje; Ko YJ, 2004, J UROLOGY, V172, P1140, DOI 10.1097/01.ju.0000134698.87862.e6; Koch T., 2008, ANTISENSE DRUG DISCO, P519; Koivisto P, 1997, CANCER RES, V57, P314; Kuroda K, 2009, PROSTATE, V69, P1579, DOI 10.1002/pros.21004; Li TH, 2007, NUCLEIC ACIDS RES, V35, P2767, DOI 10.1093/nar/gkm198; Liao XB, 2005, MOL CANCER THER, V4, P505, DOI 10.1158/1535-7163.MCT-04-0313; Lin FM, 2007, CARCINOGENESIS, V28, P2521, DOI 10.1093/carcin/bgm137; Lin HK, 2002, J BIOL CHEM, V277, P36570, DOI 10.1074/jbc.M204751200; Masiello D, 2002, J BIOL CHEM, V277, P26321, DOI 10.1074/jbc.M203310200; Mitchell SH, 1999, CANCER RES, V59, P5892; MIZOKAMI A, 1994, J BIOL CHEM, V269, P25655; Mohler JL, 2004, CLIN CANCER RES, V10, P440, DOI 10.1158/1078-0432.CCR-1146-03; Mostaghel Elahe A, 2007, Curr Urol Rep, V8, P224, DOI 10.1007/s11934-007-0010-z; Mukhopadhyay NK, 2009, CANCER RES, V69, P2210, DOI 10.1158/0008-5472.CAN-08-2308; Pajonk F, 2005, CANCER RES, V65, P4836, DOI 10.1158/0008-5472.CAN-03-2749; Reddy GPV, 2006, J CELL BIOCHEM, V98, P1408, DOI 10.1002/jcb.20927; Reid AHM, 2010, J CLIN ONCOL, V28, P1489, DOI 10.1200/JCO.2009.24.6819; Ryan CJ, 2010, J CLIN ONCOL, V28, P1481, DOI 10.1200/JCO.2009.24.1281; Schayowitz A, 2008, MOL CANCER THER, V7, P121, DOI 10.1158/1535-7163.MCT-07-0581; Seligson DB, 2007, CLIN CANCER RES, V13, P6056, DOI 10.1158/1078-0432.CCR-07-0960; Shamji AF, 2003, MOL CELL, V12, P271, DOI 10.1016/j.molcel.2003.08.016; She QB, 2010, CANCER CELL, V18, P39, DOI 10.1016/j.ccr.2010.05.023; Singh P, 2006, ENDOCR-RELAT CANCER, V13, P653, DOI 10.1677/erc.1.00797; Snoek R, 2009, CLIN CANCER RES, V15, P39, DOI 10.1158/1078-0432.CCR-08-1726; Stein CA, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp841; TAPLIN ME, 1995, NEW ENGL J MED, V332, P1393, DOI 10.1056/NEJM199505253322101; Thomson AA, 2001, REPRODUCTION, V121, P187, DOI 10.1530/rep.0.1210187; Tilley WD, 1996, CLIN CANCER RES, V2, P277; Vasaitis T, 2008, MOL CANCER THER, V7, P2348, DOI 10.1158/1535-7163.MCT-08-0230; VELDSCHOLTE J, 1992, J STEROID BIOCHEM, V41, P665, DOI 10.1016/0960-0760(92)90401-4; VISAKORPI T, 1995, NAT GENET, V9, P401, DOI 10.1038/ng0495-401; Xing NZ, 2001, CARCINOGENESIS, V22, P409, DOI 10.1093/carcin/22.3.409; Yong EL, 2000, ANN MED, V32, P15, DOI 10.3109/07853890008995905; Zegarra-Moro OL, 2002, CANCER RES, V62, P1008; Zhu W, 1999, ENDOCRINOLOGY, V140, P5451, DOI 10.1210/en.140.11.5451	58	60	69	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					3777	3787		10.1074/jbc.M111.261933	http://dx.doi.org/10.1074/jbc.M111.261933			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22174412	hybrid, Green Published			2022-12-27	WOS:000300410900015
J	Shichiri, M; Kono, N; Shimanaka, Y; Tanito, M; Rotzoll, DE; Yoshida, Y; Hagihara, Y; Tamai, H; Arai, H				Shichiri, Mototada; Kono, Nozomu; Shimanaka, Yuta; Tanito, Masaki; Rotzoll, Daisy E.; Yoshida, Yasukazu; Hagihara, Yoshihisa; Tamai, Hiroshi; Arai, Hiroyuki			A Novel Role for alpha-Tocopherol Transfer Protein (alpha-TTP) in Protecting against Chloroquine Toxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; NIEMANN-PICK-DISEASE; VITAMIN-E-DEFICIENCY; CELLS; HYDROXYCHLOROQUINE; ATAXIA; LIVER; C1; HEPATOCYTES; SPHINGOSINE	Chloroquine (CQ) is a widely prescribed anti-malarial agent and is also prescribed to treat autoimmune diseases. Clinical treatment with CQ is often accompanied by serious side effects such as hepatitis and retinopathy. As a weak base, CQ accumulates in intracellular acidic organelles, raises the pH, and induces osmotic swelling and permeabilization of acidic organelles, which account for CQ-induced cytotoxicity. We reported previously that CQ treatment caused alpha-tocopherol transfer protein (alpha-TTP), a gene product of familial vitamin E deficiency, to change its location from the cytosol to the surface of acidic organelles. Here we show that alpha-TTP plays a novel role in protecting against CQ toxicity both in vitro and in vivo. In the presence of CQ, rat hepatoma McARH7777 cells, which do not express alpha-TTP endogenously, showed more severe cytotoxicity, such as larger vacuolation of acidic organelles and caspase activation, than alpha-TTP transfectant cells. Similarly, alpha-TTP knockout mice showed more severe CQ toxicity, such as hepatotoxicity and retinopathy, than wild-type mice. These effects were not ameliorated by vitamin E supplementation. In contrast to bafilomycin A1 treatment, which prevents CQ accumulation in cells by raising the pH of acidic organelles, alpha-TTP expression prevented CQ accumulation without affecting the pH of acidic organelles. Taken together, our data suggest that alpha-TTP protects against CQ toxicity by preventing CQ accumulation in acidic organelles through a mechanism distinct from vitamin E transport.	[Shichiri, Mototada; Kono, Nozomu; Shimanaka, Yuta; Arai, Hiroyuki] Univ Tokyo, Dept Hlth Chem, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Shichiri, Mototada; Yoshida, Yasukazu; Hagihara, Yoshihisa] Natl Inst Adv Ind Sci & Technol, Hlth Res Inst, Ikeda, Osaka 5638577, Japan; [Shichiri, Mototada; Tamai, Hiroshi] Osaka Med Coll, Dept Pediat, Takatsuki, Osaka 5698686, Japan; [Tanito, Masaki] Shimane Univ, Fac Med, Dept Ophthalmol, Matsue, Shimane 6938501, Japan; [Rotzoll, Daisy E.] Heidelberg Univ, Div Neonatol, Dept Pediat, D-69120 Heidelberg, Germany	University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST); Osaka Medical College; Shimane University; Ruprecht Karls University Heidelberg	Arai, H (corresponding author), Univ Tokyo, Dept Hlth Chem, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	harai@mol.f.u-tokyo.ac.jp	Shimanaka, Yuta/AHA-3394-2022; YOSHIDA, YASUKAZU/H-8510-2016; KONO, nozomu/AAM-3178-2020; Shichiri, Mototada/L-9276-2018; HAGIHARA, Yoshihisa/K-4996-2016	Shimanaka, Yuta/0000-0002-2333-0091; YOSHIDA, YASUKAZU/0000-0001-6034-2502; Shichiri, Mototada/0000-0003-1108-7597; HAGIHARA, Yoshihisa/0000-0002-5980-1764	Core Research for Evolutional Science and Technology, Japan Science and Technology Agency; Program for Promotion of Basic and Applied Research for Innovations in Bio-Oriented Industry; Japanese Ministry of Education, Culture, Sports, Science, and Technology; Japanese Ministry of Health, Labor, and Welfare; Grants-in-Aid for Scientific Research [23227004] Funding Source: KAKEN	Core Research for Evolutional Science and Technology, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Program for Promotion of Basic and Applied Research for Innovations in Bio-Oriented Industry; Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Core Research for Evolutional Science and Technology, Japan Science and Technology Agency (to H. A.), the Program for Promotion of Basic and Applied Research for Innovations in Bio-Oriented Industry (to H. A.), Grants-in-aid from the Japanese Ministry of Education, Culture, Sports, Science, and Technology, and the Japanese Ministry of Health, Labor, and Welfare (to H. A.).	Arita M, 1997, P NATL ACAD SCI USA, V94, P12437, DOI 10.1073/pnas.94.23.12437; Boya P, 2003, ONCOGENE, V22, P3927, DOI 10.1038/sj.onc.1206622; CAMBIAGGI A, 1957, ARCH OPHTHALMOL-CHIC, V57, P451; CHEN HW, 1984, J BIOL CHEM, V259, P8156; Davies JP, 2000, SCIENCE, V290, P2295, DOI 10.1126/science.290.5500.2295; EKPECHI OL, 1964, ARCH DERMATOL, V89, P631; Galvan VG, 2007, CLIN RHEUMATOL, V26, P971, DOI 10.1007/s10067-006-0218-1; GOLDIN E, 1992, BIOCHIM BIOPHYS ACTA, V1127, P303, DOI 10.1016/0005-2760(92)90236-O; Gong YP, 2006, J PHARMACOL EXP THER, V316, P242, DOI 10.1124/jpet.105.089482; Horiguchi M, 2003, GENES CELLS, V8, P789, DOI 10.1046/j.1365-2443.2003.00676.x; Hosomi A, 1998, NEUROSCI LETT, V256, P159, DOI 10.1016/S0304-3940(98)00785-X; Hosomi A, 1997, FEBS LETT, V409, P105, DOI 10.1016/S0014-5793(97)00499-7; Jishage K, 2001, J BIOL CHEM, V276, P1669, DOI 10.1074/jbc.C000676200; Kaempf-Rotzoll DE, 2002, BIOL REPROD, V67, P599, DOI 10.1095/biolreprod67.2.599; Kaufmann AM, 2008, J BIOL CHEM, V283, P24584, DOI 10.1074/jbc.M803715200; LINSER PJ, 1984, DEV BRAIN RES, V13, P65, DOI 10.1016/0165-3806(84)90077-4; Lloyd-Evans E, 2008, NAT MED, V14, P1247, DOI 10.1038/nm.1876; MAKIN AJ, 1994, GUT, V35, P569, DOI 10.1136/gut.35.4.569; Marmor MF, 2002, OPHTHALMOLOGY, V109, P1377, DOI 10.1016/S0161-6420(02)01168-5; Michihara A, 2005, BIOL PHARM BULL, V28, P947, DOI 10.1248/bpb.28.947; Min KC, 2003, P NATL ACAD SCI USA, V100, P14713, DOI 10.1073/pnas.2136684100; NEURINGER M, 1988, ANNU REV NUTR, V8, P517, DOI 10.1146/annurev.nu.08.070188.002505; Newman E, 1996, TRENDS NEUROSCI, V19, P307, DOI 10.1016/0166-2236(96)10040-0; OUAHCHI K, 1995, NAT GENET, V9, P141, DOI 10.1038/ng0295-141; Qian JH, 2005, J LIPID RES, V46, P2072, DOI 10.1194/jlr.M500143-JLR200; SATO Y, 1993, J BIOL CHEM, V268, P17705; Schotte P, 1998, BIOCHEM BIOPH RES CO, V251, P379, DOI 10.1006/bbrc.1998.9425; Shacka JJ, 2006, MOL PHARMACOL, V69, P1125, DOI 10.1124/mol.105.018408; Shichiri M, 2007, BRAIN RES, V1182, P106, DOI 10.1016/j.brainres.2007.08.084; Soyombo AA, 2006, J BIOL CHEM, V281, P7294, DOI 10.1074/jbc.M508211200; VANES HHG, 1994, MOL BIOCHEM PARASIT, V68, P209, DOI 10.1016/0166-6851(94)90166-X; WIBO M, 1974, J CELL BIOL, V63, P430, DOI 10.1083/jcb.63.2.430; Wozniacka A, 2007, LUPUS, V16, P89, DOI 10.1177/0961203306075384; Yokota T, 1997, ANN NEUROL, V41, P826, DOI 10.1002/ana.410410621; Yokota T, 2001, P NATL ACAD SCI USA, V98, P15185, DOI 10.1073/pnas.261456098	35	17	19	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2926	2934		10.1074/jbc.M111.321281	http://dx.doi.org/10.1074/jbc.M111.321281			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22147702	Green Published, hybrid			2022-12-27	WOS:000300292300064
J	Tchigvintsev, A; Singer, A; Brown, G; Flick, R; Evdokimova, E; Tan, KM; Gonzalez, CF; Savchenko, A; Yakunin, AF				Tchigvintsev, Anatoli; Singer, Alexander; Brown, Greg; Flick, Robert; Evdokimova, Elena; Tan, Kemin; Gonzalez, Claudio F.; Savchenko, Alexei; Yakunin, Alexander F.			Biochemical and Structural Studies of Uncharacterized Protein PA0743 from Pseudomonas aeruginosa Revealed NAD(+)-dependent L-Serine Dehydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHYLMALONATE-SEMIALDEHYDE DEHYDROGENASE; BETA-HYDROXYACID DEHYDROGENASES; 3-HYDROXYISOBUTYRATE DEHYDROGENASE; ESCHERICHIA-COLI; VALINE METABOLISM; CRYSTAL-STRUCTURE; PURIFICATION; MODEL; REFINEMENT; ACID	The beta-hydroxyacid dehydrogenases form a large family of ubiquitous enzymes that catalyze oxidation of various beta-hydroxy acid substrates to corresponding semialdehydes. Several known enzymes include beta-hydroxyisobutyrate dehydrogenase, 6-phosphogluconate dehydrogenase, 2-(hydroxymethyl)glutarate dehydrogenase, and phenylserine dehydrogenase, but the vast majority of beta-hydroxyacid dehydrogenases remain uncharacterized. Here, we demonstrate that the predicted beta-hydroxyisobutyrate dehydrogenase PA0743 from Pseudomonas aeruginosa catalyzes an NAD(+)-dependent oxidation of L-serine and methyl-L-serine but exhibits low activity against beta-hydroxyisobutyrate. Two crystal structures of PA0743 were solved at 2.2-2.3-angstrom resolution and revealed an N-terminal Rossmann fold domain connected by a long alpha-helix to the C-terminal all-alpha domain. The PA0743 apostructure showed the presence of additional density modeled as HEPES bound in the interdomain cleft close to the predicted catalytic Lys-171, revealing the molecular details of the PA0743 substrate-binding site. The structure of the PA0743-NAD(+) complex demonstrated that the opposite side of the enzyme active site accommodates the cofactor, which is also bound near Lys-171. Site-directed mutagenesis of PA0743 emphasized the critical role of four amino acid residues in catalysis including the primary catalytic residue Lys-171. Our results provide further insight into the molecular mechanisms of substrate selectivity and activity of beta-hydroxyacid dehydrogenases.	[Tchigvintsev, Anatoli; Singer, Alexander; Brown, Greg; Flick, Robert; Evdokimova, Elena; Savchenko, Alexei; Yakunin, Alexander F.] Univ Toronto, Banting & Best Dept Med Res, Dept Chem Engn & Appl Chem, Toronto, ON M5G 1L6, Canada; [Tan, Kemin] Argonne Natl Lab, Midw Ctr Struct Genom, Biosci Div, Argonne, IL 60439 USA; [Gonzalez, Claudio F.] Univ Florida, Genet Inst, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA; [Tan, Kemin] Struct Biol Ctr, Argonne, IL 60439 USA	University of Toronto; United States Department of Energy (DOE); Argonne National Laboratory; State University System of Florida; University of Florida	Yakunin, AF (corresponding author), Univ Toronto, Banting & Best Dept Med Res, Dept Chem Engn & Appl Chem, 112 Coll St, Toronto, ON M5G 1L6, Canada.	a.iakounine@utoronto.ca	Yakunin, Alexander/J-1519-2014	Yakunin, Alexander/0000-0003-0813-6490	National Institutes of Health from the Protein Structure Initiative [GM074942]; Government of Canada through Genome Canada; Ontario Genomics Institute [2009-OGI-ABC-1405]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074942, U54GM094585] Funding Source: NIH RePORTER	National Institutes of Health from the Protein Structure Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Government of Canada through Genome Canada(Genome Canada); Ontario Genomics Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM074942 from the Protein Structure Initiative (to the Midwest Center for Structural Genomics). This work was also supported by the Government of Canada through Genome Canada and Ontario Genomics Institute Grant 2009-OGI-ABC-1405.	ADAMS MJ, 1994, STRUCTURE, V2, P651, DOI 10.1016/S0969-2126(00)00066-6; Afonine P. V., 2005, CONTRIBUTION DARESBU; Anthon GE, 2004, J AGR FOOD CHEM, V52, P3749, DOI 10.1021/jf035284w; Carius Y, 2010, J BIOL CHEM, V285, P20006, DOI 10.1074/jbc.M110.113738; Chen YY, 2010, J STRUCT BIOL, V169, P25, DOI 10.1016/j.jsb.2009.08.006; Chowdhury EK, 1996, BIOSCI BIOTECH BIOCH, V60, P2043, DOI 10.1271/bbb.60.2043; Chowdhury EK, 1997, BIOSCI BIOTECH BIOCH, V61, P152, DOI 10.1271/bbb.61.152; Ciulli A, 2007, J BIOL CHEM, V282, P8487, DOI 10.1074/jbc.M611171200; CONGDON PJ, 1981, J INHERIT METAB DIS, V4, P79, DOI 10.1007/BF02263600; Cowtan K., 1994, CRYSTALLOGRAPHY, V31, P34; DeLaBarre B, 2000, NAT STRUCT BIOL, V7, P238; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fujisawa H, 2003, BBA-PROTEINS PROTEOM, V1645, P89, DOI 10.1016/S1570-9639(02)00533-2; GOODWIN GW, 1989, J BIOL CHEM, V264, P14965; Gutteridge A, 2005, TRENDS BIOCHEM SCI, V30, P622, DOI 10.1016/j.tibs.2005.09.006; HASEGAWA J, 1981, AGR BIOL CHEM TOKYO, V45, P2805, DOI 10.1080/00021369.1981.10864958; HAWES JW, 1995, BIOCHEMISTRY-US, V34, P4231, DOI 10.1021/bi00013a012; Hawes JW, 1996, FEBS LETT, V389, P263, DOI 10.1016/0014-5793(96)00597-2; Heering HA, 1997, J AM CHEM SOC, V119, P11628, DOI 10.1021/ja9723242; HEPTINST.J, 1970, BIOCHEM J, V117, P563, DOI 10.1042/bj1170563; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Keune H., 1976, EUR J APPL MICROBIOL, V2, P2175; Kimber MS, 2003, PROTEINS, V51, P562, DOI 10.1002/prot.10340; KO FJ, 1991, PEDIATR RES, V30, P322, DOI 10.1203/00006450-199110000-00006; LANDAAS S, 1975, CLIN CHIM ACTA, V64, P143, DOI 10.1016/0009-8981(75)90196-5; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LETTO J, 1986, BIOCHEM J, V240, P909, DOI 10.1042/bj2400909; Lokanath NK, 2005, J MOL BIOL, V352, P905, DOI 10.1016/j.jmb.2005.07.068; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Njau RK, 2001, CHEM-BIOL INTERACT, V130, P785, DOI 10.1016/S0009-2797(00)00234-9; Njau RK, 2000, J BIOL CHEM, V275, P38780, DOI 10.1074/jbc.M007432200; Otwinowski Z, 1991, P CCP4 STUD WEEK IS, P80; PACKDIBAMRUNG K, 1993, J BIOCHEM, V114, P930, DOI 10.1093/oxfordjournals.jbchem.a124279; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Reitz S, 2008, J MOL BIOL, V382, P802, DOI 10.1016/j.jmb.2008.07.050; ROBINSON WG, 1957, J BIOL CHEM, V225, P511; Rosenbaum G, 2006, J SYNCHROTRON RADIAT, V13, P30, DOI 10.1107/S0909049505036721; ROUGRAFF PM, 1989, J BIOL CHEM, V264, P5899; ROUGRAFF PM, 1988, J BIOL CHEM, V263, P327; Saito N, 2009, J BIOL CHEM, V284, P16442, DOI 10.1074/jbc.M109.002089; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Smith E.L., 1975, ENZYMES, P293, DOI DOI 10.1016/S1874-6047(08)60213-9; SOLORZANO L, 1969, LIMNOL OCEANOGR, V14, P799, DOI 10.4319/lo.1969.14.5.0799; STEELE MI, 1992, J BIOL CHEM, V267, P13585; van Maris AJA, 2004, METAB ENG, V6, P245, DOI 10.1016/j.ymben.2004.05.001; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; WONG HC, 1979, J BACTERIOL, V140, P240, DOI 10.1128/JB.140.1.240-245.1979; Yamazawa R, 2011, J BIOCHEM, V149, P701, DOI 10.1093/jb/mvr024; Yao TR, 2010, APPL BIOCHEM BIOTECH, V160, P694, DOI 10.1007/s12010-009-8685-x; Zhang RG, 2001, STRUCTURE, V9, P1095, DOI 10.1016/S0969-2126(01)00675-X	55	19	21	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					1874	1883		10.1074/jbc.M111.294561	http://dx.doi.org/10.1074/jbc.M111.294561			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22128181	hybrid, Green Published			2022-12-27	WOS:000299321000028
J	Ueta, T; Inoue, T; Furukawa, T; Tamaki, Y; Nakagawa, Y; Imai, H; Yanagi, Y				Ueta, Takashi; Inoue, Tatsuya; Furukawa, Takahisa; Tamaki, Yasuhiro; Nakagawa, Yasuhito; Imai, Hirotaka; Yanagi, Yasuo			Glutathione Peroxidase 4 Is Required for Maturation of Photoreceptor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED RETINAL DEGENERATION; RETINITIS-PIGMENTOSA; INCREASED EXPRESSION; OXIDATIVE DAMAGE; LIPID-PEROXIDATION; ROD PHOTORECEPTORS; DEATH; MOUSE; GENE; MICE	Oxidative stress is implicated in the pathologies of photoreceptor cells, and the protective role of antioxidant enzymes for photoreceptor cells have been well understood. However, their essentiality has remained unknown. In this study we generated photoreceptor-specific conditional knock-out (CKO) mice of glutathione peroxidase 4 (GPx4) and showed the critical role of GPx4 for photoreceptor cells. In the wild-type retina the dominant GPx4 expression was in the mitochondria, indicating the mitochondrial variant was the major GPx4 in the retina. In the GPx4-CKO mice, although photoreceptor cells developed and differentiated into rod and cone cells by P12, they rapidly underwent drastic degeneration and completely disappeared by P21. The photoreceptor cell death in the GPx4-CKO mice was associated with the nuclear translocation of apoptosis-inducing factor (AIF) and TUNEL-positive cells. Photoreceptor cells before undergoing apoptosis (P11) exhibited decreased mitochondrial biomass, decreased number of connecting cilia, as well as disorganized structure of outer segments. These findings indicate that GPx4 is a critical antioxidant enzyme for the maturation and survival of photoreceptor cells.	[Ueta, Takashi] Univ Tokyo, Sch Med, Dept Ophthalmol, Bunkyo Ku, Tokyo 1138655, Japan; [Furukawa, Takahisa] JST, CREST, Osaka 5650874, Japan; [Furukawa, Takahisa] Osaka Biosci Inst, Dept Dev Biol, Osaka 5650874, Japan; [Nakagawa, Yasuhito; Imai, Hirotaka] Kitasato Univ, Sch Pharmaceut Sci, Tokyo 1088641, Japan	University of Tokyo; Japan Science & Technology Agency (JST); Kitasato University	Ueta, T (corresponding author), Univ Tokyo, Sch Med, Dept Ophthalmol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	ueta-tky@umin.ac.jp	Yanagi, Yasuo/AAF-2670-2020; Yanagi, Yasuo/AAA-5441-2022	Yanagi, Yasuo/0000-0002-0362-7285	Japan Society for the Promotion of Science [21791669, 20390446, 23659806]; Grants-in-Aid for Scientific Research [10J06326] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research from Japan Society for the Promotion of Science (21791669) ( to Y. Y.), and (20390446 and 23659806) (to Y. T.).	Cayouette M, 1999, NEUROBIOL DIS, V6, P523, DOI 10.1006/nbdi.1999.0263; Cronin T, 2010, CELL DEATH DIFFER, V17, P1199, DOI 10.1038/cdd.2010.2; Dong A, 2007, J NEUROCHEM, V103, P1041, DOI 10.1111/j.1471-4159.2007.04839.x; Frasson M, 1999, INVEST OPHTH VIS SCI, V40, P2724; Gosbell AD, 2006, INVEST OPHTH VIS SCI, V47, P2613, DOI 10.1167/iovs.05-0962; Harada T, 2002, J NEUROSCI, V22, P9228, DOI 10.1523/jneurosci.22-21-09228.2002; Haruta M, 2009, P NATL ACAD SCI USA, V106, P9397, DOI 10.1073/pnas.0808940106; Hashizume K, 2008, AM J PATHOL, V172, P1325, DOI 10.2353/ajpath.2008.070730; Imai H, 2003, BIOCHEM BIOPH RES CO, V305, P278, DOI 10.1016/S0006-291X(03)00734-4; Imai H, 2001, BIOL REPROD, V64, P674, DOI 10.1095/biolreprod64.2.674; Imai H, 2010, J CLIN BIOCHEM NUTR, V46, P1, DOI 10.3164/jcbn.09-94R; Imai H, 2009, J BIOL CHEM, V284, P32522, DOI 10.1074/jbc.M109.016139; Komeima K, 2006, P NATL ACAD SCI USA, V103, P11300, DOI 10.1073/pnas.0604056103; Lu LL, 2009, ANTIOXID REDOX SIGN, V11, P715, DOI [10.1089/ars.2008.2171, 10.1089/ARS.2008.2171]; Maiorino M, 2003, J BIOL CHEM, V278, P34286, DOI 10.1074/jbc.M305327200; Nishida A, 2003, NAT NEUROSCI, V6, P1255, DOI 10.1038/nn1155; Okoye G, 2003, J NEUROSCI, V23, P4164; Osborne NN, 2004, INVEST OPHTH VIS SCI, V45, P3787, DOI 10.1167/iovs.04-0147; Ramamurthy V, 2009, CLIN GENET, V76, P137, DOI 10.1111/j.1399-0004.2009.01240.x; ROOF DJ, 1994, INVEST OPHTH VIS SCI, V35, P4049; Ross CA, 2006, NAT MED, V12, P1239, DOI 10.1038/nm1106-1239; Schneider M, 2009, FASEB J, V23, P3233, DOI 10.1096/fj.09-132795; Seiler A, 2008, CELL METAB, V8, P237, DOI 10.1016/j.cmet.2008.07.005; Shen JK, 2005, J CELL PHYSIOL, V203, P457, DOI 10.1002/jcp.20346; Tanito M, 2002, INVEST OPHTH VIS SCI, V43, P1162; Tanito M, 2005, J NEUROSCI, V25, P2396, DOI 10.1523/JNEUROSCI.4866-04.2005; THOMAS JP, 1990, BIOCHIM BIOPHYS ACTA, V1045, P252, DOI 10.1016/0005-2760(90)90128-K; Uchida K, 1998, J BIOL CHEM, V273, P16058, DOI 10.1074/jbc.273.26.16058; Ufer C, 2008, GENE DEV, V22, P1838, DOI 10.1101/gad.466308; Usui S, 2009, MOL THER, V17, P778, DOI 10.1038/mt.2009.47; Wirth EK, 2010, FASEB J, V24, P844, DOI 10.1096/fj.09-143974; Yang Y, 2009, MOL THER, V17, P787, DOI 10.1038/mt.2009.28; Zhang M, 2009, CURR EYE RES, V34, P791, DOI 10.1080/02713680903086018	33	76	79	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7675	7682		10.1074/jbc.M111.335174	http://dx.doi.org/10.1074/jbc.M111.335174			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22207760	Green Published, hybrid			2022-12-27	WOS:000301060200066
J	Ota, A; Wang, YB				Ota, Asuka; Wang, Yibin			Cdc37/Hsp90 Protein-mediated Regulation of IRE1 alpha Protein Activity in Endoplasmic Reticulum Stress Response and Insulin Synthesis in INS-1 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER STRESS; MESSENGER-RNA; SACCHAROMYCES-CEREVISIAE; INDUCED APOPTOSIS; KINASE IRE1; BETA-CELL; ATF6; ACTIVATION; TRANSCRIPTION; INDUCTION	IRE1 alpha is an endoplasmic reticulum (ER) localized signaling molecule critical for unfolded protein response. During ER stress, IRE1 alpha activation is induced by oligomerization and autophosphorylation in its cytosolic domain, a process triggered by dissociation of an ER luminal chaperone, binding immunoglobulin-protein (BiP), from IRE1 alpha. In addition, inhibition of a cytosolic chaperone protein Hsp90 also induces IRE1 alpha oligomerization and activation in the absence of an ER stressor. Here, we report that the Hsp90 cochaperone Cdc37 directly interacts with IRE1 alpha through a highly conserved cytosolic motif of IRE1 alpha. Cdc37 knockdown or disruption of Cdc37 interaction with IRE1 alpha significantly increased basal IRE1 alpha activity. In INS-1 cells, Hsp90 inhibition and disruption of IRE1 alpha-Cdc37 interaction both induced an ER stress response and impaired insulin synthesis and secretion. These data suggest that Cdc37-mediated direct interaction between Hsp90/Cdc37 and an IRE1 alpha cytosolic motif is important to maintain basal IRE1 alpha activity and contributes to normal protein homeostasis and unfolded protein response under physiological stimulation.	[Ota, Asuka; Wang, Yibin] Univ Calif Los Angeles, David Geffen Sch Med, Div Mol Med, Dept Anesthesiol, Los Angeles, CA 90095 USA; [Ota, Asuka; Wang, Yibin] Univ Calif Los Angeles, David Geffen Sch Med, Div Mol Med, Dept Physiol, Los Angeles, CA 90095 USA; [Ota, Asuka; Wang, Yibin] Univ Calif Los Angeles, David Geffen Sch Med, Div Mol Med, Dept Med, Los Angeles, CA 90095 USA; [Wang, Yibin] Univ Calif Los Angeles, David Geffen Sch Med, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Wang, YB (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Mol Med, Dept Anesthesiol, BH 569,CHS,650 Charles E Young Dr, Los Angeles, CA 90095 USA.	yibinwang@mednet.ucla.edu		Wang, Yibin/0000-0003-0852-0767	National Institutes of Health [F31AG032163, HL070079, 088640]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F31AG032163] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported, in whole or in part, by National Institutes of Health Pre-doctoral Individual Fellowship Award F31AG032163 (to A. O.) and Grants HL070079 and 088640 (to Y. W.). This work was also supported by an American Heart Association Established Investigator award (to Y. W.).	Allagnat F, 2010, DIABETOLOGIA, V53, P1120, DOI 10.1007/s00125-010-1699-7; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Csermely P, 1998, PHARMACOL THERAPEUT, V79, P129, DOI 10.1016/S0163-7258(98)00013-8; Davenport EL, 2007, BLOOD, V110, P2641, DOI 10.1182/blood-2006-11-053728; Fonseca SG, 2010, ISLETS, V2, P1, DOI 10.4161/isl.2.1.10456; Fonseca V, 2010, CURR MED RES OPIN, V26, P1621, DOI 10.1185/03007995.2010.485087; Guo J, 2006, EMBO REP, V7, P1124, DOI 10.1038/sj.embor.7400813; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Hartley T, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-59; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Lai MT, 2003, CELL SIGNAL, V15, P585, DOI 10.1016/S0898-6568(03)00004-4; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Lee KPK, 2008, CELL, V132, P89, DOI 10.1016/j.cell.2007.10.057; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Lipson KL, 2006, CELL METAB, V4, P245, DOI 10.1016/j.cmet.2006.07.007; Ma YJ, 2004, J BIOL CHEM, V279, P13792, DOI 10.1074/jbc.M313724200; Ma YJ, 2001, CELL, V107, P827, DOI 10.1016/S0092-8674(01)00623-7; Marcu MG, 2002, MOL CELL BIOL, V22, P8506, DOI 10.1128/MCB.22.24.8506-8513.2002; Niwa M, 1999, CELL, V99, P691, DOI 10.1016/S0092-8674(00)81667-0; Okada T, 2002, BIOCHEM J, V366, P585, DOI 10.1042/BJ20020391; Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2; Shen JS, 2002, DEV CELL, V3, P99, DOI 10.1016/S1534-5807(02)00203-4; Sommer T, 2002, DEV CELL, V3, P1, DOI 10.1016/S1534-5807(02)00210-1; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Taiyab A, 2009, BIOCHEM PHARMACOL, V78, P142, DOI 10.1016/j.bcp.2009.04.001; Tirasophon W, 2000, GENE DEV, V14, P2725, DOI 10.1101/gad.839400; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Welihinda AA, 1996, J BIOL CHEM, V271, P18181, DOI 10.1074/jbc.271.30.18181; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 2003, DEV CELL, V4, P265, DOI 10.1016/S1534-5807(03)00022-4; Yoshida H, 2007, FEBS J, V274, P630, DOI 10.1111/j.1742-4658.2007.05639.x	31	26	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6266	6274		10.1074/jbc.M111.331264	http://dx.doi.org/10.1074/jbc.M111.331264			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22199355	hybrid, Green Published			2022-12-27	WOS:000300791800019
J	Zapater, JL; Colley, KJ				Zapater, Joseph L.; Colley, Karen J.			Sequences Prior to Conserved Catalytic Motifs of Polysialyltransferase ST8Sia IV Are Required for Substrate Recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION MOLECULE; CENTRAL-NERVOUS-SYSTEM; AMINO-ACID-RESIDUES; POLYSIALIC-ACID; III REPEAT; DIFFERENTIAL BIOSYNTHESIS; INTERNEURON PRECURSORS; GLYCAN POLYSIALYLATION; NCAM POLYSIALYLATION; PROTEIN SECONDARY	Polysialic acid on the neural cell adhesion molecule (NCAM) modulates cell-cell adhesion and signaling, is required for proper brain development, and plays roles in neuronal regeneration and the growth and invasiveness of tumor cells. Evidence indicates that NCAM polysialylation is highly protein-specific, requiring an initial polysialyltransferase-NCAM protein-protein interaction. Previous work suggested that a polybasic region located prior to the conserved polysialyltransferase catalytic motifs may be involved in NCAM recognition, but not overall enzyme activity (Foley, D. A., Swartzentruber, K. G., and Colley, K. J. (2009) J. Biol. Chem. 284, 15505-15516). Here, we employ a competition assay to evaluate the role of this region in substrate recognition. We find that truncated, catalytically inactive ST8SiaIV/PST proteins that include the polybasic region, but not those that lack this region, compete with endogenous ST8SiaIV/PST and reduce NCAM polysialylation in SW2 small cell lung carcinoma cells. Replacing two polybasic region residues, Arg(82) and Arg(93), eliminates the ability of a full-length, catalytically inactive enzyme (PST H331K) to compete with SW2 cell ST8SiaIV/PST and block NCAM polysialylation. Replacing these residues singly or together in ST8SiaIV/PST substantially reduces or eliminates NCAM polysialylation, respectively. In contrast, replacing Arg(82), but not Arg(93), substantially reduces the ability of ST8SiaIV/PST to polysialylate neuropilin-2 and SynCAM 1, suggesting that Arg(82) plays a general role in substrate recognition, whereas Arg(93) specifically functions in NCAM recognition. Taken together, our results indicate that the ST8SiaIV/PST polybasic region plays a critical role in substrate recognition and suggest that different combinations of basic residues may mediate the recognition of distinct substrates.	[Zapater, Joseph L.; Colley, Karen J.] Univ Illinois, Coll Med, Dept Biochem & Mol Genet, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Colley, KJ (corresponding author), 900 S Ashland Ave,M-C 669, Chicago, IL 60607 USA.	karenc@uic.edu			National Institutes of Health [RO1 GM063843]; NIGMS [F31 GM096739]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063843, F31GM096739] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 GM063843 (to K.J.C.) and Fellowship F31 GM096739 from the NIGMS (to J.L.Z.).	Angata K, 2003, BIOCHIMIE, V85, P195, DOI 10.1016/S0300-9084(03)00051-8; Angata K, 2000, J BIOL CHEM, V275, P18594, DOI 10.1074/jbc.M910204199; Angata K, 2004, J BIOL CHEM, V279, P25883, DOI 10.1074/jbc.M401562200; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Bonfanti L, 2006, PROG NEUROBIOL, V80, P129, DOI 10.1016/j.pneurobio.2006.08.003; Bruses JL, 2001, BIOCHIMIE, V83, P635, DOI 10.1016/S0300-9084(01)01293-7; Burgess A, 2008, DEV NEUROBIOL, V68, P1580, DOI 10.1002/dneu.20681; Chiu CPC, 2004, NAT STRUCT MOL BIOL, V11, P163, DOI 10.1038/nsmb720; Close BE, 2003, J BIOL CHEM, V278, P30796, DOI 10.1074/jbc.M305390200; Close BE, 1998, J BIOL CHEM, V273, P34586, DOI 10.1074/jbc.273.51.34586; CUNNINGHAM BA, 1987, SCIENCE, V236, P799, DOI 10.1126/science.3576199; Curreli S, 2007, J BIOL CHEM, V282, P30346, DOI 10.1074/jbc.M702965200; DATTA AK, 1995, J BIOL CHEM, V270, P1497, DOI 10.1074/jbc.270.4.1497; Datta AK, 1998, J BIOL CHEM, V273, P9608, DOI 10.1074/jbc.273.16.9608; Ditlevsen DK, 2008, J NEUROSCI RES, V86, P727, DOI 10.1002/jnr.21551; Durbec P, 2001, MOL NEUROBIOL, V24, P53; ECKHARDT M, 1995, NATURE, V373, P715, DOI 10.1038/373715a0; Foley DA, 2010, J BIOL CHEM, V285, P35056, DOI 10.1074/jbc.M110.170209; Foley DA, 2010, J BIOL CHEM, V285, P27360, DOI 10.1074/jbc.M110.140038; Foley DA, 2009, J BIOL CHEM, V284, P15505, DOI 10.1074/jbc.M809696200; Forsee WT, 2006, J BIOL CHEM, V281, P6283, DOI 10.1074/jbc.M511124200; Fujimoto I, 2001, J BIOL CHEM, V276, P31745, DOI 10.1074/jbc.M104525200; Galuska SP, 2006, J BIOL CHEM, V281, P31605, DOI 10.1074/jbc.M606516200; Galuska SP, 2010, P NATL ACAD SCI USA, V107, P10250, DOI 10.1073/pnas.0912103107; Geremia RA, 1997, GLYCOBIOLOGY, V7, pR5; Geyer H, 2001, EUR J BIOCHEM, V268, P6587, DOI 10.1046/j.0014-2956.2001.02613.x; Hildebrandt H, 1998, CANCER RES, V58, P779; Hildebrandt H, 2007, J NEUROCHEM, V103, P56, DOI 10.1111/j.1471-4159.2007.04716.x; Horstkorte R, 1999, EXP CELL RES, V246, P122, DOI 10.1006/excr.1998.4255; Hu HY, 2000, J NEUROSCI RES, V61, P480, DOI 10.1002/1097-4547(20000901)61:5<480::AID-JNR2>3.0.CO;2-M; Hu HY, 1996, NEURON, V16, P735, DOI 10.1016/S0896-6273(00)80094-X; Isomura R, 2011, J BIOL CHEM, V286, P21535, DOI 10.1074/jbc.M111.221143; JAMES WM, 1987, BIOCHEM BIOPH RES CO, V148, P817, DOI 10.1016/0006-291X(87)90949-1; Jeanneau C, 2004, J BIOL CHEM, V279, P13461, DOI 10.1074/jbc.M311764200; Johnson CP, 2005, J BIOL CHEM, V280, P137, DOI 10.1074/jbc.M410216200; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Jungnickel J, 2009, MOL CELL NEUROSCI, V40, P374, DOI 10.1016/j.mcn.2008.12.003; Kanato Y, 2008, GLYCOBIOLOGY, V18, P1044, DOI 10.1093/glycob/cwn084; KISS JZ, 1993, NEUROSCIENCE, V53, P213, DOI 10.1016/0306-4522(93)90299-U; Kitazume-Kawaguchi S, 2001, J BIOL CHEM, V276, P15696, DOI 10.1074/jbc.M010371200; KOJIMA N, 1995, FEBS LETT, V360, P1, DOI 10.1016/0014-5793(95)00059-I; Kojima N, 1996, J BIOL CHEM, V271, P19457, DOI 10.1074/jbc.271.32.19457; Kudo M, 1996, J BIOL CHEM, V271, P32667, DOI 10.1074/jbc.271.51.32667; Laha KT, 2011, MOL PHARMACOL, V79, P662, DOI 10.1124/mol.110.068619; LIVINGSTON BD, 1988, J BIOL CHEM, V263, P9443; Meiler J, 2003, P NATL ACAD SCI USA, V100, P12105, DOI 10.1073/pnas.1831973100; Mendiratta SS, 2006, J BIOL CHEM, V281, P36052, DOI 10.1074/jbc.M608073200; Mendiratta SS, 2005, J BIOL CHEM, V280, P32340, DOI 10.1074/jbc.M506217200; Miyahara R, 2001, J SURG ONCOL, V77, P49, DOI 10.1002/jso.1065; Moreira IS, 2007, PROTEINS, V68, P803, DOI 10.1002/prot.21396; Muhlenhoff M, 1996, EMBO J, V15, P6943, DOI 10.1002/j.1460-2075.1996.tb01086.x; Nakata D, 2006, GLYCOCONJUGATE J, V23, P423, DOI 10.1007/s10719-006-6356-5; NAKAYAMA J, 1995, P NATL ACAD SCI USA, V92, P7031, DOI 10.1073/pnas.92.15.7031; Nakayama J, 1998, PATHOL INT, V48, P665, DOI 10.1111/j.1440-1827.1998.tb03967.x; NELSON RW, 1995, J BIOL CHEM, V270, P17171, DOI 10.1074/jbc.270.29.17171; Pellet-Many C, 2008, BIOCHEM J, V411, P211, DOI 10.1042/BJ20071639; PERERA AD, 1993, ENDOCRINOLOGY, V133, P2729, DOI 10.1210/en.133.6.2729; Petridis AK, 2009, ACTA NEUROCHIR, V151, P601, DOI 10.1007/s00701-009-0324-3; Rao FV, 2009, NAT STRUCT MOL BIOL, V16, P1186, DOI 10.1038/nsmb.1685; Rey-Gallardo A, 2010, GLYCOBIOLOGY, V20, P1139, DOI 10.1093/glycob/cwq078; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; SCHEIDEGGER EP, 1995, J BIOL CHEM, V270, P22685, DOI 10.1074/jbc.270.39.22685; SCHEIDEGGER EP, 1994, LAB INVEST, V70, P95; Seidenfaden R, 2000, EUR J CELL BIOL, V79, P680, DOI 10.1078/0171-9335-00093; SEKI T, 1993, NEUROSCI RES, V17, P265, DOI 10.1016/0168-0102(93)90111-3; Soroka V, 2003, STRUCTURE, V11, P1291, DOI 10.1016/j.str.2003.09.006; STANLEY P, 1984, ANNU REV GENET, V18, P525, DOI 10.1146/annurev.ge.18.120184.002521; Stoenica L, 2006, EUR J NEUROSCI, V23, P2255, DOI 10.1111/j.1460-9568.2006.04771.x; Suzuki M, 2005, GLYCOBIOLOGY, V15, P887, DOI 10.1093/glycob/cwi071; Thomas LA, 2008, J COMP NEUROL, V510, P47, DOI 10.1002/cne.21773; Thompson MG, 2011, J BIOL CHEM, V286, P4525, DOI 10.1074/jbc.M110.200386; von der Ohe M, 2002, GLYCOBIOLOGY, V12, P47, DOI 10.1093/glycob/12.1.47; Walmod PS, 2004, NEUROCHEM RES, V29, P2015, DOI 10.1007/s11064-004-6875-z; Weinhold B, 2005, J BIOL CHEM, V280, P42971, DOI 10.1074/jbc.M511097200; Yabe U, 2003, J BIOL CHEM, V278, P13875, DOI 10.1074/jbc.M300458200	75	23	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6441	6453		10.1074/jbc.M111.322024	http://dx.doi.org/10.1074/jbc.M111.322024			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22184126	Green Published, hybrid			2022-12-27	WOS:000300791800034
J	Le, HT; Gautier, V; Kthiri, F; Malki, A; Messaoudi, N; Mihoub, M; Landoulsi, A; An, YJ; Cha, SS; Richarme, G				Hai-Tuong Le; Gautier, Valerie; Kthiri, Fatoum; Malki, Abderrahim; Messaoudi, Nadia; Mihoub, Mouadh; Landoulsi, Ahmed; An, Young Jun; Cha, Sun-Shin; Richarme, Gilbert			YajL, Prokaryotic Homolog of Parkinsonism-associated Protein DJ-1, Functions as a Covalent Chaperone for Thiol Proteome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI HSP31; RESOLUTION CRYSTAL-STRUCTURE; DISULFIDE-ISOMERASE; OXIDATIVE STRESS; ALPHA-SYNUCLEIN; ENDOPLASMIC-RETICULUM; BACTERIAL HOMOLOG; MUTANT DEFICIENT; CELL-DEATH; THIOREDOXIN	YajL is the closest Escherichia coli homolog of the Parkinsonism-associated protein DJ-1, a multifunctional oxidative stress response protein whose biochemical function remains unclear. We recently reported the aggregation of proteins in a yajL mutant in an oxidative stress-dependent manner and that YajL exhibits chaperone activity. Here, we show that YajL displays covalent chaperone and weak protein oxidoreductase activities that are dependent on its exposed cysteine 106. It catalyzes reduced RNase oxidation and scrambled RNase isomerization and insulin reduction and forms mixed disulfides with many cellular proteins upon oxidative stress. The formation of mixed disulfides was detected by immunoblotting bacterial extracts with anti-YajL antibodies under nonreducing conditions. Disulfides were purified from bacterial extracts on a YajL affinity column, separated by nonreducing-reducing SDS-PAGE, and identified by mass spectrometry. Covalent YajL substrates included ribosomal proteins, aminoacyl-tRNA synthetases, chaperones, catalases, peroxidases, and other proteins containing cysteines essential for catalysis or FeS cluster binding, such as glyceraldehyde-3-phosphate dehydrogenase, aldehyde dehydrogenase, aconitase, and FeS cluster-containing subunits of respiratory chains. In addition, we show that DJ-1 also forms mixed disulfides with cytoplasmic proteins upon oxidative stress. These results shed light on the oxidative stress-dependent chaperone function of YajL and identify YajL substrates involved in translation, stress protection, protein solubilization, and metabolism. They reveal a crucial role for cysteine 106 and suggest that DJ-1 also functions as a covalent chaperone. These findings are consistent with several defects observed in yajL or DJ-1 mutants, including translational defects, protein aggregation, oxidative stress sensitivity, and metabolic deficiencies.	[Hai-Tuong Le; Gautier, Valerie; Kthiri, Fatoum; Malki, Abderrahim; Messaoudi, Nadia; Mihoub, Mouadh; Richarme, Gilbert] Univ Paris 07, Stress Mol Grp, Inst Jacques Monod, CNRS, F-75013 Paris, France; [An, Young Jun; Cha, Sun-Shin] Korea Ocean Res & Dev Inst, Marine Biotechnol Res Ctr, Ansan 426744, South Korea; [Malki, Abderrahim] Univ Hassan II Mohammedia, Fac Sci Ben MSik, Casablanca, Morocco; [Kthiri, Fatoum; Messaoudi, Nadia; Mihoub, Mouadh; Landoulsi, Ahmed] Fac Sci Bizerte, Lab Biochim & Biol Mol, UR 0902 03, Bizerte, Tunisia	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Korea Institute of Ocean Science & Technology (KIOST); Hassan II University of Casablanca; Universite de Carthage	Richarme, G (corresponding author), Univ Paris 07, Stress Mol Grp, Inst Jacques Monod, CNRS, 15 Rue Helene Brion, F-75013 Paris, France.	richarme@paris7.jussieu.fr		Cha, Sun-Shin/0000-0002-0913-8706; Landoulsi, Ahmed/0000-0002-5101-7641	PHC-Utique [10G0803]; la Fondation de la Recherche Medicale; Marine and Extreme Genome Research Cente of Ministry of Land, Transport, and Maritime Affairs, South Korea	PHC-Utique; la Fondation de la Recherche Medicale; Marine and Extreme Genome Research Cente of Ministry of Land, Transport, and Maritime Affairs, South Korea	This work was supported by grants from the PHC-Utique (to N. M. and M. M.) (Grant 10G0803), la Fondation de la Recherche Medicale (to F. K.), and the Marine and Extreme Genome Research Center program of Ministry of Land, Transport, and Maritime Affairs, South Korea (to Y. J. A. and S. C.).	Abdallah J, 2007, J BACTERIOL, V189, P9140, DOI 10.1128/JB.01208-07; Andres-Mateos E, 2007, P NATL ACAD SCI USA, V104, P14807, DOI 10.1073/pnas.0703219104; Anelli T, 2002, EMBO J, V21, P835, DOI 10.1093/emboj/21.4.835; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; CALHOUN MW, 1993, J BACTERIOL, V175, P3013, DOI 10.1128/JB.175.10.3013-3019.1993; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Clements CM, 2006, P NATL ACAD SCI USA, V103, P15091, DOI 10.1073/pnas.0607260103; Cookson MR, 2005, ANNU REV BIOCHEM, V74, P29, DOI 10.1146/annurev.biochem.74.082803.133400; Cortini M, 2010, DIABETES OBES METAB, V12, P39, DOI 10.1111/j.1463-1326.2010.01272.x; Cumming RC, 2004, J BIOL CHEM, V279, P21749, DOI 10.1074/jbc.M312267200; DECROUYCHANEL A, 1995, J BIOL CHEM, V270, P22669, DOI 10.1074/jbc.270.39.22669; Dyson HJ, 1997, BIOCHEMISTRY-US, V36, P2622, DOI 10.1021/bi961801a; Friedrich T, 2004, BBA-BIOENERGETICS, V1608, P1, DOI 10.1016/j.bbabio.2003.10.002; Guzman JN, 2010, NATURE, V468, P696, DOI 10.1038/nature09536; HAWKINS HC, 1991, BIOCHEM J, V275, P349, DOI 10.1042/bj2750349; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; Hu WT, 2010, ANAL BIOCHEM, V398, P245, DOI 10.1016/j.ab.2009.11.002; Jin JH, 2007, MOL CELL PROTEOMICS, V6, P845, DOI 10.1074/mcp.M600182-MCP200; Jordan PA, 1999, BIOCHEM J, V344, P739, DOI 10.1042/0264-6021:3440739; Junn E, 2005, P NATL ACAD SCI USA, V102, P9691, DOI 10.1073/pnas.0409635102; Kadokura H, 2004, SCIENCE, V303, P534, DOI 10.1126/science.1091724; Kthiri F, 2010, J BACTERIOL, V192, P6302, DOI 10.1128/JB.01077-10; Kthiri F, 2010, J BIOL CHEM, V285, P10328, DOI 10.1074/jbc.M109.077529; Lee SJ, 2003, J BIOL CHEM, V278, P44552, DOI 10.1074/jbc.M304517200; Leichert LI, 2008, P NATL ACAD SCI USA, V105, P8197, DOI 10.1073/pnas.0707723105; Li HM, 2005, FREE RADICAL RES, V39, P1091, DOI 10.1080/10715760500260348; Maisonneuve E, 2008, J BACTERIOL, V190, P6609, DOI 10.1128/JB.00588-08; Maisonneuve E, 2008, J BACTERIOL, V190, P887, DOI 10.1128/JB.01603-07; Malki A, 2005, J BIOL CHEM, V280, P14420, DOI 10.1074/jbc.M408296200; Nakajima H, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M704199200; Park SW, 2009, P NATL ACAD SCI USA, V106, P6950, DOI 10.1073/pnas.0808722106; Poole LB, 2005, ARCH BIOCHEM BIOPHYS, V433, P240, DOI 10.1016/j.abb.2004.09.006; Quigley PM, 2003, P NATL ACAD SCI USA, V100, P3137, DOI 10.1073/pnas.0530312100; Ramsey CP, 2010, HUM MOL GENET, V19, P1425, DOI 10.1093/hmg/ddq017; Sastry MSR, 2002, J BIOL CHEM, V277, P46026, DOI 10.1074/jbc.M205800200; Shendelman S, 2004, PLOS BIOL, V2, P1764, DOI 10.1371/journal.pbio.0020362; van der Brug MP, 2008, P NATL ACAD SCI USA, V105, P10244, DOI 10.1073/pnas.0708518105; van Lith M, 2005, J BIOL CHEM, V280, P1376, DOI 10.1074/jbc.M408651200; Varghese S, 2003, J BACTERIOL, V185, P221, DOI 10.1128/JB.185.1.221-230.2003; Waak J, 2009, J BIOL CHEM, V284, P14245, DOI 10.1074/jbc.M806902200; Walker KW, 1997, J BIOL CHEM, V272, P8845; WALLACE BJ, 1977, BIOCHIM BIOPHYS ACTA, V461, P84, DOI 10.1016/0005-2728(77)90071-8; Wang LK, 2008, EMBO REP, V9, P642, DOI 10.1038/embor.2008.88; Wilson MA, 2005, J MOL BIOL, V353, P678, DOI 10.1016/j.jmb.2005.08.033; Wilson MA, 2003, P NATL ACAD SCI USA, V100, P9256, DOI 10.1073/pnas.1133288100; Wilson MA, 2011, ANTIOXID REDOX SIGN, V15, P111, DOI 10.1089/ars.2010.3481; Xu XM, 2010, J CELL SCI, V123, P1644, DOI 10.1242/jcs.063222; Zhou WB, 2006, J MOL BIOL, V356, P1036, DOI 10.1016/j.jmb.2005.12.030; Zhou WB, 2005, J BIOL CHEM, V280, P43150, DOI 10.1074/jbc.M507124200	49	32	34	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5861	5870		10.1074/jbc.M111.299198	http://dx.doi.org/10.1074/jbc.M111.299198			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22157000	hybrid, Green Published			2022-12-27	WOS:000300638000060
J	Page, TH; D'Souza, Z; Nakanishi, S; Serikawa, T; Pusey, CD; Aitman, TJ; Cook, HT; Behmoaras, J				Page, Theresa H.; D'Souza, Zelpha; Nakanishi, Satoshi; Serikawa, Tadao; Pusey, Charles D.; Aitman, Timothy J.; Cook, H. Terence; Behmoaras, Jacques			Role of Novel Rat-specific Fc Receptor in Macrophage Activation Associated with Crescentic Glomerulonephritis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-RIII CD16; MEDIATED PHAGOCYTOSIS; FUNCTIONAL ASSOCIATION; SIGNAL-TRANSDUCTION; TYROSINE KINASES; IMMUNOGLOBULIN-G; DEFICIENT MICE; CHAIN; POLYMORPHISM; EXPRESSION	Crescentic glomerulonephritis (Crgn) is a complex disease where the initial insult is often the glomerular deposition of antibodies against intrinsic or deposited antigens in the glomerulus. The role of Fc receptors in the induction and progression of Crgn is increasingly recognized, and our previous studies have shown that copy number variation in Fcgr3 partially explains the genetic susceptibility of the Wistar-Kyoto (WKY) rat to nephrotoxic nephritis, a rat model of Crgn. The Fcgr3-related sequence (Fcgr3-rs) is a novel rat-specific Fc receptor with a cytoplasmic domain 6 amino acids longer than its paralogue, Fcgr3. The Fcgr3-rs gene is deleted from the WKY rat genome, and this deletion is associated with enhanced macrophage activity in this strain. Here, we investigated the mechanism by which the deletion of Fcgr3-rs in the WKY strain leads to increased macrophage activation. By lentivirus-mediated gene delivery, we generated stably transduced U937 cells expressing either Fcgr3-rs or Fcgr3. In these cells, which lack endogenous Fcgr3 receptors, we show that Fcgr3-rs interacts with the common Fc-gamma chain but that Fc receptor-mediated phagocytosis and signaling are defective. Furthermore, in primary macrophages, expression of Fcgr3-rs inhibits Fc receptor-mediated functions, because WKY bone marrow-derived macrophages transduced with Fcgr3-rs had significantly reduced phagocytic activity. This inhibitory effect on phagocytosis was mediated by the novel cytoplasmic domain of Fcgr3-rs. These results suggest that Fcgr3-rs may act to inhibit Fcgr3-mediated signaling and phagocytosis and could be considered as a novel mechanism in the modulation of Fc receptor-mediated cell activation in autoimmune diseases.	[Cook, H. Terence; Behmoaras, Jacques] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Ctr Complement & Inflammat Res, London W12 0NN, England; [Page, Theresa H.] Univ London Imperial Coll Sci Technol & Med, Div Rheumatol, Kennedy Inst, London W6 8LH, England; [Pusey, Charles D.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Renal Dept, London W12 0NN, England; [D'Souza, Zelpha; Aitman, Timothy J.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Med Res Council Clin Sci Ctr, London W12 0NN, England; [Nakanishi, Satoshi; Serikawa, Tadao] Kyoto Univ, Grad Sch Med, Inst Lab Anim, Sakyo Ku, Kyoto 6068501, Japan	Imperial College London; Imperial College London; University of Oxford; Imperial College London; Imperial College London; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); Kyoto University	Behmoaras, J (corresponding author), Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Ctr Complement & Inflammat Res, Du Cane Rd, London W12 0NN, England.	Jacquesb@imperial.ac.uk		Page, Theresa/0000-0002-2664-4256; Aitman, Timothy/0000-0002-7875-4502	Wellcome Trust; Clinical Sciences Centre; United Kingdom Medical Research Council; Imperial College; MRC [MC_U120061454, G0400116] Funding Source: UKRI; Medical Research Council [G0400116, MC_U120061454] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Clinical Sciences Centre; United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Imperial College; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by intramural funding from the Wellcome Trust, Clinical Sciences Centre, and the United Kingdom Medical Research Council. Recipient of an Imperial College Junior Research Fellowship.	Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Bainbridge JWB, 2001, GENE THER, V8, P1665, DOI 10.1038/sj.gt.3301574; Behmoaras J, 2008, NAT GENET, V40, P553, DOI 10.1038/ng.137; Behmoaras J, 2010, J AM SOC NEPHROL, V21, P1136, DOI 10.1681/ASN.2009090968; Brown EE, 2007, AUTOIMMUNITY, V40, P567, DOI 10.1080/08916930701763710; Crowley MT, 1997, J EXP MED, V186, P1027, DOI 10.1084/jem.186.7.1027; DAVIS W, 1995, EMBO J, V14, P432, DOI 10.1002/j.1460-2075.1995.tb07019.x; Floto RA, 2005, NAT MED, V11, P1056, DOI 10.1038/nm1288; GHAZIZADEH S, 1994, J BIOL CHEM, V269, P8878; Hou XH, 1996, J BIOL CHEM, V271, P22815, DOI 10.1074/jbc.271.37.22815; Huang ZY, 2004, J LEUKOCYTE BIOL, V76, P491, DOI 10.1189/jlb.1103562; INDIK ZK, 1995, BLOOD, V86, P4389, DOI 10.1182/blood.V86.12.4389.bloodjournal86124389; Kim MK, 2003, BLOOD, V101, P4479, DOI 10.1182/blood.V101.11.4479; Kuramoto T, 2008, PHYSIOL GENOMICS, V33, P205, DOI 10.1152/physiolgenomics.00222.2007; LANIER LL, 1991, J IMMUNOL, V146, P1571; Lowry MB, 1998, J EXP MED, V187, P161, DOI 10.1084/jem.187.2.161; Maratou K, 2011, GENES IMMUN, V12, P78, DOI 10.1038/gene.2010.61; Mason JC, 2008, HANDB SYST AUTOIMMUN, V7, pV; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; Nimmerjahn F, 2007, ADV IMMUNOL, V96, P179, DOI 10.1016/S0065-2776(07)96005-8; PARK JG, 1993, J CLIN INVEST, V92, P1967, DOI 10.1172/JCI116790; Park SY, 1998, J CLIN INVEST, V102, P1229, DOI 10.1172/JCI3256; Sharif O, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-1; Strzelecka A, 1997, FEBS LETT, V400, P11, DOI 10.1016/S0014-5793(96)01359-2; Suzuki Y, 1998, KIDNEY INT, V54, P1166, DOI 10.1046/j.1523-1755.1998.00108.x; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; Tarzi RM, 2002, KIDNEY INT, V62, P2087, DOI 10.1046/j.1523-1755.2002.00687.x; Wakayama H, 2000, EUR J IMMUNOL, V30, P1182, DOI 10.1002/(SICI)1521-4141(200004)30:4<1182::AID-IMMU1182>3.0.CO;2-H; WANG AVT, 1994, J EXP MED, V180, P1165, DOI 10.1084/jem.180.3.1165; WIRTHMUELLER U, 1992, J EXP MED, V175, P1381, DOI 10.1084/jem.175.5.1381	30	8	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5710	5719		10.1074/jbc.M111.260695	http://dx.doi.org/10.1074/jbc.M111.260695			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22184119	hybrid, Green Published			2022-12-27	WOS:000300638000047
J	Maeno, Y; Li, Q; Park, K; Rask-Madsen, C; Gao, BB; Matsumoto, M; Liu, YJ; Wu, IH; White, MF; Feener, EP; King, GL				Maeno, Yasuhiro; Li, Qian; Park, Kyoungmin; Rask-Madsen, Christian; Gao, Benbo; Matsumoto, Motonobu; Liu, Yingjie; Wu, I-Hsien; White, Morris F.; Feener, Edward P.; King, George L.			Inhibition of Insulin Signaling in Endothelial Cells by Protein Kinase C-induced Phosphorylation of p85 Subunit of Phosphatidylinositol 3-Kinase (PI3K)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-1 TYROSINE PHOSPHORYLATION; RECEPTOR SUBSTRATE-1; NITRIC-OXIDE; DIABETIC COMPLICATIONS; GENE-EXPRESSION; PAI-1 GENE; IN-VIVO; ACTIVATION; GROWTH; RESISTANCE	The regulation of endothelial function by insulin is consistently abnormal in insulin-resistant states and diabetes. Protein kinase C (PKC) activation has been reported to inhibit insulin signaling selectively in endothelial cells via the insulin receptor substrate/PI3K/Akt pathway to reduce the activation of endothelial nitric-oxide synthase (eNOS). In this study, it was observed that PKC activation differentially inhibited insulin receptor substrate 1/2 (IRS1/2) signaling of insulin's activation of PI3K/eNOS by decreasing only tyrosine phosphorylation of IRS2. In addition, PKC activation, by general activator and specifically by angiotensin II, increased the phosphorylation of p85/PI3K, which decreases its association with IRS1 and activation. Thr-86 of p85/PI3K was identified to be phosphorylated by PKC activation and confirmed to affect IRS1-mediated activation of Akt/eNOS by insulin and VEGF using a deletion mutant of the Thr-86 region of p85/PI3K. Thus, PKC and angiotensin-induced phosphorylation of Thr-86 of p85/PI3K may partially inhibit the activation of PI3K/eNOS by multiple cytokines and contribute to endothelial dysfunction in metabolic disorders.	[Maeno, Yasuhiro; Li, Qian; Park, Kyoungmin; Rask-Madsen, Christian; Gao, Benbo; Matsumoto, Motonobu; Liu, Yingjie; Wu, I-Hsien; Feener, Edward P.; King, George L.] Harvard Univ, Sch Med, Joslin Diabet Ctr, Sect Vasc Cell Biol, Boston, MA 02115 USA; [White, Morris F.] Childrens Hosp Boston, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Boston Children's Hospital	King, GL (corresponding author), Joslin Diabet Ctr, Sect Vasc Cell Biol & Complicat, Dianne Nunnally Hoppes Lab Diabet Complicat, 1 Joslin Pl, Boston, MA 02215 USA.	George.king@joslin.harvard.edu		Park, Kyoungmin/0000-0003-0772-1217; Rask-Madsen, Christian/0000-0002-8548-466X	National Institutes of Health from NIDDK [R01-DK53105]; National Institutes of Health from NIDDK (DERC) [P30-DK36836-21]; American Diabetes Association [1-08-RA-93]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038712, R01DK053105, P30DK036836] Funding Source: NIH RePORTER	National Institutes of Health from NIDDK; National Institutes of Health from NIDDK (DERC); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-DK53105 from NIDDK and P30-DK36836-21 from NIDDK (DERC). This work was also supported by American Diabetes Association Grant 1-08-RA-93.	Abe H, 1998, J CLIN INVEST, V101, P1784, DOI 10.1172/JCI1594; BACKER JM, 1992, EMBO J, V11, P3469, DOI 10.1002/j.1460-2075.1992.tb05426.x; Beckman JA, 2002, CIRC RES, V90, P107, DOI 10.1161/hh0102.102359; Cosentino C, 2007, ONCOGENE, V26, P2095, DOI 10.1038/sj.onc.1210027; DeFea K, 1997, BIOCHEMISTRY-US, V36, P12939, DOI 10.1021/bi971157f; Esposito DL, 2001, ENDOCRINOLOGY, V142, P2833, DOI 10.1210/en.142.7.2833; Geraldes P, 2010, CIRC RES, V106, P1319, DOI 10.1161/CIRCRESAHA.110.217117; Geraldes P, 2008, J BIOL CHEM, V283, P34327, DOI 10.1074/jbc.M807036200; GOLDSTEIN RH, 1989, ENDOCRINOLOGY, V124, P964, DOI 10.1210/endo-124-2-964; Greene MW, 2004, BIOCHEM J, V378, P105, DOI 10.1042/BJ20031493; Grenett HE, 1998, ARTERIOSCL THROM VAS, V18, P1803, DOI 10.1161/01.ATV.18.11.1803; GUO DQ, 1995, J BIOL CHEM, V270, P6729, DOI 10.1074/jbc.270.12.6729; Harja E, 2009, FASEB J, V23, P1081, DOI 10.1096/fj.08-120345; Jiang ZY, 2003, J BIOL CHEM, V278, P31964, DOI 10.1074/jbc.M303314200; Jiang ZY, 1999, J CLIN INVEST, V104, P447, DOI 10.1172/JCI5971; Koya D, 1998, DIABETES, V47, P859, DOI 10.2337/diabetes.47.6.859; Kuboki K, 2000, CIRCULATION, V101, P676, DOI 10.1161/01.CIR.101.6.676; Li Y, 2004, J BIOL CHEM, V279, P45304, DOI 10.1074/jbc.C400186200; MOLLER DE, 1991, NEW ENGL J MED, V325, P938; Naruse K, 2006, DIABETES, V55, P691, DOI 10.2337/diabetes.55.03.06.db05-0771; Nawaratne R, 2006, MOL ENDOCRINOL, V20, P1838, DOI 10.1210/me.2005-0536; Nordt TK, 1998, J MOL CELL CARDIOL, V30, P1535, DOI 10.1006/jmcc.1998.0719; OLIVER FJ, 1991, J BIOL CHEM, V266, P23251; Pillay TS, 1996, J CLIN INVEST, V97, P613, DOI 10.1172/JCI118457; Rask-Madsen C, 2010, CELL METAB, V11, P379, DOI 10.1016/j.cmet.2010.03.013; Rask-Madsen C, 2007, NAT CLIN PRACT ENDOC, V3, P46, DOI 10.1038/ncpendmet0366; Rui LY, 2001, J CLIN INVEST, V107, P181, DOI 10.1172/JCI10934; Schmitz-Peiffer C, 2008, DIABETES, V57, P1774, DOI 10.2337/db07-1769; STEINBERG HO, 1994, J CLIN INVEST, V94, P1172, DOI 10.1172/JCI117433; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Ueki K, 2000, J CLIN INVEST, V105, P1437, DOI 10.1172/JCI7656; Ueki K, 2002, MOL CELL BIOL, V22, P965, DOI 10.1128/MCB.22.3.965-977.2002; Waraich RS, 2008, J BIOL CHEM, V283, P11226, DOI 10.1074/jbc.M708588200; Xia P, 1996, J CLIN INVEST, V98, P2018, DOI 10.1172/JCI119006; YU HT, 1994, CELL, V76, P933, DOI 10.1016/0092-8674(94)90367-0; Zeng GY, 1996, J CLIN INVEST, V98, P894, DOI 10.1172/JCI118871; Zeng GY, 2000, CIRCULATION, V101, P1539, DOI 10.1161/01.CIR.101.13.1539	37	40	42	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4518	4530		10.1074/jbc.M111.286591	http://dx.doi.org/10.1074/jbc.M111.286591			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22158866	hybrid, Green Published			2022-12-27	WOS:000300608500015
J	Sun, HG; Ruszczycky, MW; Chang, WC; Thibodeaux, CJ; Liu, HW				Sun, He G.; Ruszczycky, Mark W.; Chang, Wei-Chen; Thibodeaux, Christopher J.; Liu, Hung-Wen			Nucleophilic Participation of Reduced Flavin Coenzyme in Mechanism of UDP-galactopyranose Mutase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSITIONAL ISOTOPE-EXCHANGE; STEREOSELECTIVE-SYNTHESIS; CATALYTIC MECHANISM; ESCHERICHIA-COLI; INHIBITORS; OXIDASE; GALACTOFURANOSE; RESONANCE; BINDING; ROLES	UDP-galactopyranose mutase (UGM) requires reduced FAD (FAD(red)) to catalyze the reversible interconversion of UDP-galactopyranose (UDP-Galp) and UDP-galactofuranose (UDP-Galf). Recent structural and mechanistic studies of UGM have provided evidence for the existence of an FAD-Galf/p adduct as an intermediate in the catalytic cycle. These findings are consistent with Lewis acid/base chemistry involving nucleophilic attack by N5 of FAD(red) at C1 of UDP-Galf/p. In this study, we employed a variety of FAD analogues to characterize the role of FAD(red) in the UGM catalytic cycle using positional isotope exchange (PIX) and linear free energy relationship studies. PIX studies indicated that UGM reconstituted with 5-deaza-FAD(red) is unable to catalyze PIX of the bridging C1-OP beta oxygen of UDP-Galp, suggesting a direct role for the FAD(red) N5 atom in this process. In addition, analysis of kinetic linear free energy relationships of k(cat) versus the nucleophilicity of N5 of FAD(red) gave a slope of rho = -2.4 +/- 0.4. Together, these findings are most consistent with a chemical mechanism for UGM involving an S(N)2-type displacement of UDP from UDP-Galf/p by N5 of FAD(red).	[Sun, He G.; Ruszczycky, Mark W.; Chang, Wei-Chen; Thibodeaux, Christopher J.; Liu, Hung-Wen] Univ Texas Austin, Coll Pharm, Dept Chem & Biochem, Div Med Chem, Austin, TX 78712 USA; [Sun, He G.; Ruszczycky, Mark W.; Chang, Wei-Chen; Thibodeaux, Christopher J.; Liu, Hung-Wen] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Liu, HW (corresponding author), Univ Texas Austin, Coll Pharm, Dept Chem & Biochem, Div Med Chem, 2409 Univ Ave,PHR 3-206B, Austin, TX 78712 USA.	h.w.liu@mail.utexas.edu		CHANG, WEI-CHEN/0000-0002-2341-9846	National Institutes of Health [GM035906, GM054346]; NIAID [F32AI082906]; Welch Foundation [F-1511]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI082906] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035906, R37GM035906, R01GM054346] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM035906 and GM054346 and Fellowship Award F32AI082906 from NIAID (to M. W. R.). This work was also supported by Welch Foundation Grant F-1511.	Barlow JN, 1999, J AM CHEM SOC, V121, P6968, DOI 10.1021/ja991582r; Caravano A, 2006, CHEM-EUR J, V12, P3114, DOI 10.1002/chem.200500991; Caravano A, 2004, CHEM COMMUN, P1216, DOI 10.1039/b402469a; Desvergnes S, 2007, BIOORGAN MED CHEM, V15, P6443, DOI 10.1016/j.bmc.2007.06.059; Edmondson D.E., 1999, FLAVINS FLAVOPROTEIN, P71; Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; Gruber TD, 2009, BIOCHEMISTRY-US, V48, P9171, DOI 10.1021/bi901437v; HANSCH C, 1991, CHEM REV, V91, P165, DOI 10.1021/cr00002a004; Huang ZH, 2003, BIOORG CHEM, V31, P494, DOI 10.1016/j.bioorg.2003.08.002; Itoh K, 2007, ORG LETT, V9, P879, DOI 10.1021/ol0631408; Kommoju PR, 2009, BIOCHEMISTRY-US, V48, P6951, DOI 10.1021/bi9006918; Legrand YM, 2003, J AM CHEM SOC, V125, P15789, DOI 10.1021/ja036940b; Liautard V, 2008, J ORG CHEM, V73, P3103, DOI 10.1021/jo8001134; Mansoorabadi SO, 2007, J ORG CHEM, V72, P6329, DOI 10.1021/jo0703092; MIDELFORT CF, 1976, J BIOL CHEM, V251, P5881; MULLINS LS, 1995, METHOD ENZYMOL, V249, P398; Pan F, 2001, J BACTERIOL, V183, P3991, DOI 10.1128/JB.183.13.3991-3998.2001; Peltier P, 2008, CARBOHYD RES, V343, P1897, DOI 10.1016/j.carres.2008.02.010; Peltier P, 2010, CHEM BIOL, V17, P1356, DOI 10.1016/j.chembiol.2010.10.014; Rauch G, 2007, BIOCHEMISTRY-US, V46, P3768, DOI 10.1021/bi602420u; Richards MR, 2009, CHEMBIOCHEM, V10, P1920, DOI 10.1002/cbic.200900208; Roth JP, 2004, J AM CHEM SOC, V126, P15120, DOI 10.1021/ja047050e; Soltero-Higgin M, 2004, NAT STRUCT MOL BIOL, V11, P539, DOI 10.1038/nsmb772; Taft RW, 1960, J PHYS CHEM-US, V64, P1805, DOI 10.1021/j100841a003; TAFT RW, 1959, J AM CHEM SOC, V81, P5352, DOI 10.1021/ja01529a026; Thibodeaux CJ, 2010, J AM CHEM SOC, V132, P9994, DOI 10.1021/ja104090m; WALSH C, 1986, ACCOUNTS CHEM RES, V19, P216, DOI 10.1021/ar00127a004; Yorita K, 2000, P NATL ACAD SCI USA, V97, P2480, DOI 10.1073/pnas.040559797; Yu QJ, 2010, J BIOL CHEM, V285, P12109, DOI 10.1074/jbc.M109.091843; Yuan Y, 2008, J AM CHEM SOC, V130, P3157, DOI 10.1021/ja7104152; Zhang QB, 2001, J AM CHEM SOC, V123, P6756, DOI 10.1021/ja010473l; Zhang QB, 2000, J AM CHEM SOC, V122, P9065, DOI 10.1021/ja001333z	32	32	32	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4602	4608		10.1074/jbc.M111.312538	http://dx.doi.org/10.1074/jbc.M111.312538			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22187430	Green Published, hybrid			2022-12-27	WOS:000300608500023
J	Ulsamer, A; Wei, Y; Kim, KK; Tan, K; Wheeler, S; Xi, Y; Thies, RS; Chapman, HA				Ulsamer, Arnau; Wei, Ying; Kim, Kevin K.; Tan, Kevin; Wheeler, Sarah; Xi, Ying; Thies, R. Scott; Chapman, Harold A.			Axin Pathway Activity Regulates in Vivo pY654-beta-catenin Accumulation and Pulmonary Fibrosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; ENDOPLASMIC-RETICULUM STRESS; BETA-CATENIN; TYROSINE PHOSPHORYLATION; GROWTH-FACTOR; E-CADHERIN; BINDING-PROTEIN; LIVER FIBROSIS; CELL-ADHESION; SRC	Epithelial to mesenchymal transition (EMT) and pulmonary fibrogenesis require epithelial integrin alpha 3 beta 1-mediated crosstalk between TGF beta 1 and Wnt signaling pathways. One hallmark of this cross-talk is pY654-beta-catenin accumulation, but whether pY654-beta-catenin is a biomarker of fibrogenesis or functionally important is unknown. To clarify further the role of beta-catenin in fibrosis, we explored pY654-beta-catenin generation and function. alpha 3 beta 1 was required for TGF beta 1-mediated activation of Src family kinases, and Src inhibition blocked both pY654 and EMT in primary alveolar epithelial cells (AECs). TGF beta 1 stimulated beta-catenin/Lef1-dependent promoter activity comparably in immortalized AECs stably expressing WT beta-catenin as well as Y654E or Y654F beta-catenin point mutants. But EMT was abrogated in the Tyr to Phe mutant. pY654-beta-catenin was sensitive to the axin beta-catenin turnover pathway as inhibition of tankyrase 1 led to high AEC axin levels, loss of pY654-beta-catenin, and inhibition of EMT ex vivo. Mice given a tankyrase inhibitor (50 mg/kg orally) daily for 7 days beginning 10 days after intratracheal bleomycin had improved survival over controls. Treated mice developed raised axin levels in the lung that abrogated pY654-beta-catenin and attenuated lung Snail1, Twist1, alpha-smooth muscle actin, and type I collagen accumulation. Total beta-catenin levels were unaltered. These findings identify Src kinase(s) as a mediator of TGF beta 1-induced pY654-beta-catenin, provide evidence that pY654-beta-catenin levels are a critical determinant of EMT and fibrogenesis, and suggest regulation of axin levels as a novel therapeutic approach to fibrotic disorders.	[Ulsamer, Arnau; Wei, Ying; Kim, Kevin K.; Tan, Kevin; Wheeler, Sarah; Xi, Ying; Chapman, Harold A.] Univ Calif San Francisco, Pulm & Crit Care Div, Dept Med, San Francisco, CA 94143 USA; [Ulsamer, Arnau; Wei, Ying; Kim, Kevin K.; Tan, Kevin; Wheeler, Sarah; Xi, Ying; Chapman, Harold A.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Thies, R. Scott] Fate Therapeut Inc, San Diego, CA 92121 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Chapman, HA (corresponding author), Univ Calif San Francisco, Pulm & Crit Care Div, Dept Med, 513 Parnassus Ave, San Francisco, CA 94143 USA.	hal.chapman@ucsf.edu	Ulsamer, A/H-7994-2014	Ulsamer, A/0000-0001-7808-1005	National Institutes of Health [HL 44712, K08HL085290]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL085290, R01HL044712] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL 44712 (to H. A. C.) and K08HL085290 (to K. K. K.).	Avizienyte E, 2005, CURR OPIN CELL BIOL, V17, P542, DOI 10.1016/j.ceb.2005.08.007; Avizienyte E, 2002, NAT CELL BIOL, V4, P632, DOI 10.1038/ncb829; BEHRENS J, 1993, J CELL BIOL, V120, P757, DOI 10.1083/jcb.120.3.757; Bergmann C, 2011, ANN RHEUM DIS, V70, P2191, DOI 10.1136/ard.2010.147140; Boyer B, 1997, EMBO J, V16, P5904, DOI 10.1093/emboj/16.19.5904; Brembeck FH, 2006, CURR OPIN GENET DEV, V16, P51, DOI 10.1016/j.gde.2005.12.007; Burkhalter RJ, 2011, J BIOL CHEM, V286, P23467, DOI 10.1074/jbc.M110.199539; Chapman HA, 2011, J CLIN INVEST, V121, P2855, DOI 10.1172/JCI57673; Chapman HA, 2011, ANNU REV PHYSIOL, V73, P413, DOI 10.1146/annurev-physiol-012110-142225; Cheng JH, 2008, AM J PHYSIOL-GASTR L, V294, pG39, DOI 10.1152/ajpgi.00263.2007; Chilosi M, 2003, AM J PATHOL, V162, P1495, DOI 10.1016/S0002-9440(10)64282-4; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Eger A, 2004, ONCOGENE, V23, P2672, DOI 10.1038/sj.onc.1207416; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Flozak AS, 2010, J BIOL CHEM, V285, P3157, DOI 10.1074/jbc.M109.070326; Fujita Y, 2002, NAT CELL BIOL, V4, P222, DOI 10.1038/ncb758; He WC, 2009, J AM SOC NEPHROL, V20, P765, DOI 10.1681/ASN.2008060566; Henderson WR, 2010, P NATL ACAD SCI USA, V107, P14309, DOI 10.1073/pnas.1001520107; Hinz Boris, 2009, Curr Rheumatol Rep, V11, P120; Howard S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023899; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; JAT PS, 1991, P NATL ACAD SCI USA, V88, P5096, DOI 10.1073/pnas.88.12.5096; Jayachandran A, 2009, THORAX, V64, P1053, DOI 10.1136/thx.2009.121798; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; Kim KK, 2009, J CLIN INVEST, V119, P213, DOI 10.1172/JCI36940; Kim Y, 2009, J CELL BIOL, V184, P309, DOI 10.1083/jcb.200806067; Konigshoff M, 2010, AM J RESP CELL MOL, V42, P21, DOI 10.1165/rcmb.2008-0485TR; Konigshoff M, 2009, J CLIN INVEST, V119, P772, DOI 10.1172/JCI33950; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Lee H, 2000, MOL ENDOCRINOL, V14, P1750, DOI 10.1210/me.14.11.1750; Lei S, 2004, J BIOL CHEM, V279, P42492, DOI 10.1074/jbc.M404025200; Medici D, 2006, MOL BIOL CELL, V17, P1871, DOI 10.1091/mbc.E05-08-0767; Minami Y, 2008, P NATL ACAD SCI USA, V105, P17967, DOI 10.1073/pnas.0808303105; Pechkovsky DV, 2008, J BIOL CHEM, V283, P12898, DOI 10.1074/jbc.M708226200; Piedra J, 2001, J BIOL CHEM, V276, P20436, DOI 10.1074/jbc.M100194200; Pozharskaya V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007559; Roura S, 1999, J BIOL CHEM, V274, P36734, DOI 10.1074/jbc.274.51.36734; Rowe RG, 2011, MOL CELL BIOL, V31, P2392, DOI 10.1128/MCB.01218-10; Rowe RG, 2009, J CELL BIOL, V184, P399, DOI 10.1083/jcb.200810113; Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; SHIBAMOTO S, 1994, CELL ADHES COMMUN, V1, P295, DOI 10.3109/15419069409097261; Simoneau M, 2011, CELL SIGNAL, V23, P269, DOI 10.1016/j.cellsig.2010.09.011; Tanjore H, 2011, J BIOL CHEM, V286, P30972, DOI 10.1074/jbc.M110.181164; Thannickal VJ, 2003, J BIOL CHEM, V278, P12384, DOI 10.1074/jbc.M208544200; van Veelen W, 2011, GUT, V60, P1204, DOI 10.1136/gut.2010.233460; Zhang F, 2003, J CELL BIOL, V163, P177, DOI 10.1083/jcb.200304065; Zhong Q, 2011, AM J RESP CELL MOL, V45, P498, DOI 10.1165/rcmb.2010-0347OC	48	71	74	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					5164	5172		10.1074/jbc.M111.322123	http://dx.doi.org/10.1074/jbc.M111.322123			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22203675	Green Published, hybrid			2022-12-27	WOS:000300608500074
J	Zhi, XY; Zhou, XE; Melcher, K; Motola, DL; Gelmedin, V; Hawdon, J; Kliewer, SA; Mangelsdorf, DJ; Xu, HE				Zhi, Xiaoyong; Zhou, X. Edward; Melcher, Karsten; Motola, Daniel L.; Gelmedin, Verena; Hawdon, John; Kliewer, Steven A.; Mangelsdorf, David J.; Xu, H. Eric			Structural Conservation of Ligand Binding Reveals a Bile Acid-like Signaling Pathway in Nematodes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEGANS DAUER FORMATION; NUCLEAR RECEPTOR; CRYSTAL-STRUCTURE; DAF-12; IDENTIFICATION; ACTIVATION; BETA	Bile acid-like molecules named dafachronic acids (DAs) control the dauer formation program in Caenorhabditis elegans through the nuclear receptor DAF-12. This mechanism is conserved in parasitic nematodes to regulate their dauer-like infective larval stage, and as such, the DAF-12 ligand binding domain has been identified as an important therapeutic target in human parasitic hookworm species that infect more than 600 million people worldwide. Here, we report two x-ray crystal structures of the hookworm Ancylostoma ceylanicum DAF-12 ligand binding domain in complex with DA and cholestenoic acid (a bile acid-like metabolite), respectively. Structure analysis and functional studies reveal key residues responsible for species-specific ligand responses of DAF-12. Furthermore, DA binds to DAF-12 mechanistically and is structurally similar to bile acids binding to the mammalian bile acid receptor farnesoid X receptor. Activation of DAF-12 by cholestenoic acid and the cholestenoic acid complex structure suggest that bile acid-like signaling pathways have been conserved in nematodes and mammals. Together, these results reveal the molecular mechanism for the interplay between parasite and host, provide a structural framework for DAF-12 as a promising target in treating nematode parasitism, and provide insight into the evolution of gut parasite hormone-signaling pathways.	[Zhi, Xiaoyong; Zhou, X. Edward; Melcher, Karsten; Xu, H. Eric] Van Andel Res Inst, Lab Struct Sci, Grand Rapids, MI 49503 USA; [Melcher, Karsten] Van Andel Res Inst, Lab Struct Biol & Biochem, Grand Rapids, MI 49503 USA; [Motola, Daniel L.; Kliewer, Steven A.; Mangelsdorf, David J.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Gelmedin, Verena; Hawdon, John] George Washington Univ, Med Ctr, Dept Microbiol Immunol & Trop Med, Washington, DC 20037 USA; [Xu, H. Eric] Chinese Acad Sci, Shanghai Inst Mat Med, Ctr Struct & Funct Drug Targets, VARI SIMM Ctr,State Key Lab Drug Res, Shanghai 201203, Peoples R China; [Kliewer, Steven A.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Mangelsdorf, David J.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	Van Andel Institute; Van Andel Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; George Washington University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Xu, HE (corresponding author), Van Andel Res Inst, Lab Struct Sci, Grand Rapids, MI 49503 USA.	eric.xu@vai.org	Hawdon, John/I-1201-2019; Xu, H. Eric/ABD-7487-2021; Melcher, Karsten/AAZ-3861-2020	Hawdon, John/0000-0002-6164-1413; Melcher, Karsten/0000-0002-9125-4027; Xu, H. Eric/0000-0002-6829-8144; Mangelsdorf, David/0000-0002-4355-0796	National Institutes of Health [DK071662, DK066202, HL089301, DK62434]; Jay and Betty Van Andel Foundation; Howard Hughes Medical Institute; Robert A. Welch Foundation [I-1275, I-1558]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066202, U19DK062434, R01DK071662] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jay and Betty Van Andel Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Robert A. Welch Foundation(The Welch Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK071662, DK066202, and HL089301 (to H. E. X.) and DK62434 (to D. J. M.). This work was also supported by the Jay and Betty Van Andel Foundation, Howard Hughes Medical Institute (to D. J. M.), and the Robert A. Welch Foundation Grants I-1275 (to D. J. M.) and I-1558 (to S. A. K.).	Antebi A, 2000, GENE DEV, V14, P1512; Dieterich C, 2009, TRENDS GENET, V25, P203, DOI 10.1016/j.tig.2009.03.006; Fielenbach N, 2008, GENE DEV, V22, P2149, DOI 10.1101/gad.1701508; HAWDON JM, 1993, PARASITOLOGY, V106, P163, DOI 10.1017/S0031182000074953; Held JM, 2006, AGING CELL, V5, P283, DOI 10.1111/j.1474-9726.2006.00218.x; Hotez PJ, 2006, TRENDS PARASITOL, V22, P327, DOI 10.1016/j.pt.2006.05.004; Hu Patrick J, 2007, WormBook, P1; Jasmer DP, 2003, ANNU REV PHYTOPATHOL, V41, P245, DOI 10.1146/annurev.phyto.41.052102.104023; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kaplan RM, 2004, TRENDS PARASITOL, V20, P477, DOI 10.1016/j.pt.2004.08.001; Krylova IN, 2005, CELL, V120, P343, DOI 10.1016/j.cell.2005.01.024; Li Y, 2005, P NATL ACAD SCI USA, V102, P9505, DOI 10.1073/pnas.0501204102; Li Y, 2005, MOL CELL, V17, P491, DOI 10.1016/j.molcel.2005.02.002; Ludewig AH, 2004, GENE DEV, V18, P2120, DOI 10.1101/gad.312604; Martinez-Augustin O, 2008, WORLD J GASTROENTERO, V14, P5630, DOI 10.3748/wjg.14.5630; Mi LZ, 2003, MOL CELL, V11, P1093, DOI 10.1016/S1097-2765(03)00112-6; Modica Salvatore, 2010, Nucl Recept Signal, V8, pe005, DOI 10.1621/nrs.08005; Mooijaart SP, 2005, AGEING RES REV, V4, P351, DOI 10.1016/j.arr.2005.03.006; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Motola DL, 2006, CELL, V124, P1209, DOI 10.1016/j.cell.2006.01.037; Ogawa A, 2009, CURR BIOL, V19, P67, DOI 10.1016/j.cub.2008.11.063; Rochel N, 2000, MOL CELL, V5, P173, DOI 10.1016/S1097-2765(00)80413-X; Rottiers V, 2006, DEV CELL, V10, P473, DOI 10.1016/j.devcel.2006.02.008; Russell DW, 2003, ANNU REV BIOCHEM, V72, P137, DOI 10.1146/annurev.biochem.72.121801.161712; Setchell KDR, 1998, J CLIN INVEST, V102, P1690, DOI 10.1172/JCI2962; Sharma KK, 2009, MOL ENDOCRINOL, V23, P640, DOI 10.1210/me.2008-0415; Shulman AI, 2004, CELL, V116, P417, DOI 10.1016/S0092-8674(04)00119-9; Viney ME, 2009, BIOESSAYS, V31, P496, DOI 10.1002/bies.200900010; Viney ME, 2005, INT J PARASITOL, V35, P1473, DOI 10.1016/j.ijpara.2005.07.006; Wang Z, 2009, P NATL ACAD SCI USA, V106, P9138, DOI 10.1073/pnas.0904064106; Williams S, 2003, J BIOL CHEM, V278, P27138, DOI 10.1074/jbc.M302260200; Wollam J, 2011, AGING CELL, V10, P879, DOI 10.1111/j.1474-9726.2011.00733.x	32	24	24	1	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4894	4903		10.1074/jbc.M111.315242	http://dx.doi.org/10.1074/jbc.M111.315242			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22170062	hybrid, Green Published			2022-12-27	WOS:000300608500050
J	Kirkwood, JS; Lebold, KM; Miranda, CL; Wright, CL; Miller, GW; Tanguay, RL; Barton, CL; Traber, MG; Stevens, JF				Kirkwood, Jay S.; Lebold, Katie M.; Miranda, Cristobal L.; Wright, Charlotte L.; Miller, Galen W.; Tanguay, Robert L.; Barton, Carrie L.; Traber, Maret G.; Stevens, Jan F.			Vitamin C Deficiency Activates the Purine Nucleotide Cycle in Zebrafish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; ASCORBIC-ACID; AMP-DEAMINASE; ANTIOXIDANT DEFENSE; OXIDATIVE STRESS; PROTEIN-KINASE; FREE-RADICALS; DANIO-RERIO; PLASMA; MUSCLE	Vitamin C (ascorbic acid, AA) is a cofactor for many important enzymatic reactions and a powerful antioxidant. AA provides protection against oxidative stress by acting as a scavenger of reactive oxygen species, either directly or indirectly by recycling of the lipid-soluble antioxidant, alpha-tocopherol (vitamin E). Only a few species, including humans, guinea pigs, and zebrafish, cannot synthesize AA. Using an untargeted metabolomics approach, we examined the effects of alpha-tocopherol and AA deficiency on the metabolic profiles of adult zebrafish. We found that AA deficiency, compared with subsequent AA repletion, led to oxidative stress (using malondialdehyde production as an index) and to major increases in the metabolites of the purine nucleotide cycle (PNC): IMP, adenylosuccinate, and AMP. The PNC acts as a temporary purine nucleotide reservoir to keep AMP levels low during times of high ATP utilization or impaired oxidative phosphorylation. The PNC promotes ATP regeneration by converting excess AMP into IMP, thereby driving forward the myokinase reaction (2ADP3AMP -> ATP). On the basis of this finding, we investigated the activity of AMP deaminase, the enzyme that irreversibly deaminates AMP to form IMP. We found a 47% increase in AMP deaminase activity in the AA-deficient zebrafish, complementary to the 44-fold increase in IMP concentration. These results suggest that vitamin C is crucial for the maintenance of cellular energy metabolism.	[Stevens, Jan F.] Oregon State Univ, Linus Pauling Inst, Linus Pauling Sci Ctr 307, Corvallis, OR 97331 USA; [Kirkwood, Jay S.; Miranda, Cristobal L.; Stevens, Jan F.] Oregon State Univ, Coll Pharm, Corvallis, OR 97331 USA; [Lebold, Katie M.; Traber, Maret G.] Oregon State Univ, Sch Biol & Populat Hlth Sci, Corvallis, OR 97331 USA; [Tanguay, Robert L.; Barton, Carrie L.] Oregon State Univ, Dept Environm & Mol Toxicol, Corvallis, OR 97331 USA	Oregon State University; Oregon State University; Oregon State University; Oregon State University	Stevens, JF (corresponding author), Oregon State Univ, Linus Pauling Inst, Linus Pauling Sci Ctr 307, Corvallis, OR 97331 USA.	fred.stevens@oregonstate.edu	Traber, Maret G./ABI-2511-2020; Miller, Galen/J-4386-2012	Traber, Maret G./0000-0002-2892-4024; Stevens, Jan Frederik/0000-0002-6348-9347	National Institutes of Health [S10RR027878, R01HL081721, R01HD062109, P30ES000210]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD062109] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027878] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081721] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000210] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health Grants S10RR027878, R01HL081721, R01HD062109, and P30ES000210.	AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858; Bohensky J, 2010, PEDIATR NEPHROL, V25, P633, DOI 10.1007/s00467-009-1310-y; Boulahbel H, 2009, BIOCHEM SOC T, V37, P291, DOI 10.1042/BST0370291; Bruno RS, 2006, FREE RADICAL BIO MED, V40, P689, DOI 10.1016/j.freeradbiomed.2005.10.051; BUETTNER GR, 1993, ARCH BIOCHEM BIOPHYS, V300, P535, DOI 10.1006/abbi.1993.1074; Buettner GR, 2000, TERATOLOGY, V62, P234, DOI 10.1002/1096-9926(200010)62:4<234::AID-TERA10>3.0.CO;2-9; Dodd A, 2000, HUM MOL GENET, V9, P2443, DOI 10.1093/hmg/9.16.2443; Duggan GE, 2011, J BIOMOL NMR, V49, P165, DOI 10.1007/s10858-011-9485-5; FREI B, 1989, P NATL ACAD SCI USA, V86, P6377, DOI 10.1073/pnas.86.16.6377; Halliwell B, 1999, FREE RADICAL RES, V31, P261, DOI 10.1080/10715769900300841; Hardie DG, 2001, BIOESSAYS, V23, P1112, DOI 10.1002/bies.10009; Harrison FE, 2010, BRAIN RES, V1349, P143, DOI 10.1016/j.brainres.2010.06.037; Hong YL, 2000, CLIN BIOCHEM, V33, P619, DOI 10.1016/S0009-9120(00)00177-6; ISHERWOOD FA, 1954, BIOCHEM J, V56, P15, DOI 10.1042/bj0560015; Ji H, 2010, FISH PHYSIOL BIOCHEM, V36, P749, DOI 10.1007/s10695-009-9349-z; KALYANARAMAN B, 1992, J BIOL CHEM, V267, P6789; KREBS H, 1964, PROC R SOC SER B-BIO, V159, P545, DOI 10.1098/rspb.1964.0019; Lebold KM, 2011, J NUTR, V141, P2113, DOI 10.3945/jn.111.144279; LOWENSTEIN JM, 1972, PHYSIOL REV, V52, P382, DOI 10.1152/physrev.1972.52.2.382; Lushchak V. I., 1995, Biokhimiya, V60, P270; Lushchak VI, 2009, FISH PHYSIOL BIOCHEM, V35, P443, DOI 10.1007/s10695-008-9270-x; May JM, 2000, FREE RADICAL BIO MED, V28, P1421, DOI 10.1016/S0891-5849(00)00269-0; Miller GW, 2011, J NUTR BIOC IN PRESS; MOMMSEN TP, 1988, METABOLISM, V37, P552, DOI 10.1016/0026-0495(88)90170-9; Moreau R, 2001, ASCORBIC ACID IN AQUATIC ORGANISMS, P13; NISHIKIMI M, 1994, J BIOL CHEM, V269, P13685; Oakhill JS, 2011, SCIENCE, V332, P1433, DOI 10.1126/science.1200094; PADH H, 1990, BIOCHEM CELL BIOL, V68, P1166, DOI 10.1139/o90-173; Page EL, 2008, MOL BIOL CELL, V19, P86, DOI 10.1091/mbc.E07-06-0612; Podda M, 1996, J LIPID RES, V37, P893; RUNDELL KW, 1993, J APPL PHYSIOL, V74, P2004, DOI 10.1152/jappl.1993.74.4.2004; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; SHAPIRO IM, 1991, AM J CLIN NUTR, V54, pS1209, DOI 10.1093/ajcn/54.6.1209s; Sims B, 1998, NEUROBIOL AGING, V19, P385, DOI 10.1016/S0197-4580(98)00083-9; Sok DE, 1998, J NEUROCHEM, V70, P1167; Tavazzi B, 2001, J BIOL CHEM, V276, P48083, DOI 10.1074/jbc.M101715200; Telang S, 2007, NEOPLASIA, V9, P47, DOI 10.1593/neo.06664; Traber MG, 2011, FREE RADICAL BIO MED, V51, P1000, DOI 10.1016/j.freeradbiomed.2011.05.017; Udvadia AJ, 2003, DEV BIOL, V256, P1, DOI 10.1016/S0012-1606(02)00083-0; VANWAARDE A, 1988, BIOL REV, V63, P259; Wixon J, 2000, YEAST, V17, P225, DOI 10.1002/1097-0061(20000930)17:3&lt;225::AID-YEA34&gt;3.0.CO;2-5; YOUNG IS, 1991, ANN CLIN BIOCHEM, V28, P504, DOI 10.1177/000456329102800514	42	48	49	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					3833	3841		10.1074/jbc.M111.316018	http://dx.doi.org/10.1074/jbc.M111.316018			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22170049	Green Published, hybrid			2022-12-27	WOS:000300410900020
J	King, SM; Patel-King, RS				King, Stephen M.; Patel-King, Ramila S.			Functional Architecture of the Outer Arm Dynein Conformational Switch	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-CHAIN 1; MOTOR DOMAIN; FLAGELLAR BEAT; HEAVY-CHAIN; MICROTUBULES; DYNAMICS; COMPLEX; LC1	Dynein light chain 1 (LC1/DNAL1) is one of the most highly conserved components of ciliary axonemal outer arm dyneins, and it associates with both a heavy chain motor unit and tubulin located within the A-tubule of the axonemal outer doublet microtubules. In a variety of model systems, lack of LC1 or expression of mutant forms leads to profound defects in ciliary motility, including the failure of the hydrodynamic coupling needed for ciliary metachronal synchrony, random stalling during the power/recovery stroke transition, an aberrant response to imposed viscous load, and in some cases partial failure of motor assembly. These phenotypes have led to the proposal that LC1 acts as part of a mechanical switch to control motor function in response to alterations in axonemal curvature. Here we have used NMR chemical shift mapping to define the regions perturbed by a series of mutations in the C-terminal domain that yield a range of phenotypic effects on motility. In addition, we have identified the subdomain of LC1 involved in binding microtubules and characterized the consequences of an Asn -> Ser alteration within the terminal leucine-rich repeat that in humans causes primary ciliary dyskinesia. Together, these data define a series of functional subdomains within LC1 and allow us to propose a structural model for the organization of the dynein heavy chain-LC1-microtubule ternary complex that is required for the coordinated activity of dynein motors in cilia.	[King, Stephen M.; Patel-King, Ramila S.] Univ Connecticut, Ctr Hlth, Dept Mol Microbial & Struct Biol, Farmington, CT 06030 USA	University of Connecticut	King, SM (corresponding author), Univ Connecticut, Ctr Hlth, Dept Mol Microbial & Struct Biol, 263 Farmington Ave, Farmington, CT 06030 USA.	king@neuron.uchc.edu			National Institutes of Health [GM051293]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051293] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM051293 (to S. M. K.).	Alushin GM, 2010, NATURE, V467, P805, DOI 10.1038/nature09423; Baron DM, 2007, J CELL SCI, V120, P1513, DOI 10.1242/jcs.004846; Benashski SE, 1999, BIOCHEMISTRY-US, V38, P7253, DOI 10.1021/bi990466y; Brokaw CJ, 2009, CELL MOTIL CYTOSKEL, V66, P425, DOI 10.1002/cm.20313; Carter AP, 2011, SCIENCE, V331, P1159, DOI 10.1126/science.1202393; Hayashibe K, 1997, CELL MOTIL CYTOSKEL, V37, P232, DOI 10.1002/(SICI)1097-0169(1997)37:3<232::AID-CM5>3.0.CO;2-8; Hom EFY, 2011, CYTOSKELETON, V68, P555, DOI 10.1002/cm.20533; Ishikawa T, 2007, J MOL BIOL, V368, P1249, DOI 10.1016/j.jmb.2007.02.072; KING SM, 1988, J CELL BIOL, V107, P1799, DOI 10.1083/jcb.107.5.1799; King SM, 2009, CHLAMYDOMONAS SOURCE, V3, P131; King SM, 2010, CYTOSKELETON, V67, P207, DOI 10.1002/cm.20445; Kubo T, 2010, CURR BIOL, V20, P441, DOI 10.1016/j.cub.2009.12.058; Lindemann CB, 2002, CELL MOTIL CYTOSKEL, V52, P242, DOI 10.1002/cm.10049; Lindemann CB, 2007, CELL MOTIL CYTOSKEL, V64, P580, DOI 10.1002/cm.20205; Liu ZM, 2008, EUKARYOT CELL, V7, P1136, DOI 10.1128/EC.00102-08; Mazor M, 2011, AM J HUM GENET, V88, P599, DOI 10.1016/j.ajhg.2011.03.018; Mosavi LK, 2003, PROTEIN ENG, V16, P739, DOI 10.1093/protein/gzg098; Movassagh T, 2010, NAT STRUCT MOL BIOL, V17, P761, DOI 10.1038/nsmb.1832; Narayan RD, 2010, FUNGAL GENET BIOL, V47, P663, DOI 10.1016/j.fgb.2010.04.008; Nicastro D, 2006, SCIENCE, V313, P944, DOI 10.1126/science.1128618; Oda T, 2007, J CELL BIOL, V177, P243, DOI 10.1083/jcb.200609038; Patel-King RS, 2009, J CELL BIOL, V186, P283, DOI 10.1083/jcb.200905083; Peitsch MC, 1996, BIOCHEM SOC T, V24, P274, DOI 10.1042/bst0240274; PFISTER KK, 1982, CELL MOTIL CYTOSKEL, V2, P525, DOI 10.1002/cm.970020604; PFISTER KK, 1984, J BIOL CHEM, V259, P2072; Ralston KS, 2011, EUKARYOT CELL, V10, P884, DOI 10.1128/EC.00298-10; Rompolas P, 2010, MOL BIOL CELL, V21, P3669, DOI 10.1091/mbc.E10-04-0373; Sakakibara H, 1998, J CELL SCI, V111, P1155; Sakato M, 2007, MOL BIOL CELL, V18, P3620, DOI 10.1091/mbc.e06-10-0917; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; SUGINO K, 1982, NATURE, V295, P609, DOI 10.1038/295609a0; Ueno H, 2008, P NATL ACAD SCI USA, V105, P19702, DOI 10.1073/pnas.0808194105; Vyas J, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp616; WITMAN GB, 1986, METHOD ENZYMOL, V134, P280; Wu HW, 1999, J BIOMOL NMR, V13, P309, DOI 10.1023/A:1008340420295; Wu HW, 2000, NAT STRUCT BIOL, V7, P575; Wu HW, 2003, CELL MOTIL CYTOSKEL, V54, P267, DOI 10.1002/cm.10108; Wu HW, 2003, BIOCHEMISTRY-US, V42, P57, DOI 10.1021/bi026762j; Yagi T, 2005, J BIOL CHEM, V280, P41412, DOI 10.1074/jbc.M509072200	39	9	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3108	3122		10.1074/jbc.M111.286211	http://dx.doi.org/10.1074/jbc.M111.286211			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22157010	Green Published, hybrid			2022-12-27	WOS:000300295100017
J	Singh, SK; Thirumalai, A; Hammond, DJ; Pangburn, MK; Mishra, VK; Johnson, DA; Rusinol, AE; Agrawal, A				Singh, Sanjay K.; Thirumalai, Avinash; Hammond, David J., Jr.; Pangburn, Michael K.; Mishra, Vinod K.; Johnson, David A.; Rusinol, Antonio E.; Agrawal, Alok			Exposing a Hidden Functional Site of C-reactive Protein by Site-directed Mutagenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; STREPTOCOCCUS-PNEUMONIAE INFECTION; E-DEFICIENT MICE; FACTOR-H; ACIDIC PH; ATHEROSCLEROSIS DEVELOPMENT; CONFORMATIONAL-CHANGES; COMPLEMENT ACTIVATION; MACULAR DEGENERATION; SINGLE INJECTION	C-reactive protein (CRP) is a cyclic pentameric protein whose major binding specificity, at physiological pH, is for substances bearing exposed phosphocholine moieties. Another pentameric form of CRP, which exists at acidic pH, displays binding activity for oxidized LDL (ox-LDL). The ox-LDL-binding site in CRP, which is hidden at physiological pH, is exposed by acidic pH-induced structural changes in pentameric CRP. The aim of this study was to expose the hidden ox-LDL-binding site of CRP by site-directed mutagenesis and to generate a CRP mutant that can bind to ox-LDL without the requirement of acidic pH. Mutation of Glu(42), an amino acid that participates in intersubunit interactions in the CRP pentamer and is buried, to Gln resulted in a CRP mutant (E42Q) that showed significant binding activity for ox-LDL at physiological pH. For maximal binding to ox-LDL, E42Q CRP required a pH much less acidic than that required by wild-type CRP. At any given pH, E42Q CRP was more efficient than wild-type CRP in binding to ox-LDL. Like wild-type CRP, E42Q CRP remained pentameric at acidic pH. Also, E42Q CRP was more efficient than wild-type CRP in binding to several other deposited, conformationally altered proteins. The E42Q CRP mutant provides a tool to investigate the functions of CRP in defined animal models of inflammatory diseases including atherosclerosis because wild-type CRP requires acidic pH to bind to deposited, conformationally altered proteins, including ox-LDL, and available animal models may not have sufficient acidosis or other possible modifiers of the pentameric structure of CRP at the sites of inflammation.	[Singh, Sanjay K.; Thirumalai, Avinash; Hammond, David J., Jr.; Agrawal, Alok] E Tennessee State Univ, Quillen Coll Med, Dept Pharmacol, Johnson City, TN 37614 USA; [Johnson, David A.; Rusinol, Antonio E.] E Tennessee State Univ, Quillen Coll Med, Dept Biochem & Mol Biol, Johnson City, TN 37614 USA; [Pangburn, Michael K.] Univ Texas Hlth Sci Ctr, Dept Biochem, Ctr Biomed Res, Tyler, TX 75708 USA; [Mishra, Vinod K.] Univ Alabama, Dept Med, Birmingham, AL 35294 USA	East Tennessee State University; East Tennessee State University; University of Texas System; University of Texas at Tyler; University of Texas-Health Sciences Center at Tyler (UTHSCT); University of Alabama System; University of Alabama Birmingham	Agrawal, A (corresponding author), E Tennessee State Univ, Quillen Coll Med, Dept Pharmacol, POB 70577, Johnson City, TN 37614 USA.	agrawal@etsu.edu	Mishra, Vinod/S-1151-2019	Mishra, Vinod/0000-0002-4527-1512; Thirumalai, Avinash/0000-0002-7722-7479	National Institutes of Health [R01HL071233, R01DK35081, R15HL091770, 1R15HL091502]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071233, R15HL091770, R15HL091502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK035081] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL071233 (to A. A.), R01DK35081 (to M. K. P.), R15HL091770 (to D. A. J.), and 1R15HL091502 (to A. R.).	AGRAWAL A, 1992, J BIOL CHEM, V267, P25352; Agrawal Alok, 2010, Cardiovascular & Hematological Disorders - Drug Targets, V10, P235; Agrawal Alok, 2008, Endocrine Metabolic & Immune Disorders-Drug Targets, V8, P231, DOI 10.2174/187153008786848321; Bhakdi S, 1999, ARTERIOSCL THROM VAS, V19, P2348, DOI 10.1161/01.ATV.19.10.2348; Bjornheden T, 1999, ARTERIOSCL THROM VAS, V19, P870, DOI 10.1161/01.ATV.19.4.870; Black S, 2004, J BIOL CHEM, V279, P48487, DOI 10.1074/jbc.R400025200; Brown AJ, 1997, J LIPID RES, V38, P1730; Carlucci F, 2010, ARTHRITIS RHEUM-US, V62, P245, DOI 10.1002/art.27232; Chang MK, 2002, P NATL ACAD SCI USA, V99, P13043, DOI 10.1073/pnas.192399699; Costantini S, 2008, BIOINFORMATION, V3, P137, DOI 10.6026/97320630003137; DONG AC, 1994, J BIOL CHEM, V269, P6424; Gaitonde S, 2008, ARTHRIT RHEUM-ARTHR, V59, P1814, DOI 10.1002/art.24316; Gallagher FA, 2008, NATURE, V453, P940, DOI 10.1038/nature07017; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Haka AS, 2009, MOL BIOL CELL, V20, P4932, DOI 10.1091/mbc.E09-07-0559; Hammond DJ, 2010, J BIOL CHEM, V285, P36235, DOI 10.1074/jbc.M110.142026; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Hayashi M, 2006, RESPIROLOGY, V11, P24, DOI 10.1111/j.1440-1843.2006.00780.x; Hirschfield GM, 2005, P NATL ACAD SCI USA, V102, P8309, DOI 10.1073/pnas.0503202102; Jarva H, 1999, J IMMUNOL, V163, P3957; Ji SR, 2006, INT J BIOCHEM CELL B, V38, P648, DOI 10.1016/j.biocel.2005.11.004; Koike T, 2009, CIRCULATION, V120, P2088, DOI 10.1161/CIRCULATIONAHA.109.872796; Kovacs A, 2007, P NATL ACAD SCI USA, V104, P13768, DOI 10.1073/pnas.0706027104; Kumar S, 2002, BIOPHYS J, V83, P1595, DOI 10.1016/S0006-3495(02)73929-5; KUSHNER I, 1961, J EXP MED, V114, P961, DOI 10.1084/jem.114.6.961; Kushner I, 2010, ARTHRIT CARE RES, V62, P442, DOI 10.1002/acr.20052; Leake DS, 1997, ATHEROSCLEROSIS, V129, P149, DOI 10.1016/S0021-9150(96)06035-2; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; MIYAZAWA K, 1988, J IMMUNOL, V141, P570; MOLD C, 1984, J IMMUNOL, V133, P882; MULLENIX MC, 1994, MOL IMMUNOL, V31, P615, DOI 10.1016/0161-5890(94)90169-4; Naghavi M, 2002, ATHEROSCLEROSIS, V164, P27, DOI 10.1016/S0021-9150(02)00018-7; Oorni K, 2006, CURR OPIN LIPIDOL, V17, P534; Ortiz MA, 2009, EXP BIOL MED, V234, P624, DOI 10.3181/0812-RM-347; PANGBURN MK, 1983, BIOCHEMISTRY-US, V22, P178, DOI 10.1021/bi00270a026; Reifenberg K, 2005, ARTERIOSCL THROM VAS, V25, P1641, DOI 10.1161/01.ATV.0000171983.95612.90; Rodriguez W, 2006, ARTHRITIS RHEUM-US, V54, P325, DOI 10.1002/art.21556; Schroeder BO, 2011, NATURE, V469, P419, DOI 10.1038/nature09674; Sheu BC, 2010, BIOSENS BIOELECTRON, V26, P822, DOI 10.1016/j.bios.2010.06.001; Shrive AK, 1996, NAT STRUCT BIOL, V3, P346, DOI 10.1038/nsb0496-346; SILVER IA, 1988, EXP CELL RES, V175, P266, DOI 10.1016/0014-4827(88)90191-7; Singh SK, 2008, J IMMUNOL, V180, P4316, DOI 10.4049/jimmunol.180.6.4316; Singh SK, 2009, CLIN CHIM ACTA, V409, P143, DOI 10.1016/j.cca.2009.08.013; Singh U, 2008, J LIPID RES, V49, P1015, DOI 10.1194/jlr.M700535-JLR200; Singh V, 2009, CURR VASC PHARMACOL, V7, P75, DOI 10.2174/157016109787354097; Sjoberg AP, 2007, J BIOL CHEM, V282, P10894, DOI 10.1074/jbc.M610256200; Skerka C, 2007, MOL IMMUNOL, V44, P3398, DOI 10.1016/j.molimm.2007.02.012; Sneck M, 2005, J BIOL CHEM, V280, P37449, DOI 10.1074/jbc.M508565200; SRINIVASAN N, 1994, STRUCTURE, V2, P1017, DOI 10.1016/S0969-2126(94)00105-7; Suresh MV, 2007, J IMMUNOL, V178, P1158, DOI 10.4049/jimmunol.178.2.1158; Suresh MV, 2006, J IMMUNOL, V176, P4369, DOI 10.4049/jimmunol.176.7.4369; Szalai AJ, 2003, ARTHRITIS RHEUM-US, V48, P1602, DOI 10.1002/art.11026; Tada Y, 2008, SCIENCE, V321, P952, DOI 10.1126/science.1156970; Taskinen S, 2002, BIOCHEM J, V367, P403, DOI 10.1042/BJ20020492; Teupser D, 2011, J BIOL CHEM, V286, P6272, DOI 10.1074/jbc.M110.161414; Thompson D, 1999, STRUCTURE, V7, P169, DOI 10.1016/S0969-2126(99)80023-9; Torzewski M, 2000, ARTERIOSCL THROM VAS, V20, P2094, DOI 10.1161/01.ATV.20.9.2094; Torzewski M, 2008, THROMB HAEMOSTASIS, V99, P196, DOI 10.1160/TH07-10-0595; Trion A, 2005, ARTERIOSCL THROM VAS, V25, P1635, DOI 10.1161/01.ATV.0000171992.36710.1e; van Tits L, 2005, ARTERIOSCL THROM VAS, V25, P717, DOI 10.1161/01.ATV.0000157979.51673.2c; VOLANAKI.JE, 1971, P SOC EXP BIOL MED, V136, P612; Wang MY, 2011, FASEB J, V25, P3186, DOI 10.1096/fj.11-182741	63	24	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3550	3558		10.1074/jbc.M111.310011	http://dx.doi.org/10.1074/jbc.M111.310011			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22158621	Green Published, hybrid			2022-12-27	WOS:000300295100059
J	Blumbach, K; Niehoff, A; Belgardt, BF; Ehlen, HWA; Schmitz, M; Hallinger, R; Schulz, JN; Bruning, JC; Krieg, T; Schubert, M; Gullberg, D; Eckes, B				Blumbach, Katrin; Niehoff, Anja; Belgardt, Bengt F.; Ehlen, Harald W. A.; Schmitz, Markus; Hallinger, Ralf; Schulz, Jan-Niklas; Bruening, Jens C.; Krieg, Thomas; Schubert, Markus; Gullberg, Donald; Eckes, Beate			Dwarfism in Mice Lacking Collagen-binding Integrins alpha 2 beta 1 and alpha 11 beta 1 Is Caused by Severely Diminished IGF-1 Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-I; EXTRACELLULAR-MATRIX; STRUCTURAL BASIS; GENE-EXPRESSION; TRANSGENIC MICE; BONE; RECEPTOR; FIBROBLASTS; HORMONE; MOUSE	Mice with a combined deficiency in the alpha 2 beta 1 and alpha 11 beta 1 integrins lack the major receptors for collagen I. These mutants are born with inconspicuous differences in size but develop dwarfism within the first 4 weeks of life. Dwarfism correlates with shorter, less mineralized and functionally weaker bones that do not result from growth plate abnormalities or osteoblast dysfunction. Besides skeletal dwarfism, internal organs are correspondingly smaller, indicating proportional dwarfism and suggesting a systemic cause for the overall size reduction. In accordance with a critical role of insulin-like growth factor (IGF)-1 in growth control and bone mineralization, circulating IGF-1 levels in the sera of mice lacking either alpha 2 beta 1 or alpha 11 beta 1 or both integrins were sharply reduced by 39%, 64%, or 81% of normal levels, respectively. Low hepatic IGF-1 production resulted from diminished growth hormone-releasing hormone expression in the hypothalamus and, subsequently, reduced growth hormone expression in the pituitary glands of these mice. These findings point out a novel role of collagen-binding integrin receptors in the control of growth hormone/IGF-1-dependent biological activities. Thus, coupling hormone secretion to extracellular matrix signaling via integrins represents a novel concept in the control of endocrine homeostasis.	[Blumbach, Katrin; Schmitz, Markus; Hallinger, Ralf; Schulz, Jan-Niklas; Krieg, Thomas; Eckes, Beate] Univ Cologne, Dept Dermatol, D-50937 Cologne, Germany; [Niehoff, Anja] German Sport Univ Cologne, Inst Biomech & Orthopaed, D-50933 Cologne, Germany; [Belgardt, Bengt F.; Bruening, Jens C.] Univ Cologne, Inst Mouse Genet & Metab, D-50674 Cologne, Germany; [Belgardt, Bengt F.; Bruening, Jens C.; Krieg, Thomas; Schubert, Markus] Cologne Excellence Cluster Cellular Stress Respon, D-50674 Cologne, Germany; [Belgardt, Bengt F.; Bruening, Jens C.; Krieg, Thomas; Schubert, Markus] Univ Cologne, Ctr Mol Med CMMC, D-50931 Cologne, Germany; [Ehlen, Harald W. A.] Univ Cologne, Fac Med, Ctr Biochem, D-50931 Cologne, Germany; [Ehlen, Harald W. A.] Univ Duisburg Essen, Ctr Med Biotechnol ZMB Biol & Geog, Inst Dev Biol 1, D-45117 Essen, Germany; [Bruening, Jens C.; Schubert, Markus] Univ Hosp Cologne, Ctr Endocrinol Diabet & Prevent Med CEDP, D-50937 Cologne, Germany; [Bruening, Jens C.] Max Planck Inst Neurol Res, D-50931 Cologne, Germany; [Gullberg, Donald] Univ Bergen, Dept Biomed, N-5009 Bergen, Norway	University of Cologne; German Sport University Cologne; University of Cologne; University of Cologne; University of Cologne; University of Cologne; University of Duisburg Essen; University of Cologne; Max Planck Society; University of Bergen	Schubert, M (corresponding author), Univ Cologne, Ctr Endocrinol Diabet & Prevent Med CEDP, Kerpener Str 62, D-50937 Cologne, Germany.	markus.schubert@uk-koeln.de; beate.eckes@uni-koeln.de	Gullberg, Donald/H-2495-2016; Schubert, Markus/F-5150-2010; Niehoff, Anja/K-6626-2015	Gullberg, Donald/0000-0002-7245-4437; Niehoff, Anja/0000-0002-4165-0929; Schulz, Jan-Niklas/0000-0001-9286-206X; Belgardt, Bengt-Frederik/0000-0003-4537-9002	Deutsche Forschungsgemeinschaft [SFB 829, BR1492/7-1]; Research Council of Norway [1823258/S10, 197066/V40]; Norwegian Cancer Association [536711-2010]; Else Kroner-Fresenius-Stiftung [2010_A93]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Research Council of Norway(Research Council of Norway); Norwegian Cancer Association; Else Kroner-Fresenius-Stiftung	This project was supported in part by Deutsche Forschungsgemeinschaft Grant SFB 829 (to B.E. and T.K.) and BR1492/7-1 (to J.C.B.), by Research Council of Norway Grants 1823258/S10 and 197066/V40 (to D.G.), by Norwegian Cancer Association Grant 536711-2010 (to D.G.), and by Else Kroner-Fresenius-Stiftung Grant 2010_A93 (to M.S.).	Ahmed SF, 2010, J ENDOCRINOL, V206, P249, DOI 10.1677/JOE-10-0045; Aszodi A, 2003, GENE DEV, V17, P2465, DOI 10.1101/gad.277003; Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6; Baur A, 2011, FREE RADICAL RES, V45, P550, DOI 10.3109/10715762.2011.555483; Bengtsson T, 2005, J CELL SCI, V118, P929, DOI 10.1242/jcs.01678; Bikle DD, 2008, OSTEOPOROSIS INT, V19, P1237, DOI 10.1007/s00198-008-0597-z; Canalis E, 2009, J CELL BIOCHEM, V108, P769, DOI 10.1002/jcb.22322; Carracedo S, 2010, J BIOL CHEM, V285, P10434, DOI 10.1074/jbc.M109.078766; Chen JC, 2002, AM J PATHOL, V161, P337, DOI 10.1016/S0002-9440(10)64185-5; Duong L, 2000, MATRIX BIOL, V19, P97, DOI 10.1016/S0945-053X(00)00051-2; Eckes B, 2010, FIBROGENESIS TISSUE, V3, DOI 10.1186/1755-1536-3-4; Ekholm E, 2002, AM J PATHOL, V160, P1779, DOI 10.1016/S0002-9440(10)61124-8; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820; Giustina A, 2008, ENDOCR REV, V29, P535, DOI 10.1210/er.2007-0036; GLUCKMAN PD, 1981, ENDOCR REV, V2, P363, DOI 10.1210/edrv-2-4-363; Goel HL, 2004, J CELL BIOL, V166, P407, DOI 10.1083/jcb.200403003; Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002; Gruner S, 2004, CIRCULATION, V110, P2946, DOI 10.1161/01.CIR.0000146341.63677.3C; Harburger DS, 2009, J CELL SCI, V122, P159, DOI 10.1242/jcs.018093; He JN, 2006, BONE, V38, P826, DOI 10.1016/j.bone.2005.11.021; Holtkotter O, 2002, J BIOL CHEM, V277, P10789, DOI 10.1074/jbc.M112307200; Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kadler KE, 2007, J CELL SCI, V120, P1955, DOI 10.1242/jcs.03453; Karsdal MA, 2007, J BONE MINER RES, V22, P487, DOI 10.1359/JBMR.070109; Katsumi A, 2004, J BIOL CHEM, V279, P12001, DOI 10.1074/jbc.R300038200; KLEIN CE, 1991, J CELL BIOL, V115, P1427, DOI 10.1083/jcb.115.5.1427; Knight CG, 1998, J BIOL CHEM, V273, P33287, DOI 10.1074/jbc.273.50.33287; Langholz O, 1995, J CELL BIOL, V131, P1903, DOI 10.1083/jcb.131.6.1903; Larsen M, 2006, CURR OPIN CELL BIOL, V18, P463, DOI 10.1016/j.ceb.2006.08.009; Le Roith D, 2001, ENDOCR REV, V22, P53, DOI 10.1210/er.22.1.53; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/0092-8674(93)90679-K; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long RK, 2007, CLIN REV BONE MINER, V5, P222, DOI 10.1007/s12018-008-9009-3; Nakayamada S, 2003, J BIOL CHEM, V278, P45368, DOI 10.1074/jbc.M308786200; Nystrom A, 2009, BLOOD, V114, P4897, DOI 10.1182/blood-2009-02-207134; Ohlsson C, 2009, ENDOCR REV, V30, P494, DOI 10.1210/er.2009-0010; Phillips JA, 2008, MATRIX BIOL, V27, P609, DOI 10.1016/j.matbio.2008.05.003; Popova SN, 2004, DEV BIOL, V270, P427, DOI 10.1016/j.ydbio.2004.03.006; Popova SN, 2007, MOL CELL BIOL, V27, P4306, DOI 10.1128/MCB.00041-07; Romero CJ, 2010, MOL ENDOCRINOL, V24, P1077, DOI 10.1210/me.2009-0393; Rozario T, 2010, DEV BIOL, V341, P126, DOI 10.1016/j.ydbio.2009.10.026; Schmitz M, 2008, MATRIX BIOL, V27, P67, DOI 10.1016/j.matbio.2007.08.001; Seeman E, 2006, NEW ENGL J MED, V354, P2250, DOI 10.1056/NEJMra053077; Shane E, 2010, J BONE MINER RES, V25, P2267, DOI 10.1002/jbmr.253; Sims NA, 2000, J CLIN INVEST, V106, P1095, DOI 10.1172/JCI10753; Sjogren K, 1999, P NATL ACAD SCI USA, V96, P7088, DOI 10.1073/pnas.96.12.7088; Takahashi Y, 1996, NEW ENGL J MED, V334, P432, DOI 10.1056/NEJM199602153340704; Tiger CF, 2001, DEV BIOL, V237, P116, DOI 10.1006/dbio.2001.0363; Tulla M, 2001, J BIOL CHEM, V276, P48206, DOI 10.1074/jbc.M104058200; TURNER CH, 1993, BONE, V14, P595, DOI 10.1016/8756-3282(93)90081-K; Velling T, 2002, J BIOL CHEM, V277, P37377, DOI 10.1074/jbc.M206286200; Velling T, 1999, J BIOL CHEM, V274, P25735, DOI 10.1074/jbc.274.36.25735; Wickstrom S., 2011, EXTRACELLULAR MATRIX, P223; Woodall BP, 2008, J BIOL CHEM, V283, P2335, DOI 10.1074/jbc.M708364200; WU JE, 1994, DEV DYNAM, V199, P292, DOI 10.1002/aja.1001990405; Yakar S, 1999, P NATL ACAD SCI USA, V96, P7324, DOI 10.1073/pnas.96.13.7324; Yakar S, 2002, J CLIN INVEST, V110, P771, DOI 10.1172/JCI200215463; Yakar S, 2009, J BONE MINER RES, V24, P1481, DOI [10.1359/JBMR.090226, 10.1359/jbmr.090226]; Yamada KM, 2002, NAT CELL BIOL, V4, pE75, DOI 10.1038/ncb0402-e75; Zhang M, 2002, J BIOL CHEM, V277, P44005, DOI 10.1074/jbc.M208265200; Zhang WM, 2003, J BIOL CHEM, V278, P7270, DOI 10.1074/jbc.M210313200; Zhang ZG, 2006, J CELL SCI, V119, P1886, DOI 10.1242/jcs.02921; Zhao G, 2000, ENDOCRINOLOGY, V141, P2674, DOI 10.1210/en.141.7.2674; Zhu CQ, 2007, P NATL ACAD SCI USA, V104, P11754, DOI 10.1073/pnas.0703040104; Zweers MC, 2007, J INVEST DERMATOL, V127, P467, DOI 10.1038/sj.jid.5700546	68	23	23	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6431	6440		10.1074/jbc.M111.283119	http://dx.doi.org/10.1074/jbc.M111.283119			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22210772	Green Accepted, Green Published, hybrid			2022-12-27	WOS:000300791800033
J	Neve, EPA; Nordling, A; Andersson, TB; Hellman, U; Diczfalusy, U; Johansson, I; Ingelman-Sundberg, M				Neve, Etienne P. A.; Nordling, Asa; Andersson, Tommy B.; Hellman, Ulf; Diczfalusy, Ulf; Johansson, Inger; Ingelman-Sundberg, Magnus			Amidoxime Reductase System Containing Cytochrome b(5) Type B (CYB5B) and MOSC2 Is of Importance for Lipid Synthesis in Adipocyte Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIRECT THROMBIN INHIBITOR; RAT-LIVER; OUTER MITOCHONDRIAL; PROTEIN; PRODRUG; IDENTIFICATION; DETOXIFICATION; INVOLVEMENT; ABSORPTION; ACID	Reduction of hydroxylamines and amidoximes is important for drug activation and detoxification of aromatic and heterocyclic amines. Such a reductase system was previously found to be of high activity in adipose tissue and liver, and furthermore, in vitro studies using recombinant truncated and purified enzymes suggested the participation of cytochrome b(5) reductase (CYB5R), cytochrome b(5) (CYB5), and molybdenum cofactor sulfurase C-terminal containing 1 and 2 (MOSC1 and -2). Here, we show that purified rat liver outer mitochondrial membrane contains high amidoxime reductase activity and that MOSC2 is exclusively localized to these membranes. Moreover, using the same membrane fraction, we could show direct binding of a radiolabeled benzamidoxime substrate to MOSC2. Following differentiation of murine 3T3-L1 cells into mature adipocytes, the MOSC2 levels as well as the amidoxime reductase activity were increased, indicating that the enzyme is highly regulated under lipogenic conditions. siRNA-mediated down-regulation of MOSC2 and the mitochondrial form of cytochrome b(5) type B (CYB5B) significantly inhibited the reductase activity in the differentiated adipocytes, whereas down-regulation of MOSC1, cytochrome b(5) type A (CYB5A), CYB5R1, CYB5R2, or CYB5R3 had no effect. Down-regulation of MOSC2 caused impaired lipid synthesis. These results demonstrate for the first time the direct involvement of MOSC2 and CYB5B in the amidoxime reductase activity in an intact cell system. We postulate the presence of a novel reductive enzyme system of importance for lipid synthesis that is exclusively localized to the outer mitochondrial membrane and is composed of CYB5B, MOSC2, and a third unknown component (a CYB5B reductase).	[Neve, Etienne P. A.; Nordling, Asa; Andersson, Tommy B.; Johansson, Inger; Ingelman-Sundberg, Magnus] Karolinska Inst, Dept Physiol & Pharmacol, Pharmacogenet Sect, SE-17177 Stockholm, Sweden; [Andersson, Tommy B.] AstraZeneca Res & Dev, SE-43183 Molndal, Sweden; [Hellman, Ulf] Ludwig Inst Canc Res Ltd, Uppsala Branch, SE-75123 Uppsala, Sweden; [Diczfalusy, Ulf] Karolinska Inst, Karolinska Univ Hosp Huddinge, Div Clin Chem, Dept Lab Med, SE-14186 Huddinge, Sweden	Karolinska Institutet; AstraZeneca; Ludwig Institute for Cancer Research; Karolinska Institutet; Karolinska University Hospital	Neve, EPA (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, Pharmacogenet Sect, SE-17177 Stockholm, Sweden.	etienne.neve@ki.se	Ingelman-Sundberg, Magnus/ABD-9302-2021; Diczfalusy, Ulf/A-5336-2008	Diczfalusy, Ulf/0000-0001-6643-3763	AstraZeneca; Swedish Research Council	AstraZeneca(AstraZeneca); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by grants from AstraZeneca and from the Swedish Research Council.	Altuve A, 2004, BIOCHEM BIOPH RES CO, V314, P602, DOI 10.1016/j.bbrc.2003.12.138; Anantharaman V, 2002, FEMS MICROBIOL LETT, V207, P55, DOI 10.1016/S0378-1097(01)00515-8; Andersson AM, 1998, J VIROL, V72, P9585, DOI 10.1128/JVI.72.12.9585-9596.1998; Andersson S, 2005, DRUG METAB DISPOS, V33, P570, DOI 10.1124/dmd.104.002972; BERNHEIM ML, 1968, ARCH BIOCHEM BIOPHYS, V124, P436, DOI 10.1016/0003-9861(68)90349-4; Borgese N, 1996, J CELL BIOL, V135, P1501, DOI 10.1083/jcb.135.6.1501; CARLSEN J, 1995, CELL BIOL INT, V19, P759, DOI 10.1006/cbir.1995.1127; Clement B, 1997, J BIOL CHEM, V272, P19615, DOI 10.1074/jbc.272.31.19615; COUGHLAN MP, 1980, J BIOL CHEM, V255, P2694; Deinum J, 2009, THROMB HAEMOSTASIS, V101, P1051, DOI 10.1160/TH08-09-0586; deKroon AIPM, 1997, BBA-BIOMEMBRANES, V1325, P108, DOI 10.1016/S0005-2736(96)00240-4; Eriksson UG, 2003, DRUG METAB DISPOS, V31, P294, DOI 10.1124/dmd.31.3.294; Gruenewald S, 2008, J MED CHEM, V51, P8173, DOI 10.1021/jm8010417; Gustafsson D, 2001, THROMB RES, V101, P171, DOI 10.1016/S0049-3848(00)00399-6; Havemeyer A, 2006, J BIOL CHEM, V281, P34796, DOI 10.1074/jbc.M607697200; Hellman U, 2000, EXS, V88, P43; HOVIUS R, 1990, BIOCHIM BIOPHYS ACTA, V1021, P217, DOI 10.1016/0005-2736(90)90036-N; ITO A, 1981, BIOCHEM BIOPH RES CO, V101, P591, DOI 10.1016/0006-291X(81)91300-0; Johansson S, 2011, INT J CLIN PHARM TH, V49, P258, DOI 10.5414/CP201465; KADLUBAR FF, 1974, ARCH BIOCHEM BIOPHYS, V162, P83, DOI 10.1016/0003-9861(74)90107-6; KARIYA K, 1984, LIFE SCI, V35, P2327, DOI 10.1016/0024-3205(84)90524-1; Kilroy G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006940; King RS, 1999, CANCER LETT, V143, P167, DOI 10.1016/S0304-3835(99)00119-6; Kozmin SG, 2008, MOL MICROBIOL, V68, P51, DOI 10.1111/j.1365-2958.2008.06128.x; Kurian JR, 2006, CHEM RES TOXICOL, V19, P1366, DOI 10.1021/tx060106t; Kurian JR, 2004, J PHARMACOL EXP THER, V311, P1171, DOI 10.1124/jpet.104.072389; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Malik AN, 2007, BIOCHEM BIOPH RES CO, V357, P237, DOI 10.1016/j.bbrc.2007.03.132; Mikula M, 2011, FUNCT INTEGR GENOMIC, V11, P215, DOI 10.1007/s10142-010-0200-5; Mkrtchian S, 1998, EUR J BIOCHEM, V251, P304, DOI 10.1046/j.1432-1327.1998.2510304.x; Murphy D, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-14; Ntambi JM, 2000, J NUTR, V130, p3122S, DOI 10.1093/jn/130.12.3122S; Ogishima T, 2003, J BIOL CHEM, V278, P21204, DOI 10.1074/jbc.M301698200; Pinski J, 2011, PROSTATE, V71, P892, DOI 10.1002/pros.21305; Reh R, 2008, XENOBIOTICA, V38, P1177, DOI [10.1080/00498250802109199, 10.1080/00498250802109199 ]; Schwarz G, 2009, NATURE, V460, P839, DOI 10.1038/nature08302; Sivertsson L, 2010, DRUG METAB DISPOS, V38, P995, DOI 10.1124/dmd.110.032367; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Timm U, 1997, J CHROMATOGR B, V691, P397, DOI 10.1016/S0378-4347(96)00477-X; Wahl B, 2010, J BIOL CHEM, V285, P37847, DOI 10.1074/jbc.M110.169532; Zhang Y, 2008, J MOL BIOL, V379, P881, DOI 10.1016/j.jmb.2008.03.051	41	44	45	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6307	6317		10.1074/jbc.M111.328237	http://dx.doi.org/10.1074/jbc.M111.328237			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22203676	hybrid, Green Published			2022-12-27	WOS:000300791800023
J	Fritsch, C; Sawala, A; Harris, R; Maartens, A; Sutcliffe, C; Ashe, HL; Ray, RP				Fritsch, Cornelia; Sawala, Annick; Harris, Robin; Maartens, Aidan; Sutcliffe, Catherine; Ashe, Hilary L.; Ray, Robert P.			Different Requirements for Proteolytic Processing of Bone Morphogenetic Protein 5/6/7/8 Ligands in Drosophila melanogaster	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE ENCODES; PRO-DOMAINS; ACTIVATION; PRODOMAIN; COMPLEX; DPP; PROPROTEIN; CLEAVAGE; EMBRYO; FAMILY	Bone morphogenetic proteins (BMPs) are synthesized as proproteins that undergo proteolytic processing by furin/subtilisin proprotein convertases to release the active ligand. Here we study processing of BMP5/6/7/8 proteins, including the Drosophila orthologs Glass Bottom Boat (Gbb) and Screw (Scw) and human BMP7. Gbb and Scw have three functional furin/subtilisin proprotein convertase cleavage sites; two between the prodomain and ligand domain, which we call the Main and Shadow sites, and one within the prodomain, which we call the Pro site. In Gbb each site can be cleaved independently, although efficient cleavage at the Shadow site requires cleavage at the Main site, and remarkably, none of the sites is essential for Gbb function. Rather, Gbb must be processed at either the Pro or Main site to produce a functional ligand. Like Gbb, the Pro and Main sites in Scw can be cleaved independently, but cleavage at the Shadow site is dependent on cleavage at the Main site. However, both Pro and Main sites are essential for Scw function. Thus, Gbb and Scw have different processing requirements. The BMP7 ligand rescues gbb mutants in Drosophila, but full-length BMP7 cannot, showing that functional differences in the prodomain limit the BMP7 activity in flies. Furthermore, unlike Gbb, cleavage-resistant BMP7, although non-functional in rescue assays, activates the downstream signaling cascade and thus retains some functionality. Our data show that cleavage requirements evolve rapidly, supporting the notion that changes in post-translational processing are used to create functional diversity between BMPs within and between species.	[Sawala, Annick; Harris, Robin; Sutcliffe, Catherine; Ashe, Hilary L.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Fritsch, Cornelia; Maartens, Aidan; Ray, Robert P.] Univ Sussex, Sch Life Sci, Falmer Brighton BN1 9QG, England	University of Manchester; University of Sussex	Ashe, HL (corresponding author), Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England.	Hilary.Ashe@manchester.ac.uk; r.ray@sussex.ac.uk	Harris, Robin/ABA-6788-2020	Harris, Robin/0000-0001-6945-6741; Maartens, Aidan/0000-0001-7112-819X; Sawala, Annick/0000-0002-3845-4206	Wellcome Trust Studentship [083271/Z/07/Z]; Medical Research Council [G0500916]; Biotechnology and Biological Sciences Research Council [BB/C508050/1, G19755]; MRC [G0500916] Funding Source: UKRI	Wellcome Trust Studentship(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Wellcome Trust Studentship 083271/Z/07/Z (to A. S. and H. L. A.), Medical Research Council Grant G0500916 (to R. P. R.), and Biotechnology and Biological Sciences Research Council Grants BB/C508050/1 and G19755 (to R. P. R. and H. L. A.), respectively.	Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; ARORA K, 1994, GENE DEV, V8, P2588, DOI 10.1101/gad.8.21.2588; Bergeron F, 2000, J MOL ENDOCRINOL, V24, P1, DOI 10.1677/jme.0.0240001; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Brown MA, 2005, J BIOL CHEM, V280, P25111, DOI 10.1074/jbc.M503328200; Chen YJ, 1998, DEVELOPMENT, V125, P1759; Christoforou CP, 2008, DEV BIOL, V313, P519, DOI 10.1016/j.ydbio.2007.09.044; Conley CA, 2000, DEVELOPMENT, V127, P3947; Constam DB, 1999, J CELL BIOL, V144, P139, DOI 10.1083/jcb.144.1.139; Cui YZ, 1998, EMBO J, V17, P4735, DOI 10.1093/emboj/17.16.4735; Cui YZ, 2001, GENE DEV, V15, P2797; Degnin C, 2004, MOL BIOL CELL, V15, P5012, DOI 10.1091/mbc.E04-08-0673; Duckert P, 2004, PROTEIN ENG DES SEL, V17, P107, DOI 10.1093/protein/gzh013; FRISTROM D, 1993, DEVELOPMENT, V117, P509; Fritsch C, 2010, DEV GENES EVOL, V220, P235, DOI 10.1007/s00427-010-0341-5; Ge GX, 2005, MOL CELL BIOL, V25, P5846, DOI 10.1128/MCB.25.14.5846-5858.2005; Gregory KE, 2005, J BIOL CHEM, V280, P27970, DOI 10.1074/jbc.M504270200; Harris RE, 2011, EMBO REP, V12, P519, DOI 10.1038/embor.2011.80; Hashimoto O, 2005, P NATL ACAD SCI USA, V102, P5426, DOI 10.1073/pnas.0409533102; Hauburger A, 2009, FEBS J, V276, P6386, DOI 10.1111/j.1742-4658.2009.07361.x; HAWLEY SHB, 1995, GENE DEV, V9, P2923, DOI 10.1101/gad.9.23.2923; Herpin A, 2004, DEV COMP IMMUNOL, V28, P461, DOI 10.1016/j.dci.2003.09.007; Ho DM, 2010, MECH DEVELOP, V127, P485, DOI 10.1016/j.mod.2010.08.004; Hogan BLM, 1996, CURR OPIN GENET DEV, V6, P432, DOI 10.1016/S0959-437X(96)80064-5; Jiang MS, 2004, BIOCHEM BIOPH RES CO, V315, P525, DOI 10.1016/j.bbrc.2004.01.085; JONES WK, 1994, GROWTH FACTORS, V11, P215, DOI 10.3109/08977199409046919; Kunnapuu J, 2009, P NATL ACAD SCI USA, V106, P8501, DOI 10.1073/pnas.0809885106; LOPEZ AR, 1992, MOL CELL BIOL, V12, P1674, DOI 10.1128/MCB.12.4.1674; McGuire S. E., 2004, SCI STKE, V2004, pp16, DOI DOI 10.1125/STKE.2202004P16; Nakayama K, 1997, BIOCHEM J, V327, P625, DOI 10.1042/bj3270625; Nishimatsu S, 1998, MECH DEVELOP, V74, P75, DOI 10.1016/S0925-4773(98)00070-7; O'Connor MB, 2006, DEVELOPMENT, V133, P183; Pirrotta V, 1988, Biotechnology, V10, P437; Ray RP, 2001, DEVELOPMENT, V128, P3913; SAMPATH TK, 1992, J BIOL CHEM, V267, P20352; Sengle G, 2008, J MOL BIOL, V381, P1025, DOI 10.1016/j.jmb.2008.06.074; Sengle G, 2008, J BIOL CHEM, V283, P13874, DOI 10.1074/jbc.M707820200; Sengle G, 2011, J BIOL CHEM, V286, P5087, DOI 10.1074/jbc.M110.188615; Shi ML, 2011, NATURE, V474, P343, DOI 10.1038/nature10152; Shimmi O, 2005, DEV BIOL, V282, P70, DOI 10.1016/j.ydbio.2005.02.029; Shimmi O, 2005, CELL, V120, P873, DOI 10.1016/j.cell.2005.02.009; Simpson P, 2008, ADV GENET, V61, P67, DOI 10.1016/S0065-2660(07)00003-X; Sopory S, 2010, DEV BIOL, V346, P102, DOI 10.1016/j.ydbio.2010.07.019; Wharton KA, 1999, GENETICS, V152, P629; WITTBRODT J, 1994, GENE DEV, V8, P1448, DOI 10.1101/gad.8.12.1448; Wolfman NM, 2003, P NATL ACAD SCI USA, V100, P15842, DOI 10.1073/pnas.2534946100	46	16	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5942	5953		10.1074/jbc.M111.316745	http://dx.doi.org/10.1074/jbc.M111.316745			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22199351	Green Published, hybrid			2022-12-27	WOS:000300638000068
J	Kim, W; Chakraborty, G; Kim, S; Shin, J; Park, CH; Jeong, MW; Bharatham, N; Yoon, HS; Kim, KT				Kim, Wanil; Chakraborty, Goutam; Kim, Sangjune; Shin, Joon; Park, Choon-Ho; Jeong, Min-Woo; Bharatham, Nagakumar; Yoon, Ho Sup; Kim, Kyong-Tai			Macro Histone H2A1.2 (MacroH2A1) Protein Suppresses Mitotic Kinase VRK1 during Interphase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VACCINIA-RELATED KINASE-1; INACTIVE X-CHROMOSOME; VARIANT MACROH2A; PHOSPHORYLATION; MITOSIS; VACCINIA-RELATED-KINASE-1; ACCUMULATION; PROGRESSION; EXPRESSION; NUCLEUS	VRK1-mediated phosphorylation of histone H3 should be restricted in mitosis for consistent cell cycling, and defects in this process trigger cellular catastrophe. However, an interphasic regulator against VRK1 has not been actually investigated so far. Here, we show that the histone variant macrodomain-containing histone H2A1.2 functions as a suppressor against VRK1 during interphase. The level of macroH2A1.2 was markedly reduced in the mitotic phase, and the macroH2A1.2-mediated inhibition of histone H3 phosphorylation occurred mainly during interphase. We also found direct interaction and binding features between VRK1 and macroH2A1.2 by NMR spectroscopy. Hence, our findings might provide valuable insight into the underlying molecular mechanism regarding an epigenetic regulation of histone H3 during the cell cycle.	[Kim, Wanil; Kim, Sangjune; Park, Choon-Ho; Jeong, Min-Woo; Kim, Kyong-Tai] Pohang Univ Sci & Technol, Dept Life Sci, Div Mol & Life Sci, Pohang 790784, South Korea; [Kim, Kyong-Tai] Pohang Univ Sci & Technol, Div Integrat Biosci & Biotechnol, Pohang 790784, South Korea; [Chakraborty, Goutam; Shin, Joon; Bharatham, Nagakumar; Yoon, Ho Sup] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Kim, KT (corresponding author), Pohang Univ Sci & Technol, Dept Life Sci, Div Mol & Life Sci, Pohang 790784, South Korea.	ktk@postech.ac.kr	Yoon, Ho Sup/A-2193-2011	Yoon, Ho Sup/0000-0002-8243-3904; Kim, Sangjune/0000-0003-3052-3163; KIM, KYONG-TAI/0000-0001-7292-2627	National Research Foundation of Korea [20100030089, 20100002146, 20100019706]; Brain Korea 21 Program; World Class University [R31-10105]; Anti-aging and Well Being Research Center; Korean Ministry of Education, Science, and Technology	National Research Foundation of Korea(National Research Foundation of Korea); Brain Korea 21 Program(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); World Class University; Anti-aging and Well Being Research Center; Korean Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by National Research Foundation of Korea Grants 20100030089, 20100002146, and 20100019706, the Brain Korea 21 Program, the World Class University Program Grant R31-10105, and the Regional Core Research Program/Anti-aging and Well Being Research Center funded by the Korean Ministry of Education, Science, and Technology.	Agelopoulos M, 2006, EMBO J, V25, P4843, DOI 10.1038/sj.emboj.7601364; Angelov D, 2003, MOL CELL, V11, P1033, DOI 10.1016/S1097-2765(03)00100-X; Barcia R, 2002, ARCH BIOCHEM BIOPHYS, V399, P1, DOI 10.1006/abbi.2001.2746; Bernstein E, 2008, P NATL ACAD SCI USA, V105, P1533, DOI 10.1073/pnas.0711632105; Chadwick BP, 2002, J CELL BIOL, V157, P1113, DOI 10.1083/jcb.200112074; Choi YH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015254; Costanzi C, 1998, NATURE, V393, P599, DOI 10.1038/31275; Crosio C, 2002, MOL CELL BIOL, V22, P874, DOI 10.1128/MCB.22.3.874-885.2002; Dai J, 2005, GENE DEV, V19, P472, DOI 10.1101/gad.1267105; Gorjanacz M, 2007, EMBO J, V26, P132, DOI 10.1038/sj.emboj.7601470; Kang TH, 2008, J CELL SCI, V121, P3035, DOI 10.1242/jcs.026757; Kang TH, 2007, MOL CELL BIOL, V27, P8533, DOI 10.1128/MCB.00018-07; Kohn EA, 2002, J BIOL CHEM, V277, P26553, DOI 10.1074/jbc.M202040200; Lancaster OM, 2007, J CELL BIOL, V179, P817, DOI 10.1083/jcb.200706067; Lopez-Borges S, 2000, ONCOGENE, V19, P3656, DOI 10.1038/sj.onc.1203709; Nichols RJ, 2006, MOL BIOL CELL, V17, P2451, DOI 10.1091/mbc.E05-12-1179; Nichols RJ, 2004, J BIOL CHEM, V279, P7934, DOI 10.1074/jbc.M310813200; Park CH, 2011, MOL BIOL CELL, V22, P1398, DOI 10.1091/mbc.E10-08-0717; PEHRSON JR, 1992, SCIENCE, V257, P1398; Santos CR, 2006, MOL CANCER RES, V4, P177, DOI 10.1158/1541-7786.MCR-05-0212; Schober CS, 2011, MECH DEVELOP, V128, P178, DOI 10.1016/j.mod.2011.01.004; Sevilla A, 2004, ONCOGENE, V23, P8950, DOI 10.1038/sj.onc.1208015; Sevilla A, 2004, J BIOL CHEM, V279, P27458, DOI 10.1074/jbc.M401009200; Shin J, 2011, J BIOL CHEM, V286, P22131, DOI 10.1074/jbc.M110.200162; Vader G, 2008, BBA-REV CANCER, V1786, P60, DOI 10.1016/j.bbcan.2008.07.003; Valbuena A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001642; Valbuena A, 2006, MOL CELL BIOL, V26, P4782, DOI 10.1128/MCB.00069-06; Valbuena A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017320; Vega FM, 2004, MOL CELL BIOL, V24, P10366, DOI 10.1128/MCB.24.23.10366-10380.2004; Wang FW, 2011, CURR BIOL, V21, P1061, DOI 10.1016/j.cub.2011.05.016; Wiebe MS, 2010, BIOL REPROD, V82, P182, DOI 10.1095/biolreprod.109.079095	31	34	34	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5278	5289		10.1074/jbc.M111.281709	http://dx.doi.org/10.1074/jbc.M111.281709			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22194607	hybrid, Green Published			2022-12-27	WOS:000300638000010
J	Marzook, H; Li, DQ; Nair, VS; Mudvari, P; Reddy, SDN; Pakala, SB; Santhoshkumar, TR; Pillai, MR; Kumar, R				Marzook, Hezlin; Li, Da-Qiang; Nair, Vasudha S.; Mudvari, Prakriti; Reddy, Sirigiri Divijendra Natha; Pakala, Suresh B.; Santhoshkumar, T. R.; Pillai, M. Radhakrishna; Kumar, Rakesh			Metastasis-associated Protein 1 Drives Tumor Cell Migration and Invasion through Transcriptional Repression of RING Finger Protein 144A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOCRINE MOTILITY FACTOR; BREAST-CANCER; ESTROGEN-RECEPTOR; RNA-POLYMERASE; IN-VITRO; MTA1; EXPRESSION; GENE; DNA; INVASIVENESS	Metastasis-associated protein 1 (MTA1), a component of the nucleosome-remodeling and histone deacetylase complex, is widely up-regulated in human cancers and significantly correlated with tumor invasion and metastasis, but the mechanisms involved remain largely unknown. Here, we report that MTA1 transcriptionally represses the expression of RING finger protein 144A (RNF144A), an uncharacterized gene whose protein product possesses potential E3 ubiquitin ligase activity, by recruiting the histone deacetylase 2 (HDAC2) and CCAAT/enhancer-binding protein alpha (c/EBP alpha) co-repressor complex onto human RNF144A promoter. Furthermore, an inverse correlation between the expression levels of MTA1 and RNF144A was demonstrated in publicly available breast cancer microarray datasets and the MCF10 breast cancer progression model system. To address functional aspects of MTA1 regulation of RNF144A, we demonstrate that RNF144A is a novel suppressor of cancer migration and invasion, two requisite steps of metastasis in vivo, and knockdown of endogenous RNF144A by small interfering RNAs accelerates the migration and invasion of MTA1-overexpressing cells. These results suggest that RNF144A is partially responsible for MTA1-mediated migration and invasion and that MTA1 overexpression in highly metastatic cancer cells drives cell migration and invasion by, at least in part, interfering with the suppressive function of RNF144A through transcriptional repression of RNF144A expression. Together, these findings provide novel mechanistic insights into regulation of tumor progression and metastasis by MTA1 and highlight a previously unrecognized role of RNF144A in MTA1-driven cancer cell migration and invasion.	[Marzook, Hezlin; Santhoshkumar, T. R.; Pillai, M. Radhakrishna; Kumar, Rakesh] Rajiv Gandhi Ctr Biotechnol, Canc Res Program, Thiruvananthapuram 695014, Kerala, India; [Li, Da-Qiang; Nair, Vasudha S.; Mudvari, Prakriti; Reddy, Sirigiri Divijendra Natha; Pakala, Suresh B.; Kumar, Rakesh] George Washington Univ, Sch Med & Hlth Sci, Dept Biochem & Mol Biol, Washington, DC 20037 USA	Department of Biotechnology (DBT) India; Rajiv Gandhi Centre for Biotechnology (RGCB); George Washington University	Pillai, MR (corresponding author), Rajiv Gandhi Ctr Biotechnol, Canc Res Program, Thiruvananthapuram 695014, Kerala, India.	mrpillai@rgcb.res.in; bcmrxk@gwumc.edu	Kumar, Rakesh/ABD-1065-2020	Kumar, Rakesh/0000-0001-7664-0803	National Institutes of Health [CA98823]; NATIONAL CANCER INSTITUTE [R01CA098823] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA98823 (to R. K.).	Dawson PJ, 1996, AM J PATHOL, V148, P313; Didier C, 2003, MOL CELL BIOL, V23, P5331, DOI 10.1128/MCB.23.15.5331-5345.2003; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Divijendra S, 2009, CANCER RES, V69, P5639, DOI 10.1158/0008-5472.CAN-09-0898; Duan H, 2005, MOL CELL BIOL, V25, P1608, DOI 10.1128/MCB.25.5.1608-1619.2005; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Fang SY, 2001, P NATL ACAD SCI USA, V98, P14422, DOI 10.1073/pnas.251401598; FLAMEE PA, 1985, BIOCHEM J, V230, P557, DOI 10.1042/bj2300557; Ghanta KS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017135; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hofer MD, 2004, BRIT J CANCER, V90, P455, DOI 10.1038/sj.bjc.6601535; Hurst DR, 2009, CLIN EXP METASTAS, V26, P89, DOI 10.1007/s10585-008-9216-9; Iwamoto T, 2011, J NATL CANCER I, V103, P264, DOI 10.1093/jnci/djq524; Jiang QM, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-60; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Kai L, 2011, PROSTATE, V71, P268, DOI 10.1002/pros.21240; Khaleque M, 2008, ONCOGENE, V27, P1886, DOI 10.1038/sj.onc.1210834; Kumar R, 2003, SEMIN ONCOL, V30, P30, DOI 10.1053/j.seminoncol.2003.08.005; Kumar R, 2002, NATURE, V418, P654, DOI 10.1038/nature00889; Lee H, 2010, J CELL BIOCHEM, V111, P1169, DOI 10.1002/jcb.22839; Li DQ, 2011, P NATL ACAD SCI USA, V108, P8791, DOI 10.1073/pnas.1018389108; Li DQ, 2010, J BIOL CHEM, V285, P19802, DOI 10.1074/jbc.M109.085258; Li DQ, 2010, J BIOL CHEM, V285, P10044, DOI 10.1074/jbc.M109.079095; Li DQ, 2009, P NATL ACAD SCI USA, V106, P17493, DOI 10.1073/pnas.0908027106; Lipkowitz S, 2011, NAT REV CANCER, V11, P629, DOI 10.1038/nrc3120; Mahoney MG, 2002, ONCOGENE, V21, P2161, DOI 10.1038/sj.onc.1205277; Manavathi Bramanandam, 2007, Nucl Recept Signal, V5, pe010, DOI 10.1621/nrs.05010; Manavathi B, 2007, P NATL ACAD SCI USA, V104, P13128, DOI 10.1073/pnas.0705878104; Manavathi B, 2007, J BIOL CHEM, V282, P1529, DOI 10.1074/jbc.R600029200; Mazumdar A, 2001, NAT CELL BIOL, V3, P30, DOI 10.1038/35050532; Miller FR, 2000, J NATL CANCER I, V92, P1185, DOI 10.1093/jnci/92.14.1185A; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; NABI IR, 1992, CANCER METAST REV, V11, P5, DOI 10.1007/BF00047599; NABI IR, 1987, INT J CANCER, V40, P396, DOI 10.1002/ijc.2910400319; Nicolson GL, 2003, CLIN EXP METASTAS, V20, P19, DOI 10.1023/A:1022534217769; Oian HL, 2007, BIOL CELL, V99, P573, DOI 10.1042/BC20060130; Qian HL, 2005, CLIN EXP METASTAS, V22, P653, DOI 10.1007/s10585-006-9005-2; Rao YM, 2011, J HUAZHONG U SCI-MED, V31, P1, DOI 10.1007/s11596-011-0141-9; Rodriguez-Rigueiro T, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-474; Santner SJ, 2001, BREAST CANCER RES TR, V65, P101, DOI 10.1023/A:1006461422273; SOBELL HM, 1985, P NATL ACAD SCI USA, V82, P5328, DOI 10.1073/pnas.82.16.5328; SOULE HD, 1990, CANCER RES, V50, P6075; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; TOH Y, 1994, J BIOL CHEM, V269, P22958; Toh Y, 2009, CLIN EXP METASTAS, V26, P215, DOI 10.1007/s10585-008-9233-8; Tsai YC, 2007, NAT MED, V13, P1504, DOI 10.1038/nm1686; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Wang WG, 2007, NAT REV CANCER, V7, P429, DOI 10.1038/nrc2148; Wicki A, 2006, CANCER CELL, V9, P261, DOI 10.1016/j.ccr.2006.03.010; Zhang Q, 2009, CELL RES, V19, P348, DOI 10.1038/cr.2008.285	50	15	15	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5615	5626		10.1074/jbc.M111.314088	http://dx.doi.org/10.1074/jbc.M111.314088			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22184113	hybrid, Green Published			2022-12-27	WOS:000300638000039
J	Mogilenko, DA; Kudriavtsev, IV; Trulioff, AS; Shavva, VS; Dizhe, EB; Missyul, BV; Zhakhov, AV; Ischenko, AM; Perevozchikov, AP; Orlov, SV				Mogilenko, Denis A.; Kudriavtsev, Igor V.; Trulioff, Andrey S.; Shavva, Vladimir S.; Dizhe, Ella B.; Missyul, Boris V.; Zhakhov, Alexander V.; Ischenko, Alexander M.; Perevozchikov, Andrej P.; Orlov, Sergey V.			Modified Low Density Lipoprotein Stimulates Complement C3 Expression and Secretion via Liver X Receptor and Toll-like Receptor 4 Activation in Human Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-ENDOTHELIAL CELLS; NECROSIS-FACTOR-ALPHA; FACTOR-KAPPA-B; 3RD COMPONENT; SIGNALING PATHWAYS; GENE-EXPRESSION; DENDRITIC CELLS; HUMAN MONOCYTES; ATHEROSCLEROSIS; LIPOPOLYSACCHARIDE	Complement C3 is a pivotal component of three cascades of complement activation. C3 is expressed in human atherosclerotic lesions and is involved in atherogenesis. However, the mechanism of C3 accumulation in atherosclerotic lesions is not well elucidated. We show that acetylated low density lipoprotein and oxidized low density lipoprotein (oxLDL) increase C3 gene expression and protein secretion by human macrophages. Modified LDL (mLDL)-mediated activation of C3 expression mainly depends on liver X receptor (LXR) and partly on Toll-like receptor 4 (TLR4), whereas C3 secretion is increased due to TLR4 activation by mLDL. LXR agonist TO901317 stimulates C3 gene expression in human monocyte-macrophage cells but not in human hepatoma (HepG2) cells. We find LXR-responsive element inside of the promoter region of the human C3 gene, which binds to LXR beta in macrophages but not in HepG2 cells. We show that C3 expression and secretion is decreased in IL-4-treated (M2) and increased in IFN gamma/LPS-stimulated (M1) human macrophages as compared with resting macrophages. LXR agonist TO901317 potentiates LPS-induced C3 gene expression and protein secretion in macrophages, whereas oxLDL differently modulates LPS-mediated regulation of C3 in M1 or M2 macrophages. Treatment of human macrophages with anaphylatoxin C3a results in stimulation of C3 transcription and secretion as well as increased oxLDL accumulation and augmented oxLDL-mediated up-regulation of the C3 gene. These data provide a novel mechanism of C3 gene regulation in macrophages and suggest new aspects of cross-talk between mLDL, C3, C3a, and TLR4 during development of atherosclerotic lesions.	[Mogilenko, Denis A.; Shavva, Vladimir S.; Dizhe, Ella B.; Missyul, Boris V.; Perevozchikov, Andrej P.; Orlov, Sergey V.] Russian Acad Med Sci, Dept Biochem, Inst Expt Med, St Petersburg 197376, Russia; [Kudriavtsev, Igor V.; Trulioff, Andrey S.] Russian Acad Med Sci, Dept Immunol, Inst Expt Med, St Petersburg 197376, Russia; [Mogilenko, Denis A.; Shavva, Vladimir S.; Perevozchikov, Andrej P.; Orlov, Sergey V.] St Petersburg State Univ, Dept Embryol, St Petersburg 199034, Russia; [Kudriavtsev, Igor V.] St Petersburg State Univ, Dept Cytol & Histol, St Petersburg 199034, Russia; [Zhakhov, Alexander V.; Ischenko, Alexander M.] Res Inst Highly Pure Biopreparat, St Petersburg 197110, Russia	Institute of Experimental Medicine; Russian Academy of Medical Sciences; Institute of Experimental Medicine; Russian Academy of Medical Sciences; Saint Petersburg State University; Saint Petersburg State University	Mogilenko, DA (corresponding author), Russian Acad Med Sci, Dept Biochem, Inst Expt Med, Acad Pavlov Str 12, St Petersburg 197376, Russia.	denis@iem.sp.ru; serge@iem.sp.ru	Orlov, Sergey V./N-6823-2014; Mogilenko, Denis/H-4436-2013; Mogilenko, Denis/ABE-9454-2021; Dizhe, Ella B./N-6842-2014; Kudryavtsev, Igor/D-2124-2013; Perevozchikov, Andrej/M-9744-2015; Trulioff, Andrey/AAF-5844-2021	Orlov, Sergey V./0000-0002-3134-1989; Mogilenko, Denis/0000-0001-5427-5243; Kudryavtsev, Igor/0000-0001-7204-7850; Perevozchikov, Andrej/0000-0001-7049-3224; Trulioff, Andrey/0000-0002-7495-446X; Dizhe, Ella/0000-0001-5147-4749; Shavva, Vladimir S./0000-0002-5080-8636	Russian Fund of Basic Research [11-04-02012]	Russian Fund of Basic Research(Russian Foundation for Basic Research (RFBR))	This work was supported by Russian Fund of Basic Research Grant 11-04-02012.	Ajjan R, 2005, THROMB HAEMOSTASIS, V94, P1048, DOI 10.1160/TH05-06-0384; ALPER CA, 1969, SCIENCE, V163, P286, DOI 10.1126/science.163.3864.286; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; BENNETT S, 1994, J LEUKOCYTE BIOL, V56, P236; Bosisio D, 2002, BLOOD, V99, P3427, DOI 10.1182/blood.V99.9.3427; Buono C, 2002, CIRCULATION, V105, P3025, DOI 10.1161/01.CIR.0000019584.04929.83; Calkin AC, 2010, ARTERIOSCL THROM VAS, V30, P1513, DOI 10.1161/ATVBAHA.109.191197; Chinetti-Gbaguidi G, 2011, CIRC RES, V108, P985, DOI 10.1161/CIRCRESAHA.110.233775; CHOY LN, 1992, J BIOL CHEM, V267, P12736; Dardik BN, 2000, J LIPID RES, V41, P1013; EINSTEIN LP, 1977, J CLIN INVEST, V60, P963, DOI 10.1172/JCI108876; Fischer WH, 1999, J IMMUNOL, V162, P453; Fontaine C, 2007, CIRC RES, V101, P40, DOI 10.1161/CIRCRESAHA.106.135814; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; Getz GS, 2005, J LIPID RES, V46, P1, DOI 10.1194/jlr.R400013-JLR200; Groeneweg M, 2006, J LIPID RES, V47, P2259, DOI 10.1194/jlr.M600181-JLR200; HANSSON GK, 1984, ACTA PATH MICRO IM A, V92, P429; Hong C, 2008, CURR OPIN GENET DEV, V18, P461, DOI 10.1016/j.gde.2008.07.016; [Institute of Laboratory Animal Research Commission on Life Sciences National Research Council], 1996, GUID CAR US LAB AN; Ischenko A, 1998, J NEUROCHEM, V71, P2487; JIALAL I, 1989, J LIPID RES, V30, P1561; KATZ Y, 1988, ARTHRITIS RHEUM, V31, P1365, DOI 10.1002/art.1780311104; KHAN BV, 1995, J CLIN INVEST, V95, P1262, DOI 10.1172/JCI117776; Klos A, 2009, MOL IMMUNOL, V46, P2753, DOI 10.1016/j.molimm.2009.04.027; Landis MS, 2002, J BIOL CHEM, V277, P4713, DOI 10.1074/jbc.M108807200; LEVISTRAUSS M, 1987, J IMMUNOL, V139, P2361; Li K, 2008, BLOOD, V112, P5084, DOI 10.1182/blood-2008-05-156646; Maess M.B., 2011, COLD SPRING HARB PRO, V2011; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Mevorach D, 1998, J EXP MED, V188, P2313, DOI 10.1084/jem.188.12.2313; Miller YI, 2005, ARTERIOSCL THROM VAS, V25, P1213, DOI 10.1161/01.ATV.0000159891.73193.31; Miller YI, 2003, CURR OPIN LIPIDOL, V14, P437, DOI 10.1097/00041433-200310000-00004; Mogilenko DA, 2010, BIOCHEM BIOPH RES CO, V402, P477, DOI 10.1016/j.bbrc.2010.10.053; Mogilenko DA, 2009, BIOCHEMISTRY-US, V48, P11950, DOI 10.1021/bi9015742; Muscari A, 2000, EUR HEART J, V21, P1081, DOI 10.1053/euhj.1999.2013; NICHOLS W K, 1984, Complement, V1, P108; Niculescu F, 1999, MOL IMMUNOL, V36, P949, DOI 10.1016/S0161-5890(99)00117-0; Ohlsson BG, 1996, J CLIN INVEST, V98, P78, DOI 10.1172/JCI118780; Oksjoki R, 2003, CURR OPIN LIPIDOL, V14, P477, DOI 10.1097/00041433-200310000-00008; Oksjoki R, 2007, ATHEROSCLEROSIS, V195, P90, DOI 10.1016/j.atherosclerosis.2006.12.016; Onat A, 2011, CLIN CHIM ACTA, V412, P1171, DOI 10.1016/j.cca.2011.03.005; Orlov SV, 2007, FEBS J, V274, P4848, DOI 10.1111/j.1742-4658.2007.06006.x; Patel S, 2001, BIOCHEM BIOPH RES CO, V286, P164, DOI 10.1006/bbrc.2001.5276; Peng Q, 2008, BLOOD, V111, P2452, DOI 10.1182/blood-2007-06-095018; Persson L, 2004, ARTERIOSCL THROM VAS, V24, P1062, DOI 10.1161/01.ATV.0000127302.24266.40; Purwar R, 2006, J IMMUNOL, V177, P4444, DOI 10.4049/jimmunol.177.7.4444; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Rodgers JT, 2000, ANAL BIOCHEM, V277, P254, DOI 10.1006/abio.1999.4394; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sahu A, 2001, IMMUNOL REV, V180, P35, DOI 10.1034/j.1600-065X.2001.1800103.x; Sandelin A, 2005, MOL ENDOCRINOL, V19, P595, DOI 10.1210/me.2004-0101; Schmiedt W, 1998, ARTERIOSCL THROM VAS, V18, P1790, DOI 10.1161/01.ATV.18.11.1790; Schmitz G, 2005, BBA-MOL CELL BIOL L, V1735, P1, DOI 10.1016/j.bbalip.2005.04.004; SUTTON MBS, 1986, J IMMUNOL, V136, P1366; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; WARREN HB, 1987, AM J PATHOL, V129, P9; Wiesner P, 2010, CIRC RES, V107, P56, DOI 10.1161/CIRCRESAHA.110.218420; Yasojima K, 2001, ARTERIOSCL THROM VAS, V21, P1214, DOI 10.1161/hq0701.092160	62	39	41	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5954	5968		10.1074/jbc.M111.289322	http://dx.doi.org/10.1074/jbc.M111.289322			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22194611	Green Published, hybrid			2022-12-27	WOS:000300638000069
J	Kim, MY; Mo, JS; Ann, EJ; Yoon, JH; Park, HS				Kim, Mi-Yeon; Mo, Jung-Soon; Ann, Eun-Jung; Yoon, Ji-Hye; Park, Hee-Sae			Dual Regulation of Notch1 Signaling Pathway by Adaptor Protein Fe65	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; E3 UBIQUITIN LIGASE; INTRACELLULAR DOMAIN; MAMMALIAN NUMB; DOWN-REGULATION; CELL FATE; DEGRADATION; RECEPTOR; APP; TRANSCRIPTION	Notch1 receptor functions as a critical controller of cell fate decisions and also as a key regulator of cell growth, differentiation, and proliferation in invertebrates and vertebrates. In this study, we have demonstrated that the adaptor protein Fe65 attenuates Notch1 signaling via the accelerated degradation of the membrane-tethered Notch1 in the cytoplasm. Fe65 also suppresses Notch1 transcriptional activity via the dissociation of the Notch1-IC-recombining binding protein suppressor of hairless (RBP)-Jk complex within the nucleus. Fe65 is capable of forming a trimeric complex with Itch and membrane-tethered Notch1, and Fe65 enhances the protein degradation of membrane-tethered Notch1 via an Itch-dependent proteasomal pathway. Collectively, our results demonstrate that Fe65 carries out different functions depending on its location in the regulation of Notch1 signaling.	[Kim, Mi-Yeon; Mo, Jung-Soon; Ann, Eun-Jung; Yoon, Ji-Hye; Park, Hee-Sae] Chonnam Natl Univ, Sch Biol Sci & Technol, Hormone Res Ctr, Kwangju 500757, South Korea	Chonnam National University	Park, HS (corresponding author), Chonnam Natl Univ, Sch Biol Sci & Technol, Hormone Res Ctr, Kwangju 500757, South Korea.	proteome@jnu.ac.kr			National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2009-0071386, 2011-0014796]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by Ministry of Education, Science and Technology Grants 2009-0071386 and 2011-0014796.	ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Capell A, 2000, NAT CELL BIOL, V2, P205, DOI 10.1038/35008626; Chastagner P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002735; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Cornell M, 1999, GENETICS, V152, P567; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Dho SE, 1999, J BIOL CHEM, V274, P33097, DOI 10.1074/jbc.274.46.33097; Dievart A, 1999, ONCOGENE, V18, P5973, DOI 10.1038/sj.onc.1202991; Egan SE, 1998, CURR TOP MICROBIOL, V228, P273; Gandy S, 2005, J CLIN INVEST, V115, P1121, DOI 10.1172/JCI200525100; Gupta-Rossi N, 2001, J BIOL CHEM, V276, P34371, DOI 10.1074/jbc.M101343200; Kageyama R, 1999, CELL RES, V9, P179, DOI 10.1038/sj.cr.7290016; Kesavapany S, 2002, NEUROSCIENCE, V115, P951, DOI 10.1016/S0306-4522(02)00422-0; Kim MY, 2007, MOL CELL BIOL, V27, P6506, DOI 10.1128/MCB.01515-06; Kim SY, 2007, BBA-MOL CELL RES, V1773, P736, DOI 10.1016/j.bbamcr.2007.02.001; Lai EC, 2004, DEVELOPMENT, V131, P965, DOI 10.1242/dev.01074; Lai EC, 2002, CURR BIOL, V12, pR74, DOI 10.1016/S0960-9822(01)00679-0; Lieber T, 2002, GENE DEV, V16, P209, DOI 10.1101/gad.942302; Liu YC, 2007, SEMIN IMMUNOL, V19, P197, DOI 10.1016/j.smim.2007.02.003; McGill MA, 2003, J BIOL CHEM, V278, P23196, DOI 10.1074/jbc.M302827200; McGill MA, 2009, J BIOL CHEM, V284, P26427, DOI 10.1074/jbc.M109.014845; McLoughlin DM, 2008, J NEUROSCI RES, V86, P744, DOI 10.1002/jnr.21532; Minella AC, 2005, CELL CYCLE, V4, P1356, DOI 10.4161/cc.4.10.2058; Mo JS, 2007, MOL CELL BIOL, V27, P5565, DOI 10.1128/MCB.02372-06; Mo JS, 2011, J CELL SCI, V124, P100, DOI 10.1242/jcs.073924; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Nakaya T, 2008, J BIOL CHEM, V283, P19119, DOI 10.1074/jbc.M801827200; Nakaya T, 2006, GENES CELLS, V11, P633, DOI 10.1111/j.1365-2443.2006.00968.x; Oberg C, 2001, J BIOL CHEM, V276, P35847, DOI 10.1074/jbc.M103992200; Pan DJ, 1997, CELL, V90, P271, DOI 10.1016/S0092-8674(00)80335-9; Perry WL, 1998, NAT GENET, V18, P143, DOI 10.1038/ng0298-143; Qiu L, 2000, J BIOL CHEM, V275, P35734, DOI 10.1074/jbc.M007300200; Ray WJ, 1999, J BIOL CHEM, V274, P36801, DOI 10.1074/jbc.274.51.36801; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Russo T, 1998, FEBS LETT, V434, P1, DOI 10.1016/S0014-5793(98)00941-7; Scheinfeld MH, 2002, J BIOL CHEM, V277, P44195, DOI 10.1074/jbc.M208110200; Steiner H, 1999, J BIOL CHEM, V274, P28669, DOI 10.1074/jbc.274.40.28669; Sudol M, 2001, FEBS LETT, V490, P190, DOI 10.1016/S0014-5793(01)02122-6; Sudol M, 2000, CELL, V103, P1001, DOI 10.1016/S0092-8674(00)00203-8; Telese F, 2005, EMBO REP, V6, P77, DOI 10.1038/sj.embor.7400309; Verdi J, 1996, CURR BIOL, V6, P1134, DOI 10.1016/S0960-9822(02)70680-5; von Rotz RC, 2004, J CELL SCI, V117, P4435, DOI 10.1242/jcs.01323; Wakamatsu Y, 1999, NEURON, V23, P71, DOI 10.1016/S0896-6273(00)80754-0; Weinmaster G, 1998, CURR OPIN GENET DEV, V8, P436, DOI 10.1016/S0959-437X(98)80115-9; Weinmaster G, 1997, MOL CELL NEUROSCI, V9, P91, DOI 10.1006/mcne.1997.0612; Wu GY, 2001, MOL CELL BIOL, V21, P7403, DOI 10.1128/MCB.21.21.7403-7415.2001	49	9	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4690	4701		10.1074/jbc.M111.289637	http://dx.doi.org/10.1074/jbc.M111.289637			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22199353	hybrid, Green Published			2022-12-27	WOS:000300608500031
J	Lambeck, IC; Fischer-Schrader, K; Niks, D; Roeper, J; Chi, JC; Hille, R; Schwarz, G				Lambeck, Iris C.; Fischer-Schrader, Katrin; Niks, Dimitri; Roeper, Juliane; Chi, Jen-Chih; Hille, Russ; Schwarz, Guenter			Molecular Mechanism of 14-3-3 Protein-mediated Inhibition of Plant Nitrate Reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; KINETIC-ANALYSIS; BINDING; PHOSPHORYLATION; 14-3-3-PROTEINS; ISOFORM; NITRITE; DOMAIN; DEAMINATION; METABOLISM	14-3-3 proteins regulate key processes in eukaryotic cells including nitrogen assimilation in plants by tuning the activity of nitrate reductase (NR), the first and rate-limiting enzyme in this pathway. The homodimeric NR harbors three cofactors, each of which is bound to separate domains, thus forming an electron transfer chain. 14-3-3 proteins inhibit NR by binding to a conserved phosphorylation site localized in the linker between the heme and molybdenum cofactor-containing domains. Here, we have investigated the molecular mechanism of 14-3-3-mediated NR inhibition using a fragment of the enzyme lacking the third domain, allowing us to analyze electron transfer from the heme cofactor via the molybdenum center to nitrate. The kinetic behavior of the inhibited Mo-heme fragment indicates that the principal point at which 14-3-3 acts is the electron transfer from the heme to the molybdenum cofactor. We demonstrate that this is not due to a perturbation of the reduction potentials of either the heme or the molybdenum center and conclude that 14-3-3 most likely inhibits nitrate reductase by inducing a conformational change that significantly increases the distance between the two redox-active sites.	[Lambeck, Iris C.; Fischer-Schrader, Katrin; Roeper, Juliane; Chi, Jen-Chih; Schwarz, Guenter] Univ Cologne, Inst Biochem, Dept Chem, D-50674 Cologne, Germany; [Lambeck, Iris C.; Fischer-Schrader, Katrin; Roeper, Juliane; Chi, Jen-Chih; Schwarz, Guenter] Univ Cologne, Ctr Mol Med, D-50674 Cologne, Germany; [Niks, Dimitri; Hille, Russ] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA	University of Cologne; University of Cologne; University of California System; University of California Riverside	Schwarz, G (corresponding author), Zuelpicher Str 47, D-50674 Cologne, Germany.	gschwarz@uni-koeln.de	Schwarz, Guenter/F-2217-2013; Schwarz, Guenter/ABE-9643-2021; Schrader, Katrin/GWM-7389-2022	Schwarz, Guenter/0000-0002-2118-9338; Schrader, Katrin/0000-0003-4532-8918	German Science Foundation [Schw 759/6-1, SFB 635 TP-A5]; National Institutes of Health [GM075036, ES012658]; Fonds der Chemischen Industrie; Alexander von Humboldt Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012658] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075036] Funding Source: NIH RePORTER	German Science Foundation(German Research Foundation (DFG)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the German Science Foundation (Grants Schw 759/6-1 and SFB 635 TP-A5 to G. S.), the National Institutes of Health (Grants GM075036 and ES012658 to R. H.), and the Fonds der Chemischen Industrie (to G. S.).; Supported by a grant from the Alexander von Humboldt Foundation.	Aitken A, 2006, SEMIN CANCER BIOL, V16, P162, DOI 10.1016/j.semcancer.2006.03.005; Bachmann M, 1996, FEBS LETT, V398, P26, DOI 10.1016/S0014-5793(96)01188-X; Barbier GG, 2005, J BIOL CHEM, V280, P26049, DOI 10.1074/jbc.M409694200; Campbell WH, 1999, ANNU REV PLANT PHYS, V50, P277, DOI 10.1146/annurev.arplant.50.1.277; CANNONS AC, 1993, J BIOL CHEM, V268, P3268; Chevalier D, 2009, ANNU REV PLANT BIOL, V60, P67, DOI 10.1146/annurev.arplant.59.032607.092844; DeLille JM, 2001, PLANT PHYSIOL, V126, P35, DOI 10.1104/pp.126.1.35; Deng HT, 2006, RAPID COMMUN MASS SP, V20, P3634, DOI 10.1002/rcm.2776; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Gokirmak T, 2010, CURR OPIN PLANT BIOL, V13, P527, DOI 10.1016/j.pbi.2010.06.001; HUBER JL, 1992, ARCH BIOCHEM BIOPHYS, V296, P58, DOI 10.1016/0003-9861(92)90544-7; Huber SC, 2002, PLANT MOL BIOL, V50, P1053, DOI 10.1023/A:1021284002779; KAISER WM, 1991, PLANT PHYSIOL, V96, P363, DOI 10.1104/pp.96.2.363; Kanamaru K, 1999, J BIOL CHEM, V274, P4160, DOI 10.1074/jbc.274.7.4160; Kuper J, 2004, NATURE, V430, P803, DOI 10.1038/nature02681; Lambeck I, 2010, BIOCHEMISTRY-US, V49, P8177, DOI 10.1021/bi1003487; Lillo C, 2008, BIOCHEM J, V415, P11, DOI 10.1042/BJ20081115; LIU D, 1995, NATURE, V376, P191, DOI 10.1038/376191a0; LU GH, 1994, PLANT CELL, V6, P501, DOI 10.1105/tpc.6.4.501; Mackintosh C, 2004, BIOCHEM J, V381, P329, DOI 10.1042/BJ20031332; MACKINTOSH C, 1992, BIOCHIM BIOPHYS ACTA, V1137, P121, DOI 10.1016/0167-4889(92)90109-O; MACKINTOSH C, 1995, PLANT PHYSIOL, V107, P451, DOI 10.1104/pp.107.2.451; Marzinzig M, 1997, NITRIC OXIDE-BIOL CH, V1, P177, DOI 10.1006/niox.1997.0116; Moore BE, 1967, PHYSL BIOCH ASPECTS, P343; Obsil T, 2001, CELL, V105, P257, DOI 10.1016/S0092-8674(01)00316-6; Obsil T, 2011, SEMIN CELL DEV BIOL, V22, P663, DOI 10.1016/j.semcdb.2011.09.001; Obsilova V, 2008, BIOCHEMISTRY-US, V47, P1768, DOI 10.1021/bi7019468; Ottmann C, 2007, MOL CELL, V25, P427, DOI 10.1016/j.molcel.2006.12.017; Ottmann C, 2007, EMBO J, V26, P902, DOI 10.1038/sj.emboj.7601530; Paul AL, 2005, MOL BIOL CELL, V16, P1735, DOI 10.1091/mbc.E04-09-0839; Rittinger K, 1999, MOL CELL, V4, P153, DOI 10.1016/S1097-2765(00)80363-9; Sehnke PC, 2002, PLANT CELL, V14, pS339, DOI 10.1105/tpc.010430; Shen W, 2003, PLANT J, V34, P473, DOI 10.1046/j.1365-313X.2003.01739.x; Skipper L, 2001, J BIOL CHEM, V276, P26995, DOI 10.1074/jbc.M100356200; Spencer JPE, 2000, FREE RADICAL BIO MED, V28, P1039, DOI 10.1016/S0891-5849(00)00190-8; Wang BC, 1999, BIOCHEMISTRY-US, V38, P12499, DOI 10.1021/bi991353h; Wurtele M, 2003, EMBO J, V22, P987, DOI 10.1093/emboj/cdg104; Yaffe MB, 2001, STRUCTURE, V9, pR33, DOI 10.1016/S0969-2126(01)00580-9; Yao Y, 2007, J BIOCHEM MOL BIOL, V40, P349	39	51	53	3	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4562	4571		10.1074/jbc.M111.323113	http://dx.doi.org/10.1074/jbc.M111.323113			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22170050	hybrid, Green Published			2022-12-27	WOS:000300608500019
J	Rudashevskaya, EL; Ye, JY; Jensen, ON; Fuglsang, AT; Palmgren, MG				Rudashevskaya, Elena L.; Ye, Juanying; Jensen, Ole N.; Fuglsang, Anja T.; Palmgren, Michael G.			Phosphosite Mapping of P-type Plasma Membrane H+-ATPase in Homologous and Heterologous Environments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LARGE-SCALE ANALYSIS; C-TERMINAL END; PROTEIN-KINASE; QUANTITATIVE PHOSPHOPROTEOMICS; PROTEOMIC ANALYSIS; PROTON PUMP; IN-VIVO; PHOSPHORYLATION NETWORKS; REVEALS EVOLUTIONARY; ARABIDOPSIS-THALIANA	Phosphorylation is an important posttranslational modification of proteins in living cells and primarily serves regulatory purposes. Several methods were employed for isolating phosphopeptides from proteolytically digested plasma membranes of Arabidopsis thaliana. After a mass spectrometric analysis of the resulting peptides we could identify 10 different phosphorylation sites in plasma membrane H+-ATPases AHA1, AHA2, AHA3, and AHA4/11, five of which have not been reported before, bringing the total number of phosphosites up to 11, which is substantially higher than reported so far for any other P-type ATPase. Phosphosites were almost exclusively (9 of 10) in the terminal regulatory domains of the pumps. The AHA2 isoform was subsequently expressed in the yeast Saccharomyces cerevisiae. The plant protein was phosphorylated at multiple sites in yeast, and surprisingly, seven of nine of the phosphosites identified in AHA2 were identical in the plant and fungal systems even though none of the target sequences in AHA2 show homology to proteins of the fungal host. These findings suggest an unexpected accessibility of the terminal regulatory domain of plasma membrane H+-ATPase to protein kinase action.	[Rudashevskaya, Elena L.; Fuglsang, Anja T.; Palmgren, Michael G.] Univ Copenhagen, Dept Plant Biol & Biotechnol, Ctr Membrane Pumps Cells & Dis PUMPkin, DK-1871 Frederiksberg C, Denmark; [Ye, Juanying; Jensen, Ole N.] Univ So Denmark, Dept Biochem & Mol Biol, DK-5230 Odense, Denmark	University of Copenhagen; University of Southern Denmark	Palmgren, MG (corresponding author), Univ Copenhagen, Dept Plant Biol & Biotechnol, Ctr Membrane Pumps Cells & Dis PUMPkin, Thorvaldsensvej 40, DK-1871 Frederiksberg C, Denmark.	palmgren@life.ku.dk	Jensen, Ole N/J-1763-2012; Fuglsang, Anja Thoe/A-6733-2015; Palmgren, Michael/A-9808-2013; fuglsang, anja thoe t/E-1683-2012	Jensen, Ole N/0000-0003-1862-8528; Fuglsang, Anja Thoe/0000-0003-1153-8394; Palmgren, Michael/0000-0002-9982-6114; fuglsang, anja thoe t/0000-0003-1153-8394	Danish Research Council; Danish Basic Research Foundation	Danish Research Council(Det Frie Forskningsrad (DFF)); Danish Basic Research Foundation	This work was supported by a Danish Research Council for Technology and Production grant (to M. G. P. and O. N. J.) and a Danish Basic Research Foundation grant (to M. G. P.).	Axelsen KB, 2001, PLANT PHYSIOL, V126, P696, DOI 10.1104/pp.126.2.696; Axelsen KB, 1999, BIOCHEMISTRY-US, V38, P7227, DOI 10.1021/bi982482l; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Benschop JJ, 2007, MOL CELL PROTEOMICS, V6, P1198, DOI 10.1074/mcp.M600429-MCP200; Bhattacharyya RP, 2006, ANNU REV BIOCHEM, V75, P655, DOI 10.1146/annurev.biochem.75.103004.142710; Biondi RM, 2003, BIOCHEM J, V372, P1, DOI 10.1042/BJ20021641; Bodenmiller B, 2007, MOL BIOSYST, V3, P275, DOI 10.1039/b617545g; Bodenmiller B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001182; Boekhorst J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r144; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buch-Pedersen MJ, 2003, J BIOL CHEM, V278, P17845, DOI 10.1074/jbc.M212729200; CID A, 1987, CURR GENET, V12, P105, DOI 10.1007/BF00434664; Cohen P, 2000, TRENDS BIOCHEM SCI, V25, P596, DOI 10.1016/S0968-0004(00)01712-6; Collins MO, 2005, J BIOL CHEM, V280, P5972, DOI 10.1074/jbc.M411220200; de Lichtenberg U, 2005, SCIENCE, V307, P724, DOI 10.1126/science.1105103; Duby G, 2009, J BIOL CHEM, V284, P4213, DOI 10.1074/jbc.M807311200; Ekberg K, 2010, J BIOL CHEM, V285, P7344, DOI 10.1074/jbc.M109.096123; Fuglsang AT, 2007, PLANT CELL, V19, P1617, DOI 10.1105/tpc.105.035626; Fuglsang AT, 1999, J BIOL CHEM, V274, P36774, DOI 10.1074/jbc.274.51.36774; Fuglsang AT, 2003, J BIOL CHEM, V278, P42266, DOI 10.1074/jbc.M306707200; Glover JNM, 2004, TRENDS BIOCHEM SCI, V29, P579, DOI 10.1016/j.tibs.2004.09.010; Gobom J, 1999, J MASS SPECTROM, V34, P105, DOI 10.1002/(SICI)1096-9888(199902)34:2<105::AID-JMS768>3.0.CO;2-4; Gould CM, 2010, NUCLEIC ACIDS RES, V38, pD167, DOI 10.1093/nar/gkp1016; Gruhler A, 2005, MOL CELL PROTEOMICS, V4, P310, DOI 10.1074/mcp.M400219-MCP200; Haruta M, 2010, J BIOL CHEM, V285, P17918, DOI 10.1074/jbc.M110.101733; Holland PM, 1999, CURR BIOL, V9, pR329, DOI 10.1016/S0960-9822(99)80205-X; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Jahn TP, 2002, J BIOL CHEM, V277, P6353, DOI 10.1074/jbc.M109637200; Jelich-Ottmann C, 2001, J BIOL CHEM, V276, P39852, DOI 10.1074/jbc.M106746200; Jensen LJ, 2006, NATURE, V443, P594, DOI 10.1038/nature05186; Jimenez JL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r90; Jones AME, 2009, J PROTEOMICS, V72, P439, DOI 10.1016/j.jprot.2009.02.004; KEMP BE, 1990, TRENDS BIOCHEM SCI, V15, P342, DOI 10.1016/0968-0004(90)90073-K; KOCH CA, 1991, SCIENCE, V252, P668, DOI 10.1126/science.1708916; Kornev AP, 2010, BBA-PROTEINS PROTEOM, V1804, P440, DOI 10.1016/j.bbapap.2009.10.017; Krupa A, 2006, GENE, V380, P1, DOI 10.1016/j.gene.2006.05.016; Landry CR, 2009, TRENDS GENET, V25, P193, DOI 10.1016/j.tig.2009.03.003; LARSSON C, 1994, METHOD ENZYMOL, V228, P451; Lecchi S, 2007, J BIOL CHEM, V282, P35471, DOI 10.1074/jbc.M706094200; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Macek B, 2008, MOL CELL PROTEOMICS, V7, P299, DOI 10.1074/mcp.M700311-MCP200; Malik R, 2008, BIOINFORMATICS, V24, P1426, DOI 10.1093/bioinformatics/btn197; Malmstrom J, 2007, CURR OPIN BIOTECH, V18, P378, DOI 10.1016/j.copbio.2007.07.005; Mann M, 2003, NAT BIOTECHNOL, V21, P255, DOI 10.1038/nbt0303-255; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Manning G, 2002, TRENDS BIOCHEM SCI, V27, P514, DOI 10.1016/S0968-0004(02)02179-5; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Miller ML, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159433; Mok J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000482; Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003; Moses AM, 2007, P NATL ACAD SCI USA, V104, P17713, DOI 10.1073/pnas.0700997104; Nakagami H, 2010, PLANT PHYSIOL, V153, P1161, DOI 10.1104/pp.110.157347; Neduva V, 2005, FEBS LETT, V579, P3342, DOI 10.1016/j.febslet.2005.04.005; Niittylae T, 2007, MOL CELL PROTEOMICS, V6, P1711, DOI 10.1074/mcp.M700164-MCP200; Nuhse TS, 2007, PLANT J, V51, P931, DOI 10.1111/j.1365-313X.2007.03192.x; Nuhse TS, 2004, PLANT CELL, V16, P2394, DOI 10.1105/tpc.104.023150; Nuhse TS, 2003, MOL CELL PROTEOMICS, V2, P1234, DOI 10.1074/mcp.T300006-MCP200; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Olsson A, 1998, PLANT PHYSIOL, V118, P551, DOI 10.1104/pp.118.2.551; Ozlu N, 2010, WIRES SYST BIOL MED, V2, P255, DOI 10.1002/wsbm.41; Palmgren MG, 2001, ANNU REV PLANT PHYS, V52, P817, DOI 10.1146/annurev.arplant.52.1.817; Pawson T, 2000, GENE DEV, V14, P1027; Pedersen BP, 2007, NATURE, V450, P1111, DOI 10.1038/nature06417; Ptacek J, 2006, TRENDS GENET, V22, P545, DOI 10.1016/j.tig.2006.08.005; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; REGENBERG B, 1995, PLANT CELL, V7, P1655, DOI 10.1105/tpc.7.10.1655; Reiland S, 2009, PLANT PHYSIOL, V150, P889, DOI 10.1104/pp.109.138677; Remenyi A, 2005, MOL CELL, V20, P951, DOI 10.1016/j.molcel.2005.10.030; Remenyi A, 2006, CURR OPIN STRUC BIOL, V16, P676, DOI 10.1016/j.sbi.2006.10.008; Rigbolt KTG, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001570; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Tan CSH, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000316; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; Thingholm TE, 2006, NAT PROTOC, V1, P1929, DOI 10.1038/nprot.2006.185; VENEMA K, 1995, J BIOL CHEM, V270, P19659, DOI 10.1074/jbc.270.33.19659; Wilson-Grady JT, 2008, J PROTEOME RES, V7, P1088, DOI 10.1021/pr7006335; Wolf-Yadlin A, 2007, P NATL ACAD SCI USA, V104, P5860, DOI 10.1073/pnas.0608638104; Won AP, 2011, P NATL ACAD SCI USA, V108, P9809, DOI 10.1073/pnas.1016337108; Ye JY, 2010, J PROTEOME RES, V9, P3561, DOI 10.1021/pr100075x; Zhang X, 2007, MOL CELL PROTEOMICS, V6, P2032, DOI 10.1074/mcp.M700278-MCP200	81	50	51	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4904	4913		10.1074/jbc.M111.307264	http://dx.doi.org/10.1074/jbc.M111.307264			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22174420	Green Published, hybrid			2022-12-27	WOS:000300608500051
J	van der Deen, M; Akech, J; Lapointe, D; Gupta, S; Young, DW; Montecino, MA; Galindo, M; Lian, JB; Stein, JL; Stein, GS; van Wijnen, AJ				van der Deen, Margaretha; Akech, Jacqueline; Lapointe, David; Gupta, Sneha; Young, Daniel W.; Montecino, Martin A.; Galindo, Mario; Lian, Jane B.; Stein, Janet L.; Stein, Gary S.; van Wijnen, Andre J.			Genomic Promoter Occupancy of Runt-related Transcription Factor RUNX2 in Osteosarcoma Cells Identifies Genes Involved in Cell Adhesion and Motility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ONCOGENE-INDUCED SENESCENCE; CHROMATIN IMMUNOPRECIPITATION; METASTATIC TUMOR; CANCER-CELLS; EXPRESSION; BINDING; GROWTH; CBFA1; CYCLE; DNA	Runt-related transcription factors (RUNX1, RUNX2, and RUNX3) are key lineage-specific regulators of progenitor cell growth and differentiation but also function pathologically as cancer genes that contribute to tumorigenesis. RUNX2 attenuates growth and stimulates maturation of osteoblasts during bone formation but is also robustly expressed in a subset of osteosarcomas, as well as in metastatic breast and prostate tumors. To assess the biological function of RUNX2 in osteosarcoma cells, we examined human genomic promoter interactions for RUNX2 using chromatin immunoprecipitation (ChIP)-microarray analysis in SAOS-2 cells. Promoter binding of both RUNX2 and RNA polymerase II was compared with gene expression profiles of cells in which RUNX2 was depleted by RNA interference. Many RUNX2-bound loci (1550 of 2339 total) exhibit promoter occupancy by RNA polymerase II and contain the RUNX consensus motif 5'-((T/A/C) G(T/A/C) GG(T/G). Gene ontology analysis indicates that RUNX2 controls components of multiple signaling pathways (e. g. WNT, TGF beta, TNF alpha, and interleukins), as well as genes linked to cell motility and adhesion (e. g. the focal adhesion-related genes FAK/PTK2 and TLN1). Our results reveal that siRNA depletion of RUNX2, PTK2, or TLN1 diminishes motility of U2OS osteosarcoma cells. Thus, RUNX2 binding to diverse gene loci may support the biological properties of osteosarcoma cells.	[Lapointe, David] Univ Massachusetts, Sch Med, Informat Serv Dept, Worcester, MA 01655 USA; [Montecino, Martin A.] Univ Andres Bello, Fac Ciencias Biol, Ctr Invest Biomed, Santiago, Chile; [Montecino, Martin A.] Univ Andres Bello, Fac Med, Santiago, Chile; [Galindo, Mario] Univ Chile, Fac Med, Inst Biomed Sci, Program Cellular & Mol Biol, Santiago, Chile; [Galindo, Mario] Univ Chile, Inst Immunol & Immunotherapy, Santiago, Chile; [van der Deen, Margaretha; Akech, Jacqueline; Gupta, Sneha; Young, Daniel W.; Lian, Jane B.; Stein, Janet L.; Stein, Gary S.; van Wijnen, Andre J.] Univ Massachusetts, Sch Med, Dept Cell Biol & Canc Ctr, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester; Universidad Andres Bello; Universidad Andres Bello; Universidad de Chile; Universidad de Chile; University of Massachusetts System; University of Massachusetts Worcester	Stein, GS (corresponding author), Univ Massachusetts, Sch Med, Dept Cell Biol, 55 Lake Ave N, Worcester, MA 01655 USA.	gary.stein@umassmed.edu; andre.vanwijnen@umassmed.edu	van Wijnen, Andre J./AAG-3578-2019	van Wijnen, Andre J./0000-0002-4458-0946	National Institutes of Health [AR49069, CA082834, AR048818]; FONDAP [15090007]; NATIONAL CANCER INSTITUTE [P01CA082834] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049069, R01AR039588, P01AR048818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R37DE012528] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FONDAP; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants AR49069, CA082834, and AR048818, as well as from contract grant sponsor FONDAP 15090007.	Akech J, 2010, ONCOGENE, V29, P811, DOI 10.1038/onc.2009.389; Balint E, 2003, J CELL BIOCHEM, V89, P401, DOI 10.1002/jcb.10515; Baniwal SK, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-258; Blyth K, 2006, CANCER RES, V66, P2195, DOI 10.1158/0008-5472.CAN-05-3558; Blyth K, 2005, NAT REV CANCER, V5, P376, DOI 10.1038/nrc1607; Choi JY, 2001, P NATL ACAD SCI USA, V98, P8650, DOI 10.1073/pnas.151236498; Chuang LSH, 2010, ONCOGENE, V29, P2605, DOI 10.1038/onc.2010.88; Das K, 2009, EUR J CANCER, V45, P2239, DOI 10.1016/j.ejca.2009.06.021; Dowdy CR, 2010, HUM MOL GENET, V19, P1048, DOI 10.1093/hmg/ddp568; Drissi H, 2002, J CELL BIOCHEM, V86, P403, DOI 10.1002/jcb.10238; Drissi H, 2000, J CELL PHYSIOL, V184, P341, DOI 10.1002/1097-4652(200009)184:3<341::AID-JCP8>3.0.CO;2-Z; Farnham PJ, 2009, NAT REV GENET, V10, P605, DOI 10.1038/nrg2636; Frith MC, 2004, NUCLEIC ACIDS RES, V32, P1372, DOI 10.1093/nar/gkh299; Galindo M, 2005, J BIOL CHEM, V280, P20274, DOI 10.1074/jbc.M413665200; Galindo M, 2007, J MOL HISTOL, V38, P501, DOI 10.1007/s10735-007-9143-0; Han MS, 2010, J CELL BIOCHEM, V110, P97, DOI 10.1002/jcb.22516; Haupt LM, 2009, J CELL PHYSIOL, V220, P780, DOI 10.1002/jcp.21825; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Inoue K, 2002, NAT NEUROSCI, V5, P946, DOI 10.1038/nn925; Jensen ED, 2008, J CELL BIOCHEM, V103, P1438, DOI 10.1002/jcb.21526; Jeong JH, 2010, MOL CELL BIOL, V30, P2365, DOI 10.1128/MCB.00672-09; Kilbey A, 2008, CELL CYCLE, V7, P2333; Kilbey A, 2007, CANCER RES, V67, P11263, DOI 10.1158/0008-5472.CAN-07-3016; Kilbey A, 2010, CANCER RES, V70, P5860, DOI 10.1158/0008-5472.CAN-10-0726; Kim HJ, 2006, J CELL PHYSIOL, V207, P114, DOI 10.1002/jcp.20552; Knuppel R, 1994, J Comput Biol, V1, P191, DOI 10.1089/cmb.1994.1.191; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Leong DT, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2762; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li QL, 2002, CELL, V109, P113, DOI 10.1016/S0092-8674(02)00690-6; Lian JB, 2006, REV ENDOCR METAB DIS, V7, P1, DOI 10.1007/s11154-006-9001-5; Lou Y, 2009, HUM MOL GENET, V18, P556, DOI 10.1093/hmg/ddn383; Martin JW, 2010, CYTOGENET GENOME RES, V128, P199, DOI 10.1159/000308353; McLeay RC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-165; MEYERS S, 1993, MOL CELL BIOL, V13, P6336, DOI 10.1128/MCB.13.10.6336; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Niebuhr B, 2008, BLOOD CELL MOL DIS, V40, P211, DOI 10.1016/j.bcmd.2007.07.018; O'Geen H, 2006, BIOTECHNIQUES, V41, P577, DOI 10.2144/000112268; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Ott CE, 2010, HUM MUTAT, V31, pE1587, DOI 10.1002/humu.21298; Otto F, 2003, J CELL BIOCHEM, V89, P9, DOI 10.1002/jcb.10491; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Pereira BP, 2009, J CELL PHYSIOL, V221, P778, DOI 10.1002/jcp.21921; Pratap J, 2006, CANCER METAST REV, V25, P589, DOI 10.1007/s10555-006-9032-0; Pratap J, 2005, MOL CELL BIOL, V25, P8581, DOI 10.1128/MCB.25.19.8581-8591.2005; Pratap J, 2003, CANCER RES, V63, P5357; Pratap J, 2008, CANCER RES, V68, P7795, DOI 10.1158/0008-5472.CAN-08-1078; Pratap J, 2011, BONE, V48, P30, DOI 10.1016/j.bone.2010.05.035; Pratap J, 2009, CANCER RES, V69, P6807, DOI 10.1158/0008-5472.CAN-09-1471; Pregizer S, 2007, J CELL BIOCHEM, V102, P1458, DOI 10.1002/jcb.21366; RODAN G A, 1991, Critical Reviews in Eukaryotic Gene Expression, V1, P85; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Sadikovic B, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-202; San Martin IA, 2009, J CELL PHYSIOL, V221, P560, DOI 10.1002/jcp.21894; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Stewart M, 1997, P NATL ACAD SCI USA, V94, P8646, DOI 10.1073/pnas.94.16.8646; Stewart M, 1996, J GEN VIROL, V77, P443, DOI 10.1099/0022-1317-77-3-443; Subramaniam MM, 2009, BBA-REV CANCER, V1796, P315, DOI 10.1016/j.bbcan.2009.07.004; Teplyuk NM, 2008, J BIOL CHEM, V283, P27585, DOI 10.1074/jbc.M802453200; Teplyuk NM, 2009, MOL ENDOCRINOL, V23, P849, DOI 10.1210/me.2008-0270; Teplyuk NM, 2009, J CELL BIOCHEM, V107, P144, DOI 10.1002/jcb.22108; Thirunavukkarasu K, 2007, MOL BIOL REP, V34, P225, DOI 10.1007/s11033-006-9037-3; Thirunavukkarasu K, 2007, MOL BIOL REP, V34, P1, DOI 10.1007/s11033-006-9001-2; Vaillant F, 2002, J IMMUNOL, V169, P2866, DOI 10.4049/jimmunol.169.6.2866; van der Deen M, 2010, J CELL BIOCHEM, V109, P828, DOI 10.1002/jcb.22463; van der Deen Margaretha, 2008, V455, P165, DOI 10.1007/978-1-59745-104-8_13; van der Meijden CMJ, 2002, CANCER RES, V62, P3233; Vlieghe D, 2006, NUCLEIC ACIDS RES, V34, pD95, DOI 10.1093/nar/gkj115; Wang CG, 2001, FRONT BIOSCI-LANDMRK, V6, pD610, DOI 10.2741/1wang1; Wang CQ, 2010, BLOOD CELL MOL DIS, V44, P275, DOI 10.1016/j.bcmd.2010.01.006; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444; Westendorf JJ, 2002, MOL CELL BIOL, V22, P7982, DOI 10.1128/MCB.22.22.7982-7992.2002; Woolf E, 2003, P NATL ACAD SCI USA, V100, P7731, DOI 10.1073/pnas.1232420100; Young DW, 2007, P NATL ACAD SCI USA, V104, P3189, DOI 10.1073/pnas.0611419104; Young DW, 2007, NATURE, V445, P442, DOI 10.1038/nature05473; Zaidi SK, 2007, P NATL ACAD SCI USA, V104, P19861, DOI 10.1073/pnas.0709650104	79	63	64	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4503	4517		10.1074/jbc.M111.287771	http://dx.doi.org/10.1074/jbc.M111.287771			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22158627	Green Published, hybrid			2022-12-27	WOS:000300608500014
J	Cichon, J; Sun, CC; Chen, B; Jiang, M; Chen, XA; Sun, YJ; Wang, Y; Chen, G				Cichon, Joseph; Sun, Chicheng; Chen, Ben; Jiang, Min; Chen, Xiangyun Amy; Sun, Yajie; Wang, Yun; Chen, Gong			Cofilin Aggregation Blocks Intracellular Trafficking and Induces Synaptic Loss in Hippocampal Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN DEPOLYMERIZING FACTOR; GROWTH CONE MOTILITY; DENDRITIC SPINES; LIM-KINASE; ALZHEIMERS-DISEASE; MYOTONIC-DYSTROPHY; REGULATES COFILIN; FILAMENT TURNOVER; CULTURED-CELLS; ROD FORMATION	Cofilin is an actin-binding protein and a major actin depolymerization factor in the central nervous system (CNS). Cofilin-actin aggregates are associated with neurodegenerative disorders, but how cofilin-actin aggregation induces pathological effects in the CNS remains unclear. Here, we demonstrated that cofilin rods disrupted dendritic microtubule integrity in rat hippocampal cultures. Long term time-lapse imaging revealed that cofilin rods block intracellular trafficking of both mitochondria and early endosomes. Importantly, cofilin rod formation induced a significant loss of SV2 and PSD-95 puncta as well as dendritic spines. Cofilin rods also impaired local glutamate receptor responses. We discovered an inverse relationship between the number of synaptic events and the accumulation of cofilin rods in dendrites. We also detected cofilin rods in aging rat brains in vivo. These results suggest that cofilin aggregation may contribute to neurodegeneration and brain aging by blocking intracellular trafficking and inducing synaptic loss.	[Chen, Ben; Jiang, Min; Chen, Xiangyun Amy; Sun, Yajie; Wang, Yun] Fudan Univ, Inst Brain Sci, Shanghai 200032, Peoples R China; [Chen, Ben; Jiang, Min; Chen, Xiangyun Amy; Sun, Yajie; Wang, Yun] Fudan Univ, State Key Lab Med Neurobiol, Shanghai 200032, Peoples R China; [Cichon, Joseph; Sun, Chicheng; Chen, Xiangyun Amy; Chen, Gong] Penn State Univ, Huck Inst Life Sci, Dept Biol, University Pk, PA 16802 USA	Fudan University; Fudan University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Wang, Y (corresponding author), Fudan Univ, Inst Brain Sci, Shanghai 200032, Peoples R China.	yunwang@fudan.edu.cn; gongchen@psu.edu	Sun, Chicheng/C-9980-2016	Sun, Chicheng/0000-0003-3837-2267; Chen JNU, Gong/0000-0002-1857-3670	National Institutes of Health [NS054858, MH083911]; National Science Foundation [0821955]; American Heart Association [0765258U]; Natural Science Foundation of China [30828014, 31129003, 81171224]; Ministry of Science and Technology of China [2009CB522000]; Science and Technology Commission of Shanghai Municipality [09JC1401900]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083911] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS054858] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); American Heart Association(American Heart Association); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS054858 and MH083911. This work was also supported by National Science Foundation Grant 0821955 and American Heart Association Grant 0765258U (to G. C.), Natural Science Foundation of China Grants 30828014 (to G. C. and Y. W.) and 31129003 and 81171224 (to Y. W.), and Ministry of Science and Technology of China Grant 2009CB522000 and Science and Technology Commission of Shanghai Municipality Grant 09JC1401900 (to Y. W.).	Andrianantoandro E, 2006, MOL CELL, V24, P13, DOI 10.1016/j.molcel.2006.08.006; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Bernard O, 2007, INT J BIOCHEM CELL B, V39, P1071, DOI 10.1016/j.biocel.2006.11.011; Bernstein BW, 2006, AM J PHYSIOL-CELL PH, V291, pC828, DOI 10.1152/ajpcell.00066.2006; BUCCI C, 1995, FEBS LETT, V366, P65, DOI 10.1016/0014-5793(95)00477-Q; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; Chan C, 2009, CURR BIOL, V19, P537, DOI 10.1016/j.cub.2009.02.060; Chen LY, 2007, J NEUROSCI, V27, P5363, DOI 10.1523/JNEUROSCI.0164-07.2007; Chua BT, 2003, NAT CELL BIOL, V5, P1083, DOI 10.1038/ncb1070; CULEBRAS A, 1973, J NEUROL SCI, V19, P319, DOI 10.1016/0022-510X(73)90095-6; Davis RC, 2009, J ALZHEIMERS DIS, V18, DOI 10.3233/JAD-2009-1122; Davis RC, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-10; Deng L, 2007, J NEUROSCI, V27, P10860, DOI 10.1523/JNEUROSCI.2744-07.2007; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Endo M, 2007, J BIOL CHEM, V282, P13692, DOI 10.1074/jbc.M610873200; Fulga TA, 2007, NAT CELL BIOL, V9, P139, DOI 10.1038/ncb1528; Futai K, 2007, NAT NEUROSCI, V10, P186, DOI 10.1038/nn1837; Garvalov BK, 2007, J NEUROSCI, V27, P13117, DOI 10.1523/JNEUROSCI.3322-07.2007; Gearing M, 2002, ANN NEUROL, V52, P465, DOI 10.1002/ana.10319; Ghosh M, 2004, SCIENCE, V304, P743, DOI 10.1126/science.1094561; Gohla A, 2005, NAT CELL BIOL, V7, P21, DOI 10.1038/ncb1201; Gu JP, 2010, NAT NEUROSCI, V13, P1208, DOI 10.1038/nn.2634; Hotulainen P, 2010, J CELL BIOL, V189, P619, DOI 10.1083/jcb.201003008; Hotulainen P, 2009, J CELL BIOL, V185, P323, DOI 10.1083/jcb.200809046; Huang TY, 2008, DEV CELL, V15, P691, DOI 10.1016/j.devcel.2008.09.017; Huang TY, 2006, CURR OPIN CELL BIOL, V18, P26, DOI 10.1016/j.ceb.2005.11.005; Jang DH, 2005, P NATL ACAD SCI USA, V102, P16072, DOI 10.1073/pnas.0507675102; Jiang M, 2006, NAT PROTOC, V1, P695, DOI 10.1038/nprot.2006.86; Kim JS, 2009, MOL BIOL CELL, V20, P2650, DOI 10.1091/mbc.E09-02-0131; Klamt F, 2009, NAT CELL BIOL, V11, P1241, DOI 10.1038/ncb1968; Kuhn TB, 2000, J NEUROBIOL, V44, P126, DOI 10.1002/1097-4695(200008)44:2<126::AID-NEU4>3.0.CO;2-Z; Lee CW, 2009, NAT NEUROSCI, V12, P848, DOI 10.1038/nn.2322; Maloney MT, 2005, J NEUROSCI, V25, P11313, DOI 10.1523/JNEUROSCI.3711-05.2005; MASLIAH E, 1993, NEUROLOGY, V43, P192, DOI 10.1212/WNL.43.1_Part_1.192; Mattson MP, 2003, NEUROMOL MED, V3, P65, DOI 10.1385/NMM:3:2:65; Matus A, 2005, CURR OPIN NEUROBIOL, V15, P67, DOI 10.1016/j.conb.2005.01.015; Meberg PJ, 2000, J NEUROSCI, V20, P2459; Meng YH, 2002, NEURON, V35, P121, DOI 10.1016/S0896-6273(02)00758-4; Minamide LS, 2000, NAT CELL BIOL, V2, P628, DOI 10.1038/35023579; Montani L, 2009, J BIOL CHEM, V284, P10793, DOI 10.1074/jbc.M808297200; Morrison JH, 1997, SCIENCE, V278, P412, DOI 10.1126/science.278.5337.412; Muller WE, 2010, MOL NEUROBIOL, V41, P159, DOI 10.1007/s12035-010-8141-5; Navarro A, 2007, AM J PHYSIOL-CELL PH, V292, pC670, DOI 10.1152/ajpcell.00213.2006; NISHIDA E, 1987, P NATL ACAD SCI USA, V84, P5262, DOI 10.1073/pnas.84.15.5262; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; ONO S, 1987, J NEUROL SCI, V81, P301, DOI 10.1016/0022-510X(87)90105-5; Racz B, 2006, NEUROSCIENCE, V138, P447, DOI 10.1016/j.neuroscience.2005.11.025; RATHKE PC, 1977, EXP CELL RES, V105, P253, DOI 10.1016/0014-4827(77)90123-9; Rex CS, 2007, J NEUROSCI, V27, P3017, DOI 10.1523/JNEUROSCI.4037-06.2007; Rosso S, 2004, MOL BIOL CELL, V15, P3433, DOI 10.1091/mbc.E03-05-0328; Rust MB, 2010, EMBO J, V29, P1889, DOI 10.1038/emboj.2010.72; Sarmiere PD, 2004, J NEUROBIOL, V58, P103, DOI 10.1002/neu.10267; Schon EA, 2011, NEURON, V70, P1033, DOI 10.1016/j.neuron.2011.06.003; Shi Y, 2009, J NEUROSCI, V29, P8129, DOI 10.1523/JNEUROSCI.4681-08.2009; Tavazoie SF, 2005, NAT NEUROSCI, V8, P1727, DOI 10.1038/nn1566; von Blume J, 2011, DEV CELL, V20, P652, DOI 10.1016/j.devcel.2011.03.014; von Blume J, 2009, J CELL BIOL, V187, P1055, DOI 10.1083/jcb.200908040; Wen ZX, 2007, J CELL BIOL, V178, P107, DOI 10.1083/jcb.200703055; Whiteman IT, 2009, J NEUROSCI, V29, P12994, DOI 10.1523/JNEUROSCI.3531-09.2009; Wilson JM, 2000, MOL BIOL CELL, V11, P2657, DOI 10.1091/mbc.11.8.2657; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Yao JQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015546; Yao J, 2006, J NEUROSCI, V26, P8137, DOI 10.1523/JNEUROSCI.1183-06.2006; Yuen EY, 2010, J PHYSIOL-LONDON, V588, P2361, DOI 10.1113/jphysiol.2009.186353; Zhao LX, 2006, NAT NEUROSCI, V9, P234, DOI 10.1038/nn1630; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011	67	63	68	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					3919	3929		10.1074/jbc.M111.301911	http://dx.doi.org/10.1074/jbc.M111.301911			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22184127	hybrid, Green Published			2022-12-27	WOS:000300410900028
J	Miller, A; Phillips, A; Gor, J; Wallis, R; Perkins, SJ				Miller, Ami; Phillips, Anna; Gor, Jayesh; Wallis, Russell; Perkins, Stephen J.			Near-planar Solution Structures of Mannose-binding Lectin Oligomers Provide Insight on Activation of Lectin Pathway of Complement	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLLAGEN-LIKE DOMAIN; NATURALLY-OCCURRING MUTATIONS; NEUTRON-SCATTERING; X-RAY; FACTOR-H; ANALYTICAL ULTRACENTRIFUGATION; CRYSTAL-STRUCTURE; HYDRODYNAMIC PROPERTIES; SEDIMENTATION-VELOCITY; MOLECULAR-STRUCTURE	The complement system is a fundamental component of innate immunity that orchestrates complex immunological and inflammatory processes. Complement comprises over 30 proteins that eliminate invading microorganisms while maintaining host cell integrity. Protein-carbohydrate interactions play critical roles in both the activation and regulation of complement. Mannose-binding lectin (MBL) activates the lectin pathway of complement via the recognition of sugar arrays on pathogenic surfaces. To determine the solution structure of MBL, synchrotron x-ray scattering and analytical ultracentrifugation experiments showed that the carbohydrate-recognition domains in the MBL dimer, trimer, and tetramer are positioned close to each other in near-planar fan-like structures. These data were subjected to constrained modeling fits. A bent structure for the MBL monomer was identified starting from two crystal structures for its carbohydrate-recognition domain and its triple helical region. The MBL monomer structure was used to identify 10-12 near-planar solution structures for each of the MBL dimers, trimers, and tetramers starting from 900 to 6,859 randomized structures for each. These near-planar fan-like solution structures joined at an N-terminal hub clarified how the carbohydrate-recognition domain of MBL binds to pathogenic surfaces. They also provided insight on how MBL presents a structural template for the binding and auto-activation of the MBL-associated serine proteases to initiate the lectin pathway of complement activation.	[Miller, Ami; Gor, Jayesh; Perkins, Stephen J.] UCL, Dept Struct & Mol Biol, London WC1E 6BT, England; [Phillips, Anna; Wallis, Russell] Univ Leicester, Dept Infect Immun & Inflammat, Leicester LE1 9HN, Leics, England	University of London; University College London; University of Leicester	Perkins, SJ (corresponding author), UCL, Dept Struct & Mol Biol, Darwin Bldg,Gower St, London WC1E 6BT, England.	s.perkins@ucl.ac.uk		Wallis, Russell/0000-0002-8705-5295	Biotechnology and Biological Sciences Research Council; Fight for Sight Charity; Wellcome Trust [077400]; BBSRC [BB/E013104/1] Funding Source: UKRI; MRC [G1000191, G0501425] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E013104/1] Funding Source: researchfish; Medical Research Council [G0501425, G1000191] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Fight for Sight Charity; Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by the Biotechnology and Biological Sciences Research Council and the Fight for Sight Charity.; Supported by Wellcome Trust Grant 077400.	Ashton AW, 1997, J MOL BIOL, V272, P408, DOI 10.1006/jmbi.1997.1271; Aslam M, 2003, J MOL BIOL, V329, P525, DOI 10.1016/S0022-2836(03)00492-3; Aslam M, 2001, J MOL BIOL, V309, P1117, DOI 10.1006/jmbi.2001.4720; BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699; Bella J, 2006, J MOL BIOL, V362, P298, DOI 10.1016/j.jmb.2006.07.014; Boehm MK, 1999, J MOL BIOL, V286, P1421, DOI 10.1006/jmbi.1998.2556; Bonner A, 2008, J IMMUNOL, V180, P1008, DOI 10.4049/jimmunol.180.2.1008; Chamberlain D, 1998, BIOCHEMISTRY-US, V37, P13918, DOI 10.1021/bi9805184; Chen CB, 2001, J BIOL CHEM, V276, P25894, DOI 10.1074/jbc.M103539200; Chong WP, 2005, HEPATOLOGY, V42, P1037, DOI 10.1002/hep.20891; Cole JL, 2008, METHOD CELL BIOL, V84, P143, DOI 10.1016/S0091-679X(07)84006-4; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; Dong MD, 2007, J IMMUNOL, V178, P3016, DOI 10.4049/jimmunol.178.5.3016; DRICKAMER K, 1986, J BIOL CHEM, V261, P6878; DRICKAMER K, 1993, ANNU REV CELL BIOL, V9, P237, DOI 10.1146/annurev.cb.09.110193.001321; Feinberg H, 2003, EMBO J, V22, P2348, DOI 10.1093/emboj/cdg236; Fernando AN, 2007, J MOL BIOL, V368, P564, DOI 10.1016/j.jmb.2007.02.038; Fidler KJ, 2009, THORAX, V64, P150, DOI 10.1136/thx.2008.100073; FRASER RDB, 1979, J MOL BIOL, V129, P463, DOI 10.1016/0022-2836(79)90507-2; Gal P, 2005, J BIOL CHEM, V280, P33435, DOI 10.1074/jbc.M506051200; Garred P, 2002, PEDIATR PULM, V33, P201, DOI 10.1002/ppul.10064; Gilbert HE, 2005, J MOL BIOL, V346, P859, DOI 10.1016/j.jmb.2004.12.006; Glatter O., 1982, SMALL ANGLE XRAY SCA; HAURUM JS, 1993, AIDS, V7, P1307, DOI 10.1097/00002030-199310000-00002; JENCKS WP, 1981, P NATL ACAD SCI-BIOL, V78, P4046, DOI 10.1073/pnas.78.7.4046; Jensen PH, 2005, J BIOL CHEM, V280, P11043, DOI 10.1074/jbc.M412472200; Jensenius H, 2009, J MOL BIOL, V391, P246, DOI 10.1016/j.jmb.2009.05.083; KURATA H, 1993, BIOCHEM BIOPH RES CO, V191, P1204, DOI 10.1006/bbrc.1993.1345; LIPSCOMBE RJ, 1995, IMMUNOLOGY, V85, P660; LU J, 1990, J IMMUNOL, V144, P2287; Mohs A, 2006, J BIOL CHEM, V281, P17197, DOI 10.1074/jbc.M601763200; Narayanan T, 2001, NUCL INSTRUM METH A, V467, P1005, DOI 10.1016/S0168-9002(01)00553-8; Okemefuna AI, 2008, J MOL BIOL, V375, P80, DOI 10.1016/j.jmb.2007.09.026; Okemefuna AI, 2010, J BIOL CHEM, V285, P1041, DOI 10.1074/jbc.M109.044495; Okemefuna AI, 2009, J MOL BIOL, V391, P98, DOI 10.1016/j.jmb.2009.06.010; Okuyama K, 2006, BIOPOLYMERS, V84, P181, DOI 10.1002/bip.20381; PERKINS SJ, 1986, EUR J BIOCHEM, V157, P169, DOI 10.1111/j.1432-1033.1986.tb09653.x; Perkins SJ, 2001, BIOPHYS CHEM, V93, P129, DOI 10.1016/S0301-4622(01)00216-2; PERKINS SJ, 1985, BIOCHEM J, V228, P13, DOI 10.1042/bj2280013; Perkins SJ, 2008, METHOD CELL BIOL, V84, P375, DOI 10.1016/S0091-679X(07)84013-1; Perkins SJ, 2009, J R SOC INTERFACE, V6, pS679, DOI 10.1098/rsif.2009.0164.focus; Prosser BE, 2007, J EXP MED, V204, P2277, DOI 10.1084/jem.20071069; Roversi P, 2011, P NATL ACAD SCI USA, V108, P12839, DOI 10.1073/pnas.1102167108; Roversi P, 2011, ACTA CRYSTALLOGR F, V67, P739, DOI 10.1107/S1744309111016551; Schuck P, 1998, BIOPHYS J, V75, P1503, DOI 10.1016/S0006-3495(98)74069-X; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; SHERIFF S, 1994, NAT STRUCT BIOL, V1, P789, DOI 10.1038/nsb1194-789; Teillet F, 2008, J BIOL CHEM, V283, P25715, DOI 10.1074/jbc.M803551200; Thiel S, 1997, NATURE, V386, P506, DOI 10.1038/386506a0; Thielens NM, 2001, J IMMUNOL, V166, P5068, DOI 10.4049/jimmunol.166.8.5068; Wallis R, 1999, J BIOL CHEM, V274, P3580, DOI 10.1074/jbc.274.6.3580; Wallis R, 2004, J BIOL CHEM, V279, P14065, DOI 10.1074/jbc.M400171200; Wallis R, 1997, BIOCHEM J, V325, P391, DOI 10.1042/bj3250391; Wallis R, 2000, J BIOL CHEM, V275, P30962, DOI 10.1074/jbc.M004030200; Wallis R, 2007, IMMUNOBIOLOGY, V212, P289, DOI 10.1016/j.imbio.2006.11.004; WEIS WI, 1994, STRUCTURE, V2, P1227, DOI 10.1016/S0969-2126(94)00124-3; Wu J, 2009, NAT IMMUNOL, V10, P728, DOI 10.1038/ni.1755	58	19	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					3930	3945		10.1074/jbc.M111.320341	http://dx.doi.org/10.1074/jbc.M111.320341			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22167201	Green Published, hybrid			2022-12-27	WOS:000300410900029
J	Rowe, DD; Leonardo, CC; Recio, JA; Collier, LA; Willing, AE; Pennypacker, KR				Rowe, Derrick D.; Leonardo, Christopher C.; Recio, Jesus A.; Collier, Lisa A.; Willing, Alison E.; Pennypacker, Keith R.			Human Umbilical Cord Blood Cells Protect Oligodendrocytes from Brain Ischemia through Akt Signal Transduction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CEREBRAL-ARTERY OCCLUSION; NF-KAPPA-B; IN-VITRO; PHOSPHATIDYLINOSITOL 3-KINASE; THERAPEUTIC IMPLICATIONS; NEURONAL SURVIVAL; OXIDATIVE STRESS; GROWTH-FACTOR; PEROXIREDOXIN; STROKE	Human umbilical cord blood (HUCB) cells protect the brain against ischemic injury, yet the mechanism of protection remains unclear. Using both in vitro and in vivo paradigms, this study examined the role of Akt signaling and peroxiredoxin 4 expression in human umbilical cord blood cell-mediated protection of oligodendrocytes from ischemic conditions. As previously reported, the addition of HUCB cells to oligodendrocyte cultures prior to oxygen glucose deprivation significantly enhanced oligodendrocyte survival. The presence of human umbilical cord blood cells also increased Akt phosphorylation and elevated peroxiredoxin 4 expression in oligodendrocytes. Blocking either Akt or peroxiredoxin 4 activity with Akt Inhibitor IV or a peroxiredoxin 4-neutralizing antibody, respectively, negated the protective effects of human umbilical cord blood cells. In vivo, systemic administration of human umbilical cord blood cells 48 h after middle cerebral artery occlusion increased Akt phosphorylation and peroxiredoxin 4 protein expression while reducing proteolytic cleavage of caspase 3 in oligodendrocytes residing in the ipsilateral external capsule. Moreover, human umbilical cord blood cells protected striatal white matter bundles from degeneration following middle cerebral artery occlusion. These results suggest that the soluble factors released from human umbilical cord blood cells converge on Akt to elevate peroxiredoxin 4 levels, and these effects contribute to oligodendrocyte survival.	[Rowe, Derrick D.; Recio, Jesus A.; Collier, Lisa A.; Pennypacker, Keith R.] Univ S Florida, Dept Mol Pharmacol & Physiol, Sch Basic Biomed Sci, Coll Med, Tampa, FL 33612 USA; [Leonardo, Christopher C.] Univ Florida, Dept Anesthesiol, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL 32610 USA; [Willing, Alison E.] Univ S Florida, Ctr Excellence Aging & Brain Repair, Tampa, FL 33612 USA	State University System of Florida; University of South Florida; State University System of Florida; University of Florida; State University System of Florida; University of South Florida	Pennypacker, KR (corresponding author), Univ S Florida, Dept Mol Pharmacol & Physiol, Sch Basic Biomed Sci, Coll Med, Tampa, FL 33612 USA.	kpennypa@health.usf.edu	Willing, Alison/I-4946-2012; Pennypacker, Keith/I-5092-2012; Willing, Alison/AAP-7759-2021	Recio, Juan Angel/0000-0002-7320-3832	National Institutes of Health [1-R01-NS052839]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052839] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1-R01-NS052839.	Brouns R, 2010, CLIN CHEM, V56, P451, DOI 10.1373/clinchem.2009.134122; Butler TL, 2002, BRAIN RES, V929, P252, DOI 10.1016/S0006-8993(01)03371-6; Carnero A, 2008, CURR CANCER DRUG TAR, V8, P187, DOI 10.2174/156800908784293659; Chua SJ, 2010, SPINE, V35, P1520, DOI 10.1097/BRS.0b013e3181c3e963; Dasari VR, 2008, NEUROBIOL DIS, V32, P486, DOI 10.1016/j.nbd.2008.09.005; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Dolcet X, 1999, J NEUROCHEM, V73, P521, DOI 10.1046/j.1471-4159.1999.0730521.x; Erices A, 2000, BRIT J HAEMATOL, V109, P235, DOI 10.1046/j.1365-2141.2000.01986.x; Fridmacher V, 2003, J NEUROSCI, V23, P9403; Garbuzova-Davis S, 2003, J HEMATOTH STEM CELL, V12, P255, DOI 10.1089/152581603322022990; Hall AA, 2009, J NEUROSCI RES, V87, P333, DOI 10.1002/jnr.21857; Hall A, 2009, J MOL BIOL, V393, P867, DOI 10.1016/j.jmb.2009.08.040; Haridas V, 1998, J IMMUNOL, V161, P1; Ho JN, 2010, MOL CANCER THER, V9, P825, DOI 10.1158/1535-7163.MCT-09-0904; Hofmann B, 2002, BIOL CHEM, V383, P347, DOI 10.1515/BC.2002.040; Hwang IK, 2010, FREE RADICAL BIO MED, V48, P1242, DOI 10.1016/j.freeradbiomed.2010.02.007; Jang HH, 2004, CELL, V117, P625, DOI 10.1016/j.cell.2004.05.002; Jin KL, 2000, P NATL ACAD SCI USA, V97, P10242, DOI 10.1073/pnas.97.18.10242; Jin MH, 2005, NEUROSCI LETT, V381, P252, DOI 10.1016/j.neulet.2005.02.048; Jung H, 2001, J BIOL CHEM, V276, P15504, DOI 10.1074/jbc.M009620200; Kang SW, 2005, TRENDS MOL MED, V11, P571, DOI 10.1016/j.molmed.2005.10.006; Kassed CA, 2002, EXP NEUROL, V176, P277, DOI 10.1006/exnr.2002.7967; Kau TR, 2003, CANCER CELL, V4, P463, DOI 10.1016/S1535-6108(03)00303-9; Kulik G, 1997, MOL CELL BIOL, V17, P1595, DOI 10.1128/MCB.17.3.1595; Kwon J, 2004, P NATL ACAD SCI USA, V101, P16419, DOI 10.1073/pnas.0407396101; Le Rhun Y, 1998, BIOCHEM BIOPH RES CO, V245, P1; Lee SJ, 2003, BIOCHEM BIOPH RES CO, V312, P1196, DOI 10.1016/j.bbrc.2003.11.050; Lentzsch S, 2004, LEUKEMIA, V18, P1883, DOI 10.1038/sj.leu.2403486; Leonardo CC, 2010, J NEUROSCI RES, V88, P1213, DOI 10.1002/jnr.22306; Lyons SA, 1998, J CEREBR BLOOD F MET, V18, P521, DOI 10.1097/00004647-199805000-00007; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; McTigue DM, 2008, J NEUROCHEM, V107, P1, DOI 10.1111/j.1471-4159.2008.05570.x; Mullonkal CJ, 2007, J INVEST SURG, V20, P195, DOI 10.1080/08941930701366471; NAKAHATA T, 1982, J CLIN INVEST, V70, P1324, DOI 10.1172/JCI110734; Neuhoff S, 2007, EXP HEMATOL, V35, P1119, DOI 10.1016/j.exphem.2007.03.019; Newcomb JD, 2006, CELL TRANSPLANT, V15, P213, DOI 10.3727/000000006783982043; Newman MB, 2006, EXP NEUROL, V199, P201, DOI 10.1016/j.expneurol.2006.04.001; Newman MB, 2005, STEM CELLS DEV, V14, P576, DOI 10.1089/scd.2005.14.576; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Nieda M, 1997, BRIT J HAEMATOL, V98, P775, DOI 10.1046/j.1365-2141.1997.2583074.x; Noshita N, 2001, J CEREBR BLOOD F MET, V21, P1442, DOI 10.1097/00004647-200112000-00009; Okado-Matsumoto A, 2000, J BIOCHEM, V127, P493, DOI 10.1093/oxfordjournals.jbchem.a022632; Pantoni L, 1996, STROKE, V27, P1641, DOI 10.1161/01.STR.27.9.1641; Plaisant F, 2003, FREE RADICAL BIO MED, V34, P862, DOI 10.1016/S0891-5849(02)01440-5; Radyuk SN, 2010, BBA-GEN SUBJECTS, V1800, P1153, DOI 10.1016/j.bbagen.2010.06.010; Rowe DD, 2010, BRAIN RES, V1366, P172, DOI 10.1016/j.brainres.2010.09.078; Shibata M, 2002, BRAIN RES, V942, P1, DOI 10.1016/S0006-8993(02)02474-5; Vendrame M, 2004, STROKE, V35, P2390, DOI 10.1161/01.STR.0000141681.06735.9b; Wegiel B, 2008, INT J CANCER, V122, P1521, DOI 10.1002/ijc.23261; Won H, 2012, ANTIOXID REDOX SIGN, V16, P245, DOI 10.1089/ars.2011.3952; Zhao H, 2006, MOL NEUROBIOL, V34, P249, DOI 10.1385/MN:34:3:249; Zhao Y, 2006, FASEB J, V20, P1162, DOI 10.1096/fj.05-5007com	52	38	39	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					4177	4187		10.1074/jbc.M111.296434	http://dx.doi.org/10.1074/jbc.M111.296434			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22158864	Green Published, hybrid			2022-12-27	WOS:000300410900051
J	Tardiff, DF; Tucci, ML; Caldwell, KA; Caldwell, GA; Lindquist, S				Tardiff, Daniel F.; Tucci, Michelle L.; Caldwell, Kim A.; Caldwell, Guy A.; Lindquist, Susan			Different 8-Hydroxyquinolines Protect Models of TDP-43 Protein, alpha-Synuclein, and Polyglutamine Proteotoxicity through Distinct Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; A-BETA; NEURODEGENERATIVE DISEASES; SACCHAROMYCES-CEREVISIAE; TRANSGENIC MICE; IRON CHELATION; AMYLOID-BETA; METAL-IONS	No current therapies target the underlying cellular pathologies of age-related neurodegenerative diseases. Model organisms provide a platform for discovering compounds that protect against the toxic, misfolded proteins that initiate these diseases. One such protein, TDP-43, is implicated in multiple neurodegenerative diseases, including amyotrophic lateral sclerosis and frontotemporal lobar degeneration. In yeast, TDP-43 expression is toxic, and genetic modifiers first discovered in yeast have proven to modulate TDP-43 toxicity in both neurons and humans. Here, we describe a phenotypic screen for small molecules that reverse TDP-43 toxicity in yeast. One group of hit compounds was 8-hydroxyquinolines (8-OHQ), a class of clinically relevant bioactive metal chelators related to clioquinol. Surprisingly, in otherwise wild-type yeast cells, different 8-OHQs had selectivity for rescuing the distinct toxicities caused by the expression of TDP-43, alpha-synuclein, or polyglutamine proteins. In fact, each 8-OHQ synergized with the other, clearly establishing that they function in different ways. Comparative growth and molecular analyses also revealed that 8-OHQs have distinct metal chelation and ionophore activities. The diverse bioactivity of 8-OHQs indicates that altering different aspects of metal homeostasis and/or metalloprotein activity elicits distinct protective mechanisms against several neurotoxic proteins. Indeed, phase II clinical trials of an 8-OHQ has produced encouraging results in modifying Alzheimer disease. Our unbiased identification of 8-OHQs in a yeast TDP-43 toxicity model suggests that tailoring 8-OHQ activity to a particular neurodegenerative disease may be a viable therapeutic strategy.	[Tardiff, Daniel F.; Lindquist, Susan] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Tardiff, Daniel F.; Lindquist, Susan] Univ Alabama, Dept Biol Sci, Tuscaloosa, AL 35487 USA; [Lindquist, Susan] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; University of Alabama System; University of Alabama Tuscaloosa; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Lindquist, S (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	Lindquist_admin@wi.mit.edu		Thompson, Michelle/0000-0001-8134-9017; Caldwell, Kim/0000-0003-1580-6122; Caldwell, Guy/0000-0002-8283-9090	National Institutes of Health [5 P50 NS038372]; Robert P. and Judith N. Goldberg Foundation (RJG); American Parkinson's Disease Association; Ruth L. Kirschstein National Research Service [NS614192]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS038372] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert P. and Judith N. Goldberg Foundation (RJG); American Parkinson's Disease Association; Ruth L. Kirschstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant 5 P50 NS038372. This work was also supported by a grant from the Robert P. and Judith N. Goldberg Foundation (RJG) (to S. L.).; Funded first by a fellowship from the American Parkinson's Disease Association and subsequently by Ruth L. Kirschstein National Research Service Award Fellowship Grant NS614192.	Adlard PA, 2008, NEURON, V59, P43, DOI 10.1016/j.neuron.2008.06.018; Adlard PA, 2006, J ALZHEIMERS DIS, V10, P145; Andreini C, 2008, J BIOL INORG CHEM, V13, P1205, DOI 10.1007/s00775-008-0404-5; Ash PEA, 2010, HUM MOL GENET, V19, P3206, DOI 10.1093/hmg/ddq230; Bishop GM, 2002, DEV NEUROSCI-BASEL, V24, P184, DOI 10.1159/000065696; Bonini NM, 2011, J MOL NEUROSCI, V45, P676, DOI 10.1007/s12031-011-9548-9; Buratti E, 2010, RNA BIOL, V7, P420, DOI 10.4161/rna.7.4.12205; BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293; Chen-Plotkin AS, 2010, NAT REV NEUROL, V6, P211, DOI 10.1038/nrneurol.2010.18; Cherny RA, 2001, NEURON, V30, P665, DOI 10.1016/S0896-6273(01)00317-8; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Cushman M, 2010, J CELL SCI, V123, P1191, DOI 10.1242/jcs.051672; De Freitas J, 2003, BIOMETALS, V16, P185, DOI 10.1023/A:1020771000746; Deibel MA, 1996, J NEUROL SCI, V143, P137, DOI 10.1016/S0022-510X(96)00203-1; DEXTER DT, 1989, J NEUROCHEM, V52, P1830, DOI 10.1111/j.1471-4159.1989.tb07264.x; Dong J, 2003, BIOCHEMISTRY-US, V42, P2768, DOI 10.1021/bi0272151; Duennwald ML, 2006, P NATL ACAD SCI USA, V103, P11045, DOI 10.1073/pnas.0604547103; Duennwald ML, 2006, P NATL ACAD SCI USA, V103, P11051, DOI 10.1073/pnas.0604548103; Duennwald ML, 2008, GENE DEV, V22, P3308, DOI 10.1101/gad.1673408; Elden AC, 2010, NATURE, V466, P1069, DOI 10.1038/nature09320; Faux NG, 2010, J ALZHEIMERS DIS, V20, P509, DOI 10.3233/JAD-2010-1390; Fox JH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000334; Giaever G, 2004, P NATL ACAD SCI USA, V101, P793, DOI 10.1073/pnas.0307490100; Gitler AD, 2008, P NATL ACAD SCI USA, V105, P145, DOI 10.1073/pnas.0710685105; Gitler AD, 2009, NAT GENET, V41, P308, DOI 10.1038/ng.300; Goedert M, 2001, NAT REV NEUROSCI, V2, P492, DOI 10.1038/35081564; Hu YH, 2007, GENOME RES, V17, P536, DOI 10.1101/gr.6037607; Johnson BS, 2008, P NATL ACAD SCI USA, V105, P6439, DOI 10.1073/pnas.0802082105; Johnson BS, 2009, J BIOL CHEM, V284, P20329, DOI 10.1074/jbc.M109.010264; Kaur D, 2004, AGEING RES REV, V3, P327, DOI 10.1016/j.arr.2004.01.003; Kaur D, 2003, NEURON, V37, P899, DOI 10.1016/S0896-6273(03)00126-0; Khurana V, 2010, NAT REV NEUROSCI, V11, P436, DOI 10.1038/nrn2809; King ONF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015535; Krobitsch S, 2000, P NATL ACAD SCI USA, V97, P1589, DOI 10.1073/pnas.97.4.1589; Lannfelt L, 2008, LANCET NEUROL, V7, P779, DOI 10.1016/S1474-4422(08)70167-4; Li CH, 2010, J ALZHEIMERS DIS, V21, P1249, DOI 10.3233/JAD-2010-100024; Liachko NF, 2010, J NEUROSCI, V30, P16208, DOI 10.1523/JNEUROSCI.2911-10.2010; Nakashima-Yasuda H, 2007, ACTA NEUROPATHOL, V114, P221, DOI 10.1007/s00401-007-0261-2; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nguyen T, 2005, P NATL ACAD SCI USA, V102, P11840, DOI 10.1073/pnas.0502177102; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; Ramirez A, 2006, NAT GENET, V38, P1184, DOI 10.1038/ng1884; Rutherford NJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000193; Schwab C, 2008, J NEUROPATH EXP NEUR, V67, P1159, DOI 10.1097/NEN.0b013e31818e8951; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Su LHJ, 2010, DIS MODEL MECH, V3, P194, DOI 10.1242/dmm.004267; Thayanidhi N, 2010, MOL BIOL CELL, V21, P1850, DOI 10.1091/mbc.E09-09-0801; van Ham TJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000027; Waldron KJ, 2009, NATURE, V460, P823, DOI 10.1038/nature08300; Wang Y, 2009, J BIOL CHEM, V284, P314, DOI 10.1074/jbc.M807579200; Wilson AC, 2011, INT J CLIN EXP PATHO, V4, P147; Youdim MBH, 2004, J NEURAL TRANSM, V111, P1455, DOI 10.1007/s00702-004-0143-x	54	64	65	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					4107	4120		10.1074/jbc.M111.308668	http://dx.doi.org/10.1074/jbc.M111.308668			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22147697	Green Published, hybrid			2022-12-27	WOS:000300410900044
J	Wixted, JHF; Rothstein, JL; Eisenlohr, LC				Wixted, Josephine H. F.; Rothstein, Jay L.; Eisenlohr, Laurence C.			Identification of Functionally Distinct TRAF Proinflammatory and Phosphatidylinositol 3-Kinase/Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase Kinase (PI3K/MEK) Transforming Activities Emanating from RET/PTC Fusion Oncoprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; PAPILLARY THYROID-CARCINOMA; RET TYROSINE KINASE; MONOCYTE CHEMOATTRACTANT PROTEIN-1; CHRONIC LYMPHOCYTIC THYROIDITIS; COLONY-STIMULATING FACTORS; HASHIMOTOS-THYROIDITIS; GENE-EXPRESSION; HUMAN THYROCYTES; BRAF MUTATIONS	Thyroid carcinomas that harbor RET/PTC oncogenes are well differentiated, relatively benign neoplasms compared with those expressing oncogenic RAS or BRAF mutations despite signaling through shared transforming pathways. A distinction, however, is that RET/PTCs induce immunostimulatory programs, suggesting that, in the case of this tumor type, the additional pro-inflammatory pathway reduces aggressiveness. Here, we demonstrate that pro-inflammatory programs are selectively activated by TRAF2 and TRAF6 association with RET/PTC oncoproteins. Eliminating this mechanism reduces pro-inflammatory cytokine production without decreasing transformation efficiency. Conversely, ablating MEK/ERK or PI3K/AKT signaling eliminates transformation but not pro-inflammatory cytokine secretion. Functional uncoupling of the two pathways demonstrates that intrinsic pro-inflammatory pathways are not required for cellular transformation and suggests a need for further investigation into the role inflammation plays in thyroid tumor progression.	[Eisenlohr, Laurence C.] Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Immunol, Philadelphia, PA 19107 USA; [Wixted, Josephine H. F.] Thomas Jefferson Univ, Immunol & Microbial Pathogenesis Program, Philadelphia, PA 19107 USA; [Rothstein, Jay L.] Amgen Inc, Inflammat Res, Seattle, WA 98119 USA	Jefferson University; Jefferson University; Amgen	Eisenlohr, LC (corresponding author), Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Immunol, Rm 730,Bluemle Life Sci Bldg,233 S 10th St, Philadelphia, PA 19107 USA.	Laurence.Eisenlohr@jefferson.edu			National Institutes of Health [F31NS054444, R21A1063065, R01AI069192]; State of Pennsylvania [SAP 4100026302]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069192] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS054444] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); State of Pennsylvania; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants F31NS054444 (to J .H. F. W.), R21A1063065 (to J. L. R. and L. C. E.), and R01AI069192 (to L. C. E.). This work was also supported by State of Pennsylvania Grant SAP 4100026302 (to J. L. R. and L. C. E.).	Akiba H, 1998, J BIOL CHEM, V273, P13353, DOI 10.1074/jbc.273.21.13353; Alberti L, 1998, ONCOGENE, V17, P1079, DOI 10.1038/sj.onc.1202046; Antonaci A, 2009, ONCOL RES, V17, P495, DOI 10.3727/096504009789735431; Arighi E, 2005, CYTOKINE GROWTH F R, V16, P441, DOI 10.1016/j.cytogfr.2005.05.010; Basseres DS, 2010, CANCER RES, V70, P3537, DOI 10.1158/0008-5472.CAN-09-4290; Besset V, 2000, J BIOL CHEM, V275, P39159, DOI 10.1074/jbc.M006908200; Bongarzone I, 1997, GENOMICS, V42, P252, DOI 10.1006/geno.1997.4685; Borrello MG, 2005, P NATL ACAD SCI USA, V102, P14825, DOI 10.1073/pnas.0503039102; Bozec A, 2010, CURR MED CHEM, V17, P3449, DOI 10.2174/092986710792927804; Castellone MD, 2004, ONCOGENE, V23, P5958, DOI 10.1038/sj.onc.1207790; Caudill CM, 2005, J CLIN ENDOCR METAB, V90, P2364, DOI 10.1210/jc.2004-1811; Darnay BG, 1999, J BIOL CHEM, V274, P7724, DOI 10.1074/jbc.274.12.7724; Davies L, 2006, JAMA-J AM MED ASSOC, V295, P2164, DOI 10.1001/jama.295.18.2164; De Falco V, 2007, CANCER RES, V67, P381, DOI 10.1158/0008-5472.CAN-06-0981; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Frattini M, 2004, ONCOGENE, V23, P7436, DOI 10.1038/sj.onc.1207980; FUGAZZOLA L, 1995, CANCER RES, V55, P5617; Gallel P, 2008, HUM PATHOL, V39, P994, DOI 10.1016/j.humpath.2007.11.015; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Grivennikov SI, 2010, CYTOKINE GROWTH F R, V21, P11, DOI 10.1016/j.cytogfr.2009.11.005; Guarino V, 2010, MOL CELL ENDOCRINOL, V321, P94, DOI 10.1016/j.mce.2009.10.003; Ha Hyunil, 2009, Curr Protoc Immunol, VChapter 11, DOI 10.1002/0471142735.im1109ds87; Hanson JL, 2004, CANCER RES, V64, P7248, DOI 10.1158/0008-5472.CAN-03-3898; Hanson JL, 2003, J BIOL CHEM, V278, P34910, DOI 10.1074/jbc.M304189200; Heuer M, 1996, THYROID, V6, P97, DOI 10.1089/thy.1996.6.97; Hildebrand JM, 2010, J EXP MED, V207, P2569, DOI 10.1084/jem.20100857; Hostager BS, 2007, IMMUNOL RES, V39, P105, DOI 10.1007/s12026-007-0082-3; Hwang ES, 2004, MOL ENDOCRINOL, V18, P2672, DOI 10.1210/me.2004-0168; Iavarone C, 2006, J BIOL CHEM, V281, P10567, DOI 10.1074/jbc.M513397200; ITO T, 1993, CANCER RES, V53, P2940; Kasai K, 1997, BIOCHEM BIOPH RES CO, V238, P191, DOI 10.1006/bbrc.1997.7244; Kasai K, 1996, FEBS LETT, V394, P137, DOI 10.1016/0014-5793(96)00935-0; Kawamoto Y, 2004, J BIOL CHEM, V279, P14213, DOI 10.1074/jbc.M312600200; Kebebew E, 2001, WORLD J SURG, V25, P632, DOI 10.1007/s002680020165; Kimura ET, 2003, CANCER RES, V63, P1454; King CG, 2006, NAT MED, V12, P1088, DOI 10.1038/nm1449; Knauf JA, 2003, ONCOGENE, V22, P4406, DOI 10.1038/sj.onc.1206602; Knowles PP, 2006, J BIOL CHEM, V281, P33577, DOI 10.1074/jbc.M605604200; Kuhne MR, 1997, J EXP MED, V186, P337, DOI 10.1084/jem.186.2.337; Lin CI, 2011, J CLIN ENDOCR METAB, V96, pE554, DOI 10.1210/jc.2010-1800; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Ludwig L, 2001, CANCER RES, V61, P4526; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; Matsumura M, 1999, LIFE SCI, V65, pPL129, DOI 10.1016/S0024-3205(99)00368-9; Mechler C, 2001, BRIT J CANCER, V85, P1831, DOI 10.1054/bjoc.2001.2187; Melillo RM, 2005, J CLIN INVEST, V115, P1068, DOI 10.1172/JCI22758; Mesa C, 2006, CANCER RES, V66, P6521, DOI 10.1158/0008-5472.CAN-06-0739; Neely RJ, 2011, ONCOGENE, V30, P87, DOI 10.1038/onc.2010.396; Nikiforov YE, 2008, MODERN PATHOL, V21, pS37, DOI 10.1038/modpathol.2008.10; OTT RA, 1985, SURGERY, V98, P1202; Ouyang B, 2006, CLIN CANCER RES, V12, P1785, DOI 10.1158/1078-0432.CCR-05-1729; Powell DJ, 2003, J IMMUNOL, V170, P861, DOI 10.4049/jimmunol.170.2.861; Powell DJ, 2001, ONCOGENE, V20, P3235, DOI 10.1038/sj.onc.1204425; PREHN RT, 1972, SCIENCE, V176, P170, DOI 10.1126/science.176.4031.170; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; Puxeddu E, 2005, ENDOCR-RELAT CANCER, V12, P319, DOI 10.1677/erc.1.00947; Rabes HM, 1998, RECENT RES CANCER, V154, P248; Rhoden KJ, 2006, J CLIN ENDOCR METAB, V91, P2414, DOI 10.1210/jc.2006-0240; Ricarte-Filho JC, 2009, CANCER RES, V69, P4885, DOI 10.1158/0008-5472.CAN-09-0727; Ruan DT, 2008, SURGERY, V144, P908, DOI 10.1016/j.surg.2008.07.028; Russell JP, 2004, J IMMUNOL, V172, P4059, DOI 10.4049/jimmunol.172.7.4059; Russell JP, 2003, ONCOGENE, V22, P4569, DOI 10.1038/sj.onc.1206759; Ryder M, 2008, ENDOCR-RELAT CANCER, V15, P1069, DOI 10.1677/ERC-08-0036; Salvatore D, 2001, CANCER RES, V61, P1426; SEGAL K, 1985, INT SURG, V70, P205; Shinohara S, 2004, ONCOGENE, V23, P7571, DOI 10.1038/sj.onc.1207964; Singh B, 1999, SURGERY, V126, P1070, DOI 10.1067/msy.2099.101431; Soares P, 2003, ONCOGENE, V22, P4578, DOI 10.1038/sj.onc.1206706; Ulrich CM, 2006, NAT REV CANCER, V6, P130, DOI 10.1038/nrc1801; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Weetman AP, 2004, CLIN ENDOCRINOL, V61, P405, DOI 10.1111/j.1365-2265.2004.02085.x; Wirtschafter A, 1997, LARYNGOSCOPE, V107, P95, DOI 10.1097/00005537-199701000-00019; Xiao GH, 2001, P NATL ACAD SCI USA, V98, P247, DOI 10.1073/pnas.011532898; Yamashita M, 2008, MOL CELL, V31, P918, DOI 10.1016/j.molcel.2008.09.002; YIP I, 1995, J CLIN ENDOCR METAB, V80, P1664, DOI 10.1210/jc.80.5.1664; Zarnegar B, 2008, P NATL ACAD SCI USA, V105, P3503, DOI 10.1073/pnas.0707959105; Ziech D, 2011, MUTAT RES-FUND MOL M, V711, P167, DOI 10.1016/j.mrfmmm.2011.02.015	80	10	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					3691	3703		10.1074/jbc.M111.322677	http://dx.doi.org/10.1074/jbc.M111.322677			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22158616	Green Published, hybrid			2022-12-27	WOS:000300410900007
J	Morita, T; Mayanagi, T; Sobue, K				Morita, Tsuyoshi; Mayanagi, Taira; Sobue, Kenji			Caldesmon Regulates Axon Extension through Interaction with Myosin II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE; ATPASE ACTIVITY; ACTIN-BINDING; GROWTH CONES; TROPOMYOSIN; GIZZARD; PROTEIN; INHIBITION; ARP2/3; SITES	To begin the process of forming neural circuits, new neurons first establish their polarity and extend their axon. Axon extension is guided and regulated by highly coordinated cytoskeletal dynamics. Here we demonstrate that in hippocampal neurons, the actin-binding protein caldesmon accumulates in distal axons, and its N-terminal interaction with myosin II enhances axon extension. In cortical neural progenitor cells, caldesmon knockdown suppresses axon extension and neuronal polarity. These results indicate that caldesmon is an important regulator of axon development.	[Mayanagi, Taira; Sobue, Kenji] Iwate Med Univ, Inst Biomed Sci, Dept Neurosci, Yahaba, Iwate 0283694, Japan; [Morita, Tsuyoshi; Mayanagi, Taira; Sobue, Kenji] Osaka Univ, Grad Sch Med, Dept Neurosci, Suita, Osaka 5650871, Japan	Iwate Medical University; Osaka University	Sobue, K (corresponding author), Iwate Med Univ, Inst Biomed Sci, Dept Neurosci, 2-1-1 Nishitokuta, Yahaba, Iwate 0283694, Japan.	ksobue@iwate-med.ac.jp			Japan Society for the Promotion of Science [20240038]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) [23110510]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-aid for Scientific Research 20240038 from the Japan Society for the Promotion of Science (to K. S.) and 23110510 from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) (to K. S.).	Bradke F, 1999, SCIENCE, V283, P1931, DOI 10.1126/science.283.5409.1931; Bridgman PC, 2009, RESULTS PROBL CELL D, V48, P91, DOI 10.1007/400_2009_10; Chantler P D, 2003, IEE Proc Nanobiotechnol, V150, P111, DOI 10.1049/ip-nbt:20031076; Fukumoto K, 2009, MOL PSYCHIATR, V14, P1119, DOI 10.1038/mp.2009.60; Garvalov BK, 2007, J NEUROSCI, V27, P13117, DOI 10.1523/JNEUROSCI.3322-07.2007; HAYASHI K, 1991, J BIOL CHEM, V266, P355; HEMRIC ME, 1988, J BIOL CHEM, V263, P1878; Hur EM, 2011, P NATL ACAD SCI USA, V108, P5057, DOI 10.1073/pnas.1011258108; ISHIKAWA R, 1989, J BIOL CHEM, V264, P7490; Jiang M, 2006, NAT PROTOC, V1, P695, DOI 10.1038/nprot.2006.86; KIRA M, 1995, J NEUROSCI RES, V40, P294, DOI 10.1002/jnr.490400303; Kuhn TB, 2000, J NEUROBIOL, V44, P126, DOI 10.1002/1097-4695(200008)44:2<126::AID-NEU4>3.0.CO;2-Z; Kwiatkowski AV, 2007, NEURON, V56, P441, DOI 10.1016/j.neuron.2007.09.008; LETOURNEAU PC, 1987, CELL MOTIL CYTOSKEL, V8, P193, DOI 10.1002/cm.970080302; Li Y, 2004, J CELL SCI, V117, P3593, DOI 10.1242/jcs.01216; Li YH, 2000, J BIOL CHEM, V275, P10989, DOI 10.1074/jbc.275.15.10989; Loudon RR, 2006, J NEUROBIOL, V66, P847, DOI 10.1002/neu.20258; Mayanagi T, 2011, CELL ADHES MIGR, V5, P150, DOI 10.4161/cam.5.2.14398; Morita T, 2007, J BIOL CHEM, V282, P8454, DOI 10.1074/jbc.M609983200; NGAI PK, 1984, J BIOL CHEM, V259, P3656; Poulain FE, 2010, MOL CELL NEUROSCI, V43, P15, DOI 10.1016/j.mcn.2009.07.012; RAY J, 1993, P NATL ACAD SCI USA, V90, P3602, DOI 10.1073/pnas.90.8.3602; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Rosner H, 2007, BRAIN RES, V1176, P1, DOI 10.1016/j.brainres.2007.07.081; SOBUE K, 1991, J BIOL CHEM, V266, P12115; SOBUE K, 1982, BIOMED RES-TOKYO, V3, P188, DOI 10.2220/biomedres.3.188; SOBUE K, 1981, P NATL ACAD SCI-BIOL, V78, P5652, DOI 10.1073/pnas.78.9.5652; SOBUE K, 1985, BIOCHEM BIOPH RES CO, V132, P645, DOI 10.1016/0006-291X(85)91181-7; Sobue K, 2010, CELL ADHES MIGR, V4, P185, DOI 10.4161/cam.4.2.10886; Strasser GA, 2004, NEURON, V43, P81, DOI 10.1016/j.neuron.2004.05.015; TANAKA J, 1993, J CELL SCI, V104, P595; Turney SG, 2005, NAT NEUROSCI, V8, P717, DOI 10.1038/nn1466; VELAZ L, 1990, J BIOL CHEM, V265, P2929; Wang Z, 1997, P NATL ACAD SCI USA, V94, P11899, DOI 10.1073/pnas.94.22.11899; WARREN KS, 1994, J CELL BIOL, V125, P359, DOI 10.1083/jcb.125.2.359; Yamashiro S, 2001, MOL BIOL CELL, V12, P239, DOI 10.1091/mbc.12.1.239	36	9	9	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3349	3356		10.1074/jbc.M111.295618	http://dx.doi.org/10.1074/jbc.M111.295618			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22158623	Green Published, hybrid			2022-12-27	WOS:000300295100040
J	Podar, D; Scherer, J; Noordally, Z; Herzyk, P; Nies, D; Sanders, D				Podar, Dorina; Scherer, Judith; Noordally, Zeenat; Herzyk, Pawel; Nies, Dietrich; Sanders, Dale			Metal Selectivity Determinants in a Family of Transition Metal Transporters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFUSION FACILITATOR FAMILY; ZINC TRANSPORTER; ARABIDOPSIS-THALIANA; SUBSTRATE-SPECIFICITY; THLASPI-GOESINGENSE; ANTIPORT MECHANISM; VACUOLAR MEMBRANE; CDF FAMILY; TOLERANCE; PROTEIN	Metal tolerance proteins (MTPs) are plant members of the cation diffusion facilitator (CDF) transporter family involved in cellular metal homeostasis. Members of the CDF family are ubiquitously found in all living entities and show principal selectivity for Zn2+, Mn2+, and Fe2+. Little is known regarding metal selectivity determinants of CDFs. We identified a novel cereal member of CDFs in barley, termed HvMTP1, that localizes to the vacuolar membrane. Unlike its close relative AtMTP1, which is highly selective for Zn2+, HvMTP1 exhibits selectivity for both Zn2+ and Co2+ as assessed by its ability to suppress yeast mutant phenotypes for both metals. Expression of HvMTP1/AtMTP1 chimeras in yeast revealed a five-residue sequence within the AtMTP1 N-segment of the His-rich intracytoplasmic loop that confines specificity to Zn2+. Furthermore, mutants of AtMTP1 generated through random mutagenesis revealed residues embedded within transmembrane domain 3 that additionally specify the high degree of Zn2+ selectivity. We propose that the His-rich loop, which might play a role as a zinc chaperone, determines the identity of the metal ions that are transported. The residues within transmembrane domain 3 can also influence metal selectivity, possibly through conformational changes induced at the cation transport site located within the membrane or at the cytoplasmic C-terminal domain.	[Podar, Dorina] Univ Babes Bolyai, Fac Biol Geol, Cluj Napoca 400084, Romania; [Podar, Dorina; Noordally, Zeenat; Sanders, Dale] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Sanders, Dale] John Innes Ctr, Norwich NR4 7UH, Norfolk, England; [Scherer, Judith; Nies, Dietrich] Univ Halle, Inst Mikrobiol, D-06120 Halle, Germany; [Herzyk, Pawel] Univ Glasgow, Inst Mol Cell & Syst Biol, Glasgow G12 8QQ, Lanark, Scotland	Babes Bolyai University from Cluj; University of York - UK; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Martin Luther University Halle Wittenberg; University of Glasgow	Podar, D (corresponding author), Univ Babes Bolyai, Fac Biol Geol, Cluj Napoca 400084, Romania.	dorina.podar@gmail.com	Nies, Dietrich H/H-4143-2011; Podar, Dorina/AAK-3437-2021; Podar, Dorina/B-8702-2012	Podar, Dorina/0000-0002-0955-7425; Podar, Dorina/0000-0002-0955-7425; Noordally, Zeenat/0000-0003-2817-1330	European Union; CNCSIS-UEFISCSU [PN II_PD_424/2010]; BBSRC [BBS/E/J/000C0662, BBS/E/J/000C0651] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/J/000C0662, BBS/E/J/000C0651] Funding Source: researchfish	European Union(European Commission); CNCSIS-UEFISCSU(Consiliul National al Cercetarii Stiintifice (CNCS)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the European Union Framework Programme 6 "PHIME" and CNCSIS-UEFISCSU, PN II_PD_424/2010.	Alberts IL, 1998, PROTEIN SCI, V7, P1700, DOI 10.1002/pro.5560070805; Andreini C, 2006, J PROTEOME RES, V5, P196, DOI 10.1021/pr050361j; Arrivault S, 2006, PLANT J, V46, P861, DOI 10.1111/j.1365-313X.2006.02746.x; Auld DS, 2008, CELL MOL LIFE SCI, V65, P3961, DOI 10.1007/s00018-008-8593-1; Bhutta ZA, 2000, AM J CLIN NUTR, V72, P1516; Blaudez D, 2003, PLANT CELL, V15, P2911, DOI 10.1105/tpc.017541; Blindauer CA, 2010, METALLOMICS, V2, P510, DOI 10.1039/c004880a; Brown CK, 1998, J PROTEIN CHEM, V17, P855, DOI 10.1023/A:1020790604887; Caulfield LE, 2004, AM J CLIN NUTR, V80, P193; Chao Y, 2004, J BIOL CHEM, V279, P12043, DOI 10.1074/jbc.M313510200; Cherezov V, 2008, STRUCTURE, V16, P1378, DOI 10.1016/j.str.2008.05.014; Desbrosses-Fonrouge AG, 2005, FEBS LETT, V579, P4165, DOI 10.1016/j.febslet.2005.06.046; Drager DB, 2004, PLANT J, V39, P425, DOI 10.1111/j.1365-313X.2004.02143.x; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Grass G, 2005, ARCH MICROBIOL, V183, P9, DOI 10.1007/s00203-004-0739-4; Guffanti AA, 2002, MOL MICROBIOL, V45, P145, DOI 10.1046/j.1365-2958.2002.02998.x; Haney CJ, 2005, J IND MICROBIOL BIOT, V32, P215, DOI 10.1007/s10295-005-0224-3; Higuchi T, 2009, PROTEINS, V76, P768, DOI 10.1002/prot.22444; Kawachi M, 2008, J BIOL CHEM, V283, P8374, DOI 10.1074/jbc.M707646200; Kim D, 2004, PLANT J, V39, P237, DOI 10.1111/j.1365-313X.2004.02126.x; Kobae Y, 2004, PLANT CELL PHYSIOL, V45, P1749, DOI 10.1093/pcp/pci015; Lin HL, 2009, BIOCHEM J, V422, P273, DOI 10.1042/BJ20090853; Lin HL, 2008, J BIOL CHEM, V283, P33865, DOI 10.1074/jbc.M804377200; Lu M, 2007, SCIENCE, V317, P1746, DOI 10.1126/science.1143748; Lu M, 2009, NAT STRUCT MOL BIOL, V16, P1063, DOI 10.1038/nsmb.1662; Montanini B, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-107; Muthukumar B, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-32; Nakanishi Y, 2001, J BIOL CHEM, V276, P7654, DOI 10.1074/jbc.M009743200; Palmgren MG, 2008, TRENDS PLANT SCI, V13, P464, DOI 10.1016/j.tplants.2008.06.005; Paulsen IT, 1997, J MEMBRANE BIOL, V156, P99, DOI 10.1007/s002329900192; Peiter E, 2007, P NATL ACAD SCI USA, V104, P8532, DOI 10.1073/pnas.0609507104; Persans MW, 2001, P NATL ACAD SCI USA, V98, P9995, DOI 10.1073/pnas.171039798; PRASAD AS, 1963, J LAB CLIN MED, V61, P537; Shingu Y, 2005, BIOCHEM BIOPH RES CO, V331, P675, DOI 10.1016/j.bbrc.2005.04.010; Tauris B, 2009, J EXP BOT, V60, P1333, DOI 10.1093/jxb/erp023; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Yuan LY, 2012, PLANT CELL REP, V31, P67, DOI 10.1007/s00299-011-1140-9; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	38	72	77	1	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3185	3196		10.1074/jbc.M111.305649	http://dx.doi.org/10.1074/jbc.M111.305649			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22139846	Green Published, hybrid			2022-12-27	WOS:000300295100024
J	Mersman, DP; Du, HN; Fingerman, IM; South, PF; Briggs, SD				Mersman, Douglas P.; Du, Hai-Ning; Fingerman, Ian M.; South, Paul F.; Briggs, Scott D.			Charge-based Interaction Conserved within Histone H3 Lysine 4 (H3K4) Methyltransferase Complexes Is Needed for Protein Stability, Histone Methylation, and Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINEAGE LEUKEMIA PROTEIN-1; MLL1 CORE COMPLEX; SACCHAROMYCES-CEREVISIAE; STRUCTURAL BASIS; MOLECULAR RECOGNITION; TRITHORAX FAMILY; SET1 COMPLEX; WDR5; TRIMETHYLATION; COMPASS	Histone H3 lysine 4 (H3K4) methyltransferases are conserved from yeast to humans, assemble in multisubunit complexes, and are needed to regulate gene expression. The yeast H3K4 methyltransferase complex, Set1 complex or complex of proteins associated with Set1 (COMPASS), consists of Set1 and conserved Set1-associated proteins: Swd1, Swd2, Swd3, Spp1, Bre2, Sdc1, and Shg1. The removal of the WD40 domain-containing subunits Swd1 and Swd3 leads to a loss of Set1 protein and consequently a complete loss of H3K4 methylation. However, until now, how these WD40 domain-containing proteins interact with Set1 and contribute to the stability of Set1 and H3K4 methylation has not been determined. In this study, we identified small basic and acidic patches that mediate protein interactions between the C terminus of Swd1 and the nSET domain of Set1. Absence of either the basic or acidic patches of Set1 and Swd1, respectively, disrupts the interaction between Set1 and Swd1, diminishes Set1 protein levels, and abolishes H3K4 methylation. Moreover, these basic and acidic patches are also important for cell growth, telomere silencing, and gene expression. We also show that the basic and acidic patches of Set1 and Swd1 are conserved in their human counterparts SET1A/B and RBBP5, respectively, and are needed for the protein interaction between SET1A and RBBP5. Therefore, this charge-based interaction is likely important for maintaining the protein stability of the human SET1A/B methyltransferase complexes so that proper H3K4 methylation, cell growth, and gene expression can also occur in mammals.	[Briggs, Scott D.] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; Purdue Univ, Purdue Univ Ctr Canc Res, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Briggs, SD (corresponding author), Purdue Univ, Dept Biochem, 175 S Univ, W Lafayette, IN 47907 USA.	sdbriggs@purdue.edu	Du, Hai-Ning/AAI-2020-2021; South, Paul/AAG-2634-2020; South, Paul/H-2636-2017; du, hai-ning/AAE-5626-2022	Du, Hai-Ning/0000-0001-8062-5411; South, Paul/0000-0001-7885-7096; South, Paul/0000-0001-7885-7096; Briggs, Scott D/0000-0003-2852-3594	National Institutes of Health [GM74183]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL048743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074183] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM74183 to (to S. D. B.).	Altaf M, 2007, MOL CELL, V28, P1002, DOI 10.1016/j.molcel.2007.12.002; Avdic V, 2011, STRUCTURE, V19, P101, DOI 10.1016/j.str.2010.09.022; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; Bryk M, 2002, CURR BIOL, V12, P165, DOI 10.1016/S0960-9822(01)00652-2; Couture JF, 2006, NAT STRUCT MOL BIOL, V13, P698, DOI 10.1038/nsmb1116; Dehe PM, 2006, J BIOL CHEM, V281, P35404, DOI 10.1074/jbc.M603099200; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Du HN, 2008, GENE DEV, V22, P2786, DOI 10.1101/gad.1700008; Fingerman IM, 2007, GENE DEV, V21, P2018, DOI 10.1101/gad.1560607; Fingerman IM, 2005, J BIOL CHEM, V280, P28761, DOI 10.1074/jbc.C500097200; Halbach A, 2009, EMBO J, V28, P2959, DOI 10.1038/emboj.2009.240; Han ZF, 2006, MOL CELL, V22, P137, DOI 10.1016/j.molcel.2006.03.018; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; Krogan NJ, 2002, J BIOL CHEM, V277, P10753, DOI 10.1074/jbc.C200023200; Lee JH, 2008, MOL CELL BIOL, V28, P609, DOI 10.1128/MCB.01356-07; Lee JH, 2007, J BIOL CHEM, V282, P13419, DOI 10.1074/jbc.M609809200; Lee JS, 2007, CELL, V131, P1084, DOI 10.1016/j.cell.2007.09.046; Mersman DP, 2009, GENE DEV, V23, P951, DOI 10.1101/gad.1769209; Miller T, 2001, P NATL ACAD SCI USA, V98, P12902, DOI 10.1073/pnas.231473398; Milne TA, 2005, P NATL ACAD SCI USA, V102, P14765, DOI 10.1073/pnas.0503630102; Milne TA, 2005, CANCER RES, V65, P11367, DOI 10.1158/0008-5472.CAN-05-1041; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Mueller JE, 2006, GENETICS, V173, P557, DOI 10.1534/genetics.106.055400; Nagy PL, 2002, P NATL ACAD SCI USA, V99, P90, DOI 10.1073/pnas.221596698; Nguyen P, 2008, MOL CELL BIOL, V28, P6720, DOI 10.1128/MCB.00568-08; Nislow C, 1997, MOL BIOL CELL, V8, P2421, DOI 10.1091/mbc.8.12.2421; Odho Z, 2010, J BIOL CHEM, V285, P32967, DOI 10.1074/jbc.M110.159921; Patel A, 2008, J BIOL CHEM, V283, P32162, DOI 10.1074/jbc.M806317200; Patel A, 2011, J BIOL CHEM, V286, P3359, DOI 10.1074/jbc.M110.174524; Patel A, 2009, J BIOL CHEM, V284, P24242, DOI 10.1074/jbc.M109.014498; Roguev A, 2001, EMBO J, V20, P7137, DOI 10.1093/emboj/20.24.7137; Ruthenburg AJ, 2006, NAT STRUCT MOL BIOL, V13, P704, DOI 10.1038/nsmb1119; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schlichter A, 2005, EMBO J, V24, P1222, DOI 10.1038/sj.emboj.7600607; Schuetz A, 2006, EMBO J, V25, P4245, DOI 10.1038/sj.emboj.7601316; Song JJ, 2008, J BIOL CHEM, V283, P35258, DOI 10.1074/jbc.M806900200; South PF, 2010, J BIOL CHEM, V285, P595, DOI 10.1074/jbc.M109.042697; Southall SM, 2009, MOL CELL, V33, P181, DOI 10.1016/j.molcel.2008.12.029; Steward MM, 2006, NAT STRUCT MOL BIOL, V13, P852, DOI 10.1038/nsmb1131; Takahashi YH, 2009, MOL CELL BIOL, V29, P3478, DOI 10.1128/MCB.00013-09; Wu M, 2008, MOL CELL BIOL, V28, P7337, DOI 10.1128/MCB.00976-08; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004	43	28	30	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2652	2665		10.1074/jbc.M111.280867	http://dx.doi.org/10.1074/jbc.M111.280867			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22147691	Green Published, hybrid			2022-12-27	WOS:000300292300038
J	Pan, M; Yuan, H; Brent, M; Ding, EC; Marmorstein, R				Pan, Min; Yuan, Hua; Brent, Michael; Ding, Emily Chen; Marmorstein, Ronen			SIRT1 Contains N- and C-terminal Regions That Potentiate Deacetylase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NAD(+)-DEPENDENT HISTONE DEACETYLASES; SMALL-MOLECULE ACTIVATORS; SACCHAROMYCES-CEREVISIAE; STRUCTURAL BASIS; PROTEIN SIR2; SIRTUINS; INHIBITORS; MECHANISM; GENE; LONGEVITY	SIRT1 is one of seven mammalian sirtuin (silent information regulator 2-related) proteins that harbor NAD(+)-dependent protein deacetylase activity and is implicated in multiple metabolic and age-associated pathways and disorders. The sirtuin proteins contain a central region of high sequence conservation that is required for catalytic activity, but more variable N- and C-terminal regions have been proposed to mediate protein specific activities. Here we show that the conserved catalytic core domain of SIRT1 has very low catalytic activity toward several known protein substrates, but that regions N- and C-terminal to the catalytic core potentiate catalytic efficiency by between 12- and 45-fold, with the N-terminal domain contributing predominantly to catalytic rate, relatively independent of the nature of the acetyl-lysine protein substrate, and the C-terminal domain contributing significantly to the K-m for NAD(+). We show that the N- and C-terminal regions stimulate SIRT1 deacetylase activity intramolecularly and that the C-terminal region stably associates with the catalytic core domain to form a SIRT1 holoenzyme. We also demonstrate that the C-terminal region of SIRT1 can influence the inhibitory activity of some sirtuin inhibitors that are known to function through the catalytic core domain. Together, these studies highlight the unique properties of the SIRT1 member of the sirtuin proteins and have implications for the development of SIRT1-specific regulatory molecules.	[Pan, Min; Yuan, Hua; Brent, Michael; Ding, Emily Chen; Marmorstein, Ronen] Univ Penn, Wistar Inst, Philadelphia, PA 19104 USA; [Pan, Min; Brent, Michael; Ding, Emily Chen; Marmorstein, Ronen] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA	The Wistar Institute; University of Pennsylvania; University of Pennsylvania	Marmorstein, R (corresponding author), Univ Penn, Wistar Inst, 3601 Spruce St, Philadelphia, PA 19104 USA.	marmor@wistar.org			National Institutes of Health [GM060293, CA107107, CA010815]; NATIONAL CANCER INSTITUTE [R01CA107107, P30CA010815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060293] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG031862] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants GM060293 and CA107107 (to R. M.) and CA010815 (to the Wistar Proteomics Core facility).	Bedalov A, 2001, P NATL ACAD SCI USA, V98, P15113, DOI 10.1073/pnas.261574398; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; BRACHMANN CB, 1995, GENE DEV, V9, P2888, DOI 10.1101/gad.9.23.2888; Cen Y, 2010, BBA-PROTEINS PROTEOM, V1804, P1635, DOI 10.1016/j.bbapap.2009.11.010; Chakrabarty SP, 2008, MOL BIOCHEM PARASIT, V158, P139, DOI 10.1016/j.molbiopara.2007.12.003; Donmez G, 2010, AGING CELL, V9, P285, DOI 10.1111/j.1474-9726.2010.00548.x; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Frye RA, 1999, BIOCHEM BIOPH RES CO, V260, P273, DOI 10.1006/bbrc.1999.0897; Grozinger CM, 2001, J BIOL CHEM, V276, P38837, DOI 10.1074/jbc.M106779200; Guarente L, 2007, COLD SPRING HARB SYM, V72, P483, DOI 10.1101/sqb.2007.72.024; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Heltweg B, 2006, CANCER RES, V66, P4368, DOI 10.1158/0008-5472.CAN-05-3617; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jackson AD, 2002, J BIOL CHEM, V277, P18535, DOI 10.1074/jbc.M200671200; Jackson MD, 2003, J BIOL CHEM, V278, P50985, DOI 10.1074/jbc.M306552200; Kaeberlein M, 2005, J BIOL CHEM, V280, P17038, DOI 10.1074/jbc.M500655200; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kim E, 1999, ONCOGENE, V18, P7310, DOI 10.1038/sj.onc.1203139; Lain S, 2008, CANCER CELL, V13, P454, DOI 10.1016/j.ccr.2008.03.004; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Laue T.M., 1992, ANAL ULTRACENTRIFUGA; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Nayagam VM, 2006, J BIOMOL SCREEN, V11, P959, DOI 10.1177/1087057106294710; Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Sanders BD, 2010, BBA-PROTEINS PROTEOM, V1804, P1604, DOI 10.1016/j.bbapap.2009.09.009; Sauve AA, 2003, BIOCHEMISTRY-US, V42, P9249, DOI 10.1021/bi034959l; Sauve AA, 2001, BIOCHEMISTRY-US, V40, P15456, DOI 10.1021/bi011858j; Schmidt C, 2010, NAT BIOTECHNOL, V28, P185, DOI 10.1038/nbt0310-185; Schuetz A, 2007, STRUCTURE, V15, P377, DOI 10.1016/j.str.2007.02.002; Solomon JM, 2006, MOL CELL BIOL, V26, P28, DOI 10.1128/MCB.26.1.28-38.2006; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Trapp J, 2007, CHEMMEDCHEM, V2, P1419, DOI 10.1002/cmdc.200700003; Trapp J, 2006, J MED CHEM, V49, P7307, DOI 10.1021/jm060118b; Wilson JM, 2006, EMBO REP, V7, P1247, DOI 10.1038/sj.embor.7400829; Zhao KH, 2003, NAT STRUCT BIOL, V10, P864, DOI 10.1038/nsb978	37	51	51	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2468	2476		10.1074/jbc.M111.285031	http://dx.doi.org/10.1074/jbc.M111.285031			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22157016	hybrid, Green Published			2022-12-27	WOS:000300292300021
J	Govaert, J; Pellis, M; Deschacht, N; Vincke, C; Conrath, K; Muyldermans, S; Saerens, D				Govaert, Jochen; Pellis, Mireille; Deschacht, Nick; Vincke, Cecile; Conrath, Katja; Muyldermans, Serge; Saerens, Dirk			Dual Beneficial Effect of Interloop Disulfide Bond for Single Domain Antibody Fragments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAVY-CHAIN ANTIBODIES; ANTIGEN-BINDING; MOLECULAR CONVERGENCE; CRYSTAL-STRUCTURE; LIGHT-CHAINS; V-REGION; PROTEIN; MATURATION; SHARK; VHH	The antigen-binding fragment of functional heavy chain antibodies (HCAbs) in camelids comprises a single domain, named the variable domain of heavy chain of HCAbs (VHH). The VHH harbors remarkable amino acid substitutions in the framework region-2 to generate an antigen-binding domain that functions in the absence of a light chain partner. The substitutions provide a more hydrophilic, hence more soluble, character to the VHH but decrease the intrinsic stability of the domain. Here we investigate the functional role of an additional hallmark of dromedary VHHs, i.e. the extra disulfide bond between the first and third antigen-binding loops. After substituting the cysteines forming this interloop cystine by all 20 amino acids, we selected and characterized several VHHs that retain antigen binding capacity. Although VHH domains can function in the absence of an interloop disulfide bond, we demonstrate that its presence constitutes a net advantage. First, the disulfide bond stabilizes the domain and counteracts the destabilization by the framework region-2 hallmark amino acids. Second, the disulfide bond rigidifies the long third antigen-binding loop, leading to a stronger antigen interaction. This dual beneficial effect explains the in vivo antibody maturation process favoring VHH domains with an interloop disulfide bond.	[Muyldermans, Serge] Vrije Univ Brussel, Cellular & Mol Immunol Lab, VIB Dept Struct Biol, B-1050 Brussels, Belgium; VIB, Dept Biol Struct, B-1050 Brussels, Belgium	Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB)	Muyldermans, S (corresponding author), Vrije Univ Brussel, Cellular & Mol Immunol Lab, VIB Dept Struct Biol, Pl Laan 2, B-1050 Brussels, Belgium.	svmuylde@vub.ac.be	Muyldermans, Serge/AAC-7374-2019; Saerens, Dirk/B-9162-2008; Muyldermans, Serge V/C-6418-2016; Vincke, Cecile/C-6590-2016	Muyldermans, Serge/0000-0002-3678-3575; Muyldermans, Serge V/0000-0002-3678-3575; Saerens, Dirk/0000-0001-8894-8039; Vincke, Cecile/0000-0003-0681-7444	VIB; Fonds voor wetenschappelijk onderzoek-Vlaanderen (FWO-Vlaanderen); Vrije Universiteit Brussel (Onderzoeksraad and Geconcerteerde Onderzoeks Acties); Instituut voor de aanmoediging van Innovatie door Wetenschap en Technologie in Vlaanderen (IWT-Vlaanderen)	VIB; Fonds voor wetenschappelijk onderzoek-Vlaanderen (FWO-Vlaanderen)(FWO); Vrije Universiteit Brussel (Onderzoeksraad and Geconcerteerde Onderzoeks Acties); Instituut voor de aanmoediging van Innovatie door Wetenschap en Technologie in Vlaanderen (IWT-Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This work was supported in part by the VIB, Fonds voor wetenschappelijk onderzoek-Vlaanderen (FWO-Vlaanderen), and Vrije Universiteit Brussel (Onderzoeksraad and Geconcerteerde Onderzoeks Acties).; Supported by the Instituut voor de aanmoediging van Innovatie door Wetenschap en Technologie in Vlaanderen (IWT-Vlaanderen).	Abkevich VI, 2000, J MOL BIOL, V300, P975, DOI 10.1006/jmbi.2000.3893; Baral TN, 2006, NAT MED, V12, P580, DOI 10.1038/nm1395; BETZ SF, 1993, PROTEIN SCI, V2, P1551, DOI 10.1002/pro.5560021002; Clarke J, 2000, PROTEIN SCI, V9, P2394, DOI 10.1110/ps.9.12.2394; Conrath K, 2005, J MOL BIOL, V350, P112, DOI 10.1016/j.jmb.2005.04.050; Conrath KE, 2003, DEV COMP IMMUNOL, V27, P87, DOI 10.1016/S0145-305X(02)00071-X; Conrath KE, 2001, ANTIMICROB AGENTS CH, V45, P2807, DOI 10.1128/AAC.45.10.2807-2812.2001; Davies J, 1996, PROTEIN ENG, V9, P531, DOI 10.1093/protein/9.6.531; De Genst E, 2004, J BIOL CHEM, V279, P53593, DOI 10.1074/jbc.M407843200; De Genst E, 2002, J BIOL CHEM, V277, P29897, DOI 10.1074/jbc.M202359200; Decanniere K, 2000, J MOL BIOL, V300, P83, DOI 10.1006/jmbi.2000.3839; Desmyter A, 1996, NAT STRUCT BIOL, V3, P803, DOI 10.1038/nsb0996-803; Dove SL, 1997, NATURE, V386, P627, DOI 10.1038/386627a0; Dumoulin M, 2002, PROTEIN SCI, V11, P500, DOI 10.1110/ps.34602; Furukawa K, 1999, IMMUNITY, V11, P329, DOI 10.1016/S1074-7613(00)80108-9; Ghahroudi MA, 1997, FEBS LETT, V414, P521, DOI 10.1016/S0014-5793(97)01062-4; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Johansson J, 2002, J IMMUNOL, V168, P5155, DOI 10.4049/jimmunol.168.10.5155; Jones JM, 2004, IMMUNOL REV, V200, P233, DOI 10.1111/j.0105-2896.2004.00168.x; Kabat E. A., 1991, SEQUENCES PROTEINS I; Kirchhofer A, 2010, NAT STRUCT MOL BIOL, V17, P133, DOI 10.1038/nsmb.1727; Lambert C, 2002, BIOINFORMATICS, V18, P1250, DOI 10.1093/bioinformatics/18.9.1250; Lauwereys M, 1998, EMBO J, V17, P3512, DOI 10.1093/emboj/17.13.3512; Lefranc MP, 2004, MOL IMMUNOL, V40, P647, DOI 10.1016/j.molimm.2003.09.006; LESK AM, 1982, J MOL BIOL, V160, P325, DOI 10.1016/0022-2836(82)90179-6; Li ZQ, 2004, GENE DEV, V18, P1, DOI 10.1101/gad.1161904; Lipovsek D, 2007, J MOL BIOL, V368, P1024, DOI 10.1016/j.jmb.2007.02.029; Manivel V, 2000, IMMUNITY, V13, P611, DOI 10.1016/S1074-7613(00)00061-3; MUYLDERMANS S, 1994, PROTEIN ENG, V7, P1129, DOI 10.1093/protein/7.9.1129; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; Nguyen VK, 1998, J MOL BIOL, V275, P413, DOI 10.1006/jmbi.1997.1477; Nguyen VK, 2000, EMBO J, V19, P921, DOI 10.1093/emboj/19.5.921; Nuttall S. D., 2000, Current Pharmaceutical Biotechnology, V1, P253, DOI 10.2174/1389201003378906; Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200; Rothbauer U, 2006, NAT METHODS, V3, P887, DOI 10.1038/NMETH953; Roux KH, 1998, P NATL ACAD SCI USA, V95, P11804, DOI 10.1073/pnas.95.20.11804; Saerens D, 2004, J BIOL CHEM, V279, P51965, DOI 10.1074/jbc.M409292200; Saerens D, 2005, J MOL BIOL, V352, P597, DOI 10.1016/j.jmb.2005.07.038; Saerens D, 2008, J MOL BIOL, V377, P478, DOI 10.1016/j.jmb.2008.01.022; Saerens D, 2008, J IMMUNOL METHODS, V329, P138, DOI 10.1016/j.jim.2007.10.005; Saerens D, 2008, CURR OPIN PHARMACOL, V8, P600, DOI 10.1016/j.coph.2008.07.006; Scholz O, 2000, EUR J BIOCHEM, V267, P1565, DOI 10.1046/j.1432-1327.2000.01170.x; Serruys B, 2010, J GEN VIROL, V91, P643, DOI 10.1099/vir.0.016063-0; Stanfield RL, 2004, SCIENCE, V305, P1770, DOI 10.1126/science.1101148; Stanfield RL, 2007, J MOL BIOL, V367, P358, DOI 10.1016/j.jmb.2006.12.045; Stijlemans B, 2004, J BIOL CHEM, V279, P1256, DOI 10.1074/jbc.M307341200; Tsai CH, 2007, CURR PROTEIN PEPT SC, V8, P243, DOI 10.2174/138920307780831848; Wedemeyer WJ, 2000, BIOCHEMISTRY-US, V39, P4207, DOI 10.1021/bi992922o; Welker E, 2001, BIOCHEMISTRY-US, V40, P9059, DOI 10.1021/bi010409g; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121	50	96	102	3	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					1970	1979		10.1074/jbc.M111.242818	http://dx.doi.org/10.1074/jbc.M111.242818			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22128183	Green Published, hybrid			2022-12-27	WOS:000299321000038
J	Li, TG; Francl, JM; Boehme, S; Ochoa, A; Zhang, YC; Klaassen, CD; Erickson, SK; Chiang, JYL				Li, Tiangang; Francl, Jessica M.; Boehme, Shannon; Ochoa, Adrian; Zhang, Youcai; Klaassen, Curtis D.; Erickson, Sandra K.; Chiang, John Y. L.			Glucose and Insulin Induction of Bile Acid Synthesis MECHANISMS AND IMPLICATION IN DIABETES AND OBESITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHOLESTEROL 7-ALPHA-HYDROXYLASE GENE; HUMAN HEPATOCYTES; HISTONE ACETYLATION; ENERGY-EXPENDITURE; DIURNAL-VARIATION; RECEPTOR LXR; EXPRESSION; TRANSCRIPTION; METABOLISM; LIVER	Bile acids facilitate postprandial absorption of nutrients. Bile acids also activate the farnesoid X receptor (FXR) and the G protein-coupled receptor TGR5 and play a major role in regulating lipid, glucose, and energy metabolism. Transgenic expression of cholesterol 7 alpha-hydroxylase (CYP7A1) prevented high fat diet-induced diabetes and obesity in mice. In this study, we investigated the nutrient effects on bile acid synthesis. Refeeding of a chow diet to fasted mice increased CYP7A1 expression, bile acid pool size, and serum bile acids in wild type and humanized CYP7A1-transgenic mice. Chromatin immunoprecipitation assays showed that glucose increased histone acetylation and decreased histone methylation on the CYP7A1 gene promoter. Refeeding also induced CYP7A1 in fxr-deficient mice, indicating that FXR signaling did not play a role in postprandial regulation of bile acid synthesis. In streptozocin-induced type I diabetic mice and genetically obese type II diabetic ob/ob mice, hyperglycemia increased histone acetylation status on the CYP7A1 gene promoter, leading to elevated basal Cyp7a1 expression and an enlarged bile acid pool with altered bile acid composition. However, refeeding did not further increase CYP7A1 expression in diabetic mice. In summary, this study demonstrates that glucose and insulin are major postprandial factors that induce CYP7A1 gene expression and bile acid synthesis. Glucose induces CYP7A1 gene expression mainly by epigenetic mechanisms. In diabetic mice, CYP7A1 chromatin is hyperacetylated, and fasting to refeeding response is impaired and may exacerbate metabolic disorders in diabetes.	[Li, Tiangang; Francl, Jessica M.; Boehme, Shannon; Ochoa, Adrian; Chiang, John Y. L.] NE Ohio Med Univ, Dept Integrat Med Sci, Rootstown, OH 44272 USA; [Zhang, Youcai; Klaassen, Curtis D.] Univ Kansas, Dept Pharmacol Toxicol & Therapeut, Med Ctr, Kansas City, KS 66160 USA; [Erickson, Sandra K.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94121 USA; [Erickson, Sandra K.] Vet Affairs Med Ctr, San Francisco, CA 94121 USA	Northeast Ohio Medical University (NEOMED); University of Kansas; University of Kansas Medical Center; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Chiang, JYL (corresponding author), NE Ohio Med Univ, Dept Integrat Med Sci, Rootstown, OH 44272 USA.	jchiang@neomed.edu	Zhang, Youcai/C-9085-2013; zhang, youcai/K-1303-2015; Ferrell, Jessica/AAI-6996-2021; Chiang, John Y. L./G-2658-2011	Ferrell, Jessica/0000-0003-3691-3330; Chiang, John Y. L./0000-0001-9360-7650	National Institutes of Health [R01DK-44442, R37DK-58379, DK-081461, ES-009649, DK-072187]; Veterans Affairs merit award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081461, R37DK058379, R01DK072187, R01DK044442] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES009649] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs merit award(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK-44442 and R37DK-58379 (to J.Y.L.C.), DK-081461 and ES-009649 (to C. D. K.), and DK-072187 (to S. K. E.). This work was also supported by a Veterans Affairs merit award (to S. K. E.).	BENNION LJ, 1977, NEW ENGL J MED, V296, P1365, DOI 10.1056/NEJM197706162962401; Chiang JYL, 2009, J LIPID RES, V50, P1955, DOI 10.1194/jlr.R900010-JLR200; Chiang JYL, 2001, GENE, V262, P257, DOI 10.1016/S0378-1119(00)00518-7; CHIANG JYL, 1990, J BIOL CHEM, V265, P3889; CHIANG JYL, 1991, METHOD ENZYMOL, V206, P483; Duez H, 2008, GASTROENTEROLOGY, V135, P689, DOI 10.1053/j.gastro.2008.05.035; Friis RMN, 2009, NUCLEIC ACIDS RES, V37, P3969, DOI 10.1093/nar/gkp270; Galman C, 2005, GASTROENTEROLOGY, V129, P1445, DOI 10.1053/j.gastro.2005.09.009; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; HEUMAN DM, 1989, J LIPID RES, V30, P719; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Kir S, 2011, SCIENCE, V331, P1621, DOI 10.1126/science.1198363; Lefebvre P, 2009, PHYSIOL REV, V89, P147, DOI 10.1152/physrev.00010.2008; Lehmann JM, 1997, J BIOL CHEM, V272, P3137, DOI 10.1074/jbc.272.6.3137; Li TG, 2005, AM J PHYSIOL-GASTR L, V288, pG74, DOI 10.1152/ajpgi.00258.2004; Li TG, 2007, GASTROENTEROLOGY, V133, P1660, DOI 10.1053/j.gastro.2007.08.042; Li TG, 2006, J BIOL CHEM, V281, P28745, DOI 10.1074/jbc.M605815200; Li TG, 2011, HEPATOLOGY, V53, P996, DOI 10.1002/hep.24107; Li TG, 2010, HEPATOLOGY, V52, P678, DOI 10.1002/hep.23721; Li TG, 2010, J LIPID RES, V51, P832, DOI 10.1194/jlr.M002782; Lundasen T, 2006, J INTERN MED, V260, P530, DOI 10.1111/j.1365-2796.2006.01731.x; Murphy C, 2005, BBA-MOL CELL BIOL L, V1735, P167, DOI 10.1016/j.bbalip.2005.06.001; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; Noshiro M, 2007, J BIOL RHYTHM, V22, P299, DOI 10.1177/0748730407302461; Patti ME, 2009, OBESITY, V17, P1671, DOI 10.1038/oby.2009.102; Pinney SE, 2010, TRENDS ENDOCRIN MET, V21, P223, DOI 10.1016/j.tem.2009.10.002; Pirola L, 2010, NAT REV ENDOCRINOL, V6, P665, DOI 10.1038/nrendo.2010.188; Potthoff MJ, 2011, CELL METAB, V13, P729, DOI 10.1016/j.cmet.2011.03.019; Shaham O, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.50; Shin DJ, 2003, J BIOL CHEM, V278, P50047, DOI 10.1074/jbc.M309736200; Song KH, 2006, HEPATOLOGY, V43, P117, DOI 10.1002/hep.20919; Song KH, 2009, HEPATOLOGY, V49, P297, DOI 10.1002/hep.22627; SUBBIAH MTR, 1984, BIOCHEM BIOPH RES CO, V124, P896, DOI 10.1016/0006-291X(84)91042-8; Thomas C, 2009, CELL METAB, V10, P167, DOI 10.1016/j.cmet.2009.08.001; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Watanabe M, 2011, J BIOL CHEM, V286, P26913, DOI 10.1074/jbc.M111.248203; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Zhang YC, 2010, J LIPID RES, V51, P3230, DOI 10.1194/jlr.M007641; Zhang YKJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016683	40	145	150	1	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					1861	1873		10.1074/jbc.M111.305789	http://dx.doi.org/10.1074/jbc.M111.305789			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22144677	hybrid, Green Published			2022-12-27	WOS:000299321000027
J	Sokolowska, I; Woods, AG; Gawinowicz, MA; Roy, U; Darie, CC				Sokolowska, Izabela; Woods, Alisa G.; Gawinowicz, Mary Ann; Roy, Urmi; Darie, Costel C.			Identification of Potential Tumor Differentiation Factor (TDF) Receptor from Steroid-responsive and Steroid-resistant Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VITELLINE ENVELOPE PROTEINS; HEAT-SHOCK PROTEINS; FACTOR PROCOAGULANT ACTIVITY; FAST INTERACTION REFINEMENT; RAINBOW-TROUT EGG; BLUE NATIVE PAGE; ENDOPLASMIC-RETICULUM; ESTROGEN-RECEPTOR; MASS-SPECTROMETRY; PROSTATE-CANCER	Tumor differentiation factor (TDF) is a recently discovered protein, produced by the pituitary gland and secreted into the bloodstream. TDF and TDF-P1, a 20-amino acid peptide selected from the open reading frame of TDF, induce differentiation in human breast and prostate cancer cells but not in other cells. TDF protein has no identified site of action or receptor, and its mechanism of action is unknown. Here, we used TDF-P1 to purify and identify potential TDF receptor (TDF-R) candidates from MCF7 steroid-responsive breast cancer cells and non-breast HeLa cancerous cells using affinity purification chromatography (AP), and mass spectrometry (MS). We identified four candidate proteins from the 70-kDa heat shock protein (HSP70) family in MCF7 cells. Experiments in non-breast HeLa cancerous cells did not identify any TDF-R candidates. AP and MS experiments were validated by AP and Western blotting (WB). We additionally looked for TDF-R in steroid-resistant BT-549 cells and human dermal fibroblasts (HDF-a) using AP and WB. TDF-P1 interacts with potential TDF-R candidates from MCF7 and BT-549 breast cells but not from HeLa or HDF-a cells. Immunofluorescence (IF) experiments identified GRP78, a TDF-R candidate, at the cell surface of MCF7, BT-549 breast cells, and HeLa cells but not HDF-a cells. IF of other HSP70 proteins demonstrated labeling on all four cell types. These results point toward GRP78 and HSP70 proteins as strong TDF-R candidates and suggest that TDF interacts with its receptor, exclusively on breast cells, through a steroid-independent pathway.	[Sokolowska, Izabela; Woods, Alisa G.; Roy, Urmi; Darie, Costel C.] Clarkson Univ, Dept Chem & Biomol Sci, Biochem & Prote Grp, Potsdam, NY 13699 USA; [Gawinowicz, Mary Ann] Columbia Univ, Coll Phys & Surg, Prot Core Facil, New York, NY 10032 USA	Clarkson University; Columbia University	Darie, CC (corresponding author), Clarkson Univ, Dept Chem & Biomol Sci, Biochem & Prote Grp, 8 Clarkson Ave, Potsdam, NY 13699 USA.	cdarie@clarkson.edu	Roy, Urmi/ABG-3629-2020; Darie, Costel/F-1274-2011	Roy, Urmi/0000-0003-0928-0574; Darie, Costel C./0000-0001-6402-2311	Clarkson University; United States Army Research Office through the Defense University Research Instrumentation Program [W911NF-11-1-0304]	Clarkson University; United States Army Research Office through the Defense University Research Instrumentation Program	This work was supported in part by a start-up grant provided by Clarkson University (to C. C. D.) and by support from the United States Army Research Office through the Defense University Research Instrumentation Program (DURIP Grant W911NF-11-1-0304).	Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Al-Hashimi AA, 2010, J BIOL CHEM, V285, P28912, DOI 10.1074/jbc.M110.119107; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andrusier N, 2007, PROTEINS, V69, P139, DOI 10.1002/prot.21495; Arap MA, 2004, CANCER CELL, V6, P275, DOI 10.1016/j.ccr.2004.08.018; Awad W, 2008, P NATL ACAD SCI USA, V105, P1164, DOI 10.1073/pnas.0702132105; BRABANT G, 1993, CANCER RES, V53, P4987; Calvert Meredith E, 2003, Reprod Biol Endocrinol, V1, P27, DOI 10.1186/1477-7827-1-27; Daneshmand S, 2007, HUM PATHOL, V38, P1547, DOI 10.1016/j.humpath.2007.03.014; Darie CC, 2004, BIOCHEMISTRY-US, V43, P7459, DOI 10.1021/bi0495937; Darie CC, 2005, J BIOL CHEM, V280, P37585, DOI 10.1074/jbc.M506709200; Darie CC, 2005, FEBS J, V272, P2705, DOI 10.1111/j.1742-4658.2005.04685.x; Darie CC, 2008, NATO SCI PEACE SEC A, P3, DOI 10.1007/978-1-4020-8811-7_1; Darie CC, 2008, NATO SCI PEACE SEC A, P23, DOI 10.1007/978-1-4020-8811-7_2; Darie CC, 2008, BBA-PROTEINS PROTEOM, V1784, P385, DOI 10.1016/j.bbapap.2007.10.011; Darie CC, 2011, PROTEOMICS, V11, P4514, DOI 10.1002/pmic.201000819; DeLeeuw WJF, 1997, J PATHOL, V183, P404, DOI 10.1002/(SICI)1096-9896(199712)183:4<404::AID-PATH1148>3.0.CO;2-9; Delpino A, 2002, BIOSCIENCE REP, V22, P407, DOI 10.1023/A:1020966008615; Delpino A, 1998, MOL MEMBR BIOL, V15, P21, DOI 10.3109/09687689809027514; Didelot C, 2007, CURR MED CHEM, V14, P2839, DOI 10.2174/092986707782360079; Dul JL, 2001, J CELL BIOL, V152, P705, DOI 10.1083/jcb.152.4.705; EDELMAN GM, 1991, ANNU REV BIOCHEM, V60, P155, DOI 10.1146/annurev.bi.60.070191.001103; FRIXEN UH, 1991, J CELL BIOL, V113, P173, DOI 10.1083/jcb.113.1.173; Fu Y, 2006, CANCER BIOL THER, V5, P741, DOI 10.4161/cbt.5.7.2970; Graner MW, 2009, CANCER SCI, V100, P1870, DOI 10.1111/j.1349-7006.2009.01269.x; Hafker T, 1998, MICROBIOL-UK, V144, P37, DOI 10.1099/00221287-144-1-37; Hetenyi C, 2002, PROTEIN SCI, V11, P1729, DOI 10.1110/ps.0202302; Jang JH, 2003, PROTEOMICS, V3, P1947, DOI 10.1002/pmic.200300563; Jensen MR, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1996; Jiang HF, 2007, BBA-MOL CELL BIOL L, V1771, P66, DOI 10.1016/j.bbalip.2006.10.004; Jiang JW, 2005, MOL CELL, V20, P513, DOI 10.1016/j.molcel.2005.09.028; Jorgensen MM, 2000, J BIOL CHEM, V275, P33861, DOI 10.1074/jbc.M004663200; Katanasaka Y, 2010, INT J CANCER, V127, P2685, DOI 10.1002/ijc.25276; Kelber JA, 2009, ONCOGENE, V28, P2324, DOI 10.1038/onc.2009.97; Lanneau D, 2007, PRION, V1, P53, DOI 10.4161/pri.1.1.4059; Lee AS, 2007, CANCER RES, V67, P3496, DOI 10.1158/0008-5472.CAN-07-0325; Levin ER, 2005, MOL ENDOCRINOL, V19, P1951, DOI 10.1210/me.2004-0390; Li JZ, 2006, CURR MOL MED, V6, P45, DOI 10.2174/156652406775574523; Liu Y, 2007, MOL PHARMACEUT, V4, P435, DOI 10.1021/mp060122j; Macias AT, 2011, J MED CHEM, V54, P4034, DOI 10.1021/jm101625x; Mashiach E, 2008, NUCLEIC ACIDS RES, V36, pW229, DOI 10.1093/nar/gkn186; Misra UK, 2011, J BIOL CHEM, V286, P1248, DOI 10.1074/jbc.M110.129767; Misra UK, 2010, CANCER BIOL THER, V9, P142, DOI 10.4161/cbt.9.2.10422; Nair SC, 1996, CELL STRESS CHAPERON, V1, P237, DOI 10.1379/1466-1268(1996)001<0237:APOMCI>2.3.CO;2; NEMOTO T, 1992, J STEROID BIOCHEM, V42, P803, DOI 10.1016/0960-0760(92)90088-Z; Ni M, 2011, BIOCHEM J, V434, P181, DOI 10.1042/BJ20101569; Ni M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006868; Nilsson S, 2002, CRIT REV EUKAR GENE, V12, P237, DOI 10.1615/CritRevEukaryotGeneExpr.v12.i4.10; Nilsson S, 2001, PHYSIOL REV, V81, P1535, DOI 10.1152/physrev.2001.81.4.1535; Pfaffenbach KT, 2011, CURR OPIN CELL BIOL, V23, P150, DOI 10.1016/j.ceb.2010.09.007; PFEFFER U, 1995, CANCER RES, V55, P2158; Platica M, 2004, P NATL ACAD SCI USA, V101, P1560, DOI 10.1073/pnas.0307829100; PLATICA M, 1992, ENDOCRINOLOGY, V131, P2573, DOI 10.1210/en.131.6.2573; Quinones QJ, 2008, HISTOL HISTOPATHOL, V23, P1409, DOI 10.14670/HH-23.1409; Rauschert N, 2008, LAB INVEST, V88, P375, DOI 10.1038/labinvest.2008.2; RAY DB, 1981, ENDOCRINOLOGY, V108, P573, DOI 10.1210/endo-108-2-573; Saba JA, 2007, J PROTEOME RES, V6, P2211, DOI 10.1021/pr070031u; SANCHEZ ER, 1990, BIOCHEMISTRY-US, V29, P5145, DOI 10.1021/bi00473a021; Sato M, 2010, ADV GENET, V69, P97, DOI 10.1016/S0065-2660(10)69006-2; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Schwarze S, 2010, CANCER BIOL THER, V9, P153, DOI 10.4161/cbt.9.2.10760; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shida M, 2010, ACTA CRYSTALLOGR D, V66, P223, DOI 10.1107/S0907444909053979; Solit DB, 2006, CURR TOP MED CHEM, V6, P1205, DOI 10.2174/156802606777812068; SOMMERS CL, 1991, CELL GROWTH DIFFER, V2, P365; Spellman DS, 2008, MOL CELL PROTEOMICS, V7, P1067, DOI 10.1074/mcp.M700387-MCP200; THEAN ET, 1990, BRIT J CANCER, V61, P773, DOI 10.1038/bjc.1990.173; Tovchigrechko A, 2005, PROTEINS, V60, P296, DOI 10.1002/prot.20573; Tovchigrechko A, 2006, NUCLEIC ACIDS RES, V34, pW310, DOI 10.1093/nar/gkl206; VELDSCHOLTE J, 1992, BIOCHEMISTRY-US, V31, P2393, DOI 10.1021/bi00123a026; VELDSCHOLTE J, 1992, BIOCHEMISTRY-US, V31, P742, DOI 10.1021/bi00147a029; Vladusic EA, 2000, ONCOL REP, V7, P157; VLEMINCKX K, 1991, CELL, V66, P107, DOI 10.1016/0092-8674(91)90143-M; Watson LM, 2003, J BIOL CHEM, V278, P17438, DOI 10.1074/jbc.M301006200; Wolfson H, 2002, LECT NOTES COMPUTER; Zhang LH, 2011, BRAIN RES, V1371, P23, DOI 10.1016/j.brainres.2010.11.063; Zhang LH, 2010, J CELL BIOCHEM, V110, P1299, DOI 10.1002/jcb.22679; Zhang Y, 2010, J BIOL CHEM, V285, P15065, DOI 10.1074/jbc.M109.087445	78	40	41	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					1719	1733		10.1074/jbc.M111.284091	http://dx.doi.org/10.1074/jbc.M111.284091			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22130669	Green Published, hybrid			2022-12-27	WOS:000299321000015
J	Wilhelm, M; Kukekov, NV; Schmit, TL; Biagas, KV; Sproul, AA; Gire, S; Maes, ME; Xu, ZH; Greene, LA				Wilhelm, Michael; Kukekov, Nickolay V.; Schmit, Travis L.; Biagas, Katherine V.; Sproul, Andrew A.; Gire, Stephen; Maes, Margaret E.; Xu, Zhiheng; Greene, Lloyd A.			Sh3rf2/POSHER Protein Promotes Cell Survival by Ring-mediated Proteasomal Degradation of the c-Jun N-terminal Kinase Scaffold POSH (Plenty of SH3s) Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JNK ACTIVATION; SYMPATHETIC NEURONS; PEPTIDE INHIBITOR; CEREBRAL-ISCHEMIA; APOPTOSIS; DEATH; PATHWAY; STRESS; IDENTIFICATION; EXCITOTOXICITY	We report that Sh3rf2, a homologue of the pro-apoptotic scaffold POSH (Plenty of SH3s), acts as an anti-apoptotic regulator for the c-Jun N-terminal kinase (JNK) pathway. siRNA-mediated knockdown of Sh3rf2 promotes apoptosis of neuronal PC12 cells, cultured cortical neurons, and C6 glioma cells. This death appears to result from activation of JNK signaling. Loss of Sh3rf2 triggers activation of JNK and its target c-Jun. Also, apoptosis promoted by Sh3rf2 knockdown is inhibited by dominant-negative c-Jun as well as by a JNK inhibitor. Investigation of the mechanism by which Sh3rf2 regulates cell survival implicates POSH, a scaffold required for activation of pro-apoptotic JNK/c-Jun signaling. In cells lacking POSH, Sh3rf2 knockdown is unable to activate JNK. We further find that Sh3rf2 binds POSH to reduce its levels by a mechanism that requires the RING domains of both proteins and that appears to involve proteasomal POSH degradation. Conversely, knockdown of Sh3rf2 promotes the stabilization of POSH protein and activation of JNK signaling. Finally, we show that endogenous Sh3rf2 protein rapidly decreases following several different apoptotic stimuli and that knockdown of Sh3rf2 activates the proapoptotic JNK pathway in neuronal cells. These findings support a model in which Sh3rf2 promotes proteasomal degradation of pro-apoptotic POSH in healthy cells and in which apoptotic stimuli lead to rapid loss of Sh3rf2 expression, and consequently to stabilization of POSH and JNK activation and cell death. On the basis of these observations, we propose the alter-native name POSHER (POSH-eliminating RING protein) for the Sh3rf2 protein.	[Wilhelm, Michael; Schmit, Travis L.; Maes, Margaret E.] Univ Wisconsin Madison, Dept Pediat, Madison, WI 53792 USA; [Wilhelm, Michael; Biagas, Katherine V.; Gire, Stephen] Columbia Univ Hlth Sci, Dept Pediat, New York, NY 10032 USA; [Kukekov, Nickolay V.; Sproul, Andrew A.; Xu, Zhiheng; Greene, Lloyd A.] Columbia Univ Hlth Sci, Dept Pathol & Cell Biol, New York, NY 10032 USA	University of Wisconsin System; University of Wisconsin Madison; Columbia University; Columbia University	Wilhelm, M (corresponding author), Univ Wisconsin Madison, Dept Pediat, H4-411 CSC,600 Highland Ave, Madison, WI 53792 USA.	mwilhelm@pediatrics.wisc.edu		Biagas, Katherine/0000-0002-4669-703X; Sproul, Andrew/0000-0001-6972-1592; Xu, Zhiheng/0000-0002-4809-2851; Maes, Margaret/0000-0001-9642-1085	National Institutes of Health [5RO1NS033689, 5PO1 NS38370]; National Basic Research Program of China 973 Program [2006CB504100/2006CB500701]; National Institutes of Health NICHD [K12-HD00850]; Child Health Research Career Development Award [K12-HD043389-02]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD000850, P30HD003352] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K12HD043389] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025011] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033689, P50NS038370] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Basic Research Program of China 973 Program(National Basic Research Program of China); National Institutes of Health NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Child Health Research Career Development Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants 5RO1NS033689 and 5PO1 NS38370 (to L. A. G.) and National Basic Research Program of China 973 Program number 2006CB504100/2006CB500701 (to Z. X.).; Supported by the Pediatric Scientist Development Program, National Institutes of Health NICHD Grant K12-HD00850 and Child Health Research Career Development Award K12-HD043389-02.	Borsello T, 2003, NAT MED, V9, P1180, DOI 10.1038/nm911; Bruckner SR, 2001, J NEUROCHEM, V78, P298, DOI 10.1046/j.1471-4159.2001.00400.x; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; CHOI KY, 1994, CELL, V78, P499; Choi WS, 1999, J NEUROSCI RES, V57, P86, DOI 10.1002/(SICI)1097-4547(19990701)57:1<86::AID-JNR9>3.0.CO;2-E; Dickens M, 1997, SCIENCE, V277, P693, DOI 10.1126/science.277.5326.693; Dong ZH, 2005, MOL BRAIN RES, V134, P282, DOI 10.1016/j.molbrainres.2004.10.039; Karkkainen S, 2006, EMBO REP, V7, P186, DOI 10.1038/sj.embor.7400596; Kim GH, 2006, CELL SIGNAL, V18, P553, DOI 10.1016/j.cellsig.2005.05.026; Kuan CY, 2005, CNS NEUROL DISORD-DR, V4, P63, DOI 10.2174/1568007053005145; Kuan CY, 2003, P NATL ACAD SCI USA, V100, P15184, DOI 10.1073/pnas.2336254100; Kuan CY, 1999, NEURON, V22, P667, DOI 10.1016/S0896-6273(00)80727-8; Kukekov NV, 2006, J BIOL CHEM, V281, P15517, DOI 10.1074/jbc.M601056200; Maroney AC, 1999, J NEUROCHEM, V73, P1901; Pirianov G, 2007, J CEREBR BLOOD F MET, V27, P1022, DOI 10.1038/sj.jcbfm.9600413; Tapon N, 1998, EMBO J, V17, P1395, DOI 10.1093/emboj/17.5.1395; Troy CM, 2001, J NEUROCHEM, V77, P157, DOI 10.1046/j.1471-4159.2001.00218.x; Vande Walle L, 2008, CELL DEATH DIFFER, V15, P453, DOI 10.1038/sj.cdd.4402291; Wang J, 2003, J NEUROSCI, V23, P8596; Westmark CJ, 2007, PLOS BIOL, V5, P629, DOI 10.1371/journal.pbio.0050052; Whitmarsh AJ, 2001, GENE DEV, V15, P2421, DOI 10.1101/gad.922801; Wilhelm M, 2007, DEV NEUROSCI-BASEL, V29, P355, DOI 10.1159/000105476; Wilhelm M, 2007, J BIOL CHEM, V282, P1288, DOI 10.1074/jbc.M607038200; Xu ZH, 2005, MOL CELL BIOL, V25, P9949, DOI 10.1128/MCB.25.22.9949-9959.2005; Xu ZH, 2006, J BIOL CHEM, V281, P303, DOI 10.1074/jbc.M509060200; Xu ZH, 2003, EMBO J, V22, P252, DOI 10.1093/emboj/cdg021; Yang DD, 1997, NATURE, V389, P865, DOI 10.1038/39899; Yasuda J, 1999, MOL CELL BIOL, V19, P7245; Zhang QG, 2005, J NEUROCHEM, V95, P784, DOI 10.1111/j.1471-4159.2005.03435.x	29	23	29	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					2247	2256		10.1074/jbc.M111.269431	http://dx.doi.org/10.1074/jbc.M111.269431			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22128169	Green Published, hybrid			2022-12-27	WOS:000299321000062
J	Casillas-Ituarte, NN; Lower, BH; Lamlertthon, S; Fowler, VG; Lower, SK				Casillas-Ituarte, Nadia N.; Lower, Brian H.; Lamlertthon, Supaporn; Fowler, Vance G., Jr.; Lower, Steven K.			Dissociation Rate Constants of Human Fibronectin Binding to Fibronectin-binding Proteins on Living Staphylococcus aureus Isolated from Clinical Patients	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DYNAMIC FORCE SPECTROSCOPY; DEVICE-RELATED INFECTIONS; TANDEM BETA-ZIPPER; LACTOCOCCUS-LACTIS; ENERGY LANDSCAPES; SINGLE; BONDS; ADHESION; SURFACE; ENDOCARDITIS	Staphylococcus aureus is part of the indigenous microbiota of humans. Sometimes, S. aureus bacteria enter the bloodstream, where they form infections on implanted cardiovascular devices. A critical, first step in such infections is a bond that forms between fibronectin-binding protein (FnBP) on S. aureus and host proteins, such as fibronectin (Fn), that coat the surface of implants in vivo. In this study, native FnBPs on living S. aureus were shown to form a mechanically strong conformational structure with Fn by atomic force microscopy. The tensile acuity of this bond was probed for 46 bloodstream isolates, each from a patient with a cardiovascular implant. By analyzing the force spectra with the worm-like chain model, we determined that the binding events were consistent with a multivalent, cluster bond consisting of similar to 10 or similar to 80 proteins in parallel. The dissociation rate constant (k(off), s(-1)) of each multibond complex was determined by measuring strength as a function of the loading rate, normalized by the number of bonds. The bond lifetime (1/k(off)) was two times longer for bloodstream isolates from patients with an infected device (1.79 or 69.47 s for the 10- or 80-bond clusters, respectively; n = 26 isolates) relative to those from patients with an uninfected device (0.96 or 34.02 s; n = 20 isolates). This distinction could not be explained by different amounts of FnBP, as confirmed by Western blots. Rather, amino acid polymorphisms within the Fn-binding repeats of FnBPA explain, at least partially, the statistically (p < 0.05) longer bond lifetime for isolates associated with an infected cardiovascular device.	[Lower, Steven K.] Ohio State Univ, Mendenhall Lab 275, Columbus, OH 43210 USA; [Lamlertthon, Supaporn; Fowler, Vance G., Jr.] Duke Univ, Med Ctr, Durham, NC 27710 USA; [Lamlertthon, Supaporn] Naresuan Univ, Phitsanulok 65000, Thailand	University System of Ohio; Ohio State University; Duke University; Naresuan University	Lower, SK (corresponding author), Ohio State Univ, Mendenhall Lab 275, 125 S Oval Mall, Columbus, OH 43210 USA.	Lower.9@osu.edu	Fowler, Vance/AAW-2017-2021; Lower, Steven/A-2440-2008	Lower, Steven/0000-0001-9796-0830; Lower, Brian/0000-0002-2581-548X; Lamlertthon, Supaporn/0000-0002-5504-3433	National Institutes of Health [R21HL086593, R01AI068804, K24AI093969]; National Science Foundation [EAR0745808]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL086593] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI093969, R01AI068804] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health Grant R21HL086593 (to S.K.L.). This work was also supported by National Science Foundation Grant EAR0745808 (to S.K.L.).; Supported by National Institutes of Health Grants R01AI068804 and K24AI093969.	Arrecubieta C, 2006, J INFECT DIS, V193, P1109, DOI 10.1086/501366; Baddour LM, 2010, CIRCULATION, V121, P458, DOI 10.1161/CIRCULATIONAHA.109.192665; Baumgartner W, 2000, ULTRAMICROSCOPY, V82, P85, DOI 10.1016/S0304-3991(99)00154-0; Baumgartner W, 2000, P NATL ACAD SCI USA, V97, P4005, DOI 10.1073/pnas.070052697; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Bingham RJ, 2008, P NATL ACAD SCI USA, V105, P12254, DOI 10.1073/pnas.0803556105; Bisognano C, 1997, ANTIMICROB AGENTS CH, V41, P906, DOI 10.1128/AAC.41.5.906; Buck AW, 2010, LANGMUIR, V26, P10764, DOI 10.1021/la100549u; Bustanji Y, 2003, P NATL ACAD SCI USA, V100, P13292, DOI 10.1073/pnas.1735343100; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694; Chandran KB, 1998, ANN BIOMED ENG, V26, P546, DOI 10.1114/1.79; Cheung LSL, 2011, BIOPHYS J, V100, P2338, DOI 10.1016/j.bpj.2011.04.013; Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415; Dietz H, 2004, P NATL ACAD SCI USA, V101, P16192, DOI 10.1073/pnas.0404549101; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; ENGEL J, 1981, J MOL BIOL, V150, P97, DOI 10.1016/0022-2836(81)90326-0; ERICKSON HP, 1981, J CELL BIOL, V91, P673, DOI 10.1083/jcb.91.3.673; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; Evans E, 1998, FARADAY DISCUSS, V111, P1; Evans E, 2001, P NATL ACAD SCI USA, V98, P3784, DOI 10.1073/pnas.061324998; Foster TJ, 1998, TRENDS MICROBIOL, V6, P484, DOI 10.1016/S0966-842X(98)01400-0; FROMAN G, 1987, J BIOL CHEM, V262, P6564; Gomez-Casado A, 2011, J AM CHEM SOC, V133, P10849, DOI 10.1021/ja2016125; Gordon RJ, 2008, CLIN INFECT DIS, V46, pS350, DOI 10.1086/533591; GREENE C, 1995, MOL MICROBIOL, V17, P1143, DOI 10.1111/j.1365-2958.1995.mmi_17061143.x; Grundmeier M, 2004, INFECT IMMUN, V72, P7155, DOI 10.1128/IAI.72.12.7155-7163.2004; Habib G, 2009, EUR HEART J, V30, P2369, DOI 10.1093/eurheartj/ehp285; Hanley W, 2003, J BIOL CHEM, V278, P10556, DOI 10.1074/jbc.M213233200; Hanley WD, 2004, J CELL SCI, V117, P2503, DOI 10.1242/jcs.01088; Henderson B, 2011, FEMS MICROBIOL REV, V35, P147, DOI 10.1111/j.1574-6976.2010.00243.x; HousePompeo K, 1996, J BIOL CHEM, V271, P1379, DOI 10.1074/jbc.271.3.1379; Kellermayer MSZ, 1997, SCIENCE, V276, P1112, DOI 10.1126/science.276.5315.1112; KUUSELA P, 1984, INFECT IMMUN, V45, P433, DOI 10.1128/IAI.45.2.433-436.1984; Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753; Lower BH, 2005, J BACTERIOL, V187, P2127, DOI 10.1128/JB.187.6.2127-2137.2005; Lower BH, 2007, J BACTERIOL, V189, P4944, DOI 10.1128/JB.01518-06; Lower SK, 2011, P NATL ACAD SCI USA, V108, P18372, DOI 10.1073/pnas.1109071108; Lower SK, 2010, BIOPHYS J, V99, P2803, DOI 10.1016/j.bpj.2010.08.063; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Margey R, 2010, EUROPACE, V12, P64, DOI 10.1093/europace/eup362; Meenan NAG, 2007, J BIOL CHEM, V282, P25893, DOI 10.1074/jbc.M703063200; Mosher DF, 2006, ARTERIOSCL THROM VAS, V26, P1193, DOI 10.1161/01.ATV.0000223342.15969.7a; Mueller H, 1999, BIOPHYS J, V76, P1072, DOI 10.1016/S0006-3495(99)77272-3; Muller DJ, 1999, P NATL ACAD SCI USA, V96, P13170, DOI 10.1073/pnas.96.23.13170; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Peacock SJ, 1999, MICROBIOL-SGM, V145, P3477, DOI 10.1099/00221287-145-12-3477; PROCTOR RA, 1982, J BIOL CHEM, V257, P4788; Provenza G, 2010, FEBS J, V277, P4490, DOI 10.1111/j.1742-4658.2010.07835.x; Que YA, 2001, INFECT IMMUN, V69, P6296, DOI 10.1128/IAI.69.10.6296-6302.2001; Que YA, 2005, J EXP MED, V201, P1627, DOI 10.1084/jem.20050125; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Ros R, 1998, P NATL ACAD SCI USA, V95, P7402, DOI 10.1073/pnas.95.13.7402; SAKATA N, 1994, J BIOCHEM-TOKYO, V115, P843, DOI 10.1093/oxfordjournals.jbchem.a124427; Schwarz-Linek U, 2003, NATURE, V423, P177, DOI 10.1038/nature01589; Schwarz-Linek U, 2004, MOL MICROBIOL, V52, P631, DOI 10.1111/j.1365-2958.2004.04027.x; Schwesinger F, 2000, P NATL ACAD SCI USA, V97, P9972, DOI 10.1073/pnas.97.18.9972; Strunz T, 1999, P NATL ACAD SCI USA, V96, P11277, DOI 10.1073/pnas.96.20.11277; Sulchek TA, 2005, P NATL ACAD SCI USA, V102, P16638, DOI 10.1073/pnas.0505208102; Sulchek T, 2006, BIOPHYS J, V90, P4686, DOI 10.1529/biophysj.105.080291; Tees DFJ, 2001, BIOPHYS J, V80, P668, DOI 10.1016/S0006-3495(01)76047-X; Teulon JM, 2011, J MOL RECOGNIT, V24, P490, DOI 10.1002/jmr.1109; Tortonese M, 1997, P SOC PHOTO-OPT INS, V3009, P53, DOI 10.1117/12.271229; Voigt A, 2006, J AM COLL CARDIOL, V48, P590, DOI 10.1016/j.jacc.2006.05.016; Wang A, 2007, JAMA-J AM MED ASSOC, V297, P1354, DOI 10.1001/jama.297.12.1354; Williams PM, 2003, ANAL CHIM ACTA, V479, P107, DOI 10.1016/S0003-2670(02)01569-6; Yongsunthon R, 2007, LANGMUIR, V23, P2289, DOI 10.1021/la063117v; Zhang XH, 2002, BIOPHYS J, V83, P2270, DOI 10.1016/S0006-3495(02)73987-8	68	28	28	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6693	6701		10.1074/jbc.M111.285692	http://dx.doi.org/10.1074/jbc.M111.285692			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22219202	hybrid, Green Published			2022-12-27	WOS:000300791800055
J	Zhang, LP; Dong, YJ; Dong, YL; Cheng, JZ; Du, J				Zhang, Liping; Dong, Yanjun; Dong, Yanlan; Cheng, Jizhong; Du, Jie			Role of Integrin-beta 3 Protein in Macrophage Polarization and Regeneration of Injured Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE; MUSCULAR-DYSTROPHY; FIBROSIS; EXPRESSION; MICE; ACTIVATION; MECHANISMS; ATROPHY; CELLS	Following injury, skeletal muscle achieves repair by a highly coordinated, dynamic process resulting from interplay among numerous inflammatory, growth factors and myogenic regulators. To identify genes involved in muscle regeneration, we used a microarray analysis; there was a significant increase in the expression of a group of integrin genes. To verify these results, we used RT-PCR and Western blotting and found that 12 integrins were up-regulated from 3 h to 15 days following injury. Following muscle injury, integrin-beta 3 was initially expressed, mainly in macrophages. In integrin-beta 3 global KO mice, the expression of myogenic genes was decreased and muscle regeneration was impaired, whereas fibrosis was enhanced versus events in wild type (WT) mice. The mechanism for these responses in integrin-beta 3 KO mice included an infiltration of macrophages that were polarized into the M2 phenotype. These macrophages produced more TGF-beta 1 and increased TGF-beta 1/Smad signaling. In vitro, we confirmed that M2 macrophages lacking integrin-beta 3 produced more TGF-beta 1. Furthermore, transplantation of bone marrow cells from integrin-beta 3 KO mice into WT mice led to suppression of the infiltration and accumulation of macrophages into injured muscles. There was also impaired muscle regeneration with an increase in muscle fibrosis. Our results demonstrate that integrin-beta 3 plays a fundamental role in muscle regeneration through a regulation of macrophage infiltration and polarization leading to suppressed TGF-beta 1 production. This promotes efficient muscle regeneration. Thus, an improvement in integrin-beta 3 function could stimulate muscle regeneration.	[Zhang, Liping; Dong, Yanjun; Dong, Yanlan; Cheng, Jizhong] Baylor Coll Med, Dept Med, Div Nephrol, Houston, TX 77030 USA; [Du, Jie] Capital Med Univ, Minist Educ, Beijing Anzhen Hosp, Key Lab Remodeling Related Cardiovasc Dis, Beijing 100029, Peoples R China	Baylor College of Medicine; Capital Medical University	Zhang, LP (corresponding author), Baylor Coll Med, Dept Med, Div Nephrol, Houston, TX 77030 USA.	lipingz@bcm.edu		Dong, Yanjun/0000-0001-6396-8949	National Institutes of Health [R37 DK37175]; Satellite Health; American Diabetic Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK037175] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Satellite Health; American Diabetic Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R37 DK37175 (to W. E. Mitch). This work was also supported by a Norman S. Coplon extramural research grant from the Satellite Health and American Diabetic Association (to L. Z.) and by the generous support of Dr. and Mrs. Harold Selzman.	Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Bastos KRB, 2002, J LEUKOCYTE BIOL, V71, P271; Desguerre I, 2009, J NEUROPATH EXP NEUR, V68, P762, DOI 10.1097/NEN.0b013e3181aa31c2; Dumont N, 2010, AM J PATHOL, V176, P2228, DOI 10.2353/ajpath.2010.090884; Li Y, 2004, AM J PATHOL, V164, P1007, DOI 10.1016/S0002-9440(10)63188-4; Liu HJ, 2011, FASEB J, V25, P1914, DOI 10.1096/fj.10-170449; Longbrake EE, 2007, J NEUROCHEM, V102, P1083, DOI 10.1111/j.1471-4159.2007.04617.x; Marino JS, 2008, AM J PHYSIOL-CELL PH, V295, pC1026, DOI 10.1152/ajpcell.212.2008; Mayer U, 1997, NAT GENET, V17, P318, DOI 10.1038/ng1197-318; Reynolds LE, 2005, NAT MED, V11, P167, DOI 10.1038/nm1165; RIEU P, 1993, J LEUKOCYTE BIOL, V53, P576, DOI 10.1002/jlb.53.5.576; Runyan CE, 2003, AM J PHYSIOL-RENAL, V285, pF413, DOI 10.1152/ajprenal.00082.2003; Segawa M, 2008, EXP CELL RES, V314, P3232, DOI 10.1016/j.yexcr.2008.08.008; Serrano AL, 2010, EXP CELL RES, V316, P3050, DOI 10.1016/j.yexcr.2010.05.035; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sierra-Filardi E, 2011, BLOOD, V117, P5092, DOI 10.1182/blood-2010-09-306993; Sorokin LM, 2000, EXP CELL RES, V256, P500, DOI 10.1006/excr.2000.4842; Taverna D, 1998, J CELL BIOL, V143, P849, DOI 10.1083/jcb.143.3.849; Tidball JG, 2010, AM J PHYSIOL-REG I, V298, pR1173, DOI 10.1152/ajpregu.00735.2009; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vidal B, 2008, GENE DEV, V22, P1747, DOI 10.1101/gad.465908; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Zhang LP, 2010, J AM SOC NEPHROL, V21, P419, DOI 10.1681/ASN.2009060571; Zhang LP, 2009, AM J PATHOL, V175, P2518, DOI 10.2353/ajpath.2009.090275; Zhang LP, 2009, J AM SOC NEPHROL, V20, P604, DOI 10.1681/ASN.2008060628	25	28	29	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6177	6186		10.1074/jbc.M111.292649	http://dx.doi.org/10.1074/jbc.M111.292649			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22210777	Green Published, hybrid			2022-12-27	WOS:000300791800011
J	Bonente, G; Pippa, S; Castellano, S; Bassi, R; Ballottari, M				Bonente, Giulia; Pippa, Sara; Castellano, Stefania; Bassi, Roberto; Ballottari, Matteo			Acclimation of Chlamydomonas reinhardtii to Different Growth Irradiances	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-HARVESTING COMPLEXES; PHOTOSYSTEM-II ANTENNA; NONPHOTOCHEMICAL ENERGY-DISSIPATION; CHLOROPHYLL-A/B PROTEINS; CYCLIC ELECTRON FLOW; PHOTOSYNTHETIC APPARATUS; STATE TRANSITIONS; LESS MUTANT; IN-VIVO; CHLOROPLAST	We report on the changes the photosynthetic apparatus of Chlamydomonas reinhardtii undergoes upon acclimation to different light intensity. When grown in high light, cells had a faster growth rate and higher biomass production compared with low and control light conditions. However, cells acclimated to low light intensity are indeed able to produce more biomass per photon available as compared with high light-acclimated cells, which dissipate as heat a large part of light absorbed, thus reducing their photosynthetic efficiency. This dissipative state is strictly dependent on the accumulation of LhcSR3, a protein related to light-harvesting complexes, responsible for nonphotochemical quenching in microalgae. Other changes induced in the composition of the photosynthetic apparatus upon high light acclimation consist of an increase of carotenoid content on a chlorophyll basis, particularly zeaxanthin, and a major down-regulation of light absorption capacity by decreasing the chlorophyll content per cell. Surprisingly, the antenna size of both photosystem I and II is not modulated by acclimation; rather, the regulation affects the PSI/PSII ratio. Major effects of the acclimation to low light consist of increased activity of state 1 and 2 transitions and increased contributions of cyclic electron flow.	[Bonente, Giulia; Pippa, Sara; Castellano, Stefania; Bassi, Roberto; Ballottari, Matteo] Univ Verona, Dipartimento Biotecnol, I-37134 Verona, Italy; [Bassi, Roberto] KFA Julich GmbH, Inst Bio & Geowissensch IBG 2, D-52425 Julich, Germany	University of Verona; Helmholtz Association; Research Center Julich	Bassi, R (corresponding author), Univ Verona, Dipartimento Biotecnol, CaVignal 1,Str Grazie 15, I-37134 Verona, Italy.	roberto.bassi@univr.it	Ballottari, Matteo/N-1916-2019	Ballottari, Matteo/0000-0001-8410-3397; bassi, roberto/0000-0002-4140-8446	European Union [245070]	European Union(European Commission)	This work was supported by European Union Project 245070 FP7-KBBE-2009-3 SUNBIOPATH.	Ahn TK, 2008, SCIENCE, V320, P794, DOI 10.1126/science.1154800; Alboresi A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002033; ALLEN KD, 1994, PLANTA, V194, P42; Alric J, 2010, PHOTOSYNTH RES, V106, P47, DOI 10.1007/s11120-010-9566-4; Alric J, 2010, BBA-BIOENERGETICS, V1797, P44, DOI 10.1016/j.bbabio.2009.07.009; Aluru MR, 2006, J EXP BOT, V57, P1871, DOI 10.1093/jxb/erj008; Andersson J, 2003, PLANT J, V35, P350, DOI 10.1046/j.1365-313X.2003.01811.x; Avenson TJ, 2008, J BIOL CHEM, V283, P3550, DOI 10.1074/jbc.M705645200; Avenson TJ, 2009, J BIOL CHEM, V284, P2830, DOI 10.1074/jbc.M807192200; Bailey S, 2001, PLANTA, V213, P794, DOI 10.1007/s004250100556; Bailleul B, 2010, PHOTOSYNTH RES, V106, P179, DOI 10.1007/s11120-010-9579-z; Ballottari M, 2007, J BIOL CHEM, V282, P8947, DOI 10.1074/jbc.M606417200; Baroli I, 2003, PLANT CELL, V15, P992, DOI 10.1105/tpc.010405; BASSI R, 1991, PLANTA, V183, P423, DOI 10.1007/BF00197742; BASSI R, 1992, J BIOL CHEM, V267, P25714; Bellafiore S, 2005, NATURE, V433, P892, DOI 10.1038/nature03286; Betterle N, 2010, ARCH BIOCHEM BIOPHYS, V504, P67, DOI 10.1016/j.abb.2010.05.016; Betterle N, 2009, J BIOL CHEM, V284, P15255, DOI 10.1074/jbc.M808625200; Bonente G, 2008, J BIOL CHEM, V283, P8434, DOI 10.1074/jbc.M708291200; Bonente G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000577; Carol P, 1999, PLANT CELL, V11, P57, DOI 10.1105/tpc.11.1.57; Cournac L, 2000, PHILOS T ROY SOC B, V355, P1447, DOI 10.1098/rstb.2000.0705; Cruz JA, 2005, PHOTOSYNTH RES, V85, P221, DOI 10.1007/s11120-005-4731-x; DAINESE P, 1990, PHOTOCHEM PHOTOBIOL, V51, P693, DOI 10.1111/php.1990.51.6.693; Dall'Osto L, 2005, PLANT CELL, V17, P1217, DOI 10.1105/tpc.104.030601; Dall'Osto L, 2007, J BIOL CHEM, V282, P35056, DOI 10.1074/jbc.M704729200; Dall'Osto L, 2010, MOL PLANT, V3, P576, DOI 10.1093/mp/ssp117; de Bianchi S, 2008, PLANT CELL, V20, P1012, DOI 10.1105/tpc.107.055749; DemmigAdams B, 1996, PHYSIOL PLANTARUM, V98, P253, DOI 10.1034/j.1399-3054.1996.980206.x; DEMMIGADAMS B, 1990, PLANT PHYSIOL, V92, P293, DOI 10.1104/pp.92.2.293; DEMMIGADAMS B, 1995, AUST J PLANT PHYSIOL, V22, P249, DOI 10.1071/PP9950249; DEVITRY C, 1984, BIOCHIM BIOPHYS ACTA, V767, P415, DOI 10.1016/0005-2728(84)90039-2; Diaz M, 2007, PLANT CELL ENVIRON, V30, P1578, DOI 10.1111/j.1365-3040.2007.01735.x; DINER BA, 1980, EUR J BIOCHEM, V110, P521, DOI 10.1111/j.1432-1033.1980.tb04894.x; Dominici P, 2002, J BIOL CHEM, V277, P22750, DOI 10.1074/jbc.M200604200; Durnford DG, 2003, PHYSIOL PLANTARUM, V118, P193, DOI 10.1034/j.1399-3054.2003.00078.x; FALK S, 1992, PHOTOSYNTH RES, V31, P31, DOI 10.1007/BF00049534; FALKOWSKI PG, 1980, PLANT PHYSIOL, V66, P592, DOI 10.1104/pp.66.4.592; Fleischmann MM, 1999, J BIOL CHEM, V274, P30987, DOI 10.1074/jbc.274.43.30987; Gordillo FJL, 2001, PHOTOSYNTH RES, V68, P225, DOI 10.1023/A:1012969324756; Grossman AR, 2010, PHOTOSYNTH RES, V106, P3, DOI 10.1007/s11120-010-9555-7; Havaux M, 1999, P NATL ACAD SCI USA, V96, P8762, DOI 10.1073/pnas.96.15.8762; Holub O, 2007, J MICROSC-OXFORD, V226, P90, DOI 10.1111/j.1365-2818.2007.01763.x; Ibanez H, 2010, J PLANT PHYSIOL, V167, P732, DOI 10.1016/j.jplph.2009.12.013; Iwai M, 2010, NATURE, V464, P1210, DOI 10.1038/nature08885; Johnson MP, 2009, PLANT PHYSIOL, V149, P1061, DOI 10.1104/pp.108.129957; Joliot P, 2005, P NATL ACAD SCI USA, V102, P4913, DOI 10.1073/pnas.0501268102; Josse EM, 2000, PLANT PHYSIOL, V123, P1427, DOI 10.1104/pp.123.4.1427; Lambrev PH, 2010, PLANT PHYSIOL, V152, P1611, DOI 10.1104/pp.109.148213; Lemeille S, 2009, PLOS BIOL, V7, P664, DOI 10.1371/journal.pbio.1000045; Lucinski R, 2007, PHOTOSYNTH RES, V91, P214; Ma YZ, 2003, P NATL ACAD SCI USA, V100, P4377, DOI 10.1073/pnas.0736959100; Melis A, 1999, TRENDS PLANT SCI, V4, P130, DOI 10.1016/S1360-1385(99)01387-4; Melis A, 1998, J APPL PHYCOL, V10, P515, DOI 10.1023/A:1008076231267; MERCHANT S, 1984, PLANT PHYSIOL, V75, P781, DOI 10.1104/pp.75.3.781; Morosinotto T, 2003, PHYSIOL PLANTARUM, V119, P347, DOI 10.1034/j.1399-3054.2003.00213.x; Morosinotto T, 2006, FEBS J, V273, P4616, DOI 10.1111/j.1742-4658.2006.05465.x; Moya I, 2001, BIOCHEMISTRY-US, V40, P12552, DOI 10.1021/bi010342x; Mozzo M, 2010, BBA-BIOENERGETICS, V1797, P212, DOI 10.1016/j.bbabio.2009.10.005; Mussgnug JH, 2010, J BIOTECHNOL, V150, P51, DOI 10.1016/j.jbiotec.2010.07.030; Nandha B, 2007, BBA-BIOENERGETICS, V1767, P1252, DOI 10.1016/j.bbabio.2007.07.007; Naumann B, 2005, J BIOL CHEM, V280, P20431, DOI 10.1074/jbc.M414486200; Niyogi KK, 1997, P NATL ACAD SCI USA, V94, P14162, DOI 10.1073/pnas.94.25.14162; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; Peers G, 2009, NATURE, V462, P518, DOI 10.1038/nature08587; Peltier G, 2002, ANNU REV PLANT BIOL, V53, P523, DOI 10.1146/annurev.arplant.53.100301.135242; Peltier G, 2010, PHOTOSYNTH RES, V106, P19, DOI 10.1007/s11120-010-9575-3; Peng LW, 2009, PLANT CELL, V21, P3623, DOI 10.1105/tpc.109.068791; Pesaresi P, 2009, PLANT CELL, V21, P2402, DOI 10.1105/tpc.108.064964; Polle JEW, 2000, PLANTA, V211, P335, DOI 10.1007/s004250000279; RAVENEL J, 1994, PLANTA, V193, P251; ROCHAIX JD, 1989, EMBO J, V8, P1013, DOI 10.1002/j.1460-2075.1989.tb03468.x; Ruban AV, 2010, ARCH BIOCHEM BIOPHYS, V504, P78, DOI 10.1016/j.abb.2010.06.034; Ruban AV, 1999, PLANT PHYSIOL, V119, P531, DOI 10.1104/pp.119.2.531; Rumeau D, 2007, PLANT CELL ENVIRON, V30, P1041, DOI 10.1111/j.1365-3040.2007.01675.x; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schmid VHR, 2008, CELL MOL LIFE SCI, V65, P3619, DOI 10.1007/s00018-008-8333-6; SMITH BM, 1990, PLANT PHYSIOL, V93, P1433, DOI 10.1104/pp.93.4.1433; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Wollman FA, 2001, EMBO J, V20, P3623, DOI 10.1093/emboj/20.14.3623	80	147	153	4	82	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5833	5847		10.1074/jbc.M111.304279	http://dx.doi.org/10.1074/jbc.M111.304279			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22205699	hybrid, Green Published			2022-12-27	WOS:000300638000058
J	Jin, YY; Dong, L; Lu, Y; Wu, WQ; Hao, Q; Zhou, ZC; Jiang, J; Zhao, Y; Zhang, L				Jin, Yunyun; Dong, Liang; Lu, Yi; Wu, Wenqing; Hao, Qian; Zhou, Zhaocai; Jiang, Jin; Zhao, Yun; Zhang, Lei			Dimerization and Cytoplasmic Localization Regulate Hippo Kinase Signaling Activity in Organ Size Control	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR PATHWAY; CELL-CYCLE EXIT; DROSOPHILA HOMOLOG; PROMOTES APOPTOSIS; TEAD/TEF FAMILY; PROTEIN-KINASE; MST1 KINASE; GROWTH; PROLIFERATION; ACTIVATION	The Hippo (Hpo) signaling pathway controls organ size by regulating the balance between cell proliferation and apoptosis. Although the Hpo function is conserved, little is known about the mechanism of how its kinase activity is regulated. Based on structural information, we performed mutation-function analysis and provided in vitro and in vivo evidence that Hpo activation requires proper dimerization of its N-terminal kinase domain as well as the C-terminal SARAH domain. Hpo carrying point mutation M242E can still dimerize, yet the dimers formed between intermolecular kinase domains were altered in conformation. As a result, autophosphorylation of Hpo at Thr-195 was blocked, and its kinase activity was abolished. In contrast, Hpo carrying I634D, a single mutation introduced in the Hpo C-terminal SARAH domain, disrupted the dimerization of the SARAH domain, leading to reduced Hippo activity. We also find that the Hpo C-terminal half contains two nuclear export signals that promote cytoplasmic localization and activity of Hpo. Taken together, our results suggest that dimerization and nucleocytoplasmic translocation of Hpo are crucial for its biological function and indicate that a proper dimer conformation of the kinase domain is essential for Hpo autophosphorylation and kinase activity.	[Jin, Yunyun; Dong, Liang; Lu, Yi; Wu, Wenqing; Hao, Qian; Zhou, Zhaocai; Zhao, Yun; Zhang, Lei] Chinese Acad Sci, State Key Lab Cell Biol, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; [Jiang, Jin] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Texas System; University of Texas Southwestern Medical Center Dallas	Zhao, Y (corresponding author), Chinese Acad Sci, Hundred Talents Program, Beijing 100864, Peoples R China.	yunzhao@sibs.ac.cn; rayzhang@sibs.ac.cn	jin, yun/GQZ-6618-2022		National Basic Research Program of China 973 Program [2010CB912101, 2012CB945001, 2011CB943902]; National Natural Science Foundation of China [30971646, 30971647, 31171394, 31171414]; Shanghai Pujiang Program [09PJ1410900]; National Key Basic Research and Development Program of China [2011CB915502]; Chinese Academy of Sciences [XDA01010405, XDA01010406]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061269, R01GM067045] Funding Source: NIH RePORTER	National Basic Research Program of China 973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Program(Shanghai Pujiang Program); National Key Basic Research and Development Program of China(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Basic Research Program of China 973 Program Grants 2010CB912101, 2012CB945001, and 2011CB943902; National Natural Science Foundation of China Grants 30971646, 30971647, 31171394, and 31171414; Shanghai Pujiang Program Grant 09PJ1410900; National Key Basic Research and Development Program of China Grant 2011CB915502; and "Strategic Priority Research Program" of the Chinese Academy of Sciences Grants XDA01010405 and XDA01010406.	Alarcon C, 2009, CELL, V139, P757, DOI 10.1016/j.cell.2009.09.035; Baena-Lopez LA, 2008, P NATL ACAD SCI USA, V105, P9645, DOI 10.1073/pnas.0803747105; Avruch J, 2009, J BIOL CHEM, V284, P11001, DOI 10.1074/jbc.R800073200; Baumgartner R, 2010, DEV CELL, V18, P309, DOI 10.1016/j.devcel.2009.12.013; Bennett FC, 2006, CURR BIOL, V16, P2101, DOI 10.1016/j.cub.2006.09.045; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Callus BA, 2006, FEBS J, V273, P4264, DOI 10.1111/j.1742-4658.2006.05427.x; Centonze Victoria E., 2004, Biol Proced Online, V6, P78, DOI 10.1251/bpo75; Cheung WL, 2003, CELL, V113, P507, DOI 10.1016/S0092-8674(03)00355-6; Cho E, 2006, NAT GENET, V38, P1142, DOI 10.1038/ng1887; Clackson T, 1998, P NATL ACAD SCI USA, V95, P10437, DOI 10.1073/pnas.95.18.10437; Colombani J, 2006, CURR BIOL, V16, P1453, DOI 10.1016/j.cub.2006.05.059; Conlon I, 1999, CELL, V96, P235, DOI 10.1016/S0092-8674(00)80563-2; Creasy CL, 1996, J BIOL CHEM, V271, P21049, DOI 10.1074/jbc.271.35.21049; Fernandez A, 2009, GENE DEV, V23, P2729, DOI 10.1101/gad.1824509; Gazdoiu S, 2005, P NATL ACAD SCI USA, V102, P15053, DOI 10.1073/pnas.0507646102; Genevet A, 2010, DEV CELL, V18, P300, DOI 10.1016/j.devcel.2009.12.011; Glantschnig H, 2002, J BIOL CHEM, V277, P42987, DOI 10.1074/jbc.M208538200; Goulev Y, 2008, CURR BIOL, V18, P435, DOI 10.1016/j.cub.2008.02.034; Graves JD, 1998, EMBO J, V17, P2224, DOI 10.1093/emboj/17.8.2224; Halder G, 2011, DEVELOPMENT, V138, P9, DOI 10.1242/dev.045500; Hamaratoglu F, 2006, NAT CELL BIOL, V8, P27, DOI 10.1038/ncb1339; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Hwang E, 2007, P NATL ACAD SCI USA, V104, P9236, DOI 10.1073/pnas.0610716104; Jia JH, 2003, GENE DEV, V17, P2514, DOI 10.1101/gad.1134003; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Lai ZC, 2005, CELL, V120, P675, DOI 10.1016/j.cell.2004.12.036; Lee KK, 2002, J BIOL CHEM, V277, P12351, DOI 10.1074/jbc.M108138200; Lee KK, 2001, J BIOL CHEM, V276, P19276, DOI 10.1074/jbc.M005109200; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Lu L, 2010, P NATL ACAD SCI USA, V107, P1437, DOI 10.1073/pnas.0911427107; Maitra S, 2006, CURR BIOL, V16, P702, DOI 10.1016/j.cub.2006.02.063; Mattaj IW, 1998, ANNU REV BIOCHEM, V67, P265, DOI 10.1146/annurev.biochem.67.1.265; McNeill H, 2010, NAT REV MOL CELL BIO, V11, P404, DOI 10.1038/nrm2902; Neto-Silva RM, 2010, DEV CELL, V19, P507, DOI 10.1016/j.devcel.2010.09.009; Pan DJ, 2007, GENE DEV, V21, P886, DOI 10.1101/gad.1536007; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Pantalacci S, 2003, NAT CELL BIOL, V5, P921, DOI 10.1038/ncb1051; Pellock BJ, 2007, DEV BIOL, V304, P102, DOI 10.1016/j.ydbio.2006.12.021; Polesello C, 2006, CURR BIOL, V16, P2459, DOI 10.1016/j.cub.2006.10.060; Praskova M, 2004, BIOCHEM J, V381, P453, DOI 10.1042/BJ20040025; Qiao M, 2010, MOL CELL, V38, P512, DOI 10.1016/j.molcel.2010.03.017; Radu M, 2009, CURR BIOL, V19, pR421, DOI 10.1016/j.cub.2009.04.022; Record CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011905; Ren FF, 2010, P NATL ACAD SCI USA, V107, P21064, DOI 10.1073/pnas.1012759107; Ribeiro PS, 2010, MOL CELL, V39, P521, DOI 10.1016/j.molcel.2010.08.002; Scheel H, 2003, CURR BIOL, V13, pR899, DOI 10.1016/j.cub.2003.11.007; Silva E, 2006, CURR BIOL, V16, P2081, DOI 10.1016/j.cub.2006.09.004; Song H, 2010, P NATL ACAD SCI USA, V107, P1431, DOI 10.1073/pnas.0911409107; Sun GP, 2011, DEV BIOL, V350, P139, DOI 10.1016/j.ydbio.2010.11.036; Tyler DM, 2007, GENETICS, V175, P643, DOI 10.1534/genetics.106.061929; Udan RS, 2003, NAT CELL BIOL, V5, P914, DOI 10.1038/ncb1050; Varelas X, 2010, DEV CELL, V18, P579, DOI 10.1016/j.devcel.2010.03.007; Wei X, 2007, EMBO J, V26, P1772, DOI 10.1038/sj.emboj.7601630; Willecke M, 2006, CURR BIOL, V16, P2090, DOI 10.1016/j.cub.2006.09.005; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Wu S, 2008, DEV CELL, V14, P388, DOI 10.1016/j.devcel.2008.01.007; Yin MX, 2011, J GENET GENOMICS, V38, P471, DOI 10.1016/j.jgg.2011.09.009; Yu JZ, 2010, DEV CELL, V18, P288, DOI 10.1016/j.devcel.2009.12.012; Zhang JM, 2009, NAT CELL BIOL, V11, P1444, DOI 10.1038/ncb1993; Zhang L, 2008, DEV CELL, V14, P377, DOI 10.1016/j.devcel.2008.01.006; Zhang L, 2009, FLY, V3, P68, DOI 10.4161/fly.3.1.7788; Zhao B, 2010, J CELL SCI, V123, P4001, DOI 10.1242/jcs.069070; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026	67	34	34	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5784	5796		10.1074/jbc.M111.310334	http://dx.doi.org/10.1074/jbc.M111.310334			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22215676	Green Published, hybrid			2022-12-27	WOS:000300638000054
J	Kim, W; Kim, R; Park, G; Park, JW; Kim, JE				Kim, Wootae; Kim, Ranah; Park, Geunyeong; Park, Jong-Wan; Kim, Ja-Eun			Deficiency of H3K79 Histone Methyltransferase Dot1-like Protein (DOT1L) Inhibits Cell Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL ELONGATION; LYSINE-79 METHYLTRANSFERASE; HETEROCHROMATIN FORMATION; SACCHAROMYCES-CEREVISIAE; MAMMALIAN-CELLS; H3 METHYLATION; SET DOMAIN; S-PHASE; TRIMETHYLATION; H4	Dot1-like protein (DOT1L) is an evolutionarily conserved histone methyltransferase that methylates lysine 79 of histone H3 (H3K79). Mammalian DOT1L participates in the regulation of transcription, development, erythropoiesis, differentiation, and proliferation of normal cells. However, the role of DOT1L in cancer cell proliferation has not been fully elucidated. DOT1L siRNA-transfected A549 or NCI-H1299 lung cancer cells displayed a nonproliferating multinucleated phenotype. DOT1L-deficient cells also showed abnormal mitotic spindle formation and centrosome number, suggesting that DOT1L deficiency leads to chromosomal missegregation. This chromosomal instability in DOT1L-deficient cells led to cell cycle arrest at the G1 phase and induced senescence as determined by enhanced activity of senescence-associated beta-galactosidase activity. Meanwhile, overexpression of a catalytically active DOT1L, not an inactive mutant, restored DOT1L siRNA-induced phenotypes. Overall, these data imply that down-regulation of DOT1L-mediated H3K79 methylation disturbs proliferation of human cells. In addition, although H3K79 methylation is down-regulated in aged tissues, it is up-regulated in lung cancer cell lines and tumor tissues of lung cancer patients. Therefore, H3K79 methylation is a critical histone modification that regulates cell proliferation and would be a novel histone mark for aging and cancer.	[Kim, Wootae; Kim, Ranah; Park, Geunyeong; Kim, Ja-Eun] Kyung Hee Univ, Sch Med, Dept Pharmacol, Seoul 130701, South Korea; [Kim, Wootae; Kim, Ranah; Park, Geunyeong; Kim, Ja-Eun] Kyung Hee Univ, Sch Med, Dept Biomed Sci, Seoul 130701, South Korea; [Park, Jong-Wan] Seoul Natl Univ, Coll Med, Dept Pharmacol, Seoul 110799, South Korea	Kyung Hee University; Kyung Hee University; Seoul National University (SNU)	Park, JW (corresponding author), 28 Yongon Dong, Seoul 110799, South Korea.	parkjw@snu.ac.kr; jekim@khu.ac.kr	Kim, Ja-Eun/AAI-1896-2020; Kim, Wootae/AAV-9894-2020	Kim, Ja-Eun/0000-0002-9132-1277; Kim, Wootae/0000-0003-4364-3260	National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology (MEST) [2010-0009414, 2008-314-E00054]; NRF; Korea government (MEST) [2010-0001754, 2011-0030722]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea); NRF; Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This research was in part supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (MEST) (2010-0009414 and 2008-314-E00054). This work was also supported by the NRF Grant funded by the Korea government (MEST) (2010-0001754 and 2011-0030722).	Altaf M, 2007, MOL CELL, V28, P1002, DOI 10.1016/j.molcel.2007.12.002; Nguyen AT, 2011, BLOOD, V117, P6912, DOI 10.1182/blood-2011-02-334359; Barry ER, 2009, STEM CELLS, V27, P1538, DOI 10.1002/stem.86; Bhaumik SR, 2007, NAT STRUCT MOL BIOL, V14, P1008, DOI 10.1038/nsmb1337; Bitoun E, 2007, HUM MOL GENET, V16, P92, DOI 10.1093/hmg/ddl444; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Bringold F, 2000, EXP GERONTOL, V35, P317, DOI 10.1016/S0531-5565(00)00083-8; Calvanese V, 2009, AGEING RES REV, V8, P268, DOI 10.1016/j.arr.2009.03.004; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Dang WW, 2009, NATURE, V459, P802, DOI 10.1038/nature08085; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Fingerman IM, 2007, GENE DEV, V21, P2018, DOI 10.1101/gad.1560607; Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531; Giannattasio M, 2005, J BIOL CHEM, V280, P9879, DOI 10.1074/jbc.M414453200; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Jacinto FV, 2009, ONCOGENE, V28, P4212, DOI 10.1038/onc.2009.267; Janzen CJ, 2006, MOL CELL, V23, P497, DOI 10.1016/j.molcel.2006.06.027; Jones B, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000190; Kim JE, 2005, MOL CELL BIOL, V25, P10907, DOI 10.1128/MCB.25.24.10907-10915.2005; Krivtsov AV, 2008, CANCER CELL, V14, P355, DOI 10.1016/j.ccr.2008.10.001; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Mathon NE, 2001, NAT REV CANCER, V1, P203, DOI 10.1038/35106045; Miller KM, 2010, NAT STRUCT MOL BIOL, V17, P1144, DOI 10.1038/nsmb.1899; Min JR, 2003, CELL, V112, P711, DOI 10.1016/S0092-8674(03)00114-4; Mohan M, 2010, GENE DEV, V24, P574, DOI 10.1101/gad.1898410; Mueller D, 2007, BLOOD, V110, P4445, DOI 10.1182/blood-2007-05-090514; Nakanishi S, 2009, J CELL BIOL, V186, P371, DOI 10.1083/jcb.200906005; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Ng HH, 2003, P NATL ACAD SCI USA, V100, P1820, DOI 10.1073/pnas.0437846100; Ng HH, 2002, J BIOL CHEM, V277, P34655, DOI 10.1074/jbc.C200433200; Ng HH, 2002, GENE DEV, V16, P1518, DOI 10.1101/gad.1001502; Okada Y, 2005, CELL, V121, P167, DOI 10.1016/j.cell.2005.02.020; Ooga M, 2008, BIOL REPROD, V78, P413, DOI 10.1095/biolreprod.107.063453; Park G, 2010, PROTEIN J, V29, P213, DOI 10.1007/s10930-010-9242-8; Reisenauer MR, 2010, AM J PHYSIOL-RENAL, V299, pF63, DOI 10.1152/ajprenal.00105.2010; San-Segundo PA, 2000, MOL BIOL CELL, V11, P3601, DOI 10.1091/mbc.11.10.3601; Sarg B, 2002, J BIOL CHEM, V277, P39195, DOI 10.1074/jbc.M205166200; Sawada K, 2004, J BIOL CHEM, V279, P43296, DOI 10.1074/jbc.M405902200; Sawado T, 2008, BLOOD, V112, P406, DOI 10.1182/blood-2007-12-128983; Scaffidi P, 2006, SCIENCE, V312, P1059, DOI 10.1126/science.1127168; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; Schulze JM, 2009, MOL CELL, V35, P626, DOI 10.1016/j.molcel.2009.07.017; Shanower GA, 2005, GENETICS, V169, P173, DOI 10.1534/genetics.104.033191; Shumaker DK, 2006, P NATL ACAD SCI USA, V103, P8703, DOI 10.1073/pnas.0602569103; Singer MS, 1998, GENETICS, V150, P613; Solomon DA, 2008, CANCER RES, V68, P2564, DOI 10.1158/0008-5472.CAN-07-6388; Steger DJ, 2008, MOL CELL BIOL, V28, P2825, DOI 10.1128/MCB.02076-07; Tzatsos A, 2009, P NATL ACAD SCI USA, V106, P2641, DOI 10.1073/pnas.0813139106; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; Verzijlbergen KF, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-76; Wang CM, 2010, BIOGERONTOLOGY, V11, P87, DOI 10.1007/s10522-009-9231-5; Wu LP, 2011, MOL CELL, V43, P132, DOI 10.1016/j.molcel.2011.05.015; Wysocki R, 2005, MOL CELL BIOL, V25, P8430, DOI 10.1128/MCB.25.19.8430-8443.2005; Xiao PF, 2005, COLLOID SURFACE B, V40, P165, DOI 10.1016/j.colsurfb.2004.10.018; Zhang WZ, 2006, J BIOL CHEM, V281, P18059, DOI 10.1074/jbc.M601903200	58	90	97	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5588	5599		10.1074/jbc.M111.328138	http://dx.doi.org/10.1074/jbc.M111.328138			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	242WW	22190683	hybrid, Green Published			2022-12-27	WOS:000326277000001
J	Yan, BX; Boyd, D; Kaschak, T; Tsukuda, J; Shen, A; Lin, YW; Chung, S; Gupta, P; Kamath, A; Wong, A; Vernes, JM; Meng, GY; Totpal, K; Schaefer, G; Jiang, GY; Nogal, B; Emery, C; Vanderlaan, M; Carter, P; Harris, R; Amanullah, A				Yan, Boxu; Boyd, Daniel; Kaschak, Timothy; Tsukuda, Joni; Shen, Amy; Lin, Yuwen; Chung, Shan; Gupta, Priyanka; Kamath, Amrita; Wong, Anne; Vernes, Jean-Michel; Meng, Gloria Y.; Totpal, Klara; Schaefer, Gabriele; Jiang, Guoying; Nogal, Bartek; Emery, Craig; Vanderlaan, Martin; Carter, Paul; Harris, Reed; Amanullah, Ashraf			Engineering Upper Hinge Improves Stability and Effector Function of a Human IgG1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEONATAL FC-RECEPTOR; THERAPEUTIC ANTIBODIES; MONOCLONAL-ANTIBODIES; DEVELOPMENT TRENDS; ELECTRON-TRANSFER; GAMMA-RI; VARIANTS; PROTEINS; MECHANISMS; AFFINITY	Upper hinge is vulnerable to radical attacks that result in breakage of the heavy-light chain linkage and cleavage of the hinge of an IgG1. To further explore mechanisms responsible for the radical induced hinge degradation, nine mutants were designed to determine the roles that the upper hinge Asp and His play in the radical reactions. The observation that none of these substitutions could inhibit the breakage of the heavy-light chain linkage suggests that the breakage may result from electron transfer from Cys(231) directly to the heavy-light chain linkage upon radical attacks, and implies a pathway separate from His(229)-mediated hinge cleavage. On the other hand, the substitution of His(229) with Tyr showed promising advantages over the native antibody and other substitutions in improving the stability and function of the IgG1. This substitution inhibited the hinge cleavage by 98% and suggests that the redox active nature of Tyr did not enable it to replicate the ability of His to facilitate radical induced degradation. We propose that the lower redox potential of Tyr, a residue that may be the ultimate sink for oxidizing equivalents in proteins, is responsible for the inhibition. More importantly, the substitution increased the antibody's binding to Fc gamma RIII receptors by 2-3-fold, and improved ADCC activity by 2-fold, while maintaining a similar pharmacokinetic profile with respect to the wild type. Implications of these observations for antibody engineering and development are discussed.	[Yan, Boxu; Boyd, Daniel; Kaschak, Timothy; Nogal, Bartek; Emery, Craig; Amanullah, Ashraf] Genentech Inc, Dept Pharma Tech Dev, Oceanside, CA 92056 USA; [Tsukuda, Joni; Shen, Amy] Genentech Inc, Dept Early Stage Cell Culture, San Francisco, CA 94080 USA; [Lin, Yuwen; Chung, Shan] Genentech Inc, Dept Bioanalyt Sci, San Francisco, CA 94080 USA; [Gupta, Priyanka; Kamath, Amrita] Genentech Inc, Dept Pharmacokinet & Pharmacodynam, San Francisco, CA 94080 USA; [Wong, Anne; Vernes, Jean-Michel; Meng, Gloria Y.] Genentech Inc, Dept Assay & Automat Technol, San Francisco, CA 94080 USA; [Totpal, Klara; Schaefer, Gabriele] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA; [Jiang, Guoying; Vanderlaan, Martin; Harris, Reed] Genentech Inc, Dept Analyt Dev & Qual Control, San Francisco, CA 94080 USA; [Carter, Paul] Genentech Inc, Dept Antibody Engn, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Yan, BX (corresponding author), Genentech Inc, Dept Pharma Tech Dev, Oceanside, CA 92056 USA.	byan1027@gmail.com	Shen, Amy/GVT-6125-2022; Chung, Shan/AAK-5790-2021	Schaefer, Gabriele/0000-0001-9727-3555				Beck A, 2010, NAT REV IMMUNOL, V10, P345, DOI 10.1038/nri2747; Carter PJ, 2006, NAT REV IMMUNOL, V6, P343, DOI 10.1038/nri1837; Chan AC, 2010, NAT REV IMMUNOL, V10, P301, DOI 10.1038/nri2761; Dall'Acqua WF, 2006, J IMMUNOL, V177, P1129, DOI 10.4049/jimmunol.177.2.1129; Datta-Mannan A, 2007, J BIOL CHEM, V282, P1709, DOI 10.1074/jbc.M607161200; Davies M. J., 1997, RADICAL MEDIATED PRO, P50; Ducry L, 2010, BIOCONJUGATE CHEM, V21, P5, DOI 10.1021/bc9002019; GARRISON WM, 1987, CHEM REV, V87, P381, DOI 10.1021/cr00078a006; Goldmacher VS, 2011, THER DELIV, V2, P397, DOI 10.4155/TDE.10.98; HORNE C, 1982, J IMMUNOL, V129, P660; Jefferis R, 2009, NAT REV DRUG DISCOV, V8, P226, DOI 10.1038/nrd2804; Jiang XR, 2011, NAT REV DRUG DISCOV, V10, P101, DOI 10.1038/nrd3365; Kirby JP, 1997, J AM CHEM SOC, V119, P9230, DOI 10.1021/ja970176+; Lazar GA, 2006, P NATL ACAD SCI USA, V103, P4005, DOI 10.1073/pnas.0508123103; Lu YM, 2011, J IMMUNOL METHODS, V365, P132, DOI 10.1016/j.jim.2010.12.014; Mohammad R., 2007, J AM CHEM SOC, V129, P15060; Nelson AL, 2010, NAT REV DRUG DISCOV, V9, P767, DOI 10.1038/nrd3229; Nelson AL, 2009, NAT BIOTECHNOL, V27, P331, DOI 10.1038/nbt0409-331; Oganesyan V, 2008, MOL IMMUNOL, V45, P1872, DOI 10.1016/j.molimm.2007.10.042; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; Page CC, 2003, CURR OPIN CHEM BIOL, V7, P551, DOI 10.1016/j.cbpa.2003.08.005; Reece SY, 2009, ANNU REV BIOCHEM, V78, P673, DOI 10.1146/annurev.biochem.78.080207.092132; Reichert JM, 2007, NAT REV DRUG DISCOV, V6, P349, DOI 10.1038/nrd2241; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Saphire EO, 2002, J MOL BIOL, V319, P9, DOI 10.1016/S0022-2836(02)00244-9; Schneider CK, 2008, NAT BIOTECHNOL, V26, P985, DOI 10.1038/nbt0908-985; Seyedsayamdost MR, 2006, J AM CHEM SOC, V128, P1562, DOI 10.1021/ja055927j; Shields RL, 2001, J BIOL CHEM, V276, P6591, DOI 10.1074/jbc.M009483200; Stewart R, 2011, PROTEIN ENG DES SEL, V24, P671, DOI 10.1093/protein/gzr015; Tabrizi MA, 2006, DRUG DISCOV TODAY, V11, P81, DOI 10.1016/S1359-6446(05)03638-X; Walsh G, 2006, NAT BIOTECHNOL, V24, P1241, DOI 10.1038/nbt1252; Yan BX, 2011, J BIOL CHEM, V286, P24674, DOI 10.1074/jbc.M111.255026; Yan BX, 2009, J BIOL CHEM, V284, P35390, DOI 10.1074/jbc.M109.064147; Yates Z, 2010, J BIOL CHEM, V285, P18662, DOI 10.1074/jbc.M110.108597; Yeung YA, 2009, J IMMUNOL, V182, P7663, DOI 10.4049/jimmunol.0804182	35	18	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5891	5897		10.1074/jbc.M111.311811	http://dx.doi.org/10.1074/jbc.M111.311811			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22203673	hybrid, Green Published			2022-12-27	WOS:000300638000063
J	Chang, YW; Lin, TW; Li, YC; Huang, YS; Sun, YJ; Hsiao, CD				Chang, Yi-Wei; Lin, Tai-Wen; Li, Yi-Chuan; Huang, Yu-Shan; Sun, Yuh-Ju; Hsiao, Chwan-Deng			Interaction Surface and Topology of Get3-Get4-Get5 Protein Complex, Involved in Targeting Tail-anchored Proteins to Endoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAY SOLUTION SCATTERING; SMALL-ANGLE SCATTERING; MEMBRANE INSERTION; GET4/GET5 COMPLEX; STRUCTURAL BASIS; ER MEMBRANE; GET3; SGT2; MECHANISM; CLUSPRO	Recent work has uncovered the "GET system," which is responsible for endoplasmic reticulum targeting of tail-anchored proteins. Although structural information and the individual roles of most components of this system have been defined, the interactions and interplay between them remain to be elucidated. Here, we investigated the interactions between Get3 and the Get4-Get5 complex from Saccharomyces cerevisiae. We show that Get3 interacts with Get4-Get5 via an interface dominated by electrostatic forces. Using isothermal titration calorimetry and small-angle x-ray scattering, we further demonstrate that the Get3 homodimer interacts with two copies of the Get4-Get5 complex to form an extended conformation in solution.	[Chang, Yi-Wei; Lin, Tai-Wen; Li, Yi-Chuan; Hsiao, Chwan-Deng] Acad Sinica, Inst Mol Biol, Taipei 115, Taiwan; [Li, Yi-Chuan; Sun, Yuh-Ju] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu 300, Taiwan; [Huang, Yu-Shan] Natl Synchrotron Radiat Res Ctr, Hsinchu 300, Taiwan	Academia Sinica - Taiwan; National Tsing Hua University; National Synchrotron Radiation Research Center	Hsiao, CD (corresponding author), Acad Sinica, Inst Mol Biol, Taipei 115, Taiwan.	hsiao@gate.sinica.edu.tw	Chang, Yi-Wei/ABH-1418-2020; Hsiao, Chwan-Deng/AAZ-8869-2021	Chang, Yi-Wei/0000-0003-2391-473X; Hsiao, Chwan-Deng/0000-0002-7012-1532; Li, Yi-Chuan/0000-0002-1795-1051	National Science Council [NSC-95-2311-B-001-064]; Academia Sinica (Taiwan)	National Science Council(Ministry of Science and Technology, Taiwan); Academia Sinica (Taiwan)(Academia Sinica - Taiwan)	This work was supported by National Science Council Grant NSC-95-2311-B-001-064 (to C.-D.H.) and Academia Sinica (Taiwan).	Borgese N, 2007, CURR OPIN CELL BIOL, V19, P368, DOI 10.1016/j.ceb.2007.04.019; Bozkurt G, 2009, P NATL ACAD SCI USA, V106, P21131, DOI 10.1073/pnas.0910223106; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Chang YW, 2010, J BIOL CHEM, V285, P9962, DOI 10.1074/jbc.M109.087098; Chartron JW, 2011, J BIOL CHEM, V286, P34325, DOI 10.1074/jbc.M111.277798; Chartron JW, 2010, P NATL ACAD SCI USA, V107, P12127, DOI 10.1073/pnas.1006036107; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; Dietmeier K, 1997, NATURE, V388, P195, DOI 10.1038/40663; Egan B, 1999, FEBS LETT, V451, P243, DOI 10.1016/S0014-5793(99)00581-5; Hu JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008061; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983; Kohl C, 2011, BIOL CHEM, V392, P601, DOI 10.1515/BC.2011.066; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Liou ST, 2007, CELL STRESS CHAPERON, V12, P59, DOI 10.1379/CSC-220R.1; Mariappan M, 2011, NATURE, V477, P61, DOI 10.1038/nature10362; Mateja A, 2009, NATURE, V461, P361, DOI 10.1038/nature08319; Schuldiner M, 2008, CELL, V134, P634, DOI 10.1016/j.cell.2008.06.025; Stefanovic S, 2007, CELL, V128, P1147, DOI 10.1016/j.cell.2007.01.036; Stefer S, 2011, SCIENCE, V333, P758, DOI 10.1126/science.1207125; Suloway CJM, 2009, P NATL ACAD SCI USA, V106, P14849, DOI 10.1073/pnas.0907522106; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Walensky LD, 2006, CELL DEATH DIFFER, V13, P1339, DOI 10.1038/sj.cdd.4401992; Wang F, 2011, MOL CELL, V43, P738, DOI 10.1016/j.molcel.2011.07.020; Wang F, 2010, MOL CELL, V40, P159, DOI 10.1016/j.molcel.2010.08.038; Wattenberg B, 2001, TRAFFIC, V2, P66, DOI 10.1034/j.1600-0854.2001.20108.x; Yamagata A, 2010, GENES CELLS, V15, P29, DOI 10.1111/j.1365-2443.2009.01362.x	32	14	14	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4783	4789		10.1074/jbc.M111.318329	http://dx.doi.org/10.1074/jbc.M111.318329			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22190685	Green Published, hybrid			2022-12-27	WOS:000300608500039
J	Kim, JG; Moon, MY; Kim, HJ; Li, Y; Song, DK; Kim, JS; Lee, JY; Kim, J; Kim, SC; Park, JB				Kim, Jae-Gyu; Moon, Mi-Young; Kim, Hee-Jun; Li, Yi; Song, Dong-Keun; Kim, Jun-Sub; Lee, Jae-Yong; Kim, Jaebong; Kim, Sung-Chan; Park, Jae-Bong			Ras-related GTPases Rap1 and RhoA Collectively Induce the Phagocytosis of Serum-opsonized Zymosan Particles in Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; FC-GAMMA-R; BINDING PARTNER; ACTIVATION; MOTILITY; DISTINCT; IDENTIFICATION; MECHANISMS; COMPLEX; LIGAND	Phagocytosis occurs primarily through two main processes in macrophages: the Fc gamma receptor-and the integrin alpha M beta 2-mediated processes. Complement C3bi-opsonized particles are known to be engulfed through integrin alpha M beta 2-mediated process, which is regulated by RhoA GTPase. C3 toxin fused with Tat-peptide (Tat-C3 toxin), an inhibitor of the Rho GTPases, was shown to markedly inhibit the phagocytosis of serum (C3bi)-opsonized zymosans (SOZs). However, 8CPT-2Me-cAMP, an activator of exchange protein directly activated by cAMP (Epac, Rap1 guanine nucleotide exchange factor), restored the phagocytosis of the SOZs that was previously inhibited by the Tat-C3 toxin. In addition, a constitutively active form of Rap1 GTPase (CA-Rap1) also restored the phagocytosis that was previously reduced by a dominant negative form of RhoA GTPase (DN-RhoA). This suggests that Rap1 can replace the function of RhoA in the phagocytosis. Inversely, CA-RhoA rescued the phagocytosis that was suppressed by DN-Rap1. These findings suggest that both RhoA and Rap1 GTPases collectively regulate the phagocytosis of SOZs. In addition, filamentous actin was reduced by the Tat-C3 toxin, which was again restored by 8CPT-2MecAMP. Small interfering profilin suppressed the phagocytosis, suggesting that profilin is essential for the phagocytosis of SOZs. Furthermore, 8CPT-2Me-cAMP increased the co-immunoprecipitation of profilin with Rap1, whereas Tat-C3 toxin decreased that of profilin with RhoA. Co-immunoprecipitations of profilin with actin, Rap1, and RhoA GTPases were augmented in the presence of GTP gamma S rather than GDP. Therefore, we propose that both Rap1 and RhoA GTPases regulate the formation of filamentous actin through the interaction between actin and profilin, thereby collectively inducing the phagocytosis of SOZs in macrophages.	[Kim, Jae-Gyu; Moon, Mi-Young; Kim, Hee-Jun; Li, Yi; Lee, Jae-Yong; Kim, Jaebong; Kim, Sung-Chan; Park, Jae-Bong] Hallym Univ, Coll Med, Dept Biochem, Chunchon 200702, Kangwon Do, South Korea; [Song, Dong-Keun] Hallym Univ, Coll Med, Dept Pharmacol, Chunchon 200702, Kangwon Do, South Korea; [Kim, Jun-Sub] Hangang Sacred Heart Hosp, Specialized Res Ctr, Seoul 150719, South Korea	Hallym University; Hallym University	Park, JB (corresponding author), Hallym Univ, Coll Med, Dept Biochem, Chunchon 200702, Kangwon Do, South Korea.	jbpark@hallym.ac.kr	Kim, Jaebong/AAV-1986-2021	Kim, Jaebong/0000-0003-1609-338X; LI, YI/0000-0002-7059-9317	National Research Foundation of Korea; Ministry of Education, Science, and Technology [MRC-2011-0006211, 2010-0007865]	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea funded by Ministry of Education, Science, and Technology Grants MRC-2011-0006211 and 2010-0007865.	Adachi R, 2002, J BIOL CHEM, V277, P45566, DOI 10.1074/jbc.M207419200; Arthur WT, 2004, J CELL BIOL, V167, P111, DOI 10.1083/jcb.200404068; Birukova AA, 2008, J CELL PHYSIOL, V215, P715, DOI 10.1002/jcp.21354; Boettner B, 2000, P NATL ACAD SCI USA, V97, P9064, DOI 10.1073/pnas.97.16.9064; Bos JL, 2003, BIOCHEM SOC T, V31, P83, DOI 10.1042/bst0310083; Brandt DT, 2007, J CELL BIOL, V178, P193, DOI 10.1083/jcb.200612071; Caron E, 1998, SCIENCE, V282, P1717, DOI 10.1126/science.282.5394.1717; Caron E, 2000, CURR BIOL, V10, P974, DOI 10.1016/S0960-9822(00)00641-2; Chimini G, 2000, NAT CELL BIOL, V2, pE191, DOI 10.1038/35036454; Chung J, 2008, J IMMUNOL, V181, P5501, DOI 10.4049/jimmunol.181.8.5501; Colucci-Guyon E, 2005, CURR BIOL, V15, P2007, DOI 10.1016/j.cub.2005.09.051; Cox D, 1997, J EXP MED, V186, P1487, DOI 10.1084/jem.186.9.1487; CURNUTTE JT, 1994, J BIOL CHEM, V269, P10813; Da Silva JS, 2003, J CELL BIOL, V162, P1267, DOI 10.1083/jcb.200304021; Dupuy AG, 2008, J CELL SCI, V121, P1773, DOI 10.1242/jcs.018036; El Benna J, 1999, J LEUKOCYTE BIOL, V66, P1014; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; Geese M, 2000, J CELL SCI, V113, P1415; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Herrmann C, 1996, J BIOL CHEM, V271, P6794, DOI 10.1074/jbc.271.12.6794; Jenei V, 2006, J BIOL CHEM, V281, P35008, DOI 10.1074/jbc.M601335200; Jeong HW, 2007, J BIOL CHEM, V282, P20752, DOI 10.1074/jbc.M700487200; Katagiri K, 2000, MOL CELL BIOL, V20, P1956, DOI 10.1128/MCB.20.6.1956-1969.2000; Kim JS, 2004, J BIOL CHEM, V279, P21589, DOI 10.1074/jbc.M308386200; Krugmann S, 2004, CURR BIOL, V14, P1380, DOI 10.1016/j.cub.2004.07.058; Lafuente EM, 2004, DEV CELL, V7, P585, DOI 10.1016/j.devcel.2004.07.021; Lim J, 2007, MOL BIOL CELL, V18, P976, DOI 10.1091/mbc.E06-09-0813; Massol P, 1998, EMBO J, V17, P6219, DOI 10.1093/emboj/17.21.6219; May RC, 2000, NAT CELL BIOL, V2, P246, DOI 10.1038/35008673; Ohashi K, 2000, J BIOL CHEM, V275, P3577, DOI 10.1074/jbc.275.5.3577; Olazabal IM, 2002, CURR BIOL, V12, P1413, DOI 10.1016/S0960-9822(02)01069-2; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Radha V, 2007, EXP CELL RES, V313, P2476, DOI 10.1016/j.yexcr.2007.03.019; Ren XD, 2000, METHOD ENZYMOL, V325, P264; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744; Watanabe N, 1997, EMBO J, V16, P3044, DOI 10.1093/emboj/16.11.3044; Wiedemann AS, 2006, J CELL BIOL, V172, P1069, DOI 10.1083/jcb.200508075; Witke W, 2004, TRENDS CELL BIOL, V14, P461, DOI 10.1016/j.tcb.2004.07.003; Xu JG, 2007, CELL SIGNAL, V19, P1575, DOI 10.1016/j.cellsig.2007.02.004	41	32	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					5145	5155		10.1074/jbc.M111.257634	http://dx.doi.org/10.1074/jbc.M111.257634			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22194606	Green Published, hybrid			2022-12-27	WOS:000300608500072
J	Nakamura, R; Nakamoto, C; Obama, H; Durward, E; Nakamoto, M				Nakamura, Ritsuko; Nakamoto, Chizu; Obama, Hiroya; Durward, Elaine; Nakamoto, Masaru			Structure-Function Analysis of Nel, a Thrombospondin-1-like Glycoprotein Involved in Neural Development and Functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARIN-BINDING DOMAIN; GROWTH-FACTOR; FAMILY PROTEIN; RECEPTOR; EXPRESSION; MICE; DEGRADATION; MITOGENESIS; TERMINUS; REPEATS	Nel (neural epidermal growth factor (EGF)-like molecule) is a multimeric, multimodular extracellular glycoprotein with heparin- binding activity and structural similarities to thrombospondin- 1. Nel is predominantly expressed in the nervous system and has been implicated in neuronal proliferation and differentiation, retinal axon guidance, synaptic functions, and spatial learning. The Nel protein contains an N-terminal thrombospondin- 1 (TSP-N) domain, five cysteine-rich domains, and six EGF-like domains. However, little is known about the functions of specific domains of the Nel protein. In this study, we have performed structure-function analysis of Nel, by using a series of expression constructs for different regions of the Nel protein. Our studies demonstrate that the TSP-N domain is responsible for homo-multimer formation of Nel and its heparin-binding activity. In vivo, Nel and related Nell1 are expressed in several regions of the mouse central nervous system with partly overlapping patterns. When they are expressed in the same cells in vitro, Nel and Nell1 can form hetero-multimers through the TSP-N domain, but they do not hetero-oligomerize with thrombospondin- 1. Whereas both the TSP-N domain and cysteinerich domains can bind to retinal axons in vivo, only the latter causes growth cone collapse in cultured retinal axons, suggesting that cysteine-rich domains interact with and activate an inhibitory axon guidance receptor. These results suggest that Nel interacts with a range of molecules through its different domains and exerts distinct functions.	[Nakamoto, Masaru] Univ Aberdeen, Sch Med Sci, Aberdeen Dev Biol Grp, Inst Med Sci, Aberdeen AB25 2ZD, Scotland; [Obama, Hiroya] Cleveland Clin Fdn, Dept Neurosci, Lerner Res Inst, Cleveland, OH 44195 USA; [Obama, Hiroya] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Dept Mol Med, Cleveland, OH 44195 USA	University of Aberdeen; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation	Nakamoto, M (corresponding author), Univ Aberdeen, Sch Med Sci, Aberdeen Dev Biol Grp, Inst Med Sci, Foresterhill, Aberdeen AB25 2ZD, Scotland.	m.nakamoto@abdn.ac.uk		Nakamoto, Masaru/0000-0001-9356-1189; Nakamoto, Chizu/0000-0002-6560-3545	Royal Society (UK); Biotechnology and Biological Sciences Research Council (UK); BBSRC [BB/G007632/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G007632/1] Funding Source: researchfish	Royal Society (UK)(Royal Society of London); Biotechnology and Biological Sciences Research Council (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants from the Royal Society (UK) and the Biotechnology and Biological Sciences Research Council (UK) (to M. N.).	Abreu JG, 2002, GENE, V287, P39, DOI 10.1016/S0378-1119(01)00827-7; Aihara K, 2003, MOL BRAIN RES, V116, P86, DOI 10.1016/S0169-328X(03)00256-0; Beckmann G, 1998, J MOL BIOL, V275, P725, DOI 10.1006/jmbi.1997.1510; Bokui N, 2008, FEBS LETT, V582, P365, DOI 10.1016/j.febslet.2007.12.006; Chen H, 1996, BIOCHEM J, V318, P959, DOI 10.1042/bj3180959; Chen H, 2000, MATRIX BIOL, V19, P597, DOI 10.1016/S0945-053X(00)00107-4; DAVIS C G, 1990, New Biologist, V2, P410; Desai J, 2006, HUM MOL GENET, V15, P1329, DOI 10.1093/hmg/ddl053; DIXIT VM, 1984, J BIOL CHEM, V259, P100; Elzie CA, 2004, INT J BIOCHEM CELL B, V36, P1090, DOI 10.1016/j.biocel.2003.12.012; Flanagan JG, 2000, METHOD ENZYMOL, V327, P19, DOI 10.1016/S0076-6879(00)27264-9; GOSHIMA Y, 1995, NATURE, V376, P509, DOI 10.1038/376509a0; HALFTER W, 1993, J NEUROSCI, V13, P2863; Hwang EM, 2007, BIOCHEM BIOPH RES CO, V353, P805, DOI 10.1016/j.bbrc.2006.12.115; Jeong JK, 2008, MOL CELLS, V26, P186; Jiang YL, 2009, MOL CELL NEUROSCI, V41, P113, DOI 10.1016/j.mcn.2009.02.006; Kim DG, 2010, BIOCHEM BIOPH RES CO, V391, P529, DOI 10.1016/j.bbrc.2009.11.092; Kuroda S, 1999, BIOCHEM BIOPH RES CO, V265, P79, DOI 10.1006/bbrc.1999.1638; LAWLER JW, 1978, J BIOL CHEM, V253, P8609; Liu AG, 2009, J BIOL CHEM, V284, P6389, DOI 10.1074/jbc.M809198200; MATSUHASHI S, 1995, DEV DYNAM, V203, P212, DOI 10.1002/aja.1002030209; Matsuhashi S, 1996, DEV DYNAM, V207, P233; Matsuyama S, 2005, J PHARMACOL SCI, V98, P239, DOI 10.1254/jphs.FP0050211; Matsuyama S, 2004, NEUROREPORT, V15, P417, DOI 10.1097/00001756-200403010-00007; Mikhailenko I, 1997, J BIOL CHEM, V272, P6784, DOI 10.1074/jbc.272.10.6784; Nakamoto M, 1996, CELL, V86, P755, DOI 10.1016/S0092-8674(00)80150-6; Nelson BR, 2004, DEV BIOL, V270, P322, DOI 10.1016/j.ydbio.2004.03.004; Nelson Branden R., 2002, Gene Expression Patterns, V2, P7, DOI 10.1016/S0925-4773(02)00347-7; ORNITZ DM, 1992, MOL CELL BIOL, V12, P240, DOI 10.1128/MCB.12.1.240; OROURKE KM, 1992, J BIOL CHEM, V267, P24921; Piccolo S, 1997, CELL, V91, P407, DOI 10.1016/S0092-8674(00)80424-9; SASAI Y, 1995, NATURE, V376, P333, DOI 10.1038/376333a0; Ting K, 1999, J BONE MINER RES, V14, P80, DOI 10.1359/jbmr.1999.14.1.80; Watanabe TK, 1996, GENOMICS, V38, P273, DOI 10.1006/geno.1996.0628; Zhang XL, 2002, J CLIN INVEST, V110, P861, DOI 10.1172/JCI200215375	35	30	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3282	3291		10.1074/jbc.M111.281485	http://dx.doi.org/10.1074/jbc.M111.281485			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22157752	Green Published, hybrid			2022-12-27	WOS:000300295100034
J	Barrientos, GC; Feng, W; Truong, K; Matthaei, KI; Yang, TZ; Allen, PD; Lopez, JR; Pessah, IN				Barrientos, Genaro C.; Feng, Wei; Kim Truong; Matthaei, Klaus I.; Yang, Tianzhong; Allen, Paul D.; Lopez, Jose R.; Pessah, Isaac N.			Gene Dose Influences Cellular and Calcium Channel Dysregulation in Heterozygous and Homozygous T4826I-RYR1 Malignant Hyperthermia-susceptible Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYPE-1 RYANODINE RECEPTOR; CENTRAL CORE DISEASE; KNOCK-IN MOUSE; SKELETAL-MUSCLE; SARCOPLASMIC-RETICULUM; RELEASE CHANNEL; COUPLED CALCIUM; CA2+ RELEASE; MG2+ INHIBITION; CARDIAC-MUSCLE	Malignant hyperthermia susceptibility (MHS) is primarily conferred by mutations within ryanodine receptor type 1 (RYR1). Here we address how the MHS mutation T4826I within the S4-S5 linker influences excitation-contraction coupling and resting myoplasmic Ca2+ concentration ([Ca2+](rest)) in flexor digitorum brevis (FDB) and vastus lateralis prepared from heterozygous (Het) and homozygous (Hom) T4826I-RYR1 knock-in mice (Yuen, B. T., Boncompagni, S., Feng, W., Yang, T., Lopez, J. R., Matthaei, K. I., Goth, S. R., Protasi, F., Franzini-Armstrong, C., Allen, P. D., and Pessah, I. N. (2011) FASEB J. doi:22131268). FDB responses to electrical stimuli and acute halothane (0.1%, v/v) exposure showed a rank order of Hom >> Het >> WT. Release of Ca2+ from the sarcoplasmic reticulum and Ca2+ entry contributed to halothane-triggered increases in [Ca2+](rest) in Hom FDBs and elicited pronounced Ca2+ oscillations in similar to 30% of FDBs tested. Genotype contributed significantly elevated [Ca2+](rest) (Hom > Het > WT) measured in vivo using ion-selective microelectrodes. Het and Hom oxygen consumption rates measured in intact myotubes using the Seahorse Bioscience (Billerica, MA) flux analyzer and mitochondrial content measured with MitoTracker were lower than WT, whereas total cellular calpain activity was higher than WT. Muscle membranes did not differ in RYR1 expression nor in Ser(2844) phosphorylation among the genotypes. Single channel analysis showed highly divergent gating behavior with Hom and WT favoring open and closed states, respectively, whereas Het exhibited heterogeneous gating behaviors. [H-3] Ryanodine binding analysis revealed a gene dose influence on binding density and regulation by Ca2+, Mg2+, and temperature. Pronounced abnormalities inherent in T4826I-RYR1 channels confer MHS and promote basal disturbances of excitation-contraction coupling, [Ca2+](rest), and oxygen consumption rates. Considering that both Het and Hom T4826I-RYR1 mice are viable, the remarkable isolated single channel dysfunction mediated through this mutation in S4-S5 cytoplasmic linker must be highly regulated in vivo.	[Barrientos, Genaro C.; Feng, Wei; Kim Truong; Pessah, Isaac N.] Univ Calif Davis, Dept Mol Biosci, Sch Vet Med, Davis, CA 95616 USA; [Matthaei, Klaus I.] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 0200, Australia; [Yang, Tianzhong; Allen, Paul D.; Lopez, Jose R.] Brigham & Womens Hosp, Dept Anesthesiol, Boston, MA 02115 USA	University of California System; University of California Davis; Australian National University; John Curtin School of Medical Research; Harvard University; Brigham & Women's Hospital	Pessah, IN (corresponding author), Univ Calif Davis, Dept Mol Biosci, Sch Vet Med, 1 Shields Ave, Davis, CA 95616 USA.	inpessah@ucdavis.edu	Barrientos, Genaro/I-2778-2013; Pessah, Isaac N/K-7985-2017	Pessah, Isaac N/0000-0002-8149-588X	National Institutes of Health [1P01 AR52354, 3R01 AR043140, 1R01 ES014901]; J. B. Johnson Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR052354, R01AR043140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES014901] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); J. B. Johnson Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants 1P01 AR52354 and 3R01 AR043140 (to P. D. A. and I. N. P.) and 1R01 ES014901 (to I. N. P.). This work was also supported by a grant from the J. B. Johnson Foundation.	AIREY JA, 1990, J BIOL CHEM, V265, P14187; Andronache Z, 2009, P NATL ACAD SCI USA, V106, P4531, DOI 10.1073/pnas.0812661106; Bannister RA, 2010, J GEN PHYSIOL, V135, P629, DOI 10.1085/jgp.200910329; Barrientos G, 2009, MOL PHARMACOL, V76, P560, DOI 10.1124/mol.109.057265; Boncompagni S, 2009, P NATL ACAD SCI USA, V106, P21996, DOI 10.1073/pnas.0911496106; Brady JE, 2009, ANESTH ANALG, V109, P1162, DOI 10.1213/ane.0b013e3181ac1548; BROOKS SPJ, 1992, ANAL BIOCHEM, V201, P119, DOI 10.1016/0003-2697(92)90183-8; Brown RL, 2000, HUM MOL GENET, V9, P1515, DOI 10.1093/hmg/9.10.1515; Carpenter D, 2009, ANN HUM GENET, V73, P10, DOI 10.1111/j.1469-1809.2008.00482.x; Carpenter D, 2009, MUSCLE NERVE, V40, P633, DOI 10.1002/mus.21397; Chelu MG, 2006, FASEB J, V20, P329, DOI 10.1096/fj.05-4497fje; Cherednichenko G, 2004, P NATL ACAD SCI USA, V101, P15793, DOI 10.1073/pnas.0403485101; Cherednichenko G, 2008, MOL PHARMACOL, V73, P1203, DOI 10.1124/mol.107.043299; Civitarese AE, 2006, CELL METAB, V4, P75, DOI 10.1016/j.cmet.2006.05.002; Durham WJ, 2008, CELL, V133, P53, DOI 10.1016/j.cell.2008.02.042; Eltit JM, 2011, P NATL ACAD SCI USA, V108, P7046, DOI 10.1073/pnas.1018380108; Feng W, 2011, MOL PHARMACOL, V79, P420, DOI 10.1124/mol.110.067959; Gailly P, 2007, J PHYSIOL-LONDON, V582, P1261, DOI 10.1113/jphysiol.2007.132191; Giulivi C, 2011, J BIOL CHEM, V286, P99, DOI 10.1074/jbc.M110.153247; HAIN J, 1994, BIOPHYS J, V67, P1823, DOI 10.1016/S0006-3495(94)80664-2; Hurne AM, 2005, J BIOL CHEM, V280, P36994, DOI 10.1074/jbc.M506441200; Jurkat-Rott K, 2002, J NEUROL, V249, P1493, DOI 10.1007/s00415-002-0871-5; Kobayashi S, 2005, J BIOL CHEM, V280, P6580, DOI 10.1074/jbc.M408375200; LAMB GD, 1993, J MUSCLE RES CELL M, V14, P554, DOI 10.1007/BF00141551; Laver DR, 1997, BIOPHYS J, V73, P1913, DOI 10.1016/S0006-3495(97)78222-5; Laver DR, 1997, J MEMBRANE BIOL, V156, P213, DOI 10.1007/s002329900202; Litman RS, 2005, JAMA-J AM MED ASSOC, V293, P2918, DOI 10.1001/jama.293.23.2918; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; LOPEZ J R, 1985, Acta Cientifica Venezolana, V36, P102; Louis CF, 2001, BIOSCIENCE REP, V21, P155, DOI 10.1023/A:1013644107519; Lynch PJ, 1997, ANESTHESIOLOGY, V86, P620, DOI 10.1097/00000542-199703000-00014; MACK MM, 1992, J PHARMACOL EXP THER, V262, P1028; MacLennan DH, 2011, BBA-MOL CELL RES, V1813, P948, DOI 10.1016/j.bbamcr.2010.11.009; McCarthy TV, 2000, HUM MUTAT, V15, P410, DOI 10.1002/(SICI)1098-1004(200005)15:5<410::AID-HUMU2>3.0.CO;2-D; Meissner G, 2002, FRONT BIOSCI, V7, pD2072, DOI 10.2741/meissner; Monnier N, 2002, ANESTHESIOLOGY, V97, P1067, DOI 10.1097/00000542-200211000-00007; Murayama T, 2007, BIOCHEM J, V402, P349, DOI 10.1042/BJ20061040; Murayama T, 2011, J BIOL CHEM, V286, P35571, DOI 10.1074/jbc.M111.255240; Nakai J, 1996, NATURE, V380, P72, DOI 10.1038/380072a0; Owen VJ, 1997, AM J PHYSIOL-CELL PH, V272, pC203, DOI 10.1152/ajpcell.1997.272.1.C203; Pendergrass W, 2004, CYTOM PART A, V61A, P162, DOI 10.1002/cyto.a.20033; Pessah IN, 1997, AM J PHYSIOL-CELL PH, V272, pC601, DOI 10.1152/ajpcell.1997.272.2.C601; PESSAH IN, 1985, BIOCHEM BIOPH RES CO, V128, P449, DOI 10.1016/0006-291X(85)91699-7; PESSAH IN, 1987, MOL PHARMACOL, V31, P232; PESSAH IN, 1991, MOL PHARMACOL, V39, P679; Rando TA, 1997, METHOD CELL BIOL, V52, P261, DOI 10.1016/S0091-679X(08)60382-9; Reiken S, 2003, J CELL BIOL, V160, P919, DOI 10.1083/jcb.200211012; Robinson R, 2006, HUM MUTAT, V27, P977, DOI 10.1002/humu.20356; Robinson RL, 2003, EUR J HUM GENET, V11, P342, DOI 10.1038/sj.ejhg.5200964; Rueffert H, 2001, BRIT J ANAESTH, V87, P240, DOI 10.1093/bja/87.2.240; SAITO A, 1984, J CELL BIOL, V99, P875, DOI 10.1083/jcb.99.3.875; Sonnleitner A, 1997, CELL CALCIUM, V21, P283, DOI 10.1016/S0143-4160(97)90116-0; Stewart SL, 2001, CLIN GENET, V59, P178, DOI 10.1034/j.1399-0004.2001.590306.x; Toppin PJ, 2010, CAN J ANAESTH, V57, P689, DOI 10.1007/s12630-010-9314-4; Vinciguerra M, 2010, ADV EXP MED BIOL, V694, P211; Voss AA, 2008, BIOCHEM BIOPH RES CO, V366, P988, DOI 10.1016/j.bbrc.2007.12.058; Yang TZ, 2006, ANESTHESIOLOGY, V105, P1164, DOI 10.1097/00000542-200612000-00016; Yang TZ, 2007, AM J PHYSIOL-CELL PH, V292, pC1591, DOI 10.1152/ajpcell.00133.2006; Yang TZ, 2003, J BIOL CHEM, V278, P25722, DOI 10.1074/jbc.M302165200; Yuen B. T., 2011, FASEB J, DOI 22131268; Zhao XL, 2006, J BIOL CHEM, V281, P33477, DOI 10.1074/jbc.M602306200; Zhou J, 2010, MILLERS ANESTHESIA, P1171	63	25	27	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2863	2876		10.1074/jbc.M111.307926	http://dx.doi.org/10.1074/jbc.M111.307926			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22139840	Green Published, hybrid			2022-12-27	WOS:000300292300058
J	Gogna, R; Madan, E; Kuppusamy, P; Pati, U				Gogna, Rajan; Madan, Esha; Kuppusamy, Periannan; Pati, Uttam			Chaperoning of Mutant p53 Protein by Wild-type p53 Protein Causes Hypoxic Tumor Regression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR CHAPERONES; P53-DEPENDENT TRANSACTIVATION; CANCER-THERAPY; APOPTOSIS; RESTORATION; CONFORMATION; ACTIVATION; MUTATIONS; PATHWAYS; PATIENT	Mutant (Mt) p53 abrogates tumor suppression functions of wild-type (WT) p53 through mutant-specific, gain-of-function effects, and patients bearing Mt p53 are chemoresistant. The dominant negative effect of p53 mutants results from their aggregation propensity which causes co-aggregation of WT p53. We explored the mechanism of p53 inactivation in hypoxia and hypothesized whether WT p53 could rescue Mt p53 in hypoxic tumors. WT p53 exists in mutant conformation in hypoxic core of MCF-7 solid tumors, and its conformation is oxygen-dependent. Under simulated hypoxia in cells, WT p53 undergoes conformational change in acquiring mutant conformation. An in vivo chaperone assay shows that WT p53 functions as a molecular chaperone in rescuing conformational and structural p53 mutants in cancer cells both at the transcription and proteome levels. WT p53 chaperone therapy is further shown to cause significant regression of tumor xenografts through reconversion of the mutant phenotype to wild-type p53. The chaperone function of WT p53 is directly linked to the induction of apoptosis in both cancer cells and tumor xenografts. As oncogenic p53 mutants are linked to chemoresistance in hypoxic tumors, p53 chaperone therapy will introduce new dimensions to existing cancer therapeutics. We propose that in cancer cells, WT p53 chaperoning may either exist as a cellular event to potentially reverse the dominant negative effect of its oncogenic mutants or to stabilize yet unidentified factors.	[Gogna, Rajan; Madan, Esha; Pati, Uttam] Jawaharlal Nehru Univ, Sch Biotechnol, Transcript & Human Biol Lab, New Delhi 110067, India; [Kuppusamy, Periannan] Ohio State Univ, Dept Internal Med, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA	Jawaharlal Nehru University, New Delhi; University System of Ohio; Ohio State University	Pati, U (corresponding author), Jawaharlal Nehru Univ, Sch Biotechnol, Transcript & Human Biol Lab, New Delhi 110067, India.	uttam@mail.jnu.ac.in	Pati, Uttam/L-9345-2019	GOGNA, RAJAN/0000-0001-7304-7692; MADAN, ESHA/0000-0002-4941-0612	Department of Biotechnology (India); University Grant Commission	Department of Biotechnology (India)(Department of Biotechnology (DBT) India); University Grant Commission(University Grants Commission, India)	This work was supported by grants from the Department of Biotechnology (India), and the University Grant Commission.	Achison M, 2003, ONCOGENE, V22, P3431, DOI 10.1038/sj.onc.1206434; Ashcroft M, 2000, MOL CELL BIOL, V20, P3224, DOI 10.1128/MCB.20.9.3224-3233.2000; Bajgelman MC, 2006, PROSTATE, V66, P1455, DOI 10.1002/pros.20462; Bourdon JC, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2811; Chandrachud U, 2009, TECHNOL CANCER RES T, V8, P445, DOI 10.1177/153303460900800606; Freeman BC, 2002, SCIENCE, V296, P2232, DOI 10.1126/science.1073051; GANNON JV, 1990, EMBO J, V9, P1595, DOI 10.1002/j.1460-2075.1990.tb08279.x; Goh AM, 2011, J PATHOL, V223, P116, DOI 10.1002/path.2784; GRAEBER TG, 1994, MOL CELL BIOL, V14, P6264, DOI 10.1128/MCB.14.9.6264; Hammond EM, 2006, CLIN CANCER RES, V12, P5007, DOI 10.1158/1078-0432.CCR-06-0613; Joerger AC, 2008, ANNU REV BIOCHEM, V77, P557, DOI 10.1146/annurev.biochem.77.060806.091238; Kim H, 2012, J MOL BIOL, V415, P843, DOI 10.1016/j.jmb.2011.12.001; Koumenis C, 2001, MOL CELL BIOL, V21, P1297, DOI 10.1128/MCB.21.4.1297-1310.2001; Kuppusamy P, 2002, CANCER RES, V62, P307; Lavrrar JL, 2004, J BIOL CHEM, V279, P46343, DOI 10.1074/jbc.M402692200; Liu T, 2007, CELL DEATH DIFFER, V14, P411, DOI 10.1038/sj.cdd.4402022; Martins CP, 2006, CELL, V127, P1323, DOI 10.1016/j.cell.2006.12.007; MILNER J, 1991, CELL, V65, P765, DOI 10.1016/0092-8674(91)90384-B; Nollen EAA, 2002, J CELL SCI, V115, P2809; Pan Y, 2004, ONCOGENE, V23, P4975, DOI 10.1038/sj.onc.1207657; Sauter ER, 2002, CANCER GENE THER, V9, P807, DOI 10.1038/sj.cgt.7700492; Schnitzer SE, 2006, CELL DEATH DIFFER, V13, P1611, DOI 10.1038/sj.cdd.4401864; Senzer N, 2007, MOL CANCER THER, V6, P1478, DOI 10.1158/1535-7163.MCT-07-0125; Shangary S, 2009, ANNU REV PHARMACOL, V49, P223, DOI 10.1146/annurev.pharmtox.48.113006.094723; Sharma AK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007159; SOMERS KD, 1992, CANCER RES, V52, P5997; Tripathi V, 2007, J BIOL CHEM, V282, P28441, DOI 10.1074/jbc.M703698200; Vaupel P, 2007, ANTIOXID REDOX SIGN, V9, P1221, DOI 10.1089/ars.2007.1628; Vazquez A, 2008, NAT REV DRUG DISCOV, V7, P979, DOI 10.1038/nrd2656; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Waldo GS, 1999, NAT BIOTECHNOL, V17, P691, DOI 10.1038/10904; Walerych D, 2009, ONCOGENE, V28, P4284, DOI 10.1038/onc.2009.281; Wang PL, 2001, ONCOGENE, V20, P2318, DOI 10.1038/sj.onc.1204316; Wiman KG, 2010, ONCOGENE, V29, P4245, DOI 10.1038/onc.2010.188; Xu J, 2011, NAT CHEM BIOL, V7, P285, DOI 10.1038/nchembio.546; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529	36	28	28	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2907	2914		10.1074/jbc.M111.317354	http://dx.doi.org/10.1074/jbc.M111.317354			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22147694	Green Published, hybrid			2022-12-27	WOS:000300292300062
J	Kelkar, DA; Khushoo, A; Yang, ZY; Skach, WR				Kelkar, Devaki A.; Khushoo, Amardeep; Yang, Zhongying; Skach, William R.			Kinetic Analysis of Ribosome-bound Fluorescent Proteins Reveals an Early, Stable, Cotranslational Folding Intermediate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NASCENT CHAIN COMPLEXES; IN-VITRO; EXIT TUNNEL; CHROMOPHORE FORMATION; CRYSTAL-STRUCTURE; NMR-SPECTROSCOPY; ENERGY LANDSCAPE; HELIX FORMATION; VIVO; GFP	Protein folding in cells reflects a delicate interplay between biophysical properties of the nascent polypeptide, the vectorial nature and rate of translation, molecular crowding, and cellular biosynthetic machinery. To better understand how this complex environment affects de novo folding pathways as they occur in the cell, we expressed beta-barrel fluorescent proteins derived from GFP and RFP in an in vitro system that allows direct analysis of cotranslational folding intermediates. Quantitative analysis of ribosome-bound eCFP and mCherry fusion proteins revealed that productive folding exhibits a sharp threshold as the length of polypeptide from the C terminus to the ribosome peptidyltransferase center is increased. Fluorescence spectroscopy, urea denaturation, and limited protease digestion confirmed that sequestration of only 10-15 C-terminal residues within the ribosome exit tunnel effectively prevents stable barrel formation, whereas folding occurs unimpeded when the C terminus is extended beyond the ribosome exit site. Nascent FPs with 10 of the 11 beta-strands outside the ribosome exit tunnel acquire a non-native conformation that is remarkably stable in diverse environments. Upon ribosome release, these structural intermediates fold efficiently with kinetics that are unaffected by the cytosolic crowding or cellular chaperones. Our results indicate that during synthesis, fluorescent protein folding is initiated cotranslationally via rapid formation of a highly stable, on-pathway structural intermediate and that the rate-limiting step of folding involves autonomous incorporation of the 11th beta-strand into the mature barrel structure.	[Kelkar, Devaki A.; Khushoo, Amardeep; Yang, Zhongying; Skach, William R.] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA	Oregon Health & Science University	Skach, WR (corresponding author), MC L-224,3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	skachw@ohsu.edu		Kelkar, Devaki/0000-0002-4442-9680	National Institutes of Health [GM53456, DK51818]; Cystic Fibrosis Foundation Therapeutics [SKACH05X0]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053456, R01GM053457] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation Therapeutics(Italian Cystic Fibrosis Research Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM53456 and DK51818 and Cystic Fibrosis Foundation Therapeutics Grant SKACH05X0.	Andrews BT, 2007, J MOL BIOL, V373, P476, DOI 10.1016/j.jmb.2007.07.071; Andrews BT, 2009, J MOL BIOL, V392, P218, DOI 10.1016/j.jmb.2009.06.072; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Bertz M, 2008, ANGEW CHEM INT EDIT, V47, P8192, DOI 10.1002/anie.200802987; Cabantous S, 2006, NAT METHODS, V3, P845, DOI 10.1038/nmeth932; Cabrita LD, 2009, P NATL ACAD SCI USA, V106, P22239, DOI 10.1073/pnas.0903750106; Clark PL, 2004, TRENDS BIOCHEM SCI, V29, P527, DOI 10.1016/j.tibs.2004.08.008; Clark PL, 2001, J BIOL CHEM, V276, P25411, DOI 10.1074/jbc.M008490200; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Daniel CJ, 2008, J BIOL CHEM, V283, P20864, DOI 10.1074/jbc.M803517200; Devaraneni PK, 2011, CELL, V146, P134, DOI 10.1016/j.cell.2011.06.004; Eichmann C, 2010, P NATL ACAD SCI USA, V107, P9111, DOI 10.1073/pnas.0914300107; Enoki S, 2004, BIOCHEMISTRY-US, V43, P14238, DOI 10.1021/bi048733+; Etchells SA, 2005, J BIOL CHEM, V280, P28118, DOI 10.1074/jbc.M504110200; Evans MS, 2008, J MOL BIOL, V383, P683, DOI 10.1016/j.jmb.2008.07.035; Evans MS, 2005, NAT METHODS, V2, P757, DOI 10.1038/NMETH790; FEDOROV AN, 1995, P NATL ACAD SCI USA, V92, P1227, DOI 10.1073/pnas.92.4.1227; Fukuda H, 2000, BIOCHEMISTRY-US, V39, P12025, DOI 10.1021/bi000543l; Fulle S, 2009, J MOL BIOL, V387, P502, DOI 10.1016/j.jmb.2009.01.037; Gajewski C, 2011, P NATL ACAD SCI USA, V108, P3240, DOI 10.1073/pnas.1017097108; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; HASEGAWA H, 1992, SCIENCE, V258, P1477, DOI 10.1126/science.1279809; Hoffmann A, 2006, J BIOL CHEM, V281, P6539, DOI 10.1074/jbc.M512345200; Hsu STD, 2009, CHEM SOC REV, V38, P2951, DOI 10.1039/b908170b; Hsu STD, 2009, BIOMOL NMR ASSIGN, V3, P67, DOI 10.1007/s12104-009-9143-y; Huang JR, 2007, J MOL BIOL, V370, P356, DOI 10.1016/j.jmb.2007.04.039; Huang JR, 2008, HFSP J, V2, P378, DOI 10.2976/1.2976660; Jansens A, 2002, SCIENCE, V298, P2401, DOI 10.1126/science.1078376; Johnson AE, 2005, FEBS LETT, V579, P916, DOI 10.1016/j.febslet.2004.11.046; Kamagata K, 2004, J MOL BIOL, V339, P951, DOI 10.1016/j.jmb.2004.04.015; Kent KP, 2008, J AM CHEM SOC, V130, P9664, DOI 10.1021/ja803782x; Kent KP, 2011, J AM CHEM SOC, V133, P4046, DOI 10.1021/ja110256c; Khushoo A, 2011, MOL CELL, V41, P682, DOI 10.1016/j.molcel.2011.02.027; Kleizen B, 2005, MOL CELL, V20, P277, DOI 10.1016/j.molcel.2005.09.007; Kosolapov A, 2009, NAT STRUCT MOL BIOL, V16, P405, DOI 10.1038/nsmb.1571; Kowarik M, 2002, MOL CELL, V10, P769, DOI 10.1016/S1097-2765(02)00685-8; Kramer G, 2009, NAT STRUCT MOL BIOL, V16, P589, DOI 10.1038/nsmb.1614; Krukenberg KA, 2011, Q REV BIOPHYS, V44, P229, DOI 10.1017/S0033583510000314; LEOPOLD PE, 1992, P NATL ACAD SCI USA, V89, P8721, DOI 10.1073/pnas.89.18.8721; Li XQ, 1997, J BIOL CHEM, V272, P28545, DOI 10.1074/jbc.272.45.28545; Lu JL, 2005, NAT STRUCT MOL BIOL, V12, P1123, DOI 10.1038/nsmb1021; Maggioni MC, 2005, NAT STRUCT MOL BIOL, V12, P258, DOI 10.1038/nsmb897; Mankin AS, 2006, TRENDS BIOCHEM SCI, V31, P11, DOI 10.1016/j.tibs.2005.11.007; Matagne A, 1998, CELL MOL LIFE SCI, V54, P363, DOI 10.1007/s000180050165; McCormick PJ, 2003, MOL CELL, V12, P329, DOI 10.1016/S1097-2765(03)00304-6; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Nicola AV, 1999, NAT CELL BIOL, V1, P341, DOI 10.1038/14032; O'Brien EP, 2008, NANO LETT, V8, P3702, DOI 10.1021/nl8019328; O'Brien EP, 2010, J AM CHEM SOC, V132, P16928, DOI 10.1021/ja106530y; Oberdorf Jon, 2002, Methods Mol Med, V70, P295; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; Ozkan SB, 2002, PROTEIN SCI, V11, P1958, DOI 10.1110/ps.0207102; PICKING WD, 1992, BIOCHEMISTRY-US, V31, P2368, DOI 10.1021/bi00123a023; POKROVSKAYA ID, 1994, ANAL BIOCHEM, V220, P420, DOI 10.1006/abio.1994.1360; Reeder PJ, 2010, BIOCHEMISTRY-US, V49, P10773, DOI 10.1021/bi100975z; Reid BG, 1997, BIOCHEMISTRY-US, V36, P6786, DOI 10.1021/bi970281w; Remington SJ, 2006, CURR OPIN STRUC BIOL, V16, P714, DOI 10.1016/j.sbi.2006.10.001; Sadlish H, 2005, NAT STRUCT MOL BIOL, V12, P870, DOI 10.1038/nsmb994; Schaffitzel C, 2007, J STRUCT BIOL, V158, P463, DOI 10.1016/j.jsb.2007.01.005; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Shu XK, 2006, BIOCHEMISTRY-US, V45, P9639, DOI 10.1021/bi060773l; Sniegowski JA, 2005, BIOCHEM BIOPH RES CO, V332, P657, DOI 10.1016/j.bbrc.2005.04.166; Svetlov MS, 2006, PROTEIN SCI, V15, P242, DOI 10.1110/ps.051752506; Thulasiraman V, 1999, EMBO J, V18, P85, DOI 10.1093/emboj/18.1.85; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Ugrinov KG, 2010, BIOPHYS J, V98, P1312, DOI 10.1016/j.bpj.2009.12.4291; Verkhusha VV, 2004, CHEM BIOL, V11, P845, DOI 10.1016/j.chembiol.2004.04.007; Voss NR, 2006, J MOL BIOL, V360, P893, DOI 10.1016/j.jmb.2006.05.023; WARD WW, 1982, PHOTOCHEM PHOTOBIOL, V35, P803, DOI 10.1111/j.1751-1097.1982.tb02651.x; Woolhead CA, 2004, CELL, V116, P725, DOI 10.1016/S0092-8674(04)00169-2; Xia K, 2007, P NATL ACAD SCI USA, V104, P17329, DOI 10.1073/pnas.0705417104; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246; Yarbrough D, 2001, P NATL ACAD SCI USA, V98, P462, DOI 10.1073/pnas.98.2.462; Ziv G, 2005, P NATL ACAD SCI USA, V102, P18956, DOI 10.1073/pnas.0508234102	75	37	37	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2568	2578		10.1074/jbc.M111.318766	http://dx.doi.org/10.1074/jbc.M111.318766			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22128180	Green Published, hybrid			2022-12-27	WOS:000300292300030
J	Torres-Bugeau, CM; Avila, CL; Raisman-Vozari, R; Papy-Garcia, D; Itri, R; Barbosa, LRS; Cortez, LM; Sim, VL; Chehin, RN				Torres-Bugeau, Clarisa M.; Avila, Cesar L.; Raisman-Vozari, Rita; Papy-Garcia, Dulce; Itri, Rosangela; Barbosa, Leandro R. S.; Cortez, Leonardo M.; Sim, Valerie L.; Chehin, Rosana N.			Characterization of Heparin-induced Glyceraldehyde-3-phosphate Dehydrogenase Early Amyloid-like Oligomers and Their Implication in alpha-Synuclein Aggregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-SCATTERING; FILAMENTOUS INCLUSIONS; MOONLIGHTING PROTEINS; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; FIBRIL FORMATION; BETA; GLYCOSAMINOGLYCANS; NEURODEGENERATION; FIBRILLOGENESIS	Lewy bodies and Lewy neurites, neuropathological hallmarks of several neurological diseases, are mainly made of filamentous assemblies of alpha-synuclein. However, other macromolecules including Tau, ubiquitin, glyceraldehyde-3-phosphate dehydrogenase, and glycosaminoglycans are routinely found associated with these amyloid deposits. Glyceraldehyde-3-phosphate dehydrogenase is a glycolytic enzyme that can form fibrillar aggregates in the presence of acidic membranes, but its role in Parkinson disease is still unknown. In this work, the ability of heparin to trigger the amyloid aggregation of this protein at physiological conditions of pH and temperature is demonstrated by infrared and fluorescence spectroscopy, dynamic light scattering, small angle x-ray scattering, circular dichroism, and fluorescence microscopy. Aggregation proceeds through the formation of short rod-like oligomers, which elongates in one dimension. Heparan sulfate was also capable of inducing glyceraldehyde-3-phosphate dehydrogenase aggregation, but chondroitin sulfates A, B, and C together with dextran sulfate had a negligible effect. Aided with molecular docking simulations, a putative binding site on the protein is proposed providing a rational explanation for the structural specificity of heparin and heparan sulfate. Finally, it is demonstrated that in vitro the early oligomers present in the glyceraldehyde-3-phosphate dehydrogenase fibrillation pathway promote alpha-synuclein aggregation. Taking into account the toxicity of alpha-synuclein prefibrillar species, the heparin-induced glyceraldehyde-3-phosphate dehydrogenase early oligomers might come in useful as a novel therapeutic strategy in Parkinson disease and other synucleinopathies.	[Torres-Bugeau, Clarisa M.; Avila, Cesar L.; Chehin, Rosana N.] CCT Tucuman, Inst Super Invest Biol, San Miguel De Tucuman, Argentina; [Torres-Bugeau, Clarisa M.; Avila, Cesar L.; Chehin, Rosana N.] Inst Quim Biol Dr Bernabe Bloj CONICET UNT, San Miguel De Tucuman, Argentina; [Raisman-Vozari, Rita] INSERM, CRICM, ICM, UMRS 975, F-91010 Creteil, France; [Papy-Garcia, Dulce] Univ Paris Est Creteil, Lab CRRET EAC CNRS 7149, F-94010 Creteil, France; [Itri, Rosangela; Barbosa, Leandro R. S.] Univ Sao Paulo, Inst Fis, BR-05508900 Sao Paulo, Brazil; [Cortez, Leonardo M.; Sim, Valerie L.] Univ Alberta, Ctr Prions & Prot Folding Dis, Edmonton, AB T6G 2M8, Canada	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Universidade de Sao Paulo; University of Alberta	Chehin, RN (corresponding author), INSIBIO, Chacabuco 461, RA-4000 San Miguel De Tucuman, Argentina.	rosana@fbqf.unt.edu.ar	Barbosa, Leandro Ramos Souza/E-6577-2012; Barbosa, Leandro Ramos Souza/GRJ-9680-2022; Barbosa, L. R. S./AAN-7787-2020; Itri, Rosangela/B-4312-2014; Sim, Valerie/C-4137-2013	Barbosa, Leandro Ramos Souza/0000-0001-5997-2160; Barbosa, Leandro Ramos Souza/0000-0001-5997-2160; Sim, Valerie/0000-0002-0088-8666; Avila, Cesar Luis/0000-0003-0187-7915; Cortez, Leonardo/0000-0003-4080-8728; Chehin, Rosana/0000-0003-3504-7952; Itri, Rosangela/0000-0001-9311-0804	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [PIP 2518]; Consejo Investigaciones de la Universidad Nacional de Tucuman (CIUNT) [26/D439-1]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Consejo Investigaciones de la Universidad Nacional de Tucuman (CIUNT); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) Grants PIP 2518 and Consejo Investigaciones de la Universidad Nacional de Tucuman (CIUNT) Grant 26/D439-1.; Recipient of a Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) research fellowship.	Ancsin JB, 2003, AMYLOID, V10, P67, DOI 10.3109/13506120309041728; Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200; ARRONDO JLR, 1994, BIOCHEMISTRY-US, V33, P11650, DOI 10.1021/bi00204a029; ARRONDO JLR, 1993, PROG BIOPHYS MOL BIO, V59, P23, DOI 10.1016/0079-6107(93)90006-6; ARRONDO JLR, 1988, BIOCHIM BIOPHYS ACTA, V952, P261, DOI 10.1016/0167-4838(88)90125-2; Avila CL, 2008, BIOPHYS CHEM, V137, P126, DOI 10.1016/j.bpc.2008.08.003; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BANEULOS S, 1995, J BIOL CHEM, V270, P9192; Barbosa LRS, 2008, J PHYS CHEM B, V112, P4261, DOI 10.1021/jp710332t; Barbosa LRS, 2010, BIOPHYS J, V98, P147, DOI 10.1016/j.bpj.2009.09.056; Bemporad F, 2009, FEBS LETT, V583, P2630, DOI 10.1016/j.febslet.2009.07.013; Bitomsky W, 1999, J AM CHEM SOC, V121, P3004, DOI 10.1021/ja983319g; Bourgault S, 2011, BIOCHEMISTRY-US, V50, P1001, DOI 10.1021/bi101822y; Calero Miguel, 2004, V299, P129; Carrotta R, 2001, PROTEIN SCI, V10, P1312, DOI 10.1110/ps.42501; Castillo GM, 1999, J NEUROCHEM, V72, P1681, DOI 10.1046/j.1471-4159.1999.721681.x; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Cohlberg JA, 2002, BIOCHEMISTRY-US, V41, P1502, DOI 10.1021/bi011711s; CORBIER C, 1990, BIOCHEMISTRY-US, V29, P7101, DOI 10.1021/bi00482a022; Cortez LM, 2010, FEBS LETT, V584, P625, DOI 10.1016/j.febslet.2009.12.012; Cotman SL, 2000, MOL CELL NEUROSCI, V15, P183, DOI 10.1006/mcne.1999.0816; Cowan-Jacob SW, 2003, ACTA CRYSTALLOGR D, V59, P2218, DOI 10.1107/S0907444903020493; DISCHE Z, 1950, J BIOL CHEM, V184, P517; DURRIEU C, 1987, ARCH BIOCHEM BIOPHYS, V252, P32, DOI 10.1016/0003-9861(87)90005-1; Eakin CM, 2004, BIOCHEMISTRY-US, V43, P7808, DOI 10.1021/bi049792q; Elam JS, 2003, NAT STRUCT BIOL, V10, P461, DOI 10.1038/nsb935; Glatter O., 1982, SMALL ANGLE XRAY SCA; Guinier A., 1955, SMALL ANGLE SCATTERI; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hoyer W, 2002, J MOL BIOL, V322, P383, DOI 10.1016/S0022-2836(02)00775-1; Huberts DHEW, 2010, BBA-MOL CELL RES, V1803, P520, DOI 10.1016/j.bbamcr.2010.01.022; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hurshman AR, 2004, BIOCHEMISTRY-US, V43, P7365, DOI 10.1021/bi049621l; Jeffery CJ, 2009, MOL BIOSYST, V5, P345, DOI 10.1039/b900658n; Valle-Delgado JJ, 2010, FASEB J, V24, P4250, DOI 10.1096/fj.09-153551; Khan S, 2010, J MOL BIOL, V395, P504, DOI 10.1016/j.jmb.2009.10.064; Kragten E, 1998, J BIOL CHEM, V273, P5821, DOI 10.1074/jbc.273.10.5821; Krysmann MJ, 2008, LANGMUIR, V24, P8158, DOI 10.1021/la800942n; LeVine H, 1999, METHOD ENZYMOL, V309, P274; Liu C, 2007, J BIOL CHEM, V282, P14558, DOI 10.1074/jbc.M700422200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maruyama W, 2001, J NEUROCHEM, V78, P727, DOI 10.1046/j.1471-4159.2001.00448.x; McLaurin J, 1999, EUR J BIOCHEM, V266, P1101, DOI 10.1046/j.1432-1327.1999.00957.x; Nussbaum RL, 2003, NEW ENGL J MED, V348, P1356, DOI 10.1056/NEJM2003ra020003; Ortore MG, 2009, J R SOC INTERFACE, V6, pS619, DOI 10.1098/rsif.2009.0163.focus; Papy-Garcia D, 2011, CURR PROTEIN PEPT SC, V12, P258, DOI 10.2174/138920311795860188; PERRY G, 1992, BRAIN RES, V579, P350, DOI 10.1016/0006-8993(92)90074-J; RISEMAN J, 1950, J CHEM PHYS, V18, P512, DOI 10.1063/1.1747672; Sirover MA, 1999, BBA-PROTEIN STRUCT M, V1432, P159, DOI 10.1016/S0167-4838(99)00119-3; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; SUGAHARA T, 1995, FEBS LETT, V368, P92, DOI 10.1016/0014-5793(95)00607-B; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tatton NA, 2000, EXP NEUROL, V166, P29, DOI 10.1006/exnr.2000.7489; Tatton WG, 2000, ADV RES NEURODEGENER, V8, P77; Tong JC, 2010, BRAIN, V133, P172, DOI 10.1093/brain/awp282; Tsuchiya K, 2005, EUR J NEUROSCI, V21, P317, DOI 10.1111/j.1460-9568.2005.03870.x; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; WEBER K, 1969, J BIOL CHEM, V244, P4406; Wood SJ, 1999, J BIOL CHEM, V274, P19509, DOI 10.1074/jbc.274.28.19509; Yamaji R, 2005, BBA-GEN SUBJECTS, V1726, P261, DOI 10.1016/j.bbagen.2005.07.013; ZHANG J, 1992, P NATL ACAD SCI USA, V89, P9382, DOI 10.1073/pnas.89.20.9382; Zhao HX, 2004, BIOCHEMISTRY-US, V43, P10302, DOI 10.1021/bi049002c	63	16	17	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2398	2409		10.1074/jbc.M111.303503	http://dx.doi.org/10.1074/jbc.M111.303503			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22134915	Green Published, hybrid			2022-12-27	WOS:000300292300015
J	Lee, CYD; Tse, W; Smith, JD; Landreth, GE				Lee, C. Y. Daniel; Tse, Wayne; Smith, Jonathan D.; Landreth, Gary E.			Apolipoprotein E Promotes beta-Amyloid Trafficking and Degradation by Modulating Microglial Cholesterol Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ONSET ALZHEIMER-DISEASE; ISOFORM-SPECIFIC BINDING; HIGH-DENSITY-LIPOPROTEIN; TRANSGENIC MOUSE MODEL; CENTRAL-NERVOUS-SYSTEM; A-I; RAB GTPASES; ENDOCYTIC PATHWAY; ENDOSOME MOTILITY; TRANSPORT PROTEIN	Allelic variation in the apolipoprotein E (APOE) gene is the major risk factor of sporadic Alzheimer disease. ApoE is the primary cholesterol carrier in the brain. Previously, we demonstrated that intracellular degradation of beta-amyloid (A beta) peptides by microglia is dramatically enhanced in the presence of apoE. However, the molecular mechanisms subserving this effect remain unknown. This study reports a mechanistic link between apoE-regulated cholesterol homeostasis and A beta degradation. We demonstrate that promoting intracellular A beta degradation by microglia is a common feature of HDL apolipoproteins, including apoE and apoA-I. This effect was not dependent on the direct interaction of apoE and A beta. Regulation of A beta degradation was achieved by solely manipulating cellular cholesterol levels. The expression and the activity of A beta degrading enzymes, however, were not regulated by cholesterol. We observed that reducing cellular cholesterol levels by apoE resulted in faster delivery of A beta to lysosomes and enhanced degradation. Moreover, apoE facilitated the recycling of Rab7, a small GTPase responsible for recruiting the motor complex to late endosomes/lysosomes. These data indicate that faster endocytic trafficking of A beta-containing vesicles in the presence of apoE resulted from efficient recycling of Rab7 from lysosomes to early endosomes. Thus, apoE-induced intracellular A beta degradation is mediated by the cholesterol efflux function of apoE, which lowers cellular cholesterol levels and subsequently facilitates the intracellular-trafficking of A beta to lysosomes for degradation. These findings demonstrate a direct role of cholesterol in the intracellular A beta degradation.	[Lee, C. Y. Daniel; Tse, Wayne; Landreth, Gary E.] Case Western Reserve Univ, Dept Neurosci, Cleveland, OH 44106 USA; [Smith, Jonathan D.] Cleveland Clin Fdn, Dept Cell Biol, Cleveland, OH 44195 USA	Case Western Reserve University; Cleveland Clinic Foundation	Landreth, GE (corresponding author), Case Western Reserve Univ, Dept Neurosci, 10900 Euclid Ave, Cleveland, OH 44106 USA.	gary.landreth@case.edu	Smith, Jonathan D./H-9723-2013	Smith, Jonathan D./0000-0002-0415-386X; Tse, Wayne/0000-0001-9868-1593	National Institutes of Health [R01-AG030482]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL098055] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG030482] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-AG030482 (to G. E. L.).	Aleshkov S, 1997, BIOCHEMISTRY-US, V36, P10571, DOI 10.1021/bi9626362; Bales KR, 2009, J NEUROSCI, V29, P6771, DOI 10.1523/JNEUROSCI.0887-09.2009; Castellano JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002156; Cavalli V, 2001, MOL CELL, V7, P421, DOI 10.1016/S1097-2765(01)00189-7; Chen HT, 2008, BIOPHYS J, V94, P1508, DOI 10.1529/biophysj.106.099366; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Datta G, 2001, J LIPID RES, V42, P1096; Falcone S, 2006, J CELL SCI, V119, P4758, DOI 10.1242/jcs.03238; Falkevall A, 2006, J BIOL CHEM, V281, P29096, DOI 10.1074/jbc.M602532200; Feng B, 2003, P NATL ACAD SCI USA, V100, P10423, DOI 10.1073/pnas.1732494100; Fielding PE, 2000, BIOCHEMISTRY-US, V39, P14113, DOI 10.1021/bi0004192; Fitz NF, 2010, J NEUROSCI, V30, P6862, DOI 10.1523/JNEUROSCI.1051-10.2010; Ganley IG, 2006, J BIOL CHEM, V281, P17890, DOI 10.1074/jbc.M601679200; Grehan S, 2001, J NEUROSCI, V21, P812, DOI 10.1523/JNEUROSCI.21-03-00812.2001; Gruenberg J, 2001, NAT REV MOL CELL BIO, V2, P721, DOI 10.1038/35096054; Handattu SP, 2009, NEUROBIOL DIS, V34, P525, DOI 10.1016/j.nbd.2009.03.007; Hara M, 2003, ARTERIOSCL THROM VAS, V23, P269, DOI 10.1161/01.ATV.0000054199.78458.4B; Helms JB, 2004, TRAFFIC, V5, P247, DOI 10.1111/j.1600-0854.2004.0181.x; Hirsch-Reinshagen V, 2005, J BIOL CHEM, V280, P43243, DOI 10.1074/jbc.M508781200; Holtzman DM, 2004, J MOL NEUROSCI, V23, P247, DOI 10.1385/JMN:23:3:247; Hutt DM, 2000, J BIOL CHEM, V275, P18511, DOI 10.1074/jbc.M909309199; Iwata N, 2000, NAT MED, V6, P143, DOI 10.1038/72237; Jiang Q, 2008, NEURON, V58, P681, DOI 10.1016/j.neuron.2008.04.010; Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026; Koenigsknecht J, 2004, J NEUROSCI, V24, P9838, DOI 10.1523/JNEUROSCI.2557-04.2004; Koldamova R, 2005, J BIOL CHEM, V280, P43224, DOI 10.1074/jbc.M504513200; Koldamova RP, 2001, BIOCHEMISTRY-US, V40, P3553, DOI 10.1021/bi002186k; Koldamova T, 2005, J BIOL CHEM, V280, P4079, DOI 10.1074/jbc.M411420200; Kuo YM, 1996, J BIOL CHEM, V271, P4077; LADU MJ, 1994, J BIOL CHEM, V269, P23403; LADU MJ, 1995, J BIOL CHEM, V270, P9039, DOI 10.1074/jbc.270.16.9039; Lebrand C, 2002, EMBO J, V21, P1289, DOI 10.1093/emboj/21.6.1289; Lefterov I, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-20; Levin-Allerhand J A, 2002, J Nutr Health Aging, V6, P315; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Lund-Katz S, 2010, SUBCELL BIOCHEM, V51, P183, DOI 10.1007/978-90-481-8622-8_7; Ma JY, 1996, NEUROBIOL AGING, V17, P773; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Mandrekar S, 2009, J NEUROSCI, V29, P4252, DOI 10.1523/JNEUROSCI.5572-08.2009; Martins IJ, 2009, J NEUROCHEM, V111, P1275, DOI 10.1111/j.1471-4159.2009.06408.x; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; Maxfield FR, 2006, BIOCHEM SOC T, V34, P335, DOI 10.1042/BST0340335; Maxfield FR, 2002, J CLIN INVEST, V110, P891, DOI 10.1172/JCI200216500; Michikawa M, 2000, J NEUROCHEM, V74, P1008, DOI 10.1046/j.1471-4159.2000.0741008.x; Mukhejee S, 2004, BBA-MOL CELL BIOL L, V1685, P28, DOI 10.1016/j.bbalip.2004.08.009; Mukherjee A, 2002, J ALZHEIMERS DIS, V4, P341, DOI 10.3233/JAD-2002-4501; NAMBA Y, 1991, BRAIN RES, V541, P163, DOI 10.1016/0006-8993(91)91092-F; NASLUND J, 1995, NEURON, V15, P219, DOI 10.1016/0896-6273(95)90079-9; Navab M, 2005, CIRC RES, V97, P1085, DOI 10.1161/01.RES.0000194558.86099.ba; Navab M, 2005, ARTERIOSCL THROM VAS, V25, P1325, DOI 10.1161/01.ATV.0000165694.39518.95; Navab M, 2004, CIRCULATION, V109, P3215, DOI 10.1161/01.CIR.0000134275.90823.87; Novick P, 1997, CURR OPIN CELL BIOL, V9, P496, DOI 10.1016/S0955-0674(97)80025-7; Ou JS, 2005, CIRC RES, V97, P1190, DOI 10.1161/01.RES.0000190634.60042.cb; Petanceska SS, 2002, J MOL NEUROSCI, V19, P155, DOI 10.1007/s12031-002-0026-2; Pfeffer S, 2004, NAT REV MOL CELL BIO, V5, P886, DOI 10.1038/nrm1500; Pfeffer SR, 2001, TRENDS CELL BIOL, V11, P487, DOI 10.1016/S0962-8924(01)02147-X; Pfrieger FW, 2003, CELL MOL LIFE SCI, V60, P1158, DOI 10.1007/s00018-003-3018-7; Poteryaev D, 2010, CELL, V141, P497, DOI 10.1016/j.cell.2010.03.011; Refolo LM, 2001, NEUROBIOL DIS, V8, P890, DOI 10.1006/nbdi.2001.0422; Refolo LM, 2000, NEUROBIOL DIS, V7, P321, DOI 10.1006/nbdi.2000.0304; Remaley AT, 2003, J LIPID RES, V44, P828, DOI 10.1194/jlr.M200475-JLR200; Riddell DR, 2007, MOL CELL NEUROSCI, V34, P621, DOI 10.1016/j.mcn.2007.01.011; Rocha N, 2009, J CELL BIOL, V185, P1209, DOI 10.1083/jcb.200811005; Rupper A, 2001, MOL BIOL CELL, V12, P2813, DOI 10.1091/mbc.12.9.2813; Sadowski M, 2004, AM J PATHOL, V165, P937, DOI 10.1016/S0002-9440(10)63355-X; Saura J, 2003, GLIA, V44, P183, DOI 10.1002/glia.10274; SCHMECHEL DE, 1993, P NATL ACAD SCI USA, V90, P9649, DOI 10.1073/pnas.90.20.9649; Seabra MC, 2002, TRENDS MOL MED, V8, P23, DOI 10.1016/S1471-4914(01)02227-4; Seachrist JL, 2003, LIFE SCI, V74, P225, DOI 10.1016/j.lfs.2003.09.009; SHEN CL, 1995, BIOPHYS J, V69, P640, DOI 10.1016/S0006-3495(95)79940-4; Soto C, 1996, BIOCHEM J, V314, P701, DOI 10.1042/bj3140701; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P8098, DOI 10.1073/pnas.90.17.8098; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Tokuda T, 2000, BIOCHEM J, V348, P359, DOI 10.1042/0264-6021:3480359; Umebayashi K, 2003, CELL STRUCT FUNCT, V28, P443, DOI 10.1247/csf.28.443; Vihervaara T, 2011, CELL MOL LIFE SCI, V68, P537, DOI 10.1007/s00018-010-0470-z; Wahrle SE, 2004, J BIOL CHEM, V279, P40987, DOI 10.1074/jbc.M407963200; Wahrle SE, 2008, J CLIN INVEST, V118, P671, DOI 10.1172/JCI33622; Wang N, 2001, J BIOL CHEM, V276, P23742, DOI 10.1074/jbc.M102348200; WISNIEWSKI T, 1992, NEUROSCI LETT, V135, P235, DOI 10.1016/0304-3940(92)90444-C; WISNIEWSKI T, 1993, BIOCHEM BIOPH RES CO, V192, P359, DOI 10.1006/bbrc.1993.1423; Xu SZ, 1997, J LIPID RES, V38, P1289; Yancey PG, 1996, J BIOL CHEM, V271, P16026, DOI 10.1074/jbc.271.27.16026; Zhang M, 2001, P NATL ACAD SCI USA, V98, P4466, DOI 10.1073/pnas.081070898	87	114	123	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					2032	2044		10.1074/jbc.M111.295451	http://dx.doi.org/10.1074/jbc.M111.295451			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22130662	hybrid, Green Published			2022-12-27	WOS:000299321000044
J	Silva, AC; Xu, XM; Kim, HS; Fillingham, J; Kislinger, T; Mennella, TA; Keogh, MC				Silva, Andrea C.; Xu, Xiaomeng; Kim, Hyun-Soo; Fillingham, Jeffrey; Kislinger, Thomas; Mennella, Thomas A.; Keogh, Michael-Christopher			The Replication-independent Histone H3-H4 Chaperones HIR, ASF1, and RTT106 Co-operate to Maintain Promoter Fidelity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION ELONGATION; INTRAGENIC TRANSCRIPTION; SPURIOUS TRANSCRIPTION; CRYPTIC TRANSCRIPTION; CHROMATIN-STRUCTURE; EUKARYOTIC GENOME; YEAST; DEPOSITION	RNA polymerase II initiates from low complexity sequences so cells must reliably distinguish "real" from "cryptic" promoters and maintain fidelity to the former. Further, this must be performed under a range of conditions, including those found within inactive and highly transcribed regions. Here, we used genome-scale screening to identify those factors that regulate the use of a specific cryptic promoter and how this is influenced by the degree of transcription over the element. We show that promoter fidelity is most reliant on histone gene transactivators (Spt10, Spt21) and H3-H4 chaperones (Asf1, HIR complex) from the replication-independent deposition pathway. Mutations of Rtt106 that abrogate its interactions with H3-H4 or dsDNA permit extensive cryptic transcription comparable with replication-independent deposition factor deletions. We propose that nucleosome shielding is the primary means to maintain promoter fidelity, and histone replacement is most efficiently mediated in yeast cells by a HIR/Asf1/H3-H4/Rtt106 pathway.	[Silva, Andrea C.; Xu, Xiaomeng; Kim, Hyun-Soo; Keogh, Michael-Christopher] Albert Einstein Coll Med, Dept Cell Biol, New York, NY 10461 USA; [Fillingham, Jeffrey] Ryerson Univ, Dept Biol & Chem, Toronto, ON ONB 2K3, Canada; [Kislinger, Thomas] Ontario Canc Inst, Toronto, ON M5G 1L7, Canada; [Mennella, Thomas A.] Delaware State Univ, Dept Biol Sci, Dover, DE 19901 USA	Yeshiva University; Toronto Metropolitan University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Delaware State University	Keogh, MC (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Cell Biol, Chanin 415A,1300 Morris Pk Ave, Bronx, NY 10461 USA.	michael.keogh@einstein.yu.edu	Silva, Andrea Cristina/K-8837-2014; Silva, Andrea/O-8852-2019; Kislinger, Thomas/A-5934-2008	Silva, Andrea Cristina/0000-0001-5248-5511; Kislinger, Thomas/0000-0003-3525-5540; kim, Hyun Soo/0000-0002-1792-1928	National Institutes of Health [T32 GM007491-34, 1R21 ES019966-01]; National Institutes of Health Cancer Center [2P30 CA013330]; NCI; Ryerson University; Natural Sciences and Engineering Research Council of Canada; National Institutes of Health under National Center for Research Resources [2P20 RR016472-11]; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016472] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES019966] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007491] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ryerson University; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Institutes of Health under National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by the National Institutes of Health Grants T32 GM007491-34 and 1R21 ES019966-01 and National Institutes of Health Cancer Center Support Grant 2P30 CA013330 Grant through the NCI (to the Albert Einstein College of Medicine).; Supported by start-up funding from Ryerson University and a Natural Sciences and Engineering Research Council of Canada discovery grant.; Supported by National Institutes of Health Grant 2P20 RR016472-11 under the IDeA Networks of Biomedical Research Excellence program of the National Center for Research Resources.	Agez M, 2007, STRUCTURE, V15, P191, DOI 10.1016/j.str.2007.01.002; Bai L, 2010, TRENDS GENET, V26, P476, DOI 10.1016/j.tig.2010.08.003; Breslow DK, 2008, NAT METHODS, V5, P711, DOI 10.1038/nmeth.1234; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Cheung V, 2008, PLOS BIOL, V6, P2550, DOI 10.1371/journal.pbio.0060277; Chu Y, 2007, EMBO J, V26, P4646, DOI 10.1038/sj.emboj.7601887; Daganzo SM, 2003, CURR BIOL, V13, P2148, DOI 10.1016/S0960-9822(03)00869-8; Das C, 2010, TRENDS BIOCHEM SCI, V35, P476, DOI 10.1016/j.tibs.2010.04.001; DOLLARD C, 1994, MOL CELL BIOL, V14, P5223, DOI 10.1128/MCB.14.8.5223; Drane P, 2010, GENE DEV, V24, P1253, DOI 10.1101/gad.566910; Driscoll R, 2007, SCIENCE, V315, P649, DOI 10.1126/science.1135862; English CM, 2006, CELL, V127, P495, DOI 10.1016/j.cell.2006.08.047; Eriksson PR, 2005, MOL CELL BIOL, V25, P9127, DOI 10.1128/MCB.25.20.9127-9137.2005; Fiedler D, 2009, CELL, V136, P952, DOI 10.1016/j.cell.2008.12.039; Fillingham J, 2008, MOL CELL BIOL, V28, P4342, DOI 10.1128/MCB.00182-08; Fillingham J, 2009, MOL CELL, V35, P340, DOI 10.1016/j.molcel.2009.06.023; Galvani A, 2008, MOL CELL BIOL, V28, P3672, DOI 10.1128/MCB.00510-07; Gillette TG, 2004, P NATL ACAD SCI USA, V101, P5904, DOI 10.1073/pnas.0305411101; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; Green EM, 2005, CURR BIOL, V15, P2044, DOI 10.1016/j.cub.2005.10.053; Heintzman ND, 2007, CELL MOL LIFE SCI, V64, P386, DOI 10.1007/s00018-006-6295-0; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Huang SB, 2005, P NATL ACAD SCI USA, V102, P13410, DOI 10.1073/pnas.0506176102; Huang SB, 2007, EMBO J, V26, P2274, DOI 10.1038/sj.emboj.7601670; Hwang WW, 2003, MOL CELL, V11, P261, DOI 10.1016/S1097-2765(02)00826-2; Imbeault D, 2008, J BIOL CHEM, V283, P27350, DOI 10.1074/jbc.C800147200; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Joshi AA, 2005, MOL CELL, V20, P971, DOI 10.1016/j.molcel.2005.11.021; Kaplan CD, 2003, SCIENCE, V301, P1096, DOI 10.1126/science.1087374; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Keogh MC, 2003, MOL CELL BIOL, V23, P7005, DOI 10.1128/MCB.23.19.7005-7018.2003; Keogh Michael-Christopher, 2004, Methods Mol Biol, V257, P1, DOI 10.1385/1-59259-750-5:001; Kim HS, 2009, NAT STRUCT MOL BIOL, V16, P1286, DOI 10.1038/nsmb.1688; Krawitz DC, 2002, MOL CELL BIOL, V22, P614, DOI 10.1128/MCB.22.2.614-625.2002; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Lambert JP, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.104; Lewis PW, 2010, P NATL ACAD SCI USA, V107, P14075, DOI 10.1073/pnas.1008850107; Li B, 2009, J BIOL CHEM, V284, P7970, DOI 10.1074/jbc.M808220200; Li Q, 2008, CELL, V134, P244, DOI 10.1016/j.cell.2008.06.018; Libuda DE, 2006, NATURE, V443, P1003, DOI 10.1038/nature05205; Liu YW, 2010, J BIOL CHEM, V285, P4251, DOI 10.1074/jbc.M109.055996; Mehta M, 2010, J BIOL CHEM, V285, P39855, DOI 10.1074/jbc.M110.185967; Mousson F, 2007, CHROMOSOMA, V116, P79, DOI 10.1007/s00412-006-0087-z; Nourani A, 2006, MOL CELL BIOL, V26, P1496, DOI 10.1128/MCB.26.4.1496-1509.2006; Osley M. A., 1987, MOL CELL BIOL, V7, P4202; OSLEY MA, 1986, CELL, V45, P537, DOI 10.1016/0092-8674(86)90285-0; OSLEY MA, 1981, CELL, V24, P377, DOI 10.1016/0092-8674(81)90327-5; Pattenden SG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012927; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pinskaya M, 2009, EMBO J, V28, P1697, DOI 10.1038/emboj.2009.108; Ransom M, 2010, CELL, V140, P183, DOI 10.1016/j.cell.2010.01.004; Schwabish MA, 2004, MOL CELL BIOL, V24, P10111, DOI 10.1128/MCB.24.23.10111-10117.2004; Schwabish MA, 2006, MOL CELL, V22, P415, DOI 10.1016/j.molcel.2006.03.014; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Segal E, 2009, TRENDS GENET, V25, P335, DOI 10.1016/j.tig.2009.06.002; Sipiczki M, 2000, GENOME BIOL, V1, DOI [10.1186/gb-2000-1-2-reviews1011, DOI 10.1186/GB-2000-1-2-REVIEWS1011]; Sutton A, 2001, GENETICS, V158, P587; Tang Y, 2006, NAT STRUCT MOL BIOL, V13, P921, DOI 10.1038/nsmb1147; Thebault P, 2011, MOL CELL BIOL, V31, P1288, DOI 10.1128/MCB.01083-10; Tong Amy Hin Yan, 2006, Methods Mol Biol, V313, P171; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Workman JL, 2006, GENE DEV, V20, P2009, DOI 10.1101/gad.1435706; Xie LQ, 2011, EMBO J, V30, P1473, DOI 10.1038/emboj.2011.91	63	45	47	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					1709	1718		10.1074/jbc.M111.316489	http://dx.doi.org/10.1074/jbc.M111.316489			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22128187	Green Published, hybrid			2022-12-27	WOS:000299321000014
J	Derache, C; Meudal, H; Aucagne, V; Mark, KJ; Cadene, M; Delmas, AF; Lalmanach, AC; Landon, C				Derache, Chrystelle; Meudal, Herve; Aucagne, Vincent; Mark, Kevin J.; Cadene, Martine; Delmas, Agnes F.; Lalmanach, Anne-Christine; Landon, Celine			Initial Insights into Structure-Activity Relationships of Avian Defensins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIMICROBIAL PEPTIDES; MAMMALIAN DEFENSINS; BETA-DEFENSINS; PREVENTION; MECHANISM; APIDAECIN; PROGRAM	Numerous beta-defensins have been identified in birds, and the potential use of these peptides as alternatives to antibiotics has been proposed, in particular to fight antibiotic-resistant and zoonotic bacterial species. Little is known about the mechanism of antibacterial activity of avian beta-defensins, and this study was carried out to obtain initial insights into the involvement of structural features or specific residues in the antimicrobial activity of chicken AvBD2. Chicken AvBD2 and its enantiomeric counterpart were chemically synthesized. Peptide elongation and oxidative folding were both optimized. The similar antimicrobial activity measured for both L-and D-proteins clearly indicates that there is no chiral partner. Therefore, the bacterial membrane is in all likelihood the primary target. Moreover, this work indicates that the three-dimensional fold is required for an optimal antimicrobial activity, in particular for Gram-positive bacterial strains. The three-dimensional NMR structure of chicken AvBD2 defensin displays the structural three-stranded antiparallel beta-sheet characteristic of beta-defensins. The surface of the molecule does not display any amphipathic character. In light of this new structure and of the king penguin AvBD103b defensin structure, the consensus sequence of the avian beta-defensin family was analyzed. Well conserved residues were highlighted, and the potential strategic role of the lysine 31 residue of AvBD2 was emphasized. The synthetic AvBD2-K31A variant displayed substantial N-terminal structural modifications and a dramatic decrease in activity. Taken together, these results demonstrate the structural as well as the functional role of the critical lysine 31 residue in antimicrobial activity.	[Lalmanach, Anne-Christine] INRA, UR1282, Ctr Rech Tours, Unite Infectiol Anim & Sante Publ, F-37380 Nouzilly, France; [Derache, Chrystelle; Meudal, Herve; Aucagne, Vincent; Mark, Kevin J.; Cadene, Martine; Delmas, Agnes F.; Landon, Celine] CNRS, UPR4301, Ctr Biophys Mol, F-45071 Orleans, France	INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC)	Lalmanach, AC (corresponding author), INRA, UR1282, Ctr Rech Tours, Unite Infectiol Anim & Sante Publ, F-37380 Nouzilly, France.	Anne-Christine.Lalmanach@tours.inra.fr; celine.landon@cnrs-orleans.fr	Meudal, Hervé/B-5851-2016; Aucagne, Vincent/AAB-1856-2019	Meudal, Hervé/0000-0002-9642-3643; Lalmanach, Anne-Christine/0000-0002-2666-4839; Cadene, Martine/0000-0003-4936-2662; Aucagne, Vincent/0000-0002-2647-0188	Region Centre, France [3200068]; Institut National de la Recherche Agronomique and Region Centre; CNRS; TGE RMN THC [Fr3050]	Region Centre, France(Region Centre-Val de Loire); Institut National de la Recherche Agronomique and Region Centre(Region Centre-Val de Loire); CNRS(Centre National de la Recherche Scientifique (CNRS)); TGE RMN THC	The work was supported by "Biotechnocentre" Grant 3200068 from the Region Centre, France, by a doctoral fellowship from Institut National de la Recherche Agronomique and Region Centre, by a postdoctoral fellowship from CNRS. Financial support from the TGE RMN THC Fr3050 for conducting the research is gratefully acknowledged.	Boisbouvier J, 2000, J BIOMOL NMR, V16, P197, DOI 10.1023/A:1008354007926; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Cadene M, 2000, ANAL CHEM, V72, P5655, DOI 10.1021/ac000811l; CASTEELS P, 1994, BIOCHEM BIOPH RES CO, V199, P339, DOI 10.1006/bbrc.1994.1234; Castle M, 1999, J BIOL CHEM, V274, P32555, DOI 10.1074/jbc.274.46.32555; Chen J, 2000, BIOPOLYMERS, V55, P88, DOI 10.1002/1097-0282(2000)55:1<88::AID-BIP80>3.3.CO;2-B; Cremer GA, 2006, J PEPT SCI, V12, P437, DOI 10.1002/psc.746; Dathe M, 1999, BBA-BIOMEMBRANES, V1462, P71, DOI 10.1016/S0005-2736(99)00201-1; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Derache C, 2009, ANTIMICROB AGENTS CH, V53, P4647, DOI 10.1128/AAC.00301-09; Derache C, 2009, DEV COMP IMMUNOL, V33, P959, DOI 10.1016/j.dci.2009.03.005; EFSA, 2007, EFSA J, P97, DOI DOI 10.2903/J.EFSA.2007.98R; Epand R, 2003, BIOPOLYMERS, V71, P2, DOI 10.1002/bip.10372; Gabant G, 2008, METHODS, V46, P54, DOI 10.1016/j.ymeth.2008.10.021; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; HARWIG SSL, 1994, FEBS LETT, V342, P281, DOI 10.1016/0014-5793(94)80517-2; Hoover DM, 2003, ANTIMICROB AGENTS CH, V47, P2804, DOI 10.1128/AAC.47.9.2804-2809.2003; Hubbard SJ, 1993, NACCESS COMPUTER PRO; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Landon C, 2004, PROTEIN SCI, V13, P703, DOI 10.1110/ps.03404404; LEHRER RI, 1991, J IMMUNOL METHODS, V137, P167, DOI 10.1016/0022-1759(91)90021-7; Linge JP, 2001, METHOD ENZYMOL, V339, P71, DOI 10.1016/S0076-6879(01)39310-2; Marcos JF, 2009, EXPERT OPIN DRUG DIS, V4, P659, DOI 10.1517/17460440902992888; Melo MN, 2009, NAT REV MICROBIOL, V7, P245, DOI 10.1038/nrmicro2095; MILTON RCD, 1992, SCIENCE, V256, P1445, DOI 10.1126/science.1604320; NIKAIDO H, 1994, SCIENCE, V264, P382, DOI 10.1126/science.8153625; Pag U, 2008, J ANTIMICROB CHEMOTH, V61, P341, DOI 10.1093/jac/dkm479; Papo N, 2005, J BIOL CHEM, V280, P10378, DOI 10.1074/jbc.M412865200; Papo N, 2003, PEPTIDES, V24, P1693, DOI 10.1016/j.peptides.2003.09.013; Paquet F, 2010, FEBS J, V277, P5133, DOI 10.1111/j.1742-4658.2010.07927.x; Powers JPS, 2003, PEPTIDES, V24, P1681, DOI 10.1016/j.peptides.2003.08.023; Raetz C. R. H., 1987, ESCHERICHIA COLI SAL, P498; Sadeyen JR, 2006, MICROBES INFECT, V8, P1308, DOI 10.1016/j.micinf.2005.12.014; Sass V, 2008, INT J MED MICROBIOL, V298, P619, DOI 10.1016/j.ijmm.2008.01.011; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; Srinivas N, 2010, SCIENCE, V327, P1010, DOI 10.1126/science.1182749; Sugiarto H, 2007, FEMS MICROBIOL LETT, V270, P195, DOI 10.1111/j.1574-6968.2007.00642.x; Thouzeau C, 2003, J BIOL CHEM, V278, P51053, DOI 10.1074/jbc.M306839200; van Dijk A, 2008, VET IMMUNOL IMMUNOP, V124, P1, DOI 10.1016/j.vetimm.2007.12.006; WADE D, 1990, P NATL ACAD SCI USA, V87, P4761, DOI 10.1073/pnas.87.12.4761; Wei G, 2009, J BIOL CHEM, V284, P29180, DOI 10.1074/jbc.M109.018085; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Xie C, 2005, J BIOL CHEM, V280, P32921, DOI 10.1074/jbc.M503084200; Yang D, 2002, TRENDS IMMUNOL, V23, P291, DOI 10.1016/S1471-4906(02)02246-9; Yeung ATY, 2011, CELL MOL LIFE SCI, V68, P2161, DOI 10.1007/s00018-011-0710-x; Yount NY, 2006, BIOPOLYMERS, V84, P435, DOI 10.1002/bip.20543	48	25	26	1	21	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7746	7755		10.1074/jbc.M111.312108	http://dx.doi.org/10.1074/jbc.M111.312108			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22205704	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000301060200073
J	Quezada, LAL; Sajid, M; Lim, KC; McKerrow, JH				Quezada, Landys A. Lopez; Sajid, Mohammed; Lim, Kee C.; McKerrow, James H.			A Blood Fluke Serine Protease Inhibitor Regulates an Endogenous Larval Elastase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCHISTOSOMA-MANSONI; PROTEOMIC ANALYSIS; SKIN INVASION; CERCARIAE; SEQUENCE; HOST; PRAZIQUANTEL; INFLAMMATION; SENSITIVITY; SECRETIONS	The larvae of Schistosoma mansoni invade their mammalian host by utilizing a serine protease, cercarial elastase (SmCE), to degrade macromolecular proteins in host skin. The catalytic activity of serine and cysteine proteases can be regulated after activation by serpins. SmSrpQ, one of two S. mansoni serpins found in larval secretions, is only expressed during larval development and in the early stages of mammalian infection. In vitro, S-35-SmSrpQ was able to form an SDS-stable complex with a component of the larval lysate, but no complex was detected when S-35-SmSrpQ was incubated with several mammalian host proteases. Formation of a complex was sensitive to the protease active site inhibitors PMSF, Z-AAPF-CMK, and Z-AAPL-CMK. Western blot analysis of parasite lysates from different life stages detected a complex of comparable size to SmCE bound to SmSrpQ using anti-SmSrpQ or anti-SmCE antibodies. SmSrpQ and SmCE are located in adjacent but discrete compartments in the secretion glands of the parasite. Fluorescence immunohistochemical analysis of simulated infection showed co-localization of SmCE and SmSrpQ in host tissue suggesting a post release regulation of parasite protease activity during skin transversal. The results of this study suggest that cercarial elastase degradation of skin tissue is carefully regulated by SmSrpQ.	[Quezada, Landys A. Lopez] Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94158 USA; [Sajid, Mohammed] Leiden Univ, Med Ctr, NL-2333 ZA Leiden, Netherlands; [Lim, Kee C.; McKerrow, James H.] Univ Calif San Francisco, Dept Pathol, Sandler Ctr Drug Discovery, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of California System; University of California San Francisco	McKerrow, JH (corresponding author), 1700 4th St,Box 2550,UCSF QB3, San Francisco, CA 94158 USA.	James.McKerrow@ucsf.edu		Lopez Quezada, Landys/0000-0002-8789-4283	National Institutes of Health from NIGMS [R25 GM56847]; UCSF Microbial Pathogenesis Host Defense [T32AI060537]; Sandler Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007334, T32AI060537] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM056847] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); UCSF Microbial Pathogenesis Host Defense; Sandler Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health training grant R25 GM56847 from NIGMS. This work was also supported by the UCSF Microbial Pathogenesis Host Defense (training grant T32AI060537) and the Sandler Foundation.	ANDREWS P, 1981, ARZNEIMITTEL-FORSCH, V31-1, P538; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWNE HG, 1963, J PARASITOL, V49, P371, DOI 10.2307/3275800; CAMPBELL EJ, 1982, J CLIN INVEST, V70, P845, DOI 10.1172/JCI110681; CAMPBELL EJ, 1987, CHEST, V92, P161, DOI 10.1378/chest.92.1.161; Chen L, 2002, J BIOL CHEM, V277, P34329, DOI 10.1074/jbc.M201344200; COOK GC, 1988, LANCET, V1, P127; Cooley J, 2001, BIOCHEMISTRY-US, V40, P15762, DOI 10.1021/bi0113925; Curwen RS, 2006, MOL CELL PROTEOMICS, V5, P835, DOI 10.1074/mcp.M500313-MCP200; Dorsey CH, 2002, MICRON, V33, P279, DOI 10.1016/S0968-4328(01)00019-1; Duvoisin R., 2011, TRANSG IN PRESS 0928; Dvorak J, 2008, BIOCHIMIE, V90, P345, DOI 10.1016/j.biochi.2007.08.013; Ekeowa UI, 2009, CLIN SCI, V116, P837, DOI 10.1042/CS20080484; FISHELSON Z, 1992, EXP PARASITOL, V75, P87, DOI 10.1016/0014-4894(92)90124-S; GHENDLER Y, 1994, EXP PARASITOL, V78, P121, DOI 10.1006/expr.1994.1013; GONNERT R, 1977, Z PARASITENKD, V52, P129, DOI 10.1007/BF00389899; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Hansell E, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000262; Harrop R, 2000, PARASITOLOGY, V121, P385, DOI 10.1017/S003118209900640X; He YX, 2002, EXP PARASITOL, V102, P99, DOI 10.1016/S0014-4894(03)00024-9; INCANI RN, 1984, INT J PARASITOL, V14, P259, DOI 10.1016/0020-7519(84)90077-8; Kang JM, 2010, ACTA TROP, V116, P134, DOI 10.1016/j.actatropica.2010.06.007; Knight M, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001212; Knudsen GM, 2005, MOL CELL PROTEOMICS, V4, P1862, DOI 10.1074/mcp.M500097-MCP200; Kourilova P, 2004, J IMMUNOL, V172, P3766, DOI 10.4049/jimmunol.172.6.3766; LACLETTE JP, 1992, J IMMUNOL, V148, P124; Lim KC, 1999, AM J TROP MED HYG, V60, P487, DOI 10.4269/ajtmh.1999.60.487; Luke CJ, 2007, CELL, V130, P1108, DOI 10.1016/j.cell.2007.07.013; MCKERROW JH, 1985, J BIOL CHEM, V260, P3703; Quezada LAL, 2011, AN ACAD BRAS CIENC, V83, P663, DOI 10.1590/S0001-37652011000200025; RAY CA, 1992, CELL, V69, P597, DOI 10.1016/0092-8674(92)90223-Y; REMOLDODONNELL E, 1992, P NATL ACAD SCI USA, V89, P5635, DOI 10.1073/pnas.89.12.5635; Ross AG, 2007, LANCET INFECT DIS, V7, P218, DOI 10.1016/S1473-3099(07)70053-1; Salter JP, 2000, J BIOL CHEM, V275, P38667, DOI 10.1074/jbc.M006997200; Salter JP, 2002, J BIOL CHEM, V277, P24618, DOI 10.1074/jbc.M202364200; Skelly PJ, 2001, J PARASITOL, V87, P1218, DOI 10.1645/0022-3395(2001)087[1218:SMPSCB]2.0.CO;2; Stefanic S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000850; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; WHO, 2004, WORLD MED SITUATION, P93; WHO, 2010, SCHIST FACT SHEET 11; Yang YB, 2009, PARASITOL RES, V106, P221, DOI 10.1007/s00436-009-1654-z	41	20	21	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7074	7083		10.1074/jbc.M111.313304	http://dx.doi.org/10.1074/jbc.M111.313304			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22174417	Green Published, hybrid			2022-12-27	WOS:000301060200012
J	Kumar, V; Fahey, PG; Jong, YJI; Ramanan, N; O'Malley, KL				Kumar, Vikas; Fahey, Paul G.; Jong, Yuh-Jiin I.; Ramanan, Narendrakumar; O'Malley, Karen L.			Activation of Intracellular Metabotropic Glutamate Receptor 5 in Striatal Neurons Leads to Up-regulation of Genes Associated with Sustained Synaptic Transmission Including Arc/Arg3.1 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMEDIATE-EARLY GENE; SERUM RESPONSE FACTOR; ION CHANNELS; KINASE-II; EXPRESSION; RELEASE; TRANSCRIPTION; PLASTICITY; NUCLEUS; STIM1	The G-protein coupled receptor, metabotropic glutamate receptor 5 (mGluR5), is expressed on both cell surface and intracellular membranes in striatal neurons. Using pharmacological tools to differentiate membrane responses, we previously demonstrated that cell surface mGluR5 triggers rapid, transient cytoplasmic Ca2+ rises, resulting in c-Jun N-terminal kinase, Ca2+/calmodulin-dependent protein kinase, and cyclic adenosine 3',5'-monophosphate-responsive element-binding protein (CREB) phosphorylation, whereas stimulation of intracellular mGluR5 induces long, sustained Ca2+ responses leading to the phosphorylation of extracellular signal-regulated kinase (ERK1/2) and Elk-1 (Jong, Y. J., Kumar, V., and O'Malley, K. L. (2009) J. Biol. Chem. 284, 35827-35838). Using pharmacological, genetic, and bioinformatics approaches, the current findings show that both receptor populations up-regulate many immediate early genes involved in growth and differentiation. Activation of intracellular mGluR5 also up-regulates genes involved in synaptic plasticity including activity-regulated cytoskeletal-associated protein (Arc/Arg3.1). Mechanistically, intracellular mGluR5-mediated Arc induction is dependent upon extracellular and intracellular Ca2+ and ERK1/2 as well as calmodulin-dependent kinases as known chelators, inhibitors, and a dominant negative Ca2+/calmodulin-dependent protein kinase II construct block Arc increases. Moreover, intracellular mGluR5-induced Arc expression requires the serum response transcription factor (SRF) as wild type but not SRF-deficient neurons show this response. Finally, increased Arc levels due to high K+ depolarization is significantly reduced in response to a permeable but not an impermeable mGluR5 antagonist. Taken together, these data highlight the importance of intracellular mGluR5 in the cascade of events associated with sustained synaptic transmission.	[Kumar, Vikas; Fahey, Paul G.; Jong, Yuh-Jiin I.; Ramanan, Narendrakumar; O'Malley, Karen L.] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Washington University (WUSTL)	O'Malley, KL (corresponding author), 660 S Euclid Ave,Campus Box 8108, St Louis, MO 63110 USA.	omalleyk@pcg.wustl.edu	RAMANAN, NARENDRAKUMAR/L-7487-2018		National Institutes of Health [MH57817, MH69646, NS057105]; FRAXA; Simons Foundation; Bakewell Family Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH069646, R01MH057817] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057105] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FRAXA; Simons Foundation; Bakewell Family Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants MH57817 and MH69646 (to K. L. O.) and NS057105 (a Neuroscience Blueprint Core grant to Washington University). This work was also supported by a FRAXA Research Grant (to K. L. O. and V. K.), the Simons Foundation, and by the Bakewell Family Foundation, Bioinformatics Core and Chemical Genetics Screening Core facilities at Washington University School of Medicine.	ABRAHAM WC, 1991, MOL NEUROBIOL, V5, P297, DOI 10.1007/BF02935553; Alberi L, 2011, NEURON, V69, P437, DOI 10.1016/j.neuron.2011.01.004; Alvarez FJ, 2000, J COMP NEUROL, V422, P464, DOI 10.1002/1096-9861(20000703)422:3<464::AID-CNE11>3.0.CO;2-#; Bauer DC, 2011, BIOINFORMATICS, V27, pI7, DOI 10.1093/bioinformatics/btr217; Bloomer WAC, 2008, J BIOL CHEM, V283, P582, DOI 10.1074/jbc.M702451200; Bloomer WAC, 2007, BRAIN RES, V1153, P20, DOI 10.1016/j.brainres.2007.03.079; Boivin B, 2008, J RECEPT SIG TRANSD, V28, P15, DOI [10.1080/10799890801941889, 10.1080/10799890801941889 ]; Borlikova G, 2009, MOL NEUROBIOL, V40, P73, DOI 10.1007/s12035-009-8072-1; Bramham CR, 2008, J NEUROSCI, V28, P11760, DOI 10.1523/JNEUROSCI.3864-08.2008; Catania MV, 2007, MOL NEUROBIOL, V35, P298, DOI 10.1007/s12035-007-0022-1; Chai J, 2002, J PHYSIOL PHARMACOL, V53, P147; Chavis P, 1996, NATURE, V382, P719, DOI 10.1038/382719a0; Cheng KT, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001025; Choe ES, 2002, INT J MOL MED, V9, P3; Chotiner JK, 2010, LEARN MEMORY, V17, P117, DOI 10.1101/lm.1585910; Chowdhury S, 2006, NEURON, V52, P445, DOI 10.1016/j.neuron.2006.08.033; Dolen G, 2008, J PHYSIOL-LONDON, V586, P1503, DOI 10.1113/jphysiol.2008.150722; Donai H, 2003, NEUROSCI RES, V47, P399, DOI 10.1016/j.neures.2003.08.004; Fagni L, 2000, TRENDS NEUROSCI, V23, P80, DOI 10.1016/S0166-2236(99)01492-7; Feijoo CG, 2009, DEV DYNAM, V238, P2034, DOI 10.1002/dvdy.22006; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Galbraith MD, 2011, CURR OPIN GENET DEV, V21, P160, DOI 10.1016/j.gde.2011.01.011; Gasparini F, 2008, CURR OPIN DRUG DISC, V11, P655; Gomes DA, 2008, J BIOL CHEM, V283, P4344, DOI 10.1074/jbc.M706550200; Hermans E, 2001, BIOCHEM J, V359, P465, DOI 10.1042/0264-6021:3590465; Hoover PJ, 2011, P NATL ACAD SCI USA, V108, P13299, DOI 10.1073/pnas.1101664108; Huang F, 2007, J NEUROSCI, V27, P9054, DOI 10.1523/JNEUROSCI.2410-07.2007; Jones NM, 1998, NEUROCHEM INT, V32, P31, DOI 10.1016/S0197-0186(97)00050-8; Jong YJI, 2005, J BIOL CHEM, V280, P30469, DOI 10.1074/jbc.M501775200; Jong YJI, 2009, J BIOL CHEM, V284, P35827, DOI 10.1074/jbc.M109.046276; Katoh Y, 2004, EUR J BIOCHEM, V271, P4307, DOI 10.1111/j.1432-1033.2004.04372.x; Kim J, 2011, P NATL ACAD SCI USA, V108, P7838, DOI 10.1073/pnas.1103113108; Kucharska A, 2009, CELL SIGNAL, V21, P1794, DOI 10.1016/j.cellsig.2009.07.015; Kumar V, 2008, J BIOL CHEM, V283, P14072, DOI 10.1074/jbc.M708551200; Lefebvre C, 2000, NEUROREPORT, V11, P1631, DOI 10.1097/00001756-200006050-00007; de Maturana RL, 2010, CNS NEUROL DISORD-DR, V9, P601, DOI 10.2174/187152710793361531; Lorrain DS, 2002, NEUROSCI LETT, V327, P198, DOI 10.1016/S0304-3940(02)00393-2; MENNERICK S, 1995, J NEUROPHYSIOL, V73, P320, DOI 10.1152/jn.1995.73.1.320; Murtazina DA, 2011, BIOL REPROD, V85, P315, DOI 10.1095/biolreprod.111.091082; O'Malley KL, 2003, J BIOL CHEM, V278, P28210, DOI 10.1074/jbc.M300792200; Park CY, 2010, SCIENCE, V330, P101, DOI 10.1126/science.1191027; Park S, 2008, NEURON, V59, P70, DOI 10.1016/j.neuron.2008.05.023; Perez-Cadahia B, 2011, BIOCHEM CELL BIOL, V89, P61, DOI 10.1139/O10-138; Pintchovski SA, 2009, J NEUROSCI, V29, P1525, DOI 10.1523/JNEUROSCI.5575-08.2009; Pisani A, 2000, AMINO ACIDS, V19, P119, DOI 10.1007/s007260070040; Ramanan N, 2005, NAT NEUROSCI, V8, P759, DOI 10.1038/nn1462; Romano C, 1996, J COMP NEUROL, V367, P403, DOI 10.1002/(SICI)1096-9861(19960408)367:3<403::AID-CNE6>3.0.CO;2-9; Rozen S, 2000, Methods Mol Biol, V132, P365; Salido GM, 2011, ADV EXP MED BIOL, V704, P413, DOI 10.1007/978-94-007-0265-3_23; Shepherd JD, 2006, NEURON, V52, P475, DOI 10.1016/j.neuron.2006.08.034; Smith-Hicks C, 2010, NAT NEUROSCI, V13, P1082, DOI 10.1038/nn.2611; Stritt C, 2010, MOL CELL BIOL, V30, P1828, DOI 10.1128/MCB.01434-09; Thomas LS, 2001, NEUROPHARMACOLOGY, V41, P523, DOI 10.1016/S0028-3908(01)00091-0; Thomas LS, 2000, NEUROPHARMACOLOGY, V39, P1554, DOI 10.1016/S0028-3908(99)00223-3; Tian XY, 2010, MOL CELL NEUROSCI, V44, P94, DOI 10.1016/j.mcn.2010.01.012; Torocsik B, 2002, J NEUROSCI, V22, P8971; Tullai JW, 2004, J BIOL CHEM, V279, P20167, DOI 10.1074/jbc.M309260200; Tzingounis AV, 2006, NEURON, V52, P403, DOI 10.1016/j.neuron.2006.10.016; Vazdarjanova A, 2006, J COMP NEUROL, V498, P317, DOI 10.1002/cne.21003; Verde EMR, 2006, NEURON, V52, P461, DOI 10.1016/j.neuron.2006.09.031; Wang Y, 2009, NEUROSCI LETT, V460, P36, DOI 10.1016/j.neulet.2009.05.023; Wang YJ, 2010, SCIENCE, V330, P105, DOI 10.1126/science.1191086; Waung MW, 2008, NEURON, V59, P84, DOI 10.1016/j.neuron.2008.05.014; Wayman GA, 2006, NEURON, V50, P897, DOI 10.1016/j.neuron.2006.05.008; Zanocco-Marani T, 2010, CELL CYCLE, V9, P4771, DOI 10.4161/cc.9.24.14217; Zhao Y, 2010, ARTERIOSCL THROM VAS, V30, P1535, DOI 10.1161/ATVBAHA.109.191163	66	56	58	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5412	5425		10.1074/jbc.M111.301366	http://dx.doi.org/10.1074/jbc.M111.301366			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22179607	Green Published, hybrid			2022-12-27	WOS:000300638000022
J	Starr, AE; Dufour, A; Maier, J; Overall, CM				Starr, Amanda E.; Dufour, Antoine; Maier, Josefine; Overall, Christopher M.			Biochemical Analysis of Matrix Metalloproteinase Activation of Chemokines CCL15 and CCL23 and Increased Glycosaminoglycan Binding of CCL16	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCYTE CHEMOTACTIC PROTEIN-1; CC-CHEMOKINE; IN-VIVO; BIOLOGICAL-ACTIVITY; RECEPTOR-BINDING; CD26/DIPEPTIDYL-PEPTIDASE IV; HEMOFILTRATE CC-CHEMOKINE-1; PROTEOLYTIC ACTIVATION; NEUTROPHIL CHEMOTAXIS; NH2-TERMINAL RESIDUES	Leukocyte migration and activation is orchestrated by chemokines, the cleavage of which modulates their activity and glycosaminoglycan binding and thus their roles in inflammation and immunity. Early research identified proteolysis as a means of both activating or inactivating CXC chemokines and inactivating CC chemokines. Recent evidence has shown activating cleavages of the monocyte chemoattractants CCL15 and CCL23 by incubation with synovial fluid, although the responsible proteases could not be identified. Herein we show that CCL15 is processed in human synovial fluid by matrix metalloproteinases (MMPs) and serine proteases. Furthermore, a family-wide investigation of MMP processing of all 14 monocyte-directed CC chemokines revealed that each is precisely cleaved by one or more MMPs. By MALDI-TOF-MS, 149 cleavage sites were sequenced including the first reported instance of CCL1, CCL16, and CCL17 proteolysis. Full-length CCL15-(1-92) and CCL23-(1-99) were cleaved within their unique 31 and 32-amino acid residue extended amino termini, respectively. Unlike other CCL chemokines that lose activity and become receptor antagonists upon MMP cleavage, the prominent MMP-processed products CCL15-(25-92, 28-92) and CCL23-(26-99) are stronger agonists in calcium flux and Transwell CC receptor transfectant and monocytic THP-1 migration assays. MMP processing of CCL16-(1-97) in its extended carboxyl terminus yields two products, CCL16-(8-77) and CCL16-(8-85), with both showing unexpected enhanced glycosaminoglycan binding. Hence, our study reveals for the first time that MMPs activate the long amino-terminal chemokines CCL15 and CCL23 to potent forms that have potential to increase monocyte recruitment during inflammation.	[Overall, Christopher M.] Univ British Columbia, Ctr Blood Res, Life Sci Inst 4 401, Vancouver, BC V6T 1Z3, Canada; [Starr, Amanda E.; Dufour, Antoine; Overall, Christopher M.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Dufour, Antoine; Maier, Josefine; Overall, Christopher M.] Univ British Columbia, Dept Oral Biol & Med Sci, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia; University of British Columbia	Overall, CM (corresponding author), Univ British Columbia, Ctr Blood Res, Life Sci Inst 4 401, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	chris.overall@ubc.ca	Dufour, Antoine/AAB-7886-2019		Canadian Institutes; Michael Smith Research Foundation (University of British Columbia Centre for Blood Research); British Columbia Proteomics Network; Natural Sciences and Engineering Research Council of Canada; Michael Smith Foundation for Health Research; Canadian Institutes of Health Research Strategic Training [STP-53877]	Canadian Institutes(Canadian Institutes of Health Research (CIHR)); Michael Smith Research Foundation (University of British Columbia Centre for Blood Research); British Columbia Proteomics Network; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Canadian Institutes of Health Research Strategic Training(Canadian Institutes of Health Research (CIHR))	This work was supported by a Canadian Institutes of Health Research grant, an Infrastructure Grant from the Michael Smith Research Foundation (University of British Columbia Centre for Blood Research), and by the British Columbia Proteomics Network.; Supported by the Natural Sciences and Engineering Research Council of Canada, the Michael Smith Foundation for Health Research, and Canadian Institutes of Health Research Strategic Training Program STP-53877.	Baysal C, 2001, PROTEINS, V43, P150, DOI 10.1002/1097-0134(20010501)43:2<150::AID-PROT1027>3.0.CO;2-M; Berahovich RD, 2005, J IMMUNOL, V174, P7341, DOI 10.4049/jimmunol.174.11.7341; Blanpain C, 2003, J BIOL CHEM, V278, P5179, DOI 10.1074/jbc.M205684200; Butler GS, 2004, J BIOL CHEM, V279, P15615, DOI 10.1074/jbc.M312727200; CLARKLEWIS I, 1991, J BIOL CHEM, V266, P23128; ClarkLewis I, 1997, METHOD ENZYMOL, V287, P233; Cox JH, 2008, J BIOL CHEM, V283, P19389, DOI 10.1074/jbc.M800266200; Cox JH, 2010, ARTHRITIS RHEUM-US, V62, P3645, DOI 10.1002/art.27757; Dean RA, 2008, BLOOD, V112, P3455, DOI 10.1182/blood-2007-12-129080; Dean RA, 2007, MOL CELL PROTEOMICS, V6, P611, DOI 10.1074/mcp.M600341-MCP200; Delgado MB, 2001, EUR J IMMUNOL, V31, P699, DOI 10.1002/1521-4141(200103)31:3<699::AID-IMMU699>3.0.CO;2-6; Detheux M, 2000, J EXP MED, V192, P1501, DOI 10.1084/jem.192.10.1501; Escher SE, 1999, J PEPT RES, V54, P505, DOI 10.1034/j.1399-3011.1999.00125.x; Escher SE, 2004, J PEPT RES, V63, P36, DOI 10.1046/j.1399-3011.2004.00102.x; Forssmann U, 1997, FEBS LETT, V408, P211, DOI 10.1016/S0014-5793(97)00408-0; Forssmann U, 2001, J LEUKOCYTE BIOL, V70, P357; GONG JH, 1995, J EXP MED, V181, P631, DOI 10.1084/jem.181.2.631; Graham GJ, 1996, EMBO J, V15, P6506, DOI 10.1002/j.1460-2075.1996.tb01041.x; Howard OMZ, 2000, BLOOD, V96, P840, DOI 10.1182/blood.V96.3.840.015k32_840_845; Jarnagin K, 1999, BIOCHEMISTRY-US, V38, P16167, DOI 10.1021/bi9912239; Keller UAD, 2010, CANCER RES, V70, P7562, DOI 10.1158/0008-5472.CAN-10-1584; Kim JK, 2005, J LEUKOCYTE BIOL, V78, P442, DOI 10.1189/jlb.0305161; Kotarsky K, 2010, MUCOSAL IMMUNOL, V3, P40, DOI 10.1038/mi.2009.115; Kuschert GSV, 1999, BIOCHEMISTRY-US, V38, P12959, DOI 10.1021/bi990711d; Laguri C, 2008, CARBOHYD RES, V343, P2018, DOI 10.1016/j.carres.2008.01.047; Lambeir AM, 2001, J BIOL CHEM, V276, P29839, DOI 10.1074/jbc.M103106200; Laurence JS, 1998, BIOCHEMISTRY-US, V37, P9346, DOI 10.1021/bi980329l; Laurence JS, 2000, BIOCHEMISTRY-US, V39, P3401, DOI 10.1021/bi9923196; Laurence JS, 2001, BIOCHEMISTRY-US, V40, P4990, DOI 10.1021/bi002593w; Li QL, 2002, CELL, V111, P635, DOI 10.1016/S0092-8674(02)01079-6; Macphee CH, 1998, J IMMUNOL, V161, P6273; McQuibban GA, 2000, SCIENCE, V289, P1202, DOI 10.1126/science.289.5482.1202; McQuibban GA, 2002, BLOOD, V100, P1160, DOI 10.1182/blood.V100.4.1160.h81602001160_1160_1167; McQuibban GA, 2001, J BIOL CHEM, V276, P43503, DOI 10.1074/jbc.M107736200; Miao ZH, 2007, J IMMUNOL, V178, P7395, DOI 10.4049/jimmunol.178.11.7395; Mortier A, 2008, PHARMACOL THERAPEUT, V120, P197, DOI 10.1016/j.pharmthera.2008.08.006; Murphy PM, 2000, PHARMACOL REV, V52, P145; Murphy PM, 2002, PHARMACOL REV, V54, P227, DOI 10.1124/pr.54.2.227; Noso N, 1998, EUR J BIOCHEM, V253, P114, DOI 10.1046/j.1432-1327.1998.2530114.x; Nufer O, 1999, BIOCHEMISTRY-US, V38, P636, DOI 10.1021/bi981294s; Oravecz T, 1997, J EXP MED, V186, P1865, DOI 10.1084/jem.186.11.1865; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; Overall CM, 2004, BIOL CHEM, V385, P493, DOI 10.1515/BC.2004.058; Pardigol A, 1998, P NATL ACAD SCI USA, V95, P6308, DOI 10.1073/pnas.95.11.6308; Proost P, 2000, BLOOD, V96, P1674, DOI 10.1182/blood.V96.5.1674.h8001674a_1674_1680; Proost P, 1998, FEBS LETT, V432, P73, DOI 10.1016/S0014-5793(98)00830-8; Proost P, 1999, J BIOL CHEM, V274, P3988, DOI 10.1074/jbc.274.7.3988; Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100; Proudfoot AEI, 2001, J BIOL CHEM, V276, P10620, DOI 10.1074/jbc.M010867200; Quintero PA, 2010, J IMMUNOL, V184, P1575, DOI 10.4049/jimmunol.0900290; Richter R, 2005, J IMMUNOL, V175, P1599, DOI 10.4049/jimmunol.175.3.1599; Richter R, 2009, J IMMUNOL, V183, P1229, DOI 10.4049/jimmunol.0802145; Starr AE, 2009, METHOD ENZYMOL, V461, P281, DOI 10.1016/S0076-6879(09)05413-5; Stropes MP, 2009, J VIROL, V83, P10016, DOI 10.1128/JVI.00354-09; Struyf S, 1998, EUR J IMMUNOL, V28, P1262, DOI 10.1002/(SICI)1521-4141(199804)28:04<1262::AID-IMMU1262>3.0.CO;2-G; Tester AM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000312; Vakili J, 2001, J IMMUNOL, V167, P3406, DOI 10.4049/jimmunol.167.6.3406; Van den Steen PE, 2003, EUR J BIOCHEM, V270, P3739, DOI 10.1046/j.1432-1033.2003.03760.x; Van den Steen PE, 2003, BIOCHEM BIOPH RES CO, V310, P889, DOI 10.1016/j.bbrc.2003.09.098; Van den Steen PE, 2000, BLOOD, V96, P2673, DOI 10.1182/blood.V96.8.2673.h8002673_2673_2681; Vergote D, 2006, P NATL ACAD SCI USA, V103, P19182, DOI 10.1073/pnas.0604678103; Weber M, 1996, J EXP MED, V183, P681, DOI 10.1084/jem.183.2.681; Wolf M, 2003, AM J PATHOL, V162, P1183, DOI 10.1016/S0002-9440(10)63914-4; Wolf M, 2008, INT J BIOCHEM CELL B, V40, P1185, DOI 10.1016/j.biocel.2007.12.009; Wuyts A, 1999, J IMMUNOL, V163, P6155; Youn BS, 1997, J IMMUNOL, V159, P5201	66	50	54	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5848	5860		10.1074/jbc.M111.314609	http://dx.doi.org/10.1074/jbc.M111.314609			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22147696	Green Published, hybrid			2022-12-27	WOS:000300638000059
J	Xiong, H; Hong, J; Du, W; Lin, YW; Ren, LL; Wang, YC; Su, WY; Wang, JL; Cui, Y; Wang, ZH; Fang, JY				Xiong, Hua; Hong, Jie; Du, Wan; Lin, Yan-wei; Ren, Lin-lin; Wang, Ying-chao; Su, Wen-yu; Wang, Ji-lin; Cui, Yun; Wang, Zhen-hua; Fang, Jing-Yuan			Roles of STAT3 and ZEB1 Proteins in E-cadherin Down-regulation and Human Colorectal Cancer Epithelial-Mesenchymal Transition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION MOLECULES; COLON-CANCER; SIGNALING PATHWAY; TUMOR PROGRESSION; CARCINOMA-CELLS; EXPRESSION; PROMOTES; GROWTH; SNAIL; MIGRATION	The progression of colorectal carcinoma (CRC) to invasive and metastatic disease may involve localized occurrences of epithelial-mesenchymal transition (EMT). However, mechanisms of the EMT process in CRC progression are not fully understood. We previously showed that knockdown of signal transducer and activator of transcription 3 (STAT3) up-regulated E-cadherin (a key component in EMT progression) in CRC. In this study, we examined the roles of STAT3 in CRC EMT and ZEB1, an EMT inducer, in STAT3-induced down-regulation of E-cadherin. Knockdown of STAT3 significantly increased E-cadherin and decreased N-cadherin and vimentin expressions in highly invasive LoVo CRC cells. Meanwhile, overexpression of STAT3 significantly reduced E-cadherin and enhanced N-cadherin and vimentin expressions in weakly invasive SW1116 CRC cells. Activation of STAT3 significantly increased CRC cell invasiveness and resistance to apoptosis. Knockdown of STAT3 dramatically enhanced chemosensitivity of CRC cells to fluorouracil. STAT3 regulated ZEB1 expression in CRC cells, and the STAT3-induced decrease in E-cadherin and cell invasion depended on activation of ZEB1 in CRC cells. Additionally, pSTAT3Tyr-(705) and ZEB1 expressions were significantly correlated with TNM (tumor, lymph node, and metastasis stages) (p < 0.01). In conclusion, STAT3 may directly mediate EMT progression and regulate ZEB1 expression in CRC. ZEB1 may participate in STAT3-induced cell invasion and E-cadherin down-regulation in CRC cells. The expressions of pSTAT3Tyr-(705) and ZEB1 may be positively associated with CRC metastasis. Our data may provide potential targets to prevent and/ or treat CRC invasion and metastasis.	[Xiong, Hua; Hong, Jie; Du, Wan; Lin, Yan-wei; Ren, Lin-lin; Wang, Ying-chao; Su, Wen-yu; Wang, Ji-lin; Cui, Yun; Wang, Zhen-hua; Fang, Jing-Yuan] Shanghai Jiao Tong Univ, Gastrointestinal Div,State Key Lab Oncogenes & Ge, Sch Med,Shanghai Inst Digest Dis,Minist Hlth, Renji Hosp,Key Lab Gastroenterol & Hepatol, Shanghai 200001, Peoples R China	Shanghai Jiao Tong University	Hong, J (corresponding author), Shanghai Jiao Tong Univ, Gastrointestinal Div,State Key Lab Oncogenes & Ge, Sch Med,Shanghai Inst Digest Dis,Minist Hlth, Renji Hosp,Key Lab Gastroenterol & Hepatol, 145 Middle Shandong Rd, Shanghai 200001, Peoples R China.	jiehong97@gmail.com; jingyuanfang@yahoo.com	wang, yingying/GRS-3058-2022		National Natural Science Foundation of China [30900757, 91129724]; "Chen Guang" Project [09CG13]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "Chen Guang" Project	This work was supported by National Natural Science Foundation of China Grant 30900757 (to F. J. Y.), National Natural Science Foundation of China Grant 91129724 (to J. H.), and "Chen Guang" Project Grant 09CG13 (to J. H.).	Aigner K, 2007, ONCOGENE, V26, P6979, DOI 10.1038/sj.onc.1210508; Alvarez JV, 2006, CANCER RES, V66, P3162, DOI 10.1158/0008-5472.CAN-05-3757; Arias AM, 2001, CELL, V105, P425, DOI 10.1016/S0092-8674(01)00365-8; Arima Y, 2008, CANCER RES, V68, P5104, DOI 10.1158/0008-5472.CAN-07-5680; Bates RC, 2005, CANCER BIOL THER, V4, P365; Bhowmick NA, 2001, MOL BIOL CELL, V12, P27, DOI 10.1091/mbc.12.1.27; Blaschuk OW, 2009, EUR J PHARMACOL, V625, P195, DOI 10.1016/j.ejphar.2009.05.033; Cavallaro U, 2006, EXP CELL RES, V312, P659, DOI 10.1016/j.yexcr.2005.09.019; Chen YL, 2011, HEPATOLOGY, V53, P1708, DOI 10.1002/hep.24254; Colomiere M, 2009, BRIT J CANCER, V100, P134, DOI 10.1038/sj.bjc.6604794; Cottonham CL, 2010, J BIOL CHEM, V285, P35293, DOI 10.1074/jbc.M110.160069; Ellenrieder V, 2001, CANCER RES, V61, P4222; Ferrand A, 2004, EXP CELL RES, V301, P128, DOI 10.1016/j.yexcr.2004.07.037; Fu XY, 2006, J BIOL CHEM, V281, P20368, DOI 10.1074/jbc.M603353200; Gan Y, 2010, ONCOGENE, V29, P4947, DOI 10.1038/onc.2010.240; Gire W, 2004, EMBO J, V23, P2554, DOI 10.1038/sj.emboj.7600259; Gulhati P, 2011, CANCER RES, V71, P3246, DOI 10.1158/0008-5472.CAN-10-4058; Hay ED, 1995, ACTA ANAT, V154, P8; Hecht M, 2004, CANCER RES, V64, P6109, DOI 10.1158/0008-5472.CAN-04-1014; Jaattela M, 1999, EXP CELL RES, V248, P30, DOI 10.1006/excr.1999.4455; Jeanes A, 2008, ONCOGENE, V27, P6920, DOI 10.1038/onc.2008.343; Joyce T, 2009, CLIN EXP METASTAS, V26, P569, DOI 10.1007/s10585-009-9256-9; Kalogeropoulou M, 2010, MOL CANCER RES, V8, P554, DOI 10.1158/1541-7786.MCR-09-0159; Kusaba T, 2006, ONCOL REP, V15, P1445; Lassmann S, 2007, J CLIN PATHOL, V60, P173, DOI 10.1136/jcp.2005.035113; Lu R, 2007, J BIOL CHEM, V282, P12249, DOI 10.1074/jbc.M608525200; Luna-Zurita L, 2010, J CLIN INVEST, V120, P3493, DOI 10.1172/JCI42666; Makrilia N, 2009, CANCER INVEST, V27, P1023, DOI 10.3109/07357900902769749; Markowitz SD, 2002, CANCER CELL, V1, P233, DOI 10.1016/S1535-6108(02)00053-3; Morita Y, 2000, P NATL ACAD SCI USA, V97, P5405, DOI 10.1073/pnas.090084797; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Niwa Y, 2005, ONCOGENE, V24, P6406, DOI 10.1038/sj.onc.1208788; Papageorgis P, 2010, CANCER RES, V70, P968, DOI 10.1158/0008-5472.CAN-09-1872; Paschos KA, 2009, CELL SIGNAL, V21, P665, DOI 10.1016/j.cellsig.2009.01.006; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Perez-Moreno M, 2003, CELL, V112, P535, DOI 10.1016/S0092-8674(03)00108-9; Qiao YY, 2011, CANCER RES, V71, P3076, DOI 10.1158/0008-5472.CAN-10-2787; Ren DY, 2011, GENES CELLS, V16, P304, DOI 10.1111/j.1365-2443.2011.01487.x; Sano S, 1999, EMBO J, V18, P4657, DOI 10.1093/emboj/18.17.4657; Savagner P, 2001, BIOESSAYS, V23, P912, DOI 10.1002/bies.1132; Spano JP, 2006, EUR J CANCER, V42, P2668, DOI 10.1016/j.ejca.2006.07.006; Stemmer V, 2008, ONCOGENE, V27, P5075, DOI 10.1038/onc.2008.140; Sullivan NJ, 2009, ONCOGENE, V28, P2940, DOI 10.1038/onc.2009.180; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Vincent T, 2009, NAT CELL BIOL, V11, P943, DOI 10.1038/ncb1905; Wang YY, 2005, P NATL ACAD SCI USA, V102, P1104, DOI 10.1073/pnas.0408831102; Xiong H, 2008, NEOPLASIA, V10, P287, DOI 10.1593/neo.07971; Yamashita S, 2002, DEV CELL, V2, P363, DOI 10.1016/S1534-5807(02)00126-0; Zhang F, 2003, ONCOGENE, V22, P894, DOI 10.1038/sj.onc.1206158	50	226	238	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5819	5832		10.1074/jbc.M111.295964	http://dx.doi.org/10.1074/jbc.M111.295964			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22205702	hybrid, Green Published			2022-12-27	WOS:000300638000057
J	Hess, DT; Stamler, JS				Hess, Douglas T.; Stamler, Jonathan S.			Regulation by S-Nitrosylation of Protein Post-translational Modification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							NITRIC-OXIDE SYNTHASE; AKT/PROTEIN KINASE-B; NEURONAL CELL-DEATH; NF-KAPPA-B; PARKINSONS-DISEASE; TYROSINE PHOSPHATASES; MEDIATED DEGRADATION; SIGNAL-TRANSDUCTION; INSULIN-RESISTANCE; OXIDATIVE STRESS	Protein post-translational modification by S-nitrosylation conveys a ubiquitous influence of nitric oxide on signal transduction in eukaryotic cells. The wide functional purview of S-nitrosylation reflects in part the regulation by S-nitrosylation of the principal protein post-translational modifications that play a role in cell signaling, including phosphorylation, acetylation, ubiquitylation and related modifications, palmitoylation, and alternative Cys-based redox modifications. In this minireview, we discuss the mechanisms through which S-nitrosylation exerts its broad pleiotropic influence on protein post-translational modification.	[Hess, Douglas T.; Stamler, Jonathan S.] Case Western Reserve Univ, Inst Transformat Mol Med, Cleveland, OH 44106 USA; [Hess, Douglas T.; Stamler, Jonathan S.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Stamler, Jonathan S.] Univ Hosp Case Med Ctr, Cleveland, OH USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital	Stamler, JS (corresponding author), Case Western Reserve Univ, Inst Transformat Mol Med, Cleveland, OH 44106 USA.	jonathan.stamler@case.edu		Stamler, Jonathan/0000-0002-6866-1572	National Institutes of Health [R01HL059130, R01HL095463, R01HL091876, P01HL75443]; Defense Advanced Research Projects Agency [N66001-10-C-2015]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091876, R01HL059130, R01HL095463, P01HL075443] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL059130, R01HL095463, R01HL091876, and P01HL75443. This work was also supported by Defense Advanced Research Projects Agency Grant N66001-10-C-2015. This is the third article in the Thematic Minireview Series on Redox Sensing and Regulation.	Adam L, 1999, J BIOL CHEM, V274, P26337, DOI 10.1074/jbc.274.37.26337; Akerstrom S, 2009, VIROLOGY, V395, P1, DOI 10.1016/j.virol.2009.09.007; ARNELLE DR, 1995, ARCH BIOCHEM BIOPHYS, V318, P279, DOI 10.1006/abbi.1995.1231; Azad N, 2006, J BIOL CHEM, V281, P34124, DOI 10.1074/jbc.M602551200; Baba SP, 2009, CHEM-BIOL INTERACT, V178, P250, DOI 10.1016/j.cbi.2008.11.007; Baker TL, 2000, J BIOL CHEM, V275, P22037, DOI 10.1074/jbc.M001813200; Barrett DM, 2005, J BIOL CHEM, V280, P14453, DOI 10.1074/jbc.M411523200; Benhar M, 2009, NAT REV MOL CELL BIO, V10, P721, DOI 10.1038/nrm2764; Bogdan C, 2001, TRENDS CELL BIOL, V11, P66, DOI 10.1016/S0962-8924(00)01900-0; Brune B, 2001, CELL SIGNAL, V13, P525, DOI 10.1016/S0898-6568(01)00175-9; Carvalho MA, 2005, DIABETES, V54, P959, DOI 10.2337/diabetes.54.4.959; Chanvorachote P, 2005, J BIOL CHEM, V280, P42044, DOI 10.1074/jbc.M510080200; Chen YY, 2008, J BIOL CHEM, V283, P35265, DOI 10.1074/jbc.M805287200; Choi H, 2011, J CARDIOVASC PHARM, V57, P65, DOI 10.1097/FJC.0b013e3181fef9cb; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Chung KKK, 2004, SCIENCE, V304, P1328, DOI 10.1126/science.1093891; Colussi C, 2008, P NATL ACAD SCI USA, V105, P19183, DOI 10.1073/pnas.0805514105; El-Husseini AED, 2002, NAT REV NEUROSCI, V3, P791, DOI 10.1038/nrn940; Erwin PA, 2005, J BIOL CHEM, V280, P19888, DOI 10.1074/jbc.M413058200; Eu JP, 2000, CELL, V102, P499, DOI 10.1016/S0092-8674(00)00054-4; Fang JG, 2007, P NATL ACAD SCI USA, V104, P18742, DOI 10.1073/pnas.0705904104; Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095; Foster MW, 2003, TRENDS MOL MED, V9, P160, DOI 10.1016/S1471-4914(03)00028-5; Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; HESS DT, 1993, NATURE, V366, P562, DOI 10.1038/366562a0; Ho GPH, 2011, NEURON, V71, P131, DOI 10.1016/j.neuron.2011.05.033; Hsu MF, 2010, J BIOL CHEM, V285, P7919, DOI 10.1074/jbc.M109.057513; Hu RG, 2005, NATURE, V437, P981, DOI 10.1038/nature04027; Illi B, 2009, PHARMACOL THERAPEUT, V123, P344, DOI 10.1016/j.pharmthera.2009.05.003; Janssen-Heininger YMW, 2008, FREE RADICAL BIO MED, V45, P1, DOI 10.1016/j.freeradbiomed.2008.03.011; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kelleher ZT, 2007, J BIOL CHEM, V282, P30667, DOI 10.1074/jbc.M705929200; Kim S, 2004, MOL CELL BIOL, V24, P330, DOI 10.1128/MCB.24.1.330-337.2004; Kim SO, 2002, CELL, V109, P383, DOI 10.1016/S0092-8674(02)00723-7; Kornberg MD, 2010, NAT CELL BIOL, V12, P1094, DOI 10.1038/ncb2114; Kumar S, 2010, FREE RADICAL BIO MED, V48, P851, DOI 10.1016/j.freeradbiomed.2010.01.004; Kwak YD, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-49; Li F, 2007, MOL CELL, V26, P63, DOI 10.1016/j.molcel.2007.02.024; Lima B, 2009, P NATL ACAD SCI USA, V106, P6297, DOI 10.1073/pnas.0901043106; Lopez-Otin C, 2010, NAT REV CANCER, V10, P278, DOI 10.1038/nrc2823; Mannick JB, 2001, J CELL BIOL, V154, P1111, DOI 10.1083/jcb.200104008; Mannick JB, 1999, SCIENCE, V284, P651, DOI 10.1126/science.284.5414.651; Murillo-Carretero M, 2009, FREE RADICAL BIO MED, V46, P471, DOI 10.1016/j.freeradbiomed.2008.10.048; Murphy E., 2012, J MOL CELL IN PRESS; Nakamura T, 2010, MOL CELL, V39, P184, DOI 10.1016/j.molcel.2010.07.002; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nott A, 2008, NATURE, V455, P411, DOI 10.1038/nature07238; Numajiri N, 2011, P NATL ACAD SCI USA, V108, P10349, DOI 10.1073/pnas.1103503108; Okumura F, 2008, J BIOL CHEM, V283, P24484, DOI 10.1074/jbc.M803795200; Ozawa K, 2008, MOL CELL, V31, P395, DOI 10.1016/j.molcel.2008.05.024; Palmer LA, 2000, MOL PHARMACOL, V58, P1197, DOI 10.1124/mol.58.6.1197; Park HS, 2006, BIOCHEM BIOPH RES CO, V351, P281, DOI 10.1016/j.bbrc.2006.10.034; Park HS, 2000, P NATL ACAD SCI USA, V97, P14382, DOI 10.1073/pnas.97.26.14382; Park HS, 2004, J BIOL CHEM, V279, P7584, DOI 10.1074/jbc.M304183200; Pei DS, 2009, NEUROCHEM RES, V34, P1507, DOI 10.1007/s11064-009-9938-3; Pi XC, 2009, P NATL ACAD SCI USA, V106, P5675, DOI 10.1073/pnas.0809568106; Qu J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001085; Qu J, 2011, P NATL ACAD SCI USA, V108, P14330, DOI 10.1073/pnas.1105172108; Rahman MA, 2010, J BIOL CHEM, V285, P3806, DOI 10.1074/jbc.M109.059782; Reynaert NL, 2004, P NATL ACAD SCI USA, V101, P8945, DOI 10.1073/pnas.0400588101; Rhee SG, 2005, CURR OPIN CELL BIOL, V17, P183, DOI 10.1016/j.ceb.2005.02.004; Rizzo MA, 2003, J CELL BIOL, V161, P243, DOI 10.1083/jcb.200301063; Salaun C, 2010, J CELL BIOL, V191, P1229, DOI 10.1083/jcb.201008160; Schonhoff CM, 2002, BIOCHEMISTRY-US, V41, P13570, DOI 10.1021/bi026262q; Sen N, 2011, P NATL ACAD SCI USA, V108, P20178, DOI 10.1073/pnas.1117820108; Sen N, 2010, TRENDS NEUROSCI, V33, P493, DOI 10.1016/j.tins.2010.07.004; Seth D, 2011, CURR OPIN CHEM BIOL, V15, P129, DOI 10.1016/j.cbpa.2010.10.012; Stamler JS, 2010, NAT CELL BIOL, V12, P1024, DOI 10.1038/ncb1110-1024; Tsang AHK, 2009, P NATL ACAD SCI USA, V106, P4900, DOI 10.1073/pnas.0810595106; West MB, 2006, FASEB J, V20, P1715, DOI 10.1096/fj.06-5843fje; Whalen EJ, 2007, CELL, V129, P511, DOI 10.1016/j.cell.2007.02.046; Woo HA, 2010, CELL, V140, P517, DOI 10.1016/j.cell.2010.01.009; Wu MZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006430; Yao DD, 2004, P NATL ACAD SCI USA, V101, P10810, DOI 10.1073/pnas.0404161101; Yasukawa T, 2005, J BIOL CHEM, V280, P7511, DOI 10.1074/jbc.M411871200; Zhang P, 2010, J NEUROSCI, V30, P14366, DOI 10.1523/JNEUROSCI.3899-10.2010	78	276	286	4	60	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4411	4418		10.1074/jbc.R111.285742	http://dx.doi.org/10.1074/jbc.R111.285742			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22147701	Green Published, hybrid			2022-12-27	WOS:000300608500004
J	Hutt, M; Farber-Schwarz, A; Unverdorben, F; Richter, F; Kontermann, RE				Hutt, Meike; Faerber-Schwarz, Aline; Unverdorben, Felix; Richter, Fabian; Kontermann, Roland E.			Plasma Half-life Extension of Small Recombinant Antibodies by Fusion to Immunoglobulin-binding Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STAPHYLOCOCCAL PROTEIN-A; HUMAN SERUM-ALBUMIN; FC-RECEPTOR; LIGHT-CHAIN; CRYSTAL-STRUCTURE; STRATEGIES; FRAGMENT; COMPLEX; FAB; INTERFACE	Many therapeutic proteins possessing a small size are rapidly cleared from circulation. Half-life extension strategies have therefore become increasingly important to improve the pharmacokinetic and pharmacodynamic properties of protein therapeutics. Here, we performed a comparative analysis of the half-life extension properties of various bacterial immunoglobulin-binding domains (IgBDs) derived from Staphylococcus protein A (SpA), Streptococcus protein G (SpG), and Finegoldia (formerly Peptostreptococcus) protein L (PpL). These domains, composed of 50-60 amino acid residues, were fused to the C terminus of a single-chain Fv and a bispecific single-chain diabody, respectively. All fusion proteins were produced in mammalian cells and retained their antigen-binding properties. The half-lives of the antibody molecules were prolonged to varying extents for the different IgBDs. The strongest effects in mice were observed for domain C3 of SpG (SpG(C3)) followed by domains B and D of SpA, suggesting that SpG(C3) is particularly useful to extend the plasma half-life of small proteins.	[Hutt, Meike; Faerber-Schwarz, Aline; Unverdorben, Felix; Richter, Fabian; Kontermann, Roland E.] Univ Stuttgart, Inst Zellbiol & Immunol, D-70569 Stuttgart, Germany	University of Stuttgart	Kontermann, RE (corresponding author), Univ Stuttgart, Inst Zellbiol & Immunol, Allmandring 31, D-70569 Stuttgart, Germany.	roland.kontermann@izi.uni-stuttgart.de	Kontermann, Roland E./F-9263-2014		Deutsche Forschungsgemeinschaft [Ko1461/5]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant Ko1461/5.	AKERSTROM B, 1989, J BIOL CHEM, V264, P19740; AKERSTROM B, 1986, J BIOL CHEM, V261, P240; Beckingham JA, 1999, BIOCHEM J, V340, P193, DOI 10.1042/0264-6021:3400193; Benedict CA, 1997, J IMMUNOL METHODS, V201, P223, DOI 10.1016/S0022-1759(96)00227-X; BURMEISTER WP, 1994, NATURE, V372, P379, DOI 10.1038/372379a0; CHESTER KA, 1994, LANCET, V343, P455, DOI 10.1016/S0140-6736(94)92695-6; Chuang VTG, 2002, PHARMACEUT RES, V19, P569; Clark MR, 1997, CHEM IMMUNOL, V65, P88; DEISENHOFER J, 1981, BIOCHEMISTRY-US, V20, P2361, DOI 10.1021/bi00512a001; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; DERRICK JP, 1994, J MOL BIOL, V243, P906, DOI 10.1006/jmbi.1994.1691; GOUDA H, 1992, BIOCHEMISTRY-US, V31, P9665, DOI 10.1021/bi00155a020; Graille M, 2002, J BIOL CHEM, V277, P47500, DOI 10.1074/jbc.M206105200; Graille M, 2000, P NATL ACAD SCI USA, V97, P5399, DOI 10.1073/pnas.97.10.5399; Haraldsson B, 2004, NEWS PHYSIOL SCI, V19, P7, DOI 10.1152/nips.01461.2003; Hopp J, 2010, PROTEIN ENG DES SEL, V23, P827, DOI 10.1093/protein/gzq058; Huang CC, 2009, CURR OPIN BIOTECH, V20, P692, DOI 10.1016/j.copbio.2009.10.010; Jansson B, 1998, FEMS IMMUNOL MED MIC, V20, P69, DOI 10.1016/S0928-8244(97)00108-9; Jovic M, 2010, HISTOL HISTOPATHOL, V25, P99, DOI 10.14670/HH-25.99; KIM JK, 1994, EUR J IMMUNOL, V24, P2429, DOI 10.1002/eji.1830241025; Kontermann RE, 2011, CURR OPIN BIOTECH, V22, P868, DOI 10.1016/j.copbio.2011.06.012; Kontermann RE, 2009, BIODRUGS, V23, P93, DOI 10.2165/00063030-200923020-00003; Meininger DP, 2000, BIOCHEMISTRY-US, V39, P26, DOI 10.1021/bi9920174; Muller D, 2008, J IMMUNOTHER, V31, P714, DOI 10.1097/CJI.0b013e31818353e9; Muller D, 2007, J BIOL CHEM, V282, P12650, DOI 10.1074/jbc.M700820200; RAGHAVAN M, 1994, IMMUNITY, V1, P303, DOI 10.1016/1074-7613(94)90082-5; [Сидорин Е.В. Sidorin E.V.], 2011, [Биохимия, BIOCHEMISTRY (MOSCOW), Biokhimiya], V76, P363; Stork R, 2009, J BIOL CHEM, V284, P25612, DOI 10.1074/jbc.M109.027078; TASHIRO M, 1995, CURR OPIN STRUC BIOL, V5, P471, DOI 10.1016/0959-440X(95)80031-X; Unverdorben F., 2012, PROTEIN ENG IN PRESS	30	54	55	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4462	4469		10.1074/jbc.M111.311522	http://dx.doi.org/10.1074/jbc.M111.311522			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22147690	Green Published, hybrid			2022-12-27	WOS:000300608500010
J	Meng, XB; Zhu, DL; Yang, SJ; Wang, XJ; Xiong, Z; Zhang, YP; Brachova, P; Leslie, KK				Meng, Xiangbing; Zhu, Danlin; Yang, Shujie; Wang, Xinjun; Xiong, Zhi; Zhang, Yuping; Brachova, Pavla; Leslie, Kimberly K.			Cytoplasmic Metadherin (MTDH) Provides Survival Advantage under Conditions of Stress by Acting as RNA-binding Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASTROCYTE ELEVATED GENE-1; GRANULE SEQUESTRATION; ENDOMETRIAL-CANCER; BREAST-CANCER; METASTASIS; LYRIC/AEG-1; ACTIVATION; EXPRESSION; ASTROCYTE-ELEVATED-GENE-1; CHEMORESISTANCE	Overexpression of metadherin (MTDH) has been documented in many solid tumors and is implicated in metastasis and chemoresistance. MTDH has been detected at the plasma membrane as well as in the cytoplasm and nucleus, and the function of MTDH in these locales remains under investigation. In the nucleus, MTDH acts as a transcription co-factor to induce expression of chemoresistance-associated genes. However, MTDH is predominantly cytoplasmic in prostate tumors, and this localization correlates with poor prognosis. Herein, we used endometrial cancer cells as a model system to define a new role for MTDH in the cytoplasm. First, MTDH was primarily localized to the cytoplasm in endometrial cancer cells, and the N-terminal region of MTDH was required to maintain cytoplasmic localization. Next, we identified novel binding partners for cytoplasmic MTDH, including RNA-binding proteins and components of the RNA-induced silencing complex. Nucleic acids were required for the association of MTDH with these cytoplasmic proteins. Furthermore, MTDH interacted with and regulated protein expression of multiple mRNAs, such as PDCD10 and KDM6A. Depletion of cytoplasmic MTDH was associated with increased stress granule formation, reduced survival in response to chemotherapy and the tyrosine kinase inhibitor BIBF1120, Rad51 nuclear accumulation, and cell cycle arrest at G(2)/M. Finally, in vivo tumor formation was abrogated with knockdown of cytoplasmic MTDH. Taken together, our data identify a novel function for cytoplasmic MTDH as an RNA-binding protein. Our findings implicate cytoplasmic MTDH in cell survival and broad drug resistance via association with RNA and RNA-binding proteins.	[Meng, Xiangbing; Zhu, Danlin; Yang, Shujie; Wang, Xinjun; Xiong, Zhi; Zhang, Yuping; Brachova, Pavla; Leslie, Kimberly K.] Univ Iowa, Dept Obstet & Gynecol, Iowa City, IA 52242 USA; [Meng, Xiangbing; Leslie, Kimberly K.] Univ Iowa, Holden Comprehens Canc Ctr, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Meng, XB (corresponding author), Univ Iowa, Dept Obstet & Gynecol, 200 Hawkins Dr, Iowa City, IA 52242 USA.	xiangbing-meng@uiowa.edu	Brachova, Pavla/AAA-1477-2021	Wang, Xinjun/0000-0002-5062-4765; Brachova, Pavla/0000-0002-9014-132X; Yang, Shujie/0000-0003-1753-3068; meng, xiangbing/0000-0002-9612-6438; Leslie, Kimberly/0000-0002-2704-8990	National Institutes of Health [R01CA99908-7]; Department of Obstetrics and Gynecology from American Cancer Society [IRG-77-004-31]; NATIONAL CANCER INSTITUTE [R01CA099908] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Obstetrics and Gynecology from American Cancer Society; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA99908-7 (to K. K. L.). This work was also supported by the Department of Obstetrics and Gynecology Research Development Fund and Institutional Research Grant IRG-77-004-31 from the American Cancer Society (to X. M.), administered through the Holden Comprehensive Cancer Center at the University of Iowa.	Ash SC, 2008, BIOCHEM BIOPH RES CO, V371, P333, DOI 10.1016/j.bbrc.2008.04.084; Blanco MA, 2011, J BIOL CHEM, V286, P19982, DOI 10.1074/jbc.M111.240077; Brown DM, 2004, CANCER CELL, V5, P365, DOI 10.1016/S1535-6108(04)00079-0; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Dai DH, 2005, CANCER RES, V65, P9517, DOI 10.1158/0008-5472.CAN-05-1613; DOWNLOADED F, ISI THOMSON SCI; Emdad L, 2006, CANCER RES, V66, P1509, DOI 10.1158/0008-5472.CAN-05-3029; Gao XJ, 2010, FEBS LETT, V584, P3525, DOI 10.1016/j.febslet.2010.07.022; Hu GH, 2009, CLIN CANCER RES, V15, P5615, DOI 10.1158/1078-0432.CCR-09-0049; Hu GH, 2009, CANCER CELL, V15, P9, DOI 10.1016/j.ccr.2008.11.013; Kang DC, 2005, GENE, V353, P8, DOI [10.1016/j.gene.2005.04.006, 10.1016/j.gene.2005.04.005]; Li C, 2011, INT J GYNECOL CANCER, V21, P602, DOI 10.1097/IGC.0b013e3182145561; Liu HY, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-19; Meng FL, 2011, INT J GYNECOL PATHOL, V30, P145, DOI 10.1097/PGP.0b013e3181ffd2f7; Meng XB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020920; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Park S, 2006, BREAST CANCER RES TR, V99, P9, DOI 10.1007/s10549-006-9175-2; Sarkar D, 2008, CANCER RES, V68, P1478, DOI 10.1158/0008-5472.CAN-07-6164; Song HT, 2010, INT J GYNECOL CANCER, V20, P1188, DOI 10.1111/IGC.0b013e3181ef8e21; Sutherland HGE, 2004, EXP CELL RES, V294, P94, DOI 10.1016/j.yexcr.2003.11.020; Thirkettle HJ, 2009, ONCOGENE, V28, P3663, DOI 10.1038/onc.2009.223; Thirkettle HJ, 2009, CLIN CANCER RES, V15, P3003, DOI 10.1158/1078-0432.CCR-08-2046; Unsworth H, 2010, FASEB J, V24, P3370, DOI 10.1096/fj.09-151142; Villen J, 2007, P NATL ACAD SCI USA, V104, P1488, DOI 10.1073/pnas.0609836104; Xiang Hua, 2011, Chinese Journal of Pathology, V40, P94, DOI 10.3760/cma.j.issn.0529-5807.2011.02.006; Yague E, 2010, BIOCHEM SOC T, V38, P1537, DOI 10.1042/BST0381537; Yoo BK, 2011, HEPATOLOGY, V53, P1538, DOI 10.1002/hep.24216; Yoo BK, 2011, PHARMACOL THERAPEUT, V130, P1, DOI 10.1016/j.pharmthera.2011.01.008; Yoo BK, 2010, CANCER RES, V70, P3249, DOI 10.1158/0008-5472.CAN-09-4009; Yoo BK, 2009, P NATL ACAD SCI USA, V106, P12938, DOI 10.1073/pnas.0901451106; Zong XY, 2011, RNA BIOL, V8, P968, DOI 10.4161/rna.8.6.17606	32	44	46	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4485	4491		10.1074/jbc.C111.291518	http://dx.doi.org/10.1074/jbc.C111.291518			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22199357	Green Published, hybrid			2022-12-27	WOS:000300608500012
J	Sakamoto, T; Inoue, T; Otomo, Y; Yokomori, N; Ohno, M; Arai, H; Nakagawa, Y				Sakamoto, Taro; Inoue, Takao; Otomo, Yukae; Yokomori, Nagaharu; Ohno, Motoki; Arai, Hiroyuki; Nakagawa, Yasuhito			Deficiency of Cardiolipin Synthase Causes Abnormal Mitochondrial Function and Morphology in Germ Cells of Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C REDUCTASE; SACCHAROMYCES-CEREVISIAE; YEAST MITOCHONDRIA; RESPIRATORY-CHAIN; ATP SYNTHASE; NMR-SPECTROSCOPY; MEMBRANE; PHOSPHOLIPIDS; APOPTOSIS; HEART	Cardiolipin (CL) is a major membrane phospholipid specifically localized in mitochondria. At the cellular level, CL has been shown to have a role in mitochondrial energy production, mitochondrial membrane dynamics, and the triggering of apoptosis. However, the in vivo role of CL in multicellular organisms is largely unknown. In this study, by analyzing deletion mutants of a CL synthase gene (crls-1) in Caenorhabditis elegans, we demonstrated that CL depletion selectively caused abnormal mitochondrial function and morphology in germ cells but not in somatic cell types such as muscle cells. crls-1 mutants reached adulthood but were sterile with reduced germ cell proliferation and impaired oogenesis. In the gonad of crls-1 mutants, mitochondrial membrane potential was significantly decreased, and the structure of the mitochondrial cristae was disrupted. Contrary to the abnormalities in the gonad, somatic tissues in crls-1 mutants appeared normal with respect to cell proliferation, mitochondrial function, and mitochondrial morphology. Increased susceptibility to CL depletion in germ cells was also observed in mutants of phosphatidylglycerophosphate synthase, an enzyme responsible for producing phosphatidylglycerol, a precursor phospholipid of CL. We propose that the contribution of CL to mitochondrial function and morphology is different among the cell types in C. elegans.	[Sakamoto, Taro] Kitasato Univ, Sch Pharm, Minato Ku, Tokyo 1088641, Japan; [Inoue, Takao; Arai, Hiroyuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo 1130033, Japan; [Inoue, Takao] Natl Inst Hlth Sci, Div Cellular & Gene Therapy Prod, Tokyo 1588501, Japan; [Inoue, Takao; Arai, Hiroyuki] Japan Sci & Technol Agcy, CREST, Tokyo 1020075, Japan	Kitasato University; University of Tokyo; National Institute of Health Sciences - Japan; Japan Science & Technology Agency (JST)	Sakamoto, T (corresponding author), Kitasato Univ, Sch Pharm, Minato Ku, 5-9-1 Shirokane, Tokyo 1088641, Japan.	sakamotot@pharm.kitasato-u.ac.jp			Japan Society for the Promotion of Science [22590072]; Kitasato University; National Institutes of Health, NCRR; Grants-in-Aid for Scientific Research [23227004] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Kitasato University; National Institutes of Health, NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-aid for Scientific Research (C) 22590072 from the Japan Society for the Promotion of Science (to Y. N.) and by a Kitasato University research grant for young researchers (to T. S.).; We greatly thank A. Takimoto and M. Ikuta for excellent technical assistance; Drs. K. Gengyo-Ando (Saitama University) and S. Mitani (Tokyo Women's Medical University School of Medicine) for providing alleles of crls-1 and pgs-1; Dr. A. Fire (Stanford University School of Medicine) for convenient vectors; and Dr. T. Inoue (National University of Singapore) for helpful discussions and comments on this study. Some strains were provided by the Caenorhabditis Genetics Center (University of Minnesota, Minneapolis), which is funded by the National Institutes of Health, NCRR.	Acehan D, 2011, BIOPHYS J, V100, P2184, DOI 10.1016/j.bpj.2011.03.031; Acehan D, 2011, J BIOL CHEM, V286, P899, DOI 10.1074/jbc.M110.171439; Ariz M, 2009, DEV BIOL, V326, P295, DOI 10.1016/j.ydbio.2008.11.024; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boxem M, 1999, DEVELOPMENT, V126, P2227; BRENNER S, 1974, GENETICS, V77, P71; Chang SC, 1998, J BIOL CHEM, V273, P9829, DOI 10.1074/jbc.273.16.9829; Choi SY, 2007, CELL DEATH DIFFER, V14, P597, DOI 10.1038/sj.cdd.4402020; COURTADE S, 1967, BIOCHIM BIOPHYS ACTA, V137, P121, DOI 10.1016/0005-2760(67)90015-X; Crittenden SL, 2006, MOL BIOL CELL, V17, P3051, DOI 10.1091/mbc.E06-03-0170; EBLE KS, 1990, J BIOL CHEM, V265, P19434; Fay DS, 2000, DEVELOPMENT, V127, P4049; FRY M, 1981, J BIOL CHEM, V256, P1874; Gaskova D, 2007, BIOCHEM BIOPH RES CO, V354, P814, DOI 10.1016/j.bbrc.2007.01.073; Gengyo-Ando K, 2000, BIOCHEM BIOPH RES CO, V269, P64, DOI 10.1006/bbrc.2000.2260; Gomez B, 1999, BIOCHEMISTRY-US, V38, P9031, DOI 10.1021/bi990603r; Gonzalvez F, 2007, APOPTOSIS, V12, P877, DOI 10.1007/s10495-007-0718-8; HANUKOGLU I, 1992, J STEROID BIOCHEM, V43, P779, DOI 10.1016/0960-0760(92)90307-5; HAYERHARTL M, 1992, EUR J BIOCHEM, V209, P423, DOI 10.1111/j.1432-1033.1992.tb17305.x; Houtkooper RH, 2008, CELL MOL LIFE SCI, V65, P2493, DOI 10.1007/s00018-008-8030-5; Huang ZT, 2008, FREE RADICAL BIO MED, V44, P1935, DOI 10.1016/j.freeradbiomed.2008.02.016; Hunter T, 1997, J BIOL CHEM, V272, P28652, DOI 10.1074/jbc.272.45.28652; Jiang F, 1997, MOL MICROBIOL, V26, P481, DOI 10.1046/j.1365-2958.1997.5841950.x; Jiang F, 2000, J BIOL CHEM, V275, P22387, DOI 10.1074/jbc.M909868199; Johnson DT, 2007, AM J PHYSIOL-CELL PH, V292, pC689, DOI 10.1152/ajpcell.00108.2006; Joshi AS, 2009, BBA-MOL CELL RES, V1793, P212, DOI 10.1016/j.bbamcr.2008.07.024; Kawasaki I, 2007, MECH DEVELOP, V124, P237, DOI 10.1016/j.mod.2006.11.004; Kawasaki K, 1999, J BIOL CHEM, V274, P1828, DOI 10.1074/jbc.274.3.1828; KIMBLE J, 1979, DEV BIOL, V70, P396, DOI 10.1016/0012-1606(79)90035-6; Koshkin V, 2002, BIOCHEM J, V364, P317, DOI 10.1042/bj3640317; Koshkin V, 2000, BIOCHEM J, V347, P687, DOI 10.1042/0264-6021:3470687; Kuznetsov AV, 2009, INT J BIOCHEM CELL B, V41, P1928, DOI 10.1016/j.biocel.2009.03.007; Lutter M, 2000, NAT CELL BIOL, V2, P754, DOI 10.1038/35036395; Maciejowski J, 2006, DEV BIOL, V292, P142, DOI 10.1016/j.ydbio.2005.12.046; Mancuso DJ, 2007, J BIOL CHEM, V282, P34611, DOI 10.1074/jbc.M707795200; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Michaelson D, 2010, DEVELOPMENT, V137, P671, DOI 10.1242/dev.042523; Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7; Munn E. A., 1974, STRUCTURE MITOCHONDR, P1; Nomura K, 2000, BIOCHEM J, V351, P183, DOI 10.1042/0264-6021:3510183; Osman C, 2011, J CELL BIOL, V192, P7, DOI 10.1083/jcb.201006159; Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200; Reinke V, 2000, MOL CELL, V6, P605, DOI 10.1016/S1097-2765(00)00059-9; ROBINSON NC, 1990, BIOCHEMISTRY-US, V29, P8962, DOI 10.1021/bi00490a012; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; SCHAGGER H, 1990, EUR J BIOCHEM, V190, P123, DOI 10.1111/j.1432-1033.1990.tb15554.x; SCHLAME M, 1993, J BIOL CHEM, V268, P74; Schlame M, 2000, PROG LIPID RES, V39, P257, DOI 10.1016/S0163-7827(00)00005-9; Sedlak E, 1999, BIOCHEMISTRY-US, V38, P14966, DOI 10.1021/bi9914053; Shen LR, 2010, J LIPID RES, V51, P2985, DOI 10.1194/jlr.M008524; Simmer F, 2002, CURR BIOL, V12, P1317, DOI 10.1016/S0960-9822(02)01041-2; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; Sumitani M, 2011, J BIOCHEM, V149, P581, DOI 10.1093/jb/mvr008; Timmons L, 2004, BIOESSAYS, V26, P715, DOI 10.1002/bies.20078; Van Gilst MR, 2005, P NATL ACAD SCI USA, V102, P13496, DOI 10.1073/pnas.0506234102; White D.A., 1973, FORM FUNCTION PHOSPH; Williams JG, 1998, J BIOL CHEM, V273, P13482, DOI 10.1074/jbc.273.22.13482; YU CA, 1980, BIOCHEMISTRY-US, V19, P5715, DOI 10.1021/bi00566a008; Zhang M, 2005, J BIOL CHEM, V280, P29403, DOI 10.1074/jbc.M504955200; Zhang M, 2003, J BIOL CHEM, V278, P35204, DOI 10.1074/jbc.M306729200; Zhang M, 2002, J BIOL CHEM, V277, P43553, DOI 10.1074/jbc.C200551200; Zhong Q, 2004, J BIOL CHEM, V279, P32294, DOI 10.1074/jbc.M403275200	62	32	44	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4590	4601		10.1074/jbc.M111.314823	http://dx.doi.org/10.1074/jbc.M111.314823			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22174409	Green Published, hybrid			2022-12-27	WOS:000300608500022
J	Christensen, B; Klaning, E; Nielsen, MS; Andersen, MH; Sorensen, ES				Christensen, Brian; Klaning, Eva; Nielsen, Mette S.; Andersen, Mikkel H.; Sorensen, Esben S.			C-terminal Modification of Osteopontin Inhibits Interaction with the alpha(V)beta(3)-Integrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTTRANSLATIONAL MODIFICATIONS; BONE SIALOPROTEIN; SIBLING PROTEINS; PHOSPHORYLATION; BINDING; IDENTIFICATION; SITES; ALPHA-V-BETA-3; SUBSTRATE; FRAGMENT	Osteopontin (OPN) is a multifunctional phosphorylated protein containing the integrin binding sequence Arg-Gly-Asp through which it interacts with several integrin receptors, such as the alpha(V)beta(3)-integrin. OPN exists in many different isoforms differing in phosphorylation status that are likely to interact differently with integrins. The C-terminal region of OPN is particularly well conserved among mammalian species, which suggests an important functional role of this region. In this study, we show that modification of the extreme C terminus of OPN plays an important regulatory role for the interaction with the alpha(V)beta(3)-integrin. It is demonstrated that highly phosphorylated OPN has a much reduced capability to promote cell adhesion via the alpha(V)beta(3)-integrin compared with lesser phosphorylated forms. The cell attachment promoted by highly phosphorylated OPN could be greatly increased by both dephosphorylation and proteolytic removal of the C terminus. Using recombinantly expressed OPN containing a tag in the N or C terminus, it is shown that a modification in the C-terminal part significantly reduces the adhesion of cells to OPN via the alpha(V)beta(3)-integrin, whereas modification of the N terminus does not influence the binding. The inhibited binding of the alpha(V)beta(3)-integrin to OPN could be restored by proteolytic removal of the C terminus by thrombin and plasmin. These data illustrate a novel mechanism regulating the interaction of OPN and the alpha(V)beta(3)-integrin by modification of the highly conserved C-terminal region of the protein.	[Christensen, Brian; Klaning, Eva; Nielsen, Mette S.; Sorensen, Esben S.] Aarhus Univ, Dept Mol Biol & Genet, Prot Chem Lab, DK-8000 Aarhus, Denmark; [Andersen, Mikkel H.] Aarhus Univ, Dept Mol Biol & Genet, Prot Core Facil, DK-8000 Aarhus, Denmark	Aarhus University; Aarhus University	Sorensen, ES (corresponding author), Univ Aarhus, Dept Mol Biol & Genet, Prot Chem Lab, Sci Pk,Gustav Wieds Vej 10C, DK-8000 Aarhus C, Denmark.	ess@mb.au.dk		Sorensen, Esben Skipper/0000-0002-7050-3354	Novo Nordisk Foundation; Danish Council for Independent Research	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Council for Independent Research(Det Frie Forskningsrad (DFF))	This work was supported by grants from the Novo Nordisk Foundation and the Danish Council for Independent Research.	Agnihotri R, 2001, J BIOL CHEM, V276, P28261, DOI 10.1074/jbc.M103608200; Anborgh PH, 2011, J CELL COMMUN SIGNAL, V5, P111, DOI 10.1007/s12079-011-0130-6; Bayless KJ, 2001, J BIOL CHEM, V276, P13483, DOI 10.1074/jbc.M011392200; CHEN YP, 1995, BLOOD, V86, P2606, DOI 10.1182/blood.V86.7.2606.bloodjournal8672606; Christensen B, 2005, BIOCHEM J, V390, P285, DOI 10.1042/BJ20050341; Christensen B, 2008, BIOCHEM J, V411, P53, DOI 10.1042/BJ20071021; Christensen B, 2007, J BIOL CHEM, V282, P19463, DOI 10.1074/jbc.M703055200; Christensen B, 2010, J BIOL CHEM, V285, P7929, DOI 10.1074/jbc.M109.075010; Ek-Rylander B, 2010, EXP CELL RES, V316, P443, DOI 10.1016/j.yexcr.2009.10.019; EKRYLANDER B, 1994, J BIOL CHEM, V269, P14853; Fisher LW, 2001, BIOCHEM BIOPH RES CO, V280, P460, DOI 10.1006/bbrc.2000.4146; Frenzel DF, 2011, EXPERT REV CLIN IMMU, V7, P93, DOI 10.1586/ECI.10.82; Gericke A, 2005, CALCIFIED TISSUE INT, V77, P45, DOI 10.1007/s00223-004-1288-1; Ito K, 2009, MATRIX BIOL, V28, P11, DOI 10.1016/j.matbio.2008.10.002; Katayama Y, 1998, J CELL PHYSIOL, V176, P179, DOI 10.1002/(SICI)1097-4652(199807)176:1<179::AID-JCP19>3.3.CO;2-M; Kazanecki CC, 2007, J CELL BIOCHEM, V102, P912, DOI 10.1002/jcb.21558; Kazanecki CC, 2007, J CELL BIOCHEM, V102, P925, DOI 10.1002/jcb.21487; Keykhosravani M, 2005, BIOCHEMISTRY-US, V44, P6990, DOI 10.1021/bi050109p; Lee JL, 2007, CANCER RES, V67, P2089, DOI 10.1158/0008-5472.CAN-06-3625; Lund SA, 2009, J CELL COMMUN SIGNAL, V3, P311, DOI 10.1007/s12079-009-0068-0; Miura Y, 2010, ANAL CHEM, V82, P10021, DOI 10.1021/ac101599p; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Platzer G, 2011, BIOCHEMISTRY-US, V50, P6113, DOI 10.1021/bi200291e; Qin C, 2004, CRIT REV ORAL BIOL M, V15, P126, DOI 10.1177/154411130401500302; ROSS FP, 1993, J BIOL CHEM, V268, P9901; Schack L, 2009, J DAIRY SCI, V92, P5378, DOI 10.3168/jds.2009-2360; Schack L, 2009, J IMMUNOL, V182, P6943, DOI 10.4049/jimmunol.0900065; SENGER DR, 1994, MOL BIOL CELL, V5, P565, DOI 10.1091/mbc.5.5.565; SENGER DR, 1988, CANCER RES, V48, P5770; Sodek J, 2000, CRIT REV ORAL BIOL M, V11, P279, DOI 10.1177/10454411000110030101; SORENSEN ES, 1995, PROTEIN SCI, V4, P2040, DOI 10.1002/pro.5560041009; Weber GF, 2002, J LEUKOCYTE BIOL, V72, P752; Yamaguchi Y, 2010, BIOCHEM BIOPH RES CO, V393, P487, DOI 10.1016/j.bbrc.2010.02.030; Yokosaki Y, 2005, MATRIX BIOL, V24, P418, DOI 10.1016/j.matbio.2005.05.005; Yokosaki Y, 1999, J BIOL CHEM, V274, P36328, DOI 10.1074/jbc.274.51.36328	35	43	46	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					3788	3797		10.1074/jbc.M111.277996	http://dx.doi.org/10.1074/jbc.M111.277996			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22179617	hybrid, Green Published			2022-12-27	WOS:000300410900016
J	Mayati, A; Levoin, N; Paris, H; N'Diaye, M; Courtois, A; Uriac, P; Lagadic-Gossmann, D; Fardel, O; Le Ferrec, E				Mayati, Abdullah; Levoin, Nicolas; Paris, Herve; N'Diaye, Monique; Courtois, Arnaud; Uriac, Philippe; Lagadic-Gossmann, Dominique; Fardel, Olivier; Le Ferrec, Eric			Induction of Intracellular Calcium Concentration by Environmental Benzo(a)pyrene Involves a beta 2-Adrenergic Receptor/Adenylyl Cyclase/Epac-1/Inositol 1,4,5-Trisphosphate Pathway in Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; BETA-ADRENERGIC-RECEPTOR; NITRIC-OXIDE SYNTHASE; CYCLIC-AMP; CONTAMINANT BENZO(A)PYRENE; DEPENDENT INDUCTION; HUMAN MACROPHAGES; PHOSPHOLIPASE-C; EPAC; ACTIVATION	Polycyclic aromatic hydrocarbons (PAHs) such as benzo-(a)pyrene (B(a)P) are widely distributed environmental contaminants, known as potent ligands of the aryl hydrocarbon receptor (AhR). These chemicals trigger an early and transient increase of intracellular calcium concentration ([Ca2+](i)), required for AhR-related effects of PAHs. The mechanisms involved in this calcium mobilization were investigated in the present study. We demonstrated that B(a)P-mediated [Ca2+](i) induction was prevented in endothelial HMEC-1 cells by counteracting beta 2-adrenoreceptor (beta 2ADR) activity using pharmacological antagonists, anti-beta 2ADR antibodies, or siRNA-mediated knockdown of beta 2ADR expression; by contrast, it was strongly potentiated by beta 2ADR overexpression in human kidney HEK293 cells. B(a)P was shown, moreover, to directly bind to beta 2ADR, as assessed by in vitro binding assays and molecular modeling. Pharmacological inhibition and/or siRNA-mediated silencing of various signaling actors acting downstream of beta 2ADR in a sequential manner, such as G protein, adenylyl cyclase, Epac-1 protein, and inositol 1,4,5-trisphosphate (IP3)/IP3 receptor, were next demonstrated to prevent B(a)P-induced calcium signal. Inhibition or knockdown of these signaling elements, as well as the use of chemical beta-blockers, were finally shown to counteract B(a)P-mediated induction of cytochrome P-450 1B1, a prototypical AhR target gene. Taken together, our results show that B(a)P binds directly to beta 2ADR and consequently utilizes beta 2ADR machinery to mobilize [Ca2+](i),through activation of a G protein/adenylyl cyclase/cAMP/Epac-1/IP3 pathway. This beta 2ADR-dependent signaling pathway activated by PAHs may likely be crucial for PAH-mediated up-regulation of AhR target genes, thus suggesting a contribution of beta 2ADR to the health-threatening effects of these environmental pollutants.	[Mayati, Abdullah; N'Diaye, Monique; Lagadic-Gossmann, Dominique; Fardel, Olivier; Le Ferrec, Eric] Univ Rennes 1, INSERM IRSET U1085, IFR140, F-35043 Rennes, France; [Levoin, Nicolas] Bioprojet Biotech, F-35762 St Gregoire, France; [Paris, Herve] INSERM, I2MR U858, F-31432 Toulouse 4, France; [Courtois, Arnaud] Univ Bordeaux 2, INSERM U1045, F-33076 Bordeaux, France; [Fardel, Olivier] Ctr Hosp Univ, Hop Pontchaillou, F-35033 Rennes, France; [Uriac, Philippe] CNRS 6226 Sci Chim Rennes, UMR, Equipe Prod Nat Synth & Chim Med 4, F-35033 Rennes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; CHU Rennes; Centre National de la Recherche Scientifique (CNRS)	Le Ferrec, E (corresponding author), Univ Rennes 1, Fac Pharm, EA SeRAIC IRSET 4427, IFR140, 2 Ave Pr L Bernard, F-35043 Rennes, France.	eric.leferrec@univ-rennes1.fr	LAGADIC-GOSSMANN, Dominique/I-5079-2015; Fardel, Olivier/J-8560-2015; Le FERREC, Eric/K-1374-2015; N'DIAYE, Monique MND/K-6209-2015	LAGADIC-GOSSMANN, Dominique/0000-0002-4888-236X; Le FERREC, Eric/0000-0002-2015-2779; N'DIAYE, Monique MND/0000-0001-8867-0778; levoin, nicolas/0000-0002-7731-736X; courtois, arnaud/0000-0002-0996-7133	French Ecology minister	French Ecology minister	This work was supported by the Programme National de Recherche sur les Perturbateurs Endocriniens from the French Ecology minister.	ATACK JR, 1993, J NEUROCHEM, V60, P652, DOI 10.1111/j.1471-4159.1993.tb03197.x; Aygun SF, 2005, INT J FOOD SCI NUTR, V56, P581, DOI 10.1080/09637480500465436; Aygun SF, 2005, J SEP SCI, V28, P2370, DOI 10.1002/jssc.200500132; Bader AN, 2005, CHEM RES TOXICOL, V18, P1405, DOI 10.1021/tx050056c; Baker JG, 2005, BRIT J PHARMACOL, V144, P317, DOI 10.1038/sj.bjp.0706048; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; Bohm HJ, 1998, J COMPUT AID MOL DES, V12, P309, DOI 10.1023/A:1007999920146; BURCHIEL SW, 1992, TOXICOL APPL PHARM, V113, P126, DOI 10.1016/0041-008X(92)90016-L; CANGA L, 1993, MOL PHARMACOL, V44, P1142; CANGA L, 1988, P NATL ACAD SCI USA, V85, P905, DOI 10.1073/pnas.85.3.905; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; COLLINS S, 1990, BIOCHEM SOC T, V18, P541, DOI 10.1042/bst0180541; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Deupi X, 2010, PHYSIOLOGY, V25, P293, DOI 10.1152/physiol.00002.2010; Factor P, 2011, AM J RESP CELL MOL, V45, P1045, DOI 10.1165/rcmb.2010-0499OC; Gao J, 2005, TOXICOL SCI, V87, P419, DOI 10.1093/toxsci/kfi265; Gloerich M, 2010, ANNU REV PHARMACOL, V50, P355, DOI 10.1146/annurev.pharmtox.010909.105714; Gong Z, 2006, TOXICOL LETT, V166, P229, DOI 10.1016/j.toxlet.2006.07.307; Han EH, 2009, TOXICOLOGY, V266, P38, DOI 10.1016/j.tox.2009.10.013; Hankinson O, 2005, ARCH BIOCHEM BIOPHYS, V433, P379, DOI 10.1016/j.abb.2004.09.031; Hanson MA, 2008, STRUCTURE, V16, P897, DOI 10.1016/j.str.2008.05.001; Herm M, 2002, CHEM-EUR J, V8, P1485, DOI 10.1002/1521-3765(20020315)8:6<1485::AID-CHEM1485>3.0.CO;2-H; Irigaray P, 2006, FEBS J, V273, P1362, DOI 10.1111/j.1742-4658.2006.05159.x; Kang JJ, 1997, TOXICOL LETT, V93, P39, DOI 10.1016/S0378-4274(97)00072-6; Karpen JW, 2004, P W PHARMACOL SOC, P1; Kaszuba K, 2010, J PHYS CHEM B, V114, P8374, DOI 10.1021/jp909971f; Keiper M, 2004, J BIOL CHEM, V279, P46497, DOI 10.1074/jbc.M403604200; Kobayashi D, 2009, TOXICOLOGY, V258, P25, DOI 10.1016/j.tox.2009.01.002; Kobilka BK, 2011, TRENDS PHARMACOL SCI, V32, P213, DOI 10.1016/j.tips.2011.02.005; Korashy HM, 2006, DRUG METAB REV, V38, P411, DOI 10.1080/03602530600632063; KRIEGER JA, 1994, TOXICOL APPL PHARM, V127, P268, DOI 10.1006/taap.1994.1161; LAUSTIOLA KE, 1988, CIRCULATION, V78, P1234, DOI 10.1161/01.CIR.78.5.1234; LAUSTIOLA KE, 1991, J CARDIOVASC PHARM, V17, P923, DOI 10.1097/00005344-199106000-00010; Le Ferrec E, 2002, J BIOL CHEM, V277, P24780, DOI 10.1074/jbc.M111319200; Lecureur V, 2005, FEBS LETT, V579, P1904, DOI 10.1016/j.febslet.2005.01.081; Lefkowitz R J, 1998, Adv Pharmacol, V42, P416; Lewtas J, 2007, MUTAT RES-REV MUTAT, V636, P95, DOI 10.1016/j.mrrev.2007.08.003; Malcolm CS, 1996, J NEUROCHEM, V66, P2350; Mayati A, 2012, ENVIRON TOXICOL, V27, P556, DOI 10.1002/tox.20675; Monteiro P, 2008, MOL PHARMACOL, V73, P769, DOI 10.1124/mol.107.043125; N'Diaye M, 2006, J BIOL CHEM, V281, P19906, DOI 10.1074/jbc.M601192200; Oesch-Bartlomowicz B, 2009, BIOCHEM PHARMACOL, V77, P627, DOI 10.1016/j.bcp.2008.10.017; Oestreich EA, 2007, J BIOL CHEM, V282, P5488, DOI 10.1074/jbc.M608495200; Omori N, 2007, HUM EXP TOXICOL, V26, P811, DOI 10.1177/0960327107072394; Phiel CJ, 2001, ANNU REV PHARMACOL, V41, P789, DOI 10.1146/annurev.pharmtox.41.1.789; Phillips DH, 1999, MUTAT RES-GEN TOX EN, V443, P139, DOI 10.1016/S1383-5742(99)00016-2; Rich TC, 2002, ANN BIOMED ENG, V30, P1088, DOI 10.1114/1.1511242; Roscioni SS, 2008, N-S ARCH PHARMACOL, V377, P345, DOI 10.1007/s00210-007-0246-7; Rousseau G, 1997, EUR J PHARMACOL, V326, P75, DOI 10.1016/S0014-2999(97)00138-6; Schmidt M, 2001, NAT CELL BIOL, V3, P1020, DOI 10.1038/ncb1101-1020; Sinnokrot MO, 2004, J AM CHEM SOC, V126, P7690, DOI 10.1021/ja049434a; Sommer RJ, 2005, TOXICOL SCI, V83, P363, DOI 10.1093/toxsci/kfi041; Sparfel L, 2010, TOXICOL SCI, V114, P247, DOI 10.1093/toxsci/kfq007; van Grevenynghe J, 2006, BIOCHEM BIOPH RES CO, V341, P763, DOI 10.1016/j.bbrc.2006.01.028; Vogel CFA, 2004, J BIOL CHEM, V279, P8886, DOI 10.1074/jbc.M310190200; VONZASTROW M, 1992, J BIOL CHEM, V267, P3530; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Xiao JJ, 2010, EXP BIOL MED, V235, P862, DOI 10.1258/ebm.2010.009362; Zhao MF, 1996, INT J IMMUNOPHARMACO, V18, P589, DOI 10.1016/S0192-0561(96)00063-X; Zhong N, 2005, J NEUROSCI, V25, P208, DOI 10.1523/JNEUROSCI.3703-04.2005; Zsila F, 2006, BBA-GEN SUBJECTS, V1760, P1248, DOI 10.1016/j.bbagen.2006.04.006	61	47	50	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					4041	4052		10.1074/jbc.M111.319970	http://dx.doi.org/10.1074/jbc.M111.319970			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22167199	Green Published, hybrid			2022-12-27	WOS:000300410900038
J	O'Brien, XM; Heflin, KE; Lavigne, LM; Yu, KB; Kim, M; Salomon, AR; Reichner, JS				O'Brien, Xian M.; Heflin, Katie E.; Lavigne, Liz M.; Yu, Kebing; Kim, Minsoo; Salomon, Arthur R.; Reichner, Jonathan S.			Lectin Site Ligation of CR3 Induces Conformational Changes and Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNOMODULATOR PGG-GLUCAN; RISK SURGICAL PATIENTS; PROTEIN-KINASE-C; BETA-GLUCAN; INTEGRIN ALPHA(M)BETA(2); NEUTROPHIL CHEMOTAXIS; CANCER-IMMUNOTHERAPY; CELL-MIGRATION; HOST-DEFENSE; I-DOMAIN	Neutrophils provide an innate immune response to tissues infected with fungal pathogens such as Candida albicans. This response is tightly regulated in part through the interaction of integrins with extracellular matrix ligands that are distributed within infected tissues. The beta(2) integrin, CR3 (CD11b/CD18), is unique among integrins in containing a lectin-like domain that binds the fungal pathogen-associated molecular pattern beta S-glucan and serves as the dominant receptor for recognition of fungal pathogens by human granulocytes. beta-Glucan, when isolated in soluble form, has been shown to be a safe and effective immune potentiator when administered therapeutically. Currently a pharmaceutical grade preparation of beta-glucan is in several clinical trials with an anti-cancer indication. CR3 binding of extracellular matrix, carbohydrate, or both ligands simultaneously differentially regulates neutrophil function through a mechanism not clearly understood. Using FRET reporters, we interrogated the effects of soluble beta-glucan on intracellular and extracellular CR3 structure. Although the canonical CR3 ligand fibrinogen induced full activation, beta-glucan alone or in conjunction with fibrinogen stabilized an intermediate conformation with moderate headpiece extension and full cytoplasmic tail separation. A set of phosphopeptides differentially regulated by beta-glucan in a CR3-dependent manner were identified using functional proteomics and found to be enriched for signaling molecules and proteins involved in transcriptional regulation, mRNA processing, and alternative splicing. These data confirm that CR3 is a signaling pattern recognition receptor for beta-glucan and represent the first direct evidence of soluble beta-glucan binding and affecting a signaling-competent intermediate CR3 conformation on living cells.	[O'Brien, Xian M.; Heflin, Katie E.; Lavigne, Liz M.; Reichner, Jonathan S.] Brown Univ, Rhode Isl Hosp, Dept Surg, Div Surg Res, Providence, RI 02903 USA; [O'Brien, Xian M.; Heflin, Katie E.; Lavigne, Liz M.; Reichner, Jonathan S.] Brown Univ, Warren Alpert Med Sch, Providence, RI 02903 USA; [O'Brien, Xian M.; Heflin, Katie E.] Brown Univ, Grad Program Pathobiol, Providence, RI 02912 USA; [Yu, Kebing; Salomon, Arthur R.] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02914 USA; [Kim, Minsoo] Univ Rochester, David H Smith Ctr Vaccine Biol & Immunol, Dept Microbiol & Immunol, Rochester, NY 14642 USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Brown University; Brown University; University of Rochester	O'Brien, XM (corresponding author), Brown Univ, Rhode Isl Hosp, Dept Surg, Div Surg Res, 593 Eddy St, Providence, RI 02903 USA.	xianobrien@gmail.com	Yu, Kebing/D-4585-2014	Reichner, Jonathan/0000-0002-7349-6321	National Institutes of Health [GM-066194, AI-079582]; United States Department of Education; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI079582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066194, R56GM066194] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Education(US Department of Education); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM-066194 and AI-079582 (to J. S. R.). This work was also supported by Grant Assistance in Areas of National Need from the United States Department of Education (to X. M. O.) and allocations to the Department of Surgery by Rhode Island Hospital.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alam H, 2011, J CELL SCI, V124, P2096, DOI 10.1242/jcs.073585; Askari JA, 2009, J CELL SCI, V122, P165, DOI 10.1242/jcs.018556; BABINEAU TJ, 1994, ANN SURG, V220, P601, DOI 10.1097/00000658-199411000-00002; BABINEAU TJ, 1994, ARCH SURG-CHICAGO, V129, P1204; Bernaciak TM, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2341; Cabodi S, 2009, J CELL PHYSIOL, V218, P294, DOI 10.1002/jcp.21603; CZOP JK, 1991, J EXP MED, V173, P1511, DOI 10.1084/jem.173.6.1511; Defilippi P, 1997, J BIOL CHEM, V272, P21726, DOI 10.1074/jbc.272.35.21726; Dellinger EP, 1999, ARCH SURG-CHICAGO, V134, P977, DOI 10.1001/archsurg.134.9.977; DIAMOND MS, 1993, J CELL BIOL, V120, P1031, DOI 10.1083/jcb.120.4.1031; Gelderman KA, 2004, TRENDS IMMUNOL, V25, P158, DOI 10.1016/j.it.2004.01.008; Goodridge HS, 2011, NATURE, V472, P471, DOI 10.1038/nature10071; Harler MB, 1999, J IMMUNOL, V162, P6792; Hong F, 2004, J IMMUNOL, V173, P797, DOI 10.4049/jimmunol.173.2.797; Khunkaewla P, 2008, MOL IMMUNOL, V45, P1703, DOI 10.1016/j.molimm.2007.09.032; Kim M, 2003, SCIENCE, V301, P1720, DOI 10.1126/science.1084174; Kougias P, 2001, INFECT IMMUN, V69, P3933, DOI 10.1128/IAI.69.6.3933-3938.2001; Lavigne LM, 2007, J IMMUNOL, V178, P7276, DOI 10.4049/jimmunol.178.11.7276; Lavigne LM, 2006, J IMMUNOL, V177, P8667, DOI 10.4049/jimmunol.177.12.8667; LeBlanc BW, 2006, J LEUKOCYTE BIOL, V79, P667, DOI 10.1189/jlb.0305150; Lefort CT, 2009, J IMMUNOL, V183, P6460, DOI 10.4049/jimmunol.0900983; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Li B, 2006, J IMMUNOL, V177, P1661, DOI 10.4049/jimmunol.177.3.1661; Liu JJ, 2009, EXP MOL PATHOL, V86, P208, DOI 10.1016/j.yexmp.2009.01.006; Mori T, 1997, EUR J CLIN CHEM CLIN, V35, P553; Mould AP, 2004, CURR OPIN CELL BIOL, V16, P544, DOI 10.1016/j.ceb.2004.07.003; Mueller A, 2000, GLYCOBIOLOGY, V10, P339, DOI 10.1093/glycob/10.4.339; Nakamura K, 2007, MICROBIOL IMMUNOL, V51, P1115, DOI 10.1111/j.1348-0421.2007.tb04007.x; Osuchowski MF, 2007, J IMMUNOL, V179, P623, DOI 10.4049/jimmunol.179.1.623; PHAFF HJ, 1963, ANNU REV MICROBIOL, V17, P15, DOI 10.1146/annurev.mi.17.100163.000311; Qi CJ, 2011, BLOOD, V117, P6825, DOI 10.1182/blood-2011-02-339812; Saijo S, 2007, NAT IMMUNOL, V8, P39, DOI 10.1038/ni1425; Sanada T, 2008, J BIOL CHEM, V283, P33858, DOI 10.1074/jbc.M806923200; Shimaoka M, 2003, NAT REV DRUG DISCOV, V2, P703, DOI 10.1038/nrd1174; Shimaoka M, 2003, CELL, V112, P99, DOI 10.1016/S0092-8674(02)01257-6; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Trucy M, 2006, CELL IMMUNOL, V244, P33, DOI 10.1016/j.cellimm.2007.02.002; Tuck AB, 2000, J CELL BIOCHEM, V78, P465, DOI 10.1002/1097-4644(20000901)78:3<465::AID-JCB11>3.0.CO;2-C; van Bruggen R, 2009, MOL IMMUNOL, V47, P575, DOI 10.1016/j.molimm.2009.09.018; Vetvicka V, 1996, J CLIN INVEST, V98, P50, DOI 10.1172/JCI118777; Xia Y, 1999, J IMMUNOL, V162, P7285; Xiong YM, 2003, J IMMUNOL, V171, P1042, DOI 10.4049/jimmunol.171.2.1042; Yakubenko VP, 2001, J BIOL CHEM, V276, P13995, DOI 10.1074/jbc.M010174200; Yauch RL, 1998, MOL BIOL CELL, V9, P2751, DOI 10.1091/mbc.9.10.2751; Zhang L, 1999, BIOCHEMISTRY-US, V38, P8064, DOI 10.1021/bi990141h; Zimmerman JW, 1998, J BIOL CHEM, V273, P22014, DOI 10.1074/jbc.273.34.22014	48	50	51	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3337	3348		10.1074/jbc.M111.298307	http://dx.doi.org/10.1074/jbc.M111.298307			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22158618	Green Published, hybrid			2022-12-27	WOS:000300295100039
J	Bubner, P; Dohr, J; Plank, H; Mayrhofer, C; Nidetzky, B				Bubner, Patricia; Dohr, Judith; Plank, Harald; Mayrhofer, Claudia; Nidetzky, Bernd			Cellulases Dig Deep IN SITU OBSERVATION OF THE MESOSCOPIC STRUCTURAL DYNAMICS OF ENZYMATIC CELLULOSE DEGRADATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATOMIC-FORCE MICROSCOPY; X-RAY-SCATTERING; TRICHODERMA-REESEI; CELLOBIOHYDROLASE-I; ENDOGLUCANASE-I; IONIC LIQUIDS; HYDROLYSIS; VISUALIZATION; PRETREATMENT; BIOFUELS	Enzymatic hydrolysis of cellulose is key for the production of second generation biofuels, which represent a long-standing leading area in the field of sustainable energy. Despite the wealth of knowledge about cellulase structure and function, the elusive mechanism by which these enzymes disintegrate the complex structure of their insoluble substrate, which is the gist of cellulose saccharification, is still unclear. We herein present a time-resolved structural characterization of the action of cellulases on a nano-flat cellulose preparation, which enabled us to overcome previous limitations, using atomic force microscopy (AFM). As a first step in substrate disintegration, elongated fissures emerge which develop into coniform cracks as disintegration continues. Detailed data analysis allowed tracing the surface evolution back to the dynamics of crack morphology. This, in turn, reflects the interplay between surface degradation inside and outside of the crack. We observed how small cracks evolved and initially increased in size. At a certain point, the crack diameter stagnated and then started decreasing again. Stagnation corresponds with a decrease in the total amount of surface which is fissured and thus leads to the conclusion that the surface hydrolysis "around" the cracks is proceeding more rapidly than inside the cracks. The mesoscopic view presented here is in good agreement with various mechanistic proposals from the past and allows a novel insight into the structural dynamics occurring on the cellulosic substrate through cellulase action.	[Bubner, Patricia; Nidetzky, Bernd] Graz Univ Technol, Inst Biotechnol & Biochem Engn, A-8010 Graz, Austria; [Dohr, Judith; Plank, Harald; Mayrhofer, Claudia] Graz Univ Technol, Inst Electron Microscopy, A-8010 Graz, Austria	Graz University of Technology; Graz University of Technology	Nidetzky, B (corresponding author), Graz Univ Technol, Inst Biotechnol & Biochem Engn, Petersgasse 12, A-8010 Graz, Austria.	bernd.nidetzky@tugraz.at		Nidetzky, Bernd/0000-0002-5030-2643	Austrian Science Fund FWF [P 24156-B21]; Austrian Science Fund (FWF) [P 24156] Funding Source: researchfish	Austrian Science Fund FWF(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Grant P 24156-B21 from the Austrian Science Fund FWF (to B. N.).	ABUJA PM, 1988, EUR BIOPHYS J BIOPHY, V15, P339, DOI 10.1007/BF00254721; ABUJA PM, 1988, BIOCHEM BIOPH RES CO, V156, P180, DOI 10.1016/S0006-291X(88)80821-0; Arantes V, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-4; Bansal P, 2009, BIOTECHNOL ADV, V27, P833, DOI 10.1016/j.biotechadv.2009.06.005; Bommarius AS, 2008, METAB ENG, V10, P370, DOI 10.1016/j.ymben.2008.06.008; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cui ST, 2005, J CHEM PHYS, V123, DOI 10.1063/1.1989314; Ding SY, 2008, CURR OPIN BIOTECH, V19, P218, DOI 10.1016/j.copbio.2008.04.008; ESTERBAUER H, 1991, BIORESOURCE TECHNOL, V36, P51, DOI 10.1016/0960-8524(91)90099-6; GHOSE TK, 1987, PURE APPL CHEM, V59, P257, DOI 10.1351/pac198759020257; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; HOLTZAPPLE M, 1990, BIOTECHNOL BIOENG, V36, P275, DOI 10.1002/bit.260360310; Igarashi K, 2009, J BIOL CHEM, V284, P36186, DOI 10.1074/jbc.M109.034611; Kim SJ, 2010, BIORESOURCE TECHNOL, V101, P8273, DOI 10.1016/j.biortech.2010.06.047; Kleywegt GJ, 1997, J MOL BIOL, V272, P383, DOI 10.1006/jmbi.1997.1243; Lee I, 2000, ULTRAMICROSCOPY, V82, P213, DOI 10.1016/S0304-3991(99)00158-8; Levine SE, 2010, BIOTECHNOL BIOENG, V107, P37, DOI 10.1002/bit.22789; Liu H, 2009, ENZYME MICROB TECH, V45, P274, DOI 10.1016/j.enzmictec.2009.06.009; Liu YS, 2011, J BIOL CHEM, V286, P11195, DOI 10.1074/jbc.M110.216556; Lynd LR, 2008, NAT BIOTECHNOL, V26, P169, DOI 10.1038/nbt0208-169; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Mansfield SD, 1999, BIOTECHNOL PROGR, V15, P804, DOI 10.1021/bp9900864; NIEVES RA, 1991, APPL ENVIRON MICROB, V57, P3163, DOI 10.1128/AEM.57.11.3163-3170.1991; Nigmatullin R, 2004, COLLOID SURFACE B, V35, P125, DOI 10.1016/j.colsurfb.2004.02.013; Ohtani H, 2008, ANAL SCI, V24, P1335, DOI 10.2116/analsci.24.1335; Penttila PA, 2010, BIOMACROMOLECULES, V11, P1111, DOI 10.1021/bm1001119; Prasad K, 2009, MACROMOL BIOSCI, V9, P376, DOI 10.1002/mabi.200800179; Quirk A, 2010, LANGMUIR, V26, P5007, DOI 10.1021/la9037028; Solomon BD, 2007, BIOMASS BIOENERG, V31, P416, DOI 10.1016/j.biombioe.2007.01.023; Zhang YHP, 2004, BIOTECHNOL BIOENG, V88, P797, DOI 10.1002/bit.20282; Zhao H, 2009, J BIOTECHNOL, V139, P47, DOI 10.1016/j.jbiotec.2008.08.009	32	44	44	3	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2759	2765		10.1074/jbc.M111.257717	http://dx.doi.org/10.1074/jbc.M111.257717			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22128148	Green Published, hybrid			2022-12-27	WOS:000300292300047
J	Sarfstein, R; Pasmanik-Chor, M; Yeheskel, A; Edry, L; Shomron, N; Warman, N; Wertheimer, E; Maor, S; Shochat, L; Werner, H				Sarfstein, Rive; Pasmanik-Chor, Metsada; Yeheskel, Adva; Edry, Liat; Shomron, Noam; Warman, Naama; Wertheimer, Efrat; Maor, Sharon; Shochat, Lea; Werner, Haim			Insulin-like Growth Factor-I Receptor (IGF-IR) Translocates to Nucleus and Autoregulates IGF-IR Gene Expression in Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING RESIDUES; ESTROGEN-RECEPTOR; TUMOR-CELLS; TRANSCRIPTION FACTOR; SEQUENCE; PREDICTION; PROTEINS; PROMOTER; BRCA1; PROLIFERATION	The insulin-like growth factor (IGF) system plays an important role in mammary gland biology as well as in the etiology of breast cancer. The IGF-I receptor (IGF-IR), which mediates the biological actions of IGF-I and IGF-II, has emerged in recent years as a promising therapeutic target. The IGF and estrogen signaling pathways act in a synergistic manner in breast epithelial cells. The present study was aimed at investigating 1) the putative translocation of IGF-IR and the related insulin receptor (IR) to the nucleus in breast cancer cells, 2) the impact of IGF-IR and IR levels on IGF-IR biosynthesis in estrogen receptor (ER)positive and ER-depleted breast cancer cells, and 3) the potential transcription factor role of IGF-IR in the specific context of IGF-IR gene regulation. We describe here a novel mechanism of autoregulation of IGF-IR gene expression by cellular IGF-IR, which is seemingly dependent on ER status. Regulation of the IGF-IR gene by IGF-IR protein is mediated at the level of transcription, as demonstrated by 1) binding assays (DNA affinity chromatography and ChIP) showing specific IGF-IR binding to IGF-IR promoter DNA and 2) transient transfection assays showing transactivation of the IGF-IR promoter by exogenous IGF-IR. The IR is also capable of translocating to the nucleus and binding the IGF-IR promoter in ER-depleted, but not in ER-positive, cells. However, transcription factors IGF-IR and IR display diametrically opposite activities in the context of IGF-IR gene regulation. Thus, whereas IGF-IR stimulated IGF-IR gene expression, IR inhibited IGF-IR promoter activity. In summary, we have identified a novel mechanism of IGF-IR gene autoregulation in breast cancer cells. The clinical implications of these findings and, in particular, the impact of IGF-IR/IR nuclear localization on targeted therapy require further investigation.	[Sarfstein, Rive; Maor, Sharon; Shochat, Lea; Werner, Haim] Tel Aviv Univ, Sackler Sch Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel; [Edry, Liat; Shomron, Noam] Tel Aviv Univ, Sackler Sch Med, Dept Cell & Dev Biol, IL-69978 Tel Aviv, Israel; [Warman, Naama; Wertheimer, Efrat] Tel Aviv Univ, Sackler Sch Med, Dept Pathol, IL-69978 Tel Aviv, Israel; [Pasmanik-Chor, Metsada; Yeheskel, Adva] Tel Aviv Univ, George Wise Fac Life Sci, Bioinformat Unit, IL-69978 Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University	Werner, H (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel.	hwerner@post.tau.ac.il						Abramovitch S, 2003, HORM METAB RES, V35, P758; Ahmad S, 2004, BIOINFORMATICS, V20, P477, DOI 10.1093/bioinformatics/btg432; Aleksic T, 2010, CANCER RES, V70, P6412, DOI 10.1158/0008-5472.CAN-10-0052; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Becker MA, 2011, MOL ENDOCRINOL, V25, P516, DOI 10.1210/me.2010-0373; Belfiore A, 2008, J MAMMARY GLAND BIOL, V13, P381, DOI 10.1007/s10911-008-9099-z; Boutet Emmanuel, 2007, V406, P89; Bruchim I, 2009, EXPERT OPIN THER TAR, V13, P1179, DOI 10.1517/14728220903201702; Cannata D, 2010, ENDOCRINOLOGY, V151, P5751, DOI 10.1210/en.2010-0792; Casa A. J., 2011, BREAST CANC IN PRESS; Chitnis MM, 2008, CLIN CANCER RES, V14, P6364, DOI 10.1158/1078-0432.CCR-07-4879; COOKE DW, 1991, BIOCHEM BIOPH RES CO, V177, P1113, DOI 10.1016/0006-291X(91)90654-P; Creighton CJ, 2008, J CLIN ONCOL, V26, P4078, DOI 10.1200/JCO.2007.13.4429; Deng H, 2011, BIOCHEM BIOPH RES CO, V404, P667, DOI 10.1016/j.bbrc.2010.12.038; Happerfield LC, 1997, J PATHOL, V183, P412; HernandezSanchez C, 1997, J BIOL CHEM, V272, P4663, DOI 10.1074/jbc.272.8.4663; Hwang S, 2007, BIOINFORMATICS, V23, P634, DOI 10.1093/bioinformatics/btl672; Idelman G, 2003, J BIOL CHEM, V278, P3474, DOI 10.1074/jbc.M211606200; Jones RA, 2007, ONCOGENE, V26, P1636, DOI 10.1038/sj.onc.1209955; Kahlert S, 2000, J BIOL CHEM, V275, P18447, DOI 10.1074/jbc.M910345199; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Maor SB, 2000, MOL GENET METAB, V69, P130, DOI 10.1006/mgme.1999.2958; Maor S, 2007, CANCER LETT, V257, P236, DOI 10.1016/j.canlet.2007.07.019; Maor S, 2006, J ENDOCRINOL, V191, P605, DOI 10.1677/joe.1.07016; Martin MB, 2000, ENDOCRINOLOGY, V141, P4503, DOI 10.1210/en.141.12.4503; Martin MB, 2002, J NUTR, V132, p3799S, DOI 10.1093/jn/132.12.3799S; Oesterreich S, 2001, CANCER RES, V61, P5771; Ofran Y, 2007, BIOINFORMATICS, V23, pI347, DOI 10.1093/bioinformatics/btm174; PEYRAT JP, 1992, BREAST CANCER RES TR, V22, P59, DOI 10.1007/BF01833334; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Rowzee A, 2008, J MAMMARY GLAND BIOL, V13, P361, DOI 10.1007/s10911-008-9102-8; Samani AA, 2007, ENDOCR REV, V28, P20, DOI 10.1210/er.2006-0001; Sarfstein Rive, 2010, Cancers (Basel), V2, P233, DOI 10.3390/cancers2020233; Schnarr B, 2000, INT J CANCER, V89, P506, DOI 10.1002/1097-0215(20001120)89:6<506::AID-IJC7>3.0.CO;2-F; Scotlandi K, 2008, CURR OPIN ONCOL, V20, P419, DOI 10.1097/CCO.0b013e328302edab; Sehat B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000628; SELL C, 1993, P NATL ACAD SCI USA, V90, P11217, DOI 10.1073/pnas.90.23.11217; SMALE ST, 1989, CELL, V57, P103, DOI 10.1016/0092-8674(89)90176-1; Sun HZ, 2003, MOL ENDOCRINOL, V17, P472, DOI 10.1210/me.2002-0276; Surmacz E, 2000, J MAMMARY GLAND BIOL, V5, P95, DOI 10.1023/A:1009523501499; Vigneri R, 2010, ACTA DIABETOL, V47, P271, DOI 10.1007/s00592-010-0215-3; Wang LJ, 2006, NUCLEIC ACIDS RES, V34, pW243, DOI 10.1093/nar/gkl298; Werner H, 2000, CELL MOL LIFE SCI, V57, P932, DOI 10.1007/PL00000735; WERNER H, 1994, J BIOL CHEM, V269, P12577; WERNER H, 1992, MOL ENDOCRINOL, V6, P1545, DOI 10.1210/me.6.10.1545; Werner H, 1996, P NATL ACAD SCI USA, V93, P8318, DOI 10.1073/pnas.93.16.8318; Werner H, 2006, TRENDS ENDOCRIN MET, V17, P236, DOI 10.1016/j.tem.2006.06.007; Werner Haim, 2009, Pediatr Endocrinol Rev, V7, P2; Werner Haim, 2009, Archives of Physiology and Biochemistry, V115, P58, DOI 10.1080/13813450902783106; Yee D, 2000, J MAMMARY GLAND BIOL, V5, P107, DOI 10.1023/A:1009575518338; Yerushalmi R, 2012, BREAST CANCER RES TR, V132, P131, DOI 10.1007/s10549-011-1529-8; Yuen JSP, 2008, EXPERT OPIN THER TAR, V12, P589, DOI 10.1517/14728222.12.5.589 	54	64	69	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2766	2776		10.1074/jbc.M111.281782	http://dx.doi.org/10.1074/jbc.M111.281782			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22128190	Green Published, hybrid			2022-12-27	WOS:000300292300048
J	Weiss, N; Hameed, S; Fernandez-Fernandez, JM; Fablet, K; Karmazinova, M; Poillot, C; Proft, J; Chen, LN; Bidaud, I; Monteil, A; Huc-Brandt, S; Lacinova, L; Lory, P; Zamponi, GW; De Waard, M				Weiss, Norbert; Hameed, Shahid; Fernandez-Fernandez, Jose M.; Fablet, Katell; Karmazinova, Maria; Poillot, Cathy; Proft, Juliane; Chen, Lina; Bidaud, Isabelle; Monteil, Arnaud; Huc-Brandt, Sylvaine; Lacinova, Lubica; Lory, Philippe; Zamponi, Gerald W.; De Waard, Michel			A Ca(v)3.2/Syntaxin-1A Signaling Complex Controls T-type Channel Activity and Low-threshold Exocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-INTERACTION SITE; N-TYPE; CA2+ CHANNELS; CALCIUM-CHANNELS; MOLECULAR DETERMINANTS; NEUROTRANSMITTER RELEASE; SUBCELLULAR-DISTRIBUTION; FUNCTIONAL INTERACTION; ALPHA(1A) SUBUNITS; KINETIC-PROPERTIES	T-type calcium channels represent a key pathway for Ca2+ entry near the resting membrane potential. Increasing evidence supports a unique role of these channels in fast and low-threshold exocytosis in an action potential-independent manner, but the underlying molecular mechanisms have remained unknown. Here, we report the existence of a syntaxin-1A/Ca(v)3.2 T-type calcium channel signaling complex that relies on molecular determinants that are distinct from the synaptic protein interaction site (synprint) found in synaptic high voltage-activated calcium channels. This interaction potently modulated Ca(v)3.2 channel activity, by reducing channel availability. Other members of the T-type calcium channel family were also regulated by syntaxin-1A, but to a smaller extent. Overexpression of Ca(v)3.2 channels in MPC 9/3L-AH chromaffin cells induced low-threshold secretion that could be prevented by uncoupling the channels from syntaxin-1A. Altogether, our findings provide compelling evidence for the existence of a syntaxin-1A/T-type Ca2+ channel signaling complex and provide new insights into the molecular mechanism by which these channels control low-threshold exocytosis.	[De Waard, Michel] INSERM, U836, Grenoble Inst Neurosci, Lab Ion Channels Funct & Pathol, F-38706 La Tronche, France; [Weiss, Norbert; Hameed, Shahid; Chen, Lina; Zamponi, Gerald W.] Univ Calgary, Dept Physiol & Pharmacol, Hotchkiss Brain Inst, Calgary, AB T2N 4N1, Canada; [Proft, Juliane] Univ Calgary, Dept Clin Neurosci, Hotchkiss Brain Inst, Calgary, AB T2N 4N1, Canada; [Weiss, Norbert; Fablet, Katell; Poillot, Cathy; De Waard, Michel] Univ Grenoble 1, F-38000 Grenoble, France; [Fernandez-Fernandez, Jose M.] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Lab Mol Physiol & Channelopathies, Barcelona 08003, Spain; [Karmazinova, Maria; Lacinova, Lubica] Slovak Acad Sci, Biophys Lab, Inst Mol Physiol & Genet, Bratislava 83334, Slovakia; [Bidaud, Isabelle; Monteil, Arnaud; Huc-Brandt, Sylvaine; Lory, Philippe] Inst Genom Fonct, Dept Physiol, F-34094 Montpellier, France; [Bidaud, Isabelle; Monteil, Arnaud; Huc-Brandt, Sylvaine; Lory, Philippe] CNRS, Unite Mixte Rech 5203, F-34396 Montpellier, France; [Bidaud, Isabelle; Monteil, Arnaud; Huc-Brandt, Sylvaine; Lory, Philippe] CNRS, INSERM, U661, F-34094 Montpellier, France; [Bidaud, Isabelle; Monteil, Arnaud; Huc-Brandt, Sylvaine; Lory, Philippe] Univ Montpellier I, Inst Federatif Rech 3, F-34090 Montpellier, France; [Bidaud, Isabelle; Monteil, Arnaud; Huc-Brandt, Sylvaine; Lory, Philippe] Univ Montpellier 2, Inst Federatif Rech 3, F-34090 Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); University of Calgary; University of Calgary; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Pompeu Fabra University; Slovak Academy of Sciences; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Universite de Montpellier	De Waard, M (corresponding author), INSERM, U836, Grenoble Inst Neurosci, Lab Ion Channels Funct & Pathol, Batiment Edmond J Safra,Chemin Fortune Ferrini, F-38706 La Tronche, France.	dewaardm@ujf-grenoble.fr	Brandt, Sylvaine/AAJ-1277-2021; Proft, Juliane/H-6549-2014; Monteil, Arnaud/G-3113-2012; Fernández-Fernández, José Manuel M/M-8157-2015; Weiss, Norbert/G-5330-2014; De Waard, Michel/G-7406-2014; Lacinova, Lubica/A-9645-2014	Brandt, Sylvaine/0000-0002-5582-4643; Proft, Juliane/0000-0003-0980-8930; Monteil, Arnaud/0000-0003-1632-7318; Fernández-Fernández, José Manuel M/0000-0003-2330-8449; Weiss, Norbert/0000-0002-0040-1109; De Waard, Michel/0000-0002-2782-9615; Lacinova, Lubica/0000-0001-9207-0978; LORY, philippe/0000-0002-1638-7604; Zamponi, Gerald W./0000-0002-0644-9066; BIDAUD, Isabelle/0000-0002-1812-1447	Alberta Innovates, Health Solutions (AIHS); Hotchkiss Brain Institute; Spanish Ministry of Science and Innovation; Fondos Europeos de Desarrollo Regional (FEDER) Funds, and Plan E [SAF2009-13182-C03-02]; Fondo de Investigacion Sanitaria [Red HERACLES RD06/0009]; Generalitat de Catalunya [2009SGR1369]; VEGA [2/0195/10]; Canadian Institutes of Health Research;  [ANR-2006-Neuro35];  [ANR-09-MNPS-035]	Alberta Innovates, Health Solutions (AIHS); Hotchkiss Brain Institute; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fondos Europeos de Desarrollo Regional (FEDER) Funds, and Plan E; Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); Generalitat de Catalunya(Generalitat de Catalunya); VEGA(Vedecka grantova agentura MSVVaS SR a SAV (VEGA)European Commission); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); ; 	This work was supported in part by fellowships from Alberta Innovates, Health Solutions (AIHS) and from the Hotchkiss Brain Institute (to N. W.), by Spanish Ministry of Science and Innovation, Fondos Europeos de Desarrollo Regional (FEDER) Funds, and Plan E (Grant SAF2009-13182-C03-02), Fondo de Investigacion Sanitaria (Red HERACLES RD06/0009) and Generalitat de Catalunya (Grant 2009SGR1369) (to J. M. F.-F.), by VEGA 2/0195/10 grant (to L. L.), by ANR-2006-Neuro35 and ANR-09-MNPS-035 grants (to P. L.), and by the Canadian Institutes of Health Research (to G. W. Z.).	Baumgart JP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002976; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; Bezprozvanny I, 2000, P NATL ACAD SCI USA, V97, P13943, DOI 10.1073/pnas.220389697; BEZPROZVANNY I, 1995, NATURE, V378, P623, DOI 10.1038/378623a0; Carabelli V, 2007, J PHYSIOL-LONDON, V584, P149, DOI 10.1113/jphysiol.2007.132274; COHEN MW, 1991, J NEUROSCI, V11, P1032; Cueni L, 2008, NAT NEUROSCI, V11, P683, DOI 10.1038/nn.2124; Cueni L, 2009, PFLUG ARCH EUR J PHY, V457, P1161, DOI 10.1007/s00424-008-0582-6; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Egger V, 2003, J NEUROSCI, V23, P7551; Fiebig KM, 1999, NAT STRUCT BIOL, V6, P117; Harkins AB, 2004, P NATL ACAD SCI USA, V101, P15219, DOI 10.1073/pnas.0401001101; Harkins AB, 2003, J NEUROPHYSIOL, V90, P2325, DOI 10.1152/jn.00425.2003; HUGUENARD JR, 1992, J NEUROSCI, V12, P3804, DOI 10.1523/jneurosci.12-10-03804.1992; Ivanov AI, 2000, J NEUROSCI, V20, P4930; Jarvis SE, 2000, J BIOL CHEM, V275, P6388, DOI 10.1074/jbc.275.9.6388; Jarvis SE, 2002, J BIOL CHEM, V277, P44399, DOI 10.1074/jbc.M206902200; Jarvis SE, 2001, TRENDS PHARMACOL SCI, V22, P519, DOI 10.1016/S0165-6147(00)01800-9; Jarvis SE, 2001, J NEUROSCI, V21, P2939, DOI 10.1523/JNEUROSCI.21-09-02939.2001; Joksovic PM, 2005, J PHYSIOL-LONDON, V566, P125, DOI 10.1113/jphysiol.2005.086579; Keith RK, 2007, J NEUROSCI, V27, P265, DOI 10.1523/JNEUROSCI.4213-06.2007; Khosravani H, 2006, PHYSIOL REV, V86, P941, DOI 10.1152/physrev.00002.2006; Kim K, 1997, P NATL ACAD SCI USA, V94, P14782, DOI 10.1073/pnas.94.26.14782; LEVEQUE C, 1994, J BIOL CHEM, V269, P6306; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; LLINAS R, 1992, SCIENCE, V256, P677, DOI 10.1126/science.1350109; McKay BE, 2006, EUR J NEUROSCI, V24, P2581, DOI 10.1111/j.1460-9568.2006.05136.x; Mochida S, 2003, P NATL ACAD SCI USA, V100, P2819, DOI 10.1073/pnas.262787699; Mochida S, 1996, NEURON, V17, P781, DOI 10.1016/S0896-6273(00)80209-3; Neher E, 2008, NEURON, V59, P861, DOI 10.1016/j.neuron.2008.08.019; Pan ZH, 2001, NEURON, V32, P89, DOI 10.1016/S0896-6273(01)00454-8; Rettig J, 1996, P NATL ACAD SCI USA, V93, P7363, DOI 10.1073/pnas.93.14.7363; Rettig J, 1997, J NEUROSCI, V17, P6647; Richmond JE, 2001, NATURE, V412, P338, DOI 10.1038/35085583; Serra SA, 2010, P NATL ACAD SCI USA, V107, P1672, DOI 10.1073/pnas.0908359107; Sheng ZH, 1997, P NATL ACAD SCI USA, V94, P5405, DOI 10.1073/pnas.94.10.5405; SHENG ZH, 1994, NEURON, V13, P1303, DOI 10.1016/0896-6273(94)90417-0; Sutton KG, 1999, NATURE, V401, P800, DOI 10.1038/44586; Tang AH, 2011, J NEUROSCI, V31, P13546, DOI 10.1523/JNEUROSCI.2781-11.2011; Tscherter A, 2011, J PHYSIOL-LONDON, V589, P1707, DOI 10.1113/jphysiol.2010.203836; Vitko I, 2007, J NEUROSCI, V27, P322, DOI 10.1523/JNEUROSCI.1817-06.2007; Weber AM, 2010, NAT NEUROSCI, V13, P1348, DOI 10.1038/nn.2657; Weiss N, 2008, PFLUG ARCH EUR J PHY, V457, P315, DOI 10.1007/s00424-008-0541-2; WESTENBROEK RE, 1995, J NEUROSCI, V15, P6403; WESTENBROEK RE, 1992, NEURON, V9, P1099, DOI 10.1016/0896-6273(92)90069-P; Wiser O, 1997, FEBS LETT, V404, P203, DOI 10.1016/S0014-5793(97)00130-0; Wiser O, 1996, EMBO J, V15, P4100, DOI 10.1002/j.1460-2075.1996.tb00785.x; YOSHIDA A, 1992, J BIOL CHEM, V267, P24925; Zamponi GW, 2003, J PHARMACOL SCI, V92, P79; Zhong HJ, 1999, NAT NEUROSCI, V2, P939, DOI 10.1038/14721	50	82	84	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2810	2818		10.1074/jbc.M111.290882	http://dx.doi.org/10.1074/jbc.M111.290882			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22130660	Green Submitted, Green Published, hybrid			2022-12-27	WOS:000300292300052
J	Fang, Z; Zhang, T; Dizeyi, N; Chen, S; Wang, HY; Swanson, KD; Cai, CM; Balk, SP; Yuan, X				Fang, Zi; Zhang, Tao; Dizeyi, Nishtman; Chen, Sen; Wang, Hongyun; Swanson, Kenneth D.; Cai, Changmeng; Balk, Steven P.; Yuan, Xin			Androgen Receptor Enhances p27 Degradation in Prostate Cancer Cells through Rapid and Selective TORC2 Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MTOR COMPLEX 2; KINASE 1 SGK1; MOTIF PHOSPHORYLATION; REGULATES PROTEOLYSIS; CYCLE PROGRESSION; UBIQUITIN LIGASE; NUCLEAR EXPORT; P27(KIP1); AKT; SPECIFICITY	Androgen receptor (AR) plays a central role in prostate cancer (PCa) growth, with androgen deprivation or AR down-regulation causing cell-cycle arrest and accumulation of the p27 cyclin-dependent kinase inhibitor. The molecular basis for this AR regulation of cell-cycle progression remains unclear. Here we demonstrate that androgen can rapidly reduce p27 protein in PCa cells by increasing its proteasome-mediated degradation. This rapid androgen-stimulated p27 degradation was mediated by AKT through the phosphorylation of p27 T157. Significantly, androgen increased TORC2-mediated AKT S473 phosphorylation without affecting the PDK1-mediated AKT T308 phosphorylation or TORC1 activity. The TORC2 activation was further supported by enhanced mTOR/RICTOR association and increased phosphorylation of additional TORC2 substrates, SGK1 and PKC alpha. The androgen-stimulated nuclear translocation of AR was associated with markedly-increased nuclear SIN1, a critical component of TORC2. Finally, the androgen-mediated TORC2/AKT activation targets a subset of AKT substrates including p27 and FOXO1, but not PRAS40. This study reveals a pathway linking AR to a selective activation of TORC2, the subsequent activation of AKT, and phosphorylation of a discrete set of AKT substrates that regulate cellular proliferation and survival. These findings establish that TORC2 can function as a central regulator of growth in response to signals that are distinct from those regulating TORC1, and support efforts to target TORC2 for cancer therapy.	[Fang, Zi; Zhang, Tao; Dizeyi, Nishtman; Chen, Sen; Wang, Hongyun; Swanson, Kenneth D.; Cai, Changmeng; Balk, Steven P.; Yuan, Xin] Harvard Univ, Div Hematol Oncol, Dept Med, Beth Israel Deaconess Med Ctr,Med Sch, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Balk, SP (corresponding author), 330 Brookline Ave,CLS 0443, Boston, MA 02115 USA.	sbalk@bidmc.harvard.edu; xyuan@bidmc.harvard.edu	Cai, Changmeng/AAE-6835-2020	Cai, Changmeng/0000-0002-8701-2586	National Institutes of Health [R01DK079962, R56AI085131]; Dana-Farber/Harvard SPORE in prostate cancer [P50 CA 090381]; Department of Defense [PC020320]; NATIONAL CANCER INSTITUTE [P50CA090381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI085131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079962] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana-Farber/Harvard SPORE in prostate cancer; Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by Grants R01DK079962 (to X. Y.) and R56AI085131 (to K. D. S.) from the National Institutes of Health. This work was also supported by Grant P50 CA 090381 from the Dana-Farber/Harvard SPORE in prostate cancer (to S. P. B.) and Grant PC020320 from the Department of Defense (to X. Y.).	Balk Steven P, 2008, Nucl Recept Signal, V6, pe001, DOI 10.1621/nrs.06001; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Calleja V, 2009, PLOS BIOL, V7, P189, DOI 10.1371/journal.pbio.1000017; Chen SY, 2009, J BIOL CHEM, V284, P25576, DOI 10.1074/jbc.M109.043133; Chu I, 2007, CELL, V128, P281, DOI 10.1016/j.cell.2006.11.049; Connor MK, 2003, MOL BIOL CELL, V14, P201, DOI 10.1091/mbc.E02-06-0319; Di Pietro N, 2010, MOL ENDOCRINOL, V24, P370, DOI 10.1210/me.2009-0265; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; Grimmler M, 2007, CELL, V128, P269, DOI 10.1016/j.cell.2006.11.047; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Guertin DA, 2009, CANCER CELL, V15, P148, DOI 10.1016/j.ccr.2008.12.017; Hong F, 2008, MOL CELL, V30, P701, DOI 10.1016/j.molcel.2008.04.027; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Ishida N, 2002, J BIOL CHEM, V277, P14355, DOI 10.1074/jbc.C100762200; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Kamura T, 2004, NAT CELL BIOL, V6, P1229, DOI 10.1038/ncb1194; Knudsen KE, 2009, CLIN CANCER RES, V15, P4792, DOI 10.1158/1078-0432.CCR-08-2660; Knudsen KE, 1998, J BIOL CHEM, V273, P20213, DOI 10.1074/jbc.273.32.20213; Kotoshiba S, 2005, J BIOL CHEM, V280, P17694, DOI 10.1074/jbc.M500866200; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; Lu M, 2010, J AM SOC NEPHROL, V21, P811, DOI 10.1681/ASN.2009111168; Migliaccio A, 2005, CANCER RES, V65, P10585, DOI 10.1158/0008-5472.CAN-05-0912; Murray JT, 2004, BIOCHEM J, V384, P477, DOI 10.1042/BJ20041057; Nakayama K, 2004, DEV CELL, V6, P661, DOI 10.1016/S1534-5807(04)00131-5; Nardella C, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000189; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Servant MJ, 2000, J CELL BIOL, V148, P543, DOI 10.1083/jcb.148.3.543; Sherk AB, 2008, CANCER RES, V68, P7475, DOI 10.1158/0008-5472.CAN-08-1047; Shin I, 2002, NAT MED, V8, P1145, DOI 10.1038/nm759; Susaki E, 2007, CELL CYCLE, V6, P3015, DOI 10.4161/cc.6.24.5087; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Truica CI, 2000, CANCER RES, V60, P4709; Viglietto G, 2002, NAT MED, V8, P1136, DOI 10.1038/nm762; Wang HB, 2010, NAT GENET, V42, P83, DOI 10.1038/ng.498; Xu YY, 2006, CANCER RES, V66, P7783, DOI 10.1158/0008-5472.CAN-05-4472; Yan L, 2008, J BIOL CHEM, V283, P7411, DOI 10.1074/jbc.M708083200; Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206; Yuan X, 2006, AM J PATHOL, V169, P682, DOI 10.2353/ajpath.2006.051047; Yuan X, 2009, UROL ONCOL-SEMIN ORI, V27, P36, DOI 10.1016/j.urolonc.2008.03.021; ZHOU ZX, 1995, MOL ENDOCRINOL, V9, P208, DOI 10.1210/me.9.2.208	40	54	56	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					2090	2098		10.1074/jbc.M111.323303	http://dx.doi.org/10.1074/jbc.M111.323303			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22139837	Green Published, hybrid			2022-12-27	WOS:000299321000049
J	Parthibane, V; Rajakumari, S; Venkateshwari, V; Iyappan, R; Rajasekharan, R				Parthibane, Velayoudame; Rajakumari, Sona; Venkateshwari, Varadarajan; Iyappan, Ramachandiran; Rajasekharan, Ram			Oleosin Is Bifunctional Enzyme That Has Both Monoacylglycerol Acyltransferase and Phospholipase Activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSOPHOSPHATIDIC ACID ACYLTRANSFERASE; DEVELOPING PEANUT COTYLEDONS; SEED OIL BODIES; ENDOPLASMIC-RETICULUM; BRASSICA-NAPUS; ARABIDOPSIS; BIOSYNTHESIS; ACCUMULATION; MEMBRANE; PROTEINS	In plants, fatty oils are generally stored in spherical intracellular organelles referred to as oleosomes that are covered by proteins such as oleosin. Seeds with high oil content have more oleosin than those with low oil content. However, the exact role of oleosin in oil accumulation is thus far unclear. Here, we report the isolation of a catalytically active 14 S multiprotein complex capable of acylating monoacylglycerol from the microsomal membranes of developing peanut cotyledons. Microsomal membranes from immature peanut seeds were solubilized using 8 M urea and 10 mM CHAPS. Using two-dimensional gel electrophoresis and mass spectrometry, we identified 27 proteins in the 14 S complex. The major proteins present in the 14 S complex are conarachin, the major allergen Ara h 1, and other seed storage proteins. We identified oleosin 3 as a part of the 14 S complex, which is capable of acylating monoacylglycerol. The recombinant OLE3 microsomes from Saccharomyces cerevisiae have been shown to have both a monoacylglycerol acyltransferase and a phospholipase A(2) activity. Overexpression of the oleosin 3 (OLE3) gene in S. cerevisiae resulted in an increased accumulation of diacylglycerols and triacylglycerols and decreased phospholipids. These findings provide a direct role for a structural protein (OLE3) in the biosynthesis and mobilization of plant oils.	[Venkateshwari, Varadarajan; Rajasekharan, Ram] CSIR, Cent Inst Med & Aromat Plants, Lucknow 226015, Uttar Pradesh, India; [Parthibane, Velayoudame; Rajakumari, Sona; Iyappan, Ramachandiran; Rajasekharan, Ram] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Institute of Medicinal & Aromatic Plants (CIMAP); Indian Institute of Science (IISC) - Bangalore	Rajasekharan, R (corresponding author), CSIR, Cent Inst Med & Aromat Plants, Lucknow 226015, Uttar Pradesh, India.	lipid@biochem.iisc.ernet.in; ram@cimap.res.in	Rajasekharan, Ram/R-2257-2019; Ramachandiran, Iyappan/AAC-4258-2019	Ramachandiran, Iyappan/0000-0002-0271-5478; Ram, Rajasekharan/0000-0002-4114-0654; Varadharajan, Venkateshwari/0000-0002-4557-9840; Rajasekharan, Ram/0000-0002-2124-6013	Council of Scientific and Industrial Research, New Delhi	Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the Council of Scientific and Industrial Research, New Delhi.	Abell BM, 1997, PLANT CELL, V9, P1481, DOI 10.1105/tpc.9.8.1481; Abell BM, 2004, PLANT J, V37, P461, DOI 10.1111/j.1365-313X.2003.01988.x; BELL RM, 1980, ANNU REV BIOCHEM, V49, P459, DOI 10.1146/annurev.bi.49.070180.002331; Cao JS, 2003, J BIOL CHEM, V278, P13860, DOI 10.1074/jbc.M300139200; Chuang RLC, 1996, J BIOCHEM-TOKYO, V120, P74, DOI 10.1093/oxfordjournals.jbchem.a021396; Ciambella C, 2005, PROTEOMICS, V5, P746, DOI 10.1002/pmic.200401129; Gangar A, 2001, J BIOL CHEM, V276, P10290, DOI 10.1074/jbc.M009550200; Ghosh AK, 2009, PLANT PHYSIOL, V151, P869, DOI 10.1104/pp.109.144261; Heath RJ, 1998, J BACTERIOL, V180, P1425, DOI 10.1128/JB.180.6.1425-1430.1998; Hsieh K, 2004, PLANT PHYSIOL, V136, P3427, DOI 10.1104/pp.104.051060; HUANG AHC, 1992, ANNU REV PLANT PHYS, V43, P177, DOI 10.1146/annurev.pp.43.060192.001141; Huang CY, 2009, PLANT PHYSIOL, V150, P1192, DOI 10.1104/pp.109.138123; Imamura M, 2002, AM J PHYSIOL-ENDOC M, V283, pE775, DOI 10.1152/ajpendo.00040.2002; Kayden H. J., 1967, J CLIN INVEST, V46, P1965; KENNEDY EP, 1961, FED PROC, V20, P934; Kim HU, 2002, J BIOL CHEM, V277, P22677, DOI 10.1074/jbc.M109298200; Lehner R, 1996, PROG LIPID RES, V35, P169, DOI 10.1016/0163-7827(96)00005-7; Li M, 2002, J BIOL CHEM, V277, P37888, DOI 10.1074/jbc.M202721200; Maisonneuve S, 2010, PLANT PHYSIOL, V152, P670, DOI 10.1104/pp.109.148247; MURPHY DJ, 1989, J PLANT PHYSIOL, V135, P63, DOI 10.1016/S0176-1617(89)80225-1; Murphy DJ, 1998, PLANT J, V13, P1; Napier JA, 1996, PLANT MOL BIOL, V31, P945, DOI 10.1007/BF00040714; Peng FY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-286; RADETZKY R, 1994, PLANTA, V194, P1, DOI 10.1007/BF00201027; ROSS JHE, 1993, PLANT SCI, V93, P203, DOI 10.1016/0168-9452(93)90050-A; Sandager L, 2002, J BIOL CHEM, V277, P6478, DOI 10.1074/jbc.M109109200; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Schmidt MA, 2008, MOL PLANT, V1, P910, DOI 10.1093/mp/ssn049; Shekar S, 2002, PLANT PHYSIOL, V128, P988, DOI 10.1104/pp.010654; Siloto RMP, 2006, PLANT CELL, V18, P1961, DOI 10.1105/tpc.106.041269; Stahl U, 2008, FEBS LETT, V582, P305, DOI 10.1016/j.febslet.2007.12.020; Ting JTL, 1996, PLANTA, V199, P158, DOI 10.1007/BF00196892; Tumaney AW, 2001, J BIOL CHEM, V276, P10847, DOI 10.1074/jbc.M100005200; TZEN JTC, 1993, PLANT PHYSIOL, V101, P267, DOI 10.1104/pp.101.1.267; Yen CLE, 2002, P NATL ACAD SCI USA, V99, P8512, DOI 10.1073/pnas.132274899; Zheng ZF, 2003, PLANT CELL, V15, P1872, DOI 10.1105/tpc.012427	36	72	89	2	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					1946	1954		10.1074/jbc.M111.309955	http://dx.doi.org/10.1074/jbc.M111.309955			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22128159	Green Published, hybrid			2022-12-27	WOS:000299321000035
J	Baldo, B; Weiss, A; Parker, CN; Bibel, M; Paganetti, P; Kaupmann, K				Baldo, Barbara; Weiss, Andreas; Parker, Christian N.; Bibel, Miriam; Paganetti, Paolo; Kaupmann, Klemens			A Screen for Enhancers of Clearance Identifies Huntingtin as a Heat Shock Protein 90 (Hsp90) Client Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUTANT HUNTINGTIN; MOUSE MODEL; SYSTEM IMPAIRMENT; DISEASE; HSP70; NEUROPATHOLOGY; PATHOGENESIS; AGGREGATION; EXPRESSION; CONFORMATION	Mechanisms to reduce the cellular levels of mutant huntingtin (mHtt) provide promising strategies for treating Huntington disease (HD). To identify compounds enhancing the degradation of mHtt, we performed a high throughput screen using a hippocampal HN10 cell line expressing a 573-amino acid mHtt fragment. Several hit structures were identified as heat shock protein 90 (Hsp90) inhibitors. Cell treatment with these compounds reduced levels of mHtt without overt toxic effects as measured by time-resolved Forster resonance energy transfer assays and Western blots. To characterize the mechanism of mHtt degradation, we used the potent and selective Hsp90 inhibitor NVP-AUY922. In HdhQ150 embryonic stem (ES) cells and in ES cell-derived neurons, NVP-AUY922 treatment substantially reduced soluble full-length mHtt levels. In HN10 cells, Hsp90 inhibition by NVP-AUY922 enhanced mHtt clearance in the absence of any detectable Hsp70 induction. Furthermore, inhibition of protein synthesis with cycloheximide or overexpression of dominant negative heat shock factor 1(Hsf1) in HdhQ150 ES cells attenuated Hsp70 induction but did not affect NVP-AUY922-mediated mHtt clearance. Together, these data provided evidence that direct inhibition of Hsp90 chaperone function was crucial for mHtt degradation rather than heat shock response induction and Hsp70 up-regulation. Co-immunoprecipitation experiments revealed a physical interaction of mutant and wild-type Htt with the Hsp90 chaperone. Hsp90 inhibition disrupted the interaction and induced clearance of Htt through the ubiquitin-proteasome system. Our data suggest that Htt is an Hsp90 client protein and that Hsp90 inhibition may provide a means to reduce mHtt in HD.	[Baldo, Barbara; Weiss, Andreas; Bibel, Miriam; Paganetti, Paolo; Kaupmann, Klemens] Novartis Pharma AG, Novartis Inst BioMed Res, Neurosci, CH-4002 Basel, Switzerland; [Parker, Christian N.] Novartis Pharma AG, Novartis Inst BioMed Res, Dev & Mol Pathways, CH-4002 Basel, Switzerland	Novartis; Novartis	Kaupmann, K (corresponding author), Novartis Pharma AG, Novartis Inst BioMed Res, Neurosci, WSJ-355-3-051-11, CH-4002 Basel, Switzerland.	klemens.kaupmann@novartis.com	Paganetti, Paolo/AAF-8039-2020	Paganetti, Paolo/0000-0003-1896-6324; Kaupmann, Klemens/0000-0001-8903-2508	European Community [215618, FP7/2008]	European Community(European Commission)	This work was supported by the European Community's Seventh Framework Programme FP7/2008 under Grant Agreement 215618.	Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; Bett JS, 2006, HUM MOL GENET, V15, P33, DOI 10.1093/hmg/ddi423; Bibel M, 2007, NAT PROTOC, V2, P1034, DOI 10.1038/nprot.2007.147; Bowman AB, 2005, HUM MOL GENET, V14, P679, DOI 10.1093/hmg/ddi064; Brough PA, 2008, J MED CHEM, V51, P196, DOI 10.1021/jm701018h; Cummings CJ, 2001, HUM MOL GENET, V10, P1511, DOI 10.1093/hmg/10.14.1511; DiFiglia M, 2007, P NATL ACAD SCI USA, V104, P17204, DOI 10.1073/pnas.0708285104; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; DUYAO MP, 1995, SCIENCE, V269, P407, DOI 10.1126/science.7618107; Eccles SA, 2008, CANCER RES, V68, P2850, DOI 10.1158/0008-5472.CAN-07-5256; Fecke W, 2009, DRUG DISCOV TODAY, V14, P453, DOI 10.1016/j.drudis.2009.02.006; Heldens L, 2010, CELL MOL LIFE SCI, V67, P4035, DOI 10.1007/s00018-010-0430-7; Hunter JM, 2007, J NEUROSCI RES, V85, P1774, DOI 10.1002/jnr.21287; JOHNSON JL, 1995, MOL ENDOCRINOL, V9, P670, DOI 10.1210/me.9.6.670; Kaarniranta K, 2002, MOL BRAIN RES, V101, P136, DOI 10.1016/S0169-328X(02)00179-1; Kamal A, 2003, NATURE, V425, P407, DOI 10.1038/nature01913; Kamal Adeela, 2004, Discov Med, V4, P277; Ko J, 2001, BRAIN RES BULL, V56, P319, DOI 10.1016/S0361-9230(01)00599-8; Labbadia J, 2011, J CLIN INVEST, V121, P3306, DOI 10.1172/JCI57413; Lin CH, 2001, HUM MOL GENET, V10, P137, DOI 10.1093/hmg/10.2.137; Lotz GP, 2010, J BIOL CHEM, V285, P38183, DOI 10.1074/jbc.M110.160218; Luo WJ, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-24; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; McBride JL, 2008, P NATL ACAD SCI USA, V105, P5868, DOI 10.1073/pnas.0801775105; Muchowski PJ, 2000, P NATL ACAD SCI USA, V97, P7841, DOI 10.1073/pnas.140202897; Ortega Z, 2010, J NEUROSCI, V30, P3675, DOI 10.1523/JNEUROSCI.5673-09.2010; Paganetti P, 2009, CHEMBIOCHEM, V10, P1678, DOI 10.1002/cbic.200900131; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Ross CA, 2011, LANCET NEUROL, V10, P83, DOI 10.1016/S1474-4422(10)70245-3; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Sah DWY, 2011, J CLIN INVEST, V121, P500, DOI 10.1172/JCI45130; Schilb A, 2004, J BIOMOL SCREEN, V9, P569, DOI 10.1177/1087057104265538; Sittler A, 2001, HUM MOL GENET, V10, P1307, DOI 10.1093/hmg/10.12.1307; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Thomas M, 2006, HUM MOL GENET, V15, P1876, DOI 10.1093/hmg/ddl110; Tokui K, 2009, HUM MOL GENET, V18, P898, DOI 10.1093/hmg/ddn419; Turturici G, 2011, BIOCHEM RES INT, V2011, DOI 10.1155/2011/618127; Wacker JL, 2009, J NEUROSCI, V29, P9104, DOI 10.1523/JNEUROSCI.2250-09.2009; Waza M, 2005, NAT MED, V11, P1088, DOI 10.1038/nm1298; Weiss A, 2011, ANAL BIOCHEM, V410, P304, DOI 10.1016/j.ab.2010.11.044; Weiss A, 2009, ANAL BIOCHEM, V395, P8, DOI 10.1016/j.ab.2009.08.001; Weiss A, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-11; Yamamoto A, 2000, CELL, V101, P57, DOI 10.1016/S0092-8674(00)80623-6; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968	44	70	71	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1406	1414		10.1074/jbc.M111.294801	http://dx.doi.org/10.1074/jbc.M111.294801			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22123826	Green Published, hybrid			2022-12-27	WOS:000299170300054
J	van Lummel, M; van Veelen, PA; Zaldumbide, A; de Ru, A; Janssen, GMC; Moustakas, AK; Papadopoulos, GK; Drijfhout, JW; Roep, BO; Koning, F				van Lummel, Menno; van Veelen, Peter A.; Zaldumbide, Arnaud; de Ru, Arnoud; Janssen, George M. C.; Moustakas, Antonis K.; Papadopoulos, George K.; Drijfhout, Jan W.; Roep, Bart O.; Koning, Frits			Type 1 Diabetes-associated HLA-DQ8 Transdimer Accommodates a Unique Peptide Repertoire	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISEASE-ASSOCIATED DQ(ALPHA-1-ASTERISK-0501; T-CELL RESPONSES; HLA-DQ; CELIAC-DISEASE; BINDING CHARACTERISTICS; INSULIN; SUSCEPTIBILITY; GENETICS; EPITOPES; COMPLEX	HLA-DQ2 and HLA-DQ8 are strongly predisposing haplotypes for type 1 diabetes (T1D). Yet HLA-DQ2/8 heterozygous individuals have a synergistically increased risk compared with HLA-DQ2 or HLA-DQ8 homozygote subjects that may result from the presence of a transdimer formed between the alpha-chain of HLA-DQ2 (DQA1*05:01) and the beta-chain of HLA-DQ8 (DQB1*03:02). We generated cells exclusively expressing this transdimer (HLA-DQ8trans), characterized its peptide binding repertoire, and defined a unique transdimer-specific peptide binding motif that was found to be distinct from those of HLA-DQ2 and HLA-DQ8. This motif predicts an array of peptides of islet autoantigens as candidate T cell epitopes, many of which selectively bind to the HLA transdimer, whereas others bind to both HLA-DQ8 and transdimer with similar affinity. Our findings provide a molecular basis for the association between HLA-DQ transdimers and T1D and set the stage for rational testing of potential diabetogenic peptide epitopes.	[van Lummel, Menno; van Veelen, Peter A.; de Ru, Arnoud; Janssen, George M. C.; Roep, Bart O.; Koning, Frits] Leiden Univ, Dept Immunohematol & Blood Transfus, Med Ctr, NL-2300 RC Leiden, Netherlands; [Zaldumbide, Arnaud] Leiden Univ, Dept Mol Cell Biol, Med Ctr, NL-2300 RC Leiden, Netherlands; [Moustakas, Antonis K.] Technol Educ Inst Ionian Isl, Dept Organ Farming, GR-27100 Argostoli, Greece; [Papadopoulos, George K.] Epirus Inst Technol, Biochem & Biophys Lab, Fac Agr Technol, GR-47100 Arta, Greece	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Koning, F (corresponding author), Leiden Univ, Dept Immunohematol & Blood Transfus, Med Ctr, E3-Q,POB 9600, NL-2300 RC Leiden, Netherlands.	fkoning@lumc.nl	Roep, Bart/AAD-7609-2021; Drijfhout, Jan Wouter/ABA-6318-2021	Drijfhout, Jan Wouter/0000-0003-4808-5296; Papadopoulos, George K/0000-0002-6944-6591; Koning, Frits/0000-0002-4007-5715; van Veelen, Peter/0000-0002-7898-9408	Dutch Diabetes Foundation [2007.00.038]; Celiac Disease Consortium; Dutch government [BSIK03009]; European Union [241447]; The Netherlands Organization for Scientific Research [VICI 918.86.611]	Dutch Diabetes Foundation; Celiac Disease Consortium; Dutch government; European Union(European Commission); The Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was supported by Dutch Diabetes Foundation Grant 2007.00.038, by the Celiac Disease Consortium, an Innovative Cluster approved by The Netherlands Genomics Initiative partially funded by the Dutch government (BSIK03009), by the European Union 7th Framework Programme (FP7/2007-2013) under Grant Agreement 241447 (Natural Immunomodulators as Novel Immunotherapies for Type 1 Diabetes; NAIMIT), and by a VICI grant of The Netherlands Organization for Scientific Research (VICI 918.86.611).	ATKINSON MA, 1994, NEW ENGL J MED, V331, P1428; Bluestone JA, 2010, NATURE, V464, P1293, DOI 10.1038/nature08933; Bondinas GP, 2007, IMMUNOGENETICS, V59, P539, DOI 10.1007/s00251-007-0224-8; Carlotti F, 2004, MOL THER, V9, P209, DOI 10.1016/j.ymthe.2003.11.021; Colaert N, 2009, NAT METHODS, V6, P786, DOI 10.1038/nmeth1109-786; Concannon P, 2009, NEW ENGL J MED, V360, P1646, DOI 10.1056/NEJMra0808284; Di Lorenzo TP, 2007, CLIN EXP IMMUNOL, V148, P1, DOI 10.1111/j.1365-2249.2006.03244.x; Eerligh P, 2011, GENES IMMUN, V12, P415, DOI 10.1038/gene.2011.24; Erlich H, 2008, DIABETES, V57, P1084, DOI 10.2337/db07-1331; Fremont DH, 1998, IMMUNITY, V8, P305, DOI 10.1016/S1074-7613(00)80536-1; Godkin A, 1997, INT IMMUNOL, V9, P905, DOI 10.1093/intimm/9.6.905; Harfouch-Hammoud E, 1999, DIABETES, V48, P1937, DOI 10.2337/diabetes.48.10.1937; Kelemen K, 2004, J IMMUNOL, V172, P3955, DOI 10.4049/jimmunol.172.6.3955; Kent SC, 2005, NATURE, V435, P224, DOI 10.1038/nature03625; KHALIL I, 1992, DIABETES, V41, P378, DOI 10.2337/diabetes.41.3.378; Kim CY, 2004, P NATL ACAD SCI USA, V101, P4175, DOI 10.1073/pnas.0306885101; Koeleman BPC, 2004, GENES IMMUN, V5, P381, DOI 10.1038/sj.gene.6364106; Kooy-Winkelaar Y, 2011, J IMMUNOL, V187, P5123, DOI 10.4049/jimmunol.1101179; Lee KH, 2001, NAT IMMUNOL, V2, P501, DOI 10.1038/88694; MILLER GG, 1987, J IMMUNOL, V139, P3622; Moustakas AK, 2002, AM J MED GENET, V115, P37, DOI 10.1002/ajmg.10342; Moustakas AK, 2000, INT IMMUNOL, V12, P1157, DOI 10.1093/intimm/12.8.1157; Nepom GT, 1998, DIABETES, V47, P1177, DOI 10.2337/diabetes.47.8.1177; Oling V, 2010, AUTOIMMUNITY, V43, P573, DOI 10.3109/08916930903540424; Pinkse GGM, 2005, P NATL ACAD SCI USA, V102, P18425, DOI 10.1073/pnas.0508621102; Pociot F, 2002, GENES IMMUN, V3, P235, DOI 10.1038/sj.gene.6363875; Schloot NC, 1998, J AUTOIMMUN, V11, P169, DOI 10.1006/jaut.1997.0183; Stepniak D, 2008, J IMMUNOL, V180, P3268, DOI 10.4049/jimmunol.180.5.3268; Tollefsen S, 2006, J CLIN INVEST, V116, P2226, DOI 10.1172/JCI27620; Tree TIM, 2004, DIABETES, V53, P1692, DOI 10.2337/diabetes.53.7.1692; Vader W, 2002, GASTROENTEROLOGY, V122, P1729, DOI 10.1053/gast.2002.33606; Van Belle TL, 2011, PHYSIOL REV, V91, P79, DOI 10.1152/physrev.00003.2010; van de Wal Y, 1998, P NATL ACAD SCI USA, V95, P10050, DOI 10.1073/pnas.95.17.10050; vandeWal Y, 1997, IMMUNOGENETICS, V46, P484, DOI 10.1007/s002510050309; vandeWal Y, 1996, IMMUNOGENETICS, V44, P246, DOI 10.1007/s002510050120; Vartdal F, 1996, EUR J IMMUNOL, V26, P2764, DOI 10.1002/eji.1830261132	36	54	54	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9514	9524		10.1074/jbc.M111.313940	http://dx.doi.org/10.1074/jbc.M111.313940			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22184118	Green Published, hybrid			2022-12-27	WOS:000301797800082
J	Davydov, DR; Rumfeldt, JAO; Sineva, EV; Fernando, H; Davydova, NY; Halpert, JR				Davydov, Dmitri R.; Rumfeldt, Jessica A. O.; Sineva, Elena V.; Fernando, Harshica; Davydova, Nadezhda Y.; Halpert, James R.			Peripheral Ligand-binding Site in Cytochrome P450 3A4 Located with Fluorescence Resonance Energy Transfer (FRET)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE SUBSTRATE-BINDING; ALPHA-NAPHTHOFLAVONE; HETEROTROPIC COOPERATIVITY; TESTOSTERONE BINDING; MOLECULAR-MECHANICS; P450; TRANSITIONS; COMPLEXES; KINETICS; CYP3A4	The mechanisms of ligand binding and allostery in the major human drug-metabolizing enzyme cytochrome P450 3A4 (CYP3A4) were explored with fluorescence resonance energy transfer (FRET) using a laser dye, fluorol-7GA (F7GA), as a model substrate. Incorporation into the enzyme of a thiol-reactive FRET probe, pyrene iodoacetamide, allowed us to monitor the binding by FRET from the pyrene donor to the F7GA acceptor. Cooperativity of the interactions detected by FRET indicates that the enzyme possesses at least two F7GA-binding sites that have different FRET efficiencies and are therefore widely separated. To probe spatial localization of these sites, we studied FRET in a series of mutants bearing pyrene iodoacetamide at different positions, and we measured the distances from each of the sites to the donor. Our results demonstrate the presence of a high affinity binding site at the enzyme periphery. Analysis of the set of measured distances complemented with molecular modeling and docking allowed us to pinpoint the most probable peripheral site. It is located in the vicinity of residues 217-220, similar to the position of the progesterone molecule bound at the distal surface of the CYP3A4 in a prior x-ray crystal structure. Peripheral binding of F7GA causes a substantial spin shift and serves as a prerequisite for the binding in the active site. This is the first indication of functionally important ligand binding outside of the active site in cytochromes P450. The findings strongly suggest that the mechanisms of CYP3A4 cooperativity involve a conformational transition triggered by an allosteric ligand.	[Davydov, Dmitri R.; Rumfeldt, Jessica A. O.; Sineva, Elena V.; Davydova, Nadezhda Y.; Halpert, James R.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Fernando, Harshica] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77551 USA	University of California System; University of California San Diego; University of Texas System; University of Texas Medical Branch Galveston	Davydov, DR (corresponding author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, MC 0703,9500 Gilman Dr, La Jolla, CA 92093 USA.	ddavydov@ucsd.edu	Davydov, Dmitri R/H-2736-2013; Sineva, Elena/A-5267-2008	Davydov, Dmitri R/0000-0001-8520-0033; Sineva, Elena/0000-0003-2307-0581	National Institutes of Health [GM054995]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM054995, R01GM054995] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM054995 (to J. R. H.).	ALLINGER NL, 1989, J AM CHEM SOC, V111, P8551, DOI 10.1021/ja00205a001; Atkins WM, 2001, CHEM RES TOXICOL, V14, P338, DOI 10.1021/tx0002132; Baas BJ, 2004, ARCH BIOCHEM BIOPHYS, V430, P218, DOI 10.1016/j.abb.2004.07.003; Brackman U., 2000, LAMBDACHROME LASER D; Conner KP, 2011, ARCH BIOCHEM BIOPHYS, V507, P56, DOI 10.1016/j.abb.2010.10.006; Dabrowski MJ, 2002, J AM CHEM SOC, V124, P11866, DOI 10.1021/ja027552x; Davydov DR, 2008, BIOCHEMISTRY-US, V47, P11348, DOI 10.1021/bi8011803; Davydov DR, 2006, BIOPHYS CHEM, V123, P95, DOI 10.1016/j.bpc.2006.04.007; Davydov DR, 2010, BBA-BIOENERGETICS, V1797, P378, DOI 10.1016/j.bbabio.2009.12.008; Davydov DR, 2008, EXPERT OPIN DRUG MET, V4, P1523, DOI 10.1517/17425250802500028 ; Davydov DR, 2005, BIOPHYS J, V89, P418, DOI 10.1529/biophysj.104.058479; DAVYDOV DR, 1995, ARCH BIOCHEM BIOPHYS, V320, P330, DOI 10.1016/0003-9861(95)90017-9; Davydov DR, 2002, BIOCHEM BIOPH RES CO, V294, P806, DOI 10.1016/S0006-291X(02)00565-X; Denisov IG, 2007, J BIOL CHEM, V282, P7066, DOI 10.1074/jbc.M609589200; Denisov IG, 2009, PHARMACOL THERAPEUT, V124, P151, DOI 10.1016/j.pharmthera.2009.05.011; Dixon JM, 2005, PHOTOCHEM PHOTOBIOL, V81, P212, DOI 10.1562/2004-11-06-TSN-361.1; Domanski TL, 2000, J PHARMACOL EXP THER, V293, P585; Domanski TL, 1998, ARCH BIOCHEM BIOPHYS, V350, P223, DOI 10.1006/abbi.1997.0525; Domanski TL, 2001, BIOCHEMISTRY-US, V40, P10150, DOI 10.1021/bi010758a; Ekroos M, 2006, P NATL ACAD SCI USA, V103, P13682, DOI 10.1073/pnas.0603236103; Fernando H, 2006, BIOCHEMISTRY-US, V45, P4199, DOI 10.1021/bi052491b; Fernando H, 2011, XENOBIOTICA, V41, P281, DOI 10.3109/00498254.2010.538748; Harlow GR, 1998, P NATL ACAD SCI USA, V95, P6636, DOI 10.1073/pnas.95.12.6636; Haugland R. P., 2007, HDB FLUORESCENT PROB; Hosea NA, 2000, BIOCHEMISTRY-US, V39, P5929, DOI 10.1021/bi992765t; Isin EM, 2006, J BIOL CHEM, V281, P9127, DOI 10.1074/jbc.M511375200; Isin EM, 2008, ANAL BIOANAL CHEM, V392, P1019, DOI 10.1007/s00216-008-2244-0; Isin EM, 2007, J BIOL CHEM, V282, P6863, DOI 10.1074/jbc.M610346200; JONES G, 1985, J PHYS CHEM-US, V89, P294, DOI 10.1021/j100248a024; Kapelyukh Y, 2008, DRUG METAB DISPOS, V36, P2136, DOI 10.1124/dmd.108.021733; Korzekwa KR, 1998, BIOCHEMISTRY-US, V37, P4137, DOI 10.1021/bi9715627; Koushik SV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008031; Lakowitz J., 1999, PRINCIPLES FLUORESCE; Lewis DFV, 2004, XENOBIOTICA, V34, P549, DOI 10.1080/00498250410001691325; Masuko M, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.8.e34; Niwa T, 2008, CURR DRUG METAB, V9, P453, DOI 10.2174/138920008784746364; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PONDER JW, 1987, J COMPUT CHEM, V8, P1016, DOI 10.1002/jcc.540080710; Renaud JP, 1996, BIOCHEM J, V319, P675, DOI 10.1042/bj3190675; Roberts AG, 2005, BIOCHEMISTRY-US, V44, P1353, DOI 10.1021/bi0481390; Roberts AG, 2007, ARCH BIOCHEM BIOPHYS, V463, P89, DOI 10.1016/j.abb.2007.03.006; Schoch GA, 2004, J BIOL CHEM, V279, P9497, DOI 10.1074/jbc.M312516200; Segel IH, 1975, ENZYME KINETICS BEHA; Sevrioukova IF, 2010, P NATL ACAD SCI USA, V107, P18422, DOI 10.1073/pnas.1010693107; Szklarz GD, 1997, LIFE SCI, V61, P2507, DOI 10.1016/S0024-3205(97)00717-0; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tsalkova TN, 2007, BIOCHEMISTRY-US, V46, P106, DOI 10.1021/bi061944p; Ueng YF, 1997, BIOCHEMISTRY-US, V36, P370, DOI 10.1021/bi962359z; Williams PA, 2004, SCIENCE, V305, P683, DOI 10.1126/science.1099736	50	53	54	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6797	6809		10.1074/jbc.M111.325654	http://dx.doi.org/10.1074/jbc.M111.325654			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22194603	Green Published, hybrid			2022-12-27	WOS:000300791800065
J	Dhar, S; Thota, A; Rao, MRS				Dhar, Surbhi; Thota, Anusha; Rao, Manchanahalli Rangaswamy Satyanarayana			Insights into Role of Bromodomain, Testis-specific (Brdt) in Acetylated Histone H4-dependent Chromatin Remodeling in Mammalian Spermiogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL REGULATION; MOUSE SPERMATOGENESIS; PROTEIN INTERACTIONS; SWI/SNF SUBUNIT; TOPOISOMERASE-I; SPLICING FACTOR; BASIC-PROTEINS; RAINBOW-TROUT; DNA; HYPERACETYLATION	Mammalian spermiogenesis is of considerable biological interest especially due to the unique chromatin remodeling events that take place during spermatid maturation. Here, we have studied the expression of chromatin remodeling factors in different spermatogenic stages and narrowed it down to bromodomain, testis-specific (Brdt) as a key molecule participating in chromatin remodeling during rat spermiogenesis. Our immunocytochemistry experiments reveal that Brdt colocalizes with acetylated H4 in elongating spermatids. Remodeling assays showed an acetylation-dependent but ATP-independent chromatin reorganization property of Brdt in haploid round spermatids. Furthermore, Brdt interacts with Smarce1, a member of the SWI/SNF family. We have studied the genomic organization of smarce1 and identified that it has two splice variants expressed during spermatogenesis. The N terminus of Brdt is involved in the recognition of Smarce1 as well as in the reorganization of hyperacetylated round spermatid chromatin. Interestingly, the interaction between Smarce1 and Brdt increases dramatically upon histone hyperacetylation both in vitro and in vivo. Thus, our results indicate this interaction to be a vital step in the chromatin remodeling process during mammalian spermiogenesis.	[Dhar, Surbhi; Thota, Anusha; Rao, Manchanahalli Rangaswamy Satyanarayana] Jawaharlal Nehru Ctr Adv Sci Res, Mol Biol & Genet Unit, Bangalore 560064, Karnataka, India	Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR)	Rao, MRS (corresponding author), Jawaharlal Nehru Ctr Adv Sci Res, Mol Biol & Genet Unit, Bangalore 560064, Karnataka, India.	mrsrao@jncasr.ac.in			Department of Biotechnology, New Delhi, India; Council of Scientific and Industrial Research; Department of Science and Technology	Department of Biotechnology, New Delhi, India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology(Department of Science & Technology (India))	This work was supported in part by the Department of Biotechnology, New Delhi, India.; Recipient of fellowship support from the Council of Scientific and Industrial Research.; Recipient of a J. C. Bose fellowship from the Department of Science and Technology. To whom correspondence should be addressed. Tel.: 91-80-2208-2864; Fax: 91-80-2362-2762; E-mail: mrsrao@jncasr.ac.in.	Aslam I, 1998, HUM REPROD, V13, P634, DOI 10.1093/humrep/13.3.634; Awe S, 2010, SYST BIOL REPROD MED, V56, P44, DOI 10.3109/19396360903490790; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Barda S, 2012, FERTIL STERIL, V97, P46, DOI 10.1016/j.fertnstert.2011.10.010; Belandia B, 2002, EMBO J, V21, P4094, DOI 10.1093/emboj/cdf412; Bladen CL, 2005, J BIOL CHEM, V280, P5205, DOI 10.1074/jbc.M412758200; Blessing CA, 2004, TRENDS CELL BIOL, V14, P435, DOI 10.1016/j.tcb.2004.07.009; Boussouar F, 2008, CELL CYCLE, V7, P3499, DOI 10.4161/cc.7.22.6975; Carrell DT, 2010, MOL HUM REPROD, V16, P37, DOI 10.1093/molehr/gap090; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Chen JG, 2005, MOL CELL BIOL, V25, P9016, DOI 10.1128/MCB.25.20.9016-9027.2005; Chichiarelli S, 2010, ARCH BIOCHEM BIOPHYS, V494, P178, DOI 10.1016/j.abb.2009.12.004; Chichiarelli S, 2007, J CELL PHYSIOL, V210, P343, DOI 10.1002/jcp.20824; CHRISTENSEN ME, 1984, NUCLEIC ACIDS RES, V12, P4575, DOI 10.1093/nar/12.11.4575; CHRISTENSEN ME, 1982, DEV BIOL, V93, P404, DOI 10.1016/0012-1606(82)90127-0; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Dehnugara T, 2012, MOL REPROD DEV, V79, P19, DOI 10.1002/mrd.21396; Denis GV, 2006, J PROTEOME RES, V5, P502, DOI 10.1021/pr050430u; Durand-Dubief M, 2010, EMBO J, V29, P2126, DOI 10.1038/emboj.2010.109; DURRIN LK, 1991, CELL, V65, P1023, DOI 10.1016/0092-8674(91)90554-C; Faure AK, 2003, MOL HUM REPROD, V9, P757, DOI 10.1093/molehr/gag101; Fischle W, 2008, GENE DEV, V22, P3375, DOI 10.1101/gad.1759708; Garcia-Pedrero JM, 2006, J BIOL CHEM, V281, P22656, DOI 10.1074/jbc.M602561200; GERTON GL, 1984, J CELL BIOL, V98, P619, DOI 10.1083/jcb.98.2.619; Govin J, 2004, EUR J BIOCHEM, V271, P3459, DOI 10.1111/j.1432-1033.2004.04266.x; GOZANI O, 1994, EMBO J, V13, P3356, DOI 10.1002/j.1460-2075.1994.tb06638.x; Grad I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015770; GRIMES SR, 1984, EXP CELL RES, V152, P91, DOI 10.1016/0014-4827(84)90232-5; GRUPPI CM, 1993, DEV GENET, V14, P119, DOI 10.1002/dvg.1020140206; Hah N, 2010, CANCER RES, V70, P4402, DOI 10.1158/0008-5472.CAN-09-2767; Hazzouri M, 2000, EUR J CELL BIOL, V79, P950, DOI 10.1078/0171-9335-00123; Hui JY, 2005, EMBO J, V24, P1988, DOI 10.1038/sj.emboj.7600677; Hui JY, 2003, NAT STRUCT BIOL, V10, P33, DOI 10.1038/nsb875; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; KADURA SN, 1983, COMP BIOCHEM PHYS B, V74, P343, DOI 10.1016/0305-0491(83)90023-8; Kazantseva A, 2009, J NEUROCHEM, V109, P807, DOI 10.1111/j.1471-4159.2009.06005.x; KENNEDY BP, 1980, J BIOL CHEM, V255, P2533; Keppler BR, 2010, J BIOL CHEM, V285, P35665, DOI 10.1074/jbc.M110.173997; Kolthur-Seetharam U, 2009, J HISTOCHEM CYTOCHEM, V57, P951, DOI 10.1369/jhc.2009.953414; KORNBERG RD, 1974, SCIENCE, V184, P868, DOI 10.1126/science.184.4139.868; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krynetskaia NF, 2009, MOL CANCER THER, V8, P864, DOI 10.1158/1535-7163.MCT-08-0695; Kuo MH, 1998, GENE DEV, V12, P627, DOI 10.1101/gad.12.5.627; Lewis JD, 2003, BIOCHEM CELL BIOL, V81, P131, DOI 10.1139/o03-045; Link KA, 2008, CANCER RES, V68, P4551, DOI 10.1158/0008-5472.CAN-07-6392; Lu LY, 2010, DEV CELL, V18, P371, DOI 10.1016/j.devcel.2010.01.010; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Chi MN, 2011, MOL BIOL CELL, V22, P2875, DOI 10.1091/mbc.E11-03-0212; Meetei AR, 2002, BIOCHEMISTRY-US, V41, P185, DOI 10.1021/bi0117652; MEISTRICH ML, 1992, MOL REPROD DEV, V31, P170, DOI 10.1002/mrd.1080310303; Montellier E., 2011, BIOESSAYS       1215, DOI [10.1002/ bies.201100141, DOI 10.1002/BIES.201100141]; Moriniere J, 2009, NATURE, V461, P664, DOI 10.1038/nature08397; OLIVA R, 1982, NUCLEIC ACIDS RES, V10, P8049, DOI 10.1093/nar/10.24.8049; Peterson CL, 2004, CURR BIOL, V14, pR546, DOI 10.1016/j.cub.2004.07.007; Pivot-Pajot C, 2003, MOL CELL BIOL, V23, P5354, DOI 10.1128/MCB.23.15.5354-5365.2003; Pradeepa MM, 2008, MOL CELL BIOL, V28, P4331, DOI 10.1128/MCB.00519-07; Pradeepa MM, 2009, J BIOL CHEM, V284, P29956, DOI 10.1074/jbc.M109.052043; Rathke C, 2007, J CELL SCI, V120, P1689, DOI 10.1242/jcs.004663; Reid JL, 2000, MOL CELL, V6, P1297, DOI 10.1016/S1097-2765(00)00128-3; Sassone-Corsi P, 2002, SCIENCE, V296, P2176, DOI 10.1126/science.1070963; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Shang EY, 2007, DEVELOPMENT, V134, P3507, DOI 10.1242/dev.004481; Shipra A, 2006, BIOINFORMATICS, V22, P2940, DOI 10.1093/bioinformatics/btl509; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Shumaker DK, 2003, CURR OPIN CELL BIOL, V15, P358, DOI 10.1016/S0955-0674(03)00050-4; Straub T, 2000, BIOCHEMISTRY-US, V39, P7552, DOI 10.1021/bi992898e; SUDHAKAR L, 1990, J BIOL CHEM, V265, P22526; Tan MJ, 2011, CELL, V146, P1015, DOI 10.1016/j.cell.2011.08.008; Turner BM, 2002, CELL, V111, P285, DOI 10.1016/S0092-8674(02)01080-2; Visa N, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000620; Winston F, 1999, NAT STRUCT BIOL, V6, P601, DOI 10.1038/10640; Wouters-Tyrou D, 1998, BIOCHIMIE, V80, P117, DOI 10.1016/S0300-9084(98)80018-7; Wu SY, 2007, J BIOL CHEM, V282, P13141, DOI 10.1074/jbc.R700001200; Yap KL, 2011, BIOCHEMISTRY-US, V50, P1966, DOI 10.1021/bi101885m; Yu JK, 2009, J BIOL CHEM, V284, P1505, DOI 10.1074/jbc.M805113200; Zhao KJ, 1998, CELL, V95, P625, DOI 10.1016/S0092-8674(00)81633-5	76	49	55	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6387	6405		10.1074/jbc.M111.288167	http://dx.doi.org/10.1074/jbc.M111.288167			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22215678	hybrid, Green Published			2022-12-27	WOS:000300791800030
J	Zhou, K; Gao, Y; Hoy, JA; Mann, FM; Honzatko, RB; Peters, RJ				Zhou, Ke; Gao, Yang; Hoy, Julie A.; Mann, Francis M.; Honzatko, Richard B.; Peters, Reuben J.			Insights into Diterpene Cyclization from Structure of Bifunctional Abietadiene Synthase from Abies grandis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENT-COPALYL DIPHOSPHATE; SINGLE RESIDUE SWITCH; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; FUNCTIONAL-ANALYSIS; TERPENE SYNTHASES; KAURENE SYNTHASE; GERANYLGERANYL DIPHOSPHATE; (+)-COPALYL DIPHOSPHATE; ARISTOLOCHENE SYNTHASE	Abietadiene synthase from Abies grandis (AgAS) is a model system for diterpene synthase activity, catalyzing class I (ionization-initiated) and class II (protonation-initiated) cyclization reactions. Reported here is the crystal structure of AgAS at 2.3 angstrom resolution and molecular dynamics simulations of that structure with and without active site ligands. AgAS has three domains (alpha, beta, and gamma). The class I active site is within the C-terminal alpha domain, and the class II active site is between the N-terminal gamma and beta domains. The domain organization resembles that of monofunctional diterpene synthases and is consistent with proposed evolutionary origins of terpene synthases. Molecular dynamics simulations were carried out to determine the effect of substrate binding on enzymatic structure. Although such studies of the class I active site do lead to an enclosed substrate-Mg2+ complex similar to that observed in crystal structures of related plant enzymes, it does not enforce a single substrate conformation consistent with the known product stereochemistry. Simulations of the class II active site were more informative, with observation of a well ordered external loop migration. This "loop-in" conformation not only limits solvent access but also greatly increases the number of conformational states accessible to the substrate while destabilizing the nonproductive substrate conformation present in the "loop-out" conformation. Moreover, these conformational changes at the class II active site drive the substrate toward the proposed transition state. Docked substrate complexes were further assessed with regard to the effects of site-directed mutations on class I and II activities.	[Zhou, Ke; Gao, Yang; Hoy, Julie A.; Mann, Francis M.; Honzatko, Richard B.; Peters, Reuben J.] Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA	Iowa State University	Peters, RJ (corresponding author), Iowa State Univ, Dept Biochem Biophys & Mol Biol, 4216 Mol Biol Bldg, Ames, IA 50011 USA.	rjpeters@iastate.edu	Gao, Yang/O-3445-2016; Peters, Reuben J./D-1196-2010	Peters, Reuben J./0000-0003-4691-8477	National Institutes of Health [GM076324, NS010546]; Department of Enery [W-31-109-ENG-38, DE-AC02-06CH11357]; National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076324] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS010546, R01NS010546, R56NS010546] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Enery; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM076324 (to R. J. P.) and NS010546 (to R. B. H.). This work was also supported in part by Department of Enery Grants W-31-109-ENG-38 and DE-AC02-06CH11357 and by the National Science Foundation.	Aaron JA, 2010, BIOCHEMISTRY-US, V49, P1787, DOI 10.1021/bi902088z; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bohlmann J, 1998, P NATL ACAD SCI USA, V95, P4126, DOI 10.1073/pnas.95.8.4126; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buckingham J, 2002, DICT NATURAL PRODUCT; Cao R, 2010, PROTEINS, V78, P2417, DOI 10.1002/prot.22751; Caruthers JM, 2000, J BIOL CHEM, V275, P25533, DOI 10.1074/jbc.M000433200; Chen F, 2011, PLANT J, V66, P212, DOI 10.1111/j.1365-313X.2011.04520.x; Christianson DW, 2006, CHEM REV, V106, P3412, DOI 10.1021/cr050286w; Croteau R., 2000, BIOCH MOL BIOL PLANT, P1250, DOI DOI 10.1201/B11003-3; Cyr A, 2007, J AM CHEM SOC, V129, P6684, DOI 10.1021/ja071158n; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Gennadios HA, 2009, BIOCHEMISTRY-US, V48, P6175, DOI 10.1021/bi900483b; Glykos NM, 2006, J COMPUT CHEM, V27, P1765, DOI 10.1002/jcc.20482; Hamelberg D, 2004, J CHEM PHYS, V120, P11919, DOI 10.1063/1.1755656; Hayashi K, 2006, FEBS LETT, V580, P6175, DOI 10.1016/j.febslet.2006.10.018; Hillwig ML, 2011, PLANT J, V68, P1051, DOI 10.1111/j.1365-313X.2011.04756.x; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hyatt DC, 2007, P NATL ACAD SCI USA, V104, P5360, DOI 10.1073/pnas.0700915104; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kampranis SC, 2007, PLANT CELL, V19, P1994, DOI 10.1105/tpc.106.047779; Kawaide H, 2000, J BIOL CHEM, V275, P2276, DOI 10.1074/jbc.275.4.2276; Kawaide H, 1997, J BIOL CHEM, V272, P21706, DOI 10.1074/jbc.272.35.21706; Keeling CI, 2006, PHYTOCHEMISTRY, V67, P2415, DOI 10.1016/j.phytochem.2006.08.019; Keeling CI, 2010, PLANT PHYSIOL, V152, P1197, DOI 10.1104/pp.109.151456; Koksal M, 2011, NAT CHEM BIOL, V7, P431, DOI [10.1038/NCHEMBIO.578, 10.1038/nchembio.578]; Koksal M, 2011, NATURE, V469, P116, DOI 10.1038/nature09628; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lesburg CA, 1997, SCIENCE, V277, P1820, DOI 10.1126/science.277.5333.1820; MacKerell AD, 2001, BIOPOLYMERS, V56, P257; Mann FM, 2010, J BIOL CHEM, V285, P20558, DOI 10.1074/jbc.M110.123307; Martin DM, 2004, PLANT PHYSIOL, V135, P1908, DOI 10.1104/pp.104.042028; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Morrone D, 2009, FEBS LETT, V583, P475, DOI 10.1016/j.febslet.2008.12.052; Oikawa H, 2001, J AM CHEM SOC, V123, P5154, DOI 10.1021/ja015747j; Peters RJ, 2010, NAT PROD REP, V27, P1521, DOI 10.1039/c0np00019a; Peters RJ, 2003, BIOCHEMISTRY-US, V42, P2700, DOI 10.1021/bi020492n; Peters RJ, 2002, BIOCHEMISTRY-US, V41, P1836, DOI 10.1021/bi011879d; Peters RJ, 2002, P NATL ACAD SCI USA, V99, P580, DOI 10.1073/pnas.022627099; Peters RJ, 2001, J AM CHEM SOC, V123, P8974, DOI 10.1021/ja010670k; Peters RJ, 2000, BIOCHEMISTRY-US, V39, P15592, DOI 10.1021/bi001997l; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Prisic S, 2007, CHEMBIOCHEM, V8, P869, DOI 10.1002/cbic.200700045; Prisic S, 2007, PLANT PHYSIOL, V144, P445, DOI 10.1104/pp.106.095208; Ravn MM, 2002, J AM CHEM SOC, V124, P6998, DOI 10.1021/ja017734b; Ravn MM, 1998, CHEM COMMUN, P21, DOI 10.1039/a706202h; Ravn MM, 2000, ORG LETT, V2, P573, DOI 10.1021/ol991230p; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Rynkiewicz MJ, 2001, P NATL ACAD SCI USA, V98, P13543, DOI 10.1073/pnas.231313098; Sato T, 1999, BIOSCI BIOTECH BIOCH, V63, P2189, DOI 10.1271/bbb.63.2189; Schepmann HG, 2001, ARCH BIOCHEM BIOPHYS, V392, P263, DOI 10.1006/abbi.2001.2438; Shishova EY, 2007, BIOCHEMISTRY-US, V46, P1941, DOI 10.1021/bi0622524; Shortle D, 1998, P NATL ACAD SCI USA, V95, P11158, DOI 10.1073/pnas.95.19.11158; Starks CM, 1997, SCIENCE, V277, P1815, DOI 10.1126/science.277.5333.1815; Thoma R, 2004, NATURE, V432, P118, DOI 10.1038/nature02993; Trapp SC, 2001, GENETICS, V158, P811; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Vogel BS, 1996, J BIOL CHEM, V271, P23262, DOI 10.1074/jbc.271.38.23262; Wang YK, 2011, PHYS REV D, V83, DOI 10.1103/PhysRevD.83.015002; Wendt KU, 2005, ANGEW CHEM INT EDIT, V44, P3966, DOI 10.1002/anie.200500804; Wendt KU, 1998, STRUCTURE, V6, P127, DOI 10.1016/S0969-2126(98)00015-X; Wendt KU, 1997, SCIENCE, V277, P1811, DOI 10.1126/science.277.5333.1811; Whittington DA, 2002, P NATL ACAD SCI USA, V99, P15375, DOI 10.1073/pnas.232591099; Wilderman PR, 2007, J AM CHEM SOC, V129, P15736, DOI 10.1021/ja074977g; Xu MM, 2007, P NATL ACAD SCI USA, V104, P7397, DOI 10.1073/pnas.0611454104; Xu MM, 2004, PLANT J, V39, P309, DOI 10.1111/j.1365-313X.2004.02137.x; Zhou K, 2011, CHEM COMMUN, V47, P4074, DOI 10.1039/c0cc02960b; Zhou K, 2009, PHYTOCHEMISTRY, V70, P366, DOI 10.1016/j.phytochem.2008.12.022	71	74	80	1	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6840	6850		10.1074/jbc.M111.337592	http://dx.doi.org/10.1074/jbc.M111.337592			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22219188	Green Published, hybrid			2022-12-27	WOS:000300791800069
J	Li, L; Cao, XH; Chen, SR; Han, HD; Lopez-Berestein, G; Sood, AK; Pan, HL				Li, Li; Cao, Xue-Hong; Chen, Shao-Rui; Han, Hee-Dong; Lopez-Berestein, Gabriel; Sood, Anil K.; Pan, Hui-Lin			Up-regulation of Cav beta(3) Subunit in Primary Sensory Neurons Increases Voltage-activated Ca2+ Channel Activity and Nociceptive Input in Neuropathic Pain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCARINIC RECEPTOR SUBTYPES; SPINAL NERVE LIGATION; ROOT GANGLION NEURONS; BETA-SUBUNIT; MICE LACKING; INTRATHECAL ZICONOTIDE; PERIPHERAL NEUROPATHY; CALCIUM-CHANNELS; SKELETAL-MUSCLE; EXPRESSION	High voltage-activated calcium channels (HVACCs) are essential for synaptic and nociceptive transmission. Although blocking HVACCs can effectively reduce pain, this treatment strategy is associated with intolerable adverse effects. Neuronal HVACCs are typically composed of alpha(1), beta (Cav beta), and alpha(2)delta subunits. The Cav beta subunit plays a crucial role in the membrane expression and gating properties of the pore-forming alpha(1) subunit. However, little is known about how nerve injury affects the expression and function of Cav beta subunits in primary sensory neurons. In this study, we found that Cav beta(3) and Cav beta(4) are the most prominent subtypes expressed in the rat dorsal root ganglion (DRG) and dorsal spinal cord. Spinal nerve ligation (SNL) in rats significantly increased mRNA and protein levels of the Cav beta(3), but not Cav beta(4), subunit in the DRG. SNL also significantly increased HVACC currents in small DRG neurons and monosynaptic excitatory postsynaptic currents of spinal dorsal horn neurons evoked from the dorsal root. Intrathecal injection of Cav beta(3)-specific siRNA significantly reduced HVACC currents in small DRG neurons and the amplitude of monosynaptic excitatory postsynaptic currents of dorsal hornneurons in SNL rats. Furthermore, intrathecal treatment with Cav beta(3)-specific siRNA normalized mechanical hyperalgesia and tactile allodynia caused by SNL but had no significant effect on the normal nociceptive threshold. Our findings provide novel evidence that increased expression of the Cav beta(3) subunit augments HVACC activity in primary sensory neurons and nociceptive input to dorsal horn neurons in neuropathic pain. Targeting the Cav beta(3) subunit at the spinal level represents an effective strategy for treating neuropathic pain.	[Pan, Hui-Lin] Univ Texas MD Anderson Canc Ctr, Dept Anesthesiol & Perioperat Med, Unit 110, Houston, TX 77030 USA; [Li, Li; Cao, Xue-Hong; Chen, Shao-Rui; Pan, Hui-Lin] Univ Texas MD Anderson Canc Ctr, Ctr Neurosci & Pain Res, Houston, TX 77030 USA; [Han, Hee-Dong; Lopez-Berestein, Gabriel] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Han, Hee-Dong; Lopez-Berestein, Gabriel; Sood, Anil K.; Pan, Hui-Lin] Univ Texas MD Anderson Canc Ctr, Ctr RNA Interference & Noncoding RNA, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Pan, HL (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Anesthesiol & Perioperat Med, Unit 110, 1515 Holcombe Blvd, Houston, TX 77030 USA.	huilinpan@mdanderson.org	Li, Li/K-9630-2013	Pan, Hui-Lin/0000-0001-8444-3770	National Institutes of Health [GM064830, NS045602, NS073935, CA151668]; N. G. and Helen T. Hawkins endowment; NATIONAL CANCER INSTITUTE [U54CA151668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064830] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073935, R01NS045602] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); N. G. and Helen T. Hawkins endowment; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM064830, NS045602, and NS073935 (to H.-L. P.) and CA151668 (to A. K. S. and G. L.-B.). This work was also supported by the N. G. and Helen T. Hawkins endowment (to H.-L. P.).	Abdulla FA, 2001, J NEUROPHYSIOL, V85, P644, DOI 10.1152/jn.2001.85.2.644; Andrade A, 2009, CELL CALCIUM, V46, P282, DOI 10.1016/j.ceca.2009.08.006; Buraei Z, 2010, PHYSIOL REV, V90, P1461, DOI 10.1152/physrev.00057.2009; Burgess DL, 1997, CELL, V88, P385, DOI 10.1016/S0092-8674(00)81877-2; Cai YQ, 2009, J NEUROCHEM, V111, P1000, DOI 10.1111/j.1471-4159.2009.06396.x; Campero M, 1998, MUSCLE NERVE, V21, P1661, DOI 10.1002/(SICI)1097-4598(199812)21:12<1661::AID-MUS6>3.3.CO;2-E; CASTELLANO A, 1993, J BIOL CHEM, V268, P3450; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; Catterall WA, 2008, NEURON, V59, P882, DOI 10.1016/j.neuron.2008.09.005; CERVERO F, 1980, BRAIN, V103, P717, DOI 10.1093/brain/103.4.717; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chen CC, 1998, P NATL ACAD SCI USA, V95, P10240, DOI 10.1073/pnas.95.17.10240; Chen SR, 2011, J PHARMACOL EXP THER, V337, P285, DOI 10.1124/jpet.110.176586; Chen SR, 2009, J NEUROCHEM, V110, P352, DOI 10.1111/j.1471-4159.2009.06138.x; Chen SR, 2000, ANESTHESIOLOGY, V92, P500, DOI 10.1097/00000542-200002000-00033; Chu PJ, 2004, J MOL CELL CARDIOL, V36, P423, DOI 10.1016/j.yjmcc.2003.12.012; DEWAARD M, 1994, NEURON, V13, P495, DOI 10.1016/0896-6273(94)90363-8; Dworkin RH, 2007, PAIN, V132, P237, DOI 10.1016/j.pain.2007.08.033; Fossat P, 2010, J NEUROSCI, V30, P1073, DOI 10.1523/JNEUROSCI.3145-09.2010; Frey UH, 2008, NAT PROTOC, V3, P1312, DOI 10.1038/nprot.2008.112; GRACELY RH, 1992, PAIN, V51, P175, DOI 10.1016/0304-3959(92)90259-E; Gregg RG, 1996, P NATL ACAD SCI USA, V93, P13961, DOI 10.1073/pnas.93.24.13961; HOFMANN F, 1994, ANNU REV NEUROSCI, V17, P399, DOI 10.1146/annurev.neuro.17.1.399; HULLIN R, 1992, EMBO J, V11, P885, DOI 10.1002/j.1460-2075.1992.tb05126.x; Kang MG, 2001, J BIOL CHEM, V276, P32917, DOI 10.1074/jbc.M100787200; Kim DH, 2005, NAT BIOTECHNOL, V23, P222, DOI 10.1038/nbt1051; Kim DS, 2001, MOL BRAIN RES, V96, P151, DOI 10.1016/S0169-328X(01)00285-6; KIM SH, 1992, PAIN, V50, P355, DOI 10.1016/0304-3959(92)90041-9; Liu XZ, 2001, BRAIN RES, V900, P119, DOI 10.1016/S0006-8993(01)02274-0; Ludwig A, 1997, J NEUROSCI, V17, P1339; Luo ZD, 2002, J PHARMACOL EXP THER, V303, P1199, DOI 10.1124/jpet.102.041574; Luo ZD, 2001, J NEUROSCI, V21, P1868, DOI 10.1523/JNEUROSCI.21-06-01868.2001; McDavid S, 2006, J NEUROSCI, V26, P13373, DOI 10.1523/JNEUROSCI.3332-06.2006; Murakami M, 2003, J BIOL CHEM, V278, P43261, DOI 10.1074/jbc.M211380200; Murakami M, 2002, J BIOL CHEM, V277, P40342, DOI 10.1074/jbc.M203425200; Murakami M, 2007, BRAIN RES, V1160, P102, DOI 10.1016/j.brainres.2007.05.041; Namkung Y, 1998, P NATL ACAD SCI USA, V95, P12010, DOI 10.1073/pnas.95.20.12010; Newton RA, 2001, MOL BRAIN RES, V95, P1, DOI 10.1016/S0169-328X(01)00188-7; Pan HL, 2003, J NEUROSCI, V23, P2911; Pan YZ, 2004, J NEUROPHYSIOL, V91, P2413, DOI 10.1152/jn.01242.2003; PERRY MJ, 1991, J NEUROCYTOL, V20, P746, DOI 10.1007/BF01187848; POWERS PA, 1992, J BIOL CHEM, V267, P22967; PRAGNELL M, 1994, NATURE, V368, P67, DOI 10.1038/368067a0; Saegusa H, 2001, EMBO J, V20, P2349, DOI 10.1093/emboj/20.10.2349; Schmidtko A, 2010, LANCET, V375, P1569, DOI 10.1016/S0140-6736(10)60354-6; Staats PS, 2004, JAMA-J AM MED ASSOC, V291, P63, DOI 10.1001/jama.291.1.63; Wallace MS, 2008, ANESTH ANALG, V106, P628, DOI 10.1213/ane.0b013e3181606fad; Wang XL, 2006, J PHYSIOL-LONDON, V571, P403, DOI 10.1113/jphysiol.2005.102905; Weissgerber P, 2006, CIRC RES, V99, P749, DOI 10.1161/01.RES.0000243978.15182.c1; Wu ZZ, 2009, J BIOL CHEM, V284, P36453, DOI 10.1074/jbc.M109.075523; Wu ZZ, 2004, NEUROSCI LETT, V368, P96, DOI 10.1016/j.neulet.2004.06.067; Yamaguchi H, 1998, J BIOL CHEM, V273, P19348, DOI 10.1074/jbc.273.30.19348; Zhou HY, 2008, J PHARMACOL EXP THER, V324, P1000, DOI 10.1124/jpet.107.133470; Zhou HY, 2011, J PHARMACOL EXP THER, V336, P254, DOI 10.1124/jpet.110.173112; Zhou HY, 2010, J NEUROSCI, V30, P4460, DOI 10.1523/JNEUROSCI.5857-09.2010	56	24	24	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					6002	6013		10.1074/jbc.M111.310110	http://dx.doi.org/10.1074/jbc.M111.310110			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22187436	Green Published, hybrid			2022-12-27	WOS:000300638000073
J	Rafiq, K; Guo, JF; Vlasenko, L; Guo, XJ; Kolpakov, MA; Sanjay, A; Houser, SR; Sabri, A				Rafiq, Khadija; Guo, Jianfen; Vlasenko, Liudmila; Guo, Xinji; Kolpakov, Mikhail A.; Sanjay, Archana; Houser, Steven R.; Sabri, Abdelkarim			c-Cbl Ubiquitin Ligase Regulates Focal Adhesion Protein Turnover and Myofibril Degeneration Induced by Neutrophil Protease Cathepsin G	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIAL REGULATION; CARDIOMYOCYTE SURVIVAL; MYOCARDIAL-INFARCTION; DOWN-REGULATION; QUALITY CONTROL; HEART-FAILURE; KINASE; HYPERTROPHY; RECEPTOR; PATHWAY	The neutrophil-derived serine protease, cathepsin G (Cat. G), has been shown to induce myocyte detachment and apoptosis by anoikis through down-regulation of focal adhesion (FA) signaling. However, the mechanisms that control FA protein stability and turnover in myocytes are not well understood. Here, we have shown that the Casitas b-lineage lymphoma (c-Cbl), adaptor protein with an intrinsic E3 ubiquitin ligase activity, is involved in FA and myofibrillar protein stability and turnover in myocytes. Cat. G treatment induced c-Cbl activation and its interaction with FA proteins. Deletion of c-Cbl using c-Cbl knock-out derived myocytes or inhibition of c-Cbl ligase activity significantly reduced FA protein degradation, myofibrillar degeneration, and myocyte apoptosis induced by Cat. G. We also found that inhibition of the proteasome activity, but not the lysosome or the calpain activity, markedly attenuated FA and myofibrillar protein degradation induced by Cat. G. Interestingly, c-Cbl activation induced by Cat. G was mediated through epidermal growth factor receptor (EGFR) transactivation as inhibition of EGFR kinase activity markedly attenuated c-Cbl phosphorylation and FA protein degradation induced by Cat. G. These findings support a model in which neutrophil protease Cat. G promotes c-Cbl interaction with FA proteins, resulting in enhanced c-Cbl-mediated FA protein ubiquitination and degradation, myofibril degradation, and subsequent down-regulation of myocyte survival signaling.	[Rafiq, Khadija; Guo, Jianfen; Vlasenko, Liudmila; Guo, Xinji; Kolpakov, Mikhail A.; Sanjay, Archana; Houser, Steven R.; Sabri, Abdelkarim] Temple Univ, Cardiovasc Res Ctr, Dept Physiol, Sch Med, Philadelphia, PA 19140 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Sabri, A (corresponding author), Temple Univ, Cardiovasc Res Ctr, Dept Physiol, Sch Med, MERB 1045,3500 N Broad St, Philadelphia, PA 19140 USA.	sabri@temple.edu			National Institutes of Health [HL360338, HL 360343]; American Heart Association [240052]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association)	This work was supported, in whole or in part, by National Institutes of Health Grants HL360338 and HL 360343.; Recipient of an American Heart Association award (240052).	Arya R, 2004, J CELL BIOL, V167, P1147, DOI 10.1083/jcb.200402033; Balasubramanian S, 2006, J MOL CELL CARDIOL, V41, P669, DOI 10.1016/j.yjmcc.2006.04.022; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Ciechanover A, 2000, J CELL BIOCHEM, P40; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Du J, 2004, J CLIN INVEST, V113, P115, DOI 10.1172/JCI200418330; Frangogiannis NG, 2002, CARDIOVASC RES, V53, P31, DOI 10.1016/S0008-6363(01)00434-5; Friedman J, 2004, DEV CELL, V6, P460, DOI 10.1016/S1534-5807(04)00104-2; Hakim ZS, 2009, J MOL CELL CARDIOL, V46, P241, DOI 10.1016/j.yjmcc.2008.10.017; HANSEN PR, 1995, CIRCULATION, V91, P1872, DOI 10.1161/01.CIR.91.6.1872; IACOVIELLO L, 1995, ARTERIOSCL THROM VAS, V15, P2037, DOI 10.1161/01.ATV.15.11.2037; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Le Y, 2007, IMMUNITY, V27, P811, DOI 10.1016/j.immuni.2007.09.011; Li HH, 2004, J CLIN INVEST, V114, P1058, DOI 10.1172/JCl200422220; Lu ZM, 2001, MOL CELL BIOL, V21, P4016, DOI 10.1128/MCB.21.12.4016-4031.2001; Meng WY, 1999, NATURE, V398, P84, DOI 10.1038/18050; MOLINO M, 1995, J BIOL CHEM, V270, P11168, DOI 10.1074/jbc.270.19.11168; Nian M, 2004, CIRC RES, V94, P1543, DOI 10.1161/01.RES.0000130526.20854.fa; Niemeyer CM, 2010, NAT GENET, V42, P794, DOI 10.1038/ng.641; Pfister R, 2007, BASIC RES CARDIOL, V102, P257, DOI 10.1007/s00395-006-0640-1; Rafiq K, 2006, J BIOL CHEM, V281, P19781, DOI 10.1074/jbc.M513040200; Sabri A, 2003, J BIOL CHEM, V278, P23944, DOI 10.1074/jbc.M302718200; Samarel AM, 2005, AM J PHYSIOL-HEART C, V289, pH2291, DOI 10.1152/ajpheart.00749.2005; Sambrano GR, 2000, J BIOL CHEM, V275, P6819, DOI 10.1074/jbc.275.10.6819; Sanjay A, 2001, J CELL BIOL, V152, P181, DOI 10.1083/jcb.152.1.181; Schmidt MHH, 2005, NAT REV MOL CELL BIO, V6, P907, DOI 10.1038/nrm1762; Shai SY, 2002, CIRC RES, V90, P458, DOI 10.1161/hh0402.105790; Solomon V, 1996, J BIOL CHEM, V271, P26690, DOI 10.1074/jbc.271.43.26690; Thien CBF, 2001, NAT REV MOL CELL BIO, V2, P294, DOI 10.1038/35067100; Tidball JG, 2002, J PHYSIOL-LONDON, V545, P819, DOI 10.1113/jphysiol.2002.024935; Toth A, 2006, J BIOL CHEM, V281, P3679, DOI 10.1074/jbc.M509630200; Vadlamudi RK, 2002, J CELL PHYSIOL, V190, P189, DOI 10.1002/JCP.10054; Wang XJ, 2006, CIRC RES, V99, P1315, DOI 10.1161/01.RES.0000252342.61447.a2; White DE, 2006, GENE DEV, V20, P2355, DOI 10.1101/gad.1458906; Wiedow O, 2005, J INTERN MED, V257, P319, DOI 10.1111/j.1365-2796.2005.01476.x; Zhang CL, 2005, AM J PHYSIOL-HEART C, V288, pH2836, DOI 10.1152/ajpheart.01122.2004	36	34	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5327	5339		10.1074/jbc.M111.307009	http://dx.doi.org/10.1074/jbc.M111.307009			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22203672	Green Published, hybrid			2022-12-27	WOS:000300638000015
J	Sandstrom, A; Scharf, L; McRae, G; Hawk, AJ; Meredith, SC; Adams, EJ				Sandstrom, Andrew; Scharf, Louise; McRae, Gabrielle; Hawk, Andrew J.; Meredith, Stephen C.; Adams, Erin J.			gamma delta T Cell Receptors Recognize the Non-classical Major Histocompatibility Complex (MHC) Molecule T22 via Conserved Anchor Residues in a MHC Peptide-like Fashion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONPEPTIDE ANTIGENS; ALPHA-BETA; SPECIFICITY; PRODUCT; T10	The molecular mechanisms by which gamma delta T cells recognize ligand remain a mystery. The non-classical MHC molecule T22 represents the best characterized ligand for murine gamma delta T cells, with a motif (W ... EGYEL) present in the gamma delta T cell receptor complementary-determining region 3 delta (CDR3 delta) loop mediating gamma delta T cell recognition of this molecule. Produced through V(D)J recombination, this loop is quite diverse, with different numbers and chemical types of amino acids between Trp and EGYEL, which have unknown functional consequences for T22 recognition. We have investigated the biophysical and structural effects of CDR3 delta loop diversity, revealing a range of affinities for T22 but a common thermodynamic pattern. Mutagenesis of these CDR3 delta loops defines the key anchor residues involved in T22 recognition as W ... EGYEL, similar to those found for the G8 CDR3 delta loop, and demonstrates that spacer residues modulate but are not required for T22 recognition. Comparison of the location of these residues in the T22 interface reveals a striking similarity to peptide anchor residues in classically presented MHC peptides, with the key Trp residue of the CDR3 delta motif completing the deficient peptide-binding groove of T22. This suggests that gamma delta T cell recognition of T22 utilizes the conserved ligand-presenting nature of the MHC fold.	[Sandstrom, Andrew; Scharf, Louise; McRae, Gabrielle; Meredith, Stephen C.; Adams, Erin J.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Hawk, Andrew J.; Meredith, Stephen C.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Adams, Erin J.] Univ Chicago, Comm Immunol, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Adams, EJ (corresponding author), Univ Chicago, Dept Biochem & Mol Biol, 929 E 57th St,GCIS W236, Chicago, IL 60637 USA.	ejadams@uchicago.edu		Sandstrom, Andrew/0000-0002-8629-9087	National Institutes of Health [R01 AI073922]; Kinship Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073922] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kinship Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI073922. This work was also supported by the Kinship Foundation Searle Scholars Award (to E. J. A.).	Adams EJ, 2005, SCIENCE, V308, P227, DOI 10.1126/science.1106885; Adams EJ, 2008, NAT IMMUNOL, V9, P777, DOI 10.1038/ni.1620; BLUESTONE JA, 1988, J EXP MED, V168, P1899, DOI 10.1084/jem.168.5.1899; BONNEVILLE M, 1989, P NATL ACAD SCI USA, V86, P5928, DOI 10.1073/pnas.86.15.5928; Carding SR, 2002, NAT REV IMMUNOL, V2, P336, DOI 10.1038/nri797; Crowley MP, 2000, SCIENCE, V287, P314, DOI 10.1126/science.287.5451.314; Crowley MP, 1997, J EXP MED, V185, P1223, DOI 10.1084/jem.185.7.1223; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; Garcia KC, 2005, CELL, V122, P333, DOI 10.1016/j.cell.2005.07.015; HAAS W, 1993, ANNU REV IMMUNOL, V11, P637, DOI 10.1146/annurev.immunol.11.1.637; ITO K, 1990, CELL, V62, P549, DOI 10.1016/0092-8674(90)90019-B; Jameson J, 2002, SCIENCE, V296, P747, DOI 10.1126/science.1069639; Jensen KDC, 2008, IMMUNITY, V29, P90, DOI 10.1016/j.immuni.2008.04.022; Kazen AR, 2011, P NATL ACAD SCI USA, V108, pE332, DOI 10.1073/pnas.1105105108; Maynard J, 2005, J IMMUNOL METHODS, V306, P51, DOI 10.1016/j.jim.2005.07.022; Mishra R, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000924; MOMBAERTS P, 1993, NATURE, V365, P53, DOI 10.1038/365053a0; Morita CT, 2007, IMMUNOL REV, V215, P59, DOI 10.1111/j.1600-065X.2006.00479.x; RAMMENSEE HG, 1995, IMMUNOGENETICS, V41, P178, DOI 10.1007/BF00172063; Rock E. P., 1994, J EXP MED, V179, P323; Rudolph MG, 2002, CURR OPIN IMMUNOL, V14, P52, DOI 10.1016/S0952-7915(01)00298-9; SCHILD H, 1994, CELL, V76, P29, DOI 10.1016/0092-8674(94)90170-8; Shin S, 2005, SCIENCE, V308, P252, DOI 10.1126/science.1106480; TANAKA Y, 1995, NATURE, V375, P155, DOI 10.1038/375155a0; Wingren C, 2000, SCIENCE, V287, P310, DOI 10.1126/science.287.5451.310	25	13	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					6035	6043		10.1074/jbc.M111.333153	http://dx.doi.org/10.1074/jbc.M111.333153			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22215668	hybrid, Green Published			2022-12-27	WOS:000300638000076
J	Chen, Y; Okano, K; Maeda, T; Chauhan, V; Golczak, M; Maeda, A; Palczewski, K				Chen, Yu; Okano, Kiichiro; Maeda, Tadao; Chauhan, Vishal; Golczak, Marcin; Maeda, Akiko; Palczewski, Krzysztof			Mechanism of All-trans-retinal Toxicity with Implications for Stargardt Disease and Age-related Macular Degeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECESSIVE RETINITIS-PIGMENTOSA; NEUTROPHIL NADPH-OXIDASE; ACTIVATED PROTEIN-KINASE; VISUAL CYCLE; PHOSPHOLIPASE-C; GENE ABCR; IN-VIVO; BINDING-PROPERTIES; 5-HT1A RECEPTORS; OXIDATIVE STRESS	Compromised clearance of all-trans-retinal (atRAL), a component of the retinoid cycle, increases the susceptibility of mouse retina to acute light-induced photoreceptor degeneration. Abca4(-/-)Rdh8(-/-) mice featuring defective atRAL clearance were used to examine the one or more underlying molecular mechanisms, because exposure to intense light causes severe photoreceptor degeneration in these animals. Here we report that bright light exposure of Abca4(-/-)Rdh8(-/-) mice increased atRAL levels in the retina that induced rapid NADPH oxidase-mediated overproduction of intracellular reactive oxygen species (ROS). Moreover, such ROS generation was inhibited by blocking phospholipase C and inositol 1,4,5-trisphosphate-induced Ca2+ release, indicating that activation occurs upstream of NADPH oxidase-mediated ROS generation. Because multiple upstream G protein-coupled receptors can activate phospholipase C, we then tested the effects of antagonists of serotonin 2A (5-HT2AR) and M-3-muscarinic (M3R) receptors and found they both protected Abca4(-/-)Rdh8(-/-) mouse retinas from light-induced degeneration. Thus, a cascade of signaling events appears to mediate the toxicity of atRAL in light-induced photoreceptor degeneration of Abca4(-/-)Rdh8(-/-) mice. A similar mechanism may be operative in human Stargardt disease and age-related macular degeneration.	[Chen, Yu; Okano, Kiichiro; Maeda, Tadao; Chauhan, Vishal; Golczak, Marcin; Maeda, Akiko; Palczewski, Krzysztof] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Maeda, Tadao; Chauhan, Vishal; Maeda, Akiko] Case Western Reserve Univ, Sch Med, Dept Ophthalmol, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Palczewski, K (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, 10900 Euclid Ave, Cleveland, OH 44106 USA.	kxp65@case.edu			National Institutes of Health [EY009339, EY021126, EY019031, EY019880, P30 EY11373]; Research to Prevent Blindness Foundation; Ohio Lions Eye Research Foundation; NATIONAL EYE INSTITUTE [R24EY021126, K08EY019031, R01EY009339, K08EY019880, P30EY011373] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness Foundation(Research to Prevent Blindness (RPB)); Ohio Lions Eye Research Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY009339, EY021126, EY019031, EY019880, and P30 EY11373. This work was also supported by the Research to Prevent Blindness Foundation and the Ohio Lions Eye Research Foundation.	Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; Allikmets R, 2000, AM J HUM GENET, V67, P487, DOI 10.1086/303018; ARVIDSSON LE, 1981, J MED CHEM, V24, P921, DOI 10.1021/jm00140a002; BADWEY JA, 1989, J BIOL CHEM, V264, P14947; BADWEY JA, 1986, J CELL PHYSIOL, V127, P223, DOI 10.1002/jcp.1041270206; BLEASDALE JE, 1990, J PHARMACOL EXP THER, V255, P756; Bootman MD, 2001, SEMIN CELL DEV BIOL, V12, P3, DOI 10.1006/scdb.2000.0211; Collier RJ, 2011, INVEST OPHTH VIS SCI, V52, P2118, DOI 10.1167/iovs.10-6304; Cremers FPM, 1998, HUM MOL GENET, V7, P355, DOI 10.1093/hmg/7.3.355; Donovan M, 2001, J BIOL CHEM, V276, P23000, DOI 10.1074/jbc.M005359200; DOUSSIERE J, 1992, EUR J BIOCHEM, V208, P61, DOI 10.1111/j.1432-1033.1992.tb17159.x; Finkel T, 2003, CURR OPIN CELL BIOL, V15, P247, DOI 10.1016/S0955-0674(03)00002-4; FISHER SK, 1992, J NEUROCHEM, V58, P18, DOI 10.1111/j.1471-4159.1992.tb09273.x; Fishkin N, 2005, BIOORGAN MED CHEM, V13, P5189, DOI 10.1016/j.bmc.2005.05.001; Fleisch VC, 2008, J NEUROSCI, V28, P8208, DOI 10.1523/JNEUROSCI.2367-08.2008; Golczak M, 2005, P NATL ACAD SCI USA, V102, P8162, DOI 10.1073/pnas.0503318102; Greene EL, 2000, AM J PHYSIOL-RENAL, V278, pF650, DOI 10.1152/ajprenal.2000.278.4.F650; Haruta M, 2009, P NATL ACAD SCI USA, V106, P9397, DOI 10.1073/pnas.0808940106; Hensler JG, 1998, NEUROPSYCHOPHARMACOL, V19, P354, DOI 10.1016/S0893-133X(98)00037-2; HOYER D, 1994, PHARMACOL REV, V46, P157; Hsu YC, 2011, CELL SIGNAL, V23, P2013, DOI 10.1016/j.cellsig.2011.07.015; JONES GJ, 1989, P NATL ACAD SCI USA, V86, P9606, DOI 10.1073/pnas.86.23.9606; Kim YK, 2008, J BIOL CHEM, V283, P5611, DOI 10.1074/jbc.M708885200; Kiser P. D., 2011, BIOCHIM BIOPHYS ACTA; Kiser PD, 2010, PROG RETIN EYE RES, V29, P428, DOI 10.1016/j.preteyeres.2010.03.002; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; LEYSEN JE, 1985, MOL PHARMACOL, V27, P600; LEYSEN JE, 1982, MOL PHARMACOL, V21, P301; LOCHNER JE, 1986, P NATL ACAD SCI USA, V83, P7673, DOI 10.1073/pnas.83.20.7673; Maeda A, 2005, J BIOL CHEM, V280, P18822, DOI 10.1074/jbc.M501757200; Maeda A, 2008, J BIOL CHEM, V283, P26684, DOI 10.1074/jbc.M804505200; Maeda A, 2012, NAT CHEM BIOL, V8, P170, DOI 10.1038/nchembio.759; Maeda A, 2009, J BIOL CHEM, V284, P15173, DOI 10.1074/jbc.M900322200; Martinez-Mir A, 1998, NAT GENET, V18, P11, DOI 10.1038/ng0198-11; Maruyama T, 1997, J BIOCHEM-TOKYO, V122, P498; Mata NL, 2000, P NATL ACAD SCI USA, V97, P7154, DOI 10.1073/pnas.130110497; Mata NL, 2002, NEURON, V36, P69, DOI 10.1016/S0896-6273(02)00912-1; MICHEL AD, 1989, EUR J PHARMACOL, V166, P459, DOI 10.1016/0014-2999(89)90359-2; Molday RS, 2006, ADV EXP MED BIOL, V572, P465; Movitz C, 1997, INFLAMMATION, V21, P531, DOI 10.1023/A:1027363730746; Naumenko VS, 2010, GENES BRAIN BEHAV, V9, P519, DOI 10.1111/j.1601-183X.2010.00581.x; ORGANISCIAK DT, 1992, INVEST OPHTH VIS SCI, V33, P1599; Palczewska G, 2010, NAT MED, V16, P1444, DOI 10.1038/nm.2260; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; Parish CA, 1998, P NATL ACAD SCI USA, V95, P14609, DOI 10.1073/pnas.95.25.14609; Rattner A, 2000, J BIOL CHEM, V275, P11034, DOI 10.1074/jbc.275.15.11034; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Rozanowska M, 2005, PHOTOCHEM PHOTOBIOL, V81, P1305, DOI 10.1562/2004-11-13-IR-371; Shiose S, 2011, J BIOL CHEM, V286, P15543, DOI 10.1074/jbc.M111.228551; STEINBECK MJ, 1991, J BIOL CHEM, V266, P16336; STOLK J, 1994, AM J RESP CELL MOL, V11, P95, DOI 10.1165/ajrcmb.11.1.8018341; Travis GH, 2007, ANNU REV PHARMACOL, V47, P469, DOI 10.1146/annurev.pharmtox.47.120505.105225; Tsybovsky Y, 2011, BIOCHEMISTRY-US, V50, P6855, DOI 10.1021/bi200774w; Usui S, 2009, J NEUROCHEM, V110, P1028, DOI 10.1111/j.1471-4159.2009.06195.x; von Lintig J, 2010, TRENDS BIOCHEM SCI, V35, P400, DOI 10.1016/j.tibs.2010.01.005; Yannuzzi LA, 2004, AM J OPHTHALMOL, V137, P511, DOI 10.1016/j.ajo.2003.12.035; Zhang QJ, 2005, HUM GENET, V118, P356, DOI 10.1007/s00439-005-0054-4; Zhang YH, 2004, J PHARMACOL EXP THER, V310, P59, DOI 10.1124/jpet.103.062224; Zhang YH, 2001, J NEUROSCI, V21, P7919, DOI 10.1523/JNEUROSCI.21-20-07919.2001	59	142	145	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					5059	5069		10.1074/jbc.M111.315432	http://dx.doi.org/10.1074/jbc.M111.315432			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22184108	hybrid, Green Published			2022-12-27	WOS:000300608500064
J	Gautherot, J; Durand-Schneider, AM; Delautier, D; Delaunay, JL; Rada, A; Gabillet, J; Housset, C; Maurice, M; Ait-Slimane, T				Gautherot, Julien; Durand-Schneider, Anne-Marie; Delautier, Daniele; Delaunay, Jean-Louis; Rada, Alegna; Gabillet, Julie; Housset, Chantal; Maurice, Michele; Ait-Slimane, Tounsia			Effects of Cellular, Chemical, and Pharmacological Chaperones on the Rescue of a Trafficking-defective Mutant of the ATP-binding Cassette Transporter Proteins ABCB1/ABCB4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN P-GLYCOPROTEIN; TRANSMEMBRANE CONDUCTANCE REGULATOR; FIBROSIS EPITHELIAL-CELLS; QUALITY-CONTROL; CYSTIC-FIBROSIS; SODIUM 4-PHENYLBUTYRATE; ENDOPLASMIC-RETICULUM; SURFACE EXPRESSION; RECEPTOR MUTANTS; DELTA-F508 CFTR	The ATP-binding cassette transporter ABCB4 is a phosphatidylcholine translocator specifically expressed at the bile canalicular membrane in hepatocytes, highly homologous to the multidrug transporter ABCB1. Variations in the ABCB4 gene sequence cause progressive familial intrahepatic cholestasis type 3. We have shown previously that the I541F mutation, when reproduced either in ABCB1 or in ABCB4, led to retention in the endoplasmic reticulum (ER)/Golgi. Here, Madin-Darby canine kidney cells expressing ABCB1-GFP were used as a model to investigate this mutant. We show that ABCB1-I541F is not properly folded and is more susceptible to in situ protease degradation. It colocalizes and coprecipitates with the ER chaperone calnexin and coprecipitates with the cytosolic chaperone Hsc/Hsp70. Silencing of calnexin or overexpression of Hsp70 have no effect on maturation of the mutant. We also tested potential rescue by chemical and pharmacological chaperones. Thapsigargin and sodium 4-phenyl butyrate were inefficient. Glycerol improved maturation and exit of the mutant from the ER. Cyclosporin A, a competitive substrate for ABCB1, restored maturation, plasma membrane expression, and activity of ABCB1-I541F. Cyclosporin A also improved maturation of ABCB4-I541F in Madin-Darby canine kidney cells. In HepG(2) cells transfected with ABCB4-I541F cDNA, cyclosporin A allowed a significant amount of the mutant protein to reach the membrane of bile canaliculi. These results show that the best strategy to rescue conformation-defective ABCB4 mutants is provided by pharmacological chaperones that specifically target the protein. They identify cyclosporin A as a potential novel therapeutic tool for progressive familial intrahepatic cholestasis type 3 patients.	[Gautherot, Julien; Durand-Schneider, Anne-Marie; Delautier, Daniele; Delaunay, Jean-Louis; Rada, Alegna; Gabillet, Julie; Housset, Chantal; Maurice, Michele; Ait-Slimane, Tounsia] UPMC Univ Paris 06, INSERM, UMR S 938, CdR St Antoine, F-75012 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Maurice, M (corresponding author), Fac Med Pierre & Marie Curie, UMR S 938, Site St Antoine,27 Rue Chaligny, F-75571 Paris, France.	Michele.Maurice@inserm.fr		Delaunay, jean-louis/0000-0002-6512-5483; Housset, Chantal/0000-0001-6469-0651; AIT SLIMANE, Tounsia/0000-0002-7459-859X	French National Society of Gastroenterology (SNFGE); Mucoviscidose ABCF2 Association; Albi; Robert Debre; Vaincre la Mucoviscidose associations	French National Society of Gastroenterology (SNFGE); Mucoviscidose ABCF2 Association; Albi; Robert Debre; Vaincre la Mucoviscidose associations	This work was supported by grants from the French National Society of Gastroenterology (SNFGE) and by Mucoviscidose ABCF2 Association. This work was also supported by fellowships from the Albi, Robert Debre, and Vaincre la Mucoviscidose associations (to J. G.).	Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; Arakawa T, 2006, BBA-PROTEINS PROTEOM, V1764, P1677, DOI 10.1016/j.bbapap.2006.08.012; Bernier V, 2004, TRENDS ENDOCRIN MET, V15, P222, DOI 10.1016/j.tem.2004.05.003; Choo-Kang LR, 2001, AM J PHYSIOL-LUNG C, V281, pL58, DOI 10.1152/ajplung.2001.281.1.L58; Delaunay JL, 2009, HEPATOLOGY, V49, P1218, DOI 10.1002/hep.22775; Delisle BP, 2003, J BIOL CHEM, V278, P35749, DOI 10.1074/jbc.M305787200; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Egan ME, 2002, NAT MED, V8, P485, DOI 10.1038/nm0502-485; Fan JQ, 1999, NAT MED, V5, P112, DOI 10.1038/4801; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Hayashi H, 2007, HEPATOLOGY, V45, P1506, DOI 10.1002/hep.21630; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; Jacquemin E, 2001, GASTROENTEROLOGY, V120, P1448, DOI 10.1053/gast.2001.23984; Janovick JA, 2002, J CLIN ENDOCR METAB, V87, P3255, DOI 10.1210/jc.87.7.3255; Kleizen B, 2004, CURR OPIN CELL BIOL, V16, P343, DOI 10.1016/j.ceb.2004.06.012; Liu XL, 2004, J AM SOC NEPHROL, V15, P1731, DOI 10.1097/01.ASN.0000129826.28932.FD; Loo TW, 1997, J BIOL CHEM, V272, P709, DOI 10.1074/jbc.272.2.709; Loo TW, 2003, J BIOL CHEM, V278, P13603, DOI 10.1074/jbc.C300073200; Loo TW, 2004, BIOCHEM BIOPH RES CO, V325, P580, DOI 10.1016/j.bbrc.2004.10.070; LOO TW, 1995, J BIOL CHEM, V270, P21839, DOI 10.1074/jbc.270.37.21839; LOO TW, 1994, J BIOL CHEM, V269, P28683; Maattanen P, 2010, SEMIN CELL DEV BIOL, V21, P500, DOI 10.1016/j.semcdb.2010.03.006; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Morello JP, 2000, TRENDS PHARMACOL SCI, V21, P466, DOI 10.1016/S0165-6147(00)01575-3; Morello JP, 2001, BIOCHEMISTRY-US, V40, P6766, DOI 10.1021/bi002699r; Morello JP, 2000, J CLIN INVEST, V105, P887, DOI 10.1172/JCI8688; Norez C, 2006, TRAFFIC, V7, P562, DOI 10.1111/j.1600-0854.2006.00409.x; Okiyoneda T, 2008, BBA-MOL CELL RES, V1783, P1585, DOI 10.1016/j.bbamcr.2008.04.002; Petaja-Repo UE, 2002, EMBO J, V21, P1628, DOI 10.1093/emboj/21.7.1628; Plass JRM, 2004, J HEPATOL, V40, P24, DOI 10.1016/S0168-8278(03)00483-5; Polli JW, 2001, J PHARMACOL EXP THER, V299, P620; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Pruliere-Escabasse V, 2007, J BIOL CHEM, V282, P34048, DOI 10.1074/jbc.M702384200; Robben JH, 2006, MOL BIOL CELL, V17, P379, DOI 10.1091/mbc.E05-06-0579; Rubenstein RC, 2000, AM J PHYSIOL-CELL PH, V278, pC259, DOI 10.1152/ajpcell.2000.278.2.C259; Rubenstein RC, 1997, J CLIN INVEST, V100, P2457, DOI 10.1172/JCI119788; Singh LR, 2009, J BIOL CHEM, V284, P4238, DOI 10.1074/jbc.M806387200; Sobolewski A, 2008, HUM MOL GENET, V17, P3180, DOI 10.1093/hmg/ddn214; Swanton E, 2003, EMBO J, V22, P2948, DOI 10.1093/emboj/cdg300; TAMAI I, 1990, J BIOL CHEM, V265, P16509; Tveten K, 2007, FEBS J, V274, P1881, DOI 10.1111/j.1742-4658.2007.05735.x; Ulloa-Aguirre A, 2004, TRAFFIC, V5, P821, DOI 10.1111/j.1600-0854.2004.00232.x; van der Velden LM, 2010, HEPATOLOGY, V51, P286, DOI 10.1002/hep.23268; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; Welch WJ, 2004, SEMIN CELL DEV BIOL, V15, P31, DOI 10.1016/j.semcdb.2003.12.011; Zhang F, 1998, NAT STRUCT BIOL, V5, P180, DOI 10.1038/nsb0398-180; Zhang XM, 2003, J BIOL CHEM, V278, P51232, DOI 10.1074/jbc.M309076200	48	45	46	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					5070	5078		10.1074/jbc.M111.275438	http://dx.doi.org/10.1074/jbc.M111.275438			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22184139	Green Published, hybrid			2022-12-27	WOS:000300608500065
J	Herrmann, JM; Riemer, J				Herrmann, Johannes M.; Riemer, Jan			Mitochondrial Disulfide Relay: Redox-regulated Protein Import into the Intermembrane Space	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							CYTOCHROME-C-OXIDASE; RNA-BINDING PROTEIN; IRON-SULFUR PROTEIN; SULFHYDRYL OXIDASE; SACCHAROMYCES-CEREVISIAE; LIVER-REGENERATION; CRYSTAL-STRUCTURE; ELECTRON-TRANSFER; COPPER CHAPERONE; TIM8-TIM13 COMPLEX	99% of all mitochondrial proteins are synthesized in the cytosol, from where they are imported into mitochondria. In contrast to matrix proteins, many proteins of the intermembrane space (IMS) lack presequences and are imported in an oxidation-driven reaction by the mitochondrial disulfide relay. Incoming polypeptides are recognized and oxidized by the IMS-located receptor Mia40. Reoxidation of Mia40 is facilitated by the sulfhydryl oxidase Erv1 and the respiratory chain. Although structurally unrelated, the mitochondrial disulfide relay functionally resembles the Dsb (disufide bond) system of the bacterial periplasm, the compartment from which the IMS was derived 2 billion years ago.	[Herrmann, Johannes M.; Riemer, Jan] Univ Kaiserslautern, Dept Cell Biol, D-67663 Kaiserslautern, Germany	University of Kaiserslautern	Herrmann, JM (corresponding author), Univ Kaiserslautern, Dept Cell Biol, Erwin Schrodinger Str 13, D-67663 Kaiserslautern, Germany.	hannes.herrmann@biologie.uni-kl.de	Riemer, Jan/AAC-1072-2021; Riemer, Jan/B-3340-2012	Riemer, Jan/0000-0002-7574-8457	Deutsche Forschungsgemeinschaft; Landesschwerpunkt Rheinland-Pfalz on Membrane Transport	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Landesschwerpunkt Rheinland-Pfalz on Membrane Transport	This work was supported by grants from the Deutsche Forschungsgemeinschaft and the Landesschwerpunkt Rheinland-Pfalz on Membrane Transport (to J. M. H. and J. R.). This is the fifth article in the Thematic Minireview Series on Redox Sensing and Regulation.	Abajian C, 2004, J BIOL CHEM, V279, P53584, DOI 10.1074/jbc.M408099200; Allen S, 2005, J MOL BIOL, V353, P937, DOI 10.1016/j.jmb.2005.08.049; Ang SK, 2009, J BIOL CHEM, V284, P28754, DOI 10.1074/jbc.M109.021113; Arnesano F, 2005, STRUCTURE, V13, P713, DOI 10.1016/j.str.2005.02.015; Baker MJ, 2009, MOL BIOL CELL, V20, P769, DOI 10.1091/mbc.E08-09-0903; Banci L, 2004, J BIOL CHEM, V279, P34833, DOI 10.1074/jbc.M403655200; Banci L, 2008, P NATL ACAD SCI USA, V105, P6803, DOI 10.1073/pnas.0800019105; Banci L, 2011, P NATL ACAD SCI USA, V108, P4811, DOI 10.1073/pnas.1014542108; Banci L, 2010, P NATL ACAD SCI USA, V107, P20190, DOI 10.1073/pnas.1010095107; Banci L, 2010, NATURE, V465, P645, DOI 10.1038/nature09018; Banci L, 2009, NAT STRUCT MOL BIOL, V16, P198, DOI 10.1038/nsmb.1553; Barros MH, 2004, J BIOL CHEM, V279, P31943, DOI 10.1074/jbc.M405014200; Becher D, 1999, YEAST, V15, P1171, DOI 10.1002/(SICI)1097-0061(19990915)15:12<1171::AID-YEA443>3.0.CO;2-T; Beverly KN, 2008, J MOL BIOL, V382, P1144, DOI 10.1016/j.jmb.2008.07.069; Bien M, 2010, MOL CELL, V37, P516, DOI 10.1016/j.molcel.2010.01.017; Bihlmaier K, 2007, J CELL BIOL, V179, P389, DOI 10.1083/jcb.200707123; Carr HS, 2003, ACCOUNTS CHEM RES, V36, P309, DOI 10.1021/ar0200807; Carr HS, 2002, J BIOL CHEM, V277, P31237, DOI 10.1074/jbc.M204854200; Casareno RLB, 1998, J BIOL CHEM, V273, P23625, DOI 10.1074/jbc.273.37.23625; Cavallaro G, 2010, MOL BIOSYST, V6, P2459, DOI 10.1039/c0mb00058b; Chacinska A, 2004, EMBO J, V23, P3735, DOI 10.1038/sj.emboj.7600389; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Coppock DL, 2006, ANTIOXID REDOX SIGN, V8, P300, DOI 10.1089/ars.2006.8.300; Culotta VC, 1997, J BIOL CHEM, V272, P23469, DOI 10.1074/jbc.272.38.23469; Curran SP, 2004, J BIOL CHEM, V279, P43744, DOI 10.1074/jbc.M404878200; Curran SP, 2002, J CELL BIOL, V158, P1017, DOI 10.1083/jcb.200205124; Curran SP, 2002, EMBO J, V21, P942, DOI 10.1093/emboj/21.5.942; Dabir DV, 2007, EMBO J, V26, P4801, DOI 10.1038/sj.emboj.7601909; Daithankar VN, 2010, BIOCHEMISTRY-US, V49, P6737, DOI 10.1021/bi100912m; Eliyahu E, 2010, MOL CELL BIOL, V30, P284, DOI 10.1128/MCB.00651-09; Endo T, 2010, BBA-MOL CELL RES, V1803, P706, DOI 10.1016/j.bbamcr.2009.11.007; Esser K, 2004, MOL GENET GENOMICS, V271, P616, DOI 10.1007/s00438-004-1011-y; Farrell SR, 2005, BIOCHEMISTRY-US, V44, P1532, DOI 10.1021/bi0479555; Fass D, 2008, BBA-MOL CELL RES, V1783, P557, DOI 10.1016/j.bbamcr.2007.11.009; Fischer LR, 2011, BRAIN, V134, P196, DOI 10.1093/brain/awq314; Gabriel K, 2007, J MOL BIOL, V365, P612, DOI 10.1016/j.jmb.2006.10.038; Garcia-Rodriguez LJ, 2007, J CELL BIOL, V176, P197, DOI 10.1083/jcb.200606054; Glerum DM, 1996, J BIOL CHEM, V271, P14504, DOI 10.1074/jbc.271.24.14504; GLICK BS, 1992, CELL, V69, P809, DOI 10.1016/0092-8674(92)90292-K; GRAHAM LA, 1991, J BIOL CHEM, V266, P22485; Gross E, 2002, NAT STRUCT BIOL, V9, P61, DOI 10.1038/nsb740; HAGIYA M, 1994, P NATL ACAD SCI USA, V91, P8142, DOI 10.1073/pnas.91.17.8142; Herrmann JM, 2010, ANTIOXID REDOX SIGN, V13, P1341, DOI 10.1089/ars.2009.3063; Hofhaus G, 2003, EUR J BIOCHEM, V270, P1528, DOI 10.1046/j.1432-1033.2003.03519.x; Hofmann S, 2002, J BIOL CHEM, V277, P23287, DOI 10.1074/jbc.M201154200; Hoppins SC, 2004, J BIOL CHEM, V279, P12396, DOI 10.1074/jbc.M313037200; Horn D, 2008, MOL CELL BIOL, V28, P4354, DOI 10.1128/MCB.01920-07; Horn D, 2010, J BIOL CHEM, V285, P15088, DOI 10.1074/jbc.M110.104786; Hunte C, 2000, STRUCTURE, V8, P669, DOI 10.1016/S0969-2126(00)00152-0; Jan PS, 2000, MOL GEN GENET, V263, P483, DOI 10.1007/s004380051192; Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850; Kawano S, 2009, P NATL ACAD SCI USA, V106, P14403, DOI 10.1073/pnas.0901793106; Kloppel C, 2011, MOL BIOL CELL, V22, P3749, DOI 10.1091/mbc.E11-04-0293; Kloppel C, 2010, BIOCHEM BIOPH RES CO, V403, P114, DOI 10.1016/j.bbrc.2010.10.129; Koehler CM, 2004, ANNU REV CELL DEV BI, V20, P309, DOI 10.1146/annurev.cellbio.20.010403.105057; Koehler CM, 1998, EMBO J, V17, P6477, DOI 10.1093/emboj/17.22.6477; Kumar C, 2011, EMBO J, V30, P2044, DOI 10.1038/emboj.2011.105; Lamb AL, 2001, NAT STRUCT BIOL, V8, P751, DOI 10.1038/nsb0901-751; Leary SC, 2010, ANTIOXID REDOX SIGN, V13, P1403, DOI 10.1089/ars.2010.3116; Leary SC, 2009, HUM MOL GENET, V18, P2230, DOI 10.1093/hmg/ddp158; Lee JE, 2000, FEBS LETT, V477, P62, DOI 10.1016/S0014-5793(00)01767-1; Liang HB, 2004, J BIOL CHEM, V279, P39396, DOI 10.1074/jbc.M406915200; Lionaki E, 2010, ANTIOXID REDOX SIGN, V13, P1327, DOI 10.1089/ars.2010.3200; LISOWSKY T, 1994, CURR GENET, V26, P15, DOI 10.1007/BF00326299; Longen S, 2009, J MOL BIOL, V393, P356, DOI 10.1016/j.jmb.2009.08.041; Lu H, 2005, J MOL BIOL, V353, P897, DOI 10.1016/j.jmb.2005.09.002; Lu H, 2004, J BIOL CHEM, V279, P18952, DOI 10.1074/jbc.M313045200; Lutz T, 2003, EMBO J, V22, P4400, DOI 10.1093/emboj/cdg421; Marc P, 2002, EMBO REP, V3, P159, DOI 10.1093/embo-reports/kvf025; Merbitz-Zahradnik T, 2003, BIOCHEMISTRY-US, V42, P13637, DOI 10.1021/bi035344r; Mesecke N, 2005, CELL, V121, P1059, DOI 10.1016/j.cell.2005.04.011; Mesecke N, 2008, EMBO REP, V9, P1107, DOI 10.1038/embor.2008.173; Milenkovic D, 2009, MOL BIOL CELL, V20, P2530, DOI 10.1091/mbc.E08-11-1108; Morgan B, 2008, BIOCHEM J, V411, P115, DOI 10.1042/BJ20071476; Morgan B, 2009, J BIOL CHEM, V284, P6818, DOI 10.1074/jbc.M808691200; Naoe M, 2004, J BIOL CHEM, V279, P47815, DOI 10.1074/jbc.M410272200; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Nobrega MP, 2002, J BIOL CHEM, V277, P40206, DOI 10.1074/jbc.M207348200; NUNNARI J, 1993, SCIENCE, V262, P1997, DOI 10.1126/science.8266095; Potting C, 2010, EMBO J, V29, P2888, DOI 10.1038/emboj.2010.169; Quenault T, 2011, TRENDS CELL BIOL, V21, P104, DOI 10.1016/j.tcb.2010.09.013; Reddehase S, 2009, J MOL BIOL, V385, P331, DOI 10.1016/j.jmb.2008.10.088; Roesch K, 2002, HUM MOL GENET, V11, P477, DOI 10.1093/hmg/11.5.477; Saint-Georges Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002293; SCHNEIDER A, 1991, EMBO J, V10, P247, DOI 10.1002/j.1460-2075.1991.tb07944.x; Sickmann A, 2003, P NATL ACAD SCI USA, V100, P13207, DOI 10.1073/pnas.2135385100; Sideris DP, 2009, J CELL BIOL, V187, P1007, DOI 10.1083/jcb.200905134; Sirrenberg C, 1998, NATURE, V391, P912, DOI 10.1038/36136; Stojanovski D, 2008, J CELL BIOL, V183, P195, DOI 10.1083/jcb.200804095; Sturtz LA, 2001, J BIOL CHEM, V276, P38084; Tamura Y, 2009, J CELL BIOL, V185, P1029, DOI 10.1083/jcb.200812018; Terziyska N, 2005, FEBS LETT, V579, P179, DOI 10.1016/j.febslet.2004.11.072; Terziyska N, 2007, FEBS LETT, V581, P1098, DOI 10.1016/j.febslet.2007.02.014; Tienson HL, 2009, MOL BIOL CELL, V20, P3481, DOI 10.1091/mbc.E08-10-1062; Vitu E, 2006, J MOL BIOL, V362, P89, DOI 10.1016/j.jmb.2006.06.070; Vogtle FN, 2009, CELL, V139, P428, DOI 10.1016/j.cell.2009.07.045; Voronova A, 2007, BIOCHEM J, V408, P139, DOI 10.1042/BJ20070804; Webb CT, 2006, MOL CELL, V21, P123, DOI 10.1016/j.molcel.2005.11.010; Williams JC, 2005, J BIOL CHEM, V280, P15202, DOI 10.1074/jbc.M410705200; Wu CK, 2003, PROTEIN SCI, V12, P1109, DOI 10.1110/ps.0238103	100	94	94	1	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4426	4433		10.1074/jbc.R111.270678	http://dx.doi.org/10.1074/jbc.R111.270678			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22157015	Green Published, hybrid			2022-12-27	WOS:000300608500006
J	Wang, T; Leyh, TS				Wang, Ting; Leyh, Thomas S.			Three-stage Assembly of the Cysteine Synthase Complex from Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							O-ACETYLSERINE SULFHYDRYLASE; SERINE ACETYLTRANSFERASE; SALMONELLA-TYPHIMURIUM; BIENZYME COMPLEX; KINETIC MECHANISM; CYSB PROTEIN; ACTIVE-SITE; A-ISOZYME; B-ISOZYME; IN-VITRO	Control of sulfur metabolism in plants and bacteria is linked, in significant measure, to the behavior of the cysteine synthase complex (CSC). The complex is comprised of the two enzymes that catalyze the final steps in cysteine biosynthesis: serine O-acetyltransferase (SAT, EC 2.3.1.30), which produces O-acetyl-L-serine, and O-acetyl-L-serine sulfhydrylase (OASS, EC 2.5.1.47), which converts it to cysteine. SAT (a dimer of homotrimers) binds a maximum of two molecules of OASS (a dimer) in an interaction believed to involve docking of the C terminus from a protomer in an SAT trimer into an OASS active site. This interaction inactivates OASS catalysis and prevents further binding to the trimer; thus, the system exhibits a contact-induced inactivation of half of each biomolecule. To better understand the dynamics and energetics that underlie formation of the CSC, the interactions of OASS and SAT from Escherichia coli were studied at equilibrium and in the pre-steady state. Using an experimental strategy that initiates dissociation of the CSC at different points in the CSC-forming reaction, three stable forms of the complex were identified. Comparison of the binding behaviors of SAT and its C-terminal peptide supports a mechanism in which SAT interacts with OASS in a non-allosteric interaction involving its C terminus. This early docking event appears to fasten the proteins in close proximity and thus prepares the system to engage in a series of subsequent, energetically favorable isomerizations that inactivate OASS and produce the fully isomerized CSC.	[Wang, Ting; Leyh, Thomas S.] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Leyh, TS (corresponding author), 1300 Morris Pk Ave, Bronx, NY 10461 USA.	tom.leyh@einstein.yu.edu	Wang, Ting/J-7577-2015		National Institutes of Health [GM54469]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054469] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM54469 (to T. S. L.).	Andreassi JL, 2004, BIOCHEMISTRY-US, V43, P14594, DOI 10.1021/bi048963o; Auger S, 2002, J BACTERIOL, V184, P5179, DOI 10.1128/JB.184.18.5179-5186.2002; Benci S, 1999, BBA-PROTEIN STRUCT M, V1429, P317, DOI 10.1016/S0167-4838(98)00229-5; Bhave Devayani P., 2007, Infectious Disorders - Drug Targets, V7, P140; Campanini B, 2005, PROTEIN SCI, V14, P2115, DOI 10.1110/ps.051492805; Chattopadhyay A, 2007, BIOCHEMISTRY-US, V46, P8315, DOI 10.1021/bi602603c; CLELAND WW, 1975, BIOCHEMISTRY-US, V14, P3220, DOI 10.1021/bi00685a029; COOK PF, 1977, ARCH BIOCHEM BIOPHYS, V178, P293, DOI 10.1016/0003-9861(77)90194-1; CORDINGLEY MG, 1990, J BIOL CHEM, V265, P9062; Droux M, 1998, EUR J BIOCHEM, V255, P235, DOI 10.1046/j.1432-1327.1998.2550235.x; Feldman-Salit A, 2009, J MOL BIOL, V386, P37, DOI 10.1016/j.jmb.2008.08.075; FLAVIN M, 1965, BIOCHEMISTRY-US, V4, P1370, DOI 10.1021/bi00883a022; Forquin MP, 2011, APPL ENVIRON MICROB, V77, P1449, DOI 10.1128/AEM.01708-10; Gyaneshwar P, 2005, P NATL ACAD SCI USA, V102, P3453, DOI 10.1073/pnas.0500141102; Gyaneshwar P, 2005, J BACTERIOL, V187, P1074, DOI 10.1128/JB.187.3.1074-1090.2005; Hatzios SK, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002036; Hindson VJ, 2003, BIOCHEM J, V375, P745, DOI 10.1042/BJ20030429; Hindson VJ, 2003, BIOCHEMISTRY-US, V42, P3113, DOI 10.1021/bi0267893; Hirai MY, 2003, PLANT J, V33, P651, DOI 10.1046/j.1365-313X.2003.01658.x; Huang B, 2005, J BACTERIOL, V187, P3201, DOI 10.1128/JB.187.9.3201-3205.2005; Johnson CM, 2004, ARCH BIOCHEM BIOPHYS, V429, P115, DOI 10.1016/j.abb.2004.06.006; Kapust RB, 1999, PROTEIN SCI, V8, P1668, DOI 10.1110/ps.8.8.1668; Keseler IM, 2011, NUCLEIC ACIDS RES, V39, pD583, DOI 10.1093/nar/gkq1143; Kredich N.M., 1987, ESCHERICHIA COLI SAL, P419; Kredich N.M., 1967, ORG BIOSYNTHESIS, P189; KREDICH NM, 1969, J BIOL CHEM, V244, P2428; KREDICH NM, 1966, J BIOL CHEM, V241, P4955; KREDICH NM, 1992, MOL MICROBIOL, V6, P2747, DOI 10.1111/j.1365-2958.1992.tb01453.x; Kumar S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.197376; LEU LS, 1994, BIOCHEMISTRY-US, V33, P2667, DOI 10.1021/bi00175a040; Mino K, 2000, BIOSCI BIOTECH BIOCH, V64, P1628, DOI 10.1271/bbb.64.1628; Mino K, 1999, BIOSCI BIOTECH BIOCH, V63, P168, DOI 10.1271/bbb.63.168; Mino K, 2000, BIOSCI BIOTECH BIOCH, V64, P1874, DOI 10.1271/bbb.64.1874; Mino K, 2001, BIOSCI BIOTECH BIOCH, V65, P865, DOI 10.1271/bbb.65.865; Olsen LR, 2004, BIOCHEMISTRY-US, V43, P6013, DOI 10.1021/bi0358521; OSTROWSKI J, 1989, J BACTERIOL, V171, P130, DOI 10.1128/jb.171.1.130-140.1989; OSTROWSKI J, 1991, J BACTERIOL, V173, P2212, DOI 10.1128/JB.173.7.2212-2218.1991; Pye VE, 2004, J BIOL CHEM, V279, P40729, DOI 10.1074/jbc.M403751200; Rabeh WM, 2004, J BIOL CHEM, V279, P26803, DOI 10.1074/jbc.R400001200; Salsi E, 2010, J BIOL CHEM, V285, P12813, DOI 10.1074/jbc.M109.075762; Salsi E, 2010, J MED CHEM, V53, P345, DOI 10.1021/jm901325e; SCHNACKERZ KD, 1995, BIOCHEMISTRY-US, V34, P12152, DOI 10.1021/bi00038a008; Schnell R, 2007, J BIOL CHEM, V282, P23473, DOI 10.1074/jbc.M703518200; Strambini GB, 1996, BIOCHEMISTRY-US, V35, P8392, DOI 10.1021/bi952919e; TAI CH, 1993, BIOCHEMISTRY-US, V32, P6433, DOI 10.1021/bi00076a017; Zare H, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-39; Zhao CH, 2006, BIOCHEM BIOPH RES CO, V341, P911, DOI 10.1016/j.bbrc.2006.01.054	47	22	22	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					4360	4367		10.1074/jbc.M111.288423	http://dx.doi.org/10.1074/jbc.M111.288423			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22179612	Green Published, hybrid			2022-12-27	WOS:000300410900066
J	Kaczocha, M; Vivieca, S; Sun, J; Glaser, ST; Deutsch, DG				Kaczocha, Martin; Vivieca, Stephanie; Sun, Jing; Glaser, Sherrye T.; Deutsch, Dale G.			Fatty Acid-binding Proteins Transport N-Acylethanolamines to Nuclear Receptors and Are Targets of Endocannabinoid Transport Inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANANDAMIDE CELLULAR UPTAKE; AMIDE HYDROLASE; MONOACYLGLYCEROL LIPASE; CANNABINOID RECEPTORS; SELECTIVE-INHIBITION; MEMBRANE-TRANSPORT; NEUROPATHIC PAIN; AM404; RAT; HYDROLYSIS	N-Acylethanolamines (NAEs) are bioactive lipids that engage diverse receptor systems. Recently, we identified fatty acid-binding proteins (FABPs) as intracellular NAE carriers. Here, we provide two new functions for FABPs in NAE signaling. We demonstrate that FABPs mediate the nuclear translocation of the NAE oleoylethanolamide, an agonist of nuclear peroxisome proliferator-activated receptor alpha (PPAR alpha). Antagonism of FABP function through chemical inhibition, dominant-negative approaches, or shRNA-mediated knockdown reduced PPAR alpha activation, confirming a requisite role for FABPs in this process. In addition, we show that NAE analogs, traditionally employed as inhibitors of the putative endocannabinoid transmembrane transporter, target FABPs. Support for the existence of the putative membrane transporter stems primarily from pharmacological inhibition of endocannabinoid uptake by such transport inhibitors, which are widely employed in endocannabinoid research despite lacking a known cellular target(s). Our approach adapted FABP-mediated PPAR alpha signaling and employed in vitro binding, arachidonoyl-[1-C-14] ethanolamide ([C-14] AEA) uptake, and FABP knockdown to demonstrate that transport inhibitors exert their effects through inhibition of FABPs, thereby providing a molecular rationale for the underlying physiological effects of these compounds. Identification of FABPs as targets of transport inhibitors undermines the central pharmacological support for the existence of an endocannabinoid transmembrane transporter.	[Kaczocha, Martin; Vivieca, Stephanie; Sun, Jing; Deutsch, Dale G.] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Glaser, Sherrye T.] Kingsborough Community Coll, Dept Biol Sci, Brooklyn, NY 11235 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; City University of New York (CUNY) System	Kaczocha, M (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA.	MKaczoch@notes.sunysb.edu		Kaczocha, Martin/0000-0002-2527-1398	National Institute on Drug Abuse [DA032232, DA021806, DA016419, DA026953]; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA021806, R01DA016419, R21DA032232, R21DA026953] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institute on Drug Abuse Grants DA032232 (to M. K.), DA021806 (to S. T. G.), and DA016419 and DA026953 (to D. G. D.).	Adermark L, 2007, P NATL ACAD SCI USA, V104, P20564, DOI 10.1073/pnas.0706873104; Adermark L, 2009, EUR J NEUROSCI, V29, P32, DOI 10.1111/j.1460-9568.2008.06551.x; Alptekin A, 2010, EUR J PHARMACOL, V634, P10, DOI 10.1016/j.ejphar.2010.02.013; Beltramo M, 1997, SCIENCE, V277, P1094, DOI 10.1126/science.277.5329.1094; Bojesen IN, 2005, J LIPID RES, V46, P1652, DOI 10.1194/jlr.M400498-JLR200; Chuang S, 2008, J MED CHEM, V51, P3755, DOI 10.1021/jm701192w; Cravatt BF, 2001, P NATL ACAD SCI USA, V98, P9371, DOI 10.1073/pnas.161191698; Day TA, 2001, MOL PHARMACOL, V59, P1369, DOI 10.1124/mol.59.6.1369; De Petrocellis L, 2000, FEBS LETT, V483, P52, DOI 10.1016/S0014-5793(00)02082-2; Deutsch DG, 2001, J BIOL CHEM, V276, P6967, DOI 10.1074/jbc.M003161200; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Erbay E, 2009, NAT MED, V15, P1383, DOI 10.1038/nm.2067; Fasia L, 2003, EUR J BIOCHEM, V270, P3498, DOI 10.1046/j.1432-1033.2003.03724.x; Fegley D, 2004, P NATL ACAD SCI USA, V101, P8756, DOI 10.1073/pnas.0400997101; Fezza F, 2008, J LIPID RES, V49, P1216, DOI 10.1194/jlr.M700486-JLR200; Fowler CJ, 2004, EUR J PHARMACOL, V492, P1, DOI 10.1016/j.ejphar.2004.03.048; Fu J, 2003, NATURE, V425, P90, DOI 10.1038/nature01921; Fu J, 2012, NAT NEUROSCI, V15, P64, DOI 10.1038/nn.2986; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Furuhashi M, 2007, NATURE, V447, P959, DOI 10.1038/nature05844; Glaser ST, 2010, J PHARMACOL EXP THER, V335, P380, DOI 10.1124/jpet.110.168831; Glaser ST, 2003, P NATL ACAD SCI USA, V100, P4269, DOI 10.1073/pnas.0730816100; Glaser ST, 2005, LIFE SCI, V77, P1584, DOI 10.1016/j.lfs.2005.05.007; Hasanein P, 2009, NEUROSCI LETT, V462, P230, DOI 10.1016/j.neulet.2009.07.026; Hogestatt ED, 2005, J BIOL CHEM, V280, P31405, DOI 10.1074/jbc.M501489200; Howlett AC, 2011, BRIT J PHARMACOL, V163, P1329, DOI 10.1111/j.1476-5381.2011.01364.x; Kaczocha M, 2006, J BIOL CHEM, V281, P9066, DOI 10.1074/jbc.M509721200; Kaczocha M, 2010, J BIOL CHEM, V285, P2796, DOI 10.1074/jbc.M109.058461; Kaczocha M, 2009, P NATL ACAD SCI USA, V106, P6375, DOI 10.1073/pnas.0901515106; Karlsson M, 2004, EUR J PHARM SCI, V22, P181, DOI 10.1016/j.ejps.2004.03.009; Kelley BG, 2004, EUR J PHARMACOL, V496, P33, DOI 10.1016/j.ejphar.2004.06.011; Kim J, 2010, NAT NEUROSCI, V13, P592, DOI 10.1038/nn.2517; La Rana G, 2008, NEUROPHARMACOLOGY, V54, P521, DOI 10.1016/j.neuropharm.2007.10.021; La Rana G, 2006, J PHARMACOL EXP THER, V317, P1365, DOI 10.1124/jpet.105.100792; Lastres-Becker I, 2003, J NEUROCHEM, V84, P1097, DOI 10.1046/j.1471-4159.2003.01595.x; Lichtman AH, 2004, PAIN, V109, P319, DOI 10.1016/j.pain.2004.01.022; Lo Verme J, 2005, MOL PHARMACOL, V67, P15, DOI 10.1124/mol.104.006353; Mallet C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012748; McFarland MJ, 2004, PHARMACOL THERAPEUT, V104, P117, DOI 10.1016/j.pharmthera.2004.07.008; Nicholson RA, 2003, BRAIN RES, V978, P194, DOI 10.1016/S0006-8993(03)02808-7; Oddi S, 2005, CELL MOL LIFE SCI, V62, P386, DOI 10.1007/s00018-004-4446-8; Oddi S, 2009, CHEM BIOL, V16, P624, DOI 10.1016/j.chembiol.2009.05.004; Ortar G, 2003, BIOCHEM PHARMACOL, V65, P1473, DOI 10.1016/S0006-2952(03)00109-6; Owada Y, 1996, J CHEM NEUROANAT, V12, P113, DOI 10.1016/S0891-0618(96)00192-5; Piomelli D, 1999, P NATL ACAD SCI USA, V96, P5802, DOI 10.1073/pnas.96.10.5802; Richieri GV, 2000, BIOCHEMISTRY-US, V39, P7197, DOI 10.1021/bi000314z; Ronesi J, 2004, J NEUROSCI, V24, P1673, DOI 10.1523/JNEUROSCI.5214-03.2004; Sagar DR, 2010, EUR J NEUROSCI, V31, P1414, DOI 10.1111/j.1460-9568.2010.07162.x; Sandberg A, 2005, CHEM PHYS LIPIDS, V134, P131, DOI 10.1016/j.chemphyslip.2004.12.010; Schug TT, 2007, CELL, V129, P723, DOI 10.1016/j.cell.2007.02.050; Spradley JM, 2010, PHARMACOL RES, V62, P249, DOI 10.1016/j.phrs.2010.03.007; Tan NS, 2002, MOL CELL BIOL, V22, P5114, DOI 10.1128/MCB.22.14.5114-5127.2002; Thors L, 2006, BRIT J PHARMACOL, V149, P73, DOI 10.1038/sj.bjp.0706831; Trezza V, 2009, J PHARMACOL EXP THER, V328, P343, DOI 10.1124/jpet.108.141069; Vandevoorde S, 2005, BRIT J PHARMACOL, V145, P885, DOI 10.1038/sj.bjp.0706253; Wolfrum C, 2007, CELL MOL LIFE SCI, V64, P2465, DOI 10.1007/s00018-007-7279-4; Xu LZ, 1996, J BIOL CHEM, V271, P24711; Ziouzenkova O, 2003, P NATL ACAD SCI USA, V100, P2730, DOI 10.1073/pnas.0538015100; Zygmunt PM, 2000, EUR J PHARMACOL, V396, P39, DOI 10.1016/S0014-2999(00)00207-7	59	117	121	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3415	3424		10.1074/jbc.M111.304907	http://dx.doi.org/10.1074/jbc.M111.304907			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22170058	hybrid, Green Published			2022-12-27	WOS:000300295100046
J	Carnarius, C; Kreir, M; Krick, M; Methfessel, C; Moehrle, V; Valerius, O; Bruggemann, A; Steinem, C; Fertig, N				Carnarius, Christian; Kreir, Mohamed; Krick, Marcel; Methfessel, Christoph; Moehrle, Volker; Valerius, Oliver; Brueggemann, Andrea; Steinem, Claudia; Fertig, Niels			Green Fluorescent Protein Changes the Conductance of Connexin 43 (Cx43) Hemichannels Reconstituted in Planar Lipid Bilayers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAP-JUNCTION HEMICHANNELS; ION CHANNELS; METABOLIC INHIBITION; ZONULA OCCLUDENS-1; STRUCTURAL-CHANGES; CARBOXYL-TERMINUS; ATP RELEASE; EXPRESSION; LIPOSOMES; CHIP	In mammalian tissues, connexin 43 (Cx43) is the most prominent member of the connexin family. In a single lipid bilayer, six connexin subunits assemble into a hemichannel (connexon). Direct communication of apposing cells is realized by two adjacent hemichannels, which can form gap junction channels. Here, we established an expression system in Pichia pastoris to recombinantly produce and purify Cx43 as well as Cx43 fused to green fluorescent protein (GFP). Proteins were isolated from crude cell membrane fractions via affinity chromatography. Cx43 and Cx43-GFP hemichannels were reconstituted in giant unilamellar vesicles as proven by fluorescence microscopy, and their electrophysiological behavior was analyzed on the single channel level by planar patch clamping. Cx43 and Cx43-GFP both showed an ohmic behavior and a voltage-dependent open probability. Cx43 hemichannels exhibited one major mean conductance of 224 +/- 26 picosiemens (pS). In addition, a subconductance state at 124 +/- 5 pS was identified. In contrast, the analysis of Cx43-GFP single channels revealed 10 distinct conductance states in the range of 15 to 250 pS, with a larger open probability at 0 mV as compared with Cx43, which suggests that intermolecular interactions between the GFP molecules alter the electrophysiology of the protein.	[Carnarius, Christian; Krick, Marcel; Steinem, Claudia] Univ Gottingen, Inst Organ & Biomol Chem, D-37077 Gottingen, Germany; [Kreir, Mohamed; Brueggemann, Andrea; Fertig, Niels] Nan Technol GmbH, D-80636 Munich, Germany; [Methfessel, Christoph; Moehrle, Volker] Bayer Technol Serv GmbH, D-51368 Leverkusen, Germany; [Valerius, Oliver] Univ Gottingen, Inst Microbiol & Genet, D-37077 Gottingen, Germany	University of Gottingen; Bayer AG; University of Gottingen	Steinem, C (corresponding author), Univ Gottingen, Inst Organ & Biomol Chem, Tammannstr 2, D-37077 Gottingen, Germany.	csteine@gwdg.de	Steinem, Claudia/K-7534-2018; Steinem, Claudia/O-4801-2019	Steinem, Claudia/0000-0001-8778-9283; Bruggemann, Andrea/0000-0002-7325-6715; Kreir, Mohamed/0000-0001-9159-9554	European Union [019335]; Bundesministerium fur Bildung und Forschung (BMBF) [13N9110, 13N9108]	European Union(European Commission); Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by the European Union within the framework of the Marie Curie Training Network 019335 "Translocation" and by grants from the Bundesministerium fur Bildung und Forschung (BMBF 13N9110 and 13N9108).	Ahmad S, 1999, BIOCHEM J, V339, P247, DOI 10.1042/0264-6021:3390247; ANGELOVA MI, 1986, FARADAY DISCUSS, V81, P303, DOI 10.1039/dc9868100303; Bao XY, 2004, J BIOL CHEM, V279, P20058, DOI 10.1074/jbc.M311137200; Bennett MVL, 2003, TRENDS NEUROSCI, V26, P610, DOI 10.1016/j.tins.2003.09.008; Bevans CG, 1999, J BIOL CHEM, V274, P3711, DOI 10.1074/jbc.274.6.3711; Bouvier D, 2009, J BIOL CHEM, V284, P34257, DOI 10.1074/jbc.M109.039594; BRIERLEY RA, 1990, ANN NY ACAD SCI, V589, P350, DOI 10.1111/j.1749-6632.1990.tb24257.x; Bruzzone S, 2001, FASEB J, V15, P10; Contreras JE, 2003, P NATL ACAD SCI USA, V100, P11388, DOI 10.1073/pnas.1434298100; Cotrina ML, 1998, P NATL ACAD SCI USA, V95, P15735, DOI 10.1073/pnas.95.26.15735; Cottrell GT, 2002, AM J PHYSIOL-CELL PH, V282, pC1469, DOI 10.1152/ajpcell.00484.2001; Cottrell GT, 2001, AM J PHYSIOL-CELL PH, V281, pC1559, DOI 10.1152/ajpcell.2001.281.5.C1559; Essner JJ, 1996, DEV BIOL, V177, P449, DOI 10.1006/dbio.1996.0177; Falk MM, 1997, EMBO J, V16, P2703, DOI 10.1093/emboj/16.10.2703; Fertig N, 2003, RECEPTOR CHANNEL, V9, P29, DOI 10.1080/10606820308256; Fertig N, 2002, BIOPHYS J, V82, P3056, DOI 10.1016/S0006-3495(02)75646-4; Gassmann O, 2009, J STRUCT BIOL, V168, P168, DOI 10.1016/j.jsb.2009.02.004; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gnidehou S, 2011, PROTEIN EXPRES PURIF, V78, P174, DOI 10.1016/j.pep.2011.04.018; Harris AL, 2001, Q REV BIOPHYS, V34, P325, DOI 10.1017/S0033583501003705; HEIM R, 1995, NATURE, V373, P663, DOI 10.1038/373663b0; Hunter AW, 2005, MOL BIOL CELL, V16, P5686, DOI 10.1091/mbc.E05-08-0737; Hunter AW, 2003, CELL COMMUN ADHES, V10, P211, DOI 10.1080/714040429; John SA, 1999, J BIOL CHEM, V274, P236, DOI 10.1074/jbc.274.1.236; Jordan K, 1999, MOL BIOL CELL, V10, P2033, DOI 10.1091/mbc.10.6.2033; Kaneda M, 2009, BIOMATERIALS, V30, P3971, DOI 10.1016/j.biomaterials.2009.04.006; Kang J, 2008, J NEUROSCI, V28, P4702, DOI 10.1523/JNEUROSCI.5048-07.2008; Kondo RP, 2000, J MOL CELL CARDIOL, V32, P1859, DOI 10.1006/jmcc.2000.1220; Kreir M, 2008, LAB CHIP, V8, P587, DOI 10.1039/b713982a; Laird DW, 2006, BIOCHEM J, V394, P527, DOI 10.1042/BJ20051922; Macauley-Patrick S, 2005, YEAST, V22, P249, DOI 10.1002/yea.1208; Maeda S, 2009, NATURE, V458, P597, DOI 10.1038/nature07869; Martinac B, 2010, METHODS MOL BIOL, V606, P31, DOI 10.1007/978-1-60761-447-0_4; MAZET JL, 1992, EUR J BIOCHEM, V210, P249, DOI 10.1111/j.1432-1033.1992.tb17415.x; Moritani Y, 2010, FEBS J, V277, P3343, DOI 10.1111/j.1742-4658.2010.07736.x; Oshima A, 2003, J BIOL CHEM, V278, P1807, DOI 10.1074/jbc.M207713200; Pantoja R, 2001, BIOPHYS J, V81, P2389, DOI 10.1016/S0006-3495(01)75885-7; Paznekas WA, 2009, HUM MUTAT, V30, P724, DOI 10.1002/humu.20958; Plotkin LI, 2002, J BIOL CHEM, V277, P8648, DOI 10.1074/jbc.M108625200; Ponsaerts R, 2010, FASEB J, V24, P4378, DOI 10.1096/fj.09-153007; Rigaud JL, 2003, METHOD ENZYMOL, V372, P65; Rochefort GY, 2010, OSTEOPOROSIS INT, V21, P1457, DOI 10.1007/s00198-010-1194-5; Schalper KA, 2010, AM J PHYSIOL-CELL PH, V299, pC1504, DOI 10.1152/ajpcell.00015.2010; Schmidt C, 2000, ANGEW CHEM INT EDIT, V39, P3137, DOI 10.1002/1521-3773(20000901)39:17<3137::AID-ANIE3137>3.0.CO;2-D; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Sohl G, 2004, CARDIOVASC RES, V62, P228, DOI 10.1016/j.cardiores.2003.11.013; Solan JL, 2009, BIOCHEM J, V419, P261, DOI 10.1042/BJ20082319; Sondermann M, 2006, BBA-BIOMEMBRANES, V1758, P545, DOI 10.1016/j.bbamem.2006.03.023; Song YN, 2009, PHARMAZIE, V64, P291, DOI 10.1691/ph.2009.8814; Sorgen PL, 2004, J BIOL CHEM, V279, P54695, DOI 10.1074/jbc.M409552200; Sosinsky GE, 2005, BBA-BIOMEMBRANES, V1711, P99, DOI 10.1016/j.bbamem.2005.04.001; STAUFFER KA, 1991, J CELL BIOL, V115, P141, DOI 10.1083/jcb.115.1.141; Stout CE, 2002, J BIOL CHEM, V277, P10482, DOI 10.1074/jbc.M109902200; Streicher P, 2009, BBA-BIOMEMBRANES, V1788, P2291, DOI 10.1016/j.bbamem.2009.07.025; Thompson RJ, 2006, SCIENCE, V312, P924, DOI 10.1126/science.1126241; Trexler EB, 1996, P NATL ACAD SCI USA, V93, P5836, DOI 10.1073/pnas.93.12.5836; Ye ZC, 2003, J NEUROSCI, V23, P3588, DOI 10.1523/jneurosci.23-09-03588.2003; YEAGER M, 1992, J MOL BIOL, V223, P929, DOI 10.1016/0022-2836(92)90253-G; Yeager M, 1998, J STRUCT BIOL, V121, P231, DOI 10.1006/jsbi.1998.3972	59	13	14	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2877	2886		10.1074/jbc.M111.319871	http://dx.doi.org/10.1074/jbc.M111.319871			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22139870	Green Published, hybrid			2022-12-27	WOS:000300292300059
J	Chimote, AA; Kuras, Z; Conforti, L				Chimote, Ameet A.; Kuras, Zerrin; Conforti, Laura			Disruption of Kv1.3 Channel Forward Vesicular Trafficking by Hypoxia in Human T Lymphocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANS-GOLGI NETWORK; BREFELDIN-A; POTASSIUM CHANNEL; PLASMA-MEMBRANE; CELL-SURFACE; LIVING CELLS; K+ CHANNEL; CLATHRIN; VESICLE; EXPRESSION	Hypoxia in solid tumors contributes to decreased immunosurveillance via down-regulation of Kv1.3 channels in T lymphocytes and associated T cell function inhibition. However, the mechanisms responsible for Kv1.3 down-regulation are not understood. We hypothesized that chronic hypoxia reduces Kv1.3 surface expression via alterations in membrane trafficking. Chronic hypoxia decreased Kv1.3 surface expression and current density in Jurkat T cells. Inhibition of either protein synthesis or degradation and endocytosis did not prevent this effect. Instead, blockade of clathrin-coated vesicle formation and forward trafficking prevented the Kv1.3 surface expression decrease in hypoxia. Confocal microscopy revealed an increased retention of Kv1.3 in the trans-Golgi during hypoxia. Expression of adaptor protein-1 (AP1), responsible for clathrin-coated vesicle formation at the trans-Golgi, was selectively down-regulated by hypoxia. Furthermore, AP1 down-regulation increased Kv1.3 retention in the trans-Golgi and reduced Kv1.3 currents. Our results indicate that hypoxia disrupts AP1/clathrin-mediated forward trafficking of Kv1.3 from the trans-Golgi to the plasma membrane thus contributing to decreased Kv1.3 surface expression in T lymphocytes.	[Chimote, Ameet A.; Kuras, Zerrin; Conforti, Laura] Univ Cincinnati, Dept Internal Med, Cincinnati, OH 45267 USA; [Conforti, Laura] Univ Cincinnati, Dept Mol & Cellular Physiol, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Conforti, L (corresponding author), 231 Albert Sabin Way, Cincinnati, OH 45267 USA.	laura.conforti@uc.edu	Chimote, Ameet A/R-5357-2016	Chimote, Ameet/0000-0001-5163-0123	National Institutes of Health [2R01CA095286]; NATIONAL CANCER INSTITUTE [R01CA095286] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant 2R01CA095286 (to L. C.).	Ang AL, 2004, J CELL BIOL, V167, P531, DOI 10.1083/jcb.200408165; Anitei M, 2010, MOL MEMBR BIOL, V27, P443, DOI 10.3109/09687688.2010.522601; Bonifacino JS, 2003, NAT REV MOL CELL BIO, V4, P409, DOI 10.1038/nrm1099; Cahalan MD, 2009, IMMUNOL REV, V231, P59, DOI 10.1111/j.1600-065X.2009.00816.x; Caldwell CC, 2001, J IMMUNOL, V167, P6140, DOI 10.4049/jimmunol.167.11.6140; CHAKRABARTI R, 1994, J BIOL CHEM, V269, P7926; Chardin P, 1999, CELL, V97, P153, DOI 10.1016/S0092-8674(00)80724-2; Choi WS, 2005, CIRC RES, V97, P363, DOI 10.1161/01.RES.0000179535.06458.f8; Cole NB, 1996, SCIENCE, V273, P797, DOI 10.1126/science.273.5276.797; Conforti L, 1997, J PHYSIOL-LONDON, V502, P293, DOI 10.1111/j.1469-7793.1997.293bk.x; Conforti L, 2003, J IMMUNOL, V170, P695, DOI 10.4049/jimmunol.170.2.695; Dinter A, 1998, HISTOCHEM CELL BIOL, V109, P571, DOI 10.1007/s004180050256; Doray B, 2001, MOL BIOL CELL, V12, P1925, DOI 10.1091/mbc.12.7.1925; Gonzalez A, 2009, FEBS LETT, V583, P3784, DOI 10.1016/j.febslet.2009.10.050; Gonzalez-Gronow M, 2007, J BIOL CHEM, V282, P32811, DOI 10.1074/jbc.M703342200; Guo J, 2009, J CLIN INVEST, V119, P2745, DOI 10.1172/JCI39027; Hansen JS, 2008, BIOCHEM J, V410, P463, DOI 10.1042/BJ20070559; Hartness ME, 2003, J BIOL CHEM, V278, P51422, DOI 10.1074/jbc.M309463200; Hirschberg K, 1998, J CELL BIOL, V143, P1485, DOI 10.1083/jcb.143.6.1485; Huang BH, 2011, BLOOD, V118, P2918, DOI 10.1182/blood-2011-03-341214; Jansen JA, 2008, BIOCHEM BIOPH RES CO, V367, P687, DOI 10.1016/j.bbrc.2007.12.168; Jones SM, 1998, SCIENCE, V279, P573, DOI 10.1126/science.279.5350.573; Kirchhausen T, 1999, ANNU REV CELL DEV BI, V15, P705, DOI 10.1146/annurev.cellbio.15.1.705; Kirchhausen T, 2000, NAT REV MOL CELL BIO, V1, P187, DOI 10.1038/35043117; Kirchhof MG, 2008, J IMMUNOL, V181, P1927, DOI 10.4049/jimmunol.181.3.1927; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Kojima H, 2003, CURR PHARM DESIGN, V9, P1827, DOI 10.2174/1381612033454388; Kosolapov A, 2004, NEURON, V44, P295, DOI 10.1016/j.neuron.2004.09.011; Lee I, 2008, ARCH BIOCHEM BIOPHYS, V479, P63, DOI 10.1016/j.abb.2008.08.009; LEWIS RS, 1995, ANNU REV IMMUNOL, V13, P623, DOI 10.1146/annurev.iy.13.040195.003203; Lopez-Barneo J, 2001, ANNU REV PHYSIOL, V63, P259, DOI 10.1146/annurev.physiol.63.1.259; Lu A, 2009, J CELL BIOL, V184, P863, DOI 10.1083/jcb.200807186; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Mattera R, 2011, J BIOL CHEM, V286, P2022, DOI 10.1074/jbc.M110.197178; McMahon HT, 2004, CURR OPIN CELL BIOL, V16, P379, DOI 10.1016/j.ceb.2004.06.009; Mellman I, 2000, CELL, V100, P99, DOI 10.1016/S0092-8674(00)81687-6; Moudgil R, 2006, MICROCIRCULATION, V13, P615, DOI 10.1080/10739680600930222; Nanduri J, 2009, BIOCHEM BIOPH RES CO, V388, P212, DOI 10.1016/j.bbrc.2009.07.149; Nesti E, 2004, MOL BIOL CELL, V15, P4073, DOI 10.1091/mbc.E03-11-0788; Nichols BJ, 2001, J CELL BIOL, V153, P529, DOI 10.1083/jcb.153.3.529; Nicolaou SA, 2010, CELL CALCIUM, V47, P19, DOI 10.1016/j.ceca.2009.11.001; Nicolaou SA, 2009, J IMMUNOL, V183, P6296, DOI 10.4049/jimmunol.0900613; O'Neil-Andersen NJ, 2002, CLIN DIAGN LAB IMMUN, V9, P243, DOI 10.1128/CDLI.9.2.243-250.2001; Park JH, 1999, AM J PHYSIOL-CELL PH, V277, pC1066, DOI 10.1152/ajpcell.1999.277.6.C1066; Peers C, 2004, CELL CALCIUM, V36, P341, DOI 10.1016/j.ceca.2004.02.005; Presley JF, 1997, J BIOL CHEM, V272, P13929, DOI 10.1074/jbc.272.21.13929; Progida C, 2010, J CELL SCI, V123, P1480, DOI 10.1242/jcs.051474; Pucadyil TJ, 2009, SCIENCE, V325, P1217, DOI 10.1126/science.1171004; Ren QG, 2009, J MOL NEUROSCI, V38, P57, DOI 10.1007/s12031-008-9161-8; Robbins JR, 2005, J PHYSIOL-LONDON, V564, P131, DOI 10.1113/jphysiol.2004.081893; Roche PA, 1999, IMMUNITY, V11, P391, DOI 10.1016/S1074-7613(00)80114-4; Rodriguez-Boulan E, 2005, BBA-MOL CELL RES, V1744, P455, DOI 10.1016/j.bbamcr.2005.04.007; Schneider-Poetsch T, 2010, NAT CHEM BIOL, V6, P209, DOI 10.1038/NCHEMBIO.304; Sole L, 2009, J CELL SCI, V122, P3738, DOI 10.1242/jcs.056689; Steele DF, 2007, J PHYSIOL-LONDON, V582, P17, DOI 10.1113/jphysiol.2007.130245; Szigligeti P, 2006, J PHYSIOL-LONDON, V573, P357, DOI 10.1113/jphysiol.2006.109967; Traub LM, 2010, NATURE, V465, P556, DOI 10.1038/465556a; Traub LM, 2005, BBA-MOL CELL RES, V1744, P415, DOI 10.1016/j.bbamcr.2005.04.005; Vanoye CG, 2010, CHANNELS, V4, P108, DOI 10.4161/chan.4.2.11141; Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501; Yoon SO, 2005, CANCER RES, V65, P2761, DOI 10.1158/0008-5472.CAN-04-4122; Yotnda P, 2010, METHODS MOL BIOL, V651, P1, DOI 10.1007/978-1-60761-786-0_1; Zaal KJM, 1999, CELL, V99, P589, DOI 10.1016/S0092-8674(00)81548-2; Zadeh AD, 2008, J PHYSIOL-LONDON, V586, P4793, DOI 10.1113/jphysiol.2008.161570; Zinchuk V, 2007, ACTA HISTOCHEM CYTOC, V40, P101, DOI 10.1267/ahc.07002	65	27	28	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					2055	2067		10.1074/jbc.M111.274209	http://dx.doi.org/10.1074/jbc.M111.274209			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22134923	hybrid, Green Published			2022-12-27	WOS:000299321000046
J	Pullen, NA; Barnstein, BO; Falanga, YT; Wang, ZQ; Suzuki, R; Tamang, TDL; Khurana, MC; Harry, EA; Draber, P; Bunting, KD; Mizuno, K; Wilson, BS; Ryan, JJ				Pullen, Nicholas A.; Barnstein, Brian O.; Falanga, Yves T.; Wang, Zhengqi; Suzuki, Ryo; Tamang, Tenchee D. Lama; Khurana, Michele C.; Harry, Emily A.; Draber, Petr; Bunting, Kevin D.; Mizuno, Kazuya; Wilson, Bridget S.; Ryan, John J.			Novel Mechanism for Fc epsilon RI-mediated Signal Transducer and Activator of Transcription 5 (STAT5) Tyrosine Phosphorylation and the Selective Influence of STAT5B over Mast Cell Cytokine Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALLERGIC RESPONSES; PROLIFERATION; EXPRESSION; SURVIVAL; DOMAINS; PATHWAY; ASTHMA; KINASE; GAB2; DEGRANULATION	Previous studies indicate that STAT5 expression is required for mast cell development, survival, and IgE-mediated function. STAT5 tyrosine phosphorylation is swiftly and transiently induced by activation of the high affinity IgE receptor, Fc epsilon RI. However, the mechanism for this mode of activation remains unknown. In this study we observed that STAT5 co-localizes with Fc epsilon RI in antigen-stimulated mast cells. This localization was supported by cholesterol depletion of membranes, which ablated STAT5 tyrosine phosphorylation. Through the use of various pharmacological inhibitors and murine knock-out models, we found that IgE-mediated STAT5 activation is dependent upon Fyn kinase, independent of Syk, PI3K, Akt, Bruton's tyrosine kinase, and JAK2, and enhanced in the context of Lyn kinase deficiency. STAT5 immunoprecipitation revealed that unphosphorylated protein preassociates with Fyn and that this association diminishes significantly during mast cell activation. SHP-1 tyrosine phosphatase deficiency modestly enhanced STAT5 phosphorylation. This effect was more apparent in the absence of Gab2, a scaffolding protein that docks with multiple negative regulators, including SHP-1, SHP-2, and Lyn. Targeting of STAT5A or B with specific siRNA pools revealed that IgE-mediated mast cell cytokine production is selectively dependent upon the STAT5B isoform. Altogether, these data implicate Fyn as the major positive mediator of STAT5 after Fc epsilon RI engagement and demonstrate importantly distinct roles for STAT5A and STAT5B in mast cell function.	[Pullen, Nicholas A.; Barnstein, Brian O.; Falanga, Yves T.; Tamang, Tenchee D. Lama; Khurana, Michele C.; Harry, Emily A.; Ryan, John J.] Virginia Commonwealth Univ, Dept Biol, Richmond, VA 23284 USA; [Pullen, Nicholas A.; Barnstein, Brian O.; Falanga, Yves T.; Tamang, Tenchee D. Lama; Khurana, Michele C.; Harry, Emily A.; Ryan, John J.] Virginia Commonwealth Univ, Asthma & Allerg Dis Cooperat Res Ctr, Richmond, VA 23284 USA; [Wang, Zhengqi; Bunting, Kevin D.] Emory Univ, Aflac Canc Ctr Childrens Healthcare Atlanta, Atlanta, GA 30345 USA; [Wang, Zhengqi; Bunting, Kevin D.] Emory Univ, Dept Pediat, Atlanta, GA 30345 USA; [Suzuki, Ryo] NIAMS, Immunogenet Mol Lab, NIH, Bethesda, MD 20892 USA; [Draber, Petr] Acad Sci Czech Republic, Dept Signal Transduct, Inst Mol Genet, Prague 4, Czech Republic; [Mizuno, Kazuya] Tokyo Metropolitan Org Med Res, Tokyo Metropolitan Inst Neurosci, Tokyo 1838526, Japan; [Wilson, Bridget S.] Univ New Mexico, Dept Pathol, Hlth Sci Ctr, Albuquerque, NM 87131 USA	Virginia Commonwealth University; Virginia Commonwealth University; Children's Healthcare of Atlanta (CHOA); Emory University; Emory University; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Tokyo Metropolitan Institute for Neuroscience; Tokyo Metropolitan Institute of Medical Science; University of New Mexico; University of New Mexico's Health Sciences Center	Ryan, JJ (corresponding author), Virginia Commonwealth Univ, Dept Biol, 1000 W Cary St, Richmond, VA 23284 USA.	jjryan@vcu.edu	Draber, Petr/E-1119-2018; Pullen, Nicholas/X-3294-2019; Draber, Petr/G-3412-2014	Draber, Petr/0000-0002-3986-2025; Pullen, Nicholas/0000-0002-4014-9278; Draber, Petr/0000-0002-3986-2025	National Institutes of Health [1R01 AI59638, R01DK059380, AI051575, GM065794]; Virginia Commonwealth University [U19A1077435]; Ministry of Education, Youth and Sports of the Czech Republic [1M0506]; Grant Agency of the Czech Republic [P302/10/1759, 301/09/1826]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059638, R01AI051575] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059380] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM093857, F32GM065794] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Virginia Commonwealth University; Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R01 AI59638 (to J. R.), R01DK059380 (to K. D. B.), and AI051575 and GM065794 (to B. S. W.). This work was also supported by Virginia Commonwealth University Allergy Core Grant U19A1077435, Ministry of Education, Youth and Sports of the Czech Republic Project 1M0506 (to P. D.), and Grant Agency of the Czech Republic Grants P302/10/1759 and 301/09/1826 (to P. D.).	Andrews NL, 2008, NAT CELL BIOL, V10, P955, DOI 10.1038/ncb1755; Barbu EA, 2010, J BIOL CHEM, V285, P15761, DOI 10.1074/jbc.M110.109413; Barnstein BO, 2006, J IMMUNOL, V177, P3421, DOI 10.4049/jimmunol.177.5.3421; Benekli M, 2009, J CLIN ONCOL, V27, P4422, DOI 10.1200/JCO.2008.21.3264; Bunting KD, 2007, FRONT BIOSCI-LANDMRK, V12, P2807, DOI 10.2741/2274; Chaix A, 2011, J BIOL CHEM, V286, P5956, DOI 10.1074/jbc.M110.182642; Field KA, 2000, MOL BIOL CELL, V11, P3661, DOI 10.1091/mbc.11.10.3661; Friedbichler K, 2010, BLOOD, V116, P1548, DOI 10.1182/blood-2009-12-258913; Fuhlbrigge AL, 2002, AM J RESP CRIT CARE, V166, P1044, DOI 10.1164/rccm.2107057; Galli SJ, 2000, CURR OPIN HEMATOL, V7, P32, DOI 10.1097/00062752-200001000-00007; Galli SJ, 2008, NATURE, V454, P445, DOI 10.1038/nature07204; Gibson PG, 2010, LANCET, V376, P803, DOI 10.1016/S0140-6736(10)61087-2; Gomez G, 2005, J IMMUNOL, V175, P7602, DOI 10.4049/jimmunol.175.11.7602; Gotoh A, 1996, BLOOD, V88, P138; Grimley PM, 1999, CYTOKINE GROWTH F R, V10, P131, DOI 10.1016/S1359-6101(99)00011-8; HAASE P, 1995, J VEG SCI, V6, P575, DOI 10.2307/3236356; Harir N, 2007, BLOOD, V109, P1678, DOI 10.1182/blood-2006-01-029918; Hexner EO, 2008, BLOOD, V111, P5663, DOI 10.1182/blood-2007-04-083402; Ikeda K, 2005, INT ARCH ALLERGY IMM, V137, P45, DOI 10.1159/000085431; Iwaki S, 2007, INT J BIOCHEM CELL B, V39, P868, DOI 10.1016/j.biocel.2006.10.018; Kim HJ, 2009, P NATL ACAD SCI USA, V106, P2325, DOI 10.1073/pnas.0806963106; Kim MS, 2008, TRENDS IMMUNOL, V29, P493, DOI 10.1016/j.it.2008.07.004; Li GQ, 2010, BLOOD, V115, P1416, DOI 10.1182/blood-2009-07-234963; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; Morales JK, 2010, GENES IMMUN, V11, P599, DOI 10.1038/gene.2010.35; MUI ALF, 1995, EMBO J, V14, P1166, DOI 10.1002/j.1460-2075.1995.tb07100.x; Nakata K, 2011, MOL IMMUNOL, V48, P472, DOI 10.1016/j.molimm.2010.10.001; Nishida K, 2002, BLOOD, V99, P1866, DOI 10.1182/blood.V99.5.1866; Odom S, 2004, J EXP MED, V199, P1491, DOI 10.1084/jem.20040382; Parravicini V, 2002, NAT IMMUNOL, V3, P741, DOI 10.1038/ni817; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; Ryan JJ, 1997, EXP HEMATOL, V25, P357; Schindler C, 2007, J BIOL CHEM, V282, P20059, DOI 10.1074/jbc.R700016200; Setiadi H, 2008, BLOOD, V111, P1989, DOI 10.1182/blood-2007-09-113423; Shelburne CP, 2003, BLOOD, V102, P1290, DOI 10.1182/blood-2002-11-3490; Suzuki R, 2010, J LEUKOCYTE BIOL, V88, P863, DOI 10.1189/jlb.0510253; Wilson Bridget S., 2007, V398, P245, DOI 10.1007/978-1-59745-513-8_17; Wilson BS, 2004, MOL BIOL CELL, V15, P2580, DOI 10.1091/mbc.E03-08-0574; Xue M, 2007, MOL BIOL CELL, V18, P1410, DOI 10.1091/mbc.E05-11-1073; Yamashita Y, 2007, J IMMUNOL, V179, P740, DOI 10.4049/jimmunol.179.2.740; Yao ZJ, 2006, P NATL ACAD SCI USA, V103, P1000, DOI 10.1073/pnas.0507350103; Yu WM, 2002, BLOOD, V99, P2351, DOI 10.1182/blood.V99.7.2351; Zhang Y, 2007, BLOOD, V110, P116, DOI 10.1182/blood-2006-11-060707	43	30	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					2045	2054		10.1074/jbc.M111.311142	http://dx.doi.org/10.1074/jbc.M111.311142			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22130676	Green Published, hybrid			2022-12-27	WOS:000299321000045
J	Hitomi, K; Arvai, AS; Yamamoto, J; Hitomi, C; Teranishi, M; Hirouchi, T; Yamamoto, K; Iwai, S; Tainer, JA; Hidema, J; Getzoff, ED				Hitomi, Kenichi; Arvai, Andrew S.; Yamamoto, Junpei; Hitomi, Chiharu; Teranishi, Mika; Hirouchi, Tokuhisa; Yamamoto, Kazuo; Iwai, Shigenori; Tainer, John A.; Hidema, Jun; Getzoff, Elizabeth D.			Eukaryotic Class II Cyclobutane Pyrimidine Dimer Photolyase Structure Reveals Basis for Improved Ultraviolet Tolerance in Plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI DNA PHOTOLYASE; CRYSTAL-STRUCTURE; DAMAGE RECOGNITION; REPAIR; GENE; PHOTOREPAIR; REMOVAL; PROTEIN; CLONING; RICE	Ozone depletion increases terrestrial solar ultraviolet B (UV-B; 280-315 nm) radiation, intensifying the risks plants face from DNA damage, especially covalent cyclobutane pyrimidine dimers (CPD). Without efficient repair, UV-B destroys genetic integrity, but plant breeding creates rice cultivars with more robust photolyase (PHR) DNA repair activity as an environmental adaptation. So improved strains of Oryza sativa (rice), the staple food for Asia, have expanded rice cultivation worldwide. Efficient light-driven PHR enzymes restore normal pyrimidines to UV-damaged DNA by using blue light via flavin adenine dinucleotide to break pyrimidine dimers. Eukaryotes duplicated the photolyase gene, producing PHRs that gained functions and adopted activities that are distinct from those of prokaryotic PHRs yet are incompletely understood. Many multicellular organisms have two types of PHR: (6-4) PHR, which structurally resembles bacterial CPD PHRs but recognizes different substrates, and Class II CPD PHR, which is remarkably dissimilar in sequence from bacterial PHRs despite their common substrate. To understand the enigmatic DNA repair mechanisms of PHRs in eukaryotic cells, we determined the first crystal structure of a eukaryotic Class II CPD PHR from the rice cultivar Sasanishiki. Our 1.7 angstrom resolution PHR structure reveals structure-activity relationships in Class II PHRs and tuning for enhanced UV tolerance in plants. Structural comparisons with prokaryotic Class I CPD PHRs identified differences in the binding site for UV-damaged DNA substrate. Convergent evolution of both flavin hydrogen bonding and a Trp electron transfer pathway establish these as critical functional features for PHRs. These results provide a paradigm for light-dependent DNA repair in higher organisms.	[Hitomi, Kenichi; Yamamoto, Junpei; Iwai, Shigenori] Osaka Univ, Grad Sch Engn Sci, Toyonaka, Osaka 5608531, Japan; [Hitomi, Kenichi; Arvai, Andrew S.; Hitomi, Chiharu; Tainer, John A.; Getzoff, Elizabeth D.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Hitomi, Kenichi; Arvai, Andrew S.; Hitomi, Chiharu; Tainer, John A.; Getzoff, Elizabeth D.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Hitomi, Kenichi; Tainer, John A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [Hitomi, Kenichi] Natl Inst Biomed Innovat, Sect Lab Equipment, Osaka 5670085, Japan; [Teranishi, Mika; Hirouchi, Tokuhisa; Yamamoto, Kazuo; Hidema, Jun] Tohoku Univ, Grad Sch Life Sci, Aoba Ku, Sendai, Miyagi 9808577, Japan	Osaka University; Scripps Research Institute; Scripps Research Institute; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; National Institute of Health Sciences - Japan; Tohoku University	Getzoff, ED (corresponding author), 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	edg@scripps.edu	Tainer, John/GWQ-4878-2022; Hidema, Jun/AAH-5124-2019	Tainer, John/0000-0003-1659-2429; 	National Institutes of Health [GM37684, GM046312]; Japan Society for the Promotion of Science; Skaggs Institute for Chemical Biology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046312, R01GM037684] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [21780294, 21380205] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Skaggs Institute for Chemical Biology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	* This work was supported, in whole or in part, by National Institutes of Health Grants. GM37684 (to E. D. G.) and in part by Grant GM046312 (to J. A. T.).; <SUP>1</SUP> Supported in part by Japan Society for the Promotion of Science Fellowship and The Skaggs Institute for Chemical Biology.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ahmad M, 1997, PLANT CELL, V9, P199, DOI 10.1105/tpc.9.2.199; Biskup T, 2009, ANGEW CHEM INT EDIT, V48, P404, DOI 10.1002/anie.200803102; Brudler R, 2003, MOL CELL, V11, P59, DOI 10.1016/S1097-2765(03)00008-X; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Christine KS, 2002, J BIOL CHEM, V277, P38339, DOI 10.1074/jbc.M206531200; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fan L, 2008, CELL, V133, P789, DOI 10.1016/j.cell.2008.04.030; Friedberg EC, 2005, DNA REPAIR MUTAGENES; Fuss JO, 2011, DNA REPAIR, V10, P697, DOI 10.1016/j.dnarep.2011.04.028; Hidema J, 2005, PLANT J, V43, P57, DOI 10.1111/j.1365-313X.2005.02428.x; Hidema J, 2000, PLANT CELL, V12, P1569, DOI 10.1105/tpc.12.9.1569; Hidema J, 2007, PLANT J, V50, P70, DOI 10.1111/j.1365-313X.2007.03041.x; Hitomi K, 2001, J BIOL CHEM, V276, P10103, DOI 10.1074/jbc.M008828200; Hitomi K, 1997, J BIOL CHEM, V272, P32591, DOI 10.1074/jbc.272.51.32591; Hitomi K, 2007, DNA REPAIR, V6, P410, DOI 10.1016/j.dnarep.2006.10.004; Hitomi K, 2009, P NATL ACAD SCI USA, V106, P6962, DOI 10.1073/pnas.0809180106; Huffman JL, 2005, MUTAT RES-FUND MOL M, V577, P55, DOI 10.1016/j.mrfmmm.2005.03.012; Iwamatsu Y, 2008, PHOTOCH PHOTOBIO SCI, V7, P311, DOI 10.1039/b719034d; Iwata T, 2010, BIOCHEMISTRY-US, V49, P8882, DOI 10.1021/bi1009979; Jiang CZ, 1997, P NATL ACAD SCI USA, V94, P7441, DOI 10.1073/pnas.94.14.7441; Kanai S, 1997, J MOL EVOL, V45, P535, DOI 10.1007/PL00006258; KATO T, 1994, NUCLEIC ACIDS RES, V22, P4119, DOI 10.1093/nar/22.20.4119; KIM ST, 1992, P NATL ACAD SCI USA, V89, P900, DOI 10.1073/pnas.89.3.900; Kondoh M, 2011, J AM CHEM SOC, V133, P2183, DOI 10.1021/ja107691w; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Maul MJ, 2008, ANGEW CHEM INT EDIT, V47, P10076, DOI 10.1002/anie.200804268; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Miyazawa Y, 2008, BIOPHYS J, V94, P2194, DOI 10.1529/biophysj.107.119248; Nakajima S, 1998, NUCLEIC ACIDS RES, V26, P638, DOI 10.1093/nar/26.2.638; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Okafuji A, 2010, DNA REPAIR, V9, P495, DOI 10.1016/j.dnarep.2010.01.014; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PARK HW, 1995, SCIENCE, V268, P1866, DOI 10.1126/science.7604260; Pellequer JL, 1998, P NATL ACAD SCI USA, V95, P5884, DOI 10.1073/pnas.95.11.5884; Roussel A., 1989, TURBO FRODO; Tamada T, 1997, NAT STRUCT BIOL, V4, P887, DOI 10.1038/nsb1197-887; Teranishi M, 2008, PLANT PHYSIOL, V146, P1941, DOI 10.1104/pp.107.110189; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Tubbs JL, 2009, NATURE, V459, P808, DOI 10.1038/nature08076; Xu L, 2008, BIOCHEMISTRY-US, V47, P8736, DOI 10.1021/bi800391j; Yamamoto J, 2006, NUCLEIC ACIDS RES, V34, P4406, DOI 10.1093/nar/gkl572; YASUI A, 1994, EMBO J, V13, P6143, DOI 10.1002/j.1460-2075.1994.tb06961.x	44	26	29	0	22	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12060	12069		10.1074/jbc.M111.244020	http://dx.doi.org/10.1074/jbc.M111.244020			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22170053	Green Published, hybrid			2022-12-27	WOS:000302782200043
J	Tan, SX; Ng, Y; Meoli, CC; Kumar, A; Khoo, PS; Fazakerley, DJ; Junutula, JR; Vali, S; James, DE; Stockli, J				Tan, Shi-Xiong; Ng, Yvonne; Meoli, Christopher C.; Kumar, Ansu; Khoo, Poh-Sim; Fazakerley, Daniel J.; Junutula, Jagath R.; Vali, Shireen; James, David E.; Stoeckli, Jacqueline			Amplification and Demultiplexing in Insulin-regulated Akt Protein Kinase Pathway in Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3T3-L1 ADIPOCYTES; RECEPTOR SUBSTRATE-1; GLUT4 TRANSLOCATION; GLUCOSE-TRANSPORT; RAPAMYCIN PATHWAY; PLASMA-MEMBRANE; MICE LACKING; PHOSPHORYLATION; ACTIVATION; RESISTANCE	Akt plays a major role in insulin regulation of metabolism in muscle, fat, and liver. Here, we show that in 3T3-L1 adipocytes, Akt operates optimally over a limited dynamic range. This indicates that Akt is a highly sensitive amplification step in the pathway. With robust insulin stimulation, substantial changes in Akt phosphorylation using either pharmacologic or genetic manipulations had relatively little effect on Akt activity. By integrating these data we observed that half-maximal Akt activity was achieved at a threshold level of Akt phosphorylation corresponding to 5-22% of its full dynamic range. This behavior was also associated with lack of concordance or demultiplexing in the behavior of downstream components. Most notably, FoxO1 phosphorylation was more sensitive to insulin and did not exhibit a change in its rate of phosphorylation between 1 and 100 nM insulin compared with other substrates (AS160, TSC2, GSK3). Similar differences were observed between various insulin-regulated pathways such as GLUT4 translocation and protein synthesis. These data indicate that Akt itself is a major amplification switch in the insulin signaling pathway and that features of the pathway enable the insulin signal to be split or demultiplexed into discrete outputs. This has important implications for the role of this pathway in disease.	[Tan, Shi-Xiong; Ng, Yvonne; Meoli, Christopher C.; Fazakerley, Daniel J.; James, David E.; Stoeckli, Jacqueline] St Vincents Hosp, Garvan Inst Med Res, Diabet & Obes Res Program, Sydney, NSW 2010, Australia; [James, David E.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2050, Australia; [Kumar, Ansu; Vali, Shireen] Cellworks Grp Inc, Saratoga, CA 95070 USA; [Khoo, Poh-Sim; Junutula, Jagath R.] Genentech Inc, San Francisco, CA 94080 USA	Garvan Institute of Medical Research; St Vincents Hospital Sydney; University of New South Wales Sydney; Roche Holding; Genentech	James, DE (corresponding author), St Vincents Hosp, Garvan Inst Med Res, Diabet & Obes Res Program, 384 Victoria St, Sydney, NSW 2010, Australia.	d.james@garvan.org.au	Stoeckli, Jacqueline/D-7053-2016; Fazakerley, Daniel/J-2652-2019; Stoeckli, Jacqueline/Z-4443-2019; Tan, Shi-Xiong/Y-3728-2019; Junutula, Jagath Reddy/ABD-4753-2020	Stoeckli, Jacqueline/0000-0002-6446-7350; Fazakerley, Daniel/0000-0001-8241-2903; Stoeckli, Jacqueline/0000-0002-6446-7350; Junutula, Jagath Reddy/0000-0002-5942-4428; Tan, Shi-Xiong/0000-0002-0020-2572; James, David/0000-0001-5946-5257	National Health and Medical Research Council of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by grants from the National Health and Medical Research Council of Australia.	Alessi DR, 1998, BBA-MOL CELL BIOL L, V1436, P151, DOI 10.1016/S0005-2760(98)00133-7; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Brandman O, 2005, SCIENCE, V310, P496, DOI 10.1126/science.1113834; CHANEY LK, 1983, J BIOL CHEM, V258, P62; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Cirstea D, 2010, MOL CANCER THER, V9, P963, DOI 10.1158/1535-7163.MCT-09-0763; Currie RA, 1999, BIOCHEM J, V337, P575, DOI 10.1042/0264-6021:3370575; DeFeo-Jones D, 2005, MOL CANCER THER, V4, P271; Dibble CC, 2009, MOL CELL BIOL, V29, P5657, DOI 10.1128/MCB.00735-09; Dummler B, 2006, MOL CELL BIOL, V26, P8042, DOI 10.1128/MCB.00722-06; Foukas LC, 2006, NATURE, V441, P366, DOI 10.1038/nature04694; Gonzalez E, 2009, CELL CYCLE, V8, P2502, DOI 10.4161/cc.8.16.9335; Gonzalez E, 2009, P NATL ACAD SCI USA, V106, P7004, DOI 10.1073/pnas.0901933106; Govers R, 2004, MOL CELL BIOL, V24, P6456, DOI 10.1128/MCB.24.14.6456-6466.2004; Haruta T, 2000, MOL ENDOCRINOL, V14, P783, DOI 10.1210/me.14.6.783; Hoehn KL, 2008, CELL METAB, V7, P421, DOI 10.1016/j.cmet.2008.04.005; Huang JX, 2009, BIOCHEM SOC T, V37, P217, DOI 10.1042/BST0370217; Jiang ZY, 2003, P NATL ACAD SCI USA, V100, P7569, DOI 10.1073/pnas.1332633100; KAHN CR, 1978, METABOLISM, V27, P1893; Katome T, 2003, J BIOL CHEM, V278, P28312, DOI 10.1074/jbc.M302094200; Kazi AA, 2010, MOL MED, V16, P359, DOI 10.2119/molmed.2009.00168; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; KOSHLAND DE, 1982, SCIENCE, V217, P220, DOI 10.1126/science.7089556; Larance M, 2005, J BIOL CHEM, V280, P37803, DOI 10.1074/jbc.M503897200; Mak DOD, 1998, P NATL ACAD SCI USA, V95, P15821, DOI 10.1073/pnas.95.26.15821; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Ng Y, 2008, CELL METAB, V7, P348, DOI 10.1016/j.cmet.2008.02.008; Ng Y, 2010, J BIOL CHEM, V285, P2255, DOI 10.1074/jbc.M109.060236; ORAHILLY S, 1988, NEW ENGL J MED, V318, P1225, DOI 10.1056/NEJM198805123181902; RICE KM, 1993, BIOCHEM BIOPH RES CO, V190, P961, DOI 10.1006/bbrc.1993.1143; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shanmugam MK, 2011, J MOL MED, V89, P713, DOI 10.1007/s00109-011-0746-2; Takano T, 2001, MOL CELL BIOL, V21, P5050, DOI 10.1128/MCB.21.15.5050-5062.2001; Tan SX, 2010, BIOCHEM J, V432, P191, DOI 10.1042/BJ20100750; Tan SX, 2011, BIOCHEM J, V435, P539, DOI 10.1042/BJ20110040; Tellam JT, 1997, J BIOL CHEM, V272, P6179, DOI 10.1074/jbc.272.10.6179; Tremblay F, 2005, ENDOCRINOLOGY, V146, P1328, DOI 10.1210/en.2004-0777; Tzatsos A, 2006, MOL CELL BIOL, V26, P63, DOI 10.1128/MCB.26.1.63-76.2006; Vali Shireen, 2010, Syst Synth Biol, V4, P25, DOI 10.1007/s11693-009-9046-3; Wang LF, 2007, J BIOL CHEM, V282, P20036, DOI 10.1074/jbc.M702376200; Whitehead JP, 2001, J BIOL CHEM, V276, P27816, DOI 10.1074/jbc.M011590200; Whiteman EL, 2002, TRENDS ENDOCRIN MET, V13, P444, DOI 10.1016/S1043-2760(02)00662-8	44	54	55	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6128	6138		10.1074/jbc.M111.318238	http://dx.doi.org/10.1074/jbc.M111.318238			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22207758	Green Published, hybrid			2022-12-27	WOS:000300791800006
J	Yang, J; Wang, Q; Zheng, W; Tuli, J; Li, Q; Wu, Y; Hussein, S; Dai, XQ; Shafiei, S; Li, XG; Shen, PY; Tu, JC; Chen, XZ				Yang, Jungwoo; Wang, Qian; Zheng, Wang; Tuli, Jagdeep; Li, Qiang; Wu, Yuliang; Hussein, Shaimaa; Dai, Xiao-Qing; Shafiei, Shiva; Li, Xiao-Gai; Shen, Patrick Y.; Tu, Jian-Cheng; Chen, Xing-Zhen			Receptor for Activated C Kinase 1 (RACK1) Inhibits Function of Transient Receptor Potential (TRP)-type Channel Pkd2L1 through Physical Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYCYSTIC KIDNEY-DISEASE; TRPP3 CHANNEL; BETA-SUBUNIT; SCAFFOLDING PROTEIN; TASTE RECEPTOR; CA2+ RELEASE; ION CHANNELS; TROPONIN-I; PKD1L3; CELLS	Pkd2L1 (also called TRPP3) is a non-selective cation channel permeable to Ca2+, Na+, and K+ and is activated by Ca2+. It is also part of an acid-triggered off-response cation channel complex. We previously reported roles of the Pkd2L1 C-terminal fragments in its channel function, but the role of the N terminus remains unclear. Using a yeast two-hybrid screening, we found that the Pkd2L1 N terminus interacts with the receptor for activated C kinase 1 (RACK1), a scaffolding/anchoring protein implicated in various cellular functions. This interaction requires the last two Trp-Asp (WD) motifs of RACK1 and fragment Ala(19)-Pro(45) of Pkd2L1. The interaction was confirmed by GST pulldown, blot overlay, and co-immunoprecipitation assays. By Ca-45 tracer uptake and two-microelectrode voltage clamp electrophysiology, we found that in Xenopus oocytes with RACK1 overexpression Pkd2L1 channel activity is abolished or substantially reduced. Combining with oocyte surface biotinylation experiments, we demonstrated that RACK1 inhibits the function of Pkd2L1 channel on the plasma membrane in addition to reducing its total and plasma membrane expression. Overexpressing Pkd2L1 N- or C-terminal fragments as potential blocking peptides for the Pkd2L1-RACK1 interaction, we found that Pkd2L1 N- terminal fragment Met(1)-Pro(45), but not Ile(40)-Ile(97) or C-terminal fragments, abolishes the inhibition of Pkd2L1 channel by overexpressed and oocyte-native RACK1 likely through disrupting the Pkd2L1-RACK1 association. Taken together, our study demonstrated that RACK1 inhibits Pkd2L1 channel function through binding to domain Met(1)-Pro(45) of Pkd2L1. Thus, Pkd2L1 is a novel target channel whose function is regulated by the versatile scaffolding protein RACK1.	[Yang, Jungwoo; Wang, Qian; Zheng, Wang; Tuli, Jagdeep; Li, Qiang; Wu, Yuliang; Hussein, Shaimaa; Dai, Xiao-Qing; Shafiei, Shiva; Shen, Patrick Y.; Chen, Xing-Zhen] Univ Alberta, Dept Physiol, Edmonton, AB T6G 2H7, Canada; [Li, Xiao-Gai; Tu, Jian-Cheng] Wuhan Univ, Zhongnan Hosp, Wuhan 430071, Peoples R China	University of Alberta; Wuhan University	Chen, XZ (corresponding author), Univ Alberta, Dept Physiol, 7-29 Med Sci Bldg, Edmonton, AB T6G 2H7, Canada.	xzchen@ualberta.ca	Hussein, Shaimaa/HHZ-5533-2022	Hussein, Shaimaa/0000-0003-0849-9670	Canadian Institutes of Health Research; Alberta Innovates Health Solutions; Kidney Foundation of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates Health Solutions; Kidney Foundation of Canada	This work was supported by the Canadian Institutes of Health Research, the Alberta Innovates Health Solutions, and the Kidney Foundation of Canada (to X.-Z.C.).	Bandyopadhyay BC, 2008, J BIOL CHEM, V283, P32821, DOI 10.1074/jbc.M805382200; Basora N, 2002, J AM SOC NEPHROL, V13, P293, DOI 10.1681/ASN.V132293; Brandon NJ, 2002, J NEUROSCI, V22, P6353; Bui-Xuan EF, 2006, AM J PHYSIOL-RENAL, V291, pF395, DOI 10.1152/ajprenal.00282.2005; Cao G, 2008, CURR OPIN NEPHROL HY, V17, P373, DOI 10.1097/MNH.0b013e328303e184; Ceci M, 2003, NATURE, V426, P579, DOI 10.1038/nature02160; Chandrashekar J, 2009, SCIENCE, V326, P443, DOI 10.1126/science.1174601; Chang BY, 1998, MOL CELL BIOL, V18, P3245, DOI 10.1128/MCB.18.6.3245; Chang BY, 2002, ONCOGENE, V21, P7619, DOI 10.1038/sj.onc.1206002; Chang RB, 2010, P NATL ACAD SCI USA, V107, P22320, DOI 10.1073/pnas.1013664107; Chen XZ, 1999, NATURE, V401, P383, DOI 10.1038/43907; Dai XQ, 2007, MOL PHARMACOL, V72, P1576, DOI 10.1124/mol.107.037150; Dai XQ, 2006, BBA-BIOMEMBRANES, V1758, P197, DOI 10.1016/j.bbamem.2006.01.020; Horio N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020007; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; Huque T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007347; Inada H, 2008, EMBO REP, V9, P690, DOI 10.1038/embor.2008.89; Ishimaru Y, 2006, P NATL ACAD SCI USA, V103, P12569, DOI 10.1073/pnas.0602702103; Ishimaru Y, 2010, FASEB J, V24, P4058, DOI 10.1096/fj.10-162925; Koulen P, 2002, NAT CELL BIOL, V4, P191, DOI 10.1038/ncb754; Li Q, 2005, HUM MOL GENET, V14, P1587, DOI 10.1093/hmg/ddi167; Li Q, 2003, BIOCHEMISTRY-US, V42, P7618, DOI 10.1021/bi034210a; Li Q, 2003, J MOL BIOL, V325, P949, DOI 10.1016/S0022-2836(02)01333-5; Li Q, 2003, BIOCHEMISTRY-US, V42, P450, DOI 10.1021/bi0267792; Li Q, 2002, FEBS LETT, V516, P270, DOI 10.1016/S0014-5793(02)02513-9; Li Q, 2007, J NEUROCHEM, V103, P2391, DOI 10.1111/j.1471-4159.2007.04940.x; Li SD, 2011, P NATL ACAD SCI USA, V108, P2264, DOI 10.1073/pnas.1013170108; Liliental J, 1998, J BIOL CHEM, V273, P2379, DOI 10.1074/jbc.273.4.2379; Liu Y, 2002, FEBS LETT, V525, P71, DOI 10.1016/S0014-5793(02)03071-5; LopezJimenez ND, 2006, J NEUROCHEM, V98, P68, DOI 10.1111/j.1471-4159.2006.03842.x; Lorenz L, 1996, P NATL ACAD SCI USA, V93, P13362, DOI 10.1073/pnas.93.23.13362; McCahill A, 2002, MOL PHARMACOL, V62, P1261, DOI 10.1124/mol.62.6.1261; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Mourton T, 2001, J BIOL CHEM, V276, P14896, DOI 10.1074/jbc.M010823200; Murakami M, 2005, J BIOL CHEM, V280, P5626, DOI 10.1074/jbc.M411496200; Nelson TM, 2010, CHEM SENSES, V35, P565, DOI 10.1093/chemse/bjq070; Nilsson J, 2004, EMBO REP, V5, P1137, DOI 10.1038/sj.embor.7400291; Nomura H, 1998, J BIOL CHEM, V273, P25967, DOI 10.1074/jbc.273.40.25967; Parent A, 2008, TRAFFIC, V9, P394, DOI 10.1111/j.1600-0854.2007.00692.x; Patterson RL, 2004, P NATL ACAD SCI USA, V101, P2328, DOI 10.1073/pnas.0308567100; Robles MS, 2010, SCIENCE, V327, P463, DOI 10.1126/science.1180067; Ron D, 2004, NEUROSCIENTIST, V10, P325, DOI 10.1177/1073858404263516; RON D, 1994, P NATL ACAD SCI USA, V91, P839, DOI 10.1073/pnas.91.3.839; Schechtman D, 2001, ONCOGENE, V20, P6339, DOI 10.1038/sj.onc.1204778; Shimizu T, 2009, PFLUG ARCH EUR J PHY, V457, P795, DOI 10.1007/s00424-008-0558-6; Sklan EH, 2006, PROG NEUROBIOL, V78, P117, DOI 10.1016/j.pneurobio.2005.12.002; Usacheva A, 2001, J BIOL CHEM, V276, P22948, DOI 10.1074/jbc.M100087200; Vassilev PM, 2001, BIOCHEM BIOPH RES CO, V282, P341, DOI 10.1006/bbrc.2001.4554; Yaka R, 2002, P NATL ACAD SCI USA, V99, P5710, DOI 10.1073/pnas.062046299; Yarwood SJ, 1999, J BIOL CHEM, V274, P14909, DOI 10.1074/jbc.274.21.14909	50	18	21	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6551	6561		10.1074/jbc.M111.305854	http://dx.doi.org/10.1074/jbc.M111.305854			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22174419	Green Published, hybrid			2022-12-27	WOS:000300791800043
J	Jang, Y; Jung, J; Kim, H; Oh, J; Jeon, JH; Jung, S; Kim, KT; Cho, H; Yang, DJ; Kim, SM; Kim, IB; Song, MR; Oh, U				Jang, Yongwoo; Jung, Jooyoung; Kim, Hyungsup; Oh, Jungeun; Jeon, Ji Hyun; Jung, Saewoon; Kim, Kyung-Tai; Cho, Hawon; Yang, Dong-Jin; Kim, Sung Min; Kim, In-Beom; Song, Mi-Ryoung; Oh, Uhtaek			Axonal Neuropathy-associated TRPV4 Regulates Neurotrophic Factor-derived Axonal Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MARIE-TOOTH DISEASE; CATION CHANNEL TRPV4; CYCLIC-AMP; NEURITE OUTGROWTH; NEURONS; MUTATIONS; MICE; ACTIVATION; CELLS; GENE	Spinal muscular atrophy and hereditary motor and sensory neuropathies are characterized by muscle weakness and atrophy caused by the degenerations of peripheral motor and sensory nerves. Recent advances in genetics have resulted in the identification of missense mutations in TRPV4 in patients with these hereditary neuropathies. Neurodegeneration caused by Ca2+ overload due to the gain-of-function mutation of TRPV4 was suggested as the molecular mechanism for the neuropathies. Despite the importance of TRPV4 mutations in causing neuropathies, the precise role of TRPV4 in the sensory/motor neurons is unknown. Here, we report that TRPV4 mediates neurotrophic factor-derived neuritogenesis in developing peripheral neurons. TRPV4 was found to be highly expressed in sensory and spinal motor neurons in early development as well as in the adult, and the overexpression or chemical activation of TRPV4 was found to promote neuritogenesis in sensory neurons as well as PC12 cells, whereas its knockdown and pharmacologic inhibition had the opposite effect. More importantly, nerve growth factor or cAMP treatment up-regulated the expression of phospholipase A(2) and TRPV4. Neurotrophic factor-derived neuritogenesis appears to be regulated by the phospholipase A(2)-mediated TRPV4 pathway. These findings show that TRPV4 mediates neurotrophic factor-induced neuritogenesis in developing peripheral nerves. Because neurotrophic factors are essential for the maintenance of peripheral nerves, these findings suggest that aberrant TRPV4 activity may lead to some types of pathology of sensory and motor nerves.	[Jang, Yongwoo; Jung, Jooyoung; Kim, Hyungsup; Jung, Saewoon; Cho, Hawon; Oh, Uhtaek] Seoul Natl Univ, Sensory Res Ctr, Coll Pharm, Seoul 151742, South Korea; [Oh, Jungeun; Yang, Dong-Jin; Oh, Uhtaek] Seoul Natl Univ, Dept Mol Med & Biopharmaceut Sci, Grad Sch Convergence Sci & Technol, Seoul 151742, South Korea; [Kim, Sung Min] Hanyang Univ, Coll Phys Educ, Seoul 133791, South Korea; [Jeon, Ji Hyun; Kim, In-Beom] Catholic Univ Korea, Dept Anat, Coll Med, Seoul 137701, South Korea; [Kim, Kyung-Tai; Song, Mi-Ryoung] Gwangju Inst Sci & Technol, Sch Life Sci, Bioimaging Res Ctr, Kwangju 500712, South Korea; [Kim, Kyung-Tai; Song, Mi-Ryoung] Gwangju Inst Sci & Technol, Cell Dynam Res Ctr, Kwangju 500712, South Korea	Seoul National University (SNU); Seoul National University (SNU); Hanyang University; Catholic University of Korea; Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST)	Oh, U (corresponding author), Seoul Natl Univ, Sensory Res Ctr, Coll Pharm, Seoul 151742, South Korea.	utoh@snu.ac.kr	Kim, In-Beom/A-6728-2011; Jang, Yongwoo/Y-9854-2018; KIM, SUNG MIN/U-5269-2017	Jang, Yongwoo/0000-0003-1574-9009; KIM, SUNG MIN/0000-0002-0590-9868; Kim, Kyung-Tai/0000-0001-7405-2258; Kim, Hyungsup/0000-0003-2008-198X	World Class University program; Creative Research Initiatives Program [20110018358]; Ministry of Education Science and Technology; National Research Foundation of Korea	World Class University program; Creative Research Initiatives Program; Ministry of Education Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by Grant R31-2008-000-10103-0 from the World Class University program and Creative Research Initiatives Program Grant 20110018358 of the Ministry of Education Science and Technology and the National Research Foundation of Korea.	Akiyama N, 2004, NEUROSCI LETT, V365, P218, DOI 10.1016/j.neulet.2004.05.001; Aloe L, 2000, AUTON NEUROSCI-BASIC, V86, P84, DOI 10.1016/S1566-0702(00)00247-2; Anand P, 2004, PROG BRAIN RES, V146, P477; Auer-Grumbach M, 2010, NAT GENET, V42, P160, DOI 10.1038/ng.508; AVILA MA, 1993, DEV BIOL, V159, P266, DOI 10.1006/dbio.1993.1239; Bai JZ, 2010, NEUROTOXICOLOGY, V31, P204, DOI 10.1016/j.neuro.2010.01.001; Benfenati V, 2007, NEUROSCIENCE, V148, P876, DOI 10.1016/j.neuroscience.2007.06.039; Berti C, 2006, NEUROMOL MED, V8, P191, DOI 10.1385/NMM:8:1:191; Cai D, 2001, J NEUROSCI, V21, P4731, DOI 10.1523/JNEUROSCI.21-13-04731.2001; Causing CG, 1997, NEURON, V18, P257, DOI 10.1016/S0896-6273(00)80266-4; CONNOLLY JL, 1979, J CELL BIOL, V82, P820, DOI 10.1083/jcb.82.3.820; Costantini LC, 2000, EXP NEUROL, V164, P60, DOI 10.1006/exnr.2000.7417; CROWLEY C, 1994, CELL, V76, P1001, DOI 10.1016/0092-8674(94)90378-6; Dehmelt L, 2003, J NEUROSCI, V23, P9479; DELONG R, 1992, ARCH NEUROL-CHICAGO, V49, P905, DOI 10.1001/archneur.1992.00530330027010; Deng HX, 2010, NAT GENET, V42, P165, DOI 10.1038/ng.509; Drew AP, 2011, CURR MOL MED, V11, P650; Everaerts W, 2010, P NATL ACAD SCI USA, V107, P19084, DOI 10.1073/pnas.1005333107; Everaerts W, 2010, PROG BIOPHYS MOL BIO, V103, P2, DOI 10.1016/j.pbiomolbio.2009.10.002; Fecto F, 2011, J BIOL CHEM, V286, P17281, DOI 10.1074/jbc.M111.237685; Fernyhough P, 2010, CELL CALCIUM, V47, P130, DOI 10.1016/j.ceca.2009.11.008; Gehler S, 2004, J NEUROSCI, V24, P10741, DOI 10.1523/JNEUROSCI.2836-04.2004; Glebova NO, 2004, J NEUROSCI, V24, P743, DOI 10.1523/JNEUROSCI.4523-03.2004; Granholm ACE, 1997, J NEUROSCI, V17, P1168; GU XN, 1994, J NEUROSCI, V14, P6325; Gupton SL, 2010, DEV CELL, V18, P725, DOI [10.1016/j.devcel.2010.02.017, 10.1016/j.devce1.2010.02.017]; Hansen TVO, 2000, J NEUROCHEM, V75, P1870, DOI 10.1046/j.1471-4159.2000.0751870.x; Herring TL, 1999, J MEMBRANE BIOL, V171, P151, DOI 10.1007/s002329900567; Hiltunen PH, 2004, MOL CELL NEUROSCI, V26, P450, DOI 10.1016/j.mcn.2004.04.003; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Indo Y, 1996, NAT GENET, V13, P485, DOI 10.1038/ng0896-485; Jin M, 2005, J NEUROSCI, V25, P2338, DOI 10.1523/JNEUROSCI.4889-04.2005; Lamande SR, 2011, NAT GENET, V43, P1142, DOI 10.1038/ng.945; Landoure G, 2010, NAT GENET, V42, P170, DOI 10.1038/ng.512; LARGE TH, 1986, SCIENCE, V234, P352, DOI 10.1126/science.3764415; LEVIMONTALCINI R, 1987, EMBO J, V6, P1145, DOI 10.1002/j.1460-2075.1987.tb02347.x; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P13698, DOI 10.1073/pnas.1735416100; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Lin CJ, 1995, J BIOMECH, V28, P1429, DOI 10.1016/0021-9290(95)00091-7; Parisiadou L, 2009, J NEUROSCI, V29, P13971, DOI 10.1523/JNEUROSCI.3799-09.2009; Pullikuth AK, 2007, CELL SIGNAL, V19, P1621, DOI 10.1016/j.cellsig.2007.04.012; Reilly MM, 2011, J PERIPHER NERV SYST, V16, P1, DOI 10.1111/j.1529-8027.2011.00324.x; Rock MJ, 2008, NAT GENET, V40, P999, DOI 10.1038/ng.166; RYDEL RE, 1988, P NATL ACAD SCI USA, V85, P1257, DOI 10.1073/pnas.85.4.1257; Shibasaki K, 2010, J NEUROSCI, V30, P4601, DOI 10.1523/JNEUROSCI.5830-09.2010; Shy ME, 2011, CURR OPIN NEUROL, V24, P475, DOI 10.1097/WCO.0b013e32834aa331; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Tang Z, 2005, PHYSIOL RES, V54, P671, DOI 10.33549/physiolres.930719; Thorneloe KS, 2008, J PHARMACOL EXP THER, V326, P432, DOI 10.1124/jpet.108.139295; Tian W, 2009, P NATL ACAD SCI USA, V106, P14034, DOI 10.1073/pnas.0904084106; Tojima T, 2003, BRAIN RES, V985, P43, DOI 10.1016/S0006-8993(03)03113-5; Tosaki T, 2008, EXP NEUROL, V213, P381, DOI 10.1016/j.expneurol.2008.06.017; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Vriens J, 2004, P NATL ACAD SCI USA, V101, P396, DOI 10.1073/pnas.0303329101; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; Watanabe H, 2002, J BIOL CHEM, V277, P13569, DOI 10.1074/jbc.M200062200; Yu WM, 2007, MOL NEUROBIOL, V35, P288, DOI 10.1007/s12035-007-0026-x; Zimon M, 2010, BRAIN, V133, P1798, DOI 10.1093/brain/awq109	58	41	43	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					6014	6024		10.1074/jbc.M111.316315	http://dx.doi.org/10.1074/jbc.M111.316315			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22187434	Green Published, hybrid			2022-12-27	WOS:000300638000074
J	Kon, N; Zhong, JY; Qiang, L; Accili, D; Gu, W				Kon, Ning; Zhong, Jiayun; Qiang, Li; Accili, Domenico; Gu, Wei			Inactivation of arf-bp1 Induces p53 Activation and Diabetic Phenotypes in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-PROTEIN LIGASE; TUMOR-SUPPRESSOR; EMBRYONIC LETHALITY; MDM2-DEFICIENT MICE; IN-VIVO; PROLIFERATION; DEGRADATION; STABILITY; HUWE1; MDM2	It is well accepted that the Mdm2 ubiquitin ligase acts as a major factor in controlling p53 stability and activity in vivo. Although several E3 ligases have been reported to be involved in Mdm2-independent p53 degradation, the roles of these ligases in p53 regulation in vivo remain largely unknown. To elucidate the physiological role of the ubiquitin ligase ARF-BP1, we generated arf-bp1 mutant mice. We found that inactivation of arf-bp1 during embryonic development in mice resulted in p53 activation and embryonic lethality, but the mice with arf-bp1 deletion specifically in the pancreatic beta-cells (arf-bp1(FL/Y)/RIP-cre) were viable and displayed no obvious abnormality after birth. Interestingly, these mice showed dramatic loss of beta-cells as mice aged, and >50% of these mice died of severe diabetic symptoms before reaching 1 year of age. Notably, the diabetic phenotype of these mice was largely reversed by concomitant deletion of p53, and the life span of the mice was significantly extended (p53(LFL/FL)/arf-bp1(FL/Y)/RIP-cre). These findings underscore an important role of ARF-BP1 in maintaining beta-cell homeostasis in aging mice and reveal that the stability of p53 is critically regulated by ARF-BP1 in vivo.	[Gu, Wei] Columbia Univ, Inst Canc Genet, Dept Pathol & Cell Biol, Coll Phys & Surg, New York, NY 10032 USA; [Qiang, Li; Accili, Domenico] Columbia Univ, Naomi Berrie Diabet Ctr, Dept Med, Coll Phys & Surg, New York, NY 10032 USA	Columbia University; Columbia University	Gu, W (corresponding author), Columbia Univ, Inst Canc Genet, Dept Pathol & Cell Biol, Coll Phys & Surg, 1130 St Nicholas Ave, New York, NY 10032 USA.	wg8@columbia.edu	Qiang, Li/C-9560-2012	Qiang, Li/0000-0001-8322-1797	National Institutes of Health from the NCI; Leukemia and Lymphoma Society; Diabetes Research Center [DK63608]; NATIONAL CANCER INSTITUTE [R01CA129627, R01CA118561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063608] Funding Source: NIH RePORTER	National Institutes of Health from the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Diabetes Research Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by a National Institutes of Health grant from the NCI. This work was also supported by a grant from the Leukemia and Lymphoma Society (to W. G.) and by Diabetes Research Center Grant DK63608 (to D. A.).	Armata HL, 2010, MOL CELL BIOL, V30, P5787, DOI 10.1128/MCB.00347-10; Bitti MLM, 2011, J PEDIATR ENDOCR MET, V24, P437, DOI 10.1515/JPEM.2011.058; Chen DL, 2005, CELL, V121, P1071, DOI 10.1016/j.cell.2005.03.037; Chen HA, 2009, GENE DEV, V23, P975, DOI 10.1101/gad.1742509; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Dornan D, 2004, NATURE, V429, P86, DOI 10.1038/nature02514; Eischen CM, 2009, CANCER CELL, V15, P161, DOI 10.1016/j.ccr.2009.02.004; Gudkov AV, 2005, BIOCHEM BIOPH RES CO, V331, P726, DOI 10.1016/j.bbrc.2005.03.153; Gurzov EN, 2010, J BIOL CHEM, V285, P19910, DOI 10.1074/jbc.M110.122374; Hall JR, 2007, MOL BIOL CELL, V18, P3340, DOI 10.1091/mbc.E07-02-0173; Herold S, 2008, EMBO J, V27, P2851, DOI 10.1038/emboj.2008.200; Herrera PL, 2000, DEVELOPMENT, V127, P2317; Hinault C, 2011, DIABETES, V60, P1210, DOI 10.2337/db09-1379; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Liu ZQ, 2007, DEV DYNAM, V236, P2889, DOI 10.1002/dvdy.21302; LUNA RMD, 1995, NATURE, V378, P203; Marine JC, 2010, CELL DEATH DIFFER, V17, P93, DOI 10.1038/cdd.2009.68; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Migliorini D, 2011, J CLIN INVEST, V121, P1329, DOI 10.1172/JCI45784; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Qian YJ, 2010, HISTOL HISTOPATHOL, V25, P515, DOI 10.14670/HH-25.515; Ringshausen I, 2006, CANCER CELL, V10, P501, DOI 10.1016/j.ccr.2006.10.010; Sherr CJ, 2006, NAT REV CANCER, V6, P663, DOI 10.1038/nrc1954; Tschen SI, 2009, DIABETES, V58, P1312, DOI 10.2337/db08-1651; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vitari AC, 2011, NATURE, V474, P403, DOI 10.1038/nature10005; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Xuan SH, 2002, J CLIN INVEST, V110, P1011, DOI 10.1172/JCI200215276; Yin L, 2010, P NATL ACAD SCI USA, V107, P11614, DOI 10.1073/pnas.1000438107; Zhang XN, 2011, EMBO J, V30, P2177, DOI 10.1038/emboj.2011.125; Zhang YP, 2009, CANCER CELL, V16, P369, DOI 10.1016/j.ccr.2009.09.024; Zhang YP, 2004, CELL CYCLE, V3, P259; Zhao XD, 2008, NAT CELL BIOL, V10, P643, DOI 10.1038/ncb1727; Zhao X, 2009, DEV CELL, V17, P210, DOI 10.1016/j.devcel.2009.07.009; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009	40	38	40	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					5102	5111		10.1074/jbc.M111.322867	http://dx.doi.org/10.1074/jbc.M111.322867			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22187431	Green Published, hybrid			2022-12-27	WOS:000300608500068
J	Van Ba, IAT; Marchal, S; Francois, F; Silhol, M; Lleres, C; Michel, B; Benyamin, Y; Verdier, JM; Trousse, F; Marcilhac, A				Van Ba, Isabelle Acquatella-Tran; Marchal, Stephane; Francois, Florence; Silhol, Michele; Lleres, Coline; Michel, Bernard; Benyamin, Yves; Verdier, Jean-Michel; Trousse, Francoise; Marcilhac, Anne			Regenerating Islet-derived 1 alpha (Reg-1 alpha) Protein Is New Neuronal Secreted Factor That Stimulates Neurite Outgrowth via Exostosin Tumor-like 3 (EXTL3) Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC STONE PROTEIN; REG GENE FAMILY; THREAD PROTEIN; ALZHEIMERS-DISEASE; GROWTH-FACTOR; LITHOSTATHINE; EXPRESSION; DIFFERENTIATION; CELL	Regenerating islet-derived 1 alpha (Reg-1 alpha)/lithostathine, amember of a family of secreted proteins containing a C-type lectin domain, is expressed in various organs and plays a role in proliferation, differentiation, inflammation, and carcinogenesis of cells of the digestive system. We previously reported that Reg-1 alpha is overexpressed during the very early stages of Alzheimer disease, and Reg-1 alpha deposits were detected in the brain of patients with Alzheimer disease. However, the physiological function of Reg-1 alpha in neural cells remains unknown. Here, we show that Reg-1 alpha is expressed in neuronal cell lines (PC12 and Neuro-2a) and in rat primary hippocampal neurons (E17.5). Reg-1 alpha is mainly localized around the nucleus and at the membrane of cell bodies and neurites. Transient overexpression of Reg-1 alpha or addition of recombinant Reg-1 alpha significantly increases the number of cells with longer neurites by stimulating neurite outgrowth. These effects are abolished upon down-regulation of Reg-1 alpha by siRNA and following inhibition of secreted Reg-1 alpha by antibodies. Moreover, Reg-1 alpha colocalizes with exostosin tumor-like 3 (EXTL3), its putative receptor, at the membrane of these cells. Overexpression of EXTL3 increases the effect of recombinant Reg-1 alpha on neurite outgrowth, and Reg-1 alpha is not effective when EXTL3 overexpression is down-regulated by shRNA. Our findings indicate that Reg-1 alpha regulates neurite outgrowth and suggest that this effect is mediated by its receptor EXTL3.	[Van Ba, Isabelle Acquatella-Tran; Marchal, Stephane; Francois, Florence; Silhol, Michele; Lleres, Coline; Michel, Bernard; Verdier, Jean-Michel; Trousse, Francoise; Marcilhac, Anne] Univ Montpellier 2, INSERM, U710, F-34095 Montpellier 05, France; [Van Ba, Isabelle Acquatella-Tran; Marchal, Stephane; Francois, Florence; Silhol, Michele; Lleres, Coline; Michel, Bernard; Verdier, Jean-Michel; Trousse, Francoise; Marcilhac, Anne] EPHE, F-75007 Paris, France; [Michel, Bernard] Hop St Marguerite, Serv Neurol, F-13009 Marseille, France; [Benyamin, Yves] CNRS, UMR5539, F-34095 Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Centre National de la Recherche Scientifique (CNRS)	Marcilhac, A (corresponding author), Univ Montpellier 2, INSERM, U710, Pl E Bataillon,CC 105, F-34095 Montpellier 05, France.	marcilhac@univ-montp2.fr	MARCHAL, stéphane/M-4324-2017	MARCHAL, stéphane/0000-0002-1101-7890; , francoise/0000-0002-6354-3331; VERDIER, Jean-Michel/0000-0002-7252-1556	Groupe de Recherche sur la Maladie d'Alzheimer	Groupe de Recherche sur la Maladie d'Alzheimer	This work was supported by grants from Groupe de Recherche sur la Maladie d'Alzheimer.	Averill S, 2002, J NEUROSCI, V22, P7493; Bandtlow CE, 2000, PHYSIOL REV, V80, P1267, DOI 10.1152/physrev.2000.80.4.1267; Bimmler D, 1997, J BIOL CHEM, V272, P3073, DOI 10.1074/jbc.272.5.3073; Cerini C, 1999, J BIOL CHEM, V274, P22266, DOI 10.1074/jbc.274.32.22266; DECARO A, 1979, BIOCHEM BIOPH RES CO, V87, P1176, DOI 10.1016/S0006-291X(79)80031-5; DELAMONTE SM, 1990, J CLIN INVEST, V86, P1004, DOI 10.1172/JCI114762; delaMonte SM, 1996, J NEUROL SCI, V138, P26, DOI 10.1016/0022-510X(95)00350-B; DEREGGI M, 1995, EUR J BIOCHEM, V230, P503; Duplan L, 2001, NEUROBIOL AGING, V22, P79, DOI 10.1016/S0197-4580(00)00182-2; Geider S, 1996, J BIOL CHEM, V271, P26302, DOI 10.1074/jbc.271.42.26302; Gregoire C, 2001, EMBO J, V20, P3313, DOI 10.1093/emboj/20.13.3313; Hashimoto M, 2003, NEUROCHEM RES, V28, P1743, DOI 10.1023/A:1026073324672; Iovanna JL, 2005, BBA-GEN SUBJECTS, V1723, P8, DOI 10.1016/j.bbagen.2005.01.002; Kinoshita Y, 2004, J GASTROENTEROL, V39, P507, DOI 10.1007/s00535-004-1354-5; Kobayashi S, 2000, J BIOL CHEM, V275, P10723, DOI 10.1074/jbc.275.15.10723; Laurine E, 2005, BBA-GENE STRUCT EXPR, V1727, P177, DOI 10.1016/j.bbaexp.2005.01.011; Laurine E, 2003, J BIOL CHEM, V278, P51770, DOI 10.1074/jbc.M306767200; Marchal S, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.01.002; MILWARD EA, 1992, NEURON, V9, P129, DOI 10.1016/0896-6273(92)90228-6; Miyaoka Y, 2004, ONCOGENE, V23, P3572, DOI 10.1038/sj.onc.1207333; Nishimune H, 2000, NAT CELL BIOL, V2, P906, DOI 10.1038/35046558; Osman NMS, 2004, DEV BRAIN RES, V151, P111, DOI 10.1016/j.devbrainres.2004.04.008; Sanchez D, 2004, PANCREAS, V29, P14, DOI 10.1097/00006676-200407000-00050; Sanchez D, 2009, PANCREAS, V38, P572, DOI 10.1097/MPA.0b013e3181a1d9f9; WATANABE T, 1990, J BIOL CHEM, V265, P7432; Xu YY, 1995, J MOL NEUROSCI, V6, P91, DOI 10.1007/BF02736769; Zhang YW, 2003, WORLD J GASTROENTERO, V9, P2635	27	27	27	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4726	4739		10.1074/jbc.M111.260349	http://dx.doi.org/10.1074/jbc.M111.260349			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22158612	hybrid, Green Published			2022-12-27	WOS:000300608500034
J	Yuan, XJ; Protchenko, O; Philpott, CC; Hamza, I				Yuan, Xiaojing; Protchenko, Olga; Philpott, Caroline C.; Hamza, Iqbal			Topologically Conserved Residues Direct Heme Transport in HRG-1-related Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; IRON UPTAKE; FERRIC REDUCTASE; YEAST; GENES; TRANSCRIPTION; BIOSYNTHESIS; HOMEOSTASIS; ACTIVATION; MECHANISM	Caenorhabditis elegans and human HRG-1-related proteins are conserved, membrane-bound permeases that bind and translocate heme in metazoan cells via a currently uncharacterized mechanism. Here, we show that cellular import of heme by HRG-1-related proteins from worms and humans requires strategically located amino acids that are topologically conserved across species. We exploit a heme synthesis-defective Saccharomyces cerevisiae mutant to model the heme auxotrophy of C. elegans and demonstrate that, under heme-deplete conditions, the endosomal CeHRG-1 requires both a specific histidine in the predicted second transmembrane domain (TMD2) and the FARKY motif in the C terminus tail for heme transport. By contrast, the plasma membrane CeHRG-4 transports heme by utilizing a histidine in the exoplasmic (E2) loop and the FARKY motif. Optimal activity under heme-limiting conditions, however, requires histidine in the E2 loop of CeHRG-1 and tyrosine in TMD2 of CeHRG-4. An analogous system exists in humans, because mutation of the synonymous histidine in TMD2 of hHRG-1 eliminates heme transport activity, implying an evolutionary conserved heme transport mechanism that predates vertebrate origins. Our results support a model in which heme is translocated across membranes facilitated by conserved amino acids positioned on the exoplasmic, cytoplasmic, and transmembrane regions of HRG-1-related proteins. These findings may provide a framework for understanding the structural basis of heme transport in eukaryotes and human parasites, which rely on host heme for survival.	[Yuan, Xiaojing; Hamza, Iqbal] Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA; [Yuan, Xiaojing; Hamza, Iqbal] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA; [Protchenko, Olga; Philpott, Caroline C.] NIDDK, Genet & Metab Sect, Liver Dis Branch, NIH, Bethesda, MD 20892 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Hamza, I (corresponding author), Univ Maryland, Dept Anim & Avian Sci, 2413 Anim & Avian Sci,Bldg 142, College Pk, MD 20742 USA.	hamza@umd.edu	Yuan, Xiaojing/V-6882-2019; Protchenko, Olga/AAU-9237-2021	Yuan, Xiaojing/0000-0002-0969-5748; Protchenko, Olga/0000-0002-4688-4214; Hamza, Iqbal/0000-0003-0045-0610	National Institutes of Health [R01DK74797, R01DK85035]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK054513] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK74797 and R01DK85035 (to I. H.).	BODE HP, 1995, EUR J BIOCHEM, V228, P337; Brown JK, 2006, J VIROL, V80, P1742, DOI 10.1128/JVI.80.4.1742-1751.2006; Burke D., 2000, METHODS YEAST GENETI; Cescau S, 2007, BIOMETALS, V20, P603, DOI 10.1007/s10534-006-9050-y; Chen CY, 2011, CELL, V145, P720, DOI 10.1016/j.cell.2011.04.025; Crisp RJ, 2003, J BIOL CHEM, V278, P45499, DOI 10.1074/jbc.M307229200; DANCIS A, 1990, MOL CELL BIOL, V10, P2294, DOI 10.1128/MCB.10.5.2294; De Feo CJ, 2009, P NATL ACAD SCI USA, V106, P4237, DOI 10.1073/pnas.0810286106; Diallinas G, 2008, SCIENCE, V322, P1644, DOI 10.1126/science.1168107; Duffy SP, 2010, MOL CELL BIOL, V30, P5318, DOI 10.1128/MCB.00690-10; Frawley ER, 2009, P NATL ACAD SCI USA, V106, P10201, DOI 10.1073/pnas.0903132106; GEORGATSOU E, 1994, MOL CELL BIOL, V14, P3065, DOI 10.1128/MCB.14.5.3065; Goodwin DC, 2000, BIOCHEMISTRY-US, V39, P5422, DOI 10.1021/bi992752f; Grigg JC, 2010, J INORG BIOCHEM, V104, P341, DOI 10.1016/j.jinorgbio.2009.09.012; GUARENTE L, 1983, CELL, V32, P1279, DOI 10.1016/0092-8674(83)90309-4; Hon T, 2003, J BIOL CHEM, V278, P50771, DOI 10.1074/jbc.M303677200; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Keel SB, 2008, SCIENCE, V319, P825, DOI 10.1126/science.1151133; Layer G, 2010, PROTEIN SCI, V19, P1137, DOI 10.1002/pro.405; LI JM, 1988, J BACTERIOL, V170, P1021, DOI 10.1128/jb.170.2.1021-1025.1988; Lipovich L, 2002, GENE, V286, P203, DOI 10.1016/S0378-1119(02)00457-2; Liu Y, 1999, BIOCHEMISTRY-US, V38, P3733, DOI 10.1021/bi982707s; Maines MD, 2005, ANTIOXID REDOX SIGN, V7, P1761, DOI 10.1089/ars.2005.7.1761; Merchant SS, 2009, P NATL ACAD SCI USA, V106, P10069, DOI 10.1073/pnas.0905189106; Nass R., 2007, CURRENT PROTOCOLS TO, P191; O'Callaghan KM, 2010, J BIOL CHEM, V285, P381, DOI 10.1074/jbc.M109.063248; Protchenko O, 2008, EUKARYOT CELL, V7, P859, DOI 10.1128/EC.00414-07; Protchenko O, 2006, J BIOL CHEM, V281, P21445, DOI 10.1074/jbc.M512812200; Quigley JG, 2004, CELL, V118, P757, DOI 10.1016/j.cell.2004.08.014; RAGUZZI F, 1988, FEBS LETT, V231, P253, DOI 10.1016/0014-5793(88)80742-7; Rajagopal A, 2008, NATURE, V453, P1127, DOI 10.1038/nature06934; Rao AU, 2005, P NATL ACAD SCI USA, V102, P4270, DOI 10.1073/pnas.0500877102; Schultz IJ, 2010, J BIOL CHEM, V285, P26753, DOI 10.1074/jbc.R110.119503; Severance S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001044; Severance S, 2009, CHEM REV, V109, P4596, DOI 10.1021/cr9001116; Shatwell KP, 1996, J BIOL CHEM, V271, P14240, DOI 10.1074/jbc.271.24.14240; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Sinclair J, 2010, J BIOL CHEM, V285, P39536, DOI 10.1074/jbc.M110.167619; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Tong Y, 2009, ARCH BIOCHEM BIOPHYS, V481, P1, DOI 10.1016/j.abb.2008.10.013; Villareal VA, 2011, J AM CHEM SOC, V133, P14176, DOI 10.1021/ja203805b; West AR, 2008, WORLD J GASTROENTERO, V14, P4101, DOI 10.3748/wjg.14.4101; Wilks A, 2007, NAT PROD REP, V24, P511, DOI 10.1039/b604193k; Yadav J, 2007, MOL BIOL CELL, V18, P1480, DOI 10.1091/mbc.E06-11-1049; Yang ZT, 2010, J BIOL CHEM, V285, P28874, DOI 10.1074/jbc.M110.119131	45	40	42	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4914	4924		10.1074/jbc.M111.326785	http://dx.doi.org/10.1074/jbc.M111.326785			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22174408	Green Published, hybrid			2022-12-27	WOS:000300608500052
J	Audfray, A; Claudinon, J; Abounit, S; Ruvoen-Clouet, N; Larson, G; Smith, DF; Wimmerova, M; Le Pendu, J; Romer, W; Varrot, A; Imberty, A				Audfray, Aymeric; Claudinon, Julie; Abounit, Saida; Ruvoen-Clouet, Nathalie; Larson, Goran; Smith, David F.; Wimmerova, Michaela; Le Pendu, Jacques; Roemer, Winfried; Varrot, Annabelle; Imberty, Anne			Fucose-binding Lectin from Opportunistic Pathogen Burkholderia ambifaria Binds to Both Plant and Human Oligosaccharidic Epitopes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CEPACIA COMPLEX; PSEUDOMONAS-AERUGINOSA; MOLECULAR-BASIS; SP-NOV.; INFECTION; GLYCOSYLATION; POLYMORPHISM; SPECIFICITY; RECOGNITION; DIVERSITY	Burkholderia ambifaria is generally associated with the rhizosphere of plants where it has biocontrol effects on other microorganisms. It is also a member of the Burkholderia cepacia complex, a group of closely related bacteria that cause lung infections in immunocompromised patients as well as in patients with granulomatous disease or cystic fibrosis. Our previous work indicated that fucose on human epithelia is a frequent target for lectins and adhesins of lung pathogens (Sulak, O., Cioci, G., Lameignere, E., Balloy, V., Round, A., Gutsche, I., Malinovska, L., Chignard, M., Kosma, P., Aubert, D. F., Marolda, C. L., Valvano, M. A., Wimmerova, M., and Imberty, A. (2011) PLoS Pathog. 7, e1002238). Analysis of the B. ambifaria genome identified BambL as a putative fucose-binding lectin. The 87-amino acid protein was produced recombinantly and demonstrated to bind to fucosylated oligosaccharides with a preference for alpha Fuc1-2Gal epitopes. Crystal structures revealed that it associates as a trimer with two fucose-binding sites per monomer. The overall fold is a six-bladed beta-propeller formed by oligomerization as in the Ralstonia solanacearum lectin and not by sequential domains like the fungal fucose lectin from Aleuria aurantia. The affinity of BambL for small fucosylated glycans is very high as demonstrated by microcalorimetry (K-D < 1 mu M). Plant cell wall oligosaccharides and human histo-blood group oligosaccharides H-type 2 and Lewis Y are bound with equivalent efficiency. Binding to artificial glycosphingolipid-containing vesicles, human saliva, and lung tissues confirmed that BambL could recognize a wide spectrum of fucosylated epitopes, albeit with a lower affinity for biological material from nonsecretor individuals.	[Audfray, Aymeric; Varrot, Annabelle; Imberty, Anne] Univ Grenoble 1, Ctr Rech Macromol Vegetales CERMAV CNRS, F-38041 Grenoble, France; [Audfray, Aymeric; Varrot, Annabelle; Imberty, Anne] Inst Chim Mol Grenoble, F-38041 Grenoble, France; [Claudinon, Julie; Roemer, Winfried] Univ Freiburg, Inst Biol 2, D-79104 Freiburg, Germany; [Claudinon, Julie; Roemer, Winfried] Univ Freiburg, Ctr Biol Signaling Studies BIOSS, D-79104 Freiburg, Germany; [Abounit, Saida; Roemer, Winfried] Inst Curie, Traff Signaling & Delivery Grp, Ctr Rech, CNRS UMR 144, F-75248 Paris, France; [Ruvoen-Clouet, Nathalie; Le Pendu, Jacques] Univ Nantes, INSERM U892, Inst Rech Therapeut IRT UN, F-44007 Nantes, France; [Larson, Goran] Sahlgrens Univ Hosp, Dept Clin Chem & Transfus Med, S-41345 Gothenburg, Sweden; [Smith, David F.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Wimmerova, Michaela] Masaryk Univ, Cent European Inst Technol, Brno 62500, Czech Republic	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); University of Freiburg; University of Freiburg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Sahlgrenska University Hospital; Emory University; Masaryk University Brno	Imberty, A (corresponding author), CERMAV CNRS, 601 Rue Chim,BP53, F-38041 Grenoble 9, France.	Imberty@cermav.cnrs.fr	Ruvoen-clouet, Nathalie/K-9609-2015; Le Pendu, Jacques/F-4760-2013; Larson, Göran/AAF-3404-2019; Wimmerova, Michaela/A-4114-2010; Imberty, Anne/P-6451-2018	Le Pendu, Jacques/0000-0002-4856-0387; Wimmerova, Michaela/0000-0002-7108-4198; Varrot, Annabelle/0000-0001-6667-8162; Imberty, Anne/0000-0001-6825-9527	CNRS-INSERM; German Excellence Initiative of the Deutsche Forschungsgemeinschaft; Association Vaincre la Mucoviscidose; Agence Nationale de la Recherche [NeoLect 11-BSV5-002-01]; GlycanClust; Czech Science Foundation [GA303/09/1168]; CEITEC-Central European Institute of Technology [CZ.1.05/1.1.00/02.0068]; European Community; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER	CNRS-INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)Centre National de la Recherche Scientifique (CNRS)); German Excellence Initiative of the Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Association Vaincre la Mucoviscidose; Agence Nationale de la Recherche(French National Research Agency (ANR)); GlycanClust; Czech Science Foundation(Grant Agency of the Czech Republic); CEITEC-Central European Institute of Technology; European Community(European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by CNRS-INSERM, the German Excellence Initiative of the Deutsche Forschungsgemeinschaft, and the Association Vaincre la Mucoviscidose. This work was also supported by Agence Nationale de la Recherche Grants NeoLect 11-BSV5-002-01 (to A. I., W. R., and J. L. P.) and GlycanClust (to W. R.) and by grants from the Czech Science Foundation (GA303/09/1168) and the CEITEC-Central European Institute of Technology (CZ.1.05/1.1.00/02.0068) from the European Regional Development Fund (to M. W.).; The glycan array resources were provided by the Consortium for Functional Glycomics (GM62116). Crystal data collection was performed at the European Synchrotron Radiation Facility, and we are grateful for the assistance in using beamline BM30A. Access to the High Throughput Crystallization facility of the Partnership for Structural Biology (PSB) in Grenoble was supported by the European Community PCube program. We acknowledge the help received from the Cell and Tissue Imaging Core Facility of the Institut Curie (PICT-IBiSA) and the staff of the Life Imaging Center (LIC) Freiburg and the use of the advanced microscopy equipment of the LIC Freiburg and the Nikon Imaging Center at the Institut Curie-CNRS. We also thank the MicroPiCell core facility of IFR26, Nantes, for the preparation of tissue microarrays.	Aaron SD, 2000, AM J RESP CRIT CARE, V161, P1206, DOI 10.1164/ajrccm.161.4.9907147; Aspholm-Hurtig M, 2004, SCIENCE, V305, P519, DOI 10.1126/science.1098801; Azevedo M, 2008, J PATHOL, V215, P308, DOI 10.1002/path.2363; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Chiarini L, 2006, TRENDS MICROBIOL, V14, P277, DOI 10.1016/j.tim.2006.04.006; Coenye T, 2001, INT J SYST EVOL MICR, V51, P1481, DOI 10.1099/00207713-51-4-1481; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ferrer-Admetlla A, 2009, MOL BIOL EVOL, V26, P1993, DOI 10.1093/molbev/msp108; GILBOAGARBER N, 1982, METHOD ENZYMOL, V83, P378; Glick MC, 2001, BIOCHIMIE, V83, P743, DOI 10.1016/S0300-9084(01)01323-2; Holmner A, 2010, FEBS LETT, V584, P2548, DOI 10.1016/j.febslet.2010.03.050; IMBERTY A, 1995, GLYCOCONJUGATE J, V12, P331, DOI 10.1007/BF00731336; Imberty A, 2004, MICROBES INFECT, V6, P221, DOI 10.1016/j.micinf.2003.10.016; Imberty A, 2008, CURR OPIN STRUC BIOL, V18, P567, DOI 10.1016/j.sbi.2008.08.001; KARLSSON KA, 1981, J BIOL CHEM, V256, P3512; KIARASH A, 1994, J BIOL CHEM, V269, P11138; Kostlanova N, 2005, J BIOL CHEM, V280, P27839, DOI 10.1074/jbc.M505184200; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Le Pendu J, 2006, SEMIN IMMUNOL, V18, P375, DOI 10.1016/j.smim.2006.07.009; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Linden S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040002; Marionneau S, 2005, J INFECT DIS, V192, P1071, DOI 10.1086/432546; Marionneau S, 2001, BIOCHIMIE, V83, P565, DOI 10.1016/S0300-9084(01)01321-9; Mathivet L, 1996, BIOPHYS J, V70, P1112, DOI 10.1016/S0006-3495(96)79693-5; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mitchell E, 2002, NAT STRUCT BIOL, V9, P918, DOI 10.1038/nsb865; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nystrom K, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002188; Parke JL, 2001, ANNU REV PHYTOPATHOL, V39, P225, DOI 10.1146/annurev.phyto.39.1.225; Pieters RJ, 2011, ADV EXP MED BIOL, V715, P227, DOI 10.1007/978-94-007-0940-9_14; Pirone L, 2005, ENVIRON MICROBIOL, V7, P1734, DOI 10.1111/j.1462-2920.2005.00897.x; Romer W, 2007, NATURE, V450, P670, DOI 10.1038/nature05996; Saiman L, 2004, CLIN MICROBIOL REV, V17, P57, DOI 10.1128/CMR.17.1.57-71.2004; Scanlin TF, 2001, RESP RES, V2, P276, DOI 10.1186/rr69; Schmidt S, 2009, ENVIRON MICROBIOL, V11, P1422, DOI 10.1111/j.1462-2920.2009.01870.x; Smith DF, 2010, METHOD ENZYMOL, V480, P417, DOI 10.1016/S0076-6879(10)80033-3; Staudacher E, 1999, BBA-GEN SUBJECTS, V1473, P216, DOI 10.1016/S0304-4165(99)00181-6; Sulak O, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002238; Sulak O, 2010, STRUCTURE, V18, P59, DOI 10.1016/j.str.2009.10.021; Taylor-Cousar JL, 2009, PLOS ONE, V4, pCP5, DOI 10.1371/journal.pone.0004270; Valvano MA, 2005, CURR OPIN MICROBIOL, V8, P99, DOI 10.1016/j.mib.2004.12.002; Vanlaere E, 2008, INT J SYST EVOL MICR, V58, P1580, DOI 10.1099/ijs.0.65634-0; Vanlaere E, 2009, INT J SYST EVOL MICR, V59, P102, DOI 10.1099/ijs.0.001123-0; Vial L, 2008, J BACTERIOL, V190, P5339, DOI 10.1128/JB.00400-08; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wimmerova M, 2003, J BIOL CHEM, V278, P27059, DOI 10.1074/jbc.M302642200	48	75	75	0	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					4335	4347		10.1074/jbc.M111.314831	http://dx.doi.org/10.1074/jbc.M111.314831			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22170069	hybrid, Green Published			2022-12-27	WOS:000300410900064
J	Pal, C; Bindu, S; Dey, S; Alam, A; Goyal, M; Iqbal, MS; Sarkar, S; Kumar, R; Halder, KK; Debnath, MC; Adhikari, S; Bandyopadhyay, U				Pal, Chinmay; Bindu, Samik; Dey, Sumanta; Alam, Athar; Goyal, Manish; Iqbal, Mohd. Shameel; Sarkar, Souvik; Kumar, Rahul; Halder, Kamal Krishna; Debnath, Mita Chatterjee; Adhikari, Susanta; Bandyopadhyay, Uday			RETRACTED: Tryptamine-Gallic Acid Hybrid Prevents Non-steroidal Anti-inflammatory Drug-induced Gastropathy CORRECTION OF MITOCHONDRIAL DYSFUNCTION AND INHIBITION OF APOPTOSIS IN GASTRIC MUCOSAL CELLS (Retracted article. See vol. 294, pg. 20261, 2019)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication							OXYGEN SPECIES GENERATION; OXIDATIVE STRESS; MOLECULAR-MECHANISMS; IRON TOXICITY; LIVER; RAT; INDOMETHACIN; ANTIOXIDANT; INDUCTION; DEATH	We have investigated the gastroprotective effect of SEGA (3a), a newly synthesized tryptamine-gallic acid hybrid molecule against non-steroidal anti-inflammatory drug (NSAID)-induced gastropathy with mechanistic details. SEGA (3a) prevents indomethacin (NSAID)-induced mitochondrial oxidative stress (MOS) and dysfunctions in gastric mucosal cells, which play a pathogenic role in inducing gastropathy. SEGA (3a) offers this mitoprotective effect by scavenging of mitochondrial superoxide anion (O-2(radical anion)) and intramitochondrial free iron released as a result of MOS. SEGA (3a) in vivo blocks indomethacin-mediated MOS, as is evident from the inhibition of indomethacin-induced mitochondrial protein carbonyl formation, lipid peroxidation, and thiol depletion. SEGA (3a) corrects indomethacin-mediated mitochondrial dysfunction in vivo by restoring defective electron transport chain function, collapse of transmembrane potential, and loss of dehydrogenase activity. SEGA (3a) not only corrects mitochondrial dysfunction but also inhibits the activation of the mitochondrial pathway of apoptosis by indomethacin. SEGA (3a) inhibits indomethacin-induced down-regulation of bcl-2 and up-regulation of bax genes in gastric mucosa. SEGA (3a) also inhibits indometacin-induced activation of caspase-9 and caspase-3 in gastric mucosa. Besides the gastroprotective effect against NSAID, SEGA (3a) also expedites the healing of already damaged gastric mucosa. Radiolabeled (Tc-99m-labeled SEGA (3a)) tracer studies confirm that SEGA (3a) enters into mitochondria of gastric mucosal cell in vivo, and it is quite stable in serum. Thus, SEGA (3a) bears an immense potential to be a novel gastroprotective agent against NSAID-induced gastropathy.	[Pal, Chinmay; Bindu, Samik; Dey, Sumanta; Alam, Athar; Goyal, Manish; Iqbal, Mohd. Shameel; Sarkar, Souvik; Kumar, Rahul; Bandyopadhyay, Uday] Indian Inst Chem Biol, Div Infect Dis & Immunol, Kolkata 700032, W Bengal, India; [Halder, Kamal Krishna; Debnath, Mita Chatterjee] Indian Inst Chem Biol, Div Nucl Med, Kolkata 700032, W Bengal, India; [Adhikari, Susanta] Univ Calcutta, Dept Chem, Kolkata 700009, W Bengal, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); University of Calcutta	Bandyopadhyay, U (corresponding author), Indian Inst Chem Biol, Div Infect Dis & Immunol, 4 Raja SC Mullick Rd, Kolkata 700032, W Bengal, India.	ubandyo_1964@yahoo.com	Iqbal, Mohd Shameel/AAD-9641-2021; Alam, Athar/B-3642-2010	Iqbal, Mohd Shameel/0000-0002-0353-3561; 	Council of Scientific and Industrial Research, New Delhi; University Grants Commission, New Delhi	Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission, New Delhi(University Grants Commission, India)	This work was supported by the Council of Scientific and Industrial Research, New Delhi, and the University Grants Commission, New Delhi.	Bandyopadhyay U, 2002, LIFE SCI, V71, P2845, DOI 10.1016/S0024-3205(02)02143-4; Basu B, 2008, REPRODUCTION, V135, P657, DOI 10.1530/REP-07-0577; Becker JC, 2004, BRIT J CLIN PHARMACO, V58, P587, DOI 10.1111/j.1365-2125.2004.02198.x; Ben Farhat M, 2009, J AGR FOOD CHEM, V57, P10349, DOI 10.1021/jf901877x; Bindu S, 2011, J BIOL CHEM, V286, P39387, DOI 10.1074/jbc.M111.279893; Biswas K, 2003, J BIOL CHEM, V278, P10993, DOI 10.1074/jbc.M210328200; BRITTON RS, 1994, ADV EXP MED BIOL, V356, P239; Carelli V, 2004, PROG RETIN EYE RES, V23, P53, DOI 10.1016/j.preteyeres.2003.10.003; CECCARELLI D, 1995, BIOCHEM BIOPH RES CO, V209, P53, DOI 10.1006/bbrc.1995.1469; Chattopadhyay Ishita, 2004, Inflammopharmacology, V12, P153, DOI 10.1163/1568560041352257; Clark DWJ, 2006, EUR J CLIN PHARMACOL, V62, P473, DOI 10.1007/s00228-006-0131-1; DELALASTRA CA, 1994, PHARMACOLOGY, V48, P56; Demaurex N, 2009, NAT NEUROSCI, V12, P819, DOI 10.1038/nn0709-819; Dey S, 2009, FREE RADICAL BIO MED, V46, P271, DOI 10.1016/j.freeradbiomed.2008.10.032; Dial S, 2005, JAMA-J AM MED ASSOC, V294, P2989, DOI 10.1001/jama.294.23.2989; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Fariss MW, 2005, MOL INTERV, V5, P94, DOI 10.1124/mi.5.2.7; Fazary AE, 2009, J CHEM ENG DATA, V54, P35, DOI 10.1021/je800441u; Fornai M, 2011, PHARMACOL RES, V63, P59, DOI 10.1016/j.phrs.2010.10.013; FORT FL, 1995, FUND APPL TOXICOL, V26, P191, DOI 10.1006/faat.1995.1090; Fraga CG, 2002, TOXICOLOGY, V180, P23, DOI 10.1016/S0300-483X(02)00379-7; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Gonzalez P, 2002, Allergol Immunopathol (Madr), V30, P342; GONZALEZFLECHA B, 1993, J CLIN INVEST, V91, P456, DOI 10.1172/JCI116223; Halder KK, 2008, J DRUG TARGET, V16, P311, DOI [10.1080/10611860801899300, 10.1080/10611860801899300 ]; Jacob M, 2001, ALIMENT PHARM THER, V15, P1837, DOI 10.1046/j.1365-2036.2001.01095.x; Jing XB, 2007, BIOCHEM CELL BIOL, V85, P265, DOI 10.1139/O07-014; Jose Jimmy, 2008, J Pak Med Assoc, V58, P206; Ko JKS, 1998, FREE RADICAL BIO MED, V24, P1007, DOI 10.1016/S0891-5849(97)00428-0; Kumar S, 2008, ANTIMICROB AGENTS CH, V52, P705, DOI 10.1128/AAC.00898-07; Kwiecien S, 2002, J PHYSIOL PHARMACOL, V53, P39; Laheij RJF, 2004, JAMA-J AM MED ASSOC, V292, P1955, DOI 10.1001/jama.292.16.1955; Liang LP, 2008, J NEUROSCI, V28, P11550, DOI 10.1523/JNEUROSCI.3016-08.2008; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Ling YH, 2003, J BIOL CHEM, V278, P33714, DOI 10.1074/jbc.M302559200; Link G, 1998, J LAB CLIN MED, V131, P466, DOI 10.1016/S0022-2143(98)90148-2; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maity P, 2008, J BIOL CHEM, V283, P14391, DOI 10.1074/jbc.M800414200; Maity P, 2009, J PINEAL RES, V46, P314, DOI 10.1111/j.1600-079X.2009.00663.x; Maity P, 2009, J BIOL CHEM, V284, P3058, DOI 10.1074/jbc.M805329200; Malik F, 2007, APOPTOSIS, V12, P2115, DOI 10.1007/s10495-007-0129-x; Mukherjee S, 2003, J GASTROEN HEPATOL, V18, P602, DOI 10.1046/j.1440-1746.2003.02801.x; Mulac D, 2011, TOXICOLOGY, V282, P112, DOI 10.1016/j.tox.2011.01.019; Musumba C, 2009, ALIMENT PHARM THER, V30, P517, DOI 10.1111/j.1365-2036.2009.04086.x; NAUMANN M, 1995, ACTA NEUROPATHOL, V89, P152; Orrenius S, 2007, ANNU REV PHARMACOL, V47, P143, DOI 10.1146/annurev.pharmtox.47.120505.105122; Pal C, 2011, BIOORG MED CHEM LETT, V21, P3563, DOI 10.1016/j.bmcl.2011.04.127; Pal C, 2010, FREE RADICAL BIO MED, V49, P258, DOI 10.1016/j.freeradbiomed.2010.04.013; Panting KJ, 2009, CLIN EXP DERMATOL, V34, P733, DOI 10.1111/j.1365-2230.2008.03105.x; Parish Rebecca, 2005, Curr Diab Rep, V5, P177, DOI 10.1007/s11892-005-0006-3; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Regula J, 2006, AM J GASTROENTEROL, V101, P1747, DOI 10.1111/j.1572-0241.2006.00686.x; Ren J, 2010, J MOL MED, V88, P993, DOI 10.1007/s00109-010-0663-9; Robinson KM, 2006, P NATL ACAD SCI USA, V103, P15038, DOI 10.1073/pnas.0601945103; Rousou AJ, 2004, AM J PHYSIOL-HEART C, V287, pH1967, DOI 10.1152/ajpheart.00338.2004; Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8; Serviddio G, 2010, CURR MED CHEM, V17, P2325, DOI 10.2174/092986710791698530; Sims NR, 2008, NAT PROTOC, V3, P1228, DOI 10.1038/nprot.2008.105; Szabo I, 2000, J PHYSIOL PHARMACOL, V51, P3; THOMPSON M, 1966, BMJ-BRIT MED J, V1, P80, DOI 10.1136/bmj.1.5479.80; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Turrens JF, 1997, BIOSCIENCE REP, V17, P3, DOI 10.1023/A:1027374931887; Umeno J, 2008, GASTROINTEST ENDOSC, V67, P1185, DOI 10.1016/j.gie.2008.02.013; Wallace JL, 1996, FASEB J, V10, P731, DOI 10.1096/fasebj.10.7.8635690; Wallace JL, 2011, GASTROENTEROLOGY, V141, P1314, DOI 10.1053/j.gastro.2011.06.075; WOLFE MM, 1988, NEW ENGL J MED, V319, P1707; Yusuke H, 2009, ENDOSCOPY, V41, pE281, DOI 10.1055/s-0029-1215007; Zimmerman MC, 2009, HYPERTENSION, V53, P112, DOI 10.1161/HYPERTENSIONAHA.108.125567	68	20	21	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3495	3509		10.1074/jbc.M111.307199	http://dx.doi.org/10.1074/jbc.M111.307199			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22157011	Green Published, hybrid			2022-12-27	WOS:000300295100054
J	Park, KJ; Lee, CH; Kim, A; Jeong, KJ; Kim, CH; Kim, YS				Park, Kyung-Jin; Lee, Chang-Han; Kim, Aeyung; Jeong, Ki Jun; Kim, Chul-Ho; Kim, Yong-Sung			Death Receptors 4 and 5 Activate Nox1 NADPH Oxidase through Riboflavin Kinase to Induce Reactive Oxygen Species-mediated Apoptotic Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUSTAINED JNK ACTIVATION; TNF-RECEPTOR; INVOLVEMENT; GENERATION; CASPASE-8; ANTIBODY; PATHWAY; COUPLES; STRESS; FAMILY	Stimulation of the proapoptotic tumor necrosis factor (TNF)related apoptosis-inducing ligand (TRAIL) receptors, death receptors 4 (DR4) and 5 (DR5), conventionally induces caspase-dependent apoptosis in tumor cells. Here we report that stimulation of DR4 and/or DR5 by the agonistic protein KD548-Fc, an Fc-fused DR4/DR5 dual-specific Kringle domain variant, activates plasma membrane-associated Nox1 NADPH oxidase to generate superoxide anion and subsequently accumulates intracellular reactive oxygen species (ROS), leading to sustained c-Jun N-terminal kinase activation and eventual apoptotic cell death in human HeLa and Jurkat tumor cells. KD548-Fc treatment induces the formation of a DR4/DR5 signaling complex containing riboflavin kinase (RFK), Nox1, the Nox1 subunits (Rac1, Noxo1, and Noxa1), TNF receptor-associated death domain (TRADD), and TNF receptor-associated factor 2 (TRAF2). Depletion of RFK, but not the Nox1 subunits, TRADD and TRAF2, failed to recruit Nox1 and Rac1 to DR4 and DR5, demonstrating that RFK plays an essential role in linking DR4/DR5 with Nox1. Knockdown studies also reveal that RFK, TRADD, and TRAF2 play critical, intermediate, and negligible roles, respectively, in the KD548-Fc-mediated ROS accumulation and downstream signaling. Binding assays using recombinantly expressed proteins suggest that DR4/DR5 directly interact with cytosolic RFK through RFK-binding regions within the intracellular death domains, and TRADD stabilizes the DR4/DR5-RFK complex. Our results suggest that DR4 and DR5 have a capability to activate Nox1 by recruiting RFK, resulting in ROS-mediated apoptotic cell death in tumor cells.	[Park, Kyung-Jin; Lee, Chang-Han; Kim, Aeyung; Kim, Yong-Sung] Ajou Univ, Dept Mol Sci & Technol, Suwon 443749, South Korea; [Jeong, Ki Jun] Korea Adv Inst Sci & Technol, Dept Chem & Biomol Engn, Taejon 305701, South Korea; [Kim, Chul-Ho] Ajou Univ, Sch Med, Dept Otolaryngol, Suwon 443749, South Korea	Ajou University; Korea Advanced Institute of Science & Technology (KAIST); Ajou University	Kim, YS (corresponding author), Ajou Univ, Dept Mol Sci & Technol, San 5, Suwon 443749, South Korea.	kimys@ajou.ac.kr	Lee, Chang-Han/AAG-9178-2019; JEONG, KI JUN/C-1704-2011	Lee, Chang-Han/0000-0002-7156-4423; Kim, Yong-Sung/0000-0003-2673-1509	Ministry for Health, Welfare Family Affairs [A101800]; National Research Foundation of MEST [2009-0093653, 2011-0022978]; Gyeonggi Provincial Government, Republic of Korea	Ministry for Health, Welfare Family Affairs; National Research Foundation of MEST(Ministry of Education, Science & Technology (MEST), Republic of Korea); Gyeonggi Provincial Government, Republic of Korea	This work was supported by grants from the Korean Health Technology R&D Project (A101800) from the Ministry for Health, Welfare & Family Affairs, the Converging Research Center Program (2009-0093653) and the Priority Research Center Program (2011-0022978) from the National Research Foundation of MEST, and the "GRRC" Project of the Gyeonggi Provincial Government, Republic of Korea.	AdamKlages S, 1996, CELL, V86, P937, DOI 10.1016/S0092-8674(00)80169-5; Cao XM, 2011, FASEB J, V25, P1353, DOI 10.1096/fj.10-170480; Chaudhary PM, 1997, IMMUNITY, V7, P821, DOI 10.1016/S1074-7613(00)80400-8; Chen CF, 2009, CELL RES, V19, P984, DOI 10.1038/cr.2009.60; Cheng GJ, 2001, GENE, V269, P131, DOI 10.1016/S0378-1119(01)00449-8; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Jiang F, 2011, PHARMACOL REV, V63, P218, DOI 10.1124/pr.110.002980; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Karthikeyan S, 2003, STRUCTURE, V11, P265, DOI 10.1016/S0969-2126(03)00024-8; Kieser A, 2008, BIOL CHEM, V389, P1261, DOI 10.1515/BC.2008.144; Kim YS, 2007, MOL CELL, V26, P675, DOI 10.1016/j.molcel.2007.04.021; Kischkel FC, 2000, IMMUNITY, V12, P611, DOI 10.1016/S1074-7613(00)80212-5; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Lee CH, 2011, J MOL BIOL, V411, P201, DOI 10.1016/j.jmb.2011.05.040; Lee CH, 2010, P NATL ACAD SCI USA, V107, P9567, DOI 10.1073/pnas.1001541107; Lee MW, 2002, CANCER LETT, V182, P75; Morgan MJ, 2010, MOL CELLS, V30, P1, DOI 10.1007/s10059-010-0105-0; Nam YJ, 2004, MOL CELL, V15, P901, DOI 10.1016/j.molcel.2004.08.020; Park HH, 2011, APOPTOSIS, V16, P209, DOI 10.1007/s10495-010-0571-z; Park KJ, 2007, CANCER RES, V67, P7327, DOI 10.1158/0008-5472.CAN-06-4766; Pennarun B, 2010, BBA-REV CANCER, V1805, P123, DOI 10.1016/j.bbcan.2009.11.004; Petry A, 2010, ANTIOXID REDOX SIGN, V13, P467, DOI 10.1089/ars.2009.3026; Reinehr R, 2005, J BIOL CHEM, V280, P27179, DOI 10.1074/jbc.M414361200; Shen HM, 2006, FASEB J, V20, P1589, DOI 10.1096/fj.05-5603rev; Sprick MR, 2000, IMMUNITY, V12, P599, DOI 10.1016/S1074-7613(00)80211-3; Sung ES, 2010, APOPTOSIS, V15, P1256, DOI 10.1007/s10495-010-0521-9; Suzuki Y, 1998, FEBS LETT, V425, P209, DOI 10.1016/S0014-5793(98)00228-2; Wilson NS, 2009, NAT IMMUNOL, V10, P348, DOI 10.1038/ni.1714; Yazdanpanah B, 2009, NATURE, V460, P1159, DOI 10.1038/nature08206	29	34	36	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3313	3325		10.1074/jbc.M111.309021	http://dx.doi.org/10.1074/jbc.M111.309021			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22158615	Green Published, hybrid			2022-12-27	WOS:000300295100037
J	Svastova, E; Witarski, W; Csaderova, L; Kosik, I; Skvarkova, L; Hulikova, A; Zatovicova, M; Barathova, M; Kopacek, J; Pastorek, J; Pastorekova, S				Svastova, Eliska; Witarski, Wojciech; Csaderova, Lucia; Kosik, Ivan; Skvarkova, Lucia; Hulikova, Alzbeta; Zatovicova, Miriam; Barathova, Monika; Kopacek, Juraj; Pastorek, Jaromir; Pastorekova, Silvia			Carbonic Anhydrase IX Interacts with Bicarbonate Transporters in Lamellipodia and Increases Cell Migration via Its Catalytic Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH; CANCER; ADHESION; METASTASIS; EXPRESSION; BIOLOGY; FRONT	Carbonic anhydrase IX (CA IX) is a hypoxia-induced cell surface enzyme expressed in solid tumors, and functionally involved in acidification of extracellular pH and destabilization of intercellular contacts. Since both extracellular acidosis and reduced cell adhesion facilitate invasion and metastasis, we investigated the role of CA IX in cell migration, which promotes the metastatic cascade. As demonstrated here, ectopically expressed CA IX increases scattering, wound healing and transwell migration of MDCK cells, while an inactive CA IX variant lacking the catalytic domain (Delta CA) fails to do so. Correspondingly, hypoxic HeLa cells exhibit diminished migration upon inactivation of the endogenous CA IX either by forced expression of the dominant-negative Delta CA variant or by treatment with CA inhibitor, implying that the catalytic activity is indispensable for the CA IX function. Interestingly, CA IX improves cell migration both in the absence and presence of hepatocyte growth factor (HGF), an established inducer of epithelial-mesenchymal transition. On the other hand, HGF up-regulates CA IX transcription and triggers CA IX protein accumulation at the leading edge of lamellipodia. In these membrane regions CA IX co-localizes with sodium bicarbonate co-transporter (NBCe1) and anion exchanger 2 (AE2) that are both components of the migration apparatus and form bicarbonate transport metabolon with CA IX. Moreover, CA IX physically interacts with AE2 and NBCe1 in situ, as shown here for the first time. Thus, our findings suggest that CA IX actively contributes to cell migration via its ability to facilitate ion transport and pH control at protruding fronts of moving cells.	[Svastova, Eliska; Witarski, Wojciech; Csaderova, Lucia; Kosik, Ivan; Skvarkova, Lucia; Hulikova, Alzbeta; Zatovicova, Miriam; Barathova, Monika; Kopacek, Juraj; Pastorek, Jaromir; Pastorekova, Silvia] Slovak Acad Sci, Inst Virol, Dept Mol Med, Bratislava 84505, Slovakia; [Csaderova, Lucia] Slovak Acad Sci, Ctr Mol Med, Bratislava 84505, Slovakia	Slovak Academy of Sciences; Slovak Academy of Sciences	Pastorekova, S (corresponding author), Slovak Acad Sci, Inst Virol, Dept Mol Med, Dubravska Cesta 9, Bratislava 84505, Slovakia.	virusipa@savba.sk	Pastorek, Jaromir/AAR-2647-2020; Kopacek, Juraj/GRF-4984-2022; Pastorekova, Silvia/C-6685-2018; Zaťovičová, Miriam/ABA-3268-2021; Witarski, Wojciech/M-8692-2015; Svastova, Eliska/AAD-9768-2019	Zaťovičová, Miriam/0000-0002-8682-4232; Witarski, Wojciech/0000-0001-8957-8623; Kosik, Ivan/0000-0001-5756-5182; Barathova, Monika/0000-0002-6577-220X; Kopacek, Juraj/0000-0003-3069-646X; Svastova, Eliska/0000-0003-0679-1061; Csaderova, Lucia/0000-0003-4728-0305	Slovak Scientific Grant Agency [VEGA 2/0130/11]; ERDF [TRANSMED 2, ITMS 26240120030]; EU; Research and Development Support Agency [DO7RP-0017-09]; Research & Development Operational Program	Slovak Scientific Grant Agency(Vedecka grantova agentura MSVVaS SR a SAV (VEGA)); ERDF(European Commission); EU(European Commission); Research and Development Support Agency(Slovak Research and Development Agency); Research & Development Operational Program	This work was supported by Grants VEGA 2/0130/11, 2/0129/11 from the Slovak Scientific Grant Agency, from the 7th Framework program of EU (Collaborative Project METOXIA), from the Research and Development Support Agency (DO7RP-0017-09), from the 6th Framework program of EU (Marie Curie RTN project CELLCHECK), and from the Research & Development Operational Program funded by the ERDF (Project TRANSMED 2, ITMS 26240120030).	Bakin AV, 2000, J BIOL CHEM, V275, P36803, DOI 10.1074/jbc.M005912200; Brahimi-Horn MC, 2011, CURR OPIN GENET DEV, V21, P67, DOI 10.1016/j.gde.2010.10.006; Chen J, 2005, GUT, V54, P920, DOI 10.1136/gut.2004.047340; Chiche J, 2009, CANCER RES, V69, P358, DOI 10.1158/0008-5472.CAN-08-2470; Cristini V, 2005, CLIN CANCER RES, V11, P6772, DOI 10.1158/1078-0432.CCR-05-0852; Ditte P, 2011, CANCER RES, V71, P7558, DOI 10.1158/0008-5472.CAN-11-2520; Dorai T, 2005, EUR J CANCER, V41, P2935, DOI 10.1016/j.ejca.2005.09.011; Dubois L, 2011, RADIOTHER ONCOL, V99, P424, DOI 10.1016/j.radonc.2011.05.045; Hulikova A, 2009, FEBS LETT, V583, P3563, DOI 10.1016/j.febslet.2009.10.060; Innocenti A, 2009, BIOORG MED CHEM LETT, V19, P5825, DOI 10.1016/j.bmcl.2009.08.088; Klein M, 2000, J GEN PHYSIOL, V115, P599, DOI 10.1085/jgp.115.5.599; Lou YM, 2011, CANCER RES, V71, P3364, DOI 10.1158/0008-5472.CAN-10-4261; Morgan P. E., 2005, INT C PHYS SCI MARCH; Morgan PE, 2007, AM J PHYSIOL-CELL PH, V293, pC738, DOI 10.1152/ajpcell.00157.2007; Opavsky R, 1996, GENOMICS, V33, P480, DOI 10.1006/geno.1996.0223; PASTOREKOVA S, 1992, VIROLOGY, V187, P620, DOI 10.1016/0042-6822(92)90464-Z; Pastorekova S., 2010, TUMOR MICROENVIRONME, P59; Pennacchietti S, 2003, CANCER CELL, V3, P347, DOI 10.1016/S1535-6108(03)00085-0; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Sansone P, 2009, J CELL MOL MED, V13, P3876, DOI 10.1111/j.1582-4934.2008.00580.x; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Shin HJ, 2011, J CELL SCI, V124, P1077, DOI 10.1242/jcs.072207; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Stock C, 2009, PFLUG ARCH EUR J PHY, V458, P981, DOI 10.1007/s00424-009-0677-8; Studebaker AW, 2008, CANCER RES, V68, P9087, DOI 10.1158/0008-5472.CAN-08-0400; Supuran CT, 2008, NAT REV DRUG DISCOV, V7, P168, DOI 10.1038/nrd2467; Svastova E, 2003, EXP CELL RES, V290, P332, DOI 10.1016/S0014-4827(03)00351-3; Svastova E, 2004, FEBS LETT, V577, P439, DOI 10.1016/j.febslet.2004.10.043; Swietach P, 2010, ONCOGENE, V29, P6509, DOI 10.1038/onc.2010.455; Swietach P, 2009, J BIOL CHEM, V284, P20299, DOI 10.1074/jbc.M109.006478; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Troyanovsky Sergey M, 2009, Front Biosci (Schol Ed), V1, P61, DOI 10.2741/s7; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Woelber L, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-12; Worthylake RA, 2003, J BIOL CHEM, V278, P13578, DOI 10.1074/jbc.M211584200; Wykoff CC, 2000, CANCER RES, V60, P7075; Yap AS, 2007, CURR OPIN CELL BIOL, V19, P508, DOI 10.1016/j.ceb.2007.09.008; Zat'ovicova M, 2003, J IMMUNOL METHODS, V282, P117, DOI 10.1016/j.jim.2003.08.011; Zavada J, 2000, BRIT J CANCER, V82, P1808, DOI 10.1054/bjoc.2000.1111	40	130	131	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3392	3402		10.1074/jbc.M111.286062	http://dx.doi.org/10.1074/jbc.M111.286062			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22170054	hybrid, Green Published			2022-12-27	WOS:000300295100044
J	Yan, CG; Zhu, M; Staiger, J; Johnson, PF; Gao, HW				Yan, Chunguang; Zhu, Mei; Staiger, Jennifer; Johnson, Peter F.; Gao, Hongwei			C5a-regulated CCAAT/Enhancer-binding Proteins beta and delta Are Essential in Fc gamma Receptor-mediated Inflammatory Cytokine and Chemokine Production in Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C/EBP-BETA; PROINFLAMMATORY CYTOKINES; KINASE ACTIVATION; IMMUNE-COMPLEXES; LUNG INJURY; GENE; EXPRESSION; INDUCTION; CELLS; C5A	CCAAT/enhancer-binding protein beta (C/EBP beta) and C/EBP delta are known to participate in the regulation of many genes associated with inflammation. However, little is known about the activation and function of C/EBP beta and -delta in inflammatory responses elicited by Fc gamma receptor (Fc gamma R) activation. Here we show that C/EBP beta and -delta activation are induced in IgG immune complex (IC)-treated macrophages. The increased expression of C/EBP beta and -delta occurred at both mRNA and protein levels. Furthermore, induction of C/EBP beta and -delta was mediated, to a large extent, by activating Fc gamma Rs. Using siRNA-mediated knockdown as well as macrophages deficient for C/EBP beta and/or -delta, we demonstrate that C/EBP beta and -delta play a critical role in the production of TNF-alpha, MIP-2, and MIP-1 alpha in IgG IC-stimulated macrophages. Moreover, both ERK1/2 and p38 MAPK are involved in C/EBP induction and TNF-alpha, MIP-2, and MIP-1 alpha production induced by IgGIC. We provide the evidence that C5a regulates IgGIC-induced inflammatory responses by enhancing ERK1/2 and p38 MAPK activities as well as C/EBP beta and -delta activities. Collectively, these data suggest that C/EBP beta and -delta are key regulators for Fc gamma R-mediated induction of cytokines and chemokines in macrophages. Furthermore, C/EBPs may play an important regulatory role in IC-associated inflammatory responses.	[Yan, Chunguang; Gao, Hongwei] Harvard Univ, Brigham & Womens Hosp, Ctr Expt Therapeut & Reperfus Injury, Dept Anesthesiol Perioperat & Pain Med,Sch Med, Boston, MA 02115 USA; [Zhu, Mei] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Staiger, Jennifer] Mt St Marys Univ, Dept Sci, Sch Nat Sci & Math, Emmitsburg, MD 21727 USA; [Johnson, Peter F.] NCI, Lab Canc Prevent, Ctr Canc Res, NIH, Frederick, MD 21702 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Gao, HW (corresponding author), Harvard Univ, Brigham & Womens Hosp, Ctr Expt Therapeut & Reperfus Injury, Dept Anesthesiol,Sch Med, 20 Shattuck St, Boston, MA 02115 USA.	hgao@zeus.bwh.harvard.edu	Yan, Chunguang/ABE-5021-2021; Johnson, Peter/A-1940-2012	Johnson, Peter/0000-0002-4145-4725	National Institutes of Health (NIH) [5R01HL092905-04, 3R01HL092905-02S1]; NIH, NCI, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010328] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092905] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, NCI, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grants 5R01HL092905-04 and 3R01HL092905-02S1 (to H. G.) and the Intramural Research Program of the NIH, NCI, Center for Cancer Research.	Adelmant G, 1998, J BIOL CHEM, V273, P15574, DOI 10.1074/jbc.273.25.15574; Akagi T, 2008, BRIT J CANCER, V99, P781, DOI 10.1038/sj.bjc.6604544; AKIRA S, 1990, EMBO J, V9, P1897, DOI 10.1002/j.1460-2075.1990.tb08316.x; ALAM T, 1992, J BIOL CHEM, V267, P5021; Anastasov N, 2010, HAEMATOL-HEMATOL J, V95, P760, DOI 10.3324/haematol.2009.014050; Arnett Brenda, 2003, Mol Cancer, V2, P21, DOI 10.1186/1476-4598-2-21; Bayon Y, 1997, J IMMUNOL, V159, P887; Bianchi G, 2007, ANN NY ACAD SCI, V1095, P209, DOI 10.1196/annals.1397.025; Bless NM, 1999, AM J PHYSIOL-LUNG C, V276, pL57, DOI 10.1152/ajplung.1999.276.1.L57; Cloutier A, 2009, J IMMUNOL, V182, P563, DOI 10.4049/jimmunol.182.1.563; COX GW, 1989, J NATL CANCER I, V81, P1492, DOI 10.1093/jnci/81.19.1492; DAVATELIS G, 1988, J EXP MED, V167, P1939, DOI 10.1084/jem.167.6.1939; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; Fernandez N, 2002, J IMMUNOL, V169, P3321, DOI 10.4049/jimmunol.169.6.3321; Gao HW, 2006, ANNU REV PATHOL-MECH, V1, P215, DOI 10.1146/annurev.pathol.1.110304.100155; Garcia-Garcia E, 2001, J LEUKOCYTE BIOL, V70, P649; Gerbitz A, 2005, TRANSPLANTATION, V79, P536, DOI 10.1097/01.TP.0000151763.16800.B0; Gorgoni B, 2002, J IMMUNOL, V168, P4055, DOI 10.4049/jimmunol.168.8.4055; Halstead SB, 2010, LANCET INFECT DIS, V10, P712, DOI 10.1016/S1473-3099(10)70166-3; Hillyard DZ, 2004, ATHEROSCLEROSIS, V172, P219, DOI 10.1016/j.atherosclerosis.2003.11.004; KINOSHITA S, 1992, P NATL ACAD SCI USA, V89, P1473, DOI 10.1073/pnas.89.4.1473; Konrad S, 2007, J BIOL CHEM, V282, P37906, DOI 10.1074/jbc.M707937200; Konrad S, 2008, J BIOL CHEM, V283, P33296, DOI 10.1074/jbc.M804617200; Kumar V, 2006, J CLIN INVEST, V116, P512, DOI 10.1172/JCI25536; Litvak V, 2009, NAT IMMUNOL, V10, P437, DOI 10.1038/ni.1721; Lu YC, 2009, J IMMUNOL, V182, P7212, DOI 10.4049/jimmunol.0802971; Lucas M, 2005, J IMMUNOL, V175, P469, DOI 10.4049/jimmunol.175.1.469; Maitra U, 2011, J IMMUNOL, V186, P4467, DOI 10.4049/jimmunol.1003300; Masumoto M, 1999, J IMMUNOL, V163, P5039; Nakano H, 1998, P NATL ACAD SCI USA, V95, P3537, DOI 10.1073/pnas.95.7.3537; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; Nimmerjahn F, 2007, ADV IMMUNOL, V96, P179, DOI 10.1016/S0065-2776(07)96005-8; OPPENHEIM JJ, 1991, ANNU REV IMMUNOL, V9, P617, DOI 10.1146/annurev.iy.09.040191.003153; Poli V, 1998, J BIOL CHEM, V273, P29279, DOI 10.1074/jbc.273.45.29279; POPE RM, 1994, J CLIN INVEST, V94, P1449, DOI 10.1172/JCI117482; RAMJI DP, 1993, NUCLEIC ACIDS RES, V21, P289, DOI 10.1093/nar/21.2.289; Rittirsch D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000464; Sanchez-Mejorada G, 1998, J BIOL CHEM, V273, P27610, DOI 10.1074/jbc.273.42.27610; Schmal H, 1998, J IMMUNOL, V161, P3685; Shushakova N, 2002, J CLIN INVEST, V110, P1823, DOI 10.1172/JCI200216577; Song XY, 2004, J LEUKOCYTE BIOL, V75, P1147, DOI 10.1189/jlb.0403128; Sterneck E, 1998, P NATL ACAD SCI USA, V95, P10908, DOI 10.1073/pnas.95.18.10908; Sterneck E, 1997, GENE DEV, V11, P2153, DOI 10.1101/gad.11.17.2153; TANAKA T, 1995, CELL, V80, P353, DOI 10.1016/0092-8674(95)90418-2; Trotta R, 1996, J EXP MED, V184, P1027, DOI 10.1084/jem.184.3.1027; Uematsu S, 2002, J IMMUNOL, V168, P5811, DOI 10.4049/jimmunol.168.11.5811; Uematsu S, 2007, J IMMUNOL, V179, P5378, DOI 10.4049/jimmunol.179.8.5378; Walpen S, 2001, FASEB J, V15, P571; WIDMER U, 1993, J IMMUNOL, V150, P4996; WOLPE SD, 1988, J EXP MED, V167, P570, DOI 10.1084/jem.167.2.570; WOLPE SD, 1989, FASEB J, V3, P2565, DOI 10.1096/fasebj.3.14.2687068; WOLPE SD, 1989, P NATL ACAD SCI USA, V86, P612, DOI 10.1073/pnas.86.2.612; ZHANG Y, 1993, MOL CELL BIOL, V13, P3831, DOI 10.1128/MCB.13.6.3831	53	33	39	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3217	3230		10.1074/jbc.M111.280834	http://dx.doi.org/10.1074/jbc.M111.280834			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22147692	Green Published, hybrid			2022-12-27	WOS:000300295100027
J	Dockter, C; Muller, AH; Dietz, C; Volkov, A; Polyhach, Y; Jeschke, G; Paulsen, H				Dockter, Christoph; Mueller, Andre H.; Dietz, Carsten; Volkov, Aleksei; Polyhach, Yevhen; Jeschke, Gunnar; Paulsen, Harald			Rigid Core and Flexible Terminus STRUCTURE OF SOLUBILIZED LIGHT-HARVESTING CHLOROPHYLL a/b COMPLEX (LHCII) MEASURED BY EPR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTOSYSTEM-II; PROTEIN; PHOSPHORYLATION; CRYSTALS; SITE; PHOTOSYNTHESIS; RECONSTITUTION; SPINACH; DOMAIN	The structure of the major light-harvesting chlorophyll a/b complex ( LHCII) was analyzed by pulsed EPR measurements and compared with the crystal structure. Site-specific spin labeling of the recombinant protein allowed the measurement of distance distributions over several intra-and intermolecular distances in monomeric and trimeric LHCII, yielding information on the protein structure and its local flexibility. A spin label rotamer library based on a molecular dynamics simulation was used to take the local mobility of spin labels into account. The core of LHCII in solution adopts a structure very similar or identical to the one seen in crystallized LHCII trimers with little motional freedom as indicated by narrow distance distributions along and between alpha helices. However, distances comprising the lumenal loop domain show broader distance distributions, indicating some mobility of this loop structure. Positions in the hydrophilic N-terminal domain, upstream of the first trans-membrane alpha helix, exhibit more and more mobility the closer they are to the N terminus. The nine amino acids at the very N terminus that have not been resolved in any of the crystal structure analyses give rise to very broad and possibly bimodal distance distributions, which may represent two families of preferred conformations.	[Dockter, Christoph; Mueller, Andre H.; Dietz, Carsten; Paulsen, Harald] Johannes Gutenberg Univ Mainz, Inst Allgemeine Bot, D-55099 Mainz, Germany; [Volkov, Aleksei] Max Planck Inst Polymer Res, D-55021 Mainz, Germany; [Polyhach, Yevhen; Jeschke, Gunnar] ETH, Phys Chem Lab, CH-8093 Zurich, Switzerland	Johannes Gutenberg University of Mainz; Max Planck Society; Swiss Federal Institutes of Technology Domain; ETH Zurich	Paulsen, H (corresponding author), Johannes Gutenberg Univ Mainz, Inst Allgemeine Bot, Mullerweg 6, D-55099 Mainz, Germany.	paulsen@uni-mainz.de	Paulsen, Harald/D-3742-2011	Jeschke, Gunnar/0000-0001-6853-8585	Deutsche Forschungsgemeinschaft [SFB 625, TP B10, Pa 324/9-1]; Swiss National Science Foundation [200020-103550/1]; Max Planck Graduate Center, Johannes Gutenberg-Universitat Mainz	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Max Planck Graduate Center, Johannes Gutenberg-Universitat Mainz	This work was supported in part by Deutsche Forschungsgemeinschaft Grants SFB 625, TP B10 (to G. J. and H. P.), and Pa 324/9-1 (to H. P.) and Swiss National Science Foundation Grant 200020-103550/1 (to G. J.).; Supported by the Max Planck Graduate Center, Johannes Gutenberg-Universitat Mainz.	Altenbach C, 2008, P NATL ACAD SCI USA, V105, P7439, DOI 10.1073/pnas.0802515105; Andersson J, 2003, PLANT J, V35, P350, DOI 10.1046/j.1365-313X.2003.01811.x; Avenson TJ, 2008, J BIOL CHEM, V283, P3550, DOI 10.1074/jbc.M705645200; Barros T, 2009, BBA-BIOENERGETICS, V1787, P753, DOI 10.1016/j.bbabio.2009.03.012; CASHMORE AR, 1984, P NATL ACAD SCI-BIOL, V81, P2960, DOI 10.1073/pnas.81.10.2960; Daum B, 2010, PLANT CELL, V22, P1299, DOI 10.1105/tpc.109.071431; Dockter C, 2009, P NATL ACAD SCI USA, V106, P18485, DOI 10.1073/pnas.0906462106; Hilger D, 2009, BIOPHYS J, V96, P217, DOI 10.1016/j.bpj.2008.09.030; Hobe S, 2000, EUR J BIOCHEM, V267, P616, DOI 10.1046/j.1432-1327.2000.01060.x; HOBE S, 1994, EMBO J, V13, P3423, DOI 10.1002/j.1460-2075.1994.tb06647.x; Jeschke G, 2006, APPL MAGN RESON, V30, P473, DOI 10.1007/BF03166213; Jeschke G, 2005, J BIOL CHEM, V280, P18623, DOI 10.1074/jbc.M501171200; Jeschke G, 2007, PHYS CHEM CHEM PHYS, V9, P1895, DOI 10.1039/b614920k; Jeschke G, 2009, PHYS CHEM CHEM PHYS, V11, P6580, DOI 10.1039/b905724b; Kargul J, 2008, FEBS J, V275, P1056, DOI 10.1111/j.1742-4658.2008.06262.x; Kavalenka AA, 2009, BIOPHYS J, V96, P3620, DOI 10.1016/j.bpj.2009.01.038; Klein JC, 2008, P NATL ACAD SCI USA, V105, P12867, DOI 10.1073/pnas.0802286105; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; KUHLBRANDT W, 1987, J MOL BIOL, V194, P757, DOI 10.1016/0022-2836(87)90255-5; KUHLBRANDT W, 1994, NATURE, V367, P614, DOI 10.1038/367614a0; Lemeille S, 2010, PHOTOSYNTH RES, V106, P33, DOI 10.1007/s11120-010-9538-8; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Miloslavina Y, 2008, FEBS LETT, V582, P3625, DOI 10.1016/j.febslet.2008.09.044; Nilsson A, 1997, J BIOL CHEM, V272, P18350, DOI 10.1074/jbc.272.29.18350; NUSSBERGER S, 1993, J MOL BIOL, V234, P347, DOI 10.1006/jmbi.1993.1591; Pannier M, 2000, J MAGN RESON, V142, P331, DOI 10.1006/jmre.1999.1944; Pascal AA, 2005, NATURE, V436, P134, DOI 10.1038/nature03795; PAULSEN H, 1990, PLANTA, V181, P204, DOI 10.1007/BF02411539; PAULSEN H, 1993, EUR J BIOCHEM, V215, P809, DOI 10.1111/j.1432-1033.1993.tb18096.x; Pesaresi P, 2010, PLANT SIGNAL BEHAV, V5, P21, DOI 10.4161/psb.5.1.10198; PETER GF, 1991, J BIOL CHEM, V266, P16745; PLUMLEY FG, 1987, P NATL ACAD SCI USA, V84, P146, DOI 10.1073/pnas.84.1.146; Polyhach Y, 2011, PHYS CHEM CHEM PHYS, V13, P2356, DOI 10.1039/c0cp01865a; Rochaix JD, 2011, BBA-BIOENERGETICS, V1807, P878, DOI 10.1016/j.bbabio.2011.05.009; ROTH M, 1989, NATURE, V340, P659, DOI 10.1038/340659a0; Ruban AV, 2007, NATURE, V450, P575, DOI 10.1038/nature06262; Ruhle W, 2011, METHODS MOL BIOL, V684, P113, DOI [10.1007/978.1.60761.925.3_11, 10.1007/978-1-60761-925-3_11]; Standfuss R, 2005, EMBO J, V24, P919, DOI 10.1038/sj.emboj.7600585; Tikkanen M, 2011, TRENDS PLANT SCI, V16, P126, DOI 10.1016/j.tplants.2010.11.006; Volkov A, 2009, BIOPHYS J, V96, P1124, DOI 10.1016/j.bpj.2008.09.047; Zer H, 1999, P NATL ACAD SCI USA, V96, P8277, DOI 10.1073/pnas.96.14.8277	41	31	31	1	49	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2915	2925		10.1074/jbc.M111.307728	http://dx.doi.org/10.1074/jbc.M111.307728			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22147706	Green Published, hybrid			2022-12-27	WOS:000300292300063
J	Khan, MM; Chatterjee, S; Dwivedi, VP; Pandey, NK; Singh, Y; Tousif, S; Bhavesh, NS; Van Kaer, L; Das, J; Das, G				Khan, Mohd Moin; Chatterjee, Samit; Dwivedi, Ved Prakash; Pandey, Nishant Kumar; Singh, Yogesh; Tousif, Sultan; Bhavesh, Neel Sarovar; Van Kaer, Luc; Das, Jyoti; Das, Gobardhan			CD4(+) T Cell-derived Novel Peptide Thp5 Induces Interleukin-4 Production in CD4(+) T Cells to Direct T Helper 2 Cell Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASOACTIVE-INTESTINAL-PEPTIDE; TH2 DIFFERENTIATION; IN-VIVO; IL-4; EXPRESSION; DYNAMICS; PROGRAM; NMR	The differentiation of naive CD4(+) T cells into T helper 2 (Th2) cells requires production of the cytokine IL-4 in the local microenvironment. It is evident that naive/quiescently activated CD4(+) T cells produce the IL-4 that drives Th2 cell differentiation. Because early production of IL-4 in naive T cells leads to preferential Th2 cell differentiation, this process needs to be tightly regulated so as to avoid catastrophic and misdirected Th2 cell differentiation. Here, we show that Thp5, a novel peptide with structural similarity to vasoactive intestinal peptide, regulates production of early IL-4 in newly activated CD4(+) T cells. Induction of IL-4 in CD4(+) T cells by Thp5 is independent of the transcription factor STAT6 but dependent on ERK1/2 signaling. Furthermore, cytokines (IL-12 and TGF-beta) that promote the differentiation of Th1 or Th17 cells inhibit Thp5 induction, thus suppressing Th2 cell differentiation. We further showed that Thp5 enhances Th2 responses and exacerbates allergic airway inflammation in mice. Taken together, our findings reveal that early activated CD4(+) T cells produce Thp5, which plays a critical role as a molecular switch in the differentiation of Th cells, biasing the response toward the Th2 cell phenotype.	[Das, Jyoti] Natl Inst Malaria Res, Dept Immunol, Sect 8, New Delhi 110077, India; [Khan, Mohd Moin; Chatterjee, Samit; Dwivedi, Ved Prakash; Singh, Yogesh; Tousif, Sultan; Das, Gobardhan] Int Ctr Genet Engn & Biotechnol, Immunol Grp, New Delhi 110067, India; [Pandey, Nishant Kumar; Bhavesh, Neel Sarovar] Int Ctr Genet Engn & Biotechnol, Struct & Computat Biol Grp, New Delhi 110067, India; [Van Kaer, Luc] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA	Indian Council of Medical Research (ICMR); ICMR - National Institute of Malaria Research (NIMR); Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Vanderbilt University	Das, J (corresponding author), Natl Inst Malaria Res, Dept Immunol, Sect 8, New Delhi 110077, India.	jyoti@mrcindia.org; dasgo@icgeb.res.in	Khan, Mohd Moin/GYQ-7170-2022; Van Kaer, Luc/H-1033-2015; Chatterjee, Samit/ABZ-2522-2022; Singh, Yogesh/T-8230-2017; Bhavesh, Neel Sarovar/F-3127-2015	Van Kaer, Luc/0000-0001-5275-2309; Chatterjee, Samit/0000-0001-8176-3410; Singh, Yogesh/0000-0001-6919-6273; Bhavesh, Neel Sarovar/0000-0002-7248-4978; Dwivedi, Ved Prakash/0000-0003-4321-2567; Tousif, Sultan/0000-0001-6174-6541	Wellcome Trust Department of Biotechnology (DBT) alliance; DBT, Government of India; Department of Biotechnology, Government of India; Council of Scientific and Industrial Research, Government of India	Wellcome Trust Department of Biotechnology (DBT) alliance(Department of Biotechnology (DBT) IndiaWellcome Trust DBT India Alliance); DBT, Government of India(Department of Biotechnology (DBT) India); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by grants from The Wellcome Trust Department of Biotechnology (DBT) alliance, and by the DBT, Government of India, for the 500 MHz and 700 MHz NMR spectrometers at the International Centre for Genetic Engineering and Biotechnology, New Delhi, and National Institute of Immunology, New Delhi.; Supported by a Department of Biotechnology, Government of India, senior research fellowship.; Supported by a Council of Scientific and Industrial Research senior research fellowship, Government of India.	Chorny A, 2005, P NATL ACAD SCI USA, V102, P13562, DOI 10.1073/pnas.0504484102; Das J, 2001, NAT IMMUNOL, V2, P45, DOI 10.1038/83158; Delgado M, 2005, J LEUKOCYTE BIOL, V78, P1327, DOI 10.1189/jlb.0605299; Delgado M, 2003, TRENDS IMMUNOL, V24, P221, DOI 10.1016/S1471-4906(03)00069-3; FRY DC, 1989, BIOCHEMISTRY-US, V28, P2399, DOI 10.1021/bi00432a010; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Keller R., 2004, COMPUTER AIDED RESON, V1; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Mendiratta SK, 1997, IMMUNITY, V6, P469, DOI 10.1016/S1074-7613(00)80290-3; Nakahara T, 2006, J DERMATOL SCI, V42, P1, DOI 10.1016/j.jdermsci.2005.11.004; Noben-Trauth N, 2002, EUR J IMMUNOL, V32, P1428, DOI 10.1002/1521-4141(200205)32:5<1428::AID-IMMU1428>3.0.CO;2-0; Noben-Trauth N, 2000, J IMMUNOL, V165, P3620, DOI 10.4049/jimmunol.165.7.3620; Ono K, 2007, IMMUNOL RES, V38, P319, DOI 10.1007/s12026-007-0011-5; So EY, 2007, MOL IMMUNOL, V44, P3416, DOI 10.1016/j.molimm.2007.02.022; Sokol CL, 2010, CURR OPIN IMMUNOL, V22, P73, DOI 10.1016/j.coi.2010.01.012; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Yamane H, 2005, J EXP MED, V202, P793, DOI 10.1084/jem.20051304; YOSHIMOTO T, 1994, J EXP MED, V179, P1285, DOI 10.1084/jem.179.4.1285; Zhu JF, 2010, IMMUNOL REV, V238, P247, DOI 10.1111/j.1600-065X.2010.00951.x	20	12	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2830	2835		10.1074/jbc.M111.319947	http://dx.doi.org/10.1074/jbc.M111.319947			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22130674	hybrid, Green Published			2022-12-27	WOS:000300292300054
J	Scheidt, HA; Morgado, I; Rothemund, S; Huster, D				Scheidt, Holger A.; Morgado, Isabel; Rothemund, Sven; Huster, Daniel			Dynamics of Amyloid beta Fibrils Revealed by Solid-state NMR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-MAGNETIC-RESONANCE; STRUCTURAL MODEL; POLYMORPHISM; A-BETA(1-40); PEPTIDE; SPECTROSCOPY; DOMAIN	We have investigated the site-specific backbone dynamics of mature amyloid beta (A beta) fibrils using solid-state NMR spectroscopy. Overall, the known beta-sheet segments and the turn linking these two beta-strands exhibit high order parameters between 0.8 and 0.95, suggesting low conformational flexibility. The first approximately eight N-terminal and the last C-terminal residues exhibit lower order parameters between similar to 0.4 and 0.8. Interestingly, the order parameters increase again for the first two residues, Asp(1) and Ala(2), suggesting that the N terminus could carry some structural importance.	[Huster, Daniel] Univ Leipzig, Inst Med Phys & Biophys, D-04107 Leipzig, Germany; [Morgado, Isabel] Univ Halle Wittenberg, Inst Biochem Biotechnol, D-06120 Halle, Germany; [Rothemund, Sven] Univ Leipzig, Interdisciplinary Ctr Clin Res, D-04103 Leipzig, Germany	Leipzig University; Martin Luther University Halle Wittenberg; Leipzig University	Huster, D (corresponding author), Univ Leipzig, Inst Med Phys & Biophys, Hartelstr 16-18, D-04107 Leipzig, Germany.	daniel.huster@medizin.uni-leipzig.de	Morgado, Isabel/J-4798-2013; Scheidt, Holger A./C-1416-2014	Morgado, Isabel/0000-0002-7826-997X; 	Deutsche Forschungsgemeinschaft [Transregio-SFB 102]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (Transregio-SFB 102, A6 and a personal grant to I. M.).	Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; Barre P, 2003, BIOCHEMISTRY-US, V42, P8377, DOI 10.1021/bi034239e; Bertini I, 2011, J AM CHEM SOC, V133, P16013, DOI 10.1021/ja2035859; Buchete NV, 2007, BIOPHYS J, V92, P3032, DOI 10.1529/biophysj.106.100404; Chimon S, 2007, NAT STRUCT MOL BIOL, V14, P1157, DOI 10.1038/nsmb1345; Colletier JP, 2011, P NATL ACAD SCI USA, V108, P16938, DOI 10.1073/pnas.1112600108; Fandrich M, 2011, TRENDS BIOCHEM SCI, V36, P338, DOI 10.1016/j.tibs.2011.02.002; Heise H, 2005, P NATL ACAD SCI USA, V102, P15871, DOI 10.1073/pnas.0506109102; Helmus JJ, 2010, J AM CHEM SOC, V132, P2393, DOI 10.1021/ja909827v; Hoyer W, 2008, P NATL ACAD SCI USA, V105, P5099, DOI 10.1073/pnas.0711731105; Huster D, 2005, PROG NUCL MAG RES SP, V46, P79, DOI 10.1016/j.pnmrs.2005.01.001; Huster D, 2001, BIOCHEMISTRY-US, V40, P7662, DOI 10.1021/bi0027231; Kodali R, 2010, J MOL BIOL, V401, P503, DOI 10.1016/j.jmb.2010.06.023; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Miller Y, 2011, J AM CHEM SOC, V133, P2742, DOI 10.1021/ja1100273; MUNOWITZ MG, 1981, J AM CHEM SOC, V103, P2529, DOI 10.1021/ja00400a007; Olofsson A, 2007, BIOCHEM J, V404, P63, DOI 10.1042/BJ20061561; Paravastu AK, 2006, BIOPHYS J, V90, P4618, DOI 10.1529/biophysj.105.076927; Paravastu AK, 2009, P NATL ACAD SCI USA, V106, P7443, DOI 10.1073/pnas.0812033106; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Sachse C, 2008, P NATL ACAD SCI USA, V105, P7462, DOI 10.1073/pnas.0712290105; Sackewitz M, 2008, J AM CHEM SOC, V130, P7172, DOI 10.1021/ja800120s; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Scheidt HA, 2011, ANGEW CHEM INT EDIT, V50, P2837, DOI 10.1002/anie.201007265; Schmidt M, 2009, P NATL ACAD SCI USA, V106, P19813, DOI 10.1073/pnas.0905007106; SZEVERENYI NM, 1982, J MAGN RESON, V47, P462, DOI 10.1016/0022-2364(82)90213-X; Tarus B, 2006, J AM CHEM SOC, V128, P16159, DOI 10.1021/ja064872y; Tycko R, 2006, Q REV BIOPHYS, V39, P1, DOI 10.1017/S0033583506004173	30	70	72	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					2017	2021		10.1074/jbc.M111.308619	http://dx.doi.org/10.1074/jbc.M111.308619			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22130659	hybrid, Green Published			2022-12-27	WOS:000299321000042
J	Kosaka, N; Iguchi, H; Yoshioka, Y; Hagiwara, K; Takeshita, F; Ochiya, T				Kosaka, Nobuyoshi; Iguchi, Haruhisa; Yoshioka, Yusuke; Hagiwara, Keitaro; Takeshita, Fumitaka; Ochiya, Takahiro			Competitive Interactions of Cancer Cells and Normal Cells via Secretory MicroRNAs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR; PROSTATE; PATHWAY	Normal epithelial cells regulate the secretion of autocrine and paracrine factors that prevent aberrant growth of neighboring cells, leading to healthy development and normal metabolism. One reason for tumor initiation is considered to be a failure of this homeostatic cell competitive system. Here we identify tumor-suppressive microRNAs (miRNAs) secreted by normal cells as anti-proliferative signal entities. Culture supernatant of normal epithelial prostate PNT-2 cells attenuated proliferation of PC-3M-luc cells, prostate cancer cells. Global analysis of miRNA expression signature revealed that a variety of tumor-suppressive miRNAs are released from PNT-2 cells. Of these miRNAs, secretory miR-143 could induce growth inhibition exclusively in cancer cells in vitro and in vivo. These results suggest that secretory tumor-suppressive miRNAs can act as a death signal in a cell competitive process. This study provides a novel insight into a tumor initiation mechanism.	[Kosaka, Nobuyoshi; Iguchi, Haruhisa; Yoshioka, Yusuke; Hagiwara, Keitaro; Takeshita, Fumitaka; Ochiya, Takahiro] Natl Canc Ctr, Div Mol & Cellular Med, Chuo Ku, Tokyo 1040045, Japan; [Iguchi, Haruhisa] Dainippon Sumitomo Pharma Co Ltd, Pharmacol Res Labs, Konohana Ku, Osaka 5540022, Japan; [Hagiwara, Keitaro] Tokyo Inst Technol, Dept Biol Informat, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 2268501, Japan	National Cancer Center - Japan; Dainippon Sumitomo Pharmaceutical Company; Tokyo Institute of Technology	Ochiya, T (corresponding author), Natl Canc Ctr, Div Mol & Cellular Med, Chuo Ku, 1-1 Tsukiji,5 Chome, Tokyo 1040045, Japan.	tochiya@ncc.go.jp	Ochiya, Takahiro/AAH-7585-2019		Ministry of Education, Culture, Sports, Science, and Technology; National Institute of Biomedical Innovation; Japan Society for the Promotion of Science through Council for Science and Technology Policy; Grants-in-Aid for Scientific Research [21115008] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Japan Society for the Promotion of Science through Council for Science and Technology Policy(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a grant-in-aid for the Third-Term Comprehensive 10-Year Strategy for Cancer Control, a grant-in-aid for Scientific Research on Priority Areas Cancer from the Ministry of Education, Culture, Sports, Science, and Technology, the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation, and the Japan Society for the Promotion of Science through the "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)" initiated by the Council for Science and Technology Policy.	Bondar T, 2010, CELL STEM CELL, V6, P309, DOI 10.1016/j.stem.2010.03.002; Bourhis XFDL, 1997, INT J CANCER, V71, P42, DOI 10.1002/(SICI)1097-0215(19970328)71:1<42::AID-IJC9>3.0.CO;2-3; Clape C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007542; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Diaz B, 2005, EXP CELL RES, V306, P317, DOI 10.1016/j.yexcr.2005.03.017; Franses JW, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001542; Fujita Y, 2010, J BIOL CHEM, V285, P19076, DOI 10.1074/jbc.M109.079525; Gandellini P, 2009, CANCER RES, V69, P2287, DOI 10.1158/0008-5472.CAN-08-2894; Gibbings DJ, 2009, NAT CELL BIOL, V11, P1143, DOI 10.1038/ncb1929; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Johnston LA, 2009, SCIENCE, V324, P1679, DOI 10.1126/science.1163862; Kong DJ, 2009, STEM CELLS, V27, P1712, DOI 10.1002/stem.101; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Kwak PB, 2010, CANCER SCI, V101, P2309, DOI 10.1111/j.1349-7006.2010.01683.x; Miyanishi M, 2007, NATURE, V450, P435, DOI 10.1038/nature06307; Pegtel DM, 2010, P NATL ACAD SCI USA, V107, P6328, DOI 10.1073/pnas.0914843107; Peng XS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020341; Rauhala HE, 2010, INT J CANCER, V127, P1363, DOI 10.1002/ijc.25162; Saito Y, 2009, BIOCHEM BIOPH RES CO, V379, P726, DOI 10.1016/j.bbrc.2008.12.098; Savina A, 2002, J CELL SCI, V115, P2505; Senoo-Matsuda N, 2007, P NATL ACAD SCI USA, V104, P18543, DOI 10.1073/pnas.0709021104; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Takeshita F, 2010, MOL THER, V18, P181, DOI 10.1038/mt.2009.207; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Xu B, 2011, MOL CELL BIOCHEM, V350, P207, DOI 10.1007/s11010-010-0700-6; Yu X, 2006, CANCER RES, V66, P4795, DOI 10.1158/0008-5472.CAN-05-4579	26	207	218	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1397	1405		10.1074/jbc.M111.288662	http://dx.doi.org/10.1074/jbc.M111.288662			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22123823	Green Published, hybrid			2022-12-27	WOS:000299170300053
J	Schwindinger, WF; Mirshahi, UL; Baylor, KA; Sheridan, KM; Stauffer, AM; Usefof, S; Stecker, MM; Mirshahi, T; Robishaw, JD				Schwindinger, William F.; Mirshahi, Uyenlinh L.; Baylor, Kelly A.; Sheridan, Kathleen M.; Stauffer, Anna M.; Usefof, Stephanie; Stecker, Mark M.; Mirshahi, Tooraj; Robishaw, Janet D.			Synergistic Roles for G-protein gamma(3) and gamma(7) Subtypes in Seizure Susceptibility as Revealed in Double Knock-out Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOPAMINE D1 RECEPTOR; KETOGENIC DIET; IMMUNOHISTOCHEMICAL LOCALIZATION; GABA(B) RECEPTORS; EEG COHERENCE; BRAIN-INJURY; ADENOSINE; LACKING; SUBUNITS; NEURONS	The functions of differentG-protein alpha beta gamma subunit combinations are traditionally ascribed to their various alpha components. However, the discovery of similarly diverse gamma subtypes raises the possibility that they may also contribute to specificity. To test this possibility, we used a gene targeting approach to determine whether the closely related gamma(3) and gamma(7) subunits can perform functionally interchangeable roles in mice. In contrast to single knock-out mice that show normal survival, Gng3(-/-) Gng7(-/-) double knock-out mice display a progressive seizure disorder that dramatically reduces their median life span to only 75 days. Biochemical analyses reveal that the severe phenotype is not due to redundant roles for the two gamma subunits in the same signaling pathway but rather is attributed to their unique actions in different signaling pathways. The results suggest that the gamma(3) subunit is a component of a G(i/o) protein that is required for gamma-aminobutyric acid, type B, receptor-regulated neuronal excitability, whereas the gamma(7) subunit is a component of a G(olf) protein that is responsible for A(2A) adenosine or D-1 dopamine receptor-induced neuro-protective response. The development of this mouse model offers a novel experimental framework for exploring how signaling pathways integrate to produce normal brain function and how their combined dysfunction leads to spontaneous seizures and premature death. The results underscore the critical role of the gamma subunit in this process.	[Schwindinger, William F.; Mirshahi, Uyenlinh L.; Baylor, Kelly A.; Sheridan, Kathleen M.; Stauffer, Anna M.; Usefof, Stephanie; Stecker, Mark M.; Mirshahi, Tooraj; Robishaw, Janet D.] Geisinger Med Clin, Weis Ctr Res, Danville, PA 17822 USA	Geisinger Medical Center	Robishaw, JD (corresponding author), 100 N Acad Ave, Danville, PA 17822 USA.	jrobishaw@geisinger.edu		Stecker, Mark/0000-0002-9632-168X	National Institutes of Health [GM039867]; American Heart Association [0765275U]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039867, R29GM039867] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM039867 (to J. D. R.). This work was also supported by American Heart Association-Great Rivers Affiliate Beginning Grant-in-aid 0765275U (to T.M.).	ANDERSON KD, 1991, BRAIN RES, V568, P235, DOI 10.1016/0006-8993(91)91403-N; BANKER G, 1988, NATURE, V336, P185, DOI 10.1038/336185a0; Bernacer J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001174; Bertran-Gonzalez J, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00136; CALABRESI P, 1991, J PHYSIOL-LONDON, V440, P581, DOI 10.1113/jphysiol.1991.sp018726; Charara A, 2000, NEUROSCIENCE, V95, P127; Charles KJ, 2001, NEUROSCIENCE, V106, P447, DOI 10.1016/S0306-4522(01)00296-2; Chen JF, 2007, PROG NEUROBIOL, V83, P310, DOI 10.1016/j.pneurobio.2007.09.002; Chou SY, 2005, J NEUROCHEM, V93, P310, DOI 10.1111/j.1471-4159.2005.03029.x; Cross JH, 2010, ARCH DIS CHILD, V95, P550, DOI 10.1136/adc.2009.159848; Dai SS, 2010, J NEUROSCI, V30, P5802, DOI 10.1523/JNEUROSCI.0268-10.2010; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; DRAGO J, 1994, P NATL ACAD SCI USA, V91, P12564, DOI 10.1073/pnas.91.26.12564; Dupre DJ, 2009, ANNU REV PHARMACOL, V49, P31, DOI 10.1146/annurev-pharmtox-061008-103038; DURING MJ, 1992, ANN NEUROL, V32, P618, DOI 10.1002/ana.410320504; Eder DN, 2003, J PSYCHIAT RES, V37, P305, DOI 10.1016/S0022-3956(03)00007-4; Gantois I, 2007, P NATL ACAD SCI USA, V104, P4182, DOI 10.1073/pnas.0611625104; Gassmann M, 2004, J NEUROSCI, V24, P6086, DOI 10.1523/JNEUROSCI.5635-03.2004; Hartman AL, 2007, PEDIATR NEUROL, V36, P281, DOI 10.1016/j.pediatrneurol.2007.02.008; Hildebrandt JD, 1997, BIOCHEM PHARMACOL, V54, P325, DOI 10.1016/S0006-2952(97)00269-4; Isler JR, 2010, CLIN NEUROPHYSIOL, V121, P2035, DOI 10.1016/j.clinph.2010.05.004; Jones PA, 1998, NEUROSCIENCE, V85, P229, DOI 10.1016/S0306-4522(97)00613-1; Kerns RT, 2005, J NEUROSCI, V25, P2255, DOI 10.1523/JNEUROSCI.4372-04.2005; Kitaoka K, 2011, BRAIN RES, V1423, P10, DOI 10.1016/j.brainres.2011.09.023; Kreitzer AC, 2009, ANNU REV NEUROSCI, V32, P127, DOI 10.1146/annurev.neuro.051508.135422; Leaney JL, 2003, EUR J NEUROSCI, V18, P2110, DOI 10.1046/j.1460-9568.2003.02933.x; Ledent C, 1997, NATURE, V388, P674, DOI 10.1038/41771; Li W, 2009, EXP NEUROL, V215, P69, DOI 10.1016/j.expneurol.2008.09.012; LI Y, 1994, J BIOL CHEM, V269, P27589; Lopez-Meraz ML, 2010, NEUROBIOL DIS, V37, P394, DOI 10.1016/j.nbd.2009.10.019; Ma WY, 2007, J NEUROSCI, V27, P3618, DOI 10.1523/JNEUROSCI.0132-07.2007; Mantis John G, 2004, Nutr Metab (Lond), V1, P11, DOI 10.1186/1743-7075-1-11; Miskovic V, 2010, DEV PSYCHOPATHOL, V22, P419, DOI 10.1017/S0954579410000155; Neal EG, 2010, J HUM NUTR DIET, V23, P113, DOI 10.1111/j.1365-277X.2010.01043.x; Nylen K, 2008, EXP NEUROL, V210, P449, DOI 10.1016/j.expneurol.2007.11.015; Oldenburg IA, 2011, CURR OPIN NEUROBIOL, V21, P425, DOI 10.1016/j.conb.2011.04.004; Padgett CL, 2010, ADV PHARMACOL, V58, P123, DOI 10.1016/S1054-3589(10)58006-2; Perez-Garci E, 2006, NEURON, V50, P603, DOI 10.1016/j.neuron.2006.04.019; Pinard A, 2010, ADV PHARMACOL, V58, P231, DOI 10.1016/S1054-3589(10)58010-4; Prosser HM, 2001, MOL CELL NEUROSCI, V17, P1059, DOI 10.1006/mcne.2001.0995; Rau TF, 2011, NEUROPHARMACOLOGY, V61, P677, DOI 10.1016/j.neuropharm.2011.05.010; Robishaw J. D., 2009, HDB CELL SIGNALING, P623; ROBISHAW JD, 1994, METHOD ENZYMOL, V237, P498; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; Schuler V, 2001, NEURON, V31, P47, DOI 10.1016/S0896-6273(01)00345-2; Schwindinger WF, 2004, MOL CELL BIOL, V24, P7758, DOI 10.1128/MCB.24.17.7758-7768.2004; Schwindinger WF, 2003, J BIOL CHEM, V278, P6575, DOI 10.1074/jbc.M211132200; Schwindinger WF, 2010, J BIOL CHEM, V285, P29787, DOI 10.1074/jbc.M110.142620; Schwindinger WF, 2009, AM J PHYSIOL-REG I, V297, pR1494, DOI 10.1152/ajpregu.00308.2009; Signorini S, 1997, P NATL ACAD SCI USA, V94, P923, DOI 10.1073/pnas.94.3.923; Smrcka AV, 2008, CELL MOL LIFE SCI, V65, P2191, DOI 10.1007/s00018-008-8006-5; So EL, 2010, J CLIN NEUROPHYSIOL, V27, P227, DOI 10.1097/WNP.0b013e3181eaa60e; Sodickson DL, 1998, J NEUROSCI, V18, P8153; Stone Trevor W, 2009, Handb Exp Pharmacol, P535, DOI 10.1007/978-3-540-89615-9_17; Styer AM, 2010, J BIOL CHEM, V285, P41290, DOI 10.1074/jbc.M110.178541; TECOTT LH, 1995, NATURE, V374, P542, DOI 10.1038/374542a0; Vigot R, 2006, NEURON, V50, P589, DOI 10.1016/j.neuron.2006.04.014; Winterer G, 2001, SCHIZOPHR RES, V49, P129, DOI 10.1016/S0920-9964(00)00128-6; XU M, 1994, CELL, V79, P729, DOI 10.1016/0092-8674(94)90557-6; Yang WL, 2006, CELL SIGNAL, V18, P194, DOI 10.1016/j.cellsig.2005.04.011; Zimmermann G, 1998, J BIOL CHEM, V273, P19650, DOI 10.1074/jbc.273.31.19650	61	32	35	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7121	7133		10.1074/jbc.M111.308395	http://dx.doi.org/10.1074/jbc.M111.308395			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22207761	Green Published, hybrid			2022-12-27	WOS:000301060200016
J	Selvakumar, T; Gjidoda, A; Hovde, SL; Henry, RW				Selvakumar, Tharakeswari; Gjidoda, Alison; Hovde, Stacy L.; Henry, R. William			Regulation of Human RNA Polymerase III Transcription by DNMT1 and DNMT3a DNA Methyltransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL NUCLEAR-RNA; TUMOR-SUPPRESSOR PROTEIN; SNRNA GENE-TRANSCRIPTION; BOX-BINDING PROTEIN; TATA-BOX; RETINOBLASTOMA PROTEIN; ACTIVATING PROTEIN; COMPLEX SNAP(C); 7SK SNRNA; METHYLATION	The human small nuclear RNA (snRNA) and small cytoplasmic RNA (scRNA) gene families encode diverse non-coding RNAs that influence cellular growth and division. Many snRNA and scRNA genes are related via their compact and yet powerful promoters that support RNA polymerase III transcription. We have utilized the human U6 snRNA gene family to examine the mechanism for regulated transcription of these potent transcription units. Analysis of nine U6 family members showed enriched CpG density within the promoters of actively transcribed loci relative to inert genes, implying a relationship between gene potency and DNA methylation. Indeed, both pharmacological inhibition of DNA methyltransferase (DNMT) activity and the forced diminution of DNMT-1, DNMT-3a, and DNMT-3b by siRNA targeting resulted in increased U6 levels in asynchronously growing MCF7 adenocarcinoma cells. In vitro transcription assays further showed that template methylation impedes U6 transcription by RNA polymerase III. Both DNMT-1 and DNMT-3a were detected at the U6-1 locus by chromatin immunoprecipitation directly linking these factors to RNA polymerase III regulation. Despite this association, the endogenous U6-1 locus was not substantially methylated in actively growing cells. However, both DNMT occupancy and low frequency methylation were correlated with increased Retinoblastoma tumor suppressor (RB) expression, suggesting that the RB status can influence specific epigenetic marks.	[Selvakumar, Tharakeswari; Gjidoda, Alison; Hovde, Stacy L.; Henry, R. William] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Selvakumar, Tharakeswari; Henry, R. William] Michigan State Univ, Cell & Mol Biol Program, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Henry, RW (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, Rm 409 Biochem Bldg,Wilson Rd, E Lansing, MI 48824 USA.	henryrw@msu.edu			National Institutes of Health [R01-GM59805]; Michigan State University Gene Expression in Development and Disease Initiative; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059805] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michigan State University Gene Expression in Development and Disease Initiative; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-GM59805. This work was also supported by the Michigan State University Gene Expression in Development and Disease Initiative.	BAER MF, 1988, J BIOL CHEM, V263, P2344; Bai SM, 2006, J BIOL CHEM, V281, P13604, DOI 10.1074/jbc.M513278200; Ballestar E, 2008, ADV GENET, V61, P247, DOI 10.1016/S0065-2660(07)00009-0; Banati F, 2008, FEBS LETT, V582, P705, DOI 10.1016/j.febslet.2008.01.042; Cabart P, 2001, J BIOL CHEM, V276, P43056, DOI 10.1074/jbc.M108515200; Cairns CA, 1998, EMBO J, V17, P3112, DOI 10.1093/emboj/17.11.3112; Chesnokov I, 1996, MOL CELL BIOL, V16, P7084; Chu WM, 1997, J BIOL CHEM, V272, P14755, DOI 10.1074/jbc.272.23.14755; Domitrovich AM, 2003, NUCLEIC ACIDS RES, V31, P2344, DOI 10.1093/nar/gkg331; Egloff S, 2008, BIOCHEM SOC T, V36, P590, DOI 10.1042/BST0360590; Ehrlich M, 2002, ONCOGENE, V21, P5400, DOI 10.1038/sj.onc.1205651; Esteller M, 2007, HUM MOL GENET, V16, pR50, DOI 10.1093/hmg/ddm018; Fatemi M, 2002, EUR J BIOCHEM, V269, P4981, DOI 10.1046/j.1432-1033.2002.03198.x; Felton-Edkins ZA, 2003, CELL CYCLE, V2, P181, DOI 10.4161/cc.2.3.375; Gardiner TJ, 2009, RNA, V15, P1375, DOI 10.1261/rna.1472009; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Gomez-Roman N, 2003, NATURE, V421, P290, DOI 10.1038/nature01327; Gridasova AA, 2005, MOL CELL BIOL, V25, P3247, DOI 10.1128/MCB.25.8.3247-3260.2005; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HENRY RW, 1995, NATURE, V374, P653, DOI 10.1038/374653a0; Henry RW, 1996, EMBO J, V15, P7129, DOI 10.1002/j.1460-2075.1996.tb01104.x; Henry RW, 1998, GENE DEV, V12, P2664, DOI 10.1101/gad.12.17.2664; Hermann A, 2004, CELL MOL LIFE SCI, V61, P2571, DOI 10.1007/s00018-004-4201-1; Hinkley CS, 2003, J BIOL CHEM, V278, P18649, DOI 10.1074/jbc.M204247200; Hirsch HA, 2004, MOL CELL BIOL, V24, P5989, DOI 10.1128/MCB.24.13.5989-5999.2004; Hirsch HA, 2000, MOL CELL BIOL, V20, P9182, DOI 10.1128/MCB.20.24.9182-9191.2000; Hu P, 2004, MOL CELL, V16, P81, DOI 10.1016/j.molcel.2004.09.008; Jawdekar GW, 2008, BBA-GENE REGUL MECH, V1779, P295, DOI 10.1016/j.bbagrm.2008.04.001; Jiang H, 2000, ONCOGENE, V19, P3878, DOI 10.1038/sj.onc.1203722; JUTTERMANN R, 1991, J VIROL, V65, P1735; Kangaspeska S, 2008, NATURE, V452, P112, DOI 10.1038/nature06640; KUNKEL GR, 1986, P NATL ACAD SCI USA, V83, P8575, DOI 10.1073/pnas.83.22.8575; Lobo Ruppert Susan M., 1996, Hybridoma, V15, P55; LOBO SM, 1989, CELL, V58, P55, DOI 10.1016/0092-8674(89)90402-9; LOBO SM, 1990, NUCLEIC ACIDS RES, V18, P2891, DOI 10.1093/nar/18.10.2891; Lorincz MC, 2004, NAT STRUCT MOL BIOL, V11, P1068, DOI 10.1038/nsmb840; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Michels AA, 2004, EMBO J, V23, P2608, DOI 10.1038/sj.emboj.7600275; Michels AA, 2010, MOL CELL BIOL, V30, P3749, DOI 10.1128/MCB.00319-10; MURPHY S, 1987, CELL, V51, P81, DOI 10.1016/0092-8674(87)90012-2; Nguyen VT, 2001, NATURE, V414, P322, DOI 10.1038/35104581; Noonberg SB, 1996, J BIOL CHEM, V271, P10477, DOI 10.1074/jbc.271.18.10477; Pradhan S, 2002, EMBO J, V21, P779, DOI 10.1093/emboj/21.4.779; Reina JH, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000134; Roberts DN, 2006, MOL CELL, V22, P633, DOI 10.1016/j.molcel.2006.04.009; Robertson KD, 2000, NAT GENET, V25, P338, DOI 10.1038/77124; Rohde C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-230; Rountree MR, 1997, GENE DEV, V11, P2383, DOI 10.1101/gad.11.18.2383; Sadowski CL, 1996, P NATL ACAD SCI USA, V93, P4289, DOI 10.1073/pnas.93.9.4289; SADOWSKI CL, 1993, GENE DEV, V7, P1535, DOI 10.1101/gad.7.8.1535; Santoro R, 2001, MOL CELL, V8, P719, DOI 10.1016/S1097-2765(01)00317-3; Schramm L, 2000, GENE DEV, V14, P2650, DOI 10.1101/gad.836400; SHARP PA, 1987, SCIENCE, V235, P766, DOI 10.1126/science.3544217; Shor B, 2010, J BIOL CHEM, V285, P15380, DOI 10.1074/jbc.M109.071639; SNEIDER TW, 1980, NUCLEIC ACIDS RES, V8, P3829, DOI 10.1093/nar/8.17.3829; Stirzaker C, 1997, CANCER RES, V57, P2229; Sutcliffe JE, 2000, MOL CELL BIOL, V20, P9192, DOI 10.1128/MCB.20.24.9192-9202.2000; WEINBERG RA, 1968, J MOL BIOL, V38, P289, DOI 10.1016/0022-2836(68)90387-2; White RJ, 1996, NATURE, V382, P88, DOI 10.1038/382088a0; Wong MW, 1998, MOL CELL BIOL, V18, P368, DOI 10.1128/MCB.18.1.368; Yang ZY, 2001, NATURE, V414, P317, DOI 10.1038/35104575; Yik JHN, 2003, MOL CELL, V12, P971, DOI 10.1016/S1097-2765(03)00388-5	62	20	20	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7039	7050		10.1074/jbc.M111.285601	http://dx.doi.org/10.1074/jbc.M111.285601			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22219193	hybrid, Green Published			2022-12-27	WOS:000301060200009
J	Xia, W; Li, HY; Yang, XM; Wong, KB; Sun, HZ				Xia, Wei; Li, Hongyan; Yang, Xinming; Wong, Kam-Bo; Sun, Hongzhe			Metallo-GTPase HypB from Helicobacter pylori and Its Interaction with Nickel Chaperone Protein HypA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTIDINE-RICH PROTEIN; BINDING; HYDROGENASE; UREASE; MATURATION; METALLOCHAPERONE; TITRATION; INSERTION; SYNTHASE; DOMAIN	The maturation of [NiFe]-hydrogenase is highly dependent on a battery of chaperone proteins. Among these, HypA and HypB were proposed to exert nickel delivery functions in the metallocenter assembly process, although the detailed mechanism remains unclear. Herein, we have overexpressed and purified wild-type HypB as well as two mutants, K168A and M186L/F190V, from Helicobacter pylori. We demonstrated that all proteins bind Ni2+ at a stoichiometry of one Ni2+ per monomer of the proteins with dissociation constants at micromolar levels. Ni2+ elevated GTPase activity of WT HypB, which is attributable to a lower affinity of the protein toward GDP as well as Ni2+-induced dimerization. The disruption of GTP-dependent dimerization has led to GTPase activities of both mutants in apo-forms almost completely abolished, compared with the wild-type protein. The GTPase activity is partially restored for HypB(M186L/F190V) mutant but not for HypB(K168A) mutant upon Ni2+ binding. HypB forms a complex with its partner protein HypA with a low affinity (K-d of 52.2 +/- 8.8 mu M). Such interactions were also observed in vivo both in the absence and presence of nickel using a GFP-fragment reassembly technique. The putative protein-protein interfaces on H. pylori HypA and HypB proteins were identified by NMR chemical shift perturbation and mutagenesis studies, respectively. Intriguingly, the unique N terminus of H. pylori HypB was identified to participate in the interaction with H. pylori HypA. These structural and functional studies provide insight into the molecular mechanism of Ni2+ delivery during maturation of [NiFe]-hydrogenase.	[Xia, Wei; Li, Hongyan; Yang, Xinming; Sun, Hongzhe] Univ Hong Kong, Dept Chem, Hong Kong, Hong Kong, Peoples R China; [Wong, Kam-Bo] Chinese Univ Hong Kong, Sch Life Sci, Ctr Prot Sci & Crystallog, Shatin, Hong Kong, Peoples R China	University of Hong Kong; Chinese University of Hong Kong	Sun, HZ (corresponding author), Univ Hong Kong, Dept Chem, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.	hsun@hku.hk	Wong, Kam-Bo/G-4258-2013; Wong, Kam-Bo/AAU-9364-2021; xia, wei/C-2628-2015; /D-3123-2009	Wong, Kam-Bo/0000-0002-6984-5373; Wong, Kam-Bo/0000-0002-6984-5373; xia, wei/0000-0001-6480-3265; /0000-0001-6697-6899; YANG, Xinming/0000-0001-6240-5212	Council of Hong Kong [HKU1/07C, HKU7042/07P, HKU7049/09P, N_HKU752/09, CUHK4610/06]; Croucher Foundation; University of Hong Kong	Council of Hong Kong(Hong Kong Research Grants Council); Croucher Foundation; University of Hong Kong(University of Hong Kong)	This work was supported by Research Grants Council of Hong Kong Grants HKU1/07C, HKU7042/07P, HKU7049/09P, N_HKU752/09, and CUHK4610/06, the Croucher Foundation, and the University of Hong Kong.	Ajees AA, 2011, BIOMETALS, V24, P391, DOI 10.1007/s10534-010-9398-x; Bai YC, 2008, ANAL CHIM ACTA, V616, P115, DOI 10.1016/j.aca.2008.04.003; Bauerfeind P, 1997, GUT, V40, P25, DOI 10.1136/gut.40.1.25; Blokesch M, 2002, BIOCHEM SOC T, V30, P674, DOI 10.1042/BST0300674; Cheng T., 2011, J BIOL INORG CHEM, DOI [10.1007/s00775-011-0855y, DOI 10.1007/S00775-011-0855Y]; Ciurli S., 2009, PROTEINS, V74, P222; Covacci A, 1999, SCIENCE, V284, P1328, DOI 10.1126/science.284.5418.1328; Cun SJ, 2008, J BIOL CHEM, V283, P15142, DOI 10.1074/jbc.M800591200; Cun SJ, 2010, P NATL ACAD SCI USA, V107, P4943, DOI 10.1073/pnas.0913970107; Cunha L, 2008, PROTEINS, V71, P855, DOI 10.1002/prot.21755; Danielli A, 2010, FEMS MICROBIOL REV, V34, P738, DOI 10.1111/j.1574-6976.2010.00233.x; Forzi L, 2007, BIOMETALS, V20, P565, DOI 10.1007/s10534-006-9048-5; Freyer MW, 2008, METHOD CELL BIOL, V84, P79, DOI 10.1016/S0091-679X(07)84004-0; Gasper R, 2006, J BIOL CHEM, V281, P27492, DOI 10.1074/jbc.M600809200; Gasper R, 2009, NAT REV MOL CELL BIO, V10, P423, DOI 10.1038/nrm2689; Ge RG, 2006, BIOCHEM J, V393, P285, DOI 10.1042/BJ20051160; Ge RG, 2006, J AM CHEM SOC, V128, P11330, DOI 10.1021/ja062589t; Jeoung JH, 2009, BIOCHEMISTRY-US, V48, P11505, DOI 10.1021/bi901443z; Kaluarachchi H, 2011, BIOCHEMISTRY-US, V50, P10761, DOI 10.1021/bi201590d; Kunzelmann S, 2005, METHOD ENZYMOL, V404, P512, DOI 10.1016/S0076-6879(05)04045-0; Leach MR, 2007, CURR OPIN CHEM BIOL, V11, P159, DOI 10.1016/j.cbpa.2007.01.011; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Lin YF, 2006, P NATL ACAD SCI USA, V103, P15617, DOI 10.1073/pnas.0603974103; Ma C, 2011, NAT STRUCT MOL BIOL, V18, P542, DOI 10.1038/nsmb.2047; Macomber L, 2011, METALLOMICS, V3, P1153, DOI 10.1039/c1mt00063b; Maier RJ, 2007, BIOMETALS, V20, P655, DOI 10.1007/s10534-006-9061-8; MAIER T, 1995, EUR J BIOCHEM, V230, P133, DOI 10.1111/j.1432-1033.1995.tb20543.x; MARSHALL BJ, 1984, LANCET, V1, P1311; Mehta N, 2003, J BACTERIOL, V185, P726, DOI 10.1128/JB.185.3.726-734.2003; Morell M, 2007, PROTEOMICS, V7, P1023, DOI 10.1002/pmic.200600966; Olson JW, 2002, SCIENCE, V298, P1788, DOI 10.1126/science.1077123; Olson JW, 2001, MOL MICROBIOL, V39, P176, DOI 10.1046/j.1365-2958.2001.02244.x; PARSONNET J, 1991, JNCI-J NATL CANCER I, V83, P640, DOI 10.1093/jnci/83.9.640; Roberts G. C. K., 1993, NMR MACROMOLECULES P, P153; Rosen BP, 2002, FEBS LETT, V529, P86, DOI 10.1016/S0014-5793(02)03186-1; Stingl K, 2008, MOL CELL PROTEOMICS, V7, P2429, DOI 10.1074/mcp.M800160-MCP200; Sydor AM, 2011, J BACTERIOL, V193, P1359, DOI 10.1128/JB.01333-10; Tugarinov V, 2003, J MOL BIOL, V327, P1121, DOI 10.1016/S0022-2836(03)00238-9; Vinogradova O, 2012, TOP CURR CHEM, V326, P35, DOI 10.1007/128_2011_216; Watanabe S, 2009, J MOL BIOL, V394, P448, DOI 10.1016/j.jmb.2009.09.030; Wilson CG, 2004, NAT METHODS, V1, P255, DOI 10.1038/nmeth1204-255; Xia W, 2009, J AM CHEM SOC, V131, P10031, DOI 10.1021/ja900543y; Yang JB, 2010, BIOCHEMISTRY-US, V49, P3658, DOI 10.1021/bi100026a; Zeng YB, 2011, CHEM-EUR J, V17, P5852, DOI 10.1002/chem.201100279; Zhang JW, 2005, J BIOL CHEM, V280, P4360, DOI 10.1074/jbc.M411799200	45	44	44	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6753	6763		10.1074/jbc.M111.287581	http://dx.doi.org/10.1074/jbc.M111.287581			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22179820	Green Published, hybrid			2022-12-27	WOS:000300791800061
J	Wu, N; Rollin, J; Masse, I; Lamartine, J; Gidrol, X				Wu, Ning; Rollin, Jerome; Masse, Ingrid; Lamartine, Jerome; Gidrol, Xavier			p63 Regulates Human Keratinocyte Proliferation via MYC-regulated Gene Network and Differentiation Commitment through Cell Adhesion-related Gene Network	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL STEM-CELLS; C-MYC; HAIR FOLLICLE; PROGENITOR CELLS; BETA-CATENIN; EXPRESSION; GROWTH; NOTCH; SKIN; ACTIVATION	Although p63 and MYC are important in the control of epidermal homeostasis, the underlying molecular mechanisms governing keratinocyte proliferation or differentiation downstream of these two genes are not completely understood. By analyzing the transcriptional changes and phenotypic consequences of the loss of either p63 or MYC in human developmentally mature keratinocytes, we have characterized the networks acting downstream of these two genes to control epidermal homeostasis. We show that p63 is required to maintain growth and to commit to differentiation by two distinct mechanisms. Knockdown of p63 led to down-regulation of MYC via the Wnt/beta-catenin and Notch signaling pathways and in turn reduced keratinocyte proliferation. We demonstrate that a p63-controlled keratinocyte cell fate network is essential to induce the onset of keratinocyte differentiation. This network contains several secreted proteins involved in cell migration/adhesion, including fibronectin 1 (FN1), interleukin-1 beta (IL1B), cysteine-rich protein 61 (CYR61), and jagged-1 (JAG1), that act downstream of p63 as key effectors to trigger differentiation. Our results characterized for the first time a connection between p63 and MYC and a cell adhesion-related network that controls differentiation. Furthermore, we show that the balance between the MYC-controlled cell cycle progression network and the p63-controlled cell adhesion-related network could dictate skin cell fate.	[Wu, Ning; Gidrol, Xavier] Commissariat Energie Atom, F-38054 Grenoble, France; [Wu, Ning; Gidrol, Xavier] INSERM, U1038, F-38054 Grenoble, France; [Wu, Ning; Gidrol, Xavier] Univ Grenoble 1, F-38000 Grenoble 1, France; [Rollin, Jerome] Hop Tours, Lab Hematol Hemostase, UMR6239, CNRS, F-37100 Tours, France; [Masse, Ingrid; Lamartine, Jerome] Univ Lyon 1, CNRS, UMR5534, Ctr Genet & Physiol Mol & Cellulaire, F-69622 Villeurbanne, France	CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CHU Tours; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Gidrol, X (corresponding author), Commissariat Energie Atom, F-38054 Grenoble, France.	xavier.gidrol@cea.fr	Jerome, Rollin/K-2157-2019	Lamartine, Jerome/0000-0003-2322-1618; Gidrol, Xavier/0000-0002-4233-3749; MASSE, Ingrid/0000-0003-3193-970X	Commissariat a l'Energie Atomique; Fondation pour la Recherche Medicale	Commissariat a l'Energie Atomique(French Atomic Energy Commission); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	Supported by Commissariat a l'Energie Atomique and Fondation pour la Recherche Medicale.	Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Arnold I, 2001, CURR BIOL, V11, P558, DOI 10.1016/S0960-9822(01)00154-3; Barbieri CE, 2006, CANCER RES, V66, P7589, DOI 10.1158/0008-5472.CAN-06-2020; Blanpain C, 2006, GENE DEV, V20, P3022, DOI 10.1101/gad.1477606; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Bull JJ, 2001, J INVEST DERMATOL, V116, P617, DOI 10.1046/j.1523-1747.2001.12771234.x; Carroll DK, 2006, NAT CELL BIOL, V8, P551, DOI 10.1038/ncb1420; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Dai X, 2004, CURR OPIN GENET DEV, V14, P485, DOI 10.1016/j.gde.2004.07.002; Devgan V, 2005, GENE DEV, V19, P1485, DOI 10.1101/gad.341405; DLUGOSZ AA, 1993, J CELL BIOL, V120, P217, DOI 10.1083/jcb.120.1.217; Estrach S, 2006, DEVELOPMENT, V133, P4427, DOI 10.1242/dev.02644; Fuchs E, 2002, NAT REV GENET, V3, P199, DOI 10.1038/nrg758; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Fuchs E, 2009, CELL STEM CELL, V4, P499, DOI 10.1016/j.stem.2009.05.001; Gandarillas A, 1997, GENE DEV, V11, P2869, DOI 10.1101/gad.11.21.2869; Gebhardt A, 2006, J CELL BIOL, V172, P139, DOI 10.1083/jcb.200506057; HASHIRO M, 1991, BIOCHEM BIOPH RES CO, V174, P287, DOI 10.1016/0006-291X(91)90518-C; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766; Jensen KB, 2006, P NATL ACAD SCI USA, V103, P11958, DOI 10.1073/pnas.0601886103; Koster MI, 2004, GENE DEV, V18, P126, DOI 10.1101/gad.1165104; Le Brigand K, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl485; Maas-Szabowski N, 2003, J CELL SCI, V116, P2937, DOI 10.1242/jcs.00474; McKeon F, 2004, GENE DEV, V18, P465, DOI 10.1101/gad.1190504; Mehic D, 2005, J INVEST DERMATOL, V124, P212, DOI 10.1111/j.0022-202X.2004.23558.x; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Muller EJ, 2008, J INVEST DERMATOL, V128, P501, DOI 10.1038/sj.jid.5701248; Nguyen BC, 2006, GENE DEV, V20, P1028, DOI 10.1101/gad.1406006; Nickoloff BJ, 2002, CELL DEATH DIFFER, V9, P842, DOI 10.1038/sj.cdd.4401036; Ogawa E, 2008, J BIOL CHEM, V283, P34241, DOI 10.1074/jbc.M804101200; OSTERLAND CK, 1990, CLIN EXP RHEUMATOL, V8, P145; PIETENPOL JA, 1990, P NATL ACAD SCI USA, V87, P3758, DOI 10.1073/pnas.87.10.3758; Pozzi S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005008; Rangarajan A, 2001, EMBO J, V20, P3427, DOI 10.1093/emboj/20.13.3427; Reuter JA, 2009, CANCER CELL, V15, P477, DOI 10.1016/j.ccr.2009.04.002; Sasaki Y, 2002, J BIOL CHEM, V277, P719, DOI 10.1074/jbc.M108080200; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Seoane J, 2002, NATURE, V419, P729, DOI 10.1038/nature01119; Seoane J, 2001, NAT CELL BIOL, V3, P400, DOI 10.1038/35070086; Shimizu H, 1997, CELL GROWTH DIFFER, V8, P1349; Slavik MA, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-9; Staller P, 2001, NAT CELL BIOL, V3, P392, DOI 10.1038/35070076; Su XH, 2009, EMBO J, V28, P1904, DOI 10.1038/emboj.2009.151; Testoni B, 2006, NUCLEIC ACIDS RES, V34, P928, DOI 10.1093/nar/gkj477; Truong AB, 2007, CELL CYCLE, V6, P295, DOI 10.4161/cc.6.3.3753; Truong AB, 2006, GENE DEV, V20, P3185, DOI 10.1101/gad.1463206; Vigano MA, 2006, EMBO J, V25, P5105, DOI 10.1038/sj.emboj.7601375; Waikel RL, 2001, NAT GENET, V28, P165, DOI 10.1038/88889; Watt FM, 2008, CURR OPIN CELL BIOL, V20, P171, DOI 10.1016/j.ceb.2008.01.010; Watt FM, 2008, NAT REV CANCER, V8, P234, DOI 10.1038/nrc2328; Watt FM, 2002, EMBO J, V21, P3919, DOI 10.1093/emboj/cdf399; Westfall MD, 2003, MOL CELL BIOL, V23, P2264, DOI 10.1128/MCB.23.7.2264-2276.2003; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yano S, 2008, J CELL PHYSIOL, V214, P1, DOI 10.1002/jcp.21300; Yu XB, 2006, STEM CELLS, V24, P876, DOI 10.1634/stemcells.2005-0598	56	56	57	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5627	5638		10.1074/jbc.M111.328120	http://dx.doi.org/10.1074/jbc.M111.328120			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22184109	Green Published, hybrid			2022-12-27	WOS:000300638000040
J	Perriches, T; Singleton, MR				Perriches, Thibaud; Singleton, Martin R.			Structure of Yeast Kinetochore Ndc10 DNA-binding Domain Reveals Unexpected Evolutionary Relationship to Tyrosine Recombinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTROMERIC DNA; TOPOISOMERASE-I; CBF3; COMPLEX; SPINDLE; COMPONENT; INSIGHTS; SKP1P; SGT1P	We have solved the x-ray structure of the N-terminal half of the yeast kinetochore protein Ndc10 at 1.9 angstrom resolution. This essential protein is a key constituent of the budding yeast centromere and is essential for the recruitment of the centromeric nucleosome and establishment of the kinetochore. The fold of the protein shows unexpected similarities to the tyrosine recombinase/lambda-integrase family of proteins, most notably Cre, with some variation in the relative position of the subdomains. This finding offers new insights into kinetochore evolution and the adaptation of a well studied protein fold to a novel role. By comparison with tyrosine recombinases and mutagenesis studies, we have been able to define some of the key DNA-binding motifs.	[Perriches, Thibaud; Singleton, Martin R.] Canc Res UK London Res Inst, Macromol Struct & Funct Lab, London WC2A 3LY, England	Cancer Research UK	Singleton, MR (corresponding author), Canc Res UK London Res Inst, Macromol Struct & Funct Lab, 44 Lincolns Inn Fields, London WC2A 3LY, England.	Martin.Singleton@cancer.org.uk		Singleton, Martin/0000-0001-5716-7715	Cancer Research UK; Cancer Research UK [15656] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	This work was supported by a grant from Cancer Research UK.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAKER RE, 1989, J BIOL CHEM, V264, P10843; Bellizzi JJ, 2007, STRUCTURE, V15, P1422, DOI 10.1016/j.str.2007.09.008; Bouck DC, 2005, P NATL ACAD SCI USA, V102, P5408, DOI 10.1073/pnas.0405925102; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Camahort R, 2007, MOL CELL, V26, P853, DOI 10.1016/j.molcel.2007.05.013; CARBON J, 1984, J CELL SCI, P43; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; Cheng CH, 1998, CELL, V92, P841, DOI 10.1016/S0092-8674(00)81411-7; Cho US, 2012, NAT STRUCT MOL BIOL, V19, P48, DOI 10.1038/nsmb.2178; CLARKE L, 1980, NATURE, V287, P504, DOI 10.1038/287504a0; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Espelin CW, 1997, J CELL BIOL, V139, P1383, DOI 10.1083/jcb.139.6.1383; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Furuyama S, 2007, P NATL ACAD SCI USA, V104, P14706, DOI 10.1073/pnas.0706985104; Ghosh K, 2005, J BIOL CHEM, V280, P8290, DOI 10.1074/jbc.M411668200; Gibb B, 2010, NUCLEIC ACIDS RES, V38, P5817, DOI 10.1093/nar/gkq384; Gillis AN, 2005, J CELL BIOL, V171, P773, DOI 10.1083/jcb.200507017; Glover CVC, 1998, PROG NUCLEIC ACID RE, V59, P95; GOH PY, 1993, J CELL BIOL, V121, P503, DOI 10.1083/jcb.121.3.503; Guo F, 1997, NATURE, V389, P40, DOI 10.1038/37925; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; JIANG WD, 1993, J CELL BIOL, V121, P513, DOI 10.1083/jcb.121.3.513; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; LECHNER J, 1991, CELL, V64, P717, DOI 10.1016/0092-8674(91)90501-O; Lingelbach LB, 2004, MOL CELL BIOL, V24, P8938, DOI 10.1128/MCB.24.20.8938-8950.2004; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Meraldi P, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r23; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nunes-Duby SE, 2002, J BACTERIOL, V184, P1385, DOI 10.1128/JB.184.5.1385-1394.2002; Peng YT, 2011, MOL BIOL CELL, V22, P2680, DOI 10.1091/mbc.E10-11-0915; Pietrasanta LI, 1999, P NATL ACAD SCI USA, V96, P3757, DOI 10.1073/pnas.96.7.3757; Purvis A, 2008, EMBO REP, V9, P56, DOI 10.1038/sj.embor.7401139; Redinbo MR, 1998, SCIENCE, V279, P1504, DOI 10.1126/science.279.5356.1504; Rodrigo-Brenni MC, 2004, MOL BIOL CELL, V15, P3366, DOI 10.1091/mbc.E03-12-0887; Romao M, 2008, J STRUCT BIOL, V163, P18, DOI 10.1016/j.jsb.2008.03.015; Russell ID, 1999, J CELL BIOL, V145, P933, DOI 10.1083/jcb.145.5.933; Santaguida S, 2009, EMBO J, V28, P2511, DOI 10.1038/emboj.2009.173; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; Stemmann O, 2002, P NATL ACAD SCI USA, V99, P8585, DOI 10.1073/pnas.082223899; Widlund PO, 2006, MOL BIOL CELL, V17, P1065, DOI 10.1091/mbc.E05-07-0640	43	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					5173	5179		10.1074/jbc.C111.318501	http://dx.doi.org/10.1074/jbc.C111.318501			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22215672	hybrid, Green Published			2022-12-27	WOS:000300608500075
J	Seabold, GK; Wang, PY; Petralia, RS; Chang, K; Zhou, A; McDermott, MI; Wang, YX; Milgram, SL; Wenthold, RJ				Seabold, Gail K.; Wang, Philip Y.; Petralia, Ronald S.; Chang, Kai; Zhou, Arthur; McDermott, Mark I.; Wang, Ya-Xian; Milgram, Sharon L.; Wenthold, Robert J.			Dileucine and PDZ-binding Motifs Mediate Synaptic Adhesion-like Molecule 1 (SALM1) Trafficking in Hippocampal Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER RETENTION SIGNAL; MENTAL-RETARDATION; DENDRITIC SPINES; PLASMA-MEMBRANE; RECEPTOR; NMDA; PROTEINS; FAMILY; EXPRESSION; RHO	Synaptic adhesion-like molecules (SALMs) are a family of cell adhesion molecules involved in neurite outgrowth and synapse formation. Of the five family members, only SALM1, -2, and -3 contain a cytoplasmic C-terminal PDZ-binding motif. We have found that SALM1 is unique among the SALMs because deletion of its PDZ-binding motif (SALM1 Delta PDZ) blocks its surface expression in heterologous cells. When expressed in hippocampal neurons, SALM1 Delta PDZ had decreased surface expression in dendrites and the cell soma but not in axons, suggesting that the PDZ-binding domain may influence cellular trafficking of SALMs to specific neuronal locations. Endoglycosidase H digestion assays indicated that SALM1 Delta PDZ is retained in the endoplasmic reticulum (ER) in heterologous cells. However, when the entire C-terminal tail of SALM1 was deleted, SALM1 was detected on the cell surface. Using serial deletions, we identified a region of SALM1 that contains a putative dileucine ER retention motif, which is not present in the other SALMs. Mutation of this DXXXLL motif allowed SALM1 to leave the ER and enhanced its surface expression in heterologous cells and neurons. An increase in the number of protrusions at the dendrites and cell body was observed when this SALM1 mutant was expressed in hippocampal neurons. With electron microscopy, these protrusions appeared to be irregular, enlarged spines and filopodia. Thus, enrichment of SALM1 on the cell surface affects dendritic arborization, and intracellular motifs regulate its dendritic versus axonal localization.	[Seabold, Gail K.; Wang, Philip Y.; Petralia, Ronald S.; Chang, Kai; Zhou, Arthur; Wang, Ya-Xian; Wenthold, Robert J.] NIDCD, Neurochem Lab, Bethesda, MD 20892 USA; [Seabold, Gail K.; McDermott, Mark I.; Milgram, Sharon L.] NHLBI, Kidney & Electrolyte Metab Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Seabold, GK (corresponding author), NIDCD, NIH, 50 S Dr,Bldg 50,Rm 4144, Bethesda, MD 20892 USA.	Gail.Seabold@nih.gov			National Institutes of Health, NIDCD; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZICDC000081, ZIADC000003] Funding Source: NIH RePORTER	National Institutes of Health, NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by the National Institutes of Health, NIDCD, Intramural Research Program.	Benson D. L., 2010, HIPPOCAMPUS IN PRESS; Betancur C, 2009, TRENDS NEUROSCI, V32, P402, DOI 10.1016/j.tins.2009.04.003; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Carrel D, 2006, J CELL SCI, V119, P4276, DOI 10.1242/jcs.03189; Chih B, 2004, HUM MOL GENET, V13, P1471, DOI 10.1093/hmg/ddh158; Comoletti D, 2004, J NEUROSCI, V24, P4889, DOI 10.1523/JNEUROSCI.0468-04.2004; Dalva MB, 2007, NAT REV NEUROSCI, V8, P206, DOI 10.1038/nrn2075; De Angelis E, 2002, HUM MOL GENET, V11, P1, DOI 10.1093/hmg/11.1.1; de Bruijn DRH, 2010, MOL SYNDROMOL, V1, P46, DOI 10.1159/000280290; Dierssen M, 2006, GENES BRAIN BEHAV, V5, P48, DOI 10.1111/j.1601-183X.2006.00224.x; Dong CM, 2007, BBA-BIOMEMBRANES, V1768, P853, DOI 10.1016/j.bbamem.2006.09.008; Durand CM, 2012, MOL PSYCHIATR, V17, P71, DOI 10.1038/mp.2011.57; Duvernay MT, 2004, J BIOL CHEM, V279, P30741, DOI 10.1074/jbc.M313881200; Ethell IM, 1999, J CELL BIOL, V144, P575, DOI 10.1083/jcb.144.3.575; Fairless R, 2008, J NEUROSCI, V28, P12969, DOI 10.1523/JNEUROSCI.5294-07.2008; Fan YJ, 2011, J NEUROSCI, V31, P10228, DOI 10.1523/JNEUROSCI.0115-11.2011; Francesconi A, 2002, J NEUROSCI, V22, P2196, DOI 10.1523/JNEUROSCI.22-06-02196.2002; Gauthier J, 2011, HUM GENET, V130, P563, DOI 10.1007/s00439-011-0975-z; Gustafsson MGL, 2008, BIOPHYS J, V94, P4957, DOI 10.1529/biophysj.107.120345; Hering H, 2003, J NEUROSCI, V23, P11759; HINTON VJ, 1991, AM J MED GENET, V41, P289, DOI 10.1002/ajmg.1320410306; Homma S, 2009, GENE EXPR PATTERNS, V9, P1, DOI 10.1016/j.gep.2008.09.004; Ko JW, 2006, NEURON, V50, P233, DOI 10.1016/j.neuron.2006.04.005; Konakahara S, 2011, FEBS LETT, V585, P2377, DOI 10.1016/j.febslet.2011.06.011; Lasiecka ZM, 2009, INT REV CEL MOL BIO, V272, P303, DOI 10.1016/S1937-6448(08)01607-9; Lin YL, 2007, J CELL BIOL, V177, P829, DOI 10.1083/jcb.200608121; Linhoff MW, 2009, NEURON, V61, P734, DOI 10.1016/j.neuron.2009.01.017; Loo TW, 2005, J BIOL CHEM, V280, P2522, DOI 10.1074/jbc.M411483200; Ludwig T, 2008, J BIOL CHEM, V283, P35410, DOI 10.1074/jbc.M801816200; Mah W, 2010, J NEUROSCI, V30, P5559, DOI 10.1523/JNEUROSCI.4839-09.2010; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; Marrs GS, 2001, NAT NEUROSCI, V4, P1006, DOI 10.1038/nn717; Mikhail FM, 2011, AM J MED GENET A, V155A, P2386, DOI 10.1002/ajmg.a.34177; Mogilner A, 1996, BIOPHYS J, V71, P3030, DOI 10.1016/S0006-3495(96)79496-1; Morimura N, 2006, GENE, V380, P72, DOI 10.1016/j.gene.2006.05.014; Mu YY, 2003, NEURON, V40, P581, DOI 10.1016/S0896-6273(03)00676-7; Naisbitt S, 1999, NEURON, V23, P569, DOI 10.1016/S0896-6273(00)80809-0; Nakagawa T, 2004, NEUROPHARMACOLOGY, V47, P734, DOI 10.1016/j.neuropharm.2004.07.022; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Newey SE, 2005, J NEUROBIOL, V64, P58, DOI 10.1002/neu.20153; Penzes P, 2001, NEURON, V29, P229, DOI 10.1016/S0896-6273(01)00193-3; Petralia RS, 2010, NEUROSCIENCE, V167, P68, DOI 10.1016/j.neuroscience.2010.01.022; PORTERACAILLIAU C, 2011, NEUROSCIENT IN PRESS; Poyatos I, 2000, MOL CELL NEUROSCI, V15, P99, DOI 10.1006/mcne.1999.0807; PURPURA DP, 1974, SCIENCE, V186, P1126, DOI 10.1126/science.186.4169.1126; Ramakers GJA, 2012, HUM MOL GENET, V21, P268, DOI 10.1093/hmg/ddr457; Restituito S, 2005, MOL CELL NEUROSCI, V28, P747, DOI 10.1016/j.mcn.2004.12.006; Rivera JF, 2003, NAT NEUROSCI, V6, P243, DOI 10.1038/nn1020; Robert J, 2005, J BIOL CHEM, V280, P2300, DOI 10.1074/jbc.M410655200; Rosales CR, 2005, EUR J NEUROSCI, V22, P2381, DOI 10.1111/j.1460-9568.2005.04400.x; Ruberti F, 2000, J NEUROSCI, V20, part. no.; Sampo B, 2003, NEURON, V37, P611, DOI 10.1016/S0896-6273(03)00058-8; Sans N, 2005, NAT CELL BIOL, V7, P1179, DOI 10.1038/ncb1325; Sans N, 2003, NAT CELL BIOL, V5, P520, DOI 10.1038/ncb990; Schafer MKE, 2010, NEUROBIOL DIS, V40, P222, DOI 10.1016/j.nbd.2010.05.029; Scheiffele P, 2003, ANNU REV NEUROSCI, V26, P485, DOI 10.1146/annurev.neuro.26.043002.094940; Schulein R, 1998, MOL PHARMACOL, V54, P525, DOI 10.1124/mol.54.3.525; Scott DB, 2001, J NEUROSCI, V21, P3063, DOI 10.1523/JNEUROSCI.21-09-03063.2001; Seabold GK, 2008, J BIOL CHEM, V283, P8395, DOI 10.1074/jbc.M709456200; Standley S, 2000, NEURON, V28, P887, DOI 10.1016/S0896-6273(00)00161-6; Stowell JN, 1999, NEURON, V22, P525, DOI 10.1016/S0896-6273(00)80707-2; Taniguchi H, 2007, J NEUROSCI, V27, P2815, DOI 10.1523/JNEUROSCI.0032-07.2007; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; Tran TS, 2009, NATURE, V462, P1065, DOI 10.1038/nature08628; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Wang CY, 2006, J NEUROSCI, V26, P2174, DOI 10.1523/JNEUROSCI.3799-05.2006; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Wang PY, 2008, MOL CELL NEUROSCI, V39, P83, DOI 10.1016/j.mcn.2008.05.019; Wenthold RJ, 2003, ANNU REV PHARMACOL, V43, P335, DOI 10.1146/annurev.pharmtox.43.100901.135803; Wisco D, 2003, J CELL BIOL, V162, P1317, DOI 10.1083/jcb.200307069; Xia H, 2001, NEUROPHARMACOLOGY, V41, P714, DOI 10.1016/S0028-3908(01)00103-4; Xu J, 2006, J NEUROSCI, V26, P9780, DOI 10.1523/JNEUROSCI.0840-06.2006; Yamagata M, 2003, CURR OPIN CELL BIOL, V15, P621, DOI 10.1016/S0955-0674(03)00107-8	73	11	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4470	4484		10.1074/jbc.M111.279661	http://dx.doi.org/10.1074/jbc.M111.279661			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22174418	Green Published, hybrid			2022-12-27	WOS:000300608500011
J	Yuan, FH; Qian, LY; Zhao, XL; Liu, JY; Song, LM; D'Urso, G; Jain, C; Zhang, YB				Yuan, Fenghua; Qian, Liangyue; Zhao, Xinliang; Liu, Jesse Y.; Song, Limin; D'Urso, Gennaro; Jain, Chaitanya; Zhang, Yanbin			Fanconi Anemia Complementation Group A (FANCA) Protein Has Intrinsic Affinity for Nucleic Acids with Preference for Single-stranded Forms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CROSS-LINK REPAIR; CORE COMPLEX; DNA-DAMAGE; REPLICATION FORKS; PATHWAY; CELLS; IDENTIFICATION; CHROMATIN; SLX4; LOCALIZATION	The Fanconi anemia complementation group A (FANCA) gene is one of 15 disease-causing genes and has been found to be mutated in similar to 60% of Fanconi anemia patients. Using purified protein, we report that human FANCA has intrinsic affinity for nucleic acids. FANCA binds to both single-stranded (ssDNA) and double-stranded (dsDNA) DNAs; however, its affinity for ssDNA is significantly higher than for dsDNA in an electrophoretic mobility shift assay. FANCA also binds to RNA with an intriguingly higher affinity than its DNA counterpart. FANCA requires a certain length of nucleic acids for optimal binding. Using DNA and RNA ladders, we determined that the minimum number of nucleotides required for FANCA recognition is similar to 30 for both DNA and RNA. By testing the affinity between FANCA and a variety of DNA structures, we found that a 5'-flap or 5'-tail on DNA facilitates its interaction with FANCA. A patient-derived FANCA truncation mutant (Q772X) has diminished affinity for both DNA and RNA. In contrast, the complementing C-terminal fragment of Q772X, C772-1455, retains the differentiated nucleic acid-binding activity (RNA > ssDNA > dsDNA), indicating that the nucleic acid-binding domain of FANCA is located primarily at its C terminus, where most disease-causing mutations are found.	[Yuan, Fenghua; Qian, Liangyue; Zhao, Xinliang; Liu, Jesse Y.; Song, Limin; Jain, Chaitanya; Zhang, Yanbin] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33136 USA; [D'Urso, Gennaro] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA	University of Miami; University of Miami	Zhang, YB (corresponding author), Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Gautier Bldg,Rm 310,1011 NW 15th St, Miami, FL 33136 USA.	yzhang4@med.miami.edu	Zhang, Yanbin/F-2998-2011; Jain, Chaitanya/ABA-4238-2021	Zhang, Yanbin/0000-0002-7263-5510; Jain, Chaitanya/0000-0003-2429-0105	National Institutes of Health [R01 HL105631]; Florida Biomedical Research Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105631] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Florida Biomedical Research Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL105631 (to Y.Z.). This work was also supported by a new investigator research grant from the Florida Biomedical Research Program (to Y.Z.).	Alter BP, 2003, CANCER-AM CANCER SOC, V97, P425, DOI 10.1002/cncr.11046; Auerbach AD, 2009, MUTAT RES-FUND MOL M, V668, P4, DOI 10.1016/j.mrfmmm.2009.01.013; Bakker ST, 2009, HUM MOL GENET, V18, P3484, DOI 10.1093/hmg/ddp297; Christianson TA, 2000, BLOOD, V95, P725, DOI 10.1182/blood.V95.2.725; Ciccia A, 2008, ANNU REV BIOCHEM, V77, P259, DOI 10.1146/annurev.biochem.77.070306.102408; Ciccia A, 2007, MOL CELL, V25, P331, DOI 10.1016/j.molcel.2007.01.003; Collins NB, 2009, BLOOD, V113, P2181, DOI 10.1182/blood-2008-05-154294; Crossan GP, 2011, NAT GENET, V43, P147, DOI 10.1038/ng.752; Cybulski KE, 2011, CELL CYCLE, V10, P1757, DOI 10.4161/cc.10.11.15818; D'Andrea AD, 2010, NEW ENGL J MED, V362, P1909, DOI 10.1056/NEJMra0809889; de Oca RM, 2005, BLOOD, V105, P1003, DOI 10.1182/blood-2003-11-3997; de Winter JP, 2009, MUTAT RES-FUND MOL M, V668, P11, DOI 10.1016/j.mrfmmm.2008.11.004; Du W, 2010, J BIOL CHEM, V285, P37436, DOI 10.1074/jbc.M110.113209; Fanning E, 2006, NUCLEIC ACIDS RES, V34, P4126, DOI 10.1093/nar/gkl550; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Garcia-Higuera I, 2000, BLOOD, V96, P3224, DOI 10.1182/blood.V96.9.3224.h8003224_3224_3230; Garcia-Higuera I, 1999, MOL CELL BIOL, V19, P4866; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Gari K, 2008, P NATL ACAD SCI USA, V105, P16107, DOI 10.1073/pnas.0804777105; Gari K, 2008, MOL CELL, V29, P141, DOI 10.1016/j.molcel.2007.11.032; Joenje H, 2001, NAT REV GENET, V2, P446, DOI 10.1038/35076590; Kee Y, 2010, GENE DEV, V24, P1680, DOI 10.1101/gad.1955310; Kim JM, 2008, BLOOD, V111, P5215, DOI 10.1182/blood-2007-09-113092; Kim Y, 2011, NAT GENET, V43, P142, DOI 10.1038/ng.750; Kruyt FAE, 1997, BLOOD, V90, P3288, DOI 10.1182/blood.V90.9.3288; Kutler DI, 2003, BLOOD, V101, P1249, DOI 10.1182/blood-2002-07-2170; Li YL, 1997, J CLIN INVEST, V100, P2873, DOI 10.1172/JCI119836; Ling C, 2007, EMBO J, V26, P2104, DOI 10.1038/sj.emboj.7601666; Mao GG, 2007, NUCLEIC ACIDS RES, V35, P2759, DOI 10.1093/nar/gkm189; Medhurst AL, 2006, BLOOD, V108, P2072, DOI 10.1182/blood-2005-11-008151; Meetei AR, 2003, MOL CELL BIOL, V23, P3417, DOI 10.1128/MCB.23.10.3417-3426.2003; Meetei AR, 2005, NAT GENET, V37, P958, DOI 10.1038/ng1626; Mirchandani KD, 2008, DNA REPAIR, V7, P902, DOI 10.1016/j.dnarep.2008.03.001; Moldovan GL, 2009, ANNU REV GENET, V43, P223, DOI 10.1146/annurev-genet-102108-134222; Mosedale G, 2005, NAT STRUCT MOL BIOL, V12, P763, DOI 10.1038/nsmb981; Naf D, 1998, MOL CELL BIOL, V18, P5952; Niedernhofer LJ, 2005, CELL, V123, P1191, DOI 10.1016/j.cell.2005.12.009; Oakley GG, 2010, FRONT BIOSCI-LANDMRK, V15, P883, DOI 10.2741/3652; Otsuki T, 2001, HUM MOL GENET, V10, P2651, DOI 10.1093/hmg/10.23.2651; PAPADOPOULO D, 1990, CANCER RES, V50, P3289; Park SJ, 2004, J BIOL CHEM, V279, P30053, DOI 10.1074/jbc.M403527200; Qiao FY, 2001, J BIOL CHEM, V276, P23391, DOI 10.1074/jbc.M101855200; Reuter T, 2000, BLOOD, V95, P719, DOI 10.1182/blood.V95.2.719; Rosado IV, 2009, NUCLEIC ACIDS RES, V37, P4360, DOI 10.1093/nar/gkp365; Singh TR, 2009, BLOOD, V114, P174, DOI 10.1182/blood-2009-02-207811; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Sobeck A, 2006, MOL CELL BIOL, V26, P425, DOI 10.1128/MCB.26.2.425-437.2006; Stoepker C, 2011, NAT GENET, V43, P138, DOI 10.1038/ng.751; Thompson LH, 2009, MUTAT RES-FUND MOL M, V668, P54, DOI 10.1016/j.mrfmmm.2009.02.003; Tremblay CS, 2008, BLOOD, V112, P2062, DOI 10.1182/blood-2008-04-152710; Tremblay CS, 2009, J BIOL CHEM, V284, P13384, DOI 10.1074/jbc.M807921200; Tulpule A, 2010, BLOOD, V115, P3453, DOI 10.1182/blood-2009-10-246694; Vaz F, 2010, NAT GENET, V42, P406, DOI 10.1038/ng.570; Wang LC, 2008, DNA REPAIR, V7, P1973, DOI 10.1016/j.dnarep.2008.08.005; Wang WD, 2007, NAT REV GENET, V8, P735, DOI 10.1038/nrg2159; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Yang YG, 2005, CARCINOGENESIS, V26, P1731, DOI 10.1093/carcin/bgi134; Yuan FH, 2010, FRONT BIOSCI-LANDMRK, V15, P1131, DOI 10.2741/3666; Yuan FH, 2009, J BIOL CHEM, V284, P24443, DOI 10.1074/jbc.M109.016006; Zhang XL, 2004, J BIOL CHEM, V279, P43910, DOI 10.1074/jbc.M403884200; Zhang YB, 2005, CELL, V122, P693, DOI 10.1016/j.cell.2005.06.027	61	22	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4800	4807		10.1074/jbc.M111.315366	http://dx.doi.org/10.1074/jbc.M111.315366			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22194614	Green Published, hybrid			2022-12-27	WOS:000300608500041
J	Chiang, CY; Veckman, V; Limmer, K; David, M				Chiang, Chih-Yuan; Veckman, Ville; Limmer, Kirsten; David, Michael			Phospholipase C gamma-2 and Intracellular Calcium Are Required for Lipopolysaccharide-induced Toll-like Receptor 4 (TLR4) Endocytosis and Interferon Regulatory Factor 3 (IRF3) Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-ALPHA PRODUCTION; TOLL-LIKE-RECEPTOR-4; INNATE; MICE; MUTATIONS; DYNAMICS; CA2+; CELL; SYK	Toll-like receptor 4 (TLR4) is unique among the TLRs in its use of multiple adaptor proteins leading to activation of both the interferon regulatory factor 3 (IRF3) and nuclear factor kappa B (NF-kappa B) pathways. Previous work has demonstrated that TLR4 initiates NF-kappa B activation from the plasma membrane, but that subsequent TLR4 translocation to the endosomes is required for IRF3 activation. Here we have characterized several components of the signaling pathway that governs TLR4 translocation and subsequent IRF3 activation. We find that phospholipase C gamma 2 (PLC gamma 2) accounts for LPS-induced inositol 1,4,5-trisphosphate (IP3) production and subsequent calcium (Ca2+) release. Blockage of PLC gamma 2 function by inhibitors or knockdown of PLC gamma 2 expression by siRNAs in RAW 264.7 macrophages lead to reduced IRF3, but enhanced NF-kappa B activation. In addition, bone marrow-derived macrophages from PLC gamma 2-deficient mice showed impaired IRF3 phosphorylation and expression of IRF3-regulated genes after LPS stimulation. Using cell fractionation, we show that PLC gamma 2-IP3-Ca2+ signaling cascade is required for TLR4 endocytosis following LPS stimulation. In conclusion, our results describe a novel role of the PLC gamma 2-IP3-Ca2+ cascade in the LPS-induced innate immune response pathway where release of intracellular Ca2+ mediates TLR4 trafficking and subsequent activation of IRF3.	[Chiang, Chih-Yuan; Veckman, Ville; Limmer, Kirsten; David, Michael] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	David, M (corresponding author), Univ Calif San Diego, Div Biol Sci, 9500 Gilman Dr,Bonner Hall 3138, La Jolla, CA 92093 USA.	midavid@ucsd.edu			National Institutes of Health [R01 AI 047182]; Academy of Finland; Sigrid Juselius Foundation; Finnish Cultural Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047182] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI 047182 (to M. D.) and grants from the Academy of Finland, Sigrid Juselius Foundation, and Finnish Cultural Foundation (to V. V.).	Aki D, 2008, GENES CELLS, V13, P199, DOI 10.1111/j.1365-2443.2007.01159.x; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Chaudhary A, 2007, IMMUNOL CELL BIOL, V85, P249, DOI 10.1038/sj.icb7100030; Chiang E, 2006, J IMMUNOL, V176, P5720, DOI 10.4049/jimmunol.176.10.5720; Cremasco V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008909; Dang O, 2004, SHOCK, V21, P470, DOI 10.1097/00024382-200405000-00012; Dearden-Badet MT, 2005, CELL SIGNAL, V17, P1560, DOI 10.1016/j.cellsig.2005.03.018; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Hagen E, 1999, J LIPID RES, V40, P309; Higo T, 2005, CELL, V120, P85, DOI 10.1016/j.cell.2004.11.048; Husebye H, 2006, EMBO J, V25, P683, DOI 10.1038/sj.emboj.7600991; Husebye H, 2010, IMMUNITY, V33, P583, DOI 10.1016/j.immuni.2010.09.010; Jin SW, 2006, MEDIAT INFLAMM, V2006, DOI 10.1155/MI/2006/36192; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kurosaki T, 2000, IMMUNITY, V12, P1, DOI 10.1016/S1074-7613(00)80153-3; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Qureshi ST, 1999, J EXP MED, V189, P615, DOI 10.1084/jem.189.4.615; Singh DK, 2005, CELL, V121, P281, DOI 10.1016/j.cell.2005.02.036; Wang DM, 2000, IMMUNITY, V13, P25, DOI 10.1016/S1074-7613(00)00005-4; Watanabe N, 1996, J BIOCHEM-TOKYO, V120, P1190; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051; Zanoni I, 2009, NATURE, V460, P264, DOI 10.1038/nature08118; Zhou XY, 2006, J BIOL CHEM, V281, P31337, DOI 10.1074/jbc.M602739200	27	84	88	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					3704	3709		10.1074/jbc.C111.328559	http://dx.doi.org/10.1074/jbc.C111.328559			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22158869	hybrid, Green Published			2022-12-27	WOS:000300410900008
J	Lee, AYL; Chiba, T; Truong, LN; Cheng, AN; Do, J; Cho, MJ; Chen, LC; Wu, XH				Lee, Alan Yueh-Luen; Chiba, Takuya; Truong, Lan N.; Cheng, An Ning; Do, Johnny; Cho, Michael Jeffrey; Chen, Longchuan; Wu, Xiaohua			Dbf4 Is Direct Downstream Target of Ataxia Telangiectasia Mutated (ATM) and Ataxia Telangiectasia and Rad3-related (ATR) Protein to Regulate Intra-S-phase Checkpoint	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE REGULATION; DNA-DAMAGE CHECKPOINT; HUMAN CDC7-RELATED KINASE; MAMMALIAN-CELLS; EUKARYOTIC CELLS; SCHIZOSACCHAROMYCES-POMBE; PREVENTS REREPLICATION; CHROMOSOME-REPLICATION; ALKYLATION DAMAGE; GENOME INTEGRITY	Dbf4/Cdc7 (Dbf4-dependent kinase (DDK)) is activated at the onset of S-phase, and its kinase activity is required for DNA replication initiation from each origin. We showed that DDK is an important target for the S-phase checkpoint in mammalian cells to suppress replication initiation and to protect replication forks. We demonstrated that ataxia telangiectasia mutated (ATM) and ataxia telangiectasia and Rad3-related (ATR) proteins directly phosphorylate Dbf4 in response to ionizing radiation and replication stress. We identified novel ATM/ATR phosphorylation sites on Dbf4 and showed that ATM/ATR-mediated phosphorylation of Dbf4 is critical for the intra-S-phase checkpoint to inhibit DNA replication. The kinase activity of DDK, which is not suppressed upon DNA damage, is required for fork protection under replication stress. We further demonstrated that ATM/ATR-mediated phosphorylation of Dbf4 is important for preventing DNA rereplication upon loss of replication licensing through the activation of the S-phase checkpoint. These studies indicate that DDK is a direct substrate of ATM and ATR to mediate the intra-S-phase checkpoint in mammalian cells.	[Lee, Alan Yueh-Luen; Chiba, Takuya; Truong, Lan N.; Do, Johnny; Cho, Michael Jeffrey; Wu, Xiaohua] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Lee, Alan Yueh-Luen; Cheng, An Ning] Natl Hlth Res Inst, Natl Inst Canc Res, Zhunan 35053, Miaoli, Taiwan; [Chiba, Takuya] Nagasaki Univ, Grad Sch Biomed Sci, Dept Invest Pathol, Nagasaki 8528523, Japan; [Cheng, An Ning] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan; [Chen, Longchuan] Vet Adm Med Ctr, Dept Pathol, Long Beach, CA 90822 USA	Scripps Research Institute; National Health Research Institutes - Taiwan; Nagasaki University; National Tsing Hua University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Long Beach Healthcare System	Lee, AYL (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA.	alanylee@nhri.org.tw; xiaohwu@scripps.edu	Lee, Alan Yueh-Luen/B-1097-2010	Cho, Michael Jeffrey/0000-0002-4628-303X; Lee, Alan Yueh-Luen/0000-0003-0252-0571	National Institutes of Health [CA102361, GM080677, CA140972, CA102361-07S1, DK007022-30]; National Science Council [NSC 98-2311-B-037-001-MY3]; National Health Research Institutes [CA-100-PP-08]; Department of Health, Taiwan [DOH99-TD-C-111-004]; Takeda Science Foundation; Japan Society for the Promotion of Science [17790269]; NATIONAL CANCER INSTITUTE [R01CA102361, R01CA140972] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080677] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institutes(National Health Research Institutes, Japan); Department of Health, Taiwan; Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA102361, GM080677, CA140972, and CA102361-07S1 (to X. W.) and Training Grant DK007022-30 (to L. T.). This work was also supported by National Science Council Grant NSC 98-2311-B-037-001-MY3, National Health Research Institutes Grant CA-100-PP-08, and Department of Health Grant DOH99-TD-C-111-004), Taiwan, (to A. Y.-L. L.). This work was also supported by a grant from the Takeda Science Foundation and Grant-in-Aid for Young Scientists (B) 17790269 from the Japan Society for the Promotion of Science (to T. C.).	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Aguilera A, 2008, NAT REV GENET, V9, P204, DOI 10.1038/nrg2268; Arias EE, 2007, GENE DEV, V21, P497, DOI 10.1101/gad.1508907; Bartek J, 2004, NAT REV MOL CELL BIO, V5, P792, DOI 10.1038/nrm1493; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Bousset K, 1998, GENE DEV, V12, P480, DOI 10.1101/gad.12.4.480; Brown GW, 1999, P NATL ACAD SCI USA, V96, P8443, DOI 10.1073/pnas.96.15.8443; Cheng LA, 1999, MOL CELL BIOL, V19, P4270; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Cliby WA, 1998, EMBO J, V17, P159, DOI 10.1093/emboj/17.1.159; Cortez D, 2004, P NATL ACAD SCI USA, V101, P10078, DOI 10.1073/pnas.0403410101; Costanzo V, 2003, MOL CELL, V11, P203, DOI 10.1016/S1097-2765(02)00799-2; Dierov J, 2004, CANCER CELL, V5, P275, DOI 10.1016/S1535-6108(04)00056-X; Diffley TFX, 1996, GENE DEV, V10, P2819, DOI 10.1101/gad.10.22.2819; Donaldson AD, 1998, GENE DEV, V12, P491, DOI 10.1101/gad.12.4.491; Duncker BP, 2003, MUTAT RES-FUND MOL M, V532, P21, DOI 10.1016/j.mrfmmm.2003.08.007; Fung AD, 2002, MOL CELL BIOL, V22, P4477, DOI 10.1128/MCB.22.13.4477-4490.2002; Furuya K, 2010, MOL CELL, V40, P606, DOI 10.1016/j.molcel.2010.10.026; Guo WY, 2004, J RADIAT RES, V45, P269, DOI 10.1269/jrr.45.269; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Heffernan TP, 2007, J BIOL CHEM, V282, P9458, DOI 10.1074/jbc.M611292200; JACKSON AL, 1993, MOL CELL BIOL, V13, P2899, DOI 10.1128/MCB.13.5.2899; Jares P, 2000, EMBO REP, V1, P319, DOI 10.1093/embo-reports/kvd076; Jiang W, 1999, EMBO J, V18, P5703, DOI 10.1093/emboj/18.20.5703; Johnston L H, 2000, Prog Cell Cycle Res, V4, P61; Kelly TJ, 2000, ANNU REV BIOCHEM, V69, P829, DOI 10.1146/annurev.biochem.69.1.829; Kihara M, 2000, J BIOL CHEM, V275, P35051, DOI 10.1074/jbc.M003491200; Kim JM, 2008, ONCOGENE, V27, P3475, DOI 10.1038/sj.onc.1210994; Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538; Kumagai H, 1999, MOL CELL BIOL, V19, P5083; Labib K, 2010, GENE DEV, V24, P1208, DOI 10.1101/gad.1933010; Lee AYL, 2007, J BIOL CHEM, V282, P32243, DOI 10.1074/jbc.M705486200; Lee JH, 2007, ONCOGENE, V26, P7741, DOI 10.1038/sj.onc.1210872; Lei M, 2001, J CELL SCI, V114, P1447; Li XH, 2003, J BIOL CHEM, V278, P30854, DOI 10.1074/jbc.C300251200; Liu E, 2007, J CELL BIOL, V179, P643, DOI 10.1083/jcb.200704138; Liu PJ, 2006, J BIOL CHEM, V281, P30631, DOI 10.1074/jbc.M602982200; Lopez-Mosqueda J, 2010, NATURE, V467, P479, DOI 10.1038/nature09377; Masai H, 2002, J CELL PHYSIOL, V190, P287, DOI 10.1002/jcp.10070; Masai H, 2000, J BIOL CHEM, V275, P29042, DOI 10.1074/jbc.M002713200; Masutomi K, 2003, CELL, V114, P241, DOI 10.1016/S0092-8674(03)00550-6; Matsumoto S, 2005, J BIOL CHEM, V280, P42536, DOI 10.1074/jbc.M510575200; Matsumoto S, 2010, CELL CYCLE, V9, P4627, DOI 10.4161/cc.9.23.13937; Montagnoli A, 2006, J BIOL CHEM, V281, P10281, DOI 10.1074/jbc.M512921200; Nghiem P, 2002, J BIOL CHEM, V277, P4428, DOI 10.1074/jbc.M106113200; Nishitani H, 2004, FRONT BIOSCI-LANDMRK, V9, P2115; O'Neill T, 2000, J BIOL CHEM, V275, P22719, DOI 10.1074/jbc.M001002200; Olson E, 2007, MOL CELL BIOL, V27, P6053, DOI 10.1128/MCB.00532-07; Olson E, 2006, J BIOL CHEM, V281, P39517, DOI 10.1074/jbc.M605121200; Pasero P, 1999, GENE DEV, V13, P2159, DOI 10.1101/gad.13.16.2159; Petermann E, 2010, MOL CELL, V37, P492, DOI 10.1016/j.molcel.2010.01.021; Petersen P, 2006, MOL CELL BIOL, V26, P1997, DOI 10.1128/MCB.26.5.1997-2011.2006; Sato N, 2003, GENES CELLS, V8, P451, DOI 10.1046/j.1365-2443.2003.00647.x; Sclafani RA, 2000, J CELL SCI, V113, P2111; Silva T, 2006, J BIOL CHEM, V281, P11569, DOI 10.1074/jbc.M510278200; Snaith HA, 2000, MOL CELL BIOL, V20, P7922, DOI 10.1128/MCB.20.21.7922-7932.2000; Sommariva E, 2005, MOL CELL BIOL, V25, P2770, DOI 10.1128/MCB.25.7.2770-2784.2005; Takahashi TS, 2005, GENE DEV, V19, P2295, DOI 10.1101/gad.1339805; Takeda T, 1999, MOL CELL BIOL, V19, P5535; Tenca P, 2007, J BIOL CHEM, V282, P208, DOI 10.1074/jbc.M604457200; Truong LN, 2011, J MOL CELL BIOL, V3, P13, DOI 10.1093/jmcb/mjq052; Tsuji T, 2008, MOL CELL, V32, P862, DOI 10.1016/j.molcel.2008.12.005; Tsuji T, 2006, MOL BIOL CELL, V17, P4459, DOI 10.1091/mbc.E06-03-0241; Uno S, 2011, GENES CELLS, V16, P842, DOI 10.1111/j.1365-2443.2011.01535.x; Vaziri C, 2003, MOL CELL, V11, P997, DOI 10.1016/S1097-2765(03)00099-6; Weinreich M, 1999, EMBO J, V18, P5334, DOI 10.1093/emboj/18.19.5334; Wu XH, 2000, NATURE, V405, P477, DOI 10.1038/35013089; YOON HJ, 1993, MOL BIOL CELL, V4, P195, DOI 10.1091/mbc.4.2.195; Zegerman P, 2010, NATURE, V467, P474, DOI 10.1038/nature09373; Ziv Y, 1997, ONCOGENE, V15, P159, DOI 10.1038/sj.onc.1201319	70	35	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2531	2543		10.1074/jbc.M111.291104	http://dx.doi.org/10.1074/jbc.M111.291104			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22123827	Green Published, hybrid			2022-12-27	WOS:000300292300027
J	Montagna, GN; Buscaglia, CA; Munter, S; Goosmann, C; Frischknecht, F; Brinkmann, V; Matuschewski, K				Montagna, Georgina N.; Buscaglia, Carlos A.; Muenter, Sylvia; Goosmann, Christian; Frischknecht, Friedrich; Brinkmann, Volker; Matuschewski, Kai			Critical Role for Heat Shock Protein 20 (HSP20) in Migration of Malarial Sporozoites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN-DEPOLYMERIZING FACTOR; TRAP-LIKE PROTEIN; PLASMODIUM SPOROZOITES; TOXOPLASMA-GONDII; GLIDING MOTILITY; MICROFILAMENT DYNAMICS; ANONYMOUS PROTEIN; CRYSTAL-STRUCTURE; CELL INVASION; MYOSIN-A	Plasmodium sporozoites, single cell eukaryotic pathogens, use their own actin/myosin-based motor machinery for life cycle progression, which includes forward locomotion, penetration of cellular barriers, and invasion of target cells. To display fast gliding motility, the parasite uses a high turnover of actin polymerization and adhesion sites. Paradoxically, only a few classic actin regulatory proteins appear to be encoded in the Plasmodium genome. Small heat shock proteins have been associated with cytoskeleton modulation in various biological processes. In this study, we identify HSP20 as a novel player in Plasmodium motility and provide molecular genetics evidence for a critical role of a small heat shock protein in cell traction and motility. We demonstrate that HSP20 ablation profoundly affects sporozoite-substrate adhesion, which translates into aberrant speed and directionality in vitro. Loss of HSP20 function impairs migration in the host, an important sporozoite trait required to find a blood vessel and reach the liver after being deposited in the skin by the mosquito. Our study also shows that fast locomotion of sporozoites is crucial during natural malaria transmission.	[Matuschewski, Kai] Max Planck Inst Infect Biol, Parasitol Unit, D-10117 Berlin, Germany; [Buscaglia, Carlos A.] Univ Nacl San Martin, Inst Invest Biotecnol IIB INTECH, RA-1650 Buenos Aires, DF, Argentina; [Muenter, Sylvia; Frischknecht, Friedrich] Heidelberg Univ, Sch Med, Dept Infect Dis, D-69120 Heidelberg, Germany	Max Planck Society; Ruprecht Karls University Heidelberg	Matuschewski, K (corresponding author), Max Planck Inst Infect Biol, Parasitol Unit, D-10117 Berlin, Germany.	matuschewski@mpiib-berlin.mpg.de	Montagna, Georgina/D-1202-2013; Brinkmann, Volker/A-6015-2009	Matuschewski, Kai/0000-0001-6147-8591; Montagna, Georgina/0000-0003-0283-8977; Buscaglia, Carlos/0000-0001-6466-4138; Frischknecht, Friedrich/0000-0002-8332-6668	European Commission (European Virtual Institute) [34]; Max Planck Society; Joachim Siebeneicher Foundation; Chica and Heinz Schaller Foundation; German Ministry of Education and Research (Bundesministerium fur Bildung und Forschung); University of Heidelberg; von Humboldt Foundation; Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina); United Nations Children's Fund/United Nations Development Program/World Bank/World Health Organization Special Program for Research and Training in Tropical Diseases	European Commission (European Virtual Institute)(European Commission); Max Planck Society(Max Planck SocietyFoundation CELLEX); Joachim Siebeneicher Foundation; Chica and Heinz Schaller Foundation; German Ministry of Education and Research (Bundesministerium fur Bildung und Forschung)(Federal Ministry of Education & Research (BMBF)); University of Heidelberg; von Humboldt Foundation(Alexander von Humboldt Foundation); Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina)(ANPCyT); United Nations Children's Fund/United Nations Development Program/World Bank/World Health Organization Special Program for Research and Training in Tropical Diseases	This work was supported by the European Commission (European Virtual Institute for Malaria Research Grants 2 and 34 to F. F. and K. M.); the Max Planck Society, the Joachim Siebeneicher Foundation, and the Chica and Heinz Schaller Foundation (to K. M.); the German Ministry of Education and Research (Bundesministerium fur Bildung und Forschung, BioFuture program) and the Frontier Program of the University of Heidelberg (to F. F.); the von Humboldt Foundation (to G. N. M.); and the Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina) and the United Nations Children's Fund/United Nations Development Program/World Bank/World Health Organization Special Program for Research and Training in Tropical Diseases (to C. A. B.).	Amino R, 2006, NAT MED, V12, P220, DOI 10.1038/nm1350; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; Baum J, 2006, NAT REV MICROBIOL, V4, P621, DOI 10.1038/nrmicro1465; Bear JE, 2000, CELL, V101, P717, DOI 10.1016/S0092-8674(00)80884-3; BENNDORF R, 1994, J BIOL CHEM, V269, P20780; Bergman LW, 2003, J CELL SCI, V116, P39, DOI 10.1242/jcs.00194; Bhanot P, 2005, J BIOL CHEM, V280, P6752, DOI 10.1074/jbc.M411465200; Bosch J, 2007, P NATL ACAD SCI USA, V104, P7015, DOI 10.1073/pnas.0605301104; Buscaglia CA, 2003, MOL BIOL CELL, V14, P4947, DOI 10.1091/mbc.E03-06-0355; Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Chakravarty S, 2007, NAT MED, V13, P1035, DOI 10.1038/nm1628; de Miguel N, 2008, BIOL CELL, V100, P479, DOI 10.1042/BC20080004; Dreiza CM, 2004, FASEB J, V18, P261, DOI 10.1096/fj.04-2911fje; Edwards HV, 2011, CELL SIGNAL, V23, P1447, DOI 10.1016/j.cellsig.2011.05.009; Engelmann S, 2009, EUKARYOT CELL, V8, P640, DOI 10.1128/EC.00347-08; Frevert U, 2005, PLOS BIOL, V3, P1034, DOI 10.1371/journal.pbio.0030192; Frischknecht F, 2004, CELL MICROBIOL, V6, P687, DOI 10.1111/j.1462-5822.2004.00395.x; Ganter M, 2009, MOL MICROBIOL, V74, P1356, DOI 10.1111/j.1365-2958.2009.06828.x; Goosmann C, 2008, METHOD CELL BIOL, V88, P477, DOI 10.1016/S0091-679X(08)00424-X; Gu JR, 1997, MOL CELL BIOL, V17, P4033, DOI 10.1128/MCB.17.7.4033; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993; Heaslip AT, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000720; Hegge S, 2010, FASEB J, V24, P2222, DOI 10.1096/fj.09-148700; Heiss K, 2008, EUKARYOT CELL, V7, P1062, DOI 10.1128/EC.00089-08; Hliscs M, 2010, J BIOL CHEM, V285, P11572, DOI 10.1074/jbc.M109.054916; Ishino T, 2004, PLOS BIOL, V2, P77, DOI 10.1371/journal.pbio.0020004; Janse CJ, 2006, MOL BIOCHEM PARASIT, V145, P60, DOI 10.1016/j.molbiopara.2005.09.007; Jayabalasingham B, 2010, CELL RES, V20, P1043, DOI 10.1038/cr.2010.88; Jewett TJ, 2003, MOL CELL, V11, P885, DOI 10.1016/S1097-2765(03)00113-8; Kappe SHI, 2003, TRENDS PARASITOL, V19, P135, DOI 10.1016/S1471-4922(03)00007-2; Karolczak-Bayatti M, 2011, J BIOL CHEM, V286, P34346, DOI 10.1074/jbc.M111.278549; Kim KK, 1998, NATURE, V394, P595, DOI 10.1038/29106; Kleinschmidt I, 2009, AM J TROP MED HYG, V80, P882, DOI 10.4269/ajtmh.2009.80.882; Krause M, 2003, ANNU REV CELL DEV BI, V19, P541, DOI 10.1146/annurev.cellbio.19.050103.103356; Kursula I, 2008, STRUCTURE, V16, P1638, DOI 10.1016/j.str.2008.09.008; Lacayo CI, 2007, PLOS BIOL, V5, P2035, DOI 10.1371/journal.pbio.0050233; Lacroix C, 2008, TRENDS PARASITOL, V24, P431, DOI 10.1016/j.pt.2008.07.003; LAVOIE JN, 1993, J BIOL CHEM, V268, P3420; LAVOIE JN, 1995, MOL CELL BIOL, V15, P505, DOI 10.1128/MCB.15.1.505; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Matuschewski K, 2006, CELL MICROBIOL, V8, P1547, DOI 10.1111/j.1462-5822.2006.00778.x; Mehta S, 2010, J BIOL CHEM, V285, P6835, DOI 10.1074/jbc.M109.068155; MEIS JFGM, 1985, CELL TISSUE RES, V241, P353, DOI 10.1007/BF00217180; Meissner M, 2002, SCIENCE, V298, P837, DOI 10.1126/science.1074553; Menard R, 2001, CELL MICROBIOL, V3, P63, DOI 10.1046/j.1462-5822.2001.00097.x; MIRON T, 1988, EUR J BIOCHEM, V178, P543, DOI 10.1111/j.1432-1033.1988.tb14481.x; MIRON T, 1991, J CELL BIOL, V114, P255, DOI 10.1083/jcb.114.2.255; Moon RW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000599; Mota MM, 2001, SCIENCE, V291, P141, DOI 10.1126/science.291.5501.141; Munter S, 2009, CELL HOST MICROBE, V6, P551, DOI 10.1016/j.chom.2009.11.007; Narberhaus F, 2002, MICROBIOL MOL BIOL R, V66, P64, DOI 10.1128/MMBR.66.1.64-93.2002; Plattner F, 2008, CELL HOST MICROBE, V3, P77, DOI 10.1016/j.chom.2008.01.001; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; POTOCNJAK P, 1980, J EXP MED, V151, P1504, DOI 10.1084/jem.151.6.1504; Rembold CM, 2000, J PHYSIOL-LONDON, V524, P865, DOI 10.1111/j.1469-7793.2000.00865.x; Sahoo N, 2006, MOL BIOL CELL, V17, P895, DOI 10.1091/mbc.E05-06-0512; Sattler JM, 2011, EUR J CELL BIOL, V90, P966, DOI 10.1016/j.ejcb.2010.11.011; Schmitz S, 2005, J MOL BIOL, V349, P113, DOI 10.1016/j.jmb.2005.03.056; Schmitz S, 2010, J BIOL CHEM, V285, P36577, DOI 10.1074/jbc.M110.142638; Schuler H, 2006, TRAFFIC, V7, P1433, DOI 10.1111/j.1600-0854.2006.00484.x; Schuler H, 2005, MOL BIOL CELL, V16, P4013, DOI 10.1091/mbc.E05-02-0086; Schuler H, 2005, FEBS LETT, V579, P655, DOI 10.1016/j.febslet.2004.12.037; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shaw MK, 1999, P NATL ACAD SCI USA, V96, P9095, DOI 10.1073/pnas.96.16.9095; Sibley LD, 2004, SCIENCE, V304, P248, DOI 10.1126/science.1094717; Siden-Kiamos I, 2011, CELL MICROBIOL, V13, P1996, DOI 10.1111/j.1462-5822.2011.01686.x; Steinbuechel M, 2009, CELL MICROBIOL, V11, P279, DOI 10.1111/j.1462-5822.2008.01252.x; Sultan AA, 1997, CELL, V90, P511, DOI 10.1016/S0092-8674(00)80511-5; TSUJI M, 1994, PARASITOL RES, V80, P16, DOI 10.1007/BF00932618; van Montfort RLM, 2001, NAT STRUCT BIOL, V8, P1025, DOI 10.1038/nsb722; VANDERBERG JP, 1975, J PARASITOL, V61, P43, DOI 10.2307/3279102; VANDERBERG JP, 1974, J PROTOZOOL, V21, P527, DOI 10.1111/j.1550-7408.1974.tb03693.x; Wetzel DM, 2003, MOL BIOL CELL, V14, P396, DOI 10.1091/mbc.E02-08-0458	74	50	53	0	17	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2410	2422		10.1074/jbc.M111.302109	http://dx.doi.org/10.1074/jbc.M111.302109			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22139844	hybrid, Green Published			2022-12-27	WOS:000300292300016
J	Ohkita, M; Saito, S; Imagawa, T; Takahashi, K; Tominaga, M; Ohta, T				Ohkita, Masashi; Saito, Shigeru; Imagawa, Toshiaki; Takahashi, Kenji; Tominaga, Makoto; Ohta, Toshio			Molecular Cloning and Functional Characterization of Xenopus tropicalis Frog Transient Receptor Potential Vanilloid 1 Reveal Its Functional Evolution for Heat, Acid, and Capsaicin Sensitivities in Terrestrial Vertebrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRIMARY SENSORY NEURONS; ION-CHANNEL; PAIN PATHWAY; TRPV1; TEMPERATURE; ACTIVATION; EXPRESSION; RESPONSES; PROTEIN; GENOME	The functional difference of thermosensitive transient receptor potential (TRP) channels in the evolutionary context has attracted attention, but thus far little information is available on the TRP vanilloid 1 (TRPV1) function of amphibians, which diverged earliest from terrestrial vertebrate lineages. In this study we cloned Xenopus tropicalis frog TRPV1 (xtTRPV1), and functional characterization was performed using HeLa cells heterologously expressing xtTRPV1 (xtTRPV1-HeLa) and dorsal root ganglion neurons isolated from X. tropicalis (xtDRG neurons) by measuring changes in the intracellular calcium concentration ([Ca2+](i)). The channel activity was also observed in xtTRPV1-expressing Xenopus oocytes. Furthermore, we tested capsaicin-and heat-induced nocifensive behaviors of the frog X. tropicalis in vivo. At the amino acid level, xtTRPV1 displays similar to 60% sequence identity to other terrestrial vertebrate TRPV1 orthologues. Capsaicin induced [Ca2+](i) increases in xtTRPV1-HeLa and xtDRG neurons and evoked nocifensive behavior in X. tropicalis. However, its sensitivity was extremely low compared with mammalian orthologues. Low extracellular pH and heat activated xtTRPV1-HeLa and xtDRG neurons. Heat also evoked nocifensive behavior. In oocytes expressing xtTRPV1, inward currents were elicited by heat and low extracellular pH. Mutagenesis analysis revealed that two amino acids (tyrosine 523 and alanine 561) were responsible for the low sensitivity to capsaicin. Taken together, our results indicate that xtTRPV1 functions as a polymodal receptor similar to its mammalian orthologues. The present study demonstrates that TRPV1 functions as a heat-and acid-sensitive channel in the ancestor of terrestrial vertebrates. Because it is possible to examine vanilloid and heat sensitivities in vitro and in vivo, X. tropicalis could be the ideal experimental lower vertebrate animal for the study of TRPV1 function.	[Ohkita, Masashi; Takahashi, Kenji; Ohta, Toshio] Tottori Univ, Fac Agr, Dept Vet Pharmacol, Tottori 6808553, Japan; [Saito, Shigeru; Tominaga, Makoto] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Div Cell Signaling, Okazaki, Aichi 4448787, Japan; [Imagawa, Toshiaki] Hokkaido Univ, Grad Sch Sci, Div Chem,Grad, Sapporo, Hokkaido 0600810, Japan	Tottori University; National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); Hokkaido University	Ohta, T (corresponding author), Tottori Univ, Fac Agr, Dept Vet Pharmacol, Koyama South 4, Tottori 6808553, Japan.	tohta@muses.tottori-u.ac.jp	Saito, Shigeru/B-4698-2015	Saito, Shigeru/0000-0002-6237-8979	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [22380160] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; Bianchi BR, 2006, EUR J PHARMACOL, V537, P20, DOI 10.1016/j.ejphar.2006.03.003; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; CHERYCROZE S, 1985, N-S ARCH PHARMACOL, V331, P159, DOI 10.1007/BF00634233; Correll CC, 2004, NEUROSCI LETT, V370, P55, DOI 10.1016/j.neulet.2004.07.058; Dowland LK, 2000, J BIOL CHEM, V275, P37765, DOI 10.1074/jbc.M004840200; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gavva NR, 2004, J BIOL CHEM, V279, P20283, DOI 10.1074/jbc.M312577200; Gracheva EO, 2010, NATURE, V464, P1006, DOI 10.1038/nature08943; Guler AD, 2002, J NEUROSCI, V22, P6408; Hayes P, 2000, PAIN, V88, P205, DOI 10.1016/S0304-3959(00)00353-5; Hellsten U, 2010, SCIENCE, V328, P633, DOI 10.1126/science.1183670; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jordt SE, 2000, P NATL ACAD SCI USA, V97, P8134, DOI 10.1073/pnas.100129497; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Kajihara Y, 2010, NEUROSCIENCE, V166, P292, DOI 10.1016/j.neuroscience.2009.12.001; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Kashiwagi K, 2010, EXP ANIM TOKYO, V59, P395, DOI 10.1538/expanim.59.395; Khokha MK, 2002, DEV DYNAM, V225, P499, DOI 10.1002/dvdy.10184; Kuffler DP, 2002, J NEUROPHYSIOL, V88, P1843, DOI 10.1152/jn.2002.88.4.1843; McIntyre P, 2001, BRIT J PHARMACOL, V132, P1084, DOI 10.1038/sj.bjp.0703918; Myers BR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005741; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Ohta T, 2008, J BIOL CHEM, V283, P9377, DOI 10.1074/jbc.M709377200; Ohta T, 2006, J PHYSIOL-LONDON, V576, P809, DOI 10.1113/jphysiol.2006.112250; Phelps PT, 2005, EUR J PHARMACOL, V513, P57, DOI 10.1016/j.ejphar.2005.02.045; PHILIPPI M, 1995, J NEUROSCI RES, V40, P387, DOI 10.1002/jnr.490400313; Rosenblum EB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006494; RZHETSKY A, 1992, MOL BIOL EVOL, V9, P945; Saito S, 2006, PHYSIOL GENOMICS, V27, P219, DOI 10.1152/physiolgenomics.00322.2005; Saito S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002041; Savidge J, 2002, NEUROPHARMACOLOGY, V43, P450, DOI 10.1016/S0028-3908(02)00122-3; Seebacher F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000281; SZALLASI A, 1993, N-S ARCH PHARMACOL, V347, P84; Szolcsanyi J, 2004, NEUROPEPTIDES, V38, P377, DOI 10.1016/j.npep.2004.07.005; Tewksbury JJ, 2001, NATURE, V412, P403, DOI 10.1038/35086653; Tominaga M, 2005, PFLUG ARCH EUR J PHY, V451, P143, DOI 10.1007/s00424-005-1457-8; WOOD JN, 1988, J NEUROSCI, V8, P3208; Xu HX, 2002, NATURE, V418, P181, DOI 10.1038/nature00882	40	30	33	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2388	2397		10.1074/jbc.M111.305698	http://dx.doi.org/10.1074/jbc.M111.305698			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22130664	Green Published, hybrid			2022-12-27	WOS:000300292300014
J	Hinz, J; Lehnhardt, L; Zakrzewski, S; Zhang, G; Ignatova, Z				Hinz, Justyna; Lehnhardt, Lothar; Zakrzewski, Silke; Zhang, Gong; Ignatova, Zoya			Polyglutamine Expansion Alters the Dynamics and Molecular Architecture of Aggregates in Dentatorubropallidoluysian Atrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY; HUNTINGTONS-DISEASE; INTRANUCLEAR INCLUSIONS; PROTEIN AGGREGATION; REPRESSES TRANSCRIPTION; NUCLEAR-LOCALIZATION; SEEDING SPECIFICITY; CELLULAR TOXICITY; GENE-PRODUCT; LIVING CELLS	Preferential accumulation of mutant proteins in the nucleus has been suggested to be the molecular culprit that confers cellular toxicity in the neurodegenerative disorders caused by polyglutamine (polyQ) expansion. Here, we use dynamic imaging approaches, orthogonal cross-seeding, and composition analysis to examine the dynamics and structure of nuclear and cytoplasmic inclusions of atrophin-1, implicated in dentatorubropallidoluysian atrophy, a polyQ-based disease with complex clinical features. Our results reveal a large heterogeneity in the dynamics of the nuclear inclusions compared with the compact and immobile cytoplasmic aggregates. At least two types of inclusions of expanded atrophin-1 with different mobility of the molecular species and ability to exchange with the surrounding monomer pool coexist in the nucleus. Intriguingly, the enrichment of nuclear inclusions with slow dynamics parallels changes in the aggregate core architecture that are dominated by the polyQ stretch. We propose that the observed complexity in the dynamics of the nuclear inclusions provides a molecular explanation for the enhanced cellular toxicity of the nuclear aggregates in polyQ-based neurodegeneration.	[Hinz, Justyna; Lehnhardt, Lothar; Zakrzewski, Silke; Zhang, Gong; Ignatova, Zoya] Univ Potsdam, Inst Biochem & Biol, D-14467 Potsdam, Germany	University of Potsdam	Ignatova, Z (corresponding author), Univ Potsdam, Inst Biochem & Biol, Karl Liebknecht Str 24-25, D-14467 Potsdam, Germany.	ignatova@uni-potsdam.de	Zhang, Gong/Q-7419-2017	Zhang, Gong/0000-0003-0418-3433; Ignatova, Zoya/0000-0002-9478-8825	Deutsche Forschungsgemeinschaft [IG 73/8-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant IG 73/8-1 (to Z. I.).	Allen TD, 2000, J CELL SCI, V113, P1651; Bhattacharyya A, 2006, J MOL BIOL, V355, P524, DOI 10.1016/j.jmb.2005.10.053; Bhattacharyya AM, 2005, P NATL ACAD SCI USA, V102, P15400, DOI 10.1073/pnas.0501651102; Bulone D, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000111; Chai YH, 2002, P NATL ACAD SCI USA, V99, P9310, DOI 10.1073/pnas.152101299; Chapple JP, 2008, NEUROSCI LETT, V447, P172, DOI 10.1016/j.neulet.2008.09.075; Chen SM, 2002, P NATL ACAD SCI USA, V99, P11884, DOI 10.1073/pnas.182276099; Chien P, 2001, NATURE, V410, P223, DOI 10.1038/35065632; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; de Chiara C, 2005, J MOL BIOL, V354, P883, DOI 10.1016/j.jmb.2005.09.083; Duennwald ML, 2006, P NATL ACAD SCI USA, V103, P11045, DOI 10.1073/pnas.0604547103; Ellisdon AM, 2006, J BIOL CHEM, V281, P16888, DOI 10.1074/jbc.M601470200; Hands SL, 2010, ACTA NEUROPATHOL, V120, P419, DOI 10.1007/s00401-010-0703-0; Harjes P, 2003, TRENDS BIOCHEM SCI, V28, P425, DOI 10.1016/S0968-0004(03)00168-3; Hinz J, 2008, BIOCHEMISTRY-US, V47, P4196, DOI 10.1021/bi800002j; Holmberg CI, 2004, EMBO J, V23, P4307, DOI 10.1038/sj.emboj.7600426; Ignatova Z, 2007, J BIOL CHEM, V282, P36736, DOI 10.1074/jbc.M703682200; Iwahashi CK, 2006, BRAIN, V129, P256, DOI 10.1093/brain/awh650; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Kazantsev A, 1999, P NATL ACAD SCI USA, V96, P11404, DOI 10.1073/pnas.96.20.11404; Kim S, 2002, NAT CELL BIOL, V4, P826, DOI 10.1038/ncb863; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; Krol HA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001503; Lammerding J, 2006, J BIOL CHEM, V281, P25768, DOI 10.1074/jbc.M513511200; Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068; Luthi-Carter R, 2002, HUM MOL GENET, V11, P1927, DOI 10.1093/hmg/11.17.1927; Masino L, 2004, J MOL BIOL, V344, P1021, DOI 10.1016/j.jmb.2004.09.065; Matsumoto G, 2006, J BIOL CHEM, V281, P4477, DOI 10.1074/jbc.M509201200; Miyashita T, 1998, BIOCHEM BIOPH RES CO, V249, P96, DOI 10.1006/bbrc.1998.9096; Mohan A, 2006, J MOL BIOL, V362, P1043, DOI 10.1016/j.jmb.2006.07.087; Nagai Y, 2007, NAT STRUCT MOL BIOL, V14, P332, DOI 10.1038/nsmb1215; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Nucifora FC, 2003, J BIOL CHEM, V278, P13047, DOI 10.1074/jbc.M211224200; O'Nuallain B, 2004, J BIOL CHEM, V279, P17490, DOI 10.1074/jbc.M311300200; Okamura-Oho Y, 1999, HUM MOL GENET, V8, P947, DOI 10.1093/hmg/8.6.947; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Poirier MA, 2005, HUM MOL GENET, V14, P765, DOI 10.1093/hmg/ddi071; Poirier MA, 2002, J BIOL CHEM, V277, P41032, DOI 10.1074/jbc.M205809200; Rajan RS, 2001, P NATL ACAD SCI USA, V98, P13060, DOI 10.1073/pnas.181479798; Romero Pedro, 2004, Appl Bioinformatics, V3, P105, DOI 10.2165/00822942-200403020-00005; Rousseau F, 2006, CURR OPIN STRUC BIOL, V16, P118, DOI 10.1016/j.sbi.2006.01.011; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Schilling G, 1999, NEURON, V24, P275, DOI 10.1016/S0896-6273(00)80839-9; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Shen Y, 2009, CELL MOL LIFE SCI, V66, P437, DOI 10.1007/s00018-008-8403-9; Steffan JS, 2000, P NATL ACAD SCI USA, V97, P6763, DOI 10.1073/pnas.100110097; Stenoien DL, 2002, NAT CELL BIOL, V4, P806, DOI 10.1038/ncb859; Tam S, 2009, NAT STRUCT MOL BIOL, V16, P1279, DOI 10.1038/nsmb.1700; Thakur AK, 2009, NAT STRUCT MOL BIOL, V16, P380, DOI 10.1038/nsmb.1570; Waelter S, 2001, MOL BIOL CELL, V12, P1393, DOI 10.1091/mbc.12.5.1393; Wanker EE, 2000, BIOL CHEM, V381, P937, DOI 10.1515/BC.2000.114; Wanker EE, 1999, METHOD ENZYMOL, V309, P375; Wood JD, 2000, J CELL BIOL, V150, P939, DOI 10.1083/jcb.150.5.939; Yamada M, 2001, AM J PATHOL, V159, P1785, DOI 10.1016/S0002-9440(10)63025-8; Yamada M, 2001, ANN NEUROL, V49, P14, DOI 10.1002/1531-8249(200101)49:1<14::AID-ANA5>3.0.CO;2-X; YAZAWA I, 1995, NAT GENET, V10, P99, DOI 10.1038/ng0595-99	58	7	7	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					2068	2078		10.1074/jbc.M111.318915	http://dx.doi.org/10.1074/jbc.M111.318915			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22134925	Green Published, hybrid			2022-12-27	WOS:000299321000047
J	Roy, G; Placzek, E; Scanlan, TS				Roy, Gouriprasanna; Placzek, Ekaterina; Scanlan, Thomas S.			ApoB-100-containing Lipoproteins Are Major Carriers of 3-Iodothyronamine in Circulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; HUMAN APOLIPOPROTEIN-B; PLASMA-LIPOPROTEINS; THYROXINE-BINDING; THYROID-HORMONE; HEPG2 CELLS; ATHEROSCLEROTIC LESIONS; MASS-SPECTROMETRY; TRANSGENIC MICE; DEFICIENT MICE	3-Iodothyronamine (T(1)AM) is a biogenic amine derivative of thyroid hormone present in tissue and blood of vertebrates. Approximately 99% of the circulating thyroid hormones are bound to plasma proteins, including three major thyroid hormone-binding proteins, and the question arises as to whether circulating T(1)AMis also bound to serum factors. We report here that T(1)AM is largely bound to a single protein component of human serum. Using T(1)AM-affinity chromatography, we isolated this protein, and sequence analysis identified it as apolipoprotein B-100 (apoB-100), the protein component of several low density lipoprotein particles. Consistent with this finding, we demonstrate that >90% of specifically bound T(1)AM in human serum resides in the apoB-100-containing low density lipoprotein fraction. T(1)AM reversibly binds to apoB-100-containing lipoprotein particles with an equilibrium dissociation constant (K-D) of 17nM and a T(1)AM/apoB-100 stoichiometry of 1:1. Competition binding assays demonstrate that this binding site is highly selective for T(1)AM. Intracellular T(1)AM uptake is significantly enhanced by apoB-100-containing lipoprotein particles. Modest enhancements to apoB-100 cellular uptake and secretion by T(1)AM were observed; however, multidose T(1)AM treatment did not affect lipid or lipoprotein inventory in vivo. Thus, it appears that apoB-100 serves as a carrier of circulating T(1)AM and affords a novel mechanism by which T(1)AM gains entry to cells.	[Roy, Gouriprasanna; Placzek, Ekaterina; Scanlan, Thomas S.] Oregon Hlth & Sci Univ, Dept Physiol & Pharmacol, Portland, OR 97239 USA	Oregon Health & Science University	Scanlan, TS (corresponding author), 3181 SW Sam Jackson Pk Rd,L334, Portland, OR 97239 USA.	scanlant@ohsu.edu	Roy, Gouriprasanna/AAV-8533-2021	Roy, Gouriprasanna/0000-0002-0047-3575	National Institutes of Health [DK-52798]; Center [5P30CA-069533, 5P30EY-010572]; Proteomics Shared Resource; Oregon Opportunity; NATIONAL CANCER INSTITUTE [P30CA069533] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY010572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091539, R56DK052798, R01DK052798] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center; Proteomics Shared Resource; Oregon Opportunity; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK-52798 (to T. S. S.) and Center Grants 5P30CA-069533 and 5P30EY-010572. This work was also supported by the Proteomics Shared Resource that is generously funded by Oregon Opportunity.	ADELI K, 1990, FEBS LETT, V263, P345, DOI 10.1016/0014-5793(90)81410-P; AVIRAM M, 1988, J BIOL CHEM, V263, P15416; AVIRAM M, 1988, J BIOL CHEM, V263, P16842; Beghin L, 2000, J LIPID RES, V41, P1172; BENVENGA S, 1992, ENDOCRINOLOGY, V131, P2805, DOI 10.1210/en.131.6.2805; Benvenga S, 1998, ENDOCRINOLOGY, V139, P4311, DOI 10.1210/en.139.10.4311; BENVENGA S, 1990, ENDOCRINOLOGY, V127, P2241, DOI 10.1210/endo-127-5-2241; BENVENGA S, 1988, J CLIN ENDOCR METAB, V67, P6, DOI 10.1210/jcem-67-1-6; BENVENGA S, 1990, ENDOCRINOLOGY, V126, P933, DOI 10.1210/endo-126-2-933; Bietrix F, 2006, J BIOL CHEM, V281, P7214, DOI 10.1074/jbc.M508868200; Braulke LJ, 2008, J COMP PHYSIOL B, V178, P167, DOI 10.1007/s00360-007-0208-x; BROUSSEAU T, 1993, CLIN CHEM, V39, P960; CALLOW MJ, 1994, P NATL ACAD SCI USA, V91, P2130, DOI 10.1073/pnas.91.6.2130; Chiellini G, 2007, FASEB J, V21, P1597, DOI 10.1096/fj.06-7474com; Doyle KP, 2007, STROKE, V38, P2569, DOI 10.1161/STROKEAHA.106.480277; Fu T, 2004, J BIOL CHEM, V279, P28662, DOI 10.1074/jbc.M403271200; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; Hart ME, 2006, J MED CHEM, V49, P1101, DOI 10.1021/jm0505718; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Hoefig CS, 2011, J CLIN ENDOCR METAB, V96, P1864, DOI 10.1210/jc.2010-2680; Ianculescu AG, 2010, MOL BIOSYST, V6, P1403, DOI 10.1039/b926588k; Ianculescu AG, 2009, ENDOCRINOLOGY, V150, P1991, DOI 10.1210/en.2008-1339; Jonas A, 2008, N COMP BIOC, P485, DOI 10.1016/B978-044453219-0.50019-2; Klieverik LP, 2009, J ENDOCRINOL, V201, P377, DOI 10.1677/JOE-09-0043; Lynn EG, 2001, KIDNEY INT, V60, P520, DOI 10.1046/j.1523-1755.2001.060002520.x; Maiyoh GK, 2007, J NUTR, V137, P2185, DOI 10.1093/jn/137.10.2185; Manthey KC, 2005, J NUTR, V135, P978, DOI 10.1093/jn/135.5.978; Miyakawa M, 2006, SYNTHETIC COMMUN, V36, P891, DOI 10.1080/00397910500466074; Piehl S, 2011, ENDOCR REV, V32, P64, DOI 10.1210/er.2009-0040; PURCELLHUYNH DA, 1995, J CLIN INVEST, V95, P2246, DOI 10.1172/JCI117915; Qiu SQ, 1998, J LIPID RES, V39, P1661; Regard JB, 2007, J CLIN INVEST, V117, P4034, DOI 10.1172/JCI32994; Robbins J, 1976, Prog Clin Biol Res, V5, P331; Saba A, 2010, ENDOCRINOLOGY, V151, P5063, DOI 10.1210/en.2010-0491; Scanlan TS, 2011, J CLIN ENDOCR METAB, V96, P1674, DOI 10.1210/jc.2011-0688; Scanlan TS, 2009, ENDOCRINOLOGY, V150, P1108, DOI 10.1210/en.2008-1596; Scanlan TS, 2004, NAT MED, V10, P638, DOI 10.1038/nm1051; Schurer H, 2001, BIOORGAN MED CHEM, V9, P2557, DOI 10.1016/S0968-0896(01)00030-X; Schussler G C, 1990, Thyroid, V1, P25, DOI 10.1089/thy.1990.1.25; Schussler GC, 2000, THYROID, V10, P141, DOI 10.1089/thy.2000.10.141; Stahlman M, 2008, J LIPID RES, V49, P481, DOI 10.1194/jlr.D700025-JLR200; Stewart BJ, 2009, BBA-MOL CELL BIOL L, V1791, P772, DOI 10.1016/j.bbalip.2009.04.004; THERIAULT A, 1992, BIOCHEM BIOPH RES CO, V186, P617, DOI 10.1016/0006-291X(92)90791-I; Wiesner P, 2009, J LIPID RES, V50, P574, DOI 10.1194/jlr.D800028-JLR200; Wood WJL, 2009, CHEMBIOCHEM, V10, P361, DOI 10.1002/cbic.200800607	45	36	36	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					1790	1800		10.1074/jbc.M111.275552	http://dx.doi.org/10.1074/jbc.M111.275552			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22128163	Green Published, hybrid			2022-12-27	WOS:000299321000021
J	Dickhout, JG; Carlisle, RE; Jerome, DE; Mohammed-Ali, Z; Jiang, H; Yang, GD; Mani, S; Garg, SK; Banerjee, R; Kaufman, RJ; Maclean, KN; Wang, R; Austin, RC				Dickhout, Jeffrey G.; Carlisle, Rachel E.; Jerome, Danielle E.; Mohammed-Ali, Zahraa; Jiang, Hua; Yang, Guangdong; Mani, Sarathi; Garg, Sanjay K.; Banerjee, Ruma; Kaufman, Randal J.; Maclean, Kenneth N.; Wang, Rui; Austin, Richard C.			Integrated Stress Response Modulates Cellular Redox State via Induction of Cystathionine gamma-Lyase CROSS-TALK BETWEEN INTEGRATED STRESS RESPONSE AND THIOL METABOLISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; BETA-SYNTHASE; OXIDATIVE STRESS; PLASMA HOMOCYSTEINE; TRANSSULFURATION PATHWAY; CARDIOVASCULAR-DISEASE; TRANSCRIPTION FACTOR; GENE-EXPRESSION; FOLIC-ACID; ER STRESS	The integrated stress response mediated by eukaryotic translation initiation factor 2 alpha (eIF2 alpha) phosphorylation maintains cellular homeostasis under endoplasmic reticulum (ER) stress. eIF2 alpha phosphorylation induces activating transcription factor 4 (ATF4), a basic leucine zipper transcription factor that regulates the expression of genes responsible for amino acid metabolism, cellular redox state, and anti-stress responses. Cystathionine gamma-lyase (CSE) and cystathionine beta-synthase are critical enzymes in the transsulfuration pathway, which also regulate cellular redox status by modulating glutathione (GSH) levels. To determine the link between the integrated stress response and the transsulfuration pathway, we used homocysteine (Hcy) as an inducer of eIF2 alpha phosphorylation and ATF4 gene induction. Mouse embryonic fibroblasts (MEFs) lacking ATF4 (ATF4(-/-)) had reduced GSH levels and increased reactive oxygen species and were susceptible to apoptotic cell death under normal culture conditions. Further, ATF4(-/-) MEFs were more sensitive to Hcy-induced cytotoxicity and showed significantly reduced intracellular GSH levels associated with apoptosis. ATF4(-/-) MEFs could be rescued from L-Hcy-induced apoptosis by beta-mercaptoethanol medium supplementation that increases cysteine levels and restores GSH synthesis. ATF4(-/-) MEFs showed little or no CSE protein but did express cystathionine beta-synthase. Further, ER stress-inducing agents, including tunicamycin and thapsigargin, induced the expression of CSE in ATF4(-/-) MEFs. Consistent with ATF4(-/-) MEFs, CSE-/- MEFs showed significantly greater apoptosis when treated with tunicamycin, thapsigargin, and L-Hcy, compared with CSE-/- MEFs. Liver and kidney GSH levels were also reduced in CSE-/- mice, suggesting that CSE is a critical factor in GSH synthesis and may act to protect the liver and kidney from a variety of conditions that cause ER stress.	[Austin, Richard C.] St Josephs Hosp, Hamilton Ctr Kidney Res, Hamilton, ON L8N 4A6, Canada; [Austin, Richard C.] McMaster Univ, St Josephs Healthcare Hamilton, Div Nephrol, Dept Med, Hamilton, ON L8N 4A6, Canada; [Jiang, Hua; Maclean, Kenneth N.] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO 80045 USA; [Mani, Sarathi; Wang, Rui] Lakehead Univ, Dept Biol, Thunder Bay, ON P7B 5E1, Canada; [Yang, Guangdong] Lakehead Univ, Sch Kinesiol, Thunder Bay, ON P7B 5E1, Canada; [Garg, Sanjay K.; Banerjee, Ruma] Univ Michigan, Med Ctr, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Garg, Sanjay K.] Univ Michigan, Med Ctr, Dept Internal Med Geriatr Med, Ann Arbor, MI 48109 USA; [Kaufman, Randal J.] Sanford Burnham Med Res Inst, Neurosci Aging & Stem Cell Res Ctr, La Jolla, CA 92037 USA	McGill University; McMaster University; McMaster University; University of Colorado System; University of Colorado Anschutz Medical Campus; Lakehead University; Lakehead University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Sanford Burnham Prebys Medical Discovery Institute	Austin, RC (corresponding author), St Josephs Hosp, Hamilton Ctr Kidney Res, 50 Charlton Ave E, Hamilton, ON L8N 4A6, Canada.	raustin@thrombosis.hhscr.org	Dickhout, Jeffrey/R-2606-2019; Yang, Guangdong/G-4129-2011; Wang, Rui/C-7824-2012	Wang, Rui/0000-0003-3825-3620; MANI, SARATHI/0000-0001-8383-4788	National Institutes of Health [P01HL057346, R37DK042394, R01DK088227, R01HL052173, HL58984]; Heart and Stroke Foundation of Ontario [T-5385]; Canadian Institutes of Health Research [MOP-74477, MOP-86708]; St. Joseph's Healthcare Hamilton; Jerome Lejeune Foundation; Special Products U.K; William R. Hummel Homocystinuria Research Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL057346, R01HL052173, R01HL058984] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088227, R37DK042394] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); St. Joseph's Healthcare Hamilton; Jerome Lejeune Foundation; Special Products U.K; William R. Hummel Homocystinuria Research Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants P01HL057346, R37DK042394, R01DK088227, and R01HL052173 (to R. J. K.) and HL58984 (to R. B.). This work was also supported in part by Heart and Stroke Foundation of Ontario Grant T-5385 (to R. C. A.) and Canadian Institutes of Health Research Grant MOP-74477 (to R. C. A.). This work was also supported by St. Joseph's Healthcare Hamilton.; Supported by the Jerome Lejeune Foundation, Special Products U.K., and the William R. Hummel Homocystinuria Research Fund.; Supported by Canadian Institutes of Health Research operating Grant MOP-86708.	Albert CM, 2008, JAMA-J AM MED ASSOC, V299, P2027, DOI 10.1001/jama.299.17.2027; Armitage JM, 2010, JAMA-J AM MED ASSOC, V303, P2486, DOI 10.1001/jama.2010.840; Bi MX, 2005, EMBO J, V24, P3470, DOI 10.1038/sj.emboj.7600777; Bonaa KH, 2006, NEW ENGL J MED, V354, P1578, DOI 10.1056/NEJMoa055227; BOUSHEY CJ, 1995, JAMA-J AM MED ASSOC, V274, P1049, DOI 10.1001/jama.274.13.1049; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; de Koning ABL, 2003, CLIN BIOCHEM, V36, P431, DOI 10.1016/S0009-9120(03)00062-6; Dey S, 2010, J BIOL CHEM, V285, P33165, DOI 10.1074/jbc.M110.167213; Dickhout JG, 2007, ANTIOXID REDOX SIGN, V9, P1863, DOI 10.1089/ars.2007.1780; Dickhout JG, 2005, ARTERIOSCL THROM VAS, V25, P2623, DOI 10.1161/01.ATV.0000189159.96900.d9; Dickhout JG, 2002, CIRC RES, V91, P487, DOI 10.1161/01.RES.0000035243.66189.92; Dombroski BA, 2010, AM J HUM GENET, V86, P719, DOI 10.1016/j.ajhg.2010.03.017; Eikelboom JW, 1999, ANN INTERN MED, V131, P363, DOI 10.7326/0003-4819-131-5-199909070-00008; Espinos C, 2010, CLIN GENET, V78, P554, DOI 10.1111/j.1399-0004.2010.01431.x; Fels DR, 2006, CANCER BIOL THER, V5, P723, DOI 10.4161/cbt.5.7.2967; FINKELSTEIN JD, 1990, J NUTR BIOCHEM, V1, P228, DOI 10.1016/0955-2863(90)90070-2; Garg SK, 2010, METHODS IN REDOX SIGNALING, P7; Handy DE, 2005, J BIOL CHEM, V280, P15518, DOI 10.1074/jbc.M501452200; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hossain GS, 2003, J BIOL CHEM, V278, P30317, DOI 10.1074/jbc.M212897200; Ishii I, 2004, BIOCHEM J, V381, P113, DOI 10.1042/BJ20040243; Ishii I, 2010, J BIOL CHEM, V285, P26358, DOI 10.1074/jbc.M110.147439; ISHII T, 1981, J BIOL CHEM, V256, P2387; Jakubowski H, 2003, CLIN CHEM LAB MED, V41, P1462, DOI 10.1515/CCLM.2003.224; Jakubowski H, 2008, FASEB J, V22, P4071, DOI 10.1096/fj.08-112086; Kraus JP, 2009, MOL GENET METAB, V97, P250, DOI 10.1016/j.ymgme.2009.04.001; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lange PS, 2008, J EXP MED, V205, P1227, DOI 10.1084/jem.20071460; Lewerenz J, 2009, J BIOL CHEM, V284, P1106, DOI 10.1074/jbc.M807325200; Lu PD, 2004, EMBO J, V23, P169, DOI 10.1038/sj.emboj.7600030; Maclean KN, 2010, MOL GENET METAB, V101, P153, DOI 10.1016/j.ymgme.2010.06.010; Maclean KN, 2010, MOL GENET METAB, V101, P163, DOI 10.1016/j.ymgme.2010.06.007; Maclean KN, 2004, J BIOL CHEM, V279, P8558, DOI 10.1074/jbc.M310211200; Maclean KN, 2002, J CELL PHYSIOL, V192, P81, DOI 10.1002/jcp.10118; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Malhotra JD, 2007, ANTIOXID REDOX SIGN, V9, P2277, DOI 10.1089/ars.2007.1782; Malhotra JD, 2008, P NATL ACAD SCI USA, V105, P18525, DOI 10.1073/pnas.0809677105; Martin J. A., 2007, CELL MOL BIOL S, V53; Mosharov E, 2000, BIOCHEMISTRY-US, V39, P13005, DOI 10.1021/bi001088w; O'Brien M, 2000, J PHARMACOL EXP THER, V294, P480; Outinen PA, 1999, BLOOD, V94, P959, DOI 10.1182/blood.V94.3.959.415k20_959_967; Patel H, 2003, J BIOL CHEM, V278, P19436, DOI 10.1074/jbc.M301718200; Reddy RK, 2003, J BIOL CHEM, V278, P20915, DOI 10.1074/jbc.M212328200; Roybal CN, 2004, J BIOL CHEM, V279, P14844, DOI 10.1074/jbc.M312948200; Shastry S, 2007, KIDNEY INT, V71, P304, DOI 10.1038/sj.ki.5002031; Ueda S, 2002, ANTIOXID REDOX SIGN, V4, P405, DOI 10.1089/15230860260196209; Vitvitsky V, 2004, AM J PHYSIOL-REG I, V287, pR39, DOI 10.1152/ajpregu.00036.2004; Vitvitsky V, 2006, J BIOL CHEM, V281, P35785, DOI 10.1074/jbc.M602799200; Wang H, 2003, BLOOD, V101, P3901, DOI 10.1182/blood-2002-08-2606; Wang J, 2004, CLIN GENET, V65, P483, DOI 10.1111/j.1399-0004.2004.00250.x; Wek RC, 2007, ANTIOXID REDOX SIGN, V9, P2357, DOI 10.1089/ars.2007.1764; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Wu LY, 2004, P NATL ACAD SCI USA, V101, P7094, DOI 10.1073/pnas.0402004101; Yan SK, 2006, BIOCHEM BIOPH RES CO, V351, P485, DOI 10.1016/j.bbrc.2006.10.058; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Yap S, 2001, ARTERIOSCL THROM VAS, V21, P2080, DOI 10.1161/hq1201.100225; Zhang C, 2001, J BIOL CHEM, V276, P35867, DOI 10.1074/jbc.M100747200; Zhou J, 2004, CIRCULATION, V110, P207, DOI 10.1161/01.CIR.0000134487.51510.97; Zhou J, 2003, ATHEROSCLEROSIS, V168, P255, DOI 10.1016/S0021-9150(03)00138-2; Zhou J, 2001, ARTERIOSCL THROM VAS, V21, P1470, DOI 10.1161/hq0901.096582; Zhou J, 2008, FASEB J, V22, P2569, DOI 10.1096/fj.07-105353; Zhu WD, 2008, BIOCHEMISTRY-US, V47, P6226, DOI 10.1021/bi800351a	62	81	87	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7603	7614		10.1074/jbc.M111.304576	http://dx.doi.org/10.1074/jbc.M111.304576			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22215680	hybrid, Green Published			2022-12-27	WOS:000301060200060
J	Challa, TD; Beaton, N; Arnold, M; Rudofsky, G; Langhans, W; Wolfrum, C				Challa, Tenagne Delessa; Beaton, Nigel; Arnold, Myrtha; Rudofsky, Gottfried; Langhans, Wolfgang; Wolfrum, Christian			Regulation of Adipocyte Formation by GLP-1/GLP-1R Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCAGON-LIKE PEPTIDE-1; BETA-CELL FUNCTION; ADIPOSE-TISSUE; INSULIN SENSITIVITY; BODY-WEIGHT; RECEPTOR; DIFFERENTIATION; PROLIFERATION; LIRAGLUTIDE; OBESITY	Increased nutrient intake leads to excessive adipose tissue accumulation, obesity, and the development of associated metabolic disorders. How the intestine signals to adipose tissue to adapt to increased nutrient intake, however, is still not completely understood. We show here, that the gut peptide GLP-1 or its long-lasting analog liraglutide, function as intestinally derived signals to induce adipocyte formation, both in vitro and in vivo. GLP-1 and liraglutide activate the GLP-1R, thereby promoting pre-adipocyte proliferation and inhibition of apoptosis. This is achieved at least partly through activation of ERK, PKC, and AKT signaling pathways. In contrast, loss of GLP-1R expression causes reduction in adipogenesis, through induction of apoptosis in pre-adipocytes, by inhibition of the above mentioned pathways. Because GLP-1 and liraglutide are used for the treatment of type 2 diabetes, these findings implicate GLP-1 as a regulator of adipogenesis, which could be an alternate pathway leading to improved lipid homeostasis and controlled downstream insulin signaling.	[Challa, Tenagne Delessa; Beaton, Nigel; Arnold, Myrtha; Langhans, Wolfgang; Wolfrum, Christian] Swiss Fed Inst Technol, Inst Food Nutr & Hlth, Swiss Fed Inst Technol, CH-8603 Schwerzenbach, Switzerland; [Rudofsky, Gottfried] Heidelberg Univ, Dept Med & Clin Chem 1, D-69120 Heidelberg, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; Ruprecht Karls University Heidelberg	Wolfrum, C (corresponding author), Swiss Fed Inst Technol, Inst Food Nutr & Hlth, Swiss Fed Inst Technol, SLA C92,Schorenstr 16, CH-8603 Schwerzenbach, Switzerland.	Christian-wolfrum@ethz.ch	Langhans, Wolfgang/C-4073-2016	Wolfrum, Christian/0000-0002-3862-6805; Beaton, Nigel/0000-0003-3852-0223; Challa, PhD, Tenagne Delessa/0000-0002-5898-8061	ERC (AdipoDif); SNF	ERC (AdipoDif); SNF	This work was supported by the ERC (AdipoDif) and by the SNF.	Baudry A, 2006, J CELL SCI, V119, P889, DOI 10.1242/jcs.02792; Bays Harold E, 2008, Expert Rev Cardiovasc Ther, V6, P343, DOI 10.1586/14779072.6.3.343; Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; Bost F, 2005, BIOCHIMIE, V87, P51, DOI 10.1016/j.biochi.2004.10.018; Bregenbolt S, 2005, BIOCHEM BIOPH RES CO, V330, P577, DOI 10.1016/j.bbrc.2005.03.013; Buteau J, 2008, DIABETES METAB, V34, pS73, DOI 10.1016/S1262-3636(08)73398-6; CLEMENS MJ, 1992, J CELL SCI, V103, P881; CORNELIUS P, 1994, ANNU REV NUTR, V14, P99, DOI 10.1146/annurev.nu.14.070194.000531; Davidson LA, 2000, CARCINOGENESIS, V21, P1513, DOI 10.1093/carcin/21.8.1513; Drucker DJ, 2010, NAT REV DRUG DISCOV, V9, P267, DOI 10.1038/nrd3148; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Dubuisson O, 2011, ENDOCRINOLOGY, V152, P3648, DOI 10.1210/en.2011-0225; Egan JM, 2003, DIABETES-METAB RES, V19, P115, DOI 10.1002/dmrr.357; EGAN JM, 1994, ENDOCRINOLOGY, V135, P2070, DOI 10.1210/en.135.5.2070; Friedrichsen BN, 2006, J ENDOCRINOL, V188, P481, DOI 10.1677/joe.1.06160; Hansotia T, 2007, J CLIN INVEST, V117, P143, DOI 10.1172/JCI25483; Harvey NL, 2005, NAT GENET, V37, P1072, DOI 10.1038/ng1642; Hausman D B, 2001, Obes Rev, V2, P239, DOI 10.1046/j.1467-789X.2001.00042.x; Hayes MR, 2011, OBESITY, V19, P1342, DOI 10.1038/oby.2011.50; Hoffstedt J, 2010, DIABETOLOGIA, V53, P2496, DOI 10.1007/s00125-010-1889-3; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Huang Y, 2010, BRIT J PHARMACOL, V159, P237, DOI 10.1111/j.1476-5381.2009.00517.x; Hwang CS, 1997, ANNU REV CELL DEV BI, V13, P231, DOI 10.1146/annurev.cellbio.13.1.231; Jo J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000324; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kaplan NM, 1998, J HYPERTENS, V16, pS35; Kim JE, 2004, DIABETES, V53, P2748, DOI 10.2337/diabetes.53.11.2748; Knudsen LB, 2000, J MED CHEM, V43, P1664, DOI 10.1021/jm9909645; Korner Antje, 2005, Hormones (Athens), V4, P189; Kortum RL, 2005, MOL CELL BIOL, V25, P7592, DOI 10.1128/MCB.25.17.7592-7604.2005; LACASA D, 1995, BIOCHEM BIOPH RES CO, V217, P123, DOI 10.1006/bbrc.1995.2753; Lee NK, 2008, TRENDS ENDOCRIN MET, V19, P161, DOI 10.1016/j.tem.2008.02.006; Li YZ, 2010, J NEUROCHEM, V113, P1621, DOI 10.1111/j.1471-4159.2010.06731.x; Lo Yung-Feng, 2009, Chang Gung Med J, V32, P51; Lovshin JA, 2009, NAT REV ENDOCRINOL, V5, P262, DOI 10.1038/nrendo.2009.48; Mari A, 2007, DIABETES CARE, V30, P2032, DOI 10.2337/dc07-0310; Meissburger B, 2011, DIABETOLOGIA, V54, P1468, DOI 10.1007/s00125-011-2093-9; Meissburger B, 2011, EMBO MOL MED, V3, P637, DOI 10.1002/emmm.201100172; MontroseRafizadeh C, 1997, J CELL PHYSIOL, V172, P275, DOI 10.1002/(SICI)1097-4652(199709)172:3<275::AID-JCP1>3.0.CO;2-L; Noyan-Ashraf MH, 2009, DIABETES, V58, P975, DOI 10.2337/db08-1193; Quoyer J, 2010, J BIOL CHEM, V285, P1989, DOI 10.1074/jbc.M109.067207; Rask E, 2001, DIABETES CARE, V24, P1640, DOI 10.2337/diacare.24.9.1640; Sanz C, 2010, AM J PHYSIOL-ENDOC M, V298, pE634, DOI 10.1152/ajpendo.00460.2009; Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8; THORENS B, 1992, P NATL ACAD SCI USA, V89, P8641, DOI 10.1073/pnas.89.18.8641; Tong J, 2010, AM J PHYSIOL-GASTR L, V298, pG474, DOI 10.1152/ajpgi.00367.2009; Verdich C, 2001, INT J OBESITY, V25, P1206, DOI 10.1038/sj.ijo.0801655; von der Weid PY, 2010, ALIMENT PHARM THER, V32, P697, DOI 10.1111/j.1365-2036.2010.04407.x; Wolfrum C, 2003, J CLIN INVEST, V112, P345, DOI 10.1172/JCI18698; Zander M, 2002, LANCET, V359, P824, DOI 10.1016/S0140-6736(02)07952-7; Zhou YR, 2006, INT J BIOCHEM CELL B, V38, P2151, DOI 10.1016/j.biocel.2006.06.009	52	86	92	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6421	6430		10.1074/jbc.M111.310342	http://dx.doi.org/10.1074/jbc.M111.310342			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22207759	Green Published, hybrid			2022-12-27	WOS:000300791800032
J	Deng, W; Bukiya, AN; Rodriguez-Menchaca, AA; Zhang, Z; Baumgarten, CM; Logothetis, DE; Levitan, I; Rosenhouse-Dantsker, A				Deng, Wu; Bukiya, Anna N.; Rodriguez-Menchaca, Aldo A.; Zhang, Zhe; Baumgarten, Clive M.; Logothetis, Diomedes E.; Levitan, Irena; Rosenhouse-Dantsker, Avia			Hypercholesterolemia Induces Up-regulation of K-ACh Cardiac Currents via a Mechanism Independent of Phosphatidylinositol 4,5-Bisphosphate and G beta gamma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATRIAL-FIBRILLATION; POTASSIUM CHANNEL; CHOLESTEROL SENSITIVITY; KIR CHANNELS; I-KACH; PROTEIN; ACTIVATION; RECEPTOR; BINDING; IDENTIFICATION	Hypercholesterolemia is a well-known risk factor for cardiovascular disease. In the heart, activation of K-ACh mediates the vagal (parasympathetic) negative chronotropic effect on heart rate. Yet, the effect of cholesterol on K-ACh is unknown. Here we show that cholesterol plays a critical role in modulating K-ACh currents (I-K,I-ACh) in atrial cardiomyocytes. Specifically, cholesterol enrichment of rabbit atrial cardiomyocytes led to enhanced channel activity while cholesterol depletion suppressed I-K,I-ACh. Moreover, a high-cholesterol diet resulted in up to 3-fold increase in I-K,I-ACh in rodents. In accordance, elevated currents were observed in Xenopus oocytes expressing the Kir3.1/Kir3.4 heteromer that underlies I-K,I-ACh. Furthermore, our data suggest that cholesterol affects I-K,I-ACh via a mechanism which is independent of both PI(4,5)P-2 and G(beta gamma). Interestingly, the effect of cholesterol on I-K,I-ACh is opposite to its effect on I-K1 in atrial myocytes. The latter are suppressed by cholesterol enrichment and by high-cholesterol diet, and facilitated following cholesterol depletion. These findings establish that cholesterol plays a critical role in modulating I-K,I-ACh in atrial cardiomyocytes via a mechanism independent of the channel's major modulators.	[Levitan, Irena; Rosenhouse-Dantsker, Avia] Univ Illinois, Dept Med, Pulm Sect, Chicago, IL 60612 USA; [Deng, Wu; Rodriguez-Menchaca, Aldo A.; Zhang, Zhe; Baumgarten, Clive M.; Logothetis, Diomedes E.] Virginia Commonwealth Univ, Sch Med, Dept Physiol & Biophys, Richmond, VA 23298 USA; [Bukiya, Anna N.] Univ Tennessee, Ctr Hlth Sci, Dept Pharmacol, Memphis, TN 38163 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Virginia Commonwealth University; University of Tennessee System; University of Tennessee Health Science Center	Rosenhouse-Dantsker, A (corresponding author), Univ Illinois, Dept Med, Pulm Sect, Chicago, IL 60612 USA.	dantsker@uic.edu	Zhang, Zhe/C-2685-2011; Rodríguez-Menchaca, Aldo A./AAD-4603-2019; Bukiya, Anna/N-5361-2019	Rodríguez-Menchaca, Aldo A./0000-0001-7501-8836; 	National Institutes of Health [HL-073965, HL-083298, HL-059949, 5T32HL094290]; American Heart Association [11SDG5190025]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083298, R01HL059949, R01HL073965] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-073965, HL-083298 (to I. L.), and HL-059949 (to D. E. L.) and Scientist Development Grant 11SDG5190025 from the American Heart Association (to A. R.-D.).; Supported by National Institutes of Health Training Grant 5T32HL094290.	Adam O, 2008, CIRCULATION, V118, P1285, DOI 10.1161/CIRCULATIONAHA.107.760892; Bettahi H, 2002, J BIOL CHEM, V277, P48282, DOI 10.1074/jbc.M209599200; Blednov YA, 2001, J PHARMACOL EXP THER, V298, P521; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; BREITWIESER GE, 1985, NATURE, V317, P538, DOI 10.1038/317538a0; Carman CV, 2000, J BIOL CHEM, V275, P10443, DOI 10.1074/jbc.275.14.10443; Cha TJ, 2006, CIRCULATION, V113, P1730, DOI 10.1161/CIRCULATIONAHA.105.561738; Christian AE, 1997, J LIPID RES, V38, P2264; Dobrev D, 2005, CIRCULATION, V112, P3697, DOI 10.1161/circulationaha.105.575332; Ehrlich JR, 2004, J PHYSIOL-LONDON, V557, P583, DOI 10.1113/jphysiol.2004.061119; Epshtein Y, 2009, P NATL ACAD SCI USA, V106, P8055, DOI 10.1073/pnas.0809847106; Fang Y, 2006, CIRC RES, V98, P1064, DOI 10.1161/01.RES.0000218776.87842.43; Fauchier L, 2008, J AM COLL CARDIOL, V51, P828, DOI 10.1016/j.jacc.2007.09.063; Finley M, 2004, J PHYSIOL-LONDON, V555, P643, DOI 10.1113/jphysiol.2003.056101; GURDON JB, 1971, NATURE, V233, P177, DOI 10.1038/233177a0; He C, 1999, J BIOL CHEM, V274, P12517, DOI 10.1074/jbc.274.18.12517; He C, 2002, J BIOL CHEM, V277, P6088, DOI 10.1074/jbc.M104851200; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Hughes M, 2008, THROMB HAEMOSTASIS, V99, P295, DOI 10.1160/TH07-08-0508; JONES OT, 1988, BIOCHEMISTRY-US, V27, P2364, DOI 10.1021/bi00407a018; Kim D, 1997, AM J PHYSIOL-HEART C, V272, pH195, DOI 10.1152/ajpheart.1997.272.1.H195; Kitamura H, 2000, J PHARMACOL EXP THER, V293, P196; Kobayashi T, 2006, CURR PHARM DESIGN, V12, P4513, DOI 10.2174/138161206779010468; Kovoor P, 2001, J AM COLL CARDIOL, V37, P2136, DOI 10.1016/S0735-1097(01)01304-3; KRAPIVINSKY G, 1995, NATURE, V374, P135, DOI 10.1038/374135a0; KURACHI Y, 1986, AM J PHYSIOL, V251, pH681, DOI 10.1152/ajpheart.1986.251.3.H681; Lee AG, 2003, BBA-BIOMEMBRANES, V1612, P1, DOI 10.1016/S0005-2736(03)00056-7; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; Lopes CMB, 2002, NEURON, V34, P933, DOI 10.1016/S0896-6273(02)00725-0; Marius P, 2008, BIOPHYS J, V94, P1689, DOI 10.1529/biophysj.107.117507; Menke J, 2010, AM J CARDIOL, V105, P502, DOI 10.1016/j.amjcard.2009.10.018; Murata Y, 2007, J PHYSIOL-LONDON, V583, P875, DOI 10.1113/jphysiol.2007.134775; Pegan S, 2005, NAT NEUROSCI, V8, P279, DOI 10.1038/nn1411; PFAFFINGER PJ, 1985, NATURE, V317, P536, DOI 10.1038/317536a0; Rankin SE, 1997, BIOPHYS J, V73, P2446, DOI 10.1016/S0006-3495(97)78273-0; REUVENY E, 1994, NATURE, V370, P143, DOI 10.1038/370143a0; Rishal I, 2005, J BIOL CHEM, V280, P16685, DOI 10.1074/jbc.M412196200; Romanenko VG, 2004, BIOPHYS J, V87, P3850, DOI 10.1529/biophysj.104.043273; Romanenko VG, 2002, BIOPHYS J, V83, P3211, DOI 10.1016/S0006-3495(02)75323-X; Rosenhouse-Dantsker A, 2008, NAT CHEM BIOL, V4, P624, DOI 10.1038/nchembio.112; Rosenhouse-Dantsker A, 2011, BIOPHYS J, V100, P381, DOI 10.1016/j.bpj.2010.11.086; Rosenhouse-Dantsker A, 2010, CHANNELS, V4, P63, DOI 10.4161/chan.4.1.10366; SHOUFFANI A, 1990, J BIOL CHEM, V265, P6002; Signorini S, 1997, P NATL ACAD SCI USA, V94, P923, DOI 10.1073/pnas.94.3.923; Slesinger PA, 1997, P NATL ACAD SCI USA, V94, P12210, DOI 10.1073/pnas.94.22.12210; SOEJIMA M, 1984, PFLUG ARCH EUR J PHY, V400, P424, DOI 10.1007/BF00587544; SUNSHINE C, 1994, BBA-BIOMEMBRANES, V1191, P59, DOI 10.1016/0005-2736(94)90233-X; Vivaudou M, 1997, J BIOL CHEM, V272, P31553, DOI 10.1074/jbc.272.50.31553; Wang ZG, 1998, CIRCULATION, V98, P2422, DOI 10.1161/01.CIR.98.22.2422; Wickman K, 1998, NEURON, V20, P103, DOI 10.1016/S0896-6273(00)80438-9; Zhang HL, 1999, NAT CELL BIOL, V1, P183, DOI 10.1038/11103	52	25	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4925	4935		10.1074/jbc.M111.306134	http://dx.doi.org/10.1074/jbc.M111.306134			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22174416	hybrid, Green Published			2022-12-27	WOS:000300608500053
J	Thome, R; Gust, A; Toci, R; Mendel, R; Bittner, F; Magalon, A; Walburger, A				Thome, Remi; Gust, Alexander; Toci, Rene; Mendel, Ralf; Bittner, Florian; Magalon, Axel; Walburger, Anne			A Sulfurtransferase Is Essential for Activity of Formate Dehydrogenases in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERIPLASMIC NITRATE REDUCTASE; MOLYBDENUM COFACTOR SULFURATION; THALIANA PROVIDES INSIGHT; FE-S CLUSTER; XANTHINE DEHYDROGENASE; CRYSTAL-STRUCTURE; CYSTEINE DESULFURASE; ARABIDOPSIS-THALIANA; 4-THIOURIDINE BIOSYNTHESIS; TRANSFER-RNA	L-Cysteine desulfurases provide sulfur to several metabolic pathways in the form of persulfides on specific cysteine residues of an acceptor protein for the eventual incorporation of sulfur into an end product. IscS is one of the three Escherichia coli L-cysteine desulfurases. It interacts with FdhD, a protein essential for the activity of formate dehydrogenases (FDHs), which are iron/molybdenum/selenium-containing enzymes. Here, we address the role played by this interaction in the activity of FDH-H (FdhF) in E. coli. The interaction of IscS with FdhD results in a sulfur transfer between IscS and FdhD in the form of persulfides. Substitution of the strictly conserved residue Cys-121 of FdhD impairs both sulfur transfer from IscS to FdhD and FdhF activity. Furthermore, inactive FdhF produced in the absence of FdhD contains both metal centers, albeit the molybdenum cofactor is at a reduced level. Finally, FdhF activity is sulfur-dependent, as it shows reversible sensitivity to cyanide treatment. Conclusively, FdhD is a sulfurtransferase between IscS and FdhF and is thereby essential to yield FDH activity.	[Thome, Remi; Toci, Rene; Magalon, Axel; Walburger, Anne] CNRS, Inst Microbiol Mediterranee, Chim Bacterienne Lab, UPR9043, F-13009 Marseille, France; [Thome, Remi; Toci, Rene; Magalon, Axel; Walburger, Anne] Aix Marseille Univ, F-13009 Marseille, France; [Gust, Alexander; Mendel, Ralf; Bittner, Florian] Tech Univ Carolo Wilhelmina Braunschweig, Inst Pflanzenbiol, D-38023 Braunschweig, Germany	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Braunschweig University of Technology	Magalon, A (corresponding author), CNRS, Inst Microbiol Mediterranee, Chim Bacterienne Lab, UPR9043, F-13009 Marseille, France.	magalon@ifr88.cnrs-mrs.fr		Magalon, Axel/0000-0002-3375-738X	Agence Nationale Recherche Jeunes Chercheurs; CNRS; Aix-Marseille University; Deutsche Forschungsgemeinschaft	Agence Nationale Recherche Jeunes Chercheurs(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); Aix-Marseille University; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Agence Nationale Recherche Jeunes Chercheurs (to A. M.), CNRS, the Aix-Marseille University (to R. T. and A. W.), and the Deutsche Forschungsgemeinschaft (to F. B. and R. M.).	ABAIBOU H, 1995, J BACTERIOL, V177, P7141, DOI 10.1128/jb.177.24.7141-7149.1995; Arifuzzaman M, 2006, GENOME RES, V16, P686, DOI 10.1101/gr.4527806; Arnoux P, 2003, NAT STRUCT BIOL, V10, P928, DOI 10.1038/nsb994; AXLEY MJ, 1990, J BIOL CHEM, V265, P18213; AXLEY MJ, 1991, P NATL ACAD SCI USA, V88, P8450, DOI 10.1073/pnas.88.19.8450; Bittner F, 2001, J BIOL CHEM, V276, P40381, DOI 10.1074/jbc.C100472200; Boyington JC, 1997, SCIENCE, V275, P1305, DOI 10.1126/science.275.5304.1305; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Coelho C, 2011, J MOL BIOL, V408, P932, DOI 10.1016/j.jmb.2011.03.016; Cupp-Vickery JR, 2003, J MOL BIOL, V330, P1049, DOI 10.1016/S0022-2836(03)00690-9; Enroth C, 2000, P NATL ACAD SCI USA, V97, P10723, DOI 10.1073/pnas.97.20.10723; Heidenreich T, 2005, J BIOL CHEM, V280, P4213, DOI 10.1074/jbc.M411195200; Ikeuchi Y, 2006, MOL CELL, V21, P97, DOI 10.1016/j.molcel.2005.11.001; Jepson BJN, 2007, J BIOL CHEM, V282, P6425, DOI 10.1074/jbc.M607353200; JONES RW, 1977, BIOCHEM J, V164, P199, DOI 10.1042/bj1640199; Jormakka M, 2002, SCIENCE, V295, P1863, DOI 10.1126/science.1068186; Kambampati R, 2000, J BIOL CHEM, V275, P10727, DOI 10.1074/jbc.275.15.10727; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Kato S, 2002, P NATL ACAD SCI USA, V99, P5948, DOI 10.1073/pnas.082123599; Kessler D, 2006, FEMS MICROBIOL REV, V30, P825, DOI 10.1111/j.1574-6976.2006.00036.x; Lehrke M., 2011, BIOCH J IN PRESS; Leimkuhler S, 2003, J BIOL CHEM, V278, P20802, DOI 10.1074/jbc.M303091200; Loiseau L, 2005, J BIOL CHEM, V280, P26760, DOI 10.1074/jbc.M504067200; Loiseau L, 2003, J BIOL CHEM, V278, P38352, DOI 10.1074/jbc.M305953200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Magalon A, 2002, J BIOL CHEM, V277, P48199, DOI 10.1074/jbc.M205806200; Magalon A, 2011, COORDIN CHEM REV, V255, P1159, DOI 10.1016/j.ccr.2010.12.031; MANDRANDBERTHELOT MA, 1988, J GEN MICROBIOL, V134, P3129; Mihara H, 2002, APPL MICROBIOL BIOT, V60, P12, DOI 10.1007/s00253-002-1107-4; Najmudin S, 2008, J BIOL INORG CHEM, V13, P737, DOI 10.1007/s00775-008-0359-6; Neumann M, 2007, BIOCHEMISTRY-US, V46, P9586, DOI 10.1021/bi700630p; Neumann M, 2006, J BIOL CHEM, V281, P15701, DOI 10.1074/jbc.M601617200; Raaijmakers H, 2002, STRUCTURE, V10, P1261, DOI 10.1016/S0969-2126(02)00826-2; Raaijmakers HCA, 2006, J BIOL INORG CHEM, V11, P849, DOI 10.1007/s00775-006-0129-2; SCHLINDWEIN C, 1990, J BACTERIOL, V172, P6112, DOI 10.1128/jb.172.10.6112-6121.1990; Shi R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000354; Stanley NR, 2002, MOL MICROBIOL, V43, P1005, DOI 10.1046/j.1365-2958.2002.02797.x; STEWART V, 1991, J BACTERIOL, V173, P4417, DOI 10.1128/JB.173.14.4417-4423.1991; WAHL RC, 1982, J BIOL CHEM, V257, P3958; Wollers S, 2008, J BIOL CHEM, V283, P9642, DOI 10.1074/jbc.M708549200; Wright CM, 2006, CHEM COMMUN, P3104, DOI 10.1039/b604040c; Wright CM, 2002, CHEM COMMUN, P2708, DOI 10.1039/b208626c; WU LF, 1986, BIOCHIMIE, V68, P167, DOI 10.1016/S0300-9084(86)81081-1; Zhang WJ, 2010, J BIOL CHEM, V285, P2302, DOI 10.1074/jbc.M109.082172; ZHENG LM, 1994, J BIOL CHEM, V269, P18723; ZHENG LM, 1994, BIOCHEMISTRY-US, V33, P4714, DOI 10.1021/bi00181a031	46	55	57	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4671	4678		10.1074/jbc.M111.327122	http://dx.doi.org/10.1074/jbc.M111.327122			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22194618	hybrid, Green Published			2022-12-27	WOS:000300608500029
J	Fenyk, S; Campillo, AD; Pohl, E; Hussey, PJ; Cann, MJ				Fenyk, Stepan; Campillo, Alba de San Eustaquio; Pohl, Ehmke; Hussey, Patrick J.; Cann, Martin J.			A Nucleotide Phosphatase Activity in the Nucleotide Binding Domain of an Orphan Resistance Protein from Rice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NB-ARC DOMAIN; GENE-PRODUCTS; CELL-DEATH; EXCHANGE; APOPTOSOME; ARABIDOPSIS; HYDROLYSIS; DEFENSE; APAF-1; I-2	Plant resistance proteins (R-proteins) are key components of the plant immune system activated in response to a plethora of different pathogens. R-proteins are P-loop NTPase superfamily members, and current models describe their main function as ATPases in defense signaling pathways. Here we show that a subset of R-proteins have evolved a new function to combat pathogen infection. This subset of R-proteins possesses a nucleotide phosphatase activity in the nucleotide-binding domain. Related R-proteins that fall in the same phylogenetic clade all show the same nucleotide phosphatase activity indicating a conserved function within at least a subset of R-proteins. R-protein nucleotide phosphatases catalyze the production of nucleoside from nucleotide with the nucleotide monophosphate as the preferred substrate. Mutation of conserved catalytic residues substantially reduced activity consistent with the biochemistry of P-loop NTPases. Kinetic analysis, analytical gel filtration, and chemical cross-linking demonstrated that the nucleotide-binding domain was active as a multimer. Nuclear magnetic resonance and nucleotide analogues identified the terminal phosphate bond as the target of a reaction that utilized a metal-mediated nucleophilic attack by water on the phosphoester. In conclusion, we have identified a group of R-proteins with a unique function. This biochemical activity appears to have co-evolved with plants in signaling pathways designed to resist pathogen attack.	[Fenyk, Stepan; Campillo, Alba de San Eustaquio; Pohl, Ehmke; Hussey, Patrick J.; Cann, Martin J.] Univ Durham, Sch Biol & Biomed Sci, Durham DH1 3LE, England; [Fenyk, Stepan; Campillo, Alba de San Eustaquio; Pohl, Ehmke; Hussey, Patrick J.; Cann, Martin J.] Univ Durham, Biophys Sci Inst, Durham DH1 3LE, England; [Pohl, Ehmke] Univ Durham, Dept Chem, Durham DH1 3LE, England	Durham University; Durham University; Durham University	Cann, MJ (corresponding author), Univ Durham, Sch Biol & Biomed Sci, South Rd, Durham DH1 3LE, England.	m.j.cann@durham.ac.uk	Pohl, Ehmke/I-2408-2012; Cann, Martin/G-2864-2012	Pohl, Ehmke/0000-0002-9949-4471; Cann, Martin/0000-0001-6305-8769; Hussey, Patrick/0000-0002-7349-8722	Leverhulme Trust [F/00128/AU]; BBSRC [BB/I011994/1]; Biotechnology and Biological Sciences Research Council [BB/I011994/1, 1220464] Funding Source: researchfish	Leverhulme Trust(Leverhulme Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Leverhulme Trust Grant F/00128/AU and BBSRC Grant BB/I011994/1 (to M. J. C.).	Allen RL, 2004, SCIENCE, V306, P1957, DOI 10.1126/science.1104022; Bao Q, 2007, MOL CELL, V25, P181, DOI 10.1016/j.molcel.2006.12.013; COHN M, 1978, P NATL ACAD SCI USA, V75, P200, DOI 10.1073/pnas.75.1.200; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; de Marco A, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-32; Dixon DP, 2009, J EXP BOT, V60, P1207, DOI 10.1093/jxb/ern365; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eswar N., 2006, CURR PROTOC BIOINFOR, V15, P5; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kang K, 2008, PLANT SIGNAL BEHAV, V3, P389, DOI 10.4161/psb.3.6.5401; Kim HE, 2005, P NATL ACAD SCI USA, V102, P17545, DOI 10.1073/pnas.0507900102; Lelpe DD, 2004, J MOL BIOL, V343, P1, DOI 10.1016/j.jmb.2004.08.023; Moffett P, 2002, EMBO J, V21, P4511, DOI 10.1093/emboj/cdf453; Moutinho A, 2001, P NATL ACAD SCI USA, V98, P10481, DOI 10.1073/pnas.171104598; Pillai MA, 2002, THEOR APPL GENET, V105, P34, DOI 10.1007/s00122-001-0833-9; Qi SQ, 2010, CELL, V141, P446, DOI 10.1016/j.cell.2010.03.017; Rairdan GJ, 2006, PLANT CELL, V18, P2082, DOI 10.1105/tpc.106.042747; Riedl SJ, 2005, NATURE, V434, P926, DOI 10.1038/nature03465; Takken FLW, 2009, SCIENCE, V324, P744, DOI 10.1126/science.1171666; Takken FLW, 2006, CURR OPIN PLANT BIOL, V9, P383, DOI 10.1016/j.pbi.2006.05.009; Tameling WIL, 2002, PLANT CELL, V14, P2929, DOI 10.1105/tpc.005793; Tameling WIL, 2006, PLANT PHYSIOL, V140, P1233, DOI 10.1104/pp.105.073510; Ueda H, 2006, PLANT MOL BIOL, V61, P31, DOI 10.1007/s11103-005-5817-8; van der Biezen EA, 1998, CURR BIOL, V8, pR226, DOI 10.1016/S0960-9822(98)70145-9; VANETTEN RL, 1978, P NATL ACAD SCI USA, V75, P4784	25	17	18	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					4023	4032		10.1074/jbc.M111.314450	http://dx.doi.org/10.1074/jbc.M111.314450			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22157756	Green Published, hybrid, Green Accepted			2022-12-27	WOS:000300410900036
J	Zhang, DM; van der Wel, H; Johnson, JM; West, CM				Zhang, Dongmei; van der Wel, Hanke; Johnson, Jennifer M.; West, Christopher M.			Skp1 Prolyl 4-Hydroxylase of Dictyostelium Mediates Glycosylation-independent and -dependent Responses to O-2 without Affecting Skp1 Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLCNAC-TRANSFERASE; MODIFIES SKP1; CYTOPLASM; DIFFERENTIATION; HYDROXYLASE; EXPRESSION; INITIATION; PATHWAYS; BEHAVIOR; GROWTH	Cytoplasmic prolyl 4-hydroxylases (PHDs) have a primary role in O-2 sensing in animals via modification of the transcriptional factor subunit HIF alpha, resulting in its polyubiquitination by the E3(VHL)ubiquitin (Ub) ligase and degradation in the 26 S proteasome. Previously thought to be restricted to animals, a homolog (P4H1) of HIF alpha-type PHDs is expressed in the social amoeba Dictyostelium where it also exhibits characteristics of an O-2 sensor for development. Dictyostelium lacks HIF alpha, and P4H1 modifies a different protein, Skp1, an adaptor of the SCF class of E3-Ub ligases related to the E3(VHL)Ub ligase that targets animal HIF alpha. Normally, the HO-Skp1 product of the P4H1 reaction is capped by a GlcNAc sugar that can be subsequently extended to a pentasaccharide by novel glycosyltransferases. To analyze the role of glycosylation, the Skp1 GlcNAc-transferase locus gnt1 was modified with a missense mutation to block catalysis or a stop codon to truncate the protein. Despite the accumulation of the hydroxylated form of Skp1, Skp1 was not destabilized based on metabolic labeling. However, hydroxylation alone allowed for partial correction of the high O-2 requirement of P4H1-null cells, therefore revealing both glycosylation-independent and glycosylation-dependent roles for hydroxylation. Genetic complementation of the latter function required an enzymatically active form of Gnt1. Because the effect of the gnt1 deficiency depended on P4H1, and Skp1 was the only protein labeled when the GlcNAc-transferase was restored to mutant extracts, Skp1 apparently mediates the cellular functions of both P4H1 and Gnt1. Although Skp1 stability itself is not affected by hydroxylation, its modification may affect the stability of targets of Skp1-dependent Ub ligases.	[West, Christopher M.] Univ Oklahoma, Dept Biochem & Mol Biol, Hlth Sci Ctr, OUHSC, Oklahoma City, OK 73104 USA; [Johnson, Jennifer M.; West, Christopher M.] Univ Oklahoma, Oklahoma Ctr Med Glycobiol, Hlth Sci Ctr, Oklahoma City, OK 73104 USA; [Zhang, Dongmei] Fujian Agr & Forestry Univ, Key Lab Biopesticide & Chem Biol, Minist Educ, Fuzhou 350002, Peoples R China	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Fujian Agriculture & Forestry University	West, CM (corresponding author), Univ Oklahoma, Dept Biochem & Mol Biol, Hlth Sci Ctr, OUHSC, 975 NE 10th St,BRC 417, Oklahoma City, OK 73104 USA.	Cwest2@ouhsc.edu	zhang, dongmei/B-8011-2013	Johnson Hays, Jennifer/0000-0001-5855-7352	National Institutes of Health [R01-GM037539]; Oklahoma Center for Advancement of Science and Technology [HR10-181]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037539] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oklahoma Center for Advancement of Science and Technology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-GM037539 ( to C. M. W.). This work was also supported by Grant HR10-181 from the Oklahoma Center for Advancement of Science and Technology.	Bien CM, 2010, EUKARYOT CELL, V9, P352, DOI 10.1128/EC.00358-09; Bonner JT, 2005, MYCOLOGIA, V97, P178, DOI 10.3852/mycologia.97.1.178; Borst P, 2008, ANNU REV MICROBIOL, V62, P235, DOI 10.1146/annurev.micro.62.081307.162750; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Ennis HL, 2000, P NATL ACAD SCI USA, V97, P3292, DOI 10.1073/pnas.050005097; Ercan A, 2006, J BIOL CHEM, V281, P12713, DOI 10.1074/jbc.M513664200; Ercan A, 2005, GLYCOBIOLOGY, V15, P489, DOI 10.1093/glycob/cwi034; Fey P, 2007, NAT PROTOC, V2, P1307, DOI 10.1038/nprot.2007.178; Funakoshi Y, 2009, BBA-GEN SUBJECTS, V1790, P81, DOI 10.1016/j.bbagen.2008.09.009; Hart G. W., 2009, ESSENTIALS GLYCOBIOL, P249; Heise N, 2009, GLYCOBIOLOGY, V19, P918, DOI 10.1093/glycob/cwp068; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Loenarz C, 2009, ANGEW CHEM INT EDIT, V48, P1784, DOI 10.1002/anie.200805427; Mohanty S, 2001, GENE DEV, V15, P1435, DOI 10.1101/gad.871101; Nelson MK, 2000, DEV BIOL, V224, P42, DOI 10.1006/dbio.2000.9793; NEWELL PC, 1969, J BACTERIOL, V100, P763, DOI 10.1128/JB.100.2.763-768.1969; NEWELL PC, 1982, J GEN MICROBIOL, V128, P1639; SANDONA D, 1995, J BIOL CHEM, V270, P5587, DOI 10.1074/jbc.270.10.5587; Sassi S, 2001, GLYCOBIOLOGY, V11, P283, DOI 10.1093/glycob/11.4.283; SCHINDLER J, 1977, J MOL BIOL, V116, P161, DOI 10.1016/0022-2836(77)90124-3; Singleton CK, 2006, EUKARYOT CELL, V5, P991, DOI 10.1128/EC.00058-06; SMITH E, 1980, J EMBRYOL EXP MORPH, V57, P233; Sucgang R, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r20; Tan AM, 2009, BIOPHYS CHEM, V144, P108, DOI 10.1016/j.bpc.2009.07.003; Ten Hagen KG, 2003, GLYCOBIOLOGY, V13, p1R, DOI 10.1093/glycob/cwg007; Teng-umnuay P, 1999, J BIOL CHEM, V274, P36392, DOI 10.1074/jbc.274.51.36392; van der Wel H, 2005, J BIOL CHEM, V280, P14645, DOI 10.1074/jbc.M500600200; van der Wel H, 2002, J BIOL CHEM, V277, P46527, DOI 10.1074/jbc.M208824200; van der Wel H, 2002, J BIOL CHEM, V277, P46328, DOI 10.1074/jbc.M208024200; van der Wel H, 2011, BIOCHEMISTRY-US, V50, P1700, DOI 10.1021/bi101977w; Wang B, 2002, EUKARYOT CELL, V1, P126, DOI 10.1128/EC.1.1.126-136.2002; Wang ZA, 2011, DEV BIOL, V349, P283, DOI 10.1016/j.ydbio.2010.10.013; Wang ZA, 2009, J BIOL CHEM, V284, P28896, DOI 10.1074/jbc.M109.022574; Ward JPT, 2008, BBA-BIOENERGETICS, V1777, P1, DOI 10.1016/j.bbabio.2007.10.010; West CM, 2006, METHOD ENZYMOL, V417, P389, DOI 10.1016/S0076-6879(06)17023-8; West CM, 2007, DEVELOPMENT, V134, P3349, DOI 10.1242/dev.000893; West CM, 2010, BBA-GEN SUBJECTS, V1800, P160, DOI 10.1016/j.bbagen.2009.11.006; West CM, 2004, BBA-GEN SUBJECTS, V1673, P29, DOI 10.1016/j.bbagen.2004.04.007; Willems AR, 2004, BBA-MOL CELL RES, V1695, P133, DOI 10.1016/j.bbamcr.2004.09.027	39	16	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					2006	2016		10.1074/jbc.M111.314021	http://dx.doi.org/10.1074/jbc.M111.314021			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22128189	Green Published, hybrid			2022-12-27	WOS:000299321000041
J	Nadiminty, N; Tummala, R; Lou, W; Zhu, YZ; Zhang, J; Chen, XB; White, RWD; Kung, HJ; Evans, CP; Gao, AC				Nadiminty, Nagalakshmi; Tummala, Ramakumar; Lou, Wei; Zhu, Yezi; Zhang, Jin; Chen, Xinbin; White, Ralph W. deVere; Kung, Hsing-Jien; Evans, Christopher P.; Gao, Allen C.			MicroRNA let-7c Suppresses Androgen Receptor Expression and Activity via Regulation of Myc Expression in Prostate Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STAT3 ACTIVATION; PROGRESSION; LIN28; NF-KAPPA-B2/P52; DIFFERENTIATION; ANTIANDROGEN; ONCOGENE; PROFILES; THERAPY; MIRNAS	Castration-resistant prostate cancer continues to rely on androgen receptor (AR) expression. AR plays a central role in the development of prostate cancer and progression to castration resistance during and after androgen deprivation therapy. Here, we identified miR-let-7c as a key regulator of expression of AR. miR-let-7c suppresses AR expression and activity in human prostate cancer cells by targeting its transcription via c-Myc. Suppression of AR by let-7c leads to decreased cell proliferation of human prostate cancer cells. Down-regulation of Let-7c in prostate cancer specimens is inversely correlated with AR expression, whereas the expression of Lin28 (a repressor of let-7) is correlated positively with AR expression. Our study demonstrates that the miRNA let-7c plays an important role in the regulation of androgen signaling in prostate cancer by down-regulating AR expression. These results suggest that reconstitution of miR-let-7c may aid in targeting enhanced and hypersensitive AR in advanced prostate cancer.	[Nadiminty, Nagalakshmi; Gao, Allen C.] Univ Calif Davis, Med Ctr, Dept Urol, Sacramento, CA 95817 USA; [Chen, Xinbin; White, Ralph W. deVere; Kung, Hsing-Jien; Evans, Christopher P.; Gao, Allen C.] Univ Calif Davis, Ctr Canc, Sacramento, CA 95817 USA; [Zhang, Jin] Univ Calif Davis, Comparat Oncol Lab, Sch Vet Med, Sacramento, CA 95817 USA; [Kung, Hsing-Jien] Univ Calif Davis, Dept Biochem & Mol Med, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Nadiminty, N (corresponding author), Univ Calif Davis, Med Ctr, Dept Urol, 4645 2nd Ave,Res 3,Suite 1300, Sacramento, CA 95817 USA.	nnadiminty@ucdavis.edu; acgao@ucdavis.edu	Zhu, Yezi/F-2373-2014; Kung, Hsing-Jien/C-7651-2013; Jackson, Benjamin L/C-4297-2012		National Institutes of Health [CA140468, CA118887, CA109441, DOD PC080538]; NATIONAL CANCER INSTITUTE [R01CA118887, P30CA093373, R01CA081237, R01CA168601, R01CA123227, R01CA140468, R01CA109441] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA140468, CA118887, CA109441, and DOD PC080538.	Bonkhoff H, 2010, PROSTATE, V70, P100, DOI 10.1002/pros.21042; Boyerinas B, 2010, ENDOCR-RELAT CANCER, V17, pF19, DOI 10.1677/ERC-09-0184; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Chandran UR, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-64; Chang TC, 2009, P NATL ACAD SCI USA, V106, P3384, DOI 10.1073/pnas.0808300106; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Chen Y, 2008, CURR OPIN PHARMACOL, V8, P440, DOI 10.1016/j.coph.2008.07.005; Coppola V, 2010, ENDOCR-RELAT CANCER, V17, pF1, DOI 10.1677/ERC-09-0172; Dangi-Garimella S, 2009, EMBO J, V28, P347, DOI 10.1038/emboj.2008.294; Dhir R, 2002, PROSTATE, V51, P241, DOI 10.1002/pros.10079; Donovan MJ, 2009, J UROLOGY, V182, P125, DOI 10.1016/j.juro.2009.02.135; Gandellini P, 2009, TRENDS MOL MED, V15, P381, DOI 10.1016/j.molmed.2009.07.004; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Jiang JM, 2005, NUCLEIC ACIDS RES, V33, P5394, DOI 10.1093/nar/gki863; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Koscianska E, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-79; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Lamont KR, 2010, ADV CANCER RES, V107, P137, DOI 10.1016/S0065-230X(10)07005-3; Lee SO, 2003, CLIN CANCER RES, V9, P370; Lee SO, 2007, PROSTATE, V67, P764, DOI 10.1002/pros.20553; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Nadiminty N, 2006, P NATL ACAD SCI USA, V103, P7264, DOI 10.1073/pnas.0509808103; Nadiminty N, 2010, CANCER RES, V70, P3309, DOI 10.1158/0008-5472.CAN-09-3703; Nadiminty N, 2010, PROSTATE, V70, P276, DOI 10.1002/pros.21062; Ni ZY, 2002, J UROLOGY, V167, P1859, DOI 10.1016/S0022-5347(05)65249-4; Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809; Pienta KJ, 2006, CLIN CANCER RES, V12, P1665, DOI 10.1158/1078-0432.CCR-06-0067; Prasad PD, 2010, CELL TISSUE RES, V339, P337, DOI 10.1007/s00441-009-0902-y; Shi XB, 2008, CELL CYCLE, V7, P1529, DOI 10.4161/cc.7.11.5977; Singh P, 2006, ENDOCR-RELAT CANCER, V13, P653, DOI 10.1677/erc.1.00797; Tran C, 2009, SCIENCE, V324, P787, DOI 10.1126/science.1168175; Vanaja DK, 2003, CANCER RES, V63, P3877; Varambally S, 2005, CANCER CELL, V8, P393, DOI 10.1016/j.ccr.2005.10.001; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Viswanathan SR, 2010, CELL, V140, P445, DOI 10.1016/j.cell.2010.02.007; Wallace TA, 2008, CANCER RES, V68, P927, DOI 10.1158/0008-5472.CAN-07-2608; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158	39	148	154	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1527	1537		10.1074/jbc.M111.278705	http://dx.doi.org/10.1074/jbc.M111.278705			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22128178	hybrid, Green Published			2022-12-27	WOS:000299170300066
J	Eisenhauer, K; Kuhne, J; Ritter, E; Berndt, A; Wolf, S; Freier, E; Bartl, F; Hegemann, P; Gerwert, K				Eisenhauer, Kirstin; Kuhne, Jens; Ritter, Eglof; Berndt, Andre; Wolf, Steffen; Freier, Erik; Bartl, Franz; Hegemann, Peter; Gerwert, Klaus			In Channelrhodopsin-2 Glu-90 Is Crucial for Ion Selectivity and Is Deprotonated during the Photocycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							4TH CYTOPLASMIC LOOP; WATER-MOLECULES; PROTON-TRANSFER; RHODOPSIN; PROTEIN; LIGHT; BACTERIORHODOPSIN; DYNAMICS; MODEL; CHLAMYDOMONAS	The light-activated microbial ion channel channelrhodopsin-2 (ChR2) is a powerful tool to study cellular processes with high spatiotemporal resolution in the emerging field of optogenetics. To customize the channel properties for optogenetic experiments, a detailed understanding of its molecular reaction mechanism is essential. Here, Glu-90, a key residue involved in the gating and selectivity mechanism of the ion channel is characterized in detail. The deprotonation of Glu-90 during the photocycle is elucidated by time-resolved FTIR spectroscopy, which seems to be part of the opening mechanism of the conductive pore. Furthermore, Glu-90 is crucial to ion selectivity as also revealed by mutation of this residue combined with voltage clamp experiments. By dynamic homology modeling, we further hypothesized that the conductive pore is flanked by Glu-90 and located between helices A, B, C, and G.	[Eisenhauer, Kirstin; Kuhne, Jens; Freier, Erik; Gerwert, Klaus] Ruhr Univ Bochum, Dept Biophys, D-44801 Bochum, Germany; [Ritter, Eglof; Bartl, Franz] Univ Med Berlin, Inst Med Phys & Biophys, Charite, D-10117 Berlin, Germany; [Berndt, Andre; Hegemann, Peter] Univ Berlin, Inst Biol, D-10115 Berlin, Germany; [Wolf, Steffen; Gerwert, Klaus] Shanghai Inst Biol Sci, CAS Max Planck Partner Inst Computat Biol, Shanghai 200031, Peoples R China	Ruhr University Bochum; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society	Gerwert, K (corresponding author), Ruhr Univ Bochum, Dept Biophys, Univ Str 150, D-44801 Bochum, Germany.	gerwert@bph.rub.de	Wolf, Steffen/A-1721-2010; Gerwert, Klaus/G-7311-2015; Eisenhauer, Kirstin/E-9791-2013; Freier, Erik/F-8013-2012	Wolf, Steffen/0000-0003-1752-6175; Kuhne, Jens/0000-0002-6071-6428; Berndt, Andre/0000-0003-4758-5598; Freier, Erik/0000-0002-0559-4210	Deutsche Forschungsgemeinschaft [HE3824/9-1, 17-1, BA 2242/ 2-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (Grants HE3824/9-1 and 17-1 to P. H. and BA 2242/ 2-1 to F. B.).	Bamann C, 2010, BIOCHEMISTRY-US, V49, P267, DOI 10.1021/bi901634p; Belrhali H, 1999, STRUCTURE, V7, P909, DOI 10.1016/S0969-2126(99)80118-X; Berndt A, 2011, P NATL ACAD SCI USA, V108, P7595, DOI 10.1073/pnas.1017210108; Berndt A, 2009, NAT NEUROSCI, V12, P229, DOI 10.1038/nn.2247; Canutescu AA, 2003, PROTEIN SCI, V12, P2001, DOI 10.1110/ps.03154503; Doszczak L, 2007, ANGEW CHEM INT EDIT, V46, P3367, DOI 10.1002/anie.200605002; Ernst OP, 2008, J BIOL CHEM, V283, P1637, DOI 10.1074/jbc.M708039200; Ernst OP, 2000, J BIOL CHEM, V275, P1937, DOI 10.1074/jbc.275.3.1937; Freier E, 2011, P NATL ACAD SCI USA, V108, P11435, DOI 10.1073/pnas.1104735108; Fritze O, 2003, P NATL ACAD SCI USA, V100, P2290, DOI 10.1073/pnas.0435715100; Garczarek F, 2006, NATURE, V439, P109, DOI 10.1038/nature04231; Gelis L., 2011, ANGEW CHEM INT EDIT, DOI [10.1002/anie.201107509, DOI 10.1002/ANIE.201107509]; GERWERT K, 1990, P NATL ACAD SCI USA, V87, P9774, DOI 10.1073/pnas.87.24.9774; GERWERT K, 1989, P NATL ACAD SCI USA, V86, P4943, DOI 10.1073/pnas.86.13.4943; Govorunova EG, 2011, MBIO, V2, DOI 10.1128/mBio.00115-11; Gradmann D, 2011, BIOPHYS J, V101, P1057, DOI 10.1016/j.bpj.2011.07.040; Gunaydin LA, 2010, NAT NEUROSCI, V13, P387, DOI 10.1038/nn.2495; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hoeweler U., 2007, MAXIMOBY 8 1 MOBY 3; Joh NH, 2008, NATURE, V453, P1266, DOI 10.1038/nature06977; Kandt C, 2004, BIOPHYS J, V86, P705, DOI 10.1016/S0006-3495(04)74149-1; Kufareva I, 2011, STRUCTURE, V19, P1108, DOI 10.1016/j.str.2011.05.012; Lanyi JK, 2006, BBA-BIOENERGETICS, V1757, P1012, DOI 10.1016/j.bbabio.2005.11.003; Lin JY, 2009, BIOPHYS J, V96, P1803, DOI 10.1016/j.bpj.2008.11.034; Marin EP, 2000, J BIOL CHEM, V275, P1930, DOI 10.1074/jbc.275.3.1930; MOLDAY RS, 1983, BIOCHEMISTRY-US, V22, P653, DOI 10.1021/bi00272a020; Muller M, 2011, J MOL BIOL, V414, P86, DOI 10.1016/j.jmb.2011.09.049; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Radu I, 2009, J AM CHEM SOC, V131, P7313, DOI 10.1021/ja8084274; Ritter E, 2008, J BIOL CHEM, V283, P35033, DOI 10.1074/jbc.M806353200; Ruffert K, 2011, BIOCHEM BIOPH RES CO, V410, P737, DOI 10.1016/j.bbrc.2011.06.024; Schneider M, 2011, FEBS LETT, V585, P3587, DOI 10.1016/j.febslet.2011.10.027; Schoenenberger P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008185; Sineshchekov OA, 2002, P NATL ACAD SCI USA, V99, P8689, DOI 10.1073/pnas.122243399; Stehfest K, 2010, J MOL BIOL, V398, P690, DOI 10.1016/j.jmb.2010.03.031; Stehfest K, 2010, CHEMPHYSCHEM, V11, P1120, DOI 10.1002/cphc.200900980; Sugiyama Y, 2009, PHOTOCH PHOTOBIO SCI, V8, P328, DOI 10.1039/b815762f; Suzuki T, 2003, BIOCHEM BIOPH RES CO, V301, P711, DOI 10.1016/S0006-291X(02)03079-6; Tieleman DP, 1998, BIOCHEMISTRY-US, V37, P17554, DOI 10.1021/bi981802y; Verhoefen MK, 2010, CHEMPHYSCHEM, V11, P3113, DOI 10.1002/cphc.201000181; Wolf S, 2008, FEBS LETT, V582, P3335, DOI 10.1016/j.febslet.2008.08.022; Wolf S, 2010, ANGEW CHEM INT EDIT, V49, P6889, DOI 10.1002/anie.201001243; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004	43	65	66	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6904	6911		10.1074/jbc.M111.327700	http://dx.doi.org/10.1074/jbc.M111.327700			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22219197	Green Published, hybrid			2022-12-27	WOS:000300791800075
J	Qi, Q; He, KY; Yoo, MH; Chan, CB; Liu, X; Zhang, ZB; Olson, JJ; Xiao, G; Wang, LY; Mao, H; Fu, HA; Tao, H; Ramalingam, SS; Sun, SY; Mischel, PS; Ye, KQ				Qi, Qi; He, Kunyan; Yoo, Min-Heui; Chan, Chi-Bun; Liu, Xia; Zhang, Zhaobin; Olson, Jeffrey J.; Xiao, Ge; Wang, Liya; Mao, Hui; Fu, Haian; Tao, Hui; Ramalingam, Suresh S.; Sun, Shi-Yong; Mischel, Paul S.; Ye, Keqiang			Acridine Yellow G Blocks Glioblastoma Growth via Dual Inhibition of Epidermal Growth Factor Receptor and Protein Kinase C Kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLIOMA CELL-LINES; TOPOISOMERASE-II; INDUCE APOPTOSIS; TYROSINE KINASE; LUNG-CANCER; TUMOR-CELLS; GEFITINIB; GENE; PROLIFERATION; SUPPRESSION	Amplification of the epidermal growth factor receptor (EGFR), frequently expressed as a constitutively active deletion mutant (EGFRvIII), occurs commonly in glioblastoma multiformes (GBM). However, blockade of EGFR is therapeutically disappointing for gliomas with PTEN deletion. To search for small molecules treating this aggressive cancer, we have established a cell-based screening and successfully identified acridine yellow G that preferentially blocks cell proliferation of the most malignant U87MG/EGFRvIII cells over the less malignant U87MG/PTEN cells. Oral administration of this compound markedly diminishes the brain tumor volumes in both subcutaneous and intracranial models. It directly inhibits EGFR and PKCs with IC50 values of similar to 7.5 and 5 mu M, respectively. It dually inhibits EGFR and PKCs, resulting in a blockade of mammalian target of rapamycin signaling and cell cycle arrest in the G(1) phase, which leads to activation of apoptosis in the tumors. Hence, combinatorial inhibition of EGFR and PKCs might provide proof of concept in developing therapeutic agents for treating malignant glioma and other human cancers.	[Qi, Qi; He, Kunyan; Yoo, Min-Heui; Chan, Chi-Bun; Liu, Xia; Ye, Keqiang] Emory Univ, Sch Med, Ctr Syst Imaging, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Zhang, Zhaobin; Olson, Jeffrey J.] Emory Univ, Sch Med, Ctr Syst Imaging, Dept Neurol Surg, Atlanta, GA 30322 USA; [Wang, Liya; Mao, Hui] Emory Univ, Sch Med, Ctr Syst Imaging, Dept Radiol, Atlanta, GA 30322 USA; [Fu, Haian] Emory Univ, Sch Med, Winship Canc Inst, Dept Pharmacol, Atlanta, GA 30322 USA; [Tao, Hui; Ramalingam, Suresh S.; Sun, Shi-Yong] Emory Univ, Sch Med, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA; [Xiao, Ge] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; [Mischel, Paul S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Mischel, Paul S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med Pharmacol, Los Angeles, CA 90095 USA	Emory University; Emory University; Emory University; Emory University; Emory University; Centers for Disease Control & Prevention - USA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Ye, KQ (corresponding author), 615 Michael St, Atlanta, GA 30300 USA.	kye@emory.edu	Qi, Qi/J-3508-2013; Ramalingam, Suresh/AAV-7478-2020	Qi, Qi/0000-0003-4460-0713; 	National Institutes of Health [RO1 CA127119]; NATIONAL CANCER INSTITUTE [R01CA127119] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 CA127119 (to K. Y.).	Akhavan D, 2010, NEURO-ONCOLOGY, V12, P882, DOI 10.1093/neuonc/noq052; BALTUCH GH, 1993, NEUROSURGERY, V33, P495; Bianco R, 2003, ONCOGENE, V22, P2812, DOI 10.1038/sj.onc.1206388; Capranico G, 1998, J BIOL CHEM, V273, P12732, DOI 10.1074/jbc.273.21.12732; Cho KK, 1999, INT J DEV NEUROSCI, V17, P447, DOI 10.1016/S0736-5748(99)00054-4; Chow JYC, 2008, AM J PHYSIOL-GASTR L, V294, pG899, DOI 10.1152/ajpgi.00411.2007; CORNFORD EM, 1992, CANCER CHEMOTH PHARM, V29, P439, DOI 10.1007/BF00684844; COULDWELL WT, 1994, FEBS LETT, V345, P43, DOI 10.1016/0014-5793(94)00415-3; COULDWELL WT, 1990, J NEUROSURG, V73, P594, DOI 10.3171/jns.1990.73.4.0594; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; EKSTRAND AJ, 1992, P NATL ACAD SCI USA, V89, P4309, DOI 10.1073/pnas.89.10.4309; Fan QW, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000014; Ferguson LR, 2007, MUTAT RES-FUND MOL M, V623, P14, DOI 10.1016/j.mrfmmm.2007.03.014; Fukuoka M, 2003, J CLIN ONCOL, V21, P2237, DOI 10.1200/JCO.2003.10.038; Ghosh R., MOL CELL BIOCH; Goodell JR, 2008, J MED CHEM, V51, P179, DOI 10.1021/jm701228e; Haas-Kogan DA, 2005, JNCI-J NATL CANCER I, V97, P880, DOI 10.1093/jnci/dji161; HANNUN YA, 1988, J BIOL CHEM, V263, P5124; HERMAN RK, 1971, J BACTERIOL, V106, P543, DOI 10.1128/JB.106.2.543-550.1971; Huang PH, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.287re6; Korth C, 2001, P NATL ACAD SCI USA, V98, P9836, DOI 10.1073/pnas.161274798; Kreisl TN, 2009, J NEURO-ONCOL, V92, P99, DOI 10.1007/s11060-008-9741-z; Kris MG, 2003, JAMA-J AM MED ASSOC, V290, P2149, DOI 10.1001/jama.290.16.2149; LIBERMANN TA, 1985, NATURE, V313, P144, DOI 10.1038/313144a0; Mackay HJ, 2007, NAT REV CANCER, V7, P554, DOI 10.1038/nrc2168; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; MASUI H, 1984, CANCER RES, V44, P1002; Mellinghoff IK, 2005, NEW ENGL J MED, V353, P2012, DOI 10.1056/NEJMoa051918; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Wang MY, 2006, CANCER RES, V66, P7864, DOI 10.1158/0008-5472.CAN-04-4392; WEI Z, 1992, NEUROSURGERY, V31, P725; WONG AJ, 1992, P NATL ACAD SCI USA, V89, P2965, DOI 10.1073/pnas.89.7.2965; YAISH P, 1988, SCIENCE, V242, P933, DOI 10.1126/science.3263702; Zhang W., 1992, NEUROSURGERY, V31, P729; ZWELLING LA, 1989, J BIOL CHEM, V264, P16411	36	10	10	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6113	6127		10.1074/jbc.M111.293605	http://dx.doi.org/10.1074/jbc.M111.293605			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22215664	Green Published, hybrid			2022-12-27	WOS:000300791800005
J	Frampton, R; Aggio, RBM; Villas-Boas, SG; Arcus, VL; Cook, GM				Frampton, Rebekah; Aggio, Raphael B. M.; Villas-Boas, Silas G.; Arcus, Vickery L.; Cook, Gregory M.			Toxin-Antitoxin Systems of Mycobacterium smegmatis Are Essential for Cell Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAIN AMINO-ACIDS; MESSENGER-RNA INTERFERASES; ESCHERICHIA-COLI; F-PLASMID; STATIONARY-PHASE; MICROBIAL-CELLS; PIN-DOMAIN; TUBERCULOSIS; OPERON; LOCI	The role of chromosomal toxin-antitoxin (TA) modules in bacterial physiology remains enigmatic despite their abundance in the genomes of many bacteria. Mycobacterium smegmatis contains three putative TA systems, VapBC, MazEF, and Phd/Doc, and previous work from our group has shown VapBC to be a bona fide TA system. In this study, we show that MazEF and Phd/Doc are also TA systems that are constitutively expressed, transcribed as leaderless transcripts, and subject to autoregulation, and expression of the toxin component leads to growth inhibition that can be rescued by the cognate antitoxin. No phenotype was identified for deletions of the individual TA systems, but a triple deletion strain (Delta vapBC, mazEF, phd/doc), designated Delta TA(triple), exhibited a survival defect in complex growth medium demonstrating an essential role for these TA modules in mycobacterial survival. Transcriptomic analysis revealed no significant differences in gene expression between wild type and the Delta TA(triple) mutant under these conditions suggesting that the growth defect was not at a transcriptional level. Metabolomic analysis demonstrated that in response to starvation in complex medium, both the wild type and Delta TA(triple) mutant consumed a wide range of amino acids from the external milieu. Analysis of intracellular metabolites revealed a significant difference in the levels of branched-chain amino acids between the wild type and Delta TA(triple) mutant, which are proposed to play essential roles in monitoring the nutritional supply and physiological state of the cell and linking catabolic with anabolic reactions. Disruption of this balance in the Delta TA(triple) mutant may explain the survival defect in complex growth medium.	[Frampton, Rebekah; Cook, Gregory M.] Univ Otago, Dept Microbiol & Immunol, Otago Sch Med Sci, Dunedin 9054, New Zealand; [Aggio, Raphael B. M.; Villas-Boas, Silas G.] Univ Auckland, Sch Biol Sci, Auckland 1142, New Zealand; [Arcus, Vickery L.] Univ Waikato, Dept Biol Sci, Hamilton 3240, New Zealand	University of Otago; University of Auckland; University of Waikato	Cook, GM (corresponding author), Univ Otago, Dept Microbiol & Immunol, Otago Sch Med Sci, POB 56, Dunedin 9054, New Zealand.	gregory.cook@otago.ac.nz	Villas-Boas, Silas/AAS-5888-2020; Villas-Boas, Silas/AAR-6748-2020; Frampton, Rebekah A/M-7719-2017; Cook, Gregory/E-5665-2011	Villas-Boas, Silas/0000-0003-0148-5882; Frampton, Rebekah A/0000-0001-5283-2878; 	Health Research Council New Zealand; University of Otago	Health Research Council New Zealand(Health Research Council of New Zealand); University of Otago	This work was supported in part by the Health Research Council New Zealand.; Supported by Ph.D. scholarships from the University of Otago.	Aggio RBM, 2010, BIOINFORMATICS, V26, P2969, DOI 10.1093/bioinformatics/btq567; Aizenman E, 1996, P NATL ACAD SCI USA, V93, P6059, DOI 10.1073/pnas.93.12.6059; Anantharaman V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-12-r81; Arcus VL, 2011, PROTEIN ENG DES SEL, V24, P33, DOI 10.1093/protein/gzq081; Arcus VL, 2004, J BIOL CHEM, V279, P16471, DOI 10.1074/jbc.M313833200; BERNARD P, 1992, J MOL BIOL, V226, P735, DOI 10.1016/0022-2836(92)90629-X; Berney M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008614; Beste DJV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005349; Blokpoel MCJ, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni023; BLUM PH, 1988, J BACTERIOL, V170, P5125, DOI 10.1128/jb.170.11.5125-5133.1988; Bull TJ, 2000, MICROBIOL-SGM, V146, P2185, DOI 10.1099/00221287-146-9-2185; Buts L, 2005, TRENDS BIOCHEM SCI, V30, P672, DOI 10.1016/j.tibs.2005.10.004; Christensen SK, 2004, MOL MICROBIOL, V53, P587, DOI 10.1111/j.1365-2958.2004.04127.x; Christensen-Dalsgaard M, 2008, NUCLEIC ACIDS RES, V36, P6472, DOI 10.1093/nar/gkn667; Christensen-Dalsgaard M, 2006, MOL MICROBIOL, V62, P397, DOI 10.1111/j.1365-2958.2006.05385.x; Dahl JL, 2003, P NATL ACAD SCI USA, V100, P10026, DOI 10.1073/pnas.1631248100; Dussurget O, 1999, J BACTERIOL, V181, P3402, DOI 10.1128/JB.181.11.3402-3408.1999; Ehrt S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni013; Fineran PC, 2009, P NATL ACAD SCI USA, V106, P894, DOI 10.1073/pnas.0808832106; Fu ZB, 2007, J BACTERIOL, V189, P8871, DOI 10.1128/JB.01272-07; Gebhard S, 2006, MICROBIOL-SGM, V152, P3453, DOI 10.1099/mic.0.29201-0; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Guedon E, 2001, MOL MICROBIOL, V40, P1227, DOI 10.1046/j.1365-2958.2001.02470.x; Guo XV, 2007, J BACTERIOL, V189, P4614, DOI 10.1128/JB.00216-07; Gupta A, 2009, FEMS MICROBIOL LETT, V290, P45, DOI 10.1111/j.1574-6968.2008.01400.x; Han JS, 2010, BIOCHEM BIOPH RES CO, V400, P293, DOI 10.1016/j.bbrc.2010.08.023; HANAHAN D, 1991, METHOD ENZYMOL, V204, P63; HIRAGA S, 1989, J BACTERIOL, V171, P1496, DOI 10.1128/jb.171.3.1496-1505.1989; Hopper S, 2000, INFECT IMMUN, V68, P896, DOI 10.1128/IAI.68.2.896-905.2000; HORN DB, 1966, CLIN CHIM ACTA, V14, P185, DOI 10.1016/0009-8981(66)90085-4; JAFFE A, 1985, J BACTERIOL, V163, P841; Jiang Y, 2002, MOL MICROBIOL, V44, P971, DOI 10.1046/j.1365-2958.2002.02921.x; Kim YH, 2009, J BACTERIOL, V191, P1258, DOI 10.1128/JB.01465-08; Kolodkin-Gal I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006785; Korch SB, 2009, J BACTERIOL, V191, P1618, DOI 10.1128/JB.01318-08; LARSSON CM, 1979, PLANT CELL PHYSIOL, V20, P145; Lemos JAC, 2005, FEMS MICROBIOL LETT, V253, P251, DOI 10.1016/j.femsle.2005.09.045; Liu M, 2008, P NATL ACAD SCI USA, V105, P5885, DOI 10.1073/pnas.0711949105; LUNDIN A, 1975, ANAL BIOCHEM, V66, P47, DOI 10.1016/0003-2697(75)90723-X; Luo S, 2009, FASEB J, V23, P464, DOI 10.1096/fj.08-118414; Magnuson RD, 2007, J BACTERIOL, V189, P6089, DOI 10.1128/JB.00958-07; MAKI S, 1992, J BIOL CHEM, V267, P12244; Mantovani HC, 2002, MICROBIOL-SGM, V148, P3347, DOI 10.1099/00221287-148-11-3347; MENARD R, 1993, J BACTERIOL, V175, P5899; Moll I, 2004, NUCLEIC ACIDS RES, V32, P3354, DOI 10.1093/nar/gkh663; MONK BC, 1991, J BACTERIOL, V173, P6826, DOI 10.1128/jb.173.21.6826-6836.1991; OGURA T, 1983, P NATL ACAD SCI-BIOL, V80, P4784, DOI 10.1073/pnas.80.15.4784; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Pedersen K, 2003, CELL, V112, P131, DOI 10.1016/S0092-8674(02)01248-5; Pelicic V, 1996, MOL MICROBIOL, V20, P919, DOI 10.1111/j.1365-2958.1996.tb02533.x; Pelicic V, 1997, P NATL ACAD SCI USA, V94, P10955, DOI 10.1073/pnas.94.20.10955; Pellegrini O, 2005, MOL MICROBIOL, V56, P1139, DOI 10.1111/j.1365-2958.2005.04606.x; Ramage HR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000767; Rao M, 2001, MICROBIOL-UK, V147, P1017, DOI 10.1099/00221287-147-4-1017; Robson J, 2009, J MOL BIOL, V390, P353, DOI 10.1016/j.jmb.2009.05.006; RUSCETTI FW, 1972, J BACTERIOL, V11, P142, DOI 10.1128/JB.111.1.142-151.1972; Schumacher MA, 2009, SCIENCE, V323, P396, DOI 10.1126/science.1163806; Shivers RP, 2004, MOL MICROBIOL, V53, P599, DOI 10.1111/j.1365-2958.2004.04135.x; Singh R, 2010, J BACTERIOL, V192, P1279, DOI 10.1128/JB.01285-09; Smart KF, 2010, NAT PROTOC, V5, P1709, DOI 10.1038/nprot.2010.108; Smeulders MJ, 1999, J BACTERIOL, V181, P270, DOI 10.1128/JB.181.1.270-283.1999; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; Syed MA, 2011, J BACTERIOL, V193, P1122, DOI 10.1128/JB.01114-10; TIMM JL, 1994, J BACTERIOL, V176, P6749, DOI 10.1128/JB.176.21.6749-6753.1994; Tojo S, 2005, MOL MICROBIOL, V56, P1560, DOI 10.1111/j.1365-2958.2005.04635.x; Tsilibaris V, 2007, J BACTERIOL, V189, P6101, DOI 10.1128/JB.00527-07; UCHIDA T, 1970, BIOCHEM BIOPH RES CO, V41, P1048, DOI 10.1016/0006-291X(70)90191-9; Van Melderen L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000437; Villas-Boas SG, 2007, ANAL BIOCHEM, V370, P87, DOI 10.1016/j.ab.2007.06.028; Yamanaka K, 1996, MOL GEN GENET, V250, P241; Yang M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010672; Zhang YL, 2005, J BIOL CHEM, V280, P26080, DOI 10.1074/jbc.M502050200; Zhang YL, 2003, MOL CELL, V12, P913, DOI 10.1016/S1097-2765(03)00402-7; Zhang YL, 2009, J BIOL CHEM, V284, P25522, DOI 10.1074/jbc.M109.036624; Zhao LX, 2008, FEBS LETT, V582, P710, DOI 10.1016/j.febslet.2008.01.045; Zhu L, 2008, MOL MICROBIOL, V69, P559, DOI 10.1111/j.1365-2958.2008.06284.x; Zhu L, 2006, J BIOL CHEM, V281, P18638, DOI 10.1074/jbc.M512693200; ZILBERSTEIN D, 1982, J BIOL CHEM, V257, P3687	78	50	61	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5340	5356		10.1074/jbc.M111.286856	http://dx.doi.org/10.1074/jbc.M111.286856			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22199354	hybrid, Green Published			2022-12-27	WOS:000300638000016
J	Haynes, LM; Dubief, YC; Mann, KG				Haynes, Laura M.; Dubief, Yves C.; Mann, Kenneth G.			Membrane Binding Events in the Initiation and Propagation Phases of Tissue Factor-initiated Zymogen Activation under Flow	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE FACTOR-V; COAGULATION FACTOR-X; BLOOD-COAGULATION; FACTOR-VIIA; PROTHROMBIN ACTIVATION; SHEAR RATE; PHOSPHOLIPID-VESICLES; CATALYZED ACTIVATION; PLATELET DEPOSITION; THROMBIN GENERATION	This study investigates the dynamics of zymogen activation when both extrinsic tenase and prothrombinase are assembled on an appropriate membrane. Although the activation of prothrombin by surface-localized prothrombinase is clearly mediated by flow-induced dilutional effects, we find that when factor X is activated in isolation by surface-localized extrinsic tenase, it exhibits characteristics of diffusion-mediated activation in which diffusion of substrate to the catalytically active region is rate-limiting. When prothrombin and factor X are activated coincident with each other, competition for available membrane binding sites masks the diffusion-limiting effects of factor X activation. To verify the role of membrane binding in the activation of factor X by extrinsic tenase under flow conditions, we demonstrate that bovine lactadherin competes for both factor X and Xa binding sites, limiting factor X activation and forcing the release of bound factor Xa from the membrane at a venous shear rate (100 s(-1)). Finally, we present steady-state models of prothrombin and factor X activation under flow showing that zymogen and enzyme membrane binding events further regulate the coagulation process in an open system representative of the vasculature geometry.	[Haynes, Laura M.; Mann, Kenneth G.] Univ Vermont, Dept Biochem, Coll Med, Colchester, VT 05446 USA; [Dubief, Yves C.] Univ Vermont, Dept Mech Engn, Coll Engn & Math Sci, Burlington, VT 05405 USA	University of Vermont; University of Vermont	Mann, KG (corresponding author), Univ Vermont, Dept Biochem, Coll Med, S Pk Dr, Colchester, VT 05446 USA.	kenneth.mann@uvm.edu	Dubief, Yves/B-5714-2011	Dubief, Yves/0000-0001-8181-7597	National Institutes of Health [P01 HL46703, 5T32HL007594]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL046703, T32HL007594] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant P01 HL46703 (project 1) (to K. G. M.). This work was presented in part at the XXIII Congress of the International Society of Thrombosis and Haemostasis, Kyoto, Japan, July 25-29, 2011 (58).; Supported by National Institutes of Health Thrombosis and Hemostasis Training Grant 5T32HL007594 (to K. G. M.).	Andersen MH, 2000, BIOCHEMISTRY-US, V39, P6200, DOI 10.1021/bi992221r; BAJAJ SP, 1973, J BIOL CHEM, V248, P7729; BILLY D, 1995, J BIOL CHEM, V270, P1029, DOI 10.1074/jbc.270.3.1029; BLOOM JW, 1979, BIOCHEMISTRY-US, V18, P4419, DOI 10.1021/bi00587a023; BROZE GJ, 1990, BIOCHEMISTRY-US, V29, P7539, DOI 10.1021/bi00485a001; Brummel KE, 2002, BLOOD, V100, P148, DOI 10.1182/blood.V100.1.148; BUNTING PS, 1974, BIOTECHNOL BIOENG, V16, P119, DOI 10.1002/bit.260160109; Butenas S, 2003, J THROMB HAEMOST, V1, P2103, DOI 10.1046/j.1538-7836.2003.00431.x; Butenas S, 2003, J THROMB HAEMOST, V1, P1158, DOI 10.1046/j.1538-7836.2003.00181.x; Butenas S, 2003, ARTERIOSCL THROM VAS, V23, P123, DOI 10.1161/01.ATV.0000042081.57854.A2; Contino P B, 1994, J Physiol Pharmacol, V45, P81; Diamond SL, 2010, THROMB RES, V125, pS29, DOI 10.1016/j.thromres.2010.01.029; ESMON CT, 1981, P NATL ACAD SCI-BIOL, V78, P2249, DOI 10.1073/pnas.78.4.2249; Fogelson AL, 2005, PATHOPHYSIOL HAEMO T, V34, P91, DOI 10.1159/000089930; GEMMELL CH, 1990, MICROVASC RES, V40, P327, DOI 10.1016/0026-2862(90)90031-L; GEMMELL CH, 1988, BLOOD, V72, P1404; Hathcock J, 2007, BIOCHEMISTRY-US, V46, P6134, DOI 10.1021/bi700136a; Hathcock JJ, 2006, ARTERIOSCL THROM VAS, V26, P1729, DOI 10.1161/01.ATV.0000229658.76797.30; Hathcock JJ, 2005, BIOCHEMISTRY-US, V44, P8187, DOI 10.1021/bi050338b; Haynes LM, 2011, J THROMB HAEMOST, V9, P346; Haynes LM, 2011, BIOPHYS J, V100, P765, DOI 10.1016/j.bpj.2010.12.3720; HIGGINS DL, 1983, J BIOL CHEM, V258, P6503; JACKSON CM, 1968, BIOCHEMISTRY-US, V7, P4506, DOI 10.1021/bi00852a047; Jordan SW, 2011, BIOPHYS J, V101, P276, DOI 10.1016/j.bpj.2011.05.056; KALB E, 1992, BIOCHIM BIOPHYS ACTA, V1103, P307, DOI 10.1016/0005-2736(92)90101-Q; Kastrup CJ, 2007, BIOPHYS J, V93, P2969, DOI 10.1529/biophysj.107.109009; KATZMANN JA, 1981, P NATL ACAD SCI-BIOL, V78, P162, DOI 10.1073/pnas.78.1.162; KOBAYASHI T, 1974, BIOTECHNOL BIOENG, V16, P77, DOI 10.1002/bit.260160107; KOYAYASHI T, 1974, BIOTECHNOL BIOENG, V16, P99, DOI 10.1002/bit.260160108; KRISHNASWAMY S, 1992, J BIOL CHEM, V267, P26110; KRISHNASWAMY S, 1992, J BIOL CHEM, V267, P23696; KRISHNASWAMY S, 1988, J BIOL CHEM, V263, P3823; Krudysz-Amblo J, 2010, J BIOL CHEM, V285, P3371, DOI 10.1074/jbc.M109.055178; Kuharsky AL, 2001, BIOPHYS J, V80, P1050, DOI 10.1016/S0006-3495(01)76085-7; KUNG C, 1994, J BIOL CHEM, V269, P25838; Laidler K J, 1980, Methods Enzymol, V64, P227; LANCHANTIN GF, 1963, J BIOL CHEM, V238, P238; Leiderman K, 2011, MATH MED BIOL, V28, P47, DOI 10.1093/imammb/dqq005; Lundblad R L, 1976, Methods Enzymol, V45, P156; MANN KG, 1990, BLOOD, V76, P1; Marsh D, 1996, BIOPHYS J, V70, P2248, DOI 10.1016/S0006-3495(96)79790-4; MCGEE MP, 1992, J BIOL CHEM, V267, P24333; NESHEIM ME, 1984, J BIOL CHEM, V259, P1447; NESHEIM ME, 1981, J BIOL CHEM, V256, P9874; NESHEIM ME, 1979, J BIOL CHEM, V254, P952; Okorie UM, 2008, BLOOD, V111, P3507, DOI 10.1182/blood-2007-08-106229; Orfeo T, 2004, J BIOL CHEM, V279, P19580, DOI 10.1074/jbc.M400727200; Parhami-Seren B, 2006, J THROMB HAEMOST, V4, P1747, DOI 10.1111/j.1538-7836.2006.02000.x; RADCLIFFE RD, 1972, J BIOL CHEM, V247, P7735; ROSING J, 1980, J BIOL CHEM, V255, P274; Runyon MK, 2008, J AM CHEM SOC, V130, P3458, DOI 10.1021/ja076301r; SCHOEN P, 1991, BLOOD, V78, P118; SCHOEN P, 1990, THROMB HAEMOSTASIS, V64, P542; Shaw AW, 2007, J BIOL CHEM, V282, P6556, DOI 10.1074/jbc.M607973200; Shen F, 2008, ARTERIOSCL THROM VAS, V28, P2035, DOI 10.1161/ATVBAHA.108.173930; Shi JL, 2003, BLOOD, V101, P2628, DOI 10.1182/blood-2002-07-1951; SILVERBERG SA, 1977, J BIOL CHEM, V252, P8481; TAMM LK, 1985, BIOPHYS J, V47, P105, DOI 10.1016/S0006-3495(85)83882-0	58	14	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5225	5234		10.1074/jbc.M111.302075	http://dx.doi.org/10.1074/jbc.M111.302075			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22187432	Green Published, hybrid			2022-12-27	WOS:000300638000005
J	Tran, DT; Zhang, LP; Zhang, Y; Tian, E; Earl, LA; Ten Hagen, KG				Tran, Duy T.; Zhang, Liping; Zhang, Ying; Tian, E.; Earl, Lesley A.; Ten Hagen, Kelly G.			Multiple Members of the UDP-GalNAc: Polypeptide N-Acetylgalactosaminyltransferase Family Are Essential for Viability in Drosophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							O-GLYCOSYLATION; TRANSGENIC RNAI; CELL-ADHESION; GERM-LINE; PROTEIN; EXPRESSION; MELANOGASTER; MUTATIONS; SECRETION; GLYCANS	Mucin-type O-glycosylation represents a major form of post-translational modification that is conserved across most eukaryotic species. This type of glycosylation is initiated by a family of enzymes (GalNAc-Ts in mammals and PGANTs in Drosophila) whose members are expressed in distinct spatial and temporal patterns during development. Previous work from our group demonstrated that one member of this family is essential for viability and another member modulates extracellular matrix composition and integrin-mediated cell adhesion during development. To investigate whether other members of this family are essential, we employed RNA interference (RNAi) to each gene in vivo. Using this approach, we identified 4 additional pgant genes that are required for viability. Ubiquitous RNAi to pgant4, pgant5, pgant7, or the putative glycosyltransferase CG30463 resulted in lethality. Tissue-specific RNAi was also used to define the specific organ systems and tissues in which each essential family member is required. Interestingly, each essential pgant had a unique complement of tissues in which it was required. Additionally, certain tissues (mesoderm, digestive system, and tracheal system) required more than one pgant, suggesting unique functions for specific enzymes in these tissues. Expanding upon our RNAi results, we found that conventional mutations in pgant5 resulted in lethality and specific defects in specialized cells of the digestive tract, resulting in loss of proper digestive system acidification. In summary, our results highlight essential roles for O-glycosylation and specific members of the pgant family in many aspects of development and organogenesis.	[Tran, Duy T.; Zhang, Liping; Tian, E.; Earl, Lesley A.; Ten Hagen, Kelly G.] NIDCR, Dev Glycobiol Unit, NIH, Bethesda, MD 20892 USA; [Zhang, Ying] Univ Virginia, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22908 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University of Virginia	Ten Hagen, KG (corresponding author), Bldg 30,Rm 426,30 Convent Dr,MSC 4370, Bethesda, MD 20892 USA.	Kelly.Tenhagen@nih.gov			National Institutes of Health of the NIDCR; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000713] Funding Source: NIH RePORTER	National Institutes of Health of the NIDCR; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program of the NIDCR.	An GY, 2007, J EXP MED, V204, P1417, DOI 10.1084/jem.20061929; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Dubreuil RR, 2004, INT J BIOCHEM CELL B, V36, P745, DOI 10.1016/j.biocel.2003.07.004; Fakhro KA, 2011, P NATL ACAD SCI USA, V108, P2915, DOI 10.1073/pnas.1019645108; Gerken TA, 2008, GLYCOBIOLOGY, V18, P861, DOI 10.1093/glycob/cwn073; Guda K, 2009, P NATL ACAD SCI USA, V106, P12921, DOI 10.1073/pnas.0901454106; Hart GW, 2010, CELL, V143, P672, DOI 10.1016/j.cell.2010.11.008; Ichikawa S, 2007, J CLIN ENDOCR METAB, V92, P1943, DOI 10.1210/jc.2006-1825; Ju TZ, 2005, NATURE, V437, P1252, DOI 10.1038/4371252a; Kathiresan S, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S17; Kingsley PD, 2000, GLYCOBIOLOGY, V10, P1317, DOI 10.1093/glycob/10.12.1317; Kramer KL, 2010, SEMIN CELL DEV BIOL, V21, P631, DOI 10.1016/j.semcdb.2010.06.002; Lee YS, 2003, METHODS, V30, P322, DOI 10.1016/S1046-2023(03)00051-3; Liu L, 2010, SEMIN CELL DEV BIOL, V21, P600, DOI 10.1016/j.semcdb.2010.02.002; Love DC, 2010, SEMIN CELL DEV BIOL, V21, P646, DOI 10.1016/j.semcdb.2010.05.001; Nakamura N, 2010, SEMIN CELL DEV BIOL, V21, P622, DOI 10.1016/j.semcdb.2010.03.010; Neumuller RA, 2011, CELL STEM CELL, V8, P580, DOI 10.1016/j.stem.2011.02.022; Pastor-Pareja JC, 2011, DEV CELL, V21, P245, DOI 10.1016/j.devcel.2011.06.026; Perrine CL, 2009, J BIOL CHEM, V284, P20387, DOI 10.1074/jbc.M109.017236; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Schachter H, 2010, SEMIN CELL DEV BIOL, V21, P609, DOI 10.1016/j.semcdb.2010.02.010; Schwientek T, 2002, J BIOL CHEM, V277, P22623, DOI 10.1074/jbc.M202684200; Shanbhag S, 2009, J EXP BIOL, V212, P1731, DOI 10.1242/jeb.029306; Shiga Y, 1996, DEV GROWTH DIFFER, V38, P99; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; Tabak LA, 2010, SEMIN CELL DEV BIOL, V21, P616, DOI 10.1016/j.semcdb.2010.02.001; Takeuchi H, 2010, SEMIN CELL DEV BIOL, V21, P638, DOI 10.1016/j.semcdb.2010.03.003; Ten Hagen KG, 2002, J BIOL CHEM, V277, P22616, DOI 10.1074/jbc.M201807200; Ten Hagen KG, 1999, J BIOL CHEM, V274, P27867; Ten Hagen KG, 2003, J BIOL CHEM, V278, P35039, DOI 10.1074/jbc.M303836200; Ten Hagen KG, 2003, GLYCOBIOLOGY, V13, p1R, DOI 10.1093/glycob/cwg007; Ten Hagen KG, 2001, J BIOL CHEM, V276, P17395, DOI 10.1074/jbc.M009638200; Tenno M, 2007, MOL CELL BIOL, V27, P8783, DOI 10.1128/MCB.01204-07; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Tian E, 2007, GLYCOBIOLOGY, V17, P820, DOI 10.1093/glycob/cwm056; Tian E, 2007, J BIOL CHEM, V282, P606, DOI 10.1074/jbc.M606268200; Tian E, 2006, GLYCOBIOLOGY, V16, P83, DOI 10.1093/glycob/cwj051; Tian E, 2009, GLYCOCONJUGATE J, V26, P325, DOI 10.1007/s10719-008-9162-4; Topaz O, 2004, NAT GENET, V36, P579, DOI 10.1038/ng1358; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; Velcich A, 2002, SCIENCE, V295, P1726, DOI 10.1126/science.1069094; Wandall HH, 1997, J BIOL CHEM, V272, P23503, DOI 10.1074/jbc.272.38.23503; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Young WW, 2003, GLYCOBIOLOGY, V13, P549, DOI 10.1093/glycob/cwg062; Zacharogianni M, 2011, EMBO J, V30, P3684, DOI 10.1038/emboj.2011.253; Zhang LP, 2010, J BIOL CHEM, V285, P19491, DOI 10.1074/jbc.M109.098145; Zhang LP, 2008, J BIOL CHEM, V283, P34076, DOI 10.1074/jbc.M804267200	48	38	38	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5243	5252		10.1074/jbc.M111.306159	http://dx.doi.org/10.1074/jbc.M111.306159			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22157008	hybrid, Green Published			2022-12-27	WOS:000300638000007
J	Michailidou, Z; Turban, S; Miller, E; Zou, XT; Schrader, J; Ratcliffe, PJ; Hadoke, PWF; Walker, BR; Iredale, JP; Morton, NM; Seckl, JR				Michailidou, Zoi; Turban, Sophie; Miller, Eileen; Zou, Xiantong; Schrader, Joerg; Ratcliffe, Peter J.; Hadoke, Patrick W. F.; Walker, Brian R.; Iredale, John P.; Morton, Nicholas M.; Seckl, Jonathan R.			Increased Angiogenesis Protects against Adipose Hypoxia and Fibrosis in Metabolic Disease-resistant 11 beta-Hydroxysteroid Dehydrogenase Type 1 (HSD1)-deficient Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED VISCERAL OBESITY; INDUCIBLE FACTOR 1-ALPHA; GENE-EXPRESSION; GLUCOCORTICOID-RECEPTOR; TISSUE HYPOXIA; INFLAMMATION; INSULIN; CELLS; HIF-1-ALPHA; PATHWAY	In obesity, rapidly expanding adipose tissue becomes hypoxic, precipitating inflammation, fibrosis, and insulin resistance. Compensatory angiogenesis may prevent these events. Mice lacking the intracellular glucocorticoid-amplifying enzyme 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta HSD1(-/-)) have "healthier" adipose tissue distribution and resist metabolic disease with diet-induced obesity. Here we show that adipose tissues of 11 beta HSD1(-/-) mice exhibit attenuated hypoxia, induction of hypoxia-inducible factor (HIF-1 alpha) activation of the TGF beta/Smad3/alpha-smooth muscle actin (alpha-SMA) signaling pathway, and fibrogenesis despite similar fat accretion with diet-induced obesity. Moreover, augmented 11 beta HSD1(-/-) adipose tissue angiogenesis is associated with enhanced peroxisome proliferator-activated receptor gamma (PPAR gamma)-inducible expression of the potent angiogenic factors VEGF-A, apelin, and angiopoietin-like protein 4. Improved adipose angiogenesis and reduced fibrosis provide a novel mechanism whereby suppression of intracellular glucocorticoid regeneration promotes safer fat expansion with weight gain.	[Michailidou, Zoi; Schrader, Joerg; Iredale, John P.] Univ Edinburgh, Queens Med Res Inst, MRC, Ctr Inflammat Res, Edinburgh EH16 4TJ, Midlothian, Scotland; [Turban, Sophie; Miller, Eileen; Zou, Xiantong; Hadoke, Patrick W. F.; Walker, Brian R.; Morton, Nicholas M.; Seckl, Jonathan R.] Univ Edinburgh, Queens Med Res Inst, Univ British Heart Fdn BHF, Ctr Cardiovasc Sci, Edinburgh EH16 4TJ, Midlothian, Scotland; [Ratcliffe, Peter J.] Univ Oxford, Nuffield Dept Clin Med, Oxford OX3 7BN, England	University of Edinburgh; University of Edinburgh; University of Oxford	Michailidou, Z (corresponding author), Univ Edinburgh, Queens Med Res Inst, MRC, Ctr Inflammat Res, 47 Little France Crescent, Edinburgh EH16 4TJ, Midlothian, Scotland.	v1zmicha@staffmail.ed.ac.uk	Morton, NICHOLAS/ABF-3774-2020; Seckl, Jonathan R/C-3555-2013	Ratcliffe, Peter/0000-0002-2853-806X; Iredale, John/0000-0003-2174-5127; Miller, Eileen/0000-0003-1566-8217	British Heart Foundation Centre of Research Excellence; Henry Wellcome Postdoctoral Fellowship; Wellcome Trust [079660/z/06/z]; European Community [201608]; British Heart Foundation [RG/11/4/28734] Funding Source: researchfish	British Heart Foundation Centre of Research Excellence(British Heart Foundation); Henry Wellcome Postdoctoral Fellowship; Wellcome Trust(Wellcome TrustEuropean Commission); European Community(European Commission); British Heart Foundation(British Heart Foundation)	We acknowledge the support of the British Heart Foundation Centre of Research Excellence. We are grateful to the Centre for Inflammation Research Histology staff for excellent technical support and Sheila Macpherson in the MRC-Centre for Reproductive Biology (CRB) for expertise and generous help on CD31 immunohistochemistry.; This work was supported by a Henry Wellcome Postdoctoral Fellowship (to Z. M.), a Wellcome Trust Programme Grant (to J. R. S.), and a grant from the European Community 7th Framework Programme (FP7/2007-2013) under Grant Agreement 201608, entitled Targeting Obesity-driven Inflammation (TOBI). B. R. W., J. R. S., and N. M. M. are inventors on relevant patents owned by the University of Edinburgh. B. R. W. and J. R. S. have consulted on 11 beta HSD1 inhibitors for a number of pharmaceutical companies.; Supported by a Wellcome Trust Career Development Fellowship (079660/z/06/z).	Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Copple BL, 2010, HEPATOL RES, V40, P530, DOI 10.1111/j.1872-034X.2010.00635.x; Eickelberg O, 2001, FEBS LETT, V506, P11, DOI 10.1016/S0014-5793(01)02875-7; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Feldser D, 1999, CANCER RES, V59, P3915; Friedman SL, 2010, NAT REV GASTRO HEPAT, V7, P425, DOI 10.1038/nrgastro.2010.97; Gealekman O, 2008, AM J PHYSIOL-ENDOC M, V295, pE1056, DOI 10.1152/ajpendo.90345.2008; Haddad JJ, 2001, FEBS LETT, V505, P269, DOI 10.1016/S0014-5793(01)02833-2; Halberg N, 2009, MOL CELL BIOL, V29, P4467, DOI 10.1128/MCB.00192-09; He Q, 2011, AM J PHYSIOL-ENDOC M, V300, pE877, DOI 10.1152/ajpendo.00626.2010; Hosogai N, 2007, DIABETES, V56, P901, DOI 10.2337/db06-0911; Iredale JP, 2007, J CLIN INVEST, V117, P539, DOI 10.1172/JCI30542; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jung YJ, 2003, FASEB J, V17, P2115, DOI 10.1096/fj.03-0329fje; Keophiphath M, 2009, MOL ENDOCRINOL, V23, P11, DOI 10.1210/me.2008-0183; Kodama T, 2003, J BIOL CHEM, V278, P33384, DOI 10.1074/jbc.M302581200; Kotelevtsev Y, 1997, P NATL ACAD SCI USA, V94, P14924, DOI 10.1073/pnas.94.26.14924; Leonard MO, 2005, J IMMUNOL, V174, P2250, DOI 10.4049/jimmunol.174.4.2250; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; McSweeney SJ, 2010, CARDIOVASC RES, V88, P159, DOI 10.1093/cvr/cvq149; Michailidou Z, 2007, OBESITY, V15, P1155, DOI 10.1038/oby.2007.618; Morton NM, 2004, DIABETES, V53, P931, DOI 10.2337/diabetes.53.4.931; Nauck M, 1998, EUR J PHARMACOL, V341, P309, DOI 10.1016/S0014-2999(97)01464-7; Ndubuizu OI, 2010, BRAIN RES, V1366, P101, DOI 10.1016/j.brainres.2010.09.064; Pasarica M, 2009, DIABETES, V58, P718, DOI 10.2337/db08-1098; Peixoto RADS, 2008, ENDOCRINOLOGY, V149, P1861, DOI 10.1210/en.2007-1028; Rask E, 2001, J CLIN ENDOCR METAB, V86, P1418, DOI 10.1210/jc.86.3.1418; Rausch ME, 2008, INT J OBESITY, V32, P451, DOI 10.1038/sj.ijo.0803744; Shimba S, 2004, J BIOL CHEM, V279, P40946, DOI 10.1074/jbc.M400840200; Small GR, 2005, P NATL ACAD SCI USA, V102, P12165, DOI 10.1073/pnas.0500641102; Stockmann C, 2010, P NATL ACAD SCI USA, V107, P4329, DOI 10.1073/pnas.0912766107; Treins C, 2002, J BIOL CHEM, V277, P27975, DOI 10.1074/jbc.M204152200; Villaret A, 2010, DIABETES, V59, P2755, DOI 10.2337/db10-0398; Wamil M, 2011, DIABETES, V60, P1158, DOI 10.2337/db10-0830; Ye JP, 2007, AM J PHYSIOL-ENDOC M, V293, pE1118, DOI 10.1152/ajpendo.00435.2007; Yin J, 2009, AM J PHYSIOL-ENDOC M, V296, pE333, DOI 10.1152/ajpendo.90760.2008; Yun Z, 2002, DEV CELL, V2, P331, DOI 10.1016/S1534-5807(02)00131-4	38	61	62	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					4188	4197		10.1074/jbc.M111.259325	http://dx.doi.org/10.1074/jbc.M111.259325			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22158867	hybrid, Green Published			2022-12-27	WOS:000300410900052
J	Xue, Y; Ha, Y				Xue, Yi; Ha, Ya			Catalytic Mechanism of Rhomboid Protease GlpG Probed by 3,4-Dichloroisocoumarin and Diisopropyl Fluorophosphonate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRAMEMBRANE PROTEOLYSIS; DROSOPHILA RHOMBOID-1; CRYSTAL-STRUCTURE; SERINE PROTEASES; STRUCTURAL BASIS; FAMILY; REVEALS; TOXOPLASMA; ACTIVATION; PROTEINS	Rhomboid proteases have many important biological functions. Unlike soluble serine proteases such as chymotrypsin, the active site of rhomboid protease, which contains a Ser-His catalytic dyad, is submerged in the membrane and surrounded by membrane-spanning helices. Previous crystallographic analyses of GlpG, a bacterial rhomboid protease, and its complex with isocoumarin have provided insights into the mechanism of the membrane protease. Here, we studied the interaction of GlpG with 3,4-dichloroisocoumarin and diisopropyl fluorophosphonate, both mechanism-based inhibitors for the serine protease, and describe the crystal structure of the covalent adduct between GlpG and diisopropyl fluorophosphonate, which mimics the oxyanion-containing tetrahedral intermediate of the hydrolytic reaction. The crystal structure confirms that the oxyanion is stabilized by the main chain amide of Ser-201 and by the side chains of His-150 and Asn-154. The phosphorylation of the catalytic Ser-201 weakens its interaction with His-254, causing the catalytic histidine to rotate away from the serine. The rotation of His-254 is accompanied by further rearrangement of the side chains of Tyr-205 and Trp-236 within the substrate-binding groove. The formation of the tetrahedral adduct is also accompanied by opening of the L5 cap and movement of transmembrane helix S5 toward S6 in a direction different from that predicted by the lateral gating model. Combining the new structural data with those on the isocoumarin complex sheds further light on the plasticity of the active site of rhomboid membrane protease.	[Xue, Yi; Ha, Ya] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA	Yale University	Ha, Y (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, 333 Cedar St, New Haven, CT 06520 USA.	ya.ha@yale.edu			National Institutes of Health [GM082839]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082839] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM082839 (to Y. H.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adrain C, 2011, EMBO REP, V12, P421, DOI 10.1038/embor.2011.50; Baker RP, 2007, P NATL ACAD SCI USA, V104, P8257, DOI 10.1073/pnas.0700814104; Ben-Shem A, 2007, P NATL ACAD SCI USA, V104, P462, DOI 10.1073/pnas.0609773104; BENOIT F, 1969, ORG MASS SPECTROM, V2, P591, DOI 10.1002/oms.1210020605; Bondar AN, 2009, STRUCTURE, V17, P395, DOI 10.1016/j.str.2008.12.017; BONE R, 1991, BIOCHEMISTRY-US, V30, P2263, DOI 10.1021/bi00222a032; Brooks CL, 2011, J MOL BIOL, V407, P687, DOI 10.1016/j.jmb.2011.01.046; Chao JR, 2008, NATURE, V452, P98, DOI 10.1038/nature06604; Cipolat S, 2006, CELL, V126, P163, DOI 10.1016/j.cell.2006.06.021; Cole LB, 1998, ACTA CRYSTALLOGR D, V54, P711, DOI 10.1107/S0907444997010457; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Erez E, 2009, BIOCHEMISTRY-US, V48, P12314, DOI 10.1021/bi901648g; Erez E, 2009, NATURE, V459, P371, DOI 10.1038/nature08146; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Freeman M, 2008, ANNU REV GENET, V42, P191, DOI 10.1146/annurev.genet.42.110807.091628; Ha Y, 2009, SEMIN CELL DEV BIOL, V20, P240, DOI 10.1016/j.semcdb.2008.11.006; HARPER JW, 1985, BIOCHEMISTRY-US, V24, P1831, DOI 10.1021/bi00329a005; Hill RB, 2010, SEMIN CELL DEV BIOL, V21, P582, DOI 10.1016/j.semcdb.2009.12.011; Koonin EV, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-r19; Larsen NA, 2006, BIOCHEMISTRY-US, V45, P10184, DOI 10.1021/bi060950i; Lee JR, 2001, CELL, V107, P161, DOI 10.1016/S0092-8674(01)00526-8; Lemberg MK, 2007, GENOME RES, V17, P1634, DOI 10.1101/gr.6425307; Lemberg MK, 2005, EMBO J, V24, P464, DOI 10.1038/sj.emboj.7600537; Lemieux MJ, 2007, P NATL ACAD SCI USA, V104, P750, DOI 10.1073/pnas.0609981104; Maegawa S, 2005, BIOCHEMISTRY-US, V44, P13543, DOI 10.1021/bi051363k; Maegawa S, 2007, MOL MICROBIOL, V64, P435, DOI 10.1111/j.1365-2958.2007.05679.x; MAYER U, 1988, GENE DEV, V2, P1496, DOI 10.1101/gad.2.11.1496; McQuibban GA, 2003, NATURE, V423, P537, DOI 10.1038/nature01633; O'Donnell RA, 2006, J CELL BIOL, V174, P1023, DOI 10.1083/jcb.200604136; Opitz C, 2002, EMBO J, V21, P1577, DOI 10.1093/emboj/21.7.1577; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; POWERS JC, 1994, METHOD ENZYMOL, V244, P442; Radisky ES, 2006, P NATL ACAD SCI USA, V103, P6835, DOI 10.1073/pnas.0601910103; Santos JM, 2011, SCIENCE, V331, P473, DOI 10.1126/science.1199284; Stevenson LG, 2007, P NATL ACAD SCI USA, V104, P1003, DOI 10.1073/pnas.0608140104; Urban S, 2005, P NATL ACAD SCI USA, V102, P1883, DOI 10.1073/pnas.0408306102; Urban S, 2001, CELL, V107, P173, DOI 10.1016/S0092-8674(01)00525-6; Urban S, 2008, BIOL CHEM, V389, P1107, DOI 10.1515/BC.2008.122; Urban S, 2006, GENE DEV, V20, P3054, DOI 10.1101/gad.1488606; VIJAYALAKSHMI J, 1991, BIOCHEMISTRY-US, V30, P2175, DOI 10.1021/bi00222a022; Vinothkumar KR, 2011, J MOL BIOL, V407, P232, DOI 10.1016/j.jmb.2011.01.029; Vinothkumar KR, 2010, EMBO J, V29, P3797, DOI 10.1038/emboj.2010.243; Wang YC, 2007, J MOL BIOL, V374, P1104, DOI 10.1016/j.jmb.2007.10.014; Wang YC, 2007, P NATL ACAD SCI USA, V104, P2098, DOI 10.1073/pnas.0611080104; Wang YC, 2006, NATURE, V444, P179, DOI 10.1038/nature05255; Wasserman JD, 2000, GENE DEV, V14, P1651; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Wu ZR, 2006, NAT STRUCT MOL BIOL, V13, P1084, DOI 10.1038/nsmb1179	49	48	49	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3099	3107		10.1074/jbc.M111.310482	http://dx.doi.org/10.1074/jbc.M111.310482			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22130671	hybrid, Green Published			2022-12-27	WOS:000300295100016
J	Gutierrez-Uzquiza, A; Arechederra, M; Bragado, P; Aguirre-Ghiso, JA; Porras, A				Gutierrez-Uzquiza, Alvaro; Arechederra, Maria; Bragado, Paloma; Aguirre-Ghiso, Julio A.; Porras, Almudena			p38 alpha Mediates Cell Survival in Response to Oxidative Stress via Induction of Antioxidant Genes EFFECT ON THE p70S6K PATHWAY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P38 MAP-KINASES; H2O2-INDUCED APOPTOSIS; SIGNAL-TRANSDUCTION; SENSITIZES CELLS; MESSENGER-RNA; PATHWAY; ACTIVATION; CANCER; MECHANISMS; SENESCENCE	We reveal a novel pro-survival role for mammalian p38 alpha in response to H2O2, which involves an up-regulation of antioxidant defenses. The presence of p38 alpha increases basal and H2O2-induced expression of the antioxidant enzymes: superoxide-dismutase 1 (SOD-1), SOD-2, and catalase through different mechanisms, which protects from reactive oxygen species (ROS) accumulation and prevents cell death. p38 alpha was found to regulate (i) H2O2-induced SOD-2 expression through a direct regulation of transcription mediated by activating transcription factor 2 (ATF-2) and (ii) H2O2-induced catalase expression through regulation of protein stability and mRNA expression and/or stabilization. As a consequence, SOD and catalase activities are higher in WT MEFs. We also found that this p38 alpha-dependent antioxidant response allows WT cells to maintain an efficient activation of the mTOR/p70S6K pathway. Accordingly, the loss of p38 alpha leads to ROS accumulation in response to H2O2, which causes cell death and inactivation of mTOR/p70S6K signaling. This can be rescued by either p38 alpha re-expression or treatment with the antioxidants, N-acetyl cysteine, or exogenously added catalase. Therefore, our results reveal a novel homeostatic role for p38 alpha in response to oxidative stress, where ROS removal is favored by antioxidant enzymes up-regulation, allowing cell survival and mTOR/p70S6K activation.	[Porras, Almudena] Univ Complutense Madrid, Fac Farm, Dept Bioquim & Biol Mol 2, Inst Invest Sanitaria Hosp Clin San Carlos, E-28040 Madrid, Spain; [Bragado, Paloma; Aguirre-Ghiso, Julio A.] Mt Sinai Sch Med, Div Hematol & Oncol, Dept Med, New York, NY 10029 USA; [Bragado, Paloma; Aguirre-Ghiso, Julio A.] Mt Sinai Sch Med, Dept Otolaryngol, Tisch Canc Inst, Black Family Stem Cell Inst, New York, NY 10029 USA	Complutense University of Madrid; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Porras, A (corresponding author), Univ Complutense Madrid, Fac Farm, Dept Bioquim & Biol Mol 2, Inst Invest Sanitaria Hosp Clin San Carlos, Ciudad Univ, E-28040 Madrid, Spain.	maporras@farm.ucm.es	Porras, Almudena/N-2121-2015; Uzquiza, Alvaro Gutierrez/E-4073-2012; Arechederra, María/L-9108-2019; Bragado Domingo, Paloma/A-8679-2015; Arechederra, Maria/F-4373-2016	Porras, Almudena/0000-0002-6495-3308; Uzquiza, Alvaro Gutierrez/0000-0002-0446-4131; Arechederra, María/0000-0002-4830-1924; Bragado Domingo, Paloma/0000-0002-7642-1245; Arechederra, Maria/0000-0002-4830-1924; Aguirre-Ghiso, Julio/0000-0002-6694-6507	National Institutes of Health [CA109182, ES017146]; Ministry of Science and Innovation of Spain [FIS-PI070071, SAF-2010-20198-C02-01]; Comunidad de Madrid/Universidad Complutense de Madrid [920384]; Samuel Waxman Cancer Research Foundation; New York Stem Cell Science; Comunidad de Madrid; Ministry of Education, Spain; NATIONAL CANCER INSTITUTE [R01CA109182] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES017146] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Science and Innovation of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Comunidad de Madrid/Universidad Complutense de Madrid(Comunidad de Madrid); Samuel Waxman Cancer Research Foundation; New York Stem Cell Science; Comunidad de Madrid(Comunidad de Madrid); Ministry of Education, Spain(Spanish Government); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA109182 and ES017146 (to J. A. A.-G.). This work was also supported by Grants FIS-PI070071 and SAF-2010-20198-C02-01 from Ministry of Science and Innovation of Spain and Grant 920384 from Comunidad de Madrid/Universidad Complutense de Madrid (to A. P.), grants from the Samuel Waxman Cancer Research Foundation Tumor Dormancy Program, and a grant from New York Stem Cell Science (to J. A. A.-G.).; Predoctoral student supported by Comunidad de Madrid.; Ph.D. student supported by Ministry of Education (FPU fellowship), Spain.	Aggeli IKS, 2006, CELL SIGNAL, V18, P1801, DOI 10.1016/j.cellsig.2006.02.001; Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256; Bragado P, 2007, APOPTOSIS, V12, P1733, DOI 10.1007/s10495-007-0082-8; Cai WK, 2011, MOL BIOL CELL, V22, P3231, DOI 10.1091/mbc.E11-05-0400; Cao C, 2008, J BIOL CHEM, V283, P28897, DOI 10.1074/jbc.M804144200; Chen L, 2010, LAB INVEST, V90, P762, DOI 10.1038/labinvest.2010.36; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; Cully M, 2010, MOL CELL BIOL, V30, P481, DOI 10.1128/MCB.00688-09; Dann SG, 2007, TRENDS MOL MED, V13, P252, DOI 10.1016/j.molmed.2007.04.002; del Castillo G, 2008, AM J PATHOL, V172, P1238, DOI 10.2353/ajpath.2008.070793; Dolado I, 2007, CANCER CELL, V11, P191, DOI 10.1016/j.ccr.2006.12.013; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Ferreiro I, 2010, J BIOL CHEM, V285, P31819, DOI 10.1074/jbc.M110.155846; Frippiat C, 2002, FREE RADICAL BIO MED, V33, P1334, DOI 10.1016/S0891-5849(02)01044-4; Gutierrez-Uzquiza A, 2010, CELL SIGNAL, V22, P533, DOI 10.1016/j.cellsig.2009.11.008; Han EKH, 2007, ONCOGENE, V26, P5655, DOI 10.1038/sj.onc.1210343; Jin HO, 2009, FREE RADICAL BIO MED, V46, P1158, DOI 10.1016/j.freeradbiomed.2009.01.015; Kurata S, 2000, J BIOL CHEM, V275, P23413, DOI 10.1074/jbc.C000308200; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Matsuzawa A, 2008, BBA-GEN SUBJECTS, V1780, P1325, DOI 10.1016/j.bbagen.2007.12.011; Nebreda AR, 2000, TRENDS BIOCHEM SCI, V25, P257, DOI 10.1016/S0968-0004(00)01595-4; Nogueira V, 2008, CANCER CELL, V14, P458, DOI 10.1016/j.ccr.2008.11.003; Porras A, 2004, MOL BIOL CELL, V15, P922, DOI 10.1091/mbc.E03-08-0592; Schewe DM, 2008, P NATL ACAD SCI USA, V105, P10519, DOI 10.1073/pnas.0800939105; Sen P, 2005, FEBS LETT, V579, P4402, DOI 10.1016/j.febslet.2005.06.081; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Wada T, 2004, ONCOGENE, V23, P2838, DOI 10.1038/sj.onc.1207556; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; WENG QP, 1995, MOL CELL BIOL, V15, P2333; Xu QH, 2004, FREE RADICAL BIO MED, V36, P985, DOI 10.1016/j.freeradbiomed.2004.01.009; Zhang XC, 2005, J BIOL CHEM, V280, P8714, DOI 10.1074/jbc.M408092200; Zuluaga S, 2007, CELL SIGNAL, V19, P62, DOI 10.1016/j.cellsig.2006.05.032	33	101	102	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2632	2642		10.1074/jbc.M111.323709	http://dx.doi.org/10.1074/jbc.M111.323709			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22139847	Green Published, hybrid			2022-12-27	WOS:000300292300036
J	Willimott, S; Wagner, SD				Willimott, Shaun; Wagner, Simon D.			miR-125b and miR-155 Contribute to BCL2 Repression and Proliferation in Response to CD40 Ligand (CD154) in Human Leukemic B-cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; NEOPLASTIC LYMPHOID-TISSUES; ANTIBODY-FORMING-CELLS; GERMINAL CENTER; MESSENGER-RNA; CYCLE ENTRY; TRANSLATION INITIATION; PROTEIN EXPRESSION; UP-REGULATION; INHIBITION	Developmental stage-specific regulation of BCL2 occurs during B-cell maturation and has a role in normal immunity. CD40 signaling promotes proliferation and rescues B-cells from apoptosis, partly through induction of BCL2L1 and BCL2A1 and repression of BCL2. We previously showed that a stromal cell/CD40 ligand (CD154) culture system reproduced this switch in survival protein expression in primary human leukemic B-cells and we employed this model system to investigate BCL2 repression. BCL2 was post-transcriptionally regulated and the repressed BCL2 mRNA was associated with non-polysomal, but dense fractions on sucrose density gradients. Microarrays identified a set of miRNA that were induced by culture conditions and potentially able to bind to the BCL2 3'-UTR. Luciferase reporter assays demonstrated that miR-125b and miR-155 repressed BCL2 mRNA but while stromal cell contact alone was sufficient to induce strongly miR-125b this did not cause BCL2 repression. miR-155, which is the most abundant miRNA under basal conditions, specifically required CD154 for further induction above a threshold to exert its full repressive effects. Anti-miR-125b and anti-miR-155 prevented CD154-mediated repression of BCL2 and reduced CD154-mediated proliferation in the MEC1 B-cell line. We suggest that miR-155 and miR-125b, which are induced by CD154 and stromal cell signals, contribute to regulating proliferation and that BCL2 is one of their target mRNAs.	[Wagner, Simon D.] Univ Leicester, Dept Canc Studies & Mol Med, Leicester LE1 9HN, Leics, England; [Wagner, Simon D.] Univ Leicester, MRC Toxicol Unit, Leicester LE1 9HN, Leics, England	University of Leicester; University of Leicester	Wagner, SD (corresponding author), Univ Leicester, Dept Canc Studies & Mol Med, Lancaster Rd, Leicester LE1 9HN, Leics, England.	sw227@le.ac.uk		Wagner, Simon/0000-0002-8914-0370	Kay Kendall Leukemia Fund	Kay Kendall Leukemia Fund	This work was supported by grants from the Kay Kendall Leukemia Fund.	AKAGI T, 1994, LEUKEMIA LYMPHOMA, V13, P81, DOI 10.3109/10428199409051655; AZZAM ME, 1973, P NATL ACAD SCI USA, V70, P3866, DOI 10.1073/pnas.70.12.3866; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Basso K, 2009, IMMUNITY, V30, P744, DOI 10.1016/j.immuni.2009.03.017; Bousquet M, 2010, P NATL ACAD SCI USA, V107, P21558, DOI 10.1073/pnas.1016611107; Burger JA, 2009, BLOOD, V114, P3367, DOI 10.1182/blood-2009-06-225326; Caligaris-Cappio F, 2003, BRIT J HAEMATOL, V123, P380, DOI 10.1046/j.1365-2141.2003.04679.x; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; CHLEQDESCHAMPS CM, 1993, BLOOD, V81, P293; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Cuni S, 2004, LEUKEMIA, V18, P1391, DOI 10.1038/sj.leu.2403398; Deng XM, 2004, P NATL ACAD SCI USA, V101, P153, DOI 10.1073/pnas.2533920100; Deng XM, 2003, BLOOD, V102, P3179, DOI 10.1182/blood-2003-04-1027; Gururajan M, 2010, INT IMMUNOL, V22, P583, DOI 10.1093/intimm/dxq042; Huang DCS, 1997, EMBO J, V16, P4628, DOI 10.1093/emboj/16.15.4628; Husson H, 2002, BLOOD, V99, P282, DOI 10.1182/blood.V99.1.282; Janumyan YM, 2003, EMBO J, V22, P5459, DOI 10.1093/emboj/cdg533; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Klein U, 2003, P NATL ACAD SCI USA, V100, P2639, DOI 10.1073/pnas.0437996100; Klein U, 2010, CANCER CELL, V17, P28, DOI 10.1016/j.ccr.2009.11.019; KONDO E, 1992, BLOOD, V80, P2044; Lee HH, 1999, P NATL ACAD SCI USA, V96, P9136, DOI 10.1073/pnas.96.16.9136; Linette GP, 1996, P NATL ACAD SCI USA, V93, P9545, DOI 10.1073/pnas.93.18.9545; Linsley PS, 2007, MOL CELL BIOL, V27, P2240, DOI 10.1128/MCB.02005-06; Malumbres R, 2009, BLOOD, V113, P3754, DOI 10.1182/blood-2008-10-184077; Mason KD, 2007, CELL, V128, P1173, DOI 10.1016/j.cell.2007.01.037; Mathonnet G, 2007, SCIENCE, V317, P1764, DOI 10.1126/science.1146067; Mazel S, 1996, J EXP MED, V183, P2219, DOI 10.1084/jem.183.5.2219; Nottrott S, 2006, NAT STRUCT MOL BIOL, V13, P1108, DOI 10.1038/nsmb1173; O'Reilly L. A., 1997, J IMMUNOL; OReilly LA, 1997, INT IMMUNOL, V9, P1291, DOI 10.1093/intimm/9.9.1291; OReilly LA, 1996, EMBO J, V15, P6979, DOI 10.1002/j.1460-2075.1996.tb01090.x; Petersen CP, 2006, MOL CELL, V21, P533, DOI 10.1016/j.molcel.2006.01.031; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; SCHENA M, 1992, BLOOD, V79, P2981; SCHMID C, 1994, HISTOPATHOLOGY, V24, P445, DOI 10.1111/j.1365-2559.1994.tb00553.x; Sellmann L, 2010, CANCER GENET CYTOGEN, V203, P149, DOI 10.1016/j.cancergencyto.2010.09.002; Shen YL, 2004, BLOOD, V104, P2936, DOI 10.1182/blood-2004-01-0243; Sherrill KW, 2004, J BIOL CHEM, V279, P29066, DOI 10.1074/jbc.M402727200; Smith KGC, 2000, J EXP MED, V191, P475, DOI 10.1084/jem.191.3.475; Tarlinton DM, 2000, IMMUNOL TODAY, V21, P436, DOI 10.1016/S0167-5699(00)01687-X; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Thermann R, 2007, NATURE, V447, P875, DOI 10.1038/nature05878; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; Vogler M, 2009, BLOOD, V113, P4403, DOI 10.1182/blood-2008-08-173310; Wang M, 2008, J PATHOL, V215, P13, DOI 10.1002/path.2333; Willimott S, 2007, BRIT J HAEMATOL, V138, P721, DOI 10.1111/j.1365-2141.2007.06717.x; Winter JN, 1998, BLOOD, V91, P1391, DOI 10.1182/blood.V91.4.1391; Yin QY, 2008, J BIOL CHEM, V283, P2654, DOI 10.1074/jbc.M708218200	50	51	53	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2608	2617		10.1074/jbc.M111.285718	http://dx.doi.org/10.1074/jbc.M111.285718			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22139839	hybrid, Green Published			2022-12-27	WOS:000300292300034
J	Xiong, Y; Sheen, J				Xiong, Yan; Sheen, Jen			Rapamycin and Glucose-Target of Rapamycin (TOR) Protein Signaling in Plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MTOR FUNCTION; ARABIDOPSIS; GROWTH; KINASE; EXPRESSION; GENE; TRANSDUCTION; METABOLISM; COMPLEX; INHIBITION	Target of rapamycin (TOR) kinase is an evolutionarily conserved master regulator that integrates energy, nutrients, growth factors, and stress signals to promote survival and growth in all eukaryotes. The reported land plant resistance to rapamycin and the embryo lethality of the Arabidopsis tor mutants have hindered functional dissection of TOR signaling in plants. We developed sensitive cellular and seedling assays to monitor endogenous Arabidopsis TOR activity based on its conserved S6 kinase (S6K) phosphorylation. Surprisingly, rapamycin effectively inhibits Arabidopsis TOR-S6K1 signaling and retards glucose-mediated root and leaf growth, mimicking estradiol-inducible tor mutants. Rapamycin inhibition is relieved in transgenic plants deficient in Arabidopsis FK506-binding protein 12 (FKP12), whereas FKP12 overexpression dramatically enhances rapamycin sensitivity. The role of Arabidopsis FKP12 is highly specific as overexpression of seven closely related FKP proteins fails to increase rapamycin sensitivity. Rapamycin exerts TOR inhibition by inducing direct interaction between the TOR-FRB (FKP-rapamycin binding) domain and FKP12 in plant cells. We suggest that variable endogenous FKP12 protein levels may underlie the molecular explanation for longstanding enigmatic observations on inconsistent rapamycin resistance in plants and in various mammalian cell lines or diverse animal cell types. Integrative analyses with rapamycin and conditional tor and fkp12 mutants also reveal a central role of glucose-TOR signaling in root hair formation. Our studies demonstrate the power of chemical genetic approaches in the discovery of previously unknown and pivotal functions of glucose-TOR signaling in governing the growth of cotyledons, true leaves, petioles, and primary and secondary roots and root hairs.	[Sheen, Jen] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School	Sheen, J (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	sheen@molbio.mgh.harvard.edu		Xiong, Yan/0000-0003-0676-8267	National Institutes of Health [R01 GM60493]; National Science Foundation [IOS-0843244]; Massachusetts General Hospital; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060493] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Massachusetts General Hospital(General Electric); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM60493 (to J. S.). This work was also supported by National Science Foundation Grant IOS-0843244 (to J. S.).; Supported by the Massachusetts General Hospital Tosteson postdoctoral fellowship.	Ahn CS, 2011, PLANT CELL, V23, P185, DOI 10.1105/tpc.110.074005; Anderson GH, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-12; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Baena-Gonzalez E, 2008, TRENDS PLANT SCI, V13, P474, DOI 10.1016/j.tplants.2008.06.006; Bai XC, 2007, SCIENCE, V318, P977, DOI 10.1126/science.1147379; Brand L, 2006, PLANT PHYSIOL, V141, P1194, DOI 10.1104/pp.106.081299; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Choi JW, 1996, SCIENCE, V273, P239, DOI 10.1126/science.273.5272.239; Deprost D, 2005, BIOCHEM BIOPH RES CO, V326, P844, DOI 10.1016/j.bbrc.2004.11.117; Deprost D, 2007, EMBO REP, V8, P864, DOI 10.1038/sj.embor.7401043; Dobrenel T, 2011, BIOCHEM SOC T, V39, P477, DOI 10.1042/BST0390477; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Gao XS, 2002, NAT CELL BIOL, V4, P699, DOI 10.1038/ncb847; He ZY, 2004, PLANT PHYSIOL, V134, P1248, DOI 10.1104/pp.103.031005; Hwang I, 2001, NATURE, V413, P383, DOI 10.1038/35096500; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Ishida T, 2008, ANNU REV PLANT BIOL, V59, P365, DOI 10.1146/annurev.arplant.59.032607.092949; Kovtun Y, 1998, NATURE, V395, P716, DOI 10.1038/27240; Li JF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027364; Mahfouz MM, 2006, PLANT CELL, V18, P477, DOI 10.1105/tpc.105.035931; Menand B, 2002, P NATL ACAD SCI USA, V99, P6422, DOI 10.1073/pnas.092141899; Moore B, 2003, SCIENCE, V300, P332, DOI 10.1126/science.1080585; Oshiro N, 2004, GENES CELLS, V9, P359, DOI 10.1111/j.1356-9597.2004.00727.x; Ren MZ, 2011, PLANT PHYSIOL, V155, P1367, DOI 10.1104/pp.110.169045; Rolland F, 2006, ANNU REV PLANT BIOL, V57, P675, DOI 10.1146/annurev.arplant.57.032905.105441; Russell RC, 2011, DEVELOPMENT, V138, P3343, DOI 10.1242/dev.058230; Sormani R, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-26; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Wesley SV, 2001, PLANT J, V27, P581, DOI 10.1046/j.1365-313X.2001.01105.x; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xiao WY, 2000, PLANT MOL BIOL, V44, P451, DOI 10.1023/A:1026501430422; Yip CK, 2010, MOL CELL, V38, P768, DOI 10.1016/j.molcel.2010.05.017; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	34	175	190	3	52	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2836	2842		10.1074/jbc.M111.300749	http://dx.doi.org/10.1074/jbc.M111.300749			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22134914	Green Published, hybrid			2022-12-27	WOS:000300292300055
J	Li, XZ; Yan, J; Huang, SH; Zhao, L; Wang, J; Chen, ZY				Li, Xue-Zhi; Yan, Jing; Huang, Shu-Hong; Zhao, Ling; Wang, Jue; Chen, Zhe-Yu			Identification of a Key Motif That Determines the Differential Surface Levels of RET and TrkB Tyrosine Kinase Receptors and Controls Depolarization Enhanced RET Surface Insertion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; DORSAL-ROOT; GDNF FAMILY; PHEOCHROMOCYTOMA CELLS; GANGLION NEURONS; PLASMA-MEMBRANE; NMDA RECEPTORS; AMPA RECEPTORS; DRG NEURONS; TRAFFICKING	The RET tyrosine kinase receptor plays an important role in the development and maintenance of the nervous system. Although the ligand-induced RET signaling pathway has been well described, little is known about the regulation of RET surface expression, which is integral to the cell ability to control the response to ligand stimuli. We found that in dorsal root ganglion (DRG) neurons, which co-express RET and TrkB, the receptor surface levels of RET are significantly higher than that of TrkB. Using a sequence substitution strategy, we identified a key motif (Box1), which is necessary and sufficient for the differential RET and TrkB surface levels. Furthermore, pharmacological and mutagenesis assays revealed that protein kinase C (PKC) and high K+ depolarization increase RET surface levels through phosphorylation of the Thr(675) residue in the Box1 motif. Finally, we found that the phosphorylation status of the Thr(675) residue influences RET mediated response to GDNF stimulation. In all, these findings provide a novel mechanism for the modulation of RET surface expression.	[Li, Xue-Zhi; Yan, Jing; Huang, Shu-Hong; Zhao, Ling; Wang, Jue; Chen, Zhe-Yu] Shandong Univ, Dept Neurobiol, Shandong Prov Key Lab Mental Disorders, Sch Med, Jinan 250012, Shandong, Peoples R China	Shandong University	Chen, ZY (corresponding author), Shandong Univ, Dept Neurobiol, Shandong Prov Key Lab Mental Disorders, Sch Med, 44 Wenhua Xi Rd, Jinan 250012, Shandong, Peoples R China.	zheyuchen@sdu.edu.cn	Li, Xuezhi/ABF-6626-2021; Wang, Jue/GVU-0480-2022	Li, Xuezhi/0000-0003-1030-9688	National Natural Science Foundation of China [30725020, 30900717, 31071254, 31130026]; National 973 Basic Research Program of China [2010CB912004, 2012CB911004]; National Natural Science Foundation of China for Innovative Research Group [81021001]; Foundation for Excellent Young Scientists of Shandong Province [BS2010SW022, BS2010SW023]; Research Fund for the Doctoral Program of Higher Education of China [200804221070]; Independent Innovation Foundation of Shandong University (IIFSDU)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 973 Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China for Innovative Research Group(National Natural Science Foundation of China (NSFC)); Foundation for Excellent Young Scientists of Shandong Province; Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Independent Innovation Foundation of Shandong University (IIFSDU)	This study was supported by National Natural Science Foundation of China (No. 30725020, 30900717, 31071254, 31130026), the National 973 Basic Research Program of China (No. 2010CB912004, 2012CB911004), the State Program of National Natural Science Foundation of China for Innovative Research Group (No. 81021001), the Foundation for Excellent Young Scientists of Shandong Province (BS2010SW022, BS2010SW023), Research Fund for the Doctoral Program of Higher Education of China (200804221070), and Independent Innovation Foundation of Shandong University (IIFSDU).	Achour L, 2008, TRENDS PHARMACOL SCI, V29, P528, DOI 10.1016/j.tips.2008.07.009; Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; ASAI N, 1995, MOL CELL BIOL, V15, P1613; Baloh RH, 2000, CURR OPIN NEUROBIOL, V10, P103, DOI 10.1016/S0959-4388(99)00048-3; Bouchard JF, 2008, J NEUROCHEM, V107, P398, DOI 10.1111/j.1471-4159.2008.05609.x; Brismar H, 1998, P NATL ACAD SCI USA, V95, P5573, DOI 10.1073/pnas.95.10.5573; Califano D, 1996, P NATL ACAD SCI USA, V93, P7933, DOI 10.1073/pnas.93.15.7933; Chen ZY, 2005, MOL BIOL CELL, V16, P5761, DOI 10.1091/mbc.E05-07-0651; Crump FT, 2001, J NEUROSCI, V21, P5079, DOI 10.1523/JNEUROSCI.21-14-05079.2001; Doxakis E, 2000, DEVELOPMENT, V127, P1477; Dupre DJ, 2006, CELL SIGNAL, V18, P1549, DOI 10.1016/j.cellsig.2006.03.009; Fisher CE, 2001, DEVELOPMENT, V128, P4329; Fukuda T, 2002, J BIOL CHEM, V277, P19114, DOI 10.1074/jbc.M200643200; Gomes AR, 2007, TRAFFIC, V8, P259, DOI 10.1111/j.1600-0854.2006.00521.x; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Grosshans DR, 2002, NAT NEUROSCI, V5, P27, DOI 10.1038/nn779; HEIN L, 1994, J BIOL CHEM, V269, P27719; Honma Y, 2010, DEVELOPMENT, V137, P2319, DOI 10.1242/dev.046995; Horak M, 2008, J NEUROSCI, V28, P3500, DOI 10.1523/JNEUROSCI.5239-07.2008; Huang SH, 2009, J BIOL CHEM, V284, P15126, DOI 10.1074/jbc.M809763200; Jijiwa M, 2004, MOL CELL BIOL, V24, P8026, DOI 10.1128/MCB.24.18.8026-8036.2004; Kashiba H, 2003, MOL BRAIN RES, V110, P52, DOI 10.1016/S0169-328X(02)00584-3; Kelly-Spratt KS, 1999, CELL GROWTH DIFFER, V10, P805; Kirchhausen T, 2002, NAT STRUCT BIOL, V9, P241, DOI 10.1038/nsb0402-241; Kramer I, 2006, NEURON, V49, P379, DOI 10.1016/j.neuron.2006.01.008; Kurokawa K, 2001, ONCOGENE, V20, P1929, DOI 10.1038/sj.onc.1204290; Lan JY, 2001, NAT NEUROSCI, V4, P382, DOI 10.1038/86028; Luo WQ, 2007, NEURON, V54, P739, DOI 10.1016/j.neuron.2007.04.027; Man HY, 2007, P NATL ACAD SCI USA, V104, P3579, DOI 10.1073/pnas.0611698104; Miyamoto R, 2011, DEV BIOL, V349, P160, DOI 10.1016/j.ydbio.2010.11.002; Molliver DC, 1997, NEURON, V19, P849, DOI 10.1016/S0896-6273(00)80966-6; OLAGUE PH, 1980, P NATL ACAD SCI-BIOL, V77, P1701, DOI 10.1073/pnas.77.3.1701; Patten SA, 2009, P NATL ACAD SCI USA, V106, P6796, DOI 10.1073/pnas.0811171106; Sariola H, 2003, J CELL SCI, V116, P3855, DOI 10.1242/jcs.00786; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; Scott DB, 2003, NEUROPHARMACOLOGY, V45, P755, DOI 10.1016/S0028-3908(03)00250-8; Segouffin-Cariou C, 2000, J BIOL CHEM, V275, P3568, DOI 10.1074/jbc.275.5.3568; Tong W, 2006, J BIOL CHEM, V281, P38930, DOI 10.1074/jbc.M607524200; Valdes-Sanchez T, 2010, DEV BIOL, V339, P465, DOI 10.1016/j.ydbio.2010.01.001; WAKADE TD, 1991, J BIOL CHEM, V266, P6424; Zhao L, 2009, J CELL SCI, V122, P3123, DOI 10.1242/jcs.047712	41	3	3	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					1932	1945		10.1074/jbc.M111.283457	http://dx.doi.org/10.1074/jbc.M111.283457			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22128160	Green Published, hybrid			2022-12-27	WOS:000299321000034
J	Ma, WB; Xie, SS; Ni, MJ; Huang, XX; Hu, SG; Liu, Q; Liu, AH; Zhang, JS; Zhang, YL				Ma, Wubin; Xie, Shengsong; Ni, Minjie; Huang, Xingxu; Hu, Shuanggang; Liu, Qiang; Liu, Aihua; Zhang, Jinsong; Zhang, Yonglian			MicroRNA-29a Inhibited Epididymal Epithelial Cell Proliferation by Targeting Nuclear Autoantigenic Sperm Protein (NASP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; HISTONE CHAPERONE; SELF-RENEWAL; MIR-29; TUMORIGENICITY; EXPRESSION; REGULATORS; GROWTH; CANCER; MOUSE	Cell proliferation often decreases gradually during postnatal development of some organs. However, the underlying molecular mechanisms remain unclear. Epididymis, playing important roles in sperm maturation, is a typical organ of this type, which displays a decreased proliferation during postnatal development and even ceased at the adult stage. Here, epididymis was employed as a model to explore the underlying mechanisms. We profiled the microRNA and mRNA expression of newborn (1 day) and adult (90 day) rat epididymis by microarray analysis, and found that the level of miR-29a was dramatically up-regulated during postnatal development of rat epididymis. Subsequent investigations demonstrated that overexpression of miR-29a inhibited the proliferation of epididymal epithelial cells in vitro. The nuclear autoantigenic sperm protein (NASP), a novel target of miR-29a, was significantly down-regulated during postnatal development of rat epididymis. Further analysis showed that silence of NASP mimicked the anti-proliferation effect of miR-29a, whereas overexpression of this protein attenuated the effect of miR-29a. As in rat epididymis, miR-29a was up-regulated and Nasp was down-regulated during postnatal development of mouse epididymis, heart, liver, and lung. Moreover, miR-29a can also inhibit the proliferation of cancer cells by targeting Nasp. Thus, an increase of miR-29a, and hence decrease of Nasp, may contribute to inhibit cell proliferation during postnatal organ development.	[Ma, Wubin; Xie, Shengsong; Ni, Minjie; Hu, Shuanggang; Liu, Qiang; Liu, Aihua; Zhang, Jinsong; Zhang, Yonglian] Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Labs Shanghai Key Lab Mol Androl, Shanghai 200031, Peoples R China; [Ma, Wubin; Xie, Shengsong; Hu, Shuanggang] Chinese Acad Sci, Grad Sch, Shanghai 200031, Peoples R China; [Huang, Xingxu] Nanjing Univ, Model Anim Res Ctr, Nanjing 210061, Peoples R China; [Zhang, Yonglian] Shanghai Inst Planned Parenthood Res, Shanghai 200032, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Nanjing University	Zhang, YL (corresponding author), Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Labs Shanghai Key Lab Mol Androl, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	ylzhang@sibs.ac.cn	Ma, Wubin/P-3045-2017; Liu, Qiang/HHZ-3181-2022	huang, xingxu/0000-0001-8934-1247; Zhang, Jinsong/0000-0002-6457-0235	National Basic Science Research and Development Project of China [30930053, 31101069]; Chinese Academy of Sciences (CAS) [KSCX2-EW-R-07]	National Basic Science Research and Development Project of China; Chinese Academy of Sciences (CAS)(Chinese Academy of Sciences)	This work was supported by National Basic Science Research and Development Project of China Grants 30930053 and 31101069 and Chinese Academy of Sciences (CAS) Knowledge Innovation Program Grant KSCX2-EW-R-07.	Akao Y, 2007, CANCER SCI, V98, P1914, DOI 10.1111/j.1349-7006.2007.00618.x; Akao Y, 2006, BIOL PHARM BULL, V29, P903, DOI 10.1248/bpb.29.903; Alekseev OM, 2003, J BIOL CHEM, V278, P8846, DOI 10.1074/jbc.M210352200; Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Araki Y, 2002, J ANDROL, V23, P854; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Cornwall GA, 2009, HUM REPROD UPDATE, V15, P213, DOI 10.1093/humupd/dmn055; CROCKER TT, 1970, CANCER RES, V30, P357; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gupta A, 2011, METHODS MOL BIOL, V676, P73, DOI 10.1007/978-1-60761-863-8_6; Han YC, 2010, J EXP MED, V207, P475, DOI 10.1084/jem.20090831; Huang TH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003225; Ivey KN, 2010, CELL STEM CELL, V7, P36, DOI 10.1016/j.stem.2010.06.012; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Li XQ, 2010, BRIT J HAEMATOL, V148, P69, DOI 10.1111/j.1365-2141.2009.07920.x; Li Y, 2009, DEV DYNAM, V238, P2388, DOI 10.1002/dvdy.22056; Lin TX, 2009, J UROLOGY, V181, P1372, DOI 10.1016/j.juro.2008.10.149; Liu SJ, 2010, CANCER CELL, V17, P333, DOI 10.1016/j.ccr.2010.03.008; Liu Y, 2010, HYPERTENSION, V55, P974, DOI 10.1161/HYPERTENSIONAHA.109.144428; Machida N, 1997, J MOL CELL CARDIOL, V29, P1895, DOI 10.1006/jmcc.1997.0427; Marquez MG, 2002, ANAT EMBRYOL, V205, P431, DOI 10.1007/s00429-002-0262-9; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Mott JL, 2007, ONCOGENE, V26, P6133, DOI 10.1038/sj.onc.1210436; Muniyappa MK, 2009, EUR J CANCER, V45, P3104, DOI 10.1016/j.ejca.2009.09.014; Nuovo GJ, 2008, METHODS, V44, P39, DOI 10.1016/j.ymeth.2007.10.008; Ott CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016250; Park SY, 2009, NAT STRUCT MOL BIOL, V16, P23, DOI 10.1038/nsmb.1533; Pauli A, 2011, NAT REV GENET, V12, P136, DOI 10.1038/nrg2904; Pekarsky Y, 2006, CANCER RES, V66, P11590, DOI 10.1158/0008-5472.CAN-06-3613; Podolska A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014494; Richardson RT, 2006, J BIOL CHEM, V281, P21526, DOI 10.1074/jbc.M603816200; Richardson RT, 2000, J BIOL CHEM, V275, P30378, DOI 10.1074/jbc.M003781200; Robaire B., 1988, P999; Rodriguez C. M., 2001, EPIDIDYMIS MOL CLIN, P251; Sampson VB, 2007, CANCER RES, V67, P9762, DOI 10.1158/0008-5472.CAN-07-2462; Santanam U, 2010, P NATL ACAD SCI USA, V107, P12210, DOI 10.1073/pnas.1007186107; Shenouda SK, 2009, CANCER METAST REV, V28, P369, DOI 10.1007/s10555-009-9188-5; Wang HY, 2008, NUCLEIC ACIDS RES, V36, P5763, DOI 10.1093/nar/gkn574; Wang JF, 2010, BIOCHEM BIOPH RES CO, V402, P222, DOI 10.1016/j.bbrc.2010.10.002; Williams AE, 2007, DEV DYNAM, V236, P572, DOI 10.1002/dvdy.21047; Winbanks CE, 2011, J BIOL CHEM, V286, P13805, DOI 10.1074/jbc.M110.192625; Wu HL, 2009, CELL RES, V19, P439, DOI 10.1038/cr.2009.18; Xiong YJ, 2010, HEPATOLOGY, V51, P836, DOI 10.1002/hep.23380; Xu JA, 2011, NUCLEIC ACIDS RES, V39, P825, DOI 10.1093/nar/gkq832; Xu T, 2009, HEPATOLOGY, V50, P113, DOI 10.1002/hep.22919; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zhang JS, 2010, ACTA BIOCH BIOPH SIN, V42, P145, DOI 10.1093/abbs/gmp116; Zhao JJ, 2010, BLOOD, V115, P2630, DOI 10.1182/blood-2009-09-243147; Zhu CF, 2007, BIOL REPROD, V76, P63, DOI 10.1095/biolreprod.106.054635	51	29	31	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10189	10199		10.1074/jbc.M111.303636	http://dx.doi.org/10.1074/jbc.M111.303636			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22194605	hybrid, Green Published			2022-12-27	WOS:000302167200050
J	Cheng, W; Yang, F; Liu, S; Colton, CK; Wang, CB; Cui, YY; Cao, X; Zhu, MX; Sun, CS; Wang, KW; Zheng, J				Cheng, Wei; Yang, Fan; Liu, Shuang; Colton, Craig K.; Wang, Chunbo; Cui, Yuanyuan; Cao, Xu; Zhu, Michael X.; Sun, Changsen; Wang, KeWei; Zheng, Jie			Heteromeric Heat-sensitive Transient Receptor Potential Channels Exhibit Distinct Temperature and Chemical Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROOT GANGLION NEURONS; CAPSAICIN RECEPTOR; TRP CHANNELS; ION CHANNELS; ANKYRIN REPEAT; MICE LACKING; THERMOSENSATION; ACTIVATION; PAIN; EXPRESSION	TRPV1 and TRPV3 are two heat-sensitive ion channels activated at distinct temperature ranges perceived by human as hot and warm, respectively. Compounds eliciting human sensations of heat or warmth can also potently activate these channels. In rodents, TRPV3 is expressed predominantly in skin keratinocytes, whereas in humans TRPV1 and TRPV3 are co-expressed in sensory neurons of dorsal root ganglia and trigeminal ganglion and are known to form heteromeric channels with distinct single channel conductances as well as sensitivities to TRPV1 activator capsaicin and inhibitor capsazepine. However, how heteromeric TRPV1/TRPV3 channels respond to heat and other stimuli remains unknown. In this study, we examined the behavior of heteromeric TRPV1/TRPV3 channels activated by heat, capsaicin, and voltage. Our results demonstrate that the heteromeric channels exhibit distinct temperature sensitivity, activation threshold, and heat-induced sensitization. Changes in gating properties apparently originate from interactions between TRPV1 and TRPV3 subunits. Our results suggest that heteromeric TRPV1/TRPV3 channels are unique heat sensors that may contribute to the fine-tuning of sensitivity to sensory inputs.	[Liu, Shuang; Cui, Yuanyuan; Cao, Xu; Wang, KeWei] Peking Univ, Hlth Sci Ctr, Dept Neurobiol, Neurosci Res Inst, Beijing 100083, Peoples R China; [Cheng, Wei; Sun, Changsen] Dalian Univ Technol, Coll Phys & Optoelect Engn, Lab Biomed Opt, Dalian 116023, Peoples R China; [Cheng, Wei; Yang, Fan; Cui, Yuanyuan; Cao, Xu; Zheng, Jie] Univ Calif Davis, Dept Physiol & Membrane Biol, Davis, CA 95616 USA; [Yang, Fan] Univ Calif Davis, Mol Cellular & Integrat Physiol Grad Grp, Davis, CA 95616 USA; [Colton, Craig K.; Wang, Chunbo] Ohio State Univ, Ctr Mol Neurobiol, Columbus, OH 43210 USA; [Zhu, Michael X.] Univ Texas Hlth Sci Ctr, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA	Peking University; Dalian University of Technology; University of California System; University of California Davis; University of California System; University of California Davis; University System of Ohio; Ohio State University; University of Texas System; University of Texas Health Science Center Houston	Wang, KW (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Neurobiol, Neurosci Res Inst, Beijing 100083, Peoples R China.	wangkw@bjmu.edu; jzheng@ucdavis.edu	Yang, Fan/C-6586-2012; Cao, Xu/G-6209-2015; Cui, Yuanyuan/G-1787-2017; Yang, Fan/AAA-6904-2022; Yang, Fan/GYU-4249-2022; Cui, Yuanyuan/G-1899-2015; Yang, Fan/J-4562-2015; chegn, maizy/GVU-3127-2022; Zhu, Ren-Yuan/V-8966-2019	Yang, Fan/0000-0002-9406-7710; Cao, Xu/0000-0003-1796-2735; Cui, Yuanyuan/0000-0002-1455-5643; Yang, Fan/0000-0002-0520-5254; Yang, Fan/0000-0002-9406-7710; Zhu, Ren-Yuan/0000-0003-3091-7461	National Institutes of Health [NS072377, GM081658]; University of California Davis Health System; National Science Foundation of China [30970919, 3092800]; Ministry of Education of China [B07001]; American Heart Association; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081658] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072377] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California Davis Health System; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS072377 (to J. Z.) and GM081658 (to M. X. Z.). This work was also supported by the University of California Davis Health System (to J. Z.), National Science Foundation of China Grants 30970919 (to K. W. W.) and 3092800 (to J. Z.), Ministry of Education of China 111 Project B07001 (to K. W. W.), and an American Heart Association predoctoral fellowship (to F. Y.).	Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Bandell M, 2007, CURR OPIN NEUROBIOL, V17, P490, DOI 10.1016/j.conb.2007.07.014; Baumann TK, 1996, PAIN, V65, P31, DOI 10.1016/0304-3959(95)00145-X; Benham CD, 2003, CELL CALCIUM, V33, P479, DOI 10.1016/S0143-4160(03)00063-0; Brauchi S, 2006, J NEUROSCI, V26, P4835, DOI 10.1523/JNEUROSCI.5080-05.2006; Brauchi S, 2007, P NATL ACAD SCI USA, V104, P10246, DOI 10.1073/pnas.0703420104; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cheng W, 2007, J GEN PHYSIOL, V129, P191, DOI 10.1085/jgp.200709731; Cheng W, 2010, PROTEIN CELL, V1, P802, DOI 10.1007/s13238-010-0108-9; Chung MK, 2005, J BIOL CHEM, V280, P15928, DOI 10.1074/jbc.M500596200; Clapham DE, 2002, SCIENCE, V295, P2228, DOI 10.1126/science.1070766; Colton C. K., 2006, THESIS OHIO STATE U; Facer P, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-11; Garcia-Sanz N, 2007, J NEUROSCI, V27, P11641, DOI 10.1523/JNEUROSCI.2457-07.2007; Gopinath Preethi, 2005, BMC Womens Health, V5, P2, DOI 10.1186/1472-6874-5-2; Greffrath W, 2003, NEUROREPORT, V14, P2251, DOI 10.1097/00001756-200312020-00023; Gunthorpe MJ, 2002, TRENDS PHARMACOL SCI, V23, P183, DOI 10.1016/S0165-6147(02)01999-5; Hjerling-Leffler J, 2007, J NEUROSCI, V27, P2435, DOI 10.1523/JNEUROSCI.5614-06.2007; Huang SM, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-37; ISACOFF EY, 1990, NATURE, V345, P530, DOI 10.1038/345530a0; Jordt SE, 2003, CURR OPIN NEUROBIOL, V13, P487, DOI 10.1016/S0959-4388(03)00101-6; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Latorre R, 2007, CELL CALCIUM, V42, P427, DOI 10.1016/j.ceca.2007.04.004; Latorre R, 2009, Q REV BIOPHYS, V42, P201, DOI 10.1017/S0033583509990072; Liang SS, 2009, CELL BIOCHEM BIOPHYS, V53, P33, DOI 10.1007/s12013-008-9035-2; Macpherson LJ, 2006, MOL CELL NEUROSCI, V32, P335, DOI 10.1016/j.mcn.2006.05.005; Moiseenkova-Bell VY, 2008, P NATL ACAD SCI USA, V105, P7451, DOI 10.1073/pnas.0711835105; Moqrich A, 2005, SCIENCE, V307, P1468, DOI 10.1126/science.1108609; Mosavi LK, 2004, PROTEIN SCI, V13, P1435, DOI 10.1110/ps.03554604; Peier AM, 2002, SCIENCE, V296, P2046, DOI 10.1126/science.1073140; Puntambekar P, 2005, J NEUROCHEM, V95, P1689, DOI 10.1111/j.1471-4159.2005.03518.x; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Sedgwick SG, 1999, TRENDS BIOCHEM SCI, V24, P311, DOI 10.1016/S0968-0004(99)01426-7; Siemens J, 2006, NATURE, V444, P208, DOI 10.1038/nature05285; Smith GD, 2002, NATURE, V418, P186, DOI 10.1038/nature00894; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Szallasi A, 1995, Acta Physiol Scand Suppl, V629, P1; Valente P, 2008, FASEB J, V22, P3298, DOI 10.1096/fj.08-107425; Vetter I, 2008, J BIOL CHEM, V283, P19540, DOI 10.1074/jbc.M707865200; Vlachova V, 2003, J NEUROSCI, V23, P1340, DOI 10.1523/JNEUROSCI.23-04-01340.2003; Wang CB, 2004, J BIOL CHEM, V279, P37423, DOI 10.1074/jbc.M407205200; Xiao R, 2008, J BIOL CHEM, V283, P6162, DOI 10.1074/jbc.M706535200; Xu HX, 2006, NAT NEUROSCI, V9, P628, DOI 10.1038/nn1692; Xu HX, 2002, NATURE, V418, P181, DOI 10.1038/nature00882; Yan T, 2007, ANESTH ANALG, V104, P1246, DOI 10.1213/01.ane.0000263270.39480.a2; Yang F, 2010, P NATL ACAD SCI USA, V107, P7083, DOI 10.1073/pnas.1000357107; Zhang F, 2011, J BIOL CHEM, V286, P15308, DOI 10.1074/jbc.M111.223941	48	57	57	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7279	7288		10.1074/jbc.M111.305045	http://dx.doi.org/10.1074/jbc.M111.305045			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22184123	Green Published, hybrid			2022-12-27	WOS:000301060200030
J	Camp, ND; James, RG; Dawson, DW; Yan, F; Davison, JM; Houck, SA; Tang, XB; Zheng, N; Major, MB; Moon, RT				Camp, Nathan D.; James, Richard G.; Dawson, David W.; Yan, Feng; Davison, James M.; Houck, Scott A.; Tang, Xiaobo; Zheng, Ning; Major, Michael B.; Moon, Randall T.			Wilms Tumor Gene on X Chromosome (WTX) Inhibits Degradation of NRF2 Protein through Competitive Binding to KEAP1 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIOXIDANT RESPONSE ELEMENT; CUL3-BASED E3 LIGASE; SUPPRESSOR WTX; BETA-CATENIN; MUTATIONS; ACTIVATION; ADAPTER; INACTIVATION; PROTEOMICS; INTERFACE	WTX is a tumor suppressor protein that is lost or mutated in up to 30% of cases of Wilms tumor. Among its known functions, WTX interacts with the beta-transducin repeat containing family of ubiquitin ligase adaptors and promotes the ubiquitination and degradation of the transcription factor beta-catenin, a key control point in the WNT/beta-catenin signaling pathway. Here, we report that WTX interacts with a second ubiquitin ligase adaptor, KEAP1, which functions to regulate the ubiquitination of the transcription factor NRF2, a key control point in the antioxidant response. Surprisingly, we find that unlike its ability to promote the ubiquitination of beta-catenin, WTX inhibits the ubiquitination of NRF2. WTX and NRF2 compete for binding to KEAP1, and thus loss of WTX leads to rapid ubiquitination and degradation of NRF2 and a reduced response to cytotoxic insult. These results expand our understanding of the molecular mechanisms of WTX and reveal a novel regulatory mechanism governing the antioxidant response.	[Camp, Nathan D.; James, Richard G.; Moon, Randall T.] Univ Washington, Howard Hughes Med Inst, Sch Med, Dept Pharmacol,Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA; [Dawson, David W.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Yan, Feng; Davison, James M.; Houck, Scott A.; Major, Michael B.] Univ N Carolina, Sch Med, Dept Cell & Dev Biol, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Major, MB (corresponding author), 450 West Dr,Rm 31-351, Chapel Hill, NC 27599 USA.	ben_major@med.unc.edu; rtmoon@uw.edu	Moon, Randall/M-5605-2019; Moon, Randall T/B-1743-2014; Dawson, David/I-5917-2014	Moon, Randall/0000-0002-9352-1408; Moon, Randall T/0000-0002-9352-1408; Major, Michael/0000-0002-6753-8513; james, richard/0000-0002-2302-7367	National Institutes of Health from USPHS [T32 GM07270]; NRSA; NATIONAL CANCER INSTITUTE [R01CA107134] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL103768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007270] Funding Source: NIH RePORTER	National Institutes of Health from USPHS; NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant T32 GM07270 from USPHS and NRSA (to N.D.C.).; Supported by a National Institutes of Health Directors New Innovator Award and a Sidney Kimmel Scholar Award. To whom correspondence may be addressed: 450 West Dr., Rm. 31-351, Chapel Hill, NC 27599. Tel.: 919-259-2695; E-mail: ben_major@med.unc.edu.	Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Chen WM, 2009, MOL CELL, V34, P663, DOI 10.1016/j.molcel.2009.04.029; Cohen AA, 2008, SCIENCE, V322, P1511, DOI 10.1126/science.1160165; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; Grohmann A, 2007, J CELL SCI, V120, P3738, DOI 10.1242/jcs.011320; Hayes JD, 2009, TRENDS BIOCHEM SCI, V34, P176, DOI 10.1016/j.tibs.2008.12.008; Homma S, 2009, CLIN CANCER RES, V15, P3423, DOI 10.1158/1078-0432.CCR-08-2822; Jenkins ZA, 2009, NAT GENET, V41, P95, DOI 10.1038/ng.270; Katoh Y, 2005, ARCH BIOCHEM BIOPHYS, V433, P342, DOI 10.1016/j.abb.2004.10.012; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kim MKH, 2011, ONCOGENE, V30, P832, DOI 10.1038/onc.2010.452; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kobayashi M, 2002, GENES CELLS, V7, P807, DOI 10.1046/j.1365-2443.2002.00561.x; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Lee JM, 2001, J BIOL CHEM, V276, P20011, DOI 10.1074/jbc.M100734200; Liu CM, 1999, P NATL ACAD SCI USA, V96, P6273, DOI 10.1073/pnas.96.11.6273; Lo SC, 2006, EMBO J, V25, P3605, DOI 10.1038/sj.emboj.7601243; Major MB, 2007, SCIENCE, V316, P1043, DOI 10.1126/science/1141515; McMahon M, 2004, J BIOL CHEM, V279, P31556, DOI 10.1074/jbc.M403061200; Moisan A, 2011, DEV CELL, V20, P583, DOI 10.1016/j.devcel.2011.03.013; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nguyen T, 2003, J BIOL CHEM, V278, P4536, DOI 10.1074/jbc.M207293200; Ogura T, 2010, P NATL ACAD SCI USA, V107, P2842, DOI 10.1073/pnas.0914036107; Owen C, 2008, HAEMATOLOGICA, V93, P947, DOI 10.3324/haematol.12509; Padmanabhan B, 2006, MOL CELL, V21, P689, DOI 10.1016/j.molcel.2006.01.013; Perdu B, 2010, J BONE MINER RES, V25, P82, DOI 10.1359/jbmr.090707; Perotti D, 2008, ONCOGENE, V27, P4625, DOI 10.1038/onc.2008.93; Rada P, 2011, MOL CELL BIOL, V31, P1121, DOI 10.1128/MCB.01204-10; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Rivera MN, 2007, SCIENCE, V315, P642, DOI 10.1126/science.1137509; Rivera MN, 2009, P NATL ACAD SCI USA, V106, P8338, DOI 10.1073/pnas.0811349106; Ruteshouser EC, 2008, GENE CHROMOSOME CANC, V47, P461, DOI 10.1002/gcc.20553; Singh A, 2006, PLOS MED, V3, P1865, DOI 10.1371/journal.pmed.0030420; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Tanneberger K, 2011, EMBO J, V30, P1433, DOI 10.1038/emboj.2011.28; Tong KI, 2006, MOL CELL BIOL, V26, P2887, DOI 10.1128/MCB.26.8.2887-2900.2006; van Amerongen R, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.135re9; Venugopal R, 1996, P NATL ACAD SCI USA, V93, P14960, DOI 10.1073/pnas.93.25.14960; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Yamamoto T, 2008, MOL CELL BIOL, V28, P2758, DOI 10.1128/MCB.01704-07; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004; Zipper LM, 2002, J BIOL CHEM, V277, P36544, DOI 10.1074/jbc.M206530200	44	78	84	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6539	6550		10.1074/jbc.M111.316471	http://dx.doi.org/10.1074/jbc.M111.316471			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22215675	hybrid, Green Published			2022-12-27	WOS:000300791800042
J	Cardarelli, F; Tosti, L; Serresi, M; Beltram, F; Bizzarri, R				Cardarelli, Francesco; Tosti, Luca; Serresi, Michela; Beltram, Fabio; Bizzarri, Ranieri			Fluorescent Recovery after Photobleaching (FRAP) Analysis of Nuclear Export Rates Identifies Intrinsic Features of Nucleocytoplasmic Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PORE COMPLEX; FACILITATED TRANSPORT; CYTOPLASM; DOMAIN; SIGNAL; CELLS; CRM1; REV	A quantitative description of carrier-mediated nuclear export in live cells is presented. To this end, we fused a prototypical leucine-rich nuclear export signal (NES) to GFP as a cargo model and expressed the fluorescent chimera in live CHO-K1 cells. By modeling FRAP data, we calculate the NES affinity for the export machinery and the maximum rate of nuclear export achievable at saturation of endogenous carriers. The measured active-export time through the Nuclear Pore Complex (NPC) is 18 ms, remarkably similar to the previously determined active-import rate. Also, our results reveal that active export/import and active export/passive diffusion fluxes are uncoupled, thus complementing previous reports on active import/passive diffusion uncoupling. These findings suggest differential gating at the NPC level.	[Cardarelli, Francesco; Serresi, Michela; Beltram, Fabio; Bizzarri, Ranieri] Ist Italiano Tecnol, Ctr Nanotechnol Innovat NEST, I-56124 Pisa, Italy; [Tosti, Luca; Beltram, Fabio; Bizzarri, Ranieri] Scuola Normale Super Pisa, NEST, I-56124 Pisa, Italy; [Tosti, Luca; Beltram, Fabio; Bizzarri, Ranieri] Ist Nanosci CNR, I-56124 Pisa, Italy	Istituto Italiano di Tecnologia - IIT; Scuola Normale Superiore di Pisa; Consiglio Nazionale delle Ricerche (CNR); Istituto Nanoscienze (NANO-CNR)	Bizzarri, R (corresponding author), Ist Biofis CNR, Via Moruzzi 1, I-56124 Pisa, Italy.	r.bizzarri@sns.it	Beltram, Fabio/L-9486-2019; Beltram, Fabio/F-2920-2013; Bizzarri, Ranieri/H-1779-2011; Bizzarri, Ranieri/ABH-8343-2020	Beltram, Fabio/0000-0002-6081-436X; Beltram, Fabio/0000-0002-6081-436X; Bizzarri, Ranieri/0000-0002-8222-2672; Tosti, Luca/0000-0003-2941-965X	Italian Ministry for University and Research (MIUR) [RBLA03ER38, RBPR05JH2P, 2008JZ4MLB]	Italian Ministry for University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR))	This work was supported in part by the Italian Ministry for University and Research (MIUR) under the framework of the FIRB Projects RBLA03ER38 and RBPR05JH2P, and PRIN 2008JZ4MLB.	Cardarelli F, 2008, TRAFFIC, V9, P528, DOI 10.1111/j.1600-0854.2007.00696.x; Cardarelli F, 2011, BIOPHYS J, V101, pL27, DOI 10.1016/j.bpj.2011.04.057; Cardarelli F, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.203083; Cardarelli F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010475; Cardarelli F, 2009, J BIOL CHEM, V284, P36638, DOI 10.1074/jbc.M109.036699; Conti E, 2006, CURR OPIN STRUC BIOL, V16, P237, DOI 10.1016/j.sbi.2006.03.010; Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106; Daelemans D, 2005, MOL CELL BIOL, V25, P728, DOI 10.1128/MCB.25.2.728-739.2005; DINGWALL C, 1982, CELL, V30, P449, DOI 10.1016/0092-8674(82)90242-2; Dong XH, 2009, NATURE, V458, P1136, DOI 10.1038/nature07975; Fahrenkrog B, 2003, NAT REV MOL CELL BIO, V4, P757, DOI 10.1038/nrm1230; FISCHER U, 1995, CELL, V82, P475, DOI 10.1016/0092-8674(95)90436-0; Fiserova J, 2010, J CELL SCI, V123, P2773, DOI 10.1242/jcs.070730; Frey S, 2006, SCIENCE, V314, P815, DOI 10.1126/science.1132516; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Lim RYH, 2007, SCIENCE, V318, P640, DOI 10.1126/science.1145980; Lindsay ME, 2001, J CELL BIOL, V153, P1391, DOI 10.1083/jcb.153.7.1391; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; Naim B, 2007, J BIOL CHEM, V282, P3881, DOI 10.1074/jbc.M608329200; Neville M, 1997, CURR BIOL, V7, P767, DOI 10.1016/S0960-9822(06)00335-6; PAINE PL, 1975, J CELL BIOL, V66, P652, DOI 10.1083/jcb.66.3.652; Paraskeva E, 1999, J CELL BIOL, V145, P255, DOI 10.1083/jcb.145.2.255; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; Ribbeck K, 2002, EMBO J, V21, P2664, DOI 10.1093/emboj/21.11.2664; Ribbeck K, 2001, EMBO J, V20, P1320, DOI 10.1093/emboj/20.6.1320; Walde S, 2010, TRENDS CELL BIOL, V20, P461, DOI 10.1016/j.tcb.2010.05.001; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; Wente SR, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000562	29	16	16	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5554	5561		10.1074/jbc.M111.304899	http://dx.doi.org/10.1074/jbc.M111.304899			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22190681	Green Published, hybrid			2022-12-27	WOS:000300638000034
J	Heinhuis, B; Koenders, MI; van den Berg, WB; Netea, MG; Dinarello, CA; Joosten, LAB				Heinhuis, Bas; Koenders, Marije I.; van den Berg, Wim B.; Netea, Mihai G.; Dinarello, Charles A.; Joosten, Leo A. B.			Interleukin 32 (IL-32) Contains a Typical alpha-Helix Bundle Structure That Resembles Focal Adhesion Targeting Region of Focal Adhesion Kinase-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST-LIKE SYNOVIOCYTES; INDUCED CELL-DEATH; A VIRUS-INFECTION; RHEUMATOID-ARTHRITIS; PROINFLAMMATORY CYTOKINE; INTEGRIN ALPHA-V-BETA-3; TYROSINE KINASE; RGD-PEPTIDES; CROSS-TALK; I-TASSER	IL-32 can be expressed in several isoforms. The amino acid sequences of the major IL-32 isoforms were used to predict the secondary and tertiary protein structure by I-TASSER software. The secondary protein structure revealed coils and alpha-helixes, but no beta sheets. Furthermore, IL-32 contains an RGD motif, which potentially activates procaspase-3 intracellular and or binds to integrins. Mutation of the RGD motif did not result in inhibition of the IL-32 beta- or IL-32 gamma-induced cytotoxicity mediated through caspase-3. Although IL-32 alpha interacted with the extracellular part of alpha V beta 3 and alpha V beta 6 integrins, only the alpha V beta 3 binding was inhibited by small RGD peptides. Additionally, IL-32 beta was able to bind to alpha V beta 3 integrins, whereas this binding was not inhibited by small RGD peptides. In addition to the IL-32/integrin interactions, we observed that IL-32 is also able to interact with intracellular proteins that are involved in integrin and focal adhesion signaling. Modeling of IL-32 revealed a distinct alpha-helix protein resembling the focal adhesion targeting region of focal adhesion kinase (FAK). Inhibition of FAK resulted in modulation of the IL-32 beta- or IL-32 gamma-induced cytotoxicity. Interestingly, IL-32 alpha binds to paxillin without the RGD motif being involved. Finally, FAK inhibited IL-32 alpha/paxillin binding, whereas FAK also could interact with IL-32 alpha, demonstrating that IL-32 is a member of the focal adhesion protein complex. This study demonstrates for the first time that IL-32 binds to the extracellular domain of integrins and to intracellular proteins like paxillin and FAK, suggesting a dual role for IL-32 in integrin signaling.	[Netea, Mihai G.; Dinarello, Charles A.; Joosten, Leo A. B.] Radboud Univ Nijmegen, Med Ctr, Dept Med, NL-6500 HB Nijmegen, Netherlands; [Netea, Mihai G.; Joosten, Leo A. B.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Inst Infect Inflammat & Immun, NL-6500 HB Nijmegen, Netherlands; [Heinhuis, Bas; Koenders, Marije I.; van den Berg, Wim B.] Radboud Univ Nijmegen, Med Ctr, Dept Rheumatol, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Joosten, LAB (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Med, POB 9101, NL-6500 HB Nijmegen, Netherlands.	l.joosten@aig.umcn.nl	Dinarello, Charles/C-8524-2013; Netea, Mihai/N-5155-2014; Heinhuis, Bas/G-6076-2016; Joosten, Leo AB/H-3138-2015; van den Berg, W.B./H-8010-2014; Koenders, Marije I/A-1341-2012	Joosten, Leo AB/0000-0001-6166-9830; Koenders, Marije I/0000-0001-5845-8362	National Institutes of Health [AI-15614]; Dutch Arthritis Association [06-1-301]; Netherlands Organization for Scientific Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI015614, R01AI015614, R56AI015614] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dutch Arthritis Association; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI-15614 (to C. A. D.).; Supported by Dutch Arthritis Association Grant 06-1-301.; Supported by a Vici grant from The Netherlands Organization for Scientific Research.	Abram CL, 2009, ANNU REV IMMUNOL, V27, P339, DOI 10.1146/annurev.immunol.021908.132554; Aguzzi MS, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-84; Bai XY, 2010, J IMMUNOL, V184, P3830, DOI 10.4049/jimmunol.0901913; Beierle EA, 2010, CELL CYCLE, V9, P1005, DOI 10.4161/cc.9.5.10936; Broxterman HJ, 1999, DRUG RESIST UPDATE, V2, P139, DOI 10.1054/drup.1999.0081; Buckley CD, 1999, NATURE, V397, P534, DOI 10.1038/17409; Cagnard N, 2005, EUR CYTOKINE NETW, V16, P289; Calabrese F, 2008, AM J RESP CRIT CARE, V178, P894, DOI 10.1164/rccm.200804-646OC; DAHL CA, 1992, J IMMUNOL, V148, P597; Dinarello CA, 2006, ANN RHEUM DIS, V65, P61, DOI 10.1136/ard.2006.058511; DSOUZA SE, 1991, TRENDS BIOCHEM SCI, V16, P246, DOI 10.1016/0968-0004(91)90096-E; DU XP, 1991, CELL, V65, P409, DOI 10.1016/0092-8674(91)90458-B; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Gilmore AP, 1996, MOL BIOL CELL, V7, P1209, DOI 10.1091/mbc.7.8.1209; Goda C, 2006, INT IMMUNOL, V18, P233, DOI 10.1093/intimm/dxh339; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hasegawa H, 2011, CYTOKINE, V53, P74, DOI 10.1016/j.cyto.2010.09.002; Hayashi I, 2002, NAT STRUCT BIOL, V9, P101, DOI 10.1038/nsb755; HAYMAN EG, 1985, EXP CELL RES, V160, P245, DOI 10.1016/0014-4827(85)90173-9; Heinhuis B, 2011, P NATL ACAD SCI USA, V108, P4962, DOI 10.1073/pnas.1016005108; Heinhuis B, 2011, ANN RHEUM DIS, V70, P660, DOI 10.1136/ard.2010.139196; Heinhuis B, 2010, ANN RHEUM DIS, V69, P1866, DOI 10.1136/ard.2009.127399; Hochwald SN, 2009, CELL CYCLE, V8, P2435, DOI 10.4161/cc.8.15.9145; Joosten LAB, 2006, P NATL ACAD SCI USA, V103, P3298, DOI 10.1073/pnas.0511233103; Kim SH, 2005, IMMUNITY, V22, P131, DOI 10.1016/j.immuni.2004.12.003; Kim S, 2008, BMB REP, V41, P814, DOI 10.5483/BMBRep.2008.41.11.814; Kim YG, 2010, ARTHRITIS RHEUM-US, V62, P515, DOI 10.1002/art.27197; Li W, 2010, J IMMUNOL, V185, P5056, DOI 10.4049/jimmunol.0902667; Li W, 2009, EUR J IMMUNOL, V39, P1019, DOI 10.1002/eji.200838885; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001985; Lietha D, 2007, CELL, V129, P1177, DOI 10.1016/j.cell.2007.05.041; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Mabilleau G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004173; Majid S, 2010, CANCER-AM CANCER SOC, V116, P5637, DOI 10.1002/cncr.25488; Marcondes AM, 2008, P NATL ACAD SCI USA, V105, P2865, DOI 10.1073/pnas.0712391105; Matsuki K, 2008, J ORTHOP SCI, V13, P524, DOI 10.1007/s00776-008-1281-z; Millard M, 2011, THERANOSTICS, V1, P154, DOI 10.7150/thno/v01p0154; Mould AP, 2003, J BIOL CHEM, V278, P39993, DOI 10.1074/jbc.M304627200; Mun SH, 2009, ARTHRITIS RHEUM-US, V60, P678, DOI 10.1002/art.24299; Neff L, 2003, J BIOL CHEM, V278, P27721, DOI 10.1074/jbc.M212065200; Netea MG, 2005, P NATL ACAD SCI USA, V102, P16309, DOI 10.1073/pnas.0508237102; Netea MG, 2008, P NATL ACAD SCI USA, V105, P3515, DOI 10.1073/pnas.0712381105; Netea MG, 2006, PLOS MED, V3, P1310, DOI 10.1371/journal.pmed.0030277; Nishida A, 2009, J BIOL CHEM, V284, P17868, DOI 10.1074/jbc.M900368200; Nolan K, 1999, MOL CELL BIOL, V19, P6120; Nold MF, 2008, J IMMUNOL, V181, P557, DOI 10.4049/jimmunol.181.1.557; Nold-Petry CA, 2009, P NATL ACAD SCI USA, V106, P3883, DOI 10.1073/pnas.0813334106; Novick D, 2006, P NATL ACAD SCI USA, V103, P3316, DOI 10.1073/pnas.0511206103; Parsons JT, 2000, ONCOGENE, V19, P5606, DOI 10.1038/sj.onc.1203877; PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0; Porter AG, 2006, NAT CHEM BIOL, V2, P509, DOI 10.1038/nchembio1006-509; PYTELA R, 1985, P NATL ACAD SCI USA, V82, P5766, DOI 10.1073/pnas.82.17.5766; PYTELA R, 1985, CELL, V40, P191, DOI 10.1016/0092-8674(85)90322-8; Rasool ST, 2008, IMMUNOL LETT, V117, P161, DOI 10.1016/j.imlet.2008.01.007; Richards S, 2008, TISSUE ENG PT C-METH, V14, P221, DOI 10.1089/ten.tec.2007.0428; Richardson A, 1996, NATURE, V380, P538, DOI 10.1038/380538a0; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Semaan N, 2008, J IMMUNOL, V180, P3485, DOI 10.4049/jimmunol.180.5.3485; Seo EH, 2008, J MICROBIOL BIOTECHN, V18, P1606; Shimaoka M, 2003, NAT REV DRUG DISCOV, V2, P703, DOI 10.1038/nrd1174; Shioya M, 2007, CLIN EXP IMMUNOL, V149, P480, DOI 10.1111/j.1365-2249.2007.03439.x; Shoda H, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2074; Slack-Davis JK, 2007, J BIOL CHEM, V282, P14845, DOI 10.1074/jbc.M606695200; Sorrentino C, 2009, AM J RESP CRIT CARE, V180, P769, DOI 10.1164/rccm.200903-0400OC; Stupp R, 2007, J CLIN ONCOL, V25, P1637, DOI 10.1200/JCO.2006.09.8376; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Wilder RL, 2002, ANN RHEUM DIS, V61, P96, DOI 10.1136/ard.61.suppl_2.ii96; Witko-Sarsat V, 1999, J AM SOC NEPHROL, V10, P1224; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Xu LH, 2000, J BIOL CHEM, V275, P30597, DOI 10.1074/jbc.M910027199; Zeisel MB, 2005, J IMMUNOL, V174, P7393, DOI 10.4049/jimmunol.174.11.7393; Zepp JA, 2011, J IMMUNOL, V186, P4110, DOI 10.4049/jimmunol.1000081; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	74	62	64	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5733	5743		10.1074/jbc.M111.288290	http://dx.doi.org/10.1074/jbc.M111.288290			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22203669	hybrid, Green Published			2022-12-27	WOS:000300638000049
J	Liu, YC; Dos Santos, PC; Zhu, X; Orlando, R; Dean, DR; Soll, D; Yuan, J				Liu, Yuchen; Dos Santos, Patricia C.; Zhu, Xiang; Orlando, Ron; Dean, Dennis R.; Soell, Dieter; Yuan, Jing			Catalytic Mechanism of Sep-tRNA:Cys-tRNA Synthase SULFUR TRANSFER IS MEDIATED BY DISULFIDE AND PERSULFIDE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARCHAEON METHANOCOCCUS-MARIPALUDIS; DEPENDENT CYSTEINE BIOSYNTHESIS; ESCHERICHIA-COLI; CYS-TRNA(CYS) FORMATION; SELENOCYSTEINE; 4-THIOURIDINE; PROTEINS; RESIDUES; REVEALS; COMPLEX	Sep-tRNA: Cys-tRNA synthase (SepCysS) catalyzes the sulfhydrylation of tRNA-boundO-phosphoserine (Sep) to form cysteinyl-tRNA(Cys) (Cys-tRNA(Cys)) in methanogens that lack the canonical cysteinyl-tRNA synthetase (CysRS). A crystal structure of the Archaeoglobus fulgidus SepCysS apoenzyme provides information on the binding of the pyridoxal phosphate cofactor as well as on amino acid residues that may be involved in substrate binding. However, the mechanism of sulfur transfer to form cysteine was not known. Using an in vivo Escherichia coli complementation assay, we showed that all three highly conserved Cys residues in SepCysS (Cys(64), Cys(67), and Cys(272) in the Methanocaldococcus jannaschii enzyme) are essential for the sulfhydrylation reaction in vivo. Biochemical and mass spectrometric analysis demonstrated that Cys(64) and Cys(67) form a disulfide linkage and carry a sulfane sulfur in a portion of the enzyme. These results suggest that a persulfide group (containing a sulfane sulfur) is the proximal sulfur donor for cysteine biosynthesis. The presence of Cys(272) increased the amount of sulfane sulfur in SepCysS by 3-fold, suggesting that this Cys residue facilitates the generation of the persulfide group. Based upon these findings, we propose for SepCysS a sulfur relay mechanism that recruits both disulfide and persulfide intermediates.	[Liu, Yuchen; Soell, Dieter; Yuan, Jing] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Dos Santos, Patricia C.] Wake Forest Univ, Dept Chem, Winston Salem, NC 27109 USA; [Zhu, Xiang; Orlando, Ron] Univ Georgia, Dept Chem, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Dean, Dennis R.] Virginia Tech, Dept Biochem, Blacksburg, VA 24060 USA; [Soell, Dieter] Yale Univ, Dept Chem, New Haven, CT 06520 USA	Yale University; Wake Forest University; University System of Georgia; University of Georgia; Virginia Polytechnic Institute & State University; Yale University	Soll, D (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA.	dieter.soll@yale.edu; yuanj@msn.com	Yuan, Jing/ABB-3977-2021	Yuan, Jing/0000-0003-1219-3316; Dos Santos, Patricia/0000-0002-3364-0931; Liu, Yuchen/0000-0003-0842-5882	National Institutes of Health [P41-RR-018502]; Department of Energy Office of Basic Energy Sciences [DE-FG02-98ER20311]; NIGMS/National Institutes of Health [GM22854]; National Science Foundation [MCB-071770]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR018502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM022854, R37GM022854] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy Office of Basic Energy Sciences(United States Department of Energy (DOE)); NIGMS/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant P41-RR-018502 (to R. O.). This work was also supported by Department of Energy Office of Basic Energy Sciences Grant DE-FG02-98ER20311 and NIGMS/National Institutes of Health Grant GM22854 (to D. S.) and National Science Foundation Grant MCB-071770 (to D. R. D.).	Ambrogelly A, 2004, CELL MOL LIFE SCI, V61, P2437, DOI 10.1007/s00018-004-4194-9; CAVALLINI D, 1970, EUR J BIOCHEM, V14, P169, DOI 10.1111/j.1432-1033.1970.tb00275.x; Fukunaga R, 2007, J MOL BIOL, V370, P128, DOI 10.1016/j.jmb.2007.04.050; Hauenstein SI, 2008, J BIOL CHEM, V283, P22007, DOI 10.1074/jbc.M801839200; Helgadottir S, 2012, FEBS LETT, V586, P60, DOI 10.1016/j.febslet.2011.11.024; Hidese R, 2011, APPL MICROBIOL BIOT, V91, P47, DOI 10.1007/s00253-011-3336-x; HUDSON EN, 1973, BIOCHEMISTRY-US, V12, P4154, DOI 10.1021/bi00745a019; JOHNSON R. J., 1970, Methods in Enzymology, V18A, P433, DOI 10.1016/0076-6879(71)18345-0; Kambampati R, 2003, BIOCHEMISTRY-US, V42, P1109, DOI 10.1021/bi026536+; Kato S, 2002, P NATL ACAD SCI USA, V99, P5948, DOI 10.1073/pnas.082123599; Kessler D, 2006, FEMS MICROBIOL REV, V30, P825, DOI 10.1111/j.1574-6976.2006.00036.x; Lacourciere GM, 2002, P NATL ACAD SCI USA, V99, P9150, DOI 10.1073/pnas.142291199; Li T, 1999, FEBS LETT, V462, P302, DOI 10.1016/S0014-5793(99)01550-1; Liu YC, 2010, J BIOL CHEM, V285, P31923, DOI 10.1074/jbc.M110.152447; MCFARLAN SC, 1992, J BIOL CHEM, V267, P10561; Mihara H, 2002, APPL MICROBIOL BIOT, V60, P12, DOI 10.1007/s00253-002-1107-4; Mueller EG, 2006, NAT CHEM BIOL, V2, P185, DOI 10.1038/nchembio779; Mueller EG, 2001, J BIOL CHEM, V276, P33588, DOI 10.1074/jbc.M104067200; NEWTON GL, 1985, J BACTERIOL, V161, P438, DOI 10.1128/JB.161.1.438-441.1985; Numata T, 2006, NATURE, V442, P419, DOI 10.1038/nature04896; O'Donoghue P, 2005, P NATL ACAD SCI USA, V102, P19003, DOI 10.1073/pnas.0509617102; Palioura S, 2009, SCIENCE, V325, P321, DOI 10.1126/science.1173755; Pedrioli PGA, 2004, NAT BIOTECHNOL, V22, P1459, DOI 10.1038/nbt1031; RIDDLES PW, 1983, METHOD ENZYMOL, V91, P49; Sauerwald A, 2005, SCIENCE, V307, P1969, DOI 10.1126/science.1108329; Sheppard K, 2008, NUCLEIC ACIDS RES, V36, P1813, DOI 10.1093/nar/gkn015; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SORBO B, 1957, BIOCHIM BIOPHYS ACTA, V24, P324, DOI 10.1016/0006-3002(57)90201-9; Stathopoulos C, 2001, P NATL ACAD SCI USA, V98, P14292, DOI 10.1073/pnas.201540498; Wright CM, 2006, CHEM COMMUN, P3104, DOI 10.1039/b604040c; Yuan J, 2006, P NATL ACAD SCI USA, V103, P18923, DOI 10.1073/pnas.0609703104; Yuan J, 2010, FEBS LETT, V584, P2857, DOI 10.1016/j.febslet.2010.05.028	32	14	16	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5426	5433		10.1074/jbc.M111.313700	http://dx.doi.org/10.1074/jbc.M111.313700			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22167197	Green Published, hybrid			2022-12-27	WOS:000300638000023
J	Rittiner, JE; Korboukh, I; Hull-Ryde, EA; Jin, J; Janzen, WP; Frye, SV; Zylka, MJ				Rittiner, Joseph E.; Korboukh, Ilia; Hull-Ryde, Emily A.; Jin, Jian; Janzen, William P.; Frye, Stephen V.; Zylka, Mark J.			AMP Is an Adenosine A(1) Receptor Agonist	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENINE-NUCLEOTIDES; HETEROMERIC ASSOCIATION; DORSAL HORN; ATP; ACTIVATION; CELLS; DERIVATIVES; CONVERSION; NEUROTRANSMISSION; IDENTIFICATION	Numerous receptors for ATP, ADP, and adenosine exist; however, it is currently unknown whether a receptor for the related nucleotide adenosine 5'-monophosphate (AMP) exists. Using a novel cell-based assay to visualize adenosine receptor activation in real time, we found that AMP and a non-hydrolyzable AMP analog (deoxyadenosine 5'-monophosphonate, ACP) directly activated the adenosine A(1) receptor (A(1)R). In contrast, AMP only activated the adenosine A(2B) receptor (A(2B)R) after hydrolysis to adenosine by ecto-5'-nucleotidase (NT5E, CD73) or prostatic acid phosphatase (PAP, ACPP). Adenosine and AMP were equipotent human A(1)R agonists in our real-time assay and in a cAMP accumulation assay. ACP also depressed cAMP levels in mouse cortical neurons through activation of endogenous A(1)R. Non-selective purinergic receptor antagonists (pyridoxalphosphate-6-azophenyl-2',4'-disulfonic acid and suramin) did not block adenosine-or AMP-evoked activation. Moreover, mutation of His-251 in the human A(1)R ligand binding pocket reduced AMP potency without affecting adenosine potency. In contrast, mutation of a different binding pocket residue (His-278) eliminated responses to AMP and to adenosine. Taken together, our study indicates that the physiologically relevant nucleotide AMP is a full agonist of A(1)R. In addition, our study suggests that some of the physiological effects of AMP may be direct, and not indirect through ectonucleotidases that hydrolyze this nucleotide to adenosine.	[Zylka, Mark J.] Univ N Carolina, Dept Cell & Mol Physiol, Ctr Neurosci, Chapel Hill, NC 27599 USA; [Korboukh, Ilia; Hull-Ryde, Emily A.; Jin, Jian; Janzen, William P.; Frye, Stephen V.] Univ N Carolina, Ctr Integrat Chem Biol & Drug Discovery, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Zylka, MJ (corresponding author), Univ N Carolina, Dept Cell & Mol Physiol, Ctr Neurosci, 5109A NRB,CB 7545, Chapel Hill, NC 27599 USA.	zylka@med.unc.edu			National Institutes of Health from the NINDS [R01NS060725, R01NS067688]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067688, R01NS060725] Funding Source: NIH RePORTER	National Institutes of Health from the NINDS; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01NS060725 and R01NS067688 from the NINDS (to M. J. Z.).	Abbracchio MP, 2005, TRENDS PHARMACOL SCI, V26, P8, DOI 10.1016/j.tips.2004.10.010; Arcuino G, 2002, P NATL ACAD SCI USA, V99, P9840, DOI 10.1073/pnas.152588599; Ashton TD, 2008, BIOORGAN MED CHEM, V16, P1861, DOI 10.1016/j.bmc.2007.11.010; Boyer JL, 1996, BRIT J PHARMACOL, V118, P1959, DOI 10.1111/j.1476-5381.1996.tb15630.x; BRUNS RF, 1980, N-S ARCH PHARMACOL, V315, P5, DOI 10.1007/BF00504224; Burnstock G, 2007, PHYSIOL REV, V87, P659, DOI 10.1152/physrev.00043.2006; Cappellacci L, 2008, BIOORGAN MED CHEM, V16, P336, DOI 10.1016/j.bmc.2007.09.035; Cooper J, 1997, BRIT J PHARMACOL, V122, P546, DOI 10.1038/sj.bjp.0701401; Coward P, 1999, ANAL BIOCHEM, V270, P242, DOI 10.1006/abio.1999.4061; Dalpiaz A, 2001, PHARM RES-DORDR, V18, P531, DOI 10.1023/A:1011018730459; Daniels IS, 2010, J BIOL CHEM, V285, P20716, DOI 10.1074/jbc.M109.090845; Dulla CG, 2005, NEURON, V48, P1011, DOI 10.1016/j.neuron.2005.11.009; Dunwiddie TV, 1997, J NEUROSCI, V17, P7673; El-Tayeb A, 2009, J MED CHEM, V52, P7669, DOI 10.1021/jm900538v; Elzein E, 2008, EXPERT OPIN INV DRUG, V17, P1901, DOI [10.1517/13543780802497284, 10.1517/13543780802497284 ]; Fredholm BB, 2001, PHARMACOL REV, V53, P527; Gao N, 2007, AM J PHYSIOL-GASTR L, V292, pG492, DOI 10.1152/ajpgi.00257.2006; GERWINS P, 1990, MOL PHARMACOL, V38, P660; Halassa MM, 2009, NEURON, V61, P213, DOI 10.1016/j.neuron.2008.11.024; Inbe H, 2004, J BIOL CHEM, V279, P19790, DOI 10.1074/jbc.M400360200; Jacobson KA, 2006, NAT REV DRUG DISCOV, V5, P247, DOI 10.1038/nrd1983; Kumar TS, 2010, J MED CHEM, V53, P2562, DOI 10.1021/jm9018542; Lebon G, 2011, NATURE, V474, P521, DOI 10.1038/nature10136; LEE KS, 1981, NEUROSCI LETT, V23, P309, DOI 10.1016/0304-3940(81)90016-1; MAILLARD MC, 1994, J PHARM SCI, V83, P46, DOI 10.1002/jps.2600830112; MOODY CJ, 1984, EUR J PHARMACOL, V97, P47, DOI 10.1016/0014-2999(84)90511-9; Mustafa SJ, 2007, J PHARMACOL EXP THER, V320, P1246, DOI 10.1124/jpet.106.112250; NAITO Y, 1985, BIOCHEM J, V226, P645, DOI 10.1042/bj2260645; Nakata H, 2005, J MOL NEUROSCI, V26, P233, DOI 10.1385/JMN:26:2-3:233; Ohkubo S, 2000, BRIT J PHARMACOL, V131, P1667, DOI 10.1038/sj.bjp.0703750; OLAH ME, 1992, J BIOL CHEM, V267, P10764; Patterson SL, 2001, J NEUROCHEM, V76, P234, DOI 10.1046/j.1471-4159.2001.00016.x; PIROTTON S, 1993, EUR J PHARMACOL, V241, P55, DOI 10.1016/0014-2999(93)90932-8; Qi Ai-Dong, 2004, Purinergic Signal, V1, P67, DOI 10.1007/s11302-004-5069-0; RAGAZZI E, 1991, CIRC RES, V68, P1035, DOI 10.1161/01.RES.68.4.1035; SALTER MW, 1985, NEUROSCIENCE, V15, P815, DOI 10.1016/0306-4522(85)90080-6; Schachter JB, 1997, NEUROPHARMACOLOGY, V36, P1181, DOI 10.1016/S0028-3908(97)00138-X; Schenone S, 2010, CURR TOP MED CHEM, V10, P878, DOI 10.2174/156802610791268729; Sowa NA, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-20; Street SE, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-80; Suzuki T, 2006, BIOCHEM BIOPH RES CO, V351, P559, DOI 10.1016/j.bbrc.2006.10.075; Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793; Yoshioka K, 2001, P NATL ACAD SCI USA, V98, P7617, DOI 10.1073/pnas.121587098; Zhang JF, 2006, NATURE, V439, P340, DOI 10.1038/nature04368; Zhang JY, 2003, EUR J PHARMACOL, V472, P33, DOI 10.1016/S0014-2999(03)01855-7; Zhou SY, 2010, J PHARMACOL EXP THER, V333, P920, DOI 10.1124/jpet.109.164376; Zimmermann H, 2000, N-S ARCH PHARMACOL, V362, P299, DOI 10.1007/s002100000309; Zylka MJ, 2008, NEURON, V60, P111, DOI 10.1016/j.neuron.2008.08.024; Zylka MJ, 2011, TRENDS MOL MED, V17, P188, DOI 10.1016/j.molmed.2010.12.006	49	99	105	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5301	5309		10.1074/jbc.M111.291666	http://dx.doi.org/10.1074/jbc.M111.291666			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22215671	Green Published, hybrid			2022-12-27	WOS:000300638000012
J	Saha, D; Khandelia, P; O'Keefe, RT; Vijayraghavan, U				Saha, Debjani; Khandelia, Piyush; O'Keefe, Raymond T.; Vijayraghavan, Usha			Saccharomyces cerevisiae NineTeen Complex (NTC)-associated Factor Bud31/Ycr063w Assembles on Precatalytic Spliceosomes and Improves First and Second Step Pre-mRNA Splicing Efficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRP19P-ASSOCIATED COMPLEX; MASS-SPECTROMETRY; SNRNP ADDITION; YEAST; PROTEIN; COMPONENTS; U5; IDENTIFICATION; ACTIVATION; INTERACTS	Pre-mRNA splicing occurs in spliceosomes whose assembly and activation are critical for splice site selection and catalysis. The highly conserved NineTeen complex protein complex stabilizes various snRNA and protein interactions early in the spliceosome assembly pathway. Among several NineTeen complex-associated proteins is the nonessential protein Bud31/Ycr063w, which is also a component of the Cef1p subcomplex. A role for Bud31 in pre-mRNA splicing is implicated by virtue of its association with splicing factors, but its specific functions and spliceosome interactions are uncharacterized. Here, using in vitro splicing assays with extracts from a strain lacking Bud31, we illustrate its role in efficient progression to the first catalytic step and its requirement for the second catalytic step in reactions at higher temperatures. Immunoprecipitation of functional epitope-tagged Bud31 from in vitro reactions showed that its earliest association is with precatalytic B complex and that the interaction continues in catalytically active complexes with stably bound U2, U5, and U6 small nuclear ribonucleoproteins. In complementary experiments, wherein precatalytic spliceosomes are selected from splicing reactions, we detect the occurrence of Bud31. Cross-linking of proteins to pre-mRNAs with a site-specific 4-thio uridine residue at the -3 position of exon 1 was tested in reactions with WT and bud31 null extracts. The data suggest an altered interaction between a similar to 25-kDa protein and this exonic residue of pre-mRNAs in the arrested bud31 null spliceosomes. These results demonstrate the early spliceosomal association of Bud31 and provide plausible functions for this factor in stabilizing protein interactions with the pre-mRNA.	[Saha, Debjani; Khandelia, Piyush; Vijayraghavan, Usha] Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India; [O'Keefe, Raymond T.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	Indian Institute of Science (IISC) - Bangalore; University of Manchester	Vijayraghavan, U (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India.	uvr@mcbl.iisc.ernet.in			Department of Biotechnology; Council of Scientific and Industrial Research, Government of India; International Relations Cell, IISc; Biotechnology and Biological Sciences Research Council (courtesy of The University of Manchester) for the stay in Manchester	Department of Biotechnology; Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); International Relations Cell, IISc; Biotechnology and Biological Sciences Research Council (courtesy of The University of Manchester) for the stay in Manchester(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by an infrastructure grant to the Indian Institute of Science (IISc) from the Department of Biotechnology (to U. V.); by scholarships (to D. S. and P. K.) from the Council of Scientific and Industrial Research, Government of India; and by a short term travel fellowship by the International Relations Cell, IISc, and funding from the Biotechnology and Biological Sciences Research Council (courtesy of The University of Manchester) for the stay in Manchester (to D. S.), which facilitated the UV cross-linking experiments.	ABOVICH N, 1994, GENE DEV, V8, P843, DOI 10.1101/gad.8.7.843; Ajuh P, 2000, EMBO J, V19, P6569, DOI 10.1093/emboj/19.23.6569; ANSARI A, 1995, EMBO J, V14, P4001, DOI 10.1002/j.1460-2075.1995.tb00071.x; Caspary F, 1998, EMBO J, V17, P6348, DOI 10.1093/emboj/17.21.6348; Chan SP, 2005, J BIOL CHEM, V280, P31190, DOI 10.1074/jbc.M505060200; Chan SP, 2003, SCIENCE, V302, P279, DOI 10.1126/science.1086602; Chen CH, 2002, NUCLEIC ACIDS RES, V30, P1029, DOI 10.1093/nar/30.4.1029; Chen CH, 2001, J BIOL CHEM, V276, P488, DOI 10.1074/jbc.M006958200; Chen HR, 1999, P NATL ACAD SCI USA, V96, P5406, DOI 10.1073/pnas.96.10.5406; Chen HR, 1998, MOL CELL BIOL, V18, P2196, DOI 10.1128/MCB.18.4.2196; CHENG SC, 1994, NUCLEIC ACIDS RES, V22, P1548, DOI 10.1093/nar/22.9.1548; CHENG SC, 1987, GENE DEV, V1, P1014, DOI 10.1101/gad.1.9.1014; Chiu YF, 2009, MOL CELL BIOL, V29, P5671, DOI 10.1128/MCB.00773-09; Chung SY, 1999, RNA, V5, P1042, DOI 10.1017/S1355838299990635; Fabrizio P, 2009, MOL CELL, V36, P593, DOI 10.1016/j.molcel.2009.09.040; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; HLA T, 1995, BBA-GENE STRUCT EXPR, V1260, P227, DOI 10.1016/0167-4781(94)00219-S; Hogg R, 2010, BIOCHEM SOC T, V38, P1110, DOI 10.1042/BST0381110; James SA, 2002, RNA, V8, P1068, DOI 10.1017/S1355838202022033; JONES MH, 1995, P NATL ACAD SCI USA, V92, P9687, DOI 10.1073/pnas.92.21.9687; Masciadri B, 2004, BIOCHEM BIOPH RES CO, V320, P1342, DOI 10.1016/j.bbrc.2004.05.228; McGrail JC, 2008, NUCLEIC ACIDS RES, V36, P814, DOI 10.1093/nar/gkm1098; McGrail JC, 2009, NUCLEIC ACIDS RES, V37, P4205, DOI 10.1093/nar/gkp341; MCGREW LL, 1989, GENE DEV, V3, P803, DOI 10.1101/gad.3.6.803; McPheeters DS, 2003, MOL CELL BIOL, V23, P4174, DOI 10.1128/MCB.23.12.4174-4186.2003; MOORE MJ, 1992, SCIENCE, V256, P992, DOI 10.1126/science.1589782; NEWMAN AJ, 1985, CELL, V42, P335, DOI 10.1016/S0092-8674(85)80129-X; Ohi MD, 2002, MOL CELL BIOL, V22, P2011, DOI 10.1128/MCB.22.7.2011-2024.2002; Sapra AK, 2008, BIOCHEM J, V416, P365, DOI 10.1042/BJ20081195; Seshadri V, 1996, GENETICS, V143, P45; Stevens SW, 1999, P NATL ACAD SCI USA, V96, P7226, DOI 10.1073/pnas.96.13.7226; Stevens SW, 2000, METHOD ENZYMOL, V318, P385; TARN WY, 1993, P NATL ACAD SCI USA, V90, P10821, DOI 10.1073/pnas.90.22.10821; TARN WY, 1994, EMBO J, V13, P2421, DOI 10.1002/j.1460-2075.1994.tb06527.x; TEIGELKAMP S, 1995, EMBO J, V14, P2602, DOI 10.1002/j.1460-2075.1995.tb07258.x; Tsai WY, 1999, J BIOL CHEM, V274, P9455, DOI 10.1074/jbc.274.14.9455; VIJAYRAGHAVAN U, 1989, GENE DEV, V3, P1206, DOI 10.1101/gad.3.8.1206; VIJAYRAGHAVAN U, 1990, MOL CELL BIOL, V10, P324, DOI 10.1128/MCB.10.1.324; VIJAYRAGHAVAN U, 1986, EMBO J, V5, P1683, DOI 10.1002/j.1460-2075.1986.tb04412.x; Wang Q, 2005, MOL CELL BIOL, V25, P10745, DOI 10.1128/MCB.25.24.10745-10754.2005; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901	41	12	12	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5390	5399		10.1074/jbc.M111.298547	http://dx.doi.org/10.1074/jbc.M111.298547			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22215661	Green Published, hybrid			2022-12-27	WOS:000300638000020
J	Wei, GZ; Yin, Y; Li, WM; Bito, H; She, H; Mao, ZX				Wei, Gengze; Yin, Yue; Li, Wenming; Bito, Haruhiko; She, Hua; Mao, Zixu			Calpain-mediated Degradation of Myocyte Enhancer Factor 2D Contributes to Excitotoxicity by Activation of Extrasynaptic N-Methyl-D-aspartate Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CEREBELLAR GRANULE NEURONS; TRANSCRIPTION FACTOR MEF2; NMDA RECEPTORS; CELL-DEATH; HIPPOCAMPAL-NEURONS; SURVIVAL; NEURODEGENERATION; APOPTOSIS; BLOCKADE; CLEAVAGE	Synaptic and extrasynaptic NMDA receptors (NMDARs) appear to play opposite roles in neuronal survival and death. Here we report the new findings on the dysregulation of survival factor, myocyte enhancer factor 2D (MEF2D), by extrasynaptic NMDARs. Excitotoxicity led to the NMDAR-dependent degradation of MEF2D protein and inhibition of its transactivation activity in mature cortical neurons. The activation of extrasynaptic NMDARs alone was sufficient for degradation of MEF2D. Calpain directly cleaved MEF2D in vitro and blocking this protease activity greatly attenuated NMDAR signaled degradation of MEF2D in neurons. Consistently, inhibition of calpain protected cortical neurons from NMDA-induced excitotoxicity. Furthermore, knockdown of MEF2D sensitized neurons to NMDA-induced excitotoxicity, which was not protected by calpain inhibition. Collectively, these findings suggest that dysregulation of MEF2D by calpain may mediate excitotoxicity via an extrasynaptic NMDAR-dependent manner.	[Wei, Gengze; Li, Wenming; She, Hua; Mao, Zixu] Emory Univ, Dept Pharmacol, Sch Med, Atlanta, GA 30322 USA; [Wei, Gengze; Li, Wenming; She, Hua; Mao, Zixu] Emory Univ, Dept Neurol, Sch Med, Atlanta, GA 30322 USA; [Bito, Haruhiko] Univ Tokyo, Dept Neurochem, Grad Sch Med, Tokyo 1130033, Japan; [Yin, Yue] Fourth Mil Med Univ, Xian 710032, Shaanxi, Peoples R China	Emory University; Emory University; University of Tokyo; Air Force Military Medical University	Mao, ZX (corresponding author), Emory Univ, Dept Pharmacol, Sch Med, Whitehead Bldg Rm505L,615 Michael St, Atlanta, GA 30322 USA.	zmao@pharm.emory.edu	Bito, Haruhiko/A-8635-2008; Wei, Gengze/B-3572-2014	Bito, Haruhiko/0000-0001-6315-9594	National Institutes of Health [AG023695, NS048254, ES015317, ES016731-002]; Michael J. Fox Foundation; Grants-in-Aid for Scientific Research [20670002] Funding Source: KAKEN; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES016731, R01ES015317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048254] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023695] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michael J. Fox Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by National Institutes of Health Grants AG023695, NS048254, ES015317, and ES016731-002 (to Z. M.). This work was also supported by the Michael J. Fox Foundation (to Z. M.).	Adams SM, 2004, J NEUROSCI, V24, P9441, DOI 10.1523/JNEUROSCI.3290-04.2004; Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; Bano D, 2005, CELL, V120, P275, DOI 10.1016/j.cell.2004.11.049; Battaglia F, 2003, J MOL NEUROSCI, V20, P357, DOI 10.1385/JMN:20:3:357; Bevers MB, 2009, J NEUROCHEM, V108, P1237, DOI 10.1111/j.1471-4159.2008.05860.x; Cui H, 2007, J NEUROSCI, V27, P9901, DOI 10.1523/JNEUROSCI.1464-07.2007; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Gong XM, 2003, NEURON, V38, P33, DOI 10.1016/S0896-6273(03)00191-0; GOULD E, 1994, J COMP NEUROL, V340, P551, DOI 10.1002/cne.903400408; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hardingham GE, 2009, BIOCHEM SOC T, V37, P1147, DOI 10.1042/BST0371147; Heidenreich KA, 2004, MOL NEUROBIOL, V29, P155, DOI 10.1385/MN:29:2:155; Ikonomidou C, 1999, SCIENCE, V283, P70, DOI 10.1126/science.283.5398.70; Ikonomidou C, 2000, P NATL ACAD SCI USA, V97, P12885, DOI 10.1073/pnas.220412197; Ivanov A, 2006, J PHYSIOL-LONDON, V572, P789, DOI 10.1113/jphysiol.2006.105510; Khosravani H, 2008, J CELL BIOL, V181, P551, DOI 10.1083/jcb.200711002; Lau A, 2010, PFLUG ARCH EUR J PHY, V460, P525, DOI 10.1007/s00424-010-0809-1; Leveille F, 2008, FASEB J, V22, P4258, DOI 10.1096/fj.08-107268; Li MT, 2001, J NEUROSCI, V21, P6544, DOI 10.1523/JNEUROSCI.21-17-06544.2001; Liu LD, 2003, P NATL ACAD SCI USA, V100, P8532, DOI 10.1073/pnas.1332804100; Mao ZX, 1999, J BIOL CHEM, V274, P31102, DOI 10.1074/jbc.274.43.31102; Mao ZX, 1999, SCIENCE, V286, P785, DOI 10.1126/science.286.5440.785; Monti B, 2000, EUR J NEUROSCI, V12, P3117, DOI 10.1046/j.1460-9568.2000.00189.x; Okamoto S, 2002, P NATL ACAD SCI USA, V99, P3974, DOI 10.1073/pnas.022036399; Pohl D, 1999, P NATL ACAD SCI USA, V96, P2508, DOI 10.1073/pnas.96.5.2508; Scholzke MN, 2003, EUR J NEUROSCI, V18, P3305, DOI 10.1111/j.1460-9568.2003.03079.x; She H, 2011, J CLIN INVEST, V121, P930, DOI 10.1172/JCI43871; Smith PD, 2006, J NEUROSCI, V26, P440, DOI 10.1523/JNEUROSCI.2875-05.2006; Tang XL, 2005, J NEUROSCI, V25, P4823, DOI 10.1523/JNEUROSCI.1331-05.2005; Tian B, 2009, NAT CELL BIOL, V11, P211, DOI 10.1038/ncb1829; Vosler PS, 2008, MOL NEUROBIOL, V38, P78, DOI 10.1007/s12035-008-8036-x; Wang XM, 2005, J BIOL CHEM, V280, P16705, DOI 10.1074/jbc.M501819200; Wiedmann M, 2005, J NEUROSCI RES, V81, P226, DOI 10.1002/jnr.20556; Xia P, 2010, J NEUROSCI, V30, P11246, DOI 10.1523/JNEUROSCI.2488-10.2010; Xu J, 2009, J NEUROSCI, V29, P9330, DOI 10.1523/JNEUROSCI.2212-09.2009; Xu W, 2007, NEURON, V53, P399, DOI 10.1016/j.neuron.2006.12.020; Yang QA, 2010, APOPTOSIS, V15, P1410, DOI 10.1007/s10495-010-0475-y; Yang Q, 2009, CELL CYCLE, V8, P1304, DOI 10.4161/cc.8.9.8363; Yang Q, 2009, SCIENCE, V323, P124, DOI 10.1126/science.1166088; YU YT, 1992, GENE DEV, V6, P1783, DOI 10.1101/gad.6.9.1783	40	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5797	5805		10.1074/jbc.M111.260109	http://dx.doi.org/10.1074/jbc.M111.260109			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22215669	Green Published, hybrid			2022-12-27	WOS:000300638000055
J	Wu, YN; Wang, S; Farooq, SM; Castelvetere, MP; Hou, YN; Gao, JL; Navarro, JV; Oupicky, D; Sun, F; Li, CY				Wu, Yanning; Wang, Shuo; Farooq, Shukkur M.; Castelvetere, Marcello P.; Hou, Yuning; Gao, Ji-Liang; Navarro, Javier V.; Oupicky, David; Sun, Fei; Li, Chunying			A Chemokine Receptor CXCR2 Macromolecular Complex Regulates Neutrophil Functions in Inflammatory Diseases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; PHOSPHOLIPASE-C-BETA; CYSTIC-FIBROSIS; PDZ DOMAINS; PROTEIN; MIGRATION; ROLES; CFTR; INTERLEUKIN-8; BINDING	Inflammation plays an important role in a wide range of human diseases such as ischemia-reperfusion injury, arteriosclerosis, cystic fibrosis, inflammatory bowel disease, etc. Neutrophilic accumulation in the inflamed tissues is an essential component of normal host defense against infection, but uncontrolled neutrophilic infiltration can cause progressive damage to the tissue epithelium. The CXC chemokine receptor CXCR2 and its specific ligands have been reported to play critical roles in the pathophysiology of various inflammatory diseases. However, it is unclear how CXCR2 is coupled specifically to its downstream signaling molecules and modulates cellular functions of neutrophils. Here we show that the PDZ scaffold protein NHERF1 couples CXCR2 to its downstream effector phospholipase C( PLC)beta 2, forming a macromolecular complex, through a PDZ-based interaction. We assembled a macromolecular complex of CXCR2.NHERF1.PLC-beta 2 in vitro, and we also detected such a complex in neutrophils by co-immunoprecipitation. We further observed that the CXCR2-containing macromolecular complex is critical for the CXCR2-mediated intracellular calcium mobilization and the resultant migration and infiltration of neutrophils, as disrupting the complex with a cell permeant CXCR2-specific peptide (containing the PDZ motif) inhibited intracellular calcium mobilization, chemotaxis, and transepithelial migration of neutrophils. Taken together, our data demonstrate a critical role of the PDZ-dependent CXCR2 macromolecular signaling complex in regulating neutrophil functions and suggest that targeting the CXCR2 multiprotein complex may represent a novel therapeutic strategy for certain inflammatory diseases.	[Wu, Yanning; Wang, Shuo; Farooq, Shukkur M.; Castelvetere, Marcello P.; Hou, Yuning; Li, Chunying] Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48201 USA; [Li, Chunying] Wayne State Univ, Sch Med, Cardiovasc Res Inst, Detroit, MI 48201 USA; [Li, Chunying] Wayne State Univ, Sch Med, Barbara Ann Karmanos Canc Inst, Detroit, MI 48201 USA; [Sun, Fei] Wayne State Univ, Sch Med, Dept Physiol, Detroit, MI 48201 USA; [Oupicky, David] Wayne State Univ, Sch Med, Dept Pharmaceut Sci, Detroit, MI 48201 USA; [Gao, Ji-Liang] NIAID, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA; [Navarro, Javier V.] Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA	Wayne State University; Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University; Wayne State University; Wayne State University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Texas System; University of Texas Medical Branch Galveston	Li, CY (corresponding author), Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, 540 E Canfield,5312 Scott Hall, Detroit, MI 48201 USA.	cl@med.wayne.edu	Gao, Ji-Liang/Y-4397-2019; Oupicky, David/AAR-1655-2021	Hou, Yuning/0000-0001-9894-3821; Oupicky, David/0000-0003-4710-861X; Navarro, Javier/0000-0001-7098-4373	American Heart Association [0765185B]; Elsa U. Pardee Foundation; Wayne State University; Cardiovascular Research Institute Isis Initiative; National Institutes of Health [HL096800]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096800] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000615] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Elsa U. Pardee Foundation; Wayne State University; Cardiovascular Research Institute Isis Initiative; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by American Heart Association (Greater SE Affiliate) Beginning Grant-in-aid 0765185B (to C. L.), an Elsa U. Pardee Foundation research grant (to C. L.), Wayne State University intramural startup fund and a Cardiovascular Research Institute Isis Initiative award (to C. L.), and National Institutes of Health Grant HL096800 (to F. S.).	Ajuebor MN, 2004, EXP MOL PATHOL, V76, P1, DOI 10.1016/j.yexmp.2003.08.004; BAGGIOLINI M, 1995, INT J IMMUNOPHARMACO, V17, P103, DOI 10.1016/0192-0561(94)00088-6; Baugher PJ, 2008, J BIOL CHEM, V283, P30868, DOI 10.1074/jbc.M804054200; Bento AF, 2008, J LEUKOCYTE BIOL, V84, P1213, DOI 10.1189/jlb.0408231; Bezprozvanny I, 2001, P NATL ACAD SCI USA, V98, P787, DOI 10.1073/pnas.98.3.787; Bizzarri C, 2006, PHARMACOL THERAPEUT, V112, P139, DOI 10.1016/j.pharmthera.2006.04.002; Buanne P, 2007, J LEUKOCYTE BIOL, V82, P1239, DOI 10.1189/jlb.0207118; Carrigan SO, 2005, IMMUNOLOGY, V115, P108, DOI 10.1111/j.1365-2567.2005.02131.x; Choi JW, 2010, CELL SIGNAL, V22, P1153, DOI 10.1016/j.cellsig.2010.03.010; CHUNTHARAPAI A, 1995, J IMMUNOL, V155, P2587; Cicchetti G, 2002, CRIT REV ORAL BIOL M, V13, P220, DOI 10.1177/154411130201300302; COLLINS SJ, 1987, BLOOD, V70, P1233; Donowitz M, 2010, PHYSIOL GENOMICS, V42A, P200, DOI 10.1152/physiolgenomics.00001.2010; Fan GH, 2001, BIOCHEMISTRY-US, V40, P791, DOI 10.1021/bi001661b; Fanning AS, 1999, J CLIN INVEST, V103, P767, DOI 10.1172/JCI6509; Farooq SM, 2009, J PHARMACOL EXP THER, V329, P123, DOI 10.1124/jpet.108.145862; Geng JG, 2001, CELL RES, V11, P85, DOI 10.1038/sj.cr.7290071; Greene CM, 2005, J IMMUNOL, V174, P1638, DOI 10.4049/jimmunol.174.3.1638; Hall RA, 1998, P NATL ACAD SCI USA, V95, P8496, DOI 10.1073/pnas.95.15.8496; Harden TK, 2009, J LIPID RES, V50, pS243, DOI 10.1194/jlr.R800045-JLR200; Hess DJ, 2002, J SURG RES, V104, P88, DOI 10.1006/jsre.2002.6417; Hirst Robert A, 2006, Methods Mol Biol, V312, P37; HOLMES WE, 1991, SCIENCE, V253, P1278, DOI 10.1126/science.1840701; HUBER AR, 1991, SCIENCE, V254, P99, DOI 10.1126/science.1718038; Hwang JI, 2000, J BIOL CHEM, V275, P16632, DOI 10.1074/jbc.M001410200; Hwang JI, 2005, J BIOL CHEM, V280, P12467, DOI 10.1074/jbc.M410740200; Jiang HP, 1996, P NATL ACAD SCI USA, V93, P14598, DOI 10.1073/pnas.93.25.14598; Jiang HP, 1997, P NATL ACAD SCI USA, V94, P7971, DOI 10.1073/pnas.94.15.7971; Kano M, 1998, P NATL ACAD SCI USA, V95, P15724, DOI 10.1073/pnas.95.26.15724; Lee WY, 2006, METH MOL B, V341, P205; Li CY, 2007, CELL, V131, P940, DOI 10.1016/j.cell.2007.09.037; Li CY, 2011, METHODS MOL BIOL, V741, P255, DOI 10.1007/978-1-61779-117-8_17; Li CY, 2010, CANCER LETT, V292, P246, DOI 10.1016/j.canlet.2009.12.009; Li CY, 2010, INTEGR BIOL-UK, V2, P161, DOI [10.1039/B924455G, 10.1039/b924455g]; Li CY, 2005, J EXP MED, V202, P975, DOI 10.1084/jem.20050421; Li CY, 2004, J BIOL CHEM, V279, P24673, DOI 10.1074/jbc.M400688200; Li Z, 2000, SCIENCE, V287, P1046, DOI 10.1126/science.287.5455.1046; Liu Y, 2004, J IMMUNOL, V172, P7, DOI 10.4049/jimmunol.172.1.7; Matzer SP, 2004, IMMUNOBIOLOGY, V209, P225, DOI 10.1016/j.imbio.2004.02.009; McColl SR, 1999, J IMMUNOL, V163, P2829; Murphy CT, 2010, CLIN EXP IMMUNOL, V162, P188, DOI 10.1111/j.1365-2249.2010.04234.x; MURPHY PM, 1991, SCIENCE, V253, P1280, DOI 10.1126/science.1891716; Naren AP, 2003, P NATL ACAD SCI USA, V100, P342, DOI 10.1073/pnas.0135434100; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Neel NF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023813; Neel NF, 2009, J CELL SCI, V122, P1882, DOI 10.1242/jcs.039057; Niggli V, 2003, INT J BIOCHEM CELL B, V35, P1619, DOI 10.1016/S1357-2725(03)00144-4; Olson TS, 2002, AM J PHYSIOL-REG I, V283, pR7, DOI 10.1152/ajpregu.00738.2001; Pease James E, 2002, Am J Respir Med, V1, P19; Pizurki L, 2000, AM J PATHOL, V156, P1407, DOI 10.1016/S0002-9440(10)65009-2; Rah SY, 2005, J BIOL CHEM, V280, P2888, DOI 10.1074/jbc.M409592200; Raman D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010050; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Sai JQ, 2006, J BIOL CHEM, V281, P35931, DOI 10.1074/jbc.M605883200; Short DB, 1998, J BIOL CHEM, V273, P19797, DOI 10.1074/jbc.273.31.19797; Suh PG, 2001, BIOCHEM BIOPH RES CO, V288, P1, DOI 10.1006/bbrc.2001.5710; Tang Y, 2000, J BIOL CHEM, V275, P37559, DOI 10.1074/jbc.M006635200; THOMAS KM, 1990, J BIOL CHEM, V265, P20061; Wang SS, 2000, CELL, V103, P169, DOI 10.1016/S0092-8674(00)00096-9; White JR, 1998, J BIOL CHEM, V273, P10095, DOI 10.1074/jbc.273.17.10095; WU DQ, 1993, SCIENCE, V261, P101, DOI 10.1126/science.8316840; Wu DQ, 2000, J CELL SCI, V113, P2935; Xu L, 2005, CANCER RES, V65, P5711, DOI 10.1158/0008-5472.CAN-04-4313	63	51	53	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5744	5755		10.1074/jbc.M111.315762	http://dx.doi.org/10.1074/jbc.M111.315762			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22203670	Green Published, hybrid			2022-12-27	WOS:000300638000050
J	Zhao, ZS; Choi, JW; Zhao, CY; Ma, ZA				Zhao, Zhengshan; Choi, Jinwoo; Zhao, Chunying; Ma, Zhongmin Alex			FTY720 Normalizes Hyperglycemia by Stimulating beta-Cell in Vivo Regeneration in db/db Mice through Regulation of Cyclin D3 and p57(KIP2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPHINGOSINE 1-PHOSPHATE; MULTIPLE-SCLEROSIS; INSULIN-SECRETION; DIABETES-MELLITUS; SPHINGOSINE-1-PHOSPHATE RECEPTOR; PHOSPHATIDYLINOSITOL-3 KINASE; PHOSPHOINOSITIDE 3-KINASE; IMMUNOMODULATOR FTY720; FINGOLIMOD FTY720; MODULATOR FTY720	Loss of insulin-producing beta-cell mass is a hallmark of type 2 diabetes in humans and diabetic db/db mice. Pancreatic beta-cells can modulate their mass in response to a variety of physiological and pathophysiological cues. There are currently few effective therapeutic approaches targeting beta-cell regeneration although some anti-diabetic drugs may positively affect beta-cell mass. Here we show that oral administration of FTY720, a sphingosine 1-phosphate (S1P) receptor modulator, to db/db mice normalizes fasting blood glucose by increasing beta-cell mass and blood insulin levels without affecting insulin sensitivity. Fasting blood glucose remained normal in the mice even after the drug was withdrawn after 23 weeks of treatment. The islet area in the pancreases of the FTY720-treated db/db mice was more than 2-fold larger than that of the untreated mice after 6 weeks of treatment. Furthermore, BrdU incorporation assays and Ki67 staining demonstrated cell proliferation in the islets and pancreatic duct areas. Finally, islets from the treated mice exhibited a significant decrease in the level of cyclin-dependent kinase inhibitor p57(KIP2) and an increase in the level of cyclin D3 as compared with those of untreated mice, which could be reversed by the inhibition of phosphatidylinositol 3-kinase (PI3K). Our findings reveal a novel network that controls beta-cell regeneration in the obesity-diabetes setting by regulating cyclin D3 and p57(KIP2) expression through the S1P signaling pathway. Therapeutic strategies targeting this network may promote in vivo regeneration of beta-cells in patients and prevent and/or cure type 2 diabetes.	[Zhao, Zhengshan; Choi, Jinwoo; Zhao, Chunying; Ma, Zhongmin Alex] Mt Sinai Sch Med, Dept Geriatr & Palliat Med, Div Expt Diabet & Aging, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Ma, ZA (corresponding author), Mt Sinai Sch Med, Dept Geriatr & Palliat Med, Div Expt Diabet & Aging, 1 Gustave L Levy Pl, New York, NY 10029 USA.	Zhongmin.ma@mssm.edu			National Institutes of Health from the NINDS [R01 NS063962]; Iacocca Family foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK074805, R01DK063076] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063962] Funding Source: NIH RePORTER	National Institutes of Health from the NINDS; Iacocca Family foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 NS063962 from the NINDS and the Iacocca Family foundation.	Albert R, 2005, J MED CHEM, V48, P5373, DOI 10.1021/jm050242f; Ashizawa S, 2004, PANCREAS, V28, P109, DOI 10.1097/00006676-200403000-00001; Assmann A, 2009, PEDIATR DIABETES, V10, P14, DOI 10.1111/j.1399-5448.2008.00468.x; Bonner-Weir S, 2010, DIABETES, V59, P2340, DOI 10.2337/db10-0084; Bouwens L, 2005, PHYSIOL REV, V85, P1255, DOI 10.1152/physrev.00025.2004; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Butler PC, 2007, NAT CLIN PRACT ENDOC, V3, P758, DOI 10.1038/ncpendmet0647; Cohen JA, 2010, NEW ENGL J MED, V362, P402, DOI 10.1056/NEJMoa0907839; Desai BM, 2007, J CLIN INVEST, V117, P971, DOI 10.1172/JCI29988; Dhawan S, 2009, GENE DEV, V23, P906, DOI 10.1101/gad.1742609; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Fiaschi-Taesch NM, 2010, DIABETES, V59, P1926, DOI 10.2337/db09-1776; Gardell SE, 2006, TRENDS MOL MED, V12, P65, DOI 10.1016/j.molmed.2005.12.001; Georgia S, 2004, J CLIN INVEST, V114, P963, DOI 10.1172/JCI200422098; Georgia S, 2006, DEV BIOL, V298, P22, DOI 10.1016/j.ydbio.2006.05.036; Guillermet-Guibert J, 2008, P NATL ACAD SCI USA, V105, P8292, DOI 10.1073/pnas.0707761105; Holland WL, 2011, NAT MED, V17, P55, DOI 10.1038/nm.2277; Huwiler A, 2008, BIOCHEM PHARMACOL, V75, P1893, DOI 10.1016/j.bcp.2007.12.018; Ishii I, 2004, ANNU REV BIOCHEM, V73, P321, DOI 10.1146/annurev.biochem.73.011303.073731; Jongsma M, 2006, BRIT J PHARMACOL, V149, P277, DOI 10.1038/sj.bjp.0706872; Kassem SA, 2001, DIABETES, V50, P2763, DOI 10.2337/diabetes.50.12.2763; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Lauber K, 2004, MOL CELL, V14, P277, DOI 10.1016/S1097-2765(04)00237-0; Laychock SG, 2006, ENDOCRINOLOGY, V147, P4705, DOI 10.1210/en.2006-0456; Leahy JL, 2010, J CLIN ENDOCR METAB, V95, P4206, DOI 10.1210/jc.2010-0668; LEITER EH, 1989, ENDOCRINOLOGY, V124, P912, DOI 10.1210/endo-124-2-912; Levine YC, 2007, J BIOL CHEM, V282, P20351, DOI 10.1074/jbc.M702182200; Li WC, 2010, J CELL SCI, V123, P2792, DOI 10.1242/jcs.065268; Lipsett M, 2002, DIABETES, V51, P1834, DOI 10.2337/diabetes.51.6.1834; Maceyka M, 2012, TRENDS CELL BIOL, V22, P50, DOI 10.1016/j.tcb.2011.09.003; Menge BA, 2008, DIABETES, V57, P142, DOI 10.2337/db07-1294; Minami K, 2005, P NATL ACAD SCI USA, V102, P15116, DOI 10.1073/pnas.0507567102; Pateras IS, 2009, MOL CANCER RES, V7, P1902, DOI 10.1158/1541-7786.MCR-09-0317; PORTE D, 1991, DIABETES, V40, P166, DOI 10.2337/diabetes.40.2.166; Potteck H, 2010, CELL PHYSIOL BIOCHEM, V26, P67, DOI 10.1159/000315107; Radeff-Huang J, 2004, J CELL BIOCHEM, V92, P949, DOI 10.1002/jcb.20094; Rhodes CJ, 2005, SCIENCE, V307, P380, DOI 10.1126/science.1104345; Rieck S, 2010, TRENDS ENDOCRIN MET, V21, P151, DOI 10.1016/j.tem.2009.11.001; Rothschild G, 2006, MOL CELL BIOL, V26, P4351, DOI 10.1128/MCB.01743-05; Samad F, 2006, DIABETES, V55, P2579, DOI 10.2337/db06-0330; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Seleznev K, 2006, J BIOL CHEM, V281, P22275, DOI 10.1074/jbc.M604330200; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Shen Y, 2007, CANCER LETT, V254, P288, DOI 10.1016/j.canlet.2007.03.013; Sicinska E, 2003, CANCER CELL, V4, P451, DOI 10.1016/S1535-6108(03)00301-5; Song K, 2005, MOL ENDOCRINOL, V19, P504, DOI 10.1210/me.2004-0169; Sorenson RL, 1997, HORM METAB RES, V29, P301, DOI 10.1055/s-2007-979040; Strader CR, 2011, J NAT PROD, V74, P900, DOI 10.1021/np2000528; Thorel F, 2010, NATURE, V464, P1149, DOI 10.1038/nature08894; Tokumura A, 2002, BIOL REPROD, V67, P1386, DOI 10.1095/biolreprod.102.004051; Truong W, 2007, AM J TRANSPLANT, V7, P2031, DOI 10.1111/j.1600-6143.2007.01880.x; VANASSCHE FA, 1978, BRIT J OBSTET GYNAEC, V85, P818; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Verzijl D, 2010, MOL CELLS, V29, P99, DOI 10.1007/s10059-010-0041-z; Watanabe H, 2008, BIOCHEM BIOPH RES CO, V370, P33, DOI 10.1016/j.bbrc.2008.03.012; Watanabe H, 2008, PANCREAS, V36, P153, DOI 10.1097/MPA.0b013e318157753e; Wymann MP, 1996, MOL CELL BIOL, V16, P1722; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015; Zhang XH, 2006, J CELL SCI, V119, P1005, DOI 10.1242/jcs.02821; Zhang XH, 2007, J CELL SCI, V120, P4134, DOI 10.1242/jcs.015834; Zhao ZS, 2010, ENDOCRINOLOGY, V151, P3038, DOI 10.1210/en.2010-0016; Zhao ZS, 2009, ENDOCRINOLOGY, V150, P2569, DOI 10.1210/en.2008-1342	64	43	46	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5562	5573		10.1074/jbc.M111.305359	http://dx.doi.org/10.1074/jbc.M111.305359			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22194608	hybrid, Green Published			2022-12-27	WOS:000300638000035
J	Giguere, PM; Laroche, G; Oestreich, EA; Siderovski, DP				Giguere, Patrick M.; Laroche, Genevieve; Oestreich, Emily A.; Siderovski, David P.			G-protein Signaling Modulator-3 Regulates Heterotrimeric G-protein Dynamics through Dual Association with G beta and G alpha(i) Protein Subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISSOCIATION INHIBITOR ACTIVITY; NUCLEOTIDE EXCHANGE FACTOR; GOLOCO MOTIF; GAMMA-SUBUNITS; MOLECULAR CHAPERONE; COUPLED RECEPTORS; THP-1 CELLS; ACTIVATION; IDENTIFICATION; DIFFERENTIATION	Regulation of the assembly and function of G-protein heterotrimers (G alpha center dot GDP/G beta gamma) is a complex process involving the participation of many accessory proteins. One of these regulators, GPSM3, is a member of a family of proteins containing one or more copies of a small regulatory motif known as the GoLoco (or GPR) motif. Although GPSM3 is known to bind G alpha(i)center dot GDP subunits via its GoLoco motifs, here we report that GPSM3 also interacts with the G beta subunits G beta 1 to G beta 4, independent of G gamma or G alpha center dot GDP subunit interactions. Bimolecular fluorescence complementation studies suggest that the G beta-GPSM3 complex is formed at, and transits through, the Golgi apparatus and also exists as a soluble complex in the cytoplasm. GPSM3 and G beta co-localize endogenously in THP-1 cells at the plasma membrane and in a juxtanuclear compartment. We provide evidence that GPSM3 increases G beta stability until formation of the G beta gamma dimer, including association of the G beta-GPSM3 complex with phosducin-like protein PhLP and T-complex protein 1 subunit eta (CCT7), two known chaperones of neosynthesized G beta subunits. The G beta interaction site within GPSM3 was mapped to a leucinerich region proximal to the N-terminal side of its first GoLoco motif. Both G beta and G alpha(i)center dot GDP binding events are required for GPSM3 activity in inhibiting phospholipase-C beta activation. GPSM3 is also shown in THP-1 cells to be important for Akt activation, a known G beta gamma-dependent pathway. Discovery of a G beta/GPSM3 interaction, independent of G alpha center dot GDP and G gamma involvement, adds to the combinatorial complexity of the role of GPSM3 in heterotrimeric G-protein regulation.	[Giguere, Patrick M.; Laroche, Genevieve; Oestreich, Emily A.; Siderovski, David P.] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Siderovski, David P.] Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Siderovski, David P.] Univ N Carolina, Sch Med, UNC Neurosci Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Siderovski, DP (corresponding author), Univ N Carolina, Sch Med, Dept Pharmacol, Genet Med Bldg,120 Mason Farm Rd, Chapel Hill, NC 27599 USA.	dsiderov@med.unc.edu	Siderovski, David Peter/AAA-9603-2019; , PEP-MX Core/AGV-4051-2022	Siderovski, David Peter/0000-0002-0688-8210; 	National Institutes of Health from NIGMS [GM082892]; NIAMS [F32 AR057644]; Heart and Stroke Foundation of Canada; Fond de la Recherche en Sante Quebec; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR057644] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082892] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Fond de la Recherche en Sante Quebec; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM082892 from NIGMS (to D. P. S.) and F32 AR057644 from NIAMS (Postdoctoral Fellowship to E. A. O.). This work was also supported by post-doctoral fellowships from the Heart and Stroke Foundation of Canada and Fond de la Recherche en Sante Quebec (to P. M. G. and G. L., respectively).	Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; Brock C, 2003, J CELL BIOL, V160, P89, DOI 10.1083/jcb.200210115; Cao XQ, 2004, J BIOL CHEM, V279, P27567, DOI 10.1074/jbc.M312786200; Chung KY, 2011, NATURE, V477, P611, DOI 10.1038/nature10488; Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668; Dupre DJ, 2007, J BIOL CHEM, V282, P13703, DOI 10.1074/jbc.M608846200; Dupre DJ, 2009, ANNU REV PHARMACOL, V49, P31, DOI 10.1146/annurev-pharmtox-061008-103038; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Gurevich VV, 2008, MOL PHARMACOL, V74, P312, DOI 10.1124/mol.108.049015; Hewavitharana T, 2012, CELL SIGNAL, V24, P25, DOI 10.1016/j.cellsig.2011.08.014; Humrich J, 2005, J BIOL CHEM, V280, P20042, DOI 10.1074/jbc.M409233200; Johnston CA, 2007, P NATL ACAD SCI USA, V104, P17317, DOI 10.1073/pnas.0704751104; Johnston CA, 2007, MOL PHARMACOL, V72, P219, DOI 10.1124/mol.107.034348; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Jordan JD, 1999, J BIOL CHEM, V274, P21507, DOI 10.1074/jbc.274.31.21507; Kenworthy AK, 2001, METHODS, V24, P289, DOI 10.1006/meth.2001.1189; Kerppola TK, 2008, ANNU REV BIOPHYS, V37, P465, DOI 10.1146/annurev.biophys.37.032807.125842; Kimple RJ, 2004, BIOCHEM J, V378, P801, DOI 10.1042/BJ20031686; Kimple RJ, 2002, NATURE, V416, P878, DOI 10.1038/416878a; Kimple RJ, 2001, J BIOL CHEM, V276, P29275, DOI 10.1074/jbc.M103208200; Kubota S, 2006, P NATL ACAD SCI USA, V103, P8360, DOI 10.1073/pnas.0600195103; Lambert NA, 2010, P NATL ACAD SCI USA, V107, P7066, DOI 10.1073/pnas.0912934107; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; Lukov GL, 2005, EMBO J, V24, P1965, DOI 10.1038/sj.emboj.7600673; Luo Y, 1999, J BIOL CHEM, V274, P10685, DOI 10.1074/jbc.274.16.10685; Luttrell LM, 2008, MOL BIOTECHNOL, V39, P239, DOI 10.1007/s12033-008-9031-1; Marrari Y, 2007, BIOCHEMISTRY-US, V46, P7665, DOI 10.1021/bi700338m; McCoy KL, 2009, PROG MOL BIOL TRANSL, V86, P49, DOI 10.1016/S1877-1173(09)86003-1; Mochizuki N, 1996, GENE, V181, P39, DOI 10.1016/S0378-1119(96)00456-8; Neubig RR, 2002, NAT REV DRUG DISCOV, V1, P187, DOI 10.1038/nrd747; Offermanns S, 2003, PROG BIOPHYS MOL BIO, V83, P101, DOI 10.1016/S0079-6107(03)00052-X; Oner SS, 2010, J BIOL CHEM, V285, P20588, DOI 10.1074/jbc.C109.088070; Peterson YK, 2000, J BIOL CHEM, V275, P33193, DOI 10.1074/jbc.C000509200; Ponting CP, 1999, J MOL MED, V77, P695, DOI 10.1007/s001099900054; Rhee SG, 1997, J BIOL CHEM, V272, P15045, DOI 10.1074/jbc.272.24.15045; Saliba RS, 2002, J CELL SCI, V115, P2907; Sato M, 2006, ANNU REV PHARMACOL, V46, P151, DOI 10.1146/annurev.pharmtox.46.120604.141115; Schwende H, 1996, J LEUKOCYTE BIOL, V59, P555, DOI 10.1002/jlb.59.4.555; Siderovski DP, 2005, INT J BIOL SCI, V1, P51, DOI 10.7150/ijbs.1.51; Siderovski DP, 1999, TRENDS BIOCHEM SCI, V24, P340, DOI 10.1016/S0968-0004(99)01441-3; Sondek J, 2001, BIOCHEM PHARMACOL, V61, P1329, DOI 10.1016/S0006-2952(01)00633-5; Takesono A, 1999, J BIOL CHEM, V274, P33202, DOI 10.1074/jbc.274.47.33202; TSUCHIYA S, 1982, CANCER RES, V42, P1530; Wang JT, 2009, J BIOL CHEM, V284, P16906, DOI 10.1074/jbc.M109.006585; Webb CK, 2005, J NEUROCHEM, V92, P1408, DOI 10.1111/j.1471-4159.2004.02997.x; Westwick JK, 2006, METHOD ENZYMOL, V407, P388, DOI 10.1016/S0076-6879(05)07032-1; Willard FS, 2004, ANNU REV BIOCHEM, V73, P925, DOI 10.1146/annurev.biochem.73.011303.073756; Willardson BM, 2007, CELL SIGNAL, V19, P2417, DOI 10.1016/j.cellsig.2007.06.013; Zhao PS, 2010, J BIOL CHEM, V285, P9008, DOI 10.1074/jbc.M109.057174	50	14	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4863	4874		10.1074/jbc.M111.311712	http://dx.doi.org/10.1074/jbc.M111.311712			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22167191	Green Published, hybrid			2022-12-27	WOS:000300608500047
J	Hallows, WC; Yu, W; Denu, JM				Hallows, William C.; Yu, Wei; Denu, John M.			Regulation of Glycolytic Enzyme Phosphoglycerate Mutase-1 by Sirt1 Protein-mediated Deacetylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID OXIDATION; HEPATIC GLUCONEOGENESIS; CALORIE RESTRICTION; SIRTUINS; PROMOTES; GLUCOSE; METABOLISM; SUBSTRATE	Emerging proteomic evidence suggests that acetylation of metabolic enzymes is a prevalent post-translational modification. In a few recent reports, acetylation down-regulated activity of specific enzymes in fatty acid oxidation, urea cycle, electron transport, and anti-oxidant pathways. Here, we reveal that the glycolytic enzyme phosphoglycerate mutase-1 (PGAM1) is negatively regulated by Sirt1, a member of the NAD(+)-dependent protein deacetylases. Acetylated PGAM1 displays enhanced activity, although Sirt1-mediated deacetylation reduces activity. Acetylation sites mapped to the C-terminal "cap," a region previously known to affect catalytic efficiency. Overexpression of a constitutively active variant (acetylated mimic) of PGAM1 stimulated flux through glycolysis. Under glucose restriction, Sirt1 levels dramatically increased, leading to PGAM1 deacetylation and attenuated activity. Previously, Sirt1 has been implicated in the adaptation from glucose to fat burning. This study (i) demonstrates that protein acetylation can stimulate metabolic enzymes, (ii) provides biochemical evidence that glycolysis is modulated by reversible acetylation, and (iii) demonstrates that PGAM1 deacetylation and activity are directly controlled by Sirt1.	[Yu, Wei; Denu, John M.] Univ Wisconsin, Wisconsin Inst Discovery, Madison, WI 53715 USA; [Hallows, William C.; Yu, Wei; Denu, John M.] Univ Wisconsin, Dept Biomol Chem, Madison, WI 53715 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Denu, JM (corresponding author), Univ Wisconsin, Wisconsin Inst Discovery, 330 N Orchard St, Madison, WI 53715 USA.	jmdenu@wisc.edu	YU, WEI/G-4128-2013; YU, WEI/C-3822-2012	YU, WEI/0000-0001-9898-4607	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM059785] Funding Source: NIH RePORTER; NIGMS NIH HHS [R37 GM059785] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bordone L, 2006, PLOS BIOL, V4, P210, DOI 10.1371/journal.pbio.0040031; Borra MT, 2004, BIOCHEMISTRY-US, V43, P9877, DOI 10.1021/bi049592e; Caton PW, 2011, J ENDOCRINOL, V208, P273, DOI 10.1530/JOE-10-0190; Caton PW, 2010, J ENDOCRINOL, V205, P97, DOI 10.1677/JOE-09-0345; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Donmez G, 2010, AGING CELL, V9, P285, DOI 10.1111/j.1474-9726.2010.00548.x; Engel M, 2004, J BIOL CHEM, V279, P35803, DOI 10.1074/jbc.M402768200; Evans MJ, 2007, MOL BIOSYST, V3, P495, DOI 10.1039/b705113a; Evans MJ, 2005, NAT BIOTECHNOL, V23, P1303, DOI 10.1038/nbt1149; Fothergill-Gilmore L. A., 1989, ADV ENZYMOLOGY RELAT, V62, P227; Gillum MP, 2011, TRENDS MOL MED, V17, P8, DOI 10.1016/j.molmed.2010.09.005; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Hallows WC, 2011, MOL CELL, V41, P139, DOI 10.1016/j.molcel.2011.01.002; Harlow E, 1988, ANTIBODIES LABORATOR, P471; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Imai S, 2010, TRENDS PHARMACOL SCI, V31, P212, DOI 10.1016/j.tips.2010.02.003; Imai SI, 2009, CURR OPIN CLIN NUTR, V12, P350, DOI 10.1097/MCO.0b013e32832c932d; Imai S, 2009, CURR PHARM DESIGN, V15, P20, DOI 10.2174/138161209787185814; Imai S, 2009, CELL BIOCHEM BIOPHYS, V53, P65, DOI 10.1007/s12013-008-9041-4; Kan Y, 2008, FEBS LETT, V582, P2417, DOI 10.1016/j.febslet.2008.06.005; KASHIWAYA Y, 1994, J BIOL CHEM, V269, P25502; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Lin YY, 2009, CELL, V136, P1073, DOI 10.1016/j.cell.2009.01.033; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Nakagawa T, 2009, CELL, V137, P560, DOI 10.1016/j.cell.2009.02.026; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103; Shalom-Barak T, 2002, J BIOL CHEM, V277, P40659, DOI 10.1074/jbc.M206650200; Shimazu T, 2010, CELL METAB, V12, P654, DOI 10.1016/j.cmet.2010.11.003; Smith BC, 2008, CHEM BIOL, V15, P1002, DOI 10.1016/j.chembiol.2008.09.009; SOLANKI K, 1980, BIOCHEM J, V192, P377, DOI 10.1042/bj1920377; Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002; Sun C, 2007, CELL METAB, V6, P307, DOI 10.1016/j.cmet.2007.08.014; Tao RD, 2010, MOL CELL, V40, P893, DOI 10.1016/j.molcel.2010.12.013; Walter RA, 1999, BIOCHEM J, V337, P89, DOI 10.1042/0264-6021:3370089; Wei D, 2011, AM J PHYSIOL-ENDOC M, V300, pE312, DOI 10.1152/ajpendo.00524.2010; WINN SI, 1981, PHILOS T ROY SOC B, V293, P121, DOI 10.1098/rstb.1981.0066; Yu JJ, 2009, ANN NY ACAD SCI, V1173, pE10, DOI 10.1111/j.1749-6632.2009.04952.x; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	44	127	138	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					3850	3858		10.1074/jbc.M111.317404	http://dx.doi.org/10.1074/jbc.M111.317404			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22157007	Green Published, hybrid			2022-12-27	WOS:000300410900022
J	Hamza, A; Baetz, K				Hamza, Akil; Baetz, Kristin			Iron-responsive Transcription Factor Aft1 Interacts with Kinetochore Protein Iml3 and Promotes Pericentromeric Cohesin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN-REMODELING COMPLEX; DOUBLE-STRAND BREAKS; SACCHAROMYCES-CEREVISIAE; CHROMOSOME SEGREGATION; BUDDING YEAST; SISTER CHROMATIDS; DNA-REPLICATION; INTERACTION MAP; MEIOSIS-I; RSC	The Saccharomyces cerevisiae iron-responsive transcription factor, Aft1, has a well established role in regulating iron homeostasis through the transcriptional induction of iron-regulon genes. However, recent studies have implicated Aft1 in other cellular processes independent of iron regulation such as chromosome stability. In addition, chromosome spreads and two-hybrid data suggest that Aft1 interacts with and co-localizes with kinetochore proteins; however, the cellular implications of this have not been established. Here, we demonstrate that Aft1 associates with the kinetochore complex through Iml3. Furthermore, like Iml3, Aft1 is required for the increased association of cohesin with pericentric chromatin, which is required to resist microtubule tension, and aft1 Delta cells display chromosome segregation defects in meiosis. Our work defines a new role for Aft1 in chromosome stability and transmission.	[Hamza, Akil; Baetz, Kristin] Univ Ottawa, Ottawa Inst Syst Biol, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada	University of Ottawa	Baetz, K (corresponding author), Univ Ottawa, Ottawa Inst Syst Biol, Dept Biochem Microbiol & Immunol, Roger Guindon Hall,Rm 4510B,451 Smyth Ave, Ottawa, ON K1H 8M5, Canada.	kbaetz@uottawa.ca	Baetz, Kristin/E-6859-2013	Hamza, Akil/0000-0002-3613-8744	Natural Sciences and Engineering Research Council of Canada; Canadian Institute of Health Research	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported in part by a Natural Sciences and Engineering Research Council of Canada Discovery grant (to K. B.).; Supported by a Canadian Institute of Health Research Master's Award.	Baetz KK, 2004, MOL CELL BIOL, V24, P1232, DOI 10.1128/MCB.24.3.1232-1244.2003; Berthelet S, 2010, GENETICS, V185, P1111, DOI 10.1534/genetics.110.117531; Bruckner A, 2009, INT J MOL SCI, V10, P2763, DOI 10.3390/ijms10062763; Choy JS, 2011, GENETICS, V189, P11, DOI 10.1534/genetics.111.130781; De Wulf P, 2003, GENE DEV, V17, P2902, DOI 10.1101/gad.1144403; Dubacq C, 2006, MOL GENET GENOMICS, V275, P114, DOI 10.1007/s00438-005-0077-5; Eckert CA, 2007, GENE DEV, V21, P278, DOI 10.1101/gad.1498707; Fernius J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000629; Ghosh SK, 2004, CURR GENET, V46, P82, DOI 10.1007/s00294-004-0516-6; Gkikopoulos T, 2011, EMBO J, V30, P1919, DOI 10.1038/emboj.2011.112; Hakimi MA, 2002, NATURE, V418, P994, DOI 10.1038/nature01024; Hsu JM, 2003, MOL CELL BIOL, V23, P3202, DOI 10.1128/MCB.23.9.3202-3215.2003; Huang J, 2004, MOL CELL, V13, P739, DOI 10.1016/S1097-2765(04)00103-0; Kiburz BM, 2005, GENE DEV, V19, P3017, DOI 10.1101/gad.1373005; Klein F, 1999, CELL, V98, P91, DOI 10.1016/S0092-8674(00)80609-1; Krogan NJ, 2004, P NATL ACAD SCI USA, V101, P13513, DOI 10.1073/pnas.0405753101; Lambert JP, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.104; Lee KK, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.40; Lee W, 2005, PLOS GENET, V1, P235, DOI 10.1371/journal.pgen.0010024; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Marston AL, 2004, NAT REV MOL CELL BIO, V5, P983, DOI 10.1038/nrm1526; Marston AL, 2003, DEV CELL, V4, P711, DOI 10.1016/S1534-5807(03)00130-8; Marston AL, 2004, SCIENCE, V303, P1367, DOI 10.1126/science.1094220; Measday V, 2005, P NATL ACAD SCI USA, V102, P13956, DOI 10.1073/pnas.0503504102; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Nasmyth K, 2009, ANNU REV GENET, V43, P525, DOI 10.1146/annurev-genet-102108-134233; Ng TM, 2009, MOL BIOL CELL, V20, P3818, DOI 10.1091/mbc.E09-04-0330; Ocampo-Hafalla MT, 2011, J CELL SCI, V124, P685, DOI 10.1242/jcs.073866; Ogiwara H, 2007, CELL CYCLE, V6, P1090, DOI 10.4161/cc.6.9.4130; Oum JH, 2011, MOL CELL BIOL, V31, P3924, DOI 10.1128/MCB.01269-10; Philpott CC, 2008, EUKARYOT CELL, V7, P20, DOI 10.1128/EC.00354-07; Philpott CC, 1998, EMBO J, V17, P5026, DOI 10.1093/emboj/17.17.5026; Pot I, 2003, MOL BIOL CELL, V14, P460, DOI 10.1091/mbc.E02-08-0517; Rutherford JC, 2003, J BIOL CHEM, V278, P27636, DOI 10.1074/jbc.M300076200; SIKORSKI RS, 1989, GENETICS, V122, P19; Skibbens RV, 1999, GENE DEV, V13, P307, DOI 10.1101/gad.13.3.307; SORA S, 1982, GENETICS, V101, P17; Stephens AD, 2011, J CELL BIOL, V193, P1167, DOI 10.1083/jcb.201103138; Strom L, 2004, MOL CELL, V16, P1003, DOI 10.1016/j.molcel.2004.11.026; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Unal E, 2004, MOL CELL, V16, P991, DOI 10.1016/j.molcel.2004.11.027; Verdaasdonk JS, 2011, NAT REV MOL CELL BIO, V12, P320, DOI 10.1038/nrm3107; Westermann S, 2007, ANNU REV BIOCHEM, V76, P563, DOI 10.1146/annurev.biochem.76.052705.160607; Wong J, 2007, MOL BIOL CELL, V18, P3800, DOI 10.1091/mbc.E07-06-0536; Yamaguchi-Iwai Y, 2002, J BIOL CHEM, V277, P18914, DOI 10.1074/jbc.M200949200; YAMAGUCHIIWAI Y, 1995, EMBO J, V14, P1231, DOI 10.1002/j.1460-2075.1995.tb07106.x; YamaguchiIwai Y, 1996, EMBO J, V15, P3377, DOI 10.1002/j.1460-2075.1996.tb00703.x; Yeh E, 2008, CURR BIOL, V18, P81, DOI 10.1016/j.cub.2007.12.019; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Yuen KWY, 2007, P NATL ACAD SCI USA, V104, P3925, DOI 10.1073/pnas.0610642104	52	13	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					4139	4147		10.1074/jbc.M111.319319	http://dx.doi.org/10.1074/jbc.M111.319319			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22157760	hybrid, Green Published			2022-12-27	WOS:000300410900047
J	Kimura, T; Yeliseev, AA; Vukoti, K; Rhodes, SD; Cheng, KJ; Rice, KC; Gawrisch, K				Kimura, Tomohiro; Yeliseev, Alexei A.; Vukoti, Krishna; Rhodes, Steven D.; Cheng, Kejun; Rice, Kenner C.; Gawrisch, Klaus			Recombinant Cannabinoid Type 2 Receptor in Liposome Model Activates G Protein in Response to Anionic Lipid Constituents	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL RECONSTITUTION; CRYSTAL-STRUCTURE; PHASE-TRANSITION; CB2 RECEPTORS; BINDING-SITE; ANNEXIN-V; PHOSPHATIDYLSERINE; EXPRESSION; RHODOPSIN; MEMBRANE	Human cannabinoid type 2 (CB2) receptor expressed in Escherichia coli was purified and successfully reconstituted in the functional form into lipid bilayers composed of POPC, 1-palmitoyl- 2-oleoyl-sn-glycero-3-phosphocholine, 1-palmitoyl-2-oleoyl- sn-glycero-3-phospho-L-serine (POPS), and cholesteryl hemisuccinate (CHS). Reconstitution was performed by detergent removal from the protein/lipid/detergent mixed micelles either on an adsorbent column, or by rapid dilution to below the critical micelle concentration of detergent followed by removal of detergent monomers on a concentrator. Proteoliposomes prepared at a protein/phospholipid/CHS molar ratio of 1/620 - 650/210-220 are free of detergent as shown by H-1 NMR, have a homogeneous protein/lipid ratio shown by isopycnic gradient ultracentrifugation, and are small in size with a mean diameter of 150-200 nm as measured by dynamic light scattering. Functional integrity of the reconstituted receptor was confirmed by quantitative binding of H-2-labeled agonist CP-55,940-d(6) measured by H-2 magic angle spinning NMR, as well as by activation of G protein. The efficiency of G protein activation by agonist-bound CB2 receptor was affected by negative electric surface potentials of proteoliposomes controlled by the content of anionic CHS or POPS. The activation was highest at an anionic lipid content of about 50 mol %. There was no correlation between the efficiency of G protein activation and an increase of hydrocarbon chain order induced by CHS or cholesterol. The results suggest the importance of anionic lipids in regulating signal transduction by CB2 receptor and other class A GPCR. The successful reconstitution of milligram quantities of pure, functional CB2 receptor enables a wide variety of structural studies.	[Kimura, Tomohiro; Yeliseev, Alexei A.; Vukoti, Krishna; Rhodes, Steven D.; Gawrisch, Klaus] NIAAA, Lab Membrane Biochem & Biophys, NIH, Bethesda, MD 20852 USA; [Cheng, Kejun; Rice, Kenner C.] NIDA, Chem Biol Res Branch, NIH, Bethesda, MD 20852 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Yeliseev, AA (corresponding author), NIAAA, Lab Membrane Biochem & Biophys, NIH, Bethesda, MD 20852 USA.	yeliseeva@mail.nih.gov; gawrisch@helix.nih.gov	Kimura, Tomohiro/AEJ-1621-2022; Yeliseev, Alexei A/B-3143-2009	Kimura, Tomohiro/0000-0002-4192-7852	National Institutes of Health from the of the NIAAA; NIDA; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000529] Funding Source: NIH RePORTER	National Institutes of Health from the of the NIAAA; NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by a National Institutes of Health grant from the Intramural Research Programs of the NIAAA and NIDA.	Appelt U, 2005, CELL DEATH DIFFER, V12, P194, DOI 10.1038/sj.cdd.4401527; Aveyard R., 1973, INTRO PRINCIPLES SUR; Baker M, 2010, NATURE, V465, P823, DOI 10.1038/465823a; Bari M, 2005, J BIOL CHEM, V280, P12212, DOI 10.1074/jbc.M411642200; Bari M, 2005, J NEUROSCI RES, V81, P275, DOI 10.1002/jnr.20546; Bari M, 2008, NEUROPHARMACOLOGY, V54, P45, DOI 10.1016/j.neuropharm.2007.06.030; Bari M, 2006, J IMMUNOL, V177, P4971, DOI 10.4049/jimmunol.177.8.4971; Berger C, 2010, PROTEIN EXPRES PURIF, V70, P236, DOI 10.1016/j.pep.2009.12.011; Cabral GA, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409000957; Calandra B, 1997, BIOTECHNOL LETT, V19, P425, DOI 10.1023/A:1018383808401; Callahan MK, 2000, CELL DEATH DIFFER, V7, P645, DOI 10.1038/sj.cdd.4400690; CEVC G, 1981, BIOCHEMISTRY-US, V20, P4955, DOI 10.1021/bi00520a023; Chattopadhyay A, 1996, FEBS LETT, V391, P199, DOI 10.1016/0014-5793(96)00733-8; CHEN NR, 1985, BIOCHEM BIOPH RES CO, V127, P220, DOI 10.1016/S0006-291X(85)80147-9; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Choi G, 2005, BBA-BIOMEMBRANES, V1668, P1, DOI 10.1016/j.bbamem.2004.10.011; DAVIS JH, 1976, CHEM PHYS LETT, V42, P390, DOI 10.1016/0009-2614(76)80392-2; DeGrip WJ, 1998, BIOCHEM J, V330, P667; DEGRIP WJ, 1983, BIOCHIM BIOPHYS ACTA, V734, P168, DOI 10.1016/0005-2736(83)90115-3; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Dillon SR, 2000, J IMMUNOL, V164, P1322, DOI 10.4049/jimmunol.164.3.1322; Escriba PV, 1997, P NATL ACAD SCI USA, V94, P11375, DOI 10.1073/pnas.94.21.11375; EYTAN GD, 1982, BIOCHIM BIOPHYS ACTA, V694, P185, DOI 10.1016/0304-4157(82)90024-7; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; GALIEGUE S, 1995, EUR J BIOCHEM, V232, P54, DOI 10.1111/j.1432-1033.1995.tb20780.x; Grace CRR, 2007, J STRUCT BIOL, V159, P359, DOI 10.1016/j.jsb.2007.04.004; Granier S, 2007, J BIOL CHEM, V282, P13895, DOI 10.1074/jbc.M611904200; Hafez IM, 2000, BBA-BIOMEMBRANES, V1463, P107, DOI 10.1016/S0005-2736(99)00186-8; Heerklotz H, 2006, BIOPHYS J, V91, P600, DOI 10.1529/biophysj.106.082669; HERRMANN KW, 1962, J PHYS CHEM-US, V66, P295, DOI 10.1021/j100808a025; HOLTE LL, 1995, BIOPHYS J, V68, P2396, DOI 10.1016/S0006-3495(95)80422-4; Hurst DP, 2010, J BIOL CHEM, V285, P17954, DOI 10.1074/jbc.M109.041590; Ibrahim MM, 2005, P NATL ACAD SCI USA, V102, P3093, DOI 10.1073/pnas.0409888102; Ibrahim MM, 2003, P NATL ACAD SCI USA, V100, P10529, DOI 10.1073/pnas.1834309100; JACKSON ML, 1982, BIOCHEMISTRY-US, V21, P5601, DOI 10.1021/bi00265a033; JACKSON ML, 1985, BIOCHIM BIOPHYS ACTA, V812, P369, DOI 10.1016/0005-2736(85)90311-6; Kimura T, 2006, BIOCHEMISTRY-US, V45, P15601, DOI 10.1021/bi061641v; Kimura T, 2010, BIOPHYS J, V98, p625A, DOI 10.1016/j.bpj.2009.12.3421; Kimura T, 2009, BIOPHYS J, V96, P4916, DOI 10.1016/j.bpj.2009.03.033; Koenig BW, 2005, BBA-BIOMEMBRANES, V1715, P65, DOI 10.1016/j.bbamem.2005.07.006; Kosloff M, 2008, J BIOL CHEM, V283, P31197, DOI 10.1074/jbc.M803799200; Krepkiy D, 2007, PROTEIN PEPTIDE LETT, V14, P1031, DOI 10.2174/092986607782541051; Krishna AG, 2002, BIOCHEMISTRY-US, V41, P8298, DOI 10.1021/bi025534m; Leitz AJ, 2006, BIOTECHNIQUES, V40, P601, DOI 10.2144/000112169; MECHOULAM R, 1995, BIOCHEM PHARMACOL, V50, P83, DOI 10.1016/0006-2952(95)00109-D; Messerschmidt A., 2007, XRAY DIFFRACTION BIO; Miller AM, 2008, BRIT J PHARMACOL, V153, P299, DOI 10.1038/sj.bjp.0707523; MITCHELL DC, 1990, BIOCHEMISTRY-US, V29, P9143, DOI 10.1021/bi00491a007; Mozsolits H, 2002, BIOCHEMISTRY-US, V41, P7830, DOI 10.1021/bi0121813; MUMBY SM, 1994, METHOD ENZYMOL, V237, P254; Nebane NM, 2008, BIOCHEMISTRY-US, V47, P13811, DOI 10.1021/bi8007802; Niu SL, 2009, BIOCHEMISTRY-US, V48, P156, DOI 10.1021/bi801835s; Nunez E, 2004, SYNAPSE, V53, P208, DOI 10.1002/syn.20050; Pacher P, 2006, PHARMACOL REV, V58, P389, DOI 10.1124/pr.58.3.2; Petrache HI, 2004, BIOPHYS J, V86, P1574, DOI 10.1016/S0006-3495(04)74225-3; Polozov IV, 2006, BIOPHYS J, V90, P2051, DOI 10.1529/biophysj.105.070441; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rigaud JL, 2003, METHOD ENZYMOL, V372, P65; Roy MT, 1998, J COLLOID INTERF SCI, V206, P512, DOI 10.1006/jcis.1998.5715; Sarnataro D, 2005, FEBS LETT, V579, P6343, DOI 10.1016/j.febslet.2005.10.016; Sarramegna V, 2006, CELL MOL LIFE SCI, V63, P1149, DOI 10.1007/s00018-005-5557-6; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Schubert R, 2003, METHOD ENZYMOL, V367, P46; Shoemaker JL, 2005, J PHARMACOL EXP THER, V315, P828, DOI 10.1124/jpet.105.089474; SILVIUS JR, 1992, ANNU REV BIOPH BIOM, V21, P323, DOI 10.1146/annurev.bb.21.060192.001543; Soubias O, 2006, BIOCHEMISTRY-US, V45, P15583, DOI 10.1021/bi061416d; SUGIURA T, 1995, BIOCHEM BIOPH RES CO, V215, P89, DOI 10.1006/bbrc.1995.2437; Swaminath G, 2005, J BIOL CHEM, V280, P22165, DOI 10.1074/jbc.M502352200; THOMAS BF, 1990, J PHARMACOL EXP THER, V255, P624; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; VANAKEN T, 1986, METHOD ENZYMOL, V125, P27; WATTS A, 1979, BIOCHEMISTRY-US, V18, P5006, DOI 10.1021/bi00589a031; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; WILDMAN DE, 1993, P NATL ACAD SCI USA, V90, P794, DOI 10.1073/pnas.90.3.794; Xie XQ, 2005, J BIOL CHEM, V280, P3605, DOI 10.1074/jbc.M410294200; Xie XQ, 2003, PROTEINS, V53, P307, DOI 10.1002/prot.10511; Yeliseev AA, 2005, PROTEIN SCI, V14, P2638, DOI 10.1110/ps.051550305; Yeliseev A, 2007, PROTEIN EXPRES PURIF, V53, P153, DOI 10.1016/j.pep.2006.12.003; ZACHOWSKI A, 1993, BIOCHEM J, V294, P1	79	35	35	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					4076	4087		10.1074/jbc.M111.268425	http://dx.doi.org/10.1074/jbc.M111.268425			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22134924	hybrid, Green Published			2022-12-27	WOS:000300410900041
J	Miller, TW; Wang, EA; Gould, S; Stein, EV; Kaur, S; Lim, L; Amarnath, S; Fowler, DH; Roberts, DD				Miller, Thomas W.; Wang, Evelyn A.; Gould, Serge; Stein, Erica V.; Kaur, Sukhbir; Lim, Langston; Amarnath, Shoba; Fowler, Daniel H.; Roberts, David D.			Hydrogen Sulfide Is an Endogenous Potentiator of T Cell Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISCHEMIA-REPERFUSION INJURY; CYSTATHIONINE-GAMMA-LYASE; ANIMATION-LIKE STATE; ACTIN POLYMERIZATION; MYOCARDIAL-ISCHEMIA; COLONIC SULFIDE; LYMPHOCYTE; MICE; GLUTATHIONE; INHIBITION	H2S is an endogenous signaling molecule that may act via protein sulfhydrylation to regulate various physiological functions. H2S is also a byproduct of dietary sulfate metabolism by gut bacteria. Inflammatory bowel diseases such as ulcerative colitis are associated with an increase in the colonization of the intestine by sulfate reducing bacteria along with an increase in H2S production. Consistent with its increased production, H2S is implicated as a mediator of ulcerative colitis both in its genesis or maintenance. As T cells are well established mediators of inflammatory bowel disease, we investigated the effect of H2S exposure on T cell activation. Using primary mouse T lymphocytes (CD3+), OT-II CD4+ T cells, and the human Jurkat T cell line, we show that physiological levels of H2S potentiate TCR-induced activation. Nanomolar levels of H2S (50-500 nM) enhance T cell activation assessed by CD69 expression, interleukin-2 expression, and CD25 levels. Exposure of T cells to H2S dose-dependently enhances TCR-stimulated proliferation with a maximum at 300 nM (30% increase, p < 0.01). Furthermore, activation increases the capacity of T cells to make H2S via increased expression of cystathionine gamma-lyase and cystathionine beta-synthase. Disrupting this response by silencing these H2S producing enzymes impairs T cell activation, and proliferation and can be rescued by the addition of 300 nM H2S. Thus, H2S represents a novel autocrine immunomodulatory molecule in T cells.	[Miller, Thomas W.; Wang, Evelyn A.; Gould, Serge; Stein, Erica V.; Kaur, Sukhbir; Roberts, David D.] NCI, Pathol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Lim, Langston] NCI, Expt Carcinogenesis Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Amarnath, Shoba; Fowler, Daniel H.] NCI, Expt Transplantat & Immunol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Roberts, DD (corresponding author), NCI, Pathol Lab, Ctr Canc Res, NIH, Bldg 10,Rm 2A33,10 Ctr Dr,MSC1500, Bethesda, MD 20892 USA.	droberts@helix.nih.gov	Miller, Thomas W/G-1215-2011; amarnath, shoba/AAP-4391-2020; Roberts, David D./A-9699-2008; Kaur, Sukhbir/ADW-6023-2022	Miller, Thomas W/0000-0001-8645-2785; Roberts, David D./0000-0002-2481-2981; Kaur, Sukhbir/0000-0003-0513-6225; Stein, Erica/0000-0001-8778-8846	National Institutes of Health of the National Cancer Institute, Center for Cancer Research [1ZIA SC 009174]; NATIONAL CANCER INSTITUTE [ZIASC009174, ZIASC010288] Funding Source: NIH RePORTER	National Institutes of Health of the National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program of the National Cancer Institute, Center for Cancer Research (Grant 1ZIA SC 009174).	Abe K, 1996, J NEUROSCI, V16, P1066; Atienza JM, 2005, J BIOMOL SCREEN, V10, P795, DOI 10.1177/1087057105279635; Barathi S, 2007, INDIAN J BIOCHEM BIO, V44, P179; Baratt A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003861; Bhatia M, 2005, BRIT J PHARMACOL, V145, P141, DOI 10.1038/sj.bjp.0706186; Blackstone E, 2005, SCIENCE, V308, P518, DOI 10.1126/science.1108581; Blackstone E, 2007, SHOCK, V27, P370, DOI 10.1097/SHK.0b013e31802e27a0; BRODIE AE, 1982, EUR J BIOCHEM, V123, P159, DOI 10.1111/j.1432-1033.1982.tb06512.x; Bucci M, 2010, ARTERIOSCL THROM VAS, V30, P1998, DOI 10.1161/ATVBAHA.110.209783; Bunnell SC, 2001, IMMUNITY, V14, P315, DOI 10.1016/S1074-7613(01)00112-1; Collin M, 2005, BRIT J PHARMACOL, V146, P498, DOI 10.1038/sj.bjp.0706367; Cunha TM, 2008, EUR J PHARMACOL, V590, P127, DOI 10.1016/j.ejphar.2008.05.048; CUTHBERT JA, 1983, J CELL PHYSIOL, V116, P127, DOI 10.1002/jcp.1041160202; de Kok JB, 2005, LAB INVEST, V85, P154, DOI 10.1038/labinvest.3700208; Elrod JW, 2007, P NATL ACAD SCI USA, V104, P15560, DOI 10.1073/pnas.0705891104; Fu ZF, 2008, LIFE SCI, V82, P1196, DOI 10.1016/j.lfs.2008.04.005; Furne J, 2008, AM J PHYSIOL-REG I, V295, pR1479, DOI 10.1152/ajpregu.90566.2008; Garg SK, 2011, ANTIOXID REDOX SIGN, V15, P39, DOI 10.1089/ars.2010.3496; Garlie NK, 1999, J IMMUNOTHER, V22, P336, DOI 10.1097/00002371-199907000-00007; GIBSON GR, 1991, FEMS MICROBIOL ECOL, V86, P103, DOI 10.1111/j.1574-6968.1991.tb04799.x; GMUNDER H, 1990, CELL IMMUNOL, V129, P32, DOI 10.1016/0008-8749(90)90184-S; Griesbeck C, 2002, BIOCHEMISTRY-US, V41, P11552, DOI 10.1021/bi026032b; HARA T, 1986, J EXP MED, V164, P1988, DOI 10.1084/jem.164.6.1988; Hosoki R, 1997, BIOCHEM BIOPH RES CO, V237, P527, DOI 10.1006/bbrc.1997.6878; IWATA S, 1994, J IMMUNOL, V152, P5633; Jha S, 2008, AM J PHYSIOL-HEART C, V295, pH801, DOI 10.1152/ajpheart.00377.2008; Jiang B, 2010, ANTIOXID REDOX SIGN, V12, P1167, DOI 10.1089/ars.2009.2894; KAMATANI N, 1982, INT ARCH ALLER A IMM, V68, P84, DOI 10.1159/000233071; Kanazawa K, 1996, CANCER-AM CANCER SOC, V77, P1701, DOI 10.1002/(SICI)1097-0142(19960415)77:8<1701::AID-CNCR42>3.3.CO;2-E; Lee ZW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021077; Levine J, 1998, AM J GASTROENTEROL, V93, P83, DOI 10.1111/j.1572-0241.1998.083_c.x; Levitt MD, 1999, J CLIN INVEST, V104, P1107, DOI 10.1172/JCI7712; Li L, 2008, CIRCULATION, V117, P2351, DOI 10.1161/CIRCULATIONAHA.107.753467; Li L, 2007, FREE RADICAL BIO MED, V42, P706, DOI 10.1016/j.freeradbiomed.2006.12.011; Li ZQ, 2001, J IMMUNOL, V166, P2427, DOI 10.4049/jimmunol.166.4.2427; Lowin-Kropf B, 1998, J CELL BIOL, V140, P861, DOI 10.1083/jcb.140.4.861; Medani M, 2011, INFLAMM BOWEL DIS, V17, P1620, DOI 10.1002/ibd.21528; Mirandola P, 2007, J CELL PHYSIOL, V213, P826, DOI 10.1002/jcp.21151; Mustafa AK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000464; NOELLE RJ, 1980, CELL IMMUNOL, V50, P416, DOI 10.1016/0008-8749(80)90295-6; Olson KR, 2010, ANTIOXID REDOX SIGN, V12, P1219, DOI 10.1089/ars.2009.2921; Papapetropoulos A, 2009, P NATL ACAD SCI USA, V106, P21972, DOI 10.1073/pnas.0908047106; PARSEY MV, 1993, J IMMUNOL, V151, P1881; Pitcher MCL, 1996, GUT, V39, P1, DOI 10.1136/gut.39.1.1; REIFFENSTEIN RJ, 1992, ANNU REV PHARMACOL, V32, P109, DOI 10.1146/annurev.pa.32.040192.000545; Roediger WEW, 1997, DIGEST DIS SCI, V42, P1571, DOI 10.1023/A:1018851723920; Sechi AS, 2004, TRENDS IMMUNOL, V25, P257, DOI 10.1016/j.it.2004.03.003; Sivarajah A, 2006, SHOCK, V26, P154, DOI 10.1097/01.shk.0000225722.56681.64; Sivarajah A, 2009, SHOCK, V31, P267, DOI 10.1097/SHK.0b013e318180ff89; Smith JL, 2003, J BIOL CHEM, V278, P41034, DOI 10.1074/jbc.M305615200; STERN JB, 1986, SCIENCE, V233, P203, DOI 10.1126/science.3523754; Tan BH, 2010, NEUROCHEM INT, V56, P3, DOI 10.1016/j.neuint.2009.08.008; Taniguchi E, 2009, TOXICOLOGY, V264, P96, DOI 10.1016/j.tox.2009.07.018; Tiranti V, 2009, NAT MED, V15, P200, DOI 10.1038/nm.1907; Tripatara P, 2008, LAB INVEST, V88, P1038, DOI 10.1038/labinvest.2008.73; VALITUTTI S, 1995, J EXP MED, V181, P577, DOI 10.1084/jem.181.2.577; Vicente-Manzanares M, 2004, NAT REV IMMUNOL, V4, P110, DOI 10.1038/nri1268; Wang MJ, 2010, CLIN EXP PHARMACOL P, V37, P764, DOI 10.1111/j.1440-1681.2010.05371.x; Wilson K, 2008, DIGEST DIS SCI, V53, P277, DOI 10.1007/s10620-007-9854-9; Yan ZH, 2009, NAT CHEM BIOL, V5, P721, DOI 10.1038/nchembio.212; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Yong QC, 2008, AM J PHYSIOL-HEART C, V295, pH1330, DOI 10.1152/ajpheart.00244.2008; Yong R, 2001, COMP BIOCHEM PHYS B, V129, P129, DOI 10.1016/S1096-4959(01)00309-8; Zanardo RCO, 2006, FASEB J, V20, P2118, DOI 10.1096/fj.06-6270fje; Zhang HL, 2007, AM J PHYSIOL-LUNG C, V292, pL960, DOI 10.1152/ajplung.00388.2006; Zhu XY, 2010, CELL MOL LIFE SCI, V67, P1119, DOI 10.1007/s00018-009-0250-9	67	86	90	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					4211	4221		10.1074/jbc.M111.307819	http://dx.doi.org/10.1074/jbc.M111.307819			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22167178	Green Published, hybrid			2022-12-27	WOS:000300410900054
J	Fernandez, JA; Skryma, R; Bidaux, G; Magleby, KL; Scholfield, CN; McGeown, JG; Prevarskaya, N; Zholos, AV				Fernandez, Jose A.; Skryma, Roman; Bidaux, Gabriel; Magleby, Karl L.; Scholfield, C. Norman; McGeown, J. Graham; Prevarskaya, Natalia; Zholos, Alexander V.			Short Isoforms of the Cold Receptor TRPM8 Inhibit Channel Gating by Mimicking Heat Action Rather than Chemical Inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ION-CHANNEL; KINETIC STRUCTURE; SENSORY NEURONS; SINGLE; TEMPERATURE; ACTIVATION; MENTHOL; VOLTAGE; THERMOSENSATION; IDENTIFICATION	Transient receptor potential (TRP) channels couple various environmental factors to changes in membrane potential, calcium influx, and cell signaling. They also integrate multiple stimuli through their typically polymodal activation. Thus, although the TRPM8 channel has been extensively investigated as the major neuronal cold sensor, it is also regulated by various chemicals, as well as by several short channel isoforms. Mechanistic understanding of such complex regulation is facilitated by quantitative single-channel analysis. We have recently proposed a single-channel mechanism of TRPM8 regulation by voltage and temperature. Using this gating mechanism, we now investigate TRPM8 inhibition in cell-attached patches using HEK293 cells expressing TRPM8 alone or coexpressed with its short sM8-6 isoform. This is compared with inhibition by the chemicals N-(4-tert-butylphenyl)-4-(3-chloropyridin-2-yl)piperazine-1-carboxamide (BCTC) and clotrimazole or by elevated temperature. We found that within the seven-state single-channel gating mechanism, inhibition of TRPM8 by short sM8-6 isoforms closely resembles inhibition by increased temperature. In contrast, inhibition by BCTC and that by clotrimazole share a different set of common features.	[Fernandez, Jose A.; McGeown, J. Graham; Zholos, Alexander V.] Queens Univ Belfast, Ctr Vis & Vasc Sci, Belfast BT12 6BA, Antrim, North Ireland; [Skryma, Roman; Bidaux, Gabriel; Prevarskaya, Natalia] Lille Univ Sci & Technol, INSERM, U800, Lab Cell Physiol, F-59655 Villeneuve Dascq, France; [Magleby, Karl L.] Univ Miami, Miller Sch Med, Dept Physiol & Biophys, Miami, FL 33101 USA; [Scholfield, C. Norman] Naresuan Univ, Fac Pharmaceut Sci, Phitsanulok 65000, Thailand	Queens University Belfast; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; University of Miami; Naresuan University	Fernandez, JA (corresponding author), Queens Univ Belfast, Ctr Vis & Vasc Sci, Belfast BT12 6BA, Antrim, North Ireland.	jfernandezgonzalez01@qub.ac.uk; a.zholos@qub.ac.uk	Zholos, Alexander/A-7017-2011; Bidaux, Gabriel/F-1294-2016	Zholos, Alexander/0000-0002-4320-149X; Scholfield, Charles Norman/0000-0001-7288-590X; Prevarskaya, natacha/0000-0003-0316-197X; Fernandez, Jose A/0000-0002-4199-5513; Bidaux, Gabriel/0000-0002-6162-3223	European Social Fund; National Institutes of Health [AR32805]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR032805, R37AR032805] Funding Source: NIH RePORTER	European Social Fund(European Social Fund (ESF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the European Social Fund (to A. V. Z., J. G. M., C. N. S., and J. A. F.) and by National Institutes of Health Grant AR32805 (to K. L. M.).	Abeele FV, 2006, J BIOL CHEM, V281, P40174, DOI 10.1074/jbc.M605779200; Behrendt HJ, 2004, BRIT J PHARMACOL, V141, P737, DOI 10.1038/sj.bjp.0705652; Bidaux G, 2012, J BIOL CHEM, V287, P2948, DOI 10.1074/jbc.M111.270256; BLATZ AL, 1986, BIOPHYS J, V49, P967, DOI 10.1016/S0006-3495(86)83725-0; Brauchi S, 2006, J NEUROSCI, V26, P4835, DOI 10.1523/JNEUROSCI.5080-05.2006; Brauchi S, 2007, P NATL ACAD SCI USA, V104, P10246, DOI 10.1073/pnas.0703420104; Chu X, 2005, CELL CALCIUM, V37, P173, DOI 10.1016/j.ceca.2004.08.005; Colquhoun David, 1995, P483; Fernandez JA, 2011, J GEN PHYSIOL, V137, P173, DOI 10.1085/jgp.201010498; Gkika D, 2009, BBA-MOL CELL RES, V1793, P953, DOI 10.1016/j.bbamcr.2008.11.010; Grandl J, 2008, NAT NEUROSCI, V11, P1007, DOI 10.1038/nn.2169; Grandl J, 2010, NAT NEUROSCI, V13, P708, DOI 10.1038/nn.2552; HAWKES AG, 1992, PHILOS T ROY SOC B, V337, P383, DOI 10.1098/rstb.1992.0116; HORN R, 1983, BIOPHYS J, V43, P207, DOI 10.1016/S0006-3495(83)84341-0; Hui KK, 2003, BIOPHYS J, V84, P2957, DOI 10.1016/S0006-3495(03)70022-8; Latorre R, 2007, CELL CALCIUM, V42, P427, DOI 10.1016/j.ceca.2007.04.004; Madrid R, 2006, J NEUROSCI, V26, P12512, DOI 10.1523/JNEUROSCI.3752-06.2006; MAGLEBY KL, 1992, P ROY SOC B-BIOL SCI, V249, P133, DOI 10.1098/rspb.1992.0095; Malkia A, 2007, J PHYSIOL-LONDON, V581, P155, DOI 10.1113/jphysiol.2006.123059; Malkia A, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-62; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Meseguer V, 2008, J NEUROSCI, V28, P576, DOI 10.1523/JNEUROSCI.4772-07.2008; Otsuguro KI, 2008, J BIOL CHEM, V283, P10026, DOI 10.1074/jbc.M707306200; Patel T, 2007, J AM ACAD DERMATOL, V57, P873, DOI 10.1016/j.jaad.2007.04.008; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Qin F, 1996, BIOPHYS J, V70, P264, DOI 10.1016/S0006-3495(96)79568-1; Qin F, 1997, P ROY SOC B-BIOL SCI, V264, P375, DOI 10.1098/rspb.1997.0054; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Rothberg BS, 2000, J GEN PHYSIOL, V116, P75, DOI 10.1085/jgp.116.1.75; Rothberg BS, 1998, J GEN PHYSIOL, V111, P751, DOI 10.1085/jgp.111.6.751; Rothberg BS, 1997, BIOPHYS J, V72, P2524, DOI 10.1016/S0006-3495(97)78897-0; SIGWORTH FJ, 1987, BIOPHYS J, V52, P1047, DOI 10.1016/S0006-3495(87)83298-8; Studer M, 2010, J PHYSIOL-LONDON, V588, P3743, DOI 10.1113/jphysiol.2010.190611; Voets T, 2007, NAT CHEM BIOL, V3, P174, DOI 10.1038/nchembio862; Weil A, 2005, MOL PHARMACOL, V68, P518, DOI 10.1124/mol.105.012146; Zholos AV, 2004, J GEN PHYSIOL, V123, P581, DOI 10.1085/jgp.200309002	36	12	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					2963	2970		10.1074/jbc.M111.272823	http://dx.doi.org/10.1074/jbc.M111.272823			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22128172	Green Published, hybrid			2022-12-27	WOS:000300295100004
J	Fu, R; Jinnah, HA				Fu, Rong; Jinnah, H. A.			Genotype-Phenotype Correlations in Lesch-Nyhan Disease MOVING BEYOND THE GENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE; SINGLE NUCLEOTIDE SUBSTITUTION; KELLEY-SEEGMILLER-SYNDROME; VITRO AMPLIFIED CDNA; HPRT DEFICIENCY; MOLECULAR-BASIS; TRANSFERASE DEFICIENCY; PLASMODIUM-FALCIPARUM; ARGENTINE PATIENTS; MISSENSE MUTATION	Lesch-Nyhan disease and its attenuated variants are caused by mutations in the HPRT1 gene, which encodes the purine recycling enzyme hypoxanthine-guanine phosphoribosyltransferase. The mutations are heterogeneous, with more than 400 different mutations already documented. Prior efforts to correlate variations in the clinical phenotype with different mutations have suggested that milder phenotypes typically are associated with mutants that permit some residual enzyme function, whereas the most severe phenotype is associated with null mutants. However, multiple exceptions to this concept have been reported. In the current studies 44 HPRT1 mutations associated with a wide spectrum of clinical phenotypes were reconstructed by site-directed mutagenesis, the mutant enzymes were expressed in vitro and purified, and their kinetic properties were examined toward their substrates hypoxanthine, guanine, and phosphoribosylpyrophosphate. The results provide strong evidence for a correlation between disease severity and residual catalytic activity of the enzyme (k(cat)) toward each of its substrates as well as several mechanisms that result in exceptions to this correlation. There was no correlation between disease severity and the affinity of the enzyme for its substrates (K-m). These studies provide a valuable model for understanding general principles of genotype-phenotype correlations in human disease, as the mechanisms involved are applicable to many other disorders.	[Jinnah, H. A.] Emory Univ, Dept Neurol, Atlanta, GA 30322 USA; Emory Univ, Dept Human Genet, Atlanta, GA 30322 USA; Emory Univ, Dept Pediat, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University	Jinnah, HA (corresponding author), Emory Univ, Dept Neurol, Woodruff Mem Res Bldg,Suite 6300, Atlanta, GA 30322 USA.	hjinnah@emory.edu			National Institutes of Health [HD R01 053312, DK R24 082840]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD053312] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK082840] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HD R01 053312 and DK R24 082840.	Bertelli M, 2004, J INHERIT METAB DIS, V27, P767, DOI 10.1023/B:BOLI.0000045799.78633.23; BOUWENSROMBOUTS AGM, 1993, HUM GENET, V91, P451, DOI 10.1007/BF00217770; BOYD M, 1993, HUM MUTAT, V2, P127, DOI 10.1002/humu.1380020212; BURGEMEISTER R, 1994, ADV EXP MED BIOL, V370, P331; Chang SJ, 1999, J RHEUMATOL, V26, P1802; CHOI Y, 1993, PEDIATR NEPHROL, V7, P739, DOI 10.1007/BF01213340; Cossu A, 2002, Clin Exp Rheumatol, V20, P851; Craig SP, 2000, J BIOL CHEM, V275, P20231, DOI 10.1074/jbc.R000002200; Curto R, 1998, BIOCHEM J, V329, P477, DOI 10.1042/bj3290477; DAVIDSON BL, 1989, J CLIN INVEST, V84, P342, DOI 10.1172/JCI114160; DAVIDSON BL, 1991, AM J HUM GENET, V48, P951; de Gemmis P, 2010, MUTAT RES-FUND MOL M, V692, P1, DOI 10.1016/j.mrfmmm.2010.07.003; Deutsch SI, 2005, CLIN NEUROPHARMACOL, V28, P28, DOI 10.1097/01.wnf.0000152043.36198.25; Duan JX, 2004, HUM MUTAT, V23, P599, DOI 10.1002/humu.20047; Dussol B, 2004, J INHERIT METAB DIS, V27, P543, DOI 10.1023/B:BOLI.0000037399.72152.a9; Ea HK, 2009, ARTHRITIS RHEUM-US, V60, P2201, DOI 10.1002/art.24617; Fairbanks L D, 1986, Adv Exp Med Biol, V195 Pt A, P101; FAIRBANKS LD, 1987, J INHERIT METAB DIS, V10, P174, DOI 10.1007/BF01800045; FUJIMORI S, 1994, ADV EXP MED BIOL, V370, P679; FUJIMORI S, 1991, ADV EXP MED BIOL, V309, P101; FUJIMORI S, 1992, HUM GENET, V90, P385; GIACOMELLO A, 1978, J BIOL CHEM, V253, P6038; GIBBS RA, 1989, P NATL ACAD SCI USA, V86, P1919, DOI 10.1073/pnas.86.6.1919; GIBBS RA, 1990, GENOMICS, V7, P235, DOI 10.1016/0888-7543(90)90545-6; GORDON RB, 1990, J INHERIT METAB DIS, V13, P692, DOI 10.1007/BF01799570; Hersh J H, 1986, Pediatr Neurol, V2, P302, DOI 10.1016/0887-8994(86)90025-1; HidalgoLaos RI, 1997, PEDIATR NEPHROL, V11, P645, DOI 10.1007/s004670050357; HOLLAND MJC, 1976, J CLIN INVEST, V57, P1600, DOI 10.1172/JCI108430; Jinnah H, 2001, METABOLIC MOL BASES, P2537; Jinnah HA, 2010, BRAIN, V133, P671, DOI 10.1093/brain/awq013; Jinnah HA, 2006, BRAIN, V129, P1201, DOI 10.1093/brain/awl056; Jinnah HA, 2004, NUCLEOS NUCLEOT NUCL, V23, P1153, DOI 10.1081/NCN-200027400; Jinnah HA, 2000, MUTAT RES-REV MUTAT, V463, P309, DOI 10.1016/S1383-5742(00)00052-1; JOLLY DJ, 1983, P NATL ACAD SCI-BIOL, V80, P477, DOI 10.1073/pnas.80.2.477; Jurecka A, 2008, J INHERIT METAB DIS, V31, pS447, DOI 10.1007/s10545-008-1013-8; Keebaugh AC, 2007, GENOMICS, V89, P134, DOI 10.1016/j.ygeno.2006.07.003; Keough DT, 1999, MOL BIOCHEM PARASIT, V98, P29, DOI 10.1016/S0166-6851(98)00139-X; KEOUGH DT, 1988, J INHERIT METAB DIS, V11, P229, DOI 10.1007/BF01800364; Kim Ki Joong, 1997, Journal of Korean Medical Science, V12, P332; KIM SH, 1986, NUCLEIC ACIDS RES, V14, P3103, DOI 10.1093/nar/14.7.3103; Larovere LE, 2007, NUCLEOS NUCLEOT NUCL, V26, P255, DOI 10.1080/15257770701257269; Larovere LE, 2004, MOL GENET METAB, V81, P352, DOI 10.1016/j.ymgme.2004.01.013; Lee W J, 1995, Zhonghua Yi Xue Za Zhi (Taipei), V56, P359; LIGHTFOOT T, 1994, HUM MOL GENET, V3, P1377, DOI 10.1093/hmg/3.8.1377; Mak BS, 2000, PEDIATR NEUROL, V23, P332, DOI 10.1016/S0887-8994(00)00199-5; Melton D W, 1987, Oxf Surv Eukaryot Genes, V4, P34; OLSEN AS, 1977, BIOCHEMISTRY-US, V16, P2501, DOI 10.1021/bi00630a029; PAGE T, 1989, ADV EXP MED BIOL, V253, P129; PAGE T, 1981, J INHERIT METAB DIS, V4, P203, DOI 10.1007/BF02263652; PATEL PI, 1986, MOL CELL BIOL, V6, P393, DOI 10.1128/MCB.6.2.393; Popowska Ewa, 1998, Journal of Applied Genetics, V39, P103; Puig JG, 2001, MEDICINE, V80, P102, DOI 10.1097/00005792-200103000-00003; RIJKSEN G, 1981, HUM GENET, V57, P39, DOI 10.1007/BF00271165; Sampat R, 2011, HUM GENET, V129, P71, DOI 10.1007/s00439-010-0901-9; SCULLEY DG, 1992, HUM GENET, V90, P195; SCULLEY DG, 1991, HUM GENET, V87, P688; Sebesta I, 2008, NUCLEOS NUCLEOT NUCL, V27, P648, DOI 10.1080/15257770802143863; Sege-Peterson Karin, 1992, Human Molecular Genetics, V1, P427, DOI 10.1093/hmg/1.6.427; Shi WX, 1999, NAT STRUCT BIOL, V6, P588; Sinha SC, 2001, CURR OPIN STRUC BIOL, V11, P733, DOI 10.1016/S0959-440X(01)00274-3; Srivastava T, 2002, AM J MED GENET, V108, P219, DOI 10.1002/ajmg.10217; STOUT JT, 1985, ANNU REV GENET, V19, P127, DOI 10.1146/annurev.genet.19.1.127; Subbayya INS, 2000, BIOCHEM BIOPH RES CO, V272, P596, DOI 10.1006/bbrc.2000.2816; TARLE SA, 1991, GENOMICS, V10, P499, DOI 10.1016/0888-7543(91)90341-B; TOHYAMA J, 1994, HUM GENET, V93, P175; Torres RJ, 2000, HUM MUTAT, V15, P383, DOI 10.1002/(SICI)1098-1004(200004)15:4<383::AID-HUMU17>3.0.CO;2-2; Willers I, 1999, J INHERIT METAB DIS, V22, P845, DOI 10.1023/A:1005522527689; WILSON JM, 1983, NEW ENGL J MED, V309, P900; WILSON JM, 1986, J CLIN INVEST, V77, P188, DOI 10.1172/JCI112275; Wu CH, 2007, J RHEUMATOL, V34, P794; Xu YM, 1997, BIOCHEMISTRY-US, V36, P3700, DOI 10.1021/bi9616007; Yamada Y, 2004, NUCLEOS NUCLEOT NUCL, V23, P1169, DOI 10.1081/NCN-200027439; YAMADA Y, 1992, HUM GENET, V90, P379; YAMADA Y, 1991, ADV EXP MED BIOL, V309, P121; Yamada Y, 2008, NUCLEOS NUCLEOT NUCL, V27, P570, DOI 10.1080/15257770802135869	75	30	36	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					2997	3008		10.1074/jbc.M111.317701	http://dx.doi.org/10.1074/jbc.M111.317701			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22157001	Green Published, hybrid			2022-12-27	WOS:000300295100007
J	Fuchs, SM; Kizer, KO; Braberg, H; Krogan, NJ; Strahl, BD				Fuchs, Stephen M.; Kizer, Kelby O.; Braberg, Hannes; Krogan, Nevan J.; Strahl, Brian D.			RNA Polymerase II Carboxyl-terminal Domain Phosphorylation Regulates Protein Stability of the Set2 Methyltransferase and Histone H3 Di- and Trimethylation at Lysine 36	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; TRANSCRIPTIONAL ELONGATION; CRYPTIC TRANSCRIPTION; DEACETYLASE COMPLEX; SET2/RPD3S PATHWAY; GENETIC-ANALYSIS; BINDING MODULES; GENOME-WIDE; CTD CODE; YEAST	Methylation of lysine 36 on histone H3 (H3K36) is catalyzed by the Set2 methyltransferase and is linked to transcriptional regulation. Previous studies have shown that trimethylation of H3K36 by Set2 is directed through its association with the phosphorylated repeats of the RNA polymerase C-terminal domain (RNAPII CTD). Here, we show that disruption of this interaction through the use of yeast mutants defective in CTD phosphorylation at serine 2 results in a destabilization of Set2 protein levels and H3K36 methylation. Consistent with this, we find that Set2 has a short half-life and is co-regulated, with RNAPII CTD phosphorylation levels, during logarithmic growth in yeast. To probe the functional consequence of uncoupling Set2-RNAPII regulation, we expressed a truncated and more stable form of Set2 that is capable of dimethylation but not trimethylation in vivo. Results of high throughput synthetic genetic analyses show that this Set2 variant has distinct genetics from either SET2 or set2 Delta and is synthetically sick or lethal with a number of transcription elongation mutants. Collectively, these results provide molecular insight into the regulation of Set2 protein levels that influence H3K36 methylation states.	[Fuchs, Stephen M.; Kizer, Kelby O.; Strahl, Brian D.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Fuchs, Stephen M.; Strahl, Brian D.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Braberg, Hannes; Krogan, Nevan J.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California San Francisco	Strahl, BD (corresponding author), 120 Mason Farm Rd,Suite 3010, Chapel Hill, NC 27599 USA.	brian_strahl@med.unc.edu	Fuchs, Stephen/I-7251-2012; Strahl, Brian/C-7601-2012	Strahl, Brian/0000-0002-4947-6259; Fuchs, Stephen/0000-0001-7261-9214	National Institutes of Health [R01GM68088]; National Research Service [F32 GM80896]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084448, F32GM080896, R01GM068088] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM68088 (to B. D. S.). This work was also supported by National Research Service Award Postdoctoral Fellowship F32 GM80896 (to S. M. F.).	Belle A, 2006, P NATL ACAD SCI USA, V103, P13004, DOI 10.1073/pnas.0605420103; Biswas D, 2006, EMBO J, V25, P4479, DOI 10.1038/sj.emboj.7601333; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Bua DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006789; Buratowski S, 2003, NAT STRUCT BIOL, V10, P679, DOI 10.1038/nsb0903-679; Burke D., 2000, METHODS YEAST GENETI, P174; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Chapman RD, 2007, SCIENCE, V318, P1780, DOI 10.1126/science.1145977; Cheung V, 2008, PLOS BIOL, V6, P2550, DOI 10.1371/journal.pbio.0060277; Chu Y, 2007, EMBO J, V26, P4646, DOI 10.1038/sj.emboj.7601887; Chu YY, 2006, MOL CELL BIOL, V26, P3029, DOI 10.1128/MCB.26.8.3029-3038.2006; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Egloff S, 2007, SCIENCE, V318, P1777, DOI 10.1126/science.1145989; Fuchs SM, 2009, BBA-GENE REGUL MECH, V1789, P26, DOI 10.1016/j.bbagrm.2008.07.008; Gardner KE, 2011, J MOL BIOL, V409, P36, DOI 10.1016/j.jmb.2011.01.040; Gelbart ME, 2001, MOL CELL BIOL, V21, P2098, DOI 10.1128/MCB.21.6.2098-2106.2001; Gietz RD, 2007, NAT PROTOC, V2, P35, DOI 10.1038/nprot.2007.14; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Joshi AA, 2005, MOL CELL, V20, P971, DOI 10.1016/j.molcel.2005.11.021; Kaplan CD, 2003, SCIENCE, V301, P1096, DOI 10.1126/science.1087374; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kim T, 2009, CELL, V137, P259, DOI 10.1016/j.cell.2009.02.045; Kizer KO, 2005, MOL CELL BIOL, V25, P3305, DOI 10.1128/MCB.25.8.3305-3316.2005; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; Lenstra TL, 2011, MOL CELL, V42, P536, DOI 10.1016/j.molcel.2011.03.026; Li B, 2003, J BIOL CHEM, V278, P8897, DOI 10.1074/jbc.M212134200; Li B, 2007, GENE DEV, V21, P1422, DOI 10.1101/gad.1539307; Li B, 2007, SCIENCE, V316, P1050, DOI 10.1126/science.1139004; Li B, 2009, J BIOL CHEM, V284, P7970, DOI 10.1074/jbc.M808220200; Lickwar CR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004886; Martin DGE, 2006, MOL CELL BIOL, V26, P3018, DOI 10.1128/MCB.26.8.3018-3028.2006; Nordick K, 2008, EUKARYOT CELL, V7, P1158, DOI 10.1128/EC.00434-07; Pal B, 2007, MOL BIOL CELL, V18, P426, DOI 10.1091/mbc.E06-04-0304; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Rando OJ, 2007, CURR OPIN GENET DEV, V17, P94, DOI 10.1016/j.gde.2007.02.006; Rao B, 2005, MOL CELL BIOL, V25, P9447, DOI 10.1128/MCB.25.21.9447-9459.2005; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Schaft D, 2003, NUCLEIC ACIDS RES, V31, P2475, DOI 10.1093/nar/gkg372; Schuldiner M, 2006, METHODS, V40, P344, DOI 10.1016/j.ymeth.2006.07.034; Shivaswamy S, 2008, MOL CELL BIOL, V28, P2221, DOI 10.1128/MCB.01659-07; Strahl BD, 2002, MOL CELL BIOL, V22, P1298, DOI 10.1128/MCB.22.5.1298-1306.2002; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Taverna SD, 2006, MOL CELL, V24, P785, DOI 10.1016/j.molcel.2006.10.026; Tietjen JR, 2010, NAT STRUCT MOL BIOL, V17, P1154, DOI 10.1038/nsmb.1900; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Tong AHY, 2007, METHOD MICROBIOL, V36, P369, DOI 10.1016/S0580-9517(06)36016-3; Vojnic E, 2006, J BIOL CHEM, V281, P13, DOI 10.1074/jbc.C500423200; WEST ML, 1995, GENETICS, V140, P1223; Xiao TJ, 2003, GENE DEV, V17, P654, DOI 10.1101/gad.1055503; Youdell ML, 2008, MOL CELL BIOL, V28, P4915, DOI 10.1128/MCB.00001-08; Yun MY, 2011, CELL RES, V21, P564, DOI 10.1038/cr.2011.42; Zhou K, 2009, P NATL ACAD SCI USA, V106, P6956, DOI 10.1073/pnas.0806302106	53	38	40	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3249	3256		10.1074/jbc.M111.273953	http://dx.doi.org/10.1074/jbc.M111.273953			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22157004	hybrid, Green Published			2022-12-27	WOS:000300295100030
J	Lugassy, J; Zaffryar-Eilot, S; Soueid, S; Mordoviz, A; Smith, V; Kessler, O; Neufeld, G				Lugassy, Jennie; Zaffryar-Eilot, Shelly; Soueid, Sharon; Mordoviz, Amit; Smith, Victoria; Kessler, Ofra; Neufeld, Gera			The Enzymatic Activity of Lysyl Oxidas-like-2 (LOXL2) Is Not Required for LOXL2-induced Inhibition of Keratinocyte Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR PROGRESSION; OXIDASE; EXPRESSION; ADHESION; CARCINOMAS; MODULATION; PROTEIN; DOMAIN; CELLS; ASSAY	Lysyl oxidase-like-2 (LOXL2) induces tumor progression and fibrosis. It also inhibits the differentiation of keratinocytes promoting development of squamous cell carcinomas. Stimulation of HaCaT skin keratinocytes with exogenous LOXL2 or overexpression of LOXL2 in these cells inhibits their differentiation as manifested by inhibition of calcium or vitamin D-induced involucrin expression. The inhibition was abrogated by the LOXL2 function-blocking monoclonal antibody AB0023 as well as by an anti-LOXL2 polyclonal antibody. Surprisingly, a point-mutated form of LOXL2 (LOXL2(Y689F)) lacking enzymatic activity, as well as a LOXL2 deletion mutant lacking the entire catalytic domain, also inhibited calcium or vitamin D-induced up-regulation of involucrin expression, suggesting that the enzymatic activity of LOXL2 is not required for this activity. This conclusion was supported by experiments that showed that beta-aminoproprionitrile, an irreversible competitive inhibitor of the enzymatic activity of all lysyl oxidases, is unable to abolish the LOXL2-induced inhibition of HaCaT cell differentiation. The activity of LOXL2(Y689F) required the presence of the fourth scavenger receptor-cysteine-rich (SRCR) domain of LOXL2, which is also the binding target of AB0023. Epitope-tagged LOXL2(Y689F) was internalized at 37 degrees C by HaCaT cells. The internalization was inhibited by AB0023 and by competition with unlabeled LOXL2, suggesting that these cells may express a LOXL2 receptor. Our results suggest that agents that inhibit the enzymatic activity of LOXL2 may not suffice to inhibit completely the effects of LOXL2 on complex processes that involve altered states of cellular differentiation.	[Smith, Victoria] Gilead Sci Inc, Foster City, CA 94404 USA; [Lugassy, Jennie; Zaffryar-Eilot, Shelly; Soueid, Sharon; Mordoviz, Amit; Kessler, Ofra; Neufeld, Gera] Technion Israel Inst Technol, Canc & Vasc Biol Res Ctr, Bruce Rappaport Fac Med, Rappaport Res Inst Med Sci, IL-31096 Haifa, Israel	Gilead Sciences; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Neufeld, G (corresponding author), Israel Inst Technol, Canc Res & Vasc Biol Ctr, Bruce Rappaport Fac Med Technion, POB 9679,1 Efron St, IL-31096 Haifa, Israel.	gera@tx.technion.ac.il	Neufeld, Gera/F-1524-2019		Arresto Biosciences Inc.; Israel Cancer Research Fund; Rappaport Family Institute for Research in the Medical Sciences of Technion	Arresto Biosciences Inc.; Israel Cancer Research Fund; Rappaport Family Institute for Research in the Medical Sciences of Technion	This work was supported by a research grant from Arresto Biosciences Inc., by a grant from the Israel Cancer Research Fund (to G. N.), and by a grant from the Rappaport Family Institute for Research in the Medical Sciences of Technion. Gilead Sciences is clinically testing a drug targeting LOXL2, which is based upon my patents (G. N.). However, Gilead Sciences does not fund research in my laboratory, nor am I or any of the other authors on their payroll except for V. S., who is a Gilead Sciences employee.	Akiri G, 2003, CANCER RES, V63, P1657; Akiri G, 2009, ONCOGENE, V28, P2163, DOI 10.1038/onc.2009.82; Barry-Hamilton V, 2010, NAT MED, V16, P1009, DOI 10.1038/nm.2208; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Bowen MA, 1996, J BIOL CHEM, V271, P17390, DOI 10.1074/jbc.271.29.17390; Brekhman V, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-415; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Fujimoto E, 2009, J DERMATOL SCI, V55, P91, DOI 10.1016/j.jdermsci.2009.03.010; Fux L, 2009, CANCER RES, V69, P1758, DOI 10.1158/0008-5472.CAN-08-1837; Martinez VG, 2011, PHARMACOL REV, V63, P967, DOI 10.1124/pr.111.004523; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Hussain MM, 2001, FRONT BIOSCI, V6, pD417, DOI 10.2741/Hussain1; Jiang YJ, 2008, J INVEST DERMATOL, V128, P104, DOI 10.1038/sj.jid.5700944; Kigel B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003287; Kikuchi A, 2007, J BIOCHEM, V141, P443, DOI 10.1093/jb/mvm061; Le Provost GS, 2010, EXP DERMATOL, V19, P1080, DOI 10.1111/j.1600-0625.2010.01135.x; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Lucero HA, 2006, CELL MOL LIFE SCI, V63, P2304, DOI 10.1007/s00018-006-6149-9; Maki JM, 2009, HISTOL HISTOPATHOL, V24, P651, DOI 10.14670/HH-24.651; Moreno-Bueno G, 2011, EMBO MOL MED, V3, P528, DOI 10.1002/emmm.201100156; Ohman T, 1999, AM J RESP CELL MOL, V21, P119, DOI 10.1165/ajrcmb.21.1.3521; Palamakumbura AH, 2002, ANAL BIOCHEM, V300, P245, DOI 10.1006/abio.2001.5464; Payne SL, 2005, CANCER RES, V65, P11429, DOI 10.1158/0008-5472.CAN-05-1274; Peinado H, 2005, EMBO J, V24, P3446, DOI 10.1038/sj.emboj.7600781; Peinado H, 2008, CANCER RES, V68, P4541, DOI 10.1158/0008-5472.CAN-07-6345; Rodriguez HM, 2010, J BIOL CHEM, V285, P20964, DOI 10.1074/jbc.M109.094136; Saito H, 1997, J BIOL CHEM, V272, P8157, DOI 10.1074/jbc.272.13.8157; Schietke R, 2010, J BIOL CHEM, V285, P6658, DOI 10.1074/jbc.M109.042424; TANG SS, 1983, J BIOL CHEM, V258, P4331; Vadasz Z, 2005, J HEPATOL, V43, P499, DOI 10.1016/j.jhep.2005.02.052; Varshavsky A, 2008, CANCER RES, V68, P6922, DOI 10.1158/0008-5472.CAN-07-5408; Wang SX, 1996, SCIENCE, V273, P1078, DOI 10.1126/science.273.5278.1078	34	38	45	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3541	3549		10.1074/jbc.M111.261016	http://dx.doi.org/10.1074/jbc.M111.261016			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22157764	Green Published, hybrid			2022-12-27	WOS:000300295100058
J	Mulligan, C; Leech, AP; Kelly, DJ; Thomas, GH				Mulligan, Christopher; Leech, Andrew P.; Kelly, David J.; Thomas, Gavin H.			The Membrane Proteins SiaQ and SiaM Form an Essential Stoichiometric Complex in the Sialic Acid Tripartite ATP-independent Periplasmic (TRAP) Transporter SiaPQM (VC1777-1779) from Vibrio cholerae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACYTOPLASMIC-SOLUTE-RECEPTOR; HAEMOPHILUS-INFLUENZAE; ESCHERICHIA-COLI; RHODOBACTER-CAPSULATUS; CRYSTAL-STRUCTURES; VIRULENCE FACTOR; BINDING; BACTERIA; EVOLUTION; FAMILY	Tripartite ATP-independent periplasmic (TRAP) transporters are widespread in bacteria but poorly characterized. They contain three subunits, a small membrane protein, a large membrane protein, and a substrate-binding protein (SBP). Although the function of the SBP is well established, the membrane components have only been studied in detail for the sialic acid TRAP transporter SiaPQM from Haemophilus influenzae, where the membrane proteins are genetically fused. Herein, we report the first in vitro characterization of a truly tripartite TRAP transporter, the SiaPQM system (VC1777-1779) from the human pathogen Vibrio cholerae. The active reconstituted transporter catalyzes unidirectional Na+-dependent sialic acid uptake having similar biochemical features to the orthologous system in H. influenzae. However, using this tripartite transporter, we demonstrate the tight association of the small, SiaQ, and large, SiaM, membrane proteins that form a 1:1 complex. Using reconstituted proteoliposomes containing particular combinations of the three subunits, we demonstrate biochemically that all three subunits are likely to be essential to form a functional TRAP transporter.	[Mulligan, Christopher; Thomas, Gavin H.] Univ York, Dept Biol, Area 10, York YO10 5YW, N Yorkshire, England; [Leech, Andrew P.] Univ York, Dept Biol, Technol Facil, York YO10 5YW, N Yorkshire, England; [Kelly, David J.] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England	University of York - UK; University of York - UK; University of Sheffield	Thomas, GH (corresponding author), Univ York, Dept Biol, Area 10, York YO10 5YW, N Yorkshire, England.	gavin.thomas@york.ac.uk	Thomas, Gavin H/E-5753-2011	Thomas, Gavin H/0000-0002-9763-1313; Mulligan, Christopher/0000-0001-5157-4651	Biotechnology and Biological Sciences Research Council [BB/F014759/1]; BBSRC [BB/F014759/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council Grant BB/F014759/1 (to G. H. T.).	Allen S, 2005, INFECT IMMUN, V73, P5291, DOI 10.1128/IAI.73.9.5291-5300.2005; Almagro-Moreno S, 2009, INFECT IMMUN, V77, P3807, DOI 10.1128/IAI.00279-09; Almagro-Moreno S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-118; BARON C, 1975, BIOCHIM BIOPHYS ACTA, V382, P276, DOI 10.1016/0005-2736(75)90270-9; Bouchet V, 2003, P NATL ACAD SCI USA, V100, P8898, DOI 10.1073/pnas.1432026100; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Fischer M, 2010, TRENDS MICROBIOL, V18, P471, DOI 10.1016/j.tim.2010.06.009; Forward JA, 1997, J BACTERIOL, V179, P5482, DOI 10.1128/jb.179.17.5482-5493.1997; Gonin S, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-11; Jenkins GA, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-48; Jeong HG, 2009, INFECT IMMUN, V77, P3209, DOI 10.1128/IAI.00109-09; Jermyn WS, 2005, MICROBIOL-SGM, V151, P311, DOI 10.1099/mic.0.27621-0; Jermyn WS, 2002, MICROBIOL-SGM, V148, P3681, DOI 10.1099/00221287-148-11-3681; Johnston JW, 2008, J BIOL CHEM, V283, P855, DOI 10.1074/jbc.M706603200; KACZOROWSKI GJ, 1979, BIOCHEMISTRY-US, V18, P3691, DOI 10.1021/bi00584a009; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kuhlmann SI, 2008, BIOCHEMISTRY-US, V47, P9475, DOI 10.1021/bi8006719; Lecher J, 2009, J MOL BIOL, V389, P58, DOI 10.1016/j.jmb.2009.03.077; MARTINEZ J, 1995, J BACTERIOL, V177, P6005, DOI 10.1128/jb.177.20.6005-6010.1995; Muller A, 2006, J BIOL CHEM, V281, P22212, DOI 10.1074/jbc.M603463200; Mulligan C, 2007, J MOL MICROB BIOTECH, V12, P218, DOI 10.1159/000099643; Mulligan C, 2011, FEMS MICROBIOL REV, V35, P68, DOI 10.1111/j.1574-6976.2010.00236.x; Mulligan C, 2009, P NATL ACAD SCI USA, V106, P1778, DOI 10.1073/pnas.0809979106; Nielsen AT, 2006, PLOS PATHOG, V2, P933, DOI 10.1371/journal.ppat.0020109; POOLMAN B, 1993, BIOCHIM BIOPHYS ACTA, V1183, P5, DOI 10.1016/0005-2728(93)90003-X; Rabus R, 1999, MICROBIOL-SGM, V145, P3431, DOI 10.1099/00221287-145-12-3431; Rohmer L, 2011, TRENDS MICROBIOL, V19, P341, DOI 10.1016/j.tim.2011.04.003; Rucktooa P, 2007, J MOL BIOL, V370, P93, DOI 10.1016/j.jmb.2007.04.047; Severi E, 2005, MOL MICROBIOL, V58, P1173, DOI 10.1111/j.1365-2958.2005.04901.x; Severi E, 2010, FEMS MICROBIOL LETT, V304, P47, DOI 10.1111/j.1574-6968.2009.01881.x; Slotboom DJ, 2008, METHODS, V46, P73, DOI 10.1016/j.ymeth.2008.06.012; Urbani A, 2005, ANAL BIOCHEM, V336, P117, DOI 10.1016/j.ab.2004.09.040; VIMR ER, 1985, J BACTERIOL, V164, P845, DOI 10.1128/JB.164.2.845-853.1985; Vimr ER, 2004, MICROBIOL MOL BIOL R, V68, P132, DOI 10.1128/MMBR.68.1.132-153.2004; Ward A, 1999, BIOCHEM SOC T, V27, P893, DOI 10.1042/bst0270893; Wyborn NR, 2001, FEMS MICROBIOL LETT, V194, P13, DOI 10.1111/j.1574-6968.2001.tb09439.x	36	28	32	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3598	3608		10.1074/jbc.M111.281030	http://dx.doi.org/10.1074/jbc.M111.281030			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22167185	hybrid, Green Published			2022-12-27	WOS:000300295100064
J	Iwata, J; Tung, L; Urata, M; Hacia, JG; Pelikan, R; Suzuki, A; Ramenzoni, L; Chaudhry, O; Parada, C; Sanchez-Lara, PA; Chai, Y				Iwata, Jun-ichi; Tung, Lily; Urata, Mark; Hacia, Joseph G.; Pelikan, Richard; Suzuki, Akiko; Ramenzoni, Liza; Chaudhry, Obaid; Parada, Carolina; Sanchez-Lara, Pedro A.; Chai, Yang			Fibroblast Growth Factor 9 (FGF9)-Pituitary Homeobox 2 (PITX2) Pathway Mediates Transforming Growth Factor beta (TGF beta) Signaling to Regulate Cell Proliferation in Palatal Mesenchyme during Mouse Palatogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEFT-RIGHT ASYMMETRY; NEURAL CREST CELLS; CRANIOFACIAL DEVELOPMENT; AORTIC-ANEURYSM; MARFAN-SYNDROME; RIEGER-SYNDROME; TOOTH MORPHOGENESIS; DOWN-REGULATION; RECEPTOR ALK5; II RECEPTOR	Cleft palate represents one of the most common congenital birth defects. Transforming growth factor beta (TGF beta) signaling plays crucial functions in regulating craniofacial development, and loss of TGF beta receptor type II in cranial neural crest cells leads to craniofacial malformations, including cleft palate in mice (Tgfbr2(fl/fl); Wnt1-Cre mice). Here we have identified candidate target genes of TGF beta signaling during palatal formation. These target genes were selected based on combining results from gene expression profiles of embryonic day 14.5 palates from Tgfbr2(fl/fl); Wnt1-Cre mice and previously identified cleft palate phenotypes in genetically engineered mouse models. We found that fibroblast growth factor 9 (Fgf9) and transcription factor pituitary homeobox 2 (Pitx2) expressions are significantly down-regulated in the palate of Tgfbr2(fl/fl); Wnt1-Cre mice, and Fgf9 and Pitx2 loss of function mutations result in cleft palate in mice. Pitx2 expression is down-regulated by siRNA knockdown of Fgf9, suggesting that Fgf9 is upstream of Pitx2. We detected decreased expression of both cyclins D1 and D3 in the palates of Tgfbr2(fl/fl); Wnt1-Cre mice, consistent with the defect in cell proliferation. Significantly, exogenous FGF9 restores expression of cyclins D1 and D3 in a Pitx2-dependent manner and rescues the cell proliferation defect in the palatal mesenchyme of Tgfbr2(fl/fl); Wnt1-Cre mice. Our study indicates that a TGF beta-FGF9-PITX2 signaling cascade regulates cranial neural crest cell proliferation during palate formation.	[Iwata, Jun-ichi; Tung, Lily; Urata, Mark; Pelikan, Richard; Suzuki, Akiko; Ramenzoni, Liza; Chaudhry, Obaid; Parada, Carolina; Chai, Yang] Univ So Calif, Ostrow Sch Dent, Ctr Craniofacial Mol Biol, Los Angeles, CA 90033 USA; [Hacia, Joseph G.] Univ So Calif, Dept Biochem & Mol Biol, Broad Ctr Regenerat Med & Stem Cell Res, Los Angeles, CA 90033 USA; [Sanchez-Lara, Pedro A.] Univ So Calif, Dept Pediat, Los Angeles, CA 90089 USA; [Tung, Lily; Urata, Mark; Chaudhry, Obaid] Univ So Calif, Keck Sch Med, Div Plast & Reconstruct Surg, Los Angeles, CA 90089 USA; [Sanchez-Lara, Pedro A.] Childrens Hosp Los Angeles, Div Med Genet, Los Angeles, CA 90027 USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California; Children's Hospital Los Angeles	Chai, Y (corresponding author), Univ So Calif, Ostrow Sch Dent, Ctr Craniofacial Mol Biol, 2250 Alcazar St,CSA 103, Los Angeles, CA 90033 USA.	ychai@usc.edu	Sanchez, Pedro/HHM-5713-2022; Sanchez-Lara, Pedro A./AAP-5644-2021; Sanchez, Pedro/P-1377-2018; Pelikan, Richard/I-4109-2013	Sanchez, Pedro/0000-0003-1181-7828; Sanchez-Lara, Pedro A./0000-0003-1181-7828; Ramenzoni, Liza L./0000-0002-7732-2118	National Institutes of Health, NIDCR [DE012711, DE014078, DE017007]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014078, R37DE012711, R01DE022503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE017007, R01DE012711] Funding Source: NIH RePORTER	National Institutes of Health, NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health, NIDCR, Grants DE012711, DE014078, and DE017007 (to Y. C.).	Ai D, 2006, DEV BIOL, V296, P437, DOI 10.1016/j.ydbio.2006.06.009; Bellusci S, 2008, NAT GENET, V40, P822, DOI 10.1038/ng0708-822; Brooke BS, 2008, NEW ENGL J MED, V358, P2787, DOI 10.1056/NEJMoa0706585; Chai Y, 2003, CRIT REV ORAL BIOL M, V14, P78, DOI 10.1177/154411130301400202; Ciminello Frank S., 2009, Comprehensive Therapy, V35, P37; Colvin JS, 2001, DEVELOPMENT, V128, P2095; Cui XM, 1998, INT J DEV BIOL, V42, P817; Denissova NG, 2000, P NATL ACAD SCI USA, V97, P6397, DOI 10.1073/pnas.090099297; Dorsky RI, 2000, BIOESSAYS, V22, P708, DOI 10.1002/1521-1878(200008)22:8<708::AID-BIES4>3.3.CO;2-E; Dudas M, 2006, DEV BIOL, V296, P298, DOI 10.1016/j.ydbio.2006.05.030; Espinoza HM, 2002, HUM MOL GENET, V11, P743, DOI 10.1093/hmg/11.7.743; Geske MJ, 2008, DEVELOPMENT, V135, P2959, DOI 10.1242/dev.020453; Govindarajan V, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-7; Habashi JP, 2011, SCIENCE, V332, P361, DOI 10.1126/science.1192152; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; HAI T, 1991, P NATL ACAD SCI USA, V88, P3720, DOI 10.1073/pnas.88.9.3720; HAI TW, 1989, GENE DEV, V3, P2083, DOI 10.1101/gad.3.12b.2083; Hayashi M, 2008, J BIOL CHEM, V283, P565, DOI 10.1074/jbc.M708154200; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Holm TM, 2011, SCIENCE, V332, P358, DOI 10.1126/science.1192149; Hosokawa R, 2010, DEV BIOL, V341, P186, DOI 10.1016/j.ydbio.2010.02.030; Ito Y, 2003, DEVELOPMENT, V130, P5269, DOI 10.1242/dev.00708; Iwao K, 2009, J CLIN INVEST, V119, P1997, DOI 10.1172/JCI38519; Iwata J, 2006, J BIOL CHEM, V281, P4035, DOI 10.1074/jbc.M512283200; Iwata J, 2010, J BIOL CHEM, V285, P4975, DOI 10.1074/jbc.M109.035105; Kalluri R, 2008, DEV CELL, V15, P1, DOI 10.1016/j.devcel.2008.06.005; Karaman MW, 2003, GENOME RES, V13, P1619, DOI 10.1101/gr.1289803; Kettunen P, 1998, DEV GENET, V22, P374, DOI 10.1002/(SICI)1520-6408(1998)22:4<374::AID-DVG7>3.0.CO;2-3; Kimura N, 2008, J MOL ENDOCRINOL, V40, P75, DOI 10.1677/JME-07-0108; Kioussi C, 2002, CELL, V111, P673, DOI 10.1016/S0092-8674(02)01084-X; Koziczak M, 2004, ONCOGENE, V23, P3501, DOI 10.1038/sj.onc.1207331; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lin CR, 1999, NATURE, V401, P279, DOI 10.1038/45803; Lindsay EA, 2001, NAT REV GENET, V2, P858, DOI 10.1038/35098574; Liu CY, 2002, DEVELOPMENT, V129, P5081; Liu CY, 2001, DEVELOPMENT, V128, P2039; Liu W, 2003, DEVELOPMENT, V130, P6375, DOI 10.1242/dev.00849; Loeys BL, 2006, NEW ENGL J MED, V355, P788, DOI 10.1056/NEJMoa055695; Loeys BL, 2005, NAT GENET, V37, P275, DOI 10.1038/ng1511; Lu MF, 1999, NATURE, V401, P276, DOI 10.1038/45797; Martin DM, 2002, AM J MED GENET, V111, P27, DOI 10.1002/ajmg.10473; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; McKeehan WL, 1998, PROG NUCLEIC ACID RE, V59, P135; Mizuguchi T, 2004, NAT GENET, V36, P855, DOI 10.1038/ng1392; Mossey PA, 2009, LANCET, V374, P1773, DOI 10.1016/S0140-6736(09)60695-4; NAKAMURA T, 1995, EXP CELL RES, V216, P422, DOI 10.1006/excr.1995.1053; Nomura M, 1998, NATURE, V393, P786, DOI 10.1038/31693; Oka K, 2007, DEV BIOL, V303, P391, DOI 10.1016/j.ydbio.2006.11.025; Oka S, 2007, MECH DEVELOP, V124, P409, DOI 10.1016/j.mod.2007.02.003; PELTON RW, 1990, DEV BIOL, V141, P456, DOI 10.1016/0012-1606(90)90401-4; Riley BM, 2007, P NATL ACAD SCI USA, V104, P4512, DOI 10.1073/pnas.0607956104; Sasaki T, 2006, DEVELOPMENT, V133, P371, DOI 10.1242/dev.02200; Semina EV, 1996, NAT GENET, V14, P392, DOI 10.1038/ng1296-392; Shah NM, 1996, CELL, V85, P331, DOI 10.1016/S0092-8674(00)81112-5; Sou Y, 2008, MOL BIOL CELL, V19, P4762, DOI 10.1091/mbc.E08-03-0309; Tolarova MM, 1998, AM J MED GENET, V75, P126; Vitelli F, 2002, HUM MOL GENET, V11, P915, DOI 10.1093/hmg/11.8.915; Wang Y., 2009, COLD SPRING HARB PRO; WANG YQ, 1995, MECH DEVELOP, V52, P275, DOI 10.1016/0925-4773(95)00408-S; Wurdak H, 2005, GENE DEV, V19, P530, DOI 10.1101/gad.317405; Xia XQ, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-306; Yoshioka H, 1998, CELL, V94, P299, DOI 10.1016/S0092-8674(00)81473-7; Yu WL, 2009, INDIAN J PLAST SURG, V42, pS35, DOI 10.4103/0970-0358.57185; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1; Zhao H, 2008, DEV BIOL, V320, P19, DOI 10.1016/j.ydbio.2008.03.045; Zhu T, 2000, J BIOL CHEM, V275, P2103, DOI 10.1074/jbc.275.3.2103	67	49	50	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2353	2363		10.1074/jbc.M111.280974	http://dx.doi.org/10.1074/jbc.M111.280974			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22123828	Green Published, hybrid			2022-12-27	WOS:000300292300011
J	Kou, RQ; Shiroto, T; Sartoretto, JL; Michel, T				Kou, Ruqin; Shiroto, Takashi; Sartoretto, Juliano L.; Michel, Thomas			Suppression of G alpha(s) Synthesis by Simvastatin Treatment of Vascular Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; EPITHELIAL-CELLS; PHOSPHORYLATION; PROTEIN; TRANSLATION; ACTIVATION; INITIATION; RAPAMYCIN; SYSTEM; 4E-BP1	These studies explore the effects of statins on cyclic AMP-modulated signaling pathways in vascular endothelial cells. We previously observed (Kou, R., Sartoretto, J., and Michel, T. (2009) J. Biol. Chem. 284, 14734-14743) that simvastatin treatment of endothelial cells leads to a marked decrease in PKA-modulated phosphorylation of the protein VASP. Here we show that long-term treatment of mice with simvastatin attenuates the vasorelaxation response to the beta-adrenergic agonist isoproterenol, without affecting endothelin-induced vasoconstriction or carbachol-induced vasorelaxation. We found that statin treatment of endothelial cells dose-dependently inhibits PKA activation as assessed by analyses of serine 157 VASP phosphorylation as well as Epac-mediated Rap1 activation. These effects of simvastatin are completely reversed by mevalonate and by geranylgeranyl pyrophosphate, implicating geranylgeranylation as a critical determinant of the stain response. We used biochemical approaches as well as fluorescence resonance energy transfer (FRET) methods with a cAMP biosensor to show that simvastatin treatment of endothelial cells markedly inhibits cAMP accumulation in response to epinephrine. Importantly, simvastatin treatment significantly decreases G alpha(s) abundance, without affecting other G alpha subunits. Simvastatin treatment does not influence G alpha(s) protein stability, and paradoxically increases the abundance of G alpha(s) mRNA. Finally, we found that simvastatin treatment inhibits G alpha(s) translation mediated by Akt/mTOR/eIF4/4EBP. Taken together, these findings establish a novel mechanism by which simvastatin modulates beta-adrenergic signaling in vascular wall, and may have implications for cardiovascular therapeutics.	[Kou, Ruqin; Shiroto, Takashi; Sartoretto, Juliano L.; Michel, Thomas] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Michel, T (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc, 75 Francis St, Boston, MA 02115 USA.	thomas_michel@harvard.edu		sartoretto, juliano/0000-0002-0355-5541	National Institutes of Health [GM36259, HL46457, HL48743]; Japan Heart Foundation; Uehara Memorial Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL046457, R01HL046457, P01HL048743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM036259, R01GM036259] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Heart Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM36259, HL46457, and HL48743 (to T. M.), and by funding from the Japan Heart Foundation and the Uehara Memorial Foundation (to T. S.).	Beretta L, 1996, EMBO J, V15, P658, DOI 10.1002/j.1460-2075.1996.tb00398.x; Bhandari BK, 2001, KIDNEY INT, V59, P866; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; Comerford KM, 2002, FASEB J, V16, P583, DOI 10.1096/fj.01-0739fje; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Gloerich M, 2010, ANNU REV PHARMACOL, V50, P355, DOI 10.1146/annurev.pharmtox.010909.105714; Igarashi J, 2001, J BIOL CHEM, V276, P12420, DOI 10.1074/jbc.M008375200; Jain MK, 2005, NAT REV DRUG DISCOV, V4, P977, DOI 10.1038/nrd1901; Kou RQ, 2002, J BIOL CHEM, V277, P29669, DOI 10.1074/jbc.M204519200; Kou RQ, 2002, BIOCHEMISTRY-US, V41, P4982, DOI 10.1021/bi016017r; Kou R, 2009, J BIOL CHEM, V284, P14734, DOI 10.1074/jbc.M808664200; Lilja JJ, 1998, CLIN PHARMACOL THER, V64, P477, DOI 10.1016/S0009-9236(98)90130-8; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MICHEL T, 1993, P NATL ACAD SCI USA, V90, P6252, DOI 10.1073/pnas.90.13.6252; Moens AL, 2010, J MOL CELL CARDIOL, V48, P1088, DOI 10.1016/j.yjmcc.2010.02.011; Muhlhauser U, 2006, FASEB J, V20, P785, DOI 10.1096/fj.05-5067fje; Namiecinska M, 2006, PHARMACOL REP, V58, P884; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Ponsioen B, 2004, EMBO REP, V5, P1176, DOI 10.1038/sj.embor.7400290; Schmechel A, 2009, CARDIOVASC RES, V82, P100, DOI 10.1093/cvr/cvp005; Senthil D, 2001, BIOCHEM J, V360, P87, DOI 10.1042/0264-6021:3600087; Stenestrand U, 2001, JAMA-J AM MED ASSOC, V285, P430, DOI 10.1001/jama.285.4.430	22	13	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2643	2651		10.1074/jbc.M111.303594	http://dx.doi.org/10.1074/jbc.M111.303594			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22144680	Green Published, hybrid			2022-12-27	WOS:000300292300037
J	Tep, C; Kim, ML; Opincariu, LI; Limpert, AS; Chan, JR; Appel, B; Carter, BD; Yoon, SO				Tep, Chhavy; Kim, Mi Lyang; Opincariu, Laura I.; Limpert, Allison S.; Chan, Jonah R.; Appel, Bruce; Carter, Bruce D.; Yoon, Sung Ok			Brain-derived Neurotrophic Factor (BDNF) Induces Polarized Signaling of Small GTPase (Rac1) Protein at the Onset of Schwann Cell Myelination through Partitioning-defective 3 (Par3) Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P75; MIGRATION; KINASE; PHOSPHORYLATION; ACTIVATION; COMPLEXES; RECEPTOR; BINDING; AXONS	Brain-derived neurotrophic factor (BDNF) was shown to play a role in Schwann cell myelination by recruiting Par3 to the axon-glial interface, but the underlying mechanism has remained unclear. Here we report that Par3 regulates Rac1 activation by BDNF but not by NRG1-Type III in Schwann cells, although both ligands activate Rac1 in vivo. During development, active Rac1 signaling is localized to the axon-glial interface in Schwann cells by a Par3-dependent polarization mechanism. Knockdown of p75 and Par3 individually inhibits Rac1 activation, whereas constitutive activation of Rac1 disturbs the polarized activation of Rac1 in vivo. Polarized Rac1 activation is necessary for myelination as Par3 knockdown attenuates myelination in mouse sciatic nerves as well as in zebrafish. Specifically, Par3 knockdown in zebrafish disrupts proper alignment between the axon and Schwann cells without perturbing Schwann cell migration, suggesting that localized Rac1 activation at the axon-glial interface helps identify the initial wrapping sites. We therefore conclude that polarization of Rac1 activation is critical for myelination.	[Tep, Chhavy; Kim, Mi Lyang; Yoon, Sung Ok] Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Tep, Chhavy] Ohio State Univ, Biochem Program, Columbus, OH 43210 USA; [Kim, Mi Lyang] Ohio State Univ, Mol Cellular & Dev Biol Program, Columbus, OH 43210 USA; [Opincariu, Laura I.; Appel, Bruce] Univ Colorado, Dept Pediat, Sch Med, Aurora, CO 80045 USA; [Limpert, Allison S.; Carter, Bruce D.] Vanderbilt Univ Sch Med, Dept Biochem, Nashville, TN USA; [Chan, Jonah R.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Chan, Jonah R.] Univ Calif San Francisco, Program Neurosci, San Francisco, CA 94143 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Colorado System; University of Colorado Anschutz Medical Campus; Vanderbilt University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Yoon, SO (corresponding author), Ohio State Univ, Dept Mol & Cellular Biochem, 184 Rightmire Hall,1060 Carmack Rd, Columbus, OH 43210 USA.	sung.yoon@osumc.edu	Yoon, Sung Ok/C-5992-2012; Appel, Bruce/X-6418-2019	Appel, Bruce/0000-0003-4500-0672	National Institute of Health [NS039472, P30NS045758, NS062796, NS048249, NS062717]; Muscular Distrophy Association [MDA115761]; NATIONAL CANCER INSTITUTE [T32CA009582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048249, R01NS062717, R01NS039472, P30NS045758, R01NS062796] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Distrophy Association; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institute of Health grants NS039472 (to S.O.Y.), P30NS045758 (to the Ohio State Neuroscience Center Core), NS062796 (to J.R.C.), NS048249 (to B.D.C.), and NS062717 (to B.A.). This work was also supported by Muscular Distrophy Association Grant MDA115761 (to A.S.L.).	Bentley CA, 2000, J NEUROSCI, V20, P7706; Chan JR, 2006, SCIENCE, V314, P832, DOI 10.1126/science.1134069; Chan JR, 2004, NEURON, V43, P183, DOI 10.1016/j.neuron.2004.06.024; Chen XY, 2005, NAT CELL BIOL, V7, P262, DOI 10.1038/ncb1226; Ebnet K, 2001, EMBO J, V20, P3738, DOI 10.1093/emboj/20.14.3738; Fang LH, 2007, CELL RES, V17, P100, DOI 10.1038/sj.cr.7310145; Flanagan-Steet H, 2005, DEVELOPMENT, V132, P4471, DOI 10.1242/dev.02044; Goldstein B, 2007, DEV CELL, V13, P609, DOI 10.1016/j.devcel.2007.10.007; Harrington AW, 2002, J NEUROSCI, V22, P156, DOI 10.1523/JNEUROSCI.22-01-00156.2002; Hurd TW, 2003, CURR BIOL, V13, P2082, DOI 10.1016/j.cub.2003.11.020; Kucenas S, 2008, NAT NEUROSCI, V11, P143, DOI 10.1038/nn2025; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; Manser E, 1997, MOL CELL BIOL, V17, P1129, DOI 10.1128/MCB.17.3.1129; Maurel P, 2000, J NEUROSCI, V20, P4635, DOI 10.1523/JNEUROSCI.20-12-04635.2000; Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862; Ng BK, 2007, J NEUROSCI, V27, P7597, DOI 10.1523/JNEUROSCI.0563-07.2007; Nishimura T, 2004, NAT CELL BIOL, V6, P328, DOI 10.1038/ncb1118; Nodari A, 2007, J CELL BIOL, V177, P1063, DOI 10.1083/jcb.200610014; Schmoranzer J, 2009, CURR BIOL, V19, P1065, DOI 10.1016/j.cub.2009.05.065; Schober M, 1999, NATURE, V402, P548, DOI 10.1038/990135; Shin Jimann, 2003, Methods in Cell Science, V25, P7, DOI 10.1023/B:MICS.0000006847.09037.3a; Takekuni K, 2003, J BIOL CHEM, V278, P5497, DOI 10.1074/jbc.C200707200; Taveggia C, 2005, NEURON, V47, P681, DOI 10.1016/j.neuron.2005.08.017; Vilar M, 2009, NEURON, V62, P72, DOI 10.1016/j.neuron.2009.02.020; Xiao JH, 2009, J NEUROSCI, V29, P4016, DOI 10.1523/JNEUROSCI.3811-08.2009; Yamauchi J, 2004, P NATL ACAD SCI USA, V101, P8774, DOI 10.1073/pnas.0402795101; Yoon C, 2008, J NEUROSCI, V28, P3738, DOI 10.1523/JNEUROSCI.4439-07.2008	27	31	32	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1600	1608		10.1074/jbc.M111.312736	http://dx.doi.org/10.1074/jbc.M111.312736			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22128191	hybrid, Green Published			2022-12-27	WOS:000299170300073
J	Gupta, S; Jie, S; Colby, DW				Gupta, Sharad; Jie, Shy'Ann; Colby, David W.			Protein Misfolding Detected Early in Pathogenesis of Transgenic Mouse Model of Huntington Disease Using Amyloid Seeding Assay	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL INTRANUCLEAR INCLUSIONS; MUTANT HUNTINGTIN; IN-VITRO; NEUROPATHOLOGICAL ABNORMALITIES; NUCLEAR-LOCALIZATION; PRION DETECTION; MOTOR; AGGREGATION; FORM; HD	Huntington disease (HD) is one of several fatal neurodegenerative disorders associated with misfolded proteins. Here, we report a novel method for the sensitive detection of misfolded huntingtin (HTT) isolated from the brains of transgenic (Tg) mouse models of HD and humans with HD using an amyloid seeding assay (ASA), which is based on the propensity of misfolded proteins to act as a seed and shorten the nucleation-associated lag phase in the kinetics of amyloid formation in vitro. Using synthetic polyglutamine peptides as the substrate for amyloid formation, we found that partially purified misfolded HTT obtained from end-stage brain tissue of two Tg HD mouse models and brain tissue of post-mortem human HD patients was capable of specifically accelerating polyglutamine amyloid formation compared with unseeded reactions and controls. Alzheimer and prion disease brain tissues did not do so, demonstrating the specificity of the ASA. It is unclear whether early intermediates or later conformational species in the protein misfolding process act as seeds in the ASA for HD. However, we were able to detect misfolded protein in the brains of YAC128 mice early in disease pathogenesis (11 weeks of age), whereas large inclusion bodies have not been observed in the brains of these mice by histology until 78 weeks of age, much later in the pathogenic process. The sensitive detection of misfolded HTT protein early in the disease pathogenesis in the YAC128 Tg mouse model strengthens the argument for a causative role of protein misfolding in HD.	[Gupta, Sharad; Jie, Shy'Ann; Colby, David W.] Univ Delaware, Dept Chem Engn, Newark, DE 19716 USA	University of Delaware	Colby, DW (corresponding author), Univ Delaware, Dept Chem Engn, 150 Acad St, Newark, DE 19716 USA.	colby@udel.edu	colby, david/E-5821-2011	Colby, David/0000-0002-4856-6295	National Institutes of Health from NINDS [R00 NS064173]; National Center for Research Resources [P30 RR031160]; United States Public Health Service from the National Institutes of Health [R24 MH068855]; NINDS/National Institute of Mental Health; NATIONAL CENTER FOR RESEARCH RESOURCES [P30RR031160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R24MH068855] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS064173] Funding Source: NIH RePORTER	National Institutes of Health from NINDS; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); United States Public Health Service from the National Institutes of Health; NINDS/National Institute of Mental Health; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R00 NS064173 from NINDS and Grant P30 RR031160 from the National Center for Research Resources.; We thank Natalie Barnes for help with breeding mouse colonies and harvesting tissue samples, Zachary March for purification of AD and control brain tissue samples, and Kyle Doolan for purification of PrPSc from brain tissue sample. We thank the patients and families who donated tissue samples and the Harvard Brain Tissue Resource Center (supported in part by United States Public Health Service Grant R24 MH068855 from the National Institutes of Health) and the Human Brain and Spinal Fluid Resource Center at UCLA (supported in part by NINDS/National Institute of Mental Health) for providing tissues.	Andreassen OA, 2001, NEUROBIOL DIS, V8, P479, DOI 10.1006/nbdi.2001.0406; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Atarashi R, 2011, NAT MED, V17, P175, DOI 10.1038/nm.2294; Campioni S, 2010, NAT CHEM BIOL, V6, P140, DOI [10.1038/NCHEMBIO.283, 10.1038/nchembio.283]; Chen S, 2001, J MOL BIOL, V311, P173, DOI 10.1006/jmbi.2001.4850; Chen SM, 2002, P NATL ACAD SCI USA, V99, P11884, DOI 10.1073/pnas.182276099; Colby DW, 2007, P NATL ACAD SCI USA, V104, P20914, DOI 10.1073/pnas.0710152105; Colby DW, 2006, NAT CHEM BIOL, V2, P319, DOI 10.1038/nchembio792; Colby DW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000736; Colby DW, 2004, P NATL ACAD SCI USA, V101, P17616, DOI 10.1073/pnas.0408134101; Crook ZR, 2011, NEURON, V69, P423, DOI 10.1016/j.neuron.2010.12.035; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; Dedeoglu A, 2002, J NEUROSCI, V22, P8942; DeMarch Z, 2008, NEUROBIOL DIS, V30, P375, DOI 10.1016/j.nbd.2008.02.010; Diaz-Hernandez M, 2004, J NEUROSCI, V24, P9361, DOI 10.1523/JNEUROSCI.2365-04.2004; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Du DG, 2011, BIOCHEMISTRY-US, V50, P1607, DOI 10.1021/bi1013744; Ferrante RJ, 2000, J NEUROSCI, V20, P4389, DOI 10.1523/JNEUROSCI.20-12-04389.2000; Gourfinkel-An I, 1998, NEUROREPORT, V9, P1823, DOI 10.1097/00001756-199806010-00028; Harper SQ, 2005, P NATL ACAD SCI USA, V102, P5820, DOI 10.1073/pnas.0501507102; Herndon ES, 2009, J NEUROPATH EXP NEUR, V68, P250, DOI 10.1097/NEN.0b013e318198d320; Hodgson JG, 1999, NEURON, V23, P181, DOI 10.1016/S0896-6273(00)80764-3; Huntington G., 1872, MED SURG REP, V26, P320; Legleiter J, 2010, J BIOL CHEM, V285, P14777, DOI 10.1074/jbc.M109.093708; Li H, 1999, HUM MOL GENET, V8, P1227, DOI 10.1093/hmg/8.7.1227; Maat-Schieman M, 2007, BRAIN PATHOL, V17, P31, DOI 10.1111/j.1750-3639.2006.00040.x; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Masuda N, 2008, NEUROBIOL DIS, V30, P293, DOI 10.1016/j.nbd.2008.01.014; Menalled LB, 2003, J COMP NEUROL, V465, P11, DOI 10.1002/cne.10776; Nekooki-Machida Y, 2009, P NATL ACAD SCI USA, V106, P9679, DOI 10.1073/pnas.0812083106; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; O'Nuallain B, 2006, METHOD ENZYMOL, V413, P34, DOI 10.1016/S0076-6879(06)13003-7; SAEED SM, 1967, AM J CLIN PATHOL, V47, P588, DOI 10.1093/ajcp/47.5.588; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Schilling G, 1999, HUM MOL GENET, V8, P397, DOI 10.1093/hmg/8.3.397; Schilling G, 2001, NEUROBIOL DIS, V8, P405, DOI 10.1006/nbdi.2001.0385; Sieradzan KA, 1999, EXP NEUROL, V156, P92, DOI 10.1006/exnr.1998.7005; Simmons DA, 2011, NEUROBIOL DIS, V41, P436, DOI 10.1016/j.nbd.2010.10.015; Slow EJ, 2003, HUM MOL GENET, V12, P1555, DOI 10.1093/hmg/ddg169; Van Raamsdonk JM, 2007, NEUROBIOL DIS, V26, P189, DOI 10.1016/j.nbd.2006.12.010; Van Raamsdonk JM, 2005, HUM MOL GENET, V14, P3823, DOI 10.1093/hmg/ddi407; Van Raamsdonk JM, 2005, J NEUROSCI, V25, P4169, DOI 10.1523/JNEUROSCI.0590-05.2005; Wheeler VC, 2000, HUM MOL GENET, V9, P503, DOI 10.1093/hmg/9.4.503; Wilham JM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001217; Yang W, 2002, HUM MOL GENET, V11, P2905, DOI 10.1093/hmg/11.23.2905; Zadori D, 2011, J NEURAL TRANSM, V118, P865, DOI 10.1007/s00702-010-0573-6	48	25	26	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					9982	9989		10.1074/jbc.M111.305417	http://dx.doi.org/10.1074/jbc.M111.305417			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22187438	hybrid, Green Published			2022-12-27	WOS:000302167200030
J	Khalimonchuk, O; Jeong, MY; Watts, T; Ferris, E; Winge, DR				Khalimonchuk, Oleh; Jeong, Mi-Young; Watts, Talina; Ferris, Elliott; Winge, Dennis R.			Selective Oma1 Protease-mediated Proteolysis of Cox1 Subunit of Cytochrome Oxidase in Assembly Mutants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							M-AAA PROTEASE; SACCHAROMYCES-CEREVISIAE; C-OXIDASE; MITOCHONDRIAL COX1P; YEAST MITOCHONDRIA; MAMMALIAN-CELLS; MESSENGER-RNA; NUCLEAR GENE; 2.8 ANGSTROM; BIOGENESIS	Stalled biogenesis of the mitochondrial cytochrome c oxidase (CcO) complex results in degradation of subunits containing redox cofactors. The conserved Oma1 metalloproteinase mediates facile Cox1 degradation in cells lacking the Coa2 assembly factor, but not in a series of other mutants stalled in CcO maturation. Oma1 is activated in coa2 Delta cells, but the selective Cox1 degradation does not arise merely from its activation. Oma1 is also active in cells with dysfunctional mitochondria and cox11 Delta cells impaired in CcO maturation, but this activation does not result in Oma1-mediated Cox1 degradation. The facile and selective degradation of Cox1 in coa2 Delta cells, relative to other CcO assembly mutants, is likely due to impaired hemylation and subsequent misfolding of the subunit. Specific Cox1 proteolysis in coa2 Delta cells arises from a combination of Oma1 activation and a susceptible conformation of Cox1.	[Winge, Dennis R.] Univ Utah, Hlth Sci Ctr, Dept Med, Salt Lake City, UT 84132 USA; Univ Utah, Hlth Sci Ctr, Dept Biochem, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Winge, DR (corresponding author), Univ Utah, Hlth Sci Ctr, Dept Med, SOM 5C 426, Salt Lake City, UT 84132 USA.	dennis.winge@hsc.utah.edu	Khalimonchuk, Oleh/AAM-1194-2021	Khalimonchuk, Oleh/0000-0002-3972-8678	National Institutes of Health, NIEHS [ES03817]; American Heart Association [10POST4300044]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R37ES003817, R01ES003817] Funding Source: NIH RePORTER	National Institutes of Health, NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health, NIEHS Grant ES03817 (to D. R. W.). This work was also supported by American Heart Association Grant 10POST4300044 (to O. K.).	Barrientos A, 2004, EMBO J, V23, P3472, DOI 10.1038/sj.emboj.7600358; Barrientos A, 2002, EMBO J, V21, P43, DOI 10.1093/emboj/21.1.43; Bestwick M, 2010, MOL CELL BIOL, V30, P172, DOI 10.1128/MCB.00869-09; BONNEFOY N, 1994, J MOL BIOL, V239, P201, DOI 10.1006/jmbi.1994.1363; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bulteau AL, 2007, FREE RADICAL BIO MED, V42, P1561, DOI 10.1016/j.freeradbiomed.2007.02.014; Capaldi RA, 1995, METHOD ENZYMOL, V260, P117, DOI 10.1016/0076-6879(95)60134-1; DAUM G, 1982, J BIOL CHEM, V257, P3028; Dickinson BC, 2010, CURR OPIN CHEM BIOL, V14, P50, DOI 10.1016/j.cbpa.2009.10.014; Ehses S, 2009, J CELL BIOL, V187, P1023, DOI 10.1083/jcb.200906084; Fontanesi F, 2010, MOL CELL BIOL, V30, P245, DOI 10.1128/MCB.00983-09; GARDNER PR, 1994, P NATL ACAD SCI USA, V91, P12248, DOI 10.1073/pnas.91.25.12248; GLERUM DM, 1994, P NATL ACAD SCI USA, V91, P8452, DOI 10.1073/pnas.91.18.8452; Head B, 2009, J CELL BIOL, V187, P959, DOI 10.1083/jcb.200906083; Heinemeyer J, 2007, J BIOL CHEM, V282, P12240, DOI 10.1074/jbc.M610545200; Hell K, 2001, EMBO J, V20, P1281, DOI 10.1093/emboj/20.6.1281; Hiser L, 2000, J BIOL CHEM, V275, P619, DOI 10.1074/jbc.275.1.619; Kaser M, 2003, J BIOL CHEM, V278, P46414, DOI 10.1074/jbc.M305584200; Khalimonchuk O, 2007, J BIOL CHEM, V282, P17442, DOI 10.1074/jbc.M702379200; Khalimonchuk O, 2010, MOL CELL BIOL, V30, P1004, DOI 10.1128/MCB.00640-09; Lee S, 2011, J BIOL CHEM, V286, P4404, DOI 10.1074/jbc.M110.158741; MANTHEY GM, 1995, EMBO J, V14, P4031, DOI 10.1002/j.1460-2075.1995.tb00074.x; Manthey GM, 1998, EUR J BIOCHEM, V255, P156, DOI 10.1046/j.1432-1327.1998.2550156.x; Mick DU, 2007, EMBO J, V26, P4347, DOI 10.1038/sj.emboj.7601862; Mick DU, 2010, J CELL BIOL, V191, P141, DOI 10.1083/jcb.201007026; Nolden M, 2005, CELL, V123, P277, DOI 10.1016/j.cell.2005.08.003; Oyedotun KS, 2004, J BIOL CHEM, V279, P9424, DOI 10.1074/jbc.M311876200; Pain J, 2010, J BIOL CHEM, V285, P39409, DOI 10.1074/jbc.M110.178947; Perez-Martinez X, 2003, EMBO J, V22, P5951, DOI 10.1093/emboj/cdg566; Pierrel F, 2008, MOL CELL BIOL, V28, P4927, DOI 10.1128/MCB.00057-08; Pierrel F, 2007, EMBO J, V26, P4335, DOI 10.1038/sj.emboj.7601861; Sambrook J., 2002, MOL CLONING LAB MANU; Savel'ev AS, 1998, J BIOL CHEM, V273, P20596, DOI 10.1074/jbc.273.32.20596; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Shingu-Vazquez M, 2010, J BIOL CHEM, V285, P34382, DOI 10.1074/jbc.M110.161976; Siep M, 2000, CURR GENET, V37, P213, DOI 10.1007/s002940050522; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; TSUKIHARA T, 1995, SCIENCE, V269, P1069, DOI 10.1126/science.7652554; Wang F, 2011, J BIOL CHEM, V286, P43454, DOI 10.1074/jbc.M111.274332; Wang ZH, 2009, J BIOL CHEM, V284, P839, DOI 10.1074/jbc.M804167200; Zara V, 2004, EUR J BIOCHEM, V271, P1209, DOI 10.1111/j.1432-1033.2004.04024.x	41	47	48	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7289	7300		10.1074/jbc.M111.313148	http://dx.doi.org/10.1074/jbc.M111.313148			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22219186	Green Published, hybrid			2022-12-27	WOS:000301060200031
J	Berezniuk, I; Vu, HT; Lyons, PJ; Sironi, JJ; Xiao, H; Burd, B; Setou, M; Angeletti, RH; Ikegami, K; Fricker, LD				Berezniuk, Iryna; Vu, Hang T.; Lyons, Peter J.; Sironi, Juan J.; Xiao, Hui; Burd, Berta; Setou, Mitsutoshi; Angeletti, Ruth H.; Ikegami, Koji; Fricker, Lloyd D.			Cytosolic Carboxypeptidase 1 Is Involved in Processing alpha- and beta-Tubulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PURKINJE-CELL-DEGENERATION; MOUSE-BRAIN; POSTTRANSLATIONAL MODIFICATIONS; TETRAHYMENA-THERMOPHILA; MICE REVEALS; PCD MICE; NNA1; POLYGLUTAMYLATION; MICROTUBULES; NEURODEGENERATION	The Purkinje cell degeneration (pcd) mouse has a disruption in the gene encoding cytosolic carboxypeptidase 1 (CCP1). This study tested two proposed functions of CCP1: degradation of intracellular peptides and processing of tubulin. Overexpression (2-3-fold) or knockdown (80-90%) of CCP1 in human embryonic kidney 293T cells (HEK293T) did not affect the levels of most intracellular peptides but altered the levels of alpha-tubulin lacking two C-terminal amino acids (delta2-tubulin) >= 5-fold, suggesting that tubulin processing is the primary function of CCP1, not peptide degradation. Purified CCP1 produced delta2-tubulin from purified porcine brain alpha-tubulin or polymerized HEK293T microtubules. In addition, CCP1 removed Glu residues from the polyglutamyl side chains of porcine brain alpha- and beta-tubulin and also generated a form of alpha-tubulin with two C-terminal Glu residues removed (delta3-tubulin). Consistent with this, pcd mouse brain showed hyperglutamylation of both alpha- and beta-tubulin. The hyperglutamylation of alpha- and beta-tubulin and subsequent death of Purkinje cells in pcd mice was counteracted by the knock-out of the gene encoding tubulin tyrosine ligase-like-1, indicating that this enzyme hyperglutamylates alpha- and beta-tubulin. Taken together, these results demonstrate a role for CCP1 in the processing of Glu residues from beta- as well as alpha- tubulin in vitro and in vivo.	[Vu, Hang T.; Setou, Mitsutoshi; Ikegami, Koji] Hamamatsu Univ Sch Med, Dept Cell Biol & Anat, Hamamatsu, Shizuoka 4313192, Japan; [Sironi, Juan J.] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA; [Berezniuk, Iryna; Fricker, Lloyd D.] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA; [Xiao, Hui; Burd, Berta; Angeletti, Ruth H.] Albert Einstein Coll Med, Lab Macromol Anal & Prote, Bronx, NY 10461 USA; [Lyons, Peter J.; Sironi, Juan J.; Fricker, Lloyd D.] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA	Hamamatsu University School of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Ikegami, K (corresponding author), Hamamatsu Univ Sch Med, Dept Cell Biol & Anat, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	kikegami@hama-med.ac.jp; lloyd.fricker@einstein.yu.edu		Lyons, Peter/0000-0001-5214-5445	National Institutes of Health [DA-004494, 1P20 DA026149, 1R01 CA124898]; Uehara Memorial Foundation; Japan Society for the Promotion of Science [23570209, 23117517]; Sao Paulo State Research Foundation; Financiadora de Estudos e Projetos; Brazilian National Research Council; NATIONAL CANCER INSTITUTE [R01CA124898] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019352, S10RR019891] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA004494, P20DA026149] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23570209] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Uehara Memorial Foundation(Uehara Memorial Foundation); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Sao Paulo State Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Financiadora de Estudos e Projetos(Financiadora de Inovacao e Pesquisa (Finep)); Brazilian National Research Council(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in whole or in part, by National Institutes of Health Grants DA-004494 (to L.D.F.), 1P20 DA026149 (to R.H.A.), and 1R01 CA124898 (to S.B. Horwitz). This work was also supported by the Uehara Memorial Foundation and Japan Society for the Promotion of Science Grants 23570209 and 23117517 (to K.I.).; Mass spectrometry for the analysis of peptides in HEK293T cells was performed in the laboratory of Prof. Fabio Gozzo, Universidade de Campinas, Brazil, by Leandro M. Castro and was supported by grants from Sao Paulo State Research Foundation, Financiadora de Estudos e Projetos, and Brazilian National Research Council. Antibodies to tubulin were provided by Prof. Martin Gorovsky (University of Rochester, Rochester, NY) and by Prof. Carsten Janke (Universite Montpellier, France).	ARGARANA CE, 1978, MOL CELL BIOCHEM, V19, P17; Baltanas FC, 2011, J BIOL CHEM, V286, P28287, DOI 10.1074/jbc.M111.246041; BAURLE J, 1994, ACTA NEUROPATHOL, V88, P237; Berezniuk I, 2010, AUTOPHAGY, V6, P558, DOI 10.4161/auto.6.4.11813; Berezniuk I, 2010, FASEB J, V24, P1813, DOI 10.1096/fj.09-147942; Berti DA, 2009, J BIOL CHEM, V284, P14105, DOI 10.1074/jbc.M807916200; Cartelli D, 2010, J NEUROCHEM, V115, P247, DOI 10.1111/j.1471-4159.2010.06924.x; Chakrabarti L, 2008, VISION RES, V48, P1999, DOI 10.1016/j.visres.2008.05.026; Chakrabarti L, 2010, NEURON, V66, P835, DOI 10.1016/j.neuron.2010.05.024; de la Vega MR, 2007, FASEB J, V21, P851, DOI 10.1096/fj.06-7330com; Dunn S, 2008, J CELL SCI, V121, P1085, DOI 10.1242/jcs.026492; EDDE B, 1990, SCIENCE, V247, P83, DOI 10.1126/science.1967194; Fernandez D., 2011, ENZYME RES, V2011; Fernandez-Gonzalez A, 2002, SCIENCE, V295, P1904, DOI 10.1126/science.1068912; FRICKER LD, 1982, P NATL ACAD SCI-BIOL, V79, P3886, DOI 10.1073/pnas.79.12.3886; Gelman JS, 2010, J NEUROCHEM, V113, P871, DOI 10.1111/j.1471-4159.2010.06653.x; Harris A, 2000, MOL CELL NEUROSCI, V16, P578, DOI 10.1006/mcne.2000.0900; Ikegami K, 2007, P NATL ACAD SCI USA, V104, P3213, DOI 10.1073/pnas.0611547104; Ikegami K, 2006, J BIOL CHEM, V281, P30707, DOI 10.1074/jbc.M603984200; Ikegami K, 2010, P NATL ACAD SCI USA, V107, P10490, DOI 10.1073/pnas.1002128107; Ikegami K, 2010, CELL STRUCT FUNCT, V35, P15, DOI 10.1247/csf.09027; Janke C, 2005, SCIENCE, V308, P1758, DOI 10.1126/science.1113010; Janke C, 2011, NAT REV MOL CELL BIO, V12, P773, DOI 10.1038/nrm3227; Kalinina E, 2007, FASEB J, V21, P836, DOI 10.1096/fj.06-7329com; Kimura Y, 2010, J BIOL CHEM, V285, P22934, DOI 10.1074/jbc.C110.128280; Kreitzer G, 1999, MOL BIOL CELL, V10, P1105, DOI 10.1091/mbc.10.4.1105; Kyuhou S, 2006, NEUROSCI LETT, V396, P91, DOI 10.1016/j.neulet.2005.11.023; LANDIS SC, 1978, J COMP NEUROL, V177, P125, DOI 10.1002/cne.901770109; Li JX, 2010, NEURON, V68, P45, DOI 10.1016/j.neuron.2010.08.013; Lyons PJ, 2011, J BIOL CHEM, V286, P39023, DOI 10.1074/jbc.M111.265819; Million K, 1999, J CELL SCI, V112, P4357; Morano C, 2008, ANAL CHEM, V80, P9298, DOI 10.1021/ac801654h; MULLEN RJ, 1976, P NATL ACAD SCI USA, V73, P208, DOI 10.1073/pnas.73.1.208; NALAMACHU SR, 1994, J BIOL CHEM, V269, P11192; O'Hagan R, 2011, CURR BIOL, V21, P1685, DOI 10.1016/j.cub.2011.08.049; PATURLELAFANECHERE L, 1994, J CELL SCI, V107, P1529; PATURLELAFANECHERE L, 1991, BIOCHEMISTRY-US, V30, P10523, DOI 10.1021/bi00107a022; RAYBIN D, 1977, BIOCHEMISTRY-US, V16, P2189, DOI 10.1021/bi00629a023; Rogowski K, 2010, CELL, V143, P564, DOI 10.1016/j.cell.2010.10.014; SCHIFF PB, 1980, P NATL ACAD SCI-BIOL, V77, P1561, DOI 10.1073/pnas.77.3.1561; SCHULZE E, 1987, J CELL BIOL, V105, P2167, DOI 10.1083/jcb.105.5.2167; Shang YH, 2002, J CELL BIOL, V158, P1195, DOI 10.1083/jcb.200205101; SONG LX, 1995, J BIOL CHEM, V270, P25007, DOI 10.1074/jbc.270.42.25007; Valero J, 2006, MOL CELL NEUROSCI, V33, P283, DOI 10.1016/j.mcn.2006.08.002; Van Dijk J, 2008, J BIOL CHEM, V283, P3915, DOI 10.1074/jbc.M705813200; van Dijk J, 2007, MOL CELL, V26, P437, DOI 10.1016/j.molcel.2007.04.012; Vassal E, 2006, J BIOMOL SCREEN, V11, P377, DOI 10.1177/1087057106286210; Wang TY, 2007, BRAIN RES, V1140, P26, DOI 10.1016/j.brainres.2006.07.065; Wang TY, 2006, MOL CELL NEUROSCI, V33, P200, DOI 10.1016/j.mcn.2006.07.009; Wardman J, 2011, METHODS MOL BIOL, V768, P307, DOI 10.1007/978-1-61779-204-5_17; Wei SW, 2002, J BIOL CHEM, V277, P14954, DOI 10.1074/jbc.M112254200; Wloga D, 2008, EUKARYOT CELL, V7, P1362, DOI 10.1128/EC.00084-08; Wloga D, 2010, J CELL SCI, V123, P3447, DOI 10.1242/jcs.063727; WOLFF A, 1992, EUR J CELL BIOL, V59, P425	54	58	60	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6503	6517		10.1074/jbc.M111.309138	http://dx.doi.org/10.1074/jbc.M111.309138			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22170066	Green Published, hybrid			2022-12-27	WOS:000300791800039
J	Font-Nieves, M; Sans-Fons, MG; Gorina, R; Bonfill-Teixidor, E; Salas-Perdomo, A; Marquez-Kisinousky, L; Santalucia, T; Planas, AM				Font-Nieves, Miriam; Gloria Sans-Fons, M.; Gorina, Roser; Bonfill-Teixidor, Ester; Salas-Perdomo, Angelica; Marquez-Kisinousky, Leonardo; Santalucia, Tomas; Planas, Anna M.			Induction of COX-2 Enzyme and Down-regulation of COX-1 Expression by Lipopolysaccharide (LPS) Control Prostaglandin E-2 Production in Astrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL CEREBRAL-ISCHEMIA; GENE-EXPRESSION; NITRIC-OXIDE; KAPPA-B; CYCLOOXYGENASE-2; SYNTHASE; BRAIN; INHIBITION; ACTIVATION; DELETION	Pathological conditions and pro-inflammatory stimuli in the brain induce cyclooxygenase-2 (COX-2), a key enzyme in arachidonic acid metabolism mediating the production of prostanoids that, among other actions, have strong vasoactive properties. Although low basal cerebral COX-2 expression has been reported, COX-2 is strongly induced by pro-inflammatory challenges, whereas COX-1 is constitutively expressed. However, the contribution of these enzymes in prostanoid formation varies depending on the stimuli and cell type. Astrocyte feet surround cerebral microvessels and release molecules that can trigger vascular responses. Here, we investigate the regulation of COX-2 induction and its role in prostanoid generation after a pro-inflammatory challenge with the bacterial lipopolysaccharide (LPS) in astroglia. Intracerebral administration of LPS in rodents induced strong COX-2 expression mainly in astroglia and microglia, whereas COX-1 expression was predominant in microglia and did not increase. In cultured astrocytes, LPS strongly induced COX-2 and microsomal prostaglandin-E-2 (PGE(2)) synthase-1, mediated by the MyD88-dependent NF kappa B pathway and influenced by mitogen-activated protein kinase pathways. Studies in COX-deficient cells and using COX inhibitors demonstrated that COX-2 mediated the high production of PGE(2) and, to a lesser extent, other prostanoids after LPS. In contrast, LPS down-regulated COX-1 in an MyD88-dependent fashion, and COX-1 deficiency increased PGE(2) production after LPS. The results show that astrocytes respond to LPS by a COX-2-dependent production of prostanoids, mainly vasoactive PGE(2), and suggest that the coordinated down-regulation of COX-1 facilitates PGE(2) production after TLR-4 activation. These effects might induce cerebral blood flow responses to brain inflammation.	[Planas, Anna M.] IDIBAPS, IIBB, Dept Brain Ischemia & Neurodegenerat,CSIC, Inst Biomed Res Barcelona,Inst Invest Biomed Augu, Barcelona 08036, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas de Barcelona (IIBB); University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Planas, AM (corresponding author), IDIBAPS, IIBB, Dept Brain Ischemia & Neurodegenerat,CSIC, Inst Biomed Res Barcelona,Inst Invest Biomed Augu, Rossello 161,Planta 6, Barcelona 08036, Spain.	anna.planas@iibb.csic.es	Santalucia, Tomas/I-7411-2012; Planas, Anna M/J-5991-2014; Santalucia, Tomas/B-6140-2012	Santalucia, Tomas/0000-0003-4604-9195; Planas, Anna M/0000-0002-6147-1880; Santalucia, Tomas/0000-0003-4604-9195; Marquez, Leonardo/0000-0002-5019-5753; Bonfill Teixidor, Ester/0000-0002-9260-448X; Salas-Perdomo, Angelica/0000-0002-4220-2570	Spanish Ministry of Science and Innovation [SAF2008-04515]; European Community [201024]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Community(European Commission)	This work was supported in part by Spanish Ministry of Science and Innovation Grant SAF2008-04515 and by European Community FP7/2007-2013 Project, Agreement 201024.; Recipient of a Ph.D. fellowship from the Spanish Ministry of Science and Innovation.	Aid S, 2010, J CEREBR BLOOD F MET, V30, P370, DOI 10.1038/jcbfm.2009.223; Aid S, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-17; Aisen PS, 2008, CURR ALZHEIMER RES, V5, P73, DOI 10.2174/156720508783884602; Araki E, 2001, STROKE, V32, P2370, DOI 10.1161/hs1001.096057; Brenneis C, 2006, FASEB J, V20, P1352, DOI 10.1096/fj.05-5346com; Candelario-Jalil E, 2008, CURR PHARM DESIGN, V14, P1401, DOI 10.2174/138161208784480216; Candelario-Jalil E, 2007, J NEUROCHEM, V100, P1108, DOI 10.1111/j.1471-4159.2006.04280.x; Chaudhry UA, 2008, ALZHEIMERS DEMENT, V4, P6, DOI 10.1016/j.jalz.2007.10.015; Choi JK, 2010, EXP NEUROL, V223, P377, DOI 10.1016/j.expneurol.2009.07.032; Choi SH, 2010, PHARMACOGENOMICS J, V10, P448, DOI 10.1038/tpj.2009.68; Choi SH, 2008, FASEB J, V22, P1491, DOI 10.1096/fj.07-9411com; Choi SH, 2009, TRENDS PHARMACOL SCI, V30, P174, DOI 10.1016/j.tips.2009.01.002; Diaz-Munoz MD, 2010, CELL SIGNAL, V22, P1427, DOI 10.1016/j.cellsig.2010.05.011; Friguls B, 2002, NEUROBIOL DIS, V11, P443, DOI 10.1006/nbdi.2002.0553; Gordon GRJ, 2007, GLIA, V55, P1214, DOI 10.1002/glia.20543; Gorina R, 2011, GLIA, V59, P242, DOI 10.1002/glia.21094; Gorina R, 2009, GLIA, V57, P93, DOI 10.1002/glia.20738; Grosser T, 2006, J CLIN INVEST, V116, P4, DOI 10.1172/JCI27291; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Hata AN, 2004, PHARMACOL THERAPEUT, V103, P147, DOI 10.1016/j.pharmthera.2004.06.003; Ikeda-Matsuo Y, 2005, J NEUROCHEM, V94, P1546, DOI 10.1111/j.1471-4159.2005.03302.x; Johann S, 2008, J MOL NEUROSCI, V34, P177, DOI 10.1007/s12031-007-9028-4; Kunz A, 2007, J NEUROSCI, V27, P7083, DOI 10.1523/JNEUROSCI.1645-07.2007; Ladecola C, 2001, P NATL ACAD SCI USA, V98, P1294, DOI 10.1073/pnas.98.3.1294; Lamon BD, 2010, AM J PHYSIOL-HEART C, V299, pH613, DOI 10.1152/ajpheart.00144.2010; Liu SF, 1996, CLIN SCI, V90, P301, DOI 10.1042/cs0900301; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loftin CD, 2001, P NATL ACAD SCI USA, V98, P1059, DOI 10.1073/pnas.031573498; Lyketsos CG, 2007, NEUROLOGY, V68, P1800; Matsuura T, 2009, NEUROSCI RES, V65, P64, DOI 10.1016/j.neures.2009.05.006; Nagayama M, 1999, J CEREBR BLOOD F MET, V19, P1213, DOI 10.1097/00004647-199911000-00005; Ruiz-Valdepenas L, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-5; Satoh K, 2000, NEUROSCI LETT, V283, P221, DOI 10.1016/S0304-3940(00)00926-5; Saura J, 2003, GLIA, V44, P183, DOI 10.1002/glia.10274; Smith E F 3rd, 1989, Eicosanoids, V2, P199; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Ueno N, 2001, J BIOL CHEM, V276, P34918, DOI 10.1074/jbc.M100429200; Wang TG, 2004, J NEUROCHEM, V88, P939, DOI 10.1046/j.1471-4159.2003.02242.x; Wu T, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-22	39	132	136	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6454	6468		10.1074/jbc.M111.327874	http://dx.doi.org/10.1074/jbc.M111.327874			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22219191	Green Published, hybrid			2022-12-27	WOS:000300791800035
J	Singh, KK; Shukla, PC; Quan, A; Desjardins, JF; Lovren, F; Pan, Y; Garg, V; Gosal, S; Garg, A; Szmitko, PE; Schneider, MD; Parker, TG; Stanford, WL; Leong-Poi, H; Teoh, H; Al-Omran, M; Verma, S				Singh, Krishna K.; Shukla, Praphulla C.; Quan, Adrian; Desjardins, Jean-Francois; Lovren, Fina; Pan, Yi; Garg, Vinay; Gosal, Sumandeep; Garg, Ankit; Szmitko, Paul E.; Schneider, Michael D.; Parker, Thomas G.; Stanford, William L.; Leong-Poi, Howard; Teoh, Hwee; Al-Omran, Mohammed; Verma, Subodh			BRCA2 Protein Deficiency Exaggerates Doxorubicin-induced Cardiomyocyte Apoptosis and Cardiac Failure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER SUSCEPTIBILITY; DOUBLE-STRAND BREAKS; DNA-DAMAGE; MYOCARDIAL-INFARCTION; TRANSGENIC MICE; CELL-CYCLE; HOMOLOGOUS RECOMBINATION; CRE-RECOMBINASE; IN-VIVO; CARDIOTOXICITY	The tumor suppressor breast cancer susceptibility gene 2 (BRCA2) plays an important role in the repair of DNA damage, and loss of BRCA2 predisposes carriers to breast and ovarian cancers. Doxorubicin (DOX) remains the cornerstone of chemotherapy in such individuals. However, it is often associated with cardiac failure, which once manifests carries a poor prognosis. Because BRCA2 regulates genome-wide stability and facilitates DNA damage repair, we hypothesized that loss of BRCA2 may increase susceptibility to DOX-induced cardiac failure. To this aim, we generated cardiomyocyte-specific BRCA2 knock-out (CM-BRCA2(-/-)) mice using the Cre-loxP technology and evaluated their basal and post-DOX treatment phenotypes. Although CM-BRCA2(-/-) mice exhibited no basal cardiac phenotype, DOX treatment resulted in markedly greater cardiac dysfunction and mortality in CM-BRCA2(-/-) mice compared with control mice. Apoptosis in left ventricular (LV) sections from CM-BRCA2(-/-) mice compared with that in corresponding sections from wild-type (WT) littermate controls was also significantly enhanced after DOX treatment. Microscopic examination of LV sections from DOX-treated CM-BRCA2(-/-) mice revealed a greater number of DNA double-stranded breaks and the absence of RAD51 focus formation, an essential marker of double-stranded break repair. The levels of p53 and the p53-related proapoptotic proteins p53-up-regulated modulator of apoptosis (PUMA) and Bax were significantly increased in samples from CM-BRCA2(-/-) mice. This corresponded with increased Bax to Bcl-2 ratios and elevated cytochrome c release in the LV sections of DOX-treated CM-BRCA2(-/-) mice. Taken together, these data suggest a critical and previously unrecognized role of BRCA2 as a gatekeeper of DOX-induced cardiomyocyte apoptosis and susceptibility to overt cardiac failure. Pharmacogenomic studies evaluating cardiac function in BRCA2 mutation carriers treated with doxorubicin are encouraged.	[Singh, Krishna K.; Shukla, Praphulla C.; Quan, Adrian; Lovren, Fina; Pan, Yi; Gosal, Sumandeep; Teoh, Hwee; Verma, Subodh] St Michaels Hosp, Li Ka Shing Knowledge Inst, Div Cardiac Surg, Toronto, ON M5B 1W8, Canada; [Desjardins, Jean-Francois; Parker, Thomas G.; Leong-Poi, Howard] St Michaels Hosp, Li Ka Shing Knowledge Inst, Div Cardiol, Toronto, ON M5B 1W8, Canada; [Singh, Krishna K.; Shukla, Praphulla C.; Quan, Adrian; Desjardins, Jean-Francois; Lovren, Fina; Pan, Yi; Gosal, Sumandeep; Parker, Thomas G.; Leong-Poi, Howard; Teoh, Hwee; Al-Omran, Mohammed; Verma, Subodh] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON M5B 1W8, Canada; [Szmitko, Paul E.; Parker, Thomas G.; Leong-Poi, Howard] Univ Toronto, Dept Med, Toronto, ON M5B 1W8, Canada; [Verma, Subodh] Univ Toronto, Dept Surg, Toronto, ON M5B 1W8, Canada; [Garg, Vinay; Garg, Ankit] Queens Univ, Kingston, ON K7L 3N6, Canada; [Schneider, Michael D.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, British Heart Fdn Ctr Res Excellence, London SW7 2AZ, England; [Stanford, William L.] Univ Ottawa, Ottawa Hosp Res Inst, Sprott Ctr Stem Cell Res, Ottawa, ON K1H 8L6, Canada; [Stanford, William L.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1H 8L6, Canada; [Al-Omran, Mohammed] King Saud Univ, Coll Med, Div Vasc Surg, Riyadh 11472, Saudi Arabia; [Al-Omran, Mohammed] King Saud Univ, Peripheral Vasc Dis Res Chair, Riyadh 11472, Saudi Arabia	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; Queens University - Canada; Imperial College London; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; King Saud University; King Saud University	Verma, S (corresponding author), St Michaels Hosp, Li Ka Shing Knowledge Inst, Div Cardiac Surg, Suite 8-003,Bond Wing,30 Bond St, Toronto, ON M5B 1W8, Canada.	subodh.verma@sympatico.ca	Shukla, Praphulla Chandra/GSO-1633-2022; Pan, Yi/AAJ-2341-2021; Teoh, Hwee/F-2498-2018	Shukla, Praphulla Chandra/0000-0001-9031-1547; Teoh, Hwee/0000-0003-1036-4767; Quan, Adrian/0000-0001-8008-028X; Stanford, William/0000-0002-5813-8016; Schneider, Michael/0000-0001-9645-1938	Canadian Institutes for Health Research [93704, PPP99487]; Heart and Stroke Foundation of Canada/Pfizer; AstraZeneca; Physicians' Services Inc. Foundation	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada/Pfizer; AstraZeneca(AstraZeneca); Physicians' Services Inc. Foundation	This work was supported in part by Canadian Institutes for Health Research Grants 93704 and PPP99487 (to S.V.).; Recipient of a Heart and Stroke Foundation of Canada/Pfizer research fellowship.; Recipient of an AstraZeneca research fellowship.; Recipient of a Physicians' Services Inc. Foundation resident research grant.	Agah R, 1997, J CLIN INVEST, V100, P169, DOI 10.1172/JCI119509; Arola OJ, 2000, CANCER RES, V60, P1789; Basu A, 1998, MOL HUM REPROD, V4, P1099, DOI 10.1093/molehr/4.12.1099; Beltrami AP, 2001, NEW ENGL J MED, V344, P1750, DOI 10.1056/NEJM200106073442303; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bordeleau L, 2011, CANCER-AM CANCER SOC, V117, P1812, DOI 10.1002/cncr.25595; Botto N, 2001, MUTAT RES-GEN TOX EN, V493, P23, DOI 10.1016/S1383-5718(01)00162-0; Buerger A, 2006, J CARD FAIL, V12, P392, DOI 10.1016/j.cardfail.2006.03.002; Chen PL, 1998, P NATL ACAD SCI USA, V95, P5287, DOI 10.1073/pnas.95.9.5287; Connor F, 1997, NAT GENET, V17, P423, DOI 10.1038/ng1297-423; Davies AA, 2001, MOL CELL, V7, P273, DOI 10.1016/S1097-2765(01)00175-7; DeGeorge BR, 2008, CIRCULATION, V117, P1378, DOI 10.1161/CIRCULATIONAHA.107.752618; Di Padova M, 2003, J BIOL CHEM, V278, P36496, DOI 10.1074/jbc.M306694200; Dickey JS, 2009, CARCINOGENESIS, V30, P1686, DOI 10.1093/carcin/bgp192; Hakem R, 1998, J MAMMARY GLAND BIOL, V3, P431, DOI 10.1023/A:1018792200700; Henderson I C, 1979, N Engl J Med, V300, P1393; Hochhauser E, 2003, AM J PHYSIOL-HEART C, V284, pH2351, DOI 10.1152/ajpheart.00783.2002; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Holloman WK, 2011, NAT STRUCT MOL BIOL, V18, P748, DOI 10.1038/nsmb.2096; Jiang H, 2009, GENE DEV, V23, P1895, DOI 10.1101/gad.1815309; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Kang YJ, 1997, J CLIN INVEST, V100, P1501, DOI 10.1172/JCI119672; Kennedy RD, 2004, JNCI-J NATL CANCER I, V96, P1659, DOI 10.1093/jnci/djh312; Kinzler KW, 1997, NATURE, V386, P761, DOI 10.1038/386761a0; Kondo N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019659; Kurz EU, 2004, J BIOL CHEM, V279, P53272, DOI 10.1074/jbc.M406879200; L'Ecuyer T, 2006, AM J PHYSIOL-HEART C, V291, pH1273, DOI 10.1152/ajpheart.00738.2005; Lebrecht D, 2007, CARDIOVASC TOXICOL, V7, P108, DOI 10.1007/s12012-007-0009-1; LEFRAK EA, 1973, CANCER-AM CANCER SOC, V32, P302, DOI 10.1002/1097-0142(197308)32:2<302::AID-CNCR2820320205>3.0.CO;2-2; Long XL, 1997, J CLIN INVEST, V99, P2635, DOI 10.1172/JCI119452; Lu HM, 2005, MOL CELL BIOL, V25, P1949, DOI 10.1128/MCB.25.5.1949-1957.2005; Ludwig T, 1997, GENE DEV, V11, P1226, DOI 10.1101/gad.11.10.1226; Mai PL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004812; McAllister KA, 1997, CANCER RES, V57, P3121; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Misao J, 1996, CIRCULATION, V94, P1506, DOI 10.1161/01.CIR.94.7.1506; Olivetti G, 1997, NEW ENGL J MED, V336, P1131, DOI 10.1056/NEJM199704173361603; Rahman N, 1998, ANNU REV GENET, V32, P95, DOI 10.1146/annurev.genet.32.1.95; Saleh-Gohari N, 2004, NUCLEIC ACIDS RES, V32, P3683, DOI 10.1093/nar/gkh703; Sauer B, 1998, METHODS, V14, P381, DOI 10.1006/meth.1998.0593; Shizukuda Y, 2005, MOL CELL BIOCHEM, V273, P25, DOI 10.1007/s11010-005-5905-8; Shukla PC, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1601; Tavtigian SV, 1996, NAT GENET, V12, P333, DOI 10.1038/ng0396-333; Teoh H, 2013, GENE THER, V20, P51, DOI 10.1038/gt.2011.214; Tsutsui H, 2001, CIRCULATION, V104, P2883, DOI 10.1161/hc4901.101347; Tutt A, 2001, EMBO J, V20, P4704, DOI 10.1093/emboj/20.17.4704; Welcsh PL, 2001, HUM MOL GENET, V10, P705, DOI 10.1093/hmg/10.7.705; Yang HJ, 2002, SCIENCE, V297, P1837, DOI 10.1126/science.297.5588.1837; Yen HC, 1996, J CLIN INVEST, V98, P1253, DOI 10.1172/JCI118909; Yoshida K, 2004, CANCER SCI, V95, P866, DOI 10.1111/j.1349-7006.2004.tb02195.x; Yoshida M, 2009, J MOL CELL CARDIOL, V47, P698, DOI 10.1016/j.yjmcc.2009.07.024; Yuan SSF, 1999, CANCER RES, V59, P3547	52	31	33	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6604	6614		10.1074/jbc.M111.292664	http://dx.doi.org/10.1074/jbc.M111.292664			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22157755	Green Published, hybrid			2022-12-27	WOS:000300791800048
J	Elhassan, MO; Christie, J; Duxbury, MS				Elhassan, Mohamed O.; Christie, Jennifer; Duxbury, Mark S.			Homo sapiens Systemic RNA Interference-defective-1 Transmembrane Family Member 1 (SIDT1) Protein Mediates Contact-dependent Small RNA Transfer and MicroRNA-21-driven Chemoresistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAP JUNCTIONAL COMMUNICATION; SHORT INTERFERING RNA; TUMOR-NECROSIS-FACTOR; PHASE-I; CARCINOMA CELLS; DOWN-REGULATION; GEMCITABINE; MICRORNA; MECHANISMS; EXPRESSION	Locally initiated RNA interference (RNAi) has the potential for spatial propagation, inducing posttranscriptional gene silencing in distant cells. In Caenorhabditis elegans, systemic RNAi requires a phylogenetically conserved transmembrane channel, SID-1. Here, we show that a human SID-1 orthologue, SIDT1, facilitates rapid, contact-dependent, bidirectional small RNA transfer between human cells, resulting in target-specific non-cell-autonomous RNAi. Intercellular small RNA transfer can be both homotypic and heterotypic. We show SIDT1-mediated intercellular transfer of microRNA-21 to be a driver of resistance to the nucleoside analog gemcitabine in human adenocarcinoma cells. Documentation of a SIDT1-dependent small RNA transfer mechanism and the associated phenotypic effects on chemoresistance in human cancer cells raises the possibility that conserved systemic RNAi pathways contribute to the acquisition of drug resistance. Mediators of non-cell-autonomous RNAi may be tractable targets for novel therapies aimed at improving the efficacy of current cytotoxic agents.	[Elhassan, Mohamed O.; Duxbury, Mark S.] Univ Edinburgh, Royal Infirm, Edinburgh EH16 4SA, Midlothian, Scotland; [Elhassan, Mohamed O.; Christie, Jennifer; Duxbury, Mark S.] Western Gen Hosp, Pancreat Canc Biol Grp, Edinburgh Canc Res UK Ctr, Inst Genet & Mol Med, Edinburgh EH4 2XR, Midlothian, Scotland	Royal Infirmary of Edinburgh; University of Edinburgh; University of Edinburgh	Duxbury, MS (corresponding author), Western Gen Hosp, Pancreat Canc Biol Grp, Edinburgh Canc Res Ctr, Crewe Rd S, Edinburgh EH4 2XR, Midlothian, Scotland.	mark.duxbury@ed.ac.uk			Chief Scientist Office Project Grant [CZB/4/693]; Melville Trust for the Care and Cure of Cancer; National Health Service Education Scotland Clinician Scientist Fellowship; Chief Scientist Office [CZB/4/693] Funding Source: researchfish	Chief Scientist Office Project Grant; Melville Trust for the Care and Cure of Cancer; National Health Service Education Scotland Clinician Scientist Fellowship; Chief Scientist Office	This work was supported by Chief Scientist Office Project Grant CZB/4/693 and by the Melville Trust for the Care and Cure of Cancer.; Supported by a National Health Service Education Scotland Clinician Scientist Fellowship. To whom correspondence should be addressed: Pancreatic Cancer Biology Group, Edinburgh Cancer Research Centre, Western General Hospital, Crewe Rd. S., Edinburgh EH4 2XR, Scotland, United Kingdom. Tel.: 44-131-7773500; E-mail: mark.duxbury@ed.ac.uk.	ABBRUZZESE JL, 1991, J CLIN ONCOL, V9, P491, DOI 10.1200/JCO.1991.9.3.491; Ammerpohl O, 2007, BRIT J CANCER, V96, P73, DOI 10.1038/sj.bjc.6603511; Bachem MG, 2005, GASTROENTEROLOGY, V128, P907, DOI 10.1053/j.gastro.2004.12.036; Bachem MG, 1998, GASTROENTEROLOGY, V115, P421, DOI 10.1016/S0016-5085(98)70209-4; Bai HT, 2011, FEBS LETT, V585, P402, DOI 10.1016/j.febslet.2010.12.027; Bantly Andrew D, 2007, Immunol Invest, V36, P581, DOI 10.1080/08820130701712461; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Bhargava P, 2001, CANCER CHEMOTH PHARM, V48, P95, DOI 10.1007/s002800100317; Chitwood DH, 2010, NATURE, V467, P415, DOI 10.1038/nature09351; Cottin S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-141; Dalton WS, 1999, DRUG RESIST UPDATE, V2, P285, DOI 10.1054/drup.1999.0097; Dinger ME, 2008, J MOL ENDOCRINOL, V40, P151, DOI 10.1677/JME-07-0160; Duxbury MS, 2007, BIOCHEM BIOPH RES CO, V354, P190, DOI 10.1016/j.bbrc.2006.12.177; Duxbury MS, 2005, BIOCHEM BIOPH RES CO, V331, P459, DOI 10.1016/j.bbrc.2005.03.199; Duxbury MS, 2004, CANCER RES, V64, P3987, DOI 10.1158/0008-5472.CAN-04-0424; Duxbury MS, 2004, J BIOL CHEM, V279, P23176, DOI 10.1074/jbc.M402051200; ELFOULY MH, 1987, EXP CELL RES, V168, P422, DOI 10.1016/0014-4827(87)90014-0; Feinberg EH, 2003, SCIENCE, V301, P1545, DOI 10.1126/science.1087117; Fujita H, 2009, CANCER SCI, V100, P2309, DOI 10.1111/j.1349-7006.2009.01317.x; Garcia-Rodriguez L, 2011, MOL CANCER THER, V10, P505, DOI 10.1158/1535-7163.MCT-10-0693; Giovannetti E, 2010, CANCER RES, V70, P4528, DOI 10.1158/0008-5472.CAN-09-4467; Goldberg GS, 1996, EXP CELL RES, V222, P48, DOI 10.1006/excr.1996.0006; Green SK, 1999, ANTI-CANCER DRUG DES, V14, P153; GRUNEWALD R, 1991, CANCER CHEMOTH PHARM, V27, P258, DOI 10.1007/BF00685109; Herr AJ, 2004, COLD SPRING HARB SYM, V69, P363, DOI 10.1101/sqb.2004.69.363; HORAN PK, 1989, NATURE, V340, P167, DOI 10.1038/340167a0; Hunter CP, 2006, COLD SPRING HARB SYM, V71, P95, DOI 10.1101/sqb.2006.71.060; Hwang HW, 2009, P NATL ACAD SCI USA, V106, P7016, DOI 10.1073/pnas.0811523106; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; John SA, 1999, J BIOL CHEM, V274, P236, DOI 10.1074/jbc.274.1.236; Jose AM, 2007, ANNU REV GENET, V41, P305, DOI 10.1146/annurev.genet.41.110306.130216; Katakowski M, 2010, CANCER RES, V70, P8259, DOI 10.1158/0008-5472.CAN-10-0604; KIANG DT, 1994, IN VITRO CELL DEV-AN, V30A, P796; KOBAYASHI H, 1993, P NATL ACAD SCI USA, V90, P3294, DOI 10.1073/pnas.90.8.3294; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Lahlou H, 2005, MOL CELL BIOL, V25, P4034, DOI 10.1128/MCB.25.10.4034-4045.2005; Li H, 2006, NUCLEIC ACIDS RES, V34, pD572, DOI 10.1093/nar/gkj118; Lin J, 2011, LEUKEMIA, V25, P145, DOI 10.1038/leu.2010.230; Lwin T, 2010, BLOOD, V116, P5228, DOI 10.1182/blood-2010-03-275925; MacFarlane LA, 2010, CURR GENOMICS, V11, P537, DOI 10.2174/138920210793175895; McSpadden LC, 2009, AM J PHYSIOL-CELL PH, V297, pC339, DOI 10.1152/ajpcell.00024.2009; Misawa A, 2010, ONCOL RES, V19, P23, DOI 10.3727/096504010X12828372551759; Pan XA, 2010, CANCER BIOL THER, V10, P1224, DOI 10.4161/cbt.10.12.14252; PATEK PQ, 1989, P SOC EXP BIOL MED, V190, P234; RAITANO AB, 1990, PANCREAS, V5, P267, DOI 10.1097/00006676-199005000-00005; Rechavi O, 2009, GENE DEV, V23, P1971, DOI 10.1101/gad.1789609; Rocha JJE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019087; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Shih JD, 2011, RNA, V17, P1057, DOI 10.1261/rna.2596511; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tomoyasu Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r10; Toyofuku T, 1998, J BIOL CHEM, V273, P1519, DOI 10.1074/jbc.273.3.1519; Tsang SY, 2007, BIOCHEM BIOPH RES CO, V357, P480, DOI 10.1016/j.bbrc.2007.03.187; Valiunas V, 2005, J PHYSIOL-LONDON, V568, P459, DOI 10.1113/jphysiol.2005.090985; van Riel JM, 2009, EUR J CANCER, V45, P2519, DOI 10.1016/j.ejca.2009.05.025; Veltkamp SA, 2008, ONCOLOGIST, V13, P261, DOI 10.1634/theoncologist.2007-0215; WALLACE PK, 1993, CANCER RES, V53, P2358; Winston WM, 2002, SCIENCE, V295, P2456, DOI 10.1126/science.1068836; Wolfrum C, 2007, NAT BIOTECHNOL, V25, P1149, DOI 10.1038/nbt1339; Wolvetang EJ, 2007, BIOCHEM BIOPH RES CO, V363, P610, DOI 10.1016/j.bbrc.2007.09.035; Zhang ZQ, 1998, CARCINOGENESIS, V19, P1889, DOI 10.1093/carcin/19.11.1889; Zhao TY, 2006, J NEUROCHEM, V98, P1541, DOI 10.1111/j.1471-4159.2006.03974.x	62	42	43	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5267	5277		10.1074/jbc.M111.318865	http://dx.doi.org/10.1074/jbc.M111.318865			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22174421	hybrid, Green Published			2022-12-27	WOS:000300638000009
J	Jiang, ZH; Yu, N; Kuang, PP; Chen, M; Shao, FZ; Martin, G; Chui, DHK; Cardoso, WV; Ai, XB; Lu, JN				Jiang, Zhihua; Yu, Nan; Kuang, Pingping; Chen, Melody; Shao, Fengzhi; Martin, Gregory; Chui, David H. K.; Cardoso, Wellington V.; Ai, Xingbin; Lu, Jining			Trinucleotide Repeat Containing 6a (Tnrc6a)-mediated MicroRNA Function Is Required for Development of Yolk Sac Endoderm	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GW BODIES; GW182; FAMILY; COMPONENT; DEADENYLASE; BIOGENESIS; REGULATOR; PROTEINS; CCR4-NOT; DOMAINS	Tnrc6 family members (Tnrc6a/b/c) are key components of the RNA-induced silencing complex in microRNA (miRNA)mediated gene suppression. Here, we show that Tnrc6a, also known as GW182, is selectively expressed in the yolk sac endoderm and that gene trap disruption of GW182 leads to growth arrest and apoptosis. We found that targets of miRNAs highly expressed in the yolk sac are significantly derepressed in GW182(gt/gt) mutant mice, although levels of miRNAs are not altered. Specifically, growth arrest and apoptosis phenotype are associated with significant derepression of Cdkn1a (p21), Cdkn1c (P27), Lats1, Lats2, Rb1, Rbl, Bim, and Pten, known targets of miRNAs from miR-17/20/93/106 clusters highly expressed in yolk sac endoderm. Together, these data strongly suggest that GW182 is an essential functional component in the RNA-induced silencing complex for miRNA-mediated gene silencing in vivo, and selectively regulation of miRNA activity plays an important role in the proper development of yolk sac.	[Jiang, Zhihua; Yu, Nan; Kuang, Pingping; Chen, Melody; Shao, Fengzhi; Cardoso, Wellington V.; Ai, Xingbin; Lu, Jining] Boston Univ, Ctr Pulm, Sch Med, Boston, MA 02118 USA; [Martin, Gregory] Boston Univ, Transgen Core Facil, Sch Med, Boston, MA 02118 USA; [Chui, David H. K.] Boston Univ, Dept Med, Sch Med, Boston, MA 02118 USA	Boston University; Boston University; Boston University	Lu, JN (corresponding author), 715 Albany St,R304, Boston, MA 02118 USA.	jining@bu.edu	jiang, zhihua/I-6998-2012	Cardoso, Wellington/0000-0002-2550-3697; Ai, Xingbin/0000-0002-2178-0080	National Institutes of Health [P01 HL47049, R01 HL081800]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081800, R01HL105971, P01HL047049] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 HL47049 and R01 HL081800.	Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Astorga J, 2007, DEVELOPMENT, V134, P3753, DOI 10.1242/dev.004432; Baillat D, 2009, MOL CELL BIOL, V29, P4144, DOI 10.1128/MCB.00380-09; Baron MH, 2003, EXP HEMATOL, V31, P1160, DOI 10.1016/j.exphem.2003.08.019; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Behm-Ansmant I, 2006, COLD SPRING HARB SYM, V71, P523, DOI 10.1101/sqb.2006.71.013; Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Braun JE, 2011, MOL CELL, V44, P120, DOI 10.1016/j.molcel.2011.09.007; Chekulaeva M, 2011, NAT STRUCT MOL BIOL, V18, P1218, DOI 10.1038/nsmb.2166; Cushing L, 2011, AM J RESP CELL MOL, V45, P287, DOI 10.1165/rcmb.2010-0323OC; Czech B, 2011, NAT REV GENET, V12, P19, DOI 10.1038/nrg2916; Damert A, 2002, DEVELOPMENT, V129, P1881; Ding L, 2005, MOL CELL, V19, P437, DOI 10.1016/j.molcel.2005.07.013; Ding L, 2007, TRENDS CELL BIOL, V17, P411, DOI 10.1016/j.tcb.2007.06.003; Eulalio A, 2009, RNA, V15, P1433, DOI 10.1261/rna.1703809; Eulalio A, 2009, RNA, V15, P1067, DOI 10.1261/rna.1605509; Eystathioy T, 2002, MOL BIOL CELL, V13, P1338, DOI 10.1091/mbc.01-11-0544; Fabian MR, 2011, NAT STRUCT MOL BIOL, V18, P1211, DOI 10.1038/nsmb.2149; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Jakymiw A, 2005, NAT CELL BIOL, V7, P1267, DOI 10.1038/ncb1334; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Lazzaretti D, 2009, RNA, V15, P1059, DOI 10.1261/rna.1606309; Lian SL, 2006, CELL CYCLE, V5, P242, DOI 10.4161/cc.5.3.2410; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Liu JD, 2005, NAT CELL BIOL, V7, P1261, DOI 10.1038/ncb1333; Malpel S, 2000, DEVELOPMENT, V127, P3057; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Obernosterer G, 2007, NAT PROTOC, V2, P1508, DOI 10.1038/nprot.2007.153; Olive V, 2010, INT J BIOCHEM CELL B, V42, P1348, DOI 10.1016/j.biocel.2010.03.004; Olive V, 2009, GENE DEV, V23, P2839, DOI 10.1101/gad.1861409; Schneider MD, 2006, J CELL BIOL, V174, P349, DOI 10.1083/jcb.200512103; Sen GL, 2005, NAT CELL BIOL, V7, P633, DOI 10.1038/ncb1265; Spruce T, 2010, DEV CELL, V19, P207, DOI 10.1016/j.devcel.2010.07.014; Tsao PN, 2009, DEVELOPMENT, V136, P2297, DOI 10.1242/dev.034884; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Wang Y, 2008, NAT GENET, V40, P1478, DOI 10.1038/ng.250; Zipprich JT, 2009, RNA, V15, P781, DOI 10.1261/rna.1448009	38	4	5	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5979	5987		10.1074/jbc.M111.297937	http://dx.doi.org/10.1074/jbc.M111.297937			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22187428	Green Published, hybrid			2022-12-27	WOS:000300638000071
J	Jimenez, B; Ugwu, F; Zhao, RM; Orti, L; Makhnevych, T; Pineda-Lucena, A; Houry, WA				Jimenez, Beatriz; Ugwu, Francisca; Zhao, Rongmin; Orti, Leticia; Makhnevych, Taras; Pineda-Lucena, Antonio; Houry, Walid A.			Structure of Minimal Tetratricopeptide Repeat Domain Protein Tah1 Reveals Mechanism of Its Interaction with Pih1 and Hsp90	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TPR-DOMAIN; SACCHAROMYCES-CEREVISIAE; R2TP COMPLEX; SNAP HELIX; CHAPERONE; MOTIF; MACHINERY; BINDING; NMR; TRANSCRIPTION	Tah1 and Pih1 are novel Hsp90 interactors. Tah1 acts as a cofactor of Hsp90 to stabilize Pih1. In yeast, Hsp90, Tah1, and Pih1 were found to form a complex that is required for ribosomal RNA processing through their effect on box C/D small nucleolar ribonucleoprotein assembly. Tah1 is a minimal tetratricopeptide repeat protein of 111 amino acid residues that binds to the C terminus of the Hsp90 molecular chaperone, whereas Pih1 consists of 344 residues of unknown fold. The NMR structure of Tah1 has been solved, and this structure shows the presence of two tetratricopeptide repeat motifs followed by a C helix and an unstructured region. The binding of Tah1 to Hsp90 is mediated by the EEVD C-terminal residues of Hsp90, which bind to a positively charged channel formed by Tah1. Five highly conserved residues, which form a two-carboxylate clamp that tightly interacts with the ultimate Asp-0 residue of the bound peptide, are also present in Tah1. Tah1 was found to bind to the C terminus of Pih1 through the C helix and the unstructured region. The C terminus of Pih1 destabilizes the protein in vitro and in vivo, whereas the binding of Tah1 to Pih1 allows for the formation of a stable complex. Based on our data, a model for an Hsp90-Tah1-Pih1 ternary complex is proposed.	[Jimenez, Beatriz; Orti, Leticia; Pineda-Lucena, Antonio] Ctr Invest Principe Felipe, Dept Med Chem, Struct Biochem Lab, E-46012 Valencia, Spain; [Ugwu, Francisca; Makhnevych, Taras; Houry, Walid A.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Zhao, Rongmin] Univ Toronto, Dept Biol Sci, Scarborough, ON M1C 1A4, Canada	Prince Felipe Research Center; University of Toronto; University of Toronto; University Toronto Scarborough	Pineda-Lucena, A (corresponding author), Ctr Invest Principe Felipe, Dept Med Chem, Struct Biochem Lab, E-46012 Valencia, Spain.	apineda@cipf.es; walid.houry@utoronto.ca	Pineda-Lucena, Antonio/B-1320-2014	Pineda-Lucena, Antonio/0000-0002-3532-8781; Zhao, Rongmin/0000-0003-1300-5882	Canadian Institutes of Health Research [MOP-93778]; Spanish Ministerio de Ciencia e Innovacion (MICINN) [SAF2008-01845]; EC [RII3-026145]; Ontario Institute for Cancer Research; Faculty of Medicine at the University of Toronto; European FP7 e-Infrastructure grant [261572]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Spanish Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); EC(European CommissionEuropean Commission Joint Research Centre); Ontario Institute for Cancer Research; Faculty of Medicine at the University of Toronto(University of Toronto); European FP7 e-Infrastructure grant	This work was supported by a grant from the Canadian Institutes of Health Research (MOP-93778) to WAH, Spanish Ministerio de Ciencia e Innovacion (MICINN, SAF2008-01845) to AP-L.; Supported by the Access to Research Infrastructures activity in the 6th FP of the EC (Contract RII3-026145, EU-NMR).; Supported in part by the Ontario Institute for Cancer Research and by the Grant Miller Cancer Research Grant from the Faculty of Medicine at the University of Toronto.; We thank Dr. Francesca Cantini and Prof. Antonio Rosato for help with the structure calculations and software usage. We thank Dr. Hermann Torsten for help with UNIO. We thank Elisa Leung and Usheer Kanjee for help with the ITC experiments and Dr. Majida El Bakkouri for help with the structure figures. A.P.-L. and B. J. acknowledge the We NMR project (European FP7 e-Infrastructure grant, Contract 261572) for use of Web portals, computing, and storage facilities and CERM (University of Florence) for technical support.	Abe Y, 2000, CELL, V100, P551, DOI 10.1016/S0092-8674(00)80691-1; Alberti S, 2007, YEAST, V24, P913, DOI 10.1002/yea.1502; Bertini I, 2011, BIOINFORMATICS, V27, P2384, DOI 10.1093/bioinformatics/btr415; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; Boulon S, 2008, J CELL BIOL, V180, P579, DOI 10.1083/jcb.200708110; Boulon S, 2010, MOL CELL, V39, P912, DOI 10.1016/j.molcel.2010.08.023; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cliff MJ, 2005, J MOL BIOL, V346, P717, DOI 10.1016/j.jmb.2004.12.017; Cliff MJ, 2006, STRUCTURE, V14, P415, DOI 10.1016/j.str.2005.12.009; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Cortajarena AL, 2010, FEBS J, V277, P1058, DOI 10.1111/j.1742-4658.2009.07549.x; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Eckert K, 2010, J BIOL CHEM, V285, P31304, DOI 10.1074/jbc.M110.138263; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Feldman DE, 1999, MOL CELL, V4, P1051, DOI 10.1016/S1097-2765(00)80233-6; GOEBL M, 1991, TRENDS BIOCHEM SCI, V16, P173, DOI 10.1016/0968-0004(91)90070-C; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; HIRANO T, 1990, CELL, V60, P319, DOI 10.1016/0092-8674(90)90746-2; Horejsi Z, 2010, MOL CELL, V39, P839, DOI 10.1016/j.molcel.2010.08.037; Hu YH, 2007, GENOME RES, V17, P536, DOI 10.1101/gr.6037607; Huen J, 2010, BIOCHEM CELL BIOL, V88, P29, DOI [10.1139/o09-122, 10.1139/O09-122]; Inoue M, 2010, BIOCHEM BIOPH RES CO, V403, P340, DOI 10.1016/j.bbrc.2010.11.031; Jeronimo C, 2007, MOL CELL, V27, P262, DOI 10.1016/j.molcel.2007.06.027; Jha S, 2009, MOL CELL, V34, P521, DOI 10.1016/j.molcel.2009.05.016; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li JX, 2009, J BIOL CHEM, V284, P23852, DOI 10.1074/jbc.M109.023986; Magliery TJ, 2004, J MOL BIOL, V343, P731, DOI 10.1016/j.jmb.2004.08.026; Millson SH, 2008, BIOCHEM J, V413, P261, DOI 10.1042/BJ20080105; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Ni L, 2009, J CELL BIOCHEM, V106, P920, DOI 10.1002/jcb.22073; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Rocchia W, 2002, J COMPUT CHEM, V23, P128, DOI 10.1002/jcc.1161; Savchenko A, 2003, PROTEINS, V50, P392, DOI 10.1002/prot.10282; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; SIKORSKI RS, 1990, CELL, V60, P307, DOI 10.1016/0092-8674(90)90745-Z; Smith DF, 2004, CELL STRESS CHAPERON, V9, P109, DOI 10.1379/CSC-31.1; Wegele H, 2004, REV PHYSIOL BIOCH P, V151, P1, DOI 10.1007/s10254-003-0021-1; Yang J, 2005, EMBO J, V24, P1, DOI 10.1038/sj.emboj.7600496; Zhang MH, 2005, MOL CELL, V20, P525, DOI 10.1016/j.molcel.2005.09.023; Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024; Zhao RM, 2008, J CELL BIOL, V180, P563, DOI 10.1083/jcb.200709061	46	37	38	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5698	5709		10.1074/jbc.M111.287458	http://dx.doi.org/10.1074/jbc.M111.287458			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22179618	Green Published, hybrid			2022-12-27	WOS:000300638000046
J	Plazzo, AP; De Franceschi, N; Da Broi, F; Zonta, F; Sanasi, MF; Filippini, F; Mongillo, M				Plazzo, Anna Pia; De Franceschi, Nicola; Da Broi, Francesca; Zonta, Francesco; Sanasi, Maria Federica; Filippini, Francesco; Mongillo, Marco			Bioinformatic and Mutational Analysis of Channelrhodopsin-2 Protein Cation-conducting Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPTICAL CONTROL; LIGHT; ACTIVATION; WEB	Channelrhodopsin-2 (ChR2) is a light-gated cation channel widely used as a biotechnological tool to control membrane depolarization in various cell types and tissues. Although several ChR2 variants with modified properties have been generated, the structural determinants of the protein function are largely unresolved. We used bioinformatic modeling of the ChR2 structure to identify the putative cationic pathway within the channel, which is formed by a system of inner cavities that are uniquely present in this microbial rhodopsin. Site-directed mutagenesis combined with patch clamp analysis in HeLa cells was used to determine key residues involved in ChR2 conductance and selectivity. Among them, Gln-56 is important for ion conductance, whereas Ser-63, Thr-250, and Asn-258 are previously unrecognized residues involved in ion selectivity and photocurrent kinetics. This study widens the current structural information on ChR2 and can assist in the design of new improved variants for specific biological applications.	[Plazzo, Anna Pia; Da Broi, Francesca; Sanasi, Maria Federica; Mongillo, Marco] Univ Padua, Dept Biomed Sci, I-35100 Padua, Italy; [De Franceschi, Nicola; Filippini, Francesco] Univ Padua, Dept Biol, I-35100 Padua, Italy; [Filippini, Francesco] Univ Padua, Dept Phys, I-35100 Padua, Italy; [Plazzo, Anna Pia; De Franceschi, Nicola; Da Broi, Francesca; Mongillo, Marco] VIMM, I-35129 Padua, Italy	University of Padua; University of Padua; University of Padua; Veneto Institute Molecular Medicine	Mongillo, M (corresponding author), Univ Padua, Dept Biomed Sci, Viale Colombo 3, I-35100 Padua, Italy.	marco.mongillo@unipd.it	Filippini, Francesco/AAH-2897-2021; Zonta, Francesco/GXW-1979-2022; De Franceschi, Nicola/S-8194-2016	Zonta, Francesco/0000-0001-8729-1071; FILIPPINI, FRANCESCO/0000-0001-5672-0726; De Franceschi, Nicola/0000-0002-7221-613X	European Community [HEALTH-F2-2009-241526]	European Community(European Commission)	This work was supported by funding from the European Community Seventh Framework Program FP7/2007-2013 under Grant Agreement HEALTH-F2-2009-241526, EUTrigTreat (to M. M.).	Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bamann C, 2010, BIOCHEMISTRY-US, V49, P267, DOI 10.1021/bi901634p; Beltramello M, 2003, BIOCHEM BIOPH RES CO, V305, P1024, DOI 10.1016/S0006-291X(03)00868-4; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berndt A, 2011, P NATL ACAD SCI USA, V108, P7595, DOI 10.1073/pnas.1017210108; Berndt A, 2009, NAT NEUROSCI, V12, P229, DOI 10.1038/nn.2247; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; BROWN LS, 1995, BIOCHEMISTRY-US, V34, P12903, DOI 10.1021/bi00039a053; Bruegmann T, 2010, NAT METHODS, V7, P897, DOI 10.1038/nmeth.1512; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Deisseroth K, 2011, NAT METHODS, V8, P26, DOI 10.1038/NMETH.F.324; DER A, 1991, P NATL ACAD SCI USA, V88, P4751, DOI 10.1073/pnas.88.11.4751; Enamil N, 2006, J MOL BIOL, V358, P675, DOI 10.1016/j.jmb.2006.02.032; Feldbauer K, 2009, P NATL ACAD SCI USA, V106, P12317, DOI 10.1073/pnas.0905852106; FOSTER KW, 1984, NATURE, V311, P756, DOI 10.1038/311756a0; Gunaydin LA, 2010, NAT NEUROSCI, V13, P387, DOI 10.1038/nn.2495; Hegemann P, 2005, BIOPHYS J, V89, P3911, DOI 10.1529/biophysj.105.069716; Hegemann P., 2007, CELL SCI REV, V3, P108; Hegemann P, 2011, NAT METHODS, V8, P39, DOI 10.1038/NMETH.F.327; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hofmann B, 2010, LAB CHIP, V10, P2588, DOI 10.1039/c003091k; Ishizuka T, 2006, NEUROSCI RES, V54, P85, DOI 10.1016/j.neures.2005.10.009; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kleinlogel S, 2011, NAT NEUROSCI, V14, P513, DOI 10.1038/nn.2776; Kouyama T, 2010, J MOL BIOL, V396, P564, DOI 10.1016/j.jmb.2009.11.061; LESSEL U, 1994, PROTEIN ENG, V7, P1175, DOI 10.1093/protein/7.10.1175; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Lill MA, 2011, J COMPUT AID MOL DES, V25, P13, DOI 10.1007/s10822-010-9395-8; Muller M, 2011, J MOL BIOL, V414, P86, DOI 10.1016/j.jmb.2011.09.049; Nack M, 2010, PHOTOCH PHOTOBIO SCI, V9, P194, DOI 10.1039/b9pp00157c; Nagel G, 2002, SCIENCE, V296, P2395, DOI 10.1126/science.1072068; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Radu I, 2009, J AM CHEM SOC, V131, P7313, DOI 10.1021/ja8084274; Ruffert K, 2011, BIOCHEM BIOPH RES CO, V410, P737, DOI 10.1016/j.bbrc.2011.06.024; Stehfest K, 2010, J MOL BIOL, V398, P690, DOI 10.1016/j.jmb.2010.03.031; Sugiyama Y, 2009, PHOTOCH PHOTOBIO SCI, V8, P328, DOI 10.1039/b815762f; Tsunoda SP, 2009, PHOTOCHEM PHOTOBIOL, V85, P564, DOI 10.1111/j.1751-1097.2008.00519.x; Wolf S, 2010, ANGEW CHEM INT EDIT, V49, P6889, DOI 10.1002/anie.201001243; Yoshimura K, 2008, J MOL BIOL, V375, P1267, DOI 10.1016/j.jmb.2007.11.039; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936	44	28	29	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4818	4825		10.1074/jbc.M111.326207	http://dx.doi.org/10.1074/jbc.M111.326207			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22139833	hybrid, Green Published			2022-12-27	WOS:000300608500043
J	Wang, Y; Kallgren, SP; Reddy, BD; Kuntz, K; Lopez-Maury, L; Thompson, J; Watt, S; Ma, C; Hou, HT; Shi, Y; Yates, JR; Bahler, J; O'Connell, MJ; Jia, ST				Wang, Yu; Kallgren, Scott P.; Reddy, Bharat D.; Kuntz, Karen; Lopez-Maury, Luis; Thompson, James; Watt, Stephen; Ma, Chun; Hou, Haitong; Shi, Yang; Yates, John R., III; Baehler, Juerg; O'Connell, Matthew J.; Jia, Songtao			Histone H3 Lysine 14 Acetylation Is Required for Activation of a DNA Damage Checkpoint in Fission Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCHIZOSACCHAROMYCES-POMBE; ACETYLTRANSFERASE COMPLEXES; PROTEIN COMPLEXES; CHROMATIN; GENOME; H4; TRANSCRIPTION; METHYLATION; MUTANTS; BIOLOGY	Histone lysine acetylation has emerged as a key regulator of genome organization. However, with a few exceptions, the contribution of each acetylated lysine to cellular functions is not well understood because of the limited specificity of most histone acetyltransferases and histone deacetylases. Here we show that the Mst2 complex in Schizosaccharomyces pombe is a highly specific H3 lysine 14 (H3K14) acetyltransferase that functions together with Gcn5 to regulate global levels of H3K14 acetylation (H3K14ac). By analyzing the effect of H3K14ac loss through both enzymatic inactivation and histone mutations, we found that H3K14ac is critical for DNA damage checkpoint activation by directly regulating the compaction of chromatin and by recruiting chromatin remodeling protein complex RSC.	[Jia, Songtao] Columbia Univ, Fairchild Ctr 1114, Dept Biol Sci, New York, NY 10027 USA; [Kuntz, Karen; O'Connell, Matthew J.] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY 10029 USA; [Lopez-Maury, Luis; Watt, Stephen; Baehler, Juerg] UCL, Dept Genet Evolut & Environm, London WC1E 6BT, England; [Lopez-Maury, Luis; Watt, Stephen; Baehler, Juerg] UCL, Inst Canc, London WC1E 6BT, England; [Thompson, James; Yates, John R., III] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Ma, Chun; Shi, Yang] Fudan Univ, Lab Epigenet, Inst Biomed Sci, Sch Med, Shanghai 20032, Peoples R China; [Ma, Chun; Shi, Yang] Fudan Univ, Dept Biochem, Sch Med, Shanghai 20032, Peoples R China; [Shi, Yang] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Shi, Yang] Childrens Hosp, Div Newborn Med, Dept Med, Boston, MA 02115 USA	Columbia University; Icahn School of Medicine at Mount Sinai; University of London; University College London; University of London; University College London; Scripps Research Institute; Fudan University; Fudan University; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Jia, ST (corresponding author), Columbia Univ, Fairchild Ctr 1114, Dept Biol Sci, MC2458, New York, NY 10027 USA.	jia@biology.columbia.edu	Hou, Haitong/E-8416-2013; Lopez-Maury, Luis/B-3715-2015; Bahler, Jurg/B-4572-2009; hou, haitong/D-5188-2019	Lopez-Maury, Luis/0000-0002-3510-0621; Bahler, Jurg/0000-0003-4036-1532; Kallgren, Scott/0000-0002-6318-3268; hou, haitong/0000-0003-4493-9645; Jia, Songtao/0000-0002-7927-0227	National Institutes of Health [R01-GM085145, R01-GM087326, T32-GM008798]; National Institutes of Health NCI [T32-CA78207]; Cancer Research UK; National Center for Research Resources [P41 RR11823]; Chinese Ministry of Education [2009CB825602]; "973" State Key Development Program of Basic Research of China [2009CB825603]; NATIONAL CANCER INSTITUTE [T32CA078207] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008798, R01GM087326, R01GM085145] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research UK(Cancer Research UK); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Chinese Ministry of Education(Ministry of Education, China); "973" State Key Development Program of Basic Research of China(National Basic Research Program of China); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported, in whole or in part, by National Institutes of Health Grants R01-GM085145 (to S. J.) and R01-GM087326 (to M. J. O), by National Institutes of Health Training Grant T32-GM008798 (to S. P. K. and B. D. R.), and by National Institutes of Health NCI Training Grant T32-CA78207 (to K. K.). This work was also supported by a Cancer Research UK grant (to J. B.), by National Center for Research Resources Grant P41 RR11823 (to T. N.D.), by "985" Program Grant 2009CB825602 from the Chinese Ministry of Education, and by "973" State Key Development Program of Basic Research of China Grant 2009CB825603.	Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Dai J, 2008, CELL, V134, P1066, DOI 10.1016/j.cell.2008.07.019; Dion MF, 2005, P NATL ACAD SCI USA, V102, P5501, DOI 10.1073/pnas.0500136102; Driscoll R, 2007, SCIENCE, V315, P649, DOI 10.1126/science.1135862; Du LL, 2006, GENE DEV, V20, P1583, DOI 10.1101/gad.1422606; DURRIN LK, 1991, CELL, V65, P1023, DOI 10.1016/0092-8674(91)90554-C; Eberharter A, 1998, METHODS, V15, P315, DOI 10.1006/meth.1998.0635; Ferreira H, 2007, J MOL BIOL, V374, P563, DOI 10.1016/j.jmb.2007.09.059; Gomez EB, 2005, MOL CELL BIOL, V25, P8887, DOI 10.1128/MCB.25.20.8887-8903.2005; Han JH, 2007, SCIENCE, V315, P653, DOI 10.1126/science.1133234; Helmlinger D, 2008, GENE DEV, V22, P3184, DOI 10.1101/gad.1719908; Howe L, 2002, MOL CELL BIOL, V22, P5047, DOI 10.1128/MCB.22.14.5047-5053.2002; Howe L, 2001, GENE DEV, V15, P3144, DOI 10.1101/gad.931401; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; John S, 2000, GENE DEV, V14, P1196; Kasten M, 2004, EMBO J, V23, P1348, DOI 10.1038/sj.emboj.7600143; Kim YC, 2009, NAT CELL BIOL, V11, P92, DOI 10.1038/ncb1817; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Kuntz K, 2009, CANCER BIOL THER, V8, P1433, DOI 10.4161/cbt.8.15.9081; Kuo MH, 1996, NATURE, V383, P269, DOI 10.1038/383269a0; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Liang B, 2007, CURR BIOL, V17, P1432, DOI 10.1016/j.cub.2007.07.035; Lopez-Girona A, 2001, P NATL ACAD SCI USA, V98, P11289, DOI 10.1073/pnas.191557598; Martin DGE, 2006, MOL CELL BIOL, V26, P7871, DOI 10.1128/MCB.00573-06; MEGEE PC, 1990, SCIENCE, V247, P841, DOI 10.1126/science.2106160; MEGEE PC, 1995, GENE DEV, V9, P1716, DOI 10.1101/gad.9.14.1716; Mellone BG, 2003, CURR BIOL, V13, P1748, DOI 10.1016/j.cub.2003.09.031; Monahan BJ, 2008, NAT STRUCT MOL BIOL, V15, P873, DOI 10.1038/nsmb.1452; Nakanishi S, 2008, NAT STRUCT MOL BIOL, V15, P881, DOI 10.1038/nsmb.1454; Nugent RL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-59; PARK EC, 1990, MOL CELL BIOL, V10, P4932, DOI 10.1128/MCB.10.9.4932; Pidoux A, 2004, METHODS, V33, P252, DOI 10.1016/j.ymeth.2003.11.021; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Reddy BD, 2011, GENE DEV, V25, P214, DOI 10.1101/gad.1993611; Sanchez R, 2009, CURR OPIN DRUG DISC, V12, P659; Schneider J, 2006, J BIOL CHEM, V281, P37270, DOI 10.1074/jbc.C600265200; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Shim EY, 2007, MOL CELL BIOL, V27, P1602, DOI 10.1128/MCB.01956-06; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Taverna SD, 2006, MOL CELL, V24, P785, DOI 10.1016/j.molcel.2006.10.026; Tsutsui Y, 2001, GENETICS, V159, P91; Vermeulen M, 2010, CELL, V142, P967, DOI 10.1016/j.cell.2010.08.020; Wang Y, 2009, MOL CELL, V33, P428, DOI 10.1016/j.molcel.2009.02.002; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wiren M, 2005, EMBO J, V24, P2906, DOI 10.1038/sj.emboj.7600758	47	50	58	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					4386	4393		10.1074/jbc.M111.329417	http://dx.doi.org/10.1074/jbc.M111.329417			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22184112	hybrid, Green Published			2022-12-27	WOS:000300410900069
J	Yue, CY; Soboloff, J; Gamero, AM				Yue, Chanyu; Soboloff, Jonathan; Gamero, Ana M.			Control of Type I Interferon-induced Cell Death by Orai1-mediated Calcium Entry in T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; CRAC CHANNEL; LYMPHOCYTE-ACTIVATION; PLASMA-MEMBRANE; CA2+ SENSOR; APOPTOSIS; RECEPTOR; STORE; INHIBITION; SIGNALS	Store-operated Ca2+ entry (SOCE) is an essential process in T cell activation. SOCE is controlled by the Ca2+ release-activated Ca2+ (CRAC) channel encoded by the gene Orai1 that is expressed on the plasma membrane and activated by STIM1 when ER Ca2+ stores are depleted. Our earlier work showed that a somatic T-cell line Jurkat mutant H123 bearing a defect in Ca2+ signaling was susceptible to the apoptotic effects of type I interferons (IFN-alpha/beta). The nature of the mutation and whether this mutation was linked to IFN-alpha/beta apoptotic susceptibility was unknown. Here we show that H123 cells lacked Orai1 and exhibit reduced STIM1 protein. Reconstitution of both Orai1 and STIM1 in H123 cells rescued SOCE in response to thapsigargin and ionomycin and abrogated IFN-alpha/beta-induced apoptosis. Reciprocally, overexpression of the dominant negative Orai1-E106A in either parental Jurkat cells or an unrelated human T cell line (CEM391) inhibited SOCE and led to sensitization to IFN-alpha/beta-induced apoptosis. Furthermore, we showed that the Ca2+ response pathway antagonized the IFN-alpha/beta-induced transcriptional responses; in the absence of SOCE, this negative regulatory effect was lost. However, the inhibitory effect of Ca2+ on type IIFN-induced gene transcription was diminished by pharmacological inhibition of NF-kappa B in cells with intact SOCE. Our findings reveal an unexpected and novel regulatory crosstalk mechanism between type I IFNs and storeoperated Ca2+ signaling pathways mediated at least in part by NF-kappa B activity with significant clinical implications to both viral and tumor immunology.	[Yue, Chanyu; Soboloff, Jonathan; Gamero, Ana M.] Temple Univ, Sch Med, Dept Biochem, Philadelphia, PA 19140 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Soboloff, J (corresponding author), 3400 N Broad St,Kresge Hall, Philadelphia, PA 19140 USA.	soboloff@temple.edu; gameroa@temple.edu	Yue, Chanyu/H-1792-2015; Soboloff, Jonathan/I-6995-2012	Soboloff, Jonathan/0000-0001-5192-1297	NCI, National Institutes of Health [R01CA140499, K22CA095326]; American Heart Association; Pennsylvania Dept. of Health; NATIONAL CANCER INSTITUTE [R01CA140499, K22CA095326] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097335] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Heart Association(American Heart Association); Pennsylvania Dept. of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by Grants R01CA140499 and K22CA095326 (to A. M. G.) from the NCI, National Institutes of Health, the American Heart Association (to J. S.), and the Pennsylvania Dept. of Health (to J. S. and A. M. G.).	Abraham RT, 2000, IMMUNOL RES, V22, P95, DOI 10.1385/IR:22:2-3:95; Belka C, 2003, ONCOGENE, V22, P176, DOI 10.1038/sj.onc.1206103; Borden EC, 2011, J INTERF CYTOK RES, V31, P1, DOI 10.1089/jir.2010.0129; Chang JW, 2006, NEPHRON EXP NEPHROL, V103, pE156, DOI 10.1159/000092906; Curtsinger JM, 2005, J IMMUNOL, V174, P4465, DOI 10.4049/jimmunol.174.8.4465; Dellis O, 2002, J BIOL CHEM, V277, P6044, DOI 10.1074/jbc.M111831200; Deng XX, 2009, J BIOL CHEM, V284, P22501, DOI 10.1074/jbc.R109.018655; Dondi E, 2004, J IMMUNOL, V173, P3740, DOI 10.4049/jimmunol.173.6.3740; Dondi E, 2003, J IMMUNOL, V170, P749, DOI 10.4049/jimmunol.170.2.749; Erickson S, 1999, CELL GROWTH DIFFER, V10, P575; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Gamero AM, 2006, CELL SIGNAL, V18, P1299, DOI 10.1016/j.cellsig.2005.10.008; Gimeno R, 2005, MOL CELL BIOL, V25, P5456, DOI 10.1128/MCB.25.13.5456-5465.2005; Hervas-Stubbs S, 2011, CLIN CANCER RES, V17, P2619, DOI 10.1158/1078-0432.CCR-10-1114; Hewavitharana T, 2008, J BIOL CHEM, V283, P26252, DOI 10.1074/jbc.M802239200; Hewavitharana T, 2007, CELL CALCIUM, V42, P173, DOI 10.1016/j.ceca.2007.03.009; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Jayaraman T, 1997, MOL CELL BIOL, V17, P3005, DOI 10.1128/MCB.17.6.3005; Le Bon A, 2008, CYTOKINE GROWTH F R, V19, P33, DOI 10.1016/j.cytogfr.2007.10.007; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; Li SY, 2010, BIOCHEMISTRY-MOSCOW+, V75, P101, DOI 10.1134/S000629791001013X; Liang SH, 2006, BIOCHEM J, V393, P201, DOI 10.1042/BJ20050374; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; May MJ, 2000, SCIENCE, V289, P1550, DOI 10.1126/science.289.5484.1550; Palkowitsch L, 2011, J BIOL CHEM, V286, P7522, DOI 10.1074/jbc.M110.155895; Petricoin EF, 1997, NATURE, V390, P629, DOI 10.1038/37648; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Rodriguez B, 2006, AIDS, V20, P1379, DOI 10.1097/01.aids.0000233571.51899.ab; Roifman CM, 2010, J ALLERGY CLIN IMMUN, V126, P1226, DOI 10.1016/j.jaci.2010.07.029; Soboloff J, 2002, J BIOL CHEM, V277, P13812, DOI 10.1074/jbc.M112129200; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Stathopulos PB, 2008, CELL, V135, P110, DOI 10.1016/j.cell.2008.08.006; Valdes JA, 2007, AM J PHYSIOL-CELL PH, V292, pC1960, DOI 10.1152/ajpcell.00320.2006; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Wei L, 2006, J BIOL CHEM, V281, P11678, DOI 10.1074/jbc.M513286200; Williams BL, 1998, MOL CELL BIOL, V18, P1388, DOI 10.1128/MCB.18.3.1388; Yang CH, 2001, J BIOL CHEM, V276, P13756, DOI 10.1074/jbc.M011006200; Yang CH, 2000, P NATL ACAD SCI USA, V97, P13631, DOI 10.1073/pnas.250477397; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; Zhou YD, 2009, J BIOL CHEM, V284, P19164, DOI 10.1074/jbc.C109.010900; Zitt C, 2004, J BIOL CHEM, V279, P12427, DOI 10.1074/jbc.M309297200	46	18	18	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3207	3216		10.1074/jbc.M111.269068	http://dx.doi.org/10.1074/jbc.M111.269068			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22144678	Green Published, hybrid			2022-12-27	WOS:000300295100026
J	Chan, RB; Oliveira, TG; Cortes, EP; Honig, LS; Duff, KE; Small, SA; Wenk, MR; Shui, GH; Di Paolo, G				Chan, Robin B.; Oliveira, Tiago G.; Cortes, Etty P.; Honig, Lawrence S.; Duff, Karen E.; Small, Scott A.; Wenk, Markus R.; Shui, Guanghou; Di Paolo, Gilbert			Comparative Lipidomic Analysis of Mouse and Human Brain with Alzheimer Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID-BETA-PEPTIDE; COGNITIVE DEFICITS; COMMON VARIANTS; TRANSGENIC MICE; CHOLESTEROL; METABOLISM; CERAMIDE; PRESENILIN-1; PATHOGENESIS; PATHWAYS	Lipids are key regulators of brain function and have been increasingly implicated in neurodegenerative disorders including Alzheimer disease (AD). Here, a systems-based approach was employed to determine the lipidome of brain tissues affected by AD. Specifically, we used liquid chromatography-mass spectrometry to profile extracts from the prefrontal cortex, entorhinal cortex, and cerebellum of late-onset AD(LOAD) patients, as well as the forebrain of three transgenic familial AD (FAD) mouse models. Although the cerebellum lacked major alterations in lipid composition, we found an elevation of a signaling pool of diacylglycerol as well as sphingolipids in the prefrontal cortex of AD patients. Furthermore, the diseased entorhinal cortex showed specific enrichment of lysobisphosphatidic acid, sphingomyelin, the ganglioside GM3, and cholesterol esters, all of which suggest common pathogenic mechanisms associated with endolysosomal storage disorders. Importantly, a significant increase in cholesterol esters and GM3 was recapitulated in the transgenic FAD models, suggesting that these mice are relevant tools to study aberrant lipid metabolism of endolysosomal dysfunction associated with AD. Finally, genetic ablation of phospholipase D-2, which rescues the synaptic and behavioral deficits of an FAD mouse model, fully normalizes GM3 levels. These data thus unmask a cross-talk between the metabolism of phosphatidic acid, the product of phospholipase D-2, and gangliosides, and point to a central role of ganglioside anomalies in AD pathogenesis. Overall, our study highlights the hypothesis generating potential of lipidomics and identifies novel region-specific lipid anomalies potentially linked to AD pathogenesis.	[Chan, Robin B.; Oliveira, Tiago G.; Duff, Karen E.; Di Paolo, Gilbert] Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Honig, Lawrence S.; Small, Scott A.] Columbia Univ, Med Ctr, Dept Neurol, New York, NY 10032 USA; [Chan, Robin B.; Oliveira, Tiago G.; Cortes, Etty P.; Honig, Lawrence S.; Duff, Karen E.; Small, Scott A.; Di Paolo, Gilbert] Columbia Univ, Med Ctr, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10032 USA; [Oliveira, Tiago G.] Univ Minho, Life & Hlth Sci Res Inst ICVS, Sch Hlth Sci, P-4710057 Braga, Portugal; [Oliveira, Tiago G.] Univ Minho, Life & Hlth Sci Res Inst 3Bs, Portuguese Govt Associate Lab, P-4710057 Braga, Portugal; [Wenk, Markus R.; Shui, Guanghou] Natl Univ Singapore, Dept Biochem, Singapore 117597, Singapore; [Wenk, Markus R.; Shui, Guanghou] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore	Columbia University; Columbia University; Columbia University; Universidade do Minho; Universidade do Minho; National University of Singapore; National University of Singapore	Shui, GH (corresponding author), Ctr Life Sci, 28 Med Dr,04-21, Singapore 117456, Singapore.	guanghou_shui@nuhs.edu.sg; gil.dipaolo@columbia.edu	Oliveira, Tiago Gil/AAL-2147-2021; Wenk, Markus Rene/D-1441-2014	Oliveira, Tiago Gil/0000-0003-0509-0562; Shui, Guanghou/0000-0002-1621-9643; Duff, Karen/0000-0002-6177-868X	National Institutes of Health [R01 HD05547, P50 AG008702]; Lejeune Foundation; National Research Foundation [R-183-000-218-281]; Biomedical Research Council [R-183-000-234-305]; National University of Singapore-Life Sciences Institute (SLING) [R-711-000-021-133]; NATIONAL INSTITUTE ON AGING [P50AG008702] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lejeune Foundation; National Research Foundation; Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); National University of Singapore-Life Sciences Institute (SLING)(National University of Singapore); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HD05547 (to G. D. P.) and P50 AG008702 (to M. Shelanski), and a Lejeune Foundation grant (to G. D. P.), National Research Foundation-Competitive Research Programme Grant R-183-000-218-281, Biomedical Research Council Grant R-183-000-234-305, and National University of Singapore-Life Sciences Institute (SLING) Grant R-711-000-021-133 (to M. R. W.).	Andreyev AY, 2010, J LIPID RES, V51, P2785, DOI 10.1194/jlr.M008748; Berman DE, 2008, NAT NEUROSCI, V11, P547, DOI 10.1038/nn.2100; Bhattacharyya R, 2010, BBA-MOL CELL BIOL L, V1801, P960, DOI 10.1016/j.bbalip.2010.04.003; Birnbaum SG, 2004, SCIENCE, V306, P882, DOI 10.1126/science.1100021; Bu GJ, 2009, NAT REV NEUROSCI, V10, P333, DOI 10.1038/nrn2620; Cataldo AM, 2008, AM J PATHOL, V173, P370, DOI 10.2353/ajpath.2008.071053; Chan R, 2008, J VIROL, V82, P11228, DOI 10.1128/JVI.00981-08; Cheng D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017299; Cutler RG, 2004, P NATL ACAD SCI USA, V101, P2070, DOI 10.1073/pnas.0305799101; Dall'Armi C, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1144; Di Paolo G, 2011, NAT REV NEUROSCI, V12, P284, DOI 10.1038/nrn3012; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; Falguieres T, 2009, EXP CELL RES, V315, P1567, DOI 10.1016/j.yexcr.2008.12.006; Foley P, 2010, BBA-MOL CELL BIOL L, V1801, P750, DOI 10.1016/j.bbalip.2010.05.004; Ginsberg SD, 2010, BIOL PSYCHIAT, V68, P885, DOI 10.1016/j.biopsych.2010.05.030; GomezIsla T, 1996, J NEUROSCI, V16, P4491; Gong B, 2006, CELL, V126, P775, DOI 10.1016/j.cell.2006.06.046; Grimm MOW, 2005, NAT CELL BIOL, V7, P1118, DOI 10.1038/ncb1313; Grosgen S, 2010, BBA-MOL CELL BIOL L, V1801, P966, DOI 10.1016/j.bbalip.2010.05.002; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Han XL, 2002, J NEUROCHEM, V82, P809, DOI 10.1046/j.1471-4159.2002.00997.x; Han XL, 2001, J NEUROCHEM, V77, P1168, DOI 10.1046/j.1471-4159.2001.00332.x; Haughey NJ, 2010, BBA-MOL CELL BIOL L, V1801, P878, DOI 10.1016/j.bbalip.2010.05.003; Hodgkin MN, 1998, TRENDS BIOCHEM SCI, V23, P200, DOI 10.1016/S0968-0004(98)01200-6; Hoetzl S, 2007, J NEUROCHEM, V103, P3, DOI 10.1111/j.1471-4159.2007.04721.x; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Katsel P, 2007, NEUROCHEM RES, V32, P845, DOI 10.1007/s11064-007-9297-x; Kim K, 2010, J NEUROCHEM, V112, P577, DOI 10.1111/j.1471-4159.2009.06499.x; Kobayashi T, 1998, NATURE, V392, P193, DOI 10.1038/32440; Lavieri RR, 2010, J MED CHEM, V53, P6706, DOI 10.1021/jm100814g; Martin V, 2010, J ALZHEIMERS DIS, V19, P489, DOI 10.3233/JAD-2010-1242; Mateos MV, 2010, BBA-BIOMEMBRANES, V1798, P624, DOI 10.1016/j.bbamem.2009.12.008; Matsuzaki K, 2010, BBA-MOL CELL BIOL L, V1801, P868, DOI 10.1016/j.bbalip.2010.01.008; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Nixon RA, 2007, J CELL SCI, V120, P4081, DOI 10.1242/jcs.019265; Oliveira TG, 2010, J NEUROSCI, V30, P16419, DOI 10.1523/JNEUROSCI.3317-10.2010; Osenkowski P, 2008, J BIOL CHEM, V283, P22529, DOI 10.1074/jbc.M801925200; Raghu P, 2009, J CELL BIOL, V185, P129, DOI 10.1083/jcb.200807027; Ryan SD, 2009, P NATL ACAD SCI USA, V106, P20936, DOI 10.1073/pnas.0905654106; Sampaio JL, 2011, P NATL ACAD SCI USA, V108, P1903, DOI 10.1073/pnas.1019267108; Sanchez-Mejia RO, 2008, NAT NEUROSCI, V11, P1311, DOI 10.1038/nn.2213; Schulze H, 2009, BBA-MOL CELL RES, V1793, P674, DOI 10.1016/j.bbamcr.2008.09.020; Shui GH, 2011, J CHROMATOGR A, V1218, P4357, DOI 10.1016/j.chroma.2011.05.011; Shui G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011956; Shui GH, 2010, MOL BIOSYST, V6, P1008, DOI 10.1039/b913353d; Simons K, 2000, TRENDS CELL BIOL, V10, P459, DOI 10.1016/S0962-8924(00)01847-X; Small SA, 2006, NEURON, V52, P15, DOI 10.1016/j.neuron.2006.09.001; SPECTOR AA, 1985, J LIPID RES, V26, P1015; Tamboli IY, 2011, J NEUROSCI, V31, P1837, DOI 10.1523/JNEUROSCI.2954-10.2011; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Wang G, 2008, GLIA, V56, P449, DOI 10.1002/glia.20626; Wassall SR, 2009, BBA-BIOMEMBRANES, V1788, P24, DOI 10.1016/j.bbamem.2008.10.011; Wenk MR, 2010, CELL, V143, P888, DOI 10.1016/j.cell.2010.11.033; Wu William, 2006, Current Alzheimer Research, V3, P529, DOI 10.2174/156720506779025161	56	349	355	8	112	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2678	2688		10.1074/jbc.M111.274142	http://dx.doi.org/10.1074/jbc.M111.274142			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22134919	Green Published, hybrid			2022-12-27	WOS:000300292300040
J	Fan, E; Fiedler, S; Jacob-Dubuisson, F; Muller, M				Fan, Enguo; Fiedler, Silke; Jacob-Dubuisson, Francoise; Mueller, Matthias			Two-partner Secretion of Gram-negative Bacteria A SINGLE beta-BARREL PROTEIN ENABLES TRANSPORT ACROSS THE OUTER MEMBRANE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERTUSSIS FILAMENTOUS HEMAGGLUTININ; PERIPLASMIC CHAPERONE SKP; ESCHERICHIA-COLI; SIGNAL PEPTIDE; OMP85 FAMILY; AUTOTRANSPORTER; BORDETELLA; DOMAIN; BIOGENESIS; PATHWAY	The mechanisms of protein secretion by pathogenic bacteria remain poorly understood. In Gram-negative bacteria, the two-partner secretion pathway exports large, mostly virulence-related "TpsA" proteins across the outer membrane via their dedicated "TpsB" transporters. TpsB transporters belong to the ubiquitous Omp85 superfamily, whose members are involved in protein translocation across, or integration into, cellular membranes. The filamentous hemagglutinin/FhaC pair of Bordetella pertussis is a model two-partner secretion system. We have reconstituted the TpsB transporter FhaC into proteoliposomes and demonstrate that FhaC is the sole outer membrane protein required for translocation of its cognate TpsA protein. This is the first in vitro system for analyzing protein secretion across the outer membrane of Gram-negative bacteria. Our data also provide clear evidence for the protein translocation function of Omp85 transporters.	[Fan, Enguo; Fiedler, Silke; Mueller, Matthias] Univ Freiburg, Inst Biochem & Mol Biol, ZBMZ, D-79104 Freiburg, Germany; [Jacob-Dubuisson, Francoise] Inst Pasteur, Ctr Infect & Immun Lille, CNRS UMR8204, INSERM U1019, F-59019 Lille, France	University of Freiburg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille	Muller, M (corresponding author), Univ Freiburg, Inst Biochem & Mol Biol, ZBMZ, Stefan Meier Str 17, D-79104 Freiburg, Germany.	matthias.mueller@biochemie.uni-freiburg.de	Jacob-Dubuisson, Françoise/F-1610-2018	Jacob-Dubuisson, Françoise/0000-0002-5102-1704	Deutsche Forschungsgemeinschaft [Sonderforschungsbereich 746, Forschergruppe 929]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Sonderforschungsbereich 746 and Forschergruppe 929 from the Deutsche Forschungsgemeinschaft.	Baud C, 2009, MOL MICROBIOL, V74, P315, DOI 10.1111/j.1365-2958.2009.06860.x; Baud C, 2011, MOL MICROBIOL, V80, P1625, DOI 10.1111/j.1365-2958.2011.07672.x; Bennion D, 2010, MOL MICROBIOL, V77, P1153, DOI 10.1111/j.1365-2958.2010.07280.x; Bodelon G, 2009, J BACTERIOL, V191, P5169, DOI 10.1128/JB.00458-09; Brandon LD, 2003, MOL MICROBIOL, V50, P45, DOI 10.1046/j.1365-2958.2003.03674.x; Chevalier N, 2004, J MOL MICROB BIOTECH, V8, P7, DOI 10.1159/000082076; Choi PS, 2010, MOL MICROBIOL, V75, P440, DOI 10.1111/j.1365-2958.2009.06993.x; Clantin B, 2004, P NATL ACAD SCI USA, V101, P6194, DOI 10.1073/pnas.0400291101; Clantin B, 2007, SCIENCE, V317, P957, DOI 10.1126/science.1143860; Coutte L, 2001, EMBO J, V20, P5040, DOI 10.1093/emboj/20.18.5040; Dautin N, 2007, ANNU REV MICROBIOL, V61, P89, DOI 10.1146/annurev.micro.61.080706.093233; Desvaux M, 2009, TRENDS MICROBIOL, V17, P139, DOI 10.1016/j.tim.2009.01.004; DOMENIGHINI M, 1990, MOL MICROBIOL, V4, P787, DOI 10.1111/j.1365-2958.1990.tb00649.x; Economou A, 2006, MOL MICROBIOL, V62, P308, DOI 10.1111/j.1365-2958.2006.05377.x; Emsley P, 1996, NATURE, V381, P90, DOI 10.1038/381090a0; Gentle I, 2004, J CELL BIOL, V164, P19, DOI 10.1083/jcb.200310092; Gentle IE, 2005, MOL MICROBIOL, V58, P1216, DOI 10.1111/j.1365-2958.2005.04906.x; Guedin S, 1998, MOL MICROBIOL, V29, P763, DOI 10.1046/j.1365-2958.1998.00970.x; Hagan CL, 2010, SCIENCE, V328, P890, DOI 10.1126/science.1188919; Harms N, 2001, J BIOL CHEM, V276, P18804, DOI 10.1074/jbc.M011194200; Hodak H, 2006, MOL MICROBIOL, V61, P368, DOI 10.1111/j.1365-2958.2006.05242.x; Ieva R, 2009, P NATL ACAD SCI USA, V106, P19120, DOI 10.1073/pnas.0907912106; Jacob-Dubuisson F, 1999, J BIOL CHEM, V274, P37731, DOI 10.1074/jbc.274.53.37731; Jacob-Dubuisson F, 2004, BBA-MOL CELL RES, V1694, P235, DOI 10.1016/j.bbamcr.2004.03.008; Jacob-Dubuisson F, 2009, BIOL CHEM, V390, P675, DOI 10.1515/BC.2009.099; JacobDubuisson F, 1996, MOL MICROBIOL, V19, P65, DOI 10.1046/j.1365-2958.1996.349883.x; Jain S, 2007, J BACTERIOL, V189, P5393, DOI 10.1128/JB.00228-07; LOCHT C, 1993, MOL MICROBIOL, V9, P653, DOI 10.1111/j.1365-2958.1993.tb01725.x; Marin E, 2010, J BACTERIOL, V192, P5588, DOI 10.1128/JB.00432-10; Meli AC, 2006, J BIOL CHEM, V281, P158, DOI 10.1074/jbc.M508524200; Moser Michael, 2007, V390, P63; Neumann-Haefelin C, 2000, EMBO J, V19, P6419, DOI 10.1093/emboj/19.23.6419; Nummelin H, 2004, EMBO J, V23, P701, DOI 10.1038/sj.emboj.7600100; Oomen CJ, 2004, EMBO J, V23, P1257, DOI 10.1038/sj.emboj.7600148; Paschen SA, 2003, NATURE, V426, P862, DOI 10.1038/nature02208; RenauldMongenie G, 1996, J BACTERIOL, V178, P1053, DOI 10.1128/jb.178.4.1053-1060.1996; Sauri A, 2009, MICROBIOL-SGM, V155, P3982, DOI 10.1099/mic.0.034991-0; Schafer U, 1999, J BIOL CHEM, V274, P24567, DOI 10.1074/jbc.274.35.24567; Schleiff E, 2005, EMBO REP, V6, P1023, DOI 10.1038/sj.embor.7400563; Skillman KM, 2005, MOL MICROBIOL, V58, P945, DOI 10.1111/j.1365-2958.2005.04885.x; SkorkoGlonek J, 1997, J BIOL CHEM, V272, P8974; Soll J, 2004, NAT REV MOL CELL BIO, V5, P198, DOI 10.1038/nrm1333; van Dalen A, 2002, FEBS LETT, V511, P51, DOI 10.1016/S0014-5793(01)03278-1; van der Does C, 2003, METHOD ENZYMOL, V372, P86; VOGEL HJ, 1956, J BIOL CHEM, V218, P97; Voulhoux R, 2003, SCIENCE, V299, P262, DOI 10.1126/science.1078973; Wagner JK, 2009, J BACTERIOL, V191, P815, DOI 10.1128/JB.00989-08; Werner J, 2005, MOL MICROBIOL, V57, P1450, DOI 10.1111/j.1365-2958.2005.04775.x; Wiedemann N, 2003, NATURE, V424, P565, DOI 10.1038/nature01753; Wu T, 2005, CELL, V121, P235, DOI 10.1016/j.cell.2005.02.015	50	29	30	2	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2591	2599		10.1074/jbc.M111.293068	http://dx.doi.org/10.1074/jbc.M111.293068			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22134917	Green Published, hybrid			2022-12-27	WOS:000300292300032
J	Bhuwan, M; Lee, HJ; Peng, HL; Chang, HY				Bhuwan, Manish; Lee, Hui-Ju; Peng, Hwei-Ling; Chang, Hwan-You			Histidine-containing Phosphotransfer Protein-B (HptB) Regulates Swarming Motility through Partner-switching System in Pseudomonas aeruginosa PAO1 Strain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTI-SIGMA FACTOR; MEDIATED MULTISTEP PHOSPHORELAY; TRANSCRIPTION FACTOR SIGMA(F); BACILLUS-SUBTILIS; FACTOR SPOIIAB; BACTERIAL CHEMOTAXIS; 2-COMPONENT SYSTEMS; PULMONARY INFECTION; SIGNAL-TRANSDUCTION; RESPONSE REGULATOR	The histidine-containing phosphotransfer protein-B (HptB; PA3345) is an intermediate protein involved in transferring a phosphoryl group from multiple sensor kinases to the response regulator PA3346 in Pseudomonas aeruginosa PAO1. The objective of this study was to elucidate the biological significance of the HptB-PA3346 interaction and the regulatory mechanisms thereafter. The transcription profiling analysis of an hptB knock-out mutant showed that the expression of a number of motility-related genes was altered consistent with the non-swarming phenotype observed for the mutant. Domain analysis indicated that the PA3346 C-terminal region (PA3346C) exhibits similar to 30% identity with the anti-sigma factor SpoIIAB of Bacillus subtilis. The presence of Ser/Thr protein kinase activity targeting an anti-sigma antagonist, PA3347, at Ser-56 was confirmed in PA3346C using an in vitro phosphorelay assay. Furthermore, PA3346C and the anti-sigma(28) factor FlgM were found to interact with PA3347 individually both in vivo and in vitro. FlgM displaced PA3346C in binding of PA3347 and was then competitively displaced by sigma(28) from the PA3347-FlgM complex, forming a phosphorylation-dependent partner-switching system. The significance of PA3347 phosphorylation in linking the partner-switching system and swarming motility was established by analyzing the swarming phenotype of the PA3347 knock-out mutant and its complement strains.	[Bhuwan, Manish; Chang, Hwan-You] Natl Tsing Hua Univ, Inst Mol Med, Hsinchu 300, Taiwan; [Lee, Hui-Ju; Peng, Hwei-Ling] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu 300, Taiwan	National Tsing Hua University; National Yang Ming Chiao Tung University	Chang, HY (corresponding author), Natl Tsing Hua Univ, Inst Mol Med, Hsinchu 300, Taiwan.	hychang@life.nthu.edu.tw						Alon U, 1998, EMBO J, V17, P4238, DOI 10.1093/emboj/17.15.4238; ALPER S, 1994, CELL, V77, P195, DOI 10.1016/0092-8674(94)90312-3; Arora SK, 1998, INFECT IMMUN, V66, P1000, DOI 10.1128/IAI.66.3.1000-1007.1998; Beaton AR, 2002, P NATL ACAD SCI USA, V99, P13154, DOI 10.1073/pnas.192432299; Bordi C, 2010, MOL MICROBIOL, V76, P1427, DOI 10.1111/j.1365-2958.2010.07146.x; Bren A, 1998, J MOL BIOL, V278, P507, DOI 10.1006/jmbi.1998.1730; Brencic A, 2009, MOL MICROBIOL, V73, P434, DOI 10.1111/j.1365-2958.2009.06782.x; Campbell EA, 2002, CELL, V108, P795, DOI 10.1016/S0092-8674(02)00662-1; Chen YT, 2004, J MOL EVOL, V59, P725, DOI 10.1007/s00239-004-2663-2; COTTER PA, 1994, INFECT IMMUN, V62, P3381, DOI 10.1128/IAI.62.8.3381-3390.1994; Da Re S, 1999, MOL MICROBIOL, V34, P504, DOI 10.1046/j.1365-2958.1999.01614.x; Dasgupta N, 2003, MOL MICROBIOL, V50, P809, DOI 10.1046/j.1365-2958.2003.03740.x; DIEDERICH B, 1994, GENE DEV, V8, P2653, DOI 10.1101/gad.8.21.2653; Dutta R, 2000, TRENDS BIOCHEM SCI, V25, P24, DOI 10.1016/S0968-0004(99)01503-0; Feldman M, 1998, INFECT IMMUN, V66, P43, DOI 10.1128/IAI.66.1.43-51.1998; Finelli A, 2003, J BACTERIOL, V185, P2700, DOI 10.1128/JB.185.9.2700-2710.2003; Francez-Charlot A, 2009, P NATL ACAD SCI USA, V106, P3467, DOI 10.1073/pnas.0810291106; Frisk A, 2002, J BACTERIOL, V184, P1514, DOI 10.1128/JB.184.6.1514-1521.2002; FURSTE JP, 1986, GENE, V48, P119, DOI 10.1016/0378-1119(86)90358-6; Garsin DA, 1998, J MOL BIOL, V284, P569, DOI 10.1006/jmbi.1998.2202; Hsu JL, 2008, J BIOL CHEM, V283, P9933, DOI 10.1074/jbc.M708836200; Hua L, 2006, MOL MICROBIOL, V59, P623, DOI 10.1111/j.1365-2958.2005.04962.x; Kozak NA, 2005, J BACTERIOL, V187, P5665, DOI 10.1128/JB.187.16.5665-5676.2005; Lin CT, 2006, RES MICROBIOL, V157, P169, DOI 10.1016/j.resmic.2005.06.012; Magliery TJ, 2005, J AM CHEM SOC, V127, P146, DOI 10.1021/ja046699g; Mariconda S, 2006, MOL MICROBIOL, V60, P1590, DOI 10.1111/j.1365-2958.2006.05208.x; MARTIN PR, 1993, MOL MICROBIOL, V9, P857, DOI 10.1111/j.1365-2958.1993.tb01744.x; Mascher T, 2006, MICROBIOL MOL BIOL R, V70, P910, DOI 10.1128/MMBR.00020-06; Masuda S, 2004, J MOL BIOL, V340, P941, DOI 10.1016/j.jmb.2004.05.040; Mattoo S, 2004, MOL MICROBIOL, V52, P1201, DOI 10.1111/j.1365-2958.2004.04053.x; MIN KT, 1993, CELL, V74, P735, DOI 10.1016/0092-8674(93)90520-Z; MONTIE TC, 1982, INFECT IMMUN, V38, P1296, DOI 10.1128/IAI.38.3.1296-1298.1982; Morey JS, 2006, BIOL PROCED ONLINE, V8, P175, DOI 10.1251/bpo126; Mukhopadhyay S, 1999, J BACTERIOL, V181, P6615, DOI 10.1128/JB.181.21.6615-6622.1999; Petrova OE, 2011, J BACTERIOL, V193, P6614, DOI 10.1128/JB.00305-11; Rodrigue A, 2000, TRENDS MICROBIOL, V8, P498, DOI 10.1016/S0966-842X(00)01833-3; Sanchez CJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001044; Savli H, 2003, J MED MICROBIOL, V52, P403, DOI 10.1099/jmm.0.05132-0; Scharf BE, 1998, P NATL ACAD SCI USA, V95, P201, DOI 10.1073/pnas.95.1.201; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shivshankar P, 2009, MOL MICROBIOL, V73, P663, DOI 10.1111/j.1365-2958.2009.06796.x; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Toker AS, 1997, J MOL BIOL, V273, P623, DOI 10.1006/jmbi.1997.1335; TOTTEN PA, 1990, J BACTERIOL, V172, P389, DOI 10.1128/JB.172.1.389-396.1990; Wilderman PJ, 2001, MOL MICROBIOL, V39, P291, DOI 10.1046/j.1365-2958.2001.02282.x; Wilson CG, 2004, NAT METHODS, V1, P255, DOI 10.1038/nmeth1204-255; Wyman C, 1997, SCIENCE, V275, P1658, DOI 10.1126/science.275.5306.1658; Yang XF, 1996, GENE DEV, V10, P2265, DOI 10.1101/gad.10.18.2265; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Zhang CC, 1996, MOL MICROBIOL, V20, P9, DOI 10.1111/j.1365-2958.1996.tb02483.x	52	32	32	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					1903	1914		10.1074/jbc.M111.256586	http://dx.doi.org/10.1074/jbc.M111.256586			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22128156	Green Published, hybrid			2022-12-27	WOS:000299321000031
J	Pumroy, RA; Nardozzi, JD; Hart, DJ; Root, MJ; Cingolani, G				Pumroy, Ruth A.; Nardozzi, Jonathan D.; Hart, Darren J.; Root, Michael J.; Cingolani, Gino			Nucleoporin Nup50 Stabilizes Closed Conformation of Armadillo repeat 10 in Importin alpha 5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-LOCALIZATION SIGNAL; STRUCTURAL BASIS; CRYSTALLOGRAPHIC ANALYSIS; YEAST NUCLEOPORIN; MOLECULAR-BASIS; PORE COMPLEX; PROTEIN; NUP2P; RECOGNITION; TRANSPORT	The human genome encodes six isoforms of importin alpha that show greater than 60% sequence similarity and remarkable substrate specificity. The isoform importin alpha 5 can bind phosphorylated cargos such as STAT1 and Epstein-Barr Virus Nuclear Antigen 1, as well as the influenza virus polymerase subunit PB2. In this work, we have studied the interaction of the nucleoporin Nup50 with importin alpha 5. We show that the first 47 residues of Nup50 bind to the C terminus of importin alpha 5 like a "clip," stabilizing the closed conformation of ARM 10. In vitro, Nup50 binds with high affinity either to empty importin alpha 5 or to a preassembled complex of importin alpha 5 bound to the C-terminal domain of the import cargo PB2, resulting in a trimeric complex. By contrast, PB2 can only bind with high affinity to importin alpha 5 in the absence of Nup50. This suggests that Nup50 primary function may not be to actively displace the import cargo from importin alpha 5 but rather to prevent cargo rebinding in preparation for recycling. This is the first evidence for a nucleoporin modulating the import reaction by directly altering the three-dimensional structure of an import adaptor.	[Pumroy, Ruth A.; Root, Michael J.; Cingolani, Gino] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Nardozzi, Jonathan D.] Brigham & Womens Hosp, Ctr Neurol Dis, Dept Neurol, Boston, MA 02115 USA; [Hart, Darren J.] European Mol Biol Lab, Grenoble Outstn, F-38042 Grenoble 9, France; [Hart, Darren J.] UJF EMBL CNRS, Unit Virus Host Cell Interact, UMI3265, F-38042 Grenoble 9, France	Jefferson University; Harvard University; Brigham & Women's Hospital; European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Cingolani, G (corresponding author), Thomas Jefferson Univ, Dept Biochem & Mol Biol, 233 S 10th St, Philadelphia, PA 19107 USA.	gino.cingolani@jefferson.edu	; Hart, Darren/C-4858-2015	Pumroy, Ruth/0000-0002-6200-6083; Nardozzi, Jonathan/0000-0002-6655-4765; Hart, Darren/0000-0002-3502-2002	National Institutes of Health [GM074846]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074846] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM074846 (to G. C.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Andrade MA, 2001, J MOL BIOL, V309, P1, DOI 10.1006/jmbi.2001.4624; Boivin S, 2011, J BIOL CHEM, V286, P10439, DOI 10.1074/jbc.M110.182964; Booth JW, 1999, J BIOL CHEM, V274, P32360, DOI 10.1074/jbc.274.45.32360; Cingolani G, 2000, FEBS LETT, V484, P291, DOI 10.1016/S0014-5793(00)02154-2; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1; Conti E, 2006, CURR OPIN STRUC BIOL, V16, P237, DOI 10.1016/j.sbi.2006.03.010; Conti E, 2000, STRUCTURE, V8, P329, DOI 10.1016/S0969-2126(00)00107-6; Darling RJ, 2004, ASSAY DRUG DEV TECHN, V2, P647, DOI 10.1089/adt.2004.2.647; Dilworth DJ, 2001, J CELL BIOL, V153, P1465, DOI 10.1083/jcb.153.7.1465; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fontes MRM, 2000, J MOL BIOL, V297, P1183, DOI 10.1006/jmbi.2000.3642; Forwood JK, 2010, STRUCTURE, V18, P1171, DOI 10.1016/j.str.2010.06.015; Gabriel G, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1158; Giesecke A, 2010, J BIOL CHEM, V285, P17628, DOI 10.1074/jbc.M110.102343; Gilchrist D, 2003, J BIOL CHEM, V278, P51937, DOI 10.1074/jbc.M307371200; Gilchrist D, 2002, J BIOL CHEM, V277, P18161, DOI 10.1074/jbc.M112306200; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Guan TL, 2000, MOL CELL BIOL, V20, P5619, DOI 10.1128/MCB.20.15.5619-5630.2000; Hood JK, 2000, J CELL SCI, V113, P1471; Kitamura R, 2006, J VIROL, V80, P1979, DOI 10.1128/JVI.80.4.1979-1991.2006; Kobe B, 1999, NAT STRUCT BIOL, V6, P388, DOI 10.1038/7625; Kohler M, 1999, MOL CELL BIOL, V19, P7782; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Laskowski RA, 1997, TRENDS BIOCHEM SCI, V22, P488, DOI 10.1016/S0968-0004(97)01140-7; Lindsay ME, 2002, CELL, V110, P349, DOI 10.1016/S0092-8674(02)00836-X; Lott K, 2011, J BIOL CHEM, V286, P28160, DOI 10.1074/jbc.M111.228007; Lott K, 2011, BBA-MOL CELL RES, V1813, P1578, DOI 10.1016/j.bbamcr.2010.10.012; Marfori M, 2011, BBA-MOL CELL RES, V1813, P1562, DOI 10.1016/j.bbamcr.2010.10.013; Matsuura Y, 2005, EMBO J, V24, P3681, DOI 10.1038/sj.emboj.7600843; Matsuura Y, 2003, EMBO J, V22, P5358, DOI 10.1093/emboj/cdg538; Matsuura Y, 2004, NATURE, V432, P872, DOI 10.1038/nature03144; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meyer T, 2004, EUR J BIOCHEM, V271, P4606, DOI 10.1111/j.1432-1033.2004.04423.x; Mitrousis G, 2008, J BIOL CHEM, V283, P7877, DOI 10.1074/jbc.M709093200; Mosammaparast N, 2004, TRENDS CELL BIOL, V14, P547, DOI 10.1016/j.tcb.2004.09.004; Nardozzi J, 2010, J MOL BIOL, V402, P83, DOI 10.1016/j.jmb.2010.07.013; Nardozzi JD, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-32; Ogawa Y, 2010, MOL BIOL CELL, V21, P630, DOI 10.1091/mbc.E09-05-0374; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rabut G, 2004, NAT CELL BIOL, V6, P1114, DOI 10.1038/ncb1184; Resa-Infante P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003904; Ribbeck K, 2001, EMBO J, V20, P1320, DOI 10.1093/emboj/20.6.1320; Riddick G, 2005, J CELL BIOL, V168, P1027, DOI 10.1083/jcb.200409024; Smitherman M, 2000, MOL CELL BIOL, V20, P5631, DOI 10.1128/MCB.20.15.5631-5642.2000; Solsbacher J, 2000, MOL CELL BIOL, V20, P8468, DOI 10.1128/MCB.20.22.8468-8479.2000; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Sun C, 2008, P NATL ACAD SCI USA, V105, P8613, DOI 10.1073/pnas.0710867105; Tarendeau F, 2007, NAT STRUCT MOL BIOL, V14, P229, DOI 10.1038/nsmb1212; Wente SR, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000562	52	21	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					2022	2031		10.1074/jbc.M111.315838	http://dx.doi.org/10.1074/jbc.M111.315838			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22130666	hybrid, Green Published			2022-12-27	WOS:000299321000043
J	Yang, JC; Corsello, TR; Ma, YP				Yang, Jianchang; Corsello, Tyler R.; Ma, Yupo			Stem Cell Gene SALL4 Suppresses Transcription through Recruitment of DNA Methyltransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMATOPOIETIC STEM; OKIHIRO-SYNDROME; LEUKEMIC-CELLS; SELF-RENEWAL; REPRESSOR; MUTATIONS; COMPLEX; DIFFERENTIATION; PLURIPOTENCY; REGULATOR	The stem cell protein SALL4 plays a vital role in maintaining stem cell identity and governing stem cell self-renewal through transcriptional repression. To explore SALL4-mediated mechanisms involved in transcriptional repression, we investigated DNA modifications underlying its regulatory activities. By a luciferase activity assay, we found that both histone deacetylase inhibitor valproic acid (VPA) and DNA methylation inhibitor 5-azacytidine (5-azaC) specifically reversed the repression effect of SALL4 on its own as well as other Sal gene promoter activities. Cotreatment of VPA with 5-azaC in cells almost completely blocked this repression effect. Further co-immunoprecipitation assay and enzyme activity analysis demonstrated that SALL4 protein directly interacted with different DNA methyltransferases (DNMTs) and purified DNMT enzymatic activities from nuclear extracts. In addition, SALL4 isoforms co-occupied the same regions of its own promoter as DNMT corepressors, and ectopic overexpression of SALL4 led to increased CpG island promoter methylation of silenced genes in various cell types. These included primary hematopoietic stem/progenitor cells, fibroblasts, and NB4 leukemic cells. In NB4 cells, treatment of cells with 5-azaC also caused decreased amounts of methylated alleles of SALL4 and PTEN and dramatically increased their mRNA expression. Our studies identify a new mechanism by which SALL4 represses gene expression through interaction with DNMTs. Furthermore, DNMTs and histone deacetylase repressors synergistically contribute to the regulatory effects of SALL4. These findings provide new insights into stem cell self-renewal mediated by SALL4 via epigenetic machinery.	[Yang, Jianchang] Nevada Canc Inst, Div Canc Biol, Las Vegas, NV 89135 USA; [Corsello, Tyler R.; Ma, Yupo] SUNY Stony Brook, Dept Pathol, Stony Brook, NY 11794 USA; [Ma, Yupo] Chinese Acad Med Sci, Biopharmaceut Res Ctr, Suzhou 215126, Peoples R China; [Ma, Yupo] Peking Union Med Coll, Suzhou 215126, Peoples R China	University of California System; University of California San Diego; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Yang, JC (corresponding author), Nevada Canc Inst, Div Canc Biol, 1 Breakthrough Way, Las Vegas, NV 89135 USA.	jyang@nvcancer.org			National Institutes of Health [R01HL087948]; American Cancer Society; Leukemia and Lymphoma Society [3366-09]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087948] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01HL087948 (to Y. M.). This work was also supported in part by American Cancer Society-Institutional Research Grant 2011-2012 (to J. Y.) and Leukemia and Lymphoma Society special fellow award 3366-09 (to J. Y.).	Aguila JR, 2011, EXPERT REV HEMATOL, V4, P479, DOI [10.1586/ehm.11.46, 10.1586/EHM.11.46]; Aguila JR, 2011, BLOOD, V118, P576, DOI 10.1182/blood-2011-01-333641; Al-Baradie R, 2002, AM J HUM GENET, V71, P1195, DOI 10.1086/343821; Borozdin W, 2004, J MED GENET, V41, DOI 10.1136/jmg.2004.019505; Brenner C, 2005, EMBO J, V24, P336, DOI 10.1038/sj.emboj.7600509; Broske AM, 2009, NAT GENET, V41, P1207, DOI 10.1038/ng.463; Chen ZX, 2005, J CELL BIOCHEM, V95, P902, DOI 10.1002/jcb.20447; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; Elling U, 2006, P NATL ACAD SCI USA, V103, P16319, DOI 10.1073/pnas.0607884103; Fuks F, 2001, EMBO J, V20, P2536, DOI 10.1093/emboj/20.10.2536; Fuks F, 2000, NAT GENET, V24, P88, DOI 10.1038/71750; Ghoshal K, 2005, MOL CELL BIOL, V25, P4727, DOI 10.1128/MCB.25.11.4727-4741.2005; Habano W, 2007, INT J CANCER, V121, P1487, DOI 10.1002/ijc.22847; Kim GD, 2002, EMBO J, V21, P4183, DOI 10.1093/emboj/cdf401; Kohlhase J, 2002, HUM MOL GENET, V11, P2979, DOI 10.1093/hmg/11.23.2979; Kohlhase J, 1996, GENOMICS, V38, P291, DOI 10.1006/geno.1996.0631; Kuhnlein RP, 1996, DEVELOPMENT, V122, P2215; Kundakovic M, 2009, MOL PHARMACOL, V75, P342, DOI 10.1124/mol.108.051763; Laurenzana A, 2009, CANCER RES, V69, P55, DOI 10.1158/0008-5472.CAN-08-0245; Lim CY, 2008, CELL STEM CELL, V3, P543, DOI 10.1016/j.stem.2008.08.004; Lu JY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005577; Maier H, 2002, SEMIN IMMUNOL, V14, P415, DOI 10.1016/S1044532302000763; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; Sakaki-Yumoto M, 2006, DEVELOPMENT, V133, P3005, DOI 10.1242/dev.02457; SANTI DV, 1984, P NATL ACAD SCI-BIOL, V81, P6993, DOI 10.1073/pnas.81.22.6993; Tadokoro Y, 2007, J EXP MED, V204, P715, DOI 10.1084/jem.20060750; Trowbridge JJ, 2009, CELL STEM CELL, V5, P442, DOI 10.1016/j.stem.2009.08.016; Tsubooka N, 2009, GENES CELLS, V14, P683, DOI 10.1111/j.1365-2443.2009.01301.x; Wu Q, 2006, J BIOL CHEM, V281, P24090, DOI 10.1074/jbc.C600122200; Yang JC, 2008, BLOOD, V112, P805, DOI 10.1182/blood-2007-11-126326; Yang JC, 2007, P NATL ACAD SCI USA, V104, P10494, DOI 10.1073/pnas.0704001104; Yang JC, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-38; Yang JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010766; Yang JC, 2008, P NATL ACAD SCI USA, V105, P19756, DOI 10.1073/pnas.0809321105; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481	35	47	48	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					1996	2005		10.1074/jbc.M111.308734	http://dx.doi.org/10.1074/jbc.M111.308734			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22128185	hybrid, Green Published			2022-12-27	WOS:000299321000040
J	Dembek, M; Reynolds, CB; Fairweather, NF				Dembek, Marcin; Reynolds, Catherine B.; Fairweather, Neil F.			Clostridium difficile Cell Wall Protein CwpV Undergoes Enzyme-independent Intramolecular Autoproteolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECRETION SYSTEMS; GLYCOSYLASPARAGINASE; MECHANISM; IDENTIFICATION; ACTIVATION; PROTEASOME; CLEAVAGE	Clostridium difficile infection is a leading cause of antibiotic-associated diarrhea, placing considerable economic pressure on healthcare systems and resulting in significant morbidity and mortality. The pathogen produces a proteinaceous array on its cell surface known as the S-layer, consisting primarily of the major S-layer protein SlpA and a family of SlpA homologs. CwpV is the largest member of this family and is expressed in a phase-variable manner. The protein is post-translationally processed into two fragments that form a noncovalent, heterodimeric complex. To date, no specific proteases capable of cleaving CwpV have been identified. Using site-directed mutagenesis we show that CwpV undergoes intramolecular autoproteolysis, most likely facilitated by a N-O acyl shift, with Thr-413 acting as the source of a nucleophile driving this rearrangement. We demonstrate that neighboring residues are also important for correct processing of CwpV. Based on protein structural predictions and analogy to the glycosylasparaginase family of proteins, it appears likely that these residues play key roles in determining the correct protein fold and interact directly with Thr-413 to promote nucleophilic attack. Furthermore, using a cell-free protein synthesis assay we show that CwpV maturation requires neither cofactors nor auxiliary enzymes.	[Dembek, Marcin; Reynolds, Catherine B.; Fairweather, Neil F.] Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, Ctr Mol Microbiol & Infect, London SW7 2AZ, England	Imperial College London	Fairweather, NF (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, Ctr Mol Microbiol & Infect, S Kensington Campus, London SW7 2AZ, England.	n.fairweather@imperial.ac.uk	Dembek, Marcin/AAA-8852-2021	Dembek, Marcin/0000-0003-2831-3335	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by Wellcome Trust studentships (to M.D. and C.B.R.).	Bensing BA, 2002, MOL MICROBIOL, V44, P1081, DOI 10.1046/j.1365-2958.2002.02949.x; BRANNIGAN JA, 1995, NATURE, V378, P416, DOI 10.1038/378416a0; Braunstein M, 2001, J BACTERIOL, V183, P6979, DOI 10.1128/JB.183.24.6979-6990.2001; Calabi E, 2001, MOL MICROBIOL, V40, P1187, DOI 10.1046/j.1365-2958.2001.02461.x; Chen Q, 2004, MOL MICROBIOL, V53, P843, DOI 10.1111/j.1365-2958.2004.04116.x; Dang THT, 2010, ACS CHEM BIOL, V5, P279, DOI 10.1021/cb9002859; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Ditzel L, 1998, J MOL BIOL, V279, P1187, DOI 10.1006/jmbi.1998.1818; Emerson JE, 2009, MOL MICROBIOL, V74, P541, DOI 10.1111/j.1365-2958.2009.06812.x; Fagan RP, 2011, J BIOL CHEM, V286, P27483, DOI 10.1074/jbc.M111.263889; Guan CD, 1996, J BIOL CHEM, V271, P1732, DOI 10.1074/jbc.271.3.1732; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kirby JM, 2009, J BIOL CHEM, V284, P34666, DOI 10.1074/jbc.M109.051177; Klabunde T, 1998, NAT STRUCT BIOL, V5, P31, DOI 10.1038/nsb0198-31; Lenz LL, 2002, MOL MICROBIOL, V45, P1043, DOI 10.1046/j.1365-2958.2002.03072.x; Liu Y, 1998, J BIOL CHEM, V273, P9688, DOI 10.1074/jbc.273.16.9688; McFarland LV, 2008, FUTURE MICROBIOL, V3, P563, DOI 10.2217/17460913.3.5.563; Perler FB, 1997, CURR OPIN CHEM BIOL, V1, P292, DOI 10.1016/S1367-5931(97)80065-8; PORTER JA, 1995, NATURE, V374, P363, DOI 10.1038/374363a0; Purdy D, 2002, MOL MICROBIOL, V46, P439, DOI 10.1046/j.1365-2958.2002.03134.x; Qian XF, 2003, STRUCTURE, V11, P997, DOI 10.1016/S0969-2126(03)00150-3; Reynolds CB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002024; Rigel NW, 2008, MOL MICROBIOL, V69, P291, DOI 10.1111/j.1365-2958.2008.06294.x; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; Siboo IR, 2008, J BACTERIOL, V190, P6188, DOI 10.1128/JB.00300-08; Sleytr UB, 2007, FEBS J, V274, P323, DOI 10.1111/j.1742-4658.2006.05606.x; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005; XU MQ, 1993, CELL, V75, P1371, DOI 10.1016/0092-8674(93)90623-X; Xu QA, 1999, CELL, V98, P651, DOI 10.1016/S0092-8674(00)80052-5; ZWICKL P, 1994, NAT STRUCT BIOL, V1, P765, DOI 10.1038/nsb1194-765	30	9	9	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1538	1544		10.1074/jbc.M111.302463	http://dx.doi.org/10.1074/jbc.M111.302463			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22128177	Green Published, hybrid			2022-12-27	WOS:000299170300067
J	Auldridge, ME; Satyshur, KA; Anstrom, DM; Forest, KT				Auldridge, Michele E.; Satyshur, Kenneth A.; Anstrom, David M.; Forest, Katrina T.			Structure-guided Engineering Enhances a Phytochrome-based Infrared Fluorescent Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PSEUDOMONAS-AERUGINOSA BACTERIOPHYTOCHROME; CHROMOPHORE-BINDING DOMAIN; RAMAN-SPECTROSCOPY; CRYSTAL-STRUCTURE; QUANTUM YIELD; GROUND-STATE; PHOTOCONVERSION; LIGHT; REFINEMENT; PFR	Phytochrome is a multidomain dimeric red light photoreceptor that utilizes a chromophore-binding domain (CBD), a PHY domain, and an output module to induce cellular changes in response to light. A promising biotechnology tool emerged when a structure-based substitution at Asp-207 was shown to be an infrared fluorophore that uses a biologically available tetrapyrrole chromophore. We report multiple crystal structures of this D207H variant of the Deinococcus radiodurans CBD, in which His-207 is observed to form a hydrogen bond with either the tetrapyrrole A-ring oxygen or the Tyr-263 hydroxyl. Based on the implications of this duality for fluorescence properties, Y263F was introduced and shown to have stronger fluorescence than the original D207H template. Our structures are consistent with the model that the Y263F change prevents a red light-induced far-red light absorbing phytochrome chromophore configuration. With the goal of decreasing size and thereby facilitating use as a fluorescent tag in vivo, we also engineered a monomeric form of the CBD. Unexpectedly, photoconversion was observed in the monomer despite the lack of a PHY domain. This observation underscores an interplay between dimerization and the photochemical properties of phytochrome and suggests that the monomeric CBD could be used for further studies of the photocycle. The D207H substitution on its own in the monomer did not result in fluorescence, whereas Y263F did. Combined, the D207H and Y263F substitutions in the monomeric CBD lead to the brightest of our variants, designated Wisconsin infrared phytofluor (Wi-Phy).	[Auldridge, Michele E.; Satyshur, Kenneth A.; Anstrom, David M.; Forest, Katrina T.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Forest, KT (corresponding author), Univ Wisconsin, Dept Bacteriol, 6552 Microbial Sci Bldg,1550 Linden Dr, Madison, WI 53706 USA.	forest@bact.wisc.edu		Satyshur, Kenneth/0000-0001-9371-2493	United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; Michigan Economic Development Corp; Michigan Technology Tri-Corridor [085P1000817]; National Science Foundation [BIR-9512577, MCB0424062, MCB07191530]; National Institutes of Health [S10 RR13790, GM59721]; University of Wisconsin-Madison Graduate School; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR013790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059721] Funding Source: NIH RePORTER	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Michigan Economic Development Corp; Michigan Technology Tri-Corridor; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Wisconsin-Madison Graduate School; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Drs. Robert Landick and Jorge Escalante-Semerena for use of equipment, Dr. Darrell McCaslin for carrying out analytical centrifugation experiments, Dr. Roger Tsien for the gift of an IFP1.4-expressing plasmid, and Shyamosree Bhattacharya for purification of IFP1.4. Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-06CH11357. Use of LS-CAT Sector 21 was supported by the Michigan Economic Development Corp. and the Michigan Technology Tri-Corridor for the support of this research program (Grant 085P1000817). Analytical centrifugation data were obtained at the University of Wisconsin-Madison Biophysics Instrumentation Facility, which is supported by National Science Foundation Grant BIR-9512577 and National Institutes of Health Grant S10 RR13790.; This work was supported, in whole or in part, by National Institutes of Health Grant GM59721 (to K. T. F.). This work was also supported by a grant from the University of Wisconsin-Madison Graduate School (to K. T. F.) and National Science Foundation Grants MCB0424062 and MCB07191530 (to R. D. Vierstra and K. T. F.).	Auldridge ME, 2011, CRIT REV BIOCHEM MOL, V46, P67, DOI 10.3109/10409238.2010.546389; Darnell SJ, 2007, PROTEINS, V68, P813, DOI 10.1002/prot.21474; Dasgupta J, 2009, P NATL ACAD SCI USA, V106, P1784, DOI 10.1073/pnas.0812056106; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Essen LO, 2008, P NATL ACAD SCI USA, V105, P14709, DOI 10.1073/pnas.0806477105; Filonov GS, 2011, NAT BIOTECHNOL, V29, P757, DOI 10.1038/nbt.1918; Fischer AJ, 2005, BIOCHEMISTRY-US, V44, P15203, DOI 10.1021/bi051633z; Fischer AJ, 2004, P NATL ACAD SCI USA, V101, P17334, DOI 10.1073/pnas.0407645101; Frangioni JV, 2003, CURR OPIN CHEM BIOL, V7, P626, DOI 10.1016/j.cbpa.2003.08.007; Kortemme T, 2004, NAT STRUCT MOL BIOL, V11, P371, DOI 10.1038/nsmb749; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MUJUMDAR RB, 1993, BIOCONJUGATE CHEM, V4, P105, DOI 10.1021/bc00020a001; Murphy JT, 1997, CURR BIOL, V7, P870, DOI 10.1016/S0960-9822(06)00375-7; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; PRATT LH, 1973, PLANT PHYSIOL, V51, P203, DOI 10.1104/pp.51.1.203; Rockwell NC, 2010, CHEMPHYSCHEM, V11, P1172, DOI 10.1002/cphc.200900894; Rohmer T, 2010, J AM CHEM SOC, V132, P4431, DOI 10.1021/ja9108616; Samma AA, 2010, J PHYS CHEM B, V114, P15362, DOI 10.1021/jp107119q; Schumann C, 2007, CHEMPHYSCHEM, V8, P1657, DOI 10.1002/cphc.200700210; Shu XK, 2009, SCIENCE, V324, P804, DOI 10.1126/science.1168683; Song C, 2011, P NATL ACAD SCI USA, V108, P3842, DOI 10.1073/pnas.1013377108; Su YS, 2007, PLANT CELL, V19, P2124, DOI 10.1105/tpc.107.051516; Toh KC, 2011, PHYS CHEM CHEM PHYS, V13, P11985, DOI 10.1039/c1cp00050k; Toh KC, 2010, P NATL ACAD SCI USA, V107, P9170, DOI 10.1073/pnas.0911535107; von Stetten D, 2008, ANGEW CHEM INT EDIT, V47, P4753, DOI 10.1002/anie.200705716; Wagner JR, 2008, J BIOL CHEM, V283, P12212, DOI 10.1074/jbc.M709355200; Wagner JR, 2007, J BIOL CHEM, V282, P12298, DOI 10.1074/jbc.M611824200; Wagner JR, 2005, NATURE, V438, P325, DOI 10.1038/nature04118; Wegele R, 2004, J BIOL CHEM, V279, P45791, DOI 10.1074/jbc.M408303200; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yang X, 2008, P NATL ACAD SCI USA, V105, P14715, DOI 10.1073/pnas.0806718105; Yang X, 2007, P NATL ACAD SCI USA, V104, P12571, DOI 10.1073/pnas.0701737104; Yang XJ, 2009, P NATL ACAD SCI USA, V106, P15639, DOI 10.1073/pnas.0902178106; Zienicke B, 2011, J BIOL CHEM, V286, P1103, DOI 10.1074/jbc.M110.155143	34	99	104	0	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7000	7009		10.1074/jbc.M111.295121	http://dx.doi.org/10.1074/jbc.M111.295121			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22210774	Green Published, hybrid			2022-12-27	WOS:000301060200006
J	Kappo, MA; AB, E; Hassem, F; Atkinson, RA; Faro, A; Muleya, V; Mulaudzi, T; Poole, JO; McKenzie, JM; Chibi, M; Moolman-Smook, JC; Rees, DJG; Pugh, DJR				Kappo, Mautin A.; AB, Eiso; Hassem, Faqeer; Atkinson, R. Andrew; Faro, Andrew; Muleya, Victor; Mulaudzi, Takalani; Poole, John O.; McKenzie, Jean M.; Chibi, Moredreck; Moolman-Smook, Joanna C.; Rees, D. Jasper G.; Pugh, David J. R.			Solution Structure of RING Finger-like Domain of Retinoblastoma-binding Protein-6 (RBBP6) Suggests It Functions as a U-box	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E3 UBIQUITIN LIGASES; TORSION ANGLE DYNAMICS; MESSENGER-RNA; P2P-R PROTEIN; INDUCED APOPTOSIS; CRYSTAL-STRUCTURE; QUALITY-CONTROL; NMR RELAXATION; P44 SUBUNIT; CHIP	Retinoblastoma-binding protein-6 (RBBP6) plays a facilitating role, through its RING finger-like domain, in the ubiquitination of p53 by Hdm2 that is suggestive of E4-like activity. Although the presence of eight conserved cysteine residues makes it highly probable that the RING finger-like domain coordinates two zinc ions, analysis of the primary sequence suggests an alternative classification as a member of the U-box family, the members of which do not bind zinc ions. We show here that despite binding two zinc ions, the domain adopts a homodimeric structure highly similar to those of a number of U-boxes. Zinc ions could be replaced by cadmium ions without significantly disrupting the structure or the stability of the domain, although the rate of substitution was an order of magnitude slower than any previous measurement, suggesting that the structure is particularly stable, a conclusion supported by the high thermal stability of the domain. A hallmark of U-box-containing proteins is their association with chaperones, with which they cooperate in eliminating irretrievably unfolded proteins by tagging them for degradation by the proteasome. Using a yeast two-hybrid screen, we show that RBBP6 interacts with chaperones Hsp70 and Hsp40 through its N-terminal ubiquitin-like domain. Taken together with the structural similarities to U-box-containing proteins, our data suggest that RBBP6 plays a role in chaperone-mediated ubiquitination and possibly in protein quality control.	[Kappo, Mautin A.; Hassem, Faqeer; Faro, Andrew; Muleya, Victor; Mulaudzi, Takalani; Poole, John O.; Chibi, Moredreck; Rees, D. Jasper G.; Pugh, David J. R.] Univ Western Cape, Dept Biotechnol, ZA-7535 Bellville, South Africa; [AB, Eiso] ZoBio BV, NL-2333 CC Leiden, Netherlands; [Atkinson, R. Andrew] Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France; [McKenzie, Jean M.] Univ Stellenbosch, Cent Analyt Facil, NMR Lab, ZA-7602 Matieland, South Africa; [Moolman-Smook, Joanna C.] Univ Stellenbosch, Fac Hlth Sci, ZA-7505 Tygerberg, South Africa	University of the Western Cape; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Stellenbosch University; Stellenbosch University	Pugh, DJR (corresponding author), Univ Western Cape, Dept Biotechnol, Private Bag X17, ZA-7535 Bellville, South Africa.	dpugh@uwc.ac.za	Muleya, Victor/CAI-0188-2022; Rees, Jasper/D-9672-2011; Atkinson, Robert Andrew/ABE-8068-2020; AB, Eiso/H-8177-2012; Rees, David Jasper Gilbert/AAZ-8073-2020	Muleya, Victor/0000-0003-2315-4953; Rees, Jasper/0000-0003-3321-1325; Atkinson, Robert Andrew/0000-0002-3645-9492; Rees, David Jasper Gilbert/0000-0003-3321-1325; AB, Eiso/0000-0002-5758-0435	National Research Foundation of South Africa; Medical Research Council of South Africa; CNRS; Oppenheimer Memorial Trust	National Research Foundation of South Africa(National Research Foundation - South Africa); Medical Research Council of South Africa(South African Medical Research Council); CNRS(Centre National de la Recherche Scientifique (CNRS)); Oppenheimer Memorial Trust	This work was supported in part by the National Research Foundation of South Africa and the Medical Research Council of South Africa.; Recipient of grants from National Research Foundation of South Africa and the CNRS.; Recipient of sabbatical funding from The Oppenheimer Memorial Trust.	Andersen P, 2004, J BIOL CHEM, V279, P40053, DOI 10.1074/jbc.M405057200; Aravind L, 2000, CURR BIOL, V10, pR132, DOI 10.1016/S0960-9822(00)00398-5; Atkinson RA, 2004, PROG NUCL MAG RES SP, V44, P141, DOI 10.1016/j.pnmrs.2004.01.001; Bombarda E, 2001, J MOL BIOL, V310, P659, DOI 10.1006/jmbi.2001.4770; Brzovic PS, 2003, P NATL ACAD SCI USA, V100, P5646, DOI 10.1073/pnas.0836054100; Buchwald G, 2006, EMBO J, V25, P2465, DOI 10.1038/sj.emboj.7601144; Caffrey DR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-381; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1; Chibi M, 2008, J MOL BIOL, V384, P908, DOI 10.1016/j.jmb.2008.09.060; Chou CC, 2003, J BIOL CHEM, V278, P30311, DOI 10.1074/jbc.M304563200; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Cyr DM, 2002, TRENDS BIOCHEM SCI, V27, P368, DOI 10.1016/S0968-0004(02)02125-4; Daragan VA, 1997, PROG NUCL MAG RES SP, V31, P63, DOI 10.1016/S0079-6565(97)00006-X; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Dudev T, 2003, J AM CHEM SOC, V125, P3168, DOI 10.1021/ja0209722; Dudev T, 2002, J AM CHEM SOC, V124, P6759, DOI 10.1021/ja012620l; Gao S, 2003, J CELL PHYSIOL, V197, P445, DOI 10.1002/jcp.10381; Gao SZ, 2002, J CELL PHYSIOL, V193, P199, DOI 10.1002/jcp.10163; Gao SZ, 2002, J CELL PHYSIOL, V191, P145, DOI 10.1002/jcp.10084; Goodfellow BJ, 1998, INORG CHIM ACTA, V273, P279, DOI 10.1016/S0020-1693(97)06074-X; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hanzawa H, 2001, J BIOL CHEM, V276, P10185, DOI 10.1074/jbc.M009298200; Harris R. K., 1978, NMR PERIOD TABLE, P263; Hashizume R, 2001, J BIOL CHEM, V276, P14537, DOI 10.1074/jbc.C000881200; Hatakeyama S, 2004, GENES CELLS, V9, P533, DOI 10.1111/j.1356-9597.2004.00742.x; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Houben K, 2005, J MOL BIOL, V349, P621, DOI 10.1016/j.jmb.2005.04.007; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Jones C, 2006, GENETICS, V173, P793, DOI 10.1534/genetics.106.056762; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Kellenberger E, 2005, J BIOL CHEM, V280, P20785, DOI 10.1074/jbc.M412999200; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Li L, 2007, P NATL ACAD SCI USA, V104, P7951, DOI 10.1073/pnas.0701916104; Mulder FAA, 1999, J MOL BIOL, V292, P111, DOI 10.1006/jmbi.1999.3034; Nikolay R, 2004, J BIOL CHEM, V279, P2673, DOI 10.1074/jbc.M311112200; Nordquist KA, 2010, BIOCHEMISTRY-US, V49, P347, DOI 10.1021/bi901620v; Ohi MD, 2003, NAT STRUCT BIOL, V10, P250, DOI 10.1038/nsb906; Peng HM, 2004, J BIOL CHEM, V279, P52970, DOI 10.1074/jbc.M406926200; Pugh DJR, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-1; Rosser MFN, 2007, J BIOL CHEM, V282, P22267, DOI 10.1074/jbc.M700513200; Scott RE, 2003, J CELL BIOCHEM, V90, P6, DOI 10.1002/jcb.10618; Scott RE, 2002, ANTICANCER RES, V22, P3837; Shi YS, 2009, MOL CELL, V33, P365, DOI 10.1016/j.molcel.2008.12.028; Simons A, 1997, ONCOGENE, V14, P145, DOI 10.1038/sj.onc.1200825; Stoilov P, 2002, TRENDS BIOCHEM SCI, V27, P495, DOI 10.1016/S0968-0004(02)02189-8; Vander Kooi CW, 2006, BIOCHEMISTRY-US, V45, P121, DOI 10.1021/bi051787e; Vitorino M, 2007, J MOL BIOL, V368, P473, DOI 10.1016/j.jmb.2007.02.020; Vo LTA, 2001, MOL CELL BIOL, V21, P8346, DOI 10.1128/MCB.21.24.8346-8356.2001; Wan T, 2004, BLOOD, V103, P1747, DOI 10.1182/blood-2003-08-2828; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Witte MM, 1997, P NATL ACAD SCI USA, V94, P1212, DOI 10.1073/pnas.94.4.1212; Xu Z, 2006, BIOCHEMISTRY-US, V45, P4749, DOI 10.1021/bi0601508; Xu Z, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-26; Yoshitake Y, 2004, CLIN CANCER RES, V10, P6437, DOI 10.1158/1078-0432.CCR-04-0841; Younger JM, 2004, J CELL BIOL, V167, P1075, DOI 10.1083/jcb.200410065; Zhang MH, 2005, MOL CELL, V20, P525, DOI 10.1016/j.molcel.2005.09.023; Zhang ZY, 2010, J BIOL CHEM, V285, P14701, DOI 10.1074/jbc.M110.104711	61	12	14	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7146	7158		10.1074/jbc.M110.217059	http://dx.doi.org/10.1074/jbc.M110.217059			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22130672	Green Published, hybrid			2022-12-27	WOS:000301060200018
J	Ma, SL; Pastorino, L; Zhou, XZ; Lu, KP				Ma, Suk Ling; Pastorino, Lucia; Zhou, Xiao Zhen; Lu, Kun Ping			Prolyl Isomerase Pin1 Promotes Amyloid Precursor Protein (APP) Turnover by Inhibiting Glycogen Synthase Kinase-3 beta (GSK3 beta) Activity NOVEL MECHANISM FOR Pin1 TO PROTECT AGAINST ALZHEIMER DISEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; DOWNS-SYNDROME; TAU-PROTEIN; PHOSPHORYLATION; BETA; DEMENTIA	Alzheimer disease (AD) is characterized by the presence of senile plaques of amyloid-beta (A beta) peptides derived from amyloid precursor protein (APP) and neurofibrillary tangles made of hyperphosphorylated Tau. Increasing APP gene dosage or expression has been shown to cause familial early-onset AD. However, whether and how protein stability of APP is regulated is unclear. The prolyl isomerase Pin1 and glycogen synthase kinase-3 beta (GSK3 beta) have been shown to have the opposite effects on APP processing and Tau hyperphosphorylation, relevant to the pathogenesis of AD. However, nothing is known about their relationship. In this study, we found that Pin1 binds to the pT330-P motif in GSK3 beta to inhibit its kinase activity. Furthermore, Pin1 promotes protein turnover of APP by inhibiting GSK3 beta activity. A point mutation either at Thr-330, the Pin1-binding site in GSK3 beta, or at Thr-668, the GSK3 beta phosphorylation site in APP, abolished the regulation of GSK3 beta activity, Thr-668 phosphorylation, and APP stability by Pin1, resulting in reduced non-amyloidogenic APP processing and increased APP levels. These results uncover a novel role of Pin1 in inhibiting GSK3 beta kinase activity to reduce APP protein levels, providing a previously unrecognized mechanism by which Pin1 protects against Alzheimer disease.	[Pastorino, Lucia] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Ctr Life Sci, Boston, MA 02115 USA; Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Pastorino, L (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Ctr Life Sci, Rm 0408, Boston, MA 02115 USA.	lpastori@bidmc.harvard.edu; klu@bidmc.harvard.edu	Ma, Suk Ling/AAF-2859-2019	Ma, Suk Ling/0000-0001-6175-5691	National Institutes of Health [R01AG017870, R01AG039405, K01AG030007]; NATIONAL INSTITUTE ON AGING [R01AG039405, K01AG030007, R01AG017870] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AG017870 and R01AG039405 (to K. P. L).; Recipient of a National Institutes of Health Mentored Research Scientist Development Award (K01AG030007).	Aplin AE, 1996, J NEUROCHEM, V67, P699; Castano Z, 2010, J NEUROCHEM, V113, P117, DOI 10.1111/j.1471-4159.2010.06581.x; Engel T, 2006, J NEUROSCI, V26, P5083, DOI 10.1523/JNEUROSCI.0604-06.2006; Flaherty DB, 2000, J NEUROSCI RES, V62, P463, DOI 10.1002/1097-4547(20001101)62:3<463::AID-JNR16>3.0.CO;2-7; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Lim J, 2008, J CLIN INVEST, V118, P1877, DOI 10.1172/JCI34308; Liou YC, 2003, NATURE, V424, P556, DOI 10.1038/nature01832; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Lu PJ, 1999, NATURE, V399, P784; Ma S. L., 2012, NEUROBIOL A IN PRESS; MANN DMA, 1988, HISTOPATHOLOGY, V13, P125, DOI 10.1111/j.1365-2559.1988.tb02018.x; Nakamura K., 2012, CELL IN PRESS; Pastorino L, 2006, NATURE, V440, P528, DOI 10.1038/nature04543; Pei JJ, 1997, J NEUROPATH EXP NEUR, V56, P70, DOI 10.1097/00005072-199701000-00007; Prasher VP, 1998, ANN NEUROL, V43, P380, DOI 10.1002/ana.410430316; Rayasam GV, 2009, BRIT J PHARMACOL, V156, P885, DOI 10.1111/j.1476-5381.2008.00085.x; Sleegers K, 2006, BRAIN, V129, P2977, DOI 10.1093/brain/awl203; Theuns J, 2006, AM J HUM GENET, V78, P936, DOI 10.1086/504044; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Thornton TM, 2008, SCIENCE, V320, P667, DOI 10.1126/science.1156037	20	65	70	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					6969	6973		10.1074/jbc.C111.298596	http://dx.doi.org/10.1074/jbc.C111.298596			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22184106	Green Published, hybrid			2022-12-27	WOS:000301060200002
J	Chattopadhyay, S; Tchesnokova, V; McVeigh, A; Kisiela, DI; Dori, K; Navarro, A; Sokurenko, EV; Savarino, SJ				Chattopadhyay, Sujay; Tchesnokova, Veronika; McVeigh, Annette; Kisiela, Dagmara I.; Dori, Kathleen; Navarro, Armando; Sokurenko, Evgeni V.; Savarino, Stephen J.			Adaptive Evolution of Class 5 Fimbrial Genes in Enterotoxigenic Escherichia coli and Its Functional Consequences	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR ANTIGEN-I; COLONIZATION FACTOR; FIMH ADHESIN; BINDING SPECIFICITIES; BACTERIAL ADHESION; CFA/I FIMBRIAE; MUTATIONS; DIARRHEA; DIVERSITY; VIRULENCE	Class 5 fimbriae of enterotoxigenic Escherichia coli (ETEC) comprise eight serologically discrete colonization factors that mediate small intestinal adhesion. Their differentiation has been attributed to the pressure imposed by host adaptive immunity. We sequenced the major pilin and minor adhesin subunit genes of a geographically diverse population of ETEC elaborating CFA/I (n = 31), CS17 (n = 20), and CS2 (n = 18) and elucidated the functional effect of microevolutionary processes. Between the fimbrial types, the pairwise nucleotide diversity for the pilin or adhesin genes ranged from 35-43%. Within each fimbrial type, there were 17 non-synonymous and 1 synonymous point mutations among all pilin or adhesin gene copies, implying that each fimbrial type was acquired by ETEC strains very recently, consistent with a recent origin of this E. coli pathotype. The 17 non-synonymous allelic differences occurred in the CFA/I pilin gene cfaB (two changes) and adhesin gene cfaE (three changes), and CS17 adhesin gene csbD (12 changes). All but one amino acid change in the adhesins clustered around the predicted ligand-binding pocket. Functionally, these changes conferred an increase in cell adhesion in a flow chamber assay. In contrast, the two mutations in the non-adhesive CfaB subunit localized to the intersubunit interface and significantly reduced fimbrial adhesion in this assay. In conclusion, naturally occurring mutations in the ETEC adhesive and non-adhesive subunits altered function, were acquired under positive selection, and are predicted to impact bacteria-host interactions.	[Chattopadhyay, Sujay; Tchesnokova, Veronika; Kisiela, Dagmara I.; Sokurenko, Evgeni V.] Univ Washington, Dept Microbiol, Sch Med, Seattle, WA 98195 USA; [McVeigh, Annette; Dori, Kathleen; Savarino, Stephen J.] USN, Med Res Ctr, Enter Dis Dept, Silver Spring, MD 20910 USA; [Navarro, Armando] Univ Nacl Autonoma Mexico, Fac Med, Dept Salud Publ, Mexico City 04510, DF, Mexico; [Savarino, Stephen J.] Uniformed Serv Univ Hlth Sci, Dept Pediat, Bethesda, MD 20814 USA	University of Washington; University of Washington Seattle; United States Department of Defense; United States Navy; Universidad Nacional Autonoma de Mexico; Uniformed Services University of the Health Sciences - USA	Sokurenko, EV (corresponding author), Univ Washington, Dept Microbiol, Sch Med, Room E309,Hlth Sci Bldg,Campus Box 357242, Seattle, WA 98195 USA.	evs@u.washington.edu; stephen.savarino@med.navy.mil	NAVARRO, ARMANDO/AAO-7368-2020; Navarro, Armando/AAE-3832-2022; Chattopadhyay, Sujay/AAA-5772-2022	NAVARRO, ARMANDO/0000-0002-6693-7168; Chattopadhyay, Sujay/0000-0003-1785-2683	U.S. Army Medical Research and Materiel Command Award [6000 RAD1 DA2 A0307]; Henry M. Jackson Foundation for the Advancement of Military Medicine [G1876KI]	U.S. Army Medical Research and Materiel Command Award(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Henry M. Jackson Foundation for the Advancement of Military Medicine	This work was supported by the U.S. Army Medical Research and Materiel Command Award 6000 RAD1 DA2 A0307 (to S. J. S.) and the Henry M. Jackson Foundation for the Advancement of Military Medicine Grant G1876KI (to S. J. S.).	Anantha RP, 2004, INFECT IMMUN, V72, P7190, DOI 10.1128/IAI.72.12.7190-7201.2004; [Anonymous], 2006, Wkly Epidemiol Rec, V81, P97; Aprikian P, 2007, J BIOL CHEM, V282, P23437, DOI 10.1074/jbc.M702037200; Aprikian P, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000617; Baker KK, 2009, CELL MICROBIOL, V11, P742, DOI 10.1111/j.1462-5822.2009.01287.x; BARTUS H, 1985, J CLIN MICROBIOL, V21, P951, DOI 10.1128/JCM.21.6.951-954.1985; BLACK RE, 1990, REV INFECT DIS, V12, pS73; Bullitt E, 1998, BIOPHYS J, V74, P623, DOI 10.1016/S0006-3495(98)77821-X; Chattopadhyay S, 2007, J MOL EVOL, V64, P204, DOI 10.1007/s00239-006-0063-5; Chattopadhyay S, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-187; Choudhury D, 1999, SCIENCE, V285, P1061, DOI 10.1126/science.285.5430.1061; Duncan MJ, 2005, J BIOL CHEM, V280, P37707, DOI 10.1074/jbc.M501249200; EVANS DG, 1979, INFECT IMMUN, V25, P738, DOI 10.1128/IAI.25.2.738-748.1979; EVANS DG, 1975, INFECT IMMUN, V12, P656, DOI 10.1128/IAI.12.3.656-667.1975; EVANS DG, 1977, INFECT IMMUN, V18, P330, DOI 10.1128/IAI.18.2.330-337.1977; Feng L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004053; Fleckenstein JM, 2010, MICROBES INFECT, V12, P89, DOI 10.1016/j.micinf.2009.10.002; Forero M, 2006, PLOS BIOL, V4, P1509, DOI 10.1371/journal.pbio.0040298; Fussenegger M, 1997, GENE, V192, P125, DOI 10.1016/S0378-1119(97)00038-3; Gaastra W, 1996, TRENDS MICROBIOL, V4, P444, DOI 10.1016/0966-842X(96)10068-8; Gomez-Duarte OG, 2007, J BACTERIOL, V189, P9145, DOI 10.1128/JB.00722-07; Grewal HMS, 1997, INFECT IMMUN, V65, P507, DOI 10.1128/IAI.65.2.507-513.1997; Ho SYW, 2006, TRENDS GENET, V22, P79, DOI 10.1016/j.tig.2005.11.006; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; HUILAN S, 1991, B WORLD HEALTH ORGAN, V69, P549; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Khalil S. B., 2000, 100 GEN M AM SOC MIC; Korotkova N, 2007, MOL MICROBIOL, V64, P180, DOI 10.1111/j.1365-2958.2007.05648.x; Li YF, 2007, J BIOL CHEM, V282, P23970, DOI 10.1074/jbc.M700921200; Li YF, 2009, P NATL ACAD SCI USA, V106, P10793, DOI 10.1073/pnas.0812843106; MADISON B, 1994, INFECT IMMUN, V62, P843, DOI 10.1128/IAI.62.3.843-848.1994; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; NEI M, 1986, MOL BIOL EVOL, V3, P418; Philippe N, 2007, BIOESSAYS, V29, P846, DOI 10.1002/bies.20629; Poole ST, 2007, MOL MICROBIOL, V63, P1372, DOI 10.1111/j.1365-2958.2007.05612.x; Qadri F, 2000, J CLIN MICROBIOL, V38, P27; Sokurenko EV, 2004, MOL BIOL EVOL, V21, P1373, DOI 10.1093/molbev/msh136; Steinsland H, 2010, J CLIN MICROBIOL, V48, P2916, DOI 10.1128/JCM.02432-09; Suzuki Y., 2004, PHYLOGENETIC HDB PRA, P283; Swofford DL, 2002, PHYLOGENETIC ANAL US; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tchesnokova V, 2008, J BIOL CHEM, V283, P7823, DOI 10.1074/jbc.M707804200; Tchesnokova V, 2010, MOL MICROBIOL, V76, P489, DOI 10.1111/j.1365-2958.2010.07116.x; Thomas WE, 2004, MOL MICROBIOL, V53, P1545, DOI 10.1111/j.1365-2958.2004.04226.x; Thomas WE, 2002, CELL, V109, P913, DOI 10.1016/S0092-8674(02)00796-1; von Sonnenburg F, 2000, LANCET, V356, P133, DOI 10.1016/S0140-6736(00)02451-X; Weissman SJ, 2007, INFECT IMMUN, V75, P3548, DOI 10.1128/IAI.01963-06; Weissman SJ, 2006, MOL MICROBIOL, V59, P975, DOI 10.1111/j.1365-2958.2005.04985.x; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x	49	21	21	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6150	6158		10.1074/jbc.M111.303735	http://dx.doi.org/10.1074/jbc.M111.303735			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22215679	Green Published, hybrid			2022-12-27	WOS:000300791800008
J	Zhang, QH; Wang, CM; Liu, ZL; Liu, XG; Han, CF; Cao, XT; Li, N				Zhang, Qinghua; Wang, Chunmei; Liu, Zhaolong; Liu, Xingguang; Han, Chaofeng; Cao, Xuetao; Li, Nan			Notch Signal Suppresses Toll-like Receptor-triggered Inflammatory Responses in Macrophages by Inhibiting Extracellular Signal-regulated Kinase 1/2-mediated Nuclear Factor kappa B Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNE-RESPONSES; NEGATIVE REGULATION; DEPENDENT PATHWAY; IL-10 PRODUCTION; DENDRITIC CELLS; UP-REGULATION; NITRIC-OXIDE; I INTERFERON; T-CELLS; LIPOPOLYSACCHARIDE	Multiple signaling pathways are involved in the tight regulation of Toll-like receptor (TLR) signaling, which is important for the tailoring of inflammatory response to pathogens in macrophages. It is widely accepted that TLR signaling can activate Notch pathway; however, whether full activation of Notch signaling can feedback modulate TLR signaling pathway so as to control inflammation response remains unclear. Here, we demonstrated that stimulation with TLR ligands up-regulated Notch1 and Notch2 expression in macrophages. The expression of Notch target genes including Hes1 and Hes5 was also induced in macrophages by LPS, suggesting that TLR4 signaling enhances the activation of Notch pathway. Importantly, overexpression of constituted active form of Notch1 (NICD1) and Notch2 (NICD2) suppressed production of TLR4-triggered pro-inflammatory cytokines such as TNF-alpha and IL-6 but promoted production of antiinflammatory cytokine IL-10, which is dependent on the PEST domain of NICD. In addition, NICD1 and NICD2 suppressed TLR-triggered ERK phosphorylation, which is indispensable for Notch-mediated inhibition of TLR4-triggered proinflammatory cytokine production. Furthermore, activation of Notch signaling inhibited NF-kappa B transcription activity by MyD88/TRAF6 and TRIF pathways, which was dependent on ERK activity. Therefore, our results showed that Notch signaling negatively regulates TLR-triggered inflammation responses, revealing a new mechanism for negative regulation of TLR signaling via Notch pathway.	[Zhang, Qinghua; Wang, Chunmei; Liu, Xingguang; Han, Chaofeng; Cao, Xuetao; Li, Nan] Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai 200433, Peoples R China; [Zhang, Qinghua; Wang, Chunmei; Liu, Xingguang; Han, Chaofeng; Cao, Xuetao; Li, Nan] Second Mil Med Univ, Inst Immunol, Shanghai 200433, Peoples R China; [Zhang, Qinghua] Shanghai Ocean Univ, Minist Educ, Key Lab Explorat & Utilizat Aquat Genet Resources, Shanghai 201306, Peoples R China; [Liu, Zhaolong] Peoples Hosp Pudong New Area, Dept Gen Surg, Shanghai 201200, Peoples R China	Naval Medical University; Naval Medical University; Shanghai Ocean University	Cao, XT (corresponding author), Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai 200433, Peoples R China.	caoxt@immunol.org; linan@immunol.org	Zhang, Qinghua/F-3602-2012		National Key Basic Research Program of China [2010CB911903, 2012CB910202]; National Natural Science Foundation of China [81123006, 30801009, 31070789]; Shanghai Committee of Science and Technology [10DZ1910300]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee)	This work was supported by National Key Basic Research Program of China Grants 2010CB911903 and 2012CB910202, National Natural Science Foundation of China Grants 81123006, 30801009, and 31070789, and Shanghai Committee of Science and Technology Grant 10DZ1910300.	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Artayanis-Tsakonas S, 2010, CURR TOP DEV BIOL, V92, P1, DOI 10.1016/S0070-2153(10)92001-2; Aster JC, 2011, J PATHOL, V223, P262, DOI 10.1002/path.2789; Bellavia D, 2000, EMBO J, V19, P3337, DOI 10.1093/emboj/19.13.3337; Berlato C, 2002, J IMMUNOL, V168, P6404, DOI 10.4049/jimmunol.168.12.6404; Bray S, 2010, CURR TOP DEV BIOL, V92, P253, DOI 10.1016/S0070-2153(10)92008-5; Cao WS, 2008, J EXP MED, V205, P1491, DOI 10.1084/jem.20071728; Cua DJ, 1997, J IMMUNOL, V159, P5834; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Foldi J, 2010, J IMMUNOL, V185, P5023, DOI 10.4049/jimmunol.1001544; Fung E, 2007, CIRCULATION, V115, P2948, DOI 10.1161/CIRCULATIONAHA.106.675462; Han CF, 2010, NAT IMMUNOL, V11, P734, DOI 10.1038/ni.1908; Haruki N, 2005, CANCER RES, V65, P3555, DOI 10.1158/0008-5472.CAN-04-3132; Hass MR, 2009, SEMIN CELL DEV BIOL, V20, P201, DOI 10.1016/j.semcdb.2008.11.014; Heitzler P, 2010, CURR TOP DEV BIOL, V92, P457, DOI 10.1016/S0070-2153(10)92014-0; Hertzog P, 2008, IMMUNITY, V29, P663, DOI 10.1016/j.immuni.2008.10.006; Hu XY, 2008, IMMUNITY, V29, P691, DOI 10.1016/j.immuni.2008.08.016; Ivashkiv LB, 2009, NAT IMMUNOL, V10, P340, DOI 10.1038/ni.1706; Kassner N, 2010, J IMMUNOL, V184, P550, DOI 10.4049/jimmunol.0903152; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kim MY, 2008, J CELL SCI, V121, P1466, DOI 10.1242/jcs.019018; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Lawrence T, 2001, NAT MED, V7, P1291, DOI 10.1038/nm1201-1291; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Liu XG, 2011, NAT IMMUNOL, V12, P416, DOI 10.1038/ni.2015; Liu XG, 2008, BLOOD, V112, P4961, DOI 10.1182/blood-2008-03-144022; Mathur RK, 2004, NAT MED, V10, P540, DOI 10.1038/nm1045; Monsalve E, 2006, J IMMUNOL, V176, P5362, DOI 10.4049/jimmunol.176.9.5362; Narayana Y, 2008, J BIOL CHEM, V283, P12501, DOI 10.1074/jbc.M709960200; Niranjan T, 2008, NAT MED, V14, P290, DOI 10.1038/nm1731; O'Neill LAJ, 2008, IMMUNITY, V29, P12, DOI 10.1016/j.immuni.2008.06.004; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Okamoto M, 2008, J EXP MED, V205, P1087, DOI 10.1084/jem.20072200; Okamoto M, 2009, J IMMUNOL, V183, P2995, DOI 10.4049/jimmunol.0900692; Ong CT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002823; Palaga T, 2008, EUR J IMMUNOL, V38, P174, DOI 10.1002/eji.200636999; Qasimi P, 2006, J BIOL CHEM, V281, P6316, DOI 10.1074/jbc.M508608200; RECHSTEINER M, 1988, ADV ENZYME REGUL, V27, P135; Rutz S, 2008, P NATL ACAD SCI USA, V105, P3497, DOI 10.1073/pnas.0712102105; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Tsao PN, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-56; Wang CM, 2009, J BIOL CHEM, V284, P16183, DOI 10.1074/jbc.M109.002105; Yang PY, 2010, NAT IMMUNOL, V11, P487, DOI 10.1038/ni.1876; Yuan JS, 2010, ANNU REV IMMUNOL, V28, P343, DOI 10.1146/annurev.immunol.021908.132719; Zhang Y, 2011, BLOOD, V117, P299, DOI 10.1182/blood-2010-03-271940	46	102	120	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6208	6217		10.1074/jbc.M111.310375	http://dx.doi.org/10.1074/jbc.M111.310375			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22205705	Green Published, hybrid			2022-12-27	WOS:000300791800014
J	Scudiero, I; Zotti, T; Ferravante, A; Vessichelli, M; Reale, C; Masone, MC; Leonardi, A; Vito, P; Stilo, R				Scudiero, Ivan; Zotti, Tiziana; Ferravante, Angela; Vessichelli, Mariangela; Reale, Carla; Masone, Maria C.; Leonardi, Antonio; Vito, Pasquale; Stilo, Romania			Tumor Necrosis Factor (TNF) Receptor-associated Factor 7 Is Required for TNF alpha-induced Jun NH2-terminal Kinase Activation and Promotes Cell Death by Regulating Polyubiquitination and Lysosomal Degradation of c-FLIP Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TRAIL-INDUCED APOPTOSIS; CHRONIC LYMPHOCYTIC-LEUKEMIA; MEDIATED APOPTOSIS; INHIBITORY PROTEIN; DOWN-REGULATION; CASPASE-8 ACTIVATION; THERAPEUTIC TARGET; JNK; RESISTANCE	The pro-inflammatory cytokine tumor necrosis factor (TNF) alpha signals both cell survival and death. The biological outcome of TNF alpha treatment is determined by the balance between survival factors and Jun NH2-terminal kinase (JNK) signaling, which promotes cell death. Here, we show that TRAF7, the most recently identified member of the TNF receptor-associated factors (TRAFs) family of proteins, is essential for activation of JNK following TNF alpha stimulation. We also show that TRAF6 and TRAF7 promote unconventional polyubiquitination of the antiapoptotic protein c-FLIPL and demonstrate that degradation of c-FLIPL also occurs through a lysosomal pathway. RNA interference-mediated depletion of TRAF7 correlates with increased c-FLIPL expression level, which, in turn, results in resistance to TNF alpha cytotoxicity. Collectively, our results indicate an important role for TRAF7 in the activation of JNK following TNF alpha stimulation and clearly point to an involvement of this protein in regulating the turnover of c-FLIP and, consequently, cell death.	[Scudiero, Ivan; Zotti, Tiziana; Ferravante, Angela; Vessichelli, Mariangela; Reale, Carla; Masone, Maria C.; Vito, Pasquale; Stilo, Romania] Univ Sannio, Dipartimento Sci Biol Geol & Ambiente, I-82100 Benevento, Italy; [Scudiero, Ivan; Zotti, Tiziana; Ferravante, Angela; Vessichelli, Mariangela; Reale, Carla; Masone, Maria C.; Vito, Pasquale; Stilo, Romania] Biogem Consortium, I-83031 Ariano Irpino, Italy; [Leonardi, Antonio] Univ Naples Federico 2, Dipartimento Biol & Patol Cellulare Mol, I-80131 Naples, Italy	University of Sannio; University of Naples Federico II	Vito, P (corresponding author), Univ Sannio, Dipartimento Sci Biol Geol & Ambiente, Via PortArsa 11, I-82100 Benevento, Italy.	P.V.vito@unisannio.it	Zotti, Tiziana/AAV-6768-2021; Reale, Carla/AAB-7939-2020; leonardi, antonio/A-2887-2009; vito, pasquale/ABF-5505-2020	Zotti, Tiziana/0000-0003-4753-116X; Reale, Carla/0000-0001-7682-4784; leonardi, antonio/0000-0001-8636-9623; scudiero, ivan/0000-0001-5559-5548; vito, pasquale/0000-0002-5721-7716; ferravante, angela/0000-0002-4932-3877	Telethon Grant [GGP08125B]	Telethon Grant(Fondazione Telethon)	This work was supported by Telethon Grant GGP08125B.	Bartke T, 2001, ONCOGENE, V20, P571, DOI 10.1038/sj.onc.1204124; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Chang DW, 2003, EMBO J, V22, P4132, DOI 10.1093/emboj/cdg414; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Chastagner P, 2006, EMBO REP, V7, P1147, DOI 10.1038/sj.embor.7400822; Chawla-Sarkar M, 2004, CELL DEATH DIFFER, V11, P915, DOI 10.1038/sj.cdd.4401416; De Smaele E, 2001, NATURE, V414, P308, DOI 10.1038/35104560; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Djerbi M, 1999, J EXP MED, V190, P1025, DOI 10.1084/jem.190.7.1025; Donepudi M, 2003, MOL CELL, V11, P543, DOI 10.1016/S1097-2765(03)00059-5; Fukazawa T, 2001, ONCOGENE, V20, P5225, DOI 10.1038/sj.onc.1204673; Galligan L, 2005, MOL CANCER THER, V4, P2026, DOI 10.1158/1535-7163.MCT-05-0262; Golks A, 2005, J BIOL CHEM, V280, P14507, DOI 10.1074/jbc.M414425200; Guiet C, 2002, CELL DEATH DIFFER, V9, P138, DOI 10.1038/sj/cdd/4400947; Herr I, 2000, LEUKEMIA, V14, P1859, DOI 10.1038/sj.leu.2401911; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Korkolopoulou P, 2004, UROLOGY, V63, P1198, DOI 10.1016/j.urology.2004.01.007; Kreuz S, 2001, MOL CELL BIOL, V21, P3964, DOI 10.1128/MCB.21.12.3964-3973.2001; Krueger A, 2001, J BIOL CHEM, V276, P20633, DOI 10.1074/jbc.M101780200; Longley DB, 2006, ONCOGENE, V25, P838, DOI 10.1038/sj.onc.1209122; MacFarlane M, 2002, ONCOGENE, V21, P6809, DOI 10.1038/sj.onc.1205853; Micheau O, 2003, EXPERT OPIN THER TAR, V7, P559, DOI 10.1517/eott.7.4.559.22500; Micheau O, 2001, MOL CELL BIOL, V21, P5299, DOI 10.1128/MCB.21.16.5299-5305.2001; Okano H, 2003, LAB INVEST, V83, P1033, DOI 10.1097/01.LAB.0000079328.76631.28; Olsson A, 2001, LEUKEMIA, V15, P1868, DOI 10.1038/sj.leu.2402287; Peter ME, 2003, CELL DEATH DIFFER, V10, P26, DOI 10.1038/sj.cdd.4401186; Salon C, 2006, CELL DEATH DIFFER, V13, P260, DOI 10.1038/sj.cdd.4401739; Sanchez-Perez T, 2010, CELL DEATH DIFFER, V17, P883, DOI 10.1038/cdd.2009.176; Shirley S., 2010, CANC LETT IN PRESS; Son YG, 2007, CANCER RES, V67, P8274, DOI 10.1158/0008-5472.CAN-07-0407; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Tran SEF, 2003, CELL DEATH DIFFER, V10, P1137, DOI 10.1038/sj.cdd.4401278; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Xu LG, 2004, J BIOL CHEM, V279, P17278, DOI 10.1074/jbc.C400063200; Yang JK, 2008, YONSEI MED J, V49, P19, DOI 10.3349/ymj.2008.49.1.19; Yeh WC, 1997, IMMUNITY, V7, P715, DOI 10.1016/S1074-7613(00)80391-X; Zong HJ, 2009, TOHOKU J EXP MED, V217, P203, DOI 10.1620/tjem.217.203; Zotti T., 2011, J CELL PHYS IN PRESS; Zotti T, 2011, J BIOL CHEM, V286, P22924, DOI 10.1074/jbc.M110.215426; Zou W, 2007, CANCER BIOL THER, V6, P1614, DOI 10.4161/cbt.6.10.4763	43	31	32	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					6053	6061		10.1074/jbc.M111.300137	http://dx.doi.org/10.1074/jbc.M111.300137			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22219201	Green Published, hybrid			2022-12-27	WOS:000300638000078
J	Tsukatani, Y; Romberger, SP; Golbeck, JH; Bryant, DA				Tsukatani, Yusuke; Romberger, Steven P.; Golbeck, John H.; Bryant, Donald A.			Isolation and Characterization of Homodimeric Type-I Reaction Center Complex from Candidatus Chloracidobacterium thermophilum, an Aerobic Chlorophototroph	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GREEN SULFUR BACTERIUM; PHOTOSYNTHETIC REACTION-CENTER; FMO ANTENNA PROTEIN; CHLOROPHYLL-PROTEIN; CHLOROBIUM-TEPIDUM; ELECTRON-TRANSFER; PIGMENT COMPOSITION; CYTOCHROME-C; BACTERIOCHLOROPHYLL; CHLOROSOMES	The recently discovered thermophilic acidobacterium Candidatus Chloracidobacterium thermophilum is the first aerobic chlorophototroph that has a type-I, homodimeric reaction center (RC). This organism and its type-I RCs were initially detected by the occurrence of pscA gene sequences, which encode the core subunit of the RC complex, in metagenomic sequence data derived from hot spring microbial mats. Here, we report the isolation and initial biochemical characterization of the type-I RC from Ca. C. thermophilum. After removal of chlorosomes, crude membranes were solubilized with 0.1% (w/v) n-dodecyl beta-D-maltoside, and the RC complex was purified by ion-exchange chromatography. The RC complex comprised only two polypeptides: the reaction center core protein PscA and a 22-kDa carotenoid-binding protein denoted CbpC. The absorption spectrum showed a large, broad absorbance band centered at similar to 483 nm from carotenoids as well as smaller Q(y) absorption bands at 672 and 812 nm from chlorophyll a and bacteriochlorophyll a, respectively. The light-induced difference spectra of whole cells, membranes, and the isolated RC showed maximal bleaching at 840 nm, which is attributed to the special pair and which we denote as P840. Making it unique among homodimeric type-I RCs, the isolated RC was photoactive in the presence of oxygen. Analyses by optical spectroscopy, chromatography, and mass spectrometry revealed that the RC complex contained 10.3 bacteriochlorophyll a(P), 6.4 chlorophyll a(PD), and 1.6 Zn-bacteriochlorophyll a(P)' molecules per P840 (12.8:8.0:2.0). The possible functions of the Zn-bacteriochlorophyll a(P)' molecules and the carotenoid-binding protein are discussed.	[Bryant, Donald A.] Penn State Univ, Dept Biochem & Mol Biol, Althouse Lab 108, University Pk, PA 16802 USA; [Golbeck, John H.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; [Bryant, Donald A.] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Montana State University System; Montana State University Bozeman	Bryant, DA (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, Althouse Lab 108, University Pk, PA 16802 USA.	dab14@psu.edu	Tsukatani, Yusuke/A-6448-2014	Tsukatani, Yusuke/0000-0003-2831-8996	United States Department of Energy [DE-FG02-94ER20137]; National Science Foundation [MCB-0519743, MCB-1021725]; Uehara Memorial Foundation	United States Department of Energy(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); Uehara Memorial Foundation(Uehara Memorial Foundation)	This work was supported in part by United States Department of Energy Grant DE-FG02-94ER20137 (to D. A. B.) and National Science Foundation Grants MCB-0519743 and MCB-1021725 (to J. H. G. and D. A. B.).; Supported by a postdoctoral fellowship from The Uehara Memorial Foundation.	ALLEN KD, 1991, ANAL BIOCHEM, V194, P214, DOI 10.1016/0003-2697(91)90170-X; Azai C, 2010, PHOTOSYNTH RES, V104, P189, DOI 10.1007/s11120-009-9521-4; BRITTON G, 1985, METHOD ENZYMOL, V111, P113, DOI 10.1016/S0076-6879(85)11007-4; Bryant DA, 2007, SCIENCE, V317, P523, DOI 10.1126/science.1143236; Costas AMG, 2012, ENVIRON MICROBIOL, V14, P177, DOI 10.1111/j.1462-2920.2011.02592.x; Costas AMG, 2011, J BACTERIOL, V193, P6701, DOI 10.1128/JB.06124-11; FOWLER CF, 1971, P NATL ACAD SCI USA, V68, P2278, DOI 10.1073/pnas.68.9.2278; Frank HA, 2004, BIOCHEMISTRY-US, V43, P8607, DOI 10.1021/bi0492096; Frigaard N-U., 2006, COMPLEX INTRACELLULA, V2, P79, DOI [10.1007/7171_021, DOI 10.1007/7171_021]; Frigaard NU, 1997, ARCH MICROBIOL, V167, P343, DOI 10.1007/s002030050453; Ganapathy S, 2009, P NATL ACAD SCI USA, V106, P8525, DOI 10.1073/pnas.0903534106; Garcia Costas A. M., 2008, PHOTOSYNTHESIS ENERG, V1, P1161; Garcia Costas A. M., 2010, THESIS PENNSYLVANIA; Garcia Costas A. M., 2011, J BACTERIOL IN PRESS; Garrity GM, 2007, TAXONOMIC OUTLINE BA; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; GOLBECK JH, 1993, P NATL ACAD SCI USA, V90, P1642, DOI 10.1073/pnas.90.5.1642; Griesbeck C, 1998, BBA-BIOENERGETICS, V1365, P285, DOI 10.1016/S0005-2728(98)00081-4; Hauska G, 2001, BBA-BIOENERGETICS, V1507, P260, DOI 10.1016/S0005-2728(01)00200-6; Heinnickel M, 2007, PHOTOSYNTH RES, V92, P35, DOI 10.1007/s11120-007-9162-4; Hofmann E, 1996, SCIENCE, V272, P1788, DOI 10.1126/science.272.5269.1788; HOLO H, 1985, ARCH MICROBIOL, V143, P94, DOI 10.1007/BF00414775; Jagannathan B, 2008, BBA-BIOENERGETICS, V1777, P1535, DOI 10.1016/j.bbabio.2008.09.001; Jaschke PR, 2011, J BIOL CHEM, V286, P20313, DOI 10.1074/jbc.M110.212605; Kirilovsky D, 2010, ADV EXP MED BIOL, V675, P139, DOI 10.1007/978-1-4419-1528-3_9; Klatt CG, 2011, ISME J, V5, P1262, DOI 10.1038/ismej.2011.73; Kobayashi M, 1996, J PLANT RES, V109, P223, DOI 10.1007/BF02344549; Kobayashi M, 2000, PHOTOSYNTH RES, V63, P269, DOI 10.1023/A:1006480629059; Larson CR, 2011, PHOTOSYNTH RES, V107, P139, DOI 10.1007/s11120-010-9604-2; Li H, 2009, ARCH MICROBIOL, V191, P853, DOI 10.1007/s00203-009-0514-7; Liu ZF, 2011, ISME J, V5, P1279, DOI 10.1038/ismej.2011.37; Madigan MT, 2001, BERGEYS MANUAL SYSTE, P625, DOI [DOI 10.1021/JP809094Y, 10.1021/jp809094y]; Maresca JA, 2008, J BACTERIOL, V190, P6384, DOI 10.1128/JB.00758-08; Maresca JA, 2008, PHOTOSYNTH RES, V97, P121, DOI 10.1007/s11120-008-9312-3; Maresca JA, 2007, P NATL ACAD SCI USA, V104, P11784, DOI 10.1073/pnas.0702984104; Mattick JS, 1996, GENE, V179, P147, DOI 10.1016/S0378-1119(96)00441-6; Noy D, 1998, J AM CHEM SOC, V120, P3684, DOI 10.1021/ja970875m; Oh-oka H, 2007, PHOTOCHEM PHOTOBIOL, V83, P177, DOI 10.1562/2006-03-29-IR-860; OhOka H, 1997, BIOCHEMISTRY-US, V36, P9267, DOI 10.1021/bi9701787; OHOKA H, 1995, FEBS LETT, V365, P30, DOI 10.1016/0014-5793(95)00433-A; OHOKA H, 1995, BIOCHEMISTRY-US, V34, P13091, DOI 10.1021/bi00040a021; Olson J M, 1976, Brookhaven Symp Biol, P238; Olson JM, 2004, PHOTOSYNTH RES, V80, P181, DOI 10.1023/B:PRES.0000030428.36950.43; OLSON JM, 1973, BIOCHIM BIOPHYS ACTA, V292, P206, DOI 10.1016/0005-2728(73)90265-X; Overmann J, 2001, BERGEYS MANUAL SYSTE, V1, P601; Pedersen MO, 2010, PHOTOSYNTH RES, V104, P233, DOI 10.1007/s11120-009-9519-y; Permentier HP, 2000, PHOTOSYNTH RES, V64, P27, DOI 10.1023/A:1026515027824; Polivka T, 2007, ARCH BIOCHEM BIOPHYS, V458, P111, DOI 10.1016/j.abb.2006.10.006; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Romberger SP, 2010, PHOTOSYNTH RES, V104, P293, DOI 10.1007/s11120-010-9558-4; Sakurai H, 1996, PHOTOCHEM PHOTOBIOL, V64, P5, DOI 10.1111/j.1751-1097.1996.tb02414.x; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Takaichi S, 1999, PLANT CELL PHYSIOL, V40, P691, DOI 10.1093/oxfordjournals.pcp.a029594; Tsukatani Y, 2006, FEBS LETT, V580, P2191, DOI 10.1016/j.febslet.2006.03.016; Tsukatani Y, 2004, J BIOL CHEM, V279, P51122, DOI 10.1074/jbc.M410432200; Tsukatani Y, 2010, PHOTOSYNTH RES, V104, P201, DOI 10.1007/s11120-009-9517-0; Vassilieva EV, 2001, BIOCHEMISTRY-US, V40, P464, DOI 10.1021/bi001917d; Wakao N, 1996, PLANT CELL PHYSIOL, V37, P889, DOI 10.1093/oxfordjournals.pcp.a029029; Wen JZ, 2011, BBA-BIOENERGETICS, V1807, P157, DOI 10.1016/j.bbabio.2010.09.008; Wen JZ, 2009, P NATL ACAD SCI USA, V106, P6134, DOI 10.1073/pnas.0901691106	60	31	31	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5720	5732		10.1074/jbc.M111.323329	http://dx.doi.org/10.1074/jbc.M111.323329			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22184116	Green Published, hybrid			2022-12-27	WOS:000300638000048
J	Banerjee, R				Banerjee, Ruma			Redox outside the Box: Linking Extracellular Redox Remodeling with Intracellular Redox Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							CYSTATHIONINE BETA-SYNTHASE; REGULATORY T-CELLS; AMINO-ACID-TRANSPORT; TRANSSULFURATION PATHWAY; HOMOCYSTEINE METABOLISM; TESTOSTERONE REGULATION; GLUTATHIONE METABOLISM; THIOL/DISULFIDE REDOX; HYDROGEN-PEROXIDE; DENDRITIC CELLS	Aerobic organisms generate reactive oxygen species as metabolic side products and must achieve a delicate balance between using them for signaling cellular functions and protecting against collateral damage. Small molecule (e. g. glutathione and cysteine)- and protein (e. g. thioredoxin)-based buffers regulate the ambient redox potentials in the various intracellular compartments, influence the status of redox-sensitive macromolecules, and protect against oxidative stress. Less well appreciated is the fact that the redox potential of the extracellular compartment is also carefully regulated and is dynamic. Changes in intracellular metabolism alter the redox poise in the extracellular compartment, and these are correlated with cellular processes such as proliferation, differentiation, and death. In this minireview, the mechanism of extracellular redox remodeling due to intracellular sulfur metabolism is discussed in the context of various cell-cell communication paradigms.	Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Banerjee, R (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA.	rbanerje@umich.edu			National Institutes of Health [HL58984, DK64959]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058984] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064959] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL58984 and DK64959. This is the first article in the Thematic Minireview Series on Redox Sensing and Regulation.	Angelini G, 2002, P NATL ACAD SCI USA, V99, P1491, DOI 10.1073/pnas.022630299; Bae YS, 1997, J BIOL CHEM, V272, P217, DOI 10.1074/jbc.272.1.217; Ballatori N, 2009, MOL ASPECTS MED, V30, P13, DOI 10.1016/j.mam.2008.08.004; BANNAI S, 1984, BIOCHIM BIOPHYS ACTA, V779, P289, DOI 10.1016/0304-4157(84)90014-5; Broer S, 2008, PHYSIOL REV, V88, P249, DOI 10.1152/physrev.00018.2006; Chang TS, 2004, J BIOL CHEM, V279, P50994, DOI 10.1074/jbc.M409482200; Dringen R, 2000, EUR J BIOCHEM, V267, P4912, DOI 10.1046/j.1432-1327.2000.01597.x; Evande R, 2002, BIOCHEMISTRY-US, V41, P11832, DOI 10.1021/bi026248d; FINKELSTEIN JD, 1975, BIOCHEM BIOPH RES CO, V66, P81, DOI 10.1016/S0006-291X(75)80297-X; Franco R., 2007, Archives of Physiology and Biochemistry, V113, P234, DOI 10.1080/13813450701661198; Garg SK, 2008, J IMMUNOL, V180, P3866, DOI 10.4049/jimmunol.180.6.3866; Garg SK, 2011, ANTIOXID REDOX SIGN, V14, P2385, DOI 10.1089/ars.2010.3681; Garg SK, 2011, ANTIOXID REDOX SIGN, V15, P39, DOI 10.1089/ars.2010.3496; Irani K, 1997, SCIENCE, V275, P1649, DOI 10.1126/science.275.5306.1649; Jonas CR, 2002, FREE RADICAL BIO MED, V33, P1499, DOI 10.1016/S0891-5849(02)01081-X; Jones DP, 2006, REJUV RES, V9, P169, DOI 10.1089/rej.2006.9.169; Jones DP, 2000, FREE RADICAL BIO MED, V28, P625, DOI 10.1016/S0891-5849(99)00275-0; Jones DP, 2004, FASEB J, V18, P1246, DOI 10.1096/fj.03-0971fje; Jones DP, 2002, FREE RADICAL BIO MED, V33, P1290, DOI 10.1016/S0891-5849(02)01040-7; Kabil O, 1999, J BIOL CHEM, V274, P31256, DOI 10.1074/jbc.274.44.31256; Karala AR, 2009, ANTIOXID REDOX SIGN, V11, P963, DOI 10.1089/ARS.2008.2326; Knickelbein RG, 1997, AM J PHYSIOL-LUNG C, V273, pL1147, DOI 10.1152/ajplung.1997.273.6.L1147; Kodali VK, 2010, ANTIOXID REDOX SIGN, V13, P1217, DOI 10.1089/ars.2010.3098; Kondo N, 2004, J IMMUNOL, V172, P442, DOI 10.4049/jimmunol.172.1.442; LEE WS, 1993, J CLIN INVEST, V91, P1959, DOI 10.1172/JCI116415; Lillig CH, 2007, ANTIOXID REDOX SIGN, V9, P25, DOI 10.1089/ars.2007.9.25; Mannery YO, 2010, AM J PHYSIOL-GASTR L, V299, pG523, DOI 10.1152/ajpgi.00359.2009; Margittai E, 2009, INT J MOL SCI, V10, P1346, DOI 10.3390/ijms10031346; Martinov MV, 2000, J THEOR BIOL, V204, P521, DOI 10.1006/jtbi.2000.2035; McBean GJ, 2001, BIOCHEM SOC T, V29, P717, DOI 10.1042/BST0290717; Meier C, 2002, EMBO J, V21, P580, DOI 10.1093/emboj/21.4.580; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; Miller LT, 2002, J NUTR, V132, P2303, DOI 10.1093/jn/132.8.2303; Moriarty-Craige SE, 2004, ANNU REV NUTR, V24, P481, DOI 10.1146/annurev.nutr.24.012003.132208; Mosharov E, 2000, BIOCHEMISTRY-US, V39, P13005, DOI 10.1021/bi001088w; Nakamura H, 2006, SEMIN CANCER BIOL, V16, P444, DOI 10.1016/j.semcancer.2006.09.001; Nkabyo YS, 2002, AM J PHYSIOL-GASTR L, V283, pG1352, DOI 10.1152/ajpgi.00183.2002; OLNEY JW, 1990, SCIENCE, V248, P596, DOI 10.1126/science.2185543; ORLOWSKI M, 1970, P NATL ACAD SCI USA, V67, P1248, DOI 10.1073/pnas.67.3.1248; Park Y, 2010, J NUTR, V140, P760, DOI 10.3945/jn.109.116764; Pekkari K, 2003, FEBS LETT, V539, P143, DOI 10.1016/S0014-5793(03)00214-X; Prudova A, 2006, P NATL ACAD SCI USA, V103, P6489, DOI 10.1073/pnas.0509531103; Prudova A, 2007, ANTIOXID REDOX SIGN, V9, P1875, DOI 10.1089/ars.2007.1712; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Schwertassek U, 2007, EMBO J, V26, P3086, DOI 10.1038/sj.emboj.7601746; Soderberg A, 2000, CANCER RES, V60, P2281; Vitvitsky V, 2007, AM J PHYSIOL-RENAL, V293, pF594, DOI 10.1152/ajprenal.00171.2007; Vitvitsky V, 2006, J BIOL CHEM, V281, P35785, DOI 10.1074/jbc.M602799200; Weissbach H, 2005, BBA-PROTEINS PROTEOM, V1703, P203, DOI 10.1016/j.bbapap.2004.10.004; Winterbourn CC, 1999, FREE RADICAL BIO MED, V27, P322, DOI 10.1016/S0891-5849(99)00051-9; Yan ZH, 2010, J BIOL CHEM, V285, P41525, DOI 10.1074/jbc.M110.189944; Yan ZH, 2010, BIOCHEMISTRY-US, V49, P1059, DOI 10.1021/bi902022n; Yan ZH, 2009, NAT CHEM BIOL, V5, P721, DOI 10.1038/nchembio.212	53	142	146	0	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4397	4402		10.1074/jbc.R111.287995	http://dx.doi.org/10.1074/jbc.R111.287995			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22147695	hybrid, Green Published			2022-12-27	WOS:000300608500002
J	Hou, ZJ; Desmoulin, SK; Etnyre, E; Olive, M; Hsiung, B; Cherian, C; Wloszczynski, PA; Moin, K; Matherly, LH				Hou, Zhanjun; Desmoulin, Sita Kugel; Etnyre, Erika; Olive, Mary; Hsiung, Benjamin; Cherian, Christina; Wloszczynski, Patrick A.; Moin, Kamiar; Matherly, Larry H.			Identification and Functional Impact of Homo-oligomers of the Human Proton-coupled Folate Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-BINDING DOMAIN; OF-FUNCTION MUTATION; HUMAN SOLID TUMORS; THIENOYL ANTIFOLATE; PURINE BIOSYNTHESIS; ANTITUMOR-ACTIVITY; GENE PCFT-SLC46A1; PHASE-III; CARRIER; MEMBRANE	The proton-coupled folate transporter (PCFT; SLC46A1) is a proton-folate symporter that is abundantly expressed in solid tumors and normal tissues, such as duodenum. The acidic pH optimum for PCFT is relevant to intestinal absorption of folates and could afford a means of selectively targeting tumors with novel cytotoxic antifolates. PCFT is a member of the major facilitator superfamily of transporters. Because major facilitator superfamily members exist as homo-oligomers, we tested this for PCFT because such structures could be significant to PCFT mechanism and regulation. By transiently expressing PCFT in reduced folate carrier-and PCFT-null HeLa (R1-11) cells and chemical cross-linking with 1,1-methanediyl bismethanethiosulfonate and Western blotting, PCFT species with molecular masses approximating those of the PCFT dimer and higher order oligomers were detected. Blue native polyacrylamide gel electrophoresis identified PCFT dimer, trimer, and tetramer forms. PCFT monomers with hemagglutinin and His(10) epitope tags were co-expressed in R1-11 cells, solubilized, and bound to nickel affinity columns, establishing their physical associations. Co-expressing YPet and ECFP*-tagged PCFT monomers enabled transport and fluorescence resonance energy transfer in plasma membranes of R1-11 cells. Combined wild-type (WT) and inactive mutant P425R PCFTs were targeted to the cell surface by surface biotinylation/Western blots and confocal microscopy and functionally exhibited a "dominant-positive" phenotype, implying positive cooperativity between PCFT monomers and functional rescue of mutant by WT PCFT. Our results demonstrate the existence of PCFT homo-oligomers and imply their functional and regulatory impact. Better understanding of these higher order PCFT structures may lead to therapeutic applications related to folate uptake in hereditary folate malabsorption, and delivery of PCFT-targeted chemotherapy drugs for cancer.	[Hou, Zhanjun; Etnyre, Erika; Hsiung, Benjamin; Cherian, Christina; Wloszczynski, Patrick A.; Matherly, Larry H.] Wayne State Univ, Sch Med, Dev Therapeut Program, Barbara Ann Karmanos Canc Inst, Detroit, MI 48201 USA; [Desmoulin, Sita Kugel; Matherly, Larry H.] Wayne State Univ, Sch Med, Canc Biol Grad Program, Dept Oncol, Detroit, MI 48201 USA; [Moin, Kamiar; Matherly, Larry H.] Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA	Barbara Ann Karmanos Cancer Institute; Wayne State University; Wayne State University; Wayne State University	Hou, ZJ (corresponding author), 110 E Warren Ave, Detroit, MI 48201 USA.	houz@karmanos.org; matherly@karmanos.org	/S-1117-2019		National Institutes of Health (NIH), NCI [R01 CA53535]; NIH Center [P30CA22453]; Perinatology Research Branch of NICHD, NIH, Wayne State University; Canadian Institutes of Health Research; NATIONAL CANCER INSTITUTE [R01CA053535, P30CA022453] Funding Source: NIH RePORTER	National Institutes of Health (NIH), NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Perinatology Research Branch of NICHD, NIH, Wayne State University; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health (NIH), NCI, Grant R01 CA53535. The Microscopy, Imaging and Cytometry Resources Core is supported, in part, by NIH Center Grant P30CA22453 (to the Barbara Ann Karmanos Cancer Institute) and the Perinatology Research Branch of NICHD, NIH, Wayne State University.; Supported by a Doctoral Research Award from the Canadian Institutes of Health Research.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Atabay B, 2010, PEDIATR HEMAT ONCOL, V27, P614, DOI 10.3109/08880018.2010.481705; Bamber L, 2007, P NATL ACAD SCI USA, V104, P10830, DOI 10.1073/pnas.0703969104; Bisetto Elena, 2007, Ital J Biochem, V56, P254; Borzutzky A, 2009, CLIN IMMUNOL, V133, P287, DOI 10.1016/j.clim.2009.08.006; Ciuleanu T, 2009, LANCET, V374, P1432, DOI 10.1016/S0140-6736(09)61497-5; Dahl NK, 2003, J BIOL CHEM, V278, P44949, DOI 10.1074/jbc.M308660200; Desmoulin SK, 2011, MOL PHARMACOL, V80, P1096, DOI 10.1124/mol.111.073833; Desmoulin SK, 2010, MOL PHARMACOL, V78, P577, DOI 10.1124/mol.110.065896; Duan Peng, 2011, Int J Biochem Mol Biol, V2, P1; Fleming JC, 1999, NAT GENET, V22, P305, DOI 10.1038/10379; Hanna N, 2004, J CLIN ONCOL, V22, P1589, DOI 10.1200/JCO.2004.08.163; Helmlinger G, 1997, NAT MED, V3, P177, DOI 10.1038/nm0297-177; Heuberger EHML, 2002, J MOL BIOL, V317, P591, DOI 10.1006/jmbi.2002.5416; HICKMAN RK, 1988, J BACTERIOL, V170, P1715, DOI 10.1128/jb.170.4.1715-1720.1988; Hou ZJ, 2010, J BIOL CHEM, V285, P4732, DOI 10.1074/jbc.M109.086033; Hou ZJ, 2009, J BIOL CHEM, V284, P3285, DOI 10.1074/jbc.M807206200; Hou ZJ, 2005, J BIOL CHEM, V280, P36206, DOI 10.1074/jbc.M507295200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lasry I, 2008, BLOOD, V112, P2055, DOI 10.1182/blood-2008-04-150276; Lasry I, 2009, BIOCHEM BIOPH RES CO, V386, P426, DOI 10.1016/j.bbrc.2009.06.007; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; Mahadeo K, 2010, AM J PHYSIOL-CELL PH, V299, pC1153, DOI 10.1152/ajpcell.00113.2010; Mahadeo KM, 2011, J PEDIATR-US, V159, P623, DOI 10.1016/j.jpeds.2011.03.005; Matherly LH, 2007, CANCER METAST REV, V26, P111, DOI 10.1007/s10555-007-9046-2; MATHERLY LH, 1991, CANCER RES, V51, P3420; Meyer E, 2010, MOL GENET METAB, V99, P325, DOI 10.1016/j.ymgme.2009.11.004; Min SH, 2008, J PEDIATR-US, V153, P435, DOI 10.1016/j.jpeds.2008.04.009; Nakai Y, 2007, J PHARMACOL EXP THER, V322, P469, DOI 10.1124/jpet.107.122606; Ohashi T, 2007, PROTEIN SCI, V16, P1429, DOI 10.1110/ps.072845607; Payton SG, 2007, BBA-GENE STRUCT EXPR, V1769, P131, DOI 10.1016/j.bbaexp.2006.12.006; Polgar O, 2010, BIOCHEMISTRY-US, V49, P2235, DOI 10.1021/bi902085q; Qiu A, 2007, AM J PHYSIOL-CELL PH, V293, pC1669, DOI 10.1152/ajpcell.00202.2007; Qiu AD, 2006, CELL, V127, P917, DOI 10.1016/j.cell.2006.09.041; Raghunand N, 1999, BIOCHEM PHARMACOL, V57, P309, DOI 10.1016/S0006-2952(98)00306-2; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Shin DS, 2011, MOL GENET METAB, V103, P33, DOI 10.1016/j.ymgme.2011.01.008; Shin DS, 2010, BLOOD, V116, P5162, DOI 10.1182/blood-2010-06-291237; Stokstad E. L. R., 1990, HIST PERSPECTIVE KEY, P1; Subramanian VS, 2008, AM J PHYSIOL-CELL PH, V294, pC233, DOI 10.1152/ajpcell.00468.2007; SWAMY M, 2006, SCI STKE; Taylor AM, 2001, BIOCHEM J, V359, P661, DOI 10.1042/0264-6021:3590661; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Unal ES, 2009, AM J PHYSIOL-CELL PH, V297, pC66, DOI 10.1152/ajpcell.00096.2009; Unal ES, 2009, J BIOL CHEM, V284, P17846, DOI 10.1074/jbc.M109.008060; Unal ES, 2008, BBA-BIOMEMBRANES, V1778, P1407, DOI 10.1016/j.bbamem.2008.03.009; Veenhoff LM, 2001, EMBO J, V20, P3056, DOI 10.1093/emboj/20.12.3056; Vogelzang NJ, 2003, J CLIN ONCOL, V21, P2636, DOI 10.1200/JCO.2003.11.136; Wang L, 2011, J MED CHEM, V54, P7150, DOI 10.1021/jm200739e; Wang L, 2010, J MED CHEM, V53, P1306, DOI 10.1021/jm9015729; Witt TL, 2004, J BIOL CHEM, V279, P46755, DOI 10.1074/jbc.M408696200; Wouters FS, 2001, TRENDS CELL BIOL, V11, P203, DOI 10.1016/S0962-8924(01)01982-1; Yerushalmi H, 1996, J BIOL CHEM, V271, P31044, DOI 10.1074/jbc.271.49.31044; Yin CC, 2000, MOL MICROBIOL, V38, P482, DOI 10.1046/j.1365-2958.2000.02149.x; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhao RB, 2004, CLIN CANCER RES, V10, P718, DOI 10.1158/1078-0432.CCR-1066-03; Zhao RB, 2008, MOL PHARMACOL, V74, P854, DOI 10.1124/mol.108.045443; Zhao R, 2007, BLOOD, V110, P1147, DOI 10.1182/blood-2007-02-077099; Zhao RB, 2007, CANCER METAST REV, V26, P129, DOI 10.1007/s10555-007-9047-1; Zhao RB, 2010, BIOCHEMISTRY-US, V49, P2925, DOI 10.1021/bi9021439; Zhao RB, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409000969; ZOTTOLA RJ, 1995, BIOCHEMISTRY-US, V34, P9734, DOI 10.1021/bi00030a011	63	29	29	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4982	4995		10.1074/jbc.M111.306860	http://dx.doi.org/10.1074/jbc.M111.306860			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22179615	hybrid, Green Published			2022-12-27	WOS:000300608500058
J	Min, J; Choi, ES; Hwang, K; Kim, J; Sampath, S; Venkitaraman, AR; Lee, H				Min, Jaewon; Choi, Eun Shik; Hwang, Kwangwoo; Kim, Jimi; Sampath, Srihari; Venkitaraman, Ashok R.; Lee, Hyunsook			The Breast Cancer Susceptibility Gene BRCA2 Is Required for the Maintenance of Telomere Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE RESPONSE; QUADRUPLEX DNA; HOMOLOGOUS RECOMBINATION; SACCHAROMYCES-CEREVISIAE; DYSFUNCTIONAL TELOMERES; MAMMALIAN TELOMERES; REPLICATION FORKS; GENOMIC STABILITY; FRAGILE SITES; HUMAN-CELLS	Inactivating mutations in the breast cancer susceptibility gene BRCA2 cause gross chromosomal rearrangements. Chromosome structural instability in the absence of BRCA2 is thought to result from defective homology-directed DNA repair. Here, we show that BRCA2 links the fidelity of telomere maintenance with genetic integrity. Absence of BRCA2 resulted in signs of dysfunctional telomeres, such as telomere shortening, erosions, and end fusions in proliferating mouse fibroblasts. BRCA2 localized to the telomeres in S phase in an ATR-dependent manner, and its absence resulted in the accumulation of common fragile sites, particularly at the G-rich lagging strand, and increased the telomere sister chromatid exchange in unchallenged cells. The incidence of common fragile sites and telomere sister chromatid exchange increased markedly after treatment with replication inhibitors. Congruently, telomere-induced foci were frequently observed in the absence of Brca2, denoting activation of the DNA damage response and abnormal chromosome end joining. These telomere end fusions constituted a significant portion of chromosome aberrations in Brca2-deficient cells. Our results suggest that BRCA2 is required for telomere homeostasis and may be particularly important for the replication of G-rich telomeric lagging strands.	[Min, Jaewon; Choi, Eun Shik; Hwang, Kwangwoo; Kim, Jimi; Lee, Hyunsook] Seoul Natl Univ, Dept Biol Sci, Seoul 151742, South Korea; [Min, Jaewon; Choi, Eun Shik; Hwang, Kwangwoo; Kim, Jimi; Lee, Hyunsook] Seoul Natl Univ, Inst Mol Biol & Genet, Seoul 151742, South Korea; [Sampath, Srihari; Venkitaraman, Ashok R.] Univ Cambridge, Hutchison Med Res Council, Med Res Council, Canc Cell Unit,Res Ctr, Cambridge CB2 0XZ, England	Seoul National University (SNU); Seoul National University (SNU); UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Cambridge	Lee, H (corresponding author), Seoul Natl Univ, Dept Biol Sci, 599 Gwanak Ro, Seoul 151742, South Korea.	HL212@snu.ac.kr	Kim, Jimi/AAL-8563-2021	Lee, Hyunsook/0000-0002-2251-5019; Kim, Jimi/0000-0002-6764-9934; Choi, Eun Shik/0000-0002-2306-2103	Basic Science Research Program [2011-0018630]; National Research Foundation of Korea [2009-0093927, 2010-0026104]; Research Center for Functional Cellulomics, Seoul National University (Seoul, Korea) [2005-0048590]; MRC [G0600332, G0700651, MC_U105359877, G1001521] Funding Source: UKRI; Medical Research Council [MC_U105359877, G1001521, G0600332, G0700651] Funding Source: researchfish	Basic Science Research Program; National Research Foundation of Korea(National Research Foundation of Korea); Research Center for Functional Cellulomics, Seoul National University (Seoul, Korea); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Basic Science Research Program Grant 2011-0018630 and National Research Foundation of Korea Grants 2009-0093927 and 2010-0026104.; HeLa_CFLAP_BRCA2 was a gift from M. Petronczki (Claire Hall Laboratories, London, United Kingdom). We are grateful to Dr. Titia de Lange (The Rockefeller University, New York) for providing telomere DNA constructs. Imaging and flow cytometric analyses were supported by Grant 2005-0048590 from the Research Center for Functional Cellulomics, Seoul National University (Seoul, Korea).	Alao JP, 2009, RADIAT ONCOL, V4, DOI 10.1186/1748-717X-4-51; Badie S, 2010, NAT STRUCT MOL BIOL, V17, P1461, DOI 10.1038/nsmb.1943; Baur JA, 2001, SCIENCE, V292, P2075, DOI 10.1126/science.1062329; Burge S, 2006, NUCLEIC ACIDS RES, V34, P5402, DOI 10.1093/nar/gkl655; Cesare AJ, 2010, NAT REV GENET, V11, P319, DOI 10.1038/nrg2763; Choi E, 2009, EMBO J, V28, P2077, DOI 10.1038/emboj.2009.123; Cimino-Reale G, 2003, J BIOL CHEM, V278, P2136, DOI 10.1074/jbc.M208939200; Cimino-Reale G, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.7.e35; DADDA DF, 2003, NATURE, V426, P194, DOI DOI 10.1038/NATURE02118; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Dimitrova DS, 2000, NAT CELL BIOL, V2, P686, DOI 10.1038/35036309; Durkin SG, 2008, P NATL ACAD SCI USA, V105, P246, DOI 10.1073/pnas.0708097105; Durkin SG, 2007, ANNU REV GENET, V41, P169, DOI 10.1146/annurev.genet.41.042007.165900; Durocher D, 2001, CURR OPIN CELL BIOL, V13, P225, DOI 10.1016/S0955-0674(00)00201-5; Gilson E, 2007, NAT REV MOL CELL BIO, V8, P825, DOI 10.1038/nrm2259; Gohler T, 2011, J CELL BIOL, V192, P219, DOI 10.1083/jcb.201008076; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Hackett JA, 2002, ONCOGENE, V21, P619, DOI 10.1038/sj.onc.1205061; Hashimoto Y, 2010, NAT STRUCT MOL BIOL, V17, P1305, DOI 10.1038/nsmb.1927; Hemann MT, 1999, NUCLEIC ACIDS RES, V27, P3964, DOI 10.1093/nar/27.20.3964; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Ijpma AS, 2003, MOL BIOL CELL, V14, P987, DOI 10.1091/mbc.02-04-0057; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Lekomtsev S, 2010, J CELL SCI, V123, P1395, DOI 10.1242/jcs.068015; Liu QH, 2000, GENE DEV, V14, P1448; Lomonosov M, 2003, GENE DEV, V17, P3017, DOI 10.1101/gad.279003; Londono-Vallejo JA, 2004, CANCER RES, V64, P2324, DOI 10.1158/0008-5472.CAN-03-4035; Longhese MP, 2008, GENE DEV, V22, P125, DOI 10.1101/gad.1626908; Maizels N, 2008, CURR BIOL, V18, pR613, DOI 10.1016/j.cub.2008.06.011; McGowan CH, 2004, CURR OPIN CELL BIOL, V16, P629, DOI 10.1016/j.ceb.2004.09.005; Melchionna R, 2000, NAT CELL BIOL, V2, P762, DOI 10.1038/35036406; Morrish TA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000357; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; Opresko PL, 2005, J BIOL CHEM, V280, P32069, DOI 10.1074/jbc.M505211200; Paeschke K, 2011, CELL, V145, P678, DOI 10.1016/j.cell.2011.04.015; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Patel KJ, 1998, MOL CELL, V1, P347, DOI 10.1016/S1097-2765(00)80035-0; Paulsen RD, 2007, DNA REPAIR, V6, P953, DOI 10.1016/j.dnarep.2007.02.015; Pellegrini L, 2004, TRENDS BIOCHEM SCI, V29, P310, DOI 10.1016/j.tibs.2004.04.009; Petermann E, 2010, MOL CELL, V37, P492, DOI 10.1016/j.molcel.2010.01.021; Poon Steven S S, 2001, Curr Protoc Cell Biol, VChapter 18, DOI 10.1002/0471143030.cb1804s12; Rizzo A, 2009, NUCLEIC ACIDS RES, V37, P5353, DOI 10.1093/nar/gkp582; ROSCHE WA, 1995, J BACTERIOL, V177, P4385, DOI 10.1128/jb.177.15.4385-4391.1995; Schlacher K, 2011, CELL, V145, P529, DOI 10.1016/j.cell.2011.03.041; Schwartz M, 2005, GENE DEV, V19, P2715, DOI 10.1101/gad.340905; Sfeir A, 2009, CELL, V138, P90, DOI 10.1016/j.cell.2009.06.021; Shiloh Y, 2001, CURR OPIN GENET DEV, V11, P71, DOI 10.1016/S0959-437X(00)00159-3; Shiloh Y, 2001, BIOCHEM SOC T, V29, P661, DOI 10.1042/0300-5127:0290661; Skoulidis F, 2010, CANCER CELL, V18, P499, DOI 10.1016/j.ccr.2010.10.015; SMITH FW, 1992, NATURE, V356, P164, DOI 10.1038/356164a0; Stewart SA, 2003, NAT GENET, V33, P492, DOI 10.1038/ng1127; Sun H, 1998, J BIOL CHEM, V273, P27587, DOI 10.1074/jbc.273.42.27587; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Tavtigian SV, 1996, NAT GENET, V12, P333, DOI 10.1038/ng0396-333; TRINH TQ, 1991, NATURE, V352, P544, DOI 10.1038/352544a0; Venkitaraman AR, 2004, NAT REV CANCER, V4, P266, DOI 10.1038/nrc1321; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Venkitaraman AR, 2009, ANNU REV PATHOL-MECH, V4, P461, DOI 10.1146/annurev.pathol.3.121806.151422; Verdun RE, 2007, NATURE, V447, P924, DOI 10.1038/nature05976; Verdun RE, 2006, CELL, V127, P709, DOI 10.1016/j.cell.2006.09.034; Wang B, 2002, SCIENCE, V298, P1435, DOI 10.1126/science.1076182; Wang YS, 2005, P NATL ACAD SCI USA, V102, P10256, DOI 10.1073/pnas.0504635102; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Williams E. S., 2009, COLD SPRING HARB PRO; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; Wu X, 2001, NUCLEIC ACIDS RES, V29, P1765, DOI 10.1093/nar/29.8.1765; Wu YL, 2008, MOL CELL BIOL, V28, P4116, DOI 10.1128/MCB.02210-07; Yang Q, 2005, MOL CELL BIOL, V25, P1070, DOI 10.1128/MCB.25.3.1070-1080.2005; Yang XH, 2008, GENE DEV, V22, P1147, DOI 10.1101/gad.1632808; Yu VPCC, 2000, GENE DEV, V14, P1400; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001	71	32	33	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					5091	5101		10.1074/jbc.M111.278994	http://dx.doi.org/10.1074/jbc.M111.278994			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22187435	hybrid, Green Published			2022-12-27	WOS:000300608500067
J	Uchida, H; Maruyama, T; Nishikawa-Uchida, S; Oda, H; Miyazaki, K; Yamasaki, A; Yoshimura, Y				Uchida, Hiroshi; Maruyama, Tetsuo; Nishikawa-Uchida, Sayaka; Oda, Hideyuki; Miyazaki, Kaoru; Yamasaki, Akiko; Yoshimura, Yasunori			Studies Using an in Vitro Model Show Evidence of Involvement of Epithelial-Mesenchymal Transition of Human Endometrial Epithelial Cells in Human Embryo Implantation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENOCARCINOMA CELLS; UP-REGULATION; GLYCODELIN; APOPTOSIS; ADHESION; DIFFERENTIATION; TROPHOBLAST; EXPRESSION; MIGRATION; CADHERINS	Human embryo implantation is a critical multistep process consisting of embryo apposition/adhesion, followed by penetration and invasion. Through embryo penetration, the endometrial epithelial cell barrier is disrupted and remodeled by an unknown mechanism. We have previously developed an in vitro model for human embryo implantation employing the human choriocarcinoma cell line JAR and the human endometrial adenocarcinoma cell line Ishikawa. Using this model we have shown that stimulation with ovarian steroid hormones (17 beta-estradiol and progesterone, E2P4) and suberoylanilide hydroxamic acid (SAHA), a histone deacetylase inhibitor, enhances the attachment and adhesion of JAR spheroids to Ishikawa. In the present study we showed that the attachment and adhesion of JAR spheroids and treatment with E2P4 or SAHA individually induce the epithelial-mesenchymal transition (EMT) in Ishikawa cells. This was evident by up-regulation of N-cadherin and vimentin, a mesenchymal cell marker, and concomitant down-regulation of E-cadherin in Ishikawa cells. Stimulation with E2P4 or SAHA accelerated Ishikawa cell motility, increased JAR spheroid outgrowth, and enhanced the unique redistribution of N-cadherin, which was most prominent in proximity to the adhered spheroids. Moreover, an N-cadherin functional blocking antibody attenuated all events but not JAR spheroid adhesion. These results collectively provide evidence suggesting that E2P4- and implanting embryo-induced EMT of endometrial epithelial cells may play a pivotal role in the subsequent processes of human embryo implantation with functional control of N-cadherin.	[Uchida, Hiroshi; Maruyama, Tetsuo; Nishikawa-Uchida, Sayaka; Oda, Hideyuki; Miyazaki, Kaoru; Yamasaki, Akiko; Yoshimura, Yasunori] Keio Univ, Sch Med, Dept Obstet & Gynecol, Shinjuku Ku, Tokyo 1608582, Japan	Keio University	Uchida, H (corresponding author), Keio Univ, Sch Med, Dept Obstet & Gynecol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	uchida@a5.keio.jp			Japan Society for the Promotion of Science [21592108]; Kanzawa Medical Research Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Kanzawa Medical Research Foundation(Kanzawa Medical Research Foundation)	This work was supported in part by Grant-in-aid for Scientific Research C 21592108 (to H. U.) from the Japan Society for the Promotion of Science and by grants from the Kanzawa Medical Research Foundation (to H. U.).	Achache H, 2006, HUM REPROD UPDATE, V12, P731, DOI 10.1093/humupd/dml004; Anastasiadis PZ, 2001, CURR OPIN CELL BIOL, V13, P604, DOI 10.1016/S0955-0674(00)00258-1; Berger SL, 2002, CURR OPIN GENET DEV, V12, P142, DOI 10.1016/S0959-437X(02)00279-4; Galan A, 2000, BIOL REPROD, V63, P430, DOI 10.1093/biolreprod/63.2.430; Grewal S, 2008, P NATL ACAD SCI USA, V105, P16189, DOI 10.1073/pnas.0806219105; Hannan NJ, 2010, BIOL REPROD, V82, P235, DOI 10.1095/biolreprod.109.077800; Hay ED, 1995, ACTA ANAT, V154, P8; Hazan RB, 2004, ANN NY ACAD SCI, V1014, P155, DOI 10.1196/annals.1294.016; Hohn HP, 2000, MOL REPROD DEV, V57, P135; Kamijo T, 1998, MOL HUM REPROD, V4, P990, DOI 10.1093/molehr/4.10.990; Kao LC, 2002, ENDOCRINOLOGY, V143, P2119, DOI 10.1210/en.143.6.2119; Li HY, 2003, BIOL REPROD, V69, P1515, DOI 10.1095/biolreprod.103.015669; Nishida Masato, 2002, Hum Cell, V15, P104, DOI 10.1111/j.1749-0774.2002.tb00105.x; Norwitz ER, 2001, NEW ENGL J MED, V345, P1400, DOI 10.1056/NEJMra000763; Simon C, 2001, ANN NY ACAD SCI, V943, P1; TAKEICHI M, 1990, ANNU REV BIOCHEM, V59, P237, DOI 10.1146/annurev.biochem.59.1.237; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Uchida H, 2005, ENDOCRINOLOGY, V146, P5365, DOI 10.1210/en.2005-0359; Uchida H, 2007, HUM REPROD, V22, P2615, DOI 10.1093/humrep/dem263; Uchida H, 2007, ENDOCRINOLOGY, V148, P896, DOI 10.1210/en.2006-0896; VANDERLINDEN PJQ, 1995, FERTIL STERIL, V63, P1210, DOI 10.1016/S0015-0282(16)57599-2; VLEMINCKX K, 1991, CELL, V66, P107, DOI 10.1016/0092-8674(91)90143-M; Wheelock MJ, 2003, CURR OPIN CELL BIOL, V15, P509, DOI 10.1016/S0955-0674(03)00101-7	23	60	64	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4441	4450		10.1074/jbc.M111.286138	http://dx.doi.org/10.1074/jbc.M111.286138			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22174415	Green Published, hybrid			2022-12-27	WOS:000300608500008
J	Beauchef, G; Bigot, N; Kypriotou, M; Renard, E; Poree, B; Widom, R; Dompmartin-Blanchere, A; Oddos, T; Maquart, FX; Demoor, M; Boumediene, K; Galera, P				Beauchef, Gallic; Bigot, Nicolas; Kypriotou, Magdalini; Renard, Emmanuelle; Poree, Benoit; Widom, Russell; Dompmartin-Blanchere, Anne; Oddos, Thierry; Maquart, Francois-Xavier; Demoor, Magali; Boumediene, Karim; Galera, Philippe			The p65 Subunit of NF-kappa B Inhibits COL1A1 Gene Transcription in Human Dermal and Scleroderma Fibroblasts through Its Recruitment on Promoter by Protein Interaction with Transcriptional Activators (c-Krox, Sp1, and Sp3)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; HEPATIC STELLATE CELLS; PROCOLLAGEN MESSENGER-RNA; GROWTH-FACTOR BETA(1); I COLLAGEN GENE; TNF-ALPHA; TGF-BETA; REPRESSES TRANSCRIPTION; DEPENDENT MECHANISM; BINDING SITES	Transcriptional mechanisms regulating type I collagen genes expression in physiopathological situations are not completely known. In this study, we have investigated the role of nuclear factor-kappa B (NF-kappa B) transcription factor on type I collagen expression in adult normal human (ANF) and scleroderma (SF) fibroblasts. We demonstrated that NF-kappa B, a master transcription factor playing a major role in immune response/apoptosis, down-regulates COL1A1 expression by a transcriptional control involving the -112/-61 bp sequence. This 51-bp region mediates the action of two zinc fingers, Sp1 (specific protein-1) and Sp3, acting as trans-activators of type I collagen expression in ANF and SF. Knockdown of each one of these trans factors by siRNA confirmed the trans-activating effect of Sp1/Sp3 and the p65 subunit of NF-kappa B trans-inhibiting effect on COL1A1 expression. Despite no existing kappa B consensus sequence in the COL1A1 promoter, we found that Sp1/Sp3/c-Krox and NF-kappa B bind and/or are recruited on the proximal promoter in chromatin immunoprecipitation (ChIP) assays. Attempts to elucidate whether interactions between Sp1/Sp3/c-Krox and p65 are necessary to mediate the NF-kappa B inhibitory effect on COL1A1 in ANF and SF were carried out; in this regard, immunoprecipitation assays revealed that they interact, and this was validated by re-ChIP. Finally, the knockdown of Sp1/Sp3/c-Krox prevents the p65 inhibitory effect on COL1A1 transcription in ANF, whereas only the siRNAs targeting Sp3 and c-Krox provoked the same effect in SF, suggesting that particular interactions are characteristic of the scleroderma phenotype. In conclusion, our findings highlight a new mechanism for COL1A1 transcriptional regulation by NF-kappa B, and these data could allow the development of new antifibrotic strategies.	[Beauchef, Gallic; Bigot, Nicolas; Kypriotou, Magdalini; Renard, Emmanuelle; Poree, Benoit; Demoor, Magali; Boumediene, Karim; Galera, Philippe] Univ Caen Basse Normandie, Lab Matrice Extracellulaire & Pathol, IFR ICORE 146, UFR Med,CHU Niveau 3, F-14032 Caen, France; [Widom, Russell] Boston Univ, Sch Med, Dept Med, Arthrit Ctr, Boston, MA 02118 USA; [Widom, Russell] Boston Vet Affairs Med Ctr, Boston, MA 02118 USA; [Dompmartin-Blanchere, Anne] CHR, Serv Dermatol, F-14032 Caen, France; [Oddos, Thierry] R&D Europe, Johnson & Johnson Consumer France, F-27106 Val De Reuil, France; [Maquart, Francois-Xavier] Univ Reims, Lab Biochim Med & Biol Mol, UMR CNRS URCA 6237, F-51095 Reims, France	CHU de Caen NORMANDIE; Universite de Caen Normandie; Boston University; CHU de Caen NORMANDIE; Johnson & Johnson; Universite de Reims Champagne-Ardenne	Galera, P (corresponding author), Univ Caen Basse Normandie, Lab Matrice Extracellulaire & Pathol, IFR ICORE 146, UFR Med,CHU Niveau 3, Ave Cote Nacre, F-14032 Caen, France.	philippe.galera@unicaen.fr		Bigot, Nicolas/0000-0002-4247-0217; BOUMEDIENE, Karim/0000-0001-6517-8318	Regional Council of Lower Normandy; French Ministry of Regional Development; Johnson & Johnson Consumer France	Regional Council of Lower Normandy(Region Normandie); French Ministry of Regional Development; Johnson & Johnson Consumer France	This work was supported by the Regional Council of Lower Normandy, the French Ministry of Regional Development, and Johnson & Johnson Consumer France.	ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Aoki T, 2009, ARTERIOSCL THROM VAS, V29, P1080, DOI 10.1161/ATVBAHA.108.180760; Artlett CM, 1998, MATRIX BIOL, V17, P425, DOI 10.1016/S0945-053X(98)90102-0; Ashburner BP, 2001, MOL CELL BIOL, V21, P7065, DOI 10.1128/MCB.21.20.7065-7077.2001; Azakie A, 2006, AM J PHYSIOL-HEART C, V291, pH600, DOI 10.1152/ajpheart.01305.2005; Baeuerle PA, 1997, ADV IMMUNOL, V65, P111, DOI 10.1016/S0065-2776(08)60742-7; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; BAEUERLE PA, 1991, BIOCHIM BIOPHYS ACTA, V1072, P63, DOI 10.1016/0304-419X(91)90007-8; Bitzer M, 2000, GENE DEV, V14, P187; Buss H, 2004, J BIOL CHEM, V279, P49571, DOI 10.1074/jbc.C400442200; Chen LF, 2003, J MOL MED, V81, P549, DOI 10.1007/s00109-003-0469-0; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Chun JY, 2007, MOL CANCER THER, V6, P2572, DOI 10.1158/1535-7163.MCT-07-0172; Dechend R, 1999, ONCOGENE, V18, P3316, DOI 10.1038/sj.onc.1202717; DeLuca P, 1996, J BIOL CHEM, V271, P8533, DOI 10.1074/jbc.271.15.8533; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; FRANZOSO G, 1992, NATURE, V359, P339, DOI 10.1038/359339a0; Gao ZG, 2005, J BIOL CHEM, V280, P21091, DOI 10.1074/jbc.M500754200; Garcia-Trevijano ER, 1999, HEPATOLOGY, V29, P960, DOI 10.1002/hep.510290346; Ghayor C, 2001, J BIOL CHEM, V276, P36881, DOI 10.1074/jbc.M105083200; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; GOLDBERG H, 1992, J BIOL CHEM, V267, P19622; Greene Warner C, 2004, Novartis Found Symp, V259, P208; He SH, 2005, MOL BIOL CELL, V16, P4073, DOI 10.1091/mbc.e05-05-0388; Hitraya EG, 1998, ARTHRITIS RHEUM-US, V41, P2048, DOI 10.1002/1529-0131(199811)41:11<2048::AID-ART21>3.0.CO;2-X; Ihn H, 2000, ARTHRITIS RHEUM, V43, P2240, DOI 10.1002/1529-0131(200010)43:10<2240::AID-ANR11>3.0.CO;2-2; Ihn H, 1997, J BIOL CHEM, V272, P24666, DOI 10.1074/jbc.272.39.24666; Ihn H, 1997, NUCLEIC ACIDS RES, V25, P3712, DOI 10.1093/nar/25.18.3712; INAGAKI Y, 1995, J BIOL CHEM, V270, P3353, DOI 10.1074/jbc.270.7.3353; Iraburu MJ, 2000, HEPATOLOGY, V31, P1086, DOI 10.1053/he.2000.5981; JIMENEZ SA, 1994, J BIOL CHEM, V269, P12684; Jimenez SA, 1996, RHEUM DIS CLIN N AM, V22, P647, DOI 10.1016/S0889-857X(05)70294-5; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kim JM, 2004, CLIN EXP IMMUNOL, V137, P341, DOI 10.1111/j.1365-2249.2004.02542.x; Kouba DJ, 1999, J IMMUNOL, V162, P4226; Kum YS, 2007, BIOCHEM BIOPH RES CO, V363, P368, DOI 10.1016/j.bbrc.2007.08.176; Kurland JF, 2001, J BIOL CHEM, V276, P45380, DOI 10.1074/jbc.M108294200; Kypriotou M, 2007, J BIOL CHEM, V282, P32000, DOI 10.1074/jbc.M705197200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu Y, 2006, EXP EYE RES, V83, P560, DOI 10.1016/j.exer.2006.02.008; MAJELLO B, 1995, ONCOGENE, V10, P1841; Majello B, 1997, J BIOL CHEM, V272, P4021, DOI 10.1074/jbc.272.7.4021; Marshall HE, 2000, FASEB J, V14, P1889, DOI 10.1096/fj.00.011rev; Mori K, 1996, BIOCHEM J, V319, P811, DOI 10.1042/bj3190811; Okamoto T, 1997, CURR TOP CELL REGUL, V35, P149, DOI 10.1016/S0070-2137(97)80006-4; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; PETERKOFSKY B, 1971, BIOCHEMISTRY-US, V10, P988, DOI 10.1021/bi00782a009; Quivy V, 2004, BIOCHEM PHARMACOL, V68, P1221, DOI 10.1016/j.bcp.2004.05.039; RAMIREZ F, 1990, FASEB J, V4, P1616, DOI 10.1096/fasebj.4.6.2180769; Reuter U, 2002, ANN NEUROL, V51, P507, DOI 10.1002/ana.10159; Rippe RA, 1999, DNA CELL BIOL, V18, P751, DOI 10.1089/104454999314890; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; SCHMITZ ML, 1995, J BIOL CHEM, V270, P7219, DOI 10.1074/jbc.270.13.7219; Schreiber J, 2005, SURGERY, V138, P940, DOI 10.1016/j.surg.2005.05.020; SOLISHERRUZO JA, 1988, J BIOL CHEM, V263, P5841; TAMAKI T, 1995, J BIOL CHEM, V270, P4299, DOI 10.1074/jbc.270.9.4299; Tassorelli C, 2005, CEPHALALGIA, V25, P612, DOI 10.1111/j.1468-2982.2005.00915.x; Teunissen BEJ, 2002, BIOCHEM BIOPH RES CO, V292, P71, DOI 10.1006/bbrc.2002.6621; Trojanowska M, 1998, J MOL MED, V76, P266, DOI 10.1007/s001090050216; Udalova IA, 2000, MOL CELL BIOL, V20, P9113, DOI 10.1128/MCB.20.24.9113-9119.2000; URBAN MB, 1991, NEW BIOL, V3, P279; Varela-Rey M, 2002, FEBS LETT, V528, P133, DOI 10.1016/S0014-5793(02)03276-3; Vermes C, 2000, J BONE MINER RES, V15, P1756, DOI 10.1359/jbmr.2000.15.9.1756; Verrecchia F, 2004, CELL SIGNAL, V16, P873, DOI 10.1016/j.cellsig.2004.02.007; Verrecchia F, 2001, J INVEST DERMATOL, V116, P755, DOI 10.1046/j.1523-1747.2001.01326.x; VUORIO E, 1990, ANNU REV BIOCHEM, V59, P837, DOI 10.1146/annurev.bi.59.070190.004201; Wang J, 2005, J NEUROCHEM, V93, P474, DOI 10.1111/j.1471-4159.2005.03051.x; Yamane K, 2003, J IMMUNOL, V171, P3855, DOI 10.4049/jimmunol.171.7.3855; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6; Zhou A, 2003, ONCOGENE, V22, P2054, DOI 10.1038/sj.onc.1206262; Zhu NL, 2007, GENE, V393, P70, DOI 10.1016/j.gene.2007.01.016	73	40	43	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3462	3478		10.1074/jbc.M111.286443	http://dx.doi.org/10.1074/jbc.M111.286443			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22139845	Green Published, hybrid			2022-12-27	WOS:000300295100051
J	Piacente, F; Marin, M; Molinaro, A; De Castro, C; Seltzer, V; Salis, A; Damonte, G; Bernardi, C; Claverie, JM; Abergel, C; Tonetti, M				Piacente, Francesco; Marin, Margherita; Molinaro, Antonio; De Castro, Cristina; Seltzer, Virginie; Salis, Annalisa; Damonte, Gianluca; Bernardi, Cinzia; Claverie, Jean-Michel; Abergel, Chantal; Tonetti, Michela			Giant DNA Virus Mimivirus Encodes Pathway for Biosynthesis of Unusual Sugar 4-Amino-4,6-dideoxy-D-glucose (Viosamine)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHIGELLA-DYSENTERIAE TYPE-7; FRANCISELLA-TULARENSIS; PHYLOGENETIC ANALYSIS; ESCHERICHIA-COLI; GENOME; RHAMNOSE; PROTEIN; ENZYME; GLYCOSYLTRANSFERASE; EXOPOLYSACCHARIDES	Mimivirus is one the largest DNA virus identified so far, infecting several Acanthamoeba species. Analysis of its genome revealed the presence of a nine-gene cluster containing genes potentially involved in glycan formation. All of these genes are co-expressed at late stages of infection, suggesting their role in the formation of the long fibers covering the viral surface. Among them, we identified the L136 gene as a pyridoxal phosphate-dependent sugar aminotransferase. This enzyme was shown to catalyze the formation of UDP-4-amino-4,6-dideoxy-D-glucose (UDP-viosamine) from UDP-4-keto-6-deoxy-D-glucose, a key compound involved also in the biosynthesis of L-rhamnose. This finding further supports the hypothesis that Mimivirus encodes a glycosylation system that is completely independent of the amoebal host. Viosamine, together with rhamnose, (N-acetyl) glucosamine, and glucose, was found as a major component of the viral glycans. Most of the sugars were associated with the fibers, confirming a capsular-like nature of the viral surface. Phylogenetic analysis clearly indicated that L136 was not a recent acquisition from bacteria through horizontal gene transfer, but it was acquired very early during evolution. Implications for the origin of the glycosylation machinery in giant DNA virus are also discussed.	[Seltzer, Virginie; Claverie, Jean-Michel; Abergel, Chantal] Aix Marseille Univ, CNRS UPR 2589, Inst Microbiol Mediterranee, FR-13288 Marseille, France; [Piacente, Francesco; Marin, Margherita; Salis, Annalisa; Damonte, Gianluca; Bernardi, Cinzia; Tonetti, Michela] Univ Genoa, Ctr Excellence Biomed Res, I-16132 Genoa, Italy; [Piacente, Francesco; Marin, Margherita; Salis, Annalisa; Damonte, Gianluca; Bernardi, Cinzia; Tonetti, Michela] Univ Genoa, Dept Expt Med, I-16132 Genoa, Italy; [Molinaro, Antonio; De Castro, Cristina] Univ Naples Federico II, Dept Organ Chem & Biochem, Naples, Italy	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; University of Genoa; University of Genoa; University of Naples Federico II	Abergel, C (corresponding author), Aix Marseille Univ, CNRS UPR 2589, Inst Microbiol Mediterranee, Parc Sci Luminy,Case 934, FR-13288 Marseille, France.	Chantal.Abergel@igs.cnrs-mrs.fr; tonetti@unige.it	Tonetti, Michela/F-3039-2018; De Castro, Cristina/I-5899-2012; Piacente, Francesco/J-8295-2016; TONETTI, MICHELA/AAF-3404-2021; Claverie, Jean-Michel/AAG-4889-2019; Claverie, Jean Michel/Z-2183-2019; Bernardi, Cinzia/K-3416-2018; Molinaro, Antonio/J-1866-2012; Salis, Annalisa/R-9241-2018	De Castro, Cristina/0000-0002-5147-1756; Piacente, Francesco/0000-0001-5470-5987; TONETTI, MICHELA/0000-0002-8829-7173; Claverie, Jean-Michel/0000-0003-1424-0315; Bernardi, Cinzia/0000-0001-9342-5929; Abergel, Chantal/0000-0003-1875-4049; Molinaro, Antonio/0000-0002-3456-7369; Salis, Annalisa/0000-0002-3082-2908	CNRS, Agence Nationale de la Recherche [ANRBLAN08-0089]	CNRS, Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by CNRS, Agence Nationale de la Recherche, Grant ANRBLAN08-0089.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arslan D, 2011, P NATL ACAD SCI USA, V108, P17486, DOI 10.1073/pnas.1110889108; Badger J, 2005, PROTEINS, V60, P787, DOI 10.1002/prot.20541; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Boyer M, 2011, P NATL ACAD SCI USA, V108, P10296, DOI 10.1073/pnas.1101118108; Burgie ES, 2007, BIOCHEMISTRY-US, V46, P8999, DOI 10.1021/bi700751d; Byrne D, 2009, GENOME RES, V19, P1233, DOI 10.1101/gr.091561.109; Chothi MP, 2010, J VIROL, V84, P8829, DOI 10.1128/JVI.00770-10; Claverie JM, 2010, TRENDS GENET, V26, P431, DOI 10.1016/j.tig.2010.07.003; Cook PD, 2008, BIOCHEMISTRY-US, V47, P10685, DOI 10.1021/bi801309q; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dereeper A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-8; Dong SL, 2010, J BACTERIOL, V192, P5053, DOI 10.1128/JB.00568-10; Drsata J, 2005, J PHARMACEUT BIOMED, V37, P1173, DOI 10.1016/j.jpba.2004.10.004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fischer MG, 2010, P NATL ACAD SCI USA, V107, P19508, DOI 10.1073/pnas.1007615107; Fruscione F, 2008, J BIOL CHEM, V283, P184, DOI 10.1074/jbc.M706614200; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Herasimenka Y, 2007, CARBOHYD RES, V342, P2404, DOI 10.1016/j.carres.2007.07.012; Hwang BY, 2004, CHEM BIOL, V11, P915, DOI 10.1016/j.chembiol.2004.04.015; Ivashina TV, 2010, J APPL MICROBIOL, V109, P731, DOI 10.1111/j.1365-2672.2010.04702.x; Iyer LA, 2006, VIRUS RES, V117, P156, DOI 10.1016/j.virusres.2006.01.009; JANN B, 1967, EUR J BIOCHEM, V2, P26, DOI 10.1111/j.1432-1033.1967.tb00100.x; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; KNIREL YA, 1988, CARBOHYD RES, V179, P51, DOI 10.1016/0008-6215(88)84109-0; Kondakova AN, 2011, CARBOHYD RES, V346, P1951, DOI 10.1016/j.carres.2011.05.019; Kubler-Kielb J., 2008, P NATL ACAD SCI USA, V105, P8709; Kuznetsov YG, 2010, VIROLOGY, V404, P127, DOI 10.1016/j.virol.2010.05.007; Legendre M, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-99; Leone S, 2007, MAR DRUGS, V5, P85, DOI 10.3390/md503085; Lewis AL, 2006, J BIOL CHEM, V281, P11186, DOI 10.1074/jbc.M513772200; Luther KB, 2011, J BIOL CHEM, V286, P43701, DOI 10.1074/jbc.M111.309096; Manzi A., 2001, CURR PROTOC MOL BIOL, V17; Mutsafi Y, 2010, P NATL ACAD SCI USA, V107, P5978, DOI 10.1073/pnas.0912737107; Nazarenko EL, 2003, CARBOHYD RES, V338, P2449, DOI 10.1016/j.carres.2003.06.004; Pelletier N, 2009, FEMS MICROBIOL LETT, V297, P117, DOI 10.1111/j.1574-6968.2009.01675.x; PIANTINI U, 1982, J AM CHEM SOC, V104, P6800, DOI 10.1021/ja00388a062; Pieper U, 2011, NUCLEIC ACIDS RES, V39, pD465, DOI 10.1093/nar/gkq1091; Poli A, 2010, MAR DRUGS, V8, P1779, DOI 10.3390/md8061779; RANCE M, 1983, BIOCHEM BIOPH RES CO, V117, P479, DOI 10.1016/0006-291X(83)91225-1; Raoult D, 2004, SCIENCE, V306, P1344, DOI 10.1126/science.1101485; Renesto P, 2006, J VIROL, V80, P11678, DOI 10.1128/JVI.00940-06; Sharon N, 2007, GLYCOBIOLOGY, V17, P1150, DOI 10.1093/glycob/cwm089; STATES DJ, 1982, J MAGN RESON, V48, P286, DOI 10.1016/0022-2364(82)90279-7; Sun LW, 1999, VIROLOGY, V263, P376, DOI 10.1006/viro.1999.9958; Takeuchi K, 2007, J BACTERIOL, V189, P6945, DOI 10.1128/JB.00500-07; Tonetti M, 2003, J BIOL CHEM, V278, P21559, DOI 10.1074/jbc.M301543200; Van Etten JL, 2010, BBA-GEN SUBJECTS, V1800, P152, DOI 10.1016/j.bbagen.2009.07.024; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Wang Y, 2007, J BACTERIOL, V189, P8626, DOI 10.1128/JB.00777-07; Xiao C, 2009, PLOS BIOL, V7, P958, DOI 10.1371/journal.pbio.1000092; Zhang Y, 2007, STRUCTURE, V15, P1031, DOI 10.1016/j.str.2007.07.006	53	34	34	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3009	3018		10.1074/jbc.M111.314559	http://dx.doi.org/10.1074/jbc.M111.314559			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22157758	Green Published, hybrid			2022-12-27	WOS:000300295100008
J	Taylor, CB; Talib, MF; McCabe, C; Bu, LT; Adney, WS; Himmel, ME; Crowley, MF; Beckham, GT				Taylor, Courtney B.; Talib, M. Faiz; McCabe, Clare; Bu, Lintao; Adney, William S.; Himmel, Michael E.; Crowley, Michael F.; Beckham, Gregg T.			Computational Investigation of Glycosylation Effects on a Family 1 Carbohydrate-binding Module	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FREE-ENERGY CALCULATIONS; CELLULOSE-BINDING; CELLOBIOHYDROLASE-I; MOLECULAR-DYNAMICS; MICROCRYSTALLINE CELLULOSE; CRYSTAL-STRUCTURE; O-GLYCOSYLATION; AMINO-ACIDS; AFFINITY; DOMAIN	Carbohydrate-binding modules (CBMs) are ubiquitous components of glycoside hydrolases, which degrade polysaccharides in nature. CBMs target specific polysaccharides, and CBM binding affinity to cellulose is known to be proportional to cellulase activity, such that increasing binding affinity is an important component of performance improvement. To ascertain the impact of protein and glycan engineering on CBM binding, we use molecular simulation to quantify cellulose binding of a natively glycosylated Family 1 CBM. To validate our approach, we first examine aromatic-carbohydrate interactions on binding, and our predictions are consistent with previous experiments, showing that a tyrosine to tryptophan mutation yields a 2-fold improvement in binding affinity. We then demonstrate that enhanced binding of 3-6-fold over a nonglycosylated CBM is achieved by the addition of a single, native mannose or a mannose dimer, respectively, which has not been considered previously. Furthermore, we show that the addition of a single, artificial glycan on the anterior of the CBM, with the native, posterior glycans also present, can have a dramatic impact on binding affinity in our model, increasing it up to 140-fold relative to the nonglycosylated CBM. These results suggest new directions in protein engineering, in that modifying glycosylation patterns via heterologous expression, manipulation of culture conditions, or introduction of artificial glycosylation sites, can alter CBM binding affinity to carbohydrates and may thus be a general strategy to enhance cellulase performance. Our results also suggest that CBM binding studies should consider the effects of glycosylation on binding and function.	[Taylor, Courtney B.; Talib, M. Faiz; McCabe, Clare] Vanderbilt Univ, Dept Chem & Biomol Engn, Nashville, TN 37235 USA; [McCabe, Clare] Vanderbilt Univ, Dept Chem, Nashville, TN 37235 USA; [Bu, Lintao; Beckham, Gregg T.] Natl Renewable Energy Lab, Natl Bioenergy Ctr, Golden, CO 80401 USA; [Adney, William S.; Himmel, Michael E.; Crowley, Michael F.] Natl Renewable Energy Lab, Biosci Ctr, Golden, CO 80401 USA; [Beckham, Gregg T.] Colorado Sch Mines, Dept Chem Engn, Golden, CO 80401 USA	Vanderbilt University; Vanderbilt University; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; Colorado School of Mines	McCabe, C (corresponding author), Vanderbilt Univ, Dept Chem & Biomol Engn, 221 Kirkland Hall, Nashville, TN 37235 USA.	c.mccabe@vanderbilt.edu; Gregg.Beckham@nrel.gov	crowley, michael F/A-4852-2013; McCabe, Clare/I-8017-2012	crowley, michael F/0000-0001-5163-9398; McCabe, Clare/0000-0002-8552-9135	United States Department of Energy Office of the Biomass Program; National Institute for Computational Sciences Athena and Kraken clusters under National Science Foundation [MCB090159]; National Energy Research Scientific Computing Center; Office of Science of the United States Department of Energy [DE-AC02-05CH11231]	United States Department of Energy Office of the Biomass Program(United States Department of Energy (DOE)); National Institute for Computational Sciences Athena and Kraken clusters under National Science Foundation; National Energy Research Scientific Computing Center; Office of Science of the United States Department of Energy(United States Department of Energy (DOE))	This work was supported by the United States Department of Energy Office of the Biomass Program. Computer time was provided by the Texas Advanced Computing Center Ranger cluster and the National Institute for Computational Sciences Athena and Kraken clusters under National Science Foundation Teragrid Grant MCB090159, and the National Energy Research Scientific Computing Center, which is supported by the Office of Science of the United States Department of Energy under Contract No. DE-AC02-05CH11231.	Adney WS, 2009, CELLULOSE, V16, P699, DOI 10.1007/s10570-009-9305-1; Bansal P, 2009, BIOTECHNOL ADV, V27, P833, DOI 10.1016/j.biotechadv.2009.06.005; Beckham GT, 2011, CURR OPIN BIOTECH, V22, P231, DOI 10.1016/j.copbio.2010.11.005; Beckham GT, 2010, BIOPHYS J, V99, P3773, DOI 10.1016/j.bpj.2010.10.032; Beckham GT, 2010, J PHYS CHEM B, V114, P1447, DOI 10.1021/jp908810a; Blake AW, 2006, J BIOL CHEM, V281, P29321, DOI 10.1074/jbc.M605903200; Boraston AB, 2003, J MOL MICROB BIOTECH, V5, P29, DOI 10.1159/000068721; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Boraston AB, 2001, BIOCHEM J, V358, P423, DOI 10.1042/0264-6021:3580423; Boyce SE, 2009, J MOL BIOL, V394, P747, DOI 10.1016/j.jmb.2009.09.049; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Bu LT, 2009, J PHYS CHEM B, V113, P10994, DOI 10.1021/jp904003z; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chundawat S. P. S., 2011, ANNU REV CHEM BIOMOL, V2, P61; Creagh AL, 1996, P NATL ACAD SCI USA, V93, P12229, DOI 10.1073/pnas.93.22.12229; Deng YQ, 2009, J PHYS CHEM B, V113, P2234, DOI 10.1021/jp807701h; Deshpande N, 2008, GLYCOBIOLOGY, V18, P626, DOI 10.1093/glycob/cwn044; Divne C, 1998, J MOL BIOL, V275, P309, DOI 10.1006/jmbi.1997.1437; DIVNE C, 1994, SCIENCE, V265, P524, DOI 10.1126/science.8036495; DURELL SR, 1994, J PHYS CHEM-US, V98, P2198, DOI 10.1021/j100059a038; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Frenkel D., 2000, UNDERSTANDING MOL SI; Fujitani H, 2005, J CHEM PHYS, V123, DOI 10.1063/1.1999637; Guvench O, 2008, J COMPUT CHEM, V29, P2543, DOI 10.1002/jcc.21004; Guvench O, 2009, J CHEM THEORY COMPUT, V5, P2353, DOI 10.1021/ct900242e; Harrison MJ, 1998, EUR J BIOCHEM, V256, P119, DOI 10.1046/j.1432-1327.1998.2560119.x; Heinzelman P, 2009, J BIOL CHEM, V284, P26229, DOI 10.1074/jbc.C109.034058; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Horn SJ, 2006, P NATL ACAD SCI USA, V103, P18089, DOI 10.1073/pnas.0608909103; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Igarashi K, 2009, J BIOL CHEM, V284, P36186, DOI 10.1074/jbc.M109.034611; Jeoh T, 2008, BIOTECHNOL BIOFUELS, V1, DOI 10.1186/1754-6834-1-10; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kim TW, 2010, BIOTECHNOL BIOENG, V107, P601, DOI 10.1002/bit.22856; KOLLMAN P, 1993, CHEM REV, V93, P2395, DOI 10.1021/cr00023a004; KRAULIS PJ, 1989, BIOCHEMISTRY-US, V28, P7241, DOI 10.1021/bi00444a016; Lantz SE, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-20; Lehtio J, 2003, P NATL ACAD SCI USA, V100, P484, DOI 10.1073/pnas.212651999; Levine SE, 2010, BIOTECHNOL BIOENG, V107, P37, DOI 10.1002/bit.22789; LINDER M, 1995, PROTEIN SCI, V4, P1056, DOI 10.1002/pro.5560040604; LINDER M, 1995, FEBS LETT, V372, P96, DOI 10.1016/0014-5793(95)00961-8; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mobley DL, 2007, J MOL BIOL, V371, P1118, DOI 10.1016/j.jmb.2007.06.002; Mobley DL, 2007, J CHEM THEORY COMPUT, V3, P1231, DOI 10.1021/ct700032n; Nishiyama Y, 2002, J AM CHEM SOC, V124, P9074, DOI 10.1021/ja0257319; Paliwal H, 2011, J CHEM THEORY COMPUT, V7, P4115, DOI 10.1021/ct2003995; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pohorille A, 2010, J PHYS CHEM B, V114, P10235, DOI 10.1021/jp102971x; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Stals I, 2004, GLYCOBIOLOGY, V14, P713, DOI 10.1093/glycob/cwh080; Steinbrecher T, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2799191; Takashima S, 2007, FEBS LETT, V581, P5891, DOI 10.1016/j.febslet.2007.11.068; van Aalten DMF, 2000, P NATL ACAD SCI USA, V97, P5842, DOI 10.1073/pnas.97.11.5842; Varki A., 2009, ESSENTIALS GLYCOBIOL; Wang JY, 2006, BIOPHYS J, V91, P2798, DOI 10.1529/biophysj.106.084301; Wilson DB, 2009, CURR OPIN BIOTECH, V20, P295, DOI 10.1016/j.copbio.2009.05.007; Zhang YHP, 2006, BIOTECHNOL ADV, V24, P452, DOI 10.1016/j.biotechadv.2006.03.003; Zhao X, 2008, CHEM PHYS LETT, V460, P284, DOI 10.1016/j.cplett.2008.05.060; Zhong LH, 2009, CARBOHYD RES, V344, P1984, DOI 10.1016/j.carres.2009.07.005; Zhou W, 2009, BIOTECHNOL BIOENG, V104, P275, DOI 10.1002/bit.22388	62	52	54	0	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3147	3155		10.1074/jbc.M111.270389	http://dx.doi.org/10.1074/jbc.M111.270389			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22147693	hybrid, Green Published			2022-12-27	WOS:000300295100020
J	Dunn, CA; Su, V; Lau, AF; Lampe, PD				Dunn, Clarence A.; Su, Vivian; Lau, Alan. F.; Lampe, Paul D.			Activation of Akt, Not Connexin 43 Protein Ubiquitination, Regulates Gap Junction Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEASOME-DEPENDENT DEGRADATION; LIVER EPITHELIAL-CELLS; INTERCELLULAR COMMUNICATION; CELLULAR-DISTRIBUTION; DOWN-REGULATION; GROWTH-FACTOR; LIFE-CYCLE; PHOSPHORYLATION; KINASE; INHIBITION	The pore-forming gap junctional protein connexin 43 (Cx43) has a short (1-3 h) half-life in cells in tissue culture and in whole tissues. Although critical for cellular function in all tissues, the process of gap junction turnover is not well understood because treatment of cells with a proteasomal inhibitor results in larger gap junctions but little change in total Cx43 protein whereas lysosomal inhibitors increase total, mostly nonjunctional Cx43. To better understand turnover and identify potential sites of Cx43 ubiquitination, we prepared constructs of Cx43 with different lysines converted to arginines. However, when transfected into cells, a mutant version of Cx43 with all lysines converted to arginines behaved similarly to wild type in the presence of proteasomal and lysosomal inhibitors, indicating that ubiquitination of Cx43 did not appear to be playing a role in gap junction stability. Through the use of inhibitors and dominant negative constructs, we found that Akt (protein kinase B) activity controlled gap junction stability and was necessary to form larger stable gap junctions. Akt activation was increased upon proteasomal inhibition and resulted in phosphorylation of Cx43 at Akt phosphorylation consensus sites. Thus, we conclude that Cx43 ubiquitination is not necessary for the regulation of Cx43 turnover; rather, Akt activity, probably through direct phosphorylation of Cx43, controls gap junction stability. This linkage of a kinase involved in controlling cell survival and growth to gap junction stability may mechanistically explain how gap junctions and Akt play similar regulatory roles.	[Dunn, Clarence A.; Lampe, Paul D.] Fred Hutchinson Canc Res Ctr, Mol Diagnost Program, Seattle, WA 98109 USA; [Su, Vivian; Lau, Alan. F.] Univ Hawaii, Ctr Canc, Canc Biol Program, Honolulu, HI 96813 USA	Fred Hutchinson Cancer Center; Cancer Research Center of Hawaii; University of Hawaii System	Lampe, PD (corresponding author), Fred Hutchinson Canc Res Ctr, Mol Diagnost Program, M5-C800,1100 Fairview Ave N,Box 19024, Seattle, WA 98109 USA.	plampe@fhcrc.org			National Institutes of Health [GM55632-16, CA052098-18]; American Heart Association [11POST5460028]; NATIONAL CANCER INSTITUTE [R01CA052098, P30CA015704] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055632] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM55632-16 (to P. D. L.) and CA052098-18 (to A. F. L.). This work was also supported by American Heart Association Grant 11POST5460028 (to V. S.).	Adachi M, 2003, FEBS LETT, V554, P77, DOI 10.1016/S0014-5793(03)01109-8; Alessi DR, 1996, FEBS LETT, V399, P333, DOI 10.1016/S0014-5793(96)01370-1; ATKINSON MM, 1995, J CELL SCI, V108, P3079; Beardslee MA, 1998, CIRC RES, V83, P629, DOI 10.1161/01.RES.83.6.629; BERGOFFEN J, 1993, SCIENCE, V262, P2039, DOI 10.1126/science.8266101; Burghardt RC, 1995, J MEMBRANE BIOL, V148, P243; Cong LN, 1997, MOL ENDOCRINOL, V11, P1881, DOI 10.1210/me.11.13.1881; Cooper CD, 2002, J BIOL CHEM, V277, P44962, DOI 10.1074/jbc.M209427200; CROW DS, 1990, MOL CELL BIOL, V10, P1754, DOI 10.1128/MCB.10.4.1754; Dai BB, 2010, CANCER RES, V70, P2951, DOI 10.1158/0008-5472.CAN-09-3909; Fallon L, 2006, NAT CELL BIOL, V8, P834, DOI 10.1038/ncb1441; Feng JH, 2004, J BIOL CHEM, V279, P41189, DOI 10.1074/jbc.M406731200; Franke TF, 2008, ONCOGENE, V27, P6473, DOI 10.1038/onc.2008.313; Girao H, 2003, MOL VIS, V9, P24; Girao H, 2009, EXP CELL RES, V315, P3587, DOI 10.1016/j.yexcr.2009.10.003; Hossain MZ, 1998, J CELL PHYSIOL, V174, P66; Huang T, 2010, CANCER SCI, V101, P713, DOI 10.1111/j.1349-7006.2009.01421.x; Jordan K, 1999, MOL BIOL CELL, V10, P2033, DOI 10.1091/mbc.10.6.2033; Kelsell DP, 1997, NATURE, V387, P80, DOI 10.1038/387080a0; Kjenseth A, 2010, CELL SIGNAL, V22, P1267, DOI 10.1016/j.cellsig.2010.03.005; Kwak YD, 2010, J BIOL CHEM, V285, P9847, DOI 10.1074/jbc.M109.091637; LAING JG, 1995, J BIOL CHEM, V270, P26399, DOI 10.1074/jbc.270.44.26399; Laing JG, 1997, EXP CELL RES, V236, P482, DOI 10.1006/excr.1997.3747; Laird DW, 2010, TRENDS CELL BIOL, V20, P92, DOI 10.1016/j.tcb.2009.11.001; Laird DW, 2006, BIOCHEM J, V394, P527, DOI 10.1042/BJ20051922; LAIRD DW, 1991, BIOCHEM J, V273, P67, DOI 10.1042/bj2730067; Lampe PD, 2006, J CELL SCI, V119, P3435, DOI 10.1242/jcs.03089; LAMPE PD, 1994, J CELL BIOL, V127, P1895, DOI 10.1083/jcb.127.6.1895; Leithe E, 2006, BIOCHEM J, V393, P59, DOI 10.1042/BJ20050674; Leithe E, 2004, J BIOL CHEM, V279, P50089, DOI 10.1074/jbc.M402006200; Leithe E, 2004, J CELL SCI, V117, P1211, DOI 10.1242/jcs.00951; Leithe E, 2009, J CELL SCI, V122, P3883, DOI 10.1242/jcs.053801; Leykauf K, 2006, J CELL SCI, V119, P3634, DOI 10.1242/jcs.03149; Lindsley CW, 2005, BIOORG MED CHEM LETT, V15, P761, DOI 10.1016/j.bmcl.2004.11.011; Moreno AP, 2005, BBA-BIOMEMBRANES, V1711, P164, DOI 10.1016/j.bbamem.2005.02.016; Musil Linda S., 2009, P225, DOI 10.1007/978-1-59745-489-6_9; Musil LS, 2000, J BIOL CHEM, V275, P25207, DOI 10.1074/jbc.275.33.25207; MUSIL LS, 1991, J CELL BIOL, V115, P1357, DOI 10.1083/jcb.115.5.1357; MUSIL LS, 1993, CELL, V74, P1065, DOI 10.1016/0092-8674(93)90728-9; MUSIL LS, 1990, J MEMBRANE BIOL, V116, P163, DOI 10.1007/BF01868674; Naus CC, 2010, NAT REV CANCER, V10, P435, DOI 10.1038/nrc2841; Park DJ, 2007, CELL COMMUN ADHES, V14, P211, DOI 10.1080/15419060701755958; Paznekas WA, 2003, AM J HUM GENET, V72, P408, DOI 10.1086/346090; Richards TS, 2004, J CELL BIOL, V167, P555, DOI 10.1083/jcb.200404142; Rivedal E, 2005, EXP CELL RES, V302, P143, DOI 10.1016/j.yexcr.2004.09.004; Ruch RJ, 2001, J CELL BIOCHEM, V83, P163, DOI 10.1002/jcb.1227; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Scemes E, 2007, NEURON GLIA BIOL, V3, P199, DOI 10.1017/S1740925X08000069; Sohl G, 2004, CARDIOVASC RES, V62, P228, DOI 10.1016/j.cardiores.2003.11.013; Solan JL, 2003, J CELL SCI, V116, P2203, DOI 10.1242/jcs.00428; Solan JL, 2007, J CELL BIOL, V179, P1301, DOI 10.1083/jcb.200707060; Solan JL, 2007, J MEMBRANE BIOL, V217, P35, DOI 10.1007/s00232-007-9035-y; Solan JL, 2009, BIOCHEM J, V419, P261, DOI 10.1042/BJ20082319; Sosinsky GE, 2007, BIOCHEM J, V408, P375, DOI 10.1042/BJ20070550; Su V, 2010, J BIOL CHEM, V285, P40979, DOI 10.1074/jbc.M110.170753; VanSlyke JK, 2005, MOL BIOL CELL, V16, P5247, DOI 10.1091/mbc.E05-05-0415; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065	57	81	85	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2600	2607		10.1074/jbc.M111.276261	http://dx.doi.org/10.1074/jbc.M111.276261			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22139843	Green Published, hybrid			2022-12-27	WOS:000300292300033
J	Howes, J; Shimizu, Y; Feige, MJ; Hendershot, LM				Howes, Jennifer; Shimizu, Yuichiro; Feige, Matthias J.; Hendershot, Linda M.			C-terminal Mutations Destabilize SIL1/BAP and Can Cause Marinesco-Sjogren Syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; ENDOPLASMIC-RETICULUM; QUALITY-CONTROL; STRUCTURAL-ANALYSIS; ATPASE ACTIVITY; HEAVY-CHAINS; PROTEIN; ER; CHAPERONE; BINDING	Marinesco-Sjogren syndrome (MSS) is an autosomal recessive, neurodegenerative, multisystem disorder characterized by severe phenotypes developing in infancy. Recently, mutations in the endoplasmic reticulum (ER)-associated co-chaperone SIL1/BAP were identified to be the major cause of MSS. SIL1 acts as a nucleotide exchange factor for BiP, the ER Hsp70 orthologue, which plays an essential role in the folding and assembly of nascent polypeptide chains in the ER. SIL1 facilitates the release of BiP from unfolded protein substrates, enabling the subsequent folding and transport of the protein. Although most mutations leading to MSS result in deletion of the majority of the protein, three separate mutations have been identified that disrupt only the last five or six amino acids of the protein, which were assumed to encode a divergent ER retention motif. This study presents an in depth analysis of two of these mutants and reveals that the phenotype in the affected individuals is not likely to be due to depletion of SIL1 from the ER via secretion. Instead, our analyses show that the mutant proteins are particularly unstable and either form large aggregates in the ER or are rapidly degraded via the proteasome. In agreement with our findings, homology modeling suggests that the very C-terminal residues of SIL1 play a role in its structural integrity rather than its localization. These new insights might be a first step toward a possible pharmacological treatment of certain types of MSS by specifically stabilizing the mutant SIL1 protein.	[Howes, Jennifer; Shimizu, Yuichiro; Feige, Matthias J.; Hendershot, Linda M.] St Jude Childrens Res Hosp, Dept Genet & Tumor Cell Biol, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Hendershot, LM (corresponding author), 262 Danny Thomas Pl, Memphis, TN 38105 USA.	linda.hendershot@stjude.org	Hendershot, Linda/N-8124-2018	Hendershot, Linda/0000-0002-5473-0274; Howes, Jennifer/0000-0003-1138-6183; Feige, Matthias/0000-0001-5435-4312	National Institutes of Health [GM54068]; Cancer Center CORE [CA21765]; American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital; St. Jude Children's Research Hospital; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054068] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center CORE; American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC)); St. Jude Children's Research Hospital; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM54068 (to L. M. H.) and Cancer Center CORE Grant CA21765. This work was also supported by the American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital.; Recipient of the Paul Barrett Endowed Fellowship of St. Jude Children's Research Hospital.	Anttonen AK, 2005, NAT GENET, V37, P1309, DOI 10.1038/ng1677; Anttonen AK, 2008, EUR J HUM GENET, V16, P961, DOI 10.1038/ejhg.2008.22; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; BOLE DG, 1986, J CELL BIOL, V102, P1558, DOI 10.1083/jcb.102.5.1558; Bu GJ, 1997, J CELL SCI, V110, P65; Cheetham ME, 1998, CELL STRESS CHAPERON, V3, P28, DOI 10.1379/1466-1268(1998)003<0028:SFAEOD>2.3.CO;2; Chung KT, 2002, J BIOL CHEM, V277, P47557, DOI 10.1074/jbc.M208377200; Ellgaard L, 2001, CURR OPIN CELL BIOL, V13, P431, DOI 10.1016/S0955-0674(00)00233-7; Eriguchi M, 2008, J NEUROL SCI, V270, P197, DOI 10.1016/j.jns.2008.02.012; FRA AM, 1993, EMBO J, V12, P4755, DOI 10.1002/j.1460-2075.1993.tb06164.x; HAAS IG, 1983, NATURE, V306, P387, DOI 10.1038/306387a0; Hamman BD, 1998, CELL, V92, P747, DOI 10.1016/S0092-8674(00)81403-8; HAMMOND C, 1995, CURR OPIN CELL BIOL, V7, P523, DOI 10.1016/0955-0674(95)80009-3; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; HENDERSHOT L, 1987, J CELL BIOL, V104, P761, DOI 10.1083/jcb.104.3.761; Herczenik E, 2008, FASEB J, V22, P2115, DOI 10.1096/fj.07-099671; Kabani M, 2002, FEBS LETT, V531, P339, DOI 10.1016/S0014-5793(02)03570-6; Karim MA, 2006, CLIN GENET, V70, P420, DOI 10.1111/j.1399-0004.2006.00695.x; Konagurthu AS, 2006, PROTEINS, V64, P559, DOI 10.1002/prot.20921; LIBEREK K, 1991, P NATL ACAD SCI USA, V88, P2874, DOI 10.1073/pnas.88.7.2874; LIBEREK K, 1991, J BIOL CHEM, V266, P14491; Lievremont JP, 1997, J BIOL CHEM, V272, P30873, DOI 10.1074/jbc.272.49.30873; Luo SZ, 2006, MOL CELL BIOL, V26, P5688, DOI 10.1128/MCB.00779-06; Michalak M, 2009, BIOCHEM J, V417, P651, DOI 10.1042/BJ20081847; Moremen KW, 2006, CURR OPIN STRUC BIOL, V16, P592, DOI 10.1016/j.sbi.2006.08.005; Munoz V, 1997, BIOPOLYMERS, V41, P495, DOI 10.1002/(SICI)1097-0282(19970415)41:5<495::AID-BIP2>3.3.CO;2-6; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; MUNRO S, 1986, CELL, V46, P291, DOI 10.1016/0092-8674(86)90746-4; Nishikawa S, 2001, J CELL BIOL, V153, P1061, DOI 10.1083/jcb.153.5.1061; Otero JH, 2010, SEMIN CELL DEV BIOL, V21, P472, DOI 10.1016/j.semcdb.2009.12.008; Paton AW, 2006, NATURE, V443, P548, DOI 10.1038/nature05124; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Raykhel I, 2007, J CELL BIOL, V179, P1193, DOI 10.1083/jcb.200705180; Sambrook J., 2001, MOL CLONING LAB MANU; Satomi Y, 2004, FEBS LETT, V576, P51, DOI 10.1016/j.febslet.2004.08.061; Senderek J, 2005, NAT GENET, V37, P1312, DOI 10.1038/ng1678; Shen JS, 2002, DEV CELL, V3, P99, DOI 10.1016/S1534-5807(02)00203-4; Shomura Y, 2005, MOL CELL, V17, P367, DOI 10.1016/j.molcel.2004.12.023; Skowronek MH, 1998, P NATL ACAD SCI USA, V95, P1574, DOI 10.1073/pnas.95.4.1574; TITANI K, 1986, BIOCHEMISTRY-US, V25, P3171, DOI 10.1021/bi00359a015; Weitzmann A, 2007, FEBS J, V274, P5175, DOI 10.1111/j.1742-4658.2007.06039.x; Weitzmann A, 2006, FEBS LETT, V580, P5237, DOI 10.1016/j.febslet.2006.08.055; Yan M, 2011, BIOCHEM J, V438, P447, DOI 10.1042/BJ20110500; Zhao LH, 2005, NAT GENET, V37, P974, DOI 10.1038/ng1620	44	24	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8552	8560		10.1074/jbc.M111.333286	http://dx.doi.org/10.1074/jbc.M111.333286			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22219183	hybrid, Green Published			2022-12-27	WOS:000301349400068
J	Aziz, Q; Thomas, AM; Khambra, T; Tinker, A				Aziz, Qadeer; Thomas, Alison M.; Khambra, Tapsi; Tinker, Andrew			Regulation of the ATP-sensitive Potassium Channel Subunit, Kir6.2, by a Ca2+-dependent Protein Kinase C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; K+ CHANNELS; SULFONYLUREA RECEPTOR; ACETYLCHOLINE-RECEPTOR; PHOSPHORYLATION; ACTIVATION; INHIBITION; MECHANISM; IDENTIFICATION; MODULATION	The activity of ATP-sensitive potassium (K-ATP) channels is governed by the concentration of intracellular ATP and ADP and is thus responsive to the metabolic status of the cell. Phosphorylation of KATP channels by protein kinase A (PKA) or protein kinase C (PKC) results in the modulation of channel activity and is particularly important in regulating smooth muscle tone. At the molecular level the smooth muscle channel is composed of a sulfonylurea subunit (SUR2B) and a pore-forming subunit Kir6.1 and/or Kir6.2. Previously, Kir6.1/SUR2B channels have been shown to be inhibited by PKC, and Kir6.2/SUR2B channels have been shown to be activated or have no response to PKC. In this study we have examined the modulation of channel complexes formed of the inward rectifier subunit, Kir6.2, and the sulfonylurea subunit, SUR2B. Using a combination of biochemical and electrophysiological techniques we show that this complex can be inhibited by protein kinase C in a Ca2+-dependent manner and that this inhibition is likely to be as a result of internalization. We identify a residue in the distal C terminus of Kir6.2 (Ser-372) whose phosphorylation leads to down-regulation of the channel complex. This inhibitory effect is distinct from activation which is seen with low levels of channel activity.	[Aziz, Qadeer; Thomas, Alison M.; Khambra, Tapsi; Tinker, Andrew] Barts & London Queen Marys Sch Med & Dent, William Harvey Heart Ctr, London EC1M 6BQ, England	University of London; Queen Mary University London	Tinker, A (corresponding author), Barts & London Queen Marys Sch Med & Dent, William Harvey Heart Ctr, Rm 1-02,Charterhouse Sq, London EC1M 6BQ, England.	a.tinker@qmul.ac.uk		Aziz, Qadeer/0000-0002-7636-6813	British Heart Foundation; British Heart Foundation [RG/10/10/28447] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation)	This work was supported by the British Heart Foundation.	AGUILARBRYAN L, 1995, SCIENCE, V268, P423, DOI 10.1126/science.7716547; Alekseev AE, 2005, J MOL CELL CARDIOL, V38, P895, DOI 10.1016/j.yjmcc.2005.02.022; Babenko AP, 1998, ANNU REV PHYSIOL, V60, P667, DOI 10.1146/annurev.physiol.60.1.667; BAZZI MD, 1989, BIOCHEMISTRY-US, V28, P9317, DOI 10.1021/bi00450a011; BEECH DJ, 1993, BRIT J PHARMACOL, V110, P573, DOI 10.1111/j.1476-5381.1993.tb13849.x; Beguin P, 1999, EMBO J, V18, P4722, DOI 10.1093/emboj/18.17.4722; Cole WC, 2000, CIRC RES, V87, P112, DOI 10.1161/01.RES.87.2.112; Cui Y, 2001, P NATL ACAD SCI USA, V98, P729, DOI 10.1073/pnas.011370498; Damron DS, 1998, AM J PHYSIOL-LUNG C, V274, pL278, DOI 10.1152/ajplung.1998.274.2.L278; Farzaneh T, 2008, CARDIOVASC RES, V79, P621, DOI 10.1093/cvr/cvn138; Flagg TP, 2010, PHYSIOL REV, V90, P799, DOI 10.1152/physrev.00027.2009; French AD, 2009, INT J MED SCI, V6, P93; Garlid KD, 1997, CIRC RES, V81, P1072; Giblin JP, 2002, EUR J BIOCHEM, V269, P5303, DOI 10.1046/j.1432-1033.2002.03249.x; Gopalakrishnan M, 1999, J PHARMACOL EXP THER, V289, P551; Hayabuchi Y, 2001, J PHYSIOL-LONDON, V530, P193, DOI 10.1111/j.1469-7793.2001.0193l.x; Hu KL, 2003, NEURON, V38, P417, DOI 10.1016/S0896-6273(03)00256-3; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; INOUE I, 1991, NATURE, V352, P244, DOI 10.1038/352244a0; Isomoto S, 1996, J BIOL CHEM, V271, P24321, DOI 10.1074/jbc.271.40.24321; Ito K, 2001, J PHYSIOL-LONDON, V532, P165, DOI 10.1111/j.1469-7793.2001.0165g.x; Jiao JD, 2008, HYPERTENSION, V52, P499, DOI 10.1161/HYPERTENSIONAHA.108.110817; Jonas EA, 1996, CURR OPIN NEUROBIOL, V6, P318, DOI 10.1016/S0959-4388(96)80114-0; Jun JY, 2001, AM J PHYSIOL-CELL PH, V281, pC857, DOI 10.1152/ajpcell.2001.281.3.C857; Koh SD, 1998, BIOPHYS J, V75, P1793, DOI 10.1016/S0006-3495(98)77621-0; Leaney JL, 2001, J PHYSIOL-LONDON, V534, P367, DOI 10.1111/j.1469-7793.2001.00367.x; LEVITAN IB, 1994, ANNU REV PHYSIOL, V56, P193, DOI 10.1146/annurev.ph.56.030194.001205; Light P, 1996, BBA-REV BIOMEMBRANES, V1286, P65, DOI 10.1016/0304-4157(96)00004-4; Light PE, 2000, P NATL ACAD SCI USA, V97, P9058, DOI 10.1073/pnas.160068997; Light PE, 1996, CIRC RES, V79, P399, DOI 10.1161/01.RES.79.3.399; Manna PT, 2010, J BIOL CHEM, V285, P5963, DOI 10.1074/jbc.M109.066902; Meimaridou E, 2011, MOL ENDOCRINOL, V25, P1650, DOI 10.1210/me.2011-1020; Miki T, 2002, NAT MED, V8, P466, DOI 10.1038/nm0502-466; Muzyamba M, 2007, CLIN ENDOCRINOL, V67, P115, DOI 10.1111/j.1365-2265.2007.02847.x; Nelson CP, 2008, AM J PHYSIOL-CELL PH, V295, pC1590, DOI 10.1152/ajpcell.00365.2008; Ohanian V, 1996, CIRC RES, V78, P806, DOI 10.1161/01.RES.78.5.806; Park WS, 2005, J CARDIOVASC PHARM, V45, P99, DOI 10.1097/01.fjc.0000150442.49051.f7; QUAYLE JM, 1994, CARDIOVASC RES, V28, P797, DOI 10.1093/cvr/28.6.797; Quayle JM, 1997, PHYSIOL REV, V77, P1165, DOI 10.1152/physrev.1997.77.4.1165; Quinn KV, 2004, CIRC RES, V94, P1359, DOI 10.1161/01.RES.0000128513.34817.c4; Quinn KV, 2003, CIRC RES, V93, P646, DOI 10.1161/01.RES.0000095247.81449.8E; Rainbow RD, 2009, CARDIOVASC RES, V83, P493, DOI 10.1093/cvr/cvp143; Rodrigo GC, 2005, CURR PHARM DESIGN, V11, P1915, DOI 10.2174/1381612054021015; SAFRAN A, 1990, BIOCHEMISTRY-US, V29, P6730, DOI 10.1021/bi00480a024; SAFRAN A, 1987, J BIOL CHEM, V262, P10506; Sampson LJ, 2007, CARDIOVASC RES, V76, P61, DOI 10.1016/j.cardiores.2007.05.020; Seino S, 1999, ANNU REV PHYSIOL, V61, P337, DOI 10.1146/annurev.physiol.61.1.337; Shi Y, 2008, J BIOL CHEM, V283, P2488, DOI 10.1074/jbc.M708769200; Thomas AM, 2006, J MEMBRANE BIOL, V211, P43, DOI 10.1007/s00232-006-0014-5; Thorneloe KS, 2002, J PHYSIOL-LONDON, V541, P65, DOI 10.1113/jphysiol.2002.018101; Trapp S, 2003, EMBO J, V22, P2903, DOI 10.1093/emboj/cdg282; Tucker SJ, 1998, EMBO J, V17, P3290, DOI 10.1093/emboj/17.12.3290; Tucker SJ, 1997, NATURE, V387, P179, DOI 10.1038/387179a0; Yamada M, 1997, J PHYSIOL-LONDON, V499, P715, DOI 10.1113/jphysiol.1997.sp021963; Yamada M, 2010, J PHYSIOL-LONDON, V588, P283, DOI 10.1113/jphysiol.2009.179028; Yellon DM, 2003, PHYSIOL REV, V83, P1113, DOI 10.1152/physrev.00009.2003; Zhang HL, 1996, BRIT J PHARMACOL, V118, P105, DOI 10.1111/j.1476-5381.1996.tb15372.x	57	24	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6196	6207		10.1074/jbc.M111.243923	http://dx.doi.org/10.1074/jbc.M111.243923			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22207763	Green Published, hybrid			2022-12-27	WOS:000300791800013
J	Kim, K; Kim, SH; Kim, J; Kim, H; Yim, J				Kim, Kiyoung; Kim, Song-Hee; Kim, Jaekwang; Kim, Heuijong; Yim, Jeongbin			Glutathione S-Transferase Omega 1 Activity Is Sufficient to Suppress Neurodegeneration in a Drosophila Model of Parkinson Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-PROTEIN LIGASE; DOPAMINERGIC NEURON LOSS; AGE-AT-ONSET; OXIDATIVE STRESS; MITOCHONDRIAL DYSFUNCTION; ALZHEIMER-DISEASE; GENE-EXPRESSION; CALCIUM-RELEASE; ALPHA-SYNUCLEIN; SYNTHASE	A loss-of-function mutation in the gene parkin causes a common neurodegenerative disease that may be caused by mitochondrial dysfunction. Glutathione S-transferase Omega (GSTO) is involved in cell defense mechanisms, but little is known about the role of GSTO in the progression of Parkinson disease. Here, we report that restoration of Drosophila GSTO1 (DmGSTO1), which is down-regulated in parkin mutants, alleviates some of the parkin pathogenic phenotypes and that the loss of DmGSTO1 function enhances parkin mutant phenotypes. We further identified the ATP synthase beta subunit as a novel in vivo target of DmGSTO1. We found that glutathionylation of the ATP synthase beta subunit is rescued by DmGSTO1 and that the expression of DmGSTO1 partially restores the activity and assembly of the mitochondrial F1F0-ATP synthase in parkin mutants. Our results suggest a novel mechanism for the protective role of DmGSTO1 in parkin mutants, through the regulation of ATP synthase activity, and provide insight into potential therapies for Parkinson disease neurodegeneration.	[Kim, Kiyoung; Kim, Song-Hee; Kim, Jaekwang; Kim, Heuijong; Yim, Jeongbin] Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea	Seoul National University (SNU)	Yim, J (corresponding author), Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea.	jyim@snu.ac.kr		Kim, Jaekwang/0000-0002-7312-4077	National Research Foundation of Korea (NRF); Ministry of Education, Science, and Technology (MEST) [KRF-2008-313-E00068, 2011-0004860]; Ministry of Education, Science, and Technology of Korea	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science, and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry of Education, Science, and Technology of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by Ministry of Education, Science, and Technology (MEST) Grants KRF-2008-313-E00068 and 2011-0004860 and by Brain Korea 21 Research Fellowships from the Ministry of Education, Science, and Technology of Korea.	Abou-Sleiman PM, 2006, NAT REV NEUROSCI, V7, P207, DOI 10.1038/nrn1868; Adachi T, 2004, NAT MED, V10, P1200, DOI 10.1038/nm1119; Board PG, 2000, J BIOL CHEM, V275, P24798, DOI 10.1074/jbc.M001706200; Brown SV, 2006, EUKARYOT CELL, V5, P45, DOI 10.1128/EC.5.1.45-53.2006; Capaldi RA, 2002, TRENDS BIOCHEM SCI, V27, P154, DOI 10.1016/S0968-0004(01)02051-5; Celotto AM, 2006, J NEUROSCI, V26, P810, DOI 10.1523/JNEUROSCI.4162-05.2006; Cha GH, 2005, P NATL ACAD SCI USA, V102, P10345, DOI 10.1073/pnas.0500346102; Chen Z, 2003, P NATL ACAD SCI USA, V100, P3525, DOI 10.1073/pnas.0635176100; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Cross RL, 2004, FEBS LETT, V576, P1, DOI 10.1016/j.febslet.2004.08.065; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105; Dulhunty A, 2001, J BIOL CHEM, V276, P3319, DOI 10.1074/jbc.M007874200; Friggi-Grelin F, 2003, J NEUROBIOL, V54, P618, DOI 10.1002/neu.10185; Greene JC, 2005, HUM MOL GENET, V14, P799, DOI 10.1093/hmg/ddi074; Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Haynes CM, 2010, J CELL SCI, V123, P3849, DOI 10.1242/jcs.075119; Henn IH, 2007, J NEUROSCI, V27, P1868, DOI 10.1523/JNEUROSCI.5537-06.2007; Hidalgo C, 2006, J BIOL CHEM, V281, P26473, DOI 10.1074/jbc.M600451200; Hoopfer ED, 2008, J NEUROSCI, V28, P6092, DOI 10.1523/JNEUROSCI.0677-08.2008; Hoozemans JJM, 2007, BIOCHEM BIOPH RES CO, V354, P707, DOI 10.1016/j.bbrc.2007.01.043; Kim J, 2006, BIOCHEM J, V398, P451, DOI 10.1042/BJ20060424; Laliberte RE, 2003, J BIOL CHEM, V278, P16567, DOI 10.1074/jbc.M211596200; Li HM, 2008, INSECT MOL BIOL, V17, P325, DOI 10.1111/j.1365-2583.2008.00808.x; Li YJ, 2006, NEUROBIOL AGING, V27, P1087, DOI 10.1016/j.neurobiolaging.2005.05.013; Li YJ, 2003, HUM MOL GENET, V12, P3259, DOI 10.1093/hmg/ddg357; Matyunina LV, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-55; Mayr JA, 2010, HUM MOL GENET, V19, P3430, DOI 10.1093/hmg/ddq254; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; PENA P, 1993, BIOCHEM BIOPH RES CO, V195, P785, DOI 10.1006/bbrc.1993.2114; Pesah Y, 2004, DEVELOPMENT, V131, P2183, DOI 10.1242/dev.01095; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; Ren Y, 2003, J NEUROSCI, V23, P3316; ROSING J, 1975, BIOCHIM BIOPHYS ACTA, V376, P13, DOI 10.1016/0005-2728(75)90201-7; Sheehan D, 2001, BIOCHEM J, V360, P1, DOI 10.1042/0264-6021:3600001; Shi M, 2009, AM J PATHOL, V175, P54, DOI 10.2353/ajpath.2009.081019; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Smeyne M, 2007, P NATL ACAD SCI USA, V104, P1977, DOI 10.1073/pnas.0610978104; Smith WW, 2005, HUM MOL GENET, V14, P3801, DOI 10.1093/hmg/ddi396; Sorensen JG, 2005, CELL STRESS CHAPERON, V10, P312, DOI 10.1379/CSC-128R1.1; Stroombergen MCMJ, 1999, HUM EXP TOXICOL, V18, P141, DOI 10.1191/096032799678839815; Tain LS, 2009, NAT NEUROSCI, V12, P1129, DOI 10.1038/nn.2372; Tew KD, 2011, DRUG METAB REV, V43, P179, DOI 10.3109/03602532.2011.552912; Townsend DM, 2009, J BIOL CHEM, V284, P436, DOI 10.1074/jbc.M805586200; Trinh K, 2008, J NEUROSCI, V28, P465, DOI 10.1523/JNEUROSCI.4778-07.2008; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Verstreken P, 2005, NEURON, V47, P365, DOI 10.1016/j.neuron.2005.06.018; Walters KB, 2009, J HERED, V100, P742, DOI 10.1093/jhered/esp043; Wang C, 2007, J NEUROSCI, V27, P8563, DOI 10.1523/JNEUROSCI.0218-07.2007; Whitworth AJ, 2005, P NATL ACAD SCI USA, V102, P8024, DOI 10.1073/pnas.0501078102; Willingham S, 2003, SCIENCE, V302, P1769, DOI 10.1126/science.1090389; Yang YF, 2008, P NATL ACAD SCI USA, V105, P7070, DOI 10.1073/pnas.0711845105; Yin SP, 2005, J BIOL CHEM, V280, P34985, DOI 10.1074/jbc.M503522200; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797	55	35	37	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6628	6641		10.1074/jbc.M111.291179	http://dx.doi.org/10.1074/jbc.M111.291179			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22219196	hybrid, Green Published			2022-12-27	WOS:000300791800050
J	Marcinkiewicz, MM; Sinha, D; Walsh, PN				Marcinkiewicz, Mariola M.; Sinha, Dipali; Walsh, Peter N.			Productive Recognition of Factor IX by Factor XIa Exosites Requires Disulfide Linkage between Heavy and Light Chains of Factor XIa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-COAGULATION FACTOR; PLASMA THROMBOPLASTIN ANTECEDENT; CATALYTIC DOMAIN; CHRISTMAS-FACTOR; TISSUE FACTOR; FUNCTIONAL-CHARACTERIZATION; SUBSTRATE RECOGNITION; BINDING-SITE; FACTOR XA; ACTIVATION	In the intrinsic pathway of blood coagulation factor XIa (FXIa) activates factor IX (FIX) by cleaving the zymogen at Arg(145)-Ala(146) and Arg(180)-Val(181) bonds releasing an 11-kDa activation peptide. FXIa and its isolated light chain (FXIa-LC) cleave S-2366 at comparable rates, but FXIa-LC is a very poor activator of FIX, possibly because FIX undergoes allosteric modification on binding to an exosite on the heavy chain of FXIa (FXIa-HC) required for optimal cleavage rates of the two scissile bonds of FIX. However preincubation of FIX with a saturating concentration of isolated FXIa-HC did not result in any potentiation in the rate of FIX cleavage by FXIa-LC. Furthermore, if FIX binding via the heavy chain exosite of FXIa determines the affinity of the enzyme-substrate interaction, then the isolated FXIa-HC should inhibit the rate of FIX activation by depleting the substrate. However, whereas FXIa/S557A inhibited FIX activation of by FXIa, FXIa-HC did not. Therefore, we examined FIX binding to FXIa/S557A, FXIa-HC, FXIa-LC, FXIa/C362S/C482S, and FXIa/S557A/C362S/C482S. The heavy and light chains are disulfide-linked in FXIa/S557A but not in FXIa/C362S/C482S and FXIa/S557A/C362S/C482S. In an ELISA assay only FXI/S557A ligated FIX with high affinity. Partial reduction of FXIa/S557A to produce heavy and light chains resulted in decreased FIX binding, and this function was regained upon reformation of the disulfide linkage between the heavy and the light chains. We therefore conclude that substrate recognition by the FXIa exosite(s) requires disulfide-linked heavy and light chains.	[Marcinkiewicz, Mariola M.; Sinha, Dipali; Walsh, Peter N.] Temple Univ, Sch Med, Sol Sherry Thrombosis Res Ctr, Philadelphia, PA 19140 USA; [Walsh, Peter N.] Temple Univ, Sch Med, Dept Biochem, Philadelphia, PA 19140 USA; [Walsh, Peter N.] Temple Univ, Sch Med, Dept Med, Philadelphia, PA 19140 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Sinha, D (corresponding author), Temple Univ, Sch Med, Sol Sherry Thrombosis Res Ctr, 3400 N Broad St, Philadelphia, PA 19140 USA.	dipali@temple.edu; pnw@temple.edu			National Institutes of Health [HL74124, HL46213]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL046213, P01HL074124] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported, in whole or in part, by National Institutes of Health Grants HL74124 and HL46213 (to P. N. W.).	BAJAJ SP, 1983, BIOCHEMISTRY-US, V22, P4047, DOI 10.1021/bi00286a009; Baugh RJ, 2000, J BIOL CHEM, V275, P28826, DOI 10.1074/jbc.M005266200; Betz A, 1997, BIOCHEMISTRY-US, V36, P181, DOI 10.1021/bi962060g; BROZE GJ, 1988, BLOOD, V71, P335; BROZE GJ, 1990, BIOCHEMISTRY-US, V29, P7539, DOI 10.1021/bi00485a001; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; DISCIPIO RG, 1978, J CLIN INVEST, V61, P1528, DOI 10.1172/JCI109073; Edgington TS, 1997, THROMB HAEMOSTASIS, V78, P401; FUJIKAWA K, 1974, BIOCHEMISTRY-US, V13, P4508, DOI 10.1021/bi00719a006; FUJIKAWA K, 1986, BIOCHEMISTRY-US, V25, P2417, DOI 10.1021/bi00357a018; GAILANI D, 1991, SCIENCE, V253, P909, DOI 10.1126/science.1652157; Jin L, 2005, J BIOL CHEM, V280, P4704, DOI 10.1074/jbc.M411309200; Krishnaswamy S, 1997, BIOCHEMISTRY-US, V36, P12080, DOI 10.1021/bi970979+; LINDQUIST PA, 1978, J BIOL CHEM, V253, P1902; Mann KG, 2003, ARTERIOSCL THROM VAS, V23, P17, DOI 10.1161/01.ATV.0000046238.23903.FC; MCMULLEN BA, 1991, BIOCHEMISTRY-US, V30, P2056, DOI 10.1021/bi00222a008; Miller TN, 2007, BIOCHEMISTRY-US, V46, P14450, DOI 10.1021/bi701310x; NAITO K, 1991, J BIOL CHEM, V266, P7353; Navaneetham D, 2005, J BIOL CHEM, V280, P36165, DOI 10.1074/jbc.M504990200; NEMERSON Y, 1992, SEMIN HEMATOL, V29, P170; Ogawa T, 2005, J BIOL CHEM, V280, P23523, DOI 10.1074/jbc.M500894200; OSTERUD B, 1977, P NATL ACAD SCI USA, V74, P5260, DOI 10.1073/pnas.74.12.5260; Papagrigoriou E, 2006, NAT STRUCT MOL BIOL, V13, P557, DOI 10.1038/nsmb1095; Renne T, 2002, J BIOL CHEM, V277, P4892, DOI 10.1074/jbc.M105221200; Samuel D, 2007, P NATL ACAD SCI USA, V104, P15693, DOI 10.1073/pnas.0703080104; Sinha D, 2005, BIOCHEMISTRY-US, V44, P10416, DOI 10.1021/bi050361x; SINHA D, 1985, J BIOL CHEM, V260, P714; SINHA D, 1987, BIOCHEMISTRY-US, V26, P3768, DOI 10.1021/bi00387a005; Sinha D, 2007, BIOCHEMISTRY-US, V46, P9830, DOI 10.1021/bi062296c; Smith SB, 2008, J BIOL CHEM, V283, P6696, DOI 10.1074/jbc.M707234200; Sun MF, 1999, J BIOL CHEM, V274, P36373, DOI 10.1074/jbc.274.51.36373; Sun YH, 1996, J BIOL CHEM, V271, P29023, DOI 10.1074/jbc.271.46.29023; THOMPSON RE, 1977, J CLIN INVEST, V60, P1376, DOI 10.1172/JCI108898; VANDERGRAAF F, 1983, J BIOL CHEM, V258, P9669; WAGENVOORD R, 1990, HAEMOSTASIS, V20, P276; Wolberg AS, 1997, BIOCHEMISTRY-US, V36, P4074, DOI 10.1021/bi962274y; Wu WM, 2008, J BIOL CHEM, V283, P18655, DOI 10.1074/jbc.M802275200	37	5	5	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6187	6195		10.1074/jbc.M111.291989	http://dx.doi.org/10.1074/jbc.M111.291989			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22207756	Green Published, hybrid			2022-12-27	WOS:000300791800012
J	Shibata, TK; Matsumura, F; Wang, P; Yu, SY; Chou, CC; Khoo, KH; Kitayama, K; Akama, TO; Sugihara, K; Kanayama, N; Kojima-Aikawa, K; Seeberger, PH; Fukuda, M; Suzuki, A; Aoki, D; Fukuda, MN				Shibata, Toshiaki K.; Matsumura, Fumiko; Wang, Ping; Yu, ShinYi; Chou, Chi-Chi; Khoo, Kay-Hooi; Kitayama, Kazuko; Akama, Tomoya O.; Sugihara, Kazuhiro; Kanayama, Naohiro; Kojima-Aikawa, Kyoko; Seeberger, Peter H.; Fukuda, Minoru; Suzuki, Atsushi; Aoki, Daisuke; Fukuda, Michiko N.			Identification of Mono- and Disulfated N-Acetyl-lactosaminyl Oligosaccharide Structures as Epitopes Specifically Recognized by Humanized Monoclonal Antibody HMOCC-1 Raised against Ovarian Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORNEAL KERATAN SULFATE; BLOOD-GROUP ANTIGEN; MOLECULAR-CLONING; L-SELECTIN; SIALYL LEWIS(X); O-GLYCANS; GLCNAC 6-O-SULFOTRANSFERASE; HEPARAN-SULFATE; EXPRESSION; GENE	A humanized monoclonal antibody raised against human ovarian cancer RMG-I cells and designated as HMOCC-1 (Suzuki, N., Aoki, D., Tamada, Y., Susumu, N., Orikawa, K., Tsukazaki, K., Sakayori, M., Suzuki, A., Fukuchi, T., Mukai, M., Kojima-Aikawa, K., Ishida, I., and Nozawa, S. (2004) Gynecol. Oncol. 95, 290-298) was characterized for its carbohydrate epitope structure. Specifically, a series of co-transfections was performed using mammalian expression vectors encoding specific glycosyltransferases and sulfotransferases. These experiments identified one sulfotransferase, GAL3ST3, and one glycosyltransferase, B3GNT7, as required for HMOCC-1 antigen formation. They also suggested that the sulfotransferase CHST1 regulates the abundance and intensity of HMOCC-1 antigen. When HEK293T cells were co-transfected with GAL3ST3 and B3GNT7 expression vectors, transfected cells weakly expressed HMOCC-1 antigen. When cells were first co-transfected with GAL3ST3 and B3GNT7 and then with CHST1, the resulting cells strongly expressed HMOCC-1 antigen. However, when cells were transfected with a mixture of GAL3ST3 and CHST1 before or after transfection with B3GNT7, the number of anti-gen-positive cells decreased relative to the number seen with only GAL3ST3 and B3GNT7, suggesting that CHST1 plays a regulatory role in HMOCC-1 antigen formation. Because these results predicted that HMOCC-1 antigens are SO3 -> 3Gal beta 1 -> 4GlcNAc beta 1 -> 3(+/- SO3 -> 6)Gal beta 1 -> 4GlcNAc, we chemically synthesized mono- and disulfated and unsulfated oligosaccharides. Immunoassays using these oligosaccharides as inhibitors showed the strongest activity by disulfated tetrasaccharide, weak but positive activity by monosulfated tetrasaccharide at the terminal galactose, and no activity by nonsulfated tetrasaccharides. These results establish the HMOCC-1 epitope, which should serve as a useful reagent to further characterize ovarian cancer.	[Shibata, Toshiaki K.; Matsumura, Fumiko; Wang, Ping; Kitayama, Kazuko; Akama, Tomoya O.; Seeberger, Peter H.; Fukuda, Minoru; Fukuda, Michiko N.] Sanford Burnham Med Res Inst, Tumor Microenvironm Program, Ctr Canc, La Jolla, CA 92037 USA; [Yu, ShinYi; Chou, Chi-Chi; Khoo, Kay-Hooi] Acad Sinica, Inst Biol Chem, Taipei 11529, Taiwan; [Sugihara, Kazuhiro; Kanayama, Naohiro] Hamamatsu Univ Sch Med, Dept Gynecol & Obstet, Hamamatsu, Shizuoka 4313192, Japan; [Kojima-Aikawa, Kyoko] Ochanomizu Univ, Grad Sch Humanities & Sci, Tokyo 1128610, Japan; [Seeberger, Peter H.] Max Planck Inst Colloids & Interfaces, Dept Biomol Syst, D-14476 Potsdam, Germany; [Suzuki, Atsushi; Aoki, Daisuke] Keio Univ, Sch Med, Dept Obstet & Gynecol, Shinjuku Ku, Tokyo 1600016, Japan	Sanford Burnham Prebys Medical Discovery Institute; Academia Sinica - Taiwan; Hamamatsu University School of Medicine; Ochanomizu University; Max Planck Society; Keio University	Fukuda, MN (corresponding author), Sanford Burnham Med Res Inst, Tumor Microenvironm Program, Ctr Canc, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	michiko@sanfordburnham.org	Chou, Chi-Chi/X-6053-2019; Khoo, Kay-Hooi/E-1989-2019; Wang, Ping/I-6183-2013; Aoki, Daisuke/E-6650-2014	Chou, Chi-Chi/0000-0002-7862-7757; Khoo, Kay-Hooi/0000-0003-2906-406X; Kitayama, Kazuko/0000-0003-2829-762X; KAWASAKI, FUMIKO/0000-0002-6641-2599; YU, Shin-Yi/0000-0003-0197-9575; Wang, Ping/0000-0002-8640-1483	National Institutes of Health [CA33895, EY014620]; NSC [100-2325-B-001-029]; NATIONAL CANCER INSTITUTE [R01CA033895] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY014620] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23792096] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSC(Ministry of Science and Technology, Taiwan); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA33895 (to M.N.F.) and EY014620 (to T.O.A.).; The MS data were acquired at the Core Facilities for Protein Structural Analysis at Academia Sinica, supported under the Taiwan National Core Facility Program for Biotechnology, NSC Grant 100-2325-B-001-029. We thank Dr. Elise Lamar for editing of the manuscript.	Aguilan JT, 2009, GLYCOBIOLOGY, V19, P971, DOI 10.1093/glycob/cwp074; Akama TO, 2000, NAT GENET, V26, P237, DOI 10.1038/79987; Akama TO, 2002, J BIOL CHEM, V277, P42505, DOI 10.1074/jbc.M207412200; Akama TO, 2001, J BIOL CHEM, V276, P16271, DOI 10.1074/jbc.M009995200; ALBANO RM, 1986, J BIOL CHEM, V261, P758; BIERHUIZEN MFA, 1993, GENE DEV, V7, P468, DOI 10.1101/gad.7.3.468; Bullock SL, 1998, GENE DEV, V12, P1894, DOI 10.1101/gad.12.12.1894; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Clark RA, 1998, J CELL BIOL, V140, P721, DOI 10.1083/jcb.140.3.721; FEIZI T, 1994, METHOD ENZYMOL, V230, P484; Fukuda M, 1996, CANCER RES, V56, P2237; Fukuda MN, 2008, J OBSTET GYNAECOL RE, V34, P129, DOI 10.1111/j.1447-0756.2008.00776.x; Fukui S, 2002, NAT BIOTECHNOL, V20, P1011, DOI 10.1038/nbt735; Fukuta M, 1997, J BIOL CHEM, V272, P32321, DOI 10.1074/jbc.272.51.32321; Genbacev OD, 2003, SCIENCE, V299, P405, DOI 10.1126/science.1079546; HAKOMORI S, 1983, B CANCER, V70, P118; HAKOMORI SI, 1989, ADV CANCER RES, V52, P257; Hirakawa J, 2010, J BIOL CHEM, V285, P40864, DOI 10.1074/jbc.M110.167296; Hiraoka N, 1999, IMMUNITY, V11, P79, DOI 10.1016/S1074-7613(00)80083-7; Isshiki S, 1999, J BIOL CHEM, V274, P12499, DOI 10.1074/jbc.274.18.12499; Iwai T, 2002, J BIOL CHEM, V277, P12802, DOI 10.1074/jbc.M112457200; Izawa M, 2000, CANCER RES, V60, P1410; Jain RK, 1997, CHEM COMMUN, P23, DOI 10.1039/a605439k; KANNAGI R, 1986, CANCER RES, V46, P2619; Kannagi R, 2000, METHOD ENZYMOL, V312, P160; Khoo KH, 2010, METHOD ENZYMOL, V478, P3, DOI 10.1016/S0076-6879(10)78001-0; Kitayama K, 2007, J BIOL CHEM, V282, P30085, DOI 10.1074/jbc.M703695200; KUKOWSKALATALLO JF, 1990, GENE DEV, V4, P1288, DOI 10.1101/gad.4.8.1288; Kumamoto K, 1998, BIOCHEM BIOPH RES CO, V247, P514, DOI 10.1006/bbrc.1998.8824; LARSEN RD, 1990, P NATL ACAD SCI USA, V87, P6674, DOI 10.1073/pnas.87.17.6674; MAGNANI JL, 1984, ARCH BIOCHEM BIOPHYS, V233, P501, DOI 10.1016/0003-9861(84)90473-9; MCEVER RP, 1995, J BIOL CHEM, V270, P11025, DOI 10.1074/jbc.270.19.11025; MIYAKE M, 1992, NEW ENGL J MED, V327, P14, DOI 10.1056/NEJM199207023270103; NAKAMORI S, 1993, CANCER RES, V53, P3632; Noti C, 2006, CHEM-EUR J, V12, P8664, DOI 10.1002/chem.200601103; Nozawa S, 2004, CLIN CANCER RES, V10, P7071, DOI 10.1158/1078-0432.CCR-04-0802; Plante OJ, 2001, SCIENCE, V291, P1523, DOI 10.1126/science.1057324; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; Rosen SD, 2004, ANNU REV IMMUNOL, V22, P129, DOI 10.1146/annurev.immunol.21.090501.080131; Rosen SD, 2006, J IMMUNOL, V177, P3, DOI 10.4049/jimmunol.177.1.3; Seeberger PH, 2005, NAT REV DRUG DISCOV, V4, P751, DOI 10.1038/nrd1823; Seko A, 2004, FEBS LETT, V556, P216, DOI 10.1016/S0014-5793(03)01440-6; Seko A, 2002, GLYCOBIOLOGY, V12, P379, DOI 10.1093/glycob/12.6.379; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Stoll MS, 2000, EUR J BIOCHEM, V267, P1795, DOI 10.1046/j.1432-1327.2000.01178.x; STREETER PR, 1988, J CELL BIOL, V107, P1853, DOI 10.1083/jcb.107.5.1853; Suzuki A, 2001, J BIOL CHEM, V276, P24388, DOI 10.1074/jbc.M103135200; Suzuki N, 2004, GYNECOL ONCOL, V95, P290, DOI 10.1016/j.ygyno.2004.06.024; Tsuda M, 1999, NATURE, V400, P276, DOI 10.1038/22336; Tully SE, 2006, J AM CHEM SOC, V128, P7740, DOI 10.1021/ja061906t; Uchimura K, 1998, J BIOL CHEM, V273, P22577, DOI 10.1074/jbc.273.35.22577; vanSeeventer PB, 1997, CARBOHYD RES, V299, P181, DOI 10.1016/S0008-6215(97)00013-X; Yeh JC, 2001, CELL, V105, P957, DOI 10.1016/S0092-8674(01)00394-4; Yeh JC, 1999, J BIOL CHEM, V274, P3215, DOI 10.1074/jbc.274.5.3215; Yin BWT, 1996, INT J CANCER, V65, P406, DOI 10.1002/(SICI)1097-0215(19960208)65:4<406::AID-IJC2>3.3.CO;2-5; Yu B, 2002, J ORG CHEM, V67, P9099, DOI 10.1021/jo026103c; Yusa A, 2010, CANCER RES, V70, P4064, DOI 10.1158/0008-5472.CAN-09-2383	57	18	19	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6592	6602		10.1074/jbc.M111.305334	http://dx.doi.org/10.1074/jbc.M111.305334			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22194598	hybrid, Green Published			2022-12-27	WOS:000300791800047
J	Bonawitz, ND; Soltau, WL; Blatchley, MR; Powers, BL; Hurlock, AK; Seals, LA; Weng, JK; Stout, J; Chapple, C				Bonawitz, Nicholas D.; Soltau, Whitney L.; Blatchley, Michael R.; Powers, Brendan L.; Hurlock, Anna K.; Seals, Leslie A.; Weng, Jing-Ke; Stout, Jake; Chapple, Clint			REF4 and RFR1, Subunits of the Transcriptional Coregulatory Complex Mediator, Are Required for Phenylpropanoid Homeostasis in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGNIN BIOSYNTHESIS; THALIANA; ACTIVATION; GENETICS; LIGHT; EXPRESSION; MUTATIONS; REGULATOR; MUTANTS; DEFENSE	The plant phenylpropanoid pathway produces an array of metabolites that impact human health and the utility of feed and fiber crops. We previously characterized several Arabidopsis thaliana mutants with dominant mutations in REDUCED EPIDERMAL FLUORESCENCE 4 (REF4) that cause dwarfing and decreased accumulation of phenylpropanoids. In contrast, ref4 null plants are of normal stature and have no apparent defect in phenylpropanoid biosynthesis. Here we show that disruption of both REF4 and its paralog, REF4-RELATED 1 (RFR1), results in enhanced expression of multiple phenylpropanoid biosynthetic genes, as well as increased accumulation of numerous downstream products. We also show that the dominant ref4-3 mutant protein interferes with the ability of the PAP1/MYB75 transcription factor to induce the expression of PAL1 and drive anthocyanin accumulation. Consistent with our experimental results, both REF4 and RFR1 have been shown to physically associate with the conserved transcriptional coregulatory complex, Mediator, which transduces information from cis-acting DNA elements to RNA polymerase II at the core promoter. Taken together, our data provide critical genetic support for a functional role of REF4 and RFR1 in the Mediator complex, and for Mediator in the maintenance of phenylpropanoid homeostasis. Finally, we show that wild-type RFR1 substantially mitigates the phenotype of the dominant ref4-3 mutant, suggesting that REF4 and RFR1 may compete with one another for common binding partners or for occupancy in Mediator. Determining the functions of diverse Mediator subunits is essential to understand eukaryotic gene regulation, and to facilitate rational manipulation of plant metabolic pathways to better suit human needs.	[Bonawitz, Nicholas D.; Soltau, Whitney L.; Blatchley, Michael R.; Powers, Brendan L.; Hurlock, Anna K.; Seals, Leslie A.; Weng, Jing-Ke; Stout, Jake; Chapple, Clint] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Chapple, C (corresponding author), 175 S Univ St, W Lafayette, IN 47907 USA.	chapple@purdue.edu	Weng, Jing-Ke/E-7343-2013; Weng, Jing-Ke/V-5934-2019; Ye, Mingli/G-4909-2012; Chapple, Clint CS/Q-5456-2017; Weng, Jing-Ke/A-6900-2015	Weng, Jing-Ke/0000-0003-1079-3668; Weng, Jing-Ke/0000-0003-3059-0075; Chapple, Clint CS/0000-0002-5195-562X; Weng, Jing-Ke/0000-0003-3059-0075; Dolan, Whitney/0000-0001-9069-9764; Stout, Jake/0000-0002-0193-9066	Division of Energy Biosciences, United States Department of Energy [DE-FG02-07ER15905]; Global Climate and Energy Program (GCEP); Life Sciences Research Foundation; Howard Hughes Medical Institute	Division of Energy Biosciences, United States Department of Energy(United States Department of Energy (DOE)); Global Climate and Energy Program (GCEP); Life Sciences Research Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported by grants from the Division of Energy Biosciences, United States Department of Energy Grant DE-FG02-07ER15905, the Global Climate and Energy Program (GCEP), a fellowship from the Life Sciences Research Foundation (to N. D. B.), and a summer research fellowship from the Howard Hughes Medical Institute (to M. R. B.).	Adlercreutz H, 2002, LANCET ONCOL, V3, P364, DOI 10.1016/S1470-2045(02)00777-5; Autran D, 2002, EMBO J, V21, P6036, DOI 10.1093/emboj/cdf614; Backstrom S, 2007, MOL CELL, V26, P717, DOI 10.1016/j.molcel.2007.05.007; BellLelong DA, 1997, PLANT PHYSIOL, V113, P729, DOI 10.1104/pp.113.3.729; Beve J, 2005, J BIOL CHEM, V280, P41366, DOI 10.1074/jbc.M511181200; Bonawitz ND, 2010, ANNU REV GENET, V44, P337, DOI 10.1146/annurev-genet-102209-163508; Borevitz JO, 2000, PLANT CELL, V12, P2383, DOI 10.1105/tpc.12.12.2383; Boudet AM, 2003, TRENDS PLANT SCI, V8, P576, DOI 10.1016/j.tplants.2003.10.001; Bourbon HM, 2008, NUCLEIC ACIDS RES, V36, P3993, DOI 10.1093/nar/gkn349; Bourbon HM, 2004, MOL CELL, V14, P553, DOI 10.1016/j.molcel.2004.05.011; Boyce JM, 2003, PLANT J, V34, P395, DOI 10.1046/j.1365-313X.2003.01734.x; Butelli E, 2008, NAT BIOTECHNOL, V26, P1301, DOI 10.1038/nbt.1506; Cerdan PD, 2003, NATURE, V423, P881, DOI 10.1038/nature01636; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Davis JA, 2002, MOL CELL, V10, P409, DOI 10.1016/S1097-2765(02)00598-1; Derikvand MM, 2008, PLANTA, V227, P943, DOI 10.1007/s00425-007-0669-x; Dhawan R, 2009, PLANT CELL, V21, P1000, DOI 10.1105/tpc.108.062364; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; FLANAGAN PM, 1991, NATURE, V350, P436, DOI 10.1038/350436a0; Gonzalez A, 2008, PLANT J, V53, P814, DOI 10.1111/j.1365-313X.2007.03373.x; HAHLBROCK K, 1976, EUR J BIOCHEM, V61, P199, DOI 10.1111/j.1432-1033.1976.tb10012.x; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Humphreys JM, 2002, CURR OPIN PLANT BIOL, V5, P224, DOI 10.1016/S1369-5266(02)00257-1; Kidd BN, 2009, PLANT CELL, V21, P2237, DOI 10.1105/tpc.109.066910; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; Kim YJ, 2011, EMBO J, V30, P814, DOI 10.1038/emboj.2011.3; Kitts DD, 1999, MOL CELL BIOCHEM, V202, P91, DOI 10.1023/A:1007022329660; Kornberg RD, 2007, P NATL ACAD SCI USA, V104, P12955, DOI 10.1073/pnas.0704138104; Li X, 2010, PLANT CELL, V22, P1620, DOI 10.1105/tpc.110.074161; Nakatsubo T, 2008, J BIOL CHEM, V283, P15550, DOI 10.1074/jbc.M801131200; Niggeweg R, 2004, NAT BIOTECHNOL, V22, P746, DOI 10.1038/nbt966; Ralph John, 2004, Phytochemistry Reviews, V3, P29, DOI 10.1023/B:PHYT.0000047809.65444.a4; Ro DK, 2004, J BIOL CHEM, V279, P2600, DOI 10.1074/jbc.M309951200; Rogers LA, 2005, J EXP BOT, V56, P1651, DOI 10.1093/jxb/eri162; Rogers LA, 2004, NEW PHYTOL, V164, P17, DOI 10.1111/j.1469-8137.2004.01143.x; Rohde A, 2004, PLANT CELL, V16, P2749, DOI 10.1105/tpc.104.023705; Ruegger M, 2001, GENETICS, V159, P1741; Stout J, 2008, GENETICS, V178, P2237, DOI 10.1534/genetics.107.083881; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Umezawa T, 2010, PHYTOCHEM REV, V9, P1, DOI 10.1007/s11101-009-9155-3; Vanholme R, 2008, CURR OPIN PLANT BIOL, V11, P278, DOI 10.1016/j.pbi.2008.03.005; Vanholme R, 2010, PLANT PHYSIOL, V153, P895, DOI 10.1104/pp.110.155119; Weng JK, 2008, CURR OPIN BIOTECH, V19, P166, DOI 10.1016/j.copbio.2008.02.014; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; Zhong RQ, 2007, CURR OPIN PLANT BIOL, V10, P564, DOI 10.1016/j.pbi.2007.09.001	46	86	91	2	32	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5434	5445		10.1074/jbc.M111.312298	http://dx.doi.org/10.1074/jbc.M111.312298			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22167189	Green Published, hybrid			2022-12-27	WOS:000300638000024
J	Emara, M; Royer, PJ; Mahdavi, J; Shakib, F; Ghaemmaghami, AM				Emara, Mohamed; Royer, Pierre-Joseph; Mahdavi, Jafar; Shakib, Farouk; Ghaemmaghami, Amir M.			Retagging Identifies Dendritic Cell-specific Intercellular Adhesion Molecule-3 (ICAM3)-grabbing Non-integrin (DC-SIGN) Protein as a Novel Receptor for a Major Allergen from House Dust Mite	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TYPE LECTINS; MEMBRANE CHOLESTEROL DEPLETION; MANNOSE RECEPTOR; RECOGNITION; DER-P-1; POLARIZATION; MECHANISMS; PROFILES; BINDING; ICAM-3	Dendritic cells (DCs) have been shown to play a key role in the initiation and maintenance of immune responses to microbial pathogens as well as to allergens, but the exact mechanisms of their involvement in allergic responses and Th2 cell differentiation have remained elusive. Using retagging, we identified DC-SIGN as a novel receptor involved in the initial recognition and uptake of the major house dust mite and dog allergens Der p 1 and Can f 1, respectively. To confirm this, we used gene silencing to specifically inhibit DC-SIGN expression by DCs followed by allergen uptake studies. Binding and uptake of Der p 1 and Can f 1 allergens was assessed by ELISA and flow cytometry. Intriguingly, our data showed that silencing DC-SIGN on DCs promotes a Th2 phenotype in DC/T cell co-cultures. These findings should lead to better understanding of the molecular basis of allergen-induced Th2 cell polarization and in doing so paves the way for the rational design of novel intervention strategies by targeting allergen receptors on innate immune cells or their carbohydrate counterstructures on allergens.	[Emara, Mohamed; Royer, Pierre-Joseph; Mahdavi, Jafar; Shakib, Farouk; Ghaemmaghami, Amir M.] Univ Nottingham, Sch Mol Med Sci, Queens Med Ctr, Nottingham NG7 2UH, England; [Shakib, Farouk; Ghaemmaghami, Amir M.] Univ Nottingham, Resp Biomed Res Unit, Nottingham NG7 2UH, England	University of Nottingham; University of Nottingham	Ghaemmaghami, AM (corresponding author), Univ Nottingham, Sch Mol Med Sci, Queens Med Ctr, Nottingham NG7 2UH, England.	amg@nottingham.ac.uk	Ghaemmaghami, Amir/S-2627-2019; Ghaemmaghami, Amir/AAP-2968-2020; Emara, Mohamed M./C-8220-2013; Royer, Pierre-Joseph/D-4768-2015	Ghaemmaghami, Amir/0000-0003-3160-8759; Emara, Mohamed M./0000-0001-7708-9435; Royer, Pierre-Joseph/0000-0001-5534-7982	University of Nottingham School of Molecular Medical Sciences; Wellcome Trust; Asthma UK [06/001] Funding Source: researchfish	University of Nottingham School of Molecular Medical Sciences; Wellcome Trust(Wellcome TrustEuropean Commission); Asthma UK	This study was supported in part by the University of Nottingham School of Molecular Medical Sciences.; Recipient of a Wellcome Trust Value In People (VIP) award.	Appelmelk BJ, 2003, J IMMUNOL, V170, P1635, DOI 10.4049/jimmunol.170.4.1635; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Bleijs DA, 1999, EUR J IMMUNOL, V29, P2248, DOI 10.1002/(SICI)1521-4141(199907)29:07<2248::AID-IMMU2248>3.0.CO;2-9; Broide DH, 2011, J ALLERGY CLIN IMMUN, V127, P689, DOI 10.1016/j.jaci.2011.01.027; Cambi A, 2005, CELL MICROBIOL, V7, P481, DOI 10.1111/j.1462-5822.2005.00506.x; Coelho V, 2010, P NATL ACAD SCI USA, V107, P18587, DOI 10.1073/pnas.1009388107; De Wit D, 2000, J ALLERGY CLIN IMMUN, V105, P346, DOI 10.1016/S0091-6749(00)90086-1; Deslee G, 2002, J ALLERGY CLIN IMMUN, V110, P763, DOI 10.1067/mai.2002.129121; Drickamer K, 2002, BIOCHEM SOC SYMP, V69, P59; Drickamer K, 1999, CURR OPIN STRUC BIOL, V9, P585, DOI 10.1016/S0959-440X(99)00009-3; Eisenbarth SC, 2003, CURR OPIN IMMUNOL, V15, P620, DOI 10.1016/j.coi.2003.09.003; Emara M, 2011, J BIOL CHEM, V286, P13033, DOI 10.1074/jbc.M111.220657; Feinberg H, 2001, SCIENCE, V294, P2163, DOI 10.1126/science.1066371; Figdor CG, 2002, NAT REV IMMUNOL, V2, P77, DOI 10.1038/nri723; Furmonaviciene R, 2007, CLIN EXP ALLERGY, V37, P231, DOI 10.1111/j.1365-2222.2007.02651.x; Geijtenbeek TBH, 2004, ANNU REV IMMUNOL, V22, P33, DOI 10.1146/annurev.immunol.22.012703.104558; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Ghaemmaghami AM, 2002, CLIN EXP ALLERGY, V32, P1468, DOI 10.1046/j.1365-2745.2002.01504.x; Gold S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011360; Gould S, 2005, FOOD CHEM TOXICOL, V43, P1451, DOI 10.1016/j.fct.2005.03.007; Hammad H, 2001, BLOOD, V98, P1135, DOI 10.1182/blood.V98.4.1135; Horlock C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r30; Hsu SC, 2010, J BIOL CHEM, V285, P7903, DOI 10.1074/jbc.M109.058370; Ilver D, 1998, SCIENCE, V279, P373, DOI 10.1126/science.279.5349.373; Lambrecht BN, 2001, CURR OPIN ALLERGY CL, V1, P51, DOI 10.1097/01.all.0000010985.57414.74; Lanzavecchia A, 1996, CURR OPIN IMMUNOL, V8, P348, DOI 10.1016/S0952-7915(96)80124-5; Mahdavi J, 2002, SCIENCE, V297, P573, DOI 10.1126/science.1069076; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; McGreal EP, 2005, CURR OPIN IMMUNOL, V17, P18, DOI 10.1016/j.coi.2004.12.001; Naslavsky N, 2004, MOL BIOL CELL, V15, P3542, DOI 10.1091/mbc.E04-02-0151; Potocnik SJ, 2007, J VASC RES, V44, P292, DOI 10.1159/000101451; Royer PJ, 2010, J IMMUNOL, V185, P1522, DOI 10.4049/jimmunol.1000774; Shreffler WG, 2006, J IMMUNOL, V177, P3677, DOI 10.4049/jimmunol.177.6.3677; Soares CP, 2010, CELLS TISSUES ORGANS, V192, P187, DOI 10.1159/000316005; Subtil A, 1999, P NATL ACAD SCI USA, V96, P6775, DOI 10.1073/pnas.96.12.6775; Van Gestel RA, 2005, MOL REPROD DEV, V72, P386, DOI 10.1002/mrd.20351; van Kooyk Y, 2008, BIOCHEM SOC T, V36, P1478, DOI 10.1042/BST0361478; van Vliet SJ, 2008, IMMUNOL CELL BIOL, V86, P580, DOI 10.1038/icb.2008.55; Wu L, 2002, J VIROL, V76, P5905, DOI 10.1128/JVI.76.12.5905-5914.2002	39	44	44	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5756	5763		10.1074/jbc.M111.312520	http://dx.doi.org/10.1074/jbc.M111.312520			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22205703	Green Published, hybrid, Green Accepted			2022-12-27	WOS:000300638000051
J	Goh, WI; Lim, KB; Sudhaharan, T; Sem, KP; Bu, WY; Chou, AM; Ahmed, S				Goh, Wah Ing; Lim, Kim Buay; Sudhaharan, Thankiah; Sem, Kai Ping; Bu, Wenyu; Chou, Ai Mei; Ahmed, Sohail			mDia1 and WAVE2 Proteins Interact Directly with IRSp53 in Filopodia and Are Involved in Filopodium Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIAPHANOUS-RELATED FORMINS; ACTIN-BUNDLING ACTIVITY; MIGRATING CELLS; GTPASE RIF; RHO; MEMBRANE; COMPLEX; CDC42; RAC; LOCALIZATION	Filopodia are dynamic actin-rich cell surface protrusions involved in cell migration, axon guidance, and wound healing. The RhoGTPase Cdc42 generates filopodia via IRSp53, a multidomain protein that links the processes of plasma membrane deformation and actin dynamics required for their formation in mammalian cells. The Src homology 3 domain of IRSp53 binds to the actin regulators Mena, Eps8, WAVE1, WAVE2, mDia1, and mDia2. We show that mDia1 and WAVE2 synergize with IRSp53 to form filopodia. IRSp53 also interacts directly with these two proteins within filopodia, as observed in acceptor photobleaching FRET studies. Measurement of filopodium formation by time-lapse imaging of live cells also revealed that depleting neuronal cells of either mDia1 or WAVE2 protein decreases the ability of IRSp53 to induce filopodia. In contrast, IRSp53 does not appear to partner WAVE1 or mDia2 to give rise to these structures. In addition, although all three isoforms of mDia are capable of inducing filopodia, IRSp53 requires only mDia1 to do so. These findings suggest that mDia1 and WAVE2 are important Src homology 3 domain partners of IRSp53 in forming filopodia.	[Goh, Wah Ing; Lim, Kim Buay; Sudhaharan, Thankiah; Sem, Kai Ping; Bu, Wenyu; Chou, Ai Mei; Ahmed, Sohail] Inst Med Biol, Immunos 138665, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB)	Ahmed, S (corresponding author), Inst Med Biol, 8A Biomed Grove, Immunos 138665, Singapore.	sohail.ahmed@imb.a-star.edu.sg		Chou, Amy/0000-0002-6831-0799; Goh, Wah Ing/0000-0001-6594-0640				Abou-Kheir W, 2008, J CELL SCI, V121, P379, DOI 10.1242/jcs.010272; Ahmed S, 2010, SEMIN CELL DEV BIOL, V21, P350, DOI 10.1016/j.semcdb.2009.11.008; Arakawa Y, 2003, J CELL BIOL, V161, P381, DOI 10.1083/jcb.200210149; Beli P, 2008, NAT CELL BIOL, V10, P849, DOI 10.1038/ncb1745; Berger CN, 2009, CELL MICROBIOL, V11, P309, DOI 10.1111/j.1462-5822.2008.01254.x; Block J, 2008, J MICROSC-OXFORD, V231, P506, DOI 10.1111/j.1365-2818.2008.02063.x; Bu WY, 2009, J BIOL CHEM, V284, P11622, DOI 10.1074/jbc.M805940200; Carramusa L, 2007, J CELL SCI, V120, P3870, DOI 10.1242/jcs.014365; Chesarone MA, 2010, NAT REV MOL CELL BIO, V11, P62, DOI 10.1038/nrm2816; Chhabra ES, 2007, NAT CELL BIOL, V9, P1110, DOI 10.1038/ncb1007-1110; Dent EW, 2007, NAT CELL BIOL, V9, P1347, DOI 10.1038/ncb1654; Disanza A, 2006, NAT CELL BIOL, V8, P1337, DOI 10.1038/ncb1502; Dixit R, 2008, NEUROSCI LETT, V440, P113, DOI 10.1016/j.neulet.2008.05.031; Faix J, 2006, DEV CELL, V10, P693, DOI 10.1016/j.devcel.2006.05.001; Fan LF, 2010, J CELL SCI, V123, P1247, DOI 10.1242/jcs.061754; Fujiwara T, 2000, BIOCHEM BIOPH RES CO, V271, P626, DOI 10.1006/bbrc.2000.2671; Goh WI, 2011, J BIOL CHEM, V286, P13681, DOI 10.1074/jbc.M110.182683; Gomez TS, 2007, IMMUNITY, V26, P177, DOI 10.1016/j.immuni.2007.01.008; Govind S, 2001, J CELL BIOL, V152, P579, DOI 10.1083/jcb.152.3.579; Harris ES, 2006, J BIOL CHEM, V281, P14383, DOI 10.1074/jbc.M510923200; Hotulainen P, 2009, J CELL BIOL, V185, P323, DOI 10.1083/jcb.200809046; Ji P, 2008, NAT CELL BIOL, V10, P314, DOI 10.1038/ncb1693; Krugmann S, 2001, CURR BIOL, V11, P1645, DOI 10.1016/S0960-9822(01)00506-1; Kurisu S, 2010, CANCER SCI, V101, P2093, DOI 10.1111/j.1349-7006.2010.01654.x; Lanier LM, 1999, NEURON, V22, P313, DOI 10.1016/S0896-6273(00)81092-2; Lee K, 2010, SCIENCE, V329, P1341, DOI 10.1126/science.1191710; Lim KB, 2008, J BIOL CHEM, V283, P20454, DOI 10.1074/jbc.M710185200; Lin L, 2010, EXP CELL RES, V316, P2260, DOI 10.1016/j.yexcr.2010.05.006; Lizarraga F, 2009, CANCER RES, V69, P2792, DOI 10.1158/0008-5472.CAN-08-3709; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; Mellor H, 2010, BBA-MOL CELL RES, V1803, P191, DOI 10.1016/j.bbamcr.2008.12.018; Miki H, 2000, NATURE, V408, P732, DOI 10.1038/35047107; Miki H, 1998, NATURE, V391, P93, DOI 10.1038/34208; Nakagawa H, 2003, J CELL SCI, V116, P2577, DOI 10.1242/jcs.00462; Nozumi M, 2003, J CELL SCI, V116, P239, DOI 10.1242/jcs.00233; Pellegrin S, 2005, CURR BIOL, V15, P129, DOI 10.1016/j.cub.2005.01.011; Peng J, 2003, CURR BIOL, V13, P534, DOI 10.1016/S0960-9822(03)00170-2; Ramalingam N, 2010, EUR J CELL BIOL, V89, P723, DOI 10.1016/j.ejcb.2010.06.001; Robens JM, 2010, MOL CELL BIOL, V30, P829, DOI 10.1128/MCB.01574-08; Roffers-Agarwal J, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-36; Sudhaharan T, 2009, J BIOL CHEM, V284, P13602, DOI 10.1074/jbc.M900894200; Suetsugu S, 2003, DEV CELL, V5, P595, DOI 10.1016/S1534-5807(03)00297-1; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Tokuo H, 2004, BIOCHEM BIOPH RES CO, V319, P214, DOI 10.1016/j.bbrc.2004.04.167; Tominaga T, 2000, MOL CELL, V5, P13, DOI 10.1016/S1097-2765(00)80399-8; Wallar BJ, 2003, TRENDS CELL BIOL, V13, P435, DOI 10.1016/S0962-8924(03)00153-3; Wallar BJ, 2007, EXP CELL RES, V313, P560, DOI 10.1016/j.yexcr.2006.10.033; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; Watanabe S, 2010, MOL BIOL CELL, V21, P3193, DOI 10.1091/mbc.E10-04-0324; Yamagishi A, 2004, J BIOL CHEM, V279, P14929, DOI 10.1074/jbc.M309408200; Yamana N, 2006, MOL CELL BIOL, V26, P6844, DOI 10.1128/MCB.00283-06; Yamazaki D, 2003, NATURE, V424, P452, DOI 10.1038/nature01770; Yan C, 2003, EMBO J, V22, P3602, DOI 10.1093/emboj/cdg350; Yang C, 2007, PLOS BIOL, V5, P2624, DOI 10.1371/journal.pbio.0050317; Young KG, 2010, BBA-MOL CELL RES, V1803, P183, DOI 10.1016/j.bbamcr.2008.09.017; Zaoui K, 2008, J CELL BIOL, V183, P401, DOI 10.1083/jcb.200805107	56	54	55	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4702	4714		10.1074/jbc.M111.305102	http://dx.doi.org/10.1074/jbc.M111.305102			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22179776	Green Published, hybrid			2022-12-27	WOS:000300608500032
J	Rhee, SG; Woo, HA; Kil, IS; Bae, SH				Rhee, Sue Goo; Woo, Hyun Ae; Kil, In Sup; Bae, Soo Han			Peroxiredoxin Functions as a Peroxidase and a Regulator and Sensor of Local Peroxides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							THIOL-SPECIFIC ANTIOXIDANT; CYSTEINE-SULFINIC ACID; LUNG PHOSPHOLIPID-METABOLISM; ACTIVE-SITE CYSTEINE; 2-CYS PEROXIREDOXIN; OXIDATIVE STRESS; HYDROGEN-PEROXIDE; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; 1-CYS PEROXIREDOXIN	Peroxiredoxins (Prxs) contain an active site cysteine that is sensitive to oxidation by H2O2. Mammalian cells express six Prx isoforms that are localized to various cellular compartments. The oxidized active site cysteine of Prx can be reduced by a cellular thiol, thus enabling Prx to function as a locally constrained peroxidase. Regulation of Prx via phosphorylation in response to extracellular signals allows the local accumulation of H2O2 and thereby enables its messenger function. The fact that the oxidation state of the active site cysteine of Prx can be transferred to other proteins that are less intrinsically susceptible to H2O2 also allows Prx to function as an H2O2 sensor.	[Rhee, Sue Goo; Woo, Hyun Ae; Kil, In Sup; Bae, Soo Han] Ewha Womans Univ, Div Life & Pharmaceut Sci, Seoul 120750, South Korea; [Rhee, Sue Goo] Ewha Womans Univ, Dept Bioinspired Sci, Seoul 120750, South Korea; [Woo, Hyun Ae] Ewha Womans Univ, Coll Pharm, Seoul 120750, South Korea	Ewha Womans University; Ewha Womans University; Ewha Womans University	Rhee, SG (corresponding author), Ewha Womans Univ, Div Life & Pharmaceut Sci, Seoul 120750, South Korea.	rheesg@ewha.ac.kr	Woo, Hyun Ae/AAT-9586-2021		National Research Foundation of Korea [2009-0052293, M10642040001-07N4204-00110]	National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by National Honor Scientist Program Grant 2009-0052293 and Bio R&D Program Grant M10642040001-07N4204-00110 (to S. G. R.) from the National Research Foundation of Korea. This is the second article in the Thematic Minireview Series on Redox Sensing and Regulation.	Bae SH, 2011, HEPATOLOGY, V53, P945, DOI 10.1002/hep.24104; Bae YS, 1997, J BIOL CHEM, V272, P217, DOI 10.1074/jbc.272.1.217; Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; Boileau C, 2011, NEW PHYTOL, V191, P1108, DOI 10.1111/j.1469-8137.2011.03774.x; Bozonet SM, 2005, J BIOL CHEM, V280, P23319, DOI 10.1074/jbc.M502757200; Bryk R, 2000, NATURE, V407, P211, DOI 10.1038/35025109; Cao JX, 2009, EMBO J, V28, P1505, DOI 10.1038/emboj.2009.101; Cederbaum AI, 2009, ARCH TOXICOL, V83, P519, DOI 10.1007/s00204-009-0432-0; CHAE HZ, 1993, J BIOL CHEM, V268, P16815; CHAE HZ, 1994, P NATL ACAD SCI USA, V91, P7017, DOI 10.1073/pnas.91.15.7017; CHAE HZ, 1994, J BIOL CHEM, V269, P27670; CHAE HZ, 1994, P NATL ACAD SCI USA, V91, P7022, DOI 10.1073/pnas.91.15.7022; Chang TS, 2002, J BIOL CHEM, V277, P25370, DOI 10.1074/jbc.M110432200; Chen JW, 2000, J BIOL CHEM, V275, P28421, DOI 10.1074/jbc.M005073200; Choi HJ, 1998, NAT STRUCT BIOL, V5, P400, DOI 10.1038/nsb0598-400; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Delaunay A, 2002, CELL, V111, P471, DOI 10.1016/S0092-8674(02)01048-6; Dey A, 2006, HEPATOLOGY, V43, pS63, DOI 10.1002/hep.20957; Fang JG, 2007, P NATL ACAD SCI USA, V104, P18742, DOI 10.1073/pnas.0705904104; Fisher AB, 2005, J LIPID RES, V46, P1248, DOI 10.1194/jlr.M400499-JLR200; Fisher AB, 2011, ANTIOXID REDOX SIGN, V15, P831, DOI 10.1089/ars.2010.3412; Grecco HE, 2011, CELL, V144, P897, DOI 10.1016/j.cell.2011.01.029; Hall A, 2011, ANTIOXID REDOX SIGN, V15, P795, DOI 10.1089/ars.2010.3624; Hirotsu S, 1999, P NATL ACAD SCI USA, V96, P12333, DOI 10.1073/pnas.96.22.12333; Hugo M, 2009, BIOCHEMISTRY-US, V48, P9416, DOI 10.1021/bi901221s; Jang HH, 2004, CELL, V117, P625, DOI 10.1016/j.cell.2004.05.002; Kang SW, 1998, J BIOL CHEM, V273, P6303, DOI 10.1074/jbc.273.11.6303; KIM IH, 1989, P NATL ACAD SCI USA, V86, P6018, DOI 10.1073/pnas.86.16.6018; KIM K, 1985, J BIOL CHEM, V260, P5394; KIM KW, 1988, J BIOL CHEM, V263, P4704; Kim TS, 1998, AM J PHYSIOL-LUNG C, V274, pL750, DOI 10.1152/ajplung.1998.274.5.L750; Kim TS, 1997, J BIOL CHEM, V272, P2542; Knoops B, 2011, ANTIOXID REDOX SIGN, V15, P817, DOI 10.1089/ars.2010.3584; Koo KH, 2002, ARCH BIOCHEM BIOPHYS, V397, P312, DOI 10.1006/abbi.2001.2700; Kusumi A, 1996, CURR OPIN CELL BIOL, V8, P566, DOI 10.1016/S0955-0674(96)80036-6; Kwon J, 2004, P NATL ACAD SCI USA, V101, P16419, DOI 10.1073/pnas.0407396101; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lee SR, 1999, J BIOL CHEM, V274, P4722, DOI 10.1074/jbc.274.8.4722; Lee TH, 2003, BLOOD, V101, P5033, DOI 10.1182/blood-2002-08-2548; Leslie NR, 2003, EMBO J, V22, P5501, DOI 10.1093/emboj/cdg513; Lim JC, 2008, J BIOL CHEM, V283, P28873, DOI 10.1074/jbc.M804087200; Manevich Y, 2005, FREE RADICAL BIO MED, V38, P1422, DOI 10.1016/j.freeradbiomed.2005.02.011; Manevich Y, 2004, P NATL ACAD SCI USA, V101, P3780, DOI 10.1073/pnas.0400181101; Montemartini M, 1999, EUR J BIOCHEM, V264, P516, DOI 10.1046/j.1432-1327.1999.00656.x; Moon JC, 2005, J BIOL CHEM, V280, P28775, DOI 10.1074/jbc.M505362200; Nelson KJ, 2008, BIOCHEMISTRY-US, V47, P12860, DOI 10.1021/bi801718d; Neumann CA, 2003, NATURE, V424, P561, DOI 10.1038/nature01819; Noh YH, 2009, J BIOL CHEM, V284, P8470, DOI 10.1074/jbc.M808981200; Oakley FD, 2009, ANTIOXID REDOX SIGN, V11, P1313, DOI 10.1089/ARS.2008.2363; Ogusucu R, 2007, FREE RADICAL BIO MED, V42, P326, DOI 10.1016/j.freeradbiomed.2006.10.042; Okazaki S, 2007, MOL CELL, V27, P675, DOI 10.1016/j.molcel.2007.06.035; Park JW, 2011, BIOCHEMISTRY-US, V50, P3204, DOI 10.1021/bi101373h; Park JW, 2009, J BIOL CHEM, V284, P23364, DOI 10.1074/jbc.M109.021394; Parmigiani RB, 2008, P NATL ACAD SCI USA, V105, P9633, DOI 10.1073/pnas.0803749105; Pascual MB, 2010, J BIOL CHEM, V285, P34485, DOI 10.1074/jbc.M110.160465; Peskin AV, 2007, J BIOL CHEM, V282, P11885, DOI 10.1074/jbc.M700339200; Rabilloud T, 2002, J BIOL CHEM, V277, P19396, DOI 10.1074/jbc.M106585200; RASHBASTEP J, 1993, ARCH BIOCHEM BIOPHYS, V300, P401, DOI 10.1006/abbi.1993.1054; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Rhee SG, 2011, ANTIOXID REDOX SIGN, V15, P781, DOI 10.1089/ars.2010.3393; Seo JH, 2009, J BIOL CHEM, V284, P13455, DOI 10.1074/jbc.M900641200; Seo MS, 2000, J BIOL CHEM, V275, P20346, DOI 10.1074/jbc.M001943200; Shaikhali J, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-48; SHICHI H, 1990, EXP EYE RES, V50, P513, DOI 10.1016/0014-4835(90)90040-2; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Smeets A, 2008, ARCH BIOCHEM BIOPHYS, V477, P98, DOI 10.1016/j.abb.2008.04.036; Song BJ, 1996, ALCOHOL CLIN EXP RES, V20, pA138, DOI 10.1111/j.1530-0277.1996.tb01764.x; Sorokina EM, 2011, AM J PHYSIOL-CELL PH, V300, pC1430, DOI 10.1152/ajpcell.00285.2010; Stone JR, 2006, ANTIOXID REDOX SIGN, V8, P243, DOI 10.1089/ars.2006.8.243; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Tavender TJ, 2008, BIOCHEM J, V411, P191, DOI 10.1042/BJ20071428; Tavender TJ, 2010, EMBO J, V29, P4185, DOI 10.1038/emboj.2010.273; Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016; Trujillo Madia, 2007, V44, P83; Tu BP, 2004, J CELL BIOL, V164, P341, DOI 10.1083/jcb.200311055; Ushio-Fukai M, 2009, ANTIOXID REDOX SIGN, V11, P1289, DOI [10.1089/ars.2008.2333, 10.1089/ARS.2008.2333]; Vivancos AP, 2005, P NATL ACAD SCI USA, V102, P8875, DOI 10.1073/pnas.0503251102; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85; Woo HA, 2005, J BIOL CHEM, V280, P3125, DOI 10.1074/jbc.C400496200; Woo HA, 2010, CELL, V140, P517, DOI 10.1016/j.cell.2010.01.009; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Yan Y, 2009, CELL, V138, P1209, DOI 10.1016/j.cell.2009.06.042; Yang KS, 2002, J BIOL CHEM, V277, P38029, DOI 10.1074/jbc.M206626200; Zito E, 2010, MOL CELL, V40, P787, DOI 10.1016/j.molcel.2010.11.010; Zito E, 2010, J CELL BIOL, V188, P821, DOI 10.1083/jcb.200911086; Zykova TA, 2010, J BIOL CHEM, V285, P29138, DOI 10.1074/jbc.M110.135905	88	383	395	7	76	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4403	4410		10.1074/jbc.R111.283432	http://dx.doi.org/10.1074/jbc.R111.283432			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22147704	hybrid, Green Published			2022-12-27	WOS:000300608500003
J	Cracan, V; Banerjee, R				Cracan, Valentin; Banerjee, Ruma			Novel Coenzyme B-12-dependent Interconversion of Isovaleryl-CoA and Pivalyl-CoA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ETHANOLAMINE AMMONIA-LYASE; TERT-BUTYL ETHER; STREPTOMYCES-CINNAMONENSIS; METHYLMALONIC ACIDURIA; LYSINE 5,6-AMINOMUTASE; GLYCEROL DEHYDRATASES; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; FATTY-ACID; MUTASE	5'-Deoxyadenosylcobalamin (AdoCbl)-dependent isomerases catalyze carbon skeleton rearrangements using radical chemistry. We have recently characterized a fusion protein that comprises the two subunits of the AdoCbl-dependent isobutyryl-CoA mutase flanking a G-protein chaperone and named it isobutyryl-CoA mutase fused (IcmF). IcmF catalyzes the interconversion of isobutyryl-CoA and n-butyryl-CoA, whereas GTPase activity is associated with its G-protein domain. In this study, we report a novel activity associated with IcmF, i.e. the interconversion of isovaleryl-CoA and pivalyl-CoA. Kinetic characterization of IcmF yielded the following values: a Km for isovaleryl-CoA of 62 +/- 8 mu M and V-max of 0.021 +/- 0.004 mu mol min(-1) mg(-1) at 37 degrees C. Biochemical experiments show that an IcmF in which the base specificity loop motif NKXD is modified to NKXE catalyzes the hydrolysis of both GTP and ATP. IcmF is susceptible to rapid inactivation during turnover, and GTP conferred modest protection during utilization of isovaleryl-CoA as substrate. Interestingly, there was no protection from inactivation when either isobutyryl-CoA or n-butyryl-CoA was used as substrate. Detailed kinetic analysis indicated that inactivation is associated with loss of the 5'-deoxyadenosine moiety from the active site, precluding reformation of AdoCbl at the end of the turnover cycle. Under aerobic conditions, oxidation of the cob(II)alamin radical in the inactive enzyme results in accumulation of aquacobalamin. Because pivalic acid found in sludge can be used as a carbon source by some bacteria and isovaleryl-CoA is an intermediate in leucine catabolism, our discovery of a new isomerase activity associated with IcmF expands its metabolic potential.	[Cracan, Valentin; Banerjee, Ruma] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Banerjee, R (corresponding author), Univ Michigan, Dept Biol Chem, 3220B MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	rbanerje@umich.edu		Cracan, Valentin/0000-0002-3280-0593	National Institutes of Health [DK45776]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK045776, R01DK045776] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK45776.	Alm EJ, 2005, GENOME RES, V15, P1015, DOI 10.1101/gr.3844805; BABIOR BM, 1974, J BIOL CHEM, V249, P1689; Banerjee R, 2003, CHEM REV, V103, P2083, DOI 10.1021/cr0204395; Brigham CJ, 2010, J BACTERIOL, V192, P5454, DOI 10.1128/JB.00493-10; Chang CH, 2000, J BIOL CHEM, V275, P106, DOI 10.1074/jbc.275.1.106; Cracan V, 2010, J BIOL CHEM, V285, P655, DOI 10.1074/jbc.M109.062182; Dobson CM, 2002, P NATL ACAD SCI USA, V99, P15554, DOI 10.1073/pnas.242614799; DRENNAN CL, 1994, SCIENCE, V266, P1669, DOI 10.1126/science.7992050; Erb TJ, 2008, J BIOL CHEM, V283, P32283, DOI 10.1074/jbc.M805527200; Gaal T, 1997, SCIENCE, V278, P2092, DOI 10.1126/science.278.5346.2092; Gruber K, 2011, CHEM SOC REV, V40, P4346, DOI 10.1039/c1cs15118e; Hubbard PA, 2007, J BIOL CHEM, V282, P31308, DOI 10.1074/jbc.M704850200; Kajiura H, 2007, FEBS J, V274, P5556, DOI 10.1111/j.1742-4658.2007.06074.x; Koller-Eichhorn R, 2007, J BIOL CHEM, V282, P19928, DOI 10.1074/jbc.M700541200; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Lerner-Ellis JP, 2004, HUM MUTAT, V24, P509, DOI 10.1002/humu.20104; Maiti N, 1999, J BIOL CHEM, V274, P32733, DOI 10.1074/jbc.274.46.32733; Mancia F, 1998, STRUCTURE, V6, P711, DOI 10.1016/S0969-2126(98)00073-2; Mancia F, 1996, STRUCTURE, V4, P339, DOI 10.1016/S0969-2126(96)00037-8; Matsuoka H, 2007, J BIOL CHEM, V282, P5180, DOI 10.1074/jbc.M606831200; Mori K, 2004, J BACTERIOL, V186, P6845, DOI 10.1128/JB.186.20.6845-6854.2004; Muller RH, 2007, APPL ENVIRON MICROB, V73, P1783, DOI 10.1128/AEM.01899-06; Padovani D, 2006, BIOCHEMISTRY-US, V45, P9300, DOI 10.1021/bi0604532; Padovani D, 2009, P NATL ACAD SCI USA, V106, P21567, DOI 10.1073/pnas.0908106106; Pandit SB, 2003, PROTEINS, V52, P585, DOI 10.1002/prot.10420; Probian C, 2003, APPL ENVIRON MICROB, V69, P1866, DOI 10.1128/AEM.69.3.1866-1870.2003; Ratnatilleke A, 1999, J BIOL CHEM, V274, P31679, DOI 10.1074/jbc.274.44.31679; Reddick JJ, 2008, BIOTECHNOL LETT, V30, P1045, DOI 10.1007/s10529-008-9642-4; Rezanka T, 2011, ENVIRON MICROBIOL, V13, P1577, DOI 10.1111/j.1462-2920.2011.02465.x; Rohwerder T, 2008, VITAMIN B NEW RES, P81; Rohwerder T, 2006, APPL ENVIRON MICROB, V72, P4128, DOI 10.1128/AEM.00080-06; Rohwerder T, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-13; Solano-Serena F, 2004, J APPL MICROBIOL, V97, P629, DOI 10.1111/j.1365-2672.2004.02344.x; Soundararajan M, 2007, BIOCHEM J, V401, P679, DOI 10.1042/BJ20060555; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Tang KH, 2001, BIOCHEMISTRY-US, V40, P5190, DOI 10.1021/bi010157j; Toraya T, 2000, CELL MOL LIFE SCI, V57, P106, DOI 10.1007/s000180050502; Toraya T, 2008, J BIOCHEM, V144, P437, DOI 10.1093/jb/mvn086; Vrijbloed JW, 1999, J BACTERIOL, V181, P5600, DOI 10.1128/JB.181.18.5600-5605.1999; Wittinghofer A, 2011, ANNU REV BIOCHEM, V80, P943, DOI 10.1146/annurev-biochem-062708-134043; ZELDER O, 1994, EUR J BIOCHEM, V226, P577, DOI 10.1111/j.1432-1033.1994.tb20083.x; Zhang YX, 1999, MICROBIOL-SGM, V145, P2323, DOI 10.1099/00221287-145-9-2323	43	17	19	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					3723	3732		10.1074/jbc.M111.320051	http://dx.doi.org/10.1074/jbc.M111.320051			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22167181	Green Published, hybrid			2022-12-27	WOS:000300410900010
J	Das, F; Ghosh-Choudhury, N; Dey, N; Mandal, CC; Mahimainathan, L; Kasinath, BS; Abboud, HE; Choudhury, GG				Das, Falguni; Ghosh-Choudhury, Nandini; Dey, Nirmalya; Mandal, Chandi Charan; Mahimainathan, Lenin; Kasinath, Balakuntalam S.; Abboud, Hanna E.; Choudhury, Goutam Ghosh			Unrestrained Mammalian Target of Rapamycin Complexes 1 and 2 Increase Expression of Phosphatase and Tensin Homolog Deleted on Chromosome 10 to Regulate Phosphorylation of Akt Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR GENE; TUBEROUS-SCLEROSIS; INSULIN-RESISTANCE; SIGNALING PATHWAY; BINDING PARTNER; MTOR; ACTIVATION; PTEN; TSC2; GROWTH	Tuberous sclerosis complex 2 (TSC2) and phosphatase and tensin homolog deleted on chromosome 10 (PTEN) function to block growth factor-induced mammalian target of rapamycin (mTOR) signaling and are mutated in autosomal dominant hamartoma syndromes. mTOR binds to a spectrum of common and different proteins to form TOR complex 1 (TORC1) and TORC2, which regulate cell growth, division, and metabolism. TSC2 deficiency induces constitutive activation of mTOR, leading to a state of insulin resistance due to a negative feedback regulation, resulting in reduced Akt phosphorylation. We have recently described an alternative mechanism showing that in TSC2 deficiency, enhanced PTEN expression contributes to reduced Akt phosphorylation. To explore the mechanism of PTEN regulation, we used rapamycin and constitutively active mTOR to show that TORC1 increases the expression of PTEN mRNA and protein. We found that in TSC2(-/-) mouse embryonic fibroblasts expression of a kinase-dead mutant of mTOR, which inhibits both TORC1 and TORC2, decreases the expression of PTEN via transcriptional mechanism. Furthermore, kinase-deadm TOR increased and decreased phosphorylation of Akt at catalytic loop site Thr-308 and hydrophobic motif site Ser-473, respectively. Moreover, inhibition of deregulated TORC1 in TSC2-null mouse embryonic fibroblasts or in 293 cells by down-regulation of raptor decreased the levels of the transcription factor Hif1 alpha and blocked PTEN expression, resulting in enhanced phosphorylation of Akt at Thr-308 and Ser-473. Finally, knockdown of rictor or mSin1 attenuated the expression of Hif1 alpha, which decreased transcription of PTEN. These results unravel a previously unrecognized cell-autonomous function of TORC1 and TORC2 in the up-regulation of PTEN, which prevents phosphorylation of Akt and may shield against the development of malignancy in TSC patients.	[Das, Falguni; Dey, Nirmalya; Mahimainathan, Lenin; Kasinath, Balakuntalam S.; Abboud, Hanna E.; Choudhury, Goutam Ghosh] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Ghosh-Choudhury, Nandini; Mandal, Chandi Charan] Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX 78229 USA; [Choudhury, Goutam Ghosh] S Texas Vet Hlth Care Syst, Geriatr Res Educ & Clin Ctr, San Antonio, TX 78229 USA; [Ghosh-Choudhury, Nandini; Choudhury, Goutam Ghosh] S Texas Vet Hlth Care Syst, Vet Affairs Res, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Choudhury, GG (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Med, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	choudhuryg@uthscsa.edu		/0000-0001-5077-3552; Mandal, Chandi/0000-0002-2292-6635	National Institutes of Health [RO1 DK50190, RO1 AR 52425, RO1 DK 077295, RC2A 036613]; Veterans Affairs Merit Review; Cancer Therapy and Research Center, San Antonio; Veterans Affairs Senior Research Career Scientist Award; Juvenile Diabetes Research Foundation [1-2008-185]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050190, R01DK077295, R01DK078971] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Review(US Department of Veterans Affairs); Cancer Therapy and Research Center, San Antonio; Veterans Affairs Senior Research Career Scientist Award; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 DK50190 (to G. G. C.), RO1 AR 52425 (to N. G. C.). This work was also supported by Veterans Affairs Merit Review grant (to G. G. C.).; Supported by Veterans Affairs Merit Review grants and a Ronald P. Williams Orthopedic Oncology Developmental Research Award from Cancer Therapy and Research Center, San Antonio.; Supported by NIH RO1 DK 077295, RC2A 036613, and Veterans Affairs Research Service grant.; Recipient of a Veterans Affairs Senior Research Career Scientist Award and supported by Regular Research Grant 1-2008-185 from the Juvenile Diabetes Research Foundation. To whom correspondence should be addressed: Dept. of Medicine, University of Texas Health Science Center, 7703 Floyd Curl Dr., San Antonio, TX 78229. E-mail: choudhuryg@uthscsa.edu.	Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Brugarolas JB, 2003, CANCER CELL, V4, P147, DOI 10.1016/S1535-6108(03)00187-9; Chandarlapaty S, 2011, CANCER CELL, V19, P58, DOI 10.1016/j.ccr.2010.10.031; Chandrasekar B, 2006, BIOCHEM BIOPH RES CO, V339, P956, DOI 10.1016/j.bbrc.2005.11.100; Cheadle JP, 2000, HUM GENET, V107, P97, DOI 10.1007/s004390000348; Choudhury GG, 2004, J BIOL CHEM, V279, P27399, DOI 10.1074/jbc.M403530200; Cloughesy TF, 2008, PLOS MED, V5, P139, DOI 10.1371/journal.pmed.0050008; Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; Dabora SL, 2001, AM J HUM GENET, V68, P64, DOI 10.1086/316951; Das F, 2008, CELL SIGNAL, V20, P409, DOI 10.1016/j.cellsig.2007.10.027; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; El-Hashemite N, 2003, LANCET, V361, P1348, DOI 10.1016/S0140-6736(03)13044-9; Eng C, 2003, HUM MUTAT, V22, P183, DOI 10.1002/humu.10257; Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001; Ghosh-Choudhury T, 2009, BREAST CANCER RES TR, V118, P213, DOI 10.1007/s10549-008-0227-7; Goncharova EA, 2002, J BIOL CHEM, V277, P30958, DOI 10.1074/jbc.M202678200; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Huang JX, 2008, MOL CELL BIOL, V28, P4104, DOI 10.1128/MCB.00289-08; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Ji SP, 2006, NAT MED, V12, P324, DOI 10.1038/nm1349; Kasinath BS, 2009, AM J PHYSIOL-RENAL, V297, pF1153, DOI 10.1152/ajprenal.90748.2008; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kwiatkowski DJ, 2005, HUM MOL GENET, V14, pR251, DOI 10.1093/hmg/ddi260; Lamborn KR, 2008, NEURO-ONCOLOGY, V10, P162, DOI 10.1215/15228517-2007-062; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Laughner E, 2001, MOL CELL BIOL, V21, P3995, DOI 10.1128/MCB.21.12.3995-4004.2001; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Li Y, 2004, TRENDS BIOCHEM SCI, V29, P32, DOI 10.1016/j.tibs.2003.11.007; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Ma L, 2007, CANCER RES, V67, P7106, DOI 10.1158/0008-5472.CAN-06-4798; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Mahimainathan L, 2004, J BIOL CHEM, V279, P15258, DOI 10.1074/jbc.M314328200; Mahimainathan L, 2009, J BIOL CHEM, V284, P27790, DOI 10.1074/jbc.M109.028860; Manning BD, 2005, GENE DEV, V19, P1773, DOI 10.1101/gad.1314605; Manning BD, 2004, J CELL BIOL, V167, P399, DOI 10.1083/jcb.200408161; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Ohne Y, 2008, J BIOL CHEM, V283, P31861, DOI 10.1074/jbc.M801546200; Riemenschneider MJ, 2006, CANCER RES, V66, P5618, DOI 10.1158/0008-5472.CAN-06-0364; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; Saal LH, 2008, NAT GENET, V40, P102, DOI 10.1038/ng.2007.39; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Scheid MP, 2003, FEBS LETT, V546, P108, DOI 10.1016/S0014-5793(03)00562-3; Shah OJ, 2006, MOL CELL BIOL, V26, P6425, DOI 10.1128/MCB.01254-05; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Shah OJ, 2005, CELL CYCLE, V4, P46, DOI 10.4161/cc.4.1.1343; Stambolic V, 2001, MOL CELL, V8, P317, DOI 10.1016/S1097-2765(01)00323-9; Stiles BL, 2009, INT J BIOCHEM CELL B, V41, P757, DOI 10.1016/j.biocel.2008.09.022; Tamura M, 1998, SCIENCE, V280, P1614, DOI 10.1126/science.280.5369.1614; Thomas GV, 2006, NAT MED, V12, P122, DOI 10.1038/nm1337; Virolle T, 2001, NAT CELL BIOL, V3, P1124, DOI 10.1038/ncb1201-1124; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Wymann MP, 2005, CURR OPIN CELL BIOL, V17, P141, DOI 10.1016/j.ceb.2005.02.011; Yang J, 2002, MOL CELL, V9, P1227, DOI 10.1016/S1097-2765(02)00550-6; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222; Zhang HB, 2007, J CLIN INVEST, V117, P730, DOI 10.1172/JCI28984; Zinzalla V, 2011, CELL, V144, P757, DOI 10.1016/j.cell.2011.02.014; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	65	32	32	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					3808	3822		10.1074/jbc.M111.246397	http://dx.doi.org/10.1074/jbc.M111.246397			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22184110	Green Published, hybrid			2022-12-27	WOS:000300410900018
J	Bidaux, G; Beck, B; Zholos, A; Gordienko, D; Lemonnier, L; Flourakis, M; Roudbaraki, M; Borowiec, AS; Fernandez, J; Delcourt, P; Lepage, G; Shuba, Y; Skryma, R; Prevarskaya, N				Bidaux, Gabriel; Beck, Benjamin; Zholos, Alexander; Gordienko, Dmitri; Lemonnier, Loic; Flourakis, Matthieu; Roudbaraki, Morad; Borowiec, Anne-Sophie; Fernandez, Jose; Delcourt, Philippe; Lepage, Gilbert; Shuba, Yaroslav; Skryma, Roman; Prevarskaya, Natalia			Regulation of Activity of Transient Receptor Potential Melastatin 8 (TRPM8) Channel by Its Short Isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLD RECEPTOR; PROSTATE-CANCER; CATION CHANNEL; SPLICE VARIANT; ACTIVATION; REVEALS; IDENTIFICATION; GENE	One important mechanism of the regulation of membrane ion channels involves their nonfunctional isoforms generated by alternative splicing. However, knowledge of such isoforms for the members of the transient receptor potential (TRP) superfamily of ion channels remains quite limited. This study focuses on the TRPM8, which functions as a cold receptor in sensory neurons but is also expressed in tissues not exposed to ambient temperatures, as well as in cancer tissues. We report the cloning from prostate cancer cells of new short splice variants of TRPM8, termed short TRPM8 alpha and short TRPM8 beta. Our results show that both variants are in a closed configuration with the C-terminal tail of the full-length TRPM8 channel, resulting in stabilization of its closed state and thus reducing both its cold sensitivity and activity. Our findings therefore uncover a new mode of regulation of the TRPM8 channel by its splice variants.	[Bidaux, Gabriel; Beck, Benjamin; Zholos, Alexander; Gordienko, Dmitri; Lemonnier, Loic; Flourakis, Matthieu; Roudbaraki, Morad; Borowiec, Anne-Sophie; Delcourt, Philippe; Lepage, Gilbert; Shuba, Yaroslav; Skryma, Roman; Prevarskaya, Natalia] INSERM, U1003, Equipe Labellisee Ligue Natl Canc, F-59655 Villeneuve Dascq, France; [Bidaux, Gabriel; Beck, Benjamin; Zholos, Alexander; Gordienko, Dmitri; Lemonnier, Loic; Flourakis, Matthieu; Roudbaraki, Morad; Borowiec, Anne-Sophie; Delcourt, Philippe; Lepage, Gilbert; Shuba, Yaroslav; Skryma, Roman; Prevarskaya, Natalia] USTL, F-59655 Villeneuve Dascq, France; [Fernandez, Jose] Queens Univ Belfast, Ctr Vis & Vasc Sci, Belfast BT12 6BA, Antrim, North Ireland	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Queens University Belfast	Bidaux, G (corresponding author), INSERM, U1003, Equipe Labellisee Ligue Natl Canc, F-59655 Villeneuve Dascq, France.	gabriel.bidaux@univ-lille1.fr; natacha.prevarskaya@univ-lille1.fr	Lemonnier, Loic/L-7289-2018; Shuba, Yaroslav/AAT-6758-2021; Zholos, Alexander/A-7017-2011; Bidaux, Gabriel/F-1294-2016	Lemonnier, Loic/0000-0001-6200-5382; Zholos, Alexander/0000-0002-4320-149X; Fernandez, Jose A/0000-0002-4199-5513; Prevarskaya, natacha/0000-0003-0316-197X; Beck, Benjamin/0000-0001-8162-7566; Bidaux, Gabriel/0000-0002-6162-3223; Flourakis, Matthieu/0000-0002-5366-9125; Gordienko, Dmitri (Dmytro)/0000-0002-4118-9976; Morad, Roudbaraki/0000-0001-5751-3323	INSERM; Ministere de l'Education Nationale; Ligue Nationale contre le Cancer; Agence Nationale de Recherche; Association de Recherche sur les Tumeurs de la Prostate; Region Nord-Pas-de-Calais; Derzhavniy Fond Fundamental'nikh Dosliddhzen [F46.2/001]; University of Lille; Fondation pour la Recherche Medicale	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Ministere de l'Education Nationale; Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Agence Nationale de Recherche(French National Research Agency (ANR)); Association de Recherche sur les Tumeurs de la Prostate; Region Nord-Pas-de-Calais(Region Hauts-de-FranceEuropean Commission); Derzhavniy Fond Fundamental'nikh Dosliddhzen; University of Lille; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported in part by grants from INSERM, the Ministere de l'Education Nationale, the Ligue Nationale contre le Cancer, the Agence Nationale de Recherche, the Association de Recherche sur les Tumeurs de la Prostate, and the Region Nord-Pas-de-Calais.; Supported by Derzhavniy Fond Fundamental'nikh Dosliddhzen Grant F46.2/001. Present address: Lab. of Molecular Pharmacology and Biophysics of Cell Signalling, State Key Laboratory of Molecular and Cell Biology, Bogomoletz Institute of Physiology, 01024 Kiev, Ukraine.; Supported by the Visiting Scientist Program of the University of Lille. Present address: International Center of Molecular Physiology, State Key Laboratory of Molecular and Cell Biology, Bogomoletz Institute of Physiology, National Academy of Sciences of Ukraine, 01024 Kyiv, Ukraine.; Charge de Recherche of the FRS/Fonds de la Recherche Scientifique (FNRS). Supported by the Fondation pour la Recherche Medicale. Present address: Inst. de Recherche Interdisciplinaire en Biologie Humaine et Moleculaire (IRIBHM), 808 route de Lennik, 1070 Brussels, Belgium.	Abeele FV, 2006, J BIOL CHEM, V281, P40174, DOI 10.1074/jbc.M605779200; Andersson DA, 2007, J NEUROSCI, V27, P3347, DOI 10.1523/JNEUROSCI.4846-06.2007; Bidaux G, 2007, J CLIN INVEST, V117, P1647, DOI 10.1172/JCI30168; Brauchi S, 2006, J NEUROSCI, V26, P4835, DOI 10.1523/JNEUROSCI.5080-05.2006; Brauchi S, 2004, P NATL ACAD SCI USA, V101, P15494, DOI 10.1073/pnas.0406773101; Chu X, 2005, CELL CALCIUM, V37, P173, DOI 10.1016/j.ceca.2004.08.005; Chuang HH, 2004, NEURON, V43, P859, DOI 10.1016/j.neuron.2004.08.038; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Dhaka A, 2006, ANNU REV NEUROSCI, V29, P135, DOI 10.1146/annurev.neuro.29.051605.112958; Dragoni I, 2006, J BIOL CHEM, V281, P37353, DOI 10.1074/jbc.M607227200; Erler I, 2006, J BIOL CHEM, V281, P38396, DOI 10.1074/jbc.M607756200; Fang D, 2000, BIOCHEM BIOPH RES CO, V279, P53, DOI 10.1006/bbrc.2000.3894; Fernandez JA, 2012, J BIOL CHEM, V287, P2963, DOI 10.1074/jbc.M111.272823; Fernandez JA, 2011, J GEN PHYSIOL, V137, P173, DOI 10.1085/jgp.201010498; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Oberwinkler J, 2005, J BIOL CHEM, V280, P22540, DOI 10.1074/jbc.M503092200; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Strubing C, 2001, NEURON, V29, P645, DOI 10.1016/S0896-6273(01)00240-9; Thebault S, 2005, J BIOL CHEM, V280, P39423, DOI 10.1074/jbc.M503544200; Tsavaler L, 2001, CANCER RES, V61, P3760; Vazquez E, 2006, SEMIN CELL DEV BIOL, V17, P607, DOI 10.1016/j.semcdb.2006.11.004; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Wehage E, 2002, J BIOL CHEM, V277, P23150, DOI 10.1074/jbc.M112096200; Werten PJL, 1999, MOL BIOL REP, V26, P201, DOI 10.1023/A:1007046926233; Xu XZS, 2001, P NATL ACAD SCI USA, V98, P10692, DOI 10.1073/pnas.191360198; Zhang W, 2003, J BIOL CHEM, V278, P16222, DOI 10.1074/jbc.M300298200	28	38	40	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					2948	2962		10.1074/jbc.M111.270256	http://dx.doi.org/10.1074/jbc.M111.270256			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22128173	Green Published, hybrid			2022-12-27	WOS:000300295100003
J	Somyajit, K; Subramanya, S; Nagaraju, G				Somyajit, Kumar; Subramanya, Shreelakshmi; Nagaraju, Ganesh			Distinct Roles of FANCO/RAD51C Protein in DNA Damage Signaling and Repair IMPLICATIONS FOR FANCONI ANEMIA AND BREAST CANCER SUSCEPTIBILITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CROSS-LINK REPAIR; HOMOLOGOUS RECOMBINATION; MONOUBIQUITINATED FANCD2; REPLICATION FORKS; GENE CONVERSION; S-PHASE; BRCA1; RAD51C; PATHWAY; ACTIVATION	RAD51C, a RAD51 paralog, has been implicated in homologous recombination (HR), and germ line mutations in RAD51C are known to cause Fanconi anemia (FA)-like disorder and breast and ovarian cancers. The role of RAD51C in the FA pathway of DNA interstrand cross-link (ICL) repair and as a tumor suppressor is obscure. Here, we report that RAD51C deficiency leads to ICL sensitivity, chromatid-type errors, and G(2)/M accumulation, which are hallmarks of the FA phenotype. We find that RAD51C is dispensable for ICL unhooking and FANCD2 monoubiquitination but is essential for HR, confirming the downstream role of RAD51C in ICL repair. Furthermore, we demonstrate that RAD51C plays a vital role in the HR-mediated repair of DNA lesions associated with replication. Finally, we show that RAD51C participates in ICL and double strand break-induced DNA damage signaling and controls intra-S-phase checkpoint through CHK2 activation. Our analyses with pathological mutants of RAD51C that were identified in FA and breast and ovarian cancers reveal that RAD51C regulates HR and DNA damage signaling distinctly. Together, these results unravel the critical role of RAD51C in the FA pathway of ICL repair and as a tumor suppressor.	[Somyajit, Kumar; Subramanya, Shreelakshmi; Nagaraju, Ganesh] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Nagaraju, G (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.	nganesh@biochem.iisc.ernet.in		Somyajit, Kumar/0000-0003-2496-7155	Indian Institute of Science; Department of Biotechnology; Council of Scientific and Industrial Research; Department of Science and Technology	Indian Institute of Science; Department of Biotechnology; Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology(Department of Science & Technology (India))	This work was supported in part by the Indian Institute of Science, Department of Biotechnology, Council of Scientific and Industrial Research, and Department of Science and Technology.	Aguilera A, 2008, NAT REV GENET, V9, P204, DOI 10.1038/nrg2268; Ali AM, 2009, MUTAT RES-FUND MOL M, V668, P20, DOI 10.1016/j.mrfmmm.2009.04.002; Badie S, 2009, J CELL BIOL, V185, P587, DOI 10.1083/jcb.200811079; Bartek J, 2004, NAT REV MOL CELL BIO, V5, P792, DOI 10.1038/nrm1493; Branzei D, 2010, NAT REV MOL CELL BIO, V11, P208, DOI 10.1038/nrm2852; Budzowska M, 2009, CELL BIOCHEM BIOPHYS, V53, P17, DOI 10.1007/s12013-008-9039-y; Buscemi G, 2001, MOL CELL BIOL, V21, P5214, DOI 10.1128/MCB.21.15.5214-5222.2001; Chen JJ, 1998, MOL CELL, V2, P317, DOI 10.1016/S1097-2765(00)80276-2; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Deans AJ, 2011, NAT REV CANCER, V11, P467, DOI 10.1038/nrc3088; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; French CA, 2003, J BIOL CHEM, V278, P45445, DOI 10.1074/jbc.M308621200; Garcia-Higuera I, 2000, BLOOD, V96, P3224, DOI 10.1182/blood.V96.9.3224.h8003224_3224_3230; Gildemeister OS, 2009, J BIOL CHEM, V284, P31945, DOI 10.1074/jbc.M109.024646; Greenberg RA, 2006, GENE DEV, V20, P34, DOI 10.1101/gad.1381306; Huang J, 2009, NAT CELL BIOL, V11, P592, DOI 10.1038/ncb1865; Huen MSY, 2010, NAT REV MOL CELL BIO, V11, P138, DOI 10.1038/nrm2831; Jensen RB, 2010, NATURE, V467, P678, DOI 10.1038/nature09399; Joenje H, 2001, NAT REV GENET, V2, P446, DOI 10.1038/35076590; Johnson RD, 2000, EMBO J, V19, P3398, DOI 10.1093/emboj/19.13.3398; Kee Y, 2010, GENE DEV, V24, P1680, DOI 10.1101/gad.1955310; Kennedy RD, 2005, GENE DEV, V19, P2925, DOI 10.1101/gad.1370505; Kraakman-van der Zwet M, 2002, MOL CELL BIOL, V22, P669, DOI 10.1128/MCB.22.2.669-679.2002; Kuznetsov S, 2007, J CELL BIOL, V176, P581, DOI 10.1083/jcb.200608130; Lio YC, 2003, J BIOL CHEM, V278, P2469, DOI 10.1074/jbc.M211038200; Liu YL, 2007, J BIOL CHEM, V282, P1973, DOI 10.1074/jbc.M609066200; Lomonosov M, 2003, GENE DEV, V17, P3017, DOI 10.1101/gad.279003; Long DT, 2011, SCIENCE, V333, P84, DOI 10.1126/science.1204258; McKinnon PJ, 2007, ANNU REV GENOM HUM G, V8, P37, DOI 10.1146/annurev.genom.7.080505.115648; Meindl A, 2010, NAT GENET, V42, P410, DOI 10.1038/ng.569; Moldovan GL, 2009, ANNU REV GENET, V43, P223, DOI 10.1146/annurev-genet-102108-134222; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Muniandy PA, 2010, CRIT REV BIOCHEM MOL, V45, P23, DOI 10.3109/10409230903501819; Nagaraju G, 2007, DNA REPAIR, V6, P1018, DOI 10.1016/j.dnarep.2007.02.020; Nagaraju G, 2006, MOL CELL BIOL, V26, P8075, DOI 10.1128/MCB.01235-06; Nagaraju G, 2009, MOL CELL BIOL, V29, P4283, DOI 10.1128/MCB.01406-08; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; O'Driscoll M, 2006, NAT REV GENET, V7, P45, DOI 10.1038/nrg1746; OLIVE PL, 1991, CANCER RES, V51, P4671; Patel KJ, 1998, MOL CELL, V1, P347, DOI 10.1016/S1097-2765(00)80035-0; Petermann E, 2010, NAT REV MOL CELL BIO, V11, P683, DOI 10.1038/nrm2974; Petermann E, 2010, MOL CELL, V37, P492, DOI 10.1016/j.molcel.2010.01.021; Puget N, 2005, DNA REPAIR, V4, P149, DOI 10.1016/j.dnarep.2004.08.010; Raschle M, 2008, CELL, V134, P969, DOI 10.1016/j.cell.2008.08.030; Rodrigue A, 2006, EMBO J, V25, P222, DOI 10.1038/sj.emboj.7600914; Rothfuss A, 2004, MOL CELL BIOL, V24, P123, DOI 10.1128/MCB.24.1.123-134.2004; Scully R, 2000, NATURE, V408, P429, DOI 10.1038/35044000; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Scully R, 1997, CELL, V90, P425, DOI 10.1016/S0092-8674(00)80503-6; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Somyajit K, 2010, CARCINOGENESIS, V31, P2031, DOI 10.1093/carcin/bgq210; Takata M, 1998, EMBO J, V17, P5497, DOI 10.1093/emboj/17.18.5497; Takemura H, 2006, J BIOL CHEM, V281, P30814, DOI 10.1074/jbc.M603747200; Taniguchi T, 2002, BLOOD, V100, P2414, DOI 10.1182/blood-2002-01-0278; Taniguchi T, 2002, CELL, V109, P459, DOI 10.1016/S0092-8674(02)00747-X; Tarsounas M, 2003, ONCOGENE, V22, P1115, DOI 10.1038/sj.onc.1206263; Vaz F, 2010, NAT GENET, V42, P406, DOI 10.1038/ng.570; Venkitaraman AR, 2004, NAT REV CANCER, V4, P266, DOI 10.1038/nrc1321; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Venkitaraman AR, 2009, ANNU REV PATHOL-MECH, V4, P461, DOI 10.1146/annurev.pathol.3.121806.151422; Wang XZ, 2004, MOL CELL BIOL, V24, P5850, DOI 10.1128/MCB.24.13.5850-5862.2004; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022; Xu B, 2002, MOL CELL BIOL, V22, P1049, DOI 10.1128/MCB.22.4.1049-1059.2002; Xu B, 2001, MOL CELL BIOL, V21, P3445, DOI 10.1128/MCB.21.10.3445-3450.2001	66	57	58	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3366	3380		10.1074/jbc.M111.311241	http://dx.doi.org/10.1074/jbc.M111.311241			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22167183	Green Published, hybrid			2022-12-27	WOS:000300295100042
J	Usatyuk, PV; Singleton, PA; Pendyala, S; Kalari, SK; He, DH; Gorshkova, IA; Camp, SM; Moitra, J; Dudek, SM; Garcia, JGN; Natarajan, V				Usatyuk, Peter V.; Singleton, Patrick A.; Pendyala, Srikanth; Kalari, Satish K.; He, Donghong; Gorshkova, Irina A.; Camp, Sara M.; Moitra, Jaideep; Dudek, Steven M.; Garcia, Joe G. N.; Natarajan, Viswanathan			Novel Role for Non-muscle Myosin Light Chain Kinase (MLCK) in Hyperoxia-induced Recruitment of Cytoskeletal Proteins, NADPH Oxidase Activation, and Reactive Oxygen Species Generation in Lung Endothelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; ACTIN CYTOSKELETON; TYROSINE PHOSPHORYLATION; SUPEROXIDE GENERATION; ANGIOTENSIN-II; P47(PHOX); MEMBRANE; CORTACTIN; ISOFORM; INJURY	We recently demonstrated that hyperoxia (HO) activates lung endothelial cell NADPH oxidase and generates reactive oxygen species(ROS)/superoxide via Src-dependent tyrosine phosphorylation of p47(phox) and cortactin. Here, we demonstrate that the non-muscle similar to 214-kDa myosin light chain (MLC) kinase (nmMLCK) modulates the interaction between cortactin and p47(phox) that plays a role in the assembly and activation of endothelial NADPH oxidase. Overexpression of FLAG-tagged wild type MLCK in human pulmonary artery endothelial cells enhanced interaction and co-localization between cortactin and p47(phox) at the cell periphery and ROS production, whereas abrogation of MLCK using specific siRNA significantly inhibited the above. Furthermore, HO stimulated phosphorylation of MLC and recruitment of phosphorylated and non-phosphorylated cortactin, MLC, Src, and p47(phox) to caveolin-enriched microdomains (CEM), whereas silencing nmMLCK with siRNA blocked recruitment of these components to CEM and ROS generation. Exposure of nmMLCK(-/-) null mice to HO (72 h) reduced ROS production, lung inflammation, and pulmonary leak compared with control mice. These results suggest a novel role for nmMLCK in hyperoxia induced recruitment of cytoskeletal proteins and NADPH oxidase components to CEM, ROS production, and lung injury.	[Usatyuk, Peter V.; Pendyala, Srikanth; He, Donghong; Natarajan, Viswanathan] Univ Illinois, Dept Pharmacol, Chicago, IL 60612 USA; [Gorshkova, Irina A.; Camp, Sara M.; Dudek, Steven M.; Garcia, Joe G. N.; Natarajan, Viswanathan] Univ Illinois, Dept Med, Chicago, IL 60612 USA; [Usatyuk, Peter V.; Pendyala, Srikanth; He, Donghong; Gorshkova, Irina A.; Camp, Sara M.; Dudek, Steven M.; Garcia, Joe G. N.; Natarajan, Viswanathan] Univ Illinois, Inst Personalized Resp Med, Chicago, IL 60612 USA; [Singleton, Patrick A.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Kalari, Satish K.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Biol, Duarte, CA 91010 USA; [Moitra, Jaideep] Gennova Biopharmaceut Ltd, Pune 411026, Maharashtra, India	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Chicago; City of Hope; Beckman Research Institute of City of Hope	Natarajan, V (corresponding author), Univ Illinois, Dept Pharmacol, E403,Med Sci Bldg,Rm 3137,835 S Wolcott Ave, Chicago, IL 60612 USA.	visnatar@uic.edu	Kalari, Satish/C-6967-2012		National Institutes of Health [HL08553, HL58064]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL058064, R01HL095723] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL08553 and HL58064 (to V. N.).	BERGSTRAND H, 1992, J PHARMACOL EXP THER, V263, P1334; Birukov KG, 2001, J BIOL CHEM, V276, P8567, DOI 10.1074/jbc.M005270200; Brown M, 2010, MICROVASC RES, V80, P75, DOI 10.1016/j.mvr.2009.12.010; Callera GE, 2007, CURR OPIN NEPHROL HY, V16, P90, DOI 10.1097/MNH.0b013e328040bfbd; Chichili GR, 2007, J BIOL CHEM, V282, P36682, DOI 10.1074/jbc.M702959200; Chichili GR, 2009, CELL MOL LIFE SCI, V66, P2319, DOI 10.1007/s00018-009-0022-6; Chowdhury AK, 2005, J BIOL CHEM, V280, P20700, DOI 10.1074/jbc.M411722200; Dudek SM, 2001, J APPL PHYSIOL, V91, P1487, DOI 10.1152/jappl.2001.91.4.1487; El Benna J, 1999, J LEUKOCYTE BIOL, V66, P1014; Frey RS, 2009, ANTIOXID REDOX SIGN, V11, P791, DOI [10.1089/ars.2008.2220, 10.1089/ARS.2008.2220]; GALLAGHER PJ, 1995, J BIOL CHEM, V270, P29090, DOI 10.1074/jbc.270.49.29090; Gallagher PJ, 1997, MOL CELL BIOCHEM, V173, P51, DOI 10.1023/A:1006876318155; Gallagher PJ, 1997, J MUSCLE RES CELL M, V18, P1, DOI 10.1023/A:1018616814417; GARCIA JGN, 1995, J CELL PHYSIOL, V163, P510, DOI 10.1002/jcp.1041630311; Garcia JGN, 1999, AM J PHYSIOL-LUNG C, V276, pL989, DOI 10.1152/ajplung.1999.276.6.L989; Garcia JGN, 1997, AM J RESP CELL MOL, V16, P489, DOI 10.1165/ajrcmb.16.5.9160829; GOECKELER ZM, 1995, J CELL BIOL, V130, P613, DOI 10.1083/jcb.130.3.613; Goeckeler ZM, 2008, AM J PHYSIOL-CELL PH, V295, pC994, DOI 10.1152/ajpcell.00318.2008; Griffith B, 2009, ANTIOXID REDOX SIGN, V11, P2505, DOI [10.1089/ars.2009.2599, 10.1089/ARS.2009.2599]; HEYWORTH PG, 1995, BIOCHEM J, V311, P81, DOI 10.1042/bj3110081; Lazar V, 1999, GENOMICS, V57, P256, DOI 10.1006/geno.1999.5774; Li JM, 2002, J BIOL CHEM, V277, P19952, DOI 10.1074/jbc.M110073200; Li YS, 2000, J BIOL CHEM, V275, P37187, DOI 10.1074/jbc.M000490200; Mansfield PJ, 2000, BLOOD, V95, P2407, DOI 10.1182/blood.V95.7.2407.007k02_2407_2412; Mirzapoiazova T, 2011, AM J RESP CELL MOL, V44, P40, DOI 10.1165/rcmb.2009-0197OC; Moitra J, 2008, TRANSL RES, V151, P141, DOI 10.1016/j.trsl.2007.12.008; Moldovan L, 2000, CIRC RES, V86, P549, DOI 10.1161/01.RES.86.5.549; Odani K, 2003, HISTOCHEM CELL BIOL, V119, P363, DOI 10.1007/s00418-003-0531-6; Parinandi NL, 2003, AM J PHYSIOL-LUNG C, V284, pL26, DOI 10.1152/ajplung.00123.2002; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Patel HH, 2009, ANTIOXID REDOX SIGN, V11, P1357, DOI [10.1089/ars.2008.2365, 10.1089/ARS.2008.2365]; Pendyala S, 2009, ANTIOXID REDOX SIGN, V11, P841, DOI [10.1089/ars.2008.2231, 10.1089/ARS.2008.2231]; Singleton PA, 2009, J BIOL CHEM, V284, P34964, DOI 10.1074/jbc.M109.013771; Sumimoto H, 1996, J BIOL CHEM, V271, P22152, DOI 10.1074/jbc.271.36.22152; Tiruppathi C, 2002, CIRC RES, V91, P70, DOI 10.1161/01.RES.0000023391.40106.A8; Touyz RM, 2005, ARTERIOSCL THROM VAS, V25, P512, DOI 10.1161/01.ATV.0000154141.66879.98; Touyz RM, 2003, ARTERIOSCL THROM VAS, V23, P981, DOI 10.1161/01.ATV.0000069236.27911.68; Usatyuk PV, 2007, J BIOL CHEM, V282, P23284, DOI 10.1074/jbc.M700535200; Usatyuk PV, 2009, J BIOL CHEM, V284, P15339, DOI 10.1074/jbc.M109.005439; Ushio-Fukai M, 2006, SCI STKE, V2006, pre8, DOI DOI 10.1126/STKE.3492006RE8; Verin AD, 1998, AM J RESP CELL MOL, V19, P758, DOI 10.1165/ajrcmb.19.5.3125; Verin AD, 1998, AM J RESP CELL MOL, V19, P767, DOI 10.1165/ajrcmb.19.5.3126; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Wainwright MS, 2003, P NATL ACAD SCI USA, V100, P6233, DOI 10.1073/pnas.1031595100; Wu RF, 2003, J BIOL CHEM, V278, P36830, DOI 10.1074/jbc.M302251200; Yuan SY, 2002, CIRC RES, V90, P1214, DOI 10.1161/01.RES.0000020402.73609.F1; Zhan Y, 2004, J CELL BIOCHEM, V92, P795, DOI 10.1002/jcb.20084	47	36	42	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9360	9375		10.1074/jbc.M111.294546	http://dx.doi.org/10.1074/jbc.M111.294546			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22219181	Green Published, hybrid			2022-12-27	WOS:000301797800067
J	Guler, GD; Liu, HJ; Vaithiyalingam, S; Arnett, DR; Kremmer, E; Chazin, WJ; Fanning, E				Guler, Gulfem Dilek; Liu, Hanjian; Vaithiyalingam, Sivaraja; Arnett, Diana R.; Kremmer, Elisabeth; Chazin, Walter J.; Fanning, Ellen			Human DNA Helicase B (HDHB) Binds to Replication Protein A and Facilitates Cellular Recovery from Replication Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; DEPENDENT ADENOSINE-TRIPHOSPHATASE; POLYMERASE ALPHA-PRIMASE; MOUSE FM3A CELLS; HOMOLOGOUS RECOMBINATION; SACCHAROMYCES-CEREVISIAE; GENOME INTEGRITY; DAMAGE RESPONSE; TERMINAL DOMAIN; T-ANTIGEN	Maintenance of genomic stability in proliferating cells depends on a network of proteins that coordinate chromosomal replication with DNA damage responses. Human DNA helicase B (HELB or HDHB) has been implicated in chromosomal replication, but its role in this coordinated network remains undefined. Here we report that cellular exposure to UV irradiation, camptothecin, or hydroxyurea induces accumulation of HDHB on chromatin in a dose- and time-dependent manner, preferentially in S phase cells. Replication stress-induced recruitment of HDHB to chromatin is independent of checkpoint signaling but correlates with the level of replication protein A (RPA) recruited to chromatin. We show using purified proteins that HDHB physically interacts with the N-terminal domain of the RPA 70-kDa subunit (RPA70N). NMR spectroscopy and site-directed mutagenesis reveal that HDHB docks on the same RPA70N surface that recruits S phase checkpoint signaling proteins to chromatin. Consistent with this pattern of recruitment, cells depleted of HDHB display reduced recovery from replication stress.	[Guler, Gulfem Dilek; Liu, Hanjian; Arnett, Diana R.; Fanning, Ellen] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA; [Vaithiyalingam, Sivaraja; Chazin, Walter J.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Vaithiyalingam, Sivaraja; Chazin, Walter J.] Vanderbilt Univ, Dept Chem, Nashville, TN 37232 USA; [Vaithiyalingam, Sivaraja; Chazin, Walter J.] Vanderbilt Univ, Struct Biol Ctr, Nashville, TN 37232 USA; [Kremmer, Elisabeth] Helmholtz Ctr Munich, D-81377 Munich, Germany	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Fanning, E (corresponding author), Vanderbilt Univ, Dept Biol Sci, 2325 Stevenson Ctr,1161 21st Ave S, Nashville, TN 37232 USA.	ellen.fanning@vanderbilt.edu			National Institutes of Health [GM52948, GM65484, P30 CA068485, P30 ES00267]; Vanderbilt University; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052948, R01GM065484] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM52948 (to E.F.), GM65484 (to W.J.C.), P30 CA068485 (to the Vanderbilt-Ingram Cancer Center), and P30 ES00267 (to the Center for Molecular Toxicology) and Vanderbilt University.	Arunkumar AI, 2005, NAT STRUCT MOL BIOL, V12, P332, DOI 10.1038/nsmb916; Atkinson J, 2011, NUCLEIC ACIDS RES, V39, P1351, DOI 10.1093/nar/gkq975; Azvolinsky A, 2006, GENE DEV, V20, P3104, DOI 10.1101/gad.1478906; Azvolinsky A, 2009, MOL CELL, V34, P722, DOI 10.1016/j.molcel.2009.05.022; Ball HL, 2007, MOL CELL BIOL, V27, P3367, DOI 10.1128/MCB.02238-06; Bochkareva E, 1998, J BIOL CHEM, V273, P3932, DOI 10.1074/jbc.273.7.3932; Bochkareva E, 2005, P NATL ACAD SCI USA, V102, P15412, DOI 10.1073/pnas.0504614102; Branzei D, 2010, NAT REV MOL CELL BIO, V11, P208, DOI 10.1038/nrm2852; BRATTAIN MG, 1981, CANCER RES, V41, P1751; Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8; Byun TS, 2005, GENE DEV, V19, P1040, DOI 10.1101/gad.1301205; Cannavo E, 2007, J BIOL CHEM, V282, P2976, DOI 10.1074/jbc.M609989200; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; COLLINS KL, 1991, MOL CELL BIOL, V11, P2108, DOI 10.1128/MCB.11.4.2108; Cordeiro-Stone M, 1999, J MOL BIOL, V289, P1207, DOI 10.1006/jmbi.1999.2847; Davies AA, 2008, MOL CELL, V29, P625, DOI 10.1016/j.molcel.2007.12.016; DILLER L, 1990, MOL CELL BIOL, V10, P5772, DOI 10.1128/MCB.10.11.5772; Doherty KM, 2005, J BIOL CHEM, V280, P29494, DOI 10.1074/jbc.M500653200; Driscoll R, 2009, GENE DEV, V23, P2359, DOI 10.1101/gad.1860609; Durkin SG, 2007, ANNU REV GENET, V41, P169, DOI 10.1146/annurev.genet.41.042007.165900; Elvers I, 2011, NUCLEIC ACIDS RES, V39, P7049, DOI 10.1093/nar/gkr420; Fanning E, 2006, NUCLEIC ACIDS RES, V34, P4126, DOI 10.1093/nar/gkl550; GOMES XV, 1995, J BIOL CHEM, V270, P4534, DOI 10.1074/jbc.270.9.4534; Goodwin EC, 2000, P NATL ACAD SCI USA, V97, P12513, DOI 10.1073/pnas.97.23.12513; Gu JM, 2004, MOL BIOL CELL, V15, P3320, DOI 10.1091/mbc.E04-03-0227; Guy CP, 2009, MOL CELL, V36, P654, DOI 10.1016/j.molcel.2009.11.009; Heller RC, 2006, NAT REV MOL CELL BIO, V7, P932, DOI 10.1038/nrm2058; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; Huang H, 2010, J BIOL CHEM, V285, P33475, DOI 10.1074/jbc.M110.156240; Huang H, 2010, J BIOL CHEM, V285, P17112, DOI 10.1074/jbc.M110.116830; Iftode C, 1999, CRIT REV BIOCHEM MOL, V34, P141, DOI 10.1080/10409239991209255; Inagaki A, 2009, DNA REPAIR, V8, P190, DOI 10.1016/j.dnarep.2008.10.008; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kadyrov FA, 2004, J BIOL CHEM, V279, P35735, DOI 10.1074/jbc.M403942200; KENNY M K, 1990, Journal of Biological Chemistry, V265, P7693; KREMMER E, 1995, VIROLOGY, V208, P336, DOI 10.1006/viro.1995.1157; Lecointe F, 2007, EMBO J, V26, P4239, DOI 10.1038/sj.emboj.7601848; Letessier A, 2011, NATURE, V470, P120, DOI 10.1038/nature09745; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Liu J, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-357; Lopes M, 2006, MOL CELL, V21, P15, DOI 10.1016/j.molcel.2005.11.015; Lukas J, 2011, NAT CELL BIOL, V13, P1161, DOI 10.1038/ncb2344; Machwe A, 2011, J BIOL CHEM, V286, P3497, DOI 10.1074/jbc.M110.105411; Mackintosh SG, 2006, NUCLEIC ACIDS RES, V34, P4154, DOI 10.1093/nar/gkl501; MATSUMOTO K, 1995, BIOCHEMISTRY-US, V34, P7913, DOI 10.1021/bi00024a016; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; MELENDY T, 1993, J BIOL CHEM, V268, P3389; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Mer G, 2000, CELL, V103, P449, DOI 10.1016/S0092-8674(00)00136-7; Michael WM, 2000, SCIENCE, V289, P2133, DOI 10.1126/science.289.5487.2133; Mimitou EP, 2009, TRENDS BIOCHEM SCI, V34, P264, DOI 10.1016/j.tibs.2009.01.010; Motegi A, 2008, P NATL ACAD SCI USA, V105, P12411, DOI 10.1073/pnas.0805685105; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Olson E, 2007, MOL CELL BIOL, V27, P6053, DOI 10.1128/MCB.00532-07; PAPADOPOULOS N, 1994, SCIENCE, V263, P1625, DOI 10.1126/science.8128251; PARSONS R, 1993, CELL, V75, P1227, DOI 10.1016/0092-8674(93)90331-J; Petermann E, 2010, NAT REV MOL CELL BIO, V11, P683, DOI 10.1038/nrm2974; Pfuetzner RA, 1997, J BIOL CHEM, V272, P430; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Rost B, 2003, NUCLEIC ACIDS RES, V31, P3300, DOI 10.1093/nar/gkg508; SAITOH A, 1995, NUCLEIC ACIDS RES, V23, P2014, DOI 10.1093/nar/23.11.2014; Saleh-Gohari N, 2005, MOL CELL BIOL, V25, P7158, DOI 10.1128/MCB.25.16.7158-7169.2005; Sarkaria JN, 1998, CANCER RES, V58, P4375; Schmidt KH, 2004, MOL CELL BIOL, V24, P3213, DOI 10.1128/MCB.24.8.3213-3226.2004; SEKI M, 1986, BIOCHEMISTRY-US, V25, P3239, DOI 10.1021/bi00359a024; SEKI M, 1995, MOL CELL BIOL, V15, P165, DOI 10.1128/MCB.15.1.165; SEKI M, 1987, BIOCHEMISTRY-US, V26, P2924, DOI 10.1021/bi00384a038; SEKI M, 1988, BIOCHEMISTRY-US, V27, P1766, DOI 10.1021/bi00405a057; Shen JC, 2003, MECH AGEING DEV, V124, P921, DOI 10.1016/S0047-6374(03)00164-7; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Sogo JM, 2002, SCIENCE, V297, P599, DOI 10.1126/science.1074023; Stauffer ME, 2004, J BIOL CHEM, V279, P30915, DOI 10.1074/jbc.R400015200; Stott FJ, 1998, EMBO J, V17, P5001, DOI 10.1093/emboj/17.17.5001; Tada S, 2001, NUCLEIC ACIDS RES, V29, P3835, DOI 10.1093/nar/29.18.3835; Taneja P, 2002, J BIOL CHEM, V277, P40853, DOI 10.1074/jbc.M208067200; Vanoli F, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001205; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Xu X, 2008, MOL CELL BIOL, V28, P7345, DOI 10.1128/MCB.01079-08; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430; Zou Y, 2006, J CELL PHYSIOL, V208, P267, DOI 10.1002/jcp.20622	81	33	36	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6469	6481		10.1074/jbc.M111.324582	http://dx.doi.org/10.1074/jbc.M111.324582			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22194613	Green Published, hybrid			2022-12-27	WOS:000300791800036
J	Wang, Q; Hillwig, ML; Okada, K; Yamazaki, K; Wu, YS; Swaminathan, S; Yamane, H; Peters, RJ				Wang, Qiang; Hillwig, Matthew L.; Okada, Kazunori; Yamazaki, Kohei; Wu, Yisheng; Swaminathan, Sivakumar; Yamane, Hisakazu; Peters, Reuben J.			Characterization of CYP76M5-8 Indicates Metabolic Plasticity within a Plant Biosynthetic Gene Cluster	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COPALYL DIPHOSPHATE SYNTHASES; CULTURED RICE CELLS; BILE-ACID ELICITOR; PHYTOALEXIN BIOSYNTHESIS; SECONDARY METABOLISM; CHOLIC-ACID; ENT-COPALYL; PATHWAY; GIBBERELLIN; DEFENSE	Recent reports have revealed genomic clustering of enzymatic genes for particular biosynthetic pathways in plant specialized/secondary metabolism. Rice (Oryza sativa) carries two such clusters for production of antimicrobial diterpenoid phytoalexins, with the cluster on chromosome 2 containing four closely related/homologous members of the cytochrome P450 CYP76M subfamily (CYP76M5-8). Notably, the underlying evolutionary expansion of these CYP appears to have occurred after assembly of the ancestral biosynthetic gene cluster, suggesting separate roles. It has been demonstrated that CYP76M7 catalyzes C11 alpha-hydroxylation of ent-cassadiene, and presumably mediates an early step in biosynthesis of the derived phytocassane class of phytoalexins. Here we report biochemical characterization of CYP76M5, -6, and -8. Our results indicate that CYP76M8 is a multifunctional/promiscuous hydroxylase, with CYP76M5 and -7 seeming to provide only redundant activity, while CYP76M6 seems to provide both redundant and novel activity, relative to CYP76M8. RNAi-mediated double knockdown of CYP76M7 and -8 suppresses elicitor inducible phytocassane production, indicating a role for these monooxygenases in phytocassane biosynthesis. In addition, our data suggests that CYP76M5, -6, and -8 may play redundant roles in production of the oryzalexin class of phytoalexins as well. Intriguingly, the preceding diterpene synthase for oryzalexin biosynthesis, unlike that for the phytocassanes, is not found in the chromosome 2 diterpenoid biosynthetic gene cluster. Accordingly, our results not only uncover a complex evolutionary history, but also further suggest some intriguing differences between plant biosynthetic gene clusters and the seemingly similar microbial operons. The implications for the underlying metabolic evolution of plants are then discussed.	[Wang, Qiang; Hillwig, Matthew L.; Wu, Yisheng; Swaminathan, Sivakumar; Peters, Reuben J.] Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA; [Okada, Kazunori; Yamazaki, Kohei; Yamane, Hisakazu] Univ Tokyo, Biotechnol Res Ctr, Bunkyo Ku, Tokyo 1138657, Japan	Iowa State University; University of Tokyo	Peters, RJ (corresponding author), Rm 4216, Ames, IA 50011 USA.	rjpeters@iastate.edu	Wu, Yisheng/D-2937-2014; Peters, Reuben J./D-1196-2010; Wang, Qiang/GOE-4599-2022	Peters, Reuben J./0000-0003-4691-8477; Hillwig, Matthew/0000-0002-1168-4191; Swaminathan, Sivakumar/0000-0003-3931-275X	National Institutes of Health [GM086281]; USDA-NIFA-NRI/AFRI [2008-35318-05027]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086281] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USDA-NIFA-NRI/AFRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM086281 (to R. J. P.) and USDA-NIFA-NRI/AFRI Grant 2008-35318-05027.	Cho EM, 2004, PLANT J, V37, P1, DOI 10.1046/j.1365-313X.2003.01926.x; Chu HY, 2011, PLANT J, V66, P66, DOI 10.1111/j.1365-313X.2011.04503.x; Cyr A, 2007, J AM CHEM SOC, V129, P6684, DOI 10.1021/ja071158n; Field B, 2008, SCIENCE, V320, P543, DOI 10.1126/science.1154990; Fischbach MA, 2008, P NATL ACAD SCI USA, V105, P4601, DOI 10.1073/pnas.0709132105; Frey M, 1997, SCIENCE, V277, P696, DOI 10.1126/science.277.5326.696; Kaku H, 2006, P NATL ACAD SCI USA, V103, P11086, DOI 10.1073/pnas.0508882103; Kanno Y, 2006, BIOSCI BIOTECH BIOCH, V70, P1702, DOI 10.1271/bbb.60044; KATO H, 1995, ARCH BIOCHEM BIOPHYS, V316, P707, DOI 10.1006/abbi.1995.1094; Kikuchi S, 2003, SCIENCE, V301, P376, DOI 10.1126/science.1081288; Koga J, 2006, PLANT PHYSIOL, V140, P1475, DOI 10.1104/pp.105.070334; Martin VJJ, 2003, NAT BIOTECHNOL, V21, P796, DOI 10.1038/nbt833; Morrone D, 2011, BIOCHEM J, V435, P589, DOI 10.1042/BJ20101429; Morrone D, 2010, BIOCHEM J, V431, P337, DOI 10.1042/BJ20100597; Morrone D, 2010, APPL MICROBIOL BIOT, V85, P1893, DOI 10.1007/s00253-009-2219-x; Okada A, 2007, PLANT MOL BIOL, V65, P177, DOI 10.1007/s11103-007-9207-2; OMURA T, 1964, J BIOL CHEM, V239, P2379; Osbourn A, 2010, PLANT PHYSIOL, V154, P531, DOI 10.1104/pp.110.161315; Osbourn AE, 2009, CELL MOL LIFE SCI, V66, P3755, DOI 10.1007/s00018-009-0114-3; Otomo K, 2004, PLANT J, V39, P886, DOI 10.1111/j.1365-313X.2004.02175.x; Peters RJ, 2006, PHYTOCHEMISTRY, V67, P2307, DOI 10.1016/j.phytochem.2006.08.009; Peters RJ, 2010, NAT PROD REP, V27, P1521, DOI 10.1039/c0np00019a; Prisic S, 2004, PLANT PHYSIOL, V136, P4228, DOI 10.1104/pp.104.050567; Qi X, 2004, P NATL ACAD SCI USA, V101, P8233, DOI 10.1073/pnas.0401301101; Qi X, 2006, P NATL ACAD SCI USA, V103, P18848, DOI 10.1073/pnas.0607849103; REN YY, 1992, PLANT PHYSIOL, V99, P1169, DOI 10.1104/pp.99.3.1169; Sakamoto T, 2004, PLANT PHYSIOL, V134, P1642, DOI 10.1104/pp.103.033696; Sato Y, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-127; Scott EE, 2001, ARCH BIOCHEM BIOPHYS, V395, P57, DOI 10.1006/abbi.2001.2574; Shimizu T, 2008, PHYTOCHEMISTRY, V69, P973, DOI 10.1016/j.phytochem.2007.10.005; Shimura K, 2007, J BIOL CHEM, V282, P34013, DOI 10.1074/jbc.M703344200; Swaminathan S, 2009, PLANT CELL, V21, P3315, DOI 10.1105/tpc.108.063677; Toyomasu T, 2008, BIOSCI BIOTECH BIOCH, V72, P1168, DOI 10.1271/bbb.80044; Wang QA, 2011, PLANT J, V65, P87, DOI 10.1111/j.1365-313X.2010.04408.x; Watanabe M, 1996, BIOSCI BIOTECH BIOCH, V60, P1460, DOI 10.1271/bbb.60.1460; Wilderman PR, 2004, PLANT PHYSIOL, V135, P2098, DOI 10.1104/pp.104.045971; Xu MM, 2007, P NATL ACAD SCI USA, V104, P7397, DOI 10.1073/pnas.0611454104; Xu MM, 2007, PHYTOCHEMISTRY, V68, P312, DOI 10.1016/j.phytochem.2006.10.016; Zhang JW, 2006, NUCLEIC ACIDS RES, V34, pD745, DOI 10.1093/nar/gkj016	39	88	96	2	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6159	6168		10.1074/jbc.M111.305599	http://dx.doi.org/10.1074/jbc.M111.305599			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22215681	hybrid, Green Published			2022-12-27	WOS:000300791800009
J	Yang, XH; Qiao, DH; Meyer, K; Pier, T; Keles, S; Friedl, A				Yang, Xinhai; Qiao, Dianhua; Meyer, Kristy; Pier, Thomas; Keles, Sunduz; Friedl, Andreas			Angiogenesis Induced by Signal Transducer and Activator of Transcription 5A (STAT5A) Is Dependent on Autocrine Activity of Proliferin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMARY EPITHELIAL-CELLS; GENE-EXPRESSION; ENDOTHELIAL-CELLS; MESSENGER-RNA; GROWTH; PROLACTIN; RECEPTOR; PROTEIN; FAMILY; FIBROSARCOMA	Multiple secreted factors induce the formation of new blood vessels (angiogenesis). The signal transduction events that orchestrate the numerous cellular activities required for angiogenesis remain incompletely understood. We have shown previously that STAT5 plays a pivotal role in angiogenesis induced by FGF2 and FGF8b. To delineate the signaling pathway downstream of STAT5, we expressed constitutively active (CA) or dominant-negative (DN) mutant STAT5A in mouse brain endothelial cells (EC). We found that the conditioned medium from CA-STAT5A but not from dominant-negative STAT5A overexpressing EC is sufficient to induce EC invasion and tube formation, indicating that STAT5A regulates the secretion of autocrine proangiogenic factors. Conversely, CA-STAT5A-induced conditioned medium had no effect on EC proliferation. Using a comparative genome-wide transcription array screen, we identified the prolactin family member proliferin (PLF1 and PLF4) as a candidate autocrine factor. The CA-STAT5A-dependent transcription and secretion of PLF by EC was confirmed by quantitative RT-PCR and Western blotting, respectively. CA-STAT5A binds to the PLF1 promoter region, suggesting a direct transcriptional regulation. Knockdown of PLF expression by shRNA or by blocking of PLF activity with neutralizing antibodies removed the CA-STAT5A-dependent proangiogenic activity from the conditioned medium of EC. Similarly, the ability of concentrated conditioned medium from CA-STAT5A transfected EC to induce angiogenesis in Matrigel plugs in vivo was abolished when PLF was depleted from the medium. These observations demonstrate a FGF/STAT5/PLF signaling cascade in EC and implicate PLF as autocrine regulator of EC invasion and tube formation.	[Yang, Xinhai; Qiao, Dianhua; Meyer, Kristy; Pier, Thomas; Friedl, Andreas] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53792 USA; [Keles, Sunduz] Univ Wisconsin, Dept Stat & Biostat & Med Informat, Madison, WI 53792 USA; [Friedl, Andreas] William S Middleton Mem Vet Adm Med Ctr, Pathol & Lab Med Serv, Dept Vet Affairs Med Ctr, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital	Friedl, A (corresponding author), WIMR Rm 6051,1111 Highland Ave, Madison, WI 53705 USA.	afriedl@wisc.edu			National Institutes of Health [RO1NS048921-01]; Biomedical Laboratory Research and Development Service of the VA Office of Research and Development [I01BX000137]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048921] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000137] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biomedical Laboratory Research and Development Service of the VA Office of Research and Development; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grant RO1NS048921-01. This work was also based upon work supported in part by Award I01BX000137 from the Biomedical Laboratory Research and Development Service of the VA Office of Research and Development.	Auerbach R, 2000, CANCER METAST REV, V19, P167, DOI 10.1023/A:1026574416001; Brockman JL, 2002, MOL ENDOCRINOL, V16, P774, DOI 10.1210/me.16.4.774; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; CLAPP C, 1992, ENDOCRINOLOGY, V130, P1380, DOI 10.1210/en.130.3.1380; Corbacho AM, 2002, J ENDOCRINOL, V173, P219, DOI 10.1677/joe.0.1730219; DaSilva L, 1996, MOL CELL ENDOCRINOL, V117, P131, DOI 10.1016/0303-7207(95)03738-1; Deo DD, 2002, J BIOL CHEM, V277, P21237, DOI 10.1074/jbc.M110955200; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Fassett JT, 2000, ENDOCRINOLOGY, V141, P1863, DOI 10.1210/en.141.5.1863; Groskopf JC, 1997, ENDOCRINOLOGY, V138, P2835, DOI 10.1210/en.138.7.2835; GROSKOPF JC, 1994, MOL CELL BIOL, V14, P6013, DOI 10.1128/MCB.14.9.6013; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hemberger M, 2003, DEV DYNAM, V227, P185, DOI 10.1002/dvdy.10291; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; JACKSON D, 1994, SCIENCE, V266, P1581, DOI 10.1126/science.7527157; KANDEL J, 1991, CELL, V66, P1095, DOI 10.1016/0092-8674(91)90033-U; Kendziorski CM, 2003, STAT MED, V22, P3899, DOI 10.1002/sim.1548; KIBBEY MC, 1992, J NATL CANCER I, V84, P1633, DOI 10.1093/jnci/84.21.1633; Langley RR, 2003, CANCER RES, V63, P2971; LINZER DIH, 1985, P NATL ACAD SCI USA, V82, P4356, DOI 10.1073/pnas.82.13.4356; LINZER DIH, 1984, P NATL ACAD SCI-BIOL, V81, P4255, DOI 10.1073/pnas.81.14.4255; MORDACQ JC, 1989, GENE DEV, V3, P760, DOI 10.1101/gad.3.6.760; MUSCAT GEO, 1991, MOL ENDOCRINOL, V5, P802, DOI 10.1210/mend-5-6-802; NELSON JT, 1995, ENDOCRINOLOGY, V136, P283, DOI 10.1210/en.136.1.283; Peles E, 2004, NEUROSURGERY, V55, P562, DOI 10.1227/01.NEU.0000134383.27713.9A; Su WCS, 1997, NATURE, V386, P288, DOI 10.1038/386288a0; Toft DJ, 2001, P NATL ACAD SCI USA, V98, P13055, DOI 10.1073/pnas.231364798; TOURKINE N, 1995, J BIOL CHEM, V270, P20952, DOI 10.1074/jbc.270.36.20952; Volpert O, 1996, ENDOCRINOLOGY, V137, P3871, DOI 10.1210/en.137.9.3871; Wang JW, 2006, NEUROSCI RES, V56, P80, DOI 10.1016/j.neures.2006.05.011; WELTE T, 1994, MOL ENDOCRINOL, V8, P1091, DOI 10.1210/me.8.8.1091; Wiemers DO, 2003, ENDOCRINOLOGY, V144, P313, DOI 10.1210/en.2002-220724; Yang XH, 2009, CANCER RES, V69, P1668, DOI 10.1158/0008-5472.CAN-07-6385	33	19	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6490	6502		10.1074/jbc.M111.254631	http://dx.doi.org/10.1074/jbc.M111.254631			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22199350	Green Published, hybrid			2022-12-27	WOS:000300791800038
J	Han, WQ; Wu, BL; Li, L; Zhao, GH; Woodward, R; Pettit, N; Cai, L; Thon, V; Wang, PG				Han, Weiqing; Wu, Baolin; Li, Lei; Zhao, Guohui; Woodward, Robert; Pettit, Nicholas; Cai, Li; Thon, Vireak; Wang, Peng G.			Defining Function of Lipopolysaccharide O-antigen Ligase WaaL Using Chemoenzymatically Synthesized Substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI O86-H2; RFB GENE-CLUSTER; OUTER-MEMBRANE; VIBRIO-CHOLERAE; BIOSYNTHESIS; CORE; EXPRESSION; CLONING; OVEREXPRESSION; ANTIBODIES	The WaaL-mediated ligation of O-antigen onto the core region of the lipid A-core block is an important step in the lipopolysaccharide (LPS) biosynthetic pathway. Although the LPS biosynthesis has been largely characterized, only a limited amount of in vitro biochemical evidence has been established for the ligation reaction. Such limitations have primarily resulted from the barriers in purifying WaaL homologues and obtaining chemically defined substrates. Accordingly, we describe herein a chemical biology approach that enabled the reconstitution of this ligation reaction. The O-antigen repeating unit (O-unit) of Escherichia coli O86 was first enzymatically assembled via sequential enzymatic glycosylation of a chemically synthesized GalNAc-pyrophosphate-undecaprenyl precursor. Subsequent expression of WaaL through use of a chaperone co-expression system then enabled the demonstration of the in vitro ligation between the synthesized donor (O-unit-pyrophosphate-undecaprenyl) and the isolated lipid A-core acceptor. The previously reported ATP and divalent metal cation dependence were not observed using this system. Further analyses of other donor substrates revealed that WaaL possesses a highly relaxed specificity toward both the lipid moiety and the glycan moiety of the donor. Lastly, three conserved amino acid residues identified by sequence alignment were found essential for the WaaL activity. Taken together, the present work represents an in vitro systematic investigation of the WaaL function using a chemical biology approach, providing a system that could facilitate the elucidation of the mechanism of WaaL-catalyzed ligation reaction.	[Han, Weiqing; Wu, Baolin; Zhao, Guohui; Thon, Vireak; Wang, Peng G.] Georgia State Univ, Dept Chem, Atlanta, GA 30302 USA; [Li, Lei] Nankai Univ, Coll Pharm, Tianjin 300071, Peoples R China; [Li, Lei] Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Woodward, Robert; Pettit, Nicholas] Ohio State Univ, Dept Biochem, Columbus, OH 43210 USA; [Woodward, Robert; Pettit, Nicholas] Ohio State Univ, Dept Chem, Columbus, OH 43210 USA; [Cai, Li] Univ S Carolina Salkehatchie, Dept Chem, Walterboro, SC 29488 USA	University System of Georgia; Georgia State University; Nankai University; Nankai University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of South Carolina System; University of South Carolina Salkehatchie	Wang, PG (corresponding author), Georgia State Univ, Dept Chem, 787 Petit Sci Ctr,POB 4098, Atlanta, GA 30302 USA.	pwang11@gsu.edu	Cai, Li/A-2214-2012; Zhao, Guohui/K-8624-2012; Zhao, Guohui/J-6782-2012; Wu, Baolin/F-8387-2012; WANG, Peng/GSN-5263-2022	Cai, Li/0000-0002-6098-1168; 	National Institutes of Health [R01 GM085267]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085267] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM085267 (to P. G. W.).	Abeyrathne PD, 2007, MOL MICROBIOL, V65, P1345, DOI 10.1111/j.1365-2958.2007.05875.x; ALHENDY A, 1991, MICROB PATHOGENESIS, V10, P47, DOI 10.1016/0882-4010(91)90065-I; Amor K, 2000, INFECT IMMUN, V68, P1116, DOI 10.1128/IAI.68.3.1116-1124.2000; BASTIN DA, 1991, MOL MICROBIOL, V5, P2223, DOI 10.1111/j.1365-2958.1991.tb02152.x; Brockhausen I, 2008, GLYCOCONJUGATE J, V25, P663, DOI 10.1007/s10719-008-9127-7; Brown S, 2008, CHEM BIOL, V15, P12, DOI 10.1016/j.chembiol.2007.11.011; Chimalakonda G, 2011, P NATL ACAD SCI USA, V108, P2492, DOI 10.1073/pnas.1019089108; Chng SS, 2010, BIOCHEMISTRY-US, V49, P4565, DOI 10.1021/bi100493e; Chung HS, 2011, P NATL ACAD SCI USA, V108, P510, DOI 10.1073/pnas.1016462108; Cuthbertson L, 2010, MICROBIOL MOL BIOL R, V74, P341, DOI 10.1128/MMBR.00009-10; Freinkman E, 2011, P NATL ACAD SCI USA, V108, P2486, DOI 10.1073/pnas.1015617108; GALANOS C, 1969, EUR J BIOCHEM, V9, P245, DOI 10.1111/j.1432-1033.1969.tb00601.x; GOLDBERG JB, 1992, P NATL ACAD SCI USA, V89, P10716, DOI 10.1073/pnas.89.22.10716; Guo H, 2006, PROTEIN EXPRES PURIF, V48, P49, DOI 10.1016/j.pep.2006.01.015; Hug I, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000819; Islam ST, 2011, J BIOL CHEM, V286, P20600, DOI 10.1074/jbc.C110.204651; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Li M, 2008, BIOCHEMISTRY-US, V47, P11590, DOI 10.1021/bi801067s; Meredith TC, 2007, J BIOL CHEM, V282, P7790, DOI 10.1074/jbc.M611034200; Nesper J, 2001, INFECT IMMUN, V69, P435, DOI 10.1128/IAI.69.1.435-445.2001; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Palusiak A, 2008, ARCH IMMUNOL THER EX, V56, P135, DOI 10.1007/s00005-008-0012-7; Perez JM, 2008, MOL MICROBIOL, V70, P1424, DOI 10.1111/j.1365-2958.2008.06490.x; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Ruan X., 2011, GLYCOBIOLOG IN PRESS; Rush JS, 2010, J BIOL CHEM, V285, P1671, DOI 10.1074/jbc.M109.061630; Schild S, 2005, J BIOL CHEM, V280, P25936, DOI 10.1074/jbc.M501259200; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; Thomas JG, 1997, APPL BIOCHEM BIOTECH, V66, P197, DOI 10.1007/BF02785589; Tran AX, 2010, J BIOL CHEM, V285, P33529, DOI 10.1074/jbc.M110.144709; Valvano MA, 2008, MOL MICROBIOL, V67, P232, DOI 10.1111/j.1365-2958.2007.06052.x; Wagner S, 2008, P NATL ACAD SCI USA, V105, P14371, DOI 10.1073/pnas.0804090105; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; Woodward R, 2010, NAT CHEM BIOL, V6, P418, DOI 10.1038/nchembio.351; Yi W, 2006, BIOCHEM BIOPH RES CO, V344, P631, DOI 10.1016/j.bbrc.2006.03.181; Yi W, 2005, J AM CHEM SOC, V127, P2040, DOI 10.1021/ja045021y; YOKOTA S, 1992, J GEN MICROBIOL, V138, P289, DOI 10.1099/00221287-138-2-289	38	49	49	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5357	5365		10.1074/jbc.M111.308486	http://dx.doi.org/10.1074/jbc.M111.308486			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22158874	Green Published, hybrid			2022-12-27	WOS:000300638000017
J	Matsubara, T; Ikeda, M; Kiso, Y; Sakuma, M; Yoshino, K; Sakane, F; Merida, I; Saito, N; Shirai, Y				Matsubara, Takehiro; Ikeda, Momo; Kiso, Yuko; Sakuma, Megumi; Yoshino, Ken-ichi; Sakane, Fumio; Merida, Isabel; Saito, Naoaki; Shirai, Yasuhito			c-Abl Tyrosine Kinase Regulates Serum-induced Nuclear Export of Diacylglycerol Kinase alpha by Phosphorylation at Tyr-218	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL 4-PHOSPHATE 5-KINASE; SUBTYPE-SPECIFIC TRANSLOCATION; PHOSPHATIDIC-ACID; FAMILY KINASES; IMPORTIN-ALPHA; I-ALPHA; ACTIVATION; CELLS; DOMAINS; ZETA	c-Abl is a tyrosine kinase involved in many cellular processes, including cell cycle control and proliferation. However, little is known about its substrates. Here, we show that c-Abl directly phosphorylates diacylglycerol kinase alpha (DGK alpha), an important regulator of many cellular events through its conversion of diacylglycerol to phosphatidic acid. We found that DGK alpha was transported from the cytoplasm to the nucleus in response to serum starvation, and serum restoration induced the nuclear export of the enzyme to the cytoplasm. This serum-induced export involves two tyrosine kinases, c-Src and c-Abl. The latter, c-Abl, is activated by c-Src, phosphorylates DGK alpha, and shuttles between the nucleus and the cytoplasm in a direction opposite to that of DGK alpha in response to serum restoration. Moreover, an in vitro phosphorylation assay using purified mutants of DGK alpha identified Tyr-218 as a site of phosphorylation by c-Abl. We confirmed these results for endogenous DGK alpha using an antibody specific for phospho-Tyr-218, and this phosphorylation was necessary for the serum-induced export of DGK alpha. These results demonstrate that the nucleo-cytoplasmic shuttling of DGK alpha is orchestrated by tyrosine phosphorylation by the Src-activated tyrosine kinase c-Abl and that this phosphorylation is important for regulating the function of cytoplasmic and/or nuclear DGK alpha.	[Shirai, Yasuhito] Kobe Univ, Grad Sch Agr Sci, Dept Appl Chem Biosci, Lab Chem & Utilizat Anim Prod Resources,Nada Ku, Kobe, Hyogo 6578501, Japan; [Matsubara, Takehiro; Ikeda, Momo; Kiso, Yuko; Sakuma, Megumi; Yoshino, Ken-ichi; Saito, Naoaki; Shirai, Yasuhito] Kobe Univ, Biosignal Res Ctr, Mol Pharmacol Lab, Nada Ku, Kobe, Hyogo 6578501, Japan; [Sakane, Fumio] Chiba Univ, Grad Sch Sci, Dept Chem, Inage Ku, Chiba 2638522, Japan; [Merida, Isabel] CSIC, Natl Biotechnol Ctr, Dept Immunol & Oncol, E-28049 Madrid, Spain	Kobe University; Kobe University; Chiba University; Consejo Superior de Investigaciones Cientificas (CSIC)	Shirai, Y (corresponding author), Kobe Univ, Grad Sch Agr Sci, Dept Appl Chem Biosci, Lab Chem & Utilizat Anim Prod Resources,Nada Ku, Rokkodai Cho 1-1, Kobe, Hyogo 6578501, Japan.	shirai@kobe-u.ac.jp	Sakane, Fumio/H-2693-2017; Merida, Isabel/A-9713-2014; Shirai, Yasuhito/O-3255-2018	Sakane, Fumio/0000-0003-0857-0377; Merida, Isabel/0000-0003-2762-6241; 	Global Center of Excellence of the Ministry of Education, Culture, Sports, Science, and Technology of Japan	Global Center of Excellence of the Ministry of Education, Culture, Sports, Science, and Technology of Japan	This work was supported in part by a Grant-in-aid for Scientific Research (C) and the Global Center of Excellence Program of the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Baldanzi G, 2008, ONCOGENE, V27, P942, DOI 10.1038/sj.onc.1210717; Brasher BB, 2000, J BIOL CHEM, V275, P35631, DOI 10.1074/jbc.M005401200; Bregoli L, 2002, ADV ENZYME REGUL, V42, P213, DOI 10.1016/S0065-2571(01)00032-2; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; Colon-Gonzalez F, 2006, BBA-MOL CELL BIOL L, V1761, P827, DOI 10.1016/j.bbalip.2006.05.001; Deacon EM, 2002, J CELL SCI, V115, P983; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Fukunaga-Takenaka R, 2005, GENES CELLS, V10, P311, DOI 10.1111/j.1365-2443.2005.00842.x; GOFF SP, 1980, CELL, V22, P777, DOI 10.1016/0092-8674(80)90554-1; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; GOTO K, 1992, MOL BRAIN RES, V16, P75, DOI 10.1016/0169-328X(92)90196-I; Goto K, 1996, P NATL ACAD SCI USA, V93, P11196, DOI 10.1073/pnas.93.20.11196; GROFFEN J, 1984, CELL, V36, P93, DOI 10.1016/0092-8674(84)90077-1; Hodgkin MN, 1998, TRENDS BIOCHEM SCI, V23, P200, DOI 10.1016/S0968-0004(98)01200-6; Irie N, 2002, BIOCHEM BIOPH RES CO, V298, P738, DOI 10.1016/S0006-291X(02)02531-7; IRVINE R, 2000, SCI STKE, pRE1; Jones DR, 2000, FEBS LETT, V476, P160, DOI 10.1016/S0014-5793(00)01702-6; Kamio N, 2011, FREE RADICAL RES, V45, P336, DOI 10.3109/10715762.2010.532495; LIMATOLA C, 1994, BIOCHEM J, V304, P1001, DOI 10.1042/bj3041001; Luo B, 2004, CELL SIGNAL, V16, P891, DOI 10.1016/j.cellsig.2004.01.010; Martelli AM, 2004, CELL MOL LIFE SCI, V61, P1143, DOI 10.1007/s00018-004-3414-7; Martelli AM, 2000, CANCER RES, V60, P815; Matsubara T, 2006, J BIOL CHEM, V281, P6152, DOI 10.1074/jbc.M509873200; Melo JV, 1996, BLOOD, V88, P2375, DOI 10.1182/blood.V88.7.2375.bloodjournal8872375; Merino E, 2007, J BIOL CHEM, V282, P35396, DOI 10.1074/jbc.M702085200; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; Pendergast AM, 2002, ADV CANCER RES, V85, P51, DOI 10.1016/S0065-230X(02)85003-5; Plattner R, 1999, GENE DEV, V13, P2400, DOI 10.1101/gad.13.18.2400; ROSTI V, 1995, BLOOD, V86, P3387, DOI 10.1182/blood.V86.9.3387.bloodjournal8693387; Sakane F, 2007, BBA-MOL CELL BIOL L, V1771, P793, DOI 10.1016/j.bbalip.2007.04.006; Shirai Y, 2000, J BIOL CHEM, V275, P24760, DOI 10.1074/jbc.M003151200; Taagepera S, 1998, P NATL ACAD SCI USA, V95, P7457, DOI 10.1073/pnas.95.13.7457; Tabellini G, 2003, EXP CELL RES, V287, P143, DOI 10.1016/S0014-4827(03)00115-0; Topham MK, 1998, NATURE, V394, P697, DOI 10.1038/29337; Wada I, 1996, FEBS LETT, V393, P48, DOI 10.1016/0014-5793(96)00857-5; WANG JYJ, 1984, CELL, V36, P349; Zha YY, 2006, NAT IMMUNOL, V7, P1166, DOI 10.1038/ni1394	37	17	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5507	5517		10.1074/jbc.M111.296897	http://dx.doi.org/10.1074/jbc.M111.296897			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22199356	Green Published, hybrid			2022-12-27	WOS:000300638000030
J	Hassan, IH; Zhang, MS; Powers, LS; Shao, JQ; Baltrusaitis, J; Rutkowski, DT; Legge, K; Monick, MM				Hassan, Ihab H.; Zhang, Michael S.; Powers, Linda S.; Shao, Jian Q.; Baltrusaitis, Jonas; Rutkowski, D. Thomas; Legge, Kevin; Monick, Martha M.			Influenza A Viral Replication Is Blocked by Inhibition of the Inositol-requiring Enzyme 1 (IRE1) Stress Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; HEPATITIS-C VIRUS; NF-KAPPA-B; ER STRESS; EPITHELIAL-CELLS; CHEMICAL CHAPERONES; INFECTION; INDUCTION; DISEASE	Known therapies for influenza A virus infection are complicated by the frequent emergence of resistance. A therapeutic strategy that may escape viral resistance is targeting host cellular mechanisms involved in viral replication and pathogenesis. The endoplasmic reticulum (ER) stress response, also known as the unfolded protein response (UPR), is a primitive, evolutionary conserved molecular signaling cascade that has been implicated in multiple biological phenomena including innate immunity and the pathogenesis of certain viral infections. We investigated the effect of influenza A viral infection on ER stress pathways in lung epithelial cells. Influenza A virus induced ER stress in a pathway-specific manner. We showed that the virus activates the IRE1 pathway with little or no concomitant activation of the PERK and the ATF6 pathways. When we examined the effects of modulating the ER stress response on the virus, we found that the molecular chaperone tauroursodeoxycholic acid (TUDCA) significantly inhibits influenza A viral replication. In addition, a specific inhibitor of the IRE1 pathway also blocked viral replication. Our findings constitute the first evidence that ER stress plays a role in the pathogenesis of influenza A viral infection. Decreasing viral replication by modulating the host ER stress response is a novel strategy that has important therapeutic implications.	[Hassan, Ihab H.; Zhang, Michael S.; Powers, Linda S.; Monick, Martha M.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Shao, Jian Q.; Baltrusaitis, Jonas] Univ Iowa, Cent Microscopy Res Facil, Iowa City, IA 52242 USA; [Rutkowski, D. Thomas] Univ Iowa, Dept Anat & Cell Biol, Iowa City, IA 52242 USA; [Legge, Kevin] Univ Iowa, Dept Pathol, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa	Hassan, IH (corresponding author), Rm 100 EMRB, Iowa City, IA 52242 USA.	ihab-hassan@uiowa.edu	Baltrusaitis, Jonas/AAW-6072-2021; Baltrusaitis, Jonas/F-9367-2013; Baltrusaitis, Jonas/AAT-3166-2020	Baltrusaitis, Jonas/0000-0001-5634-955X; Zhang, Michael/0000-0003-1992-2550; Rutkowski, Thomas/0000-0001-6586-4449; Legge, Kevin/0000-0001-9800-6854	National Institutes of Health [R01 HL079901, R01 HL 096625, R21 HL109589]; NIDDK [R01 DK 084058]; National Center for Research Resources (NCRR), part of the National Institutes of Health [NCRR1 UL1 RR024979]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024979] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL109589, R01HL096625, R01HL079901] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084058] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Center for Research Resources (NCRR), part of the National Institutes of Health; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL079901, R01 HL 096625, and R21 HL109589 (to M. M. M.) and NIDDK Grants R01 DK 084058 (to D. T. R.) and NCRR1 UL1 RR024979 from the National Center for Research Resources (NCRR), part of the National Institutes of Health.	Adachi Y, 2008, CELL STRUCT FUNCT, V33, P75, DOI 10.1247/csf.07044; Bermejo-Martin JF, 2009, CRIT CARE, V13, DOI 10.1186/cc8208; Cheng GF, 2005, J VIROL, V79, P1379, DOI 10.1128/JVI.79.3.1379-1388.2005; Dolan BP, 2011, CELL MOL LIFE SCI, V68, P1481, DOI 10.1007/s00018-011-0656-z; Dolan BP, 2010, J IMMUNOL, V184, P1419, DOI 10.4049/jimmunol.0901907; Fiore Anthony E., 2008, Morbidity and Mortality Weekly Report, V57, P1; GUPTA S, 2010, INT J CELL BIOL; He B, 2006, CELL DEATH DIFFER, V13, P393, DOI 10.1038/sj.cdd.4401833; He B, 1997, P NATL ACAD SCI USA, V94, P843, DOI 10.1073/pnas.94.3.843; Hirota Morihiko, 2006, Journal of Toxicological Sciences, V31, P149, DOI 10.2131/jts.31.149; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; HUNTER JA, 1985, P NATL ACAD SCI USA, V82, P4633, DOI 10.1073/pnas.82.14.4633; Jheng JR, 2010, CELL MICROBIOL, V12, P796, DOI 10.1111/j.1462-5822.2010.01434.x; Ji C, 2011, HEPATOLOGY, V54, P229, DOI 10.1002/hep.24368; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Ketterer MR, 1999, INFECT IMMUN, V67, P4161, DOI 10.1128/IAI.67.8.4161-4170.1999; Kim HT, 2004, LAB INVEST, V84, P816, DOI 10.1038/labinvest.3700104; KOZUTSUMI Y, 1988, NATURE, V332, P462, DOI 10.1038/332462a0; Langlois RA, 2010, ALCOHOL CLIN EXP RES, V34, P1425, DOI 10.1111/j.1530-0277.2010.01226.x; Li BZ, 2007, VIRUS RES, V124, P44, DOI 10.1016/j.virusres.2006.09.011; Li XD, 2005, VIROLOGY, V333, P180, DOI 10.1016/j.virol.2005.01.002; LOOK DC, 1992, AM J PHYSIOL, V263, pL79, DOI 10.1152/ajplung.1992.263.1.L79; Medigeshi GR, 2007, J VIROL, V81, P10849, DOI 10.1128/JVI.01151-07; Meyerholz DK, 2008, J IMMUNOL, V181, P641, DOI 10.4049/jimmunol.181.1.641; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Naidoo N, 2009, AGEING RES REV, V8, P150, DOI 10.1016/j.arr.2009.03.001; Nakajima S, 2011, MOL CELL BIOL, V31, P1710, DOI 10.1128/MCB.00939-10; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Pahl HL, 1996, FEBS LETT, V392, P129, DOI 10.1016/0014-5793(96)00800-9; PAHL HL, 1995, J VIROL, V69, P1480, DOI 10.1128/JVI.69.3.1480-1484.1995; Post DMB, 2002, INFECT IMMUN, V70, P909, DOI 10.1128/IAI.70.2.909-920.2002; Rajagopal S, 2007, SEMIN RESP CRIT CARE, V28, P159, DOI 10.1055/s-2007-976488; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Su HL, 2002, J VIROL, V76, P4162, DOI 10.1128/JVI.76.9.4162-4171.2002; Tardif KD, 2005, TRENDS MICROBIOL, V13, P159, DOI 10.1016/j.tim.2005.02.004; Tardif KD, 2004, J BIOL CHEM, V279, P17158, DOI 10.1074/jbc.M312144200; Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979; Ulianich L, 2011, BBA-MOL BASIS DIS, V1812, P431, DOI 10.1016/j.bbadis.2010.12.013; Volkmann K, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.199737; Welch WJ, 1996, CELL STRESS CHAPERON, V1, P109, DOI 10.1379/1466-1268(1996)001<0109:IOMACC>2.3.CO;2; Wu J, 2007, DEV CELL, V13, P351, DOI 10.1016/j.devcel.2007.07.005; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Ye ZD, 2008, BBA-GEN SUBJECTS, V1780, P1383, DOI 10.1016/j.bbagen.2008.07.009; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040	45	101	111	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4679	4689		10.1074/jbc.M111.284695	http://dx.doi.org/10.1074/jbc.M111.284695			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22194594	hybrid, Green Published			2022-12-27	WOS:000300608500030
J	Yang, FK; Hu, LY; Chen, C; Yu, JX; O'Connell, CB; Khodjakov, A; Pagano, M; Dai, W				Yang, Feikun; Hu, Liyan; Chen, Cheng; Yu, Jianxiu; O'Connell, Christopher B.; Khodjakov, Alexey; Pagano, Michele; Dai, Wei			BubR1 Is Modified by Sumoylation during Mitotic Progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENP-E; SPINDLE CHECKPOINT; CELL-CYCLE; KINETOCHORE; MICE; PHOSPHORYLATION; BINDING; MITOSIS; INSUFFICIENCY; DEGRADATION	BubR1 functions as a crucial component that monitors proper chromosome congression and mitotic timing during cell division. We investigated molecular regulation of BubR1 and found that BubR1 was modified by an unknown post-translation mechanism during the cell cycle, resulting in a significant mobility shift on denaturing gels. We termed it BubR1-M as the nature of modification was not characterized. Extended (> 24 h) treatment of HeLa cells with a microtubule disrupting agent including nocodazole and taxol or release of mitotic shake-off cells into fresh medium induced BubR1-M. BubR1-M was derived from neither phosphorylation nor acetylation. Ectopic expression coupled with pulling down analyses showed that BubR1-M was derived from SUMO modification. Mutation analysis revealed that lysine 250 was a crucial site for sumoylation. Significantly, compared with the wild-type control, ectopic expression of a sumoylation-deficient mutant of BubR1 induced chromosomal missegregation and mitotic delay. Combined, our study identifies a new type of post-translational modification that is essential for BubR1 function during mitosis.	[Yang, Feikun; Hu, Liyan; Dai, Wei] NYU, Sch Med, Langone Med Ctr, Dept Environm Med & Pharmacol, Tuxedo Pk, NY 10987 USA; [Pagano, Michele] NYU, Sch Med, Howard Hughes Med Inst, Dept Pathol, New York, NY 10016 USA; [Chen, Cheng; Yu, Jianxiu] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200025, Peoples R China; [O'Connell, Christopher B.; Khodjakov, Alexey] Wadsworth Ctr, Albany, NY 12201 USA	New York University; NYU Langone Medical Center; Howard Hughes Medical Institute; New York University; Shanghai Jiao Tong University; Wadsworth Center	Dai, W (corresponding author), NYU, Sch Med, Langone Med Ctr, Dept Environm Med & Pharmacol, Tuxedo Pk, NY 10987 USA.	wei.dai@med.nyu.edu		Dai, Wei/0000-0003-0169-8327; pagano, michele/0000-0003-3210-2442	United States Public Service [CA090658, CA113349, R01-GM057587, R21-AG032560]; NATIONAL CANCER INSTITUTE [R01CA090658, R37CA076584, R01CA113349] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057587, R01GM059363] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG032560] Funding Source: NIH RePORTER	United States Public Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by United States Public Service Awards (to W. D.) (CA090658 and CA113349) and (to M. P.) (R01-GM057587 and R21-AG032560).	Baker DJ, 2008, NAT CELL BIOL, V10, P825, DOI 10.1038/ncb1744; Baker DJ, 2004, NAT GENET, V36, P744, DOI 10.1038/ng1382; Bode AM, 2007, CANCER LETT, V247, P26, DOI 10.1016/j.canlet.2006.03.032; Cahill DP, 1998, NATURE, V392, P300, DOI 10.1038/32688; Chan GKT, 1999, J CELL BIOL, V146, P941, DOI 10.1083/jcb.146.5.941; Chan GKT, 1998, J CELL BIOL, V143, P49, DOI 10.1083/jcb.143.1.49; Cheng J, 2007, CELL, V131, P584, DOI 10.1016/j.cell.2007.08.045; Choi E, 2009, EMBO J, V28, P2077, DOI 10.1038/emboj.2009.123; Dai W, 2004, CANCER RES, V64, P440, DOI 10.1158/0008-5472.CAN-03-3119; Dawlaty MM, 2008, CELL, V133, P103, DOI 10.1016/j.cell.2008.01.045; Elowe S, 2007, GENE DEV, V21, P2205, DOI 10.1101/gad.436007; Evdokimov E, 2008, J CELL SCI, V121, P4106, DOI 10.1242/jcs.038570; Hammer E, 2007, FEBS LETT, V581, P5418, DOI 10.1016/j.febslet.2007.10.040; Harris L, 2005, EXP CELL RES, V308, P85, DOI 10.1016/j.yexcr.2005.03.036; Hoffman DB, 2001, MOL BIOL CELL, V12, P1995, DOI 10.1091/mbc.12.7.1995; Huang HM, 2009, CELL CYCLE, V8, P1164, DOI 10.4161/cc.8.8.8151; Huang HM, 2008, J CELL BIOL, V183, P667, DOI 10.1083/jcb.200805163; Kim M, 2005, MOL CELL BIOL, V25, P9232, DOI 10.1128/MCB.25.21.9232-9248.2005; Li WQ, 1999, CELL GROWTH DIFFER, V10, P769; Liu Xue-Song, 2010, Genes Cancer, V1, P26, DOI 10.1177/1947601909358184; Malureanu LA, 2009, DEV CELL, V16, P118, DOI 10.1016/j.devcel.2008.11.004; Mao YH, 2003, CELL, V114, P87, DOI 10.1016/S0092-8674(03)00475-6; Nacerddine K, 2005, DEV CELL, V9, P769, DOI 10.1016/j.devcel.2005.10.007; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Tatham MH, 2003, BIOCHEMISTRY-US, V42, P9959, DOI 10.1021/bi0345283; Wang Q, 2004, BLOOD, V103, P1278, DOI 10.1182/blood-2003-06-2158; Wang X, 2008, DEV CELL, V14, P331, DOI 10.1016/j.devcel.2007.12.007; Wu HY, 2000, ONCOGENE, V19, P4557, DOI 10.1038/sj.onc.1203803; Yu H, 2007, MOL CELL, V27, P3, DOI 10.1016/j.molcel.2007.06.009; Yu HT, 2002, CURR OPIN CELL BIOL, V14, P706, DOI 10.1016/S0955-0674(02)00382-4; Yu JX, 2009, EMBO J, V28, P21, DOI 10.1038/emboj.2008.238; Zhang XD, 2008, MOL CELL, V29, P729, DOI 10.1016/j.molcel.2008.01.013; Zhao H, 2009, CYTOM PART A, V75A, P510, DOI 10.1002/cyto.a.20727	33	25	26	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4875	4882		10.1074/jbc.M111.318261	http://dx.doi.org/10.1074/jbc.M111.318261			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22167194	Green Published, hybrid			2022-12-27	WOS:000300608500048
J	Imamura, K; Averill, A; Wallace, SS; Doublie, S				Imamura, Kayo; Averill, April; Wallace, Susan S.; Doublie, Sylvie			Structural Characterization of Viral Ortholog of Human DNA Glycosylase NEIL1 Bound to Thymine Glycol or 5-Hydroxyuracil-containing DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI ENDONUCLEASE-VIII; BASE-EXCISION-REPAIR; OXIDATIVELY DAMAGED DNA; ESCHERICHIA-COLI; DEOXYRIBONUCLEIC-ACID; SUBSTRATE-SPECIFICITY; LESION RECOGNITION; CRYSTAL-STRUCTURE; OXIDIZED BASES; ENZYME	Thymine glycol (Tg) and 5-hydroxyuracil (5-OHU) are common oxidized products of pyrimidines, which are recognized and cleaved by two DNA glycosylases of the base excision repair pathway, endonuclease III (Nth) and endonuclease VIII (Nei). Although there are several structures of Nei enzymes unliganded or bound to an abasic (apurinic or apyrimidinic) site, until now there was no structure of an Nei bound to a DNA lesion. Mimivirus Nei1 (MvNei1) is an ortholog of human NEIL1, which was previously crystallized bound to DNA containing an apurinic site (Imamura, K., Wallace, S. S., and Doublie, S. (2009) J. Biol. Chem. 284, 26174-26183). Here, we present two crystal structures of MvNei1 bound to two oxidized pyrimidines, Tg and 5-OHU. Both lesions are flipped out from the DNA helix. Tg is in the anti conformation, whereas 5-OHU adopts both anti and syn conformations in the glycosylase active site. Only two protein side chains (Glu-6 and Tyr-253) are within hydrogen-bonding contact with either damaged base, and mutating these residues did not markedly affect the glycosylase activity. This finding suggests that lesion recognition by Nei occurs before the damaged base flips into the glycosylase active site.	[Wallace, Susan S.; Doublie, Sylvie] Univ Vermont, Dept Microbiol & Mol Genet, Markey Ctr Mol Genet, Burlington, VT 05405 USA	University of Vermont	Wallace, SS (corresponding author), Univ Vermont, Dept Microbiol & Mol Genet, Markey Ctr Mol Genet, Stafford Hall,95 Carrigan Dr, Burlington, VT 05405 USA.	Susan.Wallace@uvm.edu; Sylvie.Doublie@uvm.edu		Imamura, Kayo/0000-0002-2141-8495; Wallace, Susan S./0000-0002-3906-0321; Doublie, Sylvie/0000-0002-6294-5304	National Institutes of Health from NCI [P01CA098993, Y1-CO-1020]; NIGMS [Y1-GM-1104]; United States Department of Energy, Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL CANCER INSTITUTE [P01CA098993] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); United States Department of Energy, Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant P01CA098993 from NCI.; We thank Dr. Pierre Aller and Karl Zahn for data collection of the MvNei1.Tg complex at beamline 23-ID-B at the Advanced Photon Source; Minmin Liu for helpful discussions regarding the kinetics experiments; Dr. Matthew Hogg for technical assistance with the rapid quench instrument; and Drs. Peter Orth, Terukazu Nogi, and Mark Rould for helpful crystallographic suggestions. The beamline GM/CA CAT has been funded in whole or in part by National Institutes of Health Grant Y1-CO-1020 from NCI and Grant Y1-GM-1104 from NIGMS. Use of the Advanced Photon Source was supported by United States Department of Energy, Basic Energy Sciences, Contract DE-AC02-06CH11357.	Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Aller P, 2007, P NATL ACAD SCI USA, V104, P814, DOI 10.1073/pnas.0606648104; Aller P, 2011, J MOL BIOL, V412, P22, DOI 10.1016/j.jmb.2011.07.007; Bandaru V, 2002, DNA REPAIR, V1, P517, DOI 10.1016/S1568-7864(02)00036-8; Bandaru V, 2007, DNA REPAIR, V6, P1629, DOI 10.1016/j.dnarep.2007.05.011; Brown KL, 2010, NUCLEIC ACIDS RES, V38, P428, DOI 10.1093/nar/gkp844; Brown KL, 2009, BIOCHEMISTRY-US, V48, P9722, DOI 10.1021/bi900695e; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; CHETSANGA CJ, 1981, BIOCHEMISTRY-US, V20, P5201, DOI 10.1021/bi00521a016; CHUNG MH, 1991, MUTAT RES, V254, P1, DOI 10.1016/0921-8777(91)90035-N; Coste F, 2004, J BIOL CHEM, V279, P44074, DOI 10.1074/jbc.M405928200; Coste F, 2008, CHEM BIOL, V15, P706, DOI 10.1016/j.chembiol.2008.05.014; David SS, 2007, NATURE, V447, P941, DOI 10.1038/nature05978; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dizdaroglu M, 2001, BIOCHEMISTRY-US, V40, P12150, DOI 10.1021/bi015552o; Dou H, 2003, J BIOL CHEM, V278, P49679, DOI 10.1074/jbc.M308658200; Doublie S, 2004, P NATL ACAD SCI USA, V101, P10284, DOI 10.1073/pnas.0402051101; FRENKEL K, 1981, BIOCHEMISTRY-US, V20, P7566, DOI 10.1021/bi00529a035; Fromme JC, 2003, J BIOL CHEM, V278, P51543, DOI 10.1074/jbc.M307768200; Fromme JC, 2002, NAT STRUCT BIOL, V9, P544, DOI 10.1038/nsb809; Gilboa R, 2002, J BIOL CHEM, V277, P19811, DOI 10.1074/jbc.M202058200; Hailer MK, 2005, DNA REPAIR, V4, P41, DOI 10.1016/j.dnarep.2004.07.006; Harris TK, 2002, IUBMB LIFE, V53, P85, DOI 10.1080/15216540211468; Hazra TK, 2002, P NATL ACAD SCI USA, V99, P3523, DOI 10.1073/pnas.062053799; Hazra TK, 2001, NUCLEIC ACIDS RES, V29, P1967, DOI 10.1093/nar/29.9.1967; Hegde ML, 2008, CELL RES, V18, P27, DOI 10.1038/cr.2008.8; Hickerson RP, 1999, J AM CHEM SOC, V121, P9901, DOI 10.1021/ja9923484; Imamura K, 2009, J BIOL CHEM, V284, P26174, DOI 10.1074/jbc.M109.021907; Iwai S, 2001, CHEM-EUR J, V7, P4343, DOI 10.1002/1521-3765(20011015)7:20<4343::AID-CHEM4343>3.0.CO;2-H; Jia L, 2007, BIOCHEMISTRY-US, V46, P5305, DOI 10.1021/bi062269m; Jiang DY, 1997, J BIOL CHEM, V272, P32230, DOI 10.1074/jbc.272.51.32230; Kathe SD, 2009, DNA REPAIR, V8, P643, DOI 10.1016/j.dnarep.2008.12.013; Krishnamurthy N, 2008, BIOCHEMISTRY-US, V47, P7137, DOI 10.1021/bi800160s; Kropachev KY, 2006, BIOCHEMISTRY-US, V45, P12039, DOI 10.1021/bi060663e; Laskowski R., 1993, J APPL CRYSTALLOGR, DOI [10.1107/S002188982009944, DOI 10.1107/S002188982009944]; Le Bihan YV, 2011, NUCLEIC ACIDS RES, V39, P6277, DOI 10.1093/nar/gkr215; Liu MM, 2010, P NATL ACAD SCI USA, V107, P4925, DOI 10.1073/pnas.0908307107; LUSTIG MJ, 1992, NUCLEIC ACIDS RES, V20, P4839, DOI 10.1093/nar/20.18.4839; MELAMEDE RJ, 1994, BIOCHEMISTRY-US, V33, P1255, DOI 10.1021/bi00171a028; Morland I, 2002, NUCLEIC ACIDS RES, V30, P4926, DOI 10.1093/nar/gkf618; Ocampo-Hafalla MT, 2006, DNA REPAIR, V5, P444, DOI 10.1016/j.dnarep.2005.12.004; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parsons JL, 2007, BIOCHEMISTRY-US, V46, P4158, DOI 10.1021/bi0622569; Parsons JL, 2005, NUCLEIC ACIDS RES, V33, P4849, DOI 10.1093/nar/gki816; Perry JJP, 2010, CURR OPIN STRUC BIOL, V20, P283, DOI 10.1016/j.sbi.2010.03.012; Purmal AA, 1998, J BIOL CHEM, V273, P10026, DOI 10.1074/jbc.273.16.10026; Qi Y, 2009, NATURE, V462, P762, DOI 10.1038/nature08561; Sugahara M, 2000, EMBO J, V19, P3857, DOI 10.1093/emboj/19.15.3857; Sugden KD, 2002, ENVIRON HEALTH PERSP, V110, P725, DOI 10.1289/ehp.02110s5725; Takao M, 2002, J BIOL CHEM, V277, P42205, DOI 10.1074/jbc.M206884200; TCHOU J, 1991, P NATL ACAD SCI USA, V88, P4690, DOI 10.1073/pnas.88.11.4690; TEOULE R, 1974, RADIAT RES, V57, P46, DOI 10.2307/3573754; Thiviyanathan V, 2008, BIOCHEM BIOPH RES CO, V366, P752, DOI 10.1016/j.bbrc.2007.12.010; VONSONNTAG C, 1986, INT J RADIAT BIOL, V49, P1; WAGNER JR, 1992, P NATL ACAD SCI USA, V89, P3380, DOI 10.1073/pnas.89.8.3380; Wallace SS, 2002, FREE RADICAL BIO MED, V33, P1, DOI 10.1016/S0891-5849(02)00827-4; Wallace SS, 2003, DNA REPAIR, V2, P441, DOI 10.1016/S1568-7864(02)00182-9; Wallace SS, 1998, RADIAT RES, V150, pS60, DOI 10.2307/3579809; Wilson DM, 2003, FRONT BIOSCI-LANDMRK, V8, pD963, DOI 10.2741/1109; Zharkov DO, 2005, MUTAT RES-FUND MOL M, V577, P24, DOI 10.1016/j.mrfmmm.2005.03.011; Zharkov DO, 2003, DNA REPAIR, V2, P839, DOI 10.1016/S1568-7864(03)00084-3; Zharkov DO, 2002, EMBO J, V21, P789, DOI 10.1093/emboj/21.4.789	62	44	44	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					4288	4298		10.1074/jbc.M111.315309	http://dx.doi.org/10.1074/jbc.M111.315309			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22170059	Green Published, hybrid			2022-12-27	WOS:000300410900060
J	Klenner, C; Kuhn, A				Klenner, Christian; Kuhn, Andreas			Dynamic Disulfide Scanning of the Membrane-inserting Pf3 Coat Protein Reveals Multiple YidC Substrate Contacts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI YIDC; F1F0 ATP SYNTHASE; PERIPLASMIC DOMAIN; INNER-MEMBRANE; CRYSTAL-STRUCTURE; SUBUNIT-C; BIOGENESIS; BACTERIAL; REGIONS; REQUIREMENTS	The membrane insertase YidC inserts newly synthesized proteins into the plasma membrane. While defects in YidC homologs in animals and plants cause diseases, YidC in bacteria is essential for life. Membrane insertion and assembly of ATP synthase and respiratory complexes is catalyzed by YidC. To investigate how YidC interacts with membrane-inserting proteins, we generated single cysteine mutants in YidC and in the model substrate Pf3 coat protein. The single cysteine mutants were expressed and analyzed for disulfide formation during 30 s of synthesis. The results show that the substrate contacts different YidC residues in four of the six transmembrane regions. The residues are located either in the region of the inner leaflet, in the center, as well as in the periplasmic leaflet, consistent with the hypothesis that YidC presents a hydrophobic platform for inserting membrane proteins. In a YidC mutant where most of the contacting residues were mutated to serines, YidC function was severely disturbed and no longer active in a complementation test, suggesting that the residues are important for function. In addition, a Pf3 mutant with a defect in membrane insertion was deficient to contact the periplasmic residues of YidC.	[Klenner, Christian; Kuhn, Andreas] Univ Hohenheim, Inst Microbiol & Mol Biol, D-70599 Stuttgart, Germany	University Hohenheim	Kuhn, A (corresponding author), Univ Hohenheim, Inst Microbiol & Mol Biol, D-70599 Stuttgart, Germany.	Andreas.Kuhn@uni-hohenheim.de			Deutsche Forschungsgemeinschaft [Ku749/6-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft grant Ku749/6-1 (to A. K.).	Celebi N, 2006, J MOL BIOL, V357, P1428, DOI 10.1016/j.jmb.2006.01.030; Dalbey RE, 2004, J CELL BIOL, V166, P769, DOI 10.1083/jcb.200405161; Facey SJ, 2007, J MOL BIOL, V365, P995, DOI 10.1016/j.jmb.2006.10.083; Facey SJ, 2010, CELL MOL LIFE SCI, V67, P2343, DOI 10.1007/s00018-010-0303-0; Gerken U, 2008, BIOCHEMISTRY-US, V47, P6052, DOI 10.1021/bi800116t; Imhof N, 2011, BIOCHEMISTRY-US, V50, P3229, DOI 10.1021/bi1020293; Jiang FL, 2003, J BIOL CHEM, V278, P48965, DOI 10.1074/jbc.M307362200; Jiang FL, 2002, J BIOL CHEM, V277, P19281, DOI 10.1074/jbc.M110857200; Kiefer D, 1999, EMBO J, V18, P6299, DOI 10.1093/emboj/18.22.6299; Kiefer D, 1997, EMBO J, V16, P2197, DOI 10.1093/emboj/16.9.2197; Kiefer D, 2007, INT REV CYTOL, V259, P113, DOI 10.1016/S0074-7969(06)59003-5; Klenner C, 2008, FEBS LETT, V582, P3967, DOI 10.1016/j.febslet.2008.10.044; Kuhn A, 2003, TRENDS CELL BIOL, V13, P510, DOI 10.1016/j.tcb.2003.08.005; KUHN A, 1985, J BIOL CHEM, V260, P5907; Nagler C, 2007, J BACTERIOL, V189, P2897, DOI 10.1128/JB.01551-06; Oliver DC, 2008, J BIOL CHEM, V283, P5208, DOI 10.1074/jbc.M708936200; Price CE, 2010, BBA-MOL CELL RES, V1803, P748, DOI 10.1016/j.bbamcr.2010.01.019; Ravaud S, 2008, J BIOL CHEM, V283, P9350, DOI 10.1074/jbc.M710493200; Samuelson JC, 2000, NATURE, V406, P637, DOI 10.1038/35020586; Serek J, 2004, EMBO J, V23, P294, DOI 10.1038/sj.emboj.7600063; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; van der Laan M, 2004, J CELL BIOL, V165, P213, DOI 10.1083/jcb.200402100; Wang P, 2010, J BACTERIOL, V192, P2193, DOI 10.1128/JB.00484-09; Winterfeld S, 2009, BIOCHEMISTRY-US, V48, P6684, DOI 10.1021/bi9003809; Xie K, 2006, BIOCHEMISTRY-US, V45, P13401, DOI 10.1021/bi060826z; Yi L, 2004, J BIOL CHEM, V279, P39260, DOI 10.1074/jbc.M405490200; Yu Z, 2008, J BIOL CHEM, V283, P34635, DOI 10.1074/jbc.M804344200; Yuan J, 2007, J BACTERIOL, V189, P8961, DOI 10.1128/JB.01365-07	29	34	35	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					3769	3776		10.1074/jbc.M111.307223	http://dx.doi.org/10.1074/jbc.M111.307223			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22179606	hybrid, Green Published			2022-12-27	WOS:000300410900014
J	Kodippili, GC; Spector, J; Hale, J; Giger, K; Hughes, MR; McNagny, KM; Birkenmeier, C; Peters, L; Ritchie, K; Low, PS				Kodippili, Gayani C.; Spector, Jeff; Hale, Jacob; Giger, Katie; Hughes, Michael R.; McNagny, Kelly M.; Birkenmeier, Connie; Peters, Luanne; Ritchie, Ken; Low, Philip S.			Analysis of the Mobilities of Band 3 Populations Associated with Ankyrin Protein and Junctional Complexes in Intact Murine Erythrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RED-CELL MEMBRANE; COMPENSATED HEMOLYTIC-ANEMIA; CYTOPLASMIC DOMAIN; LATERAL MOBILITY; HEREDITARY SPHEROCYTOSIS; ROTATIONAL DIFFUSION; GLYCOPHORIN-C; TARGETED DISRUPTION; CRYSTAL-STRUCTURE; BETA-ADDUCIN	Current models of the erythrocyte membrane depict three populations of band 3: (i) a population tethered to spectrin via ankyrin, (ii) a fraction attached to the spectrin-actin junctional complex via adducin, and (iii) a freely diffusing population. Because many studies of band 3 diffusion also distinguish three populations of the polypeptide, it has been speculated that the three populations envisioned in membrane models correspond to the three fractions observed in diffusion analyses. To test this hypothesis, we characterized band 3 diffusion by single-particle tracking in wild-type and ankyrin-and adducin-deficient erythrocytes. We report that similar to 40% of total band 3 in wild-type murine erythrocytes is attached to ankyrin, whereas similar to 33% is immobilized by adducin, and similar to 27% is not attached to any cytoskeletal anchor. Moredetailed analyses reveal that mobilities of individual ankyrin- and adducin-tethered band 3 molecules are heterogeneous, varying by nearly 2 orders of magnitude and that there is considerable overlap in diffusion coefficients for adducin and ankyrin-tethered populations. Taken together, the data suggest that although the ankyrin-and adducin-immobilized band 3 can be monitored separately, significant heterogeneity still exists within each population, suggesting that structural and compositional properties likely vary considerably within each band 3 complex.	[Spector, Jeff; Hale, Jacob; Ritchie, Ken] Purdue Univ, Dept Phys, W Lafayette, IN 47907 USA; [Kodippili, Gayani C.; Giger, Katie; Low, Philip S.] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA; [Spector, Jeff] Natl Inst Stand & Technol, Gaithersburg, MD 20899 USA; [Hughes, Michael R.; McNagny, Kelly M.] Univ British Columbia, Biomed Res Ctr, Vancouver, BC V6T 1Z3, Canada; [Birkenmeier, Connie; Peters, Luanne] Jackson Lab, Bar Harbor, ME 04609 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; National Institute of Standards & Technology (NIST) - USA; University of British Columbia; Jackson Laboratory	Ritchie, K (corresponding author), Purdue Univ, Dept Phys, 525 Northwest Ave, W Lafayette, IN 47909 USA.	kpritchie@purdue.edu; plow@purdue.edu	McNagny, Kelly/P-5239-2014; Hughes, Michael/N-6039-2015	McNagny, Kelly/0000-0003-4737-3499; Hughes, Michael/0000-0002-7925-6070; Peters, Luanne/0000-0002-0784-0534; Low, Philip/0000-0001-9042-5528	National Institute of Health [GM24417-32]; National Science Foundation [0646633]; Canadian Institutes for Health Research [MOP-93580]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024417, R37GM024417] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institute of Health Grant GM24417-32 (to P. S. L.). This work was also supported by National Science Foundation Grant 0646633 (to K. R.) and Canadian Institutes for Health Research Grant MOP-93580 (to K. M. M.).	ALLOISIO N, 1993, BLOOD, V82, P1323, DOI 10.1182/blood.V82.4.1323.bloodjournal8241323; Anong WA, 2009, BLOOD, V114, P1904, DOI 10.1182/blood-2009-02-203216; BENNETT V, 1980, J BIOL CHEM, V255, P6424; BENNETT V, 1979, NATURE, V281, P597, DOI 10.1038/281597a0; Bennett V, 2008, TRENDS MOL MED, V14, P28, DOI 10.1016/j.molmed.2007.11.005; Birkenmeier Connie S, 2003, Hematol J, V4, P445, DOI 10.1038/sj.thj.6200307; Blackman SM, 1996, BIOPHYS J, V71, P194, DOI 10.1016/S0006-3495(96)79216-0; Blackman SM, 2001, BIOPHYS J, V81, P3363, DOI 10.1016/S0006-3495(01)75969-3; Bruce LJ, 1999, BBA-BIOMEMBRANES, V1416, P258, DOI 10.1016/S0005-2736(98)00231-4; Bruce LJ, 2003, BLOOD, V101, P4180, DOI 10.1182/blood-2002-09-2824; Bruce LJ, 2002, BLOOD, V100, P1878, DOI 10.1182/blood-2002-03-0706; Burton NM, 2011, BIOCHEM CELL BIOL, V89, P200, DOI [10.1139/O10-154, 10.1139/o10-154]; Campanella ME, 2005, P NATL ACAD SCI USA, V102, P2402, DOI 10.1073/pnas.0409741102; Chang SH, 2003, J BIOL CHEM, V278, P6879, DOI 10.1074/jbc.M211137200; CORBETT JD, 1994, J CLIN INVEST, V94, P683, DOI 10.1172/JCI117385; GELLES J, 1988, NATURE, V331, P450, DOI 10.1038/331450a0; Gilligan DM, 1999, P NATL ACAD SCI USA, V96, P10717, DOI 10.1073/pnas.96.19.10717; GOLAN DE, 1980, P NATL ACAD SCI-BIOL, V77, P2537, DOI 10.1073/pnas.77.5.2537; GOLAN DE, 1984, BIOCHEMISTRY-US, V23, P332, DOI 10.1021/bi00297a024; HUGHES CA, 1995, J BIOL CHEM, V270, P18990, DOI 10.1074/jbc.270.32.18990; Hughes MR, 2011, EXP HEMATOL, V39, P305, DOI 10.1016/j.exphem.2010.12.009; Khan AA, 2008, J BIOL CHEM, V283, P14600, DOI 10.1074/jbc.M707818200; Kim S, 2011, J BIOL CHEM, V286, P20746, DOI 10.1074/jbc.M111.230326; Kodippili GC, 2010, BRIT J HAEMATOL, V150, P592, DOI 10.1111/j.1365-2141.2010.08268.x; Kodippili GC, 2009, BLOOD, V113, P6237, DOI 10.1182/blood-2009-02-205450; Lee JCM, 2001, BIOPHYS J, V81, P3178, DOI 10.1016/S0006-3495(01)75954-1; LOW PS, 1986, BIOCHIM BIOPHYS ACTA, V864, P145, DOI 10.1016/0304-4157(86)90009-2; LUX SE, 1990, NATURE, V345, P736, DOI 10.1038/345736a0; LUX SE, 1979, NATURE, V281, P426, DOI 10.1038/281426a0; MARFATIA SM, 1994, J BIOL CHEM, V269, P8631; MARFATIA SM, 1995, J BIOL CHEM, V270, P715, DOI 10.1074/jbc.270.2.715; MATAYOSHI ED, 1991, BIOCHEMISTRY-US, V30, P3527, DOI 10.1021/bi00228a025; Michaely P, 2002, EMBO J, V21, P6387, DOI 10.1093/emboj/cdf651; Mirchev R, 2001, BLOOD CELL MOL DIS, V27, P143, DOI 10.1006/bcmd.2000.0367; Mirchev R, 2011, BRIT J HAEMATOL, V155, P111, DOI 10.1111/j.1365-2141.2011.08805.x; MOHANDAS N, 1993, SEMIN HEMATOL, V30, P171; NIGG EA, 1980, P NATL ACAD SCI-BIOL, V77, P4702, DOI 10.1073/pnas.77.8.4702; NIGG EA, 1979, BIOCHEMISTRY-US, V18, P3457, DOI 10.1021/bi00583a004; Paramore S, 2006, BIOPHYS J, V90, P92, DOI 10.1529/biophysj.105.066969; PETERS LL, 1992, BLOOD, V80, P2122; Peters LL, 2004, BLOOD, V103, P3233, DOI 10.1182/blood-2003-08-2813; PETERS LL, 1991, J CELL BIOL, V114, P1233, DOI 10.1083/jcb.114.6.1233; Peters LL, 1999, J CLIN INVEST, V103, P1527, DOI 10.1172/JCI5766; PETERS LL, 2001, HEMATOPOIESIS DEV AP, P582; Rank G, 2009, BLOOD, V113, P3352, DOI 10.1182/blood-2008-08-172841; Robledo RF, 2008, BLOOD, V112, P4298, DOI 10.1182/blood-2008-05-156000; Robledo RF, 2007, BLOOD, V110, p49A, DOI 10.1182/blood.V110.11.141.141; Salhany JM, 2001, BLOOD CELL MOL DIS, V27, P901, DOI 10.1006/bcmd.2001.0464; Salomao M, 2008, P NATL ACAD SCI USA, V105, P8026, DOI 10.1073/pnas.0803225105; Satchwell TJ, 2009, BLOOD CELL MOL DIS, V42, P201, DOI 10.1016/j.bcmd.2009.01.005; SHEETZ MP, 1980, NATURE, V285, P510, DOI 10.1038/285510a0; Shultz LD, 1997, TRENDS BIOTECHNOL, V15, P302, DOI 10.1016/S0167-7799(97)01060-3; SMITH DK, 1982, NATURE, V297, P424, DOI 10.1038/297424a0; Southgate CD, 1996, NAT GENET, V14, P227, DOI 10.1038/ng1096-227; THEVENIN BJM, 1990, J BIOL CHEM, V265, P16166; Tomishige M, 1998, J CELL BIOL, V142, P989, DOI 10.1083/jcb.142.4.989; Tomishige M, 1999, MOL BIOL CELL, V10, P2475, DOI 10.1091/mbc.10.8.2475; TSUJI A, 1986, BIOCHEMISTRY-US, V25, P6133, DOI 10.1021/bi00368a045; TSUJI A, 1988, BIOCHEMISTRY-US, V27, P7447, DOI 10.1021/bi00419a041; van den Akker E, 2010, BLOOD CELL MOL DIS, V45, P1, DOI 10.1016/j.bcmd.2010.02.019; Yi SJ, 1997, BIOCHEMISTRY-US, V36, P9596, DOI 10.1021/bi9704966	61	27	27	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					4129	4138		10.1074/jbc.M111.294439	http://dx.doi.org/10.1074/jbc.M111.294439			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22147703	Green Published, hybrid			2022-12-27	WOS:000300410900046
J	Koole, C; Wootten, D; Simms, J; Savage, EE; Miller, LJ; Christopoulos, A; Sexton, PM				Koole, Cassandra; Wootten, Denise; Simms, John; Savage, Emilia E.; Miller, Laurence J.; Christopoulos, Arthur; Sexton, Patrick M.			Second Extracellular Loop of Human Glucagon-like Peptide-1 Receptor (GLP-1R) Differentially Regulates Orthosteric but Not Allosteric Agonist Binding and Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; LIGAND-BINDING; ACTIVATION; RESIDUES; ADRENOCEPTOR; ANTAGONIST; EXPRESSION; CONTRIBUTE; MUTATIONS; EXENDIN-4	The glucagon-like peptide-1 receptor (GLP-1R) is a prototypical family B G protein-coupled receptor that exhibits physiologically important pleiotropic coupling and ligand-dependent signal bias. In our accompanying article (Koole, C., Wootten, D., Simms, J., Miller, L. J., Christopoulos, A., and Sexton, P. M. (2012) J. Biol. Chem. 287, 3642-3658), we demonstrate, through alanine-scanning mutagenesis, a key role for extracellular loop (ECL) 2 of the receptor in propagating activation transition mediated by GLP-1 peptides that occurs in a peptide-and pathway-dependent manner for cAMP formation, intracellular (Ca-i(2+)) mobilization, and phosphorylation of extracellular signal-regulated kinases 1 and 2 (pERK1/2). In this study, we examine the effect of ECL2 mutations on the binding and signaling of the peptide mimetics, exendin-4 and oxyntomodulin, as well as small molecule allosteric agonist 6,7-dichloro-2-methylsulfonyl-3-tert-butylaminoquinoxaline (compound 2). Lys-288, Cys296, Trp-297, and Asn-300 were globally important for peptide signaling and also had critical roles in governing signal bias of the receptor. Peptide-specific effects on relative efficacy and signal bias were most commonly observed for residues 301-305, although R299A mutation also caused significantly different effects for individual peptides. Met-303 was more important for exendin-4 and oxyntomodulin action than those of GLP-1 peptides. Globally, ECL2 mutation was more detrimental to exendin-4-mediated Ca-i(2+) release than GLP-1(7-36)-NH2, providing additional evidence for subtle differences in receptor activation by these two peptides. Unlike peptide activation of the GLP-1R, ECL2 mutations had only limited impact on compound 2 mediated cAMP and pERK responses, consistent with this ligand having a distinct mechanism for receptor activation. These data suggest a critical role of ECL2 of the GLP-1R in the activation transition of the receptor by peptide agonists.	[Koole, Cassandra; Wootten, Denise; Simms, John; Savage, Emilia E.; Christopoulos, Arthur; Sexton, Patrick M.] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia; [Koole, Cassandra; Wootten, Denise; Simms, John; Savage, Emilia E.; Christopoulos, Arthur; Sexton, Patrick M.] Monash Univ, Dept Pharmacol, Parkville, Vic 3052, Australia; [Miller, Laurence J.] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Scottsdale, AZ 85259 USA	Monash University; Monash University; Mayo Clinic; Mayo Clinic Phoenix	Sexton, PM (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, 381 Royal Parade, Parkville, Vic 3052, Australia.	patrick.sexton@monash.edu	Sexton, Patrick M/B-1319-2008; Wootten, Denise/ABD-5703-2021; Christopoulos, Arthur/B-6207-2013	Sexton, Patrick M/0000-0001-8902-2473; Wootten, Denise/0000-0003-4563-1642; Christopoulos, Arthur/0000-0003-4442-3294; Simms, John/0000-0002-4675-0902	National Health and Medical Research Council of Australia [1002180, 519461]; National Health and Medical Research Council	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by National Health and Medical Research Council of Australia Project Grant 1002180 and Program Grant 519461 and by a National Health and Medical Research Council Principal Research Fellowship (to P. M. S.) and a Senior Research Fellowship (to A. C.).	Ahn KH, 2009, MOL PHARMACOL, V76, P833, DOI 10.1124/mol.109.057356; Al-Sabah S, 2004, PROTEIN PEPTIDE LETT, V11, P9, DOI 10.2174/0929866043478365; Al-Sabah S, 2003, FEBS LETT, V553, P342, DOI 10.1016/S0014-5793(03)01043-3; Al-Sabah S, 2003, BRIT J PHARMACOL, V140, P339, DOI 10.1038/sj.bjp.0705453; Assil-Kishawi I, 2002, J BIOL CHEM, V277, P32558, DOI 10.1074/jbc.M204964200; Avlani VA, 2007, J BIOL CHEM, V282, P25677, DOI 10.1074/jbc.M702311200; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Bergwitz C, 1997, J BIOL CHEM, V272, P28861, DOI 10.1074/jbc.272.46.28861; Conner M, 2007, J BIOL CHEM, V282, P17405, DOI 10.1074/jbc.M702151200; Coopman K, 2011, MOL ENDOCRINOL, V25, P1804, DOI 10.1210/me.2011-1160; Drucker DJ, 2010, NAT REV DRUG DISCOV, V9, P267, DOI 10.1038/nrd3148; FEHMANN HC, 1994, PEPTIDES, V15, P453, DOI 10.1016/0196-9781(94)90204-6; Furman B. L., 2010, TOXICON IN PRESS; GOKE R, 1993, J BIOL CHEM, V268, P19650; Gregory KJ, 2010, J BIOL CHEM, V285, P7459, DOI 10.1074/jbc.M109.094011; Hawtin SR, 2006, J BIOL CHEM, V281, P38478, DOI 10.1074/jbc.M607639200; Hoare SRJ, 2005, DRUG DISCOV TODAY, V10, P417, DOI 10.1016/S1359-6446(05)03370-2; Holtmann MH, 1996, J BIOL CHEM, V271, P14944, DOI 10.1074/jbc.271.25.14944; Irwin N, 2010, EUR J PHARMACOL, V628, P268, DOI 10.1016/j.ejphar.2009.11.022; Knudsen LB, 2007, P NATL ACAD SCI USA, V104, P937, DOI 10.1073/pnas.0605701104; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Kolterman OG, 2005, AM J HEALTH-SYST PH, V62, P173, DOI 10.1093/ajhp/62.2.173; Koole C, 2012, J BIOL CHEM, V287, P3642, DOI 10.1074/jbc.M111.309328; Koole C, 2011, MOL PHARMACOL, V80, P486, DOI 10.1124/mol.111.072884; Koole C, 2010, MOL PHARMACOL, V78, P456, DOI 10.1124/mol.110.065664; Liaw CW, 1997, MOL ENDOCRINOL, V11, P980, DOI 10.1210/me.11.7.980; Mann R, 2007, BIOCHEM SOC T, V35, P713, DOI 10.1042/BST0350713; Mann RJ, 2010, PEPTIDES, V31, P2289, DOI 10.1016/j.peptides.2010.09.015; Miller LJ, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.217901; MontroseRafizadeh C, 1997, J BIOL CHEM, V272, P21201, DOI 10.1074/jbc.272.34.21201; Ott TR, 2002, MOL ENDOCRINOL, V16, P1079, DOI 10.1210/me.16.5.1079; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; Scarselli M, 2007, J BIOL CHEM, V282, P7385, DOI 10.1074/jbc.M610394200; SCHMIDTLER J, 1994, AM J PHYSIOL, V267, pG423, DOI 10.1152/ajpgi.1994.267.3.G423; Sloop KW, 2010, DIABETES, V59, P3099, DOI 10.2337/db10-0689; Teng M, 2007, BIOORG MED CHEM LETT, V17, P5472, DOI 10.1016/j.bmcl.2007.06.086	38	23	23	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					3659	3673		10.1074/jbc.M111.309369	http://dx.doi.org/10.1074/jbc.M111.309369			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22147709	Green Published, hybrid, Green Accepted			2022-12-27	WOS:000300410900005
J	Ono, S; Hane, M; Kitajima, K; Sato, C				Ono, Sayaka; Hane, Masaya; Kitajima, Ken; Sato, Chihiro			Novel Regulation of Fibroblast Growth Factor 2 (FGF2)-mediated Cell Growth by Polysialic Acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULE NCAM-H; ADHESION MOLECULE; ADULT-RAT; NEUROTROPHIC FACTOR; NERVOUS-SYSTEM; POSSIBLE ROLES; DENTATE GYRUS; BINDING; EXPRESSION; COMPLEX	Polysialic acid (polySia) is a unique polysaccharide that modifies neural cell adhesion molecule (NCAM) spatiotemporally. Recently, we demonstrated that polySia functions as a reservoir for several neurotrophic factors and neurotransmitters. Here, we showed the direct interaction between polySia and fibroblast growth factor-2 (FGF2) by native-PAGE, gel filtration, and surface plasmon resonance. The minimum chain length of polySia required for the interaction with FGF2 was 17. Compared with heparan sulfate, a well known glycosaminoglycan capable of forming a complex with FGF2, polySia formed a larger complex with distinct properties in facilitating oligomerization of FGF2, as well as in binding to FGF receptors. In polySia-NCAM-expressing NIH-3T3 cells, which were established by transfecting cells with either of the plasmids for the expression of the polysialyltransferases ST8SiaII/STX and ST8SiaIV/PST that can polysialylate NCAM, FGF2-stimulated cell growth, but not cell survival, was inhibited. Taken together, these results suggest that polySia-NCAM might be involved in the regulation of FGF2-FGF receptor signaling through the direct binding of FGF2 in a manner distinct from heparan sulfate.	[Kitajima, Ken] Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi 4648601, Japan; Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan	Nagoya University; Nagoya University	Kitajima, K (corresponding author), Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi 4648601, Japan.	kitajima@agr.nagoya-u.ac.jp; chi@agr.nagoya-u.ac.jp	SATO, Chihiro/B-7396-2014; Naganawa, Shinji/I-1572-2012	Naganawa, Shinji/0000-0002-0214-613X	Ministry of Education, Science, Sports and Culture [20570107, 23570133]; Hayashi Foundation; CREST of Japan Science and Technology Agency; Grants-in-Aid for Scientific Research [23570133] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Hayashi Foundation; CREST of Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-aid for Scientific Research (C) 20570107 and 23570133 from the Ministry of Education, Science, Sports and Culture, the Hayashi Foundation (to C. S.), and CREST of Japan Science and Technology Agency (to K. K.).	Angata K, 2004, J BIOL CHEM, V279, P32603, DOI 10.1074/jbc.M403429200; Arai M, 2006, BIOL PSYCHIAT, V59, P652, DOI 10.1016/j.biopsych.2005.08.016; Bax M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006987; Bonfanti L, 2006, PROG NEUROBIOL, V80, P129, DOI 10.1016/j.pneurobio.2006.08.003; BURGESS WH, 1989, ANNU REV BIOCHEM, V58, P575, DOI 10.1146/annurev.bi.58.070189.003043; Christensen C, 2006, FEBS LETT, V580, P3386, DOI 10.1016/j.febslet.2006.05.008; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; Drake PM, 2008, J IMMUNOL, V181, P6850, DOI 10.4049/jimmunol.181.10.6850; Eckhardt M, 2000, J NEUROSCI, V20, P5234, DOI 10.1523/JNEUROSCI.20-14-05234.2000; FANTL WJ, 1993, ANNU REV BIOCHEM, V62, P453, DOI 10.1146/annurev.bi.62.070193.002321; Francavilla C, 2007, J CELL SCI, V120, P4388, DOI 10.1242/jcs.010744; Fujita KA, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000810; Fukuda M, 1996, CANCER RES, V56, P2237; Fumagalli F, 2005, NEUROBIOL DIS, V20, P731, DOI 10.1016/j.nbd.2005.05.005; Gaughran F, 2006, BRAIN RES BULL, V70, P221, DOI 10.1016/j.brainresbull.2006.04.008; Graham BM, 2010, NEUROPSYCHOPHARMACOL, V35, P1348, DOI 10.1038/npp.2010.3; Ibrahimi OA, 2004, BIOCHEMISTRY-US, V43, P4724, DOI 10.1021/bi0352320; Ibrahimi OA, 2004, HUM MOL GENET, V13, P69, DOI 10.1093/hmg/ddh011; Isomura R, 2011, J BIOL CHEM, V286, P21535, DOI 10.1074/jbc.M111.221143; Itoh N, 2007, BIOL PHARM BULL, V30, P1819, DOI 10.1248/bpb.30.1819; Jacobsen J, 2008, NEUROCHEM RES, V33, P2532, DOI 10.1007/s11064-008-9680-2; Kanato Y, 2009, BIOSCI BIOTECH BIOCH, V73, P2735, DOI 10.1271/bbb.90637; Kanato Y, 2008, GLYCOBIOLOGY, V18, P1044, DOI 10.1093/glycob/cwn084; KERN WF, 1993, LEUKEMIA LYMPHOMA, V12, P1, DOI 10.3109/10428199309059565; Kiselyov VV, 2005, J NEUROCHEM, V94, P1169, DOI 10.1111/j.1471-4159.2005.03284.x; LIVINGSTON BD, 1988, J BIOL CHEM, V263, P9443; Martersteck CM, 1996, GLYCOBIOLOGY, V6, P289, DOI 10.1093/glycob/6.3.289; Minana R, 2000, J NEUROCHEM, V75, P954, DOI 10.1046/j.1471-4159.2000.0750954.x; Miyata S, 2006, GLYCOBIOLOGY, V16, P1229, DOI 10.1093/glycob/cwl036; Mudo G, 2009, J NEURAL TRANSM, V116, P995, DOI 10.1007/s00702-009-0207-z; Murphy KJ, 2006, NEUROPSYCHOPHARMACOL, V31, P90, DOI 10.1038/sj.npp.1300810; Nakata D, 2005, J BIOL CHEM, V280, P38305, DOI 10.1074/jbc.M508762200; NUGENT MA, 1992, BIOCHEMISTRY-US, V31, P8876, DOI 10.1021/bi00152a026; Perez JA, 2009, J NEUROSCI, V29, P6379, DOI 10.1523/JNEUROSCI.4829-08.2009; Rey-Gallardo A, 2010, GLYCOBIOLOGY, V20, P1139, DOI 10.1093/glycob/cwq078; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; Sato C, 1999, TRENDS GLYCOSCI GLYC, V11, P371, DOI 10.4052/tigg.11.371; SATO C, 1995, J BIOL CHEM, V270, P18923, DOI 10.1074/jbc.270.32.18923; Sato C, 2011, TRENDS GLYCOSCI GLYC, V23, P221, DOI 10.4052/tigg.23.221; Sato C, 2010, METHOD ENZYMOL, V478, P219, DOI 10.1016/S0076-6879(10)78010-1; Saxena K, 2010, J BIOL CHEM, V285, P26628, DOI 10.1074/jbc.M109.095109; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Seidenfaden R, 2003, MOL CELL BIOL, V23, P5908, DOI 10.1128/MCB.23.16.5908-5918.2003; SEKI T, 1993, NEUROSCI RES, V17, P265, DOI 10.1016/0168-0102(93)90111-3; SEKI T, 1991, NEUROSCI RES, V12, P503, DOI 10.1016/S0168-0102(09)80003-5; SEKI T, 1993, J NEUROSCI, V13, P2351, DOI 10.1523/JNEUROSCI.13-06-02351.1993; Tanaka F, 2000, CANCER RES, V60, P3072; TROY FA, 1996, BIOL SIALIC ACIDS, P95; Turner CA, 2008, BRAIN RES, V1224, P63, DOI 10.1016/j.brainres.2008.05.088; Turner CA, 2009, PHARMACOL BIOCHEM BE, V92, P100, DOI 10.1016/j.pbb.2008.10.018; Venkataraman G, 1999, P NATL ACAD SCI USA, V96, P3658, DOI 10.1073/pnas.96.7.3658	51	74	90	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					3710	3722		10.1074/jbc.M111.276618	http://dx.doi.org/10.1074/jbc.M111.276618			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22158871	Green Published, hybrid			2022-12-27	WOS:000300410900009
J	Yu, TX; Chen, X; Zhang, W; Colon, D; Shi, JD; Napier, D; Rychahou, P; Lu, WG; Lee, EY; Weiss, HL; Evers, BM; Liu, CM				Yu, Tianxin; Chen, Xi; Zhang, Wen; Colon, Deannon; Shi, Jiandang; Napier, Dana; Rychahou, Piotr; Lu, Wange; Lee, Eun Y.; Weiss, Heidi L.; Evers, B. Mark; Liu, Chunming			Regulation of the Potential Marker for Intestinal Cells, Bmi1, by beta-Catenin and the Zinc Finger Protein KLF4 IMPLICATIONS FOR COLON CANCER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEM-CELLS; TUMOR-SUPPRESSOR; C-MYC; H2A UBIQUITYLATION; INDUCED APOPTOSIS; SELF-RENEWAL; GENE; DIFFERENTIATION; IDENTIFICATION; SENESCENCE	B lymphoma Mo-MLV insertion region 1 (Bmi1) is a Polycomb Group (PcG) protein important in gene silencing. It is a component of Polycomb Repressive Complex 1 (PRC1), which is required to maintain the transcriptionally repressive state of many genes. Bmi1 was initially identified as an oncogene that regulates cell proliferation and transformation, and is important in hematopoiesis and the development of nervous systems. Recently, it was reported that Bmi1 is a potential marker for intestinal stem cells. Because Wnt signaling plays a key role in intestinal stem cells, we analyzed the effects of Wnt signaling on Bmi1 expression. We found that Wnt signaling indeed regulates the expression of Bmi1 in colon cancer cells. In addition, the expression of Bmi1 in human colon cancers is significantly associated with nuclear beta-catenin, a hallmark for the activated Wnt signaling. Kruppel-like factor 4 (KLF4) is a zinc finger protein highly expressed in the gut and skin. We recently found that KLF4 cross-talks with Wnt/beta-catenin in regulating intestinal homeostasis. We demonstrated that KLF4 directly inhibits the expression of Bmi1 in colon cancer cells. We also found that Bmi1 regulates histone ubiquitination and is required for colon cancer proliferation in vitro and in vivo. Our findings further suggest that Bmi1 is an attractive target for cancer therapeutics.	[Yu, Tianxin; Chen, Xi; Zhang, Wen; Shi, Jiandang; Napier, Dana; Rychahou, Piotr; Lee, Eun Y.; Weiss, Heidi L.; Evers, B. Mark; Liu, Chunming] Univ Kentucky, Markey Canc Ctr, Lexington, KY 40506 USA; [Napier, Dana; Lee, Eun Y.] Univ Kentucky, Dept Pathol, Lexington, KY 40506 USA; [Rychahou, Piotr; Evers, B. Mark] Univ Kentucky, Dept Surg, Lexington, KY 40506 USA; [Yu, Tianxin; Colon, Deannon] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Lu, Wange] Univ So Calif, Keck Sch Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90033 USA; [Liu, Chunming] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40506 USA	University of Kentucky; University of Kentucky; University of Kentucky; University of Texas System; University of Texas Medical Branch Galveston; University of Southern California; University of Kentucky	Liu, CM (corresponding author), Univ Kentucky, Markey Canc Ctr, Lexington, KY 40506 USA.	chunming.liu@uky.edu		Rychahou, Piotr/0000-0001-7352-9122	National Institutes of Health [R01 DK071976]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071976] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK071976 (to C. L.).	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Brown JL, 2005, NUCLEIC ACIDS RES, V33, P5181, DOI 10.1093/nar/gki827; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Evans PM, 2007, J BIOL CHEM, V282, P33994, DOI 10.1074/jbc.M701847200; Evans PM, 2010, MOL CELL BIOL, V30, P372, DOI 10.1128/MCB.00063-09; EVERS BM, 1991, GASTROENTEROLOGY, V101, P303, DOI 10.1016/0016-5085(91)90004-5; Ghaleb AM, 2011, DEV BIOL, V349, P310, DOI 10.1016/j.ydbio.2010.11.001; Ghaleb AM, 2008, MOL CANCER RES, V6, P1920, DOI 10.1158/1541-7786.MCR-08-0224; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Guo WJ, 2007, MOL BIOL CELL, V18, P536, DOI 10.1091/mbc.E06-05-0447; HAUPT Y, 1991, CELL, V65, P753, DOI 10.1016/0092-8674(91)90383-A; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Jacobs JJL, 1999, GENE DEV, V13, P2678, DOI 10.1101/gad.13.20.2678; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kang MK, 2007, BRIT J CANCER, V96, P126, DOI 10.1038/sj.bjc.6603529; Katz JP, 2002, DEVELOPMENT, V129, P2619; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Molofsky AV, 2005, GENE DEV, V19, P1432, DOI 10.1101/gad.1299505; Qin H, 2007, J BIOL CHEM, V282, P5842, DOI 10.1074/jbc.M610464200; Rajasekhar VK, 2007, STEM CELLS, V25, P2498, DOI 10.1634/stemcells.2006-0608; Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sansom OJ, 2007, NATURE, V446, P676, DOI 10.1038/nature05674; Scoville DH, 2008, GASTROENTEROLOGY, V134, P849, DOI 10.1053/j.gastro.2008.01.079; Shields JM, 1998, NUCLEIC ACIDS RES, V26, P796, DOI 10.1093/nar/26.3.796; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; VANDEWETERING M, 1992, EMBO J, V11, P3039, DOI 10.1002/j.1460-2075.1992.tb05374.x; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang QD, 2002, CLIN CANCER RES, V8, P1940; Wei JH, 2006, J BIOL CHEM, V281, P22537, DOI 10.1074/jbc.M600826200; Yamamoto Y, 2003, HEPATOLOGY, V37, P528, DOI 10.1053/jhep.2003.50029; Zhang W, 2006, MOL CELL BIOL, V26, P2055, DOI 10.1128/MCB.26.6.2055-2064.2006; Zhao WD, 2004, ONCOGENE, V23, P395, DOI 10.1038/sj.onc.1207067; Zheng H, 2009, AM J PHYSIOL-GASTR L, V296, pG490, DOI 10.1152/ajpgi.90393.2008	43	73	80	0	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					3760	3768		10.1074/jbc.M111.316349	http://dx.doi.org/10.1074/jbc.M111.316349			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22170051	Green Published, hybrid			2022-12-27	WOS:000300410900013
J	Zhuang, XL; Northup, JK; Ray, K				Zhuang, Xiaolei; Northup, John K.; Ray, Kausik			Large Putative PEST-like Sequence Motif at the Carboxyl Tail of Human Calcium Receptor Directs Lysosomal Degradation and Regulates Cell Surface Receptor Level	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; AUTOSOMAL-DOMINANT HYPOCALCEMIA; SENSING RECEPTOR; HYPOCALCIURIC HYPERCALCEMIA; SIGNAL-TRANSDUCTION; COUPLED RECEPTORS; CYTOPLASMIC TAIL; UBIQUITINATION; EXPRESSION; PHOSPHORYLATION	A deletion between amino acid residues Ser(895) and Val(1075) in the carboxyl terminus of the human calcium receptor (hCaR), which causes autosomal dominant hypocalcemia, showed enhanced signaling activity and increased cell surface expression in HEK293 cells (Lienhardt, A., Garabedian, M. G., Bai, M., Sinding, C., Zhang, Z., Lagarde, J. P., Boulesteix, J., Rigaud, M., Brown, E. M., and Kottler, M. L. (2000) J. Clin. Endocrinol. Metab. 85, 1695-1702). To identify the underlying mechanism(s) for these increases, we investigated the effects of carboxyl tail truncation and deletion in hCaR mutants using a combination of biochemical and cell imaging approaches to define motifs that participate in regulating cell surface numbers of this G protein-coupled receptor. Our data indicate a rapid constitutive receptor internalization of the cell surface hCaR, accumulating in early (Rab7 positive) and late endosomal (LAMP1 positive) sorting compartments, before targeting to lysosomes for degradation. Recycling of hCaR back to the cell surface was also evident. Truncation and deletion mapping defined a 51-amino acid sequence between residues 920 and 970 that is required for targeting to lysosomes and degradation but not for internalization or recycling of the receptor. No singular sequence motif was identified, instead the required sequence elements seem to distribute throughout this entire interval. This interval includes a high proportion of acidic and hydroxylated amino acid residues, suggesting a similarity to PEST-like degradation motif (PEST find score of +10) and several glutamine repeats. The results define a novel large PEST-like sequence that participates in the sorting of internalized hCaR routed to the lysosomal/degradation pathway that regulates cell surface receptor numbers.	[Zhuang, Xiaolei; Northup, John K.; Ray, Kausik] NIDCD, Lab Cellular Biol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Northup, JK (corresponding author), Lab Cellular Biol, 5 Res Court,Rm 2A11, Rockville, MD 20850 USA.	northupJK@nidcd.nih.gov; rayk@nidcd.nih.gov	Ray, Kausik/Z-2055-2019		National Institutes of Health of the NIDCD, National Institues of Health; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIADC000068] Funding Source: NIH RePORTER	National Institutes of Health of the NIDCD, National Institues of Health; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program of the NIDCD, National Institues of Health.	Bai M, 1998, J BIOL CHEM, V273, P21267, DOI 10.1074/jbc.273.33.21267; Brauner-Osborne H, 2007, CURR DRUG TARGETS, V8, P169, DOI 10.2174/138945007779315614; Brown EM, 2001, PHYSIOL REV, V81, P239, DOI 10.1152/physrev.2001.81.1.239; Cavanaugh A, 2010, J BIOL CHEM, V285, P19854, DOI 10.1074/jbc.M110.124792; Chang WH, 2001, J BIOL CHEM, V276, P44129, DOI 10.1074/jbc.M104834200; Chen WG, 2005, J BIOL CHEM, V280, P29277, DOI 10.1074/jbc.M505566200; El Hiani Y, 2009, ARCH BIOCHEM BIOPHYS, V486, P58, DOI 10.1016/j.abb.2009.03.010; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; Gama L, 1998, J BIOL CHEM, V273, P29712, DOI 10.1074/jbc.273.45.29712; Goswami A, 2006, BIOCHEM BIOPH RES CO, V342, P184, DOI 10.1016/j.bbrc.2006.01.136; Grampp T, 2007, J BIOL CHEM, V282, P24157, DOI 10.1074/jbc.M702626200; Huang C, 2007, J CELL MOL MED, V11, P923, DOI 10.1111/j.1582-4934.2007.00114.x; Huang Y, 2006, J BIOL CHEM, V281, P11610, DOI 10.1074/jbc.M513552200; Huang Y, 2010, J BIOL CHEM, V285, P35919, DOI 10.1074/jbc.M110.147918; Jiang YF, 2002, J BIOL CHEM, V277, P50543, DOI 10.1074/jbc.M205798200; Lienhardt A, 2000, J CLIN ENDOCR METAB, V85, P1695, DOI 10.1210/jc.85.4.1695; Lorenz S, 2007, ENDOCRINOLOGY, V148, P2398, DOI 10.1210/en.2006-1035; Marchal C, 1998, MOL CELL BIOL, V18, P314, DOI 10.1128/MCB.18.1.314; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; Nissen PH, 2007, J CLIN ENDOCR METAB, V92, P4373, DOI 10.1210/jc.2007-0322; Pi M, 2005, MOL ENDOCRINOL, V19, P1078, DOI 10.1210/me.2004-0450; Pidasheva S, 2004, HUM MUTAT, V24, P107, DOI 10.1002/humu.20067; Ravikumar B, 2002, HUM MOL GENET, V11, P1107, DOI 10.1093/hmg/11.9.1107; Ray K, 1998, J BIOL CHEM, V273, P34558, DOI 10.1074/jbc.273.51.34558; Ray K, 1997, J BIOL CHEM, V272, P31355, DOI 10.1074/jbc.272.50.31355; Ray K, 2002, J BIOL CHEM, V277, P18908, DOI 10.1074/jbc.M202113200; Reyes-Ibarra AP, 2007, MOL ENDOCRINOL, V21, P1394, DOI 10.1210/me.2006-0523; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; Roth AF, 1998, J CELL BIOL, V142, P949, DOI 10.1083/jcb.142.4.949; Scillitani A, 2004, J CLIN ENDOCR METAB, V89, P5634, DOI 10.1210/jc.2004-0129; Simonds WF, 2002, MEDICINE, V81, P1, DOI 10.1097/00005792-200201000-00001; Stepanchick A, 2010, CELL PHYSIOL BIOCHEM, V26, P363, DOI 10.1159/000320560; Tfelt-Hansen J, 2005, CRIT REV CL LAB SCI, V42, P35, DOI 10.1080/10408360590886606; Wang N, 2003, J CLIN INVEST, V111, P99, DOI 10.1172/JCI200316808; Wolfe BL, 2007, J CELL BIOL, V177, P905, DOI 10.1083/jcb.200610154; Zhang ML, 2005, J BIOL CHEM, V280, P11140, DOI 10.1074/jbc.M412242200; Zhuang XL, 2010, ENDOCRINOLOGY, V151, P5114, DOI 10.1210/en.2010-0422; Zhuang XL, 2010, BIOCHEM BIOPH RES CO, V396, P874, DOI 10.1016/j.bbrc.2010.05.014	38	24	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					4165	4176		10.1074/jbc.M111.271528	http://dx.doi.org/10.1074/jbc.M111.271528			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22158862	hybrid, Green Published			2022-12-27	WOS:000300410900050
J	Krug, U; Zebisch, M; Krauss, M; Strater, N				Krug, Ulrike; Zebisch, Matthias; Krauss, Michel; Straeter, Norbert			Structural Insight into Activation Mechanism of Toxoplasma gondii Nucleoside Triphosphate Diphosphohydrolases by Disulfide Reduction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; ATP-DIPHOSPHOHYDROLASE; LEISHMANIA-AMAZONENSIS; CONFORMATIONAL-CHANGE; MAXIMUM-LIKELIHOOD; PROTEIN STRUCTURES; CRYSTAL-STRUCTURE; ECTO-ATPASE; HYDROLASE; PURIFICATION	The intracellular parasite Toxoplasma gondii produces two nucleoside triphosphate diphosphohydrolases (NTPDase1 and -3). These tetrameric, cysteine-rich enzymes require activation by reductive cleavage of a hitherto unknown disulfide bond. Despite a 97% sequence identity, both isozymes differ largely in their ability to hydrolyze ATP and ADP. Here, we present crystal structures of inactive NTPDase3 as an apo form and in complex with the product AMP to resolutions of 2.0 and 2.2 angstrom, respectively. We find that the enzyme is present in an open conformation that precludes productive substrate binding and catalysis. The cysteine bridge 258-268 is identified to be responsible for locking of activity. Crystal structures of constitutively active variants of NTPDase1 and -3 generated by mutation of Cys(258)-Cys(268) show that opening of the regulatory cysteine bridge induces a pronounced contraction of the whole tetramer. This is accompanied by a 12 degrees domain closure motion resulting in the correct arrangement of all active site residues. A complex structure of activated NTPDase3 with a non-hydrolyzable ATP analog and the cofactor Mg2+ to a resolution of 2.85 angstrom indicates that catalytic differences between the NTPDases are primarily dictated by differences in positioning of the adenine base caused by substitution of Arg(492) and Glu(493) in NTPDase1 by glycines in NTPDase3.	[Krug, Ulrike; Zebisch, Matthias; Krauss, Michel; Straeter, Norbert] Univ Leipzig, Inst Bioanalyt Chem, Ctr Biotechnol & Biomed, D-04103 Leipzig, Germany	Leipzig University	Strater, N (corresponding author), Univ Leipzig, Inst Bioanalyt Chem, Ctr Biotechnol & Biomed, Deutsch Pl 5, D-04103 Leipzig, Germany.	strater@bbz.uni-leipzig.de	Strater, Norbert/P-4856-2018	Strater, Norbert/0000-0002-2001-0500; Zebisch, Matthias/0000-0003-3126-3885	European Synchrotron Radiation Facility (Grenoble, France); PSF/BESSY (Berlin, Germany)	European Synchrotron Radiation Facility (Grenoble, France); PSF/BESSY (Berlin, Germany)	We thank Michael Johnson (University of Technology, Sydney, Australia) for providing cDNA. Furthermore, we thank the staff of beamlines BL14.1 and BL14.2 at PSF/BESSY (Berlin, Germany) and beamline ID23-2 at the European Synchrotron Radiation Facility (Grenoble, France) for beam time and support.	ASAI T, 1983, J BIOL CHEM, V258, P6816; ASAI T, 1995, J BIOL CHEM, V270, P11391, DOI 10.1074/jbc.270.19.11391; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; BENNETT WS, 1978, P NATL ACAD SCI USA, V75, P4848, DOI 10.1073/pnas.75.10.4848; BERMUDES D, 1994, J BIOL CHEM, V269, P29252; Berredo-Pinho M, 2001, ARCH BIOCHEM BIOPHYS, V391, P16, DOI 10.1006/abbi.2001.2384; Bianconi ML, 2007, BIOPHYS CHEM, V126, P59, DOI 10.1016/j.bpc.2006.05.017; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Cowtan K, 1999, ACTA CRYSTALLOGR D, V55, P1555, DOI 10.1107/S0907444999007416; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Drosopoulos JHF, 2000, BIOCHEMISTRY-US, V39, P6936, DOI 10.1021/bi992581e; Freyer MW, 2008, METHOD CELL BIOL, V84, P79, DOI 10.1016/S0091-679X(07)84004-0; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Grinthal Alison, 2006, Purinergic Signal, V2, P391, DOI 10.1007/s11302-005-5907-8; Handa M, 1996, BIOCHEM BIOPH RES CO, V218, P916, DOI 10.1006/bbrc.1996.0162; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; HAZES B, 1988, PROTEIN ENG, V2, P119, DOI 10.1093/protein/2.2.119; Ivanenkov VV, 2005, BIOCHEMISTRY-US, V44, P8998, DOI 10.1021/bi047487z; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kikuchi T, 2001, J EUKARYOT MICROBIOL, p195S; Kuettner EB, 2010, J BIOL CHEM, V285, P41019, DOI 10.1074/jbc.M110.185850; Mateo J, 2003, J BIOL CHEM, V278, P39960, DOI 10.1074/jbc.M307854200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Mosca R, 2008, NUCLEIC ACIDS RES, V36, pW42, DOI 10.1093/nar/gkn197; Mosca R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-352; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakaar V, 1998, MOL BIOCHEM PARASIT, V97, P209, DOI 10.1016/S0166-6851(98)00153-4; Nakaar V, 1999, J BIOL CHEM, V274, P5083, DOI 10.1074/jbc.274.8.5083; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Pinheiro CM, 2006, EXP PARASITOL, V114, P16, DOI 10.1016/j.exppara.2006.02.007; Robson Simon C, 2006, Purinergic Signal, V2, P409, DOI 10.1007/s11302-006-9003-5; Sansom FM, 2007, CELL MICROBIOL, V9, P1922, DOI 10.1111/j.1462-5822.2007.00924.x; Sansom FM, 2008, MICROBIOL MOL BIOL R, V72, P765, DOI 10.1128/MMBR.00013-08; SCHWARTZMAN JD, 1982, EXP PARASITOL, V53, P77, DOI 10.1016/0014-4894(82)90094-7; SIBLEY LD, 1994, EXP PARASITOL, V79, P301, DOI 10.1006/expr.1994.1093; Silverman JA, 1998, J BIOL CHEM, V273, P12352, DOI 10.1074/jbc.273.20.12352; Stommel EW, 1997, EXP PARASITOL, V87, P88, DOI 10.1006/expr.1997.4187; Stommel EW, 2001, EXP BIOL MED, V226, P229, DOI 10.1177/153537020122600311; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; Todd MJ, 2001, ANAL BIOCHEM, V296, P179, DOI 10.1006/abio.2001.5218; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vasconcelos EG, 1996, J BIOL CHEM, V271, P22139, DOI 10.1074/jbc.271.36.22139; VASCONCELOS EG, 1993, MOL BIOCHEM PARASIT, V58, P205, DOI 10.1016/0166-6851(93)90042-V; Vivian JP, 2010, STRUCTURE, V18, P228, DOI 10.1016/j.str.2009.11.014; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Yang F, 2001, BIOCHEMISTRY-US, V40, P3943, DOI 10.1021/bi002711f; Zebisch M., 2011, J MOL BIOL IN PRESS; Zebisch M, 2008, P NATL ACAD SCI USA, V105, P6882, DOI 10.1073/pnas.0802535105; Zebisch M, 2007, BIOCHEMISTRY-US, V46, P11945, DOI 10.1021/bi701103y	53	22	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3051	3066		10.1074/jbc.M111.294348	http://dx.doi.org/10.1074/jbc.M111.294348			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22130673	Green Published, hybrid			2022-12-27	WOS:000300295100012
J	Okada, R; Nagaosa, K; Kuraishi, T; Nakayama, H; Yamamoto, N; Nakagawa, Y; Dohmae, N; Shiratsuchi, A; Nakanishi, Y				Okada, Ryo; Nagaosa, Kaz; Kuraishi, Takayuki; Nakayama, Hiroshi; Yamamoto, Naoko; Nakagawa, Yukiko; Dohmae, Naoshi; Shiratsuchi, Akiko; Nakanishi, Yoshinobu			Apoptosis-dependent Externalization and Involvement in Apoptotic Cell Clearance of DmCaBP1, an Endoplasmic Reticulum Protein of Drosophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAENORHABDITIS-ELEGANS; DISULFIDE-ISOMERASE; C-ELEGANS; ENGULFMENT; PHAGOCYTOSIS; DEATH; CALRETICULIN; RECEPTOR; DRAPER; CED-1	To elucidate the actions of Draper, a receptor responsible for the phagocytic clearance of apoptotic cells in Drosophila, we isolated proteins that bind to the extracellular region of Draper using affinity chromatography. One of those proteins has been identified to be an uncharacterized protein called Drosophila melanogaster calcium-binding protein 1 (DmCaBP1). This protein containing the thioredoxin-like domain resided in the endoplasmic reticulum and seemed to be expressed ubiquitously throughout the development of Drosophila. DmCaBP1 was externalized without truncation after the induction of apoptosis somewhat prior to chromatin condensation and DNA cleavage in a manner dependent on the activity of caspases. A recombinant DmCaBP1 protein bound to both apoptotic cells and a hemocyte-derived cell line expressing Draper. Forced expression of DmCaBP1 at the cell surface made non-apoptotic cells susceptible to phagocytosis. Flies deficient in DmCaBP1 expression developed normally and showed Draper-mediated pruning of larval axons, but a defect in the phagocytosis of apoptotic cells in embryos was observed. Loss of Pretaporter, a previously identified ligand for Draper, did not cause a further decrease in the level of phagocytosis in DmCaBP1-lacking embryos. These results collectively suggest that the endoplasmic reticulum protein DmCaBP1 is externalized upon the induction of apoptosis and serves as a tethering molecule to connect apoptotic cells and phagocytes for effective phagocytosis to occur.	[Okada, Ryo; Nagaosa, Kaz; Kuraishi, Takayuki; Shiratsuchi, Akiko; Nakanishi, Yoshinobu] Kanazawa Univ, Grad Sch Med Sci, Kanazawa, Ishikawa 9201192, Japan; [Nagaosa, Kaz; Yamamoto, Naoko; Nakagawa, Yukiko; Shiratsuchi, Akiko; Nakanishi, Yoshinobu] Kanazawa Univ, Grad Sch Nat Sci & Technol, Kanazawa, Ishikawa 9201192, Japan; [Nakayama, Hiroshi; Dohmae, Naoshi] RIKEN Adv Sci Inst, Biomol Characterizat Team, Wako, Saitama 3510198, Japan	Kanazawa University; Kanazawa University; RIKEN	Nakanishi, Y (corresponding author), Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan.	nakanaka@p.kanazawa-u.ac.jp	Nagaosa, Kaz/G-3857-2014; Dohmae, Naoshi/C-2040-2011; Nakanishi, Yoshinobu/D-4602-2014; Shiratsuchi, Akiko/D-8391-2015	Nagaosa, Kaz/0000-0002-1695-2562; Dohmae, Naoshi/0000-0002-5242-9410; Nakanishi, Yoshinobu/0000-0002-8767-3587; Shiratsuchi, Akiko/0000-0002-7811-4409	Japan Society for the Promotion of Science [19370051, 22370049]; Grants-in-Aid for Scientific Research [22370049, 23890014] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research 19370051 and 22370049 from the Japan Society for the Promotion of Science (to Y. N.).	Awasaki T, 2006, NEURON, V50, P855, DOI 10.1016/j.neuron.2006.04.027; Callebaut I, 2003, BIOCHEM BIOPH RES CO, V300, P619, DOI 10.1016/S0006-291X(02)02904-2; Choi JY, 2002, DEV COMP IMMUNOL, V26, P335, DOI 10.1016/S0145-305X(01)00081-7; Cornwell WD, 2001, J CELL BIOCHEM, V82, P22, DOI 10.1002/jcb.1144; Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311; Franz S, 2007, CELL DEATH DIFFER, V14, P733, DOI 10.1038/sj.cdd.4402066; Freeman MR, 2003, NEURON, V38, P567, DOI 10.1016/S0896-6273(03)00289-7; Goto Y, 2011, J BIOL CHEM, V286, P21906, DOI 10.1074/jbc.M111.239111; Hamon Y, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000120; Hou YCC, 2008, J CELL BIOL, V182, P1127, DOI 10.1083/jcb.200712091; Kinchen JM, 2005, CURR TOP DEV BIOL, V65, P1; Kuraishi T, 2007, EXP CELL RES, V313, P500, DOI 10.1016/j.yexcr.2006.10.027; Kuraishi T, 2009, EMBO J, V28, P3868, DOI 10.1038/emboj.2009.343; LaJeunesse DR, 2004, BIOTECHNIQUES, V36, P784, DOI 10.2144/04365ST01; Lauber K, 2004, MOL CELL, V14, P277, DOI 10.1016/S1097-2765(04)00237-0; Lettre G, 2006, NAT REV MOL CELL BIO, V7, P97, DOI 10.1038/nrm1836; Li YB, 1998, DEV GENET, V23, P104, DOI 10.1002/(SICI)1520-6408(1998)23:2<104::AID-DVG2>3.0.CO;2-A; Liao J, 2005, MED HYPOTHESES, V65, P23, DOI 10.1016/j.mehy.2005.01.028; Lundgren J, 2005, MOL CELL BIOL, V25, P4662, DOI 10.1128/MCB.25.11.4662-4675.2005; Manaka J, 2004, J BIOL CHEM, V279, P48466, DOI 10.1074/jbc.M408597200; Mangahas PM, 2005, SEMIN CELL DEV BIOL, V16, P295, DOI 10.1016/j.semcdb.2004.12.005; Na KS, 2007, MOL CELLS, V24, P261; Nagaosa K, 2011, J BIOL CHEM, V286, P25770, DOI 10.1074/jbc.M110.204503; Nakanishi Y, 2011, DEV GROWTH DIFFER, V53, P149, DOI 10.1111/j.1440-169X.2010.01224.x; Panaretakis T, 2009, EMBO J, V28, P578, DOI 10.1038/emboj.2009.1; Ravichandran KS, 2007, NAT REV IMMUNOL, V7, P964, DOI 10.1038/nri2214; Ravichandran KS, 2011, IMMUNITY, V35, P445, DOI 10.1016/j.immuni.2011.09.004; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P193, DOI 10.1146/annurev.cellbio.20.022003.114619; Rumpf S, 2011, DEVELOPMENT, V138, P1153, DOI 10.1242/dev.062703; Savill J, 2000, NATURE, V407, P784, DOI 10.1038/35037722; Thery C, 2001, J IMMUNOL, V166, P7309, DOI 10.4049/jimmunol.166.12.7309; Turano C, 2002, J CELL PHYSIOL, V193, P154, DOI 10.1002/jcp.10172; Wang XC, 2010, NAT CELL BIOL, V12, P655, DOI 10.1038/ncb2068; Wu HH, 2009, NAT NEUROSCI, V12, P1534, DOI 10.1038/nn.2446; Xu H, 2002, J CELL SCI, V115, P4447, DOI 10.1242/jcs.00139; Zhou Z, 2001, CELL, V104, P43, DOI 10.1016/S0092-8674(01)00190-8	36	18	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3138	3146		10.1074/jbc.M111.277921	http://dx.doi.org/10.1074/jbc.M111.277921			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22158613	Green Submitted, Green Published, hybrid			2022-12-27	WOS:000300295100019
J	Rondas, D; Tomas, A; Soto-Ribeiro, M; Wehrle-Haller, B; Halban, PA				Rondas, Dieter; Tomas, Alejandra; Soto-Ribeiro, Martinho; Wehrle-Haller, Bernhard; Halban, Philippe A.			Novel Mechanistic Link between Focal Adhesion Remodeling and Glucose-stimulated Insulin Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; GTPASE-ACTIVATING PROTEIN; SMALL-MOLECULE INHIBITOR; EVANESCENT-WAVE MICROSCOPY; SKELETAL-MUSCLE CELLS; EXTRACELLULAR-MATRIX; SIGNAL-TRANSDUCTION; RHO-SUBFAMILY; TYROSINE PHOSPHORYLATION; BINDING PROTEINS	Actin cytoskeleton remodeling is well known to be positively involved in glucose-stimulated pancreatic beta cell insulin secretion. We have observed glucose-stimulated focal adhesion remodeling at the beta cell surface and have shown this to be crucial for glucose-stimulated insulin secretion. However, the mechanistic link between such remodeling and the insulin secretory machinery remained unknown and was the major aim of this study. MIN6B1 cells, a previously validated model of primary beta cell function, were used for all experiments. Total internal reflection fluorescence microscopy revealed the glucose-responsive co-localization of focal adhesion kinase (FAK) and paxillin with integrin beta 1 at the basal cell surface after short term stimulation. In addition, blockade of the interaction between beta 1 integrins and the extracellular matrix with an anti-beta 1 integrin antibody (Ha2/5) inhibited short term glucose-induced phosphorylation of FAK (Tyr-397), paxillin (Tyr-118), and ERK1/2 (Thr-202/Tyr-204). Pharmacological inhibition of FAK activity blocked glucose-induced actin cytoskeleton remodeling and glucose-induced disruption of the F-actin/SNAP-25 association at the plasma membrane as well as the distribution of insulin granules to regions in close proximity to the plasma membrane. Furthermore, FAK inhibition also completely blocked short term glucose-induced activation of the Akt/AS160 signaling pathway. In conclusion, these results indicate 1) that glucose-induced activation of FAK, paxillin, and ERK1/2 is mediated by beta 1 integrin intracellular signaling, 2) a mechanism whereby FAK mediates glucose-induced actin cytoskeleton remodeling, hence allowing docking and fusion of insulin granules to the plasma membrane, and 3) a possible functional role for the Akt/AS160 signaling pathway in the FAK-mediated regulation of glucose-stimulated insulin secretion.	[Rondas, Dieter; Halban, Philippe A.] Univ Geneva, Dept Genet Med & Dev, CH-1211 Geneva 4, Switzerland; [Tomas, Alejandra] Univ Geneva, Dept Biochem, CH-1211 Geneva 4, Switzerland; [Soto-Ribeiro, Martinho; Wehrle-Haller, Bernhard] Univ Geneva, Dept Cellular Physiol & Metab, CH-1211 Geneva 4, Switzerland	University of Geneva; University of Geneva; University of Geneva	Rondas, D (corresponding author), Univ Geneva, Dept Genet Med & Dev, 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland.	dieter.rondas@unige.ch		Tomas, Alejandra/0000-0002-2290-8453	Swiss National Science Fund [31003A_127276/1]	Swiss National Science Fund(Swiss National Science Foundation (SNSF))	This work was supported by Swiss National Science Fund Grant 31003A_127276/1.	Amin RH, 2003, ENDOCRINOLOGY, V144, P4508, DOI 10.1210/en.2003-0106; ASHCROFT FM, 1984, NATURE, V312, P446, DOI 10.1038/312446a0; Bisht B, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-48; Bosco D, 2000, DIABETES, V49, P233, DOI 10.2337/diabetes.49.2.233; Bouzakri K, 2008, DIABETES, V57, P1195, DOI 10.2337/db07-1469; BURRIDGE K, 1992, J CELL BIOL, V119, P893, DOI 10.1083/jcb.119.4.893; BURRIDGE K, 1988, ANNU REV CELL BIOL, V4, P487, DOI 10.1146/annurev.cb.04.110188.002415; COOK DL, 1984, NATURE, V311, P271, DOI 10.1038/311271a0; CURRY DL, 1968, ENDOCRINOLOGY, V83, P572, DOI 10.1210/endo-83-3-572; Desire L, 2005, J BIOL CHEM, V280, P37516, DOI 10.1074/jbc.M507913200; Duncan MD, 1996, J SURG RES, V63, P359, DOI 10.1006/jsre.1996.0276; Elias BC, 2010, CELL ADHES MIGR, V4, P419, DOI 10.4161/cam.4.3.12043; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Geny B, 2010, CELL MICROBIOL, V12, P217, DOI 10.1111/j.1462-5822.2009.01392.x; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Gilmore AP, 1996, STRUCTURE, V4, P647, DOI 10.1016/S0969-2126(96)00069-X; Golubovskaya VM, 2008, J MED CHEM, V51, P7405, DOI 10.1021/jm800483v; Gonzalez E, 2009, P NATL ACAD SCI USA, V106, P7004, DOI 10.1073/pnas.0901933106; Grodsky G., 1970, ADV METAB DISORD S1, V1, P45; Hammar E, 2004, DIABETES, V53, P2034, DOI 10.2337/diabetes.53.8.2034; Henquin JC, 2009, DIABETOLOGIA, V52, P739, DOI 10.1007/s00125-009-1314-y; Hochwald SN, 2009, CELL CYCLE, V8, P2435, DOI 10.4161/cc.8.15.9145; HOWELL SL, 1979, BIOCHEM J, V178, P367, DOI 10.1042/bj1780367; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Ishikura S, 2008, ACTA PHYSIOL, V192, P61, DOI 10.1111/j.1748-1716.2007.01778.x; Jebailey L, 2004, MOL ENDOCRINOL, V18, P359, DOI 10.1210/me.2003-0294; JeBailey L, 2007, DIABETES, V56, P394, DOI 10.2337/db06-0823; Jewell JL, 2008, J BIOL CHEM, V283, P10716, DOI 10.1074/jbc.M709876200; JULIANO RL, 1993, J CELL BIOL, V120, P577, DOI 10.1083/jcb.120.3.577; Kaido T, 2004, J BIOL CHEM, V279, P53762, DOI 10.1074/jbc.M411202200; Kaido T, 2004, J BIOL CHEM, V279, P17731, DOI 10.1074/jbc.M308425200; Kantengwa S, 1997, EXP CELL RES, V237, P394, DOI 10.1006/excr.1997.3803; Kowluru A, 2003, ENDOCR RES, V29, P363, DOI 10.1081/ERC-120025043; Kowluru A, 1997, BIOCHEM PHARMACOL, V54, P1097, DOI 10.1016/S0006-2952(97)00314-6; Krishnamurthy M, 2011, ENDOCRINOLOGY, V152, P424, DOI 10.1210/en.2010-0877; Leopoldt D, 2001, J CELL PHYSIOL, V188, P106, DOI 10.1002/jcp.1102; Li JS, 2004, AM J PHYSIOL-ENDOC M, V286, pE818, DOI 10.1152/ajpendo.00307.2003; Lilla V, 2003, ENDOCRINOLOGY, V144, P1368, DOI 10.1210/en.2002-220916; MALAISSE WJ, 1971, DIABETES, V20, P257, DOI 10.2337/diab.20.5.257; MEGLASSON M D, 1986, Diabetes Metabolism Reviews, V2, P163; Mehta D, 2002, J PHYSIOL-LONDON, V539, P779, DOI 10.1113/jphysiol.2001.013289; MIYAMOTO S, 1995, J CELL BIOL, V131, P791, DOI 10.1083/jcb.131.3.791; Nagamatsu S, 1996, J BIOL CHEM, V271, P1160, DOI 10.1074/jbc.271.2.1160; Nevins AK, 2003, AM J PHYSIOL-CELL PH, V285, pC698, DOI 10.1152/ajpcell.00093.2003; OCONNOR MDL, 1980, AM J PHYSIOL, V238, pR378, DOI 10.1152/ajpregu.1980.238.5.R378; Ohara-Imaizumi M, 2004, J BIOL CHEM, V279, P8403, DOI 10.1074/jbc.M308954200; ORCI L, 1972, SCIENCE, V175, P1128, DOI 10.1126/science.175.4026.1128; Parnaud G, 2006, DIABETES, V55, P1413, DOI 10.2337/db05-1388; PLOPPER GE, 1995, MOL BIOL CELL, V6, P1349, DOI 10.1091/mbc.6.10.1349; PRENTKI M, 1987, PHYSIOL REV, V67, P1185, DOI 10.1152/physrev.1987.67.4.1185; Randhawa VK, 2008, J BIOL CHEM, V283, P27208, DOI 10.1074/jbc.M804282200; REGAZZI R, 1995, EMBO J, V14, P2723, DOI 10.1002/j.1460-2075.1995.tb07273.x; RICHARDSON A, 1995, BIOESSAYS, V17, P229, DOI 10.1002/bies.950170309; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Riopel M, 2011, J PATHOL, V224, P45, DOI 10.1002/path.2849; ROBINSON IM, 1995, P NATL ACAD SCI USA, V92, P2474, DOI 10.1073/pnas.92.7.2474; Rondas D, 2011, DIABETES, V60, P1146, DOI 10.2337/db10-0946; Rorsman P, 2000, NEWS PHYSIOL SCI, V15, P72; Rorsman P, 2003, DIABETOLOGIA, V46, P1029, DOI 10.1007/s00125-003-1153-1; SADOUL K, 1995, J CELL BIOL, V128, P1019, DOI 10.1083/jcb.128.6.1019; Saleem S, 2009, J PATHOL, V219, P182, DOI 10.1002/path.2577; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; SATIN LS, 1985, PFLUG ARCH EUR J PHY, V404, P385, DOI 10.1007/BF00585354; SOMERS G, 1979, ENDOCRINOLOGY, V104, P255, DOI 10.1210/endo-104-1-255; Thamilselvan V, 2005, CARCINOGENESIS, V26, P1687, DOI 10.1093/carcin/bgi135; Thong FSL, 2007, DIABETES, V56, P414, DOI 10.2337/db06-0900; Thurmond DC, 2003, MOL ENDOCRINOL, V17, P732, DOI 10.1210/me.2002-0333; Tomas A, 2006, J CELL SCI, V119, P2156, DOI 10.1242/jcs.02942; Toomre D, 2001, TRENDS CELL BIOL, V11, P298, DOI 10.1016/S0962-8924(01)02027-X; Torregrosa-Hetland CJ, 2011, J CELL SCI, V124, P727, DOI 10.1242/jcs.078600; Torregrosa-Hetland CJ, 2010, CELL MOL NEUROBIOL, V30, P1315, DOI 10.1007/s10571-010-9565-1; Tsuboi T, 2006, DIABETES, V55, P1057, DOI 10.2337/diabetes.55.04.06.db05-1577; Tsuboi T, 2003, J BIOL CHEM, V278, P52042, DOI 10.1074/jbc.M307800200; Tsuboi T, 2003, CURR BIOL, V13, P563, DOI 10.1016/S0960-9822(03)00176-3; Veluthakal R, 2009, BIOCHEM PHARMACOL, V77, P101, DOI 10.1016/j.bcp.2008.09.021; Vicente-Manzanares M, 2009, J CELL SCI, V122, P199, DOI 10.1242/jcs.018564; WANG JL, 1990, BIOCHEM BIOPH RES CO, V171, P424, DOI 10.1016/0006-291X(90)91410-T; Wang ZX, 2009, J CELL SCI, V122, P893, DOI 10.1242/jcs.034355; Wheeler MB, 1996, ENDOCRINOLOGY, V137, P1340, DOI 10.1210/en.137.4.1340; Wiser O, 1996, EMBO J, V15, P4100, DOI 10.1002/j.1460-2075.1996.tb00785.x; Wiser O, 1999, P NATL ACAD SCI USA, V96, P248, DOI 10.1073/pnas.96.1.248	81	55	56	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2423	2436		10.1074/jbc.M111.279885	http://dx.doi.org/10.1074/jbc.M111.279885			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22139838	Green Published, hybrid, Green Accepted			2022-12-27	WOS:000300292300017
J	Singh, N; Wiltshire, TD; Thompson, JR; Mer, G; Couch, FJ				Singh, Namit; Wiltshire, Timothy D.; Thompson, James R.; Mer, Georges; Couch, Fergus J.			Molecular Basis for the Association of Microcephalin (MCPH1) Protein with the Cell Division Cycle Protein 27 (Cdc27) Subunit of the Anaphase-promoting Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE RESPONSE; STRUCTURAL BASIS; BRCT DOMAIN; PHOSPHOPEPTIDE RECOGNITION; BINDING SPECIFICITIES; BACH1 PHOSPHOPEPTIDE; MITOTIC ENTRY; MDC1; BRIT1/MCPH1; INTEGRITY	Microcephalin (MCPH1), the first gene identified as causative for primary recessive autosomal microcephaly, is aberrantly expressed in autism-like disorders and human malignancy of breast and ovarian origin. MCPH1, the encoded protein product, has been implicated in various cellular processes including the DNA damage checkpoint, DNA repair, and transcription. Although our understanding of the cellular context in which MCPH1 operates continues to develop, a structural understanding of the C-terminal tandem BRCT domains of MCPH1 remains unexplored. Here, we identify cell division cycle protein 27 (Cdc27), a component of the anaphase-promoting complex (APC/C), as a novel interacting partner of MCPH1. We provide in vitro and in vivo evidence that the C-terminal tandem BRCT domains of MCPH1 (C-BRCTs) bind Cdc27 in a phosphorylation-dependent manner. To characterize this interaction further, we determined the structure of MCPH1 C-BRCTs in complex with a phosphorylated Cdc27 peptide (pCdc27) using x-ray crystallography. Based on this structure, we identified single amino acid mutations targeted at the binding interface that disrupted the MCPH1-pCdc27 interaction. Collectively, our data define the biochemical, structural, and cellular determinants of the novel interaction between MCPH1 and Cdc27 and suggest that this interaction may occur within the larger context of MCPH1-APC/C.	[Singh, Namit; Mer, Georges] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Wiltshire, Timothy D.; Couch, Fergus J.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN 55905 USA; [Thompson, James R.] Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Mer, G (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, 200 1st St SW, Rochester, MN 55905 USA.	mer.georges@mayo.edu	Mer, Georges/AAT-4946-2021	Mer, Georges/0000-0002-1900-1578	National Institutes of Health [CA132878, CA116167]; NATIONAL CANCER INSTITUTE [R01CA116167, R01CA132878, U01CA116167] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA132878 (to G. M.) and CA116167 (to F. J. C.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alderton GK, 2006, NAT CELL BIOL, V8, P725, DOI 10.1038/ncb1431; Bork P, 1997, FASEB J, V11, P68, DOI 10.1096/fasebj.11.1.9034168; Botuyan MVE, 2004, STRUCTURE, V12, P1137, DOI 10.1016/j.str.2004.06.002; Callebaut I, 1997, FEBS LETT, V400, P25, DOI 10.1016/S0014-5793(96)01312-9; Campbell SJ, 2010, STRUCTURE, V18, P167, DOI 10.1016/j.str.2009.12.008; Clapperton JA, 2004, NAT STRUCT MOL BIOL, V11, P512, DOI 10.1038/nsmb775; Coster G, 2007, J BIOL CHEM, V282, P32053, DOI 10.1074/jbc.M705890200; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hutchins JRA, 2010, SCIENCE, V328, P593, DOI 10.1126/science.1181348; Jeffers LJ, 2008, ONCOGENE, V27, P139, DOI 10.1038/sj.onc.1210595; Joo WS, 2002, GENE DEV, V16, P583, DOI 10.1101/gad.959202; Joughin BA, 2005, PROTEIN SCI, V14, P131, DOI 10.1110/ps.04964705; Kilkenny ML, 2008, GENE DEV, V22, P2034, DOI 10.1101/gad.472808; Lee MS, 2005, J BIOL CHEM, V280, P32053, DOI 10.1074/jbc.C500273200; Leung CCY, 2011, CELL CYCLE, V10, P2461, DOI 10.4161/cc.10.15.16312; Leung CCY, 2011, J BIOL CHEM, V286, P4292, DOI 10.1074/jbc.M110.189555; Lin SY, 2005, P NATL ACAD SCI USA, V102, P15105, DOI 10.1073/pnas.0507722102; Lin SY, 2003, CELL, V113, P881, DOI 10.1016/S0092-8674(03)00430-6; Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; Nomine Y, 2008, BIOCHEMISTRY-US, V47, P9866, DOI 10.1021/bi702247d; Peng G, 2009, CELL CYCLE, V8, P3071, DOI 10.4161/cc.8.19.9411; Peng G, 2009, NAT CELL BIOL, V11, P865, DOI 10.1038/ncb1895; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Rai R, 2006, CANCER CELL, V10, P145, DOI 10.1016/j.ccr.2006.07.002; Rodriguez M, 2003, J BIOL CHEM, V278, P52914, DOI 10.1074/jbc.C300407200; Schreiber A, 2011, NATURE, V470, P227, DOI 10.1038/nature09756; Shiozaki EN, 2004, MOL CELL, V14, P405, DOI 10.1016/S1097-2765(04)00238-2; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Tibelius A, 2009, J CELL BIOL, V185, P1149, DOI 10.1083/jcb.200810159; Turnbull WB, 2003, J AM CHEM SOC, V125, P14859, DOI 10.1021/ja036166s; Varma AK, 2005, BIOCHEMISTRY-US, V44, P10941, DOI 10.1021/bi0509651; Williams JS, 2010, EMBO J, V29, P1136, DOI 10.1038/emboj.2009.413; Williams RS, 2004, NAT STRUCT MOL BIOL, V11, P519, DOI 10.1038/nsmb776; Williams RS, 2001, NAT STRUCT BIOL, V8, P838, DOI 10.1038/nsb1001-838; Wood JL, 2007, J BIOL CHEM, V282, P35416, DOI 10.1074/jbc.M705245200; Wu XL, 2009, CANCER RES, V69, P5531, DOI 10.1158/0008-5472.CAN-08-4834; Xu C, 2008, J MOL BIOL, V381, P361, DOI 10.1016/j.jmb.2008.05.087; Xu XZ, 2004, J BIOL CHEM, V279, P34091, DOI 10.1074/jbc.C400139200; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753	43	16	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2854	2862		10.1074/jbc.M111.307868	http://dx.doi.org/10.1074/jbc.M111.307868			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22139841	hybrid, Green Published			2022-12-27	WOS:000300292300057
J	Wang, G; Xiao, QZ; Luo, ZL; Ye, S; Xu, QB				Wang, Gang; Xiao, Qingzhong; Luo, Zhenling; Ye, Shu; Xu, Qingbo			Functional Impact of Heterogeneous Nuclear Ribonucleoprotein A2/B1 in Smooth Muscle Differentiation from Stem Cells and Embryonic Arteriogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURAL CREST CELLS; HNRNP A2/B1; MESSENGER-RNA; CHICK-EMBRYO; GENE-EXPRESSION; IN-VITRO; PROTEINS; BINDING; ACTIVATION; HINDBRAIN	Heterogeneous nuclear ribonucleoproteins (hnRNPs) play various roles in transcriptional and post-transcriptional modulation of gene expression. However, it remains unclear if hnRNPs are associated with smooth muscle cell (SMC) differentiation from stem cells and embryonic arteriogenesis. In this study, mouse embryonic stem (ES) cells were cultivated on collagen IV-coated plates and smooth muscle differentiation medium. We found that hnRNPA2/B1 gene and protein expression was significantly up-regulated following 3-7 days of cell differentiation. hnRNPA2/B1 knockdown resulted in down-regulation of specific smooth muscle markers and transcription factors, whereas enforced expression of hnRNPA2/B1 enhanced the expression of these genes. Moreover, we demonstrated by using luciferase and chromatin immunoprecipitation assays that hnRNPA2/B1 could transcriptionally regulate SMC gene expression through direct binding to promoters of Sm alpha a and Sm22 alpha genes. We further demonstrated that chromobox protein homolog gene 3, a previously identified SMC differentiation regulatory nuclear protein, is required for hnRNPA2/B1-mediated SMC differentiation gene expression. Importantly, specifically designed Hnrnpa2/b1 morpholinos for in vivo knockdown could inhibit the migration and differentiation of neural crest cells into SMCs in chick embryos. This resulted in the maldevelopment of branchial arch arteries and increased embryo lethality at a later developmental stage. Our findings demonstrated that hnRNPA2/B1 plays a functional role in SMC differentiation from stem cells in vitro and embryonic branchial arch artery development. This indicates that hnRNPA2/B1 is a potential modulating target for deriving SMCs from stem cells and cardiovascular regenerative medicine.	[Wang, Gang] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 2, Dept Cardiol, Xian 710004, Shaanxi, Peoples R China; [Xiao, Qingzhong; Ye, Shu] Queen Mary Univ London, Ctr Clin Pharmacol, William Harvey Res Inst, Barts & London Sch Med & Dent, London EC1M 6BQ, England; [Wang, Gang; Luo, Zhenling; Xu, Qingbo] Kings Coll London, Div Cardiovasc, British Heart Fdn Ctr, London SE5 9NU, England	Xi'an Jiaotong University; University of London; Queen Mary University London; University of London; King's College London	Xu, QB (corresponding author), Kings Coll London, Div Cardiovasc, British Heart Fdn Ctr, 125 Cold Harbour Lane, London SE5 9NU, England.	qingbo.xu@kcl.ac.uk	Ye, Shu/R-6384-2017	Ye, Shu/0000-0002-4126-4278	British Heart Foundation [FS/09/044/28007, PG/11/40/28891]; Oak Foundation; National Institute of Health Research; China Scholarship Council; King's College London; British Heart Foundation [RG/09/004/27647] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Oak Foundation; National Institute of Health Research(National Institute for Health Research (NIHR)); China Scholarship Council(China Scholarship Council); King's College London; British Heart Foundation(British Heart Foundation)	This work was supported in part by the British Heart Foundation and Oak Foundation. This work forms part of the research themes contributing to the translational research portfolio of Barts and the London Cardiovascular Biomedical Research Unit supported and funded by the National Institute of Health Research.; A K. C. Wong Scholar sponsored by China Scholarship Council and King's College London.; Recipient of British Heart Foundation Intermediate Basic Science Research Fellowship FS/09/044/28007 and the principal investigator of British Heart Foundation Project Grant PG/11/40/28891. To whom correspondence may be addressed: Centre for Clinical Pharmacology, William Harvey Research Institute, Barts, and the London School of Medicine and Dentistry, John Vane Science Centre, Charterhouse Square, London EC1M6BQ, United Kingdom. Tel.: 44-2078826027; Fax: 44-2078823408; E-mail:q.xiao@qmul.ac.uk.	BALL EE, 1991, NUCLEIC ACIDS RES, V19, P397, DOI 10.1093/nar/19.2.397; Campillos M, 2003, NUCLEIC ACIDS RES, V31, P3063, DOI 10.1093/nar/gkg435; Chen H, 2003, P NATL ACAD SCI USA, V100, P6109, DOI 10.1073/pnas.1031395100; Clower CV, 2010, P NATL ACAD SCI USA, V107, P1894, DOI 10.1073/pnas.0914845107; COBIANCHI F, 1988, J BIOL CHEM, V263, P1063; David CJ, 2010, NATURE, V463, P364, DOI 10.1038/nature08697; DREYFUSS G, 1993, ANNU REV BIOCHEM, V62, P289, DOI 10.1146/annurev.bi.62.070193.001445; Golan-Gerstl R, 2011, CANCER RES, V71, P4464, DOI 10.1158/0008-5472.CAN-10-4410; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; HAMBURGER V, 1992, DEV DYNAM, V195, P273, DOI 10.1002/dvdy.1001950405; Hautmann MB, 1997, J BIOL CHEM, V272, P10948; He YW, 2009, CELL MOL LIFE SCI, V66, P1239, DOI 10.1007/s00018-008-8532-1; He YW, 2005, J CELL SCI, V118, P3173, DOI 10.1242/jcs.02448; ISHIKAWA F, 1993, MOL CELL BIOL, V13, P4301, DOI 10.1128/MCB.13.7.4301; Jiang XB, 2000, DEVELOPMENT, V127, P1607; Kamma H, 1999, EXP CELL RES, V246, P399, DOI 10.1006/excr.1998.4323; Kostadinov R, 2006, NUCLEIC ACIDS RES, V34, pD119, DOI 10.1093/nar/gkj073; Leverrier S, 2000, BIOL CHEM, V381, P1031, DOI 10.1515/BC.2000.127; Liang Y, 2011, J CELL BIOCHEM, V112, P1722, DOI 10.1002/jcb.23063; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; LUMSDEN A, 1991, DEVELOPMENT, V113, P1281; Mack CP, 2011, ARTERIOSCL THROM VAS, V31, P1495, DOI 10.1161/ATVBAHA.110.221135; Margariti A, 2009, J CELL SCI, V122, P460, DOI 10.1242/jcs.034850; McGlincy NJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-565; Mende M, 2008, MECH DEVELOP, V125, P947, DOI 10.1016/j.mod.2008.08.005; Moran-Jones K, 2005, NUCLEIC ACIDS RES, V33, P486, DOI 10.1093/nar/gki203; Nakamura T, 2006, CIRC RES, V98, P1547, DOI 10.1161/01.RES.0000227505.19472.69; Pepe AE, 2010, CIRC RES, V106, P870, DOI 10.1161/CIRCRESAHA.109.211417; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Sato M, 2001, DNA SEQUENCE, V12, P97, DOI 10.3109/10425170109047562; Scacheri PC, 2004, P NATL ACAD SCI USA, V101, P1892, DOI 10.1073/pnas.0308698100; TAKIMOTO M, 1993, J BIOL CHEM, V268, P18249; Tauler J, 2010, CANCER RES, V70, P7137, DOI 10.1158/0008-5472.CAN-10-0860; Thakur S, 2003, MOL CELL BIOL, V23, P3774, DOI 10.1128/MCB.23.11.3774-3787.2003; Trainor PA, 2002, DEVELOPMENT, V129, P433; Trainor PA, 2000, NAT REV NEUROSCI, V1, P116, DOI 10.1038/35039056; Vera J, 2006, ONCOGENE, V25, P260, DOI 10.1038/sj.onc.1209050; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wiegreffe C, 2007, DEV DYNAM, V236, P2578, DOI 10.1002/dvdy.21279; Xia H, 2005, J BIOL CHEM, V280, P13171, DOI 10.1074/jbc.M414120200; Xiao QZ, 2007, AM J PHYSIOL-CELL PH, V292, pC342, DOI 10.1152/ajpcell.00341.2006; Xiao QZ, 2011, ARTERIOSCL THROM VAS, V31, P1842, DOI 10.1161/ATVBAHA.111.230110; Xiao QZ, 2010, THROMB HAEMOSTASIS, V104, P440, DOI 10.1160/TH09-11-0794; Xiao QZ, 2009, AM J PHYSIOL-CELL PH, V296, pC711, DOI 10.1152/ajpcell.00442.2008; Xu QB, 2008, CIRC RES, V102, P1011, DOI 10.1161/CIRCRESAHA.108.171488; Yamashita J, 2000, NATURE, V408, P92, DOI 10.1038/35040568; Yoshida T, 2008, CIRC RES, V102, P1548, DOI 10.1161/CIRCRESAHA.108.176974; Zhang L, 2010, J BIOL CHEM, V285, P38463, DOI 10.1074/jbc.M110.153999; Zhao S, 2008, MOL CELL NEUROSCI, V37, P69, DOI 10.1016/j.mcn.2007.08.015	49	29	29	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2896	2906		10.1074/jbc.M111.297028	http://dx.doi.org/10.1074/jbc.M111.297028			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22144681	Green Published, hybrid			2022-12-27	WOS:000300292300061
J	Seeliger, JC; Holsclaw, CM; Schelle, MW; Botyanszki, Z; Gilmore, SA; Tully, SE; Niederweis, M; Cravatt, BF; Leary, JA; Bertozzi, CR				Seeliger, Jessica C.; Holsclaw, Cynthia M.; Schelle, Michael W.; Botyanszki, Zsofia; Gilmore, Sarah A.; Tully, Sarah E.; Niederweis, Michael; Cravatt, Benjamin F.; Leary, Julie A.; Bertozzi, Carolyn R.			Elucidation and Chemical Modulation of Sulfolipid-1 Biosynthesis in Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHAGOSOME-LYSOSOME FUSION; CUTINASE-LIKE PROTEINS; CULTURED MACROPHAGES; MEMBRANE-PROTEIN; VIRULENCE; IDENTIFICATION; INHIBITION; SULFATIDE; LIPASE; TETRAHYDROLIPSTATIN	Mycobacterium tuberculosis possesses unique cell-surface lipids that have been implicated in virulence. One of the most abundant is sulfolipid-1 (SL-1), a tetraacyl-sulfotrehalose glycolipid. Although the early steps in SL-1 biosynthesis are known, the machinery underlying the final acylation reactions is not understood. We provide genetic and biochemical evidence for the activities of two proteins, Chp1 and Sap (corresponding to gene loci rv3822 and rv3821), that complete this pathway. The membrane-associated acyltransferase Chp1 accepts a synthetic diacyl sulfolipid and transfers an acyl group regioselectively from one donor substrate molecule to a second acceptor molecule in two successive reactions to yield a tetraacylated product. Chp1 is fully active in vitro, but in M. tuberculosis, its function is potentiated by the previously identified sulfolipid transporter MmpL8. We also show that the integral membrane protein Sap and MmpL8 are both essential for sulfolipid transport. Finally, the lipase inhibitor tetrahydrolipstatin disrupts Chp1 activity in M. tuberculosis, suggesting an avenue for perturbing SL-1 biosynthesis in vivo. These data complete the SL-1 biosynthetic pathway and corroborate a model in which lipid biosynthesis and transmembrane transport are coupled at the membrane-cytosol interface through the activity of multiple proteins, possibly as a macromolecular complex.	[Seeliger, Jessica C.; Schelle, Michael W.; Botyanszki, Zsofia; Bertozzi, Carolyn R.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Gilmore, Sarah A.; Bertozzi, Carolyn R.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Bertozzi, Carolyn R.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Holsclaw, Cynthia M.; Leary, Julie A.] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [Tully, Sarah E.; Cravatt, Benjamin F.] Scripps Res Inst, Skaggs Inst Chem Biol, Dept Physiol Chem, La Jolla, CA 92037 USA; [Niederweis, Michael] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Davis; Scripps Research Institute; University of Alabama System; University of Alabama Birmingham	Bertozzi, CR (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	crb@berkeley.edu	Seeliger, Jessica/J-3344-2014	Seeliger, Jessica/0000-0001-7148-1073; Niederweis, Michael/0000-0003-4068-8092	National Institutes of Health [AI51622, 1S10RR017786-01]; National Institutes of Health from NIAID [HHSN266200400091C]; NATIONAL CANCER INSTITUTE [R37CA087660] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR017786] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051622] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health from NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI51622 (to C. R. B.) and by Shared Instrumentation Grant 1S10RR017786-01 (to the QB3/Chemistry Mass Spectrometry Facility).; We thank Dr. Sloan Siegrist and Kimberly Sogi for helpful discussions and critical reading of the manuscript. The QB3/Chemistry Mass Spectrometry Facility at the University of California at Berkeley acknowledges National Institutes of Health Shared Instrumentation Grant 1S10RR017786-01. gamma-Irradiated H37Rv whole cells and anti-KatG antibody were kindly provided as part of National Institutes of Health Contract HHSN266200400091C from NIAID ("Tuberculosis Vaccine Testing and Research Materials"), which was awarded to Colorado State University.	Adindla S, 2003, J BIOSCIENCES, V28, P169, DOI 10.1007/BF02706216; Belisle JT, 1997, SCIENCE, V276, P1420, DOI 10.1126/science.276.5317.1420; Brodin P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001100; BROZNA JP, 1991, INFECT IMMUN, V59, P2542, DOI 10.1128/IAI.59.8.2542-2548.1991; Busso D, 2005, ANAL BIOCHEM, V343, P313, DOI 10.1016/j.ab.2005.05.015; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Converse SE, 2003, P NATL ACAD SCI USA, V100, P6121, DOI 10.1073/pnas.1030024100; Cotes K, 2007, BIOCHEM J, V408, P417, DOI 10.1042/BJ20070745; Cox JS, 1999, NATURE, V402, P79, DOI 10.1038/47042; Crellin PK, 2010, J BIOL CHEM, V285, P30050, DOI 10.1074/jbc.M110.150094; Deb C, 2006, J BIOL CHEM, V281, P3866, DOI 10.1074/jbc.M505556200; Deshayes C, 2010, MOL MICROBIOL, V78, P989, DOI 10.1111/j.1365-2958.2010.07385.x; Domenech P, 2004, J BIOL CHEM, V279, P21257, DOI 10.1074/jbc.M400324200; GANGADHARAM P R, 1963, Tubercle, V44, P452, DOI 10.1016/S0041-3879(63)80087-2; Ghosh D, 2001, J BIOL CHEM, V276, P11159, DOI 10.1074/jbc.M008831200; Gilleron M, 2004, J EXP MED, V199, P649, DOI 10.1084/jem.20031097; Glickman MS, 2000, MOL CELL, V5, P717, DOI 10.1016/S1097-2765(00)80250-6; Gokhale RS, 2007, NAT PROD REP, V24, P267, DOI 10.1039/b616817p; GOREN MB, 1976, P NATL ACAD SCI USA, V73, P2510, DOI 10.1073/pnas.73.7.2510; GOREN MB, 1987, J LEUKOCYTE BIOL, V41, P111, DOI 10.1002/jlb.41.2.111; Guiard J, 2009, J IMMUNOL, V182, P7030, DOI 10.4049/jimmunol.0804044; Hatzios SK, 2009, J BIOL CHEM, V284, P12745, DOI 10.1074/jbc.M809088200; Heinz C, 2000, ANAL BIOCHEM, V285, P113, DOI 10.1006/abio.2000.4728; Hotsclaw CM, 2008, ACS CHEM BIOL, V3, P619, DOI 10.1021/cb800145r; Jain M, 2005, PLOS PATHOG, V1, P12, DOI 10.1371/journal.ppat.0010002; KATO M, 1974, INFECT IMMUN, V10, P733, DOI 10.1128/IAI.10.4.733-741.1974; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kremer L, 2005, MOL MICROBIOL, V57, P1113, DOI 10.1111/j.1365-2958.2005.04717.x; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kumar P, 2007, P NATL ACAD SCI USA, V104, P11221, DOI 10.1073/pnas.0611649104; LANGSTON S, 1994, HELV CHIM ACTA, V77, P2341, DOI 10.1002/hlca.19940770821; Larsen MH, 2007, CURR PROTOC MICROBIO, V6, p10A; Layre E, 2011, J LIPID RES, V52, P1098, DOI 10.1194/jlr.M013482; Leigh CD, 2008, J ORG CHEM, V73, P1008, DOI 10.1021/jo702032c; Low KL, 2009, J BACTERIOL, V191, P5037, DOI 10.1128/JB.00530-09; MIDDLEBROOK G, 1959, P NATL ACAD SCI USA, V45, P1801, DOI 10.1073/pnas.45.12.1801; Mougous JD, 2004, NAT STRUCT MOL BIOL, V11, P721, DOI 10.1038/nsmb802; Niederweis M, 1999, MOL MICROBIOL, V33, P933, DOI 10.1046/j.1365-2958.1999.01472.x; PABST MJ, 1988, J IMMUNOL, V140, P634; Parker SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004281; Patricelli MP, 2001, PROTEOMICS, V1, P1067, DOI 10.1002/1615-9861(200109)1:9<1067::AID-PROT1067>3.0.CO;2-4; Rezwan M, 2007, J MICROBIOL METH, V68, P32, DOI 10.1016/j.mimet.2006.05.016; Rodionov DA, 2009, J BACTERIOL, V191, P42, DOI 10.1128/JB.01208-08; Rousseau C, 2003, INFECT IMMUN, V71, P4684, DOI 10.1128/IAI.71.8.4684-4690.2003; Schue M, 2010, FASEB J, V24, P1893, DOI 10.1096/fj.09-144766; Sirakova TD, 2001, J BIOL CHEM, V276, P16833, DOI 10.1074/jbc.M011468200; Sonden B, 2005, MOL MICROBIOL, V58, P426, DOI 10.1111/j.1365-2958.2005.04847.x; Sultana R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016745; Tseng Tsai-Tien, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P107; Vrljic M., 1999, Journal of Molecular Microbiology and Biotechnology, V1, P327; West NP, 2009, FASEB J, V23, P1694, DOI 10.1096/fj.08-114421; ZHANG L, 1991, J IMMUNOL, V146, P2730; ZHANG L, 1988, INFECT IMMUN, V56, P2876, DOI 10.1128/IAI.56.11.2876-2883.1988	53	53	57	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					7990	8000		10.1074/jbc.M111.315473	http://dx.doi.org/10.1074/jbc.M111.315473			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22194604	Green Published, hybrid			2022-12-27	WOS:000301349400015
J	Heitz, T; Widemann, E; Lugan, R; Miesch, L; Ullmann, P; Desaubry, L; Holder, E; Grausem, B; Kandel, S; Miesch, M; Werck-Reichhart, D; Pinot, F				Heitz, Thierry; Widemann, Emilie; Lugan, Raphael; Miesch, Laurence; Ullmann, Pascaline; Desaubry, Laurent; Holder, Emilie; Grausem, Bernard; Kandel, Sylvie; Miesch, Michel; Werck-Reichhart, Daniele; Pinot, Franck			Cytochromes P450 CYP94C1 and CYP94B3 Catalyze Two Successive Oxidation Steps of Plant Hormone Jasmonoyl-isoleucine for Catabolic Turnover	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACIDS; KEY ENZYME; ARABIDOPSIS; RECEPTOR; GENES; COI1; (+)-7-ISO-JASMONOYL-L-ISOLEUCINE; INACTIVATION; METABOLISM; PERCEPTION	The jasmonate hormonal pathway regulates important defensive and developmental processes in plants. Jasmonoyl-isoleucine (JA-Ile) has been identified as a specific ligand binding the COI1-JAZ co-receptor to relieve repression of jasmonate responses. Two JA-Ile derivatives, 12OH-JA-Ile and 12COOH-JA-Ile, accumulate in wounded Arabidopsis leaves in a COI1- and JAR1-dependent manner and reflect catabolic turnover of the hormone. Here we report the biochemical and genetic characterization of two wound-inducible cytochromes P450, CYP94C1 and CYP94B3, that are involved in JA-Ile oxidation. Both enzymes expressed in yeast catalyze two successive oxidation steps of JA-Ile with distinct characteristics. CYP94B3 performed efficiently the initial hydroxylation of JA-Ile to 12OH-JA-Ile, with little conversion to 12COOH-JA-Ile, whereas CYP94C1 catalyzed preferentially carboxy-derivative formation. Metabolic analysis of loss-and gain-of-function plant lines were consistent with in vitro enzymatic properties. cyp94b3 mutants were largely impaired in 12OH-JA-Ile levels upon wounding and to a lesser extent in 12COOH-JA-Ile levels. In contrast, cyp94c1 plants showed wild-type 12OH-JA-Ile accumulation but lost about 60% 12COOH-JA-Ile. cyp94b3cyp94c1 double mutants hyperaccumulated JA-Ile with near abolition of 12COOH-JA-Ile. Distinct JA-Ile oxidation patterns in different plant genotypes were correlated with specific JA-responsive transcript profiles, indicating that JA-Ile oxidation status affects signaling. Interestingly, exaggerated JA-Ile levels were associated with JAZ repressor hyperinduction but did not enhance durably defense gene induction, revealing a novel negative feedback signaling loop. Finally, interfering with CYP94 gene expression affected root growth sensitivity to exogenous jasmonic acid. These results identify CYP94B3/C1-mediated oxidation as a major catabolic route for turning over the JA-Ile hormone.	[Heitz, Thierry; Widemann, Emilie] Univ Strasbourg, Unite Propre Rech CNRS 2357, Inst Biol Mol Plantes, F-67084 Strasbourg, France; [Widemann, Emilie; Lugan, Raphael; Ullmann, Pascaline; Grausem, Bernard; Kandel, Sylvie; Werck-Reichhart, Daniele; Pinot, Franck] Univ Strasbourg, Unite Propre Rech CNRS 2357, Inst Biol Mol Plantes, F-67083 Strasbourg, France; [Miesch, Laurence; Holder, Emilie; Miesch, Michel] Univ Strasbourg, CNRS, Unite Mixte Rech 7177, Inst Chim,Lab Chim Organ Synthet, F-67008 Strasbourg, France; [Desaubry, Laurent] Univ Strasbourg, CNRS, Unite Mixte Rech 7200, Lab Innovat Therapeut, F-67401 Illkirch Graffenstaden, France	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Heitz, T (corresponding author), Univ Strasbourg, Unite Propre Rech CNRS 2357, Inst Biol Mol Plantes, 12 Rue Gen Zimmer, F-67084 Strasbourg, France.	thierry.heitz@ibmp-cnrs.unistra.fr	Desaubry, Laurent G/R-5446-2017; WERCK-REICHHART, Danièle/U-3713-2019; Widemann, Emilie/AAH-3825-2020	Desaubry, Laurent G/0000-0002-1192-2970; WERCK-REICHHART, Danièle/0000-0003-2869-4262; Widemann, Emilie/0000-0002-6732-5497; Heitz, Thierry/0000-0001-6238-8264; Kandel, Sylvie/0000-0002-8059-8035	Ministere de l'Enseignement Superieur et de la Recherche; CNRS; Universite de Strasbourg; Region Alsace; Institut National de la Recherche Agronomique; Tepral Company	Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite de Strasbourg; Region Alsace(Region Grand-Est); Institut National de la Recherche Agronomique; Tepral Company	Supported by a doctoral fellowship from the Ministere de l'Enseignement Superieur et de la Recherche.; We are grateful to Michel Legrand for critical reading of the manuscript. We thank Dimitri Heintz for initial jasmonate analysis, Malek Alioua for help with real-time PCR and DNA sequencing, the gardener team for producing the numerous plants used in this study, and the Nottingham Arabidopsis Stock Center for providing seeds of T-DNA insertion lines. The UPLC-MS/MS system was cofinanced by the CNRS, the Universite de Strasbourg, the Region Alsace, the Institut National de la Recherche Agronomique, and the Tepral Company.	Berr A, 2010, PLANT PHYSIOL, V154, P1403, DOI 10.1104/pp.110.161497; Brooks DM, 2005, MOL PLANT PATHOL, V6, P629, DOI [10.1111/j.1364-3703.2005.00311.x, 10.1111/J.1364-3703.2005.00311.X]; Browse J, 2009, ANNU REV PLANT BIOL, V60, P183, DOI 10.1146/annurev.arplant.043008.092007; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Chung HS, 2008, PLANT PHYSIOL, V146, P952, DOI 10.1104/pp.107.115691; Chung HS, 2010, PLANT J, V63, P613, DOI 10.1111/j.1365-313X.2010.04265.x; Chung HS, 2009, PHYTOCHEMISTRY, V70, P1547, DOI 10.1016/j.phytochem.2009.08.022; Depuydt S, 2011, CURR BIOL, V21, pR365, DOI 10.1016/j.cub.2011.03.013; Ehlting J, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-47; Fonseca S, 2009, CURR OPIN PLANT BIOL, V12, P539, DOI 10.1016/j.pbi.2009.07.013; Fonseca S, 2009, NAT CHEM BIOL, V5, P344, DOI 10.1038/nchembio.161; Glauser G, 2008, J BIOL CHEM, V283, P16400, DOI 10.1074/jbc.M801760200; Guranowski A, 2007, FEBS LETT, V581, P815, DOI 10.1016/j.febslet.2007.01.049; Howe GA, 2008, ANNU REV PLANT BIOL, V59, P41, DOI 10.1146/annurev.arplant.59.032607.092825; Kandel S, 2007, FEBS J, V274, P5116, DOI 10.1111/j.1742-4658.2007.06032.x; Katsir L, 2008, P NATL ACAD SCI USA, V105, P7100, DOI 10.1073/pnas.0802332105; Kitaoka N, 2011, PLANT CELL PHYSIOL, V52, P1757, DOI 10.1093/pcp/pcr110; Koo AJK, 2011, P NATL ACAD SCI USA, V108, P9298, DOI 10.1073/pnas.1103542108; Le Bouquin R, 2001, EUR J BIOCHEM, V268, P3083, DOI 10.1046/j.1432-1327.2001.02207.x; Leon J, 1998, MOL GEN GENET, V258, P412, DOI 10.1007/s004380050749; Miersch O, 2008, NEW PHYTOL, V177, P114, DOI 10.1111/j.1469-8137.2007.02252.x; Mizutani M, 2010, ANNU REV PLANT BIOL, V61, P291, DOI 10.1146/annurev-arplant-042809-112305; Nelson D, 2011, PLANT J, V66, P194, DOI 10.1111/j.1365-313X.2011.04529.x; OMURA T, 1964, J BIOL CHEM, V239, P2370; Paschold A, 2008, PLANT CELL PHYSIOL, V49, P1165, DOI 10.1093/pcp/pcn091; Pauwels L, 2011, PLANT CELL, V23, P3089, DOI 10.1105/tpc.111.089300; Pinot F, 2011, FEBS J, V278, P195, DOI 10.1111/j.1742-4658.2010.07948.x; Pompon D, 1996, METHOD ENZYMOL, V272, P51, DOI 10.1016/S0076-6879(96)72008-6; Saito S, 2004, PLANT PHYSIOL, V134, P1439, DOI 10.1104/pp.103.037614; Santner A, 2009, NATURE, V459, P1071, DOI 10.1038/nature08122; Scheller U, 1998, J BIOL CHEM, V273, P32528, DOI 10.1074/jbc.273.49.32528; Schuler MA, 2003, ANNU REV PLANT BIOL, V54, P629, DOI 10.1146/annurev.arplant.54.031902.134840; Sheard LB, 2010, NATURE, V468, P400, DOI 10.1038/nature09430; Spoel SH, 2008, CELL HOST MICROBE, V3, P348, DOI 10.1016/j.chom.2008.05.009; Suza WP, 2010, PLANTA, V231, P717, DOI 10.1007/s00425-009-1080-6; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Turk EM, 2005, PLANT J, V42, P23, DOI 10.1111/j.1365-313X.2005.02358.x; VanDoorn A, 2011, NEW PHYTOL, V190, P640, DOI 10.1111/j.1469-8137.2010.03622.x; Wasternack C, 2010, PLANT SIGNAL BEHAV, V5, P337, DOI 10.4161/psb.5.4.11574; Wasternack C, 2010, ACS CHEM BIOL, V5, P63, DOI 10.1021/cb900269u; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Wu JQ, 2010, ANNU REV GENET, V44, P1, DOI 10.1146/annurev-genet-102209-163500; Yan JB, 2009, PLANT CELL, V21, P2220, DOI 10.1105/tpc.109.065730; Yan YX, 2007, PLANT CELL, V19, P2470, DOI 10.1105/tpc.107.050708; Zhu YY, 2006, PLANT CELL, V18, P442, DOI 10.1105/tpc.105.038455; Ziegler J, 2000, J BIOL CHEM, V275, P19132, DOI 10.1074/jbc.M002133200	46	160	168	2	47	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6296	6306		10.1074/jbc.M111.316364	http://dx.doi.org/10.1074/jbc.M111.316364			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22215670	Green Published, hybrid			2022-12-27	WOS:000300791800022
J	Johnson, JL; Erickson, JW; Cerione, RA				Johnson, Jared L.; Erickson, Jon W.; Cerione, Richard A.			C-terminal Di-arginine Motif of Cdc42 Protein Is Essential for Binding to Phosphatidylinositol 4,5-Bisphosphate-containing Membranes and Inducing Cellular Transformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHO GTPASES; IN-VIVO; DIFFERENTIAL LOCALIZATION; PLECKSTRIN HOMOLOGY; PLASMA-MEMBRANE; SURFACE-CHARGE; RAC; PHOSPHOINOSITIDES; PIP2; PHOSPHOLIPIDS	Rho GTPases regulate a diverse range of processes that are dependent on their proper cellular localization. The membrane localization of these GTPases is due in large part to their carboxyl-terminal geranylgeranyl moiety. In addition, most of the Rho family members contain a cluster of positively charged residues (i.e. a "polybasic domain"), directly preceding their geranylgeranyl moiety, and it has been suggested that this domain serves to fine-tune their localization among different cellular membrane sites. Here, we have taken a closer look at the role of the polybasic domain of Cdc42 in its ability to bind to membranes and induce the transformation of fibroblasts. A FRET assay for the binding of Cdc42 to liposomes of defined composition showed that Cdc42 associates more strongly with liposomes containing phosphatidylinositol 4,5-bisphosphate (PIP2) when compared either with uncharged control membranes or with liposomes containing a charge-equivalent amount of phosphatidylserine. The carboxyl-terminal di-arginine motif (Arg-186 and Arg-187) was shown to play an essential role in the binding of Cdc42 to PIP2-containing membranes. We further showed that substitutions for the di-arginine motif, when introduced within a constitutively active ("fast cycling") Cdc42(F28L) background, had little effect on the ability of the activated Cdc42 mutant to induce microspikes/filopodia in NIH 3T3 cells, whereas they eliminated its ability to transform fibroblasts. Taken together, these findings suggest that the di-arginine motif within the carboxyl terminus of Cdc42 is necessary for this GTPase to bind at membrane sites containing PIP2, where it can initiate signaling activities that are essential for the oncogenic transformation of cells.	[Johnson, Jared L.; Erickson, Jon W.; Cerione, Richard A.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; [Cerione, Richard A.] Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA	Cornell University; Cornell University	Cerione, RA (corresponding author), Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA.	rac1@cornell.edu		Johnson, Jared/0000-0003-1802-6527	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047458] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM047458] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Antonyak MA, 2011, P NATL ACAD SCI USA, V108, P4852, DOI 10.1073/pnas.1017667108; Baumeister MA, 2003, J BIOL CHEM, V278, P11457, DOI 10.1074/jbc.M211901200; Bertin A, 2010, J MOL BIOL, V404, P711, DOI 10.1016/j.jmb.2010.10.002; Botelho RJ, 2000, J CELL BIOL, V151, P1353, DOI 10.1083/jcb.151.7.1353; Buboltz JT, 1999, BBA-BIOMEMBRANES, V1417, P232, DOI 10.1016/S0005-2736(99)00006-1; Cho H, 2005, P NATL ACAD SCI USA, V102, P15241, DOI 10.1073/pnas.0408851102; Crompton AM, 2000, J BIOL CHEM, V275, P25751, DOI 10.1074/jbc.M002050200; Das B, 2000, J BIOL CHEM, V275, P15074, DOI 10.1074/jbc.M907269199; del Pozo MA, 2004, SCIENCE, V303, P839, DOI 10.1126/science.1092571; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Erickson JW, 2001, CURR OPIN CELL BIOL, V13, P153, DOI 10.1016/S0955-0674(00)00192-7; Erickson JW, 1996, J BIOL CHEM, V271, P26850, DOI 10.1074/jbc.271.43.26850; Field SJ, 2005, CURR BIOL, V15, P1407, DOI 10.1016/j.cub.2005.06.059; Fooksman DR, 2009, J IMMUNOL, V182, P5179, DOI 10.4049/jimmunol.0801797; FUKUMOTO Y, 1990, ONCOGENE, V5, P1321; Gadi D, 2011, MOL BIOL CELL, V22, P4908, DOI 10.1091/mbc.E11-07-0614; Golebiewska U, 2008, MOL BIOL CELL, V19, P1663, DOI 10.1091/mbc.E07-12-1208; Gu Y, 2003, SCIENCE, V302, P445, DOI 10.1126/science.1088485; Gwanyanya A, 2006, AM J PHYSIOL-CELL PH, V291, pC627, DOI 10.1152/ajpcell.00074.2006; Harris KP, 2010, TRAFFIC, V11, P1272, DOI 10.1111/j.1600-0854.2010.01102.x; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Janetopoulos C, 2006, J CELL BIOL, V174, P485, DOI 10.1083/jcb.200603156; Johnson JL, 2009, J BIOL CHEM, V284, P23860, DOI 10.1074/jbc.M109.031815; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; Knaus UG, 1998, J BIOL CHEM, V273, P21512, DOI 10.1074/jbc.273.34.21512; LEONARD D, 1992, J BIOL CHEM, V267, P22860; Ligeti E, 2004, J BIOL CHEM, V279, P5055, DOI 10.1074/jbc.C300547200; Magalhaes MAO, 2010, J LEUKOCYTE BIOL, V87, P545, DOI 10.1189/jlb.0609390; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Micheva KD, 2001, J CELL BIOL, V154, P355, DOI 10.1083/jcb.200102098; Moissoglu K, 2006, MOL BIOL CELL, V17, P2770, DOI 10.1091/mbc.E06-01-0005; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Nomanbhoy TK, 1996, J BIOL CHEM, V271, P10004, DOI 10.1074/jbc.271.17.10004; Papayannopoulos V, 2005, MOL CELL, V17, P181, DOI 10.1016/j.molcel.2004.11.054; Raucher D, 2000, CELL, V100, P221, DOI 10.1016/S0092-8674(00)81560-3; Redfern DA, 2005, J LIPID RES, V46, P504, DOI 10.1194/jlr.M400367-JLR200; Roberts PJ, 2008, J BIOL CHEM, V283, P25150, DOI 10.1074/jbc.M800882200; SILVIUS JR, 1994, BIOCHEMISTRY-US, V33, P3014, DOI 10.1021/bi00176a034; Struckhoff AP, 2011, FRONT BIOSCI-LANDMRK, V16, P1915, DOI 10.2741/3830; van den Bogaart G, 2011, NATURE, V479, P552, DOI 10.1038/nature10545; Wu WJ, 2000, NATURE, V405, P800, DOI 10.1038/35015585; Yamauchi A, 2005, J BIOL CHEM, V280, P953, DOI 10.1074/jbc.M408820200; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; ZIMAN M, 1993, MOL BIOL CELL, V4, P1307, DOI 10.1091/mbc.4.12.1307	48	32	32	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5764	5774		10.1074/jbc.M111.336487	http://dx.doi.org/10.1074/jbc.M111.336487			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22215673	Green Published, hybrid			2022-12-27	WOS:000300638000052
J	Sankaran, D; Pakala, SB; Nair, VS; Sirigiri, DNR; Cyanam, D; Ha, NH; Li, DQ; Santhoshkumar, TR; Pillai, MR; Kumar, R				Sankaran, Deivendran; Pakala, Suresh B.; Nair, Vasudha S.; Sirigiri, Divijendra Natha Reddy; Cyanam, Dinesh; Ha, Ngoc-Han; Li, Da-Qiang; Santhoshkumar, T. R.; Pillai, M. Radhakrishna; Kumar, Rakesh			Mechanism of MTA1 Protein Overexpression-linked Invasion MTA1 REGULATION OF HYALURONAN-MEDIATED MOTILITY RECEPTOR (HMMR) EXPRESSION AND FUNCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METASTASIS-ASSOCIATED PROTEIN-1; HYALURONAN RECEPTOR RHAMM; BREAST-TUMOR CELLS; MEDIATED MOTILITY; COLORECTAL-CANCER; CD44; IDENTIFICATION; TARGET; CD168; PROGRESSION	Even though the hyaluronan-mediated motility receptor (HMMR), a cell surface oncogenic protein, is widely up-regulated in human cancers and correlates well with cell motility and invasion, the underlying molecular and nature of its putative upstream regulation remain unknown. Here, we found for the first time that MTA1 (metastatic tumor antigen 1), a master chromatin modifier, regulates the expression of HMMR and, consequently, its function in breast cancer cell motility and invasiveness. We recognized a positive correlation between the levels of MTA1 and HMMR in human cancer. Furthermore, MTA1 is required for optimal expression of HMMR. The underlying mechanism includes interaction of the MTA1.RNA polymerase II-c-Jun coactivator complex with the HMMR promoter to stimulates its transcription. Accordingly, selective siRNA-mediated knockdown of HMMR in breast cancer cells substantially reduces the invasion and migration of cells. These findings reveal a regulatory role for MTA1 as an upstream coactivator of HMMR expression and resulting biological phenotypes.	[Sankaran, Deivendran; Santhoshkumar, T. R.; Pillai, M. Radhakrishna; Kumar, Rakesh] Rajiv Gandhi Ctr Biotechnol, Integrated Canc Res Program, Thiruvananthapuram 695014, Kerala, India; [Pakala, Suresh B.; Nair, Vasudha S.; Sirigiri, Divijendra Natha Reddy; Cyanam, Dinesh; Ha, Ngoc-Han; Li, Da-Qiang; Kumar, Rakesh] George Washington Univ, Med Ctr, Dept Biochem & Mol Biol, Washington, DC 20037 USA	Department of Biotechnology (DBT) India; Rajiv Gandhi Centre for Biotechnology (RGCB); George Washington University	Pillai, MR (corresponding author), Rajiv Gandhi Ctr Biotechnol, Integrated Canc Res Program, Thiruvananthapuram 695014, Kerala, India.	mrpillai@rgcb.res.in; bcmrxk@gwumc.edu	Kumar, Rakesh/ABD-1065-2020	Kumar, Rakesh/0000-0001-7664-0803	National Institutes of Health [CA98823]; Shared Instrumentation Grant [S10RR025565]; NATIONAL CANCER INSTITUTE [R01CA098823] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025565] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shared Instrumentation Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant CA98823 (to R. K.) and Shared Instrumentation Grant S10RR025565.	Balasenthil S, 2007, CANCER RES, V67, P7132, DOI 10.1158/0008-5472.CAN-07-0750; Bourguignon LYW, 2002, J BIOL CHEM, V277, P39703, DOI 10.1074/jbc.M204320200; Crainie M, 1999, BLOOD, V93, P1684, DOI 10.1182/blood.V93.5.1684.405k22_1684_1696; Divijendra S, 2009, CANCER RES, V69, P5639, DOI 10.1158/0008-5472.CAN-09-0898; Du B, 2011, WORLD J GASTROENTERO, V17, P1219, DOI 10.3748/wjg.v17.i9.1219; Edward M, 2005, CARCINOGENESIS, V26, P1215, DOI 10.1093/carcin/bgi064; Entschladen F, 2004, LANCET ONCOL, V5, P254, DOI 10.1016/S1470-2045(04)01431-7; Ghanta KS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017135; Greiner J, 2005, BLOOD, V106, P938, DOI 10.1182/blood-2004-12-4787; Grenier J, 2002, EXP HEMATOL, V30, P1029, DOI 10.1016/S0301-472X(02)00874-3; Gururaj AE, 2006, P NATL ACAD SCI USA, V103, P6670, DOI 10.1073/pnas.0601989103; Gust KM, 2009, NEOPLASIA, V11, P956, DOI 10.1593/neo.09694; HALL CL, 1995, CELL, V82, P19, DOI 10.1016/0092-8674(95)90048-9; Hall CL, 1996, ONCOGENE, V13, P2213; Hamilton SR, 2007, J BIOL CHEM, V282, P16667, DOI 10.1074/jbc.M702078200; Hatano H, 2011, LAB INVEST, V91, P379, DOI 10.1038/labinvest.2010.176; Ishigami S, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-106; Kong QY, 2003, ONCOL REP, V10, P51; Kumar R, 2003, SEMIN ONCOL, V30, P30, DOI 10.1053/j.seminoncol.2003.08.005; Kumar R, 2002, NATURE, V418, P654, DOI 10.1038/nature00889; Kumar R, 2010, CANCER RES, V70, P6598, DOI 10.1158/0008-5472.CAN-10-0907; Manavathi Bramanandam, 2007, Nucl Recept Signal, V5, pe010, DOI 10.1621/nrs.05010; Manavathi B, 2007, J BIOL CHEM, V282, P1529, DOI 10.1074/jbc.R600029200; Molli PR, 2008, ONCOGENE, V27, P1971, DOI 10.1038/sj.onc.1210839; Moon HE, 2006, ONCOL REP, V16, P929; Pakala SB, 2011, ONCOGENE, V30, P2230, DOI 10.1038/onc.2010.608; Pakala SB, 2010, J BIOL CHEM, V285, P32787, DOI 10.1074/jbc.M110.151340; Pujana MA, 2007, NAT GENET, V39, P1338, DOI 10.1038/ng.2007.2; Rein DT, 2003, J CANCER RES CLIN, V129, P161, DOI 10.1007/s00432-003-0415-0; Sohr S, 2008, CELL CYCLE, V7, P3448, DOI 10.4161/cc.7.21.7014; Song L, 2010, MOL CELL, V38, P369, DOI 10.1016/j.molcel.2010.02.038; Tammi MI, 2002, J BIOL CHEM, V277, P4581, DOI 10.1074/jbc.R100037200; TOH Y, 1994, J BIOL CHEM, V269, P22958; Tolg C, 2006, J CELL BIOL, V175, P1017, DOI 10.1083/jcb.200511027; Tolg C, 2010, J BIOL CHEM, V285, P26461, DOI 10.1074/jbc.M110.121491; Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200; Tzircotis G, 2005, J CELL SCI, V118, P5119, DOI 10.1242/jcs.02629; Udabage L, 2005, EXP CELL RES, V310, P205, DOI 10.1016/j.yexcr.2005.07.026; Wang C, 1998, CLIN CANCER RES, V4, P567; Woodhouse EC, 1997, CANCER-AM CANCER SOC, V80, P1529, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1529::AID-CNCR2>3.0.CO;2-F; Yamano Y, 2008, INT J ONCOL, V32, P1001; Yeo TK, 1996, AM J PATHOL, V148, P1733; Yoo YG, 2006, EMBO J, V25, P1231, DOI 10.1038/sj.emboj.7601025; Zlobec I, 2008, GUT, V57, P1413, DOI 10.1136/gut.2007.141192	44	12	14	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5483	5491		10.1074/jbc.M111.324632	http://dx.doi.org/10.1074/jbc.M111.324632			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22203674	Green Published, hybrid			2022-12-27	WOS:000300638000028
J	Ejlerskov, P; Christensen, DP; Beyaie, D; Burritt, JB; Paclet, MH; Gorlach, A; Van Deurs, B; Vilhardt, F				Ejlerskov, Patrick; Christensen, Dan Ploug; Beyaie, David; Burritt, James B.; Paclet, Marie-Helene; Gorlach, Agnes; Van Deurs, Bo; Vilhardt, Frederik			NADPH Oxidase Is Internalized by Clathrin-coated Pits and Localizes to a Rab27A/B GTPase-regulated Secretory Compartment in Activated Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; INTRACELLULAR VESICLES; CYTOCHROME-B; EXOCYTOSIS; EFFECTOR; RECEPTOR; PROTEIN; ACTIN; NEUTROPHILS; PHAGOCYTES	Here, we report that activation of different types of tissue macrophages, including microglia, by lipopolysaccharide (LPS) or GM-CSF stimulation correlates with the quantitative redistribution of NADPH oxidase (cyt b(558)) from the plasma membrane to an intracellular stimulus-responsive storage compartment. Cryo-immunogold labeling of gp91(phox) and CeCl3 cytochemistry showed the presence of gp91phox and oxidant production in numerous small (< 100 nm) vesicles. Cell homogenization and sucrose gradient centrifugation in combination with transferrin-HRP/DAB ablation showed that more than half of cyt b(558) is present in fractions devoid of endosomal markers, which is supported by morphological evidence to show that the cyt b(558)-containing compartment is distinct from endosomes or biosynthetic organelles. Streptolysin-O-mediated guanosine 5'-3-O-(thio) triphosphate loading of Ra2 microglia caused exocytosis of a major complement of cyt b(558) under conditions where lysosomes or endosomes were not mobilized. We establish phagocytic particles and soluble mediators ATP, TNF alpha, and CD40L as physiological inducers of cyt b(558) exocytosis to the cell surface, and by shRNA knockdown, we identify Rab27A/B as positive or negative regulators of vesicular mobilization to the phagosome or the cell surface, respectively. Exocytosis was followed by clathrin-dependent internalization of cyt b(558), which could be blocked by a dominant negative mutant of the clathrincoated pit-associated protein Eps15. Re-internalized cyt b(558) did not reach lysosomes but associated with recycling endosomes and undefined vesicular elements. In conclusion, cyt b(558) depends on clathrin for internalization, and in activated macrophages NADPH oxidase occupies a Rab27A/B-regulated secretory compartment, which allows rapid agonist-induced redistribution of superoxide production in the cell.	[Ejlerskov, Patrick; Christensen, Dan Ploug; Beyaie, David; Van Deurs, Bo; Vilhardt, Frederik] Univ Copenhagen, Panum Inst, Fac Hlth Sci, Dept Cellular & Mol Med, DK-2200 Copenhagen N, Denmark; [Burritt, James B.] Univ Wisconsin Stout, Dept Biol, Menomonie, WI 54751 USA; [Paclet, Marie-Helene] Univ Grenoble 1, CHU Grenoble, GREPI, TIMC IMAG,CNRS,UMR 5525, F-38041 Grenoble, France; [Gorlach, Agnes] Tech Univ Munich, German Heart Ctr, D-080636 Munich, Germany	University of Copenhagen; University of Wisconsin System; University of Wisconsin Stout; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); CHU Grenoble Alpes; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); German Heart Centre Munich; Technical University of Munich	Vilhardt, F (corresponding author), Panum Inst, Dept Cellular & Mol Med, Bldg 18-4,Blegdamsvej 3, DK-2200 Copenhagen N, Denmark.	vilhardt@sund.ku.dk	Vilhardt, Frederik/AAX-4766-2021; Gorlach, Agnes/B-3494-2013; Paclet, Marie-Hélène/AAS-5029-2020	Vilhardt, Frederik/0000-0001-8604-7165; Ejlerskov, Patrick/0000-0002-2514-3185	NOVO Nordisk Foundation [50-65074]; Aase and Ejnar Danielsens Foundation [105560]; Desiree and Niels Yde Foundation	NOVO Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Aase and Ejnar Danielsens Foundation; Desiree and Niels Yde Foundation	This work was supported by NOVO Nordisk Foundation Grant 50-65074, The Aase and Ejnar Danielsens Foundation Grant 105560, and The Desiree and Niels Yde Foundation (to F. V.).	Anderson KE, 2010, BLOOD, V116, P4978, DOI 10.1182/blood-2010-03-275602; Arimura N, 2009, DEV CELL, V16, P675, DOI 10.1016/j.devcel.2009.03.005; Babior BM, 2000, AM J MED, V109, P33, DOI 10.1016/S0002-9343(00)00481-2; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Benmerah A, 2000, J BIOL CHEM, V275, P3288, DOI 10.1074/jbc.275.5.3288; Brzezinska AA, 2008, TRAFFIC, V9, P2151, DOI 10.1111/j.1600-0854.2008.00838.x; BURRITT JB, 1995, J BIOL CHEM, V270, P16974, DOI 10.1074/jbc.270.28.16974; CALAFAT J, 1993, BLOOD, V81, P3122; Campion Y, 2007, BIOCHIMIE, V89, P1145, DOI 10.1016/j.biochi.2007.01.010; Casbon AJ, 2009, J IMMUNOL, V182, P2325, DOI 10.4049/jimmunol.0803476; Chen K, 2008, J CELL BIOL, V181, P1129, DOI 10.1083/jcb.200709049; Chieregatti E, 2005, NAT REV MOL CELL BIO, V6, P181, DOI 10.1038/nrm1572; Cocucci E, 2007, TRAFFIC, V8, P742, DOI 10.1111/j.1600-0854.2007.00566.x; Coull JAM, 2005, NATURE, V438, P1017, DOI 10.1038/nature04223; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; DeLeo FR, 1999, J IMMUNOL, V163, P6732; Desnos C, 2003, J CELL BIOL, V163, P559, DOI 10.1083/jcb.200302157; Diaz B, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000368; Diebold BA, 2001, NAT IMMUNOL, V2, P211, DOI 10.1038/85259; Gelderman KA, 2007, J CLIN INVEST, V117, P3020, DOI 10.1172/JCI31935; Hashiramoto M, 2000, MOL CELL BIOL, V20, P416, DOI 10.1128/MCB.20.1.416-427.2000; Haynes SE, 2006, NAT NEUROSCI, V9, P1512, DOI 10.1038/nn1805; Hilenski LL, 2004, ARTERIOSCL THROM VAS, V24, P677, DOI 10.1161/01.ATV.0000112024.13727.2c; Hommelgaard AM, 2005, TRAFFIC, V6, P720, DOI 10.1111/j.1600-0854.2005.00314.x; Hume AN, 2001, J CELL BIOL, V152, P795, DOI 10.1083/jcb.152.4.795; Idone V, 2008, J CELL BIOL, V180, P905, DOI 10.1083/jcb.200708010; Inoue H, 1999, GLIA, V28, P265, DOI 10.1002/(SICI)1098-1136(199912)28:3<265::AID-GLIA10>3.0.CO;2-F; Jancic C, 2007, NAT CELL BIOL, V9, P367, DOI 10.1038/ncb1552; JOHANSSON A, 1995, CELL IMMUNOL, V161, P61, DOI 10.1006/cimm.1995.1009; Johnson JL, 2010, TRAFFIC, V11, P533, DOI 10.1111/j.1600-0854.2009.01029.x; Kim D, 2010, P NATL ACAD SCI USA, V107, P14851, DOI 10.1073/pnas.1009926107; Kirkham M, 2005, BBA-MOL CELL RES, V1746, P349, DOI 10.1016/j.bbamcr.2005.11.005; Kobayashi T, 1999, HISTOCHEM J, V31, P181, DOI 10.1023/A:1003547121574; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Li Q, 2008, BIOCHEM J, V411, P531, DOI 10.1042/BJ20071534; Livingstone C, 1996, BIOCHEM J, V315, P487, DOI 10.1042/bj3150487; Martin S, 1996, J CELL BIOL, V134, P625, DOI 10.1083/jcb.134.3.625; Menager MM, 2007, NAT IMMUNOL, V8, P257, DOI 10.1038/ni1431; Mizuno K, 2007, TRAFFIC, V8, P883, DOI 10.1111/j.1600-0854.2007.00571.x; MUALLEM S, 1995, J CELL BIOL, V128, P589, DOI 10.1083/jcb.128.4.589; Mumbengegwi DR, 2008, MOL CELL BIOL, V28, P3700, DOI 10.1128/MCB.02038-07; Nauseef WM, 2004, HISTOCHEM CELL BIOL, V122, P277, DOI 10.1007/s00418-004-0679-8; Neeft M, 2005, MOL BIOL CELL, V16, P731, DOI 10.1091/mbc.E04-10-0923; Oakley FD, 2009, J BIOL CHEM, V284, P33255, DOI 10.1074/jbc.M109.042127; Petry A, 2006, ANTIOXID REDOX SIGN, V8, P1473, DOI 10.1089/ars.2006.8.1473; Presley JF, 1997, J BIOL CHEM, V272, P13929, DOI 10.1074/jbc.272.21.13929; Rasmussen I, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-44; Roepstorff K, 2008, J BIOL CHEM, V283, P7983, DOI 10.1074/jbc.M708281200; Sawada M., 2007, [No title captured], Patent No. [JP3410738, 3410738]; Sawada M., 2007, U.S. Patent, Patent No. [6.673,6,5, 667365]; Sawada M., 2007, [No title captured], Patent No. [EP10/602,234, 10602234]; SENGELOV H, 1992, J BIOL CHEM, V267, P14912; Ushio-Fukai Masuko, 2006, Sci STKE, V2006, pre8; Vignais PV, 2002, CELL MOL LIFE SCI, V59, P1428, DOI 10.1007/s00018-002-8520-9; Vilhardt F, 2002, J BIOL CHEM, V277, P42136, DOI 10.1074/jbc.M200862200; Vilhardt F, 2004, EMBO J, V23, P739, DOI 10.1038/sj.emboj.7600066; Vilhardt F, 1999, MOL BIOL CELL, V10, P179, DOI 10.1091/mbc.10.1.179; Vutskits GV, 2006, BREAST CANCER RES TR, V99, P143, DOI 10.1007/s10549-006-9195-y; Walev I, 2001, P NATL ACAD SCI USA, V98, P3185, DOI 10.1073/pnas.051429498; Ward RA, 2000, J BIOL CHEM, V275, P36713, DOI 10.1074/jbc.M003017200; Wu RF, 2010, MOL CELL BIOL, V30, P3553, DOI 10.1128/MCB.01445-09	61	23	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4835	4852		10.1074/jbc.M111.293696	http://dx.doi.org/10.1074/jbc.M111.293696			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22157766	Green Published, hybrid			2022-12-27	WOS:000300608500045
J	Fluhrer, R; Martin, L; Klier, B; Haug-Kroper, M; Grammer, G; Nuscher, B; Haass, C				Fluhrer, Regina; Martin, Lucas; Klier, Baerbel; Haug-Kroeper, Martina; Grammer, Gudula; Nuscher, Brigitte; Haass, Christian			The alpha-Helical Content of the Transmembrane Domain of the British Dementia Protein-2 (Bri2) Determines Its Processing by Signal Peptide Peptidase-like 2b (SPPL2b)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATED INTRAMEMBRANE PROTEOLYSIS; TERMINAL PAL MOTIF; GAMMA-SECRETASE; PRESENILIN; PROTEASES; SEQUENCE; CLEAVAGE; IDENTIFICATION; SPECIFICITY; MECHANISM	Regulated intramembrane proteolysis is a widely accepted concept describing the processing of various transmembrane proteins via ectodomain shedding followed by an intramembrane cleavage. The resulting cleavage products can be involved in reverse signaling. Presenilins, which constitute the active center of the gamma-secretase complex, signal peptide peptidase (SPP), and its homologues, the SPP-like (SPPL) proteases are members of the family of intramembrane-cleaving aspartyl proteases of the GXGD-type. We recently demonstrated that Bri2 (itm2b) is a substrate for regulated intramembrane proteolysis by SPPL2a and SPPL2b. Intramembrane cleavage of Bri2 is triggered by an initial shedding event catalyzed by A Disintegrin and Metalloprotease 10 (ADAM10). Additionally primary sequence determinants within the intracellular domain, the transmembrane domain and the luminal juxtamembrane domain are required for efficient cleavage of Bri2 by SPPL2b. Using mutagenesis and circular dichroism spectroscopy we now demonstrate that a high alpha-helical content of the Bri2 transmembrane domain (TMD) reduces cleavage efficiency of Bri2 by SPPL2b, while the presence of a GXXXG dimerization motif influences the intramembrane cleavage only to a minor extent. Surprisingly, only one of the four conserved intramembrane glycine residues significantly affects the secondary structure of the Bri2 TMD and thereby its intramembrane cleavage. Other glycine residues do not influence the alpha-helical content of the transmembrane domain nor its intramembrane processing.	[Fluhrer, Regina; Haass, Christian] German Ctr Neurodegenerat Dis DZNE, D-80336 Munich, Germany; [Fluhrer, Regina; Martin, Lucas; Klier, Baerbel; Haug-Kroeper, Martina; Grammer, Gudula; Nuscher, Brigitte; Haass, Christian] Univ Munich, Adolf Butenandt Inst, D-80336 Munich, Germany	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Munich	Haass, C (corresponding author), German Ctr Neurodegenerat Dis DZNE, D-80336 Munich, Germany.	christian.haass@dzne.lmu.de			DFG [HA1737-11]; LMU<SUP>excellent</SUP>	DFG(German Research Foundation (DFG)); LMU<SUP>excellent</SUP>	This work was supported in part by DFG Grant HA1737-11 (to C. H. and R. F.).; Supported by a Research Professorship provided by the LMU<SUP>excellent</SUP> program.	Akiyama Y, 2007, MOL MICROBIOL, V64, P1028, DOI 10.1111/j.1365-2958.2007.05715.x; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Eggert S, 2009, J BIOL CHEM, V284, P28943, DOI 10.1074/jbc.M109.038646; Fluhrer R, 2002, J NEUROCHEM, V81, P1011, DOI 10.1046/j.1471-4159.2002.00908.x; Fluhrer R, 2008, J BIOL CHEM, V283, P30121, DOI 10.1074/jbc.M806092200; Fluhrer R, 2009, J BIOL CHEM, V284, P13975, DOI 10.1074/jbc.R800040200; Friedmann E, 2004, J BIOL CHEM, V279, P50790, DOI 10.1074/jbc.M407898200; Hemming ML, 2008, PLOS BIOL, V6, P2314, DOI 10.1371/journal.pbio.0060257; Hubbard SJ, 1998, BBA-PROTEIN STRUCT M, V1382, P191, DOI 10.1016/S0167-4838(97)00175-1; Kaden D, 2008, J BIOL CHEM, V283, P7271, DOI 10.1074/jbc.M708046200; Kaether C, 2004, EMBO J, V23, P4738, DOI 10.1038/sj.emboj.7600478; Kim SH, 2002, J BIOL CHEM, V277, P1872, DOI 10.1074/jbc.M108739200; Kim SH, 1999, NAT NEUROSCI, V2, P984, DOI 10.1038/14783; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Lemberg MK, 2007, MOL CELL, V28, P930, DOI 10.1016/j.molcel.2007.12.003; Lemberg MK, 2002, MOL CELL, V10, P735, DOI 10.1016/S1097-2765(02)00655-X; LI SC, 1994, NAT STRUCT BIOL, V1, P558; Madala PK, 2010, CHEM REV, V110, pPR1, DOI 10.1021/cr900368a; Martin L, 2008, J BIOL CHEM, V283, P1644, DOI 10.1074/jbc.M706661200; Martin L, 2009, J BIOL CHEM, V284, P5662, DOI 10.1074/jbc.M807485200; Munter LM, 2007, EMBO J, V26, P1702, DOI 10.1038/sj.emboj.7601616; Munter LM, 2010, J BIOL CHEM, V285, P21636, DOI 10.1074/jbc.M109.088005; Popot JL, 2000, ANNU REV BIOCHEM, V69, P881, DOI 10.1146/annurev.biochem.69.1.881; Ren Z, 2007, J BIOL CHEM, V282, P35350, DOI 10.1074/jbc.M702739200; Sanchez-Pulido L, 2002, TRENDS BIOCHEM SCI, V27, P329, DOI 10.1016/S0968-0004(02)02134-5; Sato C, 2008, J NEUROSCI, V28, P6264, DOI 10.1523/JNEUROSCI.1163-08.2008; Selkoe DJ, 2011, NAT MED, V17, P1060, DOI 10.1038/nm.2460; Steiner H, 2000, NAT CELL BIOL, V2, P848, DOI 10.1038/35041097; Steiner H, 2008, J BIOL CHEM, V283, P29627, DOI 10.1074/jbc.R800010200; Strisovsky K, 2009, MOL CELL, V36, P1048, DOI 10.1016/j.molcel.2009.11.006; Tolia A, 2008, J BIOL CHEM, V283, P19793, DOI 10.1074/jbc.M802461200; Urban S, 2003, MOL CELL, V11, P1425, DOI 10.1016/S1097-2765(03)00181-3; Vidal R, 1999, NATURE, V399, P776; Wang J, 2006, J NEUROCHEM, V96, P218, DOI 10.1111/j.1471-4159.2005.03548.x; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; Wolfe MS, 2010, BIOL CHEM, V391, P839, DOI 10.1515/BC.2010.086; Wolfe MS, 2009, J BIOL CHEM, V284, P13969, DOI 10.1074/jbc.R800039200; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Ye J, 2000, P NATL ACAD SCI USA, V97, P5123, DOI 10.1073/pnas.97.10.5123	39	31	33	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					5156	5163		10.1074/jbc.M111.328104	http://dx.doi.org/10.1074/jbc.M111.328104			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22194595	Green Published, hybrid			2022-12-27	WOS:000300608500073
J	Marino, SM; Gladyshev, VN				Marino, Stefano M.; Gladyshev, Vadim N.			Analysis and Functional Prediction of Reactive Cysteine Residues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							SUPPORT VECTOR MACHINES; SMOOTH-MUSCLE-CELLS; K-ATP CHANNELS; ACTIVE-SITE; ESCHERICHIA-COLI; HYDROGEN-SULFIDE; NEURAL-NETWORKS; S-NITROSOCYSTEINE; BONDING STATE; SULFENIC ACID	Cys is much different from other common amino acids in proteins. Being one of the least abundant residues, Cys is often observed in functional sites in proteins. This residue is reactive, polarizable, and redox-active; has high affinity for metals; and is particularly responsive to the local environment. A better understanding of the basic properties of Cys is essential for interpretation of high-throughput data sets and for prediction and classification of functional Cys residues. We provide an overview of approaches used to study Cys residues, from methods for investigation of their basic properties, such as exposure and pK(a), to algorithms for functional prediction of different types of Cys in proteins.	[Marino, Stefano M.; Gladyshev, Vadim N.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Genet,Dept Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Gladyshev, VN (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Genet,Dept Med, Boston, MA 02115 USA.	vgladyshev@rics.bwh.harvard.edu	Gladyshev, Vadim N/A-9894-2013; Gladyshev, Vadim N/J-6187-2013	Gladyshev, Vadim/0000-0002-0372-7016	National Institutes of Health [GM065204]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM065204, R01GM065204] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM065204 (to V. N. G.). This is the fourth article in the Thematic Minireview Series on Redox Sensing and Regulation.	Andreini C, 2004, BIOINFORMATICS, V20, P1373, DOI 10.1093/bioinformatics/bth095; Atkinson HJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000541; Atkinson HJ, 2009, BIOCHEMISTRY-US, V48, P11108, DOI 10.1021/bi901180v; Beeby M, 2005, PLOS BIOL, V3, P1549, DOI 10.1371/journal.pbio.0030309; Cabiscol E, 1996, P NATL ACAD SCI USA, V93, P4170, DOI 10.1073/pnas.93.9.4170; Cammer SA, 2003, J MOL BIOL, V334, P387, DOI 10.1016/j.jmb.2003.09.062; Cardey B, 2007, J PHYS CHEM A, V111, P673, DOI 10.1021/jp0658445; Ceroni A, 2006, NUCLEIC ACIDS RES, V34, pW177, DOI 10.1093/nar/gkl266; Chen YC, 2004, PROTEINS, V55, P1036, DOI 10.1002/prot.20079; Cheng JL, 2006, PROTEINS, V62, P617, DOI 10.1002/prot.20787; Collet JF, 2002, MOL MICROBIOL, V44, P1, DOI 10.1046/j.1365-2958.2002.02851.x; Crow A, 2004, J BIOL CHEM, V279, P23654, DOI 10.1074/jbc.M402823200; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; Dokmanic I, 2008, ACTA CRYSTALLOGR D, V64, P257, DOI 10.1107/S090744490706595X; Dyson HJ, 1997, BIOCHEMISTRY-US, V36, P2622, DOI 10.1021/bi961801a; El Hajjaji H, 2009, J MOL BIOL, V386, P60, DOI 10.1016/j.jmb.2008.11.046; Foloppe N, 2001, J MOL BIOL, V310, P449, DOI 10.1006/jmbi.2001.4767; Fomenko DE, 2007, SCIENCE, V315, P387, DOI 10.1126/science.1133114; Fomenko DE, 2012, ANTIOXID REDOX SIGN, V16, P193, DOI 10.1089/ars.2011.3980; Greco TM, 2006, P NATL ACAD SCI USA, V103, P7420, DOI 10.1073/pnas.0600729103; Han S, 2008, BIOCHEM BIOPH RES CO, V377, P612, DOI 10.1016/j.bbrc.2008.10.017; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Ilbert M, 2007, NAT STRUCT MOL BIOL, V14, P556, DOI 10.1038/nsmb1244; Jakob U, 1999, CELL, V96, P341, DOI 10.1016/S0092-8674(00)80547-4; Jiang B, 2010, ANTIOXID REDOX SIGN, V12, P1167, DOI 10.1089/ars.2009.2894; Jobson RW, 2010, MITOCHONDRION, V10, P540, DOI 10.1016/j.mito.2010.05.013; Johansen D, 2006, BASIC RES CARDIOL, V101, P53, DOI 10.1007/s00395-005-0569-9; Jordan IK, 2005, NATURE, V433, P633, DOI 10.1038/nature03306; Kroncke KD, 2009, ANTIOXID REDOX SIGN, V11, P1015, DOI [10.1089/ars.2008.2269, 10.1089/ARS.2008.2269]; Lee BC, 2011, J BIOL CHEM, V286, P18747, DOI 10.1074/jbc.M111.229807; Leonard SE, 2009, ACS CHEM BIOL, V4, P783, DOI 10.1021/cb900105q; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Lin CT, 2005, INT J NEURAL SYST, V15, P71, DOI 10.1142/S0129065705000116; Lin HH, 2010, NUCLEIC ACIDS RES, V38, pW503, DOI 10.1093/nar/gkq514; Marino SM, 2011, ANTIOXID REDOX SIGN, V15, P135, DOI 10.1089/ars.2010.3561; Marino SM, 2010, J MOL BIOL, V404, P902, DOI 10.1016/j.jmb.2010.09.027; Marino SM, 2010, J MOL BIOL, V395, P844, DOI 10.1016/j.jmb.2009.10.042; Marino SM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000383; Moosmann B, 2008, AGING CELL, V7, P32, DOI 10.1111/j.1474-9726.2007.00349.x; Moosmann B, 2011, EXP GERONTOL, V46, P164, DOI 10.1016/j.exger.2010.08.034; Neiers F, 2007, J BIOL CHEM, V282, P32397, DOI 10.1074/jbc.M704730200; Nelson KJ, 2011, PROTEINS, V79, P947, DOI 10.1002/prot.22936; Ondrechen MJ, 2001, P NATL ACAD SCI USA, V98, P12473, DOI 10.1073/pnas.211436698; OVERINGTON J, 1992, PROTEIN SCI, V1, P216; Passerini A, 2004, PROTEIN ENG DES SEL, V17, P367, DOI 10.1093/protein/gzh042; Passerini A, 2006, PROTEINS, V65, P305, DOI 10.1002/prot.21135; Poole LB, 2004, ANNU REV PHARMACOL, V44, P325, DOI 10.1146/annurev.pharmtox.44.101802.121735; Roos G, 2011, FREE RADICAL BIO MED, V51, P314, DOI 10.1016/j.freeradbiomed.2011.04.031; Roos G, 2010, PROTEIN SCI, V19, P190, DOI 10.1002/pro.269; Roos G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000461; Salsbury FR, 2008, PROTEIN SCI, V17, P299, DOI 10.1110/ps.073096508; Sanchez R, 2008, PROTEIN SCI, V17, P473, DOI 10.1110/ps.073252408; Schindeldecker M, 2011, MECH AGEING DEV, V132, P171, DOI 10.1016/j.mad.2011.03.002; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Shenton D, 2003, BIOCHEM J, V374, P513, DOI 10.1042/BJ20030414; Sigrist Christian J A, 2002, Brief Bioinform, V3, P265, DOI 10.1093/bib/3.3.265; Soito L, 2011, NUCLEIC ACIDS RES, V39, pD332, DOI 10.1093/nar/gkq1060; Tolbert BS, 2005, BIOCHEMISTRY-US, V44, P16385, DOI 10.1021/bi0514459; Tosatto SCE, 2008, ANTIOXID REDOX SIGN, V10, P1515, DOI 10.1089/ars.2008.2055; Trifonov EN, 2004, J BIOMOL STRUCT DYN, V22, P1; Tu BP, 2004, J CELL BIOL, V164, P341, DOI 10.1083/jcb.200311055; Weerapana E, 2010, NATURE, V468, P790, DOI 10.1038/nature09472; Winterbourn CC, 1999, FREE RADICAL BIO MED, V27, P322, DOI 10.1016/S0891-5849(99)00051-9; Winterbourn CC, 2008, FREE RADICAL BIO MED, V45, P549, DOI 10.1016/j.freeradbiomed.2008.05.004; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Wu H, 2007, BIOCHEM BIOPH RES CO, V362, P233, DOI 10.1016/j.bbrc.2007.07.141; Xu XM, 2010, P NATL ACAD SCI USA, V107, P21430, DOI 10.1073/pnas.1009947107; Yang GD, 2004, FASEB J, V18, P1782, DOI 10.1096/fj.04-2279fje; Zanardo RCO, 2006, FASEB J, V20, P2118, DOI 10.1096/fj.06-6270fje; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325; Zhang Y, 2005, J BIOL CHEM, V280, P20740, DOI 10.1074/jbc.M501458200	71	180	180	3	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4419	4425		10.1074/jbc.R111.275578	http://dx.doi.org/10.1074/jbc.R111.275578			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22157013	hybrid, Green Published			2022-12-27	WOS:000300608500005
J	Migueleti, DLS; Smetana, JHC; Nunes, HF; Kobarg, J; Zanchin, NIT				Migueleti, Deivid L. S.; Smetana, Juliana H. C.; Nunes, Hugo F.; Kobarg, Joerg; Zanchin, Nilson I. T.			Identification and Characterization of an Alternatively Spliced Isoform of the Human Protein Phosphatase 2A alpha Catalytic Subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E3 UBIQUITIN LIGASE; TUMOR-SUPPRESSOR; ALPHA4 PROTEIN; 2A; PP2A; REGULATOR; DOCKING; HOLOENZYME; CLUSPRO; STABILITY	PP2A is the main serine/threonine-specific phosphatase in animal cells. The active phosphatase has been described as a holoenzyme consisting of a catalytic, a scaffolding, and a variable regulatory subunit, all encoded by multiple genes, allowing for the assembly of more than 70 different holoenzymes. The catalytic subunit can also interact with alpha 4, TIPRL (TIP41, TOR signaling pathway regulator-like), the methyl-transferase LCMT-1, and the methyl-esterase PME-1. Here, we report that the gene encoding the catalytic subunit PP2Ac alpha can generate two mRNA types, the standard mRNA and a shorter isoform, lacking exon 5, which we termed PP2Ac alpha 2. Higher levels of the PP2Ac alpha 2 mRNA, equivalent to the level of the longer PP2Ac alpha mRNA, were detected in peripheral blood mononuclear cells that were left to rest for 24 h. After this time, the peripheral blood mononuclear cells are still viable and the PP2Ac alpha 2 mRNA decreases soon after they are transferred to culture medium, showing that generation of the shorter isoform depends on the incubation conditions. FLAG-tagged PP2Ac alpha 2 expressed in HEK293 is catalytically inactive. It displays a specific interaction profile with enhanced binding to the alpha 4 regulatory subunit, but no binding to the scaffolding subunit and PME-1. Consistently, alpha 4 out-competes PME-1 and LCMT-1 for binding to both PP2Ac alpha isoforms in pulldown assays. Together with molecular modeling studies, this suggests that all three regulators share a common binding surface on the catalytic sub-unit. Our findings add important new insights into the complex mechanisms of PP2A regulation.	[Migueleti, Deivid L. S.; Smetana, Juliana H. C.; Kobarg, Joerg] Ctr Nacl Pesquisa Energia & Mat, Lab Nacl Biociencias, BR-13084971 Campinas, SP, Brazil; [Migueleti, Deivid L. S.; Kobarg, Joerg] Univ Estadual Campinas, Inst Biol, BR-13083875 Campinas, SP, Brazil; [Nunes, Hugo F.; Zanchin, Nilson I. T.] Univ Estadual Campinas, Ctr Biol Mol Engn Genet, BR-13083875 Campinas, SP, Brazil; [Zanchin, Nilson I. T.] Fdn Inst Oswaldo Cruz, Inst Carlos Chagas, BR-81350010 Curitiba, Parana, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Estadual de Campinas; Fundacao Oswaldo Cruz	Kobarg, J (corresponding author), Ctr Nacl Pesquisa Energia & Mat, Lab Nacl Biociencias, Rua Giuseppe Maximo Scolfaro 10-000,CP 6192, BR-13084971 Campinas, SP, Brazil.	jorg.kobarg@lnbio.org.br; nilson.zanchin@pq.cnpq.br	Kobarg, Jörg/T-4736-2019; Smetana, Juliana/J-5354-2013; Freire, Hugo/AAD-2936-2019; Zanchin, Nilson Ivo Tonin/AAB-4907-2019; Smetana, Juliana/D-8683-2012	Kobarg, Jörg/0000-0002-9419-0145; Smetana, Juliana/0000-0001-9827-7013; Freire, Hugo/0000-0003-0075-4526; Zanchin, Nilson Ivo Tonin/0000-0002-1153-0694; 	Fundacao de Amparo a Pesquisa do Estado Sao Paulo; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Laboratorio Nacional de Biociencias, Centro Nacional de Pesquisa em Energia e Materiais	Fundacao de Amparo a Pesquisa do Estado Sao Paulo; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Laboratorio Nacional de Biociencias, Centro Nacional de Pesquisa em Energia e Materiais	This work was supported by Fundacao de Amparo a Pesquisa do Estado Sao Paulo, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, and Laboratorio Nacional de Biociencias, Centro Nacional de Pesquisa em Energia e Materiais.	Assmann EM, 2006, J BIOL CHEM, V281, P9869, DOI 10.1074/jbc.M513280200; Ausubel FM, 1998, CURRENT PROTOCOLS MO; Chen J, 1998, BIOCHEM BIOPH RES CO, V247, P827, DOI 10.1006/bbrc.1998.8792; Cho US, 2007, NATURE, V445, P53, DOI 10.1038/nature05351; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; Smetana JHC, 2006, BBA-PROTEINS PROTEOM, V1764, P724, DOI 10.1016/j.bbapap.2006.01.018; DeLano W.L, PYMOL MOL GRAPHICS S; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; Goldberg Y, 1999, BIOCHEM PHARMACOL, V57, P321, DOI 10.1016/S0006-2952(98)00245-7; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Junttila MR, 2007, CELL, V130, P51, DOI 10.1016/j.cell.2007.04.044; Kickstein E, 2010, P NATL ACAD SCI USA, V107, P21830, DOI 10.1073/pnas.0912793107; Kloeker S, 2003, PROTEIN EXPRES PURIF, V31, P19, DOI 10.1016/S1046-5928(03)00141-4; Kong M, 2004, SCIENCE, V306, P695, DOI 10.1126/science.1100537; Kong M, 2009, MOL CELL, V36, P51, DOI 10.1016/j.molcel.2009.09.025; Kozakov D, 2006, PROTEINS, V65, P392, DOI 10.1002/prot.21117; Kozakov D, 2010, PROTEINS, V78, P3124, DOI 10.1002/prot.22835; LeNoue-Newton M, 2011, J BIOL CHEM, V286, P17665, DOI 10.1074/jbc.M111.222414; Lizotte DL, 2008, J CELL BIOCHEM, V103, P1309, DOI 10.1002/jcb.21514; McConnell JL, 2007, ONCOGENE, V26, P6021, DOI 10.1038/sj.onc.1210406; McConnell JL, 2010, BIOCHEMISTRY-US, V49, P1713, DOI 10.1021/bi901837h; McDonald WJ, 2010, J CELL BIOCHEM, V110, P1123, DOI 10.1002/jcb.22624; Mumby M, 2007, CELL, V130, P21, DOI 10.1016/j.cell.2007.06.034; Prickett TD, 2004, J BIOL CHEM, V279, P38912, DOI 10.1074/jbc.M401444200; Smetana JHC, 2007, FEBS J, V274, P5891, DOI 10.1111/j.1742-4658.2007.06112.x; Stanevich V, 2011, MOL CELL, V41, P331, DOI 10.1016/j.molcel.2010.12.030; Van Hoof C, 2004, CANCER CELL, V5, P105, DOI 10.1016/S1535-6108(04)00027-3; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Xing YN, 2008, CELL, V133, P154, DOI 10.1016/j.cell.2008.02.041; Xu YH, 2008, MOL CELL, V31, P873, DOI 10.1016/j.molcel.2008.08.006; Xu YH, 2006, CELL, V127, P1239, DOI 10.1016/j.cell.2006.11.033; Zolnierowicz S, 2000, BIOCHEM PHARMACOL, V60, P1225, DOI 10.1016/S0006-2952(00)00424-X	33	8	11	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4853	4862		10.1074/jbc.M111.283341	http://dx.doi.org/10.1074/jbc.M111.283341			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22167190	Green Published, hybrid			2022-12-27	WOS:000300608500046
J	Rudloff, I; Bachmann, M; Pfeilschifter, J; Muhl, H				Rudloff, Ina; Bachmann, Malte; Pfeilschifter, Josef; Muehl, Heiko			Mechanisms of Rapid Induction of Interleukin-22 in Activated T Cells and Its Modulation by Cyclosporin A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE-SYNTHASE; PROINFLAMMATORY GENE-EXPRESSION; PROTEIN-KINASE-C; KAPPA-B KINASE; HOST-DEFENSE; TRANSCRIPTIONAL REGULATION; HUMAN KERATINOCYTES; SKIN INFLAMMATION; EPITHELIAL-CELLS; IL-2 PROMOTER	IL-22 is an immunoregulatory cytokine displaying pathological functions in models of autoimmunity like experimental psoriasis. Understanding molecular mechanisms driving IL-22, together with knowledge on the capacity of current immunosuppressive drugs to target this process, may open an avenue to novel therapeutic options. Here, we sought to characterize regulation of human IL22 gene expression with focus on the established model of Jurkat T cells. Moreover, effects of the prototypic immunosuppressant cyclosporin A (CsA) were investigated. We report that IL-22 induction by TPA/A23187 (T/A) or alpha CD3 is inhibited by CsA or related FK506. Similar data were obtained with peripheral blood mononuclear cells or purified CD3(+) T cells. IL22 promoter analysis (-1074 to +156 bp) revealed a role of an NF-AT (-95/-91 nt) and a CREB (-194/-190 nt) binding site for gene induction. Indeed, binding of CREB and NF-ATc2, but not c-Rel, under the influence of T/A to those elements could be proven by ChIP. Because CsA has the capability to impair I kappa B kinase (IKK) complex activation, the IKK alpha/beta inhibitor IKKVII was evaluated. IKKVII likewise reduced IL-22 induction in Jurkat cells and peripheral blood mononuclear cells. Interestingly, transfection of Jurkat cells with siRNA directed against IKK alpha impaired IL22 gene expression. Data presented suggest that NF-AT, CREB, and IKK alpha contribute to rapid IL22 gene induction. In particular the crucial role of NF-AT detected herein may form the basis of direct action of CsA on IL-22 expression by T cells, which may contribute to therapeutic efficacy of the drug in autoimmunity.	[Rudloff, Ina; Bachmann, Malte; Pfeilschifter, Josef; Muehl, Heiko] Univ Hosp Goethe Univ Frankfurt, Pharmazentrum Frankfurt, Zentrum Arzneimittelforsch Entwicklung & Sicherhe, D-60590 Frankfurt, Germany; [Rudloff, Ina; Bachmann, Malte; Pfeilschifter, Josef; Muehl, Heiko] Univ Hosp Goethe Univ Frankfurt, Pharmazentrum Frankfurt, Zentrum Arzneimittelforsch Entwicklung & Sicherhe, D-60590 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Muhl, H (corresponding author), Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	H.Muehl@em.uni-frankfurt.de	Rudloff, Ina/I-7085-2013; Rudloff, Ina/P-4222-2019	Rudloff, Ina/0000-0002-7885-110X; Rudloff, Ina/0000-0002-7885-110X	Deutsche Forschungsgemeinschaft (DFG) [GRK1172]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA023187] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by Deutsche Forschungsgemeinschaft (DFG) Grant GRK1172, Biologicals.	Al-Daraji WI, 2002, J INVEST DERMATOL, V118, P779, DOI 10.1046/j.1523-1747.2002.01709.x; Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Bachmann M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001144; Bamberger AM, 1997, MOL CELL ENDOCRINOL, V127, P71, DOI 10.1016/S0303-7207(96)03991-3; Blaschitz C, 2010, J CLIN IMMUNOL, V30, P196, DOI 10.1007/s10875-010-9368-7; Boniface K, 2007, CLIN EXP IMMUNOL, V150, P407, DOI 10.1111/j.1365-2249.2007.03511.x; Boniface K, 2005, J IMMUNOL, V174, P3695, DOI 10.4049/jimmunol.174.6.3695; Brand S, 2006, AM J PHYSIOL-GASTR L, V290, pG827, DOI 10.1152/ajpgi.00513.2005; Duhen T, 2009, NAT IMMUNOL, V10, P857, DOI 10.1038/ni.1767; Dumoutier L, 2000, P NATL ACAD SCI USA, V97, P10144, DOI 10.1073/pnas.170291697; Dumoutier L, 2000, GENES IMMUN, V1, P488, DOI 10.1038/sj.gene.6363716; FRANTZ B, 1994, EMBO J, V13, P861, DOI 10.1002/j.1460-2075.1994.tb06329.x; Gaffen SL, 2008, CYTOKINE, V43, P402, DOI 10.1016/j.cyto.2008.07.017; Geboes L, 2009, ARTHRITIS RHEUM-US, V60, P390, DOI 10.1002/art.24220; GRANELLIPIPERNO A, 1991, J IMMUNOL, V147, P2734; Haider AS, 2008, J IMMUNOL, V180, P1913, DOI 10.4049/jimmunol.180.3.1913; Hamalainen M, 2009, INT IMMUNOPHARMACOL, V9, P159, DOI 10.1016/j.intimp.2008.07.012; Hoegl S, 2011, AM J RESP CELL MOL, V44, P369, DOI 10.1165/rcmb.2009-0440OC; Israel A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000158; Kempiak SJ, 1999, J IMMUNOL, V162, P3176; LEDBETTER JA, 1987, MOL CELL BIOL, V7, P650, DOI 10.1128/MCB.7.2.650; Li L, 2011, J EXP MED, V208, P787, DOI 10.1084/jem.20091346; Liu XKK, 2004, J BIOL CHEM, V279, P52762, DOI 10.1074/jbc.M405764200; Liu Y, 2009, EUR J IMMUNOL, V39, P1472, DOI 10.1002/eji.200838811; Louten J, 2009, J ALLERGY CLIN IMMUN, V123, P1004, DOI 10.1016/j.jaci.2009.04.003; Ma CS, 2008, J EXP MED, V205, P1551, DOI 10.1084/jem.20080218; Ma HL, 2008, J CLIN INVEST, V118, P597, DOI 10.1172/JCI33263; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Maza A, 2011, J EUR ACAD DERMATOL, V25, P19, DOI 10.1111/j.1468-3083.2011.03992.x; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; Mosenden R, 2011, CELL SIGNAL, V23, P1009, DOI 10.1016/j.cellsig.2010.11.018; Muhl H, 2011, CELL MICROBIOL, V13, P340, DOI 10.1111/j.1462-5822.2010.01559.x; Muller MR, 2010, NAT REV IMMUNOL, V10, P645, DOI 10.1038/nri2818; MUHL H, 1993, EUR J PHARMACOL, V249, P95, DOI 10.1016/0014-2999(93)90666-6; Nograles KE, 2008, BRIT J DERMATOL, V159, P1092, DOI 10.1111/j.1365-2133.2008.08769.x; Nograles KE, 2009, J ALLERGY CLIN IMMUN, V123, P1244, DOI 10.1016/j.jaci.2009.03.041; O'Connor W, 2010, NAT IMMUNOL, V11, P471, DOI 10.1038/ni.1882; Palkowitsch L, 2011, J BIOL CHEM, V286, P7522, DOI 10.1074/jbc.M110.155895; PARK JH, 1993, BLOOD, V82, P2470; Pickert G, 2009, J EXP MED, V206, P1465, DOI 10.1084/jem.20082683; Radaeva S, 2004, HEPATOLOGY, V39, P1332, DOI 10.1002/hep.20184; Ramirez JM, 2010, EUR J IMMUNOL, V40, P2450, DOI 10.1002/eji.201040461; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Res PCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014108; Ruan QG, 2009, IMMUNITY, V31, P932, DOI 10.1016/j.immuni.2009.10.006; Sabat R, 2011, J DTSCH DERMATOL GES, V9, P518, DOI 10.1111/j.1610-0387.2011.07611.x; Sadik CD, 2009, NUCLEIC ACIDS RES, V37, P5041, DOI 10.1093/nar/gkp525; Schon MP, 2005, NEW ENGL J MED, V352, P1899, DOI 10.1056/NEJMra041320; Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025; Steinman L, 2007, NAT MED, V13, P139, DOI 10.1038/nm1551; Sugimoto K, 2008, J CLIN INVEST, V118, P534, DOI [10.1172/JC133194, 10.1172/JCI33194]; Trifari S, 2009, NAT IMMUNOL, V10, P864, DOI 10.1038/ni.1770; Trushin SA, 1999, J BIOL CHEM, V274, P22923, DOI 10.1074/jbc.274.33.22923; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Wang XF, 2011, J IMMUNOL, V186, P5791, DOI 10.4049/jimmunol.1002127; Wen AY, 2010, J IMMUNOL, V185, P6413, DOI 10.4049/jimmunol.1001829; Whitehurst CE, 1996, J IMMUNOL, V156, P1020; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Wolk K, 2006, EUR J IMMUNOL, V36, P1309, DOI 10.1002/eji.200535503; Wolk K, 2010, SEMIN IMMUNOPATHOL, V32, P17, DOI 10.1007/s00281-009-0188-x; Wolk K, 2009, EUR J IMMUNOL, V39, P3570, DOI 10.1002/eji.200939687; Xiao GT, 2001, EMBO J, V20, P6805, DOI 10.1093/emboj/20.23.6805; Yadav M, 2008, J IMMUNOL, V180, P2772, DOI 10.4049/jimmunol.180.5.2772; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Ziesche E., 2009, THESIS GOETHE U FRAN; Ziesche E, 2007, J BIOL CHEM, V282, P16006, DOI 10.1074/jbc.M611040200	66	13	14	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4531	4543		10.1074/jbc.M111.286492	http://dx.doi.org/10.1074/jbc.M111.286492			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22170067	Green Published, hybrid			2022-12-27	WOS:000300608500016
J	Koole, C; Wootten, D; Simms, J; Miller, LJ; Christopoulos, A; Sexton, PM				Koole, Cassandra; Wootten, Denise; Simms, John; Miller, Laurence J.; Christopoulos, Arthur; Sexton, Patrick M.			Second Extracellular Loop of Human Glucagon-like Peptide-1 Receptor (GLP-1R) Has a Critical Role in GLP-1 Peptide Binding and Receptor Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED-RECEPTOR; CORTICOTROPIN-RELEASING-FACTOR; PARATHYROID-HORMONE-RECEPTOR; MUSCARINIC ACETYLCHOLINE-RECEPTORS; N-TERMINAL DOMAIN; CRYSTAL-STRUCTURE; LIGAND-BINDING; MOLECULAR RECOGNITION; DETERMINE SPECIFICITY; CRITICAL DETERMINANTS	The glucagon-like peptide-1 receptor (GLP-1R) is a therapeutically important family B G protein-coupled receptor (GPCR) that is pleiotropically coupled to multiple signaling effectors and, with actions including regulation of insulin biosynthesis and secretion, is one of the key targets in the management of type II diabetes mellitus. However, there is limited understanding of the role of the receptor core in orthosteric ligand binding and biological activity. To assess involvement of the extracellular loop (ECL) 2 in ligand-receptor interactions and receptor activation, we performed alanine scanning mutagenesis of loop residues and assessed the impact on receptor expression and GLP-1(1-36)-NH2 or GLP-1(7-36)-NH2 binding and activation of three physiologically relevant signaling pathways as follows: cAMP formation, intracellular Ca2+ (Ca-i(2+)) mobilization, and phosphorylation of extracellular signal-regulated kinases 1 and 2 (pERK1/2). Although antagonist peptide binding was unaltered, almost all mutations affected GLP-1 peptide agonist binding and/or coupling efficacy, indicating an important role in receptor activation. However, mutation of several residues displayed distinct pathway responses with respect to wild type receptor, including Arg-299 and Tyr-305, where mutation significantly enhanced both GLP-1(1-36)-NH2- and GLP-1(7-36)NH2-mediated signaling bias for pERK1/2. In addition, mutation of Cys-296, Trp-297, Asn-300, Asn-302, and Leu-307 significantly increased GLP-1(7-36)-N(H)2-mediated signaling bias toward pERK1/2. Of all mutants studied, only mutation of Trp-306 to alanine abolished all biological activity. These data suggest a critical role of ECL2 of the GLP-1R in the activation transition(s) of the receptor and the importance of this region in the determination of both GLP-1 peptide-and pathway-specific effects.	[Koole, Cassandra; Wootten, Denise; Simms, John; Christopoulos, Arthur; Sexton, Patrick M.] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia; [Koole, Cassandra; Wootten, Denise; Simms, John; Christopoulos, Arthur; Sexton, Patrick M.] Monash Univ, Dept Pharmacol, Parkville, Vic 3052, Australia; [Miller, Laurence J.] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Scottsdale, AZ 85259 USA	Monash University; Monash University; Mayo Clinic; Mayo Clinic Phoenix	Sexton, PM (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, 381 Royal Parade, Parkville, Vic 3052, Australia.	Patrick.Sexton@monash.edu	Sexton, Patrick M/B-1319-2008; Christopoulos, Arthur/B-6207-2013; Wootten, Denise/ABD-5703-2021	Sexton, Patrick M/0000-0001-8902-2473; Christopoulos, Arthur/0000-0003-4442-3294; Wootten, Denise/0000-0003-4563-1642; Simms, John/0000-0002-4675-0902	National Health and Medical Research Council of Australia [1002180, 519461]; National Health and Medical Research Council	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by the National Health and Medical Research Council of Australia Project Grant 1002180 and Program Grant 519461 and by National Health and Medical Research Council Principal Research Fellowship (to P. M. S.) and a Senior Research Fellowship (to A. C.).	ADELHORST K, 1994, J BIOL CHEM, V269, P6275; Ahn KH, 2009, MOL PHARMACOL, V76, P833, DOI 10.1124/mol.109.057356; Ahuja S, 2009, NAT STRUCT MOL BIOL, V16, P168, DOI 10.1038/nsmb.1549; Al-Sabah S, 2003, FEBS LETT, V553, P342, DOI 10.1016/S0014-5793(03)01043-3; Alla SA, 1996, J BIOL CHEM, V271, P1748, DOI 10.1074/jbc.271.3.1748; Assil-Kishawi I, 2002, J BIOL CHEM, V277, P32558, DOI 10.1074/jbc.M204964200; Avlani VA, 2007, J BIOL CHEM, V282, P25677, DOI 10.1074/jbc.M702311200; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Bazarsuren A, 2002, BIOPHYS CHEM, V96, P305, DOI 10.1016/S0301-4622(02)00023-6; Bergwitz C, 1997, J BIOL CHEM, V272, P28861, DOI 10.1074/jbc.272.46.28861; Bergwitz C, 1996, J BIOL CHEM, V271, P26469, DOI 10.1074/jbc.271.43.26469; Bisello A, 1998, J BIOL CHEM, V273, P22498, DOI 10.1074/jbc.273.35.22498; BLACK JW, 1983, PROC R SOC SER B-BIO, V220, P141, DOI 10.1098/rspb.1983.0093; BUGGY JJ, 1995, J BIOL CHEM, V270, P7474, DOI 10.1074/jbc.270.13.7474; Castro M, 2005, P NATL ACAD SCI USA, V102, P16084, DOI 10.1073/pnas.0503942102; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Christopoulos A, 2002, PHARMACOL REV, V54, P323, DOI 10.1124/pr.54.2.323; Conner M, 2007, J BIOL CHEM, V282, P17405, DOI 10.1074/jbc.M702151200; de Maturana RL, 2004, PROTEIN PEPTIDE LETT, V11, P15, DOI 10.2174/0929866043478491; de Maturana RL, 2002, FEBS LETT, V530, P244, DOI 10.1016/S0014-5793(02)03492-0; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; Dong MQ, 2011, BIOCHEMISTRY-US, V50, P2983, DOI 10.1021/bi200133u; Dong MQ, 2004, J BIOL CHEM, V279, P31177, DOI 10.1074/jbc.M404113200; Dong MQ, 2004, J BIOL CHEM, V279, P2894, DOI 10.1074/jbc.M310407200; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Figueroa KW, 2009, J PHARMACOL EXP THER, V328, P331, DOI 10.1124/jpet.108.145219; Gelling RW, 1997, ENDOCRINOLOGY, V138, P2640, DOI 10.1210/en.138.6.2640; Grace CRR, 2007, P NATL ACAD SCI USA, V104, P4858, DOI 10.1073/pnas.0700682104; Grace CRR, 2004, P NATL ACAD SCI USA, V101, P12836, DOI 10.1073/pnas.0404702101; Grauschopf U, 2000, BIOCHEMISTRY-US, V39, P8878, DOI 10.1021/bi0001426; Graziano MP, 1996, RECEPTOR CHANNEL, V4, P9; Gregory KJ, 2010, J BIOL CHEM, V285, P7459, DOI 10.1074/jbc.M109.094011; Harmar AJ, 2009, NUCLEIC ACIDS RES, V37, pD680, DOI 10.1093/nar/gkn728; HJORTH SA, 1994, J BIOL CHEM, V269, P30121; Hoare SRJ, 2005, DRUG DISCOV TODAY, V10, P417, DOI 10.1016/S1359-6446(05)03370-2; Holtmann MH, 1996, J BIOL CHEM, V271, P14944, DOI 10.1074/jbc.271.25.14944; HOLTMANN MH, 1995, J BIOL CHEM, V270, P14394, DOI 10.1074/jbc.270.24.14394; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Klinger S, 2008, DIABETES, V57, P584, DOI 10.2337/db07-1414; Koole C, 2011, MOL PHARMACOL, V80, P486, DOI 10.1124/mol.111.072884; Koole C, 2010, MOL PHARMACOL, V78, P456, DOI 10.1124/mol.110.065664; Lebesgue D, 1998, EUR J PHARMACOL, V348, P123, DOI 10.1016/S0014-2999(98)00136-8; Liaw CW, 1997, MOL ENDOCRINOL, V11, P980, DOI 10.1210/me.11.7.980; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Mann RJ, 2010, BRIT J PHARMACOL, V160, P1973, DOI 10.1111/j.1476-5381.2010.00834.x; Mann RJ, 2010, PEPTIDES, V31, P2289, DOI 10.1016/j.peptides.2010.09.015; May LT, 2007, MOL PHARMACOL, V72, P463, DOI 10.1124/mol.107.037630; Miller LJ, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.217901; MOJSOV S, 1992, INT J PEPT PROT RES, V40, P333; MontroseRafizadeh C, 1997, J BIOL CHEM, V272, P21201, DOI 10.1074/jbc.272.34.21201; Nicole P, 2000, J BIOL CHEM, V275, P24003, DOI 10.1074/jbc.M002325200; Ott TR, 2002, MOL ENDOCRINOL, V16, P1079, DOI 10.1210/me.16.5.1079; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Parthier C, 2007, P NATL ACAD SCI USA, V104, P13942, DOI 10.1073/pnas.0706404104; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Pioszak AA, 2008, J BIOL CHEM, V283, P32900, DOI 10.1074/jbc.M805749200; Pioszak AA, 2008, P NATL ACAD SCI USA, V105, P5034, DOI 10.1073/pnas.0801027105; Quoyer J, 2010, J BIOL CHEM, V285, P1989, DOI 10.1074/jbc.M109.067207; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; Runge S, 2003, BRIT J PHARMACOL, V138, P787, DOI 10.1038/sj.bjp.0705120; Runge S, 2003, J BIOL CHEM, V278, P28005, DOI 10.1074/jbc.M301085200; Runge S, 2008, J BIOL CHEM, V283, P11340, DOI 10.1074/jbc.M708740200; Scarselli M, 2007, J BIOL CHEM, V282, P7385, DOI 10.1074/jbc.M610394200; SEGREST JP, 1990, PROTEINS, V8, P103, DOI 10.1002/prot.340080202; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Shi L, 2004, P NATL ACAD SCI USA, V101, P440, DOI 10.1073/pnas.2237265100; Shimamura T, 2011, NATURE, V475, P65, DOI 10.1038/nature10236; Underwood CR, 2010, J BIOL CHEM, V285, P723, DOI 10.1074/jbc.M109.033829; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Werry TD, 2005, J NEUROCHEM, V93, P1603, DOI 10.1111/j.1471-4159.2005.03161.x; Wilmen A, 1996, FEBS LETT, V398, P43, DOI 10.1016/S0014-5793(96)01214-8; Wilmen A, 1997, PEPTIDES, V18, P301, DOI 10.1016/S0196-9781(96)00321-X; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Xiao Q, 2000, J MOL ENDOCRINOL, V25, P321, DOI 10.1677/jme.0.0250321	80	69	69	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					3642	3658		10.1074/jbc.M111.309328	http://dx.doi.org/10.1074/jbc.M111.309328			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22147710	Green Published, hybrid, Green Accepted			2022-12-27	WOS:000300410900004
J	Sevrioukova, IF; Poulos, TL				Sevrioukova, Irina F.; Poulos, Thomas L.			Structural and Mechanistic Insights into the Interaction of Cytochrome P4503A4 with Bromoergocryptine, a Type I Ligand	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-BINDING; 3A4; COOPERATIVITY; BROMOCRIPTINE; HYDROXYLATION; RECOGNITION; DISPOSITION; ACTIVATION; OXIDATION; ANIMALS	Cytochrome P4503A4 (CYP3A4), a major human drug-metabolizing enzyme, is responsible for the oxidation and clearance of the majority of administered drugs. One of the CYP3A4 substrates is bromoergocryptine (BEC), a dopamine receptor agonist prescribed for the inhibition of prolactin secretion and treatment of Parkinson disease, type 2 diabetes, and several other pathological conditions. Here we present a 2.15 angstrom crystal structure of the CYP3A4-BEC complex in which the drug, a type I heme ligand, is bound in a productive mode. The manner of BEC binding is consistent with the in vivo metabolite analysis and identifies the 8' and 9' carbons of the proline ring as the primary sites of oxidation. The crystal structure predicts the importance of Arg(212) and Thr(224) for binding of the tripeptide and lysergic moieties of BEC, respectively, which we confirmed experimentally. Our data support a three-step BEC binding model according to which the drug binds first at a peripheral site without perturbing the heme spectrum and then translocates into the active site cavity, where formation of a hydrogen bond between Thr(224) and the N1 atom of the lysergic moiety is followed by a slower conformational readjustment of the tripeptide group modulated by Arg(212).	[Sevrioukova, Irina F.; Poulos, Thomas L.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; [Poulos, Thomas L.] Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA; [Poulos, Thomas L.] Univ Calif Irvine, Dept Pharmaceut Sci, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Sevrioukova, IF (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA.	sevrioui@uci.edu			National Institutes of Health [GM33688]; Gilead Sciences, Inc.; California Center for Antiviral Drug Discovery; Department of Energy, Office of Biological and Environmental Research; National Institutes of Health, National Center for Research Resources (NCRR); National Institute of General Medical Sciences (NIGMS); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033688] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gilead Sciences, Inc.(Gilead Sciences); California Center for Antiviral Drug Discovery; Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM33688. This study was also supported by Gilead Sciences, Inc. and the California Center for Antiviral Drug Discovery.; Research was carried out at the Stanford Synchrotron Radiation Laboratory (SSRL), a national user facility operated by Stanford University on behalf of the U.S. Department of Energy, Office of Basic Energy Sciences. The SSRL Structural Molecular Biology Program is supported by the Department of Energy, Office of Biological and Environmental Research and by the National Institutes of Health, National Center for Research Resources (NCRR) Biomedical Technology Program and the National Institute of General Medical Sciences (NIGMS).	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Das A, 2007, J AM CHEM SOC, V129, P13778, DOI 10.1021/ja074864x; Davydov DR, 2007, BIOCHEMISTRY-US, V46, P7852, DOI 10.1021/bi602400y; Davydov DR, 2003, BIOCHEM BIOPH RES CO, V312, P121, DOI 10.1016/j.bbrc.2003.09.247; Denisov IG, 2007, J BIOL CHEM, V282, P7066, DOI 10.1074/jbc.M609589200; Ekroos M, 2006, P NATL ACAD SCI USA, V103, P13682, DOI 10.1073/pnas.0603236103; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fernando H, 2006, BIOCHEMISTRY-US, V45, P4199, DOI 10.1021/bi052491b; Fishelovitch D, 2007, J AM CHEM SOC, V129, P1602, DOI 10.1021/ja066007j; Guengerich FP, 1998, DRUG METAB DISPOS, V26, P1175; Harlow GR, 1997, J BIOL CHEM, V272, P5396, DOI 10.1074/jbc.272.9.5396; Harlow GR, 1998, P NATL ACAD SCI USA, V95, P6636, DOI 10.1073/pnas.95.12.6636; He Y. A., 2009, 16 INT C CYT P450 OK, P91; Hendlich M, 1997, J MOL GRAPH MODEL, V15, P359, DOI 10.1016/S1093-3263(98)00002-3; Hosea NA, 1998, ARCH BIOCHEM BIOPHYS, V353, P365, DOI 10.1006/abbi.1998.0659; Isin EM, 2006, J BIOL CHEM, V281, P9127, DOI 10.1074/jbc.M511375200; Mak PJ, 2011, J AM CHEM SOC, V133, P1357, DOI 10.1021/ja105869p; MAURER G, 1982, EUR J DRUG METAB PH, V7, P281, DOI 10.1007/BF03189631; MAURER G, 1983, EUR J DRUG METAB PH, V8, P51, DOI 10.1007/BF03189581; Nath A, 2007, J BIOL CHEM, V282, P28309, DOI 10.1074/jbc.M703568200; Niwa T, 2008, CURR DRUG METAB, V9, P453, DOI 10.2174/138920008784746364; PEYRONNEAU MA, 1994, EUR J BIOCHEM, V223, P947, DOI 10.1111/j.1432-1033.1994.tb19072.x; Renaud JP, 1996, BIOCHEM J, V319, P675, DOI 10.1042/bj3190675; Scott EE, 2005, TRENDS BIOCHEM SCI, V30, P5, DOI 10.1016/j.tibs.2004.11.004; Sevrioukova IF, 2010, P NATL ACAD SCI USA, V107, P18422, DOI 10.1073/pnas.1010693107; Sono M, 1996, CHEM REV, V96, P2841, DOI 10.1021/cr9500500; Szklarz GD, 1998, DRUG METAB DISPOS, V26, P1179; Ueng YF, 1997, BIOCHEMISTRY-US, V36, P370, DOI 10.1021/bi962359z; Viner RL, 1995, BIOCHEM BIOPH RES CO, V217, P886, DOI 10.1006/bbrc.1995.2854; Williams PA, 2004, SCIENCE, V305, P683, DOI 10.1126/science.1099736; Wrighton SA, 2000, DRUG METAB REV, V32, P339, DOI 10.1081/DMR-100102338; Yano JK, 2004, J BIOL CHEM, V279, P38091, DOI 10.1074/jbc.C400293200	32	92	95	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3510	3517		10.1074/jbc.M111.317081	http://dx.doi.org/10.1074/jbc.M111.317081			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22157006	Green Published, hybrid			2022-12-27	WOS:000300295100055
J	Garcin, EB; Bornet, O; Elantak, L; Vita, N; Pieulle, L; Guerlesquin, F; Sebban-Kreuzer, C				Garcin, Edwige B.; Bornet, Olivier; Elantak, Latifa; Vita, Nicolas; Pieulle, Laetitia; Guerlesquin, Francoise; Sebban-Kreuzer, Corinne			Structural and Mechanistic Insights into Unusual Thiol Disulfide Oxidoreductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI THIOREDOXIN; ACTIVE-SITE; CHEMICAL-SHIFT; PROTEIN; ISOMERASE; DSBA; REDUCTION; GLUTAREDOXINS; MIMICKING; CATALYSIS	Cytoplasmic desulfothioredoxin (Dtrx) from the anaerobe Desulfovibrio vulgaris Hildenborough has been identified as a new member of the thiol disulfide oxidoreductase family. The active site of Dtrx contains a particular consensus sequence, CPHC, never seen in the cytoplasmic thioredoxins and generally found in periplasmic oxidases. Unlike canonical thioredoxins (Trx), Dtrx does not present any disulfide reductase activity, but it presents instead an unusual disulfide isomerase activity. We have used NMR spectroscopy to gain insights into the structure and the catalytic mechanism of this unusual Dtrx. The redox potential of Dtrx (-181 mV) is significantly less reducing than that of canonical Trx. A pH dependence study allowed the determination of the pK(a) of all protonable residues, including the cysteine and histidine residues. Thus, the pKa values for the thiol group of Cys(31) and Cys(34) are 4.8 and 11.3, respectively. The His(33) pK(a) value, experimentally determined for the first time, differs notably as a function of the redox states, 7.2 for the reduced state and 4.6 for the oxidized state. These data suggest an important role for His(33) in the molecular mechanism of Dtrx catalysis that is confirmed by the properties of mutant DtrxH33G protein. The NMR structure of Dtrx shows a different charge repartition compared with canonical Trx. The results presented are likely indicative of the involvement of this protein in the catalysis of substrates specific of the anaerobe cytoplasm of DvH. The study of Dtrx is an important step toward revealing the molecular details of the thiol-disulfide oxidoreductase catalytic mechanism.	[Garcin, Edwige B.; Bornet, Olivier; Elantak, Latifa; Vita, Nicolas; Pieulle, Laetitia; Guerlesquin, Francoise; Sebban-Kreuzer, Corinne] Aix Marseille Univ, CNRS, IFR88, IMR, F-13402 Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Sebban-Kreuzer, C (corresponding author), Aix Marseille Univ, CNRS, IFR88, IMR, F-13402 Marseille, France.	Corinne.kreuzer@ifr88.cnrs-mrs.fr	ELANTAK, Latifa/S-7004-2019	garcin, edwige b./0000-0002-0533-6940				Aslund F, 1997, J BIOL CHEM, V272, P30780, DOI 10.1074/jbc.272.49.30780; Bertini I, 2006, J BIOMOL NMR, V36, P111, DOI 10.1007/s10858-006-9068-z; Capitani G, 2001, J MOL BIOL, V311, P1037, DOI 10.1006/jmbi.2001.4913; Carvalho ATP, 2008, J PHYS CHEM B, V112, P2511, DOI 10.1021/jp7104665; Carvalho ATP, 2006, J COMPUT CHEM, V27, P966, DOI 10.1002/jcc.20404; Chambers JE, 2010, J BIOL CHEM, V285, P29200, DOI 10.1074/jbc.M110.156596; Chivers PT, 1997, BIOCHEMISTRY-US, V36, P15810, DOI 10.1021/bi971504l; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Fernandes AP, 2004, ANTIOXID REDOX SIGN, V6, P63, DOI 10.1089/152308604771978354; Garcin EB, 2010, BIOMOL NMR ASSIGN, V4, P135, DOI 10.1007/s12104-010-9226-9; GRAUSCHOPF U, 1995, CELL, V83, P947, DOI 10.1016/0092-8674(95)90210-4; Guddat LW, 1997, PROTEIN SCI, V6, P1893, DOI 10.1002/pro.5560060910; HILLSON DA, 1984, METHOD ENZYMOL, V107, P281; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; HOLMGREN A, 1995, METHOD ENZYMOL, V252, P199; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; Huber D, 2005, P NATL ACAD SCI USA, V102, P18872, DOI 10.1073/pnas.0509583102; Jeng MF, 1996, BIOCHEMISTRY-US, V35, P1, DOI 10.1021/bi952404n; JENG MF, 1995, BIOCHEMISTRY-US, V34, P10101, DOI 10.1021/bi00032a001; Kadokura H, 2010, ANTIOXID REDOX SIGN, V13, P1231, DOI 10.1089/ars.2010.3187; Keller R. L. J, 2004, CANTINA; Kersteen EA, 2003, ANTIOXID REDOX SIGN, V5, P413, DOI 10.1089/152308603768295159; KRAUSE G, 1991, J BIOL CHEM, V266, P9494; Ladenstein R, 2006, FEBS J, V273, P4170, DOI 10.1111/j.1742-4658.2006.05421.x; Lundstrom J., 1993, BIOCHEMISTRY-US, V32, P6649; MARTIN JL, 1995, STRUCTURE, V3, P245, DOI 10.1016/S0969-2126(01)00154-X; Mossner E, 1998, PROTEIN SCI, V7, P1233; Pieulle L, 2011, J BIOL CHEM, V286, P7812, DOI 10.1074/jbc.M110.197988; Quan S, 2007, J BIOL CHEM, V282, P28823, DOI 10.1074/jbc.M705291200; Rietsch A, 1998, ANNU REV GENET, V32, P163, DOI 10.1146/annurev.genet.32.1.163; Rinaldi FC, 2009, BIOCHEMISTRY-US, V48, P3508, DOI 10.1021/bi801899x; Roos G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000461; Shouldice SR, 2010, MOL MICROBIOL, V75, P13, DOI 10.1111/j.1365-2958.2009.06952.x; WUNDERLICH M, 1993, PROTEIN SCI, V2, P717, DOI 10.1002/pro.5560020503; Xu YL, 2008, APPL MICROBIOL BIOT, V81, P79, DOI 10.1007/s00253-008-1644-6	35	3	3	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					1688	1697		10.1074/jbc.M111.288316	http://dx.doi.org/10.1074/jbc.M111.288316			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22128175	Green Published, hybrid			2022-12-27	WOS:000299321000012
J	Ho, KK; McGuire, VA; Koo, CY; Muir, KW; de Olano, N; Maifoshie, E; Kelly, DJ; McGovern, UB; Monteiro, LJ; Gomes, AR; Nebreda, AR; Campbell, DG; Arthur, JSC; Lam, EWF				Ho, Ka-Kei; McGuire, Victoria A.; Koo, Chuay-Yeng; Muir, Kyle W.; de Olano, Natalia; Maifoshie, Evie; Kelly, Douglas J.; McGovern, Ursula B.; Monteiro, Lara J.; Gomes, Ana R.; Nebreda, Angel R.; Campbell, David G.; Arthur, J. Simon C.; Lam, Eric W. -F.			Phosphorylation of FOXO3a on Ser-7 by p38 Promotes Its Nuclear Localization in Response to Doxorubicin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR FOXO3A; BREAST-CANCER CELLS; MAP KINASE; INDUCED ACTIVATION; INDUCED APOPTOSIS; FOXM1 EXPRESSION; GEFITINIB IRESSA; GENE-EXPRESSION; TARGET; STRESS	FOXO3a is a forkhead transcription factor that regulates a multitude of important cellular processes, including proliferation, apoptosis, differentiation, and metabolism. Doxorubicin treatment of MCF-7 breast carcinoma cells results in FOXO3a nuclear relocation and the induction of the stress-activated kinase p38 MAPK. Here, we studied the potential regulation of FOXO3a by p38 in response to doxorubicin. Co-immunoprecipitation studies in MCF-7 cells demonstrated a direct interaction between p38 and FOXO3a. We also showed that p38 can bind and phosphorylate a recombinant FOXO3a directly in vitro. HPLC-coupled phosphopeptide mapping and mass spectrometric analyses identified serine 7 as a major site for p38 phosphorylation. Using a phosphorylated Ser-7 FOXO3a antibody, we demonstrated that FOXO3a is phosphorylated on Ser-7 in response to doxorubicin. Immunofluorescence staining studies showed that upon doxorubicin treatment, the wild-type FOXO3a relocalized to the nucleus, whereas the phosphorylation-defective FOXO3a (Ala-7) mutant remained largely in the cytoplasm. Treatment with SB202190 also inhibits the doxorubicin-induced FOXO3a Ser-7 phosphorylation and nuclear accumulation in MCF-7 cells. In addition, doxorubicin caused the nuclear translocation of FOXO3a in wild-type but not p38-depleted mouse fibroblasts. Together, our results suggest that p38 phosphorylation of FOXO3a on Ser-7 is essential for its nuclear relocalization in response to doxorubicin.	[Ho, Ka-Kei; Koo, Chuay-Yeng; Muir, Kyle W.; de Olano, Natalia; Maifoshie, Evie; Kelly, Douglas J.; McGovern, Ursula B.; Monteiro, Lara J.; Gomes, Ana R.; Lam, Eric W. -F.] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London W12 0NN, England; [McGuire, Victoria A.; Campbell, David G.; Arthur, J. Simon C.] Univ Dundee, Med Res Council Prot Phosphorylat Unit, Sch Life Sci, Dundee DD1 5EH, Scotland; [Kelly, Douglas J.] Univ London Imperial Coll Sci Technol & Med, Dept Phys, London SW7 2AZ, England; [Nebreda, Angel R.] Inst Catalana Recerca & Estudis Avancats, Barcelona 08028, Spain; [Nebreda, Angel R.] Inst Res Biomed IRB Barcelona, Barcelona 08028, Spain	Imperial College London; University of Dundee; Imperial College London; ICREA; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona	Lam, EWF (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, MRC Cyclotron Bldg,Hammersmith Hosp Campus,Du Can, London W12 0NN, England.	eric.lam@imperial.ac.uk	Nebreda, Angel Rodriguez/R-9594-2019; Lam, Eric W-F/AAW-8566-2020; Campbell, David G/K-1874-2015; Arthur, J. Simon/B-8058-2010; McGuire, Victoria/AAG-1953-2019; Monteiro, Lara J/AAU-8518-2020	Lam, Eric W-F/0000-0003-1274-3576; Campbell, David G/0000-0003-2278-2149; Arthur, J. Simon/0000-0002-8135-1958; McGuire, Victoria/0000-0002-7808-3278; Muir, Kyle/0000-0002-0294-5679; Koo, Chuay Yeng/0000-0002-9495-0554	Cancer Research UK; Breast Cancer Campaign; Engineering and Physical Sciences Research Council; Imperial College Healthcare NHS Trust-BRC; ICREA Funding Source: Custom; MRC [G1100713, MC_U127081014] Funding Source: UKRI; Cancer Research UK [12011] Funding Source: researchfish; Medical Research Council [MC_U127081014, G1100713] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Breast Cancer Campaign; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Imperial College Healthcare NHS Trust-BRC; ICREA(ICREA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by funds from Cancer Research UK (to K.K.H. and E.W.-F.L.), the Breast Cancer Campaign (to E.W.-F.L.), the Engineering and Physical Sciences Research Council (to D.J.K.), and Imperial College Healthcare NHS Trust-BRC Funding (to C.-Y.K.).	Ambrosino C, 2001, BIOL CELL, V93, P47, DOI 10.1016/S0248-4900(01)01124-8; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Boronkai A, 2009, EUR J CELL BIOL, V88, P753, DOI 10.1016/j.ejcb.2009.07.005; Brownawell AM, 2001, MOL CELL BIOL, V21, P3534, DOI 10.1128/MCB.21.10.3534-3546.2001; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Bulavin DV, 2004, ADV CANCER RES, V92, P95, DOI 10.1016/S0065-230X(04)92005-2; Bulavin DV, 1999, EMBO J, V18, P6845, DOI 10.1093/emboj/18.23.6845; Cai BB, 2008, APOPTOSIS, V13, P803, DOI 10.1007/s10495-008-0218-5; Campbell David G, 2002, J Biomol Tech, V13, P119; Chen J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012293; Chiacchiera F, 2010, CELL CYCLE, V9, P1091, DOI 10.4161/cc.9.6.11035; Corrado P, 2009, LEUKEMIA, V23, P405, DOI 10.1038/leu.2008.186; Corre S, 2009, J BIOL CHEM, V284, P18851, DOI 10.1074/jbc.M808605200; Coulthard LR, 2009, TRENDS MOL MED, V15, P369, DOI 10.1016/j.molmed.2009.06.005; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; de Mattos SF, 2004, MOL CELL BIOL, V24, P10058, DOI 10.1128/MCB.24.22.10058-10071.2004; de Nadal E, 2010, EMBO J, V29, P4, DOI 10.1038/emboj.2009.346; Deacon K, 2003, MOL BIOL CELL, V14, P2071, DOI 10.1091/mbc.e02-10-0653; Dijkers PF, 2000, MOL CELL BIOL, V20, P9138, DOI 10.1128/MCB.20.24.9138-9148.2000; Dolado I, 2007, CANCER CELL, V11, P191, DOI 10.1016/j.ccr.2006.12.013; Essafi Abdelkader, 2009, V462, P201, DOI 10.1007/978-1-60327-115-8_13; Frescas D, 2005, J BIOL CHEM, V280, P20589, DOI 10.1074/jbc.M412357200; Greer EL, 2007, J BIOL CHEM, V282, P30107, DOI 10.1074/jbc.M705325200; Hallahan AR, 2003, NAT MED, V9, P1033, DOI 10.1038/nm904; Han JH, 2007, TRENDS BIOCHEM SCI, V32, P364, DOI 10.1016/j.tibs.2007.06.007; Haq R, 2002, CANCER RES, V62, P5076; Hildesheim J, 2002, CANCER RES, V62, P7305; Ho KK, 2008, ONCOGENE, V27, P2300, DOI 10.1038/onc.2008.23; Hong SW, 2011, CANCER BIOL THER, V12, P421, DOI 10.4161/cbt.12.5.15972; Hui RCY, 2008, MOL CELL BIOL, V28, P5886, DOI 10.1128/MCB.01265-07; Hui RCY, 2008, MOL CANCER THER, V7, P670, DOI 10.1158/1535-7163.MCT-07-0397; Kaestner KH, 2000, GENE DEV, V14, P142; Kops GJPL, 2002, MOL CELL BIOL, V22, P2025, DOI 10.1128/MCB.22.7.2025-2036.2002; Krol J, 2007, MOL CANCER THER, V6, P3169, DOI 10.1158/1535-7163.MCT-07-0507; Kwok JMM, 2010, MOL CANCER RES, V8, P24, DOI 10.1158/1541-7786.MCR-09-0432; Kwok JMM, 2008, MOL CANCER THER, V7, P2022, DOI 10.1158/1535-7163.MCT-08-0188; Link W, 2009, J BIOL CHEM, V284, P28392, DOI 10.1074/jbc.M109.038984; Losa JH, 2003, ONCOGENE, V22, P3998, DOI 10.1038/sj.onc.1206608; McCubrey JA, 2006, ANTIOXID REDOX SIGN, V8, P1775, DOI 10.1089/ars.2006.8.1775; McGovern UB, 2009, MOL CANCER THER, V8, P582, DOI 10.1158/1535-7163.MCT-08-0805; Millour J, 2011, MOL CANCER THER, V10, P1046, DOI 10.1158/1535-7163.MCT-11-0024; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Myatt SS, 2011, ANTIOXID REDOX SIGN, V14, P675, DOI 10.1089/ars.2010.3383; Nagai H, 2007, J BIOCHEM MOL BIOL, V40, P1; Paradis S, 1998, GENE DEV, V12, P2488, DOI 10.1101/gad.12.16.2488; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Sanchez-Prieto R, 2000, CANCER RES, V60, P2464; Savarese DMF, 1997, J CLIN ONCOL, V15, P2981, DOI 10.1200/JCO.1997.15.8.2981; She QB, 2001, CANCER RES, V61, P1604; Shiota M, 2010, CANCER SCI, V101, P1177, DOI 10.1111/j.1349-7006.2010.01503.x; SINHA BK, 1989, CANCER RES, V49, P3844; St Germain C, 2010, NEOPLASIA, V12, P527, DOI 10.1593/neo.92048; Sunters A, 2006, CANCER RES, V66, P212, DOI 10.1158/0008-5472.CAN-05-1997; Sunters A, 2003, J BIOL CHEM, V278, P49795, DOI 10.1074/jbc.M309523200; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Torres M, 2003, BIOFACTORS, V17, P287, DOI 10.1002/biof.5520170128; Tsai K L, 2001, Health Serv Manage Res, V14, P92, DOI 10.1258/0951484011912582; UBEZIO P, 1994, FREE RADICAL BIO MED, V16, P509, DOI 10.1016/0891-5849(94)90129-5; van der Vos KE, 2011, ANTIOXID REDOX SIGN, V14, P579, DOI 10.1089/ars.2010.3419; Wang XW, 2012, J CELL PHYSIOL, V227, P1168, DOI 10.1002/jcp.22839; Wang XZ, 1996, SCIENCE, V272, P1347, DOI 10.1126/science.272.5266.1347; Wong ST, 2009, PHARMACOTHERAPY, V29, P954, DOI 10.1592/phco.29.8.954; Yang JY, 2008, NAT CELL BIOL, V10, P138, DOI 10.1038/ncb1676; Yang JY, 2009, CLIN CANCER RES, V15, P752, DOI 10.1158/1078-0432.CCR-08-0124	64	93	95	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1545	1555		10.1074/jbc.M111.284224	http://dx.doi.org/10.1074/jbc.M111.284224			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22128155	Green Published, hybrid			2022-12-27	WOS:000299170300068
J	Miroci, H; Schob, C; Kindler, S; Olschlager-Schutt, J; Fehr, S; Jungenitz, T; Schwarzacher, SW; Bagni, C; Mohr, E				Miroci, Hatmone; Schob, Claudia; Kindler, Stefan; Oelschlaeger-Schuett, Janin; Fehr, Susanne; Jungenitz, Tassilo; Schwarzacher, Stephan W.; Bagni, Claudia; Mohr, Evita			Makorin Ring Zinc Finger Protein 1 (MKRN1), a Novel Poly(A)-binding Protein-interacting Protein, Stimulates Translation in Nerve Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLY(A) BINDING-PROTEIN; MESSENGER-RNA LOCALIZATION; SYNAPTIC ACTIVATION CAUSES; LOCAL TRANSLATION; UBIQUITIN LIGASE; STRUCTURAL BASIS; DENTATE GYRUS; EXPRESSION; DENDRITES; DOMAIN	The poly(A)-binding protein (PABP), a key component of different ribonucleoprotein complexes, plays a crucial role in the control of mRNA translation rates, stability, and subcellular targeting. In this study we identify RING zinc finger protein Makorin 1 (MKRN1), a bona fide RNA-binding protein, as a binding partner of PABP that interacts with PABP in an RNA independent manner. In rat brain, a so far uncharacterized short MKRN1 isoform, MKRN1-short, predominates and is detected in forebrain nerve cells. In neuronal dendrites, MKRN1-short co-localizes with PABP in granule-like structures, which are morphological correlates of sites of mRNA metabolism. Moreover, in primary rat neurons MKRN1-short associates with dendritically localized mRNAs. When tethered to a reporter mRNA, MKRN1-short significantly enhances reporter protein synthesis. Furthermore, after induction of synaptic plasticity via electrical stimulation of the perforant path in vivo, MKRN1-short specifically accumulates in the activated dendritic lamina, the middle molecular layer of the hippocampal dentate gyrus. Collectively, these data indicate that in mammalian neurons MKRN1-short interacts with PABP to locally control the translation of dendritic mRNAs at synapses.	[Miroci, Hatmone; Mohr, Evita] Univ Med Ctr Hamburg Eppendorf, Inst Neuroanat, D-20246 Hamburg, Germany; [Schob, Claudia; Kindler, Stefan; Oelschlaeger-Schuett, Janin] Univ Med Ctr Hamburg Eppendorf, Inst Human Genet, D-20246 Hamburg, Germany; [Fehr, Susanne] Univ Med Ctr Hamburg Eppendorf, Ctr Mol Neurobiol, D-20251 Hamburg, Germany; [Jungenitz, Tassilo; Schwarzacher, Stephan W.] Goethe Univ Frankfurt, Dept Clin Neuroanat, D-60590 Frankfurt, Germany; [Bagni, Claudia] Catholic Univ Louvain VIB, Dept Dev Genet, B-3000 Louvain, Belgium; [Bagni, Claudia] Univ Rome, Dipartimento Med Sperimentale & Sci Biochem, I-00133 Rome, Italy	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Goethe University Frankfurt; Flanders Institute for Biotechnology (VIB); Sapienza University Rome	Mohr, E (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Neuroanat, D-20246 Hamburg, Germany.	emohr@uke.uni-hamburg.de		Bagni, Claudia/0000-0002-4419-210X; Jungenitz, Tassilo/0000-0001-7291-8548	Deutsche Forschungsgemeinschaft [DFG/GRK-336, Ki488/2-6, KR1321/4-1]; Fritz Thyssen Stiftung [Az. 10.05.2.185]; National Ataxia Foundation; Werner Otto Stiftung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fritz Thyssen Stiftung; National Ataxia Foundation; Werner Otto Stiftung	This work was supported by Grants of the Deutsche Forschungsgemeinschaft DFG/GRK-336 (to E. M.), Ki488/2-6 (to S. K.), and KR1321/4-1 (to S. K)., the Fritz Thyssen Stiftung (Az. 10.05.2.185 (to S. K.), the National Ataxia Foundation (to S. K.), and the Werner Otto Stiftung (to C. S.). This work forms part of the thesis of H. Miroci, Faculty of Biology (University of Hamburg, Germany).	Alvarez VA, 2007, ANNU REV NEUROSCI, V30, P79, DOI 10.1146/annurev.neuro.30.051606.094222; Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Arn EA, 2003, DEV CELL, V4, P41, DOI 10.1016/S1534-5807(02)00397-0; Bag J, 1996, EUR J BIOCHEM, V237, P143, DOI 10.1111/j.1432-1033.1996.0143n.x; Barbee SA, 2006, NEURON, V52, P997, DOI 10.1016/j.neuron.2006.10.028; Baron-Benhamou Julie, 2004, Methods Mol Biol, V257, P135, DOI 10.1385/1-59259-750-5:135; Blichenberg A, 1999, J NEUROSCI, V19, P8818, DOI 10.1523/JNEUROSCI.19-20-08818.1999; Bramham CR, 2007, NAT REV NEUROSCI, V8, P776, DOI 10.1038/nrn2150; Brendel C, 2004, BIOCHEM J, V384, P239, DOI 10.1042/BJ20040812; Cajigas IJ, 2010, EMBO J, V29, P2746, DOI 10.1038/emboj.2010.173; Craig AWB, 1998, NATURE, V392, P520, DOI 10.1038/33198; Donnelly CJ, 2010, TRAFFIC, V11, P1498, DOI 10.1111/j.1600-0854.2010.01118.x; DRAGUNOW M, 1989, NEUROSCI LETT, V101, P274, DOI 10.1016/0304-3940(89)90545-4; Ezzeddine N, 2007, MOL CELL BIOL, V27, P7791, DOI 10.1128/MCB.01254-07; FRANKLIN NC, 1985, J MOL BIOL, V181, P75, DOI 10.1016/0022-2836(85)90325-0; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Gray TA, 2000, GENOMICS, V66, P76, DOI 10.1006/geno.2000.6199; Gray TA, 2006, P NATL ACAD SCI USA, V103, P12039, DOI 10.1073/pnas.0602216103; Grosset C, 2000, CELL, V103, P29, DOI 10.1016/S0092-8674(00)00102-1; Hirokawa N, 2006, J NEUROSCI, V26, P7139, DOI 10.1523/JNEUROSCI.1821-06.2006; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Kahvejian A, 2001, COLD SPRING HARB SYM, V66, P293, DOI 10.1101/sqb.2001.66.293; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Karim MM, 2006, P NATL ACAD SCI USA, V103, P9494, DOI 10.1073/pnas.0603701103; Khaleghpour K, 2001, MOL CELL BIOL, V21, P5200, DOI 10.1128/MCB.21.15.5200-5213.2001; Kim JH, 2005, GENE DEV, V19, P776, DOI 10.1101/gad.1289405; Kozlov G, 2001, P NATL ACAD SCI USA, V98, P4409, DOI 10.1073/pnas.071024998; Kozlov G, 2004, EMBO J, V23, P272, DOI 10.1038/sj.emboj.7600048; Kozlov G, 2010, J BIOL CHEM, V285, P13599, DOI 10.1074/jbc.M109.089540; Krichevsky AM, 2001, NEURON, V32, P683, DOI 10.1016/S0896-6273(01)00508-6; Kulkarni SD, 2011, J BIOL CHEM, V286, P14146, DOI 10.1074/jbc.M110.190553; Laity JH, 2001, CURR OPIN STRUC BIOL, V11, P39, DOI 10.1016/S0959-440X(00)00167-6; Lee EW, 2009, EMBO J, V28, P2100, DOI 10.1038/emboj.2009.164; Lehner B, 2004, GENOME RES, V14, P1315, DOI 10.1101/gr.2122004; Liang J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002880; Lin AC, 2007, EMBO J, V26, P3729, DOI 10.1038/sj.emboj.7601808; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; Martin KC, 2006, J NEUROSCI, V26, P7131, DOI 10.1523/JNEUROSCI.1801-06.2006; MOHR E, 1995, P NATL ACAD SCI USA, V92, P4377, DOI 10.1073/pnas.92.10.4377; Mohr E, 2004, J NEUROENDOCRINOL, V16, P333, DOI 10.1111/j.0953-8194.2004.01176.x; Mohr E, 2001, P NATL ACAD SCI USA, V98, P7072, DOI 10.1073/pnas.111146598; Naarmann IS, 2010, RNA, V16, P2189, DOI 10.1261/rna.2211110; Naisbitt S, 1999, NEURON, V23, P569, DOI 10.1016/S0896-6273(00)80809-0; Nelson MR, 2007, J BIOL CHEM, V282, P34031, DOI 10.1074/jbc.M706363200; NETO OPD, 1995, NUCLEIC ACIDS RES, V23, P2198, DOI 10.1093/nar/23.12.2198; Nielsen J, 1999, MOL CELL BIOL, V19, P1262; Omwancha J, 2006, ENDOCRINE, V29, P363, DOI 10.1385/ENDO:29:2:363; Patel GP, 2006, FEBS J, V273, P5678, DOI 10.1111/j.1742-4658.2006.05556.x; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Richter JD, 2010, BIOCHEM SOC T, V38, P1527, DOI 10.1042/BST0381527; Roy G, 2002, MOL CELL BIOL, V22, P3769, DOI 10.1128/MCB.22.11.3769-3782.2002; Schutt J, 2009, J BIOL CHEM, V284, P25479, DOI 10.1074/jbc.M109.042663; Schuman EM, 2006, J NEUROSCI, V26, P7143, DOI 10.1523/JNEUROSCI.1796-06.2006; Schwarzacher SW, 2006, GLIA, V53, P704, DOI 10.1002/glia.20329; Skabkina OV, 2003, J BIOL CHEM, V278, P18191, DOI 10.1074/jbc.M209073200; Sossin WS, 2006, TRAFFIC, V7, P1581, DOI 10.1111/j.1600-0854.2006.00500.x; Steward O, 1999, J NEUROSCI, V19, P7834; STEWARD O, 1976, SCIENCE, V194, P426, DOI 10.1126/science.982024; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014; Zekri L, 2009, MOL CELL BIOL, V29, P6220, DOI 10.1128/MCB.01081-09; Zhong J, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-17	64	23	23	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1322	1334		10.1074/jbc.M111.315291	http://dx.doi.org/10.1074/jbc.M111.315291			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22128154	Green Published, hybrid			2022-12-27	WOS:000299170300047
J	Chatterjee, M; Hedrich, CM; Rauen, T; Ioannidis, C; Terhorst, C; Tsokos, GC				Chatterjee, Madhumouli; Hedrich, Christian M.; Rauen, Thomas; Ioannidis, Christina; Terhorst, Cox; Tsokos, George C.			CD3-T Cell Receptor Co-stimulation through SLAMF3 and SLAMF6 Receptors Enhances ROR gamma t Recruitment to the IL17A Promoter in Human T Lymphocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; EFFECTOR FUNCTIONS; NFAT; TH17; DIFFERENTIATION; SAP; DISEASE; IL-17; ACTIVATION; MECHANISMS	Th17 lymphocytes play a key role during immune responses against bacteria and fungi and are involved in the pathophysiology of multiple autoimmune disorders. The co-stimulatory molecules SLAMF3 and SLAMF6 have been implicated in the formation of Th17 phenotypes and IL-17A expression. Increased surface expression of SLAMF3 and SLAMF6 has been linked with disease activity in systemic lupus erythematosus. Here we demonstrate that in human total T lymphocytes the canonical CD28 and the non-canonical SLAMF3/SLAMF6 co-stimulatory pathways cooperate in the recruitment of the transcription factor NFAT1 to the IL17A promoter. Furthermore, the dominance of the SLAMF3/SLAMF6 pathway in inducing IL-17A production can be attributed to an increased nuclear abundance and recruitment of ROR gamma t to the IL17A promoter. Thus, we have identified an additional mechanism that may be central for the specific control of IL17A gene regulation in systemic lupus erythematosus T lymphocytes.	[Chatterjee, Madhumouli; Hedrich, Christian M.; Rauen, Thomas; Ioannidis, Christina; Tsokos, George C.] Harvard Univ, Beth Israel Deaconess Med Ctr, Div Rheumatol, Sch Med, Boston, MA 02215 USA; [Terhorst, Cox] Harvard Univ, Beth Israel Deaconess Med Ctr, Dept Med, Div Immunol,Med Sch, Boston, MA 02215 USA; [Rauen, Thomas] Rheinisch Westfael Tech Hsch Aachen Univ, Dept Nephrol & Clin Immunol, D-52056 Aachen, Germany	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; RWTH Aachen University	Tsokos, GC (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Div Rheumatol, Sch Med, Boston, MA 02215 USA.	gtsokos@bidmc.harvard.edu	tsokos, george C/O-3360-2013; Szczesny, Bartosz/D-1026-2012; BANERJEE, DIBYENDU/C-6656-2012; Rauen, Thomas/GLR-8682-2022; Chatterjee, Arpita/GPS-9141-2022; Hedrich, Christian/AAD-6855-2019; Hedrich, Christian/AAW-3958-2020; Banerjee, Dibyendu/Y-4652-2019; Mandal, Santi M./AAF-7156-2020	tsokos, george C/0000-0001-9589-2360; Banerjee, Dibyendu/0000-0003-4244-9714; Hedrich, Christian/0000-0002-1295-6179; Hegde, Muralidhar/0000-0001-7333-8123; Gustafsson, Claes/0000-0003-3531-8468; Dixit, Pavana/0000-0003-0811-3942	National Institutes of Health [R01 AI49954, P01 AI065687]; Deutsche Forschungsgemeinschaft [RA1927-1/1]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AI49954 and P01 AI065687. This work was also supported by Deutsche Forschungsgemeinschaft Grant RA1927-1/1 (to T. R.).	Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Calpe S, 2008, ADV IMMUNOL, V97, P177, DOI 10.1016/S0065-2776(08)00004-7; Chatterjee M, 2012, J IMMUNOL, V188, P1206, DOI 10.4049/jimmunol.1102773; Chatterjee M, 2011, AUTOIMMUNITY, V44, P211, DOI 10.3109/08916934.2010.530627; Cippa PE, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.38; Collins M, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-6-223; Crispin JC, 2008, J IMMUNOL, V181, P8761, DOI 10.4049/jimmunol.181.12.8761; Detre C, 2010, SEMIN IMMUNOPATHOL, V32, P157, DOI 10.1007/s00281-009-0193-0; Dong C, 2011, EXP MOL MED, V43, P1, DOI 10.3858/emm.2011.43.1.007; Garrett-Sinha LA, 2008, CURR OPIN RHEUMATOL, V20, P519, DOI 10.1097/BOR.0b013e328304b6b5; Graef IA, 2001, CURR OPIN GENET DEV, V11, P505, DOI 10.1016/S0959-437X(00)00225-2; Graham DB, 2006, J IMMUNOL, V176, P291, DOI 10.4049/jimmunol.176.1.291; Henning G, 2001, EUR J IMMUNOL, V31, P2741, DOI 10.1002/1521-4141(200109)31:9<2741::AID-IMMU2741>3.0.CO;2-6; Hermann-Kleiter N, 2010, BLOOD, V115, P2989, DOI 10.1182/blood-2009-10-233585; Howie D, 2002, BLOOD, V100, P2899, DOI 10.1182/blood-2002-02-0445; Howie D, 2005, J IMMUNOL, V174, P5931, DOI 10.4049/jimmunol.174.10.5931; Kayama H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000514; Li HM, 2011, TRENDS CELL BIOL, V21, P91, DOI 10.1016/j.tcb.2010.09.011; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; LUCAS PJ, 1995, J IMMUNOL, V154, P5757; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Rauen T, 2012, GENES IMMUN, V13, P346, DOI 10.1038/gene.2011.85; Rauen T, 2011, J BIOL CHEM, V286, P43437, DOI 10.1074/jbc.M111.299313; Rudensky AY, 2006, CELL, V126, P253, DOI 10.1016/j.cell.2006.07.005; SHAHINIAN A, 1993, SCIENCE, V261, P609, DOI 10.1126/science.7688139; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; Shen F, 2006, J BIOL CHEM, V281, P24138, DOI 10.1074/jbc.M604597200; Solt LA, 2011, NATURE, V472, P491, DOI 10.1038/nature10075; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; Sundrud MS, 2007, CURR OPIN IMMUNOL, V19, P287, DOI 10.1016/j.coi.2007.04.014; Tsokos GC, 2011, NEW ENGL J MED, V365, P2110, DOI 10.1056/NEJMra1100359; Valdez PA, 2004, J BIOL CHEM, V279, P18662, DOI 10.1074/jbc.M312313200; Veillette A, 2002, ANNU REV IMMUNOL, V20, P669, DOI 10.1146/annurev.immunol.20.081501.130710; Veillette A, 2007, IMMUNITY, V27, P698, DOI 10.1016/j.immuni.2007.11.005; Wilke CM, 2011, TRENDS IMMUNOL, V32, P603, DOI 10.1016/j.it.2011.08.003; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016	36	84	88	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.415067	http://dx.doi.org/10.1074/jbc.M112.415067			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22130663	hybrid, Green Published			2022-12-27	WOS:000310642200050
J	Mandal, SM; Hegde, ML; Chatterjee, A; Hegde, PM; Szczesny, B; Banerjee, D; Boldogh, I; Gao, R; Falkenberg, M; Gustafsson, CM; Sarkar, PS; Hazra, TK				Mandal, Santi M.; Hegde, Muralidhar L.; Chatterjee, Arpita; Hegde, Pavana M.; Szczesny, Bartosz; Banerjee, Dibyendu; Boldogh, Istvan; Gao, Rui; Falkenberg, Maria; Gustafsson, Claes M.; Sarkar, Partha S.; Hazra, Tapas K.			Role of Human DNA Glycosylase Nei-like 2 (NEIL2) and Single Strand Break Repair Protein Polynucleotide Kinase 3 '-Phosphatase in Maintenance of Mitochondrial Genome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE EXCISION-REPAIR; MAMMALIAN-CELLS; OXIDATIVE DAMAGE; OXIDIZED BASES; TRANSCRIPTION FACTORS; IN-VITRO; KAPPA-B; NUCLEAR; IDENTIFICATION; GENE	The repair of reactive oxygen species-induced base lesions and single strand breaks (SSBs) in the nuclear genome via the base excision (BER) and SSB repair (SSBR) pathways, respectively, is well characterize, and important for maintaining genomic integrity. However, the role of mitochondrial (mt) BER and SSBR proteins in mt genome maintenance is not completely clear. Here we show the presence of the oxidized base-specific DNA glycosylase Nei-like 2 (NEIL2) and the DNA end-processing enzyme polynucleotide kinase 3'-phosphatase (PNKP) in purified human mitochondrial extracts (MEs). Confocal microscopy revealed co-localization of PNKP and NEIL2 with the mitochondrion-specific protein cytochrome c oxidase subunit 2 (MT-CO2). Further, chromatin immunoprecipitation analysis showed association of NEIL2 and PNKP with the mitochondrial genes MT-CO2 and MT-CO3 (cytochrome c oxidase subunit 3); importantly, both enzymes also associated with the mitochondrion-specific DNA polymerase gamma. In cell association of NEIL2 and PNKP with polymerase gamma was further confirmed by proximity ligation assays. PNKP-depleted ME showed a significant decrease in both BER and SSBR activities, and PNKP was found to be the major 3'-phosphatase in human ME. Furthermore, individual depletion of NEIL2 and PNKP in human HEK293 cells caused increased levels of oxidized bases and SSBs in the mt genome, respectively. Taken together, these studies demonstrate the critical role of NEIL2 and PNKP in maintenance of the mammalian mitochondrial genome.	[Hazra, Tapas K.] Univ Texas Med Branch, Div Pulm & Crit Care Med, Sealy Ctr Mol Med, Dept Internal Med, Galveston, TX 77555 USA; [Hegde, Muralidhar L.; Hegde, Pavana M.; Szczesny, Bartosz; Banerjee, Dibyendu; Hazra, Tapas K.] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Boldogh, Istvan] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Gao, Rui; Sarkar, Partha S.] Univ Texas Med Branch, Dept Neurol & Neurosci & Cell Biol, Galveston, TX 77555 USA; [Falkenberg, Maria; Gustafsson, Claes M.] Univ Gothenburg, Inst Biomed, SE-40530 Gothenburg, Sweden	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Gothenburg	Hazra, TK (corresponding author), Univ Texas Med Branch, Div Pulm & Crit Care Med, Sealy Ctr Mol Med, Dept Internal Med, 6-136 Med Res Bldg,Route 1079, Galveston, TX 77555 USA.	tkhazra@utmb.edu	tsokos, george C/O-3360-2013; Szczesny, Bartosz/D-1026-2012; BANERJEE, DIBYENDU/C-6656-2012; Rauen, Thomas/GLR-8682-2022; Chatterjee, Arpita/GPS-9141-2022; Hedrich, Christian/AAD-6855-2019; Hedrich, Christian/AAW-3958-2020; Banerjee, Dibyendu/Y-4652-2019; Mandal, Santi M./AAF-7156-2020	tsokos, george C/0000-0001-9589-2360; Banerjee, Dibyendu/0000-0003-4244-9714; Hedrich, Christian/0000-0002-1295-6179; Hegde, Muralidhar/0000-0001-7333-8123; Gustafsson, Claes/0000-0003-3531-8468; Dixit, Pavana/0000-0003-0811-3942	National Institutes of Health from the USPHS [CA102271, ES017353, CA81063, ES018948]	National Institutes of Health from the USPHS	This work was supported, in whole or in part, by National Institutes of Health Grants CA102271 and ES017353 (to T. K. H.), CA81063 (to S. M. M.), and ES018948 (to I. B.) from the USPHS.	Banerjee D, 2011, J BIOL CHEM, V286, P6006, DOI 10.1074/jbc.M110.198796; BARRY MA, 1993, ARCH BIOCHEM BIOPHYS, V300, P440, DOI 10.1006/abbi.1993.1060; Bohr VA, 2002, FREE RADICAL BIO MED, V32, P804, DOI 10.1016/S0891-5849(02)00787-6; Bolender N, 2008, EMBO REP, V9, P42, DOI 10.1038/sj.embor.7401126; Bottero V, 2001, J BIOL CHEM, V276, P21317, DOI 10.1074/jbc.M005850200; BREEN AP, 1995, FREE RADICAL BIO MED, V18, P1033, DOI 10.1016/0891-5849(94)00209-3; Cadet JL, 1998, NEUROCHEM INT, V32, P117, DOI 10.1016/S0197-0186(97)00031-4; Caldecott KW, 2008, NAT REV GENET, V9, P619, DOI 10.1038/nrg2380; Caldecott KW, 2001, BIOESSAYS, V23, P447, DOI 10.1002/bies.1063; Chattopadhyay R, 2006, NUCLEIC ACIDS RES, V34, P2067, DOI 10.1093/nar/gkl177; Copeland WC, 2010, METHODS, V51, P363, DOI 10.1016/j.ymeth.2010.07.008; Das A, 2006, DNA REPAIR, V5, P1439, DOI 10.1016/j.dnarep.2006.07.003; Das BB, 2010, P NATL ACAD SCI USA, V107, P19790, DOI 10.1073/pnas.1009814107; Das S, 2007, J BIOL CHEM, V282, P28474, DOI 10.1074/jbc.M704672200; Date H, 2001, NAT GENET, V29, P184, DOI 10.1038/ng1001-184; De Bosscher K, 2003, ENDOCR REV, V24, P488, DOI 10.1210/er.2002-0006; de Souza-Pinto NC, 2008, DNA REPAIR, V7, P1098, DOI 10.1016/j.dnarep.2008.03.011; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; DODSON ML, 1994, J BIOL CHEM, V269, P32709; Dou H, 2003, J BIOL CHEM, V278, P49679, DOI 10.1074/jbc.M308658200; Dou H, 2008, J BIOL CHEM, V283, P3130, DOI 10.1074/jbc.M709186200; Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909; Fredriksson S, 2002, NAT BIOTECHNOL, V20, P473, DOI 10.1038/nbt0502-473; GILONI L, 1981, J BIOL CHEM, V256, P8608; Gordon DM, 2001, BIOCHEM J, V356, P207, DOI 10.1042/0264-6021:3560207; Hazra IK, 1998, NUCLEIC ACIDS RES, V26, P5116, DOI 10.1093/nar/26.22.5116; Hazra TK, 2002, J BIOL CHEM, V277, P30417, DOI 10.1074/jbc.C200355200; Hegde ML, 2008, CELL RES, V18, P27, DOI 10.1038/cr.2008.8; Hegde ML, 2010, J BIOL CHEM, V285, P28812, DOI 10.1074/jbc.M110.126664; HENNER WD, 1983, J BIOL CHEM, V258, P5198; Hu JP, 2005, J BIOL CHEM, V280, P40544, DOI 10.1074/jbc.M508772200; Jilani A, 1999, J BIOL CHEM, V274, P24176, DOI 10.1074/jbc.274.34.24176; Johansson H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013678; Kaneko M, 1998, TOXICOL LETT, V99, P15, DOI 10.1016/S0378-4274(98)00132-5; Karimi-Busheri F, 1999, J BIOL CHEM, V274, P24187, DOI 10.1074/jbc.274.34.24187; Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257; Kumar D, 2009, J BIOL CHEM, V284, P1853, DOI 10.1074/jbc.M806289200; Longley MJ, 1998, P NATL ACAD SCI USA, V95, P12244, DOI 10.1073/pnas.95.21.12244; Mandavilli BS, 2002, MUTAT RES-FUND MOL M, V509, P127, DOI 10.1016/S0027-5107(02)00220-8; Marchenko ND, 2000, J BIOL CHEM, V275, P16202, DOI 10.1074/jbc.275.21.16202; Mitra S, 2002, FREE RADICAL BIO MED, V33, P15, DOI 10.1016/S0891-5849(02)00819-5; Moreira MC, 2001, NAT GENET, V29, P189, DOI 10.1038/ng1001-189; Patrick ME, 2004, EMERG INFECT DIS, V10, P1; Pohjanpelto P, 1996, EMBO J, V15, P1193, DOI 10.1002/j.1460-2075.1996.tb00458.x; Psarra AMG, 2008, BBA-MOL CELL RES, V1783, P1, DOI 10.1016/j.bbamcr.2007.10.021; RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465; Santos Janine H, 2006, Methods Mol Biol, V314, P183; Scovassi AI, 2004, FASEB J, V18, P1487, DOI 10.1096/fj.04-1841rev; Shen J, 2010, NAT GENET, V42, P245, DOI 10.1038/ng.526; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Stucki M, 1998, ONCOGENE, V17, P835, DOI 10.1038/sj.onc.1202001; Sykora P, 2011, P NATL ACAD SCI USA, V108, P7437, DOI 10.1073/pnas.1100084108; Szczesny B, 2008, J BIOL CHEM, V283, P26349, DOI 10.1074/jbc.M803491200; Takashima H, 2002, NAT GENET, V32, P267, DOI 10.1038/ng987; Taylor RM, 2000, NUCLEIC ACIDS RES, V28, P3558, DOI 10.1093/nar/28.18.3558; Wallace Douglas C, 2002, Methods Mol Biol, V197, P3, DOI 10.1385/1-59259-284-8:003; Wang HX, 2003, J BIOL CHEM, V278, P28686, DOI 10.1074/jbc.M302844200; Weinfeld M, 2011, TRENDS BIOCHEM SCI, V36, P262, DOI 10.1016/j.tibs.2011.01.006; Whitehouse CJ, 2001, CELL, V104, P107, DOI 10.1016/S0092-8674(01)00195-7; Wiederhold L, 2004, MOL CELL, V15, P209, DOI 10.1016/j.molcel.2004.06.003; Zheng L, 2008, MOL CELL, V32, P325, DOI 10.1016/j.molcel.2008.09.024	62	84	88	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2819	2829		10.1074/jbc.M111.272179	http://dx.doi.org/10.1074/jbc.M111.272179			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22130663	hybrid, Green Published			2022-12-27	WOS:000300292300053
